setName	@SYSTEMATIC_NAME	@HISTORICAL_NAMES	@PMID	@AUTHORS	@GEOID	@EXACT_SOURCE	@GENESET_LISTING_URL	@EXTERNAL_DETAILS_URL	@CHIP	@CONTRIBUTOR	@CONTRIBUTOR_ORG	@DESCRIPTION_BRIEF	@DESCRIPTION_FULL	@TAGS	@FOUNDER_NAMES	@REFINEMENT_DATASETS	@VALIDATION_DATASETS	genes
GSE10325_CD4_TCELL_VS_BCELL_UP	M3076		18275831	Hutcheson J,Scatizzi JC,Siddiqui AM,Haines GK 3rd,Wu T,Li QZ,Davis LS,Mohan C,Perlman H	GSE10325	GSE10325_1069_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of healthy CD4 [GeneID=920] T cells versus healthy CD19 [GeneID=920] B cells. 	Gene expression profile studies have identified an interferon signature in whole blood or mononuclear cell samples from patients with systemic lupus erythematosus. This study was designed to determine whether specific lymphocyte and myeloid subsets freshly isolated from the blood of systemic lupus erythematosus patients demonstrated unique gene expression profiles compared to subsets isolated from healthy controls.					728855	51125	5025	11059	664	3590	642	8445	54462	5775	55336	3560	54910	155066	26010	28517	1803	3482	6777	9645	56548	4494	4068	23348	406	7049	2289	2533	5140	11320	4501	80335	360	5732	6095	3587	23059	7378	5292	51474	1849	2625	83988	3655	476	4094	6275	9759	9363	5295	10140	1263	5578	64781	51393	51070	445347	1154	8740	1806	493	23102	28683	9749	90	3631	8519	373156	23043	1534	6840	8277	940	55188	10133	25939	5829	6955	138151	1786	5567	10311	256987	53347	896	29851	5588	6404	408	10791	10123	64116	9882	9047	944	28955	7074	3964	1362	5551	5144	3001	7076	26119	8743	26289	3398	9692	7535	7431	2534	64919	64400	729230	3275	10947	28584	2776	5920	5335	894	55423	919	6775	4118	8835	9452	1234	1039	10161	79188	26034	7128	9204	161291	27018	3820	2040	5583	23171	8718	8725	57194	801	2323	3248	914	3003	9948	6001	474344	55340	51176	3945	6197	10219	5334	5552	25809	917	923	123	10125	28984	8631	9368	55303	1540	6812	5783	4603	114908	113791	4753	3702	2273	23484	7294	9781	127703	399665	3932	10507	861	7464	28639	50852	301	9814	11179	4300	6352	26018	321	3707	818	22848	5305	11123	7001
GSE10325_CD4_TCELL_VS_BCELL_DN	M3077		18275831	Hutcheson J,Scatizzi JC,Siddiqui AM,Haines GK 3rd,Wu T,Li QZ,Davis LS,Mohan C,Perlman H	GSE10325	GSE10325_1069_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of healthy CD4 [GeneID=920] T cells versus healthy CD19 [GeneID=920] B cells. 	Gene expression profile studies have identified an interferon signature in whole blood or mononuclear cell samples from patients with systemic lupus erythematosus. This study was designed to determine whether specific lymphocyte and myeloid subsets freshly isolated from the blood of systemic lupus erythematosus patients demonstrated unique gene expression profiles compared to subsets isolated from healthy controls.					26228	10099	931	10409	654817	3119	9124	6929	3112	3495	3087	5368	3109	1380	6039	3394	933	29760	9450	974	8115	2788	9873	6472	9308	8531	100133941	132	6689	5450	29064	28902	3115	652493	4208	7462	5079	973	240	3108	57228	5336	930	3512	55278	23231	23158	80183	96610	79651	55840	23268	29802	27075	2213	23596	79600	91353	55024	85236	53838	4067	3117	8728	11346	3460	6925	3507	51237	79656	695	79874	4345	23564	971	84617	100293440	25840	28823	4033	911	3725	26040	4005	28908	643	3128	4064	8798	1185	8724	23075	4066	91316	2208	1536	3493	10734	7088	8417	605	5026	28797	53335	25932	51363	9734	3123	912	5218	5244	9056	5796	30845	3514	8564	4261	23220	3663	3535	10184	9834	5993	3122	11142	5101	79368	55526	7163	54920	55638	2760	10447	3113	10451	55016	10603	9215	63910	10863	9103	9447	83478	93129	22800	3662	9788	949	28831	55114	25780	26037	54145	7942	22898	59342	5777	51296	23433	9779	23199	8914	958	773	3915	6850	3995	4048	23062	11262	114884	2683	8935	4082	30833	23221	57553	83637	57205	51284	9674	54438	51316	50862	22906	8936	953	100290557	81571	7461	9144	1690	27314	11182	9020	640	79666	307	4205	5579
GSE10325_CD4_TCELL_VS_MYELOID_UP	M3078		18275831	Hutcheson J,Scatizzi JC,Siddiqui AM,Haines GK 3rd,Wu T,Li QZ,Davis LS,Mohan C,Perlman H	GSE10325	GSE10325_1070_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of healthy CD4 [GeneID=920] T cells versus healthy myeloid cells.	Gene expression profile studies have identified an interferon signature in whole blood or mononuclear cell samples from patients with systemic lupus erythematosus. This study was designed to determine whether specific lymphocyte and myeloid subsets freshly isolated from the blood of systemic lupus erythematosus patients demonstrated unique gene expression profiles compared to subsets isolated from healthy controls.					50852	9404	4753	55423	8718	4068	2323	940	28517	53347	26119	923	4118	1039	3655	5588	7535	64400	360	5775	5335	6775	28984	80335	2625	25996	64919	56271	914	3312	9814	51321	10947	28955	113791	5583	29909	8821	5292	79652	57134	23310	56950	1154	79961	51176	9882	917	25842	8445	23059	1803	3702	54462	55340	6955	728855	23348	4054	26018	3337	54674	8607	23224	8717	3820	10666	642	91298	9663	3707	10123	8504	64116	58473	51070	8631	919	387751	5778	3097	1606	10314	6095	9806	23177	57326	6647	4603	9249	55843	8611	10516	6932	1901	2882	23522	9235	10225	10575	3590	8835	3932	6304	23588	5920	28683	9781	3560	80146	64425	6636	23345	8464	23344	7185	399665	10771	9531	83988	9840	321	2026	9184	56985	9725	10223	9452	7597	3945	51466	9363	29851	7175	5901	10133	5295	3163	5578	375449	6118	4094	28755	4300	596	7049	4436	6935	28584	94081	28990	7294	10929	622	10055	1786	4925	57125	26249	9813	10884	10000	900	57473	1540	9240	8883	26156	915	894	51335	230	23043	613	3003	10868	29121	155066	114932	8440	3796	23484	26355	11320	55325	5279	8277	288	56683	79722	2272	26240	221061	56731	4609	55718	7580	6767	5900	55795
GSE10325_CD4_TCELL_VS_MYELOID_DN	M3079		18275831	Hutcheson J,Scatizzi JC,Siddiqui AM,Haines GK 3rd,Wu T,Li QZ,Davis LS,Mohan C,Perlman H	GSE10325	GSE10325_1070_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of healthy CD4 [GeneID=920] T cells versus healthy myeloid cells.	Gene expression profile studies have identified an interferon signature in whole blood or mononuclear cell samples from patients with systemic lupus erythematosus. This study was designed to determine whether specific lymphocyte and myeloid subsets freshly isolated from the blood of systemic lupus erythematosus patients demonstrated unique gene expression profiles compared to subsets isolated from healthy controls.					9450	654817	10409	911	4208	3087	3109	6850	3394	8942	240	9805	6039	3115	51284	59342	5336	7462	4067	3108	8935	11182	22898	23433	84617	3460	695	25840	8531	1439	8564	4066	863	23596	5341	11031	1536	953	1512	3123	3310	55016	51092	3383	8507	5654	54438	81553	7453	1130	604	3663	4082	133	942	29887	3128	3113	10184	10170	9846	2760	23603	5023	157	8682	10154	51363	1608	51296	22895	6821	54508	4005	8417	4689	4048	10221	366	5606	10437	23158	3119	55625	6692	90362	535	25932	1495	11165	3120	79651	949	334	912	55840	64759	1955	3779	7380	4794	80896	2268	114885	11240	9185	4853	71	7106	5664	22906	64419	11025	57205	2212	6539	81609	8099	6556	50862	3055	3687	2934	63910	2509	29015	27287	10333	7746	55577	3149	54453	55704	1028	8876	54502	4481	1184	9123	10903	1026	4615	9315	5547	5742	1051	1545	136	2210	9896	3281	307	9473	5580	6051	1230	7100	1912	2650	1488	93129	1318	3074	6452	81570	6303	5997	64170	140885	58985	10981	8741	55969	8031	29940	4778	30817	1298	92689	11027	64581	53829	54997	51177	3579	3597	79641	23475	3684	4035	9853	9056	5329	10875	8291	5176	4947	1436	6256	217
GSE10325_BCELL_VS_MYELOID_UP	M3081		18275831	Hutcheson J,Scatizzi JC,Siddiqui AM,Haines GK 3rd,Wu T,Li QZ,Davis LS,Mohan C,Perlman H	GSE10325	GSE10325_1071_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of healthy B cells versus healthy myeloid cells.	Gene expression profile studies have identified an interferon signature in whole blood or mononuclear cell samples from patients with systemic lupus erythematosus. This study was designed to determine whether specific lymphocyte and myeloid subsets freshly isolated from the blood of systemic lupus erythematosus patients demonstrated unique gene expression profiles compared to subsets isolated from healthy controls.					7423	30833	56242	1901	28823	8940	28908	79656	3112	26228	387751	9263	4050	3535	973	27429	9124	25865	8607	8728	11040	3514	3669	3507	22800	5019	26051	5450	91316	975	100133941	11262	3512	388650	6480	5631	11224	931	1380	29802	28902	6504	933	84159	29064	91353	5079	3495	23231	11184	8115	9214	29760	489	51466	399	930	142	6689	3399	652493	596	5567	5557	55718	6929	3983	22882	29914	7163	51611	26053	5026	10099	2788	10681	81606	57228	100505761	7188	617	5790	96610	2841	27075	93144	118	100293440	23157	3376	2208	643	4799	81558	29107	4345	6119	55024	60468	55422	5287	471	6711	8440	605	231	4171	26040	8798	9674	54663	79161	5368	2744	6128	55278	51237	6118	57553	4063	971	5142	1939	4927	23344	3710	11161	166	53335	64219	1236	8906	939	974	27342	6468	6141	23318	10447	3695	9500	81539	9744	3921	8936	165	23468	9925	1235	54847	5603	80169	79368	28951	25780	4221	55840	79600	5244	11142	330	11346	56950	2971	3978	80212	2091	80008	81932	55790	1832	23588	440	3566	55638	7088	3603	55679	23062	6472	57819	63926	25873	9567	5101	9779	56985	8631	55592	28831	23224	7430	4953	9215	30845	10133	23338	10125	81618	5796
GSE10325_BCELL_VS_MYELOID_DN	M3082		18275831	Hutcheson J,Scatizzi JC,Siddiqui AM,Haines GK 3rd,Wu T,Li QZ,Davis LS,Mohan C,Perlman H	GSE10325	GSE10325_1071_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of healthy B cells versus healthy myeloid cells.	Gene expression profile studies have identified an interferon signature in whole blood or mononuclear cell samples from patients with systemic lupus erythematosus. This study was designed to determine whether specific lymphocyte and myeloid subsets freshly isolated from the blood of systemic lupus erythematosus patients demonstrated unique gene expression profiles compared to subsets isolated from healthy controls.					5654	71	3383	133	29015	1912	5476	84658	11314	9846	8876	1488	729230	80896	7100	6398	10875	9473	4668	54453	1028	4615	1955	6556	2210	4542	1545	55969	6916	1318	81609	3579	9935	7086	5739	4778	22895	8638	30817	1508	1230	136	313	366	64581	8536	114876	58528	11027	2203	140885	6256	51744	728	25797	53829	11000	2212	115207	6934	834	55704	2217	23475	6275	9314	9854	9332	114548	10981	3958	11024	2205	10261	1514	1843	1234	57476	55819	53346	637	4688	4354	5329	217	1839	10313	2015	5265	9056	1848	22918	9645	6303	11251	3957	10462	3920	1052	83716	719	4610	64170	10903	64231	5223	55711	644	79641	7097	55048	3101	2509	51734	56935	3281	8741	10019	9997	7133	9936	29992	8794	3386	5199	64127	55332	54997	5165	1051	81603	11026	56905	4005	55625	23191	1612	50856	645	7127	5873	51280	5660	943	23406	6821	10288	3557	3162	1240	9764	2769	5058	3613	8522	3074	1193	57161	11025	5580	2357	5791	1362	79887	5997	23654	7045	200315	199	1475	6817	10170	2799	7940	27235	138151	79901	1050	11138	27287	1436	4947	2581	51816	7867	432	6051	2353	54504	3779	978	23328	8099	308	1675	22921	5552	27163	91860	23129
GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_UP	M3084		18275831	Hutcheson J,Scatizzi JC,Siddiqui AM,Haines GK 3rd,Wu T,Li QZ,Davis LS,Mohan C,Perlman H	GSE10325	GSE10325_1072_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of systemic lupus erythematosus CD4 [GeneID=920] T cells versus systemic lupus erythematosus B cells.	Gene expression profile studies have identified an interferon signature in whole blood or mononuclear cell samples from patients with systemic lupus erythematosus. This study was designed to determine whether specific lymphocyte and myeloid subsets freshly isolated from the blood of systemic lupus erythematosus patients demonstrated unique gene expression profiles compared to subsets isolated from healthy controls.					56548	920	7074	9531	1803	2272	4300	57134	10947	28683	29851	4118	55336	4094	399665	940	493	7378	9882	6777	10161	6955	27018	23348	5578	55340	406	23059	8718	6840	9452	10223	5588	3937	9663	373156	81619	51696	23484	3337	28517	2776	917	3098	53347	5334	6932	5335	28755	155066	2625	64919	7867	1154	375449	8821	9840	80146	5937	6001	28639	3572	256987	5829	919	2054	1540	9781	79991	7535	914	80024	64400	8631	5292	26034	51070	79697	9797	2533	10397	7076	9235	50852	58473	11059	1534	51531	221061	3932	376267	923	2273	10133	10507	9706	79722	2534	11041	6647	1606	476	10123	7293	87	9759	1263	10626	84830	92595	51176	3097	5125	3305	55013	113791	9249	29909	9806	23043	7294	23174	2053	9047	55700	7754	54462	1493	23046	54463	2015	3702	51125	6404	916	944	9363	3655	57194	5583	3820	915	4222	4753	3575	54981	301	64781	26119	79695	3945	51474	7597	10516	3707	54910	2531	9445	994	474344	23102	1389	9764	5920	4242	921	8573	1786	51735	10291	861	55423	5732	59307	3590	55303	90	161291	9204	10000	6775	79414	11320	5775	54942	57326	9535	79188	10868	1039	4798	5295	8717	1362	26018	4501	814	51271	321	7360
GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_DN	M3085		18275831	Hutcheson J,Scatizzi JC,Siddiqui AM,Haines GK 3rd,Wu T,Li QZ,Davis LS,Mohan C,Perlman H	GSE10325	GSE10325_1072_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of systemic lupus erythematosus CD4 [GeneID=920] T cells versus systemic lupus erythematosus B cells.	Gene expression profile studies have identified an interferon signature in whole blood or mononuclear cell samples from patients with systemic lupus erythematosus. This study was designed to determine whether specific lymphocyte and myeloid subsets freshly isolated from the blood of systemic lupus erythematosus patients demonstrated unique gene expression profiles compared to subsets isolated from healthy controls.					695	3507	3514	9834	4208	29760	3535	6850	91353	6925	28902	5368	28823	3128	100293440	4067	55024	2213	3108	3122	972	930	5336	3123	931	10409	5079	91316	654817	23158	652493	9124	973	2760	5450	25932	6929	3495	26228	3493	5026	9103	28908	29064	10099	100133941	9873	10437	3394	7462	64759	80183	51363	57205	4082	8202	3119	3310	11031	23231	79368	3109	26040	55840	3512	9805	2788	1875	65998	22898	23313	6039	23433	1299	27075	974	1536	3113	23075	55526	8115	4033	8531	10863	863	6689	96610	53838	2683	9056	3115	942	5218	11182	971	196743	29802	3087	63910	3055	3654	7088	10603	5101	3112	23564	30845	81553	5547	53335	8417	22837	10385	599	9450	8935	4205	23199	28797	114884	150094	79651	28831	23596	79705	10447	54849	6472	933	55016	23062	10327	8564	51237	79789	79720	51092	3915	8930	80228	9896	4064	8942	608	2885	55205	25780	25840	1439	2896	7942	157	640	912	55326	55278	79703	951	81618	59342	8724	6328	214	79622	7163	79677	1512	773	1326	3117	23268	79656	9855	3682	2268	10859	27033	11142	5664	958	23603	240	28912	54020	79365	8395	9712	23220	5770	5580	23094	2208	2212	911	1690	10288	84617	132	6876	5244
GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_UP	M3087		18275831	Hutcheson J,Scatizzi JC,Siddiqui AM,Haines GK 3rd,Wu T,Li QZ,Davis LS,Mohan C,Perlman H	GSE10325	GSE10325_1073_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of systemic lupus erythematosus CD4 [GeneID=920] T cells versus systemic lupus erythematosus myeloid cells.	Gene expression profile studies have identified an interferon signature in whole blood or mononuclear cell samples from patients with systemic lupus erythematosus. This study was designed to determine whether specific lymphocyte and myeloid subsets freshly isolated from the blood of systemic lupus erythematosus patients demonstrated unique gene expression profiles compared to subsets isolated from healthy controls.					3560	914	5583	113791	4118	53347	6955	5588	7188	11040	9806	28755	5019	3710	8631	29909	5335	9737	81539	23157	939	917	25996	2308	471	2882	919	51176	60468	64919	3702	8883	399665	1039	4869	2625	5790	5631	10125	4063	23318	3945	10225	8718	81606	26119	7597	79652	923	3983	57134	51611	9214	5775	399	9452	6647	9235	23224	6932	440270	4050	57326	9500	54509	2273	23177	8445	51735	55268	7535	3921	3820	10771	915	2323	5533	3561	51466	9710	51303	994	54977	3932	23243	28683	23046	58516	6633	5569	6504	7508	7322	11168	23015	440	10681	29098	8440	93144	29121	3097	23348	9840	11276	26751	4300	7294	84159	9882	6480	9797	28951	8717	790	940	6777	728661	10947	28955	91782	100505761	3094	56941	23338	596	64219	388650	10962	10575	375449	894	11224	79697	9402	1911	3603	2194	5567	80169	6775	9648	9744	4691	26249	23178	10223	221061	288	80063	489	360	3163	9692	79961	65982	1901	10641	7580	54847	5578	2091	58473	4054	10929	29851	2053	23492	4736	2971	1803	10000	1974	28639	2272	4603	6767	25865	55340	6711	3655	4351	59307	4753	10868	54681	27250	57473	51070	27240	26051	23234	5037	54463	11041	5813	27018	874	23708	7049
GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_DN	M3088		18275831	Hutcheson J,Scatizzi JC,Siddiqui AM,Haines GK 3rd,Wu T,Li QZ,Davis LS,Mohan C,Perlman H	GSE10325	GSE10325_1073_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of systemic lupus erythematosus CD4 [GeneID=920] T cells versus systemic lupus erythematosus myeloid cells.	Gene expression profile studies have identified an interferon signature in whole blood or mononuclear cell samples from patients with systemic lupus erythematosus. This study was designed to determine whether specific lymphocyte and myeloid subsets freshly isolated from the blood of systemic lupus erythematosus patients demonstrated unique gene expression profiles compared to subsets isolated from healthy controls.					27235	23761	25801	10226	23313	5329	10288	115207	4067	334	217	2760	1536	10261	1488	1848	1508	23312	54502	5660	3394	11031	7305	11027	6256	83716	2217	3310	29992	6556	7940	1050	55803	3055	64759	1051	64581	28511	80896	10970	22918	9935	7462	1471	10859	2212	9056	948	5265	7165	3687	50856	3176	2207	4082	929	81553	1462	199	7077	84187	654817	533	51363	6280	11182	7045	728	2219	2717	9540	11025	10437	7127	22797	6850	3597	23166	3101	8741	54453	2548	5476	645	4688	140885	1612	55048	23191	200315	284021	206358	3142	637	1052	29015	1495	29940	55577	23654	3108	10409	6039	3162	4005	2210	1509	1439	942	3459	972	23433	290	51296	56905	2876	55911	9314	57706	11138	6916	3958	8536	4668	3728	1475	5175	6283	7097	1318	5336	4354	11000	5580	8685	3074	695	23603	1545	55016	6051	8804	10875	51280	55701	2896	1230	2512	10981	2180	79789	3759	221	114548	55819	51324	2357	526	6398	23136	5199	10295	3557	56935	599	8942	7453	30817	157	5023	79627	83937	1845	29887	8682	79651	8905	26509	9846	754	54863	2215	27036	6386	1675	1436	25932	3281	1200	4671	81570	427	1441	1978	7263	4208	25797	23071	55625	8522
GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_UP	M3089		18275831	Hutcheson J,Scatizzi JC,Siddiqui AM,Haines GK 3rd,Wu T,Li QZ,Davis LS,Mohan C,Perlman H	GSE10325	GSE10325_1074_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of systemic lupus erythematosus B cells versus systemic lupus erythromatosus myeloid cells.	Gene expression profile studies have identified an interferon signature in whole blood or mononuclear cell samples from patients with systemic lupus erythematosus. This study was designed to determine whether specific lymphocyte and myeloid subsets freshly isolated from the blood of systemic lupus erythematosus patients demonstrated unique gene expression profiles compared to subsets isolated from healthy controls.					5631	5019	3507	6480	9834	5450	3514	5026	54847	3535	29760	399	4869	28823	5790	471	5533	25865	11137	440	28902	1901	100293440	10125	2882	29098	91353	81606	6633	931	5368	5955	9500	7163	27429	9124	80063	55024	11040	5079	9214	652493	3921	29121	5569	973	64219	54977	6711	3710	3376	6929	29064	930	91316	23231	23243	3495	55622	79161	7158	23708	489	440270	23318	81873	3493	79703	2091	28908	51611	1933	6193	388650	11224	4063	196743	987	57820	26051	7597	25996	7322	1875	23157	5287	3978	5931	26228	11262	51427	9221	10301	79677	55326	93144	23015	22800	142	4736	3653	84159	9585	6925	23512	81887	5198	54919	55718	64710	3094	25926	231	790	6647	79368	23195	22882	2308	2971	974	80169	9656	28978	2788	4953	8115	55768	27075	5984	8631	30845	51188	7188	1802	399665	60468	55922	51504	132	3512	97	4176	994	64783	8202	3561	10447	28951	9263	5757	64318	56941	23234	10776	96610	55755	23224	58516	5213	7088	8409	969	56954	10099	4172	51596	55636	3945	285830	3662	6917	6689	7639	29802	5037	81618	56242	25780	23479	57819	55278	4927	3983	64754	26040	53335	51460	971	5101	79077	9873	8728	55653	3150	5832	23035	5775	27079	9452
GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_DN	M3091		18275831	Hutcheson J,Scatizzi JC,Siddiqui AM,Haines GK 3rd,Wu T,Li QZ,Davis LS,Mohan C,Perlman H	GSE10325	GSE10325_1074_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of systemic lupus erythematosus B cells versus systemic lupus erythromatosus myeloid cells.	Gene expression profile studies have identified an interferon signature in whole blood or mononuclear cell samples from patients with systemic lupus erythematosus. This study was designed to determine whether specific lymphocyte and myeloid subsets freshly isolated from the blood of systemic lupus erythematosus patients demonstrated unique gene expression profiles compared to subsets isolated from healthy controls.					7867	2217	84187	1508	5329	6556	23313	23312	6256	10261	83716	10288	1050	80896	948	29992	11027	206358	6282	728	140885	7076	11025	6916	3176	7165	1612	5029	2512	290	1051	10226	1509	57142	221	23191	645	7045	55803	9314	55911	5476	91	5660	22918	23166	1488	4055	114548	1318	9555	3074	7132	4542	9935	64581	55048	7097	8685	7127	8536	64127	2752	8804	2210	3098	55701	9997	754	199	4354	1545	54453	7940	3958	5791	3759	6303	4671	1362	526	11000	7378	57192	2799	3101	26509	3557	7100	10402	2769	10161	58528	5768	6888	51324	79180	217	6934	2212	6398	64170	1848	1436	115207	27036	55819	6277	79630	23136	6583	55654	9056	706	50856	30817	5199	9764	55357	219654	51280	10981	2203	3162	56935	57178	9414	79042	4688	9050	5912	4035	7439	83937	5879	55640	6386	5265	432	55160	23654	1675	5351	55625	11138	9637	3281	29109	23092	2776	2207	23129	10533	2581	11024	3310	11031	79754	10859	2548	200315	1441	284021	644	3916	28232	2114	3779	334	51734	3684	9046	9341	8031	3678	25797	1471	23001	10487	6993	10875	9332	409	5175	50865	23597	60	7133	138151	9645	9121	3459	3099	6275	10855	391	4947	1462	7305	719
GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_UP	M3092		18275831	Hutcheson J,Scatizzi JC,Siddiqui AM,Haines GK 3rd,Wu T,Li QZ,Davis LS,Mohan C,Perlman H	GSE10325	GSE10325_1075_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of healthy CD4 [GeneID=920] T cells versus systemic lupus erythematosus CD4 [GeneID=920] T cells.	Gene expression profile studies have identified an interferon signature in whole blood or mononuclear cell samples from patients with systemic lupus erythematosus. This study was designed to determine whether specific lymphocyte and myeloid subsets freshly isolated from the blood of systemic lupus erythematosus patients demonstrated unique gene expression profiles compared to subsets isolated from healthy controls.					2184	2254	23635	84444	818	8664	79844	27244	6746	8665	10276	27335	6128	79147	55893	7988	7423	5989	54843	29927	79269	8501	729230	10004	28984	60509	9091	2880	6767	26580	55051	6955	9531	399665	8660	55819	64174	157562	22932	54910	552889	4907	10327	51070	11252	64781	26226	2203	8471	8722	57799	4902	26156	3590	55090	21	6188	4646	3815	55846	64130	1523	231	1880	7466	5243	1521	2625	2123	919	1263	3619	738	104	79891	8632	30845	117247	790	8409	3820	79007	301	2091	8667	9703	54621	51386	28992	6856	4298	2124	1112	60468	6141	55534	6193	3646	8905	388969	23037	84525	55167	54457	5025	27352	5074	3707	9647	29125	23508	654817	57282	10023	6942	171546	60314	5863	658	57447	27316	51006	10998	79447	8416	7539	55790	6041	11237	90273	59344	5204	3983	473	10102	7052	728855	900	4892	3482	11019	30819	378	84364	23357	3399	64425	6344	2937	10316	5455	219654	63976	442216	1933	1725	57399	9501	23223	26297	4736	55188	150160	51614	408	2712	57125	3303	5608	25799	5620	22986	7287	54946	54681	9244	4070	1953	7123	64393	26289	694	23659	23624	26092	951	3030	8871	81618	79713	2879	1945	1300	55911	10472	5295	8556	6135	10728	51673
GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_DN	M3093		18275831	Hutcheson J,Scatizzi JC,Siddiqui AM,Haines GK 3rd,Wu T,Li QZ,Davis LS,Mohan C,Perlman H	GSE10325	GSE10325_1075_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of healthy CD4 [GeneID=920] T cells versus systemic lupus erythematosus CD4 [GeneID=920] T cells.	Gene expression profile studies have identified an interferon signature in whole blood or mononuclear cell samples from patients with systemic lupus erythematosus. This study was designed to determine whether specific lymphocyte and myeloid subsets freshly isolated from the blood of systemic lupus erythematosus patients demonstrated unique gene expression profiles compared to subsets isolated from healthy controls.					9985	9168	4496	2274	8651	3908	6772	7316	6403	5214	4502	7444	8503	9246	5721	56911	7098	26010	8519	10616	7314	27074	824	79370	5698	3514	3428	79155	6890	8531	4501	3128	5130	9636	3429	4939	2215	9063	10346	988	4600	81839	3437	4599	1062	4345	5367	91543	23208	64108	4647	283755	24138	2171	10678	834	5720	84159	3665	9447	7100	5771	147339	51191	7027	1644	2537	3574	11274	26263	3662	8542	5687	3430	10906	9232	9111	8638	3595	5996	56920	10561	29110	24137	7804	26255	55884	3434	3667	9085	2175	64135	3431	10964	83461	54877	6303	4615	4940	55585	5610	8565	6892	5359	6637	54809	51131	7941	55713	23626	10105	840	4938	3902	9551	50810	56995	339479	25780	51056	2491	79132	54739	140465	3669	26191	6036	9734	64854	645745	55974	3990	146909	57211	4200	55008	6672	91373	10151	84059	10563	2643	10437	6737	55273	1573	355	8741	50650	7071	79096	1230	23199	4493	1390	85236	3106	55601	3839	7453	55084	79598	11199	9764	3347	23322	81563	829	5366	22797	634	4494	3959	80223	55711	2633	56648	656	1846	523	3920	28977	384	6619	64761	5634	9760	2697	3117	23059	2487	1647	57559	5746	5898	51138	3184	23531	3458	3382
GSE10325_BCELL_VS_LUPUS_BCELL_UP	M3094		18275831	Hutcheson J,Scatizzi JC,Siddiqui AM,Haines GK 3rd,Wu T,Li QZ,Davis LS,Mohan C,Perlman H	GSE10325	GSE10325_1076_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of healthy B cells versus systemic lupus erythematosus B cells.	Gene expression profile studies have identified an interferon signature in whole blood or mononuclear cell samples from patients with systemic lupus erythematosus. This study was designed to determine whether specific lymphocyte and myeloid subsets freshly isolated from the blood of systemic lupus erythematosus patients demonstrated unique gene expression profiles compared to subsets isolated from healthy controls.					5020	3757	55727	79600	400961	883	81571	10677	55083	55036	4914	4313	1915	29914	8337	8190	5225	9725	3141	1366	2139	10207	6041	51312	3827	25907	57613	79025	3249	1832	7051	10184	80108	4643	6128	374868	7136	2859	79933	653423	197320	56242	9514	3783	79891	3854	10636	55679	3274	54910	54946	28	22977	7124	8448	5449	321	51480	59335	2199	79744	26297	54662	8940	23223	23098	55282	10656	80093	8420	142684	55638	22808	55192	55534	23413	54455	57834	7423	9501	51665	65012	51673	79153	9247	7350	63970	79948	4584	223117	440387	29122	6656	10319	55450	1406	10399	79446	27165	27345	6122	6900	9400	2820	219654	64240	54929	220077	79724	5697	2203	3752	7701	79707	57824	9203	3911	3500	8620	90326	92558	3024	28992	269	2928	260294	91782	29965	126017	6154	293	79058	55592	219699	157562	6899	100131532	8722	6535	65108	6363	256949	21	911	3816	4776	93144	25770	79639	6193	5307	2550	1208	8938	205564	29903	753	23677	6189	79754	23024	5010	1805	3921	2327	65263	79904	6610	6469	4050	7021	3316	9744	2516	9647	7287	79983	1474	253982	29991	5864	90956	4684	2892	2648	8789	622	9681	4048	54874	50626	1951	11194	9077	26504	55266	55922	120227	10529
GSE10325_BCELL_VS_LUPUS_BCELL_DN	M3095		18275831	Hutcheson J,Scatizzi JC,Siddiqui AM,Haines GK 3rd,Wu T,Li QZ,Davis LS,Mohan C,Perlman H	GSE10325	GSE10325_1076_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of healthy B cells versus systemic lupus erythematosus B cells.	Gene expression profile studies have identified an interferon signature in whole blood or mononuclear cell samples from patients with systemic lupus erythematosus. This study was designed to determine whether specific lymphocyte and myeloid subsets freshly isolated from the blood of systemic lupus erythematosus patients demonstrated unique gene expression profiles compared to subsets isolated from healthy controls.					10791	55884	729230	5610	9636	54739	6772	6890	5721	5898	23512	9246	7444	10964	3430	3669	4940	51191	8837	2537	5584	8519	9551	30009	10561	9473	4599	9985	5359	3429	2633	51056	30844	57178	2079	5720	55754	51693	7150	3437	91543	3665	1075	3434	5552	26010	3418	5698	5870	8412	84061	4939	64778	5873	51227	10170	5687	3958	60489	3839	4277	6731	2745	8542	4758	11274	1847	51287	140460	50999	7453	10018	55972	644	9377	8565	25976	6003	1486	9867	80833	80305	55501	746	7112	55601	80145	28977	6303	55281	55317	3592	7107	9111	10133	51124	3920	56267	8896	11014	51371	200315	51100	3628	140465	2673	355	5223	22936	65983	64083	4247	22983	55729	637	28785	29015	65244	55069	857	9976	91137	7071	6504	3832	51268	23054	50838	55008	10026	4818	10135	64422	8813	284325	64897	4697	642	9693	81611	3161	475	7804	51008	10905	7296	10954	1230	57379	2182	3105	55143	55055	83737	103	952	26002	9218	9324	6993	23471	23251	10105	6382	9997	55106	63931	64108	10950	4668	998	8683	3133	7332	54205	6728	8836	2109	50515	55840	8760	521	5611	8638	4121	5686	8140	1650	9787	821	1318	2734	55165	55660	54502	10802	23478	813	5996	388
GSE10325_MYELOID_VS_LUPUS_MYELOID_UP	M3096		18275831	Hutcheson J,Scatizzi JC,Siddiqui AM,Haines GK 3rd,Wu T,Li QZ,Davis LS,Mohan C,Perlman H	GSE10325	GSE10325_1077_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of healthy myeloid cells versus systemic lupus erythematosus myeloid cells.	Gene expression profile studies have identified an interferon signature in whole blood or mononuclear cell samples from patients with systemic lupus erythematosus. This study was designed to determine whether specific lymphocyte and myeloid subsets freshly isolated from the blood of systemic lupus erythematosus patients demonstrated unique gene expression profiles compared to subsets isolated from healthy controls.					64102	58985	55124	911	150967	79748	25770	51533	26027	24	9182	9727	55389	9048	1776	6189	79640	1006	54827	4879	80775	55628	3884	4914	3908	23281	64806	711	11251	4862	55025	6175	3373	80086	6702	5244	797	3141	6839	26206	27344	4952	2670	29803	7561	26154	190	25987	3765	1917	57338	3746	1975	9079	10609	9573	51619	1448	10763	338	1821	26504	3872	2779	51310	790	55199	6136	54829	11131	1573	2669	1740	8403	10529	776	2312	6586	1620	2583	55200	2575	115708	9379	7108	26083	54498	2273	79077	127534	375449	93210	3270	201229	1579	8438	650	10656	64866	55891	54475	228	23139	5507	11156	8852	81563	55752	1397	10785	1044	59335	4477	51560	2245	63893	23409	8871	1300	3875	9423	8736	8576	1565	8761	27178	2676	3558	5909	6875	2561	9620	54509	1305	26279	57447	63910	27286	5275	50624	79442	23098	56124	395	2688	33	293	350	4948	64852	51760	2695	6191	4684	5650	57834	26249	883	84900	27129	4157	11238	27314	7173	2151	10575	7287	1510	6004	1071	2819	7306	9576	7639	55282	105	9388	4681	79858	440073	81888	57863	55626	56891	3854	65094	2205	189	6506	5745	6124	335	8722	7473	846	338645	50939	54959	9761	3235
GSE10325_MYELOID_VS_LUPUS_MYELOID_DN	M3097		18275831	Hutcheson J,Scatizzi JC,Siddiqui AM,Haines GK 3rd,Wu T,Li QZ,Davis LS,Mohan C,Perlman H	GSE10325	GSE10325_1077_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of healthy myeloid cells versus systemic lupus erythematosus myeloid cells.	Gene expression profile studies have identified an interferon signature in whole blood or mononuclear cell samples from patients with systemic lupus erythematosus. This study was designed to determine whether specific lymphocyte and myeloid subsets freshly isolated from the blood of systemic lupus erythematosus patients demonstrated unique gene expression profiles compared to subsets isolated from healthy controls.					23201	710	3903	51762	488	133	2210	4924	3665	8760	27351	91543	6772	3437	5476	1861	10226	3728	51056	8638	3429	26010	2537	23670	4893	23179	3105	3959	55640	11274	8454	55008	51191	2907	84975	6347	22797	3557	3430	54407	2710	6890	10616	9636	1509	6614	9120	55741	50515	7444	3965	9749	83440	53	10775	2734	6729	8542	713	54877	10945	6774	79132	3434	56851	5359	84890	9168	9517	4001	3251	9554	57194	7295	64116	24138	123	7378	2352	10342	4502	3093	10490	967	80830	2153	55841	64135	808	2633	246243	5292	5597	55700	284021	1716	6464	553115	9881	3428	475	4600	55026	10589	79134	4061	30001	7150	4501	7494	2713	64761	5610	8813	6355	6672	8820	2760	5721	10261	5341	5315	8683	57862	7130	24145	2867	8685	30844	79568	1486	6373	4671	10630	3949	840	9997	7803	80209	89845	3601	752	23136	1659	801	8564	3142	27348	5687	4599	54739	2766	3433	9246	54676	10507	112950	9491	79577	64108	873	55013	3985	6641	8942	7145	79689	3482	55229	4277	55601	10561	79016	55303	4496	10533	51312	9946	116496	4494	54994	51371	2551	103	93487	124801	6868	687	23590	2180	1022	6515	10007	5048	366	9111	3627	8519	9444	3916
GSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_UP	M3098		18270326	Lawrence BP,Denison MS,Novak H,Vorderstrasse BA,Harrer N,Neruda W,Reichel C,Woisetschläger M	GSE10463	GSE10463_1742_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells activated in the absense of VAF347 [PubChem=10172275] versus those activated in the presence of VAF347 [PubChem=10172275].	VAF347 is a low molecular weight compound which inhibits allergic lung inflammation in vivo. This effect is likely due to a block of dendritic cell (DC) function to generate pro-inflammatory T-helper (Th) cells since VAF347 inhibits IL-6, CD86 and HLA-DR expression by human monocyte derived DC, three relevant molecules for Th-cell generation. Here we demonstrate that VAF347 interacts with the aryl hydrocarbon receptor (AhR) protein resulting in activation of the AhR signaling pathway. Functional AhR is responsible for the biological activity of VAF347 since, i) other AhR agonists display an identical activity profile in vitro, ii) gene silencing of wild type AhR expression or forced over-expression of a trans-dominant negative AhR ablates VAF347 activity to inhibit cytokine induced IL-6 expression in a human monocytic cell line and iii) AhR deficient mice are resistant to the compound’s ability to block allergic lung inflammation in vivo. These data identify the AhR protein as key molecular target of VAF347 and its essential role for mediating the anti-inflammatory effects of the compound in vitro and in vivo.					127933	1846	10225	25891	139886	23764	9787	7763	254778	2125	5732	65988	6906	2022	254228	392459	4289	64693	57695	79776	53833	285191	29943	54801	644242	10773	22928	121441	55296	284076	3608	145501	9862	63894	4430	25976	167838	29035	796	65982	23293	10447	10396	5118	9618	10626	7030	284756	64744	7422	10129	57547	6707	100506497	22839	2791	64131	55421	128611	221946	51710	23288	51438	282679	57605	144811	4943	83706	84071	5199	8661	80111	4087	10558	5423	372	51177	80204	56985	5266	146059	27154	9214	79807	29980	100507281	56605	5426	51276	1580	9414	23197	57515	10793	43849	8428	274	51029	9652	151195	84824	140856	3551	90592	5244	4851	11237	4780	3576	100131227	56034	64863	84376	5144	6464	56986	613	29949	467	51340	4072	56242	4089	221016	400550	114609	160851	7095	5983	7057	8459	133491	7768	8908	284099	23043	8500	3631	81631	9625	51312	11080	284358	286148	116844	112970	55291	57491	64793	10463	642	84826	3099	9843	23313	653602	1293	5193	29119	91304	285195	439911	5728	401522	26090	10742	64651	57396	4168	8727	1545	64327	80110	100128727	788	80835	10686	56301	57643	57161	134957	150759	375616	2803	340156	3065	6345	132851	56704	79759	7596	6398	9404	11123	5638	51776	117155	7752	3776	9025
GSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_DN	M3099		18270326	Lawrence BP,Denison MS,Novak H,Vorderstrasse BA,Harrer N,Neruda W,Reichel C,Woisetschläger M	GSE10463	GSE10463_1742_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells activated in the absense of VAF347 [PubChem=10172275] versus those activated in the presence of VAF347 [PubChem=10172275].	VAF347 is a low molecular weight compound which inhibits allergic lung inflammation in vivo. This effect is likely due to a block of dendritic cell (DC) function to generate pro-inflammatory T-helper (Th) cells since VAF347 inhibits IL-6, CD86 and HLA-DR expression by human monocyte derived DC, three relevant molecules for Th-cell generation. Here we demonstrate that VAF347 interacts with the aryl hydrocarbon receptor (AhR) protein resulting in activation of the AhR signaling pathway. Functional AhR is responsible for the biological activity of VAF347 since, i) other AhR agonists display an identical activity profile in vitro, ii) gene silencing of wild type AhR expression or forced over-expression of a trans-dominant negative AhR ablates VAF347 activity to inhibit cytokine induced IL-6 expression in a human monocytic cell line and iii) AhR deficient mice are resistant to the compound’s ability to block allergic lung inflammation in vivo. These data identify the AhR protein as key molecular target of VAF347 and its essential role for mediating the anti-inflammatory effects of the compound in vitro and in vivo.					116337	100286922	90293	732	480	79668	84128	283229	10712	85509	3955	29044	50846	64780	5923	6835	284114	78986	205	5972	8600	729866	85442	550631	1628	10488	92856	80755	23107	59339	4622	4759	3276	388588	8091	50940	4091	11126	286087	285596	100287182	255743	26259	5675	286009	10219	791114	151651	29803	7760	3018	10101	1512	100113384	856	1891	155066	100506776	218	3749	283848	1286	5787	84329	4354	58504	55178	284112	64593	3754	347365	9720	7018	401264	57642	57555	65266	51025	29924	8078	53335	92359	11185	29013	100130054	283481	5345	164684	196792	100129654	134288	1587	100129722	6855	5524	348013	219537	3868	170689	257000	100126791	2331	3456	653190	147670	134701	387640	64067	79697	54587	100507299	24146	10090	57110	55619	373863	6525	131566	338739	10267	7412	28560	10076	79073	84873	160065	2878	10825	80316	4776	26248	140893	11178	100101467	7070	2707	23125	2971	100133116	9076	140458	10588	348110	90956	154	100289494	85026	29800	728855	7098	219348	80273	3623	121838	23285	150590	58475	126147	100289061	7366	445347	100290973	100133075	399717	4486	29941	78995	2034	29883	221002	2651	100506243	1745	84865	26080	51310	9828	124460	353219	163486	200162	100292443	157739	92196	100129449	11074	79047	6136	85446	2065	55968	5414	79590	55854	6235	79140	9719	79703	146	9283
GSE10856_CTRL_VS_TNFRSF6B_IN_MACROPHAGE_UP	M3100		18349319	Chang YC,Chen TC,Lee CT,Yang CY,Wang HW,Wang CC,Hsieh SL.	GSE10856	GSE10856_2033_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages treated with control (hIgG1) versus those treated with TNFRSF6B [GeneID=8771].	Decoy receptor 3 (DcR3) is a member of the TNF receptor superfamily and is up-regulated in tumors that originate from a diversity of lineages. DcR3 is capable of promoting angiogenesis, inducing dendritic cell apoptosis, and modulating macrophage differentiation. Since tumor-associated macrophages (TAMs) are the major infiltrating leukocytes in most malignant tumors, we used microarray technology to investigate whether DcR3 contributes to the development of TAMs. Among the DcR3-modulated genes expressed by TAMs, those that encode proteins involved in MHC class II (MHC-II)-dependent antigen presentation were down-regulated substantially, together with the master regulator of MHC-II expression (the class II transactivator, CIITA). The ERK- and JNK-induced deacetylation of histones associated with the CIITA promoters was responsible for DcR3-mediated down-regulation of MHC-II expression. Furthermore, the expression level of DcR3 in cancer cells correlated inversely with HLA-DR levels on TAMs and with the overall survival time of pancreatic cancer patients. The role of DcR3 in the development of TAMs was further confirmed using transgenic mice over-expressing DcR3. This elucidates the molecular mechanism of impaired MHC-II-mediated antigen presentation by TAMs, and raises the possibility that subversion of TAM-induced immunosuppression via inhibition of DcR3 expression might represent a target for the design of new therapeutics.					60682	100507392	55643	2212	6039	100132406	203274	401172	53826	5957	11143	158880	51545	91574	81847	79004	84809	283537	23214	100286909	7182	55914	389834	89122	55041	64744	3633	81553	389765	9788	28991	55998	9311	79888	25903	5339	220972	10951	819	81930	85367	10855	64595	7475	57486	100128286	64333	1438	118425	64127	11188	9901	100287237	26277	2932	201229	3394	55534	342184	23129	29911	8554	1303	10160	170692	9368	84859	4047	10645	113189	1075	26240	5836	822	25816	808	3055	7561	23310	1974	23370	25	8844	140	100287289	2350	65258	57035	57688	403313	122258	320	65998	10409	91662	25798	56204	1612	28968	497189	5328	4848	2621	50619	9877	54103	161	9956	9177	113791	55908	3046	10296	79746	5027	7750	54847	51035	148345	387751	124460	832	157378	11243	120892	23092	5830	256281	7763	22992	1200	729614	147929	1845	55022	81035	9710	134121	6877	84672	11100	7311	9880	114783	10057	54997	55819	57018	65979	79567	56654	3631	10695	5498	3589	4758	11270	5476	54558	10087	135946	9886	9802	5660	6181	267004	55198	943	100134937	4162	79228	4214	162	84307	81558	23096	7127	55256	951	9454	200315	51057	1184	26009	80228	55340	10762	140947	22928	10507	2771	57674	7884	80148	286052	151306	3119	27345	55634
GSE10856_CTRL_VS_TNFRSF6B_IN_MACROPHAGE_DN	M3101		18349319	Chang YC,Chen TC,Lee CT,Yang CY,Wang HW,Wang CC,Hsieh SL.	GSE10856	GSE10856_2033_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages treated with control (hIgG1) versus those treated with TNFRSF6B [GeneID=8771].	Decoy receptor 3 (DcR3) is a member of the TNF receptor superfamily and is up-regulated in tumors that originate from a diversity of lineages. DcR3 is capable of promoting angiogenesis, inducing dendritic cell apoptosis, and modulating macrophage differentiation. Since tumor-associated macrophages (TAMs) are the major infiltrating leukocytes in most malignant tumors, we used microarray technology to investigate whether DcR3 contributes to the development of TAMs. Among the DcR3-modulated genes expressed by TAMs, those that encode proteins involved in MHC class II (MHC-II)-dependent antigen presentation were down-regulated substantially, together with the master regulator of MHC-II expression (the class II transactivator, CIITA). The ERK- and JNK-induced deacetylation of histones associated with the CIITA promoters was responsible for DcR3-mediated down-regulation of MHC-II expression. Furthermore, the expression level of DcR3 in cancer cells correlated inversely with HLA-DR levels on TAMs and with the overall survival time of pancreatic cancer patients. The role of DcR3 in the development of TAMs was further confirmed using transgenic mice over-expressing DcR3. This elucidates the molecular mechanism of impaired MHC-II-mediated antigen presentation by TAMs, and raises the possibility that subversion of TAM-induced immunosuppression via inhibition of DcR3 expression might represent a target for the design of new therapeutics.					1539	10519	23184	83698	84447	54920	51175	6584	1022	3652	149297	154872	100289049	9	54955	23212	79139	2317	283404	54509	142686	9061	154092	64841	4507	1349	79630	64902	1347	6734	440173	51377	23221	84946	65244	441025	79836	399512	10166	23035	55330	125965	161357	5597	652993	64216	64431	120526	55331	29895	389898	55132	5650	253559	87	1043	10734	5444	49854	6341	131408	2271	339290	284613	6921	55974	6263	3688	51023	116150	5685	79091	116496	79810	339804	246184	51499	150350	400830	8727	57805	5702	8833	23057	55290	64924	1716	54148	4040	3227	10432	79611	140458	51283	80324	80176	996	202151	51715	6810	28985	58477	6891	56647	143903	4828	104	5366	1891	201161	55907	284367	946	3216	145173	54505	34	23210	646701	255374	161823	54928	471	80755	84259	51388	79736	7355	51249	64949	84833	56935	55002	27348	201456	54469	10054	6583	80856	151393	4145	29923	10514	10969	4104	85395	10528	51009	128872	731656	84964	2534	5557	9419	51347	389124	403314	64328	23648	646588	79695	85451	55151	123016	100131283	170063	400657	1009	114789	641649	9462	1876	90417	4643	4698	4211	79837	100131721	100507632	25814	129446	54675	29090	10302	5770	2525	10434	4583	22818	100289045	285753	81502	7965	1543	84958	84541	51306	56241	400	11322
GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP	M3104		19568420	Abbas AR,Wolslegel K,Seshasayee D,Modrusan Z,Clark HF.	GSE11057	GSE11057_1610_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive T cells versus effector memory T cells.	Microarray deconvolution is a technique for quantifying the relative abundance of constituent cells in a mixture based on that mixture's microarray signature and the signatures of the purified constituents. It has been applied to yeast and other systems but not to blood samples. Here we test the ability of this technique to determine the fractions of subsets of memory T cells in peripheral blood mononuclear cell (PBMC) samples.					57713	84441	51735	6711	949	283521	2814	60468	64784	150864	55000	122773	4925	196394	10750	8609	22866	1942	4354	5152	641518	23306	5150	5324	91614	7273	492311	54674	166647	4602	91523	5163	9751	3480	440515	54439	5140	51316	57185	117247	64332	23331	3655	9214	165	9990	26960	113791	84973	11275	9241	9792	8875	1604	26289	54482	138948	23569	23731	10472	55536	10873	2686	51339	665	10838	4300	90293	116447	87	3572	50854	26227	51312	91782	5125	780	56242	4862	144132	282997	4205	79814	1117	9737	7048	338799	7562	79690	6193	10389	28996	23269	9435	114794	574407	9658	90594	339122	5293	199	27086	326625	6720	321	118980	53373	259173	9823	57605	22930	84101	2041	147837	54033	2317	10913	7594	95681	23067	6875	200424	6894	83594	472	51379	57125	3983	9762	6304	25851	339483	54876	79890	9920	55556	22869	8303	3841	80024	64221	79961	125981	83643	727956	54682	253782	26249	346887	1788	16	1184	163131	883	388011	100507218	440026	284390	129293	7325	441024	256309	80863	200830	3096	3005	400120	6001	8270	440104	166336	79656	441242	3899	7697	146691	221322	80762	2217	1937	8237	84293	924	926	6907	84838	6932	5578	51176	4054	201161	26034	7320	3875	27115	814	54850	55902	3911	9487
GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN	M3105		19568420	Abbas AR,Wolslegel K,Seshasayee D,Modrusan Z,Clark HF.	GSE11057	GSE11057_1610_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive T cells versus effector memory T cells.	Microarray deconvolution is a technique for quantifying the relative abundance of constituent cells in a mixture based on that mixture's microarray signature and the signatures of the purified constituents. It has been applied to yeast and other systems but not to blood samples. Here we test the ability of this technique to determine the fractions of subsets of memory T cells in peripheral blood mononuclear cell (PBMC) samples.					4637	196	339745	4603	303	30009	10788	2730	355	64127	114801	284996	23095	4301	493	6095	3987	940	94241	2833	79899	253461	1847	4291	6310	10602	51155	131544	56650	169200	64859	192670	9368	10666	56654	7414	360	7293	822	1192	57157	3956	440823	6515	972	9467	4967	9749	8676	79035	3601	92906	64446	9258	55122	241	116496	23397	84981	23150	64854	55336	965	3003	51101	96626	57534	6489	5552	3001	84752	8573	7295	4542	81544	23406	60481	3587	2124	967	1979	5873	2635	307	10130	125488	6352	2060	6275	1235	81831	8728	9780	8682	7171	56935	3688	55313	56255	2040	6674	9232	9788	7533	27013	831	55658	11010	338620	1396	203260	80008	60682	83442	55711	7124	3958	9645	92092	214	10105	4864	51125	221491	5998	653319	94015	90701	3429	301	84525	23180	730184	57580	8832	7098	4217	55320	84250	1075	56548	93663	8826	10263	5066	302	373156	8717	51676	80824	5476	58480	1191	26031	3820	64222	25945	89894	729230	81	5211	1890	79627	3428	201633	10874	7905	1155	10154	3939	3458	100288693	144811	28755	5499	4068	10950	8819	79180	79174	4689	55605	6747	10090	100506190	11046	79872	6282	100131176	55205	221035	29969	4815	5412	118429	10473	64764	8661	51063	3113
GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP	M3106		19568420	Abbas AR,Wolslegel K,Seshasayee D,Modrusan Z,Clark HF.	GSE11057	GSE11057_1611_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive T cells versus central memory T cells.	Microarray deconvolution is a technique for quantifying the relative abundance of constituent cells in a mixture based on that mixture's microarray signature and the signatures of the purified constituents. It has been applied to yeast and other systems but not to blood samples. Here we test the ability of this technique to determine the fractions of subsets of memory T cells in peripheral blood mononuclear cell (PBMC) samples.					157285	51339	439949	1604	91614	472	4354	641518	6609	50626	55706	2813	143098	148898	4862	10873	253782	9792	8875	10472	10913	64772	23569	3983	51429	133874	9241	780	54674	574407	6304	147837	56676	3572	196394	4602	91523	949	90293	2814	11142	54682	319101	4232	113791	5163	9823	3655	664	1942	23683	84461	5693	23331	283683	170575	92370	157657	6322	26289	144245	112483	4925	91782	4891	10099	84838	95681	55000	3298	50854	165	79656	8411	66035	345462	57605	9263	6720	22866	56948	54463	26012	26960	645784	84441	27113	3480	401067	284023	388011	5150	57713	200035	665	494513	144132	283177	8549	51361	5324	81792	5796	119559	6293	79890	255193	646762	286205	27284	10276	51312	51090	254013	80863	440104	140462	199	79667	6894	84101	2979	4952	57019	221322	100129196	9435	6477	201161	283887	57124	322	406893	84293	100286937	165082	100289019	388714	100287814	1184	6660	41	282997	57134	1122	53373	56253	83998	79612	54753	64094	7325	10110	79690	321	146691	10893	7851	29965	51379	440498	22837	7095	9610	440515	54103	283521	6975	54798	51735	1236	440699	814	57703	4811	400120	90488	81579	100507654	51765	10360	1290	64776	26996	2648	9751	359845	80321	83591	26227	535	100506258	9753	55363	22877	145873	6875	285533	9750	7048
GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN	M3107		19568420	Abbas AR,Wolslegel K,Seshasayee D,Modrusan Z,Clark HF.	GSE11057	GSE11057_1611_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive T cells versus central memory T cells.	Microarray deconvolution is a technique for quantifying the relative abundance of constituent cells in a mixture based on that mixture's microarray signature and the signatures of the purified constituents. It has been applied to yeast and other systems but not to blood samples. Here we test the ability of this technique to determine the fractions of subsets of memory T cells in peripheral blood mononuclear cell (PBMC) samples.					58480	55294	7049	92906	60481	5873	355	51125	79180	7430	493	26262	7533	79872	440823	1880	94241	92002	8573	9749	4363	196	7414	8560	4967	5552	4217	116496	7416	79677	1075	6310	7905	83442	55336	9232	55501	3587	7465	10000	6533	5315	2124	23095	23199	85437	972	3956	6275	100507564	2833	3123	10538	55122	3958	1192	10788	1396	2153	9645	2043	4644	2889	338620	8111	3688	10221	360	4291	81	965	9766	201633	55568	2040	80223	127544	79026	8477	9709	4542	307	6504	639	30844	101	56650	51100	114885	51586	64859	8826	4603	3820	4301	84888	8819	26031	377	388272	6489	6095	4214	2909	3705	10602	9910	80854	94015	3428	5412	196383	56548	1235	2826	126917	6478	285195	4026	1155	488	23406	23218	80820	3987	84282	9780	301	23333	54386	8728	5998	54704	89894	831	6836	406	5214	5476	914	967	6251	8832	64127	257160	5580	163486	92610	6747	11221	5496	93663	51101	9043	3732	27102	51088	51304	396	5912	1495	8682	6261	84159	7293	10043	53822	10098	100505687	6674	143	135112	55831	7444	4094	60682	1847	8301	55711	8407	826	23597	9679	57732	953	3268	285513	57535	9693	1979	9061	23164	79899	7286	10971	9051	26053	80176	10403	729230
GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_UP	M3108		19568420	Abbas AR,Wolslegel K,Seshasayee D,Modrusan Z,Clark HF.	GSE11057	GSE11057_1612_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive T cells versus peripheral blood mononuclear cells (PBMC).	Microarray deconvolution is a technique for quantifying the relative abundance of constituent cells in a mixture based on that mixture's microarray signature and the signatures of the purified constituents. It has been applied to yeast and other systems but not to blood samples. Here we test the ability of this technique to determine the fractions of subsets of memory T cells in peripheral blood mononuclear cell (PBMC) samples.					256380	84900	145864	25851	57291	23338	10244	23404	10868	4300	58473	10946	8192	78991	284346	23066	57659	260294	27079	9093	55260	10531	338799	79711	2308	339122	9531	54665	3702	23484	54870	6415	57134	59307	90987	79706	11083	5324	10838	23642	3932	729614	7754	50626	93185	8379	23270	23731	54780	6143	10307	5252	27018	84461	23214	818	6895	23647	64425	27076	147923	51035	286161	738	57463	23360	54553	643641	203328	196294	6777	163882	84441	1953	92370	10360	54463	113246	9923	93622	55623	27175	26034	3983	30812	4863	57185	400657	4925	492311	9238	3572	79814	8313	9252	5976	10276	389289	6293	79695	7988	7975	169981	51466	79710	1933	55268	9214	84881	51429	7743	26289	2041	5693	132299	55578	644135	10898	130916	80342	347902	3590	128077	583	10223	1942	113791	375248	11123	158	6322	55844	7580	112398	246175	55069	1350	23174	1736	23644	283130	55274	23370	79066	55893	90624	54764	388566	25926	7629	1107	10750	9241	6776	54674	91252	171023	79085	9737	3337	8711	25845	274	939	1939	1757	91523	7539	55422	9725	57095	8871	23203	282997	347918	57396	814	5293	348035	93058	91298	54856	64919	283521	923	79697	23306	90139	7001	28984	472	22869	55180	50861	55628	50854	9751	57494	81887	4054
GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_DN	M3110		19568420	Abbas AR,Wolslegel K,Seshasayee D,Modrusan Z,Clark HF.	GSE11057	GSE11057_1612_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive T cells versus peripheral blood mononuclear cells (PBMC).	Microarray deconvolution is a technique for quantifying the relative abundance of constituent cells in a mixture based on that mixture's microarray signature and the signatures of the purified constituents. It has been applied to yeast and other systems but not to blood samples. Here we test the ability of this technique to determine the fractions of subsets of memory T cells in peripheral blood mononuclear cell (PBMC) samples.					58480	5359	5768	7532	2581	1847	822	84002	284996	4357	8773	2793	7324	55717	201799	51056	9958	100507632	6533	847	9709	4683	117144	7414	55625	196	51177	1130	3717	22898	1806	4048	4637	51744	1522	10295	8819	928	57458	2529	64778	9446	1026	6695	23151	114879	4215	23199	4783	55122	8741	91404	91607	7011	84329	5226	5873	412	3987	115727	2983	7086	9056	152137	9334	9124	3660	100288617	5997	10333	2885	26040	80727	2509	255488	9528	83606	5450	2752	11025	1051	2950	9375	8099	55356	4947	4211	7041	203274	9341	10890	2034	50999	5476	2665	51760	5782	2771	26030	11261	57705	2495	84981	64170	23643	11138	55568	55287	10578	4668	100129034	94241	55331	6714	101	22906	1318	79772	79180	25946	9997	1052	8809	411	140809	6813	23129	9637	389	1326	60	83442	4046	4218	1535	9185	5141	10135	8459	79899	6252	374655	5257	53346	2171	2022	3113	3034	203228	220042	56034	56940	51726	8546	199	23092	5966	8395	488	55577	6398	5742	1545	2936	8334	2014	307	4853	11337	121260	5899	2040	84649	219855	55819	826	8879	6747	1213	10019	1439	10269	2519	8682	79168	1211	1608	10095	54507	5531	51465	8291	27044	533	1314	1675	81	4354	10797	719
GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_UP	M3111		19568420	Abbas AR,Wolslegel K,Seshasayee D,Modrusan Z,Clark HF.	GSE11057	GSE11057_1613_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of effector memory T cells versus central memory T cells from peripheral blood mononuclear cells (PBMC).	Microarray deconvolution is a technique for quantifying the relative abundance of constituent cells in a mixture based on that mixture's microarray signature and the signatures of the purified constituents. It has been applied to yeast and other systems but not to blood samples. Here we test the ability of this technique to determine the fractions of subsets of memory T cells in peripheral blood mononuclear cell (PBMC) samples.					7549	10803	1191	4354	26497	6809	55296	84250	388591	3956	5626	64800	92092	63950	55711	81615	10602	84694	206358	304	100506127	1594	11135	302	479	79071	220929	83856	2672	23305	303	59084	51676	55205	285315	305	22822	3958	9645	257	5243	100506190	192670	55216	84501	79649	54863	9650	55605	1850	196	148046	5916	677844	831	284865	5341	64065	139716	3290	51622	60489	130888	5521	2040	29967	3075	200894	81	2060	84056	493	84085	57474	8850	2892	4864	2330	100287482	221002	5066	6273	7480	3459	79134	6097	85403	84525	9748	965	148254	5141	100507470	26056	2034	25937	340061	5621	81855	4000	1289	58480	79627	4301	7076	22856	55752	8477	201134	64407	23191	29907	157638	374900	64092	481	9455	29940	653319	154	100132891	4603	9208	55062	4121	101	494513	10979	8111	8740	3026	1534	57480	53405	833	6695	54585	642273	54461	51313	126969	55254	1286	56963	5598	4291	8320	1495	392459	29110	3131	6275	90407	154807	130557	3815	55615	440864	58190	254531	387357	79180	153129	79969	84923	3080	60675	8985	57732	4285	54622	64693	3090	1729	148789	7746	6352	619343	7414	1075	5547	23531	4058	23243	8707	4331	6574	3175	121268	1235	10237	9213	4234	23236	129450	7162	8693	64080	53349	8292
GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN	M3112		19568420	Abbas AR,Wolslegel K,Seshasayee D,Modrusan Z,Clark HF.	GSE11057	GSE11057_1613_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of effector memory T cells versus central memory T cells from peripheral blood mononuclear cells (PBMC).	Microarray deconvolution is a technique for quantifying the relative abundance of constituent cells in a mixture based on that mixture's microarray signature and the signatures of the purified constituents. It has been applied to yeast and other systems but not to blood samples. Here we test the ability of this technique to determine the fractions of subsets of memory T cells in peripheral blood mononuclear cell (PBMC) samples.					22866	10178	7273	64784	4300	9241	8609	2153	6402	5533	2186	87	151556	26289	4363	23195	283174	4213	25840	4214	9792	753	26034	23240	728804	339122	253782	85464	84073	321	8997	143686	9736	57509	3572	27086	54491	8875	23043	150864	80024	113791	5315	27125	26249	50807	476	4222	6932	283521	256309	8925	163882	6907	222166	9918	27115	22807	116138	57162	84815	259173	100129407	875	81619	7294	26227	50943	5802	26137	91442	55023	401647	79690	6711	4297	808	968	100507495	51444	11059	84786	6403	10144	728743	84293	1244	641518	55183	23499	5747	472	55870	3848	6920	79722	7994	55000	100129447	5140	55869	939	5922	90827	1518	10913	814	200424	3096	57634	340481	23177	3362	138948	22844	55721	196394	84973	57551	55198	6322	29851	100128198	165	388011	201633	1119	1840	414327	5641	10461	256130	10725	9435	100129503	924	9271	597	4602	730249	5163	3983	100289058	57181	55144	113263	8295	1514	9088	55095	898	433	731852	84441	80055	23077	222255	2901	54904	3593	65108	27018	401262	100288679	10223	128553	26036	28951	3566	7874	23258	246734	474170	7100	27161	9814	388272	51176	23049	10055	3866	3662	23352	205717	51274	338799	56132	91523	116843	50615	79814	8303	79845	999	55888	51316	51231	8911	9448
GSE11057_CD4_EFF_MEM_VS_PBMC_UP	M3113		19568420	Abbas AR,Wolslegel K,Seshasayee D,Modrusan Z,Clark HF.	GSE11057	GSE11057_1614_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of effector memory T cells versus peripheral blood mononuclear cells (PBMC).	Microarray deconvolution is a technique for quantifying the relative abundance of constituent cells in a mixture based on that mixture's microarray signature and the signatures of the purified constituents. It has been applied to yeast and other systems but not to blood samples. Here we test the ability of this technique to determine the fractions of subsets of memory T cells in peripheral blood mononuclear cell (PBMC) samples.					966	5292	3163	818	9252	155400	79695	27079	51406	114801	81558	203328	10133	26018	166	55268	54856	51742	861	51460	64975	4094	9695	55824	3094	317671	23386	151963	51070	401647	1636	921	375449	57198	125488	100130581	114804	27043	8573	158584	79960	10225	9258	2833	28984	353	915	25902	6482	80003	64787	2625	23253	55658	4301	28639	57291	9531	29909	51161	3587	11059	3384	50852	51696	79718	57326	5924	6777	91252	4798	923	373156	7508	157638	7766	39	23348	80714	1953	23344	221061	79871	55260	163882	222643	54984	2035	118980	643641	158	317762	7220	55336	57157	7626	131118	9749	10892	55623	258010	54977	274	894	100288693	5335	285973	5252	8445	203260	471	9725	56172	284613	51719	222255	23492	9949	4329	92558	57169	283508	622	54496	338440	23641	51599	132299	2323	56654	10314	1917	6489	59307	51466	7984	8725	5333	387119	25945	284001	54923	84058	145748	91750	53827	51561	79710	5557	3835	79134	89894	3702	50861	23642	79786	64116	9409	3707	121355	1731	27436	8883	91782	9397	7186	56950	57185	9020	10125	54733	3710	129804	3337	288	112942	2043	90701	9240	476	25845	1628	145864	9117	839	10244	64854	6504	30968	5518	914	6633	5732	4300	3921	51616	9452	4291	112398	8607
GSE11057_CD4_EFF_MEM_VS_PBMC_DN	M3114		19568420	Abbas AR,Wolslegel K,Seshasayee D,Modrusan Z,Clark HF.	GSE11057	GSE11057_1614_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comarison of effector memory T cells versus peripheral blood mononuclear cells (PBMC).	Microarray deconvolution is a technique for quantifying the relative abundance of constituent cells in a mixture based on that mixture's microarray signature and the signatures of the purified constituents. It has been applied to yeast and other systems but not to blood samples. Here we test the ability of this technique to determine the fractions of subsets of memory T cells in peripheral blood mononuclear cell (PBMC) samples.					1522	64778	10094	9124	8773	1675	411	8395	5742	5547	55589	535	10154	26040	23209	9056	54438	4048	7086	652493	117144	83716	4946	1318	8522	200424	10603	51760	5580	84002	5552	334	6272	100507632	7739	22906	26301	1130	6039	221656	3728	1848	23433	26234	1051	11337	64407	5341	100290481	11025	8741	57705	51816	523	100288617	51744	55356	313	3460	4853	64170	114793	65220	9540	53346	100113407	58488	3034	54790	150372	2512	2907	943	59342	5359	219855	56905	84519	2876	2180	4205	11138	847	2495	6925	30817	64747	665	9545	55577	6036	5791	9555	7204	80035	3643	171546	10871	6386	5577	23136	366	5226	55704	7532	55647	23034	7226	51296	4783	11182	79895	91404	526	203228	8291	400410	84329	55625	6688	6678	117157	427	53917	55717	55819	4033	54210	654	9103	2950	55331	5351	222166	2793	3957	433	144423	3101	3109	58475	6256	84649	23603	4069	4947	51314	81622	10092	27180	7097	100128501	3111	972	4084	8804	55106	6850	9734	928	6888	8334	8778	4064	80727	27071	1612	91624	8303	284837	8682	9741	1200	1806	9764	23654	645	7099	8125	56034	8417	5660	55287	3717	430	256236	3687	161742	402483	8099	4257	157	11126	6252	25946	84898	54507	29760	146722	973
GSE11057_CD4_CENT_MEM_VS_PBMC_UP	M3116		19568420	Abbas AR,Wolslegel K,Seshasayee D,Modrusan Z,Clark HF.	GSE11057	GSE11057_1615_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of central memory T cells versus peripheral blood mononuclear cells (PBMC).	Microarray deconvolution is a technique for quantifying the relative abundance of constituent cells in a mixture based on that mixture's microarray signature and the signatures of the purified constituents. It has been applied to yeast and other systems but not to blood samples. Here we test the ability of this technique to determine the fractions of subsets of memory T cells in peripheral blood mononuclear cell (PBMC) samples.					339122	23484	3932	9020	158	2035	54496	126917	89845	54923	55294	79085	6932	54780	80003	155400	28951	10133	84916	914	10626	63925	166	6504	51696	171023	54509	257160	81558	4798	23492	23344	375449	923	401647	340061	55268	80714	28639	23341	59307	8192	57185	1107	64978	4300	146198	8445	55690	9294	55031	57062	2043	25996	51490	23348	4063	23154	90987	594	57326	85456	23048	4094	254531	10938	57414	9531	28955	84900	84159	89846	92906	26297	23043	56262	100130744	283174	163882	145864	83641	92979	7001	3707	222255	3675	921	26034	9882	9949	7804	25845	3097	23469	9725	93058	728743	27134	26018	51078	51575	90313	155066	861	1880	55152	1039	89894	169981	7508	3163	643641	113791	9546	79726	23195	112869	6749	11325	58509	129563	4363	23644	203328	3843	5603	55223	3268	55578	25864	132299	10207	8379	5588	1911	55336	23647	9780	55824	23253	56172	5871	5252	3094	2734	56950	4297	284346	874	23141	939	25851	284040	8832	11184	338620	10152	84969	4118	9749	4012	3702	6942	3590	79695	79710	1731	10868	3315	5924	9695	9290	55180	81552	2625	79863	10528	3669	9786	28978	27043	23164	53347	5335	54606	84861	399	1606	23508	6777	29126	51070	55870	11059	83638	11044	3710	5986	10538	55802
GSE11057_CD4_CENT_MEM_VS_PBMC_DN	M3117		19568420	Abbas AR,Wolslegel K,Seshasayee D,Modrusan Z,Clark HF.	GSE11057	GSE11057_1615_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of central memory T cells versus peripheral blood mononuclear cells (PBMC).	Microarray deconvolution is a technique for quantifying the relative abundance of constituent cells in a mixture based on that mixture's microarray signature and the signatures of the purified constituents. It has been applied to yeast and other systems but not to blood samples. Here we test the ability of this technique to determine the fractions of subsets of memory T cells in peripheral blood mononuclear cell (PBMC) samples.					3728	928	55625	10603	122402	4048	4610	55704	4084	8773	91624	1522	313	8395	5742	51760	100507632	10154	56034	25946	9056	80183	652493	1318	9637	11025	11138	53346	79180	131870	51099	27439	23209	64170	427	411	1808	57699	5724	100128501	9185	201176	3717	5341	3495	84649	2201	55589	51092	23129	6039	55911	5351	219855	1848	1608	54438	6398	463	23136	83930	55717	535	5791	55577	115727	1675	6252	5547	9124	26234	2203	26040	65220	10333	5925	930	307	6036	7942	9375	55356	1051	23199	64218	23433	57705	2717	6695	200424	3514	6678	100288617	374655	8741	5580	6452	239	79168	8301	255488	7086	1845	6643	2590	9764	114879	2217	54507	2180	54863	11342	3111	3460	10326	9331	4064	8291	3779	7461	4615	2162	57552	30817	5577	100113407	523	81622	7739	64420	7226	1066	4211	9741	284207	9966	55332	79627	84002	3957	2907	9555	571	6272	116448	1359	9734	334	79651	84329	8875	26301	53917	80727	6813	58488	28902	6102	9545	1240	51571	55313	10981	162073	51523	220323	8853	6688	23654	9332	7099	6256	79772	5079	11126	201895	100293440	1050	2950	9145	10261	117144	23191	59342	51296	28908	7504	4125	114793	5199	201799	91404	10956	10903	51816	5552	126014	2358	9103
GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_UP	M3118		19568420	Abbas AR,Wolslegel K,Seshasayee D,Modrusan Z,Clark HF.	GSE11057	GSE11057_1616_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive T cells versus memory T cells.	Microarray deconvolution is a technique for quantifying the relative abundance of constituent cells in a mixture based on that mixture's microarray signature and the signatures of the purified constituents. It has been applied to yeast and other systems but not to blood samples. Here we test the ability of this technique to determine the fractions of subsets of memory T cells in peripheral blood mononuclear cell (PBMC) samples.					4862	166647	23569	95681	54682	57605	23331	1604	1942	9263	64772	90293	10873	144132	91782	4602	5150	5796	199	84838	196394	4925	79656	51312	440104	84293	780	146691	80863	55363	3655	57124	6304	286205	6720	285533	4354	54463	9792	641518	100289019	147837	83998	10276	2814	1184	5163	6894	51090	574407	56479	79612	50626	440026	100286937	54674	321	319101	221322	7048	84101	5175	5270	1122	50854	84441	201161	81571	26960	22877	5324	282997	57713	284023	8411	765	79667	7851	645784	388335	55706	92370	26996	10472	4232	60468	375790	9737	157285	346887	6477	646762	91523	23067	3875	339327	140807	22859	3983	81579	51704	400120	283521	22986	143098	4205	7325	165	440515	9823	10389	51379	646808	406893	6322	9751	6293	1117	27115	6609	5125	100507218	322	26227	51735	79690	2217	1823	5152	79890	9487	122773	57019	100113407	10360	23613	10913	283887	113791	3298	55906	126259	125981	80862	344558	1791	144245	5140	7089	665	389114	51133	10099	949	83594	7593	89782	494513	7077	163131	3849	26228	54800	6638	3480	85415	492311	28996	692227	439949	11142	80762	254042	3177	2770	90488	644794	66035	114928	7569	200035	7772	55000	5293	653479	56928	93664	23086	6875	814	6001	64221	9658	100287237	118980	1290	55695	51429	22903	4891
GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_DN	M3119		19568420	Abbas AR,Wolslegel K,Seshasayee D,Modrusan Z,Clark HF.	GSE11057	GSE11057_1616_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive T cells versus memory T cells.	Microarray deconvolution is a technique for quantifying the relative abundance of constituent cells in a mixture based on that mixture's microarray signature and the signatures of the purified constituents. It has been applied to yeast and other systems but not to blood samples. Here we test the ability of this technique to determine the fractions of subsets of memory T cells in peripheral blood mononuclear cell (PBMC) samples.					355	6310	9749	3688	92906	4967	94241	338620	57580	493	4094	3820	3587	5552	55336	149628	4026	10788	6489	4644	79026	7533	116496	360	8832	9780	60481	965	23095	3987	23406	56548	4217	3560	9232	51125	8407	3732	1880	6275	5412	972	10133	7133	23108	94015	23218	56650	8560	3428	1396	2833	8573	257160	4542	90701	55122	2043	5873	1192	5476	440823	29110	1155	64127	51101	30844	54704	96626	196383	5214	8728	135112	307	64859	6515	3123	10095	81030	80820	285195	9766	60	2625	8717	7430	57157	55711	10010	80223	57175	127544	83442	84888	169200	4637	5052	7416	23224	8826	1847	7293	93663	3958	6095	302	79872	7465	285513	4603	4291	6533	23180	26018	92610	9709	196	83879	6478	6747	100507564	5355	9949	11010	51635	50515	2909	64222	2720	29887	490	23199	131544	23231	125488	301	60682	373156	100288693	11236	404636	51155	26031	2060	824	9368	10383	10602	3148	2120	7076	23597	10318	57535	11221	6282	5366	10154	4068	3003	253461	90	7171	214	10130	4267	2124	11046	2040	10043	1316	1235	28966	221035	7049	3939	58472	201633	6251	23052	23204	2889	4088	2804	79035	255231	5714	5580	8682	9055	57534	133418	26053	1730	79677	84282	55320	3956	7905	2771
GSE11057_PBMC_VS_MEM_CD4_TCELL_UP	M3120		19568420	Abbas AR,Wolslegel K,Seshasayee D,Modrusan Z,Clark HF.	GSE11057	GSE11057_1617_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of peripheral mononuclear blood cells (PBMC) versus memory T cells.	Microarray deconvolution is a technique for quantifying the relative abundance of constituent cells in a mixture based on that mixture's microarray signature and the signatures of the purified constituents. It has been applied to yeast and other systems but not to blood samples. Here we test the ability of this technique to determine the fractions of subsets of memory T cells in peripheral blood mononuclear cell (PBMC) samples.					55589	9056	11138	3514	80183	30817	3728	84002	25946	116448	8395	55356	10903	3674	53346	6678	3101	114793	219855	3495	79168	8942	5742	11025	11126	4610	199675	23136	7099	100293440	9332	5196	6252	64170	100128501	10859	1545	29094	930	284415	57864	83716	313	56034	2358	11024	55704	5724	463	10981	973	926	7941	23654	6036	9839	100129502	81027	942	3111	79895	290	284759	1066	100113407	28902	126014	26509	5079	608	10398	28959	3606	84329	1593	2162	10288	2791	10261	5577	80727	9935	284837	6925	3557	51296	4064	131870	26253	120892	57705	8754	535	146722	1848	2217	161742	115350	54790	433	9103	9886	6688	150372	79901	162073	5580	54947	53829	4082	6256	55313	943	1441	1318	80150	1130	50856	216	157	6272	3067	7127	4778	3957	949	8853	5806	23569	5055	9145	3804	64805	1050	6374	760	1240	1230	57698	911	683	100288617	1438	4208	432	2212	6039	3162	11182	10326	10924	27439	3490	121512	115761	84649	6659	81553	4055	4084	11031	25797	22797	8291	23075	55287	23166	932	55799	84519	79689	5101	83937	166929	255488	3597	4947	728	5836	2205	100507632	4900	55016	91624	10437	427	5552	116362	2201	59342	4048	1520	2242	124599	54210	55577	8115	80005	5321	10008
GSE11057_PBMC_VS_MEM_CD4_TCELL_DN	M3121		19568420	Abbas AR,Wolslegel K,Seshasayee D,Modrusan Z,Clark HF.	GSE11057	GSE11057_1617_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of peripheral mononuclear blood cells (PBMC) versus memory T cells.	Microarray deconvolution is a technique for quantifying the relative abundance of constituent cells in a mixture based on that mixture's microarray signature and the signatures of the purified constituents. It has been applied to yeast and other systems but not to blood samples. Here we test the ability of this technique to determine the fractions of subsets of memory T cells in peripheral blood mononuclear cell (PBMC) samples.					59307	26018	1731	1039	28639	5588	57185	57326	10133	23492	54923	55268	23348	2625	375449	53347	55423	10207	56172	166	9949	3945	81558	83641	4063	257160	9240	10125	2035	3835	155400	8573	4798	6489	360	55824	8821	6777	55623	132299	56731	8445	4094	25845	27043	80003	916	959	92558	3688	51466	3710	79791	125488	286161	51070	158584	94039	28955	27436	9020	274	894	81552	91252	1880	25996	5924	80714	5533	50861	5333	3932	57414	915	6482	944	284613	914	8883	338620	57496	51599	6164	340547	921	10868	92906	3702	11278	28984	4068	203328	3732	221061	23305	54496	5920	643641	923	129804	50852	123036	23344	55658	471	5820	653687	57062	4297	9531	23338	79695	146198	112942	283149	55336	55592	6188	28978	6709	51696	940	51742	57198	11044	3163	154761	5335	284129	2043	9695	28755	818	1911	11276	10225	94081	8556	1901	3094	839	11123	5583	6122	7597	7508	9524	439949	9452	57169	9669	25914	9786	401647	161253	51616	90	23370	338440	145864	9749	728743	56160	5557	64975	7186	7188	39	23076	23270	157638	7001	11168	9725	56950	373156	29851	9806	146330	389289	4300	8832	23510	57473	5631	5252	51125	1953	51477	55578	11322	9267	2882	25902	221908	113246	11059	80097	8607
GSE11864_UNTREATED_VS_CSF1_IN_MAC_UP	M3122		18976936	Hu X,Chung AY,Wu I,Foldi J,Chen J,Ji JD,Tateya T,Kang YJ,Han J,Gessler M,Kageyama R,Ivashkiv LB.	GSE11864	GSE11864_1078_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated macrophages versus those cultured with M-CSF [GeneID=1435].	Gene expression analysis of freshly isolated CD14+ human monocytes and monocytes cultured in the presence or absence of interferon (IFN) -gamma for 24 h and then stimulated with Pam3Cys, a Toll-like receptor (TLR) 2 ligand, for 6 h. Results provide insight into mechanisms by which IFN-gamma reprograms early macrophage differentiation and subsequent response to TLR ligands.					6361	9512	54480	79689	220988	8825	9586	51727	57821	181	4670	6901	400451	51616	7178	399900	92235	1043	51621	9674	55854	374291	26469	9409	84628	28981	55843	6515	9709	5350	81876	55275	115727	301	130074	84910	22934	157927	5970	55095	11236	23236	23560	55328	54431	283298	2124	80349	3592	100130557	54882	3190	162979	3142	8563	53826	6840	3727	9792	285286	4087	1938	4001	7318	1794	8575	6143	128826	8821	85464	23119	6168	83443	10095	146722	4069	284359	10632	23216	51280	2355	81704	3779	6173	819	728613	84908	53829	23192	285550	91544	5033	84305	8030	57094	23130	6688	158427	6136	1060	1806	51187	5598	55765	6203	10276	11322	9846	8106	8260	6259	9112	100130353	5023	51314	11224	4839	126364	5682	124599	432	5920	408050	91966	132321	2029	51389	100127972	11331	10892	5236	7323	54946	143689	4123	3087	7040	10180	79836	219557	1955	9146	319085	10121	60489	94241	158402	1537	6234	8099	6146	117289	352999	54758	4034	221002	84631	6188	5719	57132	23710	133121	11054	230	51020	212	619190	50854	118670	9920	10412	6194	5747	100506328	9535	159091	64754	58155	90850	80097	51304	9138	57606	84836	2782	4033	2322	55840	10713	6891	83667	282809	117178	79609	79686	28996	6430	4088	246126	10922
GSE11864_UNTREATED_VS_CSF1_IN_MAC_DN	M3123		18976936	Hu X,Chung AY,Wu I,Foldi J,Chen J,Ji JD,Tateya T,Kang YJ,Han J,Gessler M,Kageyama R,Ivashkiv LB.	GSE11864	GSE11864_1078_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated macrophages versus those cultured with M-CSF [GeneID=1435].	Gene expression analysis of freshly isolated CD14+ human monocytes and monocytes cultured in the presence or absence of interferon (IFN) -gamma for 24 h and then stimulated with Pam3Cys, a Toll-like receptor (TLR) 2 ligand, for 6 h. Results provide insight into mechanisms by which IFN-gamma reprograms early macrophage differentiation and subsequent response to TLR ligands.					7767	57095	286148	55361	23557	100289294	2567	54893	158880	100130987	92106	7905	6709	79663	284029	3399	114134	7439	5962	7539	6814	10869	686	51276	23369	114041	26122	154881	22794	55140	55764	102	64145	83544	8479	26959	24147	9282	147179	25972	8412	8974	10009	51264	2921	122970	223082	23471	29095	222236	5576	140	55705	10311	10440	90861	129285	8808	9767	284801	254013	79842	4637	9240	1555	57823	27429	26278	84868	5138	83693	29925	51368	10591	55958	55726	340527	114771	4590	131601	55536	8284	84911	26608	91607	5303	90627	84284	6102	222484	27180	8847	9131	9317	10376	54442	3978	54885	1690	286826	344	83480	10651	84678	7779	6369	57465	55659	5195	9569	54344	55628	79866	5584	153364	80772	221687	8405	3955	51311	404220	26277	125893	642826	376940	1184	25927	29796	147463	348995	55071	127687	84225	9957	84693	8893	7728	283876	387357	83605	55762	79654	2669	51063	23126	207063	10873	8505	79692	57205	1728	1616	971	51067	26058	6614	80306	283547	56005	4682	7567	1429	821	2713	9416	10081	57209	28957	2720	29082	92170	91464	3052	54908	51070	81617	50865	9793	1954	729582	56925	9166	3077	2342	644150	80045	54622	989	122830	196294	55591	29992	29127	219854	5925	116985	10057	9527	2717	9694
GSE11864_UNTREATED_VS_CSF1_IFNG_IN_MAC_UP	M3124		18976936	Hu X,Chung AY,Wu I,Foldi J,Chen J,Ji JD,Tateya T,Kang YJ,Han J,Gessler M,Kageyama R,Ivashkiv LB.	GSE11864	GSE11864_1079_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated macrophages versus those cultured with M-CSF [GeneID=1435] and IFNG [GeneID=3458].	Gene expression analysis of freshly isolated CD14+ human monocytes and monocytes cultured in the presence or absence of interferon (IFN) -gamma for 24 h and then stimulated with Pam3Cys, a Toll-like receptor (TLR) 2 ligand, for 6 h. Results provide insight into mechanisms by which IFN-gamma reprograms early macrophage differentiation and subsequent response to TLR ligands.					56675	9929	51637	6901	29066	7090	26469	145483	6171	51611	11236	93589	6203	2124	2330	6605	79862	25925	974	51135	23275	60481	22839	7867	6146	162979	51114	23528	51616	100130557	4209	10603	94101	112609	2322	2004	55000	56270	4250	3592	5859	5210	11133	8767	122953	5814	51304	56996	2782	6451	9185	57156	55186	8825	10175	8653	128646	57864	84897	683	54855	153546	26502	3707	196	7520	220972	57132	8970	27013	131583	79364	10434	4908	1998	6136	6917	6840	148423	57414	285286	619426	81559	100130428	51614	55269	51084	100288079	64376	1849	29998	90850	217	9905	8859	85464	23270	122060	1173	5906	65998	221294	100113407	10276	1628	23164	85007	7433	440193	112936	5914	23099	11129	10015	374969	10163	5412	100303755	6468	54795	100505832	83719	4005	284723	84953	9708	2268	83667	3421	199990	153	115701	113201	55909	54946	9349	63935	23764	6453	64147	64754	6152	54994	2873	9517	23230	54108	59347	64412	5908	55274	728613	84282	114915	1388	4627	3087	57654	647310	9792	100288954	3614	10884	6932	9987	221184	151056	24142	6128	6205	3964	864	6194	284756	8440	4092	90338	112483	9368	144983	5747	55625	29125	154881	22906	30836	91544	10042	100288009	8099	51228	6527	9846	4034	7404	5023	26520	313	23093	100507099
GSE11864_UNTREATED_VS_CSF1_IFNG_IN_MAC_DN	M3127		18976936	Hu X,Chung AY,Wu I,Foldi J,Chen J,Ji JD,Tateya T,Kang YJ,Han J,Gessler M,Kageyama R,Ivashkiv LB.	GSE11864	GSE11864_1079_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated macrophages versus those cultured with M-CSF [GeneID=1435] and IFNG [GeneID=3458].	Gene expression analysis of freshly isolated CD14+ human monocytes and monocytes cultured in the presence or absence of interferon (IFN) -gamma for 24 h and then stimulated with Pam3Cys, a Toll-like receptor (TLR) 2 ligand, for 6 h. Results provide insight into mechanisms by which IFN-gamma reprograms early macrophage differentiation and subsequent response to TLR ligands.					10263	3959	4291	10993	5270	9815	256586	6001	267002	23480	4905	54442	9793	402	27430	8878	55361	9765	11006	84272	8449	29969	10869	55705	4343	23404	23435	53981	1352	54840	90627	7203	200081	84437	2717	92106	23334	220	6341	9611	223082	9131	118487	23630	10964	9604	121260	28991	7905	5741	1737	9527	91966	83605	7561	51300	64422	9550	23471	140775	54209	7771	51248	8985	3093	1616	140739	55858	201254	56259	5691	10782	25902	64374	86	85465	114932	84693	6809	10296	9695	9915	8013	27101	202	9361	79728	10654	1622	5524	84848	331	100130894	7567	55622	4799	9730	10384	134492	7673	5437	54453	114134	3306	221491	1653	5709	85463	6730	9100	9451	91607	83636	6742	116225	3669	58480	407	28970	7879	23636	255231	123207	5188	31	6120	5150	10240	84079	975	5321	79968	22809	6477	148932	100129427	3572	1479	1798	84284	11267	10745	151963	100129935	5373	10960	8417	629	8565	9414	91464	22928	154092	116068	10780	55131	4850	4718	348801	124454	79891	167359	56155	27299	83863	10989	55676	8446	56975	56916	8515	207063	63920	483	9569	129138	1518	7705	79174	151636	54554	402682	55917	54780	10488	3842	10190	59344	3119	5356	1349	3310	84318	6921	83666	5702	1514	474170	283537	8996
GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_UP	M3129		18976936	Hu X,Chung AY,Wu I,Foldi J,Chen J,Ji JD,Tateya T,Kang YJ,Han J,Gessler M,Kageyama R,Ivashkiv LB.	GSE11864	GSE11864_1080_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated macrophages versus those cultured with M-CSF [GeneID=1435] and Pam3Cys (TLR2 agonist).	Gene expression analysis of freshly isolated CD14+ human monocytes and monocytes cultured in the presence or absence of interferon (IFN) -gamma for 24 h and then stimulated with Pam3Cys, a Toll-like receptor (TLR) 2 ligand, for 6 h. Results provide insight into mechanisms by which IFN-gamma reprograms early macrophage differentiation and subsequent response to TLR ligands.					147798	9500	9846	29066	6451	2001	23518	6194	221895	6901	23168	2280	266655	1666	974	84897	2322	8233	57864	11057	54883	5775	5937	9987	285512	51274	10367	613	115209	51185	285286	2788	79862	1102	79836	53917	1073	55741	55095	4209	51317	205327	154214	8776	200772	10412	160	55793	3592	10713	64376	55276	54956	79663	143684	93589	8563	8021	10239	23099	10603	91775	9975	6814	665	3399	53938	989	5920	10276	7428	100190986	51523	54890	5318	113763	54664	254531	7791	192670	26036	9532	9535	165918	6583	51616	84343	2066	150209	7290	221178	283537	81622	51660	84901	11331	81689	10427	2073	6428	619426	55959	124460	10766	4191	5256	1075	51279	10311	55174	6652	221002	84278	64130	728613	3953	80346	54828	5368	80774	5906	152195	11314	84628	4299	8273	23208	400541	79811	6480	5994	10618	29883	100507392	6565	4524	51379	673	126917	285613	51187	55852	24142	9738	9905	6046	100506328	54934	54541	6948	57096	201895	4437	54681	8621	5504	84532	84722	11262	23270	91748	9159	23406	158586	26953	4354	85464	11322	292	84519	55893	26147	9997	2771	5019	4335	91662	409	51337	285441	54471	7321	10746	282809	950	94241	2870	23033	7318	340947	5824	29072	7414	9774	22995	892	7138	54504	79745	54920
GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_DN	M3130		18976936	Hu X,Chung AY,Wu I,Foldi J,Chen J,Ji JD,Tateya T,Kang YJ,Han J,Gessler M,Kageyama R,Ivashkiv LB.	GSE11864	GSE11864_1080_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated macrophages versus those cultured with M-CSF [GeneID=1435] and Pam3Cys (TLR2 agonist).	Gene expression analysis of freshly isolated CD14+ human monocytes and monocytes cultured in the presence or absence of interferon (IFN) -gamma for 24 h and then stimulated with Pam3Cys, a Toll-like receptor (TLR) 2 ligand, for 6 h. Results provide insight into mechanisms by which IFN-gamma reprograms early macrophage differentiation and subsequent response to TLR ligands.					55858	5150	100048912	7416	10190	1007	6614	64087	22928	114897	65082	26010	26277	9533	83890	167359	7366	728431	5681	123169	113878	29969	79142	53981	150468	55131	6324	3839	55900	57510	414235	1954	5692	51067	23220	129401	55705	23660	84365	5709	79898	84141	27436	151230	9669	100131541	353355	80304	57547	57053	55762	83743	440026	84962	84706	6341	84225	10591	124872	285429	5702	10528	112398	51096	83590	55140	5902	6880	23277	55003	23480	58525	7360	54908	158434	50937	3861	83693	3664	25998	6990	54206	22821	54	25927	51388	497189	10043	161635	1793	80736	54957	60673	55250	22794	118430	5214	7251	25972	54919	56033	10021	5704	54813	57515	58189	6714	9310	283643	10780	283104	4850	6010	54840	29100	6634	865	57602	730094	161394	55341	6857	80263	441024	10656	118788	541472	4238	400657	57669	571	80010	10254	5326	7096	2010	200014	64858	27020	586	91522	10670	83896	27063	1196	9416	5682	29927	29923	55958	8517	9183	10827	79894	7770	80218	54433	400692	64778	64109	55257	9909	26589	283847	3563	51249	729658	59269	6992	552889	5518	125113	8898	10989	93649	9887	23351	3315	7866	286234	7779	6637	3998	4616	22882	1518	23429	3176	8764	100131816	55916	375035	9695	375790	11222	54554	8842	7113	10143	92979
GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP	M3131		18976936	Hu X,Chung AY,Wu I,Foldi J,Chen J,Ji JD,Tateya T,Kang YJ,Han J,Gessler M,Kageyama R,Ivashkiv LB.	GSE11864	GSE11864_1081_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated macrophages versus those cultured with M-CSF [GeneID=1435], IFNG [GeneID=3458] and Pam3Cys (TLR2 agonist).	Gene expression analysis of freshly isolated CD14+ human monocytes and monocytes cultured in the presence or absence of interferon (IFN) -gamma for 24 h and then stimulated with Pam3Cys, a Toll-like receptor (TLR) 2 ligand, for 6 h. Results provide insight into mechanisms by which IFN-gamma reprograms early macrophage differentiation and subsequent response to TLR ligands.					84196	4610	8801	23648	7249	645513	10434	266655	57132	256356	54828	100132596	51135	6917	10273	54463	7520	7323	11311	29066	6652	152195	9528	6903	54843	10641	51185	8970	9879	151056	153546	2926	81631	6451	128872	3797	51063	8905	11329	8562	26994	256435	54976	51313	6418	9889	401152	11010	83888	6619	79682	7433	22821	5144	6133	148423	7095	151393	10713	54956	1124	4670	10519	79089	317662	100505761	113763	23107	84142	8019	81622	81559	116151	9958	57107	2051	112849	29080	54934	11331	9535	9500	201562	10541	9792	100271832	54784	23406	10618	84532	2081	401577	90231	161176	10300	50626	84276	84836	9532	84058	23355	7410	7263	29789	5786	84284	84993	10095	902	665	9519	6279	112970	5050	2280	60314	7678	100288954	151306	147798	374659	80005	2131	9138	51257	84305	9905	9779	79735	3399	8289	10982	29125	55486	3953	285830	65117	920	51306	4524	51449	23623	121551	409	25941	56270	6100	388284	285346	3082	2073	26121	7805	6421	4357	2720	114915	56922	192670	57537	5058	23234	57153	246329	9896	91662	122953	283687	51669	3622	6643	4299	348094	11020	10106	100130557	84628	4258	57118	29081	283871	51720	83690	100507246	27241	27284	373156	5934	64131	160335	646450	55074	10559	2771	6201	7019	11100	5830	79609	8575
GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN	M3132		18976936	Hu X,Chung AY,Wu I,Foldi J,Chen J,Ji JD,Tateya T,Kang YJ,Han J,Gessler M,Kageyama R,Ivashkiv LB.	GSE11864	GSE11864_1081_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated macrophages versus those cultured with M-CSF [GeneID=1435], IFNG [GeneID=3458] and Pam3Cys (TLR2 agonist).	Gene expression analysis of freshly isolated CD14+ human monocytes and monocytes cultured in the presence or absence of interferon (IFN) -gamma for 24 h and then stimulated with Pam3Cys, a Toll-like receptor (TLR) 2 ligand, for 6 h. Results provide insight into mechanisms by which IFN-gamma reprograms early macrophage differentiation and subsequent response to TLR ligands.					10190	10254	9798	54435	10989	283501	8731	84272	6809	155061	5495	283208	55275	3156	25902	9683	256586	344752	440026	7026	11018	84869	57826	54093	440515	8548	79734	100506495	1386	55677	4860	55900	9604	7770	26277	54329	80306	5962	9904	5701	4842	117579	64778	24147	56650	8295	5469	162394	1603	4291	5321	51706	10067	728431	54	10527	8600	813	8754	27340	29933	60673	719	10640	55628	66036	5819	246243	10993	5645	51	51429	51311	8517	54149	400794	64211	27037	10248	7096	29927	8394	57089	56129	55361	96764	57017	3002	10000	3105	8293	7314	55909	5092	55219	90861	7107	5690	169714	54617	51567	3036	9646	9177	1795	55069	120065	147650	6637	93034	2356	8847	283847	348174	55916	56850	222229	51029	9031	2210	85455	399	10735	51177	84188	55181	6730	285556	6509	124359	3660	4064	23511	6015	55676	203859	5719	285627	7728	54332	51015	283254	27069	91752	83596	58477	83931	56005	4063	347730	11099	1601	23644	200081	26519	55732	6978	326625	6729	100506667	282808	202309	112398	55131	267002	5054	6059	80301	1435	10910	283692	51480	5373	283508	3313	7627	26010	9070	54514	9765	26003	1620	5706	10623	23480	80255	2055	80271	5682	10421	3897	8878	2512	65082	51647	26511	80010	4891	3563	340533
GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_UP	M3133		18976936	Hu X,Chung AY,Wu I,Foldi J,Chen J,Ji JD,Tateya T,Kang YJ,Han J,Gessler M,Kageyama R,Ivashkiv LB.	GSE11864	GSE11864_1082_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages cultured with M-CSF [GeneID=1435] versus macrophages cultured with M-CSF [GeneID=1435] and IFNG [GeneID=3458].	Gene expression analysis of freshly isolated CD14+ human monocytes and monocytes cultured in the presence or absence of interferon (IFN) -gamma for 24 h and then stimulated with Pam3Cys, a Toll-like receptor (TLR) 2 ligand, for 6 h. Results provide insight into mechanisms by which IFN-gamma reprograms early macrophage differentiation and subsequent response to TLR ligands.					2669	9923	135228	10585	3399	23428	2048	6196	54209	8501	51063	84937	4780	9528	590	757	4155	27018	55764	7095	10038	8339	285205	6477	50809	7145	3480	57414	7750	245812	3077	3797	22882	6533	60680	57458	25776	10782	11059	5918	57409	23639	100130581	56940	54520	116372	10933	1108	161	10397	3696	11188	56907	4833	84777	57460	79026	51382	152098	9896	4835	10420	29956	284801	4005	1300	10160	3476	8284	6388	6171	57136	5738	56257	919	100505832	5447	55486	729013	1385	55788	23613	23248	389792	284013	51098	9706	440738	100506686	5412	27197	6320	51614	100131564	9990	10257	64798	55274	154743	6605	27075	28966	10014	84309	23355	283876	1474	2921	1390	90799	3459	9218	7572	7739	3082	286002	3682	3187	9185	57504	140707	9379	221184	10194	9098	729082	55139	57539	4013	10461	23075	83986	26751	9545	25912	4082	55812	648556	646241	719	9968	642361	57209	64333	56900	63917	23112	57192	5947	5141	23166	53635	51319	54796	6711	338758	23230	10560	51309	54453	1964	10170	23582	729614	943	2857	22837	121274	219854	85001	162	8480	8021	137872	4832	79834	7037	55831	54585	11309	151963	23524	283143	55893	60677	153830	119392	56063	130355	10390	100134017	6038	3397	100288617	4145	1687	7773	11138	9363	23062
GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_DN	M3135		18976936	Hu X,Chung AY,Wu I,Foldi J,Chen J,Ji JD,Tateya T,Kang YJ,Han J,Gessler M,Kageyama R,Ivashkiv LB.	GSE11864	GSE11864_1082_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages cultured with M-CSF [GeneID=1435] versus macrophages cultured with M-CSF [GeneID=1435] and IFNG [GeneID=3458].	Gene expression analysis of freshly isolated CD14+ human monocytes and monocytes cultured in the presence or absence of interferon (IFN) -gamma for 24 h and then stimulated with Pam3Cys, a Toll-like receptor (TLR) 2 ligand, for 6 h. Results provide insight into mechanisms by which IFN-gamma reprograms early macrophage differentiation and subsequent response to TLR ligands.					3827	27339	3959	23120	661	3449	440026	340267	100506776	54780	8092	642313	145783	23630	5719	29777	50814	148932	317761	7776	5724	5693	8843	738	23313	119385	197021	5819	256586	1050	4860	26255	23480	81544	118442	353514	54020	1994	1234	205	64776	1763	81034	5557	692159	56616	9399	150291	8890	840	16	5686	55328	56954	4343	57821	54187	387921	346171	56915	9260	57510	28969	9766	55466	25886	11006	112970	151636	57706	25797	185	11024	5692	79084	1349	3431	84154	142689	23357	9550	200014	3949	79228	84883	5368	25828	161145	9127	6721	29125	144423	124491	5464	26589	283130	5707	6307	92235	153020	6737	1798	7052	4975	10712	7314	3119	9695	503519	286122	79050	1847	4668	51106	5210	4353	8869	114880	493861	55063	56300	64425	727916	400	6187	144535	10921	64595	23149	23307	9466	55920	55146	114049	9712	29940	212	6509	7386	9577	3692	6993	79759	1737	1298	683	541578	7458	29078	4839	96626	29920	285627	3281	10466	259	8607	80305	9136	11118	5702	7866	945	121053	10131	23216	55239	414235	3735	1611	8672	80975	5423	9693	10797	23070	55281	51312	26003	340542	58477	529	9487	126792	27166	60312	346157	283999	26520	5524	26040	4515	9361	5709	10525	2119	123688	84329	55113	22809
GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_UP	M3136		18976936	Hu X,Chung AY,Wu I,Foldi J,Chen J,Ji JD,Tateya T,Kang YJ,Han J,Gessler M,Kageyama R,Ivashkiv LB.	GSE11864	GSE11864_1083_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages cultured with M-CSF [GeneID=1435] versus macrophages cultured with M-CSF [GeneID=1435] and Pam3Cyc.	Gene expression analysis of freshly isolated CD14+ human monocytes and monocytes cultured in the presence or absence of interferon (IFN) -gamma for 24 h and then stimulated with Pam3Cys, a Toll-like receptor (TLR) 2 ligand, for 6 h. Results provide insight into mechanisms by which IFN-gamma reprograms early macrophage differentiation and subsequent response to TLR ligands.					56898	440498	23446	1628	5524	10313	5138	100130987	5775	11133	10765	79956	51276	150962	51780	390035	53938	23177	55082	3480	55244	8284	167681	6733	2048	23250	5859	3077	23741	9595	246329	11329	55276	1829	115548	197259	6199	6612	6894	29062	161	100310756	2644	6565	121506	3643	1073	6817	10239	91544	5210	168544	51351	55741	29035	2059	84148	57192	84058	100286909	7167	23659	55251	114134	90550	55501	4357	90987	5994	9975	2788	57465	10460	79864	26091	6480	433	23471	79035	6453	7567	130951	93589	6402	80150	3554	54622	10635	91607	8339	23648	55103	150726	152195	9586	284370	7514	57120	54583	80223	25927	79670	3433	79582	100506686	55623	55204	23603	6646	80345	8443	23077	139818	23345	10057	140	23376	5991	867	1901	8816	284029	26063	8850	339988	535	81790	80829	57136	55552	8233	100127972	6715	50839	55062	4286	338382	2330	51727	140710	8535	819	51719	10740	219731	4267	84851	51337	6613	5108	4258	5527	23033	6941	4542	1806	55704	57496	221037	26258	58190	23094	79641	8021	23075	376940	403313	1353	124997	79991	29956	196527	9215	8905	55818	54	51063	201562	56940	121665	255967	6709	143684	57531	4669	23608	79096	7716	7389	201595	23639	25961	51268	54890	23428	54861	29960	6711	493	57446
GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_DN	M3137		18976936	Hu X,Chung AY,Wu I,Foldi J,Chen J,Ji JD,Tateya T,Kang YJ,Han J,Gessler M,Kageyama R,Ivashkiv LB.	GSE11864	GSE11864_1083_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages cultured with M-CSF[GeneID=1435] versus macrophages cultured with M-CSF [GeneID=1435] and Pam3Cyc.	Gene expression analysis of freshly isolated CD14+ human monocytes and monocytes cultured in the presence or absence of interferon (IFN) -gamma for 24 h and then stimulated with Pam3Cys, a Toll-like receptor (TLR) 2 ligand, for 6 h. Results provide insight into mechanisms by which IFN-gamma reprograms early macrophage differentiation and subsequent response to TLR ligands.					2717	9875	84769	11049	7180	2113	57647	201475	10206	16	100505881	195827	80725	5887	9688	3449	647190	55854	661	6632	9868	9440	118430	100291860	3487	29889	100131532	83460	27339	607	10512	399900	2020	9097	53637	10189	26099	840	9219	23253	84141	3779	7003	23636	29896	84872	9723	100133660	54620	124872	9034	10105	1973	58525	728431	84231	7357	5782	152742	6396	6010	57720	80301	1407	10139	155060	127845	10197	166968	11036	4067	10209	84259	10056	64087	9732	541472	27	55207	59269	10952	57823	80255	10588	79048	55137	2865	79711	100506783	3096	11222	51232	352990	55031	347344	3142	9695	23011	391712	83590	100288617	27154	64859	4001	65083	64090	8013	2182	310	1690	7064	10954	5191	727916	4779	57053	50628	2355	23220	25977	10590	4927	283651	57154	9308	4969	7020	27328	4494	118460	10992	2196	83939	5425	10840	10238	10485	2633	4047	23396	201625	118788	10600	90529	9058	128272	6782	1572	6388	116729	6507	1616	9015	9261	54433	6654	330	9945	63925	8531	114897	7027	23216	55920	122704	84365	8853	24145	90362	57669	84886	1418	5886	5327	5373	7068	55848	5546	63893	26973	84132	29095	3615	100132686	80380	26155	146723	83667	127544	55509	1827	2713	51733	5700	177	5027	25775	5464	51569	387521
GSE11864_CSF1_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP	M3138		18976936	Hu X,Chung AY,Wu I,Foldi J,Chen J,Ji JD,Tateya T,Kang YJ,Han J,Gessler M,Kageyama R,Ivashkiv LB.	GSE11864	GSE11864_1084_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages cultured with M-CSF [GeneID=1435] versus macrophages cultured with M-CSF [GeneID=1435], IFNG [GeneID=3458] and Pam3Cyc.	Gene expression analysis of freshly isolated CD14+ human monocytes and monocytes cultured in the presence or absence of interferon (IFN) -gamma for 24 h and then stimulated with Pam3Cys, a Toll-like receptor (TLR) 2 ligand, for 6 h. Results provide insight into mechanisms by which IFN-gamma reprograms early macrophage differentiation and subsequent response to TLR ligands.					100133920	79956	11010	158880	51309	55631	100289294	1994	10142	29901	57095	56898	5570	6196	286148	222643	2048	23648	10618	10641	57209	79004	7178	55656	9103	25927	56987	51351	2330	50626	84869	79682	11211	64105	284801	3476	197370	4735	3795	10914	4303	23233	65123	23428	11188	127495	1954	100288656	56157	60487	114926	56255	5634	119504	4835	10972	54901	201595	3077	27067	1806	51300	57446	51304	60496	7343	6709	8473	256302	348995	26005	25949	27247	7980	317662	57506	9775	84326	527	5786	7514	10902	152926	221037	375444	57568	2644	659	10038	55501	389765	119392	10291	4258	10313	4351	5557	80856	83888	2821	54954	26219	11000	6732	56034	9779	55654	8099	54585	25814	10526	121506	55017	147929	282974	3162	11329	8986	6817	9905	729839	58485	51160	27229	8366	55625	1374	26777	56906	90231	100288693	79657	728498	432	54861	266655	8502	79096	85021	115	493812	60528	5330	105	284459	222236	3693	90987	7520	23531	30	2049	64756	93589	55425	51185	55074	5304	8733	3397	10365	5436	9512	7318	123263	1312	6612	55374	64131	57544	10287	221	55552	8396	9061	79991	388507	54946	7678	3939	5037	11020	100130581	55364	8379	4905	79443	57130	4833	55766	5525	546	80222	8339	51669	51528	6272	6502	376940	5994
GSE11864_CSF1_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN	M3140		18976936	Hu X,Chung AY,Wu I,Foldi J,Chen J,Ji JD,Tateya T,Kang YJ,Han J,Gessler M,Kageyama R,Ivashkiv LB.	GSE11864	GSE11864_1084_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages cultured with M-CSF [GeneID=1435] versus macrophages cultured with M-CSF [GeneID=1435], IFNG [GeneID=3458] and Pam3Cyc.	Gene expression analysis of freshly isolated CD14+ human monocytes and monocytes cultured in the presence or absence of interferon (IFN) -gamma for 24 h and then stimulated with Pam3Cys, a Toll-like receptor (TLR) 2 ligand, for 6 h. Results provide insight into mechanisms by which IFN-gamma reprograms early macrophage differentiation and subsequent response to TLR ligands.					55858	84926	92235	10588	57510	16	5692	2356	123775	55909	283501	29110	10090	253970	84666	142891	1192	146795	54620	8293	3827	7458	6992	9674	3142	344752	27436	54033	1890	5599	54187	1622	5054	29926	91272	283508	1973	9929	8313	352999	93643	7203	1718	165904	5778	83597	2895	100506328	3487	84779	6515	55509	5616	58515	55207	57480	283999	4067	283951	100286938	66002	5739	6509	54881	83606	10600	29940	51602	84154	2717	55916	55720	10063	1012	25902	27291	727916	8896	5092	8544	79048	1466	10206	29920	84557	100507436	9266	5150	23760	126321	23284	10485	59269	23216	256586	120103	326625	55219	8013	85463	23403	10229	2204	10970	118460	58477	10652	150379	1717	201514	83930	10432	9938	9034	221409	100506492	1435	5732	11025	9097	51703	24145	8834	9227	64928	23053	23011	662	56890	3717	1081	9446	7866	7726	445347	6868	388714	284257	223082	56155	9689	115861	3002	152992	2182	80737	83732	9209	29097	8444	5693	1543	57414	8671	55063	1737	8884	7319	10147	285627	81034	8446	9816	83636	8721	399	9638	145773	51264	253650	7052	53831	4236	64422	649305	10785	27248	4616	26037	348761	220074	4683	79879	203068	5580	57466	83931	1054	122704	51118	55201	9519	23132	3384	112970	25822	222611	5469	9451	1608
GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_UP	M3142		18976936	Hu X,Chung AY,Wu I,Foldi J,Chen J,Ji JD,Tateya T,Kang YJ,Han J,Gessler M,Kageyama R,Ivashkiv LB.	GSE11864	GSE11864_1085_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages cultured with M-CSF [GeneID=1435] and IFNG [GeneID=3458] versus macrophages cultured with M-CSF [GeneID=1435] and Pam3Cyc.	Gene expression analysis of freshly isolated CD14+ human monocytes and monocytes cultured in the presence or absence of interferon (IFN) -gamma for 24 h and then stimulated with Pam3Cys, a Toll-like receptor (TLR) 2 ligand, for 6 h. Results provide insight into mechanisms by which IFN-gamma reprograms early macrophage differentiation and subsequent response to TLR ligands.					10993	55276	6050	2788	987	79663	127700	11057	3978	57095	84868	84179	64744	57209	10239	10161	5058	23471	3312	23586	4524	284611	79956	3684	114134	115209	6480	2533	23603	4542	65123	56907	6652	85315	23765	140707	6595	301	3108	1441	113791	121260	144363	56155	115761	1737	84456	92106	55501	4329	55093	57511	64407	30	1666	6296	11221	2280	10857	8233	91607	5090	55255	283130	64127	150864	4677	23549	2177	10981	146540	10462	23070	7456	1102	6948	5501	8850	57118	6737	5414	64172	113	1296	63901	55893	196410	116447	90627	51444	9252	2634	4258	5934	80005	54206	257019	7167	9314	10367	5899	3660	255812	54664	285195	4343	84343	23608	56953	9711	51147	6614	23039	22883	7405	23654	10068	93129	59336	64764	79132	7084	9837	51669	8677	132321	144423	92241	285971	339448	5213	3621	414328	326332	535	128077	8775	2319	9764	3430	1729	10695	64422	3561	2232	91544	2235	200315	7852	64170	11322	83666	474170	5547	91748	284029	5859	58190	100131733	3098	3105	79896	8773	166378	401494	55313	5888	122060	283927	9712	55862	3717	4615	29108	80279	4179	89849	55326	64793	5557	84934	115509	27102	11238	29785	10712	23228	9220	211	26270	55328	2123	3106	717	153733	89781	10919	4175	6570	23047
GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_DN	M3143		18976936	Hu X,Chung AY,Wu I,Foldi J,Chen J,Ji JD,Tateya T,Kang YJ,Han J,Gessler M,Kageyama R,Ivashkiv LB.	GSE11864	GSE11864_1085_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages cultured with M-CSF [GeneID=1435] and IFNG [GeneID=3458] versus macrophages cultured with M-CSF [GeneID=1435] and Pam3Cyc.	Gene expression analysis of freshly isolated CD14+ human monocytes and monocytes cultured in the presence or absence of interferon (IFN) -gamma for 24 h and then stimulated with Pam3Cys, a Toll-like receptor (TLR) 2 ligand, for 6 h. Results provide insight into mechanisms by which IFN-gamma reprograms early macrophage differentiation and subsequent response to TLR ligands.					8848	2348	2717	2509	56902	7280	1117	55790	6520	6434	2113	100048912	253044	23220	9818	6714	54435	6324	10043	8565	130074	5504	92737	401612	55031	8355	5962	57720	1572	1616	6507	100190986	3985	6103	10206	7319	255231	837	79707	55207	55677	145567	285908	200172	4302	113878	10189	90589	6615	5970	8446	9263	3376	3556	9929	23351	27	221749	6581	7296	5209	3183	147837	100505718	5036	2010	118430	347344	10046	391	23212	23468	23219	203068	2617	5693	7866	25960	3014	54453	7357	10584	908	6046	65263	4067	9146	29841	2356	26821	27316	54487	26354	10409	5743	5681	162394	64794	55802	4739	65124	6125	3615	914	51703	2170	55909	83447	79740	83860	91272	81619	838	9308	25766	9776	6729	26064	83481	272	79572	79711	729059	54971	170506	5452	135228	2547	54455	56893	646329	344887	25928	54463	55003	23	1840	7037	8653	27342	11343	339476	55762	3914	23329	1285	60	54919	400548	10922	253982	80255	6533	9814	84883	1234	3487	151963	91782	8061	7762	92181	23742	9209	284013	10949	55319	4494	958	9043	2561	100131176	9448	27328	83667	57817	7378	55686	1431	127845	54918	9683	340206	10488	51088	8738	100288617	400768	3726	85450	23534	154881	64859	646113	57481	7289	2357	7832	9875	254158
GSE11864_CSF1_IFNG_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP	M3144		18976936	Hu X,Chung AY,Wu I,Foldi J,Chen J,Ji JD,Tateya T,Kang YJ,Han J,Gessler M,Kageyama R,Ivashkiv LB.	GSE11864	GSE11864_1086_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages cultured with M-CSF [GeneID=1435] and IFNG [GeneID=3458] versus macrophages cultured with M-CSF [GeneID=1435], IFNG [GeneID=3458] and Pam3Cys (TLR2 agonist).	Gene expression analysis of freshly isolated CD14+ human monocytes and monocytes cultured in the presence or absence of interferon (IFN) -gamma for 24 h and then stimulated with Pam3Cys, a Toll-like receptor (TLR) 2 ligand, for 6 h. Results provide insight into mechanisms by which IFN-gamma reprograms early macrophage differentiation and subsequent response to TLR ligands.					7905	6652	11162	8673	191	955	51611	27346	5245	25814	55801	116151	90231	9672	51533	84514	257160	30	686	2280	55843	389874	84320	100289336	3140	5879	50626	54901	54431	57175	22934	29883	221294	81544	10526	317781	9447	317649	8099	54780	348995	9775	55737	8428	51063	55486	26010	54976	728498	1124	221	6468	25	3428	549	58190	3431	401494	152195	27292	5037	4832	6392	23355	27159	64949	84993	25941	79968	29108	55313	23344	5906	80832	6296	1736	10247	9897	373156	283237	285440	23588	55157	9368	286103	2242	4285	80346	1230	11130	1786	9997	24148	2073	1798	29081	4939	128077	4927	55501	6641	81704	84936	676	54802	752014	6272	90627	140739	9844	7263	728558	374659	9051	1962	256236	56892	155038	23228	149076	7678	51433	55625	2582	51449	7405	55139	65993	115727	8664	23108	11257	51300	11274	2873	114876	2739	168544	5501	55333	10300	84329	246329	400961	3015	29956	64425	100310756	64756	7805	29058	9936	84790	51181	79639	9830	5875	4542	397	2235	2271	1176	65992	64098	64400	3939	4610	11145	10732	5223	6941	831	115106	80975	84309	6643	4094	171391	7762	8819	84286	6494	144233	199990	6595	1806	57570	9399	9815	100289420	80011	3925	1161	58500	79714	47	81533	170575	7414	92106
GSE11864_CSF1_IFNG_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN	M3145		18976936	Hu X,Chung AY,Wu I,Foldi J,Chen J,Ji JD,Tateya T,Kang YJ,Han J,Gessler M,Kageyama R,Ivashkiv LB.	GSE11864	GSE11864_1086_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages cultured with M-CSF [GeneID=1435] and IFNG [GeneID=3458] versus macrophages cultured with M-CSF [GeneID=1435], IFNG [GeneID=3458] and Pam3Cys (TLR2 agonist).	Gene expression analysis of freshly isolated CD14+ human monocytes and monocytes cultured in the presence or absence of interferon (IFN) -gamma for 24 h and then stimulated with Pam3Cys, a Toll-like receptor (TLR) 2 ligand, for 6 h. Results provide insight into mechanisms by which IFN-gamma reprograms early macrophage differentiation and subsequent response to TLR ligands.					84866	124359	28955	7319	10206	51256	256227	10783	151963	84777	400794	4780	3608	84144	64321	23761	2730	117579	1846	5150	253044	2968	84779	54463	6580	27074	3678	9352	64855	51703	8740	57720	23203	10670	4958	201514	6934	57801	4860	130617	83862	2617	100506898	1234	221786	10090	2889	10107	1795	65991	23258	6434	60685	100505832	29123	9818	23403	528	8355	2107	10260	51316	79370	1466	649305	2717	5322	56670	29080	646470	10603	51523	57128	4430	10221	25862	8544	27291	92162	57823	1307	55160	100131816	5717	131408	100507436	90850	4608	8848	55207	51634	1992	400169	5292	838	50805	5128	388951	10213	752	51187	83856	6506	3487	1390	10970	3269	5702	6529	138649	3955	1604	864	3601	80381	6696	79572	59269	100130357	6103	9043	353322	1300	6016	200014	80176	222229	10938	10786	149478	28823	5913	285148	960	8335	84689	837	3306	9146	282808	440983	9990	1026	3687	55081	118813	10133	7107	58525	91603	914	2357	84971	92482	645355	55909	51100	7378	3454	4897	3303	81697	5996	117247	3718	5707	54788	3096	9643	4493	11343	149297	5380	6611	1054	4684	23275	2140	29922	8727	79778	6793	9267	57403	7153	51009	7159	54676	100127940	51260	64092	154197	60492	3070	54455	8353	2305	205564	84876	51271
GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP	M3148		18976936	Hu X,Chung AY,Wu I,Foldi J,Chen J,Ji JD,Tateya T,Kang YJ,Han J,Gessler M,Kageyama R,Ivashkiv LB.	GSE11864	GSE11864_1087_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages cultured with M-CSF [GeneID=1435] and Pam3Cyc versus macrophages cultured with M-CSF [GeneID=1435], IFNG [GeneID=3458] and Pam3Cyc.	Gene expression analysis of freshly isolated CD14+ human monocytes and monocytes cultured in the presence or absence of interferon (IFN) -gamma for 24 h and then stimulated with Pam3Cys, a Toll-like receptor (TLR) 2 ligand, for 6 h. Results provide insight into mechanisms by which IFN-gamma reprograms early macrophage differentiation and subsequent response to TLR ligands.					256356	26205	51616	7866	9767	3003	134701	55646	3376	203068	54919	5550	339978	153830	10538	100126793	84312	115548	29940	22934	6996	5036	169522	6840	3952	10783	4739	51520	654	126792	283387	222255	79707	92856	54433	65083	128434	54435	25960	7003	7705	255488	10399	6383	5583	23446	25942	56925	582	5347	3183	2316	5055	445347	6702	5066	25902	3939	64087	8884	8664	388722	22990	10801	2865	55640	6506	9452	171391	3608	5887	1312	51187	10776	22852	51686	2773	1824	3615	9516	55179	646113	127733	56647	58489	8099	5552	1736	2921	54471	84991	5795	51074	2356	50834	440915	140832	5553	100288294	9410	10317	57128	8496	4616	64285	151963	6372	54985	285533	83940	8744	84365	10857	6999	8738	6749	7727	824	81887	9462	3613	10318	729515	375190	90768	5516	64225	6335	4869	84436	91107	10630	135295	84937	10128	100130288	2960	57338	10131	3032	8693	23136	26135	56893	6202	10056	100506274	2350	8562	4128	26354	4691	9784	5054	11231	64092	4094	116931	11226	369	56122	11325	255193	649446	219654	100507246	55256	7461	9750	56906	29789	54331	64983	3185	8879	126638	80324	347736	1965	51317	169714	4014	144233	223075	26155	64065	6611	9214	4642	5664	23462	55795	3036	348013	439990	3293	57451	51154	605	51663
GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN	M3149		18976936	Hu X,Chung AY,Wu I,Foldi J,Chen J,Ji JD,Tateya T,Kang YJ,Han J,Gessler M,Kageyama R,Ivashkiv LB.	GSE11864	GSE11864_1087_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages cultured with M-CSF [GeneID=1435] and Pam3Cyc versus macrophages cultured with M-CSF [GeneID=1435], IFNG [GeneID=3458] and Pam3Cyc.	Gene expression analysis of freshly isolated CD14+ human monocytes and monocytes cultured in the presence or absence of interferon (IFN) -gamma for 24 h and then stimulated with Pam3Cys, a Toll-like receptor (TLR) 2 ligand, for 6 h. Results provide insight into mechanisms by which IFN-gamma reprograms early macrophage differentiation and subsequent response to TLR ligands.					283991	6948	100133089	9358	203859	23352	4958	23382	92906	28517	4641	9446	10993	9586	253970	1666	3730	84698	113457	51056	64098	144715	57480	3700	6303	55122	84779	6934	535	6539	51744	10367	10673	2591	29946	64946	8578	389895	3105	1906	22809	818	26959	10603	155038	10791	338811	3384	100506328	3717	7041	4345	2329	246329	7402	55512	81870	338872	863	3002	2870	25946	4286	6509	401324	27069	10023	2202	3978	3109	54407	2135	26100	9103	55839	83642	134429	152992	387751	200315	4779	860	285025	7277	2055	10161	10211	3429	6876	116349	373863	84293	401317	79136	80821	140685	59342	159686	83666	116028	1737	10376	1439	3117	9976	4794	79056	6364	375035	64135	81704	2983	1506	26034	10170	1012	4775	8291	23764	8869	5197	80380	2151	84333	10892	3631	284513	5355	285613	4154	64130	26258	145858	4205	11080	54882	9111	201895	57143	1054	5998	953	6645	115361	2210	51371	50650	9881	8638	29995	26112	211	3811	9805	6398	55280	169355	284837	6449	54212	253832	4915	54704	84188	2124	6404	55281	79668	163486	151636	29922	23526	6867	10824	10164	100292408	3594	6891	3681	527	81579	5058	8850	2635	57168	155435	57559	100288810	81603	253018	56990	1075	9208	3683	26253	5686	94039	282991	523	84888
GSE12366_GC_BCELL_VS_PLASMA_CELL_UP	M3166		19023113	Longo NS,Lugar PL,Yavuz S,Zhang W,Krijger PH,Russ DE,Jima DD,Dave SS,Grammer AC,Lipsky PE.	GSE12366	GSE12366_2013_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of germinal center B cells versus plasma cells.	Sorted B cells using flow cytometry. CD19 selected B cells were sorted using flow cytometry.					701	11065	253143	259230	147841	50484	103910	23369	55814	641638	10766	84263	11051	205717	26148	388272	1399	387119	25828	10262	3376	7528	2872	1368	817	113612	6626	7791	120	29072	9363	79034	343099	6502	5788	5090	80025	11198	22882	7874	7157	5111	84668	10658	808	83706	79022	65125	8481	23185	9816	8411	84790	5728	257144	170954	10735	7443	51291	1844	26528	51742	2060	10092	84268	90268	10383	10235	8665	57804	4673	26578	9450	51567	10474	116028	55435	54801	84678	25913	100130744	29767	64131	196264	3613	169714	677	6597	55071	222658	5394	7562	100288693	23786	1536	121536	100129447	6232	2339	84930	9837	63979	25796	3635	57146	115352	7329	51691	3835	81545	1756	5885	10505	254394	2171	53916	6777	55813	113130	29995	55421	388685	6093	7280	8935	440915	221656	23394	80306	2651	963	1719	10714	92667	1738	9416	283417	901	27131	3633	1841	4839	2117	29068	10381	10055	84973	167227	1915	933	27004	10988	11123	83892	374403	55013	8847	2764	127544	9700	221908	4173	54433	9771	25852	92017	10106	1912	255488	115761	4171	7155	1840	3838	100272147	11146	80039	390963	100505746	7405	2023	7019	6632	10019	6144	284611	5888	7408	55038	60468	9294	2113	8607	805	9738	9933	158	9736	10762	10432
GSE12366_GC_BCELL_VS_PLASMA_CELL_DN	M3167		19023113	Longo NS,Lugar PL,Yavuz S,Zhang W,Krijger PH,Russ DE,Jima DD,Dave SS,Grammer AC,Lipsky PE.	GSE12366	GSE12366_2013_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of germinal center B cells versus plasma cells.	Sorted B cells using flow cytometry. CD19 selected B cells were sorted using flow cytometry.					28972	10454	10330	50944	441549	3339	146433	8344	892	952	8455	64061	10026	9276	114131	5732	80199	9406	64221	5007	100271722	646934	51149	148252	6730	11152	5962	1585	4485	1305	14	25797	170589	3651	26576	22983	5140	84061	9451	9236	123283	79026	339483	28786	129530	3816	6510	55254	4152	100131043	100287056	339044	26003	27090	6772	138652	363	728537	400831	2309	26286	414918	10237	115950	11119	8994	607	55218	6789	7832	11189	54732	283403	27293	9375	64763	11070	146330	144535	100287025	9034	5720	23678	51741	29123	133619	7174	3069	94241	3360	100507501	441108	8837	23479	28513	1604	81831	79876	440918	386724	10897	221476	146754	100289098	4043	10548	10195	195827	725	23588	2529	25829	90701	100240728	7293	100507424	166824	22933	143	5611	375346	54972	4601	9935	51661	140606	317649	1389	6711	10749	30008	6480	152518	80267	8542	1271	29094	55289	26470	16	80127	23600	23302	51596	11118	51352	81618	10549	8943	950	3665	4245	79586	84080	24140	64770	51124	645784	26031	1428	2081	57716	8698	58477	23604	100507050	21	79694	375056	196743	26090	7422	7737	834	11343	3214	1636	3217	51014	112703	10417	22936	7922	83858	8733	5997	10802	51363	196996	92	25930	3631	92689	92140	55547	9643	9061	608	56605	9021
GSE12366_GC_VS_NAIVE_BCELL_UP	M3168		19023113	Longo NS,Lugar PL,Yavuz S,Zhang W,Krijger PH,Russ DE,Jima DD,Dave SS,Grammer AC,Lipsky PE.	GSE12366	GSE12366_2014_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of germinal center B cells versus naive B cells.	Sorted B cells using flow cytometry. CD19 selected B cells were sorted using flow cytometry.					4171	163486	55937	27004	23089	5885	2553	4133	23310	51691	23568	4172	4173	8726	64864	401548	113130	79022	92610	10672	10952	140823	55706	944	84930	6726	5591	26511	5213	9133	3782	25932	5169	8732	10445	55723	805	2852	64785	283489	9837	7326	10632	11065	7443	5636	22995	836	11168	79575	8438	23107	3015	9475	14	9324	7762	4946	154467	3070	5450	10935	5347	4628	3281	25959	51514	23002	1939	1719	84281	7260	257144	84950	51013	6117	3838	5111	441263	79794	29995	100506233	55502	7884	5094	55653	3688	7700	4882	4233	9700	4735	79019	26271	689	5073	2741	25939	84085	51582	10381	2597	604	10186	10097	9771	2017	50808	28387	29128	23229	6251	5984	100130744	4005	7298	8761	79783	55038	24137	84316	53354	54892	6518	93550	8013	5341	51366	10592	444	7468	79754	701	55775	3184	283417	220594	26207	327657	28232	2673	3306	9380	23224	8932	55967	1062	3014	54793	84057	9183	11264	134266	638	26147	523	54386	26098	57544	55971	64218	898	84447	3183	8452	1149	975	10541	7531	55591	80039	55871	8412	3987	23637	6598	25906	81611	283454	9793	3835	400941	5716	1111	7150	84991	64395	4258	2941	80206	51012	952	83879	84900	10198	10166	10239	6662	55833	83881
GSE12366_GC_VS_NAIVE_BCELL_DN	M3170		19023113	Longo NS,Lugar PL,Yavuz S,Zhang W,Krijger PH,Russ DE,Jima DD,Dave SS,Grammer AC,Lipsky PE.	GSE12366	GSE12366_2014_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of germinal center B cells versus naive B cells.	Sorted B cells using flow cytometry. CD19 selected B cells were sorted using flow cytometry.					22838	650655	100130938	79817	7592	115708	23064	79890	65982	27128	83666	51611	1843	2550	961	55636	1235	11119	6256	8994	253512	1154	64760	57118	5142	81571	10782	84456	4125	9103	2208	9252	6497	9051	83700	6772	8445	101	386627	7259	727820	80169	23067	1378	197135	80108	8507	6155	4061	29957	1880	388403	10410	55619	55843	642852	4648	6130	120071	4214	11223	54509	80148	3099	81558	10957	3105	3597	2590	3705	22862	84527	151657	5330	387751	969	115123	3921	23499	57587	3428	10287	55601	4149	4542	6156	3074	129303	7048	23030	648	1105	971	26152	10252	4919	1635	7040	54891	23596	126917	441108	1122	5175	55284	1606	8742	152137	4478	10384	401320	834	3459	11118	54103	202309	1500	84441	10365	54832	29123	100132406	79744	116984	53827	3280	5937	65986	59338	201176	30008	1106	326624	112574	116843	90634	3903	9990	967	4907	5698	26053	441212	1453	1120	10451	151888	57479	831	84875	348378	10628	26060	3087	4929	10472	1130	3433	8985	285097	23015	100129460	5244	4853	2014	1604	4302	57181	10475	79720	23344	3972	634	283588	55008	25865	56937	118429	643641	23492	5243	9445	9308	4066	6402	55337	51177	10379	4179	5355	116447	10863	3603	54765	81030	10090	9976	151636	284004	10771
GSE12366_GC_VS_MEMORY_BCELL_UP	M3171		19023113	Longo NS,Lugar PL,Yavuz S,Zhang W,Krijger PH,Russ DE,Jima DD,Dave SS,Grammer AC,Lipsky PE.	GSE12366	GSE12366_2015_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of germinal center B cells versus memory B cells.	Sorted B cells using flow cytometry. CD19 selected B cells were sorted using flow cytometry.					26281	2941	7700	25828	4171	4233	90268	150275	22995	4173	4172	7443	55937	488	4953	23089	7458	3178	57405	100130744	9837	113130	57507	292	1756	140823	3070	5450	8317	1111	975	2954	64116	55421	3394	84790	79019	10146	4604	100131993	25932	79819	79783	79754	50808	8073	6251	50484	6688	55345	3251	4133	283489	1994	10988	27131	79022	7762	26018	83931	51088	327657	23637	9475	1786	201283	51514	26258	586	10409	3306	1445	7280	9686	64326	157313	60468	148203	9448	9477	143684	401548	9623	100506233	10189	10169	10376	55789	23063	2017	6598	24137	23075	441263	26267	51465	10615	5169	22974	283417	9555	286151	3148	55704	84900	645784	81575	343099	100130958	2103	1871	81691	55002	4176	55609	257144	7083	6447	6611	5294	8875	3190	10733	5888	991	29128	4001	79595	8661	80821	91860	220594	817	80150	6768	10055	10381	57570	8115	974	25874	10213	127544	57544	1665	54469	1063	55872	147841	100128191	4033	55508	23224	26996	7511	25906	30844	6691	7421	4005	84991	4919	387882	115703	6428	201562	55388	10672	29028	55689	6421	152485	142	84722	79822	27004	10112	7351	55638	7174	55055	22919	6867	11171	144406	6446	1622	79623	53831	2334	65244	8437	10276	129642	93550	5685	8438	8914	1773	375444
GSE12366_GC_VS_MEMORY_BCELL_DN	M3173		19023113	Longo NS,Lugar PL,Yavuz S,Zhang W,Krijger PH,Russ DE,Jima DD,Dave SS,Grammer AC,Lipsky PE.	GSE12366	GSE12366_2015_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of germinal center B cells versus memory B cells.	Sorted B cells using flow cytometry. CD19 selected B cells were sorted using flow cytometry.					51426	79890	4179	5962	65982	22926	122773	6171	8526	10346	10863	64098	387751	23015	6513	342909	128077	6156	64859	51611	10090	54765	6733	284323	6497	406893	80301	64224	51341	10491	7226	7009	6310	1285	55568	7259	5264	3916	3688	122525	55737	59338	84527	9103	10365	80169	2354	1604	9422	1026	6038	196394	23499	1960	2589	1843	22861	23479	359948	128338	1456	79810	26136	60559	23592	5770	5142	83700	64172	4542	375593	5800	151657	1497	284370	3705	386627	6165	3310	1235	4853	64926	27436	962	10782	8837	678	284273	10068	5324	83692	9725	571	56990	57178	140606	4054	4940	1606	83478	1378	51278	80162	344905	6772	10154	3841	894	6249	1105	8303	26751	10628	83440	79744	27163	80762	57118	79817	9960	9466	619426	51561	64784	4125	112574	100130742	8477	10866	1500	5355	648	56940	57048	25851	1974	5269	55619	26152	8994	9938	828	3459	10443	8204	22862	5463	4832	23341	57136	1831	118429	27244	27097	1880	4214	8590	30008	83417	23625	90634	22863	3700	9252	10618	22881	6155	10838	388	157378	64761	80765	9792	2648	326624	9528	8698	7746	54964	9445	9990	427	3134	83593	6144	57228	147138	9487	25897	401261	201799	953	151888	200958	283149	285423	1236	5159	9022	283209
GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_UP	M3174		19023113	Longo NS,Lugar PL,Yavuz S,Zhang W,Krijger PH,Russ DE,Jima DD,Dave SS,Grammer AC,Lipsky PE.	GSE12366	GSE12366_2016_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in plasma cells versus naive B cells.	Sorted B cells using flow cytometry. CD19 selected B cells were sorted using flow cytometry.					64770	28972	2950	2878	84281	60559	28786	10048	79876	728437	100233209	9276	100507424	54972	84628	84068	23139	55204	3017	55254	79575	81618	57210	10018	8836	6557	8732	8933	23678	80765	79629	1389	9595	7832	64221	2131	25972	7976	8344	199857	54923	51614	497634	9324	10084	441869	10330	6746	6509	117579	127294	4357	1613	23224	153546	166647	163486	1471	10767	10802	51226	892	9540	1534	26098	100289098	55540	26286	388021	10240	10549	58505	100131993	9375	28984	29982	54884	321	9935	146956	26471	1149	84061	414918	196996	65985	5997	5457	143	28912	85442	1954	7174	92610	79729	63977	51065	203062	3360	57507	163688	10026	93550	64150	7922	114822	51186	126402	6397	56605	140606	728743	85365	1039	11152	27090	146691	79710	6833	8894	23480	80319	9735	4133	51439	3662	144348	728701	29880	25840	54432	80267	55704	284040	5724	254439	51477	4000	100	10512	3479	283987	26031	9643	6389	189	55840	29993	163859	400550	54855	23302	6185	51750	10567	112703	27095	10237	10669	55501	10483	3669	9236	56901	608	100132741	5962	150244	4258	146330	54145	81888	3418	54732	389376	5584	64110	7106	3998	50808	5868	727957	342357	84932	113263	6370	54795	2016	133619	641649	9650	79760	4710	127733	116068	14	144535	440918	84693	84981
GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_DN	M3175		19023113	Longo NS,Lugar PL,Yavuz S,Zhang W,Krijger PH,Russ DE,Jima DD,Dave SS,Grammer AC,Lipsky PE.	GSE12366	GSE12366_2016_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in plasma cells versus naive B cells.	Sorted B cells using flow cytometry. CD19 selected B cells were sorted using flow cytometry.					4627	27106	1399	59345	6197	83607	120	10236	10735	51496	9489	901	348378	114836	868	343035	10766	53827	1235	9991	10505	6217	23596	83593	120071	11198	3190	10096	57478	5777	84973	2872	64174	170954	84376	6314	91782	64131	5612	51667	1072	29028	5788	1915	55617	9188	55601	92017	81793	6189	85460	11123	1018	8481	285527	4791	10658	8303	63979	29072	1536	6653	8906	54625	116984	8411	91408	55755	1665	3635	6304	6146	55814	92822	440915	6503	22834	79034	3841	79027	10163	51552	51742	9535	81571	137886	5728	57181	1380	3459	10390	4609	3955	152137	8815	91663	2268	695	80342	51107	64421	54458	284702	4155	23387	5205	29063	1776	202	10613	55796	4174	3930	23177	100505622	6426	3098	55813	84450	9710	6158	10618	10235	57480	55843	6233	1155	51520	9987	6147	10635	115761	10019	7405	6129	124535	9933	641638	1912	56985	26751	6144	4154	10252	9144	55893	5937	8364	27075	8289	6322	9337	10365	56829	6169	126231	5581	2760	83700	5074	3569	51291	55008	9282	644283	2550	90956	3191	88455	3394	23149	50618	131583	8396	6482	405	9792	22898	10859	165631	23195	7170	25873	150726	2208	1810	2665	54440	23526	114885	388685	517	23211	9459	677	79828	202025	6874	80223	100505746
GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_UP	M3176		19023113	Longo NS,Lugar PL,Yavuz S,Zhang W,Krijger PH,Russ DE,Jima DD,Dave SS,Grammer AC,Lipsky PE.	GSE12366	GSE12366_2017_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in plasma cells versus memory B cells.	Sorted B cells using flow cytometry. CD19 selected B cells were sorted using flow cytometry.					28972	80319	10330	51186	145853	51226	9524	55501	1471	9540	10237	117579	5997	122509	57719	488	3017	57688	4121	3507	84281	79876	64116	9693	1305	5575	7248	54732	55237	23710	2644	6510	116068	64770	100240728	57210	25829	29100	8733	5273	55254	3669	84750	84981	339483	28785	60370	9061	317649	123283	92689	147004	84920	6811	54823	55757	55704	7163	157860	10861	80765	83852	644128	56005	338864	64110	1039	23588	284187	5701	60490	11231	22818	9451	3384	5868	10103	55937	80267	26579	10493	100507299	8943	10549	127733	84669	2734	84080	2812	64241	2590	79139	10257	151473	321	23480	26227	51439	10113	9276	100129069	6329	9685	60559	220323	26018	284040	144535	6461	64374	100131993	2950	10483	90326	55540	8535	8732	892	11041	342357	7174	100505641	25930	28513	6675	26003	9638	1420	100132741	64399	1585	8501	2878	6745	8974	3416	100507424	58505	51364	81502	100506451	4739	23224	28786	5802	9080	85365	3012	92162	6734	11152	10170	6480	7106	1535	11092	28912	6441	401264	126520	9236	79575	115704	1041	29968	84893	8344	55806	54867	54480	4710	8291	2859	8575	100291336	26090	10048	7832	79770	10954	27293	1044	9399	221476	3195	6446	10802	29799	84693	199857	335	8669	10263	7139	29925	414918	1534	8073	51065	58488
GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_DN	M3177		19023113	Longo NS,Lugar PL,Yavuz S,Zhang W,Krijger PH,Russ DE,Jima DD,Dave SS,Grammer AC,Lipsky PE.	GSE12366	GSE12366_2017_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in plasma cells versus memory B cells.	Sorted B cells using flow cytometry. CD19 selected B cells were sorted using flow cytometry.					901	10714	64805	59339	57492	9453	114885	9422	26751	1018	10308	729614	390980	83593	9710	84376	6482	23240	7321	9748	10228	57674	348378	9933	7408	868	51496	55667	59348	9969	8563	9806	8773	196	3551	55814	51809	283209	29767	10396	9111	55055	23515	3732	51552	375743	6233	57532	50618	4627	205717	10236	3955	6146	10090	441168	83417	8481	10412	4673	863	5204	6234	27315	1072	5394	1155	23030	84896	51520	150962	51667	933	51765	6139	2117	23369	9779	9749	4520	80212	387535	23670	3115	25904	4790	7398	3635	91782	8019	388685	10658	2648	3841	53827	3059	6902	10618	23142	64172	3184	10613	5612	54619	6195	643	10125	55568	3716	29766	9991	3097	27163	54802	64926	3151	650669	84450	6497	54811	22823	5074	64864	57531	64421	1854	6157	8935	11073	969	57048	84973	7090	92979	23341	574028	80312	100505746	10392	64121	7124	694	79830	79832	1959	9792	91283	81571	55619	5557	6426	8480	57050	51291	9337	644283	10541	6161	55809	1665	10691	1633	114625	6778	4799	10982	91526	64174	170371	1536	51316	55813	5216	1235	7634	79890	60468	254225	6793	9797	330	8664	9466	29035	151657	57097	57585	51567	5469	84527	4154	22898	54458	10365	5965	286827	79958	55719	8725	26986
GSE12366_NAIVE_VS_MEMORY_BCELL_UP	M3178		19023113	Longo NS,Lugar PL,Yavuz S,Zhang W,Krijger PH,Russ DE,Jima DD,Dave SS,Grammer AC,Lipsky PE.	GSE12366	GSE12366_2018_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive B cells versus memory B cells.	Sorted B cells using flow cytometry. CD19 selected B cells were sorted using flow cytometry.					149041	1906	64131	3569	9308	4299	7019	51735	974	55547	2590	126820	55633	91663	8531	23263	5992	1776	3507	5863	83594	118738	51294	100506599	55238	9920	56994	79627	8115	4919	55695	9719	2710	55342	59339	404550	5243	116071	7984	2660	2222	199786	54855	27075	10390	909	23531	654817	27086	401312	1848	51520	51127	60468	9880	54874	5796	81539	115350	8507	6304	5791	4775	26999	5023	23360	59338	283665	3903	8502	644538	283663	3566	9623	8838	26226	55679	645638	165904	6543	59345	79865	9670	971	147686	84812	8854	100128252	55603	5101	5244	23180	8460	334	7031	9312	26105	80821	91646	817	4066	1901	79834	23361	1649	162	65982	2356	54625	81571	2791	5581	22865	222487	330	8527	10181	1407	54849	80215	348761	65986	9639	139599	441212	1087	115708	4703	8776	401612	535	56985	5379	79874	387119	124535	55133	4345	6452	285593	401262	205717	57728	644353	79661	8000	197021	2208	375775	84668	1804	9896	10166	6503	1953	151657	25801	51427	64116	1840	285422	158219	25999	6039	9517	11226	10634	642475	246330	680	388722	137835	10561	4829	222659	115123	222545	644283	54810	100506815	54823	27115	53346	339505	283450	22982	55800	9479	30844	9679	10093	22906	23198	254057	9674	28778	5467	54763	93145	64344
GSE12366_NAIVE_VS_MEMORY_BCELL_DN	M3181		19023113	Longo NS,Lugar PL,Yavuz S,Zhang W,Krijger PH,Russ DE,Jima DD,Dave SS,Grammer AC,Lipsky PE.	GSE12366	GSE12366_2018_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive B cells versus memory B cells.	Sorted B cells using flow cytometry. CD19 selected B cells were sorted using flow cytometry.					163486	55871	28755	59342	146850	2673	327657	387535	5567	64859	284106	8526	64805	6310	10491	58516	28978	302	5724	4664	27141	9583	153579	3688	3684	941	6038	201895	55824	100132460	55809	5450	29110	4301	10602	64092	1512	143	64221	355	5355	9528	317762	824	374618	89857	79026	6513	11046	57175	2984	440829	8848	5463	3778	8732	23012	8082	100506436	27163	23460	2857	285313	1230	54762	5552	1054	79745	55785	50854	54438	140688	285812	410	241	54997	29063	58475	3560	406	1389	7468	80067	3310	3493	27044	7185	10999	5584	1880	7431	200958	100129034	11320	5583	373863	7461	10783	56935	162073	11000	55188	6095	3956	5727	57415	2729	8600	6843	373156	7739	56990	9749	5144	23151	6894	114884	965	8543	254531	133308	55010	114327	26137	657	3570	5341	9120	9019	54503	2014	100131043	138948	975	166824	23568	100286909	127018	203274	83464	147929	220359	57045	118881	9061	157378	4250	285025	4783	55179	202	56265	1286	23178	914	939	5962	9709	2348	493	90693	1419	51063	57111	3631	51278	6598	1031	3732	7465	3614	7326	284804	100288685	6249	9649	430	25972	23002	2180	805	8942	195814	26031	23158	5002	79877	5884	9349	118429	51279	3757	79365	4094	23169	3783	127544	55638	130814	283229
GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_UP	M3182		19023113	Longo NS,Lugar PL,Yavuz S,Zhang W,Krijger PH,Russ DE,Jima DD,Dave SS,Grammer AC,Lipsky PE.	GSE12845	GSE12845_2019_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of IgD+ B cells versus IgD- B cells.	B cells from human tonsil and blood were sorted using flow cytometry. The human samples were processed immediately ex-vivo using markers for known B cell subsets.					92558	192670	114897	23508	6232	29954	958	27036	8740	6503	23386	973	266977	55139	256364	8344	933	3726	55182	683	644128	114819	26047	5429	693207	85446	4326	26012	2986	11064	8741	22914	5316	55693	9640	55657	7134	3965	84271	1911	7021	22861	9924	50856	10482	5252	51466	59338	10078	8496	605	4595	64784	10850	23531	275	54954	23524	8345	7448	8642	8936	8349	3420	55226	23162	940	8527	290	59344	1655	55661	28951	10555	23164	54859	9517	23239	9427	9934	126299	416	27244	64106	5287	1621	23241	914	8363	2208	56941	3566	79634	23600	3547	8339	25799	54891	3101	4034	53841	7536	9658	5646	5179	1373	53347	54929	23220	9647	9674	4154	8396	8531	8906	23641	10014	79970	104	23216	2319	51669	64794	9730	57205	3064	3257	79369	55603	5863	23624	8460	9909	28387	400961	26229	55786	54145	7178	23670	55713	6948	9148	27190	6331	8631	107	6653	2037	604	930	27004	29990	8440	6228	3006	10781	3122	29851	6304	9820	79865	26716	54704	8898	5335	7694	2588	55679	5922	3000	8564	80146	9968	334	8334	23308	256227	55340	93129	10267	27343	8558	23149	5101	100505879	221692	3678	6478	6900	58504	51760	57610	8449	55647	100133109	57835	6452	8343	23315
GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_DN	M3183		19023113	Longo NS,Lugar PL,Yavuz S,Zhang W,Krijger PH,Russ DE,Jima DD,Dave SS,Grammer AC,Lipsky PE.	GSE12845	GSE12845_2019_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of IgD+ B cells versus IgD- B cells.	B cells from human tonsil and blood were sorted using flow cytometry. The human samples were processed immediately ex-vivo using markers for known B cell subsets.					1019	55915	100289053	3956	51155	483	8837	4247	79585	6397	3309	1439	23564	100	29927	891	91860	5096	5935	10797	608	7295	6281	3535	1666	308	388650	25829	836	10221	51465	5464	5552	5052	283	7184	6748	79864	51303	638	79053	71	60559	6241	81566	10113	28960	79184	9601	2882	5037	65244	10437	1020	302	64083	5611	8607	9603	5884	8418	10952	27033	10549	1737	25994	51103	11163	1102	203068	4175	1820	4691	637	1039	5727	375248	2934	10018	5479	28831	26608	56005	25896	5580	54884	355	23474	3418	6396	9885	3512	4076	6182	2517	55299	4688	6890	10473	7533	58473	8615	2171	8624	11000	3514	60682	23423	481	6185	28972	304	55177	54517	10130	55020	7037	4121	506	5932	23603	2026	28778	4267	7419	3845	51283	4085	91316	120526	28299	22902	79801	55752	100506898	79174	1175	4738	4925	7873	26275	22921	38	28823	9209	2992	5476	801	9694	29100	25998	9097	30845	642	8761	23643	10327	100293440	10282	942	824	11343	2788	476	80221	51063	11329	80196	51123	1465	9212	10651	10914	2935	64374	4580	8655	50	857	5286	79796	7494	28912	28902	5861	51227	79598	898	54732	53918	27044	652493	123803	29095	2896	528	4809	28785	91353	55179
GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_UP	M3184		19023113	Longo NS,Lugar PL,Yavuz S,Zhang W,Krijger PH,Russ DE,Jima DD,Dave SS,Grammer AC,Lipsky PE.	GSE12845	GSE12845_2020_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of IgD+ peripheral blood B cells versus IgD- naive tonsil B cells.	B cells from human tonsil and blood were sorted using flow cytometry. The human samples were processed immediately ex-vivo using markers for known B cell subsets.					9797	65263	9611	4736	54145	1476	373	652493	6642	100290557	8192	3007	6915	8644	8343	9980	79086	6895	63926	5341	7343	9148	51816	1528	10473	7351	64777	79591	23250	3017	4703	8344	2114	157562	7157	7852	79800	5116	3495	84869	7077	202	8473	1953	8345	8363	155400	1469	79703	28951	84263	126299	1520	975	9715	11006	3535	55657	57205	5571	100288640	1628	22920	49856	3823	55658	3399	22977	53916	22914	3340	55830	55958	9665	9623	79777	307	4599	8546	4222	9674	25901	28992	3384	78988	339287	51678	392	26240	8498	64110	8798	23325	940	11336	6909	8906	29909	2960	11132	4298	11279	22905	79026	55652	4668	100132406	81847	55578	8886	3460	1954	8365	10430	7832	22883	84271	8407	53841	2330	29954	79922	388	6689	3275	5274	914	54856	1236	51278	4248	6097	10014	154881	79648	3055	1828	28955	2744	23646	7174	9855	79970	89845	91353	1808	7036	63916	55795	3646	64761	4900	7775	3695	376412	50862	55666	3303	55347	2316	51720	54708	100133941	2319	8848	8355	23483	11040	6275	9780	23335	9056	3192	50854	5218	4720	594	50512	10347	10608	55846	10396	55679	55900	50485	3101	8766	79893	80194	348995	7414	10267	84034	8349	79025	91754	84364	100129250	29990	57209
GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_DN	M3186		19023113	Longo NS,Lugar PL,Yavuz S,Zhang W,Krijger PH,Russ DE,Jima DD,Dave SS,Grammer AC,Lipsky PE.	GSE12845	GSE12845_2020_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of IgD+ peripheral blood B cells versus IgD- naive tonsil B cells.	B cells from human tonsil and blood were sorted using flow cytometry. The human samples were processed immediately ex-vivo using markers for known B cell subsets.					23516	79441	23196	23080	27128	2934	100288939	11259	55768	6676	79817	2033	57493	9770	64784	2309	4026	2885	64376	1788	79029	2589	8514	55279	9295	122704	687	26051	53918	5163	54407	55226	801	4063	10320	8553	1983	10865	9451	10019	4085	51203	3662	3836	729806	1785	2995	5347	2597	976	51531	51202	3572	3799	4175	79894	23122	55206	23389	25879	3638	93487	54934	29760	203068	26512	4144	3958	10409	6714	80055	9997	2969	5036	10165	10381	11214	8543	79101	81566	56912	230	84060	79706	1959	5387	7556	4839	65117	10376	10911	2869	145389	23764	10538	56242	23112	4001	51669	7175	163486	79413	79612	9698	3725	51646	7597	3459	79809	83752	80148	9101	10327	1195	4800	4691	6478	51729	79868	10226	1604	23013	51351	1595	5514	8412	91373	26586	1105	6617	7408	4261	23276	665	3720	261726	54663	1845	55781	2180	694	30835	930	10105	275	79888	912	29015	1844	23014	22992	55854	9112	9990	79705	60436	4154	71	9055	23345	3014	10253	9334	638	65108	10797	4217	8672	23315	1380	6400	23474	10982	9834	127544	6421	80267	29105	5935	4605	22890	4012	55147	3609	2717	2146	54726	79754	54916	10042	6829	7430	4097	10276	9975	23157	10752	23523	9962	7561
GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_UP	M3187		19023113	Longo NS,Lugar PL,Yavuz S,Zhang W,Krijger PH,Russ DE,Jima DD,Dave SS,Grammer AC,Lipsky PE.	GSE12845	GSE12845_2021_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of IgD+ B cells from peripheral blood versus CD19 pre-germinal center tonsil B cell	B cells from human tonsil and blood were sorted using flow cytometry. The human samples were processed immediately ex-vivo using markers for known B cell subsets.					10208	9552	126299	55830	8642	10400	79414	388	8971	6522	7289	10365	54704	7994	5195	4285	55182	1487	27241	55658	55347	23067	55113	79873	9033	55262	9990	741	11108	196743	9402	64689	4109	79639	1183	770	140461	5016	56674	1277	23059	9715	4345	9934	51301	10695	55657	55094	65264	7923	4607	7133	100287600	29125	11132	10077	27036	128553	9537	84720	23600	26226	373	29035	3725	5256	6452	644128	5218	8824	9467	5164	55049	400961	1456	54957	6441	57827	27163	10412	8334	9880	339287	51093	89944	2288	27429	63893	40	8100	6222	9855	9611	91754	3106	107	10116	10179	89845	3720	6156	8440	23259	1725	6237	2247	79591	9993	6137	260294	3303	5252	4589	29907	8363	55139	9139	6602	197	80233	53916	10076	55652	2678	10473	83442	4435	1974	728361	55810	686	5681	25799	91298	8722	6643	56604	3705	6402	4122	79608	57205	51274	6374	6208	4064	6169	90121	9797	8407	1366	23624	10014	9980	4924	57060	23378	3915	1409	5298	9730	79594	53635	3454	11176	55958	23641	83638	9308	50512	51458	79007	50854	9674	7553	6199	55205	29956	824	26001	23250	63940	79922	259197	10864	10307	3875	58190	5348	3823	51172	9203	3315	166	112464	22869	2596	3991	92104	29937
GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN	M3188		19023113	Longo NS,Lugar PL,Yavuz S,Zhang W,Krijger PH,Russ DE,Jima DD,Dave SS,Grammer AC,Lipsky PE.	GSE12845	GSE12845_2021_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of IgD+ B cells from peripheral blood versus CD19 pre-germinal center tonsil B cell	B cells from human tonsil and blood were sorted using flow cytometry. The human samples were processed immediately ex-vivo using markers for known B cell subsets.					100	9404	4176	9188	637	675	22929	3151	51659	329	26118	8438	8336	7027	387082	10019	55784	4236	4288	2934	81611	29127	6421	9169	6093	10226	124222	51218	30844	6397	2305	24137	7511	2517	2237	11116	51318	4311	10797	65244	10072	3159	29015	23122	5922	9787	10592	55120	51566	51366	9935	9232	2026	9133	55915	4830	2171	55215	9656	6175	64151	56941	27299	10102	2885	3181	54541	64759	991	10924	10615	55705	54953	9319	9493	23215	80310	6509	4085	79705	10541	7531	1509	55159	51155	475	1445	55388	23175	3309	259266	54187	55872	22823	7014	23468	3995	1844	7965	990	5918	8412	3014	55706	10112	90338	8318	10460	4691	4998	9686	79077	91860	57570	9882	6729	22948	8536	969	64943	9700	23276	167227	9380	80223	5223	836	8815	7283	3710	10299	4602	57405	1175	5424	64778	5932	3312	10635	2146	10105	10109	1719	23654	1062	5478	51514	7844	1326	7280	54908	9833	6597	7873	26098	10262	55422	23196	90956	1033	9097	5311	64864	3832	54892	9643	4012	10988	9500	23189	891	79801	23318	1211	8607	6645	220134	55752	9315	5832	9212	5730	3146	9918	11079	8875	1786	56992	1019	7941	523	84901	29901	5641	6426	6035	8727	55635	11065	26227
GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_UP	M3189		19023113	Longo NS,Lugar PL,Yavuz S,Zhang W,Krijger PH,Russ DE,Jima DD,Dave SS,Grammer AC,Lipsky PE.	GSE12845	GSE12845_2022_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of IgD+ peripheral blood B cells versus dark zone germincal center B cells.	B cells from human tonsil and blood were sorted using flow cytometry. The human samples were processed immediately ex-vivo using markers for known B cell subsets.					10346	55008	307	65263	10077	6503	5967	23474	57506	57118	53347	4122	51816	92609	3823	8343	6820	432	23081	100290557	4298	55113	79703	60370	55830	23357	10154	23199	23508	55284	63926	3460	50512	3872	55139	79943	1409	2199	57228	23281	275	8674	163	9993	57835	80739	4303	5339	3305	6098	22869	2812	79073	8395	51024	4478	27180	56623	1838	2645	29933	10397	10550	6892	6164	23077	79591	398	84669	64755	26584	54954	3164	810	55825	3569	10252	7984	7538	3590	50856	6218	57446	7054	55603	3303	55679	2580	4261	1676	7135	3738	9557	567	80724	11279	5101	7767	1937	2010	40	83478	8100	83475	51084	8496	26256	6122	29044	5151	8460	25799	9894	28912	29997	10869	27036	55366	8363	2548	8742	56983	7318	83700	54956	22992	55652	7746	24139	23461	256949	2671	2801	6337	4061	29909	80148	55316	51611	100288496	1933	9046	55584	6482	4520	2634	2309	8741	7466	1200	54715	3399	22888	1487	9909	6942	28	386627	3055	79183	26152	79891	104	3991	23108	376412	4253	9542	2273	57060	4285	79677	4736	23626	3752	728558	10577	10412	29798	5239	416	3921	57140	54704	196743	6196	3007	55187	8349	253782	51172	4000	1388	10765	23641	11083	955	27113	8344	80162
GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN	M3191		19023113	Longo NS,Lugar PL,Yavuz S,Zhang W,Krijger PH,Russ DE,Jima DD,Dave SS,Grammer AC,Lipsky PE.	GSE12845	GSE12845_2022_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of IgD+ peripheral blood B cells versus dark zone germincal center B cells.	B cells from human tonsil and blood were sorted using flow cytometry. The human samples were processed immediately ex-vivo using markers for known B cell subsets.					65117	8270	5757	2961	90861	55197	4839	51773	81605	6426	81579	5884	8892	10260	604	642	23196	23761	29994	171023	7461	79670	10169	23020	5478	9380	5982	9258	3183	9100	9025	25788	30844	1875	27338	6955	51164	10109	57035	5411	226	79707	241	3936	55739	5052	4643	55109	9885	54939	5928	79077	7150	26240	64419	8487	3707	26472	11051	55471	27131	56911	10155	26091	3615	2805	79612	1763	8479	4649	4288	5580	54870	2023	7317	5223	64398	28511	9088	80267	3995	55055	55255	55131	81544	5693	84516	6921	83988	4190	4171	10019	11243	6768	79963	211	220134	11097	7905	51204	23197	54431	7639	9031	22800	7372	3184	54708	1512	2157	10226	10175	11116	23013	65985	54517	6709	26284	4176	4809	28960	6617	3418	6478	963	23075	57862	3939	23097	6734	9477	79712	56683	9447	51351	9736	54432	6777	26097	1434	1182	3396	7251	5578	51001	8607	51106	836	54442	54606	5464	23637	221154	9131	60468	51728	9319	22889	8540	5165	6839	10248	79596	25959	9324	1380	140465	51366	5380	164	1841	6780	4686	3394	54881	57128	10055	22948	4076	79763	4739	26255	5427	259230	9686	4012	54707	1163	942	81555	1503	8774	55758	51318	4735	6829	5546	8880	1351	29899
GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_UP	M3192		19023113	Longo NS,Lugar PL,Yavuz S,Zhang W,Krijger PH,Russ DE,Jima DD,Dave SS,Grammer AC,Lipsky PE.	GSE12845	GSE12845_2023_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of IgD- peripheral blood B cells versus dark zone germinal center B cells.	B cells from human tonsil and blood were sorted using flow cytometry. The human samples were processed immediately ex-vivo using markers for known B cell subsets.					100	10067	5721	51668	11051	593	11006	7263	5690	63933	1363	553115	23463	60491	4898	682	388	83737	10113	30968	100289053	10449	10066	27238	51022	26580	60559	4056	7295	65244	5884	5693	2230	8546	11261	10051	10827	506	80169	27089	578	1175	3838	3418	6404	9391	56061	4708	6890	112611	23471	8938	6576	26135	9046	23347	4076	3148	1611	51024	171586	51155	4728	79970	54732	339287	4697	9603	518	3396	10282	2232	440	2316	4709	81533	29095	7466	5685	376412	3384	3535	5611	10490	5393	5476	4698	11279	22926	6397	5714	2788	840	2745	1349	7367	54884	56005	51303	5504	3937	54469	79703	79053	7841	54919	9611	5905	2833	92579	80342	4939	10916	8607	231	10000	10095	29789	64746	80700	8669	5580	10972	6945	81618	5498	2961	10627	4218	23646	55505	229	65084	10213	16	5464	51078	402	4493	355	115353	10467	51123	8875	51015	84908	9056	54145	5695	10211	5510	6745	50486	83394	55204	10125	10553	11034	51501	292	51506	83443	1052	3695	10548	80308	10952	5684	25896	28986	54494	10489	7332	6637	64127	10935	11047	7533	7341	55775	8761	51374	60528	4818	6626	60682	8473	6717	64960	29058	7317	55072	3183	10450	80145	7088	29880	11274	8798	7347
GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_DN	M3193		19023113	Longo NS,Lugar PL,Yavuz S,Zhang W,Krijger PH,Russ DE,Jima DD,Dave SS,Grammer AC,Lipsky PE.	GSE12845	GSE12845_2023_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of IgD- peripheral blood B cells versus dark zone germinal center B cells.	B cells from human tonsil and blood were sorted using flow cytometry. The human samples were processed immediately ex-vivo using markers for known B cell subsets.					8793	79073	1119	64376	28951	6256	7043	10042	5626	122704	25879	1647	6195	923	55854	253143	4750	55226	9595	93487	2797	10865	81566	9770	9101	1788	3710	7516	55198	3927	5228	90338	10439	89941	54704	7142	2995	81856	4851	2107	22861	3861	55716	27340	23099	9647	5426	10752	54800	50856	23216	25788	10179	8553	780	4213	5151	23255	8514	51351	4820	5252	4313	7556	79762	55603	5346	27128	9135	230	83259	50515	5430	65108	23345	64427	1153	6304	9775	55147	3164	26048	9975	55974	10555	8289	23162	51531	23152	55671	23641	6676	51339	23386	23764	619426	54934	4326	1490	63928	22898	120227	22864	22903	6503	2764	8631	28964	4242	79753	9107	55657	51669	27130	29943	23239	79706	6609	11010	6018	138050	1117	643641	51268	84172	881	29123	11039	150094	8741	56894	51643	23175	79622	50619	9334	619505	5143	59338	6867	51319	1644	5469	23499	80148	28990	1269	60673	6659	54883	26049	1026	9138	27352	9909	29083	3569	22838	22992	64784	6452	1107	114897	1122	4155	4144	23229	933	4595	10147	3099	29781	7040	54663	3964	51729	57018	23070	58494	11259	468	473	50807	9818	8399	100272216	55525	1846	7071	26586	10927	1186	150726	4956	4145	9295	6687	79862	79939	7707
GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_UP	M3194		19023113	Longo NS,Lugar PL,Yavuz S,Zhang W,Krijger PH,Russ DE,Jima DD,Dave SS,Grammer AC,Lipsky PE.	GSE12845	GSE12845_2024_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of IgD- peripheral blood B cells versus pre-germinal center B cells.	B cells from human tonsil and blood were sorted using flow cytometry. The human samples were processed immediately ex-vivo using markers for known B cell subsets.					4939	80789	28986	388650	10972	3675	55146	49855	8722	4435	51015	27296	939	339287	10067	27102	686	1611	11230	11337	197	54928	388	57215	25776	8605	55793	6199	5106	22872	79585	79777	5786	10961	550	10473	80169	10553	10273	10126	55049	942	63976	10000	100505761	8938	55072	10159	10066	1059	55268	1666	11274	9	51147	4700	6794	6909	7059	51063	155066	2882	22796	9633	23423	10682	3305	3937	26277	4247	57198	5498	54927	8334	26007	79864	10269	3137	55316	25829	51227	55179	80221	9582	56107	11000	54469	51009	2744	221154	3785	9986	6834	26286	5504	22926	755	11279	55325	9780	5443	2990	23741	51117	22818	11152	26191	5348	3208	28785	10004	54432	57223	51098	27034	10660	79085	79091	3956	2296	64689	27229	51506	23625	29064	1798	10113	6782	3705	23471	83450	55501	114327	3630	26003	114884	27090	302	9168	26232	304	5218	50802	80700	10450	3688	23378	80762	2230	6675	10445	2051	78987	5476	11231	3669	3493	80764	10973	4542	5920	81533	66035	27235	9728	27033	1269	79643	23604	85236	10788	10005	11092	64080	8971	81605	51172	27230	7088	4696	6619	23479	25959	10960	101	10256	4502	10195	5864	10827	6277	29956	8344	3315	26608	8992	6442	4778	4267	10559
GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN	M3195		19023113	Longo NS,Lugar PL,Yavuz S,Zhang W,Krijger PH,Russ DE,Jima DD,Dave SS,Grammer AC,Lipsky PE.	GSE12845	GSE12845_2024_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of IgD- peripheral blood B cells versus pre-germinal center B cells.	B cells from human tonsil and blood were sorted using flow cytometry. The human samples were processed immediately ex-vivo using markers for known B cell subsets.					5198	2171	9404	5922	84172	5426	80143	56893	90338	3927	55732	5422	3151	1576	22823	5889	930	23092	55247	8874	23189	5723	1117	2306	23175	9555	4820	7965	3178	9859	23119	9688	5250	6659	23354	4155	4232	10924	2517	22870	54908	5270	8875	23531	5917	26271	4678	29123	10988	1326	3726	7280	1213	2335	5311	7128	27299	50856	4033	80867	10403	8190	28387	10293	27347	3652	57824	10213	29127	51691	9686	1107	55142	55705	29855	7538	100170939	8438	6498	55854	6632	5902	9380	7511	5791	55422	891	55771	3070	1436	6691	971	23386	57476	6309	10586	8458	6240	79754	25788	6645	116832	60	3842	2956	7027	80310	50615	8531	9935	22833	23788	64927	9653	9212	10186	8804	4521	79980	23234	79081	8545	675	4904	81892	5901	6367	2669	5082	4602	23654	55693	2697	11332	10147	605	1479	9837	57379	217	6597	10457	6678	1434	5730	4026	4236	7342	79939	6478	8914	11116	653188	8815	6257	55720	8662	619505	10062	6303	3930	6491	3895	9666	191	5518	56941	1390	23179	3359	5205	2778	4775	10592	29789	3280	9493	203068	112479	10460	54677	10635	5911	3638	4643	150094	701	4665	6653	4686	1839	5287	8870	9414	6877	22984	1644	1994	683	5863
GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_UP	M3196		19023113	Longo NS,Lugar PL,Yavuz S,Zhang W,Krijger PH,Russ DE,Jima DD,Dave SS,Grammer AC,Lipsky PE.	GSE12845	GSE12845_2025_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of IgD- peripheral blood B cells versus dark zone germinal center B cells.	B cells from human tonsil and blood were sorted using flow cytometry. The human samples were processed immediately ex-vivo using markers for known B cell subsets.					5721	1820	3535	3676	7076	7431	54884	10456	10923	79703	3507	23199	25829	51303	10330	8837	5611	55316	10863	5479	11247	123803	8938	6748	253782	1059	8798	9592	388650	3305	3705	57140	5101	5910	57215	222255	593	7318	3055	81622	2273	6199	3614	3915	3094	229	967	352961	22862	9516	83464	64127	57228	1666	2548	6892	7466	79840	10154	100505761	3675	90864	3717	376412	841	51506	50802	2268	2788	8629	9150	3133	54344	977	4818	9022	10067	10922	28912	10004	644	6184	8334	10916	96610	51084	8722	10272	8566	8689	28902	5498	1407	64374	3695	4217	79864	8891	11279	5106	9046	29927	825	79064	3949	55268	10159	2889	10577	51123	10897	51172	22861	942	114049	5127	54517	83737	57506	91316	3162	162427	6196	11083	6404	8407	30009	53838	26136	55332	11119	6282	80342	79694	9452	166	27095	9056	8615	24140	80169	7371	56005	5196	23461	8447	55103	23474	55177	5151	9811	23155	6992	23625	10788	51237	6050	5130	11006	28785	9409	6185	79365	3454	3211	28831	3514	9187	80764	7204	93408	81618	11163	2051	25864	57326	28299	686	81855	2058	64743	23108	1777	7133	79073	7088	5473	64764	3105	25840	5355	3386	27230	81894	4105	840	55825	55072	26994	11186
GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN	M3197		19023113	Longo NS,Lugar PL,Yavuz S,Zhang W,Krijger PH,Russ DE,Jima DD,Dave SS,Grammer AC,Lipsky PE.	GSE12845	GSE12845_2025_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of IgD- peripheral blood B cells versus dark zone germinal center B cells.	B cells from human tonsil and blood were sorted using flow cytometry. The human samples were processed immediately ex-vivo using markers for known B cell subsets.					933	3936	4670	3707	29994	9695	10677	1875	51021	2193	27131	4190	3566	5021	6955	4649	5471	7150	3185	10049	9588	7639	23092	10169	5198	171023	4735	9534	23654	55048	2669	2224	1107	9686	5411	55689	10293	4801	7430	2617	27018	8345	10204	9258	5723	55661	79707	79612	391	11243	5902	7461	65117	8662	29	26135	5982	3978	1479	55739	1119	11184	5700	51501	5213	2186	11020	8880	55471	51164	4012	26512	1182	23318	8270	8501	50807	1434	81605	27094	64398	79782	54881	4174	79600	23028	84271	64081	22823	140465	4665	226	6498	11051	8241	11183	259230	26207	11056	10184	7278	27338	26098	5116	23	2000	5928	25906	22800	23386	4820	7465	55888	5496	4643	22984	8766	9551	10096	1960	1994	9380	6709	3669	355	51701	79959	2796	23175	51351	8893	1977	5426	55015	949	9025	7027	55226	9910	11331	5510	54939	7326	10527	9100	64781	7417	4436	79850	55198	51533	54431	4946	941	23403	151230	64795	7748	1841	6195	4154	55197	5996	3257	22879	963	57178	1351	3150	1876	23761	79171	84516	4809	4904	2950	55635	10106	6001	55147	5367	142	55860	10175	22902	7458	4790	164	26097	23089	6596	80010	84859	4678	55038	65108	5591	6640	23350	6642
GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_UP	M3198		19023113	Longo NS,Lugar PL,Yavuz S,Zhang W,Krijger PH,Russ DE,Jima DD,Dave SS,Grammer AC,Lipsky PE.	GSE12845	GSE12845_2026_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive B cell versus pre-germinal tonsil B cells.	B cells from human tonsil and blood were sorted using flow cytometry. The human samples were processed immediately ex-vivo using markers for known B cell subsets.					10116	1978	7710	3727	58513	9537	5348	9802	11108	55000	3861	3638	23673	4142	64423	4213	51035	4927	6176	80148	3487	90806	694	63893	11221	23361	116985	10695	8698	11180	9698	23558	79741	80223	1370	10289	83394	65258	64595	2051	10795	54556	83442	1048	780	9252	23259	51729	7090	4122	4217	81932	4306	7089	11132	79685	51531	51352	79091	57404	467	81576	386627	7561	6993	115123	64236	6515	59307	23338	51669	150094	4907	1785	3156	80005	6199	5625	1120	1195	4332	26040	90379	687	10208	11160	25793	7846	30836	64092	10668	23764	55422	4589	222161	10900	752	9	4833	8925	369	54726	4063	10922	1964	4155	6336	9976	5999	54910	2002	56242	6928	6529	148022	55794	230	4486	56905	6714	8643	79817	11214	10365	2185	5298	5770	23303	11346	58190	3659	4753	3820	644096	1130	55205	3934	57146	84159	10681	79026	83444	2246	8851	55178	8934	83786	8495	51427	51185	768	5530	6203	10625	84124	6844	11068	64130	9488	29125	1495	22909	9766	55802	1543	51276	1950	9874	6132	4359	5362	10252	22856	55327	10137	6309	8545	55024	7320	9880	10947	55615	6005	3106	91300	8824	26953	23476	147179	9865	5151	79697	10447	8446	409	2209	57292	90627	79717	55636
GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_DN	M3199		19023113	Longo NS,Lugar PL,Yavuz S,Zhang W,Krijger PH,Russ DE,Jima DD,Dave SS,Grammer AC,Lipsky PE.	GSE12845	GSE12845_2026_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive B cell versus pre-germinal tonsil B cells.	B cells from human tonsil and blood were sorted using flow cytometry. The human samples were processed immediately ex-vivo using markers for known B cell subsets.					4190	100	3418	7266	9282	3945	64110	51514	171586	51389	23406	22883	55907	29015	10130	286148	10055	6651	8669	9031	114883	54919	7014	8562	11168	1854	23463	51720	10263	9470	9131	3015	29093	55032	2108	4726	302	11065	4643	3281	10988	4998	488	30968	51142	6117	94239	23020	10951	51318	10147	10051	9978	55732	5700	5931	6613	975	29796	56992	6768	51650	5981	9555	24137	5701	2171	5690	2026	1072	4077	3161	22929	5683	28960	8924	2956	9232	8607	28958	10924	1176	5696	4670	1476	10541	1852	10213	604	3359	28985	29088	9688	23256	27336	10146	3251	5311	10097	11331	6723	1808	7150	51074	22797	5778	4723	5859	57405	6397	51021	475	22921	10169	7874	10735	10204	746	2958	10240	5688	6351	55847	55159	2961	55863	6390	25814	10125	16	899	4176	55388	6634	377	790	523	5422	51372	79903	6391	26271	51593	55718	990	55143	59269	64943	1452	8417	6637	4023	56941	51571	64759	7027	4033	26135	4697	54882	5721	3611	4947	64710	952	5024	27299	929	10476	835	80349	217	10190	23129	29082	10221	5531	3832	7913	29127	10095	3608	9377	55201	5685	51668	80224	79023	7107	5213	8673	25979	29901	2517	5884	580	939	10615	3833	3652
GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_UP	M3200		19023113	Longo NS,Lugar PL,Yavuz S,Zhang W,Krijger PH,Russ DE,Jima DD,Dave SS,Grammer AC,Lipsky PE.	GSE12845	GSE12845_2027_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive B cell versus dark zone germinal center B cells.	B cells from human tonsil and blood were sorted using flow cytometry. The human samples were processed immediately ex-vivo using markers for known B cell subsets.					54832	9215	1409	23255	23199	7204	4750	29123	5467	4926	6170	6098	81576	3055	2768	10589	55603	3717	9727	6304	9132	51077	90993	10577	55187	23361	9080	56257	55284	1820	54346	8204	55108	50865	2995	1366	6164	79154	55567	23389	8629	1635	387509	4249	55841	83259	54360	64184	2645	4054	56302	353	55366	7076	221960	90133	5163	64376	51111	10746	10982	176	23162	9839	23764	5106	55607	1777	6820	9663	54993	51274	100288939	2853	55584	6482	80055	275	27128	55008	9592	8509	4520	23001	55891	364	153	54103	23360	10957	29761	10493	6676	923	25987	56987	57468	9865	7855	57396	8741	474	2309	4155	79762	80148	6133	55525	11213	3705	3638	7559	4122	1059	56300	57551	7009	3704	10752	647070	55016	7135	23077	81855	64760	26051	8407	6256	467	1183	8626	79443	4478	3119	83464	208	63935	6503	26145	80228	9546	5969	9755	81543	10499	1500	1490	28951	1978	3842	64236	124044	80342	1388	29775	57192	4584	10346	835	81565	6196	339105	84669	57730	8851	60370	3507	55231	56997	1116	3737	4126	4794	55800	9472	79073	8553	57446	3597	3344	80201	9308	9639	841	81609	2273	11214	5900	79066	54726	51319	9046	51339	27010	79591	22936	83700	23344	10322	55320
GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_DN	M3202		19023113	Longo NS,Lugar PL,Yavuz S,Zhang W,Krijger PH,Russ DE,Jima DD,Dave SS,Grammer AC,Lipsky PE.	GSE12845	GSE12845_2027_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive B cell versus dark zone germinal center B cells.	B cells from human tonsil and blood were sorted using flow cytometry. The human samples were processed immediately ex-vivo using markers for known B cell subsets.					9156	8540	8270	23568	54606	2004	55269	4735	7461	7167	51292	377	220134	79171	5723	29994	9534	1632	8834	4221	10436	84271	6709	51035	9092	5236	60528	55236	4678	23786	100272147	8607	79077	7263	4245	5693	5471	11234	23463	51501	51533	10465	90861	1841	23595	9885	4801	5527	9681	81556	81605	3709	22852	55650	10260	22826	5780	56986	150759	8892	79670	26528	55329	896	26240	54708	5300	2000	9337	25828	9363	6300	2639	10175	25996	1182	2491	599	8345	51144	54816	51016	1022	23517	1476	3418	26135	4900	81545	1537	29902	10049	8974	53373	4670	9694	226	79084	5699	10038	2961	23654	51389	23126	2960	9690	55858	10113	11235	51116	8050	5688	5341	10987	7347	11004	23352	28956	64777	10574	6166	391	5700	6004	4190	3833	55471	10467	7541	81544	79174	10474	10527	1434	9416	7360	26091	55005	8665	55833	5936	54939	8774	51507	5431	471	506	4522	5884	22920	2762	25880	23424	373156	23097	55707	9258	54432	93081	23433	2224	8125	9070	1155	56683	57645	5714	1611	27094	966	55653	27131	7150	5546	5683	915	27316	22882	56911	11184	7905	29103	25780	55907	5710	5165	3006	54948	23075	79086	5380	1396	51001	7639	1994	84790	7074	5580	9857	8295
GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_UP	M3203		19023113	Longo NS,Lugar PL,Yavuz S,Zhang W,Krijger PH,Russ DE,Jima DD,Dave SS,Grammer AC,Lipsky PE.	GSE12845	GSE12845_2028_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of pre-germinal center B cells versus dark zone germinal center B cells.	B cells from human tonsil and blood were sorted using flow cytometry. The human samples were processed immediately ex-vivo using markers for known B cell subsets.					1576	643314	3842	5900	27299	8764	9409	221472	953	894	6332	79828	23129	10499	23596	9592	3837	55501	51111	1880	3360	1436	140710	54541	51309	3107	79026	960	26279	26051	51575	54502	4502	10861	353	63929	54103	9527	1236	8019	3915	81030	22833	6498	55024	79713	80215	3280	64778	5730	27350	3105	640	4088	9252	389	2051	4063	2537	5918	81890	4939	7050	321	56983	4069	6433	23360	9246	9168	54847	23158	3507	971	5796	4345	51284	7357	7940	23046	5168	1508	10134	22866	3385	79630	5957	10365	2348	929	7305	8741	3570	3569	6452	8635	8869	51179	29953	653188	10561	4792	1235	1411	440073	1777	51520	4665	8934	9976	6678	2920	10824	10410	101	3495	80017	3576	91966	55651	5595	55851	230	4155	23765	28959	93210	3965	9214	5469	64761	8225	2801	51316	221692	10581	9935	54	2876	23753	5660	8870	5613	834	399818	3431	84617	386627	29855	6039	2580	2207	3485	2011	55679	5151	4054	5978	4520	3652	79943	56034	3133	387509	1635	10235	6322	10577	10865	5106	5252	1117	5800	3572	619505	9254	440352	7538	2734	9194	6890	2309	3615	7941	2919	8490	26355	10457	10384	100287590	5204	28831	54853	341	28234	54677	2321	54441	3055	6793
GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_DN	M3204		19023113	Longo NS,Lugar PL,Yavuz S,Zhang W,Krijger PH,Russ DE,Jima DD,Dave SS,Grammer AC,Lipsky PE.	GSE12845	GSE12845_2028_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of pre-germinal center B cells versus dark zone germinal center B cells.	B cells from human tonsil and blood were sorted using flow cytometry. The human samples were processed immediately ex-vivo using markers for known B cell subsets.					7095	7360	2197	55954	6301	8504	605	29091	10906	4809	2950	2796	26017	221154	3493	55269	241	1653	56474	506	5439	57175	113251	29937	27229	10097	26515	79137	22920	84859	78996	23433	7584	10180	9044	29058	51218	65244	54939	55739	50813	217	1939	1022	7416	11049	4363	55850	5164	11267	56911	7844	10013	29071	9477	51103	57570	1352	54432	51035	64595	5981	8725	6844	114885	23097	10436	3831	79963	81552	79661	23232	7874	27202	51366	11258	55638	60468	1875	79707	2744	8318	11168	1213	51335	54850	641	25900	51501	8417	10260	990	29777	7465	83460	10733	29796	4221	404281	92856	54545	54987	9584	51164	4521	23378	51650	10015	22879	23194	23231	28974	23216	553115	51574	6767	6375	22906	9031	8924	23071	5324	1611	1977	9978	1876	582	10928	5411	78989	4763	10845	55758	51321	939	7326	2647	64771	56145	23530	29088	51428	80862	28511	6596	23203	2987	51117	7074	81537	51465	10049	25797	1861	9766	23063	4311	599	10541	915	6777	55069	6173	23741	55744	7345	9556	6856	177	10565	9354	22955	9685	473	10632	790	9263	84900	6640	2874	1737	10010	10552	2965	1340	3359	26469	79074	11079	7905	355	51691	6396	11232	3796	8050	3932	55081	5885	64919
GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_UP	M3239		19124732	Good KL,Avery DT,Tangye SG.	GSE13411	GSE13411_1618_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive B cells versus IgM-memory B cells.	Enhanced secondary Ab responses are a vital component of adaptive immunity, yet little is understood about the intrinsic and extrinsic regulators of naive and memory B cells that results in differences in their responses to Ag. Microarray analysis, together with surface and intracellular phenotyping, revealed that memory B cells have increased expression of members of the TNF receptor, SLAM, B7 and Bcl2 families, as well as the TLR-related molecule CD180 (RP105). Accordingly, memory B cells exhibited enhanced survival, proliferation and Ig secretion, as well as entered division more rapidly than naïve B cells in response to both T-dependent and T-independent stimuli. Furthermore, both IgM and isotype switched memory B cells, but not naïve B cells, co-stimulated CD4+ T cells in vitro through a mechanism dependent on their constitutive expression of CD80 and CD86. This study demonstrates that upregulation of genes involved in activation, co-stimulation and survival provides memory B cells with a unique ability to produce enhanced immune responses and contributes to the maintenance of the memory B cell pool.					417	8553	28981	80131	1396	79686	10381	9674	129025	9489	8651	50807	55150	79148	51471	10252	27071	54979	216	11212	51322	604	81571	50804	5923	64858	10401	56891	23635	8491	5368	28234	7178	1007	3752	25888	11099	3207	10391	27136	10388	6304	856	7128	8573	64081	7428	7175	7399	5316	140597	57795	114818	8115	9848	8348	11055	3566	131	1043	23220	64799	11224	10733	6591	3157	1413	28951	6429	60468	9215	23414	7469	4800	4976	7716	706	8527	10769	6504	9609	196	3854	9314	27063	3981	389136	84193	11247	79153	6533	79150	55840	3495	51729	2138	2998	6653	5331	6372	2660	5101	7504	25932	23142	6164	55811	23382	10586	132	54221	25850	79968	23086	1949	6581	6452	10235	22920	56648	4300	7204	51411	26583	22999	342096	883	55415	81031	1618	1831	26648	2014	336	23272	10141	8819	51363	1728	51105	9663	4946	22994	2312	7841	4345	1761	29062	387751	3024	80095	3689	1001	54964	433	10114	65981	57405	10385	8631	9162	23386	5603	10015	100286937	442194	2673	154	79025	50835	10458	339290	4008	10052	7057	80177	11169	26136	11063	27284	8110	4212	80853	283638	51275	55743	55794	3725	6281	3315	4752	23136	53630	3710	22889	55893	55084	92822	8609	6964
GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_DN	M3240		19124732	Good KL,Avery DT,Tangye SG.	GSE13411	GSE13411_1618_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive B cells versus IgM-memory B cells.	Enhanced secondary Ab responses are a vital component of adaptive immunity, yet little is understood about the intrinsic and extrinsic regulators of naive and memory B cells that results in differences in their responses to Ag. Microarray analysis, together with surface and intracellular phenotyping, revealed that memory B cells have increased expression of members of the TNF receptor, SLAM, B7 and Bcl2 families, as well as the TLR-related molecule CD180 (RP105). Accordingly, memory B cells exhibited enhanced survival, proliferation and Ig secretion, as well as entered division more rapidly than naïve B cells in response to both T-dependent and T-independent stimuli. Furthermore, both IgM and isotype switched memory B cells, but not naïve B cells, co-stimulated CD4+ T cells in vitro through a mechanism dependent on their constitutive expression of CD80 and CD86. This study demonstrates that upregulation of genes involved in activation, co-stimulation and survival provides memory B cells with a unique ability to produce enhanced immune responses and contributes to the maintenance of the memory B cell pool.					7416	27304	79863	100132341	26000	159963	23015	54442	11316	27102	8354	1075	553115	3430	11190	65080	54502	9491	3939	79174	9049	9817	632	10004	8099	9552	7593	80230	81620	80228	3236	6738	327	9636	27347	5079	10645	9688	51172	3535	200734	95	6888	1975	10107	6718	126321	65220	7134	30817	2184	7644	57178	10975	28823	23002	79740	729230	79930	26469	5184	138151	8744	10529	4129	4082	8666	5226	117178	8815	5879	208	6674	5496	1316	10465	644096	1285	10875	63916	8424	642	26986	80222	29956	4363	4704	7027	9681	26472	10616	50514	28960	5230	3512	3507	7032	60436	650	55332	23189	80153	9583	7276	80344	81552	23466	644068	115817	6352	2597	64419	826	578	5223	8543	23203	7167	3418	2110	11261	1173	4609	9404	9805	25906	54544	4520	7014	8495	6755	4191	2823	939	51361	3945	6182	2946	51237	9906	91120	4676	24139	81556	11278	6715	165	6051	57406	3098	55343	3215	51302	6576	5300	5704	2530	28992	226	55568	5937	10897	6310	10290	2494	83700	7384	11145	5092	1646	3912	7090	9114	1380	6793	6553	4642	2534	7165	5139	23368	4015	343071	5859	4050	6850	9473	55737	11118	5641	30845	56005	79038	81619	54780	10090	23643	4172	5032	92856
GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_UP	M3241		19124732	Good KL,Avery DT,Tangye SG.	GSE13411	GSE13411_1619_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive B cells versus Ig isotype switched memory B cells.	Enhanced secondary Ab responses are a vital component of adaptive immunity, yet little is understood about the intrinsic and extrinsic regulators of naive and memory B cells that results in differences in their responses to Ag. Microarray analysis, together with surface and intracellular phenotyping, revealed that memory B cells have increased expression of members of the TNF receptor, SLAM, B7 and Bcl2 families, as well as the TLR-related molecule CD180 (RP105). Accordingly, memory B cells exhibited enhanced survival, proliferation and Ig secretion, as well as entered division more rapidly than naïve B cells in response to both T-dependent and T-independent stimuli. Furthermore, both IgM and isotype switched memory B cells, but not naïve B cells, co-stimulated CD4+ T cells in vitro through a mechanism dependent on their constitutive expression of CD80 and CD86. This study demonstrates that upregulation of genes involved in activation, co-stimulation and survival provides memory B cells with a unique ability to produce enhanced immune responses and contributes to the maintenance of the memory B cell pool.					23742	343	8786	64779	4776	2794	4628	80344	6855	10218	51471	64067	6588	4114	3972	786	816	56938	54551	3569	79860	29122	55756	1907	9104	51237	51310	1572	51440	2312	29986	6128	56344	56656	5540	79075	11247	79990	23544	590	7221	113457	254896	27063	10891	23237	133619	7007	91316	81796	64344	1634	4477	22999	442194	10107	1551	4811	181	199731	160313	9162	6591	64799	2487	2342	22852	10733	79843	2138	3268	4884	81602	50509	3854	10380	55876	55584	284001	23475	57720	154796	417	4632	79774	55885	26000	23359	9108	55328	10219	567	9245	60506	9180	3242	7005	1836	100287008	55663	1909	390999	875	9468	284352	540	25945	39	1760	4602	9848	10439	134	55811	29094	666	25830	7479	28964	399904	8572	23022	1816	1741	56146	5004	6527	26664	8898	6252	54221	27099	971	50835	56924	56648	27136	23640	5923	6401	3949	5017	2641	54626	10249	3292	65009	24147	55742	80177	8110	27124	80164	83660	23432	79998	29951	1729	51343	3651	1001	174	10022	57718	89944	6447	56957	79825	3060	126	6533	201626	28234	80086	2206	79686	796	6340	54875	4681	9843	55806	1178	8629	8817	56000	9590	2862	6978	7490	10406	4597	27159	9074	10114	10512	26049	7424	4145	9313
GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_DN	M3242		19124732	Good KL,Avery DT,Tangye SG.	GSE13411	GSE13411_1619_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive B cells versus Ig isotype switched memory B cells.	Enhanced secondary Ab responses are a vital component of adaptive immunity, yet little is understood about the intrinsic and extrinsic regulators of naive and memory B cells that results in differences in their responses to Ag. Microarray analysis, together with surface and intracellular phenotyping, revealed that memory B cells have increased expression of members of the TNF receptor, SLAM, B7 and Bcl2 families, as well as the TLR-related molecule CD180 (RP105). Accordingly, memory B cells exhibited enhanced survival, proliferation and Ig secretion, as well as entered division more rapidly than naïve B cells in response to both T-dependent and T-independent stimuli. Furthermore, both IgM and isotype switched memory B cells, but not naïve B cells, co-stimulated CD4+ T cells in vitro through a mechanism dependent on their constitutive expression of CD80 and CD86. This study demonstrates that upregulation of genes involved in activation, co-stimulation and survival provides memory B cells with a unique ability to produce enhanced immune responses and contributes to the maintenance of the memory B cell pool.					6331	5966	80222	8239	4267	6182	4191	29956	4015	55069	11285	23203	5034	3486	23167	4907	9034	1441	27102	3074	506	5884	55654	23189	719	23015	64223	23241	8879	6352	11118	6793	79022	6036	1939	23002	55343	79930	10581	1388	9812	23613	26502	5937	26031	10313	7552	11056	7644	51729	10363	23327	50486	9681	593	8876	55239	9217	5230	64393	468	8495	3029	304	4522	26191	4707	9781	26586	2040	7014	1318	8720	11212	55568	3588	55803	54994	81552	8347	80153	2157	9491	9957	7414	8975	84908	1778	80212	7431	26953	57466	355	79746	2946	335	5724	5912	23474	23514	4082	4363	1975	11163	173	55704	6850	10616	55111	79001	7384	10147	3574	23275	8666	51174	5024	4201	3688	4440	11261	7403	1439	100289420	11007	217	4704	829	3933	9369	5859	3105	79109	64850	6194	23158	10795	10184	2908	5496	7165	3956	8632	55556	55737	5257	55683	5641	3376	8825	4648	3551	5988	440270	10469	5450	147179	55667	79706	5537	2352	293	4124	80205	5813	26986	259197	1794	10942	116832	9823	79718	284443	7284	10410	5305	9656	10776	527	79006	55625	3654	644068	9143	5875	8241	84619	8761	9852	54681	8748	6137	23082	254359	81570	5579	23054	9650	56954	22905
GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_UP	M3243		19124732	Good KL,Avery DT,Tangye SG.	GSE13411	GSE13411_1620_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive B cells versus plasma cells.	Enhanced secondary Ab responses are a vital component of adaptive immunity, yet little is understood about the intrinsic and extrinsic regulators of naive and memory B cells that results in differences in their responses to Ag. Microarray analysis, together with surface and intracellular phenotyping, revealed that memory B cells have increased expression of members of the TNF receptor, SLAM, B7 and Bcl2 families, as well as the TLR-related molecule CD180 (RP105). Accordingly, memory B cells exhibited enhanced survival, proliferation and Ig secretion, as well as entered division more rapidly than naïve B cells in response to both T-dependent and T-independent stimuli. Furthermore, both IgM and isotype switched memory B cells, but not naïve B cells, co-stimulated CD4+ T cells in vitro through a mechanism dependent on their constitutive expression of CD80 and CD86. This study demonstrates that upregulation of genes involved in activation, co-stimulation and survival provides memory B cells with a unique ability to produce enhanced immune responses and contributes to the maintenance of the memory B cell pool.					9815	3298	79979	23046	7403	55841	1787	4853	5966	54454	8864	51296	64393	81926	10023	4345	11009	2534	55152	8481	55278	79960	23635	9939	54434	23338	55182	22898	5796	10616	9202	23499	28639	57466	868	64421	822	80011	5976	27063	27436	79961	930	162	83700	55614	55364	1618	2254	23269	9314	4790	1196	240	10758	2932	440352	155066	10252	8780	8527	64779	2823	9737	343071	29803	7913	6894	11165	79894	93144	9308	26469	5026	23002	118987	85373	79666	80183	23225	11151	9092	3932	976	65982	5380	64762	10591	9263	339044	11056	9770	11064	274	55823	6160	54856	1107	24149	8553	911	5324	864	79571	54883	200576	202	8859	3202	7462	3566	7159	3087	25850	7475	1992	29	58155	222161	351	26053	1911	10019	26051	597	155060	23358	1606	65258	31	8635	5191	53335	8651	50862	5062	604	60485	54877	55568	51035	4775	339290	9938	3590	83955	9284	23355	3115	85458	6672	1633	54847	23258	9767	157562	10863	5204	51592	51526	79899	9823	6515	4600	7539	3903	4760	54663	3126	3633	53346	9466	972	8874	23064	79788	9459	55544	831	80223	60468	2869	144699	64400	6134	230	1727	10206	8303	4907	51466	9450	79144	55000	3670	51241	10793	9716	5293	149603
GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_DN	M3244		19124732	Good KL,Avery DT,Tangye SG.	GSE13411	GSE13411_1620_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive B cells versus plasma cells.	Enhanced secondary Ab responses are a vital component of adaptive immunity, yet little is understood about the intrinsic and extrinsic regulators of naive and memory B cells that results in differences in their responses to Ag. Microarray analysis, together with surface and intracellular phenotyping, revealed that memory B cells have increased expression of members of the TNF receptor, SLAM, B7 and Bcl2 families, as well as the TLR-related molecule CD180 (RP105). Accordingly, memory B cells exhibited enhanced survival, proliferation and Ig secretion, as well as entered division more rapidly than naïve B cells in response to both T-dependent and T-independent stimuli. Furthermore, both IgM and isotype switched memory B cells, but not naïve B cells, co-stimulated CD4+ T cells in vitro through a mechanism dependent on their constitutive expression of CD80 and CD86. This study demonstrates that upregulation of genes involved in activation, co-stimulation and survival provides memory B cells with a unique ability to produce enhanced immune responses and contributes to the maintenance of the memory B cell pool.					8654	390502	7873	642	152185	55157	54923	8360	6400	2286	5954	15	22974	861	55507	115817	3568	7644	23466	983	2944	29937	8586	7083	10133	28831	23241	360	9328	84658	10170	2847	997	8354	8424	7762	10518	3833	6238	2805	6397	11065	79968	5163	83445	7586	23336	2542	8270	91353	2950	9607	8820	558	3001	6375	8630	3601	146909	4245	8438	25854	57415	22852	83482	6514	8727	51293	64215	80307	9685	79947	57172	4324	8632	64218	3293	28912	11040	83461	2184	1571	9156	6525	80775	54938	2642	7345	2707	55219	2549	123872	7077	10912	25829	5831	10244	2203	8870	4213	1028	27289	8331	5141	65018	779	3558	28902	23193	9088	2322	4642	5989	7494	81796	2516	10881	56895	9858	81029	2826	10245	81888	55821	23649	8344	3507	79018	219654	5479	727800	3614	10221	639	9597	27293	8544	10469	578	3998	29123	27094	23254	92579	26145	255057	50486	9212	4234	2947	410	686	22996	10112	55915	652493	23676	2334	186	11126	79770	4758	10066	50649	6690	6332	8811	96610	2294	6462	28299	2832	23617	899	7518	26220	81620	79746	1783	55723	23429	23203	10256	57405	54472	10930	100	2053	6573	10761	9133	51303	51440	11153	54480	8343	23237	730101	778	51226
GSE13411_NAIVE_VS_MEMORY_BCELL_UP	M3245		19124732	Good KL,Avery DT,Tangye SG.	GSE13411	GSE13411_1621_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive B cells versus memory B cells.	Enhanced secondary Ab responses are a vital component of adaptive immunity, yet little is understood about the intrinsic and extrinsic regulators of naive and memory B cells that results in differences in their responses to Ag. Microarray analysis, together with surface and intracellular phenotyping, revealed that memory B cells have increased expression of members of the TNF receptor, SLAM, B7 and Bcl2 families, as well as the TLR-related molecule CD180 (RP105). Accordingly, memory B cells exhibited enhanced survival, proliferation and Ig secretion, as well as entered division more rapidly than naïve B cells in response to both T-dependent and T-independent stimuli. Furthermore, both IgM and isotype switched memory B cells, but not naïve B cells, co-stimulated CD4+ T cells in vitro through a mechanism dependent on their constitutive expression of CD80 and CD86. This study demonstrates that upregulation of genes involved in activation, co-stimulation and survival provides memory B cells with a unique ability to produce enhanced immune responses and contributes to the maintenance of the memory B cell pool.					27136	2888	342096	6533	55415	6591	10141	9848	50835	339290	10733	80177	4212	8644	8470	53630	10114	6217	5923	5122	11063	11247	23544	57101	64799	55893	4703	51471	4107	79968	79794	56547	11174	856	10848	1949	420	54221	27241	23431	27063	8553	89795	11096	26637	11151	79153	11141	9162	56124	5174	9118	2543	2047	958	131	150160	11169	1720	8549	336	3752	57795	79686	1413	3458	8091	100288679	433	79843	23460	55034	100129410	6854	3355	64940	23043	1415	22847	8867	6840	9348	57158	56648	1116	81571	22999	28234	23563	11243	1728	55876	8756	201134	9892	51275	55811	7469	9182	79150	10699	645784	90355	1831	81602	1124	55311	10391	50861	2916	1281	1618	220077	3593	389136	25893	5939	26659	3980	633	26064	80031	10787	54967	8629	50804	2312	29951	6978	6504	105	10763	2798	51152	7180	25888	10407	53919	22832	23414	80095	79669	3938	7711	27125	3977	55388	8573	51274	7827	4915	24137	126070	23022	2691	26105	2562	199731	23208	25827	114818	4114	55521	5331	2487	81854	3563	883	860	9912	8287	412	79780	926	2701	10648	55663	58495	815	11055	2043	2322	6638	10590	79413	27124	80776	57405	3005	11099	7710	5962	23142	1360	5795	1088	971	7434	56475	25806
GSE13411_NAIVE_VS_MEMORY_BCELL_DN	M3246		19124732	Good KL,Avery DT,Tangye SG.	GSE13411	GSE13411_1621_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive B cells versus memory B cells.	Enhanced secondary Ab responses are a vital component of adaptive immunity, yet little is understood about the intrinsic and extrinsic regulators of naive and memory B cells that results in differences in their responses to Ag. Microarray analysis, together with surface and intracellular phenotyping, revealed that memory B cells have increased expression of members of the TNF receptor, SLAM, B7 and Bcl2 families, as well as the TLR-related molecule CD180 (RP105). Accordingly, memory B cells exhibited enhanced survival, proliferation and Ig secretion, as well as entered division more rapidly than naïve B cells in response to both T-dependent and T-independent stimuli. Furthermore, both IgM and isotype switched memory B cells, but not naïve B cells, co-stimulated CD4+ T cells in vitro through a mechanism dependent on their constitutive expression of CD80 and CD86. This study demonstrates that upregulation of genes involved in activation, co-stimulation and survival provides memory B cells with a unique ability to produce enhanced immune responses and contributes to the maintenance of the memory B cell pool.					7644	80153	7384	56954	11118	23466	7165	9491	10616	26986	23015	4440	79746	2778	3376	9681	1939	2534	27102	8761	55568	9114	60559	2946	53918	10184	1615	5937	80222	27347	5790	6191	4676	9040	1778	26051	10975	162427	2309	9447	6894	55556	29956	4363	5257	5062	8632	6352	55737	51604	4600	3029	8495	375056	84747	59349	28992	9805	23608	599	533	23158	8099	2281	900	8720	5434	4082	8841	5859	4191	8666	4648	2821	8543	622	10491	79109	55739	55182	29803	254102	55057	1975	6993	4832	54544	116832	83700	3096	5230	10090	5223	57150	23753	55028	5476	173	11046	327	11261	1794	3956	79365	10318	644068	23368	51155	7262	1235	55146	468	159963	56910	5450	402	55233	7187	55727	5580	64425	5496	5879	9601	54512	23203	63916	5079	3486	25980	163131	6415	51011	51451	439	79006	9217	57142	51642	65993	81620	91966	2720	7511	3945	55246	26502	57109	79175	11190	54919	939	6173	23327	4201	6734	10529	92815	6182	1175	5439	10309	26031	3074	10330	7014	23130	64223	3018	64419	11262	22837	7027	23310	51081	55033	55009	5894	2987	1441	100289053	8439	7032	112950	103	8904	8607	64976	51706	3512	3238	5305	9049	79022	4522	51042	2896	51734	10942	3574
GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_UP	M3247		19124732	Good KL,Avery DT,Tangye SG.	GSE13411	GSE13411_1622_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of IgM-memory B cells versus Ig isotype switched memory B cells.	Enhanced secondary Ab responses are a vital component of adaptive immunity, yet little is understood about the intrinsic and extrinsic regulators of naive and memory B cells that results in differences in their responses to Ag. Microarray analysis, together with surface and intracellular phenotyping, revealed that memory B cells have increased expression of members of the TNF receptor, SLAM, B7 and Bcl2 families, as well as the TLR-related molecule CD180 (RP105). Accordingly, memory B cells exhibited enhanced survival, proliferation and Ig secretion, as well as entered division more rapidly than naïve B cells in response to both T-dependent and T-independent stimuli. Furthermore, both IgM and isotype switched memory B cells, but not naïve B cells, co-stimulated CD4+ T cells in vitro through a mechanism dependent on their constitutive expression of CD80 and CD86. This study demonstrates that upregulation of genes involved in activation, co-stimulation and survival provides memory B cells with a unique ability to produce enhanced immune responses and contributes to the maintenance of the memory B cell pool.					7345	2309	2843	634	3762	27159	10725	2184	57110	343	2346	11341	3712	650	65260	25830	23742	9108	23007	3755	50509	29914	169611	344	5862	1358	2615	165	8786	653423	11030	56344	92483	9891	3850	1116	56967	5496	4680	3242	8495	80235	1634	64084	10249	23432	3430	54674	343071	3972	400084	51440	6553	23509	4635	1394	7479	1306	6855	8904	1805	25775	1729	7518	3077	6568	9074	2806	595	11267	10590	911	2342	57626	6701	6781	23333	79698	10555	51005	100293871	4656	56475	7009	55847	56938	2138	133619	85368	3094	100130741	11015	417	1804	6755	79815	3044	3857	4081	29986	80031	64240	2252	54847	55554	10004	5619	3913	1870	2760	64405	8292	3535	56955	205	57644	23423	26059	3776	26707	995	10998	4610	4978	65992	6405	406	4435	28234	23189	29949	5650	26030	8832	6583	81616	80723	64137	8200	10149	26659	81833	80736	23315	80307	79804	51081	8549	6338	7851	11316	1135	1158	29959	10369	1580	186	2797	2832	56311	29789	79814	5365	54938	79739	1557	56107	100293440	80781	160313	540	57502	166647	5332	4356	134	100288809	23001	1829	26297	4634	83660	10742	7873	100129500	51715	3570	26509	151230	3284	57669	3960	4357	1896	4233	2560	64718	442194	22914	4520
GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_DN	M3248		19124732	Good KL,Avery DT,Tangye SG.	GSE13411	GSE13411_1622_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of IgM-memory B cells versus Ig isotype switched memory B cells.	Enhanced secondary Ab responses are a vital component of adaptive immunity, yet little is understood about the intrinsic and extrinsic regulators of naive and memory B cells that results in differences in their responses to Ag. Microarray analysis, together with surface and intracellular phenotyping, revealed that memory B cells have increased expression of members of the TNF receptor, SLAM, B7 and Bcl2 families, as well as the TLR-related molecule CD180 (RP105). Accordingly, memory B cells exhibited enhanced survival, proliferation and Ig secretion, as well as entered division more rapidly than naïve B cells in response to both T-dependent and T-independent stimuli. Furthermore, both IgM and isotype switched memory B cells, but not naïve B cells, co-stimulated CD4+ T cells in vitro through a mechanism dependent on their constitutive expression of CD80 and CD86. This study demonstrates that upregulation of genes involved in activation, co-stimulation and survival provides memory B cells with a unique ability to produce enhanced immune responses and contributes to the maintenance of the memory B cell pool.					29994	5884	1675	3952	1238	57466	26054	100129973	10855	10365	10762	2581	59342	27247	10313	84159	55791	5989	92822	2339	8239	3417	25950	6793	64062	3298	50836	51322	23203	80124	23412	27071	8195	3308	64135	22938	6210	55739	7403	8897	3148	1462	23081	56948	23405	9819	57215	11212	51116	10208	2162	9057	2071	54103	26136	26128	352961	10769	304	93210	1071	5870	5966	81698	9774	5813	2673	1318	847	29097	537	401251	9202	1432	9962	26175	5525	28387	51363	64343	51727	84975	25932	1962	58472	4005	7746	4907	55288	2212	10477	56994	10641	2219	6774	7405	1195	51312	80194	57020	6281	1528	151050	1439	719	25979	7414	7978	6845	3123	79269	9957	1655	79968	29062	79048	9792	51729	9470	7128	3157	4751	51339	23002	5867	6874	3835	23235	1397	3394	55914	677	196	7045	5898	3676	6924	7465	23294	5311	8932	8895	1604	84525	8879	5265	23256	2014	6741	23234	57707	3958	55717	217	5993	79022	4724	3000	23108	80184	8454	79746	4719	22911	7257	3915	22841	84079	6945	81550	163131	9630	79673	388677	55884	50807	50515	10385	23317	1992	286	5516	1690	22898	301	728855	55654	10613	22908	5325	55048	7639	4122	11060	64083	83716	9575	23239	11124	54925
GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_UP	M3249		19124732	Good KL,Avery DT,Tangye SG.	GSE13411	GSE13411_1623_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of IgM-memory B cells versus plasma cells.	Enhanced secondary Ab responses are a vital component of adaptive immunity, yet little is understood about the intrinsic and extrinsic regulators of naive and memory B cells that results in differences in their responses to Ag. Microarray analysis, together with surface and intracellular phenotyping, revealed that memory B cells have increased expression of members of the TNF receptor, SLAM, B7 and Bcl2 families, as well as the TLR-related molecule CD180 (RP105). Accordingly, memory B cells exhibited enhanced survival, proliferation and Ig secretion, as well as entered division more rapidly than naïve B cells in response to both T-dependent and T-independent stimuli. Furthermore, both IgM and isotype switched memory B cells, but not naïve B cells, co-stimulated CD4+ T cells in vitro through a mechanism dependent on their constitutive expression of CD80 and CD86. This study demonstrates that upregulation of genes involved in activation, co-stimulation and survival provides memory B cells with a unique ability to produce enhanced immune responses and contributes to the maintenance of the memory B cell pool.					80235	3635	3632	10758	1105	26523	9314	7913	63982	79571	339229	55601	8795	9938	933	56255	54454	343071	81931	10396	10023	241	6304	5358	5793	10206	3707	267	11165	54662	55922	29928	11275	7403	7178	8741	2186	11064	8874	3202	55622	10713	9770	25948	79829	2100	930	6171	29887	822	80264	54621	23338	25825	23295	84525	5277	56967	64784	5976	83478	64087	864	7695	8869	7475	29803	79134	3720	55735	3044	55544	57728	971	9665	5796	11009	155066	440352	1396	5380	3298	26053	7414	56997	56259	10616	222161	9839	9922	240	56915	55278	23424	1939	10123	80223	4798	23355	11151	28639	3055	5100	23358	23002	22861	55182	5090	26469	10464	23637	9459	11257	29104	9934	221749	64761	6134	11120	3603	9647	80205	4615	51490	201895	7048	7462	644068	9334	57826	7571	1196	5826	9784	55186	2132	60468	23030	80208	51312	10163	9447	5204	23503	402	64779	51385	1743	57466	9070	11216	3705	5098	80212	200576	10581	23258	1729	6777	3117	55707	10171	6156	29062	57446	5613	350	79668	9422	972	6655	5324	1787	51466	6206	9552	79788	10801	6222	126231	9767	55114	10007	3128	6328	9844	6894	23387	6205	5869	80705	9112	55670	1606	7593	7539	55722	8744	55070	81606
GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_DN	M3250		19124732	Good KL,Avery DT,Tangye SG.	GSE13411	GSE13411_1623_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of IgM-memory B cells versus plasma cells.	Enhanced secondary Ab responses are a vital component of adaptive immunity, yet little is understood about the intrinsic and extrinsic regulators of naive and memory B cells that results in differences in their responses to Ag. Microarray analysis, together with surface and intracellular phenotyping, revealed that memory B cells have increased expression of members of the TNF receptor, SLAM, B7 and Bcl2 families, as well as the TLR-related molecule CD180 (RP105). Accordingly, memory B cells exhibited enhanced survival, proliferation and Ig secretion, as well as entered division more rapidly than naïve B cells in response to both T-dependent and T-independent stimuli. Furthermore, both IgM and isotype switched memory B cells, but not naïve B cells, co-stimulated CD4+ T cells in vitro through a mechanism dependent on their constitutive expression of CD80 and CD86. This study demonstrates that upregulation of genes involved in activation, co-stimulation and survival provides memory B cells with a unique ability to produce enhanced immune responses and contributes to the maintenance of the memory B cell pool.					91353	23213	11040	3305	80150	7083	1571	152185	4900	3514	50515	83481	56935	5207	54938	652493	3568	3212	2977	4324	22845	55157	2947	11063	192683	186	28831	10133	27289	51226	51293	360	11014	80789	2622	861	10244	80830	4143	10170	2847	6382	6821	2549	53358	64218	4758	56895	84288	8178	28902	55723	390502	23676	22974	24141	23475	23617	2138	29851	11065	81570	9358	81030	1013	3738	28908	29925	54827	8993	10456	146909	6690	10295	27136	993	9764	50489	49860	57348	8344	983	5479	83445	51686	4642	27314	10993	5827	8870	57795	96610	8630	79001	2832	51440	51303	1501	128872	84658	1376	78992	91316	5141	6695	8438	54961	3915	6520	2053	7494	57172	1962	80036	7345	1209	11313	7745	639	11193	81796	8390	6238	1849	29931	332	55507	8360	65018	27293	4014	81669	9603	57125	10469	445	1491	5648	3293	64215	11156	6400	2826	25854	8586	2322	4618	5611	6397	5347	3779	64793	79947	28299	641	8348	4635	10615	7076	25839	5654	4621	8315	26155	8318	5831	55915	55821	51299	79586	2286	5267	1029	354	730051	10024	608	5577	5034	813	63877	8356	2017	8367	3835	8644	3371	7827	64927	6781	81620	686	7079	200205	302	64943	79018	64800	7253	9156
GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_UP	M3251		19124732	Good KL,Avery DT,Tangye SG.	GSE13411	GSE13411_1624_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of Ig isotype switched memory B cells versus plasma cells.	Enhanced secondary Ab responses are a vital component of adaptive immunity, yet little is understood about the intrinsic and extrinsic regulators of naive and memory B cells that results in differences in their responses to Ag. Microarray analysis, together with surface and intracellular phenotyping, revealed that memory B cells have increased expression of members of the TNF receptor, SLAM, B7 and Bcl2 families, as well as the TLR-related molecule CD180 (RP105). Accordingly, memory B cells exhibited enhanced survival, proliferation and Ig secretion, as well as entered division more rapidly than naïve B cells in response to both T-dependent and T-independent stimuli. Furthermore, both IgM and isotype switched memory B cells, but not naïve B cells, co-stimulated CD4+ T cells in vitro through a mechanism dependent on their constitutive expression of CD80 and CD86. This study demonstrates that upregulation of genes involved in activation, co-stimulation and survival provides memory B cells with a unique ability to produce enhanced immune responses and contributes to the maintenance of the memory B cell pool.					9314	2132	55187	56259	11186	65981	10623	6655	9618	80011	79960	259230	29803	51735	11120	10758	9765	7913	55727	254394	3633	80208	1105	55922	822	7541	23613	6672	64848	301	5796	7462	8648	9794	3128	59342	51230	57711	79829	933	202	57446	11165	4790	241	7915	10713	5594	5747	55850	10023	10396	1398	490	155066	1196	2186	22911	118987	26053	6281	55707	1536	9056	2948	5295	240	905	51526	1955	6197	79091	55644	3635	4798	55006	79982	50485	10464	22990	55186	9712	26065	8893	10947	5380	6942	23177	1606	6598	9282	10475	5756	79961	974	83478	64421	7159	25843	64393	9338	6477	261726	81608	9926	9489	1848	56652	11151	64087	3087	868	7048	864	27299	391	51592	8767	54454	8621	81631	51611	9767	1455	23080	51136	51177	8795	3932	144699	79828	8500	442216	79089	55070	9129	8905	81606	29887	83442	54665	80868	4609	695	55670	9922	23324	6617	972	7693	55601	29957	84065	8314	286148	351	7712	11216	930	55818	6259	64761	23515	4548	60684	399	3600	6894	83700	79666	440270	10781	10801	6160	2185	8651	10206	11011	8741	23761	5500	9143	80183	65982	79668	23564	9815	54925	55666	4947	23503	2592	5613	4615	440352	25825	9453	51742	55182	58155
GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_DN	M3252		19124732	Good KL,Avery DT,Tangye SG.	GSE13411	GSE13411_1624_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of Ig isotype switched memory B cells versus plasma cells.	Enhanced secondary Ab responses are a vital component of adaptive immunity, yet little is understood about the intrinsic and extrinsic regulators of naive and memory B cells that results in differences in their responses to Ag. Microarray analysis, together with surface and intracellular phenotyping, revealed that memory B cells have increased expression of members of the TNF receptor, SLAM, B7 and Bcl2 families, as well as the TLR-related molecule CD180 (RP105). Accordingly, memory B cells exhibited enhanced survival, proliferation and Ig secretion, as well as entered division more rapidly than naïve B cells in response to both T-dependent and T-independent stimuli. Furthermore, both IgM and isotype switched memory B cells, but not naïve B cells, co-stimulated CD4+ T cells in vitro through a mechanism dependent on their constitutive expression of CD80 and CD86. This study demonstrates that upregulation of genes involved in activation, co-stimulation and survival provides memory B cells with a unique ability to produce enhanced immune responses and contributes to the maintenance of the memory B cell pool.					6252	2944	642	54682	166647	1339	8348	10133	84444	56938	23213	84658	390502	22845	3833	5424	9590	9248	291	9088	80150	3508	23462	672	727800	2346	3673	652493	79860	3738	54923	6182	7054	5979	983	6695	51226	993	2947	4324	2847	85377	8438	8178	5479	10615	3568	360	6238	27022	79570	2950	2239	2286	80215	54674	7253	4168	2697	55157	57333	354	5163	3514	25854	186	51303	27136	91353	80830	10794	2642	11014	11313	28831	57093	7077	9685	64215	5017	57823	27077	55604	23108	3001	83988	8542	5238	79174	9358	57198	11065	23617	4641	23333	51016	9328	11122	26220	9858	2826	55507	56062	7762	7422	8344	4618	952	9597	3081	29925	81602	23254	22925	51272	23676	10881	639	5630	83445	9156	2977	8270	84722	26716	28912	23193	15	8424	54938	11187	5648	608	1013	51078	914	92104	3017	6332	11015	410	50506	1783	92579	8331	8390	152185	55010	2131	1491	29931	27293	100131298	1015	22974	81620	8332	26539	3383	5207	8612	4234	2036	54922	3069	2622	1543	8586	8644	4245	8368	949	6696	778	255057	558	1571	2516	54718	3346	5915	501	28797	27289	11153	3779	1193	5125	23429	9038	4493	6781	26503	1493	55723	2690	1962	1849	2011	445347
GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_UP	M3253		19124732	Good KL,Avery DT,Tangye SG.	GSE13411	GSE13411_1625_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of plasma cells versus memory B cells.	Enhanced secondary Ab responses are a vital component of adaptive immunity, yet little is understood about the intrinsic and extrinsic regulators of naive and memory B cells that results in differences in their responses to Ag. Microarray analysis, together with surface and intracellular phenotyping, revealed that memory B cells have increased expression of members of the TNF receptor, SLAM, B7 and Bcl2 families, as well as the TLR-related molecule CD180 (RP105). Accordingly, memory B cells exhibited enhanced survival, proliferation and Ig secretion, as well as entered division more rapidly than naïve B cells in response to both T-dependent and T-independent stimuli. Furthermore, both IgM and isotype switched memory B cells, but not naïve B cells, co-stimulated CD4+ T cells in vitro through a mechanism dependent on their constitutive expression of CD80 and CD86. This study demonstrates that upregulation of genes involved in activation, co-stimulation and survival provides memory B cells with a unique ability to produce enhanced immune responses and contributes to the maintenance of the memory B cell pool.					9601	51016	5611	28299	952	2286	8542	8727	81620	28797	26155	64793	7873	730101	64215	55604	2826	9133	57823	64788	7077	8352	813	9833	79174	4143	7494	79770	5989	25829	1783	445	146909	7038	100290557	608	7422	5827	991	1028	51659	420	55711	27136	11014	4751	65018	79669	3655	5479	1870	3069	390502	9156	2543	8367	84830	26503	3568	4758	9858	57405	1571	29925	445347	3455	8348	7184	983	11067	56341	84658	7518	5648	7153	8331	64943	6272	10945	654	5238	1193	4288	6241	8346	3489	123872	6397	8318	8344	7083	79968	10170	23193	10024	26255	8329	11065	10133	10112	16	23650	79001	100292959	27293	270	8644	9328	6382	22974	10295	27077	3149	83482	1491	224	1478	5577	6238	27314	51237	8438	96610	11145	64151	81570	1209	1033	11015	23466	8343	192683	10221	29927	1029	1048	2847	7298	8336	4493	890	23753	83445	23213	10066	3514	219654	8337	22936	10256	4286	639	4014	10456	360	22926	28778	83461	25837	24141	84722	55157	3998	81029	7762	5523	10237	9212	7345	2731	1281	9232	2949	1841	844	64798	79094	3854	11313	6748	128872	6400	10615	54961	8349	410	28831	7015	64080	255057	8332	4921	8339	54939	57171	8178	11040	64785	3479	10952
GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_DN	M3255		19124732	Good KL,Avery DT,Tangye SG.	GSE13411	GSE13411_1625_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of plasma cells versus memory B cells.	Enhanced secondary Ab responses are a vital component of adaptive immunity, yet little is understood about the intrinsic and extrinsic regulators of naive and memory B cells that results in differences in their responses to Ag. Microarray analysis, together with surface and intracellular phenotyping, revealed that memory B cells have increased expression of members of the TNF receptor, SLAM, B7 and Bcl2 families, as well as the TLR-related molecule CD180 (RP105). Accordingly, memory B cells exhibited enhanced survival, proliferation and Ig secretion, as well as entered division more rapidly than naïve B cells in response to both T-dependent and T-independent stimuli. Furthermore, both IgM and isotype switched memory B cells, but not naïve B cells, co-stimulated CD4+ T cells in vitro through a mechanism dependent on their constitutive expression of CD80 and CD86. This study demonstrates that upregulation of genes involved in activation, co-stimulation and survival provides memory B cells with a unique ability to produce enhanced immune responses and contributes to the maintenance of the memory B cell pool.					1043	22838	55544	58533	9611	3119	55278	54838	644068	9665	10090	55619	6206	6204	9262	80148	80183	51035	1794	695	5293	81606	8303	7048	971	3115	9450	79656	240	4772	54847	55024	28639	6856	9459	4067	58516	9049	57446	29803	50854	200576	79677	80021	3128	6134	5305	6894	1536	5257	9770	1455	3134	51131	6402	10023	868	51076	5062	90333	23062	65264	962	65265	79618	1975	11151	79961	9938	930	2534	5937	9815	23048	26051	3603	6160	2132	25825	1633	51646	6222	3431	963	3983	11064	51592	6793	1743	8519	144699	4615	9308	10163	10410	3633	23370	1657	10904	8935	54877	26999	51347	10171	8741	4482	4050	8481	23195	6161	969	10616	222161	9552	51526	23338	51606	155060	79829	974	1939	8767	64425	27335	3635	3632	55182	202	9144	10765	5204	4335	54663	4853	11188	51362	55707	11142	64236	11165	6672	3936	79037	6164	5026	55739	221037	23394	7050	55727	5955	819	55186	896	9830	83478	7805	80205	65982	9111	93144	81631	5796	11216	22	54977	8635	8553	23173	6147	6232	10472	3113	5590	241	10801	5244	5380	11234	55850	55568	6171	4542	55909	7469	1519	23355	677	7462	55070	8237	10581	50862	22882	3123	10781	350	9143	388677	2186
GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_UP	M3257		19029902	Querec TD,Akondy RS,Lee EK,Cao W,Nakaya HI,Teuwen D,Pirani A,Gernert K,Deng J,Marzolf B,Kennedy K,Wu H,Bennouna S,Oluoch H,Miller J,Vencio RZ,Mulligan M,Aderem A,Ahmed R,Pulendran B.	GSE13484	GSE13484_2209_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) cultured for 0 h  versus PBMC cultured for 3 h with YF17D vaccine.	The immune responses generated by YF-17D by profiling 11,639 genes in PBMCs from 2 donors cultured with YF-17D vaccine were accessed after 3 and 12 hours.					8165	2041	56731	9159	22921	9051	3945	10935	91860	57730	58503	60314	644096	64174	64895	56997	9465	79837	93974	11222	60685	23309	10005	7730	57107	1955	9898	7704	25956	1524	7163	831	55435	23478	5501	959	9662	8741	22870	9905	266	6711	4361	54878	3682	10163	9338	1102	6256	64208	55198	79415	6929	26580	128	79982	10558	11335	317781	78991	23177	27429	79180	65999	54555	23523	28978	100272228	64132	25839	6296	9354	51603	4324	51092	80152	65981	55357	6942	2821	7390	939	6910	6813	27128	9757	9459	7919	11132	4778	146057	55316	9980	83444	25771	4849	3421	3984	5529	89910	63940	63892	9782	1739	4690	9416	64397	56339	55037	7846	657	10868	83759	79829	2630	23370	6745	28755	4122	22928	8943	408050	8440	2053	8292	11260	6634	9203	9125	79958	5204	8312	10057	55005	26234	6938	11024	150726	84908	9857	51321	1892	25778	63897	987	92017	9252	55186	55743	6601	23386	80145	5213	27173	23013	28957	5125	26523	10641	11325	58478	23218	5026	50861	5372	51433	81558	10732	91647	11052	51497	23140	6464	4125	54820	754	8935	115201	1729	34	286	55914	26005	23353	51548	9994	9214	79137	23158	8405	80215	6683	55852	5984	1605	4669	5954	23348	8621	23142
GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_DN	M3260		19029902	Querec TD,Akondy RS,Lee EK,Cao W,Nakaya HI,Teuwen D,Pirani A,Gernert K,Deng J,Marzolf B,Kennedy K,Wu H,Bennouna S,Oluoch H,Miller J,Vencio RZ,Mulligan M,Aderem A,Ahmed R,Pulendran B.	GSE13484	GSE13484_2209_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) cultured for 0 h  versus PBMC cultured for 3 h with YF17D vaccine.	The immune responses generated by YF-17D by profiling 11,639 genes in PBMCs from 2 donors cultured with YF-17D vaccine were accessed after 3 and 12 hours.					23180	92482	9655	55505	7057	4001	5328	57088	79778	9242	103910	5683	652963	3667	7464	7171	23210	9689	1060	6583	6166	79720	133	55718	55916	259230	4794	126298	3157	4646	9595	22835	59348	2005	151011	1645	10121	8460	54407	205	9246	10522	4189	2359	4616	4628	51330	3158	79015	9818	10435	85363	64787	355	6628	8942	9700	84061	80124	10938	27122	8754	10767	5339	10581	398	8542	79753	840	57134	27249	80149	3620	81556	55064	7444	4084	80219	356	3632	6921	3270	9052	4502	4938	3576	11080	11153	684	7288	27291	4286	8763	8204	5516	9693	5610	65117	5030	2833	3780	79441	79003	10379	553115	9732	25841	56957	996	9055	10289	54925	2869	272	3720	54847	7903	6493	79794	2243	8884	6009	4330	836	1977	222255	10777	59269	10148	5500	79623	51422	8738	9765	51131	2213	4495	29766	2969	5885	54708	4312	9659	5230	11040	10544	2120	10135	8774	80301	9047	8128	7718	4683	55337	29940	3914	9947	26228	9412	1836	51026	50999	3595	3662	11030	1263	444	8879	7104	23062	23258	80218	57194	4318	3983	8509	10488	4116	5687	5782	4942	1540	1826	53905	51582	2534	6276	23760	27299	22862	3920	8649	4247	94081	56145	602	10630	5271	160313
GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_UP	M3262		19029902	Querec TD,Akondy RS,Lee EK,Cao W,Nakaya HI,Teuwen D,Pirani A,Gernert K,Deng J,Marzolf B,Kennedy K,Wu H,Bennouna S,Oluoch H,Miller J,Vencio RZ,Mulligan M,Aderem A,Ahmed R,Pulendran B.	GSE13484	GSE13484_2210_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) cultured for 0 h versus PBMC cultured for 12 h with YF17D vaccine.	The immune responses generated by YF-17D by profiling 11,639 genes in PBMCs from 2 donors cultured with YF-17D vaccine were accessed after 3 and 12 hours.					25983	29997	3705	79048	9044	79649	11151	10142	5566	1804	8468	9940	80209	8165	6712	3257	7511	8087	23367	9755	55793	738	6256	6230	10922	8741	2203	6886	56731	6503	948	11255	8621	4208	9994	10904	521	59342	9716	54585	10771	10423	8673	863	11325	7086	55644	374291	6653	4929	54471	23741	64848	9605	8891	23244	3115	51816	204	4121	1200	9455	51214	56288	10123	5000	25796	56998	10643	847	3590	9913	7168	10491	3921	51182	51497	55625	22852	26574	5184	80194	286	5175	54808	7163	29098	51116	114034	55275	8821	22874	29789	56996	55699	8916	55082	8725	23234	84253	140801	9159	9051	5954	1606	29109	25900	8531	4069	6205	23341	22885	5437	23211	28951	8001	9632	8335	9886	80778	5742	5372	93974	64175	6229	939	100272216	4815	11261	7103	473	79958	2918	2091	3295	79906	5613	8312	6431	29883	25825	57157	55706	30845	51071	4942	9110	8073	10857	9782	4086	9488	8666	6844	476	549	10370	55186	79086	60685	3205	55324	8099	64710	10250	10721	2313	4353	10217	1937	6198	79991	7385	2555	79716	224	4671	7541	51506	54923	3857	5160	6843	1936	55291	25966	8436	9922	54870	9770	6430	57124	9617	29086	10844	11146	29108	1994	51202	79709
GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_DN	M3264		19029902	Querec TD,Akondy RS,Lee EK,Cao W,Nakaya HI,Teuwen D,Pirani A,Gernert K,Deng J,Marzolf B,Kennedy K,Wu H,Bennouna S,Oluoch H,Miller J,Vencio RZ,Mulligan M,Aderem A,Ahmed R,Pulendran B.	GSE13484	GSE13484_2210_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) cultured for 0 h versus PBMC cultured for 12 h with YF17D vaccine.	The immune responses generated by YF-17D by profiling 11,639 genes in PBMCs from 2 donors cultured with YF-17D vaccine were accessed after 3 and 12 hours.					5683	51606	23059	79922	259230	2123	10581	2630	3005	2114	26128	7756	6368	6386	5271	6445	10539	5973	79132	10616	3920	474344	23071	1368	9723	84159	2022	8775	7693	4084	10950	5743	5704	4763	10229	63899	8586	80149	1163	9729	79924	8347	81688	3667	79072	10381	9183	378708	22865	56676	57103	10190	3665	11031	3660	23099	5168	4012	290	8740	3157	25797	81030	9771	9830	53	26286	6782	2908	5892	79147	366	29923	4493	3605	55884	6726	79690	11213	79443	2892	8542	2773	9902	26099	5877	6526	22806	9767	27095	4501	51278	79627	375346	65108	2752	80219	133	27023	5306	10094	80306	81930	7596	79712	1512	8879	10087	8649	2969	7105	10440	81831	55361	2204	56675	1535	58516	7353	403	3981	79074	5411	23042	10016	23011	8669	51056	23548	26256	79943	7444	2034	6628	55337	8754	23585	9903	10827	5367	81566	439921	5696	4502	5326	4891	27250	9363	5516	11153	28977	6670	10880	378	57192	81542	200734	4683	2200	9271	29992	29766	3037	10906	4609	7124	56913	5329	23237	7171	3290	55788	6921	7415	51365	5509	9246	79134	26051	3939	6947	7189	54850	103	4693	5695	1646	55916	5141	10221	83464	247	3482	57817	10842	10063	127544	55500	5707	8545
GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP	M3266		19029902	Querec TD,Akondy RS,Lee EK,Cao W,Nakaya HI,Teuwen D,Pirani A,Gernert K,Deng J,Marzolf B,Kennedy K,Wu H,Bennouna S,Oluoch H,Miller J,Vencio RZ,Mulligan M,Aderem A,Ahmed R,Pulendran B.	GSE13484	GSE13484_2211_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) cultured for 3 h versus PBMC cultured for 3 h with YF17D vaccine.	The immune responses generated by YF-17D by profiling 11,639 genes in PBMCs from 2 donors cultured with YF-17D vaccine were accessed after 3 and 12 hours.					8165	55111	8522	997	23533	55743	79705	11014	113791	51321	1407	6470	6996	81623	8161	23710	6282	51094	51143	5190	10267	55195	7779	114932	9419	11102	5825	3613	10795	54665	9240	64180	79797	64210	55016	23344	131408	754	11186	10190	514	1994	6942	10023	2022	644068	26268	55596	1050	5471	57140	644096	51747	11337	4601	9855	9325	6239	944	8569	10928	51084	6146	6683	5431	533	587	57506	8943	9611	11322	6903	23075	64419	2665	6624	5594	5432	51573	5780	2222	84869	10003	10541	3054	8031	23177	64858	79078	114885	79837	51109	55005	64769	5834	57728	10922	27429	1537	8655	283345	1831	5697	5324	56922	54861	8396	55198	27180	55172	266977	29099	3932	814	3008	1462	5870	23461	6843	64795	8209	23670	83759	23644	5236	4238	54468	22880	79656	53637	3930	8905	83942	79777	9647	7200	10461	10935	80746	5203	2268	7388	3399	4706	740	10302	7358	528	6165	10659	23401	7027	29922	55277	2512	26065	7539	60685	471	1109	23097	55905	64895	10245	23195	4905	9140	8729	10914	23299	1070	71	10061	81603	7701	23062	51011	54440	8192	2597	7090	10550	5090	55048	126231	4914	4335	9341	23609	201163	1736	79890	10623	57406	7766	91	11260	10660	138151	5298
GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN	M3267		19029902	Querec TD,Akondy RS,Lee EK,Cao W,Nakaya HI,Teuwen D,Pirani A,Gernert K,Deng J,Marzolf B,Kennedy K,Wu H,Bennouna S,Oluoch H,Miller J,Vencio RZ,Mulligan M,Aderem A,Ahmed R,Pulendran B.	GSE13484	GSE13484_2211_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) cultured for 3 h versus PBMC cultured for 3 h with YF17D vaccine.	The immune responses generated by YF-17D by profiling 11,639 genes in PBMCs from 2 donors cultured with YF-17D vaccine were accessed after 3 and 12 hours.					5366	4001	6238	26511	200315	54880	10943	8269	2180	8519	29909	27430	51513	387082	644	6891	5328	10678	3601	3112	100289109	25816	55180	151011	7087	26228	56829	2250	10205	3383	29104	8807	4502	2627	55303	25932	4299	726	4061	8934	1540	9111	9683	10906	6947	660	9934	4312	57402	637	127544	6648	54855	571	474344	7706	56957	81697	7185	3759	9958	4938	7293	7068	2669	9663	8564	718	5142	55515	10379	3728	838	3667	604	54962	8728	375790	80329	8542	221472	116	6714	54739	55207	10346	4729	25841	27436	9592	11030	11177	221078	55026	3595	55206	4683	3738	4082	57045	3552	7448	395	9246	5271	2005	3949	4493	8140	4600	6616	3717	3702	4824	79370	1236	29761	5292	2867	79845	6351	54676	7295	5329	79668	7318	3267	55150	123872	2957	2036	1193	92	5267	10179	2969	63916	85363	3965	5930	578	2146	8837	10616	5696	3320	4609	81854	8614	4615	26051	10261	8578	25865	3559	23673	9444	55501	55521	54877	55867	64222	3430	573	114548	9252	55748	5743	725	1665	8843	2713	3458	55603	80176	8638	50508	8450	54821	3303	2787	2683	2213	54462	961	2175	57018	29949	22837	4939	51557	3586	141	81688	9582	3624	8763	9881	30844	10865
GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP	M3271		19029902	Querec TD,Akondy RS,Lee EK,Cao W,Nakaya HI,Teuwen D,Pirani A,Gernert K,Deng J,Marzolf B,Kennedy K,Wu H,Bennouna S,Oluoch H,Miller J,Vencio RZ,Mulligan M,Aderem A,Ahmed R,Pulendran B.	GSE13484	GSE13484_2212_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) cultured for 12 h versus PBMC cultured for 12 h with YF17D vaccine.	The immune responses generated by YF-17D by profiling 11,639 genes in PBMCs from 2 donors cultured with YF-17D vaccine were accessed after 3 and 12 hours.					2734	4068	9652	23309	3108	6198	55699	57415	28996	115353	5175	3632	8459	51109	64795	50809	3820	476	1933	79665	8933	51596	6711	8673	948	4677	1939	100506190	86	51727	51214	1456	54681	1192	644	51182	56925	1213	23039	3101	1102	22884	22921	6503	140609	9114	51366	9100	3631	7692	10472	11014	643314	10558	51428	91754	10513	5261	929	5660	51096	10178	55573	26278	7385	8826	387	5042	54800	11236	27102	1465	51449	80097	81575	6139	51313	2923	55506	7311	283	1050	7696	51411	55011	91137	2219	1831	55803	11034	4718	9896	1628	2934	8609	8031	7699	2548	23659	56994	10150	821	80254	54928	10559	55144	6277	1650	23259	79844	274	27107	9752	138151	10269	6038	997	64374	83451	5226	54458	5468	10618	7678	23601	805	79184	9074	60490	23080	5311	51397	8493	9555	6843	9770	55852	26065	7485	150759	8502	2353	10897	4695	78991	9949	79882	9617	2167	3815	8161	387535	54914	79887	79684	54851	3418	79036	5742	80778	9110	9697	8879	5001	79690	64425	57706	23198	1975	4904	55016	10327	9821	645	54209	9815	4666	2359	60685	26608	4354	55361	51751	6612	2192	6426	8407	10423	664	6144	349152	8697	157680	79646	51439	201562	8289	55830	1805	3074
GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN	M3273		19029902	Querec TD,Akondy RS,Lee EK,Cao W,Nakaya HI,Teuwen D,Pirani A,Gernert K,Deng J,Marzolf B,Kennedy K,Wu H,Bennouna S,Oluoch H,Miller J,Vencio RZ,Mulligan M,Aderem A,Ahmed R,Pulendran B.	GSE13484	GSE13484_2212_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) cultured for 12 h versus PBMC cultured for 12 h with YF17D vaccine.	The immune responses generated by YF-17D by profiling 11,639 genes in PBMCs from 2 donors cultured with YF-17D vaccine were accessed after 3 and 12 hours.					2289	4430	1244	474344	11255	26034	6272	4606	3099	1388	133	29887	55930	10894	3659	347	966	5327	22990	8349	3559	10637	79805	1889	840	9094	63875	3746	7978	9587	63899	5055	5993	4493	3269	3690	22874	80017	3021	54622	22873	3939	56652	6654	5968	10133	346562	6096	24138	1164	962	63967	7189	9589	2357	2678	27348	1839	55303	475	11213	5897	6614	65220	4520	100130449	23544	801	9674	25948	4616	11343	55770	4081	7474	8270	3929	776	211	838	23433	10666	25816	55131	1906	4061	93349	5533	23258	10943	55026	79755	5270	366	578	9630	4486	7039	3306	4693	10171	58494	3458	8269	5128	27342	4133	54971	9881	467	79627	3667	3430	54207	6447	56913	8710	9623	9060	6660	1662	5366	29110	2850	196	83637	114548	55207	5872	27344	6891	8464	10439	718	79132	4794	8607	57538	10906	23099	79015	2208	10866	3834	407	51312	55337	23022	9958	6355	9242	1163	3037	8553	8717	375035	26256	79693	253959	7287	55686	51117	6840	3717	2717	8996	9056	60485	50807	9654	3290	3557	51510	25999	9411	4702	23059	9104	10950	4170	11142	154661	6515	84789	10964	5329	81697	27074	5806	10549	54020	958	1573	9435	5687	4049	51475	9209	64853	80149
GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_UP	M3275		19029902	Querec TD,Akondy RS,Lee EK,Cao W,Nakaya HI,Teuwen D,Pirani A,Gernert K,Deng J,Marzolf B,Kennedy K,Wu H,Bennouna S,Oluoch H,Miller J,Vencio RZ,Mulligan M,Aderem A,Ahmed R,Pulendran B.	GSE13484	GSE13484_2213_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) cultured with YF17D vaccine for 12 h versus PBMC cultured for 3 h.	The immune responses generated by YF-17D by profiling 11,639 genes in PBMCs from 2 donors cultured with YF-17D vaccine were accessed after 3 and 12 hours.					60496	546	29956	1244	100506963	7468	79958	1200	1368	10005	1163	10541	84864	6355	8417	3958	9419	1102	585	8269	10807	3417	9489	5433	10007	11119	23544	2222	57506	79621	64131	3295	55914	522	141	9201	79838	5052	8801	5213	474344	8710	11064	9729	6654	7057	10782	549	55647	80324	10203	55435	55125	3985	54878	10095	9473	7541	514	375790	1234	9364	838	9724	8883	3005	54927	3588	64175	5327	10535	79866	29916	57035	2678	11161	26580	5529	51734	9554	115817	6843	552889	97	55196	10184	2495	23095	10964	9061	4233	64710	5594	27180	27440	2891	4947	79415	8031	55357	5509	7786	27095	5379	4542	54112	84890	5973	57212	10560	63892	26229	81493	55743	54622	11157	4090	11343	51603	51232	9807	8658	1955	4706	83937	6625	10859	79895	29967	283537	27037	10554	254394	79078	3290	6296	23461	57711	60682	3895	7039	10801	4026	64429	8161	50861	7336	11232	10247	6361	1130	29087	527	79837	9019	8655	4430	55759	54816	9200	10180	1512	27344	51714	10435	11257	3932	56647	55602	9575	157680	55803	3927	51324	7542	10006	231	59349	57157	90362	55070	26175	27429	55885	11014	9139	201163	79622	28952	5710	10367	5326	23142	83637	1786	1070	2171	399979	79671	56339
GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_DN	M3276		19029902	Querec TD,Akondy RS,Lee EK,Cao W,Nakaya HI,Teuwen D,Pirani A,Gernert K,Deng J,Marzolf B,Kennedy K,Wu H,Bennouna S,Oluoch H,Miller J,Vencio RZ,Mulligan M,Aderem A,Ahmed R,Pulendran B.	GSE13484	GSE13484_2213_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) cultured with YF17D vaccine for 12 h versus PBMC cultured for 3 h.	The immune responses generated by YF-17D by profiling 11,639 genes in PBMCs from 2 donors cultured with YF-17D vaccine were accessed after 3 and 12 hours.					6711	59342	7029	221960	7850	23430	143	5026	9886	10892	3115	4670	3921	23174	8273	6400	80230	23091	9607	6277	51257	1349	1973	81552	9314	23135	94081	202	8809	8669	10867	54861	11030	3552	7045	1831	293	11319	476	55718	5867	10743	23258	5829	51513	710	2683	5621	6672	3383	55748	84061	3240	10019	597	7288	10492	84981	8814	54809	10123	6125	51660	29121	5175	375056	725	55149	4929	7752	10947	4548	948	5816	5244	3096	8436	22930	4258	10137	8934	51118	54821	9334	2633	5230	80777	23760	54205	81034	4802	3904	6122	6775	55183	10767	1917	2034	3566	4646	8335	57466	10399	54962	81929	56255	8418	1154	56957	23052	921	92822	4580	10865	126298	56941	3836	11283	79720	23122	3108	5068	7678	55254	79877	10522	2990	6018	54520	50831	5660	752014	10125	10746	339105	3820	2781	11321	7844	4704	23108	9044	6132	441024	8379	8543	8301	4620	5105	3684	2841	10982	4486	27348	1672	8843	27252	54812	116	79009	8607	54880	8740	9185	57165	6774	22890	5292	23589	1933	10352	578	3301	30820	5366	7050	2811	730227	10683	1124	81689	8348	4615	10365	8477	5500	25909	9588	54758	1032	5718	57118	28984	2521	3805	7090	2634	9465	11261	2935
GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP	M3277		19029902	Querec TD,Akondy RS,Lee EK,Cao W,Nakaya HI,Teuwen D,Pirani A,Gernert K,Deng J,Marzolf B,Kennedy K,Wu H,Bennouna S,Oluoch H,Miller J,Vencio RZ,Mulligan M,Aderem A,Ahmed R,Pulendran B.	GSE13484	GSE13484_2214_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) versus PBMC stimulated with YF17D vaccine.	The immune responses generated by YF-17D by profiling 11,639 genes in PBMCs from 2 donors cultured with YF-17D vaccine were accessed after 3 and 12 hours.					515	11252	23588	7155	64960	11198	6426	79447	9354	4798	3930	6745	11034	9788	9770	10844	8518	7862	4677	55011	6683	5431	26292	25900	10762	7398	26190	26039	23151	6767	51428	5537	1050	8890	6653	7507	54934	6256	81603	79169	51218	360	52	8834	57326	54838	5921	3189	989	51321	51063	55625	7737	6117	130074	6239	1456	498	58487	23451	51398	23318	4335	10929	7384	6746	27101	6144	729230	8905	5210	64419	64795	23478	54537	2593	5090	381	55486	28639	7181	22884	91137	8073	7520	26268	11344	5108	11260	10113	11052	9685	7267	8539	6940	1994	26121	60685	5204	26119	10095	55818	113	55922	100129361	91647	149986	54436	23039	55810	3337	79228	64860	4242	51076	55139	10287	6165	9827	3936	11315	51304	23353	115207	427	23262	167227	23326	4735	10594	26130	64112	23344	55819	60559	6596	7247	4707	1176	26046	26523	4650	54799	54440	1978	9046	4125	10296	9600	6885	2073	23644	23522	9867	6185	4714	23369	201562	8533	79801	10541	54870	79882	51696	3421	9716	23589	7110	2631	10023	5980	11325	1736	11336	5184	6146	10559	11057	7818	1488	57498	2665	80778	80205	23173	54942	23654	10097	80349	3033	5062	1967	25828	138151	11138	4215	58486	10427	6301	5253
GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN	M3279		19029902	Querec TD,Akondy RS,Lee EK,Cao W,Nakaya HI,Teuwen D,Pirani A,Gernert K,Deng J,Marzolf B,Kennedy K,Wu H,Bennouna S,Oluoch H,Miller J,Vencio RZ,Mulligan M,Aderem A,Ahmed R,Pulendran B.	GSE13484	GSE13484_2214_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) versus PBMC stimulated with YF17D vaccine.	The immune responses generated by YF-17D by profiling 11,639 genes in PBMCs from 2 donors cultured with YF-17D vaccine were accessed after 3 and 12 hours.					3601	81030	6993	5696	3669	3430	9111	9683	3665	9246	8542	55084	79370	11277	11274	3667	4940	54676	837	1847	4600	51131	79132	8767	2537	51191	6737	6890	54809	64108	80830	4502	8651	10549	3902	2633	4729	3759	9663	9881	4061	54877	64135	4683	55008	3569	6672	4493	85363	3437	123872	55689	8900	5610	10906	10758	22806	23424	9636	10010	79134	24138	23586	205	3624	103	5168	10215	55601	10379	23070	10410	6351	6891	4599	2867	1573	8519	3428	64761	1839	25780	55337	5359	51056	4616	11262	801	57097	3433	8837	65124	10538	2114	23780	55281	26010	3301	10616	3559	5685	7124	8763	3269	1267	6773	10561	9830	4501	55332	51733	3659	84830	6772	9693	8638	3142	10964	4049	3431	4495	952	6714	56913	4939	645745	9021	961	80021	467	55501	10475	5157	29949	7159	91543	27348	27074	3563	4494	7130	3133	56938	5875	9023	27338	4938	81553	7706	25816	9447	54739	2332	3595	6696	375790	7781	10346	684	26228	580	8743	51427	5698	23347	51510	51479	773	5371	8578	7098	7185	63875	3557	84159	4496	3959	22904	1066	64853	79015	838	2175	3434	3738	56942	79817	4856	57823	10512	11182	7726	79166	4520	3605	55026	4012	8775	604	57149
GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_UP	M3280		19029902	Querec TD,Akondy RS,Lee EK,Cao W,Nakaya HI,Teuwen D,Pirani A,Gernert K,Deng J,Marzolf B,Kennedy K,Wu H,Bennouna S,Oluoch H,Miller J,Vencio RZ,Mulligan M,Aderem A,Ahmed R,Pulendran B.	GSE13485	GSE13485_2215_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) versus PBMC 1 day after stimulation with YF17D vaccine.	The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs. The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs.					1399	51029	55161	57862	80345	256586	79725	4247	2908	146923	151194	3836	6419	127396	168455	80185	8560	29919	26503	56851	147179	59349	25912	84146	84240	124491	26092	92595	85365	51714	151195	54534	221302	25940	114971	79134	1376	122830	54819	9375	1073	400590	10404	56929	7770	51606	55010	55322	8446	57403	121457	28970	757	8740	51105	55012	55745	1960	84280	8976	10285	84078	84259	9673	23438	372	1959	81034	23514	1362	1434	54953	5985	5515	28998	285753	26128	9516	112858	7556	2237	23167	7096	64895	6102	7247	129401	8649	4238	55905	9439	55526	7076	390916	9567	9128	23168	9521	10484	100130855	81555	6790	54893	7562	9377	27292	23186	7752	60492	165918	2926	66036	84263	23469	8520	64783	27248	6674	25901	359845	151246	10513	22928	255252	55257	23548	57515	55170	11057	1737	339230	91	10973	55168	64145	93081	9878	3612	253639	9570	9134	23011	284521	9170	158293	25972	7773	4236	54165	64924	59343	284009	284029	100421561	51009	9650	7353	10691	10987	83932	643155	80148	10670	6416	51163	116068	117584	8604	57684	1207	79269	10479	729088	23582	5929	518	9562	26276	22944	58488	8879	6780	98	378	51663	57697	51077	55589	123207	57082	26271	55773	55055	1875	51021	84933	9530	55145	56180	63939
GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_DN	M3281		19029902	Querec TD,Akondy RS,Lee EK,Cao W,Nakaya HI,Teuwen D,Pirani A,Gernert K,Deng J,Marzolf B,Kennedy K,Wu H,Bennouna S,Oluoch H,Miller J,Vencio RZ,Mulligan M,Aderem A,Ahmed R,Pulendran B.	GSE13485	GSE13485_2215_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) versus PBMC 1 day after stimulation with YF17D vaccine.	The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs. The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs.					26150	6991	29930	127247	1129	10879	286207	149095	2712	128954	2849	728723	254028	5593	283902	100132767	100133308	285905	79846	100130797	50837	10164	57221	80309	22987	152586	1041	158376	4135	161142	6707	866	256764	6677	10083	8078	1501	100128988	100132354	100129455	150248	85407	204219	202051	79784	349114	2057	142680	150142	257358	54903	1956	85452	149297	146177	100287114	1551	26188	100129380	149461	100507098	139538	100505495	4958	440072	132612	139212	83755	80028	144742	8399	201501	219409	723809	100287627	8048	5897	84152	170685	51217	5083	1442	284632	100505478	8929	3694	7306	541473	100131561	54805	78990	7857	81137	728716	286149	3641	27164	114780	645687	79541	6579	160777	133874	27445	100129098	282996	100130262	171391	100302737	170425	8995	9376	317701	113691	1370	79861	728175	222183	124599	6300	56673	1238	84904	550113	730139	2786	27092	3875	100379661	187	22844	642587	147694	642976	100316868	120376	92129	4009	23632	64093	58189	6356	90655	91977	54979	7472	2916	100507135	5833	285847	374786	401022	815	200317	284612	142689	56891	2925	202333	25806	7070	54535	56099	653252	9580	165100	84818	4225	7776	2765	57758	400566	3589	29104	129080	79998	6528	84445	1555	5972	10322	388963	3855	10298	1874	283337	79981	57113	378825	6706	84632	4142	400748	54540	144347	4313	121256	9313	284395	127435
GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_UP	M3282		19029902	Querec TD,Akondy RS,Lee EK,Cao W,Nakaya HI,Teuwen D,Pirani A,Gernert K,Deng J,Marzolf B,Kennedy K,Wu H,Bennouna S,Oluoch H,Miller J,Vencio RZ,Mulligan M,Aderem A,Ahmed R,Pulendran B.	GSE13485	GSE13485_2216_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) versus PBMC 3 days after stimulation with YF17D vaccine.	The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs. The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs.					100288870	79937	8204	122786	401324	3579	222235	7130	10023	10804	284	4117	100287951	7474	7483	8330	148823	143662	374491	79689	388567	1621	56123	199974	94120	375612	3748	6490	2358	3725	5929	91948	372	91966	10957	786	5600	2867	11221	5916	27133	387885	55527	5563	222487	1116	126069	25790	388780	3458	280664	6122	744	135935	2919	83661	6294	79960	5558	4681	441054	733	644128	347689	26539	1399	27334	4651	100288238	128653	100507423	54502	366	7782	57291	5423	146845	84243	79583	338579	100134229	26138	10993	7132	83417	3556	51010	3696	50939	441061	10493	6097	26050	285962	56311	200609	689	5266	81572	284521	54490	196264	4544	6364	5290	100288438	57533	51107	7054	90196	266977	200298	6539	729970	3036	100130557	51734	7058	5918	25917	1896	149986	100129917	5894	56204	22835	9372	1232	4601	7481	2353	221981	23090	6004	644714	399726	2034	2049	2623	3306	3625	770	9516	27076	80264	5915	196883	219347	51	338864	241	9790	54882	6101	54807	762	4921	10425	91894	7033	80099	286109	6330	440730	54893	58483	60437	100292488	100131613	55280	84467	9392	5028	10929	859	57214	51299	118429	22973	79571	442186	100294414	5733	100131298	112939	100131454	285463	56658	23439	648556	26093	8887	2779	113746	541578	11107	1411	9058	164045
GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_DN	M3286		19029902	Querec TD,Akondy RS,Lee EK,Cao W,Nakaya HI,Teuwen D,Pirani A,Gernert K,Deng J,Marzolf B,Kennedy K,Wu H,Bennouna S,Oluoch H,Miller J,Vencio RZ,Mulligan M,Aderem A,Ahmed R,Pulendran B.	GSE13485	GSE13485_2216_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) versus PBMC 3 days after stimulation with YF17D vaccine.	The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs. The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs.					6614	10964	10561	54739	91543	94240	51191	129607	4599	11274	3437	710	5610	3434	4938	4600	26010	3665	2633	83666	6773	9636	4939	4940	55803	147645	3429	140691	9997	55016	200315	55601	151306	64761	23034	10410	55008	950	11311	103	717	8564	2537	23179	113730	3433	10800	219285	7444	26509	6934	4061	5303	27074	51056	221472	6772	64135	51092	3627	10989	91351	9246	6373	1445	50485	53838	25939	91860	644	55120	64108	10859	2965	79132	51338	3490	116071	26270	93343	2210	54625	56935	712	6398	8638	10111	684	114793	1955	2215	1488	55337	128346	5721	200081	23367	10346	6992	64418	84542	26147	63894	5359	3600	118932	57102	6890	1514	9447	84287	4522	2799	100131434	158405	713	23586	55100	1267	8869	695	284837	5371	9466	5373	9830	25900	84864	100290481	8574	25840	151636	3937	51493	57205	2643	57600	10581	65220	54976	1318	388722	51316	55748	670	90827	84875	6596	400941	51131	10673	29901	85363	8519	55858	6120	1945	7410	141	3728	4082	1028	10144	5095	27348	55840	57523	1666	3113	23328	64759	2630	719	6404	55308	10154	4811	126792	145853	203427	55133	6905	121512	6619	23317	390035	57514	118788	9315	55743	4343	11138	1524	100128590	7092	7100	10279	89845	6906	3394
GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_UP	M3287		19029902	Querec TD,Akondy RS,Lee EK,Cao W,Nakaya HI,Teuwen D,Pirani A,Gernert K,Deng J,Marzolf B,Kennedy K,Wu H,Bennouna S,Oluoch H,Miller J,Vencio RZ,Mulligan M,Aderem A,Ahmed R,Pulendran B.	GSE13485	GSE13485_2217_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) versus PBMC 7 days after stimulation with YF17D vaccine.	The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs. The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs.					3682	4051	57291	340947	8629	5266	11254	116447	293	91603	79862	5004	1975	8087	6122	10493	6194	100129488	3696	4973	253635	7003	283489	23767	5894	10277	7039	7474	3772	55893	5803	6202	292	2353	5205	8665	689	84311	120114	222235	8667	1937	3843	84243	6124	3593	1933	93380	9182	3815	140801	3385	1116	3858	1327	6128	390998	439911	671	157503	90196	2919	9791	51265	7686	11197	84839	2560	6134	10936	5859	25790	9903	10863	26156	6767	5250	56997	10949	375190	7782	79937	6653	5530	9804	80757	51585	10957	3579	8794	23588	253639	23492	5094	89765	4617	117145	8613	23604	100289617	91450	79730	23107	2091	2875	221785	121006	8761	3030	5018	100288418	165721	4318	196264	27039	220136	129642	115701	256126	6181	10369	387036	10023	291	9076	55412	57460	644068	6125	196883	11261	1938	84747	57533	1411	203100	148418	8649	7086	23281	260429	5375	4666	100270680	55211	202915	163126	1952	644613	63950	57634	284129	9807	54715	100129722	6284	733	100290132	7203	146225	91548	9806	200830	25874	6129	84726	1464	8760	22834	6135	60313	784	100131454	163782	220930	23584	116349	100506492	4608	138255	57520	222487	23331	860	80078	5454	6383	64174	6217	285441	23037	8664	383	284309	56111	132001	219771	284600	100287576	100505978
GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN	M3288		19029902	Querec TD,Akondy RS,Lee EK,Cao W,Nakaya HI,Teuwen D,Pirani A,Gernert K,Deng J,Marzolf B,Kennedy K,Wu H,Bennouna S,Oluoch H,Miller J,Vencio RZ,Mulligan M,Aderem A,Ahmed R,Pulendran B.	GSE13485	GSE13485_2217_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) versus PBMC 7 days after stimulation with YF17D vaccine.	The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs. The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs.					54739	11274	55008	91543	83666	10561	4600	23179	5610	4599	6614	26010	3434	10964	4938	94240	3437	129607	51191	87178	55601	710	219285	9636	4939	3429	27074	140691	2537	6772	3665	151636	54809	64761	2633	3627	4940	400941	113730	64135	10346	8638	644	81030	51056	127254	3431	91351	103	54625	64108	23586	79132	24138	5359	9246	8519	6773	23034	147645	684	51338	51131	9447	3428	93343	3959	8564	9997	4061	118932	51316	91624	200315	7444	6672	4651	51493	10410	8820	54877	158405	4082	3433	719	26509	23070	952	2210	55026	26270	1318	23424	2643	6890	3430	55337	3557	27348	4481	7706	3949	1230	85444	5685	55120	55803	6373	9985	118788	85363	51816	3728	51510	7298	950	80830	5721	10800	3161	55300	10673	1234	23328	54453	8743	84875	5698	4615	717	1524	135112	2635	114793	6934	84561	1267	51023	8061	2766	6355	53	675	57674	6398	57194	57493	10379	7205	4288	6948	151306	3717	51246	1890	838	10797	4502	1573	22974	9830	259307	29071	7402	115361	9517	199223	9381	51479	58475	55577	9111	10154	3965	440836	10859	5932	3600	3601	116443	65987	116071	5696	5635	4436	3937	57130	4811	558	8914	23597	114548	5303	10635	2793	11130	10581	873	8243	3903
GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_UP	M3289		19029902	Querec TD,Akondy RS,Lee EK,Cao W,Nakaya HI,Teuwen D,Pirani A,Gernert K,Deng J,Marzolf B,Kennedy K,Wu H,Bennouna S,Oluoch H,Miller J,Vencio RZ,Mulligan M,Aderem A,Ahmed R,Pulendran B.	GSE13485	GSE13485_2218_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) versus PBMC 21 days after stimulation with YF17D vaccine.	The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs. The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs.					155061	29919	100421561	9766	10970	26112	23533	8878	10042	150094	8408	1398	8897	342371	5306	4092	57684	1839	390980	79720	65010	9921	55096	5970	100129550	54850	9570	65986	8303	5049	23326	8976	246243	9898	22863	752	57693	91	619426	10270	9567	374383	9261	11269	55700	55257	10019	1513	57617	57700	10422	22894	5912	56681	23294	84890	10621	1073	9873	81894	64412	55823	643376	9489	255252	54887	8774	4335	112483	55668	84132	5829	3654	8314	25	9792	153546	91647	10482	9825	8567	81559	9612	100128868	10020	79716	222658	57061	284207	400590	57706	55625	25977	1499	80179	23039	4209	10737	26472	93010	79109	4783	4752	51228	143384	79585	79074	7551	100506815	9121	813	79929	51317	60625	163859	55920	488	80094	84749	57621	10746	3607	64145	23218	2885	4660	120103	79065	94005	154664	90007	100130609	23358	11037	6867	222161	23239	26276	170394	10865	9960	84945	369	126208	51729	90321	823	1523	85313	1054	165918	864	81603	8462	9889	9695	4929	4097	5534	9802	11236	7133	196383	7511	9146	9880	200186	5611	25778	84335	8315	7554	60493	377	3687	80273	9308	23588	221545	79890	5814	387893	23659	23558	5887	10765	4026	64421	5494	80035	79180	23247	403341	6829	155435	25829	55270	200205	7779	51304
GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_DN	M3290		19029902	Querec TD,Akondy RS,Lee EK,Cao W,Nakaya HI,Teuwen D,Pirani A,Gernert K,Deng J,Marzolf B,Kennedy K,Wu H,Bennouna S,Oluoch H,Miller J,Vencio RZ,Mulligan M,Aderem A,Ahmed R,Pulendran B.	GSE13485	GSE13485_2218_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) versus PBMC 21 days after stimulation with YF17D vaccine.	The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs. The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs.					441263	5787	118491	51365	7818	200261	6123	285905	29081	56891	93654	6527	56134	389336	100128909	81620	3767	100129427	63976	6387	2556	100316868	388327	399821	3703	2915	2492	100128988	144608	57191	8399	8515	5468	83448	100132005	283902	149297	285311	84283	100129098	643623	83889	286826	7350	5740	124359	6364	116093	80725	1136	338694	151657	4143	170949	79100	51046	165057	128954	79228	286207	283932	4293	374786	29092	54535	65988	23480	1041	79605	2057	1128	8506	24	1370	285352	389840	400238	4172	64901	6356	4336	286135	162699	155368	84154	85445	6902	283455	284805	2899	440699	80816	7101	347730	5396	5523	4284	5083	56112	26254	23619	83901	54827	54	90871	100292443	57586	57523	100130797	404672	100506314	35	1551	100129827	6470	84883	7694	100289508	246122	283728	100291336	79623	127833	27156	2251	113091	23538	160287	340340	10136	126393	219833	317703	339874	644139	100419017	56834	118932	79022	6568	91464	149461	142680	51617	89822	51146	206412	100192378	7728	5557	28755	145978	730441	84539	338323	284933	342527	26022	132612	401397	80317	8359	5968	7411	339457	120376	10446	2893	438	80316	25999	196913	350	54413	283461	26077	80028	22987	353174	2702	317716	541472	8228	64344	100288941	1144	150379	3110	2925	6991	100131814	126069	80164	3352	389161	157574	619351	100288447	50624	2079
GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_UP	M3291		19029902	Querec TD,Akondy RS,Lee EK,Cao W,Nakaya HI,Teuwen D,Pirani A,Gernert K,Deng J,Marzolf B,Kennedy K,Wu H,Bennouna S,Oluoch H,Miller J,Vencio RZ,Mulligan M,Aderem A,Ahmed R,Pulendran B.	GSE13485	GSE13485_2219_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 1 day after stimulation with YF17D vaccine versus PBMC 3 days after the stimulation.	The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs. The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs.					126069	55613	147694	286207	187	26188	83755	146177	84152	222183	9671	6991	440730	5075	202051	113835	128178	339442	2712	114780	57221	60437	4009	400756	6706	79981	78990	26050	9088	4958	645687	374786	3354	541473	2849	10879	91977	26353	100132767	79784	1044	142689	8995	114794	7439	100133308	128954	2192	84818	117196	132612	3855	127391	27092	94026	119587	80309	2100	339666	128229	79917	1442	1956	6866	7070	23615	3491	256764	10083	56673	767	284933	81137	157927	100128988	27445	1746	80380	162461	157627	136371	51146	133874	84951	8552	245937	285877	550113	11086	100506089	728723	1850	642976	56666	100507135	200317	5589	317701	100506667	284369	70	149297	2245	3589	80028	27164	139629	170572	283149	79998	57710	284119	9376	154092	1762	147744	4142	387601	79541	1370	84873	147700	129080	135935	1842	7857	64866	339168	3852	6300	338579	440704	63898	6122	375010	5122	29930	100288271	8078	4991	6906	374407	4824	142680	100129380	5030	13	79977	284551	100130797	60401	729173	3833	143188	26659	89866	3768	3110	3694	122042	8929	154865	158055	2903	79861	2742	161142	7481	723809	89795	283761	79885	8399	349114	732	58189	100132354	1551	161394	283933	63923	100287166	64838	647589	64093	4892	7078	2940	388906	79846	150142	100316868	9081	401022	80206	378832	1734	85300	8529
GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_DN	M3294		19029902	Querec TD,Akondy RS,Lee EK,Cao W,Nakaya HI,Teuwen D,Pirani A,Gernert K,Deng J,Marzolf B,Kennedy K,Wu H,Bennouna S,Oluoch H,Miller J,Vencio RZ,Mulligan M,Aderem A,Ahmed R,Pulendran B.	GSE13485	GSE13485_2219_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 1 day after stimulation with YF17D vaccine versus PBMC 3 days after the stimulation.	The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs. The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs.					10964	94240	950	57102	1318	55748	140691	55601	6614	834	6772	60492	83666	57862	256586	91543	1514	3981	122830	57600	2633	10561	121457	54739	64135	132320	6790	55008	3437	2271	27074	5985	51029	54819	55106	80345	54953	114793	112479	5721	91860	11274	141	8519	7444	55589	286410	4200	55120	55012	25940	28973	28970	29960	64343	200315	25972	81555	10802	127396	710	2643	6419	757	5359	1075	129607	113612	1398	4082	4739	57406	59349	54927	3454	203427	8604	5610	10987	51075	22978	84674	57231	125228	4520	159013	203197	51136	55133	147179	10691	9111	158293	27348	51092	2926	51134	1317	10111	4690	55905	1848	90075	55300	64327	55257	8992	1230	79701	84868	80052	51067	55010	400590	81790	151195	5932	51284	123803	146923	54942	79725	8915	51131	10285	7096	1193	23082	10592	219844	10269	154141	10741	93343	1500	3588	8763	24138	10775	284161	132720	8803	9837	23034	8624	6934	6307	84193	6398	151194	23678	286052	84240	26258	121274	22938	79132	136647	8882	55711	51174	10818	50865	673	54534	91351	51426	51340	6009	57404	22944	7099	9636	331	10190	160364	728769	26272	9352	2132	83548	9337	9128	6890	840	5470	128387	98	54965	56254	965	285381	57697	221472	10380	151246	340591	79137	64397	26270
GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_UP	M3295		19029902	Querec TD,Akondy RS,Lee EK,Cao W,Nakaya HI,Teuwen D,Pirani A,Gernert K,Deng J,Marzolf B,Kennedy K,Wu H,Bennouna S,Oluoch H,Miller J,Vencio RZ,Mulligan M,Aderem A,Ahmed R,Pulendran B.	GSE13485	GSE13485_2220_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 1 day after stimulation with YF17D vaccine versus PBMC 7 days after the stimulation.	The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs. The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs.					117196	284369	647310	8995	60437	286207	256764	219938	730139	149095	27164	6677	254173	26150	112609	136371	100129380	10268	400748	3694	79148	2827	158055	8552	100133308	4608	6706	1936	114817	23237	374890	904	54549	100128988	23415	283337	187	84904	767	149297	2765	728853	79541	3739	6487	1975	132612	56099	257358	79919	349114	283761	58189	84818	5083	100287479	165140	50837	10406	79981	4958	57710	254028	51050	728361	100506708	4225	146177	150696	63898	148545	285847	9081	83755	100131561	1442	3441	10290	1137	3653	181	50700	56241	2940	400756	282996	100507098	2849	9376	285766	653252	9507	142685	284939	100132354	645687	27330	100287556	8929	2192	83896	283160	6122	3400	93145	3232	26188	6900	144347	114780	4313	729173	139629	113220	2670	147429	28571	164592	56666	6262	3682	147664	503519	6448	3589	114794	286183	7343	642976	9001	387036	7857	89866	170572	283129	547	4311	339685	29075	147700	91977	5480	5030	140576	3451	9615	2742	161142	7070	9075	57030	26027	1937	10481	100290132	9498	6568	79977	2779	815	8629	81137	283149	64094	128414	541473	202051	652147	4009	142679	79574	3918	440730	254013	50937	10879	114757	80036	1791	157927	158960	79136	11122	3491	9248	160777	84152	126069	10841	79933	10164	79742	440072	3354	340273	1734	8174	646482	79470	2100
GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN	M3296		19029902	Querec TD,Akondy RS,Lee EK,Cao W,Nakaya HI,Teuwen D,Pirani A,Gernert K,Deng J,Marzolf B,Kennedy K,Wu H,Bennouna S,Oluoch H,Miller J,Vencio RZ,Mulligan M,Aderem A,Ahmed R,Pulendran B.	GSE13485	GSE13485_2220_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 1 day after stimulation with YF17D vaccine versus PBMC 7 days after the stimulation.	The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs. The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs.					83666	54739	55601	10561	11274	55008	91543	10964	219285	140691	6772	94240	3434	3437	54809	129607	4600	1318	27074	4082	51316	26010	4599	64135	87178	4939	23179	10346	2633	91624	8519	3627	256586	9636	5610	51131	51510	151636	24138	1230	5359	6614	28998	29071	200315	51191	5932	91351	286410	55300	7444	79568	710	728769	9111	3429	26270	7099	114793	23424	4940	8638	5721	81030	79132	9246	51056	27348	2643	84674	64761	10410	60492	5698	54625	4938	93343	51340	7298	28977	57862	950	3557	51493	2635	5685	55012	952	2537	23034	118788	55120	81555	1514	10393	3431	51338	6890	57493	54453	5985	80830	64343	7453	55026	64108	55773	1848	113730	7096	51264	840	103	55133	85363	127396	659	51382	3433	92255	23586	8649	10691	1234	113402	719	55589	51284	11130	28957	9447	55872	51023	10775	3959	829	135112	9493	285381	28962	23167	55863	122769	965	136647	834	3454	9837	3665	6790	284029	79725	132321	10548	348235	8564	6672	8743	59349	58533	91860	115361	3162	4709	57406	1193	757	6398	100289294	55106	441168	55010	4436	9	838	84868	400941	8803	2766	26509	203197	51174	51397	223082	10302	55337	100132884	10592	57600	1434	100287896	54790	644	6241	115106	7592	80345	5686	8992	10987
GSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_UP	M3298		19029902	Querec TD,Akondy RS,Lee EK,Cao W,Nakaya HI,Teuwen D,Pirani A,Gernert K,Deng J,Marzolf B,Kennedy K,Wu H,Bennouna S,Oluoch H,Miller J,Vencio RZ,Mulligan M,Aderem A,Ahmed R,Pulendran B.	GSE13485	GSE13485_2221_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 1 day after stimulation with YF17D vaccine versus PBMC 21 days after the stimulation.	The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs. The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs.					8408	55823	400768	84680	23218	8314	4092	79585	8861	642976	23239	55603	9898	387718	23396	7511	222161	9261	11037	4215	100287556	10322	8929	114034	79915	9146	468	6448	4898	387521	84687	116983	4974	123720	23308	57062	79890	406	10498	6829	60	135948	83985	58490	100505676	1513	9600	10865	26469	84657	2022	340348	83259	90427	57580	10482	4752	7040	752	7739	4122	8878	393	27445	23558	7844	100286937	2847	4820	10270	9442	255967	7133	7433	79949	25956	57710	10299	823	9887	403341	6421	196883	80155	54498	81559	10652	80152	904	54887	2550	170394	1639	9772	22809	5430	164	155061	8078	401320	140687	399716	645460	257415	4123	90933	26205	4131	11283	80778	80179	334	54890	79065	1794	9730	10879	8662	10273	29062	136541	84632	64423	653479	369	11343	3875	31	494513	9448	100133130	646736	158586	64689	200205	550	400360	57609	55329	440104	51228	3338	6100	338799	652147	6813	6832	100506385	57693	5371	55230	387893	55000	79109	51206	54741	4891	221545	56998	5054	10477	56965	55102	114987	10554	27099	9779	84962	9124	25	5187	57602	11044	731789	4194	254057	23387	23113	26105	51447	7486	4665	92017	9455	54850	7090	7169	55785	64283	23533	55608	114757	5269	22870	25957	10444	4994	55658	8514
GSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_DN	M3299		19029902	Querec TD,Akondy RS,Lee EK,Cao W,Nakaya HI,Teuwen D,Pirani A,Gernert K,Deng J,Marzolf B,Kennedy K,Wu H,Bennouna S,Oluoch H,Miller J,Vencio RZ,Mulligan M,Aderem A,Ahmed R,Pulendran B.	GSE13485	GSE13485_2221_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 1 day after stimulation with YF17D vaccine versus PBMC 21 days after the stimulation.	The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs. The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs.					51258	10190	35	100287896	8604	100128909	128	84154	60592	100133941	54969	26578	60492	1070	51501	92255	8195	5162	84661	199704	27292	27068	1389	404672	7411	26175	5889	55520	1965	144363	22948	55862	1207	9521	118491	401505	54165	54664	55012	7372	9836	965	29081	29071	6815	55847	83787	85285	54819	221143	8669	90871	7265	23213	10447	90693	4711	438	284029	138428	5468	10556	7257	55325	219844	7102	1875	29922	10575	6500	4709	51315	9934	64981	143879	2965	51010	51534	652963	1977	80345	6637	2271	10987	100289508	93974	63931	25913	10380	121457	4190	286826	3312	152992	64841	8520	154791	23184	6119	9477	574028	64844	34	79053	6369	112479	10302	8803	51668	317671	5985	7130	6392	83743	100134937	132625	5984	9650	51015	25996	51019	90317	84233	6169	136647	4712	26157	5557	84319	27101	10111	84792	63943	55010	84240	10098	10393	7743	51138	8089	10527	2745	9535	220930	131474	122830	60488	11200	283999	3336	28962	54534	154743	134111	118487	6146	59286	25994	10247	80254	401397	27430	59349	84816	8560	3612	6835	57231	4116	151246	5965	55166	56925	54951	51264	5686	147525	55347	4702	5481	4695	6613	54826	80145	29929	127396	7336	51065	79768	6176	9554	7702	7104	55863	100290663	54674	26122	51617	8368	27236
GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_UP	M3300		19029902	Querec TD,Akondy RS,Lee EK,Cao W,Nakaya HI,Teuwen D,Pirani A,Gernert K,Deng J,Marzolf B,Kennedy K,Wu H,Bennouna S,Oluoch H,Miller J,Vencio RZ,Mulligan M,Aderem A,Ahmed R,Pulendran B.	GSE13485	GSE13485_2222_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 3 days after stimulation with YF17D vaccine versus PBMC 7 days after the stimulation.	The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs. The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs.					146956	63914	4051	11069	3858	202181	55308	347344	51386	57628	374491	293	26156	57035	100306951	117145	4329	256126	4261	100287401	440288	285489	245928	6217	9791	359845	90649	677778	91450	2063	6129	168433	7639	4194	51449	440854	644613	55609	27328	27161	284266	4781	23030	284129	6458	3696	79152	84243	348995	285	23767	6128	820	689	29904	143241	5470	7001	3682	56886	1088	100287387	118424	114569	374860	85019	375190	51747	84914	10562	4891	55119	2067	911	79730	647310	11254	6653	54596	6929	55259	51107	84311	4728	283152	6843	399948	64240	10939	2852	6642	51263	157777	51478	284440	1290	84461	55323	85021	11325	91603	29997	3043	4048	23671	51130	83992	221785	100288745	7050	84901	273	6336	54768	5859	124923	445341	5607	8574	54682	283868	728537	389124	65059	28981	9825	23193	8629	57051	256987	388403	4317	2662	80167	10314	56658	84796	1357	6230	100507098	118460	653188	6133	10321	376497	8665	64432	285367	643923	26146	80228	79937	115196	6906	100130344	5266	6228	60313	4148	79258	89970	326332	147837	202781	3899	65266	65072	2070	645431	148137	10140	55850	123096	100505894	6234	10541	11219	134121	79856	170949	55256	642826	7178	64434	50861	653483	91749	163255	9615	6205	126069	8087	54558	92126	90639	9197	56267	8642	642361
GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN	M3302		19029902	Querec TD,Akondy RS,Lee EK,Cao W,Nakaya HI,Teuwen D,Pirani A,Gernert K,Deng J,Marzolf B,Kennedy K,Wu H,Bennouna S,Oluoch H,Miller J,Vencio RZ,Mulligan M,Aderem A,Ahmed R,Pulendran B.	GSE13485	GSE13485_2222_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 3 days after stimulation with YF17D vaccine versus PBMC 7 days after the stimulation.	The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs. The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs.					11274	55008	5610	8638	4599	3429	4600	87178	91543	26010	10561	23179	27074	94240	51191	8519	10964	3434	118932	83666	129607	3627	54739	55601	25841	10410	9636	219285	2867	54809	91624	6614	81030	3959	9246	4939	24138	2633	3437	4940	23424	127254	113730	6772	710	675	79132	51251	151636	51316	3557	8820	200315	6355	558	23586	64135	57169	64761	65987	952	5359	103	10346	8330	64108	54877	3431	731424	91351	8349	199974	7124	55300	2766	57194	1514	54625	7130	9381	6347	3433	4938	1573	4082	1234	54753	719	5427	193629	140691	9985	259307	51056	23070	3428	6364	7453	80830	257019	51493	4616	11004	2537	162417	100134229	85441	4061	10581	8204	93343	400941	5028	158405	55789	84561	8357	100294362	7298	1230	23	5449	56849	153218	79370	57405	53831	8743	55872	54498	4973	2358	27348	51514	157724	6373	219970	57674	9462	168391	9294	23034	51534	9493	51023	9111	8334	51246	135112	3161	51510	56670	10232	9787	3665	283352	57834	286382	100128554	4254	4211	6890	84126	55120	53	2274	339894	6641	5631	8318	79098	54453	6351	84281	90853	2040	3081	51131	3728	3717	6505	1144	8892	84314	497634	7706	8970	8329	644	112755	100288238	54102	9729	7132	8336	117531	29925	2643	162394
GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_UP	M3303		19029902	Querec TD,Akondy RS,Lee EK,Cao W,Nakaya HI,Teuwen D,Pirani A,Gernert K,Deng J,Marzolf B,Kennedy K,Wu H,Bennouna S,Oluoch H,Miller J,Vencio RZ,Mulligan M,Aderem A,Ahmed R,Pulendran B.	GSE13485	GSE13485_2223_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 3 days after stimulation with YF17D vaccine versus PBMC 21 days after the stimulation.	The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs. The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs.					94240	129607	54887	10561	57514	25	9997	5371	9898	149603	23034	5610	246243	2131	114793	8408	57693	80094	55823	1514	64759	10019	79716	8303	54811	4940	7073	65986	56965	488	29919	752	8737	342371	51191	100128868	55208	9764	123041	5970	9570	9612	55096	2885	3437	9922	4209	23179	710	9197	5095	390980	63971	11024	23533	9658	4891	7421	8869	8976	11138	2321	9921	84749	23239	31	222161	64420	81894	7290	4599	55008	824	57706	10461	57600	27032	79109	55257	7378	440275	1857	7128	55603	64761	4335	155061	114823	55920	124923	6421	275	10737	23218	55785	100131998	56894	147645	7037	4122	8774	374	4026	9825	4092	2120	10482	27130	9783	55718	2000	79890	84034	4939	7461	79585	9960	10001	10469	11044	22894	123803	56681	200315	5306	57466	10746	9766	9567	23313	93323	1185	10270	284207	26270	6627	254225	8315	25778	10970	65265	150094	55337	8812	388799	28511	26112	8844	9489	143689	83985	103	3394	10042	599	3338	57700	653464	10859	170394	22976	51056	641977	60493	9873	950	619426	81603	7133	3091	7453	26010	374383	84930	673	51347	55625	79701	51542	126070	3607	54953	7030	3654	79720	2990	53826	63916	653188	8314	8569	1398	200424	6429	22872	80179	80035	4194	1523	57178
GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_DN	M3306		19029902	Querec TD,Akondy RS,Lee EK,Cao W,Nakaya HI,Teuwen D,Pirani A,Gernert K,Deng J,Marzolf B,Kennedy K,Wu H,Bennouna S,Oluoch H,Miller J,Vencio RZ,Mulligan M,Aderem A,Ahmed R,Pulendran B.	GSE13485	GSE13485_2223_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 3 days after stimulation with YF17D vaccine versus PBMC 21 days after the stimulation.	The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs. The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs.					126069	7350	6866	79100	5313	153218	6123	4909	7694	389336	6387	374786	7069	83889	6326	2899	80206	165057	100134123	284798	2251	9462	51146	170949	100132005	57586	4336	245937	374286	100316868	149297	157627	56656	56134	2121	766	283999	389812	60598	5915	10840	56891	342527	286207	2492	28683	100129617	350	619351	9088	145978	5631	117531	113452	5225	91977	3577	8359	118491	284933	22999	4143	2192	8074	154810	1269	2570	54827	400238	5740	79908	202500	731424	100133885	7101	140625	100130797	147429	51010	8399	81137	147694	56666	7130	3767	387638	4158	27245	246744	80164	57010	23349	441263	2893	80316	84443	54922	25884	6528	643623	100288009	100289049	100505474	400794	1044	786	728445	3110	6336	327657	644192	10881	100289508	89944	63970	146894	3890	5444	145581	100505718	3228	8092	285877	200261	26280	83901	401463	2049	25769	3640	284648	285905	26254	348825	63976	51059	3491	125111	480	389840	64927	5523	50617	51384	400957	165829	100288271	140767	2915	339457	80350	80028	317703	56834	2057	100294350	100419017	127845	27023	100192378	100507435	6527	260429	79365	5468	113091	338579	6364	51365	1749	23241	55821	145773	135138	815	1136	51198	552	347730	4311	285311	23538	404266	282763	646282	79148	287	1822	51213	284395	51555	145258	115827	8690	286826	126204	5255	338699	22844	1370
GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_UP	M3307		19029902	Querec TD,Akondy RS,Lee EK,Cao W,Nakaya HI,Teuwen D,Pirani A,Gernert K,Deng J,Marzolf B,Kennedy K,Wu H,Bennouna S,Oluoch H,Miller J,Vencio RZ,Mulligan M,Aderem A,Ahmed R,Pulendran B.	GSE13485	GSE13485_2224_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 7 days after stimulation with YF17D vaccine versus PBMC 21 days after the stimulation.	The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs. The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs.					55008	54739	23179	5610	94240	6614	10964	4599	11274	4600	54877	83666	54625	51191	64761	4940	91543	87178	6672	91624	64420	9997	26010	8638	4939	114793	103	51056	9749	27074	24138	3437	4938	23070	3434	23034	9636	26270	55823	55603	4082	55601	55337	7706	2131	10019	53826	7739	79132	8853	7402	54453	143689	10346	10569	2537	5932	3665	7298	10477	57169	158405	11343	5747	2120	91351	5359	54887	93343	26509	824	9935	79585	57097	10855	10970	80094	285195	9886	710	7170	222161	84034	11024	10042	57568	55026	8303	90007	6772	147645	25	9706	57584	57706	3728	219285	64127	29919	9898	3162	1026	170394	112483	29761	10737	644	7511	7421	2766	55920	79890	8682	8844	9985	8314	1601	23332	400941	81030	440836	9567	91404	54108	151636	8869	57514	8408	654434	4067	5311	56894	200315	140691	2017	5970	65986	8976	2000	84132	375033	5371	79709	79711	51131	9612	64759	2509	4097	23328	8462	57612	11226	4092	11138	8820	51304	9711	1514	5494	3429	4061	5954	284207	23429	56681	4140	5912	246243	4752	4335	950	11037	10270	7378	93323	2752	79716	10643	118788	9764	7071	4026	113675	10036	6773	4524	10288	135112	80830	51061	9189	4638	10554	1200	3949	4122	283991	57600	5879
GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_DN	M3308		19029902	Querec TD,Akondy RS,Lee EK,Cao W,Nakaya HI,Teuwen D,Pirani A,Gernert K,Deng J,Marzolf B,Kennedy K,Wu H,Bennouna S,Oluoch H,Miller J,Vencio RZ,Mulligan M,Aderem A,Ahmed R,Pulendran B.	GSE13485	GSE13485_2224_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 7 days after stimulation with YF17D vaccine versus PBMC 21 days after the stimulation.	The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs. The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs.					80164	283999	4293	63976	118491	2915	246744	441263	170949	2492	56134	3767	347730	100505718	5266	54857	8515	54550	4311	100286895	400794	147429	7694	84539	54827	7350	23538	283455	149297	643623	2828	27023	100133941	148231	374786	7818	4336	1933	129642	6568	100289508	80350	5645	286207	646888	79805	342527	10840	282763	389336	126069	83901	3569	8399	93650	140625	56834	9469	148418	401442	89944	27245	64856	140801	7686	3753	150280	8590	59347	63970	7092	25984	165057	5083	9699	3703	54549	55229	10481	164592	4104	57545	149111	2121	84665	221143	646282	54922	574028	3640	4237	642924	196913	6487	401463	60598	113220	84101	7101	151657	400748	107	401106	503519	6387	25837	4143	1128	317716	79623	3577	6866	55200	5047	3884	10439	8995	387707	10874	8074	58527	619351	730236	8667	79937	766	3228	6369	79100	10446	245937	59344	84733	100128988	132612	100270680	26267	93273	100288447	1327	348825	1600	284100	692227	26070	2192	387638	8470	541472	285740	6527	931	284648	1103	253635	652	9248	79148	57586	389840	2091	10744	200261	127845	100129449	23237	730249	23767	153328	163933	6340	145773	4313	55506	113091	401	400238	285126	50837	6123	81629	374378	134145	114131	152877	6202	8359	56666	7379	145788	553103	100506655	146894	5950	80317	4225	157627	127602	6169	22873
GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_UP	M3310		19029902	Querec TD,Akondy RS,Lee EK,Cao W,Nakaya HI,Teuwen D,Pirani A,Gernert K,Deng J,Marzolf B,Kennedy K,Wu H,Bennouna S,Oluoch H,Miller J,Vencio RZ,Mulligan M,Aderem A,Ahmed R,Pulendran B.	GSE13485	GSE13485_2225_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) before vs after YF17D vaccination.	The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs. The immune responses generated by YF-17D by profiling 20,077 genes in 25 vaccine recipients were accessed at days 1, 3, 7, and 21 post-vaccination compared to pre-vaccination in PBMCs.					7474	196883	79937	118429	221687	4651	222235	3815	100288438	3579	121006	5616	10023	25790	120114	3696	2353	2560	359845	1116	5563	374491	3772	5914	90196	100287951	8204	57291	10562	57533	7039	366	116496	163782	10493	254263	154661	93380	375612	285962	2919	1411	389124	7203	100131454	387885	83417	8613	79188	7782	94120	91862	51386	51	222487	54807	372	5784	5205	9201	80264	5266	7003	57451	55350	2034	383	9516	153090	9392	23604	8897	8794	4051	6372	744	157503	51676	6383	644128	54682	79960	79689	5290	1232	11009	10804	100129488	5062	10277	3556	3482	81572	56204	6760	340947	23401	122786	55525	284521	4318	221981	1399	5929	10957	112939	84243	79730	730098	343450	202915	9806	55412	3554	25901	8087	3682	5004	8445	7686	3843	6128	127262	63946	196264	11261	5193	283489	9076	689	144423	89765	10765	51100	25962	100507421	84649	23588	55693	59277	4311	100288870	762	284	8576	10936	124936	84069	9790	57535	100507423	200205	7054	2779	3385	64211	6777	23432	1942	255394	11197	7251	6101	91603	6789	644242	8629	11254	56256	60680	1811	64850	55211	100130855	6561	54882	140461	63950	4122	642691	84747	3313	9989	22835	9903	54490	4921	54825	648556	2913	203100	80323	79862	115701	2150	116447	100134822	90019	4317	57458
GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_DN	M3311		19029902	Querec TD,Akondy RS,Lee EK,Cao W,Nakaya HI,Teuwen D,Pirani A,Gernert K,Deng J,Marzolf B,Kennedy K,Wu H,Bennouna S,Oluoch H,Miller J,Vencio RZ,Mulligan M,Aderem A,Ahmed R,Pulendran B.	GSE13485	GSE13485_2225_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) before vs after YF17D vaccination.						54739	6614	4938	10561	10964	4599	91543	3437	3434	129607	710	9636	94240	5610	51191	11274	9447	6773	4600	219285	55601	8564	55008	55016	3665	140691	2633	83666	118932	10989	4939	113730	6373	26010	2537	400941	684	10800	6772	147645	7444	2630	151306	644	91351	5303	4940	64761	26509	23179	127254	23586	717	64108	1524	103	1389	55803	84263	200315	151636	9246	8243	11311	51338	3627	25939	3431	9997	51316	3417	23034	3429	54625	79132	719	10154	10410	158405	1955	51056	64135	2210	5635	54809	302	3433	84287	116071	26035	29015	55133	51816	1352	5373	55100	201799	6619	4061	5925	93343	10111	10346	51493	4481	23341	2215	27074	4082	1781	2806	224	79631	3428	10617	10144	90861	8914	29901	55325	28976	202309	10526	84875	53	128346	1798	51092	388780	50485	950	6934	10673	10384	87178	51703	55313	5721	6641	10581	55120	11000	6120	55140	6890	56935	1666	92181	2965	54676	1267	28958	3430	118788	3959	10379	85363	10007	55737	55796	695	3416	26610	5899	84064	51734	2937	3454	25840	23317	81030	10875	5160	100288941	8638	9896	51311	1827	57823	84502	51382	55614	3903	8519	712	55862	54545	8396	23424	10951	570	3965	3033	57205	1544	5696	8061	100131067	4615	4522
GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_UP	M3319		19201849	Bangs SC,Baban D,Cattan HJ,Li CK,McMichael AJ,Xu XN.	GSE13738	GSE13738_1725_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of resting CD4 [GeneID=920] T cells versus directly activated CD4 [GeneID=920] T cells.	There is much evidence that T cells may be activated via mechanisms which act independently of direct TCR ligation. Despite this, the question of whether such forms of ‘bystander’ T cell activation occur during immune responses is hotly debated. To address some outstanding questions, we set up an in vitro system within which to analyse bystander T cell activation in human T cells, in the absence of the possibility for TCR cross-reactivity. In addition, we have investigated the genetic, phenotypic, and functional characteristics of bystander activated T cells. Here, we show that bystander T cell activation is, indeed, observed during a specific immune response, and that it occurs preferentially amongst CD4+ memory T cells. Furthermore, bystander activated T cells display a distinct gene expression profile. The mechanism for bystander T cell activation involves soluble factors, and the outcome is an elevated level of apoptosis. This may provide an explanation for the attrition of T cell memory pools of heterologous specificity during immune responses to pathogens such as viruses.					64718	22877	5252	145483	6439	57498	6399	5611	388685	170082	30061	162972	253260	54940	58508	9725	80069	10384	9197	126969	23484	4194	10746	10045	55144	51455	84532	55729	321	11329	79960	59348	284390	100129196	10207	7248	140688	23515	22884	55338	55796	2043	54520	23552	54665	9581	5361	2145	6874	91151	57463	3043	9712	6322	81856	51306	80762	9710	79970	255394	729614	284186	10194	5463	114928	2288	1629	57728	5228	100133920	222698	474170	84334	79145	386758	3460	11120	172	79668	10658	100133019	151657	80012	200298	4149	83416	387751	23353	11320	145781	6314	200765	100129792	23214	221914	3480	116843	285600	79441	58486	100132741	7775	25776	23112	254228	8816	6206	80114	6907	28232	2005	79048	2825	55007	8313	100133321	22899	389289	84267	284129	6440	7754	9987	113791	26137	81030	6432	5756	259173	55793	9394	8928	23492	8793	90338	79609	10443	140612	692227	1102	122525	285512	2965	64772	5826	10365	80332	6653	7091	221061	79918	401264	6554	388558	26953	2069	51710	643977	10867	79939	150864	79673	55333	9166	123624	51585	1107	100286909	54988	203100	5565	51335	6581	389856	3655	51512	4306	390927	28990	140710	79830	23683	8658	284904	139231	253018	4063	23360	4674	4281	29765	10595	100507043	400620	8780	5563	91392	26157	64061	9737
GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_DN	M3320		19201849	Bangs SC,Baban D,Cattan HJ,Li CK,McMichael AJ,Xu XN.	GSE13738	GSE13738_1725_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of resting CD4 [GeneID=920] T cells versus directly activated CD4 [GeneID=920] T cells.	There is much evidence that T cells may be activated via mechanisms which act independently of direct TCR ligation. Despite this, the question of whether such forms of ‘bystander’ T cell activation occur during immune responses is hotly debated. To address some outstanding questions, we set up an in vitro system within which to analyse bystander T cell activation in human T cells, in the absence of the possibility for TCR cross-reactivity. In addition, we have investigated the genetic, phenotypic, and functional characteristics of bystander activated T cells. Here, we show that bystander T cell activation is, indeed, observed during a specific immune response, and that it occurs preferentially amongst CD4+ memory T cells. Furthermore, bystander activated T cells display a distinct gene expression profile. The mechanism for bystander T cell activation involves soluble factors, and the outcome is an elevated level of apoptosis. This may provide an explanation for the attrition of T cell memory pools of heterologous specificity during immune responses to pathogens such as viruses.					8027	8669	22903	11261	79180	4026	10617	80723	2230	55915	85444	3656	23478	10252	26051	55829	7326	9616	23151	55423	55589	9990	11315	57707	10734	207063	6713	114614	3069	2153	25801	285025	8898	121260	6585	4706	266747	64764	6307	7171	84324	84548	118429	6342	10165	79931	55313	24148	55352	2769	9414	5203	8932	6821	7133	55176	3687	3685	7037	84002	64127	147645	146712	1844	3662	113402	1317	1959	4702	10434	6905	3682	9232	705	126295	2710	3604	55784	10907	57178	80145	57476	2355	23480	2669	4701	971	23516	3096	11284	171425	10231	26010	9812	55759	23180	84817	9653	598	284207	133308	10694	90871	5144	54965	2768	100287932	8427	169714	55277	23355	23071	93589	51657	23074	56267	55884	22906	5525	9770	11092	51510	3028	23412	340277	57129	4810	5872	2787	2034	84937	1803	326624	2222	8140	123355	4711	134728	157506	284325	10920	9306	7903	55326	753	7273	6636	8892	404672	2184	388962	9777	8443	1622	5962	4739	134637	586	639	56938	3783	28231	79712	112616	84034	2793	8013	8565	54928	53349	8792	1718	171546	8870	81605	55293	2760	51647	79957	817	285513	9556	6760	10478	5880	8894	55062	284273	9377	94120	29922	3902	135228	125228	57128	7813	3628	28977	5223	1687
GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP	M3321		19201849	Bangs SC,Baban D,Cattan HJ,Li CK,McMichael AJ,Xu XN.	GSE13738	GSE13738_1726_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of resting CD4 [GeneID=920] T cells versus bystander activated CD4 [GeneID=920] T cells.	There is much evidence that T cells may be activated via mechanisms which act independently of direct TCR ligation. Despite this, the question of whether such forms of ‘bystander’ T cell activation occur during immune responses is hotly debated. To address some outstanding questions, we set up an in vitro system within which to analyse bystander T cell activation in human T cells, in the absence of the possibility for TCR cross-reactivity. In addition, we have investigated the genetic, phenotypic, and functional characteristics of bystander activated T cells. Here, we show that bystander T cell activation is, indeed, observed during a specific immune response, and that it occurs preferentially amongst CD4+ memory T cells. Furthermore, bystander activated T cells display a distinct gene expression profile. The mechanism for bystander T cell activation involves soluble factors, and the outcome is an elevated level of apoptosis. This may provide an explanation for the attrition of T cell memory pools of heterologous specificity during immune responses to pathogens such as viruses.					22914	388685	6894	55744	389541	7182	23484	10194	4113	9169	168537	55914	10983	126259	51669	389289	153222	5324	150864	400620	8875	65108	23112	26137	5175	80114	2841	7068	282997	387751	113791	100131564	23248	23228	11320	283711	100505538	79668	83875	55303	57530	387357	54765	440330	10178	11168	256380	22887	84458	10735	2254	5563	26224	63923	256987	321	4753	440952	64788	9263	222698	5747	6257	5874	1107	8925	66037	100286909	145483	100288809	58508	22850	29068	51085	91548	57463	51652	7047	1122	4033	472	390874	11174	10900	147694	10913	54664	814	162282	607	64856	6638	729614	388011	387914	64221	79960	117178	389856	155382	83985	8028	57447	55629	373	26651	64772	6693	6314	196394	27145	55338	219348	7994	474170	3845	6402	9581	3480	79670	57047	9710	26115	10658	5796	9743	79612	5567	84726	285735	51306	10482	283981	152206	84307	100287556	64760	3983	126129	81571	136541	9924	9925	375743	50717	255022	30061	163050	6932	100506195	284443	80267	8848	91151	84441	139170	7048	221400	10595	58503	6524	64718	728099	55144	100129387	55086	79145	56829	91603	55095	84334	162972	255189	58497	100129196	5792	84532	254048	92370	3572	114928	50626	79745	727820	54439	11123	100507508	29767	64062	245936	7552	55000	55729	9931	23270	29765	203228	23389	192670	7216
GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN	M3322		19201849	Bangs SC,Baban D,Cattan HJ,Li CK,McMichael AJ,Xu XN.	GSE13738	GSE13738_1726_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of resting CD4 [GeneID=920] T cells versus bystander activated CD4 [GeneID=920] T cells.	There is much evidence that T cells may be activated via mechanisms which act independently of direct TCR ligation. Despite this, the question of whether such forms of ‘bystander’ T cell activation occur during immune responses is hotly debated. To address some outstanding questions, we set up an in vitro system within which to analyse bystander T cell activation in human T cells, in the absence of the possibility for TCR cross-reactivity. In addition, we have investigated the genetic, phenotypic, and functional characteristics of bystander activated T cells. Here, we show that bystander T cell activation is, indeed, observed during a specific immune response, and that it occurs preferentially amongst CD4+ memory T cells. Furthermore, bystander activated T cells display a distinct gene expression profile. The mechanism for bystander T cell activation involves soluble factors, and the outcome is an elevated level of apoptosis. This may provide an explanation for the attrition of T cell memory pools of heterologous specificity during immune responses to pathogens such as viruses.					5142	6945	55829	26051	10048	55379	4094	7037	55357	4026	286451	28977	483	9371	5606	587	8835	9777	23180	100288693	1512	387882	8027	1803	55293	26037	54965	23071	118429	5932	100505687	10135	60481	114614	8669	5899	1839	8611	23130	8850	55540	401397	1756	4049	7124	2519	116841	2710	10682	3417	8407	9734	9470	6728	23150	10952	3956	5367	4689	11275	51011	6732	57584	64127	4700	8932	84833	9414	6905	11284	339487	8682	92906	26191	3604	55917	2769	29887	639	5880	3595	1439	8742	285957	28231	340061	6472	57129	3662	5326	57149	6921	25801	302	864	6504	22807	24145	51118	10627	150771	3560	9467	201725	25979	10287	598	3098	8428	6636	153339	204	7133	705	5160	23191	25902	219790	54962	3656	976	3131	55062	54331	1844	283237	64834	4258	55835	8111	4092	196383	8553	56650	2355	57157	5141	90826	23074	9232	8655	64222	101	28956	2023	54997	255758	143903	4522	121457	1478	23075	10538	10483	5311	304	4714	481	2110	1622	375449	1743	1192	10907	4739	1960	51029	5008	23151	7046	6303	4644	7804	28985	4794	63897	9377	10870	10920	26292	1326	240	64375	6309	25840	80223	330	50515	1020	7468	84174	23516	6446	170954	10221	8784	8819	753	4602	1102
GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP	M3324		19201849	Bangs SC,Baban D,Cattan HJ,Li CK,McMichael AJ,Xu XN.	GSE13738	GSE13738_1727_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of directly activated CD4 [GeneID=920] T cells versus bystander activated CD4 [GeneID=920] T cells.	There is much evidence that T cells may be activated via mechanisms which act independently of direct TCR ligation. Despite this, the question of whether such forms of ‘bystander’ T cell activation occur during immune responses is hotly debated. To address some outstanding questions, we set up an in vitro system within which to analyse bystander T cell activation in human T cells, in the absence of the possibility for TCR cross-reactivity. In addition, we have investigated the genetic, phenotypic, and functional characteristics of bystander activated T cells. Here, we show that bystander T cell activation is, indeed, observed during a specific immune response, and that it occurs preferentially amongst CD4+ memory T cells. Furthermore, bystander activated T cells display a distinct gene expression profile. The mechanism for bystander T cell activation involves soluble factors, and the outcome is an elevated level of apoptosis. This may provide an explanation for the attrition of T cell memory pools of heterologous specificity during immune responses to pathogens such as viruses.					7525	79621	121551	53340	1020	79957	3682	10734	6821	6843	1352	5525	22856	24148	266747	23382	5998	4914	1293	130355	9577	6659	157	2669	125228	64968	9459	2194	4775	9181	1958	1992	55784	4602	80723	10252	134637	23587	2672	8562	22978	55277	22906	6894	80173	84002	10301	1213	9121	85444	64960	100131211	55313	5774	23762	9315	2120	55509	79931	55326	56267	4893	92370	285386	6526	9791	285812	65084	7326	3067	53349	148327	2181	79714	54836	29922	23022	6713	2494	51594	439938	64282	25956	27115	10396	356	10971	8874	121260	4258	51603	6711	6478	79871	1355	10617	842	8140	80183	7462	939	79631	11112	169714	11052	2999	23635	8973	387597	54920	5873	51008	5551	9363	2868	23516	163	54602	2230	177	4013	23355	283551	64087	5464	7336	146712	6402	1627	127602	23248	92597	2768	201161	1666	10417	8630	203522	886	10982	7706	79656	23478	55526	55423	22903	914	1236	3927	54928	84273	9069	5784	93589	11020	55361	23151	8655	2114	5154	85458	55915	51765	952	286442	9990	2710	119391	10363	5378	9306	647087	22836	84817	83737	8645	4664	4810	34	4354	10563	51510	9019	8875	133308	50804	2017	148229	9673	1718	100101467	63914	199	81575	4648	10175	10171	5738	4345	6919
GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN	M3325		19201849	Bangs SC,Baban D,Cattan HJ,Li CK,McMichael AJ,Xu XN.	GSE13738	GSE13738_1727_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of directly activated CD4 [GeneID=920] T cells versus bystander activated CD4 [GeneID=920] T cells.	There is much evidence that T cells may be activated via mechanisms which act independently of direct TCR ligation. Despite this, the question of whether such forms of ‘bystander’ T cell activation occur during immune responses is hotly debated. To address some outstanding questions, we set up an in vitro system within which to analyse bystander T cell activation in human T cells, in the absence of the possibility for TCR cross-reactivity. In addition, we have investigated the genetic, phenotypic, and functional characteristics of bystander activated T cells. Here, we show that bystander T cell activation is, indeed, observed during a specific immune response, and that it occurs preferentially amongst CD4+ memory T cells. Furthermore, bystander activated T cells display a distinct gene expression profile. The mechanism for bystander T cell activation involves soluble factors, and the outcome is an elevated level of apoptosis. This may provide an explanation for the attrition of T cell memory pools of heterologous specificity during immune responses to pathogens such as viruses.					2987	24145	54677	7378	3384	51449	8850	1154	80830	2936	10057	3688	7852	9737	28232	83451	4674	80149	10397	9987	100132147	7295	9252	9829	10782	9674	8556	64332	55540	114801	284129	10602	4306	10625	81846	824	9265	23365	4063	4267	4603	2150	1102	219790	57130	2288	3655	23325	10611	3123	57291	8878	1371	240	11059	3303	55041	677769	8740	23424	8660	200298	834	4747	55603	9734	91351	4189	2323	100133019	57149	100127940	7046	10598	10161	3163	57494	123606	84418	84945	1540	130399	147727	57228	23678	1839	6654	7316	84656	5611	84061	196	8835	11202	79441	1756	1030	57561	4301	596	6990	5829	3603	7096	5732	10133	6793	80146	401494	220972	5775	6403	9908	55333	22863	23013	9725	10045	127933	27436	4097	10365	54665	8793	5274	10443	55683	84666	64236	55711	55737	355	1953	3587	1605	23118	152007	54910	9710	3423	401548	8905	79673	100132341	10144	339988	112849	330	23224	1235	3460	58515	64114	57728	5521	3695	2512	10308	439931	9159	3570	81030	9581	116983	1203	6888	288	4659	7162	10804	7726	9267	51025	201633	401647	301	9940	10296	54832	7693	54520	644	22931	439916	55512	51513	83715	9394	115362	8869	8797	283547	644353	91584	533	23471	3601	643733	64778	55349
GSE14000_TRANSLATED_RNA_VS_MRNA_DC_UP	M3326		19943945	Ceppi M,Clavarino G,Gatti E,Schmidt EK,de Gassart A,Blankenship D,Ogola G,Banchereau J,Chaussabel D,Pierre P.	GSE14000	GSE14000_1528_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of polysome bound (translated) mRNA versus total mRNA in dendritic cells.	Dendritic cells (DCs) are the sentinels of the mammalian immune system and they undergo a complex maturation process mediated by activation upon pathogen detection. Recent studies described the analysis of activated DCs by transcriptional profiling, but translation regulation was never taken in account. Therefore, the nature of the mRNAs being translated at various stages of DC activation was determined with the help of translational profiling, which is the sucrose gradient fractionation of polysomal-bound mRNAs combined to microarrays analysis. Total and polysomal-bound mRNA populations were compared in immature (0h) and LPS-stimulated (4h and 16h) human monocyte-derived DCs with the help of Affymetrix microarrays. Biostatistical analysis indicated that 296 mRNA molecules are translationally regulated during DC-activation. The most abundant biological process among the regulated mRNAs was protein biosynthesis, indicating the existence of a negative feedback loop regulating translation. Interestingly, a cluster of 17 ribosomal proteins were part of the regulated mRNAs, indicating that translation may be fine-tuned by particular components of the translational machinery. Our observations highlight the importance of translation regulation during the immune response, and may favour the identification of novel gene clusters or protein networks relevant for immunity. Our study also provides information on the possible absence of correlation between gene expression and real protein production in DCs.					64219	55276	154881	8893	3939	64969	3376	7518	57696	5195	5238	84811	5983	55572	6897	64983	10055	57763	65982	57122	55967	10969	10240	60561	80273	7486	5510	84950	51067	51377	55139	5436	92345	28957	221937	10270	5203	51018	79736	2059	26589	11193	10482	51103	23708	9442	805	5687	147007	221830	54948	50650	57129	84869	51654	7771	4839	8479	11130	51490	219988	55718	2632	51118	9531	9	79090	79068	51530	5082	8891	4702	4700	7268	10213	389072	55132	9441	8669	11340	79738	51649	2926	25879	5718	65082	54908	150737	91833	55082	29104	5689	4331	1977	79697	84172	84062	56916	140688	11338	529	51121	5684	4942	123720	28985	136647	23603	10180	25977	6629	84693	4534	10436	55226	10284	81889	114883	57585	1070	55	9070	2180	9093	92344	8458	26610	5683	5151	6903	5734	51163	10096	85453	8289	84933	10524	22836	10954	56941	9588	83732	54882	6832	54433	55037	23513	2618	8480	26286	80755	1353	1962	29115	54914	9263	617	65057	528	10200	64754	2187	22949	51270	23029	86	56652	10137	84678	22876	93323	5223	79959	8446	10190	51203	55559	4175	8766	56474	85365	51388	29127	1965	64108	63899	28998	10342	3382	8574	284695	55662	51531	266675	5717	6627	10212	10671	84324	79577
GSE14000_TRANSLATED_RNA_VS_MRNA_DC_DN	M3327		19943945	Ceppi M,Clavarino G,Gatti E,Schmidt EK,de Gassart A,Blankenship D,Ogola G,Banchereau J,Chaussabel D,Pierre P.	GSE14000	GSE14000_1528_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of polysome bound (translated) mRNA versus total mRNA in dendritic cells.	Dendritic cells (DCs) are the sentinels of the mammalian immune system and they undergo a complex maturation process mediated by activation upon pathogen detection. Recent studies described the analysis of activated DCs by transcriptional profiling, but translation regulation was never taken in account. Therefore, the nature of the mRNAs being translated at various stages of DC activation was determined with the help of translational profiling, which is the sucrose gradient fractionation of polysomal-bound mRNAs combined to microarrays analysis. Total and polysomal-bound mRNA populations were compared in immature (0h) and LPS-stimulated (4h and 16h) human monocyte-derived DCs with the help of Affymetrix microarrays. Biostatistical analysis indicated that 296 mRNA molecules are translationally regulated during DC-activation. The most abundant biological process among the regulated mRNAs was protein biosynthesis, indicating the existence of a negative feedback loop regulating translation. Interestingly, a cluster of 17 ribosomal proteins were part of the regulated mRNAs, indicating that translation may be fine-tuned by particular components of the translational machinery. Our observations highlight the importance of translation regulation during the immune response, and may favour the identification of novel gene clusters or protein networks relevant for immunity. Our study also provides information on the possible absence of correlation between gene expression and real protein production in DCs.					6205	56965	10491	7940	1990	3921	6161	10430	8073	6141	6139	57835	83723	51239	6124	116832	284525	10522	2879	2352	80228	5859	10329	55004	8677	387647	6204	84992	6175	6887	131616	84231	93144	6222	90196	401115	6193	23399	11033	7644	1975	54935	6210	5800	6135	84326	124446	6208	728142	6143	6207	402665	84328	55317	10712	10898	9519	79962	7428	11212	9141	2787	637	283345	9543	100132999	23521	140801	3275	3211	25798	23568	55146	26469	146562	11285	26225	29997	90120	100289079	6176	83719	92014	116228	11014	6134	3476	9616	401494	728431	2987	100289341	6144	6147	127253	29101	6296	3615	222962	729683	9275	6136	8392	2835	55803	85014	10399	124801	4904	6230	92002	5600	79038	8636	113000	4267	11257	373861	90410	3423	1933	8724	7580	124751	100310756	11046	11224	10552	2050	100128731	9349	514	6188	51501	100288139	1845	3766	94101	8761	8632	293	146542	64714	27230	8225	51389	51324	84967	10899	339855	148137	128240	124944	1936	6132	10248	118472	7390	27023	6206	6194	84310	84065	2971	64748	55509	84316	4716	9274	126259	27141	6181	25915	284106	1611	3208	284367	84620	1	79758	9125	790955	6834	113444	6154	80194	26986	51386	64377	148170	389203	6156	23753	245973	286272	27095	388969	51573	285550	25873
GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_UP	M3328		19943945	Ceppi M,Clavarino G,Gatti E,Schmidt EK,de Gassart A,Blankenship D,Ogola G,Banchereau J,Chaussabel D,Pierre P.	GSE14000	GSE14000_1529_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of polysome bound (translated) mRNA versus total mRNA 4 h after LPS (TLR4 agonist) stimulation.	Dendritic cells (DCs) are the sentinels of the mammalian immune system and they undergo a complex maturation process mediated by activation upon pathogen detection. Recent studies described the analysis of activated DCs by transcriptional profiling, but translation regulation was never taken in account. Therefore, the nature of the mRNAs being translated at various stages of DC activation was determined with the help of translational profiling, which is the sucrose gradient fractionation of polysomal-bound mRNAs combined to microarrays analysis. Total and polysomal-bound mRNA populations were compared in immature (0h) and LPS-stimulated (4h and 16h) human monocyte-derived DCs with the help of Affymetrix microarrays. Biostatistical analysis indicated that 296 mRNA molecules are translationally regulated during DC-activation. The most abundant biological process among the regulated mRNAs was protein biosynthesis, indicating the existence of a negative feedback loop regulating translation. Interestingly, a cluster of 17 ribosomal proteins were part of the regulated mRNAs, indicating that translation may be fine-tuned by particular components of the translational machinery. Our observations highlight the importance of translation regulation during the immune response, and may favour the identification of novel gene clusters or protein networks relevant for immunity. Our study also provides information on the possible absence of correlation between gene expression and real protein production in DCs.					9879	23318	29945	51530	9360	84678	54878	79691	54788	55131	8669	11056	51118	51163	6643	27336	5921	112752	4869	29761	80230	79023	7443	84196	55181	4534	133619	2110	54934	64112	26135	60684	28957	57470	11340	8540	3929	10939	2648	5876	4678	8874	54505	117143	2730	284695	51067	79675	8493	284309	65109	4319	219844	54908	55726	55781	23503	4848	79657	51651	29071	57650	60560	3184	55164	84340	151613	5987	2237	22868	7188	5289	9512	80185	55154	7095	196513	84365	8893	54737	93621	55609	128061	8504	6597	7552	83732	8446	11073	11104	55749	5082	4682	55421	55669	11198	254170	29104	286053	113263	10054	9330	23370	10785	55168	9946	728642	55748	219541	9442	22826	54520	93643	6605	10614	25879	6885	10915	6341	79366	2287	8970	81576	55656	23545	146050	8050	23527	54499	58489	10659	51095	285464	221154	9939	8650	139596	23560	27238	22879	54906	55915	9531	51720	5707	5689	26610	222194	4942	54995	340252	83752	23398	22992	10200	50814	5170	53981	5781	3670	55308	79677	51103	51603	57147	9	58486	51224	55328	2869	25831	6248	5394	642938	63036	79665	28985	2071	55596	9987	83953	5380	51018	7746	79624	5431	81566	84811	5268	9092	10196	84311	84901	55293	84298	22950	1069	199692	400831	9099
GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_DN	M3329		19943945	Ceppi M,Clavarino G,Gatti E,Schmidt EK,de Gassart A,Blankenship D,Ogola G,Banchereau J,Chaussabel D,Pierre P.	GSE14000	GSE14000_1529_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of polysome bound (translated) mRNA versus total mRNA 4 h after LPS (TLR4 agonist) stimulation.	Dendritic cells (DCs) are the sentinels of the mammalian immune system and they undergo a complex maturation process mediated by activation upon pathogen detection. Recent studies described the analysis of activated DCs by transcriptional profiling, but translation regulation was never taken in account. Therefore, the nature of the mRNAs being translated at various stages of DC activation was determined with the help of translational profiling, which is the sucrose gradient fractionation of polysomal-bound mRNAs combined to microarrays analysis. Total and polysomal-bound mRNA populations were compared in immature (0h) and LPS-stimulated (4h and 16h) human monocyte-derived DCs with the help of Affymetrix microarrays. Biostatistical analysis indicated that 296 mRNA molecules are translationally regulated during DC-activation. The most abundant biological process among the regulated mRNAs was protein biosynthesis, indicating the existence of a negative feedback loop regulating translation. Interestingly, a cluster of 17 ribosomal proteins were part of the regulated mRNAs, indicating that translation may be fine-tuned by particular components of the translational machinery. Our observations highlight the importance of translation regulation during the immune response, and may favour the identification of novel gene clusters or protein networks relevant for immunity. Our study also provides information on the possible absence of correlation between gene expression and real protein production in DCs.					131118	92912	2787	51125	56935	9168	29058	6484	9887	10793	5411	195827	27166	522	94239	113444	94101	647087	7940	79643	29085	81853	246184	8073	10063	144363	54752	4738	2876	10169	100505576	130814	5433	27230	25915	5800	6218	400236	153339	151657	10237	84270	1454	29103	401577	6009	11272	84808	84557	11257	1961	126328	79647	7140	148223	6234	6147	10975	4707	6136	9275	26291	64928	390205	9474	3275	283345	645811	3240	541578	10336	27089	255330	43847	4695	23568	25912	84522	3151	285381	1611	441951	8195	139728	1114	4267	51727	100289577	388677	151195	2043	90701	5915	2958	91283	5906	51012	147727	7480	27091	26776	55146	22844	63933	550643	28511	10616	5365	6640	124944	83930	51330	1933	6146	63905	6208	221833	283551	5805	100287052	6881	55142	4654	729991	4239	55751	5153	51503	5868	573	5187	94	199704	9519	79144	5570	391	165324	84992	158787	91966	554203	7178	140823	22869	201475	1937	494558	6650	79768	9217	128240	56942	6232	124801	100128731	3211	730094	1428	5879	6923	23596	374969	7322	118987	6150	1748	10798	5911	51647	84063	2987	10959	730202	4482	653784	5535	54913	8831	29937	56965	100289079	130576	25873	7171	84931	6156	6176	7109	10430	51321	644068	2065	388210	11102	116228	282969	6175	347344	6001
GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_UP	M3332		19943945	Ceppi M,Clavarino G,Gatti E,Schmidt EK,de Gassart A,Blankenship D,Ogola G,Banchereau J,Chaussabel D,Pierre P.	GSE14000	GSE14000_1530_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of polysome bound (translated) mRNA versus total mRNA 16 h after LPS (TLR4 agonist) stimulation.	Dendritic cells (DCs) are the sentinels of the mammalian immune system and they undergo a complex maturation process mediated by activation upon pathogen detection. Recent studies described the analysis of activated DCs by transcriptional profiling, but translation regulation was never taken in account. Therefore, the nature of the mRNAs being translated at various stages of DC activation was determined with the help of translational profiling, which is the sucrose gradient fractionation of polysomal-bound mRNAs combined to microarrays analysis. Total and polysomal-bound mRNA populations were compared in immature (0h) and LPS-stimulated (4h and 16h) human monocyte-derived DCs with the help of Affymetrix microarrays. Biostatistical analysis indicated that 296 mRNA molecules are translationally regulated during DC-activation. The most abundant biological process among the regulated mRNAs was protein biosynthesis, indicating the existence of a negative feedback loop regulating translation. Interestingly, a cluster of 17 ribosomal proteins were part of the regulated mRNAs, indicating that translation may be fine-tuned by particular components of the translational machinery. Our observations highlight the importance of translation regulation during the immune response, and may favour the identification of novel gene clusters or protein networks relevant for immunity. Our study also provides information on the possible absence of correlation between gene expression and real protein production in DCs.					5256	1388	26137	5896	11199	10846	400965	200931	79068	23767	9905	440122	57573	131578	117178	8749	54946	64969	57585	57597	254158	53829	164	8658	57553	80709	728868	399761	284129	1135	388946	27143	10164	79012	36	2115	54546	145474	140836	387597	317671	79697	2575	55315	51540	128025	10786	167681	8626	728012	93273	259285	9156	91523	50628	266917	23370	5275	6293	128486	285905	136306	57628	113189	54850	60491	842	2830	10648	100292631	2823	6382	203102	25771	84657	5830	138065	55810	2165	642987	10240	100132708	283849	11194	147744	1822	100127972	57728	8565	158228	5318	653252	100289094	4285	8517	29128	55656	27031	11130	9093	11113	100130078	159162	100128262	340074	91603	2661	10478	201163	100505658	65258	100130609	148398	92749	285533	26205	415	303	79174	4988	25911	1063	57602	2712	285908	339468	6278	23268	1359	728591	10216	196513	10369	29998	4756	6547	23385	643641	55328	116729	401565	10505	5160	57002	4329	3237	84946	100129827	54955	147991	29991	79573	3184	9947	751816	26496	100129069	653602	56262	92591	1503	100287719	29911	6900	7915	7694	6263	5672	26212	83468	440061	55089	2941	266655	55225	23513	2189	1556	25763	53834	200523	339894	3202	343450	7443	29105	337879	54788	79096	128488	10038	374868	285093	29124	10618	51762	148979	136647	64718	91010
GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_DN	M3333		19943945	Ceppi M,Clavarino G,Gatti E,Schmidt EK,de Gassart A,Blankenship D,Ogola G,Banchereau J,Chaussabel D,Pierre P.	GSE14000	GSE14000_1530_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of polysome bound (translated) mRNA versus total mRNA 16 h after LPS (TLR4 agonist) stimulation.	Dendritic cells (DCs) are the sentinels of the mammalian immune system and they undergo a complex maturation process mediated by activation upon pathogen detection. Recent studies described the analysis of activated DCs by transcriptional profiling, but translation regulation was never taken in account. Therefore, the nature of the mRNAs being translated at various stages of DC activation was determined with the help of translational profiling, which is the sucrose gradient fractionation of polysomal-bound mRNAs combined to microarrays analysis. Total and polysomal-bound mRNA populations were compared in immature (0h) and LPS-stimulated (4h and 16h) human monocyte-derived DCs with the help of Affymetrix microarrays. Biostatistical analysis indicated that 296 mRNA molecules are translationally regulated during DC-activation. The most abundant biological process among the regulated mRNAs was protein biosynthesis, indicating the existence of a negative feedback loop regulating translation. Interestingly, a cluster of 17 ribosomal proteins were part of the regulated mRNAs, indicating that translation may be fine-tuned by particular components of the translational machinery. Our observations highlight the importance of translation regulation during the immune response, and may favour the identification of novel gene clusters or protein networks relevant for immunity. Our study also provides information on the possible absence of correlation between gene expression and real protein production in DCs.					84310	9519	11031	170622	10473	11257	83930	374969	375607	6834	7940	10425	83719	8073	84221	57128	2967	258010	140691	8293	4154	2971	10959	131616	374443	6815	79768	390998	220906	11165	138241	125150	146542	51727	100505702	440145	115557	26261	6203	10899	55146	119504	8724	140801	5800	643911	51501	388962	124801	51125	5433	285381	26994	246184	51389	57186	11272	140606	92002	27440	27230	116135	7311	130617	2101	283345	23753	94101	3574	56901	1534	6881	57150	56969	10904	6155	1176	117584	29101	432	29107	9370	80228	55004	115827	79568	100507495	84992	165324	1979	11267	6169	56655	84807	23433	401152	6156	51372	26127	9455	79038	56965	51124	100132891	149951	7322	25798	148189	100129852	8636	641638	84163	64853	23583	79144	30851	8468	158293	1455	64236	342538	5728	54901	51123	259236	9349	9589	63935	5939	83636	5283	951	100130613	641977	3673	23463	26996	91689	114614	9929	91272	6160	25804	6218	55056	84299	100507246	1845	9538	6206	64928	55022	116228	195827	124446	55884	493856	409	10907	91612	3150	126006	10793	29883	3682	112487	23531	25873	10490	84106	6181	81873	256281	100310756	647087	2987	2014	6187	65996	8000	730094	114926	55111	6168	51107	100288418	84792	6205	6170	84915	51201	11046	144360	129642	91369	23261	26225	280636	140739	100129112
GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_UP	M3337		19943945	Ceppi M,Clavarino G,Gatti E,Schmidt EK,de Gassart A,Blankenship D,Ogola G,Banchereau J,Chaussabel D,Pierre P.	GSE14000	GSE14000_1531_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of polysome bound (translated) mRNA before and 4 h after LPS (TLR4 agonist) stimulation.	Dendritic cells (DCs) are the sentinels of the mammalian immune system and they undergo a complex maturation process mediated by activation upon pathogen detection. Recent studies described the analysis of activated DCs by transcriptional profiling, but translation regulation was never taken in account. Therefore, the nature of the mRNAs being translated at various stages of DC activation was determined with the help of translational profiling, which is the sucrose gradient fractionation of polysomal-bound mRNAs combined to microarrays analysis. Total and polysomal-bound mRNA populations were compared in immature (0h) and LPS-stimulated (4h and 16h) human monocyte-derived DCs with the help of Affymetrix microarrays. Biostatistical analysis indicated that 296 mRNA molecules are translationally regulated during DC-activation. The most abundant biological process among the regulated mRNAs was protein biosynthesis, indicating the existence of a negative feedback loop regulating translation. Interestingly, a cluster of 17 ribosomal proteins were part of the regulated mRNAs, indicating that translation may be fine-tuned by particular components of the translational machinery. Our observations highlight the importance of translation regulation during the immune response, and may favour the identification of novel gene clusters or protein networks relevant for immunity. Our study also provides information on the possible absence of correlation between gene expression and real protein production in DCs.					7014	4162	27349	55572	192670	5830	60684	64112	7462	10949	29058	84058	64216	85453	7799	686	328	10746	9993	4839	55071	253635	24149	93622	8819	152185	57696	23212	79959	10277	79607	23404	54585	10111	54545	23401	51366	65005	83759	55154	3182	389792	83989	5018	768211	57613	3554	54495	57109	64860	153328	55285	6596	4610	54977	4913	57470	11162	89890	7771	139716	151525	8439	1477	54841	118672	10939	115106	80324	25831	2237	4698	23517	9831	29105	284406	126231	29929	5825	2109	23287	5985	170394	9306	55907	11022	146198	28973	58492	29127	4217	23030	440465	51118	10129	79629	60526	26276	91748	283897	60314	1831	54951	201973	116236	7965	153364	6461	10980	79728	55164	84928	7247	5203	1849	51654	5906	124222	23014	126295	57037	57478	56204	8019	29087	23729	10127	51070	56890	7248	10717	56262	65982	55858	3631	4436	23076	9860	26190	8518	54978	124995	1355	54471	283464	388403	86	5001	317781	10981	51490	65981	79829	23107	84946	23609	25879	57704	79930	51122	57496	5636	55250	6418	29068	55809	9774	54497	64963	22838	11097	805	23177	100287081	178	7532	11041	6872	5471	51527	55759	818	2956	64981	26048	11168	1967	9049	122769	6045	55002	84693	166379	83752	133746	133686	80209	93210	1854	7048
GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_DN	M3338		19943945	Ceppi M,Clavarino G,Gatti E,Schmidt EK,de Gassart A,Blankenship D,Ogola G,Banchereau J,Chaussabel D,Pierre P.	GSE14000	GSE14000_1531_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of polysome bound (translated) mRNA before and 4 h after LPS (TLR4 agonist) stimulation.	Dendritic cells (DCs) are the sentinels of the mammalian immune system and they undergo a complex maturation process mediated by activation upon pathogen detection. Recent studies described the analysis of activated DCs by transcriptional profiling, but translation regulation was never taken in account. Therefore, the nature of the mRNAs being translated at various stages of DC activation was determined with the help of translational profiling, which is the sucrose gradient fractionation of polysomal-bound mRNAs combined to microarrays analysis. Total and polysomal-bound mRNA populations were compared in immature (0h) and LPS-stimulated (4h and 16h) human monocyte-derived DCs with the help of Affymetrix microarrays. Biostatistical analysis indicated that 296 mRNA molecules are translationally regulated during DC-activation. The most abundant biological process among the regulated mRNAs was protein biosynthesis, indicating the existence of a negative feedback loop regulating translation. Interestingly, a cluster of 17 ribosomal proteins were part of the regulated mRNAs, indicating that translation may be fine-tuned by particular components of the translational machinery. Our observations highlight the importance of translation regulation during the immune response, and may favour the identification of novel gene clusters or protein networks relevant for immunity. Our study also provides information on the possible absence of correlation between gene expression and real protein production in DCs.					54742	2820	84930	440900	8548	83990	375035	8837	83856	4600	1318	2643	2526	57823	56913	2000	203197	330	2634	200315	402665	116071	9246	85463	3665	467	6352	8814	138948	1267	29126	64359	26471	158219	3600	4939	79155	58504	91351	100133660	5734	8013	3431	84166	5327	151636	2887	162394	135112	710	10979	56985	728361	9636	64748	5157	55802	94240	8934	10135	81566	123872	22809	6351	3434	79370	962	55300	84102	51191	100130078	8743	23109	64135	10964	4615	55321	140691	10561	1847	55669	64332	886	3437	29841	404217	80830	6355	10970	130367	2766	115362	3659	129607	6934	121214	8676	3433	9833	7726	64108	9099	51251	167359	152926	1379	11274	8638	3656	24138	653464	3669	57194	55332	51513	81844	81894	4938	51667	840	114614	252995	2633	441108	9966	283551	9953	79962	6373	941	54739	8519	4599	414201	5600	3211	5366	3553	650	23586	643977	8991	9447	7424	3429	6648	115004	7185	1990	84132	57579	645745	245937	5358	3601	2180	4277	10797	952	597	127124	285877	57685	60489	3620	87178	147906	1594	55008	93082	9021	6993	377677	7453	6346	91543	7130	2152	1466	83666	11025	3696	9567	29761	8434	11026	23306	54206	11044	23284	27348	9456	255231	81794	51427	157739	5008	121268	5128	6772
GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_UP	M3343		19943945	Ceppi M,Clavarino G,Gatti E,Schmidt EK,de Gassart A,Blankenship D,Ogola G,Banchereau J,Chaussabel D,Pierre P.	GSE14000	GSE14000_1532_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of polysome bound (translated) mRNA before and 16 h after LPS (TLR4 agonist) stimulation.	Dendritic cells (DCs) are the sentinels of the mammalian immune system and they undergo a complex maturation process mediated by activation upon pathogen detection. Recent studies described the analysis of activated DCs by transcriptional profiling, but translation regulation was never taken in account. Therefore, the nature of the mRNAs being translated at various stages of DC activation was determined with the help of translational profiling, which is the sucrose gradient fractionation of polysomal-bound mRNAs combined to microarrays analysis. Total and polysomal-bound mRNA populations were compared in immature (0h) and LPS-stimulated (4h and 16h) human monocyte-derived DCs with the help of Affymetrix microarrays. Biostatistical analysis indicated that 296 mRNA molecules are translationally regulated during DC-activation. The most abundant biological process among the regulated mRNAs was protein biosynthesis, indicating the existence of a negative feedback loop regulating translation. Interestingly, a cluster of 17 ribosomal proteins were part of the regulated mRNAs, indicating that translation may be fine-tuned by particular components of the translational machinery. Our observations highlight the importance of translation regulation during the immune response, and may favour the identification of novel gene clusters or protein networks relevant for immunity. Our study also provides information on the possible absence of correlation between gene expression and real protein production in DCs.					80746	253635	133418	79618	10732	8459	440465	11222	83989	89890	23174	84329	11200	29108	79956	18	170394	55333	84376	861	10396	10152	6832	29068	389792	5498	201562	4775	55841	51466	4122	23475	64172	51642	4698	2034	10460	2203	57563	401548	191	10170	10128	27161	252839	100286937	90522	57666	128077	7414	4610	5830	54893	29127	2952	10856	100129550	6461	22848	23313	23401	64236	7267	51300	54841	23170	55809	7187	84309	23212	53346	4033	349565	23191	9844	5175	9686	653121	56915	8527	408	65018	9535	282974	84693	54802	149076	403	6256	271	25927	6652	51706	3030	4688	60559	219654	60509	6894	818	84959	23326	139716	51118	3987	64801	11031	10458	4258	10277	23171	10949	4215	64326	83992	56262	79930	126231	64969	64393	51084	2934	11022	7110	414327	64397	397	120224	1112	9759	9760	133522	4259	29090	11010	4665	5985	9581	83892	92667	5198	4329	55810	6573	36	79573	23076	54518	64333	11130	79699	134145	151194	945	93129	6431	8030	79646	9529	139322	9905	7248	3033	81855	5775	56947	55154	50807	56886	64407	9831	1796	130074	100129502	1849	9779	79817	26278	140707	5424	51517	374868	26523	10462	3603	7764	283464	11311	79895	7771	51434	25923	100289420	286336	128486	8935	11162	30837	138151	79890
GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_DN	M3344		19943945	Ceppi M,Clavarino G,Gatti E,Schmidt EK,de Gassart A,Blankenship D,Ogola G,Banchereau J,Chaussabel D,Pierre P.	GSE14000	GSE14000_1532_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of polysome bound (translated) mRNA before and 16 h after LPS (TLR4 agonist) stimulation.	Dendritic cells (DCs) are the sentinels of the mammalian immune system and they undergo a complex maturation process mediated by activation upon pathogen detection. Recent studies described the analysis of activated DCs by transcriptional profiling, but translation regulation was never taken in account. Therefore, the nature of the mRNAs being translated at various stages of DC activation was determined with the help of translational profiling, which is the sucrose gradient fractionation of polysomal-bound mRNAs combined to microarrays analysis. Total and polysomal-bound mRNA populations were compared in immature (0h) and LPS-stimulated (4h and 16h) human monocyte-derived DCs with the help of Affymetrix microarrays. Biostatistical analysis indicated that 296 mRNA molecules are translationally regulated during DC-activation. The most abundant biological process among the regulated mRNAs was protein biosynthesis, indicating the existence of a negative feedback loop regulating translation. Interestingly, a cluster of 17 ribosomal proteins were part of the regulated mRNAs, indicating that translation may be fine-tuned by particular components of the translational machinery. Our observations highlight the importance of translation regulation during the immune response, and may favour the identification of novel gene clusters or protein networks relevant for immunity. Our study also provides information on the possible absence of correlation between gene expression and real protein production in DCs.					4600	9881	5327	25895	51646	200315	4629	1594	11026	10970	2643	1962	8728	83856	81553	3434	84830	4939	5599	330	6672	952	1267	56951	54662	80045	27348	64332	5157	57823	51131	51365	51191	83990	55840	1318	55008	84166	2575	27086	9334	79056	80830	3656	29761	3604	8519	3157	1528	24138	84930	64318	3437	81844	7570	11067	8013	3268	6351	597	55567	8837	203197	79155	441366	253782	6352	8464	65108	219285	467	2762	65220	114897	10000	7130	6355	3600	3665	29126	8743	375484	4850	9910	129607	8934	414201	2526	25841	64109	390035	80169	9367	100132285	2115	201725	90355	9110	51430	5142	4683	90634	5366	7280	123720	3796	91624	64761	7126	2633	2811	257144	8190	132864	51251	8820	1379	7051	51667	60489	54749	3696	133308	3641	2553	9595	57186	6993	57458	9567	7410	6364	126820	3433	140691	2766	57089	22993	10148	2887	254158	55293	9833	375035	3559	79370	27075	54957	8836	7453	55300	9447	94015	79669	55337	114614	285957	29916	4940	10964	27314	29121	54875	116984	93082	64135	81796	8349	7127	91543	6773	11274	9829	79973	51715	65264	4277	29923	55731	27154	83636	864	3620	90407	2926	123872	2983	134429	130367	56623	10957	4599	54904	55332	81563	7291	5610	6648	10979	80018
GSE14000_UNSTIM_VS_4H_LPS_DC_UP	M3345		19943945	Ceppi M,Clavarino G,Gatti E,Schmidt EK,de Gassart A,Blankenship D,Ogola G,Banchereau J,Chaussabel D,Pierre P.	GSE14000	GSE14000_1533_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) before and 4 h after LPS (TLR4 agonist) stimulation.	Dendritic cells (DCs) are the sentinels of the mammalian immune system and they undergo a complex maturation process mediated by activation upon pathogen detection. Recent studies described the analysis of activated DCs by transcriptional profiling, but translation regulation was never taken in account. Therefore, the nature of the mRNAs being translated at various stages of DC activation was determined with the help of translational profiling, which is the sucrose gradient fractionation of polysomal-bound mRNAs combined to microarrays analysis. Total and polysomal-bound mRNA populations were compared in immature (0h) and LPS-stimulated (4h and 16h) human monocyte-derived DCs with the help of Affymetrix microarrays. Biostatistical analysis indicated that 296 mRNA molecules are translationally regulated during DC-activation. The most abundant biological process among the regulated mRNAs was protein biosynthesis, indicating the existence of a negative feedback loop regulating translation. Interestingly, a cluster of 17 ribosomal proteins were part of the regulated mRNAs, indicating that translation may be fine-tuned by particular components of the translational machinery. Our observations highlight the importance of translation regulation during the immune response, and may favour the identification of novel gene clusters or protein networks relevant for immunity. Our study also provides information on the possible absence of correlation between gene expression and real protein production in DCs.					145853	64112	3615	56262	80345	55135	57470	116841	653121	121642	56986	219654	1478	286101	155060	256302	255031	57541	83759	10460	10845	57215	8563	23522	55529	55759	3014	57701	55154	84365	10491	2237	28990	284098	136647	55316	9328	54799	147015	9673	55164	10277	57002	26608	79894	10838	6461	10248	4130	196513	54677	23212	90864	60314	26100	23729	63977	148479	10949	90231	283578	6839	54977	54876	83719	10926	80700	84080	5501	5471	84705	4287	57684	79064	84260	23059	117246	56910	27349	55758	64798	50619	25886	27300	57456	8396	3954	9051	605	79707	5983	79882	84138	80789	79754	8019	126074	154807	23002	4033	200845	54828	162427	100289086	84273	10765	84662	9905	147923	57613	374666	100287081	79699	23310	112724	7965	57232	163049	6597	140685	1849	6850	25974	54801	113802	11285	84311	131870	7782	9656	25879	613	55703	9343	55239	9491	4215	10162	9545	51118	908	10314	4507	23030	8602	57465	93129	5830	64785	23401	376497	22877	55833	29107	23404	388969	79829	115992	6573	57666	23314	84126	58513	84276	3104	132001	163087	54908	201164	84327	3603	92370	326332	64921	283431	56848	9112	58492	57472	317781	55226	9772	345778	1836	7247	149420	23648	26574	79142	84247	23588	90268	93622	1938	121274	10898	79676	26094	5442	133686
GSE14000_UNSTIM_VS_4H_LPS_DC_DN	M3347		19943945	Ceppi M,Clavarino G,Gatti E,Schmidt EK,de Gassart A,Blankenship D,Ogola G,Banchereau J,Chaussabel D,Pierre P.	GSE14000	GSE14000_1533_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) before and 4 h after LPS (TLR4 agonist) stimulation.	Dendritic cells (DCs) are the sentinels of the mammalian immune system and they undergo a complex maturation process mediated by activation upon pathogen detection. Recent studies described the analysis of activated DCs by transcriptional profiling, but translation regulation was never taken in account. Therefore, the nature of the mRNAs being translated at various stages of DC activation was determined with the help of translational profiling, which is the sucrose gradient fractionation of polysomal-bound mRNAs combined to microarrays analysis. Total and polysomal-bound mRNA populations were compared in immature (0h) and LPS-stimulated (4h and 16h) human monocyte-derived DCs with the help of Affymetrix microarrays. Biostatistical analysis indicated that 296 mRNA molecules are translationally regulated during DC-activation. The most abundant biological process among the regulated mRNAs was protein biosynthesis, indicating the existence of a negative feedback loop regulating translation. Interestingly, a cluster of 17 ribosomal proteins were part of the regulated mRNAs, indicating that translation may be fine-tuned by particular components of the translational machinery. Our observations highlight the importance of translation regulation during the immune response, and may favour the identification of novel gene clusters or protein networks relevant for immunity. Our study also provides information on the possible absence of correlation between gene expression and real protein production in DCs.					8564	7726	3665	4939	22936	2766	54625	25858	2131	84102	57708	25793	8577	4615	4277	22809	375035	29126	11016	415116	840	10135	4117	10379	83990	6897	100170841	151636	5868	283551	8434	9589	80765	201475	23380	5610	5520	7832	5366	65264	8837	1267	8519	93082	5321	129607	64135	2643	3431	10964	11080	7185	58504	64332	25895	687	2820	4600	26471	200315	64359	83666	8638	3574	1318	9833	6346	64108	23586	84166	94240	22797	9636	23306	55281	3620	152926	7743	941	23034	143689	262	864	57823	84941	4502	103	3660	158219	51191	3429	2634	6352	9246	10561	4683	56983	710	51251	5341	126820	10725	116071	4792	7130	56935	3433	9242	129450	7453	8013	135112	130367	10906	7334	54936	4814	3430	64859	3440	8743	5371	55669	80830	9175	51513	93653	100294145	3669	54875	26228	597	2526	54739	255231	55300	4501	87178	3659	3371	83856	7127	54891	9674	467	6351	3434	731424	2633	123872	11274	91351	54957	3600	10970	5327	3575	441108	5698	8190	24138	6648	55871	23424	3553	93343	115362	100287052	79370	6737	51667	4938	9209	8820	6373	57169	1466	4940	80219	25945	165324	5734	84270	1847	121268	203197	2887	10859	684	6993	114614	55337	57579	2180	3437	9966	2537	5916	85463	8942
GSE14000_UNSTIM_VS_16H_LPS_DC_UP	M3348		19943945	Ceppi M,Clavarino G,Gatti E,Schmidt EK,de Gassart A,Blankenship D,Ogola G,Banchereau J,Chaussabel D,Pierre P.	GSE14000	GSE14000_1534_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) before and 16 h after LPS (TLR4 agonist) stimulation.	Dendritic cells (DCs) are the sentinels of the mammalian immune system and they undergo a complex maturation process mediated by activation upon pathogen detection. Recent studies described the analysis of activated DCs by transcriptional profiling, but translation regulation was never taken in account. Therefore, the nature of the mRNAs being translated at various stages of DC activation was determined with the help of translational profiling, which is the sucrose gradient fractionation of polysomal-bound mRNAs combined to microarrays analysis. Total and polysomal-bound mRNA populations were compared in immature (0h) and LPS-stimulated (4h and 16h) human monocyte-derived DCs with the help of Affymetrix microarrays. Biostatistical analysis indicated that 296 mRNA molecules are translationally regulated during DC-activation. The most abundant biological process among the regulated mRNAs was protein biosynthesis, indicating the existence of a negative feedback loop regulating translation. Interestingly, a cluster of 17 ribosomal proteins were part of the regulated mRNAs, indicating that translation may be fine-tuned by particular components of the translational machinery. Our observations highlight the importance of translation regulation during the immune response, and may favour the identification of novel gene clusters or protein networks relevant for immunity. Our study also provides information on the possible absence of correlation between gene expression and real protein production in DCs.					7284	6310	201562	54440	56986	26123	515	7267	219654	56996	23314	4130	5859	64098	286101	3603	440574	63977	9791	64798	255031	6461	1161	8195	6207	57103	403	29796	51084	284029	1836	60314	8677	100129550	219771	11311	114926	8396	83787	11031	10899	10801	79720	64393	79890	402	51596	283431	729082	79817	6603	84148	84967	57704	440957	90231	64170	10904	64333	83938	51205	55347	146223	10300	10634	2535	8793	133418	5613	6146	4722	8019	100289086	84276	54677	5175	84262	8733	6143	29960	84795	51522	10948	100289420	7867	79080	54930	282974	27335	7414	9466	3416	3632	4215	64115	4154	26520	8459	125144	5198	6821	6130	79707	51121	51706	10476	145853	80205	64757	4707	9581	10972	9673	1497	90410	25828	1979	3033	6256	100287081	54432	5742	140707	57446	9815	51329	9653	90871	3281	92017	23654	2101	23326	7388	51763	23344	57820	8761	8522	64147	8935	3987	5607	23765	9454	23731	23521	2271	27131	150771	6157	115992	79646	9556	60559	8694	4033	130074	5601	55847	56998	56926	83449	9203	283508	4350	23475	653121	114928	489	1350	25894	79718	28951	8533	55333	51693	286109	51657	945	54802	6159	56262	4712	8536	10732	5867	55810	57563	23313	84233	10077	284184	6767	949	84279	10844	56180	53834	91689
GSE14000_UNSTIM_VS_16H_LPS_DC_DN	M3350		19943945	Ceppi M,Clavarino G,Gatti E,Schmidt EK,de Gassart A,Blankenship D,Ogola G,Banchereau J,Chaussabel D,Pierre P.	GSE14000	GSE14000_1534_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) before and 16 h after LPS (TLR4 agonist) stimulation.	Dendritic cells (DCs) are the sentinels of the mammalian immune system and they undergo a complex maturation process mediated by activation upon pathogen detection. Recent studies described the analysis of activated DCs by transcriptional profiling, but translation regulation was never taken in account. Therefore, the nature of the mRNAs being translated at various stages of DC activation was determined with the help of translational profiling, which is the sucrose gradient fractionation of polysomal-bound mRNAs combined to microarrays analysis. Total and polysomal-bound mRNA populations were compared in immature (0h) and LPS-stimulated (4h and 16h) human monocyte-derived DCs with the help of Affymetrix microarrays. Biostatistical analysis indicated that 296 mRNA molecules are translationally regulated during DC-activation. The most abundant biological process among the regulated mRNAs was protein biosynthesis, indicating the existence of a negative feedback loop regulating translation. Interestingly, a cluster of 17 ribosomal proteins were part of the regulated mRNAs, indicating that translation may be fine-tuned by particular components of the translational machinery. Our observations highlight the importance of translation regulation during the immune response, and may favour the identification of novel gene clusters or protein networks relevant for immunity. Our study also provides information on the possible absence of correlation between gene expression and real protein production in DCs.					57708	8293	64332	9589	11067	5326	11026	9129	5292	3665	84102	116071	10135	3939	1130	7280	22902	29126	64135	2146	84901	79074	201725	8869	1267	8347	51526	27071	123720	3604	93343	124359	2926	23035	10758	7185	92745	126820	22936	55916	11167	1318	5683	2553	51478	3157	415116	55106	7726	4501	57655	129607	51667	55633	7126	84223	8460	7130	375035	10866	64983	9242	83937	134429	29923	64853	4478	9978	441951	9567	3718	81553	56548	29121	79132	23780	8743	2180	2185	84919	8357	64859	8717	2820	284086	79056	57089	9826	4091	55332	684	81894	3430	9910	103	3394	84930	840	10970	55802	10381	262	1017	4792	283643	4047	5371	8767	64761	9322	2495	27319	3660	11016	3268	5720	65998	64744	27314	1594	9662	23381	55207	864	1889	10148	57186	8353	10284	80765	64318	399	645745	2643	8728	151636	4850	5690	55014	80219	6897	541578	4779	645634	8237	247	6760	84941	84830	8440	123872	4502	7127	4204	1379	3574	4289	79577	8932	2766	4061	2887	83666	4277	5366	2526	55300	10379	23424	10561	4938	2706	4616	942	8349	3914	130367	9527	10950	6776	8837	6737	54532	57650	23070	57823	51762	2117	143689	54662	29115	3600	5238	9674	729678	65264	55669	94015	65220	285268
GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_UP	M3351		19943945	Ceppi M,Clavarino G,Gatti E,Schmidt EK,de Gassart A,Blankenship D,Ogola G,Banchereau J,Chaussabel D,Pierre P.	GSE14000	GSE14000_1535_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of polysome bound (translated) mRNA in dendritic cells (DC) at 4 h after LPS (TLR4 agonist) stimulation versus those at 16 h after the stimulation.	Dendritic cells (DCs) are the sentinels of the mammalian immune system and they undergo a complex maturation process mediated by activation upon pathogen detection. Recent studies described the analysis of activated DCs by transcriptional profiling, but translation regulation was never taken in account. Therefore, the nature of the mRNAs being translated at various stages of DC activation was determined with the help of translational profiling, which is the sucrose gradient fractionation of polysomal-bound mRNAs combined to microarrays analysis. Total and polysomal-bound mRNA populations were compared in immature (0h) and LPS-stimulated (4h and 16h) human monocyte-derived DCs with the help of Affymetrix microarrays. Biostatistical analysis indicated that 296 mRNA molecules are translationally regulated during DC-activation. The most abundant biological process among the regulated mRNAs was protein biosynthesis, indicating the existence of a negative feedback loop regulating translation. Interestingly, a cluster of 17 ribosomal proteins were part of the regulated mRNAs, indicating that translation may be fine-tuned by particular components of the translational machinery. Our observations highlight the importance of translation regulation during the immune response, and may favour the identification of novel gene clusters or protein networks relevant for immunity. Our study also provides information on the possible absence of correlation between gene expression and real protein production in DCs.					1955	4688	22848	4329	55244	3064	55201	84959	64098	11010	51466	1774	338382	9456	7187	949	85463	56886	10462	5031	414327	9535	2203	6039	23092	4643	23191	7248	64326	5742	2952	79890	3556	23475	18	397	56829	2162	472	64397	8935	25906	60559	59274	22918	79686	3030	1201	133418	22861	7172	2034	130589	6256	115560	7850	4000	8522	27161	5358	90522	53346	23344	4258	8548	3371	64231	55841	117155	339390	5613	3872	254065	120224	83938	5175	23306	202018	100133660	84795	50807	7311	4255	6515	54206	400590	10077	7267	1545	10396	6203	5321	23753	3385	130074	92017	79572	645	7090	5232	5914	158219	51706	1794	64359	8829	6152	3693	5445	135112	57486	5606	2729	481	5538	27	145389	406893	285628	29841	201562	10380	3032	1636	3684	53827	5327	1500	6275	100287182	56915	123920	7832	51313	8569	4482	84898	5130	9429	6455	2934	79956	4668	10591	7227	87	7381	6155	65983	23673	83478	23492	3915	374655	27335	6431	91942	23683	3028	51300	6001	10400	10075	191	79834	6192	6867	1776	10602	5570	8239	128346	23220	221895	4154	63036	11057	27439	23171	5806	64332	6894	401074	79905	10257	178	4712	23765	57168	29108	166929	695	5467	23200	22809	9605	3577	11184	80301	9076
GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_DN	M3352		19943945	Ceppi M,Clavarino G,Gatti E,Schmidt EK,de Gassart A,Blankenship D,Ogola G,Banchereau J,Chaussabel D,Pierre P.	GSE14000	GSE14000_1535_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of polysome bound (translated) mRNA in dendritic cells (DC) at 4 h after LPS (TLR4 agonist) stimulation versus those at 16 h after the stimulation.	Dendritic cells (DCs) are the sentinels of the mammalian immune system and they undergo a complex maturation process mediated by activation upon pathogen detection. Recent studies described the analysis of activated DCs by transcriptional profiling, but translation regulation was never taken in account. Therefore, the nature of the mRNAs being translated at various stages of DC activation was determined with the help of translational profiling, which is the sucrose gradient fractionation of polysomal-bound mRNAs combined to microarrays analysis. Total and polysomal-bound mRNA populations were compared in immature (0h) and LPS-stimulated (4h and 16h) human monocyte-derived DCs with the help of Affymetrix microarrays. Biostatistical analysis indicated that 296 mRNA molecules are translationally regulated during DC-activation. The most abundant biological process among the regulated mRNAs was protein biosynthesis, indicating the existence of a negative feedback loop regulating translation. Interestingly, a cluster of 17 ribosomal proteins were part of the regulated mRNAs, indicating that translation may be fine-tuned by particular components of the translational machinery. Our observations highlight the importance of translation regulation during the immune response, and may favour the identification of novel gene clusters or protein networks relevant for immunity. Our study also provides information on the possible absence of correlation between gene expression and real protein production in DCs.					8728	133308	8498	51646	56925	92370	23609	23370	8836	4162	57099	768211	90634	83759	9858	2322	55007	257144	29803	51667	1528	375484	5599	7188	57186	129642	84830	54749	8464	1962	55320	51715	80169	84961	7126	123720	57458	55054	79089	23522	4629	150350	10111	54904	55239	90407	11167	23234	9767	51122	9055	1594	27086	118672	25895	7073	118433	57045	6045	266812	23598	91750	23404	2145	1663	2308	113802	2237	55731	8881	79932	8481	3642	5430	2575	11067	64097	9110	79918	5195	22902	400073	51490	842	9218	740	27079	5468	55250	7594	81669	5577	79947	388650	64968	55120	155060	90355	284325	148479	1316	22794	5912	286530	84946	387521	23059	7291	29916	4071	117177	254158	55071	53349	549	4065	4595	6502	113189	23116	22909	114826	91875	54532	55165	26276	51409	23642	2926	58492	9240	10979	64216	90861	57215	55750	196	57482	7469	55830	54662	203197	8365	4676	10512	1475	10401	6491	23177	80018	3796	25942	54981	4628	839	3292	171024	7570	27075	26034	79706	25913	55814	10613	55311	56623	29761	81796	162239	3161	63027	55144	57470	91687	124790	54853	5879	6424	9882	57089	10902	100132406	54836	11127	4779	1831	121268	688	3268	57585	79873	1856	3017	23526	81533	23235	55227	26024	91893	60626
GSE14000_4H_VS_16H_LPS_DC_UP	M3354		19943945	Ceppi M,Clavarino G,Gatti E,Schmidt EK,de Gassart A,Blankenship D,Ogola G,Banchereau J,Chaussabel D,Pierre P.	GSE14000	GSE14000_1536_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) at 4 h after LPS (TLR4 agonist) stimulation versus those at 16 h after the stimulation.	Dendritic cells (DCs) are the sentinels of the mammalian immune system and they undergo a complex maturation process mediated by activation upon pathogen detection. Recent studies described the analysis of activated DCs by transcriptional profiling, but translation regulation was never taken in account. Therefore, the nature of the mRNAs being translated at various stages of DC activation was determined with the help of translational profiling, which is the sucrose gradient fractionation of polysomal-bound mRNAs combined to microarrays analysis. Total and polysomal-bound mRNA populations were compared in immature (0h) and LPS-stimulated (4h and 16h) human monocyte-derived DCs with the help of Affymetrix microarrays. Biostatistical analysis indicated that 296 mRNA molecules are translationally regulated during DC-activation. The most abundant biological process among the regulated mRNAs was protein biosynthesis, indicating the existence of a negative feedback loop regulating translation. Interestingly, a cluster of 17 ribosomal proteins were part of the regulated mRNAs, indicating that translation may be fine-tuned by particular components of the translational machinery. Our observations highlight the importance of translation regulation during the immune response, and may favour the identification of novel gene clusters or protein networks relevant for immunity. Our study also provides information on the possible absence of correlation between gene expression and real protein production in DCs.					50484	4048	283537	4712	729967	515	79646	10476	23475	80150	64098	9922	27335	5916	8905	945	10801	3064	8195	6189	10591	43847	26130	2952	84836	51596	83938	687	56886	2208	64421	4154	51075	151306	4708	5444	2922	55161	2823	338382	92017	8935	6147	6256	6342	11184	522	191	5165	1184	23396	79720	60559	7388	23196	8638	9779	6275	55937	8569	3556	84959	22848	2617	8694	23306	1213	6733	100287628	23191	5613	472	3371	4707	10247	516	9555	10097	5868	3998	130074	2162	10159	79890	6205	162	10077	1445	170622	2321	283508	440957	57168	292	259197	8829	55201	6146	4723	54752	9605	11010	414327	132228	9899	29948	55819	1955	84270	64326	23001	27	51132	6207	1364	5781	55041	23765	79686	2589	23546	645	4482	6206	8484	9456	867	59347	130589	135112	8673	376497	5321	5445	57609	79017	3987	6310	284263	51660	7356	51466	85463	4697	23586	81614	23220	5794	87	10313	201799	100170841	647946	1388	1776	5031	5980	51313	7850	1611	3872	401577	6156	51084	11199	7172	481	5310	133418	271	84253	54625	64101	10336	23344	148170	143	140809	2034	10972	9524	1241	56829	9813	1188	4258	91860	79572	7832	4354	387103	79088	4261	861	79091	7124	6515	25939	5184	6391
GSE14000_4H_VS_16H_LPS_DC_DN	M3355		19943945	Ceppi M,Clavarino G,Gatti E,Schmidt EK,de Gassart A,Blankenship D,Ogola G,Banchereau J,Chaussabel D,Pierre P.	GSE14000	GSE14000_1536_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) at 4 h after LPS (TLR4 agonist) stimulation versus those at 16 h after the stimulation.	Dendritic cells (DCs) are the sentinels of the mammalian immune system and they undergo a complex maturation process mediated by activation upon pathogen detection. Recent studies described the analysis of activated DCs by transcriptional profiling, but translation regulation was never taken in account. Therefore, the nature of the mRNAs being translated at various stages of DC activation was determined with the help of translational profiling, which is the sucrose gradient fractionation of polysomal-bound mRNAs combined to microarrays analysis. Total and polysomal-bound mRNA populations were compared in immature (0h) and LPS-stimulated (4h and 16h) human monocyte-derived DCs with the help of Affymetrix microarrays. Biostatistical analysis indicated that 296 mRNA molecules are translationally regulated during DC-activation. The most abundant biological process among the regulated mRNAs was protein biosynthesis, indicating the existence of a negative feedback loop regulating translation. Interestingly, a cluster of 17 ribosomal proteins were part of the regulated mRNAs, indicating that translation may be fine-tuned by particular components of the translational machinery. Our observations highlight the importance of translation regulation during the immune response, and may favour the identification of novel gene clusters or protein networks relevant for immunity. Our study also provides information on the possible absence of correlation between gene expression and real protein production in DCs.					80345	84318	92745	79018	64112	2237	84769	57650	79023	57215	8337	2553	10184	113802	3014	60496	64428	10951	5442	29107	152559	7957	3898	81572	10401	6118	23595	92370	9175	710	51715	162427	57186	84901	645634	29803	84196	83852	5433	56954	10921	553115	11118	7469	11067	55421	7024	8460	55716	283643	57232	55758	203228	10979	113115	55794	54926	55233	100505702	5371	57470	10581	79657	3948	51530	400073	57458	284004	55830	23047	11198	148479	284391	7582	9475	90634	375484	51478	8293	22992	25913	54749	9682	8357	84548	92597	1594	54793	23035	55731	51122	23588	9443	388650	22902	150350	10659	11285	1438	7188	11186	84830	339230	7701	11119	65080	10734	147007	90355	8717	3959	10073	3268	26190	2926	88745	8106	51667	64744	26589	1130	116841	9110	6619	57763	403313	8269	6341	129642	7570	9546	55633	116236	54707	84941	54503	306	728769	113763	80169	27238	10910	284273	55108	26005	8554	91966	1025	28957	541578	100506714	79712	23054	55695	55135	51067	9326	84311	11167	79621	8347	55186	55739	8449	23234	5257	9184	80185	4783	26024	23029	2322	1478	10866	286128	6760	79183	10239	9767	55316	90861	116225	9284	5279	28982	51759	55227	22863	55751	8836	90407	23609	91750	8344	65108	51504	688	92170	5316	23522
GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_UP	M3400		16163375	Rock RB,Hu S,Deshpande A,Munir S,May BJ,Baker CA,Peterson PK,Kapur V.	GSE1432	GSE1432_1753_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of control microglia cells versus those 1 h after stimulation with IFNG [GeneID=3458].	Microglial cells are resident macrophages in the central nervous system (CNS) and play a pivotal role in the innate and adaptive immune responses against microbial infections. The immune functions of microglia are regulated by a milieu of cytokines including interferon (IFN)-gamma. We here performed a series of experiments to acertain the transcriptional profile of human fetal microglial cells at 1, 6, and 24 h after IFN-gamma treatment. Primary human microglial cells were either untreated or treated with 200u/ml IFN-gamma. Affymetrix U133A chips were utilized. Four different tissue samples (B18, O, W, and Y20) were analyzed at the three time points.					8535	10295	5585	55172	10672	7874	94	7716	64718	60560	54882	54472	254102	2166	79930	2817	65263	11132	113878	58526	2889	58500	23625	8379	79839	7392	4209	6620	22834	5871	11079	1408	3397	80155	5986	6327	51715	7064	6199	7264	27351	2783	6305	55020	51162	1312	3237	131601	120526	5456	9454	146542	9189	55055	5211	133619	28981	7597	4059	7287	728683	27183	22807	138151	5536	53635	1059	92558	8787	7852	317662	822	4477	64376	1576	91304	26133	4820	2251	27113	5339	79999	127703	57165	25822	100292959	6015	56158	79571	29893	6699	64763	1007	1912	5594	730051	4597	2016	51725	4791	6591	9247	100288640	22992	8085	91289	54998	5971	5127	5317	10960	8751	3090	79908	7171	23476	6446	80014	55602	5424	7917	25792	1755	3998	8343	23049	100133109	8704	2041	8202	57473	80895	790	1006	23400	10926	23654	84296	3704	51313	54784	23192	10381	6389	54879	9340	25945	6525	752	6734	51293	7465	54795	9592	51282	10109	1022	434	9600	4245	285282	5976	191	114791	7707	440352	10307	9355	26281	10215	53615	10817	7625	1044	126353	10023	387893	6870	8237	3855	3806	26470	23024	51146	1263	6710	9400	387032	23250	100294391	58986	7539	26012	79581	5507	10233	56904	6650	441204	80350
GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN	M3401		16163375	Rock RB,Hu S,Deshpande A,Munir S,May BJ,Baker CA,Peterson PK,Kapur V.	GSE1432	GSE1432_1753_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of control microglia cells versus those 1 h after stimulation with IFNG [GeneID=3458].	Microglial cells are resident macrophages in the central nervous system (CNS) and play a pivotal role in the innate and adaptive immune responses against microbial infections. The immune functions of microglia are regulated by a milieu of cytokines including interferon (IFN)-gamma. We here performed a series of experiments to acertain the transcriptional profile of human fetal microglial cells at 1, 6, and 24 h after IFN-gamma treatment. Primary human microglial cells were either untreated or treated with 200u/ml IFN-gamma. Affymetrix U133A chips were utilized. Four different tissue samples (B18, O, W, and Y20) were analyzed at the three time points.					3759	3627	6004	3659	1154	10912	3003	56929	10221	5341	4616	57018	60485	5292	7855	9021	2959	115703	5537	399	4283	874	200734	80830	4238	23643	3142	79893	604	3960	10308	10767	5058	2956	51056	6355	51734	64430	7080	127544	79977	3437	10179	55603	1848	89	9978	10276	2633	22797	51399	8651	55410	55610	91355	54386	23314	63973	6323	54812	1743	54619	57162	51129	5366	2146	1991	672	404672	55083	9651	8887	27430	8698	2790	1026	51339	225	55337	54093	23317	2210	6555	79156	8509	23012	2520	7538	83480	2079	4695	9547	9715	27289	4543	9416	80351	55340	28957	11251	9517	6347	3937	30813	100131298	55204	571	9101	60495	6282	7358	6284	3433	5428	56259	100093698	51506	10777	79879	3964	9153	26211	8702	26716	6733	7769	4105	2566	80852	85476	92482	80215	1716	51510	8301	5690	10978	1387	7367	60682	2071	1609	81621	988	785	80705	7150	139081	642559	83452	51421	3861	2312	55118	9132	6278	64431	24138	51233	5510	6476	22832	5673	7547	50937	6373	1160	26234	80007	55722	79089	147	80025	259217	10599	640	9694	10382	57147	5509	5837	6098	5464	5105	81542	8387	2254	26575	8036	26093	93144	5756	60684	56943	1017	5783	91	6500	22928	27255
GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP	M3404		16163375	Rock RB,Hu S,Deshpande A,Munir S,May BJ,Baker CA,Peterson PK,Kapur V.	GSE1432	GSE1432_1754_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of control microglia cells versus those 6 h after stimulation with IFNG [GeneID=3458].	Microglial cells are resident macrophages in the central nervous system (CNS) and play a pivotal role in the innate and adaptive immune responses against microbial infections. The immune functions of microglia are regulated by a milieu of cytokines including interferon (IFN)-gamma. We here performed a series of experiments to acertain the transcriptional profile of human fetal microglial cells at 1, 6, and 24 h after IFN-gamma treatment. Primary human microglial cells were either untreated or treated with 200u/ml IFN-gamma. Affymetrix U133A chips were utilized. Four different tissue samples (B18, O, W, and Y20) were analyzed at the three time points.					23092	54810	55718	51665	4815	8459	54471	8493	22929	79754	59341	51076	2870	51809	79622	84747	3795	65010	125058	54662	1004	57380	64395	2976	22982	10300	6400	9982	55252	56890	5116	1020	25780	29923	5955	26191	5984	11184	2658	6117	3459	50834	29902	81603	64109	23015	25959	2145	55182	5437	23001	23588	9788	10069	26018	10594	51626	10899	8208	26005	64795	55164	3987	3145	64854	79154	6285	23531	1353	55251	10572	79443	25776	57460	3155	6794	10713	25903	26505	3915	7267	4888	6885	9665	51155	9454	51517	4128	23151	57496	90864	55006	10217	51631	9054	403	8270	1606	56143	6812	9595	23428	10038	744	284439	5921	4176	64393	155400	5528	6596	9647	29901	2564	27101	64943	84809	27247	57060	4702	23345	54540	79064	11276	54807	10277	622	10263	901	10578	22844	9645	9801	23221	6619	6526	23129	1894	7112	9913	64764	10745	30849	23300	554	81853	23648	10444	79612	23031	92335	3778	22884	22865	1108	4436	51499	9891	10664	55144	23178	57509	8711	7260	535	10057	51198	4968	55147	79447	64760	11082	112611	6944	4174	9508	5985	146	11155	1605	54520	55608	155066	4175	81579	55486	4695	79960	7625	23014	25865	7126	84900	93	56997	8841	22987	83759	8034	6777
GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN	M3405		16163375	Rock RB,Hu S,Deshpande A,Munir S,May BJ,Baker CA,Peterson PK,Kapur V.	GSE1432	GSE1432_1754_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of control microglia cells versus those 6 h after stimulation with IFNG [GeneID=3458].	Microglial cells are resident macrophages in the central nervous system (CNS) and play a pivotal role in the innate and adaptive immune responses against microbial infections. The immune functions of microglia are regulated by a milieu of cytokines including interferon (IFN)-gamma. We here performed a series of experiments to acertain the transcriptional profile of human fetal microglial cells at 1, 6, and 24 h after IFN-gamma treatment. Primary human microglial cells were either untreated or treated with 200u/ml IFN-gamma. Affymetrix U133A chips were utilized. Four different tissue samples (B18, O, W, and Y20) were analyzed at the three time points.					9111	5685	9590	716	5721	51513	6398	4261	3985	6772	5683	2665	1066	9605	6774	23780	3601	3627	3620	8412	64422	710	8542	961	9674	9235	5698	5920	6373	79056	2633	57493	3659	6890	10797	64135	4683	3937	10906	8578	55821	4283	79651	80380	1890	5684	55013	51279	2634	3301	2710	80830	55340	10964	51056	5696	5464	56833	661	64127	127544	91543	10791	22836	64761	3665	23424	9516	23347	9997	55860	3717	6993	81894	1439	5954	3735	6717	79134	56935	7453	7726	29761	2210	833	51371	23180	1824	3837	22809	56951	5341	3600	2622	9934	55647	10561	1996	11262	23190	377	6355	116984	1540	5899	5359	26509	56681	6778	8519	2526	5156	54442	9636	56259	840	51015	2643	3134	57823	3796	2790	3981	7332	8743	64853	3669	10973	60489	51575	1040	7444	2323	103	55601	5937	7072	5957	5898	9961	7319	5873	253782	5428	963	55863	6741	11177	1906	3133	2713	9908	9188	55008	64431	79894	55905	1497	54103	23029	8651	2000	10616	51131	24138	3726	80833	629	53942	2040	8649	192669	4067	6729	2523	11237	837	51542	26228	7150	22904	25945	93349	3122	3383	23389	3431	80025	55748	10241	65983	8676	10236	56938	23586	4599	30009	5292	57187	9129
GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP	M3407		16163375	Rock RB,Hu S,Deshpande A,Munir S,May BJ,Baker CA,Peterson PK,Kapur V.	GSE1432	GSE1432_1755_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of control microglia cells versus those 24 h after stimulation with IFNG [GeneID=3458].	Microglial cells are resident macrophages in the central nervous system (CNS) and play a pivotal role in the innate and adaptive immune responses against microbial infections. The immune functions of microglia are regulated by a milieu of cytokines including interferon (IFN)-gamma. We here performed a series of experiments to acertain the transcriptional profile of human fetal microglial cells at 1, 6, and 24 h after IFN-gamma treatment. Primary human microglial cells were either untreated or treated with 200u/ml IFN-gamma. Affymetrix U133A chips were utilized. Four different tissue samples (B18, O, W, and Y20) were analyzed at the three time points.					23428	23022	6038	3459	2589	9891	64795	57178	10007	928	9429	51596	7074	1601	206358	23596	23531	23151	4313	819	23201	22906	56034	1454	1107	6138	3554	7852	929	10497	6117	585	27352	93974	1647	23450	10277	10738	10983	5660	4176	8911	9332	10771	2308	7267	384	10247	26088	1368	2034	58529	55602	79902	57817	7298	403	79850	10477	4171	81490	4973	64764	25780	23129	79888	2203	4048	9886	84939	2309	25996	1606	79022	1382	9368	23418	55721	7554	10217	9060	9956	54344	138050	25961	80210	7164	65125	93210	7100	2353	80150	9699	4919	5921	10461	26190	9905	55818	8569	6556	665	55238	26523	23075	11326	162	1291	10424	5162	8738	4775	10951	25901	283	223	23294	55739	60370	55615	9497	8736	54796	57447	8761	8613	2048	10057	3251	8742	3707	9783	23234	54438	27445	374655	10267	5654	1837	64781	1108	54621	463	64598	3795	5376	6256	2135	6196	10313	3693	7389	2530	22905	11309	678	55589	27244	55285	4053	9121	25903	256987	23213	22982	2632	56925	5603	60682	6611	27242	940	10457	56995	10221	91860	9013	6886	4610	56548	126231	5538	10902	23705	54997	6453	3646	23178	9637	5980	9936	3357	23475	4942	9284	3235	9821	7059	10548	9937
GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN	M3408		16163375	Rock RB,Hu S,Deshpande A,Munir S,May BJ,Baker CA,Peterson PK,Kapur V.	GSE1432	GSE1432_1755_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of control microglia cells versus those 24 h after stimulation with IFNG [GeneID=3458].	Microglial cells are resident macrophages in the central nervous system (CNS) and play a pivotal role in the innate and adaptive immune responses against microbial infections. The immune functions of microglia are regulated by a milieu of cytokines including interferon (IFN)-gamma. We here performed a series of experiments to acertain the transcriptional profile of human fetal microglial cells at 1, 6, and 24 h after IFN-gamma treatment. Primary human microglial cells were either untreated or treated with 200u/ml IFN-gamma. Affymetrix U133A chips were utilized. Four different tissue samples (B18, O, W, and Y20) were analyzed at the three time points.					10346	8542	5699	9111	10866	80833	3959	80830	26228	377	4067	3431	91543	3627	5698	5696	2710	10384	6398	9934	3665	375035	8519	24145	8743	4600	3669	204	3902	26509	2633	8869	2643	7453	710	3717	3133	4615	5341	6890	952	355	10906	7052	11177	3620	8651	5690	10791	3134	57823	22836	5683	838	2634	65264	6539	3115	64422	7444	958	6251	5920	23780	51056	6373	55601	1540	716	10241	3659	64127	9997	629	4283	9246	9050	690	6402	5721	5292	2713	127544	5685	55233	55080	24138	287	961	51015	64108	23424	51202	10875	22904	3985	55177	3010	5142	7334	60489	3430	202	79651	9168	5720	9314	6772	10410	2745	81493	64167	9683	3119	10616	2210	2040	4522	79073	7127	3601	3429	6891	9235	9636	5954	54020	6993	4940	7319	3383	8578	5371	3600	83660	10385	4001	3437	9605	55905	1066	7150	976	8082	51191	29887	5899	103	4501	474344	1479	57706	56935	55303	56146	51131	5414	5058	79840	64135	6654	11262	4599	64761	645745	9447	5634	9961	10865	2146	9353	9313	81542	9693	9892	4061	8454	1810	9423	4496	4261	10561	5533	56902	4170	9663	8530	51279	262	10728	7342	3123	388650	5321	10623	10613	23198	430	27351	56951
GSE1432_1H_VS_6H_IFNG_MICROGLIA_UP	M3409		16163375	Rock RB,Hu S,Deshpande A,Munir S,May BJ,Baker CA,Peterson PK,Kapur V.	GSE1432	GSE1432_1756_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of microglia cells 1 h after stimulation with IFNG [GeneID=3458] versus microglia cells 6 h after the stimulation.	Microglial cells are resident macrophages in the central nervous system (CNS) and play a pivotal role in the innate and adaptive immune responses against microbial infections. The immune functions of microglia are regulated by a milieu of cytokines including interferon (IFN)-gamma. We here performed a series of experiments to acertain the transcriptional profile of human fetal microglial cells at 1, 6, and 24 h after IFN-gamma treatment. Primary human microglial cells were either untreated or treated with 200u/ml IFN-gamma. Affymetrix U133A chips were utilized. Four different tissue samples (B18, O, W, and Y20) were analyzed at the three time points.					159	10648	64854	5100	5362	11184	3142	4815	246126	22906	9625	2267	51155	5877	57698	3960	90864	60370	23177	23550	79622	6503	10912	4354	78988	9647	9368	6431	6256	9021	5673	1327	80243	4928	8514	54438	64393	4128	2308	10234	1180	10313	22994	23129	5201	1154	57406	7750	8635	23151	130074	23310	6461	27235	155066	5140	10343	27440	7086	10160	80765	4351	492	10217	57380	8897	54434	10307	8459	64781	4191	23201	80233	1593	2530	9497	51029	29086	8835	54810	55366	140465	26271	23314	84263	23588	221692	79888	51099	4968	23186	9825	6491	26960	9982	25822	5095	9409	118491	64109	6790	4946	51540	753	10276	55664	54345	84809	271	55062	9133	1182	10458	4175	6622	57132	79918	79071	4736	146227	7164	4647	7112	26039	23092	22982	63910	1842	8091	5968	8659	10277	4335	8683	30851	55186	112611	23268	1347	57446	55135	27244	10069	55175	56948	81853	23329	5997	10803	6633	4232	79850	7421	9397	8559	3449	51690	6304	3993	4888	10128	5162	51696	3162	26355	471	55344	5608	3707	4259	7090	11328	8506	56114	10767	5204	114884	10221	54662	55706	2252	23580	57460	55486	5236	5980	25780	9262	9463	9287	622	10300	10799	145389	9450	388	26036	64131	5467	9595
GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN	M3411		16163375	Rock RB,Hu S,Deshpande A,Munir S,May BJ,Baker CA,Peterson PK,Kapur V.	GSE1432	GSE1432_1756_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of microglia cells 1 h after stimulation with IFNG [GeneID=3458] versus microglia cells 6 h after the stimulation.	Microglial cells are resident macrophages in the central nervous system (CNS) and play a pivotal role in the innate and adaptive immune responses against microbial infections. The immune functions of microglia are regulated by a milieu of cytokines including interferon (IFN)-gamma. We here performed a series of experiments to acertain the transcriptional profile of human fetal microglial cells at 1, 6, and 24 h after IFN-gamma treatment. Primary human microglial cells were either untreated or treated with 200u/ml IFN-gamma. Affymetrix U133A chips were utilized. Four different tissue samples (B18, O, W, and Y20) were analyzed at the three time points.					715	23435	6890	10973	9111	6774	4149	51056	56833	6717	716	5685	710	6741	6373	79651	6398	5873	6645	8202	3620	91543	55013	56935	2633	377	5683	9958	23780	9520	55813	8987	3665	1576	2961	6772	80830	5684	10797	55791	7150	330	1890	7072	8542	7332	22836	51279	10791	4261	11237	55726	29761	5899	79056	2622	7874	3735	4683	64135	7474	4283	5971	7453	5721	8915	23636	2710	64431	1540	64127	1439	55601	3301	3133	2634	5920	6729	4794	80833	11152	9605	10723	55660	5954	64853	64422	3981	837	5698	10561	55312	2339	3601	10964	202	55303	6993	9817	372	2906	192669	27113	55602	2526	51131	9997	3717	8412	56905	8649	51015	5886	84079	80205	8454	2000	11177	11066	7127	3431	8615	23392	3600	1810	2553	958	9590	51188	9100	55860	80014	3985	64167	55969	961	51177	23424	64761	833	55905	10616	23212	26118	115353	11329	9453	79685	54795	23029	4599	55014	1824	1040	5158	22990	55015	55233	54708	8743	5696	10241	9693	9961	84561	29066	163486	55681	51542	51365	57154	9235	57823	25836	253782	840	5690	55008	2210	963	116984	211	26059	51513	79415	9129	262	4076	23179	5937	629	79134	80380	56943	103	64318	9833	5359	1845	5634
GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP	M3413		16163375	Rock RB,Hu S,Deshpande A,Munir S,May BJ,Baker CA,Peterson PK,Kapur V.	GSE1432	GSE1432_1757_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of microglia cells 1 h after stimulation with IFNG [GeneID=3458] versus microglia cells 24 h after the stimulation.	Microglial cells are resident macrophages in the central nervous system (CNS) and play a pivotal role in the innate and adaptive immune responses against microbial infections. The immune functions of microglia are regulated by a milieu of cytokines including interferon (IFN)-gamma. We here performed a series of experiments to acertain the transcriptional profile of human fetal microglial cells at 1, 6, and 24 h after IFN-gamma treatment. Primary human microglial cells were either untreated or treated with 200u/ml IFN-gamma. Affymetrix U133A chips were utilized. Four different tissue samples (B18, O, W, and Y20) were analyzed at the three time points.					4616	6497	2308	23596	23268	928	4928	10221	3707	26353	3459	57178	7043	10497	1880	10217	22906	4291	6383	3449	55664	57132	10267	26207	10123	4000	239	7852	2597	2947	10501	8879	10912	9368	23531	23349	7850	54438	2055	199731	79091	5877	2355	6038	9287	60370	81618	4313	3575	309	2905	4973	9956	6622	9409	5140	79850	55970	842	54434	7316	100132406	6503	9620	64781	83464	51696	9021	7431	4482	9120	7298	23413	5201	10769	6400	9060	3091	23710	3554	5932	8013	256987	9989	23177	1327	23428	23418	4128	7056	7554	4854	117247	54852	51099	1154	28992	9846	25996	3628	126298	4353	9448	25822	1601	665	302	64131	1839	27242	6004	23166	10993	9442	9128	5141	5980	7039	6319	304	7422	10457	138050	8471	929	5376	2350	10560	9625	9957	5144	9497	750	9905	23129	9891	7750	9522	1399	8738	4942	5746	5603	10046	6886	1438	55274	55062	23169	9986	9404	1346	55022	308	10625	57498	23186	29956	9332	6491	3720	25976	6304	4327	3632	4783	6193	9811	728	5236	2288	1562	8559	7936	10902	79845	283	5654	57538	5204	56034	9699	23550	6194	10307	10313	6461	55031	56895	2034	6198	26027	7421	11142	3956	1291	8493	4053	2316	147179
GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN	M3414		16163375	Rock RB,Hu S,Deshpande A,Munir S,May BJ,Baker CA,Peterson PK,Kapur V.	GSE1432	GSE1432_1757_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of microglia cells 1 h after stimulation with IFNG [GeneID=3458] versus microglia cells 24 h after the stimulation.	Microglial cells are resident macrophages in the central nervous system (CNS) and play a pivotal role in the innate and adaptive immune responses against microbial infections. The immune functions of microglia are regulated by a milieu of cytokines including interferon (IFN)-gamma. We here performed a series of experiments to acertain the transcriptional profile of human fetal microglial cells at 1, 6, and 24 h after IFN-gamma treatment. Primary human microglial cells were either untreated or treated with 200u/ml IFN-gamma. Affymetrix U133A chips were utilized. Four different tissue samples (B18, O, W, and Y20) were analyzed at the three time points.					80833	64167	10385	51131	5699	51188	9111	8743	4149	23304	9997	8542	3902	6890	710	51056	716	11262	10791	8519	55172	79651	6398	55813	10241	10561	8869	79073	23780	6402	388650	5685	163486	56935	55726	51279	377	64431	55319	54795	629	1890	2633	55303	5920	3115	3133	5058	5721	10384	6251	2961	4067	715	2729	6645	5701	5698	287	10964	79657	79415	8764	3620	55177	952	55080	690	8082	5683	55905	2923	56833	5634	22836	978	5696	26059	6772	9958	5690	85363	11177	51015	80830	976	27183	6373	2040	7453	972	7349	64127	54908	838	3431	51752	2634	3959	3717	4283	9465	9126	51202	8454	3487	80205	60489	51141	9961	65220	3119	10616	4261	135138	8634	5414	1810	10346	57215	9100	474344	55601	10111	961	55015	3134	5899	51411	4296	3665	2622	55312	26509	5720	23029	51177	23505	355	5321	2926	10866	1540	64422	3122	64135	1317	837	57037	54780	64318	10973	259	23338	3601	2210	8943	5954	7127	677	9453	5930	11119	56951	5031	1786	4522	2982	3587	27430	202	9168	5900	9235	7462	1070	22909	79132	2339	3669	3123	93349	10426	57154	7186	6891	387751	23080	51184	10728	8772	64853	114885	4076	7405	60558	51379	7874	9926	55326
GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP	M3415		16163375	Rock RB,Hu S,Deshpande A,Munir S,May BJ,Baker CA,Peterson PK,Kapur V.	GSE1432	GSE1432_1758_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of microglia cells 6 h after stimulation with IFNG [GeneID=3458] versus microglia cells 24 h after the stimulation.	Microglial cells are resident macrophages in the central nervous system (CNS) and play a pivotal role in the innate and adaptive immune responses against microbial infections. The immune functions of microglia are regulated by a milieu of cytokines including interferon (IFN)-gamma. We here performed a series of experiments to acertain the transcriptional profile of human fetal microglial cells at 1, 6, and 24 h after IFN-gamma treatment. Primary human microglial cells were either untreated or treated with 200u/ml IFN-gamma. Affymetrix U133A chips were utilized. Four different tissue samples (B18, O, W, and Y20) were analyzed at the three time points.					8545	54708	4313	7716	54952	928	10000	6880	103	10501	23424	2947	79872	10477	192669	3858	9851	389136	2014	55602	10019	7850	9673	5025	1824	57515	384	6594	6383	5359	5819	2710	55860	81490	11243	9989	5526	10423	2665	51762	304	6780	9060	9620	302	10211	100132406	3554	23239	5138	29956	7298	5048	1291	26083	2597	55970	57493	27429	7534	55293	11094	91543	3265	56034	5886	10979	1192	5420	2033	6452	11237	6774	27039	79817	2316	2861	5932	25945	8444	23139	56548	6421	6856	51491	9215	6897	6281	11137	3563	10299	23075	4327	9674	23207	6622	9991	8706	171546	55973	5478	1545	22881	7091	152	5898	26037	1857	29115	391	10267	4360	23534	528	79650	4973	57187	2350	2132	10993	6611	929	23635	5869	4000	23670	56681	83737	9412	23705	3364	1346	7039	6741	8777	3490	3690	84272	9332	996	8828	9833	10497	80210	4599	1543	8826	6319	2213	23432	54478	57498	9258	6280	55279	2617	11001	7150	29907	55914	2935	10540	3575	24145	23760	7706	131601	9956	23596	6274	221692	6711	23166	10457	262	23213	27113	10209	26207	79134	79647	6714	9320	4291	23435	3098	2011	2212	55911	1495	79791	2098	9669	6678	9064	2553	3566	10121	3956	22826
GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN	M3416		16163375	Rock RB,Hu S,Deshpande A,Munir S,May BJ,Baker CA,Peterson PK,Kapur V.	GSE1432	GSE1432_1758_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of microglia cells 6 h after stimulation with IFNG [GeneID=3458] versus microglia cells 24 h after the stimulation.	Microglial cells are resident macrophages in the central nervous system (CNS) and play a pivotal role in the innate and adaptive immune responses against microbial infections. The immune functions of microglia are regulated by a milieu of cytokines including interferon (IFN)-gamma. We here performed a series of experiments to acertain the transcriptional profile of human fetal microglial cells at 1, 6, and 24 h after IFN-gamma treatment. Primary human microglial cells were either untreated or treated with 200u/ml IFN-gamma. Affymetrix U133A chips were utilized. Four different tissue samples (B18, O, W, and Y20) were analyzed at the three time points.					282808	5424	3010	7390	25804	3778	5073	8209	9758	7915	11262	6596	9465	51377	4726	23310	55253	5984	79695	471	1775	9646	64167	6251	5699	55080	64921	1207	84861	3145	8607	64170	8864	6604	8542	593	51071	1329	55133	26515	54981	80017	3134	6400	25900	79096	10095	64764	10384	10866	2800	9057	4799	2799	51439	1774	56005	1652	4522	23076	1355	83989	81533	8508	1182	51540	79675	3115	1298	29796	9892	1786	22909	84187	10422	10277	5978	29081	4191	5281	27068	146562	3959	4711	2287	11311	64110	55856	641339	377	28957	26121	55288	1892	5920	5362	51626	93974	1004	10791	55252	5214	79754	26191	4968	64393	11007	266977	4065	55706	28673	57215	26608	8604	50650	9761	1020	6595	8433	51182	715	54345	5108	404672	54832	79630	629	57130	3952	1070	53	23324	5698	38	472	9639	55663	8504	1690	3123	10263	710	3133	2235	6342	23395	51650	26007	7052	60496	738	8925	9702	7371	5501	952	23357	55718	51809	55144	51619	78988	9450	64981	51362	2923	11062	56890	57037	10803	2542	1163	79701	23753	11119	55759	55823	3957	11319	8153	55847	23513	29109	26271	81609	79573	8277	445	3945	10302	59342	23304	7226	51192	81790	9961	11188	6328	28972	27072
GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_UP	M3436		15210650	Lee MS,Hanspers K,Barker CS,Korn AP,McCune JM.	GSE1460	GSE1460_2133_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of intrathymic T progenitor cells (ITTP) versus CD4 [GeneID=920] CD8 thymocytes. 	Subpopulations of human fetal thymocyte and circulating naïve T cells were obtained through FACS sorting, including CD3-CD4+CD8- intrathymic T progenitor cells (ITTP), CD3intCD4+CD8+ \double positive\ thymocytes (DP), CD3highCD4+CD8- \single positive\ thymocytes (SP4), CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from cord blood (CB4+), and CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from adult blood (AB4+).					29119	4683	5292	7771	2010	8454	57523	10966	79839	8568	26525	79828	79858	23220	338645	9052	80224	2947	6402	10885	55113	3441	54207	8605	6934	5087	5578	50810	1978	5733	8835	4225	6328	2888	51154	4232	3280	1006	4239	10491	5096	3915	10970	10561	56915	55819	80183	55703	51316	64131	51101	22800	64232	328	6905	972	2109	54502	9210	26284	79884	2040	7019	10060	366	51309	55651	6335	116987	5111	83990	3075	10367	10549	51778	3543	65003	51296	25864	50804	10613	25999	23543	1723	23547	7286	81553	85002	64764	25956	660	23423	2876	834	25896	23395	2107	8613	4361	2791	7431	54901	9834	29994	29889	3108	4842	7037	55784	2982	8607	22921	51284	10606	23174	9781	55344	23509	5311	10419	10794	6788	29949	5188	10161	8427	25813	27141	6964	765	79991	23596	2006	51214	2983	23171	155	2621	100133941	29969	7846	64092	8861	55332	84864	6202	5213	51377	11260	10964	1937	486	30968	9510	445347	2509	4515	7292	7691	7371	22802	1604	1998	7851	6059	54986	5470	5445	1825	27044	23108	6450	8891	8323	795	56940	7079	162972	57194	55179	3512	307	9200	3614	11142	55364	51352	5140	471	55255	23650	51364	65243	57000	23024	2882	7076	4851	214	7306
GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_DN	M3438		15210650	Lee MS,Hanspers K,Barker CS,Korn AP,McCune JM.	GSE1460	GSE1460_2133_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of intrathymic T progenitor cells (ITTP) versus CD4 [GeneID=920] CD8 thymocytes. 	Subpopulations of human fetal thymocyte and circulating naïve T cells were obtained through FACS sorting, including CD3-CD4+CD8- intrathymic T progenitor cells (ITTP), CD3intCD4+CD8+ \double positive\ thymocytes (DP), CD3highCD4+CD8- \single positive\ thymocytes (SP4), CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from cord blood (CB4+), and CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from adult blood (AB4+).					7376	51032	5526	3700	55080	1960	57102	64321	10777	10983	3749	83464	3707	28639	3937	6480	55604	51744	22900	1958	64778	5447	55251	5927	2487	9926	2195	1606	57728	1058	7074	64328	79174	140885	7424	10848	8869	4627	26628	23315	151	81552	23007	10253	7128	4985	2123	2842	10129	6446	604	2004	54939	10803	23345	57235	6560	27240	4286	28755	6375	79414	10106	9489	9673	54101	23221	8347	51360	55508	55188	4303	10014	80342	6009	7272	9235	27190	9633	23268	1293	863	50615	9651	348110	3669	8850	925	6504	23245	4828	387509	9920	51307	8545	51735	952	1130	10045	28984	7091	4846	8631	9695	9214	6955	8676	8874	147912	51198	79929	406	7048	9592	57396	54850	912	23030	79961	79695	23286	8365	7408	10734	2921	9842	85375	54883	23071	10516	399665	54583	5334	5456	115201	3097	56475	324	4796	65258	8507	23708	375449	23710	55054	5603	4063	3929	6716	79841	11176	81606	8100	8740	1136	10518	3621	9057	57707	6534	322	7262	23523	55269	28517	767	9047	5680	55296	9857	1043	9465	10178	11040	435	7277	79837	50943	55105	89853	1844	825	1490	5144	6093	374868	51561	55770	23205	56253	80036	5893	79575	415	1831	23645	92482	11079	5995	83637
GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_UP	M3439		15210650	Lee MS,Hanspers K,Barker CS,Korn AP,McCune JM.	GSE1460	GSE1460_2134_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of intrathymic T progenitor cells (ITTP) versus CD4 [GeneID=920] thymocytes.	Subpopulations of human fetal thymocyte and circulating naïve T cells were obtained through FACS sorting, including CD3-CD4+CD8- intrathymic T progenitor cells (ITTP), CD3intCD4+CD8+ \double positive\ thymocytes (DP), CD3highCD4+CD8- \single positive\ thymocytes (SP4), CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from cord blood (CB4+), and CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from adult blood (AB4+).					10049	3420	699	3028	55840	7077	10419	51309	3123	1728	23108	80243	80183	8458	7852	54107	7216	6919	10518	2791	83700	2098	6674	81839	51451	1069	29994	8427	5691	4851	4913	10777	80775	486	5188	5096	214	54806	4239	79015	80010	847	5889	403	7084	7292	51409	8892	57050	4085	50810	4580	80321	26040	6850	1460	56521	56945	9771	22800	973	25793	8099	1841	30968	4363	3925	55178	5710	307	1632	765	1653	25996	57597	25956	7295	1511	2644	5438	8522	9410	55247	5578	55501	1434	132	2114	9529	8607	55819	9534	3075	1612	7371	64764	3033	54512	80224	39	51121	81929	157	9805	7386	3954	5872	753	2672	112479	2590	8613	57122	54344	1211	10733	7296	5226	51186	55168	6788	7324	11116	5982	54927	8533	10998	4130	2983	9656	28971	5358	7771	79366	2030	2618	4609	7253	910	5897	2037	501	1047	7283	29760	27242	7102	54948	3068	171558	54793	8727	9118	10616	10962	9775	100133941	6272	10535	2769	158471	51237	5830	10758	29889	55651	23199	79991	79731	51029	6183	2982	84986	51133	6009	23240	5700	54939	5336	9212	5896	7458	7205	11252	863	51637	56912	9203	26628	3512	25874	55179	90141	6338	54504	2235	25809	4602	54207	7029
GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_DN	M3440		15210650	Lee MS,Hanspers K,Barker CS,Korn AP,McCune JM.	GSE1460	GSE1460_2134_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of intrathymic T progenitor cells (ITTP) versus CD4 [GeneID=920] thymocytes.	Subpopulations of human fetal thymocyte and circulating naïve T cells were obtained through FACS sorting, including CD3-CD4+CD8- intrathymic T progenitor cells (ITTP), CD3intCD4+CD8+ \double positive\ thymocytes (DP), CD3highCD4+CD8- \single positive\ thymocytes (SP4), CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from cord blood (CB4+), and CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from adult blood (AB4+).					5782	59338	2634	3275	677	80063	3937	55340	10964	27076	23035	3929	9806	55069	10866	79632	8934	1880	728855	10019	79652	8745	22861	5880	23345	10418	57118	6772	7124	4739	3431	2034	8743	1958	25797	79961	3107	6955	10045	10550	9937	7905	29121	7409	10475	8605	9592	18	54674	9459	114882	9706	8013	79174	23030	3757	6304	26092	9658	9249	3603	56253	3399	325	5243	23015	4974	10561	6711	8857	9663	9046	2887	26266	2308	1514	5788	3566	51385	79442	1901	27250	330	10014	79837	11040	27348	30844	664	5603	80342	7188	4478	3570	963	10178	9770	10235	3707	3572	8642	5272	7128	23452	8507	4050	9214	4939	23271	60468	6480	6322	5142	399665	81606	3357	9254	83988	5525	81552	7414	387751	87	6691	27010	54910	4092	939	6002	5583	6446	51762	5747	23406	3135	5604	6504	63917	104	11043	3560	55544	23484	8519	51669	3082	3187	79956	2123	4345	9531	2517	8869	923	1621	1293	3106	9908	4753	1236	5727	3983	113791	8879	3633	6609	868	1945	3716	3689	9466	55303	440270	79747	3097	9404	29851	7071	4063	9797	8718	865	54463	2643	7133	55423	183	92	57134	55014	8631	9056	8477	29954	23314	634	1831	57136	8735	5154
GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP	M3441		15210650	Lee MS,Hanspers K,Barker CS,Korn AP,McCune JM.	GSE1460	GSE1460_2135_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of intrathymic T progenitor cells (ITTP) versus naive CD4 [GeneID=920] T cells from cord blood.	Subpopulations of human fetal thymocyte and circulating naïve T cells were obtained through FACS sorting, including CD3-CD4+CD8- intrathymic T progenitor cells (ITTP), CD3intCD4+CD8+ \double positive\ thymocytes (DP), CD3highCD4+CD8- \single positive\ thymocytes (SP4), CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from cord blood (CB4+), and CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from adult blood (AB4+).					27348	51768	4085	1738	5226	54107	55775	5993	8454	10949	4998	3075	79719	10049	1781	54914	23322	1973	6240	10915	65003	6917	8914	11168	55070	51053	10367	9410	2617	55347	10277	412	11130	5981	10951	8562	9330	51309	3182	6009	10946	2806	307	7077	54927	55351	55032	2171	3615	203068	10190	10613	79621	7371	1653	7398	3428	7431	25941	991	50814	55732	6335	100	7295	63894	2237	1915	5445	3419	2107	9240	2287	2551	23607	10594	7555	3280	5910	7037	5096	2958	55148	1787	22800	3033	80224	387	3613	55179	2791	79796	26003	3187	6491	51573	9486	26271	4175	5111	9055	890	5889	753	5036	6938	10574	9315	27044	1829	22948	445347	4605	6674	80205	9031	27242	4267	140465	79991	59269	9805	71	10989	51292	27232	55038	26019	10733	56945	4436	128	2006	84900	8522	5660	10213	8683	1062	55771	3295	9989	4354	10981	7296	9837	9276	10592	4162	55140	3148	10477	23594	11335	9319	2114	22981	80183	56474	22850	4239	23012	9131	29994	4236	51186	54806	10280	10803	57149	54793	7216	6328	10208	9446	11004	10606	8073	2805	5771	80745	3925	29889	5687	9559	4087	55833	54069	8607	1457	3416	10236	528	9342	10857	11073	2029	8364	7159	80010
GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN	M3445		15210650	Lee MS,Hanspers K,Barker CS,Korn AP,McCune JM.	GSE1460	GSE1460_2135_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of intrathymic T progenitor cells (ITTP) versus naive CD4 [GeneID=920] T cells from cord blood.	Subpopulations of human fetal thymocyte and circulating naïve T cells were obtained through FACS sorting, including CD3-CD4+CD8- intrathymic T progenitor cells (ITTP), CD3intCD4+CD8+ \double positive\ thymocytes (DP), CD3highCD4+CD8- \single positive\ thymocytes (SP4), CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from cord blood (CB4+), and CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from adult blood (AB4+).					22982	28387	23179	9658	4598	54509	64768	6534	5595	51230	55793	116	10023	5603	53630	5467	63931	103910	10866	1901	1540	54587	7133	1953	60312	56940	3849	7294	7711	3275	58503	3097	843	57493	6543	28517	4488	23382	23345	6786	257	6480	10106	10970	57403	54877	26290	168544	3866	155	9737	3757	1420	3748	54502	2887	79977	9056	9436	54674	55028	9592	2197	9459	399665	79155	2658	29947	8675	824	3001	26651	81550	4482	55316	23250	5345	825	375790	23376	56163	1052	224	59338	11009	3357	23523	6653	5361	10794	80772	5118	3770	56950	814	8174	29763	2705	5540	6217	2049	4832	170680	10519	55661	4063	22880	3590	932	9166	7048	1437	375449	3363	136	57030	63917	81619	27250	479	51316	8915	352961	677	9633	26499	10186	251	9904	80781	5521	57194	36	1749	25802	8519	462	5276	108	27010	4878	28951	1951	80342	90485	374868	79919	10129	10399	3223	5142	51735	7043	22869	26027	23429	51083	9993	8395	25984	4139	664	140885	8991	28831	8743	8751	9094	6993	79575	23286	51276	2814	6872	4250	57115	23178	1393	11080	6338	79161	58473	56882	9235	50804	25776	5526	9326	6277	3993	56033	79962	57126	5349	51619	25890	57134	10892	64137	1436
GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP	M3446		15210650	Lee MS,Hanspers K,Barker CS,Korn AP,McCune JM.	GSE1460	GSE1460_2136_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of intrathymic T progenitor cells (ITTP) versus naive CD4 [GeneID=920] T cells from adult blood.	Subpopulations of human fetal thymocyte and circulating naïve T cells were obtained through FACS sorting, including CD3-CD4+CD8- intrathymic T progenitor cells (ITTP), CD3intCD4+CD8+ \double positive\ thymocytes (DP), CD3highCD4+CD8- \single positive\ thymocytes (SP4), CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from cord blood (CB4+), and CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from adult blood (AB4+).					10734	990	10036	5771	55689	5993	9989	1973	79719	6938	5036	4345	8030	117178	65108	10049	2617	2135	10072	1720	11041	55872	5422	10857	1460	80183	55906	10935	2305	1457	11146	9063	3280	63933	1479	5683	1829	10051	48	146909	4162	6788	1642	3066	378708	57597	80150	22948	11335	9203	9743	6297	8208	1894	55839	10248	55120	23594	991	10518	699	471	85453	5710	51097	79794	5825	4173	55840	55055	6509	6491	6674	8891	79019	55148	54850	11130	7292	27346	10971	54585	8539	54806	50814	9775	55215	11073	641	2237	7158	6059	8565	2644	10327	5830	57122	6790	8727	1111	10962	79621	51029	22903	23450	8310	5889	91137	5660	23596	5188	29980	10803	57161	54478	27338	5827	54927	5955	4763	445347	4288	79714	51809	4851	908	2956	11339	4175	51098	7077	10262	84986	2109	7319	2982	3709	217	1787	6659	7102	26586	9896	192669	5168	1108	3419	132	4085	3070	6240	8125	6597	5897	55651	26271	10383	8847	8106	6622	3182	4734	637	4683	3068	23463	11167	7570	54962	5176	51309	4751	7027	2769	3054	55255	10061	8317	501	3939	8427	11169	1523	11065	8531	5311	1164	1033	7029	890	3613	8458	9486	10643	3276	27316	10069	71	9805	23367
GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN	M3448		15210650	Lee MS,Hanspers K,Barker CS,Korn AP,McCune JM.	GSE1460	GSE1460_2136_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of intrathymic T progenitor cells (ITTP) versus naive CD4 [GeneID=920] T cells from adult blood.	Subpopulations of human fetal thymocyte and circulating naïve T cells were obtained through FACS sorting, including CD3-CD4+CD8- intrathymic T progenitor cells (ITTP), CD3intCD4+CD8+ \double positive\ thymocytes (DP), CD3highCD4+CD8- \single positive\ thymocytes (SP4), CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from cord blood (CB4+), and CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from adult blood (AB4+).					3937	29116	54674	6144	7124	145678	51296	23015	8675	22863	2254	963	11046	7561	6277	5355	9976	10609	6123	22927	55268	26092	677	63917	10519	728855	2887	51233	9592	9706	10550	1604	146562	11119	3995	64114	333	64787	9993	27010	3716	23345	136	3707	1039	8519	9139	8514	3137	10618	1135	3275	51084	57830	79961	9466	2517	440	10370	10947	51290	4804	54509	2124	7767	200424	5142	10499	1540	4674	51274	4063	224	3849	10379	79155	54861	6955	27230	9806	4327	26289	10045	5820	130814	8566	2637	53827	22861	11223	64400	54737	5603	6504	2123	4494	487	64778	251	390998	4015	5567	55423	8722	9710	440193	11123	8555	83445	4478	79837	352961	3135	10397	8399	65981	5252	2323	9663	3757	26499	9639	5525	5824	50650	79652	83464	9770	8934	23641	56882	79890	8850	9595	919	56107	4790	7433	51207	55846	87	1937	5029	51379	100129250	100129482	2814	221061	3476	1953	5467	1880	28962	23315	322	6237	59338	79412	3566	64130	4752	1291	56674	9737	2512	9659	54463	9665	57000	10529	23228	3697	9254	664	23178	4920	10970	8609	8736	79879	80853	51411	23271	387751	55422	23360	9641	80833	28984	8277	7076	81552	26137	1440	154881	8878	9204	26273	8631	57396
GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_UP	M3449		15210650	Lee MS,Hanspers K,Barker CS,Korn AP,McCune JM.	GSE1460	GSE1460_2137_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of intrathymic T progenitor cells (ITTP) versus thymic stromal cells.	Subpopulations of human fetal thymocyte and circulating naïve T cells were obtained through FACS sorting, including CD3-CD4+CD8- intrathymic T progenitor cells (ITTP), CD3intCD4+CD8+ \double positive\ thymocytes (DP), CD3highCD4+CD8- \single positive\ thymocytes (SP4), CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from cord blood (CB4+), and CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from adult blood (AB4+).					1535	80724	825	56941	25906	864	50852	1437	54880	4174	5108	10293	51768	23741	51816	11108	10570	114899	60436	56260	51478	11137	79719	2176	23358	701	53916	55567	27128	8454	343	3187	27229	337	23171	2109	50944	23	57122	4600	51654	4157	63892	1952	27094	5383	79663	5451	23341	5757	112869	4436	54971	10735	1195	9984	2271	56997	29851	55278	2926	54878	4599	10367	55748	9368	4927	60488	79675	9869	3615	8522	3033	8676	55556	8914	79946	8718	83696	51052	55070	80095	3925	752	54345	7067	1973	9111	7874	53335	3109	3148	4998	23151	8270	51364	5511	93594	283537	57111	10199	6202	54752	54870	9834	55347	9489	5188	9529	6908	144699	114	10036	56945	4255	79621	8303	25816	5333	10946	168544	4690	11232	8817	6786	847	7507	63970	2542	80069	4175	10777	11039	10235	4598	55090	6334	5981	7448	5036	1612	57209	2983	79919	55200	10913	8438	3026	55776	245	10307	54891	2146	10089	5111	9743	412	100170939	5790	4761	55905	51514	79048	54923	64421	23020	389906	10863	79665	59269	10574	9881	284001	58497	54995	7150	5525	79364	23077	7818	114791	51174	55080	10998	54948	8621	23398	54850	57215	55112	60484	6297	5133	9413	397	3416	23108	51433	3123	9310
GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_DN	M3450		15210650	Lee MS,Hanspers K,Barker CS,Korn AP,McCune JM.	GSE1460	GSE1460_2137_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of intrathymic T progenitor cells (ITTP) versus thymic stromal cells.	Subpopulations of human fetal thymocyte and circulating naïve T cells were obtained through FACS sorting, including CD3-CD4+CD8- intrathymic T progenitor cells (ITTP), CD3intCD4+CD8+ \double positive\ thymocytes (DP), CD3highCD4+CD8- \single positive\ thymocytes (SP4), CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from cord blood (CB4+), and CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from adult blood (AB4+).					6760	7005	55664	9263	435	1203	6400	10498	8804	79953	23365	64834	65983	3678	28962	9454	54431	4213	224	25758	26750	10159	2218	9314	11199	2953	10254	5604	3953	5311	57016	22982	3995	219654	55273	9231	3199	10417	54910	79837	291	8728	9411	6535	6788	51335	2790	5157	55002	53838	9658	64236	25829	7280	23743	64940	80007	23543	4627	1958	8460	169611	3775	55205	51330	2274	51704	9215	9823	1317	27286	55106	7057	55500	145389	1909	5154	53346	9643	79143	26002	9829	4494	590	8795	90993	22954	4493	7291	3091	118433	26071	51009	7431	306	54810	6529	11037	3920	84909	81034	1266	9540	6422	4052	1292	6238	51030	55785	51226	9653	8544	23641	2296	1000	9859	83468	26011	2615	55859	10190	5476	1978	283	26273	11279	3730	4199	9240	10497	90411	138151	54682	6237	25907	22873	55816	3611	8934	81552	862	7378	84617	25945	2247	7980	9353	5861	83990	79572	6196	55973	136	285203	2673	23179	3488	1910	115	5197	8553	10391	83716	22943	5782	5238	10903	9182	1287	2152	182	23333	8417	79768	4811	22856	22802	7412	25827	1833	7049	8985	7106	6372	6594	813	4646	5742	8682	57205	54928	2239	80013	81537	5069	64083	5638	11117	56654	125058
GSE1460_DP_VS_CD4_THYMOCYTE_UP	M3452		15210650	Lee MS,Hanspers K,Barker CS,Korn AP,McCune JM.	GSE1460	GSE1460_2138_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes versus T cells from cord blood.	Subpopulations of human fetal thymocyte and circulating naïve T cells were obtained through FACS sorting, including CD3-CD4+CD8- intrathymic T progenitor cells (ITTP), CD3intCD4+CD8+ \double positive\ thymocytes (DP), CD3highCD4+CD8- \single positive\ thymocytes (SP4), CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from cord blood (CB4+), and CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from adult blood (AB4+).					10867	80228	56912	7077	8228	114883	1948	3938	7443	51409	27242	2562	79716	2672	1136	217	8443	23268	2235	3954	5094	81552	8774	2983	7295	171558	56945	5250	3700	3012	100287483	55750	79991	182	10726	56943	4726	5715	65980	23129	8357	952	4602	54623	7494	4286	54881	8874	26574	90864	25840	8526	9649	55844	4116	9200	4723	23239	9846	5444	10777	7253	6428	1031	10734	57150	5332	5977	971	60491	10556	55526	11124	2842	5797	7852	10124	5684	29902	3913	50862	25793	79152	79648	55176	97	55179	23199	8924	26628	54101	435	55247	4354	7371	5435	81691	54850	84986	51118	2299	8613	912	4082	10733	5695	360	28971	926	6396	4130	79015	5710	55830	5830	55388	26548	2769	79929	5496	5274	3925	55227	11152	79595	9832	54882	6499	9805	29087	5686	11051	2639	54496	55329	80169	23205	2134	8898	23609	9771	23216	56259	118433	11176	1632	5976	51720	79970	65258	4267	25842	9633	54504	8545	7464	753	9588	5688	3903	116832	6625	5608	79145	1192	6904	80347	54436	80273	5896	913	5889	4218	57728	79661	1612	9656	53826	1460	8573	752014	165	55840	5101	23612	3146	2030	553115	10263	5605	2487	51237	89941	55296	11258	911	10063	1659	910	11167
GSE1460_DP_VS_CD4_THYMOCYTE_DN	M3454		15210650	Lee MS,Hanspers K,Barker CS,Korn AP,McCune JM.	GSE1460	GSE1460_2138_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes versus T cells from cord blood.	Subpopulations of human fetal thymocyte and circulating naïve T cells were obtained through FACS sorting, including CD3-CD4+CD8- intrathymic T progenitor cells (ITTP), CD3intCD4+CD8+ \double positive\ thymocytes (DP), CD3highCD4+CD8- \single positive\ thymocytes (SP4), CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from cord blood (CB4+), and CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from adult blood (AB4+).					9168	26751	427	23406	1909	6387	55589	55616	7187	2004	6672	79679	325	960	4837	7268	150094	23526	3107	3133	5154	2517	10365	9121	3983	3431	23462	51363	9658	963	79652	92822	27128	51762	440387	100132476	10235	9882	87	6579	10866	3798	29	79961	51316	104	1576	9595	6045	2531	1514	8702	81855	6793	6228	1508	9937	58477	5578	3106	399665	55218	8495	834	93349	3572	8857	5142	59351	9370	6328	51466	22891	65243	57447	419	9645	7322	8934	51056	9056	55106	6122	4808	9452	2357	10561	8879	3566	10550	113791	7071	54	9263	3628	6402	6662	63917	23271	4939	5144	4063	6781	59338	9450	80352	3727	3231	5293	3857	1604	7564	2014	7178	654	2634	2887	868	2047	1901	8013	55568	4088	950	79956	597	5066	29851	146712	5996	57134	4869	6331	7699	202	660	51449	728855	2788	1359	387751	10404	91	5351	9948	6322	11119	894	4300	10351	55601	1729	3764	84864	10954	9473	6136	6711	91543	9706	22861	29909	8743	10418	2213	138050	10964	57096	51548	1036	4832	408	6124	54674	351	6772	7414	4092	2034	6480	9922	10938	677	54860	11262	8477	7277	6091	9601	8200	57473	1236	7171	3560	196	9663	22802	8718	9630	3603
GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP	M3459		15210650	Lee MS,Hanspers K,Barker CS,Korn AP,McCune JM.	GSE1460	GSE1460_2139_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes versus naive CD4 [GeneID=920] T cells from cord blood.	Subpopulations of human fetal thymocyte and circulating naïve T cells were obtained through FACS sorting, including CD3-CD4+CD8- intrathymic T progenitor cells (ITTP), CD3intCD4+CD8+ \double positive\ thymocytes (DP), CD3highCD4+CD8- \single positive\ thymocytes (SP4), CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from cord blood (CB4+), and CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from adult blood (AB4+).					10054	8933	5687	23468	29889	22974	79854	5728	79719	3985	3033	10867	1861	81552	7430	10535	114899	5383	2802	4898	54069	471	9016	10623	157	51400	7464	6935	8645	10949	91316	22981	7351	10734	54830	56339	285672	952	1603	79048	28981	1163	9076	9025	9655	55508	54908	23421	9918	4068	2237	51186	94239	5094	4152	9631	11315	4686	55666	3856	2029	509	54881	8408	3562	4267	9500	360	3181	4194	56259	25896	6293	55846	25874	6745	3417	5311	9928	55732	8774	29103	8318	3835	79591	23151	9907	6749	10592	9110	1047	9987	6867	10383	6659	10721	8869	11004	498	8776	55298	55148	7077	27336	23129	4086	51283	55573	7468	55227	9879	2842	9695	51340	7296	27332	5683	57099	9854	5928	2983	3759	11186	2787	51564	283755	11339	54892	8836	9846	54914	9633	4891	6597	57149	1062	10733	53918	23303	84364	81839	26128	10198	128872	890	9256	55526	7216	57597	8655	580	1781	8613	10726	2805	10160	1525	11337	6726	10907	23633	26098	3954	7730	23256	27109	55176	5981	1164	2305	80205	10778	51360	8526	65265	8226	4091	10857	10477	5993	79682	2672	3068	8347	94104	55296	10767	29899	1737	10542	8540	7251	4354	2956	5478	10015	6635	5931	5289	11168
GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN	M3460		15210650	Lee MS,Hanspers K,Barker CS,Korn AP,McCune JM.	GSE1460	GSE1460_2139_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes versus naive CD4 [GeneID=920] T cells from cord blood.	Subpopulations of human fetal thymocyte and circulating naïve T cells were obtained through FACS sorting, including CD3-CD4+CD8- intrathymic T progenitor cells (ITTP), CD3intCD4+CD8+ \double positive\ thymocytes (DP), CD3highCD4+CD8- \single positive\ thymocytes (SP4), CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from cord blood (CB4+), and CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from adult blood (AB4+).					51230	2887	8532	7475	138151	1901	6892	30008	1936	55216	6772	4014	23387	10491	1826	10581	387751	6891	8396	4058	79755	7169	7032	10268	259173	64342	50508	2245	57096	844	1420	55616	1347	55316	442216	8440	6132	55601	56969	25975	1813	5655	23613	23464	84726	256987	3915	26577	23474	8741	9742	6155	684	8821	11120	5197	116138	3777	3355	27445	9229	1749	8626	26280	5142	274	100288758	3748	4825	55647	2197	3849	5252	8714	80352	26112	9577	55251	51759	3250	3590	6197	79861	5523	4223	3117	2564	10396	8664	3108	27239	24	185	9516	26083	57048	2191	57576	79710	6568	55184	23264	28968	2517	1953	9607	51411	2572	57509	8516	66035	10385	4606	23059	427	2768	6903	5540	3512	731	321	23403	28387	347	8632	91977	1943	6322	10399	51752	1540	90199	23382	5309	2683	84162	11318	55793	10866	9814	78991	54509	27012	57084	26284	7101	2012	7076	81501	23504	9187	9252	55968	7225	8675	318	22880	10801	30846	29930	58503	10507	5990	9322	8525	3134	23235	9727	87	7031	525	3162	170680	5509	7098	273	5829	3895	4790	91300	28232	1010	6222	116986	10162	3764	6232	29949	10913	1264	1318	9595	6793	80008	2998	22845	54	3614	1238	947
GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP	M3461		15210650	Lee MS,Hanspers K,Barker CS,Korn AP,McCune JM.	GSE1460	GSE1460_2140_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes versus naive CD4 [GeneID=920] T cells from adult blood.	Subpopulations of human fetal thymocyte and circulating naïve T cells were obtained through FACS sorting, including CD3-CD4+CD8- intrathymic T progenitor cells (ITTP), CD3intCD4+CD8+ \double positive\ thymocytes (DP), CD3highCD4+CD8- \single positive\ thymocytes (SP4), CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from cord blood (CB4+), and CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from adult blood (AB4+).					90141	4001	10239	8874	4628	10643	4345	5993	5790	5478	65108	9016	8613	1960	80010	1829	24137	23649	486	56886	10734	9124	2171	553115	5710	8318	23468	7317	9941	54478	8819	5499	8869	28639	116832	5494	6652	2033	3012	11171	84986	56943	7077	11167	3182	64689	2305	27044	3419	79669	9775	7027	85453	9500	10121	3149	7314	28981	54850	917	9968	6396	7520	6504	2195	23007	6119	51309	55227	4289	10962	9846	4076	7253	10615	952	55215	9832	79583	5796	54069	1875	2632	9743	25804	9767	509	80150	57102	84187	11065	2672	112479	83700	4176	8021	5830	55179	55862	3712	6491	8310	10572	2235	55732	10592	51053	10808	57099	991	4602	3066	79598	2983	5694	672	1958	11332	79096	10160	5715	7756	9637	10691	140465	79876	3837	79075	8772	10263	26628	1948	6297	79682	1622	54816	23239	2224	1136	9276	79801	6503	28985	6576	55211	5432	57405	23463	8237	7158	90355	10950	5687	9688	55188	55080	2932	60526	8226	5359	51465	7035	54927	7430	9653	1047	5515	54442	5901	5686	146909	483	200734	1062	1293	4686	27242	8073	23097	523	167227	56992	22918	340351	8365	5096	79733	8347	140890	8836	10867	23216	54793	6428	23268	8357	753	522	9631	1457
GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN	M3465		15210650	Lee MS,Hanspers K,Barker CS,Korn AP,McCune JM.	GSE1460	GSE1460_2140_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes versus naive CD4 [GeneID=920] T cells from adult blood.	Subpopulations of human fetal thymocyte and circulating naïve T cells were obtained through FACS sorting, including CD3-CD4+CD8- intrathymic T progenitor cells (ITTP), CD3intCD4+CD8+ \double positive\ thymocytes (DP), CD3highCD4+CD8- \single positive\ thymocytes (SP4), CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from cord blood (CB4+), and CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from adult blood (AB4+).					474344	79652	9370	11059	388677	200424	51296	5204	9961	8675	352961	6387	694	10771	100272147	27230	3566	10947	3141	3460	2010	963	2517	9409	79802	2254	23271	6948	950	10581	1540	9882	6809	6194	51207	6161	6137	140801	9659	442216	10170	10365	55819	8566	23338	8542	10938	3689	6767	10162	23195	22861	10384	55974	373156	157562	6232	8934	6207	6235	63917	3655	8555	55841	2887	100132406	57048	10840	51161	2197	6653	8764	9677	3423	57493	427	8440	8409	6942	104	9706	1440	6201	7812	6154	9267	4065	64784	6181	8821	55911	1384	6223	27284	9595	22986	8835	221061	8698	3614	6331	6157	10519	55810	4736	56915	1408	6237	495	55793	79961	894	9277	11282	6173	684	390998	64114	6202	2323	1118	2678	78991	55184	6166	4284	8532	8718	23220	224	10045	10333	1576	274	6136	23403	5293	8878	10276	23526	29937	55256	3135	7187	9909	9516	1604	22927	3363	3983	56172	9993	23780	27141	5142	55422	1953	2251	10318	644068	8804	3572	23017	79672	164656	1901	5934	1936	4306	8702	1291	10785	6535	55616	3133	5330	5292	27328	2952	57326	7076	1962	7318	5239	960	54994	346	5829	596	1454	6193	6222	58477	51149	26751	10550	1826	2091	3312	79573
GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP	M3467		15210650	Lee MS,Hanspers K,Barker CS,Korn AP,McCune JM.	GSE1460	GSE1460_2141_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes versus thymic stromal cells.	Subpopulations of human fetal thymocyte and circulating naïve T cells were obtained through FACS sorting, including CD3-CD4+CD8- intrathymic T progenitor cells (ITTP), CD3intCD4+CD8+ \double positive\ thymocytes (DP), CD3highCD4+CD8- \single positive\ thymocytes (SP4), CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from cord blood (CB4+), and CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from adult blood (AB4+).					78994	9739	10320	55515	81887	54440	2771	652147	54920	55815	7293	80208	10331	55125	26277	5165	54923	49856	8443	54069	91442	6334	1060	100287600	4927	1208	3796	8999	8802	2980	4521	35	10867	84914	54545	23742	1141	51816	80724	23451	5232	3033	4289	4686	55768	3669	8817	1844	25803	64895	81669	81693	7516	79719	23063	55722	3660	55656	100133109	51809	643641	701	80895	6751	3213	3833	29044	4802	1272	10781	148	11336	9744	5101	23398	64423	5630	65265	8674	4606	55262	56945	7840	4528	22990	54880	79944	7709	55119	55203	4255	55813	6470	9478	54471	54784	9489	2819	3570	3065	580	54807	50	655	25850	55056	51	51314	79136	6294	54207	768	23070	2676	5863	2556	2038	10641	29933	28755	55790	10520	79159	51013	3835	9984	23099	57035	4205	55150	9203	3784	4242	51710	58516	5583	4851	89944	7108	6597	694	5432	199870	55245	8209	9465	22834	9673	8326	55011	1775	23217	25816	2492	51131	6429	10526	54897	54881	114899	100288939	9208	50515	79915	9802	7133	10654	79153	29899	80011	9254	387535	6247	6777	8189	56948	10101	5973	8233	2780	165	1063	2534	9129	1469	8839	55128	63970	80143	5631	3428	3983	728661	2248	58497	9092	63935	8631	55729	167227
GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN	M3469		15210650	Lee MS,Hanspers K,Barker CS,Korn AP,McCune JM.	GSE1460	GSE1460_2141_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes versus thymic stromal cells.	Subpopulations of human fetal thymocyte and circulating naïve T cells were obtained through FACS sorting, including CD3-CD4+CD8- intrathymic T progenitor cells (ITTP), CD3intCD4+CD8+ \double positive\ thymocytes (DP), CD3highCD4+CD8- \single positive\ thymocytes (SP4), CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from cord blood (CB4+), and CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from adult blood (AB4+).					23333	55239	9318	10581	79768	6767	54682	80243	5901	467	56521	10542	11117	22845	50804	427	5009	25829	26278	55113	9255	6645	81888	3614	3920	4038	29110	56912	6315	6256	1727	9859	4644	1466	10897	23328	8975	64175	2281	5441	84159	5154	55751	55784	10903	7771	57205	9637	92482	25994	8836	3611	29902	6003	1778	10626	7324	6772	56994	50863	5586	4921	55848	9643	51363	1780	9180	9658	10285	4000	9223	2050	8634	4683	9380	2783	54996	10651	58477	4750	55093	79086	26011	8804	79068	57093	2017	23321	6238	23258	9521	4259	55450	160518	599	10560	10046	411	23015	11315	10771	5213	6310	5836	1513	6322	9829	11279	10247	8933	834	64940	5275	2683	81565	221061	4677	10079	5095	29103	10527	28981	23271	51092	6059	9532	22824	4668	80149	80210	3959	3775	4088	79071	7187	219654	23641	6748	374354	7005	2258	79135	22836	54877	55293	1266	54875	9936	5688	29780	11010	10483	2308	81542	7078	51110	4642	9215	307	26009	1317	26472	7976	6583	55859	4232	79572	5034	26071	25996	285203	10975	54480	9079	55319	285830	25959	60681	57415	6222	687	23499	14	8669	2517	1265	79870	27230	23317	4694	7172	894	6157	51495	4291	56938	26038	54733	1000	5879
GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP	M3470		15210650	Lee MS,Hanspers K,Barker CS,Korn AP,McCune JM.	GSE1460	GSE1460_2142_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of CD4 [GeneID=920] thymocytes versus naive CD4 [GeneID=920] T cells from cord blood.	Subpopulations of human fetal thymocyte and circulating naïve T cells were obtained through FACS sorting, including CD3-CD4+CD8- intrathymic T progenitor cells (ITTP), CD3intCD4+CD8+ \double positive\ thymocytes (DP), CD3highCD4+CD8- \single positive\ thymocytes (SP4), CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from cord blood (CB4+), and CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from adult blood (AB4+).					9315	5713	2034	7071	55781	4602	4436	1653	10475	83439	9517	1861	7133	57136	5144	3925	10165	4345	10127	3140	1359	80196	1196	3309	10989	5981	9783	2004	7516	103	1915	7178	128	27348	10949	10269	54918	5003	79706	960	8507	51056	57472	3073	8562	80205	1738	9452	9861	3300	5608	9854	7416	813	7159	9948	989	23435	4686	9908	23451	91543	1161	25788	51340	51377	55699	3981	2769	55069	1848	114882	8477	30836	3146	71	7707	9989	26003	9209	5701	6691	7171	9330	4772	79956	6921	5423	5250	57154	6133	10137	5154	9276	9937	27067	53339	11335	79053	10857	6612	8454	6309	2107	79796	10971	286527	6722	3184	64422	54806	57122	7431	2299	4817	3985	10713	29799	4864	10556	55623	10477	55775	26574	23548	9941	9933	9859	1432	80204	7247	10311	9759	7037	10314	138050	84908	4190	10874	25896	23585	9249	7165	4082	80007	5910	64754	7124	7517	55830	90411	11146	1781	3178	754	56889	10440	51762	2551	4664	9896	8073	10221	6428	23306	83737	4076	5243	23603	79719	10962	910	3936	6745	30849	6399	8869	5727	6047	6228	29922	5096	3320	55573	5880	7337	7385	7922	58477	2941	2274	8503	7559	3187	2805	51371	23256	8634	580	5430
GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN	M3472		15210650	Lee MS,Hanspers K,Barker CS,Korn AP,McCune JM.	GSE1460	GSE1460_2142_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of CD4 [GeneID=920] thymocytes versus naive CD4 [GeneID=920] T cells from cord blood.	Subpopulations of human fetal thymocyte and circulating naïve T cells were obtained through FACS sorting, including CD3-CD4+CD8- intrathymic T progenitor cells (ITTP), CD3intCD4+CD8+ \double positive\ thymocytes (DP), CD3highCD4+CD8- \single positive\ thymocytes (SP4), CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from cord blood (CB4+), and CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from adult blood (AB4+).					55657	6710	22880	5585	55505	26112	550	7057	3431	100506963	51230	1803	51092	2814	10616	3131	56914	7307	1831	55670	23547	5977	3663	55968	28387	10970	79722	26589	752014	57030	64137	5352	23504	419	23178	81855	5732	80164	435	27335	5435	843	5339	4832	5578	100506190	23231	26018	11252	3590	2197	3006	8581	59338	6217	8924	56997	57446	146712	3062	8440	8632	81619	6404	3633	10235	6383	79153	10519	25996	6653	116372	9814	5118	847	79977	23059	8834	8395	80271	56244	7101	6543	6194	23001	9118	9080	55246	3344	318	51136	55825	60495	3363	57626	157627	440387	54549	22848	6338	30008	5197	100291367	63916	29907	79896	5877	100288758	9148	51070	9909	79969	51316	64771	2140	6894	140467	862	26284	80781	3884	6122	1103	51205	684	3704	2267	6157	79887	5913	3810	103910	80183	3119	8664	23368	8714	51227	64714	4501	6657	23539	3512	11080	4487	79962	51297	10399	23392	4836	56912	6786	2047	26056	7277	57228	6171	5439	55793	50813	9880	2263	6643	6187	4281	28955	23362	7054	5878	2254	8586	90864	51548	10223	84658	5829	23349	2872	2494	24141	348995	553115	10407	841	26119	5930	440348	25776	90485	11320	4139	57369	652493	6525	51611	321	55794	728882	3913	27290
GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP	M3474		15210650	Lee MS,Hanspers K,Barker CS,Korn AP,McCune JM.	GSE1460	GSE1460_2143_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of CD4 [GeneID=920] thymocytes versus naive CD4 [GeneID=920] T cells from adult blood.	Subpopulations of human fetal thymocyte and circulating naïve T cells were obtained through FACS sorting, including CD3-CD4+CD8- intrathymic T progenitor cells (ITTP), CD3intCD4+CD8+ \double positive\ thymocytes (DP), CD3highCD4+CD8- \single positive\ thymocytes (SP4), CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from cord blood (CB4+), and CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from adult blood (AB4+).					117178	167227	1839	9686	26135	5880	9767	11200	79772	8013	4436	7187	3309	8357	4664	952	55247	5569	6091	23548	11335	79876	913	54874	23053	3682	80150	11124	55227	8857	27250	6039	5359	10178	71	7071	9948	22919	6297	22918	5782	10418	6964	5825	7158	1958	22903	2034	3925	2983	3399	7991	51363	11146	9805	55069	7171	155066	23518	90355	9989	25896	11138	65998	9452	865	10121	7434	10734	9249	1432	55197	9601	23603	79053	140465	9941	91	53335	54145	3248	25797	2625	5154	7128	3418	917	6659	9743	23531	64374	7409	91543	3725	3017	8613	836	4345	8874	901	27345	5243	10989	4726	3066	25814	8507	29015	51762	1117	8914	1612	6328	7570	2941	26586	54107	912	1514	55106	3146	54918	54914	11274	5096	10964	79956	1781	10857	9645	6722	3178	10451	4076	10962	2677	5996	10765	23268	10269	65108	3068	55862	5519	9783	164	4086	55752	79174	9908	9937	55500	57136	4628	2274	5887	23129	5230	85236	11052	9218	5727	11171	55699	3357	1293	80762	9276	2107	1911	23596	6446	7771	79625	23406	57473	5796	91860	7694	329	55756	3939	3301	9896	8458	3837	9034	3140	1844	54585	27336	10803	23007	60682	10971	60559	55589	4232	10253	9014
GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN	M3476		15210650	Lee MS,Hanspers K,Barker CS,Korn AP,McCune JM.	GSE1460	GSE1460_2143_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of CD4 [GeneID=920] thymocytes versus naive CD4 [GeneID=920] T cells from adult blood.	Subpopulations of human fetal thymocyte and circulating naïve T cells were obtained through FACS sorting, including CD3-CD4+CD8- intrathymic T progenitor cells (ITTP), CD3intCD4+CD8+ \double positive\ thymocytes (DP), CD3highCD4+CD8- \single positive\ thymocytes (SP4), CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from cord blood (CB4+), and CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from adult blood (AB4+).					9639	6767	10970	55422	83481	91966	134	9409	79716	23178	5355	118433	51274	6203	7754	6840	4306	1632	3570	10519	6157	4753	55086	9961	684	5265	1831	2517	79883	90864	51596	3479	6171	6653	2639	3212	22894	57326	8440	2145	373156	51406	22927	8738	23177	10170	8852	51611	57228	64778	59338	23466	1843	2254	440	56997	101	1316	55819	64782	6161	80833	8555	8260	9922	3274	390998	4048	113791	64787	214	8566	8666	3628	29125	25776	9659	9033	4295	79762	22848	10641	10392	7571	7466	9368	54785	23108	51161	8528	7852	10490	1652	54737	57150	54777	22880	51084	5142	10404	22861	79176	11223	5292	29110	6275	23641	10577	51635	5533	23052	9677	9701	3757	38	962	23348	79652	3816	6134	2512	26108	55794	100507436	8878	56945	27335	27284	22986	202	4674	79758	2197	81558	64976	57830	7054	440193	4217	967	689	874	57035	55303	26018	64764	51279	2563	25996	9204	23780	10365	26119	23231	11322	59342	79707	6775	10384	9909	51409	4139	5829	10476	9751	10936	632	9882	7378	6404	138151	51082	6143	1440	597	5578	55281	89927	51205	5435	100129250	55203	6194	84124	8722	4065	1742	3141	7737	56954	54529	79026	60314	25880	54974	5720	9550	6793	27005	55049
GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP	M3478		15210650	Lee MS,Hanspers K,Barker CS,Korn AP,McCune JM.	GSE1460	GSE1460_2144_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of CD4 [GeneID=920] thymocytes versus thymic stromal cells.	Subpopulations of human fetal thymocyte and circulating naïve T cells were obtained through FACS sorting, including CD3-CD4+CD8- intrathymic T progenitor cells (ITTP), CD3intCD4+CD8+ \double positive\ thymocytes (DP), CD3highCD4+CD8- \single positive\ thymocytes (SP4), CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from cord blood (CB4+), and CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from adult blood (AB4+).					9731	4436	5451	5143	5429	60436	5430	8888	23119	645644	55339	1576	8454	4300	647070	6778	343	80204	9368	896	22928	57165	7033	2494	55340	54777	1124	10451	54963	11184	7124	56997	7327	5346	23341	8209	4927	51654	10743	4799	1992	56948	57447	57473	1103	55049	971	11039	56123	202	23585	4242	55000	80208	51384	64781	64601	27300	23085	79064	9208	6421	55203	56	54897	9013	55080	1244	51442	752	5883	80196	5608	9881	54820	100132923	728855	10778	913	2038	9362	3635	4723	155066	5520	9860	55124	54494	149628	90864	9491	643641	952	5564	1844	9546	5757	7517	171023	78991	57551	55090	6693	27099	79877	10320	79679	7516	23742	56941	23130	50617	9427	11019	51090	8648	6294	5443	55790	92822	9783	7707	50615	9791	157697	55657	23403	6666	26574	23240	5339	1208	54549	9905	9529	1729	197320	7108	57576	29997	864	23398	23765	7507	65980	25897	23020	50944	865	23547	51433	91442	10365	4440	8743	55768	23205	93349	393	2313	29916	57035	9686	5293	22823	83696	10964	64760	57171	57118	3663	1606	5981	7840	4049	405	6228	284266	6832	7356	22888	10425	79991	5287	55200	387751	10948	9830	1952	79625	3669	114882	167227	22834	51316	10874	51547	54440	2625	177
GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN	M3479		15210650	Lee MS,Hanspers K,Barker CS,Korn AP,McCune JM.	GSE1460	GSE1460_2144_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of CD4 [GeneID=920] thymocytes versus thymic stromal cells.	Subpopulations of human fetal thymocyte and circulating naïve T cells were obtained through FACS sorting, including CD3-CD4+CD8- intrathymic T progenitor cells (ITTP), CD3intCD4+CD8+ \double positive\ thymocytes (DP), CD3highCD4+CD8- \single positive\ thymocytes (SP4), CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from cord blood (CB4+), and CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from adult blood (AB4+).					11010	89797	5445	57016	966	79870	6675	26018	9353	54928	55270	4735	5742	1277	8260	6760	306	11072	51226	79953	8553	51101	8228	55093	3775	10160	8460	25758	4493	9231	9276	6788	1513	6310	5887	7291	6535	51451	50813	23583	64834	55273	8577	55831	8476	6237	23258	51339	8804	1000	55859	27286	10342	23333	599	6566	90411	87	811	9215	2730	29922	10616	29110	3037	5441	51635	51330	8894	9508	136	5099	6897	27042	8933	5361	4312	11117	10491	9829	10059	5157	9314	9118	51067	8434	4213	10090	51454	7088	7922	435	63920	285203	55002	79139	219654	8050	10404	55701	7035	5523	467	7980	6422	10527	54796	5197	5605	53340	5250	7030	2953	5877	60314	22822	4232	5947	7280	89927	169611	6196	64943	1292	55816	7371	56944	6256	79768	27018	3488	7049	6045	8997	51309	22943	7126	65990	2247	2619	6715	8728	51371	23612	3987	8795	9187	6529	54927	23621	8819	55319	6396	291	131544	1318	8076	23641	9411	8908	83468	23321	4811	10611	23034	26011	6238	5638	29931	64374	1981	90993	54874	10254	115939	10980	10962	11171	53838	6453	2138	6447	5684	53635	11328	8898	64236	131578	2131	4052	10468	54434	387263	10726	4199	9454	116832	23266	10063	124152
GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_UP	M3480		15210650	Lee MS,Hanspers K,Barker CS,Korn AP,McCune JM.	GSE1460	GSE1460_2145_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells from cord blood versus those from adult blood.	Subpopulations of human fetal thymocyte and circulating naïve T cells were obtained through FACS sorting, including CD3-CD4+CD8- intrathymic T progenitor cells (ITTP), CD3intCD4+CD8+ \double positive\ thymocytes (DP), CD3highCD4+CD8- \single positive\ thymocytes (SP4), CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from cord blood (CB4+), and CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from adult blood (AB4+).					8819	7027	7984	7307	5325	8440	553115	170680	5359	56244	23002	55691	1618	9567	581	79722	51092	5934	4299	253782	2770	79095	10051	57493	9978	81875	7314	9326	10808	28986	3460	51316	3398	28231	6391	2683	155	3006	55432	55340	11080	54726	10410	8431	5298	8344	79666	84726	9148	6599	3117	53335	10223	55505	9315	4068	6636	23254	8687	6949	10239	4082	2146	27251	51752	5694	4771	85236	3357	79800	26115	55888	7378	284443	2556	9435	25787	3066	79690	5033	3859	10399	9124	375449	6262	26637	8407	6002	55251	114885	1445	637	9370	10140	9653	9521	54442	3001	10606	2245	55161	5156	8531	10141	24139	7128	4170	140710	54832	10447	84733	9880	64768	55076	6925	3303	81698	5886	80164	27075	4250	79018	30844	3248	466	57126	10121	3712	5118	8838	10916	79153	6936	1736	7511	8106	23318	7486	930	57242	10514	55216	8635	26057	2760	1806	462	266655	7272	5549	10434	80183	5745	64816	3491	4718	6524	6231	30845	912	6120	6185	571	375790	5426	23376	3612	1310	114819	3933	7101	8565	10178	2632	10647	57610	79017	23192	57175	8363	9767	9805	9682	407	6629	5352	8165	7035	22849	654817	11122	3976	23531	1345	2627	3810	2580	5990	440387	5932
GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_DN	M3481		15210650	Lee MS,Hanspers K,Barker CS,Korn AP,McCune JM.	GSE1460	GSE1460_2145_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells from cord blood versus those from adult blood.	Subpopulations of human fetal thymocyte and circulating naïve T cells were obtained through FACS sorting, including CD3-CD4+CD8- intrathymic T progenitor cells (ITTP), CD3intCD4+CD8+ \double positive\ thymocytes (DP), CD3highCD4+CD8- \single positive\ thymocytes (SP4), CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from cord blood (CB4+), and CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from adult blood (AB4+).					3178	1655	1915	2805	81631	11168	7541	51290	79686	2551	55422	10179	6612	23451	3628	81556	7555	2952	3184	51283	1161	9701	7398	23338	9368	9341	202	84364	8869	3035	220134	2026	8624	29058	60493	57180	9948	10943	9861	5701	51188	206358	7571	23478	5859	5981	8454	11102	7770	4152	178	7536	51161	23435	57515	51703	1432	57136	56945	26003	51292	84975	55671	25939	10244	7905	55666	80021	6605	54529	9913	55846	3916	79717	80196	2796	1933	114932	5250	389856	597	55617	7360	26152	51635	83700	3185	10291	8878	8239	11337	3073	2521	23256	7559	6726	5698	6165	57215	6921	22986	526	5813	27348	22883	6738	5578	23780	29978	79716	962	9240	8943	9025	10277	134	6668	1196	23492	54432	7584	440	2990	3476	7247	8555	7073	440515	346	83464	6856	26128	5498	4118	9812	6840	32	10045	10367	7178	10127	10404	27288	51768	923	9445	1515	9516	80833	9938	10988	5454	5355	10602	4711	50624	9453	58477	30836	51340	79009	4733	5093	1603	3936	53343	23171	150967	498	7852	2764	5269	8036	38	8761	64689	2254	128	6443	4528	9770	23029	22927	9677	5705	10299	5289	3312	2588	54623	51761	8667	7430	79672	65983	22928	10947	11188	100507436	113419
GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_UP	M3484		15210650	Lee MS,Hanspers K,Barker CS,Korn AP,McCune JM.	GSE1460	GSE1460_2146_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in naive CD4 [GeneID=920] T cells from cord blood versus thymic stromal cells.	Subpopulations of human fetal thymocyte and circulating naïve T cells were obtained through FACS sorting, including CD3-CD4+CD8- intrathymic T progenitor cells (ITTP), CD3intCD4+CD8+ \double positive\ thymocytes (DP), CD3highCD4+CD8- \single positive\ thymocytes (SP4), CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from cord blood (CB4+), and CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from adult blood (AB4+).					80235	3420	51442	55793	54862	80739	79003	8664	408	23224	2877	10781	79904	5613	5617	80778	8999	9159	7475	656	9726	5287	55806	55262	29997	64423	92609	10017	256987	4600	189	5094	619426	2912	23209	9737	5653	27232	7161	26261	6160	6187	23132	5089	23240	7818	22995	7015	64135	4242	55113	64837	3849	79944	1244	6199	4736	100289563	8512	54503	9679	55316	157697	5379	3604	7318	6191	54737	4898	55028	100287600	2733	6712	55139	6862	3166	23217	54879	3660	1953	43849	51384	405	8325	56969	9546	100506963	55220	54897	8812	55968	4296	5540	1104	84818	79929	388969	57827	100289420	1770	79809	5387	10208	54798	80149	5993	652493	274	1952	57096	78991	8824	91782	3512	55578	27290	8632	776	23250	57551	7425	8740	80094	6133	51275	56125	5155	23387	25803	57134	8224	5284	8395	81550	566	2596	23017	7626	54508	2670	63892	25770	1748	54979	22848	23446	27120	9491	3557	57147	2556	3454	23464	80164	23541	23481	8731	2053	7516	23614	9208	5309	51379	3026	9976	5078	5030	1208	3007	64772	9830	1606	51131	8348	4832	5142	8924	3645	7464	11009	51816	7867	22870	10645	6844	51752	1659	2865	55716	57610	5883	56928	25956	79979	1831	55226	56922	1132	684	7454
GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_DN	M3486		15210650	Lee MS,Hanspers K,Barker CS,Korn AP,McCune JM.	GSE1460	GSE1460_2146_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in naive CD4 [GeneID=920] T cells from cord blood versus thymic stromal cells.	Subpopulations of human fetal thymocyte and circulating naïve T cells were obtained through FACS sorting, including CD3-CD4+CD8- intrathymic T progenitor cells (ITTP), CD3intCD4+CD8+ \double positive\ thymocytes (DP), CD3highCD4+CD8- \single positive\ thymocytes (SP4), CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from cord blood (CB4+), and CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from adult blood (AB4+).					6655	23066	51809	54927	9637	63920	6722	5884	9886	4292	23333	7511	890	56986	5867	23471	80007	10285	5728	23328	10447	1781	4502	5478	4780	9890	5191	3418	64374	10535	730101	9522	81631	10404	527	165	56992	79717	83990	53340	56938	7416	1315	7227	54892	54434	6009	10950	9141	5711	5887	5226	9829	51065	5229	5861	55500	10767	55146	55647	2720	966	6446	50863	8669	7126	6921	10254	10733	8741	4684	23433	2509	51635	79752	394	467	8611	29931	80210	55425	56912	51335	5034	6396	4126	56994	81034	9474	5836	182	8833	58477	4501	8427	11339	4134	6611	2287	5621	57136	83461	56270	9319	64747	116987	7216	1827	9367	2846	55355	10247	2950	79017	10381	10121	5910	8317	27249	55745	54431	6535	23548	55839	4045	4677	11072	79070	6924	2773	90411	55969	3475	25776	2258	64236	23256	6310	6319	79659	22836	10560	1910	55450	79188	81888	25998	7049	28977	55032	6016	25994	1513	7336	4675	8761	11051	79174	84617	8987	1718	5716	4694	26071	91137	11237	54821	64943	2108	55703	9419	56886	9631	6259	6059	51606	357	7035	131544	10417	11117	805	10548	10552	51292	25978	80013	11266	3280	387	347902	54974	55070	51318	9079	2650	29967	3156	23271	2218
GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_UP	M3487		15210650	Lee MS,Hanspers K,Barker CS,Korn AP,McCune JM.	GSE1460	GSE1460_2147_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in naive CD4 [GeneID=920] T cells from adult blood versus thymic stromal cells.	Subpopulations of human fetal thymocyte and circulating naïve T cells were obtained through FACS sorting, including CD3-CD4+CD8- intrathymic T progenitor cells (ITTP), CD3intCD4+CD8+ \double positive\ thymocytes (DP), CD3highCD4+CD8- \single positive\ thymocytes (SP4), CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from cord blood (CB4+), and CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from adult blood (AB4+).					8501	9632	3064	4074	260294	1729	64781	2251	5143	1655	27229	51816	9710	7054	54878	81617	7874	4303	27072	1937	65095	51654	10499	55813	6430	55090	10948	8454	645644	55080	23370	6839	8479	1933	9051	157697	1831	4799	9976	54861	55818	25789	28823	25875	64421	2596	54440	10312	79690	1432	79788	57396	10299	6693	80125	56997	4033	8314	50615	646808	23209	352961	2643	6899	90586	7727	4736	79173	57326	80045	4327	25816	10947	2033	4300	3566	5431	5590	50624	8859	374395	1777	9514	11224	23484	2981	5568	6778	51207	5553	140801	51719	1200	1953	11119	729164	5424	27343	4295	57000	10861	9368	114932	11059	9159	1454	23401	9416	6832	55663	93594	64240	3305	80169	57730	652493	64061	79148	4144	9802	22796	4324	51379	56123	7332	3249	23403	114899	84719	9812	6294	4666	6202	6210	78991	130074	51411	5348	3241	5292	440387	51433	55086	3007	6207	22848	3795	5981	7726	8737	56941	9550	29997	60468	8303	55281	10379	495	7940	9663	57147	100288939	23759	342538	55167	57551	51478	83752	10319	56257	643641	865	8869	57830	79172	50619	197320	9860	10762	7327	8529	7294	8554	2967	5297	9806	55554	79009	8239	5837	54820	896	50852	7108	5989	7551	10320	7375	63897	3635
GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_DN	M3488		15210650	Lee MS,Hanspers K,Barker CS,Korn AP,McCune JM.	GSE1460	GSE1460_2147_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in naive CD4 [GeneID=920] T cells from adult blood versus thymic stromal cells.	Subpopulations of human fetal thymocyte and circulating naïve T cells were obtained through FACS sorting, including CD3-CD4+CD8- intrathymic T progenitor cells (ITTP), CD3intCD4+CD8+ \double positive\ thymocytes (DP), CD3highCD4+CD8- \single positive\ thymocytes (SP4), CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from cord blood (CB4+), and CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from adult blood (AB4+).					9767	79870	25996	7071	590	4085	6059	169611	966	55625	89797	8460	56944	1351	2067	9411	6447	990	23291	24137	7057	25758	9931	10090	4700	23258	11199	22903	54801	5154	55816	55032	11200	2960	57088	54962	2650	114885	83716	5742	27032	1287	875	54478	2171	51651	55179	9079	1763	56886	29957	805	26002	1318	26057	11069	9314	6715	2730	10239	9943	1909	5069	1894	6397	55425	9130	79071	9454	9991	378708	10403	10808	219654	112479	5861	145389	4811	8728	9016	1292	51318	55831	2743	5887	9521	5997	22856	55165	11282	55970	2619	55120	4171	25827	55432	4668	3612	483	7005	1829	5271	131578	7980	10254	9693	55635	217	10491	4052	23531	11051	4089	55233	22824	55273	55848	8402	5756	6319	2624	23463	10644	55973	10471	10635	165	5441	8434	637	8908	55799	4741	64943	51226	9124	9353	1809	2184	8804	23478	2281	10586	28971	6422	54431	11339	8407	6717	6760	55884	3037	23254	25945	5888	6372	1789	51155	1266	3182	55888	3066	64940	4493	2247	745	3189	1500	182	23312	5238	5361	2975	51092	92170	3488	8577	10248	23271	10552	139322	833	81888	64236	6788	51363	55106	55839	8914	2953	56929	11171	80007	54205	23621	5213	5101	29967	54928	28986
GSE15215_CD2_POS_VS_NEG_PDC_UP	M3519		19454677	Matsui T,Connolly JE,Michnevitz M,Chaussabel D,Yu CI,Glaser C,Tindle S,Pypaert M,Freitas H,Piqueras B,Banchereau J,Palucka AK.	GSE15215	GSE15215_1537_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of CD2+ plasmacytoid dendritic cells (DC) versus CD2- cells.	Plasmacytoid dendritic cells (pDCs) are key regulators of anti-viral immunity. They rapidly secrete IFN-alpha and cross-present viral antigens thereby launching adaptive immunity. Here we show that activated human pDCs inhibit replication of cancer cells, and kill them in a contact dependent fashion. Expression of CD2 distinguishes two pDC subsets with distinct phenotype and function. Both subsets secrete IFN-alpha and express Granzyme B and TRAIL. CD2high pDCs uniquely express lysozyme and can be found in tonsils and in tumors. Both subsets launch recall T cell response. However, CD2high pDCs secrete higher levels of IL12 p40, express higher levels of co-stimulatory molecule CD80 and are more efficient in triggering proliferation of naïve allogeneic T cells. Thus, human blood pDCs are composed of subsets with specific phenotype and functions.					687	23729	2022	11223	953	5607	2797	23196	6530	10085	81857	10841	64131	192669	26508	1636	55630	84243	57061	100287025	5244	192666	8976	79616	410	954	2063	79658	1491	57761	63924	81563	5210	64763	58157	55135	6945	57192	1442	28999	11135	6616	3489	1149	93129	2646	22861	904	6280	6776	2779	10686	6453	5590	3054	51686	5742	3736	6259	2268	5536	729580	56548	25788	25939	1152	5361	5141	421	6271	57165	23466	1240	81	51085	348995	90326	28969	6340	6942	2995	146562	64081	3633	78992	1296	51092	64943	619426	90273	1180	10435	1890	80736	596	10927	4544	467	6932	55133	6569	1294	51440	4507	55657	23248	6794	55203	79015	10808	2676	54498	23170	9013	27039	8321	443	375790	5010	5077	83660	9752	913	5978	7701	64180	30813	3399	56302	5467	50937	4323	8029	10249	57818	7433	2217	9663	29855	1955	5538	991	8396	3643	51015	284904	8131	5083	3340	27147	4884	6949	5224	619505	374977	646808	51276	11103	9413	4634	1512	1543	58509	623	79939	100506658	127544	2580	29062	80045	946	124044	29109	28984	3632	3014	8570	4082	7450	858	9332	10897	100286895	59269	11129	23152	9869	80301	57615	7453	9991	23498	5447	6667	2872	23139	55311	3727	29789	4134
GSE15215_CD2_POS_VS_NEG_PDC_DN	M3521		19454677	Matsui T,Connolly JE,Michnevitz M,Chaussabel D,Yu CI,Glaser C,Tindle S,Pypaert M,Freitas H,Piqueras B,Banchereau J,Palucka AK.	GSE15215	GSE15215_1537_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of CD2+ plasmacytoid dendritic cells (DC) versus CD2- cells.	Plasmacytoid dendritic cells (pDCs) are key regulators of anti-viral immunity. They rapidly secrete IFN-alpha and cross-present viral antigens thereby launching adaptive immunity. Here we show that activated human pDCs inhibit replication of cancer cells, and kill them in a contact dependent fashion. Expression of CD2 distinguishes two pDC subsets with distinct phenotype and function. Both subsets secrete IFN-alpha and express Granzyme B and TRAIL. CD2high pDCs uniquely express lysozyme and can be found in tonsils and in tumors. Both subsets launch recall T cell response. However, CD2high pDCs secrete higher levels of IL12 p40, express higher levels of co-stimulatory molecule CD80 and are more efficient in triggering proliferation of naïve allogeneic T cells. Thus, human blood pDCs are composed of subsets with specific phenotype and functions.					5393	23189	10682	25966	84124	5687	55802	54801	2203	11102	2023	4790	5728	5527	5245	2672	254359	22884	8887	120227	10425	57001	11044	6468	51714	684	387263	347240	2551	5175	10899	1622	10577	1994	54442	23300	5937	164	4752	440026	9924	27097	97	79960	6217	51106	8874	6774	10507	64167	5902	8658	5917	2934	3476	55788	6389	80232	79594	54014	7371	59342	4520	1479	3422	2235	51411	29088	55716	5108	25790	56984	3665	1739	11236	10255	84823	7109	757	487	5583	7328	9709	7186	2965	55164	6936	80183	196441	4616	80351	4750	11080	7037	9861	9246	8872	3588	7360	2803	4338	51118	51284	6122	80344	5290	79009	54968	54812	54480	54457	3397	9958	54149	10488	23483	9425	55512	8883	57645	4690	2805	4669	7803	84986	5908	29946	474344	10313	3931	6810	11138	4114	64689	7805	56945	10573	9529	2029	9131	58533	10772	10282	1432	57215	832	51275	55852	79718	10791	2117	23390	200576	4953	79073	6309	55578	760	11120	10479	22837	1213	5116	9111	23339	27175	51081	81618	54953	387	22913	55734	5580	51614	56947	9500	23451	51004	10713	9813	2747	5525	1659	10142	56965	9805	79789	7290	5431	4621	63916	25940	79081	115353	23318	57017	4745	55851	9662	6176
GSE15659_TREG_VS_TCONV_UP	M3534		19464196	Miyara M,Yoshioka Y,Kitoh A,Shima T,Wing K,Niwa A,Parizot C,Taflin C,Heike T,Valeyre D,Mathian A,Nakahata T,Yamaguchi T,Nomura T,Ono M,Amoura Z,Gorochov G,Sakaguchi S.	GSE15659	GSE15659_1415_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of regulatory T cell (Treg) versus conventional T cells.	Gene expression profiles of subsets of CD4+ T cells according to their expression of FoxP3 and CD45RA were compared. FoxP3 is a key transcription factor for the development and function of natural CD4+ regulatory T cells (Tregs). Here we show that human FoxP3+CD4+ T cells are composed of three phenotypically and functionally distinct subpopulations: CD45RA+FoxP3low resting Tregs (rTregs) and CD45RA-FoxP3high activated Tregs (aTregs), both of which are suppressive in vitro, and cytokine-secreting CD45RA-FoxP3low non-suppressive T cells. The proportion of the three subpopulations characteristically altered in cord blood, aged individuals, and patients with immunological diseases. Terminally differentiated aTregs rapidly die while rTregs proliferate and convert into aTregs in vitro and in vivo as shown by the transfer of rTregs into NOD-scid-common gamma-chain-knockout mice and by TCR sequence-based T cell clonotype tracing in peripheral blood of normal individuals. Taken together, the dissection of FoxP3+ cells into subsets enables one to analyze Treg differentiation dynamics and interactions in normal and disease states, and to control immune responses through manipulating particular FoxP3+ subpopulations.					26776	55366	643155	270	6117	100286972	26338	551	90441	7803	26777	85406	100288225	6091	653602	6098	439943	115399	5414	10637	54764	57132	142910	389458	1263	25932	51083	9848	84226	146434	136263	153745	117245	400926	5803	939	10422	50863	11011	348	27124	2266	5064	25789	245932	140686	8797	6948	727936	8358	10289	100288198	116138	2986	9135	3306	1756	100128025	100130322	26330	54933	9355	57657	100287584	136541	171024	5393	2589	84514	56254	8909	342977	10210	65264	221711	9672	57533	222	644096	162993	79924	7761	160728	57142	5121	140834	54949	55145	85465	79591	346171	56302	90273	54901	55149	730441	23432	80823	10343	7503	100288893	1616	7638	57452	401233	7249	339479	158747	714	9182	10529	138065	100506237	817	25850	220108	51471	114793	54494	23031	5564	55178	79012	2209	29777	5859	92345	23439	139596	114134	283659	81031	79868	9184	340205	55057	1215	51526	28984	3280	54812	11059	55298	285590	94134	51751	100505929	666	100129620	223075	64895	1022	53905	2768	58512	8501	85444	164045	731789	729224	79679	150384	91661	641977	6721	400548	201725	57181	10798	55167	10050	84440	4324	148930	81556	4680	56169	151171	84648	3116	55643	8567	283025	84232	284161	115110	6332	139728	1903	79036	57144	9898	383	81618	329	1659	9929	6506	26290	1805
GSE15659_TREG_VS_TCONV_DN	M3535		19464196	Miyara M,Yoshioka Y,Kitoh A,Shima T,Wing K,Niwa A,Parizot C,Taflin C,Heike T,Valeyre D,Mathian A,Nakahata T,Yamaguchi T,Nomura T,Ono M,Amoura Z,Gorochov G,Sakaguchi S.	GSE15659	GSE15659_1415_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of regulatory T cell (Treg) versus conventional T cells.	Gene expression profiles of subsets of CD4+ T cells according to their expression of FoxP3 and CD45RA were compared. FoxP3 is a key transcription factor for the development and function of natural CD4+ regulatory T cells (Tregs). Here we show that human FoxP3+CD4+ T cells are composed of three phenotypically and functionally distinct subpopulations: CD45RA+FoxP3low resting Tregs (rTregs) and CD45RA-FoxP3high activated Tregs (aTregs), both of which are suppressive in vitro, and cytokine-secreting CD45RA-FoxP3low non-suppressive T cells. The proportion of the three subpopulations characteristically altered in cord blood, aged individuals, and patients with immunological diseases. Terminally differentiated aTregs rapidly die while rTregs proliferate and convert into aTregs in vitro and in vivo as shown by the transfer of rTregs into NOD-scid-common gamma-chain-knockout mice and by TCR sequence-based T cell clonotype tracing in peripheral blood of normal individuals. Taken together, the dissection of FoxP3+ cells into subsets enables one to analyze Treg differentiation dynamics and interactions in normal and disease states, and to control immune responses through manipulating particular FoxP3+ subpopulations.					2621	29958	83473	677819	145858	10747	7026	6197	5836	463	57495	8516	8820	64711	27255	54981	154288	342096	2592	100287076	23221	2690	5832	255025	79087	1902	3698	51207	114991	338872	541565	7045	79820	100507392	140469	1849	168507	574037	203102	84281	78988	114783	260429	54868	4200	250	27004	124056	3996	57451	126668	283174	25809	139135	8335	374387	157556	909	5794	644873	94	341032	57648	781	100129361	283486	9453	5178	9253	65980	8737	85453	56101	28778	284570	271	53354	80161	491	165721	246	5954	57406	112574	84300	3773	54165	341	100134713	2290	100506874	8323	51088	129026	92	27283	25903	158067	645676	100302522	80731	79064	22999	6039	100133089	64839	57222	3490	57539	283761	10075	10129	3670	3547	100506433	57188	150000	55558	100131551	84699	9934	29909	64066	6398	92270	89801	644150	5797	284950	23230	23607	100287182	8943	27180	121278	1455	55738	51479	100499467	4342	56667	5866	7711	157773	144100	79675	3590	204801	26472	4820	3094	63877	79993	5616	79797	100329135	5432	5144	10317	100128594	149111	54550	11027	7390	27296	84188	11260	84261	5291	100506667	5459	649305	7361	2697	10740	115361	138050	100287331	5874	340094	158572	79691	54102	6235	8521	4325	11311	401505	123036	388962	51185	8553	55337	146849	147746	288	3676	53829	9466	80258
GSE15659_NAIVE_VS_PTPRC_NEG_CD4_TCELL_UP	M3536		19464196	Miyara M,Yoshioka Y,Kitoh A,Shima T,Wing K,Niwa A,Parizot C,Taflin C,Heike T,Valeyre D,Mathian A,Nakahata T,Yamaguchi T,Nomura T,Ono M,Amoura Z,Gorochov G,Sakaguchi S.	GSE15659	GSE15659_1416_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive CD4 [GeneID=920] T cells versus PTPRC+ [GeneID=5788] CD4 [GeneID=920] T cells.	Gene expression profiles of subsets of CD4+ T cells according to their expression of FoxP3 and CD45RA were compared. FoxP3 is a key transcription factor for the development and function of natural CD4+ regulatory T cells (Tregs). Here we show that human FoxP3+CD4+ T cells are composed of three phenotypically and functionally distinct subpopulations: CD45RA+FoxP3low resting Tregs (rTregs) and CD45RA-FoxP3high activated Tregs (aTregs), both of which are suppressive in vitro, and cytokine-secreting CD45RA-FoxP3low non-suppressive T cells. The proportion of the three subpopulations characteristically altered in cord blood, aged individuals, and patients with immunological diseases. Terminally differentiated aTregs rapidly die while rTregs proliferate and convert into aTregs in vitro and in vivo as shown by the transfer of rTregs into NOD-scid-common gamma-chain-knockout mice and by TCR sequence-based T cell clonotype tracing in peripheral blood of normal individuals. Taken together, the dissection of FoxP3+ cells into subsets enables one to analyze Treg differentiation dynamics and interactions in normal and disease states, and to control immune responses through manipulating particular FoxP3+ subpopulations.					39	641372	2180	57180	57188	113	189	10142	221264	126133	238	84266	80216	8092	51434	339416	55129	57719	10717	57584	79822	27237	25820	142689	51130	55210	472	8455	342371	8424	582	144233	53335	54880	100499483	10904	388962	128859	9044	696	79908	29125	25906	90488	144608	348110	400360	79447	79701	79415	80233	55181	64149	84322	126321	715	127687	9473	51430	25966	26005	150590	285382	79625	132989	63914	221322	51250	221416	100507249	157556	414319	23732	55071	340591	767	91768	59284	796	91860	23271	55013	256309	100129792	51372	9973	4179	924	246184	55755	1040	634	60677	1063	1069	8545	84952	79145	80205	1119	10752	1134	1135	1141	1146	1147	163732	1182	8218	116173	150384	1261	26504	8161	1300	149951	26958	8895	1380	51185	148327	1453	30848	1515	83992	8029	9547	392459	1536	643160	9420	9595	51339	1603	79877	54798	167227	23564	1652	84771	8886	203522	64798	79132	1733	127343	201625	54943	1776	116092	1807	64118	11062	1780	10455	1893	1842	1936	100130771	256364	10961	55224	2113	2128	23265	2162	374393	220382	51313	158724	83723	619423	55199	171482	84893	26273	23403	161247	51661	79147	79904	400761	285759	285736	645524	642691	399806	644283	643365	114984	80020	23401	79068	197258	139341	2521	23766	200959	23464	100506215
GSE15659_NAIVE_VS_PTPRC_NEG_CD4_TCELL_DN	M3538		19464196	Miyara M,Yoshioka Y,Kitoh A,Shima T,Wing K,Niwa A,Parizot C,Taflin C,Heike T,Valeyre D,Mathian A,Nakahata T,Yamaguchi T,Nomura T,Ono M,Amoura Z,Gorochov G,Sakaguchi S.	GSE15659	GSE15659_1416_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus PTPRC+ [GeneID=5788] CD4 [GeneID=920] T cells.	Gene expression profiles of subsets of CD4+ T cells according to their expression of FoxP3 and CD45RA were compared. FoxP3 is a key transcription factor for the development and function of natural CD4+ regulatory T cells (Tregs). Here we show that human FoxP3+CD4+ T cells are composed of three phenotypically and functionally distinct subpopulations: CD45RA+FoxP3low resting Tregs (rTregs) and CD45RA-FoxP3high activated Tregs (aTregs), both of which are suppressive in vitro, and cytokine-secreting CD45RA-FoxP3low non-suppressive T cells. The proportion of the three subpopulations characteristically altered in cord blood, aged individuals, and patients with immunological diseases. Terminally differentiated aTregs rapidly die while rTregs proliferate and convert into aTregs in vitro and in vivo as shown by the transfer of rTregs into NOD-scid-common gamma-chain-knockout mice and by TCR sequence-based T cell clonotype tracing in peripheral blood of normal individuals. Taken together, the dissection of FoxP3+ cells into subsets enables one to analyze Treg differentiation dynamics and interactions in normal and disease states, and to control immune responses through manipulating particular FoxP3+ subpopulations.					3598	11177	124626	223082	30834	100302737	84146	118738	51710	84330	79750	7746	7701	83637	7545	150244	389874	100381270	7455	78992	10413	7485	116143	55339	64743	7453	284415	55737	7434	7423	80124	9341	257313	124739	400952	201294	84993	10277	148581	51465	7321	55236	7288	10383	84672	83868	9694	23548	7257	283989	140803	9320	339976	493829	57159	55521	23321	10626	122553	22906	7172	7167	8626	58476	90313	7156	8742	7128	57156	135932	83935	84233	128218	145942	64114	30012	7099	7096	7093	116238	26277	7076	10440	497189	7068	7056	7032	23424	6953	6926	55171	9882	50835	255928	100130958	64420	6819	27148	8614	134429	93653	55808	6764	6345	9789	26010	79029	84690	9825	353324	122258	6664	8724	26783	9892	333929	6591	4091	10479	6553	83697	6522	126969	29015	5250	283652	6580	6472	6461	4068	253190	8293	8482	10952	9871	10483	10993	9997	6334	117156	8796	91179	192683	29115	64092	9294	6286	140576	83597	132112	728194	6240	6123	6121	152015	6093	25897	26001	8635	6016	58480	54933	79651	57139	11030	55131	58517	387496	51655	5921	10048	10267	9367	11021	84932	5836	137902	81607	5817	11122	26469	401494	5746	84722	5663	79057	574414	10544	5613	5581	10394	10549	59336	390999	51029	5525	5515	152926	5480	5470
GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_UP	M3540		19464196	Miyara M,Yoshioka Y,Kitoh A,Shima T,Wing K,Niwa A,Parizot C,Taflin C,Heike T,Valeyre D,Mathian A,Nakahata T,Yamaguchi T,Nomura T,Ono M,Amoura Z,Gorochov G,Sakaguchi S.	GSE15659	GSE15659_1417_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive CD4 [GeneID=920] T cells versus resting regulatory T cell (Treg).	Gene expression profiles of subsets of CD4+ T cells according to their expression of FoxP3 and CD45RA were compared. FoxP3 is a key transcription factor for the development and function of natural CD4+ regulatory T cells (Tregs). Here we show that human FoxP3+CD4+ T cells are composed of three phenotypically and functionally distinct subpopulations: CD45RA+FoxP3low resting Tregs (rTregs) and CD45RA-FoxP3high activated Tregs (aTregs), both of which are suppressive in vitro, and cytokine-secreting CD45RA-FoxP3low non-suppressive T cells. The proportion of the three subpopulations characteristically altered in cord blood, aged individuals, and patients with immunological diseases. Terminally differentiated aTregs rapidly die while rTregs proliferate and convert into aTregs in vitro and in vivo as shown by the transfer of rTregs into NOD-scid-common gamma-chain-knockout mice and by TCR sequence-based T cell clonotype tracing in peripheral blood of normal individuals. Taken together, the dissection of FoxP3+ cells into subsets enables one to analyze Treg differentiation dynamics and interactions in normal and disease states, and to control immune responses through manipulating particular FoxP3+ subpopulations.					55113	38	92	57188	113	115	60312	8540	23287	202	10142	10327	126133	4329	238	84266	60529	271	51434	284615	134548	283373	57719	8907	26985	57584	2909	128272	25820	8853	142685	51130	80161	11016	220202	344905	537	8424	582	53335	602	54880	617	27319	637	10904	399761	51027	388962	100505510	9044	220004	90488	144608	283551	348110	79415	147081	64149	84322	126321	84798	51430	24141	56683	25966	150590	55345	79625	132989	60684	260436	221322	221416	729515	138241	84270	767	91768	59284	796	57118	23271	93661	100506742	836	200014	55013	256309	84317	80071	100129792	79140	51372	54482	6351	57124	959	246184	983	55755	1062	1063	1069	84952	10036	118487	80205	1134	1182	116173	26504	285888	1300	1289	149951	23406	151835	51185	148327	1460	10675	30848	1075	83992	9547	392459	1535	1540	643160	9595	23500	51339	1603	79877	54798	167227	23564	1652	8886	57062	203522	79132	1738	127343	201625	79982	54943	116092	8448	1794	1807	64118	11072	1780	1893	1842	1936	9521	100130771	23167	5610	9451	8669	27335	339221	347918	2039	27248	10961	55224	2113	2120	51466	23265	51013	2140	374393	79607	220382	131177	158724	442444	9130	83723	619423	171482	144699	161247	100131561	326332	285759	285736	642691	285352	440556	645566	80020	197258	139341
GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_DN	M3542		19464196	Miyara M,Yoshioka Y,Kitoh A,Shima T,Wing K,Niwa A,Parizot C,Taflin C,Heike T,Valeyre D,Mathian A,Nakahata T,Yamaguchi T,Nomura T,Ono M,Amoura Z,Gorochov G,Sakaguchi S.	GSE15659	GSE15659_1417_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus resting regulatory T cell (Treg).	Gene expression profiles of subsets of CD4+ T cells according to their expression of FoxP3 and CD45RA were compared. FoxP3 is a key transcription factor for the development and function of natural CD4+ regulatory T cells (Tregs). Here we show that human FoxP3+CD4+ T cells are composed of three phenotypically and functionally distinct subpopulations: CD45RA+FoxP3low resting Tregs (rTregs) and CD45RA-FoxP3high activated Tregs (aTregs), both of which are suppressive in vitro, and cytokine-secreting CD45RA-FoxP3low non-suppressive T cells. The proportion of the three subpopulations characteristically altered in cord blood, aged individuals, and patients with immunological diseases. Terminally differentiated aTregs rapidly die while rTregs proliferate and convert into aTregs in vitro and in vivo as shown by the transfer of rTregs into NOD-scid-common gamma-chain-knockout mice and by TCR sequence-based T cell clonotype tracing in peripheral blood of normal individuals. Taken together, the dissection of FoxP3+ cells into subsets enables one to analyze Treg differentiation dynamics and interactions in normal and disease states, and to control immune responses through manipulating particular FoxP3+ subpopulations.					219743	1497	90324	146050	9753	223082	100302737	339500	79788	84146	65243	169270	92285	163033	348327	51710	9668	80264	79750	80778	26974	7576	10795	7752	7746	7741	7701	7690	10771	83637	7545	389874	7455	79693	78992	7484	8838	7466	116143	197335	112840	54663	55339	7453	284415	139538	7423	80124	114990	257313	84294	7874	8237	400952	643763	84993	5412	10277	148581	7321	64595	83868	440307	23170	150465	57217	54970	203062	140803	57159	55521	11277	22906	80305	7175	7172	8626	90313	7157	7156	7143	7134	8742	7124	55217	54968	29100	25907	135932	83935	128218	55374	145942	30012	83660	7093	116238	7083	26277	653252	497189	7068	7058	7056	90655	7032	6948	90843	55171	50835	6854	27284	202374	10494	8576	8614	134429	93653	6746	6345	245711	9789	26010	375686	84690	9825	353324	122258	80320	347689	26783	724102	85028	6622	9892	333929	200172	6553	6534	6522	83959	29015	124935	1811	284129	83884	80024	5002	6580	162515	6497	6472	126669	6461	151246	10262	79918	5273	327657	253190	55964	8482	57556	64218	79048	10807	9997	6334	117156	91179	192683	54938	29115	64092	55511	9294	140576	23623	83597	132112	728194	6240	6123	6098	25897	7737	8153	134701	399	389	54933	26575	84220	51655	10048	10267	9367	51762	11021	64284
GSE15659_NAIVE_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_UP	M3545		19464196	Miyara M,Yoshioka Y,Kitoh A,Shima T,Wing K,Niwa A,Parizot C,Taflin C,Heike T,Valeyre D,Mathian A,Nakahata T,Yamaguchi T,Nomura T,Ono M,Amoura Z,Gorochov G,Sakaguchi S.	GSE15659	GSE15659_1418_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive CD4 [GeneID=920] T cells versus non-suppressive T cells.	Gene expression profiles of subsets of CD4+ T cells according to their expression of FoxP3 and CD45RA were compared. FoxP3 is a key transcription factor for the development and function of natural CD4+ regulatory T cells (Tregs). Here we show that human FoxP3+CD4+ T cells are composed of three phenotypically and functionally distinct subpopulations: CD45RA+FoxP3low resting Tregs (rTregs) and CD45RA-FoxP3high activated Tregs (aTregs), both of which are suppressive in vitro, and cytokine-secreting CD45RA-FoxP3low non-suppressive T cells. The proportion of the three subpopulations characteristically altered in cord blood, aged individuals, and patients with immunological diseases. Terminally differentiated aTregs rapidly die while rTregs proliferate and convert into aTregs in vitro and in vivo as shown by the transfer of rTregs into NOD-scid-common gamma-chain-knockout mice and by TCR sequence-based T cell clonotype tracing in peripheral blood of normal individuals. Taken together, the dissection of FoxP3+ cells into subsets enables one to analyze Treg differentiation dynamics and interactions in normal and disease states, and to control immune responses through manipulating particular FoxP3+ subpopulations.					255027	14	57180	11096	92949	57188	60312	375790	10142	221264	10327	126133	4329	238	239	51434	134548	283373	57719	10717	80830	79822	128272	25820	142689	140461	25842	344905	342371	8424	582	144233	53335	54880	617	100499483	637	10904	399761	51027	388962	128859	9044	29125	25906	220004	90488	144608	388011	348110	79447	79701	147081	55181	64149	84322	126321	284369	114905	715	9473	51430	56683	25966	150590	285382	55345	79625	60684	63914	221416	100507249	157556	84270	767	91768	51475	59284	796	57118	55013	84317	80071	100129792	79140	51372	440193	6351	219771	9973	916	959	4179	924	246184	1013	53841	1040	1069	8545	79145	1119	1134	1141	1146	163732	8218	26504	285888	23242	9382	8161	1300	1346	8895	51185	148327	1442	1460	10675	30848	83992	8029	51596	9547	2920	643160	1603	23564	1652	84771	8886	203522	64798	79132	1738	1745	127343	201625	79982	54943	116092	8448	1794	83475	11072	1780	10455	1893	1842	1936	100130771	9451	27335	2009	339221	2039	79852	10961	55224	2120	2128	55179	374393	89853	158724	55199	2191	144699	23403	84261	2258	2273	161247	100131561	79904	401081	403150	326332	283401	285759	642691	163742	401260	80020	92973	23401	197258	2521	9908	23766	200959	283459	23464	647309	23062	155038	55970	221914	2719
GSE15659_NAIVE_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN	M3547		19464196	Miyara M,Yoshioka Y,Kitoh A,Shima T,Wing K,Niwa A,Parizot C,Taflin C,Heike T,Valeyre D,Mathian A,Nakahata T,Yamaguchi T,Nomura T,Ono M,Amoura Z,Gorochov G,Sakaguchi S.	GSE15659	GSE15659_1418_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus non-suppressive T cells.	Gene expression profiles of subsets of CD4+ T cells according to their expression of FoxP3 and CD45RA were compared. FoxP3 is a key transcription factor for the development and function of natural CD4+ regulatory T cells (Tregs). Here we show that human FoxP3+CD4+ T cells are composed of three phenotypically and functionally distinct subpopulations: CD45RA+FoxP3low resting Tregs (rTregs) and CD45RA-FoxP3high activated Tregs (aTregs), both of which are suppressive in vitro, and cytokine-secreting CD45RA-FoxP3low non-suppressive T cells. The proportion of the three subpopulations characteristically altered in cord blood, aged individuals, and patients with immunological diseases. Terminally differentiated aTregs rapidly die while rTregs proliferate and convert into aTregs in vitro and in vivo as shown by the transfer of rTregs into NOD-scid-common gamma-chain-knockout mice and by TCR sequence-based T cell clonotype tracing in peripheral blood of normal individuals. Taken together, the dissection of FoxP3+ cells into subsets enables one to analyze Treg differentiation dynamics and interactions in normal and disease states, and to control immune responses through manipulating particular FoxP3+ subpopulations.					55812	146330	122258	10300	3598	146050	124626	223082	65243	163033	79230	84330	84124	79750	84905	80778	7746	7701	7545	150244	389874	7455	51646	78992	7485	7484	116143	55339	11169	284415	55737	139538	9341	257313	51118	124739	400952	201294	56886	84993	5412	10277	148581	51465	7321	55236	9039	11334	7288	10383	83868	150465	57217	23548	7264	140803	9320	339976	55521	10626	122553	22906	80305	7172	7167	8626	58476	90313	26092	56993	7128	7124	55217	55362	29100	25907	83935	84233	128218	145942	30012	7099	83660	7093	116238	7083	26277	7076	653252	10440	497189	7068	7058	7056	343641	7032	56159	23424	6953	6926	55171	9882	64420	10494	8576	8614	93653	6764	6345	9789	26010	375686	84690	9825	353324	347689	6664	8724	9892	333929	4086	23315	6553	83697	6522	29015	124935	284129	91137	5250	5002	6580	162515	6461	151246	327657	253190	55964	57556	64218	10952	9871	10483	23478	6340	117156	8796	192683	29115	64092	55511	9294	6286	140576	23623	83597	132112	57142	728194	6240	6199	6184	6123	6121	152015	6093	6092	257160	25897	9921	8153	8635	389	79651	57139	5973	161253	11030	55131	51655	5912	29098	10048	642636	11021	84932	149628	5836	137902	81607	5817	126789	11122	26469	401494	84722	5623	56984	5687	5683
GSE15659_NAIVE_CD4_TCELL_VS_ACTIVATED_TREG_UP	M3549		19464196	Miyara M,Yoshioka Y,Kitoh A,Shima T,Wing K,Niwa A,Parizot C,Taflin C,Heike T,Valeyre D,Mathian A,Nakahata T,Yamaguchi T,Nomura T,Ono M,Amoura Z,Gorochov G,Sakaguchi S.	GSE15659	GSE15659_1419_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive CD4 [GeneID=920] T cells versus activated regulatory T cell (Treg).	Gene expression profiles of subsets of CD4+ T cells according to their expression of FoxP3 and CD45RA were compared. FoxP3 is a key transcription factor for the development and function of natural CD4+ regulatory T cells (Tregs). Here we show that human FoxP3+CD4+ T cells are composed of three phenotypically and functionally distinct subpopulations: CD45RA+FoxP3low resting Tregs (rTregs) and CD45RA-FoxP3high activated Tregs (aTregs), both of which are suppressive in vitro, and cytokine-secreting CD45RA-FoxP3low non-suppressive T cells. The proportion of the three subpopulations characteristically altered in cord blood, aged individuals, and patients with immunological diseases. Terminally differentiated aTregs rapidly die while rTregs proliferate and convert into aTregs in vitro and in vivo as shown by the transfer of rTregs into NOD-scid-common gamma-chain-knockout mice and by TCR sequence-based T cell clonotype tracing in peripheral blood of normal individuals. Taken together, the dissection of FoxP3+ cells into subsets enables one to analyze Treg differentiation dynamics and interactions in normal and disease states, and to control immune responses through manipulating particular FoxP3+ subpopulations.					84696	641372	92370	92	57188	115	60312	375790	221264	238	84266	200420	8092	60529	51281	284615	134548	339416	57719	90586	10717	80830	27237	128272	79642	344905	22893	8424	582	144233	53335	100499483	627	389206	637	10904	399761	388962	671	220004	283551	348110	79447	79701	147081	80233	55181	84322	126321	114905	51430	56683	25966	55345	132989	60684	63914	51250	221416	157556	55071	767	91768	51475	773	59284	796	57118	23271	93661	200014	55013	84317	80071	79140	51372	6351	219771	9973	57124	959	4179	926	55755	1040	23177	1069	84952	80205	1119	1135	1141	1146	163732	1182	8218	116173	26504	4850	285888	9382	1300	131873	26958	1346	8895	1380	51185	148327	1453	1475	8029	9547	392459	1573	23500	51339	23564	64798	25787	79132	10683	1745	127343	201625	55466	83475	1807	64118	11062	11072	10455	1893	1936	9521	100130771	9451	27335	256364	5169	347918	2039	9852	10961	2113	2120	51466	2128	55770	374393	220382	51313	158724	55199	144699	23403	8074	100131561	55338	285759	285736	645524	642691	401260	440556	644283	645566	23401	2521	23766	200959	23464	647309	2707	221914	2719	51184	2882	10750	116444	2948	2965	2982	60558	91316	3035	51564	9931	3009	255626	3167	3181	3242	8739	3292	3294	3361	3381	3620	10964
GSE15659_NAIVE_CD4_TCELL_VS_ACTIVATED_TREG_DN	M3550		19464196	Miyara M,Yoshioka Y,Kitoh A,Shima T,Wing K,Niwa A,Parizot C,Taflin C,Heike T,Valeyre D,Mathian A,Nakahata T,Yamaguchi T,Nomura T,Ono M,Amoura Z,Gorochov G,Sakaguchi S.	GSE15659	GSE15659_1419_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus activated regulatory T cell (Treg).	Gene expression profiles of subsets of CD4+ T cells according to their expression of FoxP3 and CD45RA were compared. FoxP3 is a key transcription factor for the development and function of natural CD4+ regulatory T cells (Tregs). Here we show that human FoxP3+CD4+ T cells are composed of three phenotypically and functionally distinct subpopulations: CD45RA+FoxP3low resting Tregs (rTregs) and CD45RA-FoxP3high activated Tregs (aTregs), both of which are suppressive in vitro, and cytokine-secreting CD45RA-FoxP3low non-suppressive T cells. The proportion of the three subpopulations characteristically altered in cord blood, aged individuals, and patients with immunological diseases. Terminally differentiated aTregs rapidly die while rTregs proliferate and convert into aTregs in vitro and in vivo as shown by the transfer of rTregs into NOD-scid-common gamma-chain-knockout mice and by TCR sequence-based T cell clonotype tracing in peripheral blood of normal individuals. Taken together, the dissection of FoxP3+ cells into subsets enables one to analyze Treg differentiation dynamics and interactions in normal and disease states, and to control immune responses through manipulating particular FoxP3+ subpopulations.					114036	146050	124626	30834	100302737	169270	79230	84330	84124	80778	388569	7576	11179	7701	83637	7545	677	7763	389874	23091	100381270	7455	7485	116143	11169	7453	9341	257313	124739	400952	7367	643763	84993	5412	10277	148581	51465	7307	150465	57217	23548	7264	7257	140803	9320	339976	10626	122553	22906	7177	7172	7167	8626	58476	90313	26092	7156	56993	7124	51234	29100	340061	25907	83935	84233	128218	145942	64114	7099	116238	7083	26277	10440	7068	7058	7032	23424	6953	6926	55171	9882	50835	6854	202374	10494	8576	134429	93653	6764	6746	6345	245711	26010	375686	79029	353324	347689	6664	8724	9410	26783	25992	9892	6591	200172	23315	6553	6534	83697	6522	50651	126969	29015	254428	7922	27173	148641	83884	5002	6580	162515	6472	388336	6461	4068	151246	10262	51639	55964	22928	8482	57556	64218	9871	10483	9997	6334	117156	8796	91179	54938	29115	55511	9294	140576	23623	83597	132112	728194	89765	6240	51121	6121	6098	152015	6093	257160	25897	26001	7737	9921	399	389	54933	5999	26575	5973	161253	343035	11030	55131	51655	5912	29098	10048	10267	51762	84932	149628	137902	81607	5817	26469	5746	84722	56984	5687	5683	5663	79057	53632	10394	10549	639	390999	51029	151987	5525	5518	152926
GSE15659_CD45RA_NEG_CD4_TCELL_VS_RESTING_TREG_UP	M3551		19464196	Miyara M,Yoshioka Y,Kitoh A,Shima T,Wing K,Niwa A,Parizot C,Taflin C,Heike T,Valeyre D,Mathian A,Nakahata T,Yamaguchi T,Nomura T,Ono M,Amoura Z,Gorochov G,Sakaguchi S.	GSE15659	GSE15659_1420_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of PTPRC- [GeneID=5788] CD4 [GeneID=920] T cells versus PTPRC+ [GeneID=5788] resting regulatory T cell (Treg).	Gene expression profiles of subsets of CD4+ T cells according to their expression of FoxP3 and CD45RA were compared. FoxP3 is a key transcription factor for the development and function of natural CD4+ regulatory T cells (Tregs). Here we show that human FoxP3+CD4+ T cells are composed of three phenotypically and functionally distinct subpopulations: CD45RA+FoxP3low resting Tregs (rTregs) and CD45RA-FoxP3high activated Tregs (aTregs), both of which are suppressive in vitro, and cytokine-secreting CD45RA-FoxP3low non-suppressive T cells. The proportion of the three subpopulations characteristically altered in cord blood, aged individuals, and patients with immunological diseases. Terminally differentiated aTregs rapidly die while rTregs proliferate and convert into aTregs in vitro and in vivo as shown by the transfer of rTregs into NOD-scid-common gamma-chain-knockout mice and by TCR sequence-based T cell clonotype tracing in peripheral blood of normal individuals. Taken together, the dissection of FoxP3+ cells into subsets enables one to analyze Treg differentiation dynamics and interactions in normal and disease states, and to control immune responses through manipulating particular FoxP3+ subpopulations.					3361	390999	1456	9908	83729	399884	18	38	91703	8754	27299	11096	57188	113	115	137872	60312	55750	137964	8540	202	126133	160428	60529	271	51378	286	307	8907	26985	9411	2909	128272	7984	151188	406	420	8853	142685	56676	25842	80161	11016	537	527	8455	6310	92552	57099	22893	11177	8424	79370	602	627	389206	27319	637	399761	388962	100505510	671	219793	83695	79794	283643	348110	79415	84322	114905	127687	149466	9473	25775	150590	394261	55345	79625	132989	260436	389320	63914	221416	729515	129790	138241	91768	51475	85438	59284	796	57118	836	841	55871	646019	200014	55013	64753	100129792	80125	28958	51372	440193	90324	899	25819	57124	959	926	28513	10423	983	27443	1062	55839	22897	1066	1069	79586	1134	1137	55501	1147	9075	161198	64581	1191	116173	285888	1289	28991	149951	22820	23406	1346	10814	8895	151835	1380	51185	10675	140880	1471	30848	1497	8029	9547	392459	645090	1571	199974	167227	25787	79982	54943	23234	1775	8448	83475	135656	1807	11072	1869	9521	100130771	23167	8669	27335	56648	55520	9844	953	956	8320	2039	27248	2120	51513	55770	51013	2140	55179	79607	219287	158724	442444	55177	128876	619423	144699	200933	54461	84261	2273	55338	283401	285759	285736	2353
GSE15659_CD45RA_NEG_CD4_TCELL_VS_RESTING_TREG_DN	M3552		19464196	Miyara M,Yoshioka Y,Kitoh A,Shima T,Wing K,Niwa A,Parizot C,Taflin C,Heike T,Valeyre D,Mathian A,Nakahata T,Yamaguchi T,Nomura T,Ono M,Amoura Z,Gorochov G,Sakaguchi S.	GSE15659	GSE15659_1420_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of PTPRC- [GeneID=5788] CD4 [GeneID=920] T cells versus PTPRC+ [GeneID=5788] resting regulatory T cell (Treg).	Gene expression profiles of subsets of CD4+ T cells according to their expression of FoxP3 and CD45RA were compared. FoxP3 is a key transcription factor for the development and function of natural CD4+ regulatory T cells (Tregs). Here we show that human FoxP3+CD4+ T cells are composed of three phenotypically and functionally distinct subpopulations: CD45RA+FoxP3low resting Tregs (rTregs) and CD45RA-FoxP3high activated Tregs (aTregs), both of which are suppressive in vitro, and cytokine-secreting CD45RA-FoxP3low non-suppressive T cells. The proportion of the three subpopulations characteristically altered in cord blood, aged individuals, and patients with immunological diseases. Terminally differentiated aTregs rapidly die while rTregs proliferate and convert into aTregs in vitro and in vivo as shown by the transfer of rTregs into NOD-scid-common gamma-chain-knockout mice and by TCR sequence-based T cell clonotype tracing in peripheral blood of normal individuals. Taken together, the dissection of FoxP3+ cells into subsets enables one to analyze Treg differentiation dynamics and interactions in normal and disease states, and to control immune responses through manipulating particular FoxP3+ subpopulations.					8243	9736	146050	136051	124411	57592	79788	100130934	79027	84146	65243	169270	92285	163033	79230	51710	80264	84124	30832	23567	84905	388569	57336	26974	11179	10795	7746	7741	7690	83637	7545	7763	150244	158866	389874	7455	7528	79693	78992	7484	29062	197335	112840	54663	55779	10785	23063	7434	7423	114990	55813	84294	8239	7874	124739	7372	643763	7349	130507	148581	11334	10426	64595	440307	23170	7268	54970	203062	80705	9819	140803	9321	57159	55521	22906	7172	7157	7156	9868	7143	7134	8742	9087	55217	27346	54968	388335	128218	55374	30012	83660	7093	116238	653252	79228	7058	7056	343641	90655	7029	55852	9894	6948	6920	6926	9882	83874	50835	6854	55061	23353	27284	8801	202374	10494	8614	93653	6746	85464	10250	6345	245711	9789	375686	55812	84690	122258	80320	93349	26783	724102	85028	9892	23381	64744	200172	23315	6534	83959	50651	29015	124935	9906	23169	80024	162515	6497	6461	22941	9905	151246	23451	79918	23067	55964	8482	57556	81929	10806	10807	9672	6334	117156	677766	91179	54938	401474	140576	83597	132112	50484	10325	6198	6189	442216	6123	6121	84268	6098	50862	6016	134701	54933	57139	29803	161253	55285	23637	339122	84440	126789	54517	23369	51495	118672	5623	85481	574414	55015	8842
GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_UP	M3553		19464196	Miyara M,Yoshioka Y,Kitoh A,Shima T,Wing K,Niwa A,Parizot C,Taflin C,Heike T,Valeyre D,Mathian A,Nakahata T,Yamaguchi T,Nomura T,Ono M,Amoura Z,Gorochov G,Sakaguchi S.	GSE15659	GSE15659_1421_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of PTPRC- [GeneID=5788] CD4 [GeneID=920] T cells versus non-suppressive T cells.	Gene expression profiles of subsets of CD4+ T cells according to their expression of FoxP3 and CD45RA were compared. FoxP3 is a key transcription factor for the development and function of natural CD4+ regulatory T cells (Tregs). Here we show that human FoxP3+CD4+ T cells are composed of three phenotypically and functionally distinct subpopulations: CD45RA+FoxP3low resting Tregs (rTregs) and CD45RA-FoxP3high activated Tregs (aTregs), both of which are suppressive in vitro, and cytokine-secreting CD45RA-FoxP3low non-suppressive T cells. The proportion of the three subpopulations characteristically altered in cord blood, aged individuals, and patients with immunological diseases. Terminally differentiated aTregs rapidly die while rTregs proliferate and convert into aTregs in vitro and in vivo as shown by the transfer of rTregs into NOD-scid-common gamma-chain-knockout mice and by TCR sequence-based T cell clonotype tracing in peripheral blood of normal individuals. Taken together, the dissection of FoxP3+ cells into subsets enables one to analyze Treg differentiation dynamics and interactions in normal and disease states, and to control immune responses through manipulating particular FoxP3+ subpopulations.					83729	399884	27253	14	92	27299	11096	92949	57188	115	131	121536	60312	55750	137964	126133	160428	84266	239	60529	80830	2909	394	128272	7984	10124	420	142689	140461	25842	220202	344905	374973	8455	92552	27087	8424	582	144233	53335	79370	54880	617	627	637	10904	388962	671	128859	219793	83695	144608	283551	388011	348110	414926	79447	79701	147081	80233	84322	126321	284369	51430	24141	140856	54094	150590	285382	55345	79625	389320	221322	221416	100507249	138241	51475	59284	796	57118	55871	646019	55013	84317	80071	100129792	79140	28958	51372	54482	440193	219771	25819	959	924	926	1013	53841	56971	23177	1066	1069	84952	5119	79586	1133	1134	1137	1140	1141	55501	9075	8218	1191	285888	23242	28991	10814	8895	151835	1442	1460	10675	140880	30848	1075	2920	645090	1535	23191	1540	1573	199974	9266	9595	51339	1603	84771	79132	1738	1745	79982	54943	1775	1794	83475	135656	1807	64118	11072	100130771	27335	56648	954	956	2039	79852	2113	2120	51466	2128	55770	23265	55179	219287	93343	89853	158724	9130	55177	128876	619423	55199	157693	2191	144699	146330	84261	2258	2273	79147	55338	79904	401081	403150	283401	285759	163742	401260	441094	644283	114984	2353	2300	80020	92973	2356	10468	2495	139341
GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN	M3554		19464196	Miyara M,Yoshioka Y,Kitoh A,Shima T,Wing K,Niwa A,Parizot C,Taflin C,Heike T,Valeyre D,Mathian A,Nakahata T,Yamaguchi T,Nomura T,Ono M,Amoura Z,Gorochov G,Sakaguchi S.	GSE15659	GSE15659_1421_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of PTPRC- [GeneID=5788] CD4 [GeneID=920] T cells versus non-suppressive T cells.	Gene expression profiles of subsets of CD4+ T cells according to their expression of FoxP3 and CD45RA were compared. FoxP3 is a key transcription factor for the development and function of natural CD4+ regulatory T cells (Tregs). Here we show that human FoxP3+CD4+ T cells are composed of three phenotypically and functionally distinct subpopulations: CD45RA+FoxP3low resting Tregs (rTregs) and CD45RA-FoxP3high activated Tregs (aTregs), both of which are suppressive in vitro, and cytokine-secreting CD45RA-FoxP3low non-suppressive T cells. The proportion of the three subpopulations characteristically altered in cord blood, aged individuals, and patients with immunological diseases. Terminally differentiated aTregs rapidly die while rTregs proliferate and convert into aTregs in vitro and in vivo as shown by the transfer of rTregs into NOD-scid-common gamma-chain-knockout mice and by TCR sequence-based T cell clonotype tracing in peripheral blood of normal individuals. Taken together, the dissection of FoxP3+ cells into subsets enables one to analyze Treg differentiation dynamics and interactions in normal and disease states, and to control immune responses through manipulating particular FoxP3+ subpopulations.					8243	9473	122258	4853	8509	3598	146050	9753	223082	65988	124411	57592	65243	163033	79230	9668	80264	84124	30832	84905	80778	100131017	57336	11179	7752	7701	7690	83637	7763	84240	55854	7455	78992	11197	7453	51096	51118	8239	124739	8237	201294	7367	5412	148581	7321	55236	9039	7288	51174	10383	83868	57217	7264	7260	140803	7205	55521	10626	122553	80305	7172	8626	7157	7156	56993	8742	9087	27346	283232	55362	340061	25907	84233	55374	7099	7093	7083	7068	7058	7056	55145	343641	56158	56159	6953	90843	6926	9882	6854	55061	23353	9515	202374	10494	8576	8614	93653	85464	6345	9789	26010	375686	79029	6678	25992	9892	64744	4086	200172	23315	83697	29015	124935	9906	284129	91137	5250	80024	5002	162515	6497	6472	6461	151246	51639	23067	22928	57556	64218	9871	6397	23478	10806	10807	91179	54938	64092	9294	6286	140576	132112	57142	10325	6189	257160	57484	50862	8153	6016	26575	57139	5973	161253	343035	55285	51655	5921	29098	10048	253959	51762	11021	84932	84440	149628	5836	137902	81607	126789	5746	5623	56984	85481	574414	5625	10935	84106	5539	84988	10848	10621	87178	10733	729359	389072	79990	84725	5338	5330	151056	27039	9033	29992	118788	284098	55650	5828	375033	64236	84759
GSE15659_CD45RA_NEG_CD4_TCELL_VS_ACTIVATED_TREG_UP	M3555		19464196	Miyara M,Yoshioka Y,Kitoh A,Shima T,Wing K,Niwa A,Parizot C,Taflin C,Heike T,Valeyre D,Mathian A,Nakahata T,Yamaguchi T,Nomura T,Ono M,Amoura Z,Gorochov G,Sakaguchi S.	GSE15659	GSE15659_1422_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of PTPRC- [GeneID=5788] CD4 [GeneID=920] T cells versus activated regulatory T cell (Treg).	Gene expression profiles of subsets of CD4+ T cells according to their expression of FoxP3 and CD45RA were compared. FoxP3 is a key transcription factor for the development and function of natural CD4+ regulatory T cells (Tregs). Here we show that human FoxP3+CD4+ T cells are composed of three phenotypically and functionally distinct subpopulations: CD45RA+FoxP3low resting Tregs (rTregs) and CD45RA-FoxP3high activated Tregs (aTregs), both of which are suppressive in vitro, and cytokine-secreting CD45RA-FoxP3low non-suppressive T cells. The proportion of the three subpopulations characteristically altered in cord blood, aged individuals, and patients with immunological diseases. Terminally differentiated aTregs rapidly die while rTregs proliferate and convert into aTregs in vitro and in vivo as shown by the transfer of rTregs into NOD-scid-common gamma-chain-knockout mice and by TCR sequence-based T cell clonotype tracing in peripheral blood of normal individuals. Taken together, the dissection of FoxP3+ cells into subsets enables one to analyze Treg differentiation dynamics and interactions in normal and disease states, and to control immune responses through manipulating particular FoxP3+ subpopulations.					64114	84696	641372	92370	57180	27299	57188	115	131	121536	60312	55750	137964	375790	160428	84266	80216	60529	51378	51281	134548	339416	90586	9411	2909	394	128272	25820	10124	79642	420	142685	56676	25842	80161	220202	344905	374973	92552	57099	552	27087	22893	11177	8424	627	389206	10904	51027	671	9044	219793	282966	90488	83695	283551	388011	57184	348110	79447	79701	80233	55181	92340	84322	126321	114905	149466	51430	140856	56683	150590	394261	55345	132989	389320	63914	221322	221416	286122	157556	91768	51475	773	59284	796	57118	57513	646019	200014	100129792	80125	90324	219771	25819	9973	959	4179	924	246184	28513	53841	55755	1040	56971	27443	23177	1066	80205	79586	1135	1137	1141	163732	8218	1191	116173	285888	25920	8161	1300	131873	10814	8895	51185	148327	1453	1471	1475	8029	9547	58191	392459	645090	23191	643160	1571	199974	57105	51339	1603	79016	203522	25787	79132	26070	10683	1745	8632	1775	135656	1807	64118	1780	1936	100130771	1947	5610	9451	5169	954	956	2039	27248	2120	2128	55770	55179	89853	158724	83723	55177	146330	84261	8074	2273	79147	283401	285759	285736	401260	441094	644283	114984	54752	2353	2356	161835	10468	2521	53827	23766	200959	23464	50628	9945	2674	23062	155038	2707
GSE15659_CD45RA_NEG_CD4_TCELL_VS_ACTIVATED_TREG_DN	M3557		19464196	Miyara M,Yoshioka Y,Kitoh A,Shima T,Wing K,Niwa A,Parizot C,Taflin C,Heike T,Valeyre D,Mathian A,Nakahata T,Yamaguchi T,Nomura T,Ono M,Amoura Z,Gorochov G,Sakaguchi S.	GSE15659	GSE15659_1422_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of PTPRC- [GeneID=5788] CD4 [GeneID=920] T cells versus activated regulatory T cell (Treg).	Gene expression profiles of subsets of CD4+ T cells according to their expression of FoxP3 and CD45RA were compared. FoxP3 is a key transcription factor for the development and function of natural CD4+ regulatory T cells (Tregs). Here we show that human FoxP3+CD4+ T cells are composed of three phenotypically and functionally distinct subpopulations: CD45RA+FoxP3low resting Tregs (rTregs) and CD45RA-FoxP3high activated Tregs (aTregs), both of which are suppressive in vitro, and cytokine-secreting CD45RA-FoxP3low non-suppressive T cells. The proportion of the three subpopulations characteristically altered in cord blood, aged individuals, and patients with immunological diseases. Terminally differentiated aTregs rapidly die while rTregs proliferate and convert into aTregs in vitro and in vivo as shown by the transfer of rTregs into NOD-scid-common gamma-chain-knockout mice and by TCR sequence-based T cell clonotype tracing in peripheral blood of normal individuals. Taken together, the dissection of FoxP3+ cells into subsets enables one to analyze Treg differentiation dynamics and interactions in normal and disease states, and to control immune responses through manipulating particular FoxP3+ subpopulations.					26575	268	146050	30834	65988	124411	57592	100130934	169270	348327	84124	79750	100131017	7752	7690	83637	196441	150244	84240	389874	23091	7455	7528	51646	78992	7485	116143	29062	55339	7453	80124	51118	124739	9736	8237	7367	643763	130507	84993	5412	148581	51465	55236	9039	219743	11334	10426	10383	83868	150465	54970	7264	7260	140803	7205	9320	339976	10626	122553	7177	7175	7172	58476	26092	7156	8742	9087	27346	51234	29100	340061	55374	7099	26277	10440	497189	7068	7058	55145	343641	7032	6953	90843	9882	50835	6854	387082	9515	8675	8677	202374	10494	8576	134429	10948	93653	6764	6746	6345	245711	375686	84690	347689	26783	25992	9892	23381	64744	4086	23315	83697	6522	50651	29015	124935	254428	27173	148641	9906	5250	83884	80024	9122	6497	6472	388336	4068	151246	51639	23451	23067	55964	22928	57556	64218	9871	10483	6397	10806	9672	9997	6334	91179	54938	29115	10284	64092	9294	6286	132112	57142	728194	89765	6240	6199	51121	84268	6098	152015	6093	257160	57484	7737	9921	399	54933	5999	5973	343035	10267	23637	51762	84932	84440	149628	81607	401494	84722	56984	5683	8842	10544	10196	53632	10935	639	151987	5525	5515	10848	84513	10248	57804	87178	10733	440503	729359	389072	79990	5330
GSE15659_RESTING_TREG_VS_NONSUPPRESSIVE_TCELL_UP	M3558		19464196	Miyara M,Yoshioka Y,Kitoh A,Shima T,Wing K,Niwa A,Parizot C,Taflin C,Heike T,Valeyre D,Mathian A,Nakahata T,Yamaguchi T,Nomura T,Ono M,Amoura Z,Gorochov G,Sakaguchi S.	GSE15659	GSE15659_1423_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of resting regulatory T cell (Treg) versus non-suppressive T cells.	Gene expression profiles of subsets of CD4+ T cells according to their expression of FoxP3 and CD45RA were compared. FoxP3 is a key transcription factor for the development and function of natural CD4+ regulatory T cells (Tregs). Here we show that human FoxP3+CD4+ T cells are composed of three phenotypically and functionally distinct subpopulations: CD45RA+FoxP3low resting Tregs (rTregs) and CD45RA-FoxP3high activated Tregs (aTregs), both of which are suppressive in vitro, and cytokine-secreting CD45RA-FoxP3low non-suppressive T cells. The proportion of the three subpopulations characteristically altered in cord blood, aged individuals, and patients with immunological diseases. Terminally differentiated aTregs rapidly die while rTregs proliferate and convert into aTregs in vitro and in vivo as shown by the transfer of rTregs into NOD-scid-common gamma-chain-knockout mice and by TCR sequence-based T cell clonotype tracing in peripheral blood of normal individuals. Taken together, the dissection of FoxP3+ cells into subsets enables one to analyze Treg differentiation dynamics and interactions in normal and disease states, and to control immune responses through manipulating particular FoxP3+ subpopulations.					83729	399884	255027	116143	14	29777	39	11096	92949	375790	189	238	84266	239	8092	60529	273	134548	10717	394	27237	25820	10124	415	142689	51666	56676	25842	55210	472	537	527	374973	8455	342371	92552	8424	582	53335	79370	54880	100499483	389206	10904	51027	128859	9044	219793	282966	25906	90488	283551	348110	414926	400360	79447	79701	124773	147081	92340	284369	114905	715	148898	51430	400831	140856	56683	150590	285382	55345	63914	414319	51490	55071	340591	767	91768	8913	59284	796	57118	29775	646019	55013	84317	80071	100129792	25790	79140	54482	440193	9973	916	4179	924	926	246184	1013	53841	55755	634	56971	60677	1066	8545	84952	79145	1119	10752	79586	1133	1134	1135	1140	1146	1182	8218	1261	4850	285888	1271	23242	9382	8161	131873	26958	10814	8895	9362	1442	1453	1456	10675	140880	10047	30848	1515	2920	643160	9266	1603	79877	8886	203522	64798	79132	10683	1745	127343	8632	55466	83475	1807	64118	11062	10455	1936	1947	27335	146956	129080	90187	256364	5169	339221	954	956	8320	347918	79852	9852	1161	10961	2113	374393	219287	139285	89853	23116	220382	63895	158724	55199	2191	57666	144699	146330	23403	51661	55025	401081	403150	283401	649446	645524	163742	401260	644283	114984
GSE15659_RESTING_TREG_VS_NONSUPPRESSIVE_TCELL_DN	M3560		19464196	Miyara M,Yoshioka Y,Kitoh A,Shima T,Wing K,Niwa A,Parizot C,Taflin C,Heike T,Valeyre D,Mathian A,Nakahata T,Yamaguchi T,Nomura T,Ono M,Amoura Z,Gorochov G,Sakaguchi S.	GSE15659	GSE15659_1423_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of resting regulatory T cell (Treg) versus non-suppressive T cells.	Gene expression profiles of subsets of CD4+ T cells according to their expression of FoxP3 and CD45RA were compared. FoxP3 is a key transcription factor for the development and function of natural CD4+ regulatory T cells (Tregs). Here we show that human FoxP3+CD4+ T cells are composed of three phenotypically and functionally distinct subpopulations: CD45RA+FoxP3low resting Tregs (rTregs) and CD45RA-FoxP3high activated Tregs (aTregs), both of which are suppressive in vitro, and cytokine-secreting CD45RA-FoxP3low non-suppressive T cells. The proportion of the three subpopulations characteristically altered in cord blood, aged individuals, and patients with immunological diseases. Terminally differentiated aTregs rapidly die while rTregs proliferate and convert into aTregs in vitro and in vivo as shown by the transfer of rTregs into NOD-scid-common gamma-chain-knockout mice and by TCR sequence-based T cell clonotype tracing in peripheral blood of normal individuals. Taken together, the dissection of FoxP3+ cells into subsets enables one to analyze Treg differentiation dynamics and interactions in normal and disease states, and to control immune responses through manipulating particular FoxP3+ subpopulations.					8243	80830	122258	84270	124626	223082	114991	84330	7701	83637	196441	84240	100381270	7455	78992	10413	54739	8838	11197	55339	11169	7453	55737	139538	80124	257313	51118	201294	7367	51366	84993	5412	56061	148581	51465	9039	7307	7297	83868	150465	57217	9694	23548	7264	140803	7205	9320	339976	84675	55521	23321	10626	122553	7172	58476	90313	26092	7150	8742	51234	55362	29100	25907	135932	84233	64114	7083	261726	26277	7076	10440	7056	56158	56159	23424	9882	23216	255928	64420	387082	9515	27148	202374	10494	10948	93653	6741	6345	375686	347689	6664	8724	9892	333929	6591	4086	200172	23315	10479	83697	29015	124935	254428	148641	5250	283652	5002	9122	51639	327657	55964	51091	22928	64218	10952	9871	6340	91179	29115	64092	55511	9294	6286	23623	132112	83861	728194	6199	6189	51121	6121	152015	6093	6092	257160	25897	57484	9921	58480	389	79651	5973	161253	11030	51655	5921	9367	84932	149628	5836	137902	81607	25930	26469	5746	84722	5623	56984	5687	85481	5663	5613	5577	10394	10549	10935	639	84106	151987	5515	84988	10248	10621	5435	87178	5411	5371	5354	10733	729359	55111	5337	5330	151056	257000	5320	11145	29941	9033	55650	22822	5196	375033	64236	5148	5137	5136	9141	84108	9708
GSE15659_RESTING_VS_ACTIVATED_TREG_UP	M3561		19464196	Miyara M,Yoshioka Y,Kitoh A,Shima T,Wing K,Niwa A,Parizot C,Taflin C,Heike T,Valeyre D,Mathian A,Nakahata T,Yamaguchi T,Nomura T,Ono M,Amoura Z,Gorochov G,Sakaguchi S.	GSE15659	GSE15659_1424_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of resting regulatory T cell (Treg) versus activated regulatory T cell (Treg).	Gene expression profiles of subsets of CD4+ T cells according to their expression of FoxP3 and CD45RA were compared. FoxP3 is a key transcription factor for the development and function of natural CD4+ regulatory T cells (Tregs). Here we show that human FoxP3+CD4+ T cells are composed of three phenotypically and functionally distinct subpopulations: CD45RA+FoxP3low resting Tregs (rTregs) and CD45RA-FoxP3high activated Tregs (aTregs), both of which are suppressive in vitro, and cytokine-secreting CD45RA-FoxP3low non-suppressive T cells. The proportion of the three subpopulations characteristically altered in cord blood, aged individuals, and patients with immunological diseases. Terminally differentiated aTregs rapidly die while rTregs proliferate and convert into aTregs in vitro and in vivo as shown by the transfer of rTregs into NOD-scid-common gamma-chain-knockout mice and by TCR sequence-based T cell clonotype tracing in peripheral blood of normal individuals. Taken together, the dissection of FoxP3+ cells into subsets enables one to analyze Treg differentiation dynamics and interactions in normal and disease states, and to control immune responses through manipulating particular FoxP3+ subpopulations.					6833	84696	641372	92370	57180	92949	60312	221264	238	84266	239	80216	60529	51378	51281	284615	134548	339416	90586	10717	394	27237	25820	415	79642	142689	51666	56676	80161	374973	342371	92552	552	8424	144233	100499483	627	10904	51027	671	128859	9044	696	219793	29125	25906	283551	388011	348110	400360	79447	147081	80233	92340	126321	114905	149466	148898	51430	400831	140856	54094	56683	394261	132989	63914	221322	221416	286122	157556	414319	55071	767	51475	773	59284	796	57118	23271	93661	29775	57513	55013	80071	100129792	54482	6351	219771	9973	916	4179	924	926	55755	1040	634	56971	23177	79145	80205	10752	79586	1135	1137	1146	163732	8218	1191	116173	150384	4850	285888	1271	9382	8161	1300	10814	148327	10675	1471	10047	1475	1515	51596	9547	392459	1536	643160	1573	9420	57105	23500	51339	8886	168400	64798	25787	10170	79132	26070	8632	55466	57572	1807	64118	11062	11072	1780	10455	1936	1947	9451	146956	129080	256364	5169	954	956	8320	9852	1161	374393	139285	93343	89853	220382	63895	158724	83723	55199	157693	2191	84893	23403	84261	2258	8074	161247	51661	79147	55338	79904	55025	285736	645524	401260	440556	644283	645566	54752	2353	2356	23401	161835	79068	2521	23766	200959	283459	647309
GSE15659_RESTING_VS_ACTIVATED_TREG_DN	M3563		19464196	Miyara M,Yoshioka Y,Kitoh A,Shima T,Wing K,Niwa A,Parizot C,Taflin C,Heike T,Valeyre D,Mathian A,Nakahata T,Yamaguchi T,Nomura T,Ono M,Amoura Z,Gorochov G,Sakaguchi S.	GSE15659	GSE15659_1424_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of resting regulatory T cell (Treg) versus activated regulatory T cell (Treg).	Gene expression profiles of subsets of CD4+ T cells according to their expression of FoxP3 and CD45RA were compared. FoxP3 is a key transcription factor for the development and function of natural CD4+ regulatory T cells (Tregs). Here we show that human FoxP3+CD4+ T cells are composed of three phenotypically and functionally distinct subpopulations: CD45RA+FoxP3low resting Tregs (rTregs) and CD45RA-FoxP3high activated Tregs (aTregs), both of which are suppressive in vitro, and cytokine-secreting CD45RA-FoxP3low non-suppressive T cells. The proportion of the three subpopulations characteristically altered in cord blood, aged individuals, and patients with immunological diseases. Terminally differentiated aTregs rapidly die while rTregs proliferate and convert into aTregs in vitro and in vivo as shown by the transfer of rTregs into NOD-scid-common gamma-chain-knockout mice and by TCR sequence-based T cell clonotype tracing in peripheral blood of normal individuals. Taken together, the dissection of FoxP3+ cells into subsets enables one to analyze Treg differentiation dynamics and interactions in normal and disease states, and to control immune responses through manipulating particular FoxP3+ subpopulations.					692247	124626	223082	30834	339500	100130934	114991	169270	84330	84124	79750	80778	388569	57336	7576	83637	196441	7763	150244	84240	23091	100381270	7455	7528	54739	7485	8838	116143	11169	7453	51160	80124	9341	257313	201294	7367	56886	51366	84993	56061	148581	7321	9039	7307	7297	11334	7288	83868	150465	57217	9694	23548	7264	7260	7257	140803	7205	9320	339976	84675	10626	80305	7172	7167	58476	26092	7150	56993	8742	7128	7124	51234	54968	29100	135932	84233	64114	7083	261726	497189	7068	55145	7032	56158	23424	9882	23216	6854	64420	387082	8677	27148	202374	10494	134429	93653	6764	6345	26010	375686	79029	84690	9825	347689	6664	8724	26783	9892	64744	200172	23315	10479	6534	83697	126969	29015	27173	148641	65010	91137	5250	283652	5002	9122	388336	4068	151246	51639	23451	55964	22928	10952	9871	9672	9997	6334	54938	29115	55511	9294	6286	23623	132112	83861	728194	89765	6240	51121	6098	6093	257160	26001	57484	9921	6016	58480	389	5999	26575	343035	23186	55285	10616	5912	29098	10048	5901	10267	9367	84932	149628	5836	81607	25930	401494	2185	84722	5623	56984	5683	5663	10544	114224	5613	53632	10394	10549	10935	84106	5539	51029	5525	5518	5515	152926	5495	51535	10248	10621	5435
GSE15659_NONSUPPRESSIVE_TCELL_VS_ACTIVATED_TREG_UP	M3566		19464196	Miyara M,Yoshioka Y,Kitoh A,Shima T,Wing K,Niwa A,Parizot C,Taflin C,Heike T,Valeyre D,Mathian A,Nakahata T,Yamaguchi T,Nomura T,Ono M,Amoura Z,Gorochov G,Sakaguchi S.	GSE15659	GSE15659_1425_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of non-suppressive T cells versus activated regulatory T cell (Treg).	Gene expression profiles of subsets of CD4+ T cells according to their expression of FoxP3 and CD45RA were compared. FoxP3 is a key transcription factor for the development and function of natural CD4+ regulatory T cells (Tregs). Here we show that human FoxP3+CD4+ T cells are composed of three phenotypically and functionally distinct subpopulations: CD45RA+FoxP3low resting Tregs (rTregs) and CD45RA-FoxP3high activated Tregs (aTregs), both of which are suppressive in vitro, and cytokine-secreting CD45RA-FoxP3low non-suppressive T cells. The proportion of the three subpopulations characteristically altered in cord blood, aged individuals, and patients with immunological diseases. Terminally differentiated aTregs rapidly die while rTregs proliferate and convert into aTregs in vitro and in vivo as shown by the transfer of rTregs into NOD-scid-common gamma-chain-knockout mice and by TCR sequence-based T cell clonotype tracing in peripheral blood of normal individuals. Taken together, the dissection of FoxP3+ cells into subsets enables one to analyze Treg differentiation dynamics and interactions in normal and disease states, and to control immune responses through manipulating particular FoxP3+ subpopulations.					220296	83729	8714	641372	92370	92	57188	113179	115	60312	137964	189	84266	80216	8092	268	271	286	51281	134548	339416	90586	10717	2909	394	128272	25820	10124	79642	142685	51666	80161	374973	92552	552	8424	582	617	100499483	627	389206	399761	51027	388962	671	9044	219793	282966	80007	220004	90488	83695	283551	348110	79447	162083	79701	124773	80233	55181	92340	84322	140856	25966	150590	394261	132989	260436	63914	221416	286122	157556	51475	773	8913	796	57118	23271	57513	646019	200014	64753	100129792	80125	90324	959	4179	926	56971	22897	1081	10036	79145	80205	1141	163732	161198	1191	116173	285888	25920	1300	131873	1294	22820	1346	10814	131034	1380	1475	8029	9547	58191	392459	1536	643160	1571	57105	23500	123879	8886	25787	10170	26070	10683	1745	8632	57572	55816	11062	11072	1780	1947	23167	5610	9451	129080	256364	5169	954	956	8320	2039	9852	2120	55770	2140	2162	374393	51313	158724	55177	128876	57666	84261	8074	84929	387758	79147	100131561	55338	285759	645524	401260	644283	643365	645566	114984	54752	93986	23401	161835	53827	23766	50614	283459	100506215	647309	50628	2674	155038	2707	92292	2799	151306	221914	2239	56834	2827	2863	8477	116444	79927	2948	9569	2982	60558	55127	9931	253012
GSE15659_NONSUPPRESSIVE_TCELL_VS_ACTIVATED_TREG_DN	M3567		19464196	Miyara M,Yoshioka Y,Kitoh A,Shima T,Wing K,Niwa A,Parizot C,Taflin C,Heike T,Valeyre D,Mathian A,Nakahata T,Yamaguchi T,Nomura T,Ono M,Amoura Z,Gorochov G,Sakaguchi S.	GSE15659	GSE15659_1425_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of non-suppressive T cells versus activated regulatory T cell (Treg).	Gene expression profiles of subsets of CD4+ T cells according to their expression of FoxP3 and CD45RA were compared. FoxP3 is a key transcription factor for the development and function of natural CD4+ regulatory T cells (Tregs). Here we show that human FoxP3+CD4+ T cells are composed of three phenotypically and functionally distinct subpopulations: CD45RA+FoxP3low resting Tregs (rTregs) and CD45RA-FoxP3high activated Tregs (aTregs), both of which are suppressive in vitro, and cytokine-secreting CD45RA-FoxP3low non-suppressive T cells. The proportion of the three subpopulations characteristically altered in cord blood, aged individuals, and patients with immunological diseases. Terminally differentiated aTregs rapidly die while rTregs proliferate and convert into aTregs in vitro and in vivo as shown by the transfer of rTregs into NOD-scid-common gamma-chain-knockout mice and by TCR sequence-based T cell clonotype tracing in peripheral blood of normal individuals. Taken together, the dissection of FoxP3+ cells into subsets enables one to analyze Treg differentiation dynamics and interactions in normal and disease states, and to control immune responses through manipulating particular FoxP3+ subpopulations.					692247	145845	223082	100302737	285971	339500	79027	79230	348327	84124	23567	388569	57336	7576	11179	7746	7690	10771	196441	7763	150244	84240	389874	23091	100381270	7455	7528	51646	90522	7503	7484	8838	116143	55339	51160	257313	84294	51118	124739	9736	8237	643763	84993	5412	56061	10277	148581	7321	55236	9039	7307	219743	11334	7288	10383	150465	57217	7268	23548	54970	7264	7260	7257	9819	9320	339976	84675	57159	10626	11277	122553	80305	7177	7175	7172	7167	90313	26092	7156	7155	7128	51234	388335	29100	135932	64114	7099	7083	26277	497189	7058	7032	23424	6953	55171	9882	50835	6854	387082	6819	8801	8677	202374	10494	134429	10948	6764	222183	6345	245711	26010	375686	84690	122258	347689	6664	8724	9892	64744	4086	23315	10479	83697	6522	50651	254428	27173	148641	91137	5250	9122	6472	388336	4068	151246	10262	23067	253190	55964	22928	8482	57556	10952	10483	23478	10806	9672	6334	9733	29115	64092	55511	6286	132112	57142	83861	728194	89765	6240	6198	6184	51121	6098	6093	25897	26001	57484	50862	7737	9921	6018	6016	399	54933	5999	161253	23186	5921	29098	10048	10267	51762	11021	84932	149628	81607	23369	2185	5746	5623	56984	5687	5683	5663	8842	10544	114224	10196	8575	53632
GSE16755_CTRL_VS_IFNA_TREATED_MAC_UP	M3668		19556424	Greenwell-Wild T,Vázquez N,Jin W,Rangel Z,Munson PJ,Wahl SM	GSE16755	GSE16755_2032_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of control macrophages versus macrophages treated with interferon alpha.	To study effects of IFNalpha treatment on monocyte-derived macrophages which may influence susceptibility or resistance to HIV.					339745	55625	535	55356	9545	60370	2353	157	5980	6256	92667	4126	11335	2776	9360	114799	6938	84807	79161	8576	22890	8396	1786	1629	79143	10152	8677	100306951	57107	116143	192670	25	55198	55039	54890	115273	57654	10521	8731	84286	79930	57205	3098	359948	100129387	8089	10273	9046	5573	51317	3603	27439	22822	10912	84942	55315	7008	10422	115330	9788	49854	7048	23587	10057	648	2055	57407	10659	51366	5328	9847	1787	23355	23659	91748	29108	22954	64793	55285	286336	1959	115761	10253	1605	10044	155060	11221	11062	51434	90627	4775	126731	84106	128308	93663	89846	116064	79447	57533	80820	9813	23214	148327	6453	1184	25900	23234	10184	94134	79718	2592	3631	79829	138151	100289294	54880	3398	23039	54468	9631	4208	10617	113263	283431	112936	8663	23412	23285	85460	51385	10951	9203	55325	64333	54764	200728	81603	8660	9931	3622	7100	55251	119392	2530	22821	127262	8773	6403	2035	10426	11344	4064	23307	79786	84295	8930	9453	54941	10458	151194	7158	55893	89781	23609	1601	126308	54885	9616	4094	116988	8792	10144	124961	23244	114932	22920	9815	100127972	283899	157285	80775	55818	51060	9354	10327	158747	219402	9791	8459	835	79980	57659	166815	5926	128338	5636	79882	55326	80157	164091
GSE16755_CTRL_VS_IFNA_TREATED_MAC_DN	M3669		19556424	Greenwell-Wild T,Vázquez N,Jin W,Rangel Z,Munson PJ,Wahl SM	GSE16755	GSE16755_2032_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of control macrophages versus macrophages treated with interferon alpha.	To study effects of IFNalpha treatment on monocyte-derived macrophages which may influence susceptibility or resistance to HIV.					4683	9021	3587	182	9311	3431	201725	56829	23586	135112	100	9953	440073	9587	5520	5663	23580	55603	23258	151636	10512	84815	5154	2859	148022	51278	6714	169355	80824	4082	10906	6385	55008	56985	629	9189	55122	3659	84930	9695	7323	81894	129607	2633	9674	79132	734	51762	93081	2766	6993	27074	51251	11182	8519	8676	81844	10260	10049	80013	55905	100131814	2634	645676	9111	2982	3559	51667	79669	84166	5698	92370	1540	3620	25816	219285	3430	64761	3569	56938	8744	490	3600	5456	113220	80833	9636	23590	4792	5687	79931	56929	3717	5696	90326	9334	100129407	7185	1026	2710	158830	29126	375287	83856	152926	57162	60485	5819	56882	4067	283140	10561	115362	91683	255231	58516	4615	285237	22936	27246	8820	958	151987	9683	10623	6737	3627	1318	5683	8743	5326	653464	6605	57700	25841	5970	253260	5743	2000	8444	80149	9242	29967	6741	6773	91	116071	11237	23306	5610	55802	10409	596	5157	952	4940	55183	84441	23786	9958	51742	7726	7474	3097	355	65983	3383	3575	731424	375790	5272	23424	375035	1847	6648	93082	6373	2526	54072	50805	5055	127544	51765	7412	51056	54462	11120	9945	6775	79993	3487	27348	145864	125206	51444	9263	64135	5371	10148	57194
GSE17974_0H_VS_0.5H_IN_VITRO_ACT_CD4_TCELL_UP	M4152		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1179_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 0.5 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					55061	93210	5157	9079	92483	26152	79016	6297	134864	83694	84071	3786	284613	283638	27245	643733	10201	100192379	7043	8557	29013	10380	8831	5617	132158	10217	200315	154796	55998	100287290	1767	26525	9468	10699	152831	126119	2122	65072	57732	929	285093	887	10474	29844	121214	10073	80308	51102	1215	284266	84651	79036	4312	729806	84878	57165	1136	79085	10554	8576	6334	7461	51016	81849	55714	65999	284948	8748	23170	654817	132014	79690	9784	91289	8989	933	203328	5225	57192	1748	164022	64581	374739	55239	722	1800	164592	790955	84818	51517	8332	79873	9659	116441	2550	4133	6601	84304	79087	54089	2210	30816	23105	199990	27158	117	23064	79844	23423	57567	84148	256329	10288	220047	3827	50486	10437	100287521	24146	140836	23657	2912	51523	3611	435	3055	348817	84504	84852	84993	64757	11262	84966	54440	570	26105	710	154865	92129	9056	6884	339201	151877	149703	115362	118433	1280	23708	7626	197	10390	11261	9322	5306	51117	140700	54991	51147	2560	63935	92270	93474	2176	100287569	80222	401124	221711	5496	29063	4745	1731	10859	51217	114881	646450	7022	326625	146542	65267	150992	2268	5371	10881	54210	92304	410	90589	126549	780	56478	255480	126375	7993	23498	4145	6833	260294	78992	5790	84152
GSE17974_0H_VS_0.5H_IN_VITRO_ACT_CD4_TCELL_DN	M4154		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1179_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 0.5 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					54623	9592	54880	55432	1959	1958	7832	388323	84807	10866	100131814	1960	55770	84272	3164	7738	91056	153020	400654	1846	398	100289230	55422	389170	1880	80215	1844	23532	2697	8492	54882	7071	7124	7033	146212	81875	79443	3347	2117	2841	113278	643201	200205	1317	2123	7779	644656	143686	11135	4440	3838	93081	284260	124535	389641	79693	221786	2669	6553	11069	51053	353189	51164	56342	51651	25788	5877	51276	8493	55270	2645	386627	25940	84233	283951	5209	64145	5653	4929	8506	6273	93035	3960	56942	6426	54931	27306	24145	80231	87769	440944	114780	58515	56986	79868	55680	10385	60673	84950	597	114876	653121	11066	1308	114224	3475	7399	7752	254170	222235	6594	407975	1390	353322	8013	6688	4978	9595	7372	401114	10252	654790	221079	4616	55168	5291	166012	79150	55829	3902	256987	4633	10905	388394	399761	283352	57084	10614	4780	51340	147323	6515	374	221264	79894	1164	6119	375295	3422	645431	55339	3861	197320	1073	9732	57862	3010	728841	400566	4589	8507	51278	343035	29851	26291	4189	7296	100131998	117289	100130264	64432	79770	50640	2173	474171	255403	8882	220416	84085	166793	93517	79339	100130360	9080	222698	402682	8477	648556	65997	7673	122830	3709	8604	5507	142684	29065	441528	51264	163087	969
GSE17974_0H_VS_1H_IN_VITRO_ACT_CD4_TCELL_UP	M4156		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1180_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 1 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					5997	5533	9021	100289246	8651	63970	11262	79829	8717	89849	90589	134864	441212	80094	50486	5636	90768	196792	8677	7626	339883	51117	51809	1843	4952	274	6483	55011	83879	1073	81628	26015	1647	57561	3398	79690	285492	100134361	7169	10437	104	286336	170463	58472	54981	284391	51147	374659	5710	100287569	149951	165140	51339	51409	79751	79658	9399	2548	8629	3684	84902	100303755	63951	84191	79036	9605	8341	9659	4931	283848	3725	4832	404550	5351	57567	8403	8045	653687	129293	23105	155400	339201	57761	51475	79747	63935	84214	55876	327	140771	26253	168455	440434	149703	9744	5499	112936	8460	285093	60526	56954	220202	91289	3055	285097	284273	54664	129563	6473	27440	7043	54766	410	503538	84266	9203	6320	100288152	348817	54951	25900	50853	6452	83658	120425	221960	10859	79017	6894	10540	6901	23613	389541	6604	283871	167227	51135	4935	5292	197135	345611	126375	65981	4833	3590	54923	27285	8910	112616	23225	3695	152002	9314	5211	63908	415	131616	132001	374395	25845	3112	6472	84196	100288954	84245	4782	340037	100287290	84131	115098	644890	7433	834	2064	64332	84650	5279	2550	63898	60314	64236	388591	51523	162540	441150	81606	9881	2937	284013	126259	171586	642757	51078	8848	7059	83874	6195	8349	79153	27352
GSE17974_0H_VS_1H_IN_VITRO_ACT_CD4_TCELL_DN	M4157		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1180_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 1 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					79868	22822	10224	6674	114224	3976	83480	283237	11072	643837	112858	2074	23417	100216546	9592	51645	55829	114614	54931	10385	84541	79161	2669	25940	51010	1514	4678	79693	10866	284323	388327	283219	26191	902	490	51651	4664	2124	440944	9047	51174	65082	8744	205564	56675	55654	29100	7531	130940	440122	129804	80255	7832	151888	9595	4864	10766	2123	384	132720	4665	6617	51340	7296	4345	200205	5514	134430	256643	8772	81034	55168	58515	55317	79443	81875	661	58500	114548	7372	1961	84950	83607	4682	1164	2859	597	285628	54882	4686	1958	283635	80196	5168	79770	80110	92162	54881	11146	10252	2237	55017	84807	8892	3399	8915	8740	348035	100130360	7773	1880	51318	91607	122769	23151	65243	494143	6388	4175	123879	5877	7187	9076	7718	26037	51287	3164	51278	84890	10352	8882	56941	79230	7752	1678	79142	4236	55892	122830	22800	4616	11066	9034	3838	83930	57862	54623	93517	134429	150290	79594	6503	22856	64412	8477	1846	84522	1959	5693	3475	7699	440515	7071	284454	60673	51118	10773	9412	29851	80185	79086	54964	5898	7984	6945	28512	51561	284406	84272	85025	5052	3662	387263	349075	1844	5209	8013	79833	3981	10670	54205	29950	4049	80301	51277	7124	1390	51399	55659	54433
GSE17974_0H_VS_2H_IN_VITRO_ACT_CD4_TCELL_UP	M4158		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1181_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 2 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					79844	6515	64332	8303	57561	118672	50486	817	22864	51409	51635	400986	259283	285492	25939	285550	6894	8625	100289246	9744	126259	9021	25906	5783	3725	5997	7454	4783	113763	20	3695	286262	90990	83879	57192	91289	63935	254170	23324	10687	10791	51133	155066	5996	9079	6277	100287569	84265	79683	2533	129293	970	642236	649	441108	9743	285097	286336	6051	23474	1741	834	5277	11284	149461	6309	9121	427	51239	112936	140894	23201	2581	84266	150291	64787	6901	284273	64743	326625	9314	2550	92241	7803	7169	219743	92675	768096	5257	1843	80003	56160	9826	8801	55093	54941	54932	2762	11201	283991	129807	4833	54103	80311	56829	100303755	9750	2272	26137	317649	26750	83658	79441	8672	5142	54981	3655	128408	150094	259173	10039	55876	26083	5533	94039	8576	84747	23531	7433	1939	54414	63929	201229	60685	84068	8651	55033	100507057	10140	155435	1073	93210	199746	85014	51466	2319	404550	92106	7294	7163	2053	100507436	84959	130814	10144	3676	89845	55966	203228	114971	26996	10023	57178	5590	23108	3726	26152	8875	51411	1512	10370	64577	121506	80258	147727	1774	373156	7461	65008	646450	2353	8848	51317	79695	65986	28951	286205	25771	56985	114928	80222	1647	8556	23629	7351	444	920	284391	6715	8869
GSE17974_0H_VS_2H_IN_VITRO_ACT_CD4_TCELL_DN	M4159		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1181_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 2 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					5316	7903	55646	55299	4682	644815	57688	29940	29071	10780	400581	116442	54836	10885	9412	283219	1514	9076	84365	83480	93183	7372	5932	79886	661	84520	148932	84984	2012	356	55659	9724	64089	100126793	51645	27074	643837	1019	55272	26503	3164	285628	151050	55028	92822	79833	51340	65243	4907	286223	200081	10049	25821	23417	348035	147949	965	26263	51318	11072	79443	1737	1787	6388	51175	26175	902	9644	136647	3895	54964	55183	55192	4049	51174	7485	10252	1130	22822	51605	6541	284611	123879	54980	7071	55858	18	6674	79064	384	345462	54955	5902	51603	55017	6013	8727	9310	6364	55110	7762	93081	5569	4686	65977	153443	114614	11097	9241	2123	9181	64841	9276	124961	79624	10063	10766	92162	56902	9875	5873	26191	1678	2004	10866	23271	200014	26037	79142	51134	54438	124535	26608	53838	9443	84513	5514	10282	27351	10797	11313	51010	23306	114885	100128927	84872	26517	165918	85457	3662	51287	10539	222236	60386	1154	10613	123169	7124	643911	2017	7130	7699	132864	8493	91801	1958	26031	4345	51001	1959	653121	339	80185	4602	84955	54512	81671	8892	3976	1960	387263	597	2720	84890	84876	92935	4664	348645	29889	7408	8772	10228	2805	23151	22856	29950	51003	127396	5270	11146
GSE17974_0H_VS_4H_IN_VITRO_ACT_CD4_TCELL_UP	M4160		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1182_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 4 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					50486	93210	2550	51411	150291	1843	7169	92017	8660	285097	152048	203328	842	26137	64005	7433	348094	10397	129563	100289246	5991	6901	722	55805	9744	23225	57161	5168	54103	63935	57165	121506	230	3476	2053	133	220929	51133	79844	51409	8507	3689	100128108	3587	319101	920	3993	6309	9780	4501	285195	23324	85450	2217	146330	26148	283270	147015	9314	10140	155435	92675	8303	56829	898	84961	64174	84959	474170	26289	59307	5002	284391	54414	6920	56181	7059	50861	23710	51084	57458	9079	3695	57124	10788	6277	9924	79695	55902	274	159371	338758	29125	2242	132001	10039	3337	729806	2319	3237	63901	90637	285512	84124	5797	23199	1465	254863	374	23474	114804	170626	23593	140894	54930	58476	23354	1823	3795	8717	10668	129293	9901	1730	1513	3590	7273	55061	6051	3684	150094	23108	80258	64236	5116	9697	8875	11221	84836	29044	22927	4935	54850	94097	646870	7803	153546	5445	4026	8869	84786	65258	409	8609	25939	1831	83874	57561	55268	2043	8971	118672	646701	161253	23533	84560	3738	56155	100288954	388581	401320	8576	2109	768096	22864	3338	56474	10791	9414	252839	29099	164153	64743	253769	63027	2272	9805	51439	57175	7508	170463	10577	3676	55544	4496	728073	9644	28514	7029	23093
GSE17974_0H_VS_4H_IN_VITRO_ACT_CD4_TCELL_DN	M4161		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1182_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 4 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					5425	27166	8892	6723	84306	4345	645961	221584	55017	84319	7775	25974	3276	643837	63875	29940	18	8882	285628	5690	1130	55646	5052	5316	4665	84955	27243	661	1019	3439	9076	150290	705	124401	8425	55577	80196	11146	23417	90480	4682	7124	9136	6364	58491	23450	4049	10195	23587	56902	6504	5569	2286	4678	407975	100170841	4236	7718	10549	4907	53838	51118	55759	56983	9294	8600	10224	117246	5693	10456	9204	2672	123169	29121	10591	3662	586	2887	1959	148641	23516	79080	79833	5435	51081	3559	7293	64759	25979	10916	10430	9654	84950	79711	5714	56052	26472	79692	65094	2720	54438	55248	27351	84947	3454	8890	54980	151888	7158	83743	3399	54433	114614	51678	149478	1662	4686	11066	23212	8568	389898	9031	29071	8187	65996	8320	4702	10049	10866	51287	79834	1479	54797	3394	9296	873	1514	92399	165	6182	23019	7965	29074	9997	16	1960	91734	6870	80185	129804	5450	4860	440	283219	79669	55850	1798	8894	51645	29886	79084	55131	11097	597	79077	7372	1154	494143	28989	356	2182	10940	10963	93183	54602	200894	56342	55032	121642	55352	51021	8772	9047	204	201514	2669	8809	10780	8740	84775	1787	9276	8013	58525	84520	134429	8624	26175	148932	10469
GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_UP	M4164		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1183_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 6 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					23593	51439	203228	155435	7803	10077	79668	23324	129807	285195	94039	8303	51133	339201	6920	23270	9826	100287628	100287569	54541	11258	23336	85450	728613	5797	64174	285550	9021	51170	123688	7433	254170	8971	4209	54941	259283	11122	64400	118672	10417	2053	23331	9640	100289246	79641	23522	6715	400027	51411	26137	2550	440993	6498	96459	8609	3587	54463	26112	920	79844	64207	196792	2272	6659	26289	5743	374	5991	8801	80778	57659	8507	3684	1647	23533	3622	7169	283045	10178	4084	50486	1843	285512	54102	11107	201229	285097	121506	56895	130502	9693	8660	9901	1831	10150	9779	64754	6515	7402	7351	7367	150291	10370	80318	84959	83737	7554	8869	57175	80258	58476	646450	3338	10039	23108	54414	3738	29116	9051	9414	55013	4502	9397	80201	2944	80205	114224	4026	55061	23199	274	10804	409	114928	140688	57561	10172	113763	2043	64005	133	645676	8848	10962	5533	171586	5996	4494	255758	57161	2185	2355	9605	100272147	5144	54923	100128108	84958	23764	5578	3676	4542	5618	100287290	9531	10140	55105	9921	9314	8462	25939	1200	359948	79752	51635	3590	5125	23287	100129361	9697	9046	132864	84163	5168	283897	9744	90990	202025	1730	63901	100129550	282997	10276	642313	10397	128611	100289109	3725	100289090	5152
GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_DN	M4166		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1183_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 6 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					7158	6541	5427	10606	5569	9334	79834	157	26191	10885	55863	55052	79712	5860	55559	5437	3276	3937	90701	152518	10907	7074	60468	10228	171568	5306	1479	10549	22822	5873	128240	4682	5226	10827	84890	483	55017	4907	5747	2030	8624	51096	9470	908	55171	51645	55272	51118	148932	80308	9456	26608	116447	79080	10849	51067	11260	26031	93183	375035	401505	29925	81034	113655	121642	7371	136647	10166	84955	152579	54472	25973	54475	388566	5052	1662	120425	29095	28958	51232	9443	125988	10773	5690	2634	6375	23071	10775	190	55353	5984	55646	84319	5499	59286	9817	54187	51184	25974	5830	6634	116225	6637	203068	84279	55379	79230	50615	84879	29889	91298	10780	79081	132720	79064	56983	5435	10575	84520	55192	8881	9816	134430	26517	84135	84303	3554	4345	9204	10856	55352	26472	494143	3759	2669	7411	10224	166647	5425	10490	597	94235	93663	3559	23753	55028	5714	1497	27101	23150	80223	81875	122830	55131	27341	5902	93436	10252	27030	51	3329	55009	79443	4602	226	10195	9724	65996	4664	10525	728489	8726	8809	9047	63875	81554	79023	10131	7416	3675	4665	26515	7347	79767	55281	23760	55776	10591	3838	25813	79833	8607	348645	3028	8892	23417	140838	2806	83480	2074
GSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_UP	M4167		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1184_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 12 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					3676	51646	80778	64174	114928	8869	10397	7402	57561	23287	155435	57493	10276	10235	6934	94039	5016	6515	64005	8477	2550	319101	64581	5341	26289	360	51133	359948	79668	282997	10172	79673	79818	4929	9931	9592	51411	7294	266812	54941	342371	26586	2043	4209	5144	677769	9021	51439	111	6711	285550	427	722	100128108	4601	80219	100287628	5533	7554	7803	64065	84958	64145	29116	6498	1396	10178	253782	123688	26137	23593	9448	126259	50848	54879	5292	10140	646450	90990	4189	79844	81851	7433	3655	90637	63901	645676	8576	274	9921	401647	824	5530	23764	26249	375190	11142	203328	646241	4542	55790	29944	23336	64940	400027	23258	1073	5125	8660	100129550	8848	200765	23270	401320	26053	9314	203228	80201	64332	118672	3590	7552	10870	100287569	128338	6281	57763	10150	2353	6659	6653	259283	917	83737	100289049	50640	220213	57228	59307	56160	4084	55061	728613	81689	1843	84163	23710	5116	9975	1880	26207	57659	2355	92017	7169	100506328	22863	163882	23108	64420	57161	2272	79026	80006	9214	257068	5138	339883	645460	84959	5797	161253	55766	85450	404550	130502	6309	80008	80714	254170	9640	440704	96459	1730	440307	201229	54981	80318	100289090	1513	3738	284391	57585	54629	256987	8462	64780	63877	94241	205717
GSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_DN	M4168		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1184_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 12 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					5316	25974	23306	150962	55071	10775	81554	4285	55192	10180	57508	26608	79712	8836	10525	157	57761	54438	5184	4345	134430	10989	2237	3601	729680	23294	255231	125988	55798	5001	56983	122961	9401	9136	25932	126208	26031	6541	129531	2342	29071	5425	9047	6723	60490	146760	51184	1978	11066	5873	1945	55651	55017	8669	152518	55131	79017	6941	93436	83480	10797	10400	100507436	7866	132720	3985	121642	5691	267002	79230	374659	283871	11344	55858	8086	5860	51	55171	59286	79649	116442	51042	162681	284323	55215	1798	94235	9296	8425	2182	3948	54931	9031	79834	11001	9817	8815	27351	8890	10695	1678	4175	4174	2030	27349	285628	29887	79886	1457	112858	29902	1960	10301	1725	65991	135228	84191	83862	23753	5499	3276	10613	9093	5550	2744	90701	54982	54808	57546	65260	9015	56648	483	54623	79084	9933	55052	23587	4049	23417	5438	7347	11146	63875	7775	5160	10131	8892	60314	11072	79086	751071	84950	11098	6732	29015	84328	30009	79709	8320	6895	10329	10490	54475	2271	6491	3028	9761	57380	11097	55028	10228	55239	3251	2582	55168	92906	25940	26272	146712	171546	10195	8732	2114	5690	23463	122769	57176	51651	7867	85015	55863	1104	2109	475	23170	9131	10606	131601	9836
GSE17974_0H_VS_24H_IN_VITRO_ACT_CD4_TCELL_UP	M4169		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1185_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 24 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					64174	7554	2862	51411	9605	7294	85450	8660	3726	8477	100287628	8507	10235	133746	80778	57561	3738	60685	390980	100130557	1843	10140	6934	23336	84124	10417	51646	4660	3655	57125	7556	5199	319101	22863	6446	375190	57161	1647	29116	388403	80008	80094	150291	56605	8793	121506	26289	100131941	259283	79668	100129550	79844	23764	1831	94039	2550	55095	3684	9531	83719	10163	10365	2043	7994	100289090	123688	55103	6320	200315	10870	275	5101	23533	150094	51439	22821	359948	10178	4013	202	677769	9448	56985	83737	283683	55553	256329	4084	200765	5997	90410	730092	9921	23177	55808	113791	51274	29125	338758	9314	4209	3820	10370	2355	22927	4629	114884	7305	339883	100132999	10172	5142	7378	100287569	54585	944	123720	400713	90637	3707	10628	4929	140894	5125	8556	143187	301	1767	133418	2242	26207	2272	84981	3128	94241	66035	7832	6659	57732	9383	23108	9079	27076	7169	8875	118672	222161	22861	257068	84786	114907	9737	63935	6095	1195	23199	7227	9170	161253	26253	64940	8851	83874	2353	404550	7128	202025	3575	10520	8403	10451	79690	27106	285195	55180	6498	284391	283270	26249	51526	55061	93210	7050	80117	387509	51275	22973	64784	285025	1513	65986	79862	80219	3590	645676	64780	441150	284129	4488	23484
GSE17974_0H_VS_24H_IN_VITRO_ACT_CD4_TCELL_DN	M4173		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1185_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 24 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					55711	197259	475	993	7775	3276	2030	84306	65260	6476	56006	8208	6573	27304	1798	79019	54438	55646	10866	23516	8892	1104	7371	146712	890	587	1960	79084	1678	4665	2582	661	63875	54503	222229	55856	79833	8216	9319	100287482	152579	586	9055	55192	622	5066	23306	23649	25973	641	6624	10189	84950	6182	1020	3399	56902	132989	79022	55255	9040	1503	10432	267002	140691	9156	10535	4605	55835	23587	84319	22974	55281	1841	3559	9456	5888	54962	10263	3487	705	51016	9183	79080	80086	83990	8891	8898	5932	79132	29934	9833	6941	65094	79622	51318	23780	4361	55028	6375	79000	3014	93081	8669	55759	80746	1111	26263	51118	8187	952	6385	400768	11065	7124	1164	92745	26147	64151	9031	51728	55884	64785	1163	56704	23450	7293	6790	85444	23532	23404	3604	51645	10180	898	27037	116028	4345	2171	4686	55055	30009	378708	100287081	284323	4731	8438	54512	255231	7372	5892	494143	25974	10111	2178	55620	56935	5213	2713	79447	84955	9997	55858	29071	63920	51010	10549	114614	51256	29015	23753	112812	307	5435	10963	3976	113130	11146	2760	11333	79669	170384	1033	10471	122769	28960	332	2793	9477	81554	30833	10591	5198	79142	10224	3394	64175	8568	4049	55650
GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_UP	M4174		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1186_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 48 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					92017	93058	50486	80094	285550	5116	100287628	7803	27163	79673	100131941	23336	7109	205717	127262	23270	3590	10365	56605	342371	84981	5795	79668	7169	51439	2117	64778	64332	10172	93210	10178	200765	6402	114928	54941	8507	2550	57161	26053	9640	23324	5082	9605	4069	319101	9760	4929	26234	660	3655	220972	64174	8341	4209	85450	285097	301	54764	2043	26289	28951	150291	51646	90410	144108	23090	1767	55105	9737	54934	4217	51411	283683	10235	55553	80313	9383	57728	202025	128876	56255	64145	6309	659	284361	200315	5292	10370	220213	444	25793	2776	360	54103	158586	55432	5588	3738	134957	80205	677811	7294	3684	9921	8660	5341	2122	5797	26994	55790	3820	133746	100289090	7556	8859	7994	390980	285331	22853	282997	50833	100289049	163882	80258	254170	388403	944	441666	5142	6498	441212	22927	57479	6653	84786	79667	9448	1647	3337	7982	57584	55095	57125	22863	66035	201229	51257	388685	950	2124	1953	64097	427	79960	284129	6659	51070	2353	55208	133418	221223	969	5412	1523	84248	728743	22821	7832	79609	5743	4013	55061	3575	8303	6446	1800	23619	10605	5611	51170	79844	94241	8869	54855	57561	7305	7433	140771	63935	1843	8556	10077	285464	6638	7554	123720	3726	23108	11236	84945
GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_DN	M4176		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1186_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 48 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					1063	2187	163786	5481	11124	23306	152518	83862	25804	2760	116842	7775	55135	7468	3065	84058	214	80759	55711	51192	51340	115353	1479	2184	9477	1725	55775	9551	257144	9156	3418	51510	7371	56006	93129	10856	163183	196513	10449	285628	9209	7158	3985	196074	2632	55296	1945	3181	25845	57508	2256	91057	26150	140823	5096	10797	9204	6443	84319	116143	54808	10575	30009	5714	1351	95	123	9401	2793	3833	100130872	4357	27243	10488	92906	125228	59286	54952	55858	51093	54509	10533	55183	28960	10459	284323	10131	3936	2342	10682	3093	80010	60485	221443	400745	60491	26472	80011	1798	9055	57175	899	2720	56911	29960	9031	6634	55835	3149	7372	833	10885	55300	29101	1017	80777	9603	26512	375444	3183	201633	79017	11235	83990	943	7531	84947	123228	79622	22856	7171	440983	25973	25974	93183	23587	51409	285386	10367	93974	7416	22995	84316	136647	121642	81611	3251	389741	28973	9380	10866	55071	255812	56941	27440	2665	1457	4049	2717	2109	3796	2999	93081	8821	10311	83666	29074	83854	10920	5052	5066	54535	54503	146779	902	10606	1337	9131	81889	9783	29071	79915	6652	11277	129531	3560	84869	51141	11014	10295	9093	51253	5160	11169	100128731	1632	55192	9446	57819	28969
GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_UP	M4177		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1187_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 72 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					400986	390980	9605	23324	285550	283373	8660	7803	84275	93058	56160	64434	9314	205717	220972	3398	54941	5125	23336	26137	26289	5991	1958	26234	84981	2889	79668	2043	2272	3590	6498	7169	10078	80205	150094	100131941	7433	54934	3655	100287628	3725	200315	2550	2919	79609	140771	283683	301	10221	92017	80219	8507	93210	57038	55095	51257	56996	1609	5997	1153	944	84135	23710	23270	348793	147166	7554	84124	342371	338758	57801	57125	9211	84786	4069	79034	84071	100289019	11129	51759	54103	23331	3954	55808	692227	9079	57095	22853	427	79693	64581	5396	150291	283745	80258	26053	23108	730092	64747	85450	374877	147947	9214	3575	51646	254042	254170	55718	9308	4209	8350	27242	200765	10425	23545	4217	100289049	10605	319101	2250	64332	51605	441150	10365	26994	493861	57585	439949	8462	28951	51070	55180	1523	3055	84456	22927	56674	7273	114795	1843	10178	8869	6446	5611	51411	50486	64750	8884	55790	9640	11236	124997	23112	389362	91392	202025	5783	26034	55262	6934	677811	6988	121506	9921	64061	160622	25786	79960	134957	284391	387509	266812	56652	348378	64795	55794	54822	79844	79862	4929	79080	84945	1647	4189	3553	90410	55846	55553	10172	444	1519	199953	283270	2219	9592	79697	5756	283897	27	10288
GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_DN	M4178		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1187_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 72 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					3251	10295	993	6634	1786	81554	7411	8732	92399	29074	8624	100134229	643837	55192	91057	10311	143903	1854	9817	26191	55647	92675	10856	2584	80007	51340	57862	9401	9322	8790	80045	54541	5982	51510	26512	3895	1798	3948	3953	4049	10575	79582	146779	7416	3181	586	10148	152518	5690	10866	10653	10459	29109	5437	54951	5604	9377	641	196513	90488	55578	5160	9156	5481	4174	9595	57761	25804	661	899	150274	5058	27044	26147	51067	8772	963	29934	84221	8724	10180	23306	8208	10549	10131	25845	7468	1070	57508	23204	2769	6812	10301	147525	53838	4927	92906	389	55139	57504	60489	113402	89958	286144	387103	1164	1841	55835	79086	221092	116842	10613	59286	6470	195828	11333	11169	10556	11162	9943	3732	157378	10987	8726	890	60490	3071	5033	55902	55135	7163	29956	1622	11315	55699	3418	5499	221150	7083	56938	10989	89122	115353	63875	51538	7071	79624	91419	23234	2810	11124	116143	57707	57559	57175	2733	3796	2634	157	5360	84955	8402	51316	1351	54808	9551	9209	55768	55344	51253	122786	127602	822	135154	51318	10682	112399	26263	2793	8536	5423	2237	93974	3662	11277	64754	10857	11161	126282	23587	518	6150	51668	8705	2123	337867	55285	29085	115817	1063
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0.5H_CD4_TCELL_UP	M4179		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1188_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 0.5 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					9211	728116	57732	26253	219347	84651	55998	51738	3495	387036	83656	10859	727910	100288798	100506229	629	5157	50486	51475	203286	94274	30812	54551	79690	79016	3055	441366	20	128817	91464	100505989	404550	9627	100048912	649	23144	10288	27253	11326	90990	10699	23293	2170	149699	2064	116179	339539	26015	100289982	55576	79036	441666	84843	286336	8398	100507057	5819	10297	23136	646241	283854	929	283745	28785	132228	339965	284804	51480	5225	27129	162540	9056	6760	116519	51207	55313	163154	353174	148137	93109	343990	780529	402665	441212	100507099	348817	126119	166752	114571	154865	197257	79039	2593	137868	22983	94097	79087	57192	100131655	154796	114881	113746	27158	283870	388591	55228	28584	8712	170062	641515	5592	5878	5224	285266	23583	339201	10462	91289	81472	126868	140700	151878	23457	286436	51102	79136	340206	10039	441601	326625	100505622	3694	222389	348807	57171	111	114898	5341	55365	3293	253769	23024	3359	26226	79781	117156	84304	63951	10687	8630	2176	220359	5798	54991	10903	93210	29992	339883	8515	81628	401320	132203	619427	7461	2702	151877	49856	1066	283507	1672	148014	51313	135295	255101	100129175	9332	8941	284451	2125	23254	373861	57476	64581	151516	51146	26	57010	79747	6623	112464	150197	151246	10437	65267	285492	57817	285401	11026	100132923	116123
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0.5H_CD4_TCELL_DN	M4180		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1188_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 0.5 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					7832	644890	1880	597	9747	3675	100287216	11080	153020	9412	9595	2117	284513	1959	54880	79161	1960	1958	8420	9592	3164	10252	11317	2028	401114	84807	2669	1317	51010	2123	10866	84792	51053	132989	112858	79770	7738	653121	51651	11066	3838	406991	87769	23276	1844	388327	8360	54586	7737	55168	51340	387263	55422	6426	55762	342892	1901	148266	28977	2841	200205	902	23283	91687	51276	55317	84522	7124	25940	58515	8493	55829	2526	79693	84272	221079	124535	1595	114876	407975	8013	7770	57103	54931	728081	4686	96459	9970	7752	79868	100286909	284406	23417	57862	83480	80215	8611	56342	27030	254170	4780	84890	163259	285025	6913	29802	8506	170394	257396	143686	644656	122830	8914	2237	55270	4929	969	28989	22822	79086	6617	4982	23129	400541	60673	5291	8492	81875	54205	729088	92255	201477	79854	10490	8882	10049	7412	7296	79443	50640	84541	152185	27148	494143	64145	256643	4189	55786	400745	117289	5064	401324	1390	5877	353322	84950	5168	145482	646484	6515	221786	205327	5209	22835	26052	55339	57691	8915	10385	55892	219557	10150	1876	3699	51278	338809	7485	10797	283742	1360	10161	79648	440918	389874	65986	100130360	1846	132946	8477	58160	330	6785	5082	6476	84085	10172	7096	643037	1164	79842
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_1H_CD4_TCELL_UP	M4181		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1189_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 1 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					339201	1143	57192	64077	26253	2548	79641	8717	221223	100287569	1843	89849	9021	157922	84266	22859	50486	57561	26015	63908	51102	10554	114795	23170	722	78992	220441	51078	3667	8848	5997	79036	84747	63929	63970	140465	9148	132001	10437	100289043	8833	63935	27079	115362	3354	23054	8576	54437	84328	126375	3725	159371	93664	286262	7461	84304	56906	27433	388591	203286	10288	29803	10896	27229	9306	2907	152002	55578	4829	2250	9314	7433	9079	170463	83874	90956	126789	1293	1774	199746	85014	57567	84878	79751	5533	440346	100303755	2984	23423	84072	55258	54991	166752	274	25796	3617	376267	112936	83590	50604	10533	245812	30847	117156	57761	65072	283045	10073	2064	23199	9368	646701	8876	259239	388272	23108	140700	10938	23421	23064	256329	25845	374659	126823	253769	83595	54879	113763	10465	9659	8677	83879	283745	5798	1215	2268	168455	9383	129293	57479	63877	388381	1136	283638	1647	56181	8192	283871	94097	2261	23295	140707	3895	83658	100289246	7867	409	23241	58485	10791	54629	29844	6645	5996	9203	284339	84331	152831	112616	286336	100128998	6452	6604	260436	646450	10039	9744	57409	79829	115098	3726	7188	1303	5824	50853	6833	1814	284273	64400	116	4782	23321	8045	54541	23513	100287479	149703	9348	57692	114971
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_1H_CD4_TCELL_DN	M4182		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1189_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 1 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					80818	23151	55770	9047	84890	254100	51340	10866	79064	9412	3662	283219	661	4049	2669	55017	11072	401093	7372	8013	129804	4665	22822	51318	387914	283237	9076	1880	494143	60673	65082	4682	165918	9836	11135	462	10308	7071	284454	55183	1959	4236	10049	51360	92162	26503	79230	54964	6388	7124	440515	54880	4345	8882	285628	83480	3174	4864	348035	1958	8772	7773	125113	2841	388323	10228	5877	3164	10224	80196	26586	51010	221079	84085	406991	112858	56937	2123	1390	440944	959	149478	26122	2824	26239	7399	55858	54881	1901	80255	1961	6617	22800	10475	1154	116442	79443	84807	9	85365	57862	26271	79626	1960	7096	55892	166379	123169	253635	4686	54797	54931	23587	283742	10282	79770	387263	64089	219541	7743	51174	5209	10161	84272	8846	83607	7984	9644	84950	7718	29035	84933	157285	7485	64859	84541	54900	80110	8892	55751	170575	8915	7752	6865	6877	23590	29994	79833	51561	387328	114614	56242	7770	286223	54842	384	283635	597	284513	90625	1164	84671	5514	8420	84914	57691	10294	407975	8493	6282	81034	96459	51478	353322	56342	55339	64108	54472	677	140831	23135	345462	81671	3437	51399	79042	1876	80215	51645	10490	2720	6945	3976	4664	23417	84522	1514	8740	3558	100288730
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_2H_CD4_TCELL_UP	M4185		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1190_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 2 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					23626	8833	26525	51409	63901	50486	83879	25796	8848	2550	245812	57561	22864	286336	8672	23764	150291	84266	65008	6901	104	6894	10022	25939	10239	54103	29803	79844	5533	94039	6920	8407	8507	92241	1647	57192	8875	63935	285097	26750	90990	84650	23171	100289246	9780	768096	2053	79641	1843	644	3590	51324	10140	3659	150197	9744	441108	7803	129807	7327	441212	10712	64332	64787	274	728116	201229	2319	390916	5590	23108	8462	6515	150094	92675	283270	387509	2272	51635	7167	84265	5996	64005	374	63892	11007	5510	5142	8576	23258	54541	219743	152002	285550	2185	23531	7454	284391	9079	64976	55608	57728	5116	118672	3689	4209	8303	23201	8717	5581	26529	9021	3655	11022	5026	94121	84959	9121	920	26262	140894	100128176	51239	114928	80778	4061	408	9051	80311	3683	121506	2176	9314	79690	10163	55093	93210	1043	149703	129293	605	5997	203286	80003	25870	29044	54981	92106	1741	220213	56985	146330	2353	8660	3338	7786	6793	5292	4900	90637	51466	10057	155066	56181	92017	57178	8971	285464	9677	200765	27315	10370	3725	121268	728661	284570	10288	196792	159371	64764	57467	6309	2588	100128108	84068	57175	79109	126259	112936	23225	944	2015	140771	5924	339883	56954	338758	5257	8403	100288954
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_2H_CD4_TCELL_DN	M4186		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1190_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 2 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					115207	10575	6103	5714	54949	388566	833	29940	4682	10797	23306	3557	16	6541	4907	407975	5873	1678	9093	116448	356	9412	51021	122830	55192	93183	79868	8726	2634	10653	1019	10395	4927	11066	63875	84002	1880	26263	7296	2012	6472	6015	7158	54475	9724	127703	1737	5932	5052	27074	8669	9047	1460	81034	7531	65094	84984	285628	4686	84520	28957	51340	8892	64114	55272	79770	284323	54931	55650	7071	705	8600	10987	10866	10252	84817	93081	1958	6388	132720	5569	9654	348035	84306	112858	22822	54433	64219	3164	55131	25979	4236	374383	9477	29889	284611	51174	1836	661	60673	11097	4702	113251	8890	23291	8727	7773	345462	27243	50814	1514	10989	22948	11072	25797	7775	10228	64924	6729	55052	28977	9595	79230	80830	5874	283219	54865	1787	26608	8013	84947	2720	902	2146	29071	10436	494143	384	8611	9840	64841	55737	163051	643155	5693	85365	25780	81554	5898	54472	92806	51645	84085	51096	7187	9111	57862	26122	123169	8772	54880	4345	81876	2672	79670	2787	10670	54797	2321	7150	9276	3329	203522	29095	84641	5877	51318	64859	10456	29950	10602	10613	7903	643837	8882	25940	7203	10920	10780	54205	26503	10007	54438	8864	8320	83607	79602	64116	10802	6426
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_UP	M4187		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1191_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 4 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					90990	7169	6920	26148	400986	114928	27163	51411	10788	64005	94039	3738	2550	359948	25939	55105	10140	27241	8869	9744	158471	5116	79441	1843	92675	5991	8801	1647	64174	274	9627	57161	2053	63877	100287628	93349	5797	6894	26586	92815	57561	4209	8994	427	23354	56160	660	9985	9414	51257	143098	8303	943	8576	55061	64754	8407	51439	51316	285097	155435	11096	7803	283507	9779	4008	51170	3676	54850	6277	2272	80258	4495	26525	375190	5787	4629	81550	5579	6515	80778	317649	63901	51390	441212	8462	8971	50486	92241	1200	10668	11236	3006	147015	54879	375775	1831	5805	114795	9056	768096	23336	4026	677769	130502	5533	123688	79668	201229	116179	54557	10370	23522	200765	56829	129563	81602	23331	149703	84068	2043	5002	51084	23108	7273	10397	10243	84959	79627	7163	5743	5125	50861	285195	79844	54541	5168	23619	25796	54209	8631	642236	6309	342371	100129361	1730	23112	100289049	92017	4601	230	100289246	26289	2015	23764	678	63027	84786	3725	3669	3337	4616	8717	121506	8507	285025	63935	121268	221223	29099	338758	5996	128611	118672	57476	8521	29125	440993	5000	5277	11124	8875	5144	5578	2131	54014	4063	9826	8660	722	100505989	146330	729806	149628	150094	85450	4084	92106	23270	1823
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_DN	M4188		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1191_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 4 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					9270	4049	2744	5906	7531	9204	92399	7494	79767	26031	51067	58525	5052	63875	127703	9663	79649	6674	5873	9093	3554	2634	7866	23587	54433	80775	5606	8882	64116	9136	26472	23071	8766	2030	65991	9015	54982	8864	5714	11260	5569	27101	92162	55737	92609	9412	10989	1662	166379	124401	59286	9816	10780	9456	10940	79017	440	5902	10856	151888	84306	10228	1130	84319	11072	23306	26517	4664	54865	2983	29071	170487	29940	81875	51174	28957	9933	5932	5690	55192	284323	56006	661	8892	51042	2720	171568	65263	6541	22822	117246	93183	51616	7074	51126	79084	5316	23212	93081	9310	51001	643837	29889	51184	134430	8726	833	586	56902	10430	8568	55863	3417	284129	5437	26040	150967	8832	10166	3559	345462	8772	18	100170841	9334	65260	3937	26608	57862	123606	92806	84085	29095	79142	10131	57559	203522	11146	16	27351	23450	136647	55148	165	5425	4345	50515	3276	55299	56983	7124	79770	84890	26637	84950	407975	4686	4665	84279	6182	112812	84520	55131	79443	27341	6311	90480	5693	6723	51175	100287482	26123	8600	55706	3662	9840	25929	148932	6690	92935	9277	51479	90693	83480	705	5514	8732	10175	5898	1602	5685	9435	9997	79064	6526	22893	55829	7903	9761	4907
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_6H_CD4_TCELL_UP	M4189		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1192_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 6 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					100287628	51411	5101	79668	339942	23287	51257	9046	2272	56160	1730	80201	3006	10723	8660	6515	57161	285097	80778	92815	25939	359948	23108	150291	3669	118672	266812	5125	10962	3726	6920	10788	5579	1843	9021	203328	5144	404550	3738	7803	6309	54541	85450	121506	348094	51646	79862	3148	678	150094	4209	54463	8971	130502	5168	5991	8848	11236	9779	6498	10397	9448	9780	9826	23764	10172	64754	133	205717	80714	5997	401647	143187	51439	90637	257068	8576	4501	9531	64005	64065	79026	1831	54414	4026	55061	26289	60685	283683	677769	84959	10668	94039	360	283897	150197	9314	3993	729806	100287569	54704	642236	79441	7837	50486	80318	26112	63877	81558	149703	319101	824	1073	4084	2043	84651	54103	100289246	259283	408	8407	87769	374	10140	51181	26105	3695	200172	8850	57326	5797	60412	54491	57585	79627	92241	1647	646241	54843	79844	57561	3337	79656	83737	201627	285492	149628	23336	9414	8303	5743	284391	27284	7128	10178	1823	80205	722	80258	26137	8507	374877	100289109	22821	7597	93210	4616	5002	23258	6843	220972	222161	22927	7273	10403	768096	114659	7109	4601	409	9079	58476	9121	2273	63935	9985	3725	129563	10235	56985	54879	388228	342371	973	84305	29125	51170	23533	2353	94241
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_6H_CD4_TCELL_DN	M4190		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1192_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 6 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					163051	387597	3557	10849	139411	55646	1978	6375	9477	79865	4345	81848	55798	152579	339123	8832	84807	84842	6385	165	10866	5784	23516	7371	22822	925	8187	93436	1124	7442	9761	661	80028	9412	54982	9047	9456	27074	586	7980	84872	6573	23185	389898	9031	8882	54039	54438	65260	8772	55183	5932	2021	51318	4665	3976	26637	79142	10940	356	222229	93081	221092	79080	952	84520	80746	65094	55131	57415	94235	100133612	3604	90784	84306	5198	3562	11072	7775	83444	100287482	3276	29071	93183	283237	6310	51232	84279	64175	3437	56052	200081	389170	2017	23170	26263	57168	10780	148932	257396	10613	54797	1737	5066	1798	64108	8624	54625	2730	9076	51184	51340	1678	51067	5874	26123	401585	26175	84950	81671	345462	5036	28958	401884	30009	54842	23587	7293	116143	23212	6723	124535	79886	4145	51645	57546	9603	1154	29929	6652	81831	57380	100130360	29763	116442	80223	494143	9817	29088	93663	29091	8645	10228	51102	9718	10432	25974	622	79834	6302	2122	3559	5450	204	81889	79447	79833	1960	29925	100131864	86	11146	7124	4602	79581	79709	84947	388650	59269	10395	5055	65059	8318	6541	2342	1994	3554	79064	1959	9136	1019	151888	220992	873	23150	3662	1104	8864	2560	129804
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_UP	M4192		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1193_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 12 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					5795	5991	4209	57561	79668	57732	23336	23112	285195	8341	665	4189	6934	10397	23108	342371	10170	10140	3726	10077	55432	728613	824	90637	79026	8477	283897	9170	11142	359948	9021	4929	4616	944	51411	6515	5225	388403	57161	130502	375190	100287628	6309	50486	56160	80008	9531	348094	9448	93210	7351	64940	259283	5144	154796	79441	284757	51170	6446	80219	64005	80778	90990	55790	3738	4601	1029	50640	642236	6498	54541	133746	319101	285550	1831	1730	1843	8507	100131941	8350	5116	8875	10370	54704	54491	285025	100289246	23270	2355	2043	25942	1610	57228	121506	7552	26249	3006	254170	54557	92017	378805	401261	338758	143098	7994	7169	7227	84959	134957	55766	84124	8660	85450	23764	220213	729810	9963	56985	23533	51526	57584	93349	94039	100131564	2353	100505746	2550	4026	29116	55105	6239	22898	54014	6303	9314	27284	26034	80258	1447	8848	84961	4629	20	645460	677769	6711	94241	7554	284373	51439	375593	83737	441212	645676	283518	8850	100289090	10172	3128	11027	768211	26148	3622	400986	151516	114907	54843	51646	80311	203228	1647	26289	5168	123688	203328	205717	7832	54463	23593	5101	8609	100287569	4884	25939	26112	23287	83719	400027	11236	9121	1998	161253	9214	5196	9605	150094	7128	200315	3676	5997
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_DN	M4194		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1193_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 12 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					23294	2806	26031	10606	2237	7411	283869	475	55863	90701	26608	57761	9817	9136	7866	5906	2744	79712	8624	81554	8636	25932	23306	113402	7074	3399	56006	150962	407975	1880	80757	51184	5066	10329	7371	6895	65996	9477	622	6541	11161	1960	7158	26472	6674	92745	10866	55726	100287482	6573	483	16	9031	1479	11097	55559	79622	54433	4174	9761	84306	7122	127703	79017	93183	55131	51074	8870	9093	6723	51474	23212	6941	9204	401505	9824	26637	84520	55858	9603	5437	8086	1978	51390	2288	26355	200734	8099	79023	157	2582	55650	1514	54475	5690	85015	93436	220992	23788	4665	1994	79692	205564	55646	400073	57465	117246	54931	197259	9443	6375	4285	10856	641	55299	8732	9456	55884	2720	10525	84950	55212	10653	8898	375035	80746	84034	4345	3336	28957	89944	2021	9047	7399	283742	8402	388722	5892	80196	92935	85028	11130	10527	5425	6634	140838	122830	55215	23381	5685	7187	27349	11260	2342	1802	84255	7775	29095	84649	1019	84872	6652	64949	23276	23516	51042	27351	388327	54955	55374	28958	8772	5873	63933	203068	57508	8809	1104	6367	4085	81848	10400	705	56902	60491	8726	10263	63875	152579	10248	120425	9933	10591	29074	94235	7416	64841	171546	221443	64834
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_UP	M4195		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1194_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 24 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					57561	133746	342371	4209	7433	401261	127262	266812	3655	51411	3726	60685	9448	64174	203228	3676	5125	256435	150291	84981	9605	3590	427	129807	26234	158586	920	114928	51439	3575	55103	285097	8869	254170	83595	51646	57161	6239	9760	63877	2878	221481	359948	26148	6659	319101	94039	9728	283897	202	3684	7994	944	282997	50640	79668	4069	56204	7294	81558	64940	10397	1486	57337	9921	130502	3632	23331	5783	133418	644794	149703	10077	388403	29116	57493	257068	4929	8875	23336	645676	100289090	5168	118672	90637	10370	84266	4542	64332	55432	390980	6446	55857	10365	123283	26289	4601	5743	5533	7169	1843	54557	4189	154796	400027	10178	23178	60468	7273	5016	79673	7128	2272	5082	79844	121506	2533	205717	375593	659	9931	79158	9531	8507	161253	9170	56160	92482	23177	3707	2043	10396	57584	10451	2550	56605	57728	23270	2124	8848	27	824	285025	23258	10628	84959	6711	85450	80258	59338	2355	100287628	155435	7227	23533	10520	94241	7552	84945	10668	23240	7556	196792	6309	84441	123688	54629	6653	22927	401320	1831	285550	28951	5797	3738	57659	25793	140894	92017	22861	55808	51526	64131	23199	23710	1647	5209	7554	64145	64778	7378	4013	22990	100131941	10235	8660	144108	100131043	11320	360
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_DN	M4197		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1194_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 24 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					7443	5001	10885	79022	60491	30968	79622	9204	79989	55863	4285	26637	55135	4001	286262	23649	1841	91057	55884	2806	95	23450	126208	55296	55726	5690	10488	26147	5860	10606	332	64858	28978	51003	54976	6573	2146	28958	10591	5714	9047	10533	27351	475	6541	2950	10856	54623	25804	51	1163	1020	259266	8192	10166	10549	5982	28960	8624	285628	55300	5435	91749	54913	10395	6732	4522	115098	122704	378708	523	115353	57508	26608	6182	80308	8732	8187	7918	79624	4174	23788	79676	5160	597	195828	8772	55559	80178	1293	100287482	55168	6443	81554	5066	1503	2720	9183	117246	26472	203427	7083	51192	401505	4682	2237	55055	54433	86	55835	23216	4580	890	1164	54808	27044	788	55706	79635	56938	4049	55028	2634	28985	9836	22974	83990	23417	51118	23753	51645	4201	113402	51650	38	84365	11169	4236	8726	10381	1632	908	152579	84955	79723	284323	4927	6150	51097	29015	10432	28957	84869	123263	9093	84316	29087	11161	8479	92609	29074	5699	54475	93436	54962	5052	10635	51175	134430	136647	1945	80010	55775	8819	440	23516	483	92092	29085	10535	120425	5557	9477	3613	374659	56655	8898	6637	9025	8260	2109	84313	8208	79019	221443	2542	9131	84817	10449	27166
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_UP	M4199		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1195_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 48 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					26148	203228	127262	100287628	92017	285097	55105	7803	54103	5125	401261	10365	4209	10077	94039	10605	100131941	114928	50486	10140	22853	133746	342371	5157	1523	5016	6309	64332	11096	220213	3655	123720	57494	319101	64778	84786	8303	27245	64174	84961	79594	219347	63877	3590	55553	6446	3738	90990	9021	9737	5617	7169	10451	7294	28951	100289090	9448	100289246	26137	9057	944	5292	57584	51439	9592	56605	79609	338758	22863	4069	80006	9728	220972	23764	11236	57493	654434	23629	6659	23331	4043	79668	93210	7109	8848	259283	55846	163882	5168	285550	80258	133418	7994	94241	3632	6498	91392	1823	23336	200765	27163	90637	3676	390980	4189	55790	4929	85450	3575	54764	11129	57192	79844	375593	5924	84981	646241	84071	54964	81689	3820	144108	5797	9605	3535	57125	56160	25976	57728	1953	23108	10859	4629	158586	3725	222161	10170	100289019	7305	10425	2064	9531	118672	2043	57161	285889	1647	282997	64901	8850	80778	474170	150094	6322	10178	123688	23270	3802	8660	3122	5611	79690	3128	80201	1843	79673	5341	64097	795	5991	257068	64581	9314	2919	202025	155435	139231	55095	57561	7552	22927	8507	283270	8379	5412	114795	51257	202	649	140771	29116	375190	79026	3055	26585	51759	3337	8462	3684	2124
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_DN	M4200		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1195_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 48 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					2030	150274	81554	27440	10775	100128731	5557	25804	1632	3149	113402	84328	29071	661	122961	2720	55055	79828	9446	84058	6541	51668	5425	4174	51340	284323	5481	55192	382	9477	2146	7158	63875	147841	10907	203427	55775	11161	23306	10866	7371	65996	116143	255758	8790	80757	6785	51184	9603	79639	1479	587	112399	55135	1725	60489	475	147184	387882	55296	79022	11169	79624	9204	483	80227	83590	9055	346171	170371	9817	6619	55835	10885	255231	29960	2950	8898	1841	6596	788	3418	283742	51776	26608	135154	285628	81610	29085	80010	1163	26031	204	10131	7443	2237	55858	4282	57175	29101	3181	2109	839	7468	10455	11162	11124	10488	9412	2806	79676	79886	10533	643837	123	55711	2769	91057	28992	10449	2787	79712	2184	1337	27240	148932	10856	79770	115353	622	5160	152579	89958	7027	10549	5892	22995	995	83990	79622	84284	51027	9801	11344	403	90693	9232	55646	3321	5714	80119	26147	9025	11270	55076	54509	339451	5437	29087	54930	38	5690	64080	64949	27101	2821	6297	6790	7163	54939	23208	3561	84634	871	123169	23516	9377	8479	5066	4628	4201	83461	95	56954	23279	84722	28957	2342	5092	8727	22929	8099	54938	7918	6051	3796	10670	55071	6367	57862
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_UP	M4201		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1196_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 72 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					427	127262	79960	3575	51759	1519	64174	7554	85450	9605	64747	10451	9448	493861	27163	7109	23336	80219	5125	91289	26034	79668	55095	1523	80006	390980	54103	55790	23324	80003	64332	114224	50486	659	57161	10221	56674	84572	7305	55718	23288	26148	123720	205717	8204	6498	55008	23764	118672	25939	220972	285331	2889	969	3655	57509	158586	51257	6934	163882	9113	285550	79818	83732	266812	301	79026	5997	254170	23240	284757	944	55703	8660	10396	134957	55180	57584	8556	9057	8507	84945	54617	59338	6916	400986	10077	64097	64782	84275	143686	319101	81488	5292	23064	51304	22863	1843	9941	143098	9881	114034	348378	64324	837	6646	60468	7327	57493	85369	115361	7556	57728	4929	5445	150291	8648	4952	1767	84981	10208	100289246	22853	93058	84124	10365	2272	11236	2475	85451	79693	1153	3726	9737	133418	26289	7803	54108	285097	151636	7169	10178	4338	100287628	113763	3725	64581	8851	677811	8848	5341	5396	9214	200315	112970	9640	84959	6446	4043	121506	284129	834	133746	79155	375593	57529	23533	283270	6279	8303	64434	284086	2355	23108	9314	7189	23522	10723	2043	9975	9021	3128	90637	3590	10140	51024	7273	51755	79844	10605	9693	29044	9308	65986	84248	2550	92304	6924	285958	8945
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_DN	M4202		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1196_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 72 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					26191	9455	7468	8624	170384	387882	10714	4222	9296	1725	93185	83862	27440	221184	4245	57504	11097	3149	6812	8732	55139	586	1104	115817	203427	9817	122961	6917	10989	9064	81563	5066	3181	27044	83990	84451	2793	5892	51067	1962	170371	2519	29934	9401	7775	29074	2634	4350	1798	91419	121268	3071	1017	5690	22995	10487	81618	11344	7296	23208	10533	55699	64116	55277	84842	5873	4321	10044	7903	57508	79991	7293	29937	23019	22822	8996	9456	84319	23788	29071	57707	23475	100130872	56704	80777	152518	10134	37	84984	375061	8479	25940	93081	91749	3030	622	643837	11161	6596	10311	10049	79086	38	1063	51645	587	23306	57761	171425	100129034	79833	120425	157	2146	23474	23310	5906	2665	5033	8536	2806	55028	8310	10643	57168	10457	3422	3032	11333	10856	7083	100216546	28957	6470	1615	4001	55726	8727	7918	93183	2342	2733	6281	23587	1200	9832	5557	57819	9156	9943	9380	145508	4522	871	3732	339451	60491	1622	55344	401152	23245	993	307	9076	84955	84255	2645	9231	283742	5052	55858	51008	259197	7705	5889	2762	11270	16	2615	8933	23623	135228	2030	81610	283104	822	10960	81624	7531	29109	196513	664701	10555	57646	3183	25932	6443	9603	29087	57862
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0.5H_ACT_CD4_TCELL_UP	M4206		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1197_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 0.5 h versus the untreated cells at 0.5 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					63935	1880	1376	9442	10189	5889	2059	100422737	969	100506127	8576	2272	1235	8519	85406	439	80831	6290	56114	11341	51465	9436	26059	166815	8490	100129436	694	51557	83891	60675	1329	11022	710	91862	9556	80308	148170	25873	145482	442216	150992	8339	3196	57453	646658	11261	164022	94039	100131053	51573	389874	3398	10446	54944	23436	51386	284948	1727	3594	4170	51110	10062	6839	6895	132014	26105	23676	81850	84967	162993	8666	2968	293	286190	80131	54586	51426	2582	440894	79647	79724	8665	64327	100507634	116224	51652	60490	51603	831	3484	1595	11108	441025	29890	150538	79171	22888	55039	55317	2882	54539	58160	7918	336	51725	7128	257396	567	171389	4001	284240	55585	26052	150677	1244	837	54108	4969	401324	100506243	9747	56477	140801	1019	10458	100287216	1611	347732	414194	10151	128646	219557	79065	283345	57706	8479	58533	1938	10201	90390	127396	222658	79873	1936	79791	28989	29951	10919	57409	445	29944	4192	79673	84262	654817	118433	4086	6128	29063	29034	6988	646588	5204	1215	9970	6166	10209	55290	100127950	84232	9802	1965	26532	51208	5688	149620	71	6125	124801	51493	79712	1652	5700	26063	27153	8360	93144	864	2124	100130219	401124	100289079	10623	56052	493812	6201	282566	8565	29114	10490
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0.5H_ACT_CD4_TCELL_DN	M4207		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1197_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 0.5 h versus the untreated cells at 0.5 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					23136	9080	344887	55199	3495	5071	339505	25925	139716	6369	22943	343990	1956	2170	64002	100286921	27022	9480	100507099	54880	56649	160518	6511	1046	285740	375295	84501	197407	729178	91544	79922	151742	215	54456	51313	146779	3703	51207	8630	100289612	346157	79152	10174	1990	10297	91608	100505478	50939	340205	81472	23187	3850	84725	147694	6557	5653	147685	285401	3902	8128	27253	8399	26291	100129722	199745	28797	165721	257313	85456	346007	100133116	79136	83656	100506540	5521	3488	1789	23254	9705	440503	100129654	100131015	7127	56704	58525	6372	100131814	6991	3770	9099	132200	56033	79632	646482	284338	51450	81832	9638	27023	283432	51301	5457	3227	353189	51398	10278	54507	83659	8908	3491	11141	8910	4296	729324	55713	56260	100287241	100287556	2554	56413	6689	6660	100131733	3204	1414	3010	338811	130888	348487	1672	117854	645687	5348	145474	54094	1903	100129460	4151	84651	4916	644815	114770	197320	374354	151246	256764	79166	81696	9095	57402	100130264	2621	6770	257358	3373	645961	23457	30008	7538	124056	157931	11146	3706	25854	283728	3359	26150	64087	11136	148581	83417	25966	348807	6094	255177	100506233	23220	5157	8342	643834	5167	8586	2559	51213	100131541	100287132	1412	144817	284297	727738	386627	162083	57821	25770	55561	220416	27306	554235	339539	79974
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_1H_ACT_CD4_TCELL_UP	M4208		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1198_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 1 h versus the untreated cells at 1 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					347902	54867	6792	1154	55124	283237	406991	79639	10224	57143	51135	9021	129450	81832	2972	80727	286083	283848	100130360	85407	7401	4914	90070	100131662	126308	51339	8651	29799	165140	3195	399671	64108	6913	131450	158326	9900	8349	79269	214	81628	6954	57537	89849	28983	29126	692159	642426	27202	1181	55539	261734	1901	445347	285205	257144	317754	79607	84734	8910	137872	389177	84465	100287056	157285	253805	8313	3581	51318	3559	4783	158056	619207	146845	29930	100287401	23568	84902	2487	256130	55638	9332	57125	503538	11095	345611	649305	23025	1880	5609	836	28981	283876	91523	57614	3398	5739	55000	2686	200830	80215	64288	28951	2841	286826	5079	6886	64332	10164	26085	200609	284365	149351	10232	2520	255061	10475	63978	23162	8690	64518	83401	641928	26239	200014	91608	6677	4935	6664	9852	6894	8460	125113	64418	654790	90768	113091	8553	728577	4281	80055	10297	1610	23242	90527	285782	51268	64388	94274	117289	3776	1057	54674	728730	642757	6098	338645	5476	5142	729262	374659	64689	55198	8336	239	10344	254100	25769	54762	26341	79854	7096	256126	2124	147837	4891	152078	10160	89953	9570	84366	54716	203102	645188	139221	100128961	646903	388011	2625	2706	728437	151484	7681	6004	5801	645369	286234	148170	203076	85509	84657
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_1H_ACT_CD4_TCELL_DN	M4209		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1198_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 1 h versus the untreated cells at 1 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					3399	4254	129026	5161	1303	55024	339978	7772	91894	340074	10840	134285	149643	114548	8111	145678	7152	342527	750	115196	27019	883	3354	10229	57409	139105	10912	84658	79836	51050	84072	284014	1132	79940	29113	122945	642394	2995	100130894	3352	200197	728683	25975	282808	10744	100131733	11074	6361	2315	126069	84696	7761	84322	8503	55501	80309	26102	150468	54088	1807	8988	8115	1846	4160	10126	28378	140886	85416	54854	3808	27197	4616	2074	1942	100132891	440122	6368	93650	10551	100132288	153	4642	541472	132625	312	51760	54541	100129455	6258	4654	3802	56672	100287479	81603	4920	26290	63910	64115	8536	22996	6714	5004	114571	260436	2859	26227	80725	401324	140628	2901	51151	10895	55693	93517	5154	56241	65072	7003	30845	1474	5540	2069	152015	5889	9721	118980	5726	94233	57447	23108	140735	28517	11227	100506963	140691	146852	10467	55143	5178	1277	80262	6866	27106	158405	7410	100506190	2247	3783	2941	7718	283869	283745	283254	285084	553	283948	114112	387837	5270	85450	84691	7185	5638	646241	6546	4486	1830	5798	54453	84769	55130	56937	57522	84909	54681	5777	56969	286254	83747	7479	338653	22798	4166	117531	9463	126205	100507244	376267	222256	5681	116113	26253	26821	55798	30012	100132570	2829	10533	100129794
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_2H_ACT_CD4_TCELL_UP	M4211		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1199_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 2 h versus the untreated cells at 2 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					27314	10395	54467	926	4118	54932	5732	93081	10653	8202	51021	4325	55180	404636	80764	5739	7363	100169752	347902	2770	8651	9938	115207	100132341	91523	406991	51339	80144	80830	8767	197370	56261	8349	7867	9840	79470	4200	57509	126308	10018	6988	140807	25780	58499	10224	5050	1154	84501	79019	23345	10151	1901	114801	22809	120425	9020	80223	8320	57559	8793	131450	64116	100130691	79990	836	10144	23074	645744	729522	79800	83658	6654	6519	5412	25950	55286	647107	9743	100505964	64288	92070	51318	283237	84804	1075	85480	50856	10219	607	405754	54941	89883	57520	7494	23150	100506668	2625	129293	10125	9600	79363	81671	3566	55776	10474	1880	55081	219690	79865	5175	4891	51105	147808	4060	23657	100126784	54674	2963	4214	100506237	127124	340357	8313	50836	645974	348932	170371	257396	5791	6304	132720	340351	8611	157285	60343	64850	9666	9262	817	1643	283232	30061	29887	6448	10170	11243	734	162540	51611	646576	84504	3587	255374	5959	3070	55636	148898	132612	283403	57820	5610	79413	1652	84647	340390	286184	7473	125950	961	84255	5899	64978	6282	29126	57604	54602	400618	8766	80298	342184	285513	6096	22927	125113	93190	10906	8869	3073	440498	9486	147965	28981	6150	474171	403312	8837	6839	10055	10800	10160
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_2H_ACT_CD4_TCELL_DN	M4212		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1199_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 2 h versus the untreated cells at 2 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					80045	5998	51523	2012	2171	27439	133522	3737	4739	150	51802	2295	1293	8462	59353	1847	100506083	2182	11167	8507	91056	440061	54541	646888	414777	29953	1942	151742	5780	58480	114548	100506757	285819	2550	23038	442194	23414	2669	10044	10022	150465	54438	85450	9573	26031	1846	922	4624	146754	5990	25770	7478	3638	3455	285812	10692	4922	8590	55321	100506699	100507281	5329	148696	3495	83598	64080	84620	374654	9697	219578	285016	4884	11013	1675	8613	3242	4010	4477	89872	375061	100505474	9867	60401	400952	79690	140687	246213	100287411	8492	390790	23764	93654	121643	9754	1843	65008	285419	79944	348093	653583	10143	23564	23142	57482	7293	387535	9177	1550	6494	200159	254312	401442	5133	1128	9043	100288954	93953	100113407	54830	56000	100506765	3399	2719	170850	81555	3897	245935	643623	3569	11005	2262	10186	3601	375189	83868	285908	4957	5270	388948	3912	57561	26499	54836	25774	55511	4914	8470	57701	2487	155038	23308	10879	219743	23268	84654	7368	55423	10842	7090	957	4814	286223	79791	140862	344558	5355	59269	5003	283728	613	3783	81035	56895	56648	10678	441666	388341	148113	149233	121268	55259	91464	2784	100130771	8999	83747	1647	1374	8061	4330	388	728116	100287556	100505624	3570	55332	64342	6788	157657
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_4H_ACT_CD4_TCELL_UP	M4213		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1200_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 4 h versus the untreated cells at 4 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					100132911	283237	9477	8767	5826	57171	256021	64116	10395	100527964	29886	148932	10224	284129	3587	2109	283482	8707	3418	4174	9020	646576	3717	6328	83759	222223	1017	388011	1643	400073	285386	284018	2034	10160	7049	80830	925	56006	92667	9034	10888	85415	8269	613126	129293	10653	65055	139716	152404	57125	926	51090	27314	80215	126133	8733	2625	400099	2475	123606	5152	389898	1513	8764	27343	23075	90196	55116	64063	84255	10924	25792	144571	10531	81532	7593	57704	81571	23635	9846	84034	11184	147645	9786	56897	79735	8859	8985	25839	10989	8611	388394	252839	56181	2983	101	79991	9666	145781	8402	57533	5468	10474	8675	11120	5831	23031	148170	84936	3795	7704	10791	57506	388115	90324	152687	645784	9924	51385	150967	79865	10585	283480	8349	9424	9840	5732	390940	728819	90522	6199	57109	5874	63950	84501	23345	4056	10384	4647	162	327	5899	203076	9131	153577	8408	3064	817	7414	9906	55805	28232	8651	54930	27098	3566	221477	23218	93081	79132	379034	51177	400622	92086	196743	4245	26580	90678	5775	8359	9703	94120	6448	84679	63906	6775	374383	3248	65057	55506	3275	85440	27291	5981	51135	55707	147670	149685	404636	114876	6051	22829	4168	23213	11237	1848	80853	8660	10422	4014
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_4H_ACT_CD4_TCELL_DN	M4214		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1200_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 4 h versus the untreated cells at 4 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					100507246	29930	10734	100507650	696	3890	117194	22885	255374	401612	115362	221584	943	6870	1795	27076	54763	304	5154	2670	3399	3772	400500	149628	221074	27289	6284	56253	83894	151888	80896	92840	10158	9038	100131993	462	55711	2669	284069	84939	80303	728730	23418	6334	54952	144402	150290	79690	151242	81550	23366	51619	100130742	140576	348801	646808	610	144245	29104	3960	128869	316	130340	401551	114814	79669	2786	56145	256006	85373	84616	9912	27095	5787	83850	10842	1671	149478	2891	153657	389677	84144	79877	4589	339442	6621	390059	100381270	2638	3507	728434	55635	56934	79015	56106	51533	51305	4826	8111	50836	100288693	93166	553137	171019	84293	4915	56891	57823	399	57292	8490	2152	387694	89778	126205	85450	8796	146512	7292	3291	56704	11142	60686	85027	196051	100289436	123624	125893	401282	100506708	342527	11027	6364	120376	3451	100131860	56911	54541	5355	333	100129603	147372	100506599	10325	6097	1846	100131354	83608	219525	55086	91574	122481	84959	3732	4884	338661	1238	51050	1647	340239	50964	3558	100129656	165215	202134	2692	644135	8355	2262	259286	8048	641928	83937	7476	253842	29906	84530	199920	10810	54798	939	27019	7356	8728	165829	10622	10584	2018	55422	729595	284615	148137	7227	55584	339123	57835	2558	100129476	84083
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_6H_ACT_CD4_TCELL_UP	M4216		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1201_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 6 h versus the untreated cells at 6 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					925	283483	11202	440307	10395	1741	2034	284900	25780	50838	5784	54941	645784	8828	285419	221092	1124	162540	222223	55841	58528	3485	80028	64506	646576	10194	5890	115948	3557	286442	347732	85477	100129104	100129129	10653	152404	5468	5320	91523	7367	5152	9278	926	114818	27314	5874	2770	8318	170261	100288099	129293	10590	57717	6328	9068	6641	643382	6253	8629	5681	23633	126206	57501	1848	4052	100233209	6750	388650	10842	494513	399753	54858	375791	84684	147645	57513	3587	3797	100129407	285386	114796	2625	93663	7098	23433	145781	240	4889	28232	10207	9630	28968	375295	58499	152586	2560	6775	10675	844	8651	23460	5175	64839	10039	151011	3973	283237	4992	8820	81029	160364	4128	5412	346389	374383	100288883	124540	2557	2069	55808	57125	1880	100133116	9154	8611	5778	221272	51161	149840	282618	9846	284439	2562	1017	5789	5939	401220	11030	429	10224	817	3630	89777	1152	10733	23245	56034	6282	23345	1602	7711	284611	27143	2827	55001	158401	150384	100133991	5172	100302740	10265	197135	8909	79575	1081	219670	345557	7436	317701	388115	10486	29895	139716	100287375	339977	653190	100093698	374618	92126	1769	79589	57573	6529	92922	4071	7122	5069	54842	79776	2019	440498	83447	4481	3241	25907	388011	2208	7541	100130934	1643
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_6H_ACT_CD4_TCELL_DN	M4218		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1201_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 6 h versus the untreated cells at 6 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					3759	80824	220213	8835	4601	4734	27032	727820	3433	2774	27297	130916	7100	100359394	2820	149628	6347	80705	80183	93649	5357	493911	7035	7050	1607	3667	5743	1293	23347	23518	90459	7292	6291	3902	285513	3592	55006	474344	23548	25939	26034	144811	8676	54541	441208	3890	2150	9412	118460	3552	55151	132949	5504	2444	3437	4239	5209	139886	3195	285966	80311	5359	57214	90271	246175	2710	84216	5213	51110	24138	343099	54733	722	9265	389432	55092	678	100127972	9934	83641	2171	3708	9718	7090	116154	10849	9819	84969	7171	55423	126295	84133	259230	1495	2012	408	283209	768211	100288693	94241	54806	342667	25801	149473	3399	23336	151827	11183	115362	9001	9175	23178	6458	3976	23143	10673	57514	4815	10329	5066	57217	5925	79780	8672	54145	8682	255119	139170	3859	5154	7798	8973	55589	57599	9150	355	2015	4155	3455	79890	146513	199857	9241	5144	3002	87769	55752	49854	388699	84433	2589	10892	8743	11001	6446	91056	90416	155038	10257	57194	23271	29994	148523	10089	115361	80896	92610	92482	54843	3570	60313	57406	26005	7461	9953	51184	10622	152579	3553	3725	53353	2633	728437	9650	51458	120526	23670	205717	6871	56925	92906	1385	3068	57338	79884	50508	64806	2919	11022	29969
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_UP	M4221		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1202_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 12 h versus the untreated cells at 12 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					2034	10432	7414	2534	10144	54941	134359	9846	222229	54749	114876	54842	5412	59350	256021	100129034	374383	94274	2625	147645	7547	3596	5784	10051	285386	6840	5796	157739	54521	8828	1880	139596	51105	10395	388722	204851	93081	222223	5468	285512	79956	5825	51430	64859	1604	10205	5334	222659	317762	7637	10653	51474	100287182	348235	84811	57558	9202	56261	22856	134429	205428	10221	55841	63899	5874	2673	55974	286442	2300	1602	124540	3587	9372	10224	345778	57493	64116	81847	166647	6385	23312	81671	4087	1124	2770	8318	101	50807	80789	27248	273	5791	3241	4128	1182	84285	79072	154075	400073	100506328	83860	959	81696	388272	23545	6529	4189	388650	133121	8645	23066	23635	168455	8832	118429	26053	642852	27247	9134	84343	50848	390916	23548	51759	6659	221496	54793	165100	64598	7494	7296	6641	9764	6624	8748	64866	8727	139716	22866	6674	167838	23395	5597	1848	79682	1491	123606	157922	166968	2124	7122	1827	6671	51090	151987	440952	2672	132720	8651	23633	5454	9205	6775	284611	100289026	817	57125	25780	59084	342926	23316	196740	7168	27314	121278	160365	200424	26651	7163	27075	51744	23212	6584	79143	79699	348035	123169	1497	55425	1374	79698	7027	25897	23074	6304	283713	7353	10276	8202	408050
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_DN	M4222		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1202_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 12 h versus the untreated cells at 12 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					940	1293	731424	1306	11001	256126	1444	3696	11040	151556	1179	10964	374407	3965	1890	165215	9934	51429	91647	6274	5168	4851	79683	5154	3805	7133	6004	54345	3765	9531	92558	27343	604	30009	80824	3553	481	284076	6555	353324	1001	83451	5270	100288551	115361	338328	256006	9941	921	53919	54843	140691	3449	340061	7480	11187	201725	55130	474344	115362	5962	23266	441052	9734	54541	4250	6354	51162	1610	286367	976	27111	10930	24138	729810	440560	1823	3560	79413	6446	7050	23178	60468	3576	1130	85368	58498	1577	54986	388182	84433	10673	56156	140625	972	9788	3732	123688	1830	10734	494115	55303	5301	2980	7035	5320	400622	3434	51298	10451	80216	6364	167359	1493	285492	83641	84329	283254	284751	200609	144481	8857	1909	388886	1378	58480	257144	4993	9569	150709	64881	375449	657	9693	5164	939	400745	441733	83482	50489	10266	26034	6347	4646	121268	80311	64094	23038	285267	285181	80094	222696	337878	8433	400752	3595	51333	1287	340385	7450	1776	54058	3726	283514	6578	79644	10635	83844	85413	2904	229	100289312	8900	11221	51186	155006	80258	23022	51320	83661	54112	3451	50615	5837	2560	2830	7044	283270	22808	84066	376412	3824	8638	403314	2258	257236	80731	4907	284757	7366
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_UP	M4224		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1203_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 24 h versus the untreated cells at 24 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					10783	4128	59340	400957	404037	94120	1880	285195	94274	22891	3848	286299	6252	100288099	8470	282618	57406	123606	137872	100287719	6367	348932	8701	1946	285386	3562	1848	2770	9249	118813	646576	4232	100131941	3903	64478	388	6474	5468	154881	6361	4129	91647	10018	100131683	79025	348761	8600	196264	222223	724102	192111	26353	441476	51744	128346	254778	632	9846	347730	5320	259234	246	10107	4109	6775	90639	57732	150379	339685	79143	26343	1497	10395	8629	253044	9840	5789	5913	6978	9311	4914	23114	100507386	94234	2941	1757	65055	2119	149483	100132741	54480	1466	285753	89885	439949	100506385	8828	8642	55244	925	158326	5874	84059	1604	284129	7076	608	64150	100131993	100287576	2904	1374	3804	619279	1300	90736	200523	23212	5816	55258	152404	2686	5152	5141	55911	401312	5569	100131176	57558	283856	374383	100129034	57669	2843	762	5321	8917	30061	9402	7079	54984	118425	59283	3452	54777	5726	25774	27328	4056	150297	5825	6320	2625	145270	23614	100505621	10653	286	10062	284339	80195	1185	2286	8513	55540	728853	29991	92305	4543	151171	55778	1435	9455	204474	10267	10224	2835	53841	160857	4759	100506668	64328	134	554201	2239	160365	2255	54752	6446	100505918	645369	10870	284365	55437	2615	25817	283796	100133660	7433	118663
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_DN	M4227		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1203_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 24 h versus the untreated cells at 24 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					257144	10964	8689	8418	79690	79132	1890	23023	57489	4582	55843	400768	3976	3669	121278	399967	5142	201799	54943	4599	10475	163720	27152	23677	4994	50945	4939	11262	79370	4319	55281	8573	10561	55303	5008	93129	79669	221336	684	605	11001	115362	285456	113730	283209	57823	302	4938	55008	401497	7220	2833	84941	6809	340371	3002	3965	56344	10673	9636	51058	348751	100129128	151556	114836	84969	7783	285025	2015	64135	734	26228	2537	125972	55184	1130	348094	400506	23424	3434	7539	23022	146723	100507462	84904	2272	79626	2921	7225	131831	145663	114784	115123	8743	5359	3627	4600	284541	3437	79413	116173	283416	3077	100128590	6672	2207	92482	7741	83595	100131454	89869	5017	8857	117852	219285	65072	157869	58480	283385	2897	22925	83449	10788	25937	6351	441124	51191	3595	3433	100506013	8356	54739	462	51375	51083	6496	100130429	7410	30009	115110	140469	5314	8078	84684	26998	7855	83943	27074	10110	6594	131583	3487	6374	79854	170575	4013	84071	467	26468	306	644794	157381	100131043	121256	83737	4493	728190	94240	84171	93668	2254	8638	6364	56952	304	3700	100287216	1293	389932	126074	645212	128611	135948	3645	11274	26103	100312848	643733	79915	144811	22906	8507	143503	3429	11143	646626	266747	3290	57501	643677
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_UP	M4228		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1204_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 48 h versus the untreated cells at 48 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					222223	18	23090	8611	100130360	5874	2124	389170	3321	100507099	22918	1880	11033	51474	94274	6286	27314	79731	57520	5152	2841	26053	91452	100129034	144097	339988	4281	123606	51411	2625	6361	51228	132430	10653	5784	64116	642757	6367	60677	115024	7076	282997	285386	114905	57406	9840	5997	57291	4626	2117	6482	999	54941	1514	57551	283848	1075	3848	313	201931	1848	100505518	597	164832	56261	9938	56950	147645	5955	140886	23545	57125	152404	9770	126917	5468	3484	8804	93653	284067	5321	5636	23212	285195	5175	50999	9231	2571	399753	374864	51495	7903	653857	55506	11086	53347	643338	210	5799	55667	100130331	2615	267004	51573	10018	115330	4312	6256	6424	4128	861	5774	3588	129880	23530	3269	100129961	6185	8559	83548	4828	23108	401585	81618	5728	285761	170371	1602	57662	64342	3158	137835	51626	30061	3566	2335	56655	64359	154075	27115	9846	10395	51086	5732	60529	22807	4259	349114	5334	643623	64949	221061	401233	161725	84678	11336	127391	85415	81872	1048	7122	55020	400456	10166	5019	100294362	55679	79602	2232	79575	646870	8905	112597	158160	26578	8600	255119	7414	139716	7159	55105	23155	3587	285754	4783	387882	128346	79085	254170	4118	66035	160365	55274	388650	800	10225	63899	200420	2952	4931
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_DN	M4231		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1204_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 48 h versus the untreated cells at 48 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					8835	79567	9693	10437	1326	222553	11001	8850	150185	154313	9448	80216	8543	26238	3267	10630	6932	93463	149628	5327	157	56521	5130	27074	100133019	54957	5142	51131	57691	5962	80055	92797	89778	50852	5004	23446	23533	54953	6503	10788	284677	27033	55340	467	6648	91252	7275	78998	255231	27094	29851	51297	84102	23643	55303	2150	283310	79842	285889	100507436	84557	10964	80824	4938	22920	10661	288	100288198	81629	302	6504	23118	23178	118461	553	100128830	7453	55610	1264	5168	6356	9603	6322	55095	727930	30813	2012	8807	100505783	10161	23271	57577	145663	4582	643783	6753	200312	646113	684	254887	84560	3558	11174	139411	54625	10346	619518	5947	51363	3428	9435	23317	496	128821	135398	168537	79370	4049	56106	10141	115362	51056	84930	116931	81488	2869	3458	6772	7187	55281	8844	23411	9934	23503	257144	11098	57720	285958	728081	3595	80125	214	2633	140825	84688	2798	3394	7294	84727	23381	284369	4599	283685	80328	10170	4050	2249	3690	10561	3559	9091	51107	1795	441108	6364	5196	825	11211	355	8444	81894	51191	5920	339965	3669	11129	914	160492	50486	2668	3744	51510	81543	3665	55526	8848	94240	3620	11262	1026	677844	2983	10673	6258	5595	8515	83666	100293705	128611	140689
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_UP	M4232		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1205_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 72 h versus the untreated cells at 72 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					2109	51411	9455	5740	8645	56063	4321	9076	197370	9231	283165	147645	123606	3587	130271	7434	2615	285386	642273	94120	5874	100169752	23212	10107	3566	4118	283848	26040	9211	2625	1891	54941	1880	56650	80339	27115	10962	9846	118738	1848	253461	136541	51474	5728	56905	3848	100128501	5774	56287	10874	100134040	203414	29986	283989	149840	94274	284677	146795	785	23545	22822	22807	126917	9202	140469	51246	1551	7180	5152	400622	6286	399753	56172	29935	100129034	2940	5786	728558	10445	123355	5175	440888	64949	57125	83447	10653	8320	4947	6310	4111	7200	92092	23650	166647	92104	100133039	147138	55540	100288882	30817	55753	92291	2124	4129	249	100130458	6988	4128	4087	5321	51573	79258	51444	7067	440730	222223	400986	917	339975	100130360	100128737	256987	23015	57560	84059	54602	5784	3321	729683	399761	8763	8536	24139	55327	57528	1828	6373	313	7224	79080	26279	84074	1946	23731	246312	114770	9590	3557	23052	137835	400684	64968	55530	23613	3712	10652	120425	4259	200162	388011	10798	3398	3357	7076	51385	727961	9791	100288939	54860	79581	84767	1497	139596	6450	27018	100129239	100131662	26153	23090	25972	59342	158401	347862	84524	11228	147172	57571	645188	25833	284114	729580	642533	25777	845	57558	115330	5825	57719	2770	440896
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_DN	M4233		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1205_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 72 h versus the untreated cells at 72 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					80335	81552	114614	79686	4345	8676	84766	6890	51659	256586	151636	4283	8835	5583	114036	8776	64135	84522	91851	2643	55303	84176	3003	79161	170575	3430	27074	9766	9693	57584	115361	84636	302	100132341	5888	9246	10912	10148	219285	126205	654817	6504	10666	84159	57161	23704	842	3394	122786	22914	80216	83690	83666	23764	836	9603	100132832	6322	7222	58472	29094	330	481	124220	143501	151647	5291	25996	10007	2120	10409	9976	284669	54464	1528	23411	91624	5699	9452	11277	79669	9636	11262	10673	24138	57097	23446	151888	55843	9094	84870	58488	50515	7096	2633	84918	6772	22800	1001	6583	57480	92106	84926	157	11073	161176	143384	56521	6402	55732	2794	55370	79155	80824	7456	7050	6809	7484	1130	29126	80055	10491	93550	6631	23198	23264	9446	898	5984	4300	81831	54625	91775	5734	4092	4297	151556	3097	5142	3559	286554	55656	388695	56704	203328	952	79026	10394	50802	167410	55824	100505536	375449	55720	1846	50810	28984	965	85329	144811	9113	8844	8850	10067	966	55215	26207	10788	92610	8743	8543	5641	5962	222255	5698	83891	1803	94240	285735	10346	115362	57162	155038	58480	4093	79568	254225	23191	117854	28590	168537	55300	58160	3429	283514	79567	4049	79370	50852	51429
GSE17974_0.5H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP	M4234		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1206_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0.5 h versus the untreated cells at 72 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					163049	219771	22833	9802	7536	23277	327657	92703	51018	100287932	571	7403	79691	25948	79609	79868	352999	9188	51430	93624	390980	9904	23130	23336	6421	58191	84275	9922	8462	9214	56160	1959	301	11244	9842	6259	93058	9929	150094	831	54934	84456	65083	133746	10818	4891	3398	1906	7832	57727	11269	3655	4616	641518	100302650	1983	9308	81034	55182	2550	114781	55603	5734	64145	548645	727738	64376	100286937	9741	9013	7789	55553	1105	8897	10174	28951	51276	22850	54880	64061	63877	8526	118987	338657	338758	4189	79707	283683	7174	10023	4629	57585	23117	100132832	57584	9825	51524	5552	6907	148423	1960	100289297	84707	51206	11056	23324	8445	51547	84981	6198	65986	51172	3553	6924	9267	57471	51646	55333	284695	11236	348180	100133130	23198	1901	6936	255130	8165	28232	92344	401588	140735	64645	54876	84807	5829	84135	63027	166793	441150	54910	79913	208	10291	3459	57291	22853	79364	221830	158586	7248	56261	57404	114224	54822	7561	100507218	114327	57617	144108	7556	256987	7259	728489	285550	163081	22863	5494	26747	55731	10652	677811	6988	57326	388685	23484	10365	7538	137695	6431	143689	10425	6322	8660	100505696	84897	150291	51061	57035	23533	55761	944	114817	84946	100287628	9701	24144	149041	55664	342371	9533
GSE17974_0.5H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN	M4236		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1206_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0.5 h versus the untreated cells at 72 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					10148	91057	2882	10465	51058	54440	4292	5901	388753	55620	2956	1798	27130	1727	79894	993	4864	83590	8192	91548	5501	5355	26147	79656	10128	5547	79828	8504	5571	81570	5160	54965	10491	100507436	5932	518	6810	317	89894	2987	5686	8402	57761	6051	8655	53917	83930	9134	586	92610	115004	2585	10067	55722	57175	822	4343	51106	5985	55226	51237	7728	23587	79140	10549	26263	10540	84545	65062	11196	1164	10459	91607	353322	6504	5696	6626	84693	2739	84823	5315	92675	4905	6470	7411	492311	53938	51184	22881	10572	10651	710	63875	115353	400073	29956	51510	388507	10857	401251	2710	84131	10666	9402	26060	28231	7374	55650	23450	3843	6652	6392	3796	55759	151188	118433	506	9744	29109	283643	51253	10301	51692	4176	84451	890	170371	147184	399972	644	2872	10539	1460	9184	100127983	6472	10201	100134229	79023	3953	126308	122786	55505	10113	965	23780	200734	11186	4190	116143	286826	622	5437	11162	8841	9401	55032	3418	23594	79892	90580	122704	113457	3992	708	25988	91419	6150	9784	92906	3795	29128	84920	2634	55898	5427	11124	284669	90488	55847	51053	3622	23406	22976	54509	8508	10381	80045	829	4701	2491	55863	6634	643837	84918	51103	55110	29893	3717	55062
GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP	M4237		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1207_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 1 h versus the untreated cells at 72 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					55681	7803	79868	1998	7538	55039	81034	79691	10492	9214	6259	9550	55330	1514	348180	79720	64145	64838	51307	100287932	56160	121506	27314	10018	54934	79960	10631	64061	4189	2669	150094	133746	79080	64112	51735	55731	79155	100289049	199953	51447	55892	54788	79048	25786	92344	4144	51105	65083	8446	27248	79147	6835	11244	79161	9922	23670	29107	8452	23528	301	7551	51429	7130	10557	4609	22911	84275	8911	5966	548645	57169	10276	51070	283933	53371	80149	10019	7862	30817	283683	57584	399	23336	7048	113419	692227	25799	54915	3575	256586	6924	8477	55207	1654	84135	3475	144108	133522	7718	9929	6015	64376	25851	4851	26224	284695	7310	56647	84946	342371	57414	10447	81566	130271	79668	7716	83480	219771	118987	4086	831	8897	24144	10445	55773	140775	387263	7273	10172	65986	79609	84062	8660	55466	93487	90826	56931	54902	157769	641518	7753	220972	51605	25948	51278	10795	3655	23683	51185	692205	10078	6988	22850	2354	92597	9188	10223	11218	1659	58508	10270	54964	100302650	84807	1407	66036	155060	64434	51742	969	6840	5217	266812	4149	669	58191	2219	9825	51602	85313	29933	80135	23560	117289	28990	10221	64795	254427	8884	23243	84248	100268168	57471	10208	8740	10269	3096	150291	571	11269
GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN	M4239		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1207_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 1 h versus the untreated cells at 72 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					84823	23595	10465	7416	641	27346	23478	5604	27068	8624	100507436	23306	3148	8443	84340	192669	81570	143903	92675	55620	788	90580	404636	29941	84885	115004	317	83930	9978	51657	26292	79023	4085	990	55188	51106	11264	1207	80153	26985	6904	10694	79894	54440	8208	55830	10971	10198	10906	90861	8402	311	54	84319	84245	5033	2110	201725	10549	890	23310	8726	8841	6502	506	10664	388753	79582	7329	349152	91057	2885	55246	23780	84221	10845	3710	30008	4174	7419	91548	5211	57819	2733	54962	23594	327	3895	285148	126308	2175	79968	23048	9404	3428	1854	27130	128338	23173	7041	10459	5778	3796	83590	51692	5058	10148	9156	65062	118433	1070	283927	100128108	10095	10491	55120	8615	51292	25828	10653	135154	3032	100127983	7360	26010	963	5641	7485	29844	7260	55111	26263	2193	112399	29102	5901	6652	974	4733	5315	26031	1384	5931	6626	127703	84314	7411	8614	23550	7384	9817	29803	122704	80045	10657	144455	79622	8673	54987	92906	8479	10606	221092	5696	51021	79001	7918	4292	79718	79019	23196	10401	3936	55898	79801	54951	2720	4047	55723	23511	11315	1460	55339	29956	2108	84918	8546	9110	23408	5147	440300	51142	9650	55139	822	56267	5110	10301	10311	57209
GSE17974_2H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP	M4240		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1208_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 2 h versus the untreated cells at 72 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					9076	6364	10078	91734	54980	1514	389856	339	23431	730249	57688	79691	57701	10302	9188	84925	55915	199953	57404	55603	8939	10445	642533	55783	100289019	140459	356	728489	201164	57019	153443	131096	56658	84365	56895	10492	53344	1983	10912	387263	257415	79142	6638	26053	26175	1105	6259	135892	22822	55330	7538	7716	55794	23014	1602	83850	85450	9690	7071	23545	944	92400	5290	54453	139231	147947	6924	147949	55095	1847	160418	84946	166793	10396	25852	163081	91801	8884	301	51735	219578	10019	2004	84524	7766	54925	23140	8737	5361	84135	348378	84248	54856	83480	23033	28962	7699	23281	338758	283635	677	51177	2919	55006	10447	79707	8507	9550	63826	55808	8879	84766	10099	2353	597	26503	51605	9762	10564	100287932	91120	54482	324	55646	8740	2550	93953	55299	23678	388685	92935	4040	26049	644815	10608	51429	57050	65083	79917	113419	642361	27439	79663	25836	22980	81566	10799	9373	375593	692205	10795	1519	441024	79585	7551	64897	7596	5621	51154	10223	58517	1959	4234	11234	10780	57125	147929	55659	6835	90784	57154	9308	5445	100127972	100129482	27076	64412	79147	571	219771	85377	6575	26054	3576	5806	3553	4086	55144	23151	9875	548645	7690	11010	9181	1960	3569	6907	79693	10769	10557
GSE17974_2H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN	M4243		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1208_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 2 h versus the untreated cells at 72 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					8443	401152	54927	1207	55620	196527	57178	55111	5451	10301	1495	3689	54541	84336	51397	84693	54987	311	57001	3007	9401	2584	143903	9377	5257	4292	100134229	84340	92675	401251	27130	26958	1786	84265	9896	201725	23595	112611	9824	10951	1070	55246	653464	822	51155	93974	10539	4358	317	57504	128338	5571	10549	1939	29085	10758	7867	286052	83940	9246	23550	55630	6515	64110	388507	51692	4701	154743	28985	1164	4720	890	9781	54914	10198	37	90634	92610	9650	9134	2937	284273	25828	23474	11041	22881	79184	4357	100128108	51106	51657	1376	10666	6938	7737	6717	5092	327	25845	84451	25771	5118	54496	6633	51237	55723	952	10606	3251	2491	9368	899	51728	26263	124222	84153	2585	79656	11314	8192	55916	9551	5827	55191	79968	4711	100288431	522	204	3241	79622	5033	121268	6472	10935	23468	3148	4134	54503	6652	83854	5696	54821	26060	9744	10581	83590	645212	29108	10577	387357	3796	23408	79415	64847	55133	10980	170371	402	389	29969	55876	7414	10653	23210	100505687	6790	10488	2720	6275	2542	23380	1643	11332	151188	11161	3987	54981	79004	84079	826	6786	55285	7419	1854	6491	129293	10367	51019	790955	146330	55135	2237	6415	2769	440275	580	23646	3615	4644
GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP	M4244		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1209_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 0.5 h versus those at 72 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					79161	25909	6659	285331	64651	80006	2959	64112	79960	55035	57162	57154	3091	133746	118672	23300	4753	8021	6934	1523	266812	144571	29062	63916	1519	9825	158586	22841	23484	256586	10208	51335	10451	7403	64784	8408	55095	10557	9922	56965	51276	7476	11244	54925	26065	221037	118987	5265	55790	79627	51582	64760	8204	6431	1645	9960	441024	219771	5562	284098	53827	6419	1105	7109	51099	11218	51755	1326	64145	64061	55603	9107	10172	112574	100287076	85021	85450	152006	3096	22850	8556	54902	23240	201161	84925	7852	6427	64324	9821	56674	10291	80024	100507637	55527	5734	80162	54880	30836	6875	51125	9961	388796	65980	9693	51759	90834	6988	3655	163049	140775	6924	6309	7832	1901	51763	4189	64645	11329	390063	4335	2117	25799	5829	388799	84959	390980	140735	80867	6903	79868	427	22863	1106	26034	9759	319101	285550	7174	91782	23336	9263	6646	26148	64320	65986	8720	79155	51061	9936	51090	8851	8446	6925	23140	84946	80219	5295	9842	10127	64376	25836	23129	151636	399	284307	1605	23533	9712	23169	59348	301	58476	51696	54619	4851	93487	51735	29072	10482	22877	83440	4792	50810	2308	51172	55636	155061	25829	55588	728642	10284	112970	407975	1654	253260	6198	11108	285463	9188	90784
GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN	M4245		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1209_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 0.5 h versus those at 72 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					2519	130888	9296	84842	7468	10714	6713	83862	25828	79991	57761	11336	342945	283104	388753	146795	10721	51016	64116	2305	387328	57819	91419	170371	2140	23474	689	10217	5213	23557	37	90416	170384	1466	5962	122961	27143	6019	124790	23245	84316	6836	23019	53938	928	10906	6812	135228	51293	6470	29128	7374	4245	50808	4222	5066	10555	10007	2634	91433	221150	2175	79894	51265	26292	8536	55139	8087	79447	3155	284926	54938	4864	5740	214	10963	8269	134429	100507057	5696	100133039	83990	51287	5690	622	2030	8645	54930	10765	10457	51108	7918	81624	285971	79833	643837	3783	965	318	84962	58472	64960	8310	51385	57820	84791	5889	400073	286144	4267	11041	9817	586	4430	23310	80317	115817	4720	55201	2733	6182	57491	132	90379	2157	1965	3149	51102	71	8732	10244	817	26272	80777	3628	150383	784	100288693	3925	203068	9211	7293	55760	3717	284367	643866	8933	10474	5901	1962	5686	27165	84823	10935	10073	259197	90459	23587	123228	60	57122	3611	900	1595	6119	10535	146956	5050	10293	3417	79602	2956	51103	9577	116028	39	2109	25875	54478	5892	11184	891	23397	80339	3939	3159	51318	2023	100130725	23475	3833	221184	5571	3183	58478	51258	11264	2739	80227	822
GSE17974_1.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP	M4247		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1210_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 1.5 h versus those at 72 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					9107	57639	152006	63916	284098	494115	7124	23389	969	7789	54878	8013	2824	51755	23151	57509	55661	57162	158586	118672	83480	23484	5445	375449	5290	10328	7227	387263	219541	23067	692205	10671	23300	112970	7095	9825	10153	9308	64097	121274	11086	10557	3575	140775	51763	57161	79015	163859	55170	91782	11285	143098	389856	1263	56985	64781	10569	80764	950	100133660	23338	1183	23315	10970	85369	51735	51561	10769	91300	84946	80219	4338	64784	23169	399665	4335	79663	23223	79443	201627	344558	639	768211	81832	348378	54480	84766	118460	66036	80006	51172	4839	5265	84886	84248	2669	25836	730094	64651	151636	55008	65983	57727	6932	1398	22936	55824	730092	1901	7832	55664	140735	414777	9120	9583	653519	64897	10746	54800	7403	55095	379025	1236	150864	57148	133746	7320	1503	93624	79818	57326	1390	256302	59348	5877	55280	57599	7844	29116	79693	51018	4928	4287	8556	6314	219771	1456	9821	1519	3096	94241	399	100129482	81619	23219	10208	81034	8507	51605	63925	9794	7752	90806	149478	7128	3459	6924	64145	7543	959	4600	79707	2317	5473	11129	64061	1844	22841	8972	57666	157285	944	9953	54617	143686	22821	9527	246243	6431	57585	9816	22861	23119	7321	23379	84959	163049	4683	1453	202
GSE17974_1.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN	M4248		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1210_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 1.5 h versus those at 72 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					2519	3660	25776	34	5832	221184	37	471	23310	2140	8269	126003	79132	93594	55651	79940	283104	57184	5889	387882	5422	10721	64960	1020	1725	7468	83990	1017	23595	376940	51109	2157	29935	38	23474	1622	7775	100506963	4430	140707	47	23564	2810	79019	84142	51728	10240	65993	1643	6596	8614	54995	8677	91433	285971	645212	55347	83862	55139	10244	84842	5110	3710	146712	2342	788	7414	307	9319	11344	51611	55565	10062	9832	51103	79718	120425	29780	5696	586	116841	5962	5147	55723	84343	10044	10533	9425	10498	55657	8574	10459	85012	574029	221143	7867	11161	6717	55227	64411	23386	100288432	221150	7186	51715	7371	92104	9744	29087	79187	23196	51657	130589	54478	79175	9296	581	8479	2491	51385	9368	25828	122961	55277	10401	100130872	1063	5245	375743	3149	158056	84376	54987	57504	5066	55011	23019	5699	64785	10205	55760	1856	64110	51021	84331	54930	50626	5690	518	9380	65003	84316	5188	81624	7923	9456	26517	5740	11270	3895	9231	6048	170371	63979	10095	51194	8310	79723	8226	85440	83854	3588	5033	124790	25837	8727	390940	10092	135293	80339	58472	7293	2793	55726	10856	10549	115024	284367	29128	2762	7879	10725	10714	79968	100101467	79834	2634	55526	5092	10024
GSE17974_2.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP	M4249		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1211_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 2 h versus those at 72 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					79147	51491	10019	6541	7549	23119	64114	9107	57509	55661	348035	23560	10451	91300	7789	9770	375449	3575	113419	9592	81614	51759	4799	54433	51616	9673	923	831	64121	54949	29851	379025	4928	23300	55008	56658	55041	868	57154	51399	29107	91782	9762	127262	7752	10602	55703	59348	55161	5966	26747	1519	348378	51649	79139	55677	441024	51335	338657	51755	5154	79015	5734	10127	23240	84159	80764	57161	10436	64747	256586	84923	2475	8013	55659	55588	60673	115708	29915	114049	7403	25797	112970	92935	23	9261	26278	8851	81034	57645	54931	4851	221504	79155	80135	51070	27349	8720	54520	54472	29889	55180	301	10982	4891	57634	3164	5898	7538	1876	93550	9214	54925	29116	60468	10328	4238	4092	58499	407975	23411	137695	64061	5341	79868	4839	7095	23484	9669	23160	414777	3091	54438	374383	84959	80324	57148	80006	55052	7803	28962	23336	25983	54955	8204	23169	10746	54902	54968	148867	84942	9825	25820	203547	64651	9308	79443	2841	55819	64097	1454	5412	4043	100507495	90410	26354	10153	8446	55170	54726	25836	26151	1901	93487	23223	29940	155061	4682	28232	22850	57584	6996	3707	29078	10482	1390	10564	92482	25885	115207	51561	54865	117289	4683	79161	22821	10252	54407	51735	22863
GSE17974_2.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN	M4250		20620947	Elo LL,Järvenpää H,Tuomela S,Raghav S,Ahlfors H,Laurila K,Gupta B,Lund RJ,Tahvanainen J,Hawkins RD,Oresic M,Lähdesmäki H,Rasool O,Rao KV,Aittokallio T,Lahesmaa R	GSE17974	GSE17974_1211_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 2 h versus those at 72 h.	The aim of this dataset was to study in detail the transcription kinetics initiated by cytokine IL-4 in early differentiation of Th2 cells.					37	5699	27102	342945	23474	7918	6713	130814	9781	84263	1622	57504	57819	1798	10628	160851	94081	219854	318	51657	55509	55760	51596	9184	3925	1020	390940	85012	5635	55898	1207	79902	387882	51084	170371	163183	57508	30968	4528	818	928	10038	57546	201973	132	79671	375743	8577	7923	4245	8479	29780	79004	3588	55876	84842	381	10714	5889	285819	883	25875	54995	8996	6917	55907	11184	1719	149951	79760	9110	140707	3689	7360	64110	4259	100129034	1718	921	95681	5870	8738	6652	84343	6920	3621	51205	6277	6717	307	55005	55347	121268	5696	4358	2615	122961	657	121053	10459	79187	148156	84451	2990	100288693	3628	9832	6715	91433	284367	1741	2810	2519	1431	51802	219738	51239	100144596	6812	128338	81618	389541	10473	8396	100101467	284346	5872	28976	5073	51008	84331	27018	5965	146712	25828	9455	1017	29128	7384	27346	221184	147968	22995	84964	3783	7371	5315	100130872	147645	389	10721	822	54938	7295	2319	4001	220930	150051	84273	1615	64785	6275	79712	9231	1595	4905	1466	51537	201254	55204	10367	317649	29085	284294	146956	55647	84034	401152	57122	286144	7293	994	286053	871	55011	5269	79132	5451	285753	2793	285971	6195	5710	9235	51642	26469	283104	5962	56935	118
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_UP	M4255		20164420	Zaslavsky E,Hershberg U,Seto J,Pham AM,Marquez S,Duke JL,Wetmur JG,Tenoever BR,Sealfon SC,Kleinstein SH.	GSE18791	GSE18791_1538_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 1 h.	The dendritic cell (DC) is a master regulator of immune responses. Pathogenic viruses subvert normal immune function in DCs through the expression of immune antagonists. Understanding how these antagonists interact with the host immune system requires knowledge of the underlying genetic regulatory network that operates during an uninhibited antiviral response. In order to isolate and identify this network, we studied DCs infected with Newcastle Disease Virus (NDV), which is able to stimulate innate immunity and DC maturation through activation of RIG-I signaling, but lacks the ability to evade the human interferon response. To analyze this experimental model, we developed a new approach integrating genome-wide expression kinetics and time-dependent promoter analysis. We found that the genetic program underlying the antiviral cell state transition during the first 18-hours post-infection could be explained by a single regulatory network. Gene expression changes were driven by a step-wise multi-factor cascading control mechanism, where the specific transcription factors controlling expression changed over time. Within this network, most individual genes are regulated by multiple factors, indicating robustness against virus-encoded immune evasion genes. In addition to effectively recapitulating current biological knowledge, we predicted, and validated experimentally, antiviral roles for several novel transcription factors. More generally, our results show how a genetic program can be temporally controlled through a single regulatory network to achieve the large-scale genetic reprogramming characteristic of cell state transitions.					146923	100289336	51058	25973	90293	92292	100507495	81621	149373	125704	25859	132884	5320	53829	51284	1990	10824	158381	128153	54549	133688	10780	646778	341405	40	2353	2187	129080	116	80307	160	9452	55900	728039	680	84071	23154	375189	2938	5081	3083	116071	91646	280664	85368	1946	10240	10794	6499	51179	84552	100130288	8786	53632	80728	10391	1791	253769	79849	80185	154790	100292909	339168	27253	11251	100131864	55643	3910	10076	150568	497256	7579	135250	152078	90203	100288765	1825	6689	126969	124961	23627	283385	3448	6616	283416	148304	54756	64409	100533182	153579	2974	145258	51302	221504	3776	219670	8928	400629	401098	148213	921	79230	340547	643395	116113	219731	729975	126695	342892	121551	64108	100093698	401262	2562	414245	90332	93134	100288722	4045	55504	57605	283375	80724	1160	157503	340146	221191	57452	146894	116068	7485	8930	401491	127534	10333	164592	1800	90381	692247	254128	100288447	4158	135946	64806	5730	140738	79804	201516	158135	54361	55349	7498	64902	3960	200261	1580	3077	1036	140258	643836	400456	644714	55790	2516	339327	100131510	100506497	56704	27164	731157	1551	282775	100288249	1600	5774	440279	345611	266812	649	54925	100131691	54854	23546	400926	731	116931	140689	283025	3174	727701	1285	84847	2065	197187	221833	157848	170572	100129175	100128002	80168
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_DN	M4256		20164420	Zaslavsky E,Hershberg U,Seto J,Pham AM,Marquez S,Duke JL,Wetmur JG,Tenoever BR,Sealfon SC,Kleinstein SH.	GSE18791	GSE18791_1538_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 1 h.	The dendritic cell (DC) is a master regulator of immune responses. Pathogenic viruses subvert normal immune function in DCs through the expression of immune antagonists. Understanding how these antagonists interact with the host immune system requires knowledge of the underlying genetic regulatory network that operates during an uninhibited antiviral response. In order to isolate and identify this network, we studied DCs infected with Newcastle Disease Virus (NDV), which is able to stimulate innate immunity and DC maturation through activation of RIG-I signaling, but lacks the ability to evade the human interferon response. To analyze this experimental model, we developed a new approach integrating genome-wide expression kinetics and time-dependent promoter analysis. We found that the genetic program underlying the antiviral cell state transition during the first 18-hours post-infection could be explained by a single regulatory network. Gene expression changes were driven by a step-wise multi-factor cascading control mechanism, where the specific transcription factors controlling expression changed over time. Within this network, most individual genes are regulated by multiple factors, indicating robustness against virus-encoded immune evasion genes. In addition to effectively recapitulating current biological knowledge, we predicted, and validated experimentally, antiviral roles for several novel transcription factors. More generally, our results show how a genetic program can be temporally controlled through a single regulatory network to achieve the large-scale genetic reprogramming characteristic of cell state transitions.					11280	1647	1195	59343	5366	23135	389177	9019	7159	8846	5054	100287094	64651	158405	27153	220980	254887	23360	4929	5352	1111	727897	196446	57162	100093630	5997	23093	25976	8660	387763	10308	378805	260434	56899	150159	57396	1016	441441	4337	84699	147841	2354	100130705	50940	221241	29881	203413	286223	10602	84173	8361	79992	11216	9262	57235	170626	10135	108	23099	3850	10818	283310	256051	81572	100130642	5743	285628	144535	57154	55744	4239	50804	4616	55930	253430	123775	116039	4791	525	56931	2669	29064	90737	155435	6623	11117	124912	1326	441245	100216546	22850	100131211	83461	54873	349152	386627	56961	11070	51277	390940	54764	157740	55132	92840	284950	7185	2949	54442	55030	10882	116986	162993	284475	1948	100129104	6656	51526	9071	93109	135458	9379	2849	8843	2173	161436	389161	285692	55530	10690	26074	2254	221786	100289058	219988	2886	1785	80060	4499	100133660	79087	7373	171482	339541	10151	5008	7718	57834	267004	1828	2328	100130717	7266	662	54977	64123	54578	644656	219995	3736	344595	6236	11131	3347	29035	84076	51585	283600	7102	7050	55167	79968	7291	100302650	81610	84752	11176	6583	8350	84206	4192	728475	57621	1444	27289	8552	60436	5533	28786	319101	337	3337	84417	81691	5142	9275	389376	284047	2308	117194	123606
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_UP	M4257		20164420	Zaslavsky E,Hershberg U,Seto J,Pham AM,Marquez S,Duke JL,Wetmur JG,Tenoever BR,Sealfon SC,Kleinstein SH.	GSE18791	GSE18791_1539_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 2 h.	The dendritic cell (DC) is a master regulator of immune responses. Pathogenic viruses subvert normal immune function in DCs through the expression of immune antagonists. Understanding how these antagonists interact with the host immune system requires knowledge of the underlying genetic regulatory network that operates during an uninhibited antiviral response. In order to isolate and identify this network, we studied DCs infected with Newcastle Disease Virus (NDV), which is able to stimulate innate immunity and DC maturation through activation of RIG-I signaling, but lacks the ability to evade the human interferon response. To analyze this experimental model, we developed a new approach integrating genome-wide expression kinetics and time-dependent promoter analysis. We found that the genetic program underlying the antiviral cell state transition during the first 18-hours post-infection could be explained by a single regulatory network. Gene expression changes were driven by a step-wise multi-factor cascading control mechanism, where the specific transcription factors controlling expression changed over time. Within this network, most individual genes are regulated by multiple factors, indicating robustness against virus-encoded immune evasion genes. In addition to effectively recapitulating current biological knowledge, we predicted, and validated experimentally, antiviral roles for several novel transcription factors. More generally, our results show how a genetic program can be temporally controlled through a single regulatory network to achieve the large-scale genetic reprogramming characteristic of cell state transitions.					84078	91	79714	170575	8228	8125	10240	3174	25842	153579	55039	25973	64949	84294	23708	100131816	146923	3087	57533	254778	1848	79363	64802	7096	55780	10333	6783	5999	10780	80227	93134	10363	84498	26984	53829	285331	1160	254128	2353	64283	221504	3459	7730	23503	79568	30001	196513	5987	43	282775	160	84527	54980	90075	170384	10849	55634	84455	266918	100292909	11081	79177	222236	63897	55028	168537	51250	55656	51163	100132708	84629	4857	5557	151254	339324	6730	25974	152206	147949	220042	50700	146050	4779	100130288	23627	23500	55181	7372	126206	389023	85315	1432	29102	100505893	1070	84306	54925	7485	64793	55109	9675	9678	100128164	54995	55340	2188	10740	84722	474344	54801	2187	23224	26157	729975	220992	84978	2798	283464	27030	163786	5001	64777	1477	5189	7621	11162	84518	7596	27327	57325	151194	89797	80185	4751	6120	83448	27300	50615	83893	91419	728039	51000	7044	2800	342892	26235	348793	144108	643836	11201	27164	147719	26974	2974	79023	6701	5364	55781	83544	1434	84850	1388	10940	1339	25929	80010	116143	338785	78996	9875	29985	2206	390963	51363	10194	54101	6947	29090	55355	100506428	220077	92241	55783	590	9666	10799	79830	9724	57567	203245	90993	345895	145853	1084	23154	79866	3155	1144	340554	147872
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_DN	M4259		20164420	Zaslavsky E,Hershberg U,Seto J,Pham AM,Marquez S,Duke JL,Wetmur JG,Tenoever BR,Sealfon SC,Kleinstein SH.	GSE18791	GSE18791_1539_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 2 h.	The dendritic cell (DC) is a master regulator of immune responses. Pathogenic viruses subvert normal immune function in DCs through the expression of immune antagonists. Understanding how these antagonists interact with the host immune system requires knowledge of the underlying genetic regulatory network that operates during an uninhibited antiviral response. In order to isolate and identify this network, we studied DCs infected with Newcastle Disease Virus (NDV), which is able to stimulate innate immunity and DC maturation through activation of RIG-I signaling, but lacks the ability to evade the human interferon response. To analyze this experimental model, we developed a new approach integrating genome-wide expression kinetics and time-dependent promoter analysis. We found that the genetic program underlying the antiviral cell state transition during the first 18-hours post-infection could be explained by a single regulatory network. Gene expression changes were driven by a step-wise multi-factor cascading control mechanism, where the specific transcription factors controlling expression changed over time. Within this network, most individual genes are regulated by multiple factors, indicating robustness against virus-encoded immune evasion genes. In addition to effectively recapitulating current biological knowledge, we predicted, and validated experimentally, antiviral roles for several novel transcription factors. More generally, our results show how a genetic program can be temporally controlled through a single regulatory network to achieve the large-scale genetic reprogramming characteristic of cell state transitions.					23099	378805	401317	8660	11044	57396	84002	23360	4239	23135	2646	1195	85463	100216546	54206	57162	221421	284475	58476	221786	123606	8013	160622	8361	55030	84807	7159	51277	221468	5814	100133660	23174	5376	5366	149478	2669	3433	415116	55370	374383	100130705	80223	135458	387763	3347	728475	280665	56134	84981	79875	284950	1948	100302650	54442	4144	100506988	10135	93082	28227	3627	285692	619518	9071	10625	256979	9468	4616	116986	55018	84541	197135	54438	2710	28	3437	84206	130502	2146	3656	57612	389432	339751	342538	6779	7552	3665	2854	2117	6425	7975	203413	23430	9892	284167	2309	441245	9636	54552	3640	100289209	100289494	148479	374	439951	55525	4929	246318	10573	9708	100130837	25897	4084	83450	4335	9890	83479	10260	7050	23411	3164	2904	64651	152519	4117	57731	10481	344595	138311	1179	6770	168433	1038	79159	1390	9456	23033	3456	4253	1453	285857	84524	81566	10725	171484	7124	5008	7185	4599	9479	84254	84275	2822	388	10804	10560	84699	8843	9019	253639	5743	153222	2254	283432	55132	284207	145474	6583	5997	5142	161514	7718	114614	50804	140686	389177	57728	8900	3659	5553	55208	4846	100286909	3337	79879	100128511	5734	6322	100131691	285889	117194	27	100289049	26074	256223	3434	9451	100134822	7712	57494
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_UP	M4260		20164420	Zaslavsky E,Hershberg U,Seto J,Pham AM,Marquez S,Duke JL,Wetmur JG,Tenoever BR,Sealfon SC,Kleinstein SH.	GSE18791	GSE18791_1540_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 4 h.	The dendritic cell (DC) is a master regulator of immune responses. Pathogenic viruses subvert normal immune function in DCs through the expression of immune antagonists. Understanding how these antagonists interact with the host immune system requires knowledge of the underlying genetic regulatory network that operates during an uninhibited antiviral response. In order to isolate and identify this network, we studied DCs infected with Newcastle Disease Virus (NDV), which is able to stimulate innate immunity and DC maturation through activation of RIG-I signaling, but lacks the ability to evade the human interferon response. To analyze this experimental model, we developed a new approach integrating genome-wide expression kinetics and time-dependent promoter analysis. We found that the genetic program underlying the antiviral cell state transition during the first 18-hours post-infection could be explained by a single regulatory network. Gene expression changes were driven by a step-wise multi-factor cascading control mechanism, where the specific transcription factors controlling expression changed over time. Within this network, most individual genes are regulated by multiple factors, indicating robustness against virus-encoded immune evasion genes. In addition to effectively recapitulating current biological knowledge, we predicted, and validated experimentally, antiviral roles for several novel transcription factors. More generally, our results show how a genetic program can be temporally controlled through a single regulatory network to achieve the large-scale genetic reprogramming characteristic of cell state transitions.					79714	3631	10799	56339	220042	9786	79896	53829	55039	80153	50615	8125	51499	63897	93587	84078	6047	3087	151194	10194	51629	790	6821	146050	10224	202181	4698	2353	93627	79871	4707	116236	9815	57533	23708	57461	81889	51287	126074	29090	9416	54675	6182	5557	55900	22796	57325	10885	11162	2313	113251	79230	170575	64283	1434	9678	2004	10363	8563	8697	1967	92667	80227	26608	113115	7772	201973	196513	55172	10081	10254	4436	56919	64432	64949	9666	285613	79728	5955	5987	22928	1676	4774	145853	9816	359948	5933	64979	27300	6732	51367	54433	83862	8402	64789	389362	29902	93134	112858	10333	153364	9875	27079	54482	84816	26059	84527	142940	80308	8892	8464	203245	92241	5147	440119	92105	80010	29098	10940	7485	100131801	119392	8706	4033	26953	10201	27250	134145	79682	64216	144108	78996	10240	80185	1070	64112	26276	80143	400456	64801	1678	85453	54920	122961	57093	286336	84987	6627	6874	2101	9053	6396	254128	10928	892	2188	6895	51194	90019	56181	91647	26235	84629	55110	55109	121642	768211	54849	283464	348793	10575	55154	51250	84693	51006	100130219	146223	220002	84650	55148	9093	80324	7172	10849	55656	54549	340581	375010	219654	79017	5281	79081	7096	5889	26292	56252	11020	6903	54955	283742
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_DN	M4261		20164420	Zaslavsky E,Hershberg U,Seto J,Pham AM,Marquez S,Duke JL,Wetmur JG,Tenoever BR,Sealfon SC,Kleinstein SH.	GSE18791	GSE18791_1540_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 4 h.	The dendritic cell (DC) is a master regulator of immune responses. Pathogenic viruses subvert normal immune function in DCs through the expression of immune antagonists. Understanding how these antagonists interact with the host immune system requires knowledge of the underlying genetic regulatory network that operates during an uninhibited antiviral response. In order to isolate and identify this network, we studied DCs infected with Newcastle Disease Virus (NDV), which is able to stimulate innate immunity and DC maturation through activation of RIG-I signaling, but lacks the ability to evade the human interferon response. To analyze this experimental model, we developed a new approach integrating genome-wide expression kinetics and time-dependent promoter analysis. We found that the genetic program underlying the antiviral cell state transition during the first 18-hours post-infection could be explained by a single regulatory network. Gene expression changes were driven by a step-wise multi-factor cascading control mechanism, where the specific transcription factors controlling expression changed over time. Within this network, most individual genes are regulated by multiple factors, indicating robustness against virus-encoded immune evasion genes. In addition to effectively recapitulating current biological knowledge, we predicted, and validated experimentally, antiviral roles for several novel transcription factors. More generally, our results show how a genetic program can be temporally controlled through a single regulatory network to achieve the large-scale genetic reprogramming characteristic of cell state transitions.					138311	11044	10561	4117	386627	3433	51191	57612	54809	3437	197135	54093	3434	57674	4600	1195	55603	129607	24138	93349	80078	4939	94240	23099	54625	8542	3841	11274	64895	55337	10964	6773	221079	9636	3665	133	4599	54739	149401	64651	3627	91543	7706	219988	23586	79132	80055	284001	54206	85441	10135	135152	83450	3659	3669	727820	80223	8437	4940	116071	54541	50804	84132	57169	87178	29126	64135	64108	9985	8743	199699	23135	55339	2643	51251	84930	5371	84796	91663	2537	10174	100131541	91351	54894	7404	128853	1847	54438	83666	219285	81030	51427	10403	11011	6737	5366	4651	3010	441108	7101	51365	51277	9456	93343	100216546	1820	56965	6278	55030	201176	56899	103	84166	152926	55601	55423	81894	6890	5359	10208	401317	6373	148014	57716	283651	25822	6714	55008	100286909	100128868	3796	8638	285857	57396	57592	132204	53918	55802	132671	57162	941	7366	3656	646588	8013	284475	160622	6018	23360	253260	90326	342538	55525	9334	54823	147841	6617	7138	100131015	26077	8820	221468	81622	11074	151636	163259	4791	8519	1318	7050	389119	54676	4814	2526	5624	389177	150590	4502	22824	55320	11280	51131	55669	3430	692205	56913	285237	81844	5533	80111	4616	140683	27179	6355	7185	257044	23033	200315	6511	23779
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_UP	M4262		20164420	Zaslavsky E,Hershberg U,Seto J,Pham AM,Marquez S,Duke JL,Wetmur JG,Tenoever BR,Sealfon SC,Kleinstein SH.	GSE18791	GSE18791_1541_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 6 h.	The dendritic cell (DC) is a master regulator of immune responses. Pathogenic viruses subvert normal immune function in DCs through the expression of immune antagonists. Understanding how these antagonists interact with the host immune system requires knowledge of the underlying genetic regulatory network that operates during an uninhibited antiviral response. In order to isolate and identify this network, we studied DCs infected with Newcastle Disease Virus (NDV), which is able to stimulate innate immunity and DC maturation through activation of RIG-I signaling, but lacks the ability to evade the human interferon response. To analyze this experimental model, we developed a new approach integrating genome-wide expression kinetics and time-dependent promoter analysis. We found that the genetic program underlying the antiviral cell state transition during the first 18-hours post-infection could be explained by a single regulatory network. Gene expression changes were driven by a step-wise multi-factor cascading control mechanism, where the specific transcription factors controlling expression changed over time. Within this network, most individual genes are regulated by multiple factors, indicating robustness against virus-encoded immune evasion genes. In addition to effectively recapitulating current biological knowledge, we predicted, and validated experimentally, antiviral roles for several novel transcription factors. More generally, our results show how a genetic program can be temporally controlled through a single regulatory network to achieve the large-scale genetic reprogramming characteristic of cell state transitions.					57567	84078	57019	79896	2353	53829	219654	149420	3145	126295	3603	4436	57591	3087	6182	64400	8625	55735	64172	203245	29985	220042	123263	9786	79723	23708	83695	55655	10799	55299	54920	64425	63910	55449	28990	51368	113115	171568	642946	4033	134145	7374	26472	153364	705	11162	403313	790	56252	55588	113444	8738	11066	79567	3852	84279	23283	222236	2004	55330	51073	22954	81029	9053	26094	6396	10422	84650	60673	5189	10333	29098	57325	124995	79871	113802	11007	81572	283464	3615	64216	10363	10419	328	283219	8402	64418	54938	9616	9816	84975	6730	1070	55640	83989	55794	23404	1503	116068	140459	7584	8774	29107	54859	26608	54361	91647	23401	8833	10978	80746	126917	126074	79149	11070	8604	84910	7485	84329	55900	22893	254128	10794	23014	898	10741	51116	58492	64979	10849	54816	162239	84304	91298	340547	124961	1628	148418	57693	60626	1069	54107	51497	56954	9718	55222	51388	3269	152217	10273	348793	151903	55172	84294	29087	25879	84629	64789	5147	10201	64801	54675	79810	9650	4698	11344	23212	55033	55005	55909	3459	23087	388789	283742	5471	92292	121274	6895	54545	861	4839	10081	92689	80308	84668	79760	84134	55290	51611	93134	25809	90693	2021	92342	80324	10430	152002	100288798	136647	116236
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_DN	M4264		20164420	Zaslavsky E,Hershberg U,Seto J,Pham AM,Marquez S,Duke JL,Wetmur JG,Tenoever BR,Sealfon SC,Kleinstein SH.	GSE18791	GSE18791_1541_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 6 h.	The dendritic cell (DC) is a master regulator of immune responses. Pathogenic viruses subvert normal immune function in DCs through the expression of immune antagonists. Understanding how these antagonists interact with the host immune system requires knowledge of the underlying genetic regulatory network that operates during an uninhibited antiviral response. In order to isolate and identify this network, we studied DCs infected with Newcastle Disease Virus (NDV), which is able to stimulate innate immunity and DC maturation through activation of RIG-I signaling, but lacks the ability to evade the human interferon response. To analyze this experimental model, we developed a new approach integrating genome-wide expression kinetics and time-dependent promoter analysis. We found that the genetic program underlying the antiviral cell state transition during the first 18-hours post-infection could be explained by a single regulatory network. Gene expression changes were driven by a step-wise multi-factor cascading control mechanism, where the specific transcription factors controlling expression changed over time. Within this network, most individual genes are regulated by multiple factors, indicating robustness against virus-encoded immune evasion genes. In addition to effectively recapitulating current biological knowledge, we predicted, and validated experimentally, antiviral roles for several novel transcription factors. More generally, our results show how a genetic program can be temporally controlled through a single regulatory network to achieve the large-scale genetic reprogramming characteristic of cell state transitions.					85441	85465	65264	84166	84132	4117	57169	51493	4615	64651	441108	25841	4600	7706	3659	388228	23597	116986	55337	1318	51191	87178	138311	64895	93349	57674	6773	5371	11044	29126	24138	54739	55008	103	53918	2526	55603	9189	3433	10561	3665	129607	54625	201176	3841	54809	2643	55601	4254	94240	91351	219988	10672	116071	64761	55281	3437	151636	85363	160897	3434	6890	10346	4939	79132	10964	80055	1195	64135	23347	23586	283629	91663	2256	9636	54541	81894	56913	7050	135112	3431	219285	51131	4599	11274	389119	602	5533	6993	7051	57612	5359	1657	7042	51427	54093	83666	114991	51251	2185	9781	2959	3627	5074	10135	4940	23099	55370	140691	55802	6018	6398	81689	375035	6909	9881	1267	27348	3099	8869	91543	84930	56929	6772	60489	223082	6672	51444	8743	54676	9711	11011	80765	58472	55669	10507	8638	143689	133	10208	23515	79139	23380	5883	51479	203197	6614	2537	9753	9212	55860	64108	65979	4283	83479	9818	4814	9399	54206	2332	115362	8900	83990	6355	54887	11080	23179	29841	3669	121260	54894	8542	81622	81844	65056	441366	3600	285237	81030	55014	114614	9334	55254	8676	387885	23070	147841	91624	9830	6654	6373	64109	51129	2745	2633	1540	5366	9367	3796	8013
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_UP	M4266		20164420	Zaslavsky E,Hershberg U,Seto J,Pham AM,Marquez S,Duke JL,Wetmur JG,Tenoever BR,Sealfon SC,Kleinstein SH.	GSE18791	GSE18791_1542_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 8 h.	The dendritic cell (DC) is a master regulator of immune responses. Pathogenic viruses subvert normal immune function in DCs through the expression of immune antagonists. Understanding how these antagonists interact with the host immune system requires knowledge of the underlying genetic regulatory network that operates during an uninhibited antiviral response. In order to isolate and identify this network, we studied DCs infected with Newcastle Disease Virus (NDV), which is able to stimulate innate immunity and DC maturation through activation of RIG-I signaling, but lacks the ability to evade the human interferon response. To analyze this experimental model, we developed a new approach integrating genome-wide expression kinetics and time-dependent promoter analysis. We found that the genetic program underlying the antiviral cell state transition during the first 18-hours post-infection could be explained by a single regulatory network. Gene expression changes were driven by a step-wise multi-factor cascading control mechanism, where the specific transcription factors controlling expression changed over time. Within this network, most individual genes are regulated by multiple factors, indicating robustness against virus-encoded immune evasion genes. In addition to effectively recapitulating current biological knowledge, we predicted, and validated experimentally, antiviral roles for several novel transcription factors. More generally, our results show how a genetic program can be temporally controlled through a single regulatory network to achieve the large-scale genetic reprogramming characteristic of cell state transitions.					11162	2976	80153	54433	11066	25809	55033	91298	7584	22838	10224	79714	10302	126017	11264	348793	10081	84279	113115	84078	10201	84545	23014	158	134145	22879	7374	29098	112858	6838	10560	84629	84916	64216	51204	26121	3028	29090	51287	1503	4698	84527	2101	57019	100130219	220042	51651	9650	81889	23401	1069	121457	3269	93134	124222	8125	51367	51194	29088	10194	58493	150678	6480	283464	898	375387	66008	84640	9678	29078	55039	3663	80185	126295	26035	55621	55071	9521	440574	3603	84668	9653	123263	78988	81029	55299	219654	22954	55640	23513	51538	27079	3281	84134	57567	6895	55655	7372	9616	64789	79896	57532	29105	27300	9816	79760	6047	26235	1306	64172	157285	51499	84133	861	10528	440465	7507	2353	200933	26608	9416	64400	133522	121274	78991	64170	90624	196513	5162	57704	29960	134430	57591	55691	5001	10333	283897	8636	22893	55703	26094	3416	387119	79723	149420	51018	57461	6117	55330	11344	435	79149	25813	493753	10799	84910	2313	147929	729013	11123	29	55028	79699	23412	5303	9053	7862	10981	6182	30849	84260	254170	6427	22884	84135	84294	86	10940	64418	378	79697	140460	83743	55735	10732	55172	51250	57325	55164	51268	56897	79077	100129250	83544	9533	25917	222236	56890	5501	22846
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_DN	M4267		20164420	Zaslavsky E,Hershberg U,Seto J,Pham AM,Marquez S,Duke JL,Wetmur JG,Tenoever BR,Sealfon SC,Kleinstein SH.	GSE18791	GSE18791_1542_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 8 h.	The dendritic cell (DC) is a master regulator of immune responses. Pathogenic viruses subvert normal immune function in DCs through the expression of immune antagonists. Understanding how these antagonists interact with the host immune system requires knowledge of the underlying genetic regulatory network that operates during an uninhibited antiviral response. In order to isolate and identify this network, we studied DCs infected with Newcastle Disease Virus (NDV), which is able to stimulate innate immunity and DC maturation through activation of RIG-I signaling, but lacks the ability to evade the human interferon response. To analyze this experimental model, we developed a new approach integrating genome-wide expression kinetics and time-dependent promoter analysis. We found that the genetic program underlying the antiviral cell state transition during the first 18-hours post-infection could be explained by a single regulatory network. Gene expression changes were driven by a step-wise multi-factor cascading control mechanism, where the specific transcription factors controlling expression changed over time. Within this network, most individual genes are regulated by multiple factors, indicating robustness against virus-encoded immune evasion genes. In addition to effectively recapitulating current biological knowledge, we predicted, and validated experimentally, antiviral roles for several novel transcription factors. More generally, our results show how a genetic program can be temporally controlled through a single regulatory network to achieve the large-scale genetic reprogramming characteristic of cell state transitions.					85441	2829	84166	388228	441108	11044	51421	4117	55337	26470	129607	81030	51191	11011	57674	29126	3659	8000	64895	87178	54809	4600	79132	54739	7706	2185	4283	64761	5145	3433	7051	221468	54625	5371	5366	64651	221756	219285	3841	3437	652995	2643	24138	84930	51479	100286910	4878	93349	103	4615	2537	54676	9636	54541	94240	3434	1847	4814	3665	8542	3099	10561	5883	55603	10135	55281	29841	55601	6373	9826	6398	79015	7042	4939	10964	2636	11274	3627	115362	5359	1267	83666	4940	80830	84132	57169	8743	2571	6773	6890	114991	91351	53918	255488	60489	4599	23586	64135	3620	283629	126119	9447	51513	203197	149401	80852	4289	51131	100287094	8638	5157	28232	1649	152926	1009	91624	23099	282616	710	51251	55370	55008	4502	64108	492	116071	10346	85363	91543	254263	84441	3959	57612	63948	57579	3669	3439	57717	83990	55300	116986	160897	10208	6737	5267	54206	6355	629	602	4343	9641	7124	11074	3431	55014	11262	219988	1318	5743	51493	10507	80765	85465	282618	3456	51440	6714	9189	162394	6614	23025	5802	83642	151636	647946	221079	170384	9246	941	10410	8929	1195	23070	115361	143689	57117	645744	135112	7453	255877	23347	3600	4603	81844	4616	843	2633	8521	113451	3700
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_UP	M4268		20164420	Zaslavsky E,Hershberg U,Seto J,Pham AM,Marquez S,Duke JL,Wetmur JG,Tenoever BR,Sealfon SC,Kleinstein SH.	GSE18791	GSE18791_1543_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 10 h.	The dendritic cell (DC) is a master regulator of immune responses. Pathogenic viruses subvert normal immune function in DCs through the expression of immune antagonists. Understanding how these antagonists interact with the host immune system requires knowledge of the underlying genetic regulatory network that operates during an uninhibited antiviral response. In order to isolate and identify this network, we studied DCs infected with Newcastle Disease Virus (NDV), which is able to stimulate innate immunity and DC maturation through activation of RIG-I signaling, but lacks the ability to evade the human interferon response. To analyze this experimental model, we developed a new approach integrating genome-wide expression kinetics and time-dependent promoter analysis. We found that the genetic program underlying the antiviral cell state transition during the first 18-hours post-infection could be explained by a single regulatory network. Gene expression changes were driven by a step-wise multi-factor cascading control mechanism, where the specific transcription factors controlling expression changed over time. Within this network, most individual genes are regulated by multiple factors, indicating robustness against virus-encoded immune evasion genes. In addition to effectively recapitulating current biological knowledge, we predicted, and validated experimentally, antiviral roles for several novel transcription factors. More generally, our results show how a genetic program can be temporally controlled through a single regulatory network to achieve the large-scale genetic reprogramming characteristic of cell state transitions.					91298	28990	286336	348793	7584	55033	29090	23014	55703	9957	26094	11163	254170	25809	4698	54496	83544	79567	56915	22846	51073	128061	5189	26151	219654	51538	414327	79723	55655	57215	55621	2353	7372	55640	51362	11162	84527	10201	79896	5361	84078	55094	7374	283459	25940	10980	283742	220042	112858	4774	55632	55588	58493	64400	861	123263	64172	57591	149420	57567	54908	84134	2551	79023	3663	80308	5295	54943	7733	10908	113115	121274	9816	115992	23401	64395	84617	3028	64963	55739	435	79871	57017	55111	55794	285989	51367	57542	122769	57704	130074	64789	30849	10799	222236	136	55172	9329	51368	10422	3661	113802	84693	51650	115752	85453	100507564	8106	29098	10560	9053	84899	23708	4436	10978	51003	9046	54545	339559	7260	64428	3269	3459	90075	9616	55735	152217	56252	10940	84640	23002	642946	283464	6895	60493	140459	6182	1849	8518	4860	55299	203245	2021	80153	3265	51116	54859	22893	25926	29960	57325	7770	84254	642	8192	54482	51112	8697	151903	55449	91647	79833	9328	29087	8396	25778	84629	26985	94134	9117	4033	56606	64854	84279	25879	5433	92856	79626	6446	266812	27042	126017	5147	23016	51118	54107	81029	400569	64781	4775	79697	79918	403	729082	171568	9797	489	26472	54931	79598
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_DN	M4269		20164420	Zaslavsky E,Hershberg U,Seto J,Pham AM,Marquez S,Duke JL,Wetmur JG,Tenoever BR,Sealfon SC,Kleinstein SH.	GSE18791	GSE18791_1543_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 10 h.	The dendritic cell (DC) is a master regulator of immune responses. Pathogenic viruses subvert normal immune function in DCs through the expression of immune antagonists. Understanding how these antagonists interact with the host immune system requires knowledge of the underlying genetic regulatory network that operates during an uninhibited antiviral response. In order to isolate and identify this network, we studied DCs infected with Newcastle Disease Virus (NDV), which is able to stimulate innate immunity and DC maturation through activation of RIG-I signaling, but lacks the ability to evade the human interferon response. To analyze this experimental model, we developed a new approach integrating genome-wide expression kinetics and time-dependent promoter analysis. We found that the genetic program underlying the antiviral cell state transition during the first 18-hours post-infection could be explained by a single regulatory network. Gene expression changes were driven by a step-wise multi-factor cascading control mechanism, where the specific transcription factors controlling expression changed over time. Within this network, most individual genes are regulated by multiple factors, indicating robustness against virus-encoded immune evasion genes. In addition to effectively recapitulating current biological knowledge, we predicted, and validated experimentally, antiviral roles for several novel transcription factors. More generally, our results show how a genetic program can be temporally controlled through a single regulatory network to achieve the large-scale genetic reprogramming characteristic of cell state transitions.					26470	1318	84441	1847	8542	7051	6340	200035	55013	9826	85363	55860	2526	55370	10308	10282	23306	4600	3601	29126	116986	388228	54149	83667	55337	7124	60489	150350	115362	55030	6617	84930	441108	3659	51493	93349	221079	51191	54739	29774	55601	11011	10602	65264	10135	6398	5366	56929	25841	115361	80830	54625	3660	7453	6993	55802	2959	81689	129607	6511	3569	58472	11044	11262	55008	23258	4283	10865	87178	6774	85465	5371	51513	283651	55603	54809	1657	9636	84166	6773	3449	24138	64108	596	116984	83990	219285	160897	159091	55014	80208	1466	4067	3620	151636	282616	9189	201176	10672	23597	135112	103	9966	9367	116071	57579	27019	85463	375035	79139	9750	114614	1540	83450	55300	220213	56913	355	9447	4084	65979	348938	64135	6890	51131	5533	339366	5157	57458	57664	3467	3437	7128	4940	3394	163033	7726	8638	23070	1267	100507629	79370	57169	56985	1195	203197	3700	3433	5359	55824	23586	282618	8767	4289	79132	941	4939	83641	10561	84333	5540	94240	146857	91624	2643	80765	65056	7185	3434	5142	63899	1326	8676	3446	81030	57194	64651	255488	153684	64895	55281	710	51444	1045	3448	8743	23347	10346	6550	84132	5743	1390	30001	3445	11274	57117	388685	57674	7097	64129
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_UP	M4271		20164420	Zaslavsky E,Hershberg U,Seto J,Pham AM,Marquez S,Duke JL,Wetmur JG,Tenoever BR,Sealfon SC,Kleinstein SH.	GSE18791	GSE18791_1544_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 12 h.	The dendritic cell (DC) is a master regulator of immune responses. Pathogenic viruses subvert normal immune function in DCs through the expression of immune antagonists. Understanding how these antagonists interact with the host immune system requires knowledge of the underlying genetic regulatory network that operates during an uninhibited antiviral response. In order to isolate and identify this network, we studied DCs infected with Newcastle Disease Virus (NDV), which is able to stimulate innate immunity and DC maturation through activation of RIG-I signaling, but lacks the ability to evade the human interferon response. To analyze this experimental model, we developed a new approach integrating genome-wide expression kinetics and time-dependent promoter analysis. We found that the genetic program underlying the antiviral cell state transition during the first 18-hours post-infection could be explained by a single regulatory network. Gene expression changes were driven by a step-wise multi-factor cascading control mechanism, where the specific transcription factors controlling expression changed over time. Within this network, most individual genes are regulated by multiple factors, indicating robustness against virus-encoded immune evasion genes. In addition to effectively recapitulating current biological knowledge, we predicted, and validated experimentally, antiviral roles for several novel transcription factors. More generally, our results show how a genetic program can be temporally controlled through a single regulatory network to achieve the large-scale genetic reprogramming characteristic of cell state transitions.					51274	3603	84629	55703	57567	55033	55656	51073	7584	22796	57215	84190	55621	26094	435	8396	4436	64210	29105	10419	83989	55968	80143	79833	161	8706	114791	122769	84279	10908	283459	6632	219654	28990	220042	51538	57017	56252	54859	8872	80155	404636	617	25906	221927	79567	84548	84312	55094	26039	91298	170371	55794	5316	705	348793	5889	79871	908	3141	10016	79723	54977	3712	22846	55735	5001	51368	25940	642946	5631	152559	3663	348235	25926	345778	25809	22897	51808	403313	55655	80006	257218	57019	26472	55071	113802	149420	51154	64789	9797	11232	60626	29088	8723	10254	134145	5295	9957	63877	54101	84816	11123	7013	147947	113115	25879	11162	64216	132789	55739	27042	7277	51649	23435	124961	5547	84947	84078	53829	7770	10327	7260	399818	23368	55588	3176	134957	51449	2021	28982	112858	55002	6596	53346	153364	790	7019	144406	1019	5822	56890	23417	51393	7248	23708	414327	219402	63977	84260	10907	653121	7372	4775	64949	6838	23397	127262	55640	84617	11171	80185	2976	25989	8774	81029	79736	4931	23166	5471	9646	7733	171568	83695	1836	10813	134492	51340	64400	50615	2119	222236	92342	22907	64854	643155	286336	7411	161742	63979	121506	148418	10885	79707	79810	129401	9801	3613	10929	7371
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_DN	M4272		20164420	Zaslavsky E,Hershberg U,Seto J,Pham AM,Marquez S,Duke JL,Wetmur JG,Tenoever BR,Sealfon SC,Kleinstein SH.	GSE18791	GSE18791_1544_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 12 h.	The dendritic cell (DC) is a master regulator of immune responses. Pathogenic viruses subvert normal immune function in DCs through the expression of immune antagonists. Understanding how these antagonists interact with the host immune system requires knowledge of the underlying genetic regulatory network that operates during an uninhibited antiviral response. In order to isolate and identify this network, we studied DCs infected with Newcastle Disease Virus (NDV), which is able to stimulate innate immunity and DC maturation through activation of RIG-I signaling, but lacks the ability to evade the human interferon response. To analyze this experimental model, we developed a new approach integrating genome-wide expression kinetics and time-dependent promoter analysis. We found that the genetic program underlying the antiviral cell state transition during the first 18-hours post-infection could be explained by a single regulatory network. Gene expression changes were driven by a step-wise multi-factor cascading control mechanism, where the specific transcription factors controlling expression changed over time. Within this network, most individual genes are regulated by multiple factors, indicating robustness against virus-encoded immune evasion genes. In addition to effectively recapitulating current biological knowledge, we predicted, and validated experimentally, antiviral roles for several novel transcription factors. More generally, our results show how a genetic program can be temporally controlled through a single regulatory network to achieve the large-scale genetic reprogramming characteristic of cell state transitions.					84441	2526	7453	10602	124925	9189	55013	57458	23258	55603	57556	355	90024	55860	9738	51493	54149	57579	84930	79132	4600	58472	85301	223082	55601	23306	54676	85463	55337	9966	57169	79056	60489	10135	8361	4117	126353	54625	85363	29126	55008	7124	6993	51513	492	7726	653308	3665	2040	93349	3569	1847	26157	80830	115362	256536	1318	80199	26583	388228	51191	5366	81030	3659	57449	65264	5142	55030	219285	9447	84166	9750	160897	3620	4283	8444	115361	6614	441108	135112	87178	65056	6550	941	23586	10501	387885	8807	11262	285971	55370	84333	64651	83990	4067	27074	27348	54809	10308	56929	9456	6398	23025	64135	5916	2131	1657	57162	94240	4289	255488	221079	100190939	92797	5079	222698	64108	129607	11011	85465	54739	114614	25841	7159	150275	952	24138	221468	100287094	3759	9636	51421	3552	81689	91624	23070	6890	3449	203197	79955	55281	81894	11044	6773	10561	55802	3467	401317	162394	57716	151636	2919	57592	149466	64090	2591	6774	7186	1466	26959	344887	131583	79906	4940	6364	645027	11080	7122	282616	389289	80824	93653	3433	116984	3437	56913	4739	23597	55014	388210	1390	3898	3600	1326	146822	5359	3440	57674	51309	10882	55824	220213	55300	9252	285237	8859	7706	116039	644844	2658
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_UP	M4274		20164420	Zaslavsky E,Hershberg U,Seto J,Pham AM,Marquez S,Duke JL,Wetmur JG,Tenoever BR,Sealfon SC,Kleinstein SH.	GSE18791	GSE18791_1545_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 14 h.	The dendritic cell (DC) is a master regulator of immune responses. Pathogenic viruses subvert normal immune function in DCs through the expression of immune antagonists. Understanding how these antagonists interact with the host immune system requires knowledge of the underlying genetic regulatory network that operates during an uninhibited antiviral response. In order to isolate and identify this network, we studied DCs infected with Newcastle Disease Virus (NDV), which is able to stimulate innate immunity and DC maturation through activation of RIG-I signaling, but lacks the ability to evade the human interferon response. To analyze this experimental model, we developed a new approach integrating genome-wide expression kinetics and time-dependent promoter analysis. We found that the genetic program underlying the antiviral cell state transition during the first 18-hours post-infection could be explained by a single regulatory network. Gene expression changes were driven by a step-wise multi-factor cascading control mechanism, where the specific transcription factors controlling expression changed over time. Within this network, most individual genes are regulated by multiple factors, indicating robustness against virus-encoded immune evasion genes. In addition to effectively recapitulating current biological knowledge, we predicted, and validated experimentally, antiviral roles for several novel transcription factors. More generally, our results show how a genetic program can be temporally controlled through a single regulatory network to achieve the large-scale genetic reprogramming characteristic of cell state transitions.					11264	345778	4815	79641	170371	51449	10899	23513	80301	120224	23235	51204	4771	91298	84629	22838	8943	51194	435	493753	137886	64965	210	79699	79871	9812	25879	84245	11332	55039	23250	121274	53346	51073	55691	23435	79152	63933	57567	100288617	5634	286336	54680	8567	440574	57019	55037	5295	9816	83989	55794	22897	10780	1353	8289	348235	11162	23020	64425	79064	152579	84527	51182	161	5189	518	10915	26094	9935	51367	25840	5931	10102	56915	4591	22863	617	9046	5576	25809	51393	57037	64172	4706	138151	64968	7283	10560	112858	55621	522	5859	79697	23463	55111	51018	23199	57704	11123	54468	7389	7019	29929	123016	55572	79833	121506	55071	11066	100507564	64949	1676	11163	29078	25813	120	56907	54480	22907	79145	5747	1736	11252	7443	23014	285362	2976	55735	84899	1979	113115	54938	1719	8518	6480	55101	7074	3460	55703	3028	9646	55617	78991	2767	6502	10969	10940	23450	55640	29915	79038	56655	11020	6446	64834	222236	1019	57542	51808	84187	114791	9797	23300	26035	140460	3145	79590	11151	150678	220042	10479	908	8209	8563	8604	5889	285812	10920	9053	9989	11171	55127	9990	115992	57017	9815	131474	23787	64854	10542	5780	84668	18	79723	6571	3614	9778	257218	55968	22877
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_DN	M4277		20164420	Zaslavsky E,Hershberg U,Seto J,Pham AM,Marquez S,Duke JL,Wetmur JG,Tenoever BR,Sealfon SC,Kleinstein SH.	GSE18791	GSE18791_1545_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 14 h.	The dendritic cell (DC) is a master regulator of immune responses. Pathogenic viruses subvert normal immune function in DCs through the expression of immune antagonists. Understanding how these antagonists interact with the host immune system requires knowledge of the underlying genetic regulatory network that operates during an uninhibited antiviral response. In order to isolate and identify this network, we studied DCs infected with Newcastle Disease Virus (NDV), which is able to stimulate innate immunity and DC maturation through activation of RIG-I signaling, but lacks the ability to evade the human interferon response. To analyze this experimental model, we developed a new approach integrating genome-wide expression kinetics and time-dependent promoter analysis. We found that the genetic program underlying the antiviral cell state transition during the first 18-hours post-infection could be explained by a single regulatory network. Gene expression changes were driven by a step-wise multi-factor cascading control mechanism, where the specific transcription factors controlling expression changed over time. Within this network, most individual genes are regulated by multiple factors, indicating robustness against virus-encoded immune evasion genes. In addition to effectively recapitulating current biological knowledge, we predicted, and validated experimentally, antiviral roles for several novel transcription factors. More generally, our results show how a genetic program can be temporally controlled through a single regulatory network to achieve the large-scale genetic reprogramming characteristic of cell state transitions.					4049	2645	9451	55824	10990	100128988	57876	148014	10690	84166	23154	6773	57172	1847	3138	84441	196385	54625	64651	9781	100129175	11044	85463	388228	255877	80824	653308	373863	51421	85465	348938	26254	9925	51191	2131	344887	4600	29923	8237	7706	2740	3394	100286910	773	54843	93349	3659	11250	2256	115361	9966	10642	80739	124925	246176	114614	4036	129607	387885	55504	9753	7122	5366	5371	199223	100287401	113263	149708	100286938	441108	55254	80830	5020	2993	11011	1466	115362	401317	63967	9447	4586	80199	79132	10715	3097	138311	57801	10865	643977	87178	4283	23543	8859	57125	57458	54739	81030	64090	55367	57162	3665	441072	63901	23306	3620	9953	84173	10561	23135	3433	8646	7124	25841	1029	257000	256158	1908	126433	55337	7380	116984	1428	2185	57556	5526	57194	2619	221756	8605	7051	525	91624	5307	80868	4814	171024	54149	93082	3437	1294	199713	2643	5359	147646	57823	10157	9610	9636	828	3656	220213	57639	7258	57235	55601	3236	100132999	4084	3434	952	2155	3601	27120	3084	9638	5575	27111	2057	55311	8444	9750	116071	51471	147	3449	5916	4940	136227	7128	80055	23429	80765	23434	282616	441366	55008	7542	6018	221301	6263	94240	151300	3780	132141	54809	81894	57664	641700	100506783	55811
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_UP	M4278		20164420	Zaslavsky E,Hershberg U,Seto J,Pham AM,Marquez S,Duke JL,Wetmur JG,Tenoever BR,Sealfon SC,Kleinstein SH.	GSE18791	GSE18791_1546_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 16 h.	The dendritic cell (DC) is a master regulator of immune responses. Pathogenic viruses subvert normal immune function in DCs through the expression of immune antagonists. Understanding how these antagonists interact with the host immune system requires knowledge of the underlying genetic regulatory network that operates during an uninhibited antiviral response. In order to isolate and identify this network, we studied DCs infected with Newcastle Disease Virus (NDV), which is able to stimulate innate immunity and DC maturation through activation of RIG-I signaling, but lacks the ability to evade the human interferon response. To analyze this experimental model, we developed a new approach integrating genome-wide expression kinetics and time-dependent promoter analysis. We found that the genetic program underlying the antiviral cell state transition during the first 18-hours post-infection could be explained by a single regulatory network. Gene expression changes were driven by a step-wise multi-factor cascading control mechanism, where the specific transcription factors controlling expression changed over time. Within this network, most individual genes are regulated by multiple factors, indicating robustness against virus-encoded immune evasion genes. In addition to effectively recapitulating current biological knowledge, we predicted, and validated experimentally, antiviral roles for several novel transcription factors. More generally, our results show how a genetic program can be temporally controlled through a single regulatory network to achieve the large-scale genetic reprogramming characteristic of cell state transitions.					26094	51112	55111	51449	5576	79714	11264	54433	435	6571	5708	283459	23435	63910	7074	51194	79590	84617	7389	11162	9786	23250	55127	10856	4815	26121	1979	1719	10969	4094	79699	8732	55656	4591	22846	286336	8604	10201	493753	9816	4677	440574	10575	26035	79641	5985	348235	3603	121274	55094	5303	64968	908	7374	113251	55033	55794	64425	3704	2976	11146	55341	1665	10009	51172	55691	5147	55655	84316	116236	51474	5747	9692	7443	206358	7584	10946	84899	84190	22907	5902	54522	8943	2958	152579	56916	84823	53829	10016	8209	83989	51808	9948	53339	5189	57465	389362	64854	55632	285989	8445	51538	5431	149420	522	54801	57567	79145	9990	25813	113802	100288617	57037	5634	5781	55640	8723	86	9812	84527	26040	26168	112858	55968	10283	54841	161	138199	4609	79081	387119	9159	3065	25879	9046	11164	7019	55052	3281	54919	22884	11073	2242	54951	488	22883	2764	11123	9646	65059	170371	9612	79736	257218	9879	4670	2021	7260	113115	9053	6821	91298	283742	51367	51028	1392	4706	54908	5306	55621	3396	5983	123263	4436	1075	51250	7372	80301	92609	84245	5425	54505	768211	5001	18	10073	29078	29960	124222	57380	115992	63977	56683	55119	25831	51287	4860	54859	78991	22954
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_DN	M4279		20164420	Zaslavsky E,Hershberg U,Seto J,Pham AM,Marquez S,Duke JL,Wetmur JG,Tenoever BR,Sealfon SC,Kleinstein SH.	GSE18791	GSE18791_1546_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 16 h.	The dendritic cell (DC) is a master regulator of immune responses. Pathogenic viruses subvert normal immune function in DCs through the expression of immune antagonists. Understanding how these antagonists interact with the host immune system requires knowledge of the underlying genetic regulatory network that operates during an uninhibited antiviral response. In order to isolate and identify this network, we studied DCs infected with Newcastle Disease Virus (NDV), which is able to stimulate innate immunity and DC maturation through activation of RIG-I signaling, but lacks the ability to evade the human interferon response. To analyze this experimental model, we developed a new approach integrating genome-wide expression kinetics and time-dependent promoter analysis. We found that the genetic program underlying the antiviral cell state transition during the first 18-hours post-infection could be explained by a single regulatory network. Gene expression changes were driven by a step-wise multi-factor cascading control mechanism, where the specific transcription factors controlling expression changed over time. Within this network, most individual genes are regulated by multiple factors, indicating robustness against virus-encoded immune evasion genes. In addition to effectively recapitulating current biological knowledge, we predicted, and validated experimentally, antiviral roles for several novel transcription factors. More generally, our results show how a genetic program can be temporally controlled through a single regulatory network to achieve the large-scale genetic reprogramming characteristic of cell state transitions.					2619	64651	55254	27294	55824	9925	7124	113451	85441	26233	2309	4846	9177	10148	6773	9451	84441	4600	10308	84166	23429	2185	283651	54625	80830	154043	196385	388228	6511	129607	10855	51191	29881	1847	103	115362	9826	87178	79857	5142	3601	11262	4049	9966	54149	51738	132671	3665	344887	79132	85463	9478	6018	150159	2537	85301	4192	441108	6425	2131	4283	55811	57657	22882	4784	116984	113263	2081	652995	4084	65108	93343	115361	1045	9252	221079	9636	51471	3507	3394	5359	8638	3437	93653	643977	6614	5366	8807	253260	26093	8237	11044	773	9953	4300	3433	7706	8859	54739	7453	55337	57458	23586	57162	25841	54676	2643	23135	25830	5916	55601	81894	80174	373863	54809	9750	80055	64895	3659	8767	339210	220213	23306	57823	5209	27111	152926	2591	116071	651	51421	3991	3097	114614	94031	64108	3700	5277	24138	10953	710	441366	1757	56929	474	3620	55539	100132999	3434	91624	51365	952	29923	143282	6648	84930	4940	195828	3589	80824	51131	100289049	649446	651430	654817	3445	3656	57047	4939	9881	27113	401317	10865	352961	90326	24147	3236	80868	7185	130367	79656	4320	282616	27074	57579	54795	83641	55008	162394	94240	645676	85465	843	93082	10561	355	23430	9753	5743	151300
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_UP	M4283		20164420	Zaslavsky E,Hershberg U,Seto J,Pham AM,Marquez S,Duke JL,Wetmur JG,Tenoever BR,Sealfon SC,Kleinstein SH.	GSE18791	GSE18791_1547_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 18 h.	The dendritic cell (DC) is a master regulator of immune responses. Pathogenic viruses subvert normal immune function in DCs through the expression of immune antagonists. Understanding how these antagonists interact with the host immune system requires knowledge of the underlying genetic regulatory network that operates during an uninhibited antiviral response. In order to isolate and identify this network, we studied DCs infected with Newcastle Disease Virus (NDV), which is able to stimulate innate immunity and DC maturation through activation of RIG-I signaling, but lacks the ability to evade the human interferon response. To analyze this experimental model, we developed a new approach integrating genome-wide expression kinetics and time-dependent promoter analysis. We found that the genetic program underlying the antiviral cell state transition during the first 18-hours post-infection could be explained by a single regulatory network. Gene expression changes were driven by a step-wise multi-factor cascading control mechanism, where the specific transcription factors controlling expression changed over time. Within this network, most individual genes are regulated by multiple factors, indicating robustness against virus-encoded immune evasion genes. In addition to effectively recapitulating current biological knowledge, we predicted, and validated experimentally, antiviral roles for several novel transcription factors. More generally, our results show how a genetic program can be temporally controlled through a single regulatory network to achieve the large-scale genetic reprogramming characteristic of cell state transitions.					115201	283742	80227	26094	286336	6599	84329	11264	51367	2976	9475	10422	25831	23731	100288617	51248	79641	51388	11332	414327	4771	55703	51528	10575	9678	51362	9046	26229	84527	1392	134145	120224	51029	3603	6117	9213	81029	121274	84260	84668	51497	116236	26985	26051	9816	50615	10194	51808	7372	55656	55330	55621	908	5519	1719	8732	64756	10273	29090	5550	10254	100303755	84190	100131801	100113407	861	140707	9131	374354	51138	283219	25879	51115	23014	6905	115752	5189	22907	8314	51393	10302	23397	149420	3704	55735	3416	5306	65258	5436	4722	134430	55437	138151	57704	54920	84975	26292	1069	8536	25809	161742	55902	2119	5441	55094	10526	79152	9675	4702	191	8027	28957	79096	84640	5747	29915	152002	170371	1786	23002	408	86	94134	55640	146223	7027	6821	54948	126133	79754	23555	79833	56252	4720	84816	64968	2021	8673	9770	1979	7739	64834	116138	1836	64400	23291	113115	57498	613	127262	7203	8720	84617	80024	3281	9604	10283	90459	6895	9330	9813	7084	84629	80153	3028	55632	64172	9343	84947	29844	1175	3615	4860	84078	643155	132789	54545	50862	79590	375387	6256	121457	55614	6182	9341	10072	64965	11151	80308	200933	51645	5825	25840	4706	11331	8604	285440	3092	23203	92105
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_DN	M4284		20164420	Zaslavsky E,Hershberg U,Seto J,Pham AM,Marquez S,Duke JL,Wetmur JG,Tenoever BR,Sealfon SC,Kleinstein SH.	GSE18791	GSE18791_1547_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 18 h.	The dendritic cell (DC) is a master regulator of immune responses. Pathogenic viruses subvert normal immune function in DCs through the expression of immune antagonists. Understanding how these antagonists interact with the host immune system requires knowledge of the underlying genetic regulatory network that operates during an uninhibited antiviral response. In order to isolate and identify this network, we studied DCs infected with Newcastle Disease Virus (NDV), which is able to stimulate innate immunity and DC maturation through activation of RIG-I signaling, but lacks the ability to evade the human interferon response. To analyze this experimental model, we developed a new approach integrating genome-wide expression kinetics and time-dependent promoter analysis. We found that the genetic program underlying the antiviral cell state transition during the first 18-hours post-infection could be explained by a single regulatory network. Gene expression changes were driven by a step-wise multi-factor cascading control mechanism, where the specific transcription factors controlling expression changed over time. Within this network, most individual genes are regulated by multiple factors, indicating robustness against virus-encoded immune evasion genes. In addition to effectively recapitulating current biological knowledge, we predicted, and validated experimentally, antiviral roles for several novel transcription factors. More generally, our results show how a genetic program can be temporally controlled through a single regulatory network to achieve the large-scale genetic reprogramming characteristic of cell state transitions.					85441	79370	113263	160851	3601	145864	51471	6550	23347	100131691	55824	10308	23135	4683	57117	54625	9334	9753	4084	4117	115362	7050	222962	355	63901	3394	142685	388685	3659	2294	64135	65986	115361	4036	596	9953	81691	54809	65056	57458	441366	9925	162963	100128822	9447	4283	53826	56929	773	81492	5366	253260	57194	1466	23586	9966	3665	84132	199223	284260	121441	7186	11119	79155	55601	100286910	9750	80868	114614	730631	5142	2146	57169	335	79132	100289109	54072	5533	1907	123872	151636	54149	57162	441108	55802	9212	60489	163033	93343	55008	91624	400223	80055	728769	29881	116984	8237	55337	3818	1832	140691	79656	283392	116986	143630	8061	5277	91351	7403	401317	85001	113451	5970	8743	84930	4814	5358	2263	64651	171024	23429	952	6398	373863	51298	26750	25841	55367	51365	7124	144347	6617	83642	3600	3445	8645	6890	6773	54676	148823	79730	3882	645676	26157	3589	9589	197135	103	10855	57604	55254	152926	23306	9510	2081	2253	255027	26524	634	255330	83990	55300	55320	6373	643160	575	93082	9451	100302650	80111	7159	9781	115701	154043	10616	6614	121268	4599	730227	79993	6352	94240	255783	219731	79156	348938	54413	135398	65264	85363	728543	11262	2117	4939	3305	1649	56829	5743	7703
GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_UP	M4285		20164420	Zaslavsky E,Hershberg U,Seto J,Pham AM,Marquez S,Duke JL,Wetmur JG,Tenoever BR,Sealfon SC,Kleinstein SH.	GSE18791	GSE18791_1548_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 1 h versus cDCs infected with Newcastle disease virus (NDV) at 1 h.	The dendritic cell (DC) is a master regulator of immune responses. Pathogenic viruses subvert normal immune function in DCs through the expression of immune antagonists. Understanding how these antagonists interact with the host immune system requires knowledge of the underlying genetic regulatory network that operates during an uninhibited antiviral response. In order to isolate and identify this network, we studied DCs infected with Newcastle Disease Virus (NDV), which is able to stimulate innate immunity and DC maturation through activation of RIG-I signaling, but lacks the ability to evade the human interferon response. To analyze this experimental model, we developed a new approach integrating genome-wide expression kinetics and time-dependent promoter analysis. We found that the genetic program underlying the antiviral cell state transition during the first 18-hours post-infection could be explained by a single regulatory network. Gene expression changes were driven by a step-wise multi-factor cascading control mechanism, where the specific transcription factors controlling expression changed over time. Within this network, most individual genes are regulated by multiple factors, indicating robustness against virus-encoded immune evasion genes. In addition to effectively recapitulating current biological knowledge, we predicted, and validated experimentally, antiviral roles for several novel transcription factors. More generally, our results show how a genetic program can be temporally controlled through a single regulatory network to achieve the large-scale genetic reprogramming characteristic of cell state transitions.					56288	80004	646241	10687	339457	5792	341405	196913	494514	5617	83444	10911	84168	5763	92162	63922	151477	286154	4878	55721	1949	8001	7479	495	4045	9452	90529	100293735	388780	57167	64111	128488	439938	221016	148014	9149	6928	401022	100129166	79041	9244	6701	91149	284439	222166	5320	23569	23286	7380	389328	100128416	121551	100130933	400643	89891	1803	79816	57016	838	6616	405753	3752	10863	148534	7018	90060	5526	680	138162	414245	55742	266553	149373	6290	1756	85366	285696	3976	27164	100131864	400629	83942	100329167	28999	401	131890	4158	1551	525	7058	143872	6947	1558	63895	100128002	10406	284111	5064	606	440888	4294	10811	54831	56704	91937	92346	401237	6330	6398	89792	26033	3492	84694	29895	3737	84071	55504	55643	10824	100507495	10568	54441	132954	142680	221883	26189	2692	1990	83639	57821	768239	128859	50636	201243	7276	4009	11173	183	340146	54429	339327	728705	57526	84448	123872	375449	400541	10655	317705	6751	54729	100129175	92369	4684	8340	10744	64409	943	6405	904	29950	367	8756	119369	145438	2257	114041	113622	283987	59341	5802	128646	55130	257629	127670	43849	124817	146547	149837	94160	51666	59285	115861	3651	5081	1510	10322	3798	117245	692247	347744	1002	352954	23614	8581	400617	169355	8328	40	158257
GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_DN	M4286		20164420	Zaslavsky E,Hershberg U,Seto J,Pham AM,Marquez S,Duke JL,Wetmur JG,Tenoever BR,Sealfon SC,Kleinstein SH.	GSE18791	GSE18791_1548_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 1 h versus cDCs infected with Newcastle disease virus (NDV) at 1 h.	The dendritic cell (DC) is a master regulator of immune responses. Pathogenic viruses subvert normal immune function in DCs through the expression of immune antagonists. Understanding how these antagonists interact with the host immune system requires knowledge of the underlying genetic regulatory network that operates during an uninhibited antiviral response. In order to isolate and identify this network, we studied DCs infected with Newcastle Disease Virus (NDV), which is able to stimulate innate immunity and DC maturation through activation of RIG-I signaling, but lacks the ability to evade the human interferon response. To analyze this experimental model, we developed a new approach integrating genome-wide expression kinetics and time-dependent promoter analysis. We found that the genetic program underlying the antiviral cell state transition during the first 18-hours post-infection could be explained by a single regulatory network. Gene expression changes were driven by a step-wise multi-factor cascading control mechanism, where the specific transcription factors controlling expression changed over time. Within this network, most individual genes are regulated by multiple factors, indicating robustness against virus-encoded immune evasion genes. In addition to effectively recapitulating current biological knowledge, we predicted, and validated experimentally, antiviral roles for several novel transcription factors. More generally, our results show how a genetic program can be temporally controlled through a single regulatory network to achieve the large-scale genetic reprogramming characteristic of cell state transitions.					6041	2695	100128640	253639	55790	100131067	8314	59343	9183	9129	285492	148867	135398	51562	5049	201176	123016	23360	8846	90768	220980	9694	7022	134728	284950	1416	662	389320	54762	222696	652993	27328	8110	5737	90957	160857	728288	29941	4995	64922	373	100505893	9443	60560	2122	286122	33	613212	130074	571	200895	55166	9383	3346	2949	55930	374860	136895	10778	5169	91851	50840	55750	347475	57020	375056	8471	84458	339512	9481	93594	83548	644660	27351	9355	266675	55512	129831	6815	7712	56339	254065	85476	266812	51388	84318	4976	91057	1608	51277	9330	56934	54529	115992	9778	340252	63946	64207	64863	26097	55757	50	4698	2218	100144596	54503	23503	4640	26289	1955	11035	54101	84173	283377	6575	85444	10560	130162	55300	25879	79827	1087	58472	11280	79943	161357	81789	55744	90317	10524	221302	9343	946	8618	1022	63826	9703	56100	390980	84932	55791	151636	5100	643854	10574	9517	7050	51091	126820	57115	259217	285352	7371	26092	153770	285172	1539	1016	100131763	6642	145581	54465	10602	23473	8939	4670	222553	55737	25979	10159	29105	254268	9961	7756	3149	155006	8735	11201	56648	345778	6318	134359	210	1820	89919	2258	55668	5516	6910	91949	57150	283357	441025	10488	163742	55530	9448	6627	54482	51475
GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_UP	M4287		20164420	Zaslavsky E,Hershberg U,Seto J,Pham AM,Marquez S,Duke JL,Wetmur JG,Tenoever BR,Sealfon SC,Kleinstein SH.	GSE18791	GSE18791_1549_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 2 h versus cDCs infected with Newcastle disease virus (NDV) at 2 h.	The dendritic cell (DC) is a master regulator of immune responses. Pathogenic viruses subvert normal immune function in DCs through the expression of immune antagonists. Understanding how these antagonists interact with the host immune system requires knowledge of the underlying genetic regulatory network that operates during an uninhibited antiviral response. In order to isolate and identify this network, we studied DCs infected with Newcastle Disease Virus (NDV), which is able to stimulate innate immunity and DC maturation through activation of RIG-I signaling, but lacks the ability to evade the human interferon response. To analyze this experimental model, we developed a new approach integrating genome-wide expression kinetics and time-dependent promoter analysis. We found that the genetic program underlying the antiviral cell state transition during the first 18-hours post-infection could be explained by a single regulatory network. Gene expression changes were driven by a step-wise multi-factor cascading control mechanism, where the specific transcription factors controlling expression changed over time. Within this network, most individual genes are regulated by multiple factors, indicating robustness against virus-encoded immune evasion genes. In addition to effectively recapitulating current biological knowledge, we predicted, and validated experimentally, antiviral roles for several novel transcription factors. More generally, our results show how a genetic program can be temporally controlled through a single regulatory network to achieve the large-scale genetic reprogramming characteristic of cell state transitions.					401282	283025	5087	51198	27164	3991	1510	154865	389898	23072	339221	64100	26153	285877	388533	2561	5999	729121	25827	4109	28	282996	84503	10268	3598	162137	43	186	145978	2925	27091	401114	126069	2295	345	84978	11122	84612	4882	3359	100131613	5080	27284	285848	83643	30819	100292909	317702	6928	89797	643711	254778	3347	7477	8484	286828	145845	10675	4751	816	7044	84306	51145	115948	1789	8823	10066	151484	94233	56963	143282	154822	3808	81626	728743	51378	100290278	60314	282966	27330	80028	253982	144535	285191	4857	100130967	50863	153579	400709	440300	1201	100506012	1770	8532	125206	5136	100506606	23742	83690	8078	727818	51102	646762	3886	286151	25842	158866	374786	6521	55620	80789	3070	29942	286133	100128071	283238	730	29075	400986	728577	337882	246704	80775	347240	146547	121601	3884	286204	254028	90050	391712	445	401550	285051	117531	125704	3823	125170	574036	57497	5047	643659	7434	5232	163404	10740	5542	10099	51622	79102	5575	80032	79083	1305	29124	80310	202374	440021	135892	84253	414300	3024	100129662	100506795	4343	163778	4137	54967	9278	90139	58158	64902	7142	100132354	5083	100132476	197003	89887	7275	904	358	266621	728215	284612	64288	116969	84944	3934	4256	283208	64409	54885	729975	282566	11015	26338	1826	590	221687	84518
GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_DN	M4289		20164420	Zaslavsky E,Hershberg U,Seto J,Pham AM,Marquez S,Duke JL,Wetmur JG,Tenoever BR,Sealfon SC,Kleinstein SH.	GSE18791	GSE18791_1549_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 2 h versus cDCs infected with Newcastle disease virus (NDV) at 2 h.	The dendritic cell (DC) is a master regulator of immune responses. Pathogenic viruses subvert normal immune function in DCs through the expression of immune antagonists. Understanding how these antagonists interact with the host immune system requires knowledge of the underlying genetic regulatory network that operates during an uninhibited antiviral response. In order to isolate and identify this network, we studied DCs infected with Newcastle Disease Virus (NDV), which is able to stimulate innate immunity and DC maturation through activation of RIG-I signaling, but lacks the ability to evade the human interferon response. To analyze this experimental model, we developed a new approach integrating genome-wide expression kinetics and time-dependent promoter analysis. We found that the genetic program underlying the antiviral cell state transition during the first 18-hours post-infection could be explained by a single regulatory network. Gene expression changes were driven by a step-wise multi-factor cascading control mechanism, where the specific transcription factors controlling expression changed over time. Within this network, most individual genes are regulated by multiple factors, indicating robustness against virus-encoded immune evasion genes. In addition to effectively recapitulating current biological knowledge, we predicted, and validated experimentally, antiviral roles for several novel transcription factors. More generally, our results show how a genetic program can be temporally controlled through a single regulatory network to achieve the large-scale genetic reprogramming characteristic of cell state transitions.					57573	100422737	92399	58508	121599	51052	100289577	84446	1690	8689	79027	140890	1179	4486	6489	10693	55525	23304	3785	23360	51804	1783	348254	8284	84449	196740	146880	57018	100131941	55769	84172	91461	9379	11073	346689	440983	1421	10562	80199	9708	378805	7545	4144	2516	5301	54869	400710	5893	644613	55384	285692	92154	100289209	3667	383	2812	79879	150527	284475	64773	55033	6773	6322	7730	64780	400027	7181	79706	11250	100286909	4703	26039	3433	283755	3488	442075	6779	23042	4140	85444	283078	23398	27031	54468	54620	27319	23430	339044	57593	6011	368	10180	283652	29896	5967	283214	284630	135152	130872	378938	23503	7637	4850	10739	100303728	6809	3187	1013	379025	221883	84458	100294414	55870	64377	4122	148870	9597	84865	25909	6337	130502	9140	390205	56339	100306951	65266	84131	100130837	140465	828	93099	10974	64839	197135	124842	80724	100506988	442721	11120	202181	6483	100288590	85367	2146	51380	25876	4157	4185	1427	405753	256979	5826	283131	652	56159	3437	100134445	440352	26526	9765	57396	286753	84206	10181	53947	64762	2710	6484	283464	80739	9913	81609	9132	100505545	10260	440836	157247	375248	115992	154442	727930	23456	92745	116828	4166	3551	374739	257415	3976	79927	54084	392617	23318	4528	7143	172	2169	6712	80279	51286
GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_UP	M4291		20164420	Zaslavsky E,Hershberg U,Seto J,Pham AM,Marquez S,Duke JL,Wetmur JG,Tenoever BR,Sealfon SC,Kleinstein SH.	GSE18791	GSE18791_1550_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 6 h versus cDCs infected with Newcastle disease virus (NDV) at 6 h.	The dendritic cell (DC) is a master regulator of immune responses. Pathogenic viruses subvert normal immune function in DCs through the expression of immune antagonists. Understanding how these antagonists interact with the host immune system requires knowledge of the underlying genetic regulatory network that operates during an uninhibited antiviral response. In order to isolate and identify this network, we studied DCs infected with Newcastle Disease Virus (NDV), which is able to stimulate innate immunity and DC maturation through activation of RIG-I signaling, but lacks the ability to evade the human interferon response. To analyze this experimental model, we developed a new approach integrating genome-wide expression kinetics and time-dependent promoter analysis. We found that the genetic program underlying the antiviral cell state transition during the first 18-hours post-infection could be explained by a single regulatory network. Gene expression changes were driven by a step-wise multi-factor cascading control mechanism, where the specific transcription factors controlling expression changed over time. Within this network, most individual genes are regulated by multiple factors, indicating robustness against virus-encoded immune evasion genes. In addition to effectively recapitulating current biological knowledge, we predicted, and validated experimentally, antiviral roles for several novel transcription factors. More generally, our results show how a genetic program can be temporally controlled through a single regulatory network to achieve the large-scale genetic reprogramming characteristic of cell state transitions.					57343	57693	8507	84099	57684	55299	3298	51105	27342	644283	5007	84759	5511	10397	64225	60370	10978	79142	49854	51808	3622	4436	199692	9120	10363	29985	7791	283489	84259	57062	5612	220042	10520	56478	54584	9123	1820	54541	23036	22954	79699	904	23450	10912	84942	9650	133746	23033	5636	9841	4033	55290	93323	28512	4733	161582	2752	84640	5981	148479	112611	5791	54920	81697	126917	27107	80335	122769	54876	134266	57325	57563	604	10237	7884	117143	55125	56946	29855	10625	90693	55735	23524	9816	7443	25778	7700	124995	7873	11237	257236	27335	861	8819	112950	11070	285766	147923	28990	10981	22850	144108	23087	64412	199899	50814	25885	121457	10560	8740	57547	9792	64210	7766	677	55898	114932	3628	54439	58493	55787	54802	54700	333929	84524	8455	29844	57461	26191	10541	26094	9277	55917	203245	55809	56181	84078	55588	340205	84206	23401	3661	84547	8833	170626	84924	387119	23060	51588	100129034	79230	8945	116068	2810	9530	84975	285401	7770	6574	163859	51026	7737	6903	55529	26472	11218	149420	213	51665	55422	389792	57864	10659	200933	4090	92017	9533	1070	91574	284630	145853	403150	84268	8220	317	79723	7589	54896	10422	23660	8892	55432	1649	10113	151903	162989	399694	1656	134553	148268
GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN	M4292		20164420	Zaslavsky E,Hershberg U,Seto J,Pham AM,Marquez S,Duke JL,Wetmur JG,Tenoever BR,Sealfon SC,Kleinstein SH.	GSE18791	GSE18791_1550_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 6 h versus cDCs infected with Newcastle disease virus (NDV) at 6 h.	The dendritic cell (DC) is a master regulator of immune responses. Pathogenic viruses subvert normal immune function in DCs through the expression of immune antagonists. Understanding how these antagonists interact with the host immune system requires knowledge of the underlying genetic regulatory network that operates during an uninhibited antiviral response. In order to isolate and identify this network, we studied DCs infected with Newcastle Disease Virus (NDV), which is able to stimulate innate immunity and DC maturation through activation of RIG-I signaling, but lacks the ability to evade the human interferon response. To analyze this experimental model, we developed a new approach integrating genome-wide expression kinetics and time-dependent promoter analysis. We found that the genetic program underlying the antiviral cell state transition during the first 18-hours post-infection could be explained by a single regulatory network. Gene expression changes were driven by a step-wise multi-factor cascading control mechanism, where the specific transcription factors controlling expression changed over time. Within this network, most individual genes are regulated by multiple factors, indicating robustness against virus-encoded immune evasion genes. In addition to effectively recapitulating current biological knowledge, we predicted, and validated experimentally, antiviral roles for several novel transcription factors. More generally, our results show how a genetic program can be temporally controlled through a single regulatory network to achieve the large-scale genetic reprogramming characteristic of cell state transitions.					85441	57169	100287602	24138	2643	4600	441108	117289	91351	87178	414	51191	151636	7706	3659	9189	54739	51427	10346	54625	51439	116071	65264	3431	3665	79132	219285	55008	4940	10561	10964	4599	6993	83666	51131	29126	136227	57674	2526	23338	5359	63916	6890	51493	11274	6398	60489	3437	85363	129607	4615	80055	266722	201176	6672	64135	94240	143379	3434	6614	51056	3433	160897	116986	4939	23179	23586	81622	55601	80765	2537	51251	81894	27071	27348	54809	2959	3594	56913	10507	91543	9636	5371	3959	55603	9399	64108	55337	3627	84166	138311	643866	8651	23380	10208	8743	7363	51421	440149	93343	7134	9881	6772	373861	1318	3735	389119	8737	159013	873	8638	339807	79906	7318	140691	26157	79139	221833	8542	124460	10906	6355	890	84930	4005	3669	54957	9711	83990	23070	55014	4938	115362	84446	375035	5454	23597	9447	1267	6773	4625	64651	103	91624	375346	54894	8503	10282	177	4283	100288679	143630	7051	256158	7453	83982	56829	3601	5883	3428	81689	4277	57097	23214	643977	6737	84132	64762	6373	153684	9641	55539	5610	79740	159091	51513	1657	387885	55669	81030	440101	80830	841	4343	2040	81844	4088	57194	285498	54823	54464	10379	2125	27296	2633	146880	219988	63036	55300	339210
GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_UP	M4293		20164420	Zaslavsky E,Hershberg U,Seto J,Pham AM,Marquez S,Duke JL,Wetmur JG,Tenoever BR,Sealfon SC,Kleinstein SH.	GSE18791	GSE18791_1551_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 10 h versus cDCs infected with Newcastle disease virus (NDV) at 10 h.	The dendritic cell (DC) is a master regulator of immune responses. Pathogenic viruses subvert normal immune function in DCs through the expression of immune antagonists. Understanding how these antagonists interact with the host immune system requires knowledge of the underlying genetic regulatory network that operates during an uninhibited antiviral response. In order to isolate and identify this network, we studied DCs infected with Newcastle Disease Virus (NDV), which is able to stimulate innate immunity and DC maturation through activation of RIG-I signaling, but lacks the ability to evade the human interferon response. To analyze this experimental model, we developed a new approach integrating genome-wide expression kinetics and time-dependent promoter analysis. We found that the genetic program underlying the antiviral cell state transition during the first 18-hours post-infection could be explained by a single regulatory network. Gene expression changes were driven by a step-wise multi-factor cascading control mechanism, where the specific transcription factors controlling expression changed over time. Within this network, most individual genes are regulated by multiple factors, indicating robustness against virus-encoded immune evasion genes. In addition to effectively recapitulating current biological knowledge, we predicted, and validated experimentally, antiviral roles for several novel transcription factors. More generally, our results show how a genetic program can be temporally controlled through a single regulatory network to achieve the large-scale genetic reprogramming characteristic of cell state transitions.					6838	112950	51538	29090	100129034	22846	25778	64789	2810	90987	254170	55621	286336	861	9903	51665	4832	23014	57325	100132832	4860	3265	30827	642	54908	170371	23401	8740	91647	9046	9616	112858	489	1019	138639	3480	57017	148479	115207	146223	131870	6874	28989	27034	122769	64400	8507	3663	55432	10560	10422	55552	29098	26094	285855	130074	7584	7277	79890	7187	9533	4999	79699	10362	27042	6446	57522	3459	644096	11218	4130	79142	55111	79159	9816	8106	9778	84640	51393	91445	9927	57693	9836	56647	57704	5438	1465	151903	1039	10929	51118	333929	28990	2475	5361	55703	85464	5252	85453	7056	140459	23625	64210	57542	123263	5433	51154	25926	29109	26472	219654	6867	56181	55739	22954	91582	56252	58493	79960	79813	51530	55071	11047	79717	23397	283464	2021	4090	5147	100288617	56478	55038	64981	6397	200933	22893	51362	84206	643677	3603	27097	147923	25940	57019	3460	6553	138151	283459	6256	645638	93	79723	9363	29844	93323	51024	63977	100131801	55735	11163	539	6047	283742	403	23107	22907	114932	54973	83874	54802	84527	10421	51474	401548	60370	4698	7372	79833	613	203245	6310	79811	55290	134553	23212	64781	23016	66008	54931	55033	6502	1676	5565	23568	59269	9684	64921	100507564	3028	55028
GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_DN	M4294		20164420	Zaslavsky E,Hershberg U,Seto J,Pham AM,Marquez S,Duke JL,Wetmur JG,Tenoever BR,Sealfon SC,Kleinstein SH.	GSE18791	GSE18791_1551_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 10 h versus cDCs infected with Newcastle disease virus (NDV) at 10 h.	The dendritic cell (DC) is a master regulator of immune responses. Pathogenic viruses subvert normal immune function in DCs through the expression of immune antagonists. Understanding how these antagonists interact with the host immune system requires knowledge of the underlying genetic regulatory network that operates during an uninhibited antiviral response. In order to isolate and identify this network, we studied DCs infected with Newcastle Disease Virus (NDV), which is able to stimulate innate immunity and DC maturation through activation of RIG-I signaling, but lacks the ability to evade the human interferon response. To analyze this experimental model, we developed a new approach integrating genome-wide expression kinetics and time-dependent promoter analysis. We found that the genetic program underlying the antiviral cell state transition during the first 18-hours post-infection could be explained by a single regulatory network. Gene expression changes were driven by a step-wise multi-factor cascading control mechanism, where the specific transcription factors controlling expression changed over time. Within this network, most individual genes are regulated by multiple factors, indicating robustness against virus-encoded immune evasion genes. In addition to effectively recapitulating current biological knowledge, we predicted, and validated experimentally, antiviral roles for several novel transcription factors. More generally, our results show how a genetic program can be temporally controlled through a single regulatory network to achieve the large-scale genetic reprogramming characteristic of cell state transitions.					55013	4600	171024	219285	55337	2959	1318	150350	116071	441108	23179	64135	54739	6890	5743	55300	93349	54149	3601	3700	4323	9447	23380	87178	115362	153684	201176	1951	65264	5359	55601	8458	1466	81030	80765	3569	10346	23070	83990	10561	57169	2526	84441	23328	3620	54894	4940	27348	51131	24138	51493	6993	25841	3665	3587	282616	115361	6398	51251	340547	81689	3959	7453	8204	3431	9465	60489	4283	3042	80055	9826	284004	221079	6772	55008	10865	1267	91543	9325	710	11011	159091	131583	103	5819	3759	2261	2947	83666	203197	5142	494513	2537	3449	23586	3456	3437	55669	6773	7051	8542	203274	80830	85363	10824	7726	84930	4211	80216	2643	91624	9592	9636	2919	1326	64108	5366	7124	57194	10964	282618	8638	3467	843	11274	4616	5685	414201	256586	3433	355	54625	79370	4739	3448	160897	79132	94240	3627	23214	63901	114769	3446	51191	79369	51513	8743	151636	6614	838	85465	2135	1543	952	23338	4615	4599	64332	3445	159013	93082	85441	80018	7318	3444	3669	129607	30008	140691	6672	8573	5157	4939	55266	56829	729083	116039	283483	100133885	92797	143282	8676	6373	100132707	9750	3097	7098	65979	1757	3440	5371	57292	136371	9712	2015	57821	11044	162394	54809	285489
GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_UP	M4295		20164420	Zaslavsky E,Hershberg U,Seto J,Pham AM,Marquez S,Duke JL,Wetmur JG,Tenoever BR,Sealfon SC,Kleinstein SH.	GSE18791	GSE18791_1552_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 18 h versus cDCs infected with Newcastle disease virus (NDV) at 18 h.	The dendritic cell (DC) is a master regulator of immune responses. Pathogenic viruses subvert normal immune function in DCs through the expression of immune antagonists. Understanding how these antagonists interact with the host immune system requires knowledge of the underlying genetic regulatory network that operates during an uninhibited antiviral response. In order to isolate and identify this network, we studied DCs infected with Newcastle Disease Virus (NDV), which is able to stimulate innate immunity and DC maturation through activation of RIG-I signaling, but lacks the ability to evade the human interferon response. To analyze this experimental model, we developed a new approach integrating genome-wide expression kinetics and time-dependent promoter analysis. We found that the genetic program underlying the antiviral cell state transition during the first 18-hours post-infection could be explained by a single regulatory network. Gene expression changes were driven by a step-wise multi-factor cascading control mechanism, where the specific transcription factors controlling expression changed over time. Within this network, most individual genes are regulated by multiple factors, indicating robustness against virus-encoded immune evasion genes. In addition to effectively recapitulating current biological knowledge, we predicted, and validated experimentally, antiviral roles for several novel transcription factors. More generally, our results show how a genetic program can be temporally controlled through a single regulatory network to achieve the large-scale genetic reprogramming characteristic of cell state transitions.					4698	79654	51112	3163	643365	5591	5569	93649	9948	84311	79699	7982	51763	113419	8832	1213	9270	4931	125150	5250	55536	64968	4609	23016	23002	51449	29899	51719	342892	6950	11309	25896	10885	7074	147947	64757	123016	23530	513	6599	8800	29093	10440	3281	54606	9813	11321	54472	57610	126308	50615	9957	55274	5360	861	3712	123041	25831	219402	55478	10594	150465	9697	2071	10695	22949	199857	128869	1069	5822	8703	55898	2079	84464	9459	113189	64921	90987	51497	9475	4285	92017	84105	267	64975	64924	3915	55735	57089	653121	5631	57017	64419	57410	4733	66008	10733	10325	11171	4261	145781	120224	7277	26173	389898	5985	9631	7264	84190	9790	84134	8882	6904	9854	7048	1392	60490	5694	55552	10247	55632	84617	10277	10969	57209	22884	200933	1676	51388	60386	100124700	79038	5986	440288	57496	818	59307	255520	1602	6837	1465	55437	2631	9677	51808	5747	5062	138151	10072	100507086	23203	29985	9600	57678	100289420	84108	161253	9611	339883	54681	4686	613	253558	26229	116143	129138	8892	86	51611	25940	3480	221908	4128	284021	55929	84936	5306	9786	8720	2184	79692	83879	3066	113763	23568	100303755	55226	137872	8536	3092	344148	81929	27034	28973	7791	4702	7374	3603	79693	3853
GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_DN	M4296		20164420	Zaslavsky E,Hershberg U,Seto J,Pham AM,Marquez S,Duke JL,Wetmur JG,Tenoever BR,Sealfon SC,Kleinstein SH.	GSE18791	GSE18791_1552_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 18 h versus cDCs infected with Newcastle disease virus (NDV) at 18 h.	The dendritic cell (DC) is a master regulator of immune responses. Pathogenic viruses subvert normal immune function in DCs through the expression of immune antagonists. Understanding how these antagonists interact with the host immune system requires knowledge of the underlying genetic regulatory network that operates during an uninhibited antiviral response. In order to isolate and identify this network, we studied DCs infected with Newcastle Disease Virus (NDV), which is able to stimulate innate immunity and DC maturation through activation of RIG-I signaling, but lacks the ability to evade the human interferon response. To analyze this experimental model, we developed a new approach integrating genome-wide expression kinetics and time-dependent promoter analysis. We found that the genetic program underlying the antiviral cell state transition during the first 18-hours post-infection could be explained by a single regulatory network. Gene expression changes were driven by a step-wise multi-factor cascading control mechanism, where the specific transcription factors controlling expression changed over time. Within this network, most individual genes are regulated by multiple factors, indicating robustness against virus-encoded immune evasion genes. In addition to effectively recapitulating current biological knowledge, we predicted, and validated experimentally, antiviral roles for several novel transcription factors. More generally, our results show how a genetic program can be temporally controlled through a single regulatory network to achieve the large-scale genetic reprogramming characteristic of cell state transitions.					8061	6352	64135	389336	641298	253260	2633	57823	100289079	10485	64651	161176	5212	795	10346	65056	57162	151651	7802	113452	8294	3665	4110	5348	3218	4615	57194	9592	1466	4683	150185	157983	768206	84666	121441	51365	147183	115362	3434	338785	2066	57577	100128191	256586	727930	6862	87178	51095	4600	441168	54809	2634	1416	116448	23586	374907	7130	440934	9414	3627	152	283392	7761	283078	24138	8767	8458	100289246	221091	10561	255027	100505964	2146	255783	54739	5366	85441	6772	1326	54149	6891	441108	26750	51131	1834	4616	4940	11012	100128822	83642	79730	5359	10906	90673	100302650	84132	51510	389840	64332	94240	114614	143630	9589	80219	29126	1267	54738	284615	145864	147744	399967	91351	91543	64976	3433	6398	4599	8638	645744	238	3659	135112	30008	6529	9818	84930	116071	3600	113263	153643	335	3305	5743	441366	55337	9334	3656	10817	129607	171024	51251	388685	596	221468	643160	81030	643977	79132	3818	122618	152926	55300	479	9447	100507584	4036	129881	220213	5142	7189	6565	6355	1048	80868	7161	128826	32	8743	6303	55008	147727	284912	7726	93082	773	400223	57117	440757	9753	4938	696	203197	9750	113451	7122	55601	100289312	51191	353274	219285	646962	952	11037	54625	10964	2766	22797	139135	25793	201176
GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_UP	M4309		20663022	Wright HJ,Chapple IL,Matthews JB,Cooper PR.	GSE20151	GSE20151_2128_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of contols neutrophils versus those infected with a bacterium (F. nucleatum).	Neutrophils are known to be stimulated by different periodontal bacteria to produce reactive oxygen species and cytokines. It is inportant to investigate the gene changes made by bacteria of importance, of which, for periodontal disease, fusobaterium nucleatum is one. we used microarrays to investigate gene experssion changes in peripheral blood neutrophils werwhich e stimulated with or with out Fusobacterium Nucleatum (10953).					7873	79958	7142	9162	27004	56062	3665	124222	55630	9940	10078	1300	51050	3738	10859	25984	64135	1297	814	29109	11012	8632	5164	58526	163	6835	54681	4184	10253	9153	79908	27342	2954	25828	8822	84243	100289043	10656	55704	4255	29015	11177	27304	3155	9053	23102	26002	79054	55850	1825	116985	4017	201895	728558	55157	284001	462	27340	993	170680	2208	9223	22989	5347	587	23633	11045	1889	55150	7349	4684	5073	6580	1232	3068	85002	4152	63933	214	5252	26280	5275	7753	8532	2696	6750	55870	55815	11155	81025	80149	2268	3437	170679	80183	23544	64785	54462	64981	10645	10327	23648	4488	100294145	27175	25803	2886	22844	55209	79899	100287051	58472	7471	6535	10818	80833	23022	103	26959	56673	150726	4061	5784	51806	463	27301	22846	81619	152	6237	4995	9656	5092	7185	3083	7021	6870	9618	8123	7204	4015	4293	7429	2101	27290	183	4088	23334	476	9111	7957	55909	64850	55872	23705	6772	4647	9776	79651	5260	6532	2863	63925	2052	3483	2832	11334	65250	51296	9204	388567	4296	6433	27341	51555	4868	100505741	755	2940	9820	6722	1158	53615	8506	80185	29895	338645	55036	7686	7791	741	2643	54954	7347	79810	9956	2845	54440	64223	3642
GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_DN	M4310		20663022	Wright HJ,Chapple IL,Matthews JB,Cooper PR.	GSE20151	GSE20151_2128_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of contols neutrophils versus those infected with a bacterium (F. nucleatum).	Neutrophils are known to be stimulated by different periodontal bacteria to produce reactive oxygen species and cytokines. It is inportant to investigate the gene changes made by bacteria of importance, of which, for periodontal disease, fusobaterium nucleatum is one. we used microarrays to investigate gene experssion changes in peripheral blood neutrophils werwhich e stimulated with or with out Fusobacterium Nucleatum (10953).					308	966	6451	10554	3093	7850	3275	5355	10170	5862	10559	55623	51478	9665	60467	840	3895	734	8794	7341	4835	26039	23186	203197	9826	1407	9499	56270	54187	55337	6655	8933	819	26054	4194	3336	54849	6047	221037	6304	10732	7699	55746	91442	51306	25847	8807	8462	9522	8227	8867	220594	5499	5728	9556	79982	51285	2313	79585	7433	100129128	1537	9907	54665	8972	10284	23177	9936	25994	5683	8760	9073	10456	5931	6018	51520	6996	6385	51542	10274	2560	116496	2186	8443	26512	11151	6767	5718	9354	5863	2717	6152	29095	55129	6291	10907	22911	7072	55701	2010	10539	22850	1804	1043	7474	27161	51377	7375	3673	54953	54505	22849	10949	9934	1649	54432	55823	3421	9553	78999	51780	100130741	55851	9074	10001	64376	55596	55056	5586	56606	55695	4653	4697	23326	55619	5690	29994	6400	9958	4258	3925	1147	79663	6782	6128	2810	11026	54951	22823	553115	55656	2589	7779	2987	7100	115123	7385	3739	79668	8932	64848	24138	4886	1265	762	2898	5436	6283	7145	9055	55752	6603	23469	29957	4772	677	4778	84272	4190	896	64768	51029	54872	10541	4851	3005	467	79039	9879	51371	3707	79665	4634	10981	7419	23198	29803	3448	51107	57658
GSE22045_TREG_VS_TCONV_UP	M4400		22562448	Bonacci B,Edwards B,Jia S,Williams CB,Hessner MJ,Gauld SB,Verbsky JW.	GSE22045	GSE22045_1301_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of regulatory T cell (Treg) versus conventional T cells.	Human regulatory T cells (TR) cells have potential for the treatment of immune mediated diseases, such as graft versus host disease, but the anergic phenotype of these cells makes them difficult to expand in vitro. We have examined the requirements for growth and cytokine expression from highly purified human TR cells, and correlated these findings with the signal transduction events of these cells. We demonstrate that these cells do not proliferate or secrete IL-10 even in the presence of high doses of IL-2. Stimulation with a superagonistic anti-CD28 antibody (clone 9D4) and IL-2 partially reversed the proliferative defect, and this correlated with reversal of the defective calcium mobilization in these cells. Dendritic cells were effective at promoting TR cell proliferation, and under these conditions the proliferative capacity of TR cells was comparable to conventional CD4 lymphocytes. Blocking TGF-beta activity abrogated IL-10 expression from these cells, while addition of TGF-beta resulted in IL-10 production. These data demonstrate the ability of dendritic cells to provide proper costimulation to overcome the anergic phenotype of TR cells. In addition, these data demonstrate for the first time that TGF-beta is critical to enable TR cells to express IL-10.					51255	157506	132320	9811	54842	50943	401233	6472	392465	1111	100505545	26037	54972	54776	1305	7803	841	10802	60482	100131298	57217	29103	8347	7310	10553	9622	22846	285172	9794	64005	5880	51053	29941	4199	8743	79171	9308	440823	10804	100288432	6804	165530	2149	9390	23580	54892	23125	57524	93035	100128343	89797	6753	9711	5521	284207	100128298	23002	79682	121006	58488	54546	9578	57175	9649	57700	2994	128229	100506190	304	11057	148229	149684	8365	9830	388946	942	57575	100506195	1912	197131	901	9633	6095	8573	56667	8809	83896	3312	56548	202333	3855	401913	6385	3508	92745	6295	63924	9108	4094	4916	2842	100288810	1036	965	81620	266919	3092	9256	9683	255101	27242	100130815	56992	83451	245938	29028	3832	5549	57486	54733	84542	503569	91752	646522	1235	5141	9607	10228	5020	1033	1299	3938	9429	84552	285957	55971	23053	22974	10859	254778	56956	55027	10105	223	8819	123920	149603	3813	10602	910	127703	81	55020	79677	23231	25806	200959	1062	25787	4668	1155	3077	10788	283383	23597	100128098	1592	55165	154313	29931	29954	5687	8091	51101	55609	3669	100507470	6508	84698	9183	163486	64859	80332	5303	9953	9104	503542	641928	140459	55872	2833	1544	3714	10905	170692	9760	338620	79931	90268	4751
GSE22045_TREG_VS_TCONV_DN	M4401		22562448	Bonacci B,Edwards B,Jia S,Williams CB,Hessner MJ,Gauld SB,Verbsky JW.	GSE22045	GSE22045_1301_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of regulatory T cell (Treg) versus conventional T cells.	Human regulatory T cells (TR) cells have potential for the treatment of immune mediated diseases, such as graft versus host disease, but the anergic phenotype of these cells makes them difficult to expand in vitro. We have examined the requirements for growth and cytokine expression from highly purified human TR cells, and correlated these findings with the signal transduction events of these cells. We demonstrate that these cells do not proliferate or secrete IL-10 even in the presence of high doses of IL-2. Stimulation with a superagonistic anti-CD28 antibody (clone 9D4) and IL-2 partially reversed the proliferative defect, and this correlated with reversal of the defective calcium mobilization in these cells. Dendritic cells were effective at promoting TR cell proliferation, and under these conditions the proliferative capacity of TR cells was comparable to conventional CD4 lymphocytes. Blocking TGF-beta activity abrogated IL-10 expression from these cells, while addition of TGF-beta resulted in IL-10 production. These data demonstrate the ability of dendritic cells to provide proper costimulation to overcome the anergic phenotype of TR cells. In addition, these data demonstrate for the first time that TGF-beta is critical to enable TR cells to express IL-10.					113622	84866	729799	54674	692227	9324	51667	6809	144193	57620	84634	29087	400891	6574	4601	574029	387751	79695	10418	7566	158880	137835	2944	79066	22887	23240	202134	84307	4040	50865	114926	284443	54879	285097	25776	644135	63027	54102	23366	90594	1981	5001	6641	351	339123	23361	55245	221188	8891	55200	51309	100132356	84973	286148	3035	534	79882	129303	6934	84516	51233	286097	4774	388796	55363	1514	8725	401466	8795	55773	100129427	1500	128653	4798	9453	283270	4501	25927	6398	55133	57393	55014	51422	51176	100132570	6711	25816	3159	81794	79893	1791	6322	3959	26628	8804	63970	401647	7572	5746	8722	492311	79762	5144	139538	56985	2887	29097	128866	23232	51316	8857	23635	122773	8812	10913	4300	10972	80755	3091	65059	2272	157285	5523	10276	9750	64066	11148	5578	166379	10653	93058	4693	728294	100505483	221545	476	91010	116447	282996	80775	51090	51209	11062	4952	284630	344558	613	661	100286937	55623	89782	843	7097	4621	7325	1964	6224	199692	6840	6450	284307	57235	5104	2017	90075	900	254042	6296	50832	1990	30061	406893	100286909	56937	342926	7105	51227	2956	4060	10954	947	8349	9829	55116	283238	23285	57494	5463	6812	56253	79963	7268	55071	65250	128346	51070	100113407	554206	339122	129293
GSE22886_CD8_VS_CD4_NAIVE_TCELL_UP	M4402		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1626_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive CD8 T cells versus naive CD4 [GeneID=920] T cells.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					140609	10201	55650	339448	58526	6787	55153	4594	7188	926	9870	56253	54499	81556	26000	57403	9404	1616	55830	23	10269	8237	6388	23301	11235	23335	81790	10016	23536	55239	5194	51192	286148	9204	54878	5378	4690	55812	4068	55791	11234	51290	6990	10126	10396	1736	2960	59347	1836	29922	29880	8531	925	23516	833	55615	23204	54469	5236	11276	10602	10302	5583	22856	55770	54900	5727	55312	79837	51377	22950	25994	8740	51719	11198	7168	9645	8405	56616	2619	5713	55958	4331	1676	6118	5962	51111	54980	11315	79042	7132	84859	2633	51015	54840	9938	57037	80736	79963	545	23379	56941	1234	788	10077	142	2744	54554	54843	4709	79712	27130	55667	989	10776	27010	23545	9673	80008	22954	79037	80222	2730	125893	8809	445347	5359	11321	9724	400	23788	5890	5686	112950	10224	6414	2553	5917	11345	57343	23231	51097	4204	7775	83988	8364	8302	6197	10641	51265	22800	51735	79829	1399	56674	7098	4860	10827	79893	29909	1615	10190	915	5095	25880	868	4247	83941	2235	27292	10225	27122	10061	10228	10548	10436	10311	8569	3093	9453	10240	5920	63917	6399	27429	5698	6978	27350	55319	9778	51691	541578	57226	79668	51103	29095	10775	23478	10928	1154
GSE22886_CD8_VS_CD4_NAIVE_TCELL_DN	M4404		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1626_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive CD8 T cells versus naive CD4 [GeneID=920] T cells.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					199731	4601	476	9762	11129	55790	10947	3566	11044	7074	79075	25970	3120	4137	920	1514	57799	5914	79783	27147	22853	6535	4240	23371	9583	4354	29954	126353	286	3991	3361	4868	4214	6366	8911	4820	1776	7141	55716	84914	84786	5871	8148	51686	79630	2811	552889	11059	29802	7476	2791	79065	51696	54581	9710	64170	79927	2676	6687	473	2707	7378	7089	5542	10174	57466	2153	5878	2550	100127972	10144	5025	10493	22861	2998	26173	26137	1428	1870	57162	93436	64689	7706	4795	9103	23258	1600	9267	1540	6314	5819	933	351	10865	25774	9173	843	56341	7755	3965	3111	5731	389177	6692	6337	55973	80201	57127	3175	55636	9138	150759	7869	2350	1889	53373	4118	6869	100288496	10634	6398	28986	100287204	81621	3609	945	65981	28951	116828	51622	51616	1387	2670	5747	29851	208	26102	29992	6598	5021	80055	168544	25939	5349	1750	57402	10223	196441	4759	9094	9060	55203	60493	10690	10235	1472	27091	23250	149076	23007	946	10580	752014	9080	79883	6297	5169	10089	10603	228	6010	57863	80199	57591	5064	80022	79946	27023	10499	336	921	23580	92154	85446	51308	100132341	51380	6580	5328	259173	2051	57336	9278	712	376412	6899	11040	51526	51274	1031
GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_UP	M4405		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1627_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive CD8 T cells versus naive CD4 [GeneID=920] CD8 T cells.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					55142	54956	27033	9807	51520	5228	11318	5551	55812	926	3219	1325	1576	22833	10198	85373	10827	11190	8364	27434	728498	5205	3823	6934	3712	8531	22914	56253	285231	80867	1292	79939	868	1823	63917	116987	5143	5175	64421	64897	81543	9851	7093	3651	80208	10077	5575	2967	51097	925	95	1629	7570	445347	7644	55615	9374	6720	10298	55915	23199	10396	55239	65998	9656	363	10928	4145	57124	4897	9254	27346	23	51291	55040	54535	7923	154	27254	5800	2619	54847	100133109	5571	4818	79810	4750	472	55791	9538	4171	8620	1795	7775	5311	22884	3170	10025	1524	83448	84172	8857	170960	55760	8875	64170	79783	6932	27284	54674	4494	10500	51092	8291	56893	6928	2801	57823	6327	79056	6929	2975	254359	23677	57136	6103	53829	4603	54843	81556	9145	51691	6433	6526	8405	7498	7390	1553	79712	25992	80221	11033	9256	57019	51588	5341	5727	10219	3003	55226	26112	8532	259197	23604	55888	79157	5159	3652	55501	55603	54103	7786	26005	5096	1523	2999	54952	6563	55759	11018	64682	8928	7752	2296	4753	973	79080	266655	3002	80205	5016	150967	695	2016	9456	255812	23569	23216	64975	8302	57579	64106	54878	11126	80164	6452	29948	8672	4925	81606
GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_DN	M4407		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1627_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive CD8 T cells versus naive CD4 [GeneID=920] CD8 T cells.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					196	163	1880	3987	55662	2273	171220	476	27244	2848	8560	57326	4583	6489	79872	51719	9258	79686	55790	29851	28986	65110	29907	920	10801	1508	54	1982	7706	2529	7074	51696	57157	8717	51727	831	2113	51125	57175	26018	10947	28951	4534	2043	960	120	1123	23471	6504	3939	2004	54815	7293	959	2547	26528	10125	29969	23250	5355	23741	5933	4214	1540	58472	644	10098	23244	214	8148	29896	3097	5725	57198	84705	9100	822	55793	79722	1233	51031	57003	9695	64083	90	27095	832	2079	921	1389	208	367	5194	51569	8407	801	11040	60312	65082	29766	865	55671	1396	55030	8718	100286895	84159	22872	4747	80351	3382	10990	10857	5621	253143	10161	1399	55336	55973	9766	894	7172	8428	330	7076	51552	26128	2826	5279	355	988	8635	3268	1979	2936	51013	7286	114908	81611	874	2037	81558	5732	2625	56654	3554	835	3178	64092	8743	9960	11034	55171	56548	29	4324	79075	5530	23527	51101	2015	360	677	351	1499	2313	4802	60481	11252	2124	80067	27147	25805	79968	5906	9895	1027	3749	9445	7009	4240	80346	3566	8821	1043	4999	3570	51460	56255	6275	5887	1397	3455	1757	81831	7913	10949	253982	39	9874
GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_UP	M4408		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1628_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of unstimulated memory CD4 [GeneID=920] CD8 T cells versus stimulated CD4 [GeneID=920] CD8 T cells.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					9592	763	8698	10801	5002	5295	11322	6203	10412	56941	4671	6746	6903	6181	23164	51063	7311	79090	6711	11314	10370	10473	57146	114908	3455	10636	81558	3988	4583	23081	3676	5912	50853	10021	9368	394	65108	6942	3725	7091	652493	27238	23527	5612	51596	26205	2048	250	9802	7593	1265	23108	1628	283683	4306	146542	26088	3385	5728	57446	56172	4542	861	220972	51763	6275	4815	58473	2745	3097	23171	23568	27287	1936	23552	26152	23601	27244	5298	5279	283232	1389	83481	25777	10219	3568	10106	58533	7155	54923	3275	170960	9397	7164	2254	26207	28639	5305	553	6464	6037	55423	23508	29108	55268	5583	824	9214	886	55790	64174	56271	100286937	26065	994	358	55615	192670	58190	54847	665	4824	64112	26268	847	8724	79659	822	57707	55152	54463	55291	5602	3960	3937	8742	10938	3300	3077	26119	3449	63940	54956	1117	7507	1806	3635	28968	8876	10608	51172	2047	26234	28683	5590	9550	4603	10077	51147	3476	2197	3689	55696	30820	80737	26052	274	976	26507	8848	8631	23263	56114	114882	51125	11329	5463	28517	10983	7692	9701	3727	10695	728855	8875	56674	59307	9522	9337	8409	64781	8667	6595	2313	5335	84619	55634	3655	7162	5775
GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_DN	M4410		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1628_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of unstimulated memory CD4 [GeneID=920] CD8 T cells versus stimulated CD4 [GeneID=920] CD8 T cells.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					8726	9526	9128	28969	10787	54968	9184	57103	4839	3148	4726	64834	93081	55120	11260	81892	2288	79753	8727	55706	1994	57122	60528	28998	51668	1660	3833	79980	2280	79155	8443	262	57570	10263	9646	580	10456	55973	5281	10137	6938	10001	55862	9933	10775	6632	5688	9	10051	7019	3692	10419	9918	6873	55379	29968	4172	5692	7268	5250	10469	23165	8847	51287	10855	79572	54148	5552	3185	6636	3612	7421	8662	10556	5962	26521	5861	23463	51182	84516	1537	5160	8872	10613	22936	5315	6723	6390	4686	5717	6646	1211	55718	4430	483	7150	6637	8243	3276	65264	10539	1665	5781	1959	471	1175	9532	4602	23395	8427	5422	25975	1022	84823	3312	55055	79915	79711	10236	11146	9373	9221	10926	55347	1503	29922	57099	81873	4144	10671	51805	79053	55233	10049	7263	90355	1460	375346	9868	7465	4116	3595	23429	3015	10237	10915	9320	5557	64116	9319	6491	1967	96764	7167	25897	908	9377	7905	51021	81620	6787	28957	708	5725	80218	10036	3419	26121	3336	79896	57819	56935	8886	55916	9015	7185	27301	7307	79139	1892	1719	4953	8467	3783	6385	124222	7417	2821	4809	8833	9047	10061	1371	51018	23310	5876	7453	7965	2950	4682
GSE22886_NAIVE_CD4_TCELL_VS_MEMORY_TCELL_UP	M4411		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1629_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive CD4 [GeneID=920] T cells versus unstimulated memory CD4 [GeneID=920] CD8 T cells.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					51520	2901	5542	10077	23277	10865	4353	1944	5368	1991	605	1400	10174	3982	717	5819	64061	55054	27033	55687	55095	6598	55823	2050	26049	1629	4055	79783	23637	4605	64421	55139	26959	23569	7023	1263	100272216	5328	64748	7593	7086	23434	168544	3170	64170	150759	7056	27023	51513	388677	7273	8522	486	54971	1604	1775	4317	10620	5575	11018	220134	9249	23766	51161	5143	54956	9985	117247	245	55142	138162	57591	9751	100131298	4868	2788	23580	100129503	1762	6324	51588	1515	3652	5063	79140	84786	253782	54103	6659	11154	10157	3778	5644	30062	85373	79927	55893	3219	4033	51768	79755	2128	10603	5175	6928	79663	1325	22932	199731	11189	11142	25789	26137	643314	363	2801	81577	55149	9450	199	6256	79160	57715	23373	1291	6304	9587	2980	23648	23094	54916	2792	54854	26173	80127	3400	23258	3609	10017	6327	2907	4926	6484	51008	6337	9284	22995	80022	50865	23381	57402	57124	7180	50814	8936	1030	9463	8218	611	1576	100288939	1392	81622	5586	2811	933	126353	2828	9610	5453	5662	5228	3339	64925	51078	8330	7498	221	9762	386627	7139	8629	54544	2071	2243	100287051	9982	10917	64788	26037	26151	7439	653188	29777	116828	29035	5731	6691	65083	23131
GSE22886_NAIVE_CD4_TCELL_VS_MEMORY_TCELL_DN	M4412		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1629_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus unstimulated memory CD4 [GeneID=920] CD8 T cells.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					7171	171220	54499	51031	6388	8894	26018	4552	9525	25994	9589	55081	51727	1389	51696	2004	55847	894	23636	5790	4077	51138	6877	64135	26130	5355	9240	7903	8458	4050	9459	9702	801	55781	6489	51809	57003	4222	1861	6990	360	1233	65082	10773	79947	54149	80196	23411	56172	9402	8790	27238	3570	6197	81491	56616	79872	6362	6504	7286	25842	677	8690	51719	11260	9874	7188	2585	7692	80723	79072	51569	51290	7165	9950	388650	23478	51109	5962	6500	6430	11315	6751	10443	60684	7398	60673	64116	5194	6938	7534	51184	11198	7485	29088	2741	8493	10607	474344	114908	5052	54469	498	7979	78998	10985	5378	64430	60492	51663	4247	27250	80789	27131	158	55303	55830	286148	55144	3800	7374	55172	9325	23171	4860	9519	2641	4690	2746	58478	9694	8036	1371	221154	2633	114932	7257	51637	56888	10161	11234	51192	55216	51780	10959	8266	23172	382	2178	9276	10296	9375	10550	6814	84079	22849	6787	3163	25898	80351	23480	9837	7555	2965	400	58526	3735	9236	55843	1399	10613	4999	23527	4729	10054	2870	940	6364	23741	26528	4175	64318	51015	23517	55650	11345	51389	1633	10225	254531	7168	57326	2530	990	5933	1123	79968	6653	79670	757
GSE22886_NAIVE_TCELL_VS_NKCELL_UP	M4413		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1630_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus unstimulated NK cells.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					3945	6955	1039	55013	1725	23762	51176	1236	917	8165	839	6194	6143	1606	3575	7379	2926	28755	4063	54463	4753	26119	8761	8440	10892	4034	57326	6767	4050	1265	80146	5578	1939	6204	6727	2323	587	54923	51669	2098	7431	10636	916	939	790	192286	9882	8611	26156	28639	2925	5050	79652	81932	11224	5252	1803	51070	6856	55709	10322	5037	4118	898	23177	140801	9804	6146	57128	2026	399	8575	23370	58473	6936	80762	51614	10460	53347	7866	10961	9692	2736	4953	3646	10162	55423	915	29969	3337	23508	9049	79697	525	79686	4363	3702	79864	8664	6188	166	900	874	4351	8821	4809	11168	6909	3399	6132	1353	63940	940	8793	944	55843	23309	171023	8795	5355	23178	9737	10120	84864	132	6134	55848	6001	7818	10174	51078	29937	10943	51678	23507	9725	26986	10140	9452	93144	1389	6154	10767	10516	9744	57820	25873	8409	6504	921	23484	644068	5871	56731	54663	79414	104	22955	54674	7812	2289	4609	6880	64787	8175	25956	8667	57146	6235	29080	90	56993	282997	79711	6598	10653	5569	9781	10541	51157	79608	64077	3783	10175	1797	6777	3419	10128	54919	2217	79882	3615	654434	117247	262	64919	2172	7433	360	5018
GSE22886_NAIVE_TCELL_VS_NKCELL_DN	M4415		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1630_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus unstimulated NK cells.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					3805	23365	79895	599	4684	57493	619426	28996	5509	9733	9798	728498	8809	9320	23064	5495	54438	353189	5336	919	25893	7314	81698	22836	4851	51314	6526	55106	55784	26502	10691	78994	2000	3916	7462	22920	9437	93594	23435	4090	23332	5445	5550	2934	7132	23101	5791	24144	79670	8807	313	7290	8644	4057	116984	3813	6503	23180	6907	11057	1488	53346	1601	1857	5887	50650	101	83737	3428	55284	10725	3842	56980	51773	8987	79899	23041	2591	9760	25963	23127	25820	8837	51232	6280	5788	9766	6283	54478	55501	5045	92170	51306	56951	55293	481	26005	286451	9765	5927	523	55255	7525	23053	80301	3628	56940	10625	3934	3802	57205	23433	55361	1130	3482	9342	9632	23198	3720	8417	64430	6925	79671	9256	285527	9477	23168	25836	2539	51317	29799	80223	9931	9079	5128	149628	9047	55746	64750	9425	1213	6867	261726	3490	6047	55062	54863	51574	580	23122	29919	55088	57003	10499	567	23304	10745	81847	58488	57194	26512	4864	3107	93973	9637	53637	4739	7405	10238	23761	108	788	5879	79603	26058	51320	25979	4659	55762	9325	8897	1063	1052	219654	51100	1326	79720	81553	64764	80021	9668	3064	23390	27246	11116	643314	374354	10224	1453	54434
GSE22886_NAIVE_VS_MEMORY_TCELL_UP	M4416		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1631_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus unstimulated memory CD4 [GeneID=920] CD8 T cells.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					54956	1576	1325	10198	5575	7498	1629	6452	9374	5175	7093	9851	3170	6526	166	55142	51105	3652	5252	6324	55040	6988	6820	55823	55268	54103	472	24146	23277	389677	5016	8936	2327	4602	55206	8928	29075	64421	7379	55149	5143	23613	11190	10671	11018	1291	54531	6720	11143	392555	388677	54535	4033	79140	6928	51008	11033	1823	6932	8875	5153	80221	9687	728498	54544	150967	23648	3109	6929	5205	8999	79810	7029	486	653808	3651	2967	30062	79939	117247	87	64170	363	5800	25956	55802	10982	22995	9254	6483	55718	2801	2071	10478	8629	60484	1553	23604	54674	10650	3778	785	3219	100272216	152992	60495	83448	84719	63895	9638	79753	9755	23162	1762	9145	254359	115703	7840	5176	5159	51588	55285	741	9985	5063	2296	56893	1783	2901	23268	57332	79671	695	79656	10142	9456	23523	6293	84172	10500	6924	6304	54413	100288939	7707	973	55556	11078	64106	57125	339044	60343	57715	88	25992	55744	3460	81576	51312	653188	64682	65018	126299	4926	846	5218	6554	11092	2203	7088	55720	65083	8620	1604	2128	85373	23036	54820	283232	170960	54784	8228	11119	2788	3326	57664	51333	4851	6768	30000	6327	166647	6103	22822	1961	55344	5228	51491	31	27434
GSE22886_NAIVE_VS_MEMORY_TCELL_DN	M4417		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1631_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus unstimulated memory CD4 [GeneID=920] CD8 T cells.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					171220	79872	1123	6489	23741	26018	2848	5355	677	57198	10161	3987	8560	10294	51727	1389	2004	29969	55030	801	55336	65082	90	10125	2529	360	9100	26528	1233	57326	959	9258	2678	29907	57003	51031	960	4802	5933	835	10625	7529	29766	5504	5887	196	214	7172	51125	23471	23593	9445	23527	6777	5501	1979	6504	55540	7159	80346	54815	4222	3097	55015	5906	51719	874	7290	57157	10949	7913	1982	64853	23150	657	5885	6613	3268	894	10801	10728	2313	30844	7374	64924	988	2063	11034	10803	8717	2043	7293	4999	64116	2826	4747	51012	3554	940	1849	2838	27244	4552	2547	23118	114908	9674	2936	2124	64092	7286	8335	81558	3384	55788	9695	9240	2923	3570	56155	9589	8743	54	7555	116832	10443	27095	1984	1378	79686	1396	822	10146	10857	10098	51663	80351	55081	7534	2081	9782	51696	10370	8407	30001	8440	1102	79867	60481	51320	7259	5537	382	84705	23244	79968	55843	10491	79789	55796	22872	54830	3695	5682	100291860	3185	8821	2870	23081	50852	8502	81555	151011	4583	7324	55068	23348	2736	7543	65110	3883	2810	1235	55148	4674	10626	80146	3344	865	25805	4689	7076	81689	56888	3939	57175	961	9766	8690	330
GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_UP	M4418		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1632_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive CD8 T cells versus unstimulated NK cells.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					921	5578	476	26119	1265	587	9049	27434	6955	59347	58473	54463	54919	9882	100134017	23178	1606	60487	6903	64769	6856	944	1039	2289	23508	5800	4040	225	81932	64787	10322	51599	2323	104	6727	4753	4050	916	4897	132	6936	8165	8440	7433	2926	2217	29851	1823	56672	8821	874	64429	6909	839	79414	162972	23762	4034	54476	4063	57820	51031	926	53347	84179	6194	10120	8575	3702	51176	940	79948	57326	79697	6143	27315	2678	80762	9737	4118	9692	8611	57124	5871	54674	525	1725	1939	10046	939	23423	10636	3945	7066	28755	2925	917	79652	7326	23177	51123	22818	55423	6019	6164	10516	8975	6001	4306	7430	8531	4953	5037	8761	9532	10892	2838	9529	9725	221061	5252	81025	654434	22955	1803	6430	5774	3640	4351	3575	6978	6504	51669	51078	3337	2098	55843	23507	5050	51070	6274	79752	3399	140801	26156	9531	10162	54923	55709	6204	790	27240	28639	5631	192286	80146	5834	5569	262	56654	6767	4363	55602	1736	55450	2230	51719	10681	2052	6188	1236	2531	3861	56180	898	5973	10460	57128	6990	1797	29883	23309	3698	4951	55812	28673	51614	50514	814	27090	9804	2254	56985	27349	57130	3159	11064	4733	51678	1974
GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_DN	M4421		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1632_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive CD8 T cells versus unstimulated NK cells.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					599	3805	23365	64764	5552	80223	3842	28996	11152	57118	3916	9632	93594	51552	23433	5336	9435	57205	57493	5445	3927	9320	8807	26502	435	55784	4853	23761	284443	10725	313	26053	79651	26005	7314	7462	6867	6907	11116	51317	1488	80216	5045	55023	23435	3720	2040	261726	7132	204851	81698	4057	4090	9437	5788	4684	8897	101	9798	83737	2934	5791	619426	51714	3482	5495	241	25893	22920	8148	63894	3628	30008	11057	79895	4851	5494	353189	51232	6810	78994	29799	51773	60489	79570	79899	3293	23101	9733	23139	55106	8837	10499	23180	10691	2207	25963	9477	79642	55501	7305	728498	80070	54438	51111	57551	5509	1495	3428	919	23198	5887	2000	9765	222161	79603	3002	8987	9708	493	3049	55055	53346	53637	4864	22875	23199	10234	57136	8809	3560	23064	8644	51314	1857	92170	29994	967	81566	23175	4067	3071	79670	1820	25820	9766	6925	6280	7525	1601	80012	56951	9794	116984	11342	56980	55284	3934	1718	4659	117	6850	54440	1317	10059	2539	9668	329	23041	3813	219654	80301	541578	11066	10865	5550	51013	1052	22836	117153	54842	79671	24139	5531	10848	8417	9760	1130	23168	1659	6047	567	3638	93973	163	2591	54434	3190	9342	2801
GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_UP	M4423		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1633_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive CD4 [GeneID=920] T cells versus unstimulated NK cells.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					23762	126353	22839	921	808	23263	8575	23353	476	168544	7273	64061	22818	55423	51561	8821	55061	5871	113177	8911	337	23178	84148	51333	9531	53347	7433	9882	54463	940	58473	80764	84033	3640	9448	50861	5578	55652	6878	51195	1265	2925	9762	1039	8906	6727	5050	28683	747	4034	79161	898	51312	6425	3399	920	9774	8165	814	11059	7818	2791	51157	117247	1938	285	79679	100127972	55621	874	8440	4772	22955	55013	2323	3337	27079	9048	4809	9986	944	5569	360	2678	27076	55367	81932	8793	1606	10043	10636	57000	55790	839	7089	6955	4118	28755	959	2217	1263	643224	91782	54902	6936	2051	104	23568	2550	1803	23207	161291	79444	9049	55224	3991	10767	587	5252	3748	55234	4050	6194	79783	10400	4753	51070	65083	27156	2676	6909	57326	9177	7869	29851	2926	10943	2050	79734	6196	1400	4354	27239	3159	5501	4016	9410	939	91300	221061	27134	390502	25956	100288496	65265	51176	9094	51669	4232	8471	10250	2208	55506	10634	8795	57799	29777	10516	10892	3784	2593	10750	100288640	256987	23371	9450	84830	790	4929	2308	8664	8761	5121	473	2172	64423	375449	3315	63940	892	3726	3800	51106	10322	9262	8175	3050	10681	8718	79710
GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_DN	M4424		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1633_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus unstimulated NK cells.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					3628	5336	64149	28996	23390	26005	8807	5325	57205	7462	22920	7314	3839	51111	4899	8417	83737	57122	9525	7188	7769	64864	10269	84859	27348	9765	5427	2960	27067	55784	599	9559	9488	22875	2934	55080	5082	112950	5791	23175	6810	10691	329	3482	29799	93594	241	9870	23190	313	9761	6964	56940	6400	211	23435	56951	9325	80301	5879	55055	51809	1213	7525	6047	55745	9276	10111	7371	7132	6375	9733	29994	10745	9728	26512	9724	8803	79029	3805	26277	92170	2181	339448	7559	1519	9140	5868	23008	27350	53346	3916	80196	9342	6907	5788	1362	140609	261726	115703	10228	27347	9632	51773	23101	10238	4684	25972	54165	25963	10617	55746	51574	3842	2332	348995	1488	24144	116984	9760	9817	9320	79670	55106	53637	26521	22928	26502	58488	5887	889	54469	4090	55284	55650	5573	580	55501	5509	9646	9716	93973	114932	259266	55179	7741	60489	619426	25893	5445	6938	51317	4594	9422	23438	3824	868	27300	9416	79651	51755	23365	11057	51103	9437	9022	3303	2040	1315	27072	9637	64764	22800	57187	4864	8565	23198	51118	56945	9477	11000	27131	541578	10602	641	26191	523	5511	3417	27246	2591	7456	79893	6596	10190	9101	10714	3927	55269	51306
GSE22886_TCELL_VS_BCELL_NAIVE_UP	M4425		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1634_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus naive B cells.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					9452	5829	3631	28955	9131	54981	23212	10313	25864	10460	1039	54923	919	3702	8514	4118	409	26156	80305	6182	2026	5588	917	2625	9961	149603	9235	914	11059	2323	204851	23765	5905	6653	29959	57326	23177	55268	10955	3575	9266	84747	54518	9138	22907	3683	28984	752	10456	51176	5583	8833	51586	2395	924	9806	5920	9150	80273	7841	79697	9274	79095	57185	8703	939	1849	861	2926	7076	10507	8821	7294	894	29087	81555	915	8192	55556	476	64919	339287	59307	23484	11070	3932	839	2123	4753	26207	10946	27246	6955	64092	976	58986	23474	71	6415	3275	10868	10370	7535	51070	2533	7132	55794	7791	25939	23523	79171	80762	5707	3945	4350	9466	6001	7378	4925	3835	10140	2633	10055	10123	8519	26001	399665	4034	6777	1509	8834	3655	3163	28755	25828	22870	10384	5335	57142	9903	51218	301	4061	10449	22821	4832	10410	9524	9663	916	5552	2289	6609	22937	10362	5578	6597	474344	6993	3337	6904	2634	7167	2995	56731	81628	55340	54952	5315	27018	8445	83460	4077	50619	3707	391	22850	6164	1606	5700	112398	5518	4074	203069	51393	8425	3004	116138	6404	53347	23400	706	1803	5496	741	23348	3398	11119	23016	8525
GSE22886_TCELL_VS_BCELL_NAIVE_DN	M4426		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1634_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus naive B cells.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					9834	55084	85453	2760	25825	5218	11116	5742	4345	55853	933	28968	84679	780	80144	971	115123	8115	9231	53335	6689	1183	79865	10392	605	54893	64759	10391	2823	23220	23089	3112	953	6925	84705	9215	9734	27075	2628	7288	3108	4208	9738	3109	55205	80067	8564	81571	50856	8820	91977	7980	26272	10752	10846	27042	599	2330	29760	157	7771	55206	9450	9886	100291860	8914	79789	930	79007	26230	27004	79368	5961	23035	8942	11142	29966	23268	55024	2941	140710	10505	25849	11009	19	5074	91120	51050	3111	931	8613	80129	4064	6558	5287	26253	100286895	1832	3394	3995	2938	11211	5336	390616	8395	80862	23255	50804	912	23676	11144	81025	4430	55247	27314	3157	1298	55211	4281	2192	80183	6328	1268	9187	9099	29923	55296	91647	10512	2252	29802	10389	79608	79768	8361	7252	5026	6695	4142	22866	9019	80008	23034	974	55335	26228	3444	5368	3554	79818	2213	941	57205	5268	23161	7292	4287	55668	2650	6007	8728	4102	10879	80034	695	2358	164	1395	10021	22837	3597	81035	7366	973	8110	3915	3344	10164	1269	5241	7410	3759	54621	3044	80095	3441	78998	81624	54768	6875	3985	4103	65988	79567	10584	8727	6660	3087	51517	1185
GSE22886_CD8_TCELL_VS_BCELL_NAIVE_UP	M4427		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1635_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive CD8 T cells versus naive B cells.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					54923	3631	9402	5775	7076	54981	57185	4835	399665	8525	861	9131	84747	4501	56949	27347	51586	55700	2289	3163	2975	28955	3275	5905	79037	7791	55268	28984	56253	7535	924	1849	57136	9673	9204	493	5873	4753	9452	7294	79961	2323	5551	23177	163486	29909	4502	4925	10198	6595	9903	51070	26156	7841	54518	2634	4818	26207	116496	57019	5476	23392	5116	3001	53347	2026	64919	55601	10133	9235	26119	1211	138151	9397	6095	3004	51155	3956	3820	80833	5578	112398	29959	752	23484	6675	64781	10946	11068	7337	914	4118	2633	23765	51176	445347	55615	6780	1374	55041	5829	5036	10362	301	23423	8514	253461	2395	5786	9150	9531	25864	10460	6001	8698	29087	5585	3823	6955	7494	23474	5034	10077	3418	8703	939	6182	7016	9368	25828	474344	10199	9692	10916	10424	23518	4603	79414	8364	80762	10410	10313	23523	79156	10370	63875	54681	64425	4054	11046	59307	27349	440193	613	5588	389	3575	78988	26278	4034	11145	3683	23175	8459	58473	2581	64092	23212	5707	9466	9961	26521	1981	55830	409	1039	8821	6840	10578	8302	80305	57048	4145	2533	4580	51439	79443	71	23400	8530	1292	2630	5732	26018	919	3560	4713	6352	917	79180
GSE22886_CD8_TCELL_VS_BCELL_NAIVE_DN	M4429		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1635_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive CD8 T cells versus naive B cells.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					51296	5218	84705	5023	81571	953	5742	2550	931	2330	10752	23220	80144	9834	4345	80862	3157	933	8115	1776	3394	23089	10392	1495	1103	1183	26272	3113	100286895	10846	55205	9215	3123	28968	3109	50856	11116	9734	8728	27314	51101	8942	2941	23268	23035	5961	1848	9743	25849	599	1595	10953	10800	55084	4430	4208	780	25825	84679	10633	157	8991	91977	9099	9231	400949	5463	10391	9450	9846	79865	1959	10184	64922	29966	4064	26228	535	23354	6689	6925	1380	6232	10505	2823	351	3915	3108	6850	55206	6875	8727	8395	2212	64759	8394	11009	79567	3087	8613	23329	9019	605	27004	79768	6007	5074	128872	3670	23331	5336	29923	8110	695	930	55332	4664	3554	3128	140710	80067	55662	53335	1268	2628	7706	11211	7252	50700	79966	6667	10603	9727	325	92017	26509	11142	55853	8034	3441	80742	80831	23305	29760	80129	23250	1550	8914	3444	23676	4103	91120	26508	3115	3566	8322	23097	941	10879	79608	51285	81848	85453	56106	8564	6518	4090	9308	54893	728142	2810	7771	3112	8671	10333	4281	1513	83759	22866	55024	27075	7410	23034	9060	3759	3122	5796	219595	9185	3817	51533	3995	971	3906	3495	23232	9056	2938	4142	7126
GSE22886_CD4_TCELL_VS_BCELL_NAIVE_UP	M4430		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1636_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive CD4 [GeneID=920] T cells versus naive B cells.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					7535	64425	9021	4925	64960	409	3683	84747	1991	10055	923	9531	51586	6659	924	2634	53347	64092	752	1844	3398	3275	150759	921	8821	3640	861	5372	4068	57048	64919	253461	7076	2323	9235	4054	57185	51070	6520	26156	2972	4092	10946	57326	9266	80162	9903	59307	55794	940	10460	5900	613	976	474344	23324	9278	51176	2644	51411	80762	26472	814	566	28955	28755	914	7841	54518	64400	55316	256987	57136	1107	2123	6001	1030	23016	5578	6199	23765	23484	204851	5036	6955	6352	5829	706	645	25828	10370	2633	7378	10140	2625	917	56949	3707	2053	10313	5585	998	3835	7791	140459	741	3004	1849	23400	2027	4118	3702	28984	29844	199	79414	6275	2533	3575	6829	10199	55268	10865	9806	5775	6281	4753	2987	10935	1039	8425	2289	8525	60509	2617	4074	5552	22850	29959	65125	57473	5707	9466	6904	939	2395	55830	920	9270	80833	23523	7294	2026	84148	11212	2926	26119	9452	915	2776	7128	23345	55700	919	10507	5583	4335	5295	6609	50852	1777	58473	23518	1855	7074	9131	4595	28992	994	23241	399665	6095	51329	27018	1647	476	9064	2995	10788	2630	23157	10410	2217	10538	10955	1312	10133	4123	26207	445347
GSE22886_CD4_TCELL_VS_BCELL_NAIVE_DN	M4431		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1636_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus naive B cells.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					55205	2330	931	1380	780	55206	84705	55084	54733	3122	54893	10846	3157	80067	8115	953	3123	81571	3115	3108	80862	4643	5218	50856	4208	5450	23035	85453	26272	3394	5742	6787	3507	10505	222658	283212	30845	7980	1183	2628	6925	10392	4289	25849	11116	26230	1269	29760	3109	55853	7358	5796	10451	7288	140710	9450	8914	10752	23220	9886	2591	8493	6850	29092	22849	8110	4345	3690	941	10090	1268	23089	8395	9834	2823	55784	4102	79768	80010	9655	1776	10184	115123	8505	4090	91120	2941	29966	3662	55024	9019	26040	8820	51296	9215	3087	51741	23232	90333	91977	10282	9124	1580	55211	5336	79865	79608	7204	2938	23676	5892	3119	9738	971	79979	11211	2760	55086	4171	84679	79966	9724	5268	7111	933	1360	53335	157	54676	160313	930	5961	9099	11009	26002	80144	27075	9657	8531	2550	4131	8728	79818	81035	64759	79567	100291860	2358	9734	390616	4430	8942	6232	23354	22800	26088	55668	1103	10391	51124	695	728142	55565	2328	8360	9310	7813	10953	4287	28968	164	29923	50804	3664	7092	66036	8727	535	10584	7046	54768	55332	23264	100286895	6518	9745	80133	10745	7465	55335	8671	84789	6695	5470	10529	974	7252	79794	79596	100293871
GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_UP	M4432		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1637_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive B cells versus memory IgG IgA B cells.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					8115	5023	3566	8531	3507	80146	23220	535	283212	334	5175	10451	50615	7852	3495	6452	605	6304	971	9679	694	687	53373	780	64131	1832	7771	59338	3915	6653	8460	8440	50865	8631	55084	79777	5863	7695	54662	91120	23641	63874	30844	27075	81848	23089	4088	100127972	10391	60468	8076	7594	9990	55603	4326	5101	7678	3459	7704	51276	7694	6328	2550	80022	104	59348	2330	5100	5244	275	2308	51439	8972	9704	23143	25836	57154	5008	1380	24149	1776	55841	1103	22865	57821	7299	316	8660	2205	7358	55630	57343	4306	50804	400961	2868	10879	4852	55211	9287	4313	7475	23670	7368	79865	29893	55756	933	6478	1208	9310	1806	55262	1130	2650	7782	8527	6514	9215	8564	192670	9077	139322	25778	222658	25978	22894	23331	9906	3903	79007	8334	115123	100131298	54345	51735	6503	166614	8496	66036	100128640	3373	387263	5187	3375	10623	27244	2042	25786	129025	4129	4824	10233	22987	169611	5547	11193	9941	8416	9934	23334	93643	9329	1122	7172	1911	84033	9705	2208	27092	2147	10062	6535	5272	9738	366	79661	9737	26280	57615	5981	1550	100129482	171546	2591	5090	27125	1733	26512	6496	683	4286	57586	4112	376267	59272	5007	1787	23583	6944
GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_DN	M4433		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1637_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive B cells versus memory IgG IgA B cells.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					23002	1690	939	3688	81537	3956	3783	3493	302	9805	1397	27033	9447	9061	1285	27044	79365	30845	10148	3945	9404	54762	64092	7071	71	28755	10866	2597	54	942	399665	6281	100289053	116496	1396	8938	1611	11046	970	54923	6001	57178	476	6275	2123	3684	3732	824	64222	57048	11031	4332	79026	54997	6955	5476	5900	7334	55638	822	55268	3310	2630	9681	7037	8553	55790	9473	8082	10437	58516	4082	22948	10923	304	55179	81552	154881	965	493	51155	874	253461	64114	271	5355	54187	4835	203068	23564	10952	51465	22797	10125	7494	387893	81618	5771	8543	8195	8837	30833	28978	8655	57228	11262	54469	26232	163486	7431	274	79005	6157	100289420	919	51303	9961	38	6176	10102	81873	7465	5464	10449	3512	80025	2729	9760	23158	1512	6050	27068	64834	80833	29095	4542	4522	221749	3312	8717	29110	10383	7027	10938	6277	9454	80017	653784	1808	3695	5336	7533	9057	55573	9938	79037	9636	10227	894	6095	29108	6909	498	7381	352961	1192	2617	2026	5920	7388	7090	64083	4713	51719	645	900	4726	23406	4689	8661	4267	9131	608	2529	5372	373156	10750	10095	308	60509	5917	55969	10935	26137	5698	1176	7167	4709	55619	7326
GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_UP	M4434		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1638_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive B cells versus memory IgM B cells.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					3566	2330	9679	11212	28951	4345	10451	7594	54662	8531	23220	55084	8460	6653	8609	6328	23334	6304	80146	51439	50615	7852	1183	2650	5287	334	404281	3948	5023	9310	55630	79007	51540	55039	283212	26128	4326	8971	1103	8527	104	8631	7111	10769	2308	54704	535	2591	26156	9287	605	4088	7358	5547	81848	57154	55841	10953	80067	51760	3765	4900	10392	23143	23219	23250	8914	1832	57338	23180	27079	1130	2835	1909	2919	10178	26015	115123	10391	3157	79661	23670	79865	2550	23051	51741	11226	10077	7079	585	5863	2205	29888	2941	10160	100127972	10633	4005	26508	10252	93	6504	51151	8505	29915	9215	7704	23265	9498	80201	57506	4899	1806	23097	57105	26272	27244	10021	4081	26148	5243	80005	55603	25820	57038	80052	79701	9738	9934	1534	2034	56980	63874	3597	2195	316	221061	5101	51213	10563	3770	55794	7782	55784	9086	4811	7164	79722	6795	9183	55113	1836	5820	780	9936	342096	55508	8853	2207	27075	5690	54463	7402	90861	10102	10738	55086	6422	3903	4485	3849	2040	23621	5923	8220	23632	8651	79904	51665	9099	5153	389	6478	7857	7350	9941	3495	81031	10824	23268	6554	9329	3578	8857	647070	55109	57292	23635	1562	57821
GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_DN	M4436		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1638_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive B cells versus memory IgM B cells.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					27033	81537	9681	30845	79365	2823	9447	9805	939	3783	3310	3688	9061	3945	55790	911	54	8553	64759	3732	28912	4332	2896	23158	399665	64092	64222	3684	5900	1844	9697	7071	2630	10133	8543	55268	2597	970	9404	302	6001	79026	29959	5341	4082	81618	22797	1075	3956	26278	9938	81552	1396	2212	23002	83700	1176	3587	912	6095	57048	57178	55619	11344	28978	26469	100289053	54863	10750	1285	271	1690	7187	100133941	9961	9846	27044	900	9021	7165	2537	26088	56650	476	5355	9552	23423	51562	7266	654434	51296	1512	2123	1267	11031	3106	22948	71	100289420	7090	9056	22837	11018	84196	894	93974	23234	30001	10938	822	5464	5610	23406	2171	4689	6843	10952	3621	5476	2791	5245	3695	3028	51693	51719	26119	64834	9482	10111	55062	23643	4809	1890	58516	55573	304	9375	5920	7431	80196	26137	4174	57326	6598	3838	10257	2271	221749	291	5214	51596	3052	1938	7133	863	7027	4835	26051	11184	10553	57215	23564	11262	64976	29108	5867	203068	54187	498	4074	824	100291860	29969	10970	7494	54583	10437	1666	23277	11046	6281	965	226	8869	27339	2530	26251	10383	9141	38	10105	6275	7167	9618	54205	28960	1880	6390	2593	253461
GSE22886_IGA_VS_IGM_MEMORY_BCELL_UP	M4437		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1639_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of memory IgG IgA B cells versus memory IgM B cells.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					1690	116496	3493	54996	8732	23002	23335	54762	2043	138162	5917	5420	8082	57228	79005	55151	8676	9451	29968	22898	711	8938	132	6286	7334	8604	2529	919	23764	5301	28755	10558	3597	6955	7062	4337	942	1137	4854	84525	4946	2730	7965	80201	2644	874	23169	56101	10102	55197	9454	3958	8793	6006	4907	1894	5507	10227	28	2132	355	23092	10004	55253	22913	9447	55109	7465	80833	8846	9882	373156	84159	5128	90861	6696	7088	440193	7113	347733	788	441263	55113	81544	55039	2301	11163	27079	4590	25790	6755	11181	5577	55223	7263	3688	11329	7349	8530	154881	22981	4625	2835	7743	3398	10814	221154	9760	64763	23223	9686	81578	3547	6299	58516	1111	10610	1609	7539	284325	2063	8190	54478	4613	2189	1068	7730	8609	10683	8787	5166	23533	10723	55615	9498	79921	147657	6176	64429	4653	79796	79983	23271	59347	1611	27347	8418	10667	112398	7450	3861	23635	656	5620	79722	1381	57710	84719	10178	389898	7042	10744	6817	8445	2123	6909	55179	100507436	2178	23275	5898	3948	51382	5641	7037	28983	3221	4005	83444	3265	100506658	8705	23481	55746	131408	80310	8514	1397	11108	1639	493	79366	54584	84796	9478	285203	4094	4542	26577	2810
GSE22886_IGA_VS_IGM_MEMORY_BCELL_DN	M4439		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1639_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of memory IgG IgA B cells versus memory IgM B cells.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					8891	56660	9139	10347	3507	8408	2823	79890	9674	971	599	8564	64759	911	116986	51773	3280	5610	10591	23198	442194	9681	7158	29799	3495	9152	57664	6545	3621	8672	5175	5007	2213	5101	2899	57146	8021	10875	26018	3587	23001	1420	3459	83478	64764	79659	912	1326	283232	23220	10658	55909	2868	84549	10174	79368	1844	1018	166614	23484	8334	7248	55848	5090	605	64847	4853	1984	8876	6850	25836	5351	51385	4297	83743	10750	26088	26281	79789	43	694	80195	80149	7695	64110	23283	8531	53820	63895	54913	5244	5994	59339	90634	7561	1134	51149	3717	54726	10732	51319	2976	3439	8303	56995	7357	26154	2841	8972	974	59348	1847	26092	2537	54014	10301	9103	7855	51102	3558	1969	868	241	5467	85236	9170	79066	867	6503	55790	2791	10123	2620	9880	3162	3021	7544	247	23125	3569	3850	55212	6925	26280	2101	173	5440	8115	114088	56257	5954	9802	715	256227	9668	79777	9735	23062	54555	9650	51778	55756	5341	9364	27287	23405	7832	5455	55740	9056	9274	10472	171546	9896	92973	8832	79143	11021	56112	1776	2169	10196	8924	80700	9169	9392	65982	8568	60625	1386	8724	79364	3841	22895	56997	4799	4994	50862	22848	2218
GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_UP	M4440		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1640_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive B cells versus blood plasma cells.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					79596	1380	51665	79037	2330	7852	931	3275	55084	54455	780	57599	9450	79979	7594	54454	694	54662	8019	10451	3115	8742	275	1911	10505	3707	3394	6653	9214	5187	100132406	3566	27042	5742	7695	2550	1183	23097	8609	8115	55086	55205	4050	25820	23220	23309	5796	1831	10392	8916	55601	933	23052	10752	11142	6655	6503	7994	3123	728558	3113	81848	54518	146057	5616	28968	57154	54877	9909	8832	7188	54893	5863	8028	51735	643641	4600	4345	7011	202	116984	6228	10846	23035	26249	9649	114897	1843	5090	8034	64061	54826	5293	677	23252	138050	7805	3109	10520	2938	80095	6402	1130	51276	50856	51540	1360	64131	10947	9679	4335	50807	3820	27434	23351	11116	4088	2791	23531	9315	7402	2252	4306	4313	10389	11221	7227	81606	9743	80862	687	79841	5463	6687	7050	57180	1269	22838	9779	66036	9231	6778	9057	6232	9422	29966	25778	23089	3122	55024	374354	868	2114	64581	50717	26272	157	2823	79007	5256	85453	9308	84986	22897	6667	7771	969	10057	9860	51241	54676	10090	11009	4598	10346	55211	80067	51520	51479	23135	7410	23341	10723	2941	9710	9737	3112	54463	64772	10228	3257	54956	55756	971	1848	9939	54808	10391	131408	23177
GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_DN	M4441		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1640_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive B cells versus blood plasma cells.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					64778	55830	79365	151011	2395	38	11049	10424	7922	2826	5873	2530	6470	65244	9582	54148	10592	28998	79796	64960	51363	953	10403	5096	836	3614	64151	3430	6199	55500	26275	6787	7153	9061	55204	7415	92140	81533	10945	25828	55706	79801	10059	55062	51103	10916	4552	10221	2677	54149	54923	840	7841	57136	23705	10682	991	2068	29959	23643	291	4678	5707	6747	9532	6238	2882	27090	8892	26608	51016	91775	27033	10985	10072	2630	171546	10920	6760	10026	2058	3493	10483	9373	23518	30845	81030	1642	51752	55325	100290557	929	23155	4245	7071	55847	1890	79023	1075	360	26472	3832	4121	4700	7174	5163	29926	51	55379	8760	10282	5917	857	1312	28960	4173	25829	10105	10342	304	54707	64218	9500	952	6240	54187	8607	78988	6182	5954	51081	4830	84908	8836	51272	9236	65084	57099	3418	28912	4085	79763	388650	3920	51026	4522	3998	51027	6541	1647	11014	79682	9266	51053	2673	28785	4686	8837	9761	1690	2617	29100	440193	23457	5294	7298	64943	10237	27349	9961	3956	9131	9871	6834	253461	51237	29901	79694	100289053	3052	55856	965	80349	9141	79152	9697	28986	10150	26286	9997	2237	16	81618	51121	2935	63875	1267	9133	1653	9404
GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_UP	M4442		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1641_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive B cells  versus plasma cells from bone marrow and blood.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					953	55206	4050	23219	23165	29966	9909	7594	10451	7805	79037	3123	7852	11215	4171	780	6778	3635	54826	55629	933	6168	9943	1806	4088	526	51466	5293	3115	1911	1380	81537	4678	25820	57048	202	100132406	3566	55084	23531	25913	10228	4801	222658	11116	64395	54455	9450	54969	22849	931	10308	6232	4361	50488	3122	79738	55756	79979	85453	7994	1183	8028	2550	2810	987	57599	261726	285527	8505	8914	1043	9737	6595	6944	57506	9733	80067	28968	84986	6503	23708	23334	6235	694	6402	3394	9679	9813	90333	84271	22884	5557	8942	3109	28951	4126	10801	9724	23526	6687	55086	6155	9738	7358	4522	8874	2823	6194	6171	8525	51379	8220	55205	971	9214	10592	8879	9422	4345	64131	9308	80746	91120	8915	91300	23341	10190	54148	50856	23220	29957	3707	3113	8846	23052	3108	23309	23046	27010	4001	1390	79023	112398	5191	8115	5073	5287	11212	7014	23195	11198	53373	55892	4306	55211	6169	55344	51540	23252	23097	3667	27436	6789	54877	23089	374354	79829	9217	3708	7771	55013	4853	25801	11151	9325	847	11142	25836	1130	22868	9939	84747	5579	27042	4313	116984	26088	91754	7046	54951	6655	3087	81606	677	5569	55148	25936	10752	6228
GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_DN	M4443		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1641_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive B cells  versus plasma cells from bone marrow and blood.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					10113	100289053	857	28992	4795	64778	10483	79694	4192	23155	58477	9601	26586	10370	26286	55062	4245	2700	8566	27293	79365	8703	26580	64215	8837	26608	7171	51275	84981	81555	10802	10966	22809	27090	9693	929	10548	7922	27237	11153	1890	5624	268	23430	952	1777	54361	2184	10237	6676	6236	4121	81618	8568	6199	939	6520	54923	270	50512	28986	7161	140459	3920	2637	64788	54499	645	79763	10221	9697	2537	6238	3418	2068	7494	7108	10456	10342	4000	6747	23412	29926	28955	51272	27033	5900	64092	51290	5192	608	3655	9022	4796	51237	10970	6300	5096	26251	7923	11145	1798	253461	25797	3956	3425	2617	11014	2593	2203	80307	64943	7076	54981	10945	2131	1471	79174	79876	5611	6675	29095	25864	6095	2630	6509	4830	100290557	9454	304	6782	1312	2848	4758	5163	10313	10330	11194	283	10133	6184	3455	78992	861	51660	11070	2812	3703	2535	28785	79001	55830	3493	1775	51032	10525	3614	55379	56106	4925	5954	30844	6343	6382	29100	1026	1294	29937	10424	475	57823	51009	291	64222	9468	16	7077	5034	10150	5552	37	9473	81533	22820	23659	30813	54867	23643	8702	6723	3479	51128	23475	7280	64374	4669	6397	28960	22983	4284
GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP	M4444		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1642_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of memory IgG IgA B cells versus blood plasma cells.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					26005	58511	23515	4130	56834	6155	5079	64761	25850	6161	23062	1293	780	5144	7799	7597	3431	472	55084	6228	100506658	201163	55601	23220	11346	79037	7188	50862	4224	5742	6709	51362	9450	8942	8076	1380	54877	7805	10724	8622	4760	23492	9487	10228	57599	27042	3394	22897	5293	55024	694	5577	4215	65982	283537	10486	80223	56882	2308	11275	64693	4653	10752	23526	51312	8590	114548	138050	6844	8204	29887	54665	10075	2317	9779	25801	6167	79659	7405	2534	7130	3451	7852	63826	64174	10129	5979	8600	867	6139	971	10947	26056	161291	2650	200576	1911	11199	11104	10252	2359	26575	23508	10451	9313	64077	3115	50628	56101	79890	202	4842	2114	55769	22863	241	4915	911	115123	79084	55128	5795	933	4335	10982	3841	79596	22906	51208	8289	10047	11080	4317	6777	26154	4651	7050	4948	23276	10879	10683	5101	7225	8019	55268	154881	155066	2550	10148	80183	55130	5074	79789	55296	81545	822	25957	10391	7913	26531	54996	10734	8848	6137	10637	10388	7994	3680	79649	4129	25928	10235	8742	9882	8938	55016	22838	1130	11108	112	868	4853	64595	55205	9378	55638	2628	9308	54103	83729	9162	147657	1831	6154	23314	9750	2982	1438	54487	79600
GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN	M4446		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1642_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of memory IgG IgA B cells versus blood plasma cells.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					84268	10385	1486	3430	23705	55830	808	22862	25864	10591	55093	578	64151	23262	81570	56886	4905	528	55020	8345	291	4043	79796	23405	65993	64764	100	1647	5954	79365	10552	9236	2805	8050	7263	7841	64778	2530	3479	9086	54555	7485	3958	55204	9685	8344	4802	54707	6404	929	55507	51016	28902	64175	55500	23122	440193	55062	9976	23484	2673	639	7077	3006	3386	329	51752	7251	10608	151011	2954	55974	8260	11152	51026	10424	10573	55325	9709	5096	2677	7466	9761	55080	6760	26271	9266	10558	171546	54502	54882	6747	10059	9197	6790	22809	54953	2799	25797	5163	56941	9531	902	54923	23516	836	81533	3628	410	22913	7358	91775	51816	5917	51651	6509	51056	10342	6787	203069	64218	54928	26275	7923	65244	10955	11097	23457	79670	56945	65990	78996	29071	84061	51542	7110	23644	100290557	64215	10615	10026	7922	6238	81554	7511	51075	10802	79577	10038	100293440	8733	6310	9777	54948	10169	25829	25998	90410	26608	51094	10916	5778	2826	57099	79714	642	8226	55501	27090	54914	360	2976	3455	175	5351	10221	23376	3516	58530	388650	26286	79586	939	1312	8027	54849	10651	9636	8891	10548	28912	8078	51363	115353	9320	28984	1102	8539	79703	4701
GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP	M4449		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1643_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of memory IgG IgA B cells versus plasma cells from bone marrow and blood.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					11151	6139	64427	11142	200576	9450	3108	7405	4853	6155	6430	5757	847	10075	5079	79789	55629	5567	25816	6188	64429	5481	526	8303	1293	8540	81545	5376	1657	51362	9994	8942	911	6513	10904	3551	80183	9737	11129	27430	8175	22948	971	11235	6856	11215	6777	7994	51606	79037	6778	933	23240	51567	51765	10627	3431	10252	2550	147657	79646	55164	8848	7072	1380	10801	10015	974	54482	29957	989	55278	10235	8569	29761	3635	1032	10129	23369	8417	23002	23075	953	1655	25801	6879	7597	4659	6201	23043	3109	5579	261726	55748	8317	8428	5934	822	54878	8204	9662	29887	2534	7805	1810	260294	84271	11177	6653	4089	10181	6160	154881	1911	5293	5074	6432	22898	1130	11199	178	103910	6234	10451	5966	9802	5026	64863	8879	3451	29121	9217	54487	29799	28755	10793	23062	5910	23636	57711	10982	6235	23341	55013	9337	57337	8773	10714	10093	5430	11329	23370	6844	4050	7514	54872	8622	79577	22868	9447	4666	23126	80167	8445	9710	274	9444	60481	23526	5594	9882	5993	64693	6135	2268	348995	10092	9750	10206	9815	54853	54877	55016	23515	5380	27236	1894	4869	5387	55729	10866	54778	6894	3115	8539	29116	26051	5062	57157	23347
GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_DN	M4450		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1643_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of memory IgG IgA B cells versus plasma cells from bone marrow and blood.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					28992	55062	55020	25864	7161	26286	51032	23223	11049	26580	3543	199	9423	80199	28902	25794	27293	80307	11015	27237	140465	6300	3004	23705	100293440	2517	7106	23484	8837	11153	1201	3782	78992	55080	57162	2621	664	2812	4043	28955	1102	4597	23155	64778	64215	2535	64764	51150	58477	25797	64787	56901	644	22913	10802	79703	9693	10608	5141	57144	1847	857	10548	7923	64110	8260	1675	6236	9741	146542	3643	400	5831	79600	84033	54499	6009	28785	2797	10342	5872	200316	79991	1028	4796	25854	51816	5373	268	79586	4357	6782	4000	28984	7108	54361	10113	55830	6238	30844	861	79777	727897	11314	6676	27120	8568	5066	10150	7869	100289053	9021	5660	11152	2251	81888	9022	3455	79001	64218	10221	4758	25847	4192	192683	475	3479	4326	3933	55507	9643	29071	26608	100290557	65263	50512	54502	10950	3761	56941	56681	2131	8566	22820	6520	28912	3913	1471	9468	4189	23588	8818	175	55741	90411	345	81618	440792	5163	1382	1316	23475	4925	10489	3958	177	2637	27287	3203	100289410	10591	90410	10900	1777	5611	51094	4792	96610	27090	5547	81533	51024	684	203069	1521	571	5443	929	6382	55294	59335	29937	6509	26251	54923	5861	7076	10945	29100	83743
GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP	M4451		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1644_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of memory IgM B cells versus blood plasma cells.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					11142	51435	26005	80162	78989	79066	6154	55247	6161	7994	6439	6000	54014	50613	92973	23062	1544	26228	92335	883	914	8019	2317	4111	23521	6579	4853	51365	7188	5569	26253	5204	3112	1606	57335	22838	3444	3394	79659	5293	23492	399665	9050	79812	6228	5079	1277	7490	138050	8742	54827	2330	339290	84726	9139	29035	57047	10446	7753	8864	9214	6932	4948	23220	9720	25802	26333	6155	3431	283537	11060	9450	9497	1435	7805	79596	26154	55024	694	6693	79908	79673	7681	9896	8671	11346	26152	10129	7571	56882	79650	238	5923	6206	5742	202	57188	8609	342096	6696	3635	5993	113146	154881	3730	54103	63901	11135	441151	10521	5270	7003	351	9710	54454	9073	1366	10732	10586	23338	56172	3732	6652	677	23208	126231	64793	1380	23052	3803	2192	55084	25891	972	759	79847	55086	25801	54363	1179	4590	58483	10734	4772	10188	155066	23543	9143	6135	10090	6139	10472	3953	79663	7402	6156	10895	417	57804	5339	55756	55680	10103	54463	9630	10824	3115	1551	29799	1633	1130	6170	7020	55063	55205	7852	10982	25850	4600	26059	6900	2444	1269	8564	7067	3109	26278	8648	10451	8434	3087	63971	3621	8123	5638	6224	220	57663	55740	10520
GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN	M4454		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1644_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of memory IgM B cells versus blood plasma cells.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					1486	25864	2530	8050	55322	8607	8872	51016	10059	410	22862	9236	5954	7485	3104	578	23190	54707	10072	51816	6001	51056	6787	28973	3738	56889	1052	7371	3052	1642	64764	9040	7466	2058	5440	60561	7077	5917	9086	1647	6929	55830	513	55204	81570	7922	23457	2799	25874	23433	1209	2956	5717	65244	64960	5096	23262	28958	440193	53838	100	8891	10055	25844	808	1075	3430	29959	2182	10424	25898	79365	56947	3066	55858	6240	7965	23484	64755	55109	3145	6629	11152	4277	55718	1020	54923	23042	51098	5832	25998	9197	56061	25828	81030	79796	2590	80349	51075	833	375056	3006	7150	51363	6004	64778	3572	80196	5547	78992	9997	93974	9777	2673	51693	25915	80305	26271	80762	8260	7263	9391	8676	3839	7358	10302	51569	22948	2935	64781	54149	3386	23216	9141	8520	79703	25932	10169	6238	10121	55080	51015	1070	9761	10955	55325	6734	79568	29844	8031	6446	10980	10635	3628	64746	6747	10608	1666	23518	6746	8733	51103	57099	291	65985	9368	5704	60489	10026	55052	6834	55500	55706	79657	1457	10440	10905	7064	29925	10195	23197	7337	9950	23644	10920	60496	10963	23047	7531	7415	6760	5608	23705	64216	11034	175	81533	8343	27090	10802
GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP	M4456		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1645_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of memory IgM B cells versus plasma cells from bone marrow and blood.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					29761	178	7994	23338	6155	3109	23526	974	11198	10885	54778	6430	6778	6139	27430	5293	3551	972	11167	5910	6235	11142	274	4853	5757	10129	5934	6135	11215	80183	11151	5079	55888	23062	51567	5569	25936	79618	25816	1901	25801	9349	23258	8942	5966	6170	26278	92335	9450	54482	55843	1032	4678	1606	10714	847	29887	79037	9994	138046	10472	2550	971	1130	10347	6201	8303	55278	56172	7363	23001	6856	10235	83478	6653	81926	9750	6147	55086	526	22823	5993	7072	6118	26469	3635	654434	11276	126231	55269	5796	63901	10732	10308	5481	64427	9050	55344	22948	23046	9847	55629	3108	5325	112398	260294	60481	22806	4659	1380	8527	10982	4983	60468	324	5579	9217	3326	9187	11073	5983	4046	23344	10181	54103	989	2098	26051	5567	3921	54629	6187	1435	1915	4976	4126	63971	8428	23515	23029	202	9909	6494	351	6136	81537	6418	55016	6154	397	54874	29957	51143	5383	3621	4948	8019	51362	55212	4801	3394	50618	10346	9710	6234	348995	1633	1072	23126	388677	8848	120	5612	10178	8875	26052	84726	26148	8671	28951	6224	259197	911	60488	205564	7048	3431	9946	51306	8508	10475	8175	6160	79782	7570	11177	51092	23052	55706	10219
GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_DN	M4457		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1645_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of memory IgM B cells versus plasma cells from bone marrow and blood.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					5539	5260	23412	5624	9693	51614	727897	2530	79703	25932	79575	11316	2131	28992	37	8837	58477	11034	51660	64764	78992	79001	25864	4245	2621	28831	54499	11033	270	5207	4597	857	3418	283	51635	6834	11153	9423	26286	9524	22983	9454	1382	1102	27237	64215	7389	5861	23223	100293440	56901	10802	25797	10327	3543	8566	4758	6746	6238	80199	51816	80307	51275	100289410	55080	22936	60559	10237	81555	30844	84033	27090	10276	6675	9777	124565	10980	23457	9375	23155	26580	11015	23378	5373	27180	2812	29937	56851	763	27296	7923	928	1523	9643	50999	7009	10548	6734	8277	64852	51573	54741	79935	27293	3074	2286	7922	10905	1603	79930	55062	114049	91949	90480	64778	79876	26007	3643	1298	84981	8140	684	1020	50512	11194	10483	51123	146542	5831	29926	23484	8703	7171	51599	6676	5066	79720	9367	10169	6300	28912	2517	54923	51604	54732	51032	1675	4795	5192	6748	7293	10330	11070	10370	5547	2784	6123	25844	6723	175	192683	410	2923	10240	51706	54209	401	9601	7077	1521	29925	6009	6236	7205	7905	2797	10245	1847	199	54480	9283	28785	3315	23600	10897	4000	7349	64374	51056	2760	4861	22913	4357	6520	4713	11314	3297	2184	3455	203
GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_UP	M4458		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1646_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of monocytes cultured for 0 days versus those cultured for 1 day.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					6191	10365	473	26034	9324	7433	6777	6159	10396	9046	23225	23287	3635	6799	3385	945	56994	6304	1052	30	84864	11329	8522	29125	51734	6817	10903	388	432	5293	59342	55603	51284	120	4815	6398	3101	9764	1432	51439	3676	23108	54504	4900	2353	10559	83716	22838	6144	23240	9674	54518	56996	695	8743	10581	3613	1471	28969	64174	199	953	1854	7538	5330	678	4048	138151	863	10641	972	59307	3636	51816	6604	1524	6202	6653	8635	5236	217	9450	948	10235	56997	7318	2533	81622	10023	9931	2210	4033	79887	80774	113	78991	168544	55313	23228	2162	25939	4832	6154	6156	6480	8677	79668	23324	6181	55016	6402	10961	373156	4615	5993	5836	912	1675	54930	10875	3384	4065	2219	831	23521	51317	2153	54704	10320	6275	9780	6155	2634	5859	6187	6036	951	4154	4332	5175	10144	55893	3490	2242	64077	9936	6193	26112	23077	3148	23353	51092	210	433	51411	8462	8543	9398	51744	79789	57161	29803	4601	5934	5997	7100	64231	4258	6124	2091	25840	55625	22861	7414	64222	847	55303	11240	91754	2517	7045	10695	9938	6235	6222	53829	5018	6165	978	23401	84722	8897	4005	545	729230	4208	10472	55656	22921	1441
GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_DN	M4459		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1646_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of monocytes cultured for 0 days versus those cultured for 1 day.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					475	23433	4643	56895	54145	55048	9352	9765	123	28231	7709	51400	80185	23180	29922	10488	967	5055	10105	1026	7158	5700	7295	5898	8140	154881	1545	54509	9446	5872	23601	4814	5693	4000	16	4502	10134	7378	1514	8870	1601	7941	29015	8740	6520	8900	79837	8848	64219	2920	11343	5687	6482	5704	1846	7130	54881	7107	3553	6648	7133	79572	718	51606	7357	1236	51399	4318	9034	4097	2495	64121	57823	23657	7873	221749	2921	23480	2919	55207	1687	3557	51382	5141	4501	9732	3995	4286	214	5597	4794	51022	2055	2237	7296	4520	6515	5717	2769	80149	84617	2114	2509	85377	5743	7185	5209	6888	10318	483	286451	203068	9467	1515	3097	26472	10148	3783	85236	4864	4363	9322	64109	51232	8942	23179	3575	29100	10213	23764	861	56675	5292	3563	1508	7293	6385	6696	2760	3624	29095	2012	7421	6769	10409	8877	1728	55353	9817	6347	79230	4496	5690	6351	23141	6455	11040	1839	10497	2617	6367	7283	1203	22882	27074	79155	5962	9589	6810	221692	4360	55361	330	5266	51703	3569	10135	9214	5473	1476	6775	7474	27299	23271	5603	6690	10421	205	4327	10308	29925	2814	2879	400	23099	10912	11153	586	65124	10383
GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_UP	M4460		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1647_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of monocytes cultured for 0 days versus those cultured for 7 days.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					23387	57035	9647	1105	3603	6283	388677	200315	6402	23526	2015	1052	65220	3551	5997	79888	90864	6257	22861	23108	7133	1130	80833	56905	57599	10482	9812	29125	3570	84162	9314	654817	4170	27071	3665	55082	2131	943	5199	9750	56940	3385	51185	9802	4600	25949	57396	5788	64218	728855	5355	4739	9094	4542	10365	8743	2872	10346	8875	7454	26034	10507	23030	1441	22918	3587	4778	9592	3148	11033	1195	912	3676	114548	9877	64127	57162	11064	4067	55196	23218	4853	8897	1524	1848	9039	10180	10181	11119	10903	10781	23092	29115	3632	25957	10724	4616	1843	83716	51170	7538	8698	5293	27250	6280	23360	4848	834	23112	54504	200424	26037	11024	54820	9368	54997	1120	1475	10023	10924	3720	11213	51744	22898	1032	6430	23013	3431	114034	155060	2123	84124	55320	9958	433	901	63940	11026	51316	1488	51317	6604	10472	10762	54704	10384	51621	1820	2643	9788	27141	23064	2153	3726	80774	23287	3621	863	55056	60436	271	9931	4297	80342	1831	80279	54556	5699	10581	2145	59307	58526	393	80853	9567	51585	2212	8227	51673	9852	3384	6793	2533	57161	1316	1675	79048	10636	9674	8408	6653	3310	254102	5586	2197	51379	79670	7462	3600	6304
GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_DN	M4461		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1647_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of monocytes cultured for 0 days versus those cultured for 7 days.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					140465	4259	8624	39	2034	55667	10493	3315	79017	26355	2203	25780	54	5106	1508	56954	55752	55759	10549	348	4199	6810	537	81501	1296	10062	4190	5214	23463	2878	6769	51393	51022	56942	7283	56180	23231	1718	79135	2171	51103	1163	2271	3376	1737	4702	9569	5917	56833	55283	128	1465	3163	23531	2022	1528	10497	54872	7205	7037	6697	113251	60370	5824	6678	3074	1317	64759	55240	760	9061	51154	48	22928	4712	55652	2181	81790	1593	7423	63933	10591	55856	1622	2934	26503	1291	123803	286148	1893	476	10327	55177	55500	23603	79876	211	5037	10134	2184	221749	2539	5480	56253	23043	38	2359	3241	55315	26472	3326	84193	2760	10449	10430	1509	2805	9361	23259	1116	10651	5693	28966	7384	30851	27090	23788	2110	25874	5603	64219	8270	2764	79109	4830	5468	4719	10457	224	8985	6307	975	64976	27089	518	51382	10682	4201	311	10440	5092	2023	1213	4694	388650	3336	4000	10169	302	4286	1019	55361	53	5411	10099	5201	4709	10195	9524	10939	10067	51693	3032	7077	54914	25932	7866	411	2	4285	5664	55281	51021	26519	27351	29780	125058	4358	5160	223	57103	528	29937	55033	3329	3916	23167	5052	56941	56005
GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_UP	M4462		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1648_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of monocytes cultured for 1 day versus those cultured for 7 days.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					64109	3563	2309	388677	9852	3669	9802	4520	11040	84658	11214	222161	51312	4814	10105	399	10318	3603	80149	51703	5142	22882	91543	2114	4067	5271	2145	23645	9267	56905	2769	56940	55353	51733	7185	8837	10409	6648	6775	11009	54856	7128	25948	10979	861	2355	10148	6482	25841	5209	8638	3559	5692	8870	3097	10620	1236	11182	6352	3569	23352	9371	4233	79931	22918	1846	80765	9194	5739	57035	6504	3624	4683	9969	10181	391	290	5366	9877	4312	54971	3604	3269	93643	23130	4792	8767	4820	54957	9470	23480	23387	56300	1839	4824	10938	80833	3383	100132406	3632	1263	10781	51765	3665	114548	2908	23099	5266	3720	3937	9788	5743	8710	10435	9662	6046	57228	7474	84981	54820	490	3593	54556	7158	57396	4170	3133	3570	5700	55802	51526	10043	25816	10046	5199	4899	10135	5863	11142	1820	27074	23526	9235	10482	9583	6364	6283	203069	9903	79155	9736	11213	3601	11152	1316	55521	7378	10125	9094	4082	8843	3985	23327	30836	55350	57826	2014	8091	79670	3142	6714	5272	7293	6455	22938	54882	5806	79888	4616	51316	9794	3586	4216	2643	9704	780	5971	84859	55291	29065	6346	4494	54813	3552	1577	7980	9034	51561	7030	58513
GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_DN	M4463		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1648_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of monocytes cultured for 1 day versus those cultured for 7 days.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					286148	5096	3417	1020	7267	5106	348	54	3315	55006	80349	55759	26355	2034	79017	5911	54930	7388	23107	55652	4358	38	10026	292	55752	39	9588	4354	5538	402	2990	1718	4121	5037	2821	6342	81533	8673	27131	3613	1050	3032	3945	10111	4702	2878	57037	283537	60488	517	3418	191	327	5264	5824	10493	3682	7077	55347	4190	1737	1312	34	1163	4522	56935	328	217	7385	51596	9324	5184	114876	4722	23646	388650	55667	4259	5480	55852	498	23313	192286	6576	6584	2778	6769	9637	64960	5591	55726	6120	3074	2203	9131	55283	8801	29960	53346	5910	79184	9377	10961	55856	3965	51218	29081	23231	6251	155066	100272147	51063	1892	5860	51660	6678	23344	64222	79622	506	1349	64981	79161	23531	4258	4830	51020	11057	1296	7037	23423	9317	2971	1978	5478	4200	10632	4199	3108	51650	5634	51081	23530	56994	55704	55177	5510	6175	1891	8776	11331	2806	27244	114883	3163	10682	839	56180	7414	27089	28966	10549	30	518	7423	28973	51321	178	9784	27242	11062	10062	51367	9540	55315	23625	23065	7905	2222	57406	4580	79590	6596	79109	79053	26580	8099	9054	7045	8030	6050	8802	65084	128	25780	51019	9779	7048	4711	1291
GSE22886_NEUTROPHIL_VS_DC_UP	M4464		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1649_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of neutrophils versus dendritic cells (DC).	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					54550	57147	2494	2267	1608	4899	26468	9353	4356	160313	79037	8638	3621	6096	2897	1269	55203	10690	2324	7454	820	28755	9436	283638	416	22996	100294391	55113	634	57538	54551	25801	2100	4114	2334	6570	8778	9750	9609	8794	2919	672	51191	9699	4210	100129250	5743	65258	3886	11119	29986	24141	80760	101	64129	80183	2649	5450	54210	6402	1831	5165	2302	1843	91227	55350	3006	29899	54514	10840	332	60490	8519	9262	6017	84525	3741	5999	51560	222487	11040	55784	23336	3824	51533	8743	53630	23410	100129410	50834	26253	57419	1052	26056	5423	4050	6523	6283	3906	2047	27202	5121	26013	7404	84658	2215	79818	2115	91543	150094	57535	9142	23105	8858	79849	6340	8438	8021	51725	64180	63035	3577	50624	10794	25805	3985	1912	79966	400410	200315	10164	3169	79845	2219	6286	55086	11076	1080	10211	8365	79957	6658	10409	27181	54959	55199	685	3669	11075	7857	10581	3772	8092	10365	3882	11251	23462	80258	8715	89944	5551	27122	5098	4146	7286	11314	2822	8749	50862	1441	11113	95681	27087	11172	6935	10595	79865	6569	1671	3699	10842	3815	8875	55753	4507	9620	65012	5142	9892	55227	55793	187	59353	3581	259197	51208	26692	2357	728855	1428
GSE22886_NEUTROPHIL_VS_DC_DN	M4465		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1649_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of neutrophils versus dendritic cells (DC).	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					10797	7415	23428	6428	6432	6117	2744	9612	27101	1892	518	6434	2806	6239	4710	10099	144699	2631	4904	26469	22883	10479	1537	10128	57050	6421	7050	6643	6050	1495	5096	8815	4836	6856	8682	51466	10370	25814	10476	4706	5931	1200	4074	5901	51318	29969	2934	9604	10694	7074	7107	821	10430	8065	308	51096	5707	8892	55619	114049	9255	55608	92856	9131	1050	6634	26057	2098	4125	23517	1601	9324	81853	10775	91752	5684	1845	2729	81556	10897	7417	51406	79023	91966	29088	5898	10575	10059	7494	51374	3108	23191	8801	975	2958	30844	56984	57103	7979	10490	23596	25793	6605	57003	60488	51393	79718	4729	5214	7389	57130	506	7284	23019	6646	51081	2878	9578	6448	7419	1207	2876	5604	8802	26515	64976	23313	11124	10605	10935	79161	3052	22	55699	5711	9296	55858	55153	5037	51506	3313	8454	79697	4076	4735	4719	498	64981	56672	55156	79139	84890	404672	23471	23788	54927	51637	6748	1981	4259	79038	6612	4714	8050	10111	4286	10213	2950	4128	9690	23014	3895	5201	22872	23151	7336	5052	9978	51075	2208	10988	7388	26060	2739	865	7756	55144	7295	29889	1457	5701	23412	3122	824	2547	3336	64960	10963	4358	481
GSE22886_NEUTROPHIL_VS_MONOCYTE_UP	M4466		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1650_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of neuthrophils versus monocytes.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					2267	1358	100129250	6523	4507	57535	54551	55753	10218	1178	8794	22996	400410	5450	3577	125893	63928	29986	3673	222487	9699	55567	5540	64180	54550	80760	9469	3169	4311	3886	85476	5551	253190	2494	57419	26468	7286	80183	306	4983	55227	5121	3347	80258	4105	6590	8434	1556	10022	6571	1010	2047	7425	26692	3977	79616	55784	8688	53405	1136	762	1671	5837	6017	56288	9892	81854	22847	24141	100129410	51179	148753	2867	4210	51083	699	79966	3772	58495	8092	3006	440738	56344	869	914	25825	3568	2305	54865	1232	56902	8749	5999	3938	1401	8858	2017	79865	84179	3579	3811	259	56163	3316	25984	79818	4050	3805	80868	4133	64067	7082	1610	6947	51533	9104	2115	5352	4117	1446	11113	23263	8357	9142	11043	1084	84243	1285	54581	78998	1912	8995	4254	54879	3762	81491	9100	4102	9287	10896	10021	796	57502	10803	11251	59344	4051	7412	5795	55287	54858	1869	26056	3581	5675	29842	54514	80144	359	54682	3739	5587	3560	8715	55722	26292	4146	51435	2743	282997	27181	229	53630	866	54821	51438	51310	10395	312	2898	79768	2822	634	8748	128872	4897	84525	3824	57710	6278	6658	8431	51619	1183	53905	91646	54967	4651	55203	54855
GSE22886_NEUTROPHIL_VS_MONOCYTE_DN	M4467		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1650_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of neutrophils versusl monocytes.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					10480	1537	57050	10694	6050	92856	1200	6432	79675	51386	518	2876	64764	91966	3895	6421	3420	6748	4719	4706	11000	1967	9056	51123	8443	6434	6233	29889	1973	5771	3587	4733	51506	6428	9255	4904	7388	6133	4836	3122	10212	23137	5935	22872	11213	51693	2098	2058	1508	60488	1845	23636	8664	3276	960	64759	51637	5859	302	128	304	7071	3735	4724	5160	23412	821	51081	55666	9168	9935	115207	2023	6135	54537	10327	11171	9652	8065	3956	3181	539	3295	51108	5682	2203	5441	51172	8682	5876	9716	8815	55011	55013	11222	9349	4673	23596	3073	6230	11315	9913	10492	22883	100129361	2799	79026	824	54453	1462	7417	54103	11231	9194	10440	51096	8661	1653	2990	4144	6636	5705	1512	3964	7389	10989	5250	25821	6281	10430	2950	1806	26517	6154	80155	1536	550	4726	9377	55717	2631	6229	8204	64848	1786	4682	4704	506	10059	3184	3326	7351	4528	1981	4259	6167	7203	23082	8985	3394	6232	253782	23597	10575	6448	10399	4841	23358	9804	80273	4677	5901	3113	51493	78988	7384	3958	29969	55739	11137	4697	6201	23042	7514	10856	6224	6612	1665	5709	144699	2131	9314	5965	8565	6207	6634	23654	79902	7267	55144
GSE22886_DC_VS_MONOCYTE_UP	M4471		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1651_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) versus monocytes.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					11309	79135	6285	4128	10267	23076	9455	11130	1718	51477	25780	8727	224	2	2878	5742	4199	55652	1636	2034	163486	11320	51393	5664	8569	8412	7693	3315	56833	481	3290	9902	2805	1786	388650	2170	910	64943	23397	5092	55752	140	2171	9462	10653	4094	90141	5445	79778	30835	2542	6383	56954	10398	23475	10591	898	6692	6769	4000	51466	4175	16	27244	54	713	5214	56672	221749	2359	126321	55640	5037	6361	4285	26355	29760	57406	2037	712	7205	27068	6709	5328	29	55244	11200	10939	60370	22920	2621	6535	913	3163	51022	311	57157	10682	30851	8682	1793	54877	4190	2934	55856	1893	64398	10994	2208	6566	79038	3150	5424	51495	7915	26503	85453	113251	79630	9760	23075	2167	95	675	9837	3399	109	29980	1119	182	11332	5480	4643	63933	1508	11000	51172	90956	9131	57045	874	154881	30844	1075	1291	5909	81035	8437	22845	79154	79077	10651	91752	27101	8832	9456	57136	5108	2058	10276	23417	747	4694	6251	29937	10362	10169	56910	3308	11080	22928	55201	909	6367	4026	10947	5032	1601	9868	811	51728	5411	55361	2948	50	5096	11259	9361	9023	1795	23710	7374	975	10782	7145	22954	81790	6357	4729	57103
GSE22886_DC_VS_MONOCYTE_DN	M4472		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1651_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) versus monocytes.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					51363	11213	929	1105	9194	64127	1604	1843	834	51108	5355	7462	10602	1462	7133	22918	11214	1052	11025	10507	10443	101	3683	2353	694	8660	654817	5265	5366	9592	962	6283	9314	5699	1387	8073	6793	6402	3134	2219	6672	10288	2643	23387	2357	1488	54556	10365	79651	10762	5873	9960	3384	6934	1441	1524	8875	1936	3659	3621	200315	728855	54997	3665	8743	9788	84162	2534	11152	2197	23593	2015	56905	3676	1130	10903	65220	4853	6556	11026	4739	9750	5997	8905	11024	3600	23108	10154	11027	5359	6233	11314	7097	6280	63940	1831	912	5199	23077	25801	1848	388677	11119	2634	2131	4968	4170	57162	10855	51379	23400	2004	4778	23506	1675	8897	54704	7100	11329	79792	1955	23390	51621	23761	23137	8021	6201	2153	80833	5606	22861	10211	10695	79890	976	10384	6194	951	1032	10142	4616	11151	9973	29997	7307	9368	9051	9473	23092	3480	27141	23240	57476	10472	10004	8778	6156	10480	5771	26505	7538	3632	10924	4542	5029	10859	5293	55022	63877	10691	11064	51170	671	3431	9056	83955	29902	55850	10581	23218	9045	51744	60436	3772	9252	4067	56913	23287	10970	55893	1475	3570	5368	55013	440193	10645	1316	55056	83716	53335
GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_UP	M4473		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1652_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus unstimulated neutrophils.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					6432	64112	8445	11161	10212	6117	5955	518	4904	25939	92856	3420	9324	6421	9879	29117	5901	6230	10982	79718	11331	171023	51316	10480	975	7050	9255	23338	5567	60488	51374	1606	10694	26136	11137	23014	114049	7737	6428	51506	9318	498	6434	3843	5037	25793	51172	6636	10476	5583	29969	5705	51637	10128	51123	26528	11260	6626	5682	8664	55268	55619	2971	51614	4706	6748	2926	593	10575	2098	55182	7184	6050	79161	6135	1039	26156	7267	1353	4172	10946	9913	6431	5695	4729	644068	81558	80273	11231	1653	50650	6304	1892	51386	90	7417	440270	55699	128	5631	10055	51406	57050	6605	51497	7756	11266	4282	25777	9131	5781	2073	5931	3150	10123	6154	539	740	65110	51466	8815	4836	9258	81539	80342	23270	54902	3065	79697	64210	6612	25814	4722	91754	6917	51218	23517	231	27102	79902	9931	11171	54977	9806	6448	8801	292	924	79686	54847	1967	2071	23560	10605	56984	10892	51520	3276	513	84364	8899	552889	57215	10430	1236	23234	2739	4670	51082	55037	51759	2923	9184	55144	1043	6301	3964	894	8833	5859	4691	2534	7284	6427	3735	51031	29080	23225	2821	8409	4673	5295	23070	5160	6165	38	1854	10576	26190	64848
GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_DN	M4474		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1652_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus unstimulated neutrophils.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					3553	80183	8365	253190	2919	63928	3759	29075	10092	80896	6648	24141	7286	6583	5743	26253	222487	55332	55350	64411	23657	1912	10512	5999	10610	55313	57399	22996	4210	8794	3985	6283	6809	51050	29986	23109	64180	7739	25797	3577	5899	10170	83464	23643	1608	3169	54210	148753	158471	50862	8778	79865	9586	8021	80129	9516	51167	366	8031	133	2047	25801	59353	84658	7145	2977	50856	10186	81491	1620	25805	2494	3437	5029	79887	7454	3034	1183	9100	53829	1486	2150	6888	51733	23097	4593	5540	9142	8875	10333	23452	79818	79623	10261	65258	3434	160313	414771	796	604	2710	400410	2204	26292	3772	5742	7039	6870	79746	4311	5165	2713	1441	26468	201895	6788	634	22898	9177	51083	200315	64240	4660	683	80760	1956	9892	7942	51734	9104	55113	54863	125893	10218	4778	6286	64757	51099	4117	3006	55788	1955	3579	10164	10254	3614	4332	2247	23328	526	7099	9019	3284	6386	6590	9771	4507	23462	8444	11037	7127	597	27202	8843	11337	81857	10661	54961	3890	54514	6368	60490	51311	2790	91851	3460	8334	2212	3459	6355	3775	79047	51299	312	1261	3613	6652	30837	10650	6096	3732	5587	9625	5218	173	8909	4055	22899	55711	81501
GSE22886_NAIVE_TCELL_VS_DC_UP	M4475		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1653_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus unstimulated dendritic cells (DC).	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					6144	23506	54847	3431	6128	55709	6932	29116	10921	29896	6777	6125	1236	11329	80135	596	1933	6143	6304	22861	6936	1975	4297	6158	54861	55268	1396	8440	3137	8409	5204	5790	6204	54923	5588	6165	653784	9349	6146	27250	4899	6156	29121	9194	1353	3384	3676	26751	11224	1803	55843	23228	6218	51710	2625	79034	54851	5832	5252	916	5922	3097	3983	5955	923	6235	6130	8665	79726	10982	9750	11119	29997	8317	22882	2197	54463	22821	54977	6402	274	55695	29990	6159	1936	6230	230	23077	6208	55658	2592	6209	26505	1937	7644	6935	3695	23338	51411	3134	6201	6169	10365	6139	7311	2026	11083	23270	5583	738	22887	9214	23492	3669	3631	6181	26034	2995	23348	22850	23521	6210	23240	10443	2841	23347	50853	399	64919	915	140801	90864	26065	6164	5533	28639	1606	6222	8481	26999	6228	25873	57215	3178	694	8725	25865	4666	6672	93144	10125	9159	65057	57048	80097	6154	9045	4753	5920	917	120	28755	644068	54956	8519	1831	9667	63940	6135	951	80342	6122	112869	6232	9235	5934	2004	27335	3621	6188	79913	6160	3710	994	57326	26136	23036	171023	80264	987	9744	8631	23014	8527	51176	113791	10507	728855	919	10225
GSE22886_NAIVE_TCELL_VS_DC_DN	M4476		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1653_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus unstimulated dendritic cells (DC).	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					7263	4125	2729	9144	11337	29940	50	91752	4258	79038	51167	11309	4358	9120	23428	23503	2208	6821	64747	23385	54442	3920	5052	4689	23161	9455	5879	7296	9741	6050	1718	5742	57406	5693	4779	6868	4758	2717	10797	7431	9927	6768	8546	5664	23603	57003	138050	22846	10254	4780	10226	55041	10295	23186	1318	9296	6533	25797	533	51022	948	81533	6692	10267	1020	10092	5707	4128	6769	9637	5550	57103	8682	23001	6383	55686	55640	55652	1351	1476	55704	3308	7150	55361	30844	5514	4076	5226	7107	5538	23232	157	55016	113251	8867	9375	9555	4286	3109	10105	8412	217	54502	8560	8544	1495	6888	28956	140885	9732	1595	79895	54209	6016	4729	1796	51324	2512	6386	7879	8829	55201	1728	5328	7416	23166	51232	1522	529	481	4668	8724	10308	4190	10981	953	54849	7167	6788	51816	2242	8790	56935	9341	1876	10533	5872	25801	1612	8536	1497	3459	6039	2034	115207	23313	1050	57178	5791	2548	2720	10184	10342	290	1102	23151	2162	50807	7941	6642	8013	4074	79887	8564	4900	1601	2876	5509	8942	29967	7171	55803	6120	10261	8878	64419	3281	3759	3988	7739	5092	712	3108	8804	6850	23136	56833	11000	645	23643
GSE22886_NAIVE_TCELL_VS_MONOCYTE_UP	M4478		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1654_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus monocytes cultured for 0 days.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					23348	5790	8821	7294	58473	54923	28951	923	27244	54847	4753	914	22859	596	924	9500	3710	9737	53347	440270	3983	9781	23259	23177	22850	64919	11320	26018	2026	3163	5335	3655	25864	4063	9235	23175	92822	23234	2841	10225	23224	55423	4118	64754	987	10771	27250	64400	26751	57711	51176	4925	4306	27018	51070	919	916	5019	4054	6955	23270	23043	917	60468	7535	171023	55268	8440	399665	7597	1606	2323	3337	23178	23338	3702	230	65982	969	994	64112	7029	84747	81606	5578	55653	26119	5588	6609	5922	5590	9214	28755	79961	915	489	3932	6936	939	79652	81539	29990	54977	7188	1353	664	9532	8631	23046	3275	9949	6633	868	1901	9806	894	57326	23164	4300	3150	4050	29116	11161	3652	5569	1803	60487	2995	50615	79037	5583	81890	55709	51611	3978	28978	23195	7163	54674	8464	113791	55198	57185	64219	9363	1195	4436	55556	100132341	79695	29121	1039	54463	55037	9882	9725	440515	8425	28639	55818	7525	246243	26355	940	2053	150967	921	4068	274	10985	54462	51466	23522	10198	155066	282997	55246	10962	29914	2882	11276	5387	9402	11230	56941	728855	3004	27252	26049	6095	2189	79829	7923	9049	28955	7374	57473	54680	6304	9797
GSE22886_NAIVE_TCELL_VS_MONOCYTE_DN	M4480		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1654_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus monocytes cultured for 0 days.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					3779	5742	23643	11213	4332	65220	51363	1612	23325	29916	25801	1475	3958	51108	5580	10154	64127	6280	5791	23312	4245	523	6386	6282	1318	9120	1488	51296	2212	64759	2203	929	64747	10970	8804	2799	1230	64218	7462	11025	25797	1512	1508	427	10981	834	6850	9341	7805	7077	1495	4055	7127	8795	6888	2876	654817	64419	115207	3459	1848	2268	4126	2896	54863	3303	2131	7321	27180	6283	4082	22918	10859	55577	23232	10327	27235	1462	2512	7097	9846	10261	54502	23307	56935	3460	7133	5359	2752	54453	533	8741	10019	10087	2180	5226	822	79887	3074	11027	8031	23603	1806	9114	64342	50856	8875	55763	23673	10437	116985	2357	754	2526	6556	1200	54504	11337	637	29992	6256	8301	1845	55160	55803	29887	8905	23654	10602	1439	55819	80896	81553	2745	8417	2597	334	945	64581	4853	23761	4758	1052	1536	6821	604	571	5724	5660	79772	10577	526	11000	1730	9056	9637	9958	10611	4946	140885	57178	5325	55911	4688	55357	23092	200315	1441	948	55640	10875	51099	1051	51734	7763	4689	58488	54849	5509	2720	599	54436	10533	79168	59342	23433	8682	25979	55701	23405	157	6252	114548	10903	55654	3101	58526	55704	6809	10295
GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_UP	M4481		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1655_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive B cells versus unstimulated neutrophils.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					6135	3113	3122	22800	4345	6154	81606	3115	6233	5026	9450	6232	6167	6205	6230	1043	60468	29760	53335	3119	26228	51466	51068	969	6133	28951	27075	6165	3123	4869	8115	9214	3507	9349	6925	7570	1380	6201	5450	55084	4306	3112	10212	55013	5631	23596	2550	7188	8165	51316	23195	3394	11180	7267	3514	971	6138	4216	54847	6218	9710	933	780	10946	26060	6171	6207	4953	6128	4691	4190	3326	9923	285830	55024	3109	23180	11142	6176	23035	79697	79686	80008	2841	10525	6480	84159	6217	3495	23270	6170	4595	8914	6194	6169	3178	11215	6158	972	9166	3128	6157	5287	142	6164	55344	54103	9557	3535	60488	54733	84809	930	51276	51386	9324	6193	10213	6144	1739	54455	10399	23518	54107	6224	6223	9711	11224	974	975	3708	10128	7337	10198	1736	93349	26040	293	605	6229	6155	23014	29802	7248	7430	1938	23259	5272	23157	6612	339044	5569	64427	9308	4673	10329	6689	9124	8050	80067	10892	3662	23549	6168	38	3725	4088	6130	23341	23412	7163	6432	29969	9284	9168	55544	6208	6156	25814	1974	6173	6209	973	9834	54881	2739	60487	79368	65110	6132	64784	4171	23334	440270	91754	6222	2098	57404	6134	8287
GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_DN	M4482		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1655_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive B cells versus unstimulated neutrophils.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					84981	11314	1912	6283	5743	355	7940	25797	6648	9100	80896	100129250	4580	10935	8794	55313	1475	54210	10135	820	53829	597	366	222487	728	4783	23643	3310	9936	64581	55819	11033	200315	55303	79887	976	25801	79180	602	8743	4835	8021	51571	7305	9123	7133	3437	29992	5899	1178	10866	55113	2509	10410	8843	7454	4688	65258	2219	79042	1955	54863	4778	23401	1441	5538	2215	199	8875	526	10261	10875	64411	3303	6286	9989	84658	1439	967	3614	3579	55969	26521	124044	55350	9334	5265	3613	9516	2212	7739	4332	3398	637	8519	10023	3577	6280	51734	133	10588	1486	116496	3576	404093	2123	57136	51192	6277	1052	10221	2357	10581	5552	683	3985	9111	6398	3920	4542	10313	4311	6590	84243	11031	7850	4709	6809	51100	23761	271	3142	11018	6282	6397	80301	64114	58472	10970	30	3434	101	23258	2537	10154	55281	2180	2207	7295	4815	65220	3705	3759	1075	9368	10092	306	5199	965	29982	8837	6279	9770	6888	2901	11027	7408	7867	5836	2867	81565	8698	2919	1318	837	9764	4814	51099	10507	50856	60490	2713	11025	55505	1212	3055	8870	55701	10211	1675	63035	4170	9846	51411	5341	6653	1889	5525	3006	30817
GSE22886_NAIVE_BCELL_VS_DC_UP	M4483		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1656_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive B cells versus unstimulated dendritic cells (DC).	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					6144	28968	79979	3667	11116	11009	54847	4171	6168	2591	57599	81571	6935	9860	80862	1183	4281	92017	79037	54897	3514	780	80067	51616	55205	115123	23305	23052	259197	6402	25865	55853	4345	9194	92342	1911	51312	23598	8115	55335	55206	54808	91300	53335	6232	10365	933	81606	6228	4899	26272	55784	54855	29997	22800	6205	25825	2330	54733	4050	79608	2550	5557	3112	26999	8395	54956	4088	7404	80008	4598	2941	10391	10451	952	6146	81848	54629	694	940	55296	951	5463	1380	56106	5450	23641	6157	9124	2938	5287	26230	26228	54455	8287	6210	56924	10420	9834	5026	3600	28823	10505	23089	2841	8631	987	81618	11040	959	1843	9679	1269	80144	7852	9215	7252	65998	6689	5616	9737	23035	2043	5379	64061	390616	54893	3669	55135	9231	7710	9750	23521	6691	9214	100506963	605	30845	5272	6490	4968	60436	54463	4232	6164	283212	84525	3451	23354	10151	27042	23334	374819	55086	11211	79966	5790	60468	23252	9727	2823	51276	100132341	4306	931	84705	100133941	6233	6201	387751	8317	51146	23676	394	6218	1831	9906	930	22866	6158	3111	11144	4208	55565	51611	6875	6161	1268	386627	283683	373863	352961	644450	971	6165	10499	3817	1670	9710	8323
GSE22886_NAIVE_BCELL_VS_DC_DN	M4484		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1656_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive B cells versus unstimulated dendritic cells (DC).	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					391	63931	29940	10483	1020	9637	23428	7415	8867	25797	6383	6642	27010	2207	7171	644	7867	57406	9342	3069	1642	637	51393	23474	9120	10797	10238	4125	3575	4128	5552	3418	7074	481	5707	6692	140885	51022	1050	23392	4900	65018	10226	7263	9732	64581	79038	23136	64397	2729	30844	29	55201	5911	5096	56672	4259	23076	1981	9673	29992	9150	51128	10342	6310	4358	6646	9375	4686	26057	9612	5700	10105	10111	948	22928	4758	529	51015	54209	9131	10370	10548	9107	29088	7132	10592	81533	10945	9204	7533	55704	56935	8682	79641	2548	23657	54499	3162	51155	7941	8775	3052	2878	9693	23129	55858	3613	55640	10308	1318	8741	64092	7107	2034	53346	10437	10059	57136	4835	50865	1495	5693	55915	6392	79887	23654	7416	23151	6016	965	7167	4258	8544	54502	9604	55048	116985	5917	54741	55041	23710	1523	10313	7296	10072	55379	4121	5226	1312	79180	57003	3956	22797	3303	7045	3614	2717	7071	64960	22846	57178	4236	2799	389	409	2217	116496	5912	9341	967	8525	8829	11033	2934	1806	7150	2744	5328	4286	57142	2509	10049	55700	11309	6239	9870	7940	6400	163486	95	1102	3920	3684	27068	29967	23503	8569	9520	4245
GSE22886_NAIVE_BCELL_VS_MONOCYTE_UP	M4485		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1657_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive B cells versus day 0 monocytes.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					22800	26228	60468	85453	25825	9834	971	53335	55084	28968	81606	27075	9124	2841	29064	28951	4306	100133941	55853	5450	7163	974	3514	6689	79368	5026	11116	8115	3983	1235	81539	933	969	7188	29802	23263	5796	5287	1832	29760	9737	5790	3112	80008	8914	605	79007	55296	6558	5074	50804	55024	3111	79608	4050	27042	81571	6328	930	84705	28823	5463	440270	8287	84525	8631	3566	3507	9841	973	4345	3495	959	55247	80144	28902	9500	10391	9187	51540	1183	8323	84679	440515	3535	80862	5569	91353	6875	26272	79829	23089	390616	29799	10505	10090	81848	22866	55888	7710	80183	9892	54733	65998	2938	7252	259197	80067	51276	10752	1380	50615	23255	8034	115123	987	65982	931	26230	23329	5244	9215	23231	91977	10947	9837	11211	3710	55335	79966	654434	23052	1268	54858	9214	5079	2252	79841	9618	23354	9231	26002	26053	283212	7029	780	80329	10223	4842	55722	10738	55339	79768	11262	1670	374819	22996	54768	79000	22837	55779	55784	55143	79710	23252	3444	25758	9710	78998	26005	54874	3451	57711	25780	2823	79019	644128	5540	57228	7852	400961	3670	2192	55636	55211	81025	100286895	23676	10301	11339	5368	59340	51237	284443	9469	1359	79819	3449	7292	2560
GSE22886_NAIVE_BCELL_VS_MONOCYTE_DN	M4486		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1657_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive B cells versus day 0 monocytes.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					1488	4542	5315	23636	5552	10970	3055	391	3956	5226	25797	2597	7867	6386	2512	6283	3958	1213	9935	1462	5660	1509	2207	4726	3587	11344	26521	11213	6934	1845	55819	6282	8834	25801	602	23352	54453	3303	6993	7133	834	4245	3570	79887	2509	7408	7384	439	2799	7097	7305	51108	5580	64127	4688	10437	55357	9341	302	6280	6400	10859	6256	11000	1508	57142	637	7132	11025	2131	22918	6050	1318	51363	9555	4069	1475	10327	6446	3074	5791	80896	115207	1439	10788	8804	3482	6840	1848	754	5829	7453	2992	728	6195	54502	2745	6279	7841	1051	23761	10288	3683	2876	204851	476	57178	7431	29	1200	8741	3398	7127	301	5265	3032	2123	4043	7077	253782	23643	11031	8301	304	64581	27243	908	9056	9123	55969	427	929	1806	7150	6281	51621	64422	3459	51022	822	6556	2212	51552	1981	10602	10313	55700	9645	409	9120	23597	2539	7167	55577	9637	11314	1211	6275	55003	10989	10507	64419	6310	11018	4758	6817	3684	11033	226	54952	10908	9473	23585	56005	6888	4332	4719	9556	23129	9342	1452	23654	8500	5538	5269	3241	51192	81603	79180	527	8795	6813	523	4853	3611	2896	7086	11027	7071	64218
GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_UP	M4488		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1658_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive CD8 T cells versus unstimulated neutrophils.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					26018	59347	23499	6432	23270	6421	7494	7294	7284	114049	1849	23157	51012	10198	80273	26060	864	9987	10311	10430	55608	399665	23177	8815	55182	10775	8801	9690	6612	10946	79961	51703	6117	399	2729	9924	8697	10067	64427	1677	23484	29087	26528	10490	9255	23358	55717	55601	7014	55268	10396	8565	55246	23193	3115	5775	81853	11262	4216	29080	57050	28984	29909	79568	6749	54900	25777	26137	2098	1939	23450	23318	9452	5955	8575	8703	54847	56985	57404	64112	1615	2026	26953	8899	27347	26190	10982	51406	4925	6230	57019	1653	26053	3692	23338	56941	7430	4247	51759	2058	9868	664	11017	975	1964	56271	3028	10525	10199	8802	30000	79718	3631	9324	4548	8209	7580	10897	7979	6897	5214	26051	914	23137	54765	6431	2746	51020	91966	23517	5578	9879	10538	80155	5116	5394	11137	90	9780	54664	57099	201562	54680	64116	5283	3001	4172	79443	9552	924	51466	10489	80342	29058	22850	916	6118	4063	969	6856	5532	5686	3587	6626	55272	1207	7337	54732	488	4706	4358	29121	64853	23014	10447	5682	59338	9131	8848	10449	4118	100129361	613	6636	9917	51082	10128	5551	56253	64219	55140	6001	5636	92856	9913	260294	3418	23082	9240	54981
GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_DN	M4489		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1658_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive CD8 T cells versus unstimulated neutrophils.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					253190	26468	23114	57399	3906	23643	4327	55332	7421	25805	23657	51050	8031	945	5742	1520	10863	2100	10092	25891	5999	29075	6303	56157	2752	320	56979	1317	312	3673	10135	7846	8365	79934	920	79746	5581	1080	128872	55203	7940	711	5552	4093	51299	63928	414771	23452	597	55969	7857	2790	10022	366	1608	6701	219654	2215	25859	9436	8875	5166	10409	26576	1052	1536	820	9173	23109	80760	10170	6888	23328	1776	10331	64180	30837	8909	6355	8444	2919	123872	4067	7739	3316	51298	3290	4133	6648	55647	59344	80144	25801	400410	5081	9516	6295	6386	6096	9152	2495	9355	29906	11107	3976	91851	672	3563	27202	4332	54210	24141	26292	9609	6280	6583	2509	3553	1550	6383	80129	8334	55786	11075	1439	3643	10690	3107	7039	64581	8021	55539	6283	5997	6286	7380	55819	79047	355	9123	55095	10794	1912	5265	11200	80111	6809	240	55350	222487	3310	23457	6360	5654	8743	90586	158471	10497	10875	10981	728	7043	219595	25797	148753	11085	1051	7305	2899	9034	8935	10333	79865	9019	22996	51167	2357	1475	83464	23580	5743	3759	80183	2180	80896	10164	10406	54863	57096	81854	7286	79623	65258	3913	7275	8794	5165	222663	4688	2047
GSE22886_NAIVE_CD8_TCELL_VS_DC_UP	M4490		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1659_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive CD8 T cells versus unstimulated dendritic cells (DC).	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					59347	8527	6165	58473	56985	2841	2639	23318	8317	23348	9402	9782	5142	399665	7294	6777	940	23484	29080	4968	9452	440193	5557	54923	987	23240	2113	1843	9194	387751	653784	80135	6936	10320	225	104	4297	83955	6230	5790	6209	230	900	4306	55135	60436	818	1831	57711	55601	9267	3710	29121	3431	728855	23224	2592	51320	8875	9881	5383	29909	10567	23270	57820	8440	55246	5588	5890	386627	26574	29116	54861	23506	26999	6128	2254	2814	921	54463	5551	1939	3560	8667	79037	5305	4300	4818	10396	8409	6158	10916	5590	11118	80097	9737	5775	4899	23178	84525	916	282997	53347	6633	3384	5710	8821	11040	22887	51599	2995	1524	924	55615	11224	64919	11126	29851	11329	7430	738	3631	60468	6156	4050	3661	3337	9235	9254	3646	26034	7318	80264	4054	23338	154	64376	1736	9159	9262	3184	445347	55658	5272	116987	5277	7535	6203	3590	54847	65998	8665	6844	79183	9045	994	57326	6019	58190	7597	79034	2323	22800	11100	51070	57185	6932	8241	3097	923	3134	1859	150759	10938	394	25873	64400	65057	11119	3001	83988	6143	7311	10962	1938	914	1823	60489	9882	64112	10219	10982	7525	596	29107	3178	51611	100132341	1975	140801
GSE22886_NAIVE_CD8_TCELL_VS_DC_DN	M4492		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1659_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive CD8 T cells versus unstimulated dendritic cells (DC).	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					4074	27020	2171	1512	30851	23643	302	6520	7416	5879	2207	9555	304	10159	3308	6282	23232	23186	50	55207	7295	2108	8673	830	6016	1495	9637	9120	972	54968	10548	91647	1211	10376	11275	5538	23385	7074	5223	11337	51660	23428	3281	57178	10342	4076	1173	5693	1457	8649	6510	80223	4332	2752	10169	4125	54863	51573	51022	6522	637	22845	3417	6821	2787	3087	23161	79038	3117	4258	3052	2495	2885	93129	1612	4190	57003	171546	1601	3108	6744	1175	1806	3123	25801	8804	6050	9693	54442	5663	3156	9308	51155	965	8724	55819	1230	1471	4005	7940	2876	1050	64581	2509	57645	5351	57406	55884	5872	8992	1102	10238	6239	5336	6256	6646	6769	1595	953	56935	6850	5742	1508	23122	1738	3920	84790	847	9455	23191	481	10409	533	5226	11031	526	2512	10797	10437	78996	2790	51056	308	5092	3614	79887	8790	9741	54862	55361	55640	3109	6643	523	51714	1845	10908	9826	23111	7107	10295	27072	967	2934	6039	1959	84617	29940	9144	2208	9296	51324	27131	53346	27095	23001	4891	91752	23603	9341	4794	6642	4729	54436	8546	5664	1520	64747	4055	4668	7045	3064	1728	7150	23313	51232	1318	10226	7431	529
GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_UP	M4494		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1660_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive CD8 T cells versus day 0 monocytes.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					60468	5551	79961	58473	29909	57711	23224	9452	11262	23178	4306	914	7374	924	3710	53347	9532	54923	225	969	84525	11126	64400	83988	9737	987	23348	5790	4818	282997	3823	4118	7597	4753	1901	8821	9235	22850	9402	5588	22859	54674	79829	64919	11320	64754	2841	7915	2814	26053	3560	10098	2113	664	54847	55450	51599	3163	7535	10225	3820	399665	2026	4897	259197	79441	51070	4603	440515	23234	6095	6955	81539	728855	940	7049	5335	3001	7163	10219	64219	55423	4063	55615	55268	5727	3983	9363	4204	10578	939	5274	4436	60487	150759	26751	5140	4925	5578	2053	4068	9882	28951	26018	926	26119	3702	4300	1823	2999	51735	5775	2273	26278	4054	3655	2323	10771	22800	8809	84747	9500	79652	8440	55653	3978	7525	64112	230	2625	923	56985	3275	916	23046	23177	25864	8464	23516	112611	23175	9806	9214	4050	917	57185	6609	9949	79695	23270	23398	79037	51176	4675	79667	3337	994	22914	9022	23259	3932	104	81606	126231	23338	7188	7923	1292	65982	5557	2833	54680	9781	868	925	65998	8631	23499	3002	919	915	7029	921	50615	6936	27334	27250	8807	29121	8287	64863	3003	864	3276	1803	23076	8237	1195	10641	11230
GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_DN	M4496		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1660_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive CD8 T cells versus day 0 monocytes.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					2207	51363	10437	2752	1475	3303	6280	64127	3055	23643	10859	10288	11213	1439	1495	11031	1612	4067	7133	1488	3779	4332	2268	427	7453	3394	5742	6282	25801	3958	7305	637	29916	11000	5265	4688	9935	6850	22918	9120	8741	7462	1806	1536	1508	604	929	23325	6279	6386	302	2203	23312	1052	1230	754	728	10875	51296	9637	4126	9056	1520	64759	523	6283	115207	2212	11025	1512	64581	6303	7805	55819	79887	2876	1462	7077	1471	56935	4946	25797	23232	10154	10577	1848	9846	23673	10970	2896	304	65220	64419	27180	1845	8795	5660	55577	8031	23603	9314	3074	2219	6556	50856	64342	5580	2357	2512	55640	23654	4055	57178	7127	10981	10261	23597	55803	116985	54453	3460	9123	8804	3162	945	3459	8905	4853	11027	6256	57460	9341	2180	7097	2131	54504	351	6622	64218	6252	10533	54436	4245	81553	1436	64747	240	79143	55763	334	4082	4069	55357	829	5724	29992	948	5768	5199	54863	2799	1318	10087	51108	54741	23092	602	55654	2120	10602	1820	6510	140885	5791	822	8500	25979	5226	7045	9960	200315	7030	5336	1185	200424	10327	80896	2509	1441	27235	10903	51099	5325	6821	83440	23761	571	64231	79772	9958
GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_UP	M4497		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1661_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive CD4 [GeneID=920] T cells versus unstimulated neutrophils.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					22	56271	914	54680	11340	824	64431	10425	9326	51367	7284	2747	246243	687	2995	23157	7570	23499	23358	8801	81929	29117	6431	64417	8802	9270	2625	90411	9924	51172	6749	10204	64219	10946	55423	55422	26136	8725	9531	64427	2058	22850	55186	54934	54900	22883	56339	10198	1677	51020	6468	51601	6897	114034	23658	8697	3115	55308	25793	25777	55556	917	90233	6612	26018	9868	23450	7644	8821	9917	26953	5578	55718	1901	128	5295	79868	2026	57128	55027	91298	4925	5867	4733	7294	26137	57215	6741	23353	10767	10363	3028	923	11257	8379	56985	7248	55794	4144	260294	10225	23193	9791	9879	1964	4216	22818	59338	23484	26049	994	4609	4190	285830	10067	9929	613	7050	26036	9913	483	56829	55876	26528	29121	51176	51759	4836	90	920	9452	79693	1844	10199	399	64429	27252	55739	10772	1236	81606	81873	3587	64853	7074	6428	6597	25814	65110	66008	9882	28974	10054	55327	28984	10668	6767	6596	4706	55081	60487	2592	6711	9013	23177	79918	5695	57473	9552	1653	924	440	80777	92856	64919	23348	79568	643641	2146	55272	7580	25998	3418	3702	55333	55699	5631	79073	57798	53347	51497	27339	9780	144699	4691	11051	7535	29969	10240	2631
GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_DN	M4498		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1661_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus unstimulated neutrophils.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					10254	2215	55332	1475	10409	23643	10092	6888	57096	29906	4332	23619	1269	1608	6280	2790	53630	7846	29075	8031	6870	29986	23657	114112	240	54363	7739	8875	312	5319	10875	6570	1052	2357	1912	6809	597	3310	6273	7432	6386	1947	7421	3107	27302	6096	26503	3303	9355	7462	79092	79746	25805	2275	9771	2150	79623	79047	10135	1439	6850	2719	5742	160313	4688	2100	9516	945	6283	54210	51167	10981	55647	8365	51734	9609	2752	159963	51298	1184	320	23328	64581	3565	8334	91543	4316	8743	9019	6253	3604	5552	2934	3985	4356	1109	25801	366	80301	253190	3882	6286	10170	6383	6648	57706	64180	2212	200315	58495	10690	55350	57399	5029	10164	51378	80256	3906	63928	56935	10053	54879	1051	6397	2919	3579	9989	1080	79818	27202	51192	80183	414771	51083	7940	5475	925	53829	25797	80740	10154	5999	140710	2899	2683	55095	3017	9971	51299	23114	6196	5743	158471	2047	25891	51050	80380	2649	50862	4093	7991	2713	7043	3290	64757	54514	3920	6422	100293553	10331	8858	5359	1956	100129250	219654	9936	54961	3581	8357	5166	3563	2780	80150	1486	10333	5581	8794	7033	6388	55313	637	10936	8431	8843	10588	26468	3913	526	8870	2512
GSE22886_NAIVE_CD4_TCELL_VS_DC_UP	M4501		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1662_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive CD4 [GeneID=920] T cells versus unstimulatd dendritic cells (DC).	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					2625	6935	8821	81618	55876	596	3178	1843	26049	445347	3978	57326	3097	150759	58473	11118	924	55054	53347	100272216	9730	994	285830	8667	11083	9751	386627	80162	79183	3177	9667	54463	55615	8527	6844	2995	23345	6964	9252	9262	4054	51295	923	1831	921	6932	10320	55658	7294	29777	3757	29851	23214	6468	818	9368	56985	57048	5590	79777	8725	55316	9840	8665	79872	7318	51070	4929	54851	11278	23224	54934	3738	79037	118	57185	4297	5533	6230	7273	3669	9184	2592	939	1236	4049	940	7433	83955	23484	6095	442216	2882	9267	8440	2323	51361	6165	100132341	4068	5569	26034	29121	9782	9804	81558	28986	5144	1938	57060	79652	9235	6155	814	6209	1937	23318	220988	6942	9139	900	28227	59307	8875	6188	694	8925	9973	3590	914	917	8409	51765	22882	64919	57728	23178	7644	8555	9882	55203	91316	27252	55664	322	112869	23348	93144	230	8175	5883	28755	9138	81606	3337	2841	687	6711	65057	29896	3702	113791	80135	2643	1803	26999	7163	10938	8721	728855	969	7597	79968	50854	29116	916	3646	84124	8718	5498	51586	55850	919	57127	50853	2254	9806	29080	10225	51303	613	2050	3137	253959	54861	29107	54977	2113	8573	51176
GSE22886_NAIVE_CD4_TCELL_VS_DC_DN	M4503		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1662_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus unstimulatd dendritic cells (DC).	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					8673	10548	27020	4236	1351	55884	1211	2217	5336	27069	3108	57178	5663	3303	7879	4247	64581	7296	5351	29796	55207	54914	54442	4332	50	6510	7431	60496	7905	51495	1457	10238	23643	11031	2108	2896	23313	2876	23232	4074	2787	54205	972	9341	93129	9817	533	56672	8804	2512	30851	8992	10376	64747	23428	6386	51573	9144	5573	10797	3987	6642	1050	1471	6888	7045	805	1460	6451	51015	51022	4076	1981	1495	11337	28956	3123	7251	2790	1173	9555	10295	5580	1318	1476	3155	2717	2934	8655	4289	51382	7416	2720	6050	1230	23011	8531	6714	4780	3920	84790	10409	55041	4688	6850	57103	529	3417	1806	8649	10875	10935	1781	526	3122	51324	4702	91752	1175	2729	1512	27072	10437	23596	1845	2950	3281	10308	8878	54499	26521	60370	10254	4900	1612	6945	10592	23122	7779	7319	967	51728	5836	3687	79624	23295	6768	5538	8417	10269	965	9342	6282	55161	9927	6256	1475	23001	55640	55819	9375	308	506	54	10440	1075	10169	55686	4779	1508	5872	6009	6744	5223	6039	25932	56935	10159	78996	3064	5226	6769	304	9724	9107	51056	55361	4125	55763	5693	53346	3988	5052	821	23185	3459	1102	10282	51071	224
GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_UP	M4504		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1663_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive CD4 [GeneID=920] T cells versus day 0 monocytes.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					53347	8821	22859	26049	923	7535	924	150759	23224	4068	29909	596	55423	7163	9949	7294	3702	58473	3983	23043	4118	9235	60468	64919	10947	28951	64219	22850	3978	11320	7089	917	6955	10225	29851	2053	64400	23175	969	1803	1901	4054	9806	940	6095	9737	9452	81606	939	6964	921	79652	959	3655	28978	2113	56985	23178	23234	23112	51070	27244	919	5578	3710	9882	51176	1195	994	2026	2323	4675	987	4753	57711	4925	26751	79441	5790	7597	81539	3275	11257	5588	23046	84124	9500	2593	54674	50852	60487	3001	3640	28755	360	64754	5335	4306	814	915	9840	664	7695	150967	27018	84747	246243	440270	274	5569	916	117247	5295	23164	81890	9751	50861	100132341	28639	79037	57326	2995	1039	57185	9363	230	282997	5775	7629	8631	91782	1669	6419	3932	26018	6609	5144	23348	4300	2841	23263	26119	55615	7188	8440	55876	4063	440515	54977	9532	54847	9760	23461	7767	90233	7561	54463	55198	8425	54855	28683	79961	9214	161291	26137	3800	29990	7374	27334	29116	3298	55422	55268	26249	3315	399665	81618	29107	3163	29121	54923	55636	5583	79968	1606	59338	10516	23231	7923	894	868	3652	6468	5019	3004	3276	54680	10681	90121	80201
GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_DN	M4506		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1663_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus day 0 monocytes.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					1475	7462	10437	3303	9056	6280	11213	1536	11000	4688	2219	8531	11031	51363	6850	10970	23325	2212	1439	4332	2268	29916	5580	5660	427	2896	22918	3055	1612	929	64581	10859	604	10154	6283	1230	1462	6386	8741	1318	2876	64747	11025	6556	1848	11027	1806	10602	6279	25801	834	23643	9341	115207	3394	55763	9120	200315	8031	2512	829	4946	51108	65220	1488	64127	1052	23232	64419	1495	3460	4245	8905	9645	1508	23654	1845	3459	10875	4853	64218	5742	6282	9114	7321	25797	5791	23603	7077	4817	2752	79670	2720	55819	2745	112950	637	7097	4069	2790	11337	822	10261	79887	50856	23312	3074	55577	654817	3958	26521	6888	58488	64759	1200	3611	23307	2203	2357	51022	1512	10327	8417	7127	10288	240	55357	29992	8804	9039	56935	5476	4126	8795	59342	23761	7071	27235	3101	3779	10577	1520	2799	533	3684	51296	6256	728	51099	1796	55640	23092	2353	9470	1185	304	30817	1890	5359	1730	5336	81553	4082	9314	8875	27180	2597	55803	10019	523	54453	754	55160	27020	1441	29887	2207	8500	9846	3281	140885	5226	57178	57205	2526	4778	10611	1871	23673	1955	948	23636	2182	4905	9637	4758	6688	302	10981	3570
GSE22886_TH1_VS_TH2_12H_ACT_UP	M4507		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1664_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of stimulated CD4 [GeneID=920] Th1 cells at 12 h versus stimulated CD4 [GeneID=920] Th2 cells at 12 h.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					7263	54795	7345	6503	79071	9181	288	9073	28986	10392	10747	1843	58526	51447	55802	53407	5066	23396	6152	4884	10819	196740	2052	9839	731	79893	54103	6812	30009	8976	1293	420	3836	54566	27241	7286	26137	23261	10874	55216	25966	23505	526	56902	7187	10217	1805	613	26024	79791	3725	3576	64852	994	9829	5774	10666	63906	3112	2530	23648	100287590	25774	4935	26060	4799	23299	79850	1808	1512	4359	51281	55665	3748	7227	29109	28966	1761	85458	55727	10256	1627	29890	4092	79703	8501	5728	51280	51233	8345	440193	84864	10211	51337	56606	5359	5300	22930	80036	6136	51086	64131	1259	7726	5032	8970	64834	89853	83452	283298	9119	4045	9060	55890	27159	4681	55252	54973	677	51004	51761	7050	9750	10084	5968	5270	55277	23008	36	25829	80304	4061	55036	127703	11280	56654	28983	60468	8870	23046	51046	27043	207	78990	23654	6195	1039	651	89944	5159	57698	23275	3595	2101	81491	26999	8706	23198	7036	308	4232	11098	5105	10053	6300	80032	26960	4914	26015	7205	4899	55171	2846	79644	31	4115	8013	23016	9755	23203	80740	3265	3903	200734	27033	56926	8682	2848	54596	5962	7291	9240	56890	8650	1827	54741	80150	50	563	59353
GSE22886_TH1_VS_TH2_12H_ACT_DN	M4509		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1664_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of stimulated CD4 [GeneID=920] Th1 cells at 12 h versus stimulated CD4 [GeneID=920] Th2 cells at 12 h.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					22918	27445	64860	51294	51444	54952	3449	7022	51474	3627	7126	7092	23112	10855	29083	9600	1496	6866	8190	2099	261734	55069	29887	54629	2690	79143	4224	181	6590	51065	3138	84560	4086	4661	374655	10846	79812	57051	4669	51374	127534	4756	7172	54941	140609	5455	79744	10435	57111	814	4126	9278	80321	5915	54212	2720	7200	8843	245812	64116	54852	696	2696	81543	55061	79038	7136	4504	8481	55133	8763	2815	3092	9902	28971	3717	2315	84263	55214	6490	79809	23258	9709	95681	22806	11214	8646	4199	23516	171023	9455	11187	8634	474170	9211	5101	9321	6462	8353	26152	60506	3762	8658	25897	83449	10178	55819	7447	4159	1176	9635	55335	55714	53	9083	4544	54903	6415	6926	7368	23064	79800	7903	25834	8514	757	1295	7803	4285	416	11201	3708	9847	283131	29933	2330	384	54885	780	2785	4828	3535	11083	79147	3814	6048	23385	3976	6707	23048	9629	10559	2584	27165	1734	80852	9655	29113	25770	3567	1476	8468	3596	6005	10206	5130	2591	10653	3005	27180	51362	6233	79098	80344	2104	1277	6591	9722	23092	10150	8821	147179	51008	79667	6898	57733	9716	8844	5906	162972	3001	10959	367	4499	3845	8586	2572	26001	5321	9857
GSE22886_TH1_VS_TH2_48H_ACT_UP	M4510		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1665_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of stimulated CD4 [GeneID=920] Th1 cells at 48 h versus stimulated CD4 [GeneID=920] Th2 cells at 48 h.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					2067	3866	3783	1501	7407	5450	6565	23645	9989	5629	8706	6446	23576	10252	131	5336	9654	23767	27165	30009	2829	6768	56937	83988	26291	3705	78995	51725	680	4897	1889	94026	8870	7227	1370	10580	2019	5191	24	23264	1512	6556	7941	1740	26037	347733	7070	5178	339	27158	53340	9162	6373	284244	23243	10633	57093	7450	8515	183	7350	26063	54825	6252	8818	28513	10738	54733	3203	23654	5199	55924	81494	56033	51280	2788	1137	4852	23648	525	7356	1141	1649	3958	9704	5590	4580	81035	5909	23046	51293	79639	51286	26	2069	1749	6278	49860	2651	80060	1352	2830	8538	1523	3914	56	3458	2028	2275	83716	22809	51196	1366	1152	64122	2049	304	3725	2252	100505761	1938	202018	284001	79797	7036	2566	753	23552	9033	169611	9578	81792	80350	10168	10322	60468	1827	7142	1339	80179	11141	7386	9020	3995	631	5079	152	2184	4128	3069	2078	11092	3061	8767	55346	5407	5800	4656	51760	6812	57162	27287	22808	80243	1193	4336	6915	7755	54967	11027	11135	3224	9306	4045	60401	25822	7093	24147	10215	112464	23621	7101	3315	11067	8324	1838	3744	5449	8834	10666	84909	100288944	51330	3890	30850	9308	2012	54474	54938	4053
GSE22886_TH1_VS_TH2_48H_ACT_DN	M4512		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1665_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of stimulated CD4 [GeneID=920] Th1 cells at 48 h versus stimulated CD4 [GeneID=920] Th2 cells at 48 h.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					5784	5334	4086	861	8339	63920	29102	5141	9741	6451	54	9397	112399	79738	1794	3588	55508	11259	54941	10163	3565	7728	4245	90333	9663	9841	5734	51379	4891	23248	27436	6386	85363	6448	8916	54665	26091	5786	9686	3567	64866	57097	1849	5578	3566	10092	22878	6239	2000	10154	11253	3001	51315	4149	79038	5732	3073	9831	4983	123	10745	8611	3074	283537	11093	9846	1047	1806	6342	2553	6185	23097	3845	3385	474344	1112	384	4494	5621	26994	10782	55667	91543	8202	10097	9455	84851	55364	80267	23092	8763	8821	55777	143	51283	8992	10384	272	22884	261726	23608	2308	5921	4299	3768	6879	54502	51573	5321	4493	11215	10308	55023	4189	55540	63929	54509	79770	11214	4496	3988	90806	25796	23168	64761	51719	10175	5588	26018	5295	818	2776	64921	7690	55608	93349	59342	1774	54952	10740	3717	7764	8269	64062	10554	79830	645745	27097	221061	10636	23064	8969	10313	4087	11257	51172	6746	23527	23508	55251	103	9525	57148	5311	28952	8773	2081	26190	10959	8799	2306	5698	9860	6745	79145	220972	56650	22978	8542	4832	55634	5613	55146	54826	56675	3669	81790	4012	7360	826	754	8787	55654	10312	5257	9813	23228	4495	7596	643854
GSE22886_IL2_VS_IL15_STIM_NKCELL_UP	M4514		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1666_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of NK cells stimulated with IL2 [GeneID=3558] at 16 h versus NK cells stimulated with IL15 [GeneID=3600] at 16 h.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					3911	57119	28316	51090	57818	28778	23415	5449	7058	51146	384	51147	9644	5803	400451	11174	80144	55224	148229	11328	26762	7057	100287025	50837	29949	8346	56142	29842	29986	257	8403	2151	8654	887	3645	7447	80036	27202	51332	3350	80111	50833	51360	170680	26105	100507605	2984	100131510	931	8532	92335	6514	8028	2705	10345	28983	6926	53405	150160	1114	50617	130814	3890	9584	2051	25961	8844	9771	25825	84722	116039	4107	29931	5918	56606	8526	26168	22888	79178	947	844	26230	83660	84253	337	56100	51322	8534	3709	869	7432	54831	593	22924	25787	6422	388714	196993	6578	2052	112399	79621	56062	6583	63973	4619	127833	23546	57586	55511	26532	716	9545	27159	100129503	54964	7010	23247	5118	79819	5153	9079	728577	486	5076	64087	11141	1608	3691	9071	59067	10331	26154	9586	155	63928	1144	432	570	2628	25778	25794	4199	5319	55821	51666	5079	54845	23362	11173	351	374	9019	10810	3745	81833	10110	5178	79054	55584	5764	4025	54714	116986	23473	9745	54039	6447	55228	10201	64901	7301	5459	7173	26123	5379	53832	2775	53630	6656	8590	147657	3770	1290	9344	10893	9201	10956	3881	192683	6561	54476	8038	9717	5252	50805	4293	8482	55335	6014
GSE22886_IL2_VS_IL15_STIM_NKCELL_DN	M4516		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1666_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of NK cells stimulated with IL2 [GeneID=3558] at 16 h versus NK cells stimulated with IL15 [GeneID=3600] at 16 h.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					51275	6143	1796	11162	55003	4982	23595	8435	26007	51182	652963	735	26173	54825	5692	100288944	83463	100289410	4666	11228	27006	5708	29078	57761	2779	9366	5450	4314	23434	51188	55613	7353	6135	4720	55245	29103	11066	10587	4678	5129	23478	6809	9377	6633	65993	29099	27285	10003	9217	7936	4700	4905	51155	10054	23016	51444	10726	5688	435	594	11171	525	60314	10240	83480	5950	51398	79720	5435	2787	5947	9141	10979	55975	60626	6634	57113	91442	6202	9587	9668	51021	11116	10574	50814	320	8480	8453	23119	51393	539	6169	6474	10841	5337	55272	4055	6217	55009	64768	5699	113177	55164	25873	7174	646934	8192	1370	26121	29883	100290557	79160	6950	100130449	2986	10572	23644	81490	518	9730	55854	10486	374291	11336	7319	23399	43	2146	9497	10495	1032	57194	6158	59348	8479	79017	63933	856	3008	55039	23197	11052	64215	26574	4528	11131	6388	54862	4898	51004	728361	29081	836	857	51118	79722	51127	8833	64170	51081	51550	54998	4087	8805	51181	1347	9937	4037	27097	2526	54986	8787	1876	7385	55294	5042	9180	1917	8738	2582	7358	3654	25988	23636	139322	26211	51103	5306	80304	3298	57003	9973	2694	7561	7979	79750	3945	5110	11078	63892
GSE22886_CTRL_VS_LPS_24H_DC_UP	M4518		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1667_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of unstimulated dendritic cells (DC) versus 1 day DC stimulated with LPS (TLR4 agonist).	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					3613	22884	10313	9697	5742	6181	6867	60314	78991	5906	805	2806	1350	23031	1432	10400	4482	11222	23191	1794	55353	54518	2162	23401	114112	8731	1729	4900	8536	393	78996	29796	140	23299	23151	1786	79641	51218	328	3603	948	4666	9051	22954	7388	56996	162	79718	57645	2242	79833	56833	1939	23186	27131	3108	8677	6208	51138	11200	23076	6156	55201	9529	7155	27335	9653	10243	29960	6285	8801	9791	90956	55016	113	9046	50	54583	57001	9897	23344	56994	8905	6202	25840	22846	1975	8520	51690	865	1069	51386	51024	11309	23171	23097	58190	5445	10462	6170	8829	25801	51367	6222	79090	3028	4707	9203	8673	27107	7462	6155	56915	5425	7737	4258	516	93129	51362	51573	55325	10477	3087	79145	2958	64236	64231	7879	138050	6451	79161	7862	11320	64943	4697	55163	1020	8761	1351	515	27236	10430	224	6916	9459	9761	6207	51477	56674	9871	51292	1967	25847	622	4005	51397	54914	4094	6059	10465	26190	10969	26986	5330	219654	5510	10476	1933	9601	22818	64860	2213	130074	6850	10097	6275	51295	3459	64781	2313	6189	50619	4711	54681	2876	4718	80349	3579	30835	55652	10423	6566	830	8662	2778	9338	23406	53346	4723	11010
GSE22886_CTRL_VS_LPS_24H_DC_DN	M4520		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1667_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of unstimulated dendritic cells (DC) versus 1 day DC stimulated with LPS (TLR4 agonist).	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					5366	57823	10125	3430	684	3665	24138	10964	51155	51191	3383	3017	654817	54662	9636	23214	8519	4600	200315	6352	10950	91543	694	3959	4783	55601	11040	8349	2643	6890	4939	64135	3559	6789	3134	1843	2633	55008	64092	7163	4940	7130	2537	3601	3429	8345	8334	8878	7050	1236	92815	9325	3106	9961	10379	4779	80149	3620	55254	3301	6993	54809	3662	2145	2766	84243	5721	4814	3669	56650	5966	65264	8638	10561	10318	9242	55337	55716	51510	2120	8013	23586	840	4791	152559	3434	5577	27074	3431	10410	51762	79651	54739	54145	25816	8971	79016	4065	3612	8542	836	10444	3437	7444	93081	9111	10148	3137	11011	7128	6364	3097	103	3593	5325	965	2907	1466	3433	599	6648	50486	5696	10581	2879	11118	3303	8942	9367	1847	5610	7453	11119	5025	7295	79132	8344	55038	330	1890	8775	51379	629	5739	7852	8365	5698	10488	4790	4502	3133	63897	6504	80208	23645	64108	51056	23172	8767	5533	65108	7185	5699	9308	7292	9318	11274	3105	3135	200734	10384	9567	808	1844	9997	5734	3604	51278	9788	57599	8743	5142	1267	54906	9246	81839	23240	4001	55233	9175	6772	23158	51131	10952	91966	8705	2997	11138	9711	5199
GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_UP	M4521		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1668_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive CD4 [GeneID=920] T cells versus stimulated CD4 [GeneID=920] Th1 cells at 12 h.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					11154	55187	9138	678	166	6786	10077	56997	862	10316	5869	54832	6840	1201	3988	55208	6259	3263	3750	10628	23258	64236	2319	50861	6203	55893	642559	7249	90864	22861	51477	23048	694	1911	29761	80344	10724	2841	57124	57326	23492	11044	23177	23568	84364	154881	2313	23036	54585	53827	1975	51816	11059	4054	54462	10493	408	54765	10346	51411	51274	4034	1195	4820	56998	710	55664	2166	23064	5129	63940	5087	63935	10126	10961	81888	10396	1938	10892	7259	79587	208	79891	4353	26959	10948	665	23370	11257	7536	27005	23152	25970	8631	84162	7476	25939	6159	196441	819	23523	1979	57111	755	27165	8906	2892	55139	5937	23245	23228	80022	644068	3590	27147	56995	6609	8525	51727	1389	55268	10235	57018	23353	960	4214	9697	10307	3337	93349	5345	6750	6778	5256	51149	64919	51322	26065	29911	55769	9857	51669	3631	825	58509	6320	360	1859	26577	3431	9922	7328	1120	57799	3575	476	115703	4330	4621	3112	26751	10057	79090	220972	5204	23077	6224	23506	80169	22864	582	552889	6235	9651	55316	7597	22897	27023	8036	57396	1519	3275	6132	4205	6314	63926	27134	79364	23355	8925	100132341	114908	54847	5878	5189	149986	83752	9710	5731	120
GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_DN	M4523		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1668_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus stimulated CD4 [GeneID=920] Th1 cells at 12 h.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					79071	79713	9673	1478	23074	81034	5905	8418	4085	29127	6635	9238	2067	4176	79072	57418	10213	7037	8570	9221	3145	4722	1861	908	79080	5701	10063	30968	1108	56616	10036	8886	2101	4677	51022	3615	5111	51053	5550	2553	5326	54499	10598	10282	11127	51493	387032	2805	51728	5717	8301	5682	7421	54863	11072	29093	10574	2965	50814	96764	26284	6388	5684	58478	7307	29088	411	81608	27161	2237	4292	4522	10985	10576	5983	9733	9521	26292	55147	1437	2958	7298	9373	1857	51559	2184	7347	10694	9553	9532	1234	3336	60314	11260	8894	9790	8536	23788	1798	1662	25813	7345	86	8208	10046	55500	10954	54145	3712	1477	8317	29901	10478	55858	3251	6385	64943	79714	55784	22929	9801	55161	91966	23035	79895	2395	891	9442	9871	25994	2786	1965	9055	7903	10016	488	79947	11171	1293	7372	1349	10111	1605	8891	1154	1457	51693	4706	80196	5707	27101	23277	226	11198	9128	3156	1763	3783	5901	55711	55131	1676	5984	8870	10613	1876	50810	1994	23	4729	10430	5902	54914	6472	28231	5511	94081	10438	9410	9031	475	6150	3902	6513	55239	9972	51042	8974	991	7167	898	2181	3662	80010	6526	29083	51290	55509	5888	51474
GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_UP	M4524		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1669_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive CD4 [GeneID=920] T cells versus stimulated CD4 [GeneID=920] Th1 cells at 48 h.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					23508	29116	6259	27076	1739	2197	24149	6942	6194	54765	29125	1831	53373	55914	54585	678	57396	1843	9736	54462	23527	11257	4926	9013	818	51669	6687	694	55544	6161	55333	79587	11156	150759	3875	4126	10347	26136	1195	55769	23144	55108	51172	677	8848	6609	55056	81558	4919	5297	51601	5608	755	283537	4353	1120	1514	55324	9922	476	6232	55654	339287	10724	7433	3988	22887	3133	22861	22834	9840	24138	400961	1604	51274	7832	7007	22882	56731	6256	51070	54558	6156	57326	4621	53827	55268	11044	79958	7707	23228	9923	7695	643641	552889	22897	6229	8509	9882	8471	25970	6430	9170	8519	605	728661	4214	22863	55810	9284	23683	285672	687	59348	56172	7248	23064	6777	3305	921	6176	5829	3384	2533	3993	8495	54832	1628	2300	54910	25949	4820	7644	6203	11188	6605	59338	57124	23067	23060	50853	7273	51754	55716	7541	22821	23451	80063	10943	23032	8527	56271	81669	57473	26049	220972	54581	7327	3275	9205	5578	63935	29803	57146	79918	100132341	9751	93349	4054	79666	58486	5590	6843	10235	22838	10346	57228	161291	1889	8692	4317	5922	6314	7597	51176	162427	91300	2308	64061	23383	11119	275	6224	152006	55837	3551	6840	25957	54463	55208
GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_DN	M4525		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1669_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus stimulated CD4 [GeneID=920] Th1 cells at 48 h.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					51026	9320	56910	1351	23788	2584	112479	51138	4076	5514	63943	27429	6635	7398	9645	3014	54733	6385	9443	10963	6240	23435	90355	8355	5478	6634	5685	56650	475	1060	5682	51042	2617	26000	26058	7531	29087	25994	9526	55693	10617	5160	2108	5687	51022	5701	2958	5707	8892	515	29980	5168	79072	51668	1022	1994	1017	1503	1337	80196	7388	5714	29074	27349	23741	10092	7329	1371	1163	56616	51647	6632	699	6628	2650	55907	29093	5426	11315	26128	9133	56984	2184	8836	10538	10213	10051	598	27258	56938	899	54914	3682	3015	55975	3396	330	50810	10797	10553	3145	8520	3417	4172	3181	4719	22929	5434	51493	2842	11130	54442	5052	8974	8727	4860	4723	25804	28231	4493	7307	53918	23594	10063	6016	57122	29127	9088	488	8443	54499	5691	51659	4331	1981	79682	63875	6443	54478	7167	5696	9735	6307	7421	1798	55135	55711	26284	28960	10856	4709	203068	10989	27236	6525	5888	81892	60673	6627	79714	51053	4174	3148	5832	51142	140465	4236	5708	51318	84617	2067	10935	28998	10775	25842	27338	22936	57472	56943	23636	10613	8668	25915	80153	1545	9156	5983	5214	27131	79017	1965	1537	4722	1478	8772	11332	2553	23760	51088	3313
GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_UP	M4526		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1670_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive CD4 [GeneID=920] T cells versus stimulated CD4 [GeneID=920] Th2 cells at 12 h.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					57185	905	1739	10961	2676	23566	79970	1901	4240	55761	3750	56965	23113	54956	23014	7644	100132341	27076	10724	55716	57111	4214	55423	6786	64061	4330	51447	6194	84148	337	1153	114881	1514	55333	8440	3710	10174	8665	196441	274	23338	7267	55769	9922	54585	9924	51754	2313	79921	100288640	11059	79786	23263	10493	56172	4054	351	10561	7994	55316	51614	23177	1655	5607	3707	27296	399	388796	57146	1991	9516	23017	8527	55187	5829	25957	11156	4772	22864	22861	56969	10077	7109	275	9127	9138	6122	9812	10577	50865	23451	10966	25970	85446	5590	994	7375	9751	1120	8609	55268	6687	624	10142	80022	79724	6609	1327	51526	5256	339287	50861	1387	90864	9985	25939	9988	29125	566	54861	687	476	29911	6777	23637	4673	53947	374655	51411	3748	2811	9284	23077	379	3993	56997	825	55914	84364	6430	27252	1911	23506	51274	3903	3590	55790	166	5412	54971	9697	7593	89941	552889	79679	56940	7536	53373	51477	23353	677	3815	26173	57447	8869	8495	10869	4660	5094	5498	4034	8906	79012	100272147	54540	9736	55758	9905	6002	51599	23315	8471	755	4820	7273	5871	8675	9278	114908	7405	50854	10396	161	51669	65018	58533	9860	28951	23094	23522
GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_DN	M4527		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1670_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus stimulated CD4 [GeneID=920] Th2 cells at 12 h.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					3708	4282	51026	23788	7158	2067	23483	10342	4860	157	10775	3251	9688	6240	51138	54995	10989	10067	1230	3976	10549	5711	2673	60496	79713	894	54948	4594	1213	4793	9320	55245	56650	79624	22954	2108	29097	6385	151230	6890	1478	79064	29127	7298	5701	4686	26031	56061	9562	55711	81620	6388	10421	9871	23011	475	26000	58478	54880	5214	26010	1981	51022	11315	10899	1017	7485	23176	10282	1457	51668	56253	51103	5514	9410	54442	6897	7756	51015	51371	51715	80196	55215	112950	56616	3094	9526	5721	581	7037	10447	124583	10935	9645	51144	10228	2181	63875	2584	1615	1351	10952	56910	4247	10262	25994	54733	10201	79081	9716	28977	515	2790	140609	54554	7419	1643	55147	9034	1994	29909	26128	7531	10591	6566	10959	23185	10865	2591	55500	56935	2184	23191	1716	8439	10046	2224	10010	1154	23435	5045	8493	7251	7167	9131	10063	140465	8774	5682	10768	3704	25915	22908	226	5689	10308	29922	57418	5111	26521	4709	29074	5519	60490	10016	746	7185	54952	23197	2960	5796	9841	7873	7905	4522	63943	57003	10767	6510	7728	9673	4292	8683	9520	10897	11130	2730	10598	9276	9110	9532	9546	8202	3717	10773	6728	80227	372	3839	51021
GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_UP	M4528		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1671_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive CD4 [GeneID=920] T cells versus stimulated CD4 [GeneID=920] Th2 cells at 48 h.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					5829	4065	54585	4054	9697	51520	53844	100132341	596	55905	6194	79777	8303	3340	1991	7056	23353	8664	51669	84148	115708	50853	388796	7267	7644	1998	79927	717	687	55837	3275	6173	56731	1181	4353	4621	6161	23484	24149	29116	4926	6122	8440	51727	10291	6159	1906	4242	51312	55657	1938	1496	55316	7597	7542	6156	7852	26034	5593	1855	93144	27245	201229	55186	6203	6777	23119	55544	7227	79921	91977	51195	6609	161291	51526	6181	6256	8718	9671	2648	9578	84364	4137	54504	23060	1843	5256	51599	54854	22881	8495	55924	51596	2197	2907	57228	80201	3707	2300	955	79364	473	11156	29125	3425	6239	93210	54765	2707	2217	56271	3669	1889	10077	5151	63935	1757	55636	1153	26986	1628	23214	55790	56965	10472	10943	23371	950	115207	23174	23240	1739	25939	1856	5544	6259	79758	28951	11285	9249	11025	9148	84124	80146	51601	6691	55113	87	8535	10609	51316	712	9516	6132	6234	23243	57125	5590	51070	9531	23576	1408	4609	10869	51760	51569	11129	4736	79762	56997	9750	51361	5339	10561	7342	1831	9409	10235	6139	80022	7433	54463	3671	5731	1141	57124	2117	217	27165	148753	10612	9605	6144	53947	6915	120	55652	2166	2702	80127
GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_DN	M4529		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1671_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus stimulated CD4 [GeneID=920] Th2 cells at 48 h.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					3708	79980	9031	11127	28960	4493	3148	55596	4496	51109	10745	6509	10269	55505	9320	4494	79081	4247	26128	10617	29087	54069	23204	1230	9673	7531	8726	4172	9415	60496	1994	6642	3775	9419	79038	3417	55166	11234	23150	55239	3094	4358	1315	9943	2713	142	27067	55012	54499	3017	488	7167	7037	2591	1643	56984	84722	10051	6307	56616	10797	5325	1781	580	9276	5707	79892	8317	4709	805	79677	9562	6782	9972	10016	9700	9488	8339	6241	10959	10538	113251	4495	3949	140609	5431	9	27161	7153	9133	9532	836	9587	23176	54840	27130	79714	27131	23435	51318	57107	79739	9582	10063	71	6240	8872	81790	5889	5111	6385	54145	55161	80196	26521	4718	11080	56910	2597	5933	55355	8536	5663	5701	7298	140465	55500	2739	5711	29880	1371	51103	8604	55856	6890	23335	9735	79080	7733	1213	55317	7126	54442	54797	9761	9055	211	899	991	523	54995	4282	11315	9841	51573	2672	55215	51542	56935	26000	5531	8743	3565	8655	55746	25972	11198	10548	3014	5223	28958	10989	645745	79959	1981	8395	26092	22800	2842	2023	10097	3992	7905	2553	22820	10449	4738	3074	821	4361	1615	5511	9412	51192	10952	79947	5686	5281	5315	7465
GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_UP	M4530		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1672_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of unstimulated NK cells versus those stimulated with IL2 [GeneID=3558] at 16 h.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					81888	7769	56965	10384	55823	79651	100287602	7318	27250	10370	729580	55269	23387	81857	11119	6894	6430	10223	10943	55339	5336	2322	400961	10307	4601	57118	8445	2533	29121	23077	23174	6414	10443	8897	50626	6389	51314	91746	23608	55108	2760	7320	60686	10107	80019	29799	146542	842	56997	90864	10014	8508	9541	113177	1032	9648	11253	1186	1240	3003	687	4772	4299	80017	6778	8535	11214	2309	863	9187	81550	6156	284325	56339	81030	6448	23095	5616	55818	3934	901	26007	10873	10681	4057	6512	26249	343990	3875	11108	255812	652493	339	9938	56940	6691	1132	94134	10023	8440	65012	7305	113791	23130	11336	9605	222161	55716	3587	51092	754	64762	9924	11257	64174	55283	5797	10106	6196	51586	79778	57599	84162	51317	63894	686	23401	57326	80258	51447	25778	5004	472	694	6474	27285	6257	51526	23637	11152	9842	8635	64864	7273	10444	51439	1185	5826	79096	8302	11176	6283	6538	29997	2847	1414	9913	7852	8722	57132	6480	26580	23272	374819	25966	1740	10929	6206	8969	8848	23339	10650	4926	79663	80862	57035	3476	339229	26993	1991	27343	3661	24146	4666	5116	9973	54847	4837	55937	284	9765	4004	6210	10425	11046	26211	23588	23521	11118	6310
GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_DN	M4531		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1672_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of unstimulated NK cells versus those stimulated with IL2 [GeneID=3558] at 16 h.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					4173	26168	23516	6472	5425	54962	7283	1503	27346	2237	2194	8533	1019	10935	6566	10383	4678	7027	10574	6713	1650	990	5036	6809	79077	1434	10963	90861	10576	3182	3949	51318	9128	10606	4830	5902	1154	4049	84823	378708	2058	10155	9319	9688	5901	80746	23404	6598	79135	79711	55003	11275	79174	7431	3329	10381	641	705	6628	7371	7334	54821	476	4522	65083	10213	9700	3183	4171	1460	2023	5778	7866	51540	81620	27338	23595	79000	9521	1965	63875	3566	993	83743	6541	55759	1595	29980	51053	7094	6510	10212	10263	991	54148	5707	1164	9937	5693	30968	3376	1021	23511	23234	23531	10376	3838	63933	10527	9055	9861	9948	23212	1736	3014	10196	28231	5832	3313	10969	7171	4175	5111	31	55505	5984	5034	440	56006	55862	6119	598	11260	3161	55038	4292	3615	6301	9761	203068	5886	54982	908	6839	4176	10694	1163	23590	113457	93081	10492	104	9262	4700	51490	10061	2323	9040	11222	27292	10432	1803	969	2171	894	79801	56647	64785	10940	2669	23082	11140	55388	4050	6307	6721	1717	51659	8706	396	84790	7520	80155	4144	4809	9156	9097	5315	1111	5437	79686	6950	57122	7157	55650	8318	10885	7296	79017	675
GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_UP	M4532		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1673_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of unstimulated NK cells versus those stimulated with IL15 [GeneID=3600] at 16 h.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					27250	7318	6430	7769	11119	400961	23637	10223	100131510	6257	593	26993	6894	694	901	55818	729580	64762	3049	3911	5950	5616	6512	29094	222161	11176	25956	1634	7042	26137	55108	57132	81030	113791	30008	79157	11152	57599	9187	150160	23387	10107	9152	26249	10384	729515	29799	1032	60686	23608	54540	81888	8535	79024	55251	79668	80258	10234	493	64174	25957	80017	923	6604	9079	9506	6778	24146	339229	79854	11336	7988	10370	26470	3425	6638	6699	2799	51314	3983	8648	9923	686	4820	100293553	192683	55056	400451	610	57118	23336	23390	50853	472	55283	3661	90864	1591	1195	55269	22999	79663	3003	7582	114818	100	2694	55794	1046	8302	401014	50854	29998	56997	55823	9682	1240	28902	3890	479	387535	23383	5170	5501	9806	9708	5336	57326	54504	9970	2322	154796	5909	275	4313	462	196743	55837	10724	57535	9828	7994	9022	92	10014	3202	9924	55937	5023	8508	23130	8749	22861	9139	1186	80032	7088	1687	9037	64940	4004	3645	81669	2145	440352	582	23355	9814	29121	23174	329	284	80019	22863	196441	9881	80823	6402	79970	1289	108	80144	79641	84124	387509	57030	7142	79776	26505	8395	374819	143	9641	3827	22888	4215	79800	9001	351	64901
GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_DN	M4533		15789058	Abbas AR,Baldwin D,Ma Y,Ouyang W,Gurney A,Martin F,Fong S,van Lookeren Campagne M,Godowski P,Williams PM,Chan AC,Clark HF.	GSE22886	GSE22886_1673_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of unstimulated NK cells versus those stimulated with IL2 [GeneID=3600] at 16 h.	Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. In order to identify such patterns, we set out to broadly profile gene expression in a variety of immune cells.					9937	1503	10574	476	6809	2237	79135	10213	54962	51318	30968	5902	5425	8533	4173	4678	7283	51081	3838	1154	378708	990	79077	10263	587	4144	10054	1164	1019	1163	10606	6472	1434	4700	6509	23516	93081	55156	3329	7411	9761	7027	10963	51118	6301	29980	54148	63933	9861	10383	27338	3182	6628	79023	10935	4049	28231	4085	6541	4176	4171	3949	10539	90861	1362	5111	51184	10635	11073	63875	7431	55759	1965	7416	51053	6713	29088	10576	29880	8803	1017	5702	9521	5901	51182	8318	10973	7398	641	908	7334	2023	3566	6307	440	7520	79723	8669	4050	11260	5932	94081	81614	5519	10969	5694	55003	6119	10666	29889	9948	3014	7358	27346	79017	58478	5424	23165	51330	5036	598	5985	51728	55872	3376	6744	51647	8727	10376	6950	51659	9055	991	4175	9818	2956	10269	2178	5437	80146	5471	7278	23603	1803	4522	10042	8520	5705	50814	80273	10857	22948	10072	3001	5621	4830	79071	23788	55884	7936	9040	5984	23531	10694	6637	7171	4174	26009	55388	4998	3156	9097	10527	5704	23234	10051	60488	79174	10426	2271	10204	9319	64116	2058	3066	2230	27173	64960	10600	51514	5693	9477	81620	7873	84823	1786	6510	4928	51022	1994
GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_UP	M4534		20890291	Quigley M,Pereyra F,Nilsson B,Porichis F,Fonseca C,Eichbaum Q,Julg B,Jesneck JL,Brosnahan K,Imam S,Russell K,Toth I,Piechocka-Trocha A,Dolfi D,Angelosanto J,Crawford A,Shin H,Kwon DS,Zupkosky J,Francisco L,Freeman GJ,Wherry EJ,Kaufmann DE,Walker BD,Ebert B,Haining WN.	GSE24026	GSE24026_1553_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of Jurkat T cells stimulated in the presence of PD-1 versus controls.	CD8+ T cells in chronic viral infections like HIV develop functional defects such as loss of IL-2 secretion and decreased proliferative potential that are collectively termed exhaustion1. Exhausted T cells express increased levels of multiple inhibitory receptors, such as Programmed Death 1 (PD-1). PD-1 inhibition contributes to impaired virus-specific T cell function in chronic infection because antibody-mediated blockade of its ligand, Programmed Death Ligand 1 (PD-L1) is sufficient to improve T cell function and reduce viral replication in animal models. Reversing PD-1 inhibition is therefore an attractive therapeutic target, but the cellular mechanisms by which PD-1 ligation results in T cell inhibition are not fully understood. PD-1 is thought to limit T cell activation by attenuating T cell receptor (TCR) signaling. It is not known whether PD-1 ligation also acts by upregulating genes in exhausted T cells that impair their function. Here, we analyzed gene-expression profiles from HIV-specific CD8+ T cells in patients with HIV and show that PD-1 coordinately upregulates a program of genes in exhausted CD8+ T cells from humans and mice. This program includes upregulation of basic leucine transcription factor, ATF-like (BATF), a transcription factor in the AP-1 family. Enforced expression of BATF was sufficient to impair T cell proliferation and cytokine secretion, while BATF knockdown reduced PD-1 inhibition. Silencing BATF in CD4+ and CD8+ T cells from chronic viremic patients rescued HIV-specific T cell function. Thus inhibitory receptors can cause T cell exhaustion by upregulating genes – such as BATF – that inhibit T cell function.					8743	6775	3956	22822	2633	757	3430	3001	7431	10379	5699	9246	5696	8824	92482	51382	3720	9446	4907	8530	9047	2537	6772	241	7076	3021	6737	28639	79905	5698	3669	5720	6281	3133	4502	5920	9976	911	2014	6890	5873	1687	5788	399	4501	915	83442	1893	55509	29883	940	439921	5721	3659	28755	1672	9452	55505	9535	2885	3937	53340	1230	55294	51716	445347	3157	6503	301	5204	404672	83451	2912	10001	25805	3437	6955	80830	26284	2029	84991	29799	2331	51626	11345	6222	4697	79140	83480	3575	10670	9647	23643	1349	302	6563	965	23564	64135	3588	6633	1192	1117	6013	4694	51070	11118	1081	79751	149111	23457	6201	54503	79603	23242	6571	7748	9381	51026	3106	1164	684	10678	79819	6415	9840	57804	54876	103910	29895	54900	3195	373156	56943	9034	51650	318	51478	9761	150967	1936	5581	6323	23480	8992	3107	775	84168	9046	5800	5241	874	11079	22835	79630	51157	522	2034	4589	23152	6647	2224	567	8798	23412	55168	967	54981	55337	55690	8814	29844	51097	2812	3224	51035	826	5828	25873	51380	55049	11133	51666	55856	10327	155066	3105	356	9111	607	1043	1337	1345	4086	4159	9715	10233	9570	56833	2841
GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_DN	M4538		20890291	Quigley M,Pereyra F,Nilsson B,Porichis F,Fonseca C,Eichbaum Q,Julg B,Jesneck JL,Brosnahan K,Imam S,Russell K,Toth I,Piechocka-Trocha A,Dolfi D,Angelosanto J,Crawford A,Shin H,Kwon DS,Zupkosky J,Francisco L,Freeman GJ,Wherry EJ,Kaufmann DE,Walker BD,Ebert B,Haining WN.	GSE24026	GSE24026_1553_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of Jurkat T cells stimulated in the presence of PD-1 versus controls.	CD8+ T cells in chronic viral infections like HIV develop functional defects such as loss of IL-2 secretion and decreased proliferative potential that are collectively termed exhaustion1. Exhausted T cells express increased levels of multiple inhibitory receptors, such as Programmed Death 1 (PD-1). PD-1 inhibition contributes to impaired virus-specific T cell function in chronic infection because antibody-mediated blockade of its ligand, Programmed Death Ligand 1 (PD-L1) is sufficient to improve T cell function and reduce viral replication in animal models. Reversing PD-1 inhibition is therefore an attractive therapeutic target, but the cellular mechanisms by which PD-1 ligation results in T cell inhibition are not fully understood. PD-1 is thought to limit T cell activation by attenuating T cell receptor (TCR) signaling. It is not known whether PD-1 ligation also acts by upregulating genes in exhausted T cells that impair their function. Here, we analyzed gene-expression profiles from HIV-specific CD8+ T cells in patients with HIV and show that PD-1 coordinately upregulates a program of genes in exhausted CD8+ T cells from humans and mice. This program includes upregulation of basic leucine transcription factor, ATF-like (BATF), a transcription factor in the AP-1 family. Enforced expression of BATF was sufficient to impair T cell proliferation and cytokine secretion, while BATF knockdown reduced PD-1 inhibition. Silencing BATF in CD4+ and CD8+ T cells from chronic viremic patients rescued HIV-specific T cell function. Thus inhibitory receptors can cause T cell exhaustion by upregulating genes – such as BATF – that inhibit T cell function.					1736	657	55501	642	2744	27229	191	11004	8662	22879	6527	23517	65117	10576	7776	6936	8001	64848	699	5905	4775	2202	55037	114899	51497	1730	55683	7398	10198	3159	58513	3276	4176	332	8565	9709	1398	6877	7756	51096	4677	6652	79034	7064	10004	1653	8761	23644	5981	53345	6650	23516	2935	10155	54537	90	146909	7486	55500	26009	3329	1479	55775	23301	11120	79587	22870	55379	57107	6472	11171	10112	4216	92703	11222	55732	5987	23592	1434	10592	131	7283	6996	8835	319	22948	27130	6050	56681	6594	3838	57171	3376	28232	10208	6929	3145	10131	4601	113146	7884	57134	5422	43847	9055	9688	29927	55621	8532	4864	79156	5140	54878	10664	51347	60685	25821	1635	1665	57122	57498	6123	65264	10243	23164	23503	10426	56980	255812	79631	9797	6207	3832	4899	375057	56910	259266	26205	8794	55076	23236	117246	9882	10654	10419	1646	64429	1869	166647	10466	993	55246	5431	5007	5255	10298	23353	23538	9131	54815	5198	11098	8452	23310	271	7272	6117	54453	8502	5910	11344	4200	5325	4171	7296	23309	56882	8925	23214	4175	79623	411	54957	5424	55245	10762	55832	23395	192669	11073	9939	79677	9807	1111	7187	2617	55818	90956	50628	4242
GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_UP	M4539		20890291	Quigley M,Pereyra F,Nilsson B,Porichis F,Fonseca C,Eichbaum Q,Julg B,Jesneck JL,Brosnahan K,Imam S,Russell K,Toth I,Piechocka-Trocha A,Dolfi D,Angelosanto J,Crawford A,Shin H,Kwon DS,Zupkosky J,Francisco L,Freeman GJ,Wherry EJ,Kaufmann DE,Walker BD,Ebert B,Haining WN.	GSE24081	GSE24081_1554_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of CD8 T cells with progressing HIV infection versus those with controlled HIV infection.	CD8+ T cells in chronic viral infections like HIV develop functional defects such as loss of IL-2 secretion and decreased proliferative potential that are collectively termed exhaustion1. Exhausted T cells express increased levels of multiple inhibitory receptors, such as Programmed Death 1 (PD-1). PD-1 inhibition contributes to impaired virus-specific T cell function in chronic infection because antibody-mediated blockade of its ligand, Programmed Death Ligand 1 (PD-L1) is sufficient to improve T cell function and reduce viral replication in animal models. Reversing PD-1 inhibition is therefore an attractive therapeutic target, but the cellular mechanisms by which PD-1 ligation results in T cell inhibition are not fully understood. PD-1 is thought to limit T cell activation by attenuating T cell receptor (TCR) signaling. It is not known whether PD-1 ligation also acts by upregulating genes in exhausted T cells that impair their function. Here, we analyzed gene-expression profiles from HIV-specific CD8+ T cells in patients with HIV and show that PD-1 coordinately upregulates a program of genes in exhausted CD8+ T cells from humans and mice. This program includes upregulation of basic leucine transcription factor, ATF-like (BATF), a transcription factor in the AP-1 family. Enforced expression of BATF was sufficient to impair T cell proliferation and cytokine secretion, while BATF knockdown reduced PD-1 inhibition. Silencing BATF in CD4+ and CD8+ T cells from chronic viremic patients rescued HIV-specific T cell function. Thus inhibitory receptors can cause T cell exhaustion by upregulating genes – such as BATF – that inhibit T cell function.					5734	57125	89853	5357	5641	8140	4753	646934	113791	8323	10472	26960	9499	7128	64112	4622	223117	399665	9349	11166	79754	2833	64081	10325	9412	10816	6844	3475	321	330	10693	6565	83752	4824	54455	6217	27244	358	10808	23210	54529	4256	23258	55631	3678	6521	9825	140597	923	11259	11006	2117	2696	9182	6431	4000	7686	56997	10210	55859	147172	374	5243	11022	10209	10769	8503	5047	55335	51526	1469	79133	694	7982	29940	22795	4146	11169	51094	3953	5921	5927	7124	4258	79058	79842	2776	6655	8021	6540	10876	1236	79791	2205	100287600	51172	8808	4942	9807	51084	51303	23764	10608	146	4118	8646	140578	7538	6285	26986	23020	2977	4314	6570	5569	51616	4681	112464	7041	80183	1833	80201	5042	56270	6252	55798	5565	1362	51619	6856	1776	10162	90011	124801	55559	10140	23635	7089	1152	23007	51241	55081	10451	23710	7695	394	26664	6428	1054	3178	55893	3195	10643	5149	4648	79807	9211	4147	63971	25797	6129	114034	6497	26102	80157	864	50613	1195	79661	55218	902	5244	81618	2004	734	55175	2877	79747	27299	6434	246721	23644	7247	64116	911	7280	5996	635	55012	53820	1936	51012	22874	27242	6840	7040	4973	23138	10634	50943
GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_DN	M4540		20890291	Quigley M,Pereyra F,Nilsson B,Porichis F,Fonseca C,Eichbaum Q,Julg B,Jesneck JL,Brosnahan K,Imam S,Russell K,Toth I,Piechocka-Trocha A,Dolfi D,Angelosanto J,Crawford A,Shin H,Kwon DS,Zupkosky J,Francisco L,Freeman GJ,Wherry EJ,Kaufmann DE,Walker BD,Ebert B,Haining WN.	GSE24081	GSE24081_1554_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of CD8 T cells with progressing HIV infection versus those with controlled HIV infection.	CD8+ T cells in chronic viral infections like HIV develop functional defects such as loss of IL-2 secretion and decreased proliferative potential that are collectively termed exhaustion1. Exhausted T cells express increased levels of multiple inhibitory receptors, such as Programmed Death 1 (PD-1). PD-1 inhibition contributes to impaired virus-specific T cell function in chronic infection because antibody-mediated blockade of its ligand, Programmed Death Ligand 1 (PD-L1) is sufficient to improve T cell function and reduce viral replication in animal models. Reversing PD-1 inhibition is therefore an attractive therapeutic target, but the cellular mechanisms by which PD-1 ligation results in T cell inhibition are not fully understood. PD-1 is thought to limit T cell activation by attenuating T cell receptor (TCR) signaling. It is not known whether PD-1 ligation also acts by upregulating genes in exhausted T cells that impair their function. Here, we analyzed gene-expression profiles from HIV-specific CD8+ T cells in patients with HIV and show that PD-1 coordinately upregulates a program of genes in exhausted CD8+ T cells from humans and mice. This program includes upregulation of basic leucine transcription factor, ATF-like (BATF), a transcription factor in the AP-1 family. Enforced expression of BATF was sufficient to impair T cell proliferation and cytokine secretion, while BATF knockdown reduced PD-1 inhibition. Silencing BATF in CD4+ and CD8+ T cells from chronic viremic patients rescued HIV-specific T cell function. Thus inhibitory receptors can cause T cell exhaustion by upregulating genes – such as BATF – that inhibit T cell function.					91543	10561	4940	1117	2634	2315	54739	5610	4938	3429	1373	6019	7374	10964	952	29923	79917	4430	11274	6978	1174	9678	3454	55165	1088	3002	55020	79161	26577	8334	3430	4638	54466	1832	375449	11098	5551	7130	173	23643	64422	79677	50832	66002	4488	7253	9447	22806	56913	5321	1135	225	3712	7011	7444	10665	8766	5788	7584	55320	2537	4939	6184	2999	10443	9289	1719	9994	5743	64799	9456	8833	51071	1718	55732	57116	5797	3717	84612	51643	10748	57415	115123	79657	100507436	55784	4636	1741	6241	9674	5359	10201	79635	23039	51152	6772	1017	100288944	3643	8715	55799	6368	28755	9582	10535	7634	387	29108	23741	26275	8277	56906	6491	25796	2867	85363	9156	55286	5341	28823	9376	8061	5721	64184	10313	10379	11228	10725	100506658	8170	445347	55756	23355	60313	8527	64779	2618	1006	8417	8269	54532	10247	9420	64761	1796	51313	55601	5795	9723	5478	9246	283131	57506	51109	387328	9976	23362	25790	6733	10308	64080	9617	53826	55259	26228	660	8139	23250	23108	55172	11065	9817	10586	57823	751816	51686	23114	10092	3904	55284	3652	9322	81542	9172	25840	9208	79983	6474	5933	4838	6645	28234	4332	81552	8496	10538	8894	55840	2765	7399
GSE24634_NAIVE_CD4_TCELL_VS_DAY3_IL4_CONV_TREG_UP	M4586		21347372	Prots I,Skapenko A,Lipsky PE,Schulze-Koops H.	GSE24634	GSE24634_1437_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive T cells at day 0 versus CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 3.	CD25+ regulatory T cells develop in the thymus (nTregs), but may also be generated in the periphery upon stimulation of naive CD4 T cells under appropriate conditions (iTregs). The mechanisms that regulate the generation of peripheral iTregs are largely unknown. We used microarrays to gain insights into the molecular program of extrathymic Treg development.					80201	10586	26249	5623	5295	80124	10140	9710	6988	738	2272	3655	9267	2533	923	55013	643641	25948	6165	256987	10520	79673	90864	7832	56969	81854	23670	130916	444	140801	54477	22861	8850	9905	1998	23324	663	11119	9802	8722	9910	1195	6135	64919	6232	64174	282997	11094	51526	100132923	2254	9516	55603	6296	1039	5731	10133	58473	534	79134	56731	51596	58533	11329	1901	11328	80975	59338	644068	8325	124152	5080	4300	55534	55970	23370	221037	54596	55000	4488	4598	25983	9120	80127	54934	6430	2273	3385	201229	3572	408	51621	55268	8554	23355	23484	3400	406	2534	9445	9550	962	9452	51176	9923	54855	83989	90410	23351	2308	56948	144404	472	25873	79161	51170	150094	57228	10021	9648	7128	54988	3983	60685	5837	5734	5142	3476	2131	22821	93	100129973	81619	9592	57212	55844	7048	5204	5533	6143	1777	10223	23023	10384	79090	51006	55664	831	80219	4616	23229	55049	3695	51282	26539	6609	98	10107	8525	4681	6468	10781	10423	25949	3097	22864	55290	9589	5912	57127	55716	4149	55790	11152	6932	728448	113791	3603	359	7852	2995	1831	9214	8349	4092	81558	678	7738	22905	22863	51460	6309	54941	8034	2555	919	1524	400451	54540	11320
GSE24634_NAIVE_CD4_TCELL_VS_DAY3_IL4_CONV_TREG_DN	M4587		21347372	Prots I,Skapenko A,Lipsky PE,Schulze-Koops H.	GSE24634	GSE24634_1437_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive T cells at day 0 versus CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 3.	CD25+ regulatory T cells develop in the thymus (nTregs), but may also be generated in the periphery upon stimulation of naive CD4 T cells under appropriate conditions (iTregs). The mechanisms that regulate the generation of peripheral iTregs are largely unknown. We used microarrays to gain insights into the molecular program of extrathymic Treg development.					10111	9156	241	7203	836	55326	79931	6397	10483	22948	56652	3842	140465	22907	23310	598	8566	4602	55353	65003	5872	2553	3417	6717	641	80347	27349	6119	8260	50999	4957	23463	5962	10072	10113	9700	4701	5985	7185	55839	26003	708	3303	3516	4173	51514	54908	55686	10714	10460	23404	25840	56886	26608	8317	2941	898	9817	3329	11264	9735	5725	92856	27306	10653	63875	8833	28957	7415	10409	972	5202	11014	81554	10213	3682	2107	8407	7982	84986	10295	9833	813	79639	25804	80723	51103	51022	1643	5425	840	54733	7329	645745	8131	55131	8613	55651	51728	1512	9477	403	5714	29781	8493	57003	928	4809	29925	2730	3014	516	54555	10148	5721	27161	8662	50813	3028	5471	10221	79675	8438	5686	55120	7070	55858	10989	3123	7112	7024	23560	4709	8837	55332	4522	1718	10576	63931	9935	3418	6183	6729	6634	4360	56935	27242	55109	8318	334	80198	375035	64943	10328	2582	7124	4361	10383	2720	11127	637	10574	5594	4162	3416	1439	27429	2876	51106	5822	2058	54517	644	56992	4085	2305	26521	10592	4288	11198	84908	5026	6837	81873	3512	10721	3069	51762	80010	5707	2517	7453	8449	55379	81892	2717	4689	10267	10598	28959
GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_UP	M4588		21347372	Prots I,Skapenko A,Lipsky PE,Schulze-Koops H.	GSE24634	GSE24634_1438_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive T cells at day 0 versus CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 5.	CD25+ regulatory T cells develop in the thymus (nTregs), but may also be generated in the periphery upon stimulation of naive CD4 T cells under appropriate conditions (iTregs). The mechanisms that regulate the generation of peripheral iTregs are largely unknown. We used microarrays to gain insights into the molecular program of extrathymic Treg development.					10140	57212	6988	83716	1120	1021	534	4256	79862	11236	51335	22859	79159	9516	54941	6165	10347	4600	55690	80778	23253	80975	5565	6158	79960	9120	3983	152006	80149	1112	64919	54715	596	23484	55268	9923	79441	22890	51696	9267	10346	90233	8460	10107	6135	6430	9595	22881	90410	6448	55603	10396	51307	57523	23452	124152	6314	8303	130916	54934	2272	23053	29072	54956	9139	399	79090	8675	51561	6164	140801	51439	10499	54929	81606	6204	221061	1998	635	23345	2254	4598	8722	4832	55182	9802	54855	79695	26137	8525	3590	1604	51555	55819	23031	27334	54916	22863	55049	406	25939	11119	8859	57396	90864	7480	50839	7718	6159	604	10084	6521	51282	2825	6161	65982	10472	79962	23522	22869	3655	58533	3400	939	969	221037	55850	51411	63917	5184	6604	100288594	7704	64750	83700	4601	22861	5623	112869	25948	79089	54876	1039	275	10936	55186	10603	9883	1757	868	9706	5731	4485	51385	6143	55623	100132406	3669	8396	728498	4616	268	55844	5590	84148	3133	79668	6208	2886	387751	85452	57124	4908	3699	11320	387509	80162	919	1195	58473	54851	51710	66035	79788	10916	55167	11039	57035	1327	60685	3134	2308	30827	9550	60468	4792	57111	2962	9902	54462
GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_DN	M4589		21347372	Prots I,Skapenko A,Lipsky PE,Schulze-Koops H.	GSE24634	GSE24634_1438_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive T cells at day 0 versus CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 5.	CD25+ regulatory T cells develop in the thymus (nTregs), but may also be generated in the periphery upon stimulation of naive CD4 T cells under appropriate conditions (iTregs). The mechanisms that regulate the generation of peripheral iTregs are largely unknown. We used microarrays to gain insights into the molecular program of extrathymic Treg development.					9735	10574	55226	60	3093	26472	51182	1457	57099	11127	1104	10111	10994	7203	10538	7185	23560	55856	79712	2274	55247	672	23395	8611	1736	83475	51184	4913	10212	80777	403	10146	51678	952	5571	10440	8260	1267	79174	836	64682	3837	3098	10069	26608	4702	29095	79731	10059	4718	51116	55686	10813	79447	533	81034	5511	11014	224	27338	80347	2034	51382	9361	51018	840	11162	10939	7347	2135	51103	27068	54205	9446	79228	25940	7873	3306	3301	3516	23310	10436	10989	9134	5471	1317	5877	10572	3329	3068	149603	57418	5245	54948	8774	10483	11062	10613	7965	3028	83737	60496	51121	91860	4771	38	4602	9477	55500	10598	51762	9402	5478	829	23463	10113	84296	972	4709	23234	3417	9833	23208	10576	6443	8402	4141	8570	292	10229	1020	80198	1062	7884	528	2937	8833	11051	5693	5202	64318	4354	25841	10403	7332	37	7922	8624	8974	5810	55192	55858	708	2739	5701	64422	56886	55847	10072	79139	3418	55131	1497	5427	1643	5704	645	644	2058	790	10954	7334	64108	51491	84908	54606	3336	57102	9604	2107	3312	54918	54517	51371	7453	50	55759	55127	8192	5905	79736	27349	51703	2178	943	4739	51651	9391	3159	7112
GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_UP	M4590		21347372	Prots I,Skapenko A,Lipsky PE,Schulze-Koops H.	GSE24634	GSE24634_1439_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive T cells at day 0 versus CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 7.	CD25+ regulatory T cells develop in the thymus (nTregs), but may also be generated in the periphery upon stimulation of naive CD4 T cells under appropriate conditions (iTregs). The mechanisms that regulate the generation of peripheral iTregs are largely unknown. We used microarrays to gain insights into the molecular program of extrathymic Treg development.					64750	152006	23013	6448	4043	80778	54941	738	23384	54855	5565	23787	3678	23189	51621	10347	65980	79065	9120	80219	10505	6988	10123	5734	8848	7128	26999	9728	1628	25939	4616	23389	112869	9923	728498	4092	6932	79960	5970	51307	54704	54876	3134	8034	85452	25983	54813	22869	9057	9392	23177	55167	114034	55049	9658	79134	10162	1877	29966	6309	5786	7536	8525	831	6942	1755	26993	408	8187	79441	8495	10668	32	472	57228	25843	23368	5989	23214	10325	55664	8545	79786	2802	23078	1655	6158	64112	4598	10140	80162	51759	7089	64919	113791	9592	140801	89941	55720	10084	29115	63935	80127	8460	23338	90864	4335	10482	81576	10346	3727	9710	2272	8554	7267	23007	64091	4140	4753	55113	79034	3875	81558	84809	288	9367	79690	8462	11108	5731	150094	9929	9920	51526	64778	54934	65982	126231	56965	5187	6259	11236	440515	3757	23411	6468	1039	11320	2254	755	79883	57615	7538	26137	56928	79158	9684	2308	57109	3490	23598	23383	7405	140710	57134	8694	5217	2317	944	6304	79630	7852	10045	10127	55000	79946	51430	2353	11083	8379	339287	6314	64061	56987	7803	80063	80149	57798	23228	22863	2323	9903	10423	25950	79673	23710	51520	7159	285231	83752
GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_DN	M4593		21347372	Prots I,Skapenko A,Lipsky PE,Schulze-Koops H.	GSE24634	GSE24634_1439_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive T cells at day 0 versus CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 7.	CD25+ regulatory T cells develop in the thymus (nTregs), but may also be generated in the periphery upon stimulation of naive CD4 T cells under appropriate conditions (iTregs). The mechanisms that regulate the generation of peripheral iTregs are largely unknown. We used microarrays to gain insights into the molecular program of extrathymic Treg development.					4830	4522	55353	53	226	10989	1992	3155	5082	6603	1643	2787	54836	5478	29925	80347	9446	10148	23636	6397	5686	10059	25804	140465	11068	8705	10005	4783	6713	9833	79022	5690	8226	8837	8892	26010	3071	3428	953	79139	9989	332	55120	5531	55732	9817	27089	2553	308	8317	2804	1719	6183	10213	55247	2237	4706	55526	7415	4678	10130	1062	5888	4701	9735	2672	5873	1267	10072	4361	2954	51657	26228	10606	699	5983	83737	9156	23468	10994	81554	9158	2184	5360	8682	965	9477	11014	55775	2235	37	5932	54512	292	10051	142	55686	11267	6119	1512	58472	5910	9878	518	79084	991	2034	9577	22948	11262	7884	3559	842	5985	5810	3123	39	7263	10538	29028	2274	51762	8364	2530	6241	4175	116832	55010	3709	55847	10714	55252	5141	6790	9055	10221	4258	56992	3956	80222	516	7453	11145	914	51103	9767	10540	5880	8728	2713	9761	4292	51728	51056	60490	788	55176	1234	79081	5594	51474	8847	29015	3321	1798	9133	22974	587	1232	51203	641	29095	56474	4644	6566	79622	8574	10112	4176	644	54806	2146	9700	5682	51022	10327	302	822	51155	23597	11004	10113	26191	2717	6722	1163	79174	9837	56954	8611
GSE24634_NAIVE_CD4_TCELL_VS_DAY10_IL4_CONV_TREG_UP	M4596		21347372	Prots I,Skapenko A,Lipsky PE,Schulze-Koops H.	GSE24634	GSE24634_1440_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive T cells at day 0 versus CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 10.	CD25+ regulatory T cells develop in the thymus (nTregs), but may also be generated in the periphery upon stimulation of naive CD4 T cells under appropriate conditions (iTregs). The mechanisms that regulate the generation of peripheral iTregs are largely unknown. We used microarrays to gain insights into the molecular program of extrathymic Treg development.					22869	55664	644068	5396	5163	9706	57124	388796	2272	51526	6210	7048	4745	10957	6165	5697	55061	22836	201229	25803	8331	2197	10103	7022	51621	5608	6143	7274	444	80108	63917	79772	8409	4675	9120	30814	26289	79862	7039	1442	100293679	58473	64061	6469	321	8339	4007	29842	7379	8460	23308	10922	94	9929	995	1634	113791	79960	5364	90665	22821	28974	80155	100132406	2886	53616	9743	1302	4092	55113	387509	22863	29914	6169	274	5016	7140	8525	6155	6402	10107	84900	3619	4888	26094	55821	55178	23266	3661	27290	950	54663	1018	755	268	6234	646	51316	3082	60370	54934	1937	55622	6309	29080	5204	2217	7480	5319	1525	55653	477	6296	50809	79935	9737	9781	8527	3875	9245	51195	79977	3664	7476	904	7105	55891	80303	80262	60685	1797	53841	79673	816	5731	4053	5142	6135	51181	3655	6098	55167	390998	10140	8767	189	58503	282997	23189	3004	23252	91	2041	3572	6206	1956	5184	10319	112869	8828	79034	9658	9920	8225	57134	55324	22895	84830	59344	4975	23617	54704	259173	5744	4993	3978	740	51200	26103	8912	81887	6157	10235	343071	79159	6519	79695	10570	9633	5630	114034	55422	80765	11224	56257	23484	23541	8420	93144	4684
GSE24634_NAIVE_CD4_TCELL_VS_DAY10_IL4_CONV_TREG_DN	M4597		21347372	Prots I,Skapenko A,Lipsky PE,Schulze-Koops H.	GSE24634	GSE24634_1440_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive T cells at day 0 versus CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 10.	CD25+ regulatory T cells develop in the thymus (nTregs), but may also be generated in the periphery upon stimulation of naive CD4 T cells under appropriate conditions (iTregs). The mechanisms that regulate the generation of peripheral iTregs are largely unknown. We used microarrays to gain insights into the molecular program of extrathymic Treg development.					842	10989	5911	5141	54165	528	8566	5732	567	2965	914	6888	55884	6241	6526	8705	10248	965	9055	57178	10714	10051	51022	50999	3431	56674	25979	28959	55326	9061	5547	8837	85236	4664	4914	5500	10111	4702	54554	836	38	9258	25840	26010	29108	84986	9833	8766	7107	308	3155	10327	26003	79143	1992	9768	23380	952	51203	50485	3093	79188	25841	8743	9232	6897	7045	22974	56925	55071	51363	10606	51	6397	10221	2787	63826	7905	1267	9363	23788	5910	788	3070	2110	991	7419	4074	10666	55686	56910	26191	51382	3105	7415	10538	27346	6603	147179	2730	9780	7185	142	10109	11145	2178	64834	10213	55909	10548	57157	26228	56983	51063	8226	1163	5606	5686	54806	9466	3682	26608	9817	11004	5872	1070	9761	3516	63875	203068	80223	22906	3920	5525	140465	1643	2760	54	10403	10098	51703	10190	27306	1495	1293	64764	57819	55425	3417	79770	55353	29082	302	171220	9404	5962	7083	637	10935	10540	5036	974	641	1612	51728	2720	3418	7768	83475	10112	223	9133	23636	7867	10063	57003	51347	23231	6362	6367	10130	55500	6696	5983	6790	259266	1508	3067	51099	3958	8672	115817	9325	29071	9989	7171	2672	3837	8269	6416
GSE24634_TREG_VS_TCONV_POST_DAY3_IL4_CONVERSION_UP	M4599		21347372	Prots I,Skapenko A,Lipsky PE,Schulze-Koops H.	GSE24634	GSE24634_1445_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 3 versus CD25- T cells incubated with IL4 [GeneID=3565] at day 3.	CD25+ regulatory T cells develop in the thymus (nTregs), but may also be generated in the periphery upon stimulation of naive CD4 T cells under appropriate conditions (iTregs). The mechanisms that regulate the generation of peripheral iTregs are largely unknown. We used microarrays to gain insights into the molecular program of extrathymic Treg development.					9184	8131	92856	8668	9141	10383	8891	51514	54908	23225	6627	23310	2530	3336	10926	5822	79850	63875	84908	27079	55833	9532	10270	6675	8260	7430	8192	4495	9837	80895	5725	10063	29781	79050	705	9221	29127	9735	7353	10594	79081	51188	7407	81875	23160	23386	5426	25829	5366	1163	4670	8318	51406	6449	1965	4222	23404	28969	84909	10102	6150	57476	241	580	10535	6634	10111	10212	114034	80185	56902	5202	6890	6183	4691	8140	9158	64785	3608	402055	11184	7112	81620	4493	2597	9361	6723	79023	3182	6897	27161	4605	54977	64118	23354	55143	8607	9252	9277	6240	894	3396	1058	8836	3094	115939	642	4361	1503	27297	29015	51099	55388	23545	471	3329	79022	155066	1841	259197	55270	9937	3843	10576	55131	8611	23399	4953	55081	1178	3976	6895	4288	10622	10248	4050	29105	2023	1431	5347	598	27349	5425	7185	4931	10059	56652	23203	79590	6674	79707	8241	10460	54892	28978	7278	641	57019	4913	28755	708	7167	5378	81554	2205	9688	10574	10419	57553	79669	9156	2941	55110	49856	25804	79648	25996	54821	4292	51728	79866	7866	3978	4116	25865	5134	64425	9040	51460	1063	11198	5520	8106	79989	81930	84271	7443	150726	10330	4836
GSE24634_TREG_VS_TCONV_POST_DAY3_IL4_CONVERSION_DN	M4600		21347372	Prots I,Skapenko A,Lipsky PE,Schulze-Koops H.	GSE24634	GSE24634_1445_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 3 versus CD25- T cells incubated with IL4 [GeneID=3565] at day 3.	CD25+ regulatory T cells develop in the thymus (nTregs), but may also be generated in the periphery upon stimulation of naive CD4 T cells under appropriate conditions (iTregs). The mechanisms that regulate the generation of peripheral iTregs are largely unknown. We used microarrays to gain insights into the molecular program of extrathymic Treg development.					5025	25840	145389	55357	79591	945	4189	57823	10520	3958	978	79630	10904	8569	5271	408	23328	6362	712	11343	55589	51172	10226	91860	247	2022	4217	55761	7941	9023	7052	57020	53346	3074	8869	1240	4126	55819	2633	1314	9445	115207	10561	4668	51296	3460	3073	53829	4358	528	3155	19	1075	79921	55198	533	1349	2630	5002	54	83449	64170	23136	8741	51112	23424	131544	8462	7076	972	6347	3588	2876	23129	5341	713	79668	23531	1774	58504	4005	55233	51170	51094	28959	847	6016	6383	55577	6556	8635	55823	5912	7096	51706	1519	8985	23682	1312	56895	25801	79772	64218	1955	9697	3586	50813	9338	3956	8829	6035	3119	6850	26	23023	3575	5147	151011	302	9886	3606	8714	10090	256987	29940	8804	55831	182	942	10955	8291	114876	3903	1601	5660	948	3790	3992	475	55365	286148	10062	23355	1329	4814	5538	23643	51063	3109	9784	1052	3055	25966	637	64174	571	54453	3108	22797	56674	115	2040	4647	5728	56605	1508	1026	58533	9976	55603	80896	79658	1438	2212	3916	4332	1522	8935	8613	81609	3128	5204	427	1389	27243	81553	11039	1845	221749	29994	8723	2717	3689	8455	22862	51382	3490	30844	10312	7107
GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_UP	M4601		21347372	Prots I,Skapenko A,Lipsky PE,Schulze-Koops H.	GSE24634	GSE24634_1446_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of CD25+ T cells treated with IL4 [GeneID=3565] versus CD25- T cells treated with IL4 [GeneID=3565] at day 5.	CD25+ regulatory T cells develop in the thymus (nTregs), but may also be generated in the periphery upon stimulation of naive CD4 T cells under appropriate conditions (iTregs). The mechanisms that regulate the generation of peripheral iTregs are largely unknown. We used microarrays to gain insights into the molecular program of extrathymic Treg development.					57476	55127	5631	5245	51491	7884	79080	5198	2805	54962	54919	23028	6631	163	2058	25841	54517	26051	11127	3608	26517	23463	51182	8363	5499	6749	5692	5557	51021	4345	57099	23310	516	10950	51406	7163	672	80777	23595	55178	79843	9933	1736	10939	8260	146712	55355	10212	7334	54821	708	10240	51293	51018	5481	28974	11262	5471	51388	51118	7332	5984	356	55247	10111	10535	26973	9040	23560	10105	440	23234	10856	10969	9645	2935	55299	23511	5445	83460	79731	622	10776	746	65003	9801	55239	5433	2146	7270	79187	84901	3628	204	11198	55319	56672	29914	10721	1478	2395	7347	11062	4701	27000	10293	402055	79833	440193	8833	80178	5347	9183	6611	51011	5827	3419	10915	60490	8412	9918	6566	634	8837	64897	10069	8226	3028	26472	10574	26031	2618	4913	84864	5928	9319	1716	54733	4288	81034	7272	11145	908	6059	10229	54107	29980	790	10606	10197	5982	55915	9156	3052	9111	11339	378708	83461	51016	4999	84549	10573	55280	9519	26519	9735	51728	1729	9410	4802	22929	55110	55148	55166	55775	10926	2079	9669	79723	4605	81873	5888	1662	23516	4751	8891	64216	79071	81620	5684	29078	9991	28231	5698	115353	23550	5718	7371	5702	5810
GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_DN	M4603		21347372	Prots I,Skapenko A,Lipsky PE,Schulze-Koops H.	GSE24634	GSE24634_1446_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of CD25+ T cells treated with IL4 [GeneID=3565] versus CD25- T cells treated with IL4 [GeneID=3565] at day 5.	CD25+ regulatory T cells develop in the thymus (nTregs), but may also be generated in the periphery upon stimulation of naive CD4 T cells under appropriate conditions (iTregs). The mechanisms that regulate the generation of peripheral iTregs are largely unknown. We used microarrays to gain insights into the molecular program of extrathymic Treg development.					4951	968	81606	2512	1026	112869	23053	4600	55333	2022	7305	1831	9308	57212	90864	9056	5872	65982	1536	1649	8879	5791	126231	228	3831	4065	3142	5476	3115	8564	64919	5742	4082	962	25840	6430	6624	1318	7106	7058	8925	10409	2335	2217	23345	9341	2896	55601	23312	10628	84148	10261	23433	22998	782	55819	1495	4601	80024	56997	6279	22864	23129	2207	3133	6232	3107	51646	3134	23500	8869	3535	1520	140885	27074	11337	10437	55690	4891	1438	51084	29803	408	10577	604	30835	60468	54	3958	1519	8658	716	55823	8832	23396	6507	23461	83637	26119	6916	23179	23654	11182	79758	7852	26249	6297	11119	1806	79630	975	4671	55793	57161	23201	654817	220972	8985	27128	6252	8778	57728	116985	94134	4669	2213	65018	55716	10443	537	4758	1230	6768	114044	222161	1508	5175	130916	7077	5451	2359	56034	51339	116984	3988	8848	3563	1436	55647	23466	8481	8741	6259	7850	1522	5341	26020	53	64581	942	7045	5286	23361	54540	55365	6322	3566	1890	8767	3570	6347	10781	4063	79788	2811	7096	4245	84809	3055	7105	79090	284021	23216	6367	3460	10970	8878	4067	79673	59338	9896	9936	9906	64231	8875	8804	26034	6604	9144	51761
GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_UP	M4604		21347372	Prots I,Skapenko A,Lipsky PE,Schulze-Koops H.	GSE24634	GSE24634_1447_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 7 versus CD25- T cells treated with IL4 [GeneID=3565] at day 7.	CD25+ regulatory T cells develop in the thymus (nTregs), but may also be generated in the periphery upon stimulation of naive CD4 T cells under appropriate conditions (iTregs). The mechanisms that regulate the generation of peripheral iTregs are largely unknown. We used microarrays to gain insights into the molecular program of extrathymic Treg development.					6241	7884	699	1352	55055	9133	25839	6707	116832	1644	9477	79413	994	29028	2584	9158	27338	9878	3559	25941	842	6472	11169	435	3832	991	60490	9937	5810	11267	2530	1478	11004	5888	2625	9735	9452	1271	4129	79081	26528	51053	1062	3662	54836	1846	974	2237	11065	1232	8743	309	8364	5827	54892	11262	3581	3978	25841	8318	10072	11130	2146	3418	9833	28755	79022	9156	83759	4001	3835	8809	332	1979	7936	57165	8317	2842	22974	5880	79968	891	7083	1719	55176	9837	65003	9787	3182	56654	8556	6790	2260	27089	1058	26191	10120	6119	890	1390	56992	4689	8611	64963	51514	24137	55915	10535	79019	1063	6183	26998	81623	51203	4917	55215	1369	9319	4173	4914	51364	5799	10733	9232	79714	25861	6897	5579	3014	10301	9235	1854	51155	56474	9649	4171	1163	55839	51016	4176	55355	4602	1104	9212	8989	22990	3560	8502	9055	1237	3507	84722	56061	952	5984	55165	7298	23208	54555	7027	57795	28231	55143	29980	55750	56125	23759	9768	10383	4605	378708	26051	5932	22800	8689	8847	7156	4701	2189	11151	79071	7468	27300	1033	10158	641	10381	5026	81620	10615	1800	2677	54733	1164	64410	55732	83729	23468	3709	11251
GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_DN	M4606		21347372	Prots I,Skapenko A,Lipsky PE,Schulze-Koops H.	GSE24634	GSE24634_1447_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 7 versus CD25- T cells treated with IL4 [GeneID=3565] at day 7.	CD25+ regulatory T cells develop in the thymus (nTregs), but may also be generated in the periphery upon stimulation of naive CD4 T cells under appropriate conditions (iTregs). The mechanisms that regulate the generation of peripheral iTregs are largely unknown. We used microarrays to gain insights into the molecular program of extrathymic Treg development.					240	2734	3459	8879	8829	928	7779	53829	6810	967	6518	6448	6035	3489	1512	4891	65982	4126	54741	2934	10875	23764	55823	7474	51706	54	8754	3176	9725	55092	8942	2180	55686	4205	3142	8795	1514	1508	3958	1890	11108	23433	2054	23531	6925	2217	25780	408	7096	7077	1536	1116	28959	1240	5467	2213	79946	7267	3394	6850	929	6932	3460	6303	6368	10161	5970	6367	728498	5791	79034	1075	2760	1026	79651	3606	79695	23189	8495	8804	2359	116985	57698	10512	481	217	7852	6252	2353	23179	81618	9710	80778	81501	114548	6507	8187	10180	1519	79630	427	2512	8685	51090	5054	5836	23643	5660	11000	8564	51520	55819	1408	339287	4332	11343	29967	6347	5329	3988	4063	9737	23659	7941	8878	80896	1520	4335	1545	157562	7305	1475	8848	9332	23338	55786	2335	58528	11182	1523	55244	100286937	10184	55704	54502	5252	3074	138151	9637	145389	51296	55284	55647	3992	79887	10807	10409	56271	8869	23275	126231	56034	6361	4023	1628	115207	2531	1594	8642	10970	1124	3055	5872	5328	4753	712	140885	968	2495	6369	59342	55852	11006	9765	1522	64778	4234	23568	6319	6643	202	29760	760	4318	4321	23191	1515	25797	4069	30835
GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_UP	M4607		21347372	Prots I,Skapenko A,Lipsky PE,Schulze-Koops H.	GSE24634	GSE24634_1448_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 10 versus CD25- T cells treated with IL4 [GeneID=3565] at 10 h.	CD25+ regulatory T cells develop in the thymus (nTregs), but may also be generated in the periphery upon stimulation of naive CD4 T cells under appropriate conditions (iTregs). The mechanisms that regulate the generation of peripheral iTregs are largely unknown. We used microarrays to gain insights into the molecular program of extrathymic Treg development.					79770	79081	57099	25996	55326	9787	22974	2672	29127	952	729230	3835	5732	79991	93081	10403	3428	8501	4292	6873	11073	51063	10813	6611	8837	3065	10592	8604	5093	57122	6955	7298	28231	2034	28960	10714	4175	9780	7112	9833	80010	9055	5429	8563	7083	1298	6775	580	79070	5932	8395	10111	8277	5422	330	55425	3070	55148	146909	4016	841	641	10538	8826	3094	596	5500	3559	8809	5579	51203	4049	175	10899	1478	7351	9459	6472	5600	9133	3431	55743	824	259266	27347	5026	29922	1062	3148	6867	865	701	9768	9735	60490	79677	7903	64080	9470	8835	1192	27306	9991	55120	64787	29909	9414	23108	10528	8850	2643	10365	57157	5983	84986	5367	9325	2530	9761	1719	2625	5471	64151	4171	8974	10762	23560	7582	11004	7185	23516	2592	8452	1479	6877	9632	384	891	80342	4361	8717	79174	10248	3059	5692	11262	2287	115123	5985	10051	8894	9097	6504	2547	1233	29028	9879	27250	3516	1293	833	11001	8573	4222	10133	26010	10314	3105	22838	974	9235	10235	10666	5984	9582	27334	388650	9700	56954	51347	64764	6509	79694	81930	116984	10938	5036	3927	23048	4522	9645	79188	4088	8776	3832	7334	116496	200316	55544	203068
GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_DN	M4612		21347372	Prots I,Skapenko A,Lipsky PE,Schulze-Koops H.	GSE24634	GSE24634_1448_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 10 versus CD25- T cells treated with IL4 [GeneID=3565] at 10 h.	CD25+ regulatory T cells develop in the thymus (nTregs), but may also be generated in the periphery upon stimulation of naive CD4 T cells under appropriate conditions (iTregs). The mechanisms that regulate the generation of peripheral iTregs are largely unknown. We used microarrays to gain insights into the molecular program of extrathymic Treg development.					10875	55366	321	2717	22797	2359	11031	2022	114548	55819	11328	55092	10184	140885	2535	760	8495	290	58473	6272	4668	3693	3162	145389	645	5319	57698	3687	5328	9056	55240	113791	23022	2217	54502	10462	3417	334	10134	7570	6768	9060	10493	114876	7096	6948	2752	2876	716	1382	53346	6874	140	8767	5168	54209	23216	5608	1075	51338	5660	54438	6678	10577	4125	23191	1508	942	11182	23475	4332	7106	23433	59342	1050	79746	847	7305	929	1522	29992	1581	1026	6696	1436	1318	3122	55160	55315	2934	60370	6252	6279	3109	5768	713	5836	6035	4023	23643	9103	8741	341	3055	7035	79695	80303	23621	79630	6280	2517	28959	26119	3684	10062	9540	6362	7077	50854	2512	3101	3988	5476	10099	366	444	2268	1488	51363	10461	1593	3624	10261	8829	1230	4000	6574	9781	64759	10327	822	1545	717	5376	11332	2167	56034	1514	10161	8564	11000	79887	3920	3992	8804	6319	91	9019	4360	23129	6850	5244	10437	85236	5872	2212	945	11006	56833	712	6357	3915	2896	928	8613	1051	51296	2040	6604	7046	2180	26509	58504	23313	25780	26289	3689	967	57136	84617	4128	1124	6453	27180	2203	23179	3849	9332	64581	191
GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_UP	M4613		21347372	Prots I,Skapenko A,Lipsky PE,Schulze-Koops H.	GSE24634	GSE24634_1449_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of CD25+ T effector cells treated with IL4 [GeneID=3565] at day 3 versus untreated CD25- T cells at day 3.	CD25+ regulatory T cells develop in the thymus (nTregs), but may also be generated in the periphery upon stimulation of naive CD4 T cells under appropriate conditions (iTregs). The mechanisms that regulate the generation of peripheral iTregs are largely unknown. We used microarrays to gain insights into the molecular program of extrathymic Treg development.					8726	10063	8611	54517	200734	4691	5805	5796	23378	3800	9391	1503	4809	57099	1152	27347	5427	56342	2178	51651	54623	3662	55752	10376	11156	1803	79622	9371	79677	23518	5111	25940	22876	65005	8669	5888	51042	23516	8892	10199	292	11130	10953	9258	9016	9133	1939	57157	10112	5725	5026	203068	7371	23035	8624	2171	5446	54962	7867	51067	54478	1493	80028	1058	10592	26073	55215	3837	4953	9361	54919	1854	56992	6732	11198	79019	3925	7443	8837	6119	3458	26031	55930	580	84790	10148	6502	9945	64785	642	596	7270	790	4331	51491	92856	84986	7264	246243	7639	8890	4580	115939	10926	9700	79801	7167	90861	83460	6367	65108	516	80273	51762	5366	6004	9055	10892	54707	9047	7268	3692	6504	6182	64897	7153	26228	55686	8192	51389	4913	22907	55110	10606	11056	7083	3094	5873	8458	54475	8821	65993	79598	51218	27349	23170	10617	9238	378708	23397	51154	597	701	51700	57109	5442	81620	983	80185	64682	10885	3002	11065	27346	10051	9933	22800	6675	10939	9184	1841	1434	11116	23310	4128	6877	8260	79931	79081	4050	9533	6775	55872	2153	8568	23052	1123	79084	26472	79022	26586	2530	2146	7298	8531	26517	55299	2071	4522	7813
GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_DN	M4616		21347372	Prots I,Skapenko A,Lipsky PE,Schulze-Koops H.	GSE24634	GSE24634_1449_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of CD25+ T effector cells treated with IL4 [GeneID=3565] at day 3 versus untreated CD25- T cells at day 3.	CD25+ regulatory T cells develop in the thymus (nTregs), but may also be generated in the periphery upon stimulation of naive CD4 T cells under appropriate conditions (iTregs). The mechanisms that regulate the generation of peripheral iTregs are largely unknown. We used microarrays to gain insights into the molecular program of extrathymic Treg development.					1234	23643	3128	9341	3073	56606	9338	4354	55340	53	8942	6556	58472	54504	4669	912	654817	2353	6932	6256	1310	29992	3108	56034	57134	6468	53829	8754	8291	6050	4125	64077	3283	9936	8349	7096	6850	9034	5920	799	23307	100129250	712	1601	4126	7057	56965	2720	6279	7097	145389	4925	11326	9896	26253	51084	10461	133	1316	2938	100289410	6039	9056	10327	91782	3687	79137	1519	23596	51466	22834	54925	6347	10653	282997	4332	57192	1230	10370	8829	10548	3417	2040	56935	54453	5265	1514	4053	23071	3006	10384	2859	51311	10723	80896	26509	2217	11006	6351	22806	6622	9976	1318	2207	1536	537	3613	55757	968	1051	56948	847	3693	51363	9540	10134	1389	6272	3959	321	6402	9473	115207	123803	313	9050	334	25939	51338	7580	9236	862	2799	10288	50856	1593	717	11039	83481	2268	55332	2212	8832	79411	5476	10437	929	2219	841	10161	23585	54432	8277	9920	3176	9332	9619	4600	2124	7739	54103	10253	10875	1893	5226	55803	3988	9935	8764	5002	8685	10223	64747	151011	23179	3137	5836	1730	26226	56833	3983	4688	51816	6482	23136	2272	23189	55013	114876	3055	4864	5925	8495	1026	55577	3903	710	3162	10916	1890
GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_UP	M4617		21347372	Prots I,Skapenko A,Lipsky PE,Schulze-Koops H.	GSE24634	GSE24634_1450_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated CD25+ T effector cells at day 5 versus untreated CD25- T cells at day 5.	CD25+ regulatory T cells develop in the thymus (nTregs), but may also be generated in the periphery upon stimulation of naive CD4 T cells under appropriate conditions (iTregs). The mechanisms that regulate the generation of peripheral iTregs are largely unknown. We used microarrays to gain insights into the molecular program of extrathymic Treg development.					9184	26298	9793	54107	90355	4802	26521	10111	2274	7027	11127	10102	54962	3925	6472	54517	23516	8833	5202	55379	10048	29901	63933	27101	79866	55839	3336	60528	26747	2739	9141	4085	1894	54908	1233	8900	8624	26146	23310	4176	79833	27068	10767	10654	11146	5984	51053	55509	6877	81620	6241	246126	9410	79895	55759	54948	4836	22976	79712	79023	5810	10963	29789	11124	51237	79035	10926	2935	147339	29781	79075	2237	6675	9373	1841	10592	9019	4171	10001	5910	56992	1719	4602	9768	8563	8502	6504	5902	3843	25940	3706	53918	3595	10269	8774	54927	55148	84790	7982	3835	9156	7421	10196	55239	4605	3276	5985	80273	9933	9493	10063	81892	55840	10726	26586	64976	10950	23210	23208	79081	10534	9833	9700	4001	10051	8836	2833	8540	5347	10330	2806	5717	8835	7884	5877	26354	6150	3052	55131	5932	6470	8317	54881	64785	166647	10477	27349	1965	8099	55299	2146	5435	23028	8864	55559	8106	1104	6502	57175	26472	51099	78988	10294	1854	7298	4706	4809	79863	10131	10059	4689	2305	9631	3033	11004	8668	2842	1063	10128	38	7993	27347	29078	9015	9984	7272	201254	55975	8669	8975	79019	3149	55071	5718	10560	7171	1033	26517	56886	25788
GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_DN	M4620		21347372	Prots I,Skapenko A,Lipsky PE,Schulze-Koops H.	GSE24634	GSE24634_1450_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated CD25+ T effector cells at day 5 versus untreated CD25- T cells at day 5.	CD25+ regulatory T cells develop in the thymus (nTregs), but may also be generated in the periphery upon stimulation of naive CD4 T cells under appropriate conditions (iTregs). The mechanisms that regulate the generation of peripheral iTregs are largely unknown. We used microarrays to gain insights into the molecular program of extrathymic Treg development.					3665	51621	399	10520	8666	9924	6158	8237	65981	3437	6050	79176	81894	3932	9966	22869	919	5256	90864	10964	2814	1519	3687	6237	10771	80149	9710	6892	55893	3557	29114	4940	221061	3632	5184	387751	93144	80195	55905	55844	10913	10347	51816	9744	28755	80212	5412	8971	79090	51191	10859	1316	25956	6293	4118	288	1535	26207	10970	55422	2053	9881	10169	687	84159	4671	2145	7596	4145	9806	64772	9267	22841	2537	5467	4973	6257	3097	55819	79706	9910	5151	51160	11277	56034	51176	84809	9489	7050	3137	27241	54980	26509	23765	3983	10577	26151	5590	7707	26020	4063	26034	23031	3275	51646	2041	1120	7673	51316	64112	10424	7074	54900	28823	537	6430	5411	3566	22882	4600	10346	8848	5830	5279	22864	84148	10653	3135	2588	9397	78987	65258	738	23355	27434	54765	3384	10561	4832	57612	57576	56997	114044	5163	23637	282997	27250	9242	8379	4791	9814	27165	5790	9550	9976	6834	57228	29803	79744	5125	5720	23059	9263	7696	11046	8925	9214	6193	28639	10039	3603	7045	2533	10581	5158	9764	8292	11253	56965	100272147	8481	6768	29990	100507436	861	50854	7267	23228	23324	23643	11040	2634	9802	58473	51131	10916	50865	3684	8334	51276
GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_UP	M4622		21347372	Prots I,Skapenko A,Lipsky PE,Schulze-Koops H.	GSE24634	GSE24634_1451_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated CD25+ T effector cells at day 7 versus untreated CD25- T cells at day 7.	CD25+ regulatory T cells develop in the thymus (nTregs), but may also be generated in the periphery upon stimulation of naive CD4 T cells under appropriate conditions (iTregs). The mechanisms that regulate the generation of peripheral iTregs are largely unknown. We used microarrays to gain insights into the molecular program of extrathymic Treg development.					3835	53405	1237	51053	51098	27347	8438	11124	10112	9200	388796	2530	5822	84823	8836	2235	25941	7430	10198	51634	23649	6491	64151	5569	4173	4602	3902	11100	9235	11116	4628	84986	412	5984	63894	3148	11065	1233	23397	2189	54674	5383	29789	55355	50619	56992	5557	79694	10225	7293	55775	868	10620	995	7278	7421	4175	5026	51021	5932	9143	64427	56650	79072	11130	26227	9700	65003	23157	3925	5111	6619	9780	890	11262	115201	8364	914	64087	9368	79019	1841	4085	729230	3149	1846	24137	2833	7171	10098	2804	51155	9158	6632	6241	9937	2625	1232	26051	3832	83988	9055	5367	3028	4171	952	29851	898	7083	55501	63920	25841	4734	5827	3633	3418	81620	55212	5873	3070	3560	1503	64080	5347	23208	10460	10721	259266	1958	1058	9232	55143	1493	8833	55247	4176	3161	29121	4521	7027	11284	1437	6404	641	56548	3683	824	55165	55215	1039	974	965	9841	79677	10733	2237	1164	8318	10403	9735	8914	64764	1063	9793	10635	51514	6504	22974	9133	54974	5983	64785	27067	991	5888	10221	55423	28960	983	51659	11004	6732	29063	11339	6790	149603	57476	1062	9319	51203	5496	891	9833	9787	26191	11001	3676	29127	6470	3001
GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_DN	M4624		21347372	Prots I,Skapenko A,Lipsky PE,Schulze-Koops H.	GSE24634	GSE24634_1451_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated CD25+ T effector cells at day 7 versus untreated CD25- T cells at day 7.	CD25+ regulatory T cells develop in the thymus (nTregs), but may also be generated in the periphery upon stimulation of naive CD4 T cells under appropriate conditions (iTregs). The mechanisms that regulate the generation of peripheral iTregs are largely unknown. We used microarrays to gain insights into the molecular program of extrathymic Treg development.					9456	978	55819	80301	23129	967	199	5660	10288	140885	3162	81493	23216	537	1520	9341	472	10346	2537	1050	10253	1508	54	3115	78987	23428	10161	64834	51363	28984	23613	6696	3275	4043	60370	3988	975	9764	64581	10162	10970	23095	64760	30817	2934	3875	5721	440026	23136	10614	10769	7644	1594	2760	7145	22797	23191	5297	10462	5791	2630	80024	6697	2876	6850	11314	713	23507	1116	11342	23331	23066	4306	7345	79812	3108	55114	5341	928	55601	3290	1519	11000	8741	1856	64285	5768	7941	87	8832	79663	6039	571	535	4067	79168	8760	51734	29940	79364	11006	4332	3684	2217	282997	8848	11027	3123	55361	10561	79759	23654	3176	6556	9659	60485	712	6239	8613	9732	476	55092	55604	3142	3134	58504	10184	64170	8767	23603	1153	9819	7097	1601	5054	11252	1959	283	6446	284217	1317	126321	942	10134	6303	716	6367	79365	475	5261	3460	334	79933	9730	5580	2268	6237	5836	55160	1811	411	65982	7130	54453	10913	4688	7305	10437	960	5782	53	2588	2521	1186	8829	7096	3489	56675	26232	1514	2152	59342	9647	51309	1185	55315	2799	51324	64778	79709	11337	1545	51056	6362	51606	283537	10577	8349	59338	2239
GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_UP	M4626		21347372	Prots I,Skapenko A,Lipsky PE,Schulze-Koops H.	GSE24634	GSE24634_1452_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated CD25+ T effector cells at day 10 versus untreated CD25- T cells at day 10.	CD25+ regulatory T cells develop in the thymus (nTregs), but may also be generated in the periphery upon stimulation of naive CD4 T cells under appropriate conditions (iTregs). The mechanisms that regulate the generation of peripheral iTregs are largely unknown. We used microarrays to gain insights into the molecular program of extrathymic Treg development.					55135	128872	6197	9582	3560	899	9656	79413	3014	7443	4085	1719	29899	11321	2322	3835	23516	1503	11130	868	3956	672	10237	9695	60528	3914	57761	8464	2130	1164	9212	9945	94081	55120	29909	1894	6636	3833	3676	7025	7171	64506	60490	51805	5111	1063	23048	2153	79050	9126	53371	54478	89927	3603	5827	3070	6790	384	29922	10051	55501	3149	140465	3604	11169	51182	8323	9991	10666	1491	10592	55872	9834	9143	5450	943	26292	5936	9760	10125	9200	7293	5910	1763	3925	7112	9646	26227	1736	2274	23208	11100	9452	81873	27306	9686	824	1880	9493	4664	51659	25941	5888	9937	79801	388650	3937	22822	80173	29923	3662	9231	92086	79070	10147	9702	92482	81831	55388	64780	60496	8717	3838	1803	7060	2305	79895	9716	79733	80342	127703	9787	1033	993	57405	55784	1847	51574	28974	4082	990	51514	10615	4357	51447	8555	79828	5983	9184	2590	196441	55252	56521	4815	3148	1846	1111	79770	23468	8836	80213	8728	27336	1493	55578	1690	51540	5711	10714	79577	6821	8974	5734	701	1192	4361	5358	5236	5998	3371	3251	84986	63920	29082	10721	25975	55194	2869	55423	890	9700	1233	23150	259197	60684	8318	81034	51226	648	55680
GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_DN	M4628		21347372	Prots I,Skapenko A,Lipsky PE,Schulze-Koops H.	GSE24634	GSE24634_1452_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated CD25+ T effector cells at day 10 versus untreated CD25- T cells at day 10.	CD25+ regulatory T cells develop in the thymus (nTregs), but may also be generated in the periphery upon stimulation of naive CD4 T cells under appropriate conditions (iTregs). The mechanisms that regulate the generation of peripheral iTregs are largely unknown. We used microarrays to gain insights into the molecular program of extrathymic Treg development.					79745	3310	51816	1366	7414	64422	1296	51338	4354	51393	1519	55160	3108	9103	79135	3678	8291	885	712	30844	2358	529	55361	2896	79132	4814	26504	26471	5872	55625	58528	4234	706	7096	3122	6279	10397	3101	30835	822	2242	9341	3992	79746	2207	23433	695	2203	4069	23111	10362	54795	645	7448	2181	1793	3570	23710	6252	1955	80024	6696	339	80896	55244	6280	4688	4125	25932	5834	4332	2535	284119	5660	7091	10437	11182	23160	53635	8869	10023	9839	978	10134	5031	8829	55027	3684	4285	55856	6916	9610	1522	51311	6320	79817	6932	3643	6386	211	23174	1824	90333	10457	56606	351	9754	4005	6556	64759	23313	55716	59342	79065	3687	5791	3029	1317	6284	1240	5447	9859	2512	50848	11000	9522	334	8310	3417	6196	6646	58473	27020	2017	1488	23136	7097	9033	8879	259217	975	55240	8676	217	10875	1512	7739	537	718	91	3920	10099	967	4360	3958	51085	26119	928	284021	83451	11031	945	5547	3575	6580	11342	3071	10577	57698	1612	1230	2752	1601	10723	3988	3459	23624	3106	6850	8804	7089	78987	10062	8165	25801	3073	7130	9473	10462	10611	4000	55048	23271	23529	3689	60485	79887	11337	56895	2272
GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_UP	M4630		21347372	Prots I,Skapenko A,Lipsky PE,Schulze-Koops H.	GSE24634	GSE24634_1453_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of CD25- T cells treated with IL4 [GeneID=3565] at day 3 versus untreated CD25- T cells at day 3.	CD25+ regulatory T cells develop in the thymus (nTregs), but may also be generated in the periphery upon stimulation of naive CD4 T cells under appropriate conditions (iTregs). The mechanisms that regulate the generation of peripheral iTregs are largely unknown. We used microarrays to gain insights into the molecular program of extrathymic Treg development.					3662	644	4783	6367	6362	2799	64222	23363	9697	6050	2208	7384	84790	375248	11136	5836	115817	4046	5768	29923	7052	22852	2621	51179	51363	161	10994	3920	7850	7421	4201	4163	3992	8798	911	4086	51150	9846	2810	6369	23531	51280	2662	9158	9886	1390	100507605	6048	4794	10948	3557	4161	3269	149111	1193	1306	6361	3586	10160	813	8495	9761	605	23659	9144	59269	55351	9308	3956	10989	9956	2934	247	408	3554	80301	57178	25966	37	191	388650	4905	6035	56922	4128	10267	9703	10548	6383	2990	51555	55716	23180	140	7474	51339	51398	549	7106	79622	8462	4118	10653	10531	909	23475	51203	9796	1803	1774	10577	4125	6870	23061	23199	81848	78996	23040	3852	81029	645	10376	55244	54858	7084	2628	55831	11022	54941	8566	25901	334	63933	10164	64129	4000	2335	10462	182	115	10148	9770	10134	30844	10666	6713	6821	7039	56271	4094	23682	4482	138050	4974	2322	246	6256	83449	5506	847	2037	3988	1123	79026	9896	4668	57136	79629	9355	5362	8013	55361	51094	11333	25840	8832	2717	301	50807	3117	9577	5742	3925	26998	51161	1438	7045	7813	730101	3064	1595	9228	89870	6504	53335	3029	59351	6285	1605	57125
GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_DN	M4632		21347372	Prots I,Skapenko A,Lipsky PE,Schulze-Koops H.	GSE24634	GSE24634_1453_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of CD25- T cells treated with IL4 [GeneID=3565] at day 3 versus untreated CD25- T cells at day 3.	CD25+ regulatory T cells develop in the thymus (nTregs), but may also be generated in the periphery upon stimulation of naive CD4 T cells under appropriate conditions (iTregs). The mechanisms that regulate the generation of peripheral iTregs are largely unknown. We used microarrays to gain insights into the molecular program of extrathymic Treg development.					4615	7130	3431	55340	2308	57007	51191	5920	4600	321	25865	80833	2643	6737	288	8519	387751	6932	9976	9214	217	1890	9170	51070	8542	10616	10938	79872	5590	3835	26112	834	5292	10384	64761	7535	3620	1649	23780	55790	5698	57134	7057	9619	8876	5265	5699	5031	710	55013	5376	51311	241	56155	27299	3385	9246	2713	9806	23189	81558	5790	79073	23059	729230	55559	8848	1536	57823	7321	2633	23225	7318	11201	3603	5473	6776	10581	3600	93349	11262	2779	56935	5055	5372	1961	29887	6374	25939	11326	55303	914	958	8477	58472	80162	4050	6347	8277	6890	6672	8743	23432	51295	2210	23175	3552	3627	9467	51593	6373	10235	3985	54957	3959	6563	10964	80830	63904	9636	6648	8837	3665	10396	2710	10154	55841	55374	9910	3437	6772	10241	79624	8409	79037	79132	11024	9710	1848	84900	26253	5134	3695	2919	6197	3708	2634	3624	87	10791	54432	4283	9786	597	4194	6597	5691	51411	718	10970	1117	3099	3601	3137	55614	51303	5998	25873	25777	29922	79587	2791	133	3576	952	9961	2053	6354	23283	8241	1140	91782	923	7453	6402	54606	7462	10410	100506898	3659	1116	51020	4676	2921	3590	2040	440	9447	28960	11120
GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_UP	M4633		21347372	Prots I,Skapenko A,Lipsky PE,Schulze-Koops H.	GSE24634	GSE24634_1454_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of CD25- T cells treated with IL4 [GeneID=3565] at day 5 versus untreated CD25- T cells at day 5.	CD25+ regulatory T cells develop in the thymus (nTregs), but may also be generated in the periphery upon stimulation of naive CD4 T cells under appropriate conditions (iTregs). The mechanisms that regulate the generation of peripheral iTregs are largely unknown. We used microarrays to gain insights into the molecular program of extrathymic Treg development.					200734	10769	7293	8835	22998	26	3119	1824	3117	3992	968	10148	7106	1647	55589	10409	645	10645	5742	140885	6624	3604	6362	54504	3176	3597	6363	4000	51760	162	29992	2162	3115	115353	55365	8879	9144	527	78996	4128	240	10019	27076	23475	57192	4234	11309	10221	4644	6361	975	4125	25903	7850	1193	6414	1787	6477	56034	9308	51133	2184	6453	10261	4668	23654	3055	4082	5199	1612	2859	4783	6368	9629	79140	79634	6643	10493	247	475	4758	5675	5912	4482	63897	10267	5641	30835	157	1808	23129	637	79921	7533	84617	7941	1436	4794	7975	2621	2512	81029	2879	27346	54209	2950	2037	2769	5336	8741	1475	942	5579	83937	9415	5176	6611	50807	7127	65108	2548	2810	64943	79971	28959	23531	3109	3142	6357	285203	79180	6035	7205	7739	51512	11138	6369	8291	9936	64170	57096	63895	30844	4360	22809	3554	10859	2517	8531	50615	9896	5351	3920	55796	246	1471	8672	2811	4671	57178	9770	3915	80896	11343	5447	1593	58504	29760	6916	29988	55240	10981	3459	191	114044	2232	8455	56938	284021	51338	55647	3903	11145	10577	5476	911	4814	3386	716	6925	1823	822	1124	51171	6713	126298	6573	7169	8804	4982
GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_DN	M4635		21347372	Prots I,Skapenko A,Lipsky PE,Schulze-Koops H.	GSE24634	GSE24634_1454_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of CD25- T cells treated with IL4 [GeneID=3565] at day 5 versus untreated CD25- T cells at day 5.	CD25+ regulatory T cells develop in the thymus (nTregs), but may also be generated in the periphery upon stimulation of naive CD4 T cells under appropriate conditions (iTregs). The mechanisms that regulate the generation of peripheral iTregs are largely unknown. We used microarrays to gain insights into the molecular program of extrathymic Treg development.					3938	9519	57509	10039	7707	10849	27123	288	6737	23306	11262	9658	5920	3431	4277	29114	23059	3437	57226	5610	6776	28755	1390	26034	5790	10241	29909	5698	914	9908	2633	6879	5771	9832	629	5787	56100	3669	80833	10616	3002	5998	64080	11277	7311	22930	10538	2634	11257	8519	6672	9246	1267	10443	80149	4600	57134	1435	4494	80308	23780	7068	684	6193	3620	51131	9531	57823	4501	9910	375056	3433	976	10346	54210	54739	55008	2346	8542	8292	8717	55770	3134	23070	23064	2869	5207	100288765	9760	80017	6575	23348	10791	3091	4496	9541	55014	103	9663	55281	55974	64761	4599	9881	10581	26502	29083	241	11119	24138	3953	10681	473	4502	738	1906	9049	3444	7175	894	26033	4495	2537	4308	5720	55340	23001	7091	10133	5899	8611	6890	30008	51308	1839	83638	79858	81857	9242	115653	3750	474344	25950	23224	79441	3665	6993	11056	2334	55905	4049	140461	6539	7799	10086	29953	8737	5004	4939	6158	4992	83480	6774	10964	23347	5699	8718	91543	55601	79628	10384	2152	2987	4791	80345	440193	55790	10124	79991	8877	51460	55623	11118	837	7570	8702	5165	79629	3827	10225	10254	2710	2040	6103	22881	8545	6756	3624	84159	51191
GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY7_UP	M4636		21347372	Prots I,Skapenko A,Lipsky PE,Schulze-Koops H.	GSE24634	GSE24634_1455_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of CD25- T cells treated with IL4 [GeneID=3565] at day 7 versus untreated CD25- T cells at day 7.	CD25+ regulatory T cells develop in the thymus (nTregs), but may also be generated in the periphery upon stimulation of naive CD4 T cells under appropriate conditions (iTregs). The mechanisms that regulate the generation of peripheral iTregs are largely unknown. We used microarrays to gain insights into the molecular program of extrathymic Treg development.					38	517	9833	29127	51155	1841	22974	701	4714	4171	55644	6643	2592	9787	6241	1033	91353	9232	239	2237	1719	6368	23406	6443	11130	4694	10223	4701	8372	8460	6362	56992	9768	55131	10038	50839	51203	6611	8120	435	79733	10773	1111	4175	23242	6369	4288	55915	3832	6470	64427	27068	11004	6518	8836	8685	55215	9830	1512	56654	51016	10094	9493	7083	6361	6396	7298	28823	983	6048	2037	10327	11309	23358	3303	9212	2014	7850	55750	9133	4602	3163	397	208	4738	642	7389	6925	81029	3535	84719	55224	11065	8898	29995	51514	5095	79622	22994	10112	3098	6363	10733	23113	6357	23179	5199	746	51659	8905	5328	10151	54828	64231	23468	64151	9700	55143	8366	60509	3925	27347	23166	23198	79140	9455	55540	27346	23659	22918	23028	3161	10057	2591	9886	4646	6217	23318	9956	55775	332	7474	9551	83460	50615	4624	79444	1645	11339	5860	1717	1291	1237	7272	3676	581	1690	9770	3418	10635	891	10507	7593	9470	10165	991	56474	11010	9500	11132	9144	25771	203068	64921	78996	7351	79022	7390	4331	5427	91120	4741	2091	4707	64506	10615	27089	3148	10383	994	27429	11145	9429	51154	5859	890	8396	28974	60314	325
GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY7_DN	M4638		21347372	Prots I,Skapenko A,Lipsky PE,Schulze-Koops H.	GSE24634	GSE24634_1455_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of CD25- T cells treated with IL4 [GeneID=3565] at day 7 versus untreated CD25- T cells at day 7.	CD25+ regulatory T cells develop in the thymus (nTregs), but may also be generated in the periphery upon stimulation of naive CD4 T cells under appropriate conditions (iTregs). The mechanisms that regulate the generation of peripheral iTregs are largely unknown. We used microarrays to gain insights into the molecular program of extrathymic Treg development.					10970	3452	833	8848	81493	9467	25932	1362	307	7453	1848	28984	51056	51100	9456	9766	571	929	51094	9732	6447	1051	4688	645961	2017	1959	3084	5106	718	64834	2634	30817	9050	9659	3570	7936	8543	9209	26010	5899	9361	6539	440	79135	4864	5226	7077	26227	26585	23086	2239	8760	529	84981	51099	716	3717	54442	58472	8942	11027	10797	467	10239	6897	2152	9734	1515	55604	6810	5998	51022	22876	1632	79188	5699	1054	6907	7781	27202	123872	483	9605	1594	9674	7130	8878	3489	55823	7462	23276	23339	7096	8082	23613	7296	6284	5698	10170	84288	2710	116496	942	4779	5274	971	1605	6236	7779	9569	3242	7050	6303	1474	10468	8900	6301	526	5687	1329	51606	5872	10099	629	26509	3134	10588	11237	2633	9980	1826	8630	6510	9922	3437	8869	23271	432	51734	8743	8542	29110	283	29015	4067	22983	8642	91	2117	80776	114088	9764	745	79663	22864	8740	16	23233	1501	51547	4204	23507	55329	6196	946	3643	8882	3557	9043	2495	8407	64285	2055	661	9016	2922	51533	6472	5898	83729	8321	1832	10960	2009	51368	60485	51451	51657	5824	29919	3613	138151	597	654817	5724	10768	217	79589	81553	5954
GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_UP	M4639		21347372	Prots I,Skapenko A,Lipsky PE,Schulze-Koops H.	GSE24634	GSE24634_1456_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of CD25- T cells treated with IL4 [GeneID=3565] at day 10 versus untreated CD25- T cells at day 10.	CD25+ regulatory T cells develop in the thymus (nTregs), but may also be generated in the periphery upon stimulation of naive CD4 T cells under appropriate conditions (iTregs). The mechanisms that regulate the generation of peripheral iTregs are largely unknown. We used microarrays to gain insights into the molecular program of extrathymic Treg development.					28974	26228	55353	2625	596	2995	6775	55750	7450	2135	10169	23333	140461	397	388650	6369	27075	140	2672	55540	3603	1968	55215	23468	10267	8631	59307	6362	23318	5236	51659	914	3382	987	10125	58473	3676	7293	10223	55366	4775	9452	10962	22918	27306	65998	55578	51308	54733	309	915	5037	11339	79598	9480	80243	8395	1603	3535	1776	81563	6616	9814	10810	23137	6414	3669	7158	9358	10225	80031	27347	1880	2167	57326	11064	79828	4345	11309	7153	54674	29789	8898	128872	26586	25903	4790	55423	247	10051	4068	7850	6357	64388	56165	6491	3832	8685	55805	51562	151230	8925	361	55172	79864	1736	23048	11009	3227	5199	10801	3872	6361	11022	55227	91353	8821	3849	29087	65108	10301	699	3398	642	2859	4602	1033	5008	8645	2674	8989	27345	56676	7273	6241	57473	1641	80342	3934	8364	23464	10461	590	10938	165	63940	7351	5026	79070	11146	26610	5734	1164	157680	9057	60494	2308	517	51642	9329	818	1371	3707	3925	28639	64506	4828	487	79064	2162	808	80339	23355	80207	326	1063	10089	10507	22954	9429	55204	8728	78998	9214	10154	51086	9353	7298	9159	3937	100132406	6955	5991	79057	2186	51155	5411	54210	150726	939
GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_DN	M4640		21347372	Prots I,Skapenko A,Lipsky PE,Schulze-Koops H.	GSE24634	GSE24634_1456_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of CD25- T cells treated with IL4 [GeneID=3565] at day 10 versus untreated CD25- T cells at day 10.	CD25+ regulatory T cells develop in the thymus (nTregs), but may also be generated in the periphery upon stimulation of naive CD4 T cells under appropriate conditions (iTregs). The mechanisms that regulate the generation of peripheral iTregs are largely unknown. We used microarrays to gain insights into the molecular program of extrathymic Treg development.					9659	8829	3310	29761	10062	51056	100287659	10244	1366	51100	23549	6272	6993	1495	7739	79135	7162	8676	8974	58472	3992	5836	3643	9145	7096	1296	23433	718	5226	351	5834	7453	7130	4234	529	26509	8544	55620	2180	6236	11000	2896	1026	3301	81831	9361	7779	6284	8804	2152	64759	23129	834	10539	29940	8869	79132	5321	23597	375035	211	3489	10362	942	6809	307	284119	1230	54453	55969	3703	1519	3576	29	3437	1317	6891	6252	1488	6888	5724	64422	9805	1362	7296	9764	51099	10059	4501	23545	55647	2713	1051	5329	2535	10312	645	483	26608	526	202	23276	79746	10241	527	5687	5684	7295	10170	55177	8545	3659	26227	6447	6398	4495	3101	2634	3613	1474	51393	11020	84617	8942	2710	79042	54432	6648	26064	1536	114548	10788	26585	51324	11182	5694	4615	6697	10970	10237	25932	112479	3482	55911	51311	80150	204	978	54741	4502	7305	8321	55823	9103	4496	79778	533	629	1605	3624	6772	3290	8543	64866	23158	175	7378	29967	27299	599	3113	51657	7384	50	8760	5954	578	51734	10613	4332	5721	2633	51022	51647	79627	9249	11031	5711	1847	6249	3665	8565	2239	710	833	3557	2669	9246	4067	29887
GSE25087_FETAL_VS_ADULT_TREG_UP	M4641		21164017	Mold JE,Venkatasubrahmanyam S,Burt TD,Michaëlsson J,Rivera JM,Galkina SA,Weinberg K,Stoddart CA,McCune JM	GSE25087	GSE25087_1323_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of fetal regulatory T cell (Treg) versus adult regulatory T cell (Treg).	We compared differences in fetal and adult T cells by performing whole genome profiling on sort-purified T cells (naïve CD4+ and Treg cells) from human fetal specimens (18-22 gestational weeks) and adult specimens (age 25-40 years old). Fetal and Adult Naïve CD4+ T cells phenotype: CD3+CD4+CD45RA+CCR7+CD27+, Fetal and Adult CD4+CD25+ Treg phenotype: CD3+CD4+CD25bright					1536	7184	51264	1982	57691	55686	1543	56910	10213	10391	98	79876	7444	65062	8815	1965	100128252	7421	10538	25902	10449	2030	79602	7097	788	7388	6117	141	5721	836	10907	4704	7037	404672	10360	1503	22949	3553	79135	9724	10657	894	4050	2037	54555	7528	3611	6727	199	57542	157	91768	4794	10765	51371	27173	10130	4345	7204	4628	10284	10589	4122	27258	10376	55379	84328	29088	7511	7813	10525	84790	7415	64756	10095	346887	9618	100288985	54331	90355	4038	129607	23636	790	57476	8784	5885	64651	1030	3090	59345	153579	23197	28998	132320	9380	2237	8914	51339	10542	2098	5827	56938	55552	4171	54602	6772	84992	3276	5720	113251	131474	4853	2615	387597	4713	8623	1718	55112	64793	2919	10935	5738	29923	56935	55194	3309	57189	23071	124944	4810	3149	6478	51097	29117	2053	5324	55410	400941	375790	586	152485	7798	3190	22800	64092	10054	283455	51776	8732	135932	6385	2017	8701	8334	97	116447	27074	10160	64087	387	30846	672	7411	3682	23191	9760	5367	10985	23657	151230	5796	51441	5045	2950	342908	55103	203427	2921	7205	79931	10217	339122	79085	821	468	57559	8099	8870	8803	2787	1781	23462	2739	6573	10963	389	10105	57171	6571
GSE25087_FETAL_VS_ADULT_TREG_DN	M4643		21164017	Mold JE,Venkatasubrahmanyam S,Burt TD,Michaëlsson J,Rivera JM,Galkina SA,Weinberg K,Stoddart CA,McCune JM	GSE25087	GSE25087_1323_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of fetal regulatory T cell (Treg) versus adult regulatory T cell (Treg).	We compared differences in fetal and adult T cells by performing whole genome profiling on sort-purified T cells (naïve CD4+ and Treg cells) from human fetal specimens (18-22 gestational weeks) and adult specimens (age 25-40 years old). Fetal and Adult Naïve CD4+ T cells phenotype: CD3+CD4+CD45RA+CCR7+CD27+, Fetal and Adult CD4+CD25+ Treg phenotype: CD3+CD4+CD25bright					3738	100506599	80824	154661	10507	7754	6296	10621	92154	8027	285761	3798	55205	51669	92	55605	3113	825	1027	23220	79710	4774	440918	84959	7342	57798	100130872	2081	6095	8502	283267	80854	112942	400961	10628	84281	9619	55333	147694	5813	291	123283	349152	10140	23365	51703	6653	93622	57553	493754	2026	8660	5727	8911	284677	128387	706	6432	100505576	55086	2355	100132319	100506686	56882	8997	285835	4773	8526	51654	9516	283596	81786	148930	118491	113235	84918	4801	23411	10207	9828	9750	3800	203100	374470	387535	51275	84230	100129196	89857	283278	93058	9200	3886	388552	11278	94134	6281	114791	1235	7994	4951	51310	3423	92106	51696	283131	2254	246126	254128	5286	27436	158431	122525	2151	9120	10724	56899	3978	100216545	26266	254251	51303	6709	286554	10001	100289610	100131510	585	57336	10157	6144	9043	10668	56477	201799	23620	440498	3702	84203	117289	931	150290	10695	25864	5463	28962	388011	55054	56926	687	8038	54941	222256	678	23536	23300	55664	202134	2747	79836	3570	125488	6403	89932	81579	53827	21	375513	100134822	9975	7047	427	9159	340547	10659	4983	129293	29116	80863	387119	285203	5504	23786	3985	203228	107	79168	80006	9727	11019	8795	55718	23621	55599	56920	4674	11266	285331	8322	27086
GSE25087_FETAL_VS_ADULT_TCONV_UP	M4645		21164017	Mold JE,Venkatasubrahmanyam S,Burt TD,Michaëlsson J,Rivera JM,Galkina SA,Weinberg K,Stoddart CA,McCune JM	GSE25087	GSE25087_1324_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of fetal conventional T cells versus adult conventional T cells.	We compared differences in fetal and adult T cells by performing whole genome profiling on sort-purified T cells (naïve CD4+ and Treg cells) from human fetal specimens (18-22 gestational weeks) and adult specimens (age 25-40 years old). Fetal and Adult Naïve CD4+ T cells phenotype: CD3+CD4+CD45RA+CCR7+CD27+, Fetal and Adult CD4+CD25+ Treg phenotype: CD3+CD4+CD25bright					400941	57082	11142	83543	79828	5728	157	2597	11174	1984	8857	4830	2921	57102	9087	6772	1075	65084	7552	10678	6533	1514	10963	54499	26521	54993	152404	114885	158	5683	56034	9749	9718	57480	3594	9128	5704	3190	2920	2146	22827	54477	129804	8655	64928	6929	80228	10019	9319	2956	353	51134	22807	6241	1508	55247	634	1978	6634	3336	83998	79442	10385	4049	112936	4694	55845	952	84274	4709	163486	471	302	64087	58472	151987	83607	3709	152137	6624	522	468	23509	84134	84981	146956	1038	84899	6659	29099	4791	1278	6742	29796	1184	3159	5796	55808	22934	643911	1602	57178	79094	5501	5052	90324	9294	55847	55379	1058	7386	10785	55711	64968	161582	57491	6747	23636	965	1337	64375	161424	5996	2694	5257	130916	10213	84276	581	5993	9320	57674	10204	5720	55862	3735	10018	8099	8543	4363	57544	65260	6996	123775	719	8802	23705	25976	92610	4724	284184	55636	10576	9202	55266	84365	9603	84300	729839	3992	4790	4722	2746	64397	481	79081	92092	3561	152485	91860	5806	25896	5287	292	7157	8140	123355	260425	5954	8353	3682	6566	222658	23406	6652	51001	5859	54947	10329	5058	5305	5230	5932	4200	7710	51088	9034	51360	6897	129642
GSE25087_FETAL_VS_ADULT_TCONV_DN	M4646		21164017	Mold JE,Venkatasubrahmanyam S,Burt TD,Michaëlsson J,Rivera JM,Galkina SA,Weinberg K,Stoddart CA,McCune JM	GSE25087	GSE25087_1324_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of fetal conventional T cells versus adult conventional T cells.	We compared differences in fetal and adult T cells by performing whole genome profiling on sort-purified T cells (naïve CD4+ and Treg cells) from human fetal specimens (18-22 gestational weeks) and adult specimens (age 25-40 years old). Fetal and Adult Naïve CD4+ T cells phenotype: CD3+CD4+CD45RA+CCR7+CD27+, Fetal and Adult CD4+CD25+ Treg phenotype: CD3+CD4+CD25bright					113235	25864	113791	129293	2308	7634	54737	10659	10913	80213	100134445	114915	84527	10855	6041	25873	53827	54851	93058	55023	56605	958	80045	51411	2620	10432	197370	57798	64780	10628	7351	10004	219	79722	120224	149401	283876	163255	57447	51003	3978	170691	440465	440993	1850	64407	10742	400961	83464	26289	27327	6426	113510	22944	114823	197135	1741	285148	10943	687	231	649446	161253	143884	266553	648	283284	57711	23177	6642	286499	641977	378805	400916	84942	55605	9516	55553	254887	283149	80025	2824	64755	7286	5204	344558	8725	122525	7754	8722	493753	59342	25776	59335	10207	22907	7091	5813	100129387	284129	340533	79148	5090	1953	285193	340061	85478	4117	10520	11043	55763	29116	10235	9372	79400	8555	202025	7378	6868	79626	90673	8660	116151	387921	26273	8878	51341	153222	56926	11278	10456	80867	80194	9497	100507436	378938	92	57593	255394	3115	338657	252969	23189	401261	4069	7433	100130175	5915	64061	5217	285147	706	79884	51170	84634	146330	161497	5189	57231	23111	55680	286154	93129	80006	23324	100289230	83943	85367	3587	55191	53344	162333	84260	4306	2938	79632	6990	340542	5467	57038	317719	80863	55737	158399	7840	1525	27086	25963	2550	389114	27031	492311	100129550	644068	100132356	55904	84614	126272	2543	51065
GSE25087_TREG_VS_TCONV_FETUS_UP	M4647		21164017	Mold JE,Venkatasubrahmanyam S,Burt TD,Michaëlsson J,Rivera JM,Galkina SA,Weinberg K,Stoddart CA,McCune JM	GSE25087	GSE25087_1325_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of fetal regulatory T cell (Treg) versus fetal conventional T cells.	We compared differences in fetal and adult T cells by performing whole genome profiling on sort-purified T cells (naïve CD4+ and Treg cells) from human fetal specimens (18-22 gestational weeks) and adult specimens (age 25-40 years old). Fetal and Adult Naïve CD4+ T cells phenotype: CD3+CD4+CD45RA+CCR7+CD27+, Fetal and Adult CD4+CD25+ Treg phenotype: CD3+CD4+CD25bright					196	10221	11138	4065	529	23048	2820	10911	283455	29110	5868	153579	6654	57061	27032	5532	267	406991	51729	8491	1741	9953	58488	57534	50640	672	81671	91012	6478	7813	2203	4752	3482	201595	81037	9927	29922	55090	134429	3688	81831	100129406	142940	4222	4357	122786	1136	4810	3092	22949	2790	9053	10144	51501	3815	1808	56650	23380	57189	27333	1235	200035	51150	25966	334	113263	27101	64375	22876	339745	5292	285203	283578	8784	9919	483	2034	116449	56672	2017	100131117	1543	140809	1047	80021	3683	387923	7324	197131	29931	8850	283209	6509	9508	727	157506	79686	51063	8844	7291	254158	9100	27303	80005	57551	4038	55188	112479	3149	84002	5962	10725	81491	114614	5509	192670	3560	1326	5551	79009	64411	55120	29887	865	687	2615	3131	3303	347736	3904	55010	10299	10022	404636	10055	8660	10465	51659	64092	8728	10625	80223	1154	54855	7357	23531	10397	51635	7634	4154	23118	54918	1536	1021	1030	5358	2941	5885	25963	9424	55722	5311	302	84969	388507	9760	3626	3587	5350	3958	8882	8741	9249	118788	9989	64859	8462	304	6611	64764	4763	11275	79931	481	1774	81537	27297	8835	55633	3123	100288432	64065	51101	55671	5223	57515	92906	953	115352	56888
GSE25087_TREG_VS_TCONV_FETUS_DN	M4649		21164017	Mold JE,Venkatasubrahmanyam S,Burt TD,Michaëlsson J,Rivera JM,Galkina SA,Weinberg K,Stoddart CA,McCune JM	GSE25087	GSE25087_1325_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of fetal regulatory T cell (Treg) versus fetal conventional T cells.	We compared differences in fetal and adult T cells by performing whole genome profiling on sort-purified T cells (naïve CD4+ and Treg cells) from human fetal specimens (18-22 gestational weeks) and adult specimens (age 25-40 years old). Fetal and Adult Naïve CD4+ T cells phenotype: CD3+CD4+CD45RA+CCR7+CD27+, Fetal and Adult CD4+CD25+ Treg phenotype: CD3+CD4+CD25bright					64412	58477	643837	1952	6039	5504	9531	51654	57185	339855	55604	285855	26520	10507	1380	441168	6934	80746	222229	154007	3232	8445	157247	339942	2648	5747	54414	6433	5165	80324	168850	7182	54800	55027	400073	3454	54802	53335	4666	123	7388	3983	204	4709	814	10606	2694	3886	56985	9464	5730	5094	401550	57685	5318	348995	1075	4125	11142	55116	123283	493754	10390	1024	23765	9263	50854	6284	133418	3099	399665	90410	51720	1184	6322	347862	10319	284677	120	140732	152404	84078	6929	3275	63976	79085	6015	28970	4664	1933	57696	100190939	1879	313	100289610	81609	51816	285521	4091	5463	9453	100093630	27237	51520	10419	3631	5575	51642	132299	11251	4634	10954	7169	55744	9706	126282	7554	219743	138199	54987	3988	6189	3001	4863	3398	55808	64122	4753	9221	100507246	10424	7786	729810	2395	28514	22859	83888	10270	1117	246777	126259	828	93622	11232	321	57336	3706	407738	84268	29074	124773	57864	7132	57648	78998	23031	117178	57509	22803	4774	2800	100	92	79961	440119	58526	124454	55756	6237	100134713	83890	63898	3964	731852	10269	100288721	10140	55006	124093	26136	22836	51090	26207	54680	7414	6125	91603	55333	337867	3730	119032	79956	3939	91304	26053	2267	7690	55636	442117	282997
GSE25087_TREG_VS_TCONV_ADULT_UP	M4650		21164017	Mold JE,Venkatasubrahmanyam S,Burt TD,Michaëlsson J,Rivera JM,Galkina SA,Weinberg K,Stoddart CA,McCune JM	GSE25087	GSE25087_1326_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of adult regulatory T cell (Treg) versus adult conventional T cells.	We compared differences in fetal and adult T cells by performing whole genome profiling on sort-purified T cells (naïve CD4+ and Treg cells) from human fetal specimens (18-22 gestational weeks) and adult specimens (age 25-40 years old). Fetal and Adult Naïve CD4+ T cells phenotype: CD3+CD4+CD45RA+CCR7+CD27+, Fetal and Adult CD4+CD25+ Treg phenotype: CD3+CD4+CD25bright					157769	25895	6648	25976	2531	9294	8935	2842	10875	1030	80723	100506599	25898	202052	115548	64065	440270	57700	8826	56899	29028	701	9759	8655	27303	5778	6095	8661	2534	4363	834	7371	23005	91137	4222	23097	60481	3303	8631	302	22911	145508	3559	80854	404636	3560	58155	7746	116496	51278	29957	221035	84636	143689	79443	80124	162681	4689	580	9120	10409	8850	965	1763	7402	8835	3423	54704	128239	2519	152137	5899	100507173	26035	2720	1493	8038	3248	64375	2060	196	2625	23710	116832	10401	28232	481	6385	6275	79172	4208	4929	2151	161582	23150	567	1192	9709	5604	80183	5962	92667	2650	84196	64092	92610	1235	10491	9749	4602	493	113263	283482	6002	79670	1123	129790	3626	5552	84002	7634	23347	130589	4588	339568	7464	100506190	283508	84628	5906	131583	1495	57544	55010	55165	26273	25897	6448	308	125488	6566	841	8140	596	222256	57535	22936	109	4603	304	26051	100288432	54469	54434	115123	6836	8682	644353	829	56886	57082	10602	1371	23118	142891	79872	8707	729082	29110	57198	3594	9545	8660	401548	7188	80223	5257	10133	10911	5933	5358	8530	9046	6645	64087	285386	3007	51575	3122	118788	3662	10018	22807	56650	25998	1847	5340	7133	57534	440823
GSE25087_TREG_VS_TCONV_ADULT_DN	M4652		21164017	Mold JE,Venkatasubrahmanyam S,Burt TD,Michaëlsson J,Rivera JM,Galkina SA,Weinberg K,Stoddart CA,McCune JM	GSE25087	GSE25087_1326_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of adult regulatory T cell (Treg) versus adult conventional T cells.	We compared differences in fetal and adult T cells by performing whole genome profiling on sort-purified T cells (naïve CD4+ and Treg cells) from human fetal specimens (18-22 gestational weeks) and adult specimens (age 25-40 years old). Fetal and Adult Naïve CD4+ T cells phenotype: CD3+CD4+CD45RA+CCR7+CD27+, Fetal and Adult CD4+CD25+ Treg phenotype: CD3+CD4+CD25bright					79754	60468	2053	54103	10581	727961	3631	30000	3978	389084	155038	55808	6840	11340	92106	10913	55561	221061	79015	1208	8556	51765	79085	522	25871	256227	400916	59283	9924	22982	57711	22859	286133	843	5284	55653	26115	5293	7169	351	10927	60625	100128252	55146	6124	26289	441024	6146	29083	28996	140883	64599	6574	23066	54480	790	284184	55340	9973	10954	26235	2015	57134	128308	53373	7223	6193	57182	340554	22903	4040	4343	79447	9617	79148	115330	9840	64147	91663	286154	644068	84293	692227	100132967	26520	10419	57447	23508	29844	132014	26063	11092	27352	398	231	27258	9911	8743	157285	119710	54996	196294	57684	57505	284001	80746	1646	8531	90673	313	56945	10390	83481	10410	282997	149428	51199	4488	23466	23060	10211	5796	9724	349565	9792	10848	6856	29911	6203	29914	27284	26130	197370	5245	23521	9686	1788	641518	5324	85001	648556	53343	80863	162333	23240	83449	91574	283514	199	148545	266747	80213	440465	93550	4118	6285	29767	3480	79098	57002	51650	23305	100132707	51654	64777	55049	84634	26747	51316	6347	619518	6128	4724	81888	6208	7343	56948	55604	275	100287896	26164	9531	161145	10106	4753	79890	58473	4282	1645	51133	55608	23321	153733	201229	171169	5608	22868	282996	10574	54212
GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_UP	M4654		21383243	Duraiswamy J,Ibegbu CC,Masopust D,Miller JD,Araki K,Doho GH,Tata P,Gupta S,Zilliox MJ,Nakaya HI,Pulendran B,Haining WN,Freeman GJ,Ahmed R.	GSE26495	GSE26495_1502_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive CD8 T cells versus PD-1 high CD8 T cells.	T cell dysfunction is an important feature of many chronic viral infections. In particular, it was shown that PD-1 regulates T cell dysfunction during chronic LCMV infection in mice and PD-1 high cells exhibit an intense exhausted gene signature. These findings were extended to human chronic infections such as HIV, HCV and HBV. However, it is not known if PD-1 high cells of healthy humans have the traits of exhausted cells. In this study, we provide a comprehensive description of phenotype, function and gene expression profiles of PD-1 high versus PD-1 low CD8 T cells in the peripheral blood of healthy human adults as following: 1) The percentage of naive and memory CD8 T cells varied widely in the peripheral blood cells of healthy humans and PD-1 was expressed by the memory CD8 T cells. 2) PD-1 high CD8 T cells in healthy humans did not significantly correlated with the PD-1 high exhausted gene signature of HIV specific human CD8 T cells or chronic LCMV specific CD8 T cells from mice. 3) PD-1 expression did not directly affect the ability of CD8 T cells to secrete cytokines in healthy adults. 4) PD-1 was expressed by the effector memory (TEM) compared to ‘terminally differentiated effector’ (TEMRA) CD8 T cells. 5) Finally, an interesting inverse relationship between CD45RA and PD-1 expression was observed.					1823	51309	8611	2199	27284	346887	4118	339122	79690	8642	64788	25992	4897	4907	56985	9315	259283	9241	8277	84838	79656	2041	4232	1942	64221	85012	25894	641518	54674	100128252	10472	8609	100129858	26151	117247	57124	4602	283521	282997	8460	5324	389114	285973	286097	874	26119	29978	2308	3572	87	23258	10913	84417	100287572	129293	6320	29902	79841	57134	50649	22866	7433	100289410	5042	166647	113791	51161	30812	726	622	6322	201456	2788	765	57212	6720	100130987	84033	51310	51440	100287039	200634	285533	6691	5163	79632	5990	5578	116447	79612	27086	148898	150864	27018	100505538	7325	1604	3480	26289	23178	5569	165	51176	84889	114112	440498	92106	54463	92399	2037	1203	340533	94097	147685	80746	9712	145864	6812	401431	89857	257044	344558	158880	65986	10653	157285	91782	6402	81931	26034	5152	26974	285097	55902	1573	322	388403	26751	80863	833	55437	6915	4753	1236	95681	5125	119559	85415	79145	10389	117145	439949	29914	50854	80258	3667	6875	79814	114928	57463	55180	119369	113451	100288656	79258	84441	3570	6929	388335	2814	80762	440432	6297	4306	8793	27230	57393	10256	10290	126326	5016	3655	203328	11142	25851	670	9859	83998	285965	440934	84293	23111	729614	51669	339210	80303	114804	1939	2317	2203
GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_DN	M4656		21383243	Duraiswamy J,Ibegbu CC,Masopust D,Miller JD,Araki K,Doho GH,Tata P,Gupta S,Zilliox MJ,Nakaya HI,Pulendran B,Haining WN,Freeman GJ,Ahmed R.	GSE26495	GSE26495_1502_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive CD8 T cells versus PD-1 high CD8 T cells.	T cell dysfunction is an important feature of many chronic viral infections. In particular, it was shown that PD-1 regulates T cell dysfunction during chronic LCMV infection in mice and PD-1 high cells exhibit an intense exhausted gene signature. These findings were extended to human chronic infections such as HIV, HCV and HBV. However, it is not known if PD-1 high cells of healthy humans have the traits of exhausted cells. In this study, we provide a comprehensive description of phenotype, function and gene expression profiles of PD-1 high versus PD-1 low CD8 T cells in the peripheral blood of healthy human adults as following: 1) The percentage of naive and memory CD8 T cells varied widely in the peripheral blood cells of healthy humans and PD-1 was expressed by the memory CD8 T cells. 2) PD-1 high CD8 T cells in healthy humans did not significantly correlated with the PD-1 high exhausted gene signature of HIV specific human CD8 T cells or chronic LCMV specific CD8 T cells from mice. 3) PD-1 expression did not directly affect the ability of CD8 T cells to secrete cytokines in healthy adults. 4) PD-1 was expressed by the effector memory (TEM) compared to ‘terminally differentiated effector’ (TEMRA) CD8 T cells. 5) Finally, an interesting inverse relationship between CD45RA and PD-1 expression was observed.					23108	8320	165186	3001	114836	149628	101	5873	6275	8111	121260	91607	7049	112597	57136	445347	64215	493	23208	5066	83888	51063	339988	1326	5729	115362	94015	201633	4603	83737	8850	26053	2909	3003	115352	139716	79888	3902	4864	9334	81855	2534	6352	302	9832	113263	6310	29110	9976	2040	23597	2936	152789	9046	23380	4267	9760	2992	79180	154	6452	84056	4818	1234	81839	57646	81	80310	221002	79899	3824	100507564	5274	55020	29799	192670	54732	116496	4026	4217	387882	255231	9989	5521	79443	9938	79683	94241	2591	130589	3587	440823	8073	55884	8530	26505	3683	30009	2672	965	824	382	439921	23392	60489	84525	57823	10133	9289	11145	5998	94120	79026	7402	11000	864	4092	2060	11060	55062	253461	5336	10219	2081	58480	10397	6645	83667	1075	2999	51668	80301	304	28232	598	355	9645	644	8553	2730	152100	114614	9467	50515	834	54910	4094	132864	7133	7171	257068	55784	9839	1316	26191	90102	83930	4739	10019	3600	144571	9120	285203	8503	79651	401494	221895	140809	9256	221188	23333	80119	26010	11262	29969	10971	5551	55140	20	5795	1741	831	7098	79139	10312	285812	8819	390916	84542	10766	7107	64224	4121	6513	8934	23127	26031	124995	23224	4088
GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_UP	M4658		21383243	Duraiswamy J,Ibegbu CC,Masopust D,Miller JD,Araki K,Doho GH,Tata P,Gupta S,Zilliox MJ,Nakaya HI,Pulendran B,Haining WN,Freeman GJ,Ahmed R.	GSE26495	GSE26495_1503_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive CD8 T cells versus PD-1 low CD8 T cells.	T cell dysfunction is an important feature of many chronic viral infections. In particular, it was shown that PD-1 regulates T cell dysfunction during chronic LCMV infection in mice and PD-1 high cells exhibit an intense exhausted gene signature. These findings were extended to human chronic infections such as HIV, HCV and HBV. However, it is not known if PD-1 high cells of healthy humans have the traits of exhausted cells. In this study, we provide a comprehensive description of phenotype, function and gene expression profiles of PD-1 high versus PD-1 low CD8 T cells in the peripheral blood of healthy human adults as following: 1) The percentage of naive and memory CD8 T cells varied widely in the peripheral blood cells of healthy humans and PD-1 was expressed by the memory CD8 T cells. 2) PD-1 high CD8 T cells in healthy humans did not significantly correlated with the PD-1 high exhausted gene signature of HIV specific human CD8 T cells or chronic LCMV specific CD8 T cells from mice. 3) PD-1 expression did not directly affect the ability of CD8 T cells to secrete cytokines in healthy adults. 4) PD-1 was expressed by the effector memory (TEM) compared to ‘terminally differentiated effector’ (TEMRA) CD8 T cells. 5) Finally, an interesting inverse relationship between CD45RA and PD-1 expression was observed.					84838	27284	4232	100507218	55536	84033	57463	339122	2317	51309	25894	8642	1823	440498	285973	9241	114928	66035	26119	113791	2308	259283	4897	641518	2041	23354	117247	100128252	8611	346887	119559	10913	283521	51176	57134	286097	874	339541	5324	670	25992	57124	833	282997	389114	50649	388403	166647	30812	100129858	56985	80024	3111	22866	55902	284307	4907	1293	79656	91782	157697	87	23178	64432	322	29914	56652	79690	54674	125144	100286937	57212	27018	8460	92106	2199	9315	80303	5163	158405	51011	149775	56997	6691	84417	5152	79612	6767	23484	6322	8857	100505483	55353	3572	114792	27074	285025	328	219743	53844	23552	765	26974	6320	8609	60674	150864	622	23258	949	79814	100289410	285533	64776	7433	5990	388335	79258	1573	148898	64794	439949	51114	100288656	9743	11130	3480	7325	6720	143903	9990	26151	54463	129293	8793	130399	27086	50854	64777	5018	11194	6915	220979	2814	256987	344558	9045	84650	400242	29803	79841	7766	201456	55218	10653	84293	79632	1380	80863	401431	54682	399665	100287039	10460	284391	5578	80762	928	6125	51805	342908	230	5796	5293	6929	79161	9641	6155	79145	6875	80746	100506325	55063	57473	132720	100505761	10868	23361	25851	64221	158880	203328	118980	29087	157285	4118	23508	6001	10742	57504
GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_DN	M4659		21383243	Duraiswamy J,Ibegbu CC,Masopust D,Miller JD,Araki K,Doho GH,Tata P,Gupta S,Zilliox MJ,Nakaya HI,Pulendran B,Haining WN,Freeman GJ,Ahmed R.	GSE26495	GSE26495_1503_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive CD8 T cells versus PD-1 low CD8 T cells.	T cell dysfunction is an important feature of many chronic viral infections. In particular, it was shown that PD-1 regulates T cell dysfunction during chronic LCMV infection in mice and PD-1 high cells exhibit an intense exhausted gene signature. These findings were extended to human chronic infections such as HIV, HCV and HBV. However, it is not known if PD-1 high cells of healthy humans have the traits of exhausted cells. In this study, we provide a comprehensive description of phenotype, function and gene expression profiles of PD-1 high versus PD-1 low CD8 T cells in the peripheral blood of healthy human adults as following: 1) The percentage of naive and memory CD8 T cells varied widely in the peripheral blood cells of healthy humans and PD-1 was expressed by the memory CD8 T cells. 2) PD-1 high CD8 T cells in healthy humans did not significantly correlated with the PD-1 high exhausted gene signature of HIV specific human CD8 T cells or chronic LCMV specific CD8 T cells from mice. 3) PD-1 expression did not directly affect the ability of CD8 T cells to secrete cytokines in healthy adults. 4) PD-1 was expressed by the effector memory (TEM) compared to ‘terminally differentiated effector’ (TEMRA) CD8 T cells. 5) Finally, an interesting inverse relationship between CD45RA and PD-1 expression was observed.					8320	6275	23108	339988	58190	9334	8111	6645	101	3001	64215	165186	130814	115362	9976	10219	7049	5900	149628	23533	493	3902	4121	26010	192670	302	285386	201633	57136	115	1326	83888	10578	10312	5306	9989	5998	55784	6352	5729	445347	84056	4603	9046	22898	4155	10133	11000	154	115352	6310	121260	10966	2534	26053	81	79180	57823	11060	4818	831	8850	57580	80723	54843	3824	4092	2040	9289	8073	80310	79683	114836	255231	8672	170371	83667	152789	79651	5521	91607	139716	28232	4864	116496	3587	79899	3560	221002	8819	94241	26504	81855	140809	10100	83931	9760	84525	30009	965	307	60489	4267	5873	8530	50515	824	11145	5912	58480	5664	8503	54438	4026	55020	9780	25829	221188	56895	3683	81839	54910	54732	304	55001	11098	8742	2999	11186	355	1234	127703	4134	9910	10971	3956	4094	4815	9839	430	79026	2000	23333	2580	1609	23208	439921	80301	11262	387882	221895	5551	84542	116236	5552	9832	5141	55501	51744	3688	5494	94015	5066	9467	83988	23597	3002	27131	55062	1730	7133	6351	4277	23224	27433	8553	2992	114879	51523	4145	4088	94120	686	79888	55884	29799	2909	10666	9645	1124	118788	440823	1075	83930	11033	4646	64420	5621	5775	10130
GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_UP	M4660		21383243	Duraiswamy J,Ibegbu CC,Masopust D,Miller JD,Araki K,Doho GH,Tata P,Gupta S,Zilliox MJ,Nakaya HI,Pulendran B,Haining WN,Freeman GJ,Ahmed R.	GSE26495	GSE26495_1504_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of PD-1 high CD8 T cells versus PD-1 low CD8 T cells.	T cell dysfunction is an important feature of many chronic viral infections. In particular, it was shown that PD-1 regulates T cell dysfunction during chronic LCMV infection in mice and PD-1 high cells exhibit an intense exhausted gene signature. These findings were extended to human chronic infections such as HIV, HCV and HBV. However, it is not known if PD-1 high cells of healthy humans have the traits of exhausted cells. In this study, we provide a comprehensive description of phenotype, function and gene expression profiles of PD-1 high versus PD-1 low CD8 T cells in the peripheral blood of healthy human adults as following: 1) The percentage of naive and memory CD8 T cells varied widely in the peripheral blood cells of healthy humans and PD-1 was expressed by the memory CD8 T cells. 2) PD-1 high CD8 T cells in healthy humans did not significantly correlated with the PD-1 high exhausted gene signature of HIV specific human CD8 T cells or chronic LCMV specific CD8 T cells from mice. 3) PD-1 expression did not directly affect the ability of CD8 T cells to secrete cytokines in healthy adults. 4) PD-1 was expressed by the effector memory (TEM) compared to ‘terminally differentiated effector’ (TEMRA) CD8 T cells. 5) Finally, an interesting inverse relationship between CD45RA and PD-1 expression was observed.					11185	130589	672	9139	50834	6508	670	65078	92906	7536	29851	170691	2113	8115	949	9882	100128239	5026	57156	115362	283897	3699	643401	8635	123207	100129166	6504	197342	51669	644	28639	6489	2177	124491	3655	79673	10048	92558	56969	57326	149775	3111	2593	23157	25959	100130691	339123	643641	64600	51289	130367	5133	57631	84651	287	10738	534	2909	1880	8795	283165	220074	100289410	26151	56997	6364	7783	10954	132332	26119	346653	50852	284307	79744	2936	150248	23129	84289	3003	100288418	150468	6368	1871	126204	100505746	939	23354	23597	26018	57473	9429	10562	6932	3856	944	113622	54984	57463	400593	254531	79187	8440	147949	7412	80024	257160	283508	5783	132884	285203	114614	65975	152118	93166	728591	100288656	1233	2305	100290481	285051	2534	100506127	79258	4640	25854	940	84660	9962	100287483	3565	388011	6217	3770	100507501	283507	25924	4620	10158	27250	4152	54947	10216	387357	5335	150379	84914	582	80723	25841	79153	152992	5787	27442	23511	272	387097	55778	49856	200539	9911	8764	26155	3094	25833	5796	55716	728116	26505	84705	63925	25974	11037	94039	283745	7318	11120	4753	23508	11040	11322	6459	284498	10469	51386	57602	29015	57134	113263	55065	26227	55423	10293	79625	2308	100289612	85294	1953	3784	8639	50616
GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_DN	M4662		21383243	Duraiswamy J,Ibegbu CC,Masopust D,Miller JD,Araki K,Doho GH,Tata P,Gupta S,Zilliox MJ,Nakaya HI,Pulendran B,Haining WN,Freeman GJ,Ahmed R.	GSE26495	GSE26495_1504_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of PD-1 high CD8 T cells versus PD-1 low CD8 T cells.	T cell dysfunction is an important feature of many chronic viral infections. In particular, it was shown that PD-1 regulates T cell dysfunction during chronic LCMV infection in mice and PD-1 high cells exhibit an intense exhausted gene signature. These findings were extended to human chronic infections such as HIV, HCV and HBV. However, it is not known if PD-1 high cells of healthy humans have the traits of exhausted cells. In this study, we provide a comprehensive description of phenotype, function and gene expression profiles of PD-1 high versus PD-1 low CD8 T cells in the peripheral blood of healthy human adults as following: 1) The percentage of naive and memory CD8 T cells varied widely in the peripheral blood cells of healthy humans and PD-1 was expressed by the memory CD8 T cells. 2) PD-1 high CD8 T cells in healthy humans did not significantly correlated with the PD-1 high exhausted gene signature of HIV specific human CD8 T cells or chronic LCMV specific CD8 T cells from mice. 3) PD-1 expression did not directly affect the ability of CD8 T cells to secrete cytokines in healthy adults. 4) PD-1 was expressed by the effector memory (TEM) compared to ‘terminally differentiated effector’ (TEMRA) CD8 T cells. 5) Finally, an interesting inverse relationship between CD45RA and PD-1 expression was observed.					4067	84525	50810	117157	2297	4851	100132285	2752	153	3687	8522	666	7462	11034	114879	83872	3806	1066	3810	115653	9437	51293	1828	3811	124221	11057	11279	54796	57292	7099	732275	84941	1140	10898	6256	25840	10129	57616	1728	56940	2852	3824	84223	7305	3804	5141	122525	3809	92	2215	92521	197257	285989	8548	728114	51062	100130458	387509	10100	3221	3579	79895	3684	100505687	29070	401647	55784	1240	6964	221188	57692	255631	9926	9414	3206	645634	100133131	643911	1488	51348	6318	93474	26575	53346	9340	115	55603	3162	10077	10578	599	57447	152048	440184	283970	8876	56895	163747	412	1581	83473	9960	154661	122786	84335	118788	4684	55020	3823	285556	57458	11332	284367	100507530	439921	3803	4804	5664	4062	8302	989	140739	4943	100286987	83935	353189	100288257	57605	401317	8519	257169	55010	344752	83988	57571	64393	2161	92270	554235	51715	85027	55359	79709	374946	64110	84795	8361	284018	83989	8742	9278	9482	6273	4084	54829	83937	91584	85444	55031	1641	732448	57045	6238	1979	378708	440905	5567	132320	100289071	51314	10178	9045	4026	5174	5336	100128178	128876	22998	440934	100130717	5345	283571	23554	389792	101	57099	266811	9863	408	3688	9145	10903	2792	400236	442444	9832	647115	25829	430	92552
GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP	M4674		21471443	Chevalier N,Jarrossay D,Ho E,Avery DT,Ma CS,Yu D,Sallusto F,Tangye SG,Mackay CR.	GSE26928	GSE26928_1712_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive CD4 [GeneID=920] T cells versus CD4 [GeneID=920] effector memory T cells.						80024	100132735	23085	79754	100286909	23353	23131	63977	100289436	50840	51427	27343	100130837	4507	23016	55653	114804	284307	55175	7571	85865	80194	54955	55840	7581	143879	11077	79777	6468	285533	55906	55251	7525	10210	57506	23331	6894	23185	9363	84861	22845	5296	8334	8886	1964	54540	6908	8924	91754	55536	375190	8609	11102	79652	29013	10494	728568	4891	26227	57212	8880	119559	100129482	80095	622	3384	342574	55958	64777	55245	730092	158747	3978	11193	54581	283464	22836	6322	843	157285	6608	10616	7046	54674	51367	124923	91120	1286	9530	8420	60490	259173	26235	340554	22921	114795	79623	22866	11123	51270	65982	284513	100131980	131890	55902	56997	8396	8365	55103	132720	51466	6304	7767	9135	23301	376940	2099	10178	84450	113510	91624	339804	54566	92840	115123	168451	79161	80045	130502	100287572	201501	57763	64174	26249	5578	8675	80781	85478	57396	11259	6920	9821	1830	81887	64343	4040	25901	151613	253782	30847	325	55329	84524	401303	27352	346887	6872	80331	51090	57125	54780	51258	65265	114792	4951	8125	643616	79590	64839	80868	4724	463	8630	596	90411	51309	55354	157657	10389	10282	80063	51557	64744	55737	91574	5264	50863	26034	6815	1901	22929	54901	51601	90634	85460	9801	4176	196074	1038	84060
GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN	M4676		21471443	Chevalier N,Jarrossay D,Ho E,Avery DT,Ma CS,Yu D,Sallusto F,Tangye SG,Mackay CR.	GSE26928	GSE26928_1712_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus CD4 [GeneID=920] effector memory T cells.						25945	4700	3956	118429	79100	283485	65124	488	1831	54487	2321	51571	55884	10894	79668	55294	8277	100132319	9061	58476	81542	23008	23208	9902	28231	4247	23138	5618	1123	339488	490	55041	6281	4502	4162	4552	4000	51330	2059	9910	172	6731	113457	8807	54732	6835	162417	5066	304	6645	56106	5564	23392	100131993	56134	170949	4678	200734	947	79682	51228	5373	2885	3080	10675	2149	317702	51259	84804	272	84247	84902	57082	3987	55605	386627	9134	1522	338579	51604	51145	8320	9022	26255	57595	9014	79930	7643	10298	5533	6717	4758	6787	7124	5879	9817	3783	27350	2799	57688	9637	5295	580	7158	284252	85495	131177	3957	2889	23020	7884	29940	9261	55835	1808	7045	51593	219844	1209	203260	3069	64240	100505989	7107	390874	283174	1512	100128590	5435	100287602	56660	25979	157503	5965	5783	1394	3487	154	2000	9266	10567	59269	8178	8760	148824	135228	22936	11138	5306	84888	64420	2980	123920	2040	81602	23150	5209	11269	201266	3070	56937	23555	1889	26504	9027	1062	55909	598	126328	6303	23017	6529	338811	25793	7982	6352	639	51514	10551	2650	864	1384	259307	7133	4953	80021	23054	23333	23768	6515	23074	349565	90024	5317	10590	302	57142	7295	154075	255231
GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP	M4677		21471443	Chevalier N,Jarrossay D,Ho E,Avery DT,Ma CS,Yu D,Sallusto F,Tangye SG,Mackay CR.	GSE26928	GSE26928_1713_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive CD4 [GeneID=920] T cells versus CD4 [GeneID=920] central memory T cells.						285501	65982	162137	1236	5296	7700	80823	90411	147948	256987	5864	27314	255762	64848	22845	114804	56928	27090	81609	128338	7442	22866	3631	259283	348120	196913	6908	51149	22836	114827	1964	51533	144233	100506436	56980	166378	81844	26960	55508	64093	10885	51367	10320	5264	11119	220965	57228	388011	55353	4795	146542	114224	131890	157285	51123	441549	5379	64965	2542	440570	3918	10616	92106	6259	3978	374443	84726	166647	57194	80227	4040	23081	57504	129293	26580	4649	8924	84450	284391	5481	221785	23732	94101	137835	79918	23492	51070	8650	196483	23294	337867	157657	29068	87	8420	388503	727957	256471	7693	7775	5334	79931	64784	340554	95	643977	149076	3298	79084	79590	375775	8799	3347	129401	57212	26149	100131541	51626	5193	8642	1401	8495	677	155051	8793	843	5863	3707	286002	54494	259173	9823	55780	5993	51601	7182	54978	53917	3219	553115	64174	51011	4602	54956	339448	2512	91624	81887	54832	10314	3742	7248	414328	80818	10113	10327	57473	376940	9797	112611	100132884	54954	8722	10276	345462	9421	90390	199	79612	5091	4354	57181	5747	1112	29902	196074	9869	202018	328	8933	130399	114792	64081	751071	55893	641518	23635	130502	285349	22920	10954	644135	114899	54741	153222	23331	6809	80010	126147	79411
GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN	M4678		21471443	Chevalier N,Jarrossay D,Ho E,Avery DT,Ma CS,Yu D,Sallusto F,Tangye SG,Mackay CR.	GSE26928	GSE26928_1713_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus CD4 [GeneID=920] central memory T cells.						25945	4357	84193	172	80326	64127	23219	8277	200734	56062	5435	9104	57480	4000	65124	10585	85285	51167	10381	10745	8477	317702	10488	100288673	2040	23150	135228	6478	29110	7564	83860	5931	56654	200933	4082	7444	59269	154141	3705	55450	28983	200576	10675	6731	6388	5427	1277	9997	50855	23008	11018	130589	7468	5306	7107	79954	284808	57489	4664	864	29089	176	23232	100289632	25979	22936	57731	3635	79041	8533	3486	4758	23616	79733	1512	205860	3956	51655	10011	55224	388722	9817	27229	9934	3070	10797	10418	123920	7701	26524	51005	256158	23208	221241	5690	4312	100505989	406991	55223	85457	440432	53822	10121	65244	389	246176	9902	3987	157931	54331	5783	23555	3697	387882	27099	3958	84247	9296	240	5119	29103	51061	57534	3560	682	285878	55502	26255	90701	112597	282991	57147	389125	195827	79581	55808	56910	10369	221710	124637	2059	6397	5236	196527	100292688	23636	341640	2004	22856	7332	100505658	899	100131015	23035	10294	5621	83706	2592	4326	2161	7158	29919	5052	129450	127731	22897	90362	6489	56255	27338	9474	24142	339390	8945	55094	56935	5034	3382	4258	57732	196383	2799	28378	9232	2043	10090	3075	3113	9528	9377	58191	6913	375346	6515	29980	3815	965	435	9169	6804
GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_UP	M4682		21471443	Chevalier N,Jarrossay D,Ho E,Avery DT,Ma CS,Yu D,Sallusto F,Tangye SG,Mackay CR.	GSE26928	GSE26928_1714_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of naive CD4 [GeneID=920] T cells versus CD4 [GeneID=920] CXCR5+ [GeneID=643] T cells.						55515	23085	23635	642852	56928	23247	8799	283693	80781	1236	286190	130872	65982	79652	79777	55175	64772	100506054	51272	154791	5653	5296	25809	6559	84215	2984	3248	4215	5696	259283	260293	84107	112398	54103	210	54083	401303	10320	388011	5264	5608	255104	4351	1032	80063	26517	51149	51367	583	375775	1112	65991	160762	100289436	79161	10325	1606	283464	10360	23587	127733	56997	54977	144233	157657	83636	148738	84545	80227	7477	25814	84450	1438	126248	728743	10179	100270804	2035	6304	4676	644135	25956	85478	84958	283551	166647	9363	3882	51374	328	138474	127262	285300	79846	5150	134145	9754	8411	10423	4868	5578	255626	57496	27294	149465	23386	79734	57609	4832	87	100131980	9563	201501	2648	28511	257629	163732	10623	11118	51329	873	90167	8402	7767	9241	196740	3203	55425	23359	23335	54955	541565	9448	27343	348120	6908	440498	55363	53827	23316	84266	148808	24142	285533	84792	130399	4602	85481	54765	57659	6527	100287109	27352	5079	23016	100128164	84138	79731	728537	641518	23410	6468	6999	283234	57019	83734	26259	8396	2272	64718	9587	23258	8643	10489	9024	57835	56254	2197	8303	1240	7442	219285	93622	3739	126820	92840	4507	203245	3181	5334	2709	55613	9049	55151	79896	1825	92086	64710	283463	64418
GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_DN	M4683		21471443	Chevalier N,Jarrossay D,Ho E,Avery DT,Ma CS,Yu D,Sallusto F,Tangye SG,Mackay CR.	GSE26928	GSE26928_1714_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus CD4 [GeneID=920] CXCR5+ [GeneID=643] T cells.						55727	7763	23603	66036	80834	10445	4247	51314	23478	51382	9377	3516	80854	25945	10590	56654	1026	196527	29110	7444	2799	130589	51303	55718	1984	51655	26504	440704	2252	64005	9870	100505989	286087	150771	84446	4036	51005	100131015	55294	7295	7852	394	84247	7107	83860	3964	79829	55884	4357	53616	5621	55127	57142	3070	23199	84163	222658	22846	55914	3705	5663	2580	114825	6102	29109	91893	57396	8567	5746	23276	84888	56993	100289294	79602	9388	3257	57688	10745	100506190	5910	10121	5985	10773	3987	4739	2919	23555	23208	123920	92259	55041	89845	25978	23130	55211	3486	51426	79092	283431	63982	8428	22905	50837	9910	2281	148534	120224	55722	1947	400617	54455	10011	5612	29072	64224	23636	90589	51226	5579	51343	257203	5331	1808	200734	1717	406991	255231	178	10178	150465	9833	965	2059	23553	9768	9656	9043	8295	84264	8943	100130705	7634	83607	9739	6836	23253	51571	64420	378820	284306	80262	6873	4159	100287037	51013	56910	5744	302	3627	23333	4953	286828	1387	10499	100270680	55829	440823	5870	22794	2018	1470	7262	64940	6795	286451	7511	51061	83706	100290481	2137	88455	23392	80144	80824	220441	84541	10675	101	149628	79155	8682	26018	81831	57535	84193	84902	54834	50624	79719	56000
GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_UP	M4684		21471443	Chevalier N,Jarrossay D,Ho E,Avery DT,Ma CS,Yu D,Sallusto F,Tangye SG,Mackay CR.	GSE26928	GSE26928_1715_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of CD4 [GeneID=920] effector memory T cells versus CD4 [GeneID=920] central memory T cells.						100129407	84193	389634	285548	100289049	8553	4139	8027	6352	132112	26496	3586	11075	613212	80346	56955	1209	401548	4858	256646	2274	4317	84525	9846	400793	10157	11148	100287602	149951	65977	84102	9022	7465	51303	605	3092	64111	100129309	26286	55165	59336	143282	3737	400954	2799	79070	25973	154	113230	196740	7050	6927	5074	51466	339448	2149	440712	54438	79791	7378	339456	5099	29089	80790	3002	6809	9480	4360	401115	285489	55502	8968	80759	253152	7941	100290481	10886	27306	3122	81796	83879	8320	25937	7077	3993	4542	10227	10570	1326	79820	100287290	55676	8444	79026	27097	2729	4741	283870	4094	7162	84804	284648	55540	259234	100128998	114795	7412	79080	481	79156	1495	2876	85027	84250	285758	116236	9628	151742	100272217	54434	201255	11065	5606	64783	646600	2034	389792	51118	23268	2589	63939	124783	91149	3113	23138	2185	6375	643911	285501	5780	223	1493	5378	26343	9437	51203	9926	27033	147429	23603	84681	2153	5218	83868	131583	373863	3996	1837	128710	149986	51726	598	100288225	220382	160419	100128185	57539	64769	170690	3957	100287765	2769	23365	7779	9625	116135	1579	5563	245928	100288781	22891	79888	158035	3684	55715	488	5732	100287094	55615	132228	147841	2539	83657	6857	3698	5802	154007	56901	284207	146059
GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_DN	M4685		21471443	Chevalier N,Jarrossay D,Ho E,Avery DT,Ma CS,Yu D,Sallusto F,Tangye SG,Mackay CR.	GSE26928	GSE26928_1715_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of CD4 [GeneID=920] effector memory T cells versus CD4 [GeneID=920] central memory T cells.						10294	9100	83481	140461	54463	64220	196472	9874	55068	4314	79078	10256	55805	79717	199	87	29797	51309	2838	266747	6322	8793	8074	1669	259283	60439	8082	6801	6491	27018	285955	54540	1406	90499	23200	283208	80024	59347	246176	574414	84290	8467	85452	168451	54453	5814	84547	2744	7494	7697	162239	84182	9530	60491	378825	57713	64645	407738	23321	286148	6884	57132	149297	100289632	57107	7750	5955	8416	441072	79807	9402	285423	285172	91689	4719	8420	54534	100422781	100287025	191	57731	6920	56300	23232	146795	167153	161823	402160	284865	100507244	114928	2253	130162	9135	57181	83744	174	92106	79657	6815	197370	797	100505761	128414	12	11212	51011	201229	9867	27332	83989	80145	10000	23219	54558	64718	27443	55816	128497	8483	85478	90594	160313	55283	6565	11096	55628	132720	6755	347732	727699	9590	54996	65265	91584	23515	142686	3005	220107	100128198	23563	583	152225	493753	84651	652963	50840	282706	285147	64844	23592	129293	143471	100132625	145781	943	55197	27314	100289378	1657	23193	149428	128338	26996	25807	79986	2631	6508	727936	401014	3298	143686	196996	7581	2917	6772	619423	55769	613126	54475	144360	7594	144715	6641	100131733	414899	286464	220323	85462	92736	79366	100134040	90634	3655	284391	54796	7294	80006	126017	7844
GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP	M4686		21471443	Chevalier N,Jarrossay D,Ho E,Avery DT,Ma CS,Yu D,Sallusto F,Tangye SG,Mackay CR.	GSE26928	GSE26928_1716_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of CD4 [GeneID=920] effector memory T cells versus CD4 [GeneID=920] CXCR5+ [GeneID=643] T cells.						139135	6758	550631	100287289	8320	8761	162517	127262	10572	55615	170394	3767	2793	284359	112885	54884	970	2081	81796	644096	1476	7375	11172	285172	100287290	9265	11252	55054	100128185	9040	4617	84733	2531	157777	10457	56978	9266	340074	83999	5554	5694	414157	57611	399512	9022	53349	4009	222234	10365	4585	51378	55540	1209	51069	3742	5783	23513	55605	57532	83755	10265	64130	100129034	84619	131583	23544	54834	64127	100506054	400954	9746	2242	2034	4692	10213	27352	259234	3049	284114	10635	1582	130612	4920	440570	100289061	8529	54626	648691	85481	1062	401548	3219	83942	440590	3002	11099	7378	406991	729570	8553	79152	115196	5436	646113	90586	860	116236	966	100287927	2539	1627	79913	3303	148824	643763	646808	56241	160762	27290	643837	51604	3692	79843	304	54466	80212	51231	8507	126328	399909	339488	199745	2674	4058	100131176	5052	7153	90313	154881	8835	5499	8354	128954	79803	1173	340205	6277	221527	9576	4654	10570	3396	284600	8784	3662	26343	6810	57171	202374	1639	196513	55833	3001	7391	30814	220382	3628	10066	89822	10423	7026	401546	3174	79586	253152	713	10670	374946	2833	51513	64764	375387	5757	84168	130589	2782	8807	9448	10227	100506776	7221	65992	80790	8708	645745	11107	57418	9210	5606	6281
GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN	M4687		21471443	Chevalier N,Jarrossay D,Ho E,Avery DT,Ma CS,Yu D,Sallusto F,Tangye SG,Mackay CR.	GSE26928	GSE26928_1716_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of CD4 [GeneID=920] effector memory T cells versus CD4 [GeneID=920] CXCR5+ [GeneID=643] T cells.						26249	100506497	58155	441366	379034	79632	6920	4799	140461	100507098	168451	9720	79832	3775	3081	3786	54816	51014	1278	79695	89958	25973	1665	51427	407738	51562	126695	23376	338817	5286	8204	143279	79269	5876	2253	147463	57181	57379	51307	22992	6386	137392	100128782	284716	7556	5125	60493	91120	10947	116179	132720	8821	259283	55745	23077	28514	219854	55859	64283	642987	1984	3741	4724	79717	23742	27018	256987	7518	152815	2525	10804	10653	7571	129293	57180	116328	285429	3890	1117	55529	114818	60491	7294	7750	403313	9733	1380	597	339468	100128239	1876	4675	400593	23066	80024	63929	338	85438	549	255967	100287569	1060	57718	8915	122773	79609	2589	55183	91754	57713	87	401282	2066	286382	9874	9215	7525	145389	123036	253769	55274	285955	50856	3480	253782	54463	1010	27125	26091	583	22929	80318	26119	51315	144535	5599	25938	115572	116447	83989	84138	100287572	84792	201229	4761	729614	114908	23635	79630	138804	417	5191	64777	283232	7478	339804	3187	130507	4891	85358	200728	27241	4999	64641	50628	11259	286148	80144	283848	7077	92017	115123	5042	8875	4216	9919	148156	6699	57120	55728	57102	10009	57688	5324	414328	100289378	63971	55769	10808	128338	120114	55437	253430	54942	79690	8717	3181	990	9662	23111
GSE26928_CENTR_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP	M4688		21471443	Chevalier N,Jarrossay D,Ho E,Avery DT,Ma CS,Yu D,Sallusto F,Tangye SG,Mackay CR.	GSE26928	GSE26928_1717_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of CD4 [GeneID=920] central memory T cells versus CD4 [GeneID=920] CXCR5+ [GeneID=643] T cells.						55521	84844	8567	9266	57480	51086	79643	100129098	8477	204801	22913	4247	84658	2585	50945	54900	387882	115939	404037	157848	54815	54753	3248	148113	29894	6677	91689	6505	4624	6884	25834	160622	104	5688	6810	56145	9123	9939	5696	196740	60494	29925	253805	51081	9402	5783	4920	11194	54212	4832	10631	3396	55359	374918	5315	686	220382	79896	100129917	126248	579	28957	1809	1263	4502	58503	5496	57291	85478	2830	56853	56062	92565	750	55867	6299	54106	6748	84176	92736	55194	5052	8694	51195	220323	103910	338620	51702	3400	4692	57060	51608	8991	3006	5027	127396	439933	7465	2575	221002	10213	285172	80258	581	283677	5803	134145	83999	64593	6924	84525	2782	65997	1627	79590	338773	3773	84818	255411	5144	9205	259296	2014	10870	149297	100130111	100132832	27352	8871	283208	79844	399669	139728	727936	100129034	50861	79586	5730	5045	23114	619426	1176	55093	4868	100289084	2874	266629	9902	100130889	100289061	8536	729595	5827	2248	1521	6193	435	51329	10994	5034	85462	3269	135228	79934	221527	2644	23643	57381	5715	22933	10791	91703	9290	6571	7124	25992	80097	4586	864	440574	3767	6281	80339	161145	439990	132	374946	339766	4632	100134040	100288590	83874	4604	94274	9717	138241	2625	57731	3933	254102
GSE26928_CENTR_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN	M4689		21471443	Chevalier N,Jarrossay D,Ho E,Avery DT,Ma CS,Yu D,Sallusto F,Tangye SG,Mackay CR.	GSE26928	GSE26928_1717_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of CD4 [GeneID=920] central memory T cells versus CD4 [GeneID=920] CXCR5+ [GeneID=643] T cells.						5744	79918	2595	1962	100507098	79670	2744	389641	5218	57824	286223	63939	51571	149069	93190	57661	286087	83882	51307	80834	25973	196472	25917	221294	7700	157922	89978	132625	9869	79977	4216	54849	27072	23576	57713	80852	100379224	247	2976	401145	126147	123036	23315	346653	400709	51684	58155	63899	643072	113263	29028	139538	6934	9656	642587	7976	55466	100101266	3742	7582	10314	25805	1326	114224	79983	26532	9480	9874	3708	56986	79018	53616	375287	3202	100288418	79832	23601	57018	7750	100129436	64848	495	6641	149478	28514	5607	51088	54971	50628	26495	26289	116985	56894	64067	81609	4833	9665	445	205717	10062	6882	8226	1523	81846	3987	100130905	84991	4159	100289508	5885	8876	2788	4956	92017	255967	11012	84264	2849	50808	7763	10936	3749	9826	23129	1549	5594	10211	50856	25972	83447	6863	286828	55013	285513	55914	6382	5121	22976	255762	25774	84812	64772	4629	83591	7024	25956	178	89781	60493	5617	3081	55365	84435	571	1486	27086	54881	285548	4664	29075	347862	8204	51646	117247	6386	3109	9044	196996	8303	23635	22992	120224	158427	7080	100288122	8332	124857	59343	165082	90632	155435	154141	55603	131474	54520	79940	64420	347853	8564	349114	54496	219347	222696	9949	26005	441151	54463	26999	1385	100049716
GSE2706_UNSTIM_VS_2H_R848_DC_UP	M4691		15995707	Napolitani G,Rinaldi A,Bertoni F,Sallusto F,Lanzavecchia A.	GSE2706	GSE2706_1837_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of unstimulated dendritic cells (DC) at 0 h versus DCs stimulated with R848 for 2 h.	Toll like receptors (TLRs) sense microbial products and initiate adaptive immune responses by activating dendritic cells (DCs). Since pathogens may contain several agonists we asked whether different TLRs may synergize in DC activation. We report that in human and mouse DC TLR3 or TLR4 potently synergize with TLR7, TLR8 or TLR9 in the induction of selected cytokine genes. Upon synergistic stimulation, IL-12, IL-23 and Delta-4 are induced at levels 50-100 fold higher than those induced by optimal concentrations of single agonists, leading to enhanced and sustained TH1 polarizing capacity. Using microarray analysis we show that only 1.5% of the transcripts induced by single TLR agonists are synergistically regulated by combinations of TLR4 and TLR8 agonists. These results identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses. Series_overall_design: 3 untreated, 3 treated with LPS at 2h, 3 treated with LPS at 8h, 3 treated with R848 at 2h, 3 treated with R848 at 8h, 3 treated with LPS + R848 at 2h, 3 treated with LPS + R848 at 8h					8505	145694	29072	80124	29985	57533	23030	116143	285331	51603	65124	64172	100287499	286827	51385	55900	84260	55347	64969	140707	2145	170689	10910	80143	10717	80227	729230	63939	51545	146760	7707	85459	23304	221545	94234	493869	84301	767811	54738	196513	51471	144699	1849	57191	130589	29102	112724	5354	259286	51621	123041	80184	9935	100309464	79810	131474	1050	254173	4610	10044	136051	55156	10714	79631	161753	60386	196872	23386	79018	29801	80052	203274	90806	57187	643641	64766	51255	100131564	2288	6877	100271722	80231	79660	7132	23051	84219	2535	10056	9903	79621	54554	79675	283501	9371	11064	387119	65981	2734	63901	126231	91548	84939	80817	80851	6389	220164	54407	284029	79791	257144	3292	23036	23401	8974	64772	79777	6843	29116	55035	338692	8405	145853	100506963	54777	9025	89849	10845	254225	51063	84196	219990	23438	3087	57563	7918	114907	140461	29087	100129884	9122	54496	286467	57215	55703	9314	9678	57479	57102	166379	64718	51657	23357	340252	7692	2063	64062	253512	10240	65260	4066	121053	57147	6503	23370	51400	113115	100289026	92999	9655	256281	57496	57583	7203	3399	54800	55154	11082	896	283352	148014	10615	5342	10126	55689	373	6584	57616	130872	55186	57209	284996	57799	54841	49856	54492	7466	51265	2072	56986	7770
GSE2706_UNSTIM_VS_2H_R848_DC_DN	M4692		15995707	Napolitani G,Rinaldi A,Bertoni F,Sallusto F,Lanzavecchia A.	GSE2706	GSE2706_1837_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of unstimulated dendritic cells (DC) at 0 h versus DCs stimulated with R848 for 2 h.	Toll like receptors (TLRs) sense microbial products and initiate adaptive immune responses by activating dendritic cells (DCs). Since pathogens may contain several agonists we asked whether different TLRs may synergize in DC activation. We report that in human and mouse DC TLR3 or TLR4 potently synergize with TLR7, TLR8 or TLR9 in the induction of selected cytokine genes. Upon synergistic stimulation, IL-12, IL-23 and Delta-4 are induced at levels 50-100 fold higher than those induced by optimal concentrations of single agonists, leading to enhanced and sustained TH1 polarizing capacity. Using microarray analysis we show that only 1.5% of the transcripts induced by single TLR agonists are synergistically regulated by combinations of TLR4 and TLR8 agonists. These results identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses. Series_overall_design: 3 untreated, 3 treated with LPS at 2h, 3 treated with LPS at 8h, 3 treated with R848 at 2h, 3 treated with R848 at 8h, 3 treated with LPS + R848 at 2h, 3 treated with LPS + R848 at 8h					23533	3627	83931	3587	282566	64651	10288	5996	3759	7280	84807	283229	4790	2919	64859	3569	6478	57507	1942	1847	64857	7832	3552	5966	1326	646626	3096	200315	5326	7273	149478	1647	79155	78995	124637	196383	9034	200734	7128	123872	285423	2180	374383	94015	7159	285958	117177	148022	415116	3669	53826	57823	2669	5329	114614	9693	4049	2615	353514	79868	23135	285628	8140	4814	221749	1594	5734	7743	2591	3656	9700	58476	79720	84815	3394	4651	64332	2920	731424	3437	7185	80149	694	7127	145264	9021	65108	83593	25816	440896	8837	22898	845	6356	57149	646383	50852	2921	4616	386618	1263	85463	56300	1634	29841	3383	23099	56548	84419	5606	8676	64005	9953	6352	1906	6675	55332	11177	123879	285957	5770	7490	6890	5341	10658	387914	3433	84981	5597	10950	330	245937	219333	247	284018	9076	91543	84930	9027	4792	93082	9687	9636	83856	637	9334	4493	6515	339468	166929	29933	5027	8013	55038	5743	23764	2907	5366	3624	90874	100129656	55008	255488	23529	9966	3007	3553	57713	7130	9033	602	221079	84879	6775	3593	84789	5272	4793	644090	54463	92162	654817	2643	2633	83694	3601	85359	6385	8653	129607	23645	677824	6541	114789	255231	9258	3638	6351	5687	10938
GSE2706_UNSTIM_VS_8H_R848_DC_UP	M4693		15995707	Napolitani G,Rinaldi A,Bertoni F,Sallusto F,Lanzavecchia A.	GSE2706	GSE2706_1838_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of unstimulated dendritic cells (DC) at 0 h versus DCs stimulated with R848 for 8 h.	Toll like receptors (TLRs) sense microbial products and initiate adaptive immune responses by activating dendritic cells (DCs). Since pathogens may contain several agonists we asked whether different TLRs may synergize in DC activation. We report that in human and mouse DC TLR3 or TLR4 potently synergize with TLR7, TLR8 or TLR9 in the induction of selected cytokine genes. Upon synergistic stimulation, IL-12, IL-23 and Delta-4 are induced at levels 50-100 fold higher than those induced by optimal concentrations of single agonists, leading to enhanced and sustained TH1 polarizing capacity. Using microarray analysis we show that only 1.5% of the transcripts induced by single TLR agonists are synergistically regulated by combinations of TLR4 and TLR8 agonists. These results identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses. Series_overall_design: 3 untreated, 3 treated with LPS at 2h, 3 treated with LPS at 8h, 3 treated with R848 at 2h, 3 treated with R848 at 8h, 3 treated with LPS + R848 at 2h, 3 treated with LPS + R848 at 8h					54	4129	126321	155066	5165	64131	55534	51205	5830	3350	5337	4357	349565	5724	166012	23002	114819	79622	90522	8974	147276	391267	3269	5002	5032	51146	18	886	8354	54438	94234	112487	26080	84222	10491	10916	129138	79789	64174	9120	898	1601	283431	54209	80270	115825	9314	60370	145173	440346	10126	57616	344558	53827	2273	53373	219654	4774	387535	2012	51181	3693	55909	27023	57707	114876	4778	66005	140894	150759	284382	90507	9825	146547	91107	51684	84106	2242	388115	23401	9764	4063	9697	4217	7045	284757	494513	1545	642426	6461	100128178	84722	113791	23324	501	285464	5742	59307	678	645	153328	3073	145438	169841	949	23059	3603	84309	23181	84650	79587	55556	7423	7123	2675	7466	51279	26147	5287	374882	340947	3339	116832	25799	79727	342892	100288870	116151	151306	55536	5738	388531	6584	3004	23765	51005	10044	433	163175	25864	285368	4155	9586	10194	4925	53905	5175	29985	65981	2168	7106	55343	2843	9450	7075	6450	326340	23492	83742	84216	55329	5003	57209	11186	7227	2232	79887	84680	93210	29798	54504	10572	5836	8677	6916	38	56975	3384	23344	128822	57101	56052	25927	55194	83889	8647	55009	9380	10961	1628	7390	1677	6573	6795	84316	1643	55568	283897	131870	441549
GSE2706_UNSTIM_VS_8H_R848_DC_DN	M4694		15995707	Napolitani G,Rinaldi A,Bertoni F,Sallusto F,Lanzavecchia A.	GSE2706	GSE2706_1838_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of unstimulated dendritic cells (DC) at 0 h versus DCs stimulated with R848 for 8 h.	Toll like receptors (TLRs) sense microbial products and initiate adaptive immune responses by activating dendritic cells (DCs). Since pathogens may contain several agonists we asked whether different TLRs may synergize in DC activation. We report that in human and mouse DC TLR3 or TLR4 potently synergize with TLR7, TLR8 or TLR9 in the induction of selected cytokine genes. Upon synergistic stimulation, IL-12, IL-23 and Delta-4 are induced at levels 50-100 fold higher than those induced by optimal concentrations of single agonists, leading to enhanced and sustained TH1 polarizing capacity. Using microarray analysis we show that only 1.5% of the transcripts induced by single TLR agonists are synergistically regulated by combinations of TLR4 and TLR8 agonists. These results identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses. Series_overall_design: 3 untreated, 3 treated with LPS at 2h, 3 treated with LPS at 8h, 3 treated with R848 at 2h, 3 treated with R848 at 8h, 3 treated with LPS + R848 at 2h, 3 treated with LPS + R848 at 8h					353514	282566	26031	3600	54625	29126	7357	158067	65108	257019	10391	219285	1846	11040	3914	10538	129607	11026	23180	27314	6772	283471	3638	10288	10950	10135	3434	5610	79572	654254	386597	7107	80045	6303	6478	152015	100287590	7130	10125	6373	63914	84419	5996	3574	6506	50486	284018	64109	3624	11177	8440	5366	10561	64135	3696	83666	3669	2117	9695	22973	91351	26037	84679	25816	23362	9595	5966	7128	56300	64859	8676	84223	2537	3627	7273	10148	7293	3569	23075	9636	140691	93082	694	4616	64332	970	57061	162394	94240	84467	9638	26002	203197	64750	6374	9021	29841	6775	57619	160851	646168	4316	285966	256227	4939	7057	3430	5734	117157	9662	3096	6741	7185	7127	5327	6346	3437	81553	840	6498	255231	4790	10798	6504	4982	10413	5971	100	651746	346389	3321	3553	254065	51191	54739	64782	9966	6648	200315	57674	57823	150353	114614	8743	143686	80149	53826	8013	84166	5739	23586	7295	57482	11274	330	58516	3433	6664	9111	4301	4049	29128	6934	1236	200010	11343	64129	84930	2983	3371	962	7035	5325	25841	340719	1847	1326	9693	27351	653583	10154	84441	122876	5506	1647	55008	83478	6356	51566	379	83856	7124	2633	5687	22837	57149	84632	7453	285958	23424
GSE2706_UNSTIM_VS_2H_LPS_DC_UP	M4695		15995707	Napolitani G,Rinaldi A,Bertoni F,Sallusto F,Lanzavecchia A.	GSE2706	GSE2706_1839_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of unstimulated dendritic cells (DC) at 0 h versus DCs stimulated with LPS (TLR4 agonist) for 2 h.	Toll like receptors (TLRs) sense microbial products and initiate adaptive immune responses by activating dendritic cells (DCs). Since pathogens may contain several agonists we asked whether different TLRs may synergize in DC activation. We report that in human and mouse DC TLR3 or TLR4 potently synergize with TLR7, TLR8 or TLR9 in the induction of selected cytokine genes. Upon synergistic stimulation, IL-12, IL-23 and Delta-4 are induced at levels 50-100 fold higher than those induced by optimal concentrations of single agonists, leading to enhanced and sustained TH1 polarizing capacity. Using microarray analysis we show that only 1.5% of the transcripts induced by single TLR agonists are synergistically regulated by combinations of TLR4 and TLR8 agonists. These results identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses. Series_overall_design: 3 untreated, 3 treated with LPS at 2h, 3 treated with LPS at 8h, 3 treated with R848 at 2h, 3 treated with R848 at 8h, 3 treated with LPS + R848 at 2h, 3 treated with LPS + R848 at 8h					7553	114819	84307	64763	23642	339324	100128288	115509	112812	126017	25888	203523	390980	163081	5194	195828	286046	57541	57481	284443	134266	389792	146760	8840	3087	55924	84864	317781	132241	55900	729230	113115	284406	166379	80052	9095	85459	643641	7775	25973	57786	8772	26098	387032	100507391	2026	390035	25799	284749	2302	80778	150368	79891	90624	79142	55657	284029	374354	100506963	338692	9869	3445	54663	55520	157570	90594	28563	91574	146050	163049	151556	84747	643836	23528	260294	60686	339559	645460	79446	2063	57035	55552	154881	27079	163050	119016	10795	51104	84461	27042	5798	58495	57002	54465	114132	2843	79078	10023	51213	284370	25988	79692	5883	10081	494150	54492	284697	83480	64421	54738	5342	10069	157381	284391	91181	6940	55672	100288693	9489	246126	85452	9533	7767	1027	93589	64320	5565	11063	51545	100527964	345462	23554	55039	57585	201164	161436	7566	9668	387535	100506325	51426	55592	7586	7738	29915	9139	100359394	90580	4778	168537	124923	84219	80304	55090	8620	57649	1796	254122	203260	162417	94234	399947	7571	147670	29928	1831	55689	55680	55561	85364	121274	122769	9666	401067	64895	153733	120534	23245	58484	79064	80095	57147	28990	155038	360023	23401	148254	255177	7741	57168	222236	342909	100292680	57684	492311	284307	339874	55051	1849	55028
GSE2706_UNSTIM_VS_2H_LPS_DC_DN	M4696		15995707	Napolitani G,Rinaldi A,Bertoni F,Sallusto F,Lanzavecchia A.	GSE2706	GSE2706_1839_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of unstimulated dendritic cells (DC) at 0 h versus DCs stimulated with LPS (TLR4 agonist) for 2 h.	Toll like receptors (TLRs) sense microbial products and initiate adaptive immune responses by activating dendritic cells (DCs). Since pathogens may contain several agonists we asked whether different TLRs may synergize in DC activation. We report that in human and mouse DC TLR3 or TLR4 potently synergize with TLR7, TLR8 or TLR9 in the induction of selected cytokine genes. Upon synergistic stimulation, IL-12, IL-23 and Delta-4 are induced at levels 50-100 fold higher than those induced by optimal concentrations of single agonists, leading to enhanced and sustained TH1 polarizing capacity. Using microarray analysis we show that only 1.5% of the transcripts induced by single TLR agonists are synergistically regulated by combinations of TLR4 and TLR8 agonists. These results identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses. Series_overall_design: 3 untreated, 3 treated with LPS at 2h, 3 treated with LPS at 8h, 3 treated with R848 at 2h, 3 treated with R848 at 8h, 3 treated with LPS + R848 at 2h, 3 treated with LPS + R848 at 8h					1942	220213	3383	6478	2591	3949	5029	284018	29126	2921	9693	65108	23533	338382	54625	5966	5329	285958	245937	25816	2615	3096	5371	7128	2146	731424	100	7127	8807	3638	8676	4928	3659	123879	4793	2920	2919	100132386	90874	11182	6674	5996	64135	3434	374383	79155	5326	157739	84879	441027	9034	1847	131583	64332	1647	3669	10538	467	10318	23135	64651	9021	23306	85320	56681	9636	3586	7273	80149	219333	100128185	4049	5770	3587	8843	5606	3656	7293	57169	1326	10561	4435	3627	83593	374443	5734	22809	415116	3665	3624	112597	29933	10691	694	3552	58515	441366	10950	182	2627	55008	11250	282566	26037	3757	84419	637	123872	6373	4616	6648	4792	53826	7472	200315	94015	2117	7159	27074	8638	440896	221749	1880	255488	9953	57801	5739	57162	3696	7280	84867	3759	2180	1026	7726	56300	2669	65264	8013	6890	11067	91283	3437	100130232	399949	285628	64859	114614	22936	79150	10207	196383	284099	9334	64109	3456	330	56829	10938	3569	23011	11156	11044	27314	157697	2633	84815	29015	58476	941	1844	654817	9852	60676	598	401317	10485	10125	4790	3394	7832	7130	3593	8767	196475	57477	221079	51561	10135	79931	200734	4814	8837	5971	1906	151126	651746	22973	7185	5027
GSE2706_UNSTIM_VS_8H_LPS_DC_UP	M4698		15995707	Napolitani G,Rinaldi A,Bertoni F,Sallusto F,Lanzavecchia A.	GSE2706	GSE2706_1840_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of unstimulated dendritic cells (DC) at 0 h versus DCs stimulated with LPS (TLR4 agonist) for 8 h.	Toll like receptors (TLRs) sense microbial products and initiate adaptive immune responses by activating dendritic cells (DCs). Since pathogens may contain several agonists we asked whether different TLRs may synergize in DC activation. We report that in human and mouse DC TLR3 or TLR4 potently synergize with TLR7, TLR8 or TLR9 in the induction of selected cytokine genes. Upon synergistic stimulation, IL-12, IL-23 and Delta-4 are induced at levels 50-100 fold higher than those induced by optimal concentrations of single agonists, leading to enhanced and sustained TH1 polarizing capacity. Using microarray analysis we show that only 1.5% of the transcripts induced by single TLR agonists are synergistically regulated by combinations of TLR4 and TLR8 agonists. These results identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses. Series_overall_design: 3 untreated, 3 treated with LPS at 2h, 3 treated with LPS at 8h, 3 treated with R848 at 2h, 3 treated with R848 at 8h, 3 treated with LPS + R848 at 2h, 3 treated with LPS + R848 at 8h					25840	374378	56521	55259	79718	112574	133746	128240	54930	84284	57446	51449	2026	140606	10277	6129	2353	26137	56997	9397	10755	29090	4702	56975	373156	166012	18	161	23463	6117	7414	7168	119559	388962	81029	883	9703	55343	22954	29108	112487	4774	26027	266695	23521	27131	9380	9529	5591	252839	4261	150771	64781	79663	79573	51218	50484	10007	8445	79682	27101	5165	83742	145173	79607	54738	201562	55534	283431	8742	539	5333	5445	6461	54677	3992	3418	223	3577	84314	121274	113189	7561	79698	254295	3615	55924	5108	55250	84993	51706	94234	64949	84216	93974	3613	79018	257236	8673	11164	55796	11328	55206	57505	8019	283537	4542	219623	90522	9903	9131	84545	254225	3632	23171	10462	64131	59307	5037	5775	30968	6821	93589	51199	1050	51428	54902	284325	4122	1845	26292	9697	4175	84106	79672	100289577	51693	10248	1102	55706	100289420	79152	403	81579	5510	79789	9200	112724	154881	1392	23397	339559	1975	57864	1978	57456	23002	57136	90624	4037	57496	124540	6130	4048	66005	55862	57659	1836	6189	8727	4736	1432	3087	55651	7423	112936	199953	9482	240	92105	51385	55174	29883	440275	51506	388403	57181	11057	2242	23492	51611	57291	1944	4215	911	92675	140	10897	286052	84514
GSE2706_UNSTIM_VS_8H_LPS_DC_DN	M4701		15995707	Napolitani G,Rinaldi A,Bertoni F,Sallusto F,Lanzavecchia A.	GSE2706	GSE2706_1840_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of unstimulated dendritic cells (DC) at 0 h versus DCs stimulated with LPS (TLR4 agonist) for 8 h.	Toll like receptors (TLRs) sense microbial products and initiate adaptive immune responses by activating dendritic cells (DCs). Since pathogens may contain several agonists we asked whether different TLRs may synergize in DC activation. We report that in human and mouse DC TLR3 or TLR4 potently synergize with TLR7, TLR8 or TLR9 in the induction of selected cytokine genes. Upon synergistic stimulation, IL-12, IL-23 and Delta-4 are induced at levels 50-100 fold higher than those induced by optimal concentrations of single agonists, leading to enhanced and sustained TH1 polarizing capacity. Using microarray analysis we show that only 1.5% of the transcripts induced by single TLR agonists are synergistically regulated by combinations of TLR4 and TLR8 agonists. These results identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses. Series_overall_design: 3 untreated, 3 treated with LPS at 2h, 3 treated with LPS at 8h, 3 treated with R848 at 2h, 3 treated with R848 at 8h, 3 treated with LPS + R848 at 2h, 3 treated with LPS + R848 at 8h					5265	6741	843	8440	3665	84905	83716	79669	8633	2149	646168	157739	6429	3096	26298	10538	4084	26037	2146	247	7287	5721	92745	80342	11026	1992	53335	151636	10288	113451	2131	23180	57405	23306	54532	3696	9662	80055	54953	9674	55669	23242	5610	6775	5962	27314	9938	169355	57482	4681	9695	4496	57674	1847	4499	51294	5739	154043	6478	5327	4693	2907	375346	116984	8676	79748	9659	5371	81796	100131733	151963	3600	51765	64651	3456	9448	6674	143689	7127	115362	8767	81894	10223	282566	55014	2694	3914	10154	54726	10616	1594	203197	84419	23099	7295	55795	10221	23048	596	415116	165324	7716	27033	4790	57801	9021	664	145264	6675	2632	6774	731424	84791	9447	3656	64108	7128	9181	56300	2983	51332	65264	284018	10371	158067	7709	3718	2591	4204	285957	22809	9111	285958	7107	3587	4345	87178	219347	91351	8073	10135	7410	57149	51667	10133	9638	81553	84333	57655	25816	7280	646626	57162	9043	340273	79870	3909	56913	123872	10906	11177	4301	8728	84223	54463	84937	3569	6664	64121	256586	5996	1462	7130	441168	5954	55601	1843	160428	54625	10318	4651	81563	375287	9711	6891	55332	3738	3965	64857	100	10308	8710	2643	84444	8843	3383	27351	123879	255101	26750
GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_UP	M4702		15995707	Napolitani G,Rinaldi A,Bertoni F,Sallusto F,Lanzavecchia A.	GSE2706	GSE2706_1841_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of unstimulated dendritic cells (DC) at 0 h versus DCs stimulated with LPS (TLR4 agonist) and R848 for 2 h.	Toll like receptors (TLRs) sense microbial products and initiate adaptive immune responses by activating dendritic cells (DCs). Since pathogens may contain several agonists we asked whether different TLRs may synergize in DC activation. We report that in human and mouse DC TLR3 or TLR4 potently synergize with TLR7, TLR8 or TLR9 in the induction of selected cytokine genes. Upon synergistic stimulation, IL-12, IL-23 and Delta-4 are induced at levels 50-100 fold higher than those induced by optimal concentrations of single agonists, leading to enhanced and sustained TH1 polarizing capacity. Using microarray analysis we show that only 1.5% of the transcripts induced by single TLR agonists are synergistically regulated by combinations of TLR4 and TLR8 agonists. These results identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses. Series_overall_design: 3 untreated, 3 treated with LPS at 2h, 3 treated with LPS at 8h, 3 treated with R848 at 2h, 3 treated with R848 at 8h, 3 treated with LPS + R848 at 2h, 3 treated with LPS + R848 at 8h					100289026	79607	7551	5067	203523	22823	114932	7737	9452	780	285331	55159	283219	84307	9666	115509	113115	51339	147923	286827	79692	343990	55341	56683	284029	57684	9726	126017	9778	391267	55672	2288	56478	94234	22954	116143	57466	400579	7707	9924	3087	54989	54800	373	2853	51678	55900	284702	51174	1944	2965	729230	1027	9984	129303	3399	84260	149420	140883	79142	1649	64779	10044	7553	90321	79839	389792	100288225	55520	9110	100130353	1477	91603	26036	200845	440028	9731	10436	399947	93183	7561	22863	9655	25799	8772	10838	151556	10557	387032	23642	112858	219844	57541	10081	9682	6843	63943	146325	4820	55794	1831	49856	6100	388951	6877	51213	7978	10520	7738	55854	7473	283683	100128288	54482	123041	57786	2834	100131993	221927	58484	114659	221955	28987	146059	23774	26354	57567	121274	57168	338645	140461	259286	374395	112812	64318	261729	54665	51058	26057	100129884	79810	100131564	100131827	26048	58486	9139	192669	79102	1025	64963	100506776	8495	285971	84948	79684	342892	4012	283345	91893	89890	283237	119016	25973	150771	1796	2072	79230	203274	64320	57695	80227	643836	163049	9100	9665	222484	64324	11232	65996	1493	360023	406886	84811	407738	8897	23378	203245	4297	126208	9031	134266	85364	1418	55290	55119	23401	28958	7770	58500	85367
GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_DN	M4703		15995707	Napolitani G,Rinaldi A,Bertoni F,Sallusto F,Lanzavecchia A.	GSE2706	GSE2706_1841_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of unstimulated dendritic cells (DC) at 0 h versus DCs stimulated with LPS (TLR4 agonist) and R848 for 2 h.	Toll like receptors (TLRs) sense microbial products and initiate adaptive immune responses by activating dendritic cells (DCs). Since pathogens may contain several agonists we asked whether different TLRs may synergize in DC activation. We report that in human and mouse DC TLR3 or TLR4 potently synergize with TLR7, TLR8 or TLR9 in the induction of selected cytokine genes. Upon synergistic stimulation, IL-12, IL-23 and Delta-4 are induced at levels 50-100 fold higher than those induced by optimal concentrations of single agonists, leading to enhanced and sustained TH1 polarizing capacity. Using microarray analysis we show that only 1.5% of the transcripts induced by single TLR agonists are synergistically regulated by combinations of TLR4 and TLR8 agonists. These results identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses. Series_overall_design: 3 untreated, 3 treated with LPS at 2h, 3 treated with LPS at 8h, 3 treated with R848 at 2h, 3 treated with R848 at 8h, 3 treated with LPS + R848 at 2h, 3 treated with LPS + R848 at 8h					3587	3638	5329	3665	90874	3659	3096	8676	57149	4929	7127	145264	23099	116984	4049	1462	2117	64135	2921	6373	9693	1236	65108	8807	83593	8843	54809	2919	57162	29126	25816	4790	2615	467	1843	284018	64859	27314	374443	64108	731424	100	100302650	54463	6722	3434	285958	8609	1026	80149	129607	4928	9076	1880	84879	10538	3759	27074	56681	53826	9034	10125	7128	2669	5734	200315	386597	8767	84419	7159	55008	84632	10938	10561	3949	401317	7280	440792	3552	654817	64595	10950	6506	7832	4792	112597	4153	2920	3738	415116	3669	81831	441366	3394	629	1647	27071	349408	8653	123872	285628	64651	7293	2591	64332	3383	637	2146	5996	11177	55254	6934	8638	374383	2180	6504	4493	65977	1847	10135	79155	3433	219333	57169	4283	1326	196383	148113	81553	7185	57801	9636	3909	121273	6478	100289312	1844	91543	5371	2081	93653	8837	3627	3696	255488	123879	330	84930	56300	11080	284475	694	23306	9953	1906	3601	150590	5971	10318	55332	6775	1263	3456	58515	11076	282566	2633	677769	440896	3437	7546	94015	10485	651746	57823	5966	56548	3600	5027	85463	9322	29933	5020	3726	83856	221079	116071	100288781	56829	221749	9021	23011	203197	8013	117177	5743	7273	23645	114614	3569
GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_UP	M4704		15995707	Napolitani G,Rinaldi A,Bertoni F,Sallusto F,Lanzavecchia A.	GSE2706	GSE2706_1842_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of unstimulated dendritic cells (DC) at 0 h versus DCs stimulated with LPS (TLR4 agonist) and R848 for 8 h.	Toll like receptors (TLRs) sense microbial products and initiate adaptive immune responses by activating dendritic cells (DCs). Since pathogens may contain several agonists we asked whether different TLRs may synergize in DC activation. We report that in human and mouse DC TLR3 or TLR4 potently synergize with TLR7, TLR8 or TLR9 in the induction of selected cytokine genes. Upon synergistic stimulation, IL-12, IL-23 and Delta-4 are induced at levels 50-100 fold higher than those induced by optimal concentrations of single agonists, leading to enhanced and sustained TH1 polarizing capacity. Using microarray analysis we show that only 1.5% of the transcripts induced by single TLR agonists are synergistically regulated by combinations of TLR4 and TLR8 agonists. These results identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses. Series_overall_design: 3 untreated, 3 treated with LPS at 2h, 3 treated with LPS at 8h, 3 treated with R848 at 2h, 3 treated with R848 at 8h, 3 treated with LPS + R848 at 2h, 3 treated with LPS + R848 at 8h					25771	55691	11344	63901	79791	4209	23484	388507	23234	51218	79587	9522	64781	55536	142	29903	8833	116988	3071	79663	1912	5635	4155	10717	55163	53838	360	4261	27101	201562	9678	9702	3454	3480	23428	284014	55846	911	255520	4774	79839	23765	3636	51642	79629	7374	9725	51506	818	10044	55706	57048	203260	84131	51063	10462	23593	55651	373156	57175	8459	10007	10295	3712	83871	945	22883	3029	64115	79958	57533	51428	55796	5585	3068	8123	7384	1601	23463	60528	78992	6117	8439	10465	286052	8405	254531	81579	80212	65996	84939	7084	54858	10907	403	414	10055	55902	1796	10695	9903	57210	644873	8677	387535	4201	55957	80303	55699	55217	353	84314	2873	2058	6599	30	10734	7738	2956	133746	84925	57616	1488	1497	6597	92675	57542	127262	100507564	3014	3098	64581	56995	79607	4361	51693	865	9328	54930	79801	9830	51545	50484	64965	25936	10491	5547	282997	112812	55967	116225	4357	9380	220972	55315	3930	55746	5445	64421	359948	374403	55862	112936	23588	7267	79829	5165	22808	51367	387921	121274	10723	55174	54946	23060	23030	57217	64770	153129	83959	729082	38	283209	63933	144363	51449	539	84282	23521	4702	84864	79650	9363	79902	65003	6546	64969	145173	8907	57181
GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_DN	M4705		15995707	Napolitani G,Rinaldi A,Bertoni F,Sallusto F,Lanzavecchia A.	GSE2706	GSE2706_1842_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of unstimulated dendritic cells (DC) at 0 h versus DCs stimulated with LPS (TLR4 agonist) and R848 for 8 h.	Toll like receptors (TLRs) sense microbial products and initiate adaptive immune responses by activating dendritic cells (DCs). Since pathogens may contain several agonists we asked whether different TLRs may synergize in DC activation. We report that in human and mouse DC TLR3 or TLR4 potently synergize with TLR7, TLR8 or TLR9 in the induction of selected cytokine genes. Upon synergistic stimulation, IL-12, IL-23 and Delta-4 are induced at levels 50-100 fold higher than those induced by optimal concentrations of single agonists, leading to enhanced and sustained TH1 polarizing capacity. Using microarray analysis we show that only 1.5% of the transcripts induced by single TLR agonists are synergistically regulated by combinations of TLR4 and TLR8 agonists. These results identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses. Series_overall_design: 3 untreated, 3 treated with LPS at 2h, 3 treated with LPS at 8h, 3 treated with R848 at 2h, 3 treated with R848 at 8h, 3 treated with LPS + R848 at 2h, 3 treated with LPS + R848 at 8h					5265	731424	7107	51251	6478	11040	10686	7980	1846	5610	57482	54957	5327	10538	3909	247	11026	29126	3096	5962	10590	84223	3434	23180	3383	2277	84815	7709	3738	64651	54662	2131	23429	56548	91351	3759	147	55601	27351	4683	3914	169355	158067	6675	3665	445347	56300	7162	23424	91543	970	4693	2146	22837	80055	65264	9448	51458	10953	637	26298	7127	11274	4939	23005	1326	5238	5966	285957	9447	353514	9034	23480	5021	23586	64135	596	57149	2117	285958	10154	58515	10133	26750	58494	6775	84879	117177	3112	25816	23011	4049	1847	154043	10318	54463	23306	4067	27154	90407	201725	5996	4316	400043	6166	329	284018	81831	944	8633	100287590	57655	57162	129607	10950	100144604	221749	57628	3696	7293	3429	116412	54361	256586	7280	2983	200734	654817	54625	219333	79094	9643	143686	4651	2921	116984	3456	80045	79857	2591	84419	4790	5687	694	6373	85465	4283	7453	6654	8676	9659	9021	140691	54918	57169	9076	3394	644090	3659	23327	8710	6782	123872	23529	161176	9456	23075	57801	8440	29841	1462	3638	5734	4616	6993	3600	9693	118932	6303	205	10135	8767	79931	1843	7295	4499	55008	4345	24147	10906	51667	347902	1992	3656	1647	2643	5971	824	282618	3627
GSE2706_R848_VS_LPS_2H_STIM_DC_UP	M4706		15995707	Napolitani G,Rinaldi A,Bertoni F,Sallusto F,Lanzavecchia A.	GSE2706	GSE2706_1843_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) stimulated with R848 at 2 h versus DCs stimulated with LPS (TLR4 agonist) for 2 h.	Toll like receptors (TLRs) sense microbial products and initiate adaptive immune responses by activating dendritic cells (DCs). Since pathogens may contain several agonists we asked whether different TLRs may synergize in DC activation. We report that in human and mouse DC TLR3 or TLR4 potently synergize with TLR7, TLR8 or TLR9 in the induction of selected cytokine genes. Upon synergistic stimulation, IL-12, IL-23 and Delta-4 are induced at levels 50-100 fold higher than those induced by optimal concentrations of single agonists, leading to enhanced and sustained TH1 polarizing capacity. Using microarray analysis we show that only 1.5% of the transcripts induced by single TLR agonists are synergistically regulated by combinations of TLR4 and TLR8 agonists. These results identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses. Series_overall_design: 3 untreated, 3 treated with LPS at 2h, 3 treated with LPS at 8h, 3 treated with R848 at 2h, 3 treated with R848 at 8h, 3 treated with LPS + R848 at 2h, 3 treated with LPS + R848 at 8h					786	64763	83656	261734	149047	3815	89765	259234	100128343	482	2691	55592	160824	166379	140733	8840	53344	255738	114132	8329	1594	9027	90102	2842	170062	100288224	1379	317781	645158	282679	1543	100287807	100359394	27079	2041	117177	56245	27123	23245	117289	5098	4867	8620	348761	219595	8875	388503	2252	388336	10288	1903	9262	1948	284440	100506325	285093	79891	10265	496	130540	9414	7280	2566	84966	4086	547	146434	26064	4314	221883	286046	401647	286189	7571	9076	440712	375196	89777	79860	100293830	353514	382	727738	146894	5590	11026	161291	5454	284185	554207	57455	284697	9133	285768	653275	7693	389123	80271	124152	161436	7545	23293	162962	266722	6003	116238	26493	26579	23554	642426	81566	619190	284600	5549	9071	140690	55521	150368	1111	6347	283651	2736	8847	8972	64219	1473	273	79940	25988	80178	100288798	9466	654429	228	3993	151009	2593	6091	51559	91156	100507173	148022	441242	222545	81488	4248	2780	3484	100287037	134353	7562	791115	196477	1370	4751	2196	79651	7082	5326	27153	254122	23660	129881	51162	644844	9468	6934	50834	161497	91574	59336	55038	163049	10081	6515	126068	117579	25799	9473	23040	84830	80255	93273	55762	430	440602	6662	222553	9435	259296	50617	57644	56548	79161	138255	100270680	414327	1047	100287109	8218
GSE2706_R848_VS_LPS_2H_STIM_DC_DN	M4708		15995707	Napolitani G,Rinaldi A,Bertoni F,Sallusto F,Lanzavecchia A.	GSE2706	GSE2706_1843_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) stimulated with R848 at 2 h versus DCs stimulated with LPS (TLR4 agonist) for 2 h.	Toll like receptors (TLRs) sense microbial products and initiate adaptive immune responses by activating dendritic cells (DCs). Since pathogens may contain several agonists we asked whether different TLRs may synergize in DC activation. We report that in human and mouse DC TLR3 or TLR4 potently synergize with TLR7, TLR8 or TLR9 in the induction of selected cytokine genes. Upon synergistic stimulation, IL-12, IL-23 and Delta-4 are induced at levels 50-100 fold higher than those induced by optimal concentrations of single agonists, leading to enhanced and sustained TH1 polarizing capacity. Using microarray analysis we show that only 1.5% of the transcripts induced by single TLR agonists are synergistically regulated by combinations of TLR4 and TLR8 agonists. These results identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses. Series_overall_design: 3 untreated, 3 treated with LPS at 2h, 3 treated with LPS at 8h, 3 treated with R848 at 2h, 3 treated with R848 at 8h, 3 treated with LPS + R848 at 2h, 3 treated with LPS + R848 at 8h					55601	23645	56829	170689	124401	100379224	2019	284998	6462	30847	222255	131583	220213	414245	401106	51056	4760	64109	135946	339263	9023	5366	10561	730249	182	5806	25819	148103	375056	57162	116039	641467	100288123	56158	493869	83887	441046	79722	79850	3456	283914	54718	7252	64651	100128002	2633	115362	7047	1958	3131	8638	8843	55871	283159	284996	9636	84815	2643	23601	653857	57612	3553	157697	22874	57801	54084	10370	100129500	118788	9762	54903	9333	5949	338005	1960	51191	79931	2017	282618	9314	1671	145694	126917	9953	58515	57172	81894	3437	57477	692205	152578	3938	84793	122651	256586	100	2010	729683	3586	80070	286207	4829	165215	3274	54149	164656	3669	4683	2634	55793	80124	388	283677	114614	64135	5680	7726	78989	79150	100289026	440356	54496	6847	11044	629	283685	79858	55008	64096	201475	143888	100130938	100309464	2104	3552	944	57169	199786	92659	255403	56288	29881	100287166	4291	284680	57553	220164	282566	339976	9246	100287221	11080	3434	11082	1800	9134	116448	284804	763	1288	79666	5473	254173	4154	3433	639	124936	219578	100505851	79774	10040	3860	9627	784	644	375057	2636	8086	317671	2299	286121	8318	79586	339416	3624	1284	3937	5743	10346	9447	6373	100133019	100506708	30012	100131434	168667	283238	11197	151278	494513
GSE2706_R848_VS_LPS_8H_STIM_DC_UP	M4712		15995707	Napolitani G,Rinaldi A,Bertoni F,Sallusto F,Lanzavecchia A.	GSE2706	GSE2706_1844_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) stimulated with R848 at 8 h versus DCs stimulated with LPS (TLR4 agonist) for 8 h.	Toll like receptors (TLRs) sense microbial products and initiate adaptive immune responses by activating dendritic cells (DCs). Since pathogens may contain several agonists we asked whether different TLRs may synergize in DC activation. We report that in human and mouse DC TLR3 or TLR4 potently synergize with TLR7, TLR8 or TLR9 in the induction of selected cytokine genes. Upon synergistic stimulation, IL-12, IL-23 and Delta-4 are induced at levels 50-100 fold higher than those induced by optimal concentrations of single agonists, leading to enhanced and sustained TH1 polarizing capacity. Using microarray analysis we show that only 1.5% of the transcripts induced by single TLR agonists are synergistically regulated by combinations of TLR4 and TLR8 agonists. These results identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses. Series_overall_design: 3 untreated, 3 treated with LPS at 2h, 3 treated with LPS at 8h, 3 treated with R848 at 2h, 3 treated with R848 at 8h, 3 treated with LPS + R848 at 2h, 3 treated with LPS + R848 at 8h					254295	7057	100506195	148066	11326	26996	3175	56125	253639	1264	25817	91461	57291	6702	22921	922	83694	270	144811	93589	54997	11040	399875	55343	56904	10799	2329	255275	255512	353219	554174	6014	80039	3707	100129961	3813	3004	3904	5794	100129195	140	401052	6510	29775	100505881	84771	4609	221122	25974	7173	4854	22853	2841	79161	63914	204474	3884	25784	55199	79846	23544	1473	150353	151171	100288152	3708	147429	130106	100132735	3720	255167	388125	29968	375323	219972	286126	6272	55577	200504	149773	6339	730441	55259	5578	6840	4094	341405	3375	285889	83550	26651	416	398	254958	221504	2563	158228	1543	7772	285819	112487	94160	7755	374407	9002	283745	4131	11138	440465	56924	222008	1809	83546	5333	4868	112937	140700	23492	6383	1593	55220	56853	286442	25766	64225	29128	55547	120	56269	23596	121838	388743	405754	283514	3176	84648	124857	393	2690	680	266695	9265	641467	7771	379	283392	100302650	285315	317781	57573	10317	161779	10606	147670	84916	84524	201895	9499	2353	100505540	9355	728558	100505676	100129282	65977	5676	392307	348751	5967	7103	441054	653583	10320	57513	121457	122651	60437	83954	9917	6523	115557	283508	51491	4744	286436	374907	63036	29090	83478	5348	6839	125228	53637	114770	606495	9127	256302	6271	7832	6649
GSE2706_R848_VS_LPS_8H_STIM_DC_DN	M4713		15995707	Napolitani G,Rinaldi A,Bertoni F,Sallusto F,Lanzavecchia A.	GSE2706	GSE2706_1844_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) stimulated with R848 at 8 h versus DCs stimulated with LPS (TLR4 agonist) for 8 h.	Toll like receptors (TLRs) sense microbial products and initiate adaptive immune responses by activating dendritic cells (DCs). Since pathogens may contain several agonists we asked whether different TLRs may synergize in DC activation. We report that in human and mouse DC TLR3 or TLR4 potently synergize with TLR7, TLR8 or TLR9 in the induction of selected cytokine genes. Upon synergistic stimulation, IL-12, IL-23 and Delta-4 are induced at levels 50-100 fold higher than those induced by optimal concentrations of single agonists, leading to enhanced and sustained TH1 polarizing capacity. Using microarray analysis we show that only 1.5% of the transcripts induced by single TLR agonists are synergistically regulated by combinations of TLR4 and TLR8 agonists. These results identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses. Series_overall_design: 3 untreated, 3 treated with LPS at 2h, 3 treated with LPS at 8h, 3 treated with R848 at 2h, 3 treated with R848 at 8h, 3 treated with LPS + R848 at 2h, 3 treated with LPS + R848 at 8h					92370	5473	132321	100134017	83716	7258	9683	10957	9043	54072	55601	8900	6948	2012	169355	133690	57464	11098	9314	5369	57162	3269	7403	27074	824	166863	27033	5334	29106	54435	247	100288870	167153	80223	30001	7716	57488	2887	3604	200734	23306	259230	6811	2294	22902	200298	144402	8601	5337	401324	629	79158	285422	9367	118491	8843	100128046	22862	6385	4204	132864	8553	100288673	6478	751816	8633	282618	29916	284018	9110	23118	400793	79666	6678	91351	115908	646870	158219	64091	359787	2982	941	9619	29767	79056	79908	135250	11281	130589	55506	26524	4683	10046	319089	3717	9674	5358	284808	8710	57826	5366	64109	23585	3384	9450	126820	9659	9447	5008	79834	150596	114134	2799	3242	100288675	4778	340273	25897	55303	4142	197135	85001	10950	28232	84061	7072	23071	11254	58472	92745	114897	8797	56929	55750	65264	56097	8828	7324	445347	886	4885	4681	85377	5916	23136	2040	267004	2146	2923	6745	56681	83439	51733	9685	9448	123879	256586	22797	51312	11343	80055	10223	126321	6789	3898	79753	158067	2995	201294	2983	23242	285126	9961	7292	26750	55013	2632	9819	79870	11076	115362	3594	8976	6429	330	2701	345222	9350	100132923	29887	3112	9267	150350	3430	2633	3600	4939	9423	388666	114614
GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_UP	M4714		15995707	Napolitani G,Rinaldi A,Bertoni F,Sallusto F,Lanzavecchia A.	GSE2706	GSE2706_1845_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) stimulated with R848 at 2 h versus DCs stimulated with LPS (TLR4 agonist) and R848 for 2 h.	Toll like receptors (TLRs) sense microbial products and initiate adaptive immune responses by activating dendritic cells (DCs). Since pathogens may contain several agonists we asked whether different TLRs may synergize in DC activation. We report that in human and mouse DC TLR3 or TLR4 potently synergize with TLR7, TLR8 or TLR9 in the induction of selected cytokine genes. Upon synergistic stimulation, IL-12, IL-23 and Delta-4 are induced at levels 50-100 fold higher than those induced by optimal concentrations of single agonists, leading to enhanced and sustained TH1 polarizing capacity. Using microarray analysis we show that only 1.5% of the transcripts induced by single TLR agonists are synergistically regulated by combinations of TLR4 and TLR8 agonists. These results identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses. Series_overall_design: 3 untreated, 3 treated with LPS at 2h, 3 treated with LPS at 8h, 3 treated with R848 at 2h, 3 treated with R848 at 8h, 3 treated with LPS + R848 at 2h, 3 treated with LPS + R848 at 8h					2275	3975	55762	866	677766	643338	246721	151121	55290	386618	8916	7551	100288007	100129884	50802	8906	10265	100132207	100506776	5590	374946	2252	57455	8277	5469	7693	284926	440137	10499	387644	55157	283345	54457	81623	55611	7480	9075	57507	2066	1436	4867	341640	64978	4943	9100	28965	283683	83983	729680	4756	80832	84727	10280	26057	197187	55422	388272	780	57462	7053	22850	10081	116832	29785	2979	285331	64754	5446	2867	81854	10256	64963	163131	79166	27037	116138	8425	256815	80125	259296	150384	3397	100128343	414260	221955	91862	91149	54785	342945	2056	1149	90102	160824	57489	26036	10301	51043	50852	54964	163049	56478	6396	91156	54107	2077	5439	92609	9587	402	91875	93185	55208	55272	80095	64763	5726	149478	83591	25790	57532	79102	5099	55854	283219	2842	146705	26259	79607	129790	3399	517	333929	150290	23275	84734	56245	1811	100506392	26574	283254	100507495	25788	2689	27120	79156	51491	8875	10930	150000	8079	54850	1539	285093	203413	80303	439	10401	6906	2358	6429	116238	55471	83787	11273	84337	3233	9033	10066	59307	7057	285768	285300	54441	253639	7748	116224	1857	222029	10460	90485	84073	8629	113675	23647	100359394	90809	29946	4343	126567	80262	55037	172	201292	197258	84948	117531	158293	11049	56101	23218
GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_DN	M4715		15995707	Napolitani G,Rinaldi A,Bertoni F,Sallusto F,Lanzavecchia A.	GSE2706	GSE2706_1845_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) stimulated with R848 at 2 h versus DCs stimulated with LPS (TLR4 agonist) and R848 for 2 h.	Toll like receptors (TLRs) sense microbial products and initiate adaptive immune responses by activating dendritic cells (DCs). Since pathogens may contain several agonists we asked whether different TLRs may synergize in DC activation. We report that in human and mouse DC TLR3 or TLR4 potently synergize with TLR7, TLR8 or TLR9 in the induction of selected cytokine genes. Upon synergistic stimulation, IL-12, IL-23 and Delta-4 are induced at levels 50-100 fold higher than those induced by optimal concentrations of single agonists, leading to enhanced and sustained TH1 polarizing capacity. Using microarray analysis we show that only 1.5% of the transcripts induced by single TLR agonists are synergistically regulated by combinations of TLR4 and TLR8 agonists. These results identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses. Series_overall_design: 3 untreated, 3 treated with LPS at 2h, 3 treated with LPS at 8h, 3 treated with R848 at 2h, 3 treated with R848 at 8h, 3 treated with LPS + R848 at 2h, 3 treated with LPS + R848 at 8h					54084	10561	100288781	8843	5806	171177	503569	84733	722	1958	5366	639	56829	283278	57162	597	26750	23645	30012	57016	9966	25777	100130938	349408	7130	30847	80124	2634	257629	222255	55008	3624	1960	677769	100129617	26222	730249	3553	2323	3456	115362	182	63926	885	51191	64135	64651	57051	4283	3669	3576	222389	8013	57612	2642	84858	9448	8224	11080	5743	9636	57801	357	6648	116039	8638	6373	692205	150590	9314	629	2643	3437	2920	7306	282618	25819	10370	284996	3595	9953	6456	56203	118788	79931	80765	81894	8526	7128	135112	53826	55601	3434	969	1373	6557	203274	1030	201475	1306	5930	6507	2792	375056	63901	79850	3433	3696	11044	55890	220164	54072	3656	3586	1258	84850	127002	9447	64109	145694	6690	114614	157697	9153	23424	148252	7173	254173	131583	6890	23586	84283	220213	100	100288882	58515	57823	51365	6352	4060	401463	100289312	255758	11082	8519	6462	145864	3274	8467	29947	28590	100134368	4170	57561	132864	1848	1316	5672	9034	54845	84930	57169	3552	10135	3601	115811	24138	7124	154810	2633	6773	2307	285547	9021	192668	55150	79666	65989	1138	91543	79132	6364	3592	10112	7726	7789	4750	25897	2959	100506033	23509	2921	152926	54660	6014	7634	440087	11012	445347	3620
GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_UP	M4719		15995707	Napolitani G,Rinaldi A,Bertoni F,Sallusto F,Lanzavecchia A.	GSE2706	GSE2706_1846_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) stimulated with R848 at 8 h versus DCs stimulated with LPS (TLR4 agonist) and R848 for 8 h.	Toll like receptors (TLRs) sense microbial products and initiate adaptive immune responses by activating dendritic cells (DCs). Since pathogens may contain several agonists we asked whether different TLRs may synergize in DC activation. We report that in human and mouse DC TLR3 or TLR4 potently synergize with TLR7, TLR8 or TLR9 in the induction of selected cytokine genes. Upon synergistic stimulation, IL-12, IL-23 and Delta-4 are induced at levels 50-100 fold higher than those induced by optimal concentrations of single agonists, leading to enhanced and sustained TH1 polarizing capacity. Using microarray analysis we show that only 1.5% of the transcripts induced by single TLR agonists are synergistically regulated by combinations of TLR4 and TLR8 agonists. These results identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses. Series_overall_design: 3 untreated, 3 treated with LPS at 2h, 3 treated with LPS at 8h, 3 treated with R848 at 2h, 3 treated with R848 at 8h, 3 treated with LPS + R848 at 2h, 3 treated with LPS + R848 at 8h					1230	26996	89848	50801	2752	4094	55577	5578	6456	84467	147670	56169	94103	307	100129726	121053	85352	284014	144811	197021	4199	439911	85452	58191	9828	51152	9722	118460	65990	144245	140	7078	64759	273	282997	2533	224	25939	100289109	55504	23023	55010	81537	10184	28951	54946	23428	85481	7057	283860	144742	54502	84733	9375	100128191	339122	6850	1113	63914	57829	114960	60437	124912	10690	115548	152189	83875	968	283673	4436	55592	136051	60528	148268	8741	79667	84503	6645	3707	9468	10780	5955	27442	994	49860	9473	3162	8357	283431	100130285	80790	7091	246	2690	9061	3460	6446	196264	114793	84101	2359	100289209	84667	26157	5870	89890	51281	30001	11138	54103	51149	57713	100128343	79745	54557	7096	29968	55315	116832	317	659	8459	125061	84067	283514	90226	253639	388942	1493	26118	675	283432	54976	196	22853	84961	341405	283209	10008	100132078	1794	55285	473	339745	9830	285889	146336	283745	574414	5328	54145	2055	255275	10123	80778	1959	2534	728769	54749	2040	8840	728288	1728	10924	2053	284106	1436	55026	3697	84570	23484	64407	84803	22978	2766	145389	4542	23347	4783	3455	54084	10875	126326	23564	1361	2831	6383	5570	25923	8076	132724	146330	100287896	9415	1497	149076	3176	4014	23385	79635
GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_DN	M4720		15995707	Napolitani G,Rinaldi A,Bertoni F,Sallusto F,Lanzavecchia A.	GSE2706	GSE2706_1846_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) stimulated with R848 at 8 h versus DCs stimulated with LPS (TLR4 agonist) and R848 for 8 h.	Toll like receptors (TLRs) sense microbial products and initiate adaptive immune responses by activating dendritic cells (DCs). Since pathogens may contain several agonists we asked whether different TLRs may synergize in DC activation. We report that in human and mouse DC TLR3 or TLR4 potently synergize with TLR7, TLR8 or TLR9 in the induction of selected cytokine genes. Upon synergistic stimulation, IL-12, IL-23 and Delta-4 are induced at levels 50-100 fold higher than those induced by optimal concentrations of single agonists, leading to enhanced and sustained TH1 polarizing capacity. Using microarray analysis we show that only 1.5% of the transcripts induced by single TLR agonists are synergistically regulated by combinations of TLR4 and TLR8 agonists. These results identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses. Series_overall_design: 3 untreated, 3 treated with LPS at 2h, 3 treated with LPS at 8h, 3 treated with R848 at 2h, 3 treated with R848 at 8h, 3 treated with LPS + R848 at 2h, 3 treated with LPS + R848 at 8h					64091	144402	445347	91614	378	7162	114614	57464	9043	90865	54072	53347	10046	7980	1029	284018	400043	7324	4247	57162	5021	64109	221079	9314	9643	10179	27074	51733	7128	5908	10260	2165	29106	283861	6478	154043	57826	25819	84223	80223	254272	100288798	50509	51312	2191	55329	958	169355	23306	56681	58515	81553	23414	167153	2887	8837	126075	1647	51026	27033	11098	282618	81794	79850	6518	54700	55506	284167	84061	27324	29970	824	100507240	5008	8710	359787	167359	5366	5369	22862	329	117177	134466	3112	3604	79946	92369	115908	5657	729420	100129654	80714	6866	55190	10959	2294	11343	10950	79370	56979	151987	7638	1437	145438	4651	25861	10282	27154	10406	138804	65056	285958	283711	4233	6789	9619	9448	3600	4319	4780	85001	25897	6745	4982	79977	57149	23529	285957	150350	84858	141	3725	94015	51561	85365	6675	11014	1236	284757	23059	284369	23354	4638	57488	8633	5358	401317	330	629	2983	58505	3898	23705	83439	161176	6782	6507	1992	7360	1960	9929	51030	7453	9456	8444	23243	283551	9659	51171	944	8738	8835	7169	58510	10623	23480	79666	79917	4640	115362	9662	26750	80045	5277	5898	25766	256586	378805	11076	6775	57198	3592	7314	5711	2982	10294	23118	8828	205	56300
GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_UP	M4722		15995707	Napolitani G,Rinaldi A,Bertoni F,Sallusto F,Lanzavecchia A.	GSE2706	GSE2706_1847_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 2 h versus DCs stimulated with LPS (TLR4 agonist) and R848 for 2 h.	Toll like receptors (TLRs) sense microbial products and initiate adaptive immune responses by activating dendritic cells (DCs). Since pathogens may contain several agonists we asked whether different TLRs may synergize in DC activation. We report that in human and mouse DC TLR3 or TLR4 potently synergize with TLR7, TLR8 or TLR9 in the induction of selected cytokine genes. Upon synergistic stimulation, IL-12, IL-23 and Delta-4 are induced at levels 50-100 fold higher than those induced by optimal concentrations of single agonists, leading to enhanced and sustained TH1 polarizing capacity. Using microarray analysis we show that only 1.5% of the transcripts induced by single TLR agonists are synergistically regulated by combinations of TLR4 and TLR8 agonists. These results identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses. Series_overall_design: 3 untreated, 3 treated with LPS at 2h, 3 treated with LPS at 8h, 3 treated with R848 at 2h, 3 treated with R848 at 8h, 3 treated with LPS + R848 at 2h, 3 treated with LPS + R848 at 8h					54964	951	7053	58158	54766	728099	80125	22936	374946	100131311	7432	80318	148304	341640	100289026	93185	8846	401106	283683	100132207	140875	7472	3561	148753	49860	5355	2252	747	84466	54967	4239	182	7298	10699	9023	730631	84931	9322	54729	338651	2931	705	1428	56269	9333	93517	10842	9726	7480	100288007	728841	10930	54785	677766	79774	494513	3804	5365	2859	5676	9238	1874	10207	94101	6504	170370	140732	79570	5341	432	83596	54549	163131	144132	8495	5873	91149	4584	10061	23507	201625	3137	284099	199786	146852	728621	866	3268	3233	55888	122651	11248	92922	2627	100128961	124936	79962	56904	2275	203245	10319	284805	8335	57647	83461	414319	2880	317703	57501	162494	28902	57476	63970	57343	10936	10723	91147	2944	114805	9079	283507	254531	11141	7040	403314	8986	2346	2299	126567	64951	65975	92086	5029	79726	169436	170949	26472	6688	100129449	64682	165721	57562	113828	64096	9968	3358	2811	11140	140801	91862	9230	124401	6650	91252	84054	81539	55224	83590	10716	140883	6360	5140	100131454	100505978	5698	57139	1149	90288	80824	91368	284100	1811	219	711	81894	100287426	100302522	5498	117144	23543	26152	100271832	127841	84333	730184	858	57524	122481	223075	4793	27037	7462	353132	72	90070	9075	57172	4435	4867	646113
GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_DN	M4724		15995707	Napolitani G,Rinaldi A,Bertoni F,Sallusto F,Lanzavecchia A.	GSE2706	GSE2706_1847_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 2 h versus DCs stimulated with LPS (TLR4 agonist) and R848 for 2 h.	Toll like receptors (TLRs) sense microbial products and initiate adaptive immune responses by activating dendritic cells (DCs). Since pathogens may contain several agonists we asked whether different TLRs may synergize in DC activation. We report that in human and mouse DC TLR3 or TLR4 potently synergize with TLR7, TLR8 or TLR9 in the induction of selected cytokine genes. Upon synergistic stimulation, IL-12, IL-23 and Delta-4 are induced at levels 50-100 fold higher than those induced by optimal concentrations of single agonists, leading to enhanced and sustained TH1 polarizing capacity. Using microarray analysis we show that only 1.5% of the transcripts induced by single TLR agonists are synergistically regulated by combinations of TLR4 and TLR8 agonists. These results identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses. Series_overall_design: 3 untreated, 3 treated with LPS at 2h, 3 treated with LPS at 8h, 3 treated with R848 at 2h, 3 treated with R848 at 8h, 3 treated with LPS + R848 at 2h, 3 treated with LPS + R848 at 8h					1111	57644	170392	2691	84850	6775	83856	54437	786	885	1958	348761	93444	257629	126123	100128176	388666	222389	8632	441208	1030	9076	2305	162515	30012	84560	119395	80350	117177	388948	84966	100506325	246176	100507391	1906	127254	146562	203430	5997	64518	6934	51802	597	26659	286437	79860	10154	7546	84624	6563	94015	7633	283579	221468	3593	64859	284440	5232	29765	6315	55521	8620	100506127	100287917	54798	163933	100130418	54845	53826	100287558	284240	1558	150962	79703	645638	3239	63946	83902	340146	2290	81553	8564	8972	100128298	221442	114132	161198	65108	92293	6017	100287182	7280	284475	57691	117289	283174	8526	197350	440590	80834	100289312	9618	1208	1589	5138	51276	10112	84443	3581	54083	338328	152405	23293	10888	23360	140679	140733	284424	84918	1080	388588	283663	4438	23495	4153	283731	79990	644186	3880	100132341	261734	9414	386597	80052	57051	6470	337	1396	9737	401288	8237	100506033	130399	8936	728448	1594	57399	55561	6662	197196	57481	3400	644809	5272	100130905	27158	27286	400604	81832	5121	148113	91181	7082	1720	57692	100462953	161436	138649	2128	728868	150368	645566	130540	8336	9966	286154	55890	6507	50514	1143	7258	3083	130752	27319	7173	2779	55891	159296	162962	5368	22996	11254	100292680	28983	222161	29947	146894	9229	50838	55038
GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_UP	M4727		15995707	Napolitani G,Rinaldi A,Bertoni F,Sallusto F,Lanzavecchia A.	GSE2706	GSE2706_1848_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 8 h versus DCs stimulated with LPS (TLR4 agonist) and R848 for 8 h.	Toll like receptors (TLRs) sense microbial products and initiate adaptive immune responses by activating dendritic cells (DCs). Since pathogens may contain several agonists we asked whether different TLRs may synergize in DC activation. We report that in human and mouse DC TLR3 or TLR4 potently synergize with TLR7, TLR8 or TLR9 in the induction of selected cytokine genes. Upon synergistic stimulation, IL-12, IL-23 and Delta-4 are induced at levels 50-100 fold higher than those induced by optimal concentrations of single agonists, leading to enhanced and sustained TH1 polarizing capacity. Using microarray analysis we show that only 1.5% of the transcripts induced by single TLR agonists are synergistically regulated by combinations of TLR4 and TLR8 agonists. These results identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses. Series_overall_design: 3 untreated, 3 treated with LPS at 2h, 3 treated with LPS at 8h, 3 treated with R848 at 2h, 3 treated with R848 at 8h, 3 treated with LPS + R848 at 2h, 3 treated with LPS + R848 at 8h					5434	4092	9644	11344	23259	754	1230	123096	79801	4179	220972	4542	4048	100130354	340481	5608	63978	54676	26157	115361	10791	2235	3433	8648	128153	121053	9980	4000	83605	23179	29945	116988	25939	5518	9123	6240	659	84331	1912	50485	23503	55217	3597	139818	51112	6546	22808	54863	8417	2208	59345	387921	57452	221662	120224	5786	84925	549	55010	79184	57092	7024	219285	54936	25775	83875	10712	6429	27442	9468	83666	26277	84187	64420	8450	54739	22978	126549	4257	100131454	9473	389125	3098	284427	5523	8724	3611	337878	23313	152007	10184	64853	169611	55281	4671	64780	83606	22883	60528	4361	54930	573	158801	653238	161	284014	7773	93349	257106	1519	84542	5336	6645	221656	84803	118932	406	8743	4615	28951	606553	30001	81533	9830	10208	118	26133	9459	129285	6834	23385	54809	51479	4522	55337	79073	219771	343990	5937	145567	8850	375346	5899	8439	9703	23456	55174	55577	1666	284129	7566	4302	317649	10311	65992	1959	100129550	2776	80067	4783	2766	54664	9793	273	55780	51606	3312	203427	92181	10459	10455	843	80108	2752	91687	23446	1493	836	112936	259307	4208	11123	80024	135114	84905	54749	5473	149951	87178	59	5570	2733	100131827	27068	116071	196	27348	2012	51493	6772
GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_DN	M4728		15995707	Napolitani G,Rinaldi A,Bertoni F,Sallusto F,Lanzavecchia A.	GSE2706	GSE2706_1848_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 8 h versus DCs stimulated with LPS (TLR4 agonist) and R848 for 8 h.	Toll like receptors (TLRs) sense microbial products and initiate adaptive immune responses by activating dendritic cells (DCs). Since pathogens may contain several agonists we asked whether different TLRs may synergize in DC activation. We report that in human and mouse DC TLR3 or TLR4 potently synergize with TLR7, TLR8 or TLR9 in the induction of selected cytokine genes. Upon synergistic stimulation, IL-12, IL-23 and Delta-4 are induced at levels 50-100 fold higher than those induced by optimal concentrations of single agonists, leading to enhanced and sustained TH1 polarizing capacity. Using microarray analysis we show that only 1.5% of the transcripts induced by single TLR agonists are synergistically regulated by combinations of TLR4 and TLR8 agonists. These results identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses. Series_overall_design: 3 untreated, 3 treated with LPS at 2h, 3 treated with LPS at 8h, 3 treated with R848 at 2h, 3 treated with R848 at 8h, 3 treated with LPS + R848 at 2h, 3 treated with LPS + R848 at 8h					2131	25766	3592	619207	10281	23011	54660	400043	283692	11040	56300	9406	136	144402	117177	970	91614	10562	92558	100288438	170825	414194	398	10200	51561	1437	148066	2660	199713	57699	349136	23327	1647	282618	23005	440515	202865	8444	5076	10260	7162	5590	7980	26027	50964	6840	80008	1326	401312	64332	6103	57336	445347	576	7169	100506233	10656	114770	81831	79370	4744	5021	90993	11326	54072	29970	378805	58515	256227	140700	51806	1843	54997	18	3595	3976	150094	27319	8835	64065	91942	24147	113655	11319	388743	114614	79946	116442	23109	6523	8744	6518	50506	9322	10365	146852	81553	1844	4085	54820	119548	50486	64091	25819	255130	79161	100	51293	79850	23306	4854	1960	23414	100129128	10974	7124	56681	10371	3249	23529	100507300	83895	84223	9618	8369	677766	1030	51365	83550	2050	6004	65999	254778	5154	915	646329	9533	64061	254427	57172	221079	1029	53826	25769	9282	9019	56936	136332	2353	27177	167359	140680	3394	154043	3284	1846	140691	7324	65977	4838	57520	2271	7789	571	9388	8738	54839	157739	4105	27086	5898	6144	10623	9052	8187	652493	1017	51458	4016	6493	183	84518	2114	60676	598	9928	6702	393	80111	140606	79191	60673	83856	80714	84684	401317	114026	7099	205564	3458
GSE2706_2H_VS_8H_R848_STIM_DC_UP	M4729		15995707	Napolitani G,Rinaldi A,Bertoni F,Sallusto F,Lanzavecchia A.	GSE2706	GSE2706_1849_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) stimulated with R848 at 2 h versus DCs stimulatd with R848 for 8 h.	Toll like receptors (TLRs) sense microbial products and initiate adaptive immune responses by activating dendritic cells (DCs). Since pathogens may contain several agonists we asked whether different TLRs may synergize in DC activation. We report that in human and mouse DC TLR3 or TLR4 potently synergize with TLR7, TLR8 or TLR9 in the induction of selected cytokine genes. Upon synergistic stimulation, IL-12, IL-23 and Delta-4 are induced at levels 50-100 fold higher than those induced by optimal concentrations of single agonists, leading to enhanced and sustained TH1 polarizing capacity. Using microarray analysis we show that only 1.5% of the transcripts induced by single TLR agonists are synergistically regulated by combinations of TLR4 and TLR8 agonists. These results identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses. Series_overall_design: 3 untreated, 3 treated with LPS at 2h, 3 treated with LPS at 8h, 3 treated with R848 at 2h, 3 treated with R848 at 8h, 3 treated with LPS + R848 at 2h, 3 treated with LPS + R848 at 8h					23333	55503	84858	170685	84106	23135	126321	79887	53905	3073	124637	116832	284367	4357	64174	283229	9414	224	65018	54946	145389	53827	166929	374882	5916	1545	191	2669	92162	55534	2242	64231	285628	5768	5950	2309	10658	949	5606	196383	95	23344	374383	85001	64806	90522	5175	201799	6916	1634	2745	2675	116151	5032	22898	4217	100128343	55914	5002	10068	54	90874	4774	5023	53373	124152	7915	93100	5341	65983	22850	246721	112942	127247	23764	1960	9764	6573	91319	92610	90507	349565	10577	166863	55858	9120	89765	433	8870	6557	7045	83593	36	2157	645	10491	57085	1795	4063	153328	254531	4780	5328	54976	5434	2208	57491	3383	51181	23324	9034	123879	140894	59307	91107	83716	23492	8751	25864	54209	11184	56172	55572	440465	66005	219654	348761	100287697	10435	23385	130814	200298	79888	8613	56927	1384	117177	4255	79622	2768	6272	9055	55819	5836	51084	5732	7832	2152	9524	10396	4354	55160	6711	115817	18	572	7041	489	84329	26147	978	6385	155066	7077	4900	5165	51279	642426	6450	3384	1958	131377	81854	2052	8843	5567	1075	84898	10572	2232	6446	9619	1441	57570	6515	340205	9825	55643	100286909	57707	57539	5742	23621	79720	8878	10026	57826	3109	222029	641649
GSE2706_2H_VS_8H_R848_STIM_DC_DN	M4730		15995707	Napolitani G,Rinaldi A,Bertoni F,Sallusto F,Lanzavecchia A.	GSE2706	GSE2706_1849_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) stimulated with R848 at 2 h versus DCs stimulatd with R848 for 8 h.	Toll like receptors (TLRs) sense microbial products and initiate adaptive immune responses by activating dendritic cells (DCs). Since pathogens may contain several agonists we asked whether different TLRs may synergize in DC activation. We report that in human and mouse DC TLR3 or TLR4 potently synergize with TLR7, TLR8 or TLR9 in the induction of selected cytokine genes. Upon synergistic stimulation, IL-12, IL-23 and Delta-4 are induced at levels 50-100 fold higher than those induced by optimal concentrations of single agonists, leading to enhanced and sustained TH1 polarizing capacity. Using microarray analysis we show that only 1.5% of the transcripts induced by single TLR agonists are synergistically regulated by combinations of TLR4 and TLR8 agonists. These results identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses. Series_overall_design: 3 untreated, 3 treated with LPS at 2h, 3 treated with LPS at 8h, 3 treated with R848 at 2h, 3 treated with R848 at 8h, 3 treated with LPS + R848 at 2h, 3 treated with LPS + R848 at 8h					219285	83666	6772	6456	56125	641467	10018	4316	100506495	357	57147	3574	155038	60489	94240	163154	10282	55106	54084	2983	200010	158067	10346	55601	84441	694	1846	81553	129607	54554	1833	127002	54072	10964	127428	331	3592	10561	285758	85363	1236	8875	7252	346389	7057	90580	6372	2537	64109	121053	79899	4939	140732	79577	158584	5321	51191	942	6741	30012	51056	3430	100287590	6370	257019	196913	100128191	145864	63934	11026	57482	3696	1812	8544	79960	9732	353514	84283	7035	23070	100	100147773	83990	8440	2358	285237	84125	9938	3290	8976	3321	254065	135946	54625	10512	6506	6789	22837	83478	5962	1493	51422	51251	445347	401052	204474	83737	283238	64759	2841	9595	29968	840	9882	440	1577	7453	79931	55026	100506195	23657	2694	9958	6847	7292	80055	5290	54739	65124	6758	9111	2119	1588	26271	4001	2633	1317	283673	54464	3717	5610	6773	3431	6354	7039	4089	9324	1066	6993	100133019	3223	79183	55236	10890	90362	87178	9246	153222	89857	10906	710	23424	387751	59349	7295	94235	9950	151636	168455	55335	22876	2182	6654	23586	4319	3753	11183	11138	9437	420	23111	8854	26286	3428	6659	7072	414245	51510	5352	6014	100133308	9638	9966	284013	29761	83856	8743	8454	84456	317
GSE2706_2H_VS_8H_LPS_STIM_DC_UP	M4731		15995707	Napolitani G,Rinaldi A,Bertoni F,Sallusto F,Lanzavecchia A.	GSE2706	GSE2706_1850_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 2 h versus DCs stimulated with LPS (TLR4 agonist) at 8 h.	Toll like receptors (TLRs) sense microbial products and initiate adaptive immune responses by activating dendritic cells (DCs). Since pathogens may contain several agonists we asked whether different TLRs may synergize in DC activation. We report that in human and mouse DC TLR3 or TLR4 potently synergize with TLR7, TLR8 or TLR9 in the induction of selected cytokine genes. Upon synergistic stimulation, IL-12, IL-23 and Delta-4 are induced at levels 50-100 fold higher than those induced by optimal concentrations of single agonists, leading to enhanced and sustained TH1 polarizing capacity. Using microarray analysis we show that only 1.5% of the transcripts induced by single TLR agonists are synergistically regulated by combinations of TLR4 and TLR8 agonists. These results identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses. Series_overall_design: 3 untreated, 3 treated with LPS at 2h, 3 treated with LPS at 8h, 3 treated with R848 at 2h, 3 treated with R848 at 8h, 3 treated with LPS + R848 at 2h, 3 treated with LPS + R848 at 8h					283537	29108	8745	9016	686	8673	11326	84329	240	23475	51449	25800	7915	132	136	59307	7414	4435	126299	84993	6812	53346	84954	342527	51706	10723	51368	266695	64801	26137	2242	57409	5002	4772	5305	9200	9779	56521	51248	64781	5859	4144	388	23645	30850	201562	7472	100129128	1978	6218	342667	3992	2208	3937	10077	133418	398	285550	50964	254295	79819	5547	1436	28512	55276	221079	57181	374383	5341	64332	4122	3824	2581	285989	94241	3613	137682	100129449	587	5445	84106	3976	84650	5521	619279	147965	157697	4928	80318	116039	291	10400	23171	64131	27240	79815	27101	349565	5510	89894	5775	257236	3312	84310	6189	64061	374378	83550	6130	8676	100505676	440465	56172	171391	5175	2034	2952	489	23741	84279	56269	3109	1793	64098	11007	168667	80352	8727	1548	23078	56996	1545	83871	883	84292	124540	4716	10423	114805	154	120224	29796	5982	678	415117	4242	7832	8128	4832	94160	6571	5424	25840	84681	170622	7263	10608	54828	4058	1958	51181	79887	182	2788	23492	131601	1960	114327	64395	5742	339390	9134	2878	401494	57719	84316	5108	5909	79794	5076	8870	25901	80149	3418	252839	23764	54209	51693	5825	3202	204	22874	51386	79033	79789	913	55049	10491	6191	125150
GSE2706_2H_VS_8H_LPS_STIM_DC_DN	M4733		15995707	Napolitani G,Rinaldi A,Bertoni F,Sallusto F,Lanzavecchia A.	GSE2706	GSE2706_1850_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 2 h versus DCs stimulated with LPS (TLR4 agonist) at 8 h.	Toll like receptors (TLRs) sense microbial products and initiate adaptive immune responses by activating dendritic cells (DCs). Since pathogens may contain several agonists we asked whether different TLRs may synergize in DC activation. We report that in human and mouse DC TLR3 or TLR4 potently synergize with TLR7, TLR8 or TLR9 in the induction of selected cytokine genes. Upon synergistic stimulation, IL-12, IL-23 and Delta-4 are induced at levels 50-100 fold higher than those induced by optimal concentrations of single agonists, leading to enhanced and sustained TH1 polarizing capacity. Using microarray analysis we show that only 1.5% of the transcripts induced by single TLR agonists are synergistically regulated by combinations of TLR4 and TLR8 agonists. These results identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses. Series_overall_design: 3 untreated, 3 treated with LPS at 2h, 3 treated with LPS at 8h, 3 treated with R848 at 2h, 3 treated with R848 at 8h, 3 treated with LPS + R848 at 2h, 3 treated with LPS + R848 at 8h					9674	10906	195828	9095	8633	130540	81553	5194	339505	5721	3559	91614	55300	3601	751816	4501	3914	1438	158067	284475	8440	169355	3135	81566	10288	27314	8900	22809	23780	10409	27033	1847	9662	100288224	8726	3696	6372	126820	81563	119395	9209	25823	54072	53826	654817	629	203197	58504	84333	23528	166785	7072	2982	4301	100240728	4938	100132891	6352	10148	6891	256586	3604	10154	403312	379034	4502	100288693	952	79132	8835	54662	255101	6993	962	10346	8519	7258	51316	55014	64853	24141	23505	5359	4790	11343	3717	5819	2983	93444	6890	51513	9423	26750	56951	92745	247	51365	83856	94015	84419	11281	79899	9111	9175	9448	143458	4343	27319	11262	9447	54809	3134	55601	58516	55281	10133	151636	2887	57644	644	221756	94240	5683	140691	1236	3430	81894	7280	5610	11026	5962	84830	651746	9322	7292	5883	8495	91351	115361	23180	4107	23362	85363	4067	152926	22837	1846	10725	9246	8942	57147	5265	5464	84166	375035	51667	8934	9074	5684	201725	145864	118491	221302	84791	7773	222194	29915	1594	6741	29121	100506274	51427	9869	9659	55697	1267	388666	84689	65264	7403	171024	5520	84966	161502	3718	100128590	60489	2646	55689	4850	200315	840	10643	91181	163081	6773	57482	57169	57458	2290
GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_UP	M4736		15995707	Napolitani G,Rinaldi A,Bertoni F,Sallusto F,Lanzavecchia A.	GSE2706	GSE2706_1851_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) stimulated with R848 at 2 h versus DCs stimulated with LPS (TLR4 agonist) at 8 h.	Toll like receptors (TLRs) sense microbial products and initiate adaptive immune responses by activating dendritic cells (DCs). Since pathogens may contain several agonists we asked whether different TLRs may synergize in DC activation. We report that in human and mouse DC TLR3 or TLR4 potently synergize with TLR7, TLR8 or TLR9 in the induction of selected cytokine genes. Upon synergistic stimulation, IL-12, IL-23 and Delta-4 are induced at levels 50-100 fold higher than those induced by optimal concentrations of single agonists, leading to enhanced and sustained TH1 polarizing capacity. Using microarray analysis we show that only 1.5% of the transcripts induced by single TLR agonists are synergistically regulated by combinations of TLR4 and TLR8 agonists. These results identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses. Series_overall_design: 3 untreated, 3 treated with LPS at 2h, 3 treated with LPS at 8h, 3 treated with R848 at 2h, 3 treated with R848 at 8h, 3 treated with LPS + R848 at 2h, 3 treated with LPS + R848 at 8h					23530	472	6122	7267	79058	27101	9645	1353	549	84661	79152	157	51329	92017	79895	84733	8815	23475	7384	9702	55914	360	865	349565	911	64115	25901	4350	23313	55967	121274	10160	23593	373156	10462	57447	8895	4900	84058	8459	51642	63901	204	102	23765	210	8843	137682	22949	128153	54930	64770	8677	327	6296	2208	2323	1958	8437	57452	6192	4258	51449	54946	339745	10313	292	754	10267	79829	51690	1729	150590	4713	9703	29108	152189	11344	84329	79713	79815	1124	5510	23552	254531	4716	91526	23397	10131	517	8609	56255	1519	6446	65990	3071	25840	4144	10459	84899	55559	10693	7097	255520	5732	64781	1794	116151	80856	124540	10385	5264	51248	55862	945	4736	2952	9131	6443	220972	2581	1725	333926	10980	10491	1175	284367	6237	83871	135948	132	5165	51409	51495	25804	5328	6048	51218	80024	3029	23151	64407	54929	79145	100287039	1361	85452	246	100129726	401494	147991	374403	3433	5859	10999	38	79823	27342	5982	81533	1537	4048	26090	128346	4542	9653	57705	399512	100130872	57409	6194	57182	10654	678	1374	152007	374291	3597	80270	5567	55011	201799	23556	54453	53346	51268	1512	5162	5547	5608	6315	10460	2776	3028	9528	1937	9459	23463	1939	3937
GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_DN	M4738		15995707	Napolitani G,Rinaldi A,Bertoni F,Sallusto F,Lanzavecchia A.	GSE2706	GSE2706_1851_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) stimulated with R848 at 2 h versus DCs stimulated with LPS (TLR4 agonist) at 8 h.	Toll like receptors (TLRs) sense microbial products and initiate adaptive immune responses by activating dendritic cells (DCs). Since pathogens may contain several agonists we asked whether different TLRs may synergize in DC activation. We report that in human and mouse DC TLR3 or TLR4 potently synergize with TLR7, TLR8 or TLR9 in the induction of selected cytokine genes. Upon synergistic stimulation, IL-12, IL-23 and Delta-4 are induced at levels 50-100 fold higher than those induced by optimal concentrations of single agonists, leading to enhanced and sustained TH1 polarizing capacity. Using microarray analysis we show that only 1.5% of the transcripts induced by single TLR agonists are synergistically regulated by combinations of TLR4 and TLR8 agonists. These results identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses. Series_overall_design: 3 untreated, 3 treated with LPS at 2h, 3 treated with LPS at 8h, 3 treated with R848 at 2h, 3 treated with R848 at 8h, 3 treated with LPS + R848 at 2h, 3 treated with LPS + R848 at 8h					2358	643	79684	55791	148479	55762	6891	83856	23075	4316	9406	10265	3429	6364	55008	7638	10552	23180	10179	23597	694	64065	5683	11006	400043	55601	5929	91614	11026	25983	10148	57823	10906	154043	58515	58504	56951	9425	23011	54809	8976	100287241	91351	7360	145957	5265	85365	84419	51026	4345	22837	10686	79370	151658	26133	7980	7130	23005	79094	8519	284018	84441	1029	4501	57482	54464	11014	1462	79132	7107	285958	3696	4233	80045	27351	962	3431	53826	9643	145864	10538	2887	10379	10282	10959	283219	330	51030	55300	26354	56242	3290	5433	9636	100288798	3592	84937	6993	81553	379034	970	3600	646329	146852	205	952	6775	3601	118932	5101	7295	23528	10974	51667	166785	55159	576	7554	79850	5154	1846	10410	5238	9043	285237	6789	9966	23136	644	51762	51131	596	29126	8989	22862	29970	8942	3301	1437	60468	8880	3593	55795	56681	84061	3898	445347	23336	64109	8934	10979	83666	401312	55609	6648	6838	5721	5321	5590	3796	25841	57801	6016	150094	100	27074	10154	221830	54700	150350	2170	8440	2983	90407	840	143458	2014	3608	54739	257019	26230	23480	10384	8835	51733	4502	8495	158067	89796	55339	5687	256021	100132891	57172	284365	26872	79165	58505	5464	80830
GSE29614_CTRL_VS_TIV_FLU_VACCINE_PBMC_2007_UP	M4903		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29614	GSE29614_2205_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee pre-vaccination versus that after the vaccination	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying the innate responses to the trivalent inactivated influenza (TIV) and live attenuated influenza (LAIV) vaccination in humans, and to identify early gene signatures that predict the magnitude of the antibody responses to influenza vaccination.					51362	160287	85360	2571	5308	53820	2862	115861	6555	11085	122786	9311	26577	100289494	26494	374491	94	3642	326	55742	1010	389332	6550	26493	9260	157310	3321	6347	84699	1287	56969	93429	374986	83872	337970	6525	7712	2703	145447	5414	11009	100507098	6701	388714	201292	100506699	9068	84688	619427	283652	2880	79852	402160	1600	441025	1800	132014	650	1816	26651	167359	100132169	284312	29761	11095	390066	2914	9499	145858	158427	50801	100507391	2492	128821	100130548	27164	2261	645261	51295	2523	8785	827	80329	57716	92747	51224	158062	257240	4137	5568	100293735	8812	89778	152118	56666	285740	127733	6659	116379	389084	105	100499171	55338	6572	5408	6789	79575	9752	100288618	255798	127124	166793	100505545	147166	10404	1496	7225	129807	388698	53905	29966	374875	8500	25817	126567	158055	219770	3972	56655	26189	440119	54988	100507044	1907	2898	26013	641384	10991	10324	55451	8648	26062	339366	375612	284541	644975	55891	51201	285943	26492	54541	5890	7050	222234	100288985	55897	7092	265	131566	1306	8989	149643	202865	51305	1584	5921	255082	11227	29951	51375	7386	400931	729359	285492	138724	60682	3764	155051	646282	218	100288870	127579	56155	283310	9423	613212	100506243	25822	2066	340895	1944	168741	157777	3761	7323	4625	342977	51068	23498
GSE29614_CTRL_VS_TIV_FLU_VACCINE_PBMC_2007_DN	M4905		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29614	GSE29614_2205_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee pre-vaccination versus that after the vaccination	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying the innate responses to the trivalent inactivated influenza (TIV) and live attenuated influenza (LAIV) vaccination in humans, and to identify early gene signatures that predict the magnitude of the antibody responses to influenza vaccination.					8419	100128185	29958	51454	122876	100290481	55478	1063	503569	64151	7184	84457	6580	100130097	2167	91316	79980	56992	80333	2731	2736	85016	3161	8630	23133	9787	284359	51514	22854	9928	57822	54507	653479	10615	130872	6241	64943	91353	952	28831	51237	113835	857	92092	28983	8294	64418	55266	29122	93463	100129620	84950	1414	642980	83540	54083	79801	7298	51802	286514	891	7494	11339	4171	10745	79937	946	81693	701	160518	10952	548645	608	51130	149563	7283	51318	286234	22986	25940	100287387	81790	1033	983	283726	100303728	6406	340414	6003	340037	54915	641365	57697	22832	7008	90701	51016	9719	51294	357	27143	3535	9133	5457	29925	415117	121599	114327	90589	54932	100289053	139420	9370	56164	150159	10521	220979	494143	9768	80759	286046	6953	79733	729506	10112	650662	5174	9478	79365	4288	53838	100292408	6790	137735	54522	7171	9321	29105	6779	9632	6518	81618	54953	1755	28823	26872	2305	643401	131034	6182	23251	259286	55872	145845	100505538	63977	121601	55165	81037	25849	996	11130	119	9697	28797	10592	6389	3309	100288968	400653	8703	57799	9837	23286	29999	440956	284948	51081	7163	629	10351	4487	80321	1469	100287807	23538	6407	100129858	79940	317671	100293440	7652	913	653121	154467	89766	27199	147841	100130155
GSE29614_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_UP	M4906		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29614	GSE29614_2206_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee pre-vaccination versus those from day 3 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying the innate responses to the trivalent inactivated influenza (TIV) and live attenuated influenza (LAIV) vaccination in humans, and to identify early gene signatures that predict the magnitude of the antibody responses to influenza vaccination.					115861	81789	167359	414771	1010	2571	11085	51523	55503	9752	83872	100144604	6347	51362	4739	84699	155051	613266	84240	326	64283	283571	388456	26577	92340	100505641	3761	100293735	26493	57716	55897	26189	140850	2587	26212	100130360	25817	1800	646074	1496	28785	9219	51016	53820	57484	4139	100379224	26651	337970	11227	2703	2152	105	4759	9631	5308	26154	8838	160287	1728	100507244	56884	2312	388714	53905	3642	2523	6525	100132169	158046	202559	221303	10667	26494	2560	100506699	93429	283377	26062	51550	57572	443	92747	2261	100288870	55715	6550	84798	147111	146513	1583	55504	10900	7092	90480	6631	100359394	23047	284801	9068	3981	85360	6147	9499	51567	344887	151242	128821	8811	55742	348487	6014	266621	1365	404217	2914	94	100499171	55997	80255	11095	6555	1396	5054	5245	118856	646808	3280	9521	11219	11269	285943	2253	171177	645261	8528	284551	133558	5449	94103	55679	6978	6208	162968	390066	51295	392555	1816	25904	9311	219770	7323	27121	100287051	56203	152118	4292	57804	1944	10013	100505549	100287808	200931	122618	64320	84364	6792	94122	222234	147657	1120	3329	374875	85451	80329	140823	729059	100289494	5062	8704	145858	11194	56302	79852	440119	138307	80072	6572	157753	27301	729852	85027	158427	11140	3720	157310	654429	29965	26298	27245
GSE29614_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_DN	M4907		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29614	GSE29614_2206_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee pre-vaccination versus those from day 3 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying the innate responses to the trivalent inactivated influenza (TIV) and live attenuated influenza (LAIV) vaccination in humans, and to identify early gene signatures that predict the magnitude of the antibody responses to influenza vaccination.					100128185	55478	51802	1290	151835	1414	85016	8419	100131581	100130097	121599	64002	146795	357	84457	8294	54507	1002	51454	10351	160728	23133	503569	9478	284359	117532	55713	283387	66004	6764	201725	619434	137735	84733	9719	338694	28983	643763	130872	160851	54932	139420	339298	30820	548645	64927	284403	148145	442524	121601	79937	389023	6406	284498	57795	100130155	163590	201617	90379	8454	219347	84688	1446	3745	83878	648556	84446	283455	388503	642980	285093	8646	64151	125704	1755	100507099	165829	552	222584	84950	100287241	51659	200609	3234	79940	100126784	2736	222642	5208	284948	100129476	26993	4665	27019	2167	338324	690	136157	23294	5649	89869	30814	146325	60494	340037	286464	29958	7047	400629	148898	100128175	192134	3044	26664	23624	84659	80333	10893	83881	611	644186	9758	122876	147906	80759	8189	342527	100129029	135948	147670	7771	149563	4598	6580	7272	2898	1756	113835	120939	284083	79741	9376	29105	3651	100287556	5076	333	151531	4216	23538	6407	29986	729870	26153	4634	58485	26872	317671	51514	54083	154215	100505538	100303728	147841	312	5075	84439	9515	643395	128864	1770	6664	148979	729506	8340	27127	10421	55224	5457	283902	79977	2861	81697	3347	286234	731852	2487	81693	148229	90834	5568	3050	100287387	79187	6991	163154	27295	3361	3309
GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_UP	M4908		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29614	GSE29614_2207_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee pre-vaccination versus those from day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying the innate responses to the trivalent inactivated influenza (TIV) and live attenuated influenza (LAIV) vaccination in humans, and to identify early gene signatures that predict the magnitude of the antibody responses to influenza vaccination.					2560	100289617	81688	1238	158062	100507044	29761	27302	100289494	27164	2492	1600	2261	402160	26266	160287	9965	126567	83543	122786	5141	1057	259287	100288618	1587	100505716	55891	389084	1287	79177	2220	27039	100131814	2243	8463	100288809	7225	51201	6659	29777	51224	10404	23432	84688	5763	93429	218	5161	8785	23498	100507391	962	65267	2571	5308	729975	127733	285281	157777	650	339768	781	7050	2862	1208	2523	2703	6752	55090	284541	100505545	84662	84069	441025	64711	11009	7803	55362	79470	54873	946	388552	64499	10331	168741	1794	51375	10686	79816	285740	8648	100128640	283738	374986	284312	8692	388946	388698	9507	26494	158055	6295	92400	260293	205147	1181	5890	10427	27181	10140	115861	8712	26651	56666	337970	6779	9311	1907	1133	8896	6701	55742	643714	100289632	116379	56255	25949	11095	619427	146227	400931	79904	144568	222008	81850	2592	7082	9853	84366	84070	440957	6527	51068	29966	57716	644128	83956	54541	79797	51305	9260	5314	55338	8200	5268	3217	157310	50506	339834	53820	90768	64388	100294362	9037	122042	1611	23324	646658	3589	10578	7712	56655	10544	79742	2880	55009	135250	202865	25787	2914	221223	255798	257152	60682	284800	152641	713	326	200312	6789	3200	388743	57188	9068	1459	1390	55454	94	196913
GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN	M4912		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29614	GSE29614_2207_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee pre-vaccination versus those from day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying the innate responses to the trivalent inactivated influenza (TIV) and live attenuated influenza (LAIV) vaccination in humans, and to identify early gene signatures that predict the magnitude of the antibody responses to influenza vaccination.					100290481	91316	91353	3535	28823	608	55266	51237	952	2731	28831	160518	857	6241	7184	8419	100289053	3512	64151	51465	3514	90701	29925	28797	22837	81618	10615	8836	79365	9787	7494	3161	84706	494143	10952	3507	8703	51318	10923	64943	1033	58477	25849	100293440	286514	9697	9768	114327	81037	701	9133	983	23446	1063	55840	25940	891	5479	65244	57565	79733	83540	652493	9837	145508	58505	9370	11339	4288	5450	55871	9928	28902	23231	28960	79801	54522	9319	28912	84816	6518	7298	154467	63977	2822	7367	56992	7873	2833	2788	7163	6389	10592	29106	7283	24137	55872	378708	55033	83935	55165	6747	8630	4121	51203	1286	3832	23753	25780	5238	3998	79174	6790	56938	57082	8615	79703	140465	10954	221272	11130	55507	64764	51130	10745	4141	9833	7171	2617	991	51514	29760	27248	6003	57823	9685	51726	29070	64766	3703	84102	29958	93463	55010	6185	84893	79770	6382	1111	2305	10549	29880	26271	53838	6729	92092	1434	2491	26275	139221	6182	25996	4171	51016	3630	56005	84950	9232	4522	79980	113263	51454	7466	28299	699	400653	115201	23495	64924	990	79876	79694	23516	7272	51668	10802	11164	135927	28972	51081	22974	348654	642980	400958	8364	84693	55829	4642	79796	81552
GSE29614_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_UP	M4914		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29614	GSE29614_2208_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee at day 3 post-vaccination versus those at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying the innate responses to the trivalent inactivated influenza (TIV) and live attenuated influenza (LAIV) vaccination in humans, and to identify early gene signatures that predict the magnitude of the antibody responses to influenza vaccination.					5314	201725	1587	6752	9965	388336	677824	123722	285281	3215	286204	4025	81688	80380	55090	2875	401282	2897	5161	3083	171391	2940	338588	100131581	342527	116337	79177	163590	6357	2661	5949	196477	164312	100128993	5726	2986	64002	100287147	259287	54898	282808	714	407032	55231	283387	3549	148345	8200	100128281	57795	2444	8470	100130331	30846	6344	64816	724102	6779	84733	171482	151354	400258	50937	1133	57689	440905	100505716	84439	1580	1208	7621	90161	10686	339483	54873	57084	400629	388666	83953	2864	4915	3382	284498	387601	149134	2994	126248	80350	8000	90378	713	1943	56121	283688	1238	7498	4061	23025	100287704	2203	4887	121601	50484	1014	10021	283212	6276	51151	7512	129642	27006	389073	2647	100287366	57830	23543	4760	1468	353299	26993	55794	59350	3735	404201	218	5618	5774	2249	7274	100288099	8646	181	3044	85366	4015	3763	54961	27295	7428	54660	2813	5076	9536	112744	147166	2893	159162	91862	283731	763	1910	441025	100505510	6911	1144	6954	390916	8552	27443	63928	7363	91683	375189	407	145837	326332	151760	23624	8756	2592	3273	135948	1415	390058	80036	100292688	79927	83597	100288809	163154	9037	142684	51297	10019	388743	5137	2045	91461	54922	944	79630	9211	1057	55776	284930	644090	3601	414771	83543	100505545
GSE29614_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN	M4915		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29614	GSE29614_2208_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee at day 3 post-vaccination versus those at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying the innate responses to the trivalent inactivated influenza (TIV) and live attenuated influenza (LAIV) vaccination in humans, and to identify early gene signatures that predict the magnitude of the antibody responses to influenza vaccination.					100290481	91316	91353	22837	952	3535	28831	608	51237	3512	2731	160518	79365	28823	5450	55840	100289053	26275	857	8836	100379224	51465	27033	2788	64943	84706	90701	3514	3507	7184	4121	28797	51523	23446	8082	5479	494143	57565	29760	28912	151473	83935	81618	55266	23495	55871	730101	6185	81552	81789	10923	29880	34	25780	83416	145508	8703	28960	6241	100293440	6518	79703	652493	1286	522	9697	2833	8364	9232	23231	58477	26002	84693	55507	10549	114884	199857	58505	81037	28902	55298	23626	2617	345757	79174	729852	55829	7367	6729	2822	378708	29925	9319	1033	23753	114614	701	63977	113263	28778	24137	91319	10615	9787	64151	27248	79801	79733	55179	140465	6747	3161	55289	25849	10952	90141	51726	10802	56005	7163	11262	10622	9133	65244	991	983	7494	5238	23657	1413	7873	51061	11014	5368	348654	6382	114327	28908	81793	9768	55033	3998	79675	4064	291	494150	100289641	4288	54900	10954	83540	55872	79669	11339	2491	100287547	400	699	80255	338323	90480	90355	29106	6637	64318	7366	1111	891	9837	64065	92745	6491	2287	100133019	26227	5245	84153	57823	29070	3329	8859	63931	100132388	2585	51009	79019	100505641	374618	990	8803	3981	27314	7388	1795	79731	54733	255631	11153	84240	79770
GSE29615_CTRL_VS_DAY3_LAIV_IFLU_VACCINE_PBMC_UP	M4916		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29615	GSE29615_2226_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from LAIV influenza vaccinee pre-vaccination versus those at day 3 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying the innate responses to the trivalent inactivated influenza (TIV) and live attenuated influenza (LAIV) vaccination in humans, and to identify early gene signatures that predict the magnitude of the antibody responses to influenza vaccination.					7130	64786	7056	55299	84254	51562	2107	10439	5515	79720	84632	100131262	23082	63935	51430	25949	10210	3985	222487	306	9107	51447	9976	134526	260429	57103	161394	1410	2919	5597	731656	8813	27012	253943	9741	25825	81698	3451	10342	57826	54461	7019	89792	1407	1232	6782	80127	54490	114799	84541	10746	64386	440145	50640	11171	5861	3772	673	23130	2959	7572	9055	55270	84248	55802	81565	28378	79774	26468	27074	9519	56900	54807	11221	153020	27249	100128343	23710	25978	144108	5193	727818	56905	57210	10568	145678	54556	1660	4928	710	26239	91694	100287911	83460	196374	25901	5862	51629	283373	654780	25948	65266	80219	9774	84146	8480	255919	90850	10171	55660	84002	64092	153222	8723	90390	10042	117154	9868	84440	51307	152015	55361	118932	100507650	57544	6744	148479	55604	27314	51514	51646	65977	10672	5194	84945	56130	1809	2912	58489	55970	54989	84749	60436	4654	84243	54764	6189	317762	3043	81894	7091	9217	4335	79016	51700	10425	10678	51439	5371	4189	4321	56853	8161	79143	3188	2046	55110	677	30001	729088	8834	728441	11011	100287951	56001	117195	901	1105	151987	24138	55350	4330	79066	7341	2867	163778	57538	10881	10266	5947	57568	1347	30836	10894	2872	728288	120224	26224	54557	56106
GSE29615_CTRL_VS_DAY3_LAIV_IFLU_VACCINE_PBMC_DN	M4917		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29615	GSE29615_2226_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from LAIV influenza vaccinee pre-vaccination versus those at day 3 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying the innate responses to the trivalent inactivated influenza (TIV) and live attenuated influenza (LAIV) vaccination in humans, and to identify early gene signatures that predict the magnitude of the antibody responses to influenza vaccination.					286256	839	2494	9716	7482	5052	3484	81790	131474	5518	91464	100505768	79810	161142	23318	28973	143630	27121	145282	90024	55705	7227	7520	10521	11085	4012	54209	28797	79068	345611	23367	56917	2976	286087	9581	153830	6964	51449	100129129	8991	100289577	55759	23322	9404	27120	23317	5212	729324	28755	100272228	100533182	170370	150	23341	256471	84450	50632	23591	80208	6619	729082	168400	165530	1666	60559	202151	3910	23096	4332	114836	728224	79857	56951	10261	25923	1395	23788	6480	219402	51316	170302	10240	57622	1891	100506776	148418	80198	284100	9857	5949	56683	120526	148753	6426	55209	10771	129881	1642	1363	10125	56339	100192378	79674	680	51652	51493	340061	6815	219621	23499	23456	8943	9466	608	57562	23450	80347	55212	23041	80184	85026	29121	147872	10189	151742	100133669	89866	3295	3983	4968	5567	90806	134147	6541	3702	132954	148014	585	144245	10283	55172	100302692	2705	3416	91548	10015	89886	100507206	55760	583	55601	100527964	6906	1182	90070	79885	1994	51028	115948	57506	342908	8354	4702	51426	5019	146310	79646	8717	81688	83747	7514	2960	127707	64067	7188	155060	54928	26157	55200	6936	2700	56259	116143	337878	138199	2709	7586	100129516	54495	30000	3589	11276	441179	5896	147011	116138	203286	283345	54778	127540
GSE29615_CTRL_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP	M4918		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29615	GSE29615_2227_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from LAIV influenza vaccine pre-vaccination versus those at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying the innate responses to the trivalent inactivated influenza (TIV) and live attenuated influenza (LAIV) vaccination in humans, and to identify early gene signatures that predict the magnitude of the antibody responses to influenza vaccination.					8972	654780	7015	3036	711	7153	100293830	388722	29995	118932	762	3762	3556	221421	8794	710	55663	112479	100134229	26000	64386	81035	55821	56106	5083	608	782	84734	79594	80006	348093	63898	3985	134526	2838	64407	4856	220074	722	84125	2919	8174	9825	84243	55635	25984	51802	148046	9899	5340	100287032	23120	151827	367	27303	154796	7855	8484	2912	116729	1991	1116	84056	3772	92014	127579	1482	100133308	5526	6037	83998	3790	55107	23462	644873	84443	4317	6706	9892	54509	22854	57568	55350	6836	10409	83795	115650	285987	56949	1308	100507043	169044	671	9651	5196	54490	5354	5309	286114	143678	84419	55184	26248	64412	5473	8436	25880	374973	11138	400550	320	7306	89795	92340	80115	23030	6543	641700	8334	55224	55090	150	84503	10882	2671	5193	254956	80325	55299	100506668	29842	8079	5995	222487	10699	285097	2874	146880	3882	100505835	100507629	646626	3568	9455	56302	644090	619455	283856	8590	83882	100288640	4318	79778	55349	146850	23531	4689	10888	400643	2046	90485	90850	551	1005	139628	79143	100287676	79705	100507386	246122	29930	100287602	55247	25775	65009	51257	28912	139378	149111	51237	647288	57149	791115	148281	79812	23322	3082	275	23109	5068	8529	3195	81027	4051	64943	728441	2790	2978	84418	7850
GSE29615_CTRL_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN	M4919		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29615	GSE29615_2227_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from LAIV influenza vaccine pre-vaccination versus those at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying the innate responses to the trivalent inactivated influenza (TIV) and live attenuated influenza (LAIV) vaccination in humans, and to identify early gene signatures that predict the magnitude of the antibody responses to influenza vaccination.					163115	100128946	8339	1809	388906	5896	161394	9127	100272228	345611	26251	85026	11020	23359	100289577	255330	9068	26995	644997	6364	728224	4059	100302691	26086	89882	128229	201633	147011	259230	23591	8913	100128074	3007	2246	51761	7124	100287807	58509	100128511	139629	100507206	6899	64856	80818	165530	100192378	50616	51118	140628	285696	27177	2069	337879	440028	29989	10160	7003	3569	10142	144481	5382	10040	205	29767	100505989	6401	100288122	100505967	79750	132112	9351	11170	348035	89778	118426	8366	338094	92283	28797	55200	4642	146857	54763	6897	339416	7565	285429	220441	79608	399884	7089	127707	25831	91937	339260	100288798	249	3631	728819	245937	643236	64225	375248	285668	58517	11132	286436	285878	10691	646600	161142	9656	83858	3786	4796	84310	3445	93107	10824	91464	23148	9038	203413	439990	59082	28378	203111	158833	259308	54973	4891	4915	55760	7032	145282	3952	81849	503538	163933	1146	730227	606	9940	55823	79858	2232	26080	10168	4016	353355	168400	87769	5949	54475	8364	56245	204474	2128	146310	57622	246705	7576	1038	146206	135138	84108	90957	3181	10806	150353	8354	284112	27121	2186	64108	7123	9498	81576	129881	11153	10165	100505518	338657	10198	162282	145820	9076	26191	403312	283120	151246	7113	6416	146059	159	55707	5919	80829	100289312	9808
GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP	M4921		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29615	GSE29615_2228_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from LAIV influenza vaccinee at day 3 post-vaccination versus those at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying the innate responses to the trivalent inactivated influenza (TIV) and live attenuated influenza (LAIV) vaccination in humans, and to identify early gene signatures that predict the magnitude of the antibody responses to influenza vaccination.					3977	286087	11085	608	54753	51449	89795	54509	64386	414926	124402	3664	200150	93463	339416	54988	81790	284677	165545	84450	100507064	51217	100130051	254048	6697	100505964	1991	2833	112817	6898	51257	222894	339483	50514	867	23211	11165	51224	26160	4303	653140	54461	27329	197131	1440	127579	162514	29999	22884	220134	84932	8396	23367	222662	151790	84986	55821	23272	128218	81558	389023	1666	9899	8943	64067	90135	91252	367	1891	6571	6795	158248	51327	169044	8237	2705	643529	7586	119467	90843	5196	839	9847	11276	4355	3400	647979	1874	9248	23639	9698	8174	11173	1496	5362	154386	51237	388407	59283	10320	10882	22987	440087	53820	100499467	3295	84872	55225	57835	57707	84734	551	55243	3934	148046	7015	81620	132203	347365	2641	54943	6678	2255	114770	50940	100287627	100134123	28299	79022	29895	320	1601	122961	81027	6336	11166	100129447	100506258	711	122481	100288640	2125	100507386	27018	5473	100128922	100505875	79594	3886	60673	55748	80173	91149	5526	100286922	100287032	987	8991	158381	153830	140732	728705	100134229	55635	83746	10939	6007	163747	23531	145820	9050	89927	10875	245711	51123	11005	6541	26034	6660	92999	6527	1182	2235	94107	124626	10725	282679	203068	10220	51148	4741	84190	27287	203190	12	170302	51652	30000	761	113251
GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN	M4922		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29615	GSE29615_2228_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from LAIV influenza vaccinee at day 3 post-vaccination versus those at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying the innate responses to the trivalent inactivated influenza (TIV) and live attenuated influenza (LAIV) vaccination in humans, and to identify early gene signatures that predict the magnitude of the antibody responses to influenza vaccination.					653121	2919	285878	3786	51588	11107	342908	22822	84419	8454	1088	23089	9107	1734	25842	7124	116068	4747	10321	51018	3313	5515	51646	29105	25825	93099	85375	4330	353324	285375	100131561	541578	23036	153222	6037	6364	575	26086	100130741	3458	8411	23198	100290481	29979	246175	151	710	7316	253017	7130	8794	163154	9774	64783	80350	55937	1499	4093	899	200261	902	23066	1838	728558	285282	124808	641700	53342	83903	64786	51164	121536	84146	100289246	26267	1038	51163	9085	55823	8723	7019	91937	26973	220979	9313	25961	51350	387647	151827	815	151354	100289436	57091	148266	116328	56130	55096	200159	11221	9474	284080	55614	84085	54763	94030	56674	2069	4051	317781	886	1407	57590	3839	283867	644890	641977	5091	60436	10439	4335	10991	6401	51562	257240	79608	163255	55604	50804	30816	9868	3766	7846	29989	9718	50640	80274	338004	81565	11193	2246	219537	100506795	8050	9741	7003	54752	90410	820	139231	3985	154796	122060	130916	124491	285429	653394	56131	64921	10923	10253	163115	23710	153020	55339	64403	152006	5266	84879	55160	728288	2107	440854	10746	55064	114799	84319	9576	22938	79659	7486	4928	8842	9068	100130837	8553	399959	647190	55190	10142	3841	5689	167465	51761	51053	1102	7056	353174	57691	2591	9808
GSE29615_CTRL_VS_LAIV_FLU_VACCINE_PBMC_UP	M4923		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29615	GSE29615_2229_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee pre-vaccination versus those post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying the innate responses to the trivalent inactivated influenza (TIV) and live attenuated influenza (LAIV) vaccination in humans, and to identify early gene signatures that predict the magnitude of the antibody responses to influenza vaccination.					710	3985	762	711	3429	1669	5266	56106	55299	654780	3043	2919	4318	4680	57568	134526	54490	10882	84243	222487	64207	1232	2912	55715	222235	1809	64386	7056	5193	100293830	7130	608	80115	8972	81698	3772	782	1116	7153	51562	84254	29995	81894	1410	22822	3762	100131262	26000	306	115650	260429	2872	63935	55350	25949	23462	29950	90850	84632	4856	84418	728441	5459	112479	153020	56905	9218	63895	343637	6037	729839	79143	100128343	51514	8493	84658	51447	27074	4051	5947	1446	2564	150	139081	3000	23082	84541	3556	254956	481	5354	10266	3764	7416	83795	1154	5194	9825	10321	1482	4317	84503	80829	56884	4689	81035	10342	9055	28912	80209	11011	3569	84872	6364	8529	80006	550631	249	55905	65009	5995	84749	22854	1302	51439	2790	8813	79074	8794	22853	2046	55224	92014	148479	146225	131034	8408	3036	57103	7867	3568	10888	70	10881	145678	55802	9651	56949	283373	100287221	3385	677	10572	56853	100507650	64225	28378	25843	26248	722	56262	64407	57062	6649	2107	2575	643965	8079	116068	54903	80325	29890	64943	64748	83667	901	142891	55061	3759	56521	27249	127544	254394	7015	9633	10407	100287951	29930	53919	9989	3195	100507173	23322	6398	27012	56900	7851	57210	56667	152015
GSE29615_CTRL_VS_LAIV_FLU_VACCINE_PBMC_DN	M4924		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29615	GSE29615_2229_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee pre-vaccination versus those post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying the innate responses to the trivalent inactivated influenza (TIV) and live attenuated influenza (LAIV) vaccination in humans, and to identify early gene signatures that predict the magnitude of the antibody responses to influenza vaccination.					161394	728224	345611	85026	100272228	100289577	5896	51316	100507206	147011	11020	163115	145282	5212	9127	89882	8339	91464	286256	201633	79857	730227	168400	165530	388906	6897	5949	9142	100505518	10806	9068	10824	26251	3623	583	29767	60559	23148	4225	100192378	100128946	337879	28797	100505964	161142	143630	23591	100128840	85445	4059	26468	27121	5052	100288941	275	23030	6285	57622	148418	6815	338657	255330	55707	127707	100128511	10521	50632	127540	26191	7482	10168	284100	146857	9581	23359	100505768	90024	50616	2069	5445	3484	2731	83546	3910	286087	54209	100302691	2246	10194	10040	9716	79068	731779	55760	55157	353355	644997	202151	140628	440122	55705	1620	6579	55619	23096	57650	150726	55200	55172	131474	8065	100527964	5019	731223	132112	54795	9498	285668	79745	89886	57544	220441	8913	339260	91548	388942	541473	283120	100128830	87769	7123	58509	54910	54989	23353	4891	79810	643236	100505989	283345	339751	11085	128821	1395	23321	128229	340061	7124	348035	286436	129881	259230	417	100505967	1587	51761	116123	10795	80111	79750	6964	199223	22887	3007	741	6936	2494	100507424	6517	25998	197021	503538	10691	100128074	11132	343990	65008	5382	2960	26995	137362	9993	401134	8634	196740	64577	57448	4247	22938	54928	10443	23041	5915	3952	25831	100533182	9313	100287807	153090	3251
GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_UP	M4926		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29617	GSE29617_2201_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee before vaccination versus that after the vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					55802	57062	6477	64412	25948	58155	7975	5008	4051	5266	440335	26973	3091	23469	80219	7832	1783	79782	5996	140685	602	81786	57602	5997	10135	25977	100132625	91746	2355	81565	1768	388456	5966	1665	253260	5988	27074	3720	5655	100302650	140890	10020	6429	100130135	9819	3627	163859	253738	284454	221481	80311	7538	153020	10299	55584	54906	8013	7286	100133130	10270	221037	9925	3727	9079	284805	150094	64651	160760	23127	7776	2107	7803	1839	255926	415116	9412	85450	673	140612	153222	50486	2000	118813	3576	644660	9595	84132	1499	151760	49854	9388	25976	2117	5142	9774	728577	51447	4209	3726	80213	116437	11044	84456	168455	406	5905	5055	9960	2239	55351	100289071	10780	731779	23130	79595	158228	2803	1717	6364	285889	29851	51335	84679	26043	2353	284695	84872	23138	100129722	5718	29105	383	440352	5334	10625	10002	55095	467	306	196463	260429	3164	168374	2297	54861	1263	11143	22931	677	5861	10285	9798	1880	84957	7852	55096	84733	9326	4780	7111	57018	729085	149371	29989	51646	257103	27436	56929	163051	10865	9891	10769	4189	100507650	142891	51046	9353	64386	285958	8553	123720	219690	387640	114818	4887	55195	3976	80149	503693	220213	164832	84612	284187	100133660	969	7090	221336	116238	10179	9441
GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_DN	M4927		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29617	GSE29617_2201_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee before vaccination versus that after the vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					4710	51258	7138	10549	10456	6885	51126	51065	5052	4716	7257	23788	79828	522	51019	5825	1716	29796	8405	54812	8836	8209	11130	10640	3069	10574	4702	55840	55252	27089	9456	4706	54998	57001	7266	29081	3163	81562	710	5205	60592	26521	34	203068	10213	7705	9601	4247	5378	5481	29095	64801	127534	339804	1666	5004	10007	63931	129285	54916	1633	51112	7411	56683	58505	80011	8669	4712	27180	55164	1891	1642	115209	6217	84432	5690	5510	6741	9343	10677	1008	63940	90861	3066	1836	339487	100506776	100505964	140609	4201	8802	23760	6048	79053	79590	9950	28797	9276	55791	83879	55156	9831	5710	51315	64853	54499	57187	8443	84064	10488	29074	5462	22823	16	8655	139341	3772	6195	129531	401233	5557	84893	6614	10617	5707	100290557	4717	25813	84498	84661	84986	55830	402	10399	1965	327	5685	10960	23446	219402	116143	7520	3295	2286	25961	4281	64968	6119	81502	10847	713	80777	11212	7993	64979	22878	4733	401265	11262	7112	85315	10245	3444	100129461	6241	5111	282566	219348	56729	7270	4528	51237	51283	51147	29927	28972	729991	84852	10474	6092	7184	2023	6747	10870	5532	23272	1088	2271	9582	8411	79675	220042	114836	64087	10576	3703	23753	23431	23530	11164
GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP	M4928		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29617	GSE29617_2202_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee pre-vaccination versus those at day 3 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					100130135	100133130	25977	5266	57062	58155	253260	91746	9353	10299	23469	10020	153222	146562	1106	4943	9925	84786	140612	29105	1783	5142	5252	57711	5947	29851	22887	23215	118813	57602	58517	123720	9798	51727	90799	8227	1974	148423	55802	10979	25987	54906	1665	6882	140890	27436	7799	150622	1846	55584	693207	145864	6515	7776	2239	84441	7286	160760	673	23020	26051	260429	56928	3091	6627	115426	140688	100506898	9774	55718	221037	379025	10291	9388	100506963	254170	57828	26205	51729	140685	55620	5885	406	5876	55037	81565	10270	154872	163049	9972	158830	7832	6477	55818	1263	117583	49854	64386	10135	9583	345778	8972	168374	7844	79849	2035	3283	23533	114791	7852	57396	10521	89781	55096	5905	5996	10865	80895	1540	25948	84872	150356	79609	23127	5903	10562	645460	2803	10947	55367	84132	3609	378805	3514	30001	256987	84456	100287728	9584	170425	5475	100287932	1649	440335	4838	23067	728805	5988	163859	80219	221438	4929	5094	284187	84612	9451	221496	57018	83758	3720	9499	440352	5887	9667	4089	10001	6259	51361	29123	124540	23130	54891	7538	140901	6228	6364	4209	388456	5334	1768	169714	168455	51335	29116	26959	415116	26973	9873	644660	100129722	440026	5406	26058	81894	11056	92304	149371	7073	253738	23051
GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_DN	M4929		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29617	GSE29617_2202_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee pre-vaccination versus those at day 3 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					51258	23788	4710	203068	26521	58493	5052	10640	51147	54499	5436	10870	5825	4702	54951	7257	8802	34	6048	10550	5688	51065	54812	10007	8655	8673	83941	4716	6885	1465	7705	5690	2352	10474	51248	84064	51126	7266	60492	5685	64798	5911	10213	5691	55862	127534	5111	5356	4711	401397	29796	4733	22823	63931	55164	382	286023	2023	8992	60592	26292	1213	1488	29088	80271	11212	8540	64979	84314	64801	55252	7009	1008	408	139341	7905	29095	4201	51133	10245	27020	10069	1965	3312	140609	710	112495	8459	7411	54998	10134	60489	9343	51493	6092	29074	79017	4247	204	401233	4712	2271	4706	22948	10434	5269	10456	5710	55884	4190	55737	84432	55791	400752	57600	79626	1432	58527	81562	23235	482	522	9526	6665	51124	79650	29935	1072	219348	337	56254	29087	84520	1827	5162	4528	23463	145497	2867	2108	79053	28958	25923	27235	128346	55830	11068	1043	10008	219749	5462	729262	25936	3903	54916	84522	51075	23760	3066	466	26277	1500	4709	50	401265	125893	29114	8672	10109	58485	55521	7227	10449	3627	1389	115106	6827	4738	84304	84316	55156	401098	55255	80011	27068	51111	10549	57187	1436	5532	399694	2665	1716	51501	54809	51060	10093	6902	280636	115209
GSE29617_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP	M4930		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29617	GSE29617_2203_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					5997	8013	5996	284454	10135	3164	5008	7832	5055	143384	57132	79782	5743	3576	602	7975	9107	4780	467	6303	1959	3726	7170	6515	26973	25948	9819	85450	54558	64412	2984	2000	170394	150094	135458	7763	1499	81786	9794	51307	64651	51438	284207	51646	51762	2117	2509	7323	6446	84945	5266	348808	80311	5734	54886	10124	9308	388	253943	22931	1839	221079	55802	2355	83894	9976	5966	127829	153020	2353	7069	80219	221692	220213	55225	55025	1843	1880	51444	2920	8427	10769	51335	10285	79345	6364	84440	3976	283501	2107	9529	9595	571	7803	3091	3720	79132	51320	6867	51164	284805	4335	50486	58476	6477	55207	219690	727738	4189	1894	79595	54442	80213	9412	284695	8676	4783	80139	81027	64092	2354	399671	57178	100129722	131034	84002	1960	81602	285628	84679	254394	5307	84146	11143	1844	63934	10019	10179	7111	728577	710	7402	26998	10672	8452	1290	2162	9021	3638	58155	7189	83856	9120	64072	441094	83899	7299	7453	1407	29989	3433	9638	969	100287349	25976	55195	115330	5209	5861	201626	120400	26022	10002	51343	29761	8767	54112	1641	4915	8843	1026	4139	55659	84456	8493	7852	9960	344887	100130360	3043	2495	728	51322	57103	731779	64783	51622	441394	3627	23138
GSE29617_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_DN	M4931		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29617	GSE29617_2203_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					9601	8836	100290481	100290557	11130	56005	10549	7184	28902	652493	51237	100287723	28831	6241	4176	1836	857	80336	6311	23753	10399	3163	1615	8405	28797	114836	155400	28972	4710	58505	29927	79828	10954	90673	64087	90701	28823	3669	1716	3069	1642	129285	608	7873	3703	8209	23495	10574	3535	55209	91316	952	4172	92285	5510	80011	2011	27089	84893	51019	9456	4221	51065	96610	81037	522	54998	51112	10456	11014	28778	10960	83879	57184	100132741	10130	23446	84513	55840	5832	10488	1650	2710	9371	29925	374659	10113	10575	4931	260294	7993	28912	81618	327	22984	55695	56339	283685	55657	7586	128869	2286	51106	5450	3007	8443	641	78994	116138	9500	5479	84498	26091	65244	2820	729991	3376	7052	339487	5052	56683	84245	53838	9969	29081	7270	23431	55245	4281	29929	26015	26275	768	25961	3429	8728	6885	26228	27101	80054	10525	11339	51126	81502	199857	79867	54780	1891	51253	129531	6119	6747	79174	2731	55278	3444	5378	57565	6183	10567	219743	4141	7786	27180	23231	51154	284358	80308	339044	4121	360	5462	8337	51366	6729	221294	29796	4716	16	939	130589	1690	81562	7922	4706	29909	79675	80835	57105	29086	55829	54069	4522	9862	57001	5004	79590	10952	9617	6480
GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP	M4933		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29617	GSE29617_2204_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee at day 3 post-vaccination versus those at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					83894	645591	114793	221481	389432	8676	56670	10550	6398	58493	151306	440073	100289538	5879	80139	54918	9788	7763	100506627	8013	100302650	3433	2888	5055	100286980	55603	6738	8766	57045	140578	2746	805	283387	135458	401098	6451	5352	1436	2203	2633	2000	7940	27020	6934	467	382	54558	54951	114991	100288123	2643	10673	55547	1950	9609	55504	1514	6788	10791	2059	89887	1318	391	153222	3824	79132	92999	4139	1488	100294391	158295	117159	5908	85294	221	8536	126205	161436	58475	23544	112574	1179	55233	9516	4137	128346	5660	1471	83706	259234	6275	10893	2634	29951	2040	27163	317705	13	4915	221150	25939	2015	3627	7867	7227	84975	8796	7296	2665	3569	1445	25794	143384	5341	554201	3965	647946	7416	653464	4214	10241	23034	7414	8540	1028	7167	199	57175	100287032	779	7069	26469	57132	3805	26509	9638	9158	2710	1287	9388	10577	1959	4495	30817	271	100131180	10109	81027	3351	55350	826	643210	100131860	2596	5141	127396	8099	685	100128081	9060	57093	427	84889	8932	59350	5983	4501	25994	7130	4853	637	199221	1620	29065	118932	1871	1846	8492	388	1411	11314	8321	118788	284611	5685	150147	5436	3916	1496	54741	11172	253430	7905	57600	1075	146336	6584	153657	140461	64407
GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_DN	M4935		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29617	GSE29617_2204_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee at day 3 post-vaccination versus those at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					100132741	28831	80336	160518	28797	6625	5450	80895	9923	90639	100287723	91316	9601	85015	652493	2177	28902	857	28823	6181	22887	22837	3535	23231	146562	28778	171023	9695	9284	145864	55695	25859	645460	6429	11116	55037	54856	608	23594	221442	23495	8836	23020	283130	4152	6929	100290481	51237	100290557	4051	81618	9583	4176	6687	54540	90701	222487	28912	10782	403150	7184	134637	51303	8473	4838	1615	1606	400242	4054	155400	8675	55154	84181	202781	374659	81894	51726	952	10562	339044	677778	81669	100289019	8718	124540	84705	440515	96610	8728	57711	22993	9617	54681	169714	145497	58487	3945	100287728	9057	56339	7597	7494	7553	5137	200895	6509	7163	163049	54923	2731	79703	375593	57654	113263	112703	6747	3512	317781	51805	3500	5479	94241	9451	9725	84315	140688	51513	5590	2130	389073	55268	93035	5071	400958	23029	57191	23523	3669	26048	8924	6843	10954	50861	3120	4141	9329	9044	246243	2822	440122	55082	8189	5163	202025	85300	2976	9990	57655	8527	4221	55833	2997	26002	51001	9500	208	25831	23028	114791	65244	51631	150759	100507424	100507637	55553	7185	84289	260294	143630	51654	196394	25780	10549	9866	51366	260429	100129387	10198	80765	132332	29970	84786	55556	28813	158830	9924	51380	57565	27031	9232
GSE29618_BCELL_VS_MONOCYTE_UP	M4936		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2173_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of B cells versus monocytes.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					91353	11137	23062	7163	596	22882	3983	652493	933	9214	28639	931	3507	930	26228	3535	79101	11142	5079	5450	28823	5533	3495	81539	6711	10863	26586	55081	55636	9135	28902	23075	9124	4927	8728	3921	51466	54855	22800	973	100293440	3514	4050	9451	7799	8440	971	5026	2788	27314	55024	3500	80183	64782	100293679	6480	5790	28831	330	28912	22837	11040	81606	27334	11262	951	23231	55278	57062	29121	6233	1235	605	8345	5287	57157	7088	26999	7430	10447	2208	56242	7594	6194	1875	5218	4609	6625	1656	3669	28951	5336	100133941	91782	8344	79161	11009	6193	25825	91316	4953	10776	51678	29064	9938	27075	3566	6224	23015	6206	694	7852	100419017	79368	3112	80008	643	6513	10396	2113	9467	5252	3738	360	2553	7249	6856	1236	23495	64318	11346	3899	96610	3512	868	1285	28908	974	6925	969	6175	84159	25780	200576	6228	23259	440270	4907	5368	8343	10235	10125	29760	6472	9263	5101	55768	291	58516	472	92482	1456	119	9834	10734	171392	23094	23531	5567	100505761	3111	53335	81931	23157	51427	9666	60468	961	55692	7188	375248	6929	9360	489	142	160518	9712	54733	5244	26051	11184	100129973	3017	51575	8364	54145	23253	10724	11279	1901
GSE29618_BCELL_VS_MONOCYTE_DN	M4938		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2173_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of B cells versus monocytes.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					9535	6386	6256	23580	271	7439	29108	10159	1806	55313	834	11314	1102	4637	25797	11000	4542	433	6277	2512	7076	1052	10903	645	10109	8754	9764	1318	1514	11027	523	83716	3459	80273	1200	7431	9960	55819	9706	644	23478	5768	967	51108	1839	9446	6404	2745	9586	945	23001	6604	2787	7321	2040	79772	5230	5125	54453	22918	7763	6282	7099	221	10602	8804	28232	9314	5476	5660	6916	256987	23136	7453	91860	3490	8301	55647	960	10981	51170	7165	5315	5058	4671	23765	10221	50856	7167	7422	3281	5743	3689	831	11025	5806	824	6813	10855	23406	4615	87	526	2533	8031	23258	2776	11337	55303	2799	313	2631	978	5329	81855	6252	8905	6799	11261	5724	4668	7074	308	9445	6648	9555	391	55625	1808	10437	196	54502	1848	2023	754	58472	830	5341	6036	80896	2526	2180	9935	4245	9341	4946	2203	683	10226	5829	1441	29097	9056	29992	55969	1230	57142	929	8321	6840	81619	10313	1431	728	1508	6934	3162	54210	1520	7555	84981	2280	387	4853	2920	55022	114548	2131	4354	8673	9846	968	80762	4035	54491	51816	1612	23191	353514	55012	11031	5912	8682	1050	57178	4048	527	26234	30817	5175
GSE29618_BCELL_VS_PDC_UP	M4940		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2174_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of B cells versus plasmacytoid dendritic cells (pDC) .	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					5079	652493	3983	57162	931	930	969	10863	28902	933	9214	9450	5026	22800	23075	55081	22861	5450	388	694	728855	330	64174	26228	3495	23347	596	951	100293440	6480	973	8531	7430	4609	11262	10365	3507	3566	55636	8440	29121	51466	1958	7204	6515	56882	490	79101	2308	7799	10010	4082	9124	55841	677	9447	2208	28831	10628	54855	27334	9451	5788	93349	1130	1831	55024	1235	24149	3726	3500	28912	59339	3099	200576	80774	6643	3725	285830	3112	25932	55196	971	6856	54103	399	9435	57157	28951	9788	80833	51278	5336	9712	100133941	91782	7462	9308	2872	3091	5218	80853	1378	7805	26586	27314	11009	597	10409	1843	10602	7277	8495	23240	11142	6259	28823	6672	84159	2213	8660	79368	3514	1649	100293679	3535	643	23495	397	5920	974	5287	25780	59342	9467	55589	11346	23077	55257	3669	51762	25825	4478	113791	23499	5163	3738	23094	96610	4907	3134	10914	119	6907	7163	23670	9592	101	60468	3148	9103	11275	10289	8527	55278	22821	8934	64761	63901	387751	4792	23531	962	5244	66008	4929	9938	7803	7846	5501	7188	6472	54733	1027	8609	23508	11137	571	3280	8930	51035	1604	79666	1997	5782	240	64318	1889	5366	3385
GSE29618_BCELL_VS_PDC_DN	M4942		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2174_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of B cells versus plasmacytoid dendritic cells (pDC) .	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					5251	2047	8140	4130	860	100287025	81618	8809	3665	1803	7184	54207	6925	6238	24141	26472	3799	351	28972	2286	8829	6343	4925	54806	113146	3852	6659	9948	23657	55282	7136	7357	11034	57476	950	1601	241	55088	23607	10952	375035	23390	25994	10397	25800	23316	2317	6483	3394	23547	2926	2081	9261	444	10525	1776	29108	6185	3662	5168	7169	6748	3631	9761	6335	6574	29909	2322	54491	5341	6196	11315	4602	6727	192683	1439	9375	55733	23466	9315	222161	5802	6404	5176	2987	10134	2621	8673	4610	6978	10577	5641	117178	112399	10184	4637	23677	9775	57597	9618	6000	7295	113178	10512	56889	60673	3563	9703	5245	22929	55704	377	5730	5051	5423	4175	1847	5355	1374	54407	3066	26994	55819	4521	6768	56005	2205	3482	4864	9044	11006	27128	5818	6184	2769	11010	2934	4258	11145	404093	27242	27090	1200	3002	7353	2824	165	23603	2120	100	2923	1969	57591	9500	4125	51284	1508	9709	9783	9882	2876	10966	1602	821	1075	11314	11049	9322	3455	2171	55256	51465	23400	10972	54910	3419	10788	5791	2776	5611	3338	84864	51257	1808	284021	10627	7371	4668	51635	5584	1240	131544	4697	9019	5479	5208	8079	10401	8407	8853
GSE29618_BCELL_VS_MDC_UP	M4943		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2175_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of B cells versus myeloid dendritic cells (mDC).	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					100293440	23075	6856	7799	5026	22806	652493	5079	11142	26228	9451	951	3983	3535	399	7163	5533	10447	55636	22882	5450	8728	3669	694	3566	330	4050	55841	28823	11040	23062	933	100293679	28831	81606	930	6480	23347	973	3507	931	5790	4953	22837	3495	9938	8440	26999	29064	6711	26586	2208	79368	100133941	5336	55024	10289	3514	11262	3738	80183	28639	91782	22800	2113	51363	28912	10235	57157	25825	1378	27334	11009	10724	11137	5287	84159	55081	79789	975	9447	57162	7088	11346	96610	54855	51678	28908	9448	91353	9834	119	10734	3500	25780	4609	9788	10365	971	974	4907	113791	5101	79161	6625	8609	1236	1875	55893	2553	4927	29121	10628	1657	643	7594	5368	654817	994	59339	80264	64318	7430	27314	25865	79101	22936	55196	8115	2841	200576	10863	8910	9263	7277	4983	51427	23508	4297	120	7259	83700	5218	23469	27250	10133	23015	9873	8395	60468	8036	10181	2308	3915	51696	6259	961	10125	56242	1901	9712	92482	3148	23495	23479	285830	55692	27075	4601	10099	83478	9750	387751	3708	360	10957	80169	54386	489	678	1958	1831	115123	1974	55784	23325	29919	868	27125	6643	91746	28797	100290557	2869	640	10493	1983	1456	79703	4063
GSE29618_BCELL_VS_MDC_DN	M4944		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2175_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of B cells versus myeloid dendritic cells (mDC).	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					10376	57447	6252	10140	913	4637	2934	2205	55911	7076	6001	9688	5058	196	8682	7879	1193	4697	1200	51177	911	2040	3490	57142	10462	80762	830	834	7431	9555	23406	6745	71	6396	7332	754	5743	11151	821	3516	481	2023	26034	2632	822	7386	2771	10093	1808	9446	6404	2280	11010	55819	10402	1845	80223	3597	10627	3570	57136	2322	6277	4735	9050	2203	1374	25976	8099	1601	308	60	54491	28956	9535	1351	57698	23191	1234	10487	3611	3956	558	1476	391	23478	80349	5315	10221	9948	50848	8905	8301	8553	79180	11337	9315	115207	10095	2787	55312	11165	3122	9314	5547	1806	3205	2926	10123	10105	29108	10092	2776	64218	11031	2745	4000	6275	55704	317	56005	10159	1512	4668	1471	84790	1441	5573	2597	54541	50807	5216	2896	6281	1508	26509	1973	10109	3687	6319	3689	1650	3606	5604	51192	9144	116496	847	945	2114	26010	3613	3936	79630	4046	8809	2950	7295	5912	64422	101	30	5996	302	4005	8321	2533	9168	9398	79143	408	667	10981	10397	7779	79887	6238	3705	10653	4065	7045	11240	1827	908	967	3398	55509	805	1052	912	23677	22918	55313	23544	79004	537	8986	4700	57591	10437
GSE29618_MONOCYTE_VS_PDC_UP	M4945		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2176_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of monocytes versus plasmacytoid dendritic cells (pDC).	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					57162	7091	54453	7086	8804	1806	4542	1839	2201	3687	2597	54210	28232	51313	3600	23136	5125	10581	6503	22918	1102	7940	6256	240	313	3162	7439	29992	10135	665	25797	929	3689	645	9535	6036	11275	9935	59342	9592	200315	4783	256987	7133	644	2634	7378	7097	10981	912	10903	10602	6282	3557	64581	6648	9056	4671	334	3091	26234	5836	140885	55647	834	8073	6934	9445	7127	55603	10970	9960	9103	5199	64174	79887	1130	6281	64127	56882	728	199	388	8742	11031	9450	1955	942	11025	706	55701	127544	2533	23580	50486	216	7941	8021	960	8825	831	2357	9332	6916	597	7077	22856	953	6280	4478	2180	55337	6397	10105	2124	1465	1318	6515	80833	7462	138151	11213	7321	945	4688	1514	114548	9586	683	11027	8660	3460	1958	10855	4942	80853	397	55415	6386	4082	8462	79180	6533	91860	3099	3958	7099	2153	54103	604	824	5788	7305	728855	8685	1520	53829	5315	6688	1545	2512	3705	8531	50856	5829	224	427	22861	8522	3576	83716	3055	808	5742	283131	8870	10221	11024	1050	221	412	29125	677	7076	11240	10875	301	8843	8932	55625	2268	3134	50865	81619	965	23001	6283	1436	5265	6275
GSE29618_MONOCYTE_VS_PDC_DN	M4946		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2176_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of monocytes versus plasmacytoid dendritic cells (pDC).	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					55768	4130	222161	54207	8140	54806	29803	4602	10152	28972	8809	26472	2824	2286	6238	3662	5641	6596	2317	9261	9500	3394	113146	5608	1803	351	81539	79677	360	4925	80183	100419017	2621	22837	8344	55088	6513	57730	860	23390	5251	3507	6483	23657	100287025	55282	3094	58516	8728	165	3852	6343	22882	2969	4864	6843	55686	6196	2788	55733	7136	8829	117178	2047	3653	7184	8481	8473	23607	81618	23231	9585	8343	10396	4050	9057	6727	4175	375248	26999	6689	24141	10605	9618	489	23547	5802	23062	55704	22929	29760	9315	53335	23358	2113	4605	5051	5379	444	9873	54847	6748	6335	7570	440270	192683	1969	57476	605	241	27075	1776	6925	57147	10525	3150	375035	51465	5176	23157	3925	3514	5168	8776	26051	6929	6000	26040	51747	7804	23316	2322	946	23035	3799	7357	9783	1601	4953	3631	57597	26053	10397	2055	5910	79622	27240	347902	54145	8237	4209	3665	10972	8345	27090	6659	112399	863	23015	987	10528	5245	3899	51754	7423	7169	84679	10518	1847	51237	5423	5763	11184	5380	23604	29909	399	27242	29799	9709	3921	3006	23195	55617	10952	2237	5108	2171	3561	57824	5931	1633	4643	5479	3563	9044	55695	150759	9761	6894
GSE29618_MONOCYTE_VS_MDC_UP	M4948		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2177_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of monocytes versus myeloid dendritic cells (mDC).	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					427	9056	3684	2219	6386	51411	51363	1520	728	10970	929	3460	1536	83716	200315	9445	3916	2201	9935	2131	80896	683	1545	1848	2212	3576	5660	51313	2920	54210	10855	79789	968	6280	10577	4082	2204	2512	654817	5732	10313	59342	6648	8875	1441	7941	11025	3162	2357	8825	2123	5937	948	1509	57162	334	6604	6283	51094	10209	7305	8609	1462	29992	8741	6310	7086	4035	8843	1958	51099	10135	11138	5265	4688	7133	3949	26234	1514	2153	960	6934	199	9764	4853	4792	2752	5149	84981	10326	2799	7439	1508	23312	10507	597	7378	5836	644	3600	11026	91860	53826	4048	3134	1593	2180	55340	54453	3106	216	2015	2526	665	9448	56911	55969	8870	6279	4353	25797	3482	3091	10437	7277	113791	138151	22918	6556	8685	55160	1378	3176	6256	4814	2870	1675	114548	64757	50486	6653	967	79168	22936	55625	6583	4179	5326	8660	7099	4601	19	133	10859	25900	55332	6388	5226	1318	6275	81848	7832	571	9960	8566	4354	2207	2533	55048	6799	55654	412	8932	6016	1102	4938	11213	10602	9846	978	55701	11027	57104	28232	313	8569	7321	2268	1230	7074	10129	79971	127544	8804	1362	9332	9535	10159	1051	1959
GSE29618_MONOCYTE_VS_MDC_DN	M4949		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2177_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of monocytes versus myeloid dendritic cells (mDC).	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					9124	57447	11184	911	3921	596	913	64110	81539	274	8343	2205	214	1298	3561	1193	3662	4261	3111	8344	51466	3017	3205	54145	10123	6711	971	3115	1837	8345	2322	25849	946	5641	8339	79077	7405	8809	5567	3597	10666	54733	3006	10409	64780	4728	3094	3695	558	6228	8363	9805	8329	9315	1265	10276	6745	3033	3119	2934	113146	8331	3150	23544	1235	8530	71	10462	57820	10863	10653	26355	6187	5037	6194	64782	8332	3606	64710	3113	3815	29760	28951	55509	1471	4830	3899	2788	2029	54956	23677	23118	26472	933	79817	55704	27330	9538	6133	8346	55024	55274	9249	8481	7879	28978	6189	2199	7850	966	79656	8682	728498	382	8354	10576	163486	6175	2037	64798	3159	56829	8364	23157	987	7594	10140	7531	5996	9747	6285	93974	79073	7371	26051	6636	3128	3007	6233	8030	6001	26010	6595	2628	23160	8872	3112	9467	25939	11279	9232	7380	605	9734	3183	27013	914	2171	57136	28969	50489	8099	894	10949	81931	3092	6513	9053	27335	84679	822	93144	1601	5445	54855	1234	55204	3122	653784	23225	7332	11331	8355	3009	6596	328	10131	6143	8924	6632	23015	10923	7465	23426	5464	5496	10376	3603	26123	6319
GSE29618_PDC_VS_MDC_UP	M4951		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2178_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of plasmacytoid dendritic cells (DC) versus myeloid DCs.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					8140	26472	23607	351	2047	2317	55686	10577	28972	9261	3394	55088	55733	54806	4864	5251	4925	4130	5355	5802	1439	6343	6659	165	2286	81618	2824	3852	22837	57730	53335	113146	10184	9500	6925	22929	2683	55282	654817	360	7357	23358	5176	8481	3916	5423	100287025	3665	24141	6689	444	7184	51316	9873	5051	26999	860	6238	4953	9618	79677	23390	241	23316	8473	1847	29760	6483	57147	2621	23657	3563	863	6000	112399	51237	2081	3925	79567	80183	54207	950	6748	23547	9882	8728	7169	6727	2113	8829	3482	51465	8115	5608	192683	10605	1633	9783	4050	26112	54847	51284	5730	1428	27242	29799	5168	3903	1969	7494	80345	8237	376267	2030	29919	26040	22882	375035	404093	1240	489	3741	25800	375248	10401	27075	347902	253782	10099	11083	3662	55211	23604	3653	6440	4605	9057	29909	6650	10567	6196	4926	10477	7136	441263	1601	57476	113178	4855	65220	23062	5208	8851	6894	1075	56995	51646	26994	9448	57824	51293	9711	10952	5116	23231	6978	27240	7570	10518	10152	5023	1803	393	10396	4799	1602	6596	3514	150759	11138	23224	1776	55752	6335	3998	23412	5790	54836	6843	79876	375	4209	100419017	1508	11006	375056	6574	5818	1153	9583
GSE29618_PDC_VS_MDC_DN	M4952		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2178_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of plasmacytoid dendritic cells (DC) versus myeloid DCs.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					9450	50807	29992	10409	7940	604	10105	5734	3687	2597	912	913	6252	11031	9535	11240	10581	3965	101	1955	64581	834	3516	26034	6515	490	301	6281	79887	4082	64110	3689	313	7462	3597	3398	3956	408	51466	64422	6050	5464	9124	7076	5269	8522	57447	1806	23406	8531	6907	1052	302	1298	196	11213	304	7416	10154	8073	3099	6275	10875	10221	55911	3122	10135	6688	5315	10410	911	7086	10462	79180	25976	64127	199	84099	2268	397	3705	7127	1512	9103	1476	1193	5743	28232	5782	5199	4688	3958	10437	8301	7533	909	677	240	2219	391	22918	157	3490	3726	4000	54739	5887	2950	51177	317	4005	2212	8462	6001	9050	5742	4065	79890	162	596	2634	5058	23478	3091	51324	2647	4261	7879	2040	2023	8676	3128	5018	3557	4671	388	3055	8804	4904	79630	25966	945	55022	5538	5920	4478	2014	3119	6446	23191	4332	6036	10981	8826	7846	9168	597	1471	6452	3385	9051	2633	53829	10666	80833	3570	55274	25978	3957	1265	224	51192	5788	3684	29125	8454	29957	4940	9586	1729	80774	1475	1992	942	308	7422	11024	64114	7421	26234	3340	644	9997	953	6611	645	58472	1102	256987	6280
GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_UP	M4954		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2179_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of B cells from influenza vaccinee at day 7 versus monocytes from influenza vaccinee at day 7.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					9214	973	5790	3535	29121	3983	3495	5450	28823	974	28639	931	7163	9124	5079	2841	3507	79368	933	10863	22806	81606	3112	55081	28831	3514	8728	100293440	5026	23231	91353	91316	53335	28912	55636	23495	23062	5930	994	28902	11262	288	330	489	23157	11346	55024	120	10724	28908	10734	605	100293679	11040	5567	29064	6935	6228	1656	694	1235	8527	26051	22837	969	22800	10772	27334	2208	56242	652493	23075	971	7430	399	80183	6193	5218	6711	7994	5101	4927	3566	5287	59339	29802	11142	4609	6133	5368	25780	6856	114884	2553	100133941	11184	28951	91782	442216	5336	150759	9806	26228	11009	472	79101	26040	8202	3431	4953	3921	23613	55082	8930	57820	55893	23469	6194	55768	26586	274	54855	3915	26999	6666	2788	7594	60468	375248	7188	54977	3561	64782	6643	54847	27250	27075	55876	8440	8115	9873	10125	65982	80264	3738	640	6230	7249	10793	55840	23259	7465	54920	25816	51735	387751	57157	2113	8631	11108	5955	3708	23370	9467	4345	55278	29760	51742	4869	81689	6224	57228	25825	55974	400961	9135	160518	961	23015	60485	930	10447	22882	64062	580	4907	7088	96610	23094	5569	5244	55695	11137	360	951	9452	1875	81539	6929	9126
GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_DN	M4955		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2179_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of B cells from influenza vaccinee at day 7 versus monocytes from influenza vaccinee at day 7.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					1612	10602	10981	9445	408	1052	9645	2217	58528	1362	23001	3162	54741	942	5660	10404	5125	84034	55313	23129	138151	7867	55701	2776	6272	11138	5836	8804	221	3074	55625	920	10855	28232	4668	3613	1441	54210	1973	64411	4354	79026	1509	25797	50856	2526	2769	9759	4542	5732	11337	968	8754	8843	55647	140885	55160	7086	9586	6888	80896	9764	7071	9555	6256	7077	10221	3957	7133	10645	7779	4783	51734	80005	27180	1436	51313	5315	168544	26234	8825	23580	2201	4170	6916	79180	2896	7422	23186	7378	10135	83716	58526	2512	5329	9935	950	10402	7074	29992	6446	217	9741	2950	2180	4258	2131	30817	728	3398	1495	7305	9936	3490	7791	1839	55022	2717	54491	9051	1175	10326	23765	6386	967	7431	6817	226	91860	55640	5226	8553	8522	4043	2357	55048	4000	11000	79630	3383	11213	9332	206358	1471	80346	80762	28984	79772	84981	11025	2280	2548	3557	8741	1848	1438	9706	3920	114625	1318	2023	6283	8321	6252	467	1488	8676	23191	271	54502	9749	55911	2799	3281	114548	313	8742	7321	2876	1230	683	6001	256987	6036	5873	5829	55819	965	1050	64218	79627	6799	537	7940	3068	23710	2123	11027	6604	929
GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_UP	M4958		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2180_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of B cells from influenza vaccinee at day 7 post-vaccination versus plasmacytoid dendritic cells (pDC) at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					6515	974	3983	9214	3507	22806	9124	28831	694	5079	11262	55081	23495	23075	490	6856	8527	79368	973	953	100293440	91353	994	330	79101	29121	57162	6643	28912	55717	23670	5026	677	5450	55636	11346	3280	4609	28639	9450	100293679	2208	4082	2841	28823	7462	22898	10863	7277	28908	1130	26037	113791	8531	91782	933	28902	25932	652493	22800	7846	27334	1958	54920	10734	3460	9103	3566	5336	2308	388	961	56882	1235	220972	387751	971	969	23347	25780	3148	100133941	2213	931	7430	120	59339	64771	55024	28951	79666	114884	11009	22861	64782	5287	8930	9788	597	8932	3495	60468	10602	10365	5218	23077	3535	25816	4927	23081	23240	26586	10409	10628	219333	9665	57157	3726	51366	837	951	7163	5501	1027	23635	272	4261	29802	7188	24149	9308	6907	23508	25865	51466	54855	930	8631	10724	23094	2553	5920	55974	4345	2037	240	51735	23433	8519	26228	80774	7594	808	4907	2185	1901	3514	25825	9674	1649	84159	6480	1043	6672	54812	81030	1604	57228	11238	79817	8660	8440	8555	8542	96610	435	55893	7465	3385	23370	55840	200576	54103	5290	3099	51188	1643	64110	1378	23348	728855	9806	1265	101	81606	3725	6955	7280	100290557	472
GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_DN	M4959		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2180_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of B cells from influenza vaccinee at day 7 post-vaccination versus plasmacytoid dendritic cells (pDC) at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					5608	4864	860	26472	222161	57476	5251	2934	1612	6238	253782	5763	2322	24141	1601	192683	10952	23316	2824	25994	950	81618	100	1803	3665	8809	23657	9261	351	7169	8763	2205	9775	2776	54207	54806	2047	3563	6768	23547	27242	5176	11315	5051	8829	5660	1847	5245	10525	4209	5730	1776	9882	112399	54491	4130	6727	79073	920	4125	6483	54847	100287025	54802	4258	5423	6335	5802	11006	5445	55176	753	5294	7867	404093	3074	11320	1602	9315	23390	51257	55852	1603	1633	8140	4602	4121	4668	2317	51754	3925	191	23677	2769	9618	27090	5791	5168	2286	968	29969	4610	7357	2217	1075	3419	2896	51635	3741	56005	241	2876	3903	113146	2273	2982	55512	5818	3613	8986	23423	376267	51385	6048	57597	131544	23363	3852	5376	2672	4076	3338	54741	6574	6659	10184	3394	1428	60673	1471	182	217	10134	729230	7305	6925	9741	7295	51232	23607	29909	10512	9991	165	6197	6747	11034	375035	51284	1439	2621	55088	9555	51191	6343	5226	2926	10397	3703	25800	4855	493	667	4925	7045	57698	10627	6510	57194	1184	10788	10263	3002	28972	23603	10972	9764	9792	6272	4163	2207	3383	9936	10572	23466	10859	1845	8481	55819	2950
GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_UP	M4961		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2181_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of B cells from influenza vaccinee at day 7 post-vaccination versus myeloid dendritic cells (mDC) at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					9214	28823	973	3983	3535	931	28639	974	3507	5790	6856	994	5079	330	80183	91353	22806	28831	28912	5450	3514	100293440	100293679	22837	694	81606	79368	4050	91316	23495	23062	113791	55893	5026	9263	11346	29121	10724	28902	55636	4927	933	2208	7163	3566	969	27250	29064	4953	399	11262	27334	55081	8728	3512	652493	26037	120	5101	28908	22800	7259	11142	26040	7994	5368	55024	5579	8527	23347	489	114884	25780	100133941	10447	11009	6643	8036	8930	360	640	3915	4609	5287	23231	79101	10734	375248	29802	51742	57157	23075	26999	8936	1656	56242	2113	26228	7188	1974	23670	6925	5569	26586	8115	9806	2841	7799	7430	79666	50862	8564	60468	9873	55840	8395	930	11040	59339	79788	7249	9448	975	96610	8851	23230	23508	26051	55592	25825	9834	6929	8631	55717	55790	4345	10938	4907	23370	5336	1901	10793	25865	57228	84159	57162	951	5074	91782	10418	9451	3738	51585	9674	643	9124	5930	55729	10863	54920	1378	9452	100290557	10125	6480	81689	2530	7594	55451	3500	23613	9308	54386	55664	79677	4601	5218	54856	119	6955	5796	165	80169	6672	961	3431	58486	6711	10289	10772	51237	6879	79915	7095	8440	7572	83478	10252	10235	200576
GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_DN	M4962		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2181_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of B cells from influenza vaccinee at day 7 post-vaccination versus myeloid dendritic cells (mDC) at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					54491	2322	55799	1193	2205	4000	2934	6001	913	5445	50856	2217	64218	481	10462	753	3490	8682	3606	920	2023	1052	10376	71	942	1175	3687	4668	2776	2950	10981	11337	5763	6252	23474	408	79895	3957	2896	1471	10402	7850	3613	1612	4170	57447	1973	11240	79630	7867	9555	3956	4258	8321	7779	5058	55911	79772	3074	84790	26010	1808	9315	10404	57136	196	79890	2280	10140	537	8553	910	138151	7305	80762	10019	5660	317	25976	1438	4610	217	140885	7167	3398	28984	7414	57142	23186	945	5199	9586	79180	834	1845	87	79188	9936	8530	10105	6281	10261	23406	1212	389	3570	301	7071	7431	7879	8804	2787	1436	57698	8905	7940	313	911	4615	8986	5791	7076	11031	9314	3965	1827	79005	23191	60	5538	101	199	1488	847	1298	80273	860	5315	3987	292	6272	3383	80005	115207	967	54504	3557	11315	467	55819	3939	5584	79627	2876	3597	912	5236	116496	2207	23677	64581	79887	51192	23151	51074	2769	3643	53829	4735	2114	2203	6050	79026	55454	54741	11261	30	4637	6916	667	4005	10397	6745	754	204	9050	25939	64422	8741	1475	6809	6275	22902	27141	79641	5330	7045	6319	226	7127
GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_UP	M4963		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2182_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of monocytes from influenza vaccinee at day 7 post-vaccination versus plasmacytoid dendritic cells (mDC) at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					240	23001	1441	10602	6283	11025	7321	3557	6036	10855	5873	51313	9445	1052	942	50486	28232	604	9332	408	9935	945	953	114548	29992	6907	644	9103	5269	138151	5125	6934	3576	8522	10970	199	55160	1050	645	3099	427	26234	7378	25797	2357	54453	3162	2201	3055	10221	2634	677	1318	64114	6452	7940	29097	2512	7097	1520	64422	64174	5836	9645	2268	10437	2123	8843	79887	1806	221	1051	6280	728	4671	1436	334	1102	6303	8804	7086	216	929	140885	313	55022	10981	83716	64581	7462	6256	50807	200315	433	5829	91860	5265	2219	22898	4688	59342	23478	1958	23240	2180	6648	226	9056	834	9051	7133	7439	55803	54210	6604	55701	2643	1545	55647	912	7076	9960	22918	8462	8531	10135	9647	6643	5732	8301	10154	8741	6611	5899	55625	80346	2597	1796	64411	1130	10261	3689	10903	3460	5782	9535	79180	55313	1955	80896	196	7132	84187	1192	4048	224	4082	5920	80005	51324	6515	8825	51744	1979	3098	80830	6252	101	206358	7050	10875	3267	4783	80833	7422	8870	55654	4542	7127	57162	1514	23191	22856	8021	6916	9764	23092	55048	23136	7277	1839	3684	3385	960	8875	8073	6446	55640	4478	51170
GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_DN	M4964		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2182_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of monocytes from influenza vaccinee at day 7 post-vaccination versus plasmacytoid dendritic cells (mDC) at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					192683	55176	9882	54207	55852	23390	55768	5608	9261	26040	6238	2047	28972	55088	4063	79622	9315	3094	6596	4864	113146	8829	2317	2788	54847	222161	53335	9873	7570	8728	24141	3394	3419	54806	347902	23195	51232	23596	1776	4925	5251	26472	8140	29969	10952	10972	22837	5790	6343	23316	58516	11184	489	9601	3563	9375	7184	4130	8481	399	55704	2273	23015	51237	1847	26051	351	9500	51465	2982	1633	29760	3925	8809	23157	9618	23358	3631	1601	6483	57730	23231	1439	3799	51339	165	25994	57476	6000	6727	4953	55733	23471	29803	4602	3514	1602	27090	5037	23657	8776	253782	100	55686	3007	5802	1803	404093	5641	23363	6513	22882	2683	10099	23480	11006	5423	55146	81618	6335	5116	81539	4855	10521	100419017	8450	57062	8346	6929	5294	11315	23547	28978	2969	7169	79073	860	8763	5931	10396	8473	10397	3507	241	23423	79677	26999	8339	5051	2055	6935	946	51303	10982	8115	23607	376267	5730	81606	375248	26053	92482	54802	11034	23253	3662	2824	3338	2739	6689	221692	10959	23062	3921	360	5479	3899	5380	54585	2621	7357	5383	84864	4649	8343	2286	3741	11320	51385	10653	51754	6925	6224	60559	23241	6748	83737	605	23468	9711
GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_UP	M4966		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2183_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of monocytes from influenza vaccinee at day 7 post-vaccination versus myeloid dendritic cells at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					929	59342	728	5265	10970	51411	83716	1545	1520	8825	9445	80896	2526	64581	23312	427	334	5660	51363	9332	948	8875	9056	1848	199	5732	54453	10135	6283	216	51313	6280	3267	1593	200315	10288	2512	3482	1462	8609	1509	4126	4688	683	3916	1536	2180	7133	2204	10184	3383	6653	3684	8566	9764	8897	7086	10313	10326	2799	10924	1514	6604	6386	6310	5476	4179	2219	23166	5937	7378	3162	3903	113791	8291	29992	29097	2131	5836	64114	2153	55303	968	64411	10129	960	3034	26037	1378	978	25797	6648	2752	4792	6279	4048	50486	5226	1958	3105	3576	57515	677	4354	7832	2201	26234	654817	8878	10602	79745	2920	23236	22936	7321	7941	79789	967	23303	51734	7439	8932	2517	6556	2212	51108	81619	23129	1441	54210	28232	23328	6643	353514	10159	10577	2869	79056	1051	58528	123	58526	6303	57192	55340	55332	1843	4814	387	3176	64757	55062	665	2123	3958	64174	3106	10423	8843	79887	1508	719	10365	8870	7402	7739	57162	432	25900	644	831	53826	2015	8804	55160	6934	6856	8507	55625	27163	2919	8685	2745	4601	9473	3134	2350	526	4689	11213	6916	8569	10043	55654	9341	474344	5149	5806	79689	124583
GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_DN	M4968		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2183_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of monocytes from influenza vaccinee at day 7 post-vaccination versus myeloid dendritic cells at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					11184	1193	10863	9315	10409	57447	3921	5037	913	8363	5445	911	22902	8530	23157	6228	3606	2322	966	8030	3695	7850	9124	1298	3899	8682	26355	2934	81539	6001	5641	79622	946	10462	5464	3094	9805	3111	910	23468	6193	214	5305	9934	8339	65005	3561	481	9734	10360	3150	11224	25873	25842	558	653784	3097	8809	10653	26010	605	4261	1265	2171	9249	6133	114049	7163	8342	3108	53335	2205	11251	6187	5567	1235	10276	51703	55661	23225	5058	93144	6513	6143	708	79077	7405	29103	23118	54733	3008	3122	8445	3159	7531	8481	23531	6711	23677	894	9844	8329	3276	10123	8331	79080	3984	7110	6175	79895	3687	6636	3113	80221	8776	8924	3092	8364	9538	3205	2665	8355	54509	5547	442216	8344	25939	377	23015	3516	25966	79864	274	8345	3006	6666	3123	6633	64110	51466	28951	55704	6635	3009	9467	50489	204	28955	7380	27141	10949	55799	10666	3115	28969	11161	4729	2199	81552	25849	8354	2197	5236	5216	5583	6124	26123	7416	6935	3017	6194	1880	6224	6204	3128	3662	8346	6767	7414	100505761	79877	10397	2091	64798	2037	971	221692	101	3112	4723	27334	738	471	55024	10314	1471	6472	23344	51386	3033
GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_UP	M4970		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2184_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of plasmacytoid dendritic cells (DC) from influenza vaccinee at day 7 post-vaccination versus myeloid DCs at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					6925	26040	29969	23390	54207	23547	3394	22837	25994	7357	8829	192683	5176	27075	55733	4953	1439	165	9261	5251	2047	23657	51237	2824	399	7169	80183	9873	5051	79677	10184	360	4130	24141	51465	92482	3903	23316	81618	3514	26472	6483	54847	3512	5423	222161	23358	351	1847	3002	51232	26999	55768	51284	3563	11006	4602	5383	375248	55686	5802	79622	23607	6343	28972	2317	9500	6000	8473	3925	5790	3507	8481	404093	860	57476	3482	112399	27250	3419	3433	55852	6929	4855	1602	6727	376267	3741	1633	5730	6238	489	2273	5479	5579	375035	9618	4925	100419017	6574	5608	8115	9991	51339	8851	7045	11083	11320	26051	23231	8140	51191	8728	8763	29760	7184	9882	51316	23400	5168	23480	4800	10950	1240	5379	2672	1601	1428	23062	375	654434	3916	55176	10952	113146	27242	8936	9375	253782	54806	6335	8564	5355	3852	26053	5380	8237	55512	6196	5341	10577	10099	51616	56889	7915	2621	10518	25800	100	57730	241	11145	27240	2181	950	51385	3096	6748	5754	29919	22929	79567	9601	29064	23604	4121	11315	53335	8836	23002	5368	22882	10525	9934	6747	64764	8556	552889	3665	863	2683	10477	56112	55351	81606	1536	51257	2788	9583	57728
GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_DN	M4971		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2184_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of plasmacytoid dendritic cells (DC) from influenza vaccinee at day 7 post-vaccination versus myeloid DCs at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					481	1193	23478	913	55799	79887	313	196	7462	9103	945	3557	1052	3099	7097	5265	2268	64581	834	8301	4940	9332	50807	1051	3516	64422	942	8531	334	101	912	3687	7940	57447	11031	3385	953	1806	10462	8522	408	11213	6907	6252	87	5269	4000	4261	10261	3958	10437	27141	6303	8321	5464	29992	224	1465	2665	11240	199	138151	23406	7416	51192	1955	2597	7167	79890	677	202	116496	10105	7846	5742	10875	50856	79895	9050	2037	689	490	4478	25966	1130	3965	29125	4688	29097	5920	79921	10903	3606	1298	51466	7076	9647	5199	80833	8819	8462	6515	7127	8530	9450	1475	1102	4671	51703	114548	2123	391	5291	23199	1462	2316	3055	3695	3987	64218	2219	4082	6452	1979	10981	53829	7850	79180	114908	9535	304	3689	911	303	301	5547	140885	6050	7204	10581	115207	2212	1512	1471	231	10797	64110	3678	6001	4242	23287	9124	6275	302	60481	5058	9051	9046	604	5216	6611	10410	55911	23526	427	7263	55022	910	6446	10409	2014	6281	25797	11046	2534	5734	1958	7277	1027	3956	3398	3939	71	3553	4332	8542	8073	10863	317	3984	1265	6397	80005	10154	9249	308	3122	79854	28984	1436
GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_UP	M4972		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2185_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of B cells from influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					54858	1036	4000	1232	5327	8549	26084	23481	50649	27445	4488	6862	9175	51751	9751	8557	1395	5976	5536	2696	23474	64393	8532	6491	1671	7289	866	54454	23539	54836	1259	7678	3218	26528	10332	6276	57596	55466	2303	10068	55742	79038	230	81555	5333	1004	3067	570	55806	100288007	3227	9148	6494	100131613	5097	4147	79714	3664	54976	60528	4327	2810	2117	79161	79789	6091	1072	1312	23466	55620	8440	9607	80099	3671	57134	1464	29107	79903	9267	26659	5644	51093	55663	9902	2218	5784	7076	26290	9079	7059	5754	114088	64663	55258	9277	922	1382	5178	482	221960	182	55168	169611	9071	2646	9912	29781	51023	27296	25769	5304	6924	9960	2301	57447	899	6696	79072	4976	79135	7733	26664	9900	78997	8879	2356	221078	59343	1381	79444	78995	26285	5629	155	100288809	56901	2622	81628	5864	29108	8940	363	5763	9051	388796	51179	60484	7472	10763	84909	91298	53919	79671	10311	10501	146542	799	577	2200	1944	2275	55643	8835	3291	1370	79228	10498	51471	5132	80741	374819	1103	10647	79809	2817	4212	55285	5334	6441	56984	7021	1373	10602	7869	1443	9719	11314	646934	7372	7148	23498	10799	4209	11018	81563	2009	80776	9673	757	64757
GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_DN	M4973		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2185_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of B cells from influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					26263	54431	5276	79101	55227	400961	57804	23037	9270	57820	5930	10962	23139	8654	6185	9941	10847	64693	10641	2034	1358	8939	78992	28981	5515	10987	4259	23583	2870	2492	3626	10038	55033	159	5289	5830	90355	79991	59349	8565	89874	7270	51647	23593	54901	23020	2909	89910	1070	79797	25956	79915	953	56171	100286895	10555	23587	79654	27115	8347	8449	3551	55888	55867	11080	36	2074	11047	10201	80198	24140	100293679	10980	51499	7515	7692	8881	57821	8698	2178	9871	644128	1794	54955	7156	55003	286	2548	386627	9232	9690	100129361	100293871	9697	634	7351	23658	10574	63874	83439	900	253512	55114	23647	90957	155066	551	5998	3848	5911	6879	9108	7694	5794	2517	5277	55106	10460	81693	3073	11335	1490	90410	100286972	23367	79703	6539	79970	501	63897	930	54516	2890	5626	6450	414918	60561	699	4331	10946	388567	92483	10528	51507	114881	10463	3320	4288	22933	2317	23261	734	27004	26045	11142	5203	25801	4163	9967	254102	7398	94025	50717	6616	51663	442216	5697	1277	22916	3755	54505	79685	175	7754	10060	23787	288	2274	10587	10762	9123	3198	60684	22795	10634	84726	4090	1364	54165	27299	26071	5881	56882	79269	1068	9205	7529	3305	56969	4717
GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_UP	M4975		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2186_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of monocytes from influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					85458	9819	6095	6424	51360	3891	11096	55203	29844	580	4998	23403	79065	11228	1839	55280	57348	728621	5473	3742	1238	4061	23035	79033	400961	10466	7005	51016	258	2355	29802	5479	7543	80024	6617	167	54538	100131613	2740	1285	5778	10019	8706	6847	10691	56	2645	4015	664	56302	768	7187	9922	10497	81490	26018	56986	1105	3170	942	64180	5125	58483	54676	1999	27156	100288413	6387	55713	730	270	57644	57118	66008	2822	6339	51124	10207	56667	3467	10094	51035	51444	7681	23704	80052	25819	3984	4430	9630	64130	11135	23099	83737	7141	4856	26145	369	25907	81029	79589	5346	51673	55669	5968	152015	64788	7189	22880	80831	5130	9020	1003	6853	157680	79891	51678	55735	5475	50486	81854	3250	2878	55339	3091	83786	10308	10570	4640	51145	5697	11172	79058	55612	10472	8000	8360	55194	79870	2492	78998	100129648	4209	4058	400084	83942	10444	100093698	3028	11015	55064	653483	1758	1540	10758	23430	57604	2475	10672	4025	7752	6568	9808	56886	80704	10930	10224	79750	2526	54558	3991	1469	2840	27099	64850	5267	10842	693207	5650	2591	1329	1264	23446	6926	55088	4781	83468	23263	5730	23113	56604	2072	3452	266	6723	55744	64359	124	11318	56128
GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_DN	M4977		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2186_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of monocytes from influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					84747	9592	79658	10003	57610	8512	79838	5146	1958	2936	196483	1584	57096	1438	26024	57805	55732	64210	85476	23352	6426	29902	171023	51205	55112	1186	4591	11060	8904	79960	1062	6166	93643	3376	9470	3275	84986	9534	55734	6785	57130	27257	78992	114882	51567	55471	6351	27180	29888	7768	2590	10985	11276	57035	26285	23304	5872	51278	378	7277	55094	10254	55751	4609	29081	6434	915	1261	766	51719	79611	9466	11346	91316	9477	27165	51227	51409	1690	26094	171220	64766	5514	51340	1316	9807	8864	6150	55885	7832	644096	6694	5529	57147	317	317648	28517	29121	11180	51455	7763	55850	9871	90199	10324	9344	64411	7514	7124	5498	10523	22990	5729	4548	3303	54716	89870	63875	25842	1954	1646	256949	6652	10540	9668	29956	3775	4707	9833	5928	28955	7126	25980	8846	26015	25900	23137	65986	7743	799	8672	8794	9469	55215	528	23019	994	23259	1912	856	9938	8302	7705	5394	4211	4352	150	60676	116039	6871	7779	3838	9185	80209	58526	7673	23390	5709	79740	9942	11076	23513	7336	51208	10213	8458	9332	51433	29937	7386	54878	79701	7639	9442	23412	343071	57018	53905	286148	51517	5188	25782	10611	25974	9013	7637	4221	55347	4064	6432
GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_UP	M4978		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2187_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of plasmacytoid dendritic cells (pDC) from influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					54769	51087	4993	11043	29842	3217	131601	4821	63973	3795	358	2887	4293	126299	6514	23293	5801	1103	1659	64411	27190	114112	22989	5357	3321	6543	1183	55323	376412	51286	11013	81027	8330	1828	58511	30819	79038	23660	29851	11135	55937	4892	10650	51176	10202	5064	26333	56926	80271	978	10599	7490	9379	79034	80210	3352	56891	5774	6457	9311	80700	93	89	10255	8456	11022	64582	11133	147912	462	11095	135948	55658	3617	284800	5054	212	8483	9351	60401	6327	4043	85294	65987	6326	22921	84107	6370	170679	54853	222255	8567	3773	6663	2662	8549	5789	8419	55054	2294	53405	5125	54101	9894	83716	55798	254531	24142	26658	26212	85021	89797	2904	26470	54959	6861	8614	4018	56834	3816	56300	7018	57473	159963	10548	11094	25907	7098	53844	84789	3484	3670	6300	11194	63978	95	3817	11004	4224	400410	4969	6422	64063	79047	8735	55333	8544	732	645961	54538	2115	1421	9333	2065	84033	23235	5193	2537	79144	1152	79366	3975	3488	57093	11251	10380	55209	2202	339479	7125	79006	147	6869	474344	55841	81577	7283	100129271	4071	54566	142684	80108	3897	65009	5999	23187	8940	54920	9027	729799	50859	80737	57608	4606	1813	65010	1369	146712	9671	11037
GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_DN	M4979		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2187_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of plasmacytoid dendritic cells (pDC) from influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					23325	55131	1967	4087	23595	26046	138050	6883	3093	23613	90861	26054	4218	7227	6671	317	55840	9092	51566	9554	5051	404672	6885	51021	8741	51009	402055	6129	26168	79682	5510	5257	10480	163	10162	10892	51560	9887	23360	6209	8884	1633	79665	3837	23178	4682	51111	9810	3836	9025	29115	26578	6850	27301	79882	54407	10154	2630	8411	3566	10318	9049	51347	54847	4659	9453	829	546	10243	4144	56267	3035	55669	55144	4869	6741	5048	22796	53827	4350	11171	30000	8661	11124	55148	3356	27351	23596	1347	5529	5437	9354	1965	2589	84864	79641	6432	54765	11193	11278	3965	23272	79134	23092	80167	3184	51406	55589	10381	11064	6194	283131	124801	1386	11123	7270	10475	3065	8479	51121	55911	51379	4690	92482	4205	5937	8564	26520	3626	7694	55819	9694	8539	27348	23361	10150	23588	9169	29969	2776	10955	51663	26608	51493	1316	23593	8241	4802	51241	79147	1861	51714	55661	9140	1536	47	79982	286451	54386	26279	51317	23476	1983	10808	154	2778	9364	55711	8896	26191	1314	55285	26263	51071	1654	5305	51393	50804	5019	55511	6000	54813	7175	55374	55159	26999	2186	3985	10712	4261	5930	2935	5754	8624	53335	29890	55957	23460	659	5683
GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_UP	M4980		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2188_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of plasmacytoid dendritic cells (DC) from influenza vaccinee at day 0 versus myeloid DCs at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					54957	100129482	55777	30845	2826	6566	596	57399	5569	152185	8936	7023	4223	10178	145389	23116	360	6718	5133	10102	6320	79690	23253	116	9344	79022	7711	79019	54891	8614	64097	9583	1836	57535	28673	23657	23189	51716	8187	83444	81563	26033	5783	8328	5168	4988	8829	8986	4293	1950	225	3892	79635	81494	55478	5819	51090	5528	4800	4118	4004	51435	2813	2902	2030	2568	6925	54	1238	5802	3790	991	54207	54546	316	1200	4130	3702	2690	9674	26271	2132	8851	8065	460	27075	51334	11346	83988	574	6745	4091	8756	55758	24137	79989	54893	3514	55150	54955	1915	26082	7476	1437	22994	6559	3742	5730	27147	55451	53841	11082	1907	1000	56926	4946	54472	1236	27181	5625	6247	1824	157697	10382	9214	5954	56311	80764	8396	54901	7752	6895	10894	23220	9623	55890	2247	9754	862	28999	55703	7357	3751	84900	5251	3758	2591	5243	11013	6712	7368	79792	1956	64118	5744	57213	653483	10716	390	5337	759	7761	4157	814	4049	9422	6531	54532	7363	2538	10849	1421	27240	2632	55638	3929	115123	59343	9232	196740	80323	3512	79175	27120	1240	9134	1281	6368	10324	10046	270	5375	9807	375449	567	51540	63974	10418	6363	51339
GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_DN	M4981		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2188_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of plasmacytoid dendritic cells (DC) from influenza vaccinee at day 0 versus myeloid DCs at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					4898	10802	3848	8819	29902	1958	51727	6155	251	56474	79137	9238	262	8611	23221	6432	3725	9603	5584	7439	79877	51278	2932	7221	3475	443	11033	6001	1945	91355	23513	4619	51227	56928	28955	8891	10383	9922	156	9600	1138	6870	56943	27124	7903	26039	51026	6671	3283	7768	645745	2734	5311	6508	1606	2794	10856	79097	23353	54897	79718	79632	1727	10551	79895	54952	9730	6098	8189	23151	223	9683	55048	22908	5893	8925	22999	57720	10016	3882	55014	51306	37	2339	138151	10023	9652	196	79005	3839	9450	1891	23358	51705	29923	4143	55157	7248	3654	26151	92170	9760	8654	1316	2773	51115	467	115939	55252	115207	91775	23395	4261	10370	51004	6950	56915	9046	8667	58500	4860	1982	10295	5514	7940	79663	5331	3784	1389	4625	9776	1843	4494	1056	2172	678	91316	5361	26523	30820	55016	55415	728683	23592	84890	7982	8672	386627	6742	2287	1856	3939	10618	79898	23506	5428	55119	10379	23376	54870	79188	3456	5599	8664	387263	51192	54985	79230	8529	9526	1443	79875	11006	1397	80007	11278	929	11067	54455	7322	6894	4853	81030	84908	2060	11186	8420	23363	6942	6406	1441	10381	9270	23499	2155	3449	55853	23294	1145	7080
GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_UP	M4982		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2189_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of B cells from LAIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					56984	23474	23379	8879	100131613	602	9960	54454	79641	26084	7251	1671	23481	22861	2799	100293553	5754	3842	23539	29107	8532	3229	7013	26528	23625	9905	51696	9131	8834	79789	51093	55113	6670	9525	246243	84909	9129	22850	5536	56270	375449	6276	79903	79718	10514	64318	10553	57097	4488	6175	6907	6799	9168	4000	11157	23466	885	711	26093	94239	25809	5976	51296	2014	7525	8605	26285	7189	79809	23200	2275	9535	5333	24148	2622	10723	4839	55692	4147	10671	56947	266655	5886	8462	51187	831	10269	7289	3516	64780	7873	29108	51003	6224	11018	4734	596	5685	55727	3635	10865	81631	7260	1892	2919	55014	9208	57556	29781	8549	1267	27089	4850	9533	26952	399	2197	4710	10975	81628	51271	2134	339044	4327	56915	8533	54469	57634	64689	1589	2720	55092	84617	7030	221078	9902	4591	10845	64320	9470	1716	56271	571	221960	462	2526	22992	10463	9938	3843	6862	26112	5339	1373	54858	64112	51592	79714	391	10428	2987	55051	23225	27125	9175	5805	3882	905	2646	1308	6369	64784	3663	22884	23609	55034	79228	80124	9852	158	50508	2995	830	6491	60528	89927	10632	9693	2218	64174	1201	5936	9051	10472	58526	2067	23258	9422	29094	3858
GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_DN	M4984		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2189_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of B cells from LAIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					9941	55033	22795	5276	10962	26263	3861	1628	56548	10847	400961	100507605	3800	159	55867	551	55133	5998	100287927	27178	63874	23331	84079	388567	89910	1068	8601	79101	54955	79782	64693	79723	22891	3725	3567	9871	80324	627	2564	28981	25896	5617	253512	472	5794	10570	2669	2542	26118	4907	8913	51454	4060	91775	220134	57213	2305	9781	5664	55612	22925	23261	25956	83439	55227	6616	22933	3212	7106	2627	3702	118433	11131	164022	4240	7398	7276	4051	84864	36	4116	6317	79915	51533	9044	152185	9270	55081	54431	55079	2674	57115	55624	6041	388969	442216	9753	79605	78992	1209	81693	23170	4014	1525	80067	390998	27115	56967	10038	26027	57733	4889	10201	3241	1949	53841	4674	5881	22916	54505	54954	55353	115201	51806	6364	7010	79170	2277	1474	56999	639	10249	1364	2178	56100	26173	26539	5099	2870	10587	26065	64849	3073	55777	28785	6539	51327	5860	10641	6540	25945	79413	2074	4288	9696	7083	7429	3297	9248	23787	81839	3069	940	10552	93436	930	51540	5165	28990	11012	23617	2254	9402	1140	81890	79018	65125	6284	50835	80352	23020	2587	100128640	6734	6745	92483	6524	6572	90333	100133321	414918	11231	80111	5859	54958	8938	4681	56848	100129361	55805
GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_UP	M4985		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2190_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of B cells from TIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					7678	2696	1004	1759	79718	1081	3872	8557	51751	81555	3790	23616	90627	1909	3487	50649	8322	41	25984	2568	265	8644	9751	922	54858	2160	23612	1464	57447	5449	51023	10053	79633	6906	1404	131	64393	1233	10900	1259	4072	80761	757	23281	78997	554	633	5775	6285	1036	27445	1382	866	8427	79842	55714	4885	4606	9242	84440	57731	4886	2660	4014	8532	55655	2891	3075	375035	6862	1232	2017	2516	10332	3854	3010	55742	3671	23629	8290	3850	78995	8549	5947	5097	3213	8835	4488	7733	22996	9421	169611	65009	3782	51471	55806	55258	9912	2621	10107	4110	25769	54505	570	6425	3084	53919	1501	4607	10736	7490	25977	6863	5178	9781	9718	51046	80243	11330	7005	64344	5251	100130354	80177	54836	8840	6964	6573	23366	144404	577	4292	10816	80224	147	7561	2859	91977	5784	5697	283345	6696	79173	3589	4040	51145	8756	10682	8029	1215	7482	1359	79935	56667	6441	26082	3664	4763	81494	2901	246	85452	6198	1443	8586	1142	10439	8325	27113	4745	80764	9900	220077	27120	27091	81563	7706	55247	3400	3237	4112	50626	100288809	146712	361	7991	11004	5241	1238	11254	5408	55966	3568	27132	3744	10848	5540	5506	108	5133
GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_DN	M4990		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2190_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of B cells from TIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					5515	23647	94025	79654	54431	57804	100293871	1358	26263	8939	23272	652493	55106	23139	23583	8565	644128	5050	53838	6185	55227	634	79991	7756	5955	56943	29796	79797	3551	3661	23429	5276	9232	55259	2909	55003	64693	27089	26999	8654	54516	80007	8347	4259	79101	900	23256	27348	5203	734	9123	23061	5930	57820	55705	50717	6450	56882	23450	51643	9270	10460	4253	59349	9453	4152	85363	4621	23518	10059	10308	4331	309	8999	10907	57553	51466	155066	10168	22818	9818	7185	22981	51480	7694	10276	100293679	3626	891	5289	51741	1432	9108	9870	7270	29998	23248	8824	157562	6146	7692	5743	23760	27115	10945	51659	91353	23593	6293	28981	1072	54793	7755	57118	79960	7984	55116	100505741	1386	55012	25874	4600	51088	4282	23587	51116	386627	26509	6396	7580	1456	26000	272	55603	92856	51647	29094	54882	56171	79844	9352	55033	3344	55769	3198	28902	51009	10445	11080	8337	9158	22837	100129973	1337	5368	2992	6428	1039	254102	79970	57097	5580	51019	10150	26088	2517	10746	11165	8209	79913	10949	11047	652963	6018	27258	4677	9697	11142	501	2647	54438	6128	3305	3006	84164	6668	10733	6129	22858	5201	8517	51377	26045	8412	5429	821	23212	662	2110	64975
GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_UP	M4993		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2191_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of monocytes from LAIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					6424	2740	7932	2475	9423	2355	4118	1285	79065	57118	100131613	1059	64788	81854	1051	3091	22880	10019	4209	258	9819	2034	64750	79000	1105	4335	9021	6723	26239	63898	55280	80301	7078	100129648	23563	2244	6892	2931	23403	23035	79797	1380	10169	23562	51050	26018	3984	55203	10594	4160	54469	7005	4794	5473	55735	54886	29959	6452	23430	9911	5651	55236	977	9922	23099	51271	51224	7166	6339	3742	64320	6519	80271	66036	1540	57348	11135	6237	53916	580	29115	4680	100093698	482	5778	27351	3250	2648	85458	10519	54842	2787	6853	51673	79719	51145	10281	114	25859	2014	2668	10141	27156	55096	11318	29970	7189	79033	6181	56302	84164	2940	4926	11096	10094	51428	51026	10207	5916	4430	80024	4998	8645	4015	5430	11264	10978	3801	55339	490	3111	4779	64849	23600	4061	11187	11228	10123	2729	100288413	58483	55713	6786	9546	50814	25793	8801	51035	7102	57172	140459	3891	5125	29844	56005	9437	55544	51360	6036	152015	55635	643314	768	29986	4640	5049	2020	1469	83468	6604	5528	7305	1025	377	2987	7023	10497	1630	56128	54676	283131	6649	6387	91977	51293	5032	9639	64776	6613	10923	11006	10691	4815	7378	83942	7301	81029	273	3712	1315
GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_DN	M4994		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2191_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of monocytes from LAIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					10003	1690	81931	6166	50628	5529	79658	84747	54517	29902	55812	6871	5729	57130	28517	9592	23394	55313	10324	9807	9172	4261	25974	114882	55787	55172	26285	678	7126	6434	10439	64747	695	317648	9466	25782	116039	3083	7763	7705	55734	57096	7768	79960	1958	7443	57610	5635	8458	1062	2971	8110	4211	23544	25900	57035	11073	23352	26094	55732	2289	8512	4155	54865	23176	8864	5728	64210	2354	196483	6351	6233	283	6747	292	1657	64397	994	90333	79701	54716	23506	9668	3725	9039	1180	1130	4889	10951	10610	7594	11057	7832	3569	9534	51575	79670	6138	23314	57613	51208	79772	54432	84986	8487	55094	22916	56034	79740	81034	51719	3303	7164	23380	6785	10611	11346	79838	51205	1186	6256	9860	57018	9349	23032	64425	51278	317	526	25980	51292	1902	284649	9221	54878	6601	55907	10495	10528	4668	10213	6310	26528	1843	6652	4352	81554	7058	10491	23508	93643	1796	79752	60676	8935	3838	2877	54499	8794	4301	23163	64149	328	171023	55759	22878	7957	11060	8890	11104	10347	7462	7769	7879	6883	55850	65018	3843	6503	23224	224	1983	91754	58517	55175	9581	57720	60684	8496	5990	56915	79048	8851	5146	547	55246	5203	8449	4591	651
GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MONOCYTE_UP	M4996		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2192_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of monocytes from TIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					1839	3170	3705	7543	57038	387893	9991	8360	3587	6617	25819	1131	85458	23704	26548	7681	7754	6095	51016	3742	8428	57502	54209	7545	3891	10672	23554	79074	2035	79058	6424	6712	5874	2526	66008	1431	9726	7314	53905	79033	6631	10121	148753	6533	23436	9895	8123	64063	11096	1059	54558	162972	51360	152185	23218	23475	10570	23510	730	7712	7187	9630	29844	285596	55280	7141	55203	29802	400961	55966	10005	9851	10824	2746	6430	412	80052	8706	11228	6205	4998	3036	118987	4322	80155	3218	5741	2569	4693	63897	56986	4236	1264	219699	51626	2645	22872	1238	23152	5697	54856	79652	653483	23446	664	9210	2239	79188	57379	100129482	56667	5475	4312	79589	51715	50486	4507	369	10214	55909	6295	478	730227	5740	56729	570	7752	81492	10864	8705	57348	680	63035	29066	1774	157680	19	10472	100506898	55025	9342	11054	83737	50836	4610	1060	962	6884	3604	4739	1329	2161	11194	5273	7490	3166	10645	26030	10921	5530	53918	10210	3208	54103	23029	246	1366	339479	203068	9457	10327	54798	2785	201229	51741	728621	346157	27253	64208	2936	4061	3600	81887	55713	80232	7020	57000	84060	60509	10135	28965	26145	57082	1140	54538	80206	10625	167	79720	7037
GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MONOCYTE_DN	M4997		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2192_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of monocytes from TIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					11276	6522	9592	85476	915	4221	55732	8512	150	10548	51517	1261	57062	57604	29888	1743	79611	63875	146542	91316	63894	8796	653238	29937	4919	238	4616	5709	55321	5195	57610	79838	8355	51557	1438	26024	10614	6426	23160	9344	775	56061	10985	100129460	79567	23098	407	27257	5479	381	7171	256949	5168	4591	55112	6335	6351	22889	5345	10301	5819	9790	196483	84747	10302	27071	4707	9493	51205	7124	5587	1312	64766	9469	59272	3104	10467	79658	9097	55324	79097	3275	6785	10538	22824	2242	63906	2821	25828	89870	65992	55471	3603	7439	5498	1954	83714	26289	5028	55011	56271	57147	23647	2968	1646	644096	28955	23352	7205	9399	171023	6432	5619	64419	9322	51728	7376	6830	10936	10954	3635	79767	2564	7637	7062	80254	5496	5826	81873	5146	2882	50	23137	55743	1384	58985	64210	3069	378	1212	5627	2865	55182	9477	57096	9100	6385	23550	25849	2314	3376	114883	881	10090	54979	11060	673	23231	56920	7743	57613	2661	22839	5193	11103	22982	1716	4012	1380	1503	60626	27349	343071	11126	57805	8347	2295	11180	28966	79685	64219	23558	81631	10147	64411	51278	4352	58511	78992	10786	57017	4072	84364	3954	645784	8848	93643	55006	81698	1120
GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_UP	M4999		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2193_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of plasmacytoid dendritic cells (pDC) from influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					4993	11022	51150	8572	1828	51806	54769	2887	85021	6445	60312	56891	29851	29842	10368	6318	84759	11037	135948	27023	7070	3350	65987	10255	55658	51176	23660	3488	346562	64582	1152	51198	4293	2069	661	100289053	29948	93	63973	10548	57493	7490	10202	57105	400410	978	2785	11069	3217	7984	29802	8330	8997	26212	7003	1539	11135	5357	4232	761	4352	5054	4915	23178	100133941	6579	55040	1620	30819	5064	2104	3358	100287387	858	3795	80700	126299	100128640	6663	218	6641	55303	7349	2019	51361	1183	7634	2896	4071	51087	79132	269	51005	10551	257	55323	5550	55615	9087	56926	358	6091	79680	4477	8178	55103	147912	8863	54809	100132341	55283	9547	63978	4661	552	29931	2158	56667	23263	64411	27115	11095	339479	10864	57151	2696	212	6869	3202	54956	7471	3977	25865	5657	50487	58511	8718	9513	3347	2115	1525	10053	3803	3556	100130354	8614	26470	8483	22941	1103	6474	23293	283212	80210	51286	84107	462	2779	1608	6489	54853	64795	6286	1842	4010	1068	4892	60401	6674	6366	9311	6514	2904	57235	55576	1534	26333	913	440560	5733	3834	64919	26064	1293	1369	55640	23627	25794	4153	376412	90233	6355	27190	23139	22989	80059	5865	83394	8772	9351
GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_DN	M5001		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2193_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of plasmacytoid dendritic cells (pDC) from influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					23595	1967	55957	6883	26046	26054	7694	79682	5048	25782	829	55131	54826	102	6671	6000	55165	11222	5051	51566	23613	6741	27075	55732	83478	10211	5937	23325	5955	22868	80184	9044	55269	7320	5516	10528	55511	10381	3676	5019	90861	114044	10892	5799	402055	10808	55257	2778	5257	10383	5580	51021	57035	6885	79882	79641	9025	80167	5532	80071	38	51009	10654	10495	3475	10480	26168	5437	9640	27229	10955	23317	3836	23596	57037	81539	5090	317	57018	4144	1666	54847	1657	5728	23020	51493	3295	80221	1974	3364	64324	214	94134	55144	9204	79918	51573	6328	10640	23164	7447	22884	29115	118433	11064	9448	1880	3717	51646	60626	55148	54700	10440	4802	53616	85377	83941	8881	404672	23279	372	3685	1983	7769	1316	22976	9857	3394	10109	832	5250	10184	9197	50804	8894	6850	150094	51741	404093	23460	8539	100288941	29919	523	25840	10009	8896	9049	8564	81552	22915	55819	3985	51520	222161	59	51012	55171	6335	64343	8317	26608	3566	1797	65123	79147	2004	29880	3093	9939	1997	54726	3035	1847	163	10956	8728	51121	55285	8773	23042	7922	79134	56267	54892	10010	8509	2047	84864	22796	51068	25792	124801	6431	5688	6450	9020	27351	3915	1066
GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_UP	M5003		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2194_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of plasmacytoid dendritic cells (pDC) from TIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					51806	6543	4043	4974	79893	1803	1659	3321	55209	30850	79034	54922	81501	8549	10755	54555	8567	5774	8574	55872	5002	55841	3897	54769	54957	2119	8893	57794	1969	6406	23293	11043	343	64063	9780	6862	3816	474344	4978	29110	6327	7702	7056	5023	3441	5320	9081	79091	3938	3817	182	9120	23329	100507249	10692	1660	9960	26471	732	80144	8841	9627	55038	3934	358	57473	6457	89	55888	376412	5351	78999	10990	28755	85294	22989	9906	23646	8602	57172	55323	7018	57192	80705	95	8839	51087	7596	2878	80201	54959	57093	89797	79811	353299	26658	131408	3973	29842	159963	1103	7376	3174	55612	11094	9260	2694	54531	3217	30837	79807	284800	7855	4293	5357	8749	57338	26333	55195	79363	6443	9509	55037	64423	7766	114112	81490	55647	6514	5053	9902	23235	10650	65010	55764	81027	11215	10224	56649	4776	5346	54978	2767	7142	9427	27129	56981	140467	3795	314	54985	1543	7629	5128	9968	622	11013	57710	54925	11330	55054	80737	55810	84444	80054	9730	63973	375790	4793	31	29079	6573	84830	8504	27034	27190	25787	80114	11275	9313	2041	20	496	4176	55937	64411	79047	80271	1420	2528	79366	3815	3972	1370	26232	54566	51673	7695	51622	84733
GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_DN	M5005		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2194_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of plasmacytoid dendritic cells (pDC) from TIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					30000	4087	54813	10280	7227	23325	9169	2589	7126	400506	90956	11278	23199	3093	10165	27301	4869	8365	3965	8345	55131	51478	2140	1488	5589	64319	1519	283131	8661	51491	3661	2771	5885	2702	4218	10243	10712	6811	1314	58516	79630	55248	51393	5929	8175	8420	4666	5529	546	55711	7094	7025	4026	3306	138050	4616	4350	64393	23332	51347	10320	51111	404672	23476	26263	64344	83442	8344	8125	8741	3796	79877	55911	26001	670	51560	5202	23048	11123	80150	10767	3836	8346	7337	7553	10766	3017	23092	9092	2150	9887	8337	7077	55589	3339	84619	2776	402	23741	8815	9497	114049	10928	388	1981	9472	83737	5685	6688	54815	9694	10116	11273	54856	4046	79177	90861	166	23762	4803	9949	163	5719	26118	23059	26054	8651	51319	801	7533	27316	10066	29937	7040	55213	1565	25977	79670	23513	26168	10475	317	4967	57579	8884	6141	3689	10927	969	9354	902	6880	6167	10072	7029	7468	5007	23360	51282	11224	26155	2962	2020	131566	6480	9401	63891	261726	8892	51651	23077	8910	64960	26013	3588	9759	4940	8364	79665	11193	7288	6472	23518	6143	5062	58	9453	4690	3837	5216	23613	26469	2981	7327	79834	8634	79590	5147	5886	26515
GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_UP	M5007		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2195_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of myeloid dendritic cells (mDC) from LAIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					9674	64328	9855	2690	25893	54957	711	2632	1472	11061	9945	26256	5080	79751	2030	11262	5134	11066	10101	4038	28673	3790	91120	6631	5468	154661	5819	29957	56623	115123	4499	6718	10324	5168	10648	57634	2826	23460	10178	6017	441263	8038	51016	6642	55253	10594	1236	5733	5664	3892	5208	10923	10716	441601	51164	63898	11043	4067	27240	152185	81494	54956	10525	375449	63928	7634	80161	9370	54842	24137	7188	51716	7941	8829	79022	2280	30845	4118	50807	10950	254896	2813	596	9232	7543	140597	145389	64405	51435	54546	100129482	5569	4800	405	9333	57707	1837	80776	64220	10420	360	58986	18	4685	56311	1836	25780	83637	51321	57172	8605	2475	55970	8487	574	8936	81563	3433	51552	54212	1200	4988	100506190	8187	63935	54955	1717	55565	9247	7376	23214	6895	5587	81623	8836	100272228	79792	11074	6566	80329	5217	23142	25907	2591	7711	55451	1815	8614	23657	5954	862	55638	8756	4293	10607	79176	80223	55112	8639	112479	80212	495	388969	123	2819	57535	80764	4157	60495	645784	6745	3959	7201	4091	10643	9053	50613	29035	23189	51289	50810	24141	10273	116	9892	84525	11107	10102	6752	22943	81858	1410	23116	7023	8986	2210	92170	4908	2902	3458
GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_DN	M5008		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2195_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of myeloid dendritic cells (mDC) from LAIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					9238	3283	29902	91355	10023	55853	2354	1945	687	56915	56474	8654	27036	11278	4898	3475	1958	79137	23363	9450	23590	113419	8611	1107	23358	6134	10802	23221	55157	55415	29098	156	7903	9603	51227	64847	54555	7728	251	28996	28955	3725	100287697	1960	9317	22908	3842	2314	120227	3566	56255	23513	91775	10859	26289	9776	5893	80035	23595	2993	53335	8570	55578	55016	645745	1263	4853	55119	81669	9262	23325	5578	7221	8812	5092	5331	1316	9849	8692	79718	23301	55014	9755	8273	883	1299	7768	6001	3449	4956	10016	3454	5994	29923	27067	79734	8189	65996	1441	11018	11162	6696	10196	55125	4619	10919	23443	3654	5996	64421	8086	5711	1329	10572	4261	10233	37	79005	7940	25960	6508	1975	9683	8893	2339	5834	11151	3848	3843	23151	8529	10614	84908	8891	8435	9760	100129250	7738	29088	6155	8819	1056	7179	147657	5584	2186	4647	51177	29028	4622	23530	6432	678	57132	126321	3182	64772	51705	6419	386627	81875	7439	51477	3017	57720	5311	26018	440270	8329	23078	284541	55614	81857	91754	11116	387263	79895	26024	321	140460	374977	3456	23095	152006	8861	81493	9046	26191	2172	63826	55585	79780	6601	3491	443	5439	1213	29105	9923	51204
GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_UP	M5009		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2196_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of myeloid dendritic cells (mDC) from TIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					55336	11066	54891	23515	4285	460	10507	596	9583	25893	11096	26033	80110	55758	10825	23116	10102	7582	29110	84726	81847	55346	100129482	6978	9422	28959	6745	55638	535	25769	390	8087	7752	1437	1737	3890	3790	344	1200	23090	153	9949	1063	4904	22994	56731	5498	9807	11338	8573	8851	4477	79019	51174	1915	10123	90865	11013	7023	54957	51090	57599	8744	1295	1735	348110	493	79690	56475	2908	152185	8204	170680	2248	6504	60491	9214	57535	8936	958	54946	23710	28387	6566	6519	51547	64393	56252	64097	998	990	57496	316	8065	5569	27125	26050	2792	2551	9344	55924	4085	6576	8482	7711	23265	100134017	2644	7746	22850	81850	22807	8639	27033	5475	6615	79170	51751	1479	91949	3702	57158	57192	10320	10615	54619	8078	80323	64764	79136	9013	56130	322	55150	6498	5375	5528	9263	11103	8324	54885	1907	3769	23220	10758	23101	2826	145389	5783	859	8602	759	7343	30845	10842	8614	741	113878	1482	7357	54532	7551	6531	50862	9180	4091	5954	51117	29999	1030	3993	1687	221981	8987	11082	10745	11346	26036	27239	26005	6320	1812	9185	8187	55112	116	3604	1281	51207	79022	400410	30850	9355	9752	978	79693	5133	2568	4988	56949
GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_DN	M5010		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2196_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of myeloid dendritic cells (mDC) from TIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					11052	54884	27124	79230	7768	11033	4143	56928	4204	9603	4331	80007	6870	56006	222487	92170	79877	2932	3554	10841	6508	26137	8605	26507	79739	10802	251	6432	11186	1138	51026	55663	6155	5428	23353	79714	5473	4625	6942	10136	79444	55547	9730	79898	2287	4898	23324	4619	8502	8819	1145	54455	11169	5606	730092	9681	79065	3848	388650	1009	1278	262	10381	1606	23395	5892	80380	5627	9922	9905	54985	79713	10278	6799	6006	4066	3386	8420	9652	6817	51278	3174	79137	6118	10383	7439	79679	259173	79929	389177	9466	9650	408	57835	89870	2734	208	54466	6623	5584	100288496	26097	23513	8634	1632	10295	63910	4926	2774	8189	374868	10139	10945	1727	10865	1397	7518	7248	10314	3749	6894	55070	4035	443	5378	55335	9228	55752	221823	1021	218	1489	58500	6257	201229	27173	10567	5081	5894	1396	10763	56474	7982	55252	79632	80173	64816	6671	7903	925	6779	6129	54874	6386	57602	2059	25984	6001	10438	11097	3490	8837	2961	4735	23553	29916	6455	760	6152	79895	7221	9020	79886	27306	196	79883	23378	156	55048	5436	9197	9526	23491	7779	5524	5610	5311	9183	10190	140459	54520	8910	514	11152	23177	51192	5336	6575	51306	29902
GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_UP	M5011		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2197_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of B cells from LAIV influenza vaccinee at day 7 post-vaccination versus those from TIV influenza vaccinee at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					3800	5888	23331	7762	78987	1628	10570	3212	79413	26	60385	22891	3861	8045	10666	55633	51298	152185	472	9153	91977	3444	4969	79633	80224	7706	7804	79097	9781	3699	5169	22795	79983	11072	7067	6247	203510	990	2542	56548	54581	9410	51294	55283	567	55079	28785	9024	79848	80761	3850	55714	8671	6285	5603	6906	28683	50831	51181	79842	1278	55346	1238	5892	80059	286527	51115	9340	8336	5617	80352	2978	56033	266977	27063	3991	10741	53841	25900	627	860	27178	2820	54954	7634	2568	5998	3744	140467	25896	2875	10911	611	1384	5745	7441	26272	2712	2160	859	63877	55655	9322	282808	6874	9628	55118	3914	23329	8915	55026	10017	5624	2302	373	8908	10062	50835	1551	56938	2912	2841	390998	3567	149111	4837	79973	4907	4014	10380	4308	51806	64708	4758	79728	5268	8785	84079	8322	100287927	27179	23138	1528	1776	2730	1208	55885	361	29915	4085	9808	10861	54413	1421	57152	80233	80115	80764	29881	56848	1759	6758	220077	54977	7164	27113	56934	6877	3487	3400	79990	7369	79071	79840	3641	57447	928	9903	388389	55133	55558	53905	7005	10687	1768	4674	51716	158471	56158	9542	25763	1673	970	51127	10458	7447	3195	7033	4868	2689
GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_DN	M5013		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2197_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of B cells from LAIV influenza vaccinee at day 7 post-vaccination versus those from TIV influenza vaccinee at day 7 post-vaccination.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					3008	6103	7260	6737	29959	131408	5894	84193	2534	26292	5201	79641	3099	10150	23272	79012	55916	3784	10807	100293871	92	22913	64975	5870	64960	55014	2787	4710	55147	10723	6907	10401	11151	51011	23256	22861	7251	22837	10162	2524	2647	2992	7091	9056	353	6128	6156	4502	6167	55116	8986	79844	2550	6001	9373	81545	652493	2067	4780	8667	55733	7415	6224	11343	6095	60343	7756	81608	57097	29094	1495	57819	54916	56984	6990	10370	7917	6231	2987	7284	483	51497	1021	79080	53838	1350	8999	3516	53343	2100	8565	3012	80185	10421	1800	1819	8737	3964	10169	6392	2193	339105	26093	1432	80212	51643	9470	23307	55831	7525	10945	10893	10322	11138	58526	5954	6230	23518	22936	1087	23379	6161	22875	830	9863	23609	9759	4076	64180	51296	27246	25966	22911	670	2720	6229	8803	8815	644128	5194	7471	6232	81533	8648	4152	98	23647	9960	25820	56950	6810	55705	2771	9556	6160	2908	3661	196	10668	5291	57820	4213	79184	64398	310	79676	79665	9552	6799	3135	8337	8533	824	602	56270	23248	9923	29796	7533	10308	6668	5955	7433	55603	6181	3654	5525	10263	8767	9168	475	1716	9166	6130	9341	56947	23633	79109	55008	84364
GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_UP	M5015		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2198_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of monocytes from LAIV influenza vaccinee at day 7 post-vaccination vesus those from TIV influenza vaccinee at day 7.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					2746	3208	4610	81931	55907	27005	1131	292	730227	2555	28517	6883	10428	9619	10326	962	64747	3606	221078	6173	55180	6872	54581	5729	5740	1431	6747	10769	84908	8927	55000	57470	51626	10640	55812	1130	6430	4741	7582	6256	2619	54865	51292	4929	79731	54552	26156	2035	2620	6165	55172	55655	79868	30817	79184	5140	100289109	81034	1999	27316	6138	5728	10003	23405	6653	50628	100506963	23314	3587	11186	55143	4507	3476	10527	224	734	100130958	2823	54517	6658	5788	22871	54946	8851	1510	57038	827	55827	10531	91369	6752	7551	1843	10645	1968	100128124	55175	10452	9895	9991	4155	6389	55218	445	1572	5094	26528	23338	2354	11104	8935	3312	4478	6124	10114	4775	64757	4236	9055	7058	93594	222658	4234	57124	7112	5874	5995	23163	23786	911	4261	7100	284649	8496	1774	27249	2040	678	2168	10121	9464	3593	23116	821	328	1902	1121	30001	54434	3166	2566	7686	5741	115207	9375	10051	5721	55005	220972	1447	191	3955	7545	221092	58477	10294	11285	9466	26232	2069	54148	79038	2919	841	1690	10269	3676	387893	8724	9338	57379	10439	79587	4744	5635	54994	10578	10951	9172	27237	23152	80031	1915	8570	56910	10124	2263	3705	27124	8662
GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_DN	M5016		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2198_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of monocytes from LAIV influenza vaccinee at day 7 post-vaccination vesus those from TIV influenza vaccinee at day 7.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					79567	29115	10519	25828	51728	10956	2821	977	9423	6036	29888	50	56244	29959	4707	54498	57612	727897	51026	64419	26289	26532	3603	27112	5894	10079	432	57466	6793	1812	9416	9744	5680	81797	26140	27290	150	1716	53916	29798	56271	66036	60626	8910	51412	6383	6522	23231	4680	10467	166	381	23122	22913	4118	5168	26007	3069	55506	100507436	3956	7932	402	51024	57062	8407	51050	3635	23600	1337	51179	995	30012	56920	23168	1353	9322	9021	22907	6281	7299	2638	706	100292534	65992	4956	5717	79934	63898	9168	7136	8406	9092	221472	80308	2810	373863	7378	9399	10614	7305	7004	23564	117246	9446	79144	605	2949	2242	100505761	80069	57045	3762	5350	6294	80148	4946	58513	23205	196483	2017	3875	79683	8315	29970	124583	283683	4926	100287025	2055	4794	283131	303	51063	3737	55512	10169	100129648	9439	6452	81544	8666	712	1471	4221	79669	11264	2475	51517	2554	23293	50489	79180	11279	84619	2295	26281	7171	6723	10936	2632	4919	2672	5587	22875	7988	7454	7881	64755	53340	9130	23108	100506699	54886	3712	63894	5130	7408	9260	811	10312	51352	6196	23563	407	287	6748	6737	51231	4967	55611	8390	254102	1984	10643	8438	10014	6672	5281	2644
GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_UP	M5018		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2199_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of plasmacytoid dendritic cells from LAIV influenza vaccinee at day 7 post-vaccination vesus those from TIV influenza vaccinee at day 7.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					57794	9204	83461	6903	214	10224	6164	22876	51185	9477	10363	10528	55596	55281	8509	79998	83478	55293	5116	26054	1803	10990	57035	54826	56925	114791	7056	55884	2694	10184	23353	4882	55322	64768	6993	25957	3192	55957	9968	9737	55316	54469	91966	55768	2782	1660	26049	6006	754	64940	9730	7037	25840	9989	29123	56937	56950	112869	79572	114883	81552	5955	3475	10440	54187	8639	10124	9197	60684	31	1195	116828	55006	79893	81691	54465	83660	4953	10559	9734	9847	55182	2004	54977	11260	4122	26499	57862	5048	51299	55857	2119	1969	25782	26050	222161	27075	23192	51747	6738	51646	51314	51585	84187	5899	27044	27129	10208	220594	25913	7001	27131	150094	56910	53616	5423	3843	339448	9313	118	10004	51027	3717	3151	9782	23729	54537	6882	22903	79135	1508	6189	55633	26105	6447	57003	55657	27034	2596	6883	5090	22862	3676	58155	9958	7045	27000	26280	26984	8720	57570	54726	9044	51669	54454	955	50814	10898	79829	9129	4974	26502	6431	6430	23042	2824	7766	79363	3145	8602	23131	7837	55109	56994	7342	1847	29110	217	78990	80380	65109	79811	6443	55734	6406	8847	10495	9802	10564	3092	80006	1655	8887	4100	5791	51411	9906	26035	55037	686
GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_DN	M5019		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2199_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of plasmacytoid dendritic cells from LAIV influenza vaccinee at day 7 post-vaccination vesus those from TIV influenza vaccinee at day 7.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					54813	23199	661	30000	65125	100133941	5589	11273	65987	5202	64319	107	11219	2618	83442	10927	51176	1264	9513	8863	54145	604	668	5529	3017	400506	11107	257	27023	9592	8337	79630	1376	54626	56287	996	2264	2065	4159	9064	51478	346562	8125	3142	1994	9333	875	552	9796	28232	8365	8346	51651	11337	949	8687	29058	25945	54480	9752	55040	192286	51807	58	285830	7070	8344	1620	7126	2316	9472	10563	27181	1500	3624	79931	23409	10551	10320	1209	7594	7095	11069	399664	10881	84890	25797	1981	1000	8349	8577	8614	1212	8345	5213	4821	909	3306	90956	3428	79173	5096	64130	29951	8938	79979	9397	6617	1261	10573	4071	93081	58488	2309	55339	56255	5886	2771	5885	52	8534	10280	11141	6273	6472	6811	8711	28951	3098	57151	10331	595	3661	11331	6360	29107	23072	8332	347	9085	51447	3241	4887	57821	56341	1519	91543	23037	8336	3488	3834	8818	6355	9121	3737	9401	4967	5524	6382	7349	10787	8910	4090	3625	7754	26648	23023	2159	2011	55640	5617	84951	796	26993	2350	7471	1565	2664	27147	2066	92579	429	7100	28981	55111	3796	9733	4250	10527	80059	2260	5657	5216	2488	7368	9088	4477	7802	9547	1828
GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_UP	M5020		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2200_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of myeloid dendritic cells from LAIV influenza vaccinee at day 7 post-vaccination vesus those from TIV influenza vaccinee at day 7.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					23554	54462	113419	7812	3454	26005	6576	80110	23410	51427	55128	3726	100129250	7746	64324	344	9698	65979	51174	29969	26716	26036	9262	57158	64689	27253	3280	10825	8994	28959	4647	5236	687	3993	8269	10003	64393	5921	5578	11200	54879	4929	80700	144699	51751	1398	3566	79913	3077	54987	55336	22798	10600	10745	57091	23078	1292	6650	5670	56156	1601	54585	3842	9734	55415	80224	9942	23389	28387	5613	23595	29766	5496	91754	9283	7094	29883	56106	6272	26057	79443	1075	10768	147657	8175	65996	11338	4212	5062	57132	8013	22807	22802	7582	22994	8633	3619	57192	6419	374977	27334	2354	6039	64118	9498	10507	23515	55638	4627	947	9317	9583	8968	9743	51762	4841	6598	10896	4634	153	389136	23590	51097	63826	10274	8273	23012	1735	81539	8602	7417	59339	50939	8677	7528	6187	55379	7179	23119	1618	4285	5996	51734	9180	5743	80345	8087	9949	5295	26010	5352	1479	998	84726	1195	6821	9261	23630	2791	7472	962	55159	27122	11024	55853	10196	79625	51471	6615	1175	10584	9517	40	5922	7752	149986	3024	5702	83937	81931	55763	10320	10497	7008	79168	2589	2792	5571	23281	4863	64853	23039	10434	5914	8453	152006	6756	2566	1295	7023
GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_DN	M5022		21743478	Nakaya HI,Wrammert J,Lee EK,Racioppi L,Marie-Kunze S,Haining WN,Means AR,Kasturi SP,Khan N,Li GM,McCausland M,Kanchan V,Kokko KE,Li S,Elbein R,Mehta AK,Aderem A,Subbarao K,Ahmed R,Pulendran B.	GSE29618	GSE29618_2200_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of myeloid dendritic cells from LAIV influenza vaccinee at day 7 post-vaccination vesus those from TIV influenza vaccinee at day 7.	Systems vaccinology has emerged as an interdisciplinary field that combines systems wide measurements and network and predictive modeling applied to vaccinology. Here we used the systems vaccinology approach to study the molecular mechanisms underlying th					54884	9205	26507	5168	6457	8605	4204	1460	3592	10327	10950	11097	63898	55663	64220	3763	79739	23460	441263	4838	57097	10643	11061	154661	1717	79714	22894	7518	388650	64816	57205	9416	54798	10440	10581	3174	3780	11052	140459	50626	711	57115	26873	1472	9545	100129361	51286	80335	2475	1315	338	1838	10420	10845	4331	5733	3746	7421	54866	374868	1369	83394	9197	2220	23553	2774	79731	9542	666	655	54328	6041	5281	1287	183	10763	10316	6799	23324	27101	9650	8837	3775	4143	5892	4616	55312	7375	54905	9945	80862	64747	275	11169	79679	9627	9905	2010	6569	3235	26470	5626	645784	1411	3749	5651	64318	9209	9053	6801	10007	9367	81501	4005	25818	5313	142684	6947	80776	10933	4625	4065	2999	5592	79092	349152	6249	11074	80380	9466	84525	4744	51643	10331	1910	8456	6539	9674	27124	3083	2977	25963	9452	50810	51224	8091	25896	3458	3816	6228	8905	84253	7187	55222	54874	54973	5134	26017	79676	3426	23205	10848	100291367	5468	5436	1021	79444	100288496	55714	4632	27012	51214	3988	55640	1307	7405	26576	719	7201	55547	3728	23520	10055	2630	7068	5454	92104	983	3516	6017	7846	26137	9528	9435	80199	6282	5046	83638	2079	11284
GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_UP	M5136		22398282	Ioannidis I,McNally B,Willette M,Peeples ME,Chaussabel D,Durbin JE,Ramilo O,Mejias A,Flaño E	GSE34205	GSE34205_2334_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from infanct with acute RSV infection.	To study the transcriptional profile of patients with acute RSV or Influenza infection,children of median age 2.4 months (range 1.5-8.6) hospitalized with acute RSV and influenza virus infection were offered study enrollment after microbiologic confirmation of the diagnosis. Blood samples were collected from them within 42-72 hours of hospitalization. We excluded children with suspected or proven polymicrobial infections, with underlying chronic medical conditions (i.e congenital heart disease, renal insufficiency), with immunodeficiency, or those who received systemic steroids or other immunomodulatory therapies. The RSV cohort consisted of 51 patients with median age of 2 months (range 1.5-3.9) and the influenza cohort had 28 patients with median age of 5.5 months (range 1.4-21). Control samples were obtained from healthy children undergoing elective surgical procedures or at outpatient clinic visits. To exclude viral co-infections we performed nasopharyngeal viral cultures of all subjects. We recruited 10 control patients for the RSV cohort with median age of 6.7 months (range 5-10), and 12 control patients for the influenza cohort with median age of18.5 months (range 10.5-26).					2205	140947	1975	5729	200772	6134	11251	146540	170482	4360	9805	6132	6122	6204	79002	4897	117145	22883	8554	23547	3820	11224	9289	3695	2091	9791	1937	79899	100288656	406893	6124	56995	10417	6143	4306	5243	29799	1522	117157	6222	23492	10771	7311	5775	4155	84658	11127	7804	11098	10155	7528	90673	22914	6234	55605	6156	285972	83888	53637	100288410	23180	6252	6144	6188	9022	55599	6228	4841	286087	154	25825	10000	3804	216	738	23380	4926	23031	10608	57562	114836	54737	51386	283989	84942	388228	3067	81563	3560	83988	170622	56172	57189	4603	10578	26505	4753	81926	5612	8930	8644	4261	10399	28996	6155	64769	6767	585	169841	100288673	231	170371	81537	9590	64839	57654	150381	29855	2734	5859	121274	116985	1232	1819	1359	5987	6964	7381	25777	3115	7535	116236	8761	5551	5594	140606	126133	283876	222068	3574	6625	57215	64427	115352	4054	374403	8202	9731	9404	257106	51744	83860	80194	96764	8320	6141	65264	26523	3603	286530	64333	84765	56987	59352	9570	57463	7976	48	10287	2810	29997	85379	9422	4008	11126	440915	27336	6173	51231	22882	54796	9814	23199	7284	10068	100130872	160760	6693	131583	3824	55662	50861	201633	1628	54928	55086	79156	23345	4666	7049
GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_DN	M5137		22398282	Ioannidis I,McNally B,Willette M,Peeples ME,Chaussabel D,Durbin JE,Ramilo O,Mejias A,Flaño E	GSE34205	GSE34205_2334_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from infanct with acute RSV infection.	To study the transcriptional profile of patients with acute RSV or Influenza infection,children of median age 2.4 months (range 1.5-8.6) hospitalized with acute RSV and influenza virus infection were offered study enrollment after microbiologic confirmation of the diagnosis. Blood samples were collected from them within 42-72 hours of hospitalization. We excluded children with suspected or proven polymicrobial infections, with underlying chronic medical conditions (i.e congenital heart disease, renal insufficiency), with immunodeficiency, or those who received systemic steroids or other immunomodulatory therapies. The RSV cohort consisted of 51 patients with median age of 2 months (range 1.5-3.9) and the influenza cohort had 28 patients with median age of 5.5 months (range 1.4-21). Control samples were obtained from healthy children undergoing elective surgical procedures or at outpatient clinic visits. To exclude viral co-infections we performed nasopharyngeal viral cultures of all subjects. We recruited 10 control patients for the RSV cohort with median age of 6.7 months (range 5-10), and 12 control patients for the influenza cohort with median age of18.5 months (range 10.5-26).					6279	3006	3429	3045	3042	9829	3005	1870	4057	253012	4635	4317	57018	4680	6280	8318	6283	3240	113130	8727	212	5494	759	8291	383	51327	7145	5657	6037	79887	127829	120939	7298	3044	10562	6036	284415	55432	3151	820	9768	9921	57570	8993	645	3934	6622	2038	53831	84418	8780	83879	7083	1088	4173	4354	671	6521	7504	265	51094	7386	64795	3925	6535	2766	5393	10289	1869	55437	4353	306	79682	7846	2935	9833	10661	3267	2210	84790	4288	29128	3007	6948	3049	64757	3949	10048	5888	3848	11030	25902	3939	1669	199675	4893	2790	9493	579	8394	5861	25793	378	10381	4318	91663	669	153339	898	7884	56729	6286	683	4689	2180	11065	286	51218	23762	983	133	665	25805	6590	643749	143941	57126	2235	23315	948	3956	10221	51012	57405	2305	150000	284695	7272	1033	2994	3985	1824	80745	8331	6009	7111	8991	10734	151987	10376	63899	83445	604	433	8329	347735	55363	7027	6583	3142	5819	43847	51602	84333	79442	25853	2769	202915	2852	5004	79733	10855	23608	3557	808	7320	2134	80178	81631	997	6525	3360	10410	55839	11275	137682	283991	10615	51307	9700	257397	80311	84923	4830	5909	22934	157983	6303	7059	2993
GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_UP	M5138		22398282	Ioannidis I,McNally B,Willette M,Peeples ME,Chaussabel D,Durbin JE,Ramilo O,Mejias A,Flaño E	GSE34205	GSE34205_2335_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from infanct with acute influenza infection.	To study the transcriptional profile of patients with acute RSV or Influenza infection,children of median age 2.4 months (range 1.5-8.6) hospitalized with acute RSV and influenza virus infection were offered study enrollment after microbiologic confirmation of the diagnosis. Blood samples were collected from them within 42-72 hours of hospitalization. We excluded children with suspected or proven polymicrobial infections, with underlying chronic medical conditions (i.e congenital heart disease, renal insufficiency), with immunodeficiency, or those who received systemic steroids or other immunomodulatory therapies. The RSV cohort consisted of 51 patients with median age of 2 months (range 1.5-3.9) and the influenza cohort had 28 patients with median age of 5.5 months (range 1.4-21). Control samples were obtained from healthy children undergoing elective surgical procedures or at outpatient clinic visits. To exclude viral co-infections we performed nasopharyngeal viral cultures of all subjects. We recruited 10 control patients for the RSV cohort with median age of 6.7 months (range 5-10), and 12 control patients for the influenza cohort with median age of18.5 months (range 10.5-26).					911	5859	140947	6169	84658	2091	4261	51386	6181	6124	6134	1937	3305	2205	53335	3115	9791	5586	55152	867	222068	23547	4360	8665	51552	7311	10399	738	8761	293	51614	5987	6143	54796	121274	4673	6129	56172	84765	23180	64393	6155	170622	6252	23031	57562	6188	7178	6193	55786	6132	6137	11251	7528	1936	117145	79788	8409	79718	6160	285972	146540	7804	10277	84824	64839	26523	55662	100289086	6767	400579	23158	9805	50861	5062	55904	5594	55114	960	283596	6130	6222	23030	170482	79817	216	6141	574028	79002	25923	54802	6161	23081	1933	6204	29997	51611	10998	1939	128977	84186	84939	55846	57326	9590	23199	100289420	64333	200772	6144	4666	29904	54920	5441	1676	10771	220002	83544	3030	23708	11176	6591	256435	8664	54986	79901	54876	11224	23409	9215	51727	6206	23344	3603	116236	51028	55717	3111	4753	55568	3820	53635	6228	6138	125875	340947	4841	285286	9422	2145	54585	115352	64427	1397	6125	90673	2665	6689	284346	6856	3119	283876	29799	9923	4957	5612	57189	113246	7644	10972	64426	10807	124989	55914	93380	27352	6208	116447	1938	81606	154881	10049	56986	6189	23492	10509	1380	4050	3112	4897	65123	23677	93129	55022	79874	6176	27075	8310	79018	7284
GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_DN	M5139		22398282	Ioannidis I,McNally B,Willette M,Peeples ME,Chaussabel D,Durbin JE,Ramilo O,Mejias A,Flaño E	GSE34205	GSE34205_2335_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from infanct with acute influenza infection.	To study the transcriptional profile of patients with acute RSV or Influenza infection,children of median age 2.4 months (range 1.5-8.6) hospitalized with acute RSV and influenza virus infection were offered study enrollment after microbiologic confirmation of the diagnosis. Blood samples were collected from them within 42-72 hours of hospitalization. We excluded children with suspected or proven polymicrobial infections, with underlying chronic medical conditions (i.e congenital heart disease, renal insufficiency), with immunodeficiency, or those who received systemic steroids or other immunomodulatory therapies. The RSV cohort consisted of 51 patients with median age of 2 months (range 1.5-3.9) and the influenza cohort had 28 patients with median age of 5.5 months (range 1.4-21). Control samples were obtained from healthy children undergoing elective surgical procedures or at outpatient clinic visits. To exclude viral co-infections we performed nasopharyngeal viral cultures of all subjects. We recruited 10 control patients for the RSV cohort with median age of 6.7 months (range 5-10), and 12 control patients for the influenza cohort with median age of18.5 months (range 10.5-26).					3429	10561	10964	3005	8519	6614	5359	11274	10410	129607	3949	10581	26010	6009	57570	3151	10797	4061	9381	7386	3006	6036	93343	4277	8638	3959	51246	400941	808	4353	84444	440836	80232	55008	51100	94240	51510	5393	8812	2537	5610	219988	567	7316	6279	378	83706	91543	9488	23276	55969	4599	127829	6804	51251	54739	5861	4940	9636	8971	391	84930	710	6948	113115	10367	5876	55269	3017	53826	4343	57018	65987	8775	10196	53918	3939	55601	3430	91624	55026	1351	9055	375790	134429	4493	2766	6612	2896	85441	55038	132321	128646	6303	376412	5223	10226	2512	4939	55766	475	117854	140739	6880	84790	1870	113730	2787	51316	10855	5879	714	8727	4001	51338	9985	25805	7205	8877	55337	9978	7272	387521	8329	4330	8331	27257	824	8804	79887	3586	4615	8789	10326	2219	4317	113130	497661	675	717	4213	153339	5819	133	6037	6280	6727	8349	284695	7884	25902	23315	29107	51191	79930	513	355	211	7037	10562	10376	8291	3665	135112	10346	6277	4057	7319	3148	23295	7511	6035	22862	81030	4502	79132	1514	902	9997	7097	118461	10950	84946	4600	64761	81631	30001	79682	265	55270	143689	6282	56965	157983	9517	145389	27074	1509	5971	55839
GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_UP	M5141		22398282	Ioannidis I,McNally B,Willette M,Peeples ME,Chaussabel D,Durbin JE,Ramilo O,Mejias A,Flaño E	GSE34205	GSE34205_2336_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from infancts with acute RSV infection versus PBMCs from infants with acute influenza infection.	To study the transcriptional profile of patients with acute RSV or Influenza infection,children of median age 2.4 months (range 1.5-8.6) hospitalized with acute RSV and influenza virus infection were offered study enrollment after microbiologic confirmation of the diagnosis. Blood samples were collected from them within 42-72 hours of hospitalization. We excluded children with suspected or proven polymicrobial infections, with underlying chronic medical conditions (i.e congenital heart disease, renal insufficiency), with immunodeficiency, or those who received systemic steroids or other immunomodulatory therapies. The RSV cohort consisted of 51 patients with median age of 2 months (range 1.5-3.9) and the influenza cohort had 28 patients with median age of 5.5 months (range 1.4-21). Control samples were obtained from healthy children undergoing elective surgical procedures or at outpatient clinic visits. To exclude viral co-infections we performed nasopharyngeal viral cultures of all subjects. We recruited 10 control patients for the RSV cohort with median age of 6.7 months (range 5-10), and 12 control patients for the influenza cohort with median age of18.5 months (range 10.5-26).					9366	3042	212	100287109	150000	65018	253012	3043	7111	6521	744	55415	143686	3044	55437	10661	22934	10107	2038	759	57095	84932	8659	221687	220972	2035	51218	9829	51312	114984	2996	100507043	6535	51327	2235	3045	25853	7216	6563	116151	9902	9921	55691	7145	115330	5909	9429	8991	665	65989	3049	4115	100329135	55796	140731	23198	6622	283070	8395	5208	219333	26499	598	25793	51094	286	8131	54905	5172	1379	94030	23608	27143	92949	128497	115399	79844	202915	3363	2199	340107	114794	3995	343171	669	10841	23409	254887	387496	54514	83715	80775	63899	8325	152586	51629	66002	2785	3909	2642	6175	64582	11345	56123	3029	1879	9645	63904	84767	349136	91227	284749	375295	100290663	2905	63893	286114	199699	6508	9122	2719	1933	4601	9623	728819	26247	84923	3050	93650	83606	140290	25959	388946	2993	55363	54997	284422	100287008	7327	497258	54386	100129460	92283	56937	23432	13	6767	84532	728730	84839	7837	100506049	80183	26994	79817	7850	56124	440061	1656	51454	80117	57644	50939	4147	1807	100287411	131375	680	292	157273	997	27035	54855	6130	22906	344148	23090	6193	440200	6900	79949	4635	94031	6710	23582	54967	1942	2935	5494	83882	2487	170949	389206	140597	100268168	200132	222537	642826	139378	10900
GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_DN	M5142		22398282	Ioannidis I,McNally B,Willette M,Peeples ME,Chaussabel D,Durbin JE,Ramilo O,Mejias A,Flaño E	GSE34205	GSE34205_2336_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from infancts with acute RSV infection versus PBMCs from infants with acute influenza infection.	To study the transcriptional profile of patients with acute RSV or Influenza infection,children of median age 2.4 months (range 1.5-8.6) hospitalized with acute RSV and influenza virus infection were offered study enrollment after microbiologic confirmation of the diagnosis. Blood samples were collected from them within 42-72 hours of hospitalization. We excluded children with suspected or proven polymicrobial infections, with underlying chronic medical conditions (i.e congenital heart disease, renal insufficiency), with immunodeficiency, or those who received systemic steroids or other immunomodulatory therapies. The RSV cohort consisted of 51 patients with median age of 2 months (range 1.5-3.9) and the influenza cohort had 28 patients with median age of 5.5 months (range 1.4-21). Control samples were obtained from healthy children undergoing elective surgical procedures or at outpatient clinic visits. To exclude viral co-infections we performed nasopharyngeal viral cultures of all subjects. We recruited 10 control patients for the RSV cohort with median age of 6.7 months (range 5-10), and 12 control patients for the influenza cohort with median age of18.5 months (range 10.5-26).					245972	3959	55501	4061	3134	4306	23380	93343	55605	51291	9985	3106	26010	3824	5002	283989	55026	7316	9289	3105	340542	714	100288656	23179	8877	3133	81	6355	373156	29959	8519	84941	11054	5775	1997	6351	10417	917	60490	713	81622	5610	26133	8832	23061	1643	3993	2896	55086	440836	585	51246	9445	864	3805	3137	712	8638	6046	2734	285957	2219	7884	11274	4818	55337	4494	6003	8554	27141	391	6614	79156	79101	374395	4296	9140	3398	10561	60	128710	527	56995	3689	375287	1890	10066	23166	11068	5551	83987	2512	4940	717	537	283120	10346	3135	148213	219988	9046	5025	1785	286087	4502	9381	23070	100505538	26225	65987	89853	567	8348	9047	22883	6428	8517	100131733	53637	3429	283871	3695	3683	51552	100288410	162394	51050	1351	96764	4939	23646	2069	9777	54831	1519	6209	10870	2232	85379	3107	896	80727	10603	271	55008	140699	23060	57580	9013	254359	115004	824	3430	55601	410	6881	51503	10964	103	83549	10578	3002	23224	8820	23064	81030	6720	1844	146956	94240	7009	4763	29117	64282	79832	100130872	51251	2582	10437	1234	3678	53826	51631	57476	10737	51669	4501	7318	3008	89848	3809	63940	145389	3804	5184	339448	60560	90933	51575	7475
GSE360_CTRL_VS_L_DONOVANI_DC_UP	M5143		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1001_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in untreated dendritic cells (DC) versus DCs exposed to parasite L. donovani.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					1729	4048	216	3635	22852	9056	7318	112950	26136	23126	54504	912	7409	9934	124	5305	6293	191	23133	4647	9380	2878	23382	23428	2078	7385	1463	2648	7356	124565	5547	1312	22890	10946	6509	4723	460	7915	3015	1234	2647	25859	9332	4678	23173	140	1777	4037	913	910	6195	79602	10007	3992	393	5175	23082	353	100287600	5480	22878	9703	1975	22853	929	7267	6256	4689	7001	51439	3133	5294	7143	140710	9656	23163	9948	8888	8869	81550	5096	490	91298	341	9921	23102	570	10212	7203	22846	4046	51097	6196	10140	7110	11068	11027	2720	2618	9968	883	8667	1955	6451	1978	4809	9858	8507	4050	56	6878	1020	65258	719	8673	23169	945	1477	26049	64131	9672	126353	23435	84263	8893	23468	55794	10922	1306	3675	3859	9918	81875	6455	28951	9051	23272	8514	2644	59	8874	161	7392	79036	26278	27335	9686	5204	4524	2237	6397	23341	4691	26057	23001	2976	5437	5111	9724	10895	23234	6837	6414	911	25988	10057	219	3109	2197	1806	4035	1230	6275	8189	10217	25888	10628	60496	4354	5090	11130	3178	11228	26227	5336	2637	516	6047	6653	8161	8396	27250	8125	4720	58530	644	6627	9045	259230	1122
GSE360_CTRL_VS_L_DONOVANI_DC_DN	M5144		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1001_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in untreated dendritic cells (DC) versus DCs exposed to parasite L. donovani.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					2212	7295	10882	6477	7035	816	7029	9563	7280	9308	9550	6853	7185	3601	4599	196	4065	8530	2014	8175	2568	25797	4209	7709	3576	2204	10218	9118	10397	1890	947	23043	7033	840	90362	5604	84525	51517	26585	26064	5205	3868	6351	711	2334	2026	23096	27076	1964	9242	8334	6281	9362	9516	3581	57553	2691	8482	7053	2114	1235	5987	51083	491	80853	9683	2733	4490	4318	23424	231	27074	4158	84302	3561	8870	8660	3792	2263	5923	3562	2797	283652	10468	27338	23135	1528	4238	8728	4791	4306	2825	2827	10868	133	5533	9278	8676	101	7852	1395	10929	8636	7357	84900	8632	6348	3718	3566	1687	8828	84901	9514	1112	9796	25774	1647	27290	1017	1052	6354	2213	50486	48	9212	7025	23464	10050	219699	5732	7415	2995	284	7082	694	23363	9940	5918	4004	10957	1839	3223	2902	549	1155	23644	3484	8878	11126	284403	4588	6239	64116	4502	6368	84909	950	23355	22936	7695	10938	269	63036	3475	23179	1398	5031	2323	5138	51	8775	25830	5971	5156	4155	5744	1439	23433	7275	149111	3892	5449	1459	4092	6198	5077	11332	10752	6590	4792	9121	212	1847	3299	80852	5655	1514	60489	9820	4990
GSE360_CTRL_VS_L_MAJOR_DC_UP	M5145		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1002_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in untreated dendritic cells (DC) versus DCs exposed to parasite L. major.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					29855	80347	80273	29889	8795	3476	1081	25939	7090	7320	54504	10524	254531	3860	4689	409	9911	1605	2170	3417	9741	2268	9369	7399	27238	131408	6125	3955	47	10963	3950	8671	945	2517	5715	9887	1777	162427	1968	6278	23397	473	23435	10945	2267	8677	6207	23564	23552	23279	5557	1508	3675	10180	3207	9520	1020	10873	2689	23255	22900	2692	5860	53844	2350	5498	951	51360	8890	4636	23274	5662	283537	3672	10252	5153	3880	26191	1551	6310	11100	27130	10654	79036	11004	3077	23370	2488	24144	23030	6001	29957	4858	6442	10446	9657	3428	23607	9980	1363	2077	11309	23310	9844	3635	5157	23005	23546	26278	79602	762	23303	30851	7301	6585	5294	10084	10898	468	10915	7424	7369	5747	23176	27161	8269	1953	23059	9686	7158	23160	23125	1746	25906	9455	10253	5175	10467	11068	516	412	2878	1650	9993	1407	5880	6240	3162	23347	65123	54468	5558	191	6886	23185	5256	4092	79703	4720	6122	26608	8500	3592	11196	10682	22927	23382	5530	140	23272	1185	2534	5009	23401	1306	1973	2902	8564	5096	9270	7533	572	10325	5451	1657	911	9404	3556	3028	7174	10116	5972	1876	5192	463	6678	100293553	7791	3790	4643
GSE360_CTRL_VS_L_MAJOR_DC_DN	M5146		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1002_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in untreated dendritic cells (DC) versus DCs exposed to parasite L. major.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					3290	1847	5205	7066	5265	141	5267	64116	3620	2766	10659	4209	10285	958	10670	9546	10516	694	3960	10538	1489	4222	23179	23433	5077	51083	8034	10669	8660	7852	5977	1410	4308	22882	1235	7124	3659	9246	23230	2838	2294	64750	23424	146540	23135	3576	51	2877	1069	23152	23261	3083	2114	6953	2125	3112	50618	92154	8334	10135	10326	7128	4502	3993	4495	6648	479	8934	56171	1993	3892	5996	23545	9752	10791	6440	7173	6002	9229	2549	8870	6890	5452	30836	22936	84612	7030	549	2146	8189	10221	1106	3891	27032	10735	9478	2323	22794	57030	5292	3586	55697	3398	4218	3557	80853	6398	1316	4952	8971	5468	56848	5272	28	9129	5128	196	7262	9362	7130	6347	5970	65108	5721	2026	6297	5698	127544	5308	133	5732	1236	58528	8728	10629	1890	3460	8933	4103	10410	51561	8854	6590	27076	2537	3430	4282	10677	1044	51364	6281	56242	51257	285527	7056	8547	9866	483	8879	527	5454	352961	11240	4318	649	921	5026	5037	4359	5720	3315	1647	3912	5358	4099	54541	3508	9516	4781	8698	6662	22898	2213	1577	5770	1514	7351	8942	26140	57447	50486	9414	6563	7076	3690	64743	3685	10124	8837	8835
GSE360_CTRL_VS_T_GONDII_DC_UP	M5147		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1003_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in untreated dendritic cells (DC) versus DCs exposed to parasite Toxoplasma gondii.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					6039	26136	7862	23163	6275	23076	8824	10371	115207	6256	6383	3077	56253	6310	1793	22943	256987	3866	8470	777	8178	4627	27349	10930	92211	2677	25813	8673	3071	131	2172	9131	5651	11027	54453	5539	11334	341	5023	3820	6769	23608	3087	9046	779	5412	191	10476	4935	23770	6822	26045	2637	3707	8038	100287387	23089	254531	11131	8396	11135	4635	2077	5547	6817	140	8742	3790	910	2162	9270	7464	9119	3074	5436	10618	3417	1954	9601	7857	846	114876	3745	9555	1729	84909	2119	9370	23062	7168	27286	240	10418	221	5393	22841	23659	1382	56252	1124	2350	4048	162427	5020	344	23508	7048	10908	2954	9913	5336	913	9098	9672	9976	104	65018	4094	6653	6320	25840	3709	54504	10252	2517	8727	3895	8209	112950	1043	58495	22993	4066	4957	5204	8314	1959	127833	1432	9934	581	1102	51585	2538	4900	7414	8536	10141	219654	6573	4193	3635	10628	23390	51552	5175	10919	28951	200576	55756	8301	113	516	4258	3052	4023	8677	79921	22890	3176	6284	5210	6049	9529	22846	23166	1794	762	23344	9778	8996	11043	10479	9647	1777	6387	2193	2878	8887	9813	1806	131408	719	23370	4481	7384	1340	25	346157	9536
GSE360_CTRL_VS_T_GONDII_DC_DN	M5148		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1003_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in untreated dendritic cells (DC) versus DCs exposed to parasite Toxoplasma gondii.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					9019	79073	2633	7185	23363	4065	6853	6477	6482	9589	154	1847	6559	10868	2811	8440	4791	9563	10221	7053	222	8609	9212	1846	10957	29896	5918	816	9308	665	10692	90362	356	3158	10382	5734	4345	23438	8407	8941	8828	2132	517	11067	5687	1944	7188	27334	8013	23649	3386	3612	4099	6648	4792	84140	9322	9118	1284	8676	23248	1638	10950	57798	100130418	80143	10681	1528	8462	5971	6890	7852	3575	8573	3514	84302	694	388818	3430	2590	28	1236	205	5996	4914	11122	1025	5586	890	9129	3833	5721	1052	10215	8882	710	8837	2537	55215	1356	212	10802	5796	3601	11343	3044	57148	8208	3185	8836	8997	4146	70	1964	6303	3929	586	247	3437	8607	11153	3669	3475	9625	3766	3597	7128	745	10874	8542	4842	1307	81611	6407	203	6641	1812	2846	5473	23636	2583	9077	4283	9693	1559	5604	9925	6770	100505879	400961	2334	5957	283652	9750	6440	5463	5164	7403	2623	27074	6506	1672	10205	1112	4790	30816	10409	9600	3191	90634	10507	1439	10614	2768	9021	100287809	10410	285596	4624	142684	5193	91543	8482	6375	5179	23217	10469	1418	4616	375790	7127	4147	1607	7280	1843	100292813	26051	7746	51083	2813
GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_UP	M5150		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1004_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) versus DCs exposed to B. malayi (50 worms/well).	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					2029	23062	22836	22826	11326	7332	4037	10979	8942	8934	782	57211	9902	4236	79602	23166	5294	9793	54737	5207	2977	23272	8899	7419	762	22	23197	4507	3291	8317	8125	23451	10628	27340	100287600	4046	6282	8405	23199	10007	5700	7844	3458	8648	5695	570	7399	2026	9830	677	529	23030	585	387082	80347	3868	56	3939	953	23327	10180	10769	3417	1975	126353	4860	4720	23435	1032	23347	56929	6509	7764	2078	695	27032	50814	4957	2119	9810	2170	9858	7852	5174	56171	4172	1318	22944	4602	10895	9900	162427	219	10768	1107	84193	5313	889	10141	9537	2752	2637	2172	27237	23396	100130418	163	3567	9156	25805	56253	5686	6240	719	22794	10930	7626	9671	1603	623	60312	115201	931	23007	5223	23500	3178	3857	266	4292	5997	1954	4294	9761	100287387	9767	1534	10446	1366	641	23468	221037	2224	863	23218	10388	23193	8673	3071	6786	998	10794	27030	8555	10578	10900	283638	5705	9915	55503	7351	80333	1720	8470	3703	80271	11030	2660	2115	2267	8519	834	116372	7991	29994	116986	26049	6507	9119	79586	4922	25924	9989	1070	5635	92104	2249	1195	80867	1447	23524	1111	133	7818	2040	11337	92346	10542	3008	4361
GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_DN	M5151		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1004_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) versus DCs exposed to B. malayi (50 worms/well).	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					7357	23140	140883	1112	2688	1161	4238	30851	11056	2537	2204	8801	25814	8189	708	7262	2786	8660	8266	11331	1995	8233	79036	7695	23096	958	2146	7716	5253	272	2797	3358	22858	10124	5027	1964	8848	9367	3182	23285	4689	5147	10527	2767	9753	7280	27290	10232	10157	9940	26578	91316	1612	9014	4588	5616	269	3394	5531	2209	10681	23401	10150	80853	57553	4149	6407	4099	3309	10868	10067	10728	5245	6601	747	11240	1040	4920	2273	23213	1155	10253	1489	1392	10418	5790	407	23274	1278	23433	5089	5987	5837	23659	8620	8883	22838	6317	8140	4036	10863	7508	1029	6368	92856	6375	56941	3093	5136	9353	10873	4323	728361	650	9121	8821	11060	23431	1087	27338	70	861	2859	5898	6324	54677	10326	5955	8909	8577	8332	5260	23443	138151	26227	3609	3029	8607	4110	9743	8578	8029	2053	1346	5473	8808	9478	6474	3135	56604	5008	9557	168374	9731	2882	7086	55660	9654	2986	3044	4052	5594	3145	9635	51196	2114	11075	56623	3303	22918	8818	10016	10333	8775	856	23177	2264	1672	347	5244	9265	337	7033	22930	6801	23113	5327	9212	4076	6853	142684	1440	9019	112479	5860	2817	5164	54556	25966	4914
GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_UP	M5152		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1005_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) versus DCs exposed to B. malayi (5 worms/well).	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					1070	23054	10420	10979	4236	51439	1033	3187	5207	6386	25924	51706	8233	838	23607	460	998	25948	2632	3442	78987	7553	5871	10659	387082	50804	100287600	11154	9830	3868	3270	9792	51552	23211	2691	51363	3516	570	677	5981	10205	4774	7746	3872	219654	7098	8241	10458	6878	22938	23080	7482	9467	26238	58495	131408	55120	8795	6526	220965	126353	794	7419	55823	7993	1195	777	6396	3693	23053	8574	6711	26112	25820	23030	56171	6281	4501	10895	6035	7283	3488	9900	9882	219	389	952	2120	653808	22839	1069	6129	11228	11027	220988	2030	55623	7110	26100	4170	10141	5138	9156	4325	7750	1027	56253	9546	412	26509	4685	100130354	641	4289	6241	9723	862	10930	7626	55832	51778	23089	6502	23007	8013	3371	8411	1352	1522	6515	5515	27124	5223	3820	1796	23423	10180	5539	26052	266	4951	100287387	5033	5157	8740	5601	23133	6822	27284	151230	6445	9651	10521	6229	9472	5972	5890	5173	140462	5236	23492	1846	22900	6895	10794	10951	10959	10578	3895	2186	10900	1508	59	6233	3420	196441	7730	6144	22986	303	9947	80333	4037	8661	10409	5445	8971	10438	2954	57016	259197	332	24138	22943	940	6786	10103	23005	7310	3075
GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_DN	M5153		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1005_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) versus DCs exposed to B. malayi (5 worms/well).	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					159	117	6876	23363	11331	958	10983	2914	5690	2196	9362	2204	10218	6297	8751	22858	9019	3060	1394	6368	10799	83759	140883	3929	2132	79073	10628	6440	5306	9748	27338	22936	27350	2797	8621	100129361	1540	5576	5449	265	92154	9294	6376	25797	27290	6017	1824	3752	10157	6239	4359	3575	3394	57553	5141	4588	1837	269	3937	889	5031	9046	675	8476	25814	79090	4487	5144	141	898	7536	8500	26032	6764	10641	23443	7124	11240	8609	81550	10160	23213	89910	3084	6405	3551	27349	142	5790	2688	23545	6619	4137	10129	6566	10672	407	9980	5990	9135	23266	4634	5051	576	3800	3667	5909	10629	5089	8189	2122	5837	3586	2215	7791	4076	2147	4149	3068	1832	4238	5987	5136	5638	728361	10681	5523	5519	525	23217	10816	439	1087	2264	2549	5742	9420	6906	22918	9786	26227	7030	157922	11127	6853	51561	22978	3269	5969	126299	5260	3273	25812	1346	5256	168374	2877	30008	6194	924	1378	5646	2915	5179	3904	5979	1278	10692	11126	347	3631	650	4237	23659	55558	30816	947	5565	1024	7587	10808	9479	10280	7204	9094	7029	6036	5764	9940	4188	10882	1489	4323	10178	8560	3381	11054	23475	8161	2294
GSE360_CTRL_VS_M_TUBERCULOSIS_DC_UP	M5154		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1006_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) versus DCs exposed to M.tuberculosis.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					7157	23163	5330	10454	6603	56848	5601	3297	216	23607	51760	10540	3628	10057	8558	5294	988	26001	26003	5032	11260	2346	6618	1112	1955	10462	81875	171023	10575	3015	2124	23394	9905	6510	4677	5836	171017	3707	6709	11322	4666	3074	10396	23335	5742	6749	5211	10636	3276	4542	7750	4066	945	10572	8751	4809	23428	3868	140	2976	9883	23062	11027	5664	6431	10480	5612	3385	7392	4175	8522	5207	1601	4122	473	3693	4048	393	8841	5934	9600	6778	3635	11334	23125	6233	8569	124565	678	23200	1933	2077	1975	460	65110	6122	2101	149603	4190	2631	7384	2978	9450	518	8888	23435	23549	3945	8772	51304	29855	10212	23160	6678	8651	7204	162427	25777	7091	8402	8125	54504	794	131408	11325	8536	6450	6275	6670	7077	7533	2162	1350	6050	3675	94239	1124	2309	5305	2648	10054	25771	5236	95	9815	8795	902	1795	3419	3187	23564	9404	91647	55651	4726	3727	6301	3913	10557	9592	570	842	1054	4689	10948	8667	10801	689	10781	23370	79036	9934	8890	9927	23094	10147	8073	7155	928	6311	7764	6605	11332	142	23593	9555	341	10945	50717	23191	6293	5175	5184	6173	25813	6389	9672	1312	191	9454
GSE360_CTRL_VS_M_TUBERCULOSIS_DC_DN	M5156		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1006_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) versus DCs exposed to M.tuberculosis.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					83988	2185	1822	27076	2637	3433	3939	1890	10397	3312	6427	50486	960	5467	8332	115201	6662	9708	8349	5606	10952	375790	23363	9671	5971	2820	3561	7185	51379	864	10581	10970	8676	23242	2215	11153	999	2263	9332	10561	1462	4490	10692	6351	100	8743	3475	10379	9308	871	9589	6428	4104	4958	154	4496	5209	6348	7127	9516	6282	1048	8870	3892	1528	2752	3458	26585	8878	10154	2212	23096	10791	6280	3383	4973	10381	4238	127544	952	2811	8854	2634	7804	55062	5552	10630	711	3557	3337	6645	9242	2797	6773	10184	3792	941	22936	8820	6279	6789	5686	6518	834	5996	23301	9212	684	23043	8900	53	10102	203068	7280	488	146540	5507	4316	3929	6590	3735	3299	4504	6355	3586	26013	4585	1236	7453	1847	27290	64750	64087	2688	2180	4321	4067	8655	7053	2936	10157	4792	9940	10906	10125	4318	3937	529	22904	2768	6248	23253	23558	5920	22809	8013	56548	4939	2165	719	7295	4588	1439	23387	4502	10043	6892	6497	675	269	4495	5937	10318	10221	6774	1647	8942	2633	3766	6624	81553	5918	8828	7873	2537	7422	950	10124	8454	80303	10038	1290	6741	8685	8189	2057	9362	205	10288	9325
GSE360_CTRL_VS_L_DONOVANI_MAC_UP	M5157		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1007_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages versus macrophages exposed to L.donovani.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					200081	6881	54737	5207	3122	10554	978	5514	6545	2048	6642	1642	10311	5698	2767	8685	5692	1050	60528	27043	2719	9612	1460	10985	4477	23608	8566	9261	23761	5000	8501	55643	6892	5216	23344	10426	80301	6811	56948	54504	5119	2071	51343	4637	1112	4924	11337	3101	2099	7846	22984	126353	5546	6311	1620	9551	2877	7536	23361	7386	9785	5538	1938	10946	9275	6432	1003	57211	4946	56255	23274	1200	4357	25852	5096	2800	8692	25776	3784	7329	8945	3363	1849	3005	26036	10904	706	3297	4025	51363	7743	7264	10476	8751	56171	11329	5336	10975	6678	87	7392	171017	22846	54623	9063	6006	9936	10895	9377	9056	10607	6396	143	8665	3113	10983	5606	1611	3646	10573	7001	4606	6793	4542	6035	10657	25880	51665	11130	8476	8664	219	23326	6256	8269	117	6464	23207	7390	23191	10487	2771	5091	2990	22913	951	753	463	10462	5360	6570	6227	7318	2926	3449	6786	4141	10956	2517	79026	5499	27089	2950	4299	8772	4694	381	23129	60343	10299	9497	3059	8453	1155	37	1729	162	6921	6390	5439	2219	4043	3684	9246	11118	5496	3856	5532	3728	5783	5441	10523	4751	5875	402055	409	25804	9270	10076	292
GSE360_CTRL_VS_L_DONOVANI_MAC_DN	M5159		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1007_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages versus macrophages exposed to L.donovani.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					23484	80205	1499	4953	1147	2631	23096	63941	28954	2797	54103	515	1014	23507	7322	27290	23042	9816	9940	6335	10970	10263	23131	6720	3633	4588	23369	11193	269	7402	5355	8773	4179	23481	2975	10618	23499	57187	958	939	10611	780	10320	26032	9453	3181	29969	9925	55837	7750	3857	5908	51663	9180	4591	55023	22916	1413	23765	5236	57553	64112	3326	7188	5277	7141	10217	3691	10250	54726	9860	1439	3588	2965	7267	7336	8714	4799	23213	157567	157562	2528	10945	8050	23136	10124	4189	3188	10482	133619	25	54505	9910	1665	829	9467	7371	22898	5680	10953	598	5790	2332	23271	10882	79143	10404	6996	8394	52	101	6612	8504	8904	51099	56650	112	25875	10653	5270	3914	3601	9943	57020	55742	23438	3949	23133	7798	407	899	7159	1901	7716	7779	10221	7352	6992	3703	399665	8550	3362	23118	4807	2182	9685	3068	26191	2355	1842	3858	10735	5724	3849	3423	6814	6451	1663	483	9732	5089	11212	120	1644	7295	6503	23190	8683	5125	7023	10383	7555	10626	1287	219333	80256	3581	8642	4693	7058	3752	5837	4144	367	5829	55884	3801	4217	55957	10656	51582	7125	54665	84901	5196	3459	10307	25940	1486	51592
GSE360_CTRL_VS_L_MAJOR_MAC_UP	M5160		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1008_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages versus macrophages exposed to L. major.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					1499	9138	11131	25	26469	2353	6120	1982	54361	10311	91	23047	4706	4477	2023	6508	55958	112950	5982	6693	2073	196993	3689	9332	1050	1537	11010	9100	126353	51433	1620	6721	23291	8449	10128	4436	3481	6599	79602	392	4681	9772	4103	5567	10471	5336	1018	11056	57211	5026	5910	63941	22996	7389	4677	23102	56171	5881	9883	6426	55611	2099	10895	7341	25859	10036	8019	5688	1675	6155	1808	4201	9497	1384	3792	1581	5037	2060	9673	8623	4723	5110	404672	2585	23673	6698	10277	2475	4775	6195	7001	8815	10616	8480	9939	6605	10476	23053	59	54453	1144	26257	58495	7181	5547	333	3663	10542	8501	2217	7280	8893	3065	27301	6601	8632	1717	8557	11118	6439	4724	6418	9315	20	22895	7264	9535	5681	63940	10302	1643	3945	57658	2734	2145	4141	51112	54504	8405	5264	2137	3133	22827	6843	25804	84549	23526	6850	6035	10144	3615	11213	6124	27237	6039	7597	4088	9793	167227	23193	374291	10524	8685	2665	206358	4695	6455	55746	23339	6597	7265	10400	3635	79026	84726	51257	9512	6635	3029	10195	10623	51367	994	5356	871	7089	23361	22924	5204	24142	5095	27350	23248	10636	4628	51778	8694	2483	9114	22
GSE360_CTRL_VS_L_MAJOR_MAC_DN	M5161		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1008_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages versus macrophages exposed to L. major.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					9524	8467	9708	10218	7348	3628	23096	9721	2797	5083	5714	3137	9666	5825	8773	27290	585	4615	2192	3622	9940	8882	11212	256364	4588	9179	269	5638	3134	4086	3187	4591	1635	1785	23167	1027	8500	939	23504	3299	1644	3480	91977	51517	6560	5137	54581	1995	1203	55001	898	1663	10268	7156	1820	5118	2779	5805	196	23095	2040	5326	51763	9229	5790	6845	9908	55658	23644	29774	9925	5047	57187	25813	22919	10142	4082	407	7188	6996	5996	5796	8904	1857	10495	2897	1944	10285	10873	7709	29969	5230	2925	3273	30848	4908	5918	7184	7323	5089	5598	6183	4301	84612	10857	1114	27099	10286	7782	6288	83450	1638	22936	93487	1198	10150	5837	3667	7150	9859	9456	7376	6744	1781	9183	6750	1510	10773	221830	1676	9080	26278	10912	26509	64582	25932	2936	1268	11165	2180	9728	9394	9818	8698	8091	350	5504	6755	7358	5911	10675	9107	64849	6900	7482	221823	79734	5136	27122	9685	50846	1193	4295	22797	6429	10256	9344	11168	23549	5532	9678	1727	23086	10615	329	2744	1673	10257	4213	10737	2643	1728	7727	8723	5713	6665	23483	9972	340591	10368	22796	5100	100287051	27255	4590	10133	23233	10553	100292813	9744
GSE360_CTRL_VS_T_GONDII_MAC_UP	M5162		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1009_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages versus macrophages exposed to T. gondii.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					1838	23633	54737	5207	2542	8514	23492	4928	971	9883	308	27113	1831	5000	25793	6391	10467	6135	7737	5715	126353	8992	6302	2874	8776	9993	377	7936	10036	60343	5880	6164	491	10591	1611	6721	35	57211	48	4676	10465	23191	4061	25842	51499	23598	2932	8985	4817	5875	8733	56171	955	6599	10062	1340	5930	283537	10895	51706	81552	5739	11011	9770	23332	55644	4350	6144	219	1603	8764	6844	2319	362	374868	1794	9332	5871	2219	11281	23317	57447	10628	5724	4048	8566	474170	25829	10617	5434	8729	5524	9312	10493	4542	599	2280	8536	7165	4208	6390	224	6414	22893	896	10791	6633	11100	2621	10795	3363	54014	10623	4650	10605	5606	8480	3550	83989	3417	5710	4720	28	25900	5439	823	1398	8140	22846	11024	5324	9830	2309	23240	37	6256	39	23616	9450	1535	841	6877	4938	51230	6837	689	23524	7018	6905	7016	203197	1314	10014	945	1580	753	10402	7634	1513	4163	2162	5681	3587	4728	11326	284001	2185	9601	515	513	1026	1292	7783	54453	5025	4802	6233	3059	5406	79065	495	6207	7353	100	90	79026	6494	51778	4077	1718	10109	51	5580	10660	475	22984	51031	5062	1175	4751
GSE360_CTRL_VS_T_GONDII_MAC_DN	M5163		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1009_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages versus macrophages exposed to T. gondii.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					1211	51603	482	9261	115939	23096	1537	155060	28954	9640	5598	1413	22913	2769	8607	3460	27290	4902	518	9940	6335	2767	256364	4841	9554	1474	104	3633	9146	4588	5236	5936	269	10423	440026	2838	9690	6281	573	53615	1310	6720	5094	7124	4953	1439	8517	8501	3434	9308	93081	10490	8227	9252	5883	7536	10336	6670	4335	7402	8884	2308	9563	1104	675	898	2812	2958	23421	253782	204	6819	5203	3914	6383	7336	5649	598	7430	6004	23457	29893	5790	3798	51083	3399	2925	4436	7378	3187	100292236	25804	7678	8242	10953	10142	407	8541	3293	2353	22936	10208	7188	8742	80308	10195	10236	101	6038	10099	23187	2101	25875	4681	5955	10466	10846	22992	23271	3084	8882	10286	5089	3576	10769	10869	7884	7538	148022	1827	492	6900	22874	10221	94239	801	3604	9532	10574	51379	8340	4037	5837	2355	5764	10873	8790	5355	84864	5425	1800	9570	10590	3159	10395	11044	5201	221061	10307	2634	146540	3035	56902	4864	54346	1880	56548	10613	6513	7159	5127	5552	50486	8621	2921	1234	22948	1837	83941	23095	10320	51626	4908	1352	2549	8431	752	1736	586	3909	1855	4522	2317	7465	23263	9129	8638	5732	7469	6563
GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_UP	M5165		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1010_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages versus macrophages exposed to B. malayi (50 worms/well).	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					5207	9341	10102	11131	7064	8045	9552	9600	8443	2029	9742	9063	2821	2137	51382	27043	8425	22930	6571	728642	4477	54504	970	79036	5000	22883	6281	7709	5236	23216	3693	56	8685	4360	11119	25876	7106	6672	5899	5707	5547	4125	126353	2155	1620	7737	1562	1950	4204	4719	3507	23504	6538	23142	753	4817	2553	6518	23616	6059	2242	1003	23163	9986	1431	2263	1534	6122	23673	4077	56125	4025	25852	9686	3842	8623	6284	8260	53615	51460	26065	2290	6150	89927	3064	11340	285282	4176	1595	1804	5514	339105	56171	9497	6439	7022	10653	1175	10895	2077	23039	805	6618	10623	7707	7994	8209	10632	8439	219	6790	10989	10204	5105	51493	3959	163	3853	8364	51083	3074	10947	353	7764	4521	9077	1845	1499	4686	5411	54462	2010	27250	22846	6310	8881	90326	51760	4072	2932	55174	1999	2079	23198	9123	55970	8525	5033	2492	24139	55752	6449	7832	6599	2071	5878	3758	4714	10232	2665	4066	27134	349152	26034	1943	10014	54874	5599	6875	9677	3667	94239	3495	6038	1718	2827	9479	653188	5730	8814	54788	6907	657	22	6503	6536	3142	30	3449	6302	10573	6431	6574	9601	206358	5175	11322	7390	3185	25920
GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_DN	M5167		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1010_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages versus macrophages exposed to B. malayi (50 worms/well).	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					130074	9520	23483	2204	10218	7091	2769	5049	51663	23096	23214	28954	9308	109	124801	27309	6386	25976	23507	1212	1663	7866	10284	87	9940	6335	1312	8882	6117	951	5347	2012	3399	54386	3633	4588	23352	11309	5147	269	5693	8346	27241	8570	2639	10105	816	23774	23237	9120	1211	25813	6778	29969	3191	939	2526	971	9909	11190	1203	3475	4082	928	333	3699	6882	2040	5696	5110	4902	6737	923	50813	23031	9167	8394	898	958	347902	79143	8636	6484	6576	3683	7881	3707	23213	7124	91316	5664	6004	23186	7844	6720	93164	5201	6819	8454	4860	23154	6556	5790	23133	4599	6046	613	10787	84901	6183	5496	5617	8904	5805	407	22887	9322	4771	84823	1268	23127	10286	286451	5990	9666	2220	7336	9604	22903	23476	2152	84720	57827	4967	5089	2130	7450	2524	475	23080	7156	6664	11234	1616	204851	10346	399665	4191	91752	7112	4259	5837	9819	337	889	9191	10906	29907	3293	79987	5929	9931	1557	10772	9891	22795	112611	27286	9518	5933	8530	10202	576	26278	2494	5082	9128	25924	4068	54677	4218	3310	6355	23152	5134	7358	4850	26659	9933	22904	10368	6668	573	3579	3479	7143	6249	27348	26054	3795
GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_UP	M5168		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1011_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages versus macrophages exposed to B. malayi (5 worms/well).	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					2196	23256	491	9552	4542	10500	11213	388818	5058	51585	7153	3603	400410	5552	2192	23761	6666	123720	8481	9968	9775	24144	5877	1147	10650	7832	463	10541	6721	6996	2683	116	1675	11262	5479	10277	11193	23379	7078	6398	6385	4174	54737	5207	3916	427	10846	3688	7988	54623	9260	51430	11056	3454	5553	10776	54629	4061	10160	6662	10775	10552	64750	4600	26085	730092	5653	8482	10616	10174	10208	3845	23384	2104	11119	6609	7750	5226	3146	537	3607	6693	7041	23646	593	57050	84243	2029	10312	8425	8818	7360	6432	829	6741	2263	7364	3655	55353	8859	4677	57827	9665	10076	8000	25842	2632	5195	25839	5336	5709	54462	3636	375449	9412	55810	6997	5442	1943	55830	8733	10432	2239	11281	6141	518	159	9252	92856	3604	6672	55794	11156	811	4023	9686	1050	9784	6309	23279	9753	2744	22827	515	5119	8798	4477	4656	6988	23544	3133	3151	9214	5578	8242	22985	51741	91369	5000	23604	605	1445	3992	6624	4580	5439	5786	4585	8636	1454	57187	56	3158	1195	9508	4978	23504	6280	25865	93081	6262	7016	3860	130074	132	84759	171017	128	8140	55611	2065	719	100506033	2696	55324	3191	140465	8692	1337	6461
GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_DN	M5169		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1011_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages versus macrophages exposed to B. malayi (5 worms/well).	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					6093	51669	6376	10467	23131	4861	23291	8449	9785	9468	23207	10133	5690	223117	9771	51526	1361	9048	23474	9708	2769	11340	80852	8570	4709	2739	26257	55651	26048	9818	56650	1399	10206	8454	1120	7026	6880	1606	1611	115939	8738	3310	11216	8854	10218	10036	10981	7064	445	5037	3611	4336	8031	100419017	6301	3029	57142	6473	23119	55658	2931	51606	26152	9138	27121	1537	6902	7386	23096	1198	2155	10495	5595	7126	6882	29780	6382	3054	847	10606	10921	28954	6354	23332	5452	6726	26229	1006	6657	4285	2797	158	3399	1266	1155	8890	51042	267	55233	6396	9782	29855	902	580	261734	2108	5192	3796	4593	8626	11104	79629	6051	9772	6483	5097	11335	10426	2237	60312	8796	5629	23507	2994	114932	22845	79441	90627	8334	5630	10300	2621	6238	9929	3096	27290	55884	3356	11020	4308	29774	8678	2984	5876	5094	374291	5287	951	23	1014	2010	9940	1794	6335	1548	23522	7249	2272	55702	3137	127703	10262	7014	109	1316	23392	23705	2534	6764	3181	7474	5701	25820	4588	3162	54861	8284	1859	3706	6196	22866	1844	23196	9721	10559	10561	2805	4700	269	11342	10954	1212	7319	9467	482	10915	3094	11260	5270	8301
GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_UP	M5170		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1012_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages versus macrophages exposed to M. tuberculosis.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					5207	6988	22859	9792	23475	9498	5707	8878	6194	25903	6692	9223	6382	9341	5902	4738	118	388714	5000	10204	10946	4869	56	23361	6199	729678	8453	54587	2872	167227	8623	8079	126353	1523	10423	10856	6518	51433	6311	7388	115207	23119	6721	3340	23070	10990	972	56125	81552	7188	10594	25859	4606	4681	5336	2193	10467	6691	56171	9802	1937	5372	56137	10895	51706	4023	955	4735	57405	51035	22883	9816	8985	9785	9986	971	6840	127703	6742	3126	5096	4976	4601	1513	219	23384	2098	10980	6843	84890	2219	7707	6195	30850	54468	55623	409	11337	10623	8539	1618	10947	10326	23241	66008	8815	5778	4723	8019	4676	23317	1019	1327	26017	6844	4048	9028	9497	57447	8140	5091	8021	6284	10513	966	23401	2665	10131	100129500	10768	5204	6125	4751	23492	3913	5356	23511	166	8536	55556	8482	222161	6464	7409	800	10523	84549	4208	1200	1201	25854	1175	9315	2617	7516	1845	7265	381	54939	8673	3988	8818	5529	4173	10457	10153	10542	9170	4005	2629	8396	28952	9048	728642	9815	9444	7791	1112	54440	6535	22854	23030	201229	64976	7125	1414	5789	5525	7264	11010	23102	6191	23303	8988	1558	9866	26027	978	2719	1556
GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_DN	M5171		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1012_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages versus macrophages exposed to M. tuberculosis.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					2931	8678	963	23398	23096	5630	28954	257407	2797	4600	665	1838	27290	9940	5638	3633	5154	4588	11062	1810	269	2207	8720	23108	57142	7126	200734	253782	7336	9933	5567	63036	8575	26032	597	10225	23503	10379	7417	619552	285527	283459	11213	1857	861	7743	6772	4860	1559	4171	100506658	3066	3603	3096	4653	546	6780	6636	57151	9322	5970	63928	6741	5790	25875	7321	1993	5860	26220	5203	3475	81611	25998	8819	407	1912	4163	79572	7030	7352	9554	64135	10475	8942	5771	5586	8050	5089	5082	6873	1357	3423	10588	6009	5054	10869	9988	36	6502	9819	1031	5347	5506	5225	7782	4520	4616	488	92558	4717	1236	84612	117	51668	5837	8034	7143	22828	7332	629	7029	5819	3588	5635	2494	9532	5987	3775	6363	1066	4922	1825	1910	416	10133	7050	3620	8028	3187	2000	23005	1455	4988	8647	3397	5910	2634	22800	10737	4289	9002	8340	6726	2180	9655	10395	9180	10920	647979	80273	9447	23138	55697	3754	11080	23080	10482	6119	51465	3398	2901	10735	10221	290	3310	1318	8858	30848	5184	7291	728361	2882	2886	6925	1385	11234	91543	5467	4144	3535	10505	10979	388685	4209	5914	85021	26105	23426	5862	3557
GSE360_DC_VS_MAC_UP	M5172		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1013_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) versus untreated macrophages.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					5207	6988	7415	8175	10627	7703	23234	4005	4920	63036	11331	5987	1993	25939	5715	51	7263	3704	5829	2294	56	220988	2549	7030	126353	23370	24138	8539	23352	5860	10150	604	23344	203068	10641	6881	4643	354	9135	5552	662	9256	23185	3276	387263	2720	8674	675	3787	8751	10285	8899	50618	22936	9913	1310	10659	47	56171	152559	9583	7756	6692	1236	10895	8569	51350	5834	2273	4298	9308	2744	9900	613	90411	958	9129	4261	22884	7696	7846	3111	27292	5966	219	752	55233	25813	3419	10959	2029	5154	8517	9870	4121	3858	4747	23200	1729	5538	4864	4014	23112	7105	913	9879	10898	117	1514	26128	3119	4190	952	7262	6503	10565	1968	403	5573	7678	782	10681	11238	7874	6670	171546	9126	8343	722	139322	8644	65108	2878	492	3375	23613	23438	23133	3113	51603	6477	7332	10201	5608	4004	5906	51014	9550	3712	22862	4026	10618	3632	51043	1033	3981	7168	3188	26469	5787	7374	6789	57498	164	1861	10202	7482	10196	1650	9783	10446	10404	3565	7185	23086	3207	6702	8927	81875	8536	92249	2975	9968	23094	1040	54665	5936	7352	5601	578	11007	91752	221823	9687	8677	55884	4144	8703	4988	10656
GSE360_DC_VS_MAC_DN	M5173		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1013_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) versus untreated macrophages.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					9708	8636	2204	92856	10218	51690	23096	2797	2885	8859	23193	22895	3508	22	11054	27290	3338	57405	9940	1155	23317	1043	57827	4588	6238	6229	22930	269	10672	115817	6633	10983	8140	84302	1616	2322	51112	2717	11119	6721	468	100293553	23351	9341	29889	3428	8607	26032	5777	2534	8933	1356	25913	2196	3222	5690	2644	55752	572	6194	140883	8945	4848	6764	482	10616	2492	6992	6576	5252	3476	11056	26140	5052	6396	309	9784	7138	23213	2842	5899	4209	5284	80853	9625	4722	9371	6281	2827	7392	9362	7077	4103	3488	5790	10263	5721	92	950	23764	27350	6538	4939	55651	2304	1890	401251	6609	407	5355	1382	9552	145678	8988	8881	8655	11319	5990	9349	29775	23053	4800	58495	56005	4790	2309	3611	3939	4501	9315	4624	10102	2014	10486	64976	50814	7001	5089	4199	7040	711	864	9121	8522	684	463	23136	4542	5193	5205	2637	6231	10549	5837	6196	2077	5027	100	23705	162427	25983	27341	56242	1263	100505621	51606	3665	4521	3097	5531	23534	871	4137	10567	467	7979	7257	9212	27334	25948	3576	929	6280	5217	10154	6861	7357	1831	3109	9793	527	54765	4666	393	3615	8558	5136	146540	9229	7165
GSE360_DC_VS_MAC_L_DONOVANI_UP	M5174		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1014_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus macrophages exposed to L. donovani.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					9023	91752	7867	826	1616	4792	55702	5608	997	1112	6789	80342	6367	10376	7415	3223	9957	51710	3587	2688	5780	3554	10244	114548	1439	7536	4610	284	9324	5311	6541	6996	1548	9618	3796	5580	440348	1075	3117	4158	22870	164	6944	4065	2146	9715	5971	4729	8714	7629	9208	53916	9308	1152	10322	23022	8837	717	10203	5184	23076	5939	23231	10267	23255	26039	23333	83660	8560	113457	9283	902	8530	9230	57172	9144	5932	10948	1193	177	65005	1956	6524	7384	22839	4580	5083	6356	9703	7412	5709	6355	2958	1522	8412	4321	4049	2885	8578	9513	7422	6727	7295	37	1155	570	9111	942	8332	5096	1727	55660	10299	9550	4477	27246	2580	9567	11040	9961	4799	8354	8440	9537	51176	5154	7078	27338	22869	836	4190	231	3738	9922	8751	330	10652	23199	22883	11006	8449	23405	1729	55856	1392	211	1839	9563	2108	8760	2052	10573	1460	23433	3838	5791	6545	58525	2811	23125	760	6403	8792	3575	874	126353	2281	2872	25830	9894	3663	6348	290	7351	840	1212	9516	4670	1776	2950	5376	27074	1478	191	25797	2063	25793	25800	9400	8728	4345	6388	1003	3497	8495	5510	25771	10469	27076	2859
GSE360_DC_VS_MAC_L_DONOVANI_DN	M5176		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1014_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus macrophages exposed to L. donovani.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					7071	1938	11329	26146	6451	6195	9056	23312	8161	8453	6535	6135	7001	230	23269	4023	3693	224	2745	6878	55818	79602	2239	123	7392	6811	9249	3176	2286	29969	7184	1234	2669	1831	7409	9588	2091	7873	5289	10424	1912	2488	6827	54	6193	3337	4615	58504	6347	23001	8507	10094	6036	9601	6793	39	199	285596	23133	6390	140465	1230	5732	8650	929	8874	10561	6721	7073	4659	3449	23129	6128	23096	55	9709	175	11337	3703	9100	23443	390	11027	91746	8439	6197	9877	11072	5140	6146	5921	4354	8065	2797	883	1201	81550	4584	9315	9110	22890	5236	2729	4678	3434	928	8473	8848	3423	10106	7009	1649	6401	2990	8667	348	56339	51582	2534	30837	11314	23220	8880	58530	6613	23507	10263	4691	5033	2214	9453	8270	140710	23136	10105	9943	9450	11130	51592	27290	56829	3303	1604	51109	10788	3939	9958	2026	22809	9940	1200	593	686	11014	10402	7915	57380	51020	8501	1102	10457	54103	3683	5962	8912	1933	23173	4588	6414	84909	64061	4332	6518	467	23150	1441	8930	219333	269	23166	6307	1069	1018	1687	9816	57460	6194	1486	3385	9777	4673	10217	2067	6196	6035	3604	10134	6556	6869	7076
GSE360_DC_VS_MAC_L_MAJOR_UP	M5181		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1015_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells exposed to L. major versus macrophages exposed to L. major.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					9772	23295	9377	11247	1409	22938	5688	2819	6635	10659	6698	23549	25	5800	5128	199	7074	22919	7905	6597	64750	4103	2538	167	265	3889	7293	5825	3640	7221	27295	23433	23029	8148	1027	2316	2213	5203	27292	5211	222658	3029	1537	345	9562	4999	79912	8406	5125	727897	4669	54765	10293	9936	4534	51257	5593	22979	85453	7029	2249	4706	1499	1880	10160	8840	221395	6749	3622	11098	11235	6736	6753	4016	1050	6440	283537	7568	1364	5037	1389	11076	8508	22937	150	5625	339287	7150	5986	4191	4891	10989	4713	805	5713	3148	3065	6418	57152	9612	306	10013	5881	26469	26	9895	79166	9908	57185	55218	10912	1349	5300	6659	91	23332	2290	23086	3670	2744	6886	2859	11189	2494	7247	8467	10553	3895	1312	5796	3316	7405	3641	10766	8852	361	5412	645961	26051	5480	1979	9653	140901	2903	10612	6484	50855	7712	1436	8632	23102	26986	7251	6726	1384	4796	4898	22987	554	6881	2690	2302	2237	8456	10616	196993	22796	549	4774	7088	4998	7380	54581	3142	55658	333	26140	1588	2891	729678	5348	10857	7262	10782	7678	5976	51090	9107	1627	7019	7407	23349	7341	3565	2523	51275	4213	10623	8698	6324
GSE360_DC_VS_MAC_L_MAJOR_DN	M5182		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1015_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells exposed to L. major versus macrophages exposed to L. major.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					8631	6567	29994	1977	820	9912	23580	11056	7486	5359	4714	55742	5319	2548	10299	2560	8777	5425	1717	203510	4974	116828	26574	23338	5514	22868	4855	57228	5356	639	57030	25794	653808	6331	355	2356	775	10199	682	5982	226	8336	10654	23149	282808	3937	10461	57493	6571	23129	9720	256949	4209	63826	23261	23195	2734	7746	248	2840	6908	23331	8809	1138	2073	1387	2792	80273	1831	187	9993	23511	55905	9512	53916	10695	5521	10184	9294	6385	2067	6205	151230	1968	5546	974	11019	5187	11001	10963	4660	3267	64210	7701	2651	27286	885	2074	1657	55651	54737	6170	5110	2639	80301	285672	5104	7454	1164	100507436	2192	4301	1780	7597	91851	10314	10439	2305	6555	1584	11117	5638	2324	672	2214	2872	2303	1742	22850	10282	6506	9013	9721	9582	10168	100293553	7036	4223	4947	6750	51499	9871	6407	115286	24144	6406	8395	1240	5239	23641	7291	29774	1676	6095	22941	26137	6854	2986	6895	22924	3950	64771	8904	2028	56253	5972	6280	2353	6400	4629	9557	3931	5870	8552	9937	9715	1366	3090	4863	9972	26130	6721	55746	350	6346	10482	5368	9712	27339	65979	4620	8607	2044	8805	23095	7306	5449	5095	6508	23495
GSE360_DC_VS_MAC_T_GONDII_UP	M5183		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1016_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) exposed to T. gondii versus macrophages exposed to T. gondii.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					10202	549	3113	2335	1299	22984	56271	6361	4070	5412	2811	9455	1298	4321	23034	10267	51308	570	1075	1392	23022	90362	2208	157697	7078	7127	7188	9308	388650	27232	246	54454	7314	8728	8711	1776	10221	2162	8482	23076	5721	3497	81552	8651	411	2029	25849	5319	3713	4065	26578	2167	9129	8013	6362	3122	4360	8634	10336	5376	8904	6616	4729	4185	11122	3126	2120	9778	3115	11011	1439	8828	23363	7746	8332	3067	10659	2583	26051	10111	3827	5199	8607	54874	7474	25928	22996	8787	5322	2672	5994	6357	114876	401251	7466	125	5087	22999	10653	1152	7295	1490	27074	10693	7903	11272	11155	716	55174	3866	3633	3552	2621	598	5118	911	10317	57134	2205	421	4999	4147	1024	1009	6665	5680	5179	3914	4256	4867	3029	4128	3575	783	93594	1577	4613	247	22976	23217	2037	1847	4141	3761	3784	4627	95	321	932	765	5686	4297	9863	9436	23180	4624	6883	8050	5141	8484	26040	910	4951	84525	79734	6699	7168	10495	261726	1236	859	7343	5157	7846	5523	9111	9534	9324	5801	3321	856	72	6624	506	11332	84243	155060	23030	27	1071	6789	84140	5161	5031	375057	3117	477	55233	875	3221
GSE360_DC_VS_MAC_T_GONDII_DN	M5184		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1016_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) exposed to T. gondii versus macrophages exposed to T. gondii.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					341	26608	1382	10252	1118	9541	2353	3026	7171	586	240	23263	1777	3309	10371	23390	9895	283	2774	5244	2350	9270	11135	1496	10647	3755	5651	83637	7104	2012	1404	1102	23092	4854	23139	4907	2676	6573	3004	4968	9709	11160	2817	2954	1848	154661	8396	7515	2979	4048	3957	10970	3693	348	9467	100130418	8996	9913	9529	9601	1043	23328	10220	7077	4303	2152	10126	1363	10926	23705	23659	665	2352	1340	2632	11027	23166	65018	10457	2538	6279	11117	115207	140465	51592	1831	7100	7392	3077	79143	7718	2219	3493	10000	1513	2209	3133	3490	51083	390	9119	55806	2026	8742	1488	9275	5654	3359	1052	9619	6256	6510	2299	23089	6518	9337	6461	9555	9982	664	9672	8174	9462	719	4000	3638	26050	2239	929	3177	10465	51439	11326	85021	978	7423	2534	4342	5730	109	54468	57178	8875	9214	4066	7086	3798	221	104	1948	150094	2752	6196	7039	6556	3675	8869	1797	25840	54870	6653	1962	1200	10461	10924	100129500	7016	1961	7873	6275	6678	10397	10368	23399	6531	25978	9450	3202	11314	10014	116828	5175	10879	1462	10844	2204	5732	3423	10195	2669	9332	4722	4714	3655	6535	27095	808	7857	4023	597
GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_UP	M5185		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1017_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) exposed to 50 worm/well B. malayi versus macrophages exposed to 50 worms/well B. malayi.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					10623	3181	8623	8443	9023	25898	26292	5591	5547	2882	9778	3557	25797	140	909	4065	3516	6397	1455	4174	6938	1178	9479	4131	23078	162	3800	23216	10253	55353	23302	54205	7533	3842	5878	6697	3399	8854	7168	7171	1075	5045	9466	9455	2395	290	3113	94239	912	23140	54737	5207	8301	3119	2952	10388	23002	1039	5162	7474	5328	23463	23483	56604	4033	4627	7143	549	23333	5062	5515	22930	3554	7867	310	5125	2553	8495	10462	5294	7803	8530	5330	56623	7846	5105	1445	708	3195	490	11056	644	84890	23382	27232	471	9645	977	10908	8560	159	3831	55174	2242	10449	1193	4771	8125	64131	5495	9497	55884	5160	51351	23546	23428	4194	3587	6304	570	2950	9020	51573	4321	10257	2935	4477	6709	50488	79017	7023	23022	7284	2313	23255	1654	10048	8412	9046	4092	10628	7078	27074	2957	1892	4154	56	9252	9647	23673	1727	81689	35	11260	4070	10902	23475	6480	9612	6768	1230	10726	26993	5253	7965	10632	22838	55186	5339	9619	5756	126353	50846	9818	10005	8714	1655	6310	3340	4005	55658	7421	23231	56271	8099	63036	3131	64844	3784	8818	2035	3192	5376	2905	522	56125	8233	2029	5681	4128
GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_DN	M5186		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1017_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) exposed to 50 worm/well B. malayi versus macrophages exposed to 50 worms/well B. malayi.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					56005	1890	3579	4939	3949	9170	4494	9454	10561	7280	230	2784	3675	3265	29907	6122	7844	9249	23233	488	684	1029	4047	11315	2827	9513	10346	2204	962	23764	2185	22898	6252	7127	7096	2239	3458	5606	255057	1292	762	91289	368	8417	6604	4758	5534	9541	6279	6453	5873	5265	51352	1107	4048	2286	808	6844	2531	6793	6737	4438	5996	4282	9019	6017	2152	5721	6273	23096	9686	8349	10384	23511	10014	929	6402	10990	1201	6237	671	11117	6414	4496	50814	1513	2639	4974	11343	11314	1462	6238	1717	2309	2224	4593	10241	11027	9332	54541	2766	23705	94	2048	8514	10220	6352	6888	23327	2026	6624	100	5739	64116	91782	10133	6556	4045	9312	26471	9537	7347	6303	6548	3479	23189	6721	10474	399665	389	1052	5025	8636	6915	8270	6307	3291	7917	22794	6678	6609	1280	7064	10157	9940	6335	6004	3428	6284	4318	2745	10871	116985	109	2537	4722	51421	4588	6993	23645	27243	269	1777	4542	22826	3241	7167	3992	23042	10769	9636	7040	2014	9214	5329	1025	9601	333	8857	4502	4599	51493	272	4490	3620	919	5732	3097	1831	2184	7133	2719	23240	889	2017	4615	5987	10073	3005	26056
GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_UP	M5187		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1018_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) exposed to 5 worm/well B. malayi versus macrophages exposed to 5 worms/well B. malayi.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					3151	57862	8455	5266	5207	23193	2843	653808	2108	3927	3158	2137	11054	5514	11079	56339	7461	11019	570	200576	4477	3738	5000	3635	27429	4724	5724	10519	9524	6194	8284	387082	4077	5887	10005	126353	130074	9197	9861	23443	6813	223	3551	6774	3364	10641	1147	9928	2859	25814	4437	23335	4113	6120	23046	5433	2492	6047	776	8125	9761	6009	9793	157562	5778	10075	4053	2976	6650	998	6235	4242	2997	51382	171546	833	54440	10488	23266	7178	10895	3234	54454	8560	6376	3761	54107	9900	1399	5625	6882	5032	5671	8161	57151	22900	29894	94	11329	9527	402055	57498	23344	5932	219	6191	25813	4152	25855	3684	203068	10093	1031	27350	1729	55233	3735	5190	9088	3419	11261	265	4624	10980	22845	11145	6484	6997	7334	3945	3692	1124	6428	9643	3565	8517	7108	9520	10094	6778	7384	1666	51109	9260	301	9341	3281	5213	57187	2171	5694	10487	8565	8945	7009	27013	9902	55884	3550	27109	5608	79073	8985	5330	4168	10915	5481	10180	9526	3015	8536	2068	9896	10475	8668	662	309	5161	22895	10160	1178	55353	5108	7168	253782	898	1982	9459	10097	25907	2120	1949	2618	4701	6876	5500	909	6035	25849	79646
GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_DN	M5188		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1018_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) exposed to 5 worm/well B. malayi versus macrophages exposed to 5 worms/well B. malayi.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					5151	8567	10899	10218	5203	5987	5528	27095	5250	3423	2797	53615	6382	10540	10952	8192	27290	2071	10157	5211	9552	5714	11119	4588	26003	11041	118	269	399665	1874	9146	534	22876	9242	4849	10567	1144	85236	79629	26032	8795	24138	7750	5440	8761	3069	10616	7593	5018	5638	23240	7874	57418	7454	2691	6477	5525	5685	9878	9841	810	23158	10994	5270	5210	11240	1107	6576	55735	5452	10452	2268	23213	7786	2014	3351	6478	5662	9785	23645	26100	55823	7205	3675	10695	55120	8227	5601	4335	6414	219333	26240	7077	4023	1236	197	283755	5970	11137	84560	54665	6535	407	22872	2098	3561	5990	238	4490	6046	10555	148022	10450	930	5277	28973	54432	9500	6453	7482	9816	8425	5089	131544	4282	1318	1088	50813	55556	1964	8273	3096	9355	684	8776	6696	8789	2739	6949	5837	686	2820	2040	10457	4606	50486	832	9589	924	5355	3992	51706	26585	5310	27341	29780	23514	6262	10521	2788	51020	9715	1069	11102	9577	929	9665	51606	10263	4814	4351	6280	26152	4615	6775	2628	10654	8477	115207	6713	1240	6715	26509	11024	3418	1718	10572	10549	790	22863	4706	11273	10138	221749	5867	7141	4939	3309	9322	10154
GSE360_DC_VS_MAC_M_TUBERCULOSIS_UP	M5189		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1019_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) exposed to M. tuberculosis versus macrophages exposed to L. major.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					5372	116984	1729	375790	6355	3434	350	23022	2633	8454	6741	100292813	3340	899	3627	3119	6293	488	8832	8655	55573	4058	84271	3669	10221	27241	9324	3557	9023	23511	100272228	5207	4001	11040	902	1130	5932	7159	634	9242	90634	10379	8099	8530	1236	5686	23175	4939	23306	221749	2717	7295	5618	290	2335	169522	253782	10623	2167	10878	10240	8519	2171	6351	248	3326	8550	7185	22809	7130	23576	203068	7188	913	4616	1778	29855	1973	1847	3437	8927	6773	201229	6347	6820	961	10906	3988	6362	9455	100288583	9687	1187	5168	5734	8828	6238	231	57493	84243	2859	6373	1193	26578	5707	126353	5347	1294	4804	3728	6993	8613	4360	999	9344	653808	5078	5778	7125	8737	2146	4624	7293	11030	23428	4113	1075	56125	10244	7343	7078	57151	3290	9938	8854	7296	4790	6647	56171	4653	1647	3565	3797	5721	23214	10895	4208	23119	3849	3284	6352	2120	3108	1058	4216	8638	3575	3430	7318	10953	9933	3563	1776	23081	1577	3663	9308	4583	23481	3122	2705	3431	152	2329	5346	5935	8224	388818	8289	54440	3569	10952	80344	3659	1670	4599	9902	6282	9711	54498	10276	100506032	6046	5741	2775	100294255	9830	915	2035	6367
GSE360_DC_VS_MAC_M_TUBERCULOSIS_DN	M5191		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1019_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) exposed to M. tuberculosis versus macrophages exposed to L. major.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					10397	120	8690	51668	1280	10863	1200	23613	808	4666	3096	2026	8694	1889	2920	199	945	10400	11027	2581	8740	8396	22838	7001	9450	10856	10981	9221	5091	30968	27299	137886	10123	167227	6233	23401	4199	6415	2224	10228	149603	9400	3588	9541	23096	51363	3992	988	6191	5437	26471	7257	597	6742	6618	223	3500	5184	23469	23394	2797	439921	65220	10801	1740	5352	5898	3423	6119	2309	2091	2971	39	10670	10106	53635	130	6144	3626	8565	9788	85021	9686	1382	7030	10073	10491	9332	6447	27290	11334	4481	23369	3148	90	90410	9619	51594	9940	394	1937	11213	3561	7422	5688	6645	1285	677	90326	9736	4588	10924	5528	4833	5236	955	79646	269	6678	23514	2353	3895	1118	23313	5641	1949	9747	9556	977	9454	5967	2207	4048	4316	240	1012	8079	11326	8642	4312	9044	8819	4849	9255	6196	1069	65110	56848	6192	23160	6856	10507	84726	10457	7106	6908	10634	25903	25874	2058	5046	100	11314	5728	54468	6907	3150	9679	6653	9672	3351	11240	1475	5438	6038	8574	1912	7392	4000	381	9733	51096	9577	2534	1195	1838	2921	79621	6652	1462	5790	3613	8543	23593	5867	23503	9651	9792	407	217
GSE360_L_DONOVANI_VS_L_MAJOR_DC_UP	M5192		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1020_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to L. major.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					2978	201254	79173	1081	5607	23259	1613	10797	212	5968	4025	5449	5476	5617	51230	23119	72	53916	8632	11015	4238	2268	23001	23404	5194	23552	23149	904	945	1842	1965	47	6401	224	3976	6895	5325	3706	5654	7832	9731	51196	55660	10898	775	90326	10687	5138	4320	65258	5701	819	2825	6442	54361	5275	2054	4123	1584	1428	25865	7399	23405	9715	9140	7458	306	9901	29957	6857	9846	8857	3703	2689	57405	1551	5032	11196	1953	9497	55503	5896	10447	1889	23023	9761	5648	9747	3671	2108	3169	8473	10551	11273	2976	9425	9734	54462	8888	3868	7216	7264	23191	27113	11066	3992	63923	2222	8419	56950	1071	546	6691	11165	5158	2620	7108	55651	8302	55619	25834	6285	2257	5422	4774	10062	292	7011	22978	9708	1657	26211	5870	9027	4085	1363	22839	6407	5565	4077	3358	7098	2483	4990	9014	2902	27302	11137	6525	23326	745	10322	5188	27232	9215	9894	9933	7498	1733	92856	5294	79017	10388	3198	10057	6571	5148	6141	7222	200424	4297	445	7164	3479	219699	4983	7546	1638	282808	23327	680	9188	7320	7005	11005	55702	6548	8525	5266	8395	23547	492	8540	54107	4920	9868	4617	27341	9147	4883
GSE360_L_DONOVANI_VS_L_MAJOR_DC_DN	M5194		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1020_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to L. major.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					51599	6729	6900	8604	409	8061	29927	9217	23341	3191	3290	1182	5205	1384	4222	9732	10669	23171	8912	140890	6253	4435	253782	2907	23362	101	5453	3083	2125	5783	2581	7314	3105	6366	1179	3831	25859	23086	4524	54014	6993	6433	5458	100288237	4000	1106	51232	219333	9821	1793	1316	51090	1359	9958	6748	8636	23221	26038	22833	10154	84263	25775	9921	5308	8292	6521	7360	2023	124565	51364	9400	596	1292	23468	3166	8161	6455	1120	410	7596	1933	10383	7392	5454	6375	11240	10174	9684	921	25880	9407	3674	2537	4849	1003	4640	988	10814	10493	9589	9685	100287076	30837	1059	10106	2780	6373	8013	3142	467	285596	1610	6510	10260	10737	149603	4059	1192	2889	5805	2348	55958	478	7019	2874	3161	10329	51097	2622	10255	5509	23765	10221	11234	7538	1215	3423	8717	10330	2277	7143	9040	221	970	127544	3667	23479	80350	2783	283755	26206	10912	6445	22888	140710	7087	597	7450	23169	5714	9248	6279	7978	23089	4582	6573	2531	2897	10408	10587	11326	25842	124	3586	23392	1809	6880	1134	990	9681	56951	56339	2817	6237	3081	3981	9973	837	4061	10599	10424	1843	5526	25988	6840	7062	4976	283450	728438	5900
GSE360_L_DONOVANI_VS_T_GONDII_DC_UP	M5195		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1021_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to T. gondii.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					5651	84909	23508	127833	3755	346157	9536	2817	3166	2671	10893	6736	2702	25827	26025	2649	9127	8085	23132	779	9093	2266	2636	23205	1233	4957	8516	1136	2350	2762	5754	11194	23243	10234	11037	441151	23293	26033	5619	3560	570	8456	215	9509	9079	23541	5261	27020	4185	1413	9436	1907	8807	2776	126393	3798	2176	10879	57228	23208	50859	91752	344	26234	10481	23401	3199	5079	3745	6049	2219	11248	4589	7100	10126	10149	57821	731	2774	7975	221	4821	7038	3623	57185	56253	10465	56171	8470	8314	4155	777	81855	2172	283212	4734	4948	7447	22998	2764	87	6809	9517	25878	9896	58495	8742	1539	8416	26175	7799	3910	3866	2299	6677	345	22894	4318	6870	1137	116832	595	9122	6758	85359	27335	6695	2538	10930	399904	11160	9370	9576	169841	4624	5583	3221	6019	8800	79026	9462	5539	9516	11165	2002	60682	1496	5152	361	3024	154661	954	41	4626	6916	10798	9673	3790	826	1559	6671	3895	2139	303	7779	271	7104	11342	123	5412	4700	716	6513	4111	7044	4099	2026	103910	23654	4306	80316	22905	23232	10211	1393	5340	54432	10634	2773	5732	5782	8728	3635	6120	4656	7941	3801	2769	5880	2760
GSE360_L_DONOVANI_VS_T_GONDII_DC_DN	M5196		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1021_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to T. gondii.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					222	3386	7288	64067	1418	3765	4635	2558	388699	1953	646934	6121	10825	547	100505761	23288	1757	23264	4130	10158	462	8190	8120	2125	10052	3762	8618	51592	4114	8756	2670	7515	7039	10867	23092	8607	116828	1964	28793	26003	6453	1717	4854	1805	100272147	7319	9104	2553	5236	3483	7982	7307	269	2052	2091	10643	6594	3577	230	23082	3609	10528	23169	10005	9435	1591	3321	9111	8884	4676	6665	10607	10020	27074	2145	9910	23522	1138	3015	4726	22853	3480	6138	27246	3604	81563	8395	2224	3713	147339	8344	51097	23139	3157	2632	6117	898	7726	6355	4833	2950	4314	55651	3398	55660	983	287	8876	9920	4436	9778	9811	309	5111	2492	10368	23240	1108	701	8270	26100	8638	4599	1266	3925	6993	4325	2296	874	23279	8941	3485	9618	23230	3397	6432	3044	4830	10561	5901	3148	1495	56255	4600	85236	92558	7292	4175	1267	22833	1327	2308	8988	8481	146227	2618	53335	3707	3487	10013	2305	3992	412	4548	4085	1902	330	492	6770	8893	81	7469	10217	4174	28823	9110	8079	5319	8842	23511	6495	378708	57148	808	6936	57827	6713	10424	23649	10468	6541	3276	23432	6790	22987	65108	4790	3026	54788	2475
GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_UP	M5197		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1022_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to 50 worm/well B. malayi.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					1514	7035	10912	1266	23433	7357	4616	3665	27101	221692	7412	9563	2334	11343	9020	7188	7482	816	4973	23233	23312	4683	51	2683	1045	9435	6351	4792	840	4582	3796	8349	2212	5347	7185	4128	4790	23199	23620	3601	57017	5768	10625	2532	8676	6847	7076	10957	1439	637	782	26056	7287	1580	2760	4318	491	366	3868	65108	6198	1890	4490	2026	1687	100287600	8728	9742	11165	4599	8242	4656	10903	1787	80349	5174	7709	54541	123	2639	9111	5652	8530	7399	5047	5549	4345	11006	2863	2002	6006	7637	570	4494	8854	48	3892	10409	4477	4862	8406	942	27303	6853	4292	3738	5732	196	23515	1839	56	4312	9513	8870	7422	4602	1827	1847	672	5334	90355	1017	126353	6624	133	7360	283638	3557	1263	1965	23705	388650	4495	4065	10322	1116	157567	10062	3005	2114	6348	6857	537	9636	1727	56125	3363	3662	5105	127544	23136	10947	694	5533	3562	5033	231	3939	2537	2146	8837	6004	6402	7444	6515	4891	1880	6273	84525	4814	64116	10895	4502	503639	114548	51109	205	6990	2827	7128	10154	27074	1579	2263	219	5313	3576	5577	1316	677	9242	7225	55558	50486	4738	10950	5931	3690	597	11030
GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_DN	M5201		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1022_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to 50 worm/well B. malayi.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					7392	23133	382	6049	8418	2067	4723	54504	5111	7318	23341	11015	23102	10922	23345	4217	3904	4253	9380	55660	5214	2647	11277	140	1000	8161	10424	9918	9581	6146	1102	11014	2204	9934	9314	8725	23272	6840	7915	64764	4678	5714	490	4920	4023	79053	3635	7284	6867	1601	3133	341	57380	23077	22878	22890	6464	23096	3126	701	26146	8443	55854	29969	5175	9352	26009	8604	8869	6414	5616	393	8853	23428	9976	6768	913	10097	2797	57178	5140	1777	216	150967	3054	4849	7716	1933	1955	50717	929	54	124565	10422	6445	10875	23294	2648	23443	912	8893	2193	26100	23643	161	990	910	9968	7086	6204	3241	6208	23015	3421	27316	60496	9993	23001	353	27290	10961	22870	883	5451	4833	5709	51035	9931	2950	7409	9940	2878	2534	9025	4726	410	6256	5032	11326	4205	2618	64131	81550	6609	9902	3449	4588	10628	11041	224	8545	10801	7249	9528	9126	269	1806	3073	1978	55794	6693	9686	10904	23225	23492	8895	11309	166	10589	6195	9958	91298	25940	51760	200424	4437	259230	5878	9724	9791	271	2147	2313	7832	152185	5876	6397	23505	8905	56255	642	4332	3841	140890	908	25842	149603	6643	6192	6811
GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_UP	M5203		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1023_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to 5 worm/well B. malayi.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					4065	7295	9308	4320	7280	22876	8530	4835	2669	10086	7480	29780	6515	3665	3642	7709	4814	51141	6348	10133	51517	23053	6355	6262	4616	1318	3576	8233	5582	9498	5638	1395	3624	9715	9446	5899	838	133	5033	50486	149111	636	1528	2063	11131	65108	205	460	2885	6453	5898	1964	25834	2773	9882	9425	7108	4790	9322	2309	1890	5871	5236	330	2281	2146	50649	100287600	27076	11343	3561	3764	390	9636	8991	10633	2002	89845	5819	10912	8870	4973	4502	2263	7482	48	3005	7251	6402	10135	6556	7128	1397	7035	4318	570	8837	7852	7037	440348	10123	4477	1514	10397	3796	2026	5970	54541	4683	7360	1116	3738	9683	677	11138	6853	1803	7185	2114	23179	11273	2843	22839	11259	549	5266	5376	2632	7187	56548	4794	2014	1069	126353	10318	9732	101	1847	10652	220965	954	23237	5083	2691	6648	6624	3270	694	58473	219699	10938	4495	4058	23363	284	8425	27077	4113	127544	26051	10573	6440	3671	9508	637	8854	6352	2120	23211	2874	10653	221830	6583	4493	10895	26585	10659	1439	64116	5606	10325	23135	3142	80143	4490	9363	84900	9816	219	26238	6524	2057	3351	8406	5687	7130	6368	7082	9516	231
GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_DN	M5204		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1023_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to 5 worm/well B. malayi.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					686	9459	2720	5447	23345	2067	6192	10724	4678	230	54107	3015	51109	1729	3683	910	7385	8604	2204	4048	10218	2492	3449	10138	5305	3904	9968	8675	1975	1000	6653	191	10493	6146	7915	6128	6882	10961	9056	2618	58530	140710	81550	175	166	5111	23166	5294	23173	3073	54504	4849	30837	1234	3133	4723	9332	1465	4833	2353	162	3064	79602	23344	5094	1230	2797	5137	1363	4332	10302	1777	4689	7409	11329	929	6827	6428	2217	4968	6414	539	642	5336	56829	55794	2878	7204	5271	23294	6390	8888	23460	59	1601	6401	22846	1794	9391	3111	51035	27290	2237	224	11188	8864	23384	55174	8501	9260	3109	5175	23266	140	4588	11041	6397	8106	8473	9948	4647	269	9046	7086	23191	10946	8525	5031	5547	9761	675	9934	22883	1018	2071	1955	3151	912	5437	2648	5090	4033	6867	7536	667	1312	4035	161	9581	10129	11326	4437	8893	939	6627	3385	152185	8453	6837	23478	51020	719	5742	7096	23468	5579	3684	23126	2077	271	4050	8019	5451	5032	130074	6689	10212	11240	23020	6197	1978	81609	2647	3613	60343	23443	8673	10106	6510	9917	10695	883	80765	4149	9314	5790	6275	10628	27020	10875
GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_UP	M5205		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1024_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to M. tuberculosis.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					4065	217	10302	2776	2155	10540	8751	166	56548	7392	10856	23125	9896	1327	3675	613	55218	23404	4542	167227	885	4193	902	51112	6755	4357	7188	27076	5236	94239	5836	8140	10916	2709	1727	3142	2099	23333	6944	26993	10422	8854	54535	3567	58473	6508	3663	3257	3892	9788	89845	11272	29775	80003	11131	3015	7062	11007	221692	4849	460	7204	5780	22838	2534	7158	9363	4990	8451	4809	1933	8761	23370	949	5786	10912	2309	162	4666	10814	4245	79065	1889	26065	22839	7852	30968	7384	7385	51594	8565	7030	5032	794	3868	6850	79888	6899	9255	5184	10468	25915	11332	570	57017	23401	3148	5468	55001	2859	23344	246	6916	6196	7083	4477	9413	191	6897	4091	7001	622	3115	7108	11020	3784	54	23394	347902	9957	5934	2346	6662	3385	55854	6720	2806	993	7023	23076	7284	3484	25777	7422	875	5816	7763	2617	1478	126353	6510	23503	427	402	5452	3662	219699	51760	8651	331	7082	3351	3613	317781	1687	1112	100293553	2624	8792	1003	149603	5322	8575	7458	130	156	23654	23151	4113	7267	56125	8718	23514	2281	9820	11258	256987	988	8767	25774	25771	6461	10898	10572	83759	4048	8776	11273	842	10981
GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_DN	M5206		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1024_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to M. tuberculosis.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					8161	5654	6428	6248	4332	3326	4600	8544	23136	6119	1009	221	23052	1384	2618	2353	10628	883	2936	6888	58530	3577	8728	6347	3937	208	6307	2643	8638	150967	9541	5579	23096	7318	2214	7280	30849	12	25903	27241	9830	6355	4615	6397	675	6351	2797	4738	5223	6624	6038	4939	54103	9332	5684	9918	2147	23279	9056	100506033	10106	3683	27290	8655	23064	11177	9325	597	4317	9641	9643	9188	9940	1545	1375	8880	6401	4588	11041	9636	23341	7596	269	8908	5341	25939	7078	11315	4860	2745	4599	10561	81566	2180	6498	834	1318	10384	1116	710	8662	51083	3281	10964	719	5272	939	4744	3665	2752	1462	6773	22809	3575	3303	11130	3157	680	302	2885	6280	10154	9447	3434	211	7096	6279	283638	11240	10724	23189	80228	488	23379	23169	3965	3433	5790	644	10006	952	9246	407	23126	9972	5089	1369	23424	8545	5687	5837	7203	6354	8869	4149	5271	1018	11196	1746	8343	3772	1993	10043	915	5481	4277	728361	4061	5425	10599	9019	8743	51379	56951	2012	3227	1087	84851	9100	4920	1581	8453	53844	929	7184	79053	50846	5467	5700	6241	79191	6708	1948	1305	30848	7356	9306	84991	9282	9024
GSE360_L_MAJOR_VS_T_GONDII_DC_UP	M5207		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1025_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) exposed to L. major versus DCs exposed to T. gondii.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					2570	733	23770	4899	8470	23148	23132	10052	9370	25999	85360	786	9576	353500	7100	85235	1174	27349	6019	7104	3745	6934	5068	8824	27306	7857	25803	25878	866	9517	100131434	5274	2053	57242	11012	4854	5244	80316	26050	5340	30000	51018	957	26033	4626	10926	57476	4985	8749	388567	731	6694	3755	2118	2559	2670	10930	56	2538	4638	3957	92211	60682	2636	2660	3814	50852	8329	8085	4212	3177	846	6300	8174	3000	6097	2796	3199	7044	3765	2204	8742	10418	127833	270	55567	388699	10879	8387	344	399904	4907	7139	319	4162	13	23232	5304	6236	6677	2743	9398	7694	3866	5152	22943	2824	116832	4330	58495	2299	4017	135152	6005	22915	7288	7433	6822	7718	347	23243	8416	1496	114	8357	3798	643332	2139	2954	2219	1821	25827	6758	6383	460	3623	768	22905	29895	5393	249	389715	10278	777	7328	23562	1823	9644	2918	7975	171558	5020	11250	22829	11160	41	2892	9670	79863	5539	9942	3895	10692	9098	5412	5771	8763	9555	56253	11135	8727	9168	4303	25957	7171	56252	23498	2290	988	1359	29798	23078	774	23450	9541	1847	9334	3856	10368	2016	2617	3681	23325	6656	6510	22847	5199	10221	1340	7586
GSE360_L_MAJOR_VS_T_GONDII_DC_DN	M5208		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1025_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) exposed to L. major versus DCs exposed to T. gondii.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					10325	208	7053	3707	23641	100129500	6665	8502	347344	8692	9715	2342	11001	1138	23255	9758	7746	1113	8876	3240	1287	5957	3552	5558	745	1428	57148	7352	8988	23331	7252	885	387032	22927	6689	10233	8480	85458	4060	5994	100129973	169611	57827	3205	6360	5968	3044	5473	5618	8576	339479	2318	23326	55756	27340	23085	8131	79173	8607	23195	8481	6263	81578	2672	3567	79073	8904	57007	10483	2562	8910	881	6120	26093	9601	25937	3206	1584	11066	401251	23252	7301	8079	49855	4629	4914	3449	7123	503639	5239	7380	10693	55215	5158	11318	776	23049	7058	10873	2707	3008	9933	6908	359	8809	27095	10461	6884	7163	2583	4883	63982	10439	25	154796	9077	22843	10573	55966	23030	6632	4320	90141	10716	9180	4712	3713	90338	5931	3007	1286	5463	9529	23649	64848	5053	10336	10111	1363	9993	3633	22996	9118	730	9331	5001	40	25822	7043	23510	6482	116138	636	10235	2846	5475	3077	29855	10220	904	3035	283212	27044	11060	29957	9625	9889	200081	775	90355	680	9014	57468	9911	6389	3880	50846	4858	1812	9747	23547	9313	256949	4147	8669	1901	154	84679	3632	5828	23384	51752	1295	9175	9515	2729	155060	10252	11069	10745
GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_UP	M5209		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1026_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) exposed to L. major versus DCs exposed to 50 worms/well B. malayi.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					5630	5329	6853	8323	9609	9470	4862	2819	22882	6004	3716	3117	1187	3792	3620	7586	1514	26128	4014	51031	5136	6303	1847	157567	7133	65108	22836	164656	5127	8851	8788	9435	1045	167	7321	7221	2040	369	727897	3481	6282	157680	4493	2180	49	3046	6535	23300	671	221692	10950	4670	11339	1196	10446	22794	23312	7357	60312	1032	8406	272	345	1026	6500	10133	537	8899	9443	5732	9595	7127	10293	9334	25816	4849	10154	1105	11030	91289	8622	2114	23683	22979	3557	4502	8843	7351	9242	5025	2827	23625	9563	2859	2267	54581	7185	4318	23365	26168	2524	5652	4771	6804	11098	3161	56311	8073	11333	6736	1945	4016	6348	5970	7852	9908	5199	26275	4593	4292	9125	27351	1364	10912	7412	10990	11076	10795	64116	4738	2803	9589	2537	150	100507424	65117	4683	2491	1839	919	56267	8660	9019	5174	27246	3383	169522	10797	6624	27074	10137	9086	23759	5108	57152	5996	6006	6641	4891	3824	7143	9895	8858	6649	3939	3845	10079	4739	8192	8530	5768	7128	8870	5990	9266	29114	2905	5128	366	6688	7444	7262	4792	23451	10409	3425	1827	317781	5604	8837	9687	2146	11189	25915	5408	10791	5714	9324	3796	4359
GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_DN	M5210		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1026_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) exposed to L. major versus DCs exposed to 50 worms/well B. malayi.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					360	7140	23252	11102	11145	23428	904	6567	5239	30851	9897	8405	4298	23654	6039	9885	10084	10199	23580	11056	80273	7355	6093	5330	100129500	6898	51704	9515	6183	4124	26009	1977	23376	51433	7371	22841	100287107	2246	3206	2651	27000	51460	3739	161	951	7390	10467	1601	7443	2551	23768	4967	5310	545	9314	116828	6455	11309	7905	10793	699	23225	762	490	3418	7754	10220	593	11097	6146	8131	2045	9902	11334	3728	1849	7979	5933	639	10969	10395	928	8607	2882	6331	2356	4163	23279	10654	90	55922	9851	23030	11345	5616	763	6627	5710	8412	10524	4094	7414	5925	775	6263	3720	23168	51760	1612	3069	9	9886	350	5434	3832	92856	9928	10939	3428	6811	140	10605	2786	4325	22828	9647	3044	1778	4643	7773	85458	7748	27288	5111	8985	534	8295	10943	1102	187	55705	6712	149603	8527	11223	3339	7086	136	9173	8019	1519	9761	9723	57827	4610	8888	9807	6731	199731	9158	54504	8634	27185	913	4942	5133	10396	55966	6434	9189	7005	4299	7023	6916	6122	54435	23637	10202	6786	64149	5777	8570	22893	4223	171023	5425	6895	79161	11331	23198	10232	7464	7764	26019	9962	23401	5521	4726	27161	4920
GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_UP	M5211		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1027_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) exposed to L. major versus DCs exposed to 5 worms/well B. malayi.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					1236	8604	2819	8745	10382	2986	5737	8846	6556	5230	55120	375790	10086	6515	25770	5136	10659	6396	4058	9146	496	10102	23450	57147	4790	4501	6348	9738	4295	8800	50626	6853	2997	51232	7494	10562	25948	167	5211	537	27429	6583	8548	6648	7221	3820	6597	3336	7852	7133	7128	5967	23152	4973	6612	10410	6890	81576	64285	4308	55215	24	4814	3563	23645	6715	3434	345	9683	9583	26268	197	3872	10293	5721	5685	9242	11127	5888	57146	4118	5376	694	22979	148022	10950	6526	129080	1195	4318	25920	8228	5516	6535	11054	6804	5740	11098	5270	396	219333	1803	1499	65108	64116	6736	6303	925	55832	4016	26873	23256	81628	8406	1364	26240	8237	810	6233	11076	7750	7360	150	27338	8189	6775	2874	3624	6173	10318	1675	4356	7062	8870	10244	6504	159	5190	9732	940	231	10670	3158	57152	2309	26152	10733	22862	11083	3856	2634	3824	10409	5292	3337	761	11070	665	3383	283755	3553	2040	7187	549	7849	4633	9267	220988	7482	7295	23423	8717	9516	2632	8835	1147	9311	5601	23253	10653	6402	64582	8854	9589	26103	11189	4817	3569	51141	10260	5252	8932	3641	10912	9073	10766	10938	6355	10123	8073
GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_DN	M5212		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1027_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) exposed to L. major versus DCs exposed to 5 worms/well B. malayi.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					5310	9761	50937	80273	6567	10128	10994	7203	4712	1659	695	686	23039	6495	8985	3567	7587	4660	4607	5336	1998	51704	4522	11309	11168	7024	6584	7098	397	2651	5631	8743	140465	63941	11066	1936	4023	5786	116828	3084	5243	4094	2194	3421	6376	4850	6854	409	9886	402	7905	9071	5473	5933	2045	3551	54732	55735	26137	10214	9940	639	23279	3418	6636	283345	347598	79026	6331	23160	22832	2356	10428	11200	4855	6604	3861	4123	1849	4141	23019	9948	4190	10158	28823	3459	23761	10462	282808	126208	5175	6047	7988	1797	79022	6895	3628	9194	9934	4860	5239	11104	9647	9993	78987	4967	10581	29072	11334	2215	4077	63826	64112	54700	29994	5747	84981	51601	3032	55187	4060	5558	131408	2583	6434	2792	51780	50649	10945	4033	316	3159	9470	23338	2886	10695	256949	23623	10129	51109	54435	10654	10963	23176	8165	4925	51588	23608	9270	5422	8844	8829	6786	9911	2395	187	171546	23452	10195	9508	23475	5777	4358	254531	518	22989	974	23518	7414	3195	126299	10467	10207	8722	2350	4320	783	55746	10983	23054	5828	8038	10436	5449	3015	2648	9048	8714	7409	64848	9046	2624	1163	6837	7922	9221	22982	25804	5092	9679
GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_UP	M5213		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1028_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) exposed to L. major versus DCs exposed to M. tuberculosis.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					8099	11247	875	9938	5018	5763	5211	402	2819	4312	5501	6535	100419017	11083	23433	65005	7106	8792	9640	9014	833	23645	167	56548	9377	7390	7221	3497	27295	79065	23362	94239	6929	149603	25805	317781	7422	11138	10457	360	1294	7030	23401	3148	10682	157680	4193	10928	2346	84302	7125	345	5786	8165	51430	6196	9788	26036	10293	79921	660	988	5920	10408	10498	3142	4621	4624	9936	2317	5593	22979	10668	9363	4849	6597	9032	9555	6156	162	7388	1105	1838	10659	5339	23355	11337	3624	7186	10368	23295	221692	10123	1727	79646	3667	11098	6764	9563	9454	2272	1615	694	2874	6736	6753	573	3797	23169	3784	9619	348	5184	1364	427	246	6173	3858	26993	8073	810	11076	22800	10814	150	1933	9420	100128124	1285	7083	2309	25804	2915	23081	1327	4988	4191	5101	6191	57096	9150	10636	7062	16	25813	57152	622	3563	6228	8887	6576	7392	9400	9895	3115	4071	4208	4059	3476	8629	57185	84726	8495	6164	130	89845	9674	5605	100129361	56848	166	10507	10105	1207	23212	1810	10139	9315	23423	221154	5955	11189	9820	6472	2534	5093	8225	3565	3641	3158	23093	5937	10766	8852	4668	1195	10912	1263	7077	645961
GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_DN	M5214		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1028_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) exposed to L. major versus DCs exposed to M. tuberculosis.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					5087	1164	6567	355	10043	1290	6231	9201	5239	7043	3326	54732	1594	8519	9515	6648	27099	23424	51704	3948	29994	8309	100129500	3452	5919	7097	5451	2885	1977	23053	2705	26574	3417	771	6819	1187	10288	5194	7053	3206	100507436	116828	3950	10062	5558	9636	114049	11066	203510	2045	5610	8777	23279	639	2922	1066	4600	10125	6331	56950	10128	10133	2356	2651	5579	9470	23160	5518	958	6737	2215	1657	1536	9	1848	1019	4281	26030	5514	22837	5272	63826	3980	8481	85458	647979	57187	22854	23576	904	3069	945	5880	6122	4140	9747	9256	22868	8131	56062	8542	3627	2792	7552	22900	4104	2717	6899	488	6046	9521	4603	5521	29957	913	2180	8886	6672	5500	7804	5698	23252	3340	1375	6120	10202	6993	23532	5001	241	3434	10724	974	10628	529	23546	2551	2353	940	2074	2324	283	5654	7163	2137	2592	8079	6928	55720	10046	10346	2315	79703	27130	91543	10963	1428	7050	30848	6170	9671	5909	9928	4738	9189	7287	397	858	64061	5104	5883	6428	3240	9332	680	79191	54870	11080	10856	1317	10439	2872	91851	4317	55578	65123	283459	9657	23126	58510	2986	7639	5481	1948	6249	29072	5721	2303	4826	94134
GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_UP	M5215		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1029_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) exposed to T. gondii versus DCs exposed to 50 worms/well B. malayi.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					388650	2633	1299	5463	3868	1847	205	816	4065	11343	5721	1004	388818	23649	1025	10409	1298	6303	2643	4701	51308	7185	570	9308	664	3575	9693	1236	283638	9589	4862	1293	1776	10957	7074	9129	4792	6853	4345	7746	3703	5687	8503	2334	1869	10382	1259	1855	4790	6006	26284	8013	745	81553	9715	6648	3430	22992	2023	597	84302	4791	399665	8717	1843	85458	7188	255057	8828	11074	9863	23705	1528	6847	11069	3601	4185	11122	9563	7626	5174	356	694	2983	2575	3490	8609	10410	324	2731	81611	4109	5996	8837	1013	5334	92017	7991	3669	80143	7852	7127	2997	57007	1846	114088	4489	3567	2672	40	434	3486	4283	247	10573	8289	7167	4637	10769	6993	3491	2811	3437	3425	6857	1068	3612	5475	3600	2026	6506	3400	51352	6755	6775	7444	6440	5076	8407	100130418	9021	2583	4146	7295	815	9435	100287809	6616	6443	221692	6890	22809	790	2639	10049	91543	10950	26212	932	3082	1287	1831	4297	1607	6361	27074	57148	9436	51066	8669	90634	4820	7075	7128	5966	4999	4868	7153	710	6453	10233	8904	10979	25841	6558	27429	5074	22882	23180	5971	5376	859	8676	3552	8817	3514	27102	4616	4053	72
GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_DN	M5216		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1029_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) exposed to T. gondii versus DCs exposed to 50 worms/well B. malayi.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					240	4035	23608	23076	6769	8727	9778	115207	9619	3026	10371	2077	224	2617	23175	3709	7975	3790	2350	23288	7857	9976	8085	27020	10647	23770	6510	83637	2817	1102	4900	23089	10141	2053	6310	23092	8824	3077	3904	910	90865	92211	5393	7100	7813	154661	6019	8209	4066	118	8178	7515	3073	25957	8763	6039	4094	23460	23326	4957	5064	1124	7862	7464	11027	5244	256987	3087	460	8905	270	341	114876	140	23345	23475	58495	9709	10096	7168	7086	56271	26234	7104	54453	8675	65018	8396	22847	9131	23383	1777	11250	10618	11117	191	23163	26136	3493	9098	3177	9792	64067	147339	5878	6049	41	23368	25900	4481	25978	4627	2162	9046	57178	22838	9528	4017	831	2119	55806	25840	4353	27095	9948	777	5621	3074	846	219654	3745	254531	23659	22905	10961	1612	8525	1845	5336	11334	8536	9701	57228	10418	6256	5175	9601	54504	6695	1959	10287	3910	8038	7678	6383	9934	8314	1455	113	23370	6300	22890	1020	1382	57185	51112	5636	5547	3052	3417	6461	10628	9555	3705	8446	1432	7039	913	3133	5567	909	7529	10908	7461	4258	3044	4722	8677	7414	8720	1039	22841	3635	26608	90410	8869	9337	8604	4005	6275
GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_UP	M5217		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1030_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) exposed to T. gondii versus DCs exposed to 5 worms/well B. malayi.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					7185	11343	3185	9589	6477	1847	6482	8837	4065	205	597	8828	517	5687	1298	10420	9322	664	51308	570	7746	23034	10573	3142	9662	4999	9308	388818	81611	1843	10409	776	9715	6648	10124	23649	3868	6890	6303	1528	80143	9901	546	1068	1107	3995	4345	8607	6883	55623	5721	5796	1719	5996	6853	54541	3632	23178	22992	7128	7852	10659	1195	390	8407	8503	4791	3575	9693	10964	4790	1266	221830	11067	11137	8882	2633	3430	2997	26051	665	7626	1236	6006	1025	6424	790	1478	55215	1594	10325	22866	90634	1964	8858	3437	4109	9546	3075	23017	5918	8717	2643	3669	104	57007	3017	1641	5142	2537	4489	197	114088	221981	2672	70	8444	6847	4792	6891	4325	64061	4283	1027	694	3044	247	1875	10410	23363	57468	9849	7706	9435	9447	9651	259197	90141	50810	55251	881	2632	1846	2731	4099	10981	7310	1565	1104	1508	6770	5376	9947	7984	8513	100292813	6506	440348	3703	3082	22882	1880	9750	23237	10957	6696	7403	4058	4147	10950	6278	1672	24139	8013	140609	51066	7295	2146	2120	3642	100287809	10318	23030	607	8001	23180	3696	4951	91543	7991	932	7280	4110	2788	9436	5149	151230	1828	11049
GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_DN	M5219		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1030_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) exposed to T. gondii versus DCs exposed to 5 worms/well B. malayi.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					4035	3087	9541	240	347344	4360	6039	25957	23608	7862	224	3026	3904	6769	9529	4900	846	2077	341	191	2892	539	5023	7100	25878	23161	9619	10647	7086	26234	27095	83637	910	23460	23092	1043	1797	9555	26094	9131	6510	10554	9270	26045	154661	8673	3381	8727	3084	10481	1729	7515	5079	23344	8396	254531	3073	26050	344	6275	114876	27349	10961	27020	9046	10158	5336	1496	11248	1124	6817	2119	54504	11200	2162	55174	3866	10692	3895	22894	25813	115207	2353	1777	7464	4094	100131510	113	2350	64386	23166	5340	4066	3709	4258	22847	140	219654	10476	10141	7168	7048	25840	3133	23288	3081	8038	5547	23770	11027	23659	55806	10418	4287	3417	8284	8742	8675	23062	246	58495	729	6366	8536	1102	10628	1004	3064	6653	7461	909	8314	913	23175	5585	875	6387	3077	7813	4193	116138	118	23475	9098	9934	4332	4729	1513	8209	5175	10908	7039	779	4722	9640	5447	3856	54453	6310	4048	5436	11329	11334	10096	719	3913	23345	128	11119	23299	8677	6049	2280	2517	10487	2878	7414	65018	1432	5412	10287	2205	762	147179	6531	10641	9450	6050	5567	11043	10129	7123	116828	22846	2675	10875	3312	9948	8869	1794
GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_UP	M5220		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1031_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) exposed to T. gondii versus DCs exposed to M. tuberculosis.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					4782	217	51112	3385	191	549	1299	8904	2342	9455	3868	8480	4783	23370	10160	440	1298	8292	3833	10400	6559	1287	988	4065	7074	8079	23076	23326	622	7852	51308	1776	1108	3158	9087	570	27095	7188	221692	154796	5498	9619	23394	10659	6510	22838	1025	347344	517	1350	1605	23404	23514	1054	10981	57017	4193	79073	7158	5612	1112	3142	6692	9934	2346	10507	1392	29855	816	6477	246	79888	2617	4345	16	9600	9709	439921	3858	5310	84302	7384	11143	1107	4666	3784	4185	9172	23593	9739	6715	5745	6720	9563	9407	740	8208	8842	4109	275	22872	3895	8092	197	224	1964	57060	26136	6389	58487	432	7204	256987	2672	7108	5994	8738	8576	875	6461	1428	25966	7380	10331	9014	23163	3044	247	401251	55218	54346	2030	100129973	3957	11069	7264	26751	55001	109	11013	23098	9016	26093	5957	2692	6376	6469	6770	203	6136	6001	5322	6506	51594	5834	3067	57134	9894	10147	1207	10973	4147	7746	10641	9788	3035	10653	3552	8858	815	8669	55611	120	2983	10014	23212	4998	7915	9618	5376	9312	1259	142684	8001	4141	7372	8481	9807	23217	3046	10845	932	225	65110	23492	9436	80143	3488	1454	267
GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_DN	M5221		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1031_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) exposed to T. gondii versus DCs exposed to M. tuberculosis.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					6347	10692	3309	923	9976	3430	25957	10970	430	9541	6279	7975	846	9334	4332	9370	3312	3772	10647	8876	56	83637	80316	5721	8544	6248	6888	23092	7078	283	2299	92211	23132	551	9024	115207	84991	719	3575	7515	9246	2643	9098	3988	3910	2570	2204	11119	4738	7718	950	5052	7873	7694	8742	3798	3931	4615	2637	2012	2167	7053	3745	1948	5687	3303	6993	10481	713	5771	478	2633	54870	283638	2152	3904	23078	55806	4317	4729	2752	248	11160	64067	2959	10096	5686	50846	58495	2209	7107	1545	10628	7586	23012	6383	84909	680	834	2954	2745	10052	7039	8869	22809	4067	7862	9332	221	5696	6354	1848	10791	3761	5597	2353	23175	208	7358	3959	6531	324	26150	364	10288	6708	116828	2280	2180	4283	10487	6737	597	10184	8542	100288679	7318	6890	10237	2053	6049	8416	467	2214	56252	6746	952	5698	5210	3077	2670	27241	6869	4430	7275	1902	23434	2239	929	50814	2207	710	3071	2979	7127	10255	5473	5168	50853	684	1831	64750	1215	10368	128	6769	3669	4277	8749	27032	3437	1757	3493	9830	4704	2119	84612	10627	5878	240	22943	6351	241	976	1581	1187	6672	10652	10107	3965
GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_UP	M5222		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1032_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) exposed to 50 worms/well B. malayi versus those exposed to 5 worms/well B. malayi.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					776	5531	9683	115	219654	11273	10979	1499	1849	4123	9792	23514	200424	2769	2739	5207	8131	1207	534	10899	3276	10994	10670	8477	7965	23423	11070	3693	118	8714	56948	9425	50813	100287600	3442	48	7283	3559	7874	1647	546	570	7165	283755	55623	22985	26578	4477	11154	27347	1756	3738	11027	22900	6583	55186	1955	131408	1519	84059	8233	58495	8985	126353	6845	4717	23053	8446	5469	4289	636	7993	357	1854	10659	7979	10458	9601	10950	26103	496	4999	9785	11259	56171	7205	10895	8091	483	23133	9900	329	59	2905	219	11171	27000	9318	5602	9778	5054	9903	23394	2874	4794	23185	10422	6317	25847	54454	10527	9146	9665	25771	5223	79882	5601	26574	1565	545	221061	9645	22838	6478	1029	1491	85236	9856	9367	70	6917	23383	11138	10540	2182	57468	5685	6461	5584	23285	23431	1311	2542	24142	90627	1508	26035	6847	379	8848	5406	54677	3212	29902	9917	9363	5149	2632	23089	5142	9658	665	6813	2053	2643	50810	5898	23607	5033	7292	4110	8909	6434	26039	6019	1040	3275	2731	5877	881	9928	196993	6474	23256	8038	1145	3235	8971	793	51066	23125	7310	4886	4052	57016	7857	7083	22986	9352	1114
GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_DN	M5225		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1032_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) exposed to 50 worms/well B. malayi versus those exposed to 5 worms/well B. malayi.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					9643	3449	6376	1579	7786	8614	94	10094	1045	6837	6827	9793	3110	653238	2204	4359	23007	2532	9638	6006	1975	11326	140883	9863	1580	23349	10141	54874	23266	5166	2797	4860	10900	6428	57613	23197	3159	641	27293	6273	10628	5630	5700	27290	782	10847	10449	818	1004	10157	8273	302	4588	11041	39	4236	4701	283638	2567	269	147179	5496	9124	827	27338	7175	4033	4045	152185	8406	126208	4324	9479	8624	10402	8161	5294	23270	3417	11240	2184	23213	2107	1960	5790	10871	51493	10542	4915	407	5047	1280	9173	11187	6017	3565	5094	1293	834	23620	10093	5089	6440	8317	4001	5837	6455	5458	6876	6098	3459	9470	11337	7189	5136	4820	728361	3298	238	9582	8451	1087	445	1763	340591	51109	10947	9761	2267	9125	6443	10367	3608	623	10488	6124	55503	3567	1346	6489	695	477	168374	10207	79921	10623	6503	92017	675	100507424	25956	2359	8609	6368	10613	25878	2549	23161	8829	1031	64386	9071	347	6857	378708	9135	10481	6688	63941	23072	10280	6534	529	889	2647	11330	9940	650	2515	4053	6284	8621	3400	8899	23119	10436	23193	1826	6447	5576	1577	6746	1855	7419	3760	7818	5695	10388	6405	7174
GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP	M5227		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1033_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) exposed to 50 worms/well B. malayi versus DC exposed to M. tuberculosis	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					1124	3269	23216	1675	86	4066	2077	2631	23334	8623	8536	4048	57178	7091	4141	3399	26574	11325	23370	23428	9612	8651	5825	6376	10462	3628	5125	9249	54504	5616	10054	10801	140	6414	115	81875	5822	10575	2653	7168	4005	7023	6908	118	23125	6275	65110	11322	8692	10634	9535	10480	3276	6449	1964	30968	8402	26994	678	10983	10768	7322	7862	2281	10467	4809	6709	3074	11130	23503	9686	5175	50717	1655	5207	2208	10541	23369	10572	9957	94239	1000	9367	22827	9698	55922	8751	8209	7086	708	10907	3385	874	23002	10916	622	9761	217	9931	8761	9255	8125	9785	7874	7965	23492	5495	8872	5834	4357	522	8665	3015	25771	9450	11331	9363	10945	9733	56848	6510	22872	55854	4670	5445	30851	10287	8295	11309	91647	3069	8451	10908	9980	1611	29855	9903	79161	5045	8481	6039	2162	7186	23479	10961	7461	5322	3913	51573	166	23333	5880	11171	2675	23335	5094	7284	11314	4726	3313	6208	11027	11138	124565	10557	7077	1112	23200	51760	1933	949	5612	8772	374291	928	3148	6001	25907	4122	11334	7274	26100	1445	6311	988	7533	341	11273	1891	9049	23274	51594	10522	283755	162	8543	23654	84869	570	90410
GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN	M5228		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1033_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) exposed to 50 worms/well B. malayi versus DC exposed to M. tuberculosis	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					6428	6252	4616	671	9643	3433	2214	7280	7184	3761	3557	4504	7076	2152	8349	1411	57862	8189	23233	1462	5549	30848	6279	1545	9693	5606	8676	3434	4792	8530	375790	2820	7873	6347	1890	10953	9332	4494	10964	23007	7453	51379	1827	100	10630	3690	5265	22898	94	23645	23119	9125	10381	9435	22809	6713	10791	10561	771	4490	8013	4493	1843	2634	3301	23096	6351	22904	3936	7804	1565	7444	4973	9308	6710	999	169522	9242	3458	3227	1622	6374	7185	6789	2766	2797	81553	11343	10384	127544	5684	10668	1847	4316	1036	53	1514	10038	9589	998	4939	6280	11177	6888	6649	4321	3281	4495	529	6355	5721	5652	27290	7412	4277	5996	7586	7127	4318	283638	23253	10154	5359	10157	9940	23052	1236	2752	6354	9351	1580	22836	7295	9246	4588	57187	123	11041	684	2643	51343	269	9263	22936	3778	3949	10094	10006	675	4496	3664	2633	205	2537	8850	11315	5700	10397	10124	5707	1848	23154	10542	6307	6560	8870	6303	51083	962	3559	388818	3608	10346	4790	7159	5699	6282	586	4600	10475	6737	8655	1439	4520	50486	1536	57556	1831	9334	9315	3587	710	3383	2745	4502	26509	7096	5734	7332	8728
GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP	M5229		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1034_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) exposed to 5 worms/well B. malayi versus DC exposed to M. tuberculosis	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					7168	120	217	4066	6876	1124	1849	10945	5664	2077	6446	94239	4005	118	26001	8522	113	9363	5934	8795	7001	9905	7086	100129361	6907	10961	23163	8536	4689	6749	3046	23151	6678	8451	3693	1378	2208	27013	10916	6850	1854	23654	10084	3419	5125	5494	4358	10664	3158	7157	11186	26211	5032	7461	2309	10057	6232	6050	10449	8841	9705	6709	3684	6503	4360	4809	5184	6164	54504	7384	10422	6414	2675	2217	5207	6897	6035	8140	6125	2720	1592	6144	6275	8694	23062	23094	902	10847	9555	25907	4666	1955	11131	993	9592	460	11331	7494	4193	10572	847	10400	6510	9450	4048	2346	8125	55854	23270	23166	6653	473	11329	1043	83759	6819	10628	9404	1975	10147	4724	10908	10287	3015	8731	4849	5330	3628	8665	8073	1611	6450	9761	23076	1937	3727	6001	3385	9552	2958	341	130	6605	6039	53635	113419	6189	23160	7375	8038	2162	6129	23593	23216	22872	11188	1540	4701	347344	1327	9820	140	988	1810	9896	240	8396	832	8498	27095	54440	191	4141	131408	41	4090	9400	9294	10981	678	11104	4122	142	79073	9612	495	9445	3159	570	5175	2091	8751	1212	4477	2782	3913	8888	427	1465	23125
GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN	M5230		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1034_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) exposed to 5 worms/well B. malayi versus DC exposed to M. tuberculosis	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					4686	9322	50486	10791	1890	5606	6279	9332	9589	5189	5708	10154	1069	2321	8992	9683	57187	999	9526	2705	2752	2669	7453	998	23476	22898	22809	6741	7849	2769	771	6774	3690	8131	3383	8837	10432	51232	4493	8638	203068	4502	3939	8655	205	10630	8454	23007	3587	10397	23645	4615	10652	8870	4061	3433	5209	9308	9470	6713	6280	2239	961	5611	7280	64285	11177	1827	3561	23180	6374	5638	100292813	962	3301	6347	5265	390	488	2766	467	3937	23220	302	7941	5292	1843	6773	3303	2040	3309	2797	7037	5329	838	5144	23253	11079	24144	64750	10475	8349	2015	1847	10381	1395	127544	8717	6348	6737	10616	3624	9587	684	9034	8854	9541	597	10205	3475	8942	6038	22936	5359	330	1317	10576	27290	6583	9256	1514	10102	4321	9659	10906	10157	10420	8685	4058	23258	10184	4600	6504	55120	9246	5898	1719	27338	5684	4588	4830	4495	11041	4939	10318	269	7295	1839	9546	3559	6016	6354	719	10692	1536	3563	1528	4490	1236	10409	9693	1437	6370	2634	55062	400961	8740	5516	4501	211	2263	6238	8289	939	3312	9467	85236	9516	2820	10561	8828	103	4318	6396	2215	4860	1018	3936	4683	6624
GSE360_L_DONOVANI_VS_L_MAJOR_MAC_UP	M5231		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1035_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages exposed to L. donovani versus macrophages exposed to L. major.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					54504	58495	3945	27237	84726	26469	4005	10476	4677	26156	10250	23086	6649	10454	22858	26191	23598	9332	8450	6634	5547	11168	10558	10542	7678	404672	7525	27235	4942	25909	387	5224	25898	25804	4287	23157	1312	7001	54453	412	8317	9735	6635	26092	116228	11146	80301	9497	1811	2523	22827	10092	10775	2665	10874	22796	570	5625	7398	10857	3176	5836	6418	4477	829	5571	4807	474170	10695	23291	55958	1385	8501	80256	23361	6390	27350	6869	22	126353	6426	1620	5917	9107	11157	5058	9315	3663	51031	52	8833	7994	4103	9859	113	2060	7597	987	22908	3725	26130	6786	1654	23623	23054	6652	10935	56171	23304	5780	2214	5162	196441	10895	8533	283537	7516	9831	23062	25	7705	4201	9682	9936	4191	10479	63941	4154	10105	54471	6749	2878	23036	6035	4361	8224	3683	10465	2172	199731	9851	2695	7141	8165	4733	6375	2202	4899	3885	1499	9844	2838	1644	200081	8502	51778	25807	25843	10660	51035	6453	79912	55816	8694	9538	9020	8664	56998	23173	5320	7520	2902	23302	4300	6185	1409	199	5799	2251	51096	186	23339	8148	1982	162427	7988	23114	10160	4436	2246	51588	2765	891	6827	7270	23166	9755	9927	2555	5243
GSE360_L_DONOVANI_VS_L_MAJOR_MAC_DN	M5232		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1035_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages exposed to L. donovani versus macrophages exposed to L. major.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					2921	53916	1236	81553	4792	9821	23616	3914	3849	3112	11046	9711	10299	1748	10524	8882	54661	5071	23199	23096	84612	6464	57493	2314	164	308	2797	23078	100507436	8566	3985	6881	10630	4289	35	9557	7128	23295	8887	9277	27290	64750	221823	9940	8406	6775	2560	4588	933	269	5142	177	182	10006	9715	10133	1193	58509	9516	4591	1678	939	1535	4319	9267	85236	4324	9693	11240	1843	2643	3029	2488	9377	7130	10318	51710	5532	10658	5790	22986	59	407	8666	5128	4791	7773	3716	999	5089	29855	5611	27099	3084	5837	27032	7376	152	1734	6364	1268	2954	5136	5396	83988	445	6665	5800	2015	7291	796	728361	7941	7745	5326	7029	8821	846	1087	23403	672	90338	3553	5083	5367	8798	9576	22915	221749	3593	27286	8336	9536	3760	27288	5969	5444	10553	5971	5276	5932	4635	1821	4192	5350	231	3242	63826	2892	168374	11144	79090	6834	26031	842	100133941	7185	2919	5830	5329	2674	3400	54623	10938	22824	11099	1537	2627	3706	54737	5802	1847	1111	23169	8837	1388	3797	7127	11339	4504	7070	25794	131408	1437	2028	1153	116285	9266	9720	1746	8908	25816	6727	11330	3491	87	7296	2000	6504	8440
GSE360_L_DONOVANI_VS_T_GONDII_MAC_UP	M5233		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1036_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages exposed to L. donovani versus macrophages exposed to T. gondii.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					7844	6827	57187	6503	3914	3493	10322	25842	23361	515	10402	9019	23220	11051	374868	7846	474170	79026	9129	54737	5207	4647	4077	221	9601	2286	5275	11183	54462	387	7071	37	23473	10105	5076	57460	2149	9697	80868	6729	4048	9332	4308	2185	570	10993	25829	5055	3927	3738	5000	3309	10630	8740	83660	23043	57515	22846	23258	8521	7204	126353	9778	598	753	7032	953	157627	54434	7597	1230	9863	51	51031	6390	6286	360	4958	3059	56171	8642	10062	6357	11337	25893	10895	644	84975	8732	5054	3417	26056	6414	272	8050	219	8216	57658	8875	23001	1462	84162	10904	4584	9119	2064	1368	928	11011	1603	4947	55233	5547	5724	5319	53	1137	313	10270	51360	3357	4256	4720	2695	24	8447	57144	54700	1601	4899	126393	11015	3099	100128124	321	23217	11014	51778	5408	10094	122616	5179	10660	9873	56998	1499	5320	23111	27291	4300	308	28952	186	8277	114	10454	8815	1263	9816	6641	57476	2585	9450	5118	7753	10628	4297	2765	9755	5304	7739	9654	3162	9557	1421	421	3638	3553	56848	56269	7539	9741	129025	23562	23633	7399	7225	2170	2327	786	5291	10693	2214	10263	80333	3354	4163	23353	401251	80271
GSE360_L_DONOVANI_VS_T_GONDII_MAC_DN	M5234		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1036_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages exposed to L. donovani versus macrophages exposed to T. gondii.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					93081	94239	5091	2621	7430	9170	6626	1890	4676	6449	9592	57493	4722	10131	65057	9841	402055	5071	10953	6728	23236	1390	2314	705	8854	26148	1933	23234	3084	4599	7078	6150	23096	8440	286	11328	28954	51083	2767	3609	8904	7188	2237	11047	1028	5933	7298	5425	9728	4833	7536	26574	4171	7867	55735	8772	9610	9146	52	27290	64087	6182	9261	4802	10157	6294	9940	6335	4953	22800	10430	3633	4588	87	10523	22913	84909	5966	7284	7171	55651	269	10574	6636	949	2224	10196	8501	4225	8624	5214	2769	5883	4828	6775	9208	60343	8729	4817	23389	8497	10915	7384	58504	5437	7371	79095	6356	10195	7023	283345	8761	9780	23239	23095	3265	3297	7965	11186	10469	22937	11240	5903	5438	23173	1374	6929	2146	3601	271	23231	5790	5984	999	5830	10274	29901	9363	840	10653	10681	5813	8354	407	1104	6470	5955	23623	4841	4221	10939	23295	5089	10575	11130	57154	9023	3784	5837	57591	6633	3838	3029	2954	10590	10144	6895	1371	2580	8694	6311	3487	2548	7070	7088	3241	8869	10572	7001	23263	5366	25992	8260	8882	5136	27235	3632	3665	8270	1236	728361	5328	2542	35	8821	225	9894	332	1087	2194
GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_UP	M5235		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1037_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages exposed to L. donovani versus macrophages exposed to 50 worms/well B. malayi.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					27332	8942	3385	6749	219333	8886	9972	515	2528	27074	3800	1663	3801	1183	4494	4174	23480	22903	114882	9877	5289	9332	26056	8974	7052	54462	366	9819	26046	3188	8683	4360	5780	4287	54737	5207	6996	2355	824	2752	8875	26064	3557	26036	9943	7707	597	1462	10279	5080	3895	10512	2214	9453	23036	5733	51592	23302	9467	7779	123	10253	10479	23015	4504	5732	23002	4501	2979	4490	1386	2957	9019	8502	50486	4151	9320	22859	1236	694	27043	54726	5352	91746	6927	4316	570	7023	1545	4477	5054	84890	1230	3554	5355	1195	4496	6535	6938	6846	11177	1514	4489	8732	2215	6950	5000	3101	3516	7022	2010	2665	4942	5196	374378	23255	7421	51780	6281	3575	8204	9242	838	482	3263	5433	1209	126353	1620	3930	57680	9601	290	4128	23197	101	65125	1452	94239	6560	133	1003	27258	1857	3099	3196	5917	100287600	10521	7076	25852	1839	29969	3576	23547	25976	22797	1069	528	5236	7349	157567	911	56171	284001	1556	3181	5033	10895	203068	6574	8642	11001	10123	26585	23473	6038	5824	5329	219	9643	8833	4495	84900	5066	830	4100	3449	196441	3310	3162	8843	23231	114	84981	10525	140465	6883	6515	8224
GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_DN	M5237		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1037_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages exposed to L. donovani versus macrophages exposed to 50 worms/well B. malayi.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					4521	6721	7318	684	9612	1535	313	8534	3420	283345	6881	5091	3683	6150	535	1729	3073	9191	8495	4005	9770	2052	8971	8667	2769	9898	374291	3015	10594	10410	54504	9513	23096	81605	10262	7409	8945	6396	2548	8857	8509	26747	28954	6778	10469	5933	10938	6678	3113	35	6136	826	6642	6449	8896	25828	224	27352	1527	7077	2517	6687	3109	27335	3659	26227	4599	5580	23507	23295	231	55756	7130	1611	11027	951	10188	23764	8694	1794	7317	6588	6352	162	9518	10157	9940	6335	593	100	10330	3633	9699	3487	8449	2350	4588	5336	5571	5360	203197	9537	29901	269	23129	463	9785	6541	4817	3838	2219	6890	6050	1845	90806	87	3614	7965	8743	4722	3241	9131	9686	939	1185	5496	6494	11151	6647	3965	4967	7412	3665	22913	3108	10573	10906	8764	713	9841	6398	2633	4542	23166	23213	10695	26751	211	9936	221749	23616	6293	5790	23214	10487	2015	2580	1996	9766	25900	5106	57827	23221	407	1268	4938	4297	9567	4689	3293	5692	10992	5089	3765	9551	4255	5837	8772	9111	3300	5694	5476	27286	6119	5396	10948	81609	2494	5696	5456	54677	117	402055	79090	1933	6609	7270	22996	25992	728361
GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_UP	M5239		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1038_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages exposed to L. donovani versus macrophages exposed to 5 worms/well B. malayi.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					5216	6741	5885	1642	11006	54737	5207	719	5514	9559	2878	79143	9352	4292	10217	5525	5635	6992	570	4477	23042	5073	9107	9551	3738	5000	1118	1368	22916	90411	5055	4584	966	402055	9842	6996	5325	1869	9242	4678	1460	8763	6613	9467	22920	220988	126353	7185	1620	2745	4915	23317	11193	10075	6556	6774	57862	9972	8453	29969	4026	23524	55669	9246	9863	7153	23131	1003	7295	8737	9031	5054	50486	3550	10475	9319	4733	23173	10611	10627	22826	6819	8661	9819	157562	101	10124	9208	1408	196441	8532	3801	5597	4677	10241	10895	285282	967	5270	5684	1382	10261	256987	58509	8507	23478	10395	7691	1147	864	116984	8815	5732	23473	219	51665	22936	8648	26751	1200	4864	55958	23312	5351	7779	10938	5686	2959	3646	5138	9095	7678	2760	6307	515	8742	25800	5780	3953	10512	25830	203068	51614	389	219333	6670	10097	7341	7314	10857	5520	3488	54346	57187	1307	1013	6869	5289	4637	23623	55837	1294	10094	22832	1209	27299	2561	7159	7009	7105	25983	8224	9129	285596	963	9541	120	157567	113457	8992	7385	5175	10737	6388	3419	6878	4942	22797	2355	112611	6900	23480	4288	5481	6347	159963	3939	4493	2921	23405
GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_DN	M5240		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1038_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages exposed to L. donovani versus macrophages exposed to 5 worms/well B. malayi.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					4253	5252	171017	10598	87	6288	978	6009	23196	63036	23096	8991	6721	5099	28954	11051	2797	2769	23625	23118	22984	7329	23240	23507	9962	2099	22875	23276	1176	27290	23275	10162	53	10157	9940	6335	9275	3949	4588	9315	10775	3467	269	10641	9513	5868	9375	8543	5439	2050	2801	10428	5970	10302	23095	3614	23481	25932	54623	5875	58504	26003	5727	26032	598	7415	1650	23499	28973	8001	3119	23475	3396	10957	6396	6150	10367	23654	463	6902	22887	10195	2631	6227	308	3665	6881	100292236	9612	292	4591	5858	7386	25829	10574	7264	9860	951	9785	958	26036	6311	473	6536	6633	1938	10972	5538	27235	7753	8642	11240	7392	8449	11235	2800	162	1535	23291	10263	23213	55856	26128	3704	6793	25974	10948	54440	7127	8349	8534	8476	6908	1108	5354	7693	1849	3849	2580	2219	2771	7310	5800	10952	7417	203197	2030	2747	6642	6362	5321	4779	10096	6464	407	1186	23645	8971	6294	3084	8459	1611	26469	6293	51603	7409	3683	8745	3685	25	2767	10462	5119	4005	23616	5089	9100	2965	10426	221823	684	4802	5292	9841	117	23266	1845	10051	5110	706	374291	10019	22870	25804	8872	7536	7692	5837	57493	114548
GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_UP	M5241		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1039_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages exposed to L. donovani versus macrophages exposed to M. tuberculosis.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					7001	8550	26103	6367	2617	6009	8453	9170	27013	4864	9819	7264	10204	1201	64061	387263	1643	6035	3557	966	4869	10086	79026	23086	4360	11068	57211	7873	6347	9618	6293	9905	5207	3309	27074	10221	6535	2872	23492	10542	4673	5599	378708	7707	2549	84890	114882	81875	29760	55573	6786	6136	2268	26471	5547	9270	1601	51363	1649	3303	3554	64112	10953	4048	23081	23310	6477	219333	5525	9037	468	22853	23705	5270	7296	665	10199	7125	29	6189	1499	440	1310	3738	10525	5000	3357	6046	8065	5091	57553	3459	7188	26608	7100	9020	6793	4023	6496	3162	256987	126353	9319	6184	23061	3988	317781	9816	6585	8740	3563	9785	1382	9095	482	25777	9686	3687	54	22859	26986	2898	1112	9450	5175	4606	7074	7852	56171	8013	5557	10895	1236	4956	10454	9903	83660	23471	5733	3663	10461	3073	4256	84549	6282	5252	219	6134	3728	3340	25829	6897	8887	6594	2719	9454	10426	753	8224	9601	1287	23269	23151	6533	7165	10174	10952	9520	4583	5292	9027	10127	2665	6840	8818	16	283459	8447	56604	3662	23338	7037	4899	126393	2528	55660	10457	6129	22854	127703	51778	3034	10523	23358	10660	810	4801	9924	81550	10267
GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_DN	M5242		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1039_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages exposed to L. donovani versus macrophages exposed to M. tuberculosis.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					23136	5970	6355	51668	394	3431	3113	84612	5997	51710	6119	5743	54440	3620	1846	2634	10274	23096	89845	4170	4092	28954	3222	25776	10791	11046	1839	2797	26872	1831	4321	5184	5771	22869	8819	2752	10553	4830	64116	4817	5154	162	8237	6352	27290	9447	5654	1415	5903	80347	7128	5721	9940	4670	10993	6993	6741	10681	7743	117	6789	4520	3633	7538	9610	4588	7291	8519	7056	269	10288	4289	4833	6775	283345	2224	9922	22986	8440	2542	10133	1312	10487	3627	26032	4312	7351	3601	1891	182	713	22990	164	6780	283	1992	7422	9534	3569	837	11240	4292	23595	9699	710	4216	9246	5686	23613	10907	4319	5790	2355	3588	7124	25844	3669	3659	5328	10628	407	6398	9473	4297	1843	1026	271	914	5214	10652	5089	6502	6364	5506	7417	2921	4693	5837	8034	4791	629	10962	2494	57493	6363	5698	1360	912	3914	2643	2353	6571	3754	7130	728361	9605	2633	85021	7745	8821	22904	10563	2560	7127	1087	2050	2919	57214	8509	8612	9635	6236	8850	952	4599	7097	2040	200316	131408	9536	8837	9122	10538	3145	9312	1749	2905	7173	23368	6674	11031	6335	8936	1823	846	2890	10276	2113	100462953	5550
GSE360_L_MAJOR_VS_T_GONDII_MAC_UP	M5243		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1040_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages exposed to L. major versus macrophages exposed to T. gondii.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					23353	54454	9781	1398	7378	23099	57187	10038	3055	8216	51499	8343	25998	3576	87	113878	201229	3600	173	100287723	6364	24	4077	10133	5715	9516	570	7127	51421	23616	3914	9181	10318	53616	8711	387	23085	1535	585	10327	6775	11011	126353	23335	7941	25793	1236	23034	79026	9332	388650	35	9266	23261	56171	4947	1152	10895	7130	10630	3985	83660	3553	6648	177	360	1743	417	8634	10693	5971	2290	1268	5743	2696	7032	6665	5136	6258	4791	3952	5770	9242	2297	796	1318	5450	4881	57030	10520	22915	6324	3778	1365	2248	7547	3593	51778	2040	7296	6285	10660	4958	10495	85865	1819	5444	5969	9536	2828	5350	5408	1198	3739	11144	11228	79868	4224	8547	66036	1821	5329	84272	2674	8277	1437	27254	5320	308	8123	905	10578	5830	343	54499	25956	2660	50852	6854	28952	54737	115286	1490	5775	355	856	6804	3235	26998	5521	1009	27302	116285	2585	25794	931	9557	11339	3937	23644	22986	960	5737	3232	5304	2319	7096	6571	57096	2560	5118	79586	84720	10793	23405	3753	54700	765	72	1447	231	9808	115201	10518	2170	22995	1727	1500	53	23368	92346	3606	2252	100289043	11272	11155	1581	9047	10737	1394
GSE360_L_MAJOR_VS_T_GONDII_MAC_DN	M5246		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1040_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages exposed to L. major versus macrophages exposed to T. gondii.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					10236	1499	10623	5300	7001	27237	51020	4176	8904	1949	9315	7884	3142	5688	8694	5358	23623	4726	27350	54987	3159	7181	4171	2523	3615	22858	8175	10144	7678	23647	23096	10591	85453	5111	10196	6723	4942	1717	51112	8295	221395	7525	52	8623	6513	2353	9764	705	1736	1740	3265	6182	3632	11186	57019	9780	6390	8480	6895	2058	7298	1409	8607	27290	9170	9889	6964	6470	9940	25895	353	10606	4588	10039	10195	23295	4103	10250	269	9920	516	5723	8501	3418	4681	10036	2838	891	9512	9208	23016	9415	23195	4714	84364	27013	27235	23450	4733	55658	9883	131408	2956	51439	23361	1537	7023	4798	1880	3609	4436	10733	10643	9927	6118	11240	9612	23389	9221	3704	8662	8019	26999	56125	9456	5790	4287	23173	196441	5984	4691	1632	10584	3420	513	22800	407	5976	5141	1960	328	5955	283537	9653	1961	3015	25970	51588	25	3833	4245	649	3298	5089	55816	3487	5837	6449	159	9538	6929	3035	4225	26751	9134	6430	8366	3613	8092	5378	728361	8997	871	8821	1087	9529	6375	4175	3004	23769	6754	23332	23026	2902	11010	11129	10266	23598	2153	2520	9568	79033	56941	81887	80308	9895	92856	25804	412	3507
GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_UP	M5247		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1041_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages exposed to L. major versus macrophages exposed to 50 worms/well B. malayi.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					8343	5346	7376	6574	2932	9123	3766	87	4763	3142	1193	10656	23078	4494	2779	7107	7803	55658	3576	1183	6571	2957	6854	5047	26585	11131	4502	1804	9479	3895	1857	7150	889	2919	1728	23504	5125	4293	57493	285672	3800	3667	8942	9818	3914	3185	23199	3557	11346	5347	23483	923	7185	570	4891	4477	3553	960	66036	1236	1514	50486	1727	1545	65108	2057	7941	6996	10286	4973	50846	51710	126353	1620	1326	4504	3937	4792	100272228	7130	8653	672	374378	7709	5142	8974	4790	6364	23237	10490	1780	7293	366	29774	10471	51421	56171	9656	3308	3320	4319	10895	9516	649	4496	5566	364	7037	782	834	55545	57096	4501	2549	654	3640	7782	2035	2897	8224	6672	84900	669	64849	6665	11046	728215	27332	796	22925	7259	2888	173	2968	8554	22915	10318	7128	1308	5599	11056	214	7547	89795	9693	84981	2710	301	3593	56	51778	1847	10660	6281	6261	10279	5329	10748	6927	1743	64750	2204	9576	85865	10630	5444	10006	23002	2859	5969	9536	7456	6883	2828	72	314	7125	5350	1602	5080	2921	9731	5367	10010	8828	5549	5276	4489	8837	4495	3563	1846	4635	26993	79868	33	1499	9152	27445	9242
GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_DN	M5249		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1041_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages exposed to L. major versus macrophages exposed to 50 worms/well B. malayi.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					10036	7001	4201	8209	10393	29907	8501	7994	112950	1675	2802	6721	8455	11118	7916	2193	23198	1050	920	5106	374291	10218	23166	474170	2720	10302	51112	26156	9927	50855	9114	23598	3635	23096	26137	3615	9793	7407	11186	5336	60436	5095	23067	30	7187	9191	11188	387	994	4714	9582	2217	22	5547	6635	933	805	4723	1949	20	6472	25804	2838	8694	23129	23287	6609	3420	2523	8815	5714	9940	7525	23361	6035	4588	1537	8295	84726	8935	3683	269	5664	5571	4758	8508	1349	51347	230	6453	1892	10963	891	1632	6895	23016	3614	6499	939	9415	54504	4736	54453	27243	1409	516	6886	3606	51035	55905	5625	9094	57405	10591	4141	8480	3663	7048	54471	2185	6881	5110	5790	3291	4005	5358	1643	7701	3758	7089	51096	407	333	26257	5578	79090	833	1536	23344	832	1961	23195	100289344	5089	55816	3765	9666	55756	23450	5837	1163	27335	26130	3913	8449	57148	26659	10769	54346	9603	4605	353	10556	10874	23107	9760	1175	728361	5583	63923	2734	54765	3128	8821	2628	26469	2875	10939	5320	1087	191	283345	978	7368	10039	7247	7568	91	2110	4712	23040	9138	10584	197	3073	55361	3109	4713	10992	1717
GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_UP	M5250		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1042_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages exposed to L. major versus macrophages exposed to 5 worms/well B. malayi.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					10623	23154	9056	8882	23302	570	9562	4477	871	585	2192	2821	8883	3687	7337	27301	126353	1620	4898	2639	84900	5966	2073	83450	8161	10282	6560	51710	9229	5780	2932	26112	5315	5203	6574	1780	9469	5433	1773	7150	5901	50486	5796	5514	100293553	6218	10895	285282	10553	400	4792	9585	3565	1114	5829	55658	6964	9123	6672	9818	6847	27122	1946	25793	3425	7376	5819	5128	641339	7054	374378	7597	4583	3914	4908	1804	2551	57035	8045	3895	3080	8224	8028	1734	6775	3775	8438	8395	3185	4515	7142	91977	10476	5326	654	22836	197	23149	1294	10737	66036	7975	5136	8685	10672	728215	26156	5805	7582	2618	23053	5532	11261	3952	51141	23504	1448	4891	5972	10542	87	8910	1198	9744	5100	796	4295	10245	7709	5214	26130	3320	10290	6383	4628	6649	11080	29851	3937	2888	9135	2288	11346	6732	10038	6698	173	627	10486	6827	10733	1490	5500	7378	5260	10418	22915	51499	7443	1308	4790	8216	1728	3142	1476	5026	8742	4493	6996	6415	80256	1365	93487	10107	7712	84272	1545	6755	2214	2248	27240	89795	2561	1948	6364	5083	6939	1080	24144	6261	10010	1236	1305	24142	7534	960	1359	9479	100287051	3593
GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_DN	M5251		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1042_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages exposed to L. major versus macrophages exposed to 5 worms/well B. malayi.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					6901	4140	9708	23549	10218	6721	4733	3354	5516	9147	3316	23096	6693	5387	2797	55752	8295	9881	11137	11165	6185	27290	6508	9940	8449	10236	5638	4588	2580	8935	269	1155	9377	26057	10775	22883	10235	8833	10199	7916	6195	2099	9138	54765	10616	4528	51552	10160	8634	6635	6536	5567	11056	4714	201229	5336	5480	10939	5110	11186	9512	5976	7994	4615	22980	1027	11235	3663	4723	1349	26999	11240	3567	55611	8480	4103	257407	22919	265	7693	8720	23291	1021	10036	6183	26092	100289344	221749	1675	6293	407	10659	7280	516	9315	27350	3704	1820	25970	26574	54504	10039	2067	55958	6472	23526	5089	54453	8904	1537	23054	8455	8036	4779	1175	4761	2975	23250	9114	26257	5547	79912	3614	9092	5837	10658	4681	10013	10314	196441	9638	23198	10591	1968	53916	8623	11146	8209	51112	10268	55361	25804	22808	1676	26140	5836	1808	4775	374291	9764	7029	3396	5224	261734	4298	3683	4998	5553	2838	7264	131408	23062	7181	51275	1108	1414	27235	23067	9927	5106	2060	23338	412	162427	221395	100505621	728361	9653	51668	1635	10654	23195	2976	291	5688	23335	775	9529	23510	8533	8821	6418	2523	26191	6634	23361	52	10452	112950	9100
GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_UP	M5252		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1043_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages exposed to L. major versus macrophages exposed to M. tuberculosis.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					248	55697	1236	3557	6750	8021	9818	55573	350	6843	7296	1847	3563	3670	100292813	201229	51090	10645	835	6293	2488	10086	5618	9721	2627	5713	8832	85236	182	100288583	5932	4289	10107	7188	7428	6854	3716	6464	3480	9711	3663	3797	3159	4237	9170	152	23310	100272228	2859	22980	1058	7130	672	84271	5347	126353	3851	10486	9397	79026	3565	8613	2529	8887	51499	27284	653808	8550	11165	4790	2775	23211	4208	7264	100293553	56171	2872	4495	10895	442240	445	221749	23604	9866	2898	9308	5775	5770	5372	8554	27099	1193	8224	5356	999	6665	3952	6046	83988	3687	83660	6195	5450	4881	23511	22915	1308	4606	100294255	2549	3798	10623	1305	7054	1359	3593	56	51778	5949	6285	3628	10660	9576	84900	5444	5071	80316	53405	8941	2717	1857	1266	4635	651	10199	1656	26220	3400	3784	4858	2035	283459	644128	3757	4490	231	2527	1621	3914	1111	11155	7456	10325	11099	154796	6095	29855	26027	6690	7159	5966	1558	5075	641339	8644	221037	26986	3916	177	6840	57096	6872	3849	1538	7293	4583	6865	55556	23381	9296	8631	9242	8993	1638	11062	23174	22874	6703	124152	765	72	1447	25841	10518	6541	5599	23102	3931	51172	92346
GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_DN	M5253		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1043_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages exposed to L. major versus macrophages exposed to M. tuberculosis.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					3945	5358	1385	394	84726	8623	55746	100287809	51668	4726	2838	58495	9497	1409	5567	5881	5688	2040	55752	10400	23096	1843	8450	1949	5910	4005	2797	8694	912	1740	6415	4733	26872	2224	137886	9793	27290	9940	23361	10288	10247	4588	4999	269	6453	23623	22858	140890	6726	54453	7168	4287	23129	11031	10223	22800	3597	10775	2353	11146	1831	11213	7001	2523	7701	3006	1312	60436	539	11240	5997	9736	3148	5790	23332	9415	25898	407	10695	5089	5837	2214	25813	9581	9851	6363	51433	6674	4712	2695	1465	3754	84444	5897	9927	728361	2218	63940	391	9556	55816	8821	5583	23221	1087	10630	8612	6375	213	1473	8467	200316	23007	199	9374	7791	9122	5799	9831	2246	157627	400	100133042	23089	8351	2912	26091	8715	5890	4488	4675	168374	9407	3141	401251	6635	7380	5994	51588	10659	440387	3000	3613	5625	7355	8632	65012	3066	51096	9332	5454	11010	701	3881	2330	3885	5467	51634	27235	4137	1499	7538	140462	27333	57148	6650	23071	91298	6645	5526	1717	2742	9603	7730	10682	4646	10778	11330	131566	7126	5129	3895	8508	26130	7265	3615	3291	23769	353	283345	727897	4707	9582	11119	25807	27349	4670	10476	7592	27113
GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_UP	M5254		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1044_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages exposed to T. gondii versus  macrophages exposed to 50 worms/well B. malayi.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					3604	6576	53615	8501	1827	22992	290	4436	2979	6846	2355	1462	29893	3615	100289632	3575	1537	9252	5552	4171	3418	2882	5966	23036	5732	1357	3613	89927	4502	10856	51042	694	54737	5207	101	7371	8623	9170	5201	27074	4312	3576	8974	5955	6626	460	2767	11186	3491	4712	4174	3195	10155	1236	8704	9592	6004	6281	3329	9308	8503	6515	2956	6749	871	94239	3399	23169	5355	4287	23015	9575	22800	131408	5170	10953	7334	570	6373	5733	705	23080	56604	9456	9818	2592	5163	5000	8854	3298	1396	4221	911	7205	10993	9020	23647	488	10623	5352	7023	6038	1636	6723	483	7078	57493	6854	368	126353	7535	654	1499	7171	84901	2549	3142	2752	1880	1933	6560	4176	23463	8814	1534	3490	10572	4113	4860	5437	755	65108	10630	3265	10548	23516	6304	4501	65012	4490	23140	5495	23333	1028	56171	2932	11332	9768	10895	10286	9023	8541	10787	23389	1647	7045	7163	219	366	1846	10656	1960	6697	5358	159	5549	7850	9314	6526	5142	51083	5236	4282	5763	23623	55353	11010	23421	8662	10362	55658	286	7593	22925	5214	9894	9920	10816	7298	10915	6386	4495	8366	4790	285596	1720	8651	301	8997	9153
GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_DN	M5255		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1044_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages exposed to T. gondii versus  macrophages exposed to 50 worms/well B. malayi.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					22893	25829	5693	100	51230	4048	6721	5715	9577	221	6604	3959	955	51706	22834	1535	3073	3354	3665	7318	25807	2185	20	25900	11326	5833	9312	10039	26173	1117	1595	27243	6302	23096	644	7127	2535	9931	1675	377	28954	1394	6324	57447	369	6813	7165	3891	4947	5580	11027	22846	8514	2782	945	8764	9601	374868	8346	23085	3109	10938	2286	54677	10157	9940	7124	6335	7187	113878	10038	5524	3633	9518	4849	4588	8815	7096	1794	1611	269	199	9798	4794	23207	5710	387	5739	2119	920	3115	6352	23335	2319	4668	2149	3606	27044	55041	112950	56848	8480	23166	6414	6494	2219	8890	57460	92017	9873	6890	9450	6624	4610	10966	8740	8935	4542	1198	4758	23616	10014	971	8857	8705	374291	1593	928	1211	683	4077	474170	2621	730092	11188	1796	51103	5790	1212	313	5649	6945	407	5547	953	1268	9770	7130	8522	84720	5724	6509	5089	3765	10791	23179	5837	6285	9167	2585	4722	23191	4689	10693	7106	8519	284244	22854	3659	6844	22996	3126	728361	55746	9058	6286	8555	3128	8821	5304	629	7596	2162	11228	2875	1490	5320	1087	753	7368	9282	7739	28952	55735	203197	115201	55786	5664	10327	3212
GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_UP	M5256		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1045_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages exposed to T. gondii versus macrophages exposed to 5 worms/well B. malayi.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					1368	482	10623	54737	5207	3276	5328	6302	6633	100292813	25804	283537	2960	3980	570	4714	3791	6576	3738	5000	30848	2348	10195	23301	8648	7936	7067	126353	10768	10575	8732	2101	3936	11214	8815	9863	53615	471	11044	8566	752	6850	4113	1933	107	369	3434	1742	11010	23317	92558	5780	11186	8208	256364	6535	518	54454	6670	1031	7058	3158	23399	5122	10895	10938	2022	6844	3399	101	5091	7597	4953	3604	4610	10208	85021	4221	5356	57234	6503	9332	100101112	4520	84759	5966	219	1374	8260	678	5552	11183	9512	9252	2812	871	1999	10769	402055	6164	90355	8503	2634	5569	6723	9653	4712	4616	6626	11328	10368	808	10144	3488	1499	2317	10846	9312	3418	9125	4086	5813	4590	6383	1340	23203	57794	26043	89927	1537	5229	57658	673	2201	127544	9170	5108	9575	112611	9363	7332	37	3558	10137	6004	3672	51042	8884	9643	9563	54346	5094	1652	2717	10391	26872	229	2214	8019	9790	54661	10912	4171	5358	5764	64131	23350	22836	6727	9738	7884	4121	1950	6598	8936	8048	9700	10196	9212	7343	3312	5213	2767	54014	2321	11007	6354	150094	51083	521	488	3615	1122	2355	10557	10953	4287	3425	4624	1108
GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_DN	M5257		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1045_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages exposed to T. gondii versus macrophages exposed to 5 worms/well B. malayi.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					23096	2580	28954	6721	5627	22980	25793	25970	3897	6511	23473	5127	26659	4061	79065	27290	4713	10157	9940	6335	9529	55746	4588	8935	6904	269	6883	1155	5791	924	5439	3241	3313	11051	3354	8733	10467	3084	100292236	3665	25829	5775	10036	23207	2621	7016	8459	84162	8480	5875	11311	2185	9601	1535	9690	4722	1212	11281	90	11240	7290	6390	26020	9725	56905	4726	3705	8857	10062	9748	7846	4542	3417	25988	203197	6414	8890	11345	2967	9183	5305	2976	23013	11243	7844	407	3977	945	1793	2067	29855	5025	475	7402	955	8634	4676	51606	5089	2314	7753	1102	6604	1611	9931	2064	5837	11343	5715	10772	5495	2535	5833	5739	23185	585	10791	23644	51230	4192	473	23158	51706	3914	57178	11238	5264	5509	377	10490	6527	598	8642	10307	4222	57720	9778	2874	10322	4048	5136	3704	8764	8522	2319	5880	728361	6793	5018	4267	23616	4902	5428	6050	100	8776	9181	1380	8821	5275	6693	51	5641	4669	10106	2286	23258	23526	27095	221	7127	51020	6813	23361	5300	1318	23353	1087	3891	1896	4643	3309	920	411	23034	22984	9450	8560	928	2885	25842	5524	7737	22846	9766	26240	5580	387	343	7157
GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_UP	M5258		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1046_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages exposed to T. gondii versus macrophages exposed to M. tuberculosis.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					2719	27013	9308	3615	1236	10493	10221	55619	149603	5372	1409	634	7465	84271	23241	7086	127703	8704	9575	8570	81620	1649	440	9610	5207	5356	56604	4616	4001	7023	89927	10856	10457	6510	1294	10155	3073	6133	5175	2932	10131	115817	6535	8503	3670	3399	7728	488	57591	3490	3159	10423	1019	10868	471	3632	6854	6401	5966	154881	1487	9315	2549	5091	27074	5211	30968	100292813	6894	5557	7100	84759	10523	3662	9170	2171	1759	10623	9903	29896	3554	2720	7188	57211	54498	7165	7001	7430	3738	5000	4744	4681	6347	1028	6793	25829	4640	7296	8019	4436	10953	23384	113791	5378	2523	126353	2624	6046	3284	54	9397	65108	22800	23516	4113	10939	11186	1647	3613	8140	3839	4175	3280	8761	6227	23511	10656	56171	57215	221749	4171	5445	11190	10895	7343	22980	23598	4676	253782	5902	10614	4691	219	9023	29901	5270	1310	9612	7265	9121	124152	7298	55651	201254	4756	115	7159	4335	22874	25966	4583	7852	23234	85236	25	9791	6037	2956	9456	3563	10898	26986	6514	5346	8834	3663	8366	5733	29855	2317	6526	2146	1933	22883	6095	131408	3357	5437	23338	83989	53405	8839	8854	83988	9095	51778	23263	10660	200081	8623
GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_DN	M5259		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1046_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages exposed to T. gondii versus macrophages exposed to M. tuberculosis.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					10628	7422	10281	1318	6324	51499	23361	598	7743	10038	1009	683	10133	10791	5743	10795	7538	8642	2752	411	6364	23096	9554	6813	1657	4077	5154	28954	7097	3659	271	3556	80347	394	3914	11311	3658	173	6775	25998	2920	3600	3620	27290	199	3354	9940	10322	4520	3633	4588	26872	6351	269	2040	387	8519	5686	53916	2919	11238	6352	6674	2960	5654	26133	146712	4693	3006	4071	10467	7353	90	53	5690	377	5509	5721	1026	83660	80868	11240	3985	1838	150094	6627	22854	11011	23085	771	5790	9673	8685	2180	100	9605	5328	3601	407	599	4163	64116	7351	6583	3569	5089	9332	2835	57460	1462	23474	4889	157627	5837	1594	23473	629	55746	22904	10106	6363	5826	6374	2695	7130	23138	2120	2280	3553	23332	728361	4791	7739	5319	26105	8821	931	2214	10563	1490	1087	54677	5304	55589	5179	8612	10793	1473	7539	11188	3664	460	9536	11167	54462	3145	65123	2170	114	506	375057	23368	100133042	9497	2634	10876	7903	3753	6335	11228	1823	51	7257	80273	388650	8715	5770	168374	3778	22847	90993	8518	401251	8970	5994	9246	644	10993	26998	5454	475	3235	5678	28952	5521	5969	27333	56848	162	7127
GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_UP	M5261		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1047_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages exposed to 50 worms/well B. malayi versus those exposed to 5 worms/well B. malayi.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					27241	3665	22930	10067	10961	1562	57405	1654	54737	5207	5899	7552	5875	130074	23005	4077	1616	23324	3015	3158	79143	8443	2288	2621	1595	57827	288	10300	3428	8935	8570	570	10487	8503	4477	5336	6302	7376	5000	2959	5226	56	10105	5579	5649	5376	23300	7317	7384	2219	126353	1620	1382	653188	7756	133	5768	87	4790	8666	10588	4437	27243	4719	2799	5243	1003	23360	4113	65220	6494	56125	6599	8346	51491	923	23341	10284	23511	3557	5091	4542	29893	7965	1729	3579	6004	6950	22826	123	22982	7345	3064	10895	9943	10127	9513	1628	402055	9933	8078	5694	22882	26239	8343	654	22926	22	8636	5335	516	8992	4600	10840	219	1992	9031	5780	9551	5714	7336	116	7852	2561	5514	109	9604	54765	6329	3104	7089	475	51588	1212	5125	2068	2639	4074	3281	3310	79987	29775	7994	6882	10963	4045	9757	3797	3385	6844	1307	3425	5047	6888	8815	157	7334	4168	891	1356	5108	9332	6737	27286	23438	8224	58473	4610	1973	84726	2192	488	10188	5201	9312	11315	4585	3028	9973	2072	54677	10261	23051	397	29902	8315	7511	9770	369	2804	8501	5702	1337	25924	53340	6462	84991	2585	4686	23349
GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_DN	M5262		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1047_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages exposed to 50 worms/well B. malayi versus those exposed to 5 worms/well B. malayi.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					7091	10695	6897	5709	3693	467	6117	27258	10190	10218	9612	4005	11142	1537	23096	25920	54386	6046	3074	55752	28954	25976	25840	5566	23386	6901	5099	9138	1727	5496	2914	5168	23507	10480	27238	2775	10948	7064	1399	5970	816	4849	9444	54039	10157	9940	6335	55312	8446	22797	4125	2827	4588	5346	4493	1326	5591	56905	269	10450	9001	23294	11340	6938	80308	1445	8881	23140	81875	55186	10581	1528	8718	23483	6310	2869	1240	5698	7844	3659	9454	1672	4801	11056	9242	9087	810	5494	54453	3351	7205	6635	9601	5589	203197	57556	3418	10521	7568	7832	27250	9819	2901	2846	23213	441263	10735	506	23266	7113	5176	23214	11046	26020	2263	9058	10964	3309	5730	343	1831	5411	10714	23644	407	1025	528	4615	3052	5355	10548	9686	30	10692	5990	8614	5025	3705	2314	7737	8425	54462	1380	1869	6571	4902	5089	23113	10656	6703	946	26585	11235	8642	56848	11078	4335	5837	55361	8720	10791	5732	4858	10102	138151	1655	9831	6720	8270	3758	6768	6036	5878	10239	94239	41	2155	11259	22934	22903	161	3959	97	2838	51710	24139	10010	7143	5641	381	23015	2035	3270	6894	11019	23423	25900	9879	10286	952
GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP	M5263		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1048_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages exposed to 50 worms/well B. malayi versus macrophages exposed to M. tuberculosis.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					9785	2719	224	6721	10204	955	56137	6844	1201	4048	994	23163	2720	57447	27287	10475	1382	3357	1845	10645	51706	131408	2617	11027	2193	762	3675	1643	7187	23081	23102	6199	5207	4141	79090	9170	535	6609	6293	54939	11083	10326	5269	10681	9577	221749	8720	313	3797	9896	1936	6136	7783	7940	10992	653808	8396	9308	3687	23207	2217	10107	84890	9862	7264	8740	2077	9189	10939	2949	468	6196	7409	9686	2863	11186	25777	9679	8815	5292	10057	7003	1616	6472	8503	1973	6894	3554	200081	9513	11188	9938	161	7296	3693	5091	100288583	3073	5000	5336	10982	977	23061	5578	4843	2017	22854	56	23511	978	3728	7100	23358	57211	2091	8078	2517	6363	7293	2268	25802	2219	126353	3707	27044	645	6768	7165	4736	9770	9034	2549	1729	6811	93164	1593	2329	9703	5547	1892	4113	56125	22827	9927	8565	8412	3663	54	10981	445	23203	5834	22853	55361	8519	1611	56171	22980	10474	3109	6477	7318	231	8079	10895	29855	81875	23598	971	25829	5106	2782	219	4758	1933	29760	10327	10493	9397	951	3988	3108	3117	6703	23313	10952	2529	23761	5095	25900	10127	6793	10980	3765	8411	109	23324	4208	2110	8417
GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN	M5264		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1048_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages exposed to 50 worms/well B. malayi versus macrophages exposed to M. tuberculosis.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					9497	27332	6741	3576	54462	952	5163	10656	912	5955	5970	7143	51710	3800	9575	11031	4973	3853	7097	23015	4520	55752	290	23398	1499	10288	5997	5054	8942	5528	3993	7408	4830	619552	1545	970	6355	23096	2752	27236	1195	79987	9447	1912	3575	2634	7852	28954	5142	6709	1069	6119	1857	23160	4071	2040	5743	597	6036	5654	114882	3222	9520	5599	9786	10135	4283	5721	3189	26872	54541	411	9940	285672	25794	1839	64116	2633	3633	4588	2932	10102	3620	3914	7076	269	6515	5552	861	5352	5771	11187	7128	4170	3351	23623	9651	1992	4719	9473	3659	2920	2919	2901	8364	7743	4490	26133	23136	4287	7422	123	677	9242	1462	6004	22858	4312	11010	7538	4495	8974	5144	7163	4494	7130	4501	51460	4321	1465	3895	8623	6373	6364	56926	84900	5790	1636	23473	5728	10059	10487	5698	1431	6627	23474	1728	2180	2997	1234	10970	407	1556	4163	56604	3371	602	3490	5089	2835	1352	10548	7782	7846	92558	117	5837	8034	2167	1831	366	10791	5898	27240	6788	5168	3754	7351	140890	25941	2355	728361	2218	4323	8821	1317	1087	6447	3563	9818	8850	10628	3131	728215	8651	248	100287809	4111	200316	6790
GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP	M5266		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1049_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages exposed to 5 worms/well B. malayi versus macrophages exposed to M. tuberculosis.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					22859	6867	5207	8678	83759	23398	10467	1933	5546	10221	10204	10953	5638	11062	8019	6047	5387	23332	200734	3738	5000	6382	22883	5599	6199	7033	729678	56	9308	23336	5509	126353	22854	6311	8079	10594	3480	155060	805	6721	388714	5225	118	51706	4113	56125	5669	5096	9170	6464	2193	598	9087	26017	728642	2213	10990	6009	1175	6929	23119	4606	23175	10322	4599	3675	10992	23568	5175	10895	11278	388818	64849	6691	4681	8140	8078	7343	127703	2617	84890	9785	9905	3273	5095	5252	219	117	23384	3913	3113	65110	8482	8927	23163	7005	23774	1874	350	9500	6752	955	2014	6477	8558	913	5918	1201	3182	3442	23207	10423	6195	4676	8550	10493	4723	1845	23241	9270	9612	381	23303	9095	9896	23511	4048	9450	6894	9721	57447	1058	7168	64112	1838	492	4208	8224	55556	4641	23102	5269	23030	1414	445	1385	3066	5834	84271	3670	1936	2219	25854	994	4800	26471	7264	248	978	9037	7409	10326	57591	5867	9048	256987	10131	9645	81550	25864	2720	7143	1488	84549	6609	23339	3991	5025	2268	1019	5336	5641	11027	8985	11258	8412	1382	1236	6657	11083	1672	6944	387263	3693	2863	224	6535	10982	23198	11186
GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN	M5268		12663451	Chaussabel D,Semnani RT,McDowell MA,Sacks D,Sher A,Nutman TB.	GSE360	GSE360_1049_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages exposed to 5 worms/well B. malayi versus macrophages exposed to M. tuberculosis.	Monocyte-derived dendritic cells (DC) and macrophages (MΦ) generated in vitro from the same individual blood donors were exposed to five different pathogens, and gene expression profiles were assessed by microarray analysis. Responses to Mycobacterium tuberculosis and to phylogenetically distinct protozoan (Leishmania major, L. donovani, Toxoplasma gondii) and helminth (Brugia malayi) parasites were examined, each of which produces chronic infections in humans yet vary considerably in the nature of the immune responses they trigger.					1729	7417	6194	23096	26011	89845	28954	2797	1499	5899	8405	25813	9056	27290	9180	6692	665	9940	9221	3660	4588	5707	269	1814	4481	471	972	8916	9497	7388	64976	5567	5376	26032	6518	5778	25903	8554	6129	23259	4600	10507	7030	5955	4237	51499	1513	8887	11240	7037	5328	11213	6741	6017	7126	6424	6790	597	10946	3603	727897	9897	8914	4860	3735	3096	8819	94	10094	6284	5996	9255	8539	407	3597	1947	3217	10548	5920	58495	3945	10628	7419	5635	435	5910	8467	4190	56650	9344	5771	63940	51460	5089	51668	10544	22800	5506	6355	599	983	25895	8942	5837	79646	10791	2692	3914	5698	7743	30836	1196	5433	9575	7265	3071	5828	6120	11010	1912	6742	7349	6483	8737	861	64131	1993	9246	3326	956	4719	1360	4520	9332	3557	283345	2719	10737	3434	10038	114882	3659	23168	2695	112	25776	55746	145678	8858	4738	3310	3398	23136	2634	5586	11234	27284	9975	79572	7097	6999	3222	3431	9470	2901	5201	6645	1215	7291	5168	8418	728361	6939	1195	4976	998	948	672	27240	9923	5236	6636	7072	3674	3576	78992	4854	416	9473	56929	10397	23071	2180	8821	5695	10542	2167	1855	931	6993
GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_YOUNG_UP	M5287		22434910	Yu M,Li G,Lee WW,Yuan M,Cui D,Weyand CM,Goronzy JJ.	GSE36476	GSE36476_1728_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated CD4 [GeneID=920] memory T cells from young donors versus those treated with TSST at 16 h.	With increasing age, the ability of the immune system to protect against recurring infections or to control chronic infections erodes. The objective of the current study was to identify gene expression signatures in elderly CD4 T cell responses					9445	10140	6275	3148	51170	10235	1806	8445	23522	2353	4256	64784	59307	4929	256987	29072	23370	51191	9750	51646	23228	10001	6232	2124	11320	56255	120	1105	6515	10123	10365	4542	2533	1831	4601	4306	23108	3725	969	7153	10124	222161	9736	3075	8660	283683	3689	57092	55843	150094	3337	54934	5775	11046	55013	51176	27076	7381	25906	100272147	51531	8871	10023	4600	4925	5295	5290	6451	1153	9760	360	9679	10150	25939	665	10982	60484	962	51696	57018	2043	79960	23043	6160	23270	2273	25778	55251	5335	3590	113791	55761	4694	1043	4747	54855	678	23279	64067	57326	22838	1794	55790	23130	730092	9583	4848	9063	728855	5588	715	25777	8631	6018	1911	3820	1265	10628	3003	22841	8519	64112	574	1195	5567	7405	51193	5187	1350	57447	79841	8857	51439	274	7128	5500	55175	7769	7169	3385	5144	27128	54861	9960	1859	694	200576	26207	23484	220972	2123	80774	6653	397	201229	4482	7803	4603	9459	11322	55422	29108	5411	57446	29080	114882	1408	5786	79441	23354	51316	51274	9821	253943	10581	6448	1823	283537	4217	81619	11116	100129973	1039	55223	374977	301	5530	26959	9976	7259	26249	3726	23119	23014	10627	10370	241	54910	64788	253959
GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_YOUNG_DN	M5288		22434910	Yu M,Li G,Lee WW,Yuan M,Cui D,Weyand CM,Goronzy JJ.	GSE36476	GSE36476_1728_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated CD4 [GeneID=920] memory T cells from young donors versus those treated with TSST at 16 h.	With increasing age, the ability of the immune system to protect against recurring infections or to control chronic infections erodes. The objective of the current study was to identify gene expression signatures in elderly CD4 T cell responses					10049	6351	9277	705	54512	6723	29923	6888	26135	79084	4345	22809	10607	211	7965	80896	55055	4830	2650	7283	51318	11343	3843	29015	7293	8651	79931	27161	3265	2171	3595	6307	942	3321	54517	8531	6776	2710	27074	54205	57209	7124	22928	7371	533	84890	7295	26509	1154	79413	28231	79370	8099	5223	5889	84790	80742	2271	8870	6897	217	2730	2787	7372	63933	27131	7305	10940	81831	84975	5796	1193	6361	1203	205	2314	55052	84617	84823	79711	3559	27044	7415	3303	79029	6890	9997	1876	9414	10327	5373	3554	55326	3578	2786	2617	10971	80185	7126	1318	23277	10148	26517	8804	5198	4049	10549	9790	7421	10799	8645	6367	3662	4744	11259	10606	54502	51388	10254	51734	55760	1802	9308	51603	3703	2023	1503	10885	55509	29078	79077	60490	1612	4686	1595	8544	10797	10437	6713	54997	10538	55650	1493	10531	9521	26519	9927	29901	2193	29925	7866	22926	3460	387032	6364	3326	1495	8682	56652	6895	55298	5704	8602	3113	10897	57418	10072	10282	1821	11137	7167	10131	1460	3251	79155	23636	833	5954	10576	22984	79038	3417	80830	8811	56061	10856	57019	3123	1728	5603	3419	9020	4147	5664	8662	8266	10989	10360	1545	23180
GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_UP	M5289		22434910	Yu M,Li G,Lee WW,Yuan M,Cui D,Weyand CM,Goronzy JJ.	GSE36476	GSE36476_1729_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated CD4 [GeneID=920] memory T cells from young donors versus those treated with TSST at 40 h.	With increasing age, the ability of the immune system to protect against recurring infections or to control chronic infections erodes. The objective of the current study was to identify gene expression signatures in elderly CD4 T cell responses					256987	1153	222161	1831	1843	3725	4306	51170	51646	10365	23119	10140	969	3820	360	6988	57228	2353	6095	64784	3590	29072	3075	57018	120	5295	9736	7128	150094	79960	8445	54934	22841	8722	10124	113791	220972	8660	10982	54910	5734	10123	10023	9750	23108	10235	23370	23484	59307	4601	2043	3337	55761	11320	28951	2254	2803	730092	2145	1195	9960	7690	54893	6018	7178	10001	51696	10628	22838	23279	57162	5829	100129973	1105	23043	1408	678	4600	7852	7561	4747	27076	55603	3689	10144	23522	23300	9679	51585	55000	26207	2124	23228	9267	51669	9802	55251	962	5187	5217	6653	3993	25778	23270	7294	114548	275	6165	5412	3635	56255	8945	694	51193	57126	1859	301	253959	3003	1936	491	490	56882	1823	7259	9759	51316	100132406	55422	7803	9760	100286937	5775	9764	55654	25777	54855	51125	27128	8795	6691	5500	8462	57326	7805	282997	23387	9649	8857	4189	841	6232	6164	5893	7381	81565	1880	28984	64174	29116	27252	440026	84060	1039	64112	7695	51145	79979	10219	5290	79015	100129361	6567	9583	57154	51176	9205	9140	22863	825	51439	50507	8635	23199	6446	11240	8609	3632	84159	4848	10162	55056	114908	23046	7109	10738	25976	65981	2354	3587
GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_DN	M5292		22434910	Yu M,Li G,Lee WW,Yuan M,Cui D,Weyand CM,Goronzy JJ.	GSE36476	GSE36476_1729_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated CD4 [GeneID=920] memory T cells from young donors versus those treated with TSST at 40 h.	With increasing age, the ability of the immune system to protect against recurring infections or to control chronic infections erodes. The objective of the current study was to identify gene expression signatures in elderly CD4 T cell responses					79019	9212	2184	79084	1719	29923	79022	26509	6888	7158	378708	2630	3161	23397	7965	29015	4174	5827	705	6119	5892	9768	27074	2237	11065	60490	11264	3843	898	3559	54892	8318	672	991	5111	4171	8438	9429	4830	71	51659	84823	5427	3251	51514	7453	7295	3925	10036	6897	7283	64785	2582	157	11332	1163	1493	146909	10112	10437	9793	55509	24137	7298	81839	79682	51318	9133	3662	3703	23649	995	3980	1718	217	51203	6361	79029	8645	10049	7371	4176	6539	7083	54512	9414	1058	7421	55052	3978	3832	292	55143	1728	2271	2175	9700	29901	1503	84790	84617	63933	3595	1495	57415	211	26517	10615	11004	7167	332	8266	2171	5198	6470	1841	28231	55165	91860	54517	5106	5778	200081	259266	7850	64151	5888	10963	8099	23516	51603	28973	3554	6367	10549	1164	5641	83759	4173	1033	80185	83461	1460	79728	7153	200734	5223	10606	140465	10538	8243	10989	22974	55245	10376	9447	3145	1890	2650	1062	79077	6732	95	9493	8427	55355	55847	7372	55055	79413	4345	9319	5422	29127	5984	220134	6652	55281	891	641	23682	55388	7533	675	7419	79228	203068	1854	3642	9134	2189	29925	5932	6426	1193	90861	79714	9158	4288	6241
GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_UP	M5293		22434910	Yu M,Li G,Lee WW,Yuan M,Cui D,Weyand CM,Goronzy JJ.	GSE36476	GSE36476_1730_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated CD4 [GeneID=920] memory T cells from young donors versus those treated with TSST at 72 h.	With increasing age, the ability of the immune system to protect against recurring infections or to control chronic infections erodes. The objective of the current study was to identify gene expression signatures in elderly CD4 T cell responses					1843	10144	4256	969	253943	256987	5734	7128	51646	56255	5295	6515	4929	2353	9736	79960	150094	57018	22841	120	10124	54934	4601	3075	10019	51696	1153	8445	113791	9960	57162	5579	8660	10123	27076	1831	28984	55654	6018	23108	23522	3590	55761	8519	11320	4306	5187	23370	222161	23228	2043	220972	55603	23270	9750	1105	1408	64112	1859	275	6653	4600	10140	26994	5217	4820	64784	23043	4671	51669	23484	23014	6988	2803	1911	10023	1316	321	114908	253959	27252	730092	7695	4747	25778	3135	4848	9583	6095	11228	55422	5412	8609	7259	25976	8462	282997	79134	5500	3337	301	3570	6232	678	9063	51274	51562	6165	54910	114548	1195	490	22862	3003	64061	4010	1263	10365	5829	8635	57154	10235	9725	6446	23279	10970	10219	2040	1039	7803	11083	100286937	3710	10001	81565	54855	10150	6691	59307	22863	8848	55251	285282	1844	3587	10628	29116	9649	4189	3726	7852	83752	2354	3689	8440	3134	55671	7405	3043	10410	80219	2217	1880	7832	3434	93487	11314	100132406	7076	6322	1387	9028	23175	10207	25957	3820	5287	23338	57326	57396	29072	6169	9802	29080	51193	9737	728855	3575	9256	79441	22838	65981	9764	440026	79609	140801	6314	83700	10370	1998
GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_DN	M5294		22434910	Yu M,Li G,Lee WW,Yuan M,Cui D,Weyand CM,Goronzy JJ.	GSE36476	GSE36476_1730_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated CD4 [GeneID=920] memory T cells from young donors versus those treated with TSST at 72 h.	With increasing age, the ability of the immune system to protect against recurring infections or to control chronic infections erodes. The objective of the current study was to identify gene expression signatures in elderly CD4 T cell responses					4830	2630	2237	29015	79019	3703	7263	83759	7171	51318	29923	55388	5641	6897	5888	7083	5664	8318	9232	7295	3559	9768	63933	55760	71	993	81575	991	7298	1719	10635	26509	9793	5827	9700	6790	378708	5892	6426	140465	10615	1058	79413	2710	2842	3833	57707	7126	375035	26271	55872	79022	3554	3303	2171	5106	8438	56061	3161	1854	4174	2271	4176	48	9282	622	11332	23603	6888	8836	5932	5427	26519	8243	51053	64151	7272	332	2305	51514	4602	7283	2135	11065	10112	79980	55165	10449	56992	84790	10989	80185	1164	7421	11004	5223	1163	51603	1111	7372	6119	9801	5984	55120	55509	51203	10376	259266	1960	8458	2184	10072	79077	10538	3832	1841	27074	5925	3149	4288	1495	3925	10721	6491	56935	9133	26608	7153	55313	57209	10293	891	55847	23397	7167	9371	23649	55247	84617	54512	192669	60490	4171	56938	79081	10606	54821	7453	5422	11339	292	701	4637	55143	51659	990	5049	84823	9414	5111	57415	51022	1503	1728	9158	51184	5198	699	10799	157	79029	6241	9761	7850	10437	7965	6723	2650	10049	25941	1033	79714	2717	26292	55215	90861	11130	5437	79649	83461	79801	29901	8819	79071	51123	5690	1062	9446	9787	54069
GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_OLD_UP	M5295		22434910	Yu M,Li G,Lee WW,Yuan M,Cui D,Weyand CM,Goronzy JJ.	GSE36476	GSE36476_1731_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated CD4 [GeneID=920] memory T cells from old donors versus those treated with TSST at 16 h.	With increasing age, the ability of the immune system to protect against recurring infections or to control chronic infections erodes. The objective of the current study was to identify gene expression signatures in elderly CD4 T cell responses					79015	51646	7098	10123	4482	51439	9750	32	56255	1831	8527	25777	29125	6653	722	6275	27018	9445	10681	1583	3337	64112	10235	51314	9459	7552	1380	1105	55082	360	57711	51084	253959	7128	120	8383	23043	118987	150094	10786	5333	23263	55056	5163	7769	80063	79168	113	678	10982	6515	5335	2353	84060	2217	83752	10140	7803	7476	274	8875	1117	66002	4800	57535	4837	51176	54855	4306	23108	113791	6711	220972	57446	5168	4335	9960	1063	3590	51526	10124	4753	10628	644128	51192	140597	8445	9529	5144	3688	10365	55270	27004	10039	23370	55893	2775	2533	4601	23270	92815	57496	222161	9153	26138	4256	8660	2516	51696	1998	9452	9922	7091	6018	9482	203	3725	256987	2138	57326	5500	5275	55423	79007	9119	55422	7405	665	5858	3757	56920	5579	1238	51203	4763	100287927	9139	59307	2530	23228	2902	4925	79832	23635	284649	114548	7125	54934	25939	7259	54039	3990	3003	26249	51585	4149	962	9063	10223	9779	26207	6451	51596	4324	10962	51170	915	10023	9231	1774	11320	9929	1153	9802	3689	23077	2561	11155	373156	3903	10086	64174	5498	3797	7837	5863	55733	301	5588	4515	795	7538	7597	9465	408050	11223	9074	221981	29072	1794
GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_OLD_DN	M5296		22434910	Yu M,Li G,Lee WW,Yuan M,Cui D,Weyand CM,Goronzy JJ.	GSE36476	GSE36476_1731_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated CD4 [GeneID=920] memory T cells from old donors versus those treated with TSST at 16 h.	With increasing age, the ability of the immune system to protect against recurring infections or to control chronic infections erodes. The objective of the current study was to identify gene expression signatures in elderly CD4 T cell responses					7283	6888	2079	5954	211	27351	1612	79070	10007	16	4141	84790	28231	7743	22984	217	7850	11014	203068	7319	2717	3376	3662	5245	4686	29925	27074	5223	29015	1019	5708	2618	6182	8942	90861	958	23516	6772	3703	8099	1213	55856	2806	127703	4285	3554	10954	51	51491	8804	1503	9352	51296	29078	22903	23545	10531	8890	3559	29088	6367	7203	22926	26003	23155	81929	55509	55686	5394	90480	50628	10538	708	9688	5641	2720	6520	5796	55226	11138	10969	26509	4065	23417	10606	23636	10049	84617	4830	5694	151011	348995	5373	2617	2517	10421	7421	8682	1802	9817	8651	29889	7453	6897	10437	2271	1478	79959	10528	6776	80010	8811	5437	2968	205	7086	23603	7293	51318	10885	1154	1537	58504	5719	6732	29916	5188	7185	51042	63933	79413	7415	5514	347733	5693	661	79705	8891	56342	27340	9371	7371	1890	7167	9456	3601	10146	5516	2805	5690	9793	57128	942	1193	6361	10376	55052	11343	11145	8187	9790	7419	9837	10799	9093	10963	29968	2171	7158	7107	8870	1475	79712	26521	55500	5932	3692	9391	7295	10131	27161	3597	57415	7126	2965	115353	7965	10072	63875	6183	1495	8624	64759	54517	6749	6890	5889	705	5664	55759
GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_OLD_UP	M5299		22434910	Yu M,Li G,Lee WW,Yuan M,Cui D,Weyand CM,Goronzy JJ.	GSE36476	GSE36476_1732_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated CD4 [GeneID=920] memory T cells from old donors versus those treated with TSST at 40 h.	With increasing age, the ability of the immune system to protect against recurring infections or to control chronic infections erodes. The objective of the current study was to identify gene expression signatures in elderly CD4 T cell responses					6232	63877	8527	4820	10123	4629	80124	4306	6314	6095	55623	4929	80243	7480	64112	23300	55893	118987	1831	8445	5136	644128	64800	5023	120	9245	222161	7098	1936	114548	25777	1105	4613	1998	50838	51646	3757	10208	1843	66002	3725	23522	10235	4603	6653	3688	26034	9750	11155	10365	6900	253959	23108	5727	26137	54855	23263	80115	56255	2173	10869	150094	57710	51439	41	711	8660	51145	11077	4601	3354	9929	64174	360	3689	50804	1380	57602	7327	7259	2625	10124	32	6773	23471	5893	8110	51526	5163	4299	678	5858	301	5734	2353	6542	83752	23329	5333	2355	23228	8795	10140	3337	863	9960	4104	2902	147179	1153	23370	8519	4146	6018	26105	23765	78998	6164	6515	84059	2533	57711	2561	275	4335	63910	51601	55761	8648	55082	2217	535	3590	3049	5217	7476	2357	9802	390998	6546	9922	80063	9925	56920	51520	23389	79168	57326	2043	55422	758	28951	7803	969	29125	54518	23220	4157	84060	3273	23099	22883	29951	113791	23349	11119	56944	23705	5791	26094	1015	9860	7837	79913	9550	2776	10628	5500	64285	4887	56829	220972	81030	117247	9074	7125	64131	339290	54112	4189	10891	1373	6360	5346	6446	1117	4142	7058	79015	374977
GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_OLD_DN	M5300		22434910	Yu M,Li G,Lee WW,Yuan M,Cui D,Weyand CM,Goronzy JJ.	GSE36476	GSE36476_1732_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated CD4 [GeneID=920] memory T cells from old donors versus those treated with TSST at 40 h.	With increasing age, the ability of the immune system to protect against recurring infections or to control chronic infections erodes. The objective of the current study was to identify gene expression signatures in elderly CD4 T cell responses					28231	24137	3662	22921	9212	10606	622	1163	7743	55215	4686	8870	16	84617	10535	5708	29925	10592	3925	4176	56925	4830	65003	23516	5223	2618	10969	10073	79022	10376	7965	9133	7283	79019	3376	1193	891	79682	54892	2806	6241	9833	9700	7453	7371	2237	71	11138	259266	2271	8804	4173	79968	11004	1890	22928	1478	54908	7083	90861	8345	7203	55165	51016	29088	64759	9787	5427	27074	8890	10963	11130	641	9446	7319	9793	5437	1058	1019	3597	56954	4521	9319	5694	6470	10112	27236	5693	290	64785	4171	1063	6790	55746	1503	7850	217	211	4200	51514	22974	11332	79023	84790	80010	1612	90480	4522	29127	5106	5422	5245	1719	1111	8802	6119	701	55500	5902	51318	5889	7421	10421	55355	158	56992	3554	2184	26010	22822	5557	23417	7112	7936	9978	5496	7158	9768	7153	1861	3161	2730	3033	51155	1164	55388	83759	375035	51728	200734	115353	10247	3838	63933	6182	7298	993	10018	6732	29074	3559	10615	3832	203068	84823	4358	6539	2597	29015	10726	10635	140465	2189	5985	51659	3149	23397	3417	10866	63931	3615	1537	8624	6888	10072	7374	3028	9352	8099	64151	5983	9817	5888	990	475	1475	5984	29923	79077	10131
GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_UP	M5302		22434910	Yu M,Li G,Lee WW,Yuan M,Cui D,Weyand CM,Goronzy JJ.	GSE36476	GSE36476_1733_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated CD4 [GeneID=920] memory T cells from old donors versus those treated with TSST at 72 h.	With increasing age, the ability of the immune system to protect against recurring infections or to control chronic infections erodes. The objective of the current study was to identify gene expression signatures in elderly CD4 T cell responses					10144	1843	5893	118987	1831	339290	114548	2040	6278	10124	4306	7078	117247	2217	644128	9960	23108	6528	79913	3632	9922	10125	5098	9779	55623	23228	150094	51646	8660	51314	23300	5727	56681	3337	10140	4929	6018	6653	301	8527	950	4335	54039	51526	57711	140597	1052	100129482	678	79048	1408	2353	26094	51520	51601	1124	969	23099	2561	4601	9802	7367	5630	23522	1153	408050	5217	64112	6235	5972	3486	3725	2832	7852	9550	2043	8445	5218	80036	6164	220972	8519	10962	863	23037	80316	3693	4146	8609	23119	9873	9929	57228	9139	6515	51145	54855	7410	10738	1263	9737	51585	8788	4603	2357	93487	9153	55422	9945	5163	7098	65258	84658	4837	9860	2775	100127972	79762	83700	722	4820	83752	2642	51131	644068	56920	8996	54910	3223	57824	9882	63917	1534	1592	6440	59338	3423	1373	3590	7695	50650	54544	10252	120	10235	7476	3641	5016	23362	6736	56606	55082	150	1936	56255	6259	29072	26103	8567	54845	23263	3354	55	4600	9722	8424	79015	5500	3082	8277	7776	5506	83734	53616	3077	55761	10628	81544	26137	373156	10443	9658	10208	8483	28	80023	5412	54363	79630	51176	10249	9697	28984	1601	7846	5023	6446	2533	55893	9750
GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_DN	M5303		22434910	Yu M,Li G,Lee WW,Yuan M,Cui D,Weyand CM,Goronzy JJ.	GSE36476	GSE36476_1733_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated CD4 [GeneID=920] memory T cells from old donors versus those treated with TSST at 72 h.	With increasing age, the ability of the immune system to protect against recurring infections or to control chronic infections erodes. The objective of the current study was to identify gene expression signatures in elderly CD4 T cell responses					1478	9212	10606	2634	6241	5693	23155	5188	28231	10592	3925	51514	1687	1213	203068	11130	55856	10376	2618	3151	2184	11332	3554	22928	26509	1293	4686	8542	4173	6790	55165	4522	641	7153	7371	79682	9688	90861	23603	9700	5888	9817	3662	5427	9363	29925	2968	6470	7283	891	54939	54914	9133	57128	23397	5708	79712	51155	16	51016	10969	1537	9555	55215	2717	10112	10535	1058	701	22974	3559	29127	9319	5889	10615	7743	8624	2305	54069	8802	898	622	347733	7453	3376	84790	3832	259266	9833	2178	29088	2806	29015	2805	1163	5984	9793	6897	4676	7298	26240	25979	4174	4602	2237	112950	51474	9787	11065	10733	211	7083	56954	71	22954	5932	54930	1063	55355	7374	4176	64151	9446	55055	51203	2271	4594	10072	990	79714	27074	23788	4171	51659	54892	8914	7421	10247	83461	6642	4830	7167	29081	24137	10575	890	7112	22926	10007	2720	54881	55244	3149	1512	991	83759	50485	3161	63931	1503	79959	29074	10073	1019	65003	79019	8772	140465	10714	5892	4734	4288	7203	23417	26521	56925	56935	23463	9768	4720	7158	3182	5096	79622	79022	11339	4521	5223	1960	8099	2517	51022	84975	6426	2189	4700	79413	9493	5690	55388
GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_UP	M5306		22434910	Yu M,Li G,Lee WW,Yuan M,Cui D,Weyand CM,Goronzy JJ.	GSE36476	GSE36476_1734_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated memory CD4 [GeneID=920] T cells from young donors versus those from old donors.	With increasing age, the ability of the immune system to protect against recurring infections or to control chronic infections erodes. The objective of the current study was to identify gene expression signatures in elderly CD4 T cell responses					79682	100293553	27434	6119	100506699	574	79071	27125	4618	10036	50507	5373	3046	91807	283298	23484	283683	1380	64343	55872	8061	2005	29078	10942	6201	146909	55786	4070	54494	4697	4360	64167	285282	55016	9282	9768	3606	22928	23331	1350	9753	2861	57089	27161	51659	9275	79933	26664	1307	5791	7319	2043	8470	2181	9371	9553	1678	10252	9231	64943	56061	55222	6675	1033	7716	10769	79733	79134	79018	57405	6868	1457	6318	83700	440560	9500	1052	5203	26235	64097	26038	8326	286	55002	54732	10964	64131	28986	22832	25778	54101	9218	55867	114818	7153	5450	6228	55329	1571	6617	6385	3248	9256	54934	51145	23130	6696	55451	51776	54149	51101	10614	91298	27089	23181	51741	2222	6570	84099	5509	100293871	51309	9871	7182	79801	63895	5297	1646	2052	7544	171546	26053	27284	7295	51352	5165	100288007	9825	826	4058	55146	4160	9955	100288413	1807	80704	27129	26520	5352	54714	10094	23677	79694	152185	6364	29080	619505	4335	2792	4319	3698	8871	53844	4671	7132	3667	7205	55056	23251	7691	4734	57180	55175	8864	8099	9939	5329	6129	5028	28966	51334	401014	7436	26012	79820	54896	2935	79667	54788	6144	23471	64788	7305	6584	51193	30851	9521	8390	10443	26521
GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_DN	M5307		22434910	Yu M,Li G,Lee WW,Yuan M,Cui D,Weyand CM,Goronzy JJ.	GSE36476	GSE36476_1734_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated memory CD4 [GeneID=920] T cells from young donors versus those from old donors.	With increasing age, the ability of the immune system to protect against recurring infections or to control chronic infections erodes. The objective of the current study was to identify gene expression signatures in elderly CD4 T cell responses					1374	26138	2832	643224	10144	3811	79153	27295	11155	4638	8321	1821	6490	2297	8200	3486	23037	3231	2564	160313	6751	56311	9228	10046	7421	80823	57127	55922	22847	27091	623	440738	10039	3786	8844	7434	50810	5349	63877	23626	3026	4990	8800	1601	55063	3718	22932	54596	9510	51807	10683	64782	109	3899	64344	25787	284649	79834	728882	7450	3229	7225	64388	80740	125	50624	3884	6367	54039	1473	26531	79015	23314	644128	6911	440073	5972	51237	127833	80164	27039	51435	290	9863	535	51299	26033	5340	54831	8013	4111	2135	2232	9942	56146	3802	788	8659	5218	56521	8123	1184	80183	8424	79962	8613	10497	275	2998	6649	9245	50650	8600	7056	51013	3141	10468	54762	55313	1258	9332	3381	3352	29999	8840	51778	4249	3597	2982	54898	9576	23546	100287927	29986	22986	3766	63974	5337	419	9633	80975	5051	10738	50840	79370	10268	5618	80742	9715	9037	54827	9793	81833	79874	65055	8499	255926	9873	2138	3953	1373	3084	3693	27202	100287483	3049	7327	3809	4438	5176	6456	1133	23155	100126791	55084	374977	6999	4336	13	7552	54112	7850	6531	7350	9260	4747	305	8704	2017	54546	9526	6900	3770	2899	3557	56606	79857	80307	29760	26287
GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_UP	M5313		22434910	Yu M,Li G,Lee WW,Yuan M,Cui D,Weyand CM,Goronzy JJ.	GSE36476	GSE36476_1735_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of memory CD4 [GeneID=920] T cells from young donors treated with TSST at 16 h versus those from old donors treated with TSST at 16 h.	With increasing age, the ability of the immune system to protect against recurring infections or to control chronic infections erodes. The objective of the current study was to identify gene expression signatures in elderly CD4 T cell responses					7547	977	10324	6964	83468	2192	51213	54626	64091	6318	2953	11099	10737	55847	2971	23026	2358	11133	5521	23076	8602	79990	8491	91782	7453	5179	1756	6370	81873	5166	9941	5690	169611	8820	6525	8715	79074	284244	4200	56911	23552	477	9937	22827	91120	7356	5428	55100	51270	56957	6810	55226	3990	533	54914	26053	10654	81609	1642	2222	51603	51807	3787	26255	3359	4051	3036	8428	80176	80128	9315	10650	27125	90362	5694	5273	5373	6756	2660	57559	10643	9957	23786	54982	7761	60312	273	64167	79922	642	29928	55532	770	64446	53905	4632	1583	286	667	719	157922	1723	6557	79683	25979	55852	54512	56999	79080	4993	7386	3786	4626	55347	2674	28513	5136	79754	1503	90011	79839	23120	2775	84975	10897	55326	100288944	23587	6561	22899	9890	1579	100507436	202018	1555	6667	10576	23268	1717	660	8643	10351	53822	26610	7479	3883	58985	51560	2853	29015	400084	338	1238	7043	6785	3035	3046	5544	4090	10721	7841	131	57468	9391	51075	25854	64927	51182	1620	27141	8558	6132	23243	55178	2919	58477	6923	4756	1179	8822	56130	58497	9374	114818	22836	1816	2993	6890	55821	3758	9865	79892	4692	55267	8912	51776	55259	10611	100287025	8402
GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_DN	M5317		22434910	Yu M,Li G,Lee WW,Yuan M,Cui D,Weyand CM,Goronzy JJ.	GSE36476	GSE36476_1735_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of memory CD4 [GeneID=920] T cells from young donors treated with TSST at 16 h versus those from old donors treated with TSST at 16 h.	With increasing age, the ability of the immune system to protect against recurring infections or to control chronic infections erodes. The objective of the current study was to identify gene expression signatures in elderly CD4 T cell responses					57538	56912	3033	4306	7113	3439	4254	51134	265	22932	50810	8345	64418	6018	23306	4747	11262	1438	2006	4753	8302	665	11216	23189	1300	64127	3833	84830	64579	54797	3645	4846	9948	1657	23315	1636	283459	1364	10467	2272	11247	93349	4617	55089	285527	900	5565	10438	6752	2581	1510	10422	55364	670	51594	93210	3351	7975	55604	9765	346562	57728	100294145	7109	51385	51106	10019	901	64854	5727	7584	728621	11177	9583	10023	64806	2053	5739	57226	1316	9119	51601	60467	10443	80231	8535	3551	1775	23187	55333	9935	1447	9760	120	4154	57107	23078	9534	729515	3444	8350	5507	10181	10974	79698	4791	5887	6726	1604	2819	6853	1671	7745	7852	389856	23492	4320	29064	4674	374354	6451	644128	80346	29102	514	6891	26257	440434	4007	100288809	5885	1160	9852	64866	886	10126	80095	10144	27247	2517	5188	10403	9973	831	9873	1291	6834	1556	6147	9348	55539	79841	4978	25975	84162	100129250	26575	5500	10495	9210	11113	10157	50802	3146	26228	27087	8972	6616	79156	9988	79848	5394	55323	440348	11168	55279	27334	55628	6374	10599	56106	11045	55629	51314	2274	6519	55033	79705	4925	347240	2099	1587	26191	27436	285830	85459	83482	9920	25957	11010
GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_UP	M5318		22434910	Yu M,Li G,Lee WW,Yuan M,Cui D,Weyand CM,Goronzy JJ.	GSE36476	GSE36476_1736_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of memory CD4 [GeneID=920] T cells from young donors treated with TSST at 40 h versus those from old donors treated with TSST at 40 h.	With increasing age, the ability of the immune system to protect against recurring infections or to control chronic infections erodes. The objective of the current study was to identify gene expression signatures in elderly CD4 T cell responses					6678	6382	8612	695	6470	320	56105	440738	379	5136	9114	7932	586	3354	8842	64344	4634	2296	3231	23138	4841	2913	1358	8633	7957	50838	55607	51050	22836	7851	80177	468	22918	64849	1310	79739	80243	8029	26002	9349	5473	6667	5596	79814	23547	27251	7529	4330	9370	4629	55616	6745	58513	64901	1296	50831	9721	2798	56001	84928	64167	7345	8685	4218	7520	25890	4868	54474	11077	58495	57758	2671	775	443	2101	57538	9970	2532	675	758	57235	54538	81848	925	8431	6505	441151	7033	91316	56301	5650	91543	389906	4168	80263	2867	54996	1536	23220	3687	4939	23349	863	11141	9245	139081	80346	26053	6689	3885	333	57242	6229	55870	79369	8912	577	325	53335	10551	3977	3718	10256	3373	55735	4158	81491	4986	2765	9726	10882	7087	81025	25822	1421	80157	7490	81285	51751	51438	2555	1394	55117	8444	51085	5879	5023	3240	79846	57119	9945	5655	8091	43847	220134	6169	12	7570	56944	5992	10492	655	10959	81622	56244	9358	26692	83714	56673	1382	2570	2006	5798	3479	25787	222642	57419	6652	414	9753	554	4759	9185	56606	55054	100130354	284649	331	3698	55051	2979	140885	79870	79740	7762	284244	1553	5375	53820	10669
GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_DN	M5322		22434910	Yu M,Li G,Lee WW,Yuan M,Cui D,Weyand CM,Goronzy JJ.	GSE36476	GSE36476_1736_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of memory CD4 [GeneID=920] T cells from young donors treated with TSST at 40 h versus those from old donors treated with TSST at 40 h.	With increasing age, the ability of the immune system to protect against recurring infections or to control chronic infections erodes. The objective of the current study was to identify gene expression signatures in elderly CD4 T cell responses					440434	1020	63877	8379	54681	55692	2869	5580	537	11332	10180	1476	4615	55361	22932	9710	9439	81566	613	4205	728642	53347	9448	7378	11334	5372	23033	5436	4152	3096	5590	9249	55905	5090	8209	808	84061	55249	28952	347902	59338	2149	10016	100291860	23200	11329	389	11138	2314	8636	80723	9759	57798	327	4791	2071	6888	2272	5297	10782	7294	7187	64130	54856	8804	8412	54925	6655	11186	1611	55101	29125	10490	4674	8440	55716	5272	4794	90	6133	222161	7049	51296	5894	7743	79038	22856	79982	29086	1351	10163	637	23053	1337	9320	23250	22795	8878	5692	10144	64418	64780	4616	604	25776	4351	7165	4043	26580	10438	98	8270	217	4722	2132	10484	10295	9612	2873	24144	10401	85236	9326	7273	6843	3108	1196	3783	5564	64175	7357	1716	54623	1892	23304	10627	23583	79571	84162	5900	7753	5128	64127	58473	4747	171586	9144	6224	23216	8818	29083	84830	1831	9020	9363	1958	22872	488	6633	25988	54	10781	64960	3574	23141	7297	29066	2948	94239	10614	51547	9200	2053	8665	1192	1612	5732	50810	51108	7692	54977	1960	5578	114625	9729	8363	8611	3117	64764	51397	54963	23189	26152	54762	7133	55756	200734	6834	2140	79805
GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_72H_TSST_ACT_UP	M5323		22434910	Yu M,Li G,Lee WW,Yuan M,Cui D,Weyand CM,Goronzy JJ.	GSE36476	GSE36476_1737_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of memory CD4 [GeneID=920] T cells from young donors treated with TSST at 72 h versus those from old donors treated with TSST at 72 h.	With increasing age, the ability of the immune system to protect against recurring infections or to control chronic infections erodes. The objective of the current study was to identify gene expression signatures in elderly CD4 T cell responses					5420	26094	4521	22918	9975	1066	158471	3696	54885	80316	57824	3036	8973	147657	23534	85453	63898	728361	2660	4312	54187	54039	10229	1084	6338	10133	6347	400506	11153	2770	7032	8572	54919	8148	55410	1138	79071	23252	261734	57718	5121	1075	7442	79746	926	11004	80346	79794	50940	2104	51520	6728	55604	7473	2835	202559	2294	55160	2971	5892	23211	159162	54920	2920	55205	8428	3344	2913	57146	3763	169522	2042	5243	1789	11172	8710	51622	203510	2890	51659	2267	2176	11317	3803	6666	6401	1281	3698	51155	6584	4843	495	7837	4691	81850	4107	29767	25775	7171	105	23539	64776	8438	56124	4744	4277	9638	26762	2741	117247	55020	4985	7104	1948	79843	10036	5794	9366	6528	90865	5623	783	9370	1462	8893	6964	3381	10998	5089	4634	55670	8995	27136	56123	26548	56606	9945	5972	80755	79363	23072	28971	51168	79019	793	4160	2674	1052	4606	54558	2914	9860	2035	8612	8576	51206	1378	30817	284217	11334	404281	9848	55313	9172	4885	79865	4146	7367	146227	7712	55625	9585	3429	2492	25787	3673	157627	9315	3150	1602	3619	863	5375	3576	10903	81562	64102	11187	5599	3842	6278	767	4052	9232	9942	80179	4714	50831	399818	9697
GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_72H_TSST_ACT_DN	M5324		22434910	Yu M,Li G,Lee WW,Yuan M,Cui D,Weyand CM,Goronzy JJ.	GSE36476	GSE36476_1737_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of memory CD4 [GeneID=920] T cells from young donors treated with TSST at 72 h versus those from old donors treated with TSST at 72 h.	With increasing age, the ability of the immune system to protect against recurring infections or to control chronic infections erodes. The objective of the current study was to identify gene expression signatures in elderly CD4 T cell responses					2131	22932	10144	1376	23136	4345	200734	1955	440434	4929	10443	10157	51601	2272	10475	7592	6311	4753	23078	23593	4601	5134	3567	79899	7107	130916	9371	6322	59338	9249	1687	474170	81617	118987	1843	79161	23528	54812	10412	642236	5564	57209	26151	23235	57612	55802	54209	604	29116	6004	1112	3604	58486	4515	10181	93349	9723	54925	5727	54883	10342	81631	4968	4126	104	125893	665	23208	10039	23604	4914	1236	5579	10866	26523	50615	900	55268	3131	55660	3108	4891	8343	29919	25850	100129482	8667	64130	7074	27247	23461	5739	8676	10147	28986	7564	80208	10120	8405	100462953	51669	4850	5406	26035	51592	9710	23409	9487	10396	54502	2908	347902	55082	51701	10336	26580	90634	313	814	339229	143	51380	51147	670	51302	9794	8707	6489	25957	2796	3113	10299	8228	10563	9313	113791	64109	55332	57104	3578	27125	55737	3516	970	79970	56983	3732	15	84079	686	10781	2533	6990	10437	9322	55316	9936	10207	6208	26959	10807	11119	8867	5158	9733	7050	23015	5341	5140	10346	79091	55471	260294	5993	1435	54	55251	1519	582	24139	3055	6919	4007	10019	25776	3700	81619	8337	1524	1438	7273	65981	79038	2863	57136	57396	1439	54828	80006	8675
GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_UP	M5326		22986450	Schwartz JT,Bandyopadhyay S,Kobayashi SD,McCracken J,Whitney AR,Deleo FR,Allen LA.	GSE37416	GSE37416_2050_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 0 h versus PMN treated with F. tularensis vaccine at 0 h.	We demonstrated recently that both constitutive and FAS-triggered apoptosis of human neutrophils are profoundly impaired by Francisella tularensis, but how this is achieved is largely unknown. To test the hypothesis that changes in neutrophil gene expression contribute to this phenotype, we used human oligonucleotide microarrays to identify differentially regulated genes in cells infected with F. tularensis strain LVS compared with uninfected controls. In order to examine the effect of F. tularensis on the neutrophil transcriptome, we performed microarray expression analysis on human neutrophils treated with F. tularensis subsp. holarctica live vaccine strain (LVS).					64718	100287697	389834	23670	84849	4851	60625	80060	1469	8704	199731	56121	124401	54112	400831	80274	80157	27231	24139	4493	79136	100507064	6121	123970	200403	79680	9719	28595	23132	169792	83844	6602	1266	728264	713	2867	389840	10474	3294	8826	54514	84458	57458	5292	93035	4763	10452	55096	5830	1572	11279	644128	64232	145474	53347	146433	11328	201456	23332	6830	54454	4547	79039	147650	3218	440738	83876	5253	4107	3552	339287	642938	23193	6801	400798	152118	8190	8822	27133	93436	2151	168507	10687	51631	51593	116840	1506	4600	389458	5976	83752	441208	84318	79767	3217	6811	23413	148014	644090	9073	283875	80055	29924	128497	64063	55974	5514	84504	340267	55683	285498	9410	5443	2932	5092	4897	116224	51733	54913	8508	1209	4782	197196	9125	25834	1025	100507470	6955	100287331	389170	100288693	284013	440434	100132369	26057	3385	55095	1380	3110	701	131096	11332	146664	64802	10331	11216	113655	91653	54512	23408	138428	5649	51231	10870	340390	10157	54875	765	84529	1005	1314	348654	9677	50859	5662	440854	283854	219790	440918	189	440061	1983	3742	83450	26062	56832	266722	348327	114299	266671	147670	7205	647024	55662	4799	2918	647190	22820	284418	387486	389332	145173	3386	51085	8647	54716	90379	26188	1120	1240
GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_DN	M5327		22986450	Schwartz JT,Bandyopadhyay S,Kobayashi SD,McCracken J,Whitney AR,Deleo FR,Allen LA.	GSE37416	GSE37416_2050_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 0 h versus PMN treated with F. tularensis vaccine at 0 h.	We demonstrated recently that both constitutive and FAS-triggered apoptosis of human neutrophils are profoundly impaired by Francisella tularensis, but how this is achieved is largely unknown. To test the hypothesis that changes in neutrophil gene expression contribute to this phenotype, we used human oligonucleotide microarrays to identify differentially regulated genes in cells infected with F. tularensis strain LVS compared with uninfected controls. In order to examine the effect of F. tularensis on the neutrophil transcriptome, we performed microarray expression analysis on human neutrophils treated with F. tularensis subsp. holarctica live vaccine strain (LVS).					100134123	256130	280658	283218	53820	23232	480	57496	25849	1271	117159	285696	9180	885	100507299	9231	56301	43847	143570	84720	57540	204219	51666	79819	29122	83715	4179	127731	728730	54881	1411	339505	9509	100113384	26222	642280	1303	7221	100507435	55891	4998	160857	27345	26245	100131733	5365	132612	6512	27443	151877	57051	57546	558	283392	146849	9727	23544	286254	285352	339977	100288745	121053	55998	1846	100133205	65059	4146	4881	26123	79080	11259	1618	642345	151254	57504	2324	27143	123591	160140	54959	83698	4332	10651	85444	7866	50651	619190	4774	219537	100507386	100287114	5997	30812	389336	347252	257103	4994	57824	7173	340074	2819	339352	116988	100292443	100505545	388011	400512	8175	285593	253650	167410	400952	124454	84436	55065	56704	3736	360205	146540	6943	401220	400120	415	9068	10439	11147	402	7043	10569	1518	642757	134353	55124	1131	125965	29890	9891	645566	256051	114798	6402	79025	118471	157927	29091	144817	259287	4867	284578	100507206	574538	114783	57711	100506314	168400	9824	80174	2880	114784	10923	113452	881	400258	2938	1014	57719	9229	63926	253738	11202	146853	4294	59277	3009	10878	83595	339221	254028	5906	6419	10738	2921	1740	113828	152789	28978	84068	6317	10693	90632	136157	283777	11043	22925	285878	8913	10893	100133669	100130155	100290557
GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP	M5328		22986450	Schwartz JT,Bandyopadhyay S,Kobayashi SD,McCracken J,Whitney AR,Deleo FR,Allen LA.	GSE37416	GSE37416_2051_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 3 h versus PMN treated with F. tularensis vaccine at 3 h.	We demonstrated recently that both constitutive and FAS-triggered apoptosis of human neutrophils are profoundly impaired by Francisella tularensis, but how this is achieved is largely unknown. To test the hypothesis that changes in neutrophil gene expression contribute to this phenotype, we used human oligonucleotide microarrays to identify differentially regulated genes in cells infected with F. tularensis strain LVS compared with uninfected controls. In order to examine the effect of F. tularensis on the neutrophil transcriptome, we performed microarray expression analysis on human neutrophils treated with F. tularensis subsp. holarctica live vaccine strain (LVS).					1070	26112	201477	5788	163049	2589	10402	3146	55819	29855	79101	57567	387032	8555	2342	22937	51651	5565	51003	55727	11186	199920	10170	55762	8794	10550	427	79081	79818	55285	27197	1154	55937	1153	51231	132241	146722	10328	256586	56670	25847	91368	729614	4066	728661	3385	28996	10190	401261	6898	51362	6402	285331	7096	25943	51439	60467	51379	5880	27299	220359	3087	51249	729230	1376	10487	22884	11151	220906	26100	56945	26226	10023	51528	55361	93589	5828	5162	88745	83605	1441	2150	9938	92342	200765	319085	79152	285855	196264	25842	159013	254896	10248	90355	10899	23177	801	84135	643072	373	10287	514	83892	156	79959	64421	9910	64975	51029	1457	83608	2242	55602	90231	286437	162427	929	5327	56997	60561	140707	100288294	51104	100192379	84440	2745	9528	389677	190	80347	57804	26268	54480	2123	30061	5700	1522	10095	2215	25778	8660	80267	100129387	11019	286336	84225	5955	84984	51147	23383	253018	6710	23528	1773	133396	29890	55780	9673	729683	283464	2778	153684	3682	55900	10008	51263	9770	9375	80335	54934	84273	137868	5509	6277	23401	2926	64333	11035	10616	7733	10109	317762	8993	120863	53630	400960	122961	10016	788	100287911	64224	84674	79627	28960	6888	6877	401093	55870	219402	338692
GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN	M5330		22986450	Schwartz JT,Bandyopadhyay S,Kobayashi SD,McCracken J,Whitney AR,Deleo FR,Allen LA.	GSE37416	GSE37416_2051_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 3 h versus PMN treated with F. tularensis vaccine at 3 h.	We demonstrated recently that both constitutive and FAS-triggered apoptosis of human neutrophils are profoundly impaired by Francisella tularensis, but how this is achieved is largely unknown. To test the hypothesis that changes in neutrophil gene expression contribute to this phenotype, we used human oligonucleotide microarrays to identify differentially regulated genes in cells infected with F. tularensis strain LVS compared with uninfected controls. In order to examine the effect of F. tularensis on the neutrophil transcriptome, we performed microarray expression analysis on human neutrophils treated with F. tularensis subsp. holarctica live vaccine strain (LVS).					146664	282763	8731	56929	146779	246318	4236	55279	2865	9818	6018	664	7167	2204	54936	29923	353322	3964	3939	90673	5315	57758	100289071	6495	144108	54995	51616	2023	55818	54541	170384	5033	5223	26355	196441	1259	126298	284654	8843	29896	441245	3099	4282	3110	5187	55243	79009	9686	133022	4780	6884	5277	7124	1195	359948	125228	8915	22904	55892	5230	10802	29107	7559	5163	1263	319	23543	7051	9943	154761	55681	55222	64768	8690	230	9730	80273	64900	29946	8856	64859	8933	2159	10625	100130705	100287005	283401	253959	221079	114548	150142	2117	54996	153	10096	7336	285848	25818	123	51128	134	285966	728224	5861	49854	51008	165055	2571	51428	54890	55744	90990	9700	1020	387921	84061	27243	716	55096	283635	5157	7436	2114	147040	84647	5687	3383	51537	124491	10671	80032	90199	3642	23645	57127	226	8553	9480	6830	146395	153918	79962	441094	124637	23036	131177	57003	29777	50486	55821	55257	55844	7416	5743	157777	9361	10068	51762	23365	4477	3552	283652	9363	642696	286826	51435	11127	2996	347734	84258	5598	55768	27154	22890	11319	25917	8882	1763	151477	8140	55139	7185	23457	9689	5805	3166	54623	5155	8557	25841	51271	10117	1960	81875	2256	9567	165679	4858	64651	570
GSE37416_CTRL_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP	M5332		22986450	Schwartz JT,Bandyopadhyay S,Kobayashi SD,McCracken J,Whitney AR,Deleo FR,Allen LA.	GSE37416	GSE37416_2052_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 6 h versus PMN treated with F. tularensis vaccine at 6 h.	We demonstrated recently that both constitutive and FAS-triggered apoptosis of human neutrophils are profoundly impaired by Francisella tularensis, but how this is achieved is largely unknown. To test the hypothesis that changes in neutrophil gene expression contribute to this phenotype, we used human oligonucleotide microarrays to identify differentially regulated genes in cells infected with F. tularensis strain LVS compared with uninfected controls. In order to examine the effect of F. tularensis on the neutrophil transcriptome, we performed microarray expression analysis on human neutrophils treated with F. tularensis subsp. holarctica live vaccine strain (LVS).					57132	5877	131583	554203	10935	3385	9679	57506	3682	10159	836	171586	3312	2589	30833	54849	64131	5140	80774	55529	359845	55905	22877	3087	23313	84674	2137	200765	84250	8260	9993	55975	30817	3613	6383	4534	26020	55198	4215	79161	2932	406991	51022	645158	64174	10277	5983	10170	2123	4200	6199	146542	57472	51651	219771	3071	6867	23270	4695	11186	10333	23299	153527	54920	25938	10943	9896	64843	10567	7626	8450	4707	59345	5250	23039	30851	79147	56886	81537	10134	1147	57096	5586	9019	5859	11116	647190	8346	345757	9053	55196	55056	163859	221002	27202	4179	284756	196394	7156	1052	11100	3920	81857	3396	220359	5226	10403	54762	202020	399972	65258	100130837	11165	56670	222166	64407	788	29855	11057	3065	7048	533	51527	6789	22921	10269	5982	3417	124446	140707	7871	113189	55794	57533	157769	84260	222484	9658	23091	153546	30061	253558	10008	4775	10057	10402	222161	2850	7096	55102	23588	55119	25874	64853	1486	84329	4690	441168	55526	100505702	326624	2539	23514	9673	8518	128077	146223	286336	2222	115207	2975	80817	54545	255394	55968	85460	139341	9121	11344	64236	9674	8925	51562	25778	55312	835	54407	84661	9778	84986	6573	152217	55356	51306	8726	256987	51542	23046	3633	91662
GSE37416_CTRL_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_DN	M5333		22986450	Schwartz JT,Bandyopadhyay S,Kobayashi SD,McCracken J,Whitney AR,Deleo FR,Allen LA.	GSE37416	GSE37416_2052_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 6 h versus PMN treated with F. tularensis vaccine at 6 h.	We demonstrated recently that both constitutive and FAS-triggered apoptosis of human neutrophils are profoundly impaired by Francisella tularensis, but how this is achieved is largely unknown. To test the hypothesis that changes in neutrophil gene expression contribute to this phenotype, we used human oligonucleotide microarrays to identify differentially regulated genes in cells infected with F. tularensis strain LVS compared with uninfected controls. In order to examine the effect of F. tularensis on the neutrophil transcriptome, we performed microarray expression analysis on human neutrophils treated with F. tularensis subsp. holarctica live vaccine strain (LVS).					51428	137964	170384	113791	5315	1944	337970	80207	116228	9695	8553	23036	3460	2023	3964	5163	4998	1845	158830	55818	7110	26472	6617	2865	27440	23468	9361	115330	56965	2632	2997	4792	3556	1415	284716	5598	5223	23030	4245	55257	3516	30001	56929	5277	5230	25897	2821	124460	51005	54995	23509	9150	26502	154743	359948	396	55768	5252	29923	8843	7416	55892	57655	27077	10482	226	55279	55325	1195	51128	5033	55726	3383	9686	284023	10068	3099	25798	100505967	23533	6018	26355	8731	100129794	665	55893	9363	644090	401152	4236	8780	5970	51537	10802	8886	23	125228	5236	133	84709	154761	353322	80301	230	8878	9689	152518	2987	54512	9818	7336	84306	10227	101	7133	8823	7167	3141	54890	664	4282	1912	8933	3339	79009	8566	8733	5054	339976	10231	123	6793	51616	23307	64127	23308	55139	100131043	147040	255654	4790	85450	54541	5008	22890	153577	8819	4588	1611	3939	10155	5311	8045	1540	8242	7037	2339	64778	2119	55959	51008	79729	29015	55422	79065	5687	2769	114799	692247	283028	205428	2947	80273	57617	83439	1537	4794	93487	84445	113177	203260	9939	7597	51440	10318	27154	10291	25917	943	130617	145376	56269	7046	6478	619426	3092	5903	54989	339344
GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP	M5334		22986450	Schwartz JT,Bandyopadhyay S,Kobayashi SD,McCracken J,Whitney AR,Deleo FR,Allen LA.	GSE37416	GSE37416_2053_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 12 h versus PMN treated with F. tularensis vaccine at 12 h.	We demonstrated recently that both constitutive and FAS-triggered apoptosis of human neutrophils are profoundly impaired by Francisella tularensis, but how this is achieved is largely unknown. To test the hypothesis that changes in neutrophil gene expression contribute to this phenotype, we used human oligonucleotide microarrays to identify differentially regulated genes in cells infected with F. tularensis strain LVS compared with uninfected controls. In order to examine the effect of F. tularensis on the neutrophil transcriptome, we performed microarray expression analysis on human neutrophils treated with F. tularensis subsp. holarctica live vaccine strain (LVS).					7351	1520	64744	23514	10210	7414	9545	9926	3163	9020	90933	9647	7048	130814	26020	55256	221927	60626	121506	23299	84188	5586	219771	4065	113802	23023	10673	54849	79654	64207	4332	51667	51701	134957	9993	94241	3312	9910	64844	26112	4644	6404	26019	729683	5140	55	11100	80223	123803	3015	29956	5193	9019	80774	23091	153546	6903	64393	57132	22803	7096	1209	10277	79705	84309	25847	51379	57096	100288939	4810	54799	152217	80228	57533	79627	6907	3087	51144	3482	6480	9690	222161	4775	22921	56886	3065	762	4179	2539	55568	9674	27334	7415	113189	51439	30061	90135	84329	5987	10163	359845	678	3815	4856	140707	84661	9459	643977	86	406991	392	64395	841	10762	118	22877	55794	27335	8452	5684	253558	2035	115207	85377	79680	55905	29068	55303	54662	11171	7846	220359	7454	64407	54930	345757	30837	5829	192670	80024	9948	83605	150864	25840	157922	65258	112574	4217	6867	284756	120	84945	9525	8031	222166	100129387	6372	6383	5111	27430	201973	55102	223082	155038	388403	1021	9633	5537	9262	30851	162427	220972	9586	10788	81894	80010	54682	8925	23401	7764	93380	10269	836	5694	645158	10057	6789	255252	3385	7779	55364	64174	56255	202781	5499	51734	8728	50861	23389	51028
GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN	M5335		22986450	Schwartz JT,Bandyopadhyay S,Kobayashi SD,McCracken J,Whitney AR,Deleo FR,Allen LA.	GSE37416	GSE37416_2053_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 12 h versus PMN treated with F. tularensis vaccine at 12 h.	We demonstrated recently that both constitutive and FAS-triggered apoptosis of human neutrophils are profoundly impaired by Francisella tularensis, but how this is achieved is largely unknown. To test the hypothesis that changes in neutrophil gene expression contribute to this phenotype, we used human oligonucleotide microarrays to identify differentially regulated genes in cells infected with F. tularensis strain LVS compared with uninfected controls. In order to examine the effect of F. tularensis on the neutrophil transcriptome, we performed microarray expression analysis on human neutrophils treated with F. tularensis subsp. holarctica live vaccine strain (LVS).					8566	284716	1795	5252	3241	5163	58472	200186	10482	79139	28989	219988	1649	9939	26502	29015	4201	55892	221692	23036	154743	55279	55904	3164	9775	55893	51762	93487	4601	2987	23307	284023	4794	114799	55689	56270	11216	23210	1615	56965	10428	5034	11234	116228	152518	96626	7423	4998	112942	113791	5311	30001	51428	137964	4236	84270	2821	5604	7128	10318	55818	81619	2769	2119	100170841	6696	6520	2023	2907	29946	1912	57617	7597	83874	7133	55069	2835	4007	51008	64651	84058	6868	3099	170384	2997	26472	5970	124944	7360	5291	9334	100133039	6018	81846	221424	1845	23011	665	5054	272	226	8933	10068	54890	80149	1317	79729	3383	79065	242	23030	2865	2000	943	23019	55357	57646	25771	80207	6617	84957	9363	401152	3964	64332	5008	57695	7417	124801	25871	112869	1201	125228	79583	1537	396	51255	25816	29107	55257	55325	84418	8819	55726	10144	128866	124460	26355	9818	147040	7167	51317	50486	54386	154761	204	5606	5687	770	115286	597	54995	199745	127943	881	23081	64412	23645	54512	79009	8731	5277	64127	3460	4814	2286	8340	7336	9686	9792	84709	5315	7559	51537	57655	259307	128025	9943	50834	9695	285966	79651	126321	641649	5187	6428	9361	9643	1051
GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP	M5337		22986450	Schwartz JT,Bandyopadhyay S,Kobayashi SD,McCracken J,Whitney AR,Deleo FR,Allen LA.	GSE37416	GSE37416_2054_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 24 h versus PMN treated with F. tularensis vaccine at 24 h.	We demonstrated recently that both constitutive and FAS-triggered apoptosis of human neutrophils are profoundly impaired by Francisella tularensis, but how this is achieved is largely unknown. To test the hypothesis that changes in neutrophil gene expression contribute to this phenotype, we used human oligonucleotide microarrays to identify differentially regulated genes in cells infected with F. tularensis strain LVS compared with uninfected controls. In order to examine the effect of F. tularensis on the neutrophil transcriptome, we performed microarray expression analysis on human neutrophils treated with F. tularensis subsp. holarctica live vaccine strain (LVS).					51621	10512	23272	10376	24138	10477	9459	65258	3631	3087	51379	25840	2539	201973	11266	283588	1178	79937	7048	84668	286059	23586	51701	1678	5293	59340	55256	100131096	3416	1520	201266	10762	103	55843	80017	55729	6402	5934	10057	7402	113802	2967	3815	55337	11277	3344	9881	55055	79066	400653	728661	9781	7001	55501	2150	392	26020	135927	4179	8099	23338	5143	158158	389541	953	55156	11151	165324	55008	7414	54438	6342	51028	81894	56655	93183	5631	85495	359845	4810	3336	127534	81856	653519	51651	3676	55809	84273	388962	4050	54849	84309	4600	55573	9784	10159	9678	8629	5111	55347	10677	5228	387751	84890	80070	6947	678	9295	51411	55290	7580	10682	3433	283537	9926	100287932	647070	100289294	56829	151636	11036	51434	26034	84826	5166	8993	36	54495	4149	51074	54961	140	27334	10491	57107	498	10875	7454	2730	202025	64131	23423	64174	9862	788	54832	57189	8031	8776	5565	2560	51512	5140	4968	50619	285955	51667	223082	3437	1088	54809	100506963	7846	85441	126375	23224	55813	861	219285	3841	54477	3385	8505	64969	8725	6418	400949	121599	64386	284798	55907	84267	3613	10788	1629	805	79017	9688	140707	3329	3784	6383	51126	6272	56255	79958	6596	139716	5193	214
GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN	M5338		22986450	Schwartz JT,Bandyopadhyay S,Kobayashi SD,McCracken J,Whitney AR,Deleo FR,Allen LA.	GSE37416	GSE37416_2054_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 24 h versus PMN treated with F. tularensis vaccine at 24 h.	We demonstrated recently that both constitutive and FAS-triggered apoptosis of human neutrophils are profoundly impaired by Francisella tularensis, but how this is achieved is largely unknown. To test the hypothesis that changes in neutrophil gene expression contribute to this phenotype, we used human oligonucleotide microarrays to identify differentially regulated genes in cells infected with F. tularensis strain LVS compared with uninfected controls. In order to examine the effect of F. tularensis on the neutrophil transcriptome, we performed microarray expression analysis on human neutrophils treated with F. tularensis subsp. holarctica live vaccine strain (LVS).					93487	11234	23036	51762	2769	1729	57045	162989	9043	6676	2907	203522	6294	4926	2339	8649	246184	4794	286053	128866	84919	2957	9929	4792	7128	10957	10342	9451	4928	23788	131601	57646	3241	64786	8013	23473	5706	5093	56270	6388	79602	493856	51729	9908	10549	401588	10291	120103	10892	55357	10239	205	27342	602	253430	8724	6520	10488	90799	2821	9775	1407	55689	54520	56650	60313	9839	2010	54676	3516	10728	1176	4201	84418	7750	26099	55339	29015	65109	7416	5054	5504	91355	199223	79665	55726	22936	81631	9643	80856	55002	3383	969	2752	10765	1906	4864	2865	5687	311	79009	5008	51616	3460	11213	55681	8566	85028	8812	3164	56889	5597	9943	22882	55768	221079	58528	79888	2107	4616	84957	9130	54512	967	112869	205428	25921	9139	92086	10926	9689	154761	396	3976	4698	5034	4973	23480	2859	9467	51585	79065	81855	113791	8933	6256	54890	26115	3656	26502	4189	2920	1452	3192	11345	23307	203197	3621	7187	3476	54455	1386	26127	55281	204	4780	55893	83440	5604	5734	26996	29946	9361	55279	30001	10221	7167	1017	9367	330	55122	5805	85313	5932	55818	11179	80736	3157	23429	6782	51136	2800	112942	5223	23258	2717	127943	673	5291	23011
GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP	M5339		22986450	Schwartz JT,Bandyopadhyay S,Kobayashi SD,McCracken J,Whitney AR,Deleo FR,Allen LA.	GSE37416	GSE37416_2055_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 48 h versus PMN treated with F. tularensis vaccine at 48 h.	We demonstrated recently that both constitutive and FAS-triggered apoptosis of human neutrophils are profoundly impaired by Francisella tularensis, but how this is achieved is largely unknown. To test the hypothesis that changes in neutrophil gene expression contribute to this phenotype, we used human oligonucleotide microarrays to identify differentially regulated genes in cells infected with F. tularensis strain LVS compared with uninfected controls. In order to examine the effect of F. tularensis on the neutrophil transcriptome, we performed microarray expression analysis on human neutrophils treated with F. tularensis subsp. holarctica live vaccine strain (LVS).					84529	3448	283270	54438	219285	10392	10580	55156	6947	51375	4598	2623	2593	54212	51191	8698	55055	152756	4939	2044	2891	79697	222223	1510	1524	7434	26123	8638	10346	9459	550631	116236	79901	728498	222537	22920	23164	55365	10885	6936	820	51611	149684	1719	8673	9649	127534	84108	54809	1298	25803	22807	32	6932	9650	152405	8220	113251	283078	55750	199699	1178	54739	29127	163033	117157	10505	2621	84174	56829	60489	378820	253962	79807	6240	285812	163702	7490	126353	64919	9214	283140	2902	38	50852	388962	1088	147646	3965	55347	11200	5825	81794	115704	701	730631	114836	147694	84735	654466	256815	54941	498	145389	4938	122773	56256	79754	57212	359845	481	9465	57678	26157	3676	79017	64838	81931	27092	1870	100132341	3303	100132767	50861	164153	7020	1854	9019	7401	26049	79345	11123	3934	286207	5916	145581	80830	11184	3915	22871	23216	147429	339488	100134040	29969	1479	51338	155400	55215	64405	9031	81137	25906	203111	286009	55601	126669	7444	10592	79064	4940	3431	9791	54765	22902	79874	54537	440712	4321	91543	27284	28755	886	55635	255031	2525	23529	10079	51411	387914	55303	6925	3841	79369	3437	8732	917	23225	5962	201973	29103	83894	91298	219670	133418	23314	10213	5069	84078	25822
GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN	M5340		22986450	Schwartz JT,Bandyopadhyay S,Kobayashi SD,McCracken J,Whitney AR,Deleo FR,Allen LA.	GSE37416	GSE37416_2055_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 48 h versus PMN treated with F. tularensis vaccine at 48 h.	We demonstrated recently that both constitutive and FAS-triggered apoptosis of human neutrophils are profoundly impaired by Francisella tularensis, but how this is achieved is largely unknown. To test the hypothesis that changes in neutrophil gene expression contribute to this phenotype, we used human oligonucleotide microarrays to identify differentially regulated genes in cells infected with F. tularensis strain LVS compared with uninfected controls. In order to examine the effect of F. tularensis on the neutrophil transcriptome, we performed microarray expression analysis on human neutrophils treated with F. tularensis subsp. holarctica live vaccine strain (LVS).					26175	10691	9352	140691	64746	9588	1434	1499	9276	7873	27031	116228	51428	54882	5868	55325	80829	26148	9491	10542	7353	10657	10313	23786	55726	60559	55344	124944	91	1398	80762	10670	11193	23200	10653	378	4758	8819	9550	23144	81609	9859	51014	4695	6782	9453	8763	23473	23190	10245	120103	79571	372	1460	56985	51082	7709	602	9419	23001	286451	6921	4694	11335	81876	55234	11342	54867	192669	1856	1337	51324	51639	378938	9939	9559	5932	55147	9318	23637	25843	2804	55122	58515	746	497661	9643	55773	200014	79624	5433	55094	203245	3708	51669	54808	2874	79139	9140	1213	83852	6845	2553	1871	154761	9528	5973	10513	8992	6829	8459	7185	131601	373	2509	2495	79647	7405	5435	60682	57568	25855	127687	60685	222235	54520	2869	6813	5862	529	338758	115110	3309	84191	9320	3074	90321	84062	7494	113878	56616	23326	2157	80148	100506436	5516	440434	23515	84950	4201	84232	9546	374882	6729	5597	246184	54455	10467	9775	27183	1659	5922	10326	10049	90693	8578	55201	8812	10409	81611	9818	79018	80219	64429	64319	9044	9694	147007	7324	5621	91833	3105	819	2664	56851	3337	6482	84061	22990	8349	51009	10155	10420	6667	84981	54512	51729	11051	54676	2197
GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP	M5341		22986450	Schwartz JT,Bandyopadhyay S,Kobayashi SD,McCracken J,Whitney AR,Deleo FR,Allen LA.	GSE37416	GSE37416_2056_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 0 h versus PMN treated with F. tularensis vaccine at 3 h.	We demonstrated recently that both constitutive and FAS-triggered apoptosis of human neutrophils are profoundly impaired by Francisella tularensis, but how this is achieved is largely unknown. To test the hypothesis that changes in neutrophil gene expression contribute to this phenotype, we used human oligonucleotide microarrays to identify differentially regulated genes in cells infected with F. tularensis strain LVS compared with uninfected controls. In order to examine the effect of F. tularensis on the neutrophil transcriptome, we performed microarray expression analysis on human neutrophils treated with F. tularensis subsp. holarctica live vaccine strain (LVS).					2215	22834	1488	80196	4678	6399	28996	25799	1475	8334	6821	79415	9054	9744	6603	7321	2011	4899	10129	22921	26157	55303	112616	50650	159013	112936	10553	64744	84674	387119	83941	25796	9019	388969	79657	514	945	54926	10744	22864	317	406991	131870	51768	57819	4849	80167	10015	823	9522	54491	81	55004	54849	3717	100131993	401494	4214	51251	10559	29916	5836	7514	4707	118	115416	9910	5965	57130	49856	8993	64802	8899	79441	89910	10230	4332	3030	7248	54149	51167	55082	91300	11328	58485	11198	79616	127933	10014	23023	1388	83640	146722	2342	29956	4898	3101	103	26058	128637	120425	7879	84191	55848	151556	79760	8773	283899	57092	81542	283237	26019	90333	4012	22931	10180	25771	9637	677811	262	4534	9854	27020	285550	57616	84961	9879	55793	1102	818	8677	6049	92335	130535	65981	171586	10224	55957	3621	63891	6601	128387	9070	9738	79980	51246	51747	1457	2533	2549	23383	51249	10097	25957	55968	203259	1535	8635	55074	6643	80010	51668	55109	54762	65258	1154	90693	10170	9961	84984	10403	220359	26235	154141	83719	26034	11266	6625	113802	11164	64174	9530	2035	9491	100128737	50813	140460	2242	7263	65080	64333	9673	90120	835	140707	55723	81857	6429	2776	114882
GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN	M5342		22986450	Schwartz JT,Bandyopadhyay S,Kobayashi SD,McCracken J,Whitney AR,Deleo FR,Allen LA.	GSE37416	GSE37416_2056_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 0 h versus PMN treated with F. tularensis vaccine at 3 h.	We demonstrated recently that both constitutive and FAS-triggered apoptosis of human neutrophils are profoundly impaired by Francisella tularensis, but how this is achieved is largely unknown. To test the hypothesis that changes in neutrophil gene expression contribute to this phenotype, we used human oligonucleotide microarrays to identify differentially regulated genes in cells infected with F. tularensis strain LVS compared with uninfected controls. In order to examine the effect of F. tularensis on the neutrophil transcriptome, we performed microarray expression analysis on human neutrophils treated with F. tularensis subsp. holarctica live vaccine strain (LVS).					60436	8727	9265	79572	30	51061	441366	27230	8775	23258	79879	4097	22872	3313	4809	23036	25976	56616	7850	93487	22890	93643	6990	146779	23764	58191	10137	1973	124401	51008	51646	9261	133	23275	7124	5597	9948	440944	81928	9689	10488	54882	4848	2023	55718	9908	2769	7037	27154	29015	3566	221756	55041	6648	60490	1326	55222	1847	79729	253959	9536	50640	55031	80093	9751	4928	51762	6782	2678	79899	144108	11234	5515	5142	8567	3159	80824	83593	25978	54069	92162	3587	1108	2014	84061	81602	79135	10308	9683	24139	27250	9448	10043	23533	151194	10923	1026	7564	2146	904	55209	51726	54995	7975	271	100289563	9554	5606	9589	10342	2117	2286	8731	10483	124460	10804	170506	54812	55668	25820	729085	79753	96626	10963	5583	26037	6617	943	144811	7167	10492	5996	8877	23219	29123	1844	5232	7027	9693	5034	388799	651746	440026	30836	6018	55683	8477	9730	347734	9308	3097	4780	673	5329	64781	23468	92086	11171	23150	6884	203228	9943	5144	26088	57178	22882	3914	23	3833	51278	6676	79725	84002	55294	5138	3757	137964	4794	4175	476	1964	84807	64859	120103	1595	4792	22936	80342	124491	528	8676	378	85403	7130	64080	26147	5663	1105	113791	3939
GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP	M5344		22986450	Schwartz JT,Bandyopadhyay S,Kobayashi SD,McCracken J,Whitney AR,Deleo FR,Allen LA.	GSE37416	GSE37416_2057_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 0 h versus PMN treated with F. tularensis vaccine at 6 h.	We demonstrated recently that both constitutive and FAS-triggered apoptosis of human neutrophils are profoundly impaired by Francisella tularensis, but how this is achieved is largely unknown. To test the hypothesis that changes in neutrophil gene expression contribute to this phenotype, we used human oligonucleotide microarrays to identify differentially regulated genes in cells infected with F. tularensis strain LVS compared with uninfected controls. In order to examine the effect of F. tularensis on the neutrophil transcriptome, we performed microarray expression analysis on human neutrophils treated with F. tularensis subsp. holarctica live vaccine strain (LVS).					2548	9098	2215	3101	51380	706	9491	1524	389203	23108	9445	2746	3717	64386	84641	1457	6809	3385	1155	10114	7469	55196	10230	93953	55968	26020	54682	26469	9586	64326	7170	65123	283899	55082	8805	4707	5256	5836	494143	25801	410	55213	64333	51439	57096	126208	4678	23299	1456	64180	91289	84191	54987	80010	2533	7414	55809	945	54536	10269	4170	317649	23001	147991	2060	51279	6197	3613	5921	4898	51170	823	80167	9854	11164	81	79980	64098	25840	3312	22803	54947	283521	1953	9236	5986	51071	112616	4214	65258	4709	254225	168374	7091	84250	60686	8347	23589	199	29982	115548	7813	65981	57130	55857	54762	10559	9980	54849	10943	202243	30827	84790	514	23216	472	27284	255394	11329	91526	6692	9658	22921	6546	11116	835	29929	53635	80024	170482	81537	9611	4179	8243	79699	10567	54552	6272	1622	54518	58485	26234	7321	1052	3709	9961	317	55957	2549	9522	10335	4215	130507	8345	9103	151188	406991	4810	23309	11266	10426	23527	8635	9019	51651	84669	10100	392	3071	2222	57563	9674	2217	84282	8728	11119	55529	4534	100130744	6398	79616	7248	4763	11331	56996	8661	3633	10484	63891	90693	3683	7533	9673	283219	8459	84196	112936	22926	51411
GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_DN	M5346		22986450	Schwartz JT,Bandyopadhyay S,Kobayashi SD,McCracken J,Whitney AR,Deleo FR,Allen LA.	GSE37416	GSE37416_2057_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 0 h versus PMN treated with F. tularensis vaccine at 6 h.	We demonstrated recently that both constitutive and FAS-triggered apoptosis of human neutrophils are profoundly impaired by Francisella tularensis, but how this is achieved is largely unknown. To test the hypothesis that changes in neutrophil gene expression contribute to this phenotype, we used human oligonucleotide microarrays to identify differentially regulated genes in cells infected with F. tularensis strain LVS compared with uninfected controls. In order to examine the effect of F. tularensis on the neutrophil transcriptome, we performed microarray expression analysis on human neutrophils treated with F. tularensis subsp. holarctica live vaccine strain (LVS).					79572	60436	9261	6810	3516	56658	4236	79602	23258	6006	51061	23468	673	6648	1106	23	4855	8045	113791	5597	22993	3566	8567	6520	54812	23150	84296	51230	3587	23533	170384	5142	5163	5868	9695	9260	9583	55683	2678	10485	124460	2769	347734	6018	3159	6617	4792	11179	6515	7037	81037	5687	10011	3383	54995	9123	8553	3638	51278	11044	2023	84002	26037	27154	5552	4739	80093	2597	476	597	26355	92086	22906	64768	374470	25976	27161	120103	9943	22890	27230	26524	27440	29015	1026	3914	2987	1968	5252	9689	57666	200186	124637	2286	83593	8878	5315	57471	55095	54971	22936	7071	6990	51128	29082	133	60490	23036	637	79899	64092	5606	10294	26472	55668	137964	221756	7844	8477	10912	23764	4790	8877	5778	10043	654	23235	1540	56616	9908	3418	9363	51566	9043	9732	6676	10308	8870	5329	55818	8073	6775	8303	1844	100289297	3757	118426	55030	51428	864	284454	1523	58191	64412	56257	51582	9567	7130	644090	64781	11234	9612	5878	64778	4814	196383	9818	53831	26986	4794	128866	10228	1944	65065	10625	85403	57178	5033	9308	902	23476	7597	11273	5604	10488	4973	7124	9282	9175	5584	54331	5128	7155	440026	342977	22882	284716	2117	2200	79729
GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP	M5347		22986450	Schwartz JT,Bandyopadhyay S,Kobayashi SD,McCracken J,Whitney AR,Deleo FR,Allen LA.	GSE37416	GSE37416_2058_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 0 h versus PMN treated with F. tularensis vaccine at 12 h.	We demonstrated recently that both constitutive and FAS-triggered apoptosis of human neutrophils are profoundly impaired by Francisella tularensis, but how this is achieved is largely unknown. To test the hypothesis that changes in neutrophil gene expression contribute to this phenotype, we used human oligonucleotide microarrays to identify differentially regulated genes in cells infected with F. tularensis strain LVS compared with uninfected controls. In order to examine the effect of F. tularensis on the neutrophil transcriptome, we performed microarray expression analysis on human neutrophils treated with F. tularensis subsp. holarctica live vaccine strain (LVS).					23164	9545	131870	2746	65123	83989	8563	9586	7321	57186	1524	27284	51719	317	22921	820	22926	57705	23224	84674	3312	80010	29982	54947	8350	6103	54518	10210	64744	55969	23299	23170	64863	1155	57182	706	4332	23046	823	7091	285761	54432	3101	1806	4853	84641	55512	29068	113802	2215	9098	57533	643977	79865	93953	6907	9262	57118	11027	3087	29956	81558	6277	10477	768211	10162	51155	54849	118	3717	25840	57096	392	91662	8021	3726	81	5594	403341	22803	5256	124446	23092	26234	84282	2966	3815	728577	80223	3163	9019	26020	4534	26034	6692	51380	79699	80024	4065	134957	406991	841	25796	945	79971	100289246	79760	1178	472	2319	2035	10788	79720	6403	9673	171586	10432	93380	6546	9236	7905	11328	2548	7263	389541	57706	8347	4644	168544	79056	79932	57819	192670	54682	9961	540	1848	4659	514	64844	359845	10269	11164	10744	23223	220972	4179	23569	64207	10935	60672	22931	57326	10403	1953	404636	7538	8760	54930	84669	79188	121457	130507	84790	150864	1824	64757	284756	4810	55049	10140	84986	283219	9525	1843	4709	7529	4051	7414	170482	23295	26469	3385	8291	439911	7533	7096	120	4924	5499	84263	147991	56996	221184	10614	51	8728	83853	8826	6404
GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN	M5348		22986450	Schwartz JT,Bandyopadhyay S,Kobayashi SD,McCracken J,Whitney AR,Deleo FR,Allen LA.	GSE37416	GSE37416_2058_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 0 h versus PMN treated with F. tularensis vaccine at 12 h.	We demonstrated recently that both constitutive and FAS-triggered apoptosis of human neutrophils are profoundly impaired by Francisella tularensis, but how this is achieved is largely unknown. To test the hypothesis that changes in neutrophil gene expression contribute to this phenotype, we used human oligonucleotide microarrays to identify differentially regulated genes in cells infected with F. tularensis strain LVS compared with uninfected controls. In order to examine the effect of F. tularensis on the neutrophil transcriptome, we performed microarray expression analysis on human neutrophils treated with F. tularensis subsp. holarctica live vaccine strain (LVS).					60436	8514	347734	342977	4236	5034	7417	8775	27230	119504	56616	729678	5970	55030	11216	60485	5163	6936	5142	673	2678	9818	3295	90809	4616	30001	51729	1649	200186	1615	29082	7423	6478	124801	967	79602	3914	57494	6617	203228	64412	79572	127281	6239	29886	54890	1201	2987	23179	23764	112869	170384	2769	57471	9695	60490	29015	9975	55683	5597	3241	9140	1106	221756	23011	4973	57178	10765	23476	121260	116840	10745	96626	55893	51735	3638	54971	51061	79888	11140	26088	57646	9363	84002	55350	9175	23788	3073	81631	5252	55904	528	56670	6648	9308	51400	79899	80149	23	11044	2495	7037	54880	51762	11179	8509	84058	7071	51008	10428	9296	9444	1973	57617	83593	347918	56270	9754	93487	23710	11234	3516	1017	23130	285966	23307	51278	51296	7053	3159	128866	9536	476	8303	23258	8870	22890	6810	221079	113791	10228	84225	84807	1911	7844	4601	6775	4794	7128	272	6498	284716	10007	51582	27106	57192	665	9043	6515	133	4848	441366	90673	597	51256	7027	8764	7597	63924	54557	9943	4664	51537	29066	126321	57695	51428	2907	1845	22872	22882	55209	26524	3097	51016	3561	5329	54995	7187	203197	219988	65065	6448	901	9775	2023	3958	150365	7110	6520
GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP	M5349		22986450	Schwartz JT,Bandyopadhyay S,Kobayashi SD,McCracken J,Whitney AR,Deleo FR,Allen LA.	GSE37416	GSE37416_2059_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 0 h versus PMN treated with F. tularensis vaccine at 24 h.	We demonstrated recently that both constitutive and FAS-triggered apoptosis of human neutrophils are profoundly impaired by Francisella tularensis, but how this is achieved is largely unknown. To test the hypothesis that changes in neutrophil gene expression contribute to this phenotype, we used human oligonucleotide microarrays to identify differentially regulated genes in cells infected with F. tularensis strain LVS compared with uninfected controls. In order to examine the effect of F. tularensis on the neutrophil transcriptome, we performed microarray expression analysis on human neutrophils treated with F. tularensis subsp. holarctica live vaccine strain (LVS).					6646	192670	4678	223	489	1050	129642	3312	1488	8563	58526	55969	57182	116224	93953	6403	8345	10210	3570	65123	79143	22803	4898	5547	51112	1072	6282	26157	3301	64848	10114	150372	1524	79158	150864	10226	3726	6655	84669	51340	8837	65258	64098	79971	54682	25801	23046	9051	84650	3613	3087	83989	159013	55082	2548	390035	23569	80254	7402	80024	11266	9236	1432	80868	57706	1953	5253	221442	118429	100289246	22921	762	1439	10426	10097	80010	171586	392	9586	23299	100130837	6903	199	2242	4051	5256	10109	120224	818	168374	9295	23001	5715	284757	4534	9019	55809	8543	100288893	80022	1806	11164	3838	58485	24138	84641	6342	57118	8529	65125	5499	2539	9262	4214	7351	60686	23450	103	54518	317	387032	5608	55	7305	10859	9103	4179	9647	768211	10477	8350	3631	51719	23240	1316	54987	54432	7752	51621	7454	55754	5351	11243	100288781	112574	118	4709	54947	84250	283219	5586	59342	81	9774	284996	546	7170	389541	359845	8635	25840	6674	10553	51510	22838	8655	8850	706	3156	25796	283521	11329	4947	6197	2319	7263	64083	3320	64743	150381	91300	54964	157697	4170	64333	7414	1155	841	6821	9053	54849	1824	1475	8530	7940	8639	57533	7871	51	83853
GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN	M5350		22986450	Schwartz JT,Bandyopadhyay S,Kobayashi SD,McCracken J,Whitney AR,Deleo FR,Allen LA.	GSE37416	GSE37416_2059_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 0 h versus PMN treated with F. tularensis vaccine at 24 h.	We demonstrated recently that both constitutive and FAS-triggered apoptosis of human neutrophils are profoundly impaired by Francisella tularensis, but how this is achieved is largely unknown. To test the hypothesis that changes in neutrophil gene expression contribute to this phenotype, we used human oligonucleotide microarrays to identify differentially regulated genes in cells infected with F. tularensis strain LVS compared with uninfected controls. In order to examine the effect of F. tularensis on the neutrophil transcriptome, we performed microarray expression analysis on human neutrophils treated with F. tularensis subsp. holarctica live vaccine strain (LVS).					4616	6810	65109	9231	23473	11234	286053	115286	9296	54676	57646	51061	4864	9908	9444	51729	30001	90799	3638	3383	27250	7053	9695	388272	7559	11216	4097	23429	60485	5034	5163	55350	1407	29015	284266	1678	9139	23	22936	55030	8727	7027	7133	5287	124801	528	221079	83593	3516	23190	1606	51428	673	2920	8733	55319	10342	11179	8034	51205	79602	7516	2769	51762	1978	10892	7336	55833	9818	4201	127281	3679	65056	2907	144920	51382	200186	22882	4793	51537	9536	7128	4848	23036	7423	128866	8303	112869	864	22862	80821	25816	27230	51008	4973	9689	64080	60484	80205	6239	79665	121260	59339	79788	9554	6448	57733	55112	80070	3914	54520	8645	23307	112942	5144	55041	57178	4794	55683	55768	4236	2987	85028	92086	56270	64645	84310	55904	222235	83737	2581	51152	27440	9467	56616	119504	10308	55893	170384	396	57192	5966	51400	729678	7385	10912	25771	50614	6775	3295	84002	5597	3241	203260	253959	55257	79139	93487	80149	84445	10428	9043	56889	56650	10765	4302	137964	9140	2495	6515	3164	201164	901	22890	26999	55959	55209	54890	9577	8870	5025	79142	93663	493856	63924	55726	1017	55357	51616	5326	7417	84376	10488	7187	8843	3976	1317	56951	10870	9130
GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP	M5351		22986450	Schwartz JT,Bandyopadhyay S,Kobayashi SD,McCracken J,Whitney AR,Deleo FR,Allen LA.	GSE37416	GSE37416_2060_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 0 h versus PMN treated with F. tularensis vaccine at 48 h.	We demonstrated recently that both constitutive and FAS-triggered apoptosis of human neutrophils are profoundly impaired by Francisella tularensis, but how this is achieved is largely unknown. To test the hypothesis that changes in neutrophil gene expression contribute to this phenotype, we used human oligonucleotide microarrays to identify differentially regulated genes in cells infected with F. tularensis strain LVS compared with uninfected controls. In order to examine the effect of F. tularensis on the neutrophil transcriptome, we performed microarray expression analysis on human neutrophils treated with F. tularensis subsp. holarctica live vaccine strain (LVS).					159013	92714	9054	168374	65123	1084	10403	54518	112574	54491	2215	6867	253461	1524	57118	202018	5989	123920	93953	7290	283521	137886	54149	11275	55113	5982	54762	6383	10434	51105	860	149041	84674	150864	945	6403	11073	92799	3936	2548	440503	51719	29982	23383	6049	820	256364	4853	10109	26157	5591	5990	11164	54832	3985	4678	4810	3930	79671	23304	9039	23478	51780	128646	8529	8563	6726	4659	91300	402483	23038	7456	10425	9447	1265	4214	150372	5330	286052	22926	706	57533	100505746	120224	613	3726	1441	59342	11329	8773	9586	284996	4482	64863	8559	5527	51251	494115	113201	9997	122553	6643	60489	2591	64744	2533	51291	157378	55848	3838	2180	11258	3570	57700	27439	7077	6907	3717	79626	26001	223	26092	5253	221442	83853	3965	26020	25796	1955	3628	51164	4534	1827	285172	7813	5829	22937	22838	7305	11240	24138	23585	9439	2746	57182	23345	8638	81030	81558	3689	64333	54809	83640	55088	10554	5547	387032	51742	84986	51379	339287	83716	79758	23164	283219	253558	84803	22921	10695	10744	56829	23589	4051	5836	55788	1824	8698	100289246	5586	6892	51439	9744	4671	11025	6279	8925	317649	9262	677811	6546	84953	3423	113457	5921	6451	4947	56994	8530	768211	10210
GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN	M5353		22986450	Schwartz JT,Bandyopadhyay S,Kobayashi SD,McCracken J,Whitney AR,Deleo FR,Allen LA.	GSE37416	GSE37416_2060_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 0 h versus PMN treated with F. tularensis vaccine at 48 h.	We demonstrated recently that both constitutive and FAS-triggered apoptosis of human neutrophils are profoundly impaired by Francisella tularensis, but how this is achieved is largely unknown. To test the hypothesis that changes in neutrophil gene expression contribute to this phenotype, we used human oligonucleotide microarrays to identify differentially regulated genes in cells infected with F. tularensis strain LVS compared with uninfected controls. In order to examine the effect of F. tularensis on the neutrophil transcriptome, we performed microarray expression analysis on human neutrophils treated with F. tularensis subsp. holarctica live vaccine strain (LVS).					56616	657	22890	3708	718	4194	2987	23	4245	4616	119504	54867	54520	4189	9818	57823	55112	5163	57494	83852	83707	221079	10291	6675	4793	84820	54890	55603	57646	7046	7133	79602	10397	124801	6782	10047	83955	84062	112869	7053	56927	9695	56650	9823	84310	7511	84058	26115	10250	3241	2644	6648	29062	9751	19	65065	8045	137492	599	55726	649305	9689	811	29015	116228	6520	1649	2770	29886	158830	286053	133	1198	1407	133746	4248	8780	7423	1537	2160	7037	10493	5034	3097	5583	115110	23429	3383	5025	90799	3073	100289297	9175	340184	1978	3642	1944	100190938	51428	55344	9130	170384	7178	2967	9467	25978	5966	1975	57456	23264	93643	54455	2794	54	729678	26355	10428	3516	9110	147968	114132	85028	80323	5597	6767	23645	821	8877	57828	7336	5144	51061	11216	528	55768	54984	226	10485	1234	943	51537	55352	8277	9554	3964	9546	23788	55227	729580	2920	57192	120103	4097	643836	441366	55041	55959	100506436	5287	11314	5211	8804	9908	10362	130367	100190939	6810	51008	55833	10042	8733	8764	4074	60485	7494	30001	140739	2191	1615	9296	7185	4302	10079	4794	9984	7167	57786	51566	140801	84709	55683	1856	8819	5687	5526	23764	51205	91	79888	83737
GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP	M5357		22986450	Schwartz JT,Bandyopadhyay S,Kobayashi SD,McCracken J,Whitney AR,Deleo FR,Allen LA.	GSE37416	GSE37416_2064_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 12 h versus PMN treated with F. tularensis vaccine at 24 h.	We demonstrated recently that both constitutive and FAS-triggered apoptosis of human neutrophils are profoundly impaired by Francisella tularensis, but how this is achieved is largely unknown. To test the hypothesis that changes in neutrophil gene expression contribute to this phenotype, we used human oligonucleotide microarrays to identify differentially regulated genes in cells infected with F. tularensis strain LVS compared with uninfected controls. In order to examine the effect of F. tularensis on the neutrophil transcriptome, we performed microarray expression analysis on human neutrophils treated with F. tularensis subsp. holarctica live vaccine strain (LVS).					3566	132160	5829	6402	1212	30	271	5351	80758	9592	122953	9260	7874	58472	963	27166	5150	6867	91252	8676	54971	50484	27232	5272	64848	6827	259282	27235	29107	7920	2764	30061	29940	4615	10228	29109	23506	4170	3301	9189	10460	5998	199675	84629	83716	2539	5142	83593	84649	22918	4627	57620	4218	79650	6275	2000	92822	284454	5768	10855	10057	4600	7170	5029	25904	80256	1992	55534	1889	1192	9797	6583	118426	10527	1523	7091	284029	861	207063	127544	7716	5562	3431	128346	24138	101	9020	3691	7402	4664	84440	30817	2268	9927	64411	246175	80774	25994	54440	3385	28988	10673	1998	26037	65108	56829	124935	55505	3454	22850	1471	23564	6688	4815	29094	10019	55069	84876	115727	55671	285668	7726	4790	678	11277	10451	3985	8455	5530	23586	2120	8772	388341	22906	489	79603	3709	51719	2773	55654	60436	7508	53335	57701	285527	4493	6674	290	11165	8728	51347	53346	222658	54880	115548	57688	1843	100288893	3021	54930	282997	4599	3838	85464	85441	23228	1308	369	55661	58484	79091	5610	2321	140809	3631	165918	10287	58191	23067	54509	8291	1512	11140	79180	54815	5371	1520	91300	1627	5336	8638	6383	1147	51667	1717	222487	84941	2859	6277	960
GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN	M5358		22986450	Schwartz JT,Bandyopadhyay S,Kobayashi SD,McCracken J,Whitney AR,Deleo FR,Allen LA.	GSE37416	GSE37416_2064_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 12 h versus PMN treated with F. tularensis vaccine at 24 h.	We demonstrated recently that both constitutive and FAS-triggered apoptosis of human neutrophils are profoundly impaired by Francisella tularensis, but how this is achieved is largely unknown. To test the hypothesis that changes in neutrophil gene expression contribute to this phenotype, we used human oligonucleotide microarrays to identify differentially regulated genes in cells infected with F. tularensis strain LVS compared with uninfected controls. In order to examine the effect of F. tularensis on the neutrophil transcriptome, we performed microarray expression analysis on human neutrophils treated with F. tularensis subsp. holarctica live vaccine strain (LVS).					10068	161176	79089	25816	9130	1186	3295	10428	23461	2664	1176	3920	55435	123096	7322	126	56965	128338	2632	5291	79139	529	1163	967	5287	3074	1317	5757	84310	6448	9839	84418	2821	25978	80896	729678	115286	123803	8992	400622	9342	79786	57706	11027	3482	8764	8724	23049	56477	25798	54557	83955	8843	93129	10577	2213	55893	727957	427	11314	23252	39	9667	5454	9701	5465	440423	9139	113791	10144	127943	22862	6617	80070	55697	55122	4673	8459	10081	4282	93550	83417	55824	84572	58528	203274	9695	6767	56180	11216	1911	6373	9377	146439	10289	26035	55357	25957	10390	729580	7597	10620	5451	3952	55319	55176	27020	57512	2668	11188	6009	4926	6902	28996	527	55344	11337	10007	22806	51693	55131	4201	64121	284129	1407	9361	6862	3516	8714	55672	100128830	7369	57600	4038	55281	5252	26873	23609	3568	6668	286053	2799	100132025	80262	6601	64417	64425	115353	490	57724	1201	54822	11112	440400	4074	342945	641638	81035	643836	127281	23092	79986	137492	140883	55314	84993	84062	6196	3073	8497	10087	91689	7336	9203	2035	115004	1856	4087	170384	10594	285463	26137	26091	831	23326	54472	4601	8819	51265	100131096	8106	132430	9896	7879	285636	64645	10013	9167	537	81698
GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP	M5359		22986450	Schwartz JT,Bandyopadhyay S,Kobayashi SD,McCracken J,Whitney AR,Deleo FR,Allen LA.	GSE37416	GSE37416_2065_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 12 h versus PMN treated with F. tularensis vaccine at 48 h.	We demonstrated recently that both constitutive and FAS-triggered apoptosis of human neutrophils are profoundly impaired by Francisella tularensis, but how this is achieved is largely unknown. To test the hypothesis that changes in neutrophil gene expression contribute to this phenotype, we used human oligonucleotide microarrays to identify differentially regulated genes in cells infected with F. tularensis strain LVS compared with uninfected controls. In order to examine the effect of F. tularensis on the neutrophil transcriptome, we performed microarray expression analysis on human neutrophils treated with F. tularensis subsp. holarctica live vaccine strain (LVS).					11329	27232	3431	83716	93487	4973	56255	91300	26511	128346	374655	57688	3613	55303	2589	406991	5150	54971	26020	55284	26037	9020	101	3839	8450	2000	23198	84957	114885	6498	11179	64411	56850	4627	64326	1992	10560	4794	50848	6993	60436	23228	7290	865	79650	10425	84225	10294	9412	4214	202018	9870	1084	26524	9842	115727	54509	9260	645745	83593	10451	53346	23438	10379	10870	3454	30	112574	6827	805	7155	1889	7305	114883	113201	3985	27235	200186	26092	9252	132160	10745	51439	256586	393	57472	4790	5029	57620	4077	84456	57205	1390	8930	80256	1843	5606	57154	29094	285527	6867	51582	29966	5594	4600	388341	55113	5272	23118	3055	29940	22919	84807	1212	57862	7072	84440	4629	4599	3628	3669	81602	54809	7690	25994	222658	51719	4149	7099	8079	23011	9926	6674	10695	3936	347734	8638	29109	7462	3965	9536	6683	10228	54440	5805	6249	11240	246175	199675	2713	122953	51347	976	7150	29946	51646	51191	4664	55602	23012	6494	965	140885	54682	64748	80232	340527	57222	10673	4089	5128	3631	4659	9261	84557	80149	1540	493	83931	7132	79074	284454	29992	50619	64848	29887	6688	121274	51291	23329	1810	1523	140809	84142	23506	3566	8493	6672	56900
GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN	M5361		22986450	Schwartz JT,Bandyopadhyay S,Kobayashi SD,McCracken J,Whitney AR,Deleo FR,Allen LA.	GSE37416	GSE37416_2065_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 12 h versus PMN treated with F. tularensis vaccine at 48 h.	We demonstrated recently that both constitutive and FAS-triggered apoptosis of human neutrophils are profoundly impaired by Francisella tularensis, but how this is achieved is largely unknown. To test the hypothesis that changes in neutrophil gene expression contribute to this phenotype, we used human oligonucleotide microarrays to identify differentially regulated genes in cells infected with F. tularensis strain LVS compared with uninfected controls. In order to examine the effect of F. tularensis on the neutrophil transcriptome, we performed microarray expression analysis on human neutrophils treated with F. tularensis subsp. holarctica live vaccine strain (LVS).					1186	339593	54995	100131096	3508	9823	196446	57325	2288	10068	541473	79786	93144	3568	55344	100101467	9203	5166	6406	57706	116143	729678	8611	201254	30008	23421	649305	6767	148534	595101	5291	4673	6165	8764	5287	724094	2632	115110	56965	2213	55094	83955	147968	5430	6617	100131564	10485	3925	55697	1911	1856	2821	23336	144608	10656	283104	39	339044	10493	9130	5454	84572	84836	10289	91689	57412	3295	157247	55893	284119	84310	260429	2171	100505783	399491	55672	7322	55211	653784	64078	9284	123803	6448	100289294	100506436	285231	7597	728498	3158	56670	127495	4074	338758	79961	83852	6581	25896	2967	51466	89978	100130987	23522	7757	1399	3738	199857	3952	10170	9925	54939	5465	641638	10577	643836	136371	85462	54867	79861	51265	10144	100272216	55075	55227	55437	84909	80071	55206	115939	440862	5143	23354	7316	9046	202559	5205	648691	54805	55435	8621	8076	124751	7020	1234	9045	158830	8445	5369	26471	7941	1537	284615	6136	126017	6169	51693	283981	89919	23326	286207	3074	56111	170384	9253	25831	644660	6230	64425	6234	144165	127943	1176	100288238	503639	5757	9903	153562	283431	23646	145483	1163	80350	165324	9361	401106	11342	25798	85291	8459	6204	51616	1622	80227	11188	1576	284129	54441	57600	339768	729580	90338
GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_UP	M5363		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1761_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated eosinophils versus eosinophils treated with PMA [PubChem=4792] at 2 h.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					5423	54477	114932	5547	80031	80895	10928	22852	6634	79746	23765	79831	10773	5169	9039	6923	5271	7409	167227	23484	8342	2543	130916	1183	83450	1628	9992	100462953	56992	351	54665	645745	115703	28965	79064	6935	23272	3093	3437	10318	4121	10879	60559	22858	8365	59286	7976	54969	60673	6888	682	7857	9410	7375	10302	84726	9641	912	9341	27253	80011	26103	60528	23186	51657	3987	283232	3603	65010	8195	7421	1622	11017	55281	9658	375056	10193	51765	653784	5090	11344	6259	10472	8555	5524	54739	6048	8031	80308	8301	23191	50856	5591	157562	23040	56172	27131	55668	84172	1182	90355	2132	7263	51663	5239	157567	197320	10287	9588	4542	27238	678	7727	8294	55266	55754	9061	115939	55746	9276	57658	1327	7110	8794	8328	58513	55165	7447	2203	9365	11078	29078	22894	81562	5348	79873	140885	91369	51006	272	7332	7078	2063	6399	59	64975	55890	79671	8698	100288944	3148	55577	10945	9640	5321	25880	54830	220134	5965	4496	54828	3980	22897	27071	56994	55252	374354	51552	475	3508	2332	54942	5202	55589	51329	79817	51379	10499	25979	5563	5709	5172	2015	29844	2799	3759	55069	54873	9911	6717	22832	8724	7257	9197	2153	1063	9	22866	7247	55347
GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_DN	M5364		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1761_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated eosinophils versus eosinophils treated with PMA [PubChem=4792] at 2 h.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					80868	3336	6361	51082	84909	9002	79729	93081	5329	6095	811	3838	2935	3448	9853	1395	3638	54454	50486	51116	79921	11259	1671	2355	284649	8354	6157	6637	3562	9526	8883	1406	7168	257	1144	3480	55769	55592	5187	7321	11172	5919	54494	8520	6428	25890	91120	80110	54968	54962	55653	1944	6252	942	8482	6004	10671	3337	4860	4059	10849	56156	6421	9056	84560	8467	91683	8346	1409	3574	23099	8553	84179	7156	6666	9720	79160	10962	253959	29102	3181	54839	100506898	160824	5042	4130	2509	9670	8775	5383	84669	9378	4210	9051	3697	9180	51520	25837	3640	7458	57405	2169	662	22861	5603	7781	56157	3187	64446	181	571	1995	5997	923	9595	1026	5883	90634	127534	1847	4948	54857	9479	23676	3484	9058	6810	6232	5270	1556	8833	9044	10308	55147	23072	1058	7916	6402	1649	6690	57045	9896	55634	11236	3725	5375	8777	24141	8452	9037	2064	11255	5007	8224	79133	51320	22902	51491	2646	1287	3898	11320	10894	8796	11133	9655	1356	8453	6615	8994	8526	55001	22822	11221	2999	57282	3236	10045	5930	4093	4170	2288	11250	23430	10964	26872	242	3675	6948	7380	64786	28964	11016	4430	84561	26119	55061	2055	6320	247
GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_UP	M5365		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1762_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated mast cells versus mast cells treated with IgE at 2 h.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					57326	5435	23360	8720	60481	55970	689	11017	4482	22826	7757	57019	50650	26135	6574	115939	55630	6194	79078	8992	285231	911	1760	7837	963	23383	9197	6715	55795	9827	11342	54800	10075	23705	5604	10379	51750	9925	27344	6230	79086	9258	9879	3808	55274	6908	10284	26610	23534	29081	7545	3292	6158	9425	6206	8440	26278	54955	10165	55819	10022	727800	4320	79629	9761	6208	6166	6240	79443	10465	64422	9702	7905	6136	8665	26228	3911	539	53944	9293	9717	4168	11329	56889	8826	100132285	11043	6737	9559	55290	1519	7249	8804	51029	55763	81853	4594	8674	56259	23660	3572	5431	56656	8455	64062	2743	8539	55704	6597	9201	9352	10404	4775	26275	9349	56180	6277	79982	883	51744	10881	91647	65055	4285	51506	55278	54952	26093	9764	55002	9866	6397	1857	23081	10367	56986	114882	6263	11219	9295	9530	10647	9922	23144	9813	987	5422	54986	9844	81031	51611	4351	5836	8729	6861	22982	4720	825	6778	80317	5371	93144	6584	79906	79788	51292	2124	26057	3065	57171	54542	7039	3646	5829	51585	55229	9054	80022	7476	2737	23600	2693	79739	10190	51702	7571	11104	4674	54431	23036	7867	8402	1142	2745	22833	943	5291	51606	59341	3191
GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_DN	M5366		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1762_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated mast cells versus mast cells treated with IgE at 2 h.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					55854	10362	23244	79913	27304	1655	55668	801	7158	118987	79955	59286	10084	23071	22984	6907	6129	84302	54994	124583	6170	5687	157	7763	10915	2249	10732	10151	1936	23647	80778	3835	10982	79155	23095	23787	10591	8526	2885	55831	84658	3836	9902	23014	6923	4299	5725	23255	8578	7384	5230	355	83440	64750	176	56146	9562	8882	2805	10782	57154	8669	26048	4289	79763	10972	6978	23136	51312	27342	85294	5908	6504	7321	6009	2821	84516	57162	79609	9825	9885	4336	51092	2262	5500	10482	11056	1773	23174	8651	752014	8748	284904	79017	23276	29100	5768	2794	127703	9188	10169	1175	26156	23417	4282	8266	79891	467	5064	54953	79929	642	64106	9693	9247	51121	7163	5611	11214	6449	3052	56413	28299	4758	8844	55024	79574	3593	598	1495	9986	8273	4794	4619	476	5366	1822	23142	8864	1465	373863	84617	388796	4012	10445	6461	1174	7866	81545	617	2688	63876	29948	6863	9056	22902	148753	23126	219333	1512	8751	1416	2323	56941	2879	6522	79590	7328	6992	5142	4144	5373	50508	8481	90634	26528	9103	64123	55686	9050	93081	4125	4499	7090	6385	79892	4026	4931	5148	3443	8780	2289	6875	51762	9938	23223	100287387	1827	1844	7165
GSE3982_CTRL_VS_LPS_4H_MAC_UP	M5367		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1763_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated macrophages versus macrophages treated with LPS (TLR4 agonist) at 4 h.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					55148	54438	865	23531	55317	23201	3166	23061	1455	4913	9717	22883	23390	51611	55251	9183	56255	9815	23302	23059	4931	1802	7414	23269	4351	80895	25900	4815	5511	55208	5001	790	1933	80230	55052	26039	2705	55843	9879	8697	29098	10692	1955	3161	203069	5501	57572	1870	57107	57109	81931	5141	55769	6688	64062	51372	8555	55333	5576	406	10807	9657	27231	642	55339	25941	25888	3667	79023	23229	5828	3633	10007	57178	85021	23370	284325	10902	51350	10845	9774	26586	79081	23518	55746	55701	51111	54737	79596	23484	100272147	9900	8477	51050	6231	84864	28956	9716	80345	9159	57187	8574	10939	60492	2556	30820	7227	753	81887	10013	79719	80764	27079	84658	1678	79269	9016	55344	7844	64081	6529	54815	51533	4927	9212	166647	55870	8497	7957	55297	1500	55090	80183	26005	1062	23766	2059	6821	9724	25913	23107	8688	10947	54995	11004	79782	54968	26330	79780	9777	26637	25839	64777	4690	29927	390616	4214	5612	10424	51665	10714	8655	94026	23080	3329	23528	54934	23660	23119	5983	23367	1912	3712	9533	3694	5550	7625	92342	23463	55565	11143	54878	51400	29997	2077	7270	23394	23401	54977	11266	10559	49855	7381	55906	23476	4094	7155	7058	10419	4919
GSE3982_CTRL_VS_LPS_4H_MAC_DN	M5368		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1763_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated macrophages versus macrophages treated with LPS (TLR4 agonist) at 4 h.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					4312	5366	57706	5142	4616	182	9958	80149	8519	80305	8564	7706	4791	10512	25932	6504	8900	7072	23258	56300	4938	10640	4267	3587	55707	55207	644	23533	60489	6352	1385	27074	1656	2191	60681	7036	10894	10063	79663	103	9618	8542	4069	8638	84617	10616	4683	3394	29933	22821	598	56681	571	2005	51510	3736	962	7324	6773	81565	840	10950	375790	1604	6672	6538	3183	1528	80176	51765	2773	2150	29967	3738	51284	7128	2000	200734	3696	55802	56301	1316	81566	5698	222161	2553	3981	3669	28231	941	84159	10289	952	10114	8837	23636	6478	9258	6238	8843	273	3557	219333	151050	22843	3430	8877	54221	60672	1215	11177	23158	3428	79572	5306	93349	1052	8444	1543	6772	6421	8499	23071	2130	64135	10964	3097	26471	7185	4615	5819	253461	140609	355	23424	578	51561	5862	7913	7942	3290	9363	54475	79577	3660	4311	23328	10561	54462	65220	7543	5966	1827	5326	2526	25976	29951	24138	11274	23063	4654	864	5230	3659	220965	6506	10797	7430	958	27071	23764	3433	1234	9129	6793	9846	26750	1152	4494	7403	2803	3223	3091	4501	66036	445347	23704	50515	5341	9475	1233	857	81542	148022	10409	7453	9348	329	27	51191
GSE3982_CTRL_VS_LPS_1H_NEUTROPHIL_UP	M5371		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1764_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated neutrophils versus neutrophils treated with LPS (TLR4 agonist) at 1 h.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					55825	837	285527	79641	51116	1955	3442	3229	84790	53826	25801	9516	3106	25861	51071	285203	79568	10440	10426	3354	6728	89853	5828	5530	9039	60626	3337	11325	6098	9675	11108	6048	11183	63935	26137	10692	3886	1416	54514	54502	1774	7079	4709	1964	223	23272	4179	10436	953	2222	57876	10006	8225	10817	10394	79685	22806	51809	4659	10054	5179	28778	57586	8454	27242	9874	3097	28316	440193	989	2131	5372	9958	23019	6640	360	680	7284	79999	5538	2869	9016	644	5792	3339	8019	4778	685	6919	3607	8697	23359	1820	27163	80212	3625	7737	4946	80218	114882	932	54904	80305	26065	5465	6514	579	8346	2516	9103	5291	64081	9813	5652	51167	6856	6347	146057	4543	29956	1291	23047	54978	6543	1657	6655	2299	7180	79003	1687	1994	64747	7913	8850	23080	9976	6573	79940	8476	23613	51621	57470	54769	11027	10023	3742	9439	54972	51603	9592	23196	7764	5260	54830	6882	5686	27286	80862	79132	961	51427	5047	56674	669	22900	55848	1057	64853	4958	6136	22858	7693	3158	6907	9710	64746	10205	4851	55252	64397	1054	6426	9891	9993	2719	2735	22934	8573	4534	427	6307	974	79080	6903	6623	79872	54878	56945	7738	51163
GSE3982_CTRL_VS_LPS_1H_NEUTROPHIL_DN	M5373		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1764_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated neutrophils versus neutrophils treated with LPS (TLR4 agonist) at 1 h.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					9537	66002	3732	22891	208	1847	90379	197	55111	57804	5580	55135	79849	259266	51298	56944	5900	56616	2890	63924	9612	8578	54556	85360	54882	55157	79630	81669	9798	5671	10160	23620	9344	811	10265	57473	203068	1046	64600	367	5225	339229	3887	22980	10919	22936	8516	79575	9274	23205	25998	63978	10658	1133	3699	26353	11182	8880	57175	3914	57124	5863	51449	6009	8317	10849	80228	10750	8859	9144	55610	5322	6182	10877	4590	11224	7135	375056	6535	63827	65108	79956	6932	9552	7712	3798	25974	8340	10046	55361	79917	55224	2035	8775	79836	23683	973	6455	65999	171023	2617	6548	6525	5255	79791	22802	1453	9632	55733	2006	29116	56474	1943	11187	5551	1113	23	26051	3763	3552	10818	682	4729	2557	762	2819	11140	51005	6334	10343	1477	8322	3604	57863	55668	348110	516	408050	23764	55229	24141	7692	5577	6810	2139	9701	8736	8382	5967	27254	972	100286895	253959	9356	2952	51750	553115	718	10980	10645	79729	50632	23198	9786	2649	8787	10397	27023	3460	79725	215	26993	7267	26150	5159	6924	2254	10444	9955	1066	54714	148229	8968	79863	10955	197320	7706	2243	271	6324	2740	2804	80262	5158	1398	91445	207	3802	416	83478
GSE3982_CTRL_VS_LPS_48H_DC_UP	M5375		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1765_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated dendritic cells (DC) versus DCs treated with LPS (TLR4 agonist) at 48 h.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					26034	4208	3707	2733	23161	64794	9575	8451	10123	2739	54431	910	23596	191	23530	23682	55357	55110	54941	85477	10461	23266	80212	4610	5594	55313	2534	9061	10352	50613	22838	25992	10849	9475	56901	3455	9787	9459	8658	2952	56924	2201	1124	1601	7504	9214	8447	23261	2162	79762	112611	3337	6584	6050	55333	26211	2852	2819	3177	3182	54814	138151	79366	55344	7345	10462	7414	8356	1052	10635	11261	4285	50863	55759	100272147	55872	23659	1063	23603	948	501	79672	2274	1152	79887	51101	79949	1043	8741	285830	4618	79145	5670	3693	29087	23255	4828	51123	79184	902	2661	7766	1938	83464	113457	11314	566	6571	813	1132	1562	7049	79047	10873	5725	7031	25855	9121	4115	50838	9328	5619	64231	2205	23212	58511	4145	55049	5244	5420	8895	374655	8863	2098	911	23001	136	7267	11079	29028	10404	10217	54883	55304	1967	79875	8019	10771	10079	5747	4735	11027	79080	8871	26716	5939	5673	7347	3452	7464	6886	218	2524	11276	10935	3241	23397	3115	5253	10483	9734	7174	6653	7993	1075	57817	51005	9898	9649	353299	26548	7436	55613	3294	10798	80853	55214	2535	5224	8690	114876	55798	23484	7739	832	5260	9581	643376	55711	7461
GSE3982_CTRL_VS_LPS_48H_DC_DN	M5377		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1765_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated dendritic cells (DC) versus DCs treated with LPS (TLR4 agonist) at 48 h.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					710	211	2017	4600	24138	9656	8878	629	3620	7448	64761	6647	5966	9517	10561	1981	8516	23387	9015	1435	3437	3625	4938	4599	6352	8837	5577	5993	25763	56949	6368	3429	3985	1839	3665	6614	9447	51076	9623	2040	280658	11012	51762	8861	58504	80219	11259	5226	22914	60489	10318	22902	9420	411	8339	23547	740	5054	9209	26228	7039	1843	8835	3290	127544	29117	10964	55813	89853	11262	3486	6363	10581	5721	23461	1528	3624	6504	5464	4316	6843	9636	3959	6773	64218	11067	79870	56983	3593	5294	79939	5031	10866	4363	1475	7296	57326	3014	1236	2178	23355	83716	1728	8740	10409	23165	25987	1191	11345	11011	931	55239	9170	4014	347344	217	8519	23180	1803	10046	10912	8237	6777	3669	10379	79719	390	388650	27074	26952	1066	5292	7293	6346	79651	10149	10614	28232	55332	56898	713	6351	55254	952	65108	1123	79802	55765	3559	2553	5383	8897	467	4616	80342	23250	3627	9873	7291	58516	4213	57823	3716	23536	5329	4792	3350	27348	57596	4907	29919	7128	64172	55365	10410	9238	6897	10105	10342	941	91543	864	3914	3434	50512	57493	56252	54662	51191	10221	63899	3035	5265	6624	10962	65989	4345	2537	4837	2069
GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP	M5378		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1766_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of memory CD4 [GeneID=920] T cells versus Th1 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					22859	26065	10443	8764	6793	10106	51531	474170	7738	6399	27241	3587	3384	2309	57148	57612	10628	29072	11230	57048	27006	23522	2908	9750	54665	6539	23492	6170	6156	55763	10520	93210	10000	7248	4103	54585	923	222161	5252	1523	6010	55196	1911	5567	1645	861	1880	1519	22887	274	220988	203	442216	5921	80230	8019	4306	221037	8821	29761	1974	9852	1520	7696	56965	1628	8527	678	28968	55086	23272	25956	1831	23224	5002	10801	64418	3820	104	4124	9159	51816	10198	51316	23382	10491	5075	440515	4065	9857	1043	960	22883	11238	51585	834	9314	57147	1811	26152	23387	60686	5594	50717	57326	11082	79788	57228	9649	84869	6932	10257	10404	7050	25849	22982	10142	54765	81850	79608	51303	23499	6372	55191	155060	3590	8925	5407	6259	64854	1153	54487	9957	23108	905	79868	1235	10206	728142	51185	6651	7148	84440	23261	11022	4063	6555	59338	3106	10753	283537	84162	3489	5973	51228	3107	1571	54885	57018	10057	56995	56123	3606	23526	8660	51275	51348	2980	23015	6128	89853	8658	3178	7923	9914	64816	4324	2625	9802	282997	4215	9201	79587	9214	7580	23312	51592	9409	79086	7753	79663	3678	126017	825	64766	220972	178	26030	65981	1908
GSE3982_MEMORY_CD4_TCELL_VS_TH1_DN	M5379		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1766_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of memory CD4 [GeneID=920] T cells versus Th1 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					5898	10328	3070	1163	388	6827	4522	54708	2537	55872	51053	6319	51659	10211	10105	5366	4175	191	7272	3458	5718	2242	11259	50810	6240	10204	3014	5144	7415	541578	2617	8836	79682	91860	641	9311	2023	3832	5033	533	204	4436	90861	2958	4678	9837	3902	10079	56943	6788	79023	3662	6182	9401	813	1457	1312	80223	4085	11332	9997	5165	10213	54962	55143	10419	10592	23590	7421	11007	9123	7417	306	51056	10403	51	4236	1992	51294	10963	5694	1434	5690	1460	1022	8870	10797	403	4729	1737	2335	2012	22822	1278	7167	3101	5664	5962	9694	54968	5699	3326	347	699	5026	22944	8140	231	5889	55651	4171	5831	7453	2952	5036	26872	6328	8531	91137	3336	1437	10135	81034	2821	1164	1054	55379	64065	6713	6385	27235	3093	64222	10381	7443	5329	6510	23475	1827	4624	29095	51493	63933	2547	10252	1846	23397	25915	10535	6503	224	79017	51184	1848	2067	29889	54623	9585	602	990	7077	4628	2184	163	79622	5684	8837	79683	9603	7416	5427	3419	26123	983	9582	9861	23594	3949	6695	11339	23074	28998	54892	23670	5717	488	1104	5693	114049	8914	6241	51514	2885	79053	4345	3301	2678	60490	10576	4174
GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP	M5381		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1767_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of memory CD4 [GeneID=920] T cells versus Th2 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					51531	3003	7088	637	25956	22883	56172	57612	1909	22859	9794	23338	11322	10443	9750	10209	10142	6480	5053	91316	8764	3236	25977	1519	26065	10000	3820	2742	4600	2309	57048	25970	22982	90634	7767	23522	5923	27244	120	1831	63926	4674	23272	23224	54487	1120	54714	55743	1316	2064	57326	274	4974	301	23261	51186	387032	8527	6468	104	9610	440352	9852	29761	9162	222161	79145	54207	962	9857	11120	56983	339105	2145	10491	7168	7942	1655	203	79587	834	162427	63973	23387	9649	27010	4063	84162	23499	2633	3716	23328	57148	51303	6572	3119	355	23382	79820	89853	10125	80853	6156	54970	6095	56965	23390	23175	56123	10225	9201	728642	79668	283232	25777	7690	6344	55614	112869	6263	4103	8722	1974	54885	27252	22887	55765	60684	10404	9960	57007	51592	8658	26030	360	79089	3134	79792	55340	79899	9802	64919	9757	186	10106	221037	4646	8925	4058	4052	694	283537	9620	23526	79170	2934	100129482	4170	9905	728855	10346	678	23033	10347	7048	93210	801	23461	960	81544	10133	3678	5305	10379	55167	1235	3702	55343	440270	155060	60686	8848	7148	352961	4217	23054	85363	10075	79726	4154	5335	5048	54103	3800	5408	5462	22864	4306	3590	171023
GSE3982_MEMORY_CD4_TCELL_VS_TH2_DN	M5382		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1767_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of memory CD4 [GeneID=920] T cells versus Th2 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					79682	10328	5694	5743	7167	51184	9123	4436	56943	11259	1848	4914	51514	11332	1495	7272	4522	1457	9585	8836	1434	4175	10079	2023	60673	11339	5889	10204	22822	79077	51659	4076	10963	191	79023	57570	6059	2012	2271	10105	6240	6346	7421	1163	23594	6182	6319	5367	79022	5321	51053	23516	9837	80223	641	9933	4678	9645	1371	6713	10179	2590	2885	91860	51115	2242	813	9844	890	9401	63933	10592	2067	3832	3070	10574	3326	9328	2237	2547	51491	51719	81034	23326	6827	166647	10576	54442	9061	4085	10213	11007	5270	5831	230	7075	55872	1958	79017	10419	5036	1022	204	6749	113251	7813	6566	64216	1829	7416	54962	8364	6385	9319	5202	39	10099	54968	4496	10403	5008	51575	4171	760	11052	7415	60490	983	9601	55143	4345	10432	8140	5718	79187	23397	10535	4173	8531	3615	7520	5690	10211	7027	2958	26509	84890	7417	1164	5440	55486	3336	5714	1460	8395	56992	1017	6632	8870	6617	10483	8611	10671	8894	26228	6241	3976	23074	388	5427	9446	4624	51203	4686	10063	9689	5255	3662	7153	3014	10935	8898	11130	23412	2617	4724	81554	952	55500	403	224	2952	55726	5693	29088	4628	50810	6788	27341	11051
GSE3982_MEMORY_CD4_TCELL_VS_BCELL_UP	M5384		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1768_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of memory CD4 [GeneID=920] T cells versus B cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					1123	8519	50810	8821	9852	9046	3702	301	51531	923	5464	56983	6404	1803	3820	81850	64919	55340	7535	6240	9162	163486	29909	79991	79625	51575	3003	25939	5053	3932	7148	54487	2625	1071	920	22822	2117	23328	5002	9645	5028	54910	3678	28755	1909	915	401	9949	5292	940	801	203	5923	6653	79968	26263	79820	2633	7378	8497	23277	2980	887	3236	115703	782	221960	23414	91807	1908	28639	6372	8975	2309	4747	9749	55303	728142	9404	3081	4300	9832	80258	1645	8356	51474	64781	55556	339479	1748	9050	8653	10753	23623	51347	64699	8131	916	3004	9113	79156	56731	50852	9663	5583	8642	917	839	57125	56172	54878	1545	4124	2742	79015	9402	6095	3560	3075	9208	1258	64359	3587	959	23534	8287	9706	9902	9940	3655	9235	1786	79716	10129	26034	55107	7559	146	3212	3800	6192	976	23066	6344	285672	100170939	58528	914	4814	10669	5829	3371	5588	5066	10075	3937	57048	10801	79086	3131	53347	1154	8048	6310	28984	5616	29851	25956	440352	5357	55314	27288	26033	5813	51205	57535	10225	23150	8284	3938	7134	1741	474344	6775	2026	5732	4160	607	1846	23555	10161	54718	4856	5797	56123	4068	4494	63973	10507	89853
GSE3982_MEMORY_CD4_TCELL_VS_BCELL_DN	M5385		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1768_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of memory CD4 [GeneID=920] T cells versus B cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					3514	847	51284	23075	3495	10099	1875	3621	3119	7014	91353	7942	59342	24141	10390	8417	6328	2208	64222	27342	4678	91316	6925	7088	25780	3493	3662	2185	80008	5026	6689	240	22906	9061	9103	7462	3535	3109	2788	9957	7718	23158	8820	55326	23094	10385	10409	9834	652493	55840	4345	23231	85377	5777	53335	7389	80230	388	9124	51465	26228	972	7775	8334	11031	3507	23596	29064	50856	1299	54	56951	3112	27235	118	55024	25849	1536	80021	79089	79622	24149	84890	3512	9997	51296	8531	1967	4208	8527	7453	3087	6300	51237	60468	132	23326	51092	4064	9925	22837	55589	2934	5336	27075	5175	55743	974	3783	54968	9450	6850	3394	55114	10328	3108	5694	79365	5218	11142	28902	931	6565	3566	3669	4005	55278	6279	5871	81853	54920	5664	6472	10483	952	65220	3431	608	7503	29760	3654	217	2768	3708	912	5023	54020	54847	760	1495	60485	1512	25840	11337	2760	6856	5450	773	85236	1355	57820	57553	57109	9711	8345	79161	28908	29088	79683	2067	8395	10576	5001	4067	142	8650	4907	6713	3725	64976	114884	1130	9282	10970	4174	11234	5079	10063	9451	4938	64397	8874	1457	5176	3597	1737	80324	9674	971	3295
GSE3982_DC_VS_MAC_LPS_STIM_UP	M5387		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1769_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) stimulatd with LPS (TLR4 agonist) at 48 h versus macrophages stimulated with LPS (TLR4 agonist) at 4 h.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					3198	80135	1876	23131	55196	10397	64328	29113	55317	4927	5511	4502	10007	8345	23236	55843	11060	5577	56252	84908	51111	50717	7957	54503	65123	51611	7414	3329	29098	2950	9175	95681	9031	54662	27019	3035	10123	26024	23175	23360	81501	3017	4144	9631	8996	79882	6424	7188	902	3750	6509	25963	4931	55746	55750	2308	6702	51531	8620	54851	80764	80758	4729	6897	4832	10813	23199	6464	3662	1528	6397	11026	4236	54386	2960	10424	23526	6614	5631	9869	1615	8647	541578	23341	81543	7564	9770	10149	80774	1054	22900	57154	56146	23255	3597	55164	5167	2354	25949	57720	143	23660	79899	4070	5199	22	57091	23269	23370	5141	8697	8742	11259	79175	78988	7260	23094	84243	55758	80227	874	9586	11167	9400	5328	80254	2806	2926	10401	51321	228	1434	27434	10714	26112	55167	9919	57062	1103	6332	10020	25792	23049	64794	360	9170	25842	4753	9861	32	11232	9793	2915	9656	79087	10653	51172	23484	23162	27097	6363	89845	6404	4014	8833	90133	6597	7059	1153	4201	8705	57209	8519	55034	4331	23169	11329	8473	63899	25875	80169	25896	6687	54938	130814	55272	4595	2055	26648	57116	115939	9724	9536	5550	8714	26005	55303	23047	9110	4818
GSE3982_DC_VS_MAC_LPS_STIM_DN	M5390		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1769_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) stimulatd with LPS (TLR4 agonist) at 48 h versus macrophages stimulated with LPS (TLR4 agonist) at 4 h.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					6004	2204	23078	7706	55851	7462	80765	5319	4978	2219	3433	222658	2916	27289	102	24145	2903	948	9787	8029	27342	4689	375346	5358	4048	1511	50834	79801	54843	10801	240	4697	81693	5209	7347	9129	6793	146909	9935	7328	7430	10855	80150	26499	8509	79088	55603	26470	57127	7543	2494	3553	4107	79590	6588	3762	929	23220	54619	6372	2044	26576	5027	91977	1852	3619	440738	4482	1514	5627	23387	55970	54539	23530	1363	28231	3627	2209	136	1847	9002	79892	8987	115653	8564	6144	79019	100507436	1718	10873	8000	3386	8499	78995	654817	6238	6696	11136	991	8741	8447	5034	3097	6811	9582	9475	9055	55165	9325	11326	824	133	8076	29933	30844	399664	79047	1200	154	26038	610	22955	5874	8545	23586	3371	284	55281	51136	4313	1019	5730	56886	55207	1152	5910	7049	54435	79887	3158	1462	9060	7025	1536	8650	987	3437	10635	6351	56829	4952	25841	7504	5970	128872	26059	5936	79661	4047	8900	84061	7993	5654	113457	7140	127544	79001	5606	2959	6773	10678	7102	2651	4139	11130	4312	7068	273	27251	6752	9768	26027	55975	2634	5473	1906	826	5194	4481	79690	23601	5961	4693	51397	64388	57823	27304	10826	10758	51614
GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_UP	M5391		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1770_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 48 h versus neutrophils stimulated with LPS (TLR4 agonist) at 1 h.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					25814	64219	10274	9325	4363	79644	26155	64222	84061	8528	5725	5510	79568	79366	22818	11197	55863	1318	5889	8195	5162	1849	23017	25809	29088	595	3035	9526	8714	5394	57794	56938	3394	26024	51134	9817	55094	400	27000	3563	51011	4728	79697	11006	23081	51117	63899	55825	481	4718	2806	6605	55750	51268	55005	2055	10670	22977	10059	81839	10015	114932	8550	55686	51499	55840	23160	223	51318	64963	6129	3290	50814	92	327	80349	3945	5054	23530	93974	8894	10813	4736	575	4070	52	57876	328	6880	38	56895	9391	3429	317662	22883	57553	55164	54148	6144	53838	22858	79184	1615	80227	4267	58511	90326	9317	5532	3627	56848	51002	26003	10606	9377	23478	3988	79728	25963	84747	6361	23590	4501	224	7818	9793	11259	7448	55848	115939	55852	9276	517	9330	80025	2171	26580	6224	7205	91949	58504	475	5634	55746	7283	28755	9724	79695	79631	28959	64427	6925	9833	23443	60491	51071	11224	4938	83989	23169	79713	2026	4145	50485	4292	51103	2838	1291	7915	55106	1994	9097	8697	11017	64746	440270	22902	5577	5226	51121	10914	27130	11108	5616	4729	55704	23682	64087	10478	3321	136	23175	5141	360	65243	5324	57122	2230	5939	7570
GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_DN	M5393		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1770_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 48 h versus neutrophils stimulated with LPS (TLR4 agonist) at 1 h.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					2334	10262	8659	23491	3625	6992	90379	10342	10281	8447	9002	1314	11252	3221	79729	10970	7706	80094	55628	1780	2173	285672	23761	246721	3669	7458	23432	5878	26576	3034	10214	7093	6494	1511	3552	4170	54800	5365	51411	80059	27304	10810	51167	56901	7128	7328	3131	23210	3458	2914	734	1152	10849	343	91977	4956	26511	1453	54843	7554	10379	50486	339	55194	64400	29992	6875	51442	79983	9922	135138	54386	6372	11012	8740	2636	3604	2583	55890	9457	11116	222658	3765	7099	3553	11033	7832	4311	29896	80005	23049	8019	685	56605	57513	148229	1797	51725	22987	53836	6750	2524	51193	23064	9170	5606	79791	10439	2210	55643	2324	11152	23645	54807	7376	6583	387	79698	6752	5791	8529	9883	751816	2014	139081	10235	54544	3759	79933	10420	6588	10435	56143	10938	929	26034	57061	79887	8110	25865	11027	5997	51696	29933	54777	2219	240	5551	29781	5074	9586	56924	55142	2113	51005	9885	9770	10211	100130449	9100	5444	759	7011	9903	27251	9120	3275	6653	55247	3720	64388	8079	3918	6455	10855	352961	6884	4542	2358	23038	4947	51438	8499	4586	127544	55313	5143	8519	998	79047	1613	3021	9943	64419	440895	133	29953	79893	4618	26020
GSE3982_MAC_VS_NEUTROPHIL_LPS_STIM_UP	M5394		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1771_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages stimulated with LPS (TLR4 agonist) at 4 h versus neutrophils stimulated with LPS (TLR4 agonist) at 1 h.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					80007	2022	5996	6119	55711	7520	51154	55274	54901	64219	201254	25814	3738	4200	84061	54344	11200	25841	51071	6905	6637	467	6996	55863	6207	2820	79568	64430	1207	55617	3429	90333	8454	9363	55093	51371	2055	29997	83941	253782	2806	64853	6925	10771	471	55585	7265	59286	6938	25840	79723	304	9055	11183	79630	29088	28998	3108	4673	6636	25972	6518	6788	6181	5786	10768	6507	128	6232	94	55973	22862	54987	908	10282	51809	27332	579	10561	10670	6921	84759	645745	65003	4927	7978	259266	4938	5955	10128	6812	54680	23387	7205	1315	9859	6234	23160	55630	5714	8209	9526	3735	5635	80212	84159	83447	1351	27131	64374	51575	9551	3673	23176	4694	1396	8880	64108	98	2796	10656	51117	5431	54963	10606	7072	9950	51172	54962	55769	51663	1633	22845	54209	8666	51318	372	55055	51074	587	4286	55388	81619	11264	8453	706	23658	5054	55164	113	55839	5473	3033	23301	9711	1376	7381	28985	60673	56969	5257	1968	9475	327	9276	1500	9416	5481	10399	2747	3688	5902	54872	55856	9688	55556	1607	8942	5090	2971	8724	7699	5334	1368	7159	51329	80025	54468	5819	9325	6281	23435	1601	23549	10055	9793	23516	6138	52	57613
GSE3982_MAC_VS_NEUTROPHIL_LPS_STIM_DN	M5396		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1771_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages stimulated with LPS (TLR4 agonist) at 4 h versus neutrophils stimulated with LPS (TLR4 agonist) at 1 h.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					4355	50616	29994	221823	10472	10017	754	11136	79862	5899	79089	2334	623	51564	6844	8359	22980	3338	80775	51631	26279	6511	23401	26999	306	22888	9870	6519	80143	1490	8091	23186	6559	5432	11093	23	27301	25977	3937	8349	55716	7100	417	9814	3837	4884	81543	79919	1609	2922	79180	65108	9445	64780	79729	124044	8216	126393	79818	1404	11254	22990	55196	5606	55111	1955	374819	8876	6545	4957	7832	7320	64499	912	80093	9696	11278	79048	6543	953	212	9537	389906	9592	10519	51193	60626	64422	26020	23057	5030	60506	51151	6992	55690	11153	408050	5799	222658	22913	10631	79689	6932	3250	10938	51592	10928	3274	26277	3082	6879	1144	9372	23504	2074	729238	54932	2049	8354	84243	2150	3488	64377	100129460	26692	9948	8361	343	2249	9798	79727	7399	3263	23214	221037	378	800	64376	10077	5719	2914	317648	23620	3705	80183	4059	55025	5746	3458	3361	100128124	149076	1553	10849	6283	5053	553115	392555	64211	23210	1511	3805	26576	91316	7375	22918	6664	55238	7088	23295	4294	8852	28639	266629	241	8061	2528	2765	10024	9846	2134	8897	3579	23237	1995	26472	80774	8447	11320	26094	135948	1265	1870	51450	7307	26112	26050	168544	51372	8193
GSE3982_EOSINOPHIL_VS_MAST_CELL_UP	M5397		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1772_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of eosinophils versus mast cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					644096	6399	1265	323	4853	8242	9958	1629	9708	5728	29991	6304	6256	23224	2074	84733	2891	56949	7132	1152	57282	9046	23451	51109	32	57162	1032	80705	6502	79753	54920	79966	83394	7161	23240	57105	26220	58488	11064	3101	913	9267	2743	3570	4600	284	27304	10869	64092	7275	55203	93664	79668	3003	2934	4324	54956	11000	7764	58526	114932	779	59286	11040	79690	905	10232	10106	5609	80213	10288	219595	55715	4661	1656	8646	3134	7626	55794	4586	4524	4826	222663	11076	26529	3163	7373	491	55260	8740	6503	23168	64232	3985	4046	57118	778	79890	6899	4520	1850	388677	57110	9815	79671	23608	54558	4982	6171	100507424	27159	3687	4923	9208	333	2833	55512	688	401	3717	54455	10762	53829	10645	54807	8776	79101	4534	51146	2000	10347	2120	79780	2959	55016	22980	25802	752	23508	7350	8887	91543	84162	9926	3683	7225	55911	79785	149986	80133	65220	55073	2357	5165	841	11153	727800	79750	2863	23096	10867	80867	64386	6877	8586	3587	51759	7752	6236	8557	11237	79762	3883	54809	11144	953	2145	7320	6098	2781	6840	8638	170960	5988	54971	23528	1464	9821	4811	9422	7095	10735	4314	57551	22905	1439	1901	23036	8477	4974
GSE3982_EOSINOPHIL_VS_MAST_CELL_DN	M5398		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1772_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of eosinophils versus mast cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					26580	4704	203068	54910	2630	7873	5095	10493	27336	3312	29104	6659	4081	5876	6154	10491	1802	1512	6599	23471	2091	64981	7818	10381	51073	6742	1798	51186	831	23613	6678	4698	1116	6240	203197	55651	4710	79038	30968	23176	216	2068	10277	10363	1434	4133	6124	4259	10329	4172	2766	8508	6191	54948	7385	25873	79134	1215	80135	6185	7965	522	10480	79847	51144	5198	10007	10580	5478	10980	900	7419	65992	9074	5245	5901	1994	80323	6419	55827	5826	112399	55699	55326	10061	26003	1545	819	25896	155066	54542	26057	6713	8933	1806	2926	6526	6414	683	81533	6472	29902	29103	100289420	2023	5111	6150	1207	55717	1459	375449	9255	29098	9577	9652	1054	5129	4212	63933	10527	56271	5684	221061	2896	79686	9240	2953	10133	644068	8574	8531	55070	10385	54475	64417	54680	55622	4190	9861	6117	1786	946	56986	474344	821	440	149603	3002	1958	57050	23658	10694	51074	51071	161	79733	324	7490	23429	51142	7372	79895	4701	10419	64219	154881	4115	23332	473	2590	54900	5707	293	8893	25915	269	81562	23516	8050	7469	9848	5438	1345	6207	79096	3725	9249	5073	190	5188	23468	868	81839	22948	1124	51499	3336	51374	7417	231
GSE3982_EOSINOPHIL_VS_DC_UP	M5399		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1773_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of eosinophils versus dendritic cells (DC).	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					51230	1979	2887	26059	7170	22898	56949	54807	10699	3798	2074	387751	4851	64236	719	779	5836	54494	11261	9088	3720	57191	23240	3659	9267	65220	79785	3021	3486	10581	54149	2776	3716	3055	4625	27342	7626	4212	23710	54811	32	55784	51274	652963	10432	10106	7060	26057	30817	6867	390502	201895	2357	81558	8347	9869	79690	23344	6790	56901	84914	54997	9459	6236	9498	9229	22836	4615	3598	6164	9208	55280	3274	50514	1675	5927	29087	9435	51593	23046	50507	81851	81631	59348	5728	23224	53942	51734	64061	399	6166	3185	1058	8787	3633	58488	55432	740	3669	10209	9337	3568	23345	3620	7005	80705	1359	57223	7373	80758	1649	1901	54490	8277	23491	221692	23645	1141	346	10664	51052	5551	9920	51666	4291	27333	638	1825	23767	1013	9061	7852	388	9815	6502	350	2835	63971	9262	3632	9256	55062	6018	26051	7516	91	28968	51585	9368	5137	6036	83715	22794	55259	23480	11345	2029	1232	64795	79632	8519	9663	8328	23318	947	54739	6286	5877	24138	26228	64421	3305	51076	51744	84079	26207	2870	81553	54434	3581	8794	3707	5294	388969	79883	1539	55567	27071	6399	10636	272	55149	2250	23135	23528	7027	60401	645644	23626	8028
GSE3982_EOSINOPHIL_VS_DC_DN	M5400		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1773_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of eosinophils versus dendritic cells (DC).	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					9258	80173	9133	1207	3283	51296	5287	642	3312	64210	64860	80853	23014	23468	7045	6319	9255	948	5826	1434	5244	8766	5860	5375	25966	10885	25890	8942	64170	10342	48	78990	6009	3032	9830	55719	8354	6184	8900	6767	51	90956	10767	1798	9550	216	79719	9094	51499	27072	79762	79639	467	9578	9276	132	8564	9328	6039	81533	7594	55144	55704	57050	10462	23516	2920	26355	3315	4193	79096	304	26031	5125	2230	4358	2023	5154	874	6778	57107	51374	3605	1124	7037	5188	498	4234	56940	10170	10400	8508	51318	51309	6419	27036	912	80350	3117	4860	5468	26024	8061	7263	55750	23518	23172	1594	7818	29880	5073	1317	474344	2642	4094	2630	55770	9902	51606	9270	23022	81839	23654	23061	1635	51181	1495	50865	444	55679	5303	253782	6993	9308	30844	51650	56606	7360	4267	26064	10907	509	4580	2208	5510	27244	55697	8504	6385	27130	56942	580	539	25939	1662	5373	4190	2760	51186	3840	217	11332	9183	873	3241	1075	1728	3557	8479	23471	55803	81562	63933	214	91860	27131	57175	83743	25996	7993	1593	920	5523	4013	9620	64221	5106	1981	949	138151	3956	1456	2321	5704	1476	5315	683	84890	8451	79675
GSE3982_EOSINOPHIL_VS_MAC_UP	M5401		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1774_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of eosinophils versus macrophages.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					122616	27304	23046	59335	652963	9958	6502	4851	100287600	23126	54503	79888	55625	23434	54704	54813	26054	7133	51306	2549	1586	5283	64419	10432	23209	1559	2571	90522	5199	26234	80778	6588	3720	9229	1629	51274	2353	51187	56101	8515	9185	51281	5284	8897	100462953	5514	4583	79954	11107	10917	7275	55062	10100	50616	3700	10084	10645	8621	3340	51275	23205	8887	57326	79890	10215	96610	1825	51351	59344	23446	51170	2521	740	5453	644096	28990	4799	5451	80204	59286	54529	92482	55082	28996	3798	55746	11040	9711	3053	10151	441151	51366	8227	4595	57191	23345	3631	4661	26953	23224	3150	8556	54925	26999	5903	5771	55701	1615	2357	3815	56339	79671	29943	3632	7561	100169750	4929	93144	55	80352	10974	7738	11186	10908	60	79056	5387	11146	79865	3421	10047	1233	6822	58190	5321	51631	10106	64386	6343	63876	26508	8886	51195	2891	23614	120	3669	51076	9878	58155	22836	55066	64236	79668	2776	10180	4116	4982	6867	79785	51440	1998	552889	57035	64359	26053	6286	9191	55259	79883	8216	8851	2859	8557	55249	27333	32	5877	388677	3344	58500	6397	338	10209	3087	9852	11197	335	2743	9920	22934	3716	9636	83452	6503	84298	9256	1195	3683	7403
GSE3982_EOSINOPHIL_VS_MAC_DN	M5403		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1774_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of eosinophils versus macrophages.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					4704	6009	9550	5095	2022	23078	5328	26580	91860	1678	5287	51073	10054	8714	6938	1795	7818	86	865	10654	5271	522	79709	166647	1434	10768	25956	8508	6051	79017	5121	7873	718	2052	7337	8766	593	5245	10904	6742	54681	64446	214	29098	6319	1459	3417	79443	9255	54741	7358	2952	51177	840	55847	10539	5106	3685	64981	1798	2934	1657	4081	488	8815	9652	25890	1193	7019	55425	4173	11157	1786	1327	11147	4708	284021	23659	10381	55907	28511	10885	10452	4677	11043	4037	65992	4646	5824	10412	2023	55699	7419	79763	84223	133619	3484	160824	6726	63933	1070	26135	509	4012	831	1965	8560	109	259266	226	10424	1839	51109	22948	83743	6539	3336	55296	10133	493	892	9466	4216	84561	78990	4313	64065	54432	79695	79639	8798	79019	84159	23328	1536	920	10651	51474	1635	3624	7798	9249	10059	1207	57107	10471	4706	6447	51042	51154	4891	51096	9493	7336	10061	7372	10929	51218	10723	9555	65110	9868	3035	8801	10493	10512	5638	4082	8209	8932	51236	6198	27130	572	10633	7077	9019	80205	64927	9183	4763	79109	9014	6921	3161	79886	373156	100289420	1154	9754	6050	8566	6599	1802	51284	9686	23400	10579	8491	83937
GSE3982_EOSINOPHIL_VS_NEUTROPHIL_UP	M5404		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1775_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of eosinophils versus neutrophils.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					81851	64976	23421	10513	5901	1465	4904	4619	9668	10762	644068	1657	80003	8520	23174	29960	8600	339044	5428	8504	84908	9631	9929	7060	25821	51348	7314	7428	8731	170679	4160	79023	79762	11321	219654	27339	6477	5283	22980	6191	54765	4706	3305	3815	2517	926	23438	54810	117178	11186	8631	54438	51200	55274	64848	10542	5141	25804	6368	1901	10949	1207	7137	51184	6741	10794	22876	51744	2034	2859	10282	2091	6133	27034	9782	215	79785	204	5116	8458	4515	7172	6597	51031	56616	8763	57602	80006	23014	1213	23122	81627	55718	1825	79072	51320	5052	26355	6787	5467	92822	246	8539	51593	51340	27341	23434	25999	57226	29102	23137	65005	399491	6897	10884	10876	23261	55	8336	301	51493	5800	10885	6239	10944	9188	913	79882	9603	5910	9669	27109	5707	64149	55256	56339	28955	55007	23042	51026	26018	10623	54948	4259	440270	9425	8027	6036	23172	10428	284266	51283	90362	3211	11057	11163	80324	9858	23483	4116	892	6196	55619	9868	27333	9039	79568	29959	11064	408	11140	3280	6050	9046	7095	54472	6650	23505	23412	6327	84364	402	81618	4799	10987	55253	10449	2650	374	8161	2342	23165	19	51163	22909	6938	26034	11137	9570	1975
GSE3982_EOSINOPHIL_VS_NEUTROPHIL_DN	M5405		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1775_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of eosinophils versus neutrophils.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					79720	3605	200315	2538	6398	7350	29982	8778	7132	10277	2350	8531	25888	5793	10221	6907	669	79038	9185	9020	23074	7462	26234	2353	10268	51100	1806	79132	3882	10209	4170	6774	7128	100133109	8618	8972	2209	5525	100129973	634	80183	51307	5197	100289420	56940	2630	79814	80232	5175	23023	2123	3106	7068	9517	26538	6672	9732	55969	53836	6320	1105	9710	10554	54514	2787	7125	58497	11024	10566	8513	1843	9547	6372	2064	339287	51427	5306	54432	2683	55656	3660	1265	1979	5720	6772	9637	23031	8291	5918	4783	9536	2575	4974	10849	58986	57612	3557	6888	10695	51170	2180	54861	3430	1486	8303	158747	3482	4215	23254	79716	2319	1890	9586	8175	5004	8672	5883	5608	2634	2932	80218	138151	57731	572	4082	2509	1512	838	79689	467	7405	54972	10288	55841	114882	10748	9647	6283	9334	91683	10410	8677	2776	4597	160824	3726	5580	4898	3293	5341	22878	23258	10057	60685	4311	54883	80258	8760	978	3383	7086	8794	55196	10419	79627	4050	91860	4081	6542	3172	22843	79847	81575	51296	27128	7431	10313	5209	5371	8347	55313	8743	6195	6934	1441	9674	10435	11177	81603	148753	55647	373156	79729	55652	11026	50865	9778	7791	5595	133
GSE3982_EOSINOPHIL_VS_BCELL_UP	M5406		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1776_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of eosinophils versus B cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					8356	57178	32	23345	10221	7225	5291	51744	2521	4586	6368	182	1301	2919	9050	2901	3632	7133	114932	26234	163486	6236	2887	63876	6916	23541	112399	3567	7314	716	6583	26952	8804	9046	54682	3101	6744	8349	5728	9741	9852	552	7029	1843	200315	3305	54737	9936	5141	2859	53841	5733	57706	1825	3720	7132	64359	83394	3604	325	2948	79602	3344	22932	206358	59344	4853	5609	64386	8900	64377	55283	5724	246	8408	401	79955	4040	3643	2953	59341	57188	221472	2891	50848	56903	7099	80144	57118	7752	2357	51226	978	8968	8897	3960	10472	57047	58528	6386	84099	1131	8707	4851	29094	43847	976	131566	1269	8646	6533	389177	3779	79671	25823	63974	51228	9536	11197	57515	3920	762	91851	4092	388	6296	367	4185	2275	11144	4856	651	27436	5967	301	9378	51192	783	9473	1948	3236	3700	6503	479	5732	23205	313	56288	64410	23316	28965	4354	8343	50810	2495	10800	136	23645	6511	7048	1407	3985	8519	57192	5143	29851	9908	7092	778	408	4808	3055	6690	27235	23166	55062	23604	50514	4353	5423	2517	6397	23608	10551	51652	79862	4929	59340	272	4324	204851	8913	4090	2820	5671	79903	688	2651	79883	54507
GSE3982_EOSINOPHIL_VS_BCELL_DN	M5411		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1776_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of eosinophils versus B cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					25888	55746	79132	6191	29103	6217	25983	86	79829	93974	1798	80183	11137	5826	3113	63933	6929	9550	4907	7153	9711	23415	7818	6129	1786	971	23338	55750	84726	824	9031	4702	80853	642	25932	28387	10424	6124	4860	9100	54039	7905	22843	23468	7580	4701	8943	3514	4081	10330	8455	6597	10480	3838	840	55717	203197	9779	3662	64210	5188	56940	509	6130	23005	51096	1396	84525	898	10329	4580	2091	124565	26003	54802	3507	26031	55326	26628	3621	5720	23341	25813	5272	9466	51318	90957	55638	10447	3738	6472	8575	728661	10419	54900	1495	5636	3112	7462	6167	54758	23268	11072	81575	27429	5073	7372	50853	100289420	8717	64065	57050	5608	2109	26053	3428	1937	4172	6194	4931	3128	2273	81606	8115	6227	304	80230	54700	4293	27430	80724	10664	8574	79733	29127	79068	2731	10061	11041	79683	23637	10654	3640	55311	2189	5379	1965	9788	5198	4708	2630	10884	741	79365	51650	30968	54535	440	4358	54968	91353	9805	1849	10758	23028	1719	64760	9167	8801	231	6721	23165	5824	23395	6691	23212	3601	10514	790	3607	2196	2802	6193	473	4706	5184	7873	1443	51237	79672	65094	9651	2230	1496	6240	8508	10732	5257	3535	80349
GSE3982_EOSINOPHIL_VS_BASOPHIL_UP	M5413		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1777_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of eosinophils versus basophils.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					905	79622	816	7060	23550	90379	7296	25984	170960	60482	53829	55454	26507	55200	9732	54438	221692	58488	9651	55111	2752	23345	80008	51283	10555	81848	79785	256364	5876	10825	8303	375057	23223	593	4967	57212	30811	80131	3633	9929	2123	4856	28316	51291	64794	84975	2568	11343	57061	5322	23475	4155	7561	56157	51754	280658	653639	54843	778	6556	913	6094	3960	23386	100462953	10154	10221	7376	23263	1602	5903	10636	80020	7368	6911	7275	8794	80308	1520	65979	22980	9984	10658	8974	51200	3988	64600	7700	64421	2548	4291	27341	26093	10023	1536	4353	8669	4644	7940	1441	941	55701	182	25976	1535	79168	79363	9365	23414	7305	2332	54991	574	602	10824	11140	1013	8618	9363	64778	10917	84914	3985	3700	54442	23657	23237	116	4598	51184	1978	55870	9208	84733	214	57730	10005	55847	8237	4641	6652	131408	7408	3166	123803	2260	2650	6280	100133109	9334	140885	80895	2132	26253	2209	5500	7626	7942	2850	51224	6279	5217	6783	23120	1301	25805	1948	844	6813	466	10206	9816	55206	55653	427	2591	8727	5996	157567	115123	8864	3802	55	112464	5653	51306	79632	55361	80700	79183	5932	5638	3356	8082	2581	25970	23038	55366	55746	8613
GSE3982_EOSINOPHIL_VS_BASOPHIL_DN	M5414		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1777_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of eosinophils versus basophils.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					6191	6599	8190	10980	2313	25873	23521	200576	9168	6154	51074	5478	6164	553115	2887	253959	6729	1350	2131	304	120	4048	911	10330	58472	55656	56339	2034	284021	10397	112479	79682	29929	8460	3716	23531	6416	23471	10133	3218	865	56986	3176	1798	64219	28971	5567	80853	474344	23333	64771	55717	57117	10512	10277	10412	9325	80060	3621	5588	10516	3248	2630	151050	11145	5052	81855	79811	5707	6194	54910	8801	5920	55699	2287	521	55893	2530	23212	9517	51082	9014	7818	79685	4825	5189	1345	7494	3550	51585	8542	117178	64754	6863	3032	821	23199	7462	51065	1340	79068	10464	10664	64757	5373	54987	445347	64981	10388	11161	4076	51389	6167	23039	9448	4763	65110	54431	6307	22864	51123	79893	8664	9765	55898	55907	5087	9730	9611	3824	57498	22818	58478	3646	5148	10677	23344	157680	51	7570	5525	8573	11329	10057	100289420	200315	8209	54209	29064	8504	7443	6217	152006	5311	7223	55326	27347	9994	56034	10383	11222	8644	6717	51451	60528	6711	6522	80254	55245	81537	8631	23022	2207	51691	23586	9840	10051	1124	51318	917	7410	64769	11236	1495	9694	1353	4898	23435	1806	6185	22883	26211	30968	23272	6137	64784	8508	23613	1944	10866
GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP	M5416		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1778_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of eosinophils versus effector memory CD4 [GeneID=920] T cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					32	9936	719	6256	9208	7090	51214	55851	6386	5291	200576	4292	8804	6421	3005	240	8345	1820	55727	55911	2776	8460	64397	8623	57178	2591	2353	5175	80008	3093	10313	26054	3985	10800	7057	51187	2517	11252	54809	8303	4534	51167	8520	905	6272	5878	58526	6018	79671	9885	8123	8972	5500	57061	59340	4205	64747	22979	9473	9311	5447	51184	5663	11027	29895	23071	200315	6404	1604	5899	221692	3059	7086	51340	9185	27342	5359	9236	6503	5724	10238	7133	56905	11024	55208	6502	5279	64386	3717	55	2495	51552	4778	10645	7320	79883	57515	23062	9929	9103	55256	27012	56001	65220	23135	5526	4619	2355	6821	26099	6195	597	84733	26038	7296	29948	8809	2717	56904	9926	2539	9781	10221	602	9454	1520	57035	80705	26277	3720	5586	4515	6533	1232	79663	7265	22836	9636	64794	526	2180	5704	1876	2120	79622	1132	7048	4215	9958	23476	3597	27235	207	8930	7263	79682	6850	55109	6732	219654	51510	10542	1612	8867	51526	23216	23604	23597	8635	79085	6907	11057	9328	54438	1105	9920	2920	3490	23434	2034	54145	10879	7696	762	80306	79890	5226	79903	3764	9794	1536	10438	11314	10677	5289	55957	3006	9688	10260	80228
GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN	M5417		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1778_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of eosinophils versus effector memory CD4 [GeneID=920] T cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					6217	5264	1512	644068	5739	10980	56986	88	2734	85377	4267	54039	23014	26256	4259	4543	563	9258	5884	6415	29121	57113	51725	23788	10849	1459	3312	5612	23052	28985	57147	27336	4759	64210	2672	3178	55801	81558	27292	5066	22927	55832	7993	2297	10480	11022	1806	9806	51293	811	2974	9994	25782	7471	5042	54431	81562	10007	572	6530	55760	84809	65992	29789	23415	7049	55144	79847	8504	6191	3315	6146	93974	7153	2038	27244	5287	3688	2271	54900	51236	1353	3749	79068	80194	25828	23521	9710	6775	3738	445347	6399	293	117178	1777	5567	474344	54910	10045	9730	8607	5669	28969	80853	1571	11072	23261	3115	8361	4061	9221	3796	2064	2114	4666	79006	9249	9542	7541	54680	25873	7629	8508	80021	6738	81839	10327	2091	155066	4094	824	51068	58486	51042	11137	10885	472	959	6993	79813	375449	6124	6117	50855	5676	128	55622	55196	8787	6572	55129	79086	29969	11222	26060	2575	54681	5446	11329	3710	9020	4234	55699	10057	2823	27288	25983	132	9666	284541	9949	7272	8801	9742	23348	51241	51477	22818	9557	5203	285527	166647	10130	10892	10799	4103	55812	6194	1728	25821	57496	2157	3587	79832	5198	6263	5550	11082	4216	2584
GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP	M5418		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1779_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of eosinophils versus central memory CD4 [GeneID=920] T cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					26034	79892	79101	54741	51744	8503	7403	5175	57178	27342	54809	54438	79682	354	8972	8804	57515	79602	7263	51184	9647	6503	2517	4759	57396	334	8345	79671	5899	23608	3985	27235	5624	3101	9276	5226	101	1604	11252	9673	2124	7048	9111	597	5728	313	9103	55625	10362	5724	6368	5663	8237	8741	6404	23071	8867	27250	51526	7296	4622	1955	8727	390502	23433	54777	3421	23075	246	23092	84790	51340	79954	5791	10938	51363	6239	2268	79663	87	4155	10221	719	10023	5877	6867	7942	10957	10524	10682	7057	57161	64386	2182	3815	2353	374	2743	10154	4092	427	23670	114932	10797	23135	54918	2944	55069	8477	56001	8303	11237	9114	902	26228	3563	414771	3720	80230	1536	55	27159	11261	978	604	23710	10795	1116	23168	4121	5291	8809	11160	6397	56674	9821	2495	56062	54874	57035	8623	55206	526	4215	23214	79139	6732	22905	57162	9819	23063	26118	6923	9208	7867	50486	22856	30817	8334	80008	23326	79799	6943	1824	22881	23199	3104	226	290	1890	55701	84733	3122	23645	11052	10970	4644	80228	26017	6744	10613	9489	9920	51657	10762	4853	2776	23657	2138	5494	23401	7086	59340	9858	5782	5531	2180	55785	10908	1326
GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN	M5419		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1779_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of eosinophils versus central memory CD4 [GeneID=920] T cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					6217	23521	8600	4653	5245	138151	3312	5884	27043	6385	5826	831	5612	3605	23178	9168	10277	8725	869	54585	824	940	55832	10980	80128	1534	474344	8451	1850	7913	120	11137	25873	4521	2157	55144	6949	81033	51177	4860	25792	3688	79652	3572	9652	79590	27284	100289420	4172	85377	7818	160824	5066	753	7272	27244	7580	28387	8454	51293	23613	9830	54910	6938	7153	7385	339044	7634	1803	6146	349152	23261	5198	25821	64065	445347	4676	57102	11222	3697	54517	1741	25	9666	79800	10399	3320	80194	3932	64760	8087	1512	1327	6154	55246	151230	309	7372	10892	142684	55119	1123	23070	51474	3218	9249	54960	8508	22927	9710	58486	826	4801	9725	1939	23059	9690	6218	1071	10223	50853	10342	26872	523	23637	51241	79694	54148	54847	4267	57175	23683	1663	1937	6129	55326	23633	51070	8893	5287	55656	9994	55355	30845	23348	1798	27300	7101	192286	952	51805	25828	6227	23082	666	84939	283232	4054	3587	55005	4216	7264	23468	322	9466	8453	2926	2350	64708	868	51650	1413	3315	55695	27005	54535	2064	23471	8886	3710	28951	644068	8573	8682	57212	51499	64318	21	27130	64981	22818	11201	7469	151011	8224	642	6307	55699	80021	24149
GSE3982_EOSINOPHIL_VS_NKCELL_UP	M5420		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1780_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of eosinophils versus NK cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					5291	81553	6533	3106	57178	11100	23071	7328	11261	597	3632	79682	652963	83752	9587	64747	2495	240	4170	4783	22930	4050	51167	388969	2887	222	6641	6386	6744	55727	23608	1871	1543	6503	246	5745	6256	1656	427	6502	26468	8555	29982	7412	1063	6446	25802	5537	23075	774	3717	8439	51187	5718	1675	6397	23326	30817	5625	2242	1615	58189	399665	7095	10794	389177	645644	7752	84658	23528	386627	6573	11081	3516	22983	6899	6789	374	282997	7266	57118	3274	91355	9852	22836	7005	3628	100293679	4515	80008	55208	23508	3216	6286	23524	10313	3568	4853	91543	7551	55556	7555	10861	10232	5806	7940	51652	3985	902	10500	672	101	54874	3021	2745	84733	5322	604	290	4534	8740	57348	8392	80004	4637	6453	54971	55654	10603	182	23205	8303	29087	51284	638	7107	55	647070	9775	9712	5742	801	1398	10154	1269	55366	2693	23092	149986	953	2743	9185	11237	10215	9498	6840	7057	80228	10023	196	4524	440738	3707	51347	115123	10970	23214	131408	79785	6611	5836	4700	8538	10800	2776	8031	55069	79865	7320	11086	257407	283131	5348	5230	7142	5996	58528	54937	9188	11160	79903	1948	9445	7441	54583	54918	55680	3883	5294	10957
GSE3982_EOSINOPHIL_VS_NKCELL_DN	M5421		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1780_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of eosinophils versus NK cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					642	9466	10255	819	80135	3218	8396	58503	1798	10904	4267	9562	6599	5826	26256	8515	25888	54039	5287	55177	29103	9806	5884	10489	57101	23623	80209	313	5264	2091	64981	23157	10866	3336	26057	7380	4886	6634	10606	8607	23191	5184	54948	56912	64132	79574	3786	54910	23415	1512	23335	8302	8644	7272	8633	147172	51805	55847	4684	2575	64771	10363	1806	3983	11236	51321	509	54802	4172	8354	80742	10748	55246	5676	51761	64760	5073	10962	7873	54432	9020	25966	3587	5613	4487	9742	8513	5148	93974	8243	8844	7745	29949	339044	7580	55129	23014	6130	9577	2185	3904	6775	8800	23201	9093	10592	1459	9830	8798	874	10799	9787	3932	25828	57496	10400	831	9651	5830	9722	4704	3716	408	11222	9861	51275	738	29127	10327	55799	7172	5720	55699	79037	4580	3646	23338	6964	3428	303	4054	64223	8076	81562	1676	10723	55144	29789	9002	5905	3293	22920	79006	919	4190	23176	10061	9289	7013	3284	6217	2730	3820	4259	23022	90480	4837	1556	9079	51725	910	1975	8801	10574	10277	10412	59307	139322	2297	55722	2444	9037	55076	23052	445347	10099	22796	23341	473	6124	9720	26031	2271	51303	51316	55182	7469	22884	9788	23127
GSE3982_EOSINOPHIL_VS_TH1_UP	M5422		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1781_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of eosinophils versus Th1 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					54920	56062	23175	3700	2204	51230	7414	7090	83452	8763	7042	29994	6451	4853	27159	64844	2268	55727	8356	51214	6368	5291	27342	652147	6588	57515	1539	7341	660	54878	11181	221078	4808	10296	1604	4212	51744	54918	1982	23438	5003	64359	55629	8897	100507424	5621	10866	10151	10653	9208	3455	10249	3985	81854	9397	79762	117247	666	5968	8789	5724	3815	9668	4833	64806	51442	23041	50840	57191	9103	10477	6286	65220	7095	1195	55512	960	51316	7516	83440	466	83394	55062	3798	4778	9975	3643	100505741	81553	27087	11107	7099	2835	2155	11027	64236	3620	2914	79954	90121	10942	7403	645644	200424	1629	3849	9885	64718	301	56674	9039	7764	4065	8522	9229	170960	3633	23390	4017	6009	7225	9779	10869	5791	8082	79722	325	387535	4780	3211	114882	3570	10485	5782	10106	374354	3141	101	1369	2569	22930	7561	64112	5495	23324	55957	9988	30837	10861	23258	399665	79666	2891	25802	6688	1053	9670	1176	9781	10970	6732	844	64376	80004	8972	284439	100462953	100169750	9938	5576	26133	7130	9741	11341	5523	54558	204851	4313	7060	4217	5863	115123	51696	64344	6568	3107	55914	9489	2252	26994	779	11261	1506	55578	9575	79641	4820	51363	928	26191
GSE3982_EOSINOPHIL_VS_TH1_DN	M5423		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1781_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of eosinophils versus Th1 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					10054	2023	9742	1512	29969	10980	8607	6351	9134	5905	940	332	6611	23176	865	91860	3697	112479	4628	5901	1802	64981	11137	80135	8209	6319	79023	1839	2952	6193	64768	79672	5198	3312	9735	4704	9232	5690	2950	79081	9258	7873	1798	55247	10651	4706	53339	132	11014	23157	10892	54987	522	79590	10381	4190	51065	2068	51073	8087	323	8682	8243	3945	29104	55651	3662	580	23015	55326	79719	10399	7818	203068	79643	1786	63875	81575	11017	56339	572	6184	79073	1317	5352	5264	25915	7494	51290	5156	79622	10058	5245	10535	488	79682	23512	1804	54680	55722	3420	9562	51236	10330	7415	55622	51154	2672	51659	4048	10452	79959	6597	58472	4234	55425	78990	11157	7993	4361	25804	9521	51123	6472	7905	79071	10255	8726	90957	9040	5696	10615	79006	9093	55832	55723	6119	9830	5052	9868	3904	22907	5073	79038	7298	7163	79009	27339	6993	51177	4860	911	11332	5676	10714	4580	8798	10575	79895	10726	10079	2926	2305	23590	9582	10576	1496	51650	9585	506	440	8542	79096	26256	2350	29789	10748	4830	64116	65992	8668	54431	65010	7263	4801	3428	90355	81839	7388	5036	2037	54148	10128	7336	54517	5886	873	3430	55129	79847
GSE3982_EOSINOPHIL_VS_TH2_UP	M5424		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1782_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of eosinophils versus Th2 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					7296	2887	151050	79668	6009	10154	6916	4650	10451	1629	84733	23174	3101	9815	1295	80778	11261	79762	79890	301	8804	552	7368	801	54494	4281	221078	7414	55512	84914	23140	9647	3122	10869	660	23224	60481	23175	23438	8778	25999	3631	3115	1604	6368	83452	2517	80758	57326	6847	2651	1265	1195	408	100129973	100287008	23390	3484	57105	5724	27342	89795	90485	80705	23261	5870	83394	8741	9516	7528	22836	284439	55260	206358	54925	2569	2850	170960	5175	4659	3492	5663	11166	4524	54014	3356	55283	3134	5968	329	23491	54920	9536	51363	164	9229	4313	54103	10866	7095	4077	90522	9575	80003	3920	4622	694	3123	65220	1369	8843	3770	7039	246	8312	7763	4600	55629	5728	55785	9039	10285	3815	3633	8857	27230	5791	3852	51200	23031	8460	1656	51167	80213	9779	11252	23223	56106	8789	597	9597	3008	51214	9365	9208	22932	3486	640	6840	57612	22884	79153	6857	22979	10221	26280	3305	83752	1831	22849	55787	4205	4586	53358	64844	9651	3700	6239	9778	7275	4780	7626	89874	51592	22888	23401	1269	100462953	9794	4615	100288007	8913	1820	79671	3229	22983	960	27202	10800	79666	10438	285	9111	4974	967	9741	10209	5174	51279	8495
GSE3982_EOSINOPHIL_VS_TH2_DN	M5425		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1782_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of eosinophils versus Th2 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					6191	332	10054	9686	3312	1512	26150	10329	4704	201626	9258	2023	25804	10598	54910	8904	1803	4081	5901	27336	91860	54987	5198	25932	29899	7163	54517	65998	5245	11340	10591	86	5687	23531	7873	79000	79959	10133	51118	79847	54039	29969	25792	5905	10651	4702	4628	10989	3033	3998	11157	7181	25983	7993	4292	9562	10120	2189	81839	1739	9585	2805	79081	8209	6633	54431	1495	54867	23165	23341	5935	51631	10576	146909	79109	10611	1353	790	14	100289420	63933	57102	51236	5690	51690	79770	30845	51177	890	10682	10452	81575	51073	133619	6119	6599	51154	5516	1725	10464	1958	125058	6713	9014	115939	6787	2350	8793	2091	80775	6183	9126	8668	5713	3939	2196	11332	865	5184	9183	22934	1802	23039	11137	2230	79038	53340	55907	10575	83480	6419	10330	7013	23022	8161	65992	100506898	54973	5347	79023	4720	9466	4502	64065	6319	79686	8318	8682	1503	8748	5871	8986	5450	10929	10198	112464	1786	57496	51203	9249	155066	7327	1070	9232	65010	203068	1434	1994	23107	8451	3383	55622	27247	1633	875	7514	9882	4048	64151	79683	79596	9582	63891	8050	356	10419	5694	572	54681	8607	1033	3601	100131613	5433	4798	5036	3904	908	4190	3911
GSE3982_MAST_CELL_VS_DC_UP	M5426		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1783_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of mast cells versus dendritic cells (DC).	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					4001	92249	26031	80135	55421	4210	3632	23344	8363	22980	54765	51585	50507	7332	8504	23046	6154	6886	8900	7251	10342	22844	919	11221	6634	6804	6128	695	2887	219654	8295	55843	6399	390940	57596	10902	7204	23462	8848	79869	4710	9781	5376	1828	10664	23072	5326	599	84079	261726	7552	79788	8787	57194	7105	10671	57604	5828	9088	57171	25873	55841	1072	4914	54902	22836	203197	221061	79659	51287	23632	6774	347344	9412	8835	58516	22879	57570	671	10432	2561	347902	80258	55810	25890	667	6164	9870	84549	64427	56252	79649	23127	58488	57460	4129	83988	932	1153	10055	7570	79605	51574	1109	10525	9760	79070	56112	29968	746	7111	3608	5993	2200	395	10412	54997	51076	26071	29098	8878	181	7728	4860	25977	8237	51031	29896	10575	8809	4056	8623	3676	23082	4363	3219	8390	6176	64798	79848	10363	57820	64795	6166	4907	5743	10219	29117	10379	867	29102	7571	4212	375	4602	79364	81691	3698	2029	9315	653238	55055	6809	2623	9947	9767	57419	9500	23243	9813	5725	8614	27251	1178	162427	4013	23613	55604	286527	399	56902	9459	8516	80219	23303	57223	10001	64061	23178	2534	9656	719	26960	9726	5100	54541	5972	51520	5645	5589
GSE3982_MAST_CELL_VS_DC_DN	M5427		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1783_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of mast cells versus dendritic cells (DC).	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					6009	9569	81552	8564	1844	23023	3120	10267	55647	51	2289	2017	8776	51313	3394	1392	3758	6504	10974	84617	23549	4938	411	23161	1234	7163	5577	59269	1730	81501	92	9462	8572	23594	1466	79762	79745	54431	9019	81029	3101	9145	27036	9169	311	2978	3122	55062	7850	56997	961	6272	6696	51715	23382	63933	3803	3290	3597	8942	2990	25961	2208	23654	10087	9873	2359	27158	760	51762	54187	5939	2817	1318	30835	79654	9172	51474	3988	55049	4224	5594	1512	4794	57556	3587	580	4289	4864	467	54101	29903	4070	3707	11031	949	6346	3557	23095	6509	902	2335	9706	1902	54923	8574	4881	102	9209	79949	53343	6773	6039	56833	55283	2819	3142	2875	4917	51309	3600	10970	26509	3578	79152	64170	6256	10636	36	352961	1528	79695	27074	29123	22846	4190	2688	4283	4145	8447	81609	79137	56548	290	6383	2767	6945	11279	5244	214	9830	23014	64423	9328	5664	55337	3241	8528	2121	4055	10312	253982	59342	51123	375035	4072	4618	25939	3109	5523	8350	8760	25770	5786	6385	23096	6850	3480	10867	8766	11332	10634	10935	948	55539	3108	3579	5909	79670	29992	6367	303	5824	56935	54913	913	78990	84861	79187	3077
GSE3982_MAST_CELL_VS_MAC_UP	M5429		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1784_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of mast cells versus macrophages.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					5321	29104	10296	55351	7157	55339	22836	219654	6191	55290	51596	93974	10009	80204	905	6165	7029	10123	5591	1265	27102	2119	10363	6001	10211	7111	9875	27340	54475	3702	79101	5566	8799	7019	92342	23369	7696	81577	66035	4583	51013	7711	2882	114932	3306	23046	81618	9834	23142	80335	26584	60	55000	4066	54910	10580	9748	3298	54663	6430	473	9372	23608	25873	839	9508	5902	55719	79605	9573	64062	79364	55795	6154	375449	51187	7556	1195	22938	58477	6144	23270	9987	55023	27334	28978	5832	3620	10641	6296	80350	51765	23348	3150	2766	8697	83443	328	6738	22869	57644	8519	6135	2200	9477	55222	51761	56255	4595	80349	9723	6468	11266	8273	55256	23354	1487	8436	9938	22887	10171	92170	445	8925	5969	6777	57711	10735	51631	6670	6188	10313	5534	9254	55268	8900	64754	9646	10921	3716	9025	55589	10902	1797	23268	2941	65998	54881	23209	10643	7259	10666	2005	3028	3475	55106	29902	23344	5422	54902	1019	7090	57406	23613	55421	3964	54433	10664	79054	5813	79003	552889	2830	79752	79895	2977	5144	6732	5509	55321	3175	6418	29896	4914	51029	1124	259197	55100	51601	5110	51347	26999	440270	387032	11221	202559	9562	952	8632	8241
GSE3982_MAST_CELL_VS_MAC_DN	M5431		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1784_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of mast cells versus macrophages.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					830	9609	6198	9569	55625	491	100287387	23433	23078	476	2289	7345	8566	5271	53	3838	79944	2794	6539	6772	84223	64747	9669	23136	948	3796	5718	1601	10133	51271	116138	6921	5687	1795	4072	214	64423	27131	7884	3684	1822	4055	100130741	9692	5876	160824	55340	5538	23766	1520	4289	5933	2022	6374	55281	3587	8564	5763	5358	9019	54209	3758	2875	79832	51330	7347	7706	56605	5879	4286	219333	54849	8332	23161	9295	4174	3614	10904	3512	128	8740	55016	4199	80194	23474	54913	5523	23385	3675	3642	6009	79745	316	79668	23063	79982	9466	59269	163	598	22933	3142	50999	1464	203510	54187	2309	59342	149111	25895	91752	100131298	205	9568	79624	84658	79694	3624	51309	65996	9976	2649	58511	5469	1389	1186	3439	84617	56941	11056	26499	8578	4520	8528	132	5467	27010	55852	54542	23428	27436	84296	7046	51172	3597	57476	57496	23062	1209	3073	9620	9873	9749	6102	2054	26064	2990	961	51	2034	9810	6039	55803	8366	6256	51762	1495	4905	6281	4035	253982	4601	1234	4145	55177	26577	55503	51022	23191	2167	3725	9043	2588	10205	29992	8754	5288	5127	64284	9530	2316	7132	51123	10725	2230	51313	352961	10825	63920	4125
GSE3982_MAST_CELL_VS_NEUTROPHIL_UP	M5432		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1785_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of mast cells versus neutrophils.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					5917	8925	2203	695	5428	54974	55746	5685	51614	865	4913	1650	1657	8631	9590	8933	23015	56910	9788	7045	6238	8165	9499	1434	23052	4702	84864	6477	55226	301	8815	6717	2068	5601	54872	23042	2350	57226	64864	84747	80227	51497	55109	93081	8899	55651	1213	4331	55718	29937	55070	10949	51313	9240	100506658	6182	64087	9631	84908	57099	4642	56945	8891	92342	163	9451	1164	57470	3336	23475	26580	10434	22876	10381	56616	22948	8634	5436	7268	26015	51433	54626	4350	4714	64981	1238	23172	7965	51136	7336	2243	6232	5707	51406	55326	23269	51118	55022	55239	7283	65110	2887	892	53615	9677	286527	2287	10623	7533	79033	64149	6414	7174	7779	5110	65993	80895	23480	466	5467	216	221061	6726	231	57447	5141	6748	23521	1514	5810	8883	79096	6150	8243	79101	9524	6938	64221	3559	2195	27440	57130	51362	10728	51493	6059	54900	54915	2561	79947	80324	55556	79882	211	6760	9655	90	64318	8565	58478	2590	10020	55827	4609	54663	56672	10133	977	10494	81929	23261	387263	55341	219333	28972	53827	23335	7385	23175	51520	948	10961	5631	1429	3113	9158	96764	55216	6713	9221	55722	51441	9924	23102	25821	5291	4771	174	11001
GSE3982_MAST_CELL_VS_NEUTROPHIL_DN	M5433		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1785_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of mast cells versus neutrophils.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					729580	2326	9815	406	79814	26034	55113	4883	4160	8242	55793	79720	27128	652147	6449	23761	8358	54807	6663	3985	2891	9802	51513	1490	10211	5209	3188	5672	11040	84981	10614	79616	3631	9208	51296	4155	8698	79960	8115	116496	10044	55323	7752	10435	22879	51361	11177	4184	23258	9807	23523	221037	4140	79180	5660	219595	4689	2180	55628	57834	317	6688	22838	81857	7375	81575	23074	11021	4046	81894	5698	10246	4600	81603	8079	563	7408	1466	2123	660	4001	27239	11119	3338	64410	23224	10089	65989	6935	9665	51622	8517	3428	10603	3726	51094	9547	3669	79838	10106	25945	8519	5724	2150	8646	10388	3742	9609	7128	5547	4739	10077	9881	4898	53836	6416	64786	51586	80094	3805	57799	5292	6018	54809	64135	64386	1524	64757	285755	85294	55526	3952	360	316	929	6404	10045	3356	23112	6774	7086	116985	79168	2710	7454	80758	10333	9990	8751	8178	55203	1032	51	8850	8916	7305	8694	9734	4185	604	9043	9748	57556	26065	4983	5020	2940	728	80124	80005	51380	64411	56996	5883	9169	9360	23223	79940	3738	1084	1318	54455	51291	2745	6692	50807	6556	2077	79444	199731	23362	3630	57515	26263	2776	26529	7718	29114	4055	215
GSE3982_MAST_CELL_VS_BCELL_UP	M5434		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1786_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of mast cells versus B cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					23217	6916	8807	63920	10580	2887	221061	2752	64754	9650	1213	163486	93974	84658	10544	23534	2534	51146	10332	10955	25825	9588	56125	11221	211	2017	7464	23710	54910	5118	9741	26031	30001	55256	79071	23475	3099	81847	26471	3988	479	54682	3269	7982	3853	11001	56943	683	57194	7728	11314	57460	25895	80258	26034	7782	6750	8061	8974	6624	6804	22844	54626	3176	284904	7525	8530	6744	3021	9590	5887	404672	9401	3554	9886	54491	7711	53340	10166	190	3216	6888	80323	10253	6926	64109	4081	4240	6001	51338	8436	4712	960	6368	64795	2215	4001	29967	58488	85021	2162	2203	166647	6279	1612	216	3240	152	9061	58525	23191	2135	3838	7373	10211	8676	64288	1088	4856	8553	509	23309	7490	51097	23171	63973	2853	8416	55020	813	8848	5506	23271	10671	51652	51347	6785	9254	10527	3702	6604	1827	778	2934	10257	29789	51761	5701	5023	1647	10402	671	55332	8835	91543	149111	23597	53919	6659	5295	54801	7979	9074	946	26175	56833	55353	79086	55915	649	5707	4000	57406	64798	23150	9749	3417	9412	56648	5509	4496	53345	1519	10321	2207	57136	9900	81851	6696	408	54209	3953	6993	7159	89927	8502	6347	1718	9580	2309
GSE3982_MAST_CELL_VS_BCELL_DN	M5437		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1786_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of mast cells versus B cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					9609	79705	3221	10312	2118	9466	3122	10279	55686	2768	64410	8631	79762	10520	55893	4907	84525	8395	9834	959	79829	8243	79686	54807	9788	219595	8034	11083	91949	27334	5504	80335	10365	3128	953	55512	245	5380	5045	3932	3123	1861	54938	10148	8940	728577	8879	5428	64110	3738	29121	926	3631	132	4047	9692	10664	55695	81577	80059	29803	150726	81894	81575	971	100505761	55142	6448	6691	3600	80011	29064	4600	54020	7351	10849	2971	3716	51471	103	6623	22	11279	79132	57731	23345	399	3394	26097	883	23508	7405	54737	6399	3978	5533	898	605	22898	51466	2208	3569	9814	5163	2562	9767	2213	271	1499	55503	29997	1038	2731	5079	10943	79089	8989	100286937	10045	962	5998	9875	55195	8303	7840	3749	1236	23070	347735	8626	57198	2326	3112	83700	23637	22798	9262	3492	10957	56950	9451	7706	9378	91353	64108	26470	55957	9124	3662	114	10123	54704	375057	2588	55063	3109	54920	79683	56997	8496	58516	84159	8334	5867	54758	5871	63892	23495	123803	80060	80183	79152	9057	79153	26040	51547	55841	10970	26049	80008	617	9909	80063	3597	4836	54979	694	5720	91316	636	51465	412	4939	5338	4153	10347	9214	8343	26047	57038
GSE3982_MAST_CELL_VS_BASOPHIL_UP	M5438		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1787_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of mast cells versus basophils.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					54906	54862	10971	8933	221061	5860	53340	8531	7059	51318	1629	644068	6518	1584	23556	728683	51499	1802	54438	8882	186	23136	10801	79003	593	11315	6328	55744	6003	64109	8396	4649	92249	831	58483	51283	54881	7411	25796	8891	3176	51754	6767	29959	9149	8836	6832	6813	91298	4714	6882	8848	146754	190	55759	79084	55129	79745	51073	81929	1215	8266	3688	79064	2359	671	5506	29098	11072	8727	4976	25994	1728	9240	54991	55149	5718	55256	7280	51611	269	8668	22877	808	23560	8453	81577	10190	115123	11034	4001	10961	54663	55315	51575	55200	1207	3329	6253	375057	3227	216	3586	2098	51540	6272	5538	6812	8943	3641	50700	8332	4157	51761	64240	8618	5534	91369	3376	7203	57644	2005	54788	79876	79922	10953	4830	10162	60673	29103	6588	5009	10525	55317	6307	9398	1514	253782	79077	7422	10110	10061	6696	5576	16	9054	79684	64111	79781	55164	9945	286527	9655	23271	28974	79572	339457	6567	23052	10000	2264	55757	1973	2151	2903	2040	26064	2555	10124	2023	9717	89	5597	55161	84561	54537	7041	2517	25903	7779	5118	7965	2212	51438	10447	10131	80321	64175	871	10533	4212	347902	1500	7038	5816	51186	55852	9334	51144	100131613
GSE3982_MAST_CELL_VS_BASOPHIL_DN	M5439		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1787_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of mast cells versus basophils.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					5366	55893	29080	80254	10614	80262	9815	5867	6160	719	80008	79682	7544	27334	9168	10051	2898	4763	1437	8412	81631	55281	8115	9958	55195	8443	55512	29058	5525	79944	2323	22990	241	60	3360	2034	5771	29992	734	11314	56997	55578	23499	1487	10664	26959	57162	5611	2015	1791	11083	8674	10123	1234	3964	25948	64757	10581	22898	7314	79722	23093	64762	397	8600	5430	6777	64232	2560	10106	7414	3001	51099	5683	23036	80328	1843	64397	3049	9528	10163	79685	55336	116984	2197	3669	51465	10520	91316	22950	10288	10914	6404	25819	10512	28232	57205	26112	120	4898	29117	767	896	7755	5277	6711	2114	6164	79153	6129	55063	1524	3082	94081	10516	7270	28954	9821	9770	5144	60468	1540	51	27429	79668	8557	8190	80135	5788	9921	5927	100289563	25977	4982	23199	8776	11031	7322	9881	23345	9765	51646	55763	320	8556	6478	58516	51466	28639	962	22899	5380	57596	23247	84263	6502	7706	3105	64506	55843	240	7392	7978	55788	79665	65981	80124	7402	6304	51111	100132923	57035	2794	54808	152006	84187	55810	23168	5890	1513	9536	57185	9802	5097	7515	474344	8446	10267	79811	5148	23585	4591	90634	8227	9867	4615	54145	51097	3716	3050
GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_UP	M5441		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1788_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of mast cells versus effector memory CD4 [GeneID=920] T cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					2203	6604	55364	10955	56252	10904	9459	2235	9103	3188	64759	8476	9588	2317	64976	9646	6742	56943	6280	10580	55256	203197	1601	390940	3005	6767	2561	219654	211	23753	11221	269	3964	10211	84561	51097	54765	11193	6821	7461	56942	23475	4357	9358	9851	23761	23367	4735	5289	10671	8829	875	4697	51187	2935	2766	64109	29994	63920	286527	10019	55255	64754	57460	23344	9401	6253	5962	95	79365	9655	2242	64374	2694	6414	586	29967	3632	5151	7728	8301	55222	387032	7095	51013	2119	23462	7678	23136	7490	10381	29880	55652	6400	51075	9412	8303	1124	23677	6279	9493	6309	2037	10124	4286	51022	9848	2195	9650	9688	10376	29948	5269	81691	26521	59336	11138	7329	4097	6881	16	11275	22837	29088	57862	7296	9477	51296	5530	2180	10422	56851	9404	1603	10814	10342	395	8795	51056	115123	2591	81566	240	10321	3308	4522	1876	166647	23166	55853	84187	63933	10954	3313	54968	6322	51566	26960	7086	80210	9653	7251	5693	25994	23080	4055	1612	9897	2590	10287	80094	25825	51650	51734	133	6886	3992	2034	3315	7879	22906	55106	10525	5037	5718	9601	57419	10409	2135	1119	4212	5423	5168	4976	79736	5704	4835	9658	57406	79752
GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_DN	M5445		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1788_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of mast cells versus effector memory CD4 [GeneID=920] T cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					27334	100132341	643854	8631	4068	3053	474344	10868	79147	80008	8817	100293871	1524	222	4958	5837	55334	57113	9045	26099	22838	26716	4649	1300	93664	149628	5583	2194	3749	3702	6367	55239	84525	1748	3221	284	80032	5775	10133	10046	5883	10520	10660	54847	51078	2145	57035	11083	2994	29121	740	51466	399	140461	56997	6490	8076	1844	349152	5984	5432	4293	1591	10123	2912	9905	54869	54545	7049	2999	6492	92822	79820	55695	6863	9710	10296	563	6623	6569	11123	9744	65989	63925	10022	339229	3646	7626	3991	896	26030	5045	57223	2946	7373	23093	728142	23276	28954	10801	100132285	5456	10943	26034	4818	55686	6304	10136	9806	5533	79006	116984	7166	6462	23063	10079	51517	54465	3665	6168	284443	5794	3458	3738	5139	1428	5790	8751	438	7185	10898	2643	11156	11095	56311	51666	222161	186	4641	2309	9730	29761	9814	4661	2319	80194	3350	9267	729164	11005	5053	4015	8807	63973	25865	23528	55343	3316	9046	1385	1370	271	4298	55801	57214	123803	6506	1741	2781	53405	6430	2185	55205	81796	80059	1506	4168	962	1580	55124	2693	64078	1937	6281	51720	401	100286895	1933	100287387	2257	55160	3659	339105	495	3810	11262	961	3716	9570	55833
GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_UP	M5446		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1789_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of mast cells versus central memory CD4 [GeneID=920] T cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					6659	2581	1973	8531	2242	3295	23433	4289	55827	64754	286527	7511	23171	10712	9103	11193	23659	1848	4835	8061	9114	374291	80896	11001	4236	2205	6400	54968	22875	55500	1215	8878	4097	7263	2119	57460	55743	10211	9276	2135	23475	2821	51257	6888	644	22948	5441	91752	4521	79639	4710	9412	51491	2182	2934	23534	9587	50515	10409	79682	5168	3422	10467	51428	10671	7416	5724	10544	9459	29088	81566	26064	2235	9655	4499	51340	51363	9957	1164	390940	25823	4066	2180	10352	4914	667	10253	4067	23788	22921	79768	3687	23603	7779	8848	23326	8436	9770	1119	56895	3157	55759	57572	1460	404672	10643	21	7086	8301	8544	23333	216	28958	54939	1130	4683	11221	683	8476	25840	4522	57447	6696	5706	6788	95	56937	488	29956	1351	3757	84790	55652	19	51399	4076	11275	6948	4212	5594	3557	9061	4830	1054	10381	5973	23129	2029	26521	6368	11031	23590	56943	226	6239	4074	3608	23604	7386	127703	2799	5118	9404	7296	23071	2207	5360	65243	324	29953	57136	1124	4726	2952	285203	64231	64976	55577	4697	506	728	63897	1439	23191	81698	84196	3459	23262	11154	55233	55062	22837	55332	10124	1347	166647	3326	3073	4642	29110
GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_DN	M5448		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1789_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of mast cells versus central memory CD4 [GeneID=920] T cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					10868	56413	81894	9168	81857	4068	3589	940	80003	476	23095	57730	22844	3617	79762	84296	51735	9814	79892	5428	7294	1844	100131298	2145	6304	51361	1464	6328	57035	6305	80162	79652	160824	27334	11277	6191	666	10964	55686	57212	29991	3702	3458	29121	2719	9710	11040	10957	10365	8879	11313	3665	10801	6932	5883	54938	55766	6901	1741	10077	6649	2588	474344	401	29914	10209	711	3178	25945	4583	23070	23261	11083	56829	8821	29761	80774	23594	2077	8893	65258	6125	9422	2121	4118	10174	1039	1956	1534	4072	7175	582	6450	285672	64863	79810	317781	10123	6877	6835	7260	896	926	120	51135	23362	22902	55716	51490	55063	55795	23059	3716	10737	3106	5616	29123	11255	8100	284443	55435	5775	10686	1120	9262	5771	22800	7089	84861	26205	23036	339229	23063	6555	3796	79788	101	23451	716	2124	8975	9823	8383	26287	23615	8573	57799	11264	9873	2695	2273	7350	51720	96764	920	8001	4155	26030	50619	1645	26097	6207	6124	6785	4071	399491	79722	57396	23499	9913	51561	8776	5064	394	8193	55738	79832	3683	9378	25788	54913	441601	80133	10572	4153	43	92	100134017	80342	3803	1594	83478	2946	80127	3137	399	11021	10590	9057	23336
GSE3982_MAST_CELL_VS_NKCELL_UP	M5450		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1790_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of mast cells versus NK cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					22836	2887	286527	10955	64411	23475	2195	63920	2034	27340	64754	4212	4001	3675	6001	11138	9588	269	8303	2752	3554	90411	6659	79772	11157	27299	22948	65260	6747	2037	3306	2119	29104	57447	56521	5168	522	29967	8829	90	58477	272	10580	3336	8887	9712	1215	3005	8754	51347	211	115123	56937	2098	81789	7818	64374	28969	11221	57460	10094	25823	79038	51187	57406	10527	7251	4258	51133	81537	10988	3988	91752	55332	4074	1176	8061	6744	9658	1632	50810	3916	23333	7039	26476	6634	55647	10599	404672	318	1687	9508	395	55233	5202	5683	51652	586	6419	498	2776	51596	8848	9882	2027	55853	4286	2766	1515	23507	79921	81618	2953	6319	9470	6921	58488	3303	4129	23534	10814	51068	56652	5747	4642	6611	159162	5707	4066	80135	190	4076	2205	25932	6541	5718	10321	5023	57050	7334	7678	253782	8543	9933	80014	6888	3308	22859	4697	1164	9590	10606	6253	5515	10257	4700	708	5321	28977	11328	23261	10935	7078	10129	79094	84890	5537	23367	55958	8805	23271	26123	26064	10313	946	518	136	5684	2241	5509	9655	6136	5584	5230	6472	1213	64080	4882	3417	6812	7813	112479	8509	8270	28978	19	4000	55173	8502	79682
GSE3982_MAST_CELL_VS_NKCELL_DN	M5452		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1790_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of mast cells versus NK cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					9429	3738	9609	9466	4068	54432	10868	65055	23224	23157	2898	6344	79602	1645	79823	9679	57214	55823	10288	2118	971	4818	26284	9145	8464	23623	10849	203510	22838	55153	474344	51332	3820	8631	6398	116985	389677	3904	6863	80350	7739	2149	25771	79652	90864	2563	896	11083	3101	54149	4745	5367	3991	9717	55512	22898	8519	8807	10296	3614	22899	59307	10279	146754	79753	824	79838	27102	10848	9046	9823	2081	3891	593	92	79006	1370	1016	2534	1193	5465	2592	10898	50613	8648	249	54847	57171	4600	7089	29914	29799	7294	56413	5533	974	2588	8076	4940	9487	11314	7373	580	116986	64108	4619	55124	84296	7351	1544	8837	9743	25777	8760	3804	3394	83478	5371	2643	654434	5969	9254	2572	6775	79899	55201	54913	6095	84124	10957	3084	79944	27240	7706	7827	9645	50624	9976	7185	80059	653483	3134	26716	55576	57048	9806	5609	51466	58529	10164	3802	1521	10500	3669	57446	4808	1557	23608	51725	50940	1842	3702	9546	79037	100288496	55088	2940	2794	5288	79750	79616	1445	219699	93664	54540	2040	58533	8633	26097	3746	10267	26033	2515	9267	9891	333	80162	79991	12	7414	3275	55738	10103	4595	29123	2824	9734	171023	3707	1861
GSE3982_MAST_CELL_VS_TH1_UP	M5453		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1791_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of mast cells versus Th1 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					6767	56252	66035	10493	8804	10653	8925	25800	3240	221061	7572	6451	57711	617	3176	55827	23471	5003	10472	29992	3205	90956	1500	3915	671	91752	7414	1520	10544	23515	3073	55364	1806	5264	5747	9454	948	6322	55332	2581	51619	7355	2195	130074	7251	29102	81669	57460	3455	1420	57051	10190	11026	58488	23258	78989	54902	54796	2766	114908	6253	10955	5724	23199	57402	6009	64746	2752	51160	3141	80321	25903	190	64806	5037	23333	4065	427	56937	57223	2203	4617	8788	10771	6988	9580	9926	4499	6916	445	7262	1674	10491	9741	8273	23382	23051	220972	54622	5327	7879	1601	96610	51304	9825	54765	269	8556	79811	115123	6688	4801	4212	822	4780	23613	514	10924	6400	26959	10026	23175	23438	84034	81566	4069	79634	54432	9779	10282	26152	30811	8911	27342	7111	53339	4636	157922	479	25823	9140	92703	1974	2060	79666	10326	56001	9284	10438	55328	771	4586	1495	27250	51567	7741	1828	10206	23017	9802	55763	23424	9947	301	2215	5879	9508	51363	79768	9455	23033	89853	27087	7547	23271	1130	25796	9491	10740	2776	7696	26137	54209	9655	11118	4987	23462	216	871	3178	5090	7078	1203	64798	2778	8689	2332	23136	10466	79042
GSE3982_MAST_CELL_VS_TH1_DN	M5454		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1791_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of mast cells versus Th1 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					27334	90634	332	2912	2121	3093	2305	4628	51319	8837	11277	3452	3586	993	50515	58526	27429	58472	5165	10606	55775	3101	4361	6344	60314	940	9823	64410	59269	80162	8668	896	10044	100287387	26284	11144	57162	10133	27130	23015	79682	8940	10452	3561	8914	56654	51517	50809	22974	50509	54069	8760	10379	79006	8776	9585	2932	63933	10935	11040	10615	54892	5036	6398	79669	55801	25893	140465	23095	54707	57102	3983	94081	9582	2113	5393	9735	5908	51294	5347	9904	6117	10250	9937	6891	9701	333	23062	875	8836	79686	79622	51026	93436	974	5599	4289	1466	83259	23157	4118	11014	3998	80008	9172	5533	171546	4802	6877	5510	3805	2194	79710	1326	6790	4763	79832	2057	205	51575	8884	953	4001	10714	4729	11262	133619	25945	5611	347735	2633	375	5433	2794	9777	10131	11279	11194	6385	64699	80176	8835	8418	116986	6935	4436	5496	29121	28755	10046	57084	29123	10351	4068	3135	26872	22913	5504	84296	23370	3902	2289	2643	55055	9352	10217	6785	23746	5366	5143	4793	1540	3904	54982	7293	54847	50616	55750	54552	100291860	3002	55825	641	10691	58516	541578	5698	3419	9891	8774	25803	3662	5933	10267	1434	22984	5111	5438	149628	5983
GSE3982_MAST_CELL_VS_TH2_UP	M5455		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1792_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of mast cells versus Th2 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					55625	23333	22836	79768	79713	7414	831	1500	6916	80317	3240	8799	4281	2591	6399	819	100462953	6009	2005	25890	23175	221061	23335	79048	6462	25932	26959	91752	4189	55745	23438	347902	10924	84658	51635	10491	26030	2135	9650	2589	57572	11221	54103	4883	2887	219654	80323	64795	1069	57151	10282	6239	9588	54504	23608	64754	64111	55144	9372	57136	64092	54902	130074	51363	10580	2195	23261	7728	5806	190	23613	79086	406	948	51706	9610	2215	2581	9103	5264	7078	55788	683	115123	23462	55578	4284	54796	26577	79752	1102	56937	8273	7105	7111	2317	5747	1186	8925	11255	11026	3073	9061	64109	10955	9926	51606	6750	164	55652	203197	79134	57498	10023	25963	301	56100	57644	23017	79666	55827	64374	7280	9741	2554	4299	3557	11034	55275	644	10287	9655	7048	2936	51100	4212	427	133	56940	6926	84079	55654	90411	51619	10278	1601	55106	10253	1182	2125	1200	79717	3728	51451	7168	6253	9658	10099	3784	6102	2752	22864	81545	3625	10647	7075	1305	6688	9778	8829	2203	9445	51226	3831	640	54432	8778	7511	2770	4069	26137	51705	1195	4708	2350	11314	2766	55831	2330	57447	2162	25895	7694	25758	22905	637	10409	2953	2799
GSE3982_MAST_CELL_VS_TH2_DN	M5456		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1792_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of mast cells versus Th2 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					332	6385	283345	9466	1844	5393	9289	2305	55706	4628	10825	27334	8821	4436	1606	4172	317781	924	23095	10267	5504	60468	23015	65003	2491	29883	8496	29121	2875	3805	55775	4001	2289	1468	84859	9585	93436	775	993	64328	23474	2077	8837	939	2530	80008	3904	10615	51490	378708	7756	5036	5763	6935	5424	1163	51805	9582	249	9319	1503	55278	4282	642	8886	2941	80169	9823	5369	79077	79832	7163	9875	26150	6346	28974	23014	79023	54962	5163	7867	333	8395	51116	54707	64699	80162	4958	5510	3396	8772	842	50809	2034	30009	23511	8350	11334	2633	55334	29028	23594	2794	5871	3978	93594	27130	10725	5901	100132476	54069	55124	4150	5451	9701	2109	7706	79652	28977	51319	80194	22995	3682	8668	254359	140465	6691	23528	8914	6117	51053	6448	79866	11264	11262	79006	5432	9019	641	9429	6790	94081	10452	51155	83259	10682	5600	3823	8318	54465	31	65084	10205	4595	2562	79902	9295	10691	9780	387751	79710	22976	1460	27341	9600	54982	11047	11051	5433	79958	131544	23647	5032	10935	56949	8884	224	80764	7175	10915	3507	26278	51575	6749	7185	56902	80342	5347	26610	9967	26509	10713	5778	730101	79683	64960	10051	3002	285527	55862
GSE3982_DC_VS_MAC_UP	M5458		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1793_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) versus macrophages.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					9429	629	27241	51585	9658	54869	51380	80853	4735	23549	26034	55830	56940	10621	10666	9489	6886	10895	26051	5273	90864	2553	4783	10160	8731	64895	6821	28232	1550	55337	3516	56997	9455	8334	80350	79713	773	10974	131544	347735	80212	7039	913	9717	29882	1153	84193	2274	8724	6843	220965	79939	84934	23014	3803	1311	7054	55501	5993	79767	7942	3621	27183	4618	9603	9657	51399	80124	79078	5969	54883	29803	28951	64421	8451	5073	80230	8993	51314	80184	57020	9583	64866	8651	84908	1399	79724	59348	100272147	54496	5631	9128	7448	9695	201134	4621	23212	910	23352	11283	5154	3321	1611	5509	11276	9755	2952	7776	55186	23704	23197	1048	55510	825	54	79872	55110	51734	5031	5224	7360	6717	4688	2208	2321	2073	8013	7356	9221	376267	3290	6733	2887	55304	3697	55100	10892	10123	27074	5977	311	64170	2978	5050	51599	11138	9880	10111	100507424	833	114876	55719	2848	55196	5077	11342	5214	1261	56548	6541	9734	6734	6373	7414	79154	8727	114548	4205	6416	1472	23596	9209	4070	4671	386627	54780	79762	3119	26024	80258	26548	23660	3579	63917	8717	5673	4850	246	6361	23526	5725	1018	693207	9783	9459	9520	7464	26285	9697	79854
GSE3982_DC_VS_MAC_DN	M5460		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1793_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) versus macrophages.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					29098	27342	6273	1143	10379	7332	221692	3212	4012	27333	7923	8644	1803	27291	80736	719	6790	22879	23303	8650	9388	23480	4860	2623	11037	79801	8516	3293	712	5563	390	55723	2916	4646	55239	3619	138151	7415	23328	11326	55148	5962	7046	56681	10635	51304	8875	8848	2662	79802	3161	7170	8776	8936	4998	10912	10827	23528	23120	23601	51075	55008	701	8601	7033	1513	57728	53919	64397	2219	5265	27018	6518	8540	4907	5087	5427	51497	9551	102	4843	2230	599	92689	51299	4313	891	1493	6774	51213	58511	10671	4291	4316	3578	83988	51266	3642	5422	3954	10491	57336	5093	9398	56521	9929	6241	114088	10217	26476	10001	4288	10053	5569	23194	10124	9870	8555	55149	79589	526	350	5341	347902	84679	253982	375057	56672	65260	51388	8688	9088	10497	55055	89797	1831	79621	54558	27306	3655	6653	29922	57596	586	9935	2928	10721	1058	5982	1551	6819	3077	1525	81035	11247	1066	6622	887	9332	59286	388714	3484	10432	2215	9114	148066	9962	26059	4311	1062	64859	24137	6354	25937	890	51311	3730	1435	4642	9133	7058	56943	9971	6347	22974	54332	55831	55970	60676	10687	79847	5294	8938	261726	25874	2913	3758	2210	57493	51284
GSE3982_DC_VS_NEUTROPHIL_UP	M5461		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1794_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) versus neutrophils.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					163	9588	22880	50650	51499	26031	3064	55319	11332	5973	3094	5116	1434	84864	5901	11017	3113	5523	4144	2746	51393	5827	216	10897	339044	2517	5436	10844	8815	29903	55144	92140	4128	667	51606	4702	1376	4338	55283	26747	56935	63978	23335	23175	55746	8974	29103	26577	79096	4714	55006	51318	211	948	64976	55647	6240	79023	3212	79882	6281	9557	4012	2271	5954	4216	4259	5917	1981	26024	6678	25813	24140	4522	3241	23518	1200	114112	57130	10454	6367	8942	6232	9578	5141	84928	54915	8829	6741	63877	1429	1350	304	55750	23654	57212	4145	29088	79068	1476	27252	80324	5742	51118	79762	6713	8564	5800	2971	2110	25896	51466	471	3998	7268	54344	6125	4998	231	9889	4621	1213	23303	8572	79695	79864	23788	78990	467	5813	81570	25821	5747	55839	64506	2768	80221	80789	11266	657	2926	388650	51309	2264	25926	51021	9631	81533	596	2091	54806	7283	58478	91949	4070	8131	9317	6293	2017	56986	6767	6760	246	22846	3308	10464	253982	7260	54765	6886	1471	1117	9415	10455	6659	4850	3014	23022	1514	6692	1808	9924	28955	4528	440270	1933	8336	760	2058	8453	175	2208	26155	1479	890	50615	8270	3419	9858	7045
GSE3982_DC_VS_NEUTROPHIL_DN	M5462		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1794_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) versus neutrophils.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					6935	10614	25888	710	5142	5966	102	51307	4802	9111	80758	306	10057	1828	440895	2326	4600	5209	80183	51274	3798	9990	27291	4212	5094	3749	54807	55784	4815	5927	3613	8698	10044	23462	1131	1675	602	55350	79814	728642	6018	8809	64411	51279	26034	9929	30817	80724	23569	846	11011	10106	5728	23118	8178	9262	5836	133	11262	9881	2835	1544	6404	2909	1289	79089	345	27071	7462	5266	9114	81558	23224	59348	4210	51291	65220	56676	10092	9815	9185	55568	5525	6286	5672	23023	127544	64386	2662	22898	57402	55790	969	51379	7718	11120	7852	57556	7128	26030	2634	1032	57223	5799	58513	6809	1741	8688	2867	8837	79632	7277	9665	51710	8650	57612	9895	2114	23401	9019	23526	57538	5899	80086	9208	79854	80310	100286895	8315	8358	391	23476	25977	79820	79847	3043	124583	563	55810	4051	9663	51720	9848	22838	53919	6515	6505	64400	10409	79865	5914	1936	91977	64061	8239	4664	54556	9334	11021	57604	2920	5606	10659	8347	387751	387	4001	9766	57596	2210	55841	7130	9517	91300	4170	7903	4783	3665	64236	4117	8303	8028	8434	2358	6850	10272	5586	56302	5126	30	54739	2781	6430	1013	64421	23013	3716	79364	10970	8861
GSE3982_DC_VS_BCELL_UP	M5463		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1795_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) versus B cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					948	11332	8356	1876	8974	10253	2289	211	7855	22808	5523	408	5154	3101	6009	467	6272	10714	7414	51338	1318	1594	6790	913	1781	4128	27131	5328	63933	55160	216	1116	8061	48	79086	56034	79639	6256	6821	1026	84617	51606	23023	55859	57406	2819	5420	28984	23129	8766	8507	5184	8682	411	2301	64221	2517	4618	8540	136	1497	84669	4286	11057	26509	9677	1234	1718	11031	1317	4354	90956	911	8835	8796	1213	23601	5742	26355	1827	10170	5858	27072	2121	55839	6573	9145	55062	9645	5214	51309	5509	55506	3579	6916	11000	10462	2055	81029	7263	253982	56253	27242	754	8829	4070	6809	3448	79605	3758	375035	56606	683	11027	54471	92689	81570	113146	55799	9749	27257	942	7049	246	23654	9034	9308	7305	29992	7084	4129	374286	1296	5141	26034	1200	4864	51314	2953	29109	9208	6385	84193	199	23022	1519	217	4327	4856	5664	8714	51271	6886	5077	8760	9061	351	1824	25939	4224	5911	80176	112399	2335	30835	79658	63917	6624	3576	51762	8309	1612	2637	55539	79695	8347	1051	3916	30001	4651	10742	301	2203	7132	1466	53346	23099	8727	39	3290	1491	27436	9706	10483	114548	5824	10300	7145	10267	4783
GSE3982_DC_VS_BCELL_DN	M5470		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1795_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) versus B cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					23345	9834	3219	55148	3932	3394	23014	25888	84124	51384	1143	80183	3507	6518	3514	26057	2553	9788	80724	701	1843	10866	11083	51593	2326	8717	28387	54758	3062	971	5383	63978	25849	142	64061	54807	347344	7465	55765	10024	3112	64065	6691	10432	55638	55790	4210	7170	1936	28968	54494	6711	55584	24140	286527	3716	6128	27342	2971	57596	3632	7866	150244	994	3665	81606	7033	80011	6399	24137	9815	10739	51465	1669	10124	9364	23194	54540	8115	10863	9214	51379	22879	203197	8527	4050	7570	84079	10365	79707	60494	9337	79683	80230	22	54149	5252	22974	6932	56902	79802	81888	27333	23387	7462	4939	4678	27241	55337	8776	57171	5298	3749	3212	10420	51031	4214	10664	6653	8295	84159	1877	54980	79057	10803	9711	57223	5894	3535	91782	83700	6167	3915	399	51754	51020	4261	80736	10636	5368	8395	7057	5326	28951	23231	7701	5590	9267	6189	9550	5287	5625	55810	10849	54855	8339	3683	25983	100505761	9947	1058	652493	7366	23303	1901	91353	4633	27334	6707	81558	440515	100289410	1238	58516	23020	5727	80342	100286895	7079	3305	8440	23046	54847	947	54925	11276	2591	53335	596	4232	3105	638	23630	1487	350	9929	57191	22882	23094	11142
GSE3982_DC_VS_BASOPHIL_UP	M5472		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1796_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) versus basophils.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					4145	3707	874	80176	8354	55160	8528	4048	10024	26577	29122	10897	7965	3376	23176	80212	3329	57214	23023	5827	9578	79084	3586	1839	55317	4289	79745	950	4208	5673	1727	51499	340351	22868	64221	10721	51754	4967	10461	6812	11332	4714	10319	911	1116	8564	54187	29123	55796	8291	2098	79864	5184	214	9081	6911	1535	2359	9425	815	8942	2913	467	873	6574	8128	65979	3055	1728	56938	3283	63933	30811	26064	57418	23014	6237	8864	7145	7263	5424	65990	2548	57194	266655	1514	55613	10973	948	57406	57107	8895	526	2896	3241	712	4125	10457	5860	123803	8038	9308	9569	10801	7373	2264	25992	51123	3784	79695	55663	7700	5742	92	10873	23594	79086	27072	11057	2734	55759	10994	5768	1849	78988	2520	6253	4900	55164	1010	6448	10253	8861	7205	4285	5151	9620	50807	51393	8605	28984	2023	1730	7594	7356	6367	64087	54929	10295	56935	253782	5106	7074	5223	26509	27131	10826	4864	5523	22880	5468	11033	3614	10885	79713	55332	11328	7453	84890	51382	1536	84861	6361	55662	6507	4026	1512	2720	1311	10195	51092	4128	1965	4129	8714	26580	2760	9581	4580	5037	64860	1629	23099	6588	1317	59269	1615	2688	3624	55048
GSE3982_DC_VS_BASOPHIL_DN	M5473		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1796_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) versus basophils.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					8780	1768	1803	695	26031	65981	10614	55262	7978	2114	5977	10866	8227	10209	6935	3021	10384	80254	5927	5525	6886	6399	5645	60489	1901	151050	2925	56994	2323	5894	10516	387751	8519	9781	8358	10432	81631	25924	819	51279	11083	25873	8405	51380	23613	9129	8363	8315	55062	7175	54807	22844	94081	4602	55148	79364	30817	6601	4071	6404	6128	1540	3720	51274	79788	4615	6429	55830	388969	23178	10106	7322	10581	64110	57117	9185	79809	10046	3053	10800	54784	1646	8623	4212	9459	5252	81698	8603	7701	1828	7803	1649	2932	3486	6478	26207	10781	22898	3669	7178	10409	387	23302	2131	60468	11251	6431	5050	57460	9815	10241	26228	9517	399	339290	3305	26211	79843	22900	23046	10198	8395	6286	22994	29087	3275	9337	4237	84187	7111	6018	27334	26059	51439	10892	6036	10664	4925	55578	51701	3798	4126	25977	3983	8644	5189	64754	10902	54386	84124	78991	5144	2073	7462	22864	79722	10135	55186	1123	375056	23345	1979	55843	286527	57596	8273	79640	29125	25948	84851	734	64766	11329	2591	54503	29117	5757	9920	10974	5366	6167	8809	7852	29896	140467	23198	81626	23389	10163	3676	10017	55055	57018	64895	54413	10291	9275	51304	6164	6652
GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_UP	M5474		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1797_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) versus effector memory CD4 [GeneID=920] T cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					9588	1675	6697	1497	7296	8564	948	214	22808	1839	64374	4735	51606	2517	54187	1537	6461	4070	80094	5973	5742	7965	56034	1536	1200	1435	57406	51296	2208	31	902	10053	6309	467	26355	3005	8572	64222	4938	1075	6509	2335	211	9902	6253	22928	7045	114548	6400	55803	7855	27072	1161	79705	57556	81029	64759	1186	6256	9103	90956	4091	29903	8829	303	11027	9121	8334	8682	59342	2237	253782	4618	9308	1611	64506	59336	1728	4201	5962	1612	586	55704	25966	51097	84934	48	1781	1026	11138	83464	53346	27131	23401	7251	847	51094	51552	9873	6925	57447	7056	5106	4702	1902	3576	81501	311	5244	7678	7077	10404	7305	56935	5550	25780	2359	10653	81570	945	1727	10409	63933	290	3460	9470	79745	10327	79789	30844	11133	64794	10935	6383	4125	5175	5188	11283	7360	8761	4286	4360	7205	3597	9034	23590	6812	2242	7204	3570	516	5468	10865	2876	3055	5718	351	51309	6573	4900	8714	26509	1311	10849	5547	2055	8942	3958	2067	7145	1471	3784	10981	4213	81035	54101	51474	5265	1594	5660	2110	10261	58526	2280	54453	216	3109	913	58488	8854	9341	51651	219654	1020	2561	11080	8727	26020	11261	55244
GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_DN	M5475		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1797_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) versus effector memory CD4 [GeneID=920] T cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					3305	56252	81926	474344	10781	9806	23217	84525	23345	89870	55795	29063	440895	8504	27339	2553	26030	23040	9781	1445	3219	2173	23029	8614	9663	6935	2672	10274	222	7701	11083	386627	26053	84124	11262	9649	56899	79848	54896	26034	8092	79869	78991	23354	22838	57402	6430	64236	6490	7552	3275	5676	9256	60401	346	358	388699	3716	4603	89853	10000	7373	1936	6188	2145	10800	347902	51574	2846	55765	730092	3621	2643	9738	3448	57007	563	10525	23387	7291	23046	55833	9170	54780	4212	9459	54910	23641	4675	11009	6232	2925	10659	1646	7626	55187	51666	28968	4071	10898	84079	4072	55525	151	10664	740	10581	22889	56242	10663	57187	2250	283491	23176	5583	7178	26762	10384	55843	387751	23175	51052	1018	84302	7020	1877	3749	57060	10767	6711	55280	10198	375056	83700	1741	2870	3659	55423	27342	9397	9453	9947	181	55584	286527	5757	5326	115201	23526	25873	1828	26051	80086	26083	7465	6228	8295	2323	65095	81539	2194	11329	23528	59344	8289	10616	10123	6156	4685	445347	8658	7066	9267	23020	947	8698	9229	596	6601	2911	8623	284541	23178	6491	57604	22976	9422	729230	55013	10129	4907	83445	2999	55859	916	64400	55876	26692	79820	8237
GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_UP	M5476		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1798_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) versus central memory CD4 [GeneID=920] T cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					7965	4145	51296	695	10253	1675	2242	55160	27072	9308	9902	1318	728	3101	1376	2517	3033	54187	3956	9103	56034	7296	1075	5742	6400	1536	51	57406	3394	5577	55093	63933	978	216	2495	913	1512	8507	2213	10409	81691	7030	81501	51284	8061	948	4128	10328	81029	5683	3290	55839	26509	1902	55969	51760	84981	79017	2017	10261	6678	1435	4289	7045	55697	26577	23654	2268	3579	10970	55357	55603	5836	9114	644	3122	5175	290	138151	4783	1026	90956	50515	27131	53826	5351	8334	80230	2335	1200	5154	64222	838	6888	928	683	10457	4864	6812	6361	55759	9858	8605	80896	5468	125058	56833	9620	5184	2067	2205	2230	11031	5214	6272	3283	29988	51309	6809	55244	11027	57447	8714	2896	22808	945	25780	1495	10295	27242	79903	23549	64170	311	11332	26355	533	5899	5547	246	54101	56674	64794	11079	50	4318	50814	8942	5336	4794	911	8650	56895	51706	5594	7779	8564	902	3916	53346	2203	10935	4070	6383	9578	6385	1509	7421	3295	9673	822	1522	55813	64866	2237	23682	7360	11193	55652	1718	8544	51382	81035	2321	9429	6821	5033	10160	3281	10267	910	3758	29109	51651	7414	1362	4998	8013	2171	64231
GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_DN	M5477		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1798_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) versus central memory CD4 [GeneID=920] T cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					8725	79707	64061	7170	10781	6154	9422	55841	25873	347902	80736	4345	3219	6232	28387	2145	1979	54149	582	56936	9459	5727	55038	79679	51735	387751	7033	3105	84914	51520	6935	7841	23641	26747	375	474344	839	7454	9617	286527	5375	10001	8287	1803	8886	51086	51593	3305	23370	57223	55187	28968	349152	79958	57134	1669	56829	11011	11037	55790	57556	5335	2323	11083	6711	7644	24140	11116	10384	3676	91782	79710	11009	7253	55843	60489	7957	4222	23387	2355	2909	6430	11262	388969	7175	7994	309	10964	55765	10841	51076	26030	92249	440270	5563	26036	1123	1741	5383	7291	7570	65095	3815	7066	7178	57187	10801	55340	10686	26152	6234	7356	7105	10432	3570	1901	51031	3598	80258	8623	9256	22889	79414	29851	25763	728642	23194	84159	7695	81539	6949	1181	79664	55227	9657	6707	10365	314	5583	83481	55795	55810	9214	51710	6399	10256	8809	390	55568	7294	10000	6128	4674	10053	220	440515	5077	79844	79802	4907	2550	27241	26034	29896	2915	10659	6170	7690	230	346157	261726	8445	54910	50852	81558	26005	54923	3932	8698	6504	4939	100505761	81856	5100	5142	22844	1352	10272	2308	23261	22976	8028	9695	23354	2870	394	8563	916	162427	4675
GSE3982_DC_VS_NKCELL_UP	M5478		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1799_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) versus NK cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					54187	26285	27436	2495	4070	9308	3281	136	1781	55704	5718	51606	55093	59269	55160	8507	1435	64374	3005	22808	4128	79865	7277	63933	6886	902	211	6346	1728	3241	1026	8578	8761	10318	839	1512	518	4686	467	80896	8682	2335	5747	1116	81570	28984	5523	8974	6747	2017	6678	64222	5810	8061	2213	5420	6509	6812	2819	2055	6573	246	8766	9578	4289	54502	8829	303	11283	58504	2934	28977	7263	2205	3728	8334	8572	26024	290	1191	8651	272	57460	8996	6624	2098	1062	7145	1213	79017	6319	55110	51715	8900	51	5509	55048	84669	7204	6367	56548	2937	2359	4606	28998	1730	1476	253782	55332	6453	79639	8727	57050	1594	8993	11031	59342	3142	9470	3123	586	11138	1522	1318	56935	1317	3916	58477	847	23161	23220	444	51270	6446	5468	1727	5742	1497	27072	7187	10935	79754	10261	51651	79828	55313	54413	874	4286	56034	351	4327	2852	2760	57447	8013	2615	3557	10170	5697	84909	8038	4318	6461	23307	10327	57406	913	4794	8564	3958	56139	7421	6692	5501	64506	10124	133	2274	205	5973	55647	3597	26580	10483	4190	54471	9586	23118	55244	8336	928	5214	3758	4881	8544	23096	27018	11309	2978
GSE3982_DC_VS_NKCELL_DN	M5480		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1799_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) versus NK cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					55351	6711	22838	23072	474344	10982	7170	4674	7570	9806	1979	9781	9228	57596	286527	79927	3765	8875	6128	55421	57379	10432	55584	64061	2846	2553	55765	84124	440895	56936	56912	5375	80350	26207	10616	8644	3665	65083	25888	7060	24140	8530	55664	1109	387751	1544	4210	10255	26228	4603	5894	79847	3820	23345	596	25777	23224	6783	9686	3983	55930	10962	60494	9275	5789	9811	22934	11083	8034	10384	23178	23157	1359	51031	4632	9717	1058	4208	8028	26057	10044	10849	1857	65108	57191	9885	25763	947	54808	399	1445	9267	57093	2323	10898	55784	5676	55795	80094	5920	389898	11126	5116	5727	51301	23767	23040	3105	8519	23370	7046	54661	440515	7874	54847	26762	57007	6712	6490	386627	79958	2672	11016	81797	10664	6843	6262	10866	79961	6402	2643	11082	7294	54807	51299	29065	55148	971	8292	740	9047	3954	30009	80086	4684	7102	1143	9887	2215	6189	55636	8506	22884	22974	83481	8743	3062	10317	9870	56252	2938	1487	11262	3811	4925	6398	9472	55038	10106	3619	57336	81558	8295	26664	5144	54540	6978	2911	4214	7554	55337	10581	3702	2020	55810	79820	23057	22844	9463	3852	26056	5137	2520	1551	92249	3823	59344	29922	51438	11055
GSE3982_DC_VS_TH1_UP	M5481		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1800_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) versus Th1 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					1497	6451	1186	3120	4234	3758	1675	51296	7045	214	950	6778	9103	10653	8451	8727	948	301	8682	1200	56034	29903	825	92	64087	6886	2268	7414	136	64761	79086	79745	7039	55245	22808	8195	64221	79573	6733	9588	6009	7711	59342	1043	200424	7251	22902	822	599	8942	5973	5328	4880	9899	10462	3625	727	11138	55803	89853	56674	1378	54925	216	7464	6539	8644	29125	3606	10327	55788	5660	23471	200734	51816	644	54494	2359	54622	604	8522	4070	55701	55603	5858	7097	79903	80099	10461	7812	2776	23401	27244	339290	10491	4850	1116	27072	5361	5184	2321	79630	23129	2642	57406	912	51760	51271	26577	55332	11000	25849	4091	5106	91754	8993	23161	51092	79949	2055	7056	1514	4128	8780	728	26509	2817	1594	92689	55240	29992	54209	51172	8309	58511	3241	5151	79443	83696	3455	23014	55654	4856	1520	1523	2660	9209	6361	408	5747	9462	80896	712	8654	23491	6583	2875	23654	131544	374354	2637	9306	10261	11027	7267	10634	79852	8356	1774	10577	9312	9578	6400	2036	5730	4066	4735	55144	2213	290	4794	1787	25900	1824	23355	10479	1476	79762	2205	91752	26119	10457	6688	5624	1528	64114	5997	83440	28984	949
GSE3982_DC_VS_TH1_DN	M5482		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1800_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) versus Th1 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					5901	9781	79649	6385	1768	56252	4802	25804	3219	6351	9232	10044	10291	1359	55930	332	6166	51388	8394	7298	23516	5383	55750	7465	55765	27291	55702	2672	64065	1063	10714	7701	2572	9787	50515	2194	4686	6843	3749	8861	51666	28755	80135	79927	9143	1123	8970	6429	83450	3149	306	9489	6935	8479	29028	57596	84296	8614	8837	79669	22824	23082	79710	57604	7291	3276	54997	57405	79070	6240	8563	5757	3035	26051	596	24140	55872	9760	64061	55432	53918	8728	7421	1244	26071	1390	8809	10963	81558	11262	9133	4678	3559	57171	1981	390940	11116	740	3306	4084	81888	8418	5625	1437	10962	5293	5393	914	2553	6885	55033	1741	10616	29087	23157	79847	4792	79632	3902	4843	55840	83700	79869	6713	7163	7027	55110	11004	29851	64754	5366	55038	1352	3182	60489	54942	6634	55898	9076	23234	11009	1839	3458	699	10664	10124	4602	1316	11198	51562	54441	60468	7293	9228	20	9235	2739	23178	6790	9526	8880	29117	10752	2643	5144	10135	55278	56943	53919	79621	51744	200081	10721	3954	54496	5981	22934	27339	94081	1111	8208	55055	54674	7473	4998	55148	3037	23208	1058	5864	1540	27251	5827	3161	7124	5434	81606	142	84525	6398
GSE3982_DC_VS_TH2_UP	M5484		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1801_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of dendritic cells (DC) versus Th2 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					1512	3117	22808	3728	23023	1318	81631	7054	693207	3101	3120	7045	6272	23129	3122	4600	637	6750	9569	5836	2517	1160	301	948	444	8780	140467	50856	55196	26030	6367	80219	4880	10483	1026	23014	671	51363	5973	64221	4070	23042	2642	51271	214	4091	4072	25963	29992	27244	6097	23255	5184	63877	8572	55049	7414	51606	7056	9429	253982	9842	80019	9588	9706	2509	4145	8349	28232	25849	58504	2495	7586	220965	1594	7855	79724	1471	3290	9308	50	7097	8848	5306	3455	9586	10409	4125	728	6400	22884	1611	1186	8334	58513	303	55799	9717	23645	4794	56606	5747	51734	5619	290	9902	54800	51309	9056	79762	2022	6678	131544	1116	7187	5151	26020	2978	683	945	30835	912	5660	79654	29106	6886	5252	6584	90956	9367	5806	7088	79152	3112	10636	5336	406	1522	2992	51313	5125	353514	5742	27242	56940	9103	79755	56833	4066	2852	114548	5361	4005	51296	246	133	55652	23382	54504	7145	280658	80853	2055	8507	4905	5858	1824	23161	3077	949	6253	84193	9516	11027	7766	2819	1048	8993	79746	8309	81501	23220	5997	9831	9306	6320	4286	7204	10462	1146	1730	29903	55144	5265	64506	55711	10479	64114	1200	1728
GSE3982_DC_VS_TH2_DN	M5486		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1801_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of dendritic cells (DC) versus Th2 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					5901	23224	332	3219	5683	7322	29028	60468	6166	4686	51715	596	23176	7277	9232	1063	9435	28998	60489	6935	1143	3035	23516	8479	94081	23046	6128	890	9152	55795	6634	57570	6712	24140	10198	55148	5743	10664	4860	11339	11262	23632	10525	4151	22894	5144	4602	9787	8809	79649	53919	56676	2909	5393	51020	2591	5270	57493	56992	356	55320	1741	914	8835	286527	1981	6119	347902	57820	64960	79939	79023	29902	54997	6240	54148	29896	9133	55841	4678	23178	79070	394	64061	81558	57405	7033	9459	55713	84159	11004	22934	55750	79770	57171	10671	9319	23234	7291	84296	9141	22829	7298	23528	64065	10721	399	4664	10455	6885	10432	29899	5984	5889	55005	65108	740	23506	28755	79683	28977	9738	51023	29851	3161	26228	51299	3185	11009	3683	11198	8886	10663	3182	10291	7701	53616	55353	27251	2977	8651	7060	26229	54806	8970	64785	3598	5983	8390	22976	1829	2928	23195	14	79370	971	6781	7163	7027	55254	29123	54441	55237	5366	11037	4907	22994	6711	55278	10256	54556	1352	55723	27075	1562	4998	349152	9824	2625	7175	5757	6262	10112	55839	6351	51031	7520	7001	6399	285830	1877	55215	2553	8407	5704	10024	8237	9645	3932	22929
GSE3982_MAC_VS_NEUTROPHIL_UP	M5491		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1802_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages versus neutrophils.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					79882	23175	55148	2963	10653	7965	5707	55109	50650	55256	339044	3066	399491	9686	5601	8531	27440	23078	5763	221154	85458	54953	84747	4913	9147	23174	5832	5195	8607	3617	2022	3094	182	3336	102	56945	8634	2768	439	6625	23361	56986	56993	6574	4718	9908	23172	2517	80227	84934	8605	5116	14	890	5321	55247	54943	57470	89845	6659	64087	1435	4313	9532	57707	80789	6185	51187	23418	5563	5523	5110	2287	9924	9367	78990	4642	10381	6182	64771	9603	6240	51752	81566	23102	25966	80176	1515	8027	1434	51117	2971	57060	27095	79068	5747	9521	2254	79135	644068	4148	10273	7756	7738	1465	55274	54919	488	10768	23014	3149	5917	3667	97	5828	8131	25974	8879	9859	7153	865	7174	8974	9232	64848	9655	8714	23518	6132	8453	4646	9980	5510	8692	6367	6692	1777	4070	158	1429	100	30968	1650	55015	7798	6374	25821	29922	30001	163	84864	65110	51491	26155	6618	2767	6832	23483	5203	199870	3396	9631	79101	1376	23475	2350	3290	54765	8528	4702	26586	9061	9128	23	9689	968	127703	55153	175	64418	26521	2184	283537	7494	5315	79019	81533	10827	5604	5901	54681	2109	6001	64981	91445	6647	5428	55848	115123
GSE3982_MAC_VS_NEUTROPHIL_DN	M5492		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1802_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages versus neutrophils.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					100505741	23213	5058	92482	55969	176	23162	151050	10057	1524	3700	4068	9208	219699	27334	3444	482	5678	1152	3046	3605	366	23761	6640	7022	25984	51710	9111	2891	1936	9573	26531	6781	4140	26574	100287927	54432	8115	3455	90522	6891	2309	5793	51755	79603	6663	11177	25888	369	79668	9938	84124	54210	29946	2495	6538	963	54507	57369	10603	1089	317	2138	29956	30008	11120	6677	6327	1394	2783	50619	22870	1032	8174	56001	79888	10106	160313	60	23224	4045	80329	3669	55167	7128	319	11181	652147	5538	1311	11143	53944	6286	100287387	4650	114548	130	1129	57162	23258	58190	8578	7703	23370	10614	11040	2932	4899	10096	23074	64236	23613	60313	10093	23405	27230	11119	23253	100129973	85021	23369	563	9665	23523	54997	23406	79616	55568	6397	54112	571	59272	64319	546	26097	9138	3726	5926	2672	5062	7321	10025	2776	8045	22879	23026	1602	55790	55423	54930	51279	5724	1871	4680	57658	54221	9016	22843	9348	8698	6336	23287	5660	222487	56605	10154	2130	55301	79906	5105	3442	81603	3556	9881	5020	7350	3805	57612	54809	79887	2826	1844	8675	10044	5004	9900	9710	27232	55657	5075	26584	83604	54545	1101	329	51513	54932	4067	50943	3837
GSE3982_MAC_VS_BCELL_UP	M5494		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1803_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages versus B cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					8416	2289	8714	23233	667	3417	4778	10768	8974	1781	4712	166647	23328	10312	1497	11113	127703	23788	9956	4646	64377	83660	79639	1827	81623	25937	4940	5717	3624	1678	8766	113878	5328	5523	2820	978	26034	157	10332	2273	2588	26499	5950	51762	56271	411	23710	63928	4026	6744	53	8566	7153	23475	55092	944	5446	2556	114548	23659	1808	3910	4354	1345	6921	4504	85458	7099	6556	23534	55751	7855	5090	10723	8819	27436	79698	6009	54210	1389	4070	1495	83937	163486	54843	3790	6447	205	649	8266	5583	9308	10544	8650	6279	9741	2517	56125	3303	604	5291	8578	8031	55247	1594	1026	26330	10618	4651	80176	9061	6583	874	3838	10903	3779	3240	57178	57706	5141	4240	2928	1390	26637	54968	5879	199870	64748	2309	10007	2651	9645	5783	3188	2219	26059	128	1464	23541	54813	8013	9749	2321	1543	51213	64499	2819	3604	48	55346	10395	1795	4291	30001	3516	10927	58472	54621	54478	55144	6888	1347	1622	8935	6036	79154	8528	27125	51097	51347	10079	942	10955	55911	9568	81839	23191	55143	1783	3627	2710	253982	1849	5663	55907	4314	7798	6809	55969	1124	9462	54769	2673	2052	11332	4952	4615	8061	124222	5361
GSE3982_MAC_VS_BCELL_DN	M5495		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1803_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages versus B cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					81887	51004	25888	10025	9815	283232	79979	79829	80781	2957	54880	10401	5428	3514	8916	8515	5591	5198	10949	57062	30845	23157	9802	65244	54881	54540	4678	10681	10420	150244	55512	6399	7349	11132	26285	10207	50619	10166	114932	971	6000	10188	6091	9031	330	100289420	23140	23345	100129250	6136	9860	7403	54946	7334	7318	2185	9143	7259	5796	5380	26031	5387	55906	6328	79713	55790	55746	10807	57613	5379	3493	81618	79958	84939	56948	4899	4211	63935	63934	23338	54704	5894	2027	55063	3087	23505	55559	3385	10699	1877	286527	81030	4214	10866	4867	54938	3115	2134	3601	25865	7593	11329	2853	9348	1875	3112	837	229	6235	10296	2043	23131	28387	10478	80279	1387	9834	23107	80342	220972	53345	8626	9755	58500	6206	64763	144699	9684	81875	54900	80230	6124	5720	3875	23418	203069	833	11086	5464	54386	3757	8395	4676	25825	8906	352961	9399	3298	3507	3543	10929	22869	4799	473	23332	55103	6599	56902	5252	54737	728661	10346	4850	1487	22861	6418	2731	22843	6143	115123	730101	80853	23352	55146	84900	9674	100289053	1936	1960	1120	79686	9214	6278	1859	6304	57369	4144	23550	10667	4939	9794	3921	7430	10921	9779	9938	8519	5636	6170	23229
GSE3982_MAC_VS_BASOPHIL_UP	M5496		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1804_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages versus basophils.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					5950	54438	54928	85458	3614	7133	6252	2052	2580	4967	23386	26135	54542	3707	1650	26499	2181	8815	3032	26580	831	80176	2215	7059	271	2219	56938	1629	84561	54810	8417	5321	3572	7016	23034	6447	6051	26330	4145	677	2123	8528	3667	1515	1795	51073	7046	27440	9149	1535	10161	9522	427	29982	10539	10452	6448	2119	27179	23263	29122	3642	790	63875	10592	79077	1520	9398	4677	10857	80344	8291	1368	55741	4125	4552	1164	7280	3417	23166	5523	1762	4698	9868	7321	5781	7345	8804	11147	11015	2555	6199	51318	6391	9166	51575	2023	51495	4289	1010	5467	1300	9749	5106	10105	8842	7408	2628	57212	9415	8714	22856	132	23065	186	8915	1657	753	8912	22875	51092	6539	8776	4649	253959	9808	9530	1464	360	10961	25895	9056	9807	5979	10721	8266	116	2934	8491	57818	55655	81848	2077	8848	3842	51228	100506190	2321	51499	794	9334	8763	4641	79675	57758	10312	5770	8439	58529	89944	65979	4055	8669	2767	9980	4644	8634	11131	9839	51566	9647	93210	112479	6322	3732	55280	25998	8891	2673	2948	1070	26009	6747	23464	10286	8803	4973	7187	5681	1806	5424	283459	5351	5606	266655	10678	79781	4285	4702	5501
GSE3982_MAC_VS_BASOPHIL_DN	M5498		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1804_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages versus basophils.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					6399	5366	777	23046	10641	283232	10451	1524	79668	55339	3702	55421	4050	79843	10614	5148	8227	27023	84908	80254	80230	55056	56259	3005	5771	54809	26034	51433	27295	81631	79608	57154	7414	23236	56997	6125	10397	3669	10992	222161	55512	55196	905	7093	2131	11255	8115	54880	29943	493	9814	6136	23240	57162	11064	51314	1417	60489	27284	29909	585	9289	9086	56101	57215	55082	51192	79946	3720	23434	51078	3305	9881	27102	51174	5309	1022	51279	6165	81698	959	3363	347088	78994	51765	5380	64174	100129250	26707	29080	7978	6194	11180	28639	51710	7322	4689	634	26065	7873	4595	1414	5993	7730	26234	10051	4781	6139	51526	329	83752	79571	8405	9887	5252	26051	9185	9618	121006	81626	286527	6428	29914	23287	55423	55000	51691	552889	57035	55028	10193	6205	1995	4957	54900	103	10270	55146	7403	162427	5788	10181	1604	6729	54807	94081	51076	5564	9016	3050	9363	375056	3001	10209	2134	57157	1000	80853	10129	203510	6770	445347	4068	6286	3975	3855	8273	388969	81544	837	28990	54556	220972	51422	10106	571	11236	1432	56994	9958	90864	92211	6259	80345	4094	23405	50853	10388	9716	2549	79716	7424	2322	8717	4666	4602	54987	2114	2592	80279
GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_UP	M5503		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1805_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages versus effector memory CD4 [GeneID=920] T cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					4778	1186	22921	10981	51421	65265	6518	7385	55364	6767	2773	6051	29994	1435	58488	1164	912	4702	1497	1512	308	4259	26521	6355	10768	8714	55109	753	23474	3005	10007	8566	55281	8030	7461	3315	10440	5168	28966	10313	10955	5424	26330	55691	2588	10468	56943	2517	59342	4976	9569	9655	6509	64976	51400	79745	26060	51393	5090	1795	55172	4037	23065	6812	5467	79789	29088	4717	5357	303	55727	8751	7813	5624	7170	10154	51118	6390	9308	9240	4900	1622	81853	598	1193	2647	1296	718	4719	9107	51094	23396	54852	516	8564	84561	571	8417	51715	149111	23761	9185	25797	2037	2628	51566	28985	5328	4729	4199	4238	3687	7106	51603	221692	2935	9873	9524	26175	5440	7415	6303	23788	672	4258	11027	53346	522	3832	5321	2852	390502	80183	9871	64223	79682	1808	7204	10935	2526	23428	55852	11147	23475	5291	51650	7296	8301	50856	91752	6367	8605	10105	48	23457	6819	1329	65986	3597	5704	6279	7321	6533	3778	5523	84658	6400	7855	51030	214	6461	253982	3490	5663	5151	7324	6921	79624	29927	50865	2055	537	10165	53829	91860	11014	55803	80221	9837	29956	1876	55216	123803	51309	10308	4700	166647	26355	290	6386
GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_DN	M5504		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1805_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages versus effector memory CD4 [GeneID=920] T cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					2734	3982	23345	23046	283232	11181	10846	643854	3298	2100	3889	3219	1969	56344	30008	7561	10401	23177	6942	7093	81926	23014	84809	3305	6296	22920	22891	3782	3808	5566	6165	57523	100129128	79935	79672	81887	25858	56311	84525	1586	2925	29931	3350	23162	23600	7026	26150	9573	6462	2027	1385	4544	1660	3275	10329	7738	23213	79788	3150	286527	10142	81543	100506699	57326	5961	26747	54880	758	26133	150726	1129	8406	8087	10616	55801	57119	26031	6124	3458	55113	51806	6161	6429	25865	10525	29098	10847	7978	2534	4991	4163	10902	23275	54946	64763	1877	29064	4649	83752	579	54212	10206	89853	6677	6530	339044	56172	54433	23178	3631	7166	8048	6194	50619	5387	6373	56997	4583	140801	5142	4660	3004	11120	50717	7430	81873	4122	54941	3775	11243	2323	79156	633	8668	3972	23264	9416	79832	10397	5189	5798	1493	79668	4855	58155	952	959	3428	23360	4045	8273	7049	11062	100293871	5089	472	10663	5075	765	5273	25970	7818	80310	1591	2908	10188	3662	64577	55249	1154	9632	79009	1008	4170	7541	27293	22989	1995	10138	9348	4058	26030	100287600	8711	1584	389177	29091	8807	23259	23062	11186	55000	11262	9399	203069	4209	26716	11190	228	1629
GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_UP	M5506		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1806_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages versus central memory CD4 [GeneID=920] T cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					23071	2581	6252	2180	4145	54210	9308	978	516	7083	27258	11332	6447	4070	138151	51313	55969	7416	8266	2181	1192	1066	54407	1368	4501	5683	29088	1351	719	3417	55505	3758	1520	5066	5328	6400	6241	3832	23095	58472	23475	6923	10440	1973	8335	2952	6812	79651	571	2517	8566	203068	334	4860	64976	83442	10859	4729	1119	26521	6184	3675	3927	55062	1435	83449	1376	8061	3712	25874	51092	6050	23788	11337	51304	4644	1019	262	1043	51393	9859	11154	8843	10682	5718	10539	7296	1512	4998	55244	2821	55803	2029	2052	5538	6374	55852	3315	79682	6809	2213	9976	23122	9870	53	10797	140885	2099	51816	9817	6659	84790	55556	8848	25797	8301	2647	9768	23074	8601	22881	2768	51115	1075	55751	23191	5624	2067	6747	23659	4199	285203	1164	64231	51659	53346	7415	29937	84658	9551	26577	27010	3295	26499	4067	5291	81853	4012	64343	3624	5973	1050	5577	1147	51330	10049	79901	7979	29015	53826	929	54504	5693	55697	27173	3115	3903	55839	51399	81545	10935	81691	10768	1595	3687	57003	221749	50814	51651	8930	537	10398	23646	11079	25941	55701	1102	23428	123803	23075	27235	7033	7421	48	79639	8819	84981	26355	55109	1892
GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_DN	M5507		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1806_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages versus central memory CD4 [GeneID=920] T cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					7220	3605	23162	8451	26508	3945	629	3219	25873	3106	23178	940	8925	90634	10077	55339	4222	3782	1803	2323	80003	4604	79015	23157	11181	10322	4775	64708	26531	8481	50619	1591	54997	81854	10665	6206	22986	869	100129128	3305	56731	317781	11187	23126	64061	3291	92342	66035	7561	23383	730101	7994	3631	10307	54954	51735	203069	55056	339044	25900	3590	23277	4621	57125	9465	2300	2534	79652	6399	5142	54923	117153	5771	55082	5428	10142	8048	2521	79156	55187	6294	84809	23131	6373	1660	2672	7978	51466	3662	269	100170939	1586	2197	26226	10100	51294	5863	56172	6165	1663	55568	5100	7480	64210	6194	26152	10420	349152	5731	360	1937	55000	10529	27120	582	115703	9016	26036	7105	55119	29991	11120	9110	6129	9819	162427	5727	55037	283683	27334	2556	10320	80279	6124	64816	8611	25896	4045	3587	10296	27005	10188	4839	8874	9857	64425	2956	79958	10166	26354	3660	58500	55790	27238	2648	27300	10215	55063	8995	3105	6580	728661	23774	55001	56969	120526	6218	26999	28234	25865	4088	89853	9881	9489	1039	4676	7334	5583	8405	23499	51275	1316	29914	4300	57212	83752	2882	221078	9086	7327	11040	65258	26048	1527	4801	8446	55722	6955	4913	4058
GSE3982_MAC_VS_NKCELL_UP	M5508		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1807_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages versus NK cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					138151	3417	6518	1781	4289	9185	27436	5223	10749	4258	53	26499	308	375057	59269	701	55907	58504	9308	26577	23475	10857	2213	3945	23659	5168	873	522	10226	55016	51075	79801	5728	29122	11332	10955	5747	1795	3516	3728	2180	2745	8766	55970	4313	6744	2628	6319	55281	491	81533	2037	55748	79682	5996	25937	8030	9768	1737	3162	9962	1193	10154	1329	23507	2495	2167	79695	1296	2710	5328	23161	64222	5467	10935	3161	9555	5867	91752	6038	6256	54471	6386	26060	5376	9859	50865	1368	5092	56675	4074	23743	182	4259	9569	9429	9787	3758	2055	23136	6812	1512	718	80223	7078	303	7107	9775	55177	8226	5329	8566	9530	56521	3115	51203	3916	51365	2588	10461	6769	5291	1497	54852	29015	55048	51118	56271	9712	50810	6004	7266	10165	115207	113146	81570	4066	79901	1435	26580	8650	90411	3759	55701	55143	79135	4711	28984	9553	8974	2787	29982	6367	4644	51133	81491	55757	4712	2241	54918	79074	7421	79828	2171	728	83449	4671	10553	25797	5523	2852	10221	6921	55505	55244	51606	1839	9587	55277	10213	1154	51385	272	54498	79754	27180	8740	4482	54874	7145	2934	1026	27285	7345	64109	55697	1595	23071	1495	84669
GSE3982_MAC_VS_NKCELL_DN	M5509		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1807_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages versus NK cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					3106	80209	10489	9025	5283	2041	10432	29995	9802	55146	54475	50619	3444	23345	6872	10713	4600	8045	9162	339044	79672	79720	1455	2215	22997	4674	166647	26762	9546	6988	493	64779	7903	50809	55512	5116	6775	5375	5789	661	8621	10103	25888	27241	9472	55139	4825	1544	8807	79015	26207	27128	51493	863	23224	4901	4163	10025	64789	643641	219699	343990	146754	335	26230	23383	63876	3298	51050	6857	27079	4783	6013	8273	3587	3050	10616	629	3035	7448	220972	54507	2844	1629	23338	26531	59344	7424	29909	5613	9143	10307	7414	51078	1469	358	2000	4829	4118	1877	55351	80724	57335	8028	10982	7458	399491	7091	79888	288	58190	3736	23026	11245	56270	84695	728661	57658	147172	51761	29931	60313	3385	10047	9184	740	10848	10641	9786	1955	5422	10166	54212	8913	1559	11236	347853	56114	7089	919	29091	2071	80778	183	2938	352961	53345	81577	10069	92249	5533	3707	57493	5288	4957	64067	4584	4678	29799	5126	55722	9860	1138	10664	976	51301	11132	10781	2786	80342	23157	4824	6168	3004	55147	23623	64175	81030	7110	55113	79652	3846	4781	3054	2549	8608	54020	8729	3804	100288594	64755	25837	1952	11167	4902	84720	221981	221830	51411	56905
GSE3982_MAC_VS_TH1_UP	M5510		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1808_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages versus Th1 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					2022	9655	23051	5678	79443	79864	5594	2495	54432	1186	3240	23328	2219	10955	7280	53829	2350	59342	6655	1512	8416	83478	58472	23309	6009	9185	4646	1497	23531	334	64895	4313	160824	79627	10206	9398	4287	2581	57447	2916	55211	2875	10253	2776	1787	56674	221692	5291	57105	2124	25895	51170	25796	7414	9647	51172	55364	2215	1050	905	4070	28984	220972	90634	6539	8776	219333	55589	57665	1671	114882	2309	5624	23191	23491	23258	96610	23034	6252	9462	25937	5328	29957	55086	27010	5264	11257	2055	285203	5467	4035	9905	26118	5361	55625	9338	5654	54878	219595	1176	54542	51397	6518	7913	83660	5376	5003	2628	8804	1193	26175	55350	2070	3568	3685	9043	929	23161	4610	9454	112479	163486	6303	10451	9859	3758	10493	27342	6988	6355	55703	6392	79666	51075	55556	8601	51014	968	10127	93487	54800	8773	51063	8309	7099	54951	6447	687	4055	64446	131408	80230	192670	51030	55970	25801	7132	23095	50863	8876	9980	80205	3439	27244	114112	3687	51092	80301	3232	51339	3690	221749	56255	6036	9828	23075	4778	3162	79091	137886	54494	27032	23167	55654	9575	25874	3454	7321	307	57089	116985	92017	64746	55332	1636	4065	7846	51652	8832
GSE3982_MAC_VS_TH1_DN	M5511		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1808_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages versus Th1 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					9055	2150	51744	10950	9735	54503	6240	64092	3298	55290	6891	54880	4802	23240	8891	332	55220	2521	8394	11040	5366	919	6628	5165	1768	9493	29777	2983	57602	10935	55723	53944	54529	54704	9716	5832	3702	3145	50619	8872	9590	9274	857	3800	1434	80335	6047	100129128	22856	2713	541578	7083	89941	661	7072	9631	7307	11014	940	55510	51203	6627	9701	3736	54892	3775	64167	7516	1265	55716	3421	128872	5827	3362	5438	79713	9477	11011	6561	8914	10714	9592	84296	3586	1192	27102	652147	6431	9991	2968	60560	2068	28755	11266	5544	54882	4628	55695	2957	203068	10044	11180	5511	2649	10664	10211	3669	3161	6165	3430	6729	6877	7430	2079	5533	10641	2821	3007	54487	3925	5154	1606	51379	4050	3004	9143	55055	63967	2712	6580	22994	7266	79958	54900	51026	6432	10616	3290	79895	8553	403	684	4088	9669	9093	343	22821	55870	8515	3306	8884	5504	1039	6746	2121	7799	4957	63943	2572	56938	9399	26034	7264	260294	78994	9595	7029	55038	7188	8678	4998	94081	64065	23015	8140	5050	30827	6626	9128	22997	8880	765	7036	4793	79686	284	6135	10084	10712	9630	8726	1762	7709	51430	8479	60314	1992	9600	9088	55801
GSE3982_MAC_VS_TH2_UP	M5513		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1809_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of macrophages versus Th2 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					5973	9609	2052	22875	7414	80317	10159	7855	8714	10758	6447	2022	3240	51170	2119	26499	3032	29946	81631	3730	23166	58504	5879	8843	2651	29978	1464	51014	1512	53	3709	7107	54504	6281	55743	64174	23174	1084	4189	29982	26872	26959	10285	57447	113791	89853	54800	830	6655	7345	2219	55281	6038	9367	8500	2517	3964	51281	2628	3624	137886	6750	2167	5747	9569	219333	4891	831	1193	10451	5547	3196	1795	51084	9896	79666	32	55691	64343	54432	4646	2804	57151	224	9655	64844	64778	6367	3437	2581	7248	56675	2272	388714	48	8644	80019	7078	303	53335	1657	9043	4600	8649	55244	1133	9741	5291	23140	1787	5495	10933	23161	253959	51422	5029	29957	23221	58189	80853	55969	5516	5624	59340	10007	972	7321	7204	1026	8309	9779	11043	81545	9754	3123	54210	55745	55765	123803	4125	2330	718	9575	26750	2764	55211	8050	5663	2055	290	54462	1020	5361	55327	8915	7106	56180	55614	5594	23639	55556	8832	80321	472	55827	58511	9653	4669	124044	6556	9185	10253	9056	9956	1959	8632	9513	23357	23531	9061	1124	51622	9034	3842	1186	9672	23075	3490	5376	55048	11027	9528	9462	10023	8935	54360	3099	6814	347902
GSE3982_MAC_VS_TH2_DN	M5514		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1809_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of macrophages versus Th2 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					1265	55746	79713	10432	6240	128872	54862	4913	330	919	23015	317781	890	64097	9711	23046	343	8608	56992	6165	9493	3669	823	1606	55775	23240	10847	8891	6866	50619	64149	11222	8872	7430	55116	203068	79958	8395	1739	79077	6603	2648	6135	7556	7919	23157	11056	1163	753	2006	51611	6504	5432	8607	3846	54881	23224	865	3426	23252	9489	100	81887	7514	10120	29028	10009	9862	10726	64425	51318	2068	166647	29080	8515	23197	6434	9631	1660	7709	6470	51805	5600	11180	11132	2027	10352	25890	79023	5982	291	9532	5717	3823	9055	5438	23332	54910	60560	54475	54798	3800	64789	9918	51294	1803	89941	2709	5893	22997	2859	3161	60489	5705	8668	7122	3444	9289	11284	9143	11186	54503	26228	6150	23521	1039	7517	229	6633	51762	11103	3805	7264	445347	9701	84296	939	4222	51430	79054	79073	9477	4583	60468	9704	10291	11083	64777	55510	4968	6649	26999	4152	332	2958	23002	4899	27341	10211	10598	3067	55260	55620	1543	4172	4998	8140	2591	10531	85021	54995	7372	11262	6691	349152	79169	3212	758	5453	9760	7818	974	55695	55139	56915	3615	2563	5379	55657	386627	5901	6427	7036	55723	5008	995	7716	29970	2249	4686
GSE3982_NEUTROPHIL_VS_BCELL_UP	M5515		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1810_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of neutrophils versus B cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					219699	3985	10312	51077	2114	30001	5266	6533	6750	641339	10858	23217	3433	23620	4068	11026	4650	25984	10096	4289	2891	5197	6304	55859	53340	51213	3383	7706	644	22879	10154	8778	306	2710	79960	9595	602	6372	10397	5829	3101	6891	944	10316	10110	80162	2850	710	3099	55203	10955	1469	27128	3613	4898	79180	3614	91851	25945	717	79989	5209	23099	116496	127544	8315	79089	23102	5927	619505	5897	2150	8530	53836	10435	10568	7879	5023	9807	80329	6398	8553	339287	23608	3105	5899	54491	9586	2588	51279	27036	55539	8519	54466	2158	10092	2355	6781	79616	9600	6390	3440	5966	404093	26253	9528	5672	90362	4739	479	3202	3848	25858	51094	8529	53820	6376	131566	5858	4155	8718	1109	55969	6604	8569	4184	51155	8061	462	10057	6926	4680	9050	669	29063	64386	80344	92154	59341	9208	3882	26531	6583	5350	9663	9188	10900	10402	54556	113878	57828	10105	54432	526	5328	9989	5678	2932	2162	2556	51291	10409	4835	51307	11057	8876	23617	8650	8326	4016	54897	2899	53358	103910	3373	26261	23401	5680	1475	10636	5525	2268	22871	50856	3046	56001	6404	9609	5588	387535	7791	5307	9848	3074	81631	10586	204851	9170	51363	23214
GSE3982_NEUTROPHIL_VS_BCELL_DN	M5521		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1810_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of neutrophils versus B cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					25996	9168	56259	5917	23175	6217	51265	55256	51075	1901	148229	23521	3094	51433	9711	9686	56986	8665	304	4259	79842	100129361	9491	23062	80765	51163	23518	6659	7965	3932	3838	5901	79829	5116	9639	64083	231	8165	1429	55148	140801	8395	4609	23344	9532	10520	27440	90956	51318	30968	4338	8893	55153	9908	330	53615	79882	25966	9690	90634	3108	7188	587	64976	8731	27339	400506	29103	10282	55103	25974	27247	5257	26060	9734	4799	51283	7283	8131	9221	2200	10038	14	4904	27109	26018	26228	63894	63978	5993	5827	51752	23269	23637	55006	6133	6132	4714	81929	1350	51096	3662	9466	57559	9317	56984	55893	57099	8464	6185	1633	54	10681	2592	3376	7625	6897	7541	57130	10657	6228	7385	10856	6160	4860	2243	4216	7349	6760	5192	5902	49856	5478	57060	5368	6161	1798	1487	1677	51493	2348	3065	6191	84939	1937	23623	5203	55718	5383	10898	6137	2264	883	51596	55450	8940	3073	6232	100289420	6741	79833	3109	6165	1719	23560	113251	27079	5436	26015	23505	25932	6222	9659	201134	8934	26091	9143	6240	5955	5796	971	8270	63875	10061	84908	942	8565	2802	1528	10072	6675	339044	388650	204	11052	6223	26355	23568	23495	8574
GSE3982_NEUTROPHIL_VS_BASOPHIL_UP	M5524		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1811_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of neutrophils versus basophils.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					10110	26476	9223	55111	10312	9208	3641	440895	2268	11143	3283	100129250	11177	22898	55175	79651	79056	8531	5611	89944	79836	51751	84059	10044	816	5209	3985	1108	55663	5500	1723	9054	79935	81848	306	65260	57447	6398	29911	8974	27304	1584	3356	5971	50838	10548	8552	23263	3613	482	728683	1535	51094	10555	8915	9710	9990	51380	5423	25796	525	51293	25984	27128	6588	3227	387	54442	3614	339287	79865	51754	25888	2077	131408	1490	4170	11026	11343	80183	7916	5576	6574	2204	79940	8895	8912	4644	1101	8837	23036	27071	1105	23354	4026	9926	6322	1089	10938	462	64111	51294	388714	5217	80162	51	11252	23099	3267	64218	467	90627	387535	5819	22822	6583	2495	64421	9567	23185	27019	55113	55466	5606	56920	26539	7125	9389	978	55142	87	604	1874	3586	10435	9043	28232	2804	8541	1844	10365	25847	5518	81577	100288594	80216	55313	192670	127703	3764	8671	2634	8061	729580	10824	221692	9169	79665	167	10825	23586	79083	124583	4050	124801	4117	286451	9818	79789	5979	5638	55	26043	168544	80760	26034	7376	79183	26037	54930	29982	81688	9536	55161	6283	5816	51807	23066	51291	53916	25907	5782	4641	8650	417	6199	10418	79989	55267	23383
GSE3982_NEUTROPHIL_VS_BASOPHIL_DN	M5525		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1811_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of neutrophils versus basophils.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					90634	1901	10512	23518	5428	3559	8925	64708	51184	51714	301	466	6832	79573	56994	11017	79745	91353	4259	9317	11064	4609	5713	506	5917	23172	23193	6917	151050	26353	8970	9204	57707	120	23269	1845	5090	1657	55763	23613	7385	9255	892	9617	84864	2091	27241	55157	10728	9686	54765	5984	23521	5148	11145	4860	55172	100129361	2323	5780	65981	9451	6259	25825	553115	3702	7739	5800	27252	6636	3094	8553	4698	23531	5707	7283	23122	56259	8153	1808	3082	11321	7021	81627	1915	5884	26057	55163	4150	54955	6431	6760	23335	79075	175	23252	90	26135	9168	79023	55719	6281	3688	81537	734	10982	23048	6728	27339	3205	7172	79902	4904	51136	55625	64864	29087	7314	89845	57215	6185	6938	55364	8555	23014	162427	8539	347088	50650	5436	51663	3376	2729	1429	8273	51082	7514	79068	3512	11266	28955	2530	10988	84934	27247	79871	55832	6741	708	400	905	28990	5478	695	959	79017	2203	2230	38	6233	55006	10383	55769	23434	23360	158	10072	79568	64848	9039	5635	5050	6897	5383	10171	5026	2887	23568	28639	4216	9924	10388	4338	8453	8655	6647	4706	2925	2971	9158	27032	6009	10884	6124	64427	60467	26155	10051	6734	6675
GSE3982_NEUTROPHIL_VS_EFF_MEMORY_CD4_TCELL_UP	M5526		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1812_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of neutrophils versus effector memory CD4 [GeneID=920] T cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					7263	10955	11252	26133	10614	2326	2309	57162	5209	9658	9208	6386	100129250	7879	6533	9815	23071	2787	23023	4835	1445	240	54930	2123	7090	57826	80705	4650	5976	4289	4543	3985	7132	2932	27128	604	8291	2355	2588	5447	6416	6430	1176	55	55589	10025	54809	7791	54788	23625	79411	5008	9528	3726	8648	23258	672	23604	830	79663	8529	10603	3659	10616	5894	3687	10367	1050	222487	23569	65258	10333	7251	23074	10385	1212	9934	80183	2204	5594	602	5547	57556	7940	3614	23462	5359	64411	4005	6604	55064	23406	25865	9107	5791	5914	514	84243	5500	54708	22898	26578	11177	2131	4082	2633	677	4097	55758	84124	23223	55113	54432	2209	1627	8794	4084	79651	2776	51755	619505	5423	55231	27071	7752	4800	51307	9595	978	3105	6398	55851	91860	10379	10981	5899	29108	8694	9673	2512	30817	114548	8239	200315	9358	80737	10308	5062	9990	29956	1263	1084	64121	1105	4815	55911	51706	1912	100287387	9050	4170	79940	10487	58528	3385	6272	54877	93129	1998	27284	3459	11275	4914	55691	12	9636	81565	55350	9732	23645	4664	4898	283131	28232	114882	10312	51465	6580	4547	9895	53346	527	63940	78994	10475	140885	23214	5266	124583	8677
GSE3982_NEUTROPHIL_VS_EFF_MEMORY_CD4_TCELL_DN	M5527		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1812_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of neutrophils versus effector memory CD4 [GeneID=920] T cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					1901	6217	51265	79882	23521	6872	8165	144404	5901	3559	890	8464	23178	10606	115703	54980	51433	3600	80227	51184	6636	64864	1781	26009	10273	3113	2946	84525	1571	3062	29121	51096	22880	55893	79788	9686	63897	6741	23142	4144	5436	81926	23354	9788	8763	1915	7268	7625	55187	1238	64976	8815	8891	1788	1465	79573	51156	64710	10781	10368	7514	9425	29960	416	140801	5790	55795	89845	23729	1936	1374	97	26027	905	10734	29092	51691	29948	84159	57147	9415	716	6327	30968	4331	2648	892	54517	10623	1429	100506658	10892	56672	1071	6185	26135	26355	51497	2974	1537	11215	4706	4860	9399	65110	167	10464	55626	55027	5876	1008	5116	814	7428	3458	79075	79643	5498	23534	4150	9617	9317	90956	23272	3796	29044	9994	79068	2098	54900	51092	80862	9631	10982	65981	5800	293	29937	1632	6456	6342	51075	6650	25813	3512	56910	55022	25	9656	916	54344	85294	63877	8574	6189	6812	975	23648	10994	25782	8726	84864	80895	8688	27292	7965	6504	26031	25828	27252	10728	8336	5467	5775	6917	254359	6165	5583	2995	8934	4714	2108	51302	6882	7465	2178	11022	6182	64848	23300	26999	3035	7468	55239	84934	23341	6748	55815	4609	8565
GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_UP	M5528		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1813_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of neutrophils versus central memory CD4 [GeneID=920] T cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					3613	64397	3660	9815	8529	6655	317	51751	6398	3985	6416	22856	306	55113	79778	8531	81603	3105	1050	11252	53918	23023	3614	9262	54930	51291	10435	51720	5064	8358	951	7879	1979	8291	3037	10379	10154	54809	9748	51380	8605	10614	50862	9208	334	51643	9586	5423	8837	5999	4644	5547	101	9567	55589	8648	7263	2633	8477	4097	27019	9111	23097	10859	79651	29982	29994	2783	30817	6722	23569	6692	226	4001	85236	9236	25948	9595	2123	81631	6195	116496	1084	8741	114882	5914	51100	5119	1627	2150	26253	8775	57136	23406	27128	3689	64121	976	55505	84059	5226	2355	1871	290	3107	7403	51195	3043	91860	80005	6397	9658	1675	8705	51094	8452	2647	1316	604	51292	9802	3166	23258	4835	23287	967	79663	9050	140885	5791	391	6533	54877	51706	80776	526	4898	11078	23355	6282	4318	10875	3459	6515	65258	127544	6283	10603	8609	8542	695	10855	23550	58472	29956	7350	1536	7132	23012	80232	27348	3434	7791	8672	5209	27284	3101	9693	11275	10094	79758	7462	7136	55262	8061	28232	3799	23643	10308	7091	3556	3383	1032	902	3934	7127	5728	6590	7752	51296	22898	5494	5525	26037	58528	6934	64135	51507	2512	4800
GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_DN	M5529		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1813_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of neutrophils versus central memory CD4 [GeneID=920] T cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					23518	6217	5713	2041	79643	23333	1901	9668	55216	55746	50650	9788	25996	3959	23474	65981	55893	23019	79762	6182	1512	6504	56910	3094	84720	6636	5917	8892	23014	54517	1571	127703	80895	54014	51497	203068	7514	120	2746	23480	905	26009	8891	26024	23471	10541	2830	11221	5707	90956	51092	55500	4913	51614	471	204	79810	4621	54674	10038	4153	79101	9425	9690	8336	57396	4150	11037	6185	7385	7541	55769	5498	10982	3559	80227	23348	54980	9557	64864	6812	26284	8925	56672	81929	1534	100129361	29990	9255	51663	84747	7072	25788	23137	89845	54521	51163	49856	1632	2592	4706	23169	23061	1123	975	51593	23521	8233	26637	63897	26065	92342	91353	916	9666	55180	26018	2900	81579	8726	7294	4521	6189	55718	23788	2323	4144	3590	79745	23560	80195	55038	5140	892	10623	8731	6228	5832	317781	5324	79864	55064	7174	814	55199	54919	3054	8600	23640	57819	57707	23341	56654	5533	79697	10781	1781	51117	79652	7185	2178	10892	1537	3396	2395	54619	6210	54585	29937	56922	5757	60313	4860	9698	2037	79788	3458	10600	1725	7965	26152	643	23177	6117	5635	525	5901	2729	51499	4223	26155	6647	84830	5160	254359	5583	10723	9076	51520	6352
GSE3982_NEUTROPHIL_VS_NKCELL_UP	M5530		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1814_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of neutrophils versus NK cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					100129250	10365	57162	55	9815	3433	728	1675	6583	8648	240	11033	30817	23761	10096	695	4712	23071	9990	10896	4644	84981	51100	6386	7141	5660	10616	694	8358	6772	63935	6397	10092	2713	200315	23608	6446	9595	9936	23074	5966	4782	5209	272	5322	7251	23250	25865	23275	10379	1112	6503	9673	9922	290	8347	10955	6416	3613	2801	26468	306	10226	6733	55647	4066	51094	619505	2745	80776	114548	10154	102	5359	51294	1318	5537	192670	8897	6282	4189	6388	1627	11237	571	55350	26234	9170	6286	11024	10625	5914	5894	6533	4482	23258	5020	9802	9989	158747	5976	286451	9704	79722	3557	6449	928	2180	4082	10435	2204	4067	199	2533	3207	23118	55113	131408	2209	8837	4994	677	637	3385	9334	8609	8031	3985	80017	6926	23586	4739	2634	26020	8061	50862	51347	79627	54432	79720	55048	2776	1230	2787	80232	51465	5927	53918	80339	22898	4318	101	84124	6688	4709	7136	1048	56267	444	80124	2358	6590	7297	728577	5863	9997	2710	58513	3455	2131	976	6398	55636	6653	3485	10124	65018	829	10487	28232	3142	55969	9625	5002	7706	7323	23476	22856	7421	79753	222487	4084	3107	641339	526	10970	9848	57118	53346	9375
GSE3982_NEUTROPHIL_VS_NKCELL_DN	M5531		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1814_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of neutrophils versus NK cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					23518	51265	58494	1901	29960	64708	5026	4674	892	55157	10606	3559	23335	5954	6240	11017	50650	9690	6238	442216	11186	9631	7965	642	5241	23175	5141	57101	84726	26031	5827	3420	7625	2222	10623	51200	91355	1429	64981	5901	9532	23341	11018	9143	7430	2132	231	5498	6741	6988	9255	8731	7045	3796	8607	273	100129361	971	9823	2297	3376	587	27034	4714	1497	55006	874	55718	55746	5813	55180	79836	63978	8665	304	23534	8165	1999	26073	27247	9466	3355	54765	6342	975	64149	348995	8479	389898	5510	10401	321	79019	28755	1938	64976	23360	63875	890	2672	58516	80344	657	64864	10492	56287	9557	8507	23788	63894	57130	11055	55038	30968	79086	80178	6775	51691	10781	2689	10877	56910	6182	1911	6185	6137	56986	4300	1017	79077	23434	55795	27241	7428	6165	79096	6329	4216	5184	79169	64847	55389	6001	79400	54919	23014	10061	27123	1733	55070	27122	7582	8883	2149	5707	6285	2802	5283	5763	9924	5917	56984	8891	53615	29937	2874	55664	266	162427	57335	3073	2592	4958	56944	4047	6832	146691	4603	54619	29103	6461	57470	2230	7294	9046	1528	2978	6938	23568	11322	64860	55651	9677	221830	3275	55893	10282	57226	3065	84864
GSE3982_NEUTROPHIL_VS_TH1_UP	M5532		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1815_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of neutrophils versus Th1 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					79720	50649	1828	29982	5862	7022	10312	6503	6988	7251	55625	4808	3000	5927	3798	79768	6942	80230	9665	9938	4883	5968	56918	1490	54491	5611	4017	58472	6781	10333	51725	7090	100287387	79960	3614	6398	963	9208	80183	7414	51	10568	55763	55969	2064	25849	23462	7879	22838	9990	64844	3897	9314	7375	9153	54558	2355	2901	10089	5587	65258	6372	54878	10580	8440	55727	5058	81603	5209	29063	4084	23161	6376	3172	26529	84124	27128	23532	84981	3985	9732	55777	334	4482	2572	51411	5594	51291	4140	8840	3554	55793	5362	1277	64386	147172	29994	23769	6286	3202	27230	4053	79637	23761	26538	23026	5880	160824	80232	55208	30817	83452	533	26133	5672	64218	23023	9881	6870	7781	729580	2326	63940	2556	23569	50862	3142	11119	55968	55603	55663	27087	6259	57140	8450	10485	23526	64319	54861	4168	10427	51307	57402	4880	7940	100129250	80310	64236	6322	12	3689	79854	5208	9169	50807	10983	6390	8556	1787	26037	51669	10106	29072	259173	3455	6604	2204	11082	79442	8554	116985	829	8876	25858	2891	3433	79567	54932	317	9934	55806	5894	5328	90522	23552	25984	23527	3745	10896	4170	7323	23287	55262	81857	9389	4598	23390	10625	397	771
GSE3982_NEUTROPHIL_VS_TH1_DN	M5533		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1815_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of neutrophils versus Th1 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					5917	23518	6191	29889	5428	79722	3066	3833	3586	56910	6091	4259	8453	2672	9232	400506	8464	4609	64149	56986	5683	128872	6132	1650	1827	4287	7514	56259	1164	57226	64708	7965	672	80895	79071	29937	8665	25996	1374	4704	1605	1163	3336	55651	5713	5690	79096	54344	5954	80227	1733	1798	865	5685	79864	5383	6832	7336	347	5634	64710	5905	26586	51283	54765	55893	26135	81929	2971	55216	977	57415	22822	3642	975	4216	55278	6726	55146	6717	2305	54517	8726	27440	84934	84617	4953	10844	10456	10494	3073	79159	9333	9521	54806	8940	51096	22880	23172	5050	644068	26009	9183	4012	11321	79866	27341	84939	84823	8165	26018	9690	56672	6001	7465	26031	4345	55247	55319	54487	57707	51388	4702	55226	5195	10944	6119	23178	9686	9143	25896	51071	4691	54867	9891	80176	390940	2926	5876	740	2068	29100	7268	7185	8772	55423	10600	11047	10962	23344	79882	10988	6741	7580	51073	2829	2098	4350	4118	2744	5198	29960	23753	340591	8607	3157	4836	64318	55272	10726	64981	55031	27336	2958	84864	84908	7873	11017	8886	51691	1933	10381	10061	51303	6504	84747	2178	4751	10712	56993	64771	488	25821	55775	11056	80765	54955	3070	23623	51329
GSE3982_NEUTROPHIL_VS_TH2_UP	M5534		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1816_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of neutrophils versus Th2 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					23223	23162	9208	29994	10094	55793	100505741	6583	7414	2203	5594	6769	3433	23224	9815	23620	1780	57151	416	1244	10211	514	79180	9028	10451	23761	23390	11252	1089	5209	83452	23526	23462	84124	22838	10077	27230	317	10096	1735	4140	127544	116496	9517	11255	5968	2123	51	752014	5862	4184	79627	2006	51755	85294	5586	11120	79616	7375	1871	1893	126070	7805	7141	23258	64859	9050	83464	27128	26529	4223	90522	8780	3700	9649	6556	7380	3455	3356	56940	9436	55201	7189	23198	58	57124	5062	1445	12	6372	5880	1050	8760	79668	22864	4880	677	57818	5672	80329	58985	10620	3614	9679	26092	9990	9609	51291	10427	5053	4650	6282	2150	64386	4077	3101	54739	2124	1195	9658	4684	10333	9056	9794	54877	5927	5266	10045	4916	8218	79720	25977	4800	7781	54932	221037	26253	7323	6451	1956	23140	80232	7350	1112	3620	8450	51643	54491	9314	54210	8312	5451	80114	30817	58495	5728	5915	1675	54788	9389	8867	51292	79567	3456	65258	87	482	64174	55799	81857	10124	55258	1602	23569	2572	4053	10616	830	3897	22856	5923	9903	3613	58986	22861	8031	11086	2776	9467	388714	23097	10057	6907	8227	3554	2804	9043	5058	3017	4858
GSE3982_NEUTROPHIL_VS_TH2_DN	M5535		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1816_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of neutrophils versus Th2 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					4502	6504	5917	5763	57226	79882	56259	25996	55116	8726	7748	163	330	3998	317781	4258	5198	55795	8453	8893	23344	8464	25987	7468	78990	4609	23505	55718	466	304	6161	667	79033	10396	64710	11047	5685	53615	9232	7407	57559	6125	29997	23548	3692	6917	51497	672	4345	1429	2027	60468	5954	11332	5905	124222	10728	5116	5498	4619	5026	3150	65110	11017	9143	201134	26009	6431	1657	23531	4718	9686	9054	10541	56984	2946	4150	115353	8395	7385	9557	100506658	8815	51096	4714	6124	8634	9631	79068	51073	1164	9967	3066	51265	26031	57130	7174	3313	57707	9656	26637	9455	84617	55239	11051	23175	442216	79096	9700	85458	347902	9526	57493	10450	23178	54517	6627	22880	387263	5825	26353	10020	5321	10171	55172	55423	5690	64864	56992	3800	83460	5932	2926	6232	9317	10849	10229	1063	587	9425	4216	7919	23269	6636	23169	26521	29044	64318	3073	2954	644068	29121	23341	6119	51691	51065	5600	10988	64976	92342	51283	1827	3835	2491	892	54107	1307	25792	81932	11014	5533	5683	10600	388650	8665	3181	10329	4522	2971	26060	9823	5827	219333	79643	9677	4953	54626	51203	23326	55109	1434	6832	29100	23333	11321	10061	51110	4698	57634	23481
GSE3982_BCELL_VS_BASOPHIL_UP	M5538		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1817_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of B cells versus basophils.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					51004	4678	54920	3609	10329	23550	11145	27079	4702	79574	10732	55146	23062	1455	9308	64600	291	54881	790	8974	3514	2074	9081	27440	1539	28387	4050	204	5538	23386	26093	3394	23255	9788	89944	10528	56920	91316	51540	4634	2688	65123	2555	8611	25903	7706	23367	2189	5379	7133	50628	10681	57506	794	4714	23263	9868	2580	54946	8717	79135	3838	8761	10953	340591	80183	55028	5217	127703	51593	417	23417	6568	2548	57496	5471	55111	1762	5037	271	60468	79701	10216	29122	57194	23229	64421	23457	2869	10061	9451	10233	10162	9258	10973	91782	5827	23052	23334	6406	7753	9641	815	63920	65244	80008	7268	55735	280658	9980	26548	6610	93210	56948	7593	58477	9650	10235	84059	8613	55655	65979	5999	5557	83700	8603	1933	51084	9957	157	2171	26088	3128	9413	8626	971	79183	9214	266655	8225	23277	5533	4507	2055	55175	9717	8495	142	79585	10936	3113	6227	79363	9099	9110	6472	23492	10099	10101	79161	63892	6929	6545	79007	51283	8688	60489	10557	3123	2348	55507	26040	80230	10447	79713	1397	4048	28823	9651	909	8662	50807	10013	100289420	6767	10855	80052	51760	23014	51438	10005	79084	10591	81030	4063	65990	8820	54955	25888	23508
GSE3982_BCELL_VS_BASOPHIL_DN	M5540		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1817_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of B cells versus basophils.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					8600	7314	2114	143	56994	151050	734	8528	5148	10057	10401	8001	55811	2309	51192	26234	10097	25977	54910	51275	8357	26031	56034	23126	978	7414	1843	58488	347733	22950	2517	2752	2215	22898	5077	8530	7310	11255	5525	51314	51279	9948	7099	55332	140885	51411	126	3110	51311	7323	81537	683	64174	4354	10955	3240	57117	51099	23615	10483	4898	651	4068	94081	9741	22871	9528	10313	5707	4155	3005	7803	5090	121006	347853	79843	81631	976	10092	3576	2015	9185	92211	10161	4988	81031	1234	79602	54209	1942	4719	100132923	11031	1997	9050	1000	10647	3720	22844	6744	493	6870	641339	9783	3702	6404	6286	51136	54149	4092	51232	9235	4602	7178	1622	10129	3001	9898	10512	3680	9921	567	6993	6690	54874	9536	51274	9914	10388	3196	51701	9672	8459	5992	25945	1345	7432	9990	55810	2778	8091	482	9446	6785	1471	55625	282997	9770	50515	57144	915	79899	7707	1051	4223	6653	2322	29992	25790	7422	2891	5927	5645	116372	8553	1621	3053	9580	9627	29967	55711	10507	9577	54516	2018	9802	3201	64232	9902	11197	23022	6888	1524	57515	917	928	10140	767	2887	25924	4778	55848	2668	58528	1543	90	6279	56259	8804	9673
GSE3982_BCELL_VS_EFF_MEMORY_CD4_TCELL_UP	M5541		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1818_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of B cells versus effector memory CD4 [GeneID=920] T cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					27235	8778	3108	54920	80008	240	1876	59342	9650	65244	51552	51760	4678	2952	51103	7710	9546	6518	4907	3665	2326	23326	79789	51296	6647	23630	3112	7461	847	6610	3662	23173	3507	4048	25771	5279	203197	7462	10943	3621	3115	3783	10409	8603	55746	54968	2055	7405	9185	80230	29088	64222	9094	6397	3493	10683	10576	9553	7942	2509	3109	3669	85377	3708	55064	2037	2052	79007	222255	5423	55957	80183	25780	25849	51092	11142	5079	7263	9711	25932	64759	81553	23316	9124	3394	29960	6888	22882	150726	7388	55743	7869	115123	55841	6480	1536	4345	51065	1939	5218	23677	9056	4643	63910	84900	6047	6477	79705	8334	58488	4938	51237	28972	4702	1892	5188	3460	6767	6472	7014	23231	10390	2208	1153	1299	51284	55906	953	529	5175	9688	57553	9103	23596	64780	10124	2224	516	79152	55610	56994	84890	9557	10137	79770	55326	57862	80021	4208	23211	773	8417	132	11338	65986	6856	23158	11031	11133	3654	9308	7253	1207	6326	79365	2788	55840	29064	4174	3996	4712	4927	54	3632	28998	2196	64131	1737	1132	3535	9922	57820	50485	9450	9792	1675	3784	3566	55922	51465	8799	8776	2628	79683	3492	6300	28985	3119	5799	150094
GSE3982_BCELL_VS_EFF_MEMORY_CD4_TCELL_DN	M5543		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1818_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of B cells versus effector memory CD4 [GeneID=920] T cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					8356	55584	7132	54910	23233	149628	51499	4109	55203	56899	253143	408	8530	10057	26263	5707	100130741	5829	131566	8817	9663	3977	25858	79836	495	5654	6240	9208	57119	51348	8854	641339	339	222	80144	147657	1748	26952	2235	2173	313	29967	6569	5066	6096	753	63898	27241	29931	2974	6299	1300	9902	219654	2044	7464	23129	81697	23166	79147	247	6469	783	4582	4994	11314	5950	55811	57113	10874	149111	7781	5888	10332	2135	3683	10397	1240	54892	53829	5346	8360	4618	203	9119	100132285	11113	53820	5139	6690	79096	22891	10045	50509	9531	1071	23467	1524	53405	51226	8586	26093	6367	9949	57124	839	284	100288765	7644	22927	79838	401	22871	301	55911	4808	7559	6456	9402	92335	3575	2100	8708	50840	10846	23217	55556	6304	3910	56957	7134	904	81850	22802	51077	43847	84168	3216	26150	54626	51146	57698	10168	5179	57834	6515	6491	649	9931	3062	79947	23085	3945	4211	55107	11034	8638	100129648	64359	146227	3885	3004	3237	10586	64078	9580	80263	1116	1762	5730	10123	4651	26056	2117	25939	2120	23623	567	26088	89853	5923	1908	9046	26084	3347	53841	59341	11156	5339	4129	445347	10787	91807	90993	2953	4015	6559	79968	4613	246126
GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_UP	M5544		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1819_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of B cells versus central memory CD4 [GeneID=920] T cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					150726	4289	7263	3669	26051	54847	2768	3507	3514	132	100289053	3662	9770	54	3112	51092	85236	7288	85377	153	25825	9103	23075	10221	7462	51020	3493	10409	55568	51816	10483	9788	3123	54968	80230	27235	55146	3109	3122	3108	3443	1267	23326	5001	1164	3783	9875	25780	54920	4938	272	9124	8395	55743	55589	84890	9276	4907	57761	60489	23433	10328	25974	51237	79365	9451	80324	6713	30845	79152	7253	7942	3665	84617	2984	1396	8334	24140	23438	5716	8115	8938	5660	911	2954	3394	3495	388	11031	6300	5341	2213	81892	9957	51339	847	27115	25771	5175	10094	3099	6279	3115	307	4345	7775	51093	10970	23158	22837	53335	29064	4208	1875	79089	11142	64222	57205	1326	5026	55322	4293	91752	29088	3654	8303	80021	1439	27429	51760	3087	23506	1119	80008	91316	55024	10904	2268	929	10063	8345	7184	931	10472	80776	6397	60468	9061	1026	773	51296	6689	6856	6472	60485	51363	23596	6925	55152	100293679	8650	91647	240	50856	24141	55326	1536	22794	608	5079	10099	9767	7389	25979	4066	1512	217	760	23291	30833	5664	9805	4005	8741	79789	2029	80017	54925	25849	7014	5265	8531	27342	9823	8940	23231	5101	11234	6295	2208
GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_DN	M5545		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1819_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of B cells versus central memory CD4 [GeneID=920] T cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					2619	127703	1803	8356	5923	54910	5829	3882	9208	26102	4222	6563	23271	6580	10665	8547	79899	26263	3218	5617	3046	4155	29991	6352	79096	151230	1464	10223	23233	7105	3815	4223	80003	78989	8193	9153	84243	56125	54737	9100	56936	80258	3932	11011	8001	940	401	414771	10723	22822	56171	3959	1263	3673	6932	57126	25945	23046	6125	6385	55064	6955	11043	23201	2117	9464	1123	23623	27445	2300	23555	84719	10100	23336	8369	4297	1645	25939	5028	26531	64699	3589	79086	51330	10207	9902	1006	10053	7294	23710	89853	1007	23328	57007	23305	9402	8807	9802	9982	10332	5783	6517	1750	1301	10714	10395	2121	54682	3178	57194	10174	6240	51213	25823	866	460	552	666	10900	4676	78991	4481	3064	54556	57125	839	4298	4074	4882	56983	25895	80129	7535	25861	7145	9378	10551	9645	2015	5446	4153	2915	55811	1527	84830	23095	10801	6373	4868	1300	6357	10753	8013	1071	1389	1142	92154	400451	4324	782	6304	4494	2289	4300	3680	7169	3945	64359	54516	9462	1871	79625	8642	168544	55001	81697	80778	170679	716	64714	79901	55559	4099	5563	51077	55206	60681	26249	26140	22850	7559	861	3575	26053	3201	9283	2556	3212	163486	7098
GSE3982_BCELL_VS_NKCELL_UP	M5546		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1820_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of B cells versus NK cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					25932	3394	148229	6610	22843	3662	8395	23367	6713	50939	3915	604	5611	8623	23255	3112	4048	3099	80324	65244	55063	63892	25825	2222	10576	81577	2037	23075	4907	5887	5169	11345	7405	1396	7818	4599	51103	55695	79683	11142	25771	6472	9124	8294	2731	100506963	9846	399	8115	100293679	9734	132	8761	10904	9856	9834	26051	318	2271	9185	84890	23508	2213	11285	64222	272	8334	23231	10148	23596	26297	8717	5026	4621	773	29064	80776	8820	3145	3669	23457	64787	64759	79084	23107	26024	54904	5537	971	1366	4345	23635	240	10146	79161	30845	5625	115123	8841	79368	3945	360	10094	498	9741	1428	9550	79669	56985	81875	80008	10099	79152	55024	4082	312	3281	4050	51409	4066	114884	874	57050	26628	51237	25780	171023	5142	2963	9139	9767	10681	29940	2628	29104	1299	11234	1207	51465	54471	2768	3109	8030	26047	638	23495	27109	126298	3126	6152	80183	7253	5683	3108	7430	5042	57128	8938	27334	4772	2957	7187	1153	5158	23643	7706	1378	85236	4736	930	5464	51386	55739	80746	3493	6929	5796	2984	150726	6328	6504	60485	104	9957	3115	53335	7334	6138	5368	2208	84268	4261	55890	100287322	54840	22930	51686	50814	93643	81618
GSE3982_BCELL_VS_NKCELL_DN	M5548		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1820_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of B cells versus NK cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					51499	919	54910	22932	63876	7060	26230	1301	23623	493	3853	2358	552	54491	29063	121006	4994	6847	7414	79924	2135	2844	29931	26207	2742	5141	23046	149076	3932	7296	219699	1645	79166	11086	83394	10103	84243	64838	8631	4504	2299	51004	23418	2689	1393	3820	27125	150244	2158	9717	22877	55220	8519	51213	1557	8335	6291	9046	9683	1952	23022	22844	80310	5654	9663	717	950	7252	8459	80099	11138	3683	79812	100288007	8174	8900	3846	8369	29015	4074	127703	79156	4582	27098	7080	59344	1591	1999	5609	5148	3977	3084	6448	53353	23328	9885	6346	9145	10207	22974	25858	8929	6117	6398	5178	4240	23345	4354	1016	778	2829	55	3730	55556	7827	4586	81797	3904	79885	10714	1191	154	9429	439921	79574	10255	10417	627	8502	65055	51271	9542	8553	5525	25895	728	22846	8449	2909	114548	55203	3702	3338	7305	7270	9452	80059	5858	3811	7036	9580	79650	6964	6095	11026	1007	51228	347853	1656	25939	9083	4481	79986	23710	4808	23704	3482	80072	1827	23194	7294	100130958	4507	79781	23513	50613	8854	8292	284217	10123	4026	2906	57466	3310	4684	2044	5458	138046	133	4151	26034	4647	915	7781	222	57720	56125	2625	2928	64393
GSE3982_BCELL_VS_TH1_UP	M5551		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1821_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of B cells versus Th1 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					442216	9834	54432	79979	56918	79084	91754	6778	4345	582	50649	10681	51296	9466	3364	387751	5826	9103	3257	3455	10653	9813	271	7753	4144	113791	9980	8195	4066	23630	10866	883	79089	7201	4017	8220	8440	79666	65982	80099	83440	933	22869	8527	728661	80183	54920	29803	9802	79057	9771	6876	9308	10162	5742	79939	11082	10732	55063	8572	23051	7942	4880	54902	27087	56271	100462953	7593	6691	5608	10933	7711	2308	4589	10863	57559	10520	6399	23495	23362	291	83700	23199	51754	8115	10695	441204	8660	55957	4048	23014	6767	91752	1378	8613	8337	64747	115	347733	10664	25825	11314	654817	5867	9185	6549	6733	51284	54955	1490	8724	6477	8509	1396	26998	5368	23026	2628	5042	2326	206358	91782	9947	54847	8626	55245	9284	9767	29125	55103	3915	4586	79750	28968	1397	23598	57602	9647	56995	10390	5252	55823	8556	5678	6988	79673	847	50624	9609	65250	51092	55790	54800	8635	217	51316	9836	6689	154	10021	3128	80129	6850	55638	4595	4208	27342	100289410	59342	23108	9815	6276	911	412	5863	6523	51611	3178	760	8788	7915	3055	51339	4666	10807	91316	10916	5564	91353	9855	80279	1043	10154	79152	6528	7349	84900	4143	23596	27352
GSE3982_BCELL_VS_TH1_DN	M5553		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1821_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of B cells versus Th1 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					4678	2305	58472	63920	6580	3145	652147	4289	347	993	5827	4354	80346	8530	2121	6241	2521	1050	23099	25983	56288	55247	8872	2189	701	26471	94081	9532	23475	124222	24137	4692	3938	56943	25945	80739	9787	10858	1317	9162	26128	10615	323	5739	6955	205	78999	940	1839	6398	54149	3790	3149	9631	6240	29015	53353	5347	7298	79022	3702	79574	79989	90627	10211	3604	1263	79751	10046	8819	4118	3046	8061	55723	63967	3070	3101	55750	9902	8553	28755	5506	60528	80176	4504	57405	2289	4744	8807	54948	59341	9055	7481	2801	4676	4240	79413	79070	3838	54502	10105	6993	3002	4090	8718	7464	63933	20	404672	51155	3904	9949	6891	58511	27125	9352	64151	55131	9749	5154	7263	283638	4628	6696	26872	55055	4719	8766	2630	4092	7644	81491	79968	1164	5887	9452	23788	23233	7468	25897	51512	2171	57045	10691	9600	1841	10079	57597	6319	4582	3601	56886	79071	306	79745	2017	51226	493	56475	1007	55884	10253	55911	3004	25975	7307	2696	11332	25823	55117	919	10133	8829	3673	51118	64778	10402	80273	84525	26034	11237	580	26056	699	219654	2335	11004	6351	5140	1647	6197	10950	79602	9200	9232	7756	403	6890	875	84516
GSE3982_BCELL_VS_TH2_UP	M5554		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1822_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of B cells versus Th2 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					57151	5923	10379	55765	79839	4066	1843	5218	23338	56940	9610	291	1200	6327	54432	8527	22898	3758	4600	54662	10732	7414	9609	6564	54	4880	1993	5742	79089	8778	85377	283232	54946	23051	64111	10451	6610	80352	9813	10866	126070	203197	58189	5720	79666	55211	10409	387751	3122	3113	221472	9683	3492	5420	91353	9056	10045	2675	23162	23140	54855	3495	10957	100289420	11278	51296	5026	4048	8820	9639	23225	56995	64174	79829	55286	6876	84253	5257	962	11345	9399	55064	6448	2731	837	91647	3569	10807	3514	3836	55957	100505761	54800	3579	54807	81031	10312	100462953	4170	2752	9834	10279	2802	8187	7942	5577	8741	6293	8613	8495	80853	51284	10422	4799	22802	91782	5894	3434	80022	3834	60489	55614	26959	55654	671	26175	4005	9771	11142	10124	81030	9734	9802	2844	54847	8906	80012	22914	9767	65982	79762	9925	10863	387032	22992	5870	5533	79600	4907	3460	80183	8603	81553	79770	8531	3221	113791	9957	25780	1488	7380	375056	10943	360	54956	9103	22905	9873	2219	79939	23457	55888	4208	2850	10363	9794	3394	4232	1387	8337	3112	2628	55778	27342	22932	6932	54920	3123	83759	6399	4621	11138	582	54494	50489	9856	9124	668	8396	10099
GSE3982_BCELL_VS_TH2_DN	M5555		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1822_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of B cells versus Th2 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					4678	81851	124222	993	2305	9590	78999	54910	2289	6364	4354	10483	8530	29967	9232	9692	9372	2491	6891	4128	80072	5954	9902	2534	5307	6241	1164	378708	55723	53616	9532	51155	83447	9289	151230	3567	11332	22995	79682	81491	55856	7712	10742	6240	79022	5347	7517	3846	29923	2953	10615	313	55340	79070	11222	51118	2191	94081	7296	874	7756	1656	26509	3977	55559	375035	627	23541	51659	8099	4502	4676	9787	9914	4783	23022	7185	2034	57405	55620	9200	64151	8001	2928	54478	5836	8553	2235	11013	649	9908	4222	5686	8390	81850	10950	2563	940	2625	23254	55131	2669	127703	4709	3904	23516	64785	7525	5600	1317	4240	54626	3142	25897	1033	224	81839	7298	79989	28755	10824	11004	3067	10079	131566	51171	8318	23682	1644	5887	1909	55176	55003	10691	55750	1803	53340	4602	23043	10352	4628	204	55320	1829	4815	56957	23597	1719	10229	701	100132476	904	55129	28977	5774	9882	10332	85458	2977	2521	29088	2952	9053	22928	3426	8624	1718	9824	8266	8821	80167	3702	7307	79413	3161	6390	81623	166647	55732	3212	55093	23413	54968	3182	55713	2956	8872	11113	6197	60312	3269	84272	5739	26298	3251	1612	1452	51540	622	1543
GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP	M5556		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1823_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of basophils versus effector memory CD4 [GeneID=920] T cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					55727	9815	56259	5189	10512	7978	55625	8804	3576	29967	56951	29080	10614	23316	64757	387	10955	11314	28971	22898	57205	11193	284021	56271	4689	7263	285755	55281	6322	29982	5148	5718	1435	55063	4005	55704	5704	51103	56034	23585	4084	51167	6711	55788	9658	7461	9528	51279	5289	23256	10019	55364	53829	51065	58528	7296	29117	80254	3005	9934	51094	51510	9050	6478	81691	25802	26521	945	6386	25780	56994	57826	4697	1604	3093	81031	6502	51112	4729	8837	7716	5175	9921	25825	311	51526	4248	10483	7525	2920	10135	51099	81558	51304	1195	8443	6303	2203	4494	10902	57157	50515	6259	7462	5878	2322	5867	3248	4357	5586	5621	53346	1967	11120	6821	10987	51422	3716	9655	10409	1622	10109	58488	26232	51719	1432	200576	51465	56252	5292	9236	10051	10401	64784	126	9719	26019	79677	57460	10163	4637	9341	51192	55717	87	2517	5090	57117	9185	51185	526	80762	10129	57515	3720	23613	9848	23741	9375	9373	26017	26277	858	3892	241	3556	3460	1124	9765	3196	10542	9475	4534	23389	26578	4602	51340	6429	26959	27247	3964	303	1350	3106	8972	9681	2330	91353	3015	6461	59340	54149	9867	79843	57337	157680	5453	7091	1380	11152
GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN	M5557		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1823_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of basophils versus effector memory CD4 [GeneID=920] T cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					63920	3166	2916	10915	9258	790	1207	317648	79643	5834	271	2580	9569	5066	55200	29098	280658	617	51517	8325	3921	440895	25888	2123	27304	23386	10873	23014	58525	8336	8891	7248	56130	23409	51393	644068	79745	2323	253143	79838	51275	54788	5976	9221	1089	55663	57124	60673	55775	166647	79935	2173	220988	56920	26099	1938	79633	83475	89944	8631	57506	816	59335	51495	7059	6530	22802	9776	22868	57447	11343	56899	85377	2309	55559	2906	1184	1911	26212	5501	389677	9697	247	11140	8776	6296	25970	10120	54212	3586	5225	80760	9531	1370	26716	100289420	873	100287076	2548	23052	60676	730092	23142	2914	11278	63892	196740	55027	54537	4034	6573	3001	79077	26507	79788	79086	23264	170680	79701	92249	23277	55466	54881	51807	10101	29959	1300	114897	7026	358	79840	23345	10134	11279	81577	6839	9647	28639	26585	9900	3569	9074	5681	55670	5213	57418	3297	8668	7408	5819	6328	5252	7753	9645	8727	64116	3688	146227	51282	5576	10038	29942	3227	26056	3562	5437	80344	26747	10025	9119	2004	7018	22982	23348	11082	58504	6197	6568	56897	10005	5979	6490	246721	1730	8912	3978	7049	10154	81932	3689	9045	55013	22846	349152	79135	8671	1075	8605	5424	26034
GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP	M5559		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1824_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of basophils versus central memory CD4 [GeneID=920] T cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					9815	8804	2313	1435	10051	10581	8972	26959	387	25948	8190	3815	10451	80230	51304	6888	1022	64174	55505	521	29994	57515	8780	64757	2581	11120	8358	27429	8477	6744	55788	80254	1791	10019	284021	301	7798	23333	3106	5525	9921	56034	9802	23433	7403	56001	5175	56994	734	10614	79081	30817	29117	85236	7803	8417	4069	9853	51	51340	9821	80345	23325	8412	5325	10094	7414	29965	6923	3082	84079	25825	282997	26017	23344	58528	51257	7515	10129	7091	55332	945	8878	51279	51526	64343	81631	374	3887	23097	29064	25780	2934	7462	9373	23075	4689	9325	57205	1351	11314	23596	5663	10467	9920	9989	10632	7716	79843	9934	5791	11261	27258	3087	9375	1432	7525	695	55841	23446	978	51311	23355	57162	7534	10381	3295	2124	10765	55625	11258	9551	3021	9685	79685	4591	9765	57396	81031	79640	4084	54874	64397	3550	59340	9625	573	5621	56259	2932	64065	9050	23199	4898	4905	3067	1992	683	217	777	6036	11337	51099	54209	6827	60343	26011	5782	9277	4005	571	10483	930	57178	5122	6840	51100	5899	1665	5336	26521	7296	858	10409	435	6239	53346	23451	55819	5720	6655	2015	6880	4729	7873	4602	55636	4121	51167	83443
GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN	M5560		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1824_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of basophils versus central memory CD4 [GeneID=920] T cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					354	1512	79643	51499	10110	6832	3921	57418	790	10973	940	1939	8453	2041	79864	57124	7561	23556	6272	2151	51393	256364	23383	6305	4153	10329	26088	51735	55119	7916	6532	2040	7016	7368	55070	2123	22809	26507	9081	1301	1300	29911	54914	54442	349152	3598	11343	5999	83475	29909	55748	28387	3158	84914	80344	4125	51495	4050	8481	3458	220988	85377	79710	56920	51224	89944	30811	390	23271	4604	400451	64087	8618	1584	755	23175	8891	816	23546	51293	81688	23536	1534	57496	91782	10721	22800	55222	593	23173	8665	25903	6448	57602	27097	79077	9814	142684	617	81619	79652	2254	10953	874	8824	1107	8895	247	10723	51474	92	25915	51236	8611	89845	6839	55662	11140	7535	23250	23683	6785	23218	55507	7293	23594	347902	160824	130814	23272	7373	25970	55707	6262	58477	29990	7753	5538	5037	54991	4603	10235	3297	1039	23367	55317	2806	9639	8821	51575	1911	3732	23464	10126	8722	3376	10195	6736	1770	284800	8682	55161	8899	26018	55340	2619	6322	79701	4676	10873	5576	8842	51593	8332	8883	186	79946	26205	54093	4054	4144	2648	3688	51517	56948	54477	54929	1730	525	89	6610	79781	23062	51276	2815	100132341	831	10572	2950	6406
GSE3982_BASOPHIL_VS_NKCELL_UP	M5561		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1825_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of basophils versus NK cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					3745	9815	55625	734	1022	10955	50863	64757	25983	29967	28971	79809	30817	7873	90	10677	2752	3106	4170	3021	51167	1720	56994	57205	23344	6747	8190	25816	304	79865	55279	10409	6711	694	6777	8553	4066	27258	6715	80014	571	80195	786	6840	7021	23741	8358	54149	1051	100287132	6502	634	473	5283	6386	29064	9375	6286	7323	9856	4084	347088	11076	10818	7803	1435	9957	10647	54874	8294	94081	9446	5168	57596	28977	55281	9853	102	114818	114885	25802	91355	3887	57117	23635	5992	5537	10775	374	4126	4637	959	1496	6744	57149	4122	5020	9802	1908	5430	9764	51103	7534	26011	5292	3295	83394	51701	375056	100132923	138046	3005	5867	8412	51	8031	9325	1230	4076	10483	30	9840	29883	79843	79097	81031	56139	2778	9528	672	2932	25825	1634	81789	2317	55969	3201	51744	51100	7223	25780	54904	3316	55063	90411	51582	6652	51279	51185	5376	7310	6478	5870	6629	7296	57326	4335	55364	8976	57337	318	3757	23074	54996	53346	10097	4615	26234	58528	57050	2015	57144	9659	2131	7178	10611	114548	4729	282997	64784	1440	57612	301	10765	596	5777	1044	2313	11031	79682	7266	55890	54209	80740	2069	30850	2887	64080	55505	51101
GSE3982_BASOPHIL_VS_NKCELL_DN	M5563		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1825_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of basophils versus NK cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					1370	10218	790	550	644	23345	1207	2916	2895	23386	9025	55200	54991	54438	2688	10752	58525	10801	9289	29911	23052	3625	5653	778	388714	440895	5424	10319	11145	474344	2914	3176	51611	8530	54847	9656	5634	23014	50838	8891	5976	1544	64600	80350	10447	11343	6588	1584	80310	8879	5145	8986	2132	4026	6847	4628	815	28978	3275	8292	50717	4048	56910	10061	7016	5987	27019	65010	122704	6041	54788	27304	5471	10326	10164	29916	6783	79651	50937	9956	2980	5923	83475	3001	3441	55466	3449	23546	79400	10161	54509	4886	55670	7172	4157	55930	27440	844	58529	4857	79661	5827	9334	10575	8354	146691	1946	3797	79135	25796	55748	358	1010	6450	80271	23136	2563	9079	26033	79037	5681	6964	54212	22829	55201	79940	100132476	3636	11026	4864	79071	26637	8603	186	26088	59307	1075	100288413	2938	9404	51316	29914	3768	79958	26230	8631	2040	10500	445347	22877	9855	1952	6870	23173	22875	56114	1301	23016	23265	55153	3257	10133	55070	108	5675	3704	2055	79970	617	8974	55556	6527	93210	51807	5557	57214	64087	81577	3004	55741	56912	10069	6944	5225	51275	10126	6709	26585	79064	22797	55135	6278	10607	2555	23277	4054	347733	5972	23538	55653
GSE3982_BASOPHIL_VS_TH1_UP	M5564		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1826_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of basophils versus Th1 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					23078	5867	2938	23471	3798	55788	7978	7403	6777	2581	1195	56978	55823	55727	55251	151050	4084	23333	65981	8363	53829	55701	4589	734	9039	5927	10397	51082	140883	5430	5742	23324	7580	25825	10581	57515	6286	10472	55843	3240	8848	5525	56034	8972	10902	3275	50863	26065	56271	318	10664	55815	9934	3550	4666	3055	79666	6342	57154	9774	9881	3205	57205	1176	50717	2932	5567	4586	9325	9580	5325	9922	22864	5788	4778	6230	4212	11108	2890	26234	25949	6416	64844	23175	9284	3964	9741	51411	6431	4155	55231	7099	9958	5090	64747	10955	10019	26959	29940	23608	60467	27241	9671	654817	8292	1828	2891	23197	64799	29064	55667	1843	397	25790	51100	10388	6386	10023	51669	10142	64757	3815	79722	57805	266977	10866	23247	23013	51306	5075	10580	10735	29761	54494	387	55763	10788	5619	23126	1774	81631	3115	8763	1974	11219	10443	137886	472	55063	10670	7021	83989	687	3050	10106	79887	64771	5579	23287	26105	29994	60468	9129	2268	7456	5125	6275	23075	4066	6508	54800	10313	8354	3384	7414	928	5376	81562	9528	4094	6840	1955	64397	84034	28956	6210	10943	1378	10781	10477	58488	473	604	9635	56252	140461	11236	6517	4534	8993
GSE3982_BASOPHIL_VS_TH1_DN	M5565		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1826_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of basophils versus Th1 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					55200	27339	2023	3329	2123	9956	83475	27341	6568	4068	81034	1512	1650	23550	29098	3559	9732	56935	5860	1802	51283	29959	26064	65003	5690	3376	8500	378708	5422	10452	55222	10954	1584	266655	6790	8872	79616	10046	58525	873	5704	6518	80176	26275	6199	7283	831	85458	9258	340591	8605	874	1039	51319	51022	9134	16	10892	5739	1723	64778	27346	79023	4522	56061	27304	113251	10061	55129	10105	701	5576	4436	6307	4860	3925	57212	6590	4644	3159	6240	9641	3149	1984	4289	54707	28960	51154	8688	7016	89944	26128	6351	54148	81831	26103	10307	8565	6645	79064	9136	10615	23423	6636	157	10252	27347	79168	58472	79676	6340	940	55168	79917	9902	10752	5832	23386	2181	100287076	127703	11200	51073	1164	8727	246721	1728	51144	5245	79071	6812	2913	55055	79701	9334	58516	10606	11047	23204	79989	10915	55164	5693	54862	54491	60489	23234	4751	10419	54541	51438	5504	1662	54069	9814	51474	6785	29789	641	51026	54843	231	28998	65979	5902	1839	8541	3609	6504	8208	57496	5888	26278	4678	3070	360	7516	22845	1938	4277	4830	10962	11140	29901	7533	64960	3054	23414	79017	1111	5144	8836	92170	22993	23464	81539	22880	51282	5599	10069
GSE3982_BASOPHIL_VS_TH2_UP	M5566		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1827_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of basophils versus Th2 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					8227	79899	8804	4883	10955	79755	10142	6923	2317	5148	10401	54103	2581	637	64895	23499	9639	4689	23613	84253	734	23433	22802	23140	801	9658	6158	5742	10015	2034	9101	90634	2591	64771	79668	114885	3115	9815	9050	80254	54807	91316	23236	23325	3120	7248	9517	2015	304	9039	56271	79768	3716	7168	29994	22849	9840	11059	51567	283232	1791	51275	3240	6009	28232	3550	55208	967	5325	53358	4735	22858	9881	174	100130354	143	8345	140885	5890	6239	55843	85363	683	3815	5525	79666	1536	10670	22864	137886	4066	23126	1955	10866	945	8857	9765	10209	1831	201501	9934	55089	23336	55745	8972	6715	23136	50856	54462	55578	5564	11197	9770	5867	1380	5189	2554	55020	50999	57205	55281	2322	51526	1195	9210	51167	120	9741	6993	10397	3360	22986	604	100129482	10735	51380	5048	6416	3303	51099	81544	60	5286	7461	51635	23586	6840	23615	28823	9620	10581	3082	3043	7111	2197	51701	113	567	23287	5806	26065	4155	9896	837	6655	7032	8273	51271	29940	116984	301	303	23097	54494	9655	51317	56994	10443	10664	25977	55332	3113	56259	761	5791	103910	5175	25780	10402	29967	4591	6508	23424	25963	8927	6399	1069	5927	29992	81789
GSE3982_BASOPHIL_VS_TH2_DN	M5567		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1827_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of basophils versus Th2 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					55200	23541	1370	3329	5321	1300	79713	1874	1512	617	7157	9258	55166	11157	1803	54946	23142	29911	81034	23550	9223	1629	6588	1434	5704	86	1973	2023	57418	7407	8821	51319	10452	28960	85458	58525	23065	26586	8458	11315	5198	54491	5690	23052	57506	6790	4053	790	54914	53340	644068	8479	90233	27440	1938	5860	79701	3376	27341	3775	875	1164	27019	54148	4522	29122	3904	4068	25932	10615	3609	5432	22856	5538	9862	29909	90956	6119	23423	64087	28985	51384	4436	29789	6391	5827	65244	51154	1977	10525	54806	54843	79363	83475	10539	5910	7535	79086	10061	55655	79071	6272	81554	4702	4686	26135	16	63933	8836	10280	65003	2077	3185	54707	23283	1984	92170	5468	5203	26275	2074	8669	55028	10073	7074	23676	26637	54881	55188	6240	10329	51754	79023	51022	55144	8975	9277	5245	79643	356	54962	10953	6340	28977	3932	56180	5713	50628	8626	9700	6635	100506898	641	9025	115353	10663	9081	57194	6385	54788	11047	8815	78988	6041	6504	3559	10363	5693	51073	4999	51236	23421	22822	8864	7270	5434	10105	7156	23594	11334	6223	79675	328	794	64600	51631	5915	79064	64175	51203	9074	7411	27079	23354	8842	81858	7514	5781	51495	8872
GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_UP	M5569		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1828_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of effective memory CD4 [GeneID=920] T cells versus central memory CD4 [GeneID=920] T cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					29095	8502	313	3820	2135	160824	3934	9510	3001	5478	55177	304	6367	3115	55812	2956	7625	3003	7353	64343	7133	1213	100292959	8940	9404	80017	8369	3257	10595	200734	7033	51339	57535	81693	777	51098	84981	10744	3670	374354	37	1729	65979	22802	4129	5264	23753	5990	56062	27344	55272	23604	30833	21	10525	54475	23040	1524	29965	57572	595	10381	50486	8522	84790	123872	4622	83446	80142	3443	55328	3491	79139	22875	93594	10633	3595	8828	7465	55525	8803	3371	4171	51806	7226	8447	4759	8605	284439	85375	8563	7798	4145	25945	10578	2268	7288	23504	11007	826	6722	6491	55133	1408	79683	27181	79956	85476	9244	9817	864	27303	1749	23743	10352	302	5608	445347	11186	10417	55178	5306	80205	3684	56255	2597	80776	29953	8668	23659	6251	1119	9832	801	27165	926	1478	2672	79081	100	80235	1192	56344	84525	84059	51343	79071	55262	51046	51093	11314	3452	9938	9766	157869	79668	7026	23334	10816	9023	624	51725	56895	3169	100287659	3268	5118	81035	26123	9496	7414	114932	84162	10096	23108	2999	340351	4818	146227	6810	7314	81873	5920	8346	23129	2852	79733	3689	10488	3949	60489	6275	9892	84560	5331	11279	23171	79012	23224	3565
GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_DN	M5571		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1828_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of effective memory CD4 [GeneID=920] T cells versus central memory CD4 [GeneID=920] T cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					1889	2041	23066	5375	10763	399	2944	55364	10223	26034	3673	22902	1962	7294	51351	54674	51276	7368	4583	150726	253782	26287	6649	22953	57502	716	1646	55714	55644	56967	643641	9958	2168	460	85458	9873	6450	23677	55289	9170	55156	23608	26097	26747	254531	9982	3270	7145	64772	57556	80129	79679	221061	26226	390502	54477	5217	441601	51669	4223	81930	440	6322	3157	118	51213	3861	27440	9139	51135	8945	7360	6919	55153	55862	80128	8484	1855	83955	11201	7390	60468	5334	23383	22904	1236	7293	22906	5909	9749	8875	4436	55885	2947	65982	23305	55064	55063	476	10276	7851	29914	3570	8609	57626	10814	6764	55653	7564	1454	3784	472	10904	79973	8754	4363	4795	8893	11214	286451	79048	27012	5442	51362	10491	4010	22794	7188	687	1609	151011	78994	23012	26119	10324	8690	84719	27351	753	6553	27339	26580	6604	8357	55930	7093	10053	79596	81624	6653	321	5463	7286	3803	79789	7301	10456	55139	26538	56252	157697	4331	5871	54954	9859	64319	7087	351	79961	199	22870	6402	58516	100129503	2326	607	4600	5042	1876	9662	23089	285	1802	54491	339290	866	28584	2037	747	7696	3572	10850	91353	374	5383	23676	387509	55274	55721
GSE3982_EFF_MEMORY_CD4_TCELL_VS_NKCELL_UP	M5573		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1829_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of effective memory CD4 [GeneID=920] T cells versus NK cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					844	9045	3945	3105	57113	100293559	50855	78991	4522	6130	914	1969	6168	100129648	8369	9905	6310	3841	6133	9020	29942	27097	10124	3624	959	79365	3207	23261	4170	4892	55063	9787	4088	9712	3017	50807	27436	6504	55695	186	8893	146	85294	58472	81569	221061	8392	79133	55801	3178	79991	7327	9949	7476	7818	11076	10045	7430	6155	6147	839	7070	3316	50939	51032	53405	3800	3562	26762	80095	53347	10106	3166	11123	11153	171023	1045	27241	50831	51067	90993	4613	11279	4969	50487	79442	6122	51101	5069	54810	7142	29116	1149	5728	2009	286451	9139	375057	3675	3745	26263	57326	27012	219595	80004	375449	360	23367	80776	8502	58473	64919	9775	801	1153	10749	50840	1378	10879	3749	643641	79147	9319	22927	55203	26123	2157	1915	5644	9531	5796	79858	904	5037	5042	5669	29851	8091	567	1933	55303	2038	765	304	6124	10294	27303	9957	57460	2843	29906	6170	9900	4050	64121	6347	3590	8927	10816	79844	22982	1350	64781	80111	1154	81693	56300	53904	1880	7360	54801	8996	10803	7178	923	51780	9749	51686	4107	3371	6334	23231	55687	9757	1829	56652	23059	1942	64641	23430	10892	115708	55156	5456	10667	2542	54626	3106	8336	84560
GSE3982_EFF_MEMORY_CD4_TCELL_VS_NKCELL_DN	M5575		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1829_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of effective memory CD4 [GeneID=920] T cells versus NK cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					7462	653483	6398	64759	10634	1675	85377	1955	79156	4005	8778	51213	4745	51267	3665	81553	2906	57109	8875	6285	27235	4684	8787	6037	408	23761	10379	3454	9772	23136	11314	26000	313	11024	7263	11338	2185	60673	4331	11126	6821	79650	29088	23608	9553	460	5175	7879	26097	55130	9844	5947	7294	23248	4640	55190	54963	10763	4643	81537	1052	9832	29965	6554	2224	55653	65108	3162	5148	2237	8603	29799	5375	4066	747	29986	10287	79616	23180	10489	63910	2215	22920	3101	64108	3667	55714	55691	26232	1630	7752	25844	9027	7305	4718	2689	7297	10875	1135	57556	80344	79671	7204	7283	847	63894	259197	23111	1401	10607	29914	3005	55353	8537	1230	5998	84720	862	3055	56132	56995	10437	133	4782	55364	65986	63916	79973	83737	51118	9256	9936	100287387	23326	8722	150726	11096	5165	7867	115653	55101	7494	9677	1380	23313	728	10311	10422	4547	4067	6907	952	875	51348	7275	10586	26580	23401	5336	303	5874	57862	116985	7164	3725	51065	10578	54937	5294	6850	10904	1521	6326	4926	6919	257152	28998	10163	27180	59336	79651	4104	80094	113419	4795	5265	1050	4629	2052	51008	2928	9021	4064	4201	25801	22954	55316	64397	253782	7167
GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_UP	M5577		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1830_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of effective memory CD4 [GeneID=920] T cells versus Th1 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					2693	1043	55520	814	54494	56899	23015	5042	55113	5191	3910	23175	10846	2317	55815	8527	11022	6334	3275	51816	3938	5968	51725	23129	1936	11092	51170	5184	9201	10781	10647	25849	4808	10807	80230	2157	4617	64236	8440	81550	271	4855	6462	2575	26471	100130741	212	10154	6569	25948	51316	9649	84733	220988	50805	5567	79611	55911	64761	26212	6532	7042	3972	3700	60468	203	51135	7798	51720	23033	11120	79832	9578	220972	4065	23272	11181	6942	301	7741	6623	1008	64806	694	3624	678	274	1806	25803	2776	10270	64860	3897	26152	8048	1880	54765	4991	1645	3570	4660	79710	5926	54902	10520	2309	51696	51747	8356	57326	65989	10472	51619	1628	2572	79365	23026	23014	11341	54986	57147	5935	7753	10307	9647	6489	23526	55930	59347	79086	1748	9956	440348	10404	81796	9580	51706	79852	9926	23066	79616	10847	9159	3782	55343	7781	90634	92104	11095	55205	56969	6588	55304	442216	6293	22832	23213	27303	3670	26184	29072	643641	23769	23410	1080	10000	57402	4300	960	6641	834	728661	10198	1269	50509	57447	27330	3798	633	55663	51439	64077	114881	8763	65981	2840	313	50717	27250	4103	1002	1762	26205	114899	57119	8776	51160	29125	501	55764
GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_DN	M5579		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1830_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of effective memory CD4 [GeneID=920] T cells versus Th1 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					63920	516	4782	4055	3586	231	27341	203068	25804	22974	27130	6503	7726	51022	6328	5393	5831	64976	3248	5435	29880	56935	25983	1163	6391	26128	58526	5289	5366	347	5719	4345	5359	23590	4913	80223	9493	23788	5036	390940	8914	9669	55334	3015	10606	6385	58488	9311	84617	54529	54149	5693	5203	9991	90141	3419	23065	3559	51103	1992	80094	1054	996	9532	672	4628	2983	64116	60314	51118	26227	1058	4624	1434	2034	55038	10419	4670	6240	7329	55589	54892	2821	6821	85458	2242	4940	6611	641	57045	4700	51728	5165	1230	54708	10615	1164	6491	4794	7298	6241	22903	24137	8970	8836	51074	51203	7867	1876	1495	6737	1390	6390	5504	6182	27095	29922	5168	54496	30844	6788	4289	8504	55771	5707	79603	2335	6696	1207	2108	50515	5709	5423	54674	8726	7124	23475	3902	28231	1460	55784	10607	9861	4729	10535	8668	54962	6890	31	1839	1050	60560	51184	26271	9775	2746	79159	1537	51144	91860	27235	54780	55071	1829	3998	377	1437	11014	51097	51603	5728	7027	10935	8140	2184	10211	926	4719	64222	23594	995	5019	64430	2717	26872	57103	10381	10238	55851	4174	79669	25893	51155	79413	51065	55968	4697	7262	4236	3005
GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_UP	M5580		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1831_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of effective memory CD4 [GeneID=920] T cells versus Th2 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					88	170960	49855	1936	4430	1969	5874	7337	301	3964	8925	23177	10892	2693	55113	1305	8644	51348	9663	2642	2980	100287008	23526	57125	79145	9732	80032	64895	2203	4646	51082	8685	6942	84253	10142	386627	9236	694	7781	23175	8550	6899	10076	2925	3800	9201	170680	333	10807	10943	79832	54986	57326	2145	2157	29064	79147	3123	10846	79048	247	8312	26152	57572	84809	79054	23544	1889	11120	22864	51706	26872	390616	8325	3305	10647	7405	1543	23131	9975	25948	54826	6327	5266	22838	22875	79611	23585	51186	3073	6530	7535	10641	79990	1831	3590	8857	26148	274	23499	56895	2568	9121	1875	728855	1735	81623	80853	8273	9399	55205	8076	25803	56123	23382	3897	81544	63982	3375	22932	6672	23608	960	2974	9907	63925	10544	23129	6462	1102	11223	6651	7798	90956	203	8092	1999	9542	23259	2840	11095	51555	3196	4313	25821	9649	147657	89795	9159	6430	23357	623	11024	4994	23349	7464	358	140461	116984	22888	2543	23198	93144	10379	6490	149111	8495	11314	6874	4248	1610	360	4103	9905	57834	55765	53405	442194	9583	3691	63877	2040	10125	4152	8912	29949	8506	84726	83752	3700	54474	7545	26058	7597	7741	3174	375449	8515	1285	9924
GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_DN	M5582		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1831_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of effective memory CD4 [GeneID=920] T cells versus Th2 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					26150	7157	23474	6907	51121	890	3005	27341	56992	51026	11014	25932	7296	10849	6445	2553	10432	51022	51094	1537	1994	4345	28956	14	6182	81627	10489	203068	22979	9412	79023	10535	65003	4700	54867	60673	79077	3682	26521	57103	4624	7411	1058	1962	80223	133	5203	6421	5036	1434	6635	79989	4619	51659	54962	51603	4670	1207	23516	5264	8836	90141	51493	11222	51504	26228	9532	7298	224	8476	2530	9493	1612	4686	8886	2769	9585	7386	375346	6240	5321	1164	64216	28985	5693	5504	8438	8914	29922	9928	23708	23429	8649	5743	3015	5347	55746	641	5717	10935	8345	983	2023	9603	1503	79568	84617	2762	1163	6647	4717	51719	23594	10671	6346	995	8395	2108	1839	3992	23476	4076	29982	4697	11339	23150	4724	23326	54908	11259	25804	51631	65108	6385	708	996	8504	5557	9601	2271	54529	6881	7290	79866	1892	54892	9363	79603	81929	10666	7374	51144	1958	1293	10460	5325	6241	56980	6390	2280	11332	55775	221443	9477	7086	95	10483	27130	8140	5683	9328	4357	64976	11193	5424	51650	9650	7153	58488	51056	57862	2180	1622	10105	8412	9645	5901	4602	54496	1033	54922	27247	55750	9967	4628	5634	622	11338	4174	6515
GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_UP	M5584		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1832_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of central memory CD4 [GeneID=920] T cells versus NK cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					940	23066	80128	8725	6504	3485	27241	6161	3675	343990	5339	8383	11255	3178	10665	6124	91782	6747	8821	3959	55222	7286	4736	3192	6573	23118	6125	6155	55063	65982	51735	9695	441601	7180	914	8555	10892	10089	25788	874	2742	28639	7368	3049	399665	26263	43	272	23135	1063	9725	57602	29068	6019	8359	56171	6130	399	7327	29851	157627	3800	3382	54901	55795	26249	5142	6136	22927	22850	4882	8975	23526	79973	78994	4170	26287	55556	30850	79722	8893	29062	23743	959	360	51135	8506	28984	142684	23446	6234	7441	8717	8189	196	3166	23261	6580	49856	8082	6369	3131	81930	55802	27012	2041	5306	56139	1435	4747	22982	5332	8290	7066	53347	55289	3945	79968	50839	9496	643641	6955	171023	79820	5949	100131298	80339	22909	1933	55364	9905	8887	8398	6571	5464	80003	1154	51205	1880	11043	57048	7314	5898	5217	6443	8886	8911	55930	834	9749	56954	56985	23528	3316	1871	7979	55423	64772	5592	23367	8294	60436	54674	10276	3361	8061	6156	23019	9684	79991	2098	51174	3270	55274	10599	11201	2550	55259	2615	79026	2121	80324	1606	78991	8336	1006	1850	6128	1802	9533	54477	10622	6152	56267	56829	400451	51070	7957	7476	79780
GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_DN	M5585		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1832_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of central memory CD4 [GeneID=920] T cells versus NK cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					7462	7263	23333	9002	3394	3853	1675	84720	10712	27019	79156	27235	23046	85377	3716	4289	2149	79639	26523	23682	2934	79888	54442	1408	10005	10904	303	5175	9314	3001	728	79954	80310	64763	8542	550	10633	11018	80223	3064	9256	7276	4684	51363	56001	7386	9289	967	51192	54438	7701	2672	55568	8527	55785	23022	50810	5716	51284	3452	84059	1659	200734	389715	54979	9051	55969	80896	6398	57109	27128	1052	4783	22914	445347	1955	5336	23576	4067	6352	9844	51066	478	9079	3257	4704	8834	55332	51604	22875	8335	5351	65220	3949	23040	100132285	80017	813	1075	5383	9766	7625	2563	79651	83744	25840	6988	10430	9437	27115	7414	9048	259197	55146	4332	53346	8563	8644	1087	1050	353189	7033	5782	7879	114625	11314	2242	55898	4795	8507	7167	56344	55190	3806	4069	9936	65979	5791	2207	60489	10982	199	50835	10581	1749	56062	9025	55505	23180	2937	8972	166647	9604	55576	439921	3115	27087	55178	5998	5777	23433	10063	51316	847	10049	952	79977	2805	84560	9510	29088	91752	8988	10099	55665	4221	28511	4342	3904	9500	7867	410	9625	9638	4726	23326	1519	7049	25793	695	10163	5341	23092	81570	55201	2566	23208	925	51744	1436
GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_UP	M5586		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1833_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of central memory CD4 [GeneID=920] T cells versus Th1 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					79810	114112	79068	8082	5100	9813	55763	56344	7753	64940	29969	160824	79086	9668	10781	54585	81854	221037	83752	374354	11181	3037	50506	65981	11120	2041	1520	2830	1534	8048	81857	301	1938	23015	360	26959	1527	11083	8440	10472	4319	7561	55843	825	2254	80003	10178	6322	55063	60681	170679	7597	442216	8001	6751	79762	55364	50508	9201	27175	274	5617	3107	79679	220972	8689	54765	51301	10206	91782	27006	399491	27284	10273	1346	80868	113791	1369	3455	3270	2157	51316	3134	57154	4217	7105	55423	50624	9575	7068	6399	6843	51306	5949	23247	728661	163486	8451	285282	79587	11022	89853	57212	57711	582	26152	3606	92104	92017	960	6932	2300	5297	114882	56946	23258	55761	4103	258	29761	51341	9881	60468	3782	23126	3700	5252	10023	51747	9372	5616	10404	2625	9914	4589	23608	6010	666	5826	4065	552889	269	117153	23199	25948	23092	51351	11257	51735	678	6279	6097	55086	9737	222161	79608	54516	23598	57048	6181	79629	905	54487	3803	5140	8832	2556	9988	349152	1889	6170	84440	22883	55812	8547	55790	53347	9129	64091	2908	55227	347902	1464	54964	10686	5295	55716	92815	283537	11314	1953	4666	147172	23382	80230	3115	1153	8195	51585	146754
GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_DN	M5590		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1833_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of central memory CD4 [GeneID=920] T cells versus Th1 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					79081	3093	2242	10712	4345	5165	9631	5690	2181	5245	51428	2495	56062	7293	64768	84516	3586	2952	1981	8542	1063	23788	23475	6790	9787	23594	2672	306	53918	332	10535	6503	5366	11332	28974	7298	2305	203068	11154	23065	29015	3430	9232	1627	25788	4783	4644	11186	25983	8061	55969	65993	79071	307	9929	64151	1839	55062	9673	50616	3956	516	9700	51053	54663	4012	6150	80255	23333	10352	347	701	9526	9861	1054	5902	5496	506	8335	5718	23063	6628	641	29100	4751	23753	7873	8914	79622	5709	3925	5831	8836	1026	55505	6307	541578	27235	27429	4678	7415	3421	55872	10950	5531	2068	2954	51056	10578	2184	56005	5739	902	3248	6241	1992	51506	6788	55003	3422	60490	10592	8565	6396	8544	1163	7468	966	93594	5393	5683	10897	1351	684	54962	231	5551	9133	11200	3559	1022	27346	84617	3902	6351	2189	60489	23208	4236	10099	9040	5427	6182	51290	8402	5699	1019	404672	8502	51026	4121	79070	23480	8819	4729	51167	54793	1164	55589	10973	3443	6184	8140	8605	23074	4522	3101	51237	10797	9587	54968	403	4814	9603	488	9735	9414	6695	80273	5887	672	81930	10211	5717	699	22822	5693	28998	1267	55161
GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_UP	M5591		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1834_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of central memory CD4 [GeneID=920] T cells versus Th2 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					3590	26959	83752	23236	10892	79762	79145	9610	339044	6256	26102	51706	3800	2132	4621	2675	51380	8925	9028	79785	55765	60313	64174	55843	10142	10911	55716	7454	10379	9201	3959	27286	221037	3702	7368	8666	1955	6563	7294	1527	5297	7701	51520	3572	79892	27175	4155	54996	10957	3665	55187	79630	5349	25948	51348	1534	9881	2053	79596	57125	11083	222161	6284	3298	25763	51084	8481	23140	274	2145	11059	9698	6232	54014	64895	8379	57576	80216	22802	56969	1369	22986	5894	3620	4666	55625	831	4072	7738	10209	100287008	11120	26152	56123	11314	7597	2742	3106	11328	90634	51070	51135	5142	1677	80129	3218	6649	2328	23382	9605	1843	283537	57799	678	801	55184	79587	9575	58486	8629	694	56995	57154	4065	220988	4583	9245	5616	6430	7695	9098	78997	51555	29068	9462	120	8722	7476	10023	5806	8417	1956	79188	8484	26577	960	54516	8848	4103	637	10451	23608	51313	11043	55167	6775	64111	9725	4882	1519	5007	22861	1996	301	23499	10893	9737	91782	1889	4995	28234	23522	57020	57602	54549	2099	11187	78989	50650	55340	3115	10964	55177	80127	28639	1360	55339	440515	5934	3689	55268	79839	9620	2936	79726	27244	6402	9802	10225	10346
GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_DN	M5592		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1834_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of central memory CD4 [GeneID=920] T cells versus Th2 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					9232	11332	23474	5690	4345	23063	6790	3833	29883	23788	5713	10535	79081	29899	9414	11193	10950	6749	8335	313	4172	9700	2023	26517	9412	54442	439921	8395	4502	204	6182	51428	4783	1848	10432	3692	23516	166647	57761	6628	1798	127703	3426	8836	9319	6119	1503	10691	10352	113251	1119	54674	10051	64151	9787	7288	51805	3956	51053	51115	10400	1495	26521	79017	22822	5507	1347	5551	55785	51020	63933	6346	332	3904	64216	641	10099	400506	374291	443	80775	7386	54962	2305	23480	23326	203068	55027	29100	1063	6241	6722	5393	200734	224	54806	4495	80255	7517	8318	293	7417	80142	7416	5831	488	4289	983	672	9133	79077	51142	9645	30833	967	80273	7298	1958	51002	51575	5709	27341	8645	2194	3796	10935	5982	79187	5683	8914	55500	84617	23022	230	7153	7376	4128	4904	506	3595	4686	27338	51026	79070	9767	65993	50	4678	7272	11051	6150	2952	9601	10483	28974	51693	2950	2954	9603	64963	51493	3028	29925	1829	3336	10663	4726	10897	10539	55003	516	80223	2937	6472	4602	2885	5019	23682	7086	23074	1435	760	7350	81873	10797	55215	8099	10671	7264	478	1457	112464	10328	5427	8345	5320	10721	3703	8872	54148
GSE3982_NKCELL_VS_TH1_UP	M5593		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1835_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of NK cells versus Th1 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					9813	6252	22844	8273	22836	26184	100462953	1675	9052	23265	55220	5003	3176	29063	23066	2358	64806	7380	9922	8648	116985	738	582	113791	6733	5826	2000	4808	427	301	4883	83744	3977	11022	9802	55113	8515	23072	3257	408	57818	3455	847	79627	4053	84059	22925	9314	51725	7739	9372	7481	2252	2848	23309	54796	55316	79899	358	3178	54902	79611	9388	5191	23199	3798	51619	11236	4610	51411	6568	386627	960	55182	5662	51301	11257	55665	80868	2810	6688	976	1645	9153	147172	5576	51363	23086	412	10154	5608	10317	2563	8195	1006	23361	50840	92	6278	100288007	7879	8029	80778	4595	10983	8353	3107	11341	367	146754	80072	6037	80094	63036	51050	79751	5782	23094	57171	56001	6964	2798	10482	79820	9855	2569	1946	1952	54765	4026	55036	2863	55304	8626	51271	51604	2572	3568	59307	104	9627	80099	6013	9537	773	5594	440515	10609	23026	9313	1176	121006	4684	8556	26212	3493	146691	55603	2899	10380	55624	4861	1041	5523	51816	80243	1557	54432	51027	7164	1804	55534	6047	11026	7414	89853	65987	27006	3730	9159	54494	7068	29992	57119	2550	8714	81854	2047	26538	63876	1601	23769	80086	339290	1671	23037	57634	57466	338	1577
GSE3982_NKCELL_VS_TH1_DN	M5595		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1835_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of NK cells versus Th1 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					332	59269	7283	911	8766	323	6319	1164	79017	11332	54149	5827	51659	4345	1839	2957	6241	9532	43849	347	11017	94081	63920	940	126298	9585	10447	10714	10322	55222	28755	306	79622	26872	55320	6790	51388	81887	128872	79669	9141	5168	1244	23475	54674	6747	54892	9232	10592	993	6767	51053	54502	3832	6240	26227	55284	54913	5106	51294	3306	53918	5693	64759	5718	8996	10529	79828	6504	4174	28998	23326	51	3015	54797	765	8975	5888	5366	2730	29883	10767	10606	6580	6629	84288	56985	1627	308	875	57045	9700	220134	3838	23074	8566	51728	1632	3601	4751	3149	4940	7263	2739	64151	78999	4678	5557	839	3458	79023	966	8061	1977	63933	9631	1029	3396	1022	10146	6351	7293	23516	142	587	23191	84296	51164	3383	1058	50487	3014	8140	5705	79022	2037	1437	4644	79733	5427	403	8189	1163	1728	4670	283638	7873	51776	3336	56938	10775	5019	22974	2958	7468	84516	8872	54968	3419	404672	1207	11004	3799	23028	57003	54952	4436	9401	28231	522	11065	5796	7533	58472	10252	79038	7027	2079	874	518	29104	29922	9793	6919	5464	55635	23507	3070	6634	27075	5887	641	2200	9133	54552	708	51637	3662	2171	687
GSE3982_NKCELL_VS_TH2_UP	M5596		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1836_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of NK cells versus Th2 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					22838	728	22898	23066	693207	182	10277	9755	65997	11255	29068	22875	50650	9609	4883	819	2850	81553	3820	79156	25763	6847	79654	8396	2064	389677	10451	51271	54996	6097	10163	79823	55113	23255	23031	51635	30008	58510	79611	11000	2752	552	5465	4053	9314	7424	3113	8303	2572	5671	2534	51200	8273	23338	23042	9679	5241	284244	643641	25830	9002	3359	55332	11141	23248	5806	56101	5880	8507	3631	3553	25	8848	55316	80310	10462	94026	2844	93643	55664	26577	23383	2328	55211	55030	89874	26148	2040	9802	2158	3683	10603	51332	54869	4284	10544	10869	7380	85377	55072	3084	11026	80778	23140	51619	3758	313	100462953	26020	728855	84168	7168	55765	22920	9227	81569	88	51066	7294	56895	60489	301	1910	6256	55208	9873	4077	55286	58189	386627	23224	55182	10287	1050	6988	2828	51706	11178	11278	2953	55220	64446	126070	11223	1200	960	6387	388714	5063	4126	203	5148	81030	50489	1909	92249	9842	5791	3101	55364	3823	2848	3575	55691	416	11126	8927	57658	29799	10346	22932	7702	3568	60313	51267	623	79661	2205	9331	3207	9399	4795	11013	3768	3107	80022	6285	2570	5858	22866	10417	6850	4600	8076	2998	22884	3493	55654	9288	11188
GSE3982_NKCELL_VS_TH2_DN	M5598		16474395	Jeffrey KL,Brummer T,Rolph MS,Liu SM,Callejas NA,Grumont RJ,Gillieron C,Mackay F,Grey S,Camps M,Rommel C,Gerondakis SD,Mackay CR.	GSE3982	GSE3982_1836_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of NK cells versus Th2 cells.	In the present study we used Affymetrix oligonucleotide microarrays to produce gene transcription profiles for the major leukocyte types in humans. This comprehensive dataset enabled us to not only establish which genes were expressed in each leukocyte type, but also which genes were expressed in each subset after activation. The used of a comprehensive dataset of gene profiles from all the major human leukocyte subsets enabled a novel and powerful means for identification of genes associated with single leukocyte subsets, or different immune paradigms.					6504	55706	332	128872	25987	5321	4345	7818	6790	8821	890	9590	29909	2746	1164	3945	6241	79898	65260	8395	3396	3426	9232	9585	2483	7517	5743	28755	78999	4624	55775	6634	80128	6059	9429	79022	1871	79081	11222	51805	943	7334	8996	84296	11332	56946	60436	7247	5705	55423	7430	51053	64759	57476	51659	79683	55320	79017	56902	5264	10952	6319	9363	10592	54913	60558	6240	55003	9700	64151	94081	80055	201626	6478	3832	79074	9882	2491	29028	3383	29883	10691	23516	54463	1207	2034	959	5111	4193	8872	23074	6637	8140	993	146909	1058	10102	11004	9918	5932	80742	2098	5515	9603	7417	5634	2037	23507	4709	908	10112	1163	56683	1805	3015	10663	4174	5106	7298	5693	9361	6426	51371	10935	6742	6445	26512	54892	498	29851	3190	26156	5471	54962	7027	1846	2222	8294	9767	5008	126298	56672	5694	506	51068	6767	25932	9184	8270	4678	27340	51631	29088	81570	9133	55215	5899	59269	81930	10574	28231	5888	51493	9532	5984	8438	51637	11051	11259	9555	55127	26586	3336	6635	8189	5427	51409	27079	2958	4436	4686	7873	54968	55732	6491	3099	9141	54674	1022	27075	30844	8533	8139	708	51203	51514	9937	51121	23150	23649
GSE6269_HEALTHY_VS_FLU_INF_PBMC_UP	M5639		17105821	Ramilo O,Allman W,Chung W,Mejias A,Ardura M,Glaser C,Wittkowski KM,Piqueras B,Banchereau J,Palucka AK,Chaussabel D.	GSE6269	GSE6269_1514_200_UP			HG-U133A	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMC from patients with acute influenza infection.	Each infectious agent represents a unique combination of pathogen-associated molecular patterns that interact with specific pattern-recognition receptors expressed on immune cells. Therefore, we surmised that the blood immune cells of individuals with different infections might bear discriminative transcriptional signatures. Gene expression profiles were obtained for 131 peripheral blood samples from pediatric patients with acute infections caused by influenza A virus, Gram-negative (Escherichia coli) or Gram-positive (Staphylococcus aureus and Streptococcus pneumoniae) bacteria. Thirty-five genes were identified that best discriminate patients with influenza A virus infection from patients with either E coli or S pneumoniae infection. These genes classified with 95% accuracy (35 of 37 samples) an independent set of patients with either influenza A, E coli, or S pneumoniae infection. A different signature discriminated patients with E coli versus S aureus infections with 85% accuracy (34 of 40). Furthermore, distinctive gene expression patterns were observed in patients presenting with respiratory infections of different etiologies. Thus, microarray analyses of patient peripheral blood leukocytes might assist in the differential diagnosis of infectious diseases.					54681	9827	2027	5859	388969	2145	8881	2308	57326	6124	6206	6146	51386	79960	2744	8398	6234	738	6189	5624	150967	2168	51149	27044	6122	10235	6139	4249	755	5498	7311	64781	55727	57446	23180	1327	644068	10147	9692	50717	51008	84747	7329	55692	6125	8664	1937	9349	472	27352	4301	27065	6159	9184	56941	55794	6134	6152	51372	1819	6418	51611	8665	25777	911	4034	27335	1374	3603	56997	284244	51433	23547	23633	8667	643	335	4736	347735	3831	57447	154881	55274	3117	989	3119	23075	7818	6013	6653	1933	1235	79676	54585	3843	196743	9923	24139	8409	6869	54470	10949	9791	9812	3995	2091	5051	3834	8480	5826	2047	10075	6204	5436	5579	2908	23098	4741	56926	8879	10681	65110	3097	2248	23177	120227	266655	60481	5345	8574	8938	51347	22984	6137	6430	84939	6909	58487	23231	80755	4772	7036	5453	155400	58157	54973	23450	10938	9324	53944	23028	100289410	27300	29997	64106	3820	3604	689	54487	390998	26121	8893	3382	1939	9044	5590	9695	79874	54509	6142	56980	3305
GSE6269_HEALTHY_VS_FLU_INF_PBMC_DN	M5640		17105821	Ramilo O,Allman W,Chung W,Mejias A,Ardura M,Glaser C,Wittkowski KM,Piqueras B,Banchereau J,Palucka AK,Chaussabel D.	GSE6269	GSE6269_1514_200_DN			HG-U133A	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMC from patients with acute influenza infection.	Each infectious agent represents a unique combination of pathogen-associated molecular patterns that interact with specific pattern-recognition receptors expressed on immune cells. Therefore, we surmised that the blood immune cells of individuals with different infections might bear discriminative transcriptional signatures. Gene expression profiles were obtained for 131 peripheral blood samples from pediatric patients with acute infections caused by influenza A virus, Gram-negative (Escherichia coli) or Gram-positive (Staphylococcus aureus and Streptococcus pneumoniae) bacteria. Thirty-five genes were identified that best discriminate patients with influenza A virus infection from patients with either E coli or S pneumoniae infection. These genes classified with 95% accuracy (35 of 37 samples) an independent set of patients with either influenza A, E coli, or S pneumoniae infection. A different signature discriminated patients with E coli versus S aureus infections with 85% accuracy (34 of 40). Furthermore, distinctive gene expression patterns were observed in patients presenting with respiratory infections of different etiologies. Thus, microarray analyses of patient peripheral blood leukocytes might assist in the differential diagnosis of infectious diseases.					4061	7094	7791	5127	3429	10410	5315	2771	6614	8775	10945	4924	6688	3959	127544	3135	9810	2210	10581	5359	10964	79144	7040	813	23558	2280	4599	3005	60	56894	6813	10797	3430	7454	113178	26010	4938	8519	396	27351	4939	2907	22904	29888	5371	5610	91543	9636	2885	6036	2537	4940	10367	811	8638	9191	10561	4046	6282	5973	215	972	23770	7030	63940	3428	3965	23646	2048	3105	11274	488	1200	51510	124222	55969	9826	23166	226	710	4001	133	7531	29015	9683	8407	140885	92579	9555	3437	2778	3257	4478	53826	368	23179	5739	23648	54739	51338	29931	10956	55640	808	462	2798	6721	26000	200315	90379	3434	254359	10554	2512	10261	4600	145389	1912	1509	7706	5062	23080	2896	4782	1266	5991	9749	1822	9811	2119	108	79080	284266	717	91300	4082	10855	2014	9111	55008	80896	535	9230	9777	51191	23367	405	10197	8242	968	26099	377	31	50488	7097	58526	10768	4752	4107	83442
GSE6269_HEALTHY_VS_E_COLI_INF_PBMC_UP	M5641		17105821	Ramilo O,Allman W,Chung W,Mejias A,Ardura M,Glaser C,Wittkowski KM,Piqueras B,Banchereau J,Palucka AK,Chaussabel D.	GSE6269	GSE6269_1515_200_UP			HG-U133A	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMC from patients with acute E. coli infection.	Each infectious agent represents a unique combination of pathogen-associated molecular patterns that interact with specific pattern-recognition receptors expressed on immune cells. Therefore, we surmised that the blood immune cells of individuals with different infections might bear discriminative transcriptional signatures. Gene expression profiles were obtained for 131 peripheral blood samples from pediatric patients with acute infections caused by influenza A virus, Gram-negative (Escherichia coli) or Gram-positive (Staphylococcus aureus and Streptococcus pneumoniae) bacteria. Thirty-five genes were identified that best discriminate patients with influenza A virus infection from patients with either E coli or S pneumoniae infection. These genes classified with 95% accuracy (35 of 37 samples) an independent set of patients with either influenza A, E coli, or S pneumoniae infection. A different signature discriminated patients with E coli versus S aureus infections with 85% accuracy (34 of 40). Furthermore, distinctive gene expression patterns were observed in patients presenting with respiratory infections of different etiologies. Thus, microarray analyses of patient peripheral blood leukocytes might assist in the differential diagnosis of infectious diseases.					9923	27429	2145	1235	9659	64760	254531	7016	1453	4261	10425	3495	51347	9938	11120	9924	8237	57406	7596	6837	23492	23199	23231	1196	64771	9761	5243	10421	64130	57728	25900	10235	23062	5863	6311	9368	5498	10347	23463	7841	91754	5727	11186	22914	23053	54963	1120	29125	8904	10130	6396	23526	4204	54681	10863	54973	84939	30833	50717	64222	8603	3661	51588	9546	3995	9632	155400	3119	79726	22837	10181	154	9711	25825	29990	79874	25865	5826	51230	10147	4897	64110	84901	79744	11098	11079	54872	23550	51409	3712	640	79960	89781	64175	9913	22937	2744	9667	50615	4864	79902	57553	10099	825	56339	643	22835	23341	10263	23042	266655	7767	54737	56941	100507424	11232	84859	2064	55791	6499	6526	3117	91316	57380	23142	11184	9814	4899	57205	4674	79959	10120	2580	1292	6305	84619	78987	5026	837	37	55846	8717	11188	3993	3566	24139	10514	30827	10745	7692	27352	80324	51585	3493	6199	9957	7088	55374	8165	25864	10598	23259	5998	6877	4034	9013	22990	6874	9744	375056	4306	7109	10636
GSE6269_HEALTHY_VS_E_COLI_INF_PBMC_DN	M5642		17105821	Ramilo O,Allman W,Chung W,Mejias A,Ardura M,Glaser C,Wittkowski KM,Piqueras B,Banchereau J,Palucka AK,Chaussabel D.	GSE6269	GSE6269_1515_200_DN			HG-U133A	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMC from patients with acute E. coli infection.	Each infectious agent represents a unique combination of pathogen-associated molecular patterns that interact with specific pattern-recognition receptors expressed on immune cells. Therefore, we surmised that the blood immune cells of individuals with different infections might bear discriminative transcriptional signatures. Gene expression profiles were obtained for 131 peripheral blood samples from pediatric patients with acute infections caused by influenza A virus, Gram-negative (Escherichia coli) or Gram-positive (Staphylococcus aureus and Streptococcus pneumoniae) bacteria. Thirty-five genes were identified that best discriminate patients with influenza A virus infection from patients with either E coli or S pneumoniae infection. These genes classified with 95% accuracy (35 of 37 samples) an independent set of patients with either influenza A, E coli, or S pneumoniae infection. A different signature discriminated patients with E coli versus S aureus infections with 85% accuracy (34 of 40). Furthermore, distinctive gene expression patterns were observed in patients presenting with respiratory infections of different etiologies. Thus, microarray analyses of patient peripheral blood leukocytes might assist in the differential diagnosis of infectious diseases.					57175	8200	2920	5991	3091	2280	5739	2210	5144	84981	28316	4680	133	55061	2752	6612	7105	6037	27284	22919	80099	200424	6783	4223	2119	6386	998	11060	3005	1410	6272	10816	1536	9037	11067	7706	29895	5341	4353	11223	8632	6782	5657	29931	6690	4158	7763	8817	4149	54978	2155	7323	6583	51646	1268	5329	1621	4170	57572	140885	732	23452	5968	571	5209	10950	57348	9421	3248	80742	1576	5099	3205	10643	273	1845	5915	43849	4241	6357	27351	10439	65055	23034	57333	665	9811	80896	3576	5364	10647	2036	7803	1644	2346	3910	1287	1046	9802	405	83464	79843	7416	100131825	100507009	23254	776	7321	9205	8767	10376	653	2495	10116	6530	7126	1299	8022	671	6715	5646	4478	83696	1992	2710	55647	6648	7006	3982	25758	8291	440915	10298	11213	1649	9095	7386	79170	1047	1734	9119	1991	2099	114818	79887	8717	9262	2528	4084	2877	54879	10564	10395	960	6367	2713	796	26	23759	4355	23328	55079	4040	7551	2048	1730	8407	4288	728621	1106
GSE6269_FLU_VS_STAPH_AUREUS_INF_PBMC_UP	M5643		17105821	Ramilo O,Allman W,Chung W,Mejias A,Ardura M,Glaser C,Wittkowski KM,Piqueras B,Banchereau J,Palucka AK,Chaussabel D.	GSE6269	GSE6269_1516_200_UP			HG-U133A	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMC from patients with acute S. aureus infection.	Each infectious agent represents a unique combination of pathogen-associated molecular patterns that interact with specific pattern-recognition receptors expressed on immune cells. Therefore, we surmised that the blood immune cells of individuals with different infections might bear discriminative transcriptional signatures. Gene expression profiles were obtained for 131 peripheral blood samples from pediatric patients with acute infections caused by influenza A virus, Gram-negative (Escherichia coli) or Gram-positive (Staphylococcus aureus and Streptococcus pneumoniae) bacteria. Thirty-five genes were identified that best discriminate patients with influenza A virus infection from patients with either E coli or S pneumoniae infection. These genes classified with 95% accuracy (35 of 37 samples) an independent set of patients with either influenza A, E coli, or S pneumoniae infection. A different signature discriminated patients with E coli versus S aureus infections with 85% accuracy (34 of 40). Furthermore, distinctive gene expression patterns were observed in patients presenting with respiratory infections of different etiologies. Thus, microarray analyses of patient peripheral blood leukocytes might assist in the differential diagnosis of infectious diseases.					53335	80008	5893	6480	56941	10223	54482	51134	5026	10982	2744	26048	50717	5796	23550	9841	23526	3707	64863	4063	9014	79652	80862	9788	388650	10478	57326	2823	10799	54908	22984	55888	51147	84939	6526	1353	79677	54465	54585	91754	221443	23341	9938	10507	930	4281	8621	10598	8202	10771	11120	5358	55657	10365	3507	23180	5498	9711	54872	3652	9110	55744	22889	260294	1856	2841	3635	84859	54955	3112	23508	22954	7088	7596	664	90861	54014	5074	55340	11276	9093	54737	971	3495	8604	1629	3603	22837	113251	11083	79084	1380	55735	8602	933	9923	55876	79871	84726	6929	4863	55227	23386	22880	120227	79368	120526	11232	25865	54847	3716	23384	374354	57019	55226	2648	5162	25777	54971	54674	3097	10099	23344	79842	80335	51106	79676	8893	10181	8603	10575	6689	10447	10807	1528	4261	100	5437	9924	9725	55037	4999	7728	29990	9397	79899	5101	7915	27332	6625	104	64400	9814	640	9252	23338	81606	1453	4926	28755	54900	55374	27300	6118	56950	5244	2625	2145	10803	55791	23062	5001	114884	939	26119	25782	10235	2071	23492	25970	9939	79064
GSE6269_FLU_VS_STAPH_AUREUS_INF_PBMC_DN	M5644		17105821	Ramilo O,Allman W,Chung W,Mejias A,Ardura M,Glaser C,Wittkowski KM,Piqueras B,Banchereau J,Palucka AK,Chaussabel D.	GSE6269	GSE6269_1516_200_DN			HG-U133A	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMC from patients with acute S. aureus infection.	Each infectious agent represents a unique combination of pathogen-associated molecular patterns that interact with specific pattern-recognition receptors expressed on immune cells. Therefore, we surmised that the blood immune cells of individuals with different infections might bear discriminative transcriptional signatures. Gene expression profiles were obtained for 131 peripheral blood samples from pediatric patients with acute infections caused by influenza A virus, Gram-negative (Escherichia coli) or Gram-positive (Staphylococcus aureus and Streptococcus pneumoniae) bacteria. Thirty-five genes were identified that best discriminate patients with influenza A virus infection from patients with either E coli or S pneumoniae infection. These genes classified with 95% accuracy (35 of 37 samples) an independent set of patients with either influenza A, E coli, or S pneumoniae infection. A different signature discriminated patients with E coli versus S aureus infections with 85% accuracy (34 of 40). Furthermore, distinctive gene expression patterns were observed in patients presenting with respiratory infections of different etiologies. Thus, microarray analyses of patient peripheral blood leukocytes might assist in the differential diagnosis of infectious diseases.					3958	1845	6924	3557	6386	133	9802	7077	7791	140885	4354	665	6280	5329	54472	353514	290	645	6279	2210	2769	8804	375	8754	6256	127544	967	948	84981	5538	5341	7090	2000	6648	79143	7030	334	55640	5265	5552	9741	10855	4084	2752	10043	10105	58528	8775	5355	2495	6282	9021	28232	51257	527	6583	3084	6272	1438	9811	968	1508	3920	1026	10970	79056	7076	51094	8780	2896	4814	433	22918	53826	4149	2597	6556	1992	23166	64581	64127	2275	55240	1958	10501	10209	6688	1462	6604	7071	1441	4069	9555	80896	2219	6009	9645	55647	4783	2907	3459	23645	1912	2876	8291	6624	22904	5861	683	2180	1717	57161	5025	7097	3005	3992	10226	1509	29940	51304	55969	3613	10602	25797	2526	23034	2790	9341	2357	7763	5226	1362	3383	84034	9953	7431	6036	79901	1032	23646	54741	9586	8522	7086	4758	368	717	6721	79971	79887	6612	10577	55819	8875	10437	378	3556	6281	51296	2710	3091	3910	5029	4689	1051	6253	22797
GSE6269_HEALTHY_VS_STAPH_PNEUMO_INF_PBMC_UP	M5648		17105821	Ramilo O,Allman W,Chung W,Mejias A,Ardura M,Glaser C,Wittkowski KM,Piqueras B,Banchereau J,Palucka AK,Chaussabel D.	GSE6269	GSE6269_1517_200_UP			HG-U133A	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMC from patients with acute S. pneumoniae infection.	Each infectious agent represents a unique combination of pathogen-associated molecular patterns that interact with specific pattern-recognition receptors expressed on immune cells. Therefore, we surmised that the blood immune cells of individuals with different infections might bear discriminative transcriptional signatures. Gene expression profiles were obtained for 131 peripheral blood samples from pediatric patients with acute infections caused by influenza A virus, Gram-negative (Escherichia coli) or Gram-positive (Staphylococcus aureus and Streptococcus pneumoniae) bacteria. Thirty-five genes were identified that best discriminate patients with influenza A virus infection from patients with either E coli or S pneumoniae infection. These genes classified with 95% accuracy (35 of 37 samples) an independent set of patients with either influenza A, E coli, or S pneumoniae infection. A different signature discriminated patients with E coli versus S aureus infections with 85% accuracy (34 of 40). Furthermore, distinctive gene expression patterns were observed in patients presenting with respiratory infections of different etiologies. Thus, microarray analyses of patient peripheral blood leukocytes might assist in the differential diagnosis of infectious diseases.					9957	79039	2055	10147	84939	23265	51399	10898	27429	55692	23048	1776	27352	27346	155400	5243	23015	2271	221443	5436	7322	55662	51106	3712	79078	8398	79676	8893	9391	4926	6396	5428	23526	79726	9632	5889	51611	51008	10329	22914	5984	9368	9014	6305	9938	352961	10598	56910	65109	10235	7260	7644	158	80222	23547	54908	3495	1635	57326	8567	202181	1120	79156	3431	23341	9289	4281	23550	9669	79899	9924	10574	7268	97	6239	339448	25777	2145	10384	83988	55876	100	5437	10575	79667	30000	6526	10514	11186	375056	54872	25865	6645	11083	1736	9666	23016	8498	55720	55634	5976	1235	260294	9788	3394	5551	23070	5826	100507424	80162	9692	6013	1028	50628	84901	55037	55501	3002	51134	4951	51230	5936	8451	6950	11119	4678	3716	84263	79902	7541	8237	54785	9725	55374	8227	7486	441263	11098	10771	1453	1163	91754	3097	28387	51147	79631	868	3603	9814	83752	5775	30833	9923	5521	10000	7694	3635	203197	5698	5496	9744	10803	56980	5162	4522	80895	4864	292	23344	9049	6294	4750	10181	81030	274	10608	2734	440515	56983	93594	54977	7957	4285	54465	5583	4338	10478	404672	11066
GSE6269_HEALTHY_VS_STAPH_PNEUMO_INF_PBMC_DN	M5649		17105821	Ramilo O,Allman W,Chung W,Mejias A,Ardura M,Glaser C,Wittkowski KM,Piqueras B,Banchereau J,Palucka AK,Chaussabel D.	GSE6269	GSE6269_1517_200_DN			HG-U133A	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMC from patients with acute S. pneumoniae infection.	Each infectious agent represents a unique combination of pathogen-associated molecular patterns that interact with specific pattern-recognition receptors expressed on immune cells. Therefore, we surmised that the blood immune cells of individuals with different infections might bear discriminative transcriptional signatures. Gene expression profiles were obtained for 131 peripheral blood samples from pediatric patients with acute infections caused by influenza A virus, Gram-negative (Escherichia coli) or Gram-positive (Staphylococcus aureus and Streptococcus pneumoniae) bacteria. Thirty-five genes were identified that best discriminate patients with influenza A virus infection from patients with either E coli or S pneumoniae infection. These genes classified with 95% accuracy (35 of 37 samples) an independent set of patients with either influenza A, E coli, or S pneumoniae infection. A different signature discriminated patients with E coli versus S aureus infections with 85% accuracy (34 of 40). Furthermore, distinctive gene expression patterns were observed in patients presenting with respiratory infections of different etiologies. Thus, microarray analyses of patient peripheral blood leukocytes might assist in the differential diagnosis of infectious diseases.					1462	1845	1545	9936	2052	5094	10970	127544	3958	5538	948	9741	4057	2776	6583	2710	2210	23166	140885	645	5271	2896	1536	3459	10226	55240	8416	7799	51094	2878	9314	1486	5768	2180	56998	5341	3005	6386	3934	54978	820	1088	79901	831	23001	22918	57161	6286	1441	133	2526	3557	3597	9545	79887	10043	967	1200	2357	2752	2185	6272	7706	665	1362	6280	6566	5226	671	3674	1958	683	9645	10767	2353	1984	2263	5861	8291	1669	80896	2799	953	8218	51257	1299	9236	2934	79143	7030	9826	9469	9802	1438	3992	7422	6283	1439	2153	3359	3576	10209	6036	1992	3460	55640	5739	929	5339	978	604	1991	25797	57178	5045	3920	3613	4353	6038	5329	1520	7077	6279	2885	368	6688	51652	566	10491	23673	4689	9811	602	51090	1308	51312	10880	22856	4130	2204	9530	4680	6622	9332	9454	226	5355	706	527	7791	23452	9021	5657	10398	23601	7204	9191	2219	10105	80099	27141	9341	51338	334	945	8754	1595	90411	4815
GSE6269_FLU_VS_E_COLI_INF_PBMC_UP	M5653		17105821	Ramilo O,Allman W,Chung W,Mejias A,Ardura M,Glaser C,Wittkowski KM,Piqueras B,Banchereau J,Palucka AK,Chaussabel D.	GSE6269	GSE6269_1518_200_UP			HG-U133A	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute influenza infection versus PBMC from patients with acute E. coli infection.	Each infectious agent represents a unique combination of pathogen-associated molecular patterns that interact with specific pattern-recognition receptors expressed on immune cells. Therefore, we surmised that the blood immune cells of individuals with different infections might bear discriminative transcriptional signatures. Gene expression profiles were obtained for 131 peripheral blood samples from pediatric patients with acute infections caused by influenza A virus, Gram-negative (Escherichia coli) or Gram-positive (Staphylococcus aureus and Streptococcus pneumoniae) bacteria. Thirty-five genes were identified that best discriminate patients with influenza A virus infection from patients with either E coli or S pneumoniae infection. These genes classified with 95% accuracy (35 of 37 samples) an independent set of patients with either influenza A, E coli, or S pneumoniae infection. A different signature discriminated patients with E coli versus S aureus infections with 85% accuracy (34 of 40). Furthermore, distinctive gene expression patterns were observed in patients presenting with respiratory infections of different etiologies. Thus, microarray analyses of patient peripheral blood leukocytes might assist in the differential diagnosis of infectious diseases.					26010	64755	2011	11274	6046	51291	6614	10581	4849	3959	4967	1981	9810	10410	9761	811	4599	10561	7454	3428	8519	23334	23070	9381	6185	10964	50813	7009	30827	10945	9749	10603	8820	2801	7791	7094	55026	5610	81	57130	6464	10475	396	9733	54739	5315	10197	2537	825	2771	9830	3106	55008	51290	9711	23131	90379	5813	4939	3430	91543	54676	7297	4938	23199	26007	8943	23054	1639	253980	3338	6830	2185	9683	57591	3137	29888	92140	27434	4940	9166	8554	7040	7398	22839	6522	488	3105	1312	1066	29959	54458	3665	23636	8638	80774	7841	81030	55501	1234	7317	896	23367	51495	4924	2014	80209	972	64761	9887	26099	51347	26005	9636	7531	5452	23053	80305	7318	23383	25840	23253	8050	339044	6737	6721	22985	84901	3423	55159	4001	23218	10552	4600	24145	103	55337	9757	55601	3661	84656	9100	79654	10130	996	8237	7456	2580	4318	5298	100132406	6650	9360	4650	9208	1785	2186	2867	375790	8348	23339	60
GSE6269_FLU_VS_E_COLI_INF_PBMC_DN	M5654		17105821	Ramilo O,Allman W,Chung W,Mejias A,Ardura M,Glaser C,Wittkowski KM,Piqueras B,Banchereau J,Palucka AK,Chaussabel D.	GSE6269	GSE6269_1518_200_DN			HG-U133A	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute influenza infection versus PBMC from patients with acute E. coli infection.	Each infectious agent represents a unique combination of pathogen-associated molecular patterns that interact with specific pattern-recognition receptors expressed on immune cells. Therefore, we surmised that the blood immune cells of individuals with different infections might bear discriminative transcriptional signatures. Gene expression profiles were obtained for 131 peripheral blood samples from pediatric patients with acute infections caused by influenza A virus, Gram-negative (Escherichia coli) or Gram-positive (Staphylococcus aureus and Streptococcus pneumoniae) bacteria. Thirty-five genes were identified that best discriminate patients with influenza A virus infection from patients with either E coli or S pneumoniae infection. These genes classified with 95% accuracy (35 of 37 samples) an independent set of patients with either influenza A, E coli, or S pneumoniae infection. A different signature discriminated patients with E coli versus S aureus infections with 85% accuracy (34 of 40). Furthermore, distinctive gene expression patterns were observed in patients presenting with respiratory infections of different etiologies. Thus, microarray analyses of patient peripheral blood leukocytes might assist in the differential diagnosis of infectious diseases.					5859	51386	6134	140801	9812	5143	64106	1975	7311	6129	29895	1933	80349	79057	6137	8665	259	57707	8664	6189	6124	8761	27115	51761	4673	10266	2263	6141	8717	79981	5891	4137	55810	43849	9349	390998	79999	5607	1768	6125	9568	689	51350	54752	57576	732	56969	25822	6146	960	7018	8120	1938	30846	2125	11178	25859	3753	5094	51561	5017	55879	55258	1160	57572	491	4242	771	6154	6783	5818	65009	54920	2995	7216	4015	292	7480	57104	2047	1948	10844	4301	800	9123	9693	10983	4935	10360	860	5267	93144	375790	6193	374395	23063	3170	261734	7054	835	6138	989	4059	3859	23428	3834	6513	63970	1057	6122	1852	2168	51198	57369	341	2091	5789	6767	8728	27121	25987	11333	10994	353514	486	51046	1394	27077	2267	4613	1327	57447	57128	4629	6159	9849	9644	84033	3744	55214	8531	6191	655	5156	1908	54552	354	3848	1356	5606	8840	23205	4109	2122	2100	1621	644068	10841	4914	2199	6160	3046	6508	2954
GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_UP	M5655		17105821	Ramilo O,Allman W,Chung W,Mejias A,Ardura M,Glaser C,Wittkowski KM,Piqueras B,Banchereau J,Palucka AK,Chaussabel D.	GSE6269	GSE6269_1519_200_UP			HG-U133A	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute influenza infection versus PBMC from patients with acute S. aureus infection.	Each infectious agent represents a unique combination of pathogen-associated molecular patterns that interact with specific pattern-recognition receptors expressed on immune cells. Therefore, we surmised that the blood immune cells of individuals with different infections might bear discriminative transcriptional signatures. Gene expression profiles were obtained for 131 peripheral blood samples from pediatric patients with acute infections caused by influenza A virus, Gram-negative (Escherichia coli) or Gram-positive (Staphylococcus aureus and Streptococcus pneumoniae) bacteria. Thirty-five genes were identified that best discriminate patients with influenza A virus infection from patients with either E coli or S pneumoniae infection. These genes classified with 95% accuracy (35 of 37 samples) an independent set of patients with either influenza A, E coli, or S pneumoniae infection. A different signature discriminated patients with E coli versus S aureus infections with 85% accuracy (34 of 40). Furthermore, distinctive gene expression patterns were observed in patients presenting with respiratory infections of different etiologies. Thus, microarray analyses of patient peripheral blood leukocytes might assist in the differential diagnosis of infectious diseases.					3428	4061	26010	3959	4939	55601	6614	546	10561	4599	5610	10964	27074	8519	55008	54739	23070	26005	1629	8405	53335	9636	4940	3430	9887	54908	9830	64755	28977	9381	91543	2186	23325	9110	64761	29802	9522	7398	2734	10410	55888	9698	51134	3665	85363	23043	10475	11278	5557	103	79064	54955	4297	3431	9711	4938	80067	4012	9663	8202	2537	64863	10478	221443	6046	1981	3669	9881	23049	79676	10346	10982	9733	4600	3728	8050	3106	55171	8943	23367	81030	55026	54517	8615	58517	3653	30827	120	5983	961	84901	6597	27005	1108	55729	5101	51290	54482	55084	5481	6925	4863	28973	57187	9749	80862	54454	29909	26048	26019	6619	8621	5800	10365	51755	2113	9399	5358	8638	5471	56928	10223	55337	8604	51191	55120	6772	1737	5788	80055	56987	55055	9014	9194	10492	5469	7072	54900	5965	25957	23607	93973	100170939	113251	11338	55847	55735	388	51495	25865	55615	23386	10505	10847	5371	951	10111	9112	51319	3561	90379	8317	3837	7696	22954	79829	79677	9169	51474	79649	23545
GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_DN	M5656		17105821	Ramilo O,Allman W,Chung W,Mejias A,Ardura M,Glaser C,Wittkowski KM,Piqueras B,Banchereau J,Palucka AK,Chaussabel D.	GSE6269	GSE6269_1519_200_DN			HG-U133A	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute influenza infection versus PBMC from patients with acute S. aureus infection.	Each infectious agent represents a unique combination of pathogen-associated molecular patterns that interact with specific pattern-recognition receptors expressed on immune cells. Therefore, we surmised that the blood immune cells of individuals with different infections might bear discriminative transcriptional signatures. Gene expression profiles were obtained for 131 peripheral blood samples from pediatric patients with acute infections caused by influenza A virus, Gram-negative (Escherichia coli) or Gram-positive (Staphylococcus aureus and Streptococcus pneumoniae) bacteria. Thirty-five genes were identified that best discriminate patients with influenza A virus infection from patients with either E coli or S pneumoniae infection. These genes classified with 95% accuracy (35 of 37 samples) an independent set of patients with either influenza A, E coli, or S pneumoniae infection. A different signature discriminated patients with E coli versus S aureus infections with 85% accuracy (34 of 40). Furthermore, distinctive gene expression patterns were observed in patients presenting with respiratory infections of different etiologies. Thus, microarray analyses of patient peripheral blood leukocytes might assist in the differential diagnosis of infectious diseases.					665	3084	65018	4137	8761	54472	58488	57104	51386	960	5576	27293	8522	9645	124044	5094	54997	374395	79901	1593	8996	5250	11261	1852	3489	54849	390998	6653	11152	27023	1327	10991	26508	10609	27190	2168	55065	2034	26100	56998	11178	79065	6758	8665	29937	25790	50632	4000	11334	251	220972	6129	25822	800	2619	2125	58528	3887	6622	8455	43	28232	10401	51660	313	6648	533	5606	57707	4354	54752	9132	27287	10209	689	5864	78995	6624	54555	10844	63876	9362	29895	54918	261734	5733	29122	23174	5459	10233	55968	10266	23541	55625	6011	886	1362	9941	4239	8531	57572	9341	51372	23205	2769	55547	214	11187	2303	9812	2768	100129460	3203	4147	7177	8664	6886	1438	27342	3029	3848	9620	6385	5306	55727	9185	3768	1174	6535	3082	9478	375790	5607	10313	79091	5997	51108	1979	5859	2155	2954	1137	23474	368	81689	253982	79143	9123	6888	5338	3205	5319	10501	9921	56159	219	3850	55240	8528	2038	3761	8793	64064	23053	1948	7087	4914	8780	11031	81490	10489	57110	26873	4335	51304	3338	60528
GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP	M5657		17105821	Ramilo O,Allman W,Chung W,Mejias A,Ardura M,Glaser C,Wittkowski KM,Piqueras B,Banchereau J,Palucka AK,Chaussabel D.	GSE6269	GSE6269_1520_200_UP			HG-U133A	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute influenza infection versus PBMC from patients with acute S. pneumoniae infection.	Each infectious agent represents a unique combination of pathogen-associated molecular patterns that interact with specific pattern-recognition receptors expressed on immune cells. Therefore, we surmised that the blood immune cells of individuals with different infections might bear discriminative transcriptional signatures. Gene expression profiles were obtained for 131 peripheral blood samples from pediatric patients with acute infections caused by influenza A virus, Gram-negative (Escherichia coli) or Gram-positive (Staphylococcus aureus and Streptococcus pneumoniae) bacteria. Thirty-five genes were identified that best discriminate patients with influenza A virus infection from patients with either E coli or S pneumoniae infection. These genes classified with 95% accuracy (35 of 37 samples) an independent set of patients with either influenza A, E coli, or S pneumoniae infection. A different signature discriminated patients with E coli versus S aureus infections with 85% accuracy (34 of 40). Furthermore, distinctive gene expression patterns were observed in patients presenting with respiratory infections of different etiologies. Thus, microarray analyses of patient peripheral blood leukocytes might assist in the differential diagnosis of infectious diseases.					54739	10964	26010	4061	10561	11274	55601	4939	4599	6046	8519	3428	91543	3959	4938	26005	55008	5610	3728	6614	2633	80155	6772	64761	6597	57062	23070	103	51495	3431	3430	9636	7919	57187	8106	9381	9733	10346	7398	2734	9830	5721	2537	10410	3105	23131	81030	60496	23049	81	9749	3107	9246	55660	8943	3609	9985	84656	9669	9683	5371	8638	3665	55501	3133	4289	55055	5788	5813	5469	9862	8165	4134	9111	28977	8050	10492	4940	5380	51510	4600	51291	3418	9887	23190	1981	811	1108	51290	1890	64135	55120	54908	8202	3434	3134	10379	55159	23043	54505	6651	2643	6305	2011	51399	51575	5481	55337	51619	5757	3437	57097	9169	9014	60560	221443	23607	5889	90379	64755	9360	100	5698	4297	3106	2186	6491	80184	8869	79064	3161	51586	51131	51191	6158	8402	4763	51029	9881	23060	84901	64108	25807	3561	2618	65987	9422	55026	3070	11169	25	710	58517	6095	29799	8161	9761	57493	22993	23064	1351	10581	6373	3837	55615	3594	1164	10038	23636
GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_DN	M5658		17105821	Ramilo O,Allman W,Chung W,Mejias A,Ardura M,Glaser C,Wittkowski KM,Piqueras B,Banchereau J,Palucka AK,Chaussabel D.	GSE6269	GSE6269_1520_200_DN			HG-U133A	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute influenza infection versus PBMC from patients with acute S. pneumoniae infection.	Each infectious agent represents a unique combination of pathogen-associated molecular patterns that interact with specific pattern-recognition receptors expressed on immune cells. Therefore, we surmised that the blood immune cells of individuals with different infections might bear discriminative transcriptional signatures. Gene expression profiles were obtained for 131 peripheral blood samples from pediatric patients with acute infections caused by influenza A virus, Gram-negative (Escherichia coli) or Gram-positive (Staphylococcus aureus and Streptococcus pneumoniae) bacteria. Thirty-five genes were identified that best discriminate patients with influenza A virus infection from patients with either E coli or S pneumoniae infection. These genes classified with 95% accuracy (35 of 37 samples) an independent set of patients with either influenza A, E coli, or S pneumoniae infection. A different signature discriminated patients with E coli versus S aureus infections with 85% accuracy (34 of 40). Furthermore, distinctive gene expression patterns were observed in patients presenting with respiratory infections of different etiologies. Thus, microarray analyses of patient peripheral blood leukocytes might assist in the differential diagnosis of infectious diseases.					51386	79901	4137	1593	3834	8455	5859	6653	57707	5094	8665	689	56998	644068	3029	6758	51652	1137	368	11030	10991	65018	57165	43	4048	1401	26583	79948	10313	2100	1308	3887	6124	2827	1852	94	251	5627	8733	10233	8761	54997	390998	9362	759	55621	26577	2273	10491	29895	8664	9644	9645	354	3856	665	51170	56957	89870	10579	266	3030	3597	5872	10489	5273	5091	29907	54920	3170	960	9926	2972	4975	1975	6622	6747	2125	8087	10555	58528	7291	2303	7001	253982	7818	8522	1440	55240	6189	2934	6442	51046	11178	7434	2047	10609	5576	5266	8531	2122	23038	54828	2902	79689	84658	3382	55256	8031	3818	63827	6139	55384	6573	27288	1632	1939	4295	4057	25822	7025	10266	51094	6550	11031	4673	353514	7060	23474	7168	23532	5607	55547	2300	138162	55065	7216	9185	347735	6923	6563	8996	8895	78995	10979	23205	1397	1118	27190	3077	4301	4239	140801	5639	54930	27329	5802	3084	1362	4070	7141	8608	6129	7178	1414	100133941	1365	26508	23762	80228	932	375790	138050	8824	5526	9796
GSE6269_E_COLI_VS_STAPH_AUREUS_INF_PBMC_UP	M5659		17105821	Ramilo O,Allman W,Chung W,Mejias A,Ardura M,Glaser C,Wittkowski KM,Piqueras B,Banchereau J,Palucka AK,Chaussabel D.	GSE6269	GSE6269_1521_200_UP			HG-U133A	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute E. coli infection versus PBMC from patients with acute S. aureus infection.	Each infectious agent represents a unique combination of pathogen-associated molecular patterns that interact with specific pattern-recognition receptors expressed on immune cells. Therefore, we surmised that the blood immune cells of individuals with different infections might bear discriminative transcriptional signatures. Gene expression profiles were obtained for 131 peripheral blood samples from pediatric patients with acute infections caused by influenza A virus, Gram-negative (Escherichia coli) or Gram-positive (Staphylococcus aureus and Streptococcus pneumoniae) bacteria. Thirty-five genes were identified that best discriminate patients with influenza A virus infection from patients with either E coli or S pneumoniae infection. These genes classified with 95% accuracy (35 of 37 samples) an independent set of patients with either influenza A, E coli, or S pneumoniae infection. A different signature discriminated patients with E coli versus S aureus infections with 85% accuracy (34 of 40). Furthermore, distinctive gene expression patterns were observed in patients presenting with respiratory infections of different etiologies. Thus, microarray analyses of patient peripheral blood leukocytes might assist in the differential diagnosis of infectious diseases.					6019	53335	3248	10643	2135	1117	5168	10962	100	55061	25814	4862	9079	55679	9315	80862	10178	959	54929	8745	10360	23043	9663	23271	26053	5569	120	5303	5324	55227	6659	5810	203068	79810	9706	9452	27109	57111	57116	1528	26249	1028	54674	57048	9399	8871	57134	9781	8642	969	5796	292	64710	534	9500	6091	79621	10365	9252	63826	79690	10801	57150	133619	5101	8801	3399	10799	22836	5287	6175	25961	79649	90861	10521	7273	23005	57125	23331	54463	10505	388650	6328	22859	10051	100506963	5557	54903	9249	23230	114112	3725	9875	989	3575	54840	341	6530	4939	1380	54585	1353	10140	6453	28969	117247	80349	9698	961	5213	55013	51561	85458	8717	1831	10913	85453	92017	26189	10982	3572	79135	51134	23484	57175	27099	399	115123	8556	1540	80063	399665	9397	8202	28517	2113	10301	22823	5366	9866	10499	23357	79084	9816	1290	23255	79140	9093	940	5916	751816	4300	1579	6228	6146	84298	3837	694	9898	10842
GSE6269_E_COLI_VS_STAPH_AUREUS_INF_PBMC_DN	M5660		17105821	Ramilo O,Allman W,Chung W,Mejias A,Ardura M,Glaser C,Wittkowski KM,Piqueras B,Banchereau J,Palucka AK,Chaussabel D.	GSE6269	GSE6269_1521_200_DN			HG-U133A	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute E. coli infection versus PBMC from patients with acute S. aureus infection.	Each infectious agent represents a unique combination of pathogen-associated molecular patterns that interact with specific pattern-recognition receptors expressed on immune cells. Therefore, we surmised that the blood immune cells of individuals with different infections might bear discriminative transcriptional signatures. Gene expression profiles were obtained for 131 peripheral blood samples from pediatric patients with acute infections caused by influenza A virus, Gram-negative (Escherichia coli) or Gram-positive (Staphylococcus aureus and Streptococcus pneumoniae) bacteria. Thirty-five genes were identified that best discriminate patients with influenza A virus infection from patients with either E coli or S pneumoniae infection. These genes classified with 95% accuracy (35 of 37 samples) an independent set of patients with either influenza A, E coli, or S pneumoniae infection. A different signature discriminated patients with E coli versus S aureus infections with 85% accuracy (34 of 40). Furthermore, distinctive gene expression patterns were observed in patients presenting with respiratory infections of different etiologies. Thus, microarray analyses of patient peripheral blood leukocytes might assist in the differential diagnosis of infectious diseases.					4122	8972	4318	54480	10954	3684	3482	6809	22990	334	79759	23601	11316	4758	1241	51547	5879	4644	3992	23129	54862	10970	5034	8760	140885	2920	1509	1378	55002	290	23761	4051	26007	79789	9454	7165	3614	3383	3958	10548	23166	9885	10618	79176	4094	25844	9260	2588	6280	182	1441	435	7030	1066	4317	387893	7106	64943	5806	10004	3309	214	3916	2153	51100	206358	51172	2597	6774	55911	56005	1374	57136	9170	3687	8522	56654	2319	5997	8843	79056	8733	3985	5873	8178	2069	51635	101	3084	3613	285203	7123	131601	50848	813	2896	8754	23053	3654	533	51296	5066	3636	1545	127544	55969	6037	1912	10162	6185	64834	5894	2769	1981	3092	54436	51593	5836	27128	375	1362	3423	51150	10295	7084	2529	10130	2921	3205	822	9673	6238	30001	9121	23218	11047	64222	4542	7850	26577	7791	8566	6277	5447	8870	3117	10552	10908	3340	6624	929	4069	7097	5791	5580	1201	7376	29110	3554	8794	54682	2286	116496	9989	65010	6038	5355	23231	10602	9051	9871	29109
GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_UP	M5661		17105821	Ramilo O,Allman W,Chung W,Mejias A,Ardura M,Glaser C,Wittkowski KM,Piqueras B,Banchereau J,Palucka AK,Chaussabel D.	GSE6269	GSE6269_1522_200_UP			HG-U133A	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute E. coli infection versus PBMC from patients with acute S. pneumoniae infection.	Each infectious agent represents a unique combination of pathogen-associated molecular patterns that interact with specific pattern-recognition receptors expressed on immune cells. Therefore, we surmised that the blood immune cells of individuals with different infections might bear discriminative transcriptional signatures. Gene expression profiles were obtained for 131 peripheral blood samples from pediatric patients with acute infections caused by influenza A virus, Gram-negative (Escherichia coli) or Gram-positive (Staphylococcus aureus and Streptococcus pneumoniae) bacteria. Thirty-five genes were identified that best discriminate patients with influenza A virus infection from patients with either E coli or S pneumoniae infection. These genes classified with 95% accuracy (35 of 37 samples) an independent set of patients with either influenza A, E coli, or S pneumoniae infection. A different signature discriminated patients with E coli versus S aureus infections with 85% accuracy (34 of 40). Furthermore, distinctive gene expression patterns were observed in patients presenting with respiratory infections of different etiologies. Thus, microarray analyses of patient peripheral blood leukocytes might assist in the differential diagnosis of infectious diseases.					5810	5168	1028	10643	4862	3033	26053	57111	100	6279	292	3725	9875	5152	9079	51761	3248	1117	6659	8801	1579	6091	64710	10591	5324	23357	3399	11278	55061	9452	22836	79974	2762	55374	9329	9945	7105	1803	22859	10801	10219	63826	9706	43849	57097	23005	55222	9832	5303	9816	60526	57794	7694	64232	8869	64789	9315	389898	969	203068	51147	78988	64062	155066	923	55304	22893	1160	30846	1540	79690	4522	5213	85453	6355	2135	51561	9497	79913	9045	26747	22941	10962	80129	373	7597	55810	23043	6019	23271	8556	2064	1812	8565	9663	79701	55384	3810	10389	5968	25814	3859	1973	6445	8871	5644	28316	63929	10301	6942	27074	26289	10133	5789	55744	55661	5094	5230	9975	41	26333	23133	10419	4584	10123	90956	23484	350	57513	29063	25992	9465	1768	81850	83729	4820	10521	79140	989	10276	6304	57048	8821	10842	10223	677	92170	79621	64108	80339	26998	80344	5176	2055	2813	26118	10499	10873	5436	2099	6206	26105	60681	2494	3837	1329	7965	3263	8487	54149	57493
GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_DN	M5662		17105821	Ramilo O,Allman W,Chung W,Mejias A,Ardura M,Glaser C,Wittkowski KM,Piqueras B,Banchereau J,Palucka AK,Chaussabel D.	GSE6269	GSE6269_1522_200_DN			HG-U133A	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute E. coli infection versus PBMC from patients with acute S. pneumoniae infection.	Each infectious agent represents a unique combination of pathogen-associated molecular patterns that interact with specific pattern-recognition receptors expressed on immune cells. Therefore, we surmised that the blood immune cells of individuals with different infections might bear discriminative transcriptional signatures. Gene expression profiles were obtained for 131 peripheral blood samples from pediatric patients with acute infections caused by influenza A virus, Gram-negative (Escherichia coli) or Gram-positive (Staphylococcus aureus and Streptococcus pneumoniae) bacteria. Thirty-five genes were identified that best discriminate patients with influenza A virus infection from patients with either E coli or S pneumoniae infection. These genes classified with 95% accuracy (35 of 37 samples) an independent set of patients with either influenza A, E coli, or S pneumoniae infection. A different signature discriminated patients with E coli versus S aureus infections with 85% accuracy (34 of 40). Furthermore, distinctive gene expression patterns were observed in patients presenting with respiratory infections of different etiologies. Thus, microarray analyses of patient peripheral blood leukocytes might assist in the differential diagnosis of infectious diseases.					8972	4318	5806	6947	2920	4317	6037	8993	1378	100133941	11140	4680	1118	671	4051	383	3240	4973	3684	634	1241	26577	23601	57136	7850	2319	57126	3934	813	6809	5034	3482	1545	54682	2934	4070	5273	3267	1116	7357	23569	56729	7009	10645	2526	3338	4122	11316	6286	953	377	55002	5657	2529	101	26007	4758	2153	825	5863	56005	22990	54862	79089	240	9236	2069	10970	2936	306	1088	3535	10004	57045	10954	3101	8843	4057	9454	241	5089	79895	55194	11165	30001	54480	7768	23166	6280	435	8694	566	6038	24149	5226	9260	8987	2588	334	820	3554	25844	64834	978	10863	1991	58986	2992	127544	91316	5836	1593	1432	79789	10253	683	1441	6518	65010	79056	8742	10548	11057	5873	8733	1509	8301	23129	10100	6745	51237	4644	7165	9332	10211	3613	2630	5872	822	51150	182	3340	91353	23231	7542	4689	79887	26580	759	10321	6590	23524	10313	64943	80305	8836	51099	4542	11240	3614	51635	4864	2289
GSE6269_STAPH_AUREUS_VS_STREP_PNEUMO_INF_PBMC_UP	M5663		17105821	Ramilo O,Allman W,Chung W,Mejias A,Ardura M,Glaser C,Wittkowski KM,Piqueras B,Banchereau J,Palucka AK,Chaussabel D.	GSE6269	GSE6269_1523_200_UP			HG-U133A	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute infection: S. aureus versus S. pneumoniae.	Each infectious agent represents a unique combination of pathogen-associated molecular patterns that interact with specific pattern-recognition receptors expressed on immune cells. Therefore, we surmised that the blood immune cells of individuals with different infections might bear discriminative transcriptional signatures. Gene expression profiles were obtained for 131 peripheral blood samples from pediatric patients with acute infections caused by influenza A virus, Gram-negative (Escherichia coli) or Gram-positive (Staphylococcus aureus and Streptococcus pneumoniae) bacteria. Thirty-five genes were identified that best discriminate patients with influenza A virus infection from patients with either E coli or S pneumoniae infection. These genes classified with 95% accuracy (35 of 37 samples) an independent set of patients with either influenza A, E coli, or S pneumoniae infection. A different signature discriminated patients with E coli versus S aureus infections with 85% accuracy (34 of 40). Furthermore, distinctive gene expression patterns were observed in patients presenting with respiratory infections of different etiologies. Thus, microarray analyses of patient peripheral blood leukocytes might assist in the differential diagnosis of infectious diseases.					55916	8496	56674	55304	388796	717	6181	4094	9619	5272	84168	8578	51755	9883	4681	51191	1038	3099	965	9805	51752	5610	79725	27074	10109	11152	25807	9830	83714	22822	10133	57513	8829	9663	100287932	23637	8992	6618	201895	5915	109	201501	28584	4070	10277	318	7404	9158	9912	3654	3752	3265	55384	219	10911	4233	2099	29086	3067	55700	3107	50649	3556	10521	3489	5764	4091	774	9975	29109	6196	26150	10061	53635	677	9927	55727	2055	2817	80204	79058	9811	4004	26229	57097	1415	10402	10994	4763	5172	5689	55212	2786	2863	22927	10452	5319	124044	23176	19	55697	11243	9649	55589	79968	55511	2119	6489	8178	2230	54714	1746	240	3910	8852	25980	23246	54434	2878	8480	6385	8722	1186	54545	10663	755	80014	26100	5954	399491	5763	6572	22	7108	481	27077	1791	151011	3423	146562	79647	25804	9577	5982	2116	55101	10966	25879	473	123803	11098	9148	8412	55298	4507	55195	11172	8665	5644	2201	9170	23366	4191	2987	51098	23133	554	57223	64768	401251	64222	5831	27287	3082	1466	5981	35	23410	4951	23208	862	79166
GSE6269_STAPH_AUREUS_VS_STREP_PNEUMO_INF_PBMC_DN	M5664		17105821	Ramilo O,Allman W,Chung W,Mejias A,Ardura M,Glaser C,Wittkowski KM,Piqueras B,Banchereau J,Palucka AK,Chaussabel D.	GSE6269	GSE6269_1523_200_DN			HG-U133A	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute infection: S. aureus versus S. pneumoniae.	Each infectious agent represents a unique combination of pathogen-associated molecular patterns that interact with specific pattern-recognition receptors expressed on immune cells. Therefore, we surmised that the blood immune cells of individuals with different infections might bear discriminative transcriptional signatures. Gene expression profiles were obtained for 131 peripheral blood samples from pediatric patients with acute infections caused by influenza A virus, Gram-negative (Escherichia coli) or Gram-positive (Staphylococcus aureus and Streptococcus pneumoniae) bacteria. Thirty-five genes were identified that best discriminate patients with influenza A virus infection from patients with either E coli or S pneumoniae infection. These genes classified with 95% accuracy (35 of 37 samples) an independent set of patients with either influenza A, E coli, or S pneumoniae infection. A different signature discriminated patients with E coli versus S aureus infections with 85% accuracy (34 of 40). Furthermore, distinctive gene expression patterns were observed in patients presenting with respiratory infections of different etiologies. Thus, microarray analyses of patient peripheral blood leukocytes might assist in the differential diagnosis of infectious diseases.					2934	2823	2744	6518	3344	3267	27352	120227	29802	930	6689	55103	1397	8732	1353	4481	27136	53335	8001	90861	4628	23508	26118	3732	55256	23357	3065	55024	27236	8416	79368	546	6935	825	8556	2733	1299	5528	79812	3796	23093	2246	4485	79800	3359	9445	22837	5029	9814	8871	933	25804	1380	1741	7593	6404	3495	10223	79590	7586	3308	57326	5456	55334	324	10443	2167	7357	971	170679	6161	9813	1939	489	23355	10681	54920	1116	27288	24146	84268	56947	8936	55692	6892	5074	2330	58497	6203	5213	3556	26577	11179	54929	10114	55825	3624	2208	1630	204	1183	6565	6655	1629	1776	80862	1984	2100	29966	6464	4926	51773	55340	27067	114884	25858	2925	839	11142	246	5077	26135	55699	100133941	9057	84928	317662	80781	81619	10771	57591	619505	5082	11007	5108	25790	55610	9413	10750	635	90141	3112	29760	27329	2263	5592	55607	634	120	29967	10220	3785	9581	2035	23623	4982	1435	24149	973	5880	7204	6159	622	7072	54885	2827	931	221092	8824	29094	56954	2273	678	1137	6146	28904	3633	9777	8976	84162	2294	94
GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_UP	M5665		18081042	Lozza L,Rivino L,Guarda G,Jarrossay D,Rinaldi A,Bertoni F,Sallusto F,Lanzavecchia A,Geginat J.	GSE6566	GSE6566_1724_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] cells stimulated with strong dendritic cells (DC) versus CD4 [GeneID=920] T cells stimulated with weak DCs.	The strength of T cell stimulation determines IL-7 responsiveness, recall potential and lineage commitment of primed human CD4+IL-7Rhi T cells. We analyzed how the strength of antigenic stimulation - as determined by dendritic cell (DC) number, DC maturation state and antigen concentration - controls in human CD4+ T cells IL-7R-alpha expression and responsiveness to IL-7, IL-15 and antigen. We found that T cells primed by different strengths of stimulation expressed IL-7R-alpha in different proportions and preferentially on cells that maintained expression of the central memory marker CCR7. However, while CCR7+IL-7Rhi cells generated at high strength of stimulation proliferated vigorously in response to IL-7 or IL-15, CCR7+IL-7Rhi cells generated at low strength of stimulation responded poorly. High cytokine responsiveness was associated with reduced PTEN expression and enhanced s6-kinase activation, consistent with efficient receptor coupling to downstream signalling pathways. Interestingly, while intermediate-stimulated CCR7+IL-7Rhi cells were non-polarized, self-renewed with IL-7 and expanded with antigen, high-stimulated cells generated Th1 effector cells with cytokines but showed impaired IL-2 production and survival with antigen. Gene expression analysis suggested that high-stimulated cells represented pre-Th1 cells with low recall potential and high metabolic state. Taken together these results demonstrate that IL-7 receptor expression and coupling are instructed in T cells by the strength of stimulation and suggest that memory subsets may derive from CCR7+IL-7Rhi precursors that received different strengths of stimulation.					100128653	2821	163742	100170841	64399	4254	54961	26532	54510	26256	51191	199857	80763	266977	55300	4599	7850	9145	148145	60676	5214	202151	55243	5905	27251	23576	150	149069	93668	30835	2296	158724	50859	10761	64901	10538	22833	4110	3949	283491	4642	3038	284611	389432	11005	54549	10642	114788	8342	10168	29923	158055	255743	7441	9361	51661	5332	6332	152330	150771	9111	100507246	54877	869	9618	100288673	157983	29785	613266	163782	7184	79370	3099	55920	3769	200523	79919	128817	4940	4058	4645	3559	4783	7941	143630	2937	5370	7955	63974	27074	57661	146760	10994	170062	729975	121268	5836	3595	100287556	286076	645744	6857	664701	54502	27033	3717	65012	4210	5126	7567	5738	5152	100130950	285954	1152	10803	113235	283871	6770	8497	10360	8553	3567	23762	55786	57695	10563	440864	153469	6949	26050	54566	1109	100130933	51062	642559	2921	100507240	80381	140730	9706	5176	100128590	2288	57795	63934	256227	26958	9457	374897	100127940	132954	28590	266553	283431	1718	5774	4597	5053	26145	4025	392459	7314	7516	671	286256	6890	11274	9638	339541	54997	10394	79674	284373	114038	653808	152195	9401	3043	2165	688	23139	91947	155006	171019	150297	5458	167	79778	10772	4939	3669	1717	221303	85438	641	3164	729956	480	66005
GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_DN	M5666		18081042	Lozza L,Rivino L,Guarda G,Jarrossay D,Rinaldi A,Bertoni F,Sallusto F,Lanzavecchia A,Geginat J.	GSE6566	GSE6566_1724_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] cells stimulated with strong dendritic cells (DC) versus CD4 [GeneID=920] T cells stimulated with weak DCs.	The strength of T cell stimulation determines IL-7 responsiveness, recall potential and lineage commitment of primed human CD4+IL-7Rhi T cells. We analyzed how the strength of antigenic stimulation - as determined by dendritic cell (DC) number, DC maturation state and antigen concentration - controls in human CD4+ T cells IL-7R-alpha expression and responsiveness to IL-7, IL-15 and antigen. We found that T cells primed by different strengths of stimulation expressed IL-7R-alpha in different proportions and preferentially on cells that maintained expression of the central memory marker CCR7. However, while CCR7+IL-7Rhi cells generated at high strength of stimulation proliferated vigorously in response to IL-7 or IL-15, CCR7+IL-7Rhi cells generated at low strength of stimulation responded poorly. High cytokine responsiveness was associated with reduced PTEN expression and enhanced s6-kinase activation, consistent with efficient receptor coupling to downstream signalling pathways. Interestingly, while intermediate-stimulated CCR7+IL-7Rhi cells were non-polarized, self-renewed with IL-7 and expanded with antigen, high-stimulated cells generated Th1 effector cells with cytokines but showed impaired IL-2 production and survival with antigen. Gene expression analysis suggested that high-stimulated cells represented pre-Th1 cells with low recall potential and high metabolic state. Taken together these results demonstrate that IL-7 receptor expression and coupling are instructed in T cells by the strength of stimulation and suggest that memory subsets may derive from CCR7+IL-7Rhi precursors that received different strengths of stimulation.					3305	1500	23229	150291	9862	57599	84124	26156	23219	4043	219771	339988	55748	654433	11336	28378	9404	3748	81696	657	5578	10929	199713	1445	81559	11142	25961	23414	83860	64837	26333	282706	51335	23085	57794	10075	84878	155066	201633	5516	10723	127255	79809	23201	51244	23316	50652	6224	8644	283232	3292	374403	100507508	7178	80004	2830	53347	79154	6293	26207	932	253782	53919	57414	55520	57143	22796	158960	219899	10225	27127	9420	5782	23396	730091	6975	345462	114614	84503	7805	84309	149951	9308	51172	55823	8440	3820	3695	7580	1235	8942	6217	4242	10627	5188	136051	285888	84707	126823	55147	57821	319101	285440	550643	4221	11147	3385	10748	4050	115817	493861	3903	1880	9607	23284	5734	6195	374666	728061	4087	514	100131434	90639	84973	8404	6793	113791	79890	389834	255043	8720	83992	51257	399665	146852	1487	10418	84267	9816	1591	2776	7399	1861	123606	64114	407738	114926	23345	338811	497256	23629	100130987	169834	9875	80896	286554	25864	284029	5025	389434	55089	677	51170	10127	399879	100288985	3603	100288123	85315	125170	2356	200728	4312	2994	81631	24144	93589	79339	166647	4986	23140	352961	85015	648556	79654	51024	84572	51065	729420	401320	6128	5334	4114	55340	54946	140831	6227	83638	100130548	115123
GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_UP	M5668		17761290	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7400	GSE7400_2048_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated peripheral blood mononuclear cells (PBMC) versus PBMCs treated with CSF3 [GeneID=1440].	Granulocyte-colony stimulating factor (G-CSF) is used to boost granulocyte counts in immunocompromised patients, but its effects on the immune system may be counter productive. We tested the hypothesis that G-CSF mobilized peripheral blood stem cell (PBSC) products are immunologically down regulated based on gene microarray analysis. Ten peripheral blood samples from normal donors for allogeneic PBSC transplantation were obtained before and after administration of G-CSF and tested on Affymetrix Human U133 Plus 2.0 GeneChip® microarrays. Significant changes in gene expression after G-CSF mobilization were reported by controlling the false discovery rate at 5%. Immune-related genes were isolated from the data set and categorized according to probe set annotations and a thorough, independent literature search. We found that G-CSF up-regulated inflammatory and neutrophil activation pathway gene expression; however, adaptive immune-related gene expression, such as antigen presentation, co-stimulation, T cell activation and cytolytic effector pathways, were generally down-regulated. Thus, despite significant increases in stem cells, lymphocytes and antigen presenting cells, G-CSF mobilized PBSC allografts exhibit a suppressive adaptive immune-related gene expression profile. Our data provides an explanation for the potentially immunosuppressive effects observed after G-CSF administration.					9022	57711	3329	5577	596	6678	8467	4953	23212	338758	50861	54929	121053	158586	57579	8575	56911	10949	129787	401505	6138	2332	2793	55622	7812	253260	11215	2983	6059	55333	30845	26751	9221	6428	92912	126375	8669	5820	8436	121551	664	153364	129401	8891	147923	118460	51335	9774	54876	79664	940	256987	10724	4548	1915	6130	79652	54700	114049	9781	126231	51650	4595	6322	51499	84678	4799	57134	3646	23023	9397	26354	10455	125488	10302	64863	26156	117178	340205	1736	11222	114826	117143	11218	9790	51028	7294	49854	64783	58505	142	85315	79590	79752	27018	29090	84441	5591	1937	5874	9466	120534	5924	6895	10771	23014	9782	221830	64219	81027	64376	84519	91746	10412	55617	3189	54680	27430	58477	51181	65265	10892	64776	6125	2323	25864	10915	90956	3608	5569	91523	389362	84747	27335	84365	6635	6741	84916	4638	92815	7561	26123	3326	10556	1207	79731	152579	9868	9908	6638	10785	4708	10728	65991	10199	55164	8602	7402	64216	10128	493856	3702	360023	6374	64750	23344	1803	400960	23279	2625	23473	51348	51042	23774	6875	54865	26278	388962	10527	80746	54980	23353	51455	57584	7050	55001	54439	3419	4609	9324	57181	81579	132789	80135	9710	6314	54832	10576	26272	83940
GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_DN	M5670		17761290	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7400	GSE7400_2048_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated peripheral blood mononuclear cells (PBMC) versus PBMCs treated with CSF3 [GeneID=1440].	Granulocyte-colony stimulating factor (G-CSF) is used to boost granulocyte counts in immunocompromised patients, but its effects on the immune system may be counter productive. We tested the hypothesis that G-CSF mobilized peripheral blood stem cell (PBSC) products are immunologically down regulated based on gene microarray analysis. Ten peripheral blood samples from normal donors for allogeneic PBSC transplantation were obtained before and after administration of G-CSF and tested on Affymetrix Human U133 Plus 2.0 GeneChip® microarrays. Significant changes in gene expression after G-CSF mobilization were reported by controlling the false discovery rate at 5%. Immune-related genes were isolated from the data set and categorized according to probe set annotations and a thorough, independent literature search. We found that G-CSF up-regulated inflammatory and neutrophil activation pathway gene expression; however, adaptive immune-related gene expression, such as antigen presentation, co-stimulation, T cell activation and cytolytic effector pathways, were generally down-regulated. Thus, despite significant increases in stem cells, lymphocytes and antigen presenting cells, G-CSF mobilized PBSC allografts exhibit a suppressive adaptive immune-related gene expression profile. Our data provides an explanation for the potentially immunosuppressive effects observed after G-CSF administration.					1244	5608	122402	2678	253827	84888	724087	28956	285758	5959	10855	7378	8834	967	57826	51316	147991	966	81577	284904	51228	23564	29119	3801	10011	143689	3101	284185	3360	128646	79623	80262	7319	53831	22933	341405	3797	57126	26873	26268	51314	4353	286828	81552	27010	3679	25906	55137	51103	2647	11344	56034	1176	10239	118788	131540	55129	8724	9622	1774	768239	102	6813	553115	4520	79650	148281	387885	6391	10943	84674	90231	4205	475	63027	64344	10121	162461	266919	284069	92291	58472	132160	10540	388387	1647	58484	84002	100129827	56670	6590	146909	25824	100289045	9921	5562	8766	8569	114294	272	57567	638	140564	5715	57152	79883	706	2992	56729	100128977	642475	51719	54620	113540	22803	4482	57715	25898	8876	1589	196385	54512	8974	79075	8996	1053	8530	4637	11213	5629	2352	56851	9489	825	338339	1072	6275	51222	2630	26521	10367	83464	94031	83660	2907	8609	2787	55017	3229	55122	6583	92736	4043	54997	84067	808	11001	84418	2769	1511	79001	81876	10538	4288	23125	27141	90550	9446	2854	6094	57414	283129	151056	4718	9815	140823	55233	147841	6277	4615	219402	10426	51282	389136	7076	2153	643854	249	23095	6319	838	4671	9828	51076	127829	118487	90249	9616	100288294	30
GSE7460_TCONV_VS_TREG_LN_UP	M5673		18024188	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7460	GSE7460_1327_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of TconvLN versus TregLN (see Fig. 1 in the paper for details).	"The transcription factor Foxp3 is usually considered the master regulator for the CD4+CD25+ ""Treg"" lineage, which plays a key role in controlling immune and autoimmune responses, and is characterized by a unique transcriptional signature. We have performed a meta-analysis of this signature in Treg cells in several conditions to delineate the elements that can be ascribed to T cell activation, TGFbeta signaling, or Foxp3 itself. We find that these influences synergize to activate many of the signature’s components. Foxp3 and TGFbeta signaling have interconnected relationships, as Foxp3 is induced by TGFbeta while enhancing TGFbeta’s positive feedback loop. Much of the Treg signature cannot be ascribed to Foxp3, as it contains gene clusters that are co-regulated, but cannot be transactivated, by Foxp3. This suggests that the Treg lineage is specified at a higher level of regulation, upstream of Foxp3, which does control some of the lineage’s essential immunoregulatory attributes."					2969	270	8445	55902	388886	9953	10505	2034	282679	56157	28984	8507	2166	351	8303	259236	56674	3903	2021	359845	4780	157695	124857	146779	6261	117247	1611	59341	116236	53904	8808	1259	9507	259173	29785	10723	7433	10320	79993	55198	122773	23765	7049	2820	8340	196743	833	23051	5460	9411	347902	347404	151888	161	9402	2331	6482	79961	113746	161145	286336	4155	285193	402415	149840	3824	5140	5912	6304	23533	1791	2934	8572	83448	11069	10235	481	221937	8558	253782	79575	285704	387357	51108	93190	8814	6249	8013	64744	79895	11221	112	256380	54627	23270	83606	126	55784	130576	57677	9258	1130	64743	9590	81563	220001	137835	23545	4651	23064	92196	124402	9053	3690	9586	113791	64218	54961	57484	164091	79833	11040	3558	8407	25998	79370	552889	6414	339804	367	5294	3702	643236	11234	9121	135644	57565	5753	8543	619373	6660	54842	6696	26119	7782	57528	3949	140545	57333	5427	84919	114783	29118	57655	6540	402778	54093	133418	2342	1515	5163	51016	5534	5833	5519	55	30845	51465	92595	84456	1630	152185	388753	23345	347862	5874	30011	22821	59067	4253	6251	50809	23362	285966	83999	1266	5480	174	3198	1039	29940	1755	140691	222950	8497	94	1901	54957	390594	4149
GSE7460_TCONV_VS_TREG_LN_DN	M5674		18024188	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7460	GSE7460_1327_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of TconvLN versus TregLN (see Fig. 1 in the paper for details).	"The transcription factor Foxp3 is usually considered the master regulator for the CD4+CD25+ ""Treg"" lineage, which plays a key role in controlling immune and autoimmune responses, and is characterized by a unique transcriptional signature. We have performed a meta-analysis of this signature in Treg cells in several conditions to delineate the elements that can be ascribed to T cell activation, TGFbeta signaling, or Foxp3 itself. We find that these influences synergize to activate many of the signature’s components. Foxp3 and TGFbeta signaling have interconnected relationships, as Foxp3 is induced by TGFbeta while enhancing TGFbeta’s positive feedback loop. Much of the Treg signature cannot be ascribed to Foxp3, as it contains gene clusters that are co-regulated, but cannot be transactivated, by Foxp3. This suggests that the Treg lineage is specified at a higher level of regulation, upstream of Foxp3, which does control some of the lineage’s essential immunoregulatory attributes."					114907	4689	83699	10152	63971	55748	11174	112574	92906	10079	9830	6256	26115	9034	151742	22876	84282	196	644353	57584	7410	23382	2623	3662	3394	116496	27111	1154	81618	36	5332	8897	975	55589	3560	389856	3998	9308	5996	84525	25927	147991	2149	1235	155465	80765	1237	440	8575	1803	57157	150368	51542	23176	26031	169200	2339	6558	80335	3099	29126	10219	307	3480	440730	6452	22920	56171	4783	50943	5664	57045	8111	85463	10260	58528	23239	122786	2745	11037	199786	10904	57560	10154	840	26018	837	1846	254887	2921	60682	953	10875	8829	8835	8784	80184	952	7320	27090	5627	6584	2919	4794	9404	253558	84649	1871	26100	6451	558	286827	9497	25907	126669	9734	157378	6515	23461	3587	8503	1756	123016	64866	9655	79026	6646	340152	7133	154043	1316	57608	10401	401546	168544	5243	23169	23258	89782	1326	57222	115361	7867	1021	7083	3682	11033	9819	285440	6095	29969	58486	64332	84959	9424	400746	4249	10013	285382	2838	10955	64092	598	8600	55024	9882	6483	3015	10397	8694	2634	2669	8611	79070	92799	942	3559	51768	7464	79834	9134	4147	7046	144165	23710	3604	79971	23161	488	5734	2004	692205	9108	133308	27244	10787	1493	4907	23424	51762
GSE7460_TCONV_VS_TREG_THYMUS_UP	M5675		18024188	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7460	GSE7460_1328_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of TconvThy versus TregThy (see Fig. 1 in the paper for details).	"The transcription factor Foxp3 is usually considered the master regulator for the CD4+CD25+ ""Treg"" lineage, which plays a key role in controlling immune and autoimmune responses, and is characterized by a unique transcriptional signature. We have performed a meta-analysis of this signature in Treg cells in several conditions to delineate the elements that can be ascribed to T cell activation, TGFbeta signaling, or Foxp3 itself. We find that these influences synergize to activate many of the signature’s components. Foxp3 and TGFbeta signaling have interconnected relationships, as Foxp3 is induced by TGFbeta while enhancing TGFbeta’s positive feedback loop. Much of the Treg signature cannot be ascribed to Foxp3, as it contains gene clusters that are co-regulated, but cannot be transactivated, by Foxp3. This suggests that the Treg lineage is specified at a higher level of regulation, upstream of Foxp3, which does control some of the lineage’s essential immunoregulatory attributes."					128821	23368	117	116085	29785	1601	6574	5305	8445	4286	8507	51704	259230	10723	3690	23281	80312	10486	89866	1576	9744	7077	23431	81566	6304	94	113	2035	84290	3995	2002	202018	23516	55	28232	57473	8808	29116	10482	83882	8572	9472	338692	80143	1462	83999	7433	9451	10479	6843	219333	6446	51617	7561	4676	260293	93035	7538	10106	51108	216	7321	2678	5768	220213	399665	1848	29099	130576	221079	23545	112398	50489	54751	4893	10026	2870	23086	89941	203	5777	10333	29123	84133	9501	56245	9988	79993	256380	6654	359845	58504	8323	1958	4905	8943	23401	6853	158399	124359	54492	9725	56262	10577	26268	83606	113791	387357	6039	100113407	9826	64129	256471	1130	10579	7107	10962	6489	170261	126298	23471	26207	127254	2841	10009	5016	8974	3745	121551	1036	7132	1102	286336	2124	4780	81563	158293	23586	84078	23051	81871	7779	402415	5140	91	9528	309	63827	7471	2145	9365	157695	50809	23780	54093	7013	2917	85461	63932	9121	10123	4849	5193	6711	168455	54959	81844	84836	10161	397	50488	1259	59353	3633	22848	9411	728661	2999	114883	6239	1368	57826	5025	54899	145567	961	6532	5066	10307	11069	81619	113655	3199	51092	27345	79598	51200	51363	55636	55343
GSE7460_TCONV_VS_TREG_THYMUS_DN	M5676		18024188	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7460	GSE7460_1328_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of TconvThy versus TregThy (see Fig. 1 in the paper for details).	"The transcription factor Foxp3 is usually considered the master regulator for the CD4+CD25+ ""Treg"" lineage, which plays a key role in controlling immune and autoimmune responses, and is characterized by a unique transcriptional signature. We have performed a meta-analysis of this signature in Treg cells in several conditions to delineate the elements that can be ascribed to T cell activation, TGFbeta signaling, or Foxp3 itself. We find that these influences synergize to activate many of the signature’s components. Foxp3 and TGFbeta signaling have interconnected relationships, as Foxp3 is induced by TGFbeta while enhancing TGFbeta’s positive feedback loop. Much of the Treg signature cannot be ascribed to Foxp3, as it contains gene clusters that are co-regulated, but cannot be transactivated, by Foxp3. This suggests that the Treg lineage is specified at a higher level of regulation, upstream of Foxp3, which does control some of the lineage’s essential immunoregulatory attributes."					7464	5913	6310	57409	84282	8676	4853	50943	3002	9423	55748	9446	401466	3688	8724	8897	5664	78991	91663	79971	337876	8809	5552	163126	3682	6281	3106	5734	5296	29969	3459	1154	3321	5820	23710	64375	253558	164395	1847	8600	8575	6352	92345	22806	8611	26225	26031	4953	10875	5359	84100	2355	9856	4818	8993	8828	26355	54827	8553	80256	22807	5292	944	5179	4249	5780	8740	3560	50515	5331	2838	8835	10148	50808	3775	440603	10787	64951	51232	4642	57569	10663	115361	8237	221749	196	5325	23239	6017	10923	2833	29887	4084	7293	23382	9308	3800	1466	9443	59277	134429	597	5802	6582	284352	6237	10219	116496	7772	3320	6277	28959	11238	152518	639	54887	1493	55281	29851	687	1241	134728	4094	51409	1051	54476	7273	255189	7133	8829	6051	7050	51422	5996	11332	8320	23331	54517	8728	83861	221035	3696	4689	5621	55825	389856	1326	6282	9317	1235	54458	3559	57180	6004	55603	3958	400916	10158	7410	3588	64395	837	2213	55013	1846	54675	285440	26287	56917	958	2004	27075	51474	3604	6563	10982	952	84649	79145	58488	148066	6275	4860	10912	127018	2643	6882	131965	79834	4744	80031	4643	140469	4938	11145	51762	133690	7850	5732	83699
GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_UP	M5677		18024188	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7460	GSE7460_1329_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparsion of ActCD8 versus ActCD8TGF (see Fig. 1 in the paper for details).	"The transcription factor Foxp3 is usually considered the master regulator for the CD4+CD25+ ""Treg"" lineage, which plays a key role in controlling immune and autoimmune responses, and is characterized by a unique transcriptional signature. We have performed a meta-analysis of this signature in Treg cells in several conditions to delineate the elements that can be ascribed to T cell activation, TGFbeta signaling, or Foxp3 itself. We find that these influences synergize to activate many of the signature’s components. Foxp3 and TGFbeta signaling have interconnected relationships, as Foxp3 is induced by TGFbeta while enhancing TGFbeta’s positive feedback loop. Much of the Treg signature cannot be ascribed to Foxp3, as it contains gene clusters that are co-regulated, but cannot be transactivated, by Foxp3. This suggests that the Treg lineage is specified at a higher level of regulation, upstream of Foxp3, which does control some of the lineage’s essential immunoregulatory attributes."					3398	9986	26471	970	5329	51433	165904	79980	79890	6051	8870	5146	23092	23658	6369	301	4088	23410	132	7818	79895	729230	80305	57701	375748	11035	6154	2987	10154	79585	55129	124790	122953	3956	23254	9984	22920	490	84102	814	960	113174	8836	2187	7027	92196	90204	57146	8655	84069	6352	8666	23306	2968	64841	22928	9874	57122	55621	55367	55576	2014	11230	30845	1130	5536	6531	11018	23397	10813	4033	5740	1802	27042	23401	8787	10067	51393	81551	9411	80324	25828	2806	7035	11168	177	9844	116461	57140	120224	1339	10814	10456	9412	7570	4982	9926	9473	4438	80757	115265	11033	1632	79902	8761	1829	3091	4068	55388	83986	6749	2316	9730	929	8467	130399	5433	8890	341116	816	51608	4361	4534	151888	8086	79085	50628	64005	6236	115207	5947	84450	10148	83394	25974	55794	5911	79888	93377	51473	4731	8013	55095	150864	3300	6097	4216	473	5355	8407	1849	51715	10439	3351	79657	9493	54997	55280	83445	23223	1734	79026	4233	10272	11339	7407	11321	84245	5104	1434	5093	10898	57030	83448	55192	27023	84306	3693	6573	8208	3690	27106	10875	302	89797	9088	375791	5153	26272	2770	1537	29089	10314	96459	201232	147686	9093	6464	84135	2992
GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_DN	M5679		18024188	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7460	GSE7460_1329_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparsion of ActCD8 versus ActCD8TGF (see Fig. 1 in the paper for details).	"The transcription factor Foxp3 is usually considered the master regulator for the CD4+CD25+ ""Treg"" lineage, which plays a key role in controlling immune and autoimmune responses, and is characterized by a unique transcriptional signature. We have performed a meta-analysis of this signature in Treg cells in several conditions to delineate the elements that can be ascribed to T cell activation, TGFbeta signaling, or Foxp3 itself. We find that these influences synergize to activate many of the signature’s components. Foxp3 and TGFbeta signaling have interconnected relationships, as Foxp3 is induced by TGFbeta while enhancing TGFbeta’s positive feedback loop. Much of the Treg signature cannot be ascribed to Foxp3, as it contains gene clusters that are co-regulated, but cannot be transactivated, by Foxp3. This suggests that the Treg lineage is specified at a higher level of regulation, upstream of Foxp3, which does control some of the lineage’s essential immunoregulatory attributes."					25777	9516	753	23475	2838	11320	338707	59338	92521	161357	4756	22854	6039	1464	53358	2768	81839	81029	389072	9444	8897	26018	116519	56172	283337	29909	1362	54542	83548	2199	925	401097	7043	26953	80176	22862	196	54861	55761	8675	5881	11174	284996	9760	4938	4907	2650	254887	92597	29993	8785	93587	55773	7133	3840	10565	57609	1996	3673	54877	80728	19	50943	84058	6656	80219	8626	56903	64375	3290	55466	760	84669	730094	11022	84614	79783	28955	4241	257068	5128	9778	6423	79886	7077	6262	958	116449	84085	253782	64743	8945	10425	4149	51714	3745	3487	23035	394	6708	999	4094	9750	56944	129852	6498	84062	163882	27333	5997	64754	84246	2793	26039	27163	92	23705	170370	414919	57182	57475	64115	25976	9519	283987	117177	51284	2004	158405	3708	8938	220441	389208	1387	64750	26005	313	5627	93145	50861	8658	2054	54800	57460	84146	113263	483	388228	144165	10472	5621	83597	219348	54928	3959	84174	57282	29969	10584	158219	646262	5463	79191	64858	56255	143384	57132	2308	2857	57835	4649	116369	186	57613	2892	9873	245973	4320	8702	222894	54825	84466	9620	10410	757	115650	79713	2743	3097	64761	353274	65265	7204	8939	83844	5274	91	55654	22841	64410
GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_UP	M5680		18024188	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7460	GSE7460_1330_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparsion of ActTreg versus ActTregTGF (see Fig. 1 in the paper for details).	"The transcription factor Foxp3 is usually considered the master regulator for the CD4+CD25+ ""Treg"" lineage, which plays a key role in controlling immune and autoimmune responses, and is characterized by a unique transcriptional signature. We have performed a meta-analysis of this signature in Treg cells in several conditions to delineate the elements that can be ascribed to T cell activation, TGFbeta signaling, or Foxp3 itself. We find that these influences synergize to activate many of the signature’s components. Foxp3 and TGFbeta signaling have interconnected relationships, as Foxp3 is induced by TGFbeta while enhancing TGFbeta’s positive feedback loop. Much of the Treg signature cannot be ascribed to Foxp3, as it contains gene clusters that are co-regulated, but cannot be transactivated, by Foxp3. This suggests that the Treg lineage is specified at a higher level of regulation, upstream of Foxp3, which does control some of the lineage’s essential immunoregulatory attributes."					4683	55183	11068	221150	3145	51377	3251	9221	54930	64231	5700	64859	55352	23310	10955	5727	54793	30836	6421	11035	8417	161145	11010	4172	80777	5718	113115	10939	9319	126731	22873	7804	54675	83941	22875	388581	10973	183	51010	4603	23071	79915	8836	1965	1787	11193	9847	55172	29980	54984	10460	79682	494115	29968	28981	26046	2961	84940	10733	9816	11059	51128	23287	79228	23590	91039	57476	54443	302	9134	1111	55247	79840	51678	55296	55596	10311	10988	9871	55872	89801	10188	5329	54801	51426	1595	3091	5159	27347	3182	54478	221477	93081	4665	55165	10152	50853	26608	23157	85465	57650	30968	7051	1650	10758	29851	50813	57106	81542	780	54908	5325	7398	2926	25788	81573	56851	115207	23155	10148	23423	26031	55603	11103	6566	257169	84290	23338	3398	54465	7884	8654	58478	29093	6503	11168	8993	54499	8869	7112	54997	23649	1939	9639	84275	135112	7965	64418	2673	84542	390916	57583	133418	8807	55057	132	8669	7334	5034	55635	57194	10212	157570	5732	51150	729533	63979	8502	5901	8301	3703	3882	51106	699	84455	1719	65124	54663	80119	55732	6945	4998	3690	79575	4534	27153	92241	6094	220988	25902	81930	1122	51776	10051	400087	83732	83706	155038	23270	25800
GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_DN	M5682		18024188	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7460	GSE7460_1330_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparsion of ActTreg versus ActTregTGF (see Fig. 1 in the paper for details).	"The transcription factor Foxp3 is usually considered the master regulator for the CD4+CD25+ ""Treg"" lineage, which plays a key role in controlling immune and autoimmune responses, and is characterized by a unique transcriptional signature. We have performed a meta-analysis of this signature in Treg cells in several conditions to delineate the elements that can be ascribed to T cell activation, TGFbeta signaling, or Foxp3 itself. We find that these influences synergize to activate many of the signature’s components. Foxp3 and TGFbeta signaling have interconnected relationships, as Foxp3 is induced by TGFbeta while enhancing TGFbeta’s positive feedback loop. Much of the Treg signature cannot be ascribed to Foxp3, as it contains gene clusters that are co-regulated, but cannot be transactivated, by Foxp3. This suggests that the Treg lineage is specified at a higher level of regulation, upstream of Foxp3, which does control some of the lineage’s essential immunoregulatory attributes."					360	692205	2281	23253	58528	840	84443	64410	146050	9683	8456	220323	140469	25911	57567	151242	55690	23516	57509	64342	64781	8639	54902	6091	84557	7166	8553	80176	64375	1107	284996	1278	1294	10447	6498	50488	10216	23005	64327	6194	80157	115650	5498	30061	1521	5045	9941	9144	958	6709	5463	84680	5996	9873	5800	25780	154796	3682	125058	2649	3355	753	65009	4649	392275	2983	1730	143458	5327	9404	10000	10225	157657	117286	116843	51422	84937	8675	55349	8703	60681	23052	57504	11075	80063	83636	84674	1584	374907	6556	8897	317761	441478	4907	8809	23136	19	3431	6774	477	150572	9545	4092	54785	400746	200162	79025	253980	5832	171389	51280	23604	55335	25880	2004	64750	952	9053	9495	6004	27095	90102	79582	7267	54838	23305	729359	9569	91404	79625	55450	83719	79879	91010	27091	6837	6714	2846	5157	9815	143678	92312	57182	1237	6124	51196	25924	5138	1523	6310	152519	57541	3482	64784	26256	152404	65987	23759	6497	6494	7679	388228	8555	4814	80000	26137	246	9687	79608	81491	55219	5582	9703	79637	10079	54602	26034	9811	2975	57512	55861	6489	221711	84684	5028	55909	64061	23326	727800	54331	10472	79645	1362	50649	25	26119	8829	2852	10690	338442
GSE7460_CD8_TCELL_VS_TREG_ACT_UP	M5683		18024188	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7460	GSE7460_1331_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparsion of ActCD8 versus ActTreg (see Fig. 1 in the paper for details).	"The transcription factor Foxp3 is usually considered the master regulator for the CD4+CD25+ ""Treg"" lineage, which plays a key role in controlling immune and autoimmune responses, and is characterized by a unique transcriptional signature. We have performed a meta-analysis of this signature in Treg cells in several conditions to delineate the elements that can be ascribed to T cell activation, TGFbeta signaling, or Foxp3 itself. We find that these influences synergize to activate many of the signature’s components. Foxp3 and TGFbeta signaling have interconnected relationships, as Foxp3 is induced by TGFbeta while enhancing TGFbeta’s positive feedback loop. Much of the Treg signature cannot be ascribed to Foxp3, as it contains gene clusters that are co-regulated, but cannot be transactivated, by Foxp3. This suggests that the Treg lineage is specified at a higher level of regulation, upstream of Foxp3, which does control some of the lineage’s essential immunoregulatory attributes."					27250	54928	54785	161436	83667	10320	51466	94120	641649	5063	56940	1734	4033	25927	84532	4851	10892	814	1840	5329	7267	2550	8916	153364	11152	4734	1027	6932	7561	57118	9404	94103	64744	113278	338657	389336	57186	249	23410	11188	150572	3557	57326	644353	115992	5837	51669	10848	3398	730094	283987	51283	84747	29940	23759	53829	54861	65258	6813	6304	26191	375323	10368	57580	729230	11334	80343	2217	6310	5243	5476	55	23401	440689	79142	55198	55810	23092	124790	1861	55907	63035	5142	1259	9334	169522	27145	26234	7535	8675	51206	9725	3708	57419	5335	441168	23529	493	4542	155038	414328	4240	5138	9899	285126	1521	79573	79993	138151	6827	8665	256364	10399	84163	10550	138050	79720	550631	23116	80863	3579	23136	4237	79583	146177	345895	1762	5150	719	976	124402	84669	116236	164633	165055	3693	1789	22914	94240	51135	5829	5170	8938	7091	51631	23604	8522	6351	8439	85027	4068	6712	56895	55784	1130	2150	51179	55778	285527	400451	3111	10663	2583	7328	54518	11069	23360	128414	79717	54676	10723	10505	1829	3481	80724	79933	6010	23046	1539	2841	26996	2549	9167	10590	10402	6388	65983	22835	10906	9573	10018	10956	9563	150159	3003	6193	8030	132949	54587	83988
GSE7460_CD8_TCELL_VS_TREG_ACT_DN	M5684		18024188	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7460	GSE7460_1331_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparsion of ActCD8 versus ActTreg(see Fig. 1 in the paper for details).	"The transcription factor Foxp3 is usually considered the master regulator for the CD4+CD25+ ""Treg"" lineage, which plays a key role in controlling immune and autoimmune responses, and is characterized by a unique transcriptional signature. We have performed a meta-analysis of this signature in Treg cells in several conditions to delineate the elements that can be ascribed to T cell activation, TGFbeta signaling, or Foxp3 itself. We find that these influences synergize to activate many of the signature’s components. Foxp3 and TGFbeta signaling have interconnected relationships, as Foxp3 is induced by TGFbeta while enhancing TGFbeta’s positive feedback loop. Much of the Treg signature cannot be ascribed to Foxp3, as it contains gene clusters that are co-regulated, but cannot be transactivated, by Foxp3. This suggests that the Treg lineage is specified at a higher level of regulation, upstream of Foxp3, which does control some of the lineage’s essential immunoregulatory attributes."					50852	10056	54765	9688	119710	5719	11275	55172	64976	60559	57179	54874	54443	90459	8914	149371	11164	7416	5718	1653	6647	113115	23243	5431	8939	10888	4173	57650	2180	81542	9760	125228	26118	1326	9833	11215	219541	8260	51182	9184	151742	57122	8428	285753	181	51474	9824	5577	9341	11243	29841	5433	51496	79876	283643	84310	7799	84317	166968	116461	7189	159	5822	3290	10772	10972	84950	54969	6480	27235	10073	701	23397	11218	4751	51659	22841	400746	53358	64417	5925	8029	55278	348654	4300	6790	7003	203547	10135	89801	26277	4485	23354	6845	50937	5217	4603	54930	389856	7319	58509	202374	4172	5780	84886	3364	64332	896	8833	51203	112479	4670	2030	1719	28981	79023	1362	5685	64431	221150	1019	79019	25788	1893	50614	10403	55916	115106	7074	996	10460	8784	57099	54962	1434	5955	3839	22982	60487	23047	51096	7431	9139	160335	58505	1154	9847	1965	286410	55705	728780	473	5165	25	9212	8303	81930	55293	10055	10189	117178	10196	10615	6745	84946	1793	126731	84918	10195	7251	7572	4176	7443	50	57157	25950	23382	7818	5985	5770	9126	23181	55208	23607	54107	192111	81573	10920	1060	55144	83461	1213	26128	11083	648	126669	1968	134510	2242
GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_UP	M5687		18024188	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7460	GSE7460_1332_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparsion of ActCD8 versus ActCD4 (see Fig. 1 in the paper for details).	"The transcription factor Foxp3 is usually considered the master regulator for the CD4+CD25+ ""Treg"" lineage, which plays a key role in controlling immune and autoimmune responses, and is characterized by a unique transcriptional signature. We have performed a meta-analysis of this signature in Treg cells in several conditions to delineate the elements that can be ascribed to T cell activation, TGFbeta signaling, or Foxp3 itself. We find that these influences synergize to activate many of the signature’s components. Foxp3 and TGFbeta signaling have interconnected relationships, as Foxp3 is induced by TGFbeta while enhancing TGFbeta’s positive feedback loop. Much of the Treg signature cannot be ascribed to Foxp3, as it contains gene clusters that are co-regulated, but cannot be transactivated, by Foxp3. This suggests that the Treg lineage is specified at a higher level of regulation, upstream of Foxp3, which does control some of the lineage’s essential immunoregulatory attributes."					26996	256144	1521	80863	57679	6310	286467	8743	22806	22914	1493	10875	64781	2833	4542	1234	26191	84981	80231	55667	23116	11128	10663	252983	29940	94240	22807	3383	84263	5721	3959	5329	132720	3003	3821	8890	137492	55450	50808	83988	653361	138050	55466	23423	5639	56895	6352	153769	441168	6553	115361	6561	644353	115207	57580	3001	10399	9404	57683	9873	30009	81792	65258	400451	1644	8938	10505	4067	3458	952	27293	23259	84166	2838	1829	3659	23092	23597	55080	85027	5150	3683	81490	7772	401612	139886	374986	8439	5939	6498	84747	7525	2969	50810	165324	51444	2583	113201	10260	83549	56913	3958	100129269	10906	925	84132	50515	23118	2162	53405	79625	57125	860	79895	151393	6275	926	163351	115572	116236	389072	83667	7690	6277	5446	57823	51316	3055	391059	81671	23358	677	112616	8237	8030	7549	10060	51227	54900	27130	79668	9663	256364	24139	285195	23410	22832	150368	8435	3169	23218	6531	3459	8530	139322	196383	6051	9399	8836	343990	26234	84525	27434	84749	5998	5336	29911	643	125488	341359	4851	26578	356	818	84909	249	8694	80714	389336	5104	63035	121551	115650	153745	4818	6940	55784	54847	23360	1820	57684	55691	2672	5341	57091	8434	10049	54708	58158	2274
GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_DN	M5689		18024188	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7460	GSE7460_1332_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparsion of ActCD8 versus ActCD4 (see Fig. 1 in the paper for details).	"The transcription factor Foxp3 is usually considered the master regulator for the CD4+CD25+ ""Treg"" lineage, which plays a key role in controlling immune and autoimmune responses, and is characterized by a unique transcriptional signature. We have performed a meta-analysis of this signature in Treg cells in several conditions to delineate the elements that can be ascribed to T cell activation, TGFbeta signaling, or Foxp3 itself. We find that these influences synergize to activate many of the signature’s components. Foxp3 and TGFbeta signaling have interconnected relationships, as Foxp3 is induced by TGFbeta while enhancing TGFbeta’s positive feedback loop. Much of the Treg signature cannot be ascribed to Foxp3, as it contains gene clusters that are co-regulated, but cannot be transactivated, by Foxp3. This suggests that the Treg lineage is specified at a higher level of regulation, upstream of Foxp3, which does control some of the lineage’s essential immunoregulatory attributes."					79019	989	208	10888	11022	6590	84923	4703	3017	10284	50852	23228	7074	7351	23395	84886	6942	4094	81846	122786	64417	23746	163882	5925	9989	56912	23607	54982	4253	10201	55204	50937	65260	126669	8428	27343	975	6480	9411	8772	28959	587	10267	57721	8897	181	11127	10410	258	4646	1345	201799	54874	10129	154141	8626	57184	272	219654	5861	5515	25909	83440	4709	3028	9315	84552	4651	6117	9648	9826	2760	414919	59338	8502	1487	8572	165904	4300	64789	445	8808	7056	6284	22982	8545	171546	195814	7319	151556	25870	9712	7776	920	112479	9847	57182	57458	1893	9885	169200	3487	29899	54764	25998	7325	80351	23382	127018	56904	10252	1028	144165	8303	490	1849	87769	84079	55790	4191	351	28984	390243	25876	826	10125	253980	283431	64418	9760	10610	55970	286410	1062	5621	8804	64856	91687	3690	9985	29957	124540	196264	2114	55144	283635	1058	2570	112398	92749	1175	5027	92906	80757	3146	253152	5954	389856	10277	84902	4784	399687	84881	57176	57099	308	338322	79982	59345	394	26128	79751	152002	83699	22820	55213	2995	5096	5786	7818	51398	7047	151888	7763	9831	51203	2280	221937	1039	607	7466	25764	3290	3281	387338	4702	29969	23129	326	8125
GSE7460_TREG_VS_TCONV_ACT_UP	M5690		18024188	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7460	GSE7460_1333_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparsion of ActTreg versus ActCD4 (see Fig. 1 in the paper for details).	"The transcription factor Foxp3 is usually considered the master regulator for the CD4+CD25+ ""Treg"" lineage, which plays a key role in controlling immune and autoimmune responses, and is characterized by a unique transcriptional signature. We have performed a meta-analysis of this signature in Treg cells in several conditions to delineate the elements that can be ascribed to T cell activation, TGFbeta signaling, or Foxp3 itself. We find that these influences synergize to activate many of the signature’s components. Foxp3 and TGFbeta signaling have interconnected relationships, as Foxp3 is induced by TGFbeta while enhancing TGFbeta’s positive feedback loop. Much of the Treg signature cannot be ascribed to Foxp3, as it contains gene clusters that are co-regulated, but cannot be transactivated, by Foxp3. This suggests that the Treg lineage is specified at a higher level of regulation, upstream of Foxp3, which does control some of the lineage’s essential immunoregulatory attributes."					6553	388581	54874	80380	1847	25923	115361	22841	6772	10888	2242	1493	8743	81573	4008	10398	3383	57157	151742	84267	22807	9465	8836	4697	7978	1278	1946	6498	5446	55013	4084	9324	89801	64332	54965	8784	7046	83698	375743	860	969	202374	10472	9765	952	134728	22832	8676	3682	9527	64860	6563	23164	7128	79019	256710	57560	11174	2838	255252	65056	58504	253782	51531	132720	5627	598	6399	84251	27229	23169	6385	10010	7473	9910	51128	8773	256144	1362	221545	5359	1495	962	55728	1080	50943	677	79960	26018	28996	26953	3845	85477	347733	2669	154043	1958	7003	55454	84964	7799	54708	91663	51074	284467	5996	9760	133923	3655	55144	56650	5325	1846	8999	11275	8220	11083	4689	388646	80184	64781	83734	166785	4602	65999	4907	55466	134510	80176	113201	152519	8655	80311	23250	9246	57620	400746	10243	7074	10519	55432	401097	23509	55023	10401	201294	90865	22806	345757	7293	150737	1655	23446	2274	253827	221035	57568	4067	57579	64859	4007	58	26973	56937	65124	399	140469	79577	64855	64375	51296	140880	119392	4094	119710	9360	55914	64395	8678	57569	64089	2634	56171	7780	84981	10802	65977	91442	23597	23423	29126	55179	51430	653361	23118	1147	729852	5925	9056	65217
GSE7460_TREG_VS_TCONV_ACT_DN	M5691		18024188	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7460	GSE7460_1333_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparsion of ActTreg versus ActCD4 (see Fig. 1 in the paper for details).	"The transcription factor Foxp3 is usually considered the master regulator for the CD4+CD25+ ""Treg"" lineage, which plays a key role in controlling immune and autoimmune responses, and is characterized by a unique transcriptional signature. We have performed a meta-analysis of this signature in Treg cells in several conditions to delineate the elements that can be ascribed to T cell activation, TGFbeta signaling, or Foxp3 itself. We find that these influences synergize to activate many of the signature’s components. Foxp3 and TGFbeta signaling have interconnected relationships, as Foxp3 is induced by TGFbeta while enhancing TGFbeta’s positive feedback loop. Much of the Treg signature cannot be ascribed to Foxp3, as it contains gene clusters that are co-regulated, but cannot be transactivated, by Foxp3. This suggests that the Treg lineage is specified at a higher level of regulation, upstream of Foxp3, which does control some of the lineage’s essential immunoregulatory attributes."					221120	114804	3690	51297	118460	8808	6907	11343	23223	6036	503542	55198	208	152098	6590	167127	7782	23533	28232	1259	64061	2356	89790	57828	3565	160	63941	283571	9194	63035	8913	26253	3237	10654	163882	151525	9919	83693	64757	84752	90529	116986	57134	283537	165	10394	1717	100506540	83953	10399	57484	7036	1308	389124	64087	221749	283450	23596	79025	157285	2658	9953	351	4651	10461	1938	64420	5498	149345	7915	387357	123606	93661	11040	64410	124359	55902	1611	10610	729275	150159	146177	696	9806	80185	10800	112936	9524	79605	79863	9632	10201	1501	167410	23170	255231	54914	3702	55784	80217	79817	4091	51237	161145	51108	56848	167227	7392	6175	23078	10590	4967	4033	8888	79058	23221	3241	183	92014	2859	729665	117854	25880	133418	4253	83449	148867	54	4487	8490	23325	23302	727800	29940	2359	374618	90268	51285	7048	23157	135138	1995	5924	549	221191	2969	124491	2123	55859	8566	400745	51706	326	117153	9112	57189	3801	80757	11264	157657	146664	92196	3229	283219	123803	26037	285220	1733	3300	84747	161497	10098	3775	1306	79365	5442	55246	136242	26191	818	113278	5140	3000	51114	51611	7132	57176	54785	64067	81563	91646	25876	22897	8082	11127	112	26267	4237	5365	7138
GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_UP	M5692		18024188	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7460	GSE7460_1334_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparsion of ActTregTGF versus ActCD4TGF (see Fig. 1 in the paper for details).	"The transcription factor Foxp3 is usually considered the master regulator for the CD4+CD25+ ""Treg"" lineage, which plays a key role in controlling immune and autoimmune responses, and is characterized by a unique transcriptional signature. We have performed a meta-analysis of this signature in Treg cells in several conditions to delineate the elements that can be ascribed to T cell activation, TGFbeta signaling, or Foxp3 itself. We find that these influences synergize to activate many of the signature’s components. Foxp3 and TGFbeta signaling have interconnected relationships, as Foxp3 is induced by TGFbeta while enhancing TGFbeta’s positive feedback loop. Much of the Treg signature cannot be ascribed to Foxp3, as it contains gene clusters that are co-regulated, but cannot be transactivated, by Foxp3. This suggests that the Treg lineage is specified at a higher level of regulation, upstream of Foxp3, which does control some of the lineage’s essential immunoregulatory attributes."					5832	116039	90102	10216	60437	9741	9353	339479	7166	6997	4082	5495	8935	116496	2983	1404	7046	79901	151556	117177	4345	3608	54103	115361	58528	80856	1235	3815	22824	246	57569	10681	1756	65009	952	6658	1397	134829	140469	8836	23075	155185	255189	157378	23301	151742	283237	3664	27294	1893	57560	9427	389941	9069	6526	9265	23285	147923	3800	5270	23732	56521	55596	122786	55691	388341	6091	200162	3482	1294	26279	9882	1029	131408	10591	2838	7905	388403	114793	51361	258010	55144	728392	65124	84085	10002	22891	1955	3543	1767	9823	931	64375	25801	10998	10561	11037	7840	4212	23102	22807	256586	202051	3574	9037	152405	3355	51559	51422	9173	285782	3361	11001	9068	143903	7410	1741	100302692	29993	27345	54874	8537	129285	6198	1959	51101	2258	1362	7498	10309	27328	6558	59277	84188	54329	79668	7103	56895	118442	55796	114571	11326	116843	221687	58497	55591	2168	6418	9625	347733	7074	192666	59345	11335	5617	642273	127579	91703	51458	1268	9797	55023	6002	8655	56301	27091	338949	105	126859	5925	5217	85444	124976	11217	285382	7105	160418	57698	54602	284716	3480	55013	30009	155066	139886	100271873	5966	55506	6991	80270	9615	3860	286128	22858	6004	7465	55686	79828	6591	64395
GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_DN	M5693		18024188	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7460	GSE7460_1334_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparsion of ActTregTGF versus ActCD4TGF (see Fig. 1 in the paper for details).	"The transcription factor Foxp3 is usually considered the master regulator for the CD4+CD25+ ""Treg"" lineage, which plays a key role in controlling immune and autoimmune responses, and is characterized by a unique transcriptional signature. We have performed a meta-analysis of this signature in Treg cells in several conditions to delineate the elements that can be ascribed to T cell activation, TGFbeta signaling, or Foxp3 itself. We find that these influences synergize to activate many of the signature’s components. Foxp3 and TGFbeta signaling have interconnected relationships, as Foxp3 is induced by TGFbeta while enhancing TGFbeta’s positive feedback loop. Much of the Treg signature cannot be ascribed to Foxp3, as it contains gene clusters that are co-regulated, but cannot be transactivated, by Foxp3. This suggests that the Treg lineage is specified at a higher level of regulation, upstream of Foxp3, which does control some of the lineage’s essential immunoregulatory attributes."					79038	6143	399665	5959	254122	284680	147965	150763	4651	57509	54953	3795	10148	170575	286207	9759	3949	23646	5833	4597	345456	10870	6175	5893	55636	161145	54	84905	83706	51043	57590	116115	8775	149483	8459	84940	57180	161582	79873	7079	9639	6122	11054	6236	2843	7138	91544	84433	10922	10758	50855	79159	4026	5229	10226	9247	6753	7108	51225	646962	51805	124446	10900	1611	4704	8572	170371	4703	25851	93408	914	100131496	9951	5589	3241	116236	148327	7709	283120	51547	9772	80700	183	51286	4122	81849	3300	5620	92196	8738	5967	55734	3111	9953	22898	100131187	29984	197342	11132	5476	5373	23327	6455	6202	284992	65057	10311	3638	25924	5027	80789	137835	6836	79651	51129	3783	24146	55911	64419	3155	284613	126208	6130	27136	9885	59307	11343	83737	9817	84243	112770	55908	5239	164091	5447	1937	2194	84329	389119	4916	80381	23092	25771	593	29950	64218	29906	51073	23078	728591	8574	100129269	301	54058	3921	5019	10123	55228	11202	4068	64772	9258	84461	84954	26258	161514	79602	55198	8507	2841	66005	1613	51176	6189	5480	27120	9215	8878	51507	148789	203054	55274	1509	51667	7458	9553	8209	4248	7371	26225	57706	55902	55544	80305	286336	60672	3551	6482	2953	55898
GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_UP	M5694		18024188	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7460	GSE7460_1335_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparsion of ActCD4 versus ActCD4TGF (see Fig. 1 in the paper for details).	"The transcription factor Foxp3 is usually considered the master regulator for the CD4+CD25+ ""Treg"" lineage, which plays a key role in controlling immune and autoimmune responses, and is characterized by a unique transcriptional signature. We have performed a meta-analysis of this signature in Treg cells in several conditions to delineate the elements that can be ascribed to T cell activation, TGFbeta signaling, or Foxp3 itself. We find that these influences synergize to activate many of the signature’s components. Foxp3 and TGFbeta signaling have interconnected relationships, as Foxp3 is induced by TGFbeta while enhancing TGFbeta’s positive feedback loop. Much of the Treg signature cannot be ascribed to Foxp3, as it contains gene clusters that are co-regulated, but cannot be transactivated, by Foxp3. This suggests that the Treg lineage is specified at a higher level of regulation, upstream of Foxp3, which does control some of the lineage’s essential immunoregulatory attributes."					1130	2124	161145	8807	115207	4121	9411	4253	8836	84293	6300	56479	2051	23746	255231	6590	140883	7280	23143	639	51429	133418	4646	11040	123606	441168	10610	1259	55768	3702	151525	10885	8740	2060	9348	285237	51706	154141	9806	9847	3690	11127	201299	10800	11031	1316	6907	9895	54437	118460	9451	124359	55784	1308	121268	259266	23185	23170	301	2359	7107	2123	4673	963	122786	55283	148867	79001	22891	5442	55092	128506	3565	57496	940	4780	3930	23708	4063	92196	6536	5167	27069	26191	8502	7782	3274	55103	3959	57404	118812	399818	57532	167127	3574	9271	26037	117153	152503	64420	10588	56123	51334	5450	163351	25876	153	84258	2824	3068	116448	7156	79339	4088	79817	1062	5552	51776	54843	92675	83853	1717	9459	960	168537	1611	222950	283537	254170	25802	195814	3178	2515	23129	54842	4595	3796	3664	387103	957	51611	51626	80124	345222	5429	84747	79648	51412	3708	8490	151888	1803	154661	80017	351	79895	56605	1058	9989	55970	7846	55363	55859	84243	219670	64218	2205	149345	928	147323	3305	9866	55596	60680	9771	7855	23039	22873	84079	2774	221191	79822	10750	635	1644	81539	9648	51129	83693	10590	55771	85294	1718	84803	149420	27163	9068	3614	9922	3595
GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_DN	M5695		18024188	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7460	GSE7460_1335_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparsion of ActCD4 versus ActCD4TGF (see Fig. 1 in the paper for details).	"The transcription factor Foxp3 is usually considered the master regulator for the CD4+CD25+ ""Treg"" lineage, which plays a key role in controlling immune and autoimmune responses, and is characterized by a unique transcriptional signature. We have performed a meta-analysis of this signature in Treg cells in several conditions to delineate the elements that can be ascribed to T cell activation, TGFbeta signaling, or Foxp3 itself. We find that these influences synergize to activate many of the signature’s components. Foxp3 and TGFbeta signaling have interconnected relationships, as Foxp3 is induced by TGFbeta while enhancing TGFbeta’s positive feedback loop. Much of the Treg signature cannot be ascribed to Foxp3, as it contains gene clusters that are co-regulated, but cannot be transactivated, by Foxp3. This suggests that the Treg lineage is specified at a higher level of regulation, upstream of Foxp3, which does control some of the lineage’s essential immunoregulatory attributes."					51199	140609	23052	441478	80270	91404	83468	149951	79865	2669	338707	54438	9144	51225	4249	953	653361	158219	1462	1521	11174	8743	55450	8100	64781	130399	9873	411	6489	84680	659	196	3487	91544	925	387733	10330	56937	4084	256710	26018	10472	91010	57180	64750	162239	6821	8829	3682	30851	221711	7070	477	5045	958	4689	4092	115650	4320	10410	952	1545	80176	83734	152519	151742	11034	6498	221143	117177	83440	23446	91663	11179	7003	27229	84246	50943	63943	2868	57533	388	51278	149111	9191	6925	116236	8455	4907	10243	1362	1080	10398	1730	125058	63910	64921	222487	10806	147007	57491	83636	23012	64855	284996	25924	22936	10605	80256	10725	22902	9404	134510	7408	284194	283120	23205	3635	10519	10267	51280	55262	54509	8717	3815	79823	171389	91947	4814	10053	2629	5795	389206	51507	9732	7978	274	57620	1012	56995	359948	9114	140739	253012	64375	399	169044	284131	5479	3500	951	400224	55647	116966	6175	9618	93	221178	3662	6774	154796	817	360	10875	400746	219654	7867	132720	23307	55093	23559	113201	9325	7090	3845	27434	1844	80205	11037	9424	5996	57182	23761	83658	11285	64802	537	29058	26953	7046	5028	51166	6455	534	4067	56922	9581	10581	54953	92521
GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_HET_TCONV_UP	M5696		18024188	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7460	GSE7460_1336_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparsion of WTActCD4 versus WTActCD4TGF (see Fig. 1 in the paper for details).	"The transcription factor Foxp3 is usually considered the master regulator for the CD4+CD25+ ""Treg"" lineage, which plays a key role in controlling immune and autoimmune responses, and is characterized by a unique transcriptional signature. We have performed a meta-analysis of this signature in Treg cells in several conditions to delineate the elements that can be ascribed to T cell activation, TGFbeta signaling, or Foxp3 itself. We find that these influences synergize to activate many of the signature’s components. Foxp3 and TGFbeta signaling have interconnected relationships, as Foxp3 is induced by TGFbeta while enhancing TGFbeta’s positive feedback loop. Much of the Treg signature cannot be ascribed to Foxp3, as it contains gene clusters that are co-regulated, but cannot be transactivated, by Foxp3. This suggests that the Treg lineage is specified at a higher level of regulation, upstream of Foxp3, which does control some of the lineage’s essential immunoregulatory attributes."					2151	440026	8645	84034	89782	53371	7023	468	123	23063	3843	80824	5923	2961	8467	58505	10457	3054	9415	55274	5725	7535	6478	58489	3693	207	10897	3607	4253	5433	55664	8974	8870	51020	23780	3560	6513	488	29923	51043	3099	1991	8819	4166	9869	11022	4363	6877	58986	10730	51134	79646	6520	6259	51429	10575	8460	2821	3690	55254	9367	7804	2355	149018	6655	53635	23214	4677	8894	11231	3909	5094	51097	2846	10492	940	8417	54665	55573	4047	6392	80777	4193	23210	26020	79961	3398	2224	2889	29927	10154	5534	23403	134218	81539	10111	4998	10926	8324	26256	8073	26003	2580	3418	10989	55012	148423	112399	11177	8726	83891	253714	157567	5833	6747	205	55862	51193	639	57026	23132	136	80209	10915	10972	2146	55830	255919	390072	771	55884	31	494143	92703	643008	5048	23386	3384	8565	904	51110	440138	284207	55037	57513	10451	64852	84871	153745	9162	10939	150356	116931	128869	5706	5223	285521	140687	3998	28982	171425	8844	150864	134111	226	7284	56477	84950	5049	3638	222234	3837	56670	3308	101	84259	9361	84747	7782	4097	6782	5095	7323	51455	1317	55176	10560	10767	90381	22856	22986	1386	125228	1663	11052	36	8530	7922	3091	80816
GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_HET_TCONV_DN	M5697		18024188	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7460	GSE7460_1336_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparsion of WTActCD4 versus WTActCD4TGF (see Fig. 1 in the paper for details).	"The transcription factor Foxp3 is usually considered the master regulator for the CD4+CD25+ ""Treg"" lineage, which plays a key role in controlling immune and autoimmune responses, and is characterized by a unique transcriptional signature. We have performed a meta-analysis of this signature in Treg cells in several conditions to delineate the elements that can be ascribed to T cell activation, TGFbeta signaling, or Foxp3 itself. We find that these influences synergize to activate many of the signature’s components. Foxp3 and TGFbeta signaling have interconnected relationships, as Foxp3 is induced by TGFbeta while enhancing TGFbeta’s positive feedback loop. Much of the Treg signature cannot be ascribed to Foxp3, as it contains gene clusters that are co-regulated, but cannot be transactivated, by Foxp3. This suggests that the Treg lineage is specified at a higher level of regulation, upstream of Foxp3, which does control some of the lineage’s essential immunoregulatory attributes."					57185	7189	25777	80727	653361	26001	11337	2150	534	57326	958	7070	9397	2199	54737	64375	23531	55620	864	952	29993	84959	400224	127262	5283	753	9581	23548	27086	388228	83549	6494	1535	245973	1628	999	152485	977	8829	154043	79713	83719	3682	3217	6821	1523	81565	64781	113246	441478	27238	26119	51227	916	59277	54464	7020	2875	55959	57506	84251	80776	5295	9712	54756	50943	56171	256281	8665	10449	10267	51528	6038	137492	115650	81855	3988	10243	11174	158219	8100	100271873	79874	147040	284996	822	203054	125058	55450	409	10544	29108	128710	9236	1075	9744	389072	26122	65990	64333	26133	116092	7178	51135	10252	91748	149951	8743	84282	4689	3754	550643	8076	157506	51280	8718	1155	103910	951	80700	374654	8111	115350	2643	28971	51268	706	55778	23247	26137	100134934	10077	26018	339	925	3955	54874	2308	25901	1730	3399	57658	55777	1521	134510	360	196074	84181	306	5819	1267	57182	50717	65065	57406	4907	7050	4320	8204	6446	126	9249	51523	8809	6237	64109	26092	55011	9779	283149	7097	10472	6498	9973	3605	6709	2932	84958	1128	11275	6733	22841	692205	1043	83636	57337	481	126432	2012	9167	23559	6175	23495	91404	283120	2783	5578	694	387680	8600
GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_MUT_TCONV_UP	M5698		18024188	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7460	GSE7460_1337_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparsion of sfActCD4 versus sfActCD4TGF (see Fig. 1 in the paper for details).	"The transcription factor Foxp3 is usually considered the master regulator for the CD4+CD25+ ""Treg"" lineage, which plays a key role in controlling immune and autoimmune responses, and is characterized by a unique transcriptional signature. We have performed a meta-analysis of this signature in Treg cells in several conditions to delineate the elements that can be ascribed to T cell activation, TGFbeta signaling, or Foxp3 itself. We find that these influences synergize to activate many of the signature’s components. Foxp3 and TGFbeta signaling have interconnected relationships, as Foxp3 is induced by TGFbeta while enhancing TGFbeta’s positive feedback loop. Much of the Treg signature cannot be ascribed to Foxp3, as it contains gene clusters that are co-regulated, but cannot be transactivated, by Foxp3. This suggests that the Treg lineage is specified at a higher level of regulation, upstream of Foxp3, which does control some of the lineage’s essential immunoregulatory attributes."					22897	145781	2444	6809	84886	54819	373156	79888	4134	4835	2992	6568	80017	9553	285590	7355	150864	160335	285175	27334	79712	124359	219736	7023	84612	90203	1233	51110	23176	2869	1978	54431	940	8027	201164	10741	9537	10203	23313	11043	84725	4924	5596	57226	337977	8897	3895	54538	955	4063	3975	1475	51299	8844	54893	5879	28	3593	6654	115825	29998	127018	54587	84909	7818	54914	2151	171425	114882	9046	1849	1069	839	115004	197370	55108	10981	3875	283464	259230	3516	10451	4082	5095	2355	639	92014	9637	55907	57127	97	22920	710	28981	7570	84332	696	57415	3566	1728	3693	90550	8693	27067	5210	147011	10538	5339	2033	5331	23114	6515	5436	54665	157638	401474	3732	5142	10370	8440	8073	57826	8407	27145	338596	7007	60529	26469	9957	119392	79865	50650	5732	89765	124975	549	23002	6954	283871	8313	10154	80760	8784	7158	10750	6505	23129	84636	56935	9021	10134	2317	8612	65059	10409	5144	401612	56983	27434	171023	153745	54621	80829	80762	55274	55652	5147	64092	2934	23583	197335	54810	55884	3456	2625	122258	975	80303	10555	5428	4068	23528	3500	4088	388969	9079	186	124222	343263	150771	130367	23074	85015	55911	1608	200845	91056	29063	57523	79782
GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_MUT_TCONV_DN	M5699		18024188	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7460	GSE7460_1337_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparsion of sfActCD4 versus sfActCD4TGF (see Fig. 1 in the paper for details).	"The transcription factor Foxp3 is usually considered the master regulator for the CD4+CD25+ ""Treg"" lineage, which plays a key role in controlling immune and autoimmune responses, and is characterized by a unique transcriptional signature. We have performed a meta-analysis of this signature in Treg cells in several conditions to delineate the elements that can be ascribed to T cell activation, TGFbeta signaling, or Foxp3 itself. We find that these influences synergize to activate many of the signature’s components. Foxp3 and TGFbeta signaling have interconnected relationships, as Foxp3 is induced by TGFbeta while enhancing TGFbeta’s positive feedback loop. Much of the Treg signature cannot be ascribed to Foxp3, as it contains gene clusters that are co-regulated, but cannot be transactivated, by Foxp3. This suggests that the Treg lineage is specified at a higher level of regulation, upstream of Foxp3, which does control some of the lineage’s essential immunoregulatory attributes."					64754	4058	27190	441478	3955	925	926	51123	91768	999	339479	374907	266743	79713	29801	9516	10472	151556	10205	346673	23234	84078	84246	116071	284996	8743	1075	2893	1521	4320	4907	6580	753	1730	5133	692205	3682	128439	23475	6039	55647	55721	325	93587	431707	1902	85409	158219	389	111	3824	10260	196	339977	92906	23028	653361	2245	6117	114757	50859	417	822	2841	11211	26277	10519	871	1789	286336	392275	387338	54453	11123	7465	56937	7070	27257	84313	57338	200159	22914	3661	7204	157506	6440	3267	23710	26133	53630	3899	55630	7368	90249	347734	414301	26130	254887	126119	28955	5781	944	10447	116449	127540	2305	116092	23189	64800	151963	1282	3206	3553	340120	256643	203328	140838	860	80176	149951	3394	51382	10235	10783	187	55	6940	1066	84146	23670	1105	6498	147040	1198	124404	57509	10000	23012	1545	22955	54828	56165	56953	1956	23288	79690	85027	54212	199720	124044	4794	9784	3815	55145	285513	8013	952	79637	81563	2046	116236	57332	57182	55700	8111	114827	23604	9588	54102	420	150082	9397	117289	9654	23566	140862	5724	10865	327	1362	348303	55229	79442	8909	54862	55262	2917	6564	5590	51214	10743	2275	333929	26051	4010	4796	57458	2242	2150	57613
GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_UP	M5700		18024188	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7460	GSE7460_1338_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparsion of sfActCD4 versus ActCD4 (see Fig. 1 in the paper for details).	"The transcription factor Foxp3 is usually considered the master regulator for the CD4+CD25+ ""Treg"" lineage, which plays a key role in controlling immune and autoimmune responses, and is characterized by a unique transcriptional signature. We have performed a meta-analysis of this signature in Treg cells in several conditions to delineate the elements that can be ascribed to T cell activation, TGFbeta signaling, or Foxp3 itself. We find that these influences synergize to activate many of the signature’s components. Foxp3 and TGFbeta signaling have interconnected relationships, as Foxp3 is induced by TGFbeta while enhancing TGFbeta’s positive feedback loop. Much of the Treg signature cannot be ascribed to Foxp3, as it contains gene clusters that are co-regulated, but cannot be transactivated, by Foxp3. This suggests that the Treg lineage is specified at a higher level of regulation, upstream of Foxp3, which does control some of the lineage’s essential immunoregulatory attributes."					55466	153562	401612	1776	10800	27330	10938	6051	57698	79577	196	55080	9069	6696	85477	10049	2151	387882	2745	132299	136	54914	3958	283989	3516	123	1583	8743	84909	22936	80231	9047	10409	117247	4734	7404	22987	116931	64092	5774	6242	54949	3594	165324	8435	51676	9497	11127	1820	11072	8653	122953	23150	6883	79156	3500	4651	3586	8530	4094	6646	10518	440	27067	80176	3565	51150	8836	98	8676	3090	5699	6050	5074	597	7690	64859	80021	124359	5906	648	197259	154214	353	10673	85027	7780	4082	127018	5996	57679	10148	115825	5167	55163	8576	4245	26020	860	254102	84293	81671	84969	51643	23423	57091	8784	4287	925	493869	123263	4363	56953	23708	7293	84981	115861	3001	160335	9046	2669	837	6788	7351	11082	6259	162073	55630	8935	57608	51126	127544	1051	54733	29909	9252	1847	9404	55647	58475	3956	29851	27293	3895	639	64215	282969	54972	8733	55113	23198	26000	5148	50999	2149	5523	51318	7813	5358	9873	8694	50515	10952	49856	56937	79001	9926	3708	6774	203328	55031	5721	549	79158	5133	94104	1829	220441	22832	9761	10477	7850	53340	200132	5326	11146	3101	79609	5861	51566	10910	147040	6545	84271	2947	9465	2034	5606	644353	51531
GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_DN	M5701		18024188	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7460	GSE7460_1338_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparsion of sfActCD4 versus ActCD4 (see Fig. 1 in the paper for details).	"The transcription factor Foxp3 is usually considered the master regulator for the CD4+CD25+ ""Treg"" lineage, which plays a key role in controlling immune and autoimmune responses, and is characterized by a unique transcriptional signature. We have performed a meta-analysis of this signature in Treg cells in several conditions to delineate the elements that can be ascribed to T cell activation, TGFbeta signaling, or Foxp3 itself. We find that these influences synergize to activate many of the signature’s components. Foxp3 and TGFbeta signaling have interconnected relationships, as Foxp3 is induced by TGFbeta while enhancing TGFbeta’s positive feedback loop. Much of the Treg signature cannot be ascribed to Foxp3, as it contains gene clusters that are co-regulated, but cannot be transactivated, by Foxp3. This suggests that the Treg lineage is specified at a higher level of regulation, upstream of Foxp3, which does control some of the lineage’s essential immunoregulatory attributes."					6942	2353	56912	22897	2052	126669	10252	6402	55229	57182	9411	9760	63910	51008	79828	157285	6590	23313	440193	116986	27163	57560	23200	2258	6196	56156	92196	55198	23607	54874	64087	57458	10129	338872	2570	92749	8609	7782	6262	84133	6907	4967	51754	8829	2643	151742	11259	84958	10425	203228	7392	221079	686	29965	2306	9953	7503	57658	490	256281	55975	2099	10449	5469	10267	65997	152185	1308	59345	4329	338322	8572	5921	55845	1998	10888	1849	9712	87769	154043	139285	8303	445	55283	23475	58526	84552	10472	9258	351	23078	23228	22794	1901	79993	23261	23151	10335	83440	5991	3487	10868	2868	2005	9644	79834	157638	58472	51176	148867	147138	23446	51706	670	8804	57559	160760	64756	79575	117177	1501	140807	84954	123606	285888	6433	9196	80262	367	10365	81563	147179	51334	23087	9124	50937	1236	151888	54453	7008	79817	84284	4057	324	85461	9590	10611	26262	65999	6563	339977	4784	389124	6932	112398	57205	11174	4089	9315	57153	5316	866	54816	64282	84693	84886	28971	2012	10123	114299	5897	80310	26524	83933	23013	8554	23244	10566	286410	3399	5298	387338	817	163782	63933	23268	23211	23765	1101	7874	738	7165	10396	8525	944	5600	8654	51302	4166	914
GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_UP	M5703		18024188	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7460	GSE7460_1339_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparsion of sfActCD4TGF versus ActCD4TGF (see Fig. 1 in the paper for details).	"The transcription factor Foxp3 is usually considered the master regulator for the CD4+CD25+ ""Treg"" lineage, which plays a key role in controlling immune and autoimmune responses, and is characterized by a unique transcriptional signature. We have performed a meta-analysis of this signature in Treg cells in several conditions to delineate the elements that can be ascribed to T cell activation, TGFbeta signaling, or Foxp3 itself. We find that these influences synergize to activate many of the signature’s components. Foxp3 and TGFbeta signaling have interconnected relationships, as Foxp3 is induced by TGFbeta while enhancing TGFbeta’s positive feedback loop. Much of the Treg signature cannot be ascribed to Foxp3, as it contains gene clusters that are co-regulated, but cannot be transactivated, by Foxp3. This suggests that the Treg lineage is specified at a higher level of regulation, upstream of Foxp3, which does control some of the lineage’s essential immunoregulatory attributes."					203328	9516	80305	144811	925	80705	9457	123	111	8022	8284	3458	580	55183	597	8935	23710	79001	51126	339479	27351	9069	22936	125488	4058	6051	26973	11340	7043	80318	3090	51699	55666	8653	23150	162073	11146	10588	3048	30009	586	51101	51371	3304	5133	29775	80124	439996	9663	257062	4772	6341	57082	639	6748	2274	5552	5167	836	83480	10865	8840	64754	6452	467	131377	5140	7780	926	10279	23753	3560	9443	6259	57491	10950	8532	4924	2051	85364	9761	6873	387882	11072	353	952	155066	3267	5774	54960	4734	6238	153562	51361	3586	10910	10938	136	468	23063	64858	8661	26051	55858	93587	3516	11145	5831	54842	80148	91768	196	2583	10205	29089	64151	56994	23566	9670	1955	7407	5311	4851	10219	10165	3958	10099	22914	1603	27330	346673	79723	55	10825	5686	1213	356	2569	90390	55630	85027	10477	1362	970	51316	55227	9244	50515	7106	84174	2885	3001	2705	4245	5887	4818	3394	51366	2140	54949	11014	1051	54989	860	55591	3703	220963	80824	3565	3376	3595	64105	168537	142679	8894	29948	118812	84293	6820	1829	7404	4616	2833	23480	5684	5048	81671	2356	79697	124359	89765	11040	286128	147323	5427	3824	153733	285282	10952	2149
GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_DN	M5705		18024188	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7460	GSE7460_1339_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparsion of sfActCD4TGF versus ActCD4TGF (see Fig. 1 in the paper for details).	"The transcription factor Foxp3 is usually considered the master regulator for the CD4+CD25+ ""Treg"" lineage, which plays a key role in controlling immune and autoimmune responses, and is characterized by a unique transcriptional signature. We have performed a meta-analysis of this signature in Treg cells in several conditions to delineate the elements that can be ascribed to T cell activation, TGFbeta signaling, or Foxp3 itself. We find that these influences synergize to activate many of the signature’s components. Foxp3 and TGFbeta signaling have interconnected relationships, as Foxp3 is induced by TGFbeta while enhancing TGFbeta’s positive feedback loop. Much of the Treg signature cannot be ascribed to Foxp3, as it contains gene clusters that are co-regulated, but cannot be transactivated, by Foxp3. This suggests that the Treg lineage is specified at a higher level of regulation, upstream of Foxp3, which does control some of the lineage’s essential immunoregulatory attributes."					50852	4088	473	54498	25778	958	55974	976	26034	64714	80776	9750	65018	124446	2060	27163	440193	84925	89953	3676	158293	57559	26137	55617	9794	80853	10243	7764	50937	3551	8835	92749	8527	2099	25943	255394	10723	63910	83440	25849	122525	7507	4329	11174	7342	79865	23446	3034	8434	80335	130399	9641	27244	5420	8738	8100	27136	5578	9258	83699	7403	22990	26993	3487	2131	92014	28951	10203	9644	389075	84532	6402	57571	93589	50650	23505	4240	9467	10365	8303	23401	11264	4155	9448	219681	4089	3111	26018	55450	57182	23151	84954	1080	23313	4784	221711	9910	51176	54816	51465	58472	9315	84959	3112	57154	26100	285440	26207	57509	8609	126669	51111	7392	55843	147965	79598	85464	10267	50943	255252	550643	50649	27229	8829	64855	1901	1849	23765	7096	4925	399	84726	254048	8897	55198	285175	9639	9885	23108	56997	4170	9466	150864	80205	57337	25851	284131	115	79735	401548	2258	6925	83452	7503	30851	91544	347902	79626	2065	283450	10449	23492	822	133746	2623	79144	9732	84232	114907	125058	64781	91404	3572	8572	11329	283349	3241	23568	1757	9205	9967	57492	4916	84680	4947	124935	10053	23141	152519	80700	359845	1363	6777	4258	831	389856	155435	80760	10083	270
GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_UP	M5706		18024188	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7460	GSE7460_1340_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparsion of sfActCD4 versus WTActCD4 (see Fig. 1 in the paper for details).	"The transcription factor Foxp3 is usually considered the master regulator for the CD4+CD25+ ""Treg"" lineage, which plays a key role in controlling immune and autoimmune responses, and is characterized by a unique transcriptional signature. We have performed a meta-analysis of this signature in Treg cells in several conditions to delineate the elements that can be ascribed to T cell activation, TGFbeta signaling, or Foxp3 itself. We find that these influences synergize to activate many of the signature’s components. Foxp3 and TGFbeta signaling have interconnected relationships, as Foxp3 is induced by TGFbeta while enhancing TGFbeta’s positive feedback loop. Much of the Treg signature cannot be ascribed to Foxp3, as it contains gene clusters that are co-regulated, but cannot be transactivated, by Foxp3. This suggests that the Treg lineage is specified at a higher level of regulation, upstream of Foxp3, which does control some of the lineage’s essential immunoregulatory attributes."					4651	201895	6696	7355	2243	80005	254102	10548	2637	3489	5655	3592	4924	3875	4626	89765	6277	64215	10211	54682	57188	9046	3500	23150	387882	5596	132299	6809	3958	493869	4645	2745	54810	2885	8076	201292	11057	130367	79874	11082	6039	285362	6954	10093	11328	29999	51547	29909	7351	10581	9553	8933	6622	78994	116931	1051	11344	6911	2838	57408	337976	9253	5552	11285	3824	55531	9242	23541	51313	3284	79844	93035	864	84439	192134	51676	100506564	57594	57720	389124	54939	2306	84124	50619	3766	55332	440689	115703	9683	9508	5618	136242	333926	2638	116442	3208	103	202559	6548	388552	338707	5169	51686	23583	881	10094	1155	84876	860	9779	51097	151393	56052	51760	7042	4017	1241	115290	537	54854	64375	50865	4615	5799	57471	285175	4640	57573	788	9048	311	203328	54435	93426	340351	340156	25976	256394	389015	284467	55108	79713	57406	846	3092	57586	23334	25999	2650	3198	92736	1889	84256	51135	3001	10561	9957	5294	286	399512	57189	22987	51063	3371	10040	4094	2641	124997	79958	388630	55262	1435	3821	344905	80834	5210	387804	11337	57669	4760	10505	2212	83700	2919	64800	283927	6385	22914	254528	4650	84315	5829	2952	10673	64109	137209	6988	84255	54332	131450
GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_DN	M5707		18024188	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7460	GSE7460_1340_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparsion of sfActCD4 versus WTActCD4 (see Fig. 1 in the paper for details).	"The transcription factor Foxp3 is usually considered the master regulator for the CD4+CD25+ ""Treg"" lineage, which plays a key role in controlling immune and autoimmune responses, and is characterized by a unique transcriptional signature. We have performed a meta-analysis of this signature in Treg cells in several conditions to delineate the elements that can be ascribed to T cell activation, TGFbeta signaling, or Foxp3 itself. We find that these influences synergize to activate many of the signature’s components. Foxp3 and TGFbeta signaling have interconnected relationships, as Foxp3 is induced by TGFbeta while enhancing TGFbeta’s positive feedback loop. Much of the Treg signature cannot be ascribed to Foxp3, as it contains gene clusters that are co-regulated, but cannot be transactivated, by Foxp3. This suggests that the Treg lineage is specified at a higher level of regulation, upstream of Foxp3, which does control some of the lineage’s essential immunoregulatory attributes."					2567	339479	90161	3184	8065	3899	149018	2781	341346	6461	5023	54453	23189	83876	3570	23005	57727	25925	8852	222642	1605	339977	115908	6361	9258	26049	1411	58499	54913	1961	5534	54461	338917	6638	154043	57459	146225	203228	53339	11339	55274	59349	5578	3955	11138	9687	374768	9869	10298	115353	197335	121551	9406	150962	200350	9530	11184	3843	8125	83637	7165	84966	735	11200	2258	23551	26228	285888	1385	114885	25814	65981	2052	10250	219539	643414	11098	284001	54544	157506	92181	5738	348	6508	1302	10492	54955	6431	100506049	85358	7292	80310	57646	143872	84940	221710	389058	4881	285126	1663	55327	7874	23379	440556	85438	55038	23780	51517	5781	65012	1303	22	55304	10116	51455	60509	2168	89766	50632	100289635	10714	187	54765	84993	90381	6198	63977	10243	6932	64756	23314	8726	3861	340120	51015	10622	10980	266727	84435	55719	55289	53635	1674	5923	417	387694	55301	84902	23508	25973	254887	140838	134111	431707	4784	8835	252983	6247	54788	1447	27436	60485	5367	116064	53354	5152	168433	55512	8829	4222	4057	10537	84547	54821	373	8848	256435	151531	10294	10926	8718	83550	266743	143279	51299	8534	5634	481	8019	343641	23012	114299	5091	7465	26256	64397	91694	10531	1741	5662
GSE7460_WT_VS_FOXP3_HET_ACT_TCONV_UP	M5709		18024188	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7460	GSE7460_1342_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of ActCD4 versus WTActCD4 (see Fig. 1 in the paper for details).	"The transcription factor Foxp3 is usually considered the master regulator for the CD4+CD25+ ""Treg"" lineage, which plays a key role in controlling immune and autoimmune responses, and is characterized by a unique transcriptional signature. We have performed a meta-analysis of this signature in Treg cells in several conditions to delineate the elements that can be ascribed to T cell activation, TGFbeta signaling, or Foxp3 itself. We find that these influences synergize to activate many of the signature’s components. Foxp3 and TGFbeta signaling have interconnected relationships, as Foxp3 is induced by TGFbeta while enhancing TGFbeta’s positive feedback loop. Much of the Treg signature cannot be ascribed to Foxp3, as it contains gene clusters that are co-regulated, but cannot be transactivated, by Foxp3. This suggests that the Treg lineage is specified at a higher level of regulation, upstream of Foxp3, which does control some of the lineage’s essential immunoregulatory attributes."					5972	6262	2353	6277	23313	440193	54332	22897	23261	57188	92196	339	6196	490	3241	27163	6583	157285	8725	145773	9910	79817	4166	1236	9760	2643	1889	389124	151525	23224	10335	7988	25876	11264	6590	7392	2258	63910	10252	8303	6942	130617	256364	80017	51176	113246	1849	126669	2306	2774	10723	85450	256281	56606	23143	10425	338322	8525	9411	8572	10129	10267	619373	1588	8829	165	26100	79575	57559	23339	2099	8554	26762	51280	55845	9712	84552	2072	670	11344	23151	149345	55902	6433	79828	84958	23475	5991	2012	64857	22859	57700	5351	9744	131601	4947	10449	5025	754	114790	503542	85461	221322	5339	57182	9254	55198	404217	1201	2014	283571	9919	65990	9806	782	5564	284058	161497	9266	58472	83440	8804	85464	2065	9914	686	706	3281	116986	8654	56203	23474	5819	283219	155435	391	283209	2515	58526	4299	1501	26137	1938	114803	8809	4329	2925	8446	147138	79993	54522	10123	7782	26262	2895	113402	115330	359845	55843	29999	51302	10847	55317	79661	977	5469	151742	10018	6733	1998	2052	57337	375035	55857	10444	27343	148867	195827	80853	1877	4089	64756	9975	1487	5927	151888	8682	3384	9704	339745	8569	5261	816	79618	29985	159963	339896	50937	57560	50852
GSE7460_WT_VS_FOXP3_HET_ACT_TCONV_DN	M5710		18024188	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7460	GSE7460_1342_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of ActCD4 versus WTActCD4 (see Fig. 1 in the paper for details).	"The transcription factor Foxp3 is usually considered the master regulator for the CD4+CD25+ ""Treg"" lineage, which plays a key role in controlling immune and autoimmune responses, and is characterized by a unique transcriptional signature. We have performed a meta-analysis of this signature in Treg cells in several conditions to delineate the elements that can be ascribed to T cell activation, TGFbeta signaling, or Foxp3 itself. We find that these influences synergize to activate many of the signature’s components. Foxp3 and TGFbeta signaling have interconnected relationships, as Foxp3 is induced by TGFbeta while enhancing TGFbeta’s positive feedback loop. Much of the Treg signature cannot be ascribed to Foxp3, as it contains gene clusters that are co-regulated, but cannot be transactivated, by Foxp3. This suggests that the Treg lineage is specified at a higher level of regulation, upstream of Foxp3, which does control some of the lineage’s essential immunoregulatory attributes."					28232	6883	6259	10124	127018	55031	11051	23150	5870	54949	2151	55884	93107	11022	9861	2745	23423	123	79577	84132	136	648	84131	85027	285331	126299	4734	83480	252983	151393	3594	10575	2669	253152	256710	153339	5515	1829	55012	81573	80021	3001	4889	27069	8087	84263	27330	29071	4147	56953	79158	10980	120379	3845	125488	643965	26953	5828	10910	4094	23012	4287	57593	8435	11146	64778	8477	5783	84267	139322	5359	51676	64418	165324	91614	644353	2781	51318	26020	8872	146225	8530	8669	56922	952	9587	26973	11231	23413	149095	90390	84259	10643	400120	10477	286053	90378	346673	65094	3500	7690	5705	9202	65977	9926	51555	23398	112752	5610	122481	306	56994	4247	125150	140687	143098	25921	1741	9442	5094	1812	5810	55624	80184	10459	55858	55630	60487	4881	83637	8999	2833	4528	150280	9777	729852	8726	51074	375743	5683	84909	345611	196	85365	101	203328	2149	57017	123263	10049	197259	1847	51225	401612	56267	50515	3920	202052	9690	54499	8844	6421	2109	11184	23480	9057	64859	3958	730094	8803	5720	147040	5000	25909	65998	6873	29102	127544	9761	81671	55486	657	9827	7347	84898	3267	11154	84614	10011	1982	100132884	22832	5781	53	4836	8743	79849	1820	10730	166614
GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_UP	M5711		18024188	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7460	GSE7460_1343_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of ActCD4TGF versus WTActCD4TGF (see Fig. 1 in the paper for details).	"The transcription factor Foxp3 is usually considered the master regulator for the CD4+CD25+ ""Treg"" lineage, which plays a key role in controlling immune and autoimmune responses, and is characterized by a unique transcriptional signature. We have performed a meta-analysis of this signature in Treg cells in several conditions to delineate the elements that can be ascribed to T cell activation, TGFbeta signaling, or Foxp3 itself. We find that these influences synergize to activate many of the signature’s components. Foxp3 and TGFbeta signaling have interconnected relationships, as Foxp3 is induced by TGFbeta while enhancing TGFbeta’s positive feedback loop. Much of the Treg signature cannot be ascribed to Foxp3, as it contains gene clusters that are co-regulated, but cannot be transactivated, by Foxp3. This suggests that the Treg lineage is specified at a higher level of regulation, upstream of Foxp3, which does control some of the lineage’s essential immunoregulatory attributes."					9247	50852	118490	23401	3034	387733	56888	6482	7044	2099	7073	9967	26207	23765	6453	22993	80700	713	54843	51176	3487	2330	8572	9644	28971	1183	58986	60343	91544	9256	440193	84552	5739	126669	55810	375444	9741	4240	161	246329	50937	9674	9641	87769	7538	6925	54498	7008	26272	28951	9877	255809	976	58472	283450	26137	4597	54462	11277	147138	10581	7392	23241	57559	54982	6018	1032	85450	51043	958	79735	1611	9215	79865	9953	57700	22990	7915	132612	5833	576	3949	1877	23307	1080	55904	9639	151888	8446	9770	150864	55129	4784	6480	1112	84726	9732	50650	4651	79809	375612	9772	91523	23645	338811	147965	4089	9710	83892	122786	10083	154796	1901	1588	6850	324	254048	9920	10123	2353	22821	91	7764	1739	5600	79699	84107	221711	85461	55757	64218	23095	283349	259173	10723	7057	221496	10922	308	6433	4774	8609	27434	83755	23400	148867	79971	23353	121665	6844	284131	54103	285704	5420	51166	55421	92196	4258	5743	2625	81669	57205	10252	923	55532	3109	4281	196264	388931	23200	155435	23168	367	79759	3638	272	84858	167359	51347	4300	27040	80312	84954	84680	3112	7067	10451	3551	23140	8994	9205	643008	445	79892	81844	4092	2316	132864	25849	401207
GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_DN	M5712		18024188	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7460	GSE7460_1343_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of ActCD4TGF versus WTActCD4TGF (see Fig. 1 in the paper for details).	"The transcription factor Foxp3 is usually considered the master regulator for the CD4+CD25+ ""Treg"" lineage, which plays a key role in controlling immune and autoimmune responses, and is characterized by a unique transcriptional signature. We have performed a meta-analysis of this signature in Treg cells in several conditions to delineate the elements that can be ascribed to T cell activation, TGFbeta signaling, or Foxp3 itself. We find that these influences synergize to activate many of the signature’s components. Foxp3 and TGFbeta signaling have interconnected relationships, as Foxp3 is induced by TGFbeta while enhancing TGFbeta’s positive feedback loop. Much of the Treg signature cannot be ascribed to Foxp3, as it contains gene clusters that are co-regulated, but cannot be transactivated, by Foxp3. This suggests that the Treg lineage is specified at a higher level of regulation, upstream of Foxp3, which does control some of the lineage’s essential immunoregulatory attributes."					864	116729	54455	162073	57820	114793	580	9324	9260	57406	952	8993	79447	6418	51101	245973	84085	1955	6259	145873	23531	23461	51361	51699	28834	27330	10910	10783	80705	85440	23597	353	3586	22806	9443	121642	115350	50515	4345	7046	123	389362	4082	1829	7106	131965	677768	55274	2199	55664	84293	22936	125488	283120	10643	3565	57698	222865	100132884	22824	340719	134492	22938	11335	256676	10409	8935	3386	3090	56478	163126	7866	5207	306	9797	8200	64928	10980	23710	1362	3910	6397	57418	28970	117247	11145	1741	8743	9615	283237	7840	64065	64114	25888	2833	5359	10800	3514	58512	3601	201626	131377	1952	1410	214	6586	1515	84056	10240	6821	130916	9882	4058	26973	10588	10952	147040	29103	222894	597	163590	9733	5179	10825	3605	4943	7780	80124	57221	395	64900	10597	5990	5332	6363	1832	10309	27069	1820	11159	22852	51371	23398	4313	55691	8187	389072	23075	4191	375743	356	9427	57491	51522	1388	8600	79671	221545	836	147323	55183	9522	3815	85364	9904	8736	79697	84167	29100	54887	23234	11142	716	84263	55352	84225	3708	8836	7042	401612	57176	258010	54437	55366	84909	166815	6038	57404	10456	10174	5217	727800	659	140735	7772	89765	23034	1174	9658	51316
GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_UP	M5713		18024188	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7460	GSE7460_1344_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of Ctrlrv versus Foxp3rv (see Fig. 1 in the paper for details).	"The transcription factor Foxp3 is usually considered the master regulator for the CD4+CD25+ ""Treg"" lineage, which plays a key role in controlling immune and autoimmune responses, and is characterized by a unique transcriptional signature. We have performed a meta-analysis of this signature in Treg cells in several conditions to delineate the elements that can be ascribed to T cell activation, TGFbeta signaling, or Foxp3 itself. We find that these influences synergize to activate many of the signature’s components. Foxp3 and TGFbeta signaling have interconnected relationships, as Foxp3 is induced by TGFbeta while enhancing TGFbeta’s positive feedback loop. Much of the Treg signature cannot be ascribed to Foxp3, as it contains gene clusters that are co-regulated, but cannot be transactivated, by Foxp3. This suggests that the Treg lineage is specified at a higher level of regulation, upstream of Foxp3, which does control some of the lineage’s essential immunoregulatory attributes."					9674	6907	57103	1815	285237	2705	79991	80207	284612	5424	27161	79096	125170	56138	55611	6754	5168	64005	79629	79042	50809	8560	5139	222553	147015	5118	25886	134	3853	94026	57545	1421	256006	3818	55715	116028	287015	83478	2140	10964	64111	221883	79053	53842	83878	2880	54964	222663	64073	387032	6676	29070	83547	10652	163782	26147	51302	7082	346673	2316	79810	56243	340526	5361	3578	5585	27133	148523	2697	29785	10675	80148	6640	338321	6601	168620	2646	51255	64137	80031	148252	83697	10533	25833	9630	10234	10554	23759	265	85366	94086	22882	6586	865	160492	5956	51375	1409	54329	3837	255231	2332	1413	9628	374378	11098	5547	10400	5212	114793	60681	79922	4606	6559	6832	83886	342527	345079	7051	9183	140290	80728	23253	10	9423	2035	5074	400120	388135	117247	84435	399512	105	2696	2842	115273	1208	57105	284654	4968	10844	583	51156	2670	444	551	200407	364	151195	374946	166348	115024	56928	10456	84647	8403	284307	27039	7389	23218	8310	200132	23251	23516	55213	79816	9722	8828	55586	126299	192683	6731	10686	135112	2137	104	66000	57165	9814	115948	5797	56478	4920	346171	83942	202500	2175	408186	222171	11075	2359	11213	112970	4723	100506564	3875	997	123970	2740	132671
GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_DN	M5715		18024188	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7460	GSE7460_1344_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of Ctrlrv versus Foxp3rv (see Fig. 1 in the paper for details).	"The transcription factor Foxp3 is usually considered the master regulator for the CD4+CD25+ ""Treg"" lineage, which plays a key role in controlling immune and autoimmune responses, and is characterized by a unique transcriptional signature. We have performed a meta-analysis of this signature in Treg cells in several conditions to delineate the elements that can be ascribed to T cell activation, TGFbeta signaling, or Foxp3 itself. We find that these influences synergize to activate many of the signature’s components. Foxp3 and TGFbeta signaling have interconnected relationships, as Foxp3 is induced by TGFbeta while enhancing TGFbeta’s positive feedback loop. Much of the Treg signature cannot be ascribed to Foxp3, as it contains gene clusters that are co-regulated, but cannot be transactivated, by Foxp3. This suggests that the Treg lineage is specified at a higher level of regulation, upstream of Foxp3, which does control some of the lineage’s essential immunoregulatory attributes."					3795	2027	54207	64859	55973	340706	123355	5876	5873	79071	253430	4040	79932	3097	10970	100507444	8540	9497	1080	25962	27296	8434	2868	28996	84964	84245	90576	100129269	257062	6340	84795	3026	222487	25901	8835	4763	3682	153579	78987	286451	3716	54732	84706	7014	64418	7410	4669	10302	113510	23635	25907	8204	282973	1582	2019	6398	114908	23239	64863	221223	147670	80205	23304	9990	2623	90701	55145	51744	23646	1105	4351	51141	23065	574414	10559	319	221955	27128	2857	763	4703	84514	5260	286207	55502	8085	116496	116285	63874	80864	56126	1363	30837	55356	10260	8214	118429	23528	22806	116	54827	2161	6658	51311	9652	151473	80765	25871	3656	1121	64756	4939	51360	55170	112936	197187	8821	4327	8729	29942	79834	6883	389856	147007	4922	55617	7490	23071	394	25798	170371	55365	374955	55144	10409	84326	145482	10439	98	60491	197258	168544	57565	51690	6648	1642	4856	6809	602	60436	6709	7258	25829	53822	7554	57705	9446	7128	29980	55214	134288	64651	55090	347273	2321	55756	51554	81603	1907	6856	5864	23326	55281	2788	338339	4086	23301	9670	6878	7353	54854	92675	57037	219539	11316	55661	79736	4608	143686	9465	114971	1326	29904	54928	57552	55437	10164	283849	64324	57099
GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_1_UP	M5716		18024188	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7460	GSE7460_1345_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of CTRLrv versus FOXP3rv (see Fig. 1 for details).	"The transcription factor Foxp3 is usually considered the master regulator for the CD4+CD25+ ""Treg"" lineage, which plays a key role in controlling immune and autoimmune responses, and is characterized by a unique transcriptional signature. We have performed a meta-analysis of this signature in Treg cells in several conditions to delineate the elements that can be ascribed to T cell activation, TGFbeta signaling, or Foxp3 itself. We find that these influences synergize to activate many of the signature’s components. Foxp3 and TGFbeta signaling have interconnected relationships, as Foxp3 is induced by TGFbeta while enhancing TGFbeta’s positive feedback loop. Much of the Treg signature cannot be ascribed to Foxp3, as it contains gene clusters that are co-regulated, but cannot be transactivated, by Foxp3. This suggests that the Treg lineage is specified at a higher level of regulation, upstream of Foxp3, which does control some of the lineage’s essential immunoregulatory attributes."					205	353322	92104	54554	50852	85301	5223	10921	1113	5140	3070	63036	51106	167555	55768	84696	283208	284131	154141	4291	253635	55165	2693	157570	7155	1419	9813	51110	195828	201625	344595	6011	1285	388569	8404	363	9880	54892	387718	6513	84698	79836	11171	9411	54801	340277	51108	90025	63939	3633	8636	3608	4129	6094	10663	338785	146853	147015	79877	65122	117154	5051	1736	7007	1468	130576	3099	3376	1122	27238	2697	27166	3274	4190	348995	29929	56241	84891	55733	120	6674	114789	100506884	259173	353131	10495	10800	59339	4308	5069	4618	55290	5925	55589	83604	79772	3684	79156	90141	5199	6101	54757	80896	374946	441054	133418	1060	7536	55236	23566	5214	10905	337972	9184	357	56913	118932	339488	5626	53342	164312	3157	2678	136991	5329	79169	55363	140838	7840	87769	9037	5777	6326	54734	4528	9943	56920	388531	55038	100288695	7407	79895	339778	144811	284541	9732	4200	22926	201626	10541	9363	1602	84109	114879	10970	28982	9401	84623	79075	56164	3753	8989	886	79783	337976	51097	9196	6718	143903	55709	3838	25802	79816	5005	8379	139604	6840	22	122769	123970	55336	220107	10233	1894	6628	286826	3156	286410	5427	57088	201292	4172	11339	3490	6539	114905	4253	8819	2626	4175
GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_1_DN	M5719		18024188	Buzzeo MP,Yang J,Casella G,Reddy V.	GSE7460	GSE7460_1345_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of CTRLrv versus FOXP3rv (see Fig. 1 for details).	"The transcription factor Foxp3 is usually considered the master regulator for the CD4+CD25+ ""Treg"" lineage, which plays a key role in controlling immune and autoimmune responses, and is characterized by a unique transcriptional signature. We have performed a meta-analysis of this signature in Treg cells in several conditions to delineate the elements that can be ascribed to T cell activation, TGFbeta signaling, or Foxp3 itself. We find that these influences synergize to activate many of the signature’s components. Foxp3 and TGFbeta signaling have interconnected relationships, as Foxp3 is induced by TGFbeta while enhancing TGFbeta’s positive feedback loop. Much of the Treg signature cannot be ascribed to Foxp3, as it contains gene clusters that are co-regulated, but cannot be transactivated, by Foxp3. This suggests that the Treg lineage is specified at a higher level of regulation, upstream of Foxp3, which does control some of the lineage’s essential immunoregulatory attributes."					13	220002	198437	1583	3559	11017	64781	23646	134728	55770	9489	65999	9111	51669	126003	81502	116496	3604	10667	388611	143279	404550	119559	5738	2072	89932	56204	258	7323	51657	127018	64801	117248	3383	6553	79777	501	340146	7263	79834	755	51768	51322	10243	9973	222068	183	80325	23022	6324	8676	51307	91373	6194	7073	55340	23102	10725	29101	7293	122786	390243	7084	6813	7134	84617	163782	55861	221692	57180	285888	4983	317719	26225	7813	51278	2868	2153	3682	5664	3572	57099	23446	64839	26137	3294	116534	55207	10278	11183	5326	51363	23362	3976	84959	4084	4318	26051	79786	9726	55049	283234	9877	4817	83597	65056	1456	80270	63950	55848	2531	29941	119710	2159	8784	50487	140609	5924	1264	54812	153	85444	951	10678	6944	345757	3664	163183	27012	80714	28986	503542	1515	54482	825	57453	3073	85377	5996	79713	5634	54742	10595	286467	11174	81618	140876	5368	84245	23597	54540	55512	27306	23071	3104	54544	57728	9537	64651	84439	79071	55626	25970	115825	6385	90423	340152	10451	55081	84734	4616	84893	26024	115584	340485	3632	962	100131897	1666	64063	115727	26063	54954	975	3131	55080	5269	24147	1080	84883	5993	9654	9522	9741	89780	126308	441061	22936	710	222865
GSE8515_CTRL_VS_IL1_4H_STIM_MAC_UP	M5759		18498781	Jura J,Wegrzyn P,Korostyński M,Guzik K,Oczko-Wojciechowska M,Jarzab M,Kowalska M,Piechota M,Przewłocki R,Koj A	GSE8515	GSE8515_1721_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated macrophages versus those treated with IL1.	Using whole-genome Affymetrix microarrays (HG-U133A), we characterized the transcriptome profile of cultured human macrophages stimulated for 4 h with interleukin 1 (IL-1) or interleukin 6 (IL-6). We found that, in distinction to liver cells, IL-1 is much more potent than IL-6 in modifying macrophage gene expression, although considerable heterogeneity in response of macrophages deriving from individual blood donors was observed. The obtained results permitted to identify a large number of cytokine-responsive genes. coding for proteins of unknown function that are now being studied in our laboratory. They may represent novel targets in the anti-inflammatory therapy.					474170	10487	863	27244	22834	1584	79807	3849	7172	51439	7541	25976	26239	9941	7597	55830	56969	51101	9353	54677	50650	9553	65125	6581	57380	57088	29092	10732	6905	80742	7625	23588	5617	8328	51188	10420	26060	23401	968	287	54968	8739	8800	7184	5774	5529	5288	7252	6453	25809	2324	159963	4889	55776	79959	11252	55848	80128	5538	9682	8863	7786	2512	8621	4775	4300	7033	51099	51585	81602	114876	538	80736	23300	55176	25875	5122	10140	6954	160313	9891	2810	80263	64131	9183	10765	5525	10849	79899	10457	5305	6571	55296	2568	57211	79648	220972	349152	26031	5733	27252	3443	55709	23608	54830	8437	55039	5324	28985	2971	29951	55275	1050	9016	2693	56898	2787	92342	8604	51104	9871	51321	7044	442216	79612	11082	51088	4239	8715	6239	6795	54932	56897	11279	4735	9459	6894	54848	7399	7368	818	23303	51611	23409	54732	10928	6694	118433	607	81697	3239	79038	11031	8226	5737	8895	23523	6874	9358	100293871	7067	725	23659	4917	79064	56163	9421	23173	55787	23554	3720	55216	27347	23478	6210	1959	22869	5459	55779	25780	387032	5243	1185	7168	23408	60468	79725	340351	201501	8125	26235	4126	56244	4155	185	55796	5874	64283	84253	54551
GSE8515_CTRL_VS_IL1_4H_STIM_MAC_DN	M5760		18498781	Jura J,Wegrzyn P,Korostyński M,Guzik K,Oczko-Wojciechowska M,Jarzab M,Kowalska M,Piechota M,Przewłocki R,Koj A	GSE8515	GSE8515_1721_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated macrophages versus those treated with IL1.	Using whole-genome Affymetrix microarrays (HG-U133A), we characterized the transcriptome profile of cultured human macrophages stimulated for 4 h with interleukin 1 (IL-1) or interleukin 6 (IL-6). We found that, in distinction to liver cells, IL-1 is much more potent than IL-6 in modifying macrophage gene expression, although considerable heterogeneity in response of macrophages deriving from individual blood donors was observed. The obtained results permitted to identify a large number of cytokine-responsive genes. coding for proteins of unknown function that are now being studied in our laboratory. They may represent novel targets in the anti-inflammatory therapy.					80149	4792	80255	4794	54020	79905	6351	10938	7185	8870	7128	8785	65983	8302	56260	1263	5971	10046	2920	6484	3726	4256	970	637	4779	284800	3383	2919	9334	79651	4303	27246	55707	1236	200424	11182	3576	1819	30833	23568	22882	79155	10318	79860	6360	5599	3937	8853	90133	8888	2995	1051	7804	5341	1002	55693	5966	9143	4616	5361	5704	10885	51199	9322	3055	3569	7130	5877	646934	5055	27183	51168	8975	23258	10148	100130958	3493	10276	2658	51564	11189	5429	3985	3976	23212	22809	55258	5580	29946	8999	7124	23774	9435	6364	22976	5283	29909	7582	55294	13	8409	4153	114049	11273	91353	1258	2018	80034	100506898	79693	6624	154661	23135	5027	79767	50809	22924	27113	10950	27042	65264	27304	23480	6385	65108	1030	79940	10921	9991	28513	5049	140459	9514	8843	3483	55257	64852	55108	9817	7552	4710	7127	55210	23102	10105	1778	7135	7430	54542	80262	4139	51361	79931	9212	9589	602	5533	10139	7122	29992	3601	23387	3362	23524	80217	7409	8550	254896	9673	2180	1827	2921	51491	9506	54549	58516	4148	9331	378708	6372	51174	3732	55525	4791	57369	1960	4790	54998	57826	83480	5806	6094	23096	272	7474	24147	51735	25841	1975	23189
GSE8515_CTRL_VS_IL6_4H_STIM_MAC_UP	M5763		18498781	Jura J,Wegrzyn P,Korostyński M,Guzik K,Oczko-Wojciechowska M,Jarzab M,Kowalska M,Piechota M,Przewłocki R,Koj A	GSE8515	GSE8515_1722_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated macrophages versus those treated with IL6 [GeneID=3569].	Using whole-genome Affymetrix microarrays (HG-U133A), we characterized the transcriptome profile of cultured human macrophages stimulated for 4 h with interleukin 1 (IL-1) or interleukin 6 (IL-6). We found that, in distinction to liver cells, IL-1 is much more potent than IL-6 in modifying macrophage gene expression, although considerable heterogeneity in response of macrophages deriving from individual blood donors was observed. The obtained results permitted to identify a large number of cytokine-responsive genes. coding for proteins of unknown function that are now being studied in our laboratory. They may represent novel targets in the anti-inflammatory therapy.					28985	55622	5501	9326	9575	79959	93081	5525	23505	64921	90865	7180	55839	7022	8529	79673	1955	10175	9443	23401	147339	4205	10138	8732	8548	55591	11222	8800	26984	287	2787	1871	5475	55176	5927	57380	54583	27347	4216	54955	64216	54677	26994	55799	92595	6699	23157	8915	23143	79269	79986	4085	5740	51809	3832	10438	7884	54808	80143	4289	1982	1261	11055	3658	4946	1448	23270	5001	9650	23359	10060	10281	9422	11261	51320	442216	51188	11160	29929	23173	22887	8697	27020	56656	7511	969	23421	9373	1565	9675	54517	2186	55325	6736	10048	65124	3265	23383	54885	1072	5906	1810	81892	5122	5291	8295	1811	149603	26538	114876	474170	5357	57468	8027	11122	55146	55907	10766	79157	5537	6102	84124	51552	23012	22828	55355	10959	9187	64793	79818	10675	6315	931	6133	3251	23617	4958	4430	80349	8766	54807	25998	3823	7054	1998	5529	27069	10140	2673	80168	8443	2770	8528	23255	8110	2254	3298	55784	9120	63826	80012	6646	5288	55521	4352	5973	339448	25888	5558	7403	65998	9546	4087	10786	51335	9553	6756	51669	10150	7802	1964	5707	4988	8484	23414	64795	64816	1142	1849	9865	10073	57644	10427	64960	9625	55278	1962	9014	5336	10228
GSE8515_CTRL_VS_IL6_4H_STIM_MAC_DN	M5765		18498781	Jura J,Wegrzyn P,Korostyński M,Guzik K,Oczko-Wojciechowska M,Jarzab M,Kowalska M,Piechota M,Przewłocki R,Koj A	GSE8515	GSE8515_1722_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated macrophages versus those treated with IL6 [GeneID=3569].	Using whole-genome Affymetrix microarrays (HG-U133A), we characterized the transcriptome profile of cultured human macrophages stimulated for 4 h with interleukin 1 (IL-1) or interleukin 6 (IL-6). We found that, in distinction to liver cells, IL-1 is much more potent than IL-6 in modifying macrophage gene expression, although considerable heterogeneity in response of macrophages deriving from individual blood donors was observed. The obtained results permitted to identify a large number of cytokine-responsive genes. coding for proteins of unknown function that are now being studied in our laboratory. They may represent novel targets in the anti-inflammatory therapy.					100130958	56341	10603	3350	23096	26251	23552	7135	767	5429	55351	5335	5352	6337	3889	728882	55870	3566	29034	9478	6538	57597	563	2925	2122	64748	100505761	100131755	100292534	80776	79710	55336	79680	1369	2160	28973	80060	3483	9230	56667	3578	11075	2735	22955	26664	9627	8325	9334	50717	1120	257407	8722	1215	11200	1917	79635	100287322	4212	9923	6484	245812	2672	9079	112398	6305	79940	84790	22924	23766	4986	26049	28912	4118	54865	4488	4256	312	79585	4014	3815	4324	55966	7399	10157	8387	10266	5119	646934	5950	83714	56339	9379	2324	3982	56301	14	22999	196483	64211	6618	3485	5626	28513	26548	7681	201191	22976	9093	2687	8712	55294	782	6327	2593	2250	6911	55223	1908	10631	8888	100287602	399664	1232	3933	100506898	7404	6650	10652	482	2306	55512	9152	80761	4807	5747	2028	3975	81792	1496	23632	3814	11273	23467	8170	51231	100129656	23217	3568	81932	2039	238	672	3543	7429	55117	90011	3235	9472	653238	79863	954	4913	284904	9028	11255	147657	4864	9048	8189	1299	7712	54361	5802	57152	91353	79879	10908	9957	3746	79748	3174	4649	285596	79774	5079	10957	60686	8636	79931	3694	10256	3549	11155	1230	10814	56895	8647	64210	7142	735
GSE8515_IL1_VS_IL6_4H_STIM_MAC_UP	M5766		18498781	Jura J,Wegrzyn P,Korostyński M,Guzik K,Oczko-Wojciechowska M,Jarzab M,Kowalska M,Piechota M,Przewłocki R,Koj A	GSE8515	GSE8515_1723_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of untreated macrophages versus those treated with IL1 and IL6 [GeneID=3569].	Using whole-genome Affymetrix microarrays (HG-U133A), we characterized the transcriptome profile of cultured human macrophages stimulated for 4 h with interleukin 1 (IL-1) or interleukin 6 (IL-6). We found that, in distinction to liver cells, IL-1 is much more potent than IL-6 in modifying macrophage gene expression, although considerable heterogeneity in response of macrophages deriving from individual blood donors was observed. The obtained results permitted to identify a large number of cytokine-responsive genes. coding for proteins of unknown function that are now being studied in our laboratory. They may represent novel targets in the anti-inflammatory therapy.					64222	4792	80255	7187	58504	6351	8870	22882	79651	7128	10318	140459	10938	80012	2920	7185	11182	4779	8853	970	23359	637	23568	1263	65108	1960	8303	6274	3576	79905	23189	7409	4790	3550	2919	8578	8550	4688	7262	27246	5533	23387	8744	6934	3383	27183	8732	7130	272	3569	10046	3553	59067	4193	79933	7124	2921	54020	8295	9322	8440	23135	65983	79693	23180	84124	1236	5580	27334	27284	55839	10105	10813	4294	9034	80146	5471	10148	5453	27042	9589	5272	6364	6674	23258	57826	2998	200424	10950	8767	9242	4791	2848	4216	9129	5971	23157	23764	6385	59272	80055	5806	5027	5049	7832	23480	54462	8896	599	23383	8843	6775	22809	5341	58500	64184	211	10125	9435	6372	182	6484	246243	10576	8676	57128	51031	5743	7293	2180	54807	9141	57823	7159	27329	5055	23185	4114	9308	8999	11040	941	8915	4047	81552	7474	9326	79135	9120	5973	23636	2020	2487	5966	53335	7086	5663	51104	23082	6102	1012	11142	3726	29015	10199	55707	5734	3486	29909	58516	9331	2289	5199	694	5142	2147	5514	766	5540	57731	9443	183	203197	4292	10129	51716	3838	2846	10464	26984	23348	8711	50836	688	79971	23617	50486	10178	2146	22828
GSE8515_IL1_VS_IL6_4H_STIM_MAC_DN	M5767		18498781	Jura J,Wegrzyn P,Korostyński M,Guzik K,Oczko-Wojciechowska M,Jarzab M,Kowalska M,Piechota M,Przewłocki R,Koj A	GSE8515	GSE8515_1723_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of untreated macrophages versus those treated with IL1 and IL6 [GeneID=3569].	Using whole-genome Affymetrix microarrays (HG-U133A), we characterized the transcriptome profile of cultured human macrophages stimulated for 4 h with interleukin 1 (IL-1) or interleukin 6 (IL-6). We found that, in distinction to liver cells, IL-1 is much more potent than IL-6 in modifying macrophage gene expression, although considerable heterogeneity in response of macrophages deriving from individual blood donors was observed. The obtained results permitted to identify a large number of cytokine-responsive genes. coding for proteins of unknown function that are now being studied in our laboratory. They may represent novel targets in the anti-inflammatory therapy.					55117	5335	10266	9686	83714	4807	147339	8325	22997	3756	5987	56341	4239	112398	2039	3508	10603	80144	1584	10580	10332	3931	575	55870	3350	23464	100128124	6911	9048	6538	56287	8712	5208	23434	27252	23766	35	22865	51147	482	2692	10686	26507	6337	26239	23163	11200	1674	57151	151	26050	79838	4107	55289	55351	25809	51308	11063	26548	2563	7033	51585	7755	8019	3169	752014	2324	4864	8986	7070	1028	185	337	54546	2741	55336	5733	30819	65125	51032	1392	10277	11252	6331	79679	54986	633	10847	1181	6608	7399	3983	56980	23062	11093	7368	147657	8525	29034	2100	7597	55367	954	2925	6558	4210	3138	4675	100292534	6453	7216	79585	2294	64852	10106	26272	100506699	64800	54518	8636	196740	8911	64772	80742	3744	1241	9372	3887	23092	55025	56132	54475	100288640	55204	317781	9627	10007	10869	6618	6442	1949	1815	27063	54435	51168	5582	79669	8854	4105	64284	5009	22955	27251	9720	29092	22986	728882	23409	10894	54221	5617	8484	126353	7404	4857	4137	63943	9148	2305	7673	4778	2128	54989	55638	9489	55214	8941	6476	26093	79875	7517	4796	2196	3982	9828	4998	2645	653	7786	8517	10127	100129128	9863	152015	55286	5408	79635	2650	9667	10990
GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_UP	M5774		17595242	Kaizer EC,Glaser CL,Chaussabel D,Banchereau J,Pascual V,White PC.	GSE9006	GSE9006_2237_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from patients with type 1 diabetes at the time of diagnosis.	Objective: We hypothesized that type 1 diabetes (T1D) is accompanied by changes in gene expression in peripheral blood mononuclear cells (PBMCs) due to dysregulation of adaptive and innate immunity, counterregulatory responses to immune dysregulation, insulin deficiency and hyperglycemia. Research Design and Methods: Microarray analysis was performed on PBMCs from 43 patients with newly diagnosed T1D, 12 patients with newly diagnosed type 2 diabetes (T2D) and 24 healthy controls. One and four month follow-up samples were obtained from 20 of the T1D patients. Results: Microarray analysis identified 282 genes differing in expression between newlydiagnosed T1D patients and controls at a false discovery rate of 0.05. Changes in expression of interleukin-1β (IL1B), early growth response gene 3 (EGR3), and prostaglandin-endoperoxide synthase 2 (PTGS2) resolved within four months of insulin therapy and were also observed in T2D suggesting that they resulted from hyperglycemia. With use of a knowledge base, 81/282 genes could be placed within a network of interrelated genes with predicted functions including apoptosis and cell proliferation. IL1B and the MYC oncogene were the most highly-connected genes in the network. IL1B was highly overexpressed in both T1D and T2D, whereas MYC was dysregulated only in T1D. Conclusion: T1D and T2D likely share a final common pathway for beta cell dysfunction that includes secretion of interleukin-1β and prostaglandins by immune effector cells, exacerbating existing beta cell dysfunction, and causing further hyperglycemia. The results identify several targets for disease-modifying therapy of diabetes and potential biomarkers for monitoring treatment efficacy.					5473	23300	1314	57466	51389	11212	5577	7347	2791	4638	2983	10398	56888	27246	222161	5196	7414	7332	8073	55603	6738	8574	2665	85021	10241	4026	1739	28985	2982	7168	307	3552	23531	4329	4666	4092	56922	8723	8887	7644	6281	8292	10768	1191	51084	246243	5742	7739	1601	2162	3490	7385	239	10857	8565	9377	9848	9482	100272147	5682	54739	51347	10042	2017	435	3081	29883	2273	26137	58533	5627	7360	4704	9050	64960	3429	22	8905	84223	468	9792	5687	64393	54878	3693	3550	10659	23180	23052	10553	60314	5930	3831	5090	79630	7704	8837	25994	4501	81027	10643	6659	8550	4437	29082	4711	9317	718	55252	29789	7504	8833	8802	5204	64121	3646	51754	79932	11179	51411	2734	54996	8853	10059	9315	509	9367	2781	10955	50865	5154	11343	5720	51657	7381	55173	56267	689	6891	1513	4267	10964	4684	6612	26053	1207	10632	4086	27109	81550	23043	8935	3674	51499	8895	4601	3832	51056	292	3119	55160	55670	57447	1347	4062	3595	4724	54741	26986	9450	4200	10550	7322	831	395	100288413	10899	29937	9318	539	27230	63933	23049	4087	4735	652963	81570	7011	5027	55486	4624	80035	5018	4900	10499	94081	27346	5708	80258	5739
GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_DN	M5776		17595242	Kaizer EC,Glaser CL,Chaussabel D,Banchereau J,Pascual V,White PC.	GSE9006	GSE9006_2237_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from patients with type 1 diabetes at the time of diagnosis.	Objective: We hypothesized that type 1 diabetes (T1D) is accompanied by changes in gene expression in peripheral blood mononuclear cells (PBMCs) due to dysregulation of adaptive and innate immunity, counterregulatory responses to immune dysregulation, insulin deficiency and hyperglycemia. Research Design and Methods: Microarray analysis was performed on PBMCs from 43 patients with newly diagnosed T1D, 12 patients with newly diagnosed type 2 diabetes (T2D) and 24 healthy controls. One and four month follow-up samples were obtained from 20 of the T1D patients. Results: Microarray analysis identified 282 genes differing in expression between newlydiagnosed T1D patients and controls at a false discovery rate of 0.05. Changes in expression of interleukin-1β (IL1B), early growth response gene 3 (EGR3), and prostaglandin-endoperoxide synthase 2 (PTGS2) resolved within four months of insulin therapy and were also observed in T2D suggesting that they resulted from hyperglycemia. With use of a knowledge base, 81/282 genes could be placed within a network of interrelated genes with predicted functions including apoptosis and cell proliferation. IL1B and the MYC oncogene were the most highly-connected genes in the network. IL1B was highly overexpressed in both T1D and T2D, whereas MYC was dysregulated only in T1D. Conclusion: T1D and T2D likely share a final common pathway for beta cell dysfunction that includes secretion of interleukin-1β and prostaglandins by immune effector cells, exacerbating existing beta cell dysfunction, and causing further hyperglycemia. The results identify several targets for disease-modifying therapy of diabetes and potential biomarkers for monitoring treatment efficacy.					1960	1230	3553	5743	7832	54682	6446	1959	2919	2354	10221	3126	8972	7187	2920	4609	7850	5292	5055	8843	23401	9935	2358	54210	2867	6768	79865	4170	7056	3577	5218	54883	9856	3142	1958	3985	5997	9021	4051	1374	6840	1690	7538	9592	6402	3772	8794	22835	249	26206	6573	1848	23288	641	26100	7096	50486	91353	28823	10333	11120	890	51554	719	7903	2146	7130	1025	4800	79134	3043	25849	1901	23383	788	2150	3579	3535	54937	1453	11240	4105	10409	26097	28831	9034	5082	9620	54583	55279	84890	79365	11151	4311	646934	19	55760	10849	26580	3576	124044	10445	222487	366	5791	55735	8861	9843	29982	29903	51237	10625	9133	25984	55350	6347	79689	259266	11099	4860	28984	3514	26586	9967	1015	91316	10204	3662	10016	22798	51271	6590	55892	22936	4289	9885	9674	10135	6286	10171	64151	23158	1415	2352	65263	2069	10938	1236	1997	54433	9836	10562	4210	4172	57060	8061	81565	3635	7692	8728	92558	398	64940	1299	399979	10885	26058	22882	5514	6279	28797	3978	5166	51163	7711	10670	64400	22853	51776	22808	5266	1089	1380	65998	1154	6790	1121	10868	29064	5670	5291	2180	54919	84658	4674	991	4689	10507	3482	26578
GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_UP	M5777		17595242	Kaizer EC,Glaser CL,Chaussabel D,Banchereau J,Pascual V,White PC.	GSE9006	GSE9006_2238_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from patients with type 1 diabetes at 1 month after the diagnosis.	Objective: We hypothesized that type 1 diabetes (T1D) is accompanied by changes in gene expression in peripheral blood mononuclear cells (PBMCs) due to dysregulation of adaptive and innate immunity, counterregulatory responses to immune dysregulation, insulin deficiency and hyperglycemia. Research Design and Methods: Microarray analysis was performed on PBMCs from 43 patients with newly diagnosed T1D, 12 patients with newly diagnosed type 2 diabetes (T2D) and 24 healthy controls. One and four month follow-up samples were obtained from 20 of the T1D patients. Results: Microarray analysis identified 282 genes differing in expression between newlydiagnosed T1D patients and controls at a false discovery rate of 0.05. Changes in expression of interleukin-1β (IL1B), early growth response gene 3 (EGR3), and prostaglandin-endoperoxide synthase 2 (PTGS2) resolved within four months of insulin therapy and were also observed in T2D suggesting that they resulted from hyperglycemia. With use of a knowledge base, 81/282 genes could be placed within a network of interrelated genes with predicted functions including apoptosis and cell proliferation. IL1B and the MYC oncogene were the most highly-connected genes in the network. IL1B was highly overexpressed in both T1D and T2D, whereas MYC was dysregulated only in T1D. Conclusion: T1D and T2D likely share a final common pathway for beta cell dysfunction that includes secretion of interleukin-1β and prostaglandins by immune effector cells, exacerbating existing beta cell dysfunction, and causing further hyperglycemia. The results identify several targets for disease-modifying therapy of diabetes and potential biomarkers for monitoring treatment efficacy.					6184	4670	50	3146	11221	5062	55173	3192	9601	26578	3703	2547	54855	6294	2746	2313	58533	191	71	5928	22850	2923	22872	8531	9860	3313	10097	6421	10313	7534	10294	5935	1654	8672	1536	5094	4478	7812	23471	8459	7071	9802	2821	4957	8774	6891	150094	969	8073	14	5591	3188	51295	6659	10236	8540	9589	821	220988	10921	22919	1314	23204	1810	5558	10628	3184	93487	8725	1808	26574	3725	2936	9782	23443	3178	2193	7430	6374	8932	7355	4522	124801	5708	23300	573	2055	55216	7805	3423	23530	6612	10140	8895	29766	11052	57418	10959	7184	7384	4893	8668	9991	659	3309	5585	9908	4194	308	54555	5702	3635	3091	56993	4723	9092	7357	26065	3837	1964	9262	54541	51582	11200	5859	3607	55191	11014	9584	2810	64708	8683	2665	23603	5562	5532	23608	8125	51133	27020	56949	9667	5295	2747	6780	57092	9444	640	84124	102	55069	6645	430	54847	7922	10158	26994	3726	10966	1456	8290	79695	6182	60559	10093	10144	11049	65265	90233	6595	3841	10626	2029	79982	663	51278	9482	8733	8761	226	2589	5604	53339	51593	80228	56674	3690	5500	55421	1847	3030	152006	10134	506	440915	5623	10434	10994	10978	23224
GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_DN	M5778		17595242	Kaizer EC,Glaser CL,Chaussabel D,Banchereau J,Pascual V,White PC.	GSE9006	GSE9006_2238_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from patients with type 1 diabetes at 1 month after the diagnosis.	Objective: We hypothesized that type 1 diabetes (T1D) is accompanied by changes in gene expression in peripheral blood mononuclear cells (PBMCs) due to dysregulation of adaptive and innate immunity, counterregulatory responses to immune dysregulation, insulin deficiency and hyperglycemia. Research Design and Methods: Microarray analysis was performed on PBMCs from 43 patients with newly diagnosed T1D, 12 patients with newly diagnosed type 2 diabetes (T2D) and 24 healthy controls. One and four month follow-up samples were obtained from 20 of the T1D patients. Results: Microarray analysis identified 282 genes differing in expression between newlydiagnosed T1D patients and controls at a false discovery rate of 0.05. Changes in expression of interleukin-1β (IL1B), early growth response gene 3 (EGR3), and prostaglandin-endoperoxide synthase 2 (PTGS2) resolved within four months of insulin therapy and were also observed in T2D suggesting that they resulted from hyperglycemia. With use of a knowledge base, 81/282 genes could be placed within a network of interrelated genes with predicted functions including apoptosis and cell proliferation. IL1B and the MYC oncogene were the most highly-connected genes in the network. IL1B was highly overexpressed in both T1D and T2D, whereas MYC was dysregulated only in T1D. Conclusion: T1D and T2D likely share a final common pathway for beta cell dysfunction that includes secretion of interleukin-1β and prostaglandins by immune effector cells, exacerbating existing beta cell dysfunction, and causing further hyperglycemia. The results identify several targets for disease-modifying therapy of diabetes and potential biomarkers for monitoring treatment efficacy.					9649	27113	1959	10650	8394	55760	51271	79064	667	6573	8702	389906	1656	25960	92552	8340	23621	9923	4839	3126	11120	8506	56623	26521	58189	6293	9139	55821	54738	51776	88	11285	25776	8228	7010	10563	78996	6821	66002	10044	26584	10244	23361	388886	51147	57124	7766	3603	9271	1236	6103	388714	196483	2976	5545	81577	3589	79600	3991	55279	9751	27240	1553	693207	1678	3851	64221	2077	3145	80131	54868	3071	23321	54554	10500	63875	3732	51161	80176	55657	5453	339105	1031	2147	51027	55157	80122	8490	84861	79969	8609	51454	51634	64320	83480	8995	363	27173	81566	6502	80198	11133	51287	5170	6256	399979	9669	9832	5126	10342	10588	51555	55891	392555	8092	80317	3097	5099	22902	23268	64108	59338	11129	27129	56918	57468	27112	56673	7043	221061	100289043	2168	3208	1230	55218	6217	26097	10801	6901	5335	6733	51564	3778	90522	2529	846	93408	1370	55505	10917	4261	25996	9535	55139	1826	2243	54520	55592	1746	54943	5544	23417	7187	25786	1421	1960	22798	4184	100129482	65083	3792	3352	3305	7737	55340	57060	26001	5969	636	81789	2057	53838	22894	55295	23629	29075	79149	55223	4782	158	10077	79714	408050	79081	63901	2491	89845	197320	92346	5877
GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_UP	M5779		17595242	Kaizer EC,Glaser CL,Chaussabel D,Banchereau J,Pascual V,White PC.	GSE9006	GSE9006_2239_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from patients with type 1 diabetes at 4  month after the diagnosis.	Objective: We hypothesized that type 1 diabetes (T1D) is accompanied by changes in gene expression in peripheral blood mononuclear cells (PBMCs) due to dysregulation of adaptive and innate immunity, counterregulatory responses to immune dysregulation, insulin deficiency and hyperglycemia. Research Design and Methods: Microarray analysis was performed on PBMCs from 43 patients with newly diagnosed T1D, 12 patients with newly diagnosed type 2 diabetes (T2D) and 24 healthy controls. One and four month follow-up samples were obtained from 20 of the T1D patients. Results: Microarray analysis identified 282 genes differing in expression between newlydiagnosed T1D patients and controls at a false discovery rate of 0.05. Changes in expression of interleukin-1β (IL1B), early growth response gene 3 (EGR3), and prostaglandin-endoperoxide synthase 2 (PTGS2) resolved within four months of insulin therapy and were also observed in T2D suggesting that they resulted from hyperglycemia. With use of a knowledge base, 81/282 genes could be placed within a network of interrelated genes with predicted functions including apoptosis and cell proliferation. IL1B and the MYC oncogene were the most highly-connected genes in the network. IL1B was highly overexpressed in both T1D and T2D, whereas MYC was dysregulated only in T1D. Conclusion: T1D and T2D likely share a final common pathway for beta cell dysfunction that includes secretion of interleukin-1β and prostaglandins by immune effector cells, exacerbating existing beta cell dysfunction, and causing further hyperglycemia. The results identify several targets for disease-modifying therapy of diabetes and potential biomarkers for monitoring treatment efficacy.					22850	4792	6421	55743	4670	93487	6612	9601	5062	7805	84124	3192	6184	10097	2746	150094	53339	7071	8459	124801	5935	1390	3837	4478	26574	3313	26578	26986	2923	9444	2752	9997	23764	2810	2547	10140	22919	7128	3091	1808	10313	54541	9262	4791	8932	27020	8531	663	969	11221	80380	10994	113457	3188	9688	8553	23300	5295	5094	80895	23313	7534	1536	26994	115939	8780	10434	3726	1314	80346	1847	51307	7165	9961	64374	308	51582	59342	8672	687	4616	51347	3146	23406	51278	7416	10970	58533	220988	6294	8895	4929	51604	3178	54545	4794	9908	9092	9802	6891	23092	79137	467	5529	226	55216	191	23392	430	468	6675	3184	1508	10978	1890	152006	8540	5708	51295	10422	5277	10226	4723	60559	10294	5756	79800	79441	2773	50486	6374	8204	55191	2821	1654	10728	22872	11171	7458	8774	8754	8683	483	10959	3659	8623	3725	64747	7852	64708	10250	8462	11267	1794	57826	6515	5585	2630	7874	9667	5869	54496	10420	5728	51646	8761	5500	2747	8500	7803	4082	51056	54386	1153	10043	90233	2060	127544	2313	1854	1831	10116	65265	3030	4957	58528	9589	10291	64222	8801	11052	246243	79647	7384	71	9188	29789	11231	14	23608
GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_DN	M5780		17595242	Kaizer EC,Glaser CL,Chaussabel D,Banchereau J,Pascual V,White PC.	GSE9006	GSE9006_2239_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from patients with type 1 diabetes at 4  month after the diagnosis.	Objective: We hypothesized that type 1 diabetes (T1D) is accompanied by changes in gene expression in peripheral blood mononuclear cells (PBMCs) due to dysregulation of adaptive and innate immunity, counterregulatory responses to immune dysregulation, insulin deficiency and hyperglycemia. Research Design and Methods: Microarray analysis was performed on PBMCs from 43 patients with newly diagnosed T1D, 12 patients with newly diagnosed type 2 diabetes (T2D) and 24 healthy controls. One and four month follow-up samples were obtained from 20 of the T1D patients. Results: Microarray analysis identified 282 genes differing in expression between newlydiagnosed T1D patients and controls at a false discovery rate of 0.05. Changes in expression of interleukin-1β (IL1B), early growth response gene 3 (EGR3), and prostaglandin-endoperoxide synthase 2 (PTGS2) resolved within four months of insulin therapy and were also observed in T2D suggesting that they resulted from hyperglycemia. With use of a knowledge base, 81/282 genes could be placed within a network of interrelated genes with predicted functions including apoptosis and cell proliferation. IL1B and the MYC oncogene were the most highly-connected genes in the network. IL1B was highly overexpressed in both T1D and T2D, whereas MYC was dysregulated only in T1D. Conclusion: T1D and T2D likely share a final common pathway for beta cell dysfunction that includes secretion of interleukin-1β and prostaglandins by immune effector cells, exacerbating existing beta cell dysfunction, and causing further hyperglycemia. The results identify several targets for disease-modifying therapy of diabetes and potential biomarkers for monitoring treatment efficacy.					5877	10244	54554	1043	54738	25776	63875	27113	2057	92552	363	7692	27240	81566	6217	80176	7366	51651	389906	92595	8846	3991	7984	388886	80317	7372	399979	26097	26001	10588	1951	88	78996	10650	4860	4839	54925	7849	6701	27042	51776	9374	79064	5238	10254	22798	3208	55505	3589	9093	54937	7743	8394	9938	10500	387032	7775	7010	64108	51001	51027	55218	51400	644096	84861	23635	9477	9215	9204	79842	11120	10557	55760	25974	100507424	26584	56983	27173	6293	57613	58189	10282	55612	26240	3755	1746	6733	8193	26521	4696	8228	83480	29909	1656	408050	79714	53345	23615	667	29095	9649	57406	80198	7727	25988	202018	79961	55157	2909	3500	55222	1489	11318	9419	3399	66002	57664	2744	51004	7766	7545	90522	27112	11276	7311	3851	5987	1944	3071	27092	79885	10126	6388	5545	11099	8639	55184	10670	51147	57124	1959	56652	1031	51561	51728	80775	9293	4236	4303	80196	1009	10521	79744	636	283450	1762	54988	23412	7741	9683	25960	9726	51318	3996	7773	59338	6103	8872	5453	8364	23417	60491	81850	7043	9793	79833	1232	5193	1045	5542	27097	4238	54987	9832	10885	5349	3126	6642	57876	83444	26128	3199	79586	1419	2077	6119	5526	83658	9139	79861
GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP	M5781		17595242	Kaizer EC,Glaser CL,Chaussabel D,Banchereau J,Pascual V,White PC.	GSE9006	GSE9006_2240_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from patients with type 2 diabetes at the time of diagnosis.	Objective: We hypothesized that type 1 diabetes (T1D) is accompanied by changes in gene expression in peripheral blood mononuclear cells (PBMCs) due to dysregulation of adaptive and innate immunity, counterregulatory responses to immune dysregulation, insulin deficiency and hyperglycemia. Research Design and Methods: Microarray analysis was performed on PBMCs from 43 patients with newly diagnosed T1D, 12 patients with newly diagnosed type 2 diabetes (T2D) and 24 healthy controls. One and four month follow-up samples were obtained from 20 of the T1D patients. Results: Microarray analysis identified 282 genes differing in expression between newlydiagnosed T1D patients and controls at a false discovery rate of 0.05. Changes in expression of interleukin-1β (IL1B), early growth response gene 3 (EGR3), and prostaglandin-endoperoxide synthase 2 (PTGS2) resolved within four months of insulin therapy and were also observed in T2D suggesting that they resulted from hyperglycemia. With use of a knowledge base, 81/282 genes could be placed within a network of interrelated genes with predicted functions including apoptosis and cell proliferation. IL1B and the MYC oncogene were the most highly-connected genes in the network. IL1B was highly overexpressed in both T1D and T2D, whereas MYC was dysregulated only in T1D. Conclusion: T1D and T2D likely share a final common pathway for beta cell dysfunction that includes secretion of interleukin-1β and prostaglandins by immune effector cells, exacerbating existing beta cell dysfunction, and causing further hyperglycemia. The results identify several targets for disease-modifying therapy of diabetes and potential biomarkers for monitoring treatment efficacy.					22913	81619	115939	10262	7351	8721	9377	56949	517	80895	353	26528	4717	5699	8683	10589	3190	6881	3192	5546	6184	2874	9092	5585	4714	6182	124801	11333	4501	27090	10948	64236	79095	5605	10204	6399	8175	4849	4841	55049	10250	689	1622	22850	9667	54555	2746	28952	5725	57447	5062	513	2923	60314	11100	11047	51157	64708	9907	54998	55038	7157	54815	3313	65108	5216	738	10093	6576	10961	4478	55191	54732	6294	5380	10227	9601	56904	254531	4904	3297	27183	9138	203069	22820	23406	7086	8525	57470	483	8764	5790	3423	7266	7458	11140	80774	4191	51295	5202	3398	11338	6181	10921	10494	9961	7381	57418	23480	54434	79581	79903	521	6636	26012	8106	50488	9112	6921	10236	9046	808	2934	5878	5093	4242	57473	9679	4670	5176	64960	166	9274	8425	6603	23149	11007	3265	975	51816	2962	26472	54927	10616	55658	23648	10428	11152	27338	8678	191	54994	514	55741	7040	53827	6421	23506	100129361	11267	60559	3113	10235	150726	10994	3004	63933	5935	2079	6749	6612	3607	127544	26121	916	5434	4728	64769	8535	10522	57175	29901	3162	79228	2000	10362	26578	57665	6650	79176	4627	5089	6167	6727	3984	1072	518	8665	3425	309
GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN	M5782		17595242	Kaizer EC,Glaser CL,Chaussabel D,Banchereau J,Pascual V,White PC.	GSE9006	GSE9006_2240_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from patients with type 2 diabetes at the time of diagnosis.	Objective: We hypothesized that type 1 diabetes (T1D) is accompanied by changes in gene expression in peripheral blood mononuclear cells (PBMCs) due to dysregulation of adaptive and innate immunity, counterregulatory responses to immune dysregulation, insulin deficiency and hyperglycemia. Research Design and Methods: Microarray analysis was performed on PBMCs from 43 patients with newly diagnosed T1D, 12 patients with newly diagnosed type 2 diabetes (T2D) and 24 healthy controls. One and four month follow-up samples were obtained from 20 of the T1D patients. Results: Microarray analysis identified 282 genes differing in expression between newlydiagnosed T1D patients and controls at a false discovery rate of 0.05. Changes in expression of interleukin-1β (IL1B), early growth response gene 3 (EGR3), and prostaglandin-endoperoxide synthase 2 (PTGS2) resolved within four months of insulin therapy and were also observed in T2D suggesting that they resulted from hyperglycemia. With use of a knowledge base, 81/282 genes could be placed within a network of interrelated genes with predicted functions including apoptosis and cell proliferation. IL1B and the MYC oncogene were the most highly-connected genes in the network. IL1B was highly overexpressed in both T1D and T2D, whereas MYC was dysregulated only in T1D. Conclusion: T1D and T2D likely share a final common pathway for beta cell dysfunction that includes secretion of interleukin-1β and prostaglandins by immune effector cells, exacerbating existing beta cell dysfunction, and causing further hyperglycemia. The results identify several targets for disease-modifying therapy of diabetes and potential biomarkers for monitoring treatment efficacy.					54812	55788	3516	55760	5743	1960	1959	1618	1213	7405	1230	5884	2993	3985	10333	55737	5151	51311	55279	11120	8872	56163	54807	3981	55870	4105	241	11099	3553	6651	1557	10877	9856	9334	7832	7096	284244	8239	51362	11318	56946	57147	8546	10109	2173	7692	55109	7260	26097	22841	529	51651	158747	83480	4860	28958	2180	1259	2919	1015	1581	7126	2296	5213	5629	92335	4289	2475	6018	8972	6821	783	5997	3889	660	5688	2650	51136	10161	66002	10780	9649	11108	5055	8405	54502	1958	4238	51099	9510	10044	92689	81577	9935	26058	22894	1690	54937	963	29075	8887	1373	5431	23268	4170	123	23001	5937	25847	84890	5048	22990	696	6446	719	23179	56983	81565	27042	815	51265	4520	3758	22796	8504	355	25821	1008	23041	51493	54925	25988	8340	55505	9252	10588	63899	79634	23253	202	30849	5294	23503	2150	8480	90355	79865	8324	8740	6473	6355	7518	54834	79096	3772	147179	89797	27113	387032	4124	10208	11250	55187	8843	57876	6009	2169	23026	9100	8609	1906	56945	1665	80196	79616	26503	643224	9841	63876	23369	7097	8404	51327	26268	7179	83734	63826	57214	10221	7098	1316	8876	22895	1997	1477	8092	7903	9515	10483	7161
GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_UP	M5783		17595242	Kaizer EC,Glaser CL,Chaussabel D,Banchereau J,Pascual V,White PC.	GSE9006	GSE9006_2241_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with type 1 diabetes at the time of the diagnosis versus those at 1 month later.	Objective: We hypothesized that type 1 diabetes (T1D) is accompanied by changes in gene expression in peripheral blood mononuclear cells (PBMCs) due to dysregulation of adaptive and innate immunity, counterregulatory responses to immune dysregulation, insulin deficiency and hyperglycemia. Research Design and Methods: Microarray analysis was performed on PBMCs from 43 patients with newly diagnosed T1D, 12 patients with newly diagnosed type 2 diabetes (T2D) and 24 healthy controls. One and four month follow-up samples were obtained from 20 of the T1D patients. Results: Microarray analysis identified 282 genes differing in expression between newlydiagnosed T1D patients and controls at a false discovery rate of 0.05. Changes in expression of interleukin-1β (IL1B), early growth response gene 3 (EGR3), and prostaglandin-endoperoxide synthase 2 (PTGS2) resolved within four months of insulin therapy and were also observed in T2D suggesting that they resulted from hyperglycemia. With use of a knowledge base, 81/282 genes could be placed within a network of interrelated genes with predicted functions including apoptosis and cell proliferation. IL1B and the MYC oncogene were the most highly-connected genes in the network. IL1B was highly overexpressed in both T1D and T2D, whereas MYC was dysregulated only in T1D. Conclusion: T1D and T2D likely share a final common pathway for beta cell dysfunction that includes secretion of interleukin-1β and prostaglandins by immune effector cells, exacerbating existing beta cell dysfunction, and causing further hyperglycemia. The results identify several targets for disease-modifying therapy of diabetes and potential biomarkers for monitoring treatment efficacy.					9601	55743	1025	14	6184	5292	50	57418	71	1654	640	51343	6294	29933	7852	4723	7184	91304	4957	7384	2923	2821	7165	79228	3313	3309	8733	3703	9667	3178	677	2630	5935	2130	28952	55324	659	56904	1017	5806	26146	10313	11014	5479	22820	9709	2746	54541	382	3192	2936	81619	3148	9092	8870	81620	1535	9802	22919	7534	5531	22872	10525	23151	2752	81876	632	55234	5928	2193	3385	1536	9448	24148	8683	30844	22827	5216	25855	788	513	102	9277	1843	57198	65108	51317	25893	10294	1831	56894	7922	226	1839	4893	3514	54583	5062	4082	3608	2204	682	51005	6182	9993	27338	55626	2313	55167	5725	8540	24137	191	11221	9991	8125	6840	369	80086	5702	23603	51295	51031	5166	9935	10236	55671	8774	64943	55002	3726	2069	124801	29766	440915	6347	79645	23204	8815	54847	54958	9021	8651	10097	11140	694	26578	22821	9844	10093	4800	56949	10420	79171	220988	11275	2934	64083	9410	2358	55038	4218	10105	8676	11004	4691	64324	4780	7056	3190	1509	2232	8761	23	9927	55192	8531	5591	10365	6533	1326	10171	5034	65123	64708	2289	5623	2590	55049	3142	5546	3437	2747	488	10607	79844	1595	10567	23223	29781
GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_DN	M5786		17595242	Kaizer EC,Glaser CL,Chaussabel D,Banchereau J,Pascual V,White PC.	GSE9006	GSE9006_2241_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with type 1 diabetes at the time of the diagnosis versus those at 1 month later.	Objective: We hypothesized that type 1 diabetes (T1D) is accompanied by changes in gene expression in peripheral blood mononuclear cells (PBMCs) due to dysregulation of adaptive and innate immunity, counterregulatory responses to immune dysregulation, insulin deficiency and hyperglycemia. Research Design and Methods: Microarray analysis was performed on PBMCs from 43 patients with newly diagnosed T1D, 12 patients with newly diagnosed type 2 diabetes (T2D) and 24 healthy controls. One and four month follow-up samples were obtained from 20 of the T1D patients. Results: Microarray analysis identified 282 genes differing in expression between newlydiagnosed T1D patients and controls at a false discovery rate of 0.05. Changes in expression of interleukin-1β (IL1B), early growth response gene 3 (EGR3), and prostaglandin-endoperoxide synthase 2 (PTGS2) resolved within four months of insulin therapy and were also observed in T2D suggesting that they resulted from hyperglycemia. With use of a knowledge base, 81/282 genes could be placed within a network of interrelated genes with predicted functions including apoptosis and cell proliferation. IL1B and the MYC oncogene were the most highly-connected genes in the network. IL1B was highly overexpressed in both T1D and T2D, whereas MYC was dysregulated only in T1D. Conclusion: T1D and T2D likely share a final common pathway for beta cell dysfunction that includes secretion of interleukin-1β and prostaglandins by immune effector cells, exacerbating existing beta cell dysfunction, and causing further hyperglycemia. The results identify several targets for disease-modifying therapy of diabetes and potential biomarkers for monitoring treatment efficacy.					2982	22902	1031	25960	10342	388886	8228	55680	6281	7737	4026	6130	3094	92552	63901	80150	23321	79969	5018	388969	26521	23534	9649	64081	6143	51131	644068	23412	1109	54943	27113	80195	8490	79630	1678	8609	2168	57556	9045	10540	7310	26050	667	5937	911	658	4060	5170	9886	53345	53373	51634	4897	3782	30000	8975	4190	3779	56260	55157	23060	51275	51147	55223	904	10147	114876	7043	79135	4935	8340	304	6138	9923	51287	54896	11096	10542	9669	7414	93408	9580	56673	8894	54868	6570	10392	3693	79064	1983	5453	10983	846	79591	3305	8019	5429	51637	23621	10244	4086	51124	8001	4358	56922	1356	7265	9535	2147	3476	899	5146	57835	54942	6103	9139	6433	54344	3991	5049	10231	55821	22852	9896	63932	4839	55000	1327	7289	1845	27129	8717	51352	5204	10650	51267	51161	6738	56912	302	9016	51004	7270	81577	171558	1179	100131755	222161	53844	64925	51268	8995	4158	6403	10500	10398	79714	3352	3851	5126	51108	57104	2983	6821	79005	6210	23361	54462	6939	8170	29909	79600	653238	286451	26520	64215	80122	55096	79056	3205	3778	509	493	2671	10169	728661	6136	693207	57468	80004	441024	9575	9446	57399	89845	8364	2890	58513	1601	55238
GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_UP	M5787		17595242	Kaizer EC,Glaser CL,Chaussabel D,Banchereau J,Pascual V,White PC.	GSE9006	GSE9006_2242_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with type 1 diabetes at the time of the diagnosis versus those at 4 months later.	Objective: We hypothesized that type 1 diabetes (T1D) is accompanied by changes in gene expression in peripheral blood mononuclear cells (PBMCs) due to dysregulation of adaptive and innate immunity, counterregulatory responses to immune dysregulation, insulin deficiency and hyperglycemia. Research Design and Methods: Microarray analysis was performed on PBMCs from 43 patients with newly diagnosed T1D, 12 patients with newly diagnosed type 2 diabetes (T2D) and 24 healthy controls. One and four month follow-up samples were obtained from 20 of the T1D patients. Results: Microarray analysis identified 282 genes differing in expression between newlydiagnosed T1D patients and controls at a false discovery rate of 0.05. Changes in expression of interleukin-1β (IL1B), early growth response gene 3 (EGR3), and prostaglandin-endoperoxide synthase 2 (PTGS2) resolved within four months of insulin therapy and were also observed in T2D suggesting that they resulted from hyperglycemia. With use of a knowledge base, 81/282 genes could be placed within a network of interrelated genes with predicted functions including apoptosis and cell proliferation. IL1B and the MYC oncogene were the most highly-connected genes in the network. IL1B was highly overexpressed in both T1D and T2D, whereas MYC was dysregulated only in T1D. Conclusion: T1D and T2D likely share a final common pathway for beta cell dysfunction that includes secretion of interleukin-1β and prostaglandins by immune effector cells, exacerbating existing beta cell dysfunction, and causing further hyperglycemia. The results identify several targets for disease-modifying therapy of diabetes and potential biomarkers for monitoring treatment efficacy.					9601	226	3188	7165	7852	2630	23223	1025	64374	1890	1509	55743	54541	4723	6184	2773	1831	3385	640	4791	23313	3313	10221	7805	22919	1390	28952	14	6421	22850	2354	10994	6446	22827	10970	51005	10420	26155	9935	5806	5935	93487	22820	9667	4170	3726	2746	9092	9688	2752	4792	5277	4082	8733	10135	84124	124801	374	1654	7384	8651	7378	81876	10313	2923	3178	10097	366	9844	4957	2920	2734	10625	677	55049	382	3397	1153	8764	7709	1843	10312	11267	10105	3309	24148	79228	4783	5996	1522	79137	3148	55191	6294	50488	6449	3192	8683	5062	8761	5768	2069	64324	663	5209	2358	25977	9709	6182	55911	2204	8972	79587	4218	6286	8833	6515	9021	5531	2821	9308	4929	11140	115939	3554	10227	566	57418	80301	2990	51343	200315	8553	7128	23406	5034	1088	26100	3190	535	81619	1717	3553	51317	6303	23645	55100	7534	5546	9114	1536	1263	10124	54210	3727	9529	30844	8676	54623	23092	124044	81620	1847	127544	9997	1991	150094	440915	2357	79873	1960	2810	64708	604	113457	7159	11014	133	2934	50486	5597	3240	56478	27020	6675	1839	59342	5719	54496	5786	10525	9592	2867	25998	9908	5029	220988	7408	7538	10463
GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_DN	M5788		17595242	Kaizer EC,Glaser CL,Chaussabel D,Banchereau J,Pascual V,White PC.	GSE9006	GSE9006_2242_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with type 1 diabetes at the time of the diagnosis versus those at 4 months later.	Objective: We hypothesized that type 1 diabetes (T1D) is accompanied by changes in gene expression in peripheral blood mononuclear cells (PBMCs) due to dysregulation of adaptive and innate immunity, counterregulatory responses to immune dysregulation, insulin deficiency and hyperglycemia. Research Design and Methods: Microarray analysis was performed on PBMCs from 43 patients with newly diagnosed T1D, 12 patients with newly diagnosed type 2 diabetes (T2D) and 24 healthy controls. One and four month follow-up samples were obtained from 20 of the T1D patients. Results: Microarray analysis identified 282 genes differing in expression between newlydiagnosed T1D patients and controls at a false discovery rate of 0.05. Changes in expression of interleukin-1β (IL1B), early growth response gene 3 (EGR3), and prostaglandin-endoperoxide synthase 2 (PTGS2) resolved within four months of insulin therapy and were also observed in T2D suggesting that they resulted from hyperglycemia. With use of a knowledge base, 81/282 genes could be placed within a network of interrelated genes with predicted functions including apoptosis and cell proliferation. IL1B and the MYC oncogene were the most highly-connected genes in the network. IL1B was highly overexpressed in both T1D and T2D, whereas MYC was dysregulated only in T1D. Conclusion: T1D and T2D likely share a final common pathway for beta cell dysfunction that includes secretion of interleukin-1β and prostaglandins by immune effector cells, exacerbating existing beta cell dysfunction, and causing further hyperglycemia. The results identify several targets for disease-modifying therapy of diabetes and potential biomarkers for monitoring treatment efficacy.					23412	388969	8228	388886	509	6138	10244	4190	1031	29044	100507424	286451	3094	10169	4358	10975	1327	51188	7692	51124	92552	873	10284	9122	51650	6130	80217	3155	2845	6633	9446	10542	81566	58498	3991	7311	6631	653238	8396	5439	5877	63901	26050	1071	6143	4026	728661	55222	83658	6136	53345	51131	3170	10456	2057	11276	55184	7310	644068	27335	6217	5526	6210	6152	29909	5204	6701	963	7265	55680	55157	22902	8894	79898	138046	7011	6155	4696	2329	55885	27240	1043	25960	83444	5018	9204	80004	6526	8193	56673	6375	26521	65979	81616	56983	7043	644096	6144	23019	63875	1678	23534	4736	29074	51287	4303	54896	80176	10139	8490	2982	100506963	493	6001	404281	11096	2741	54943	57556	56922	5238	55096	79574	8655	23615	79969	51027	1045	51004	51147	2168	93408	8543	1559	57731	10500	27257	3653	4259	6415	9374	9344	6665	962	8364	6119	658	283450	56912	4676	139081	7737	3929	1933	6204	10647	54149	2909	3224	51350	130814	64081	5453	445347	27113	54738	2205	80215	6281	387535	4897	3972	92815	79714	22948	100131755	80205	2890	3263	7014	8492	80317	56260	100272228	80206	5151	7855	3976	6235	1179	57406	3208	51106	767	1291	6125	6649	6207	1795	100128124
GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_UP	M5790		17595242	Kaizer EC,Glaser CL,Chaussabel D,Banchereau J,Pascual V,White PC.	GSE9006	GSE9006_2243_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with type 1 diabetes at 1 month after the diagnosis versus those at 4 months later.	Objective: We hypothesized that type 1 diabetes (T1D) is accompanied by changes in gene expression in peripheral blood mononuclear cells (PBMCs) due to dysregulation of adaptive and innate immunity, counterregulatory responses to immune dysregulation, insulin deficiency and hyperglycemia. Research Design and Methods: Microarray analysis was performed on PBMCs from 43 patients with newly diagnosed T1D, 12 patients with newly diagnosed type 2 diabetes (T2D) and 24 healthy controls. One and four month follow-up samples were obtained from 20 of the T1D patients. Results: Microarray analysis identified 282 genes differing in expression between newlydiagnosed T1D patients and controls at a false discovery rate of 0.05. Changes in expression of interleukin-1β (IL1B), early growth response gene 3 (EGR3), and prostaglandin-endoperoxide synthase 2 (PTGS2) resolved within four months of insulin therapy and were also observed in T2D suggesting that they resulted from hyperglycemia. With use of a knowledge base, 81/282 genes could be placed within a network of interrelated genes with predicted functions including apoptosis and cell proliferation. IL1B and the MYC oncogene were the most highly-connected genes in the network. IL1B was highly overexpressed in both T1D and T2D, whereas MYC was dysregulated only in T1D. Conclusion: T1D and T2D likely share a final common pathway for beta cell dysfunction that includes secretion of interleukin-1β and prostaglandins by immune effector cells, exacerbating existing beta cell dysfunction, and causing further hyperglycemia. The results identify several targets for disease-modifying therapy of diabetes and potential biomarkers for monitoring treatment efficacy.					468	8972	1522	79966	4794	23092	2526	1750	9896	26747	4094	23119	64215	9997	22795	3614	55334	23130	10345	4114	9517	112399	133	51604	79587	11060	7130	306	84034	27237	79786	26238	4792	4317	619505	10867	2919	6583	55603	3659	26032	4589	9308	9314	25960	6446	11133	6810	114548	8870	3632	2762	8825	10421	55026	55852	259266	1718	9688	2357	6286	26574	1672	7378	23363	1390	5122	7096	4311	1794	441204	9271	4636	4254	80380	23650	3101	90011	1506	63933	6888	2138	64782	4335	10036	10154	131544	6303	55970	57476	90956	604	23380	55450	26648	9182	8975	54619	7107	5806	5587	4520	2835	51301	5029	2982	8875	55191	22808	57154	7850	283755	7037	6168	5937	79369	3437	80195	84124	9865	50832	6573	650	25945	23466	51776	4060	81621	80005	1088	140883	3142	5265	23181	8507	10514	100286937	81030	8647	2790	7124	10577	7288	2262	9890	57336	4994	825	26155	9920	55313	100130331	200734	7172	23151	10463	7299	3954	3949	79735	7136	26986	10221	5292	23764	6847	27000	64693	9778	23597	23767	84981	203069	55525	7073	3386	10135	597	1551	90865	90141	10144	54996	366	51097	10437	6256	30851	240	9209	5836	943	10312	5992	7803	1296	2776	57826	51241	84779
GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_DN	M5791		17595242	Kaizer EC,Glaser CL,Chaussabel D,Banchereau J,Pascual V,White PC.	GSE9006	GSE9006_2243_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with type 1 diabetes at 1 month after the diagnosis versus those at 4 months later.	Objective: We hypothesized that type 1 diabetes (T1D) is accompanied by changes in gene expression in peripheral blood mononuclear cells (PBMCs) due to dysregulation of adaptive and innate immunity, counterregulatory responses to immune dysregulation, insulin deficiency and hyperglycemia. Research Design and Methods: Microarray analysis was performed on PBMCs from 43 patients with newly diagnosed T1D, 12 patients with newly diagnosed type 2 diabetes (T2D) and 24 healthy controls. One and four month follow-up samples were obtained from 20 of the T1D patients. Results: Microarray analysis identified 282 genes differing in expression between newlydiagnosed T1D patients and controls at a false discovery rate of 0.05. Changes in expression of interleukin-1β (IL1B), early growth response gene 3 (EGR3), and prostaglandin-endoperoxide synthase 2 (PTGS2) resolved within four months of insulin therapy and were also observed in T2D suggesting that they resulted from hyperglycemia. With use of a knowledge base, 81/282 genes could be placed within a network of interrelated genes with predicted functions including apoptosis and cell proliferation. IL1B and the MYC oncogene were the most highly-connected genes in the network. IL1B was highly overexpressed in both T1D and T2D, whereas MYC was dysregulated only in T1D. Conclusion: T1D and T2D likely share a final common pathway for beta cell dysfunction that includes secretion of interleukin-1β and prostaglandins by immune effector cells, exacerbating existing beta cell dysfunction, and causing further hyperglycemia. The results identify several targets for disease-modifying therapy of diabetes and potential biomarkers for monitoring treatment efficacy.					51343	55218	63973	8434	26082	162972	4312	6421	80086	125893	204	3554	10979	2832	2977	5763	25984	9107	114884	83714	5563	1136	4249	7849	51360	79999	1183	51371	55204	6764	362	1013	26285	3885	9970	5126	10827	9719	1977	1280	55796	5877	79033	1906	80217	722	1951	10282	7113	7745	4695	25807	6473	92595	79748	27314	6004	2555	51192	26548	7031	79135	10814	27445	389856	965	9214	9682	59347	28902	130814	6514	1244	51014	9421	81797	2618	51666	8302	89797	440792	4194	11041	5728	27257	1555	652493	10446	11080	25769	1337	762	402055	8650	4916	27006	55671	3762	405	55784	22847	3766	55220	1810	6007	79365	7222	7173	7024	632	392555	1349	56287	54807	65094	9446	5030	7251	54482	4146	2042	189	3872	2041	9491	58530	1394	80263	6477	1639	2691	776	1447	7638	55500	79605	23484	29018	27134	55777	8992	3000	4205	5536	1104	7111	83450	9953	4696	7257	1404	10175	10267	2986	7053	51200	84033	9721	6612	6542	971	2191	54967	23552	5345	6667	8692	7184	10940	29122	7311	10139	387	5864	1365	9201	3514	50509	57664	26333	6701	8341	7773	79413	3955	100462953	10458	4738	27333	3623	5973	2159	10254	7712	6457	1901	10050	29933	51733	57089
GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP	M5797		17595242	Kaizer EC,Glaser CL,Chaussabel D,Banchereau J,Pascual V,White PC.	GSE9006	GSE9006_2244_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in peripheral blood mononuclear cells (PBMC) from patients with type 1 diabetes at the time of diagnosis versus those with type 2 diabetes at the time of diagnosis.	Objective: We hypothesized that type 1 diabetes (T1D) is accompanied by changes in gene expression in peripheral blood mononuclear cells (PBMCs) due to dysregulation of adaptive and innate immunity, counterregulatory responses to immune dysregulation, insulin deficiency and hyperglycemia. Research Design and Methods: Microarray analysis was performed on PBMCs from 43 patients with newly diagnosed T1D, 12 patients with newly diagnosed type 2 diabetes (T2D) and 24 healthy controls. One and four month follow-up samples were obtained from 20 of the T1D patients. Results: Microarray analysis identified 282 genes differing in expression between newlydiagnosed T1D patients and controls at a false discovery rate of 0.05. Changes in expression of interleukin-1β (IL1B), early growth response gene 3 (EGR3), and prostaglandin-endoperoxide synthase 2 (PTGS2) resolved within four months of insulin therapy and were also observed in T2D suggesting that they resulted from hyperglycemia. With use of a knowledge base, 81/282 genes could be placed within a network of interrelated genes with predicted functions including apoptosis and cell proliferation. IL1B and the MYC oncogene were the most highly-connected genes in the network. IL1B was highly overexpressed in both T1D and T2D, whereas MYC was dysregulated only in T1D. Conclusion: T1D and T2D likely share a final common pathway for beta cell dysfunction that includes secretion of interleukin-1β and prostaglandins by immune effector cells, exacerbating existing beta cell dysfunction, and causing further hyperglycemia. The results identify several targets for disease-modifying therapy of diabetes and potential biomarkers for monitoring treatment efficacy.					5790	10235	115939	64236	65108	11047	8525	27090	5216	22913	10227	738	56904	26528	6881	7157	254531	81619	11140	11333	9092	54815	309	9973	57473	5900	59307	1025	517	6182	23265	9667	11007	29901	28952	10961	11151	56949	8815	65990	150726	975	10607	81890	25855	1265	27338	9524	57418	54998	26121	57130	2874	3265	6636	26155	55038	27339	5546	27440	79228	10155	513	2923	393	3190	55702	22820	4717	80764	8721	9049	4841	4670	90379	1072	51621	9601	55630	51116	10471	3607	1936	6874	11338	79903	54663	7351	10948	381	54732	91304	5202	8683	25920	924	3014	1209	9546	8764	6625	6181	81926	80895	553115	7709	26065	8175	5725	5425	55324	2639	10428	10262	56731	29882	10494	5434	6135	5777	9701	6494	476	55615	9907	23753	6294	11267	90480	6399	489	80774	25873	2079	4849	9040	10263	5757	9138	8140	3615	2521	55114	10460	5300	3004	10093	3181	79095	5479	1877	9112	55191	6603	9885	10250	10589	7264	54623	55192	22827	5699	9605	79171	55626	9013	3707	166	5830	79751	3661	124801	10078	2968	3313	6749	29855	10489	7266	27429	4793	14	6167	64708	6837	165	2934	23212	916	81876	51389	282997	6720	10362	6232	7086	25796	51237	10653	2171
GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN	M5799		17595242	Kaizer EC,Glaser CL,Chaussabel D,Banchereau J,Pascual V,White PC.	GSE9006	GSE9006_2244_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in peripheral blood mononuclear cells (PBMC) from patients with type 1 diabetes at the time of diagnosis versus those with type 2 diabetes at the time of diagnosis.	Objective: We hypothesized that type 1 diabetes (T1D) is accompanied by changes in gene expression in peripheral blood mononuclear cells (PBMCs) due to dysregulation of adaptive and innate immunity, counterregulatory responses to immune dysregulation, insulin deficiency and hyperglycemia. Research Design and Methods: Microarray analysis was performed on PBMCs from 43 patients with newly diagnosed T1D, 12 patients with newly diagnosed type 2 diabetes (T2D) and 24 healthy controls. One and four month follow-up samples were obtained from 20 of the T1D patients. Results: Microarray analysis identified 282 genes differing in expression between newlydiagnosed T1D patients and controls at a false discovery rate of 0.05. Changes in expression of interleukin-1β (IL1B), early growth response gene 3 (EGR3), and prostaglandin-endoperoxide synthase 2 (PTGS2) resolved within four months of insulin therapy and were also observed in T2D suggesting that they resulted from hyperglycemia. With use of a knowledge base, 81/282 genes could be placed within a network of interrelated genes with predicted functions including apoptosis and cell proliferation. IL1B and the MYC oncogene were the most highly-connected genes in the network. IL1B was highly overexpressed in both T1D and T2D, whereas MYC was dysregulated only in T1D. Conclusion: T1D and T2D likely share a final common pathway for beta cell dysfunction that includes secretion of interleukin-1β and prostaglandins by immune effector cells, exacerbating existing beta cell dysfunction, and causing further hyperglycemia. The results identify several targets for disease-modifying therapy of diabetes and potential biomarkers for monitoring treatment efficacy.					3709	54812	8887	55737	54741	3516	5151	4026	10059	7414	1601	50856	302	8239	5884	54542	50807	6136	6197	5700	8546	23086	9522	10550	9575	55843	79602	10241	2015	5937	307	55667	2776	4190	2982	286451	834	5707	51108	54878	2650	1316	6009	54739	3140	9475	222161	7405	8894	8443	3693	8405	10109	23019	10983	963	5688	10542	8609	304	2098	92689	54834	54149	8566	81577	7692	9515	4259	7110	10964	1618	4086	529	79772	22915	9535	9786	6130	5682	9848	1314	7179	81578	8714	55680	92335	51493	8648	5966	5018	493	6403	56946	2983	23208	9060	26268	25782	3839	10284	51397	9252	57214	1398	6801	79668	3964	5701	25843	9453	222658	80205	5579	7332	51703	10040	7504	22841	55526	4437	163486	5930	5571	509	4857	9446	54765	54552	132	1845	2618	2665	7360	11345	1213	10169	4520	1557	6651	6414	2162	56983	10186	8554	5813	22990	10367	7072	2296	55788	54807	79635	7292	56945	1373	55296	2965	26503	51174	80204	26010	8743	9366	56954	54629	1581	10404	23585	51136	51362	10193	54596	79096	10768	23380	83480	55096	51105	24149	22824	9317	23365	8853	9074	6678	53407	7223	2186	10010	55870	10200	9779	114876	2059	60485	57466	1193	55760	6774
GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_UP	M5844		18292579	Dower K,Ellis DK,Saraf K,Jelinsky SA,Lin LL.	GSE9988	GSE9988_2034_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] versus monocytes treated with 5000 ng/ml LPS (TLR4 agonist).	TREM-1 is an orphan immunoreceptor expressed on monocytes, macrophages, and neutrophils. TREM-1 associates with and signals via the adapter protein DAP12/TYROBP, which contains an immunoreceptor tyrosine-based activation motif (ITAM). TREM-1 activation by receptor cross-linking is pro-inflammatory, and can amplify cellular responses to Toll-like receptor (TLR) ligands such as bacterial lipopolysaccharide (LPS). To investigate the cellular consequences of TREM-1 activation, we have characterized global gene expression changes in human monocytes in response to TREM-1 cross-linking in comparison to and combined with LPS. Both TREM-1 activation and LPS up-regulate chemokines, cytokines, matrix metalloproteases, and PTGS/COX2, consistent with a core inflammatory response. However, other immunomodulatory factors are selectively induced, including SPP1 and CSF1 (i.e., M-CSF) by TREM-1 activation and IL-23 and CSF3 (i.e., G-CSF) by LPS. Additionally, cross-talk between TREM-1 activation and LPS occurs on multiple levels. While synergy in GM-CSF protein production is reflected in commensurate mRNA abundance, comparable synergy in IL-1b protein production is not. TREM-1 activation also attenuates the induction of some LPS target genes, including those that encode IL-12 cytokine family subunits. Whereas positive TREM-1 outputs are abolished by the PI3K inhibitor wortmannin, this attenuation is largely PI3K-independent. These experiments provide a detailed analysis of the cellular consequences of TREM-1 activation, and highlight some of the complexity in signal integration between ITAM- and TLR-mediated signaling.					10253	29959	51177	4327	10221	1601	64112	10993	4063	1903	79836	950	55357	23307	3927	51530	51186	25798	56253	51256	23603	83877	54877	56675	444	84868	9451	10134	8613	64121	8763	151534	89857	10215	7046	4864	10170	440400	2181	55272	375387	154092	9467	55148	3984	8740	23207	154881	56261	467	3074	10865	23175	9842	79001	23550	219855	26175	388	78999	80024	22856	23111	80218	55361	7050	55344	1306	51330	57192	4708	1514	286223	54968	5914	3958	8780	113675	54438	57600	170371	90956	6446	7090	84541	84959	80256	58528	526	255758	11072	257364	6854	262	90324	29934	9569	93129	10073	388552	8500	1230	1051	157922	10437	27439	9489	79670	27342	79720	221710	6239	8412	29062	55295	10194	4493	51514	10007	5468	26234	23765	1836	3687	1453	9619	6810	6248	4245	65260	116448	54471	4715	81631	23099	5777	163882	90	60626	6804	9454	1831	79142	51363	6696	84981	4299	55151	9966	60370	55122	9117	49854	3399	10628	4241	4023	10365	64114	6509	54815	7867	10184	27128	219931	11337	83442	23243	59274	90355	5912	80262	26503	9531	23268	23062	29982	2055	221037	148479	9046	3090	644815	221491	80270	25793	951	9550	6448	6273	8491	2012	1119	29950	9361	6809	84640	5830	80301
GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_DN	M5845		18292579	Dower K,Ellis DK,Saraf K,Jelinsky SA,Lin LL.	GSE9988	GSE9988_2034_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] versus monocytes treated with 5000 ng/ml LPS (TLR4 agonist).	TREM-1 is an orphan immunoreceptor expressed on monocytes, macrophages, and neutrophils. TREM-1 associates with and signals via the adapter protein DAP12/TYROBP, which contains an immunoreceptor tyrosine-based activation motif (ITAM). TREM-1 activation by receptor cross-linking is pro-inflammatory, and can amplify cellular responses to Toll-like receptor (TLR) ligands such as bacterial lipopolysaccharide (LPS). To investigate the cellular consequences of TREM-1 activation, we have characterized global gene expression changes in human monocytes in response to TREM-1 cross-linking in comparison to and combined with LPS. Both TREM-1 activation and LPS up-regulate chemokines, cytokines, matrix metalloproteases, and PTGS/COX2, consistent with a core inflammatory response. However, other immunomodulatory factors are selectively induced, including SPP1 and CSF1 (i.e., M-CSF) by TREM-1 activation and IL-23 and CSF3 (i.e., G-CSF) by LPS. Additionally, cross-talk between TREM-1 activation and LPS occurs on multiple levels. While synergy in GM-CSF protein production is reflected in commensurate mRNA abundance, comparable synergy in IL-1b protein production is not. TREM-1 activation also attenuates the induction of some LPS target genes, including those that encode IL-12 cytokine family subunits. Whereas positive TREM-1 outputs are abolished by the PI3K inhibitor wortmannin, this attenuation is largely PI3K-independent. These experiments provide a detailed analysis of the cellular consequences of TREM-1 activation, and highlight some of the complexity in signal integration between ITAM- and TLR-mediated signaling.					7127	79666	171024	3569	5366	114548	1326	440934	3759	80149	57162	79931	3383	731424	2643	2180	64332	84919	4082	27289	57826	10289	2867	330	127544	7128	8843	51561	4947	5743	26253	3055	5209	7124	117289	9021	25819	646023	51284	29126	399	8767	25932	8837	983	3552	283416	51347	1844	25816	92610	100128191	10010	4780	112574	5687	388685	6385	597	730249	56935	2920	7494	4683	3949	51582	56300	7130	3604	10485	329	8870	1647	54462	1440	91404	8638	6776	23384	754	9852	9693	116039	4664	112495	92	29933	127687	5806	119392	2633	255231	958	255488	79682	23118	51765	6351	200298	9444	118788	7185	3553	441072	4792	5795	92241	3656	3386	1263	57655	9766	891	8795	54509	6368	3068	5271	387763	7360	54453	100302650	58480	23529	6364	651746	24147	285848	4316	3601	3576	203859	65986	26034	3460	114908	3183	401093	81553	51199	100	8676	123879	285628	64092	84991	3593	23590	11182	5711	144455	6507	3696	10154	3738	11177	94241	10135	10938	2919	9953	29992	4520	79689	3301	10957	55340	56829	6506	64135	55332	100506229	10950	3586	79135	4790	6648	29887	23258	50486	23048	5724	8031	9750	8604	3344	415116	51316	55300	6624	445347	152926	366	10148	9308	23011	4216	1389	6934	60485
GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_UP	M5846		18292579	Dower K,Ellis DK,Saraf K,Jelinsky SA,Lin LL.	GSE9988	GSE9988_2035_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] versus monocytes treated with 1 ng/ml LPS (TLR4 agonist). 	TREM-1 is an orphan immunoreceptor expressed on monocytes, macrophages, and neutrophils. TREM-1 associates with and signals via the adapter protein DAP12/TYROBP, which contains an immunoreceptor tyrosine-based activation motif (ITAM). TREM-1 activation by receptor cross-linking is pro-inflammatory, and can amplify cellular responses to Toll-like receptor (TLR) ligands such as bacterial lipopolysaccharide (LPS). To investigate the cellular consequences of TREM-1 activation, we have characterized global gene expression changes in human monocytes in response to TREM-1 cross-linking in comparison to and combined with LPS. Both TREM-1 activation and LPS up-regulate chemokines, cytokines, matrix metalloproteases, and PTGS/COX2, consistent with a core inflammatory response. However, other immunomodulatory factors are selectively induced, including SPP1 and CSF1 (i.e., M-CSF) by TREM-1 activation and IL-23 and CSF3 (i.e., G-CSF) by LPS. Additionally, cross-talk between TREM-1 activation and LPS occurs on multiple levels. While synergy in GM-CSF protein production is reflected in commensurate mRNA abundance, comparable synergy in IL-1b protein production is not. TREM-1 activation also attenuates the induction of some LPS target genes, including those that encode IL-12 cytokine family subunits. Whereas positive TREM-1 outputs are abolished by the PI3K inhibitor wortmannin, this attenuation is largely PI3K-independent. These experiments provide a detailed analysis of the cellular consequences of TREM-1 activation, and highlight some of the complexity in signal integration between ITAM- and TLR-mediated signaling.					950	89857	1601	10215	9467	10672	1903	55357	4864	10170	25798	4063	64121	151534	9569	8740	3984	23307	10993	25793	444	55361	64112	84959	54438	4327	56253	55272	84868	2181	23167	83877	10295	154092	10221	51256	55295	58528	23207	55151	56675	5468	375387	79001	29959	3958	8500	80218	51530	22856	55148	219855	23603	8613	9842	286223	29062	54877	4493	7090	23550	9451	6446	10134	29934	78999	11072	57600	56261	1306	1230	55344	23175	170371	526	6239	255758	10457	4241	23243	5914	1211	90956	116448	5777	154881	90	65260	54968	467	54471	79836	113675	51177	4708	440400	8412	3074	10073	10007	6810	64114	10437	2171	51514	23268	9550	388552	6696	6809	262	5525	90324	10184	1514	51186	80262	3927	113419	8491	5130	4860	4758	28231	55238	7375	5830	26175	1051	80765	6273	8763	26234	92806	7046	4496	2055	10365	131408	9966	221710	3090	388	6509	6854	57192	80256	9640	163882	4502	200933	4501	56674	6804	59274	29886	79142	79759	4494	8780	124599	93129	4869	10628	79794	257364	4023	7050	56941	23765	148479	80301	24149	9361	50999	84301	283143	29946	4495	81631	7100	80024	157922	51382	27128	1973	642	645745	51592	967	80270	51429	27439	23111	26043	4245	25799	23204	51363
GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_DN	M5847		18292579	Dower K,Ellis DK,Saraf K,Jelinsky SA,Lin LL.	GSE9988	GSE9988_2035_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] versus monocytes treated with 1 ng/ml LPS (TLR4 agonist). 	TREM-1 is an orphan immunoreceptor expressed on monocytes, macrophages, and neutrophils. TREM-1 associates with and signals via the adapter protein DAP12/TYROBP, which contains an immunoreceptor tyrosine-based activation motif (ITAM). TREM-1 activation by receptor cross-linking is pro-inflammatory, and can amplify cellular responses to Toll-like receptor (TLR) ligands such as bacterial lipopolysaccharide (LPS). To investigate the cellular consequences of TREM-1 activation, we have characterized global gene expression changes in human monocytes in response to TREM-1 cross-linking in comparison to and combined with LPS. Both TREM-1 activation and LPS up-regulate chemokines, cytokines, matrix metalloproteases, and PTGS/COX2, consistent with a core inflammatory response. However, other immunomodulatory factors are selectively induced, including SPP1 and CSF1 (i.e., M-CSF) by TREM-1 activation and IL-23 and CSF3 (i.e., G-CSF) by LPS. Additionally, cross-talk between TREM-1 activation and LPS occurs on multiple levels. While synergy in GM-CSF protein production is reflected in commensurate mRNA abundance, comparable synergy in IL-1b protein production is not. TREM-1 activation also attenuates the induction of some LPS target genes, including those that encode IL-12 cytokine family subunits. Whereas positive TREM-1 outputs are abolished by the PI3K inhibitor wortmannin, this attenuation is largely PI3K-independent. These experiments provide a detailed analysis of the cellular consequences of TREM-1 activation, and highlight some of the complexity in signal integration between ITAM- and TLR-mediated signaling.					80149	114548	5366	3569	79666	3383	171024	7127	440934	731424	64332	388685	3759	1326	8843	7128	27289	5743	57162	4947	4780	2180	79931	6385	2643	51561	5209	7124	1844	3183	330	983	8837	92610	3055	144455	26253	51347	6776	3552	387763	29126	646023	597	4683	25816	25932	7130	84919	283416	56300	9021	23258	730249	100302650	10010	8767	127544	399	57826	119392	3949	9852	7185	123879	25819	203859	2867	11182	754	255488	9693	83874	57655	200298	118788	1647	8638	6507	5687	29933	4792	3604	92	1440	5806	2956	56935	100506229	50486	64092	10289	4082	91404	5711	23529	23590	3601	3553	8795	23384	255231	9766	3738	112495	113452	10938	81553	3096	56829	2920	8870	1263	8676	5795	3656	51365	6364	94241	221079	23048	2633	112574	65986	4790	285628	3068	127687	329	58480	6351	51284	50604	3386	6324	838	3301	117289	415116	10261	6478	10148	55340	60485	51765	8031	352961	10957	79682	54509	54453	5142	3696	2919	651746	5271	408	3606	7360	23136	53831	51278	3398	29992	2146	4520	51582	285848	4664	3576	3586	23118	10485	92241	9444	100	3593	3460	6648	9308	90167	2921	114614	10950	10866	7543	130367	10260	3985	4316	10318	56006	3097	51316	221756	366	55332	23338	11040	6368
GSE9988_ANTI_TREM1_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP	M5848		18292579	Dower K,Ellis DK,Saraf K,Jelinsky SA,Lin LL.	GSE9988	GSE9988_2036_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] versus monocytes treated with anti-TREM1 [GeneID=54210] and 5000 ng/ml LPS (TLR4 agonist).	TREM-1 is an orphan immunoreceptor expressed on monocytes, macrophages, and neutrophils. TREM-1 associates with and signals via the adapter protein DAP12/TYROBP, which contains an immunoreceptor tyrosine-based activation motif (ITAM). TREM-1 activation by receptor cross-linking is pro-inflammatory, and can amplify cellular responses to Toll-like receptor (TLR) ligands such as bacterial lipopolysaccharide (LPS). To investigate the cellular consequences of TREM-1 activation, we have characterized global gene expression changes in human monocytes in response to TREM-1 cross-linking in comparison to and combined with LPS. Both TREM-1 activation and LPS up-regulate chemokines, cytokines, matrix metalloproteases, and PTGS/COX2, consistent with a core inflammatory response. However, other immunomodulatory factors are selectively induced, including SPP1 and CSF1 (i.e., M-CSF) by TREM-1 activation and IL-23 and CSF3 (i.e., G-CSF) by LPS. Additionally, cross-talk between TREM-1 activation and LPS occurs on multiple levels. While synergy in GM-CSF protein production is reflected in commensurate mRNA abundance, comparable synergy in IL-1b protein production is not. TREM-1 activation also attenuates the induction of some LPS target genes, including those that encode IL-12 cytokine family subunits. Whereas positive TREM-1 outputs are abolished by the PI3K inhibitor wortmannin, this attenuation is largely PI3K-independent. These experiments provide a detailed analysis of the cellular consequences of TREM-1 activation, and highlight some of the complexity in signal integration between ITAM- and TLR-mediated signaling.					55361	10628	5914	10437	84868	5499	10105	11337	219855	51422	29959	10134	22856	54458	29982	126364	5912	83877	11344	115761	80301	10970	27128	7046	10993	57192	58190	282969	80262	7584	7532	10170	29946	5813	10193	867	1912	55700	9682	1453	7323	262	226	7693	79142	148479	8930	84895	51177	10160	9467	1656	29934	9046	84858	27439	29950	7096	23307	10949	283143	8907	2023	9842	54968	93129	5049	10421	80335	64834	23401	123920	9616	23326	1796	5898	7555	56984	144233	94107	10865	27252	55170	5777	7867	10287	54471	6155	1230	4064	1192	55357	150678	27106	255919	950	51523	1979	23550	23608	54877	154092	56970	10023	282991	90121	27166	5294	10295	25793	7090	8428	90324	51283	23557	1774	26262	4335	25920	116448	30815	4708	60	2495	6672	6500	3927	29978	9741	8655	81873	5978	118472	4076	55295	2171	56674	9778	23204	9454	7132	4063	6239	58191	55573	80306	92806	55737	200933	80347	55911	55201	1211	257106	65996	51372	6273	10487	91966	116150	112950	10215	409	93621	9960	4860	10175	11054	6613	51621	5531	51231	84254	339123	2783	9100	81502	284613	388552	6015	122961	11072	5713	23062	10623	5688	7791	9595	7528	381	124599	10116	22868	165918	9908	123803	80024	5093	4637	4782
GSE9988_ANTI_TREM1_VS_ANTI_TREM1_AND_LPS_MONOCYTE_DN	M5849		18292579	Dower K,Ellis DK,Saraf K,Jelinsky SA,Lin LL.	GSE9988	GSE9988_2036_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] versus monocytes treated with anti-TREM1 [GeneID=54210] and 5000 ng/ml LPS (TLR4 agonist).	TREM-1 is an orphan immunoreceptor expressed on monocytes, macrophages, and neutrophils. TREM-1 associates with and signals via the adapter protein DAP12/TYROBP, which contains an immunoreceptor tyrosine-based activation motif (ITAM). TREM-1 activation by receptor cross-linking is pro-inflammatory, and can amplify cellular responses to Toll-like receptor (TLR) ligands such as bacterial lipopolysaccharide (LPS). To investigate the cellular consequences of TREM-1 activation, we have characterized global gene expression changes in human monocytes in response to TREM-1 cross-linking in comparison to and combined with LPS. Both TREM-1 activation and LPS up-regulate chemokines, cytokines, matrix metalloproteases, and PTGS/COX2, consistent with a core inflammatory response. However, other immunomodulatory factors are selectively induced, including SPP1 and CSF1 (i.e., M-CSF) by TREM-1 activation and IL-23 and CSF3 (i.e., G-CSF) by LPS. Additionally, cross-talk between TREM-1 activation and LPS occurs on multiple levels. While synergy in GM-CSF protein production is reflected in commensurate mRNA abundance, comparable synergy in IL-1b protein production is not. TREM-1 activation also attenuates the induction of some LPS target genes, including those that encode IL-12 cytokine family subunits. Whereas positive TREM-1 outputs are abolished by the PI3K inhibitor wortmannin, this attenuation is largely PI3K-independent. These experiments provide a detailed analysis of the cellular consequences of TREM-1 activation, and highlight some of the complexity in signal integration between ITAM- and TLR-mediated signaling.					3569	144455	64332	5743	114548	80149	6385	3586	5366	7124	3552	65986	731424	1440	79666	25819	9034	51561	646023	283416	8837	85480	171024	387763	2920	7185	8444	7128	3383	23529	330	8843	91404	7127	56300	3386	57826	1236	92241	7130	6776	29933	2643	119392	4792	3576	1316	9693	9308	3553	23590	203859	440934	6364	114614	6351	8870	92610	9021	84777	100134229	25816	4683	441366	57162	8767	3096	1326	221079	2114	1844	53831	84919	2921	4319	3183	730249	9414	100287628	10260	2180	51765	100288009	415116	51365	79931	124637	7159	1647	6648	23645	339789	3656	983	2152	23384	1263	127544	2956	7543	92737	5329	9766	92345	64651	9181	29887	339751	3559	5932	5341	60485	6103	255488	597	23258	2157	5055	349114	5806	3456	7163	29126	4915	366	92	200298	3759	91548	90167	84991	10938	100506229	55340	3460	4814	54072	285628	3606	50486	135	1437	79993	338758	3696	26253	80063	6507	5711	388685	91283	5008	9589	7803	399	4216	2321	123879	152926	25932	160419	3398	2271	6478	374443	56155	10010	2706	3604	4891	8564	85463	54462	5209	26147	11182	84879	2081	130502	7538	400617	123606	9129	100289312	27299	10878	56829	23158	23306	2633	6278	196441	79693	441072	653483	55332	10950	29121	54509	157506
GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_UP	M5850		18292579	Dower K,Ellis DK,Saraf K,Jelinsky SA,Lin LL.	GSE9988	GSE9988_2037_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] versus monocytes treated with control IgG.	TREM-1 is an orphan immunoreceptor expressed on monocytes, macrophages, and neutrophils. TREM-1 associates with and signals via the adapter protein DAP12/TYROBP, which contains an immunoreceptor tyrosine-based activation motif (ITAM). TREM-1 activation by receptor cross-linking is pro-inflammatory, and can amplify cellular responses to Toll-like receptor (TLR) ligands such as bacterial lipopolysaccharide (LPS). To investigate the cellular consequences of TREM-1 activation, we have characterized global gene expression changes in human monocytes in response to TREM-1 cross-linking in comparison to and combined with LPS. Both TREM-1 activation and LPS up-regulate chemokines, cytokines, matrix metalloproteases, and PTGS/COX2, consistent with a core inflammatory response. However, other immunomodulatory factors are selectively induced, including SPP1 and CSF1 (i.e., M-CSF) by TREM-1 activation and IL-23 and CSF3 (i.e., G-CSF) by LPS. Additionally, cross-talk between TREM-1 activation and LPS occurs on multiple levels. While synergy in GM-CSF protein production is reflected in commensurate mRNA abundance, comparable synergy in IL-1b protein production is not. TREM-1 activation also attenuates the induction of some LPS target genes, including those that encode IL-12 cytokine family subunits. Whereas positive TREM-1 outputs are abolished by the PI3K inhibitor wortmannin, this attenuation is largely PI3K-independent. These experiments provide a detailed analysis of the cellular consequences of TREM-1 activation, and highlight some of the complexity in signal integration between ITAM- and TLR-mediated signaling.					10253	59274	3725	2717	26175	3624	27342	9966	64112	5861	2181	10672	51422	4864	89857	444	57600	257364	8439	54532	7803	401588	51256	1903	79836	2114	23111	28231	7295	64651	1847	5996	9754	338758	1514	10615	55344	4063	10402	1906	6520	6446	9052	1843	56253	4241	7071	1051	255758	100287039	8061	57801	6016	27125	2730	2152	140809	78999	8500	56650	375387	5329	84981	51186	80219	6809	4327	84002	8740	10007	4929	10221	2669	1959	221468	22856	84868	1026	9043	112399	4758	55151	51530	58528	153020	51429	49854	4493	6810	64121	8613	646329	9765	2957	1164	54407	6696	51514	2920	7975	23099	54438	6515	7056	1846	221692	56675	133	3313	131408	3164	7296	93953	286223	84541	28984	1435	56261	9456	55647	25897	166929	57520	10979	80218	5597	6617	23429	221710	331	1515	27	4860	6236	22936	219333	1958	9903	154092	2107	9467	23167	1839	467	1518	4023	5743	3554	9842	6690	23507	3576	23243	3090	10073	55357	55633	5791	221037	6239	79094	81501	26227	84890	83667	1845	6009	1655	9531	51655	526	54541	163882	1306	344887	151534	1960	8738	29948	2908	5468	1844	4097	8444	7050	22822	54971	54968	58515	7037	4319	7124	57488	6880	4616	259230	5366	653390	6921	7378
GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN	M5851		18292579	Dower K,Ellis DK,Saraf K,Jelinsky SA,Lin LL.	GSE9988	GSE9988_2037_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] versus monocytes treated with control IgG.	TREM-1 is an orphan immunoreceptor expressed on monocytes, macrophages, and neutrophils. TREM-1 associates with and signals via the adapter protein DAP12/TYROBP, which contains an immunoreceptor tyrosine-based activation motif (ITAM). TREM-1 activation by receptor cross-linking is pro-inflammatory, and can amplify cellular responses to Toll-like receptor (TLR) ligands such as bacterial lipopolysaccharide (LPS). To investigate the cellular consequences of TREM-1 activation, we have characterized global gene expression changes in human monocytes in response to TREM-1 cross-linking in comparison to and combined with LPS. Both TREM-1 activation and LPS up-regulate chemokines, cytokines, matrix metalloproteases, and PTGS/COX2, consistent with a core inflammatory response. However, other immunomodulatory factors are selectively induced, including SPP1 and CSF1 (i.e., M-CSF) by TREM-1 activation and IL-23 and CSF3 (i.e., G-CSF) by LPS. Additionally, cross-talk between TREM-1 activation and LPS occurs on multiple levels. While synergy in GM-CSF protein production is reflected in commensurate mRNA abundance, comparable synergy in IL-1b protein production is not. TREM-1 activation also attenuates the induction of some LPS target genes, including those that encode IL-12 cytokine family subunits. Whereas positive TREM-1 outputs are abolished by the PI3K inhibitor wortmannin, this attenuation is largely PI3K-independent. These experiments provide a detailed analysis of the cellular consequences of TREM-1 activation, and highlight some of the complexity in signal integration between ITAM- and TLR-mediated signaling.					23625	754	90427	27166	51621	4088	23067	10106	10550	57136	54440	2022	5049	7048	3055	3611	5293	25942	55700	54838	408	10859	123920	1432	64834	4297	9815	1445	64784	57591	6867	51780	10023	27106	90231	3068	1849	50485	4542	26100	29068	9473	91748	3071	25853	1500	81603	6942	202309	5724	23031	221955	88455	5927	54880	7096	23102	80228	678	9960	64943	126282	57506	6494	5795	374655	8021	9794	23326	54878	10228	9857	9641	25900	9371	221937	8289	3587	84792	4077	84629	79142	1436	51696	7942	79890	23608	51228	283149	51719	84271	10422	55625	10095	65018	124460	10521	22877	1240	51063	1912	1389	9665	83786	89846	1861	2783	6850	5452	729230	8683	51573	83605	254048	23369	1173	58484	271	9020	155038	259282	51112	57189	10287	283337	391	57680	11329	64744	51	25962	29109	219972	10423	2517	56984	54455	27071	23054	80262	79686	5431	2733	162427	55284	157	7903	23636	10238	55758	51528	5199	1998	283489	142	27430	51247	22838	126308	55911	2123	377	11025	65998	10288	10664	7127	11337	3454	162417	51324	144811	55023	8816	4218	8031	392	7764	79447	867	127428	1112	10509	64397	2885	929	9770	152006	50484	6195	9611	22809	23654	8019	11344	23396	6877	8449	253260	51493
GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_UP	M5852		18292579	Dower K,Ellis DK,Saraf K,Jelinsky SA,Lin LL.	GSE9988	GSE9988_2038_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] versus untreated monocytes.	TREM-1 is an orphan immunoreceptor expressed on monocytes, macrophages, and neutrophils. TREM-1 associates with and signals via the adapter protein DAP12/TYROBP, which contains an immunoreceptor tyrosine-based activation motif (ITAM). TREM-1 activation by receptor cross-linking is pro-inflammatory, and can amplify cellular responses to Toll-like receptor (TLR) ligands such as bacterial lipopolysaccharide (LPS). To investigate the cellular consequences of TREM-1 activation, we have characterized global gene expression changes in human monocytes in response to TREM-1 cross-linking in comparison to and combined with LPS. Both TREM-1 activation and LPS up-regulate chemokines, cytokines, matrix metalloproteases, and PTGS/COX2, consistent with a core inflammatory response. However, other immunomodulatory factors are selectively induced, including SPP1 and CSF1 (i.e., M-CSF) by TREM-1 activation and IL-23 and CSF3 (i.e., G-CSF) by LPS. Additionally, cross-talk between TREM-1 activation and LPS occurs on multiple levels. While synergy in GM-CSF protein production is reflected in commensurate mRNA abundance, comparable synergy in IL-1b protein production is not. TREM-1 activation also attenuates the induction of some LPS target genes, including those that encode IL-12 cytokine family subunits. Whereas positive TREM-1 outputs are abolished by the PI3K inhibitor wortmannin, this attenuation is largely PI3K-independent. These experiments provide a detailed analysis of the cellular consequences of TREM-1 activation, and highlight some of the complexity in signal integration between ITAM- and TLR-mediated signaling.					3624	51429	55344	9966	6520	7295	3725	444	9451	2669	4864	100287039	5468	9754	6696	1906	338758	2717	9034	1903	6236	26175	1847	8439	6009	140809	9052	1514	153020	7296	84868	10672	57600	28231	51256	4327	64112	5861	10615	401588	286223	56253	27	9550	89857	8061	4063	255758	84890	6810	10402	2181	23243	51422	2114	54438	84959	1051	64651	51530	59274	4758	6446	1476	2152	6880	4493	8740	3313	221692	1846	221468	23327	6690	54968	54532	79836	1959	4023	8613	51514	10221	2617	58528	2920	1164	1843	3376	56675	6364	8738	9043	166929	112399	3090	2921	154092	84981	1518	27342	1435	9765	195827	285812	4074	3638	10007	151534	6016	100287719	1306	8972	4241	51186	8500	7378	4860	9903	344887	79094	25822	6354	5025	1977	4495	56261	8808	2171	54407	23099	729678	11072	49854	5028	3554	79720	55122	23507	83667	79149	55357	8412	55151	25897	10215	84617	7071	5996	5597	10073	78999	1876	4496	22862	22856	55647	4665	154881	9531	221710	5743	79697	1845	221037	9456	81501	646329	8444	26503	84002	100134229	4501	4494	9467	57488	23603	3576	338382	8900	1973	22850	57520	6897	441478	6617	10979	1515	1836	8491	1601	4312	2107	100288781	6322	6675	80218	1026	84541	10602
GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_DN	M5853		18292579	Dower K,Ellis DK,Saraf K,Jelinsky SA,Lin LL.	GSE9988	GSE9988_2038_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] versus untreated monocytes.	TREM-1 is an orphan immunoreceptor expressed on monocytes, macrophages, and neutrophils. TREM-1 associates with and signals via the adapter protein DAP12/TYROBP, which contains an immunoreceptor tyrosine-based activation motif (ITAM). TREM-1 activation by receptor cross-linking is pro-inflammatory, and can amplify cellular responses to Toll-like receptor (TLR) ligands such as bacterial lipopolysaccharide (LPS). To investigate the cellular consequences of TREM-1 activation, we have characterized global gene expression changes in human monocytes in response to TREM-1 cross-linking in comparison to and combined with LPS. Both TREM-1 activation and LPS up-regulate chemokines, cytokines, matrix metalloproteases, and PTGS/COX2, consistent with a core inflammatory response. However, other immunomodulatory factors are selectively induced, including SPP1 and CSF1 (i.e., M-CSF) by TREM-1 activation and IL-23 and CSF3 (i.e., G-CSF) by LPS. Additionally, cross-talk between TREM-1 activation and LPS occurs on multiple levels. While synergy in GM-CSF protein production is reflected in commensurate mRNA abundance, comparable synergy in IL-1b protein production is not. TREM-1 activation also attenuates the induction of some LPS target genes, including those that encode IL-12 cytokine family subunits. Whereas positive TREM-1 outputs are abolished by the PI3K inhibitor wortmannin, this attenuation is largely PI3K-independent. These experiments provide a detailed analysis of the cellular consequences of TREM-1 activation, and highlight some of the complexity in signal integration between ITAM- and TLR-mediated signaling.					10287	408	3055	64943	9641	90427	2022	6942	4542	1849	5451	929	23067	58504	754	5879	123920	65108	83593	391	3956	65996	5293	1445	8031	219972	25942	202309	6494	56946	283149	2896	27166	84629	221955	22809	3611	23031	51063	729683	57701	84687	11337	60436	7942	6613	23625	5452	5660	54440	79690	8428	7529	54838	6867	23533	11344	2783	7127	56970	6195	6850	50484	5819	7048	5724	118788	9647	4215	8019	10521	11151	7096	57720	79650	10460	729230	5199	678	2517	1500	10550	79626	4615	4088	25853	22877	51621	10859	8717	1432	81603	6794	25778	54	9815	9466	9770	80228	50485	57217	201176	79686	392	116844	51228	403	2359	27327	10106	8819	80709	3068	10044	5594	23526	54521	3140	84105	23406	57496	55756	257106	10228	55700	8021	51112	3587	8408	9681	27106	91662	6397	65018	6653	25777	7045	51696	3460	374655	9371	83605	100288617	162417	23654	8655	90957	11188	10869	286336	88455	2885	150372	91748	84260	51247	1436	3340	64784	4253	155038	1512	8073	10023	57506	80833	8202	25900	271	51710	22834	79180	5175	2123	10288	4053	11320	128346	9595	57189	26100	1192	901	170575	11329	116138	55625	10277	57591	58191	283337	602	284323	864	23678	157	64834	1536	10095	27348
GSE9988_LPS_VS_LOW_LPS_MONOCYTE_UP	M5854		18292579	Dower K,Ellis DK,Saraf K,Jelinsky SA,Lin LL.	GSE9988	GSE9988_2039_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of monocytes treated with 5000 ng/ml LPS (TLR4 agonist) versus those treated with 1 ng/ml LPS (TLR4 agonist).	TREM-1 is an orphan immunoreceptor expressed on monocytes, macrophages, and neutrophils. TREM-1 associates with and signals via the adapter protein DAP12/TYROBP, which contains an immunoreceptor tyrosine-based activation motif (ITAM). TREM-1 activation by receptor cross-linking is pro-inflammatory, and can amplify cellular responses to Toll-like receptor (TLR) ligands such as bacterial lipopolysaccharide (LPS). To investigate the cellular consequences of TREM-1 activation, we have characterized global gene expression changes in human monocytes in response to TREM-1 cross-linking in comparison to and combined with LPS. Both TREM-1 activation and LPS up-regulate chemokines, cytokines, matrix metalloproteases, and PTGS/COX2, consistent with a core inflammatory response. However, other immunomodulatory factors are selectively induced, including SPP1 and CSF1 (i.e., M-CSF) by TREM-1 activation and IL-23 and CSF3 (i.e., G-CSF) by LPS. Additionally, cross-talk between TREM-1 activation and LPS occurs on multiple levels. While synergy in GM-CSF protein production is reflected in commensurate mRNA abundance, comparable synergy in IL-1b protein production is not. TREM-1 activation also attenuates the induction of some LPS target genes, including those that encode IL-12 cytokine family subunits. Whereas positive TREM-1 outputs are abolished by the PI3K inhibitor wortmannin, this attenuation is largely PI3K-independent. These experiments provide a detailed analysis of the cellular consequences of TREM-1 activation, and highlight some of the complexity in signal integration between ITAM- and TLR-mediated signaling.					51808	121838	157574	4887	152816	285696	26659	4493	6338	1579	128387	1493	11249	57569	6578	79733	84962	10877	114814	100291367	3116	646576	100505483	9840	399875	401261	81493	28986	642636	152404	55215	7754	6512	285989	728716	255812	660	374946	26249	5454	79782	100101938	7697	92129	50652	4653	55323	80114	57547	6862	79657	388815	3763	57530	26256	345557	442194	170572	4685	100132147	8707	5896	51537	10413	338661	10350	54821	6837	100131275	283731	10382	100506451	283033	84926	9841	130340	146223	2561	26497	54581	7472	2966	729595	6779	940	8748	11045	81930	55001	574407	220992	554207	55531	49861	85294	337970	84435	25817	8892	57282	55089	3207	55449	5275	55342	10579	55359	10215	80000	126820	83863	84867	8479	7100	2288	26219	64798	2800	79679	353174	30832	285097	10665	79608	654841	283501	131831	5744	100505967	55143	10505	2	51454	11187	51678	60401	725	662	147463	8505	22866	3739	2949	255480	284618	643749	166336	643236	100129427	10131	54850	85438	7978	64180	27300	7757	81624	5087	140807	56100	100132460	10098	162967	163778	643365	4636	7067	273	51475	642924	163351	56120	2731	6576	1833	100293830	24141	4199	81871	5313	7576	10733	441108	79150	1813	130749	11037	79819	55006	1132	164684	3752	2842	9980	724094	387882	65250	8917	84939
GSE9988_LPS_VS_LOW_LPS_MONOCYTE_DN	M5855		18292579	Dower K,Ellis DK,Saraf K,Jelinsky SA,Lin LL.	GSE9988	GSE9988_2039_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of monocytes treated with 5000 ng/ml LPS (TLR4 agonist) versus those treated with 1 ng/ml LPS (TLR4 agonist).	TREM-1 is an orphan immunoreceptor expressed on monocytes, macrophages, and neutrophils. TREM-1 associates with and signals via the adapter protein DAP12/TYROBP, which contains an immunoreceptor tyrosine-based activation motif (ITAM). TREM-1 activation by receptor cross-linking is pro-inflammatory, and can amplify cellular responses to Toll-like receptor (TLR) ligands such as bacterial lipopolysaccharide (LPS). To investigate the cellular consequences of TREM-1 activation, we have characterized global gene expression changes in human monocytes in response to TREM-1 cross-linking in comparison to and combined with LPS. Both TREM-1 activation and LPS up-regulate chemokines, cytokines, matrix metalloproteases, and PTGS/COX2, consistent with a core inflammatory response. However, other immunomodulatory factors are selectively induced, including SPP1 and CSF1 (i.e., M-CSF) by TREM-1 activation and IL-23 and CSF3 (i.e., G-CSF) by LPS. Additionally, cross-talk between TREM-1 activation and LPS occurs on multiple levels. While synergy in GM-CSF protein production is reflected in commensurate mRNA abundance, comparable synergy in IL-1b protein production is not. TREM-1 activation also attenuates the induction of some LPS target genes, including those that encode IL-12 cytokine family subunits. Whereas positive TREM-1 outputs are abolished by the PI3K inhibitor wortmannin, this attenuation is largely PI3K-independent. These experiments provide a detailed analysis of the cellular consequences of TREM-1 activation, and highlight some of the complexity in signal integration between ITAM- and TLR-mediated signaling.					55532	146857	79812	81472	23418	100128909	8424	10633	253012	120376	57822	100287372	2642	83401	286826	57405	5189	7482	3671	223117	729887	79575	323	100130744	100130232	85456	6491	26531	54474	100505929	283585	84654	7125	128218	140469	256126	266671	124975	148109	6770	7363	440590	197350	3007	728882	990	28514	284244	100287569	54212	137970	54329	22829	3578	79690	5493	656	79763	401190	9540	124912	26539	51368	199699	149954	11318	4674	27122	140828	79447	8996	4589	54544	54084	2042	9865	729121	9701	79820	3868	9957	8549	642597	100293735	283038	29080	283385	90736	100130051	4846	5099	83903	133522	7123	57393	54830	285368	80740	51412	494150	54363	2263	10495	203274	196446	7571	2295	157310	5083	2487	79629	55366	160335	54777	51305	670	55552	285598	90632	724102	148824	128817	283869	285103	55163	57580	256979	93649	8631	100506054	284756	5455	64940	79801	100289210	100286844	79861	653190	203286	100129029	342574	60343	57658	166	79674	100271722	55876	84300	339231	154007	23109	80195	124602	26150	283337	158234	100128554	166863	9883	9924	84875	7982	57120	51478	6790	100507206	5091	80816	90865	171177	9031	85455	128854	4582	80781	375790	56992	283807	4051	80714	219293	338785	90594	388948	11284	11117	145407	100128071	5078	219902	2886	154761	4350	441245	51043	4336	79741	933	79774	6657
GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_UP	M5856		18292579	Dower K,Ellis DK,Saraf K,Jelinsky SA,Lin LL.	GSE9988	GSE9988_2040_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of monocytes treated with 5000 ng/ml LPS (TLR4 agonist) versus monocytes treated with anti-TREM1 [GeneID=54210].	TREM-1 is an orphan immunoreceptor expressed on monocytes, macrophages, and neutrophils. TREM-1 associates with and signals via the adapter protein DAP12/TYROBP, which contains an immunoreceptor tyrosine-based activation motif (ITAM). TREM-1 activation by receptor cross-linking is pro-inflammatory, and can amplify cellular responses to Toll-like receptor (TLR) ligands such as bacterial lipopolysaccharide (LPS). To investigate the cellular consequences of TREM-1 activation, we have characterized global gene expression changes in human monocytes in response to TREM-1 cross-linking in comparison to and combined with LPS. Both TREM-1 activation and LPS up-regulate chemokines, cytokines, matrix metalloproteases, and PTGS/COX2, consistent with a core inflammatory response. However, other immunomodulatory factors are selectively induced, including SPP1 and CSF1 (i.e., M-CSF) by TREM-1 activation and IL-23 and CSF3 (i.e., G-CSF) by LPS. Additionally, cross-talk between TREM-1 activation and LPS occurs on multiple levels. While synergy in GM-CSF protein production is reflected in commensurate mRNA abundance, comparable synergy in IL-1b protein production is not. TREM-1 activation also attenuates the induction of some LPS target genes, including those that encode IL-12 cytokine family subunits. Whereas positive TREM-1 outputs are abolished by the PI3K inhibitor wortmannin, this attenuation is largely PI3K-independent. These experiments provide a detailed analysis of the cellular consequences of TREM-1 activation, and highlight some of the complexity in signal integration between ITAM- and TLR-mediated signaling.					3055	3068	100	3759	116039	84875	57514	6624	144811	9852	255488	9641	27289	7128	7127	79666	651746	10236	3587	5724	8031	7764	23136	2867	118788	4947	4520	55284	54331	56935	51278	54462	2358	51199	54453	51284	10957	112495	27348	127544	58516	637	1500	1942	23118	51347	1389	27230	51311	94241	5795	10435	100128191	202309	29933	7408	283149	5687	7520	83605	5209	7474	1536	2885	92610	3344	256586	7360	647115	1326	81603	6368	57826	408	10049	6503	4082	25932	133686	2180	8289	731424	64332	3696	167227	11182	80183	23533	2643	5293	3659	64092	8125	55501	80818	285957	51561	5586	51	2919	6500	10938	23102	92	6346	3188	5728	3301	7409	10673	8879	5879	5149	10459	55696	24147	103	51316	100506013	9603	372	10318	958	4077	3604	23028	3593	147912	171024	23625	114897	330	27071	51014	8843	400617	5906	5142	81894	3752	730249	54880	148867	9435	8795	6233	83593	152926	8766	7048	4542	57093	9262	11329	54432	127687	9021	9823	222255	5359	3903	51808	4780	10924	6385	56006	441394	2140	55650	65108	4729	537	9444	10320	259307	81553	7057	29760	84458	5685	23031	84876	8638	7099	112574	10627	5326	51008	5872	2963	10283	64135	116844	329	8609	202781	9997	6734	22926	339344
GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_DN	M5857		18292579	Dower K,Ellis DK,Saraf K,Jelinsky SA,Lin LL.	GSE9988	GSE9988_2040_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of monocytes treated with 5000 ng/ml LPS (TLR4 agonist) versus monocytes treated with anti-TREM1 [GeneID=54210].	TREM-1 is an orphan immunoreceptor expressed on monocytes, macrophages, and neutrophils. TREM-1 associates with and signals via the adapter protein DAP12/TYROBP, which contains an immunoreceptor tyrosine-based activation motif (ITAM). TREM-1 activation by receptor cross-linking is pro-inflammatory, and can amplify cellular responses to Toll-like receptor (TLR) ligands such as bacterial lipopolysaccharide (LPS). To investigate the cellular consequences of TREM-1 activation, we have characterized global gene expression changes in human monocytes in response to TREM-1 cross-linking in comparison to and combined with LPS. Both TREM-1 activation and LPS up-regulate chemokines, cytokines, matrix metalloproteases, and PTGS/COX2, consistent with a core inflammatory response. However, other immunomodulatory factors are selectively induced, including SPP1 and CSF1 (i.e., M-CSF) by TREM-1 activation and IL-23 and CSF3 (i.e., G-CSF) by LPS. Additionally, cross-talk between TREM-1 activation and LPS occurs on multiple levels. While synergy in GM-CSF protein production is reflected in commensurate mRNA abundance, comparable synergy in IL-1b protein production is not. TREM-1 activation also attenuates the induction of some LPS target genes, including those that encode IL-12 cytokine family subunits. Whereas positive TREM-1 outputs are abolished by the PI3K inhibitor wortmannin, this attenuation is largely PI3K-independent. These experiments provide a detailed analysis of the cellular consequences of TREM-1 activation, and highlight some of the complexity in signal integration between ITAM- and TLR-mediated signaling.					10253	286223	4327	51530	8613	64112	51186	2181	10073	51422	255758	10221	8444	26175	467	950	9966	1601	375387	1903	388	56675	9451	4864	4929	9754	444	23099	51256	8553	51514	257364	79836	10007	122402	57600	27342	28231	81606	90956	8740	23207	89857	3687	59274	1306	2669	283050	64121	6446	6809	56253	23603	55148	56261	81501	6696	79670	10402	51611	6617	1514	100287719	1906	221710	51429	55151	84981	968	9903	4758	85012	1051	378805	65124	526	10215	1435	6810	51606	84868	9821	6236	4063	25798	6690	79149	157378	6447	7975	9531	406991	151534	57801	58528	25897	401588	6854	5996	79697	55344	26234	10615	9792	54971	23243	10602	8500	55357	6018	6520	100131998	2957	4312	9467	6654	133308	23307	7378	1230	93953	55257	54881	100132987	646329	100287039	9842	51078	55352	22836	1649	5468	23327	1407	813	55122	8491	23761	8061	51177	49854	154881	7100	8832	284266	1164	3708	131408	148479	8473	26525	55608	10672	5791	4023	9361	5054	219931	284454	23142	100288781	78999	203286	79729	157922	113675	4241	57583	90809	440400	1476	9705	109	54438	8310	81671	644815	8848	10560	6009	80218	8412	79720	5603	116988	7295	92597	57621	23125	11163	441478	51330	51382	2717	90	163882	55425	4319	10184	29959
GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_UP	M5858		18292579	Dower K,Ellis DK,Saraf K,Jelinsky SA,Lin LL.	GSE9988	GSE9988_2041_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of monocytes treated with 5000 ng/ml LPS (TLR4 agonist) versus monocytes treated with control IgG.	TREM-1 is an orphan immunoreceptor expressed on monocytes, macrophages, and neutrophils. TREM-1 associates with and signals via the adapter protein DAP12/TYROBP, which contains an immunoreceptor tyrosine-based activation motif (ITAM). TREM-1 activation by receptor cross-linking is pro-inflammatory, and can amplify cellular responses to Toll-like receptor (TLR) ligands such as bacterial lipopolysaccharide (LPS). To investigate the cellular consequences of TREM-1 activation, we have characterized global gene expression changes in human monocytes in response to TREM-1 cross-linking in comparison to and combined with LPS. Both TREM-1 activation and LPS up-regulate chemokines, cytokines, matrix metalloproteases, and PTGS/COX2, consistent with a core inflammatory response. However, other immunomodulatory factors are selectively induced, including SPP1 and CSF1 (i.e., M-CSF) by TREM-1 activation and IL-23 and CSF3 (i.e., G-CSF) by LPS. Additionally, cross-talk between TREM-1 activation and LPS occurs on multiple levels. While synergy in GM-CSF protein production is reflected in commensurate mRNA abundance, comparable synergy in IL-1b protein production is not. TREM-1 activation also attenuates the induction of some LPS target genes, including those that encode IL-12 cytokine family subunits. Whereas positive TREM-1 outputs are abolished by the PI3K inhibitor wortmannin, this attenuation is largely PI3K-independent. These experiments provide a detailed analysis of the cellular consequences of TREM-1 activation, and highlight some of the complexity in signal integration between ITAM- and TLR-mediated signaling.					9034	171024	646023	56300	84919	1647	54541	133	80149	1326	8870	114548	7262	5329	3569	3624	1844	29126	440934	7124	58515	9693	10289	64332	23011	64651	7803	649446	731424	9021	8767	221079	2114	25819	415116	1263	2643	5743	6478	5337	387763	338758	79931	1843	730249	5932	100302650	2633	983	79666	1958	55629	399	219333	2157	7128	8444	11080	134429	51561	23429	8837	6362	3383	23529	28984	374	119392	7832	3576	3398	4616	157739	597	116039	1906	283635	3586	57162	5277	2919	60485	330	51765	114614	84830	2920	5209	1655	6103	9766	1440	83597	9818	130367	2180	3552	27289	100128191	7130	24147	22936	10678	10485	9363	9308	4316	283416	8061	5271	1847	3606	7159	51458	4792	2309	4216	6776	7295	123879	7321	84777	50486	23327	5341	3183	285628	65072	5805	7809	23764	84991	5996	2634	2921	5966	5806	441072	100134229	5711	124637	57520	54331	266747	23645	92610	92162	84879	5252	1942	4082	7494	79693	23384	57826	91548	92345	3593	221830	3909	3759	23590	3097	114897	196441	144455	23306	1236	7163	5734	27299	55332	203859	366	10260	9589	646329	259230	6648	7037	23258	123872	9953	53831	54453	3553	10950	541472	1026	6351	6368	57830	54462	100289049	100506229	401588	441366	2867	3280	51347
GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_DN	M5859		18292579	Dower K,Ellis DK,Saraf K,Jelinsky SA,Lin LL.	GSE9988	GSE9988_2041_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of monocytes treated with 5000 ng/ml LPS (TLR4 agonist) versus monocytes treated with control IgG.	TREM-1 is an orphan immunoreceptor expressed on monocytes, macrophages, and neutrophils. TREM-1 associates with and signals via the adapter protein DAP12/TYROBP, which contains an immunoreceptor tyrosine-based activation motif (ITAM). TREM-1 activation by receptor cross-linking is pro-inflammatory, and can amplify cellular responses to Toll-like receptor (TLR) ligands such as bacterial lipopolysaccharide (LPS). To investigate the cellular consequences of TREM-1 activation, we have characterized global gene expression changes in human monocytes in response to TREM-1 cross-linking in comparison to and combined with LPS. Both TREM-1 activation and LPS up-regulate chemokines, cytokines, matrix metalloproteases, and PTGS/COX2, consistent with a core inflammatory response. However, other immunomodulatory factors are selectively induced, including SPP1 and CSF1 (i.e., M-CSF) by TREM-1 activation and IL-23 and CSF3 (i.e., G-CSF) by LPS. Additionally, cross-talk between TREM-1 activation and LPS occurs on multiple levels. While synergy in GM-CSF protein production is reflected in commensurate mRNA abundance, comparable synergy in IL-1b protein production is not. TREM-1 activation also attenuates the induction of some LPS target genes, including those that encode IL-12 cytokine family subunits. Whereas positive TREM-1 outputs are abolished by the PI3K inhibitor wortmannin, this attenuation is largely PI3K-independent. These experiments provide a detailed analysis of the cellular consequences of TREM-1 activation, and highlight some of the complexity in signal integration between ITAM- and TLR-mediated signaling.					51177	10550	79142	29959	7852	10422	10023	10106	23067	5049	51621	54838	80262	146923	58484	26100	55700	27106	23625	27166	284370	54440	29068	90231	3087	283489	9473	23608	90427	8427	54878	10095	64834	131474	7096	51780	55625	93129	126282	51696	3927	4668	4676	9665	54458	162427	10228	8816	23557	80331	11337	23326	64769	51734	1849	1912	51228	2971	50485	123920	11221	64784	27439	80301	7528	54861	9616	112616	1445	6877	9046	9668	283991	10475	10163	7769	1436	257106	1831	5899	51112	56970	23396	9416	2123	2733	23654	51231	84271	116985	4335	56984	5898	8683	10664	8314	25853	79447	10762	55911	9784	7555	1861	7942	51063	55737	64236	124460	9815	9960	10992	57680	11276	23401	7048	10226	5093	58191	9530	283871	283337	23636	55181	8507	867	9020	221937	84248	57136	24148	6248	2124	116138	25900	79137	58190	140460	1432	26112	25793	83786	729230	23317	8932	91582	4005	284058	51573	1318	9908	10287	8021	126364	162989	4218	8073	4542	5912	25920	7862	25988	10479	88455	127262	152006	392	221955	5511	91452	2747	255812	115509	23031	122961	7469	29109	409	23774	114885	2896	1979	5499	10902	8772	60626	23008	80228	22877	9337	90410	158	7884	6945	23054	23014	1192	841	79626	6942	57541
GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP	M5860		18292579	Dower K,Ellis DK,Saraf K,Jelinsky SA,Lin LL.	GSE9988	GSE9988_2042_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of monocytes treated with 1 ng/ml LPS (TLR4 agonist) versus untreated monocytes.	TREM-1 is an orphan immunoreceptor expressed on monocytes, macrophages, and neutrophils. TREM-1 associates with and signals via the adapter protein DAP12/TYROBP, which contains an immunoreceptor tyrosine-based activation motif (ITAM). TREM-1 activation by receptor cross-linking is pro-inflammatory, and can amplify cellular responses to Toll-like receptor (TLR) ligands such as bacterial lipopolysaccharide (LPS). To investigate the cellular consequences of TREM-1 activation, we have characterized global gene expression changes in human monocytes in response to TREM-1 cross-linking in comparison to and combined with LPS. Both TREM-1 activation and LPS up-regulate chemokines, cytokines, matrix metalloproteases, and PTGS/COX2, consistent with a core inflammatory response. However, other immunomodulatory factors are selectively induced, including SPP1 and CSF1 (i.e., M-CSF) by TREM-1 activation and IL-23 and CSF3 (i.e., G-CSF) by LPS. Additionally, cross-talk between TREM-1 activation and LPS occurs on multiple levels. While synergy in GM-CSF protein production is reflected in commensurate mRNA abundance, comparable synergy in IL-1b protein production is not. TREM-1 activation also attenuates the induction of some LPS target genes, including those that encode IL-12 cytokine family subunits. Whereas positive TREM-1 outputs are abolished by the PI3K inhibitor wortmannin, this attenuation is largely PI3K-independent. These experiments provide a detailed analysis of the cellular consequences of TREM-1 activation, and highlight some of the complexity in signal integration between ITAM- and TLR-mediated signaling.					3569	1647	56300	646023	5366	3624	23327	79931	10289	29126	731424	730249	80149	1326	9034	338758	1263	983	440934	2643	5743	7124	64651	7262	25819	6478	3552	3576	2919	114548	114614	399	5337	8837	1844	9693	7128	5329	84919	2114	23590	8444	415116	84879	2157	1906	54541	51561	8870	2180	7295	2921	366	3586	285628	6364	100302650	100134229	100128191	79693	130367	2920	133	24147	84777	11080	64332	221079	3398	387763	597	3606	60485	221830	1847	123872	154	4790	8767	8140	1843	6362	79666	8061	51429	441072	79850	5341	4216	891	3914	3553	7130	134429	374	124637	57713	119392	11040	7159	58515	219333	6648	649446	10260	153020	2669	6351	1236	27	339789	6776	3383	4316	9754	3183	9021	65072	4792	118430	27074	3593	7832	7803	10485	23306	330	490	220213	91283	23645	7163	57172	144455	50486	23258	6103	84807	100289049	84830	401588	9818	53831	6880	8972	90874	5687	1655	1958	9308	4616	283416	123879	57162	100506229	54726	57520	5806	23189	10678	5966	3559	92162	27289	541472	23135	51765	7494	3601	92610	84991	838	285848	84230	753	2867	51465	5271	9363	23764	118788	57823	3725	348938	55332	445347	57600	79094	6368	79993	23429	157739	100287039	6675	259230	3386	9414	7127	92345	4772
GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN	M5861		18292579	Dower K,Ellis DK,Saraf K,Jelinsky SA,Lin LL.	GSE9988	GSE9988_2042_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of monocytes treated with 1 ng/ml LPS (TLR4 agonist) versus untreated monocytes.	TREM-1 is an orphan immunoreceptor expressed on monocytes, macrophages, and neutrophils. TREM-1 associates with and signals via the adapter protein DAP12/TYROBP, which contains an immunoreceptor tyrosine-based activation motif (ITAM). TREM-1 activation by receptor cross-linking is pro-inflammatory, and can amplify cellular responses to Toll-like receptor (TLR) ligands such as bacterial lipopolysaccharide (LPS). To investigate the cellular consequences of TREM-1 activation, we have characterized global gene expression changes in human monocytes in response to TREM-1 cross-linking in comparison to and combined with LPS. Both TREM-1 activation and LPS up-regulate chemokines, cytokines, matrix metalloproteases, and PTGS/COX2, consistent with a core inflammatory response. However, other immunomodulatory factors are selectively induced, including SPP1 and CSF1 (i.e., M-CSF) by TREM-1 activation and IL-23 and CSF3 (i.e., G-CSF) by LPS. Additionally, cross-talk between TREM-1 activation and LPS occurs on multiple levels. While synergy in GM-CSF protein production is reflected in commensurate mRNA abundance, comparable synergy in IL-1b protein production is not. TREM-1 activation also attenuates the induction of some LPS target genes, including those that encode IL-12 cytokine family subunits. Whereas positive TREM-1 outputs are abolished by the PI3K inhibitor wortmannin, this attenuation is largely PI3K-independent. These experiments provide a detailed analysis of the cellular consequences of TREM-1 activation, and highlight some of the complexity in signal integration between ITAM- and TLR-mediated signaling.					10287	7852	1192	11337	2896	2137	10437	79626	56970	51063	84687	7096	64943	123920	1849	28956	8428	7045	5451	27439	1445	11344	23406	4542	5660	57215	90427	79447	6942	10023	23067	9046	286336	6389	54440	22809	1512	9595	25778	6155	65996	3956	60436	7805	79142	4215	10550	58190	6002	54838	257106	27166	7942	80301	116985	23514	201176	27106	23654	50485	11031	6613	116138	221955	8655	80256	58191	4066	2123	8073	9031	58484	6195	170954	10422	27327	5093	91662	283871	7305	391	10228	23031	5912	64834	55898	8724	10095	51228	5813	10044	283337	1059	84440	864	51696	2752	2022	25798	57701	284013	10869	23526	29946	403	2950	1912	219972	55737	9612	729230	51621	23787	64421	80262	10126	23463	25853	1524	5499	55625	8934	79065	4350	54491	22877	5210	23008	118472	10106	8507	4782	56946	3087	81609	55756	23396	79018	93129	55969	841	4218	5914	10226	54458	115752	5293	25900	54521	100113407	8417	54	5094	9466	23625	392	84336	7132	8019	51177	84309	6455	1436	729683	55911	55700	997	8703	26953	58504	7077	84260	54518	8793	3140	10521	23326	8992	6794	168544	57217	6867	51112	11151	9815	6282	146542	10460	1831	23401	26100	3727	283489	100009676	338692	138151	7469	64114	8525	162417
GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP	M5862		18292579	Dower K,Ellis DK,Saraf K,Jelinsky SA,Lin LL.	GSE9988	GSE9988_2043_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of monocytes treated with 1 ng/ml LPS (TLR4 agonist) versus monocytes treated with anti-TREM1 [GeneID=54210] and 5000 ng/ml LPS (TLR4 agonist).	TREM-1 is an orphan immunoreceptor expressed on monocytes, macrophages, and neutrophils. TREM-1 associates with and signals via the adapter protein DAP12/TYROBP, which contains an immunoreceptor tyrosine-based activation motif (ITAM). TREM-1 activation by receptor cross-linking is pro-inflammatory, and can amplify cellular responses to Toll-like receptor (TLR) ligands such as bacterial lipopolysaccharide (LPS). To investigate the cellular consequences of TREM-1 activation, we have characterized global gene expression changes in human monocytes in response to TREM-1 cross-linking in comparison to and combined with LPS. Both TREM-1 activation and LPS up-regulate chemokines, cytokines, matrix metalloproteases, and PTGS/COX2, consistent with a core inflammatory response. However, other immunomodulatory factors are selectively induced, including SPP1 and CSF1 (i.e., M-CSF) by TREM-1 activation and IL-23 and CSF3 (i.e., G-CSF) by LPS. Additionally, cross-talk between TREM-1 activation and LPS occurs on multiple levels. While synergy in GM-CSF protein production is reflected in commensurate mRNA abundance, comparable synergy in IL-1b protein production is not. TREM-1 activation also attenuates the induction of some LPS target genes, including those that encode IL-12 cytokine family subunits. Whereas positive TREM-1 outputs are abolished by the PI3K inhibitor wortmannin, this attenuation is largely PI3K-independent. These experiments provide a detailed analysis of the cellular consequences of TREM-1 activation, and highlight some of the complexity in signal integration between ITAM- and TLR-mediated signaling.					3068	27289	84875	9852	4947	8031	23136	100	7127	7128	3759	3587	118788	114908	79666	255488	6624	51278	408	2358	51347	651746	4084	5142	57514	10957	2783	731424	5209	65108	11182	2885	10938	10435	51561	92610	5819	285957	79690	94241	5724	598	8289	50604	4780	1942	54453	64092	4520	9641	56935	25932	112495	3036	171024	259307	2140	7408	5795	7057	7360	202309	1326	51199	80818	9262	9435	2867	8843	8879	388685	160335	3659	83874	80183	2180	54331	147912	5687	2919	222255	55696	144811	148867	9444	10318	7764	1265	127544	3301	84893	6503	51316	7048	64332	1500	6776	79015	637	81553	1536	51311	1389	29933	7409	283149	23533	7520	57007	3593	125	7841	256586	23118	23048	10049	391	2907	10148	83593	116039	10236	54918	57826	23625	647115	10288	8795	57720	58516	168455	27348	6368	8676	23028	3604	10154	54462	440934	330	123879	5663	730249	3738	54455	8638	1240	352961	1992	24147	1440	3903	10807	57655	2022	5970	58480	3696	147650	55284	137682	26253	56006	9662	167227	7099	8125	255231	8717	140885	9050	81492	9322	2359	2643	537	55144	64768	203859	100302650	92	400617	8609	11329	6346	27230	9683	4615	79931	114548	162	6507	56829	10485	64951	9295	96764	54875	2146	4077
GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_DN	M5865		18292579	Dower K,Ellis DK,Saraf K,Jelinsky SA,Lin LL.	GSE9988	GSE9988_2043_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of monocytes treated with 1 ng/ml LPS (TLR4 agonist) versus monocytes treated with anti-TREM1 [GeneID=54210] and 5000 ng/ml LPS (TLR4 agonist).	TREM-1 is an orphan immunoreceptor expressed on monocytes, macrophages, and neutrophils. TREM-1 associates with and signals via the adapter protein DAP12/TYROBP, which contains an immunoreceptor tyrosine-based activation motif (ITAM). TREM-1 activation by receptor cross-linking is pro-inflammatory, and can amplify cellular responses to Toll-like receptor (TLR) ligands such as bacterial lipopolysaccharide (LPS). To investigate the cellular consequences of TREM-1 activation, we have characterized global gene expression changes in human monocytes in response to TREM-1 cross-linking in comparison to and combined with LPS. Both TREM-1 activation and LPS up-regulate chemokines, cytokines, matrix metalloproteases, and PTGS/COX2, consistent with a core inflammatory response. However, other immunomodulatory factors are selectively induced, including SPP1 and CSF1 (i.e., M-CSF) by TREM-1 activation and IL-23 and CSF3 (i.e., G-CSF) by LPS. Additionally, cross-talk between TREM-1 activation and LPS occurs on multiple levels. While synergy in GM-CSF protein production is reflected in commensurate mRNA abundance, comparable synergy in IL-1b protein production is not. TREM-1 activation also attenuates the induction of some LPS target genes, including those that encode IL-12 cytokine family subunits. Whereas positive TREM-1 outputs are abolished by the PI3K inhibitor wortmannin, this attenuation is largely PI3K-independent. These experiments provide a detailed analysis of the cellular consequences of TREM-1 activation, and highlight some of the complexity in signal integration between ITAM- and TLR-mediated signaling.					10253	286223	28231	51422	255758	2181	283050	55151	950	51530	10073	1601	4864	89857	8613	10215	4758	9966	4327	64112	1903	444	375387	64121	131408	6809	10007	57600	8740	51514	8500	51256	56675	25798	6446	2669	5468	9467	6696	58528	6810	23207	59274	467	51429	23243	51606	57801	8444	55148	90956	26175	1306	9754	646329	56253	9451	23142	2957	51078	22836	10221	8491	4312	7100	7975	10402	151534	51186	526	81606	401588	23761	84868	56261	157378	100131998	1230	79149	1435	10602	5525	81501	54438	55608	26234	23167	257364	378805	54881	9749	221710	55357	79697	26525	122402	1051	65124	23603	29886	4241	1906	1514	23307	55344	10615	100132987	4063	8553	9903	29919	84959	388	54971	23099	203197	90	100287719	79836	55352	8832	92597	133308	6617	6236	24149	9842	148479	26043	6447	85012	245972	25897	6854	9792	55257	4493	5791	51382	100130357	8412	154092	10184	1476	6690	9361	23125	6520	27342	201283	5054	113675	6018	22856	3958	4929	63917	1649	642	116988	3687	55361	79794	80218	54822	6654	9705	8310	57583	5996	9550	54877	1407	64783	10672	7378	10953	4502	11163	2055	29062	51611	5244	8411	645745	6273	55122	11072	54532	1959	55248	4023	284266	79670	57590	4501	153020	813	23507	203100
GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_UP	M5867		18292579	Dower K,Ellis DK,Saraf K,Jelinsky SA,Lin LL.	GSE9988	GSE9988_2044_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of monocytes treated with 1 ng/ml LPS (TLR4 agonist) versus monocytes treated with control IgG.	TREM-1 is an orphan immunoreceptor expressed on monocytes, macrophages, and neutrophils. TREM-1 associates with and signals via the adapter protein DAP12/TYROBP, which contains an immunoreceptor tyrosine-based activation motif (ITAM). TREM-1 activation by receptor cross-linking is pro-inflammatory, and can amplify cellular responses to Toll-like receptor (TLR) ligands such as bacterial lipopolysaccharide (LPS). To investigate the cellular consequences of TREM-1 activation, we have characterized global gene expression changes in human monocytes in response to TREM-1 cross-linking in comparison to and combined with LPS. Both TREM-1 activation and LPS up-regulate chemokines, cytokines, matrix metalloproteases, and PTGS/COX2, consistent with a core inflammatory response. However, other immunomodulatory factors are selectively induced, including SPP1 and CSF1 (i.e., M-CSF) by TREM-1 activation and IL-23 and CSF3 (i.e., G-CSF) by LPS. Additionally, cross-talk between TREM-1 activation and LPS occurs on multiple levels. While synergy in GM-CSF protein production is reflected in commensurate mRNA abundance, comparable synergy in IL-1b protein production is not. TREM-1 activation also attenuates the induction of some LPS target genes, including those that encode IL-12 cytokine family subunits. Whereas positive TREM-1 outputs are abolished by the PI3K inhibitor wortmannin, this attenuation is largely PI3K-independent. These experiments provide a detailed analysis of the cellular consequences of TREM-1 activation, and highlight some of the complexity in signal integration between ITAM- and TLR-mediated signaling.					9034	80149	56300	1844	114548	2152	3569	221079	5329	84919	7262	58515	7124	54541	338758	415116	64332	387763	3624	646023	1647	9693	5743	1326	134429	731424	374	1263	440934	6478	133	2114	649446	8870	29126	8767	1958	64651	3398	4616	100302650	7128	8837	3606	3383	119392	84830	7803	3183	730249	983	219333	1843	123879	3576	9021	51561	60485	2643	79666	23529	597	339789	79931	23429	11080	5209	2920	2633	51365	23258	2919	144455	399	6776	10289	3586	114614	1906	25819	5932	5966	4792	7130	130367	1847	9308	7159	9766	57162	124637	2956	3552	27289	330	9818	84777	8061	6362	3097	7295	100134229	10678	50486	5341	5805	5711	283416	100506229	5337	57520	203859	2921	2180	1440	92610	5277	7832	84879	285628	9754	3164	54206	1236	92345	59274	2069	23590	51765	2710	401588	9819	441366	23011	79693	91548	23306	4216	10260	4780	23764	6324	53831	6385	5142	25802	5806	4790	9589	2157	3553	221830	9181	29080	7037	100289049	22936	3280	92162	4316	8013	3725	8444	2634	4683	5271	23645	6103	6648	57713	51347	123872	366	57655	6364	90167	220213	6351	5734	1655	55916	23327	10950	838	51458	50604	4929	7163	27299	6374	2713	91283	7321	9322	3036	5996	400410	28984	1960	3559
GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_DN	M5870		18292579	Dower K,Ellis DK,Saraf K,Jelinsky SA,Lin LL.	GSE9988	GSE9988_2044_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of monocytes treated with 1 ng/ml LPS (TLR4 agonist) versus monocytes treated with control IgG.	TREM-1 is an orphan immunoreceptor expressed on monocytes, macrophages, and neutrophils. TREM-1 associates with and signals via the adapter protein DAP12/TYROBP, which contains an immunoreceptor tyrosine-based activation motif (ITAM). TREM-1 activation by receptor cross-linking is pro-inflammatory, and can amplify cellular responses to Toll-like receptor (TLR) ligands such as bacterial lipopolysaccharide (LPS). To investigate the cellular consequences of TREM-1 activation, we have characterized global gene expression changes in human monocytes in response to TREM-1 cross-linking in comparison to and combined with LPS. Both TREM-1 activation and LPS up-regulate chemokines, cytokines, matrix metalloproteases, and PTGS/COX2, consistent with a core inflammatory response. However, other immunomodulatory factors are selectively induced, including SPP1 and CSF1 (i.e., M-CSF) by TREM-1 activation and IL-23 and CSF3 (i.e., G-CSF) by LPS. Additionally, cross-talk between TREM-1 activation and LPS occurs on multiple levels. While synergy in GM-CSF protein production is reflected in commensurate mRNA abundance, comparable synergy in IL-1b protein production is not. TREM-1 activation also attenuates the induction of some LPS target genes, including those that encode IL-12 cytokine family subunits. Whereas positive TREM-1 outputs are abolished by the PI3K inhibitor wortmannin, this attenuation is largely PI3K-independent. These experiments provide a detailed analysis of the cellular consequences of TREM-1 activation, and highlight some of the complexity in signal integration between ITAM- and TLR-mediated signaling.					79142	10106	25793	80262	7852	27106	23067	10023	1912	55625	146923	26100	90427	25853	10550	54440	58191	64834	23326	55700	80335	55737	25988	51177	51696	90231	10521	23054	123920	7375	2733	11276	79065	27166	4335	10422	84440	5049	80331	283489	10664	9815	51621	7862	54838	23625	29959	6667	57541	10163	6867	7596	93129	255812	126282	10902	7096	58484	131474	8073	8683	80301	23438	55182	3087	54878	23608	10095	10044	284058	23401	11337	8021	10992	64784	9665	9020	5898	51063	10762	25778	1861	6942	10228	23654	9473	1831	56984	9046	90120	93183	22838	162427	8932	7770	51112	25920	835	8507	1849	51573	9784	51719	2896	283871	257106	25900	140460	114885	29960	10287	867	1445	5829	54458	51780	10238	7528	23317	9530	155038	65988	84271	6877	80228	23168	79626	29109	7769	9960	51185	221937	6780	5912	55069	1436	91	10475	7942	9126	91662	55758	29068	92806	56674	79447	283991	7090	1318	729230	6311	51528	9416	25798	152006	55109	54870	7555	122961	64411	116448	80196	55818	26000	23396	79188	58190	23369	162073	57215	51734	5813	7048	57680	4676	10437	3927	55911	253260	116138	27439	57470	8427	148254	5093	92912	150290	841	127262	5001	221955	8816	678	5511	286336	9668	4218	11285	64769	84678
GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP	M5873		18292579	Dower K,Ellis DK,Saraf K,Jelinsky SA,Lin LL.	GSE9988	GSE9988_2045_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of monocytes treated with 1 ng/ml LPS (TLR4 agonist) versus untreated monocytes.	TREM-1 is an orphan immunoreceptor expressed on monocytes, macrophages, and neutrophils. TREM-1 associates with and signals via the adapter protein DAP12/TYROBP, which contains an immunoreceptor tyrosine-based activation motif (ITAM). TREM-1 activation by receptor cross-linking is pro-inflammatory, and can amplify cellular responses to Toll-like receptor (TLR) ligands such as bacterial lipopolysaccharide (LPS). To investigate the cellular consequences of TREM-1 activation, we have characterized global gene expression changes in human monocytes in response to TREM-1 cross-linking in comparison to and combined with LPS. Both TREM-1 activation and LPS up-regulate chemokines, cytokines, matrix metalloproteases, and PTGS/COX2, consistent with a core inflammatory response. However, other immunomodulatory factors are selectively induced, including SPP1 and CSF1 (i.e., M-CSF) by TREM-1 activation and IL-23 and CSF3 (i.e., G-CSF) by LPS. Additionally, cross-talk between TREM-1 activation and LPS occurs on multiple levels. While synergy in GM-CSF protein production is reflected in commensurate mRNA abundance, comparable synergy in IL-1b protein production is not. TREM-1 activation also attenuates the induction of some LPS target genes, including those that encode IL-12 cytokine family subunits. Whereas positive TREM-1 outputs are abolished by the PI3K inhibitor wortmannin, this attenuation is largely PI3K-independent. These experiments provide a detailed analysis of the cellular consequences of TREM-1 activation, and highlight some of the complexity in signal integration between ITAM- and TLR-mediated signaling.					5366	56300	338758	2152	1647	731424	9034	80149	730249	1263	5743	3624	114548	646023	440934	79931	1844	29126	7124	1326	983	415116	6478	8837	339789	3606	3552	7262	387763	2919	64651	2921	23590	7128	114614	84879	10289	3576	84919	9693	1906	60485	7295	221079	100134229	64332	5329	285628	23327	3183	374	3398	2920	6364	2643	2114	100302650	51561	79693	8140	1847	54541	2180	124637	597	130367	399	25819	366	84777	51429	133	4790	9754	58515	3586	23258	134429	123872	11080	221830	8061	1843	144455	119392	3914	8870	57713	8767	6776	3553	5341	7159	7130	154	10260	51365	3383	79666	649446	1236	219333	6351	123879	4216	2669	5337	4616	11040	100506229	4792	23306	838	91283	6648	84830	374443	153020	2157	10678	9308	8972	27	6362	9021	5966	401588	27074	8444	50486	57520	220213	203859	3601	53831	100289049	3725	1958	79850	330	27289	133308	100287039	490	9818	2710	23189	6385	24147	441072	92610	2069	7803	50604	57823	5711	57162	3559	283416	23645	753	6880	7163	118788	5271	51465	79993	23429	4047	4316	5008	84807	9052	1845	84099	5806	54206	7127	3593	441366	51765	6374	4772	57655	2706	6103	23135	4780	5805	8439	23764	84444	92345	8744	57600	6775	5025	344887	3097	55332
GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN	M5874		18292579	Dower K,Ellis DK,Saraf K,Jelinsky SA,Lin LL.	GSE9988	GSE9988_2045_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of monocytes treated with 1 ng/ml LPS (TLR4 agonist) versus untreated monocytes.	TREM-1 is an orphan immunoreceptor expressed on monocytes, macrophages, and neutrophils. TREM-1 associates with and signals via the adapter protein DAP12/TYROBP, which contains an immunoreceptor tyrosine-based activation motif (ITAM). TREM-1 activation by receptor cross-linking is pro-inflammatory, and can amplify cellular responses to Toll-like receptor (TLR) ligands such as bacterial lipopolysaccharide (LPS). To investigate the cellular consequences of TREM-1 activation, we have characterized global gene expression changes in human monocytes in response to TREM-1 cross-linking in comparison to and combined with LPS. Both TREM-1 activation and LPS up-regulate chemokines, cytokines, matrix metalloproteases, and PTGS/COX2, consistent with a core inflammatory response. However, other immunomodulatory factors are selectively induced, including SPP1 and CSF1 (i.e., M-CSF) by TREM-1 activation and IL-23 and CSF3 (i.e., G-CSF) by LPS. Additionally, cross-talk between TREM-1 activation and LPS occurs on multiple levels. While synergy in GM-CSF protein production is reflected in commensurate mRNA abundance, comparable synergy in IL-1b protein production is not. TREM-1 activation also attenuates the induction of some LPS target genes, including those that encode IL-12 cytokine family subunits. Whereas positive TREM-1 outputs are abolished by the PI3K inhibitor wortmannin, this attenuation is largely PI3K-independent. These experiments provide a detailed analysis of the cellular consequences of TREM-1 activation, and highlight some of the complexity in signal integration between ITAM- and TLR-mediated signaling.					10287	7852	2896	11337	84440	57215	10437	123920	25778	7805	51063	1192	79626	6942	10023	7096	23067	58191	286336	90427	1849	10044	8428	25798	10521	1445	6389	65996	11334	5451	10869	79065	8655	64834	7045	9046	55737	8073	54440	80301	6195	27106	7942	64943	1508	28956	3516	84687	6156	7355	79142	2137	91662	1912	79018	27439	864	10126	6837	219972	25853	23654	170954	80262	6282	6794	6613	29946	27166	116138	10215	221955	56970	6002	201176	283871	5912	55969	9827	23787	5660	54838	5813	80256	55625	10550	25793	23401	64114	55700	9595	4066	8507	55339	6155	1059	2023	257106	64430	6867	729230	3663	84260	9741	29960	11031	25900	58190	80335	1524	5898	54521	79447	23326	8683	10106	8724	93129	5210	284323	5829	8445	9802	10095	29090	283489	1512	5499	58484	93621	100113407	3955	79930	9025	22809	5093	9815	3087	1230	4215	23463	391	5914	27327	155038	9466	2876	84895	23396	9681	55182	6874	7132	55911	29893	26100	6277	148254	23031	2123	7305	80331	8021	10228	4542	54491	54518	80228	24149	23514	5175	60436	4782	26953	146542	5166	7469	25988	51112	4335	9031	7532	51696	10422	11344	841	116448	126282	51386	255812	51621	51147	1831	221937	55051	829	51528	79567	3927	23008
GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_UP	M5875		18292579	Dower K,Ellis DK,Saraf K,Jelinsky SA,Lin LL.	GSE9988	GSE9988_2046_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] and 5000 ng/ml LPS (TLR4 agonist) versus monocytes treated with control IgG.	TREM-1 is an orphan immunoreceptor expressed on monocytes, macrophages, and neutrophils. TREM-1 associates with and signals via the adapter protein DAP12/TYROBP, which contains an immunoreceptor tyrosine-based activation motif (ITAM). TREM-1 activation by receptor cross-linking is pro-inflammatory, and can amplify cellular responses to Toll-like receptor (TLR) ligands such as bacterial lipopolysaccharide (LPS). To investigate the cellular consequences of TREM-1 activation, we have characterized global gene expression changes in human monocytes in response to TREM-1 cross-linking in comparison to and combined with LPS. Both TREM-1 activation and LPS up-regulate chemokines, cytokines, matrix metalloproteases, and PTGS/COX2, consistent with a core inflammatory response. However, other immunomodulatory factors are selectively induced, including SPP1 and CSF1 (i.e., M-CSF) by TREM-1 activation and IL-23 and CSF3 (i.e., G-CSF) by LPS. Additionally, cross-talk between TREM-1 activation and LPS occurs on multiple levels. While synergy in GM-CSF protein production is reflected in commensurate mRNA abundance, comparable synergy in IL-1b protein production is not. TREM-1 activation also attenuates the induction of some LPS target genes, including those that encode IL-12 cytokine family subunits. Whereas positive TREM-1 outputs are abolished by the PI3K inhibitor wortmannin, this attenuation is largely PI3K-independent. These experiments provide a detailed analysis of the cellular consequences of TREM-1 activation, and highlight some of the complexity in signal integration between ITAM- and TLR-mediated signaling.					9034	401588	3569	5329	84830	10253	134429	1906	9966	5366	344887	2114	8444	56300	4319	7295	3624	10615	7803	2181	3586	646023	28231	2717	221079	8061	1843	28984	1844	57801	3725	54532	255758	26175	7124	9754	5743	1847	6809	219333	64651	54541	9451	58515	80149	6016	144455	10402	100287039	64332	10979	338758	9693	387763	57520	9749	1958	80219	415116	171024	100134229	133	4929	114548	79094	59274	27342	6478	257364	64112	1647	93953	6362	25819	3280	8439	7037	7262	8473	339789	5996	84777	9818	140809	444	4758	133308	84919	23429	1164	9903	100130992	10678	4616	23529	4312	2920	23327	731424	10007	54971	6520	9456	5932	5805	96626	85480	8870	79134	23507	3576	8837	2669	26525	3164	4864	91283	286223	10073	1839	9819	5337	3606	9052	57600	29948	6617	84085	114614	2730	11080	51561	1440	3398	51606	153020	2157	8553	100287719	378805	2321	124637	54407	7975	83597	5597	9043	734	10560	51365	1435	9021	83667	401317	81501	6103	375387	23011	7071	5292	55728	29126	112399	6322	2957	1263	131408	5734	65072	196441	119392	7159	51530	51585	5861	3552	54206	89857	1316	51514	84981	6446	10260	29080	8767	1236	51186	51256	55151	81606	51429	441366	1326	60485	92162	1026	6515	100302650	27	730092
GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_DN	M5877		18292579	Dower K,Ellis DK,Saraf K,Jelinsky SA,Lin LL.	GSE9988	GSE9988_2046_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] and 5000 ng/ml LPS (TLR4 agonist) versus monocytes treated with control IgG.	TREM-1 is an orphan immunoreceptor expressed on monocytes, macrophages, and neutrophils. TREM-1 associates with and signals via the adapter protein DAP12/TYROBP, which contains an immunoreceptor tyrosine-based activation motif (ITAM). TREM-1 activation by receptor cross-linking is pro-inflammatory, and can amplify cellular responses to Toll-like receptor (TLR) ligands such as bacterial lipopolysaccharide (LPS). To investigate the cellular consequences of TREM-1 activation, we have characterized global gene expression changes in human monocytes in response to TREM-1 cross-linking in comparison to and combined with LPS. Both TREM-1 activation and LPS up-regulate chemokines, cytokines, matrix metalloproteases, and PTGS/COX2, consistent with a core inflammatory response. However, other immunomodulatory factors are selectively induced, including SPP1 and CSF1 (i.e., M-CSF) by TREM-1 activation and IL-23 and CSF3 (i.e., G-CSF) by LPS. Additionally, cross-talk between TREM-1 activation and LPS occurs on multiple levels. While synergy in GM-CSF protein production is reflected in commensurate mRNA abundance, comparable synergy in IL-1b protein production is not. TREM-1 activation also attenuates the induction of some LPS target genes, including those that encode IL-12 cytokine family subunits. Whereas positive TREM-1 outputs are abolished by the PI3K inhibitor wortmannin, this attenuation is largely PI3K-independent. These experiments provide a detailed analysis of the cellular consequences of TREM-1 activation, and highlight some of the complexity in signal integration between ITAM- and TLR-mediated signaling.					23625	10550	55700	131474	90231	123920	7096	90427	51621	79142	23067	9960	10106	54440	8289	1436	162427	27166	1445	5049	4297	51696	22992	23326	162417	9815	10023	27106	10095	54878	23031	5813	867	126282	8427	754	4542	54458	9473	23014	64943	5978	80262	5499	55625	2783	84271	26100	3587	29068	57680	11337	25962	80301	221955	25853	54838	284370	80335	58191	2022	25920	55911	90120	1861	3087	114885	83605	80228	7707	23054	7048	10859	1432	8405	1912	56984	55182	10521	155038	9371	64834	9416	84811	11344	93183	55737	2733	55745	8683	27013	8907	1500	5293	257106	10287	64784	23608	10869	10238	51780	4335	26130	51324	10422	51528	9020	9520	4676	100288617	152006	7770	80818	7852	7529	10226	10992	10664	56970	5431	4076	202309	7903	140460	4218	7469	10228	392	283489	51063	391	29066	23401	729230	4088	81603	50485	221937	6867	57136	84440	57591	51493	285672	10902	2768	65108	409	1173	11151	5434	7528	22809	2517	65018	8799	100129034	283357	9682	6195	126364	3071	8899	51228	5898	58190	9595	10475	22838	23654	9665	8428	9337	3611	2665	2124	678	57215	6877	26020	5199	1478	4779	29109	8507	23396	374655	88455	8021	51231	997	58484	8567	841	80700	1487	6780	22877	1849	10044
GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_UP	M5878		18292579	Dower K,Ellis DK,Saraf K,Jelinsky SA,Lin LL.	GSE9988	GSE9988_2047_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] and 5000 ng/ml LPS (TLR4 agonist) versus untreated monocytes.	TREM-1 is an orphan immunoreceptor expressed on monocytes, macrophages, and neutrophils. TREM-1 associates with and signals via the adapter protein DAP12/TYROBP, which contains an immunoreceptor tyrosine-based activation motif (ITAM). TREM-1 activation by receptor cross-linking is pro-inflammatory, and can amplify cellular responses to Toll-like receptor (TLR) ligands such as bacterial lipopolysaccharide (LPS). To investigate the cellular consequences of TREM-1 activation, we have characterized global gene expression changes in human monocytes in response to TREM-1 cross-linking in comparison to and combined with LPS. Both TREM-1 activation and LPS up-regulate chemokines, cytokines, matrix metalloproteases, and PTGS/COX2, consistent with a core inflammatory response. However, other immunomodulatory factors are selectively induced, including SPP1 and CSF1 (i.e., M-CSF) by TREM-1 activation and IL-23 and CSF3 (i.e., G-CSF) by LPS. Additionally, cross-talk between TREM-1 activation and LPS occurs on multiple levels. While synergy in GM-CSF protein production is reflected in commensurate mRNA abundance, comparable synergy in IL-1b protein production is not. TREM-1 activation also attenuates the induction of some LPS target genes, including those that encode IL-12 cytokine family subunits. Whereas positive TREM-1 outputs are abolished by the PI3K inhibitor wortmannin, this attenuation is largely PI3K-independent. These experiments provide a detailed analysis of the cellular consequences of TREM-1 activation, and highlight some of the complexity in signal integration between ITAM- and TLR-mediated signaling.					8444	344887	100287039	3624	9966	171024	2152	10253	133308	286223	7295	2730	401588	56300	9034	3586	100287719	646023	100134229	4319	9754	5366	731424	8061	28231	338758	5743	10615	2669	140809	79094	23327	84830	1847	2114	3725	51429	64651	153020	6520	114614	1647	646329	6009	2717	5329	339789	84777	255758	7124	100130992	144455	80149	154	1843	415116	3576	9903	6236	27	8900	8439	57520	23590	3552	26175	3606	2920	9052	2921	6696	4312	91283	10402	387763	221079	1263	25819	134429	6478	10979	1476	55344	8837	444	9451	7296	124637	6364	4864	29126	9693	1164	6880	51465	2157	10260	4758	84879	114548	6322	5731	54532	4327	6690	6362	5025	22845	1844	51561	5337	85480	8972	83667	7262	54541	5468	1514	8140	57600	56155	79693	440	283050	1435	195827	51514	366	734	1236	133	51530	6617	64332	3398	7803	81501	3553	7159	54407	57713	84919	84085	10073	6810	64112	6016	79149	60485	9456	23507	9043	100505881	7378	26525	54726	11080	374443	65072	5028	2617	93953	51256	5341	1958	753	58515	1903	493861	112399	51175	92181	23243	8870	100130357	1326	730249	10007	2181	219333	285628	9705	401317	100288781	348938	5597	729678	79931	2919	28984	23429	8613	130367	166929	983	3638	490	118430	54971	119392
GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_DN	M5879		18292579	Dower K,Ellis DK,Saraf K,Jelinsky SA,Lin LL.	GSE9988	GSE9988_2047_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] and 5000 ng/ml LPS (TLR4 agonist) versus untreated monocytes.	TREM-1 is an orphan immunoreceptor expressed on monocytes, macrophages, and neutrophils. TREM-1 associates with and signals via the adapter protein DAP12/TYROBP, which contains an immunoreceptor tyrosine-based activation motif (ITAM). TREM-1 activation by receptor cross-linking is pro-inflammatory, and can amplify cellular responses to Toll-like receptor (TLR) ligands such as bacterial lipopolysaccharide (LPS). To investigate the cellular consequences of TREM-1 activation, we have characterized global gene expression changes in human monocytes in response to TREM-1 cross-linking in comparison to and combined with LPS. Both TREM-1 activation and LPS up-regulate chemokines, cytokines, matrix metalloproteases, and PTGS/COX2, consistent with a core inflammatory response. However, other immunomodulatory factors are selectively induced, including SPP1 and CSF1 (i.e., M-CSF) by TREM-1 activation and IL-23 and CSF3 (i.e., G-CSF) by LPS. Additionally, cross-talk between TREM-1 activation and LPS occurs on multiple levels. While synergy in GM-CSF protein production is reflected in commensurate mRNA abundance, comparable synergy in IL-1b protein production is not. TREM-1 activation also attenuates the induction of some LPS target genes, including those that encode IL-12 cytokine family subunits. Whereas positive TREM-1 outputs are abolished by the PI3K inhibitor wortmannin, this attenuation is largely PI3K-independent. These experiments provide a detailed analysis of the cellular consequences of TREM-1 activation, and highlight some of the complexity in signal integration between ITAM- and TLR-mediated signaling.					10287	64943	11337	7096	65996	123920	11344	65108	10869	8428	9595	57215	391	56970	22809	6613	2022	5451	23067	79626	90427	221955	6389	27166	23533	2023	51063	9641	2783	7529	5813	7852	202309	5660	83593	219972	2896	54440	84687	10550	170954	58191	100288617	8655	7045	1192	25778	864	10126	6195	2359	58504	5879	408	1445	84440	4542	2137	27327	10023	80818	23406	5499	162417	23031	3663	3956	54491	7805	10437	2517	4215	1849	83605	10044	9123	10521	54838	6155	997	116844	10095	5293	286336	1524	84811	4946	201176	754	11334	7532	64834	54	25853	11031	729230	9466	6942	80301	55737	55051	116138	27106	60436	91662	257106	79690	929	8683	867	55700	7469	84464	79447	25777	51621	1436	2014	5819	55911	23625	2665	57701	155038	9770	6867	3140	11151	403	8793	84629	84895	3955	3055	50485	23598	6794	93621	729683	7132	5093	9046	7942	49856	805	51696	10487	9815	58190	55969	2123	23654	9031	678	54732	84872	283149	23510	5594	51225	3587	144233	126282	1059	80335	284323	10577	124935	1512	58484	841	1500	54458	79065	79142	829	8073	8031	843	9371	10228	5912	10226	22877	2771	5431	9682	56946	602	23008	374655	80222	8507	57496	115752	4782	81603	126308	338692	1810
GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_2H_DN	M6015		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2759_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by TGFB1 and IL4 [GeneID=7040;3565] (2h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					9342	222255	221749	84162	389125	51082	51429	57157	286205	7050	3091	401409	9135	6203	2953	100170841	5250	3955	1838	3755	284252	5613	26958	1122	9635	4204	57379	51181	64805	10131	169200	9802	55014	10133	158293	10092	284058	119032	22850	6533	90355	23011	6643	79039	11217	100134934	51247	85463	285613	80149	220002	50650	2885	219899	55255	80205	94104	83855	7991	25909	9611	144363	54942	7428	200634	1025	6575	54509	3398	10053	8883	8131	154743	161145	8577	57544	221035	2793	145226	1234	55194	115350	10260	10109	53840	57473	22800	54920	84872	27120	60490	54518	11151	7136	3932	5565	64834	27163	26228	397	157680	8030	57037	23247	9324	605	84164	81888	28955	9476	197370	84062	6100	79823	54923	10363	2495	9535	91694	81617	6282	7321	8665	9948	166815	63917	11270	10766	3845	84798	4033	4087	3643	57721	54877	55703	89848	10899	283446	54939	139716	10725	57148	6504	80742	11278	440275	7456	79677	8994	56474	4064	51099	29952	51379	8871	7408	8675	3055	832	117157	10538	55824	29940	9788	9252	8508	51655	54522	6553	2669	23016	637	92017	219681	6919	84525	10287	284611	54978	5261	64747	57533	5573	162	23741	51291	148398	2134	23064	113246	63935	23731	54949	130074	253558	388228	129080	79834	10128
GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_2H_UP	M6016		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2759_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by TGFB1 and IL4 [GeneID=7040;3565] (2h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					10245	8780	4782	64979	23184	50808	6609	115708	112487	9973	6871	2212	55164	4943	5193	9545	64359	10493	8293	84319	80146	55080	2802	284161	10989	790	55172	11068	79090	221785	84885	2539	9374	90488	27044	57595	4713	57410	5707	54498	26521	93973	3597	6768	83608	51520	55471	29956	124565	9570	26035	55501	5828	706	10871	10020	5445	55486	25847	26960	1388	64215	283254	221	1036	79647	8435	64428	26608	51116	79770	10391	6895	6556	285367	80262	57107	130507	37	5514	55527	9823	80764	11138	112611	25888	29087	55074	10783	138050	254251	79679	115752	1143	10240	23682	114327	372	11319	116541	3613	26073	55331	668	4924	10159	93436	55860	80279	9818	6837	440603	2150	730249	4054	5213	79609	64118	57704	114932	1436	152579	6697	23142	1116	10078	5701	54997	54586	28834	51256	5832	8894	55290	9039	11258	101	83938	27065	3725	339324	132720	6745	93343	3627	388	4318	23078	10717	134145	5862	10174	55106	3069	2935	252839	54674	116442	10295	10280	7475	5903	80746	10150	641700	51506	645432	4043	23233	3416	55858	5451	54968	54480	123169	51726	81556	1191	5998	163	23176	22795	10973	5444	283131	6730	11314	553115	5271	1317	55794	8195	55140	55684	55034	51537	5162	6443	25912	64114
GSE2770_UNTREATED_VS_ACT_CD4_TCELL_6H_UP	M6017		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2772_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 (6h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					84545	7703	81926	1184	64121	2953	137392	6652	55194	51493	27123	51296	22949	832	1234	622	28972	401409	6834	79568	64786	5479	80255	9040	29880	9535	1152	5372	6284	55013	3956	151903	10227	25798	28511	57190	84747	1870	57590	64420	993	9249	10069	1351	51012	10451	7905	8516	50624	57580	85027	7462	55909	57198	10544	284194	10438	54965	5064	9191	6717	6590	8497	790955	27335	200035	118424	55741	54968	84803	25977	94	54543	5130	91978	55509	23648	3030	2098	6275	8773	7038	125113	253012	10095	84330	57045	57215	608	287	55207	339229	63934	219681	7428	7136	9749	7386	10148	23654	334	2769	10006	6414	4267	84240	83853	51081	55848	6745	23484	51218	2015	8634	9616	56954	9342	29927	2882	10421	25927	51065	83982	1438	23585	25828	1652	83939	11010	29108	10538	27131	201266	126129	5798	7982	4597	51645	23423	3476	51079	9144	6171	241	56261	3977	168090	55084	733	51021	59269	11267	2833	51733	217	64236	5641	56063	10855	28834	1796	353322	114836	119504	60386	5768	6827	3684	9541	220107	54585	115817	7706	9695	137735	572	150274	84316	22921	6490	125476	10093	5121	8766	51808	116832	64425	2115	2790	79004	100134934	6397	230	119032	10007	2971	51444	152217	4258
GSE2770_UNTREATED_VS_ACT_CD4_TCELL_6H_DN	M6018		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2772_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 (6h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					101	1663	5451	23365	79809	9020	54806	51193	174	4507	9855	165324	285440	57026	3615	9350	5784	23259	54956	285704	643641	64755	9779	8844	118672	5394	54827	65117	9748	4008	5919	9818	2547	25805	10243	9867	23268	80184	51363	10585	130132	124359	132720	283131	440138	8744	439996	3726	80173	256435	375449	374920	23312	5252	25976	80714	65986	9911	84458	53344	55324	6334	9851	1960	83734	1850	153364	166614	54893	55198	55297	441054	5495	27342	5684	85453	2571	79933	958	51542	57579	5908	347902	9674	57572	91	3301	285172	729830	23078	7277	84838	57677	112487	9677	5747	80108	8174	9037	24149	4926	3710	283571	79096	648	51101	55904	283847	5514	10746	64342	25801	79780	29978	51560	6300	5681	9684	57583	27152	10135	25870	1628	85458	9495	4676	163702	4752	9214	388969	401494	79961	6259	134145	8863	80737	23020	23033	11321	55624	644815	9957	5214	85028	57620	55729	26576	26031	146857	55205	5822	2251	10659	128989	7267	92689	583	286128	84937	3643	7226	2013	133522	4899	4306	124454	22930	55647	29945	57496	9725	286319	160857	2218	5959	64754	64782	8725	55311	2618	5074	55037	285527	4051	117583	22898	23355	19	80020	84067	3275	146562	330	22891	342865	9904	79712	84163	2979	84807
GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_4H_UP	M6019		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2760_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by TGFB1 and IL4 [GeneID=7040;3565] (6h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					11046	597	64343	51181	10000	26052	64801	57654	54739	11031	64420	56927	54965	53840	60490	10611	23360	84335	6540	221749	5463	81605	26033	91526	56970	55194	7905	84498	114836	1152	145553	200035	56900	9969	388646	29959	79699	80219	55773	55892	8632	51742	158293	1269	7133	55092	29994	56063	8445	9342	51499	9526	10412	3476	7357	11076	79641	4303	9592	4354	145853	51439	80331	81559	9267	122525	219681	118881	112770	23527	51621	64236	5339	30849	8805	30	56997	2120	64121	8760	4046	30001	3556	285613	54838	4891	9021	147807	10544	200634	1522	10053	94104	26224	10181	51006	55654	286257	6717	283578	221710	54943	11055	79567	25927	128338	8491	9706	51735	5829	91543	27250	5565	26034	11231	4335	9450	26268	9639	2052	338949	23080	60370	961	81858	127703	134187	6171	1234	6205	54978	11337	10066	4794	83982	8434	2790	3454	51696	170575	23382	359948	8832	4689	26011	10875	9807	5641	219333	4302	5731	23423	54093	6382	79735	23473	6835	84747	1184	10899	23112	3726	22838	8446	219285	64147	3570	51136	90634	58487	200845	57326	80308	11176	8887	65018	80762	57333	54	8698	57282	285636	80139	51368	81631	607	6811	57614	948	10203	23362	8609	80311	28996	10307	3643	8673	55529	51284	695
GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_DN	M6020		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2771_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 (2h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					57107	54058	16	283989	51087	1653	84466	9564	134430	9855	9039	126526	4282	54806	115708	64137	5226	4086	151525	29	2241	5828	51271	286319	51678	8645	83544	84324	6612	6103	55651	4670	10643	5886	8844	57103	80746	155061	197335	93973	84248	27183	51129	2004	92106	1663	10300	10342	5318	55486	4065	3066	1736	2785	83463	83592	84955	55172	51056	27043	25801	1376	10450	79074	143282	54148	2130	197407	11123	55624	1627	51441	23184	7203	56001	5701	1737	9032	4796	51256	3998	10240	145781	54516	10102	22891	55759	11124	64114	6723	91039	4076	55133	84187	5929	4733	55667	283237	9343	9654	10243	79671	115703	51703	10514	64219	2171	9818	26035	2686	6720	10655	54928	114932	54820	8939	100188893	54733	25929	9684	10116	23170	23381	25814	79877	163702	9310	10606	80206	57695	1874	51116	51012	6871	151230	55471	5093	221154	644815	84464	1982	55273	58478	23314	3821	114609	23365	7873	6598	128989	3159	80184	10111	4522	9831	8803	11315	10844	9817	80173	79634	1479	55081	8534	5709	1870	9823	10713	10432	5394	374882	8801	374986	8634	79803	85378	25879	7013	57222	23398	59274	29081	6514	55700	7465	9677	84437	1642	84878	10525	90378	1952	31	80321	11280	5255	57620	191	8535
GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN	M6021		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2769_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by IL4 [GeneID=3565] (6h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					23264	201725	2995	22870	2885	163859	7163	23492	25876	57175	27130	55959	5108	81846	9537	6553	120	8648	440145	54899	8202	1838	219899	148413	286205	56890	2650	55023	605	54	10114	8665	8682	54509	1032	114990	11215	5600	1523	9739	7405	10059	388272	25814	115703	4155	3690	157570	7398	401548	80145	9252	3708	8577	80119	7155	4775	83461	377677	6612	4085	94101	10193	9117	6197	865	3832	54536	163882	5910	3685	10672	84901	23741	637	5966	3704	25930	89801	90135	114883	79980	80301	399818	84062	222484	55703	3843	25909	63897	6103	10992	5871	54920	64747	6688	9094	100170841	3112	4046	9053	7884	64431	57721	130074	23138	4751	5499	9620	51247	54941	7991	65082	203522	79718	4938	3091	23567	6632	8994	222255	23288	162681	11222	29072	122945	5255	734	3433	57544	221092	3566	51478	3420	7942	30011	7456	51291	2768	201305	56935	27085	148223	9068	5253	1894	155061	10806	55110	25800	100134934	84456	80025	8508	177	6817	79661	5980	3717	8916	4215	3123	7084	29123	285382	51082	23421	139716	3977	10287	8412	145226	10735	914	662	8930	6949	23218	9135	5335	91694	83853	11214	1445	9468	27077	4058	26130	5880	116138	195828	90864	7529	79882	58526	80776	8237	163486	1192	5191
GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP	M6022		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2770_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by IL4 [GeneID=3565] (48h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					79070	8780	5333	10955	54834	3418	123207	25898	6277	388403	6239	3627	25974	90488	116841	9950	338442	57460	126868	4057	23587	55106	56927	53918	51599	26035	26060	2354	115290	29904	9166	7018	27433	8721	2212	5780	5096	10957	3795	22881	10313	57595	23405	10765	309	6734	10020	197342	63027	84693	9570	6556	80223	116442	378	152579	55840	411	56243	6520	2117	80760	8434	4710	55163	8870	2639	116541	55676	55527	57002	90701	5832	9197	3005	126119	92126	54585	3783	80851	2286	55105	2055	10391	27348	80305	730249	79085	9653	286053	2672	4017	2358	54606	5438	1106	706	3687	1510	5444	55968	8435	2159	8912	10671	376497	659	85415	10066	27036	5464	283254	8887	9545	79647	9488	5264	3613	55860	92106	9453	3553	10717	63977	4007	29058	200035	65110	4891	10871	550	60343	83732	57704	784	7584	8804	146779	23317	64215	4712	55052	6840	79959	9375	661	101	54498	4191	26960	57639	6809	55827	221710	8877	6310	1388	9093	113146	79145	6171	54808	3913	3984	11068	55974	8738	1943	6697	27065	22834	375056	9482	1191	112	8805	7045	351	10783	395	4731	57658	54900	10113	6443	641700	375790	5007	51506	1312	4338	79065	146691	23333	80146	54997	57126	6730	8569	27089
GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN	M6024		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2770_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by IL4 [GeneID=3565] (48h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					4683	10072	9700	57082	10632	54069	6688	54962	355	10165	3690	5890	158427	54478	92345	54386	56935	6745	283643	286053	29922	56902	256987	100287932	902	7283	55502	6642	25876	7251	1719	56683	51633	4738	5511	4076	283742	124995	51097	9415	128239	11217	1762	115098	51659	54780	522	55308	9040	6660	2305	80145	60468	8270	84896	79882	5550	132	79665	84057	84279	51296	63931	64426	55764	57650	55660	54984	1029	117178	285237	57560	10411	9169	11073	93594	79135	51264	90459	8502	285382	280636	53981	1063	199953	28991	283237	9532	7038	84513	55794	55847	1031	2926	27085	140735	9125	29089	8930	4702	55737	112942	5036	98	91057	79980	4605	55722	89958	79366	9837	5165	90141	4751	7056	9352	8277	8318	84273	344	83853	515	2762	4602	8402	1104	144406	25902	701	11339	153090	51377	51268	50808	90381	9585	293	10549	91319	3014	4534	154197	23474	5649	2581	81558	3030	57823	10541	7517	9468	56852	8881	55839	10989	10293	202051	5634	1340	4482	55011	10055	50814	51645	1164	10602	171568	64080	112950	146456	2958	9401	7272	65080	10204	79019	10926	63922	222229	79668	6396	55013	7804	6880	5833	9411	79174	125113	27077	8869	994	3419	10330	3048	10133	26586	66036	7324	83990
GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_UP	M6025		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2771_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 (2h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					375790	65987	56262	55105	4072	55014	6520	25943	10809	65992	57614	4300	84498	90355	55283	1901	57677	80709	20	5243	374403	2027	10517	26151	219285	80700	9334	220002	155185	7726	6282	7923	79887	6671	441054	51205	8861	971	7107	5452	91526	54103	5784	116841	84230	55466	54806	9780	6772	2145	677	85456	10314	56474	128387	7277	10067	146691	57458	653361	4600	3709	5025	9665	309	684	3959	25849	5127	23220	8178	26802	4051	60490	11259	27245	54847	973	54850	8784	3087	5121	2583	3560	2166	3795	29889	25801	3111	9043	10077	594	92960	6310	23379	57326	4061	28959	583	7187	134	9453	55630	10365	79603	5916	1106	19	3300	4082	81786	57406	151742	79652	23276	9021	3309	23373	55020	905	2117	9905	9980	1051	7741	23412	6367	55198	29058	55741	3960	200845	1992	4794	9124	2355	933	6938	10135	29933	824	23269	55349	23077	55601	3914	6725	80017	219681	9901	4121	53344	394	776	7048	1512	1628	3726	57571	9314	3899	8660	27128	9465	81553	5328	3588	5339	286097	84876	23111	54149	7084	51768	3423	10567	9402	84166	115207	55974	51635	84197	27241	55850	27107	9922	643988	57143	5908	3955	6901	92105	54462	9047	399665	151888	254042	9321	958	5338
GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP	M6027		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2798_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (48h) versus TGFB1 [GeneID=7040] and IL-12 (48h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					64420	5064	6693	9781	26033	92949	914	4811	3500	79665	54	10765	8609	22926	391059	84456	57095	89886	25927	56674	6414	57326	9535	28231	5634	4647	131583	51170	5199	284194	7706	10018	10203	537	25939	2872	124359	3897	5294	29802	23347	23171	64116	55529	2180	6385	1306	7431	9051	4507	84925	8943	221749	4940	84674	8543	4938	48	83892	8459	342667	23239	54941	8698	6282	6776	5962	2593	57134	153090	10109	8315	84629	89797	6528	9960	85457	54529	757	5912	11033	7782	1845	256302	115825	2526	3977	5621	2581	79865	59342	8526	81615	1464	3416	51104	7038	6804	26268	388403	6817	10771	6688	23304	90355	847	93663	221	22899	57414	6311	323	1846	56204	79734	1384	3587	22949	6696	27246	4088	29909	55024	6449	79647	3048	283446	53346	120	91543	309	10207	11261	55300	9697	83481	3845	255231	1107	1184	10402	6775	220963	8581	57153	2995	150082	9429	80727	90196	2934	57613	375775	60682	30846	2874	90809	22918	59338	4635	55604	4125	1606	57600	219333	5663	4627	23603	6310	445	420	50808	256356	57533	8564	5516	948	4258	83931	51133	51726	23586	3455	89866	259217	411	10161	387521	51696	6768	8836	344	971	80148	113026	5660	868	79095	10235
GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN	M6028		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2798_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (48h) versus TGFB1 [GeneID=7040] and IL-12 (48h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					51605	2184	4008	89857	54960	9855	285672	731	54606	155061	90668	587	80817	25801	54806	64393	132320	151525	26267	122481	83592	6596	776	3560	55349	8844	84034	254394	3017	10397	51474	79074	9516	158405	1012	84529	85456	23120	162387	57669	23195	22891	2686	834	9569	374986	80206	83699	23587	4013	10538	375449	113115	56648	90233	4065	10393	23312	158219	10464	2785	23242	6259	619279	51115	344387	79817	25849	84236	54989	958	813	51227	9456	29081	7447	165324	84133	349565	54880	23076	255488	374882	55273	56243	6001	583	7023	54020	91775	286097	150468	6590	84969	151230	57579	84197	221002	114609	29803	192670	8611	154141	26523	258010	55812	56172	150223	594	85453	6737	3106	285761	10135	5291	57541	9498	25864	9501	29	7049	2553	8629	6871	6003	55706	23365	64901	389792	55173	9136	84164	26035	729830	145781	117157	837	9659	57539	56261	8787	23002	4646	360023	29969	1952	395	51010	80063	2781	11199	23220	970	10363	202500	376940	5357	10655	151246	657	55893	6478	26586	11221	55667	83943	57489	81566	143282	56986	79096	8555	1843	7329	55663	6000	9249	22920	29850	3600	9793	6785	80820	57178	90865	159371	9871	55061	10084	163882	10643	6772	6553	51455	256309	84100	57181	407	9061	23108
GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP	M6029		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2799_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (48h) versus IL4 [GeneID=3565] (48h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					10313	4534	90488	55509	51726	11102	57089	59345	9374	5432	10788	81618	26225	64426	55471	4718	79682	9545	64979	8293	4702	9057	26586	78992	64428	22974	140890	94056	54968	777	7070	53820	84336	55088	5827	10981	22875	2079	93594	56265	5213	115290	220042	11034	25871	9197	56945	63922	5444	995	79006	55331	8743	23233	54539	55281	115752	9488	10544	132	1031	254251	26580	280636	2868	5718	8881	5867	378	8318	51537	55173	8543	55353	56990	56852	27348	2588	83903	91179	3833	55313	283254	207063	51097	11168	5985	11314	7866	1719	57584	8870	1155	29097	29099	27044	116328	54938	84437	1143	84701	80262	9401	10317	284359	10279	57600	26060	93587	7384	10635	1212	55852	11339	84889	29956	2110	64963	5828	55164	3015	6556	5687	7517	8800	2212	9236	51022	23530	79822	9318	9669	79077	55771	26608	10767	199857	6790	223	54443	90196	1870	2762	641700	26227	51575	115416	8029	55151	5087	11130	4705	5707	1174	570	3416	80762	10391	23587	301	5372	522	11117	4294	28991	23533	124565	54834	80347	10403	146779	221785	3627	10284	79090	5861	10632	79135	285367	3958	8460	79102	821	440400	3613	717	57639	8165	25837	389610	339488	123169	79184	2802	55851	286053	11343	29920	11138	4528
GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN	M6030		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2799_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (48h) versus IL4 [GeneID=3565] (48h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					5910	165324	3710	89848	220002	4063	4232	942	55198	84678	3955	5980	56731	4204	60485	65082	84256	90355	10580	2909	84747	81846	84181	2969	6197	28978	145226	65986	10495	134429	957	54518	51517	9901	54899	3914	441054	388650	8577	9851	4773	23607	55303	54920	5820	25943	140612	57148	27125	57533	80149	81617	84798	151742	57205	112398	2330	65981	23070	3091	63897	23779	7375	8453	22828	25909	80314	64282	3308	23389	115353	2650	7430	3755	64755	22902	55255	374618	408	80224	57605	7187	1730	23191	10420	5074	4302	27033	146722	6925	130132	4775	57614	4297	85463	63935	1643	23269	9465	50807	3796	337940	348	50937	51478	286097	79664	161145	81928	10613	200424	84928	79626	84440	8871	27130	5607	2790	27010	285440	8558	162427	8767	197370	339559	3122	55014	283847	63915	10538	56606	144363	80017	2197	91544	5339	59307	163033	9739	57175	1015	254042	142940	5908	23064	10124	6203	51177	84162	9117	56255	9802	54522	60490	10614	1844	55206	28955	23264	914	374907	84614	5600	26958	54785	4665	90378	2355	57541	10139	200634	3845	6760	10053	8613	51676	10077	66004	23288	94015	222484	84062	3932	3560	8202	3663	8906	1875	10809	23567	57154	5565	221927	84263	9498	9068	50515	375444	6553	6919
GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_48H_UP	M6032		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2800_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (48h) versus untreated (48h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					200035	81545	392	55331	3163	63027	8674	8872	51006	10391	9374	23382	5829	55630	10313	80176	9592	10477	93380	54507	55113	116224	51104	84897	59285	117247	28231	57639	2140	83452	10317	2117	8887	64175	79567	9570	10159	10456	83999	138050	1486	4507	401466	8780	11320	23657	3032	3800	22834	51170	56927	9934	64215	29090	84885	8434	2286	1495	126868	25939	4253	54585	23585	157506	28834	3597	26580	5445	4782	162387	784	134145	27044	777	63891	55343	5862	2801	26151	26060	26354	22821	26608	79792	1388	537	51255	79065	55974	3913	10544	6945	821	669	56052	6173	23559	550	6048	661	54805	65059	23545	54808	10671	7293	10370	2802	64598	9588	51380	221785	11266	9375	441282	199857	168455	2281	2947	4245	7993	8444	7184	8698	25898	55840	4864	10073	6885	9583	51185	115361	55015	6301	283991	5692	10767	641700	143187	10063	10273	9351	8721	23094	53918	23544	81542	10156	27166	90196	56886	126393	4712	64410	3795	80764	1106	8405	28957	1936	55776	79070	23233	115290	9950	25829	5271	9709	9354	10857	3614	23301	339324	6509	3570	51094	10280	22901	4140	115701	285381	4007	54732	23012	26119	8527	51246	53820	80146	23626	5791	91452	51188	55080	1943	57654	10960	116328	10211	8550
GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_48H_DN	M6033		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2800_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (48h) versus untreated (48h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					4133	9656	23492	6491	148398	8767	53371	7155	84978	112939	63976	2322	4282	51517	54920	8050	23269	197407	1431	6767	7447	55133	55703	10576	3704	6477	51312	23077	3843	221830	440145	163859	23288	5532	2332	26267	2197	57565	7991	10450	200186	121268	79650	3710	80218	6103	6448	51529	256144	79832	400569	55142	5600	90668	57096	10287	84733	90007	65980	1730	79877	27010	5253	157285	83990	11190	57178	157570	6197	79664	57645	162	79133	4595	23064	3560	23312	51202	27085	51259	11174	9816	2030	84747	79809	9117	100170841	162427	1859	51053	5820	1676	79849	4869	81617	162681	374403	10643	57819	6002	5990	10538	80329	23028	56255	388272	55192	83540	79591	9768	8939	8897	7430	286827	10943	9516	3181	79661	129285	10274	158219	79072	80301	27163	6760	9696	9125	23059	400916	55352	221927	85378	729830	64901	1841	26958	734	3663	84901	55057	7247	6599	222658	94101	2885	7428	54877	5728	3090	10691	5570	973	57205	55695	65082	3835	254102	84172	136319	1512	79794	2889	6874	3895	3840	9135	57647	10193	22800	84067	58488	163033	10419	3845	10039	149420	64864	55257	6632	1017	3787	1960	123920	100506612	4149	5933	9873	55893	5331	79695	5108	22847	23099	57082	2686	80119	22850	83461	9498	11151
GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP	M6035		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2801_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 [GeneID=7040] and IL-12 (48h) versus IL4 [GeneID=3565] (48h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					23475	55501	1603	8445	55105	130132	79567	65986	80004	7133	140612	10207	9321	9807	174	54103	914	408	51104	3570	2117	5784	23473	56917	414918	132720	79630	441054	95	10379	115548	60490	11128	57614	80219	85458	54093	79961	3257	84971	9043	6925	8632	8558	10075	10924	26034	10000	23412	54739	10077	57326	84433	327	5339	10092	23357	28996	25976	84925	64343	5130	55466	4773	81786	91526	80709	84876	27334	54509	100113384	197131	115704	9021	59307	3588	4600	5121	57690	5151	146691	6919	55187	8805	2313	706	6725	9901	4641	9314	5199	5530	5153	4046	57205	1776	51444	5731	6452	152007	128387	9334	9047	3516	200845	22876	7375	5926	54467	10154	2014	6778	684	166785	3429	9922	4925	57655	115207	80149	5777	5871	4249	94104	2217	11329	10865	9094	388646	3111	10809	57580	64109	222962	1901	25927	5970	114112	1184	29948	10307	79709	9399	55669	10505	84961	63891	5581	6302	5164	153020	4354	64224	9990	971	115701	55626	8760	59342	9985	729747	81575	23080	677	23527	23580	3705	399979	4507	7011	51170	55787	91	56983	51280	64801	388324	23400	3112	8416	57541	80311	8527	79887	116151	57532	51621	255231	80231	7084	84937	26001	133522	6892	79720	65018	79603	79792	254042	220002
GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN	M6037		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2768_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by IL4 [GeneID=3565] (2h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					5859	84279	4534	28991	55421	50854	8543	5728	7247	6745	57560	7203	54888	7283	84955	51678	3145	1841	54780	51491	4683	8726	10200	9530	83853	134430	55502	64080	840	51056	8496	55172	286053	27429	51264	10396	22949	197335	50	3030	83592	10549	9125	151525	11130	221154	91057	25876	9633	2590	8912	4796	10165	23312	79071	2322	1122	29089	55367	10116	8565	4282	51386	5207	10197	57570	55120	10054	2222	8402	4705	9032	150223	115098	117178	56902	26225	4953	4863	3054	28984	5715	375323	51123	63976	9343	55471	5932	220042	54984	79006	9411	10102	132	55794	644815	114609	23354	970	6832	256309	80063	4733	56672	5429	29095	84464	4607	7447	54069	3017	51129	2184	1870	8559	3048	3149	57129	9657	199870	8419	126133	56945	57823	130502	2288	100287932	8624	2241	10988	57120	55090	54507	8914	7372	283237	90459	9663	6660	222658	51371	339229	79849	4708	4833	4713	7322	28972	10291	53981	4058	11017	57519	1736	8480	112479	55751	129080	283871	150472	98	1967	55862	54930	112950	8317	57210	56001	55328	2686	10982	10623	5719	5827	55847	55207	6878	4436	2773	79661	908	91687	160418	5687	57697	63922	6907	10573	89891	348995	51103	80218	4597	256676	3835	84057	7494	5426	10465
GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP	M6038		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2769_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by IL4 [GeneID=3565] (6h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					84557	7508	51194	3925	9205	259	149986	2628	83666	84883	51119	4828	3633	6402	51669	7453	513	83719	27173	10924	2214	55222	151903	2330	89790	2529	81929	10540	130340	56910	169200	6241	8939	26269	375287	54893	8638	26472	123355	121260	89941	26191	83707	26190	200312	56181	3839	81926	3611	54664	389125	203228	138050	4502	57124	10263	54961	4947	24145	5664	5305	57128	7084	2030	340152	3423	6809	167691	11328	5763	7247	283248	9249	440138	10397	4731	57205	686	7263	84957	89857	7253	23	952	7305	2822	9275	89953	50848	754	30851	10681	27347	537	33	4005	14	81559	2799	665	29942	4622	51715	9245	1515	26268	9094	4086	84888	6717	157506	127262	6199	57060	219681	3507	10468	3101	80700	360023	306	255809	11187	64375	3489	112936	23637	80325	8435	23531	160428	11082	7201	56995	9604	57002	8450	28966	5813	8490	136319	9541	26580	151242	5911	25764	90693	9114	144501	123920	100129271	79899	55300	51008	2145	9961	79735	91662	3915	2867	10855	10392	10908	79035	22901	10567	79627	10474	440400	5169	3669	140707	58472	27134	168002	10865	29997	51809	442721	1191	5627	6916	27022	4354	9457	26273	388	55118	7923	6590	122945	8659	6038	91775	59349	221823	492311	11341	161357	1201
GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_48H_DN	M6039		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2802_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 [GeneID=7040] and IL-12 (48h) versus untreated (48h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					9156	51116	116150	201161	23246	10988	28987	3313	57122	22823	80324	81620	51633	4973	552889	79723	132660	2617	26953	118980	22832	85365	81875	23262	3188	5756	23212	10505	54784	11278	10645	6723	22936	83852	64854	83853	55106	57826	1728	3840	8833	92345	56169	54468	163732	51133	125228	84912	8516	5306	55038	3070	23560	5036	10541	641	7705	1635	25940	388533	112970	80823	529	51428	93408	11169	79154	92370	3329	26135	241	79577	8439	5885	151516	222234	55432	56916	84146	29959	3014	157769	83743	55269	1789	182	10898	165918	79066	10055	11052	118424	9306	51361	2697	154214	7841	91442	80714	84945	55661	79072	3364	2182	9375	10585	81556	64760	79033	10950	85021	64429	360226	90353	80774	1653	161424	8479	1734	7528	57578	54433	1503	6839	3091	84678	84541	60675	4074	10558	4907	55706	152518	90861	10926	22875	64109	1736	3066	23279	23435	10933	26985	3550	6747	339327	29775	10483	220042	8539	55131	1147	81037	283638	9643	55210	54665	2969	64770	90135	64768	55602	79691	820	11073	150356	55623	6426	55207	10808	4061	9584	471	56479	84645	55254	51602	23173	83871	29927	10767	5717	6470	8480	55236	147381	224	11333	219285	79850	3837	22974	148789	2581	57082	26354	94	55660	25852	117246
GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_48H_UP	M6040		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2803_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL4 [GeneID=3565] (48h) versus untreated (48h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					84206	92906	5250	5256	975	8898	131965	5371	23220	8200	57822	4142	10549	821	7385	9855	3033	11231	10109	29097	54585	125488	26355	29095	150472	23630	10905	162073	340481	7107	285382	7023	6152	26762	9897	10634	58490	57679	71	8453	55012	7349	5154	6047	205428	51196	30836	2258	4722	3788	91012	114804	7381	55227	9260	1582	84067	29957	57798	23484	5281	84343	8668	230	8785	57600	84331	9527	6059	6747	57705	6509	80232	10205	64216	2054	93081	8495	7127	4299	58504	51493	3376	23268	23428	11215	26589	23367	203228	29803	284106	55326	10240	51061	284716	3796	55048	94	4233	10221	5601	79147	64398	29094	8192	5434	51001	79612	677	5786	50	51091	5520	403313	5654	23071	55245	5879	65987	22916	134957	27348	154214	9791	5781	285636	6443	8516	4205	4958	89849	286676	64764	648	1230	3133	8894	153768	8886	284184	57584	902	152100	4724	135112	140890	55254	92126	26035	9497	90861	339965	154141	256710	285590	8635	7957	26999	10327	2961	3678	8622	81533	10016	54893	1528	7372	139341	57223	170487	55922	64112	387882	2806	2764	9242	5291	7334	89782	4212	80013	7494	80024	29088	87	54913	100506562	9672	144402	1337	4485	53827	151195	7184	51074	488	2820	84062	11276	10152
GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_48H_DN	M6042		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2803_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL4 [GeneID=3565] (48h) versus untreated (48h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					79713	65018	10171	3964	7392	374403	920	3619	23065	9659	91543	64333	23285	3074	23191	63971	4478	136647	57562	23248	84978	3815	65980	2879	220064	4884	162979	26090	4794	55217	7305	3925	29990	55603	64342	55532	9136	2306	8491	6948	387680	5108	3747	9143	4900	728294	6539	23552	57057	55205	9716	81570	144486	114881	8507	10219	3109	23608	201299	23179	8433	57863	375298	83445	3996	81	64766	154007	5788	5782	10402	10724	5305	7047	10140	7187	8530	255758	51317	221322	57654	53840	258010	5447	80774	7517	135935	23043	57606	64061	55627	10318	137362	57560	27071	114134	84272	84708	51185	2875	2104	81553	10413	144455	25816	79366	10421	100	51430	10270	4848	57509	55700	81619	7008	64429	90952	151246	6340	401494	140885	6821	11214	81844	9249	152006	84662	8445	133690	969	23231	54739	55905	9583	115825	8503	54985	10874	4067	84034	5423	2532	23654	11259	5130	4005	6403	7884	2550	79572	55507	26122	146857	4756	57704	760	898	63901	9956	1145	79827	8317	81603	116534	9450	353322	9704	124599	10154	91937	79036	26298	6000	7410	8710	54790	248	6489	92745	1509	9967	64135	116154	83637	7941	5337	196740	59284	4123	55101	54972	8767	10602	64762	131583	317649	84281	23062	23049	10120
GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_6H_DN	M6043		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2763_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by IL-12 (6h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					56624	85301	4649	8933	64123	23491	1137	10669	9805	2806	463	30851	90060	10155	51077	3014	1026	387837	55361	54762	55012	26010	10539	58505	353	5176	139189	113829	54558	79675	9897	2244	2769	708	5862	4668	4284	205428	8502	29062	3036	1798	56652	84270	170394	9352	5570	11276	8711	2520	7127	23192	23626	93343	8731	391356	64419	8853	81543	55760	3239	8659	79585	25806	399694	6891	284004	27097	3600	226	4610	340075	25780	8444	2617	6183	57488	51343	123720	84695	23542	55342	5718	387856	6890	4299	79767	89857	94240	55022	337879	92162	135	387521	57513	10905	6711	23235	9868	56942	7381	143879	134553	6767	29095	5709	115752	8895	8635	10106	79071	23150	64645	54102	10537	112495	8477	23241	83694	9871	10276	51091	63977	6204	8612	811	670	203260	254225	115416	80255	301	128674	64431	394	23380	151195	4524	285382	9150	949	130340	15	11331	11177	197370	9578	6579	207063	5550	84706	23464	5464	8555	8575	171169	3229	9182	23105	10396	6256	123355	7476	65983	9032	64374	6650	388722	4731	79174	63027	140456	8669	3663	2258	27101	51065	136227	1012	284273	55300	59272	8324	55048	22796	196	26511	783	101	6945	9267	4646	4345	51643	1185	55437	252995	23002	2997	55568
GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_UP	M6044		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2764_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by IL-12 (48h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					10363	375387	11284	112479	7805	6539	64743	6867	91	80823	6749	25791	5591	79962	10725	486	114836	9139	389856	27241	283899	1831	146760	149840	51621	4023	57491	400506	5912	55303	23608	7133	64756	353500	64135	8204	124872	57003	8665	9813	23112	6327	340205	93978	7486	5782	714	8801	10695	64651	55667	51406	55676	6911	9882	23313	8924	27334	8784	7728	4092	2539	84057	659	84498	23043	23505	9055	3142	55101	8111	27123	5147	2168	3269	389072	57167	2023	11133	8507	221421	400569	3423	51691	23049	211	10499	64343	51562	23074	83637	1509	4703	831	9462	51582	79627	57165	5906	4650	3936	149076	5594	6640	54407	5788	8566	974	2848	143686	8452	84696	55074	4253	5527	121536	4086	64766	6610	2733	1308	4775	326624	83707	53344	54625	356	57704	9750	10320	2589	29078	2710	339983	4005	151556	9553	976	55500	144501	6491	146198	55276	3690	55269	93323	91833	143678	79956	4552	90799	8540	2889	55766	392	286128	79958	10250	7561	25938	57519	342945	10437	2650	23392	5595	8648	83596	9742	79002	51247	50484	317649	2208	10735	864	83931	389206	7323	10555	157753	6483	6565	57210	10274	6693	55055	701	678	391	124935	80162	1027	84329	5553	8726	23035	2158	23654	51060
GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_DN	M6045		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2764_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by IL-12 (48h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					5684	92400	5654	92906	81887	85363	55847	92170	23116	58490	11137	56902	10946	6432	343472	57223	55733	55763	8785	150275	5000	50865	7153	5108	55206	9969	6557	23411	7873	5306	5819	51001	51377	54919	229	4843	5814	4253	84656	91612	8886	2059	90861	54968	9925	23256	1428	128338	51575	79174	9931	79084	1122	338321	80816	7320	5147	84057	7531	55269	84460	3658	55749	64151	23534	80232	57167	5683	30836	1738	64748	128387	132720	81552	4881	372	6921	5423	27131	51566	714	3295	284403	6856	23483	134218	9716	7543	9761	57472	7323	64746	5861	55275	399818	4958	51582	81619	116238	5473	55279	2885	84293	301	54952	22807	387509	6746	10123	26994	64326	3075	56683	25917	5825	90799	4094	342667	900	54734	23239	3646	57685	83596	57606	124044	4914	1398	23443	118442	7392	27000	2244	4790	285025	91298	6801	56897	29074	121260	6385	79621	84263	8732	55299	2960	5604	92002	80835	1024	81606	79803	54749	1022	8724	94026	5223	80318	467	2563	220064	5007	84904	3717	9246	2137	55872	137682	90	283849	22927	8763	22828	11005	55975	4678	10969	7561	55922	56916	169200	5884	55017	84146	308	100287932	9659	3320	84108	138716	23177	5250	7884	91582	7791	9134	9412	8788	79876
GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP	M6047		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2765_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by TGFB1 [GeneID=7040] and IL-12 (2h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					64342	7047	154807	64078	51225	157773	10155	23460	375035	375791	4066	4884	116085	6640	23141	55227	27254	8284	79170	10533	22925	114088	3595	131870	55526	2561	54440	3996	63982	84694	133558	84966	11249	2835	126695	2588	5744	342574	23286	147381	79798	64123	3074	23414	846	10898	51447	2893	1018	51179	65003	9533	283897	63976	6160	4122	55004	3899	60482	3902	4158	79807	58524	56999	84561	6786	196410	376497	6181	387733	1448	285782	1959	7161	344657	7056	6561	2051	23552	87	25901	79140	631	245972	388403	127262	389208	1101	79645	55036	136227	65991	11047	5564	9894	23762	7515	5449	100134938	133690	377	25925	4988	51780	57088	3266	10171	134265	10163	5217	3727	10903	2146	100499467	10791	84300	10988	7472	8045	55181	134353	3061	5725	54102	353	6580	4921	440957	83694	114788	256380	154790	339929	218	5802	84107	124872	1292	3855	26154	9967	333	27030	898	54494	790955	5793	126328	283	23504	55217	203260	3547	7702	3398	8928	51	23624	3033	7517	283174	6142	158293	4926	50801	80305	4656	3030	6890	90527	6405	6004	374897	23542	2560	645832	9328	10500	7201	283629	1400	3050	25907	11182	80235	2687	26872	51495	4055	219899	9139	56850	28958	9466	54961	7295	140883	55776	3703
GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN	M6048		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2765_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by TGFB1 [GeneID=7040] and IL-12 (2h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					7293	9368	143379	23491	481	29087	7112	10225	10298	1545	9055	10158	54187	23424	221150	2275	149428	56132	115353	83475	6524	23130	672	200185	93081	220	399726	1282	54739	11079	5576	150094	402117	7474	22994	261734	375775	4629	5145	220002	23065	6754	10155	8438	5424	10379	22797	135935	8816	56938	57105	196374	8938	92597	2168	8440	5048	79589	9547	4084	10541	50813	3683	10053	23510	8872	84311	7064	5744	9658	7798	84698	5832	441518	1594	1305	2166	112	22974	221443	5049	3068	55872	11331	23403	239	10160	65094	10376	7054	57562	3665	4602	200558	94033	3512	51155	157313	10902	65083	1690	55920	999	51203	1306	55845	7022	55743	337977	9672	10573	79659	51327	126353	4698	170575	10906	7102	55654	57172	6385	151647	78999	51058	10592	11211	27347	64236	11221	25771	29889	5334	201299	353322	10063	29901	57153	80740	22918	496	56006	340024	2802	7113	27076	912	65005	4118	53834	7153	26995	200523	2820	353	123688	1031	6236	4616	57721	9948	148741	48	10426	9133	55905	7392	80000	332	23224	89910	57463	5611	1642	83539	2780	51529	56160	132851	1838	201725	10252	83440	84833	3627	387521	285051	11004	4600	23139	9578	140738	23119	124923	494551	4974	2245	374882	54620	11169	55635
GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP	M6049		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2766_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by TGFB1 [GeneID=7040] and IL-12 (6h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					51759	10294	3689	639	51429	5000	5163	1524	387680	51102	55851	4481	113829	84248	10009	22878	38	1438	81928	57396	63877	162979	147965	6621	26140	2744	8139	57018	60487	200014	50	9926	10625	6018	10989	64421	7871	55520	3123	375056	26090	6655	905	25926	51227	2746	84548	51274	5160	84804	4664	255043	23150	65990	5335	9135	26233	205564	387837	192286	54913	9665	23272	389541	205251	6272	151188	3658	127428	55850	7494	9406	54065	7286	51538	25777	51111	158234	1535	256949	64789	91746	10464	79080	10066	7251	9990	79086	9487	55870	64983	23184	24149	9014	23358	51455	65993	8636	342371	84002	168667	51001	55773	51475	122830	196441	90957	56204	79188	79058	200312	7750	100506144	5600	5756	10640	9767	65057	1841	4798	84896	7284	64581	5860	2109	4644	54431	131616	23421	55093	113246	92344	163486	23548	79738	81502	7273	84946	256471	7037	23786	157769	114825	79590	728294	5450	29994	10897	55698	55818	55157	283578	55421	90826	23607	79664	10439	55103	285195	54816	30835	2653	64216	51426	92400	131601	84343	283130	10567	8453	7013	51706	56983	55131	146542	390637	9057	25898	79876	55198	6231	84798	27297	23087	132864	53827	58155	29063	84364	143884	114883	51382	129787	27230	79183	1725	11197	6230	29035	79823
GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN	M6053		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2766_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by TGFB1 [GeneID=7040] and IL-12 (6h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					55135	10991	9658	55230	15	55604	84069	5576	8566	165545	6288	1572	51684	51311	129530	2619	151648	5048	64432	7690	54662	171169	3479	26046	9656	84910	23224	92822	23491	11247	84698	80725	29890	10043	54862	163	10047	3619	5250	10279	340075	54757	147339	9156	10060	2824	27319	163590	3326	55532	284948	26092	10204	64968	4117	83894	55209	54625	2038	199786	84272	85413	149478	91937	55238	23542	5438	7064	8000	653808	55362	10249	5352	24145	1601	10178	4914	115752	123099	79603	134429	7532	2487	55122	389177	5049	815	27076	51157	5639	51347	51728	6647	7474	11173	60686	360	7353	84939	705	9655	7111	149951	162605	8567	221150	203430	1743	84818	8501	26960	10053	9643	55777	9956	30009	5893	10926	344558	9521	140683	6340	54734	27339	399694	65094	3201	3959	64065	417	55662	84152	51057	1555	284541	55312	341032	7536	4438	5322	135935	221395	219844	89801	5023	27022	116534	9899	943	58478	100507444	10409	81616	5158	10512	23549	129607	220002	9182	203238	5611	55901	389	27023	65998	5470	64840	90522	23531	85301	25945	5993	492	4015	961	10894	55128	3776	79447	90121	118460	6495	7142	151516	57622	29909	2326	1310	7380	79918	22918	81501	9354	5063	728858	90332	7136	163351	4857	4597
GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP	M6055		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2767_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by TGFB1 [GeneID=7040] and IL-12 (48h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					3689	53834	83719	7566	283899	25791	124460	29882	2778	142	6811	387837	91433	51429	10066	11068	2301	7561	29093	5294	2872	2823	54715	83443	10903	27230	27242	552900	9630	51765	55954	150223	5463	29777	10263	55171	5167	84057	6230	79913	7442	147965	331	54869	80205	10180	374897	26033	55088	65993	56624	8852	51282	157567	90390	26277	7054	50619	26037	83989	257169	5095	8460	175	90416	60412	6877	246777	2517	137835	157769	51377	2948	85300	23270	10002	6103	701	51015	2743	53358	54585	8577	10924	9	54617	4147	54556	84102	51696	10871	7917	100506804	29088	55745	10213	1558	30001	144363	4975	81628	58531	10524	131965	81567	23339	84302	29126	54987	79983	55101	55157	57579	5578	3684	55676	124930	7867	6431	56606	8625	9745	23601	113829	4714	5764	51329	10186	57616	840	91647	100128731	1112	168667	132671	1315	378	55616	145282	57614	150274	84883	89978	648791	63898	79799	9495	23474	25842	65990	9129	129804	4249	26205	4703	161145	10198	6196	55893	4821	63877	2653	284366	5707	2139	10434	115294	151903	78986	6873	2593	55336	23557	728215	280636	5324	255043	129852	976	79064	149840	54934	9587	79027	221955	5924	8517	7046	84617	10552	168090	4331	255394	51503	10787	11187	55186	25942	521
GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN	M6056		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2767_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by TGFB1 [GeneID=7040] and IL-12 (48h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					54431	134218	54558	51491	6152	4798	84060	79009	10640	10439	55022	221294	54665	1207	3206	23389	11177	728294	4289	9135	23376	55909	6610	124872	4735	84878	5229	6181	10450	100505741	5805	64746	1029	546	492	55260	202018	56063	55074	64841	55000	3915	3123	10287	1106	147965	84826	889	399694	29078	84069	9855	389541	29116	826	126208	57189	28512	10352	26224	373156	4841	6827	255798	55297	10771	79618	285636	196441	51205	5358	3836	23361	139231	55326	4542	113829	152330	140679	10695	7871	25938	10818	84720	51499	23071	53	55676	1781	51192	54414	53938	23175	23350	91373	56204	10452	83743	10134	7037	84804	375449	115825	283742	219771	64756	26298	374739	10567	9101	952	3581	121512	26137	9813	7533	23231	339324	6201	4839	29994	140683	64421	9213	6565	6911	10524	64789	254048	7750	2683	10897	10963	3183	9429	26289	1455	9497	122042	51300	57614	55103	57654	27158	5335	10009	5939	5341	9	4224	57826	51762	587	55626	84798	152185	80304	2958	253260	9375	25855	11244	56052	389072	6667	23283	406	81894	51571	5564	22934	1432	64210	8624	26233	5165	10075	55288	219931	4318	51130	84132	254359	6988	92400	146198	118	54206	23301	57336	7776	1974	8880	1265	51728	6738	6993	3937	158234	9986
GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP	M6057		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2768_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by IL4 [GeneID=3565] (2h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					9256	57498	9837	3693	56137	9183	79962	3665	6524	714	339344	22809	8792	641700	11098	54843	84947	51083	9047	129852	4600	7079	1742	3902	400916	8601	9678	6780	7327	149840	57105	145482	83939	7486	4598	286053	1000	1310	1785	6323	80028	59345	11079	57035	2305	150468	29920	3642	57821	83604	89958	64946	93081	55872	64768	57475	10865	11068	27000	2168	1627	57522	57706	4007	1875	10047	3936	155368	481	55789	54662	29916	84246	5445	9615	8140	9956	57082	4281	2245	4091	3938	389118	30009	4715	6521	4718	93426	2492	5663	8021	1031	374655	55143	1033	825	5452	10842	196383	54814	10615	80209	113146	392	774	871	84057	163351	5744	7087	9833	25907	10225	24147	81706	3627	647087	54881	10797	84189	10657	65264	4702	1551	51155	8816	283349	9550	9080	81930	28988	10906	284194	157313	10732	55300	29086	54820	7045	1435	64064	51343	219972	6119	9791	5708	23510	10507	8502	55339	3068	286826	7077	23636	23224	57644	64073	129607	3956	23601	116255	55897	84939	9066	8439	8483	6622	338328	7293	10298	5133	54910	5100	1994	146852	53834	221336	1611	10552	10663	6146	55907	875	6598	27166	343099	6491	8872	10806	3184	23119	1936	6790	6892	51734	368	4094	3434	4298	10921
GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP	M6059		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2788_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (6h) versus TGFB1 [GeneID=7040] and IL-12 (6h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					399491	11001	3488	10652	1278	80185	27190	79913	3283	201134	26266	3619	100288941	100505761	1302	4481	23633	79092	2700	53345	4991	1636	3284	54504	26261	27023	51350	5159	5874	56142	3782	1610	3696	140461	64122	8711	81556	202559	54867	23334	93436	27158	9715	6356	6760	9143	27035	23434	10408	2820	6015	10656	9131	23241	7216	28908	3060	9376	7542	3787	23302	23412	3238	9785	79969	9153	22977	55812	23591	10369	2650	54718	54436	9219	93164	64858	26229	6474	64121	51004	71	1814	4582	4892	54938	3294	2796	10633	51020	23481	22859	1592	8748	4139	55714	8620	1613	8851	85360	23415	8843	54982	343990	6943	56731	79365	3751	5897	23291	81839	79792	2946	5475	6037	1656	57152	51493	7316	6919	7538	3360	9209	26212	2677	8153	64981	5729	8189	7180	9509	3162	4524	51161	56342	23022	100287025	7564	8513	51560	23237	4059	3753	1121	266977	79701	6799	5276	2099	118	9080	303	55364	5032	51294	1129	2064	11281	51806	440193	442194	83637	6469	9480	63976	4239	7851	1019	79934	10930	54360	8629	9478	5098	153	3937	29802	9204	2995	2237	100287602	115817	7105	1369	5476	64091	8808	23615	3615	51450	7123	27125	2308	1511	4312	7177	1807	55592	64757	65057	1448
GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN	M6060		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2788_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (6h) versus TGFB1 [GeneID=7040] and IL-12 (6h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					54469	865	64376	23036	1535	2212	10527	22911	1432	6748	2060	6203	2155	11010	6158	55837	2015	4719	701	10989	10154	5330	3098	55022	182	51082	10802	64218	55650	78990	2581	808	23533	8638	2249	1783	22823	79943	4493	55297	65117	400410	4673	51643	8087	51099	944	25852	29094	3981	6206	8289	3034	6434	56942	27071	8477	29072	7528	353	2918	3178	55255	214	23059	4800	2885	3430	10114	5525	4938	8683	27246	64925	56478	2222	710	8545	29121	8874	23588	5795	57470	6133	539	10490	6129	29103	14	2348	825	1314	3945	8554	6003	10084	123872	79134	10951	79161	6416	9455	9774	4733	64750	79147	9100	158471	55717	11079	9759	3718	8672	9921	28785	6978	3120	9786	8675	51700	25983	9841	6187	22850	23394	23528	57396	7409	9170	22861	23586	55023	953	6038	9045	55601	53339	8493	8621	8567	64940	8204	9813	8666	26092	10476	3939	50802	10161	29789	55696	83696	9683	6147	79651	10250	1060	829	7555	79005	28962	22932	55181	7529	26574	6141	5696	9445	1351	163486	3557	3301	6611	222487	8934	10560	5277	79746	1738	5606	8106	9611	4194	10849	8972	6950	6883	56997	54499	11338	64116	57180	10607	5825	7132	29896	26191	51306	6231	5977
GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP	M6061		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2789_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (6h) versus IL4 [GeneID=3565] (6h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					3699	9868	4990	94059	79086	54918	10006	192668	123722	5529	4867	4733	81631	83480	11315	8578	150275	10785	7468	51454	26010	9943	2861	27087	92106	55124	9804	339327	6640	51061	374659	80173	6367	2967	7056	9368	388536	56935	8531	23471	759	2280	2931	6005	1184	7539	7706	2645	283152	2319	79036	8565	64118	10713	83734	57161	150094	375616	5684	54955	7535	5424	8208	10535	689	57475	9635	4946	64225	25855	9409	5081	346673	1465	79892	170692	8241	285525	118980	54756	7516	55898	50624	83743	3651	2879	23196	116983	5283	28991	3849	9682	4585	649	6304	7277	58524	54915	285800	3747	9788	26280	79132	815	50964	8738	8603	1415	222658	55176	119504	55255	379	668	9188	50814	382	10921	2821	4299	84680	8538	6018	9956	10595	3351	10003	1719	116986	2339	401399	9820	57153	57106	10880	29928	6039	165	144100	375791	6925	10800	93408	55743	84552	9040	64951	9747	148304	11043	5793	9892	23417	65986	79735	9600	845	283848	3791	55748	166647	51614	60386	7709	65003	283383	23549	6804	64094	1429	81693	1306	5662	53829	10856	55766	57188	6652	5602	2676	894	94015	4352	150684	5498	25911	254295	3549	80223	389119	388591	63894	113026	60506	84720	2171	94033	55245	1678	389813
GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN	M6062		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2789_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (6h) versus IL4 [GeneID=3565] (6h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					976	7408	23478	50804	27335	338596	26519	8631	51430	55149	28232	64983	23589	83943	51374	170384	91612	10769	57095	83719	147912	84693	57484	5530	8454	5133	84939	25963	65008	64776	8303	1432	9611	659	581	558	63905	348	57573	3281	3490	26355	3689	10536	10066	79896	84321	57616	29902	3815	342371	23331	112495	8554	23609	55794	8019	143458	1595	23304	2628	55072	317671	55750	55145	80232	1152	8575	200734	9258	55729	3123	11269	285704	8445	55707	196383	56888	55272	55884	92609	7284	253558	5910	57798	64342	51147	84105	54802	254394	22818	3295	10870	29085	84987	4007	114049	1026	1875	10250	55909	64417	79969	56204	5438	8933	29959	675	26034	83932	55825	3002	317649	3188	8915	8826	51744	51535	7181	5537	7024	10465	79719	11237	10313	51188	493753	5252	5255	57610	23052	6047	54680	120526	889	6150	5598	373156	79654	25778	22876	130340	29103	154807	1153	163259	55719	4893	57102	204	2014	10051	5898	8733	4635	1017	10121	969	25829	54458	54602	7570	54882	23332	6624	91687	23218	2589	50489	56267	387521	259307	2622	3071	6949	10975	11329	152100	2113	4701	57488	25932	1647	1584	28985	5291	83860	5142	23108	28959	55852	51808	80709	29886	6720	55758	54850	56674	7982	8609
GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_6H_UP	M6063		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2790_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (6h) versus untreated (6h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					113402	157285	80222	54602	1846	116985	284001	55829	56954	1994	643529	8924	5686	2817	90701	84315	9958	54729	23543	55437	84153	26024	165631	10938	57333	4974	5684	9839	401	1822	7458	10056	92973	7327	51025	3275	6597	7264	4720	1537	58472	5791	11137	54853	131118	57414	26173	1164	51522	1992	90737	28984	23524	5719	1528	27339	400657	163071	2000	1015	340085	387885	83606	29803	23061	4176	51032	55331	128061	85495	3783	4719	1762	23582	26519	84939	23390	11221	6206	8636	11065	10987	4175	55016	573	6839	9114	6146	2194	27069	27133	100289053	5996	3754	9019	3098	8220	51733	9341	128387	23353	8544	9528	8629	81037	11018	4726	3082	63826	79903	7371	622	26136	54948	8192	55249	51529	376412	10897	946	4695	92745	1642	5863	55320	23184	23642	64777	65264	1026	2213	284889	10466	56888	58	22878	51018	399669	3799	10235	112574	79760	9166	84861	8607	5303	8792	11151	91869	79089	727957	84248	138716	6139	118813	2934	8543	2027	50865	55813	5721	23130	57491	11182	78994	1445	11345	8635	147650	10316	5756	51606	11329	6836	84262	121355	201931	9194	1457	9377	26472	51690	80178	8507	11260	128308	4043	5380	375	9088	79050	27183	8366	79683	23015	3643	6132	2962	27153
GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_6H_DN	M6064		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2790_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (6h) versus untreated (6h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					1859	9860	51125	23160	80700	331	151636	171391	51631	1804	200205	100506668	401321	79805	220108	256987	100129620	126668	4591	151534	257218	25842	10903	64100	319103	85013	219541	56271	245812	57818	9670	53919	692205	11051	10803	9016	2188	51438	57570	2920	8915	2035	6415	115019	161742	119392	54553	6722	4094	285346	246126	57051	57211	51495	124540	51421	360	917	165904	147872	100131227	2186	91368	8505	7107	2277	1299	55478	85302	7010	55904	112885	162972	57542	11178	728661	5063	54830	57496	11167	9306	55692	55848	9293	4801	56920	56967	79991	312	80010	51130	8170	10933	56944	221914	56897	9456	3151	54842	2886	9737	8577	416	6733	391267	10274	6772	55744	678	84547	169166	121278	64921	2120	147841	388695	368	24140	399	90333	10733	80012	63939	23383	204962	196403	3187	64750	379025	143098	153241	63901	6613	55188	84159	7767	100131283	64858	79582	163351	54737	84669	4321	255928	51082	6938	57530	1551	84131	57498	100130705	200132	5111	114908	5175	79441	167	54994	51742	4585	58480	26039	375387	202020	1298	6387	100131941	58155	79172	55728	84285	51097	23505	5583	339929	94239	7525	923	8687	9841	654433	130574	79666	5724	643677	100291336	6935	348995	3561	122481	145173	55796	3190	166336	3909	1111	126731	2643
GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP	M6065		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2791_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 [GeneID=7040] and IL-12 (6h) versus IL4 [GeneID=3565] (6h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					10245	84939	3747	55775	27164	1019	286053	10465	266722	166979	10949	57407	221092	10656	29899	5347	140901	81930	23514	133121	6571	56886	2972	200933	3751	6603	8872	3608	25940	11238	11333	92609	26284	890	24137	1870	132158	8450	80222	4255	1005	144455	84320	8562	79830	114781	54875	222658	6884	60686	445	3836	25758	81542	22800	55081	1017	57405	10614	202	55893	64710	84902	93273	317662	4815	51460	11143	136306	23059	9367	5910	79576	5886	23062	55916	83463	201725	5558	994	1036	151987	2935	84249	4644	1434	7153	22955	56267	10592	81887	10282	127540	54443	126526	51234	51285	5933	11340	128308	92126	8048	9918	63979	22908	56647	84068	9212	29889	90990	54623	55010	343099	9709	23594	7419	6879	112840	84515	79697	55683	55656	55055	151648	139322	58506	51333	27068	55862	23643	6854	54187	55631	5929	4783	7083	51406	203068	7700	55347	4190	126133	64110	734	224	619279	57192	339366	79645	219790	26135	3735	64112	55832	64863	23234	23788	54478	90378	9343	84759	10733	51449	63877	11004	54801	4128	84524	2627	10229	9184	192286	8910	91694	10856	9055	79624	6499	7272	163259	23617	388403	55219	51318	10735	80273	9817	83637	51365	6944	79577	58497	2286	10652	8541	4924	56916	55110	1503	22974
GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN	M6066		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2791_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 [GeneID=7040] and IL-12 (6h) versus IL4 [GeneID=3565] (6h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					56963	79987	133690	10388	1536	25782	130540	22854	3381	5104	80221	134526	9390	57631	8788	6638	4829	57113	3567	158158	9315	3458	26030	120237	338328	27440	3936	5338	3766	2863	5179	768239	4884	10494	100128071	55228	1291	837	64855	22914	5463	80237	80232	221184	57124	4125	3363	60401	65083	283953	148808	6689	23682	8468	91663	6997	119	128653	10538	8326	126969	57818	84142	60677	22858	51559	3221	119391	26092	846	162515	338692	54808	642843	288	57622	26257	54626	6919	3570	30009	55321	4004	1956	161247	9194	200523	57597	79025	285852	1311	3351	54504	9333	7466	6770	1999	23553	9545	253827	92949	3572	169841	11254	257629	90316	162417	419	2483	9181	7549	2867	57408	84525	253012	400629	11282	2252	100287362	6351	91584	10924	84617	2731	6700	2838	10198	4808	10461	134	80834	11031	64753	2009	1014	6622	4005	6295	5020	727	931	340061	121355	2644	51287	729230	55654	1184	26873	5406	11202	933	2619	9805	5212	22866	2701	158219	79696	2213	57018	160851	5581	1809	27177	388630	583	128209	100506612	83932	5996	4597	56899	3232	23371	219409	200172	64772	84134	7380	4647	55068	100129924	85456	411	3887	10870	201232	286133	115123	80199	84818	4212	129804	6299	341359	646424	146754	10803	10998
GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_UP	M6067		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2792_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 [GeneID=7040] and IL-12 (6h) versus untreated (6h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					10801	113791	6001	3399	1831	275	9742	28755	28978	399665	445347	4063	55423	7852	57446	23199	51385	23484	11138	3635	23503	442216	11015	388969	56967	79659	210	10677	51466	80070	57116	7128	1027	79175	120227	23127	23270	27165	10585	5620	26119	9087	1200	59307	1293	55825	89927	440515	55056	25875	22861	2317	51761	10681	313	81855	83463	54762	54820	2916	5802	10267	63920	53347	64174	2309	9187	80003	57326	960	25839	728661	3579	1838	80342	2051	9203	84726	9697	64798	10106	26580	57125	9923	49855	6224	57535	3445	6297	25861	8800	23409	79772	50854	9249	55785	22835	3818	1954	51011	3695	6711	91355	9254	5498	79140	23148	54923	285830	1911	5330	6932	51092	1643	272	9397	23316	79891	9806	50717	9770	5547	81618	5336	321	54996	3892	11085	1010	6135	585	6414	100126791	3590	23682	22802	26960	3952	57134	79890	857	5018	8635	26033	4983	1459	28517	6666	154881	6424	22846	56341	10022	2053	23209	2591	81606	3603	11123	9124	9338	27241	80304	10090	11118	51384	23704	56941	51205	6509	51816	9064	6041	63874	79832	10417	79867	652963	3355	115817	63917	824	149628	92815	55713	22915	91851	27128	5826	254531	79695	25840	2788	64754	9121	55129	10384	57082	643641	678
GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_DN	M6068		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2792_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 [GeneID=7040] and IL-12 (6h) versus untreated (6h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					3458	5292	10049	493	23169	3595	5316	7494	3976	10954	894	9673	356	488	7804	2531	9781	705	8807	5734	1326	8837	2288	5770	3002	26502	23531	10963	80273	26872	30009	10797	3559	3309	6637	5613	7873	2242	80196	22856	10574	5045	3182	140460	10209	5732	51491	3098	10020	22800	1457	10598	29925	26272	5125	963	2643	5082	51651	8602	3482	27033	1973	25975	7334	8728	4830	578	5026	1967	3902	8776	1604	10912	81566	7371	10342	8809	4924	55254	306	2529	55110	56902	90861	81873	79084	944	161291	4049	55328	54622	3601	10413	6304	6427	8651	10130	31	80072	5721	9690	7203	5621	23150	205	56521	3312	3430	11014	23035	9674	5367	90	632	9595	7332	64859	56681	79693	23516	10906	50810	4144	79077	6622	55270	9759	81034	4615	7453	7756	6510	8061	83483	3490	80830	1478	8934	55505	79720	5315	54928	10452	54433	6443	9871	8704	9489	4122	79109	29919	8880	204	80255	11171	993	6421	10813	3364	100130449	81614	23788	9712	6185	10728	5202	5551	54904	5036	8829	29851	3394	7124	5711	10538	3627	7171	10063	8939	55532	54968	54503	7414	3735	6993	5686	7919	2521	30811	80045	4283	291	138151	54107	81831	6780	8726	54187	80223
GSE2770_UNTREATED_VS_ACT_CD4_TCELL_48H_UP	M6069		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2773_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 (48h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					28977	202018	57128	2235	125144	92935	151648	55703	124935	6747	119559	91978	29887	80230	5049	55599	8086	8971	222584	1736	1477	55226	3006	55734	4548	3684	54935	54145	131096	127253	55915	4976	80740	54928	10238	64768	54987	10398	55216	55670	79896	1018	9392	23076	54675	55051	10799	84275	112869	7941	10940	3980	55291	8131	9730	85236	145389	55624	23173	763	5301	9967	6867	60625	10380	58478	92241	157697	118987	56983	29099	55908	4683	54882	7416	5716	5987	339287	27229	662	23471	55863	9659	58493	79133	55316	5686	7592	5058	219927	55869	79084	9373	7538	80161	8563	53981	6046	4682	79652	55181	55068	10762	25818	285282	6665	2957	9690	55794	8892	160851	5515	5519	9904	55884	83858	27069	51099	5683	22801	10713	339789	200916	5203	1908	9364	9662	64794	11157	1357	80155	57720	23450	124801	2648	29125	54332	9738	9321	25814	84134	10419	23511	81034	100288618	51082	22948	23107	163033	113174	84444	10138	391712	10954	84842	56648	55163	11049	56904	57231	4591	25842	219743	29991	836	51060	51074	708	60488	9093	8884	148709	23483	22841	58531	6698	51652	347344	58505	55852	151194	54537	3326	26995	8050	821	23161	8343	54431	87178	1953	27292	11052	9774	114036	4860	54919	440738	3609
GSE2770_UNTREATED_VS_ACT_CD4_TCELL_48H_DN	M6073		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2773_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 (48h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					80328	9256	7554	10781	284443	1514	147525	146198	64577	6804	9966	113540	285547	8519	23303	51008	3902	2672	27236	51655	467	6641	199870	8933	288	57688	22877	254128	55857	286223	340371	54102	5264	162993	4779	220930	7275	1130	129790	57149	26145	2120	10800	283861	2768	7292	923	7673	9781	5922	9759	57549	130502	284309	202781	6655	54662	51276	729013	8742	400713	254225	7553	55506	78990	8974	147923	84628	51706	163051	7422	27348	57097	8856	91543	677769	64388	51449	55034	201229	64651	8609	123879	8111	5906	6302	4123	130589	80206	642361	3300	955	79744	57763	51231	5144	9263	5067	112	51299	142678	8651	285311	285268	9382	6688	59351	163049	3656	9636	55672	3632	9265	22873	90987	25778	1958	129607	54811	730094	9710	3725	10741	79692	285500	285346	604	157562	1454	147837	441150	3433	283551	22902	387755	90594	6774	65985	387723	101	374666	5140	401124	116349	8427	221477	728537	138716	5800	11226	57181	6364	90634	158427	5151	347744	89894	57619	9711	51316	441072	10225	126231	1046	7633	23403	9907	7076	388677	283755	27164	55167	347902	3338	157627	100132999	3911	7306	2040	51754	822	84133	22980	5998	91768	150726	3707	4524	148156	597	93134	51246	57692	9051	22822	79661	23283	728855	971
GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP	M6074		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2774_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (2h) versus IL-12 (2h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					79752	51082	10106	6717	7592	8021	5279	60509	140462	29942	28977	92935	6370	6416	158809	55163	3167	5973	10412	55734	3364	641638	54879	202018	50854	204801	140832	401494	8563	6944	79814	7294	100129407	23105	4591	9948	1310	92241	6122	1993	125144	127253	22920	8892	80817	100288122	1477	160851	55274	79154	114036	151194	55181	6159	27163	476	6210	121227	3655	79652	8664	85461	56953	51115	4130	200765	26115	2041	9535	219743	56648	2961	55023	84650	339287	10699	5608	1933	9904	164832	119559	3987	9467	55869	2319	2191	29125	9016	2555	328	85438	6138	51020	441951	23616	51086	5892	8665	9326	100132596	26658	10810	55700	23164	284325	1345	84148	23108	221481	6165	25818	89941	58493	340178	85406	1350	100	100128594	100147773	27297	1663	29991	2995	1819	11281	283554	642	1849	150350	4666	10464	387921	7940	3083	154089	28232	6143	127841	6323	2790	100505881	3621	7392	100128281	6917	10092	3762	124790	55013	9093	152519	90139	84330	6130	81579	10015	4804	4973	8723	340544	54930	79133	6161	291	23521	80059	7086	732275	4327	4705	1510	8748	9364	58531	9419	55226	348093	55599	114883	83451	23093	63939	6135	51506	4976	222553	6136	10302	3620	157697	2565	100291860	22821	51167	11172	26523	27287	338094	51433
GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_2H_DN	M6075		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2774_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (2h) versus IL-12 (2h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					2768	3560	10567	80271	10148	3604	10827	27198	9907	2778	6804	55738	51299	3902	90594	5906	4056	79673	2691	22822	3709	467	5329	64651	123879	5144	3656	8784	144811	923	374	113540	9673	101	54732	9647	138948	57404	5361	9034	79230	3300	126298	256051	64577	81617	10296	4929	8974	64092	1051	10800	9047	7280	129607	147837	284801	54541	4779	310	4091	1839	10010	339479	1846	55034	10766	8140	163486	2120	65985	1146	138050	238	643376	3632	54849	3725	55791	347744	57162	3995	9261	65125	23207	23061	51706	677769	952	1130	53405	8651	100289420	91543	51008	219738	9677	9256	1513	55525	79143	1153	5734	597	1958	2744	54453	51150	23510	10404	23564	6774	6256	3433	126259	23657	3831	55332	116349	23198	147670	288	462	51278	147040	7673	375449	375035	26507	23764	84173	4193	7699	125336	64926	10425	7316	5140	9711	797	6483	55829	84419	27013	23294	54872	79038	10135	7076	7422	9258	3953	157562	59351	1649	54884	5154	114801	2242	6304	100505518	374882	8693	8560	25897	54925	9456	23303	152078	440400	79139	822	54540	23274	114785	7090	317648	8638	81796	284207	157506	26051	55237	10776	23529	7832	1318	915	27351	64127	84527	1454	8111	9595	93134	9655	1514	64332	2887
GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP	M6076		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2775_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (2h) versus TGFB1 [GeneID=7040] and IL-12 (2h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					112	64172	10644	85025	8609	80217	284900	9313	2217	5608	80206	26145	7275	84873	26100	147525	142678	284346	728716	100129449	23408	200765	27132	338094	55450	23164	347902	254128	100129407	124538	91	285513	7554	5768	389792	400960	6272	285755	2139	283120	339766	283861	57002	729013	8795	84133	126272	157285	5083	10810	54830	2064	340544	6655	143941	286135	10076	80817	1993	2555	8519	5075	220930	677778	79661	4705	100505483	441072	25823	10964	100147773	326624	340178	10516	7587	401237	5279	477	2294	11223	285268	321	51086	22953	22902	84063	5067	56953	222008	401124	51204	7392	9710	80726	283174	440503	1000	84680	285346	1588	54795	4645	79784	1489	5998	27164	1604	55506	90987	4485	3620	340371	55013	91543	204801	54662	10742	23108	140832	642361	64776	6323	79917	285550	54879	285311	554202	7432	11043	85012	130502	6019	196475	51741	145873	80011	26085	1002	158809	84441	51316	134187	51209	148327	131	386597	114769	1188	1755	732275	146853	138716	100129309	51063	5652	114041	1788	6320	388666	342909	158866	26267	100507501	7292	666	148898	288	58480	100128288	387723	871	56156	27090	57619	10800	129790	153642	2948	100128108	157627	5152	57523	473	11328	56547	5379	6641	90139	286223	26266	116931	4804	29942	54059	93183	57115	57190
GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN	M6077		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2775_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (2h) versus TGFB1 [GeneID=7040] and IL-12 (2h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					91801	2495	55908	375035	27198	6520	26507	23333	2563	79366	400	10094	130507	79691	55703	5361	29766	285203	64768	63928	23173	55226	54093	55915	84641	4717	200894	1846	132204	5144	85236	79673	25932	4976	11049	9689	9659	5203	25842	10802	57699	9690	51060	80218	7013	662	254042	56983	81034	57404	84240	54675	84275	142940	3006	9801	5885	122651	11060	5191	80271	127253	763	54145	53371	5778	79840	57128	55327	5519	3364	28977	3980	112869	4682	5719	10105	8898	654790	22929	55624	10137	145389	6747	10061	58478	8864	138948	9761	8971	51076	157697	2524	3604	57720	6510	100287547	965	4301	5987	163033	119559	23210	8294	8358	2966	55884	84444	64216	7416	7337	55802	4056	9321	56993	5049	23480	6421	5479	84896	2219	58493	8992	56270	51030	100288590	85013	8732	9677	55132	50813	6627	51808	708	60625	55330	55829	54888	285282	159013	4792	204	85451	1349	829	55622	79180	648556	10492	55170	84134	5329	116372	100133660	5533	10799	65996	54882	1605	8662	134266	11193	7763	5277	11140	10001	123263	1982	55122	10436	7533	54919	6867	29967	137964	2741	9015	5034	11157	9738	23545	5428	51260	24140	10773	83787	84461	51202	28957	2564	8451	2833	64943	2509	339231	8803	26226	54431	54942	91949
GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP	M6079		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2776_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (2h) versus IL4 [GeneID=3565] (2h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					4668	23541	10343	338692	83999	81631	23626	60490	2720	5013	1998	80173	153745	497189	644925	253558	80024	785	100505478	144406	4824	92840	196403	54884	23387	80020	2195	144486	6038	4837	6281	54961	50854	84329	27156	5783	257062	83636	136227	391365	23300	135228	9112	5954	726	6775	462	58472	924	25771	29937	9725	56121	23582	5567	6256	23408	2547	3108	2273	887	1001	1056	147807	126206	55690	10579	79828	146542	84674	127700	24148	1907	974	6324	10077	54059	4926	420	113246	58486	79140	7297	84306	152485	478	2571	84148	253012	9026	256380	10148	3172	259307	1951	64231	56917	79899	54808	84733	6936	646603	379	328	29799	79927	116444	10587	2901	64601	124857	25901	26469	9094	63923	9798	6340	55140	10449	2330	9590	4969	25825	10750	23059	283130	10107	4350	54861	256979	55819	26001	5993	8546	163479	2036	1387	90799	221472	8871	10567	653145	55616	7918	1235	3977	56675	593	11162	1200	83875	5132	115106	29941	55924	5770	131034	1996	8605	131870	127845	912	55584	9980	83591	84069	5225	9815	51524	85438	140856	51440	1427	57113	3756	1674	26160	10815	10948	7448	203074	9066	2054	84071	2134	407738	252983	200634	5973	79809	54978	3400	55195	9946	23180	11259	4887	201562	56063	57215
GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN	M6080		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2776_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (2h) versus IL4 [GeneID=3565] (2h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					5832	9818	7059	115123	51286	8139	8999	255919	60598	391253	6710	5537	6655	3972	8815	202051	3156	1826	8452	417	56704	121601	150472	3625	33	200186	2859	319	7804	6445	2979	2277	646962	30850	372	56061	345557	284111	51028	117283	7534	831	5232	22911	4191	10450	53820	404672	1039	171169	344657	2825	91404	8633	388228	51322	3236	5685	22918	57582	953	813	58538	27077	6307	9735	6440	55286	10402	1457	11260	92346	1213	4953	153769	3884	9855	1745	57620	90459	389384	54859	192134	4355	114134	404550	10810	166968	10921	11275	57687	2078	23483	8739	286410	647264	58499	9021	174	5427	668	9953	93380	51201	94103	246176	3364	5862	1525	10654	3098	6586	2161	64866	84340	2687	79591	29057	89978	84928	147183	54546	80155	55973	1003	5136	1595	9306	57463	112609	5367	257169	5597	2043	83729	3267	252995	10046	143162	55173	140576	644815	118924	8034	285	56477	9113	2018	79753	79850	27129	55765	830	55331	54101	26277	55677	6714	54517	64145	57708	51802	1161	7429	375616	196	203547	10245	9751	200132	23658	55312	84818	81611	1147	57528	9695	55326	80737	57026	8864	84000	80146	26135	4616	23435	9442	56889	64806	4282	9141	390999	51025	167410	57622	11238	8437	2182	497661	245930
GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_2H_UP	M6081		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2777_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (2h) versus untreated (2h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					5042	3682	8455	54458	3021	3106	9966	6233	22848	36	1603	6137	7381	51372	3554	729082	3858	51386	83544	158584	23492	7001	6144	201562	56172	6139	6194	7311	7089	6128	1112	6777	8195	93621	60682	7155	4050	10277	8536	91179	55629	100306951	55851	6189	100128731	128439	6218	8992	27018	22977	10972	56886	84293	5204	3107	254863	90624	55353	8677	5655	84376	735301	9926	55829	8665	28996	861	2152	5411	4695	197370	3489	55102	3552	338620	51727	258010	79718	130074	51614	6916	25816	1975	3596	150967	915	55801	25824	8761	6204	10169	6129	4707	2589	84641	100128191	284266	397	159	9827	4353	54841	9452	165057	10257	5955	84271	26278	55012	5859	80219	280636	57862	100129250	6529	6367	154467	8733	9781	6374	23344	10233	1933	116987	6638	79572	64781	55342	51150	160287	857	56994	5934	65056	51621	51228	2332	23464	130540	26986	9639	23169	84912	729088	54344	10449	222256	51192	90957	93144	201780	84679	84159	79447	10159	51596	10594	64776	6202	497049	6165	7296	6879	481	54681	4014	79612	56474	11278	8763	10949	196294	440952	51108	148423	51201	158880	23020	3560	415116	9695	6248	8738	11315	57291	53373	6122	6310	170622	9592	6188	4048	5062	6155	60559	80714	5578	4487	119504	5893
GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN	M6082		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2777_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (2h) versus untreated (2h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					4277	4218	51100	3965	1028	3429	1192	10410	8519	9517	1997	4615	8820	64135	824	55303	4779	9111	10581	1847	81894	684	201176	81030	8775	373156	51131	11044	57169	8812	2766	64761	6373	63916	55337	8900	57047	94240	3430	51510	10379	5883	51513	6993	2643	26270	10392	84875	5168	9567	10589	81844	127829	10561	23424	27013	952	4061	7726	2000	29761	5359	26133	10964	55748	55106	4940	6303	56913	8638	9325	29959	6672	23385	644	143	55603	9637	54020	729839	64859	2787	55969	23347	51421	11277	121268	7280	8743	255783	2959	3601	4600	57162	83992	7403	3431	440836	6773	353355	8269	51164	79132	100287807	81622	23033	55501	5610	64343	9885	7706	85441	10906	24138	8237	3665	140739	9247	3394	9246	25976	23586	151636	5734	2040	6737	27348	51056	50650	51667	54809	4939	55601	27074	26010	54739	51251	65979	26228	3428	6009	9636	4938	8464	148223	54877	135112	57088	132321	23070	245802	10133	22938	10678	100133019	83853	4343	6102	51422	100288551	29115	83666	64121	197259	55683	54149	10241	9334	474344	3627	28571	7444	23099	246269	84883	23351	8548	8760	285533	4332	152926	203197	9674	8906	3433	51309	3669	202	80213	3660	57590	3357	629	25793	51246	85025	219285	10179	580
GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP	M6083		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2778_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (2h) versus TGFB1 [GeneID=7040] and IL-12 (2h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					54472	225	25	80325	52	88	11085	11174	79924	136	156	84632	116987	64902	100271873	207	223	144245	440138	199857	255239	651746	203286	128240	282679	374	378	10564	10776	55102	523	51382	84752	388939	4059	79370	624	146227	633	80823	9210	51027	55643	126567	57685	157922	23271	84674	25776	646019	202243	100129792	51134	84692	729440	55704	890	899	10983	1235	923	389118	8621	80279	1028	56971	1990	9702	80254	3426	1107	1128	1135	91612	79745	22883	23059	4848	245812	152330	1280	51122	10699	57175	84940	51241	1361	131034	642843	8532	286204	84699	1389	64478	1476	1477	1488	1521	83992	2921	120227	27128	168002	147906	51163	9162	11083	1733	9231	63950	728656	55192	373863	139818	147991	51514	84062	285605	53905	79733	1891	51295	80153
GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN	M6084		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2778_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (2h) versus TGFB1 [GeneID=7040] and IL-12 (2h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					11055	23503	170261	51530	26137	388403	11260	56949	80335	54521	134430	11193	7450	4013	23355	55823	22846	219333	8237	7399	7378	100131816	7316	54957	57045	51174	80727	7270	83538	7224	27037	140691	6737	54210	27095	51673	10766	7135	80351	27242	11013	9407	29057	54867	114795	147798	7098	64518	23424	163589	26123	10915	8887	80835	319100	51760	55014	29966	92335	85439	30968	6773	83930	338596	6754	219938	8470	8724	9751	6616	10322	57154	23676	23381	54471	8140	283537	8501	55334	10999	83733	9389	6510	6496	388336	6469	284948	6422	5104	12	51734	1731	9037	64218	6404	10483	85508	6341	23034	27164	219790	56475	257160	127544	220441	9781	6041	6017	57494	196383	9886	9400	5937	375287	10156	115273	55647	5872	55278	5753	5743	5738	5737	9791	5705	5704	5693	221823	55170	5587	5567	27166	639	84106	11230	51029	5520	55607	26051	51400	134187	5456	5444	79156	51196	5331	81579	5569	5286	8554	8929	84295	192111	5214	2923	10846	115294	10914	11044	5029	53829	64805	5023
GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP	M6085		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2779_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (2h) versus IL4 [GeneID=3565] (2h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					225	176	52	156	4329	79087	85365	255239	203286	378	55207	51309	405	10776	136991	55102	527	8992	51382	145173	79630	624	633	9210	55320	57685	10203	157922	23261	4076	113201	378807	55871	285025	51134	55704	63933	51362	1008	8621	56971	1069	1072	57132	91612	23059	123920	245812	80347	51122	23412	84940	51241	1363	92359	51185	1389	4253	55917	2921	10926	79269	1642	11083	9732	147991	286148	285605	11072	79733	1891	51295	8662	1973	1978	1979	26284	2069	2079	11336	283849	11170	201627	23116	9780	64762	2176	2177	55711	80204	26268	9896	64838	96459	2298	2308	8790	2530	2596	2734	29997	51026	27238	134391	65983	134266	26061	8841	3073	79802	3024	3006	5654	3421	149233	54556	3674	8516	3700	3717	84078	56888	169522	10657	54813	55975	402569	353333	112970	3916	51056	9741	55132	91012	143903	8543	1902	222229	51631
GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN	M6086		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2779_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (2h) versus IL4 [GeneID=3565] (2h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					56893	54993	11055	57732	23503	51530	7704	7535	388403	22803	11260	56949	7477	10406	116143	80335	134430	7450	375567	127731	4013	23355	55823	9218	7390	151531	7378	137970	89766	7299	25828	57045	117581	7991	85378	51174	7270	146057	83942	25987	283989	27037	140691	4591	285852	51693	11076	53373	54472	7143	7137	7135	9966	8740	27242	79089	389827	255043	85025	113452	140738	27112	54867	55858	55654	11070	11018	83941	7098	7051	56157	64518	23424	221400	163589	26123	79867	10312	6939	10716	29110	1155	25771	9797	80835	8148	319100	134864	6804	55014	3925	6786	83930	26228	338596	81849	6745	399473	124976	404203	153218	219938	6676	6674	8403	6650	9751	9892	6616	10322	23676	54471	8140	9498	55244	283537	23516	10999	9389	6510	246213	9122	6496	6476	388336	6469	284948	84251	6425	8175	23544	79918	6906	5104	12	1731	9037	6404	9717	221935	6341	9522	23034	154075	6280	6279	864	285180	23223	56475	6158	140801	84268	257160	127544	9604	6041
GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_4H_DN	M6087		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2760_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by TGFB1 and IL4 [GeneID=7040;3565] (6h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					225	80325	79777	47	88	11085	81792	23536	136	156	116987	23746	9495	4329	230	144245	79087	57463	273	26287	651746	124401	203286	128240	344	282679	378	10564	51309	136991	1386	55102	527	8992	523	84752	2583	9529	8314	11176	582	55859	633	80823	9210	168667	51027	673	26580	55643	9256	9689	114904	126567	119395	23271	23261	4076	84674	25776	256309	202243	80125	339834	120935	729440	6361	595	894	899	10983	923	1009	1006	80279	1040	56971	1990	22995	9702	1069	1107	26511	1128	1138	91612	63924	55847	123920	245812	152330	85445	80347	8161	131873	51122	57175	84940	51241	1327	642843	84699	1400	1429	1436	4253	1488	1536	27128	1618	10926	79007	51163	79269	90379	79139	9162	11083	1733	1742	9231	63950	286148	667
GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_48H_UP	M6088		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2761_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by TGFB1 and IL4 [GeneID=7040;3565] (48h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					7791	54993	118490	23503	131540	26137	7535	64131	22803	91419	7503	54521	11193	7450	127731	7441	54532	10600	137970	89766	7347	26043	56893	7316	7299	80727	83942	7103	7224	140691	6737	51693	7150	54472	7141	27242	9407	113452	140738	29057	27112	64418	114795	56157	64518	23424	221400	10312	10915	29110	319100	9288	134864	29966	92335	6773	26228	81849	6754	6742	8724	6629	79753	9892	6616	11254	9389	23539	9122	6476	388336	6451	284948	5176	6906	5104	51734	989	11231	26984	9717	85508	6335	6336	91179	154075	6280	9853	864	6173	6147	140801	643904	127544	9781	79621	6017	57494	50700	5937	54502	54922	10156	55974	5878	5872	10890	222659	25945	10076	374462	5775	5743	5737	57540	29893	136242	55771	5630	5587	10216	639	84106	11230	5529	5520	55607	26051	6992	84814	27068	5450	10623	29944	83449	57480	51196	23236	22925	30814	81579	5317	94005	55300	8929	84295	5216	23244	2923	399967	11044	53829	64805	58495
GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_48H_DN	M6089		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2761_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by TGFB1 and IL4 [GeneID=7040;3565] (48h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					5062	8174	203068	9841	10211	4664	10808	7507	3336	375035	4862	8624	10531	7428	26018	51552	6793	11325	6397	2193	967	94039	80862	23	9695	6132	6400	3557	2517	5613	5687	3937	8664	671	54732	528	55041	7678	6949	6850	1584	483	6310	969	4809	1973	8658	10575	3560	10653	10469	7163	241	6575	8623	10370	1026	23380	3122	8651	5507	1907	1839	9470	8662	7110	80344	116984	634	9167	607	25891	25816	11314	10625	10144	4864	9915	6832	4678	4973	5142	1749	9873	4110	81553	3859	1088	100288583	4729	5292	7124	4050	9134	5479	10397	7178	4978	240	5336	2114	399	6261	10102	633	10184	3791	4781	963	8843	4891	1847	7494	2146	10550	10541	3182	8724	960	10959	6124	9957	6690	8578	3904	10239	1641	2781	57149	23483	8731	8941	3091	9477	2213	6833	8864	7867	221749	3094	10268	8417	894	3487	56061	5129	202	9683	4682	4818	7804	347733	2023	22936	5886	10969	8501	220965	6775	29896	3953	3422	11068	1512	3442	643	554	23150	5768	8553	1036	25898	64689	100133941	9933	23649	917	4043	5621	1102	148022	9859	5550	9640	842	3687	56848	4048	745	705	8477	1001	57144	29	27349	51690	100506032	1439	3109	8733
GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP	M6090		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2762_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by IL-12 (2h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					8972	23604	56255	9600	1032	11258	7009	6275	22883	6777	51103	65018	5836	8445	53635	23492	313	6155	51573	8993	22904	23168	6036	2314	6774	1209	6786	23247	22937	4005	6117	6611	4644	23216	3577	7515	1396	10423	1089	65258	54432	23196	8428	9658	9189	5218	10100	10788	8639	7414	1116	7351	25840	65110	10610	23224	6430	26173	1982	8895	22839	5586	51433	100130418	6722	120	3337	11157	114882	7704	5435	3936	7741	57326	2810	10572	2289	23149	1955	23097	10388	8875	3034	7739	6283	4856	4329	339287	8520	79095	8826	10409	27284	55	11252	22990	8125	9236	10129	3784	5743	6873	10875	5147	10567	7750	8776	2162	4069	10588	10367	57476	6135	57658	539	10554	2778	157680	8031	5591	6732	10140	9797	9459	23214	6342	8364	25778	314	11129	4627	8460	5824	9488	23324	5894	518	7439	3705	3931	8825	7318	9693	6709	7411	427	4350	4673	10014	2548	572	8694	27255	8407	2204	11057	168544	4215	2896	847	8698	1431	8522	7077	23312	9918	6205	177	2629	4660	9993	2050	6817	366	5692	2124	6548	6169	8450	9556	3661	23545	26234	27020	4942	4122	11277	3716	26037	4758	7097	246	9997	5634	4217	91	23193	1794	6159	3146
GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_DN	M6091		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2762_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by IL-12 (2h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					283985	10493	6239	10380	3838	27005	26994	100302692	2926	55670	7283	54955	7533	171546	231	51155	84254	84525	9322	7009	60488	6184	5899	9435	6342	3949	10755	7001	10556	53838	7846	22928	64756	83638	80178	8444	138199	4528	399665	23466	64897	119392	7278	23741	29109	9368	54855	23531	205327	81628	152518	741	3619	197258	3241	949	79073	7562	55796	29901	10342	5702	3301	900	3337	1677	9905	22954	65979	8111	2966	92906	91419	4351	896	348793	259173	79671	48	203068	255374	51293	164592	7205	2720	55066	64780	79888	10383	6815	5634	7298	3312	23171	84267	6500	10560	10455	5682	9538	201255	162989	55057	1802	3916	51199	7580	9531	3304	10651	160897	7416	1122	8985	6309	81603	9646	2821	6117	7804	83985	26268	80854	10657	427	2872	80851	221035	57181	80709	401097	4191	79137	1856	5372	205428	390637	79080	5883	283149	388228	54509	55559	27301	6713	133522	3675	1445	10808	161882	9813	29978	51601	285172	9563	2137	55343	51715	2026	57189	1368	2992	140838	1069	25829	6494	54823	55667	3783	150275	81926	7466	29841	55502	27352	10188	28982	7541	80755	84769	5576	79944	56904	8434	29789	2767	9896	79180	5826	6888	2923	139285	84705	6646	64132	5604	10099	10943	84984	10329
GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP	M6092		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2763_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells: untreated (0h) versus activated by anti-CD3 and anti-CD28 and then stimulated by IL-12 (6h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					5831	9526	5723	6811	5832	26227	26122	388646	5225	83931	257068	90441	10125	254170	6520	5734	119504	16	1051	467	80380	84236	6541	122809	9709	84919	388558	51520	57452	7538	6509	4779	51646	84932	51531	56829	5698	55122	2256	6539	6890	391	10538	151888	49	7422	5971	10004	284348	335	51542	7369	1054	23150	6988	222255	79094	27125	118812	84317	55771	8834	8787	22862	9069	1649	83667	85013	285148	11259	54407	3383	79626	159119	9682	10979	3659	2631	1656	1978	163351	51306	5025	53340	29950	59272	284086	57587	8894	55093	57823	120534	8609	29928	6504	22996	643236	468	254359	3815	23351	54551	122553	54971	10299	157638	440145	54149	3189	8543	219539	5106	9521	127534	440	58526	2324	143689	4037	116337	5260	54842	6301	2634	57761	84869	81615	51729	440093	4253	5936	23306	4299	5770	50486	65110	25983	3350	9167	54879	253943	81608	6536	55347	3726	29104	6478	80762	100132994	8533	10084	10962	8140	54541	4939	1198	6563	84706	2826	4665	54020	54904	833	81844	6570	84274	118987	10439	51068	3631	2029	283991	64375	26005	23654	207063	29035	23760	122953	57148	3475	25921	23764	84419	5080	27316	389384	23250	9658	10957	348110	157724	3178	9639	11320	55507	136227	1238	92162	84928
GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_UP	M6094		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2783_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL4 [GeneID=3565] (2h) versus untreated (2h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					2149	1460	11078	2760	129285	4905	57175	138428	51020	54541	5499	51693	2647	29103	347733	388228	10329	221178	28992	1340	64743	684	84250	50808	6399	57584	5829	285362	9061	4126	8883	51126	55502	51160	127281	81490	8260	25874	60468	81552	23616	10200	6001	9016	5934	283871	8027	90701	997	29781	55734	48	2987	29095	790955	29922	128	55159	4689	7283	84705	4521	122060	84769	1175	10477	9124	397	2023	441024	60558	64928	5579	25865	4709	1967	65258	201965	9831	201725	58527	92335	30	2288	54858	29089	51372	51537	7358	56947	84936	55002	116151	8546	51571	57794	5634	51650	2821	4715	54958	83982	327	81847	84337	50619	65003	64981	6205	348793	8317	3927	10556	284611	29090	27236	84525	5611	7772	64747	8079	79070	5899	64708	47	2137	22	3619	818	4714	1432	113235	26190	51263	3930	64428	10573	51264	29108	5780	197258	54440	93185	5476	5981	79447	4725	51128	3621	6102	285672	113419	25941	553115	8760	84954	56648	23600	28956	284443	55090	10960	29128	84267	29978	29925	81892	51809	10982	4773	90507	56954	10682	199990	51099	4216	22891	79587	6342	7001	4697	11315	51028	6801	2783	205327	140838	3070	1660	51155	115752	2872	115098	57506	10102	1351	23309	5479	7884	10140
GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN	M6095		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2783_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL4 [GeneID=3565] (2h) versus untreated (2h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					118491	54778	57621	83932	103	143279	10768	5820	50650	147645	51068	5334	10203	10056	9020	148479	1294	4524	9832	84919	11231	25977	23214	23429	6563	120534	5214	4779	6416	54800	9388	1629	358	8894	22926	5770	6891	3376	80762	3837	8664	3632	4939	57645	11177	64375	91694	54407	58489	84275	79670	125061	3726	80271	8553	55274	55106	993	10613	23645	57602	55798	22889	9135	8639	79084	55226	1590	694	1654	55080	2997	1880	116447	284996	388701	3192	4790	29890	158135	23200	79697	58526	118987	54545	51605	6510	1408	4345	9794	2152	84166	84162	3344	7690	11259	30815	54765	440	134218	1663	84928	10425	5832	158219	23367	158798	4335	84879	9295	254887	155038	79865	868	5036	5359	115330	3937	9489	160622	79895	2568	7327	375743	92014	8013	6744	3717	3959	57190	116135	5341	51542	25902	22882	57823	10075	84807	56965	9950	3572	85465	8140	25932	64098	3753	3383	6935	257062	83667	4026	57162	55573	22880	23326	55035	80148	7187	57673	5025	83931	3475	51735	25909	116984	283489	6566	51575	4245	146722	51236	4664	1678	9962	55636	160335	9261	91646	11052	57478	54806	8602	8312	5187	9519	5460	257068	9819	10772	55119	254428	115004	5971	467	65110	833	132720	11216	1154	8178
GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP	M6096		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2784_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (6h) versus IL-12 (6h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					29994	8774	2623	64777	8767	9877	7358	57609	115330	7832	3914	10121	23150	55187	6386	6388	2672	6001	9232	10483	10181	55303	9797	257106	3572	5153	4145	5261	25839	22904	26469	3241	3430	84859	467	1893	23077	402415	65258	4299	51669	10365	2319	55904	6737	71	6811	1521	64219	25921	10327	4627	23198	22944	347733	79183	1880	4478	55843	8609	55596	2149	10924	285172	10125	1959	22848	26140	11274	5734	10550	3628	8567	5335	26228	25777	63940	284086	23526	5058	254170	10347	9920	57018	79834	1520	79571	64108	94240	79443	140456	87	10159	51092	23360	7389	27173	6251	51763	1299	23043	388646	8651	23274	4037	8943	9043	5782	339324	5142	28951	3964	8826	330	1032	23646	55824	116224	219285	10161	55252	57559	64651	84281	81030	5588	11060	11214	29909	11259	114883	7456	317	3963	9046	3394	255809	410	26020	9016	54542	54103	10320	4125	25983	1960	11064	51574	154288	9761	7846	64857	790955	256380	11320	157695	1519	3930	2355	54625	23446	57538	80232	9674	57674	342371	1314	27239	8780	6892	81704	9815	8935	138241	54861	84901	10087	399665	146923	11325	65108	4929	83982	79009	1911	3937	1877	10577	51000	11346	84342	56204	7706	55959	8682	23140	23041	84937	83666	9744
GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_DN	M6098		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2784_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (6h) versus IL-12 (6h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					55651	9656	57630	51194	522	205	23609	58526	79944	10935	8697	25974	51079	29068	60485	59067	26115	171546	7804	138199	118472	92558	5238	7508	11164	8462	80145	10477	6152	8099	10943	55825	89978	8555	100302692	221477	23170	27340	246184	1628	8676	133522	3141	23464	57213	79830	27089	1054	202	25932	2776	84335	6122	203260	2653	95	7325	7278	27044	51601	51109	400506	55798	283985	9112	84928	54969	771	29901	90378	8464	6742	29841	337867	1122	728568	1798	55274	3838	137682	51333	517	648	91694	390916	11332	23199	55973	200933	79020	64795	84164	84529	52	11156	283459	283989	9519	10575	10678	80347	11266	8435	440	388564	57570	4718	6146	23184	10072	55735	23047	84617	152002	1388	26073	55728	64976	54913	8819	51477	84649	164592	27158	54733	81831	1371	79077	2171	128	5203	10055	375743	142940	23165	112399	64978	10166	1652	11319	6888	201161	11146	22926	60412	26994	2671	126299	8479	57476	55752	3556	835	8420	174	5438	137695	8111	10949	10560	1737	22954	80854	201266	25764	155060	6239	22902	8079	6874	9319	9100	201562	23625	3265	8662	65263	83855	55775	3895	5315	8030	10280	7268	55699	57684	7001	23129	29088	55110	54460	1847	2966	283254	8443	25796	60625	2309	64374
GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP	M6099		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2785_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (6h) versus TGFB1 [GeneID=7050] and IL-12 (6h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					4705	154214	5837	9963	540	364	7503	27328	23539	30061	3111	2911	4597	80157	6603	7126	54869	55735	83873	6692	63910	51686	53353	2146	92342	90353	100271873	90187	440957	3078	132158	4798	55966	6899	54903	27159	9467	124773	90826	4833	7867	164714	4115	64799	5050	125058	57493	57418	24146	81556	22868	8444	83638	3956	338	326	254240	55049	55365	8892	54734	255119	10205	122970	83931	2790	7293	4356	149018	23601	128637	121642	357	8733	10369	2925	84076	84947	5179	10718	3553	23258	6262	27445	146330	9380	51174	11219	79090	117531	7029	10675	1132	1496	58190	26960	2072	100507656	84514	26086	116369	727800	440026	57535	9094	4861	6945	474358	138046	55131	119	493829	91304	3656	132720	26001	51478	11344	871	100287482	4708	10641	7804	7164	383	283871	114905	4598	23014	343099	138151	127281	2621	134553	115584	5507	3746	2217	30833	65003	9563	100506884	23172	200185	10631	10975	4651	5859	9424	3265	60482	23171	60491	6758	55095	7363	130814	79840	822	285489	79001	342918	57447	56165	84153	64207	1359	285362	54952	8568	56942	8605	23266	1591	84314	85442	80764	9824	8784	339665	23468	51278	1785	10555	90993	23204	8395	10644	161835	6564	10093	8407	391059	196264	378925	6705	3549	10573	80119	5331
GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN	M6102		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2785_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (6h) versus TGFB1 [GeneID=7050] and IL-12 (6h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					28969	51444	7798	4068	10165	1955	659	6647	6367	27018	157657	9786	200186	54989	5217	151888	54888	7185	26054	90506	4602	5269	64224	2258	6789	1286	10620	51542	63901	1729	84869	868	25948	26287	9619	1389	23645	55601	266977	9635	26091	25897	10297	57088	55843	6932	1911	10059	26065	29994	27258	10249	9582	25841	3010	51735	137392	10300	84124	54464	4802	55219	81552	4170	54801	9522	55819	56479	84295	51290	10565	8445	23518	79441	51094	842	7156	8819	55167	3918	222865	1606	94086	26122	7405	54101	10392	253959	55859	4938	5933	4306	81572	23161	1959	57055	83540	54726	54093	9456	54861	526	81491	345456	132612	1831	22838	60412	7726	55802	643	29986	57179	347541	4927	51251	5928	9968	26511	1633	340120	25896	79780	25927	4013	57498	23261	26005	57214	2254	23080	58480	7128	8553	59343	725	155051	10049	1495	8013	6651	162993	57580	114836	10628	64215	55023	9910	11145	9653	286410	65249	1609	50804	27347	779	969	55186	80705	3416	3181	1974	84181	8905	9806	10912	56129	9452	22806	114034	79568	11320	201134	10206	54874	8766	79778	338645	8125	134510	64761	65983	9063	10455	84002	331	10427	8491	51163	23469	2314	9604	25801	11259	84707	5996	26057	550643	91746	2923
GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP	M6103		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2786_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (6h) versus IL4 [GeneID=3565] (6h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					440498	11162	23509	7454	9874	4232	22880	57187	23648	4595	3566	64770	4501	11066	5579	126792	124801	51028	91319	1739	56850	201627	10274	3065	79876	379025	400223	4603	284086	961	6415	10616	283234	57496	8481	9325	2051	140775	4694	51025	375010	7248	129607	100128108	4683	493753	100134713	23467	79147	140688	10225	126328	100128737	92979	64172	27030	2475	1939	254128	114926	50853	23020	285965	10691	3937	65992	100506658	790	9166	65095	6598	4087	374969	10223	50807	2944	81876	400073	5195	729515	28823	138716	6932	5184	257218	2207	81544	22883	55285	932	8078	219743	55695	10818	51585	222068	54	285147	5341	63905	3965	115209	5609	152217	1396	22906	9805	9400	150684	339290	117584	11062	8085	91875	221477	10280	2678	868	84527	4820	136895	8725	9338	28985	55032	8835	28960	79664	8502	5096	22907	2217	339500	57017	5605	4714	2305	8573	5691	63926	115110	4123	1512	10892	6505	57620	474170	51160	128338	27068	58473	10533	473	10594	169981	641518	23536	89849	60625	11266	84619	84232	57140	10068	4582	54496	55601	1121	400569	8243	4281	55739	26009	9552	114801	653687	79035	79768	283270	1632	9112	5211	10618	51380	2322	23317	29083	219854	549	1519	162962	100289090	23370	60526	4174	728294	9330	90806	131118	51205
GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN	M6104		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2786_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (6h) versus IL4 [GeneID=3565] (6h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					79892	399665	529	23560	10572	25842	262	54472	197187	171568	1605	1017	8239	63874	10432	55603	10294	23336	54986	4601	6934	79832	6647	55746	84641	64410	10682	5566	2321	123606	60560	9419	55832	55114	5516	8165	56946	4686	8339	84549	54812	283635	51306	642533	10308	51742	91373	8846	27348	171546	113612	5996	79609	7700	10105	65083	149041	7278	64795	80331	440400	57614	10539	58528	5520	11116	56242	221302	682	26959	9810	10113	64843	51182	5903	51230	9334	7001	5230	84337	121665	10963	5168	54785	578	10301	5813	8531	7965	7153	283871	8847	23545	54936	2965	3423	6619	401548	8804	8795	6729	23012	11080	51141	25874	64282	5687	6884	27245	317	10677	79685	126068	5049	9101	254251	9875	9277	9361	58476	10397	55501	54918	25909	56648	10011	126308	6924	54906	53371	85373	90268	6307	55031	161424	5329	117178	83931	100507246	9997	9516	9900	23592	93974	9857	84930	64744	10276	3419	8682	29097	55813	55294	10912	51499	4524	7341	283742	10210	28991	9440	3796	339263	6341	79101	708	7374	1613	997	84520	1738	51400	23095	221491	10376	22911	57786	4076	388650	7565	256586	7132	79657	1147	51304	3604	23291	9752	494143	11345	348995	55781	10135	22822	84947	8568	285368	3622	55300
GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_6H_UP	M6106		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2787_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (6h) versus untreated (6h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					22834	10616	29887	7874	645745	100134713	25989	55850	283899	51727	55893	4087	10163	11180	24145	64834	285282	29780	222161	152217	1237	114926	5394	3181	50650	91227	285203	196383	541471	55122	54930	768096	4193	91612	9445	9667	57198	25816	7812	27068	221294	3685	29952	55716	317649	51091	1351	2969	85007	9770	51170	1719	28960	51097	57140	51295	9802	998	7323	79876	123	60625	597	10376	322	8725	4299	653687	5045	7110	26205	5473	5140	2098	4288	874	1911	4496	158219	50808	9344	23207	84246	63939	7389	100505761	155400	130502	54509	10166	2217	121506	221061	3495	51205	64221	150684	1636	3595	7343	56950	10274	60487	60682	91012	389203	4502	583	10893	285440	51696	26355	8784	89894	5525	50488	25777	23593	1021	100303755	23165	9200	55336	2678	60	2130	4683	56931	5859	92799	84064	11066	5499	7454	80305	89857	9991	100505483	84687	10404	65123	54939	283537	7132	10489	7378	8861	55506	23070	4720	4603	23164	156	10521	9862	10591	140735	81793	57337	146206	51160	9552	65125	9985	1155	5090	8875	100129250	7515	55260	25792	284058	54733	22838	90379	57018	129607	100128737	56920	11035	4688	84964	9398	11043	9840	5195	29803	8289	58473	1843	11156	3192	285521	26272	27247	7533	285965	6786	1808	10663
GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_6H_DN	M6107		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2787_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (6h) versus untreated (6h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					124512	11261	64793	134359	64708	84318	8867	84641	286103	81847	1432	154007	10768	113612	9984	8834	23473	93058	257236	5717	26058	55342	113419	23325	51128	23065	9731	7936	84268	23557	908	8780	8239	9741	9328	8539	51729	55057	23560	51058	196264	64175	8334	537	3241	25873	64410	9937	284307	100130357	54928	327	9456	83696	5357	60492	8227	5970	199870	10459	7879	56652	54434	51660	51337	57150	5147	8658	2700	85315	79837	51141	8364	9609	6500	64895	5427	55781	3633	1030	1062	54469	7189	349152	11182	121551	55617	84274	51390	51144	51599	339263	112840	10969	23012	6785	57508	26100	403	1459	9875	83700	92935	5814	23462	10135	55279	4285	64772	518	84261	54935	10308	197187	162972	56927	64858	25807	10902	55152	7003	5971	84289	84520	89122	5982	10413	7019	51002	151556	79183	25842	64843	9439	79753	1738	28982	80213	5903	90780	11252	6047	6618	1629	55720	122616	10466	124402	1337	56946	100288893	5451	283174	253980	10960	144404	113115	9919	7385	7349	219899	9044	9144	4649	29100	6729	55787	8992	51318	58191	79145	79102	8754	124923	84947	7267	7442	55505	7798	51283	55173	84301	51255	7942	29990	11138	4621	729680	342371	57555	55654	10572	23396	6453	2131	1318	10336	59286	57380	55197
GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_48H_DN	M6108		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2794_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (48h) versus IL-12 (48h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					2810	10620	54663	79832	6249	7107	25777	10762	1656	2053	874	8985	9900	11338	8651	55114	81930	6446	5977	80301	28514	197135	902	23234	60468	51726	7403	10803	203068	152485	85377	7832	9910	55249	57198	4026	133	8661	79368	389362	55611	90007	64219	8440	1861	8178	1102	5757	387882	83737	79053	27086	1503	10797	391	127544	51104	148022	150094	54881	28563	970	51755	57194	58476	8439	10212	22822	4124	5473	11044	23533	8165	8851	6541	222194	57473	10449	116541	22807	23358	79892	103	440300	5045	8477	23011	54906	3595	4092	10663	256586	10723	8631	1632	348035	10970	8514	10189	4676	57118	1788	6648	7342	56950	10376	6351	71	28232	79626	55603	578	26094	23401	3964	23143	1390	10294	27161	140735	64795	10962	23210	7316	1643	10270	5610	285282	9445	3495	7538	391356	4714	51566	8301	81565	9584	56655	22862	84817	738	55915	4176	11098	9522	25831	392	262	85027	10671	3071	4049	55313	84516	51063	124540	5908	6150	57521	126375	100507637	9531	83541	2015	10105	109	2632	51096	9616	10404	317649	8809	3336	27350	4189	1808	2205	26207	994	56271	51082	9049	9641	3587	58516	51182	23235	332	7132	3399	29780	10221	80305	23336	6428	59307	2355	10681	126298	51320
GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP	M6109		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2795_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (48h) versus TGFB1 [GeneID-7040] and IL-12 (48h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					26015	1968	91749	54841	647087	7879	5579	84826	54602	28962	51134	112840	84318	24148	55652	27034	23381	339229	53343	6617	25885	10935	9647	22887	55437	84967	54585	3459	121551	257236	80349	100132832	146198	10818	79085	5147	253980	55057	399664	79734	151556	25895	11138	55699	11182	285178	23648	60314	2188	2356	23396	84326	5226	80194	339804	79752	10554	23029	9937	84527	222229	10904	5257	55504	51441	25766	29990	57333	2512	54676	151613	5984	8227	112487	23557	6584	9918	9984	619505	339456	8888	79725	23085	100131564	54985	283345	51422	60526	80775	206412	22827	230	80221	26520	378938	140883	85302	137964	8218	140775	57380	9054	93058	55215	8334	100289635	84984	23386	140465	259282	5893	5990	100127983	7515	9524	57212	203069	475	83787	9317	25873	572	4913	53822	84296	80127	146057	64708	168455	257218	1173	286071	6881	63905	7336	5414	4205	81571	55004	81857	5702	54942	9129	51164	56927	84872	64395	57017	2550	51011	285613	1476	285231	152579	54662	160897	60492	84126	55958	65260	84313	10459	22794	23660	23269	9729	23317	9091	4621	56995	2582	50651	163255	7349	65095	1739	57820	80208	83480	5869	57678	51241	80318	64430	128439	22926	5188	51008	10471	29894	79269	9342	7203	27175	51699	11179	84105	23623	26151
GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN	M6111		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2795_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (48h) versus TGFB1 [GeneID-7040] and IL-12 (48h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					26191	55007	671	114823	116843	100507050	207	339541	376412	28960	9315	63935	51522	157740	51763	23309	65258	5037	10791	3148	11326	81887	221	4580	100507290	285195	56997	8125	9920	100130331	7644	3490	27102	6641	5538	91355	817	256236	147138	100133660	55116	11124	5423	9185	79958	10235	2585	210	11184	113763	348110	7410	22921	3340	115825	8675	473	79642	283899	55080	23518	29902	2313	7090	8986	64223	338773	55893	56994	7086	80790	197021	8743	3164	9882	112483	64595	9092	26157	10460	10270	79033	1903	11258	80745	27141	57719	5634	9051	29125	22895	433	8677	100113407	57409	84836	26469	286676	80829	9487	57190	54997	8013	4887	94101	9987	151306	3676	54108	374659	440193	7739	4900	57446	352999	51660	54507	5165	400709	4738	79754	10279	120	154141	83938	9784	10194	9688	64386	714	2342	4048	2650	3073	832	9679	399512	7422	147727	7343	23199	2648	339390	2665	3384	55049	79792	3728	2681	55004	79701	8609	283871	200298	593	5178	4522	11230	375190	84680	51280	7454	1519	10982	2873	8825	25840	84969	7536	6320	8895	10903	23225	5728	1808	25870	55766	826	23162	5732	51642	1999	100287628	26065	9545	144577	3998	59307	1788	5613	53938	1441	1124	818	63877	91748	8527	5577	51181	26996
GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP	M6112		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2796_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (48h) versus IL4 [GeneID=3565] (48h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					286451	100288617	199675	2140	3036	10049	8992	50810	965	55884	6809	64219	5641	6868	83930	6526	1497	84879	51524	7756	6307	5663	4594	124961	5154	231	7319	10146	10046	3678	1690	56548	55640	3783	444	272	10090	162073	8870	51567	23095	10155	8655	79802	63874	975	8564	91445	283050	26286	4430	6354	53349	7743	7204	55762	54925	3482	7775	55092	6309	28996	9969	214	7251	5270	7752	9948	8848	51665	7187	2936	372	148413	55705	153745	55610	1601	3837	163227	57514	3553	84292	51340	3092	3552	80255	4363	200734	54813	8942	4864	9034	11234	3157	113179	26020	1535	51434	7773	8544	55727	55180	64859	9446	7699	96764	22936	114294	58528	55002	5430	1203	5271	6507	1595	84102	5684	57515	26099	81566	8804	643714	64121	9832	3732	153830	3301	11102	933	6690	8566	51429	10015	5872	3242	1005	57169	58472	10950	100132891	55041	55958	26277	285761	967	7296	3312	10254	4327	9968	57192	116496	3656	7415	6729	3563	4790	6671	11014	5707	2957	23670	10282	85463	148932	1234	51062	7941	1066	9654	6016	6385	4780	5514	1427	23533	83877	64968	2130	406893	10421	10010	4236	8460	2495	1836	10963	6483	50640	8649	3326	734	10952	2717	84617	718	57600	23636	93166
GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN	M6114		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2796_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (48h) versus IL4 [GeneID=3565] (48h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					9697	4647	142678	1020	26191	3490	26	216	207	55004	9315	22921	100289336	826	6626	9679	3835	11240	1396	51362	29087	65258	221002	51669	92703	55723	23309	85444	54904	1958	26121	6904	286052	4609	202018	55893	23171	2153	6286	473	154141	54518	7386	1903	7507	157	56994	27352	100113407	9189	149076	328	22838	283130	200298	275	5295	433	23344	94005	9051	5538	91355	29107	51729	339390	22934	53829	6641	51763	7090	51061	51522	5037	340542	23588	124808	9185	381	9784	219654	120	7422	25840	5859	57533	57864	388403	58485	10347	4832	7464	9545	27141	55049	4900	157697	6601	26523	84058	374969	7803	27440	10982	4515	54455	80279	83716	9882	22883	23621	54954	11253	256236	210	91647	112483	10291	25870	432	8533	7086	3164	84245	123096	130814	8675	6036	10270	9797	84901	286530	23112	23569	51433	57446	348110	11258	22895	55819	8924	283537	9337	25906	10800	23229	54997	4521	400084	63935	113763	10250	10365	87769	133746	64595	374659	116151	22834	4242	56997	3676	79754	5566	8574	124446	64781	55116	8609	65993	54558	57182	2217	8522	54108	5934	112616	309	115825	11261	8673	57418	221	5867	79701	2948	653784	116843	84456	84191	28969	56731	7940	729083	8204	57409	10975	150209	8667
GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_48H_UP	M6115		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2797_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (48h) versus untreated (48h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					54856	23352	5048	8310	10866	9043	51371	6737	3783	83877	54777	6868	7319	6809	8793	5717	3561	5430	5707	3105	528	79230	7752	5682	84933	9119	51726	3106	1876	6729	3553	9766	344887	57514	51062	59286	26286	58472	8942	3099	9754	272	9446	200081	3482	4430	11342	3753	55041	8655	54971	132789	5872	526	967	54881	8848	345462	2140	6307	51003	8992	84102	23053	1595	2957	28683	5641	57102	285381	96764	51058	93034	5810	9034	80255	2859	1847	7879	3301	3326	127687	1186	10677	286451	84649	401106	5686	81566	7222	81562	4234	100132891	3552	6507	5292	5684	7699	63906	6385	130557	85451	4363	53918	718	10213	5055	10421	3320	51429	3678	112950	8892	9730	83875	6118	146540	4729	133308	5695	10308	5271	1026	53349	51232	4864	2730	1497	148932	51567	5913	567	147007	214	8649	27436	1508	3097	8566	1512	1154	8564	4780	10096	4302	3312	22832	7415	8804	285628	26020	79628	27299	79602	9968	58480	170954	10010	91543	7124	55180	197358	9263	84879	29126	29015	4758	734	8943	54707	5690	7293	8784	51606	10318	374655	51100	23533	51264	5782	1368	4236	64219	1234	3155	399948	90459	5737	112495	3662	25816	5700	84617	9605	372	85463	1778	64108	60485
GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_48H_DN	M6118		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2797_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (48h) versus untreated (48h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					55007	51522	309	3215	7322	8519	7090	56994	604	2592	54331	4707	3490	157697	1903	53829	256236	2203	401320	64386	8030	729570	23248	2597	10791	9770	112616	8776	7805	5018	210	84250	51068	5698	23229	9679	79672	55049	10235	196264	51362	84836	7422	653784	1788	10875	28960	94005	4350	29125	8536	11258	113763	57217	10333	115752	80262	64976	55004	79754	23171	3340	10964	90427	116843	23309	11326	29062	22834	51411	8825	11165	3151	6320	1968	51768	56984	9920	1032	1787	65258	5937	64839	1608	2778	10365	25906	57106	3421	826	5836	64595	381	112483	55313	23344	374659	27434	11007	8204	80745	55766	79958	53826	10659	7343	8895	348094	11184	2209	170463	6948	22883	83716	3594	89849	84329	57471	8609	81603	143098	3676	27440	9315	7862	339541	83938	64223	23034	2665	374291	124446	4900	433	220359	7414	5873	53827	1345	51061	4705	8676	58485	390035	8073	63935	6834	51642	805	10561	29902	54847	93100	7538	147138	84316	150684	392	29087	92002	4902	3164	275	57446	5581	11240	1573	124220	56255	951	56888	8125	10472	7803	2681	8477	79887	120	136895	6641	432	26191	29086	23593	10460	1312	10420	348110	90390	6904	100507290	216	4580	1519	9545	57099	100113407	3425	285315
GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_6H_DN	M6119		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2793_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL4 [GeneID=3565] (6h) versus untreated (6h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					330	100288432	3455	7752	1595	528	57169	55884	84861	144348	51150	200734	2521	90874	55640	283050	100170841	90861	3561	79693	10049	55727	147007	1497	84675	23788	8714	8793	10010	55610	10782	3068	7319	8992	8566	6385	7419	51434	6307	283431	51248	65124	5663	3312	112950	3563	3290	10240	9733	83877	8900	51701	23435	57002	80381	5684	6671	286451	9730	7187	3092	23175	51003	84617	5700	284129	27436	1902	9948	6868	9415	5306	5717	200081	55705	4234	1066	84498	29100	8564	11343	8837	9181	7408	147040	401106	51524	2879	2859	9043	8784	3301	91445	9990	54734	130557	4864	54732	2936	57510	5250	8649	10308	2181	11079	53349	9414	64855	5271	4780	55145	205717	3482	3320	7293	1545	5707	9829	6520	2891	3315	8772	9768	9836	54856	284367	10614	526	10808	5467	92	51340	9034	9397	84513	58484	4363	25940	205564	148932	6810	22882	51264	113179	93643	4758	84879	51058	713	10950	8726	60485	8893	4094	29967	80010	10383	148413	56938	967	7415	5810	80196	347734	7699	2539	146050	51	8942	55795	23534	84102	23197	8809	54707	10318	7163	55180	3732	148479	100288617	8655	57862	958	10046	26278	124935	9242	5795	100128927	11234	5917	283237	26010	56034	535	1601	2012	344887	11148
GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_48H_UP	M6120		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2794_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 and IL4 [GeneID=7040;3565] (48h) versus IL-12 (48h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					51729	100287628	10019	5256	26225	4942	6727	79873	27102	54518	55316	4255	128817	84901	133746	7414	154141	124220	11326	55116	149076	6626	433	115752	7390	5037	81887	7422	5296	22921	9920	63935	8825	9349	3148	57136	55080	8675	55288	4214	11124	51092	9315	63877	54107	3146	389125	10534	5836	100129250	54455	201176	439914	9688	5538	11184	116843	23518	7090	115825	51522	65258	10291	6320	64976	286530	9697	671	27287	25928	5595	94239	8833	57799	64839	10217	432	50717	84836	92703	83716	6777	11258	51763	124446	286135	27141	219654	23171	7123	55893	100128822	94005	7803	80758	818	200298	381	8609	51098	98	57446	29902	90410	51362	128240	387893	157	123096	7086	58485	826	27434	53938	1020	22838	7739	283270	8673	4521	8125	151306	1903	84282	8720	10307	126789	57409	79672	29107	6723	1173	10477	51768	79991	1473	23621	23569	10800	3164	6854	9744	84320	3029	56888	25847	1788	55818	146225	5050	8204	6641	64223	275	147138	340947	817	339390	440193	10171	144983	60412	7507	26469	55766	9545	951	130814	54805	55020	10365	10299	10018	5305	2217	23039	60674	56731	6451	10005	80005	1939	26061	54558	54965	56994	9064	2153	57182	10982	10961	3030	1573	409	10636	3421	57418	2681	6452	2644
GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP	M6123		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2781_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 [GeneID=7040] and IL-12 (2h) versus IL4 [GeneID=3565] (2h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					2140	4204	125476	3561	7752	3783	10725	286451	5707	7849	528	1595	4302	3106	9903	56478	1508	3099	23082	2859	6809	84933	23352	6737	10866	7415	8772	9034	3320	5271	50604	55884	58472	10444	9043	57514	8578	51278	26277	6385	526	10691	4864	8655	200081	51429	283516	4234	342926	5713	51264	22949	1876	51340	10046	91445	64129	51150	147007	205564	83877	51645	3482	100288870	8682	84171	9263	9605	27436	272	9754	3552	10213	84879	9446	3105	10308	718	55666	26286	1026	8671	967	81844	285381	10318	5810	5055	3097	5872	83983	9733	100130232	79583	3980	8848	5898	54732	1847	6609	84498	55147	54881	4236	9768	7743	64759	53918	8942	9766	54856	8564	127687	10049	83480	6992	146540	1007	1154	141	148932	2730	3312	5641	6714	344887	7319	133957	7699	51003	3553	144455	8877	10096	6671	79596	54707	1778	23253	113179	83448	23221	54542	285628	8544	65082	7251	7941	57727	7293	9321	4643	51232	1186	8365	9817	30816	9969	10575	23271	8943	5796	7204	54777	5514	23544	23	9531	5704	79611	53349	3995	84419	389	93643	84926	26020	3837	54187	9968	83636	2919	140885	9587	13	79541	6729	1066	861	221091	399979	55762	8784	80823	27291	29126	696	4729	60485
GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_6H_UP	M6124		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2793_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL4 [GeneID=3565] (6h) versus untreated (6h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					26225	9616	10235	63877	5859	401093	22921	157697	1903	10347	55004	8125	56731	57418	23621	26191	83716	11326	116843	3594	2203	8553	4705	826	9582	53827	7422	65258	5037	64976	11184	201266	27440	8519	2153	56474	10875	9920	1854	6929	283270	283130	9315	51068	4738	92241	51368	55116	51061	285315	389541	54934	285195	433	79701	84166	92715	90864	7414	10980	286530	55766	29902	4521	9545	3421	147138	51092	8609	210	5698	57409	3122	27315	27102	29125	374659	10561	26147	5613	309	374291	7430	79958	9120	1431	7385	11240	3490	27141	3164	90871	7090	149076	25906	26996	120	825	151306	60412	27434	57217	221	9185	8907	26	113763	25870	146225	54847	328	473	8825	8543	10572	4580	91748	8013	521	3340	84836	125150	142678	23344	64839	154141	256236	390035	51389	3128	348110	9318	2210	81926	10964	100272147	54331	26157	10982	10005	7644	143098	3399	7454	53829	90427	10171	5423	114034	5743	665	275	8780	1725	6414	2681	6844	202181	8675	54935	79991	10961	4739	29087	3728	84316	23518	54440	2209	64773	401320	121506	221037	216	22934	4174	1	375190	94005	10365	51768	4832	5805	253018	115752	653784	7086	604	124565	64926	8407	27433	2081	10123	818	7536	6430	6515	116966	57101
GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_2H_UP	M6125		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2782_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 [GeneID=7040] and IL-12 (2h) versus untreated (2h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					246	53349	54434	1497	90861	5154	112950	3563	2889	3678	63934	5048	10049	9546	5707	147007	91445	4864	3092	9294	8202	6767	11117	9043	51524	57091	10902	9414	51150	401106	158863	2936	200014	8655	5684	3561	7879	284129	9424	8943	57002	7423	283050	2140	1066	6385	5226	3290	1902	57862	132789	23095	8772	9730	146434	84525	10633	440699	54953	768239	55705	231	344887	100170841	90874	10121	29100	1876	5717	84842	23435	26278	3036	9263	3312	54732	79600	5810	55640	10782	6009	7174	4234	9870	54881	9397	3320	55361	84617	11343	10421	8439	7415	8714	2730	80867	1026	10912	148479	2181	221496	51264	967	133957	9034	7419	5467	6809	283431	644242	2859	3315	1595	2512	11009	7187	4363	1545	64855	51429	2044	283663	9733	9990	152519	9829	51645	653	23780	10213	84878	3301	727956	55655	22845	79230	79142	9329	83877	7743	23022	3242	51567	23293	10808	10068	6307	284018	284367	9817	57178	3687	8241	861	27436	9798	8970	7587	340348	116988	3927	533	56478	84513	399665	7752	2521	10614	80832	6690	389792	4302	29959	55856	8784	2237	60485	7204	9242	10318	23533	8564	718	8566	27301	55002	8942	440400	10432	55180	51726	5713	100288617	123169	148932	80851	6810	29967	54856	4000
GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_2H_DN	M6126		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2782_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 [GeneID=7040] and IL-12 (2h) versus untreated (2h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					51522	7086	10791	11258	339541	1788	55011	23052	5859	23309	8676	285195	142678	65258	63935	1939	115752	3490	147138	5698	374291	11184	51768	10307	11253	9920	11176	6677	207	10365	2035	8013	55116	352999	7090	56997	8720	256236	10235	11124	4174	51084	83716	157697	473	1991	7410	55630	53829	8030	1021	51654	1611	64839	29087	5037	79958	143888	2153	8776	7390	25906	84320	29107	29125	60677	55049	26996	143098	951	54108	6641	51660	3128	23099	285958	6414	57409	80745	84941	27433	7454	91748	818	1124	3164	5423	653784	79754	375190	5165	7267	29902	51061	94015	433	11165	100133660	8986	29086	27141	1725	51321	7538	275	432	116843	8609	8462	51550	401320	23171	23621	1997	826	81603	201266	4258	9055	729570	80221	22834	26065	7430	521	161253	55843	51729	5836	10270	221	283876	3421	10151	2109	10982	6036	57446	56915	150223	27044	79629	94101	84836	6817	56255	100288139	113763	7739	5538	79792	22921	92703	93974	151306	1020	22895	51411	6320	83938	4724	10194	79701	4580	440193	124220	389125	23344	1903	51669	64757	9960	6451	5613	9844	63908	23564	23199	25840	93100	10460	7803	210	4048	79622	5577	157570	100289210	2762	55410	219654	9797	3676	9051	60528	9315	80774	55652	6901	64386
GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_2H_DN	M6127		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2780_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (2h) versus untreated (2h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					58472	80146	401106	26286	3783	5048	140885	7319	125476	221823	285043	133308	3018	1595	7150	528	57169	5684	8804	114885	6809	5707	124961	23253	5271	8566	10240	162073	54971	91445	7251	55108	5154	5641	10773	84617	9870	64219	5861	9546	55727	2069	2140	57002	10950	4363	10049	6307	51058	23132	84332	79230	6483	10046	51567	55709	54823	8564	148479	3099	83877	26164	55683	11345	51174	8992	1778	8772	272	51524	3242	283050	23095	84947	65082	4430	23271	6507	5531	10015	6737	3688	84102	3482	283508	8837	6309	7752	214	57045	55705	4780	23197	54867	131601	59286	9397	6526	51434	3301	7204	286451	147007	8848	1508	10782	23533	4864	8332	958	5863	3690	1601	5663	55238	55884	55277	27436	10444	85463	2957	965	9969	55092	65124	22930	1500	84513	4758	9263	3552	9034	6868	8655	285848	148932	51009	57493	3553	9446	83930	3995	10010	4302	63906	5782	5700	10725	7187	5704	6690	1497	415116	3312	11343	127687	5717	55041	1066	54856	9832	200081	55002	22949	3732	55686	7879	2936	285628	10383	55147	8239	54925	2237	3696	1234	51003	9656	1213	11342	81562	9242	3097	5514	526	718	25978	53349	8942	6713	79693	375035	3678	344887	51232	813	23670	90861	23788	51340
GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN	M6128		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2781_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 [GeneID=7040] and IL-12 (2h) versus IL4 [GeneID=3565] (2h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					55958	96764	51665	975	51291	440829	8697	2509	51522	23131	5229	9631	9827	26523	3622	22834	55602	51362	57498	401548	51669	51109	55274	23112	5594	284370	79738	127687	23013	283431	84572	100113407	256987	11102	2534	729082	64395	131118	2909	54899	65018	7392	84629	8460	23432	50810	10541	5654	84925	2950	27440	6744	2186	55819	25906	55102	4316	645638	23765	22906	10404	1122	4729	5867	10630	3964	427	9454	5150	51524	120939	151525	56890	10999	3418	51108	55049	23067	26268	4609	400946	112483	10087	147040	29087	10899	84266	100131561	6252	152189	23333	6787	10200	51324	83989	55002	23140	51185	1903	55357	10955	1657	55529	26286	55437	55636	56052	25798	56995	22884	4238	26175	3064	5090	8324	26953	7813	23398	2271	1070	339290	57721	5732	167838	51317	10370	1841	3212	127018	56548	55705	51503	80005	373	54737	29127	1593	6907	57505	339745	205717	253430	202018	6049	79888	23265	2932	57186	8564	55125	23169	8660	27439	140775	286451	57763	5601	51313	10073	29068	55048	5295	4708	79709	80198	219402	114781	4482	28996	26338	10287	100131980	57534	29956	79018	55295	5934	22838	159090	4048	90231	11215	57533	29086	284759	64981	122525	11068	29117	55611	5286	84331	6917	30837	51347	144363	81617
GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN	M6129		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2801_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 [GeneID=7040] and IL-12 (48h) versus IL4 [GeneID=3565] (48h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					28951	26157	3106	3225	6772	283463	25945	84636	3326	3140	100289617	3123	84922	6756	54714	197358	196446	154091	95681	3128	5696	9745	3824	8542	92822	64283	158067	497258	58503	259249	3115	284996	100131655	914	55671	201163	80745	51177	2633	26525	3122	92249	5178	5684	2023	80830	399512	6398	2681	646241	9246	65084	5423	64167	26689	3659	6566	284688	11183	93349	257152	780776	2665	83716	155038	5683	29777	3119	788	2877	3594	5920	115361	3105	2634	9921	9201	7224	66004	7124	8843	10418	54704	3980	27136	23251	81870	129684	7726	49855	1823	401024	3808	3753	3624	283160	6811	3301	10643	54625	441168	25939	7453	55607	9754	8487	164684	3909	567	136991	84072	140691	6701	10906	10947	55005	79739	11119	3346	972	6891	84166	22992	23549	10973	9607	9992	100130285	118980	221391	59340	26037	84969	147968	55177	161145	1778	11118	388531	115362	7363	5698	400624	80832	3811	3070	2286	64799	27314	3662	26245	5721	283278	2523	389	80008	653687	5634	282566	168741	100131551	642280	9605	1390	4705	203413	7295	817	163259	6737	4113	124	51733	284612	26586	2618	2329	64386	83447	51540	55254	118932	144455	10647	3113	10551	3108	339751	5332	100130331	3183	53342	710	59274	23217	10241
GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_2H_UP	M6130		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2780_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (2h) versus untreated (2h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					6354	26175	5618	374868	5654	8645	55144	4860	51108	6314	55022	79895	64219	8843	1912	6101	50640	285761	121273	51429	137492	6556	100507654	2069	3964	683	25853	27004	642475	10627	23307	53940	3044	643659	241	57491	2647	4864	58528	3622	284759	9467	3987	586	7204	728294	83999	26234	597	119	23112	84674	64411	10630	4923	8111	1729	5641	169792	23601	27127	1601	541472	3654	7112	50650	133	2847	4905	10544	864	645984	10105	5504	112483	10015	91	122509	64595	3603	100288590	81617	79071	375775	4238	55840	55789	427	55356	22834	255919	91351	2209	51289	10477	286451	10451	711	196528	55916	8660	7462	6515	6804	79772	152137	8848	9827	6934	9901	10126	414926	25798	4233	2534	4780	9446	65018	9517	4995	10206	7773	51100	283867	10678	10228	374659	10087	25972	5898	65244	100131454	129685	6809	10950	5473	55151	64926	79811	7227	10397	8685	283796	84067	4052	205717	5979	3036	51510	54715	79663	147081	6451	26253	3340	1241	54741	100506385	665	11009	26085	119395	219995	9832	8439	5329	57047	55217	79669	7564	400410	167838	6364	266747	201176	54469	81502	79888	25864	84680	9748	1318	23743	441072	349667	10333	2123	26338	221079	152118	160851	1368	26277	64285	100131561	23394	3576	100381270	28823
GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_48H_UP	M6131		14607935	Lund R,Aittokallio T,Nevalainen O,Lahesmaa R	GSE2770	GSE2770_2802_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: TGFB1 [GeneID=7040] and IL-12 (48h) versus untreated (48h).	Th1 and Th2 cells arise from a common precursor cell in response to triggering through the TCR and cytokine receptors for IL-12 or IL-4. This leads to activation of complex signaling pathways, which are not known in detail. Disturbances in the balance between type 1 and type 2 responses can lead to certain immune-mediated diseases. Thus, it is important to understand how Th1 and Th2 cells are generated. To clarify the mechanisms as to how IL-12 and IL-4 induce Th1 and Th2 differentiation and how TGF-beta can inhibit this process, we have used oligonucleotide arrays to examine the early polarization of Th1 and Th2 cells in the presence and absence of TGF-beta after 0, 2, 6 and 48 hours of polarization.					493911	9415	2023	1891	4128	6916	30835	54482	3500	79135	148266	133418	283431	28232	284018	7264	5351	51365	3455	55686	10653	231	10877	9258	84274	29904	9784	2681	23022	10594	211	84678	3753	140838	11047	5732	4094	84461	92	100288432	64423	6319	10186	714	51397	56034	2052	2208	10531	284933	4522	51076	1807	51181	55640	85453	326625	55006	6239	7343	7157	55177	9688	152195	226	9144	2950	51161	64223	123	56548	84919	28951	92249	65084	3416	2821	152518	8310	51338	5631	8809	653308	28960	1352	282890	55364	1720	1981	80157	713	10344	23166	8451	55210	7086	10847	9635	1616	100289617	150684	6361	7905	56922	63892	23481	6286	6621	9938	64419	55244	6352	9703	3992	3290	9780	57037	949	29085	54509	144348	283237	140685	3183	51069	5018	375035	80830	374890	10204	11188	5594	8495	55319	127253	338069	57118	55781	117143	10174	80309	25896	26298	23144	6367	80820	6599	6628	55610	57587	677	339390	642280	37	10123	246	115273	3326	84634	2625	7185	7295	51760	1143	6385	387119	4179	27430	55110	54581	100505894	5709	4682	54988	91120	7348	84300	84944	2120	64839	29089	6035	79639	26168	84687	5311	8440	79370	259249	100233209	6503	2029	55540	80346	2167	79657	9092	1374	30968	79792
GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_WITH_IFNA_STIM_DN	M6147		15467722	Tassiulas I,Hu X,Ho H,Kashyap Y,Paik P,Hu Y,Lowell CA,Ivashkiv LB	GSE1740	GSE1740_2639_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocyte-derived macrophages: no priming, stimulated by interferon alpha versus primed by IFNG [GeneID=3458] and then stimulated by interferon alpha.	Type I IFN-inducible gene expression in human blood monocytes primed with Type II IFN.					132789	80223	84450	9745	84443	54553	57469	729178	65009	646168	166863	100507508	168741	2920	642938	56923	29893	66004	3753	1437	162282	4250	2172	122046	140612	83867	5558	79070	157657	100506433	25903	64800	9896	574028	4860	145482	93653	64425	200150	26248	7738	7169	57689	285754	54457	7105	643650	54093	174	2262	2822	83872	285704	6701	54805	26251	5407	3553	286046	84722	56896	200312	57037	2189	163259	10350	54491	159989	89872	283385	2595	317781	93621	51361	100506243	100130725	387357	2334	122618	3832	79084	63982	84439	51100	7363	100287951	389898	158056	5741	3175	210	5274	731789	414245	2044	401024	25959	201798	150244	80063	197358	284021	143678	153364	3811	284798	157638	57610	27042	203238	100286980	79166	79172	652147	79968	9928	11081	11212	55714	387718	196477	54946	131368	51557	59344	348378	84852	253559	146227	2213	149428	10955	4173	10905	1833	56729	2267	2045	84217	57558	51412	55020	148254	5744	64412	100113407	5695	84909	90459	199990	100288870	3486	27127	26576	50489	27443	53340	57536	84069	5190	400568	84054	6886	2922	9118	5507	100287132	266919	497258	144193	5783	222643	646	10900	286359	335	81848	11254	152118	642987	123	50700	285577	375061	57606	6945	51364	4113	1301	9073	4009	153657	80184	7748	27132	84765	56898
GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_DERIVED_MACROPHAGE_UP	M6148		15467722	Tassiulas I,Hu X,Ho H,Kashyap Y,Paik P,Hu Y,Lowell CA,Ivashkiv LB	GSE1740	GSE1740_2636_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocyte-derived macrophages: untreated versus stimulated by interferon alpha.	Type I IFN-inducible gene expression in human blood monocytes primed with Type II IFN.					219623	60439	9499	441208	259266	129138	27012	283777	26873	283516	140699	80344	81623	9817	283373	205327	79862	23082	84456	285753	54680	100131980	100505474	53833	5229	2555	11077	390790	157724	3421	100289420	27229	116159	60401	26232	168975	150684	144455	9189	100132476	100130175	493754	137735	286002	4000	825	84885	54733	51177	10430	29092	9605	2192	23233	51084	165082	57661	25799	191585	162137	63935	79788	89891	400798	84759	7629	54480	90321	22833	158434	10528	79913	1841	219578	56101	135398	1007	6006	6492	221662	163933	57617	56242	51313	79863	404672	53916	23409	51608	63948	100379224	441054	100287401	3167	8395	11102	157381	100293830	4761	2661	59084	124535	131375	2644	60680	55435	441242	10388	26015	80328	283537	10168	151484	5539	2639	51230	91687	166647	23053	23609	284086	26228	80823	399761	100169750	152002	353219	340419	285601	275	54455	6875	2038	154881	729164	92249	148641	100131561	51594	9623	55784	5792	56995	128218	221424	390058	57410	10174	56884	23432	2562	374918	441666	9369	5383	11145	9759	337882	3239	5082	168544	401098	339593	797	11199	869	261729	56952	26497	5796	145957	90952	727818	4296	340239	79570	285429	5032	23632	151516	643382	916	100506089	3848	284541	257236	55228	1003	7507	55131	83473	26953	8945	22843	8590	51438	140290	56133
GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_DERIVED_MACROPHAGE_DN	M6150		15467722	Tassiulas I,Hu X,Ho H,Kashyap Y,Paik P,Hu Y,Lowell CA,Ivashkiv LB	GSE1740	GSE1740_2636_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocyte-derived macrophages: untreated versus stimulated by interferon alpha.	Type I IFN-inducible gene expression in human blood monocytes primed with Type II IFN.					85003	84636	54888	54625	285704	6772	9048	22824	1437	118980	100289617	5913	85403	5684	26575	127391	284996	5423	100288438	5329	3624	3128	30001	6747	340061	149428	10209	3123	3122	56130	4705	6737	646168	53916	23594	9246	64167	201266	200010	57689	84166	134429	66004	3654	2633	834	9754	3659	642426	58160	10788	1666	4860	3105	6809	2744	23351	84674	11119	64108	8892	100134017	91543	9958	3094	1847	257103	3115	132789	3763	5698	131920	8843	6322	2069	9605	5686	54149	25963	51733	197358	80830	155038	6258	1390	11118	100288745	283454	5721	5055	115361	219285	51177	3475	8542	7124	6364	597	643733	8645	3113	25945	57494	51726	85441	111	10643	84069	55843	6773	8894	282566	57469	9275	161502	5920	972	11183	6398	3594	3553	54777	92822	5520	8578	91351	5683	4661	317719	3106	26037	643650	284798	2920	676	6890	5743	6515	3117	7453	266727	27249	8797	63899	56005	4643	5535	286256	440757	84140	7259	55254	9365	10602	497258	374470	94240	26270	51188	84322	441024	93349	3140	55835	100506243	441168	8076	285381	26509	55916	64799	5898	7849	22931	1778	80184	3959	4610	3301	1833	6993	10616	2149	100499483	25817	84879	51371	3133	3119	28683	115362	133	196394	5696	55620	3665	283547
GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_IFNG_DERIVED_MACROPHAGE_DN	M6152		15467722	Tassiulas I,Hu X,Ho H,Kashyap Y,Paik P,Hu Y,Lowell CA,Ivashkiv LB	GSE1740	GSE1740_2637_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocyte-derived macrophages primed by IFNG [GeneID=3458]: untreated versus interferon alpha.	Type I IFN-inducible gene expression in human blood monocytes primed with Type II IFN.					10800	5325	6361	54737	27301	6834	9189	401548	7283	4128	9703	1020	55365	4782	4000	79135	10574	5911	157	10344	246	23163	28969	253650	51522	8623	51291	23274	677	54455	79029	51112	84634	283431	205327	28951	57646	152518	90135	137835	10016	90362	10528	23765	91661	9131	1212	4234	25	3421	100303755	231	9424	6709	159090	150684	7507	23112	84331	23625	4094	9647	54480	9716	22906	7293	28976	23140	64170	26523	8445	8550	4174	113802	65010	2271	8784	9784	54518	55471	23220	9499	10380	100170841	56548	112936	100127972	54890	10244	60558	10653	10430	84279	54904	4854	92667	284367	154807	23732	27440	60680	26088	10444	9328	10633	22796	2950	120939	641298	23609	202018	6286	399665	254394	221927	1891	92335	4515	340348	6367	54892	23022	8324	6272	3290	23040	5631	29796	55256	158863	10899	283237	56160	23310	64981	27352	51150	23169	8270	257236	5293	3662	51768	152189	55713	10641	51081	3064	25840	25906	22846	80820	23170	2034	5810	147040	1059	1154	337867	56919	79447	7343	9600	133418	55172	7086	200845	51076	55244	64781	27005	10169	27439	23412	1445	7905	84823	79902	51633	84892	22897	148789	23020	2681	1537	10328	400566	9581	285181	51538	51665	142678	6794	51250	84572	338692	401106	8727	283899	11100
GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_UP	M6156		15467722	Tassiulas I,Hu X,Ho H,Kashyap Y,Paik P,Hu Y,Lowell CA,Ivashkiv LB	GSE1740	GSE1740_2638_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocyte-derived macrophages: no priming versus primed by IFNG [GeneID=3458].	Type I IFN-inducible gene expression in human blood monocytes primed with Type II IFN.					317719	6258	3128	84779	27253	401320	6772	158067	161003	2274	257103	197358	8542	200150	92822	5423	80745	7124	100128977	23649	254158	64167	284798	2172	84166	396	11118	2523	1956	221391	27314	54625	3123	84322	317702	3808	5721	159371	578	80830	2633	1778	55740	8843	338645	10643	56923	266727	3115	3659	653602	6398	5729	285973	93653	10263	100288944	643650	56165	7368	646241	641928	11147	83755	387486	64388	5698	4113	3094	7453	9246	91548	653423	64386	5696	6737	5920	6602	22999	2263	4597	161145	155038	3594	54987	26270	3119	51733	115361	1390	28951	55506	23549	2634	2595	567	285704	50	64065	222236	11119	23251	157657	11237	64799	6891	64283	389043	5600	7827	284612	6590	100290663	946	916	142686	3122	7726	10906	27324	441168	164045	197135	5684	8814	284996	80086	4308	57172	23099	11036	26037	7092	26245	27152	115362	22987	10241	3070	93349	646	140691	252995	387718	259249	30010	27351	2731	131920	84141	79968	162962	9491	122046	6890	3112	283463	319	129025	54456	83692	9997	55359	1001	140564	415117	3109	148824	91543	3140	9424	7982	339230	253017	81696	81610	5699	11148	2000	201617	55808	10846	8187	3909	57169	9469	5357	9627	125972	6773	2877	57689	149773	51177	79792	283160
GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_DN	M6157		15467722	Tassiulas I,Hu X,Ho H,Kashyap Y,Paik P,Hu Y,Lowell CA,Ivashkiv LB	GSE1740	GSE1740_2638_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocyte-derived macrophages: no priming versus primed by IFNG [GeneID=3458].	Type I IFN-inducible gene expression in human blood monocytes primed with Type II IFN.					6834	100113407	8564	10541	81688	56919	83596	80344	157	3212	54480	202018	340277	387263	93380	23112	79888	54737	1454	2589	11215	6934	51366	27034	10404	112936	285367	9189	10200	23067	29956	2271	25	6286	3364	6744	7251	10670	10390	51665	427	65018	401548	5594	58484	4316	120939	22834	51347	1536	9	127018	9454	54838	80005	23169	115106	66008	51109	23140	23412	26268	2534	6642	8460	5530	25966	388566	201965	4702	4782	9611	5163	80311	283431	55970	10899	23261	7283	90390	1122	645638	57606	4609	55746	9975	3295	51522	7707	975	26953	55102	9859	26035	23197	58986	79961	246175	5090	5867	57646	51669	5887	55602	96764	1955	55632	55958	51762	10380	389834	158431	26512	23608	10999	64770	10771	10250	440145	5911	5732	51029	9827	284309	8613	56548	55167	56995	10087	51362	337867	55088	8697	57498	10955	79982	4026	91860	22883	3066	5151	1593	8239	84661	55002	58486	1903	54908	22878	55172	256987	26137	79029	27436	5566	10430	113201	65125	115416	5859	159090	5631	7764	55781	22884	199675	989	4719	7057	861	902	54904	10455	144363	55529	132949	509	55704	677	54890	94239	192669	51094	339745	143684	84925	647087	27247	23327	57189	23220	51320	4801	55125	55599	6817	10512	10560	1153	55636
GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_WITH_IFNA_STIM_UP	M6158		15467722	Tassiulas I,Hu X,Ho H,Kashyap Y,Paik P,Hu Y,Lowell CA,Ivashkiv LB	GSE1740	GSE1740_2639_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocyte-derived macrophages: no priming, stimulated by interferon alpha versus primed by IFNG [GeneID=3458] and then stimulated by interferon alpha.	Type I IFN-inducible gene expression in human blood monocytes primed with Type II IFN.					55006	94239	1891	51096	51374	5351	4221	51150	257218	2071	55256	57037	5732	55186	5510	9415	3295	2208	85460	84527	8803	9688	5631	79882	90135	79029	55958	51076	6117	8867	28976	8550	139716	199704	2589	56922	3276	123	283431	1020	6821	51522	79902	27436	6319	1718	4094	1105	5591	6533	5867	677	246175	3753	51362	2109	94104	9424	3614	29904	10404	9284	25903	79135	23022	339229	64781	23324	10653	254394	58484	54505	284367	202018	7247	3068	112936	79717	2167	23220	231	4128	5311	2120	7329	80820	79639	55667	9896	152195	84319	133418	55320	6361	5910	10344	55781	157	92399	2950	127253	51292	8942	5293	57161	5584	31	647087	51081	79145	10521	115106	2271	51633	92	5108	26268	23412	51338	10574	134492	2217	150684	114825	205327	550	9631	5279	126731	55640	1434	55274	10951	56254	84678	3146	645212	10541	124512	152518	5594	56548	27034	648	51729	84240	3417	400916	7690	144348	51247	7086	79672	10204	2052	91947	51	28969	57496	54919	64223	55776	55316	9306	142	1106	3455	8886	23608	54455	23140	23174	9821	7372	2181	8195	90592	6259	51232	56897	6642	51304	51340	51136	283237	9023	64839	664	10238	28998	344905	64979	5283	7905	8697	9703	2876	4702	4718	57118
GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_IFNG_DERIVED_MACROPHAGE_UP	M6159		15467722	Tassiulas I,Hu X,Ho H,Kashyap Y,Paik P,Hu Y,Lowell CA,Ivashkiv LB	GSE1740	GSE1740_2637_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocyte-derived macrophages primed by IFNG [GeneID=3458]: untreated versus interferon alpha.	Type I IFN-inducible gene expression in human blood monocytes primed with Type II IFN.					54732	203259	4643	51061	4761	6737	10616	9768	282809	3500	2259	578	10333	696	972	442213	3112	81502	91828	5271	162515	26341	26007	27044	26166	11154	219578	53358	23584	5898	4860	9754	3594	7124	54718	441208	83636	729164	27351	387638	64108	54586	8572	91351	728294	26085	864	219995	221301	8843	79701	54542	9467	4336	51177	2191	84674	7462	100507435	100132476	51514	2633	283638	7849	7757	26037	116443	137868	2175	474344	55356	23624	79758	26277	155038	3764	56101	29018	10738	26525	1729	54944	5873	266727	200312	80086	9828	11156	2069	84166	8578	5174	23190	6398	11027	317702	4995	285753	6772	8840	400986	11119	63970	54971	100507240	957	374454	1186	83903	58494	114769	55733	728855	196883	3549	5920	56833	288	83992	1428	10105	60490	84900	644815	5641	374918	59342	7172	60495	51733	1364	85441	647024	5866	7262	100288271	56005	3735	6515	84132	7984	6934	196394	3399	85290	9586	54490	8435	441024	100506089	6755	112464	11346	10723	29851	894	64374	9232	25898	59274	93986	339166	1778	26080	400410	55679	8972	113675	917	10627	4621	135927	53918	8685	100288944	348013	23780	7082	8682	7363	131375	8091	4804	10923	63971	3702	3779	2195	90416	56905	2012	108	55530	100507654	162137	59269
GSE2405_S_AUREUS_VS_UNTREATED_NEUTROPHIL_UP	M6192		15879137	Borjesson DL,Kobayashi SD,Whitney AR,Voyich JM,Argue CM,Deleo FR	GSE2405	GSE2405_3574_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in polymorphonuclear leukocytes (9h): S. aureus infection versus control.	Polymorphonuclear leukocytes (PMNs) were obtained from healthy individuals in accordance with protocols approved by the Institutional Review Board for Human Subjects at the University of Minnesota and the National Institute of Allergy and Infectious Diseases. PMNs (107) were combined on ice with live S. aureus (108) or with live or heat-killed A. phagocytophilum (bacteria isolated from 5x106 infected HL60 cells for a ratio of 1 infected HL60 cell: 2 PMNs, ~ 5-20 A. phagocytophilum: PMN) in wells of a 12-well tissue culture plate (pre-coated with 20% autologous normal human serum). Unstimulated control assays received either buffer (for S. aureus comparisons) or clarified HL60 lysate (for A. phagocytophilum comparisons). Plates were centrifuged at 350 x g for 8 min at 4oC to synchronize phagocytosis and incubated at 37 deg. C in a CO2 incubator for the indicated times. At the indicated times, tissue culture medium was aspirated from the plate and PMNs were lysed directly with RLT buffer (Qiagen, Valencia, CA). Purification of PMN RNA and subsequent preparation of labeled cRNA target was performed as described in Methods. Labeling of samples, hybridization of cRNA with HU133A oligonucleotide arrays (Affymetrix, Santa Clara, CA), and scanning were performed according to standard Affymetrix protocols ( http://www.affymetrix.com/pdf/expression_manual.pdf ). Experiments were performed in triplicate, using PMNs from three healthy individuals for each treatment.					27343	58515	4701	56137	11345	55142	170506	55027	26233	55219	10935	170261	9101	56915	84641	25926	9526	2109	84498	2966	6837	8844	10513	8464	3454	2000	9812	55262	25804	161145	7755	9619	1237	2258	3662	55333	79183	147965	114908	85450	2107	24139	91	64925	10632	11161	1509	55656	1852	55568	147138	9807	5551	51575	57687	26155	1437	581	8776	53615	6249	1998	26058	284486	259230	22984	9158	29909	283254	7095	4302	55062	219899	64420	26515	55168	4665	8841	222166	826	204	8733	79693	2885	1022	57448	157285	10856	10598	23387	79792	84329	58487	2533	192286	55020	84293	49855	55101	8477	84240	54840	55775	5533	283985	50852	79006	51495	7419	340481	9094	80329	9318	284106	1848	6199	54733	10765	2232	5368	57617	8662	8459	64599	51428	3761	55035	51205	55299	54331	26574	93663	1595	6527	10206	79716	2079	5289	126133	57488	89970	84335	118487	170622	55074	51143	6611	10427	4200	55276	3682	401466	11133	126382	883	355	152002	3720	25807	126328	5201	10276	10730	9801	23412	56894	9049	23093	6775	51252	11336	51399	57045	28987	9674	4795	728392	55954	201254	10450	9181	57569	55851	23160	347734	2027	11230	51726	83719	65083	10280	7873	79650	90861	6733	5689	113174	54939	597	84060
GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN	M6193		15879137	Borjesson DL,Kobayashi SD,Whitney AR,Voyich JM,Argue CM,Deleo FR	GSE2405	GSE2405_3587_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in polymorphonuclear leukocytes (24h): control versus infection by A. phagocytophilum.	Polymorphonuclear leukocytes (PMNs) were obtained from healthy individuals in accordance with protocols approved by the Institutional Review Board for Human Subjects at the University of Minnesota and the National Institute of Allergy and Infectious Diseases. PMNs (107) were combined on ice with live S. aureus (108) or with live or heat-killed A. phagocytophilum (bacteria isolated from 5x106 infected HL60 cells for a ratio of 1 infected HL60 cell: 2 PMNs, ~ 5-20 A. phagocytophilum: PMN) in wells of a 12-well tissue culture plate (pre-coated with 20% autologous normal human serum). Unstimulated control assays received either buffer (for S. aureus comparisons) or clarified HL60 lysate (for A. phagocytophilum comparisons). Plates were centrifuged at 350 x g for 8 min at 4oC to synchronize phagocytosis and incubated at 37 deg. C in a CO2 incubator for the indicated times. At the indicated times, tissue culture medium was aspirated from the plate and PMNs were lysed directly with RLT buffer (Qiagen, Valencia, CA). Purification of PMN RNA and subsequent preparation of labeled cRNA target was performed as described in Methods. Labeling of samples, hybridization of cRNA with HU133A oligonucleotide arrays (Affymetrix, Santa Clara, CA), and scanning were performed according to standard Affymetrix protocols ( http://www.affymetrix.com/pdf/expression_manual.pdf ). Experiments were performed in triplicate, using PMNs from three healthy individuals for each treatment.					401612	6925	83692	23626	7067	1760	29841	780	23464	23552	5414	83478	55667	5558	22843	387914	8526	717	28981	55859	51514	80705	6678	121457	55081	783	148479	124935	675	11099	10544	5587	7837	140809	55635	441027	84217	286319	953	5797	1763	83594	130535	23400	1466	1429	84824	10635	90799	25932	165	328	10516	23096	5241	5255	1791	7584	28966	81626	8013	1062	2650	4299	7164	5376	9754	64855	54910	23008	83544	5784	7122	9886	79915	3029	6502	57821	5783	90952	285671	55177	64764	54858	8909	23213	3075	7436	4649	221035	9214	2115	958	282996	50515	347240	1825	7098	7089	1806	57685	79172	4854	5932	84935	80014	5333	4035	51091	11076	347	79705	55010	5836	9060	57586	57647	10068	8438	11004	2305	58528	6491	56649	9232	10462	79778	4751	201475	4053	7552	3623	5321	114804	6361	3981	3667	10572	51333	8456	1845	64866	2892	23150	27351	128674	5074	122769	57091	55773	710	22974	55732	85440	126321	7915	1410	4313	5621	1063	54476	151246	26608	284119	9829	1291	1040	64778	54875	2519	112399	4318	92597	55971	5602	650	7078	92	898	7088	5199	27429	55105	241	10278	339855	8555	79684	5791	79733	85352	84314	81544	158747	9050	84318	123	1198	91694	23176
GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP	M6194		15879137	Borjesson DL,Kobayashi SD,Whitney AR,Voyich JM,Argue CM,Deleo FR	GSE2405	GSE2405_3588_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in polymorphonuclear leukocytes (9h) infection by A. phagocytophilum: heat killed versus live bacteria.	Polymorphonuclear leukocytes (PMNs) were obtained from healthy individuals in accordance with protocols approved by the Institutional Review Board for Human Subjects at the University of Minnesota and the National Institute of Allergy and Infectious Diseases. PMNs (107) were combined on ice with live S. aureus (108) or with live or heat-killed A. phagocytophilum (bacteria isolated from 5x106 infected HL60 cells for a ratio of 1 infected HL60 cell: 2 PMNs, ~ 5-20 A. phagocytophilum: PMN) in wells of a 12-well tissue culture plate (pre-coated with 20% autologous normal human serum). Unstimulated control assays received either buffer (for S. aureus comparisons) or clarified HL60 lysate (for A. phagocytophilum comparisons). Plates were centrifuged at 350 x g for 8 min at 4oC to synchronize phagocytosis and incubated at 37 deg. C in a CO2 incubator for the indicated times. At the indicated times, tissue culture medium was aspirated from the plate and PMNs were lysed directly with RLT buffer (Qiagen, Valencia, CA). Purification of PMN RNA and subsequent preparation of labeled cRNA target was performed as described in Methods. Labeling of samples, hybridization of cRNA with HU133A oligonucleotide arrays (Affymetrix, Santa Clara, CA), and scanning were performed according to standard Affymetrix protocols ( http://www.affymetrix.com/pdf/expression_manual.pdf ). Experiments were performed in triplicate, using PMNs from three healthy individuals for each treatment.					10632	3954	8776	7866	2107	80326	5931	10049	83874	124583	9094	6760	259230	497661	9146	689	7846	51693	27339	11102	113622	26225	55256	6742	23204	51112	641638	6902	58527	10914	2168	56137	55733	221830	5710	9114	2793	11133	84498	11201	23347	55850	51765	9553	51690	81553	57062	23450	912	6748	11017	3939	4836	7324	26058	27069	1509	128	51128	11165	3059	5683	220988	3251	147965	51082	684	222484	80143	90007	6671	84060	8664	3633	5723	7533	81873	24139	527	10888	3182	58487	5300	5997	2966	4637	8732	3429	2870	140456	3183	92370	54529	6302	55262	10016	122773	5702	10692	2533	9270	10018	11140	9377	51503	10235	6921	54103	9733	7259	333926	1299	26355	23678	152100	55142	4697	55656	56915	375444	359948	51726	135112	51639	4048	3927	4869	382	115350	65083	6392	204	115992	1382	1337	5223	8443	7332	2885	51504	55283	60490	80700	89970	55671	4682	54503	10327	4191	80709	79626	345	7873	26233	128866	83640	81671	54539	168544	1345	10280	27248	54556	441476	59343	7979	1152	83706	7755	51020	64852	3187	9158	327	27335	23640	55660	7001	9318	4357	4116	5162	6281	1396	5019	6637	143384	6992	6167	84549	55851	9709	55129	158219	1848	1269	10944	2022	84272	388962
GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_DN	M6196		15879137	Borjesson DL,Kobayashi SD,Whitney AR,Voyich JM,Argue CM,Deleo FR	GSE2405	GSE2405_3588_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in polymorphonuclear leukocytes (9h) infection by A. phagocytophilum: heat killed versus live bacteria.	Polymorphonuclear leukocytes (PMNs) were obtained from healthy individuals in accordance with protocols approved by the Institutional Review Board for Human Subjects at the University of Minnesota and the National Institute of Allergy and Infectious Diseases. PMNs (107) were combined on ice with live S. aureus (108) or with live or heat-killed A. phagocytophilum (bacteria isolated from 5x106 infected HL60 cells for a ratio of 1 infected HL60 cell: 2 PMNs, ~ 5-20 A. phagocytophilum: PMN) in wells of a 12-well tissue culture plate (pre-coated with 20% autologous normal human serum). Unstimulated control assays received either buffer (for S. aureus comparisons) or clarified HL60 lysate (for A. phagocytophilum comparisons). Plates were centrifuged at 350 x g for 8 min at 4oC to synchronize phagocytosis and incubated at 37 deg. C in a CO2 incubator for the indicated times. At the indicated times, tissue culture medium was aspirated from the plate and PMNs were lysed directly with RLT buffer (Qiagen, Valencia, CA). Purification of PMN RNA and subsequent preparation of labeled cRNA target was performed as described in Methods. Labeling of samples, hybridization of cRNA with HU133A oligonucleotide arrays (Affymetrix, Santa Clara, CA), and scanning were performed according to standard Affymetrix protocols ( http://www.affymetrix.com/pdf/expression_manual.pdf ). Experiments were performed in triplicate, using PMNs from three healthy individuals for each treatment.					121551	56929	84892	64225	9353	80006	54827	6324	79660	2892	9824	23552	4256	783	1066	2650	5241	154007	29841	55331	7976	1573	2040	10391	4602	3978	9215	1510	54800	26608	55329	10714	1608	284001	51334	10613	9317	9848	22843	219623	115	9630	2273	64097	64764	144402	23008	91404	390916	285852	55790	5372	23768	10336	5144	79980	116534	147463	7525	5550	3638	92345	89891	84312	51134	11169	90952	255743	56649	85440	23400	114609	1466	6356	132884	9585	348654	64327	9712	286128	8027	54014	3157	10637	23169	114876	64506	1734	151195	23303	57545	4781	55859	51164	7078	10198	5911	2152	7486	55106	148479	79918	134429	116843	84910	3643	22852	5784	9891	10644	3910	5168	8317	3199	10278	51567	10462	83594	710	8398	586	5939	9522	201191	8013	6689	5090	133584	11339	26995	4897	81930	92126	26011	4047	387707	10849	64359	79815	55667	23235	139170	157	22835	79172	57647	55071	79023	683	23176	401612	11200	4978	60506	89782	8671	441024	340277	201965	28981	4794	170082	1009	5293	11015	112399	29899	79621	7355	220929	91445	83544	2824	55164	3832	6678	5154	9738	23590	132320	3306	22995	57091	4299	63939	2070	64116	58526	10572	1902	10560	116328	11099	9060	7584	23635	55861	8573	79012	57480
GSE2405_0H_VS_12H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP	M6197		15879137	Borjesson DL,Kobayashi SD,Whitney AR,Voyich JM,Argue CM,Deleo FR	GSE2405	GSE2405_3586_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in polymorphonuclear leukocytes (12h): control versus infection by A. phagocytophilum.	Polymorphonuclear leukocytes (PMNs) were obtained from healthy individuals in accordance with protocols approved by the Institutional Review Board for Human Subjects at the University of Minnesota and the National Institute of Allergy and Infectious Diseases. PMNs (107) were combined on ice with live S. aureus (108) or with live or heat-killed A. phagocytophilum (bacteria isolated from 5x106 infected HL60 cells for a ratio of 1 infected HL60 cell: 2 PMNs, ~ 5-20 A. phagocytophilum: PMN) in wells of a 12-well tissue culture plate (pre-coated with 20% autologous normal human serum). Unstimulated control assays received either buffer (for S. aureus comparisons) or clarified HL60 lysate (for A. phagocytophilum comparisons). Plates were centrifuged at 350 x g for 8 min at 4oC to synchronize phagocytosis and incubated at 37 deg. C in a CO2 incubator for the indicated times. At the indicated times, tissue culture medium was aspirated from the plate and PMNs were lysed directly with RLT buffer (Qiagen, Valencia, CA). Purification of PMN RNA and subsequent preparation of labeled cRNA target was performed as described in Methods. Labeling of samples, hybridization of cRNA with HU133A oligonucleotide arrays (Affymetrix, Santa Clara, CA), and scanning were performed according to standard Affymetrix protocols ( http://www.affymetrix.com/pdf/expression_manual.pdf ). Experiments were performed in triplicate, using PMNs from three healthy individuals for each treatment.					55568	401097	92196	4646	4790	28951	3482	4615	162394	131450	5739	6402	3437	4215	88	54331	169200	10813	5371	3628	3682	50807	84329	114770	4345	10867	5551	56253	4665	23180	50943	55636	259230	8698	1611	8638	3633	84674	202	114294	94005	168544	29993	5908	3560	2583	4092	3662	2166	91543	8600	4818	340061	23516	30845	59067	23586	10392	8705	390637	3106	8477	22821	84795	84933	6693	1644	5996	6892	170261	4773	399665	83786	483	6483	8428	91775	2308	64375	115330	3430	400916	168537	1959	55210	596	3690	1265	3398	11123	274	8507	390243	1893	84172	7096	23070	309	51278	2323	55262	55601	10712	64410	54463	1236	10365	170954	6375	6302	2870	64926	79961	91522	10067	9830	3689	6480	54997	1521	157285	392	161582	9725	1237	409	2841	3570	79890	7293	8906	3665	285513	5971	1901	64218	822	3732	3718	23241	9953	27128	831	64115	79637	5732	7726	5583	152007	9588	10039	4302	54739	6890	81873	4063	79865	3164	10379	4308	894	2052	8530	84433	10550	55007	10912	23406	7048	7133	10287	5768	2760	5738	64109	203054	23368	5664	84969	359845	91010	924	6772	90634	864	962	57060	440193	10505	10447	5721	7204	57569	11226	79713	23370	129607	54625	92370	79711
GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP	M6198		15879137	Borjesson DL,Kobayashi SD,Whitney AR,Voyich JM,Argue CM,Deleo FR	GSE2405	GSE2405_3590_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in polymorphonuclear leukocytes (9h): treated by heat killed HC60 cell (promyelocytic leukemia) lysate versus A. phagocytophilum infection.	Polymorphonuclear leukocytes (PMNs) were obtained from healthy individuals in accordance with protocols approved by the Institutional Review Board for Human Subjects at the University of Minnesota and the National Institute of Allergy and Infectious Diseases. PMNs (107) were combined on ice with live S. aureus (108) or with live or heat-killed A. phagocytophilum (bacteria isolated from 5x106 infected HL60 cells for a ratio of 1 infected HL60 cell: 2 PMNs, ~ 5-20 A. phagocytophilum: PMN) in wells of a 12-well tissue culture plate (pre-coated with 20% autologous normal human serum). Unstimulated control assays received either buffer (for S. aureus comparisons) or clarified HL60 lysate (for A. phagocytophilum comparisons). Plates were centrifuged at 350 x g for 8 min at 4oC to synchronize phagocytosis and incubated at 37 deg. C in a CO2 incubator for the indicated times. At the indicated times, tissue culture medium was aspirated from the plate and PMNs were lysed directly with RLT buffer (Qiagen, Valencia, CA). Purification of PMN RNA and subsequent preparation of labeled cRNA target was performed as described in Methods. Labeling of samples, hybridization of cRNA with HU133A oligonucleotide arrays (Affymetrix, Santa Clara, CA), and scanning were performed according to standard Affymetrix protocols ( http://www.affymetrix.com/pdf/expression_manual.pdf ). Experiments were performed in triplicate, using PMNs from three healthy individuals for each treatment.					9249	55092	302	8440	1791	6993	55872	9969	23452	2040	2547	4288	6925	6603	4313	84303	113263	9133	8318	23462	2171	4354	27351	1397	55329	6535	8879	64781	146909	151648	2237	9423	3148	114876	8909	9308	113130	55143	83463	8848	441151	1102	3978	8099	57708	84314	3268	4775	90417	2268	219793	22918	7295	3161	10279	3514	1436	3507	27136	9768	5783	1528	4068	3981	1063	91694	144455	2968	3669	7018	6790	6241	4065	51065	54769	83540	2289	8456	3945	167359	6119	64795	25932	1164	10655	55723	3925	9289	10112	220134	3371	9394	9892	23136	2672	90381	3117	100	718	11217	10411	11185	925	1476	2114	5896	8038	54361	23635	79850	11004	55789	1515	282679	57586	8526	701	26011	501	9156	1282	5317	8819	7468	995	94120	10777	8531	57182	58473	9829	122706	5372	6327	150468	387882	1512	340024	5660	3459	55363	5897	3606	3574	65244	7852	11034	23626	9500	3140	259266	6601	80150	5360	29062	3149	55686	55024	991	84254	637	7465	2207	119710	3832	26586	3248	1198	58476	619279	54850	132299	2766	6387	6850	23710	9060	93185	4035	10376	1854	153090	9055	147841	4085	54947	51175	55281	6932	3838	3123	255743	990	1062	57405	1031	84858	5463	6422	3875
GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_DN	M6199		15879137	Borjesson DL,Kobayashi SD,Whitney AR,Voyich JM,Argue CM,Deleo FR	GSE2405	GSE2405_3590_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in polymorphonuclear leukocytes (9h): treated by heat killed HC60 cell (promyelocytic leukemia) lysate versus A. phagocytophilum infection.	Polymorphonuclear leukocytes (PMNs) were obtained from healthy individuals in accordance with protocols approved by the Institutional Review Board for Human Subjects at the University of Minnesota and the National Institute of Allergy and Infectious Diseases. PMNs (107) were combined on ice with live S. aureus (108) or with live or heat-killed A. phagocytophilum (bacteria isolated from 5x106 infected HL60 cells for a ratio of 1 infected HL60 cell: 2 PMNs, ~ 5-20 A. phagocytophilum: PMN) in wells of a 12-well tissue culture plate (pre-coated with 20% autologous normal human serum). Unstimulated control assays received either buffer (for S. aureus comparisons) or clarified HL60 lysate (for A. phagocytophilum comparisons). Plates were centrifuged at 350 x g for 8 min at 4oC to synchronize phagocytosis and incubated at 37 deg. C in a CO2 incubator for the indicated times. At the indicated times, tissue culture medium was aspirated from the plate and PMNs were lysed directly with RLT buffer (Qiagen, Valencia, CA). Purification of PMN RNA and subsequent preparation of labeled cRNA target was performed as described in Methods. Labeling of samples, hybridization of cRNA with HU133A oligonucleotide arrays (Affymetrix, Santa Clara, CA), and scanning were performed according to standard Affymetrix protocols ( http://www.affymetrix.com/pdf/expression_manual.pdf ). Experiments were performed in triplicate, using PMNs from three healthy individuals for each treatment.					11021	925	10449	23066	1359	10225	84674	84172	66000	926	10171	915	54923	79142	474344	6838	55892	55217	5306	89857	83640	64219	51621	5583	6915	114770	24139	7597	9442	8938	170261	55906	387357	56623	10730	3001	55709	6251	2051	9121	29920	9063	81611	26228	51112	53347	7323	392	8631	154661	2323	7389	55728	23457	131450	64420	80135	622	373156	22873	157285	5768	728621	6117	55559	83706	30827	54733	9452	5551	64328	9459	23647	51247	10419	8480	51071	25929	51702	25926	55798	326624	9618	4733	6402	84912	3932	202243	3384	113791	79575	115024	85450	1959	170575	3652	5018	10067	339123	399	11202	7277	222643	10524	2052	91522	466	8120	3337	541565	9577	347862	3059	7535	51143	118980	8886	257106	54960	2194	993	60680	91408	23484	919	5294	7138	29083	97	5893	112936	4063	10712	10486	4048	222487	84132	397	2547	285521	2618	3954	285753	839	10803	11146	25902	49856	23481	57504	5875	2841	124512	1233	8428	11126	81704	10788	84187	91433	1521	84148	339231	123355	51527	201229	4215	26268	10628	131118	51530	5519	10636	55585	10921	29922	50485	84705	7294	10235	9529	2805	56683	27240	80198	23646	2873	729991	54902	23085	22978	65095	84232	5564	85025	1407	11179	8705	951	116092
GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP	M6200		15879137	Borjesson DL,Kobayashi SD,Whitney AR,Voyich JM,Argue CM,Deleo FR	GSE2405	GSE2405_3591_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in polymorphonuclear leukocytes (24h): treated by heat killed HC60 cell (promyelocytic leukemia) lysate versus A. phagocytophilum infection.	Polymorphonuclear leukocytes (PMNs) were obtained from healthy individuals in accordance with protocols approved by the Institutional Review Board for Human Subjects at the University of Minnesota and the National Institute of Allergy and Infectious Diseases. PMNs (107) were combined on ice with live S. aureus (108) or with live or heat-killed A. phagocytophilum (bacteria isolated from 5x106 infected HL60 cells for a ratio of 1 infected HL60 cell: 2 PMNs, ~ 5-20 A. phagocytophilum: PMN) in wells of a 12-well tissue culture plate (pre-coated with 20% autologous normal human serum). Unstimulated control assays received either buffer (for S. aureus comparisons) or clarified HL60 lysate (for A. phagocytophilum comparisons). Plates were centrifuged at 350 x g for 8 min at 4oC to synchronize phagocytosis and incubated at 37 deg. C in a CO2 incubator for the indicated times. At the indicated times, tissue culture medium was aspirated from the plate and PMNs were lysed directly with RLT buffer (Qiagen, Valencia, CA). Purification of PMN RNA and subsequent preparation of labeled cRNA target was performed as described in Methods. Labeling of samples, hybridization of cRNA with HU133A oligonucleotide arrays (Affymetrix, Santa Clara, CA), and scanning were performed according to standard Affymetrix protocols ( http://www.affymetrix.com/pdf/expression_manual.pdf ). Experiments were performed in triplicate, using PMNs from three healthy individuals for each treatment.					2207	5971	6275	302	149345	23462	1845	55620	112752	23075	84302	3383	123	5376	1666	2335	60492	3664	55092	10602	6352	837	10437	5552	4035	54458	8013	345079	8611	5325	59345	8417	440	307	65108	22996	1796	23452	54476	10099	2171	2697	3486	23313	3918	9050	2952	219623	6422	2799	6277	91694	8828	400954	6535	79641	54845	1436	4363	9500	9516	11145	5360	6532	23263	211	2817	63874	9144	23022	9891	124857	1471	5272	84557	9060	5025	79705	4240	3855	79026	3512	1846	9476	558	717	9308	2766	220002	1495	533	51776	8510	3958	4629	3077	8581	23479	4086	7169	147798	13	162494	8456	4318	6050	3248	127544	5341	4283	1992	6002	8848	2896	92521	10406	58476	5217	23650	1488	334	374378	942	6876	81618	718	4616	54947	122618	1466	9026	64778	23191	79047	5660	9324	125488	79180	6447	200879	9912	2784	1476	3074	4688	26033	968	84552	64423	55365	126353	1191	7414	9915	8935	55861	51226	3852	9450	3394	11274	57685	72	50515	597	8502	79627	30844	5947	7127	3117	219793	2887	301	6768	2876	23446	2869	27237	1284	10783	6367	3514	3111	5317	999	2791	214	6578	58475	10410	8490	5621	5654	4256	25849	64581	80270	3304	6624
GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_DN	M6201		15879137	Borjesson DL,Kobayashi SD,Whitney AR,Voyich JM,Argue CM,Deleo FR	GSE2405	GSE2405_3591_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in polymorphonuclear leukocytes (24h): treated by heat killed HC60 cell (promyelocytic leukemia) lysate versus A. phagocytophilum infection.	Polymorphonuclear leukocytes (PMNs) were obtained from healthy individuals in accordance with protocols approved by the Institutional Review Board for Human Subjects at the University of Minnesota and the National Institute of Allergy and Infectious Diseases. PMNs (107) were combined on ice with live S. aureus (108) or with live or heat-killed A. phagocytophilum (bacteria isolated from 5x106 infected HL60 cells for a ratio of 1 infected HL60 cell: 2 PMNs, ~ 5-20 A. phagocytophilum: PMN) in wells of a 12-well tissue culture plate (pre-coated with 20% autologous normal human serum). Unstimulated control assays received either buffer (for S. aureus comparisons) or clarified HL60 lysate (for A. phagocytophilum comparisons). Plates were centrifuged at 350 x g for 8 min at 4oC to synchronize phagocytosis and incubated at 37 deg. C in a CO2 incubator for the indicated times. At the indicated times, tissue culture medium was aspirated from the plate and PMNs were lysed directly with RLT buffer (Qiagen, Valencia, CA). Purification of PMN RNA and subsequent preparation of labeled cRNA target was performed as described in Methods. Labeling of samples, hybridization of cRNA with HU133A oligonucleotide arrays (Affymetrix, Santa Clara, CA), and scanning were performed according to standard Affymetrix protocols ( http://www.affymetrix.com/pdf/expression_manual.pdf ). Experiments were performed in triplicate, using PMNs from three healthy individuals for each treatment.					79683	6575	55203	57216	121551	55246	23682	66004	57222	283643	55665	23416	3615	84961	79065	79885	10714	9509	5159	58480	7503	55363	5783	115004	79884	25852	23516	10644	1798	4897	84632	201266	153579	582	7867	2237	334	10493	10982	10769	7374	114876	80222	6002	1510	10469	64708	390594	1534	374887	5336	60561	7015	220001	79866	128239	23078	145508	5325	255743	374897	9256	5371	81490	7113	55210	339123	85508	64755	4016	58524	51755	10147	55094	5796	115708	2549	11098	51728	56980	144455	84056	4507	9749	1845	94031	9495	10813	2078	675	10970	55720	54974	5179	995	153	254359	4752	81621	10558	166378	4072	200010	4756	4281	84164	54797	7220	126823	91949	2937	9317	160622	8570	285590	210	150221	51706	7108	5226	57465	25939	8870	26015	766	55718	65244	83986	9780	9170	57480	84314	3198	54887	92595	1800	8760	79969	6850	23511	29775	63826	4313	84310	5118	84933	57099	31	586	64218	771	10060	23095	85460	144811	285025	221184	10350	55738	2736	11243	7029	11113	4345	221143	2290	154043	11128	9397	6812	7074	56931	27330	57697	84626	27297	80184	64794	2202	57325	153364	26608	7205	84529	114826	84720	83871	197335	10817	57685	7517	51435	65055	10867	55105	84861	4043	285556	11099	114112
GSE2405_0H_VS_9H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN	M6202		15879137	Borjesson DL,Kobayashi SD,Whitney AR,Voyich JM,Argue CM,Deleo FR	GSE2405	GSE2405_3585_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in polymorphonuclear leukocytes (9h): control versus infection by A. phagocytophilum.	Polymorphonuclear leukocytes (PMNs) were obtained from healthy individuals in accordance with protocols approved by the Institutional Review Board for Human Subjects at the University of Minnesota and the National Institute of Allergy and Infectious Diseases. PMNs (107) were combined on ice with live S. aureus (108) or with live or heat-killed A. phagocytophilum (bacteria isolated from 5x106 infected HL60 cells for a ratio of 1 infected HL60 cell: 2 PMNs, ~ 5-20 A. phagocytophilum: PMN) in wells of a 12-well tissue culture plate (pre-coated with 20% autologous normal human serum). Unstimulated control assays received either buffer (for S. aureus comparisons) or clarified HL60 lysate (for A. phagocytophilum comparisons). Plates were centrifuged at 350 x g for 8 min at 4oC to synchronize phagocytosis and incubated at 37 deg. C in a CO2 incubator for the indicated times. At the indicated times, tissue culture medium was aspirated from the plate and PMNs were lysed directly with RLT buffer (Qiagen, Valencia, CA). Purification of PMN RNA and subsequent preparation of labeled cRNA target was performed as described in Methods. Labeling of samples, hybridization of cRNA with HU133A oligonucleotide arrays (Affymetrix, Santa Clara, CA), and scanning were performed according to standard Affymetrix protocols ( http://www.affymetrix.com/pdf/expression_manual.pdf ). Experiments were performed in triplicate, using PMNs from three healthy individuals for each treatment.					6122	7086	6205	10327	6125	6202	6191	6230	6222	5901	3015	6130	6181	6129	6155	6139	6227	6170	26135	9349	5478	6167	6189	1933	4869	6134	6160	6204	3146	10376	11224	6223	293	7170	79036	5501	6187	6194	6188	1337	6993	1515	6133	6603	23521	71	6201	509	6235	7332	6141	3925	6241	6158	6143	9045	6147	3182	2171	10399	7178	6231	6137	27095	80774	302	6168	6142	60	6193	6157	4904	3183	203068	3094	7381	6210	5052	6427	7555	6146	6637	6175	5525	10204	4694	1528	5111	6124	6232	6387	51065	3945	6154	7323	5702	1460	28984	6135	3838	90007	5862	7993	51503	1937	4946	3921	1340	8106	6156	6415	10094	6169	6208	6164	375	11051	2665	2113	200916	3312	6203	51142	1982	3932	6228	6217	10109	6152	3320	8667	1267	9550	9377	5908	1164	6128	1973	7534	3939	51372	6119	8872	6136	9768	919	567	26097	64710	494115	114932	8073	5687	3030	8668	10632	51263	25873	6414	5928	3507	6601	4176	5983	6902	4775	6499	55544	539	6428	515	1975	4712	5682	9486	10096	5720	54993	9802	7805	917	8099	340024	5573	6392	84259	3192	7295	1655	4288	832	708	51025	22948	9618	23204	11165	518	7415	1791
GSE2405_0H_VS_12H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN	M6203		15879137	Borjesson DL,Kobayashi SD,Whitney AR,Voyich JM,Argue CM,Deleo FR	GSE2405	GSE2405_3586_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in polymorphonuclear leukocytes (12h): control versus infection by A. phagocytophilum.	Polymorphonuclear leukocytes (PMNs) were obtained from healthy individuals in accordance with protocols approved by the Institutional Review Board for Human Subjects at the University of Minnesota and the National Institute of Allergy and Infectious Diseases. PMNs (107) were combined on ice with live S. aureus (108) or with live or heat-killed A. phagocytophilum (bacteria isolated from 5x106 infected HL60 cells for a ratio of 1 infected HL60 cell: 2 PMNs, ~ 5-20 A. phagocytophilum: PMN) in wells of a 12-well tissue culture plate (pre-coated with 20% autologous normal human serum). Unstimulated control assays received either buffer (for S. aureus comparisons) or clarified HL60 lysate (for A. phagocytophilum comparisons). Plates were centrifuged at 350 x g for 8 min at 4oC to synchronize phagocytosis and incubated at 37 deg. C in a CO2 incubator for the indicated times. At the indicated times, tissue culture medium was aspirated from the plate and PMNs were lysed directly with RLT buffer (Qiagen, Valencia, CA). Purification of PMN RNA and subsequent preparation of labeled cRNA target was performed as described in Methods. Labeling of samples, hybridization of cRNA with HU133A oligonucleotide arrays (Affymetrix, Santa Clara, CA), and scanning were performed according to standard Affymetrix protocols ( http://www.affymetrix.com/pdf/expression_manual.pdf ). Experiments were performed in triplicate, using PMNs from three healthy individuals for each treatment.					219790	29920	285852	63826	8927	1062	898	26608	84930	151742	586	388336	57407	9317	54960	114885	81490	57216	169714	64421	84306	28231	332	4085	2743	221710	57405	3198	7465	79038	57125	79989	8938	260425	1789	5558	90141	10572	55906	84529	51175	10178	55329	163786	6877	25	79944	84706	5514	55771	2042	7029	51053	6002	55732	501	678655	9332	4778	343099	11185	11339	5577	57679	94031	3615	2187	8187	128178	55039	150368	6337	10840	54478	22846	63967	4969	9833	5557	118980	580	119710	150468	8458	167359	55746	50810	10644	80321	25914	8671	9415	701	8214	3978	27351	89766	9319	56890	147495	54914	9771	6323	10493	79969	79836	6387	84312	80776	8318	1359	79801	10100	84319	2547	90417	29775	79884	316	10350	9590	55164	8654	25852	55363	7827	9824	65055	55244	27136	9055	168090	166614	283431	285556	401541	387357	83990	148811	2968	54584	145508	1854	23294	23416	729533	18	151246	421	10469	26015	10171	6240	11004	85460	7503	340024	55013	23594	55930	116840	1870	11169	26173	63934	58473	3652	23569	79683	9735	10269	5075	22954	58472	54797	728621	815	57194	54859	92595	22974	55103	54820	11098	283643	84823	57182	9585	64112	5283	11112	79023	80131	641	55227	157773	54970	216	93594	5897
GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP	M6204		15879137	Borjesson DL,Kobayashi SD,Whitney AR,Voyich JM,Argue CM,Deleo FR	GSE2405	GSE2405_3587_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in polymorphonuclear leukocytes (24h): control versus infection by A. phagocytophilum.	Polymorphonuclear leukocytes (PMNs) were obtained from healthy individuals in accordance with protocols approved by the Institutional Review Board for Human Subjects at the University of Minnesota and the National Institute of Allergy and Infectious Diseases. PMNs (107) were combined on ice with live S. aureus (108) or with live or heat-killed A. phagocytophilum (bacteria isolated from 5x106 infected HL60 cells for a ratio of 1 infected HL60 cell: 2 PMNs, ~ 5-20 A. phagocytophilum: PMN) in wells of a 12-well tissue culture plate (pre-coated with 20% autologous normal human serum). Unstimulated control assays received either buffer (for S. aureus comparisons) or clarified HL60 lysate (for A. phagocytophilum comparisons). Plates were centrifuged at 350 x g for 8 min at 4oC to synchronize phagocytosis and incubated at 37 deg. C in a CO2 incubator for the indicated times. At the indicated times, tissue culture medium was aspirated from the plate and PMNs were lysed directly with RLT buffer (Qiagen, Valencia, CA). Purification of PMN RNA and subsequent preparation of labeled cRNA target was performed as described in Methods. Labeling of samples, hybridization of cRNA with HU133A oligonucleotide arrays (Affymetrix, Santa Clara, CA), and scanning were performed according to standard Affymetrix protocols ( http://www.affymetrix.com/pdf/expression_manual.pdf ). Experiments were performed in triplicate, using PMNs from three healthy individuals for each treatment.					10632	5682	6122	6205	6222	6191	6125	6181	6130	6230	5478	6202	6227	6129	6139	6160	1933	6155	9349	7086	10327	6170	6204	3336	6134	6133	3921	9045	6189	6223	79036	6902	6158	6167	3312	6141	1337	3183	6188	4637	6128	4869	6136	11224	5901	51142	10575	6187	6217	6194	6203	4904	23521	10399	6208	4076	2665	10376	6235	6147	10577	6201	4725	6143	220988	7323	5931	6231	7170	5052	1937	56889	27069	71	6137	10094	6193	7178	2098	6418	22818	55845	6168	5501	6146	6164	9987	6135	6175	302	3094	7381	6157	58527	60	9450	123803	3932	6169	4694	51372	3190	8667	7993	6210	4946	6232	80774	11040	6637	440567	6142	6124	2171	25873	6154	6647	200916	5720	3646	374454	9377	2207	7979	10923	1340	10541	51703	58191	1982	5692	155038	7531	9802	1666	10581	968	6156	79626	81030	5264	23225	718	382	7419	9375	4718	8635	81618	5710	5162	162979	9636	6152	1452	83706	114932	6228	55911	2995	3185	3309	6277	3662	3927	5699	60468	1975	121536	60436	25996	10109	1191	8844	1611	84674	3030	84557	53827	51735	9124	10933	11151	8668	4939	91408	100093630	9270	3855	51504	7332	56947	6171	528	4063	113246	3059	25824	115350	64135
GSE2405_S_AUREUS_VS_UNTREATED_NEUTROPHIL_DN	M6205		15879137	Borjesson DL,Kobayashi SD,Whitney AR,Voyich JM,Argue CM,Deleo FR	GSE2405	GSE2405_3574_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in polymorphonuclear leukocytes (9h): S. aureus infection versus control.	Polymorphonuclear leukocytes (PMNs) were obtained from healthy individuals in accordance with protocols approved by the Institutional Review Board for Human Subjects at the University of Minnesota and the National Institute of Allergy and Infectious Diseases. PMNs (107) were combined on ice with live S. aureus (108) or with live or heat-killed A. phagocytophilum (bacteria isolated from 5x106 infected HL60 cells for a ratio of 1 infected HL60 cell: 2 PMNs, ~ 5-20 A. phagocytophilum: PMN) in wells of a 12-well tissue culture plate (pre-coated with 20% autologous normal human serum). Unstimulated control assays received either buffer (for S. aureus comparisons) or clarified HL60 lysate (for A. phagocytophilum comparisons). Plates were centrifuged at 350 x g for 8 min at 4oC to synchronize phagocytosis and incubated at 37 deg. C in a CO2 incubator for the indicated times. At the indicated times, tissue culture medium was aspirated from the plate and PMNs were lysed directly with RLT buffer (Qiagen, Valencia, CA). Purification of PMN RNA and subsequent preparation of labeled cRNA target was performed as described in Methods. Labeling of samples, hybridization of cRNA with HU133A oligonucleotide arrays (Affymetrix, Santa Clara, CA), and scanning were performed according to standard Affymetrix protocols ( http://www.affymetrix.com/pdf/expression_manual.pdf ). Experiments were performed in triplicate, using PMNs from three healthy individuals for each treatment.					64225	3161	1058	83461	55796	9535	8501	79819	5983	57708	29074	390760	7153	64795	9788	144165	2289	30061	51203	2146	1910	11004	51514	64151	84986	9837	701	5253	94120	55872	676	3001	3140	3981	1102	84912	55329	94241	3838	25776	9055	8607	6993	3925	8526	27334	6935	56890	97	1033	926	3978	26586	867	54927	1176	9695	332	57405	2491	23397	3268	9156	2162	143458	2672	6790	79915	171558	9423	5558	925	1062	1359	150468	57125	90417	340075	10411	6119	2674	55081	79572	4288	2199	9700	406	302	23635	90381	90459	146909	100	54962	54478	79135	10777	83540	7852	10100	8318	65997	1854	6241	219855	898	6839	28962	7083	58473	1063	3459	11112	220134	57082	2114	54850	22974	26271	23626	6370	5897	6097	890	5111	55584	56913	23270	55143	54742	260425	91368	157313	5985	3507	9121	55726	340024	501	4354	899	5994	7280	84174	4175	53346	55274	113130	619279	10112	23569	10609	256126	3988	4602	4085	2395	814	63979	54960	113263	5625	815	219790	55759	7884	10403	10279	6502	51053	22873	401541	57650	9249	5463	26228	57472	29899	3018	10449	2224	6566	2968	29127	571	151648	55723	163589	1491	11339	5579	5075	825	348235	90355	83641	79801	55165	4068	10178
GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_UP	M6207		15879137	Borjesson DL,Kobayashi SD,Whitney AR,Voyich JM,Argue CM,Deleo FR	GSE2405	GSE2405_3575_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in polymorphonuclear leukocytes 9h after infection by: S. aureus versus A. phagocytophilum.	Polymorphonuclear leukocytes (PMNs) were obtained from healthy individuals in accordance with protocols approved by the Institutional Review Board for Human Subjects at the University of Minnesota and the National Institute of Allergy and Infectious Diseases. PMNs (107) were combined on ice with live S. aureus (108) or with live or heat-killed A. phagocytophilum (bacteria isolated from 5x106 infected HL60 cells for a ratio of 1 infected HL60 cell: 2 PMNs, ~ 5-20 A. phagocytophilum: PMN) in wells of a 12-well tissue culture plate (pre-coated with 20% autologous normal human serum). Unstimulated control assays received either buffer (for S. aureus comparisons) or clarified HL60 lysate (for A. phagocytophilum comparisons). Plates were centrifuged at 350 x g for 8 min at 4oC to synchronize phagocytosis and incubated at 37 deg. C in a CO2 incubator for the indicated times. At the indicated times, tissue culture medium was aspirated from the plate and PMNs were lysed directly with RLT buffer (Qiagen, Valencia, CA). Purification of PMN RNA and subsequent preparation of labeled cRNA target was performed as described in Methods. Labeling of samples, hybridization of cRNA with HU133A oligonucleotide arrays (Affymetrix, Santa Clara, CA), and scanning were performed according to standard Affymetrix protocols ( http://www.affymetrix.com/pdf/expression_manual.pdf ). Experiments were performed in triplicate, using PMNs from three healthy individuals for each treatment.					6238	3490	2701	306	5179	64005	149345	63027	23263	3693	10783	440603	7021	57655	64222	3659	7706	137797	83666	822	57705	10677	971	54331	91543	5721	3732	133	221188	384	57710	11226	718	3315	1512	10406	9882	10066	10439	340061	6422	2027	1366	4773	10867	115677	7133	596	64102	1733	126353	148808	64866	115361	3898	3598	715	4790	84166	2887	4025	6778	140576	389384	602	2355	2535	374454	23075	3275	9920	64423	4818	2841	25928	92196	26034	4600	64757	54458	55092	784	483	1265	7074	6692	151056	7169	1992	285590	22821	7076	4301	285966	119587	64218	56999	89781	7096	80380	8638	55323	1401	162073	5999	26012	10924	633	51278	56937	3363	5121	1284	83637	3034	57402	6480	399665	2990	11199	25939	1154	32	9766	200035	6289	3067	3106	1847	85377	9242	7187	79641	146857	462	54739	10410	1572	864	9725	9615	6352	340152	2013	9476	23406	89777	8572	81618	2353	23670	1235	79132	3135	55509	1611	121536	2760	51280	1439	151888	6361	8417	2308	9315	334	92521	3590	4050	4062	10365	5341	140606	477	1393	390243	79628	6857	23586	1893	79705	10505	90634	10039	595	3169	25907	124857	29760	81786	6696	51363	3108	5068	958	3682	10537	3695	3123	92211
GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_DN	M6208		15879137	Borjesson DL,Kobayashi SD,Whitney AR,Voyich JM,Argue CM,Deleo FR	GSE2405	GSE2405_3575_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in polymorphonuclear leukocytes 9h after infection by: S. aureus versus A. phagocytophilum.	Polymorphonuclear leukocytes (PMNs) were obtained from healthy individuals in accordance with protocols approved by the Institutional Review Board for Human Subjects at the University of Minnesota and the National Institute of Allergy and Infectious Diseases. PMNs (107) were combined on ice with live S. aureus (108) or with live or heat-killed A. phagocytophilum (bacteria isolated from 5x106 infected HL60 cells for a ratio of 1 infected HL60 cell: 2 PMNs, ~ 5-20 A. phagocytophilum: PMN) in wells of a 12-well tissue culture plate (pre-coated with 20% autologous normal human serum). Unstimulated control assays received either buffer (for S. aureus comparisons) or clarified HL60 lysate (for A. phagocytophilum comparisons). Plates were centrifuged at 350 x g for 8 min at 4oC to synchronize phagocytosis and incubated at 37 deg. C in a CO2 incubator for the indicated times. At the indicated times, tissue culture medium was aspirated from the plate and PMNs were lysed directly with RLT buffer (Qiagen, Valencia, CA). Purification of PMN RNA and subsequent preparation of labeled cRNA target was performed as described in Methods. Labeling of samples, hybridization of cRNA with HU133A oligonucleotide arrays (Affymetrix, Santa Clara, CA), and scanning were performed according to standard Affymetrix protocols ( http://www.affymetrix.com/pdf/expression_manual.pdf ). Experiments were performed in triplicate, using PMNs from three healthy individuals for each treatment.					9546	1185	57610	84056	84961	9256	147991	57216	2550	51706	84164	56931	90957	10147	84626	60561	79671	6575	84260	9015	64319	23334	257364	10444	79823	22839	10257	64145	8906	338692	84295	123879	27297	125061	7089	6002	7074	26015	51434	114770	9463	23503	10347	6327	474381	390637	55703	9879	51092	57185	84905	9649	23140	196264	60625	9013	84838	2583	339123	80742	21	197342	84861	27130	57786	23085	57567	541565	56623	55738	9854	80222	55072	158056	85441	56658	80772	26140	402415	79165	83478	55133	3268	5725	9068	9099	440193	57097	283643	64780	5371	9563	147837	5598	9931	257160	65979	3757	7318	22832	55340	91433	3594	64784	11123	55051	26276	23163	64393	23516	54902	7374	22858	8451	2870	171017	153364	89953	64802	57325	64760	4524	54856	84450	23268	54520	81490	1877	6650	84749	79091	11128	168090	162989	374897	11113	54899	55102	5442	84720	11037	417	201255	9400	79754	9159	126432	1294	23300	85015	23511	51380	51702	9481	80198	7486	57326	391002	89846	8938	27348	26505	4650	10420	5869	8916	9679	114790	100131496	81844	5298	167691	57125	9913	114804	200312	113829	7701	23567	8846	79932	10558	10307	342371	80143	55662	55540	84085	57222	100287171	54828	220001	55657	57192	26173	9117	26608	7733	79791	23492
GSE2405_0H_VS_1.5H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP	M6209		15879137	Borjesson DL,Kobayashi SD,Whitney AR,Voyich JM,Argue CM,Deleo FR	GSE2405	GSE2405_3582_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in polymorphonuclear leukocytes (1.5h): control versus infection by A. phagocytophilum.	Polymorphonuclear leukocytes (PMNs) were obtained from healthy individuals in accordance with protocols approved by the Institutional Review Board for Human Subjects at the University of Minnesota and the National Institute of Allergy and Infectious Diseases. PMNs (107) were combined on ice with live S. aureus (108) or with live or heat-killed A. phagocytophilum (bacteria isolated from 5x106 infected HL60 cells for a ratio of 1 infected HL60 cell: 2 PMNs, ~ 5-20 A. phagocytophilum: PMN) in wells of a 12-well tissue culture plate (pre-coated with 20% autologous normal human serum). Unstimulated control assays received either buffer (for S. aureus comparisons) or clarified HL60 lysate (for A. phagocytophilum comparisons). Plates were centrifuged at 350 x g for 8 min at 4oC to synchronize phagocytosis and incubated at 37 deg. C in a CO2 incubator for the indicated times. At the indicated times, tissue culture medium was aspirated from the plate and PMNs were lysed directly with RLT buffer (Qiagen, Valencia, CA). Purification of PMN RNA and subsequent preparation of labeled cRNA target was performed as described in Methods. Labeling of samples, hybridization of cRNA with HU133A oligonucleotide arrays (Affymetrix, Santa Clara, CA), and scanning were performed according to standard Affymetrix protocols ( http://www.affymetrix.com/pdf/expression_manual.pdf ). Experiments were performed in triplicate, using PMNs from three healthy individuals for each treatment.					1515	3043	3316	10864	51421	27067	26053	126353	558	1075	4013	5881	83982	11034	6414	5464	3659	10062	5947	55160	57095	3437	4692	57864	6050	6876	3107	3782	84552	400916	5872	219738	321	5954	121599	100505876	6282	6302	928	4629	5698	2171	3339	1508	9427	199	1281	6303	55505	1471	4915	822	29887	25822	1476	4016	552900	84329	291	5919	168002	2331	55240	23612	85407	4040	3916	57446	7472	386617	283298	25903	25996	339416	4908	89	374355	629	151887	358	10417	5699	9935	1675	1358	2194	6424	6470	1374	131450	8293	7018	4124	65083	6277	51162	963	4741	90411	79679	1050	1728	1992	28959	26471	51804	254863	9094	93166	10581	226	84171	8877	55970	374378	5549	3270	11274	5795	128434	2217	22938	715	2760	84066	222553	3632	2878	6622	4688	666	5692	114884	6259	55890	64359	286676	283349	137872	54453	3094	1944	1474	58476	387694	4317	54853	79651	4256	4081	1475	222663	4975	6280	122704	6281	3560	30846	56477	164714	390999	1956	55509	51056	123920	140680	3033	199964	3321	258	5691	6545	341	6712	90507	6256	1278	5866	5236	23160	7424	2925	3743	84833	7136	5091	143879	81618	9474	7253	23220	79784	325	149111	6585	212	3161	8510	84795
GSE2405_0H_VS_1.5H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN	M6211		15879137	Borjesson DL,Kobayashi SD,Whitney AR,Voyich JM,Argue CM,Deleo FR	GSE2405	GSE2405_3582_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in polymorphonuclear leukocytes (1.5h): control versus infection by A. phagocytophilum.	Polymorphonuclear leukocytes (PMNs) were obtained from healthy individuals in accordance with protocols approved by the Institutional Review Board for Human Subjects at the University of Minnesota and the National Institute of Allergy and Infectious Diseases. PMNs (107) were combined on ice with live S. aureus (108) or with live or heat-killed A. phagocytophilum (bacteria isolated from 5x106 infected HL60 cells for a ratio of 1 infected HL60 cell: 2 PMNs, ~ 5-20 A. phagocytophilum: PMN) in wells of a 12-well tissue culture plate (pre-coated with 20% autologous normal human serum). Unstimulated control assays received either buffer (for S. aureus comparisons) or clarified HL60 lysate (for A. phagocytophilum comparisons). Plates were centrifuged at 350 x g for 8 min at 4oC to synchronize phagocytosis and incubated at 37 deg. C in a CO2 incubator for the indicated times. At the indicated times, tissue culture medium was aspirated from the plate and PMNs were lysed directly with RLT buffer (Qiagen, Valencia, CA). Purification of PMN RNA and subsequent preparation of labeled cRNA target was performed as described in Methods. Labeling of samples, hybridization of cRNA with HU133A oligonucleotide arrays (Affymetrix, Santa Clara, CA), and scanning were performed according to standard Affymetrix protocols ( http://www.affymetrix.com/pdf/expression_manual.pdf ). Experiments were performed in triplicate, using PMNs from three healthy individuals for each treatment.					56623	22873	55038	84464	10449	79575	3337	3054	93589	1359	8243	7535	89857	6915	5875	64319	91408	55798	5306	56904	3603	9529	2874	374403	8631	23066	79142	9013	84717	27040	51702	7597	6117	5564	883	202243	113419	5394	10636	11021	11270	9442	57504	93643	55039	6949	80714	3676	80135	54584	51362	286336	11184	7376	27158	25	9493	51071	11276	55217	4048	6911	29928	79797	347862	49856	51061	55680	29907	2188	50619	56852	126626	6932	1785	10921	1869	27240	55695	10628	55824	399909	84733	399	23401	9844	4209	201229	65057	6867	51112	81620	27097	3954	124044	55588	919	80331	5395	55658	51143	10606	9775	333929	29888	51501	23583	84878	84240	84285	219743	3384	196513	580	3652	11264	166	3735	29108	64949	9968	5598	29789	9733	84219	9068	23683	23031	5305	8480	84937	11156	6199	55191	10743	22	23338	139322	4603	257068	5427	54440	64328	79813	7260	5893	54883	57621	55593	64784	90313	3613	9904	26999	6304	51318	112936	10125	915	5018	1723	9063	10419	285753	9675	23511	7323	2051	3614	10803	147700	5714	23431	6794	56259	55646	64756	8208	51138	9416	23550	10269	6048	57819	79101	57798	80228	25926	51617	5316	123355	55280	5883	54902	25970	388969	11194	26268	81844	2677
GSE2405_0H_VS_3H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP	M6212		15879137	Borjesson DL,Kobayashi SD,Whitney AR,Voyich JM,Argue CM,Deleo FR	GSE2405	GSE2405_3583_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in polymorphonuclear leukocytes (3h): control versus infection by A. phagocytophilum.	Polymorphonuclear leukocytes (PMNs) were obtained from healthy individuals in accordance with protocols approved by the Institutional Review Board for Human Subjects at the University of Minnesota and the National Institute of Allergy and Infectious Diseases. PMNs (107) were combined on ice with live S. aureus (108) or with live or heat-killed A. phagocytophilum (bacteria isolated from 5x106 infected HL60 cells for a ratio of 1 infected HL60 cell: 2 PMNs, ~ 5-20 A. phagocytophilum: PMN) in wells of a 12-well tissue culture plate (pre-coated with 20% autologous normal human serum). Unstimulated control assays received either buffer (for S. aureus comparisons) or clarified HL60 lysate (for A. phagocytophilum comparisons). Plates were centrifuged at 350 x g for 8 min at 4oC to synchronize phagocytosis and incubated at 37 deg. C in a CO2 incubator for the indicated times. At the indicated times, tissue culture medium was aspirated from the plate and PMNs were lysed directly with RLT buffer (Qiagen, Valencia, CA). Purification of PMN RNA and subsequent preparation of labeled cRNA target was performed as described in Methods. Labeling of samples, hybridization of cRNA with HU133A oligonucleotide arrays (Affymetrix, Santa Clara, CA), and scanning were performed according to standard Affymetrix protocols ( http://www.affymetrix.com/pdf/expression_manual.pdf ). Experiments were performed in triplicate, using PMNs from three healthy individuals for each treatment.					23462	8412	211	8510	91653	2701	29760	2947	120892	2212	6647	23075	85440	5336	56999	6271	493869	3490	4199	59345	132299	55323	5270	5321	7076	4688	3600	84445	7798	1992	2817	23263	54836	2791	30811	440	1500	3077	10945	4313	334	81544	4067	64778	834	83959	5603	345079	2869	3918	5654	1293	837	9630	283298	2952	2263	374378	57381	255488	200879	874	5317	55092	149345	5836	5774	64359	115207	1366	2017	131177	5359	80031	11160	84817	28959	152273	50515	5947	6367	10413	79057	595	79887	5358	4053	57710	1471	3590	26	169611	3852	23650	10581	338557	710	23002	54874	128414	9032	1536	4792	2120	1740	6237	64222	72	7837	79805	133	56922	9215	8404	633	1846	4240	441478	83871	79628	5360	5075	54474	6692	7052	641700	151056	1282	137797	23612	57685	53826	10630	91828	4502	64866	57453	219623	2766	8456	126353	4261	9056	5803	4629	199731	1805	7414	23313	3363	3598	1902	27143	358	9144	1278	23604	55917	8935	5627	63874	9476	54947	26064	126129	3606	375061	1501	11034	9242	10787	27445	3920	717	22996	1439	9473	4062	241	127544	3663	91107	55366	79641	3903	401262	1666	26056	6289	122618	999	8848	154810	57722	3486	6282	57864	5054	92610	7273
GSE2405_0H_VS_3H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN	M6213		15879137	Borjesson DL,Kobayashi SD,Whitney AR,Voyich JM,Argue CM,Deleo FR	GSE2405	GSE2405_3583_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in polymorphonuclear leukocytes (3h): control versus infection by A. phagocytophilum.	Polymorphonuclear leukocytes (PMNs) were obtained from healthy individuals in accordance with protocols approved by the Institutional Review Board for Human Subjects at the University of Minnesota and the National Institute of Allergy and Infectious Diseases. PMNs (107) were combined on ice with live S. aureus (108) or with live or heat-killed A. phagocytophilum (bacteria isolated from 5x106 infected HL60 cells for a ratio of 1 infected HL60 cell: 2 PMNs, ~ 5-20 A. phagocytophilum: PMN) in wells of a 12-well tissue culture plate (pre-coated with 20% autologous normal human serum). Unstimulated control assays received either buffer (for S. aureus comparisons) or clarified HL60 lysate (for A. phagocytophilum comparisons). Plates were centrifuged at 350 x g for 8 min at 4oC to synchronize phagocytosis and incubated at 37 deg. C in a CO2 incubator for the indicated times. At the indicated times, tissue culture medium was aspirated from the plate and PMNs were lysed directly with RLT buffer (Qiagen, Valencia, CA). Purification of PMN RNA and subsequent preparation of labeled cRNA target was performed as described in Methods. Labeling of samples, hybridization of cRNA with HU133A oligonucleotide arrays (Affymetrix, Santa Clara, CA), and scanning were performed according to standard Affymetrix protocols ( http://www.affymetrix.com/pdf/expression_manual.pdf ). Experiments were performed in triplicate, using PMNs from three healthy individuals for each treatment.					1244	6833	80724	9311	56	100	170690	170691	54507	23536	55811	125	173	183	51327	9590	259173	23600	154796	401138	51378	255239	253650	374860	338699	147495	187	80831	392509	10124	56938	57561	420	121549	151516	431705	55054	22994	577	343472	116071	635	23743	23629	196477	199675	440712	114897	114898	715	716	388799	114041	79640	129293	722	135398	728464	135927	222950	55064	169436	781	814	23473	57091	863	84229	9133	912	131450	10666	993	999	1010	54825	1036	1045	9620	11190	26038	11200	1122	1141	8483	9976	165530	25932	64084	1215	146225	1260	154043	246175	1268	23242	1305	1284	1296	78989	51232	1415	1441	1469	128817	3627	6373	1545	284541	1580	4051	1605	7919	1656	1671	55789	1674	139189	25979	27042	9228	29958	127602	1770	165721	23234	55619	1805	165545	84677	1828	1830	1879	1896	79645	10278	1959	83401	146956	59084	133121	255324	2043	2125	2138	729085	118670	9750	125704	55138	339145	90342	26998	642757	400863	400932	56776	390243	2299	2492	10272	2527	2538	2569	114805	2676	2681	92086	2690	2707	2741	10249	2791	2811	344561	10149	222487	84059	2886	221357	132243	3037	338442	8843	54435	6928	57110	80270	7184	27129	8692
GSE2405_0H_VS_6H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP	M6214		15879137	Borjesson DL,Kobayashi SD,Whitney AR,Voyich JM,Argue CM,Deleo FR	GSE2405	GSE2405_3584_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in polymorphonuclear leukocytes (6h): control versus infection by A. phagocytophilum.	Polymorphonuclear leukocytes (PMNs) were obtained from healthy individuals in accordance with protocols approved by the Institutional Review Board for Human Subjects at the University of Minnesota and the National Institute of Allergy and Infectious Diseases. PMNs (107) were combined on ice with live S. aureus (108) or with live or heat-killed A. phagocytophilum (bacteria isolated from 5x106 infected HL60 cells for a ratio of 1 infected HL60 cell: 2 PMNs, ~ 5-20 A. phagocytophilum: PMN) in wells of a 12-well tissue culture plate (pre-coated with 20% autologous normal human serum). Unstimulated control assays received either buffer (for S. aureus comparisons) or clarified HL60 lysate (for A. phagocytophilum comparisons). Plates were centrifuged at 350 x g for 8 min at 4oC to synchronize phagocytosis and incubated at 37 deg. C in a CO2 incubator for the indicated times. At the indicated times, tissue culture medium was aspirated from the plate and PMNs were lysed directly with RLT buffer (Qiagen, Valencia, CA). Purification of PMN RNA and subsequent preparation of labeled cRNA target was performed as described in Methods. Labeling of samples, hybridization of cRNA with HU133A oligonucleotide arrays (Affymetrix, Santa Clara, CA), and scanning were performed according to standard Affymetrix protocols ( http://www.affymetrix.com/pdf/expression_manual.pdf ). Experiments were performed in triplicate, using PMNs from three healthy individuals for each treatment.					7091	54764	54680	345462	7639	163115	155061	148206	440077	7621	79894	144348	285268	83744	25888	84905	80778	7707	153527	64397	23099	9880	403341	9278	54464	7520	7507	55841	7474	7444	57617	7431	84132	10868	83878	7390	9816	84747	7353	55148	29914	7329	91373	7307	9352	79770	7295	7287	10376	153657	55001	85453	23270	10098	142940	27037	10475	7187	29896	8459	1861	9804	79155	944	55504	56674	83460	51249	90809	10329	65062	79064	100131211	51522	28978	85014	3196	7086	80145	79725	10312	9882	57465	23232	6901	8887	259292	94120	55333	440423	25777	6612	10910	51657	9482	114790	6770	10254	135295	6717	80725	6713	6688	64847	6667	6648	27131	9784	22938	6635	6633	26785	26795	26809	94162	654319	677833	594839	9892	64754	57154	55234	10051	6597	28232	22950	6520	29985	27173	84255	10559	121260	8631	23408	81626	26751	6455	259230	84826	83852	55209	6418	91404	29946	5054	59343	6397	10389	6297	26278	6256	8607	23168	79363	222194	58528	6194	6224	6118	55178	9616	8635	55005	9610	55183	54509	64285	5993	91433	375287	51195	23108	10268	5878	22930	116442	83871	114825	5725	23198	5695	5682	79057	5631	10544	3275	5582	5580	51422	10549	10935	151987	5531	84687	151242
GSE2405_0H_VS_6H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN	M6215		15879137	Borjesson DL,Kobayashi SD,Whitney AR,Voyich JM,Argue CM,Deleo FR	GSE2405	GSE2405_3584_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in polymorphonuclear leukocytes (6h): control versus infection by A. phagocytophilum.	Polymorphonuclear leukocytes (PMNs) were obtained from healthy individuals in accordance with protocols approved by the Institutional Review Board for Human Subjects at the University of Minnesota and the National Institute of Allergy and Infectious Diseases. PMNs (107) were combined on ice with live S. aureus (108) or with live or heat-killed A. phagocytophilum (bacteria isolated from 5x106 infected HL60 cells for a ratio of 1 infected HL60 cell: 2 PMNs, ~ 5-20 A. phagocytophilum: PMN) in wells of a 12-well tissue culture plate (pre-coated with 20% autologous normal human serum). Unstimulated control assays received either buffer (for S. aureus comparisons) or clarified HL60 lysate (for A. phagocytophilum comparisons). Plates were centrifuged at 350 x g for 8 min at 4oC to synchronize phagocytosis and incubated at 37 deg. C in a CO2 incubator for the indicated times. At the indicated times, tissue culture medium was aspirated from the plate and PMNs were lysed directly with RLT buffer (Qiagen, Valencia, CA). Purification of PMN RNA and subsequent preparation of labeled cRNA target was performed as described in Methods. Labeling of samples, hybridization of cRNA with HU133A oligonucleotide arrays (Affymetrix, Santa Clara, CA), and scanning were performed according to standard Affymetrix protocols ( http://www.affymetrix.com/pdf/expression_manual.pdf ). Experiments were performed in triplicate, using PMNs from three healthy individuals for each treatment.					41	57001	8310	56	84532	100	170690	170691	54507	125	54806	9590	79053	259173	23600	154796	401138	51321	201283	51378	170961	338699	8125	93550	147495	80831	392509	200894	79637	51309	55616	151516	466	64422	80162	522	22994	29086	57597	116071	727857	635	23743	90427	91272	388962	219621	650662	145858	388289	400506	374864	126321	199675	339512	128061	338761	114898	390664	149840	114041	129293	722	55319	260436	55071	163688	125972	815	814	840	57091	57332	25790	57003	131076	729440	92558	257236	896	25819	131450	8556	168448	993	999	53841	1019	1028	201161	26973	9976	1260	1265	1268	25920	57642	1298	78989	51226	1350	56265	51232	49860	79848	128817	140690	1508	8722	1519	55280	3627	6373	643	1545	1594	51302	4051	7818	1671	25979	79132	10395	9940	1739	29958	3300	64215	79962	120526	1805	53820	1854	1857	1879	79645	80303	1991	10495	2037	26122	57222	132884	2138	79152	81926	219287	285016	399888	90050	80011	642938	441168	55026	23625	55138	84191	10160	2235	26998	9637	2268	2288	400932	56776	8061	2296	2304	2299	10817	10468	2524	2527	2538	2549	2562	2569	89792	25929	2681	84514	2690	54826	9837	2707	80318	2741	8001	51218	51292	2770	2776	2791
GSE2405_0H_VS_9H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP	M6217		15879137	Borjesson DL,Kobayashi SD,Whitney AR,Voyich JM,Argue CM,Deleo FR	GSE2405	GSE2405_3585_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in polymorphonuclear leukocytes (9h): control versus infection by A. phagocytophilum.	Polymorphonuclear leukocytes (PMNs) were obtained from healthy individuals in accordance with protocols approved by the Institutional Review Board for Human Subjects at the University of Minnesota and the National Institute of Allergy and Infectious Diseases. PMNs (107) were combined on ice with live S. aureus (108) or with live or heat-killed A. phagocytophilum (bacteria isolated from 5x106 infected HL60 cells for a ratio of 1 infected HL60 cell: 2 PMNs, ~ 5-20 A. phagocytophilum: PMN) in wells of a 12-well tissue culture plate (pre-coated with 20% autologous normal human serum). Unstimulated control assays received either buffer (for S. aureus comparisons) or clarified HL60 lysate (for A. phagocytophilum comparisons). Plates were centrifuged at 350 x g for 8 min at 4oC to synchronize phagocytosis and incubated at 37 deg. C in a CO2 incubator for the indicated times. At the indicated times, tissue culture medium was aspirated from the plate and PMNs were lysed directly with RLT buffer (Qiagen, Valencia, CA). Purification of PMN RNA and subsequent preparation of labeled cRNA target was performed as described in Methods. Labeling of samples, hybridization of cRNA with HU133A oligonucleotide arrays (Affymetrix, Santa Clara, CA), and scanning were performed according to standard Affymetrix protocols ( http://www.affymetrix.com/pdf/expression_manual.pdf ). Experiments were performed in triplicate, using PMNs from three healthy individuals for each treatment.					8895	347	9753	84083	54764	7639	284371	388558	163115	388567	79894	127665	285268	253639	83744	7596	252884	79673	64397	23099	58486	64848	7520	7498	7474	400673	7431	7414	10868	83878	84747	5412	29914	91373	7307	57544	7295	7280	10376	83538	115708	27037	10475	28683	7187	29896	8459	84969	23495	64699	388730	389177	28959	28978	124842	9032	79853	3196	7100	7086	51078	7043	374618	91646	10312	9882	57465	128637	6901	6883	9038	6839	10910	9262	10254	85464	135295	9295	57213	6704	121665	90853	221409	64847	171169	6670	6667	83891	9784	692197	26785	692075	26796	94162	677831	594839	677802	9892	55234	342527	10051	6597	6594	84464	28232	389015	284525	54716	57835	22950	8501	6520	84255	54733	1317	3177	283130	345274	283514	729956	81626	26751	51100	9467	259230	387893	55209	91404	83667	29946	222663	6332	6323	26278	25914	23168	222194	54665	23076	55178	80196	153830	8635	9783	55183	64285	388531	5993	221035	9401	9985	343035	5918	51195	23108	5900	23132	22930	116442	5805	23198	5682	146547	260429	124221	83886	5631	10594	5580	51422	10935	5535	23645	10105	5457	5452	51367	285877	11284	5366	23207	5585	8395	5281	57157	10745	23133	112885	26147	5824	246330	8566	3651	27295	5162
GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP	M6218		15879137	Borjesson DL,Kobayashi SD,Whitney AR,Voyich JM,Argue CM,Deleo FR	GSE2405	GSE2405_3589_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in polymorphonuclear leukocytes (24h) infection by A. phagocytophilum: heat killed versus live bacteria.	Polymorphonuclear leukocytes (PMNs) were obtained from healthy individuals in accordance with protocols approved by the Institutional Review Board for Human Subjects at the University of Minnesota and the National Institute of Allergy and Infectious Diseases. PMNs (107) were combined on ice with live S. aureus (108) or with live or heat-killed A. phagocytophilum (bacteria isolated from 5x106 infected HL60 cells for a ratio of 1 infected HL60 cell: 2 PMNs, ~ 5-20 A. phagocytophilum: PMN) in wells of a 12-well tissue culture plate (pre-coated with 20% autologous normal human serum). Unstimulated control assays received either buffer (for S. aureus comparisons) or clarified HL60 lysate (for A. phagocytophilum comparisons). Plates were centrifuged at 350 x g for 8 min at 4oC to synchronize phagocytosis and incubated at 37 deg. C in a CO2 incubator for the indicated times. At the indicated times, tissue culture medium was aspirated from the plate and PMNs were lysed directly with RLT buffer (Qiagen, Valencia, CA). Purification of PMN RNA and subsequent preparation of labeled cRNA target was performed as described in Methods. Labeling of samples, hybridization of cRNA with HU133A oligonucleotide arrays (Affymetrix, Santa Clara, CA), and scanning were performed according to standard Affymetrix protocols ( http://www.affymetrix.com/pdf/expression_manual.pdf ). Experiments were performed in triplicate, using PMNs from three healthy individuals for each treatment.					15	80724	55515	57001	56	90	100	102	54507	23536	125	85007	9590	126133	79868	91801	262	154796	401138	56172	253650	374860	11199	304	8905	187	94134	200894	64801	121549	431705	55252	80063	55054	64422	10533	471	23400	538	22994	8707	29086	9529	57597	343472	116071	54828	55814	727857	23743	2647	90427	83990	9024	153579	9184	387882	80017	374864	199675	390664	388799	79640	129852	129293	205428	285203	55319	260436	222166	84270	340591	781	125972	815	814	157922	23473	837	9994	57332	54862	25790	57003	79825	729440	79080	257236	896	8556	168448	1001	1036	11190	55349	1122	8483	1153	9976	9022	1213	1215	8418	1265	83548	51226	93058	1350	51232	1441	55790	79848	128817	140690	1493	1509	8722	1519	3627	1545	1594	284541	1580	1605	7818	80821	84771	11218	1655	163259	55789	139189	27042	9940	1739	58512	29958	1657	51277	55619	10072	1813	53820	171220	8446	1854	23741	1991	1993	83401	64772	59084	133121	2035	2037	26122	2043	132884	79152	51104	219287	80011	441168	55578	54629	2187	129804	2232	2288	439944	400863	400932	2294	10272	117246	2527	2539	2562	79690	2591	2670	2676	92086	84514	9837	2734	2741	8001	10672	8443	2811	63906	2835	2861	9289
GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_DN	M6219		15879137	Borjesson DL,Kobayashi SD,Whitney AR,Voyich JM,Argue CM,Deleo FR	GSE2405	GSE2405_3589_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in polymorphonuclear leukocytes (24h) infection by A. phagocytophilum: heat killed versus live bacteria.	Polymorphonuclear leukocytes (PMNs) were obtained from healthy individuals in accordance with protocols approved by the Institutional Review Board for Human Subjects at the University of Minnesota and the National Institute of Allergy and Infectious Diseases. PMNs (107) were combined on ice with live S. aureus (108) or with live or heat-killed A. phagocytophilum (bacteria isolated from 5x106 infected HL60 cells for a ratio of 1 infected HL60 cell: 2 PMNs, ~ 5-20 A. phagocytophilum: PMN) in wells of a 12-well tissue culture plate (pre-coated with 20% autologous normal human serum). Unstimulated control assays received either buffer (for S. aureus comparisons) or clarified HL60 lysate (for A. phagocytophilum comparisons). Plates were centrifuged at 350 x g for 8 min at 4oC to synchronize phagocytosis and incubated at 37 deg. C in a CO2 incubator for the indicated times. At the indicated times, tissue culture medium was aspirated from the plate and PMNs were lysed directly with RLT buffer (Qiagen, Valencia, CA). Purification of PMN RNA and subsequent preparation of labeled cRNA target was performed as described in Methods. Labeling of samples, hybridization of cRNA with HU133A oligonucleotide arrays (Affymetrix, Santa Clara, CA), and scanning were performed according to standard Affymetrix protocols ( http://www.affymetrix.com/pdf/expression_manual.pdf ). Experiments were performed in triplicate, using PMNs from three healthy individuals for each treatment.					9753	54764	81931	345462	152485	155061	148206	440077	7621	144348	89887	348327	84503	25888	84905	7542	131540	23099	403341	9278	81555	10413	7498	170626	7479	7475	8839	7450	402117	340706	128434	284415	29802	57687	83878	7390	9816	643763	114131	55148	91373	9352	7287	153657	27075	23554	285386	116447	79155	55504	23495	64699	56674	83460	643236	51249	10329	65062	79583	389177	114801	28959	55365	124842	55273	79853	3196	7086	7078	7056	79725	56156	8557	10716	57465	259292	94120	55333	56241	6612	9482	9263	6770	256435	10534	135295	80725	6713	65244	9552	171169	6670	27131	29907	677833	677831	9892	57154	28232	389015	284525	6543	160728	27173	84255	341880	116369	5250	8170	6477	81626	81858	79628	9467	84826	55209	83667	5054	3053	866	10389	29970	8796	692149	6256	8607	79363	58528	6194	6193	6184	6158	6155	4920	55178	643904	55005	9610	9783	22999	55188	54509	64285	5993	5967	83758	5948	51195	5878	29108	114825	5741	170679	5695	5687	5682	5670	146547	124221	83886	79056	79057	10594	5531	5535	10848	11281	5452	285877	5430	8228	119548	11284	55041	196463	79887	5585	91461	83394	57157	112885	26147	5245	283871	5207	23089	79955	8566	5161	5156	5138	5024	23440	344901
GSE22601_DOUBLE_NEGATIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_UP	M6226		15928199	Dik WA,Pike-Overzet K,Weerkamp F,Ridder de D,Haas de EF,Baert MR,Spek der van P,Koster EE,Reinders MJ,Dongen van JJ,Langerak AW,Staal FJ	GSE22601	GSE22601_3410_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in thymocytes: double negative versus double positive.	T cells develop from progenitors that migrate from the bone marrow into the thymus. Thymocytes are subdivided roughly as being double negative (DN), double positive (DP), or single positive (SP), based on the expression of the CD4 and CD8 coreceptors. The DN stage is heterogeneous and can be subdivided into four distinct subsets in mice based on the expression of CD44 and CD25. In human, three distinct DN stages can be recognized: a CD34+CD38−CD1a− stage that represents the most immature thymic subset and the consecutive CD34+CD38+CD1a− and CD34+CD38+CD1a+ stages. Human DN thymocytes mature via an immature single positive (ISP CD4+) and a DP stage into CD4+ or CD8+ SP T cells that express functional T cell receptors (TCR) and that exit the thymus. In this study, gene expression was measured in each of these nine stages.					1244	57001	8310	90	102	170690	54507	183	126133	79053	91801	262	154796	51321	56172	170961	338699	304	80831	392509	200894	79637	55616	151516	431705	80063	64422	80162	471	23400	522	9296	93974	9532	9529	23743	663	23629	83990	9184	119710	196446	387882	650662	388289	283897	126321	338761	114898	716	24141	388799	149840	114041	130813	205428	285203	55319	135398	352999	222950	814	157922	23473	837	840	9994	84229	57003	131076	729440	79080	257236	25819	131450	10666	168448	999	1019	1028	1036	51148	150356	11200	1122	26973	1164	1201	154043	25920	10466	93058	11151	51241	1350	1441	128817	140690	1493	1508	1509	8722	6373	1594	1600	7919	163259	8694	25979	3300	64215	120526	85479	23234	1813	92675	1857	8664	1979	59084	2035	57669	255324	2043	79852	2119	2138	79152	81926	51104	8933	90050	80011	441168	153745	23625	55138	84191	2235	9637	2257	2288	645010	439944	56776	8061	2304	2492	117246	2539	2569	89792	114805	2645	51301	2676	92086	2690	54826	9837	2734	8001	10249	51292	10672	2770	2776	8443	2811	63906	7107	2861	2828	9289	10149	9052	2886	2891	80273	2944	2957	23354	8843	10114	3145	4670	84376	51440	3251	117245	64342	80270	84263	3324	27129	200205
GSE22601_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP	M6227		15928199	Dik WA,Pike-Overzet K,Weerkamp F,Ridder de D,Haas de EF,Baert MR,Spek der van P,Koster EE,Reinders MJ,Dongen van JJ,Langerak AW,Staal FJ	GSE22601	GSE22601_3416_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in thymocytes: double positive versus CD4 [GeneID=920] single positive.	T cells develop from progenitors that migrate from the bone marrow into the thymus. Thymocytes are subdivided roughly as being double negative (DN), double positive (DP), or single positive (SP), based on the expression of the CD4 and CD8 coreceptors. The DN stage is heterogeneous and can be subdivided into four distinct subsets in mice based on the expression of CD44 and CD25. In human, three distinct DN stages can be recognized: a CD34+CD38−CD1a− stage that represents the most immature thymic subset and the consecutive CD34+CD38+CD1a− and CD34+CD38+CD1a+ stages. Human DN thymocytes mature via an immature single positive (ISP CD4+) and a DP stage into CD4+ or CD8+ SP T cells that express functional T cell receptors (TCR) and that exit the thymus. In this study, gene expression was measured in each of these nine stages.					144348	8501	203510	642757	201516	84083	54680	7644	345462	152485	163115	440077	163050	84503	252884	151126	79673	7694	7771	64397	10444	79844	23174	403341	64848	80122	81555	10413	54464	55841	7475	402117	340706	143187	54621	26276	57617	84132	83878	9816	7368	643763	164153	29914	255220	57544	7280	10376	83538	151613	85453	23270	10098	23554	254187	115708	27037	10475	29896	1861	80975	64699	83460	388730	51249	25789	10329	28959	124842	144404	284186	145942	9032	79853	3196	7056	7043	7041	374618	7012	8013	91646	6938	57465	8887	338398	4070	94122	94120	55333	440423	56241	10910	9262	114790	6770	23145	6713	163778	6704	121665	6694	65244	171169	6670	6667	10174	9655	399979	692197	26785	26796	94162	677831	594839	9892	6591	64754	6597	6594	4090	84464	28232	6543	57835	54733	81031	116369	1811	345274	283514	729956	81858	9467	23677	124923	6441	55209	5054	346288	57556	54549	222663	6332	6323	29970	8796	677772	6256	25914	23168	79363	54665	23076	6193	6158	6118	4920	55178	9616	643904	153830	55005	9610	9783	22999	158787	64285	5993	9401	343035	83758	375316	5918	11069	5900	23132	116442	54517	5805	5797	5741	170679	23198	5664	146547	260429	124221	83886	5961	10594	5629
GSE22601_DOUBLE_NEGATIVE_VS_IMMATURE_CD4_SP_THYMOCYTE_DN	M6228		15928199	Dik WA,Pike-Overzet K,Weerkamp F,Ridder de D,Haas de EF,Baert MR,Spek der van P,Koster EE,Reinders MJ,Dongen van JJ,Langerak AW,Staal FJ	GSE22601	GSE22601_3409_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in double negative thymocyte versus immature CD4 [GeneID=920] single positive cells.	T cells develop from progenitors that migrate from the bone marrow into the thymus. Thymocytes are subdivided roughly as being double negative (DN), double positive (DP), or single positive (SP), based on the expression of the CD4 and CD8 coreceptors. The DN stage is heterogeneous and can be subdivided into four distinct subsets in mice based on the expression of CD44 and CD25. In human, three distinct DN stages can be recognized: a CD34+CD38−CD1a− stage that represents the most immature thymic subset and the consecutive CD34+CD38+CD1a− and CD34+CD38+CD1a+ stages. Human DN thymocytes mature via an immature single positive (ISP CD4+) and a DP stage into CD4+ or CD8+ SP T cells that express functional T cell receptors (TCR) and that exit the thymus. In this study, gene expression was measured in each of these nine stages.					57001	56	170691	104	55811	9590	340811	84335	208	126133	79868	79053	91801	23600	262	144193	347902	51321	201283	51378	255239	8125	93550	304	147495	341	347	80831	57514	10865	200894	10124	84100	79637	51309	64801	55616	466	80063	22863	64422	471	57194	23400	522	9296	538	29086	9532	54828	2647	653	663	91272	388962	83990	7832	153579	705	219621	119710	196446	388289	400506	374864	199675	100128569	440712	338761	715	716	755	285203	55319	260436	55071	55064	58493	163688	815	157922	837	840	57091	863	57332	146849	131076	729440	92558	79080	9133	896	25819	131450	974	168448	993	1010	53841	1028	1036	9620	1153	165530	9022	8418	1260	25920	1296	1298	11316	51117	11151	23406	51241	1350	56265	90993	55790	79848	1469	128817	140690	1493	1509	8722	1519	1520	541578	1545	4051	1600	7818	29118	64794	1655	317781	1671	9993	139189	25979	27042	10395	9940	1770	51726	3300	64215	79962	51277	85479	10072	1805	1815	53820	84677	1854	1856	1896	79645	80303	1959	23741	64834	83401	11117	10495	2037	57669	26122	57222	2119	132884	79152	81926	219287	283726	80011	642938	55578	54629	55026	23625	10160	26190	2232	2235	90342	9637	2257	401281	2296	2304
GSE22601_DOUBLE_NEGATIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN	M6230		15928199	Dik WA,Pike-Overzet K,Weerkamp F,Ridder de D,Haas de EF,Baert MR,Spek der van P,Koster EE,Reinders MJ,Dongen van JJ,Langerak AW,Staal FJ	GSE22601	GSE22601_3412_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in thymocytes: double negative versus CD8 single positive.	T cells develop from progenitors that migrate from the bone marrow into the thymus. Thymocytes are subdivided roughly as being double negative (DN), double positive (DP), or single positive (SP), based on the expression of the CD4 and CD8 coreceptors. The DN stage is heterogeneous and can be subdivided into four distinct subsets in mice based on the expression of CD44 and CD25. In human, three distinct DN stages can be recognized: a CD34+CD38−CD1a− stage that represents the most immature thymic subset and the consecutive CD34+CD38+CD1a− and CD34+CD38+CD1a+ stages. Human DN thymocytes mature via an immature single positive (ISP CD4+) and a DP stage into CD4+ or CD8+ SP T cells that express functional T cell receptors (TCR) and that exit the thymus. In this study, gene expression was measured in each of these nine stages.					9753	7310	7644	345462	7639	284371	388558	163115	388567	148206	79894	127665	23361	89887	84503	83744	7771	64397	23318	403341	58486	80122	54464	170626	8839	7450	402117	29802	7414	84132	10868	80761	643763	114131	27075	80746	28683	29896	84969	116447	55504	388730	25789	90809	79583	389177	114801	55365	28978	284186	55273	7100	7086	7078	26521	201798	7045	7043	7012	374739	91646	6938	8557	6916	219899	9882	57465	338398	4070	6839	56241	25777	23145	9295	121665	90853	65244	64847	171169	6667	27131	399979	692075	26796	677833	677802	342527	10051	6597	9597	54716	160728	60482	57210	126969	10559	3177	116369	1811	283130	57084	23410	26751	79628	6441	57713	83852	55209	91404	5054	346288	6397	222663	6332	6323	677772	6304	6258	6194	6101	8635	55183	158787	79651	64285	84957	9985	343035	11030	5948	11069	10268	22930	116442	114825	5733	5671	5664	58497	124221	83886	5629	10544	5580	51422	5535	10848	23368	10105	11281	5452	5430	119548	139728	23228	79887	91461	5287	10745	112885	5204	5824	246330	79955	27295	5161	5138	347862	5132	11333	5126	55795	56122	5087	55872	143	5024	92106	114885	254783	254786	390079	23538	79317	390649	441932	26737	26529	122748	219960	221391
GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_UP	M6232		15928199	Dik WA,Pike-Overzet K,Weerkamp F,Ridder de D,Haas de EF,Baert MR,Spek der van P,Koster EE,Reinders MJ,Dongen van JJ,Langerak AW,Staal FJ	GSE22601	GSE22601_3413_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in immature CD4 [GeneID=920] single positive cells versus double positive thymocytes.	T cells develop from progenitors that migrate from the bone marrow into the thymus. Thymocytes are subdivided roughly as being double negative (DN), double positive (DP), or single positive (SP), based on the expression of the CD4 and CD8 coreceptors. The DN stage is heterogeneous and can be subdivided into four distinct subsets in mice based on the expression of CD44 and CD25. In human, three distinct DN stages can be recognized: a CD34+CD38−CD1a− stage that represents the most immature thymic subset and the consecutive CD34+CD38+CD1a− and CD34+CD38+CD1a+ stages. Human DN thymocytes mature via an immature single positive (ISP CD4+) and a DP stage into CD4+ or CD8+ SP T cells that express functional T cell receptors (TCR) and that exit the thymus. In this study, gene expression was measured in each of these nine stages.					6833	41	9311	55515	56	170690	54507	55811	125	79924	173	183	54806	51327	9590	23600	144193	401138	51378	170961	338699	8120	147495	187	341	347	80831	115703	10124	84100	51309	420	55616	121549	80162	8707	57597	577	343472	116071	635	23743	653	91653	23629	219621	119710	196446	283897	126321	284325	199675	339512	388722	114897	715	24141	388799	149840	755	114041	79640	130813	129852	722	135398	728464	352999	135927	222950	55064	169436	57091	863	84229	149483	146849	79825	84692	9133	51554	909	912	131450	10666	993	1010	1001	54825	53841	1036	1045	9620	11200	1141	8483	165530	1215	1260	154043	246175	1268	23242	1307	57642	1284	1296	1298	56265	90993	51232	49860	1415	1469	128817	1536	1545	1594	1580	1600	84771	29118	64794	1671	163259	55789	139189	25979	201140	79132	10395	9940	9228	58512	65989	29958	1770	165721	79962	85479	165545	1813	1828	1830	1879	1896	79645	10278	1991	83401	146956	11117	59084	133121	255324	79852	2119	132884	2125	79152	81926	283726	399888	90050	642938	125704	153745	55138	339145	10160	2232	90342	26998	8823	2260	2268	439944	642757	400863	400932	390243	8061	2299	10817	2492	10468	2524	2527
GSE22601_DOUBLE_NEGATIVE_VS_IMMATURE_CD4_SP_THYMOCYTE_UP	M6234		15928199	Dik WA,Pike-Overzet K,Weerkamp F,Ridder de D,Haas de EF,Baert MR,Spek der van P,Koster EE,Reinders MJ,Dongen van JJ,Langerak AW,Staal FJ	GSE22601	GSE22601_3409_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in double negative thymocyte versus immature CD4 [GeneID=920] single positive cells.	T cells develop from progenitors that migrate from the bone marrow into the thymus. Thymocytes are subdivided roughly as being double negative (DN), double positive (DP), or single positive (SP), based on the expression of the CD4 and CD8 coreceptors. The DN stage is heterogeneous and can be subdivided into four distinct subsets in mice based on the expression of CD44 and CD25. In human, three distinct DN stages can be recognized: a CD34+CD38−CD1a− stage that represents the most immature thymic subset and the consecutive CD34+CD38+CD1a− and CD34+CD38+CD1a+ stages. Human DN thymocytes mature via an immature single positive (ISP CD4+) and a DP stage into CD4+ or CD8+ SP T cells that express functional T cell receptors (TCR) and that exit the thymus. In this study, gene expression was measured in each of these nine stages.					29985	7791	9753	54764	54680	7644	345462	7639	284371	388558	163115	388567	148206	440077	7621	79894	285268	9640	83744	25888	7596	147687	7707	7545	64397	10444	23174	403341	58486	54464	7520	7507	55841	7444	7431	7414	10868	7390	10975	7378	84747	7353	55148	7329	91373	7307	9352	57544	79770	7295	57045	10376	85453	23270	80746	142940	27037	10475	28683	29896	8459	1861	9804	79155	944	56674	83460	90809	10329	65062	79583	100131211	201931	51522	28978	54732	7091	7086	80145	51078	374739	10312	6938	219899	9882	128637	8887	259292	138474	6883	94120	55333	8871	440423	6612	10910	9482	114790	10254	10534	135295	6717	80725	57213	121665	6688	64847	9552	6670	6667	10174	6648	27131	83891	399979	29907	22938	26795	26809	654319	677833	594839	677802	64754	55234	10051	6597	57835	22950	27173	54733	10559	283130	5250	57606	8631	6477	729956	6455	9467	259230	83852	387893	55209	6418	91404	83667	9554	6397	677772	26278	1901	6256	25914	23168	222194	23076	6194	6184	6155	55178	80196	153830	8635	55005	55183	55188	79651	5863	221035	91433	375316	23108	5900	23132	5878	22930	116442	83871	29108	54517	5805	5725	5682	58497	5631	3275	5580	10549	10935	151987	5531	84687	23645
GSE22601_DOUBLE_NEGATIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP	M6235		15928199	Dik WA,Pike-Overzet K,Weerkamp F,Ridder de D,Haas de EF,Baert MR,Spek der van P,Koster EE,Reinders MJ,Dongen van JJ,Langerak AW,Staal FJ	GSE22601	GSE22601_3412_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in thymocytes: double negative versus CD8 single positive.	T cells develop from progenitors that migrate from the bone marrow into the thymus. Thymocytes are subdivided roughly as being double negative (DN), double positive (DP), or single positive (SP), based on the expression of the CD4 and CD8 coreceptors. The DN stage is heterogeneous and can be subdivided into four distinct subsets in mice based on the expression of CD44 and CD25. In human, three distinct DN stages can be recognized: a CD34+CD38−CD1a− stage that represents the most immature thymic subset and the consecutive CD34+CD38+CD1a− and CD34+CD38+CD1a+ stages. Human DN thymocytes mature via an immature single positive (ISP CD4+) and a DP stage into CD4+ or CD8+ SP T cells that express functional T cell receptors (TCR) and that exit the thymus. In this study, gene expression was measured in each of these nine stages.					15	84836	80724	55515	56	90	100	170691	55811	125	127	79924	54806	51327	9590	126133	79868	91801	259173	23600	401138	51321	201283	51378	56172	255239	253650	374860	338699	93550	11199	337	347	80831	115703	392509	10124	84100	51309	56938	420	64801	121549	151516	22926	80063	471	57194	522	9296	57597	577	727857	653	663	91653	388962	83990	9024	153579	119710	196477	650662	145858	79736	374864	284325	199675	100128569	339512	128061	388722	338761	390664	715	716	388799	149840	114041	129293	260436	728464	352999	135927	222950	55071	55064	58493	340591	815	814	9994	863	79825	131076	257236	6363	56477	131450	10666	8556	56990	1010	1045	9620	26038	24146	1260	1265	246175	1268	10466	1305	1307	57642	1284	1298	78989	93058	27235	8895	56265	51232	1415	4253	140690	1508	1509	8722	55280	6373	1545	51302	284541	4051	1605	84771	29118	317781	55789	139189	201140	79132	27042	10395	9940	1739	9228	58512	29958	1657	165721	64215	120526	51277	23234	10072	1805	1815	84677	1828	92675	8446	1854	1879	1896	80303	10278	1991	1993	11117	133121	26122	255324	2043	57222	2119	132884	2125	79152	219287	139285	285016	283726	90050	642938	441168	55578	9750	153745	137392	339145	84191	171482
GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN	M6237		15928199	Dik WA,Pike-Overzet K,Weerkamp F,Ridder de D,Haas de EF,Baert MR,Spek der van P,Koster EE,Reinders MJ,Dongen van JJ,Langerak AW,Staal FJ	GSE22601	GSE22601_3414_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] single positive cells: immature versus thymocytes.	T cells develop from progenitors that migrate from the bone marrow into the thymus. Thymocytes are subdivided roughly as being double negative (DN), double positive (DP), or single positive (SP), based on the expression of the CD4 and CD8 coreceptors. The DN stage is heterogeneous and can be subdivided into four distinct subsets in mice based on the expression of CD44 and CD25. In human, three distinct DN stages can be recognized: a CD34+CD38−CD1a− stage that represents the most immature thymic subset and the consecutive CD34+CD38+CD1a− and CD34+CD38+CD1a+ stages. Human DN thymocytes mature via an immature single positive (ISP CD4+) and a DP stage into CD4+ or CD8+ SP T cells that express functional T cell receptors (TCR) and that exit the thymus. In this study, gene expression was measured in each of these nine stages.					643236	7791	54764	162962	388558	388567	7621	79894	253639	9640	25888	84905	80778	153527	79844	23174	9880	403341	58486	64848	80122	81555	10413	54464	7520	7498	55841	7474	4013	284415	57617	7431	10868	7378	55148	29914	57544	79770	7295	7280	10376	55001	151613	10098	115708	7187	8459	79155	55504	64699	25789	65062	79583	219854	114801	100131211	55365	81615	124842	7100	7086	7078	51078	7043	374618	56156	91646	10312	9882	57465	128637	51616	8871	221711	440423	6612	10910	10254	6713	163778	6704	64847	6670	6667	6648	83891	22938	26796	26809	677802	10051	6597	6594	84464	28232	389015	54716	22950	57210	8501	6520	29985	84255	54733	1317	81031	116369	283130	8170	345274	23410	6477	729956	81626	6455	9467	84826	83852	387893	55209	6418	91404	83667	29946	6397	692149	6297	6274	23168	6158	55178	6049	55005	54509	5863	5993	221035	9401	9985	343035	91433	11030	23108	10268	23132	5878	22930	83871	54517	57540	5682	260429	5631	10594	5580	10549	5535	84687	151242	333926	10248	51367	57104	55041	196463	79887	5585	9600	8395	57157	10745	23133	26147	5245	283871	5207	10471	8566	347862	10015	5132	11333	56128	56122	5094	143	29948	114885	254783	196335	23538	391190	26737	221391	4969
GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP	M6238		15928199	Dik WA,Pike-Overzet K,Weerkamp F,Ridder de D,Haas de EF,Baert MR,Spek der van P,Koster EE,Reinders MJ,Dongen van JJ,Langerak AW,Staal FJ	GSE22601	GSE22601_3415_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in single positive cells: immature CD4 [GeneID=920] versus CD8 thymocytes.	T cells develop from progenitors that migrate from the bone marrow into the thymus. Thymocytes are subdivided roughly as being double negative (DN), double positive (DP), or single positive (SP), based on the expression of the CD4 and CD8 coreceptors. The DN stage is heterogeneous and can be subdivided into four distinct subsets in mice based on the expression of CD44 and CD25. In human, three distinct DN stages can be recognized: a CD34+CD38−CD1a− stage that represents the most immature thymic subset and the consecutive CD34+CD38+CD1a− and CD34+CD38+CD1a+ stages. Human DN thymocytes mature via an immature single positive (ISP CD4+) and a DP stage into CD4+ or CD8+ SP T cells that express functional T cell receptors (TCR) and that exit the thymus. In this study, gene expression was measured in each of these nine stages.					474344	10602	64968	55544	25809	401409	3275	80765	54440	2833	2745	162989	79441	2123	7852	256302	939	339324	284273	55789	10608	25865	54509	5732	124935	5142	113791	7832	57610	84674	10628	9451	205428	5998	4690	7188	11259	10161	57561	63901	54861	9047	51393	4050	83786	4775	57182	84174	2077	54491	11080	152185	388650	10957	30845	5997	10636	124460	126282	3707	168537	23550	51379	10678	3783	245812	27244	11240	154743	2124	8600	286336	81558	56262	2672	80342	27240	4665	8819	7903	10365	122953	79447	359948	26512	6659	7357	9770	2166	55700	4602	5739	90634	150864	3603	10370	55759	83759	81628	6515	3399	1844	23531	6414	4155	8567	23046	80256	152519	541565	3594	83605	3454	83693	10235	8535	5989	57704	7128	1027	2969	79699	84329	6503	157695	285753	2625	79626	201799	55355	55603	26119	54	58526	10044	1974	6915	1831	83667	4524	8111	83607	27128	22822	7272	9709	3664	10750	4221	1716	51765	168544	10077	26191	259236	11221	10140	6195	1385	54541	23625	1267	10318	10758	339287	284207	374403	388	55279	6526	51255	64132	899	9953	10392	79144	6827	259173	26000	57097	3660	10641	9656	51734	29933	54941	26260	50614	51129	23338	9679	29089	399	81619	55363	84733	921	90313	5993	9046
GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN	M6240		15928199	Dik WA,Pike-Overzet K,Weerkamp F,Ridder de D,Haas de EF,Baert MR,Spek der van P,Koster EE,Reinders MJ,Dongen van JJ,Langerak AW,Staal FJ	GSE22601	GSE22601_3415_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in single positive cells: immature CD4 [GeneID=920] versus CD8 thymocytes.	T cells develop from progenitors that migrate from the bone marrow into the thymus. Thymocytes are subdivided roughly as being double negative (DN), double positive (DP), or single positive (SP), based on the expression of the CD4 and CD8 coreceptors. The DN stage is heterogeneous and can be subdivided into four distinct subsets in mice based on the expression of CD44 and CD25. In human, three distinct DN stages can be recognized: a CD34+CD38−CD1a− stage that represents the most immature thymic subset and the consecutive CD34+CD38+CD1a− and CD34+CD38+CD1a+ stages. Human DN thymocytes mature via an immature single positive (ISP CD4+) and a DP stage into CD4+ or CD8+ SP T cells that express functional T cell receptors (TCR) and that exit the thymus. In this study, gene expression was measured in each of these nine stages.					8897	25976	4783	84541	9934	116984	3142	26225	54149	202	3732	5464	5045	56342	197370	151648	253512	84925	9489	2867	6341	10802	639	64092	4090	10125	8482	166815	9069	27173	81030	84962	6513	2697	79612	54470	284996	11009	201626	23082	1992	83448	58528	22931	7494	151556	355	26051	22800	5516	3959	8553	8676	6484	114609	26354	1326	8651	55636	9039	132720	65095	2623	51542	5597	3717	4780	51566	162239	23528	382	6877	6773	8850	5756	9595	9920	54521	5621	652968	58489	54904	2355	2822	3430	25897	22891	7052	10672	328	3487	3665	51104	122786	330	4953	4851	6772	23588	161882	83636	10410	169200	84333	10211	30009	64332	1153	837	90007	5008	4615	286451	55589	1052	9261	8728	22894	146857	115004	80255	6446	84060	345611	10018	10379	55110	5627	56985	7133	2012	255394	196	55421	64651	136	112399	7296	3091	10507	254428	4084	55072	259230	1032	54407	92521	5770	4049	2669	8867	10892	64108	3002	4300	9908	5873	23074	6774	79865	7706	257415	92345	6403	29969	79071	54625	23150	3572	5359	8301	151636	8844	163351	1435	7782	51676	51735	8718	3595	64375	7538	83606	3976	85464	84294	9753	864	51225	54842	5734	25816	2034	366	54739	25842	22856	84909	1051	64859
GSE22601_DOUBLE_NEGATIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP	M6242		15928199	Dik WA,Pike-Overzet K,Weerkamp F,Ridder de D,Haas de EF,Baert MR,Spek der van P,Koster EE,Reinders MJ,Dongen van JJ,Langerak AW,Staal FJ	GSE22601	GSE22601_3411_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in thymocytes: double negative versus CD4 [GeneID=920] single positive.	T cells develop from progenitors that migrate from the bone marrow into the thymus. Thymocytes are subdivided roughly as being double negative (DN), double positive (DP), or single positive (SP), based on the expression of the CD4 and CD8 coreceptors. The DN stage is heterogeneous and can be subdivided into four distinct subsets in mice based on the expression of CD44 and CD25. In human, three distinct DN stages can be recognized: a CD34+CD38−CD1a− stage that represents the most immature thymic subset and the consecutive CD34+CD38+CD1a− and CD34+CD38+CD1a+ stages. Human DN thymocytes mature via an immature single positive (ISP CD4+) and a DP stage into CD4+ or CD8+ SP T cells that express functional T cell receptors (TCR) and that exit the thymus. In this study, gene expression was measured in each of these nine stages.					23478	54664	84958	55093	11329	4085	7716	51526	6732	8829	5893	6319	1237	58500	115106	3480	4734	2222	10000	1535	79699	27111	3149	9820	170575	64968	4799	81855	92196	4176	7316	201725	10397	835	10673	26260	1611	4249	285753	54509	55843	2907	55544	123	84532	90390	7832	11259	117247	6352	51564	78995	928	84311	51255	80223	10051	7779	8560	22876	56672	5106	6793	283130	80139	8805	5971	3627	1628	10228	112479	25901	64780	221443	301	27086	25923	55198	113130	10447	9524	4050	5140	6533	6515	10392	1362	388	6747	9404	10152	79829	2224	147015	5997	167153	7293	6041	57610	120103	2130	3070	6001	84680	6892	91010	80237	23531	79718	4791	445	3434	83786	1831	3482	10957	1493	80776	56257	10608	7040	256302	29105	56261	10628	2672	5728	10904	149076	84899	597	50649	255104	55219	4155	26994	113791	57189	6281	150864	26523	825	6890	54491	286148	5530	115825	26136	55768	3418	10477	8527	3676	8493	222166	5993	9415	6310	8111	51617	284273	10014	10140	84674	81622	727910	6611	55363	994	7267	121053	8819	27244	400746	83861	30845	7407	80765	2665	55509	949	54941	6489	7464	953	665	282679	54951	11123	1112	10163	3005	124935	5335	57608	55915	23046	401097	2778	3106
GSE22601_DOUBLE_NEGATIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN	M6243		15928199	Dik WA,Pike-Overzet K,Weerkamp F,Ridder de D,Haas de EF,Baert MR,Spek der van P,Koster EE,Reinders MJ,Dongen van JJ,Langerak AW,Staal FJ	GSE22601	GSE22601_3411_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in thymocytes: double negative versus CD4 [GeneID=920] single positive.	T cells develop from progenitors that migrate from the bone marrow into the thymus. Thymocytes are subdivided roughly as being double negative (DN), double positive (DP), or single positive (SP), based on the expression of the CD4 and CD8 coreceptors. The DN stage is heterogeneous and can be subdivided into four distinct subsets in mice based on the expression of CD44 and CD25. In human, three distinct DN stages can be recognized: a CD34+CD38−CD1a− stage that represents the most immature thymic subset and the consecutive CD34+CD38+CD1a− and CD34+CD38+CD1a+ stages. Human DN thymocytes mature via an immature single positive (ISP CD4+) and a DP stage into CD4+ or CD8+ SP T cells that express functional T cell receptors (TCR) and that exit the thymus. In this study, gene expression was measured in each of these nine stages.					488	6304	51606	27238	88455	11154	8313	23295	55748	3142	9538	51258	2793	201626	3559	9583	5464	3929	253512	56650	53916	10807	84962	23151	351	57460	9861	57380	1521	2120	6932	3633	26037	6484	4170	4839	56270	7381	4818	84916	51727	9934	29925	1435	5705	23788	6431	51726	28982	11188	219285	54505	8482	5576	10162	824	7043	169200	639	25764	84909	81873	27433	943	79647	2885	24140	79031	84542	10237	652968	93380	7408	4144	2824	10180	55784	7150	9238	132789	84951	126432	3416	10963	79693	23152	3091	79415	129531	56647	7514	9039	56342	4659	58489	51542	152007	4609	3838	57466	9466	64857	64115	6277	6513	1769	54834	8880	7533	1051	1326	10808	6773	340061	7965	6713	54795	9411	57446	64218	79048	10130	64979	8726	4013	7096	3566	10581	5663	174	2623	23479	677	3301	26521	65095	51340	80155	6198	168544	8651	84525	55365	1075	5684	5770	963	5216	79954	27173	5861	5688	604	25939	57532	5600	51135	22931	1893	147991	80013	11177	28231	1583	80017	6617	5450	25976	112	7922	4615	84925	220002	3939	9706	5306	1528	116150	7529	81669	8453	4084	8896	90007	57223	84315	112495	3911	9086	283131	7325	8844	2308	552889	8676	23765	6774	7756	10137	54625
GSE22601_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP	M6245		15928199	Dik WA,Pike-Overzet K,Weerkamp F,Ridder de D,Haas de EF,Baert MR,Spek der van P,Koster EE,Reinders MJ,Dongen van JJ,Langerak AW,Staal FJ	GSE22601	GSE22601_3418_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in single positive thymocytes: CD4 [GeneID=920] versus CD8.	T cells develop from progenitors that migrate from the bone marrow into the thymus. Thymocytes are subdivided roughly as being double negative (DN), double positive (DP), or single positive (SP), based on the expression of the CD4 and CD8 coreceptors. The DN stage is heterogeneous and can be subdivided into four distinct subsets in mice based on the expression of CD44 and CD25. In human, three distinct DN stages can be recognized: a CD34+CD38−CD1a− stage that represents the most immature thymic subset and the consecutive CD34+CD38+CD1a− and CD34+CD38+CD1a+ stages. Human DN thymocytes mature via an immature single positive (ISP CD4+) and a DP stage into CD4+ or CD8+ SP T cells that express functional T cell receptors (TCR) and that exit the thymus. In this study, gene expression was measured in each of these nine stages.					6642	79979	835	51434	51012	7867	996	55090	2286	506	282991	140612	51293	940	1466	6732	284086	7316	2166	10198	65263	84318	2171	408	203069	55093	5429	26994	898	8916	3838	22976	10111	51512	84223	51691	57407	388	5111	10314	53343	55219	391356	4124	65980	81622	8558	5998	1937	2222	4860	51248	55071	57409	51321	8575	55920	8805	4521	29957	57650	10084	9070	286827	202051	28970	84901	64419	60488	100506144	201299	191	84279	9032	79830	9439	2010	90141	123016	10629	2030	27250	201973	9901	1396	28984	52	8318	2237	23279	8570	29097	8435	3606	79833	140735	79157	79077	55148	79137	4869	953	4000	10055	988	55355	54908	84311	5901	167153	10943	8379	10591	10225	399687	3329	134728	2395	11156	51614	6632	55247	140838	7247	10982	27342	921	3117	1719	6281	151011	353	91289	25941	30851	4751	11169	7515	84266	11080	55437	22822	145173	5686	84787	84269	55536	30009	5893	6747	10313	11259	10376	128869	51676	2971	63901	197335	92259	6895	2869	55024	120103	5356	83990	51567	9493	51155	84678	1211	9820	4259	6612	84460	226	1026	10535	130132	51497	55215	267	9918	196743	1362	9317	55157	8930	27085	2529	85021	9278	81611	6647	1611	1058	7913	55722	113000	11174	3833
GSE22601_DOUBLE_NEGATIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN	M6246		15928199	Dik WA,Pike-Overzet K,Weerkamp F,Ridder de D,Haas de EF,Baert MR,Spek der van P,Koster EE,Reinders MJ,Dongen van JJ,Langerak AW,Staal FJ	GSE22601	GSE22601_3410_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in thymocytes: double negative versus double positive.	T cells develop from progenitors that migrate from the bone marrow into the thymus. Thymocytes are subdivided roughly as being double negative (DN), double positive (DP), or single positive (SP), based on the expression of the CD4 and CD8 coreceptors. The DN stage is heterogeneous and can be subdivided into four distinct subsets in mice based on the expression of CD44 and CD25. In human, three distinct DN stages can be recognized: a CD34+CD38−CD1a− stage that represents the most immature thymic subset and the consecutive CD34+CD38+CD1a− and CD34+CD38+CD1a+ stages. Human DN thymocytes mature via an immature single positive (ISP CD4+) and a DP stage into CD4+ or CD8+ SP T cells that express functional T cell receptors (TCR) and that exit the thymus. In this study, gene expression was measured in each of these nine stages.					155435	7534	78994	22933	26168	6304	5464	1794	11176	5576	26268	83985	57614	26133	9919	55784	51693	6402	84959	116254	57018	51720	55262	26993	3142	285237	4351	5138	3824	23142	54834	6723	151556	23598	1730	23221	6932	1803	177	10808	84541	54795	10519	6651	8773	10802	23216	10195	88455	51439	22931	1363	26019	5791	65977	202	9525	81847	9039	6484	26354	5306	7965	22878	27125	27335	2107	3419	1528	5567	55743	333926	60313	29887	7327	57471	5286	129531	64109	10162	57194	55251	84674	159371	10199	11231	27102	219333	115207	26017	79693	160760	56270	10226	57620	153222	1032	9908	2623	146923	51606	3558	55153	9934	27173	55365	10130	10237	55312	26519	26502	51228	3628	11177	2664	387521	7328	1606	85313	6480	23401	64857	79863	9988	80219	84951	6775	8653	4068	155038	283897	55898	9794	2931	834	11126	29925	2081	1051	51105	4659	140459	9238	8698	8846	64343	56647	23011	84275	55303	337867	10113	6774	10203	1398	3632	84343	7318	79085	3690	23344	7052	131450	26959	10153	317649	7323	6396	285148	11213	152926	1368	57337	4236	8718	115290	3821	112970	57132	5939	55252	257106	22926	79713	56886	54536	79064	3707	783	23074	824	8932	132789	10807	1212	22821	23002	51068	93380	23471
GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN	M6247		15928199	Dik WA,Pike-Overzet K,Weerkamp F,Ridder de D,Haas de EF,Baert MR,Spek der van P,Koster EE,Reinders MJ,Dongen van JJ,Langerak AW,Staal FJ	GSE22601	GSE22601_3413_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in immature CD4 [GeneID=920] single positive cells versus double positive thymocytes.	T cells develop from progenitors that migrate from the bone marrow into the thymus. Thymocytes are subdivided roughly as being double negative (DN), double positive (DP), or single positive (SP), based on the expression of the CD4 and CD8 coreceptors. The DN stage is heterogeneous and can be subdivided into four distinct subsets in mice based on the expression of CD44 and CD25. In human, three distinct DN stages can be recognized: a CD34+CD38−CD1a− stage that represents the most immature thymic subset and the consecutive CD34+CD38+CD1a− and CD34+CD38+CD1a+ stages. Human DN thymocytes mature via an immature single positive (ISP CD4+) and a DP stage into CD4+ or CD8+ SP T cells that express functional T cell receptors (TCR) and that exit the thymus. In this study, gene expression was measured in each of these nine stages.					3702	81855	1611	3149	92196	4783	10135	6611	7088	7407	84669	2355	80139	26225	57713	116984	55269	593	55636	64795	22848	597	163351	55872	80325	6767	5514	51296	11320	51526	54904	328	10724	55619	9516	55843	2697	10125	9261	6001	57658	10608	1846	55768	7779	3732	54841	83861	10673	953	840	5106	27086	121053	6319	58528	254428	26051	55196	166815	401612	54843	160857	79899	6773	4172	5516	5597	54855	727910	79009	51617	150864	388581	54625	7716	4780	7706	29785	22806	4084	7074	79718	2135	1844	8527	3895	6890	6732	51809	83636	825	5335	3976	85464	26136	7292	7414	30009	51696	55509	4249	56261	112479	4300	5993	5176	90390	9820	8897	388403	928	84320	64092	6489	23318	59269	91404	8560	195828	2034	5734	64780	50807	57608	167153	901	23150	345611	9541	23765	6197	9846	23028	3824	81622	51299	6310	25816	5140	401097	79161	100009676	256302	5305	55103	81620	6877	55028	306	55759	122786	230	11214	5341	10225	9833	116496	196	9069	55287	11180	5971	7267	22876	178	10000	1362	5621	10296	4601	64222	94240	284996	55589	2224	7040	84838	10397	10014	3418	5294	51104	11174	5893	92241	3383	9415	84293	10379	222166	57189	57472	221037	27333	92521	10477	83641	58500	7374
GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP	M6248		15928199	Dik WA,Pike-Overzet K,Weerkamp F,Ridder de D,Haas de EF,Baert MR,Spek der van P,Koster EE,Reinders MJ,Dongen van JJ,Langerak AW,Staal FJ	GSE22601	GSE22601_3414_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] single positive cells: immature versus thymocytes.	T cells develop from progenitors that migrate from the bone marrow into the thymus. Thymocytes are subdivided roughly as being double negative (DN), double positive (DP), or single positive (SP), based on the expression of the CD4 and CD8 coreceptors. The DN stage is heterogeneous and can be subdivided into four distinct subsets in mice based on the expression of CD44 and CD25. In human, three distinct DN stages can be recognized: a CD34+CD38−CD1a− stage that represents the most immature thymic subset and the consecutive CD34+CD38+CD1a− and CD34+CD38+CD1a+ stages. Human DN thymocytes mature via an immature single positive (ISP CD4+) and a DP stage into CD4+ or CD8+ SP T cells that express functional T cell receptors (TCR) and that exit the thymus. In this study, gene expression was measured in each of these nine stages.					23151	5216	488	375	2833	25907	286336	6603	127262	1893	84300	4013	5989	5684	6646	64744	51393	11311	9861	308	58526	57446	5790	6195	2885	51316	3161	7043	6431	56339	84498	10013	112	10067	9147	51340	55165	64924	7096	7756	53916	2824	9466	11151	5411	9200	10963	51400	10807	8697	55312	220002	7514	1528	5525	11226	7072	22800	6503	11154	28231	112495	3304	3897	5576	51258	56650	51028	84263	5450	5627	23550	388564	6404	6482	84525	57337	11340	3838	9920	9978	2132	1994	677	11188	9538	25764	1265	6277	283131	79144	1070	117154	9459	55784	79095	23299	23208	9770	51606	170463	3783	9988	79654	10430	6772	64115	54505	10910	1039	1583	7132	6432	552889	140823	2120	80267	8209	51022	8636	9270	152185	1234	55208	90196	64432	9411	55277	10383	23788	1445	122704	64422	957	1521	168537	2664	2629	4818	8266	54460	26037	55119	10063	9091	54331	57380	351	1769	10436	5600	10130	28951	23517	7188	81873	29933	8242	28988	6888	51295	1891	208	26502	1075	3090	3707	23152	168544	4303	3595	23344	3301	63940	54816	7070	6282	23295	2678	10482	7317	1509	8301	84233	25940	3633	11034	7150	10602	7782	56647	51726	9706	1107	11187	2079	87	22823	3911	5051
GSE22601_DOUBLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN	M6249		15928199	Dik WA,Pike-Overzet K,Weerkamp F,Ridder de D,Haas de EF,Baert MR,Spek der van P,Koster EE,Reinders MJ,Dongen van JJ,Langerak AW,Staal FJ	GSE22601	GSE22601_3417_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in thymocytes: double positive versus CD8 single positive.	T cells develop from progenitors that migrate from the bone marrow into the thymus. Thymocytes are subdivided roughly as being double negative (DN), double positive (DP), or single positive (SP), based on the expression of the CD4 and CD8 coreceptors. The DN stage is heterogeneous and can be subdivided into four distinct subsets in mice based on the expression of CD44 and CD25. In human, three distinct DN stages can be recognized: a CD34+CD38−CD1a− stage that represents the most immature thymic subset and the consecutive CD34+CD38+CD1a− and CD34+CD38+CD1a+ stages. Human DN thymocytes mature via an immature single positive (ISP CD4+) and a DP stage into CD4+ or CD8+ SP T cells that express functional T cell receptors (TCR) and that exit the thymus. In this study, gene expression was measured in each of these nine stages.					79157	51434	10915	7360	10919	79656	10055	1019	138162	26094	55722	4869	3832	1058	22822	8897	85444	10084	6576	90488	10897	10198	440145	84318	113000	2289	55090	123016	55133	11137	10239	5901	51567	55768	3609	10994	28970	9465	162239	286827	84062	6732	8572	4300	25902	1104	387882	55148	22848	953	64077	1666	80762	1396	221037	80755	672	54930	79830	9134	54675	57521	1466	167153	90459	3945	84529	134728	54908	55723	3383	1060	126282	2669	2517	83990	84310	51015	55226	7156	57001	2620	226	11113	9308	56985	1774	2956	1611	55024	282991	3117	91404	55159	9278	11277	3956	5580	140612	5437	84269	60488	10733	84933	388341	5706	11200	55247	5198	79077	4000	4521	81622	140838	8086	65263	79980	6611	84678	22974	84787	8318	55920	3838	8111	7372	10313	9557	2869	7494	11174	8906	8099	7292	9261	84962	940	27333	2037	648	328	1937	4291	5106	79979	116496	79070	140901	9702	93594	201931	79866	51106	220042	9918	178	4259	51256	7716	123	23326	10575	100287171	149478	5050	10460	5514	3418	55509	10236	59342	5027	4783	5176	840	3015	9409	2271	30009	23309	26277	79441	343099	990	84904	1719	23670	79807	10928	64780	6667	55719	23549	2995	9317	51012	2697	23028	57819	60492
GSE22601_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN	M6251		15928199	Dik WA,Pike-Overzet K,Weerkamp F,Ridder de D,Haas de EF,Baert MR,Spek der van P,Koster EE,Reinders MJ,Dongen van JJ,Langerak AW,Staal FJ	GSE22601	GSE22601_3418_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in single positive thymocytes: CD4 [GeneID=920] versus CD8.	T cells develop from progenitors that migrate from the bone marrow into the thymus. Thymocytes are subdivided roughly as being double negative (DN), double positive (DP), or single positive (SP), based on the expression of the CD4 and CD8 coreceptors. The DN stage is heterogeneous and can be subdivided into four distinct subsets in mice based on the expression of CD44 and CD25. In human, three distinct DN stages can be recognized: a CD34+CD38−CD1a− stage that represents the most immature thymic subset and the consecutive CD34+CD38+CD1a− and CD34+CD38+CD1a+ stages. Human DN thymocytes mature via an immature single positive (ISP CD4+) and a DP stage into CD4+ or CD8+ SP T cells that express functional T cell receptors (TCR) and that exit the thymus. In this study, gene expression was measured in each of these nine stages.					27102	10067	55720	11176	1606	30845	155435	5445	253143	11231	51304	5216	8698	80262	57194	4798	64282	22933	29887	1803	9978	50717	55312	9147	26017	116138	5576	11187	4700	8763	440567	3707	10488	388646	84233	9535	57337	55784	10270	114836	4794	5450	10483	10519	4092	23683	6195	55788	4068	28962	23221	56731	55251	3660	285195	4646	146923	177	5954	55303	115207	79095	23545	6402	9988	2764	51542	497661	11213	9637	170463	79654	9270	5791	8635	10801	91746	2664	1958	54795	571	8649	1794	23598	339324	29766	152877	121260	85441	2029	285636	26959	58472	57396	56926	23160	1528	5336	78994	28231	256380	8773	3690	159371	7328	25939	79647	33	55969	149041	8846	55847	22878	8209	337867	284207	57620	3988	29123	55907	1267	10203	9919	90249	79699	57231	55081	84275	81606	2124	23471	140739	65117	27042	3655	388701	10061	340061	205251	3628	8446	83642	79863	129685	219333	54467	55729	6431	166647	10113	90196	196441	55617	6199	26502	4242	3897	51611	55017	2885	29078	3295	3718	54834	23344	57102	84174	155038	65983	10436	399665	30827	401409	28988	26019	80344	54	206358	23118	23239	8675	392	5411	11079	51092	7305	257068	5351	375444	54861	56647	64895	8807	6503	51001	11344	7534	51257	283991	257364
GSE22601_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN	M6252		15928199	Dik WA,Pike-Overzet K,Weerkamp F,Ridder de D,Haas de EF,Baert MR,Spek der van P,Koster EE,Reinders MJ,Dongen van JJ,Langerak AW,Staal FJ	GSE22601	GSE22601_3416_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in thymocytes: double positive versus CD4 [GeneID=920] single positive.	T cells develop from progenitors that migrate from the bone marrow into the thymus. Thymocytes are subdivided roughly as being double negative (DN), double positive (DP), or single positive (SP), based on the expression of the CD4 and CD8 coreceptors. The DN stage is heterogeneous and can be subdivided into four distinct subsets in mice based on the expression of CD44 and CD25. In human, three distinct DN stages can be recognized: a CD34+CD38−CD1a− stage that represents the most immature thymic subset and the consecutive CD34+CD38+CD1a− and CD34+CD38+CD1a+ stages. Human DN thymocytes mature via an immature single positive (ISP CD4+) and a DP stage into CD4+ or CD8+ SP T cells that express functional T cell receptors (TCR) and that exit the thymus. In this study, gene expression was measured in each of these nine stages.					29957	286827	4744	2956	54982	506	10111	84269	9134	113174	84266	51248	2491	55920	1060	343099	7027	51258	51512	51031	10059	378708	54820	79184	55055	6611	118924	4869	84153	4171	84318	2171	57409	10198	55509	940	3832	8872	151011	284403	22974	79441	23468	7283	56890	8930	51497	55706	9156	55830	79077	1666	83862	146956	5933	89958	10155	91687	4673	8520	10549	55159	4689	54107	7419	220002	23397	23047	975	57380	55133	51608	3929	898	1058	10422	80856	56650	22929	221184	943	51651	5434	4860	85444	22976	55355	90459	10629	5429	10556	8464	57650	6949	130814	26094	9452	64151	25886	51175	55577	57001	1465	81611	54505	55705	672	8379	10460	84062	55775	388341	55157	11156	51566	1891	5984	6749	80755	55536	1719	80173	7347	54908	29028	124222	79833	3619	10376	8438	8575	51106	157570	79733	283871	3416	307	25941	11004	1495	9918	6767	165918	27258	8479	11113	26355	5111	197335	3014	1026	81622	3956	6633	117154	6001	1043	10051	28970	29097	23204	140735	10775	57325	197370	6472	5094	71	25936	51762	6240	10963	162681	4801	29127	51377	3068	3276	23408	120103	10531	55835	24137	23165	23510	10994	219854	125965	51299	150468	79023	84678	51659	11168	7295	122953	7074	10892	84316	5179
GSE22601_DOUBLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP	M6253		15928199	Dik WA,Pike-Overzet K,Weerkamp F,Ridder de D,Haas de EF,Baert MR,Spek der van P,Koster EE,Reinders MJ,Dongen van JJ,Langerak AW,Staal FJ	GSE22601	GSE22601_3417_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in thymocytes: double positive versus CD8 single positive.	T cells develop from progenitors that migrate from the bone marrow into the thymus. Thymocytes are subdivided roughly as being double negative (DN), double positive (DP), or single positive (SP), based on the expression of the CD4 and CD8 coreceptors. The DN stage is heterogeneous and can be subdivided into four distinct subsets in mice based on the expression of CD44 and CD25. In human, three distinct DN stages can be recognized: a CD34+CD38−CD1a− stage that represents the most immature thymic subset and the consecutive CD34+CD38+CD1a− and CD34+CD38+CD1a+ stages. Human DN thymocytes mature via an immature single positive (ISP CD4+) and a DP stage into CD4+ or CD8+ SP T cells that express functional T cell receptors (TCR) and that exit the thymus. In this study, gene expression was measured in each of these nine stages.					11329	30845	114836	79699	55720	6515	5954	55251	51092	53840	6504	54507	80262	5567	65258	10567	10950	8445	10957	91775	254170	4092	83719	27086	338596	3707	27102	11213	57620	8870	8665	8846	4794	55303	4242	23325	5507	9262	8932	6402	3988	3566	81847	85464	3679	51542	8698	7402	5578	11214	3899	155435	23765	10983	3604	25777	83985	10912	8763	8527	8204	159371	55500	10161	4659	23011	5728	26017	83642	57231	54784	9750	7050	56172	28955	337867	6275	9794	27125	54778	340061	26133	476	1363	2907	114908	55152	9535	5138	6737	80727	57132	23382	80228	1997	27430	957	55829	64222	8675	54625	9497	8408	51621	56886	81030	23626	6574	9595	57498	7832	1027	58528	3702	115294	926	54842	80325	5530	2999	25897	57162	5286	10379	5336	2145	168090	54331	9920	84959	596	2799	1794	9173	4068	54923	81844	1267	254428	146923	3135	8560	5008	10425	2150	1606	10299	26993	153222	1368	10225	55017	55074	54904	9124	57621	4646	94240	375387	51439	4798	283130	8718	1958	55603	152926	80790	285195	5463	4345	51669	27040	9953	7328	51379	414328	9776	51714	894	201595	3959	26019	7706	3601	8994	8780	963	51495	29126	114907	3821	8807	23118	3628	2117	26031	3725	152519	391002	162427
GSE8835_CD4_VS_CD8_TCELL_UP	M6254		15965501	Görgün G,Holderried TA,Zahrieh D,Neuberg D,Gribben JG	GSE8835	GSE8835_3369_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in T cells: CD4 [GeneID=920] versus CD8.	To examine the impact of tumors on the immune system, we compared global gene expression profiles of peripheral blood T cells from previously untreated patients with B cell chronic lymphocytic leukemia (CLL) with those from age-matched healthy donors. Although the cells analyzed were not part of the malignant clone, analysis revealed differentially expressed genes, mainly involved in cell differentiation in CD4 cells and defects in cytoskeleton formation, vesicle trafficking, and cytotoxicity in CD8 cells of the CLL patients. In coculture experiments using CLL cells and T cells from healthy allogeneic donors, similar defects developed in both CD4 and CD8 cells. These changes were induced only with direct contact and were not cytokine mediated. Identification of the specific pathways perturbed in the T cells of cancer-bearing patients will allow us to assess steps to repair these defects, which will likely be required to enhance antitumor immunity. Gene expression profiling was performed to determine whether CLL cells induce changes in T cells in patients with CLL.					1746	3386	7840	4515	5362	90835	93979	84219	10116	27330	65083	1856	90799	23019	154007	9967	7252	8884	5376	123920	131375	8045	56255	116843	10120	85457	26986	23304	10075	84133	64754	23527	57545	145508	83479	8013	161357	112770	27121	25970	9820	26191	31	26147	145853	90637	7462	27085	9415	84080	55260	6872	6400	5116	29902	9043	79809	64410	498	56886	23244	5997	5902	84612	222008	23293	339230	3980	8702	79925	139886	4548	7905	643836	64682	28231	8310	968	23165	2055	1677	57552	6389	199704	2542	152877	3156	3480	9844	89797	23225	4035	64318	1429	5565	160622	9147	8454	2940	81888	124404	84270	29760	57142	5136	340706	637	55839	10659	58531	100009676	948	7077	5591	829	9790	22834	10013	4926	10771	4001	64710	63934	54875	79641	79728	23059	81539	56904	55240	23683	25902	5426	4771	4175	81620	10165	3689	2872	1973	59343	8518	10611	9611	28960	9653	55250	411	79172	5256	9070	4048	79717	27352	4041	10802	54942	84769	1523	137492	79867	63951	9698	6558	57050	23020	8438	6301	124599	8273	10768	64327	55252	54936	3782	25776	23139	54726	10277	5929	55578	203102	81889	23094	51715	10594	65065	3187	3685	9183	490	55825	80267	147463	55719	9601	55529	53827	159371	23505
GSE8835_CD4_VS_CD8_TCELL_DN	M6255		15965501	Görgün G,Holderried TA,Zahrieh D,Neuberg D,Gribben JG	GSE8835	GSE8835_3369_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in T cells: CD4 [GeneID=920] versus CD8.	To examine the impact of tumors on the immune system, we compared global gene expression profiles of peripheral blood T cells from previously untreated patients with B cell chronic lymphocytic leukemia (CLL) with those from age-matched healthy donors. Although the cells analyzed were not part of the malignant clone, analysis revealed differentially expressed genes, mainly involved in cell differentiation in CD4 cells and defects in cytoskeleton formation, vesicle trafficking, and cytotoxicity in CD8 cells of the CLL patients. In coculture experiments using CLL cells and T cells from healthy allogeneic donors, similar defects developed in both CD4 and CD8 cells. These changes were induced only with direct contact and were not cytokine mediated. Identification of the specific pathways perturbed in the T cells of cancer-bearing patients will allow us to assess steps to repair these defects, which will likely be required to enhance antitumor immunity. Gene expression profiling was performed to determine whether CLL cells induce changes in T cells in patients with CLL.					23627	23024	79078	5957	158297	23769	25928	84867	7111	130367	1750	57687	11219	23626	337876	4632	163404	285761	5564	762	25937	493869	2044	9121	3653	80821	3691	344758	64067	79446	7039	1733	5770	114299	158427	56124	146439	11260	644994	6490	143503	114884	793	56159	5079	252839	79183	919	10368	3908	83881	11234	79748	3090	54474	10397	285600	51317	23194	3170	221357	3798	10076	399948	83938	794	6801	9921	6327	8988	9953	8644	2817	131540	26525	1591	85406	55558	57460	80212	3856	338339	7082	770	123775	9902	50674	4313	202559	196410	10083	51059	388364	54766	57862	56910	9495	55105	6346	255631	3565	2158	3815	51024	5284	84342	11063	374470	23284	27148	89778	220	23440	120224	91662	171024	2735	387640	100130988	126006	9427	8797	29115	4724	9177	8538	79002	140876	54856	84236	9464	23213	284612	5948	222235	256586	388722	63924	2792	65217	23247	116931	84171	3604	1602	151473	577	200403	90353	4212	132625	56203	7020	65008	114987	50863	64919	116372	84283	8654	148867	728317	50511	64091	93233	11018	9135	2697	80731	29909	7069	57795	9107	10211	283848	643664	1240	60682	1908	146206	127534	646113	55654	64787	219539	55151	9649	1300	3111	4640	56667	494143	2524	54345	91833	143678	3787	79366	80709	148014
GSE8835_CD4_VS_CD8_TCELL_CLL_PATIENT_UP	M6256		15965501	Görgün G,Holderried TA,Zahrieh D,Neuberg D,Gribben JG	GSE8835	GSE8835_3370_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in T cells from CLL (chronic lymphocytic leukemia) patients: CD4 [GeneID=920] versus CD8.	To examine the impact of tumors on the immune system, we compared global gene expression profiles of peripheral blood T cells from previously untreated patients with B cell chronic lymphocytic leukemia (CLL) with those from age-matched healthy donors. Although the cells analyzed were not part of the malignant clone, analysis revealed differentially expressed genes, mainly involved in cell differentiation in CD4 cells and defects in cytoskeleton formation, vesicle trafficking, and cytotoxicity in CD8 cells of the CLL patients. In coculture experiments using CLL cells and T cells from healthy allogeneic donors, similar defects developed in both CD4 and CD8 cells. These changes were induced only with direct contact and were not cytokine mediated. Identification of the specific pathways perturbed in the T cells of cancer-bearing patients will allow us to assess steps to repair these defects, which will likely be required to enhance antitumor immunity. Gene expression profiling was performed to determine whether CLL cells induce changes in T cells in patients with CLL.					5272	347	126526	6367	1996	356	1495	6352	10462	221302	3363	85441	29899	3434	283985	8936	4854	80020	197259	57674	8685	83852	55008	84909	64218	8743	4600	728637	55075	64135	3267	28984	9355	11274	27163	84102	140775	114883	969	2634	8323	1215	3791	54899	1964	1730	345611	4940	8819	64853	54020	80821	59345	129531	50489	3601	9153	629	729533	8676	958	8638	129607	55330	9111	388228	30814	57713	201931	51251	3665	84166	79650	219285	4524	6373	55080	8854	2995	3600	51068	8718	5327	3958	439996	3002	2838	2014	3437	9920	2281	6781	10973	3783	9162	9636	3067	8914	25879	51095	4283	7419	56241	2192	3211	3384	4860	2624	1437	3458	27115	158219	91543	57194	145781	22914	25939	6776	3433	11108	9246	10964	116449	163351	3669	8784	7098	3821	51278	9173	1511	6402	84941	5581	7905	3695	23676	6443	83661	64005	3824	26762	132720	3897	2358	1616	9957	26031	55784	2140	3627	1359	84919	57608	64407	2205	917	59340	8405	7378	10840	23236	6398	10678	79895	60	4061	6039	6361	706	8809	5717	10326	84333	7779	146857	11104	3083	6693	54503	23344	55283	3628	55601	25841	6357	8520	338557	5995	3309	387856	56133	7166	8828	10000	64108	2209	23011	7074	10383
GSE8835_CD4_VS_CD8_TCELL_CLL_PATIENT_DN	M6258		15965501	Görgün G,Holderried TA,Zahrieh D,Neuberg D,Gribben JG	GSE8835	GSE8835_3370_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in T cells from CLL (chronic lymphocytic leukemia) patients: CD4 [GeneID=920] versus CD8.	To examine the impact of tumors on the immune system, we compared global gene expression profiles of peripheral blood T cells from previously untreated patients with B cell chronic lymphocytic leukemia (CLL) with those from age-matched healthy donors. Although the cells analyzed were not part of the malignant clone, analysis revealed differentially expressed genes, mainly involved in cell differentiation in CD4 cells and defects in cytoskeleton formation, vesicle trafficking, and cytotoxicity in CD8 cells of the CLL patients. In coculture experiments using CLL cells and T cells from healthy allogeneic donors, similar defects developed in both CD4 and CD8 cells. These changes were induced only with direct contact and were not cytokine mediated. Identification of the specific pathways perturbed in the T cells of cancer-bearing patients will allow us to assess steps to repair these defects, which will likely be required to enhance antitumor immunity. Gene expression profiling was performed to determine whether CLL cells induce changes in T cells in patients with CLL.					5742	285382	11320	8522	80896	54838	221301	945	1524	56975	201266	5996	221188	28959	23220	84108	128506	9891	348	55293	79845	6309	8722	9317	4054	1102	56132	5271	8808	126374	28966	64926	1120	2217	64798	4261	57161	6817	6916	51203	10673	79020	2203	6307	3215	1305	3988	26873	7782	84695	124222	80342	4060	306	650	85014	56917	92922	27299	5228	8725	3664	4254	64420	284161	29090	5863	23008	51016	285852	84284	3269	22982	7373	90293	22921	1468	29992	145553	11138	54887	50848	197335	79683	51493	1803	79887	2134	3340	57468	10269	10743	80818	63939	389827	23312	11117	4091	9332	129880	84898	116534	3680	10579	54947	27241	7249	230	1573	5727	89857	3693	23232	84254	56944	23166	84433	5153	80169	3077	125058	23705	53616	343990	132884	3090	26011	4040	645426	6448	6369	79070	170371	64784	2330	57333	128239	2212	115286	3795	84309	6184	54463	2295	84173	27122	6356	51058	79827	2878	8892	155066	874	5365	137835	340348	216	7941	155185	6038	6653	80724	245972	9500	5732	6850	134637	97	27072	3123	975	401494	114826	83719	153090	23531	29948	2591	23341	10585	4122	64766	4640	4318	140700	8295	25927	153562	85027	27077	11309	55203	8942	5890	55152	118429	55024	8736	867
GSE8835_HEALTHY_VS_CLL_CD4_TCELL_UP	M6260		15965501	Görgün G,Holderried TA,Zahrieh D,Neuberg D,Gribben JG	GSE8835	GSE8835_3371_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells: healthy versus CLL (chronic lymphocytic leukemia)l.	To examine the impact of tumors on the immune system, we compared global gene expression profiles of peripheral blood T cells from previously untreated patients with B cell chronic lymphocytic leukemia (CLL) with those from age-matched healthy donors. Although the cells analyzed were not part of the malignant clone, analysis revealed differentially expressed genes, mainly involved in cell differentiation in CD4 cells and defects in cytoskeleton formation, vesicle trafficking, and cytotoxicity in CD8 cells of the CLL patients. In coculture experiments using CLL cells and T cells from healthy allogeneic donors, similar defects developed in both CD4 and CD8 cells. These changes were induced only with direct contact and were not cytokine mediated. Identification of the specific pathways perturbed in the T cells of cancer-bearing patients will allow us to assess steps to repair these defects, which will likely be required to enhance antitumor immunity. Gene expression profiling was performed to determine whether CLL cells induce changes in T cells in patients with CLL.					6443	2199	6934	286343	11318	317781	435	9683	84458	1846	23166	129401	9772	81693	971	348	8722	480	55113	3067	64092	1616	4850	84248	117145	5172	9321	57703	3211	83661	8936	200035	4938	10549	54514	63901	196294	80263	10964	60	51251	338811	6038	3700	2784	115353	4133	51068	5271	10524	6441	202243	51085	56937	11104	128853	23461	8744	2077	3695	8727	129607	4051	80020	7993	59340	9443	23705	6888	55683	84909	84365	3437	51271	3105	3486	894	8535	79174	284613	57761	6553	221178	2004	50489	26301	5621	54886	122618	159013	55761	64283	166336	51162	55800	79605	3234	53826	1837	6354	2717	595	4322	8819	122622	3433	54112	55075	717	83716	57194	10206	55603	55647	119587	8869	6812	6097	149281	347902	214	6050	9663	8638	3765	2036	23224	98	9403	10237	10186	83857	347	112574	8520	6860	6843	28984	51379	10188	969	79627	5915	152405	8502	151195	6453	375287	57717	54923	1119	10607	6817	3267	5714	26272	55604	132720	2709	116379	5998	240	55093	53831	51566	57007	3600	2115	7430	3399	2070	368	10622	284086	51611	9980	7295	2730	22914	7322	286075	822	5747	834	91937	7316	28960	6261	5983	5376	347404	9099	140775	729040	1802	283985	80341	2650	11072	54880
GSE8835_HEALTHY_VS_CLL_CD4_TCELL_DN	M6261		15965501	Görgün G,Holderried TA,Zahrieh D,Neuberg D,Gribben JG	GSE8835	GSE8835_3371_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells: healthy versus CLL (chronic lymphocytic leukemia)l.	To examine the impact of tumors on the immune system, we compared global gene expression profiles of peripheral blood T cells from previously untreated patients with B cell chronic lymphocytic leukemia (CLL) with those from age-matched healthy donors. Although the cells analyzed were not part of the malignant clone, analysis revealed differentially expressed genes, mainly involved in cell differentiation in CD4 cells and defects in cytoskeleton formation, vesicle trafficking, and cytotoxicity in CD8 cells of the CLL patients. In coculture experiments using CLL cells and T cells from healthy allogeneic donors, similar defects developed in both CD4 and CD8 cells. These changes were induced only with direct contact and were not cytokine mediated. Identification of the specific pathways perturbed in the T cells of cancer-bearing patients will allow us to assess steps to repair these defects, which will likely be required to enhance antitumor immunity. Gene expression profiling was performed to determine whether CLL cells induce changes in T cells in patients with CLL.					154141	80034	134492	10635	2867	5411	874	645191	3883	57082	221481	1305	79661	64798	699	5449	1393	2173	11138	10869	1364	26230	85460	10881	660	441161	3762	1731	27241	2155	54989	5649	2268	56923	641	51053	1610	7629	9133	26061	125058	779	1468	387882	2208	22949	283383	157574	3776	5793	145553	7915	203190	25827	23784	91179	728858	51366	26503	51115	9420	26225	3223	51657	9278	146760	84547	169841	115265	64784	84898	56171	8729	8897	23272	3363	1947	27328	90204	5981	135295	3417	23531	89927	11097	100131378	79783	139212	84935	25858	56271	3215	80346	2558	11251	10418	78997	3084	387601	81563	347541	114798	80821	4988	7579	135932	23617	11117	79023	100505841	129880	22982	259232	79070	7439	79071	1262	10216	286	55213	2297	54900	22948	10926	27087	161	9865	10233	273	55013	53947	100129924	29989	127391	57577	154790	29909	2038	51214	2048	50863	641649	26150	23313	375316	89782	54329	7450	3619	1951	10863	253714	11181	56006	261729	23632	11238	131669	57732	440955	81605	3077	6939	23030	2559	2009	57684	170680	4142	3680	8399	51594	84700	57605	729330	421	23111	57282	55038	144321	54797	11146	55909	388796	10013	55815	85290	5603	138046	2134	4261	4607	3929	3790	1436	818	2006	64849	256987	3070
GSE8835_HEALTHY_VS_CLL_CD8_TCELL_UP	M6262		15965501	Görgün G,Holderried TA,Zahrieh D,Neuberg D,Gribben JG	GSE8835	GSE8835_3372_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD8 T cells: healthy versus CLL (chronic lymphocytic leukemia).	To examine the impact of tumors on the immune system, we compared global gene expression profiles of peripheral blood T cells from previously untreated patients with B cell chronic lymphocytic leukemia (CLL) with those from age-matched healthy donors. Although the cells analyzed were not part of the malignant clone, analysis revealed differentially expressed genes, mainly involved in cell differentiation in CD4 cells and defects in cytoskeleton formation, vesicle trafficking, and cytotoxicity in CD8 cells of the CLL patients. In coculture experiments using CLL cells and T cells from healthy allogeneic donors, similar defects developed in both CD4 and CD8 cells. These changes were induced only with direct contact and were not cytokine mediated. Identification of the specific pathways perturbed in the T cells of cancer-bearing patients will allow us to assess steps to repair these defects, which will likely be required to enhance antitumor immunity. Gene expression profiling was performed to determine whether CLL cells induce changes in T cells in patients with CLL.					80835	7024	2992	23478	3014	3420	57446	7392	8502	81688	9611	293	51360	10343	9055	284307	147381	389333	342667	1176	23116	51172	7103	26509	130507	140809	6868	8566	79731	89857	55789	124995	10592	7040	51701	79792	7988	51552	84293	5178	2967	25963	121260	201725	9704	51426	5094	23054	8525	5066	79072	8444	57819	79733	29886	391059	1654	80142	6936	6778	364	5986	54946	396	56262	10457	131474	55823	9249	4751	64759	9138	6565	29127	91039	2124	1173	254359	4651	2936	57511	55920	81565	55315	4717	10888	120227	64801	9538	23406	142	3621	22876	50856	498	80205	5786	1763	7343	55752	55255	7039	11244	6231	64342	9836	2319	51199	29934	92579	60526	23603	150468	7745	26018	9202	126731	51719	56181	54529	57221	10058	57798	93129	4853	81928	55069	64231	85460	122706	6839	22918	114569	30844	5579	129831	51076	222487	55041	553115	339	10370	25913	55700	63971	644	526	2260	1876	85457	8692	5921	9112	11273	11314	55589	79018	94015	83442	5609	79716	80728	89848	5093	23550	79810	51398	84065	9382	7485	26511	10636	1183	57189	2189	88455	57128	27034	338949	79753	4035	22905	22914	84135	7386	257106	79832	10098	3958	5129	8658	8313	53615	10933	4051	10228	10771	23207	84912	338557
GSE8835_HEALTHY_VS_CLL_CD8_TCELL_DN	M6263		15965501	Görgün G,Holderried TA,Zahrieh D,Neuberg D,Gribben JG	GSE8835	GSE8835_3372_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD8 T cells: healthy versus CLL (chronic lymphocytic leukemia).	To examine the impact of tumors on the immune system, we compared global gene expression profiles of peripheral blood T cells from previously untreated patients with B cell chronic lymphocytic leukemia (CLL) with those from age-matched healthy donors. Although the cells analyzed were not part of the malignant clone, analysis revealed differentially expressed genes, mainly involved in cell differentiation in CD4 cells and defects in cytoskeleton formation, vesicle trafficking, and cytotoxicity in CD8 cells of the CLL patients. In coculture experiments using CLL cells and T cells from healthy allogeneic donors, similar defects developed in both CD4 and CD8 cells. These changes were induced only with direct contact and were not cytokine mediated. Identification of the specific pathways perturbed in the T cells of cancer-bearing patients will allow us to assess steps to repair these defects, which will likely be required to enhance antitumor immunity. Gene expression profiling was performed to determine whether CLL cells induce changes in T cells in patients with CLL.					6291	6372	1278	4975	51340	27286	84707	23232	54498	55905	5771	3566	23392	25797	677	729993	284716	8528	1282	10360	54206	127255	90411	57522	2213	3516	85437	29990	6318	8707	10765	123720	3338	4121	51661	23253	26063	794	10999	25805	80817	63036	7127	1837	160428	92140	9315	222865	8740	124245	55450	51028	51455	5199	27123	9520	55766	63897	344	55279	1634	6590	10776	123803	51637	4215	8864	131583	2651	10079	6120	3592	1440	56997	43	146722	80329	57178	219738	10318	91522	7045	64388	128710	1437	9536	65080	9342	128553	54941	5004	10235	6506	5054	89958	221687	113451	22990	440556	401138	4209	84168	51347	130162	132014	55731	8635	129881	115361	8633	6230	29958	2997	4313	2533	6622	8638	83607	79887	26355	3954	683	819	353322	79974	253782	5008	9322	400	7422	9422	51296	338785	1277	112399	1289	51150	9908	51337	220042	6146	5473	2121	23524	8545	9244	313	6498	53919	8578	1281	9734	338773	80774	8541	57222	55066	6738	54494	54207	1652	83938	1620	3973	54544	9500	7539	6279	10916	84152	8974	1902	23645	6330	8754	64332	4684	339487	56521	6508	254263	3240	4318	8912	30001	7003	366	64788	79905	51003	4060	59286	6376	90639	6515	56938	26033	9023	91445	8301
GSE1925_CTRL_VS_3H_IFNG_STIM_MACROPHAGE_DN	M6290		16148108	Hu X,Park-Min KH,Ho HH,Ivashkiv LB	GSE1925	GSE1925_3032_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in macrophages: untreated versus stimulated by IFNG [GeneID=3458] for 3h.	IFN-gamma transcriptional responses in control and IFN-gamma primed primary human macrophages					10777	57834	7200	51690	60401	4332	3092	25778	8216	9173	10327	3458	911	4048	389898	10113	5284	9388	56128	54998	112	11037	11237	6461	1842	8459	361	6513	2560	79627	51378	6677	91445	27242	10568	6122	904	4185	28571	54886	23095	112950	5770	2209	2806	56647	185	10276	25771	5327	26575	725	25907	54566	79711	1360	7351	29063	8001	25880	7594	590	26281	9355	7584	3751	2814	23677	8228	6569	253461	81623	6335	23673	2842	2034	8807	7276	3049	8076	63941	54432	55466	673	1359	5250	2058	64693	1638	1523	2880	6579	84790	23150	3849	10927	1310	10575	8353	138046	48	55775	56616	64777	941	84253	80067	64231	10758	56521	79804	1193	5270	6137	7180	647288	5828	9469	6336	730101	7450	4993	6368	2542	594	54475	79789	6678	56660	150244	57586	23553	7417	7389	11343	4835	5671	3725	57126	100132285	3250	29018	496	4111	2805	9953	79608	10402	51666	8876	6096	306	358	1233	4282	1608	2868	56946	23647	2561	8672	8530	91977	3772	6580	5493	80704	1669	7031	25961	945	55704	8618	3306	10665	10168	51099	6542	1038	390999	3443	9407	6558	7286	92104	57523	9420	5292	55819	1843	79953	100130331	5454	3044	138151	130074	100133941	1946	50506	10567
GSE1925_3H_VS_24H_IFNG_STIM_MACROPHAGE_DN	M6291		16148108	Hu X,Park-Min KH,Ho HH,Ivashkiv LB	GSE1925	GSE1925_3034_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in macrophages stimulated by IFNG [GeneID=3458]: 3h versus 24h.	IFN-gamma transcriptional responses in control and IFN-gamma primed primary human macrophages					4599	4340	4308	7748	23034	10988	808	7431	1912	10983	4112	6775	7024	8498	80035	65080	51157	29896	3566	29990	9712	54540	1380	54514	10392	25793	11104	221061	51177	64789	6282	3399	8403	57591	91543	10514	3293	399	22937	90233	1789	5552	10505	10410	50807	11253	55005	64782	55693	7469	51729	57047	23314	9768	8467	9730	55049	5380	3437	4140	7673	22932	9757	8312	645784	5905	1690	57337	55644	9636	336	9159	5129	2537	91807	6917	11066	4939	6208	10383	4940	3429	373156	8635	4637	3029	27102	6964	79869	939	9375	528	55036	1615	157	10626	5359	4666	6222	65125	10095	4173	55184	26103	23408	11000	56920	26707	50717	54360	203510	5172	23554	54892	6157	118	23252	352961	23536	55239	63891	55014	10389	7130	8644	27340	4242	3695	10040	11224	10964	23591	8417	4016	55198	3669	51422	10445	7468	9592	64799	6198	10230	2288	221078	5607	6230	5564	598	1236	10693	8034	4116	6883	10097	25924	146712	1606	442216	3400	1643	26574	5786	6407	55072	9946	6275	55079	3460	767	5704	11274	63895	93973	6709	3434	338	7107	3959	80224	2232	3696	1059	79689	30827	4600	3151	28996	146542	10982	9146	10163	23112	9701	10388	59269	64089	283871	26692	4802
GSE1925_3H_VS_24H_IFNG_STIM_MACROPHAGE_UP	M6292		16148108	Hu X,Park-Min KH,Ho HH,Ivashkiv LB	GSE1925	GSE1925_3034_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in macrophages stimulated by IFNG [GeneID=3458]: 3h versus 24h.	IFN-gamma transcriptional responses in control and IFN-gamma primed primary human macrophages					3773	6015	10651	6476	10234	734	3808	1843	55640	79740	1615	63973	4809	9173	3382	6779	63924	7223	112950	10665	1358	80072	51384	16	55332	3614	27121	11024	7448	84719	2897	3772	55073	80129	7417	10466	11254	7846	1992	6504	55775	140597	3439	5714	56242	3805	10230	7020	390998	5682	91445	5562	2922	9855	81623	3313	8807	79819	5336	5292	2994	4102	1641	26284	7031	54769	5096	4048	6767	1138	81849	28965	3458	3092	171220	29093	79987	11037	27440	55138	1646	8353	2806	7024	10824	23603	10402	4171	4201	2512	317662	493	11172	6708	10327	2805	10994	1359	83481	79024	6406	11062	10005	64065	123	1012	3725	8419	2648	4729	23673	55086	51778	84243	7286	4763	84159	8228	6580	54475	1588	11237	1310	842	10927	3015	2880	60598	55620	7168	7066	3347	57761	58528	2009	100093698	2180	5770	138151	84560	51008	56945	27123	79953	29091	3049	53905	1416	4306	51287	4701	8731	27242	5064	2125	8440	7351	79632	78994	25771	57820	23553	84253	6382	83729	6588	9332	25880	26628	7692	55740	8115	5217	10401	3976	10044	1669	26539	23657	4993	79147	6187	79739	27030	5961	100130354	9731	3843	51016	959	23019	22984	10738	1122	26048	23660	9248	27156	6443	79730
GSE1925_CTRL_VS_24H_IFNG_STIM_MACROPHAGE_UP	M6293		16148108	Hu X,Park-Min KH,Ho HH,Ivashkiv LB	GSE1925	GSE1925_3033_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in macrophages: untreated versus stimulated by IFNG [GeneID=3458] for 24h.	IFN-gamma transcriptional responses in control and IFN-gamma primed primary human macrophages					5201	7469	7431	81	100286937	54546	79689	64792	4599	23309	8519	11213	4775	10410	64789	1236	1644	127544	808	3429	29121	9399	6428	27352	5129	10388	27102	5725	56731	3667	10389	11066	23225	5564	9380	29990	11124	11081	90233	11138	4685	6176	2537	23367	1007	8673	6835	4940	9636	54860	57125	55654	687	22809	3437	11153	23185	400410	9887	5608	5176	5359	9246	5860	5387	221061	53615	9592	23138	5566	6878	56920	10983	3669	5552	29767	10383	10367	3566	6709	253980	4726	6885	3399	352961	3959	93973	4939	10563	919	10467	1581	22937	6275	23344	55320	5905	3346	10347	10904	10964	3476	645784	81624	55198	114791	2064	684	9815	9723	55143	373156	375346	9757	91543	11133	8237	55644	6135	2253	80097	60625	1520	51316	9659	10895	28517	6003	10217	23229	1153	54902	80021	54991	130074	8467	389715	223117	80035	7107	4772	5971	54442	22888	64837	4218	23554	9866	79365	9146	5533	8175	79832	51177	350	11274	23070	10078	57591	100289420	51729	1604	939	8398	3700	54970	29086	55750	51466	55316	64221	9768	1008	5795	23251	1043	822	54542	10816	11047	11180	63891	162427	1059	4974	1639	8451	81533	3434	7297	2051	4600	11147	5912	3695	10752	7745	64799	10019	55239
GSE1925_CTRL_VS_24H_IFNG_STIM_MACROPHAGE_DN	M6294		16148108	Hu X,Park-Min KH,Ho HH,Ivashkiv LB	GSE1925	GSE1925_3033_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in macrophages: untreated versus stimulated by IFNG [GeneID=3458] for 24h.	IFN-gamma transcriptional responses in control and IFN-gamma primed primary human macrophages					56942	64127	7327	219654	9294	644975	7029	100130894	54534	199745	157753	23513	64969	55325	9139	3557	5281	2937	147685	2972	5409	643837	5742	9904	2256	375346	9277	11163	11270	159686	79647	3636	91252	79590	84658	84058	57624	51143	4830	8740	6815	953	64411	3783	84864	246312	2098	118461	121268	6059	6619	7401	56927	64841	23095	54517	714	54806	133491	64333	4317	140890	9823	100134713	9550	23567	5734	114044	81603	26994	81493	25822	6929	60386	6810	84937	440864	100130642	1536	84623	79621	9031	4053	5719	10589	80194	7293	148014	2176	359	9123	23059	221074	5800	4064	115939	80021	23474	8668	55257	285668	10196	83445	9466	23129	400748	8985	79903	23295	7386	55705	9701	285855	245812	11017	151112	148867	23528	51043	56941	94101	6618	24140	9053	56899	55033	201595	84259	345778	10057	112479	126364	1431	10606	92597	3795	22821	1305	7417	10988	55898	157310	22979	28966	10999	114900	10047	100506658	55317	6628	29970	84833	84705	51678	54902	375444	203522	57234	23189	158427	203068	8368	10124	9531	24145	64855	255043	5780	10576	3561	9937	1366	164284	53940	6935	2165	388939	89796	7262	55065	2022	79703	8476	23555	170394	389	5730	7993	10067	163486	10969	10019	11011	25809	5717	8317	1933	5216
GSE1925_CTRL_VS_3H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP	M6295		16148108	Hu X,Park-Min KH,Ho HH,Ivashkiv LB	GSE1925	GSE1925_3036_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in macrophages primed by IFNG [GeneID=3458]: untreated versus stimulated by IFNG [GeneID=3458] for 3h.	IFN-gamma transcriptional responses in control and IFN-gamma primed primary human macrophages					54344	116443	9695	201516	6146	6383	90550	686	1974	143384	9588	80195	80317	92840	3208	54585	100131551	147040	25820	5218	441061	196441	26225	84329	84700	35	5034	1310	2821	3778	112483	6295	727957	5724	5590	11213	55311	57409	9766	26020	3851	645090	4986	26269	79758	6164	1628	64577	9337	25948	25844	5002	53349	4703	25946	6748	51125	80024	23057	1318	338005	139716	50515	6601	158295	6734	3455	8766	2950	144165	146456	7086	340719	340074	535	7535	1967	66005	339788	80145	64582	9445	91750	8336	23462	3126	6293	641364	79888	54828	56935	114971	23521	10608	22853	83868	9903	641365	765	645191	8698	643616	6171	6157	115761	6528	8996	10087	84865	31	3808	9896	549	64393	79096	401115	25801	51667	23710	51763	117144	9330	57763	26999	55958	63978	387921	85300	84171	256364	6314	30820	25938	100293735	54872	254100	116985	3849	79784	10475	10776	10881	284029	3433	138716	51253	7295	4850	23102	5336	27430	729678	5332	2713	137964	7454	84871	55788	8717	84216	54880	10610	5274	79006	65072	25840	23307	23363	9906	10008	9429	9563	100129603	84636	6451	4267	8352	10223	4128	23643	26184	9524	9050	5226	4192	4697	403314	11166	841	100287094	6992	100128343	6187	51635	26959	6879
GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_3H_IFNG_STIM_UP	M6296		16148108	Hu X,Park-Min KH,Ho HH,Ivashkiv LB	GSE1925	GSE1925_3039_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in macrophages stimulated by IFNG [GeneID=3458] for 3h: control versus primed by IFNG [GeneID=3458].	IFN-gamma transcriptional responses in control and IFN-gamma primed primary human macrophages					516	7182	57018	10575	10449	51633	908	344892	51735	54680	80853	84614	84961	27235	124540	1437	23586	6932	2940	7403	79668	57649	4799	55127	4682	3434	54847	2146	65123	10199	23047	51069	57472	6402	9641	7803	79845	29093	6175	27340	54617	10399	80821	100128927	8607	2027	11216	8924	7188	6193	7096	162282	54495	55251	6231	126003	55680	10208	10075	11160	9654	27316	1520	5791	54842	868	7402	3628	81617	5584	56265	941	56997	5884	10480	1657	84922	8725	55500	9131	84912	5717	204851	6655	834	50488	6249	4666	6122	23261	9648	944	6136	2668	391002	54454	6188	8139	1736	114836	515	9804	27297	64965	89910	90799	22884	54625	64979	11201	25875	6645	23358	7264	51135	4013	6187	25873	9232	56852	3633	6146	23309	84138	4048	6772	10456	5562	8567	10325	5887	23148	246175	6156	201595	60674	7343	10913	10280	124626	175	51373	51669	56850	55135	51585	6950	2961	6817	28996	51227	7316	51228	56658	375035	1503	51013	83480	2091	7185	4528	55291	5611	51582	51174	6001	1286	115106	23039	3028	4627	49855	23165
GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_3H_IFNG_STIM_DN	M6297		16148108	Hu X,Park-Min KH,Ho HH,Ivashkiv LB	GSE1925	GSE1925_3039_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in macrophages stimulated by IFNG [GeneID=3458] for 3h: control versus primed by IFNG [GeneID=3458].	IFN-gamma transcriptional responses in control and IFN-gamma primed primary human macrophages					9180	3915	60401	11255	5575	10816	6517	26112	116154	285313	7703	956	140685	55753	953	3001	114786	645832	10085	10413	10082	10062	50852	84109	7482	318	55116	3854	220963	10955	6331	3002	551	54544	8972	4610	1104	80003	7480	51151	2046	159296	4821	2998	54502	23429	217	79877	8364	8501	827	146862	7399	84895	132671	118788	122953	128488	2735	1466	353133	284	285848	169355	2121	3706	26052	204474	3743	4622	128178	7432	1942	10900	26093	713	4205	90693	23616	1793	130367	778	54413	378884	3764	337966	8535	3257	89932	6085	91734	50512	252983	9499	56917	9719	275	375743	25790	7473	166863	51655	2050	493856	5030	10536	10368	390992	140690	3595	8869	8082	151354	4091	5648	6856	9465	8288	350	717	64084	50801	10580
GSE1925_CTRL_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN	M6299		16148108	Hu X,Park-Min KH,Ho HH,Ivashkiv LB	GSE1925	GSE1925_3037_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in macrophages primed by IFNG [GeneID=3458]: untreated versus stimulated by IFNG [GeneID=3458] for 24h.	IFN-gamma transcriptional responses in control and IFN-gamma primed primary human macrophages					51324	55005	25929	1266	9493	33	5163	6510	348	4528	10713	10142	926	57085	1152	29103	51522	5965	51340	3065	4860	23560	81624	390916	8801	8836	2620	9053	641638	2730	114915	5498	6402	9451	6282	7486	391059	6737	58472	1366	1794	9258	55737	56947	1528	10527	81579	5463	5236	51382	204	4771	10121	3949	23216	4891	23433	79828	3670	23354	302	145781	11102	54467	7163	3340	9950	138050	51129	5122	79668	6764	83592	7490	55652	9368	51567	3676	50650	3609	5928	54968	9124	5611	9466	1493	3241	56605	383	7453	3482	10507	150356	10672	3712	640	641	83461	4140	984	728294	9108	3958	5825	55329	55920	1798	54948	6258	57703	29887	28989	6277	6726	3559	57585	7108	84640	4152	29851	2677	23761	8581	3659	6608	5292	128866	54433	83939	3959	92140	1634	1775	25798	8815	995	7528	6647	51703	9221	10765	5045	129303	3425	84271	254065	2581	8870	51053	5094	3619	10771	1111	54973	216	10797	11266	84557	11169	5634	6173	10681	481	898	1447	10630	2010	5732	55621	79621	115207	2591	23019	714	283600	5347	5371	91543	100506736	1622	10285	5558	57610	84734	10607	22938	196883	3456	64324	10501	971	8530	3303	8502	7124	6892	80128	8809	6309	10971
GSE1925_3H_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP	M6300		16148108	Hu X,Park-Min KH,Ho HH,Ivashkiv LB	GSE1925	GSE1925_3038_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in macrophages primed and then stimulated by IFNG [GeneID=3458]: 3h versus 24h.	IFN-gamma transcriptional responses in control and IFN-gamma primed primary human macrophages					56271	54981	63917	9232	130814	51398	2745	3035	23274	6733	27229	1026	917	85364	22949	7852	3034	825	3655	29058	3636	5689	10333	79876	28991	29952	23569	1969	83636	3945	1259	116143	115825	2012	7172	23405	5469	27023	4750	10899	6689	7414	56985	5602	6924	51335	5213	4534	6443	7301	7571	7786	84269	9604	9584	59345	1836	116461	129285	54093	2790	81846	55975	5090	2622	8985	64116	150572	57820	10762	23258	9545	81029	7511	2026	4162	2203	54499	23483	10482	79971	65981	373156	9249	23446	23259	1525	7415	10916	80305	55	51523	1774	54884	28512	685	8543	25897	2184	57677	915	6940	22920	2549	79022	3960	10549	4792	29094	5004	9076	8826	375790	768211	121457	6284	8407	56922	162966	2592	11127	54878	51466	65055	2051	388585	98	26137	9289	5074	4323	6370	6905	4058	51621	54764	3290	84247	23582	1471	10280	11015	133015	2631	80896	9056	138241	58528	5311	51074	51635	5867	839	5627	2671	80176	196294	119504	7779	1045	4720	30850	7570	5987	4170	4320	8784	143425	54465	51393	51318	8802	97	5178	5569	10988	6304	100507290	2059	11156	2297	149986	3281	141	3683	1196	9620	1457	55353	11269	8313	7071	6447	3720	533	22919	8994	57533	126638	23456
GSE1925_3H_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN	M6301		16148108	Hu X,Park-Min KH,Ho HH,Ivashkiv LB	GSE1925	GSE1925_3038_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in macrophages primed and then stimulated by IFNG [GeneID=3458]: 3h versus 24h.	IFN-gamma transcriptional responses in control and IFN-gamma primed primary human macrophages					115817	3860	549	55723	3241	129401	81556	51497	55502	9167	9957	9552	23014	10057	4751	83549	1515	4802	23580	839	91368	59286	150572	283991	1025	4515	5792	11112	58528	4891	4942	3925	5897	50814	10901	1032	9723	54919	8834	8408	5137	9807	26292	7320	80789	28991	6416	5634	3978	3140	6925	9962	957	10994	9883	8312	54432	23234	113419	9055	27327	987	57122	768211	9368	2521	10023	55143	13	2114	23468	55117	57409	4987	2316	399	123591	29902	3337	4085	896	27010	25896	9184	27338	3772	1995	122961	6790	51499	11130	55334	54512	332	27125	25	825	9833	920	56990	1786	1690	1212	55015	80273	23787	9477	4282	9550	90007	55071	119504	5191	10105	10847	5768	7042	3621	129685	3638	10209	3996	57599	26207	54107	51691	5130	6726	8909	3988	3586	53340	4150	10762	7832	10063	7153	27063	2717	6342	3148	5422	2729	168544	51439	6134	669	56897	100287932	11169	9963	9104	10376	1398	10951	941	51652	324	5023	9789	3838	2934	22795	79819	55206	29105	51046	3192	5879	389434	1149	84321	171558	4194	1399	346673	57541	4780	7538	7390	4299	54921	2199	8872	7942	11329	961	51084	27183	80213	6891	10716	25972	10106	112	7360	117178	3189	283871	64208
GSE1925_CTRL_VS_3H_IFNG_STIM_MACROPHAGE_UP	M6305		16148108	Hu X,Park-Min KH,Ho HH,Ivashkiv LB	GSE1925	GSE1925_3032_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in macrophages: untreated versus stimulated by IFNG [GeneID=3458] for 3h.	IFN-gamma transcriptional responses in control and IFN-gamma primed primary human macrophages					7301	7707	79001	4234	3164	9843	1809	50807	619563	84694	27000	1788	1265	56902	7016	7993	51176	5167	1459	414919	712	9452	9612	200916	79668	50813	9919	6778	2052	4953	3720	51293	10018	26355	6723	10914	57038	5184	705	644096	23082	6659	5289	27161	10491	356	2539	2697	51006	51734	1844	2734	4049	9261	51102	7133	8600	7293	921	6832	9047	971	6777	83752	150465	2356	6830	84365	6835	4005	56894	63893	923	5025	8884	80790	84172	51056	7305	63875	8707	6347	10752	8761	5460	5591	140823	51491	55848	5045	8293	51091	10813	2583	6210	3732	5133	4925	4791	5971	514	112464	4904	81691	83861	1733	1642	94081	3936	23190	56342	28976	2618	6185	5981	5611	3662	2131	2820	10330	1312	9056	2475	7137	7138	2653	4826	7407	3954	27090	2137	81570	9400	29956	10768	285855	6776	833	92521	64979	1978	57231	27089	26520	64216	79711	25849	6573	162239	7014	51318	597	7965	4830	29993	9592	7249	6232	5783	3099	10322	23786	714	84311	3958	914	1973	7415	23246	9716	1843	84300	55049	54468	4706	4772	11321	301	2987	51020	125150	79716	7052	4665	4343	6176	25929	3098	114789	7375	54968	4141	7982	1889	23315	10538	11202	10505	56253	51347
GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_UP	M6306		16148108	Hu X,Park-Min KH,Ho HH,Ivashkiv LB	GSE1925	GSE1925_3035_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in control macrophages: untreated versus primed by IFNG [GeneID=3458].	IFN-gamma transcriptional responses in control and IFN-gamma primed primary human macrophages					5973	10266	8801	23580	23787	11240	8318	1509	54908	85021	23397	598	5618	51433	6503	29035	161	4176	8914	114789	1791	8907	4826	6790	84271	7528	54820	5799	64208	7223	53	54893	2039	4886	10111	6689	26	780	51271	57446	4948	55291	9695	7259	2153	4088	9545	80206	5586	9156	1798	2242	5601	8315	6489	726	26292	1376	119504	6944	3206	57475	54898	4174	28959	8727	1191	2562	3087	10105	30850	29920	64926	6770	2768	114571	25849	7172	80005	8520	6733	84247	5311	117177	10894	3592	1797	8792	2038	9145	6402	203068	6291	896	9144	256435	5051	7162	64093	10403	6385	5055	27005	4299	7353	4048	6514	381	4958	1306	79829	11185	8829	53344	79102	11224	2017	27242	58158	150572	961	3257	7062	5137	3419	4643	51564	1869	331	9249	1419	118429	3875	558	8554	3512	284119	2114	57338	6732	79723	114876	51530	140809	10195	51274	5763	4288	1588	3112	6387	899	3371	23258	2015	221955	148281	5796	25771	64359	157657	57402	10235	6382	4208	64816	79902	6836	2257	57122	11004	5711	3006	2030	4651	132720	2004	2295	51652	5518	4548	2253	2968	23760	54097	3298	1051	9723	6310	4158	440	1062	57085	124583	302	26286	3595	1149	6197	4289
GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_24H_IFNG_STIM_UP	M6307		16148108	Hu X,Park-Min KH,Ho HH,Ivashkiv LB	GSE1925	GSE1925_3040_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in macrophages stimulated by IFNG [GeneID=3458] for 24h: control versus primed by IFNG [GeneID=3458].	IFN-gamma transcriptional responses in control and IFN-gamma primed primary human macrophages					4234	10026	567	3959	2052	57369	9452	8509	641638	7474	54855	2634	29081	440275	388581	9282	4621	4620	2001	5771	2814	5133	140576	256586	29904	1281	345611	115024	5243	3662	1820	55848	1302	4361	3164	80760	5971	6452	55636	3178	4665	3383	5739	27148	212	2254	10888	3645	4791	383	254013	5105	79101	3594	2170	6748	58515	439996	56902	3954	3667	9446	2331	7187	51293	23185	5156	10320	163183	168455	51065	132625	1266	1265	5214	55303	64062	5783	1244	643	9111	90007	6772	943	27101	64135	51246	11154	1576	4089	5552	3135	11274	202	7741	5704	5530	3429	6523	54853	1959	291	64776	10016	5570	4154	6827	8495	10018	3720	3232	10681	53340	4833	10752	55119	4335	259	56985	64429	81622	4717	2892	64215	55178	64231	55870	3659	5966	5657	10969	4781	441518	11083	317781	10652	5318	5116	63931	3213	3001	670	11127	4616	5187	3190	3273	57486	9616	958	5698	644096	115361	5067	84708	10063	2059	5721	5878	26056	8320	3208	4830	10632	80818	23082	4600	92675	7374	7462	56339	8878	54467	3581	6441	118881	3642	4780	6037	10907	5045	5627	4706	6201	125965	6632	83699	5132	56	55205	56061	51655	283600	3097	64219	54499	55500	27131	55262	23608
GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_24H_IFNG_STIM_DN	M6309		16148108	Hu X,Park-Min KH,Ho HH,Ivashkiv LB	GSE1925	GSE1925_3040_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in macrophages stimulated by IFNG [GeneID=3458] for 24h: control versus primed by IFNG [GeneID=3458].	IFN-gamma transcriptional responses in control and IFN-gamma primed primary human macrophages					6510	10142	51324	3135	5163	55005	1447	57085	1266	53340	1152	3860	8520	3437	4528	5721	54948	9053	3959	4891	140576	79668	641638	54433	114915	1943	390916	9493	33	3670	283600	204	5236	7372	25929	64135	57585	926	51522	6282	567	10713	2730	348	81624	283	3241	439996	3429	8801	4772	9124	5634	894	81620	79699	2620	9258	51340	1528	150356	7866	2634	3949	81796	29103	3340	391059	3659	10615	5768	145781	8836	3482	11274	51382	128866	6134	23560	81579	79828	55920	5122	10527	57122	5965	10379	10681	28989	51316	2637	1794	3001	51246	4600	6737	5463	9957	4790	56605	54467	23433	56947	3065	5191	9636	84693	6726	5347	80818	6402	6764	91543	9368	8909	57703	10121	4860	7486	23082	9167	1798	728392	100129792	50650	8618	55148	3559	3815	4061	5498	1622	9987	7163	22794	6416	3676	134548	8480	2010	3383	4926	10063	8809	7474	10410	138050	2717	11266	5954	3669	55505	345611	3712	129303	6038	51805	84522	4771	6277	3420	92140	302	79050	9451	984	5293	640	10797	4665	5478	498	6647	3068	11243	9883	5094	3609	328	2034	8743	7187	103	115361	63933	3359	1603	60	57541	6309	6790	9939	7490	29887	5272	7453	51673	995	54968	84734
GSE1925_CTRL_VS_3H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN	M6310		16148108	Hu X,Park-Min KH,Ho HH,Ivashkiv LB	GSE1925	GSE1925_3036_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in macrophages primed by IFNG [GeneID=3458]: untreated versus stimulated by IFNG [GeneID=3458] for 3h.	IFN-gamma transcriptional responses in control and IFN-gamma primed primary human macrophages					3604	130814	2017	54981	6733	150572	6262	5213	7172	1259	56271	917	9232	5602	5311	56985	63917	1062	1829	3512	27229	5395	119504	2745	116461	8985	1026	115825	162966	2549	3290	1051	10491	3945	27023	3035	3720	5627	3636	6689	5893	85364	6443	23405	10891	55353	283120	4255	3358	22949	64093	7415	30850	4299	4967	84247	8784	11018	5806	80206	2167	7571	29952	4747	9056	51398	93661	6557	11015	4792	10762	4826	23456	623	28991	141	5074	2257	23446	3655	57533	153090	9249	7982	57338	1836	5314	51720	29882	126638	23569	54898	84269	4534	825	57685	23274	5689	92521	59342	129285	29058	1400	3055	255231	10916	4617	1969	4750	7301	9545	9037	10007	760	23483	51393	11081	51318	355	79971	10333	83636	9898	100507290	9604	598	79022	3683	26137	51661	51763	5747	5569	219333	8577	26001	2975	4323	4221	8038	116931	2475	23258	1774	4817	726	4058	84694	2012	1045	5274	6385	80262	2015	10482	10758	2026	25849	1525	63943	143425	5987	112464	4162	8973	7570	11199	28512	100506742	3598	9584	685	51099	10642	190	84320	22828	1588	22803	6905	771	2562	1114	7414	113829	9737	80305	6284	54093	165721	53344	11164	5178	1911	8968	9455	81029	8079	84365	79876
GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_DN	M6313		16148108	Hu X,Park-Min KH,Ho HH,Ivashkiv LB	GSE1925	GSE1925_3035_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in control macrophages: untreated versus primed by IFNG [GeneID=3458].	IFN-gamma transcriptional responses in control and IFN-gamma primed primary human macrophages					4502	414919	5163	23354	6282	7528	640	6652	5440	55005	25929	8520	1152	10713	84128	79960	619563	2730	1798	10195	3609	348	5498	11169	55737	79668	81624	11224	4205	5268	9493	2620	4860	284371	5732	114915	25798	10527	6510	5928	926	57085	7486	5055	114789	735	641638	6402	7305	55651	5973	7137	984	8303	60526	126119	4771	10142	1266	5611	10452	23433	80005	25864	51340	5045	92335	3958	4528	6347	33	9843	9451	4926	391059	3670	2356	971	331	23560	8836	644096	1366	27000	23464	84153	2107	23216	4726	10894	79902	150356	714	54468	79828	8815	712	5834	4969	84271	29956	6375	64926	5586	6723	7124	4826	10538	29103	1174	383	23082	3949	6737	72	6130	51293	145781	83592	51167	9583	56181	28957	26133	54998	29920	10672	55652	4646	4234	2539	3065	10752	51081	7016	29887	51567	5292	9991	10285	1809	8801	6573	56342	221477	6202	51522	7965	51129	4830	81579	55148	388	6418	822	1832	6503	6572	1376	5781	254065	26286	55783	3425	3732	58472	23246	23645	55898	4904	9053	6288	3486	3950	10763	56947	28976	4174	200916	6382	1261	5612	7373	115207	10121	972	2618	23019	1435	11240	200185	23111	10219	990	50650	6730	1339	10801	2189	7514
GSE1925_CTRL_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP	M6314		16148108	Hu X,Park-Min KH,Ho HH,Ivashkiv LB	GSE1925	GSE1925_3037_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in macrophages primed by IFNG [GeneID=3458]: untreated versus stimulated by IFNG [GeneID=3458] for 24h.	IFN-gamma transcriptional responses in control and IFN-gamma primed primary human macrophages					3667	2687	55975	10549	29904	79876	825	51398	7852	54499	2622	138241	57486	2059	6443	283991	201965	54981	5689	58528	57369	56271	2814	6342	2149	3954	23274	10899	8802	669	2745	1515	59286	549	80194	85364	63917	2331	23582	205	9232	54764	324	22949	54708	7320	2790	10026	839	9620	3034	11217	27032	1856	116143	52	29058	51439	6523	373156	98	5004	59345	81846	55502	54541	26589	56339	10333	10762	9076	65055	5924	4684	1820	1149	3638	943	9445	1259	51335	388558	28991	56897	8549	79971	9270	5152	9528	51119	3655	2297	2012	3035	55353	201895	56985	4010	170302	2114	7786	1647	8543	2649	55723	27063	8973	1462	1471	64116	6733	55	7462	6511	130814	917	115825	129401	4987	116988	54878	768211	27327	8649	5067	6489	8313	2631	55311	6689	2203	9550	7390	3751	767	1662	5174	9570	6940	1627	29893	23569	25977	64062	23554	90007	1803	1008	1758	3003	85440	57494	901	28970	1036	8848	3689	5105	23185	29902	7141	1398	6284	97	1576	10957	64776	7436	10847	2184	51466	5345	10094	64795	4594	29952	7566	3945	9249	5627	9973	9616	8826	6452	2254	1675	2026	920	4154	8019	1176	3204	1525	9584	51122	22828	3960	143187	125965	57142
GSE3720_UNSTIM_VS_LPS_STIM_VD2_GAMMADELTA_TCELL_UP	M6337		16423401	Kress E,Hedges JF,Jutila MA	GSE3720	GSE3720_3346_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in Vd2 gamma delta T cells: untreated versus LPS.	The two major human gd T cell subsets, Vd1 and Vd2, display differences in tissue tropism and agonist responses, but we have little insight into global differences that may exist at the gene expression level. This is due to the small numbers of these cells that can be obtained from healthy donors, which limit comprehensive, comparative gene expression analyses. We established a culture method that expands Vd1 and Vd2 cells from the same PBL preparation to levels sufficient for sorting and microarray analysis. Although the subsets were expanded identically (anti-TCR mAb, plus IL-15), 392 and 614 genes were identified, which were differentially expressed in the two subsets, from two donors, respectively. Approximately 4,500 genes changed in both subsets following PMA/ionomycin treatment; about 50% of these genes were subset-specific. Both subsets responded to a crude LPS preparation, but only 6% of the responsive genes were the same. The differentially expressed genes were consistent with Vd2 cells being more inflammatory and Vd1 cells having more of a regulatory phenotype. Both subsets expressed transcripts encoding an array of innate and NK cell receptors, supporting the relationship of gd T cells to the innate immune system. Our results show that circulating Vd1 and Vd2 subsets in humans have considerable, inherent differences in gene expression following treatment with non-TCR agonists, supporting unique functional roles for these cells in vivo.					6188	6132	154141	6224	5163	6161	84941	7019	54463	121504	55850	175	1164	10849	9535	6155	1933	114836	6156	51361	7185	6175	283377	9641	6122	54847	3687	340152	9968	6125	8320	6146	1848	25874	4200	971	6150	4247	64864	6203	29997	6932	10576	84937	6206	1130	9168	11131	10538	4713	9873	90639	51246	92558	57649	57794	6204	6141	3028	944	25873	9920	10750	3615	516	5138	3921	6737	23011	196294	3551	64236	9412	26519	6170	79573	11202	155368	51602	51329	8987	2833	6635	55603	5721	6001	22800	51316	92196	4061	1606	6223	84365	55110	10243	9939	64108	25939	81890	5533	51491	60674	915	6124	6147	1965	9045	6136	84191	92241	1803	58517	1880	1736	126789	6202	3575	509	8607	8502	5696	84946	4050	1107	8665	4715	939	6198	51660	84660	6159	6722	3978	6168	6304	9349	87	57333	6173	6472	6167	552900	51444	2139	441168	6668	7433	1211	2308	29121	22948	2150	9753	10987	10111	55296	8993	10412	5305	4744	54828	6187	57038	10038
GSE3720_UNSTIM_VS_LPS_STIM_VD2_GAMMADELTA_TCELL_DN	M6338		16423401	Kress E,Hedges JF,Jutila MA	GSE3720	GSE3720_3346_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in Vd2 gamma delta T cells: untreated versus LPS.	The two major human gd T cell subsets, Vd1 and Vd2, display differences in tissue tropism and agonist responses, but we have little insight into global differences that may exist at the gene expression level. This is due to the small numbers of these cells that can be obtained from healthy donors, which limit comprehensive, comparative gene expression analyses. We established a culture method that expands Vd1 and Vd2 cells from the same PBL preparation to levels sufficient for sorting and microarray analysis. Although the subsets were expanded identically (anti-TCR mAb, plus IL-15), 392 and 614 genes were identified, which were differentially expressed in the two subsets, from two donors, respectively. Approximately 4,500 genes changed in both subsets following PMA/ionomycin treatment; about 50% of these genes were subset-specific. Both subsets responded to a crude LPS preparation, but only 6% of the responsive genes were the same. The differentially expressed genes were consistent with Vd2 cells being more inflammatory and Vd1 cells having more of a regulatory phenotype. Both subsets expressed transcripts encoding an array of innate and NK cell receptors, supporting the relationship of gd T cells to the innate immune system. Our results show that circulating Vd1 and Vd2 subsets in humans have considerable, inherent differences in gene expression following treatment with non-TCR agonists, supporting unique functional roles for these cells in vivo.					10570	9622	358	51409	80824	6238	11182	6482	64388	10129	57119	84951	3849	1008	4588	3897	131831	342527	8022	9975	3713	1804	3784	337988	3822	7498	143941	6504	8863	57186	64093	10100	10809	288	200942	85300	25825	127943	3689	23710	57156	2134	3958	53826	57338	9780	54677	56477	92235	340205	26031	23495	57178	23363	200008	3559	636	64581	55287	406	1282	4762	3716	3631	861	4661	317	2791	2621	3351	388595	151648	81615	2059	338440	2213	824	84868	84694	286828	79825	5913	89797	2081	3764	127294	644890	5332	80005	1132	134549	5551	137886	3956	822	56	407040	3915	57379	80725	124404	157	27232	729756	151	56246	51339	301	5728	10284	55752	6649	84101	5351	79971	51646	57084	90332	22849	8761	1482	9496	55041	10321	9783	114625	81558	11108	126006	79026	57016	7780	56001	6453	285367	55112	6535	6095	4585	8534	6856	26010	26033	652968	84959	8807	3053	490
GSE3720_UNSTIM_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_UP	M6340		16423401	Kress E,Hedges JF,Jutila MA	GSE3720	GSE3720_3347_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in Vd2 gamma delta T cells: untreated versus phorbol myristate acetate and ionomycin [PubChem=4792;3733].	The two major human gd T cell subsets, Vd1 and Vd2, display differences in tissue tropism and agonist responses, but we have little insight into global differences that may exist at the gene expression level. This is due to the small numbers of these cells that can be obtained from healthy donors, which limit comprehensive, comparative gene expression analyses. We established a culture method that expands Vd1 and Vd2 cells from the same PBL preparation to levels sufficient for sorting and microarray analysis. Although the subsets were expanded identically (anti-TCR mAb, plus IL-15), 392 and 614 genes were identified, which were differentially expressed in the two subsets, from two donors, respectively. Approximately 4,500 genes changed in both subsets following PMA/ionomycin treatment; about 50% of these genes were subset-specific. Both subsets responded to a crude LPS preparation, but only 6% of the responsive genes were the same. The differentially expressed genes were consistent with Vd2 cells being more inflammatory and Vd1 cells having more of a regulatory phenotype. Both subsets expressed transcripts encoding an array of innate and NK cell receptors, supporting the relationship of gd T cells to the innate immune system. Our results show that circulating Vd1 and Vd2 subsets in humans have considerable, inherent differences in gene expression following treatment with non-TCR agonists, supporting unique functional roles for these cells in vivo.					8320	55850	4217	6204	25996	2197	25873	11131	1933	1803	64236	92558	1984	5138	23406	87	1736	121504	3921	51317	54855	51361	9875	6173	5163	8821	286827	5721	29775	29997	915	1848	6175	8784	55103	6159	23157	1716	9448	5579	25874	4736	6231	55329	10538	8202	55500	8607	54869	55856	283629	4602	6143	10111	6950	79693	55623	146206	10196	6203	6170	1915	6155	55718	55296	6001	6156	6402	151888	22948	6176	65983	23484	5330	7037	51602	64108	3615	6141	6136	1130	152100	6147	51056	51176	23160	1662	23635	51316	59338	7096	51669	54663	54680	6232	85476	3572	9868	22800	26355	939	11059	9641	259230	8243	708	6168	1164	10207	6161	30845	6152	10480	684	8663	60674	140807	83440	51752	5720	6122	83879	1606	26472	84941	2091	7015	26228	10180	55603	7268	93974	8624	6188	155368	2833	6187	1211	6167	1520	10606	2517	25902	9349	54466	6206	515	4050	944	81890	5093	27044	9255	9781	8993	23327	6375	79101	4666	286336	51466	79833	8370	5631	1604	6224	59339	6124	26354	3607	409	221188	5696
GSE3720_UNSTIM_VS_LPS_STIM_VD1_GAMMADELTA_TCELL_DN	M6341		16423401	Kress E,Hedges JF,Jutila MA	GSE3720	GSE3720_3343_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in Vd1 gamma delta T cells: untreated versus LPS.	The two major human gd T cell subsets, Vd1 and Vd2, display differences in tissue tropism and agonist responses, but we have little insight into global differences that may exist at the gene expression level. This is due to the small numbers of these cells that can be obtained from healthy donors, which limit comprehensive, comparative gene expression analyses. We established a culture method that expands Vd1 and Vd2 cells from the same PBL preparation to levels sufficient for sorting and microarray analysis. Although the subsets were expanded identically (anti-TCR mAb, plus IL-15), 392 and 614 genes were identified, which were differentially expressed in the two subsets, from two donors, respectively. Approximately 4,500 genes changed in both subsets following PMA/ionomycin treatment; about 50% of these genes were subset-specific. Both subsets responded to a crude LPS preparation, but only 6% of the responsive genes were the same. The differentially expressed genes were consistent with Vd2 cells being more inflammatory and Vd1 cells having more of a regulatory phenotype. Both subsets expressed transcripts encoding an array of innate and NK cell receptors, supporting the relationship of gd T cells to the innate immune system. Our results show that circulating Vd1 and Vd2 subsets in humans have considerable, inherent differences in gene expression following treatment with non-TCR agonists, supporting unique functional roles for these cells in vivo.					3728	822	9657	56981	636	64065	186	9445	51298	10787	63035	2014	9896	6504	54677	3914	160851	80013	4885	406	55770	92211	3662	5908	8837	6856	10809	54103	6251	8328	79740	23108	337988	8611	128209	54622	2081	80128	11174	54602	2059	58157	3559	338599	1463	84000	3764	85293	80143	28990	2658	91147	9859	23710	5272	826	64386	2651	23191	79895	5406	6619	55558	3956	3915	301	9975	8807	440193	65124	941	2550	10880	7905	26031	284207	3683	1759	55803	84188	23092	90019	4854	3578	1075	140766	643414	3822	57088	3958	139596	5111	10344	1742	6095	118788	1118	23365	140465	9969	7172	84959	7189	89869	255189	824	113277	84868	79962	85439	79156	89778	27128	55619	57119	79675	2820	83902	57826	8674	490	387357	57823	3716	3821	57863	2792	2213	283420	54464	4974	57492	2937	51646	9172	10666	5879	6334	3358	1524	23175	23007	8809	23708
GSE3720_UNSTIM_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_UP	M6343		16423401	Kress E,Hedges JF,Jutila MA	GSE3720	GSE3720_3344_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in Vd1 gamma delta T cells: untreated versus phorbol myristate acetate and ionomycin [PubChem=4792;3733].	The two major human gd T cell subsets, Vd1 and Vd2, display differences in tissue tropism and agonist responses, but we have little insight into global differences that may exist at the gene expression level. This is due to the small numbers of these cells that can be obtained from healthy donors, which limit comprehensive, comparative gene expression analyses. We established a culture method that expands Vd1 and Vd2 cells from the same PBL preparation to levels sufficient for sorting and microarray analysis. Although the subsets were expanded identically (anti-TCR mAb, plus IL-15), 392 and 614 genes were identified, which were differentially expressed in the two subsets, from two donors, respectively. Approximately 4,500 genes changed in both subsets following PMA/ionomycin treatment; about 50% of these genes were subset-specific. Both subsets responded to a crude LPS preparation, but only 6% of the responsive genes were the same. The differentially expressed genes were consistent with Vd2 cells being more inflammatory and Vd1 cells having more of a regulatory phenotype. Both subsets expressed transcripts encoding an array of innate and NK cell receptors, supporting the relationship of gd T cells to the innate immune system. Our results show that circulating Vd1 and Vd2 subsets in humans have considerable, inherent differences in gene expression following treatment with non-TCR agonists, supporting unique functional roles for these cells in vivo.					3687	2150	55094	1396	11131	58517	60674	10078	51614	10758	4061	9168	6146	94239	1043	25874	4953	926	971	4085	552900	2833	51497	6124	1933	6282	54847	8667	10302	944	1389	6122	4715	6813	9641	51651	11202	5994	4666	7428	6945	221914	914	51444	23214	4713	51027	29979	6224	6143	9553	5687	6161	374291	131118	6136	11340	6155	6208	6132	1528	1880	2963	1329	4609	10544	30818	55690	5696	81037	339487	51503	6188	92241	156	3575	126282	114836	57050	4694	2135	112939	23484	3073	57333	51574	5683	139716	54998	27089	196383	6233	10961	23586	6223	28512	83930	57473	720	5305	79792	2661	84153	2079	9920	29997	55080	5585	9278	5694	2139	3921	4258	55585	4831	56474	22859	2648	79663	64333	22839	5718	6133	9349	5138	27018	4174	10328	199221	154141	5834	11221	51699	65983	11140	10437	3148	23367	30827	54948	171568	84766	79871	6206	11332	8563	84340	387893	9477	25851	4247	4209	54541	9377	5533	7170	4793	79621	25804	22948	339521	5721	64236	6235	1107	56342	124997	9587	4050	3004	126432	5901	168537	128866
GSE3720_UNSTIM_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_DN	M6344		16423401	Kress E,Hedges JF,Jutila MA	GSE3720	GSE3720_3344_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in Vd1 gamma delta T cells: untreated versus phorbol myristate acetate and ionomycin [PubChem=4792;3733].	The two major human gd T cell subsets, Vd1 and Vd2, display differences in tissue tropism and agonist responses, but we have little insight into global differences that may exist at the gene expression level. This is due to the small numbers of these cells that can be obtained from healthy donors, which limit comprehensive, comparative gene expression analyses. We established a culture method that expands Vd1 and Vd2 cells from the same PBL preparation to levels sufficient for sorting and microarray analysis. Although the subsets were expanded identically (anti-TCR mAb, plus IL-15), 392 and 614 genes were identified, which were differentially expressed in the two subsets, from two donors, respectively. Approximately 4,500 genes changed in both subsets following PMA/ionomycin treatment; about 50% of these genes were subset-specific. Both subsets responded to a crude LPS preparation, but only 6% of the responsive genes were the same. The differentially expressed genes were consistent with Vd2 cells being more inflammatory and Vd1 cells having more of a regulatory phenotype. Both subsets expressed transcripts encoding an array of innate and NK cell receptors, supporting the relationship of gd T cells to the innate immune system. Our results show that circulating Vd1 and Vd2 subsets in humans have considerable, inherent differences in gene expression following treatment with non-TCR agonists, supporting unique functional roles for these cells in vivo.					23365	3741	358	11328	83716	51164	8807	5583	23140	116159	29106	171019	9622	139189	8761	115265	55617	23333	1008	27067	3915	3736	81562	1571	83546	7465	5933	57047	342933	9500	64093	55000	3221	2060	84868	3071	285	1174	407040	79648	2957	26258	9496	57186	80059	124401	874	4353	9901	51305	9839	3930	861	8811	5591	337974	200942	11045	2621	55122	84694	26033	219990	3849	150483	402117	27253	65124	2770	266553	84910	125704	150921	9783	23026	9755	3764	644890	3358	627	118429	64388	4681	91683	10630	4582	1876	10529	57524	5406	6659	5645	122402	219988	55283	7075	1208	5228	115811	6197	114625	121441	158297	7060	54766	5255	55239	57037	5507	2919	7070	387914	6862	56246	374407	57545	55289	83657	2588	23301	116512	85462	57408	57412
GSE3720_LPS_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_DN	M6345		16423401	Kress E,Hedges JF,Jutila MA	GSE3720	GSE3720_3345_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in Vd1 gamma delta T cells: LPS versus phorbol myristate acetate and ionomycin [PubChem=4792;3733].	The two major human gd T cell subsets, Vd1 and Vd2, display differences in tissue tropism and agonist responses, but we have little insight into global differences that may exist at the gene expression level. This is due to the small numbers of these cells that can be obtained from healthy donors, which limit comprehensive, comparative gene expression analyses. We established a culture method that expands Vd1 and Vd2 cells from the same PBL preparation to levels sufficient for sorting and microarray analysis. Although the subsets were expanded identically (anti-TCR mAb, plus IL-15), 392 and 614 genes were identified, which were differentially expressed in the two subsets, from two donors, respectively. Approximately 4,500 genes changed in both subsets following PMA/ionomycin treatment; about 50% of these genes were subset-specific. Both subsets responded to a crude LPS preparation, but only 6% of the responsive genes were the same. The differentially expressed genes were consistent with Vd2 cells being more inflammatory and Vd1 cells having more of a regulatory phenotype. Both subsets expressed transcripts encoding an array of innate and NK cell receptors, supporting the relationship of gd T cells to the innate immune system. Our results show that circulating Vd1 and Vd2 subsets in humans have considerable, inherent differences in gene expression following treatment with non-TCR agonists, supporting unique functional roles for these cells in vivo.					9049	1803	51621	54869	8321	23484	63940	25874	84153	1130	11259	4731	10758	79144	3921	8477	2197	6124	5720	4736	3687	65983	4061	221188	1880	6231	9377	122830	25804	64236	57333	259230	23160	1267	10437	6159	94239	8624	57606	2833	6208	6845	51069	4217	944	51466	51504	5721	6375	7204	55120	9535	11332	54742	1933	8666	128866	6015	6141	4234	4282	6204	6402	245972	23406	56474	79031	9641	29997	5138	10983	6122	388962	4678	9833	9920	7123	79056	4209	8370	30827	83930	54847	7226	9349	94005	54855	168537	29933	9467	9168	347516	6155	5696	6175	6136	8993	54842	1604	23091	286827	51317	4609	6304	1915	4793	2043	23329	1232	54680	1211	7040	4085	30833	10460	55329	729993	9552	51574	63906	26355	51264	81488	131118	2150	58526	3895	4050	23588	79890	4780	59338	4174	8360	22948	51735	5718	6173	8089	79699	26228	114836	23533	915	55680	4185	4832	29104	9046	805	10423	55850	93082	146206	55837	8013	133418	7049	10196	7372	10054	54974	10721	25796	90326	8320	914	10536	11131	56624	83879
GSE3720_LPS_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_UP	M6346		16423401	Kress E,Hedges JF,Jutila MA	GSE3720	GSE3720_3348_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in Vd2 gamma delta T cells: LPS versus phorbol myristate acetate and ionomycin [PubChem=4792;3733].	The two major human gd T cell subsets, Vd1 and Vd2, display differences in tissue tropism and agonist responses, but we have little insight into global differences that may exist at the gene expression level. This is due to the small numbers of these cells that can be obtained from healthy donors, which limit comprehensive, comparative gene expression analyses. We established a culture method that expands Vd1 and Vd2 cells from the same PBL preparation to levels sufficient for sorting and microarray analysis. Although the subsets were expanded identically (anti-TCR mAb, plus IL-15), 392 and 614 genes were identified, which were differentially expressed in the two subsets, from two donors, respectively. Approximately 4,500 genes changed in both subsets following PMA/ionomycin treatment; about 50% of these genes were subset-specific. Both subsets responded to a crude LPS preparation, but only 6% of the responsive genes were the same. The differentially expressed genes were consistent with Vd2 cells being more inflammatory and Vd1 cells having more of a regulatory phenotype. Both subsets expressed transcripts encoding an array of innate and NK cell receptors, supporting the relationship of gd T cells to the innate immune system. Our results show that circulating Vd1 and Vd2 subsets in humans have considerable, inherent differences in gene expression following treatment with non-TCR agonists, supporting unique functional roles for these cells in vivo.					186	255220	8807	10614	54464	23365	10787	84868	4160	92211	1118	116135	29909	6693	3001	138311	1017	144404	9839	1581	10809	7089	160851	2550	130026	9575	55784	387357	6526	79895	51616	114803	5775	8452	84000	5406	2792	84910	161142	10529	116832	57128	6619	406	1112	301	55219	941	3764	953	115265	29066	79836	154	125488	79675	23333	26872	3662	10630	3664	4104	93627	10443	91012	3358	79819	10734	57539	286514	9173	55619	23710	3676	22914	54520	5016	80204	10521	8811	30851	7070	125875	55902	54622	1893	57223	1015	57205	8925	22890	10241	63895	64386	643414	360023	22897	6504	7008	222487	78987	407040	7060	23198	63892	2081	5507	6095	3821	53637	11235	8328	23092	283385	64343	64499	57185	54677	11082	26031	3187	8630	1657	79637	9631	23451	4763	23175	23066	8553	201299	80021
GSE3720_LPS_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_DN	M6347		16423401	Kress E,Hedges JF,Jutila MA	GSE3720	GSE3720_3348_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in Vd2 gamma delta T cells: LPS versus phorbol myristate acetate and ionomycin [PubChem=4792;3733].	The two major human gd T cell subsets, Vd1 and Vd2, display differences in tissue tropism and agonist responses, but we have little insight into global differences that may exist at the gene expression level. This is due to the small numbers of these cells that can be obtained from healthy donors, which limit comprehensive, comparative gene expression analyses. We established a culture method that expands Vd1 and Vd2 cells from the same PBL preparation to levels sufficient for sorting and microarray analysis. Although the subsets were expanded identically (anti-TCR mAb, plus IL-15), 392 and 614 genes were identified, which were differentially expressed in the two subsets, from two donors, respectively. Approximately 4,500 genes changed in both subsets following PMA/ionomycin treatment; about 50% of these genes were subset-specific. Both subsets responded to a crude LPS preparation, but only 6% of the responsive genes were the same. The differentially expressed genes were consistent with Vd2 cells being more inflammatory and Vd1 cells having more of a regulatory phenotype. Both subsets expressed transcripts encoding an array of innate and NK cell receptors, supporting the relationship of gd T cells to the innate immune system. Our results show that circulating Vd1 and Vd2 subsets in humans have considerable, inherent differences in gene expression following treatment with non-TCR agonists, supporting unique functional roles for these cells in vivo.					171019	399694	9032	23328	64225	8320	27247	3832	1130	6649	9622	874	1482	22871	6208	11328	272	10893	10107	55229	54847	11332	54742	6304	51557	526	51529	2621	81562	126206	55869	26301	200942	5981	10566	627	2833	84294	24145	122481	80258	4094	55752	1911	30010	5613	53919	50940	84866	124404	54749	151	54869	1139	8811	7204	126820	286753	4681	1008	4061	116159	2876	148229	6795	6159	598	5067	144501	54715	646019	8988	54796	3849	221016	7222	10268	6453	3491	1811	28965	7053	65124	29841	51375	353137	65979	85462	9783	9075	4762	5459	80055	3489	1608	55268	9920	63940	60494	1420	51056	9049	285601	122618	151887	65062	4261	63950	55125	2918	23082	5723	374986	10474	54890	3998	57864	79012	2561	25849	57101	8534	55283	894	255104	1912	27299	164592	2675	8939	29775	400673	116211	90268	118442	9144	404037	134359	3586	6534	8019	221613	134265	91683	644168	10480	158	340419	2619	4622	28513	342527
GSE3720_LPS_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_UP	M6348		16423401	Kress E,Hedges JF,Jutila MA	GSE3720	GSE3720_3345_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in Vd1 gamma delta T cells: LPS versus phorbol myristate acetate and ionomycin [PubChem=4792;3733].	The two major human gd T cell subsets, Vd1 and Vd2, display differences in tissue tropism and agonist responses, but we have little insight into global differences that may exist at the gene expression level. This is due to the small numbers of these cells that can be obtained from healthy donors, which limit comprehensive, comparative gene expression analyses. We established a culture method that expands Vd1 and Vd2 cells from the same PBL preparation to levels sufficient for sorting and microarray analysis. Although the subsets were expanded identically (anti-TCR mAb, plus IL-15), 392 and 614 genes were identified, which were differentially expressed in the two subsets, from two donors, respectively. Approximately 4,500 genes changed in both subsets following PMA/ionomycin treatment; about 50% of these genes were subset-specific. Both subsets responded to a crude LPS preparation, but only 6% of the responsive genes were the same. The differentially expressed genes were consistent with Vd2 cells being more inflammatory and Vd1 cells having more of a regulatory phenotype. Both subsets expressed transcripts encoding an array of innate and NK cell receptors, supporting the relationship of gd T cells to the innate immune system. Our results show that circulating Vd1 and Vd2 subsets in humans have considerable, inherent differences in gene expression following treatment with non-TCR agonists, supporting unique functional roles for these cells in vivo.					382	2192	25836	201299	3822	54739	79792	3002	221914	1389	348938	84106	3824	283385	9197	64343	9839	9804	10555	4085	165215	132954	6722	5533	51444	55974	6606	3764	54675	23710	10875	9205	51497	125997	55166	11131	219931	79871	91544	58157	98	51136	3001	4160	286826	10787	6275	301	57151	80013	369	3821	9859	38	55693	23191	196403	7182	998	567	917	5897	6504	170685	150350	152006	81551	5523	140707	3455	961	9236	7263	60490	92856	53637	5899	2661	115361	56890	10809	29074	339766	64780	3021	84660	11275	137835	23365	6133	54850	3003	11068	2012	348980	128240	25874	5272	51338	3868	8502	2109	57763	345557	81553	253017	339745	654790	23708	80143	57571	55907	51411	23492	92211	10425	142678	29956	716	1043	8807	3603	10666	2771	116337	11237	2867	10120	6619	29108	5366	79042	22902	10742	84717	57823	79072	3958	6170	4247
GSE3720_UNSTIM_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_DN	M6351		16423401	Kress E,Hedges JF,Jutila MA	GSE3720	GSE3720_3347_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in Vd2 gamma delta T cells: untreated versus phorbol myristate acetate and ionomycin [PubChem=4792;3733].	The two major human gd T cell subsets, Vd1 and Vd2, display differences in tissue tropism and agonist responses, but we have little insight into global differences that may exist at the gene expression level. This is due to the small numbers of these cells that can be obtained from healthy donors, which limit comprehensive, comparative gene expression analyses. We established a culture method that expands Vd1 and Vd2 cells from the same PBL preparation to levels sufficient for sorting and microarray analysis. Although the subsets were expanded identically (anti-TCR mAb, plus IL-15), 392 and 614 genes were identified, which were differentially expressed in the two subsets, from two donors, respectively. Approximately 4,500 genes changed in both subsets following PMA/ionomycin treatment; about 50% of these genes were subset-specific. Both subsets responded to a crude LPS preparation, but only 6% of the responsive genes were the same. The differentially expressed genes were consistent with Vd2 cells being more inflammatory and Vd1 cells having more of a regulatory phenotype. Both subsets expressed transcripts encoding an array of innate and NK cell receptors, supporting the relationship of gd T cells to the innate immune system. Our results show that circulating Vd1 and Vd2 subsets in humans have considerable, inherent differences in gene expression following treatment with non-TCR agonists, supporting unique functional roles for these cells in vivo.					9097	26227	976	26031	9991	368	115004	2355	29015	824	506	10844	5533	83606	10682	65997	11344	22933	5763	463	644353	64747	23180	9555	200185	157285	116496	29880	5557	2908	1062	55771	23344	29066	114879	3099	10247	23371	3420	79637	51203	3956	84896	9341	286676	7257	55289	54821	2305	140606	284467	5295	3487	127343	51727	83903	7918	3161	64220	8277	80114	8737	10615	90355	26225	11277	5516	27440	150468	79077	942	643155	63877	29127	6632	7712	10005	54900	79803	5934	822	2081	9143	2214	57504	899	387882	51280	682	79133	29940	84067	1435	10768	23411	92370	9683	10999	55794	285676	1460	57085	114	65983	202	22856	4218	8807	11345	8514	84859	8438	1796	10403	396	23533	1463	53637	3682	51160	5908	23176	83446	54458	9493	183	127544	26996	170394	26873	64225	10919	10628	387103	1102	5341	10733	348793	2783	57531	51012	51621	55829	2936	83892	2237	3155	3268	342897	2634	84166	26229	3824	56265	6385	4067	51703	22903	2591	3017	57585	56681	29766	5985	11240	4171	51053	353189	27111	4174	1786	6683	5998	26024	54478	93594	84440	84844	3897	168537	5867	2288	6871	6675	9958	201799	10581	995	25891	51635	3337	10123	332	150082	20	93550	84811	153090	4783	832
GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_LPS_STIM_UP	M6352		16423401	Kress E,Hedges JF,Jutila MA	GSE3720	GSE3720_3350_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in gamma delta T cells stimulated by LPS: Vd1 versus Vd2.	The two major human gd T cell subsets, Vd1 and Vd2, display differences in tissue tropism and agonist responses, but we have little insight into global differences that may exist at the gene expression level. This is due to the small numbers of these cells that can be obtained from healthy donors, which limit comprehensive, comparative gene expression analyses. We established a culture method that expands Vd1 and Vd2 cells from the same PBL preparation to levels sufficient for sorting and microarray analysis. Although the subsets were expanded identically (anti-TCR mAb, plus IL-15), 392 and 614 genes were identified, which were differentially expressed in the two subsets, from two donors, respectively. Approximately 4,500 genes changed in both subsets following PMA/ionomycin treatment; about 50% of these genes were subset-specific. Both subsets responded to a crude LPS preparation, but only 6% of the responsive genes were the same. The differentially expressed genes were consistent with Vd2 cells being more inflammatory and Vd1 cells having more of a regulatory phenotype. Both subsets expressed transcripts encoding an array of innate and NK cell receptors, supporting the relationship of gd T cells to the innate immune system. Our results show that circulating Vd1 and Vd2 subsets in humans have considerable, inherent differences in gene expression following treatment with non-TCR agonists, supporting unique functional roles for these cells in vivo.					6202	23112	11231	6905	79143	2743	374986	2145	23613	9882	400624	9311	10039	23253	51752	91404	140803	114799	23062	2181	23741	254359	56204	65250	221035	6533	6117	51230	55778	29078	550643	9823	27068	2533	149840	2258	29851	55558	8502	2889	23405	6935	11162	27101	5128	23208	79581	123228	25992	55352	112399	24149	7023	6648	55319	10979	8525	2583	6170	2826	10106	6002	7520	10165	64857	6014	4282	4792	9760	546	5494	126917	9205	9641	7013	25861	116138	170690	5168	8546	8714	10228	55691	163590	51555	837	5163	400566	23505	64968	23469	140707	10242	55718	64332	7158	26354	130026	5352	10946	1453	80774	54882	54541	3717	57473	7043	112	139285	25907	1654	5239	23097	3241	92558	6741	605	9806	5634	64137	92675	340719	10743	84239	97	9277	1236	83605	669	84173	9500	5921	55922	6129	55326	154141	127703	202243	79577	1803	54997	23325	4258	128553	54726	349565	9662	10399	80728	28951	5217	2247	8087	22891	2833	367	55622	205251	9444	3916	55119	646	133690	27436	23539	3091	3613	643	3988	93589	9679	57062	1605	7048	3480	6733	26520	430	100289255	708	55092	54165	83693	54039	284992	7267	9943	79884	284361	160760	164091	11214	59272	25842	79698	197407	10133	9533	4123	51097
GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_LPS_STIM_DN	M6354		16423401	Kress E,Hedges JF,Jutila MA	GSE3720	GSE3720_3350_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in gamma delta T cells stimulated by LPS: Vd1 versus Vd2.	The two major human gd T cell subsets, Vd1 and Vd2, display differences in tissue tropism and agonist responses, but we have little insight into global differences that may exist at the gene expression level. This is due to the small numbers of these cells that can be obtained from healthy donors, which limit comprehensive, comparative gene expression analyses. We established a culture method that expands Vd1 and Vd2 cells from the same PBL preparation to levels sufficient for sorting and microarray analysis. Although the subsets were expanded identically (anti-TCR mAb, plus IL-15), 392 and 614 genes were identified, which were differentially expressed in the two subsets, from two donors, respectively. Approximately 4,500 genes changed in both subsets following PMA/ionomycin treatment; about 50% of these genes were subset-specific. Both subsets responded to a crude LPS preparation, but only 6% of the responsive genes were the same. The differentially expressed genes were consistent with Vd2 cells being more inflammatory and Vd1 cells having more of a regulatory phenotype. Both subsets expressed transcripts encoding an array of innate and NK cell receptors, supporting the relationship of gd T cells to the innate immune system. Our results show that circulating Vd1 and Vd2 subsets in humans have considerable, inherent differences in gene expression following treatment with non-TCR agonists, supporting unique functional roles for these cells in vivo.					10320	10253	388611	11080	3964	26031	158234	23678	9493	23471	116496	55824	11277	63877	9088	91012	10682	10460	64225	3903	5533	9682	10577	64400	2213	81624	333929	2767	2936	6827	2014	84266	125488	1955	84124	93550	79156	255783	3925	5408	56882	55165	6574	130355	29899	25851	824	9991	23371	7855	6793	8139	90799	818	5525	8805	149951	3419	2811	84572	3695	23180	2011	9419	3004	115004	840	9143	7873	60686	10533	5954	342897	54918	9553	27245	3704	57542	89953	220002	29785	348793	63925	4012	663	4735	10225	164714	10426	5886	9442	55602	55623	53829	339669	22838	55632	3156	10906	4542	51192	2814	255252	5912	10247	4302	3074	1786	8522	27121	2256	23644	8514	1565	793	1155	283635	22928	57460	5830	3956	56910	65992	84896	2634	83903	475	8867	5681	83988	51596	51433	1794	84330	64333	2937	5496	387496	10403	4775	7832	80329	3339	1033	3174	25911	51635	9181	10015	8906	79171	2309	387521	3337	58527	3476	22879	57194	84076	2113	57118	30844	5908	92370	7414	686	23417	6821	9266	57717	134957	132720	10005	23609	84986	81691	152007	2625	4939	54478	10124	84230	3059	8682	53836	25932	9255	23175	56925	353	8045	23597	54821	8615	976	2288	6443	130813	307	79000
GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_PMA_STIM_UP	M6356		16423401	Kress E,Hedges JF,Jutila MA	GSE3720	GSE3720_3351_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in gamma delta T cells stimulated by phorbol myristate acetate and ionomycin [PubChem=4792;3733]: Vd1 versus Vd2.	The two major human gd T cell subsets, Vd1 and Vd2, display differences in tissue tropism and agonist responses, but we have little insight into global differences that may exist at the gene expression level. This is due to the small numbers of these cells that can be obtained from healthy donors, which limit comprehensive, comparative gene expression analyses. We established a culture method that expands Vd1 and Vd2 cells from the same PBL preparation to levels sufficient for sorting and microarray analysis. Although the subsets were expanded identically (anti-TCR mAb, plus IL-15), 392 and 614 genes were identified, which were differentially expressed in the two subsets, from two donors, respectively. Approximately 4,500 genes changed in both subsets following PMA/ionomycin treatment; about 50% of these genes were subset-specific. Both subsets responded to a crude LPS preparation, but only 6% of the responsive genes were the same. The differentially expressed genes were consistent with Vd2 cells being more inflammatory and Vd1 cells having more of a regulatory phenotype. Both subsets expressed transcripts encoding an array of innate and NK cell receptors, supporting the relationship of gd T cells to the innate immune system. Our results show that circulating Vd1 and Vd2 subsets in humans have considerable, inherent differences in gene expression following treatment with non-TCR agonists, supporting unique functional roles for these cells in vivo.					64857	80173	200407	23613	8546	374378	374986	6617	10613	6935	79602	284129	400624	5163	3702	1960	133308	4641	64432	2181	157657	26521	718	104	55733	55558	27101	51015	1122	27338	291	3241	147912	5128	57673	55677	23505	9882	26012	5624	9766	9641	3109	2571	79717	183	4830	157567	4621	3920	85460	10399	2956	7163	23421	54498	84081	5168	51056	8087	5971	7267	5250	55186	51495	63934	817	9823	6990	5621	23195	5599	8621	80728	9414	51315	64342	2743	11331	25842	54880	81790	55847	3988	5189	55691	65250	23423	51268	8237	4507	374654	26973	136895	8204	2275	64087	56915	26118	130367	51747	146378	348995	55651	83658	26355	1633	54870	4839	6776	253558	4953	54433	708	11127	10099	51527	55971	25992	124599	7332	254042	6856	8530	11182	7287	6117	8581	2534	140707	54541	6938	81603	23239	2194	157695	5926	83693	731220	2776	51097	23012	644815	10391	23569	54934	6397	6787	9500	340061	38	27030	4258	9203	9294	4792	6723	6789	23217	51285	3455	3615	4647	9360	79612	134526	100288695	6483	55731	57473	55332	92675	79745	6103	3596	155066	7043	2824	54039	134637	9124	10114	79961	23095	9308	8766	9846	55319	5223	25996	57620	6741	81544	55759	79143	58472	80823	6457	163590
GSE3720_UNSTIM_VS_LPS_STIM_VD1_GAMMADELTA_TCELL_UP	M6357		16423401	Kress E,Hedges JF,Jutila MA	GSE3720	GSE3720_3343_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in Vd1 gamma delta T cells: untreated versus LPS.	The two major human gd T cell subsets, Vd1 and Vd2, display differences in tissue tropism and agonist responses, but we have little insight into global differences that may exist at the gene expression level. This is due to the small numbers of these cells that can be obtained from healthy donors, which limit comprehensive, comparative gene expression analyses. We established a culture method that expands Vd1 and Vd2 cells from the same PBL preparation to levels sufficient for sorting and microarray analysis. Although the subsets were expanded identically (anti-TCR mAb, plus IL-15), 392 and 614 genes were identified, which were differentially expressed in the two subsets, from two donors, respectively. Approximately 4,500 genes changed in both subsets following PMA/ionomycin treatment; about 50% of these genes were subset-specific. Both subsets responded to a crude LPS preparation, but only 6% of the responsive genes were the same. The differentially expressed genes were consistent with Vd2 cells being more inflammatory and Vd1 cells having more of a regulatory phenotype. Both subsets expressed transcripts encoding an array of innate and NK cell receptors, supporting the relationship of gd T cells to the innate immune system. Our results show that circulating Vd1 and Vd2 subsets in humans have considerable, inherent differences in gene expression following treatment with non-TCR agonists, supporting unique functional roles for these cells in vivo.					84896	55208	27120	6574	2887	84060	53904	30009	8807	976	166979	129685	54996	10426	79794	64400	2932	1778	90007	80863	864	9535	57325	157695	90355	23344	9489	5408	9750	2313	7760	3897	143684	11161	246175	58487	55002	22878	22856	9953	256380	64218	1397	10628	51368	51160	63910	2113	1849	50484	27250	53349	55326	80004	6793	5914	159	3002	283446	63905	29103	130355	55636	51379	2011	64319	80895	83852	57217	23064	1431	65258	55683	8816	6794	54491	23075	84671	84124	55284	257068	1432	55603	221830	54847	10044	1121	202018	3482	257062	55904	51274	1176	112840	90268	402778	51280	29942	124857	2960	375035	55248	6284	57466	5912	55145	114790	54596	10209	22803	3105	10663	153657	84236	10161	11329	7268	1192	3798	10129	23095	1106	7023	4245	79576	80817	3676	79895	10585	6949	64231	8195	2817	11059	8320	29933	4242	23592	147923	7161	170690	2308	55193	169841	9969	28951	26091	727957	8396	6875	3695	1027	694	64780	309	3821	27086	57496	56063	84266	302	7376	8698	1655	883	23625	51669	23218	23092	343	23411	6738	117178	5142	7059	790955	54941	286257	10260	5525	65983	3459	170302	4853	84342	348262	78994	10459	10477	83959	4775	139285	89781	57460	222236	2060	3728	686	54206	84532
GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_DN	M6358		16423401	Kress E,Hedges JF,Jutila MA	GSE3720	GSE3720_3349_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in gamma delta T cells: Vd1 versus Vd2.	The two major human gd T cell subsets, Vd1 and Vd2, display differences in tissue tropism and agonist responses, but we have little insight into global differences that may exist at the gene expression level. This is due to the small numbers of these cells that can be obtained from healthy donors, which limit comprehensive, comparative gene expression analyses. We established a culture method that expands Vd1 and Vd2 cells from the same PBL preparation to levels sufficient for sorting and microarray analysis. Although the subsets were expanded identically (anti-TCR mAb, plus IL-15), 392 and 614 genes were identified, which were differentially expressed in the two subsets, from two donors, respectively. Approximately 4,500 genes changed in both subsets following PMA/ionomycin treatment; about 50% of these genes were subset-specific. Both subsets responded to a crude LPS preparation, but only 6% of the responsive genes were the same. The differentially expressed genes were consistent with Vd2 cells being more inflammatory and Vd1 cells having more of a regulatory phenotype. Both subsets expressed transcripts encoding an array of innate and NK cell receptors, supporting the relationship of gd T cells to the innate immune system. Our results show that circulating Vd1 and Vd2 subsets in humans have considerable, inherent differences in gene expression following treatment with non-TCR agonists, supporting unique functional roles for these cells in vivo.					1889	7415	145376	4144	85460	8851	6432	9201	55858	10460	400624	230	79609	51097	56941	136263	55651	130271	9943	10656	5450	10678	402682	64375	5781	111	10174	120103	9308	26521	5763	5496	629	112399	7781	80320	4282	153745	3281	22902	1460	7332	6810	5662	3557	131076	140803	2185	84678	5996	374467	374868	147841	2201	3091	55920	3925	55151	255877	1476	124599	55332	11126	64968	83940	64710	5997	5149	51371	51702	944	699	822	1801	9169	84986	522	57559	5015	22822	6643	84335	64172	283	50614	9249	51807	4172	3596	121053	51574	9551	4145	2944	51250	253558	80380	10844	2762	84159	57697	10631	125488	2793	10541	5209	10327	7571	5890	51310	9806	286827	10267	22818	374395	10791	7083	63948	346689	26354	1164	7434	55507	5189	10154	1241	163590	3832	1475	8019	2271	10112	3239	5168	10223	5966	28972	6288	25814	5211	64769	59286	7074	64793	2515	81606	23139	7372	113130	84248	4929	8683	3565	430	340719	8840	23462	5701	200407	29803	54742	9732	79589	23548	8600	25902	1622	10825	332	5133	23240	126820	54529	84319	7416	64087	23406	2146	718	3313	4173	131583	54331	5552	10903	255743	2043	4026	28977	5174	521	51003	6184	7398	196383	1809	6001	3937	7371	148170
GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_PMA_STIM_DN	M6360		16423401	Kress E,Hedges JF,Jutila MA	GSE3720	GSE3720_3351_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in gamma delta T cells stimulated by phorbol myristate acetate and ionomycin [PubChem=4792;3733]: Vd1 versus Vd2.	The two major human gd T cell subsets, Vd1 and Vd2, display differences in tissue tropism and agonist responses, but we have little insight into global differences that may exist at the gene expression level. This is due to the small numbers of these cells that can be obtained from healthy donors, which limit comprehensive, comparative gene expression analyses. We established a culture method that expands Vd1 and Vd2 cells from the same PBL preparation to levels sufficient for sorting and microarray analysis. Although the subsets were expanded identically (anti-TCR mAb, plus IL-15), 392 and 614 genes were identified, which were differentially expressed in the two subsets, from two donors, respectively. Approximately 4,500 genes changed in both subsets following PMA/ionomycin treatment; about 50% of these genes were subset-specific. Both subsets responded to a crude LPS preparation, but only 6% of the responsive genes were the same. The differentially expressed genes were consistent with Vd2 cells being more inflammatory and Vd1 cells having more of a regulatory phenotype. Both subsets expressed transcripts encoding an array of innate and NK cell receptors, supporting the relationship of gd T cells to the innate immune system. Our results show that circulating Vd1 and Vd2 subsets in humans have considerable, inherent differences in gene expression following treatment with non-TCR agonists, supporting unique functional roles for these cells in vivo.					54498	25851	64114	1106	64762	5890	22809	64837	51507	84264	51160	63915	25822	84286	729440	54899	6665	83851	10226	6564	3028	91272	57700	9467	26270	2760	54977	7750	55361	219	8625	7011	5939	64802	8675	79618	7764	64219	79982	346	6124	283450	55577	57030	4331	55222	312	8013	1643	9260	5498	253738	57505	23585	51222	64320	57692	23559	2119	10695	613	692227	10775	4335	22982	55810	51780	10919	4240	11176	10077	9051	1831	27129	10723	10517	285382	126917	22839	2585	83742	9960	646113	152503	151827	23423	3275	9559	56137	79736	55819	221302	55811	8805	64375	9213	154	10641	3709	83608	10916	8667	54540	2517	29850	391	84987	84787	727957	5600	83877	410	10300	5147	30	219736	23710	26994	224	54033	3398	2145	55353	149708	57708	954	222068	2571	6468	134265	3371	9586	10983	3420	3460	1891	8776	9140	55296	7553	27299	57184	143458	84836	7070	5595	3795	10927	93663	55856	83464	9325	2774	139221	5911	51230	51547	125488	11094	27433	4007	81669	65987	6901	5523	4439	10014	3338	256281	6834	57489	55041	56659	8703	4524	64210	84910	91010	1716	2184	83787	7392	10868	5526	6717	2550	54963	51027	80208	2132	125058	873	83959	64130	3155	4947	9114	8293	79934	9266
GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_UP	M6361		16423401	Kress E,Hedges JF,Jutila MA	GSE3720	GSE3720_3349_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in gamma delta T cells: Vd1 versus Vd2.	The two major human gd T cell subsets, Vd1 and Vd2, display differences in tissue tropism and agonist responses, but we have little insight into global differences that may exist at the gene expression level. This is due to the small numbers of these cells that can be obtained from healthy donors, which limit comprehensive, comparative gene expression analyses. We established a culture method that expands Vd1 and Vd2 cells from the same PBL preparation to levels sufficient for sorting and microarray analysis. Although the subsets were expanded identically (anti-TCR mAb, plus IL-15), 392 and 614 genes were identified, which were differentially expressed in the two subsets, from two donors, respectively. Approximately 4,500 genes changed in both subsets following PMA/ionomycin treatment; about 50% of these genes were subset-specific. Both subsets responded to a crude LPS preparation, but only 6% of the responsive genes were the same. The differentially expressed genes were consistent with Vd2 cells being more inflammatory and Vd1 cells having more of a regulatory phenotype. Both subsets expressed transcripts encoding an array of innate and NK cell receptors, supporting the relationship of gd T cells to the innate immune system. Our results show that circulating Vd1 and Vd2 subsets in humans have considerable, inherent differences in gene expression following treatment with non-TCR agonists, supporting unique functional roles for these cells in vivo.					7471	28987	23478	23234	57661	11068	65003	4591	79697	1503	128486	100129271	51633	5426	64097	5902	11012	26517	79833	7363	3309	4613	84549	64108	5378	57647	8815	57674	5655	7453	9156	64787	6899	27314	9031	27258	55168	3627	93664	1022	2570	56300	115004	1719	5511	11267	10978	3267	59353	63901	54888	55706	155060	3053	149461	91942	10128	10432	3329	54625	83657	4829	2194	7004	255231	6117	118881	11335	54962	28958	54505	2122	3739	2001	83857	338321	55080	4935	5456	1983	8662	340260	25907	4692	5435	10920	8501	9079	55646	152	266722	90121	150372	441161	57103	5827	4158	79053	201595	8549	441168	162427	1046	10940	55039	51307	54821	93587	81030	124626	54549	6421	23414	23432	5535	1821	4174	23670	211	4172	9992	6452	2332	55813	6691	91746	2237	55388	10664	28973	100128727	56159	10561	10302	153443	57089	10394	219927	50813	7258	887	64118	10478	10935	5464	1813	1299	26472	8528	51522	146956	4922	440093	81849	122769	8460	4830	4534	27141	5625	1188	5596	28977	54908	9184	51284	220388	54726	3141	9319	7106	11171	27246	55319	122706	7529	94121	6351	24145	166336	6346	25876	5718	6942	64710	1984	3931	4321	10500	644	25879	2740	222553	522	8518	2077	114905	5985	26802	51535
GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_3H_UP	M6398		16497887	Liu PT,Stenger S,Li H,Wenzel L,Tan BH,Krutzik SR,Ochoa MT,Schauber J,Wu K,Meinken C,Kamen DL,Wagner M,Bals R,Steinmeyer A,Zügel U,Gallo RL,Eisenberg D,Hewison M,Hollis BW,Adams JS,Bloom BR,Modlin RL	GSE8921	GSE8921_3121_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes: untreated versus M. tuberculosis 19 kDa lipopeptide (3h).	In innate immune responses, activation of Toll-like receptors (TLRs) triggers direct antimicrobial activity against intracellular bacteria, which in murine, but not human, monocytes and macrophages is mediated principally by nitric oxide. We report here that TLR activation of human macrophages up-regulated expression of the vitamin D receptor and the vitamin D-1-hydroxylase genes, leading to induction of the antimicrobial peptide cathelicidin and killing of intracellular Mycobacterium tuberculosis. We also observed that sera from African-American individuals, known to have increased susceptibility to tuberculosis, had low 25-hydroxyvitamin D and were inefficient in supporting cathelicidin messenger RNA induction. These data support a link between TLRs and vitamin D-mediated innate immunity and suggest that differences in ability of human populations to produce vitamin D may contribute to susceptibility to microbial infection. 					10847	161514	6564	5457	51399	134265	81626	153443	9586	55704	255967	348110	27343	57794	80347	10992	23536	257397	9400	29780	2517	57184	23059	51021	79869	8930	54332	29882	55471	90956	151827	2565	2262	115827	5423	6843	64762	56137	79628	51654	80774	440689	9039	100128727	2709	200845	51808	6367	171019	151525	347	64645	83479	1487	23269	146562	9411	2128	6430	22877	8533	2799	6591	343472	2743	391059	8630	3028	80310	6263	873	10393	140	162	8439	644168	22837	22899	57030	123876	54496	5922	51250	80095	9403	83876	9466	83851	7113	4922	8888	7267	9331	57118	5067	124540	120114	50856	84812	56977	83592	11144	79791	148789	401251	84629	100506540	50846	51071	636	26094	80233	79738	340069	5440	360226	158293	54584	2205	163933	79568	5062	22890	1979	116843	780	139735	50511	10300	7750	55799	9557	83594	26267	6188	317662	387804	138429	200081	5192	6879	80208	23180	375346	644353	5634	5321	948	54916	7712	140625	1536	8710	150280	140458	23600	5161	10752	160851	256536	10884	7442	4007	23155	57820	1308	118932	54848	5510	23339	3123	10245	57223	117608	23379	55869	27067	55823	63908	23148	642623	79719	54529	2157	84221	56659	65979	27115	29063	9276	388722	55361	5205	55120	79673	84967	11157	2913	8310	64221
GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_3H_DN	M6399		16497887	Liu PT,Stenger S,Li H,Wenzel L,Tan BH,Krutzik SR,Ochoa MT,Schauber J,Wu K,Meinken C,Kamen DL,Wagner M,Bals R,Steinmeyer A,Zügel U,Gallo RL,Eisenberg D,Hewison M,Hollis BW,Adams JS,Bloom BR,Modlin RL	GSE8921	GSE8921_3121_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes: untreated versus M. tuberculosis 19 kDa lipopeptide (3h).	In innate immune responses, activation of Toll-like receptors (TLRs) triggers direct antimicrobial activity against intracellular bacteria, which in murine, but not human, monocytes and macrophages is mediated principally by nitric oxide. We report here that TLR activation of human macrophages up-regulated expression of the vitamin D receptor and the vitamin D-1-hydroxylase genes, leading to induction of the antimicrobial peptide cathelicidin and killing of intracellular Mycobacterium tuberculosis. We also observed that sera from African-American individuals, known to have increased susceptibility to tuberculosis, had low 25-hydroxyvitamin D and were inefficient in supporting cathelicidin messenger RNA induction. These data support a link between TLRs and vitamin D-mediated innate immunity and suggest that differences in ability of human populations to produce vitamin D may contribute to susceptibility to microbial infection. 					283848	27161	54507	2570	253982	80216	140767	5271	10500	8900	53820	56	9805	3053	1081	55005	3674	4477	387733	83637	64121	54858	219738	5655	6337	284612	641371	745	646486	10655	4833	1310	10321	9965	51026	5629	79078	4958	2103	58524	863	89853	201305	10554	197257	4825	4897	7367	5224	10874	116535	339829	4239	83657	154790	2110	23569	79730	325	23769	85294	326340	79442	3934	55212	348303	219537	319	29767	79885	90835	645191	1896	51555	6557	23239	159296	255275	146279	2053	3359	64123	7881	152992	90102	285237	8372	114905	59285	79594	26030	1673	5506	50865	57642	2566	5313	160728	131566	3798	54814	220	55565	10920	2886	6330	541565	57731	8996	4254	5638	1384	9786	1836	338773	338321	6550	6588	5154	121275	2786	130399	146378	389084	163175	3239	2676	128272	84159	84734	85413	440590	154881	337867	64787	344657	116071	56675	7783	10090	6940	149473	64096	58190	9732	23710	390010	7139	1999	93185	2981	165100	154467	3087	25925	54549	774	4829	2243	1813	55243	5325	220136	55680	147965	23429	5624	1463	710	2740	56729	4015	123745	83881	54873	100129924	220388	482	54879	26952	26084	6323	167410	90809	80740	8468	54769	56656	2937	84935	10219	29986	51702	79663	8856	27022	55586	83896	63923
GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_6H_UP	M6403		16497887	Liu PT,Stenger S,Li H,Wenzel L,Tan BH,Krutzik SR,Ochoa MT,Schauber J,Wu K,Meinken C,Kamen DL,Wagner M,Bals R,Steinmeyer A,Zügel U,Gallo RL,Eisenberg D,Hewison M,Hollis BW,Adams JS,Bloom BR,Modlin RL	GSE8921	GSE8921_3122_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes: untreated versus M. tuberculosis 19 kDa lipopeptide (6h).	In innate immune responses, activation of Toll-like receptors (TLRs) triggers direct antimicrobial activity against intracellular bacteria, which in murine, but not human, monocytes and macrophages is mediated principally by nitric oxide. We report here that TLR activation of human macrophages up-regulated expression of the vitamin D receptor and the vitamin D-1-hydroxylase genes, leading to induction of the antimicrobial peptide cathelicidin and killing of intracellular Mycobacterium tuberculosis. We also observed that sera from African-American individuals, known to have increased susceptibility to tuberculosis, had low 25-hydroxyvitamin D and were inefficient in supporting cathelicidin messenger RNA induction. These data support a link between TLRs and vitamin D-mediated innate immunity and suggest that differences in ability of human populations to produce vitamin D may contribute to susceptibility to microbial infection. 					9656	26952	8815	130497	64949	23657	92170	56001	4899	170370	57545	9124	79675	83992	57461	30968	84954	3067	79070	4033	55273	3371	27341	2119	3514	25764	127281	155066	8697	54888	55591	5705	375	167826	2999	374291	64689	26277	3281	285521	1419	11259	7180	339123	57556	9324	8891	92196	26999	128977	3978	90273	115939	6482	57497	27249	22809	83540	6718	84869	2548	120526	55258	10797	3182	10154	51234	282969	55143	29889	10195	197322	10117	51537	440574	66002	104	10148	127700	7584	25816	4715	10799	9700	3752	56914	23423	54587	29760	4692	146956	2251	8407	79719	5212	4548	2547	10291	5435	153090	5013	23203	23543	23620	58526	57103	10461	115416	51611	196743	10856	111	57019	56655	643965	9631	55732	51501	22944	8846	10403	8106	5188	56924	9887	65059	4712	56259	151195	473	85445	6692	7545	84107	54997	338692	1238	10072	4361	246184	85294	1600	27129	51706	3329	64979	29968	5425	35	1345	5707	283985	64219	6277	126695	55173	1337	51056	5664	7288	64283	51259	388818	1441	387103	10670	271	54996	51067	1381	644	79912	55565	3037	79607	29850	2992	9169	9414	125931	219333	81617	55512	1663	8869	23170	84079	3084	84916	54998	5689	2104	57215	143888	65012	56907	51149	26521	30844	23481
GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_6H_DN	M6404		16497887	Liu PT,Stenger S,Li H,Wenzel L,Tan BH,Krutzik SR,Ochoa MT,Schauber J,Wu K,Meinken C,Kamen DL,Wagner M,Bals R,Steinmeyer A,Zügel U,Gallo RL,Eisenberg D,Hewison M,Hollis BW,Adams JS,Bloom BR,Modlin RL	GSE8921	GSE8921_3122_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes: untreated versus M. tuberculosis 19 kDa lipopeptide (6h).	In innate immune responses, activation of Toll-like receptors (TLRs) triggers direct antimicrobial activity against intracellular bacteria, which in murine, but not human, monocytes and macrophages is mediated principally by nitric oxide. We report here that TLR activation of human macrophages up-regulated expression of the vitamin D receptor and the vitamin D-1-hydroxylase genes, leading to induction of the antimicrobial peptide cathelicidin and killing of intracellular Mycobacterium tuberculosis. We also observed that sera from African-American individuals, known to have increased susceptibility to tuberculosis, had low 25-hydroxyvitamin D and were inefficient in supporting cathelicidin messenger RNA induction. These data support a link between TLRs and vitamin D-mediated innate immunity and suggest that differences in ability of human populations to produce vitamin D may contribute to susceptibility to microbial infection. 					23589	50624	10611	2760	57088	4668	5933	7903	55571	100506804	3821	10051	2237	124404	9719	23268	64207	83694	8545	692205	10068	26122	122706	203562	7363	8905	10235	55622	91	51284	55748	90441	6336	346389	54414	4091	84299	221037	9882	6772	11123	19	8722	2258	6954	65987	55093	55184	221937	11344	10561	254295	5166	23161	55856	11037	84750	163882	8635	160622	64781	57700	65009	6855	11034	84166	220388	51199	23478	11214	91526	11320	81619	6890	22841	80336	50507	648	26224	3689	377007	112937	10488	124995	3983	55742	55061	54629	5950	57491	83692	84002	11188	126147	158219	152	54413	4013	27255	25858	477	63892	64787	57231	22881	51160	9424	152815	79718	5795	8916	23205	3135	6915	23149	6553	51669	27229	54509	221302	124935	9066	3824	6446	117157	2868	80031	1521	55796	57185	2037	6095	3112	6139	10216	6760	9975	10635	400746	4258	7799	7159	51	10179	6038	8943	219972	84909	85456	285636	54879	2773	9332	80267	54625	9619	122616	63910	56904	253832	642273	441478	5141	80854	79647	7681	54676	151011	6776	374907	8707	100128927	5286	9282	9407	79899	80221	23097	79768	54331	57679	640	201725	91663	23112	23049	6764	128989	139285	284996	8434	54953	23063	9448	6376	92	84735	8703	7048	80325
GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_12H_UP	M6406		16497887	Liu PT,Stenger S,Li H,Wenzel L,Tan BH,Krutzik SR,Ochoa MT,Schauber J,Wu K,Meinken C,Kamen DL,Wagner M,Bals R,Steinmeyer A,Zügel U,Gallo RL,Eisenberg D,Hewison M,Hollis BW,Adams JS,Bloom BR,Modlin RL	GSE8921	GSE8921_3123_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes: untreated versus M. tuberculosis 19 kDa lipopeptide (12h).	In innate immune responses, activation of Toll-like receptors (TLRs) triggers direct antimicrobial activity against intracellular bacteria, which in murine, but not human, monocytes and macrophages is mediated principally by nitric oxide. We report here that TLR activation of human macrophages up-regulated expression of the vitamin D receptor and the vitamin D-1-hydroxylase genes, leading to induction of the antimicrobial peptide cathelicidin and killing of intracellular Mycobacterium tuberculosis. We also observed that sera from African-American individuals, known to have increased susceptibility to tuberculosis, had low 25-hydroxyvitamin D and were inefficient in supporting cathelicidin messenger RNA induction. These data support a link between TLRs and vitamin D-mediated innate immunity and suggest that differences in ability of human populations to produce vitamin D may contribute to susceptibility to microbial infection. 					55208	16	5256	55172	4899	4704	3556	50853	8520	5425	1062	285141	5688	10465	64149	51203	1880	29796	4701	55732	5691	8140	4436	64135	8607	6432	5202	26802	1854	55256	114987	701	79902	54505	9656	140462	112479	4763	119467	51706	81570	3164	79968	51389	3094	55835	8886	4715	80223	51096	844	267	50807	514	4669	51537	84167	55173	4836	60493	26521	8971	26469	4330	1738	79836	1017	9423	10360	200558	8187	79781	3073	23178	8208	25953	9688	9524	51127	146956	1958	9001	29097	6611	51433	10615	54148	5981	11133	7783	9111	2770	51237	9922	54675	247	25804	126792	4998	9516	54908	284403	7022	6688	10902	56135	6598	9839	90550	56672	55222	147906	55854	54496	84928	2271	80020	57134	54927	192134	6857	140767	5955	84266	201725	3832	85437	23350	9895	11051	4345	79088	79023	221895	51582	6117	29126	675	55812	51056	64963	9389	1719	5932	9319	64105	10212	2966	375757	8530	2187	1763	85477	55572	50813	10581	22995	9700	84912	27101	23609	54998	9032	348995	55553	3833	5558	5589	54438	23560	79345	3656	894	55646	135	54584	2108	80067	11339	6692	729967	23380	2050	51256	56943	51530	2119	79915	1299	4291	6746	10026	7809	8624	55388	55064	10038	908
GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_12H_DN	M6408		16497887	Liu PT,Stenger S,Li H,Wenzel L,Tan BH,Krutzik SR,Ochoa MT,Schauber J,Wu K,Meinken C,Kamen DL,Wagner M,Bals R,Steinmeyer A,Zügel U,Gallo RL,Eisenberg D,Hewison M,Hollis BW,Adams JS,Bloom BR,Modlin RL	GSE8921	GSE8921_3123_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes: untreated versus M. tuberculosis 19 kDa lipopeptide (12h).	In innate immune responses, activation of Toll-like receptors (TLRs) triggers direct antimicrobial activity against intracellular bacteria, which in murine, but not human, monocytes and macrophages is mediated principally by nitric oxide. We report here that TLR activation of human macrophages up-regulated expression of the vitamin D receptor and the vitamin D-1-hydroxylase genes, leading to induction of the antimicrobial peptide cathelicidin and killing of intracellular Mycobacterium tuberculosis. We also observed that sera from African-American individuals, known to have increased susceptibility to tuberculosis, had low 25-hydroxyvitamin D and were inefficient in supporting cathelicidin messenger RNA induction. These data support a link between TLRs and vitamin D-mediated innate immunity and suggest that differences in ability of human populations to produce vitamin D may contribute to susceptibility to microbial infection. 					5335	8904	84301	79155	163033	9236	643	54891	8706	51334	51547	2037	57109	51701	3695	534	55729	81669	1454	7020	79991	1312	10927	3381	11183	83741	440603	30	529	260425	26122	9575	780	54453	10175	286467	5660	113235	409	23166	7409	55914	83716	9535	51136	222236	126961	6533	3824	65005	55861	8877	140612	51231	7342	5463	92400	7251	197358	27240	55650	56913	91404	4340	831	6659	64784	9938	55850	7102	23190	115701	23220	23366	143686	10123	145942	440193	3918	55529	83902	5893	29070	122786	79899	55084	26149	9584	219972	2647	79770	5152	537	56650	254013	79969	23582	9445	54838	28984	55351	58476	347733	2550	64207	5641	9489	9448	51669	90809	80031	57102	85444	8943	11276	706	26033	81631	9590	847	10114	54822	170384	6548	51225	80149	10521	3689	246	57472	23149	6497	7048	80148	158293	942	51720	346673	57620	1585	91662	7533	5775	83699	22904	23155	153222	54414	7076	434	28959	389206	9991	5501	388228	222166	57498	957	59067	2907	152519	2665	64969	349667	5045	79612	79443	254048	11309	54757	51747	80700	133746	79803	51280	2280	64718	2800	55450	51265	23710	10608	147929	8924	10682	6595	50809	9037	219899	8455	84649	6549	80765	406	51317	64083	4013	9051	7462	148753
GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_24H_UP	M6410		16497887	Liu PT,Stenger S,Li H,Wenzel L,Tan BH,Krutzik SR,Ochoa MT,Schauber J,Wu K,Meinken C,Kamen DL,Wagner M,Bals R,Steinmeyer A,Zügel U,Gallo RL,Eisenberg D,Hewison M,Hollis BW,Adams JS,Bloom BR,Modlin RL	GSE8921	GSE8921_3124_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes: untreated versus M. tuberculosis 19 kDa lipopeptide (24h).	In innate immune responses, activation of Toll-like receptors (TLRs) triggers direct antimicrobial activity against intracellular bacteria, which in murine, but not human, monocytes and macrophages is mediated principally by nitric oxide. We report here that TLR activation of human macrophages up-regulated expression of the vitamin D receptor and the vitamin D-1-hydroxylase genes, leading to induction of the antimicrobial peptide cathelicidin and killing of intracellular Mycobacterium tuberculosis. We also observed that sera from African-American individuals, known to have increased susceptibility to tuberculosis, had low 25-hydroxyvitamin D and were inefficient in supporting cathelicidin messenger RNA induction. These data support a link between TLRs and vitamin D-mediated innate immunity and suggest that differences in ability of human populations to produce vitamin D may contribute to susceptibility to microbial infection. 					343450	157869	3200	27123	8529	51129	26230	55651	129049	5145	29087	29930	63877	10368	94031	64377	2070	10979	388564	6594	84844	388815	339416	10465	84319	347731	7058	1960	284615	1268	55319	158297	54831	57088	51690	3394	7363	4071	9390	55323	84281	5763	79691	7347	170825	8534	146050	2079	1902	976	115908	11167	51574	26519	151871	266655	6451	7516	23460	9768	8600	79605	80000	114571	339448	1356	222545	79849	1103	55799	79019	23654	27115	2982	400954	54969	7366	85477	55969	11267	23314	114299	23621	338917	4129	130540	285025	389941	83894	11141	729665	378708	26520	146850	386618	27339	123688	9271	79002	56977	8531	25790	6372	442213	7078	4037	6263	8448	124773	337879	91862	8562	22914	79608	23543	10766	83902	2565	2653	29083	23349	3680	65122	6886	1627	7373	64976	4760	5688	577	1746	51126	80014	57663	167410	54538	6346	644168	51604	999	1277	140456	5125	10253	162333	4317	10436	5806	9229	153643	112849	150465	221143	143471	5378	84217	151	56271	5650	2624	5129	1070	7172	3224	29095	56603	8407	9627	6182	10954	2137	170689	83597	23359	56123	6678	9068	23001	256710	6754	379	54829	5596	3036	11126	54534	1805	63027	83992	619279	221662	399948	6758	730130	55765	1301	5781	10584	56163
GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_24H_DN	M6411		16497887	Liu PT,Stenger S,Li H,Wenzel L,Tan BH,Krutzik SR,Ochoa MT,Schauber J,Wu K,Meinken C,Kamen DL,Wagner M,Bals R,Steinmeyer A,Zügel U,Gallo RL,Eisenberg D,Hewison M,Hollis BW,Adams JS,Bloom BR,Modlin RL	GSE8921	GSE8921_3124_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes: untreated versus M. tuberculosis 19 kDa lipopeptide (24h).	In innate immune responses, activation of Toll-like receptors (TLRs) triggers direct antimicrobial activity against intracellular bacteria, which in murine, but not human, monocytes and macrophages is mediated principally by nitric oxide. We report here that TLR activation of human macrophages up-regulated expression of the vitamin D receptor and the vitamin D-1-hydroxylase genes, leading to induction of the antimicrobial peptide cathelicidin and killing of intracellular Mycobacterium tuberculosis. We also observed that sera from African-American individuals, known to have increased susceptibility to tuberculosis, had low 25-hydroxyvitamin D and were inefficient in supporting cathelicidin messenger RNA induction. These data support a link between TLRs and vitamin D-mediated innate immunity and suggest that differences in ability of human populations to produce vitamin D may contribute to susceptibility to microbial infection. 					10390	4214	3646	54470	6236	2517	65249	4342	6617	1106	163033	64219	23526	6596	23582	406	256329	84060	1893	6747	11240	164832	3710	22906	22818	28959	366	23557	81671	905	51393	57396	54923	55204	8832	2185	55355	8013	26019	55500	220064	116985	10048	2760	23389	254122	163882	25816	57018	11082	64764	54469	114770	123355	100505741	83999	26269	84636	9114	51702	2531	84173	55636	51177	4864	81794	55727	8767	4321	128637	26258	10181	5223	253260	55788	51	4077	11234	23645	4926	54540	57504	5176	1643	2110	4780	26160	115330	3487	116068	55374	2886	26260	7852	93273	25839	1234	6125	58528	79637	51400	7850	29094	126432	5871	202018	53944	25865	10577	3732	10466	26747	7048	2029	4947	80331	55015	84925	6813	8027	80757	63917	4647	10363	80344	950	51566	9051	219	1290	54507	148523	200312	11052	22980	10875	2800	10765	8925	10207	64419	2120	10928	2072	64359	339287	197257	22904	57544	8744	4026	51616	160897	23152	5498	11201	5782	8408	8031	1510	3656	57496	81558	56900	116064	59307	83787	23451	51251	203328	9021	26094	26122	79934	3142	7562	124460	23368	57707	7405	9737	5595	2805	5786	27241	3064	64210	54536	5893	344595	54901	6403	3304	64718	10495	4482	4703	27106	9697	6711
GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_3H_UP	M6412		16497887	Liu PT,Stenger S,Li H,Wenzel L,Tan BH,Krutzik SR,Ochoa MT,Schauber J,Wu K,Meinken C,Kamen DL,Wagner M,Bals R,Steinmeyer A,Zügel U,Gallo RL,Eisenberg D,Hewison M,Hollis BW,Adams JS,Bloom BR,Modlin RL	GSE8921	GSE8921_3125_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes (3h): untreated versus M. tuberculosis 19 kDa lipopeptide.	In innate immune responses, activation of Toll-like receptors (TLRs) triggers direct antimicrobial activity against intracellular bacteria, which in murine, but not human, monocytes and macrophages is mediated principally by nitric oxide. We report here that TLR activation of human macrophages up-regulated expression of the vitamin D receptor and the vitamin D-1-hydroxylase genes, leading to induction of the antimicrobial peptide cathelicidin and killing of intracellular Mycobacterium tuberculosis. We also observed that sera from African-American individuals, known to have increased susceptibility to tuberculosis, had low 25-hydroxyvitamin D and were inefficient in supporting cathelicidin messenger RNA induction. These data support a link between TLRs and vitamin D-mediated innate immunity and suggest that differences in ability of human populations to produce vitamin D may contribute to susceptibility to microbial infection. 					23077	8328	79441	4298	2733	56941	10635	55177	10713	29108	26521	6553	153443	348995	400916	9184	8659	10581	1719	94121	2052	54148	6418	389421	1854	51006	441161	84946	11266	9663	8987	55646	51752	151295	387882	29985	976	220988	8208	64135	7529	3963	25788	1841	64105	10964	1062	79781	10396	3290	4884	9971	54987	1188	3048	1041	8913	83852	54187	9111	3182	4814	150962	51237	119467	5179	8506	5250	84440	29097	642273	124599	9882	10950	283643	4643	26057	11174	57458	150468	11169	648	477	284086	219285	221154	9631	85477	57107	81892	7484	51491	51386	79833	11004	9839	83694	92749	64151	2001	3791	7444	8513	79161	51750	55254	55505	23640	79968	23204	284194	91526	10225	60436	200403	79902	114984	51056	594	780789	8668	51537	152330	22885	9328	51256	8743	11339	79645	10690	9918	3458	10686	23024	60493	23279	339965	135152	10360	8438	85437	166614	6781	117177	392399	10128	255189	54606	29015	54821	9833	338557	56655	3612	389075	81691	8453	3065	401097	26009	23468	1786	22894	64097	27198	4154	63901	894	2027	404550	5150	7083	991	4534	5931	266722	4751	84239	3833	112483	8318	9401	51004	3070	3628	54969	4635	4978	146547	8501	160622	100128160	63877	317781	374291	6598	155465	79668
GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_3H_DN	M6414		16497887	Liu PT,Stenger S,Li H,Wenzel L,Tan BH,Krutzik SR,Ochoa MT,Schauber J,Wu K,Meinken C,Kamen DL,Wagner M,Bals R,Steinmeyer A,Zügel U,Gallo RL,Eisenberg D,Hewison M,Hollis BW,Adams JS,Bloom BR,Modlin RL	GSE8921	GSE8921_3125_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes (3h): untreated versus M. tuberculosis 19 kDa lipopeptide.	In innate immune responses, activation of Toll-like receptors (TLRs) triggers direct antimicrobial activity against intracellular bacteria, which in murine, but not human, monocytes and macrophages is mediated principally by nitric oxide. We report here that TLR activation of human macrophages up-regulated expression of the vitamin D receptor and the vitamin D-1-hydroxylase genes, leading to induction of the antimicrobial peptide cathelicidin and killing of intracellular Mycobacterium tuberculosis. We also observed that sera from African-American individuals, known to have increased susceptibility to tuberculosis, had low 25-hydroxyvitamin D and were inefficient in supporting cathelicidin messenger RNA induction. These data support a link between TLRs and vitamin D-mediated innate immunity and suggest that differences in ability of human populations to produce vitamin D may contribute to susceptibility to microbial infection. 					28987	57821	163033	23526	5621	3695	100131755	10123	5335	64859	4668	64784	11344	3566	5223	9590	200407	79612	5310	307	51	79991	57109	9258	121536	118426	8417	2316	3423	11276	7511	64207	22834	10809	9759	100093630	440603	3916	57446	81619	60386	7074	3594	79817	29880	91775	55632	126432	51255	3705	9575	8802	11015	79647	25824	286256	254359	56245	100506144	84301	116985	28959	1528	340152	53343	81029	55321	65250	22904	54938	166379	55727	55251	11127	222236	440193	170463	7043	29957	25851	55748	8509	222826	4601	147929	6717	3491	23376	27075	10174	90196	9852	51225	26277	26019	51720	9404	5045	55102	25822	9798	230	257160	9750	2550	51257	6548	1435	115701	84879	5601	90780	23351	83986	529	51335	727957	79603	81669	389	56980	80347	84419	79071	6050	8760	649	27291	55198	197257	400746	9873	151556	9325	10552	11060	65059	9788	51547	3725	10788	115939	5371	35	435	7319	112752	780	8718	245972	205428	26033	92	5331	3300	29945	51005	10899	55501	7535	5834	79155	5600	8943	8932	51280	23205	145553	22931	84612	80031	124997	334	7462	10014	3487	5939	5595	54507	51160	25970	54545	54467	10630	5994	157769	66002	26994	5294	5209	6522	8496	3028	84102	64219	11041	51510	4773	255394	6201
GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_6H_UP	M6415		16497887	Liu PT,Stenger S,Li H,Wenzel L,Tan BH,Krutzik SR,Ochoa MT,Schauber J,Wu K,Meinken C,Kamen DL,Wagner M,Bals R,Steinmeyer A,Zügel U,Gallo RL,Eisenberg D,Hewison M,Hollis BW,Adams JS,Bloom BR,Modlin RL	GSE8921	GSE8921_3126_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes (6h): untreated versus M. tuberculosis 19 kDa lipopeptide.	In innate immune responses, activation of Toll-like receptors (TLRs) triggers direct antimicrobial activity against intracellular bacteria, which in murine, but not human, monocytes and macrophages is mediated principally by nitric oxide. We report here that TLR activation of human macrophages up-regulated expression of the vitamin D receptor and the vitamin D-1-hydroxylase genes, leading to induction of the antimicrobial peptide cathelicidin and killing of intracellular Mycobacterium tuberculosis. We also observed that sera from African-American individuals, known to have increased susceptibility to tuberculosis, had low 25-hydroxyvitamin D and were inefficient in supporting cathelicidin messenger RNA induction. These data support a link between TLRs and vitamin D-mediated innate immunity and suggest that differences in ability of human populations to produce vitamin D may contribute to susceptibility to microbial infection. 					87	7248	203562	9180	2147	7433	120103	432	10153	54623	2982	6150	3190	9429	66000	5325	65986	30833	221711	2646	128229	202243	8445	2052	4947	79711	1454	126	10447	5747	23169	26523	6519	1605	23171	23086	7181	114883	130576	217	51335	4023	596	9831	10051	22921	27030	80055	26512	137835	79001	25851	54980	34	25907	25864	10643	64420	51170	7157	7753	28951	2012	3892	10404	6804	81833	753	8723	9481	9370	55729	339976	57447	221336	10765	59269	9266	2135	81573	10209	79960	23201	254531	2150	116372	200916	80228	90025	54881	3643	9806	114836	1791	390243	57337	1360	940	5571	85453	78990	26119	7155	26224	23428	253558	149041	23325	201595	2686	55727	9258	50852	128486	55103	10106	9967	283385	85464	23064	1106	11112	57665	51669	6595	25865	5293	8848	9452	23475	220107	9640	8725	28987	64219	3575	122258	81577	57466	400673	10614	84107	1565	23001	58500	23313	203054	10252	92002	4121	539	1901	8631	283629	27241	3480	6304	8543	1389	221687	11069	154043	55217	59277	57646	245972	9973	5033	5625	54664	2752	55798	399	92196	9124	286336	673	23588	10370	7570	83690	483	113201	57561	9826	122786	84152	89846	55283	151295	11228	79144	10621	9099	390598	93589	79892	11080	113791	55061
GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_6H_DN	M6417		16497887	Liu PT,Stenger S,Li H,Wenzel L,Tan BH,Krutzik SR,Ochoa MT,Schauber J,Wu K,Meinken C,Kamen DL,Wagner M,Bals R,Steinmeyer A,Zügel U,Gallo RL,Eisenberg D,Hewison M,Hollis BW,Adams JS,Bloom BR,Modlin RL	GSE8921	GSE8921_3126_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes (6h): untreated versus M. tuberculosis 19 kDa lipopeptide.	In innate immune responses, activation of Toll-like receptors (TLRs) triggers direct antimicrobial activity against intracellular bacteria, which in murine, but not human, monocytes and macrophages is mediated principally by nitric oxide. We report here that TLR activation of human macrophages up-regulated expression of the vitamin D receptor and the vitamin D-1-hydroxylase genes, leading to induction of the antimicrobial peptide cathelicidin and killing of intracellular Mycobacterium tuberculosis. We also observed that sera from African-American individuals, known to have increased susceptibility to tuberculosis, had low 25-hydroxyvitamin D and were inefficient in supporting cathelicidin messenger RNA induction. These data support a link between TLRs and vitamin D-mediated innate immunity and suggest that differences in ability of human populations to produce vitamin D may contribute to susceptibility to microbial infection. 					10295	785	333926	51703	55700	2678	54502	6101	10219	4664	51012	8634	10066	64946	157869	23743	4606	387521	81624	57562	55824	60386	57402	84930	3594	23586	10635	219537	9825	7468	26027	10148	9755	3458	6119	7332	3627	604	11240	55647	51538	83959	6900	83666	5868	220441	154091	9451	221154	58493	286676	168417	10791	80347	5889	6658	80162	85027	6997	11145	84833	5783	164312	9851	11126	7335	1026	151246	1286	1495	2922	3918	114770	10602	389136	4088	1263	1234	221002	55289	3161	6892	64859	733	1540	83540	1622	5081	9055	63901	10982	133	7913	1020	91612	923	255743	134728	84282	8277	728464	23670	91057	64064	6653	22920	84080	221150	8111	7083	146956	629	9424	9696	64359	10634	6468	5939	1737	158405	5333	9787	5933	10188	8448	25906	23424	51297	255798	5393	3695	2641	699	8099	347404	220134	1000	5133	22856	9915	23052	84572	7486	55328	4323	2769	54187	54795	3069	3838	7920	91373	8809	10007	51372	388364	1659	3821	5243	84419	197259	79927	3597	146712	3070	100505876	1798	84296	10227	280636	4172	729533	1164	148223	90355	9738	145264	6240	64114	283638	283174	333	30009	9334	7841	54998	101	5932	90417	1145	93129	4860	2643	2745	55110	23138	11075	29775	158798	2268
GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_12H_UP	M6418		16497887	Liu PT,Stenger S,Li H,Wenzel L,Tan BH,Krutzik SR,Ochoa MT,Schauber J,Wu K,Meinken C,Kamen DL,Wagner M,Bals R,Steinmeyer A,Zügel U,Gallo RL,Eisenberg D,Hewison M,Hollis BW,Adams JS,Bloom BR,Modlin RL	GSE8921	GSE8921_3127_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes (12h): untreated versus M. tuberculosis 19 kDa lipopeptide.	In innate immune responses, activation of Toll-like receptors (TLRs) triggers direct antimicrobial activity against intracellular bacteria, which in murine, but not human, monocytes and macrophages is mediated principally by nitric oxide. We report here that TLR activation of human macrophages up-regulated expression of the vitamin D receptor and the vitamin D-1-hydroxylase genes, leading to induction of the antimicrobial peptide cathelicidin and killing of intracellular Mycobacterium tuberculosis. We also observed that sera from African-American individuals, known to have increased susceptibility to tuberculosis, had low 25-hydroxyvitamin D and were inefficient in supporting cathelicidin messenger RNA induction. These data support a link between TLRs and vitamin D-mediated innate immunity and suggest that differences in ability of human populations to produce vitamin D may contribute to susceptibility to microbial infection. 					57412	84141	50865	9652	55088	23635	1052	6303	79143	285382	26574	21	29765	374659	130507	2739	9500	10477	196740	84948	678	6272	3554	9732	4321	162989	2149	2203	57333	54741	2217	2181	56998	1602	6203	9270	5325	8764	55589	6448	9890	57642	8800	8992	23386	5286	7373	5768	6520	57613	200845	7941	9885	55681	440603	10418	8907	2483	10179	57579	4125	3680	6622	2519	60490	55374	84916	728	7057	93185	83871	3636	8270	2643	9497	145173	6619	25976	23032	145853	79961	6049	2745	4094	90843	222236	100	129852	91694	56942	60592	55825	9153	3455	55157	258010	25980	5294	81888	256302	91012	23582	6369	57475	192683	79777	79698	6993	255758	126133	84696	84275	9759	85438	84066	4035	140901	54602	8999	7165	2940	2302	25827	114609	4689	109	150771	92106	83696	23042	55361	11123	26011	79689	64096	92610	2852	5029	23268	727910	5298	54814	140545	657	55069	1848	55128	23530	23122	134353	155066	79726	10396	4082	57561	285195	2621	23274	79873	254359	7594	10186	1769	5358	2937	8821	150465	5292	64398	5264	8714	26001	5058	9056	282969	51335	11328	54585	10333	79602	11044	57205	8985	23041	123606	2038	4191	23483	10369	80169	23708	8508	23161	84941	8796	7368	2752	9034	7037	1955
GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_12H_DN	M6419		16497887	Liu PT,Stenger S,Li H,Wenzel L,Tan BH,Krutzik SR,Ochoa MT,Schauber J,Wu K,Meinken C,Kamen DL,Wagner M,Bals R,Steinmeyer A,Zügel U,Gallo RL,Eisenberg D,Hewison M,Hollis BW,Adams JS,Bloom BR,Modlin RL	GSE8921	GSE8921_3127_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes (12h): untreated versus M. tuberculosis 19 kDa lipopeptide.	In innate immune responses, activation of Toll-like receptors (TLRs) triggers direct antimicrobial activity against intracellular bacteria, which in murine, but not human, monocytes and macrophages is mediated principally by nitric oxide. We report here that TLR activation of human macrophages up-regulated expression of the vitamin D receptor and the vitamin D-1-hydroxylase genes, leading to induction of the antimicrobial peptide cathelicidin and killing of intracellular Mycobacterium tuberculosis. We also observed that sera from African-American individuals, known to have increased susceptibility to tuberculosis, had low 25-hydroxyvitamin D and were inefficient in supporting cathelicidin messenger RNA induction. These data support a link between TLRs and vitamin D-mediated innate immunity and suggest that differences in ability of human populations to produce vitamin D may contribute to susceptibility to microbial infection. 					284106	116039	50615	25875	4064	1760	30	121551	51692	79171	154007	344	4363	7515	114908	55111	7293	124641	57514	9053	6154	4046	8412	23612	6829	6208	4780	149603	151888	116832	285267	6367	339390	57480	9414	7469	57128	948	3146	3035	2171	55686	51304	84524	55471	10952	5580	51079	2892	826	8091	5932	340351	89790	55796	30818	6890	9060	23397	6692	7268	55246	26225	56925	392636	11224	11331	8440	784	84002	5027	6770	7375	51691	54940	23244	6597	4172	2308	23269	9334	3290	11169	7052	55729	23075	6541	79993	2798	6885	8835	25804	2117	3159	84864	60485	8661	25819	55125	5108	203259	57148	56204	51091	151195	306	23151	10884	10806	29911	51167	1903	595	56975	5424	140823	7011	144811	56548	55316	55573	133	54820	3563	57474	283	51266	3628	91	388730	930	1665	4238	57211	7879	340152	211	66000	79029	4864	57460	54492	79612	63901	65080	7862	641638	10392	80254	84166	6775	25816	126382	7128	54869	27152	9040	6464	993	6542	80124	100188893	84311	55620	3921	65018	8317	4710	2936	64326	79094	401409	10949	3326	92014	640	54892	5209	11240	64005	55671	7086	5217	84959	1266	375748	3106	124512	4281	55201	208	27436	4059	55646	5547	9256	7760	23613	51669	195827
GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_24H_UP	M6420		16497887	Liu PT,Stenger S,Li H,Wenzel L,Tan BH,Krutzik SR,Ochoa MT,Schauber J,Wu K,Meinken C,Kamen DL,Wagner M,Bals R,Steinmeyer A,Zügel U,Gallo RL,Eisenberg D,Hewison M,Hollis BW,Adams JS,Bloom BR,Modlin RL	GSE8921	GSE8921_3128_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes (24h): untreated versus M. tuberculosis 19 kDa lipopeptide.	In innate immune responses, activation of Toll-like receptors (TLRs) triggers direct antimicrobial activity against intracellular bacteria, which in murine, but not human, monocytes and macrophages is mediated principally by nitric oxide. We report here that TLR activation of human macrophages up-regulated expression of the vitamin D receptor and the vitamin D-1-hydroxylase genes, leading to induction of the antimicrobial peptide cathelicidin and killing of intracellular Mycobacterium tuberculosis. We also observed that sera from African-American individuals, known to have increased susceptibility to tuberculosis, had low 25-hydroxyvitamin D and were inefficient in supporting cathelicidin messenger RNA induction. These data support a link between TLRs and vitamin D-mediated innate immunity and suggest that differences in ability of human populations to produce vitamin D may contribute to susceptibility to microbial infection. 					284161	10435	5058	56907	3384	7456	57786	4040	63027	2119	366	205428	9663	9665	2889	3821	9652	137994	57211	3683	167227	55140	57205	55787	100131496	200845	113402	3055	114825	157378	27306	5788	940	51306	4205	23158	117289	27071	645	7410	11328	94274	1796	3507	905	51380	84824	140606	26235	10207	7325	11274	10497	5634	55780	22807	89846	8942	6141	4660	54948	81786	27086	26279	7994	10267	5721	10000	3189	973	143888	5971	5599	22821	2533	90957	5740	27314	29979	53616	2966	4211	8555	6917	256302	57458	5468	55103	9636	8611	118788	4217	203260	6489	57645	1501	2776	3712	2824	100302692	2124	56965	9332	51232	9883	60370	51466	10147	347733	23136	8495	81873	643	127281	2526	57666	155038	51441	643549	3479	85480	3141	80321	713	942	345611	6263	8607	388701	114770	5931	5463	567	29904	7050	1521	151636	3600	339983	51379	9100	1716	5910	59342	23175	151903	1879	3553	3568	9569	79443	1917	79874	4610	55905	1380	10610	8706	170575	285315	8237	8536	6319	10803	25780	115350	4077	6139	2634	55500	55005	375790	3669	6430	712	5996	23150	3514	285267	79956	7373	401409	196740	55576	10363	388228	340348	9308	924	10544	1236	1235	10203	55331	8804	64087	388722	4253	10379	56922
GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_24H_DN	M6421		16497887	Liu PT,Stenger S,Li H,Wenzel L,Tan BH,Krutzik SR,Ochoa MT,Schauber J,Wu K,Meinken C,Kamen DL,Wagner M,Bals R,Steinmeyer A,Zügel U,Gallo RL,Eisenberg D,Hewison M,Hollis BW,Adams JS,Bloom BR,Modlin RL	GSE8921	GSE8921_3128_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes (24h): untreated versus M. tuberculosis 19 kDa lipopeptide.	In innate immune responses, activation of Toll-like receptors (TLRs) triggers direct antimicrobial activity against intracellular bacteria, which in murine, but not human, monocytes and macrophages is mediated principally by nitric oxide. We report here that TLR activation of human macrophages up-regulated expression of the vitamin D receptor and the vitamin D-1-hydroxylase genes, leading to induction of the antimicrobial peptide cathelicidin and killing of intracellular Mycobacterium tuberculosis. We also observed that sera from African-American individuals, known to have increased susceptibility to tuberculosis, had low 25-hydroxyvitamin D and were inefficient in supporting cathelicidin messenger RNA induction. These data support a link between TLRs and vitamin D-mediated innate immunity and suggest that differences in ability of human populations to produce vitamin D may contribute to susceptibility to microbial infection. 					57156	84910	129285	64410	51092	5119	79581	6861	10005	2281	2628	10898	27183	818	11228	51478	51645	84317	84514	132720	8693	79004	8870	54758	80128	726	56925	148738	8078	112939	3566	4353	10406	6369	23603	26996	645832	4548	353	54492	51090	22808	8892	22797	1173	9360	81621	10540	1737	4670	84191	64708	51599	56834	3159	9046	196500	8216	386746	144455	57419	22918	55276	2580	6696	51005	9641	3939	7867	10554	2023	25796	762	1612	219	23181	114804	3065	1026	10217	5160	4597	392307	10268	56606	5657	84292	57559	117166	3601	5066	6510	9601	284382	55194	55785	6037	29785	29780	55858	29890	84034	9546	116969	6401	80019	1163	51187	29934	8513	54961	57698	6416	23250	60481	10213	5329	3678	8754	706	256949	123	7922	25802	146722	339123	81502	1487	197370	9848	206358	285590	79840	11261	8852	197187	55388	5739	10078	64849	317	80142	65123	10501	4150	8266	23324	93210	1515	8854	9099	140461	5211	57380	8514	2319	25998	94031	84557	56975	25957	6711	476	1175	51008	124801	2213	4714	10970	8590	9306	4097	136	3977	92703	5223	9771	341567	2990	27230	90459	10083	80317	4713	5534	9797	84893	11231	54472	1234	118881	8546	22933	1072	2059	29967	51400	51071	89866	51026
GSE8921_3H_VS_24H_TLR1_2_STIM_MONOCYTE_UP	M6424		16497887	Liu PT,Stenger S,Li H,Wenzel L,Tan BH,Krutzik SR,Ochoa MT,Schauber J,Wu K,Meinken C,Kamen DL,Wagner M,Bals R,Steinmeyer A,Zügel U,Gallo RL,Eisenberg D,Hewison M,Hollis BW,Adams JS,Bloom BR,Modlin RL	GSE8921	GSE8921_3129_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes in response to M. tuberculosis 19 kDa lipopeptide: 3h versus 24h.	In innate immune responses, activation of Toll-like receptors (TLRs) triggers direct antimicrobial activity against intracellular bacteria, which in murine, but not human, monocytes and macrophages is mediated principally by nitric oxide. We report here that TLR activation of human macrophages up-regulated expression of the vitamin D receptor and the vitamin D-1-hydroxylase genes, leading to induction of the antimicrobial peptide cathelicidin and killing of intracellular Mycobacterium tuberculosis. We also observed that sera from African-American individuals, known to have increased susceptibility to tuberculosis, had low 25-hydroxyvitamin D and were inefficient in supporting cathelicidin messenger RNA induction. These data support a link between TLRs and vitamin D-mediated innate immunity and suggest that differences in ability of human populations to produce vitamin D may contribute to susceptibility to microbial infection. 					940	84141	10152	60592	8853	79874	1434	1107	5813	84668	57645	23475	205428	5740	650	55156	159013	254170	150368	9107	55704	8340	5906	4090	57037	2768	2033	79871	29015	1327	337867	9920	80143	9185	25932	3572	3821	63027	23158	7019	57182	79664	283897	51703	8821	27042	3712	8611	2889	10000	81618	11212	29100	3384	7188	54997	10243	2475	10892	114770	53616	60558	256586	22876	4660	9742	1265	100131496	5422	112869	22887	54520	83943	282969	1521	23583	1457	958	51327	22845	2595	9824	6002	5218	9878	56061	22794	4057	10207	3633	58526	92610	55959	48	79641	3135	389337	27010	147686	10106	2124	11215	84541	7414	6188	2060	4610	10943	2793	81558	5055	220002	23300	10161	388403	10216	51466	3708	57458	84986	83447	200576	27069	955	8685	23569	924	10062	5599	200845	64766	118788	9497	11168	81873	5245	7368	11328	124599	962	7700	56940	79656	7772	64324	81786	6845	8907	55171	100302692	130733	4211	27306	83692	10743	22937	339287	4261	494143	257106	6135	9334	5567	10664	27335	10855	388722	4651	6515	353274	57468	51013	79001	6483	790955	6249	9194	23157	65263	25917	10390	6932	10935	8764	1788	23678	21	4038	6596	22875	912	4204	2219	23264	5954	55163	780	9847	8291	84824
GSE8921_3H_VS_24H_TLR1_2_STIM_MONOCYTE_DN	M6425		16497887	Liu PT,Stenger S,Li H,Wenzel L,Tan BH,Krutzik SR,Ochoa MT,Schauber J,Wu K,Meinken C,Kamen DL,Wagner M,Bals R,Steinmeyer A,Zügel U,Gallo RL,Eisenberg D,Hewison M,Hollis BW,Adams JS,Bloom BR,Modlin RL	GSE8921	GSE8921_3129_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes in response to M. tuberculosis 19 kDa lipopeptide: 3h versus 24h.	In innate immune responses, activation of Toll-like receptors (TLRs) triggers direct antimicrobial activity against intracellular bacteria, which in murine, but not human, monocytes and macrophages is mediated principally by nitric oxide. We report here that TLR activation of human macrophages up-regulated expression of the vitamin D receptor and the vitamin D-1-hydroxylase genes, leading to induction of the antimicrobial peptide cathelicidin and killing of intracellular Mycobacterium tuberculosis. We also observed that sera from African-American individuals, known to have increased susceptibility to tuberculosis, had low 25-hydroxyvitamin D and were inefficient in supporting cathelicidin messenger RNA induction. These data support a link between TLRs and vitamin D-mediated innate immunity and suggest that differences in ability of human populations to produce vitamin D may contribute to susceptibility to microbial infection. 					28969	1874	55785	1846	55658	230	84292	5078	6277	8140	5066	2258	1823	377677	5203	84525	7159	8717	1503	16	11165	10975	25824	10726	79983	3956	51621	51726	55793	30851	6636	9797	54456	26472	84173	10970	54964	79778	4925	84900	51012	389541	9415	23650	4282	4097	54531	3604	79171	892	138199	6288	8932	55075	353	51569	8694	7130	84905	51124	3782	7128	259217	54838	128239	85300	396	51296	2151	10562	29071	51086	4201	64215	26133	338442	9092	84919	55084	164395	117584	25805	7204	10776	10015	4792	1906	2147	5603	2358	56834	28985	23764	55275	389333	51646	199675	4163	285590	9267	60313	390212	2997	389206	4084	11060	10693	5187	57514	2582	54209	10467	8609	2152	3964	51645	29108	10253	5605	5328	84191	131377	9550	8301	118424	220388	10406	64410	55374	55636	3958	3159	3601	51599	3569	9770	29890	8553	359948	83985	10409	57761	94031	26206	3755	54874	9427	7262	123	57452	7378	57497	80133	23007	2962	1964	2821	2584	79080	440957	6692	648791	79180	83442	2294	10309	91689	9218	5802	51248	284119	25796	10540	5709	3939	6513	222255	27166	1021	9200	81628	64218	115330	9520	8835	1439	26121	22949	6281	9589	222487	10863	84557	1515	57533	79670	1014	285782	284904
GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP	M6477		16717116	Macagno A,Molteni M,Rinaldi A,Bertoni F,Lanzavecchia A,Rossetti C,Sallusto F	GSE4748	GSE4748_3382_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocyte-derived dendritic cells: untreated versus LPS like antigen from O. planktothrix (3h).	A cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression. We report the identification and biologic characterization of an LPS-like molecule extracted from the cyanobacterium Oscillatoria Planktothrix FP1 (CyP).					27071	6843	5579	341	80709	23112	84458	51379	6039	3067	867	2651	1112	6770	83648	154664	153222	23351	2675	4258	89846	84674	3897	80254	6005	22928	10044	56300	6328	5516	1385	85363	51327	10261	91662	3570	669	2219	90806	56890	960	3579	1269	23765	58508	54716	1106	100131496	974	5733	57666	11010	133396	56997	3606	22821	5871	130535	53335	5150	10181	83737	6263	10320	219333	8728	26230	121512	84669	55743	375444	6789	80031	5599	8694	4217	8745	9938	9920	83742	23308	5087	7412	9481	83593	393	6002	201305	55664	23369	3480	7903	8445	10791	57509	64092	6521	1593	54943	57507	221037	3642	26224	3930	80342	79899	8675	259282	27229	90634	80776	10388	25836	79144	84460	57532	30818	10394	10803	4317	9742	7543	83641	7182	79869	25777	9885	94240	60370	7704	779	375035	160760	4125	27429	93323	6489	257106	613227	1690	7325	60313	55729	1880	924	9487	25840	23333	7266	11329	196441	8710	2870	28969	80208	65980	8933	60481	93550	2526	55024	1840	51094	221476	51306	4050	55032	8148	26999	81796	9781	90427	115123	9969	54904	11214	660	79641	4739	94104	329	80005	203328	1241	55904	9990	53616	283446	9583	282991	54799	55520	127262	56254	83891	23383	51720	3141	1974	3773
GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN	M6478		16717116	Macagno A,Molteni M,Rinaldi A,Bertoni F,Lanzavecchia A,Rossetti C,Sallusto F	GSE4748	GSE4748_3382_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocyte-derived dendritic cells: untreated versus LPS like antigen from O. planktothrix (3h).	A cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression. We report the identification and biologic characterization of an LPS-like molecule extracted from the cyanobacterium Oscillatoria Planktothrix FP1 (CyP).					54887	7264	4665	6868	55090	10200	26509	388962	84617	9718	3419	2653	171177	376497	10135	54602	65260	4731	51126	23113	54884	38	27131	5272	10229	59342	5694	1263	65062	4282	170394	377677	4323	84311	9086	92579	4717	2921	56005	9897	5937	100287932	9141	29928	113277	9212	10987	5213	8870	5705	10755	26355	83853	90522	123920	8754	2213	221150	84233	219931	6185	6472	5939	55298	23170	598	11123	284106	158	318	2963	6351	79080	10409	713	629	10975	719	9380	29968	80218	4839	755	4999	8894	63931	9641	2717	7001	915	57418	28972	581	5707	1653	4481	6302	5446	2971	55559	730249	56851	54927	10459	64855	11221	84261	2805	682	6050	4712	926	435	90843	27095	4726	128239	7070	116447	51065	5718	51390	23741	3005	2584	5973	83990	2107	7167	10549	10989	6347	51426	7374	977	26270	27000	3956	3002	4283	55621	84419	79711	79072	23166	254863	308	1819	7050	56954	6357	84909	7283	8829	131118	467	3458	4706	51296	23516	115361	6427	27166	55168	4234	51566	10175	5201	92259	2634	58191	23071	291	3604	721	10950	65003	1155	969	285590	2919	113189	90637	29087	2782	5954	85440	51529	344807	26354	8743	83861	53343	10580	124222	4925	10988	57698	283431	51248
GSE4748_CTRL_VS_LPS_STIM_DC_3H_UP	M6480		16717116	Macagno A,Molteni M,Rinaldi A,Bertoni F,Lanzavecchia A,Rossetti C,Sallusto F	GSE4748	GSE4748_3383_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocyte-derived dendritic cells: untreated versus LPS (3h).	A cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression. We report the identification and biologic characterization of an LPS-like molecule extracted from the cyanobacterium Oscillatoria Planktothrix FP1 (CyP).					51068	4684	79733	11198	55196	6897	122786	26057	4322	26750	3598	90161	7278	6657	5156	10106	3977	7353	9703	10018	57609	84861	3376	2889	55074	8826	84901	147040	10561	3437	23452	4739	10098	272	1281	200734	23036	171023	80789	219699	10163	8507	3685	892	80114	2521	7078	54407	7005	22877	29946	2004	84939	29978	1781	11346	5653	57381	2069	28989	2012	1490	4493	1809	8720	11228	83667	79026	5430	1290	9794	1408	3486	9123	9169	2200	7092	2959	6018	5054	987	11098	1959	4883	387509	283871	51684	3491	23362	8324	51719	55907	5228	25942	84961	11167	51129	27319	90993	23568	3624	114897	9173	118429	10484	710	4599	30849	8811	5469	161742	54206	1906	90627	8241	10631	6563	5149	115939	27122	23019	57124	5727	64108	22862	130951	345611	23321	26017	60485	9643	1839	54453	8872	3037	9510	286133	6387	7474	8737	7013	57007	10116	64852	2619	4502	144699	2690	857	5836	4092	9943	59353	8545	4665	25897	5781	129531	3430	5756	9590	6662	51780	9949	116064	5163	28951	92597	9695	8723	10181	284273	4319	267	55713	1545	51421	57692	5179	65264	116987	439996	146198	6811	79670	9639	1009	4121	55205	8912	8091	5911	4811	390	51312	10670	79003	25831	54726	3184
GSE4748_CTRL_VS_LPS_STIM_DC_3H_DN	M6481		16717116	Macagno A,Molteni M,Rinaldi A,Bertoni F,Lanzavecchia A,Rossetti C,Sallusto F	GSE4748	GSE4748_3383_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocyte-derived dendritic cells: untreated versus LPS (3h).	A cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression. We report the identification and biologic characterization of an LPS-like molecule extracted from the cyanobacterium Oscillatoria Planktothrix FP1 (CyP).					6888	5939	94103	1572	252983	10399	875	140625	3959	57095	23760	29960	51530	285636	1305	1791	10263	8991	7045	2224	4901	183	114900	948	25898	23237	6482	56965	5270	23552	4314	7327	10799	3162	467	5865	6274	9607	9513	1843	54557	10628	2328	479	6279	23559	5465	22807	25903	5714	124995	6945	51110	91947	5820	57104	54940	5351	80270	80212	79705	1811	1647	9370	23513	58477	23179	221937	57035	2980	2651	79869	10960	9530	54529	57187	56892	10537	51099	4644	5950	10912	23360	900	84612	2953	345274	10285	57863	51422	64786	54949	79665	153443	163590	9788	651746	587	4188	4953	6307	11282	4199	2052	27163	50	10123	7539	79443	6609	8682	201895	4681	10966	54558	9619	23429	535	9894	133619	3164	3592	9572	6444	10398	6883	79603	170392	3312	2745	9781	5913	1039	79877	4056	2303	25828	3216	6775	55048	5919	148534	5091	5071	84270	80781	79990	7050	127544	222487	51582	5601	523	7323	2280	54507	1675	51646	11112	1939	6414	9527	949	54664	968	6309	55652	5053	6948	401251	51251	1594	115111	11217	5195	10552	7132	4616	27131	64788	10553	56606	5129	8892	1565	56479	25923	1491	643988	7386	10135	143941	56270	90313	8780	9138	100505381	10538	127262
GSE4748_CTRL_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP	M6484		16717116	Macagno A,Molteni M,Rinaldi A,Bertoni F,Lanzavecchia A,Rossetti C,Sallusto F	GSE4748	GSE4748_3384_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocyte-derived dendritic cells: untreated versus LPS and LPS like antigen from O. planktothrix (3h).	A cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression. We report the identification and biologic characterization of an LPS-like molecule extracted from the cyanobacterium Oscillatoria Planktothrix FP1 (CyP).					254295	1490	10098	10606	11228	25980	3556	85480	374	2130	58472	118429	9249	3671	26585	8241	5999	22862	81608	387509	79009	339	5087	6303	11198	3455	627	54715	25831	2690	466	4319	9569	5168	595	3920	7045	5371	26191	6801	5507	55970	224	1647	10106	9173	150274	4314	5142	23371	55074	339448	152503	654	1031	3910	171546	79746	4001	9570	358	54206	3598	51526	28959	301	6907	1515	55364	10483	54453	134218	1809	56892	272	6004	9353	11135	53343	6288	90161	27063	28984	1066	57153	28951	6387	5911	552889	1184	696	63027	10163	2069	54806	9446	57634	10549	2115	81488	117177	6876	134430	9789	7321	10577	26018	3609	24148	284371	10018	79670	9703	116987	72	8568	4124	6446	26064	90865	158427	283131	8546	6372	65095	4286	30849	9945	81618	2098	4071	26577	114897	306	51567	8612	963	1601	1495	3934	7345	9663	8490	56975	6611	5339	284273	9988	81894	26136	57003	4147	8602	885	10933	84293	10847	10365	7041	2643	51780	84271	10116	6662	79752	84898	1195	58494	3554	84899	79657	122616	83593	9590	26017	83707	91833	4350	51719	2049	25960	22877	23421	51060	23683	1503	57007	3998	4801	6202	26190	9423	11080	11337	10160	7050	79834	55365	59339
GSE4748_CTRL_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN	M6485		16717116	Macagno A,Molteni M,Rinaldi A,Bertoni F,Lanzavecchia A,Rossetti C,Sallusto F	GSE4748	GSE4748_3384_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocyte-derived dendritic cells: untreated versus LPS and LPS like antigen from O. planktothrix (3h).	A cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression. We report the identification and biologic characterization of an LPS-like molecule extracted from the cyanobacterium Oscillatoria Planktothrix FP1 (CyP).					252983	4880	2908	5054	331	2934	3624	6888	79665	9512	5195	37	7422	2990	10609	9491	257160	5091	259230	302	57104	25923	27242	23157	26090	53834	140576	80194	23426	84649	5327	1263	115330	23089	3980	2582	55902	51530	334	3030	23237	7351	56913	9124	2224	54946	84818	8694	4232	84617	10272	10013	1282	9723	415116	23760	9497	3419	10867	7258	4023	3667	5141	1891	3091	134429	23420	874	84926	5499	51727	23246	1572	3875	63924	23424	10670	214	79603	127544	2247	8562	11163	11016	3032	51	2999	22978	5606	827	9159	4322	5742	1306	64746	10383	5129	23022	4478	5166	256949	47	1431	761	58477	85462	29899	1075	65220	11282	79717	140809	83483	84263	24146	9603	4882	25849	6615	3213	50	4327	22800	1293	10580	3037	8577	2691	948	1843	57178	55466	7323	124995	3995	7374	535	4435	54536	5133	84458	203228	163590	5153	1292	2288	112399	2053	9462	1302	23225	123	81887	284207	283871	56925	10267	9706	4025	3587	79705	84331	10162	949	221937	231	2167	145482	5347	283578	30846	5329	5037	5621	3988	10216	85477	85414	2230	4259	5138	871	5464	85397	60681	7365	9370	6241	54474	2935	5243	56253	33	79956	10518	10537	6609	523	3156	6934
GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_1H_UP	M6486		16717116	Macagno A,Molteni M,Rinaldi A,Bertoni F,Lanzavecchia A,Rossetti C,Sallusto F	GSE4748	GSE4748_3385_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocyte-derived dendritic cells: untreated versus LPS like antigen from O. planktothrix (1h).	A cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression. We report the identification and biologic characterization of an LPS-like molecule extracted from the cyanobacterium Oscillatoria Planktothrix FP1 (CyP).					29101	26585	81572	23530	25831	8241	57634	51390	3598	222255	8507	5524	155	79002	23645	25942	63027	57826	6801	84961	10950	4357	1774	5142	6697	10018	56950	3093	839	199990	3292	118429	64374	595	517	10390	11130	163	80255	284273	9482	10098	6018	8994	1072	10933	79004	158427	55074	894	64852	84975	28959	84522	9173	79827	25879	25960	51155	11198	10969	11070	5872	57555	8546	272	112970	7511	8613	9423	11135	150274	2643	323	6897	617	7278	1912	51611	81488	8702	5911	5878	258	1959	200734	119467	837	26017	7135	638	55222	708	10413	55957	4839	2483	84065	3489	55365	51330	339	51719	10428	29979	51780	10360	10116	2583	54345	134218	6741	23371	271	2889	5690	3251	2995	123803	8554	80851	57017	5635	84277	9703	1948	10935	28974	11167	8826	174	284217	5718	2353	22938	27319	8534	7169	25777	10897	9991	51433	26018	165545	29937	26577	6563	552900	4722	5339	148170	10280	54407	9946	51759	337970	3433	51538	126328	5898	6232	10215	9550	1351	5281	10483	8295	8840	23019	23122	65265	8872	27257	58476	28984	10210	5217	54806	22986	6171	55179	113878	552889	25842	84899	29978	529	26064	9516	8428	91614	4071	1936	10581	25836	2971	684	7322	65095	466
GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_1H_DN	M6488		16717116	Macagno A,Molteni M,Rinaldi A,Bertoni F,Lanzavecchia A,Rossetti C,Sallusto F	GSE4748	GSE4748_3385_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocyte-derived dendritic cells: untreated versus LPS like antigen from O. planktothrix (1h).	A cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression. We report the identification and biologic characterization of an LPS-like molecule extracted from the cyanobacterium Oscillatoria Planktothrix FP1 (CyP).					23473	3980	25849	51093	5153	27032	23760	7422	3030	54557	7162	142	1610	22906	23360	2241	7112	948	51129	256949	57494	5327	94233	57187	11016	875	2175	153443	3500	51738	57534	56606	3217	123	5054	60626	10914	9074	57648	4327	58477	259230	5097	85397	5314	94103	93661	85366	3211	7323	1572	673	8437	55243	220064	253260	9706	23557	3594	6535	5091	8562	29844	79443	11163	53834	535	127544	182	3164	54901	23157	7003	5129	64746	84230	6430	26240	221937	6426	79095	57104	22807	56925	3064	57586	1305	23567	114960	50810	5195	1406	1301	1810	100288695	3222	8303	8128	908	79751	3673	2167	7004	5742	23225	55384	10628	5566	375035	7368	57178	201627	163590	29957	113	84152	163351	1292	4478	9781	23132	6696	900	22820	55775	9107	1363	6615	26263	5728	79041	27040	6545	1749	8899	27075	4091	114823	10389	64324	6670	51727	7178	55815	4776	4322	7779	8036	164	10533	54540	2125	5547	4750	55089	10746	1139	10960	10772	200186	64757	94104	54664	2247	1874	1045	146691	10947	55929	63917	54507	8328	6102	9788	7531	84263	5256	9937	4308	1478	8120	51478	5361	8455	2861	3784	4647	5725	6309	11282	7514	9948	23325	1075	9266	115992	10097	79768	140625	30001
GSE4748_CYANOBACTERIUM_LPSLIKE_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP	M6491		16717116	Macagno A,Molteni M,Rinaldi A,Bertoni F,Lanzavecchia A,Rossetti C,Sallusto F	GSE4748	GSE4748_3386_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocyte-derived dendritic cells: LPS like antigen from O. planktothrix (3h) versus LPS and LPS like antigen from O. planktothrix (3h).	A cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression. We report the identification and biologic characterization of an LPS-like molecule extracted from the cyanobacterium Oscillatoria Planktothrix FP1 (CyP).					27075	643	5101	85453	2208	5368	3495	10391	9925	140733	6328	51237	26228	861	56941	84513	4345	56937	4208	91353	84265	23180	5079	3507	973	104	7704	28831	90407	28797	3514	100293440	151888	3899	5244	28823	3535	6689	5796	115350	221756	9308	974	4222	51429	55278	28908	84824	3512	81571	652493	5026	971	919	6472	60468	2149	27079	55024	9557	10236	9214	54900	84795	7700	91316	8644	100290481	66035	80063	285016	5996	10099	8892	9238	8936	83891	3394	10123	1803	92565	199786	4747	51523	79956	8479	6489	5433	28902	8914	283989	1879	3560	59338	155060	7494	83890	6158	202018	7965	51538	338620	608	1840	5581	54107	54847	401397	5551	117145	10838	3002	9788	2308	55706	4673	29760	54617	10842	22982	60488	4771	4775	1457	440288	79863	55186	25780	10785	933	55326	5168	93587	6176	23468	3112	640	3064	131096	7294	161145	342926	28387	83416	4691	5287	6368	317781	9422	79140	5933	10972	8277	53335	7634	54663	259197	7112	22866	55624	79829	7525	200772	16	9533	345611	79961	116143	90075	9047	219790	574028	9953	64318	91687	142	84890	28912	10054	26018	26260	348262	133957	51433	54908	84159	84541	80312	51388	29904	113251	6175	285331	342538	117157	54765	51569	441212	51188	9813
GSE4748_CYANOBACTERIUM_LPSLIKE_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN	M6492		16717116	Macagno A,Molteni M,Rinaldi A,Bertoni F,Lanzavecchia A,Rossetti C,Sallusto F	GSE4748	GSE4748_3386_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocyte-derived dendritic cells: LPS like antigen from O. planktothrix (3h) versus LPS and LPS like antigen from O. planktothrix (3h).	A cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression. We report the identification and biologic characterization of an LPS-like molecule extracted from the cyanobacterium Oscillatoria Planktothrix FP1 (CyP).					7280	10383	10381	22904	64101	284677	256302	4097	10124	144920	10644	820	115727	1669	100134229	1088	54578	7538	7100	219539	5872	160851	6282	83551	337880	1991	147920	7408	566	4781	4680	8993	3557	2078	66008	6583	92799	84232	4317	10321	80019	3934	9260	671	79908	57610	131540	26499	55766	5657	91612	94121	6947	409	6037	10326	827	64218	4974	84843	340581	387755	5239	79930	401494	6274	64386	4140	148534	25862	10409	2185	140809	4884	126868	6423	100286921	10957	285758	206412	9625	26285	51100	8291	81577	5836	55359	84701	23762	84418	127544	284788	79887	347273	150384	23416	2299	406991	137196	50805	121214	4023	83463	2569	3759	259239	51802	9586	80232	7277	283238	222389	64581	201477	3625	10661	50834	6732	400654	5676	8804	64084	7447	199	3624	80896	2215	6590	401093	219525	196883	55544	10562	134548	2309	4103	9463	6036	4057	100289612	57592	283847	26577	79746	2570	10602	152519	83661	8916	5595	115330	400680	84337	10804	7059	55680	27284	167826	80127	6510	11237	100130175	3010	4099	3290	4689	138046	9982	4318	254896	3516	51271	56729	2280	84777	440730	64748	9605	306	55122	8120	6781	2289	6280	11025	357	343171	114795	286	404201	402055	4055	285550	5600	10665	83538	683
GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP	M6493		16717116	Macagno A,Molteni M,Rinaldi A,Bertoni F,Lanzavecchia A,Rossetti C,Sallusto F	GSE4748	GSE4748_3387_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocyte-derived dendritic cells: LPS (3h) versus LPS and LPS like antigen from O. planktothrix (3h).	A cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression. We report the identification and biologic characterization of an LPS-like molecule extracted from the cyanobacterium Oscillatoria Planktothrix FP1 (CyP).					5869	5927	1848	9589	113277	490	55120	1514	1072	26057	1545	58480	7378	10209	90133	100381270	10859	10087	9849	439914	9839	4750	2872	64750	85509	100134445	9891	23112	51135	8553	283871	81563	55105	112574	9857	25917	27246	27333	54834	79873	55509	2207	3002	6351	29896	4818	51520	5929	729967	677811	54811	9429	5908	375190	153222	1992	25943	79982	84868	1536	7707	51744	83442	220906	58475	286451	55599	3587	10081	8809	10097	4193	9289	23208	26043	340085	113178	9208	23506	162073	283209	6275	5141	2643	9686	29940	83667	171483	9748	144983	7277	9047	25844	79979	81876	91404	51604	55294	26118	55729	1240	23071	284207	339804	51538	91056	22990	7049	285231	7805	5551	3092	9060	9935	9306	4123	81688	6923	150368	29065	7098	6645	53336	9575	221960	55275	55904	586	4094	10144	11182	1436	84131	150381	8036	115560	51230	11221	5029	7634	28232	126074	2000	481	10643	493	9731	23405	284106	373	4929	11186	53637	55973	9140	83937	149628	1462	100288139	8804	864	7270	23291	79191	10392	9050	1962	5062	9495	5371	25936	7016	55605	27109	25778	388341	135154	9422	121512	3823	339448	1958	84056	5911	1847	2847	55668	644	5903	158402	5734	4253	167153	257101	284759	154	166378	9819	26524
GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN	M6494		16717116	Macagno A,Molteni M,Rinaldi A,Bertoni F,Lanzavecchia A,Rossetti C,Sallusto F	GSE4748	GSE4748_3387_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocyte-derived dendritic cells: LPS (3h) versus LPS and LPS like antigen from O. planktothrix (3h).	A cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression. We report the identification and biologic characterization of an LPS-like molecule extracted from the cyanobacterium Oscillatoria Planktothrix FP1 (CyP).					5878	147920	10075	57124	6945	8842	10899	6929	10418	54084	150248	357	403314	64084	1606	11211	63910	51714	9542	79969	79178	284788	79814	55355	645784	27005	23138	100507290	163259	9700	55507	92949	100131655	50700	140732	100133205	1874	146691	390063	51434	8703	196385	8859	154442	8120	54898	84337	55293	643641	337880	4781	476	159371	2041	7322	58500	54921	150384	57139	126	91370	55260	133874	100290481	11147	400223	100287911	285613	5432	6276	3355	283392	8440	93273	116285	100128640	9982	414300	81931	1131	284677	57575	100507300	50509	91319	51802	84952	2894	348	389840	125144	56603	149703	23546	283297	386618	55337	7982	154089	100287927	1802	23178	1360	29920	8687	309	83551	4058	138046	51012	399875	10663	64101	57504	79654	26222	10360	1725	11223	65988	285326	343	728606	341880	100288294	9080	3913	55530	100287584	3444	283652	132625	84329	2694	57093	4485	84705	92745	5795	143630	9057	6241	4100	28563	1285	165082	221391	387758	8506	153642	159195	57408	57670	100131564	84632	200942	23089	9212	100507246	199953	827	1793	5961	157313	57291	245806	7480	1233	3820	60677	7582	1559	283403	202052	219990	5164	122953	497258	7454	163	26024	3026	390940	219743	51705	201161	85280	63950	9287	729595	203328	399491	768206
GSE4984_UNTREATED_VS_GALECTIN1_TREATED_DC_UP	M6495		16785517	Fulcher JA,Hashimi ST,Levroney EL,Pang M,Gurney KB,Baum LG,Lee B	GSE4984	GSE4984_2744_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocyte-derived dendritic cells: control versus treated with LGALS1 [GeneID=3956].	Human monocyte derived dendritic cells matured via galectin-1 or LPS.					9839	54834	80315	28232	7321	22904	2787	7100	1992	51776	8609	121512	10288	55680	50807	90133	115727	9120	6813	6590	91056	11261	9260	81603	100381270	54507	677811	150381	6282	83667	79887	8522	9605	493	91404	7707	2752	11033	55851	1072	29855	9209	23405	338692	6604	4001	27246	6688	5869	219539	1105	83442	1845	253430	84418	55119	6171	8837	7030	1958	55120	3759	440836	5027	55525	9589	439914	378938	127544	53831	6280	10859	5586	7791	6483	11031	100134445	54926	10644	9341	64748	3516	406991	55359	29940	9586	113277	10087	1545	7071	5873	2207	20	4067	55599	58480	602	6583	4774	23287	55654	2357	6279	56977	5265	10333	838	112574	10124	9635	55668	5239	6272	7538	54165	5595	79180	4671	81839	10261	81876	7378	162073	2210	56261	153222	80790	7805	51573	100128501	7412	81688	373	135154	96626	89849	7280	83737	7408	1991	153546	115761	6275	5990	6788	80896	84957	23071	6232	140687	126119	4097	115825	406893	7132	4299	100288781	57459	55729	6758	7375	283687	2185	55640	9208	643616	8347	55589	10321	904	353514	389792	27071	19	1760	2936	3010	10981	6256	80072	51512	26578	100128868	9516	92799	1508	10231	313	152007	338773	9842	2120	6423	3717	6546	256302	23389	344838
GSE4984_UNTREATED_VS_GALECTIN1_TREATED_DC_DN	M6496		16785517	Fulcher JA,Hashimi ST,Levroney EL,Pang M,Gurney KB,Baum LG,Lee B	GSE4984	GSE4984_2744_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocyte-derived dendritic cells: control versus treated with LGALS1 [GeneID=3956].	Human monocyte derived dendritic cells matured via galectin-1 or LPS.					51237	27075	100290481	5368	8115	3820	93144	84513	3507	645784	9214	4345	30812	3512	5026	79368	151888	3399	115350	1802	80063	26228	6504	5796	7294	740	60468	28387	56941	6328	9308	399	971	29802	6194	60674	100131043	652493	56937	283663	81571	3843	973	23370	28902	1235	155060	939	28831	28908	100290557	1380	2317	84824	3998	3033	7639	100293440	3514	23354	1019	608	10056	3535	22866	3495	79814	50628	199786	64946	29851	203328	6689	55024	1974	117247	6193	79084	10456	9834	79050	147184	27042	54929	148327	10131	5140	28823	27340	132789	328	155066	79956	7188	84329	10391	399665	6133	157285	2113	25875	30827	201161	80714	643	6175	5198	5287	3326	100287628	55340	933	91353	23231	5244	64061	83416	2208	9925	220002	10418	7088	1803	57017	11223	27335	26271	113612	6144	931	962	974	919	51149	10750	3899	57048	3983	930	3112	55278	121642	9648	29760	387723	8718	3875	3712	100129196	6188	1736	6208	57291	7322	6566	1840	58505	100130458	9639	28785	4839	605	160518	6122	11142	55245	2971	132299	3945	622	4753	91782	28797	125144	8237	1977	6711	3575	259283	5450	3921	55103	25914	2041	1606	54908	51012	5101	765	780	342945	114884	8664	388335	9057	3126	7957	84101	11331	27005
GSE4984_UNTREATED_VS_LPS_TREATED_DC_UP	M6498		16785517	Fulcher JA,Hashimi ST,Levroney EL,Pang M,Gurney KB,Baum LG,Lee B	GSE4984	GSE4984_2745_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocyte-derived dendritic cells: control versus LPS.	Human monocyte derived dendritic cells matured via galectin-1 or LPS.					6018	728215	9777	9372	5079	9750	286336	64837	84144	80728	116447	6668	55718	54861	11215	5155	11202	4547	54503	115286	2870	1454	27440	389206	9473	6468	11240	3757	2908	23233	25777	51151	9620	7077	25885	10203	81606	23276	56605	118813	5336	3840	2197	221188	151888	15	83699	1389	5792	23607	26574	11221	10461	10196	4779	79637	366	23219	94	23150	130827	160760	1180	6160	54106	79789	55614	57538	4209	4649	148932	54328	2909	11276	63951	9378	79660	204851	54585	8437	4780	23102	9816	841	4588	1045	23654	178	80271	122830	8412	56342	23515	4066	11022	344838	2054	84859	8720	57162	201292	2846	29904	11009	146691	26039	23420	8718	9619	54497	4249	131616	81846	55647	1368	27128	5910	9841	7750	7289	10120	5463	23529	9467	84687	171558	3605	50801	1232	9093	64921	55218	10039	65258	6571	9860	50615	255189	64220	25989	9205	28965	6455	399979	6875	63977	640
GSE4984_UNTREATED_VS_LPS_TREATED_DC_DN	M6499		16785517	Fulcher JA,Hashimi ST,Levroney EL,Pang M,Gurney KB,Baum LG,Lee B	GSE4984	GSE4984_2745_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocyte-derived dendritic cells: control versus LPS.	Human monocyte derived dendritic cells matured via galectin-1 or LPS.					51308	2065	55768	27089	5366	10069	51763	51678	768211	10844	10434	51088	1955	4345	11020	80352	160851	121441	29945	3205	4173	1521	91181	80776	27113	9334	79612	29956	10553	29893	9631	55308	388962	51023	5523	515	3299	84868	5133	221035	55168	112939	644353	8744	9352	104	2778	284403	150465	9682	100529141	55246	29097	9219	3209	51194	8370	3563	338707	56521	1317	84883	5445	64412	4591	64951	8971	5528	2063	1429	996	7425	57544	6917	51497	9143	5683	51372	126272	4126	117178	219844	9871	7301	1029	51031	9512	8909	10130	2790	23306	79077	10469	254170	9149	29796	10501	60488	54788	84893	6403	91663	11034	10540	10059	9209	51522	54529	30968	64979	9051	10013	8612	122961	4217	140735	4929	11333	5576	285367	2274	307	3459	284307	152815	401409	27069	80305	9468	65008	2189	10654	6642	2314	1620	5341	9531	8776	10946	3558	5873	51569	4068	201161	6646	2526	9414	51053	57697	1786	2936	65991	10121	6787	54434	202018	51503	3416	83891	10229	6924	84240	1104	6184	378708	90268	375316	388581	11172
GSE4984_UNTREATED_VS_VEHICLE_CTRL_TREATED_DC_UP	M6500		16785517	Fulcher JA,Hashimi ST,Levroney EL,Pang M,Gurney KB,Baum LG,Lee B	GSE4984	GSE4984_2746_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocyte-derived dendritic cells: untreated versus vehicle.	Human monocyte derived dendritic cells matured via galectin-1 or LPS.					51151	9	6468	2197	80271	253782	53347	116447	8555	5289	55000	6136	57462	6181	283777	714	94	1859	6650	7132	83933	90956	10169	154043	2870	57124	80204	283234	1385	199	84961	10087	4780	6915	8178	157506	8535	6347	64743	23555	57568	10246	54106	405	55902	6404	128637	23417	931	10203	1108	2909	27238	3801	25853	51669	8310	10818	1389	27042	80314	123688	2799	63935	56922	90427	23607	3769	6938	89792	22897	25989	1788	118429	401548	4548	2099	8840	3614	3840	79722	23067	2683	399665	4907	3757	55218	2316	84941	6482	2857	84433	135886	3071	53349	29940	55777	9829	84532	9620	3290	127	3678	148170	4287	5863	3709	3140	23248	54926	55624	4007	23220	1408	9759	9501	156	5480	10333	54491	3177	79843	3592	60343	126282	80228	133522	80196	6018	4534	7248	146691	389206	11276	10412	11244	2908	64921	81545	25780	54861	8994	4940	83719	80223	5993	90525	351	55108
GSE4984_UNTREATED_VS_VEHICLE_CTRL_TREATED_DC_DN	M6501		16785517	Fulcher JA,Hashimi ST,Levroney EL,Pang M,Gurney KB,Baum LG,Lee B	GSE4984	GSE4984_2746_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocyte-derived dendritic cells: untreated versus vehicle.	Human monocyte derived dendritic cells matured via galectin-1 or LPS.					57570	284467	2108	11260	219790	83795	114904	83715	2696	5536	51308	221895	64393	9861	1104	1762	55038	54801	9951	10200	8914	55559	10111	9512	65985	5223	125950	10073	2669	892	3155	5528	26050	51520	219670	200185	55166	51361	9911	9253	1365	768211	65124	10946	2275	3638	84336	2936	3156	51522	50632	56925	1977	126393	9271	11034	9498	9824	8317	51258	285313	84955	160777	8785	9733	142	140739	10809	51678	64975	219844	4345	84889	55844	29886	10525	11343	6242	4521	55794	55308	2790	54529	7167	25803	334	5141	80028	57180	9039	84868	85465	56984	515	7905	79831	55246	2230	9057	64979	11282	51031	4068	64327	255104	6767	7141	51138	55858	23052	3612	79959	5445	3157	5230	1735	11252	7334	10694	10988	2681	27237	3146	6506	900	79612	58526	9128	4613	163351	55168	158787	9255	3090	7498	10949	22928	57620	348995	51101	23353	9531	8487	56267	27085	10455	10221	1615	3376	175	51010	6696	2882	114900	90861	3383	4141	4291	112939	4076	121441	126129	26007	10505	345079	79050	821	5873	148	22933	3010	51569	4547
GSE4984_GALECTIN1_VS_LPS_STIM_DC_UP	M6502		16785517	Fulcher JA,Hashimi ST,Levroney EL,Pang M,Gurney KB,Baum LG,Lee B	GSE4984	GSE4984_2747_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocyte-derived dendritic cells: LGALS1 [GeneID=3956] versus LPS.	Human monocyte derived dendritic cells matured via galectin-1 or LPS.					116985	54904	11345	55283	23081	22882	92714	8867	7408	2896	9706	84532	5335	5830	6251	7716	54664	21	84893	8315	8993	2000	80212	10945	84687	51542	55218	54556	7486	5494	83752	128338	63910	3631	84263	10412	2517	90416	81794	7579	79666	256471	57680	29761	25777	83719	26260	283130	8310	5829	6915	51669	7077	4242	54545	7903	114785	391	25853	285636	23163	27244	23607	2099	11232	28231	79085	25847	928	254295	23608	5055	79654	126282	9830	1838	80304	221035	56624	3558	10379	157506	64802	7029	124540	11346	337988	9267	54910	8897	152006	84498	84265	5264	23157	10444	10333	340719	83985	916	11259	23550	26229	29940	8648	10746	4627	2519	1396	11216	3476	65258	6522	2060	7182	166863	7991	1130	286205	533	84859	23140	585	55256	57610	1523	10206	57559	84067	57658	4050	3983	255520	23230	51742	2972	56925	11064	23586	10449	122509	25851	55362	27034	55856	27030	390790	8289	6844	23046	79752	10193	2313	157680	4090	5871	130814
GSE4984_GALECTIN1_VS_LPS_STIM_DC_DN	M6504		16785517	Fulcher JA,Hashimi ST,Levroney EL,Pang M,Gurney KB,Baum LG,Lee B	GSE4984	GSE4984_2747_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocyte-derived dendritic cells: LGALS1 [GeneID=3956] versus LPS.	Human monocyte derived dendritic cells matured via galectin-1 or LPS.					284217	9261	84623	8165	8566	11108	10440	55617	84251	8707	56154	1123	1395	8453	8848	23074	83986	84522	25841	5641	2681	84216	120227	79805	6696	4026	9147	5464	9949	8645	8099	54700	24144	2963	3326	10309	55775	3843	27247	151	2125	10507	3297	55646	2091	23508	113251	283989	1238	132949	2962	2222	9464	4522	118932	79652	8869	5701	10660	54433	84952	1427	6888	26033	5653	27254	5034	6403	11025	7936	57699	2696	1687	642968	26003	60678	25998	4033	10912	634	2650	8514	717	51071	637	57645	6390	401505	57709	1800	8609	284467	10728	127829	23507	23062	7372	116362	8833	7469	208	57520	92106	10252	1019	5917	55330	388228	2669	80218	2012	51478	27037	5694	348995	166378	3667	100529141	5791	85439	833	1762	2582	85455	6574	6185	6868	25803	222236	6730	92399	5708	84230	9595	5308	9450	55658	134430	92092	1047	730	23250	7289	54187	9733	27042	3308	2177	221711	80830	10313	80005	81875	27338	56342	2534	5725	1263	158219	116984	9352	199953	9172	4141	375323	1434
GSE4984_GALECTIN1_VS_VEHICLE_CTRL_TREATED_DC_UP	M6505		16785517	Fulcher JA,Hashimi ST,Levroney EL,Pang M,Gurney KB,Baum LG,Lee B	GSE4984	GSE4984_2748_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocyte-derived dendritic cells: LGALS1 [GeneID=3956] versus vehicle.	Human monocyte derived dendritic cells matured via galectin-1 or LPS.					9860	5066	83989	641649	157285	645158	197135	283551	100132406	54465	3908	9679	114769	284757	7988	26115	151516	8976	246	257019	10261	131616	9522	10771	91452	2774	64236	65110	84628	221937	284207	55565	7084	23408	26048	2135	10420	210	123283	257044	79830	4090	390502	90410	9985	10314	8675	23358	100113407	29108	157381	80215	472	80124	55082	10009	1488	387119	84895	169355	55213	57007	4303	58155	1975	441108	23598	64601	55857	6539	20	199675	215	54956	56474	7248	23741	9169	55197	8801	4058	143630	25777	254225	27010	51060	8019	51596	9265	339210	57541	84678	57692	54436	727957	5174	574037	26523	493	393	819	201895	100129195	1643	161835	165631	221	147694	23416	89846	2826	256949	90637	1609	6789	23097	79961	84260	90933	9046	440275	5863	64788	1028	9832	200576	11223	84519	388692	57456	100127972	84572	256764	54932	79074	9459	4343	155060	9528	55837	199745	100506988	9187	1513	54838	3707	80868	54934	113	10474	1773	1729	147015	10769	283149	93622	27352	9751	7110	728769	51646	54847	1198	28683	22876	9923	89848	64132	4034	64145	389	2975	84000	2272	1741	84142	84314	4087	51601	8698	27076	89953	951	376940	3087	53827	22863	7294	27334	6850	1185	400961	148156	2814	51744	124739	55198	6834	10425	94241
GSE4984_GALECTIN1_VS_VEHICLE_CTRL_TREATED_DC_DN	M6507		16785517	Fulcher JA,Hashimi ST,Levroney EL,Pang M,Gurney KB,Baum LG,Lee B	GSE4984	GSE4984_2748_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocyte-derived dendritic cells: LGALS1 [GeneID=3956] versus vehicle.	Human monocyte derived dendritic cells matured via galectin-1 or LPS.					5599	10906	100133308	6009	80198	8061	112939	2063	55341	84280	10939	10714	55334	113402	155051	1371	813	7066	79734	23026	7251	25932	51719	4678	204	149840	80018	4711	5686	11196	4729	51728	79646	84928	100507650	9373	83759	10526	6184	9352	338	4200	4436	10124	3181	10728	84296	58494	54707	85365	287	54777	10229	79228	4744	26230	83548	80328	24140	80324	11234	6569	5194	5621	55236	402055	83871	11221	503569	115361	10540	3611	9735	8438	26354	65057	255231	285636	118461	29980	1827	60598	729522	5464	10452	55311	10772	51009	29880	5514	84315	54840	10959	7319	440915	140823	55665	79581	23507	3227	3838	390705	223	83666	7355	9948	51645	10989	8728	286023	5526	6745	6118	27292	54503	9143	139322	375686	2643	10371	64768	51163	28985	64928	10615	79018	51264	7037	8336	9868	5481	10762	3035	54901	10694	83607	7030	25879	85028	10154	23512	55968	6775	84083	3428	150275	1871	3572	8804	24145	348174	494143	5325	283078	93166	6596	51227	553115	2802	64127	64978	84706	84727	51548	23211	55289	6598	6760	11157	203190	25821	283991	64170	1653	9694	29028	10948	7156	406991	6464	6868	3708	9646	4172	171546	90324	9839	200420	84844	56907	3182	6491	51647	18	23256	5721	9688	4234	55854
GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_UP	M6508		16785517	Fulcher JA,Hashimi ST,Levroney EL,Pang M,Gurney KB,Baum LG,Lee B	GSE4984	GSE4984_2749_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocyte-derived dendritic cells: LPS versus vehicle.	Human monocyte derived dendritic cells matured via galectin-1 or LPS.					91433	79890	8906	4925	64223	6932	9241	6915	3290	2742	5575	11123	91782	157285	1088	26762	57486	79690	26119	79863	84219	10544	7294	4922	5198	51227	49856	692229	79667	8495	1953	9098	51765	197258	8749	145482	5046	6573	10204	79922	692092	58511	3784	4354	54549	225	129293	2091	359787	133923	219743	54861	128486	341676	283991	25825	6687	29914	84868	3712	5617	165	7091	91544	9400	114804	80222	84330	23428	51761	57633	54221	8460	9249	56000	26796	8498	91937	10458	91304	5452	3043	727936	90025	28514	6775	6230	87	85302	79781	56997	150864	5777	646513	64951	85366	6854	28969	51312	26034	3482	5199	10869	26532	89782	84327	26084	51005	10272	9856	51735	150248	140807	1573	284439	79962	79908	79777	677796	5992	2207	11283	90423	22903	56339	224	6929	404550	27236	53822	50859	390637	94161	51316	79847	8568	9166	80031	185	14	344558	162972	319101	283455	348378	5168	57167	1019	129684	1999	441178	79158	60468	9238	140432	54532	23508	4602	1266	2971	57591	64773	10804	9970	57124	440087	6711	8722	952	4651	26123	23223	55920	340351	677777	7064	5990	2203	5564	11023	115825	6402	57222	26249	339476	51250	326625	3662	2037	80258	57488	79918	57605	2845
GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN	M6511		16785517	Fulcher JA,Hashimi ST,Levroney EL,Pang M,Gurney KB,Baum LG,Lee B	GSE4984	GSE4984_2749_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocyte-derived dendritic cells: LPS versus vehicle.	Human monocyte derived dendritic cells matured via galectin-1 or LPS.					9760	54436	4641	51232	60489	23019	9749	6310	23108	25897	636	26053	2591	23218	7049	81	3115	2060	158358	3594	91607	26051	1233	6489	118490	9095	84513	153733	55640	57060	11214	8754	3113	5783	2775	140564	7128	55829	4644	29994	657	23625	146857	10312	130589	26505	23020	5873	662	965	23345	2081	9265	50515	116496	192670	5527	2909	23406	9813	4094	2908	4267	6509	23208	3604	959	79651	160851	65125	241	23095	145508	7009	7465	2752	27347	125488	3993	10783	3581	999	23304	10663	80176	80315	639	51279	8073	5797	139716	493	5580	10787	54477	51684	55884	313	9679	10538	154043	64926	10161	861	148867	63925	2534	92906	84629	84056	114548	56255	51348	23261	285195	9447	9055	6916	57553	6503	23291	353189	58480	285386	196513	4967	8826	4072	55254	79712	10749	56927	51248	10499	5519	10725	7704	51225	4090	158584	80212	9645	8837	23062	115992	79022	57534	4204	4763	390037	8301	133418	60485	23102	79654	23397	55809	6533	3732	1102	23392	84162	92	7922	23054	22898	5153	1634	1234	26030	50807	154141	921	396	6443	401548	85015	81563	6738	8968	64215	23151	4247	57514	5920	23129	478	10911	23603	4773	10788	26018	5925
GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP	M6512		16800785	Sanda C,Weitzel P,Tsukahara T,Schaley J,Edenberg HJ,Stephens MA,McClintick JN,Blatt LM,Li L,Brodsky L,Taylor MW	GSE5542	GSE5542_3329_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in epithelial cells (6h): untreated versus IFNG [GeneID=3458].	Type I and type II interferons (IFNs) bind to different cell surface receptors but activate overlapping signal transduction pathways. We examined the effects of a type I IFN (IFN-acon1) and a type II iFN (IFN-g1b) on gene experession in A549 cells and demonstrate that there is a common set of genes modulated by both IFNs as well as a set of gene specifically regulated by each, reflecting the activation of different signaling pathways. In particualr, IFN-g induced many more genes of the signaling pathways, apoptosis, and cytokine interactions than did IFN-a. Even with genes induced by both IFNs there were distinctive quantitativive differences in expression. IFN-g1b plays a major role in the induction and regulation of the complement pathway. Previous work has shown a synergistic antivral and antiproliferative effect of type I and type II IFNs in cell culture and in the treament of tumors in mice. We demonstrate that a majority of genes showed and additive effect of IFN-acon1 and IFN-g1b, but a subset of gene is synergistically induced; these incluce ISG10, MX2, OAS2, and other genes known to be involved in the antiviral response, TRAIL (TNFSF10) and caspases involved in apoptosis and chemokine genes RANTES, CXCL10, and CXCL11. Greater than additive transcription of some of these genes in the presence of both IFNs was confirmed by real-time kinetic RT-PCR. Elevated induction of many of these genes may be sufficient to explain the synergistic antiviral and antitumor effects of this combination of IFNS in vivo.					388650	55226	114793	8793	9241	55790	155066	283174	84868	57486	6919	26119	7086	3704	26762	6403	401647	64784	4602	5575	9750	4791	29760	29979	91782	27018	78991	3784	64951	145858	7174	26249	94081	642	1823	28969	55117	55776	143686	10541	54549	9840	57605	10606	23113	22821	8019	7343	22997	1834	8495	124535	57162	246119	1633	64816	140807	57633	7691	93463	7476	10223	10276	64062	201163	257202	26147	23386	5777	23214	27339	9086	79777	54596	2153	55163	94103	8907	55604	3945	119	51070	4118	254042	124989	26184	3566	79608	708	79690	9555	7100	54522	4208	85004	340152	22852	51611	23195	319101	9214	84230	129293	23366	8498	57488	9400	4904	27086	85445	2177	6696	388022	5796	6472	10128	2342	285282	340351	64087	157285	7048	57048	11273	64949	4500	27284	8550	11040	5617	64744	9049	10347	10943	5198	10131	114904	79667	994	7221	150864	83592	6920	898	2272	23177	29911	4351	147837	55536	1327	5871	9856	5464	23228	6711	3769	3329	51765	55716	8906	23	4534	89846	91937	57134	51444	133522	1827	163882	973	54407	6147	1019	9073	4753	119679	57189	89782	90025	89927	2015	94097	10750	80705	64210	64174	64332	10472	255394	79656	9953	93145	2207	1889
GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN	M6513		16800785	Sanda C,Weitzel P,Tsukahara T,Schaley J,Edenberg HJ,Stephens MA,McClintick JN,Blatt LM,Li L,Brodsky L,Taylor MW	GSE5542	GSE5542_3329_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in epithelial cells (6h): untreated versus IFNG [GeneID=3458].	Type I and type II interferons (IFNs) bind to different cell surface receptors but activate overlapping signal transduction pathways. We examined the effects of a type I IFN (IFN-acon1) and a type II iFN (IFN-g1b) on gene experession in A549 cells and demonstrate that there is a common set of genes modulated by both IFNs as well as a set of gene specifically regulated by each, reflecting the activation of different signaling pathways. In particualr, IFN-g induced many more genes of the signaling pathways, apoptosis, and cytokine interactions than did IFN-a. Even with genes induced by both IFNs there were distinctive quantitativive differences in expression. IFN-g1b plays a major role in the induction and regulation of the complement pathway. Previous work has shown a synergistic antivral and antiproliferative effect of type I and type II IFNs in cell culture and in the treament of tumors in mice. We demonstrate that a majority of genes showed and additive effect of IFN-acon1 and IFN-g1b, but a subset of gene is synergistically induced; these incluce ISG10, MX2, OAS2, and other genes known to be involved in the antiviral response, TRAIL (TNFSF10) and caspases involved in apoptosis and chemokine genes RANTES, CXCL10, and CXCL11. Greater than additive transcription of some of these genes in the presence of both IFNs was confirmed by real-time kinetic RT-PCR. Elevated induction of many of these genes may be sufficient to explain the synergistic antiviral and antitumor effects of this combination of IFNS in vivo.					57706	79577	79156	7057	10725	9265	2909	7905	25897	2908	26578	657	23294	8738	23102	4121	9645	81	9760	4094	11214	9962	965	9779	80790	9749	7132	79443	782	6533	6934	388552	139886	80212	3092	64926	26505	9246	123920	151393	4603	57590	8837	113263	4217	139716	29994	11221	4277	5527	1213	192670	10138	1495	9213	64215	28966	55421	3127	114881	55205	7533	90379	1979	80205	79658	9334	5552	100506736	26191	5605	4864	23020	79465	51279	91607	6484	92675	4067	2060	4627	25938	23129	23710	9746	54440	9649	115548	4542	3937	6867	6916	2778	7040	9945	9231	26051	9926	29887	91452	203427	489	23392	55796	285386	116113	5780	10548	308	115	8879	2185	9989	4763	79925	5305	2775	55738	50515	10608	30845	64746	84316	338692	254048	283578	406	5797	59084	124995	3936	51225	57489	10787	5521	55293	8216	7434	4818	146857	4644	10312	116496	84056	4739	57493	2534	5962	118788	60489	10749	1739	8705	313	4090	83988	20	130589	23062	7544	241	3600	115992	4267	26053	54762	677769	1844	59339	5333	54622	85379	604	9447	10219	57205	6352	8452	317649	3685	163486	54477	3820	1234	23218	5294	56255	22883	140564	257364	144108	79956	6510	6310	374354	377
GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP	M6514		16800785	Sanda C,Weitzel P,Tsukahara T,Schaley J,Edenberg HJ,Stephens MA,McClintick JN,Blatt LM,Li L,Brodsky L,Taylor MW	GSE5542	GSE5542_3330_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in epithelial cells (6h): untreated versus interferon alpha.	Type I and type II interferons (IFNs) bind to different cell surface receptors but activate overlapping signal transduction pathways. We examined the effects of a type I IFN (IFN-acon1) and a type II iFN (IFN-g1b) on gene experession in A549 cells and demonstrate that there is a common set of genes modulated by both IFNs as well as a set of gene specifically regulated by each, reflecting the activation of different signaling pathways. In particualr, IFN-g induced many more genes of the signaling pathways, apoptosis, and cytokine interactions than did IFN-a. Even with genes induced by both IFNs there were distinctive quantitativive differences in expression. IFN-g1b plays a major role in the induction and regulation of the complement pathway. Previous work has shown a synergistic antivral and antiproliferative effect of type I and type II IFNs in cell culture and in the treament of tumors in mice. We demonstrate that a majority of genes showed and additive effect of IFN-acon1 and IFN-g1b, but a subset of gene is synergistically induced; these incluce ISG10, MX2, OAS2, and other genes known to be involved in the antiviral response, TRAIL (TNFSF10) and caspases involved in apoptosis and chemokine genes RANTES, CXCL10, and CXCL11. Greater than additive transcription of some of these genes in the presence of both IFNs was confirmed by real-time kinetic RT-PCR. Elevated induction of many of these genes may be sufficient to explain the synergistic antiviral and antitumor effects of this combination of IFNS in vivo.					2534	9929	10019	2149	55361	8807	23597	9881	201633	56650	130576	26018	214	283989	4267	135112	127254	11100	2330	3965	149628	80790	2495	116984	782	5063	6262	92799	285759	9749	166793	200316	89795	4597	10090	285513	79931	6310	1880	79026	5314	6489	7798	3824	5527	3092	355	115992	526	9130	80228	639	2043	8242	4650	377	10783	64078	3993	8556	1192	6472	57649	83851	4957	285313	7094	143686	2782	9632	10010	23406	9711	3043	10333	55117	9047	7040	10211	11262	154141	4773	2833	823	390894	64854	5092	53349	5932	5729	23218	4864	4772	7049	94015	54020	8826	23657	11035	4214	864	84868	50515	23204	8661	57381	79180	84159	83959	146336	3688	81563	83442	2625	302	27122	157506	11221	9663	909	64859	115361	3003	130589	116496	307	63941	407013	5465	23208	30009	81793	4208	23139	146705	2040	4967	10800	9839	7786	132	353323	4542	2153	283174	6504	7804	965	2042	8530	55646	493	400661	79651	85463	353345	953	81	26286	79962	81448	51232	10051	2120	344805	26188	10461	2081	84282	9766	8320	115004	54904	23710	55901	657	112937	3662	341883	6854	64771	79368	3560	497049	4603	120400	6836	6777	2696	1371	6397	1822	406991
GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_DN	M6516		16800785	Sanda C,Weitzel P,Tsukahara T,Schaley J,Edenberg HJ,Stephens MA,McClintick JN,Blatt LM,Li L,Brodsky L,Taylor MW	GSE5542	GSE5542_3330_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in epithelial cells (6h): untreated versus interferon alpha.	Type I and type II interferons (IFNs) bind to different cell surface receptors but activate overlapping signal transduction pathways. We examined the effects of a type I IFN (IFN-acon1) and a type II iFN (IFN-g1b) on gene experession in A549 cells and demonstrate that there is a common set of genes modulated by both IFNs as well as a set of gene specifically regulated by each, reflecting the activation of different signaling pathways. In particualr, IFN-g induced many more genes of the signaling pathways, apoptosis, and cytokine interactions than did IFN-a. Even with genes induced by both IFNs there were distinctive quantitativive differences in expression. IFN-g1b plays a major role in the induction and regulation of the complement pathway. Previous work has shown a synergistic antivral and antiproliferative effect of type I and type II IFNs in cell culture and in the treament of tumors in mice. We demonstrate that a majority of genes showed and additive effect of IFN-acon1 and IFN-g1b, but a subset of gene is synergistically induced; these incluce ISG10, MX2, OAS2, and other genes known to be involved in the antiviral response, TRAIL (TNFSF10) and caspases involved in apoptosis and chemokine genes RANTES, CXCL10, and CXCL11. Greater than additive transcription of some of these genes in the presence of both IFNs was confirmed by real-time kinetic RT-PCR. Elevated induction of many of these genes may be sufficient to explain the synergistic antiviral and antitumor effects of this combination of IFNS in vivo.					79690	90321	23765	50808	11040	79781	388666	7915	145482	619208	54221	25801	57007	2746	2537	2550	157285	2329	129293	594	25788	5641	151393	79752	351	84942	57685	157657	9262	9674	116447	10127	5796	23613	146691	9765	87	9805	51678	51062	4897	124935	54826	286554	114879	607	25776	83734	132949	57504	91351	79183	283398	56913	26960	9241	90488	9019	285362	54989	64072	80024	285282	10235	23111	5334	119504	57212	25894	51309	91782	8801	8803	79148	4925	170575	7644	79744	23428	51176	90634	83444	246734	1266	65991	5090	147699	54581	151050	54549	6443	64172	677796	55604	57125	5324	51735	161145	3646	1385	157567	23683	84950	144363	353133	64219	8496	80108	408	375287	23357	84938	9743	100132916	6595	23059	51530	1939	6934	64118	224	55114	27315	2203	64778	55603	349565	161	56479	23258	3849	92370	51361	161779	337867	3718	78991	84693	8031	23635	5198	1207	3480	5051	7077	54532	80762	4482	7351	204	23321	374618	7784	1573	3111	51635	9792	56928	79694	114327	11107	340554	25936	7637	7552	3329	3784	54558	64089	29767	55790	93183	4048	391191	8495	387357	6785	220992	55629	5163	142940	57633	2620	9826	79145	148266	677830	8411	926	2814	83480	8187	55151	55888	7559
GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP	M6518		16800785	Sanda C,Weitzel P,Tsukahara T,Schaley J,Edenberg HJ,Stephens MA,McClintick JN,Blatt LM,Li L,Brodsky L,Taylor MW	GSE5542	GSE5542_3331_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in epithelial cells (6h): untreated versus interferon alpha and IFNG [GeneID=3458].	Type I and type II interferons (IFNs) bind to different cell surface receptors but activate overlapping signal transduction pathways. We examined the effects of a type I IFN (IFN-acon1) and a type II iFN (IFN-g1b) on gene experession in A549 cells and demonstrate that there is a common set of genes modulated by both IFNs as well as a set of gene specifically regulated by each, reflecting the activation of different signaling pathways. In particualr, IFN-g induced many more genes of the signaling pathways, apoptosis, and cytokine interactions than did IFN-a. Even with genes induced by both IFNs there were distinctive quantitativive differences in expression. IFN-g1b plays a major role in the induction and regulation of the complement pathway. Previous work has shown a synergistic antivral and antiproliferative effect of type I and type II IFNs in cell culture and in the treament of tumors in mice. We demonstrate that a majority of genes showed and additive effect of IFN-acon1 and IFN-g1b, but a subset of gene is synergistically induced; these incluce ISG10, MX2, OAS2, and other genes known to be involved in the antiviral response, TRAIL (TNFSF10) and caspases involved in apoptosis and chemokine genes RANTES, CXCL10, and CXCL11. Greater than additive transcription of some of these genes in the presence of both IFNs was confirmed by real-time kinetic RT-PCR. Elevated induction of many of these genes may be sufficient to explain the synergistic antiviral and antitumor effects of this combination of IFNS in vivo.					199953	114793	155066	112937	22997	22880	5777	1823	143686	285704	26184	94081	9750	7060	6920	79656	161176	4676	4863	7134	64087	4118	29979	10683	9840	79667	10943	254042	1889	22821	55604	222255	388650	2173	64983	5213	4967	79608	27284	202018	91782	64782	23366	8458	4500	3566	26147	83955	1606	999	7476	134492	441459	23177	401045	23077	441194	4214	124997	55622	645683	3572	124535	53373	283349	50807	145864	120224	440515	57134	25992	10750	3570	27086	55466	9874	5747	26119	440689	129293	29978	11059	91937	2015	84142	8368	84230	729595	80146	3707	10223	64784	2177	149840	10347	64744	87	1123	4602	388022	342979	2592	8165	8387	29851	26762	23195	4144	55250	390927	64951	403314	994	51176	23406	8544	64777	3094	55190	55471	26249	26960	56891	23312	84277	4246	23398	9203	9086	255394	144404	401647	114548	3945	163720	1244	55081	27071	54522	4798	55640	7762	6402	391190	8906	84900	56985	202865	219833	8313	22852	30061	83592	387841	6711	4753	10783	10542	7174	54557	10472	93035	340152	90204	246119	158584	23484	51460	51444	800	1604	55793	4522	3784	8661	55695	57633	2272	163882	92	84881	5270	55536	284129	51616	689	286410	90139	78991	10174	8793	7253	54910	3641
GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN	M6519		16800785	Sanda C,Weitzel P,Tsukahara T,Schaley J,Edenberg HJ,Stephens MA,McClintick JN,Blatt LM,Li L,Brodsky L,Taylor MW	GSE5542	GSE5542_3331_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in epithelial cells (6h): untreated versus interferon alpha and IFNG [GeneID=3458].	Type I and type II interferons (IFNs) bind to different cell surface receptors but activate overlapping signal transduction pathways. We examined the effects of a type I IFN (IFN-acon1) and a type II iFN (IFN-g1b) on gene experession in A549 cells and demonstrate that there is a common set of genes modulated by both IFNs as well as a set of gene specifically regulated by each, reflecting the activation of different signaling pathways. In particualr, IFN-g induced many more genes of the signaling pathways, apoptosis, and cytokine interactions than did IFN-a. Even with genes induced by both IFNs there were distinctive quantitativive differences in expression. IFN-g1b plays a major role in the induction and regulation of the complement pathway. Previous work has shown a synergistic antivral and antiproliferative effect of type I and type II IFNs in cell culture and in the treament of tumors in mice. We demonstrate that a majority of genes showed and additive effect of IFN-acon1 and IFN-g1b, but a subset of gene is synergistically induced; these incluce ISG10, MX2, OAS2, and other genes known to be involved in the antiviral response, TRAIL (TNFSF10) and caspases involved in apoptosis and chemokine genes RANTES, CXCL10, and CXCL11. Greater than additive transcription of some of these genes in the presence of both IFNs was confirmed by real-time kinetic RT-PCR. Elevated induction of many of these genes may be sufficient to explain the synergistic antiviral and antitumor effects of this combination of IFNS in vivo.					23132	192670	79465	114881	489	7057	6533	8837	9649	4121	4094	6668	4644	6693	23102	8705	9334	6867	4603	83538	8553	5305	55257	1874	23235	10608	9945	149041	6517	389	6484	80790	57706	4864	55450	139716	4627	2672	9830	2309	9746	26505	10602	90379	7132	2185	677769	151903	8738	64926	3685	1999	116986	3984	113263	83692	83988	8932	5770	1979	22849	5581	7189	1509	23129	57493	145173	55625	55796	1158	203427	56255	5957	439921	5797	5294	6722	7881	965	79925	7043	7564	115704	115548	29068	51222	26053	405	23184	79658	6938	80256	3937	80205	139231	9683	84316	10392	54914	7533	9231	6775	6934	20	79751	23466	114785	60489	79443	9962	7329	339451	170261	163486	37	102	79668	54440	26191	5027	2526	401127	9254	90102	51303	374354	53637	3110	57732	2909	8740	25938	64837	4739	5529	285761	672	430	4354	84865	1960	9261	79156	55421	10312	9542	92675	9989	100049716	22826	81	7182	57205	51348	8671	85450	55293	54477	8577	9265	23130	51621	79956	203190	10725	9813	4217	11262	57085	115	2537	10300	2992	2591	51225	27303	7592	26524	6869	10663	81873	657	79038	10150	5791	118788	8216	140459	6916	9580	9715	719	93594	4763	57118	266727	133923
GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP	M6522		16800785	Sanda C,Weitzel P,Tsukahara T,Schaley J,Edenberg HJ,Stephens MA,McClintick JN,Blatt LM,Li L,Brodsky L,Taylor MW	GSE5542	GSE5542_3332_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in epithelial cells (24h): untreated versus IFNG [GeneID=3458].	Type I and type II interferons (IFNs) bind to different cell surface receptors but activate overlapping signal transduction pathways. We examined the effects of a type I IFN (IFN-acon1) and a type II iFN (IFN-g1b) on gene experession in A549 cells and demonstrate that there is a common set of genes modulated by both IFNs as well as a set of gene specifically regulated by each, reflecting the activation of different signaling pathways. In particualr, IFN-g induced many more genes of the signaling pathways, apoptosis, and cytokine interactions than did IFN-a. Even with genes induced by both IFNs there were distinctive quantitativive differences in expression. IFN-g1b plays a major role in the induction and regulation of the complement pathway. Previous work has shown a synergistic antivral and antiproliferative effect of type I and type II IFNs in cell culture and in the treament of tumors in mice. We demonstrate that a majority of genes showed and additive effect of IFN-acon1 and IFN-g1b, but a subset of gene is synergistically induced; these incluce ISG10, MX2, OAS2, and other genes known to be involved in the antiviral response, TRAIL (TNFSF10) and caspases involved in apoptosis and chemokine genes RANTES, CXCL10, and CXCL11. Greater than additive transcription of some of these genes in the presence of both IFNs was confirmed by real-time kinetic RT-PCR. Elevated induction of many of these genes may be sufficient to explain the synergistic antiviral and antitumor effects of this combination of IFNS in vivo.					9766	9047	1741	150771	157506	257364	824	3595	10019	2060	400224	406991	9926	7371	56650	222256	9929	10608	3995	10090	2355	9760	133418	23176	302	51232	283554	4214	37	6836	79026	79651	4773	23208	196264	4641	3003	114548	5606	10525	11221	55884	6504	8826	94015	55361	94120	8661	55122	54436	2149	23597	5925	2495	54472	377	123606	23204	9749	50515	9447	100506736	9261	4159	3560	143686	4597	29	283174	60489	7415	10908	283989	51248	1880	27303	154141	7049	7465	91607	7430	533	9900	1844	782	2720	7798	26018	3710	9815	9989	285759	8566	5153	6777	4957	55640	3594	57553	8844	10538	2040	6645	28232	23710	2534	149628	23151	79815	4542	7133	5552	23062	23261	2909	340526	200316	6489	64215	10312	79654	84056	1233	8638	30009	636	9839	130589	5527	79712	201633	80149	1534	7310	3688	6397	23365	79931	407013	83442	5797	4967	10749	94241	63925	7804	81	84159	23180	60485	55605	246175	2889	55646	355	4603	8807	3824	1192	440352	4267	5997	8777	1102	90139	57514	214	10886	51063	10043	6256	1636	9881	6310	3993	7253	10133	2519	57405	140564	23345	146880	79598	6509	8408	953	784	8729	26053	130075	23129	7057	783	1123	54855	5331
GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN	M6523		16800785	Sanda C,Weitzel P,Tsukahara T,Schaley J,Edenberg HJ,Stephens MA,McClintick JN,Blatt LM,Li L,Brodsky L,Taylor MW	GSE5542	GSE5542_3332_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in epithelial cells (24h): untreated versus IFNG [GeneID=3458].	Type I and type II interferons (IFNs) bind to different cell surface receptors but activate overlapping signal transduction pathways. We examined the effects of a type I IFN (IFN-acon1) and a type II iFN (IFN-g1b) on gene experession in A549 cells and demonstrate that there is a common set of genes modulated by both IFNs as well as a set of gene specifically regulated by each, reflecting the activation of different signaling pathways. In particualr, IFN-g induced many more genes of the signaling pathways, apoptosis, and cytokine interactions than did IFN-a. Even with genes induced by both IFNs there were distinctive quantitativive differences in expression. IFN-g1b plays a major role in the induction and regulation of the complement pathway. Previous work has shown a synergistic antivral and antiproliferative effect of type I and type II IFNs in cell culture and in the treament of tumors in mice. We demonstrate that a majority of genes showed and additive effect of IFN-acon1 and IFN-g1b, but a subset of gene is synergistically induced; these incluce ISG10, MX2, OAS2, and other genes known to be involved in the antiviral response, TRAIL (TNFSF10) and caspases involved in apoptosis and chemokine genes RANTES, CXCL10, and CXCL11. Greater than additive transcription of some of these genes in the presence of both IFNs was confirmed by real-time kinetic RT-PCR. Elevated induction of many of these genes may be sufficient to explain the synergistic antiviral and antitumor effects of this combination of IFNS in vivo.					7077	5199	2537	10056	1953	84142	25894	51250	28514	56985	79781	3784	4780	1131	84449	64773	147699	134430	404550	80746	9674	1802	2053	1573	84330	157657	162972	2550	2639	3111	5860	23283	55277	129293	89782	124961	51765	10235	9241	8495	5796	2203	146691	91947	57591	57393	79863	91782	8460	54532	119504	23357	9792	55766	157285	28683	57007	26289	494143	100507444	5575	2329	25788	619208	224	55794	84186	1207	4302	64172	117247	81606	80823	64216	145482	50808	96764	51735	6856	64318	8498	677833	51678	27284	80216	148808	25966	143888	5058	54948	113612	5335	4343	151194	25776	4609	79890	79690	4008	10077	2188	87769	843	677776	4897	79738	1519	56993	57209	79814	54221	55266	677796	7754	55506	5362	6920	23404	344558	54665	283337	900	349565	57447	7372	23059	26119	90488	91975	346157	23658	114804	124935	56928	4925	23212	87	27128	1875	10804	388566	7712	56479	4306	4677	221504	55906	6869	7294	23648	10244	3480	4907	3655	55902	231	114879	7552	7915	9338	5198	8907	11222	85478	55304	57691	55536	80108	2235	51309	9805	7343	1977	2395	7637	100129858	51062	165	54558	60468	7091	23526	149830	10767	55888	6720	348378	10807	163131	51263	26960	161145	23635	9181	955	56339	4048	594	7325
GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP	M6524		16800785	Sanda C,Weitzel P,Tsukahara T,Schaley J,Edenberg HJ,Stephens MA,McClintick JN,Blatt LM,Li L,Brodsky L,Taylor MW	GSE5542	GSE5542_3333_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in epithelial cells (24h): untreated versus interferon alpha.	Type I and type II interferons (IFNs) bind to different cell surface receptors but activate overlapping signal transduction pathways. We examined the effects of a type I IFN (IFN-acon1) and a type II iFN (IFN-g1b) on gene experession in A549 cells and demonstrate that there is a common set of genes modulated by both IFNs as well as a set of gene specifically regulated by each, reflecting the activation of different signaling pathways. In particualr, IFN-g induced many more genes of the signaling pathways, apoptosis, and cytokine interactions than did IFN-a. Even with genes induced by both IFNs there were distinctive quantitativive differences in expression. IFN-g1b plays a major role in the induction and regulation of the complement pathway. Previous work has shown a synergistic antivral and antiproliferative effect of type I and type II IFNs in cell culture and in the treament of tumors in mice. We demonstrate that a majority of genes showed and additive effect of IFN-acon1 and IFN-g1b, but a subset of gene is synergistically induced; these incluce ISG10, MX2, OAS2, and other genes known to be involved in the antiviral response, TRAIL (TNFSF10) and caspases involved in apoptosis and chemokine genes RANTES, CXCL10, and CXCL11. Greater than additive transcription of some of these genes in the presence of both IFNs was confirmed by real-time kinetic RT-PCR. Elevated induction of many of these genes may be sufficient to explain the synergistic antiviral and antitumor effects of this combination of IFNS in vivo.					64215	257364	80256	139716	4597	9760	6489	3710	22883	6310	55038	146857	7533	64859	116984	55625	10392	2534	26020	55565	7430	340526	6504	23597	50515	55361	2355	784	100506736	207	81563	133418	4763	23048	59339	1844	782	2672	2060	7804	152007	56907	55450	57649	11035	115	79026	9989	2909	377	10019	10401	1857	399909	5053	9139	864	3422	130589	25897	28966	8974	9815	26578	4542	3003	79651	2157	8099	79712	8932	9749	5962	5531	6916	2488	94241	115548	6777	64926	5366	55223	9945	6693	5530	2908	9261	51063	37	23710	79443	396	254778	4121	2149	6533	2625	55177	83931	26018	4267	387882	5797	135112	63925	55293	9034	94120	9447	79658	146183	3984	91039	57590	54855	7905	2650	10608	114881	3268	5780	8837	84056	201633	60489	4739	29	2495	11100	8111	752	4627	4967	115992	8844	139231	5142	2782	9766	489	91607	4818	92799	3092	3423	27303	84079	10787	6452	57489	9663	9929	55640	214	9645	6484	2775	79931	23151	308	10745	55205	657	80790	355	23387	80212	83719	23020	493	124995	824	9881	7128	2842	5253	8682	9746	11221	28232	101	8320	5527	84282	55001	64218	64224	145508	81855	1495	5581	10908	9047	6256	23365	23333	23235
GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_DN	M6525		16800785	Sanda C,Weitzel P,Tsukahara T,Schaley J,Edenberg HJ,Stephens MA,McClintick JN,Blatt LM,Li L,Brodsky L,Taylor MW	GSE5542	GSE5542_3333_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in epithelial cells (24h): untreated versus interferon alpha.	Type I and type II interferons (IFNs) bind to different cell surface receptors but activate overlapping signal transduction pathways. We examined the effects of a type I IFN (IFN-acon1) and a type II iFN (IFN-g1b) on gene experession in A549 cells and demonstrate that there is a common set of genes modulated by both IFNs as well as a set of gene specifically regulated by each, reflecting the activation of different signaling pathways. In particualr, IFN-g induced many more genes of the signaling pathways, apoptosis, and cytokine interactions than did IFN-a. Even with genes induced by both IFNs there were distinctive quantitativive differences in expression. IFN-g1b plays a major role in the induction and regulation of the complement pathway. Previous work has shown a synergistic antivral and antiproliferative effect of type I and type II IFNs in cell culture and in the treament of tumors in mice. We demonstrate that a majority of genes showed and additive effect of IFN-acon1 and IFN-g1b, but a subset of gene is synergistically induced; these incluce ISG10, MX2, OAS2, and other genes known to be involved in the antiviral response, TRAIL (TNFSF10) and caspases involved in apoptosis and chemokine genes RANTES, CXCL10, and CXCL11. Greater than additive transcription of some of these genes in the presence of both IFNs was confirmed by real-time kinetic RT-PCR. Elevated induction of many of these genes may be sufficient to explain the synergistic antiviral and antitumor effects of this combination of IFNS in vivo.					730087	57007	3646	64784	57691	10767	767582	10606	7343	9324	26249	2005	100507444	65991	27343	4008	57128	84942	10541	56928	8736	30061	90321	22934	28969	196913	2746	23386	8498	57685	5747	55776	157657	8907	1345	2329	9238	54532	26157	51123	51187	55226	10056	4149	80216	54665	4522	5199	56985	79839	1555	619208	64983	51765	26119	55536	116447	344558	22880	285282	2272	7637	10244	3783	23357	973	89978	3570	158880	55277	283349	10913	144363	64744	4118	5777	81890	5796	124454	80746	27018	1633	10750	91782	54557	8495	9840	2550	163131	50808	89782	408	64434	708	224	23107	79961	283337	29904	84705	5757	124989	5198	128346	8460	441549	10988	346157	84441	129293	440278	140807	79979	9241	843	151393	7048	2053	55116	689	10026	6403	84142	10077	85315	64072	78991	9698	51611	1606	6920	157285	81929	94081	3784	8793	790	319101	51097	1875	4926	23177	10235	25801	79667	51633	6147	57189	79145	84498	11107	4205	2334	54581	25776	23366	22821	23428	79777	91574	29104	53347	55790	55139	91975	199	5575	374618	1327	112937	55793	283398	51312	79148	54737	25926	1122	9045	3707	51309	84307	57504	11040	92399	57600	25851	348995	2628	23214	57109	79752	27345	150864
GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP	M6527		16800785	Sanda C,Weitzel P,Tsukahara T,Schaley J,Edenberg HJ,Stephens MA,McClintick JN,Blatt LM,Li L,Brodsky L,Taylor MW	GSE5542	GSE5542_3334_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in epithelial cells (24h): untreated versus interferon alpha and IFNG [GeneID=3458].	Type I and type II interferons (IFNs) bind to different cell surface receptors but activate overlapping signal transduction pathways. We examined the effects of a type I IFN (IFN-acon1) and a type II iFN (IFN-g1b) on gene experession in A549 cells and demonstrate that there is a common set of genes modulated by both IFNs as well as a set of gene specifically regulated by each, reflecting the activation of different signaling pathways. In particualr, IFN-g induced many more genes of the signaling pathways, apoptosis, and cytokine interactions than did IFN-a. Even with genes induced by both IFNs there were distinctive quantitativive differences in expression. IFN-g1b plays a major role in the induction and regulation of the complement pathway. Previous work has shown a synergistic antivral and antiproliferative effect of type I and type II IFNs in cell culture and in the treament of tumors in mice. We demonstrate that a majority of genes showed and additive effect of IFN-acon1 and IFN-g1b, but a subset of gene is synergistically induced; these incluce ISG10, MX2, OAS2, and other genes known to be involved in the antiviral response, TRAIL (TNFSF10) and caspases involved in apoptosis and chemokine genes RANTES, CXCL10, and CXCL11. Greater than additive transcription of some of these genes in the presence of both IFNs was confirmed by real-time kinetic RT-PCR. Elevated induction of many of these genes may be sufficient to explain the synergistic antiviral and antitumor effects of this combination of IFNS in vivo.					4644	5210	2733	170371	10228	118924	57194	221294	5425	6533	29122	9092	346389	163	2817	81624	4836	80024	23129	55081	3516	115123	11231	29922	54822	255043	366	51194	339983	6891	60626	64108	10926	90381	85019	91949	57003	10901	10928	8530	58506	5603	7392	5965	141	5719	145508	55825	22906	6464	51493	1111	84264	7422	84986	84717	55652	64975	22822	11260	9256	8872	29063	2947	64105	57178	9650	55198	2098	84337	9868	124997	10016	6205	30	51283	10989	11143	64949	728489	79727	120103	151195	84002	23392	10200	112479	22897	687	54521	10628	929	3141	197259	5996	613	1831	254394	158219	51429	27338	1359	8733	54995	6168	51750	378938	54780	55561	219972	10112	392275	3843	1730	6844	3123	4726	51013	134637	10412	81552	10939	6141	283464	377007	84254	26191	9910	9847	6916	54931	146857	5087	8099	6629	57018	51260	55055	5915	83732	100505741	11331	25937	55702	1388	55686	130617	5495	3178	81565	29919	10425	10906	375757	26580	63943	9777	908	51031	9839	9021	159090	5859	7130	51642	55287	27248	79736	2958	5356	51264	5411	57291	10221	80776	5203	22818	113419	51430	10987	51720	10085	5695	2582	27089	115817	2334	483	6341	55471	5786	56929	8467	26233	80817	1861	57571	10480	976	9334
GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN	M6529		16800785	Sanda C,Weitzel P,Tsukahara T,Schaley J,Edenberg HJ,Stephens MA,McClintick JN,Blatt LM,Li L,Brodsky L,Taylor MW	GSE5542	GSE5542_3334_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in epithelial cells (24h): untreated versus interferon alpha and IFNG [GeneID=3458].	Type I and type II interferons (IFNs) bind to different cell surface receptors but activate overlapping signal transduction pathways. We examined the effects of a type I IFN (IFN-acon1) and a type II iFN (IFN-g1b) on gene experession in A549 cells and demonstrate that there is a common set of genes modulated by both IFNs as well as a set of gene specifically regulated by each, reflecting the activation of different signaling pathways. In particualr, IFN-g induced many more genes of the signaling pathways, apoptosis, and cytokine interactions than did IFN-a. Even with genes induced by both IFNs there were distinctive quantitativive differences in expression. IFN-g1b plays a major role in the induction and regulation of the complement pathway. Previous work has shown a synergistic antivral and antiproliferative effect of type I and type II IFNs in cell culture and in the treament of tumors in mice. We demonstrate that a majority of genes showed and additive effect of IFN-acon1 and IFN-g1b, but a subset of gene is synergistically induced; these incluce ISG10, MX2, OAS2, and other genes known to be involved in the antiviral response, TRAIL (TNFSF10) and caspases involved in apoptosis and chemokine genes RANTES, CXCL10, and CXCL11. Greater than additive transcription of some of these genes in the presence of both IFNs was confirmed by real-time kinetic RT-PCR. Elevated induction of many of these genes may be sufficient to explain the synergistic antiviral and antitumor effects of this combination of IFNS in vivo.					3423	8972	79791	1622	10808	619279	4815	64081	10713	55851	1432	333926	7091	3301	26122	221178	975	6717	8644	55898	147323	51105	144348	84167	55009	5894	9815	1974	1937	1267	6449	7128	7053	84696	55022	23382	23526	4215	9611	84864	59341	23409	8819	25764	7227	126432	115330	2792	7074	51170	337876	25914	55144	1137	4664	2769	6296	2280	962	9296	1509	6524	124460	151903	9424	81619	1496	55454	5790	4635	51603	84162	6294	23673	10181	57223	111	10724	375791	51205	3187	22916	203562	118429	3241	6035	4063	89857	55300	4004	598	6901	29986	84803	2132	51646	5594	50632	6714	231	6767	23070	57326	11010	54540	135	51547	26994	9609	224	6636	3273	56124	51566	134285	126410	4642	84069	1808	51218	10402	65082	8288	202374	1401	10728	266655	28231	79772	642623	201627	23176	1912	3938	1201	202243	51276	79572	26059	51693	6990	375	7512	79718	200634	774	9926	7798	55106	388662	5795	80725	1982	23601	221002	5763	3937	3071	6523	57822	23195	401548	10621	7455	83445	254102	132851	11168	683	7096	10434	51094	55752	3267	51306	23386	92609	3248	10964	79894	5029	51335	7508	5501	148753	8424	3753	7107	80021	7138	5518	83891	135886	56548	84329	1476	6670	5564	196294	56997
GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP	M6531		16800785	Sanda C,Weitzel P,Tsukahara T,Schaley J,Edenberg HJ,Stephens MA,McClintick JN,Blatt LM,Li L,Brodsky L,Taylor MW	GSE5542	GSE5542_3335_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in epithelial cells (6h): IFNG [GeneID=3458] versus IFNG [GeneID=3458] and interferon alpha.	Type I and type II interferons (IFNs) bind to different cell surface receptors but activate overlapping signal transduction pathways. We examined the effects of a type I IFN (IFN-acon1) and a type II iFN (IFN-g1b) on gene experession in A549 cells and demonstrate that there is a common set of genes modulated by both IFNs as well as a set of gene specifically regulated by each, reflecting the activation of different signaling pathways. In particualr, IFN-g induced many more genes of the signaling pathways, apoptosis, and cytokine interactions than did IFN-a. Even with genes induced by both IFNs there were distinctive quantitativive differences in expression. IFN-g1b plays a major role in the induction and regulation of the complement pathway. Previous work has shown a synergistic antivral and antiproliferative effect of type I and type II IFNs in cell culture and in the treament of tumors in mice. We demonstrate that a majority of genes showed and additive effect of IFN-acon1 and IFN-g1b, but a subset of gene is synergistically induced; these incluce ISG10, MX2, OAS2, and other genes known to be involved in the antiviral response, TRAIL (TNFSF10) and caspases involved in apoptosis and chemokine genes RANTES, CXCL10, and CXCL11. Greater than additive transcription of some of these genes in the presence of both IFNs was confirmed by real-time kinetic RT-PCR. Elevated induction of many of these genes may be sufficient to explain the synergistic antiviral and antitumor effects of this combination of IFNS in vivo.					286053	25948	10283	6990	8614	5081	51021	9801	8208	9694	286148	8546	9550	162979	11079	79690	253714	228	79886	54973	10928	90506	79803	5023	57620	147111	22933	338707	51060	2245	2581	83989	391059	84069	574414	1601	23556	54622	7180	10464	8309	411	79147	10299	2207	90507	6357	83463	3936	5584	521	9810	23067	26128	7431	4193	79573	391195	54994	286410	127002	10428	23589	79959	89849	8128	79807	348793	11344	10245	9354	11189	23032	5625	1173	79447	2553	101	55544	57594	116969	1982	8395	55148	6631	9736	142678	10682	9738	10272	8851	1314	9675	141	131965	51535	54512	27258	150372	4141	7408	23157	84255	55860	440193	9260	23057	286753	54849	197131	8402	84928	57511	116064	23530	56965	51315	2011	93594	9725	1262	1611	9351	72	11235	10368	4257	30812	10718	11092	50515	51079	4828	84085	25943	346288	400745	2033	51665	114905	8932	55529	339456	79622	10870	29107	9031	1859	57524	79723	23620	8545	27034	54554	5049	83861	59339	123811	23406	6840	419	10597	221504	116442	60560	64926	79137	10636	8815	391	728656	64400	6277	51258	218	2710	9685	23398	10057	1021	323	10247	130916	432	10042	80005	11218	128602	2664	9896	79836	160762	91181	9797	23191	84288	80208	51776	84560	146956
GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN	M6533		16800785	Sanda C,Weitzel P,Tsukahara T,Schaley J,Edenberg HJ,Stephens MA,McClintick JN,Blatt LM,Li L,Brodsky L,Taylor MW	GSE5542	GSE5542_3335_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in epithelial cells (6h): IFNG [GeneID=3458] versus IFNG [GeneID=3458] and interferon alpha.	Type I and type II interferons (IFNs) bind to different cell surface receptors but activate overlapping signal transduction pathways. We examined the effects of a type I IFN (IFN-acon1) and a type II iFN (IFN-g1b) on gene experession in A549 cells and demonstrate that there is a common set of genes modulated by both IFNs as well as a set of gene specifically regulated by each, reflecting the activation of different signaling pathways. In particualr, IFN-g induced many more genes of the signaling pathways, apoptosis, and cytokine interactions than did IFN-a. Even with genes induced by both IFNs there were distinctive quantitativive differences in expression. IFN-g1b plays a major role in the induction and regulation of the complement pathway. Previous work has shown a synergistic antivral and antiproliferative effect of type I and type II IFNs in cell culture and in the treament of tumors in mice. We demonstrate that a majority of genes showed and additive effect of IFN-acon1 and IFN-g1b, but a subset of gene is synergistically induced; these incluce ISG10, MX2, OAS2, and other genes known to be involved in the antiviral response, TRAIL (TNFSF10) and caspases involved in apoptosis and chemokine genes RANTES, CXCL10, and CXCL11. Greater than additive transcription of some of these genes in the presence of both IFNs was confirmed by real-time kinetic RT-PCR. Elevated induction of many of these genes may be sufficient to explain the synergistic antiviral and antitumor effects of this combination of IFNS in vivo.					5335	9766	11080	8648	26031	60626	83594	4214	1186	5142	3418	8800	253782	4548	10563	113655	54870	56648	9677	23077	5281	57095	91	1352	38	7779	26523	5575	55005	55700	9073	4282	171425	388701	51194	7305	54431	255758	51752	79090	6610	1967	29095	552900	55082	26090	9258	170384	51102	5292	4000	6391	92689	3419	91828	4481	56853	145173	1973	768	10298	64343	23049	339977	27245	1632	124056	81894	6510	6772	286097	9153	123606	6171	51380	54880	10075	6875	4068	55101	5025	5295	6188	4209	84522	153443	54556	7805	26580	10749	84317	56243	401466	27429	51004	27340	175	6169	23002	84617	9600	8263	9500	23158	9158	11160	30845	2309	6232	3956	9817	159371	5154	79132	8645	23428	90203	25946	27335	56915	26039	3918	55624	103	4647	6775	23271	23180	8710	163590	1595	2043	23176	4594	637	10455	7367	8893	123720	5810	26260	9843	171389	10152	3032	55644	55500	1656	5685	7019	6152	83451	51077	3600	10939	84541	57584	83723	513	642273	8503	79791	60487	256949	10809	2158	169200	56919	11173	4856	55173	6203	51029	3384	55652	205564	283373	57104	157657	8711	8082	8204	8634	2306	55015	254042	4718	824	5973	51250	23603	100128731	25977	126382	6295	8818	246269	5763	56681	30837
GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP	M6535		16800785	Sanda C,Weitzel P,Tsukahara T,Schaley J,Edenberg HJ,Stephens MA,McClintick JN,Blatt LM,Li L,Brodsky L,Taylor MW	GSE5542	GSE5542_3336_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in epithelial cells (24h): IFNG [GeneID=3458] versus IFNG [GeneID=3458] and interferon alpha.	Type I and type II interferons (IFNs) bind to different cell surface receptors but activate overlapping signal transduction pathways. We examined the effects of a type I IFN (IFN-acon1) and a type II iFN (IFN-g1b) on gene experession in A549 cells and demonstrate that there is a common set of genes modulated by both IFNs as well as a set of gene specifically regulated by each, reflecting the activation of different signaling pathways. In particualr, IFN-g induced many more genes of the signaling pathways, apoptosis, and cytokine interactions than did IFN-a. Even with genes induced by both IFNs there were distinctive quantitativive differences in expression. IFN-g1b plays a major role in the induction and regulation of the complement pathway. Previous work has shown a synergistic antivral and antiproliferative effect of type I and type II IFNs in cell culture and in the treament of tumors in mice. We demonstrate that a majority of genes showed and additive effect of IFN-acon1 and IFN-g1b, but a subset of gene is synergistically induced; these incluce ISG10, MX2, OAS2, and other genes known to be involved in the antiviral response, TRAIL (TNFSF10) and caspases involved in apoptosis and chemokine genes RANTES, CXCL10, and CXCL11. Greater than additive transcription of some of these genes in the presence of both IFNs was confirmed by real-time kinetic RT-PCR. Elevated induction of many of these genes may be sufficient to explain the synergistic antiviral and antitumor effects of this combination of IFNS in vivo.					221150	4144	158427	84189	51079	2800	4733	4716	10155	55206	58526	975	552889	26065	23603	23514	55646	3065	7074	5893	54964	5261	6470	3705	1879	129138	84317	4237	10379	50649	6583	11177	6772	22818	1608	23421	9910	56946	3156	51083	1756	64777	6294	10245	115294	79959	85460	54780	286257	140679	9183	339487	84337	7408	6901	6801	6383	51643	51031	3619	23521	79634	26010	9939	1438	400506	129607	10513	57003	5612	3141	9980	55706	79090	28984	222487	158046	208	8603	140735	23269	6867	55652	119710	11333	80222	10148	29990	79663	389610	7077	201254	57591	255783	6389	55072	10257	55819	3796	6631	65080	55342	23054	890	4724	5426	8019	56658	6929	10870	3704	836	10541	3434	1298	80817	9525	85437	9278	26523	26130	84206	5598	26164	54455	5256	10528	56882	6183	6729	51430	121536	80127	11010	64771	10565	4292	5894	29108	10370	51160	154288	79172	1455	3292	10694	3631	151473	6430	408	201725	9465	23080	117178	6651	6721	1118	5596	4633	170394	5528	5147	7305	51024	79651	51111	8925	7027	6599	85027	6404	10057	151246	171546	10904	79724	79865	79792	2820	4149	9212	10421	353274	10628	678	9049	8531	51258	4176	84693	10767	55329	55319	91947	7543	91010	89846	253430	9530	8915
GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN	M6536		16800785	Sanda C,Weitzel P,Tsukahara T,Schaley J,Edenberg HJ,Stephens MA,McClintick JN,Blatt LM,Li L,Brodsky L,Taylor MW	GSE5542	GSE5542_3336_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in epithelial cells (24h): IFNG [GeneID=3458] versus IFNG [GeneID=3458] and interferon alpha.	Type I and type II interferons (IFNs) bind to different cell surface receptors but activate overlapping signal transduction pathways. We examined the effects of a type I IFN (IFN-acon1) and a type II iFN (IFN-g1b) on gene experession in A549 cells and demonstrate that there is a common set of genes modulated by both IFNs as well as a set of gene specifically regulated by each, reflecting the activation of different signaling pathways. In particualr, IFN-g induced many more genes of the signaling pathways, apoptosis, and cytokine interactions than did IFN-a. Even with genes induced by both IFNs there were distinctive quantitativive differences in expression. IFN-g1b plays a major role in the induction and regulation of the complement pathway. Previous work has shown a synergistic antivral and antiproliferative effect of type I and type II IFNs in cell culture and in the treament of tumors in mice. We demonstrate that a majority of genes showed and additive effect of IFN-acon1 and IFN-g1b, but a subset of gene is synergistically induced; these incluce ISG10, MX2, OAS2, and other genes known to be involved in the antiviral response, TRAIL (TNFSF10) and caspases involved in apoptosis and chemokine genes RANTES, CXCL10, and CXCL11. Greater than additive transcription of some of these genes in the presence of both IFNs was confirmed by real-time kinetic RT-PCR. Elevated induction of many of these genes may be sufficient to explain the synergistic antiviral and antitumor effects of this combination of IFNS in vivo.					116071	10463	401399	8819	84133	254359	10006	80173	347404	11250	54345	84935	338596	221883	4664	114926	5533	2263	220002	969	5228	9397	7112	6617	130367	2932	229	647024	84898	3992	2069	654	22803	3918	1977	2838	5311	80013	100271849	387914	1281	9295	475	1491	50804	84649	4820	55788	253012	51361	80352	201931	3491	59341	27290	9258	84167	10497	115286	7016	55512	388650	27341	1936	285671	23161	7166	26063	55173	65993	23180	8321	3593	7957	396	55812	760	6319	51019	8828	7511	23143	51499	5770	90843	4921	22903	5727	2171	10611	55317	10390	66008	221785	56204	10047	55734	113655	80176	8660	339327	8672	84691	51463	54845	9953	51629	4711	9306	160728	27284	7113	10209	4000	25764	4225	2886	11226	387032	152185	6884	7126	79977	9424	51218	6747	3294	10809	3659	55720	92922	22904	23168	57583	7360	8906	7011	83999	6949	219972	9855	1536	874	2317	4063	26960	2730	8521	80022	8569	257106	8706	80724	84542	30009	55623	2653	5160	22	340075	84885	84069	84955	51378	2702	84614	25903	4929	2098	10489	9354	84807	22920	6561	27309	5738	51084	57190	57468	11021	259307	933	26118	10631	389072	146057	3973	9958	29911	219771	10595	10110	9896	3881	10329	5866	30833	23179	8139	65977
GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP	M6537		16800785	Sanda C,Weitzel P,Tsukahara T,Schaley J,Edenberg HJ,Stephens MA,McClintick JN,Blatt LM,Li L,Brodsky L,Taylor MW	GSE5542	GSE5542_3337_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in epithelial cells (6h): interferon alpha versus interferon alpha and IFNG [GeneID=3458].	Type I and type II interferons (IFNs) bind to different cell surface receptors but activate overlapping signal transduction pathways. We examined the effects of a type I IFN (IFN-acon1) and a type II iFN (IFN-g1b) on gene experession in A549 cells and demonstrate that there is a common set of genes modulated by both IFNs as well as a set of gene specifically regulated by each, reflecting the activation of different signaling pathways. In particualr, IFN-g induced many more genes of the signaling pathways, apoptosis, and cytokine interactions than did IFN-a. Even with genes induced by both IFNs there were distinctive quantitativive differences in expression. IFN-g1b plays a major role in the induction and regulation of the complement pathway. Previous work has shown a synergistic antivral and antiproliferative effect of type I and type II IFNs in cell culture and in the treament of tumors in mice. We demonstrate that a majority of genes showed and additive effect of IFN-acon1 and IFN-g1b, but a subset of gene is synergistically induced; these incluce ISG10, MX2, OAS2, and other genes known to be involved in the antiviral response, TRAIL (TNFSF10) and caspases involved in apoptosis and chemokine genes RANTES, CXCL10, and CXCL11. Greater than additive transcription of some of these genes in the presence of both IFNs was confirmed by real-time kinetic RT-PCR. Elevated induction of many of these genes may be sufficient to explain the synergistic antiviral and antitumor effects of this combination of IFNS in vivo.					90506	347741	8522	51703	55183	6197	4142	116442	5023	57194	137872	646174	6426	975	79791	10979	80709	85378	57594	8896	57695	10521	441161	26030	8208	402778	391195	112495	2581	93550	57583	391	163154	6631	10200	4193	6470	84289	57620	128602	7409	54465	64895	84069	515	84255	64975	29081	91369	2931	8915	83659	9351	154790	142678	4815	9138	4289	56946	4899	9230	10586	643866	4761	128178	402569	65220	7812	23760	23358	55702	80341	55248	4034	8372	54796	9236	8193	134187	2618	23406	51534	117178	3177	25929	339983	79086	83932	1453	613	84232	55359	79953	730094	402682	80011	126326	51538	51603	23161	80351	10392	115817	84071	127933	4676	10801	84083	56889	6330	2529	1633	8732	8424	345	6758	535	201254	1262	79786	25819	8516	11021	64768	1137	140689	51651	80230	8273	728294	3643	54826	286205	10137	9027	10042	3689	54973	23174	6525	2861	29902	7701	4520	80895	51660	9650	54991	114804	9869	129530	53944	411	7158	2224	10068	55833	51079	4059	7432	26229	64858	22809	55686	23527	10683	3054	150372	196051	338707	23061	9120	994	6590	25948	57556	55432	126308	7182	3191	9509	8091	22854	1280	64091	7053	338949	220002	2332	10943	53630	11270	9557	4194	1448	79147	56126	1289	57696
GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN	M6538		16800785	Sanda C,Weitzel P,Tsukahara T,Schaley J,Edenberg HJ,Stephens MA,McClintick JN,Blatt LM,Li L,Brodsky L,Taylor MW	GSE5542	GSE5542_3337_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in epithelial cells (6h): interferon alpha versus interferon alpha and IFNG [GeneID=3458].	Type I and type II interferons (IFNs) bind to different cell surface receptors but activate overlapping signal transduction pathways. We examined the effects of a type I IFN (IFN-acon1) and a type II iFN (IFN-g1b) on gene experession in A549 cells and demonstrate that there is a common set of genes modulated by both IFNs as well as a set of gene specifically regulated by each, reflecting the activation of different signaling pathways. In particualr, IFN-g induced many more genes of the signaling pathways, apoptosis, and cytokine interactions than did IFN-a. Even with genes induced by both IFNs there were distinctive quantitativive differences in expression. IFN-g1b plays a major role in the induction and regulation of the complement pathway. Previous work has shown a synergistic antivral and antiproliferative effect of type I and type II IFNs in cell culture and in the treament of tumors in mice. We demonstrate that a majority of genes showed and additive effect of IFN-acon1 and IFN-g1b, but a subset of gene is synergistically induced; these incluce ISG10, MX2, OAS2, and other genes known to be involved in the antiviral response, TRAIL (TNFSF10) and caspases involved in apoptosis and chemokine genes RANTES, CXCL10, and CXCL11. Greater than additive transcription of some of these genes in the presence of both IFNs was confirmed by real-time kinetic RT-PCR. Elevated induction of many of these genes may be sufficient to explain the synergistic antiviral and antitumor effects of this combination of IFNS in vivo.					5335	10298	8574	9424	55700	11231	26959	27429	8933	689	10563	1967	1594	375056	1741	10228	55435	56648	79142	84221	134266	54751	8792	80830	4665	6875	51386	147965	23505	84248	81693	5601	79070	5194	145173	253827	2570	57600	51205	6181	9538	55204	8634	79668	8722	8660	84261	55624	157285	1353	9871	23166	3357	10219	1525	27236	26589	23587	170384	23409	123606	2625	3133	5832	9843	27	84890	2185	56890	90639	221357	286467	26330	83479	63877	1521	56929	10528	284361	100	4848	22797	6776	2306	130576	2990	1140	1429	23184	2263	5279	5825	9275	8454	283991	84560	6357	9956	10436	64094	54101	10681	919	6239	23731	88745	4486	10207	51575	9641	84364	9073	55081	57037	401145	3593	93643	54757	9677	4124	29088	87178	7873	5187	5939	28512	138241	9716	56681	7844	2101	7507	158158	81894	85015	23603	387733	148808	4718	134430	2953	10404	23586	7102	155066	54933	4738	7798	2268	642273	2752	83985	55644	23549	22903	2877	81858	2790	6232	55652	9179	1281	6301	5163	3418	6764	257177	1495	126382	2158	80145	3588	2822	28962	343990	83594	1497	10519	100506742	1490	5834	84952	2631	10898	1796	5097	221302	2266	509	51102	8477	3476	4976	5551	10131	2197	54980	57662	2944	9531
GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP	M6539		16800785	Sanda C,Weitzel P,Tsukahara T,Schaley J,Edenberg HJ,Stephens MA,McClintick JN,Blatt LM,Li L,Brodsky L,Taylor MW	GSE5542	GSE5542_3338_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in epithelial cells (24h): interferon alpha versus interferon alpha and IFNG [GeneID=3458].	Type I and type II interferons (IFNs) bind to different cell surface receptors but activate overlapping signal transduction pathways. We examined the effects of a type I IFN (IFN-acon1) and a type II iFN (IFN-g1b) on gene experession in A549 cells and demonstrate that there is a common set of genes modulated by both IFNs as well as a set of gene specifically regulated by each, reflecting the activation of different signaling pathways. In particualr, IFN-g induced many more genes of the signaling pathways, apoptosis, and cytokine interactions than did IFN-a. Even with genes induced by both IFNs there were distinctive quantitativive differences in expression. IFN-g1b plays a major role in the induction and regulation of the complement pathway. Previous work has shown a synergistic antivral and antiproliferative effect of type I and type II IFNs in cell culture and in the treament of tumors in mice. We demonstrate that a majority of genes showed and additive effect of IFN-acon1 and IFN-g1b, but a subset of gene is synergistically induced; these incluce ISG10, MX2, OAS2, and other genes known to be involved in the antiviral response, TRAIL (TNFSF10) and caspases involved in apoptosis and chemokine genes RANTES, CXCL10, and CXCL11. Greater than additive transcription of some of these genes in the presence of both IFNs was confirmed by real-time kinetic RT-PCR. Elevated induction of many of these genes may be sufficient to explain the synergistic antiviral and antitumor effects of this combination of IFNS in vivo.					51666	29078	51056	4665	5788	3156	6559	55829	3336	9375	7873	114793	8725	55646	1406	2987	790	81037	4651	6793	51192	1880	10397	80217	6875	9628	2214	5995	7163	4234	64215	1630	9532	10636	154091	6748	1959	8515	7090	57673	10519	149478	3123	9308	23704	4261	2623	8091	11226	10107	55035	25827	230	7555	56896	59277	387338	9760	3516	133522	153657	597	5393	84103	154790	22809	129080	55303	81621	57535	8672	151112	6573	4321	51284	120534	1520	8676	10660	56341	23288	254042	118788	28966	83448	5611	257194	3977	55340	10912	79612	9313	53844	83594	6527	9324	921	6238	57590	115650	57291	51081	10260	4520	79879	25924	734	50515	29887	64857	26519	84665	84946	23647	3425	10690	641649	22802	92345	757	251	3215	129563	9147	27329	9404	6624	11326	9933	55187	6498	9144	89978	56919	57458	56270	8398	55170	29925	55364	23682	55131	6942	57521	84660	55973	6184	6319	25996	100170841	80179	2037	373156	9473	51751	10437	81671	4828	51575	10745	59269	4188	389206	10950	50999	121536	57205	51164	23308	6046	57533	79191	3708	10451	728	7481	8482	25973	84933	54681	2823	56931	340156	79673	285267	51605	5199	3635	811	89781	23528	27121	9450	3575	55720	9454	8611	57647	9911	255783
GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN	M6540		16800785	Sanda C,Weitzel P,Tsukahara T,Schaley J,Edenberg HJ,Stephens MA,McClintick JN,Blatt LM,Li L,Brodsky L,Taylor MW	GSE5542	GSE5542_3338_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in epithelial cells (24h): interferon alpha versus interferon alpha and IFNG [GeneID=3458].	Type I and type II interferons (IFNs) bind to different cell surface receptors but activate overlapping signal transduction pathways. We examined the effects of a type I IFN (IFN-acon1) and a type II iFN (IFN-g1b) on gene experession in A549 cells and demonstrate that there is a common set of genes modulated by both IFNs as well as a set of gene specifically regulated by each, reflecting the activation of different signaling pathways. In particualr, IFN-g induced many more genes of the signaling pathways, apoptosis, and cytokine interactions than did IFN-a. Even with genes induced by both IFNs there were distinctive quantitativive differences in expression. IFN-g1b plays a major role in the induction and regulation of the complement pathway. Previous work has shown a synergistic antivral and antiproliferative effect of type I and type II IFNs in cell culture and in the treament of tumors in mice. We demonstrate that a majority of genes showed and additive effect of IFN-acon1 and IFN-g1b, but a subset of gene is synergistically induced; these incluce ISG10, MX2, OAS2, and other genes known to be involved in the antiviral response, TRAIL (TNFSF10) and caspases involved in apoptosis and chemokine genes RANTES, CXCL10, and CXCL11. Greater than additive transcription of some of these genes in the presence of both IFNs was confirmed by real-time kinetic RT-PCR. Elevated induction of many of these genes may be sufficient to explain the synergistic antiviral and antitumor effects of this combination of IFNS in vivo.					5335	3660	259266	26750	85460	57095	7411	114883	79002	93166	8445	22949	5048	137872	11149	55793	51237	2134	157773	89958	161882	6543	2339	55135	84532	8543	56941	80169	84838	10302	1063	6588	55706	56935	84516	7570	55143	388364	51019	4604	387521	140578	7270	84904	403	116843	4678	3643	1412	3014	4289	7123	84902	9179	55013	51706	4245	4838	92305	3981	51203	645	3690	8909	83853	64949	63915	7013	83861	83463	5064	4124	9493	55287	5702	10478	402665	5571	9114	219749	10394	64151	10055	3421	55291	83953	79722	10564	84934	256987	7879	642623	6444	126393	5984	80342	130162	29895	3655	51061	6397	166655	21	58500	401541	22823	390205	991	51122	2979	83982	23568	158399	11173	863	994	201191	8555	55577	56674	10133	29899	54478	55860	2011	390792	92797	8549	26232	84275	10240	23149	25886	2665	11004	22974	80221	10945	27249	9902	4929	26147	5862	4331	9510	81490	5577	5859	30851	7533	56853	4641	113452	255919	80351	11187	29127	55010	7059	125113	1584	148398	983	80321	114815	10456	3418	7272	8698	146909	157313	92610	381	113510	28984	51149	55756	85464	3838	79661	5729	9468	5217	10403	84173	58530	140	83461	123811	155061	65005	23635	283991	317662	118672	3956	134266	84661	7075	1731
GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP	M6542		16800785	Sanda C,Weitzel P,Tsukahara T,Schaley J,Edenberg HJ,Stephens MA,McClintick JN,Blatt LM,Li L,Brodsky L,Taylor MW	GSE5542	GSE5542_3339_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in epithelial cells (6h): IFNG [GeneID=3458] versus interferon alpha.	Type I and type II interferons (IFNs) bind to different cell surface receptors but activate overlapping signal transduction pathways. We examined the effects of a type I IFN (IFN-acon1) and a type II iFN (IFN-g1b) on gene experession in A549 cells and demonstrate that there is a common set of genes modulated by both IFNs as well as a set of gene specifically regulated by each, reflecting the activation of different signaling pathways. In particualr, IFN-g induced many more genes of the signaling pathways, apoptosis, and cytokine interactions than did IFN-a. Even with genes induced by both IFNs there were distinctive quantitativive differences in expression. IFN-g1b plays a major role in the induction and regulation of the complement pathway. Previous work has shown a synergistic antivral and antiproliferative effect of type I and type II IFNs in cell culture and in the treament of tumors in mice. We demonstrate that a majority of genes showed and additive effect of IFN-acon1 and IFN-g1b, but a subset of gene is synergistically induced; these incluce ISG10, MX2, OAS2, and other genes known to be involved in the antiviral response, TRAIL (TNFSF10) and caspases involved in apoptosis and chemokine genes RANTES, CXCL10, and CXCL11. Greater than additive transcription of some of these genes in the presence of both IFNs was confirmed by real-time kinetic RT-PCR. Elevated induction of many of these genes may be sufficient to explain the synergistic antiviral and antitumor effects of this combination of IFNS in vivo.					7416	1019	9585	55627	92667	9424	6047	57695	57418	5690	84295	9855	1583	388569	9099	25849	150962	57380	25814	23234	23654	84986	56894	3422	4702	120103	11113	9788	79944	26275	55274	10452	7112	6627	8091	2762	6175	26065	1479	55732	2992	3689	494115	498	1104	160857	391	54517	9991	26135	54858	9851	29105	51451	84337	22919	93550	136895	64080	11171	5824	79648	5747	6565	8502	9869	50854	55133	92597	10844	11269	29841	84267	57519	3622	2547	27000	55326	197335	163882	9147	4361	10059	2035	4686	81614	55355	5868	26031	79609	28990	55854	114793	5723	6504	387103	79671	23647	56731	8663	91057	3052	204	11311	81610	9328	5347	79370	403313	166379	23165	4232	100288695	170082	8602	7936	85460	8450	8467	10114	79850	5395	91137	7913	10120	375316	100271849	7398	131076	3417	25886	4898	55135	83990	10461	9666	2138	10552	80829	3956	91689	65985	221150	23603	2806	91433	112479	54482	22995	51074	84916	23016	55151	51174	6441	170463	55559	23594	865	137392	8437	8804	55131	114034	151246	246243	767	23404	9188	7182	79829	7415	5917	22936	10856	54535	90381	143684	10855	55332	83699	8565	55356	51460	5756	4836	1039	11198	7334	84312	222255	220042	9415	8912	9918	259266	89891	3930	9738	8999
GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_DN	M6543		16800785	Sanda C,Weitzel P,Tsukahara T,Schaley J,Edenberg HJ,Stephens MA,McClintick JN,Blatt LM,Li L,Brodsky L,Taylor MW	GSE5542	GSE5542_3339_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in epithelial cells (6h): IFNG [GeneID=3458] versus interferon alpha.	Type I and type II interferons (IFNs) bind to different cell surface receptors but activate overlapping signal transduction pathways. We examined the effects of a type I IFN (IFN-acon1) and a type II iFN (IFN-g1b) on gene experession in A549 cells and demonstrate that there is a common set of genes modulated by both IFNs as well as a set of gene specifically regulated by each, reflecting the activation of different signaling pathways. In particualr, IFN-g induced many more genes of the signaling pathways, apoptosis, and cytokine interactions than did IFN-a. Even with genes induced by both IFNs there were distinctive quantitativive differences in expression. IFN-g1b plays a major role in the induction and regulation of the complement pathway. Previous work has shown a synergistic antivral and antiproliferative effect of type I and type II IFNs in cell culture and in the treament of tumors in mice. We demonstrate that a majority of genes showed and additive effect of IFN-acon1 and IFN-g1b, but a subset of gene is synergistically induced; these incluce ISG10, MX2, OAS2, and other genes known to be involved in the antiviral response, TRAIL (TNFSF10) and caspases involved in apoptosis and chemokine genes RANTES, CXCL10, and CXCL11. Greater than additive transcription of some of these genes in the presence of both IFNs was confirmed by real-time kinetic RT-PCR. Elevated induction of many of these genes may be sufficient to explain the synergistic antiviral and antitumor effects of this combination of IFNS in vivo.					160	79626	401397	775	653	84105	3695	3705	94025	339977	57030	361	60481	114987	26090	126917	2879	64108	1632	92196	115584	84944	5507	6232	55272	6387	8192	130540	23521	81491	92815	337879	2814	1455	115749	3280	51454	55040	3274	1101	8694	79173	285193	1068	9742	388228	746	27255	8125	58480	5005	25766	55526	412	55026	26469	7164	389432	1831	164684	84266	79650	1803	1535	25791	7127	4703	23536	6948	4689	644139	140739	2201	4507	390928	55113	5142	2848	4803	1476	1032	57332	10567	7555	8491	131583	219402	441873	6561	8692	55303	3621	56927	390	158866	79001	9946	56963	89	7378	79574	3074	80128	64714	322	118491	644096	90355	54165	10870	161582	799	10555	27198	374907	51170	9252	9450	51227	122616	121268	4168	29942	28971	284992	92610	26119	649	81888	4306	10488	64711	51282	126433	55359	3914	596	192683	1234	100127206	10897	128178	56606	284067	100129345	166614	53840	8495	375341	144717	768206	51024	2299	3514	643988	1992	80221	23344	1439	4759	26017	10413	286257	4357	6016	85302	7253	8968	113802	10099	93273	79844	161003	8698	6170	389320	55604	2014	54494	6142	8022	54438	7369	117155	135886	6281	10242	4322	7097	200035	10000	163154	54780	9194	150209	137835	8635	64598	54093	3081
GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP	M6544		16800785	Sanda C,Weitzel P,Tsukahara T,Schaley J,Edenberg HJ,Stephens MA,McClintick JN,Blatt LM,Li L,Brodsky L,Taylor MW	GSE5542	GSE5542_3340_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in epithelial cells (24h): IFNG [GeneID=3458] versus interferon alpha.	Type I and type II interferons (IFNs) bind to different cell surface receptors but activate overlapping signal transduction pathways. We examined the effects of a type I IFN (IFN-acon1) and a type II iFN (IFN-g1b) on gene experession in A549 cells and demonstrate that there is a common set of genes modulated by both IFNs as well as a set of gene specifically regulated by each, reflecting the activation of different signaling pathways. In particualr, IFN-g induced many more genes of the signaling pathways, apoptosis, and cytokine interactions than did IFN-a. Even with genes induced by both IFNs there were distinctive quantitativive differences in expression. IFN-g1b plays a major role in the induction and regulation of the complement pathway. Previous work has shown a synergistic antivral and antiproliferative effect of type I and type II IFNs in cell culture and in the treament of tumors in mice. We demonstrate that a majority of genes showed and additive effect of IFN-acon1 and IFN-g1b, but a subset of gene is synergistically induced; these incluce ISG10, MX2, OAS2, and other genes known to be involved in the antiviral response, TRAIL (TNFSF10) and caspases involved in apoptosis and chemokine genes RANTES, CXCL10, and CXCL11. Greater than additive transcription of some of these genes in the presence of both IFNs was confirmed by real-time kinetic RT-PCR. Elevated induction of many of these genes may be sufficient to explain the synergistic antiviral and antitumor effects of this combination of IFNS in vivo.					9424	22920	9938	342667	57519	29902	54492	51430	56925	899	79830	55105	55144	23137	11240	7416	6259	51377	57579	84248	79441	9099	1039	112479	391	4635	8467	23443	56888	117178	6047	8549	5775	79738	5824	1903	160857	79071	55615	950	152559	29105	6451	56894	5019	10513	11171	8237	7001	5496	6051	57453	197335	10165	91689	80346	220988	22995	54820	2171	11183	30845	10069	221150	54107	145773	6414	51460	55858	2079	9404	79000	340277	337867	4515	1731	10114	132320	65985	9184	2953	6868	3267	23603	3418	10775	5690	4172	3622	79003	26065	374618	2762	115024	23165	1104	54842	1491	3093	23234	91057	81873	220042	5747	7398	51250	54870	10552	55352	64710	11163	6566	122769	54816	375316	30827	8663	50804	10059	25915	11113	54535	8317	54869	55145	10054	51258	1741	22978	23376	5890	1994	55907	5395	5207	5918	5889	8502	27109	403313	84295	55722	85403	10293	280636	25814	1351	8669	404672	84656	7936	55627	79648	5710	57539	92856	124056	1647	79576	6936	23654	55704	4605	140461	4686	7756	9320	26031	54187	3939	100129269	10229	1479	51056	83699	53407	148413	81614	2992	79228	5894	80829	1642	26277	51512	5983	10120	996	1537	10135	93594	84904	137392	57472	79366	3609	222484	79876	4361	51010
GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_DN	M6546		16800785	Sanda C,Weitzel P,Tsukahara T,Schaley J,Edenberg HJ,Stephens MA,McClintick JN,Blatt LM,Li L,Brodsky L,Taylor MW	GSE5542	GSE5542_3340_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in epithelial cells (24h): IFNG [GeneID=3458] versus interferon alpha.	Type I and type II interferons (IFNs) bind to different cell surface receptors but activate overlapping signal transduction pathways. We examined the effects of a type I IFN (IFN-acon1) and a type II iFN (IFN-g1b) on gene experession in A549 cells and demonstrate that there is a common set of genes modulated by both IFNs as well as a set of gene specifically regulated by each, reflecting the activation of different signaling pathways. In particualr, IFN-g induced many more genes of the signaling pathways, apoptosis, and cytokine interactions than did IFN-a. Even with genes induced by both IFNs there were distinctive quantitativive differences in expression. IFN-g1b plays a major role in the induction and regulation of the complement pathway. Previous work has shown a synergistic antivral and antiproliferative effect of type I and type II IFNs in cell culture and in the treament of tumors in mice. We demonstrate that a majority of genes showed and additive effect of IFN-acon1 and IFN-g1b, but a subset of gene is synergistically induced; these incluce ISG10, MX2, OAS2, and other genes known to be involved in the antiviral response, TRAIL (TNFSF10) and caspases involved in apoptosis and chemokine genes RANTES, CXCL10, and CXCL11. Greater than additive transcription of some of these genes in the presence of both IFNs was confirmed by real-time kinetic RT-PCR. Elevated induction of many of these genes may be sufficient to explain the synergistic antiviral and antitumor effects of this combination of IFNS in vivo.					3914	6039	23098	3074	23586	8477	1154	23344	4306	25766	8646	3705	2014	84173	131583	64428	90355	5071	64951	1339	64332	201501	84343	51330	4689	254173	9450	23515	121268	84636	54964	1831	2879	4715	23536	84502	6948	387882	4168	64108	55808	6232	199699	676	952	23521	36	11092	768206	481	55505	92359	3073	2104	3491	90525	23286	92370	6210	140459	130355	60676	130106	10993	1992	7433	65010	58529	55359	8608	3280	65987	3695	1584	8828	6170	374907	7097	11259	2798	822	126917	348793	4050	6376	84002	6150	114879	775	26090	9443	1234	9462	9482	56896	285367	6326	11046	113246	8784	5136	9445	51024	359710	83875	79735	140823	9236	6169	84266	81607	51170	256710	118491	93663	10567	373156	257364	2123	339977	54491	127262	10251	8491	55805	115004	161357	2267	10488	205	338322	79001	151194	3111	94033	8698	10771	25901	135886	166614	6573	51272	619189	10612	10518	219681	155038	3514	10252	197257	27349	57184	54987	162394	7274	6814	4759	386746	6817	114786	9034	375061	201627	66000	54947	4975	4211	91584	389874	286077	60437	330	375387	8721	64410	23255	2828	57663	19	284067	643988	5013	8635	23357	64750	8495	3107	143689	3588	2760	222642	283985	9975	54952	9194	153768	649	745	340156	388650
GSE5142_CTRL_VS_HTERT_TRANSDUCED_CD8_TCELL_EARLY_PASSAGE_CLONE_UP	M6549		16951325	Menzel O,Migliaccio M,Goldstein DR,Dahoun S,Delorenzi M,Rufer N	GSE5142	GSE5142_3572_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD8 T cells: control versus over-expressing TERT [GeneID=7015].	Using CD8+ T lymphocyte clones over-expressing telomerase weinvestigated the molecular mechanisms that regulate T cell proliferation. Transduction and subcloning procedures were performed on CD8 + naive T-cell clones isolated from two different healthy individuals aged between 30 to 35 years (HD1 and HD2). T-cell cloneswere transduced to express hTERT/GFP or GFP alone. HD2 was profiled on U133Plus 2.0 and submitted as a separate GEO series.					53354	8439	837	3455	22938	79971	91746	54843	4054	23264	9910	4644	65980	388341	23528	23395	51540	347733	90701	152485	10521	81671	91452	55194	923	22858	375790	8241	50650	2956	253832	27229	8411	401409	22841	10051	10608	80318	7913	51246	10423	8976	54881	79893	3800	8892	5996	64423	5921	1528	338707	6788	3091	6004	5732	54621	5578	22881	7431	54108	10228	84936	10955	388646	23191	5925	79070	54928	29841	388403	4249	23205	975	79834	4926	22876	5050	340481	54458	64151	1644	6038	51155	9748	6275	80004	1476	643641	10148	27085	253827	814	9468	11174	8530	85457	158219	84525	6650	6095	9569	29126	147463	5332	399687	83940	9595	5359	11332	84188	23169	7410	867	23150	825	201163	1235	23365	129787	7141	1337	9414	6451	114804	2776	10160	55614	54801	8835	257062	3559	23379	285382	7280	253558	137392	51542	10903	51188	84938	6504	22807	941	9497	11145	6804	51429	322	90957	133746	64114	5783	5997	60485	9249	79661	317671	25927	9585	9833	8202	23274	151050	85301	59277	90933	91010	10392	7569	5686	4147	221002	6646	54681	79026	3688	10965	85021	7293	152559	4641	23424	401546	22822	4542	6777	11037	64215	11017	5338	1196	6277	29948	93663	245972	54741	80349	115361	23239	824
GSE5142_CTRL_VS_HTERT_TRANSDUCED_CD8_TCELL_EARLY_PASSAGE_CLONE_DN	M6550		16951325	Menzel O,Migliaccio M,Goldstein DR,Dahoun S,Delorenzi M,Rufer N	GSE5142	GSE5142_3572_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD8 T cells: control versus over-expressing TERT [GeneID=7015].	Using CD8+ T lymphocyte clones over-expressing telomerase weinvestigated the molecular mechanisms that regulate T cell proliferation. Transduction and subcloning procedures were performed on CD8 + naive T-cell clones isolated from two different healthy individuals aged between 30 to 35 years (HD1 and HD2). T-cell cloneswere transduced to express hTERT/GFP or GFP alone. HD2 was profiled on U133Plus 2.0 and submitted as a separate GEO series.					5293	55647	81619	54865	9411	100288695	284273	65983	285704	5786	1108	351	10184	145567	10081	11261	64417	3921	4939	359845	284346	112939	12	5019	10057	3925	3575	6251	9777	29907	79895	387357	10203	171425	57863	51108	7294	6391	104	80311	54797	3708	5094	3487	10570	389610	64801	154141	283987	51761	1880	147808	149840	146760	7049	55226	445	80852	23160	2319	81577	152273	23586	79652	100	55291	794	220001	23581	8554	10500	5163	6134	2342	84440	64096	6617	84557	120	23157	5316	140545	9953	92370	1791	7433	1565	6446	51529	26001	28232	27254	26053	83606	51154	1477	6907	334	55622	6187	5238	23223	25998	79012	133418	50614	2212	64744	898	23516	11083	388886	2036	25790	55920	29899	9670	51398	169841	50807	79913	80324	10365	4724	441168	116236	3159	285489	147015	51241	4815	256380	3097	28231	1368	57556	1875	56886	64343	23095	23401	2029	10813	387787	6194	10961	51506	8572	54996	55636	6839	1938	6342	204851	823	79833	1455	2494	100170841	10123	80228	4831	22870	88455	2103	3614	92196	79934	8507	402778	221303	83448	6329	84818	2121	87	5480	1271	57613	84691	2841	55308	286336	6518	55	1801	10487	81488	494551	113791	4150	29102	56676	159	3702	114801	11248	56683	100499483	90196
GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_UP	M6551		16951325	Menzel O,Migliaccio M,Goldstein DR,Dahoun S,Delorenzi M,Rufer N	GSE5142	GSE5142_3573_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD8 T cells: early passage clone over-expressing TERT [GeneID=7015] versus late passage control.	Using CD8+ T lymphocyte clones over-expressing telomerase weinvestigated the molecular mechanisms that regulate T cell proliferation. Transduction and subcloning procedures were performed on CD8 + naive T-cell clones isolated from two different healthy individuals aged between 30 to 35 years (HD1 and HD2). T-cell cloneswere transduced to express hTERT/GFP or GFP alone. HD2 was profiled on U133Plus 2.0 and submitted as a separate GEO series.					7153	3998	220042	834	8479	84823	55296	6629	10300	56950	1762	675	8458	51264	10467	146909	134492	23421	5272	23590	64092	84515	5422	8611	5438	132001	23480	162979	27258	51074	80231	79980	79733	6904	4705	84930	1870	2289	57584	84316	1736	7298	91687	25788	51053	56942	1841	2175	50	23150	2547	5281	11243	836	51149	55872	79135	84233	84902	4288	6632	10654	4361	114804	133015	3320	617	56479	81892	1400	64960	54433	890	151246	191	10514	27338	196383	3329	51065	10946	5902	9414	4728	90417	2271	374618	1021	219927	5723	10322	55967	5901	7818	55915	3094	10938	5557	51512	4818	10528	55789	6597	3064	4731	51056	57129	25864	7465	2519	10213	256126	6950	79075	79947	91057	388341	51659	1164	8553	79866	7030	54148	51776	3069	57102	90701	11040	729991	23160	10212	5714	10100	8487	378708	3184	2120	64802	195828	83448	211	2224	80349	4047	92345	6241	55177	84365	2653	3925	84259	79902	9377	79070	57122	9493	23397	4713	2171	137392	1154	23603	2961	23468	55732	6729	51018	6472	55847	4281	55839	3902	56916	57060	10455	291	23433	318	113130	64975	10245	56154	7407	120526	84100	80097	55345	6924	23165	79706	10988	84879	6345	5996	80169	26472	5589	51225	728568	2063
GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_DN	M6552		16951325	Menzel O,Migliaccio M,Goldstein DR,Dahoun S,Delorenzi M,Rufer N	GSE5142	GSE5142_3573_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD8 T cells: early passage clone over-expressing TERT [GeneID=7015] versus late passage control.	Using CD8+ T lymphocyte clones over-expressing telomerase weinvestigated the molecular mechanisms that regulate T cell proliferation. Transduction and subcloning procedures were performed on CD8 + naive T-cell clones isolated from two different healthy individuals aged between 30 to 35 years (HD1 and HD2). T-cell cloneswere transduced to express hTERT/GFP or GFP alone. HD2 was profiled on U133Plus 2.0 and submitted as a separate GEO series.					51176	7067	7204	408	6988	57134	51465	253260	571	147179	206358	55520	6251	57118	9232	399512	4092	220001	2729	5150	23329	283987	116236	1831	2113	220213	3707	1408	23331	5991	3632	2590	50614	9792	1454	9659	23608	26136	122786	3845	79142	22794	754	2734	94015	51278	197258	121268	9829	81847	81553	6777	8650	11228	8560	3570	79652	5989	57104	9644	1316	9741	10658	26001	84456	23429	8396	8790	84888	79780	81928	7280	3664	84124	8289	23506	23303	114609	10216	51030	10057	9903	7357	23313	9600	9205	54838	79188	58986	56676	7528	147015	50484	85377	163259	22882	158293	55014	57761	22838	10178	4240	144717	283349	3006	2908	29965	57621	164091	8609	55790	149478	23351	83786	8013	8527	128637	64132	3281	6932	8760	912	6295	5997	83742	57140	10267	26524	4012	8808	8340	414919	84060	11183	65065	57189	3141	117289	976	6948	81833	51227	54617	54602	22893	1121	56990	221927	9529	1612	388	57132	1368	359845	131616	4303	2117	64115	1590	5830	57563	137994	197135	84193	57498	8036	80233	54842	10782	57701	1565	9770	51272	23583	222487	5590	90313	5428	5875	4089	10015	8658	55850	23484	23401	6196	23469	2319	4214	5289	4189	144233	4649	374897	80724	83892	83719	286410	55793	84448
GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_UP	M6553		16982809	Szatmari I,Pap A,Rühl R,Ma JX,Illarionov PA,Besra GS,Rajnavolgyi E,Dezso B,Nagy L	GSE5679	GSE5679_3388_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocyte-derived dendritic cells: untreated versus rosiglitazone [PubChem=77999].	Our data indicated that activation of the PPARg nuclear receptor induces a retinoid response in human dendritic cells. In order to assess the contribution of retinoid signaling to the PPARg response we decided to use a combination of pharmacological activators and inhibitors of these pathways. Cells were treated with the synthetic PPARg ligand rosiglitazone (RSG), or with RSG along with the RARa antagonist (AGN193109) to block RARa mediated gene expression, or the RARa specific agonists (AM580) alone. This design allows one to determine if retinoid signaling is a downstream event of PPARg activation and what portion of PPARg regulated genes are regulated via induced retinoid signaling.					5341	52	57102	25788	10598	6119	6566	92345	2971	1894	26271	203068	5550	10212	4172	6491	27258	4285	5985	79075	8607	6950	29789	51175	51264	80224	51256	771	8479	3735	100287932	4288	5984	79050	55752	11243	54865	84365	9824	6472	29925	23178	1967	53938	83877	55720	54433	2867	51203	55789	283643	9319	23636	3838	78995	3659	55379	2653	9238	151246	83448	29015	57082	83461	79801	5901	81611	318	284361	55646	84319	5165	890	84823	4818	134429	146909	27352	11164	6391	2990	5557	80119	9493	220134	11040	283431	23511	9670	10432	6629	26147	55080	5699	64946	10797	54478	10606	2617	931	25936	8317	29893	5888	55636	56259	7936	10130	51377	210	672	131474	128239	3099	220042	10467	3014	84310	51154	81488	1736	7372	598	81890	1503	991	51501	84918	4904	55813	1763	4714	259266	22948	57136	22929	6351	11004	26354	55631	55329	2588	4830	3145	57217	127253	11035	259236	79596	57697	5693	63931	3978	56942	4174	84722	4361	10460	4141	3251	9787	51316	57038	60491	10430	1798	11222	10175	5464	10056	55748	5427	25776	26589	10402	7347	699	9768	9918	9401	51056	3925	79135	3843	708	63967	64710	9133	55723	7298	30968	6134	5393	29968	1876	10171	6626	23397	8318	51386
GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_DN	M6554		16982809	Szatmari I,Pap A,Rühl R,Ma JX,Illarionov PA,Besra GS,Rajnavolgyi E,Dezso B,Nagy L	GSE5679	GSE5679_3388_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocyte-derived dendritic cells: untreated versus rosiglitazone [PubChem=77999].	Our data indicated that activation of the PPARg nuclear receptor induces a retinoid response in human dendritic cells. In order to assess the contribution of retinoid signaling to the PPARg response we decided to use a combination of pharmacological activators and inhibitors of these pathways. Cells were treated with the synthetic PPARg ligand rosiglitazone (RSG), or with RSG along with the RARa antagonist (AGN193109) to block RARa mediated gene expression, or the RARa specific agonists (AM580) alone. This design allows one to determine if retinoid signaling is a downstream event of PPARg activation and what portion of PPARg regulated genes are regulated via induced retinoid signaling.					79912	9468	10425	81559	6777	116496	55015	8790	79026	197258	23169	57571	2113	54482	54726	26993	338707	1843	121268	23321	4147	81691	4122	55349	253558	546	6038	23205	23264	54621	59277	4306	142678	2166	7015	5325	8237	5926	10903	10782	29062	9807	245972	5332	54522	645426	57583	84981	122786	753	8976	54540	84660	571	57531	284485	55450	2729	81669	57621	7205	22927	3696	25970	322	64760	6095	977	23112	54741	221002	51276	124935	7852	51430	3897	9232	257062	23239	6650	976	7498	375033	55466	7128	4145	6804	55520	51510	23291	51422	114883	84938	8694	9778	201163	56829	8821	83742	25840	126917	151556	8672	8396	9734	26503	6574	388701	64224	11188	94104	7074	1316	22876	132864	3693	6988	23218	4947	4054	51542	79892	23142	8675	8337	5732	3190	286097	9659	6275	53354	197135	83699	5295	3845	78994	5997	375790	10957	3106	6948	687	9569	23164	5991	65018	5334	58487	284613	26524	7280	6093	79893	253827	493856	22828	65109	10270	1181	9910	55108	22881	1183	7342	64375	8428	29066	10113	64400	23161	5578	643641	4335	100506144	118490	9487	6451	1027	139728	9254	23365	2752	7174	5783	81847	54491	10743	9445	394	79661	6263	388403	677	57192	5922	1655	401097	285382	79139	1399
GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_UP	M6555		16982809	Szatmari I,Pap A,Rühl R,Ma JX,Illarionov PA,Besra GS,Rajnavolgyi E,Dezso B,Nagy L	GSE5679	GSE5679_3389_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocyte-derived dendritic cells: untreated versus AM580 [PubChem=2126].	Our data indicated that activation of the PPARg nuclear receptor induces a retinoid response in human dendritic cells. In order to assess the contribution of retinoid signaling to the PPARg response we decided to use a combination of pharmacological activators and inhibitors of these pathways. Cells were treated with the synthetic PPARg ligand rosiglitazone (RSG), or with RSG along with the RARa antagonist (AGN193109) to block RARa mediated gene expression, or the RARa specific agonists (AM580) alone. This design allows one to determine if retinoid signaling is a downstream event of PPARg activation and what portion of PPARg regulated genes are regulated via induced retinoid signaling.					5589	23636	55752	116225	79135	2588	27258	203068	23160	5699	55915	6491	598	2653	25788	134429	54433	84319	4331	57102	92345	29893	23516	8479	6950	4285	7884	80224	7453	55789	11040	10212	51264	2175	9824	26354	78995	64098	22948	1967	57038	2867	23378	11248	55247	27352	5341	25936	8607	5557	11021	81611	130340	5550	1992	11243	51175	29789	894	5985	9238	1019	84365	55697	1736	6626	5984	56942	4172	9319	3838	26271	51316	55379	10946	51203	120526	28972	10598	6629	3014	91687	54865	23178	84722	51256	29015	10467	79801	4288	1894	146909	4818	6472	55326	118487	84823	131474	890	6119	151246	84310	51386	83461	26228	9493	201266	128239	5901	10171	9957	25776	81629	29907	56259	79050	283643	1841	6470	113179	5165	388962	4867	10432	54478	51728	55771	29925	2971	672	145567	51659	4141	57673	10528	348995	3145	283431	11222	25828	90861	1460	28977	6345	3099	51154	10797	2954	259266	11035	57082	4830	259236	29108	55720	9401	55636	55651	5932	4174	10813	8318	55748	1719	23223	9918	9070	9133	388963	55133	387893	60559	84986	348235	387103	5888	220134	991	134637	7283	6319	57136	10514	708	1503	931	7298	5427	11004	1763	122945	83877	23397	10402	113115	9933	790	55723	8460	81488
GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_DN	M6556		16982809	Szatmari I,Pap A,Rühl R,Ma JX,Illarionov PA,Besra GS,Rajnavolgyi E,Dezso B,Nagy L	GSE5679	GSE5679_3389_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocyte-derived dendritic cells: untreated versus AM580 [PubChem=2126].	Our data indicated that activation of the PPARg nuclear receptor induces a retinoid response in human dendritic cells. In order to assess the contribution of retinoid signaling to the PPARg response we decided to use a combination of pharmacological activators and inhibitors of these pathways. Cells were treated with the synthetic PPARg ligand rosiglitazone (RSG), or with RSG along with the RARa antagonist (AGN193109) to block RARa mediated gene expression, or the RARa specific agonists (AM580) alone. This design allows one to determine if retinoid signaling is a downstream event of PPARg activation and what portion of PPARg regulated genes are regulated via induced retinoid signaling.					25792	54621	81559	8821	5283	9468	10892	571	6451	221002	9600	643641	8396	6777	25970	5428	645426	546	26263	122786	55349	6038	5991	11322	55520	49855	116496	151050	7126	197258	253558	23506	23169	121268	4306	152485	83699	6804	79026	9541	23529	360226	53354	23318	338707	1181	55015	3897	84981	5732	5926	4147	57621	3674	8790	7015	23321	222166	150465	374897	4947	10425	23351	345778	54540	23205	5338	5334	55898	23141	59277	64219	79661	10782	1843	23181	161436	1643	5295	201895	51780	9659	5332	54522	58487	4122	8675	22927	5498	22881	8826	9232	57571	2166	51422	4303	375033	65018	55827	83719	94104	322	22930	7128	4123	29957	155038	51560	2113	4215	2760	23526	57583	114883	5863	7205	55466	81691	253430	8609	64764	754	7280	23177	147798	9679	23239	3106	6650	8036	51290	85301	55450	1454	81669	26524	257062	26137	57132	151556	254295	245972	23379	9414	4542	57655	6498	23161	51379	3845	9778	79912	2729	54843	220213	83742	201163	79780	6095	3696	401551	286097	22807	8694	23608	9341	137994	10903	30851	643836	60626	4335	64760	7074	8976	100271873	64224	440093	493856	7107	9823	26503	136051	221496	56521	729830	6575	114112	22876	23582	5783	7111	55108	4145	51227	6988	9050	94015	5325	8635
GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP	M6558		16982809	Szatmari I,Pap A,Rühl R,Ma JX,Illarionov PA,Besra GS,Rajnavolgyi E,Dezso B,Nagy L	GSE5679	GSE5679_3390_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocyte-derived dendritic cells: untreated versus rosiglitazone and AM580 [PubChem=77999;2126].	Our data indicated that activation of the PPARg nuclear receptor induces a retinoid response in human dendritic cells. In order to assess the contribution of retinoid signaling to the PPARg response we decided to use a combination of pharmacological activators and inhibitors of these pathways. Cells were treated with the synthetic PPARg ligand rosiglitazone (RSG), or with RSG along with the RARa antagonist (AGN193109) to block RARa mediated gene expression, or the RARa specific agonists (AM580) alone. This design allows one to determine if retinoid signaling is a downstream event of PPARg activation and what portion of PPARg regulated genes are regulated via induced retinoid signaling.					10636	7225	3437	10565	26471	3109	50	8850	6573	477	55152	9636	54800	79158	5052	5297	384	6774	6546	2921	5914	558	3122	9672	26225	5948	54928	412	9456	463	113828	3184	6737	4502	10178	23636	51322	718	121599	8615	3568	51341	7173	6648	100129792	2717	3112	115361	57761	6296	9475	2054	3117	5272	57820	84302	3587	366	4115	54887	23476	439996	2180	5878	84263	1536	27032	10483	8502	3123	3624	6738	91543	51621	8611	10537	51389	2107	313	3394	706	641638	2357	9766	4520	9023	25932	6690	8613	4733	3574	9790	2152	100506736	1382	4061	9761	912	8879	3133	5261	55568	3709	6942	10428	5985	3091	6572	8453	122830	22928	55697	28984	4889	3383	8573	4651	84694	5010	952	10057	196	7402	8875	127544	26253	9276	4593	5308	388646	57169	4600	8200	3633	1855	6279	5972	1676	23528	6890	3939	27340	3627	833	8837	6582	85463	8800	4026	4851	4065	10320	80728	345611	9519	9683	2015	9397	22950	55262	10765	3665	8543	2817	84172	953	1616	1374	25942	832	2617	29887	56265	64218	10135	8822	2001	972	9857	346171	58533	11274	5277	2358	4794	1662	4299	57085	64135	57648	3204	5464	3937	6241	835	54558	1750	5696	6812	1633
GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_DN	M6560		16982809	Szatmari I,Pap A,Rühl R,Ma JX,Illarionov PA,Besra GS,Rajnavolgyi E,Dezso B,Nagy L	GSE5679	GSE5679_3390_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocyte-derived dendritic cells: untreated versus rosiglitazone and AM580 [PubChem=77999;2126].	Our data indicated that activation of the PPARg nuclear receptor induces a retinoid response in human dendritic cells. In order to assess the contribution of retinoid signaling to the PPARg response we decided to use a combination of pharmacological activators and inhibitors of these pathways. Cells were treated with the synthetic PPARg ligand rosiglitazone (RSG), or with RSG along with the RARa antagonist (AGN193109) to block RARa mediated gene expression, or the RARa specific agonists (AM580) alone. This design allows one to determine if retinoid signaling is a downstream event of PPARg activation and what portion of PPARg regulated genes are regulated via induced retinoid signaling.					2017	2205	387680	2171	1734	922	132	51186	308	116143	55365	1080	7462	83871	1788	10272	3006	91107	80176	1509	2619	23446	6147	8639	11342	4135	5480	9308	4354	3956	4240	10458	55884	4852	7267	9935	4321	2887	4684	55207	151516	4773	7356	1827	4609	2063	8801	9317	113235	58515	6700	719	122622	51382	7153	51125	122786	4047	3479	348	56905	10608	5621	54870	1595	6745	6275	9784	871	60592	56848	1265	6574	2012	6535	5063	8714	5129	129080	6204	5641	101	963	5654	10018	1028	23564	113402	56172	81873	29883	5519	5867	9500	1152	291	50856	56925	23175	2123	9452	64645	3357	6453	1634	1347	6372	1503	189	7414	4360	6001	10240	3925	1759	2697	6251	6277	5252	4734	55277	56339	991	9124	6876	1948	6713	5004	9768	9547	3720	5740	6696	383	527	9789	7375	1490	3725	80148	79073	9202	8992	1901	4839	4318	116461	114	3620	285	112464	29789	2920	5919	1164	6307	27239	3554	2596	2052	2260	6050	1606	100128731	940	761	9	2355	1191	2947	27244	10549	1687	6863	301	3487	83640	55615	5156	4317	51112	3077	55352	5714	302	7298	2621	2949	8560	523	3315	2581	210	171546	2720	9145	5218	147007	138050	60681
GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_RARA_AGONIST_AM580_TREATED_DC_UP	M6561		16982809	Szatmari I,Pap A,Rühl R,Ma JX,Illarionov PA,Besra GS,Rajnavolgyi E,Dezso B,Nagy L	GSE5679	GSE5679_3391_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocyte-derived dendritic cells: rosiglitazone [PubChem=77999] versus AM580 [PubChem=2126].	Our data indicated that activation of the PPARg nuclear receptor induces a retinoid response in human dendritic cells. In order to assess the contribution of retinoid signaling to the PPARg response we decided to use a combination of pharmacological activators and inhibitors of these pathways. Cells were treated with the synthetic PPARg ligand rosiglitazone (RSG), or with RSG along with the RARa antagonist (AGN193109) to block RARa mediated gene expression, or the RARa specific agonists (AM580) alone. This design allows one to determine if retinoid signaling is a downstream event of PPARg activation and what portion of PPARg regulated genes are regulated via induced retinoid signaling.					4282	28958	5145	84823	3099	57124	3638	79173	3978	59269	201254	30815	9324	55847	91544	22837	210	201191	79622	5739	23580	9475	125965	22906	80820	26355	53838	6992	64785	83943	2584	11164	84312	9500	65062	4430	54910	1212	3613	6553	25864	8464	10467	8605	84769	84314	400916	8611	80380	30850	284106	10683	27043	56942	29890	79706	80097	5827	404672	64225	4603	7371	80737	4900	55746	26608	388341	29103	7038	402	10791	5230	6715	6453	389362	64928	23176	79634	29843	11124	5315	5594	56948	51805	7247	6882	55825	220988	84529	98	8496	779	51460	7037	29796	79004	9551	171546	84330	7358	91689	55471	230	254863	5223	80020	4925	3149	51629	7295	8689	286053	987	5147	57221	83443	353322	8811	1122	84303	83930	770	8322	122481	1347	7525	23474	1534	80169	94032	6612	84300	51398	57026	7167	5245	3688	8724	29107	55090	25876	307	51155	81932	202051	27316	10430	27089	5028	8609	51258	55839	65108	1155	968	23187	7163	3694	5688	5931	54875	134111	10597	9738	126526	26073	9261	134728	54535	1050	11267	1059	116541	126393	54914	91057	4708	23052	57687	5050	541468	2146	518	80764	3607	23603	51807	84830	114804	2762	84316	51175	9569	112479	79947	80168	440026	57409	10797	22846
GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_RARA_AGONIST_AM580_TREATED_DC_DN	M6563		16982809	Szatmari I,Pap A,Rühl R,Ma JX,Illarionov PA,Besra GS,Rajnavolgyi E,Dezso B,Nagy L	GSE5679	GSE5679_3391_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocyte-derived dendritic cells: rosiglitazone [PubChem=77999] versus AM580 [PubChem=2126].	Our data indicated that activation of the PPARg nuclear receptor induces a retinoid response in human dendritic cells. In order to assess the contribution of retinoid signaling to the PPARg response we decided to use a combination of pharmacological activators and inhibitors of these pathways. Cells were treated with the synthetic PPARg ligand rosiglitazone (RSG), or with RSG along with the RARa antagonist (AGN193109) to block RARa mediated gene expression, or the RARa specific agonists (AM580) alone. This design allows one to determine if retinoid signaling is a downstream event of PPARg activation and what portion of PPARg regulated genes are regulated via induced retinoid signaling.					10268	9138	133418	137835	5414	256380	22983	22834	54491	3384	255809	2150	9973	2570	2117	22821	3434	1606	5476	27158	114836	9497	114770	25897	8935	6446	5243	7107	23295	3676	359845	3679	259230	602	79637	79085	10000	3399	400566	5008	10365	55521	5134	284546	3566	4653	56961	79817	79739	7175	162989	399665	124599	10379	51379	11092	84069	84640	10125	6139	375775	122773	57700	9489	79625	10225	393	10636	54799	9535	3955	375444	83605	219285	84698	91775	10457	57674	3655	57162	10631	27296	25851	5360	11274	2161	23529	6261	23329	1997	219621	10447	5293	57035	9920	23370	2868	9716	8698	54453	84329	4855	55959	345611	317649	55343	7551	54596	10211	4690	4258	2623	6239	7741	374403	2139	10238	57408	7402	6793	8743	6281	9990	9744	8289	388646	63892	10671	57168	54863	55619	27111	116842	57701	1901	89846	9726	11069	23586	3633	139716	9685	23533	5567	11213	10188	84959	6304	4089	57231	7174	57169	55231	4627	85019	84532	10203	10075	3665	81858	5373	129607	26207	3575	124857	9980	103910	83759	84206	55578	10865	54739	26001	57210	57153	54	8445	5295	118672	6041	10998	84941	242	29933	56261	7779	9370	1616	55589	5791	10628	127247	2330	57446	133686	9953	55283	64108	2124	3202
GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP	M6565		16982809	Szatmari I,Pap A,Rühl R,Ma JX,Illarionov PA,Besra GS,Rajnavolgyi E,Dezso B,Nagy L	GSE5679	GSE5679_3392_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocyte-derived dendritic cells: rosiglitazone [PubChem=77999] versus rosiglitazone and AM580 [PubChem=77999;2126].	Our data indicated that activation of the PPARg nuclear receptor induces a retinoid response in human dendritic cells. In order to assess the contribution of retinoid signaling to the PPARg response we decided to use a combination of pharmacological activators and inhibitors of these pathways. Cells were treated with the synthetic PPARg ligand rosiglitazone (RSG), or with RSG along with the RARa antagonist (AGN193109) to block RARa mediated gene expression, or the RARa specific agonists (AM580) alone. This design allows one to determine if retinoid signaling is a downstream event of PPARg activation and what portion of PPARg regulated genes are regulated via induced retinoid signaling.					10467	10982	60559	79095	3416	8829	51031	399948	79734	9749	115350	27351	8676	51527	4355	57630	91373	143888	79140	22926	8502	3280	29841	29057	944	51606	91694	2790	10063	10797	9308	254428	55565	98	54331	307	401409	7037	3386	81606	26355	79180	79622	10791	84134	11332	56941	25816	54458	9260	4354	84817	22807	9040	5017	4345	80380	6503	5774	79092	8600	23052	3920	4616	5450	834	51506	10538	8844	2534	2785	952	11033	6482	50807	9500	56005	3978	84295	1652	10421	6050	114836	8496	5334	8531	1233	23589	6525	4068	5732	57476	7329	81671	7443	79035	153339	7335	64968	5230	5243	253558	9630	5090	5527	4938	11126	11133	51128	29902	79109	1958	219738	6748	933	4249	4033	51201	25833	9144	3097	4862	837	9538	11316	27433	230	5781	613227	58505	10094	54923	3594	83658	51501	23324	54793	79634	1021	65108	3005	2923	114804	4891	100505876	59067	5634	55954	10801	80301	2123	10148	6526	57584	51063	5223	57415	2280	9094	51726	6282	84706	7798	10154	3371	10244	144110	5147	60386	53354	10165	9882	65059	11063	604	196264	23087	4772	120526	5713	51181	64215	57514	27341	253430	55356	30845	5552	22856	1445	7351	57513	23466	3688	6457	2717	4641	1534	84336	3162
GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_DN	M6567		16982809	Szatmari I,Pap A,Rühl R,Ma JX,Illarionov PA,Besra GS,Rajnavolgyi E,Dezso B,Nagy L	GSE5679	GSE5679_3392_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocyte-derived dendritic cells: rosiglitazone [PubChem=77999] versus rosiglitazone and AM580 [PubChem=77999;2126].	Our data indicated that activation of the PPARg nuclear receptor induces a retinoid response in human dendritic cells. In order to assess the contribution of retinoid signaling to the PPARg response we decided to use a combination of pharmacological activators and inhibitors of these pathways. Cells were treated with the synthetic PPARg ligand rosiglitazone (RSG), or with RSG along with the RARa antagonist (AGN193109) to block RARa mediated gene expression, or the RARa specific agonists (AM580) alone. This design allows one to determine if retinoid signaling is a downstream event of PPARg activation and what portion of PPARg regulated genes are regulated via induced retinoid signaling.					84973	55289	9138	6997	5327	84938	8577	149603	10579	2810	4939	23064	653	760	222487	2303	2139	92749	254295	5739	366	118	6427	217	222643	23361	9716	388228	2036	55718	80727	92170	23126	25938	1791	1755	25851	1302	112	23598	125058	53405	126669	6804	83787	10392	3006	84268	2874	10000	10782	23205	64333	2150	921	81577	923	3955	541565	11052	83468	57035	90624	942	137835	9603	57190	122786	142940	10671	84196	55843	5153	26953	3559	23475	10216	83860	2982	5924	22821	10400	8647	79925	23358	4320	115207	220004	54491	1102	3566	815	653361	1773	2117	81890	9528	587	3614	55703	10324	84307	113655	222950	55343	23261	10125	84795	23221	8736	114112	144406	57333	283987	57602	81621	23057	6582	83606	100271873	57538	127933	10225	255809	10260	79004	9481	10732	54987	1154	79780	66037	79567	26115	137695	55114	90407	64110	9618	10194	55568	3198	1606	145781	55197	23583	5295	92595	7433	286676	117584	135295	26470	2217	147965	26097	63910	91526	11076	11269	8013	65980	10335	7551	284467	6477	79173	56893	26284	9071	51455	1565	388886	83450	91544	3655	64772	10090	2678	1893	55272	55196	3824	1407	169200	54518	6195	80017	10803	83786	56970	8445	4855	1368	259230	5495	55599	80228	1787
GSE5679_RARA_AGONIST_AM580_VS_AM580_AND_ROSIGLITAZONE_TREATED_DC_UP	M6569		16982809	Szatmari I,Pap A,Rühl R,Ma JX,Illarionov PA,Besra GS,Rajnavolgyi E,Dezso B,Nagy L	GSE5679	GSE5679_3393_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocyte-derived dendritic cells: AM580 [PubChem=2126] versus rosiglitazone and AM580 [PubChem=77999;2126].	Our data indicated that activation of the PPARg nuclear receptor induces a retinoid response in human dendritic cells. In order to assess the contribution of retinoid signaling to the PPARg response we decided to use a combination of pharmacological activators and inhibitors of these pathways. Cells were treated with the synthetic PPARg ligand rosiglitazone (RSG), or with RSG along with the RARa antagonist (AGN193109) to block RARa mediated gene expression, or the RARa specific agonists (AM580) alone. This design allows one to determine if retinoid signaling is a downstream event of PPARg activation and what portion of PPARg regulated genes are regulated via induced retinoid signaling.					4097	4124	5781	29902	1173	339487	219738	933	8740	3416	4709	253430	23102	29886	3565	55954	55356	27257	9538	51460	27351	3902	125113	57102	3162	2948	230	80776	221895	56941	139322	779	210	54875	10791	1990	5827	388272	6282	124936	8600	57465	144110	127281	4354	284307	4717	157567	4724	100132884	84817	27071	51128	8543	1069	128240	54749	55192	84867	131583	143888	55204	643	145226	399687	4900	57210	84869	114804	56935	4026	1508	112399	57679	8851	84304	7335	84440	84706	2188	158248	51506	51606	55565	51256	79157	1050	91373	55589	79624	10367	9261	56479	79140	80380	3717	3371	402	604	286207	23237	4694	6856	3920	4772	6399	55352	5450	3998	54093	4862	2956	3087	975	54460	125965	51097	51617	22978	11264	4817	115350	57630	7163	140803	100271849	11130	79842	27433	56890	11126	25897	4718	130589	7280	9249	27347	347733	124599	29057	9414	56062	23531	375033	8800	23788	81892	9630	81932	729852	2519	9712	55667	54920	26355	140735	6812	6591	4947	57221	26030	23466	5732	51177	79634	1717	153527	122481	54806	54858	9878	941	79022	3394	25928	10651	83986	10982	4066	122953	337867	8676	7142	256987	51582	399948	5519	4891	59067	3386	1501	10944	205	138428	23452	9732	10467	4052	55349	55794
GSE5679_RARA_AGONIST_AM580_VS_AM580_AND_ROSIGLITAZONE_TREATED_DC_DN	M6570		16982809	Szatmari I,Pap A,Rühl R,Ma JX,Illarionov PA,Besra GS,Rajnavolgyi E,Dezso B,Nagy L	GSE5679	GSE5679_3393_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocyte-derived dendritic cells: AM580 [PubChem=2126] versus rosiglitazone and AM580 [PubChem=77999;2126].	Our data indicated that activation of the PPARg nuclear receptor induces a retinoid response in human dendritic cells. In order to assess the contribution of retinoid signaling to the PPARg response we decided to use a combination of pharmacological activators and inhibitors of these pathways. Cells were treated with the synthetic PPARg ligand rosiglitazone (RSG), or with RSG along with the RARa antagonist (AGN193109) to block RARa mediated gene expression, or the RARa specific agonists (AM580) alone. This design allows one to determine if retinoid signaling is a downstream event of PPARg activation and what portion of PPARg regulated genes are regulated via induced retinoid signaling.					8698	10671	9788	126669	822	5274	10750	55272	3903	5008	921	25851	51316	219621	114770	340527	11329	9679	101	23498	80228	1102	83787	684	784	56940	3662	56262	1368	25797	23205	55603	22800	55593	8718	30009	221336	22914	3655	57333	3676	27240	53822	4703	11269	84196	4038	122786	4147	10418	2323	55544	333926	6236	92960	222487	653361	285613	145781	8445	54847	63910	2355	56961	162394	301	84000	80148	22834	2810	55568	286336	4818	10090	10235	4600	7867	84909	8835	3559	118	3454	23258	3824	91544	3002	1901	254295	338596	54149	83440	283987	57704	84329	55619	5295	953	26136	10782	170954	8277	81858	2678	388228	7464	11213	1407	112	10581	10000	51280	8837	10410	80342	3575	10579	8480	54843	9588	10225	84525	8572	976	8459	483	9138	23108	8399	2857	81890	23533	10329	3434	51735	169200	9960	3929	54518	10392	157695	79895	388886	3955	10211	6835	3690	27158	64969	11092	2583	3897	10628	10397	8882	10636	160622	23221	284611	23616	388650	113177	10365	64375	5151	22821	119392	54	3606	1839	84958	259230	84864	2217	137835	7292	80143	10402	3177	64333	51611	26471	9443	64801	3487	6124	64005	3695	79637	729230	1154	23370	6804	10666	445	23095	80017	4000	6793	26207	11075
GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_UP	M6581		17082649	Martinez FO,Gordon S,Locati M,Mantovani A	GSE5099	GSE5099_3803_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes: untreated versus CSF1 [GeneID=1435].	Monocytes mature tom acrophages in the presence of the lineage determining cytokine M-CSF. They can be further polarized into M1 or M2 macrophages with distinct functional properties. We used microarrays to detail the global programme of gene expression underlying macrophage maturation and polarization and identified distinct classes of up-regulated genes during this process.					79683	9797	10952	83988	5362	57096	11082	116832	10209	4356	64682	4931	6039	391059	54543	3824	57703	64778	369	83737	9910	219681	23705	137994	51013	79768	475	84924	7357	378938	286144	323	51284	6222	8560	155060	221914	1201	130814	10284	6788	151871	114908	8195	8427	23480	55521	79191	162966	100288695	9925	2833	2483	81555	1180	84288	6204	6013	100128731	51188	221262	158234	89886	9813	317662	4345	9101	6715	6727	151195	134359	54108	2277	5439	51646	127495	26610	5878	1347	493911	283297	241	26959	2317	28514	157657	1147	729627	27309	132321	29880	1121	868	10360	10589	57467	3818	55784	84722	84824	4729	285755	57406	23033	131965	389362	5224	7441	10242	9867	6001	55862	7175	7011	81790	84280	9934	121256	57665	4281	9782	10975	3157	64221	221302	80705	27075	92259	4147	8564	10885	9852	50618	342933	92140	57492	51244	10526	11116	125988	4603	6161	387	286053	10040	10447	132	9589	55859	117145	4005	83480	51292	28962	55239	51574	64118	11137	79573	79143	22938	54832	8508	25983	85459	54482	900	65992	3570	3065	29097	84522	4594	93081	79027	131450	27089	23411	4354	145553	83982	11145	1655	50613	56919	375449	27257	83447	22807	60484	6450	64928	9585	26190	6938	149465	79057	93487	55209	2665
GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_DN	M6583		17082649	Martinez FO,Gordon S,Locati M,Mantovani A	GSE5099	GSE5099_3803_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes: untreated versus CSF1 [GeneID=1435] knockout at day 3.	Monocytes mature tom acrophages in the presence of the lineage determining cytokine M-CSF. They can be further polarized into M1 or M2 macrophages with distinct functional properties. We used microarrays to detail the global programme of gene expression underlying macrophage maturation and polarization and identified distinct classes of up-regulated genes during this process.					1453	4790	2353	60370	51629	79932	6624	400120	84230	55793	9487	7846	11091	9592	92014	25870	10544	5609	339122	10228	55666	7088	5058	3014	706	10423	2027	84964	6903	10953	6275	1316	3112	84886	54472	219699	494470	375387	6949	1889	84444	9698	8566	11240	10491	83742	9780	133	8609	6612	10238	23332	340706	339287	7086	51363	387680	9620	3459	25989	64779	222484	1981	23228	26088	5635	64109	8446	338692	5987	54492	51538	10106	401190	23616	8502	140894	11332	3055	8106	84937	7158	29109	11344	29934	10188	5518	23568	7204	1740	10573	3106	5553	9670	114928	10268	64759	286319	933	9703	4905	142678	54827	23061	4185	64285	116841	2194	66004	23214	85027	5073	84330	5442	80709	5253	4084	136319	7408	84326	23151	9898	6477	85461	11180	5834	2931	6277	55577	50	309	25992	23286	1310	1431	25862	55272	8668	84726	80728	79719	1975	537	3029	9619	146853	83706	79887	57507	10093	64651	6404	79798	58513	79753	57091	5425	57217	221074	434	55810	10148	389549	9181	9612	51296	595	2848	9127	5605	55330	9531	64005	2029	23567	5606	53353	79903	57020	7090	79042	6448	91	728294	3791	29904	6588	5573	64780	440590	7170	7407	400258	113146	9092	80207	4838	374655	140856	8539
GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_UP	M6584		17082649	Martinez FO,Gordon S,Locati M,Mantovani A	GSE5099	GSE5099_3804_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in unstimulated monocytes versus macrophages incubated with CSF1 [GeneID=435] at day 7.	Monocytes mature tom acrophages in the presence of the lineage determining cytokine M-CSF. They can be further polarized into M1 or M2 macrophages with distinct functional properties. We used microarrays to detail the global programme of gene expression underlying macrophage maturation and polarization and identified distinct classes of up-regulated genes during this process.					257106	7247	143686	7047	6039	56929	6470	50484	130507	83594	23269	55177	22824	100506049	29078	51430	55274	64418	55872	221830	57460	6713	3251	58487	11136	9837	10009	64859	23471	286148	140609	119559	54780	55968	573	5601	55082	170622	1486	1327	84833	5281	54882	51100	6845	3423	51386	8731	5501	22908	4683	10988	25940	23528	6643	27131	55500	51575	51542	6147	2730	6007	169200	3646	1803	9768	1176	29789	23029	91612	114883	22890	10772	92370	55831	54965	119710	54904	51727	196074	55791	5411	55737	51692	27161	6152	80205	493911	51284	4860	51013	10565	84897	8661	79979	9215	940	116832	143888	2551	10142	64318	22948	3015	95681	8815	2339	10455	29945	26355	114793	115207	4678	9802	54331	84365	6139	53339	84166	5962	93081	84513	7174	2824	23325	170961	26060	3588	51227	79960	983	54148	6154	9819	5527	7402	9813	9736	64645	10289	55342	51526	64118	79647	55631	81669	51371	7712	5110	3839	7555	6018	51319	51104	79768	57614	8924	55437	56605	3178	81555	115294	5701	5832	6834	4281	4594	55608	126626	57337	9367	51322	153339	11231	55664	221395	988	11244	27072	6782	112479	4715	24149	79023	5716	51188	4522	29103	23200	23054	7323	51406	84314	7332	27071	10332	51523	353274	84246
GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_DN	M6585		17082649	Martinez FO,Gordon S,Locati M,Mantovani A	GSE5099	GSE5099_3804_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in unstimulated monocytes versus macrophages incubated with CSF1 [GeneID=435] at day 7.	Monocytes mature tom acrophages in the presence of the lineage determining cytokine M-CSF. They can be further polarized into M1 or M2 macrophages with distinct functional properties. We used microarrays to detail the global programme of gene expression underlying macrophage maturation and polarization and identified distinct classes of up-regulated genes during this process.					340075	79155	23098	8324	64784	2316	10171	4267	2113	9258	3164	80757	26090	89781	57659	552889	84964	59271	23114	159296	54535	6603	9860	9097	535	55627	219790	554	9882	84517	653361	140735	79903	6610	10940	6285	148581	10549	1137	9203	84464	124056	55544	729359	339665	56927	90550	8085	6720	151742	6650	5585	64779	8971	9443	2907	84267	79934	6722	254122	51517	79847	5635	3073	80179	4221	6588	80149	7552	5228	84952	57475	4924	64342	10425	348	84707	9368	28959	9675	26953	92797	55070	79651	1280	126410	30837	27043	29926	8295	8502	197	929	10947	251	375	6570	55693	124997	153768	4125	81491	222658	84749	133	80023	55040	2280	3902	5339	645426	30851	10437	84890	79058	8284	10343	22898	4062	65999	10898	1875	5830	56130	197257	10245	10461	8608	2826	3067	2995	8852	387712	136242	83596	114781	1591	2760	64978	2629	6590	9956	83442	7222	127262	23466	2548	1521	2217	219899	4035	23536	374655	81619	9592	5371	7732	1107	126	51237	790	286319	154313	9146	55911	80243	1493	24144	91319	8837	63928	1316	84876	1590	11007	57602	4089	7032	64759	23008	388135	8497	1431	90933	10956	1981	3764	10691	170261	8581	55571	26173	4326	5430	284110	60685	3123	23246	271	23644
GSE5099_MONOCYTE_VS_CLASSICAL_M1_MACROPHAGE_UP	M6586		17082649	Martinez FO,Gordon S,Locati M,Mantovani A	GSE5099	GSE5099_3805_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes versus classically activated (M1) macrophages.	Monocytes mature tom acrophages in the presence of the lineage determining cytokine M-CSF. They can be further polarized into M1 or M2 macrophages with distinct functional properties. We used microarrays to detail the global programme of gene expression underlying macrophage maturation and polarization and identified distinct classes of up-regulated genes during this process.					83737	65250	65057	338879	3788	441282	113220	23704	4193	10897	6862	54752	10955	284541	63926	148753	1154	3945	79659	79690	3190	3716	387338	10109	79152	56993	137362	11333	9402	80005	2538	283848	9551	1447	6092	7837	6790	6235	5662	4191	57538	57105	11313	9437	8407	6203	57703	160622	4907	116138	10952	9576	9040	2676	134187	147179	23309	23053	3172	4814	1192	6671	160	284184	3786	3598	154790	79834	55521	7430	55808	7052	328	5407	59340	83667	54788	10411	10454	1743	56171	550	29785	80237	387921	10577	126917	386746	151195	81796	521	113451	5347	150726	6832	221393	2267	2845	4824	392465	2288	56944	10018	51248	1525	1438	7305	1996	64116	6376	57514	219793	22902	131450	259308	55702	348110	80303	57683	6457	146378	91862	23266	79726	7436	84271	440689	10293	4886	89894	23538	10668	4931	23178	149175	59344	112817	23612	10266	154881	54938	27339	51307	51433	60506	9945	124583	80762	9099	4139	64168	23549	5473	10412	100113384	1404	27141	339906	51166	122704	57546	2050	79923	7866	340351	23114	2629	57474	51143	94059	53947	4142	2118	5046	4520	7503	51702	6311	56938	63908	5878	8318	201475	283254	128153	85315	23544	5251	54535	6196	1846	4731	26145	3672	55004	3292	202374	117608	56157	340061
GSE5099_MONOCYTE_VS_CLASSICAL_M1_MACROPHAGE_DN	M6587		17082649	Martinez FO,Gordon S,Locati M,Mantovani A	GSE5099	GSE5099_3805_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes versus classically activated (M1) macrophages.	Monocytes mature tom acrophages in the presence of the lineage determining cytokine M-CSF. They can be further polarized into M1 or M2 macrophages with distinct functional properties. We used microarrays to detail the global programme of gene expression underlying macrophage maturation and polarization and identified distinct classes of up-regulated genes during this process.					10390	114826	51218	10628	10603	597	708	55229	388364	6016	3014	153769	112858	133060	10916	8566	23456	8539	57786	1431	3074	79090	5609	23052	93190	5931	55363	3106	83742	3055	27037	273	84975	84314	9592	84311	7965	51009	83540	23268	84950	6202	5507	51372	5255	51614	9709	7170	3281	494470	339487	4282	55154	124401	6124	1969	493753	11315	5531	2353	55133	125476	10376	1622	83478	79567	84826	3704	22949	339929	6125	10657	80011	57461	2188	113246	80209	24148	10106	84318	6130	57020	4869	79925	23654	55269	3234	128	199223	25879	1234	10771	10808	2130	65997	8675	65263	81602	9360	23567	219699	79596	9827	55835	25809	146225	8581	23111	4790	10574	6625	9487	85369	79969	6430	192286	57107	126133	286133	5573	3029	79887	3306	54103	799	161502	4752	10399	2521	1111	84937	8106	9270	3609	6611	55561	84230	84833	2120	1024	137682	55723	5660	1796	91300	10422	401397	1490	10641	7846	2014	8315	3216	113878	339122	64744	1984	57819	64780	6152	7336	79585	9987	83608	91860	167838	3107	5250	8618	130074	147965	2778	10273	11169	4084	5997	27292	9948	10491	7088	1665	10517	1337	256979	8556	220002	7458	30844	23061	6191	1939	4087	79651	2533	5861	55334	9535	79036	25948	9531
GSE5099_MONOCYTE_VS_ALTERNATIVE_M2_MACROPHAGE_UP	M6588		17082649	Martinez FO,Gordon S,Locati M,Mantovani A	GSE5099	GSE5099_3806_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes versus alternatively activated (M2) macrophages.	Monocytes mature tom acrophages in the presence of the lineage determining cytokine M-CSF. They can be further polarized into M1 or M2 macrophages with distinct functional properties. We used microarrays to detail the global programme of gene expression underlying macrophage maturation and polarization and identified distinct classes of up-regulated genes during this process.					400745	11077	1643	55509	100289210	1235	26492	2069	283867	9070	2224	388796	121506	138046	4995	91661	64843	1737	23503	10215	26272	55352	114800	54946	3652	64794	5602	100507218	50802	132884	146857	85368	9275	6697	79758	23317	3957	593	51333	100130354	83886	29886	126074	5871	100289071	5296	286436	2521	728613	83694	6873	100288870	56133	4741	5593	339352	858	7356	120227	22999	64710	65267	146433	9148	79132	9429	10056	414328	7857	100286972	80036	25834	285266	4869	60674	80201	161582	3428	150368	100506049	5475	100286844	81572	8755	84649	23005	4976	5876	23176	2617	1728	64940	113177	28786	1572	157724	284167	51728	57798	645634	730227	81494	10898	11123	9498	8508	5151	126526	386724	4113	79567	162993	64220	4594	115752	833	401134	2160	54849	175	1774	100272147	84878	51599	100505978	60485	79863	1294	90625	158399	6627	7804	5025	56034	9582	287015	340527	126075	54549	117154	51042	25984	5224	222068	2865	144568	7159	26090	126147	79915	26094	113730	55359	6041	5613	5283	4055	4907	8435	9493	79707	58503	1007	4752	202051	22918	55122	4902	85028	7096	10799	100506033	5799	503639	1000	326624	55891	6590	10699	84816	474171	646627	200933	10214	100288432	157773	128854	339988	89944	100131721	1292	7621	4744	100507634	2800	10038	256710	51052
GSE5099_MONOCYTE_VS_ALTERNATIVE_M2_MACROPHAGE_DN	M6589		17082649	Martinez FO,Gordon S,Locati M,Mantovani A	GSE5099	GSE5099_3806_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes versus alternatively activated (M2) macrophages.	Monocytes mature tom acrophages in the presence of the lineage determining cytokine M-CSF. They can be further polarized into M1 or M2 macrophages with distinct functional properties. We used microarrays to detail the global programme of gene expression underlying macrophage maturation and polarization and identified distinct classes of up-regulated genes during this process.					23133	253832	5870	9731	5033	387496	10730	534	10892	51372	8655	514	284004	100287411	348995	79949	81037	283711	7462	140730	488	155054	401397	55227	283713	6294	282763	197131	23410	283587	25975	196294	79668	51510	163154	26275	10802	10987	27230	202333	114882	23780	27020	5053	10282	162998	4990	27161	8851	85313	1522	9246	3840	51808	3631	245973	51199	9422	2124	167227	134218	10438	7170	2762	5507	149951	3183	100507423	27012	27332	842	8295	2958	9881	50834	3181	79980	53917	9330	65010	81609	85439	56254	5449	1399	27087	11179	5062	5358	50614	2140	11080	60680	375607	23143	148696	7422	646214	117852	135250	441108	64784	80207	7696	64388	7562	55958	1902	51517	729652	26157	26212	148203	260425	25833	8506	57226	7033	693207	150185	113201	4784	10605	1374	55339	84188	90594	25929	64744	83636	57169	3425	100288675	3382	83787	26225	59285	23019	51385	123722	51657	6854	1325	55013	79905	5187	353322	57674	51175	283234	116983	94160	2870	8577	23648	51764	27430	79415	22864	100302650	23526	54583	84103	8803	646324	55033	284697	55629	6814	116115	150678	51409	26586	200424	11171	1982	8867	79006	196074	1201	83860	56995	80230	80004	100329167	3300	284443	3062	890	133874	10243	84892	10472	23201	3309	64083	64750
GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_UP	M6592		17082649	Martinez FO,Gordon S,Locati M,Mantovani A	GSE5099	GSE5099_3807_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated upon CSF1 [GeneID=1435] treatment: monocytes (3 days) versus macrophages (7 days).	Monocytes mature tom acrophages in the presence of the lineage determining cytokine M-CSF. They can be further polarized into M1 or M2 macrophages with distinct functional properties. We used microarrays to detail the global programme of gene expression underlying macrophage maturation and polarization and identified distinct classes of up-regulated genes during this process.					5996	65018	55824	114926	65003	6124	80305	113419	10591	65977	164	203328	64848	57577	6160	4860	9294	3695	5151	6277	169981	93144	57463	5204	1514	6188	6137	196264	10384	8665	57447	7775	55700	1635	2043	55333	80853	54849	27086	51114	54741	64135	6208	3635	134637	7277	64777	6494	962	3107	65267	23503	23378	80153	659	7097	90204	91300	55893	8453	2000	51076	9531	50865	100289610	2635	3669	57097	282996	5018	26017	692236	26157	10519	64772	91543	694	22821	8243	309	3594	644068	10329	401505	155038	79844	175	23521	5799	288	28512	23230	10412	2533	199777	7076	574037	1604	64766	3135	3385	11174	55972	84674	1831	150365	26053	2319	94240	26119	221178	8634	2995	29997	11040	2944	55847	83641	6894	132299	7905	9263	92521	57674	6210	7378	5859	6746	84166	100292488	81555	1236	9595	56654	100093630	3988	93589	5245	386597	10124	54529	10487	6134	6161	54674	10479	1937	6205	51090	153527	6138	51696	57620	64114	274	1849	9241	286046	221061	100288722	54868	3476	51177	25885	3575	3137	84174	7433	55900	10771	79174	7414	5140	894	23406	6448	832	1889	8875	834	9790	10575	113791	120	55017	124944	4863	8519	51246	100289090	8896	114801	51204	9045	169834	3134	6181	1643	129804
GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_DN	M6593		17082649	Martinez FO,Gordon S,Locati M,Mantovani A	GSE5099	GSE5099_3807_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated upon CSF1 [GeneID=1435] treatment: monocytes (3 days) versus macrophages (7 days).	Monocytes mature tom acrophages in the presence of the lineage determining cytokine M-CSF. They can be further polarized into M1 or M2 macrophages with distinct functional properties. We used microarrays to detail the global programme of gene expression underlying macrophage maturation and polarization and identified distinct classes of up-regulated genes during this process.					256710	7167	7033	79883	7091	3183	100289563	284004	730631	56953	3187	285955	3638	255762	646214	124540	126823	3176	10923	100287411	100291860	5991	84959	6444	84515	9085	1021	57459	619190	3205	51176	974	1894	8289	378938	57690	1793	8622	118460	80233	80183	55547	285954	644450	6932	4194	10933	283711	117283	440021	56132	3149	3181	23468	10672	130827	25774	84295	57226	57492	64919	56934	22902	5923	55512	114879	8452	2738	7057	7979	8832	50852	3769	9802	83259	6421	246126	51465	8653	10971	6671	81542	26255	54988	340085	100421561	114131	1674	6303	53346	5919	113835	5870	79742	5287	149461	5616	113220	1841	389177	8418	23336	10658	6736	133690	51809	6638	2208	1572	22917	5586	391267	10864	144165	6581	9312	1136	22864	167465	8284	9266	1977	100129380	90203	488	5519	6670	23397	55835	64285	253827	4005	23133	1416	8880	5275	100130417	51015	6964	576	667	81037	119504	2590	805	8339	8287	64595	79949	23022	2121	64844	84267	65108	6651	151648	57222	100272216	93426	57105	3626	10049	3189	11116	51258	5350	100170939	246175	57486	8493	127294	54800	92815	23603	29068	3060	445347	3206	10016	10152	23683	144699	55365	51199	23264	4635	57633	7166	1386	445	51668	5083	170680	284612	64895	57119
GSE5099_CLASSICAL_M1_VS_ALTERNATIVE_M2_MACROPHAGE_UP	M6595		17082649	Martinez FO,Gordon S,Locati M,Mantovani A	GSE5099	GSE5099_3808_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in macrophages: classical (M1) versus alternative (M2).	Monocytes mature tom acrophages in the presence of the lineage determining cytokine M-CSF. They can be further polarized into M1 or M2 macrophages with distinct functional properties. We used microarrays to detail the global programme of gene expression underlying macrophage maturation and polarization and identified distinct classes of up-regulated genes during this process.					100289538	64848	1522	129804	64135	29997	288	26119	26053	55824	55718	80853	6160	169834	203328	29125	10947	4792	54981	23521	58472	962	6137	57169	824	7564	6159	9870	80833	9663	54849	22821	64375	11174	1236	401505	7277	1514	59339	10519	57713	6136	10384	54931	2517	143098	221178	389203	100289090	28512	8821	7294	55030	55364	155038	23526	81619	3135	27074	9790	694	169981	84174	64750	9241	3137	868	2995	7378	6223	2395	9770	6222	140691	1604	114625	100093630	9874	26986	6013	25939	274	51316	1901	6161	196264	6130	1350	9531	54674	27086	9470	4860	3594	7772	149628	29915	10390	57674	9383	6285	1938	151556	29956	939	27335	29926	4245	4862	353	26018	6128	6004	9466	10371	4049	9844	55144	5142	10866	5199	10418	57198	3955	9516	9764	23175	85013	3988	30	84230	1937	5204	4753	10865	5721	4242	26157	115361	80055	5033	6277	23406	283991	9692	4300	100289610	6210	50865	54910	155060	23348	2533	6133	120	2316	140730	6176	124944	7503	26354	8665	309	4094	57097	10223	3566	6181	644068	23344	10287	6139	6204	7174	54469	51177	2035	6197	1278	55229	3106	55571	29097	283713	51611	131450	84634	80324	2308	57194	6156	2678	55900	26136	57620	91543	64167	1877	5996	94240
GSE5099_CLASSICAL_M1_VS_ALTERNATIVE_M2_MACROPHAGE_DN	M6596		17082649	Martinez FO,Gordon S,Locati M,Mantovani A	GSE5099	GSE5099_3808_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in macrophages: classical (M1) versus alternative (M2).	Monocytes mature tom acrophages in the presence of the lineage determining cytokine M-CSF. They can be further polarized into M1 or M2 macrophages with distinct functional properties. We used microarrays to detail the global programme of gene expression underlying macrophage maturation and polarization and identified distinct classes of up-regulated genes during this process.					256710	93426	5003	10971	441631	6932	1294	91614	1572	912	6375	2590	2738	1737	84959	100291860	8644	3633	1021	23270	474171	114785	64919	1293	9741	4005	64595	27242	8653	1627	8284	646214	27180	124540	1787	126820	26211	3205	5616	1041	51809	3149	7035	114879	8321	246126	3206	56942	26088	23657	6671	9789	9103	65108	4241	3730	57633	730631	5475	391267	644450	375010	84900	6964	3021	9510	169841	217	28981	113835	8522	100129195	1130	9852	51195	727936	8493	9720	23239	79598	1894	1136	23007	10699	149086	1137	23468	84889	56243	55512	974	8125	80183	51465	9585	221527	11251	221692	201161	57142	5586	2769	3181	26238	9493	220047	6192	132884	576	7979	23022	7033	653252	6272	114787	254100	10864	993	92270	667	2037	23234	3356	64399	3699	643911	51371	100505978	9086	133690	57161	257103	3805	140686	645784	6744	10052	574036	8287	100170939	55509	5742	58503	29068	153745	5456	440021	284648	3190	8029	1655	55247	3626	55007	284904	204962	4297	254228	164312	22864	200734	85452	3565	246119	80205	1996	165	6659	2828	255762	728342	143458	137362	3204	286436	2119	2776	22856	60495	55680	2017	54619	96610	5110	4068	4194	10846	11314	56963	84333	202181	353514	389199	412	79832	4751
GSE3920_UNTREATED_VS_IFNA_TREATED_ENDOTHELIAL_CELL_UP	M6684		17202376	Indraccolo S,Pfeffer U,Minuzzo S,Esposito G,Roni V,Mandruzzato S,Ferrari N,Anfosso L,Dell'Eva R,Noonan DM,Chieco-Bianchi L,Albini A,Amadori A	GSE3920	GSE3920_3481_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in ndothelial cells: untreated versus interferon alpha.	IFNs are highly pleiotropic cytokines also endowed with marked anti-angiogenic activity. In this study, the mRNA expression profiles of endothelial cells (EC) exposed in vitro to IFN-alpha, IFN-beta, or IFN-gamma were determined. We found that in HUVEC as well as in other EC types 175 genes were upregulated (>2-fold increase) by IFNs, including genes involved in the host response to RNA viruses, inflammation, and apoptosis. Interestingly, 41 genes showed a >5-fold higher induction by IFN-alpha in EC compared to human fibroblasts; among them, the gene encoding the angiostatic chemokine CXCL11 was selectively induced by IFN-alpha in EC along with other genes associated with angiogenesis regulation, including CXCL10, TRAIL, and guanylate binding protein 1 (GBP-1). These transcriptional changes were confirmed and extended by quantitative PCR analysis and ELISA; whereas IFN-alpha and IFN-beta exerted virtually identical effects on transcriptome modulation, a differential gene regulation by type I and type II IFN emerged, especially as far as quantitative aspects were concerned. In vivo, IFN-alpha-producing tumors over-expressed murine CXCL10-11, GBP-1 and TRAIL, with evidence of CXCL11 production by tumor-associated EC. Overall, these findings improve our understanding of the anti-angiogenic effects of IFNs by showing that these cytokines trigger an anti-angiogenic transcriptional program in EC. Moreover, we suggest that quantitative differences in the magnitude of the transcriptional activation of IFNresponsive genes could form the basis for cell-specific transcriptional signatures.					318	64792	53827	5361	1152	10396	8773	55365	1318	54741	5476	90411	9859	598	3725	7316	54751	3357	9732	968	8491	84959	5341	10066	80824	5154	80301	6990	2990	93974	5510	23161	65003	51643	942	7098	5911	4735	55041	9522	1435	54855	145389	2185	8828	64092	7077	8519	341	3920	54209	56944	51535	55871	5412	79180	55207	114793	5996	7844	8411	6399	529	5328	64066	1848	8935	306	9846	3902	9734	64421	51510	3398	55331	89795	832	3689	100287362	2745	3685	2137	51552	51693	1441	391059	7043	8837	55315	9331	92017	2517	10875	2173	3586	3988	3162	55737	10668	96764	26256	11309	30844	9550	1495	124935	4097	5551	3417	2820	6386	51338	116064	9114	23380	5627	10630	6868	8460	2040	51181	51284	10409	6696	3298	2167	4351	81565	2966	6916	667	6354	401548	1263	3684	146722	23654	92255	10159	808	5025	57552	57458	27230	4035	10577	10507	214	27131	5264	3916	9946	51296	9517	945	3606	54502	4317	9473	3142	3998	5742	144110	22862	57117	27115	1601	4360	23166	51734	221184	81846	4067	7293
GSE3920_UNTREATED_VS_IFNA_TREATED_ENDOTHELIAL_CELL_DN	M6685		17202376	Indraccolo S,Pfeffer U,Minuzzo S,Esposito G,Roni V,Mandruzzato S,Ferrari N,Anfosso L,Dell'Eva R,Noonan DM,Chieco-Bianchi L,Albini A,Amadori A	GSE3920	GSE3920_3481_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in ndothelial cells: untreated versus interferon alpha.	IFNs are highly pleiotropic cytokines also endowed with marked anti-angiogenic activity. In this study, the mRNA expression profiles of endothelial cells (EC) exposed in vitro to IFN-alpha, IFN-beta, or IFN-gamma were determined. We found that in HUVEC as well as in other EC types 175 genes were upregulated (>2-fold increase) by IFNs, including genes involved in the host response to RNA viruses, inflammation, and apoptosis. Interestingly, 41 genes showed a >5-fold higher induction by IFN-alpha in EC compared to human fibroblasts; among them, the gene encoding the angiostatic chemokine CXCL11 was selectively induced by IFN-alpha in EC along with other genes associated with angiogenesis regulation, including CXCL10, TRAIL, and guanylate binding protein 1 (GBP-1). These transcriptional changes were confirmed and extended by quantitative PCR analysis and ELISA; whereas IFN-alpha and IFN-beta exerted virtually identical effects on transcriptome modulation, a differential gene regulation by type I and type II IFN emerged, especially as far as quantitative aspects were concerned. In vivo, IFN-alpha-producing tumors over-expressed murine CXCL10-11, GBP-1 and TRAIL, with evidence of CXCL11 production by tumor-associated EC. Overall, these findings improve our understanding of the anti-angiogenic effects of IFNs by showing that these cytokines trigger an anti-angiogenic transcriptional program in EC. Moreover, we suggest that quantitative differences in the magnitude of the transcriptional activation of IFNresponsive genes could form the basis for cell-specific transcriptional signatures.					2342	57194	5464	3376	10207	54540	59349	133418	309	5471	60561	201305	29899	100131211	10899	400961	7019	6611	23039	921	201799	152789	84067	27240	472	54617	4175	11051	51263	80279	5930	54739	10009	85441	5138	3595	8564	80258	2317	7153	10678	2778	79882	4288	84063	64135	2908	11232	80150	202018	6095	6935	26065	138050	129303	54558	84879	2550	2672	9057	28969	9709	2316	6938	11270	79738	89866	969	4635	1044	9126	6775	27316	6143	55796	84280	54407	2969	51163	339345	3434	57455	125058	1232	81611	253832	23358	4174	957	2146	7123	116496	64850	9679	57088	8170	65258	3459	5463	145567	51176	6897	5427	51466	79754	23438	3732	118490	23070	8581	10788	6534	6259	6949	387264	22882	84937	6654	121551	284266	3688	3375	3776	976	125488	79611	83943	83852	64395	1616	10186	84986	84897	10419	9804	84525	1339	151888	3004	10125	83892	112724	84456	5253	87178	1791	2058	3690	60481	55054	4122	7286	134429	6122	8148	10309	6504	3708	9702	23478	6301	4841	1417
GSE3920_UNTREATED_VS_IFNB_TREATED_ENDOTHELIAL_CELL_UP	M6686		17202376	Indraccolo S,Pfeffer U,Minuzzo S,Esposito G,Roni V,Mandruzzato S,Ferrari N,Anfosso L,Dell'Eva R,Noonan DM,Chieco-Bianchi L,Albini A,Amadori A	GSE3920	GSE3920_3482_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in endothelial cells: untreated versus interferon beta.	IFNs are highly pleiotropic cytokines also endowed with marked anti-angiogenic activity. In this study, the mRNA expression profiles of endothelial cells (EC) exposed in vitro to IFN-alpha, IFN-beta, or IFN-gamma were determined. We found that in HUVEC as well as in other EC types 175 genes were upregulated (>2-fold increase) by IFNs, including genes involved in the host response to RNA viruses, inflammation, and apoptosis. Interestingly, 41 genes showed a >5-fold higher induction by IFN-alpha in EC compared to human fibroblasts; among them, the gene encoding the angiostatic chemokine CXCL11 was selectively induced by IFN-alpha in EC along with other genes associated with angiogenesis regulation, including CXCL10, TRAIL, and guanylate binding protein 1 (GBP-1). These transcriptional changes were confirmed and extended by quantitative PCR analysis and ELISA; whereas IFN-alpha and IFN-beta exerted virtually identical effects on transcriptome modulation, a differential gene regulation by type I and type II IFN emerged, especially as far as quantitative aspects were concerned. In vivo, IFN-alpha-producing tumors over-expressed murine CXCL10-11, GBP-1 and TRAIL, with evidence of CXCL11 production by tumor-associated EC. Overall, these findings improve our understanding of the anti-angiogenic effects of IFNs by showing that these cytokines trigger an anti-angiogenic transcriptional program in EC. Moreover, we suggest that quantitative differences in the magnitude of the transcriptional activation of IFNresponsive genes could form the basis for cell-specific transcriptional signatures.					4023	201229	88455	5979	57655	2113	51148	5565	91687	473	3606	64005	339287	126626	54768	54545	5279	92703	1120	10659	50865	54822	1487	3122	5494	64180	25962	116840	90806	3512	25948	150094	239	283991	54879	1794	340527	57216	11004	653361	665	27183	6867	5729	57007	23468	285761	22914	80335	84641	57326	6453	54514	80705	79947	60494	114789	8323	375035	4068	3984	85315	56667	3543	9875	5016	54716	79892	23506	84059	5274	55312	26263	85464	339766	23529	10623	128989	2150	23333	444	6675	3725	11249	23383	3925	51706	7056	170384	2354	23047	9716	283130	79905	129285	59307	64844	79858	4642	116113	2621	257068	7852	1436	5997	64108	8309	8907	51621	7430	23293	7322	1316	80228	10016	55066	51477	840	9847	66036	54904	23097	6840	788	860	81620	5927	27163	5373	7716	1633	51274	9448	92140	84078	637	29123	55915	9712	613227	10735	28834	221150	26020	10257	90634	7538	57591	27299	400916	10365	26273	112487	81928	8906	1894	2551	3958	157638	3454	27336	8601	3985	2969	8808	57185	152503	942	51646	150290	51526	55022	54741	7294	26277	10219	3600	57509	26207	283464	8289	340784	55349	5116	10983	760	3899	2011	90550	9184	146050	222658	6038	54877	7903	10927	55728	4089	9232	388364
GSE3920_UNTREATED_VS_IFNA_TREATED_FIBROBLAST_DN	M6687		17202376	Indraccolo S,Pfeffer U,Minuzzo S,Esposito G,Roni V,Mandruzzato S,Ferrari N,Anfosso L,Dell'Eva R,Noonan DM,Chieco-Bianchi L,Albini A,Amadori A	GSE3920	GSE3920_3487_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated fibroblasts: untreated versus interferon alpha.	IFNs are highly pleiotropic cytokines also endowed with marked anti-angiogenic activity. In this study, the mRNA expression profiles of endothelial cells (EC) exposed in vitro to IFN-alpha, IFN-beta, or IFN-gamma were determined. We found that in HUVEC as well as in other EC types 175 genes were upregulated (>2-fold increase) by IFNs, including genes involved in the host response to RNA viruses, inflammation, and apoptosis. Interestingly, 41 genes showed a >5-fold higher induction by IFN-alpha in EC compared to human fibroblasts; among them, the gene encoding the angiostatic chemokine CXCL11 was selectively induced by IFN-alpha in EC along with other genes associated with angiogenesis regulation, including CXCL10, TRAIL, and guanylate binding protein 1 (GBP-1). These transcriptional changes were confirmed and extended by quantitative PCR analysis and ELISA; whereas IFN-alpha and IFN-beta exerted virtually identical effects on transcriptome modulation, a differential gene regulation by type I and type II IFN emerged, especially as far as quantitative aspects were concerned. In vivo, IFN-alpha-producing tumors over-expressed murine CXCL10-11, GBP-1 and TRAIL, with evidence of CXCL11 production by tumor-associated EC. Overall, these findings improve our understanding of the anti-angiogenic effects of IFNs by showing that these cytokines trigger an anti-angiogenic transcriptional program in EC. Moreover, we suggest that quantitative differences in the magnitude of the transcriptional activation of IFNresponsive genes could form the basis for cell-specific transcriptional signatures.					27072	80146	85364	51319	771	29803	23481	84976	643836	383	10283	10746	3569	23587	4999	2821	23399	339	81579	8303	79612	23378	26354	124540	7508	22907	2873	26574	7589	57189	27037	23433	93436	3712	51073	57659	5090	5509	127544	8476	9214	84340	54541	5214	345611	2776	55275	80020	10073	166378	9069	128077	55501	79959	889	23074	4998	23031	26058	5337	54856	4097	51752	57380	7297	708	55253	131583	9926	63891	391059	8664	51225	51507	29967	728568	55092	146923	51118	8662	6729	9757	5095	54503	440138	81566	5771	54497	79736	55296	159371	8504	93129	64061	10523	5108	5550	113278	4026	10318	29886	2935	8773	317781	80255	5193	23644	140707	23192	91833	10137	347344	9274	8744	31	84460	7866	3099	79792	23233	10410	57120	6835	2879	56245	51634	81544	64978	3976	55647	10644	65998	29087	25897	3717	10905	57291	54819	641	123355	84706	124359	219654	23646	643988	83608	54480	734	3578	1687	92312	253943	837	2686	9343	7040	79823	9203	1741	80150	2762	2800	5008	8910	151195	64794	55280	7701	55125	54885	79068	23061	27115	85302	9019	534	57181	8874	2869	65095	151887	369	79772	9957	8602	7372	79066	84812	57787	6311	29901	8802	51256	80019	10190	4043	7703	196463	51236	7424
GSE3920_UNTREATED_VS_IFNG_TREATED_FIBROBLAST_UP	M6688		17202376	Indraccolo S,Pfeffer U,Minuzzo S,Esposito G,Roni V,Mandruzzato S,Ferrari N,Anfosso L,Dell'Eva R,Noonan DM,Chieco-Bianchi L,Albini A,Amadori A	GSE3920	GSE3920_3488_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in fibroblasts: untreated versus IFNG [GeneID=3458].	IFNs are highly pleiotropic cytokines also endowed with marked anti-angiogenic activity. In this study, the mRNA expression profiles of endothelial cells (EC) exposed in vitro to IFN-alpha, IFN-beta, or IFN-gamma were determined. We found that in HUVEC as well as in other EC types 175 genes were upregulated (>2-fold increase) by IFNs, including genes involved in the host response to RNA viruses, inflammation, and apoptosis. Interestingly, 41 genes showed a >5-fold higher induction by IFN-alpha in EC compared to human fibroblasts; among them, the gene encoding the angiostatic chemokine CXCL11 was selectively induced by IFN-alpha in EC along with other genes associated with angiogenesis regulation, including CXCL10, TRAIL, and guanylate binding protein 1 (GBP-1). These transcriptional changes were confirmed and extended by quantitative PCR analysis and ELISA; whereas IFN-alpha and IFN-beta exerted virtually identical effects on transcriptome modulation, a differential gene regulation by type I and type II IFN emerged, especially as far as quantitative aspects were concerned. In vivo, IFN-alpha-producing tumors over-expressed murine CXCL10-11, GBP-1 and TRAIL, with evidence of CXCL11 production by tumor-associated EC. Overall, these findings improve our understanding of the anti-angiogenic effects of IFNs by showing that these cytokines trigger an anti-angiogenic transcriptional program in EC. Moreover, we suggest that quantitative differences in the magnitude of the transcriptional activation of IFNresponsive genes could form the basis for cell-specific transcriptional signatures.					84643	79777	1213	10456	202915	55080	23440	55604	3098	8543	84898	2957	375346	23549	83862	283373	9663	11142	9583	1642	54868	10146	3914	57626	5340	4504	57171	3688	167227	253461	7504	158	5026	23194	8522	161882	6929	79180	5709	6118	57620	1297	493869	29985	114771	9917	1848	7086	84101	285888	81857	2258	8495	3169	134285	9247	11156	9629	55384	54187	83643	4744	57091	150962	164237	25930	859	55559	143425	55140	112724	10120	8562	3837	2523	210	83639	9480	5756	56267	55156	283537	5493	54905	3001	254050	8318	90379	10102	54815	51279	23	8767	635	53407	924	222234	254531	55651	64858	170850	51540	59283	8728	10300	22934	3170	55658	26472	646962	1534	301	54497	8648	145567	80380	8078	64699	153769	5331	28231	2959	10061	129049	10204	27090	63974	3594	2672	114571	790	9	9201	115019	7357	79705	5693	55270	4081	9862	55289	8829	22883	54974	26020	55191	666	26517	84033	55225	51056	79722	5713	834	63916	10229	6390	953	22806	79006	283471	55652	27346	1762	54438
GSE3920_UNTREATED_VS_IFNG_TREATED_FIBROBLAST_DN	M6689		17202376	Indraccolo S,Pfeffer U,Minuzzo S,Esposito G,Roni V,Mandruzzato S,Ferrari N,Anfosso L,Dell'Eva R,Noonan DM,Chieco-Bianchi L,Albini A,Amadori A	GSE3920	GSE3920_3488_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in fibroblasts: untreated versus IFNG [GeneID=3458].	IFNs are highly pleiotropic cytokines also endowed with marked anti-angiogenic activity. In this study, the mRNA expression profiles of endothelial cells (EC) exposed in vitro to IFN-alpha, IFN-beta, or IFN-gamma were determined. We found that in HUVEC as well as in other EC types 175 genes were upregulated (>2-fold increase) by IFNs, including genes involved in the host response to RNA viruses, inflammation, and apoptosis. Interestingly, 41 genes showed a >5-fold higher induction by IFN-alpha in EC compared to human fibroblasts; among them, the gene encoding the angiostatic chemokine CXCL11 was selectively induced by IFN-alpha in EC along with other genes associated with angiogenesis regulation, including CXCL10, TRAIL, and guanylate binding protein 1 (GBP-1). These transcriptional changes were confirmed and extended by quantitative PCR analysis and ELISA; whereas IFN-alpha and IFN-beta exerted virtually identical effects on transcriptome modulation, a differential gene regulation by type I and type II IFN emerged, especially as far as quantitative aspects were concerned. In vivo, IFN-alpha-producing tumors over-expressed murine CXCL10-11, GBP-1 and TRAIL, with evidence of CXCL11 production by tumor-associated EC. Overall, these findings improve our understanding of the anti-angiogenic effects of IFNs by showing that these cytokines trigger an anti-angiogenic transcriptional program in EC. Moreover, we suggest that quantitative differences in the magnitude of the transcriptional activation of IFNresponsive genes could form the basis for cell-specific transcriptional signatures.					5867	9021	10723	4050	256435	55601	57568	160762	132014	5803	26984	57326	4007	1368	23329	28959	3554	6289	255967	6095	667	408	26249	54832	7378	84067	2550	286205	79668	5638	6304	23365	3800	11343	7286	1991	116236	10892	4651	23205	84937	10161	79713	104	117289	25806	91404	1880	7052	11035	4286	120425	149233	256586	6097	121536	406	79925	89857	8848	84163	23051	3678	23518	6489	84976	84674	161436	9936	1195	51560	8808	6001	55827	54757	91775	5332	54498	283209	9975	63971	84669	3460	4070	388364	138307	7832	8702	22930	5579	402415	254251	147991	80727	80223	694	23522	11059	64781	1655	55365	638	57105	55198	7750	29801	4907	22882	259230	23428	160364	28951	7464	23233	5934	23095	10529	10267	92922	1893	57205	4649	6915	133418	55	6875	11022	54918	89801	9394	9712	55852	8609	7461	57713	140803	2117	1608	3605	8473	394	83856	64132	6792	84818	79156	55197	222487	940	3559	7294	3643	22800	55346	23271	4916	26137	85461	359845	23360	79865	5140	3487	6342	85463	10505	2687	8916	26018	1003	196528	23327	971	57514	259173
GSE3920_IFNA_VS_IFNG_TREATED_FIBROBLAST_UP	M6690		17202376	Indraccolo S,Pfeffer U,Minuzzo S,Esposito G,Roni V,Mandruzzato S,Ferrari N,Anfosso L,Dell'Eva R,Noonan DM,Chieco-Bianchi L,Albini A,Amadori A	GSE3920	GSE3920_3489_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in fibroblasts: interferon alpha versus IFNG [GeneID=3458].	IFNs are highly pleiotropic cytokines also endowed with marked anti-angiogenic activity. In this study, the mRNA expression profiles of endothelial cells (EC) exposed in vitro to IFN-alpha, IFN-beta, or IFN-gamma were determined. We found that in HUVEC as well as in other EC types 175 genes were upregulated (>2-fold increase) by IFNs, including genes involved in the host response to RNA viruses, inflammation, and apoptosis. Interestingly, 41 genes showed a >5-fold higher induction by IFN-alpha in EC compared to human fibroblasts; among them, the gene encoding the angiostatic chemokine CXCL11 was selectively induced by IFN-alpha in EC along with other genes associated with angiogenesis regulation, including CXCL10, TRAIL, and guanylate binding protein 1 (GBP-1). These transcriptional changes were confirmed and extended by quantitative PCR analysis and ELISA; whereas IFN-alpha and IFN-beta exerted virtually identical effects on transcriptome modulation, a differential gene regulation by type I and type II IFN emerged, especially as far as quantitative aspects were concerned. In vivo, IFN-alpha-producing tumors over-expressed murine CXCL10-11, GBP-1 and TRAIL, with evidence of CXCL11 production by tumor-associated EC. Overall, these findings improve our understanding of the anti-angiogenic effects of IFNs by showing that these cytokines trigger an anti-angiogenic transcriptional program in EC. Moreover, we suggest that quantitative differences in the magnitude of the transcriptional activation of IFNresponsive genes could form the basis for cell-specific transcriptional signatures.					3689	8807	6645	285527	54828	64092	57147	153129	3587	256471	158866	23303	2081	23005	1408	3092	54900	254531	2824	3764	51232	3383	5783	1145	166979	1586	51646	5881	375346	4088	3001	10855	2185	953	5375	3676	80150	84898	387357	8522	7297	253461	55959	23035	54103	22806	160418	57571	57580	57823	1656	8648	987	8073	79705	327657	57412	4659	51363	10392	7107	160851	55364	125488	1435	333	10673	333926	81615	123879	29126	489	54894	9341	56957	23338	9901	116931	55294	154075	118788	145567	57190	151556	5530	3601	2889	54438	933	5734	57645	2149	56204	54843	51274	5781	1240	9980	3824	80005	23387	54868	10783	51676	130507	147645	55784	140738	80031	8816	116984	23218	8435	9120	9679	6484	317	80853	9424	5331	254122	9201	55289	9435	598	80013	81544	6375	54464	6451	4818	1509	2534	5150	84717	48	10678	11145	9910	57531	6256	124997	79718	65109	55716	9915	10608	91869	116179	5998	9839	284467	5791	84458	246269	1524	23608	5311	221002	9663	64839	11174	401612	51000	57148	9600	23132	7188	54476	134957	51547	11135	153090	84962	9153
GSE3920_IFNA_VS_IFNG_TREATED_FIBROBLAST_DN	M6691		17202376	Indraccolo S,Pfeffer U,Minuzzo S,Esposito G,Roni V,Mandruzzato S,Ferrari N,Anfosso L,Dell'Eva R,Noonan DM,Chieco-Bianchi L,Albini A,Amadori A	GSE3920	GSE3920_3489_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in fibroblasts: interferon alpha versus IFNG [GeneID=3458].	IFNs are highly pleiotropic cytokines also endowed with marked anti-angiogenic activity. In this study, the mRNA expression profiles of endothelial cells (EC) exposed in vitro to IFN-alpha, IFN-beta, or IFN-gamma were determined. We found that in HUVEC as well as in other EC types 175 genes were upregulated (>2-fold increase) by IFNs, including genes involved in the host response to RNA viruses, inflammation, and apoptosis. Interestingly, 41 genes showed a >5-fold higher induction by IFN-alpha in EC compared to human fibroblasts; among them, the gene encoding the angiostatic chemokine CXCL11 was selectively induced by IFN-alpha in EC along with other genes associated with angiogenesis regulation, including CXCL10, TRAIL, and guanylate binding protein 1 (GBP-1). These transcriptional changes were confirmed and extended by quantitative PCR analysis and ELISA; whereas IFN-alpha and IFN-beta exerted virtually identical effects on transcriptome modulation, a differential gene regulation by type I and type II IFN emerged, especially as far as quantitative aspects were concerned. In vivo, IFN-alpha-producing tumors over-expressed murine CXCL10-11, GBP-1 and TRAIL, with evidence of CXCL11 production by tumor-associated EC. Overall, these findings improve our understanding of the anti-angiogenic effects of IFNs by showing that these cytokines trigger an anti-angiogenic transcriptional program in EC. Moreover, we suggest that quantitative differences in the magnitude of the transcriptional activation of IFNresponsive genes could form the basis for cell-specific transcriptional signatures.					1407	55154	387923	2117	3460	29785	9467	8718	29801	638	4862	84102	1880	79828	55872	971	79071	132014	79865	1893	10528	55144	91404	55	27306	2150	9258	8502	2687	4171	140803	1236	4907	28959	1233	406	359845	5511	221188	2189	9823	10397	3418	28951	5600	79691	10268	115350	6932	1742	221	408	79711	8914	57568	30819	7163	28996	780	55365	2194	4355	5441	85461	79159	3480	201595	60678	10053	3487	55621	7294	197370	54475	3679	55833	757	80020	6095	23223	5570	6304	23428	60468	11069	10514	25806	57559	84937	11346	360	6001	10800	286319	10267	8241	55534	64077	23295	23464	4258	387787	6097	8492	79084	3399	85315	64781	2651	2983	5579	23205	87	9355	10607	84206	133418	23187	3623	6489	80324	7049	257062	4830	57514	79085	56259	9569	11022	147991	79843	283514	51701	388341	4651	121642	79144	1352	152789	4092	4176	222236	54039	113791	55198	9754	162239	54492	23481	83715	1612	10243	115290	11035	1400	6949	83596	333929	340554	22918	160364	57560	3978	10226	64170	115330	9124	93233	3992	54507	117177	25996	9215	54839	3675	51116	27042	498	55789	10509	51559	29767	11343
GSE3920_UNTREATED_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN	M6694		17202376	Indraccolo S,Pfeffer U,Minuzzo S,Esposito G,Roni V,Mandruzzato S,Ferrari N,Anfosso L,Dell'Eva R,Noonan DM,Chieco-Bianchi L,Albini A,Amadori A	GSE3920	GSE3920_3482_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in endothelial cells: untreated versus interferon beta.	IFNs are highly pleiotropic cytokines also endowed with marked anti-angiogenic activity. In this study, the mRNA expression profiles of endothelial cells (EC) exposed in vitro to IFN-alpha, IFN-beta, or IFN-gamma were determined. We found that in HUVEC as well as in other EC types 175 genes were upregulated (>2-fold increase) by IFNs, including genes involved in the host response to RNA viruses, inflammation, and apoptosis. Interestingly, 41 genes showed a >5-fold higher induction by IFN-alpha in EC compared to human fibroblasts; among them, the gene encoding the angiostatic chemokine CXCL11 was selectively induced by IFN-alpha in EC along with other genes associated with angiogenesis regulation, including CXCL10, TRAIL, and guanylate binding protein 1 (GBP-1). These transcriptional changes were confirmed and extended by quantitative PCR analysis and ELISA; whereas IFN-alpha and IFN-beta exerted virtually identical effects on transcriptome modulation, a differential gene regulation by type I and type II IFN emerged, especially as far as quantitative aspects were concerned. In vivo, IFN-alpha-producing tumors over-expressed murine CXCL10-11, GBP-1 and TRAIL, with evidence of CXCL11 production by tumor-associated EC. Overall, these findings improve our understanding of the anti-angiogenic effects of IFNs by showing that these cytokines trigger an anti-angiogenic transcriptional program in EC. Moreover, we suggest that quantitative differences in the magnitude of the transcriptional activation of IFNresponsive genes could form the basis for cell-specific transcriptional signatures.					10365	84941	7249	2187	55070	23288	9949	9824	23270	64745	327	286336	200558	23395	122773	5427	64395	55250	197322	64921	286128	116143	57405	151648	79621	5567	157570	6117	55218	348654	283897	63901	9131	902	7504	344807	219844	80727	7153	55032	10474	4796	55601	9937	10788	283578	23039	3433	80312	3560	5226	145173	57153	51497	7112	8165	55775	401612	27068	6259	23211	6737	4173	5429	4124	23046	10505	9917	64682	221927	29998	57479	2177	57580	84878	23344	64429	6400	223082	3009	115752	9197	1400	2317	54962	23208	3832	54879	132949	5834	84230	91775	221937	92105	10055	29985	10269	10855	91526	6840	10989	5864	80143	161823	57181	138050	136319	51167	8743	54662	7468	118	51231	84547	128854	8330	51063	80321	5192	4815	80071	7465	23333	54832	10875	144455	203245	87	51191	23353	25813	1431	201292	5610	27163	2997	114826	81542	54518	57016	387357	23155	26610	8604	120	9750	7027	6241	9203	54849	6502	151246	55689	890	4221	57678	8370	63979	26958	6929	9563	4436	57820	54995	10111	9055	6119	1876	9793	54913	10561	64151	57542
GSE3920_UNTREATED_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP	M6695		17202376	Indraccolo S,Pfeffer U,Minuzzo S,Esposito G,Roni V,Mandruzzato S,Ferrari N,Anfosso L,Dell'Eva R,Noonan DM,Chieco-Bianchi L,Albini A,Amadori A	GSE3920	GSE3920_3483_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in endothelial cells: untreated versus IFNG [GeneID=3458].	IFNs are highly pleiotropic cytokines also endowed with marked anti-angiogenic activity. In this study, the mRNA expression profiles of endothelial cells (EC) exposed in vitro to IFN-alpha, IFN-beta, or IFN-gamma were determined. We found that in HUVEC as well as in other EC types 175 genes were upregulated (>2-fold increase) by IFNs, including genes involved in the host response to RNA viruses, inflammation, and apoptosis. Interestingly, 41 genes showed a >5-fold higher induction by IFN-alpha in EC compared to human fibroblasts; among them, the gene encoding the angiostatic chemokine CXCL11 was selectively induced by IFN-alpha in EC along with other genes associated with angiogenesis regulation, including CXCL10, TRAIL, and guanylate binding protein 1 (GBP-1). These transcriptional changes were confirmed and extended by quantitative PCR analysis and ELISA; whereas IFN-alpha and IFN-beta exerted virtually identical effects on transcriptome modulation, a differential gene regulation by type I and type II IFN emerged, especially as far as quantitative aspects were concerned. In vivo, IFN-alpha-producing tumors over-expressed murine CXCL10-11, GBP-1 and TRAIL, with evidence of CXCL11 production by tumor-associated EC. Overall, these findings improve our understanding of the anti-angiogenic effects of IFNs by showing that these cytokines trigger an anti-angiogenic transcriptional program in EC. Moreover, we suggest that quantitative differences in the magnitude of the transcriptional activation of IFNresponsive genes could form the basis for cell-specific transcriptional signatures.					2898	7185	1465	7293	10458	874	7128	54902	3558	833	3976	135	969	57047	54407	5966	1959	4901	5801	1119	1847	3358	6862	3048	7037	5187	57556	64332	1846	64782	80149	84261	8600	402569	10863	79094	6541	2176	1026	136	90637	29126	92749	22895	4616	168507	8013	10268	5328	4653	11255	54860	5662	1960	81605	2557	1263	11104	117166	7186	160418	57761	388818	96459	246777	1106	6351	1237	9047	2260	7050	117245	245806	56937	6520	1390	339456	6236	8718	84879	23135	3702	2010	89849	4651	3189	203100	55620	79720	2617	4607	139411	79056	56971	57461	150094	54790	3187	7124	23767	54714	192670	54840	80824	5606	3656	984	5999	146923	8433	55153	114884	407010	581	390	89846	1591	84876	6004	4118	8694	51350	132864	83449	127	623	3627	9240	1958	1382	9667	84217	9516	139886	26051	55341	1571	157638	9819	54866	27123	57602	7542	9043	166929	10938	8518	54498	340990	2074	79155	571
GSE3920_UNTREATED_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN	M6696		17202376	Indraccolo S,Pfeffer U,Minuzzo S,Esposito G,Roni V,Mandruzzato S,Ferrari N,Anfosso L,Dell'Eva R,Noonan DM,Chieco-Bianchi L,Albini A,Amadori A	GSE3920	GSE3920_3483_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in endothelial cells: untreated versus IFNG [GeneID=3458].	IFNs are highly pleiotropic cytokines also endowed with marked anti-angiogenic activity. In this study, the mRNA expression profiles of endothelial cells (EC) exposed in vitro to IFN-alpha, IFN-beta, or IFN-gamma were determined. We found that in HUVEC as well as in other EC types 175 genes were upregulated (>2-fold increase) by IFNs, including genes involved in the host response to RNA viruses, inflammation, and apoptosis. Interestingly, 41 genes showed a >5-fold higher induction by IFN-alpha in EC compared to human fibroblasts; among them, the gene encoding the angiostatic chemokine CXCL11 was selectively induced by IFN-alpha in EC along with other genes associated with angiogenesis regulation, including CXCL10, TRAIL, and guanylate binding protein 1 (GBP-1). These transcriptional changes were confirmed and extended by quantitative PCR analysis and ELISA; whereas IFN-alpha and IFN-beta exerted virtually identical effects on transcriptome modulation, a differential gene regulation by type I and type II IFN emerged, especially as far as quantitative aspects were concerned. In vivo, IFN-alpha-producing tumors over-expressed murine CXCL10-11, GBP-1 and TRAIL, with evidence of CXCL11 production by tumor-associated EC. Overall, these findings improve our understanding of the anti-angiogenic effects of IFNs by showing that these cytokines trigger an anti-angiogenic transcriptional program in EC. Moreover, we suggest that quantitative differences in the magnitude of the transcriptional activation of IFNresponsive genes could form the basis for cell-specific transcriptional signatures.					347862	54995	64397	150771	80775	23481	26258	9468	790	9093	399664	11196	267	54741	117178	23035	284252	9517	1642	10277	79137	81537	201161	5096	92014	84230	112939	51304	1457	54797	56181	55250	10114	7109	51172	90407	757	29914	3927	65003	10162	57418	4221	23471	1520	2768	22954	55193	60559	23279	79956	949	6618	9685	51103	64077	8034	64925	64928	55435	81488	23484	79828	144699	9761	55872	5550	124790	23420	9439	64747	64682	79084	10594	5211	50626	54487	79575	5707	4864	56893	53615	9563	5781	57533	51550	285973	9632	23097	7301	79718	2968	2135	51449	9672	55113	10899	23633	10102	56674	113419	8773	51015	222236	65080	51116	23598	57798	54921	9917	5198	5279	23184	8165	23654	55741	374291	7249	7052	84522	81786	29985	6894	283219	6723	51014	9913	8729	9673	4521	5431	84899	1314	79644	4171	5356	440138	3959	5693	30849	8897	54849	83879	54499	90204	8914	55177	2618	64418	23171	10226	156	1522	5253	140461	9091	374986	9278	84321	84193	51603	10749	26127	27005	7511	26523	1676	366	3992	10295	2896	8994	131870	10296	9110	9920	9746	210	26271	94005
GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP	M6697		17202376	Indraccolo S,Pfeffer U,Minuzzo S,Esposito G,Roni V,Mandruzzato S,Ferrari N,Anfosso L,Dell'Eva R,Noonan DM,Chieco-Bianchi L,Albini A,Amadori A	GSE3920	GSE3920_3484_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in endothelial cells: interferon alpha versus IFNG [GeneID=3458].	IFNs are highly pleiotropic cytokines also endowed with marked anti-angiogenic activity. In this study, the mRNA expression profiles of endothelial cells (EC) exposed in vitro to IFN-alpha, IFN-beta, or IFN-gamma were determined. We found that in HUVEC as well as in other EC types 175 genes were upregulated (>2-fold increase) by IFNs, including genes involved in the host response to RNA viruses, inflammation, and apoptosis. Interestingly, 41 genes showed a >5-fold higher induction by IFN-alpha in EC compared to human fibroblasts; among them, the gene encoding the angiostatic chemokine CXCL11 was selectively induced by IFN-alpha in EC along with other genes associated with angiogenesis regulation, including CXCL10, TRAIL, and guanylate binding protein 1 (GBP-1). These transcriptional changes were confirmed and extended by quantitative PCR analysis and ELISA; whereas IFN-alpha and IFN-beta exerted virtually identical effects on transcriptome modulation, a differential gene regulation by type I and type II IFN emerged, especially as far as quantitative aspects were concerned. In vivo, IFN-alpha-producing tumors over-expressed murine CXCL10-11, GBP-1 and TRAIL, with evidence of CXCL11 production by tumor-associated EC. Overall, these findings improve our understanding of the anti-angiogenic effects of IFNs by showing that these cytokines trigger an anti-angiogenic transcriptional program in EC. Moreover, we suggest that quantitative differences in the magnitude of the transcriptional activation of IFNresponsive genes could form the basis for cell-specific transcriptional signatures.					984	1850	23764	55259	6498	8784	5565	7185	11104	133746	467	7422	7050	1119	9314	3187	54902	51669	54413	54799	91181	8653	3300	55364	5662	23135	163590	29126	8013	5514	51585	150094	314	79665	221079	1958	113452	90637	54623	200894	1407	2355	114789	79720	9456	2077	91746	6876	4524	22930	6023	9667	26118	54900	10458	54883	3627	285527	56658	6526	348094	26256	6844	84807	89846	57461	29950	1195	1390	55466	166378	57666	7555	26093	57396	142891	1655	80824	60674	3164	115426	81566	81669	55007	2828	5966	9531	1974	89849	131831	154	51747	9987	79748	11232	96459	55664	80149	29896	7128	22936	84138	65125	64651	23360	7059	57018	2191	9600	1263	219670	6418	80331	4092	90268	11221	4929	1106	25801	2643	5141	57532	6811	51119	5927	6520	54906	55362	6911	1514	6314	132864	8795	64783	56829	5971	9975	6770	9043	117289	27289	170850	80380	192669	55922	257415	25930	79852	54407	257062	30819	3434	23451	55716	7832	84106	79670	221302	11214	9906	6651	26277	5837	1983	84444	4084
GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN	M6699		17202376	Indraccolo S,Pfeffer U,Minuzzo S,Esposito G,Roni V,Mandruzzato S,Ferrari N,Anfosso L,Dell'Eva R,Noonan DM,Chieco-Bianchi L,Albini A,Amadori A	GSE3920	GSE3920_3484_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in endothelial cells: interferon alpha versus IFNG [GeneID=3458].	IFNs are highly pleiotropic cytokines also endowed with marked anti-angiogenic activity. In this study, the mRNA expression profiles of endothelial cells (EC) exposed in vitro to IFN-alpha, IFN-beta, or IFN-gamma were determined. We found that in HUVEC as well as in other EC types 175 genes were upregulated (>2-fold increase) by IFNs, including genes involved in the host response to RNA viruses, inflammation, and apoptosis. Interestingly, 41 genes showed a >5-fold higher induction by IFN-alpha in EC compared to human fibroblasts; among them, the gene encoding the angiostatic chemokine CXCL11 was selectively induced by IFN-alpha in EC along with other genes associated with angiogenesis regulation, including CXCL10, TRAIL, and guanylate binding protein 1 (GBP-1). These transcriptional changes were confirmed and extended by quantitative PCR analysis and ELISA; whereas IFN-alpha and IFN-beta exerted virtually identical effects on transcriptome modulation, a differential gene regulation by type I and type II IFN emerged, especially as far as quantitative aspects were concerned. In vivo, IFN-alpha-producing tumors over-expressed murine CXCL10-11, GBP-1 and TRAIL, with evidence of CXCL11 production by tumor-associated EC. Overall, these findings improve our understanding of the anti-angiogenic effects of IFNs by showing that these cytokines trigger an anti-angiogenic transcriptional program in EC. Moreover, we suggest that quantitative differences in the magnitude of the transcriptional activation of IFNresponsive genes could form the basis for cell-specific transcriptional signatures.					3416	84898	6713	5783	152137	8495	125488	338699	8165	153090	22914	9839	79143	10165	2034	953	10602	8562	56994	3001	9937	1431	5901	9424	6389	79158	3743	7027	23590	54502	84918	3852	85458	64805	153769	10643	203	3688	253461	197322	51768	79621	387357	5496	79722	9663	1462	57190	54733	57010	93663	9731	339390	8342	197259	2824	10219	1303	8743	7504	284338	8840	47	56479	3587	4635	4734	90550	10474	874	55530	8522	59283	9435	31	22979	506	2817	55289	114904	9480	987	5686	3843	144245	4619	51733	30846	85465	7291	22987	200734	161882	163351	3978	203245	3672	9949	84440	8829	6004	1737	55604	8531	9688	287015	10938	64858	10875	2625	3015	27067	488	4744	4193	376267	254531	1029	5530	10154	8435	80031	200958	27033	9334	2045	4174	23132	401612	93550	81029	6341	5327	55283	6256	5341	23344	90161	27434	83875	5727	378807	200558	23551	4646	1583	301	3565	2806	92105	6383	6464	114794	902	59340	7371	4815	2268	11142	254263	56945	6253	125875	22837	4245	23333	63916
GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_UP	M6700		17202376	Indraccolo S,Pfeffer U,Minuzzo S,Esposito G,Roni V,Mandruzzato S,Ferrari N,Anfosso L,Dell'Eva R,Noonan DM,Chieco-Bianchi L,Albini A,Amadori A	GSE3920	GSE3920_3485_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in endothelial cells: interferon alpha versus interferon beta.	IFNs are highly pleiotropic cytokines also endowed with marked anti-angiogenic activity. In this study, the mRNA expression profiles of endothelial cells (EC) exposed in vitro to IFN-alpha, IFN-beta, or IFN-gamma were determined. We found that in HUVEC as well as in other EC types 175 genes were upregulated (>2-fold increase) by IFNs, including genes involved in the host response to RNA viruses, inflammation, and apoptosis. Interestingly, 41 genes showed a >5-fold higher induction by IFN-alpha in EC compared to human fibroblasts; among them, the gene encoding the angiostatic chemokine CXCL11 was selectively induced by IFN-alpha in EC along with other genes associated with angiogenesis regulation, including CXCL10, TRAIL, and guanylate binding protein 1 (GBP-1). These transcriptional changes were confirmed and extended by quantitative PCR analysis and ELISA; whereas IFN-alpha and IFN-beta exerted virtually identical effects on transcriptome modulation, a differential gene regulation by type I and type II IFN emerged, especially as far as quantitative aspects were concerned. In vivo, IFN-alpha-producing tumors over-expressed murine CXCL10-11, GBP-1 and TRAIL, with evidence of CXCL11 production by tumor-associated EC. Overall, these findings improve our understanding of the anti-angiogenic effects of IFNs by showing that these cytokines trigger an anti-angiogenic transcriptional program in EC. Moreover, we suggest that quantitative differences in the magnitude of the transcriptional activation of IFNresponsive genes could form the basis for cell-specific transcriptional signatures.					1359	23205	4651	2687	360	157697	54828	5329	2184	9975	120	84133	5867	23233	160762	84002	9535	4862	3460	1523	1368	406	84102	80222	25806	84630	6385	3623	5579	121268	694	83988	9215	26027	1893	91775	1400	10529	10973	1601	3679	11022	4703	115123	132014	29911	140803	55365	160364	23499	221188	80325	50852	9823	1102	116236	84448	5916	9240	56965	79071	138050	55129	7294	79843	133418	8895	51761	256586	117177	11035	283316	23362	91404	84925	26578	971	83699	1266	525	152789	29785	317649	9641	28959	79156	7052	390	55103	164091	4318	6095	3675	8651	23600	26137	84067	2769	4026	256435	5567	139285	7378	57105	5274	3815	60370	59345	55577	23038	25793	50809	51560	4907	56917	64423	58473	196294	55198	51199	122773	1803	141	7389	55808	4050	8694	147991	91	171024	84343	84976	2197	23475	89857	27133	3189	6483	112744	284129	79663	2213	11069	115330	23585	780	22821	3487	6001	23224	8519	4722	23461	5147	81846	375775	10267	8850	54491	3554	348013	1608	149233	3480	55157	57514	55227
GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN	M6701		17202376	Indraccolo S,Pfeffer U,Minuzzo S,Esposito G,Roni V,Mandruzzato S,Ferrari N,Anfosso L,Dell'Eva R,Noonan DM,Chieco-Bianchi L,Albini A,Amadori A	GSE3920	GSE3920_3485_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in endothelial cells: interferon alpha versus interferon beta.	IFNs are highly pleiotropic cytokines also endowed with marked anti-angiogenic activity. In this study, the mRNA expression profiles of endothelial cells (EC) exposed in vitro to IFN-alpha, IFN-beta, or IFN-gamma were determined. We found that in HUVEC as well as in other EC types 175 genes were upregulated (>2-fold increase) by IFNs, including genes involved in the host response to RNA viruses, inflammation, and apoptosis. Interestingly, 41 genes showed a >5-fold higher induction by IFN-alpha in EC compared to human fibroblasts; among them, the gene encoding the angiostatic chemokine CXCL11 was selectively induced by IFN-alpha in EC along with other genes associated with angiogenesis regulation, including CXCL10, TRAIL, and guanylate binding protein 1 (GBP-1). These transcriptional changes were confirmed and extended by quantitative PCR analysis and ELISA; whereas IFN-alpha and IFN-beta exerted virtually identical effects on transcriptome modulation, a differential gene regulation by type I and type II IFN emerged, especially as far as quantitative aspects were concerned. In vivo, IFN-alpha-producing tumors over-expressed murine CXCL10-11, GBP-1 and TRAIL, with evidence of CXCL11 production by tumor-associated EC. Overall, these findings improve our understanding of the anti-angiogenic effects of IFNs by showing that these cytokines trigger an anti-angiogenic transcriptional program in EC. Moreover, we suggest that quantitative differences in the magnitude of the transcriptional activation of IFNresponsive genes could form the basis for cell-specific transcriptional signatures.					10219	22806	6521	8320	8778	2824	3993	125875	166979	1232	8871	2673	953	834	160851	9919	119	9988	23338	2185	4077	8784	9452	9473	64172	1384	79705	3001	10160	54843	81552	3927	11183	10253	1240	54476	51363	5781	81544	3002	80031	7220	10930	5817	976	11174	51232	2034	5734	3600	5279	3764	55959	9663	3587	5420	27086	54207	27293	57823	22914	79899	377047	84898	84240	5136	2623	154075	51338	4818	54778	57630	4622	253461	24148	4734	59283	27132	81603	326340	54585	2889	55209	10673	9731	3708	8844	970	84636	81618	8790	23604	116535	135228	2745	7187	147645	57091	3732	7597	7994	3687	57521	29121	2869	10580	1524	285527	10643	6453	3902	57600	493911	212	10524	1994	5829	30849	2268	9938	1788	71	220972	57088	401124	2534	64131	3003	9468	116496	2591	2615	201633	6696	150368	5783	64114	54904	79158	3586	114904	59340	6867	51341	118788	9901	2691	4853	7186	221178	1776	4642	83986	333	9201	9209	92270	1727	253558	9839	64421	8807	9173	57476
GSE3920_IFNB_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP	M6702		17202376	Indraccolo S,Pfeffer U,Minuzzo S,Esposito G,Roni V,Mandruzzato S,Ferrari N,Anfosso L,Dell'Eva R,Noonan DM,Chieco-Bianchi L,Albini A,Amadori A	GSE3920	GSE3920_3486_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in endothelial cells: interferon beta versus IFNG [GeneID=3458].	IFNs are highly pleiotropic cytokines also endowed with marked anti-angiogenic activity. In this study, the mRNA expression profiles of endothelial cells (EC) exposed in vitro to IFN-alpha, IFN-beta, or IFN-gamma were determined. We found that in HUVEC as well as in other EC types 175 genes were upregulated (>2-fold increase) by IFNs, including genes involved in the host response to RNA viruses, inflammation, and apoptosis. Interestingly, 41 genes showed a >5-fold higher induction by IFN-alpha in EC compared to human fibroblasts; among them, the gene encoding the angiostatic chemokine CXCL11 was selectively induced by IFN-alpha in EC along with other genes associated with angiogenesis regulation, including CXCL10, TRAIL, and guanylate binding protein 1 (GBP-1). These transcriptional changes were confirmed and extended by quantitative PCR analysis and ELISA; whereas IFN-alpha and IFN-beta exerted virtually identical effects on transcriptome modulation, a differential gene regulation by type I and type II IFN emerged, especially as far as quantitative aspects were concerned. In vivo, IFN-alpha-producing tumors over-expressed murine CXCL10-11, GBP-1 and TRAIL, with evidence of CXCL11 production by tumor-associated EC. Overall, these findings improve our understanding of the anti-angiogenic effects of IFNs by showing that these cytokines trigger an anti-angiogenic transcriptional program in EC. Moreover, we suggest that quantitative differences in the magnitude of the transcriptional activation of IFNresponsive genes could form the basis for cell-specific transcriptional signatures.					6085	29967	115330	8361	6932	8502	169792	3487	133418	406	28959	55365	152519	283514	6231	161436	6097	79843	3679	8808	51379	6001	1893	6206	4717	7782	10737	92196	338596	79865	359845	117145	5436	1152	50852	9467	3575	54039	149233	6023	3455	221188	79801	1233	55808	6152	51076	9349	10800	256586	147991	28951	9569	1163	11069	84937	971	9493	514	525	11035	55	6224	5230	200081	55361	360	91404	27133	3018	6169	1407	6210	8705	27018	2983	10529	10267	6136	51514	84818	113130	667	79156	5916	2150	51176	54463	64781	1368	6223	7433	25806	11346	80152	4603	11022	146909	29994	29105	3554	5867	3460	57544	55103	3925	115290	23607	2632	3014	4041	4862	29785	10419	6134	638	11059	9481	5570	57559	22948	375035	132014	9124	9277	3303	8038	23051	729533	140803	3070	10457	401036	2162	4700	22918	7706	152006	128239	63967	23639	286053	64969	117177	57447	54478	90025	3480	401541	1933	6161	9258	85461	6160	23327	8204	9823	4086	84861	6167	80313	55328	25797	28996
GSE3920_IFNB_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN	M6703		17202376	Indraccolo S,Pfeffer U,Minuzzo S,Esposito G,Roni V,Mandruzzato S,Ferrari N,Anfosso L,Dell'Eva R,Noonan DM,Chieco-Bianchi L,Albini A,Amadori A	GSE3920	GSE3920_3486_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in endothelial cells: interferon beta versus IFNG [GeneID=3458].	IFNs are highly pleiotropic cytokines also endowed with marked anti-angiogenic activity. In this study, the mRNA expression profiles of endothelial cells (EC) exposed in vitro to IFN-alpha, IFN-beta, or IFN-gamma were determined. We found that in HUVEC as well as in other EC types 175 genes were upregulated (>2-fold increase) by IFNs, including genes involved in the host response to RNA viruses, inflammation, and apoptosis. Interestingly, 41 genes showed a >5-fold higher induction by IFN-alpha in EC compared to human fibroblasts; among them, the gene encoding the angiostatic chemokine CXCL11 was selectively induced by IFN-alpha in EC along with other genes associated with angiogenesis regulation, including CXCL10, TRAIL, and guanylate binding protein 1 (GBP-1). These transcriptional changes were confirmed and extended by quantitative PCR analysis and ELISA; whereas IFN-alpha and IFN-beta exerted virtually identical effects on transcriptome modulation, a differential gene regulation by type I and type II IFN emerged, especially as far as quantitative aspects were concerned. In vivo, IFN-alpha-producing tumors over-expressed murine CXCL10-11, GBP-1 and TRAIL, with evidence of CXCL11 production by tumor-associated EC. Overall, these findings improve our understanding of the anti-angiogenic effects of IFNs by showing that these cytokines trigger an anti-angiogenic transcriptional program in EC. Moreover, we suggest that quantitative differences in the magnitude of the transcriptional activation of IFNresponsive genes could form the basis for cell-specific transcriptional signatures.					4171	9535	51228	5471	80745	55032	54496	56893	3092	4292	54918	962	9131	11100	57404	159090	617	57181	11276	55872	1063	51728	118	9871	4926	51347	221303	3423	28988	65999	22928	90639	4801	1876	26112	23395	57215	55529	253782	55743	57606	8522	994	10875	23225	6389	47	84912	51076	80143	974	54414	29761	4734	2046	8935	135112	79842	22929	63901	55227	8563	23527	134510	55746	64756	144699	644	2585	9656	6515	55760	339287	9055	30011	25911	153364	50809	55611	79813	23184	9631	8729	5860	9612	5604	8345	3612	8895	9468	85015	54464	197259	29978	282809	51256	3619	57544	84899	121665	11342	144321	55105	995	3903	3688	7511	1981	51449	25813	441168	528	57082	55705	54518	3660	84898	4976	5727	91775	10800	29127	23753	23484	3716	6259	23201	223082	285367	7343	79144	91949	7290	146956	653121	6878	5585	952	38	4354	8449	9585	79803	80205	93627	152185	374986	1642	8396	57016	23214	7390	4221	3633	392	580	129285	58485	66036	8099	27134	92815	114826	54505	56624	51422	4351	23208	64359	2769	51295	11311	66005	145226	148713
GSE3920_UNTREATED_VS_IFNA_TREATED_FIBROBLAST_UP	M6704		17202376	Indraccolo S,Pfeffer U,Minuzzo S,Esposito G,Roni V,Mandruzzato S,Ferrari N,Anfosso L,Dell'Eva R,Noonan DM,Chieco-Bianchi L,Albini A,Amadori A	GSE3920	GSE3920_3487_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated fibroblasts: untreated versus interferon alpha.	IFNs are highly pleiotropic cytokines also endowed with marked anti-angiogenic activity. In this study, the mRNA expression profiles of endothelial cells (EC) exposed in vitro to IFN-alpha, IFN-beta, or IFN-gamma were determined. We found that in HUVEC as well as in other EC types 175 genes were upregulated (>2-fold increase) by IFNs, including genes involved in the host response to RNA viruses, inflammation, and apoptosis. Interestingly, 41 genes showed a >5-fold higher induction by IFN-alpha in EC compared to human fibroblasts; among them, the gene encoding the angiostatic chemokine CXCL11 was selectively induced by IFN-alpha in EC along with other genes associated with angiogenesis regulation, including CXCL10, TRAIL, and guanylate binding protein 1 (GBP-1). These transcriptional changes were confirmed and extended by quantitative PCR analysis and ELISA; whereas IFN-alpha and IFN-beta exerted virtually identical effects on transcriptome modulation, a differential gene regulation by type I and type II IFN emerged, especially as far as quantitative aspects were concerned. In vivo, IFN-alpha-producing tumors over-expressed murine CXCL10-11, GBP-1 and TRAIL, with evidence of CXCL11 production by tumor-associated EC. Overall, these findings improve our understanding of the anti-angiogenic effects of IFNs by showing that these cytokines trigger an anti-angiogenic transcriptional program in EC. Moreover, we suggest that quantitative differences in the magnitude of the transcriptional activation of IFNresponsive genes could form the basis for cell-specific transcriptional signatures.					8658	79158	3702	5914	341567	134	4097	7187	6236	221037	54532	84807	93109	6478	8795	57688	51296	133746	10397	23387	5292	1850	1846	5732	27342	1195	114804	57396	11072	6095	65125	23099	10019	1263	330	9308	4335	8694	23612	64651	255967	29126	54799	3383	60386	3096	287015	25841	6314	387266	694	79670	139170	8812	64332	10018	96459	26057	7185	79720	57478	5970	7461	3685	6541	140685	3562	4953	51733	4486	468	9667	49	136	60436	27111	6348	53822	4826	84876	3300	5971	2191	5520	54902	104	10904	91147	4814	125875	23710	1362	4790	83667	135	26277	2908	9825	6885	1525	80380	10208	4665	54806	89846	22987	23162	8013	90637	57084	4084	9047	1154	347404	27	89849	1844	9043	1237	7128	65249	51669	2117	10458	2308	4616	84236	5922	54014	10725	283383	969	84078	65982	55259	64852	84261	80149	64782	51092	598	79665	221079	22822	54498	22936	8754	57568	1106	1995	26051	4601	10043	54906	84678	11214	51068	80314	9709	56929	114899	81669	57018	284996
GSE6092_CTRL_VS_BORRELIA_BIRGDOFERI_INF_ENDOTHELIAL_CELL_UP	M6707		17202382	Dame TM,Orenzoff BL,Palmer LE,Furie MB	GSE6092	GSE6092_3465_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in endothelial cells: untreated versus exposed to E. burgdoferi.	Borrelia burgdorferi, the agent of Lyme disease, promotes pro-inflammatory changes in endothelium that lead to the recruitment of leukocytes. The host immune response to infection results in increased levels of IFN-gamma in the serum and lesions of Lyme disease patients that correlate with greater severity of disease. Therefore, the effect of IFN-gamma on the gene expression profile of primary human endothelial cells exposed to B. burgdorferi was determined. B. burgdorferi and IFN-gamma synergistically augmented the expression of 34 genes, seven of which encode chemokines. Six of these (CCL7, CCL8, CX3CL1, CXCL9, CXCL10, and CXCL11) attract T lymphocytes, and one (CXCL2) is specific for neutrophils. Synergistic production of the attractants for T cells was confirmed at the protein level. IL-1beta, TNF-alpha, and LPS also cooperated with IFN-gamma to induce synergistic production of CXCL10 by endothelium, indicating that IFN-gamma potentiates inflammation in concert with a variety of mediators. An in vitro model of the blood vessel wall revealed that an increased number of human T lymphocytes traversed endothelium exposed to B. burgdorferi and IFN-gamma, as compared to unstimulated endothelial monolayers. In contrast, addition of IFN-gamma diminished the migration of neutrophils across B. burgdorferi-activated endothelium. IFN-gamma thus alters gene expression by endothelium exposed to B. burgdorferi in a manner that promotes recruitment of T cells and suppresses that of neutrophils. This modulation may facilitate the development of chronic inflammatory lesions in Lyme disease.					1615	167227	686	84331	56704	10069	54487	10434	9293	26127	11281	140461	56660	79959	5860	55615	6717	64682	9793	112	3352	2799	8451	8836	3068	6622	5510	171425	8895	255520	27244	84458	9328	26259	152100	121441	25839	29945	254251	841	51074	7520	5073	55032	515	10238	79053	8334	51684	53832	3612	388021	51650	7453	392	401036	57380	55837	151525	79637	440435	55253	51258	10015	84612	55239	6041	5532	100131439	4710	56255	51449	64172	23483	9391	23014	5427	9824	7514	93594	26258	9860	139231	84343	51209	51318	27068	4635	1384	9573	645	9158	26073	22976	8693	2526	6271	10462	25973	54784	79786	9716	64407	64087	9394	9031	29899	283927	29097	84928	3592	28955	150763	8099	2356	27043	10280	54769	55062	1763	57085	65008	84986	1427	4048	3554	283871	131870	8725	91369	55796	26145	54499	23471	5226	4833	11331	10282	53407	50852	8733	64854	217	200942	22908	78990	1798	26272	51752	56062	9175	3975	55759
GSE6092_CTRL_VS_BORRELIA_BIRGDOFERI_INF_ENDOTHELIAL_CELL_DN	M6708		17202382	Dame TM,Orenzoff BL,Palmer LE,Furie MB	GSE6092	GSE6092_3465_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in endothelial cells: untreated versus exposed to E. burgdoferi.	Borrelia burgdorferi, the agent of Lyme disease, promotes pro-inflammatory changes in endothelium that lead to the recruitment of leukocytes. The host immune response to infection results in increased levels of IFN-gamma in the serum and lesions of Lyme disease patients that correlate with greater severity of disease. Therefore, the effect of IFN-gamma on the gene expression profile of primary human endothelial cells exposed to B. burgdorferi was determined. B. burgdorferi and IFN-gamma synergistically augmented the expression of 34 genes, seven of which encode chemokines. Six of these (CCL7, CCL8, CX3CL1, CXCL9, CXCL10, and CXCL11) attract T lymphocytes, and one (CXCL2) is specific for neutrophils. Synergistic production of the attractants for T cells was confirmed at the protein level. IL-1beta, TNF-alpha, and LPS also cooperated with IFN-gamma to induce synergistic production of CXCL10 by endothelium, indicating that IFN-gamma potentiates inflammation in concert with a variety of mediators. An in vitro model of the blood vessel wall revealed that an increased number of human T lymphocytes traversed endothelium exposed to B. burgdorferi and IFN-gamma, as compared to unstimulated endothelial monolayers. In contrast, addition of IFN-gamma diminished the migration of neutrophils across B. burgdorferi-activated endothelium. IFN-gamma thus alters gene expression by endothelium exposed to B. burgdorferi in a manner that promotes recruitment of T cells and suppresses that of neutrophils. This modulation may facilitate the development of chronic inflammatory lesions in Lyme disease.					114815	56256	345079	4929	89849	54556	1493	1365	6518	3442	256356	2877	55362	29126	23205	54475	81669	10957	3669	2159	2828	4794	6992	8862	10266	6453	51278	1482	10769	8795	26277	7976	57396	1961	5214	1845	90637	79635	11047	4725	9636	400569	4097	27069	128434	389792	7128	2746	5329	284086	51567	7975	1106	7316	4159	6328	23406	10718	29950	11275	9026	283659	4974	51755	4209	100287362	388531	9478	84062	255743	7050	6434	6330	5589	8878	644021	4792	29105	4826	138065	10849	2852	10865	23708	26093	1539	4486	131578	57018	81889	23174	5187	79720	2114	2643	3822	4582	6124	24148	4666	6095	7852	200150	9877	2886	2117	221079	1880	5817	131965	1846	10482	1594	149685	6520	388336	79836	79009	9988	29933	196441	10084	8660	56521	8022	1747	65125	91582	56155	7536	8787	4646	3320	4616	6439	3866	9975	23135	8796	164045	7165	5662	170394	467	8029	2786
GSE6092_UNSTIM_VS_IFNG_STIM_ENDOTHELIAL_CELL_UP	M6710		17202382	Dame TM,Orenzoff BL,Palmer LE,Furie MB	GSE6092	GSE6092_3466_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in endothelial cells: untreated versus IFNG [GeneID=3458].	Borrelia burgdorferi, the agent of Lyme disease, promotes pro-inflammatory changes in endothelium that lead to the recruitment of leukocytes. The host immune response to infection results in increased levels of IFN-gamma in the serum and lesions of Lyme disease patients that correlate with greater severity of disease. Therefore, the effect of IFN-gamma on the gene expression profile of primary human endothelial cells exposed to B. burgdorferi was determined. B. burgdorferi and IFN-gamma synergistically augmented the expression of 34 genes, seven of which encode chemokines. Six of these (CCL7, CCL8, CX3CL1, CXCL9, CXCL10, and CXCL11) attract T lymphocytes, and one (CXCL2) is specific for neutrophils. Synergistic production of the attractants for T cells was confirmed at the protein level. IL-1beta, TNF-alpha, and LPS also cooperated with IFN-gamma to induce synergistic production of CXCL10 by endothelium, indicating that IFN-gamma potentiates inflammation in concert with a variety of mediators. An in vitro model of the blood vessel wall revealed that an increased number of human T lymphocytes traversed endothelium exposed to B. burgdorferi and IFN-gamma, as compared to unstimulated endothelial monolayers. In contrast, addition of IFN-gamma diminished the migration of neutrophils across B. burgdorferi-activated endothelium. IFN-gamma thus alters gene expression by endothelium exposed to B. burgdorferi in a manner that promotes recruitment of T cells and suppresses that of neutrophils. This modulation may facilitate the development of chronic inflammatory lesions in Lyme disease.					55835	51330	1595	55288	84440	55647	55012	136	5151	127687	115708	51014	79647	7108	9933	81556	3416	23129	10153	2224	151393	9532	55207	22820	377007	91272	6472	6713	338707	284207	60528	7942	55262	54622	253152	23550	23355	54840	9692	3157	11260	11116	84068	375	84447	8938	3304	8535	51225	369	115701	9019	5601	9147	27242	90637	56924	10677	4719	117247	5824	5214	23229	79084	4597	3308	29956	65993	53407	7415	440	8763	10962	8615	222487	54865	80198	124222	2207	3595	10456	4967	6774	150962	84981	7329	6729	57096	55210	7480	440400	399694	4836	57687	56052	22985	57719	2151	2617	9091	7770	11137	5911	6059	1315	2671	6745	29979	8565	8078	8820	5226	3313	55759	165324	3705	283635	8394	23184	64834	29094	348180	57508	54541	26031	7390	79016	525	7031	10783	4247	9415	10105	10095	4097	1146	124995	79724	83451	10602	55752	1973	5049	158405	140739	598	5522	1737	79154	55109	2323	293	79080	58476	55057	8036	57222	11146	51293	55266	2185	27316	81565	51397	55322	84142	10953	5705	70	3268	3836	3995	57089	55720	9120	22845	84280	2334	54915	7343	81873	3712	4651	1263	2672	51478	2957	10162	1654	23142	11180	488	134266	124872	54627	9581	10294	1840	5702	2289
GSE6092_UNSTIM_VS_IFNG_STIM_ENDOTHELIAL_CELL_DN	M6711		17202382	Dame TM,Orenzoff BL,Palmer LE,Furie MB	GSE6092	GSE6092_3466_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in endothelial cells: untreated versus IFNG [GeneID=3458].	Borrelia burgdorferi, the agent of Lyme disease, promotes pro-inflammatory changes in endothelium that lead to the recruitment of leukocytes. The host immune response to infection results in increased levels of IFN-gamma in the serum and lesions of Lyme disease patients that correlate with greater severity of disease. Therefore, the effect of IFN-gamma on the gene expression profile of primary human endothelial cells exposed to B. burgdorferi was determined. B. burgdorferi and IFN-gamma synergistically augmented the expression of 34 genes, seven of which encode chemokines. Six of these (CCL7, CCL8, CX3CL1, CXCL9, CXCL10, and CXCL11) attract T lymphocytes, and one (CXCL2) is specific for neutrophils. Synergistic production of the attractants for T cells was confirmed at the protein level. IL-1beta, TNF-alpha, and LPS also cooperated with IFN-gamma to induce synergistic production of CXCL10 by endothelium, indicating that IFN-gamma potentiates inflammation in concert with a variety of mediators. An in vitro model of the blood vessel wall revealed that an increased number of human T lymphocytes traversed endothelium exposed to B. burgdorferi and IFN-gamma, as compared to unstimulated endothelial monolayers. In contrast, addition of IFN-gamma diminished the migration of neutrophils across B. burgdorferi-activated endothelium. IFN-gamma thus alters gene expression by endothelium exposed to B. burgdorferi in a manner that promotes recruitment of T cells and suppresses that of neutrophils. This modulation may facilitate the development of chronic inflammatory lesions in Lyme disease.					1060	159	10955	7320	3074	51504	51141	26469	51765	440145	11198	23597	337867	10535	6451	29942	119392	221035	10712	64853	5516	4300	51024	1265	81631	9847	51126	39	80167	4063	340152	2953	23635	26136	80231	10663	1471	26207	494470	57721	60468	8111	994	914	25777	2683	54558	150274	5893	4542	4832	29851	4747	4050	2533	84255	64420	1130	864	57492	11335	56912	3937	5836	5339	286827	51542	23112	90313	93974	10274	360	121551	9742	23559	84759	1644	130576	5538	54482	56925	8405	6281	7772	4012	56997	23533	3643	10402	56062	168537	5303	6414	127544	201299	29980	3384	7128	59307	55294	64423	57088	6942	23234	51199	401546	7389	56172	6230	84674	157567	7486	81691	26036	100506144	1803	84230	91368	54904	139716	55789	1267	6717	366	23097	8631	858	27120	79585	10910	3764	19	729515	4436	51379	9535	286336	79971	50650	8492	11214	8895	80727	10002	54521	51060	7700	51101	3111	1521	56650	2124	55843	205428	152007	222229	23204	6168	55013	51621	53827	84002	5355	285513	84159	2280	1606	6402	8850	157680	8832	2145	1075	7292	3459	51316	50810	317761	23118	2035	57699	84196	26063	80262	1998	64411	5116	22938	55671	1316	2776	27345	22924	27434	10099	23626	84532	6827	2060
GSE6092_UNSTIM_VS_IFNG_STIM_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_UP	M6713		17202382	Dame TM,Orenzoff BL,Palmer LE,Furie MB	GSE6092	GSE6092_3467_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in endothelial cells: untreated versus IFNG [GeneID=3459] and B. burgdoferi.	Borrelia burgdorferi, the agent of Lyme disease, promotes pro-inflammatory changes in endothelium that lead to the recruitment of leukocytes. The host immune response to infection results in increased levels of IFN-gamma in the serum and lesions of Lyme disease patients that correlate with greater severity of disease. Therefore, the effect of IFN-gamma on the gene expression profile of primary human endothelial cells exposed to B. burgdorferi was determined. B. burgdorferi and IFN-gamma synergistically augmented the expression of 34 genes, seven of which encode chemokines. Six of these (CCL7, CCL8, CX3CL1, CXCL9, CXCL10, and CXCL11) attract T lymphocytes, and one (CXCL2) is specific for neutrophils. Synergistic production of the attractants for T cells was confirmed at the protein level. IL-1beta, TNF-alpha, and LPS also cooperated with IFN-gamma to induce synergistic production of CXCL10 by endothelium, indicating that IFN-gamma potentiates inflammation in concert with a variety of mediators. An in vitro model of the blood vessel wall revealed that an increased number of human T lymphocytes traversed endothelium exposed to B. burgdorferi and IFN-gamma, as compared to unstimulated endothelial monolayers. In contrast, addition of IFN-gamma diminished the migration of neutrophils across B. burgdorferi-activated endothelium. IFN-gamma thus alters gene expression by endothelium exposed to B. burgdorferi in a manner that promotes recruitment of T cells and suppresses that of neutrophils. This modulation may facilitate the development of chronic inflammatory lesions in Lyme disease.					3455	5533	51119	81624	55128	90417	60673	10519	94235	402569	2976	56204	4863	9177	54432	9663	5756	1727	10403	10841	83548	10486	79587	10742	23139	144455	4351	221468	5226	642	57509	25963	4488	129642	10463	55669	9043	10526	197187	9557	55208	84318	23224	1266	3080	51535	3431	1496	63925	10324	100506049	146909	374407	10048	79877	112950	7186	4144	64080	3948	23251	9328	5801	80218	404636	387680	23198	23332	126147	8242	6504	9766	80763	2840	63894	27289	5019	30837	1066	54332	130535	55588	256471	83732	9444	5598	11129	2539	401262	2177	84552	79682	7391	4811	146923	81621	123169	50650	327	161497	3157	5710	8754	57661	23040	115948	203197	919	51430	84332	9697	84650	55281	285195	64210	1362	4722	5446	56261	3581	23283	54331	25948	57082	54622	7204	8836	84258	8934	2565	57665	2952	10487	25830	79158	429	9525	64151	148641	3920	5720	5859	9217	51700	6513	55771	1134	10553	2066	55665	839	150356	200081	56667	57583	100127206	5696	653240	3135	2533	26261	80331	3433	126567	139341	10620	64429	60685	4887	3988	133022	2250	6422	79801	57551	55013	83461	9445	83448	8073	146894	57538	567	80279	23659	55831	55323	9180	10112	1287	390637	4976	8625	26277	79792	64422	675	10455	81610	221711
GSE6092_UNSTIM_VS_IFNG_STIM_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_DN	M6715		17202382	Dame TM,Orenzoff BL,Palmer LE,Furie MB	GSE6092	GSE6092_3467_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in endothelial cells: untreated versus IFNG [GeneID=3459] and B. burgdoferi.	Borrelia burgdorferi, the agent of Lyme disease, promotes pro-inflammatory changes in endothelium that lead to the recruitment of leukocytes. The host immune response to infection results in increased levels of IFN-gamma in the serum and lesions of Lyme disease patients that correlate with greater severity of disease. Therefore, the effect of IFN-gamma on the gene expression profile of primary human endothelial cells exposed to B. burgdorferi was determined. B. burgdorferi and IFN-gamma synergistically augmented the expression of 34 genes, seven of which encode chemokines. Six of these (CCL7, CCL8, CX3CL1, CXCL9, CXCL10, and CXCL11) attract T lymphocytes, and one (CXCL2) is specific for neutrophils. Synergistic production of the attractants for T cells was confirmed at the protein level. IL-1beta, TNF-alpha, and LPS also cooperated with IFN-gamma to induce synergistic production of CXCL10 by endothelium, indicating that IFN-gamma potentiates inflammation in concert with a variety of mediators. An in vitro model of the blood vessel wall revealed that an increased number of human T lymphocytes traversed endothelium exposed to B. burgdorferi and IFN-gamma, as compared to unstimulated endothelial monolayers. In contrast, addition of IFN-gamma diminished the migration of neutrophils across B. burgdorferi-activated endothelium. IFN-gamma thus alters gene expression by endothelium exposed to B. burgdorferi in a manner that promotes recruitment of T cells and suppresses that of neutrophils. This modulation may facilitate the development of chronic inflammatory lesions in Lyme disease.					9119	9806	78991	29091	3207	27344	55964	7180	8685	9715	10809	7036	64793	256297	84174	63895	7007	642658	2200	4649	90522	8608	10128	221409	6356	6518	1807	136895	124641	137492	11194	2022	10612	2920	84457	10256	57333	336	26256	6610	23779	4855	1674	339976	51702	57534	85444	7022	10023	10234	22844	92714	5900	375616	10015	149461	25999	162466	8817	139212	6000	2488	1140	100190949	4037	22874	92703	80731	6167	10362	1046	164633	8863	717	5507	222236	4004	83729	222166	253128	4889	53841	54550	56157	26291	153201	140856	1473	388324	1414	283212	10630	3174	57158	89944	401551	150572	283576	6493	7056	132321	10936	143503	8614	23539	81832	222389	5630	283129	89796	2946	57332	140710	93166	90668	23089	55684	55084	57152	5625	1759	54893	80309	154790	93145	55615	387707	2707	9332	26153	9785	118932	10613	256646	6900	254048	6658	27294	7039	56834	9814	1741	84530	4803	23671	9427	26230	57146	55353	5137	338879	9719	284359	8000	286128	6898	92815	320	2564	104	317761	2548	6578	10432	160335	6160	611	10591	6123	7179	59277	126961	221823	9880	9963	4629	57687	57159	6336	91851	64748	547	6101	2695	9270	127534	54507	5948	131375	23440	27111	286257	2621	84915	6939	114815	1145	57787	117608	6256
GSE6092_B_BURGDOFERI_VS_B_BURGDORFERI_AND_IFNG_STIM_ENDOTHELIAL_CELL_UP	M6716		17202382	Dame TM,Orenzoff BL,Palmer LE,Furie MB	GSE6092	GSE6092_3468_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in endothelial cells: B. burgdoferi versus IFNG [GeneID=3459] and B. burgdoferi .	Borrelia burgdorferi, the agent of Lyme disease, promotes pro-inflammatory changes in endothelium that lead to the recruitment of leukocytes. The host immune response to infection results in increased levels of IFN-gamma in the serum and lesions of Lyme disease patients that correlate with greater severity of disease. Therefore, the effect of IFN-gamma on the gene expression profile of primary human endothelial cells exposed to B. burgdorferi was determined. B. burgdorferi and IFN-gamma synergistically augmented the expression of 34 genes, seven of which encode chemokines. Six of these (CCL7, CCL8, CX3CL1, CXCL9, CXCL10, and CXCL11) attract T lymphocytes, and one (CXCL2) is specific for neutrophils. Synergistic production of the attractants for T cells was confirmed at the protein level. IL-1beta, TNF-alpha, and LPS also cooperated with IFN-gamma to induce synergistic production of CXCL10 by endothelium, indicating that IFN-gamma potentiates inflammation in concert with a variety of mediators. An in vitro model of the blood vessel wall revealed that an increased number of human T lymphocytes traversed endothelium exposed to B. burgdorferi and IFN-gamma, as compared to unstimulated endothelial monolayers. In contrast, addition of IFN-gamma diminished the migration of neutrophils across B. burgdorferi-activated endothelium. IFN-gamma thus alters gene expression by endothelium exposed to B. burgdorferi in a manner that promotes recruitment of T cells and suppresses that of neutrophils. This modulation may facilitate the development of chronic inflammatory lesions in Lyme disease.					143888	5664	63916	7074	7403	953	5296	1497	90634	654790	51114	8829	2132	8514	2309	51177	80728	121457	10014	23048	4835	55809	26505	9054	7462	94239	10018	23141	55198	113263	145482	11264	29083	56915	90407	192683	10447	51706	64777	10106	79026	1717	51393	10449	101	115330	6778	217	51147	2217	9563	51170	55248	219654	9538	7485	967	129563	8648	286336	223	26993	7389	523	10300	51006	55723	153129	1593	9706	6612	57533	8943	8416	5981	7168	140738	57446	139285	6397	5305	55729	5982	2581	51094	8504	2330	9842	57016	83986	9749	22920	23046	54537	57161	51474	3075	10159	3087	3795	27306	6515	57688	4077	64423	950	7172	399687	57506	11138	593	4772	6494	51112	2531	57134	142679	571	5184	57125	10363	23548	51205	79073	55803	4261	54664	23327	124935	55856	4591	9686	23218	241	139716	10123	6610	27239	2308	752	158471	54463	5997	375387	55256	51311	54982	6652	23288	55260	81688	4190	26269	51181	81539	128240	91057	3487	91107	102	874	3425	93058	3077	79791	9704	8310	54536	57504	5524	6646	23062	26063
GSE6092_B_BURGDOFERI_VS_B_BURGDORFERI_AND_IFNG_STIM_ENDOTHELIAL_CELL_DN	M6717		17202382	Dame TM,Orenzoff BL,Palmer LE,Furie MB	GSE6092	GSE6092_3468_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in endothelial cells: B. burgdoferi versus IFNG [GeneID=3459] and B. burgdoferi .	Borrelia burgdorferi, the agent of Lyme disease, promotes pro-inflammatory changes in endothelium that lead to the recruitment of leukocytes. The host immune response to infection results in increased levels of IFN-gamma in the serum and lesions of Lyme disease patients that correlate with greater severity of disease. Therefore, the effect of IFN-gamma on the gene expression profile of primary human endothelial cells exposed to B. burgdorferi was determined. B. burgdorferi and IFN-gamma synergistically augmented the expression of 34 genes, seven of which encode chemokines. Six of these (CCL7, CCL8, CX3CL1, CXCL9, CXCL10, and CXCL11) attract T lymphocytes, and one (CXCL2) is specific for neutrophils. Synergistic production of the attractants for T cells was confirmed at the protein level. IL-1beta, TNF-alpha, and LPS also cooperated with IFN-gamma to induce synergistic production of CXCL10 by endothelium, indicating that IFN-gamma potentiates inflammation in concert with a variety of mediators. An in vitro model of the blood vessel wall revealed that an increased number of human T lymphocytes traversed endothelium exposed to B. burgdorferi and IFN-gamma, as compared to unstimulated endothelial monolayers. In contrast, addition of IFN-gamma diminished the migration of neutrophils across B. burgdorferi-activated endothelium. IFN-gamma thus alters gene expression by endothelium exposed to B. burgdorferi in a manner that promotes recruitment of T cells and suppresses that of neutrophils. This modulation may facilitate the development of chronic inflammatory lesions in Lyme disease.					127544	26060	55177	9917	63035	9961	1781	4337	202018	51144	57493	5580	9685	9683	54585	441168	3593	57727	2152	80315	55153	5782	84132	23630	147650	673	1850	79039	4690	10492	54676	9948	1431	64092	221178	4288	10713	203100	92140	5971	65264	10243	57655	84950	166968	51534	121536	8664	5900	5515	26031	5699	116071	329	55601	22882	117289	5291	3068	29126	1647	3606	81488	283234	23590	22846	9322	22800	7127	840	10135	57157	8651	3696	353376	4616	114793	3592	3791	929	6693	9966	55332	23533	5604	123879	3036	57154	10544	2069	26012	6541	51012	164656	1844	10320	56650	2841	1468	1959	114908	262	10963	2159	5326	7133	10006	25841	8036	6482	799	51018	10212	3069	27338	10197	3091	9123	639	80765	11222	115361	3934	7128	5334	10194	84946	8676	338339	83999	3687	25921	6542	2921	56902	989	54329	1356	5294	160851	25801	23179	10392	2043	23424	5054	4794	8543	10221	8685	4779	27173	8562	8767	80821	6487	25897	9643	3096	5704	7186	117247	3678	7096	3799	51320	375790	27000	23516	3683	3931	50999	55113	10455	51703	4665	9409	79931
GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_UP	M6718		17202382	Dame TM,Orenzoff BL,Palmer LE,Furie MB	GSE6092	GSE6092_3469_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in endothelial cells: IFNG [GeneID=3459] versus IFNG [GeneID=3459] and B. burgdoferi.	Borrelia burgdorferi, the agent of Lyme disease, promotes pro-inflammatory changes in endothelium that lead to the recruitment of leukocytes. The host immune response to infection results in increased levels of IFN-gamma in the serum and lesions of Lyme disease patients that correlate with greater severity of disease. Therefore, the effect of IFN-gamma on the gene expression profile of primary human endothelial cells exposed to B. burgdorferi was determined. B. burgdorferi and IFN-gamma synergistically augmented the expression of 34 genes, seven of which encode chemokines. Six of these (CCL7, CCL8, CX3CL1, CXCL9, CXCL10, and CXCL11) attract T lymphocytes, and one (CXCL2) is specific for neutrophils. Synergistic production of the attractants for T cells was confirmed at the protein level. IL-1beta, TNF-alpha, and LPS also cooperated with IFN-gamma to induce synergistic production of CXCL10 by endothelium, indicating that IFN-gamma potentiates inflammation in concert with a variety of mediators. An in vitro model of the blood vessel wall revealed that an increased number of human T lymphocytes traversed endothelium exposed to B. burgdorferi and IFN-gamma, as compared to unstimulated endothelial monolayers. In contrast, addition of IFN-gamma diminished the migration of neutrophils across B. burgdorferi-activated endothelium. IFN-gamma thus alters gene expression by endothelium exposed to B. burgdorferi in a manner that promotes recruitment of T cells and suppresses that of neutrophils. This modulation may facilitate the development of chronic inflammatory lesions in Lyme disease.					58986	64781	535	57134	3575	241	25959	8202	81794	3655	1901	115294	6497	975	81566	2992	219972	57600	23654	678	2768	401548	5256	51177	56204	51706	11152	9117	10106	5351	5892	55256	9653	56180	25	3985	4327	80853	94015	9145	51734	81537	274	29886	55342	1831	153364	4669	11059	9236	4835	11232	54536	79157	56940	4176	11322	23207	5567	874	3572	10023	2806	1523	7182	79365	4033	8013	5324	23014	79626	8566	9686	10129	57559	1845	8863	3795	10447	2313	9120	6652	51449	53373	10783	10965	51129	4064	8672	5866	9404	6001	81606	1269	5305	55906	54751	84067	6916	5467	223	11264	204851	84532	26191	64772	9213	752	246754	5997	26030	4832	3394	4155	1849	2752	79683	5742	3766	4048	9842	57381	2969	6610	152185	10659	57210	23400	55198	376497	92017	4214	131450	28966	6809	2934	27244	8086	65981	83986	157378	55163	80173	3955	2145	55034	55890	5864	7106	219931	53616	1975	157638	8832	80148	23093	57192	164091	142678	23046	9306	3092	55643	115761	27241	57506	257364	23112	101	23303	7099	7074	131601	64087	23503	50809	65018
GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_DN	M6720		17202382	Dame TM,Orenzoff BL,Palmer LE,Furie MB	GSE6092	GSE6092_3469_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in endothelial cells: IFNG [GeneID=3459] versus IFNG [GeneID=3459] and B. burgdoferi.	Borrelia burgdorferi, the agent of Lyme disease, promotes pro-inflammatory changes in endothelium that lead to the recruitment of leukocytes. The host immune response to infection results in increased levels of IFN-gamma in the serum and lesions of Lyme disease patients that correlate with greater severity of disease. Therefore, the effect of IFN-gamma on the gene expression profile of primary human endothelial cells exposed to B. burgdorferi was determined. B. burgdorferi and IFN-gamma synergistically augmented the expression of 34 genes, seven of which encode chemokines. Six of these (CCL7, CCL8, CX3CL1, CXCL9, CXCL10, and CXCL11) attract T lymphocytes, and one (CXCL2) is specific for neutrophils. Synergistic production of the attractants for T cells was confirmed at the protein level. IL-1beta, TNF-alpha, and LPS also cooperated with IFN-gamma to induce synergistic production of CXCL10 by endothelium, indicating that IFN-gamma potentiates inflammation in concert with a variety of mediators. An in vitro model of the blood vessel wall revealed that an increased number of human T lymphocytes traversed endothelium exposed to B. burgdorferi and IFN-gamma, as compared to unstimulated endothelial monolayers. In contrast, addition of IFN-gamma diminished the migration of neutrophils across B. burgdorferi-activated endothelium. IFN-gamma thus alters gene expression by endothelium exposed to B. burgdorferi in a manner that promotes recruitment of T cells and suppresses that of neutrophils. This modulation may facilitate the development of chronic inflammatory lesions in Lyme disease.					1478	196383	6253	56681	80207	64218	29126	22882	10544	1356	123879	83855	6487	23275	7096	139170	55365	9489	51191	79954	9589	51643	114908	10563	10171	55970	262	221302	6478	8994	80149	6949	124460	9604	441168	3433	7763	5604	5580	84333	5694	10807	653361	91543	10148	3600	9961	54662	6385	129607	64127	8611	6714	8848	116113	29979	57157	64761	11030	10875	92597	53405	10538	5720	27338	3067	23210	4690	10228	57085	28959	929	56910	3669	2107	8546	10206	57169	137695	7127	85463	117247	2745	5214	8767	5211	8743	5469	83852	9497	65056	6504	3839	26472	11156	10320	84230	4337	133	10767	375346	4793	103	9693	55081	10209	9123	10455	10261	7812	6434	10243	23367	51703	10010	55151	5687	5721	9697	3069	5900	2120	3678	27035	8676	80219	81030	55113	117289	94240	51131	8837	57194	9322	8562	57211	4599	11135	55072	57655	6047	11145	23011	9021	26228	161742	143903	5781	29992	84946	81565	148932	51144	11044	6236	57584	64651	81553	51119	54467	85021	3937	9188	784	9470	6482	128866	5326	4600	59274	11274	10938
GSE6090_UNSTIM_VS_DC-SIGN_STIM_DC_UP	M6811		17496896	Hodges A,Sharrocks K,Edelmann M,Baban D,Moris A,Schwartz O,Drakesmith H,Davies K,Kessler B,McMichael A,Simmons A	GSE6090	GSE6090_2631_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in dendritic cells: control versus stimulated with anti-CD209 [GeneID=30835] antibody.	DC-SIGN is a C-type lectin expressed by dendritic cells (DCs) that binds HIV-1, sequestering it within multivesicular bodies to facilitate transmission to CD4+ T cells. Here we characterize the molecular basis of signalling through DC-SIGN by large-scale gene expression profiling and phosphoproteome analysis. Solitary DC-SIGN activation leads to a phenotypically disparate transcriptional program from Toll-like receptor (TLR) triggering with downregulation of MHC II, CD86, and interferon response genes and with induction of the TLR negative regulator ATF3. Phosphoproteome analysis reveals DC-SIGN signals through the leukemia-associated Rho guanine nucleotide exchange factor (LARG) to induce Rho activity. This LARG activation also occurs on DC HIV exposure and is required for effective HIV viral synapse formation. Taken together HIV mediated DC-SIGN signalling provides a mechanism by which HIV evades the immune response yet induces viral spread.					10399	22955	221091	81570	51122	11340	8891	8492	11237	1203	5805	7520	84516	6141	84922	10455	79084	5832	10196	22974	3611	64397	3987	10959	51102	5982	744	10987	1387	494143	9942	1523	55775	10171	2589	4087	63935	686	135114	257019	221336	4047	56478	26154	4172	55156	130013	64852	10549	287	253152	51002	114609	9425	10535	5176	54885	55572	152579	94081	83903	9790	79989	27072	56124	55863	221830	29127	10286	3298	100113407	116461	27241	84236	23468	55737	51433	9949	8396	10069	222234	92335	29883	8443	60559	5973	11321	58488	7289	56935	7375	133746	8321	94101	51567	2960	51726	6389	51109	90390	51514	84314	93380	2961	1848	4643	5163	255520	5781	140707	4751	1500	23559	140809	5257	3799	199857	27333	48	2551	79056	1846	54965	51377	6778	5530	29104	6002	8089	55759	55739	4253	51110	5713	29926	56270	1998	9039	3836	56127	10614	7982	440138	92105	55326	93210	6664	57510	7414	55823	64750	348654	4905	10179	9943	55631	8565	23512	6259	4128	55622	10322
GSE6090_UNSTIM_VS_DC-SIGN_STIM_DC_DN	M6812		17496896	Hodges A,Sharrocks K,Edelmann M,Baban D,Moris A,Schwartz O,Drakesmith H,Davies K,Kessler B,McMichael A,Simmons A	GSE6090	GSE6090_2631_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in dendritic cells: control versus stimulated with anti-CD209 [GeneID=30835] antibody.	DC-SIGN is a C-type lectin expressed by dendritic cells (DCs) that binds HIV-1, sequestering it within multivesicular bodies to facilitate transmission to CD4+ T cells. Here we characterize the molecular basis of signalling through DC-SIGN by large-scale gene expression profiling and phosphoproteome analysis. Solitary DC-SIGN activation leads to a phenotypically disparate transcriptional program from Toll-like receptor (TLR) triggering with downregulation of MHC II, CD86, and interferon response genes and with induction of the TLR negative regulator ATF3. Phosphoproteome analysis reveals DC-SIGN signals through the leukemia-associated Rho guanine nucleotide exchange factor (LARG) to induce Rho activity. This LARG activation also occurs on DC HIV exposure and is required for effective HIV viral synapse formation. Taken together HIV mediated DC-SIGN signalling provides a mechanism by which HIV evades the immune response yet induces viral spread.					8788	9466	4843	9636	653509	5270	84063	146330	161497	3061	6542	124274	8519	126006	80274	83693	4542	80148	128439	4985	8927	84275	942	2693	7498	283152	80731	146177	917	283951	497189	11035	29126	392509	57595	642968	6753	55509	8578	2668	64170	54546	134111	1815	392862	221472	5662	197358	11330	4610	148979	388419	90135	6404	347741	5696	9603	64478	100128927	54584	2147	79012	55079	116135	4118	151306	56833	1237	150372	401024	26998	8437	112609	919	57540	639	130827	6375	3860	140689	80381	1944	10669	11149	26049	5338	283383	23552	486	4336	57463	2646	338339	283807	2	7054	284111	53336	7060	6531	10900	2348	284467	23542	170689	5698	613	5745	348094	23533	170690	341	54434	219736	5251	51207	10418	80834	114787	10777	7941	8022	55760	7226	8971	79825	712	152789	171169	85508	283316	169966	253982	338811	83394	864	6926	11151	9379	79727	8972	55806	246176
GSE7509_UNSTIM_VS_IFNA_STIM_IMMATURE_DC_UP	M6814		17502666	Dhodapkar KM,Banerjee D,Connolly J,Kukreja A,Matayeva E,Veri MC,Ravetch JV,Steinman RM,Dhodapkar MV	GSE7509	GSE7509_3402_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in immature dendritic cells: untreated versus interferon alpha.	The ability of dendritic cells (DCs) to activate immunity is linked to their maturation status. In prior studies we have shown that selective antibody-mediated blockade of inhibitory FcgRIIB receptor on human DCs in the presence of activating immunoglobulin (Ig) ligands leads to DC maturation and enhanced immunity to antibody-coated tumor cells. Here we show that Fcg receptor (FcgR) mediated activation of human monocytes and monocyte-derived DCs is associated with a distinct gene expression pattern, including several inflammation associated chemokines as well as type 1 interferon (IFN) response genes including the activation of signal transducer and activator of transcription 1 (STAT1).					6017	1725	56907	4716	2517	148170	6196	2875	55276	4666	10999	221091	6518	3149	79850	140465	1454	57447	205	4001	4751	83999	2961	22901	146909	100188893	10160	7936	10959	140707	153768	29127	5318	5571	134429	898	6660	10891	143458	11004	6167	3607	8856	11331	3491	64065	3069	27067	221035	3638	8395	221336	283871	1846	81567	2286	5253	5201	26608	131566	26154	7414	8099	55771	9524	57222	11243	7965	4288	10926	8537	257019	56246	9244	83879	342527	51645	1039	116173	1717	1271	9479	150468	3992	22974	54825	57404	3098	92609	152110	80312	85360	79641	55388	60678	54097	8208	11252	6482	5228	6160	404217	79071	983	8175	7485	1759	57701	2487	7112	388662	64788	7079	51201	84650	171425	10398	3837	79083	112939	1317	1397	79102	1718	400451	404544	94	1058	4605	10276	114880	9793	813	9787	9212	6307	114112	63982	23554	4718	6867	9712	84309	27175	54443	6169	8492	203069	2819	81575	149986	199953	160622	160428	5973	81610	24147	3418	84986	4598	146691	83461	23397	1869	10189	53358	9781	2997	7301	79801	154141	26156	3015	57060	3949	1468	342667
GSE7509_UNSTIM_VS_IFNA_STIM_IMMATURE_DC_DN	M6816		17502666	Dhodapkar KM,Banerjee D,Connolly J,Kukreja A,Matayeva E,Veri MC,Ravetch JV,Steinman RM,Dhodapkar MV	GSE7509	GSE7509_3402_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in immature dendritic cells: untreated versus interferon alpha.	The ability of dendritic cells (DCs) to activate immunity is linked to their maturation status. In prior studies we have shown that selective antibody-mediated blockade of inhibitory FcgRIIB receptor on human DCs in the presence of activating immunoglobulin (Ig) ligands leads to DC maturation and enhanced immunity to antibody-coated tumor cells. Here we show that Fcg receptor (FcgR) mediated activation of human monocytes and monocyte-derived DCs is associated with a distinct gene expression pattern, including several inflammation associated chemokines as well as type 1 interferon (IFN) response genes including the activation of signal transducer and activator of transcription 1 (STAT1).					441168	3656	474344	94240	916	22856	5583	9636	79754	116071	84899	868	317649	3601	7920	19	5133	8764	6812	7050	10219	9830	8543	84166	89857	10461	23344	29851	3683	56155	3003	55331	26191	3096	837	9153	79026	26234	915	7375	3620	5294	27246	3821	1606	197259	834	6452	3001	8530	2099	27334	22980	637	7378	10507	54103	10396	8809	639	10225	51131	4792	2516	4013	7052	5045	81622	10392	3383	4940	9402	8482	59345	5696	7412	57097	8605	5777	3769	57047	127544	7405	4170	84889	10039	84870	10855	6774	4599	3431	22914	3559	9034	5321	8743	54739	1806	9447	22936	5699	221188	4084	163351	3645	7097	9466	64005	4851	55303	2534	1519	6892	375775	8507	51752	3437	22870	80310	9663	57105	925	6324	7706	5291	2678	29121	8651	710	375287	4065	1435	7464	493	79895	10561	10068	9672	3433	9046	7070	57823	8850	10537	11274	81688	3627	8676	11151	55784	4283	10663	64761	3932	5330	11182	3604	113451	29117	3071	3659	219285	969	81553	1540	4261	5698	91526	3595
GSE7509_UNSTIM_VS_FCGRIIB_STIM_DC_UP	M6817		17502666	Dhodapkar KM,Banerjee D,Connolly J,Kukreja A,Matayeva E,Veri MC,Ravetch JV,Steinman RM,Dhodapkar MV	GSE7509	GSE7509_3403_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in dendritic cells: untreated versus anti-FcgRIIB.	The ability of dendritic cells (DCs) to activate immunity is linked to their maturation status. In prior studies we have shown that selective antibody-mediated blockade of inhibitory FcgRIIB receptor on human DCs in the presence of activating immunoglobulin (Ig) ligands leads to DC maturation and enhanced immunity to antibody-coated tumor cells. Here we show that Fcg receptor (FcgR) mediated activation of human monocytes and monocyte-derived DCs is associated with a distinct gene expression pattern, including several inflammation associated chemokines as well as type 1 interferon (IFN) response genes including the activation of signal transducer and activator of transcription 1 (STAT1).					9612	10959	29781	4815	2875	222553	8856	149986	4666	11243	10460	9854	858	9479	6525	146691	91179	5833	973	10076	57449	4919	404217	4004	199953	2593	7862	4150	5864	64096	11330	57455	150468	994	11282	113201	8099	22921	221035	7414	23371	170463	11331	10082	8395	134429	50808	4716	10512	80313	221336	27254	165918	3835	4869	9133	361	257019	57597	9696	22949	79850	4925	6259	55143	1975	83881	11004	84823	9918	58494	653808	64781	154810	84940	23399	284129	25792	5528	10019	54551	80305	10999	7423	8419	55388	6202	84465	4751	83461	225689	221091	79006	57701	1397	91694	54620	3638	92609	10654	79641	84464	6867	64857	25789	27067	161003	254225	30815	4625	10085	114880	374407	899	9655	29085	81610	5914	54148	54328	56246	11063	79777	9055	55658	339366	375346	10771	3868	8492	7122	144423	57586	22982	150465	148170	51645	4256	10078	9787	6295	10848	5296	65244	4041	26154	132884	3320	4758	25960	128439	3418	661	29127	1846	57381	83444	10160	170690	79083	2642	153768	4605	1454	23211	84309	57333	91807	23194	5739
GSE7509_UNSTIM_VS_FCGRIIB_STIM_DC_DN	M6818		17502666	Dhodapkar KM,Banerjee D,Connolly J,Kukreja A,Matayeva E,Veri MC,Ravetch JV,Steinman RM,Dhodapkar MV	GSE7509	GSE7509_3403_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in dendritic cells: untreated versus anti-FcgRIIB.	The ability of dendritic cells (DCs) to activate immunity is linked to their maturation status. In prior studies we have shown that selective antibody-mediated blockade of inhibitory FcgRIIB receptor on human DCs in the presence of activating immunoglobulin (Ig) ligands leads to DC maturation and enhanced immunity to antibody-coated tumor cells. Here we show that Fcg receptor (FcgR) mediated activation of human monocytes and monocyte-derived DCs is associated with a distinct gene expression pattern, including several inflammation associated chemokines as well as type 1 interferon (IFN) response genes including the activation of signal transducer and activator of transcription 1 (STAT1).					3459	1471	10219	94240	219931	5777	8809	6352	4851	10875	9034	3559	114882	7920	3716	5583	3601	7375	5272	3001	6812	3824	10320	120425	29851	3656	55034	8766	221188	10039	23550	8651	3821	152877	79705	9047	26191	84889	55823	116071	9636	3683	89857	5696	307	1535	79754	3002	55303	7464	6004	54103	23218	10892	3659	837	4940	834	752	3458	915	2099	80310	3560	6901	59345	1616	272	5321	4013	8519	23344	8807	706	51056	953	9402	64005	81622	55784	5630	54949	63916	25839	1521	3431	10906	79026	197259	25932	1512	3645	9023	6355	57823	8776	5024	8543	22904	3398	5721	10135	1374	2313	8347	22870	8671	287	115362	3597	4170	8743	6737	387751	3620	5551	8530	925	916	387357	6452	55835	51393	840	8764	54918	5045	5877	57105	27246	474344	22856	3383	868	23256	3433	10392	969	4257	3595	51129	785	29121	9535	317649	4792	9844	56155	55905	4261	11274	5698	84993	27334	57097	124056	126432	79718	5996	80255	917	79792	2591	9980	54739	127544	6578	6504	2040	5699	1806
GSE7509_UNSTIM_VS_TNFA_IL1B_IL6_PGE_STIM_DC_UP	M6819		17502666	Dhodapkar KM,Banerjee D,Connolly J,Kukreja A,Matayeva E,Veri MC,Ravetch JV,Steinman RM,Dhodapkar MV	GSE7509	GSE7509_3404_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in dendritic cells: untreated versus inflammatory cytokine cocktail.	The ability of dendritic cells (DCs) to activate immunity is linked to their maturation status. In prior studies we have shown that selective antibody-mediated blockade of inhibitory FcgRIIB receptor on human DCs in the presence of activating immunoglobulin (Ig) ligands leads to DC maturation and enhanced immunity to antibody-coated tumor cells. Here we show that Fcg receptor (FcgR) mediated activation of human monocytes and monocyte-derived DCs is associated with a distinct gene expression pattern, including several inflammation associated chemokines as well as type 1 interferon (IFN) response genes including the activation of signal transducer and activator of transcription 1 (STAT1).					55146	66005	9784	5524	27068	54442	3978	3693	8321	5429	7866	440400	55623	4839	79575	26258	4338	11222	65083	327	4720	11015	10840	29127	81537	158	4482	7203	9816	14	7466	11019	2618	29967	26061	2959	2937	23246	23192	9650	10025	2495	10755	1659	9212	3035	10607	1892	517	26133	8994	90637	23154	11051	4000	57510	22845	10079	5983	203	55175	54187	9512	57047	1642	4337	6904	4343	5536	64219	160897	19	7415	823	9277	2987	1152	22820	5431	4175	79812	134430	10455	2597	114885	7375	874	9871	54821	23184	84304	207	90693	3437	172	79801	790	22836	339487	55622	55124	79607	79132	3837	3627	29922	5902	135114	1836	55759	10155	8624	7099	84064	6892	57418	2617	3615	2639	53981	5519	1843	54496	1376	5096	51645	51	55760	23670	1318	84557	8507	57407	10735	28957	79269	23640	4811	55052	5606	91949	4172	84962	152559	8208	5321	7086	54919	142891	79143	10015	56910	10884	309	9194	54915	55361	4245	51172	64065	55741	4176	5471	55907	54606	6117	1737	55003	253017	2940	84275	2678	23646	4833	30845	5681	9533	90826	55783	23787	9961	23450	84522	686	7064	90861	57477	391
GSE7509_UNSTIM_VS_TNFA_IL1B_IL6_PGE_STIM_DC_DN	M6820		17502666	Dhodapkar KM,Banerjee D,Connolly J,Kukreja A,Matayeva E,Veri MC,Ravetch JV,Steinman RM,Dhodapkar MV	GSE7509	GSE7509_3404_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in dendritic cells: untreated versus inflammatory cytokine cocktail.	The ability of dendritic cells (DCs) to activate immunity is linked to their maturation status. In prior studies we have shown that selective antibody-mediated blockade of inhibitory FcgRIIB receptor on human DCs in the presence of activating immunoglobulin (Ig) ligands leads to DC maturation and enhanced immunity to antibody-coated tumor cells. Here we show that Fcg receptor (FcgR) mediated activation of human monocytes and monocyte-derived DCs is associated with a distinct gene expression pattern, including several inflammation associated chemokines as well as type 1 interferon (IFN) response genes including the activation of signal transducer and activator of transcription 1 (STAT1).					11330	140767	63941	5081	283375	60674	4901	645426	90990	27094	441061	653583	4504	6263	246778	140733	79937	85291	7881	83897	389421	3249	5020	94030	388121	54413	118932	145873	1389	283385	2796	23642	5539	677769	58517	27164	58496	3442	3201	91181	23359	376940	378884	27161	1524	23769	6340	84952	81543	6023	6085	9196	57528	10497	26146	283629	80274	131375	49	124274	81559	114783	81615	55316	113146	55808	6521	6810	611	116966	9508	6238	64208	137075	80714	51773	283518	3217	7110	212	8715	449520	632	10817	275	6804	114825	6754	29906	7920
GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_UP	M6823		17502666	Dhodapkar KM,Banerjee D,Connolly J,Kukreja A,Matayeva E,Veri MC,Ravetch JV,Steinman RM,Dhodapkar MV	GSE7509	GSE7509_3405_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in dendritic cells: anti-FcgRIIB versus inflammatory cytokine cocktail.	The ability of dendritic cells (DCs) to activate immunity is linked to their maturation status. In prior studies we have shown that selective antibody-mediated blockade of inhibitory FcgRIIB receptor on human DCs in the presence of activating immunoglobulin (Ig) ligands leads to DC maturation and enhanced immunity to antibody-coated tumor cells. Here we show that Fcg receptor (FcgR) mediated activation of human monocytes and monocyte-derived DCs is associated with a distinct gene expression pattern, including several inflammation associated chemokines as well as type 1 interferon (IFN) response genes including the activation of signal transducer and activator of transcription 1 (STAT1).					3418	1892	54534	50862	55156	55214	6723	9070	64852	2280	262	51550	3326	23576	9343	5716	5577	100287932	54432	10296	54496	114908	5713	6472	6415	8766	5425	56954	23382	5604	139170	80349	5908	8079	1471	115752	26073	84693	11345	55256	163	5534	7283	6845	1622	8508	51122	3190	7126	56984	51234	2992	686	3837	10924	494143	55234	84296	9188	56940	4313	50813	124790	4076	4733	51228	11112	30834	10483	827	23170	8878	2771	3459	54442	10294	2012	84285	10245	116841	5595	1374	8565	55756	54700	65991	10489	5708	9470	10776	10189	51015	5356	5519	6259	6924	5501	135114	55611	92335	9861	10367	9823	4128	143686	6355	130589	5510	10001	8192	9367	29780	5939	54458	10399	9352	10484	51386	5217	55629	4686	55686	133418	387	51056	8895	10054	5176	9913	27068	57407	6175	10455	84516	1397	4809	10535	6780	5983	84922	4905	151011	8891	63916	112869	8668	134147	10430	1203	7371	128240	94239	10184	93380	2876	2137	5358	10025	4953	64792	55832	5250	4682	84269	8604	9545	4775	30844	58485	5354	3423	89978	149951	84078	64978	51571	9948	150290	5707	2593	1173	6009	9341	23643
GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_DN	M6824		17502666	Dhodapkar KM,Banerjee D,Connolly J,Kukreja A,Matayeva E,Veri MC,Ravetch JV,Steinman RM,Dhodapkar MV	GSE7509	GSE7509_3405_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in dendritic cells: anti-FcgRIIB versus inflammatory cytokine cocktail.	The ability of dendritic cells (DCs) to activate immunity is linked to their maturation status. In prior studies we have shown that selective antibody-mediated blockade of inhibitory FcgRIIB receptor on human DCs in the presence of activating immunoglobulin (Ig) ligands leads to DC maturation and enhanced immunity to antibody-coated tumor cells. Here we show that Fcg receptor (FcgR) mediated activation of human monocytes and monocyte-derived DCs is associated with a distinct gene expression pattern, including several inflammation associated chemokines as well as type 1 interferon (IFN) response genes including the activation of signal transducer and activator of transcription 1 (STAT1).					11190	92017	91977	667	11330	10908	5820	64110	389827	51720	123720	6418	112885	155435	91179	114823	7862	196403	414918	29994	6919	653509	9662	6844	57553	2550	84626	6621	7402	378884	9495	431707	8578	11064	84787	64779	677768	339366	166614	7039	79048	79153	64403	25792	26115	550631	80274	387914	81794	54361	677769	4660	7089	3201	26012	79587	54540	23224	378938	29123	55607	10660	9696	2130	10902	57572	11149	56965	3216	57455	9463	260429	27106	23360	114785	55198	92822	27185	55229	389206	55738	58513	144100	7204	8620	201255	55716	57091	9751	8224	212	57655	91433	26993	2800	84940	282616	132141	8506	5338	55692	144423	3790	1181	340371	7074	25900	7503	79713	84465	1196	170961	83902	25961	54535	317762	4504	8525	51631	326	50488	81669	55576	84691	124401	57449	54855	51312	257415	51747	5826	8831	6440	200014	9138	8225	199221	84376	10411	10712	10771	5926
GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_UP	M6825		17502666	Dhodapkar KM,Banerjee D,Connolly J,Kukreja A,Matayeva E,Veri MC,Ravetch JV,Steinman RM,Dhodapkar MV	GSE7509	GSE7509_3406_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes: untreated versus anti- FcgRIIB.	The ability of dendritic cells (DCs) to activate immunity is linked to their maturation status. In prior studies we have shown that selective antibody-mediated blockade of inhibitory FcgRIIB receptor on human DCs in the presence of activating immunoglobulin (Ig) ligands leads to DC maturation and enhanced immunity to antibody-coated tumor cells. Here we show that Fcg receptor (FcgR) mediated activation of human monocytes and monocyte-derived DCs is associated with a distinct gene expression pattern, including several inflammation associated chemokines as well as type 1 interferon (IFN) response genes including the activation of signal transducer and activator of transcription 1 (STAT1).					54965	51013	81618	6500	4704	389362	57333	79850	3934	5699	3669	9230	4199	55559	55379	10567	2222	969	80349	148170	2517	706	5571	7284	56993	1833	6631	51573	10551	56894	131474	2665	63874	3029	51734	27033	84365	2947	10419	3028	8099	51138	10519	573	3251	55856	1827	79073	5878	201562	8409	51504	11345	211	9141	23478	84324	10574	29968	1174	256281	1717	51491	8666	3329	57683	6329	827	3486	1973	5604	7555	347	51082	55860	6613	51172	84298	5537	122704	2966	51227	5683	29781	27315	57222	7203	6950	23753	2717	3326	5600	5230	529	5358	57447	5446	7001	1016	839	55335	64978	51650	6723	805	25797	29088	203	1615	5473	3084	56300	9343	8664	11112	221091	4836	11054	1514	54212	4716	8665	10643	6237	81876	3735	285	27156	5272	84833	26227	91694	9049	51534	6612	56650	26589	83939	7172	27069	3068	977	201965	170622	7076	125476	7319	9479	6992	10741	11337	6749	10960	169714	54148	54499	55686	11142	27258	8361	10987	9419	84879	84236	2593	8447
GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN	M6826		17502666	Dhodapkar KM,Banerjee D,Connolly J,Kukreja A,Matayeva E,Veri MC,Ravetch JV,Steinman RM,Dhodapkar MV	GSE7509	GSE7509_3406_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes: untreated versus anti- FcgRIIB.	The ability of dendritic cells (DCs) to activate immunity is linked to their maturation status. In prior studies we have shown that selective antibody-mediated blockade of inhibitory FcgRIIB receptor on human DCs in the presence of activating immunoglobulin (Ig) ligands leads to DC maturation and enhanced immunity to antibody-coated tumor cells. Here we show that Fcg receptor (FcgR) mediated activation of human monocytes and monocyte-derived DCs is associated with a distinct gene expression pattern, including several inflammation associated chemokines as well as type 1 interferon (IFN) response genes including the activation of signal transducer and activator of transcription 1 (STAT1).					22980	114881	7799	10426	26995	9765	79587	25900	6621	115548	345778	55680	259282	55818	8476	23523	5926	22925	9569	56980	2005	57690	55316	6901	58513	9662	22906	4216	64506	11176	5894	10312	55229	23299	64319	677769	6651	8416	113510	32	57553	10725	3831	10444	79029	29800	4798	9918	134957	10443	10482	84251	9924	6095	594	84318	26005	54891	6364	26960	57176	10129	9015	166614	83872	84976	7503	64801	27161	1783	200186	338773	9701	6525	11064	9988	9644	57560	80205	254065	8398	3708	342184	905	10174	80012	23499	10024	27327	374868	200403	8473	9208	89796	246269	55131	5141	6625	369	8943	9654	9742	5498	132949	23518	5090	27154	5789	5936	89797	23105	259173	23187	9498	57109	3680	22976	2800	27158	23225	3551	9681	23644	285025	7003	133015	79668	23380	55198	23642	49855	55252	10396	1196	22823	65125	10625	57192	84614	57700	54790	7074	79789	11325	94134	55119	6809	29066	29121	4212	9001	81669	9611	3257	51742	114785	7450	51631	5395	10243	5428
GSE7509_DC_VS_MONOCYTE_UP	M6827		17502666	Dhodapkar KM,Banerjee D,Connolly J,Kukreja A,Matayeva E,Veri MC,Ravetch JV,Steinman RM,Dhodapkar MV	GSE7509	GSE7509_3407_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in dendritic cells versus monocytes.	The ability of dendritic cells (DCs) to activate immunity is linked to their maturation status. In prior studies we have shown that selective antibody-mediated blockade of inhibitory FcgRIIB receptor on human DCs in the presence of activating immunoglobulin (Ig) ligands leads to DC maturation and enhanced immunity to antibody-coated tumor cells. Here we show that Fcg receptor (FcgR) mediated activation of human monocytes and monocyte-derived DCs is associated with a distinct gene expression pattern, including several inflammation associated chemokines as well as type 1 interferon (IFN) response genes including the activation of signal transducer and activator of transcription 1 (STAT1).					953	922	5997	7056	114879	301	81887	6271	4696	5742	3575	51466	138050	719	1439	221955	57175	9861	117246	79570	1234	2309	1282	3837	23313	1512	6432	3572	1265	79101	308	5740	1508	6183	51147	5660	968	348	8804	79683	101	79447	6168	9643	27095	4240	83877	57050	4321	23705	4698	5447	6128	1601	51170	5689	79073	23481	5654	51499	57544	8881	9450	8289	10945	5129	25804	467	538	6810	121665	23633	2949	1266	8125	81620	122622	6696	3077	2954	79932	93974	10763	55793	57045	57095	1839	10153	123	10038	5360	79022	83871	10682	3693	3006	55361	339	51186	10671	2171	1545	7078	1611	1774	1435	51495	1211	7280	54838	2934	6122	2697	90102	79887	1471	4048	51559	72	6125	713	7249	23236	10327	2778	71	55207	23175	3958	51528	27244	118429	940	25914	1509	9776	7203	84311	8013	7405	23452	3956	23184	1028	2185	54927	11212	8566	3687	5187	5430	23710	51386	2992	84276	4077	201895	2350	11335	10175	65990	338339	2224	3479	10106	714	9331	4047	1634	4257	5786	84727	10314	3073	6196	5464	79869	967	211	9516	80176	148113	29760	26207	27090	2720	5244	23423	5096	2872	2760	712	115817	9130	4023	2959	10491	7106	51271	8729
GSE7509_DC_VS_MONOCYTE_DN	M6829		17502666	Dhodapkar KM,Banerjee D,Connolly J,Kukreja A,Matayeva E,Veri MC,Ravetch JV,Steinman RM,Dhodapkar MV	GSE7509	GSE7509_3407_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in dendritic cells versus monocytes.	The ability of dendritic cells (DCs) to activate immunity is linked to their maturation status. In prior studies we have shown that selective antibody-mediated blockade of inhibitory FcgRIIB receptor on human DCs in the presence of activating immunoglobulin (Ig) ligands leads to DC maturation and enhanced immunity to antibody-coated tumor cells. Here we show that Fcg receptor (FcgR) mediated activation of human monocytes and monocyte-derived DCs is associated with a distinct gene expression pattern, including several inflammation associated chemokines as well as type 1 interferon (IFN) response genes including the activation of signal transducer and activator of transcription 1 (STAT1).					2940	116143	51274	3437	388	100	4860	7920	1528	9482	27166	85461	28984	550	8839	4741	6908	2730	2209	2921	302	1054	9056	84327	4061	129401	26471	55106	226	7430	92140	1536	9016	10467	9936	90231	8241	83452	286826	84950	63979	6279	2281	4116	54	7295	6648	10548	146542	3430	6590	765	202	6772	7124	4690	2180	5052	387	7185	3760	6609	94031	3624	4600	366	5739	200185	23541	55303	4664	9034	5376	9535	30	644096	79042	6010	55326	718	53	3240	11274	10062	7107	92597	79568	29887	7084	3123	140809	51246	6431	23166	5721	7133	6288	9314	9410	83606	961	10272	1379	6890	4973	64776	8635	51738	148423	1374	23657	28972	2745	55776	837	869	100507290	10455	10162	80347	1188	23512	64097	757	25987	3055	874	5663	25828	81628	10507	929	57169	2268	228	3959	5698	129607	23161	10954	1457	5902	375790	64135	83742	1235	2039	9373	199746	56138	8899	2589	26253	468	5894	358	8685	7494	11165	3631	9619	2634	6688	9592	4855	3364	2159	26003	11137	201965	2358	345611	706	10636	2357	2319	931	5916	5528	10544	50674	80896	1184	26716	8460	4792	2923	3117	2023	5001	8609	10365	2114	9536	5909	25932	7170	84321	730249	3627
GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_UP	M6832		17502666	Dhodapkar KM,Banerjee D,Connolly J,Kukreja A,Matayeva E,Veri MC,Ravetch JV,Steinman RM,Dhodapkar MV	GSE7509	GSE7509_3408_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in response to anti-FcgRIIB: dendritic cells versus monocytes.	The ability of dendritic cells (DCs) to activate immunity is linked to their maturation status. In prior studies we have shown that selective antibody-mediated blockade of inhibitory FcgRIIB receptor on human DCs in the presence of activating immunoglobulin (Ig) ligands leads to DC maturation and enhanced immunity to antibody-coated tumor cells. Here we show that Fcg receptor (FcgR) mediated activation of human monocytes and monocyte-derived DCs is associated with a distinct gene expression pattern, including several inflammation associated chemokines as well as type 1 interferon (IFN) response genes including the activation of signal transducer and activator of transcription 1 (STAT1).					10949	10402	23526	3145	23116	10520	9925	1628	8930	51747	1820	116985	5442	5074	6599	8819	79109	7267	4607	9020	6601	9918	7852	4303	4335	23468	26043	3708	8539	7841	9180	10450	221	5813	10016	52	10422	10928	51706	27349	10128	9679	23039	5198	4713	1050	10902	23094	5742	2145	9665	3459	694	4013	79161	23248	2193	5997	9903	1054	6418	9730	2058	24149	22889	55719	4122	5510	8321	1796	6734	2767	7366	57658	2909	3423	7048	25900	3150	64795	11216	8550	10474	3984	440026	23130	23429	140885	57418	26240	10919	5501	3029	23012	9326	6256	8971	11068	10541	9770	949	7508	10302	5546	2720	55830	26151	23598	23173	8731	10144	54520	7832	8574	23038	1802	10608	489	23051	23031	23341	4190	57019	10623	56910	171546	7541	10388	2242	8609	8073	4610	10799	23401	7586	9612	10291	23129	6621	3148	5018	6777	64210	10277	146542	10904	6415	5162	27072	2800	54838	9716	1432	7535	54665	7020	27352	11221	1955	9411	4677	7905	7187	55702	11315	7737	22838	752	11260	23112	9120	902	5279	975	6296	10856	29902	54541	114932	901	2627	54505	84759	25966	79053	400410	10641	2653	10106	223	2920	2921	552889	10472	10296	60496	412	7818	5604	1389
GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_DN	M6835		17502666	Dhodapkar KM,Banerjee D,Connolly J,Kukreja A,Matayeva E,Veri MC,Ravetch JV,Steinman RM,Dhodapkar MV	GSE7509	GSE7509_3408_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in response to anti-FcgRIIB: dendritic cells versus monocytes.	The ability of dendritic cells (DCs) to activate immunity is linked to their maturation status. In prior studies we have shown that selective antibody-mediated blockade of inhibitory FcgRIIB receptor on human DCs in the presence of activating immunoglobulin (Ig) ligands leads to DC maturation and enhanced immunity to antibody-coated tumor cells. Here we show that Fcg receptor (FcgR) mediated activation of human monocytes and monocyte-derived DCs is associated with a distinct gene expression pattern, including several inflammation associated chemokines as well as type 1 interferon (IFN) response genes including the activation of signal transducer and activator of transcription 1 (STAT1).					10410	23424	27074	23380	116984	5930	29798	3669	9683	3055	1272	3516	55183	127544	6357	5350	23294	23070	9711	51493	2959	7706	27348	3434	9781	22856	773	5756	430	10859	10561	6752	133	2358	8519	2526	9830	473	54453	6801	9636	9910	331	3902	4067	4938	1479	262	9704	10964	3097	659	55669	7538	467	6347	60489	5771	5899	11177	57493	7150	8204	8987	141	6354	56829	4600	10135	2120	25841	675	8775	10906	10643	3433	25793	4599	6429	10970	1602	11011	6773	23636	23029	8545	8737	1318	634	8672	7132	3981	6993	375035	4283	25948	100131510	23499	578	3665	5533	10616	329	27338	7152	11044	23179	5128	3965	5937	795	22926	103	5520	8869	6741	4005	6672	5168	27	6373	1230	8651	1992	6554	51350	91543	942	56650	8638	7756	684	4939	10475	8496	23328	3937	5031	5923	10892	84162	7752	4213	3021	9938	3437	558	8726	5359	9334	1735	10379	843	5819	6355	4430	3430	3301	4001	22904	23607	9473	9262	375346	9989	1848	2000	7051	10627	1109	2125	1497	51552	3431	3574	10589	580	9107	2180	2535	10865	4088	1665	25801	355	3569	6737	54462	54739	4678	7290	9140	57447	643314	2898	115353	10208	23067	5685	382
GSE4590_PRE_BCELL_VS_SMALL_PRE_BCELL_UP	M6860		17890238	Hoffmann R,Lottaz C,Kühne T,Rolink A,Melchers F	GSE4590	GSE4590_3549_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated during B lymphocyte differentiation: pre-B I versus small pre-B II.	Cells from four develppmental stages were purified by FACS from human bone marrow samples					55110	23232	161142	5217	9637	51390	80221	56648	2327	55897	9886	6419	7782	9500	57645	8971	132299	8434	57409	55297	54477	57211	121601	23607	975	5335	79656	50865	54434	80235	10840	23554	156	57154	2906	192670	254887	394	57692	51379	51616	5720	27067	84804	5820	83943	2308	8572	55810	84964	3620	5872	23413	84282	5768	54734	22987	23461	6515	7098	51133	11215	6934	23066	9934	7703	23250	55800	252839	146223	65244	51479	636	9910	283248	54531	23365	162517	342371	63908	143279	51131	29937	80318	63035	80177	55033	3563	3150	57579	51227	196403	6558	57713	23595	92312	162605	5954	29940	155368	83871	5352	9333	8237	80736	64837	10916	59345	10392	6480	54676	123016	5334	6588	9830	78990	8987	90060	5819	3315	6503	57393	5140	163351	6049	196	192683	967	79665	55561	114793	11018	27034	138639	57463	5742	95	23051	158866	11236	128822	3142	136332	84286	10492	26115	5881	5940	57084	5579	57794	10561
GSE4590_PRE_BCELL_VS_SMALL_PRE_BCELL_DN	M6861		17890238	Hoffmann R,Lottaz C,Kühne T,Rolink A,Melchers F	GSE4590	GSE4590_3549_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated during B lymphocyte differentiation: pre-B I versus small pre-B II.	Cells from four develppmental stages were purified by FACS from human bone marrow samples					6159	9746	29942	255394	7991	56674	3842	124872	121355	64093	2742	3756	91703	3993	143471	26470	9905	112885	57460	50717	9854	9256	55326	221079	50626	55283	5322	11337	97	10486	1917	3202	84951	7221	8648	8972	4255	5274	30814	90507	154810	64839	127255	4685	284439	55161	256987	89777	5137	9926	54407	9462	8506	54733	10391	253832	379	90550	150763	883	2230	64359	11107	255520	474344	84248	84692	115353	80317	6205	2027	3357	10347	6674	286828	285643	84747	84223	84260	51754	51592	2824	4758	1024	25805	338322	255027	5099	2048	3950	144501	3559	53834	64147	1954	8894	79071	3713	6170	8728	85456	56913	11244	2348	90990	2729	80762	10203	80021	91012	3299	2014	84795	59307	84466	80714	3204	9162	79607	54954
GSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_UP	M6863		17890238	Hoffmann R,Lottaz C,Kühne T,Rolink A,Melchers F	GSE4590	GSE4590_3550_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated during B lymphocyte differentiation: pre-B I versus large pre-B II.	Cells from four develppmental stages were purified by FACS from human bone marrow samples					27329	259230	9754	5768	22981	50650	5954	59345	9910	727936	65056	10125	83943	5570	51201	7703	23224	23607	11279	7025	59067	54014	51616	5966	51301	7162	4322	10916	55110	1806	56648	3627	80221	23150	55075	610	57162	51101	7098	55561	3456	27086	55800	65983	374969	1910	196	57713	9001	5881	91526	2191	63035	1902	151888	152519	23365	969	3431	81831	11277	9500	25801	4610	6304	100130771	27067	51673	3696	2895	84557	6668	30837	57520	9232	734	57406	22882	394	5600	10735	1838	131566	4082	57211	10765	26115	730249	2184	10006	3937	51251	84950	80235	4319	5727	91543	54329	125488	64135	7267	254228	120227	55660	143279	6737	81552	6352	57105	26750	131578	51390	4600	246243	5872	5352	23418	80237	94033	158219	5436	9636	54739	139170	3356	57154	8476	57551	114793	23597	54665	51232	87	5698	133022	7782	3569	7827	23318	80318	2634	8013	51347	57194	9447	56624	3791	50865	22808	3597	5720	51200	93082	3574	8419	23560	55033	667
GSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_DN	M6865		17890238	Hoffmann R,Lottaz C,Kühne T,Rolink A,Melchers F	GSE4590	GSE4590_3550_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated during B lymphocyte differentiation: pre-B I versus large pre-B II.	Cells from four develppmental stages were purified by FACS from human bone marrow samples					142678	1263	387921	23548	284439	23271	27020	254225	121355	867	79896	80745	4238	170394	84163	388552	2972	3198	256949	79598	1974	55719	23221	10123	171177	29901	63893	7461	84317	4066	4255	79738	79567	5876	26190	140700	30814	285	283897	286336	338322	6843	1269	374907	51665	22992	9659	55252	55128	55204	81889	1073	51287	85313	26751	388403	84759	729440	26995	51603	26524	133957	81888	57215	1196	23417	23598	54993	9852	2073	59338	90637	201292	115703	1951	79575	1917	6370	790955	146057	150368	9935	10289	64802	55357	90693	51559	3945	6156	5322	9213	3397	2063	83444	57534	10605	84331	84315	582	9440	8884	5924	2048	23623	9170	740	83549	65985	79671	117286	64750	2582	201163	2353	79020	64282	23522	56931	1947	7508	10620	10004	6844	9531	54776	80746	2256	80331	3157	2309	84705	143471	51564	26267	149986	842	27106	339287	10423	6619	29948	115761	782	10555	3268	55160	154881	9331	3104	55197	56947	11031	9162	25900	133619
GSE4590_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_UP	M6867		17890238	Hoffmann R,Lottaz C,Kühne T,Rolink A,Melchers F	GSE4590	GSE4590_3551_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated during B lymphocyte differentiation: pre-B I versus VPREB1+ [GeneID=7441] large pre-B II.	Cells from four develppmental stages were purified by FACS from human bone marrow samples					129607	8076	5371	10068	5600	22837	7453	3663	129530	256586	57105	55748	221981	57493	146850	9421	123720	390790	395	80318	23597	9500	9240	51379	55075	50865	56654	794	23365	10385	84255	131566	841	54877	23682	1138	5325	284	9001	7267	26057	8807	79720	158219	1493	149233	10063	8434	114793	11279	27330	80310	51227	3594	5727	29944	9754	23607	5319	57060	10125	59345	1902	7162	54662	83594	168330	3150	81831	145773	55633	84807	80235	51201	26013	55897	10840	51616	124359	1446	9355	84166	9033	55110	116931	3356	84804	10320	9232	83638	23150	10916	254065	252839	85456	10873	63946	24146	54039	2995	151507	7703	54922	30837	22914	50808	150921	149708	952	51232	282973	3645	4842	2487	5463	4065	2992	10124	259232	5217	10427	1301	5079	6098	7920	374969	55224	57154	9562	222194	5520	10225	56132	10103	146279	79132	4084	5613	9910	6913	55177	51126	55213	57162	5588	5264	151531	1040	23232	4741	27067	10392
GSE4590_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN	M6871		17890238	Hoffmann R,Lottaz C,Kühne T,Rolink A,Melchers F	GSE4590	GSE4590_3551_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated during B lymphocyte differentiation: pre-B I versus VPREB1+ [GeneID=7441] large pre-B II.	Cells from four develppmental stages were purified by FACS from human bone marrow samples					1969	55364	65065	8106	474344	51025	8019	96459	9256	149986	25966	126792	27244	2063	8992	89801	10261	9573	139231	54475	84448	11079	7326	9659	84524	23469	63897	10289	121355	53354	4597	85463	9788	286205	57188	8880	5987	4839	55527	55186	6621	84466	84747	23522	201163	116225	4848	5253	2065	10614	6236	54893	51108	79134	79829	55544	11285	51422	921	4040	7014	8636	928	10527	84248	23244	8527	51115	54532	84331	51533	63967	1608	26253	84890	5534	5863	8836	29107	153443	79572	254225	257218	84961	91010	79613	25	22823	7390	79607	57003	6348	11183	144577	117178	55197	161882	5876	200734	11138	81889	84455	998	222487	83591	10605	84817	131616	7803	142891	26505	56342	57148	9744	26523	5322	175	23288	23304	10184	6625	255967	23041	29109	283234	308	9759	10020	57570	1612	23268	51497	89857	2961	125058	83460	23046	81035	8731	3198	23378	63977	255027	9135	440275	112724	55972	5273	55111	164091	55718	54209	26502	26470	3184	81608	64324
GSE4590_SMALL_VS_LARGE_PRE_BCELL_UP	M6872		17890238	Hoffmann R,Lottaz C,Kühne T,Rolink A,Melchers F	GSE4590	GSE4590_3552_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated during B lymphocyte differentiation: small pre-B II versus large pre-B II.	Cells from four develppmental stages were purified by FACS from human bone marrow samples					5305	10333	3606	1015	51302	51676	54926	6001	10509	143686	30849	27440	1903	58485	90427	85463	3055	4217	3766	1982	22873	4734	4664	2138	1536	23555	118788	1380	58475	114960	338645	868	51316	5321	25828	4064	26509	10666	5795	84102	8482	952	1981	80237	54436	4697	2182	115701	23327	51611	5734	64792	10437	390790	5304	6238	80312	2060	153830	23071	51312	4058	9153	57026	6625	9744	55315	6327	7941	83416	10154	6704	3709	925	533	5199	8870	202309	10855	11177	4602	29760	165829	5724	1600	8828	9824	5997	5144	28969	9407	4635	7305	23158	3631	3990	5423	51292	9839	54896	29802	27040	7837	51296	51499	4082	10519	5784	145781	5925	4675	9110	10139	2920	57007	390	128178	6504	7408	9037	26279	7098	4818	8566	1362	56992	338339	133690	57476	51347	404093	22918	120425	11240	1580	120935	196383	29126	1847	1340	1060	27434	26057	4063	6494	5982	6348	6279	7227	930	1848	10769	1211	79879	219623	8470	8992	55975	27185	84447	10564	26234	3903	201305	5551	51311	6932	83875	26147	79038	4616	23310	26253
GSE4590_SMALL_VS_LARGE_PRE_BCELL_DN	M6873		17890238	Hoffmann R,Lottaz C,Kühne T,Rolink A,Melchers F	GSE4590	GSE4590_3552_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated during B lymphocyte differentiation: small pre-B II versus large pre-B II.	Cells from four develppmental stages were purified by FACS from human bone marrow samples					5142	23779	10653	10924	58472	388650	11278	8993	3897	54558	2217	302	1999	27133	7431	89866	223082	153562	9671	23097	9871	51678	23108	57469	10970	3956	79025	221154	29957	2275	308	10079	64853	151011	6300	6277	11279	6402	65987	317649	1235	83692	54033	9124	10397	129607	941	131034	1831	8560	4792	57556	10279	1236	23092	117289	969	34	56852	10226	310	92675	80005	10392	113791	1266	84230	1268	26136	6693	3958	168620	55303	23179	92689	583	6725	5355	5818	1495	115727	9781	152007	27430	83641	6675	5527	3338	154	2886	56990	56244	9535	29993	3695	10000	8444	157	51031	4773	339416	1787	5914	358	4086	53827	10491	9942	10148	22839	23424	23066	1849	84305	286676	29911	51496	4092	5366	85315	79026	222962	79017	161582	80164	3512	1845	284001	60370	146223	2571	10231	7140	9314	10385	782	79056	11182	51601	359845	11030	4072	64744	6117	726	196074	3074	84229	137835	5873	23086	678	10750	27120	27240
GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_UP	M6874		17890238	Hoffmann R,Lottaz C,Kühne T,Rolink A,Melchers F	GSE4590	GSE4590_3553_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated during B lymphocyte differentiation: small pre-B II versus VPREB1+ [GeneID=7441] large pre-B II.	Cells from four develppmental stages were purified by FACS from human bone marrow samples					80216	284252	55973	10142	80745	8848	26137	26034	22918	2966	79819	65980	87178	5536	1374	285636	3480	4345	22920	440275	92105	8473	83607	10765	26574	55623	10499	11342	89853	79668	7716	2969	1791	221184	23271	253558	55296	9466	55297	56954	27248	783	55081	90826	7798	533	54954	3708	163589	5163	401548	4734	51317	55825	9236	8454	54879	9690	7265	5352	6925	79050	8518	54014	5456	2892	8663	1523	11107	6558	10203	257218	84056	51008	54476	55619	81550	29994	7014	51274	8563	10939	255967	79664	57186	5019	55035	222171	6840	5330	114876	54536	81572	678	25901	22862	57705	64407	51690	214	9448	4763	54558	124401	253260	56624	57157	84455	84636	5576	6845	90843	2908	28959	5577	51426	79832	22978	10803	56257	80312	5926	51763	9657	3815	8526	51347	9761	54850	7227	9093	1121	23062	9447	2632	143879	29117	92610	126433	23613	79828	1635	152137	26207	221823	54799	284307	65986	10667	2120	83742	51663	402415	51703	84961	92345	10452	795	65977	5734	202243	375775	5324	56252
GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_DN	M6876		17890238	Hoffmann R,Lottaz C,Kühne T,Rolink A,Melchers F	GSE4590	GSE4590_3553_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated during B lymphocyte differentiation: small pre-B II versus VPREB1+ [GeneID=7441] large pre-B II.	Cells from four develppmental stages were purified by FACS from human bone marrow samples					83715	441168	1263	57467	55625	8609	7294	10611	3447	54	8722	55363	11221	54830	10365	5784	8728	57493	79870	201627	5146	9467	899	5228	51176	55329	56940	154810	1879	84701	5530	5159	84926	353137	7280	23596	56894	3267	50614	221301	83891	80013	55515	144455	1233	55038	3689	57462	122509	26136	55303	22806	129607	64116	285126	3744	9168	25833	1155	6675	1041	926	7461	8825	1611	26031	9133	23365	55259	64208	3606	3767	1907	411	51761	27106	3169	285175	151647	257068	64410	80736	25932	23037	8513	220359	10068	7126	3978	23367	6504	26010	5723	65983	4651	51281	64581	285498	3983	79917	399697	976	8851	10152	54756	11163	8829	925	347733	161753	914	22953	79132	3682	286676	7317	3632	2805	64388	81871	4597	84885	2203	334	23274	3001	8555	8322	339398	65989	283316	134285	203447	219287	5629	149699	5858	9119	30819	1031	8715	2131	9229	8048	54836	117144	7369	90288	8382	167410	79007	308	255809	22981	353135	337867
GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_UP	M6877		17890238	Hoffmann R,Lottaz C,Kühne T,Rolink A,Melchers F	GSE4590	GSE4590_3554_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated during B lymphocyte differentiation: large pre-B II versus VPREB1+ [GeneID=7441] pre-B Il.	Cells from four develppmental stages were purified by FACS from human bone marrow samples					57560	8581	5954	84636	283120	7046	5321	8654	51379	2776	219285	344148	122618	92610	6281	80216	79819	4048	6934	3949	7494	57504	26137	2078	7405	130814	3987	79056	11034	5332	120	55819	3903	10678	11022	11320	8526	3459	7049	84333	134957	137835	4072	64420	221184	54874	868	23586	255231	8418	124401	2760	8604	91404	6307	4864	302	139818	5538	2530	84668	55204	93663	11145	1026	3815	26509	6558	5578	22978	138639	10203	9289	26033	9447	9759	23294	54476	55601	1493	115361	6730	55691	390790	114327	79895	51422	4659	23327	55300	255967	9839	11332	974	135112	79627	64407	259239	9697	23061	5324	220002	64744	163351	9829	6867	27324	58488	81704	51566	10602	3691	56667	10529	79668	55074	23552	4345	3290	100131755	57125	84938	1718	79012	222255	3158	11342	3156	2145	6041	4818	117177	1523	93408	93594	55831	29887	10777	1021	401548	3422	11001	80205	10869	10100	23076	25782	8645	1998	283130	22824	57521	5293	29121	6282	9402	55500	1870	7371	9060	9215	3676	144100	23682	114876	757	8935	121260	7163	51429	79683	50809
GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN	M6878		17890238	Hoffmann R,Lottaz C,Kühne T,Rolink A,Melchers F	GSE4590	GSE4590_3554_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated during B lymphocyte differentiation: large pre-B II versus VPREB1+ [GeneID=7441] pre-B Il.	Cells from four develppmental stages were purified by FACS from human bone marrow samples					57713	1233	92370	2674	9693	54496	55303	51176	22806	11221	5784	9500	8728	51	84750	51246	23348	81846	975	3267	4790	5159	151888	2534	9531	81606	9452	80762	50650	22822	8313	143279	114836	55213	201627	914	939	54841	56256	1840	56940	1500	6001	28951	255809	5922	1803	30011	55075	339977	24147	921	51474	55129	7077	2113	85464	8462	841	22807	26018	768211	5723	57586	3988	4063	3689	128338	3572	9168	54503	6503	4783	9760	5412	200845	8482	143686	7535	10449	4891	10825	57605	3662	54927	10152	84336	83641	2023	83903	54941	11080	79888	8925	5991	30008	5027	55636	25865	4088	976	10125	200734	409	51735	153396	3097	7464	23032	51466	22848	3720	54749	23608	1008	3487	655	94134	10150	9202	6498	2258	81545	57688	5334	2824	5783	30819	79147	112399	6382	940	2185	84899	23150	1958	129642	3983	29995	22873	9575	131965	5588	168537	25849	667	3091	255928	3732	9258	5576	1788	3717	4216	9153	2131	5501	4643	7520	23271	6483	7126	2147	201161	7267	56995	65065	57630	26277	79017	57493	995	159371	5935	64799	10320	2805	23380	901
GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP	M6880		18003728	Chan G,Bivins-Smith ER,Smith MS,Yurochko AD	GSE9601	GSE9601_3810_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes after HCMV infection: untreated versus BAY 11-7082 [PubChem=5353431].	Human cytomegalovirus induces a pro-inflammatory monocyte following infection and we have evidence that NF-κB and phosphatidylinositol 3-kinase [PI(3)K] are key mediators in this early activation. To begin to address how these signalling pathways are responsible for the rapid activation of infected monocytes, we examined the role these pathways played in the transcriptome of infected monocytes. Global transcriptional profiling using cDNA microarrays revealed a significant number of genes, including inflammatory genes, were regulated in a NF-κB- and/or PI(3)K-dependent manner, identifying these pathways as key cellular control points in the conversion of monocytes to an activated pro-inflammatory state following HCMV infection.					55819	8581	25833	1493	26033	347733	90332	120	124872	155382	5954	122618	283120	163351	84668	11163	57580	3671	1026	9759	85477	1832	5538	302	11145	64420	1303	55615	79582	8604	10678	114800	7905	219285	79819	81871	134549	2624	137835	23327	999	9229	22866	11332	64072	1805	974	51214	5698	83715	4072	4703	255231	84333	55617	3459	4477	90990	55601	57540	334	51566	3049	115361	26509	221301	3949	80216	84885	25956	131583	196	84062	8835	30010	2078	388633	4987	6934	8654	170392	55294	1263	7163	64386	5937	552	10068	10410	7371	91461	3215	91584	135112	93408	3676	84260	8549	3987	8048	1644	9177	3691	94240	3751	221662	285498	9542	93233	9915	55283	93664	10100	200728	7046	5792	10529	1297	389058	344838	23218	7280	134957	7317	387509	123099	9829	3002	8836	23552	9427	219287	9060	3199	2273	25802	4065	9021	116173	6449	268	3956	259239	24	6282	284467	23217	10203	26301	801	3903	2645	3481	27324	64714	59269	388611	79572	130814	23586
GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN	M6881		18003728	Chan G,Bivins-Smith ER,Smith MS,Yurochko AD	GSE9601	GSE9601_3810_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes after HCMV infection: untreated versus BAY 11-7082 [PubChem=5353431].	Human cytomegalovirus induces a pro-inflammatory monocyte following infection and we have evidence that NF-κB and phosphatidylinositol 3-kinase [PI(3)K] are key mediators in this early activation. To begin to address how these signalling pathways are responsible for the rapid activation of infected monocytes, we examined the role these pathways played in the transcriptome of infected monocytes. Global transcriptional profiling using cDNA microarrays revealed a significant number of genes, including inflammatory genes, were regulated in a NF-κB- and/or PI(3)K-dependent manner, identifying these pathways as key cellular control points in the conversion of monocytes to an activated pro-inflammatory state following HCMV infection.					133418	57713	975	54800	55591	22806	10434	51246	10825	84750	55075	54841	9693	1500	81846	9500	64841	81545	8313	6249	2113	55303	54664	1233	150962	51	80208	54927	10142	25865	391059	55629	11221	23271	5576	6251	57003	23074	80762	5159	151888	10121	54496	4287	7750	178	9448	55275	54503	3572	9452	143279	22807	90826	91746	29116	58516	153396	83641	4952	5095	7267	9135	2185	22848	30011	202243	5257	57553	10150	9538	2674	11080	1803	6045	4763	2585	2937	55213	51742	8204	54879	153830	10813	6873	7520	79364	55186	26037	768211	56940	79017	23075	64397	9517	200734	3709	3487	114907	24147	339977	85476	29097	5780	2147	3097	10243	201627	22822	23269	55636	10162	55255	56919	2632	29889	55973	4437	170506	10671	79585	3662	8672	50650	54431	25978	54541	27241	57586	25998	10455	56252	60558	23032	7095	8808	55788	9575	10614	54799	3688	23262	6734	10449	9202	3720	3267	22920	84961	56256	9701	55129	4528	23295	27430	8663	2720	286826	10320	5828	92797	1781	3717	6608	4216	112399	64333	85444	152518	22926	51185	5224	55717	253461
GSE9601_UNTREATED_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP	M6882		18003728	Chan G,Bivins-Smith ER,Smith MS,Yurochko AD	GSE9601	GSE9601_3811_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes after HCMV infection: untreated versus Ly294002 [PubChem=3973].	Human cytomegalovirus induces a pro-inflammatory monocyte following infection and we have evidence that NF-κB and phosphatidylinositol 3-kinase [PI(3)K] are key mediators in this early activation. To begin to address how these signalling pathways are responsible for the rapid activation of infected monocytes, we examined the role these pathways played in the transcriptome of infected monocytes. Global transcriptional profiling using cDNA microarrays revealed a significant number of genes, including inflammatory genes, were regulated in a NF-κB- and/or PI(3)K-dependent manner, identifying these pathways as key cellular control points in the conversion of monocytes to an activated pro-inflammatory state following HCMV infection.					168537	8360	55159	79980	10428	11113	9901	4627	6169	6749	6699	59342	10992	6867	3024	3936	22974	51593	5264	156	57602	30827	3151	84687	6653	92799	6235	2962	51372	309	10946	23559	5605	4201	5692	5871	5155	8361	79016	752	8938	868	7185	5704	4172	23205	4904	4084	4542	27145	1487	151903	115361	146206	94240	11004	29123	622	10379	84766	60672	3009	1435	7094	5050	6231	120425	23264	144455	51586	23526	84661	128866	23310	3482	5292	6494	4728	79048	25939	30844	10169	822	11151	162239	672	81876	23770	54440	1535	3018	25907	396	4001	6141	7430	1996	5588	51070	255104	92815	10919	6004	29907	121504	94239	201176	55920	3191	5802	10844	10616	53916	51329	10078	10755	22827	114879	5971	8379	56882	399687	91039	84153	26586	53615	9138	51428	51150	56262	3659	6168	5699	682	9815	55143	79039	3661	27258	4794	4702	29108	1465	51547	8370	23265	6171	90324	1010	6158	10880	2635	1786	1455	401505	54539	5441	83786	10750	11285	4725	57580	80764	10636	84939	2314	6923	9659	10956	10318	112950	7352	332	51164
GSE9601_UNTREATED_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN	M6883		18003728	Chan G,Bivins-Smith ER,Smith MS,Yurochko AD	GSE9601	GSE9601_3811_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes after HCMV infection: untreated versus Ly294002 [PubChem=3973].	Human cytomegalovirus induces a pro-inflammatory monocyte following infection and we have evidence that NF-κB and phosphatidylinositol 3-kinase [PI(3)K] are key mediators in this early activation. To begin to address how these signalling pathways are responsible for the rapid activation of infected monocytes, we examined the role these pathways played in the transcriptome of infected monocytes. Global transcriptional profiling using cDNA microarrays revealed a significant number of genes, including inflammatory genes, were regulated in a NF-κB- and/or PI(3)K-dependent manner, identifying these pathways as key cellular control points in the conversion of monocytes to an activated pro-inflammatory state following HCMV infection.					734	5825	9823	9373	8655	57146	137994	8608	10495	85465	283576	137872	1534	9205	51192	1798	50807	84516	6610	3141	9258	3988	10206	51390	575	3425	5318	54165	6251	53637	5547	53944	57678	4240	54534	673	10933	388730	6932	79923	677768	54414	81037	26502	64641	23233	3909	5251	57171	4591	83716	80830	8609	54148	2073	57110	151188	84142	83597	5437	79071	25853	6855	26061	23176	1368	285193	57128	10237	583	284382	128338	57447	6342	9290	3693	1787	54903	5783	23431	9919	55	27248	9867	11031	8694	53981	140258	23534	83941	1215	11213	9934	2888	387357	93210	51176	120892	6887	93035	757	84925	8575	128077	51141	200728	10158	55664	1073	165055	79364	79072	943	971	79848	23032	1236	3673	7716	3681	51728	5814	5796	79828	4055	55176	4225	357	283518	200845	54778	84458	158866	6566	10161	10098	79669	5586	158046	51265	8891	4982	8202
GSE9601_NFKB_INHIBITOR_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP	M6884		18003728	Chan G,Bivins-Smith ER,Smith MS,Yurochko AD	GSE9601	GSE9601_3812_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes after HCMV infection: BAY 11-7082 [PubChem=5353431] versus Ly294002 [PubChem=3973].	Human cytomegalovirus induces a pro-inflammatory monocyte following infection and we have evidence that NF-κB and phosphatidylinositol 3-kinase [PI(3)K] are key mediators in this early activation. To begin to address how these signalling pathways are responsible for the rapid activation of infected monocytes, we examined the role these pathways played in the transcriptome of infected monocytes. Global transcriptional profiling using cDNA microarrays revealed a significant number of genes, including inflammatory genes, were regulated in a NF-κB- and/or PI(3)K-dependent manner, identifying these pathways as key cellular control points in the conversion of monocytes to an activated pro-inflammatory state following HCMV infection.					51706	617	56892	23394	10299	1198	6612	79830	134147	29922	51321	5571	5742	201299	29942	4351	55253	93973	3417	7533	84693	5279	3607	54345	51196	56912	51109	4329	91368	6693	92305	28970	4832	6827	54857	8436	9236	8576	9031	10663	115209	3667	5982	64115	26022	79828	10449	5058	53	5296	22916	10597	79172	6502	9130	25840	151887	64976	30061	84787	38	112936	1376	284273	26094	9754	858	3824	5934	26123	51259	57506	3416	8443	29785	26100	10007	25776	57704	5859	5147	257218	2743	10573	51451	37	6397	2029	9070	7416	5127	64393	51075	5786	2205	2064	10908	1666	7071	27005	11124	55529	8697	80169	92667	4200	6834	4047	4704	26207	283537	79987	51426	29087	2833	55198	55325	142	23613	51292	7541	3588	79020	28954	7942	9885	9477	51501	8987	1312	339231	79956	157567	6945	7024	5164	4043	3065	221092	57231	59353	58472	23345	5916	26505	9807	5007	6001	55322	58485	1432	11314	28952	53346	6272	5495	8905	63915	1876	7832	4048	1173	3903	5468	1774	199870	55819	9391	80895	23433	6901	2271	55721	113	148789	29074	199857	22874	6608	23234	54834	8575	79002	55251	84532	83690	10077	84939	51280	259230	284654	57037	1374	3092	49856	51255	23471	3195	93323	10928
GSE9601_NFKB_INHIBITOR_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN	M6887		18003728	Chan G,Bivins-Smith ER,Smith MS,Yurochko AD	GSE9601	GSE9601_3812_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes after HCMV infection: BAY 11-7082 [PubChem=5353431] versus Ly294002 [PubChem=3973].	Human cytomegalovirus induces a pro-inflammatory monocyte following infection and we have evidence that NF-κB and phosphatidylinositol 3-kinase [PI(3)K] are key mediators in this early activation. To begin to address how these signalling pathways are responsible for the rapid activation of infected monocytes, we examined the role these pathways played in the transcriptome of infected monocytes. Global transcriptional profiling using cDNA microarrays revealed a significant number of genes, including inflammatory genes, were regulated in a NF-κB- and/or PI(3)K-dependent manner, identifying these pathways as key cellular control points in the conversion of monocytes to an activated pro-inflammatory state following HCMV infection.					3491	10221	116496	1015	4880	116071	8763	6457	2710	84617	1026	84897	85027	3430	7430	10409	6385	1536	84259	340075	3959	6356	9507	8743	84935	54453	27090	7763	8800	4493	10938	23367	5327	103	10268	126353	3604	3398	23076	6354	23764	4071	8651	3036	7421	2358	3559	286676	132864	6347	9166	57169	56342	6892	9388	51666	7076	1839	7378	136	9218	8706	6776	6605	133	54475	3552	81030	5464	3665	2634	653240	80176	9980	4314	11277	50616	65108	148113	54906	64135	23657	161742	23424	51126	9063	8435	6403	3586	114789	79751	1316	80824	10018	26471	1154	83481	1440	5743	3918	55785	3625	90121	3433	5359	4783	5371	9188	2649	23704	59269	387763	2131	54987	6416	929	58525	552	10979	1417	1616	6288	3055	2669	80381	5552	29889	5597	5797	157506	152007	6496	1326	84457	864	3439	1906	3091	1153	23587	51296	4283	5908	55647	7980	3600	79050	3437	64782	114112	11274	58480	3976	3557	90865	25932	4939	4600	6352	64108	3291	4322	3274	729756	27033	144165	6351	3099	960	3002	2182	6736	730249	8854	7296	3458	781	6648	8460	3067	64097	2012	2069	9516	5782	4613	55170	4922	347	10875	51491	11054	249	3156	3000	5045	57062	6373	6357	51761
GSE9239_CTRL_VS_TNF_INHIBITOR_TREATED_DC_UP	M6965		18039949	Zaba LC,Cardinale I,Gilleaudeau P,Sullivan-Whalen M,Suárez-Fariñas M,Fariñas Suárez M,Fuentes-Duculan J,Novitskaya I,Khatcherian A,Bluth MJ,Lowes MA,Krueger JG	GSE9239	GSE9239_2477_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocyte-derived dendritic cells: control versus TNF [GeneID=7124] inhibitor etanercept.	The process for making monocyte derived DCs (moDCs) has been previously described (46). All analysis was performed on “day 5” immature DCs. Etanercept 10mg/mL was added to experimental wells on days 0, 2, and 4. We chose this concentration of etanercept as it approximates the plasma concentration of drug when given 50mg BIW.					122618	57446	230	64428	126374	84264	51493	5371	23626	3699	55256	7408	5893	23526	63939	22933	64285	3299	142678	1454	57818	6713	387700	22980	55111	23162	54784	9446	55033	744	29957	23108	3903	54828	9843	54345	10482	6041	54536	81502	27347	1154	4046	220064	1741	57184	57468	54963	10140	727957	155061	8804	6303	203074	26993	2137	4882	53834	84925	1747	51170	203522	501	29941	91748	5028	23218	1488	6844	10904	55020	51555	7127	57104	6891	2122	10840	155038	1191	92689	10370	55911	1796	64840	5213	53635	7917	23390	7137	4240	1844	285440	219537	256536	100506742	2947	51272	534	6383	55819	5339	117144	947	57545	55466	170371	54480	29887	283383	51684	56265	84173	6558	283232	255783	80318	10404	55501	154141	55198	20	322	3177	54453	79154	1432	49	56898	54926	4204	2185	6039	4782	2245	166	550643	3073	5176	84893	26509	7369	6300	1571	197257	266655	659	23013	1545	222171	55647	4924	162073	90843	2907	7205	3106	3671	6811	3678	10561	9466	2581	118812	57591	80162	11330	7873	9570	8943	56271	23176	3117	2730	5627	153020	387758	4668	6477	151525	3600	345778	22838	26253	4675	3123	133418	3206	57728	56941	7095	4776	55683	8816	302	7707	4947	7378	59307	643008	57447
GSE9239_CTRL_VS_TNF_INHIBITOR_TREATED_DC_DN	M6966		18039949	Zaba LC,Cardinale I,Gilleaudeau P,Sullivan-Whalen M,Suárez-Fariñas M,Fariñas Suárez M,Fuentes-Duculan J,Novitskaya I,Khatcherian A,Bluth MJ,Lowes MA,Krueger JG	GSE9239	GSE9239_2477_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocyte-derived dendritic cells: control versus TNF [GeneID=7124] inhibitor etanercept.	The process for making monocyte derived DCs (moDCs) has been previously described (46). All analysis was performed on “day 5” immature DCs. Etanercept 10mg/mL was added to experimental wells on days 0, 2, and 4. We chose this concentration of etanercept as it approximates the plasma concentration of drug when given 50mg BIW.					220042	1503	406	8819	53981	84824	401251	54821	9450	7372	151188	11113	51249	197358	8140	54973	1633	84986	9891	80179	9493	11044	55252	3619	29015	11001	131965	26278	401466	115098	6038	81930	4635	9134	220107	144455	5529	5133	150468	8549	3915	4507	128602	672	2177	112479	9656	6945	79161	4836	152579	55631	81575	51250	84312	57650	253782	126299	7064	219623	9464	10537	133	116984	3683	51175	5550	11016	26576	10460	4320	164832	3267	10664	58485	29115	23171	9771	962	55166	145508	146956	8292	5079	79574	29128	6728	921	3833	5889	9738	339487	729533	23321	57125	221421	55165	705	9787	6512	9816	11098	441478	8565	113130	6446	51728	51428	2308	10274	9616	9868	25855	92106	79000	283	2963	84844	10607	9221	57492	100	2593	338773	220002	83461	10814	10785	203547	84930	401541	23129	55732	348654	497189	400916	10799	2259	1063	50804	9267	23658	155066	10180	3032	3845	2620	9401	79183	114112	55342	4678	8526	8581	202051	122769	2802	4605	23157	9878	54801	55504	23057	1047	7332	84319	25797	151648	29103	147841	7260	375316	23052	23131	55771	285362	7186	496	4063	3014	6632	7503	51237	10951	10775	10525	55009	79621	1791	55320	59269	9837	158248	6399	388228	64699	150356	10322	146850	54487
GSE10240_CTRL_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN	M298		18264110	Aujla SJ,Chan YR,Zheng M,Fei M,Askew DJ,Pociask DA,Reinhart TA,McAllister F,Edeal J,Gaus K,Husain S,Kreindler JL,Dubin PJ,Pilewski JM,Myerburg MM,Mason CA,Iwakura Y,Kolls JK	GSE10240	GSE10240_2953_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in primary bronchial epithelial cells: control versus stimulated with IL17A [GeneID=3605].	Primary HBE cells were stimulated with IL-22 and IL-17, and gene expression was studied using an Affymetrix platform microarray, in order to investigate which genes may be upregulated or downregulated in response to these cytokines. Of particular interest was the host defense genes such as antimicrobial peptides, which have been shown to be upregulated by IL-22 and IL-17 in skin keratinocytes.					10664	285671	27334	11047	10093	146183	8189	55671	207	6668	80700	257106	23582	60672	9501	5478	6351	2483	6169	10458	64132	81794	26173	3914	57045	19	6753	5272	7052	55129	28955	4056	6015	23710	81532	2059	2592	5176	55257	57026	6415	23294	79735	6545	6499	6916	5430	9827	54923	2149	79778	514	55135	10295	10901	9900	8091	55049	10555	835	2664	5292	116835	3283	9136	9985	10840	83590	54947	3714	3566	25828	7128	8733	5695	55256	80162	7434	23558	5605	80223	340146	54900	214	11078	3059	6468	26001	2068	80301	11046	753	1837	131540	10567	9775	126549	29851	23175	26993	10695	4773	284194	112	10079	199720	8379	2547	219654	5997	63891	4782	5338	8086	81704	6002	79085	81610	9170	3660	4744	7430	63978	8078	54902	25822	170954	7376	3384	57655	7975	146542	10181	84717	57118	54504	971	10469	83638	83696	23200	10252	23225	3005	22985	27146	222487	51149	2550	11202	9918	57463	85028	170302	140883	3676	54107	57449	55593	79719	54331	124045	3716	10723	23215	79058	11201	100499467	10320	5567	3455	252983	7306	28992	284086	55062	7009	10452	170463	441168	80714	11162	285193	9882	57555	728858	1911	4598	94005	79585	26233	9415	22822	140	54852	23158	79786	29101	85358	53916
GSE10240_IL22_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP	M299		18264110	Aujla SJ,Chan YR,Zheng M,Fei M,Askew DJ,Pociask DA,Reinhart TA,McAllister F,Edeal J,Gaus K,Husain S,Kreindler JL,Dubin PJ,Pilewski JM,Myerburg MM,Mason CA,Iwakura Y,Kolls JK	GSE10240	GSE10240_2955_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in primary bronchial epithelial cells stimulated with: IL22 [GeneID=50616] versus IL17A [GeneID=3605].	Primary HBE cells were stimulated with IL-22 and IL-17, and gene expression was studied using an Affymetrix platform microarray, in order to investigate which genes may be upregulated or downregulated in response to these cytokines. Of particular interest was the host defense genes such as antimicrobial peptides, which have been shown to be upregulated by IL-22 and IL-17 in skin keratinocytes.					27333	1663	26003	8273	2821	3235	57447	79956	3658	129401	64431	9043	79156	10746	80007	23102	55825	6945	8898	867	117178	100302692	55754	286451	729852	11128	84301	259282	55788	91057	221830	6732	27039	6303	221092	10472	57666	51571	55884	2207	29066	55279	158747	84920	6948	3189	10572	143684	9895	199870	10897	115201	3615	10671	10190	169200	55153	9294	1147	26354	23032	29079	196441	51135	54737	27107	54542	8674	9325	29110	27079	80067	79752	55922	9712	285590	3306	6451	54941	8890	91694	10973	55347	11061	9444	599	27022	27430	54520	55102	58472	2539	23670	54665	6103	2683	8531	57465	6102	23219	55486	79577	22897	509	1488	57570	54891	100113407	26608	211	9978	10605	56986	9367	382	22928	4507	7184	51188	8932	55149	10939	9824	8450	494143	55719	56890	2892	22818	9488	79876	2213	1241	1611	26276	151195	57179	51735	26263	282991	6617	10493	10490	51316	84947	54584	51133	92002	6342	79648	9411	27090	283431	2806	375790	23512	10499	7700	55284	5928	51111	5599	7458	84196	56605	2764	990	54989	55737	5214	23262	60684	178	79848	9113	8085	1622	284443	50515	51726	22914	118487	2949	51031	10921	7037	6726	84541	84312	29078	10311	116238	10733	51250	708	2623	3032	9695	10376	117154
GSE10240_CTRL_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP	M300		18264110	Aujla SJ,Chan YR,Zheng M,Fei M,Askew DJ,Pociask DA,Reinhart TA,McAllister F,Edeal J,Gaus K,Husain S,Kreindler JL,Dubin PJ,Pilewski JM,Myerburg MM,Mason CA,Iwakura Y,Kolls JK	GSE10240	GSE10240_2953_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in primary bronchial epithelial cells: control versus stimulated with IL17A [GeneID=3605].	Primary HBE cells were stimulated with IL-22 and IL-17, and gene expression was studied using an Affymetrix platform microarray, in order to investigate which genes may be upregulated or downregulated in response to these cytokines. Of particular interest was the host defense genes such as antimicrobial peptides, which have been shown to be upregulated by IL-22 and IL-17 in skin keratinocytes.					26095	9788	1632	613	80975	153642	65018	23613	6570	3491	55825	391059	9338	8722	8566	9836	10928	10534	1592	4091	1365	9088	116835	1647	29922	64776	148811	55319	55144	56259	203245	5322	7112	80127	4780	79838	59352	10743	6414	57129	6713	29062	2584	79922	79022	79831	1803	2896	9639	54870	54708	5707	64063	79738	51200	26130	152877	80097	8910	440836	60672	51389	79000	9611	29085	6147	80222	2686	1017	286467	3590	6175	10513	9869	2184	675	340069	645426	6533	84062	5036	11162	4320	7372	5599	64762	9156	4882	29941	283985	23022	708	23158	10809	6468	79029	64084	65122	3251	7405	403314	111	11200	90843	10659	3329	6676	131540	80324	8862	130560	7027	6875	147912	118812	63901	80020	27445	9032	11270	64087	5232	7812	731	858	143503	7102	79094	79366	5536	2587	2569	23243	55204	91894	23360	5026	10427	84838	57657	6601	219899	5293	55585	649	9516	84321	6776	23049	55315	84823	26354	64841	115795	54760	1984	122961	402569	27120	124790	10946	4482	960	113791	5471	55300	388939	8204	25766	51286	100093630	157310	7052	79019	9200	8416	55325	23678	79719	81027	112	90861	4237	6158	120892	4361	3425	1745	57447	10512	23361	441518	4331	10919	389816	57590	8178	55573	79772	79053
GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN	M301		18264110	Aujla SJ,Chan YR,Zheng M,Fei M,Askew DJ,Pociask DA,Reinhart TA,McAllister F,Edeal J,Gaus K,Husain S,Kreindler JL,Dubin PJ,Pilewski JM,Myerburg MM,Mason CA,Iwakura Y,Kolls JK	GSE10240	GSE10240_2952_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in primary bronchial epithelial cells: control versus stimulated with IL22 [GeneID=50616].	Primary HBE cells were stimulated with IL-22 and IL-17, and gene expression was studied using an Affymetrix platform microarray, in order to investigate which genes may be upregulated or downregulated in response to these cytokines. Of particular interest was the host defense genes such as antimicrobial peptides, which have been shown to be upregulated by IL-22 and IL-17 in skin keratinocytes.					7408	84301	4794	9694	119504	51371	5790	55632	9677	11060	4317	8924	3459	7170	51117	23235	54443	51253	29966	3423	1955	400569	65983	283446	5529	27163	26122	10209	170463	11153	4124	2145	119032	57820	3059	7561	91689	10109	9444	9968	439921	10728	102	11079	92935	7913	51478	57700	2165	59345	23038	50515	29855	80351	7409	9354	66008	7016	84337	55356	2028	57089	9049	8648	54821	375	57678	54187	533	6202	8099	254439	9389	6890	84696	6667	10009	51726	22916	60490	256380	56204	124056	54795	10463	7798	25851	80007	8544	8853	2274	29127	6170	8515	4832	11161	65997	9058	54919	30845	8085	4300	10393	64799	9776	23065	25989	11152	92170	79697	51393	11021	57610	56890	64979	5612	93436	168850	6720	2188	27301	4717	9688	83857	26229	5911	55617	51225	54584	2914	284352	56850	1628	9039	2280	29982	55230	4149	55208	57184	51637	79581	27039	9377	7545	5683	80790	9938	64224	6205	91947	65082	78994	57521	9802	114885	10085	3235	5252	23411	151613	25966	84876	22902	79918	137392	51365	8776	51692	26037	79691	5989	6139	10311	22993	6093	80314	64951	3105	56650	899	84792	55916	90933	9860	10072	84455	89781	10225	1147	8780	6907	57019	79731	9785	55450	5110	26146	6883	133308
GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP	M302		18264110	Aujla SJ,Chan YR,Zheng M,Fei M,Askew DJ,Pociask DA,Reinhart TA,McAllister F,Edeal J,Gaus K,Husain S,Kreindler JL,Dubin PJ,Pilewski JM,Myerburg MM,Mason CA,Iwakura Y,Kolls JK	GSE10240	GSE10240_2952_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in primary bronchial epithelial cells: control versus stimulated with IL22 [GeneID=50616].	Primary HBE cells were stimulated with IL-22 and IL-17, and gene expression was studied using an Affymetrix platform microarray, in order to investigate which genes may be upregulated or downregulated in response to these cytokines. Of particular interest was the host defense genes such as antimicrobial peptides, which have been shown to be upregulated by IL-22 and IL-17 in skin keratinocytes.					5334	9555	1182	538	10152	65125	51363	91543	4335	51776	79670	4296	1524	83707	84958	64342	54407	1153	55365	8848	10765	283985	115004	84307	9920	64743	93517	3104	4238	163351	9466	4693	57161	114548	122953	9583	23370	113	339983	10018	55690	1523	23362	85457	152006	64399	596	3643	6915	3708	7024	80312	2533	55198	84174	54946	22907	4818	6453	2099	939	595	6586	400745	147495	51744	27143	50649	3654	3554	7008	125058	51246	286336	203197	1040	255967	1154	84439	6900	11176	5469	3480	7791	19	7132	124935	5626	4976	221035	84836	55605	401612	7297	8877	27106	9988	6404	55345	55349	2004	22836	196743	10579	2149	121551	57674	56606	2081	23097	7029	9857	139716	6793	3683	4853	56204	55186	222487	84617	9781	23761	80164	10507	23218	387597	80760	860	23313	55250	961	7267	81539	8725	64062	10645	8204	6195	124540	348980	947	5467	325	81621	23389	1612	201305	201161	366	83861	149041	84281	114879	389075	6913	23136	1501	55589	90678	3106	84886	100170841	4619	84445	23373	23102	79718	63874	6911	10743	399687	3759	9203	343637	80005	155038	83795	84674	127254	201163	10154	4363	10409	56667	54887	84973	10803	146760	55729	3112	57622	2322	54520	7305	253143	552889	162494	945	90427	7867
GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP	M303		18264110	Aujla SJ,Chan YR,Zheng M,Fei M,Askew DJ,Pociask DA,Reinhart TA,McAllister F,Edeal J,Gaus K,Husain S,Kreindler JL,Dubin PJ,Pilewski JM,Myerburg MM,Mason CA,Iwakura Y,Kolls JK	GSE10240	GSE10240_2954_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in primary bronchial epithelial cells: control versus stimulated with IL17A and IL22 [GeneID=3605;50616].	Primary HBE cells were stimulated with IL-22 and IL-17, and gene expression was studied using an Affymetrix platform microarray, in order to investigate which genes may be upregulated or downregulated in response to these cytokines. Of particular interest was the host defense genes such as antimicrobial peptides, which have been shown to be upregulated by IL-22 and IL-17 in skin keratinocytes.					55635	55320	402	8140	9787	973	84930	701	9904	55174	64420	9833	51176	1164	79810	23589	22868	387103	257160	4128	133690	348654	93436	10467	25962	8549	202051	81929	56926	133121	391356	4595	90639	151556	28951	23397	2972	11065	3543	78990	84986	3725	161882	348235	10102	84824	134218	5133	7503	26751	10393	146956	55270	1059	2162	126299	51110	171425	55247	381	1644	55367	58528	886	57045	150468	6446	9546	55884	340277	6794	26515	90417	84288	220323	25902	6319	347733	10667	6597	8243	142679	54	25980	26151	28834	4149	23321	25776	388722	10587	1676	441478	22934	3667	80755	3655	5429	79135	2733	81602	1955	10785	25906	5359	56948	112950	114792	5550	406	26576	29899	51400	255809	51538	10460	55869	221908	10061	219623	26608	54878	11004	55068	11017	896	7272	54855	122769	586	10186	9700	7332	4891	9183	81930	11284	55775	220134	51008	10797	64419	26504	9793	79078	60468	581	10553	55844	683	126731	55143	952	90865	833	8318	57107	1647	1368	22800	10078	11164	51124	157570	51241	55706	79019	6689	28974	64080	64410	7284	54853	91442	991	55157	79971	10814	55954	79098	7268	2395	57129	55617	3008	5553	51734	51296	9674	147841	10615	55026	401251	23366	55504	3396	219	79733	54793	11266
GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN	M304		18264110	Aujla SJ,Chan YR,Zheng M,Fei M,Askew DJ,Pociask DA,Reinhart TA,McAllister F,Edeal J,Gaus K,Husain S,Kreindler JL,Dubin PJ,Pilewski JM,Myerburg MM,Mason CA,Iwakura Y,Kolls JK	GSE10240	GSE10240_2954_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in primary bronchial epithelial cells: control versus stimulated with IL17A and IL22 [GeneID=3605;50616].	Primary HBE cells were stimulated with IL-22 and IL-17, and gene expression was studied using an Affymetrix platform microarray, in order to investigate which genes may be upregulated or downregulated in response to these cytokines. Of particular interest was the host defense genes such as antimicrobial peptides, which have been shown to be upregulated by IL-22 and IL-17 in skin keratinocytes.					1524	23397	271	6581	4208	1182	8914	9170	146057	51363	80020	142	3543	4619	439921	7029	10625	9700	6271	55365	400916	488	5121	5424	2549	23097	23456	84307	79924	3875	1111	55388	56919	5890	2004	140901	22837	2272	10970	55692	1153	4001	3835	10481	122953	79573	6850	26086	22836	115207	9555	10630	50515	3099	8725	8019	1719	23328	1510	4851	595	85440	5948	6241	9319	79098	9329	23362	9663	6586	23400	1026	55143	157313	23258	3205	51754	51380	5467	575	348980	55732	6599	860	80312	9639	79705	92579	79019	863	114804	1307	220002	85477	11251	1501	150468	23361	56834	22929	6345	54407	9820	3868	55839	6257	23468	60412	126299	5981	5581	84617	4153	23294	9829	7919	57705	28959	79709	10410	162979	9963	10656	1839	9203	59274	83461	29904	10155	348235	114987	84445	79813	80000	7158	6334	782	64770	65108	1184	64123	55250	9647	54799	85460	339983	401138	1777	9493	30815	586	5064	10409	165055	55971	27	85463	388	8495	22937	79012	9156	1040	3192	9734	4128	116362	92312	57576	57492	7072	29128	23136	10615	961	113130	168417	84733	3015	1439	51776	3033	57048	57465	153579	57584	116840	23149	4238	26019	1523	53335	57597	85457	4602	8848	144100	11142	128025	9333
GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP	M306		18264110	Aujla SJ,Chan YR,Zheng M,Fei M,Askew DJ,Pociask DA,Reinhart TA,McAllister F,Edeal J,Gaus K,Husain S,Kreindler JL,Dubin PJ,Pilewski JM,Myerburg MM,Mason CA,Iwakura Y,Kolls JK	GSE10240	GSE10240_2956_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in primary bronchial epithelial cells stimulated with: IL22 [GeneID=50616] versus IL17A and IL22 [GeneID=3605;50616].	Primary HBE cells were stimulated with IL-22 and IL-17, and gene expression was studied using an Affymetrix platform microarray, in order to investigate which genes may be upregulated or downregulated in response to these cytokines. Of particular interest was the host defense genes such as antimicrobial peptides, which have been shown to be upregulated by IL-22 and IL-17 in skin keratinocytes.					23095	2319	26133	1039	1676	1521	54834	92196	22984	55647	8694	51241	93100	6048	283234	126282	916	5998	158219	23270	475	7284	3664	57184	9456	84230	5062	51092	29959	8111	55788	728621	131450	138307	55636	3726	54541	27111	22868	9546	9637	25962	118	63892	89849	5970	147015	8507	8681	84174	926	1112	9736	55954	3565	3669	3008	6892	128977	10067	79720	259230	51150	139716	8625	9427	2583	8916	116151	56648	54464	3958	27128	84614	923	11017	226	5167	4891	10073	11046	22848	161882	581	11069	9466	23626	56829	8812	1536	7297	9325	10717	1269	6689	54785	54065	113263	375056	7293	541565	9183	84969	50649	3123	80709	5243	10808	80219	6275	639	152519	146923	8717	79695	55248	10947	51400	28988	23645	5564	51124	83862	6309	513	3003	53916	51538	4308	94103	1455	171425	283131	154141	9553	7077	10486	25928	2166	5641	55884	338596	79780	1613	56605	79034	283537	84159	126432	57720	4696	604	3559	53347	27095	1235	65095	7186	199990	9071	4907	10587	10219	6404	2034	10538	9411	57591	79887	9842	9857	8821	29957	26515	64750	7498	1893	57099	23344	10723	79571	79603	381	147807	63940	4201	90135	8837	53827	84232	1644	80012	55568	8786	129401	317662	56052	51232	60468	57154
GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN	M309		18264110	Aujla SJ,Chan YR,Zheng M,Fei M,Askew DJ,Pociask DA,Reinhart TA,McAllister F,Edeal J,Gaus K,Husain S,Kreindler JL,Dubin PJ,Pilewski JM,Myerburg MM,Mason CA,Iwakura Y,Kolls JK	GSE10240	GSE10240_2956_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in primary bronchial epithelial cells stimulated with: IL22 [GeneID=50616] versus IL17A and IL22 [GeneID=3605;50616].	Primary HBE cells were stimulated with IL-22 and IL-17, and gene expression was studied using an Affymetrix platform microarray, in order to investigate which genes may be upregulated or downregulated in response to these cytokines. Of particular interest was the host defense genes such as antimicrobial peptides, which have been shown to be upregulated by IL-22 and IL-17 in skin keratinocytes.					114804	1839	64744	2534	3117	7158	125058	4245	7008	4170	1501	84433	2648	51278	57504	2145	10957	3340	2004	149041	22837	5260	401612	57113	57507	23433	11214	80164	126695	26034	6913	23149	55589	114571	26020	4296	146857	8725	8303	8809	284129	23645	11180	57159	51228	343990	1182	340146	55062	29904	1761	54946	2005	23450	84733	4242	961	7791	3665	56834	3983	7402	4641	10758	10481	84281	23389	388341	147495	192666	60626	4598	56948	23097	113746	1742	23743	79869	389075	4201	85464	6257	142	196403	8848	389336	54852	4208	400451	6232	1339	7975	63891	833	3298	54986	3280	5626	51296	3707	1310	64777	79071	80760	150082	170954	57118	7342	129138	80312	9639	952	1396	23524	10803	59339	126308	393	92312	160622	10018	2019	1455	2100	5305	3676	51466	6865	9618	2022	57513	146183	4335	10580	220002	1267	10039	3223	66004	114879	114876	8733	23544	4050	2701	94241	55971	163479	26145	8945	222487	25780	116028	25865	10642	474344	11251	973	6563	162239	84445	1969	5142	2592	55024	254042	6597	85441	1911	517	9555	57649	64108	341346	8861	366	23400	124935	9781	55824	3543	8681	126299	79834	79670	10724	55803	256329	23294	26051	27120	3123	339105	93185	5880	653319	79659	11277	1107	640
GSE10240_IL22_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN	M310		18264110	Aujla SJ,Chan YR,Zheng M,Fei M,Askew DJ,Pociask DA,Reinhart TA,McAllister F,Edeal J,Gaus K,Husain S,Kreindler JL,Dubin PJ,Pilewski JM,Myerburg MM,Mason CA,Iwakura Y,Kolls JK	GSE10240	GSE10240_2955_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in primary bronchial epithelial cells stimulated with: IL22 [GeneID=50616] versus IL17A [GeneID=3605].	Primary HBE cells were stimulated with IL-22 and IL-17, and gene expression was studied using an Affymetrix platform microarray, in order to investigate which genes may be upregulated or downregulated in response to these cytokines. Of particular interest was the host defense genes such as antimicrobial peptides, which have been shown to be upregulated by IL-22 and IL-17 in skin keratinocytes.					26123	2821	54834	55157	199223	5742	26151	3069	7770	6446	83871	3382	79648	2207	5911	221150	85477	2888	10560	51614	55635	9895	55247	133957	65095	53838	9194	129450	79571	29091	3934	54827	1608	79594	64428	64218	4542	2187	25801	78995	79188	6309	65055	27095	10350	1269	84376	10787	497189	3590	10420	54187	4152	2892	8318	22928	116379	51375	708	80219	55425	10257	23236	54433	56521	79959	2040	112950	60682	123	10184	91056	65065	51188	154791	137695	9069	256356	25788	162681	64420	79918	10615	57465	57169	51061	81555	1990	5130	152503	219623	387103	117154	26003	5937	1116	64080	11200	6731	80305	388581	152559	2717	257160	7485	1676	5800	146923	51302	2281	29957	151011	2065	9325	1439	1832	125488	4038	10553	54793	9658	90639	79961	205	283131	253430	1408	127687	56667	1337	150737	7498	220323	115201	9819	7036	26504	199857	390637	84057	255758	79156	22936	55320	343099	119710	2180	84986	533	51124	757	55226	1512	118881	51460	65123	84668	92597	9904	27333	55652	50814	1488	79944	51241	4616	55145	122769	55970	8940	55174	55884	90417	51776	29127	692205	51250	9857	1352	84930	7280	7412	85019	2589	3674	79029	5756	1991	79810	10217	9818	1540	6590	527	90273	25938	166012	55869	2730	1241
GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN	M312		18264110	Aujla SJ,Chan YR,Zheng M,Fei M,Askew DJ,Pociask DA,Reinhart TA,McAllister F,Edeal J,Gaus K,Husain S,Kreindler JL,Dubin PJ,Pilewski JM,Myerburg MM,Mason CA,Iwakura Y,Kolls JK	GSE10240	GSE10240_2957_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in primary bronchial epithelial cells stimulated with: IL17A [GeneID=50616] versus IL17A and IL22 [GeneID=3605;50616].	Primary HBE cells were stimulated with IL-22 and IL-17, and gene expression was studied using an Affymetrix platform microarray, in order to investigate which genes may be upregulated or downregulated in response to these cytokines. Of particular interest was the host defense genes such as antimicrobial peptides, which have been shown to be upregulated by IL-22 and IL-17 in skin keratinocytes.					8914	5029	401138	4619	1534	92126	221262	5094	284001	10180	127255	53635	9056	6581	23362	83648	3643	57513	56649	51634	5948	55825	80020	1969	22836	608	10661	9639	6913	1501	126299	6510	10642	340348	10297	4292	949	57805	389336	23008	91694	166614	23518	114548	1777	51236	3759	10481	124935	79922	8945	7867	92092	28981	23682	3875	55586	27	23047	1741	9170	57649	85463	22937	201164	2022	51363	341346	57613	160140	6586	51195	9788	143903	155060	79012	5626	81621	4258	165055	7345	3543	23544	91807	11142	221184	91543	114876	4245	57631	5546	343637	6334	2099	6261	10277	3141	5334	552889	9734	55971	80312	10152	8622	6311	6272	30849	11041	6915	84247	3567	55605	93594	55250	389075	3762	64699	203190	55315	26022	5547	10970	54413	21	9899	146857	6431	6925	10298	116362	84518	2475	51776	57048	23395	863	220965	23158	9182	7941	63934	10217	761	144100	51409	5064	114793	6601	1742	58158	6385	57465	51686	10100	79659	152877	5007	55901	90427	645426	55764	3575	94235	8019	1154	126695	55604	114112	114783	134218	5469	151742	54865	1647	29802	57113	79718	55692	2909	9569	3172	2356	157	1612	56667	6935	8491	29941	1839	57159	26998	1523	79598	366	5973	973	7088	219899	27242	6865
GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP	M313		18264110	Aujla SJ,Chan YR,Zheng M,Fei M,Askew DJ,Pociask DA,Reinhart TA,McAllister F,Edeal J,Gaus K,Husain S,Kreindler JL,Dubin PJ,Pilewski JM,Myerburg MM,Mason CA,Iwakura Y,Kolls JK	GSE10240	GSE10240_2957_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in primary bronchial epithelial cells stimulated with: IL17A [GeneID=50616] versus IL17A and IL22 [GeneID=3605;50616].	Primary HBE cells were stimulated with IL-22 and IL-17, and gene expression was studied using an Affymetrix platform microarray, in order to investigate which genes may be upregulated or downregulated in response to these cytokines. Of particular interest was the host defense genes such as antimicrobial peptides, which have been shown to be upregulated by IL-22 and IL-17 in skin keratinocytes.					157680	23270	57698	79089	79747	283537	128977	4149	116151	9842	8111	2072	23012	65979	10078	23475	6645	9656	7297	8812	54919	55184	11017	56172	1955	256380	8681	84254	83463	54497	51365	2187	6892	8463	79899	54834	7016	3008	10628	55157	23132	283129	55450	54785	10641	348654	10717	80305	55600	81929	8625	55902	6844	4783	26151	54464	93100	171425	57820	93436	9978	4595	152485	157570	79961	576	54521	9456	55187	4318	55359	79777	7799	84792	53827	9898	65010	7798	3903	57169	8867	8737	10865	55367	5890	11033	439921	30061	54855	64750	389	54758	533	54878	2885	127687	11092	1524	8842	11060	333929	752	84197	10307	118	79810	23312	10752	55884	57184	9256	54840	8744	154791	64420	51101	3636	144699	56254	5218	9260	6720	221002	9545	64428	8515	79658	51150	2306	220134	83862	79780	1039	3801	23095	6671	134728	5977	80219	29940	83988	152579	5429	126119	51296	84286	146760	29933	27128	80853	257160	201163	80346	10910	9232	6653	389941	3104	93517	79768	63916	4001	10302	55625	78995	7409	3434	146909	26996	5294	8940	29899	51614	283464	151246	57580	27347	79746	56829	2358	5252	91947	8544	2669	148304	114826	90550	59345	388569	84085	54793	90135	5911	84668	54762	115290	4023	7186	11284	83938
GSE8685_IL2_STARVED_VS_IL2_ACT_IL2_STARVED_CD4_TCELL_UP	M324		18281483	Marzec M,Halasa K,Kasprzycka M,Wysocka M,Liu X,Tobias JW,Baldwin D,Zhang Q,Odum N,Rook AH,Wasik MA	GSE8685	GSE8685_3173_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in Sez-2 cells (T cell lymphoma): untreated versus IL2 [GeneID=3558].	In this study we compared the effects of IL-2, IL-15, and IL-21 on the gene expression, activation of cell signaling pathways, and functional properties of cells derived from the CD4+ cutaneous T-cell lymphoma (CTCL). Whereas both IL-2 and IL-15 that signal through receptors that share the common gamma chain and the beta chain modulated the expression of >1,000 genes, IL-21 that signals via the receptor also containing gamma chain up-regulated <40 genes. All three cytokines induced tyrosine phosphorylation of Jak1 and Jak3. However, only IL-2 and IL-15 strongly activated STAT5, PI3K/Akt, and MEK/ERK signaling pathways. In contrast, IL-21 selectively activated STAT3. Whereas all three cytokines protected CTCL cells from apoptosis, only IL-2 and IL-15 promoted their proliferation. The effects of the cytokine stimulation were Jak3- and Jak1-kinase dependent. These findings document the vastly different impact of IL-2 and IL-15 vs. IL-21 on malignant CD4+ T cells. They also suggest two novel therapeutic approaches to CTCL and, possibly, other CD4+ T cell lymphomas: inhibition of the Jak1/Jak3 kinase complex and, given the known strong immunostimulatory properties of IL-21 on CD8+ T, NK, and B cells, application of this cytokine to boost an immune response against malignant CD4+ T cells.					2149	57154	81704	23765	55129	84759	6753	4793	84340	2582	25949	5883	51763	57515	139716	6252	6804	26140	54863	11047	79834	55191	63891	284129	92558	55593	256329	3669	11214	8204	3429	246175	1791	10980	152007	51130	11236	123263	3783	79603	55727	64744	127262	3700	56904	686	6905	56063	272	355	23205	59067	157680	51016	494470	115950	51742	3985	23412	57140	4643	207	9975	51606	10801	79003	55135	55213	7376	283234	11184	8568	84954	91612	65258	50615	79443	155435	10488	1326	2314	4752	23360	9788	79735	3767	65997	80055	196264	51374	19	29086	553115	661	114799	23344	29101	27327	28958	116151	157285	23759	3123	55336	6433	23214	94059	55647	112	5924	79780	340533	5912	79159	79626	4063	81532	6891	4690	5297	7293	63892	257068	257106	84941	51019	92400	753	50650	5430	79720	30011	51735	5272	4701	80306	123803	338692	54861	219681	7186	7553	79777	80012	28955	5834	6610	1936	3660	64343	23731	5710	26277	9265	64224	254295	1739	10079	64745	221895	84246	50619	375056	3059	1613	29103	8625	93100	26136	3954	83999	51111	9136	11334	230	581	55152	3559	88	728392	962	10332	22848	3996	51000	166793	23225	5533	6284	124583	50484	4201	326624	122060	79711	144097	10924	2664	3241	3565
GSE8685_IL2_STARVED_VS_IL2_ACT_IL2_STARVED_CD4_TCELL_DN	M325		18281483	Marzec M,Halasa K,Kasprzycka M,Wysocka M,Liu X,Tobias JW,Baldwin D,Zhang Q,Odum N,Rook AH,Wasik MA	GSE8685	GSE8685_3173_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in Sez-2 cells (T cell lymphoma): untreated versus IL2 [GeneID=3558].	In this study we compared the effects of IL-2, IL-15, and IL-21 on the gene expression, activation of cell signaling pathways, and functional properties of cells derived from the CD4+ cutaneous T-cell lymphoma (CTCL). Whereas both IL-2 and IL-15 that signal through receptors that share the common gamma chain and the beta chain modulated the expression of >1,000 genes, IL-21 that signals via the receptor also containing gamma chain up-regulated <40 genes. All three cytokines induced tyrosine phosphorylation of Jak1 and Jak3. However, only IL-2 and IL-15 strongly activated STAT5, PI3K/Akt, and MEK/ERK signaling pathways. In contrast, IL-21 selectively activated STAT3. Whereas all three cytokines protected CTCL cells from apoptosis, only IL-2 and IL-15 promoted their proliferation. The effects of the cytokine stimulation were Jak3- and Jak1-kinase dependent. These findings document the vastly different impact of IL-2 and IL-15 vs. IL-21 on malignant CD4+ T cells. They also suggest two novel therapeutic approaches to CTCL and, possibly, other CD4+ T cell lymphomas: inhibition of the Jak1/Jak3 kinase complex and, given the known strong immunostimulatory properties of IL-21 on CD8+ T, NK, and B cells, application of this cytokine to boost an immune response against malignant CD4+ T cells.					85294	348995	26003	100188893	90102	55723	8237	140707	2539	166968	390594	78995	890	221150	3615	146956	1660	2568	26056	221830	79694	79019	4211	117178	637	51429	55159	9218	57465	50854	1441	4869	10389	2519	55486	56890	221955	23087	2530	9616	339230	1479	55151	7358	23649	286128	80820	152503	80169	119710	11160	55320	63901	3612	221322	391059	1991	11103	10483	56986	217	2672	343099	158747	54805	4751	375316	999	26064	2595	10615	4534	1786	3292	6103	79632	219699	5108	3838	22928	11010	29127	8914	5558	222659	6715	200407	79621	25885	79691	6809	9555	7369	51754	7298	3590	25788	10257	3419	10855	3658	150468	2766	26586	221184	23753	220323	96459	6666	57670	6581	10933	2187	5598	26135	3069	8539	7468	124976	58486	3192	26802	5599	27309	2762	283742	4946	8091	10613	55055	23198	3554	55314	221223	22920	4756	29071	374470	6240	9871	53346	776	1317	1736	8518	5176	339983	9415	91057	22845	4313	25921	8556	116064	145645	8420	64798	155060	4734	255488	92912	157313	23102	2806	178	55286	768211	123169	55635	58478	2730	51082	5147	60592	79174	3600	55663	1793	114804	8099	10250	79886	1211	1622	3837	64858	54974	8754	64755	8927	10001	7086	3382	81688	9846	157570	22929	7458	5570	51747
GSE8685_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP	M326		18281483	Marzec M,Halasa K,Kasprzycka M,Wysocka M,Liu X,Tobias JW,Baldwin D,Zhang Q,Odum N,Rook AH,Wasik MA	GSE8685	GSE8685_3174_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in Sez-2 cells (T cell lymphoma): untreated versus IL5 [GeneID=3567].	In this study we compared the effects of IL-2, IL-15, and IL-21 on the gene expression, activation of cell signaling pathways, and functional properties of cells derived from the CD4+ cutaneous T-cell lymphoma (CTCL). Whereas both IL-2 and IL-15 that signal through receptors that share the common gamma chain and the beta chain modulated the expression of >1,000 genes, IL-21 that signals via the receptor also containing gamma chain up-regulated <40 genes. All three cytokines induced tyrosine phosphorylation of Jak1 and Jak3. However, only IL-2 and IL-15 strongly activated STAT5, PI3K/Akt, and MEK/ERK signaling pathways. In contrast, IL-21 selectively activated STAT3. Whereas all three cytokines protected CTCL cells from apoptosis, only IL-2 and IL-15 promoted their proliferation. The effects of the cytokine stimulation were Jak3- and Jak1-kinase dependent. These findings document the vastly different impact of IL-2 and IL-15 vs. IL-21 on malignant CD4+ T cells. They also suggest two novel therapeutic approaches to CTCL and, possibly, other CD4+ T cell lymphomas: inhibition of the Jak1/Jak3 kinase complex and, given the known strong immunostimulatory properties of IL-21 on CD8+ T, NK, and B cells, application of this cytokine to boost an immune response against malignant CD4+ T cells.					88745	79009	10175	23327	3716	5744	378938	7352	2625	79922	51374	684	339390	85315	3664	10606	10199	55208	526	114799	5293	37	192286	6915	3301	9427	25897	10360	9869	10379	6307	60672	375387	28959	51643	5094	6518	3156	29062	285636	79165	84987	26270	29085	1741	64135	9637	23190	1183	79693	5908	100499467	6935	2098	85302	3202	5216	55151	60436	140609	401466	84134	140707	56255	55687	163590	8897	9049	84950	26130	10640	117286	8850	622	55729	28974	22820	25851	55146	151742	7277	220382	1630	6400	80314	4942	1209	115817	10482	4145	56259	1152	3433	2248	5315	2887	5720	81890	23613	100506562	7402	6670	4331	29066	926	374407	1616	55229	65012	2859	81545	65265	6289	132720	5356	2166	55284	5274	7293	3434	10623	6210	54558	597	5203	23645	163882	57511	55017	1739	9324	26523	23360	8887	6181	284058	4780	27101	5651	10390	54904	10051	26511	56160	84329	10553	152877	54942	9831	79846	117246	1112	9130	822	100287932	203522	6875	26224	27243	10427	158	66005	55256	1212	55969	55619	8611	2181	64801	11162	1803	27097	6304	9672	25917	5173	676	56681	51185	10670	5578	7257	83606	23099	51759	51125	9725	84897	54899	120	57332	10641	374395	84435	26228	84267	283571	343472	1791	27341
GSE8685_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_DN	M327		18281483	Marzec M,Halasa K,Kasprzycka M,Wysocka M,Liu X,Tobias JW,Baldwin D,Zhang Q,Odum N,Rook AH,Wasik MA	GSE8685	GSE8685_3174_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in Sez-2 cells (T cell lymphoma): untreated versus IL5 [GeneID=3567].	In this study we compared the effects of IL-2, IL-15, and IL-21 on the gene expression, activation of cell signaling pathways, and functional properties of cells derived from the CD4+ cutaneous T-cell lymphoma (CTCL). Whereas both IL-2 and IL-15 that signal through receptors that share the common gamma chain and the beta chain modulated the expression of >1,000 genes, IL-21 that signals via the receptor also containing gamma chain up-regulated <40 genes. All three cytokines induced tyrosine phosphorylation of Jak1 and Jak3. However, only IL-2 and IL-15 strongly activated STAT5, PI3K/Akt, and MEK/ERK signaling pathways. In contrast, IL-21 selectively activated STAT3. Whereas all three cytokines protected CTCL cells from apoptosis, only IL-2 and IL-15 promoted their proliferation. The effects of the cytokine stimulation were Jak3- and Jak1-kinase dependent. These findings document the vastly different impact of IL-2 and IL-15 vs. IL-21 on malignant CD4+ T cells. They also suggest two novel therapeutic approaches to CTCL and, possibly, other CD4+ T cell lymphomas: inhibition of the Jak1/Jak3 kinase complex and, given the known strong immunostimulatory properties of IL-21 on CD8+ T, NK, and B cells, application of this cytokine to boost an immune response against malignant CD4+ T cells.					4794	29940	220988	84696	4643	157570	89781	348793	689	3624	9097	130814	126526	6650	2937	388569	6337	5911	113878	8693	160	10152	339448	9088	5066	1201	27010	26259	2720	1131	22878	286128	9488	25992	7398	56256	254359	202333	286075	521	8454	85294	102	54535	5881	7535	54891	2908	283446	2548	7516	89887	7170	6093	6137	57019	9823	4603	23218	29799	55631	23243	1558	10949	4756	256364	55611	644353	10245	79627	5295	124997	55359	11344	23038	5255	29882	463	682	80346	51747	2185	124930	91947	140901	1524	10287	55184	84912	78995	1153	55746	90843	84307	6749	2049	80139	79576	727800	7079	2833	4110	5318	55561	7064	51594	64419	7371	23626	8832	25873	6256	147906	1690	114781	29899	5250	9046	79145	83463	348262	1719	1503	197259	143888	9963	9260	1293	9047	2206	114876	2931	63916	7322	9184	1437	84905	56704	23385	123016	8189	1465	121457	56890	57178	10320	10210	283237	5870	2004	3705	27173	9166	9344	79034	122970	125061	55356	153562	54621	5198	79718	145567	5890	80169	10394	51232	22916	4595	51307	3815	8648	23281	9027	51280	51117	10815	4715	26469	55766	7165	389	23240	10804	474381	26586	9868	84163	8754	23232	9830	26525	8743	1500	1438	4191	10498	84085	7468	1730
GSE8685_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP	M328		18281483	Marzec M,Halasa K,Kasprzycka M,Wysocka M,Liu X,Tobias JW,Baldwin D,Zhang Q,Odum N,Rook AH,Wasik MA	GSE8685	GSE8685_3175_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in Sez-2 cells (T cell lymphoma): untreated versus IL21 [GeneID=59067].	In this study we compared the effects of IL-2, IL-15, and IL-21 on the gene expression, activation of cell signaling pathways, and functional properties of cells derived from the CD4+ cutaneous T-cell lymphoma (CTCL). Whereas both IL-2 and IL-15 that signal through receptors that share the common gamma chain and the beta chain modulated the expression of >1,000 genes, IL-21 that signals via the receptor also containing gamma chain up-regulated <40 genes. All three cytokines induced tyrosine phosphorylation of Jak1 and Jak3. However, only IL-2 and IL-15 strongly activated STAT5, PI3K/Akt, and MEK/ERK signaling pathways. In contrast, IL-21 selectively activated STAT3. Whereas all three cytokines protected CTCL cells from apoptosis, only IL-2 and IL-15 promoted their proliferation. The effects of the cytokine stimulation were Jak3- and Jak1-kinase dependent. These findings document the vastly different impact of IL-2 and IL-15 vs. IL-21 on malignant CD4+ T cells. They also suggest two novel therapeutic approaches to CTCL and, possibly, other CD4+ T cell lymphomas: inhibition of the Jak1/Jak3 kinase complex and, given the known strong immunostimulatory properties of IL-21 on CD8+ T, NK, and B cells, application of this cytokine to boost an immune response against malignant CD4+ T cells.					221472	8914	1654	81550	445	5106	1111	150962	132299	51441	3570	63934	50854	4998	84247	3842	10605	54503	23008	55663	214	85365	79096	643008	8548	6194	5730	599	81890	2073	1728	54899	3590	27067	5007	9056	23236	53919	2672	79072	115	22843	23095	55226	6742	1191	10800	23087	23198	4247	27235	54891	3658	84524	159	2356	100506742	30061	9611	72	221092	9869	144165	55718	9129	482	7458	143098	5902	23518	1362	8323	8706	8846	85302	10591	30968	2762	152559	9734	10282	4361	79876	54816	5586	22994	29066	27333	55103	734	7390	221184	84699	1950	178	8780	1432	4009	6102	401548	338773	116236	29886	132320	613	84100	92092	6599	285753	2539	79567	1269	11022	255488	4258	196527	29929	2717	473	154807	23654	8496	55286	5993	55922	27042	339983	9559	9824	58486	6427	79846	117178	4939	4292	4055	56994	1954	348995	9532	5129	7106	10184	79831	52	51601	7163	54517	9256	64077	11200	60506	1974	79956	57685	54475	8100	5599	6581	11166	27090	5836	56919	79869	1369	9218	57579	10128	4869	11107	11159	9411	5095	51031	3643	2651	10813	9221	6431	7050	9134	22858	8451	23527	7690	5973	51076	10651	145508	81622	2790	152189	9406	94104	6676	4189	23360	60492	7257	1429
GSE8685_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN	M330		18281483	Marzec M,Halasa K,Kasprzycka M,Wysocka M,Liu X,Tobias JW,Baldwin D,Zhang Q,Odum N,Rook AH,Wasik MA	GSE8685	GSE8685_3175_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in Sez-2 cells (T cell lymphoma): untreated versus IL21 [GeneID=59067].	In this study we compared the effects of IL-2, IL-15, and IL-21 on the gene expression, activation of cell signaling pathways, and functional properties of cells derived from the CD4+ cutaneous T-cell lymphoma (CTCL). Whereas both IL-2 and IL-15 that signal through receptors that share the common gamma chain and the beta chain modulated the expression of >1,000 genes, IL-21 that signals via the receptor also containing gamma chain up-regulated <40 genes. All three cytokines induced tyrosine phosphorylation of Jak1 and Jak3. However, only IL-2 and IL-15 strongly activated STAT5, PI3K/Akt, and MEK/ERK signaling pathways. In contrast, IL-21 selectively activated STAT3. Whereas all three cytokines protected CTCL cells from apoptosis, only IL-2 and IL-15 promoted their proliferation. The effects of the cytokine stimulation were Jak3- and Jak1-kinase dependent. These findings document the vastly different impact of IL-2 and IL-15 vs. IL-21 on malignant CD4+ T cells. They also suggest two novel therapeutic approaches to CTCL and, possibly, other CD4+ T cell lymphomas: inhibition of the Jak1/Jak3 kinase complex and, given the known strong immunostimulatory properties of IL-21 on CD8+ T, NK, and B cells, application of this cytokine to boost an immune response against malignant CD4+ T cells.					1785	56980	4793	10840	9655	9877	384	286205	10953	9855	338692	55755	6830	1039	29980	388341	5463	5979	3665	23271	84626	83938	207	79089	9172	138162	8733	57182	254263	7571	3985	1911	24142	9842	51665	55135	4907	1690	55898	9135	11021	10982	7799	84065	64766	1519	2306	255231	3096	4318	84792	6142	8435	6820	124997	54460	9860	55630	91523	6522	79003	23295	4796	6139	5428	3955	11284	64420	3636	1465	126549	64110	89941	8463	55230	2051	1455	29765	1652	285782	123096	5775	25962	57787	113277	4296	6461	11234	94031	124936	6137	373863	146434	54531	128977	374407	8625	6301	55257	23492	7170	6175	6720	347733	23270	6645	115950	11309	89887	2023	55916	25950	125206	7047	55281	54492	23397	1663	5608	26149	8111	10523	11059	92335	64855	4598	23216	219855	55695	256987	84464	401551	54812	221927	144233	5529	55636	55600	439	57062	55359	89846	129685	23475	57185	2824	254065	222166	83463	54602	3959	153129	55336	8189	152007	9910	1120	2313	27433	8934	3091	2767	29799	9663	158135	2004	576	51070	55851	29940	439921	8681	7520	2914	9146	9382	283537	120	1855	55727	10078	7186	3304	84519	254359	8527	23043	55374	9887	26272	9728	84867	51447	22872	163486	10326	54093	5605	4701	2028
GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP	M331		18281483	Marzec M,Halasa K,Kasprzycka M,Wysocka M,Liu X,Tobias JW,Baldwin D,Zhang Q,Odum N,Rook AH,Wasik MA	GSE8685	GSE8685_3176_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in Sez-2 cells (T cell lymphoma): untreated versus IL15 [GeneID=3600].	In this study we compared the effects of IL-2, IL-15, and IL-21 on the gene expression, activation of cell signaling pathways, and functional properties of cells derived from the CD4+ cutaneous T-cell lymphoma (CTCL). Whereas both IL-2 and IL-15 that signal through receptors that share the common gamma chain and the beta chain modulated the expression of >1,000 genes, IL-21 that signals via the receptor also containing gamma chain up-regulated <40 genes. All three cytokines induced tyrosine phosphorylation of Jak1 and Jak3. However, only IL-2 and IL-15 strongly activated STAT5, PI3K/Akt, and MEK/ERK signaling pathways. In contrast, IL-21 selectively activated STAT3. Whereas all three cytokines protected CTCL cells from apoptosis, only IL-2 and IL-15 promoted their proliferation. The effects of the cytokine stimulation were Jak3- and Jak1-kinase dependent. These findings document the vastly different impact of IL-2 and IL-15 vs. IL-21 on malignant CD4+ T cells. They also suggest two novel therapeutic approaches to CTCL and, possibly, other CD4+ T cell lymphomas: inhibition of the Jak1/Jak3 kinase complex and, given the known strong immunostimulatory properties of IL-21 on CD8+ T, NK, and B cells, application of this cytokine to boost an immune response against malignant CD4+ T cells.					7529	3908	4215	55521	146712	10225	26005	831	55230	51061	63894	26284	7316	57198	1646	26034	37	56548	23272	254359	56658	6650	55108	84167	65983	84307	10097	333929	84133	6483	7461	23268	80177	23224	150365	23526	122042	80790	2052	8085	9043	5790	2683	3720	5160	53346	1314	256380	53838	5163	79695	9275	51290	7074	57210	23152	63940	57583	254042	112939	55198	81858	29933	22882	6197	3434	7716	6563	65010	5121	25977	23225	9128	10523	59307	91748	81553	80821	5223	64108	23093	4794	25809	83666	22980	57552	2720	729991	84529	6314	130399	7444	5732	8994	3815	257169	3622	9770	1960	26088	65258	64799	64760	79865	84941	84163	140738	342371	144348	221150	53831	6890	87	3732	637	196463	65005	384	29882	9013	51011	56731	9380	57402	6936	122970	6834	55591	23193	84519	22877	9437	8993	84811	116985	2212	5252	79894	10482	9124	79016	57504	126308	401612	51239	441168	90799	81671	4170	26503	114800	374407	51379	8776	8906	79574	54437	115207	9674	8943	643965	339829	55218	9296	57492	9686	388228	11107	9501	896	55072	79754	6711	153129	8763	9138	57140	6203	137994	57655	27347	23439	90990	23660	2206	9240	57805	57186	139818	220107	3297	8693	54795	27243	65990	85441	26873	10868	63910	223117
GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_DN	M332		18281483	Marzec M,Halasa K,Kasprzycka M,Wysocka M,Liu X,Tobias JW,Baldwin D,Zhang Q,Odum N,Rook AH,Wasik MA	GSE8685	GSE8685_3176_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in Sez-2 cells (T cell lymphoma): untreated versus IL15 [GeneID=3600].	In this study we compared the effects of IL-2, IL-15, and IL-21 on the gene expression, activation of cell signaling pathways, and functional properties of cells derived from the CD4+ cutaneous T-cell lymphoma (CTCL). Whereas both IL-2 and IL-15 that signal through receptors that share the common gamma chain and the beta chain modulated the expression of >1,000 genes, IL-21 that signals via the receptor also containing gamma chain up-regulated <40 genes. All three cytokines induced tyrosine phosphorylation of Jak1 and Jak3. However, only IL-2 and IL-15 strongly activated STAT5, PI3K/Akt, and MEK/ERK signaling pathways. In contrast, IL-21 selectively activated STAT3. Whereas all three cytokines protected CTCL cells from apoptosis, only IL-2 and IL-15 promoted their proliferation. The effects of the cytokine stimulation were Jak3- and Jak1-kinase dependent. These findings document the vastly different impact of IL-2 and IL-15 vs. IL-21 on malignant CD4+ T cells. They also suggest two novel therapeutic approaches to CTCL and, possibly, other CD4+ T cell lymphomas: inhibition of the Jak1/Jak3 kinase complex and, given the known strong immunostimulatory properties of IL-21 on CD8+ T, NK, and B cells, application of this cytokine to boost an immune response against malignant CD4+ T cells.					5147	7390	26230	53834	31	6198	4306	5176	1026	4040	80823	310	9389	7058	90459	51728	221830	291	23548	79823	375387	4836	23150	3156	7555	55825	5686	23601	7755	29078	60560	10213	4914	55149	8115	55269	2332	10938	91653	221545	56977	51575	56984	83541	7372	10554	26505	3956	10973	81533	29097	23265	7319	5527	1798	253827	10175	2582	113201	56998	4725	1847	30836	220042	57642	11010	81706	10491	84134	4717	387882	93081	79847	10785	339983	6781	3757	55775	51460	873	1644	8318	5733	55163	10527	4831	7056	8436	4330	5337	3727	23636	81542	307	145258	728661	5884	23420	4716	27131	7561	51175	1650	57215	84314	51237	2566	27163	10954	51065	6696	6634	79882	200734	51375	123263	26154	27236	80139	203069	56479	56905	411	3419	80233	114825	23214	1937	11321	55720	8220	55785	900	166378	9665	57863	57473	4711	2653	58505	2591	55120	4724	54969	55860	126328	6611	150290	8570	3001	55486	9788	56943	1990	130612	5318	11101	3674	56647	29911	84259	25907	506	6891	3017	23481	9882	10237	54537	202051	10055	1738	7015	11137	8021	6547	3202	261734	4976	3080	58526	29968	1028	51248	6709	7086	116228	79648	4722	112616	4166	113251	23072	7385	7001	57107	7782	5916	10142	8496
GSE8685_IL2_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP	M333		18281483	Marzec M,Halasa K,Kasprzycka M,Wysocka M,Liu X,Tobias JW,Baldwin D,Zhang Q,Odum N,Rook AH,Wasik MA	GSE8685	GSE8685_3177_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in Sez-2 cells (T cell lymphoma): IL2 [GeneID=3558] versus IL21 [GeneID=59067].	In this study we compared the effects of IL-2, IL-15, and IL-21 on the gene expression, activation of cell signaling pathways, and functional properties of cells derived from the CD4+ cutaneous T-cell lymphoma (CTCL). Whereas both IL-2 and IL-15 that signal through receptors that share the common gamma chain and the beta chain modulated the expression of >1,000 genes, IL-21 that signals via the receptor also containing gamma chain up-regulated <40 genes. All three cytokines induced tyrosine phosphorylation of Jak1 and Jak3. However, only IL-2 and IL-15 strongly activated STAT5, PI3K/Akt, and MEK/ERK signaling pathways. In contrast, IL-21 selectively activated STAT3. Whereas all three cytokines protected CTCL cells from apoptosis, only IL-2 and IL-15 promoted their proliferation. The effects of the cytokine stimulation were Jak3- and Jak1-kinase dependent. These findings document the vastly different impact of IL-2 and IL-15 vs. IL-21 on malignant CD4+ T cells. They also suggest two novel therapeutic approaches to CTCL and, possibly, other CD4+ T cell lymphomas: inhibition of the Jak1/Jak3 kinase complex and, given the known strong immunostimulatory properties of IL-21 on CD8+ T, NK, and B cells, application of this cytokine to boost an immune response against malignant CD4+ T cells.					1471	145226	152007	83986	6801	3015	55283	255626	9324	1362	9525	5027	10803	4597	9308	56925	83903	4697	8439	91947	256987	10160	4088	9144	29097	960	4783	54331	10217	10075	4771	7871	2146	4085	8487	5890	29980	10330	1870	26057	5515	23329	152519	5050	8993	83943	5578	27244	1175	334	8301	7227	6051	975	2896	4907	54432	93594	5873	23191	1843	10768	390790	5698	54476	9173	168537	157922	55763	84959	157378	3815	4217	5361	23208	9414	6790	79954	55796	5337	117178	64792	339122	6282	91663	55132	4794	57092	57082	10538	8938	201799	9290	5900	9404	84897	5734	23382	399	153339	64781	210	90288	84159	112574	701	10100	117579	79657	3092	9517	153020	101	5476	57045	7410	123	63967	23198	51542	9391	9663	57620	4072	1635	79956	2268	7186	145814	2822	2274	10154	8364	338707	2354	51101	340481	118663	9683	2309	63874	1058	171023	22824	51676	2992	59342	25816	79772	8530	10221	1326	6776	3663	9735	2635	140739	8800	5783	286128	11174	158219	331	10682	80823	55074	523	6646	51540	60	283431	9928	84747
GSE8685_IL2_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN	M335		18281483	Marzec M,Halasa K,Kasprzycka M,Wysocka M,Liu X,Tobias JW,Baldwin D,Zhang Q,Odum N,Rook AH,Wasik MA	GSE8685	GSE8685_3177_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in Sez-2 cells (T cell lymphoma): IL2 [GeneID=3558] versus IL21 [GeneID=59067].	In this study we compared the effects of IL-2, IL-15, and IL-21 on the gene expression, activation of cell signaling pathways, and functional properties of cells derived from the CD4+ cutaneous T-cell lymphoma (CTCL). Whereas both IL-2 and IL-15 that signal through receptors that share the common gamma chain and the beta chain modulated the expression of >1,000 genes, IL-21 that signals via the receptor also containing gamma chain up-regulated <40 genes. All three cytokines induced tyrosine phosphorylation of Jak1 and Jak3. However, only IL-2 and IL-15 strongly activated STAT5, PI3K/Akt, and MEK/ERK signaling pathways. In contrast, IL-21 selectively activated STAT3. Whereas all three cytokines protected CTCL cells from apoptosis, only IL-2 and IL-15 promoted their proliferation. The effects of the cytokine stimulation were Jak3- and Jak1-kinase dependent. These findings document the vastly different impact of IL-2 and IL-15 vs. IL-21 on malignant CD4+ T cells. They also suggest two novel therapeutic approaches to CTCL and, possibly, other CD4+ T cell lymphomas: inhibition of the Jak1/Jak3 kinase complex and, given the known strong immunostimulatory properties of IL-21 on CD8+ T, NK, and B cells, application of this cytokine to boost an immune response against malignant CD4+ T cells.					440073	127550	135228	10577	57448	23556	54502	5166	6242	55824	51302	5132	8814	255022	2977	160492	127002	4240	84440	392862	6909	9595	80312	10149	26207	223082	57701	9972	153830	11178	375775	116224	9143	7267	8809	285704	402665	3003	57097	23286	55750	84925	2965	6894	55	84910	29785	6332	168975	84283	4223	142678	4045	23002	51311	285498	10418	57549	2570	8317	4056	51105	64403	79770	154	51207	114548	58478	54956	164832	26509	117177	63924	3426	29940	25780	9241	80071	2348	54879	81027	94107	116179	3621	23051	440836	1588	340719	27340	51751	26137	81629	1447	80852	10008	55808	23333	56261	85416	51174	7866	201595	7336	23499	1797	81562	51379	7043	203	388931	55035	6843	1293	57162	167681	55226	286410	23613	51701	79158	3643	6518	1018	653121	6489	4222	6414	6687	27042	139189	55703	118424	3824	3418	346689	150696	10663	10880	810
GSE8685_IL15_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP	M337		18281483	Marzec M,Halasa K,Kasprzycka M,Wysocka M,Liu X,Tobias JW,Baldwin D,Zhang Q,Odum N,Rook AH,Wasik MA	GSE8685	GSE8685_3178_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in Sez-2 cells (T cell lymphoma): IL15 [GeneID=3600] versus IL21 [GeneID=3600].	In this study we compared the effects of IL-2, IL-15, and IL-21 on the gene expression, activation of cell signaling pathways, and functional properties of cells derived from the CD4+ cutaneous T-cell lymphoma (CTCL). Whereas both IL-2 and IL-15 that signal through receptors that share the common gamma chain and the beta chain modulated the expression of >1,000 genes, IL-21 that signals via the receptor also containing gamma chain up-regulated <40 genes. All three cytokines induced tyrosine phosphorylation of Jak1 and Jak3. However, only IL-2 and IL-15 strongly activated STAT5, PI3K/Akt, and MEK/ERK signaling pathways. In contrast, IL-21 selectively activated STAT3. Whereas all three cytokines protected CTCL cells from apoptosis, only IL-2 and IL-15 promoted their proliferation. The effects of the cytokine stimulation were Jak3- and Jak1-kinase dependent. These findings document the vastly different impact of IL-2 and IL-15 vs. IL-21 on malignant CD4+ T cells. They also suggest two novel therapeutic approaches to CTCL and, possibly, other CD4+ T cell lymphomas: inhibition of the Jak1/Jak3 kinase complex and, given the known strong immunostimulatory properties of IL-21 on CD8+ T, NK, and B cells, application of this cytokine to boost an immune response against malignant CD4+ T cells.					55970	387707	10451	29841	9465	29126	283777	124540	58480	54832	10099	59307	10006	5451	5033	3024	9687	83658	54434	147991	64747	334	5412	939	178	10410	8501	9824	83540	54567	23239	9468	338785	3738	9830	81855	22936	157378	55741	112744	4607	10825	11200	8897	171023	10077	84282	1788	51542	1959	56895	5873	117579	9709	5089	9290	6385	71	7153	9265	57720	9938	10809	8675	9945	140609	342898	11082	302	3656	256987	3002	1666	4321	11277	8871	389177	29969	23382	6262	317649	3059	5729	255189	1062	8525	727910	9498	81606	120935	10165	9655	3164	6451	5355	129831	5998	23659	64397	79660	6275	404217	51763	6003	84936	4773	152137	8611	54733	27128	5780	340596	80274	115123	1630	23075	5538	84899	2805	165186	79774	831	54331	23097	57560	3588	83541	54960	201633	10507	167691	1536	8546	55143	4354	5452	64395	9144	9683	374354	1734	10678	490	51643	57555	10221	79659	91147	27031	5187	3895	80223	23130	83699	7840	6777	84978	54806	23164	4072	23149
GSE8685_IL15_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN	M338		18281483	Marzec M,Halasa K,Kasprzycka M,Wysocka M,Liu X,Tobias JW,Baldwin D,Zhang Q,Odum N,Rook AH,Wasik MA	GSE8685	GSE8685_3178_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in Sez-2 cells (T cell lymphoma): IL15 [GeneID=3600] versus IL21 [GeneID=3600].	In this study we compared the effects of IL-2, IL-15, and IL-21 on the gene expression, activation of cell signaling pathways, and functional properties of cells derived from the CD4+ cutaneous T-cell lymphoma (CTCL). Whereas both IL-2 and IL-15 that signal through receptors that share the common gamma chain and the beta chain modulated the expression of >1,000 genes, IL-21 that signals via the receptor also containing gamma chain up-regulated <40 genes. All three cytokines induced tyrosine phosphorylation of Jak1 and Jak3. However, only IL-2 and IL-15 strongly activated STAT5, PI3K/Akt, and MEK/ERK signaling pathways. In contrast, IL-21 selectively activated STAT3. Whereas all three cytokines protected CTCL cells from apoptosis, only IL-2 and IL-15 promoted their proliferation. The effects of the cytokine stimulation were Jak3- and Jak1-kinase dependent. These findings document the vastly different impact of IL-2 and IL-15 vs. IL-21 on malignant CD4+ T cells. They also suggest two novel therapeutic approaches to CTCL and, possibly, other CD4+ T cell lymphomas: inhibition of the Jak1/Jak3 kinase complex and, given the known strong immunostimulatory properties of IL-21 on CD8+ T, NK, and B cells, application of this cytokine to boost an immune response against malignant CD4+ T cells.					8814	959	51678	57126	8303	2342	84251	23111	10111	259230	8148	55219	9188	2820	7357	810	23080	29802	84928	125050	80746	7091	57379	9693	151871	94	55109	55341	56181	11137	23113	28951	79720	10419	5611	9788	27284	10813	1468	79573	84951	9836	57677	56910	89792	10014	208	26121	9653	4833	23002	3921	3418	23212	5294	113622	10469	160760	1130	6136	23765	126248	1736	51449	9637	6188	23122	6161	359845	8535	23229	29934	9750	9684	4242	10611	9533	4780	137835	10970	3434	6208	11070	54927	23223	11040	23151	6304	388931	114805	114804	158056	5531	3398	23175	338596	9402	1933	866	8916	6143	920	55198	10412	162394	123036	2150	51805	25998	9391	145567	402415	133522	154	55210	84298	705	81539	402	9761	55647	55127	22929	6414	23588	124359	26589	51809	8703	6696	29929	9394	8602	64750	54661	366	6932	1755	390	79993	10320	64756	157506	55704	399665	64093	9919	6193	29909	10567	10367	25885	23225	55650	8668	387357	506
GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_UP	M344		18310327	Fiorentini S,Riboldi E,Facchetti F,Avolio M,Fabbri M,Tosti G,Becker PD,Guzman CA,Sozzani S,Caruso A	GSE10147	GSE10147_3523_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in plasmacytoid dendritic cells: IL3 [GeneID=3562] versus IL3 [GeneID=3562] and the HIV matrix protein p17.	We used microarrays to detail the global program of gene expression underlying the effect of p17 on human plasmacytoid dendritic cells and was compared to CpG profile.					3709	84144	8867	2976	55775	6652	134728	916	23274	27043	23268	9662	1655	199870	27327	10771	131034	1388	6653	54832	59345	5298	23192	10025	5976	8707	23248	51646	5989	2868	23126	84957	26523	23059	57142	143098	81704	3141	79968	9545	3737	80216	8508	115294	9823	80173	51496	375743	79137	51366	30827	27005	90268	5214	7536	5925	23038	57140	83759	84942	100529141	55699	3423	84961	26284	55704	79777	51098	55773	6262	29952	22870	83548	8898	868	9344	22794	146057	64397	7414	23386	90806	84669	8874	64857	3754	22864	9690	2643	124401	51398	55761	7915	23518	23530	22927	9742	22877	126282	8907	641	5660	201627	8720	1389	22862	4802	51277	23355	55122	11143	404636	23250	51114	58190	23032	57539	1445	11215	8563	9140	54880	11083	127018	752	57704	23067	8451	10207	1384	7029	57542	56979	6792	55296	5924	374659	114804	10493	2802	440603	55256	28981	79932	23133	54537	8708	53944	10067	55578	63908	23387	3636	114885	57521	55808	23163	53373	4285	55696	10267	7260	26033
GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_DN	M345		18310327	Fiorentini S,Riboldi E,Facchetti F,Avolio M,Fabbri M,Tosti G,Becker PD,Guzman CA,Sozzani S,Caruso A	GSE10147	GSE10147_3523_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in plasmacytoid dendritic cells: IL3 [GeneID=3562] versus IL3 [GeneID=3562] and the HIV matrix protein p17.	We used microarrays to detail the global program of gene expression underlying the effect of p17 on human plasmacytoid dendritic cells and was compared to CpG profile.					2780	56902	221935	4725	4948	6147	2253	23210	474344	1152	1612	23175	25924	55303	55329	92154	440435	129807	84941	399823	55187	2256	27345	5589	2018	1163	579	140032	6135	1029	627	146862	347730	90673	712	57110	2197	1301	93099	79414	10544	57167	55698	55316	3925	79136	25759	55214	84836	4647	154661	5603	9628	23484	9478	23231	84168	10076	121256	132158	399474	81029	138050	3746	54869	689	2827	124925	146547	27087	8862	863	25911	161247	140458	7373	2053	2264	5081	4666	401474	8839	84502	1585	7047	60676	112950	8325	23743	6658	6035	83442	54758	115207	93233	6164	6344	10536	9229	333926	6136	57057	5029	23187	84779	55314	22982	197	149951	10457	83878	337	3687	3303	10231	51692	152404	8490	10633	9023	7832	130497	165904	2792	2128	56124	463	116039	7873	27335	83896	5372	22918	148281	84918	1364	2981	9899
GSE10147_IL3_VS_IL3_AND_CPG_STIM_PDC_UP	M348		18310327	Fiorentini S,Riboldi E,Facchetti F,Avolio M,Fabbri M,Tosti G,Becker PD,Guzman CA,Sozzani S,Caruso A	GSE10147	GSE10147_3524_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in plasmacytoid dendritic cells: IL3 [GeneID=3562] versus IL3 [GeneID=3562] and CpG.	We used microarrays to detail the global program of gene expression underlying the effect of p17 on human plasmacytoid dendritic cells and was compared to CpG profile.					9046	7289	115362	114836	2529	196403	645832	55374	64881	5830	9787	9023	340348	163351	112744	1132	56413	84941	2286	729230	11280	4619	5698	89932	3442	125981	699	90102	9934	8560	55370	4868	580	220388	6835	90952	953	54840	53833	115861	84166	343450	3205	25890	54986	23673	3459	54941	5357	23363	134860	4063	639	9390	4778	29851	57084	3135	60675	55016	51475	11145	54843	83989	3688	2697	196	7286	147650	2354	160777	10190	100130742	9704	9771	342898	8728	254827	9683	4066	1850	3800	4753	113130	2805	340596	10054	51293	26033	4689	79132	653808	389177	253769	2833	5455	1571	1240	8881	245972	2952	525	80762	2550	1734	8399	23424	220359	3976	8411	7804	64946	9636	147409	55617	5159	92675	3812	83990	284339	55584	1594	347733	3921	6657	219770	140701	5225	1606	282616	25956	55723	3568	1493	22859	29057	9721	115703	51142	220107	56935	9987
GSE10147_IL3_AND_HIVP17_VS_IL3_AND_CPG_STIM_PDC_DN	M350		18310327	Fiorentini S,Riboldi E,Facchetti F,Avolio M,Fabbri M,Tosti G,Becker PD,Guzman CA,Sozzani S,Caruso A	GSE10147	GSE10147_3525_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in plasmacytoid dendritic cells treated with IL3 [GeneID=3562]: HIV matrix protein p17 versus CpG.	We used microarrays to detail the global program of gene expression underlying the effect of p17 on human plasmacytoid dendritic cells and was compared to CpG profile.					84144	57143	374768	91010	53347	64320	80746	29934	3609	23327	4215	57546	56655	3713	7098	83986	10269	145957	65264	29951	7145	5164	127829	10916	9397	7317	57798	4802	25942	57489	10023	3033	1979	84928	63875	7283	2995	55696	29115	2643	51109	975	93082	359948	57514	10107	84079	84749	54931	23052	4651	79735	64949	23192	29070	79658	80018	51678	686	84445	55734	63897	55824	79616	10603	79595	147463	51280	51523	5025	6723	9500	150465	201266	50	3516	79596	3716	4862	84206	256380	2319	1527	55906	8662	7918	56034	3897	125950	9545	22929	27173	6770	2051	4337	338596	4835	660	51134	5893	1108	675	53354	55593	7124	3588	54957	5447	157378	51155	79699	129685	3292	51647	6992	91368	90007	10121	3992	155368	23389	12	79056	150763	5524	23066	340533	346389	6634	51773	5955	928	57506	80223	217	9524	339896	3932	8629	6016	5741	200312	22934	8826	79709	64756	154	50488	3737	57655	65220
GSE10147_IL3_AND_HIVP17_VS_IL3_AND_CPG_STIM_PDC_UP	M351		18310327	Fiorentini S,Riboldi E,Facchetti F,Avolio M,Fabbri M,Tosti G,Becker PD,Guzman CA,Sozzani S,Caruso A	GSE10147	GSE10147_3525_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in plasmacytoid dendritic cells treated with IL3 [GeneID=3562]: HIV matrix protein p17 versus CpG.	We used microarrays to detail the global program of gene expression underlying the effect of p17 on human plasmacytoid dendritic cells and was compared to CpG profile.					2830	27190	127550	4929	58480	1760	64285	148930	72	84893	200150	10447	125965	701	1368	339906	84525	7088	79858	284612	3913	65124	342898	9046	83638	90060	79885	57554	283385	284451	6355	8740	283869	6389	53347	7407	646658	83844	84522	55617	51350	22808	25937	55074	120227	55588	9124	56895	78989	348174	10461	56155	32	54567	51309	115399	2192	9918	63924	11200	168507	9651	53840	55329	79887	5166	8000	81849	2056	80019	11248	200185	9064	149628	51214	25894	121551	65980	11012	120379	6478	2968	80727	137868	6452	50624	1893	285761	3010	10595	6231	6173	2028	8110	5702	6253	51384	5596	2049	51207	1534	79838	29121	149699	4588	79153	11036	259173	8370	1144	55568	149951	79825	9709	27440	54467	80852	474354	80320	286133	10926	151230	5507	8715	284654	114548	81792	64778	51308	27239	126306	57555	860	56981	8928	3773	60494	654	6171	10550	165186	64781	7555	23189	310	9937	55605	2155	151888	43849
GSE10147_IL3_VS_IL3_AND_CPG_STIM_PDC_DN	M353		18310327	Fiorentini S,Riboldi E,Facchetti F,Avolio M,Fabbri M,Tosti G,Becker PD,Guzman CA,Sozzani S,Caruso A	GSE10147	GSE10147_3524_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in plasmacytoid dendritic cells: IL3 [GeneID=3562] versus IL3 [GeneID=3562] and CpG.	We used microarrays to detail the global program of gene expression underlying the effect of p17 on human plasmacytoid dendritic cells and was compared to CpG profile.					54764	5133	8239	9653	57122	9	80271	9652	27067	23420	9749	9693	5366	27304	9070	55610	55283	311	10664	348235	8517	55218	23588	9068	10486	84269	9975	283742	3631	2653	10844	25950	55614	23452	79065	4173	125950	23365	81857	1477	23355	22897	10190	92017	5361	23137	6397	22835	4651	1725	51428	23595	29062	154043	22927	10797	22920	11172	8659	389668	7879	26037	4642	83986	1454	25822	202243	53354	51780	9896	11102	21	3298	4179	10155	10526	133418	115708	7376	11107	57544	9513	5613	7455	7586	58472	202	6885	23348	5214	9716	29801	10517	4952	117177	4258	55204	83743	27030	6693	51366	92106	51324	55702	2519	140766	10244	84263	10283	64412	83707	9701	9919	8572	51704	9236	257062	5590	5627	91875	3799	56954	26249	201299	89970	54806	92797	2997	203069	4968	2145	285172	388698	55341	3679	150353	5711	4040	10524	11244	2966	3191	10525	155368	1025	26259	54847	151011	79960	84928	22870	8418	25782	4828	58503	64132	84321	25809	9663	1235	55253	301	10449
GSE10500_ARTHRITIC_SYNOVIAL_FLUID_VS_HEALTHY_MACROPHAGE_UP	M358		18345002	Yarilina A,Park-Min KH,Antoniv T,Hu X,Ivashkiv LB	GSE10500	GSE10500_2635_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in macrophages from patients with synovial fluid rheumatoid arthritis versus monocyte-derived macrophages from healthy persons.	Macrophages from RA synovial fluids were compared to primary human blood-derived macrophages.					161582	523	3671	3832	79831	196383	3604	57226	1021	1175	150572	4697	5698	5860	5757	54940	6242	7153	9533	57692	80834	8501	94239	10391	10672	10330	80011	768211	8673	6176	4736	7296	147199	30833	9377	27075	9499	55617	5691	6135	170575	10314	64979	51660	6277	114805	28972	1603	10907	7150	55651	64781	93587	6390	4084	65980	27315	10248	1058	5223	84844	10615	1847	1936	1155	6801	7879	23676	6240	145814	84641	3678	2197	1152	80063	26519	10440	166968	25804	10219	1209	53371	84747	1376	126119	23175	8342	23613	7388	23171	27335	6632	125050	55650	54442	56895	83468	148713	10412	54752	10542	8364	84101	7555	8801	836	10916	6647	79628	9551	83639	2354	3685	2547	245972	6188	8668	79801	1933	79740	7407	3161	29088	1839	1368	4625	4704	3925	33	54836	7071	150771	22917	10232	220988	25864	51434	8869	30001	7884	3587	23471	2353	51665	27351	4597	1978	1802
GSE10500_ARTHRITIC_SYNOVIAL_FLUID_VS_HEALTHY_MACROPHAGE_DN	M359		18345002	Yarilina A,Park-Min KH,Antoniv T,Hu X,Ivashkiv LB	GSE10500	GSE10500_2635_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in macrophages from patients with synovial fluid rheumatoid arthritis versus monocyte-derived macrophages from healthy persons.	Macrophages from RA synovial fluids were compared to primary human blood-derived macrophages.					11215	253260	6300	201626	27067	1471	6571	23233	92	6738	92703	345778	51194	131034	257629	1803	22950	4851	114836	5565	57120	84725	155066	253782	54884	6574	149233	5274	6555	577	10048	23503	94134	9758	9604	51652	57835	57231	57148	54020	54806	6447	4154	7402	8225	1384	26060	79443	2158	113201	23259	10919	134187	10068	54847	10397	51340	256356	64754	4778	23331	23334	29057	143098	84498	255809	167691	1495	255189	8867	667	162239	375686	8100	23517	9687	9936	84159	64714	1389	80351	9749	11082	80333	8277	254887	57473	5136	9168	56267	64743	136332	51667	9578	6997	54665	23358	3006	1571	59342	392509	8809	10396	55869	657	8418	25950	54587	64089	5310	7915	5446	54850	196743	9541	10424	342371	5602	23509	340152	155435	55614	79959	51141	55313	9338	3709	89885	1514	255374	3579	9205	7455	9900	64216	1778	79696	79901	84750	55296	84910	56944	51302
GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_UP	M360		18453574	Gratchev A,Kzhyshkowska J,Kannookadan S,Ochsenreiter M,Popova A,Yu X,Mamidi S,Stonehouse-Usselmann E,Muller-Molinet I,Gooi L,Goerdt S	GSE7568	GSE7568_2503_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in macrophages differentiated in the presence of IL4 [GeneID=3565] and dexamethasone [PubChem=5743] for 5 days versus those subsequently treated with TGFB1 [GeneID=7040] for 3h.	The goal of the study was to identify the effects of TGF-beta on primary human macrophages maturated under different conditions.					551	2264	57062	1103	57057	55861	338599	284451	7879	163778	55584	79676	3241	130367	6146	165904	1152	1789	114795	347735	9372	1142	79825	2268	9002	79885	9892	11074	1160	54937	5698	132884	8335	337880	1826	55997	9836	30833	51802	23769	2950	2810	84836	163183	57380	9514	121506	402381	6506	163175	7153	124872	57576	6658	147011	579	1029	56203	8530	84632	54492	2968	701	55316	55937	5702	10568	1266	8581	283989	53836	8029	114898	64092	6534	94121	84631	130271	7851	11181	6280	57538	8074	9124	5081	3752	25984	6926	1786	27146	5338	54897	3223	1298	388595	23412	26030	80310	3861	60675	6647	1033	81606	4702	8862	261729	2018	51208	54707	8685	55092	201134	151112	140767	6478	2785	9985	83394	5064	2876	145226	11122	64218	118424	131669	122961	4597	3674	392255	1734	2230	3855	7216	28960	79012	64129	27440	128153	51471	57636	10536	340596	84941	6691	353	23593	8431
GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN	M361		18453574	Gratchev A,Kzhyshkowska J,Kannookadan S,Ochsenreiter M,Popova A,Yu X,Mamidi S,Stonehouse-Usselmann E,Muller-Molinet I,Gooi L,Goerdt S	GSE7568	GSE7568_2503_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in macrophages differentiated in the presence of IL4 [GeneID=3565] and dexamethasone [PubChem=5743] for 5 days versus those subsequently treated with TGFB1 [GeneID=7040] for 3h.	The goal of the study was to identify the effects of TGF-beta on primary human macrophages maturated under different conditions.					23239	84144	9750	5613	54880	23326	64320	116224	5361	5577	10121	79777	10663	57142	51646	3364	6780	253260	7844	79939	23141	11278	51073	55294	23243	11216	112869	55218	2316	200933	6738	84938	1107	54901	90799	55362	359845	2074	340371	27327	9652	56650	6840	23248	79612	6696	64864	1408	57680	6774	5366	9648	63915	10919	79968	54801	3074	85369	51715	56979	79819	25851	23092	51292	23198	23499	8407	2060	1859	91147	55610	23387	56944	5253	5127	56848	55197	5073	2557	55146	9475	10333	9481	57571	25966	5082	79572	51105	2802	51114	8707	8764	81573	23142	55435	6770	157922	7049	79694	7375	8021	4215	79828	55508	4548	284307	204851	124540	80025	4771	51663	5310	151525	93183	8732	114836	11188	93973	8546	7455	1445	100131211	128338	5142	10114	339977	54851	1069	6932	64848	56965	57820	375743	57140	5520	286826	5335	8019	26505	255394	7536	399665	7072	5989	255043	54439	9821	9474	57515	9205	23219	4249	55102	23603	8720	253782	29945	127933	155435	51760	2972	5144	51098
GSE7568_CTRL_VS_24H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_UP	M363		18453574	Gratchev A,Kzhyshkowska J,Kannookadan S,Ochsenreiter M,Popova A,Yu X,Mamidi S,Stonehouse-Usselmann E,Muller-Molinet I,Gooi L,Goerdt S	GSE7568	GSE7568_2504_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in macrophages differentiated in the presence of IL4 [GeneID=3565] and dexamethasone [PubChem=5743] for 5 days versus those subsequently treated with TGFB1 [GeneID=7040] for 24h.	The goal of the study was to identify the effects of TGF-beta on primary human macrophages maturated under different conditions.					29911	942	22995	114799	5911	120103	11237	219681	11168	51102	55719	55603	64081	3689	10389	3676	219990	23167	140460	51696	57458	474344	56910	161	26019	7019	2309	65117	159371	84450	4330	284996	10981	10087	1495	64285	55082	8832	374897	253260	81794	55000	10289	353322	972	54900	114907	54839	6038	114609	2317	3594	50807	9788	81545	51409	57696	54431	5959	1801	54892	54989	5213	5134	53405	2549	963	58155	125170	1326	1662	155038	9980	81029	403313	678	55905	4720	3083	4242	65010	55486	50640	25851	221322	79816	28986	7163	285141	23528	8807	8477	6773	22873	92017	10243	23097	197358	55037	115	3551	729747	8997	3514	6770	89848	53	8434	7782	80184	2746	3066	329	64231	1655	26017	27115	5051	7741	8450	85027	54463	338699	159296	10622	4041	221336	60492	22883	5058	9750	256691	60485	254225	9683	219287	4675	760	3131	130132	7705	84206	8091	6901	962	79882	5045	374618	84142	23429	3187	8790	200728	10924	57198	57228	92597	7791	57419	57134	151963	144108	84674	51715	166968	6810	79576	1632	6916	6654	5308	7994	7424	25927	2060	56897	55843	55683	286467	54875	23362	283	54664	8323	10742	10396	347344	339745	3796	388	23400	22982	51361	1195	3141	154	23074	3600	2005	8812
GSE7568_CTRL_VS_24H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN	M364		18453574	Gratchev A,Kzhyshkowska J,Kannookadan S,Ochsenreiter M,Popova A,Yu X,Mamidi S,Stonehouse-Usselmann E,Muller-Molinet I,Gooi L,Goerdt S	GSE7568	GSE7568_2504_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in macrophages differentiated in the presence of IL4 [GeneID=3565] and dexamethasone [PubChem=5743] for 5 days versus those subsequently treated with TGFB1 [GeneID=7040] for 24h.	The goal of the study was to identify the effects of TGF-beta on primary human macrophages maturated under different conditions.					116835	7070	9514	655	130612	65249	83890	3695	3559	84502	517	343472	3821	5138	201161	5444	23192	9201	1795	83449	6710	57338	64405	5307	55272	5707	3269	5916	284297	460	59341	4635	80761	3183	83714	1415	1235	54854	7379	6279	4613	1555	50674	339416	284467	8045	127002	54102	84699	29842	57630	4825	25818	375323	9097	10046	130367	85508	444	9099	5956	401565	1969	51458	6939	7516	6330	7703	8092	7033	348980	84286	2983	284069	3915	7123	7135	7349	5731	53373	5324	5624	5015	3727	753	10213	29775	153643	10640	161247	29924	8764	54933	150350	1237	348932	9124	154091	2859	9056	56901	27254	8814	7022	57611	441282	84948	3586	859	6559	7293	79094	1797	4158	4488	1013	6474	164781	3212	392465	57549	23187	1515	26575	440498	9746	23452	83938	10979	251	2637	268	337	5081	129080	10040	8704	29108	346689	79663	4900	4731	441518	9986	4854	51601	6375	1600	144100	22871	51686	11245	29933	84225	9853	23281	5188	9332	729330	2628	134285	10052	4763	79012	123811	81786	118812	83850	27036	79817	9076	64218	1310	3426	228	58499	10272	221662	51308	1173	242	28	6418	113612	78995	79345	8858	84530	219654	9521	55313	2295	23316	728588	92359	338773	392509	1340	146850	364
GSE7568_IL4_VS_IL4_AND_TGFB_TREATED_MACROPHAGE_24H_UP	M365		18453574	Gratchev A,Kzhyshkowska J,Kannookadan S,Ochsenreiter M,Popova A,Yu X,Mamidi S,Stonehouse-Usselmann E,Muller-Molinet I,Gooi L,Goerdt S	GSE7568	GSE7568_2505_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in macrophages differentiated in the presence of IL4 [GeneID=3565] for 5 days versus those subsequently treated with TGFB1 [GeneID=7040] for 24h.	The goal of the study was to identify the effects of TGF-beta on primary human macrophages maturated under different conditions.					4689	8878	23592	8667	686	55770	29946	9213	7405	5529	79598	567	64744	57515	1652	27248	84498	29761	51141	26224	1657	51315	49855	57646	11346	9873	51444	7844	145553	9742	79364	51111	80205	51092	51000	10	55578	256380	51176	5732	80021	57595	112936	27072	9946	10765	64747	57097	5781	255809	230	26119	9815	23043	81833	224	950	5567	51503	399665	84959	286053	84636	9918	10611	116496	285636	998	7503	57132	51280	22803	57680	79618	9101	3073	51614	286827	11046	5371	10553	9827	10015	10150	2052	9541	7094	55023	9267	57763	23304	55340	64844	27075	5927	57531	54541	1176	55233	26043	26272	8567	26260	22890	9867	2870	54941	29895	343099	23049	9685	9980	3985	4828	132789	406	51231	152100	6844	60685	10000	54885	154075	56900	253832	5027	9931	4154	9061	84897	5583	11276	59338	100131211	127124	26137	5791	51167	2145	11035	83658	51317	151888	55869	5264	254065	79956	10723	10363	147991	23558	8837	64761	196441	3074	51735	10039	7270	5140	5991	6653	2186	84186	28232	54629	8887
GSE7568_IL4_VS_IL4_AND_TGFB_TREATED_MACROPHAGE_24H_DN	M367		18453574	Gratchev A,Kzhyshkowska J,Kannookadan S,Ochsenreiter M,Popova A,Yu X,Mamidi S,Stonehouse-Usselmann E,Muller-Molinet I,Gooi L,Goerdt S	GSE7568	GSE7568_2505_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in macrophages differentiated in the presence of IL4 [GeneID=3565] for 5 days versus those subsequently treated with TGFB1 [GeneID=7040] for 24h.	The goal of the study was to identify the effects of TGF-beta on primary human macrophages maturated under different conditions.					1429	9532	51389	25828	8834	8562	3692	55731	10171	79050	661	2356	2936	10212	80746	9343	2673	54496	5902	5704	25873	11130	10240	2648	10907	3308	55622	10073	3202	55573	51194	8815	9120	25940	31	93487	84274	2963	26528	3615	79072	84844	57092	85476	210	8880	92675	84842	56894	1233	6183	25926	10195	262	3298	127002	51808	81890	7852	5550	1263	25909	3839	6871	55388	246184	6150	55505	2653	5691	84955	894	8801	57602	7280	64960	8165	975	821	6730	54758	51068	64924	25896	3638	51678	6768	84365	54890	51144	51013	9730	84879	5917	348995	10209	11332	2193	949	267010	1798	10197	6156	5440	5292	4292	63875	1981	55131	120526	23647	811	11320	54534	2987	51596	8086	3297	3033	92345	4128	51126	10270	23246	79572	9319	201965	51329	943	27340	3157	51012	7049	10613	2180	25800	56950	55035	23420	55256	708	5905	84321	740	29968	6745	79641	2650	91647	4725	7027	27000	57038	207	9774	4744	27346	5355	83903	10915	25885	124245	84306	80755	8460	57553	79648	29074	3001	896	3364	51081	5876	7485	51103	51043	64979	10635	5432	2529	29128	3607	84661	200185	387787
GSE7568_IL4_VS_IL4_AND_DEXAMETHASONE_TREATED_MACROPHAGE_UP	M368		18453574	Gratchev A,Kzhyshkowska J,Kannookadan S,Ochsenreiter M,Popova A,Yu X,Mamidi S,Stonehouse-Usselmann E,Muller-Molinet I,Gooi L,Goerdt S	GSE7568	GSE7568_2506_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in macrophages differentiated for 5 days in the presence of: IL4 [GeneID=3565] versus IL4 [GeneID=3565] and dexamethasone [PubChem=5743].	The goal of the study was to identify the effects of TGF-beta on primary human macrophages maturated under different conditions.					51497	8914	4285	100188893	3183	78995	4904	118	57407	4905	3309	84337	10946	4200	5372	1340	5093	8894	5531	6301	10189	642	64785	54460	3860	6281	9631	79053	51726	1019	10572	5230	151648	7419	8539	7913	5905	11169	81611	9439	6873	9173	55660	10938	375316	5859	2491	51574	54836	6877	7280	57819	29089	4116	26133	2187	10591	55775	219854	3936	5714	25886	729533	55329	113130	396	1891	55596	79075	11113	498	10733	56650	55915	586	93323	23008	29895	5478	865	7846	3006	91942	4751	26986	1622	7358	7083	29968	27338	3843	3956	84296	63979	6187	8294	28977	1031	1164	5226	387893	23594	23649	152137	2617	29128	79980	343099	202051	5687	23052	5931	5777	4728	54793	1060	56852	9735	11200	10526	4085	1738	808	64710	55247	51503	91057	4311	7384	347240	51053	9700	9948	51228	1964	29893	3978	122769	27243	54908	404672	1937	163	5693	84661	79003	64841	2771	1346	8613	4695	23029	29127	1871	339487	8663	6878	63901	580	5982	7852	2717	11020	54892	699	51703	8624	339766	9377
GSE7568_IL4_VS_IL4_AND_DEXAMETHASONE_TREATED_MACROPHAGE_DN	M369		18453574	Gratchev A,Kzhyshkowska J,Kannookadan S,Ochsenreiter M,Popova A,Yu X,Mamidi S,Stonehouse-Usselmann E,Muller-Molinet I,Gooi L,Goerdt S	GSE7568	GSE7568_2506_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in macrophages differentiated for 5 days in the presence of: IL4 [GeneID=3565] versus IL4 [GeneID=3565] and dexamethasone [PubChem=5743].	The goal of the study was to identify the effects of TGF-beta on primary human macrophages maturated under different conditions.					54014	23271	114781	8672	7433	252969	118490	23321	6574	146212	100131897	6835	868	23635	694	5204	5314	10396	55870	4222	3575	441168	25939	26123	10663	11016	795	56922	259230	6900	113791	55850	2550	131616	11259	53405	144717	8867	255394	9975	122402	84067	29765	56606	23077	91445	83795	1081	55664	54956	9021	124245	26207	894	115294	54858	84456	60490	25994	3672	5150	1318	26354	53827	6653	9232	64131	91526	3437	5989	3709	2767	1524	254048	51232	93082	3821	6563	57690	2149	1593	8821	8620	146760	10023	55006	301	333926	1603	92	80853	5138	2073	8473	4659	84925	3643	161436	83988	57162	22877	57609	5330	51170	10771	9741	4258	60676	10870	79893	3716	57504	23585	8807	11046	131870	2217	55083	23233	55795	116496	54739	1024	79993	212	1716	3551	64839	28232	23191	9655	54902	84186	57205	1983	79651	317649	79717	1407	203260	84687	153129	2151	253832	8519
GSE7568_IL4_TGFB_DEXAMETHASONE_VS_IL4_TGFB_TREATED_MACROPHAGE_UP	M370		18453574	Gratchev A,Kzhyshkowska J,Kannookadan S,Ochsenreiter M,Popova A,Yu X,Mamidi S,Stonehouse-Usselmann E,Muller-Molinet I,Gooi L,Goerdt S	GSE7568	GSE7568_2507_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in macrophages: 5 days with IL4 [GeneID=3565] and dexamethasone [PubChem=5743] followed by TGFB1 [GeneID=7040] for 24h versus 5 days with IL4 [GeneID=3565] followed by TGFB1 [GeneID=7040] for 24h.	The goal of the study was to identify the effects of TGF-beta on primary human macrophages maturated under different conditions.					84365	8834	65123	8460	6158	51025	84842	92345	80764	63875	55212	5709	740	4744	8370	262	5432	4082	79648	9532	10146	7453	9343	1635	84879	51234	80755	5550	9898	202051	25829	54758	84928	84844	23511	1981	51126	60528	7520	9987	23517	8165	27346	6472	2079	2673	23029	8880	5917	6632	81831	84135	2650	84128	25828	64062	6276	64978	4904	23150	23420	3364	51388	5214	6990	991	81890	27044	1317	51081	60558	51691	65263	55110	10240	84524	8050	7416	10212	9656	5704	7407	83743	9785	6134	6856	5982	5694	2926	902	10613	5713	127253	79050	201965	26589	57038	55718	23398	4521	6627	51144	55131	3320	284161	7982	10935	55226	8666	23332	161753	51559	10783	56751	64432	10598	55968	378708	226	6520	975	10694	140735	5433	4677	9435	2653	84321	8727	10985	10450	9943	586	56950	54675	348995	255626	51277	118812	79072	55967	6470	6558	219743	23481	8520	26100	56130	9093	56902	6150	3976	57050	8891	55621	10579	10988	134430	55178	9788	1236	3376	51134	6871	5510	23378	1964	100287932	54890	51605	3842	5496
GSE7568_IL4_TGFB_DEXAMETHASONE_VS_IL4_TGFB_TREATED_MACROPHAGE_DN	M371		18453574	Gratchev A,Kzhyshkowska J,Kannookadan S,Ochsenreiter M,Popova A,Yu X,Mamidi S,Stonehouse-Usselmann E,Muller-Molinet I,Gooi L,Goerdt S	GSE7568	GSE7568_2507_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in macrophages: 5 days with IL4 [GeneID=3565] and dexamethasone [PubChem=5743] followed by TGFB1 [GeneID=7040] for 24h versus 5 days with IL4 [GeneID=3565] followed by TGFB1 [GeneID=7040] for 24h.	The goal of the study was to identify the effects of TGF-beta on primary human macrophages maturated under different conditions.					50809	124491	567	493869	84232	65258	54014	10302	7094	55788	3433	55340	23108	27128	283209	4689	6645	5567	10608	7903	51271	4067	57515	5611	5289	27072	153745	3383	80021	79956	9016	7844	6954	54622	374407	2151	8837	54885	823	3659	9728	84912	5330	768211	57531	9553	84899	54828	10623	51399	65057	79647	10663	51280	10771	93058	56987	51199	10923	5580	29947	224	9877	2139	51734	51160	7114	8887	6515	889	80314	2207	65990	23527	3684	10023	11046	1535	51426	55233	5204	3927	80143	2149	51141	51231	84230	112936	257160	1844	10000	64784	79598	5552	220002	51720	57223	8546	7110	51111	219899	9946	2517	255809	146760	253832	7128	135	379	57231	2957	9205	6610	10765	54878	2774	11264	4775	23140	8867	80267	79720	8818	963	57132	10955	6813	90780	3709	26996	1647	196513	26272	9910	6653	85464	23043	4238	9245	58475	9686	51092	57688	51164	55437	132789	4155	26224	29121	2769	1774	26260	23335	1781	2790	55080	23389	133418	51397	64747	4694	3707	374403	9953	8349	23304	84067	100131897	54919	51317	940	8737	6747	26031
GSE9946_IMMATURE_VS_MATURE_STIMULATORY_DC_UP	M415		18802101	Popov A,Driesen J,Abdullah Z,Wickenhauser C,Beyer M,Debey-Pascher S,Saric T,Kummer S,Takikawa O,Domann E,Chakraborty T,Krönke M,Utermöhlen O,Schultze JL	GSE9946	GSE9946_2753_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in dendritic cells: immature versus mature stimulatory.	Myeloid dendritic cells (DC) and macrophages play an important role in pathogen sensing and antimicrobial defense. Recently we demonstrated that infection of human DC with intracellular bacterium Listeria monocytogenes (L.monocytogenes) leads to the induction of the immunoinhibitory enzyme indoleamine 2,3-dioxygenase (Popov et al., J Clin Invest, 2006), while in the previous studies L.monocytogenes infection was associated with a rather stimulatory DC phenotype. To clarify this discrepancy we performed comparative microarray analysis of immature mo-DC (immDC), mature stimulatory mo-DC (matDC) and mature inhibitory DC either stimulated with prostaglandin E2 (PGE2-DC) or infected with L.monocytogenes (infDC). Studying infection of human myeloid DC with Listeria monocytogenes, we found out, that infected DC are modified by the pathogen to express multiple inhibitory molecules, including indoleamine 2,3-dioxygenase (IDO), cyclooxygenase-2, interleukin 10 and CD25, which acts on DC as IL-2 scavenger. All these inhibitory molecules, expressed on regulatory DC (DCreg), are strictly TNF-dependent and are in concert suppressing T-cell responses. Moreover, only DCreg can efficiently control the number of intracellular listeria, mostly by IDO-mediated mechanisms and by other factors, remaining to be identified. Analyzing publicly acessible data of transcriptional changes in DC and macrophages, infected by various pathogens and parasites (GEO, GSE360), we noticed that infection of these cells with Mycobacterium tuberculosis causes transcriptional response, comparable with the one caused by listeria in human DC. In fact, granuloma in tuberculosis and listeriosis in vivo are enriched for myeloid DC and macrophages characterized by regulatory phenotype. In summary, regulatory myeloid DC and macrophages may play a dual role during life-threatening granulomatous infections, such as tuberculosis: on one hand, regulatory myeloid cells promote pathogen containment by efficiently killing intracellular bacteria, on the other hand these cells inhibit granuloma-associated T cells and thereby might be involved in the retention of TNF-controlled granuloma integrity protecting the host from granuloma break-down and pathogen dissemination. 					9	10412	6707	11160	3655	219844	6774	8894	7498	55020	23386	23765	55884	9411	60685	921	54414	54927	7409	752	159	7726	64744	340069	79939	80004	10928	11145	9152	283847	221504	10235	27158	9416	63891	9721	3987	84919	83550	8723	2217	8812	134147	6622	100506658	91703	4189	6683	51720	8945	22835	55832	50615	257068	8313	56970	1114	6731	9058	54896	56674	3856	2677	81929	388730	4973	282679	79828	10103	27430	92421	5929	1176	222484	780	6925	94026	23225	6778	79364	3007	355	6130	83756	145567	7538	342574	270	25988	23588	6094	51143	57590	29115	23067	259173	64598	5409	1600	6424	645864	9114	79838	23399	2009	5597	9139	4969	10529	64319	9313	260293	54842	9130	137735	29940	7267	7049	23197	152273	7088	51231	55602	114785	58528	84324	118	285368	92370	9467	26511
GSE9946_IMMATURE_VS_MATURE_STIMULATORY_DC_DN	M417		18802101	Popov A,Driesen J,Abdullah Z,Wickenhauser C,Beyer M,Debey-Pascher S,Saric T,Kummer S,Takikawa O,Domann E,Chakraborty T,Krönke M,Utermöhlen O,Schultze JL	GSE9946	GSE9946_2753_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in dendritic cells: immature versus mature stimulatory.	Myeloid dendritic cells (DC) and macrophages play an important role in pathogen sensing and antimicrobial defense. Recently we demonstrated that infection of human DC with intracellular bacterium Listeria monocytogenes (L.monocytogenes) leads to the induction of the immunoinhibitory enzyme indoleamine 2,3-dioxygenase (Popov et al., J Clin Invest, 2006), while in the previous studies L.monocytogenes infection was associated with a rather stimulatory DC phenotype. To clarify this discrepancy we performed comparative microarray analysis of immature mo-DC (immDC), mature stimulatory mo-DC (matDC) and mature inhibitory DC either stimulated with prostaglandin E2 (PGE2-DC) or infected with L.monocytogenes (infDC). Studying infection of human myeloid DC with Listeria monocytogenes, we found out, that infected DC are modified by the pathogen to express multiple inhibitory molecules, including indoleamine 2,3-dioxygenase (IDO), cyclooxygenase-2, interleukin 10 and CD25, which acts on DC as IL-2 scavenger. All these inhibitory molecules, expressed on regulatory DC (DCreg), are strictly TNF-dependent and are in concert suppressing T-cell responses. Moreover, only DCreg can efficiently control the number of intracellular listeria, mostly by IDO-mediated mechanisms and by other factors, remaining to be identified. Analyzing publicly acessible data of transcriptional changes in DC and macrophages, infected by various pathogens and parasites (GEO, GSE360), we noticed that infection of these cells with Mycobacterium tuberculosis causes transcriptional response, comparable with the one caused by listeria in human DC. In fact, granuloma in tuberculosis and listeriosis in vivo are enriched for myeloid DC and macrophages characterized by regulatory phenotype. In summary, regulatory myeloid DC and macrophages may play a dual role during life-threatening granulomatous infections, such as tuberculosis: on one hand, regulatory myeloid cells promote pathogen containment by efficiently killing intracellular bacteria, on the other hand these cells inhibit granuloma-associated T cells and thereby might be involved in the retention of TNF-controlled granuloma integrity protecting the host from granuloma break-down and pathogen dissemination. 					29930	3284	50865	55812	493829	3350	122706	55973	3868	151230	388595	5617	290	4642	57582	4225	2813	2266	149018	121227	55258	221468	132946	341640	7957	94235	284119	5314	3213	56660	64081	144321	64581	151056	2709	3223	162517	26509	253558	79147	9350	26279	4199	84517	114788	23596	3559	79068	59353	27304	8787	115908	2346	154150	260429	654429	1005	22925	85445	135892	4829	221188	1733	5457	7163	6614	285852	387990	80114	64102	55203	10656	25937	6242	23127	80168	55858	5662	143241	113091	23026	22936	85458	5911	23432	2563	5161	89866	59272	148109	3748	7436	5612	7130	182	118980	2299	6344	84953	114793	9705	22870	135644	8534	57468	30850	57554	1636	81542	1896	4481	59336	93034	51804	3955	51252	7984	7881	27091	11280	442425	339896	1956	23671	26272	6385	6279	79412	54734
GSE9946_IMMATURE_VS_LISTERIA_INF_MATURE_DC_UP	M418		18802101	Popov A,Driesen J,Abdullah Z,Wickenhauser C,Beyer M,Debey-Pascher S,Saric T,Kummer S,Takikawa O,Domann E,Chakraborty T,Krönke M,Utermöhlen O,Schultze JL	GSE9946	GSE9946_2754_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in dendritic cells: immature versus mature inhibitory infected with L. monocytogenes.	Myeloid dendritic cells (DC) and macrophages play an important role in pathogen sensing and antimicrobial defense. Recently we demonstrated that infection of human DC with intracellular bacterium Listeria monocytogenes (L.monocytogenes) leads to the induction of the immunoinhibitory enzyme indoleamine 2,3-dioxygenase (Popov et al., J Clin Invest, 2006), while in the previous studies L.monocytogenes infection was associated with a rather stimulatory DC phenotype. To clarify this discrepancy we performed comparative microarray analysis of immature mo-DC (immDC), mature stimulatory mo-DC (matDC) and mature inhibitory DC either stimulated with prostaglandin E2 (PGE2-DC) or infected with L.monocytogenes (infDC). Studying infection of human myeloid DC with Listeria monocytogenes, we found out, that infected DC are modified by the pathogen to express multiple inhibitory molecules, including indoleamine 2,3-dioxygenase (IDO), cyclooxygenase-2, interleukin 10 and CD25, which acts on DC as IL-2 scavenger. All these inhibitory molecules, expressed on regulatory DC (DCreg), are strictly TNF-dependent and are in concert suppressing T-cell responses. Moreover, only DCreg can efficiently control the number of intracellular listeria, mostly by IDO-mediated mechanisms and by other factors, remaining to be identified. Analyzing publicly acessible data of transcriptional changes in DC and macrophages, infected by various pathogens and parasites (GEO, GSE360), we noticed that infection of these cells with Mycobacterium tuberculosis causes transcriptional response, comparable with the one caused by listeria in human DC. In fact, granuloma in tuberculosis and listeriosis in vivo are enriched for myeloid DC and macrophages characterized by regulatory phenotype. In summary, regulatory myeloid DC and macrophages may play a dual role during life-threatening granulomatous infections, such as tuberculosis: on one hand, regulatory myeloid cells promote pathogen containment by efficiently killing intracellular bacteria, on the other hand these cells inhibit granuloma-associated T cells and thereby might be involved in the retention of TNF-controlled granuloma integrity protecting the host from granuloma break-down and pathogen dissemination. 					79939	23072	9467	79608	287015	404544	160335	9427	57554	4189	92856	9697	23671	3759	84667	100130771	1600	284467	3776	285782	149233	130074	11056	10985	2743	10827	3131	54883	9177	149461	57639	56670	57446	140685	348938	1291	120892	65249	113026	29068	27012	22906	439	130940	63906	1278	11333	283847	6854	6668	730249	24144	474354	23120	23154	441061	149647	51759	124912	11040	27246	91445	10242	91851	9423	134288	28	51388	79710	9863	54970	150	84033	28968	653509	83844	1427	25929	55512	5337	140690	8929	27095	579	79815	2006	9313	5338	5593	58475	64236	79813	221935	54854	51294	3055	8893	1262	3441	55821	257068	4199	9962	124056	8499	57596	3339	283229	7057	26960	57120	285966	112703	1114	170825	51382	5681	8074	3931	134147	1357	780	9705	4354	2301	51450	8328	118424	140880	90627	3237	348378	51307	338328
GSE9946_IMMATURE_VS_LISTERIA_INF_MATURE_DC_DN	M420		18802101	Popov A,Driesen J,Abdullah Z,Wickenhauser C,Beyer M,Debey-Pascher S,Saric T,Kummer S,Takikawa O,Domann E,Chakraborty T,Krönke M,Utermöhlen O,Schultze JL	GSE9946	GSE9946_2754_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in dendritic cells: immature versus mature inhibitory infected with L. monocytogenes.	Myeloid dendritic cells (DC) and macrophages play an important role in pathogen sensing and antimicrobial defense. Recently we demonstrated that infection of human DC with intracellular bacterium Listeria monocytogenes (L.monocytogenes) leads to the induction of the immunoinhibitory enzyme indoleamine 2,3-dioxygenase (Popov et al., J Clin Invest, 2006), while in the previous studies L.monocytogenes infection was associated with a rather stimulatory DC phenotype. To clarify this discrepancy we performed comparative microarray analysis of immature mo-DC (immDC), mature stimulatory mo-DC (matDC) and mature inhibitory DC either stimulated with prostaglandin E2 (PGE2-DC) or infected with L.monocytogenes (infDC). Studying infection of human myeloid DC with Listeria monocytogenes, we found out, that infected DC are modified by the pathogen to express multiple inhibitory molecules, including indoleamine 2,3-dioxygenase (IDO), cyclooxygenase-2, interleukin 10 and CD25, which acts on DC as IL-2 scavenger. All these inhibitory molecules, expressed on regulatory DC (DCreg), are strictly TNF-dependent and are in concert suppressing T-cell responses. Moreover, only DCreg can efficiently control the number of intracellular listeria, mostly by IDO-mediated mechanisms and by other factors, remaining to be identified. Analyzing publicly acessible data of transcriptional changes in DC and macrophages, infected by various pathogens and parasites (GEO, GSE360), we noticed that infection of these cells with Mycobacterium tuberculosis causes transcriptional response, comparable with the one caused by listeria in human DC. In fact, granuloma in tuberculosis and listeriosis in vivo are enriched for myeloid DC and macrophages characterized by regulatory phenotype. In summary, regulatory myeloid DC and macrophages may play a dual role during life-threatening granulomatous infections, such as tuberculosis: on one hand, regulatory myeloid cells promote pathogen containment by efficiently killing intracellular bacteria, on the other hand these cells inhibit granuloma-associated T cells and thereby might be involved in the retention of TNF-controlled granuloma integrity protecting the host from granuloma break-down and pathogen dissemination. 					79370	116379	11082	118788	1491	64783	55973	51720	284273	8639	56624	54020	55258	2596	55897	382	80761	7138	8805	388595	65078	64407	378884	8831	10208	10111	222553	140456	64172	90843	11342	26509	3550	84164	122706	23517	151473	285025	55858	399818	3669	2993	1191	23191	151230	11321	89777	1636	25975	1180	10410	3362	5995	84953	116228	654	54995	7436	56659	493829	51676	57380	115908	55203	8941	1081	3516	740	387758	1060	8654	3205	6845	23279	25782	8577	8945	152559	266629	441024	10642	55016	5450	9779	689	128338	11280	388818	1010	84647	80307	6385	4257	26272	120227	2251	2998	160428	9324	8829	953	10149	6208	136853	3226	80830	116	257019	5742	54331	2886	5365	84187	26049	54960	8761	7355	338761	7167	147011	2877	273	27245	6242	79053
GSE9946_IMMATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP	M421		18802101	Popov A,Driesen J,Abdullah Z,Wickenhauser C,Beyer M,Debey-Pascher S,Saric T,Kummer S,Takikawa O,Domann E,Chakraborty T,Krönke M,Utermöhlen O,Schultze JL	GSE9946	GSE9946_2755_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in dendritic cells: immature versus mature inhibitory treated by prostaglandin E2 [PubChem=5280360].	Myeloid dendritic cells (DC) and macrophages play an important role in pathogen sensing and antimicrobial defense. Recently we demonstrated that infection of human DC with intracellular bacterium Listeria monocytogenes (L.monocytogenes) leads to the induction of the immunoinhibitory enzyme indoleamine 2,3-dioxygenase (Popov et al., J Clin Invest, 2006), while in the previous studies L.monocytogenes infection was associated with a rather stimulatory DC phenotype. To clarify this discrepancy we performed comparative microarray analysis of immature mo-DC (immDC), mature stimulatory mo-DC (matDC) and mature inhibitory DC either stimulated with prostaglandin E2 (PGE2-DC) or infected with L.monocytogenes (infDC). Studying infection of human myeloid DC with Listeria monocytogenes, we found out, that infected DC are modified by the pathogen to express multiple inhibitory molecules, including indoleamine 2,3-dioxygenase (IDO), cyclooxygenase-2, interleukin 10 and CD25, which acts on DC as IL-2 scavenger. All these inhibitory molecules, expressed on regulatory DC (DCreg), are strictly TNF-dependent and are in concert suppressing T-cell responses. Moreover, only DCreg can efficiently control the number of intracellular listeria, mostly by IDO-mediated mechanisms and by other factors, remaining to be identified. Analyzing publicly acessible data of transcriptional changes in DC and macrophages, infected by various pathogens and parasites (GEO, GSE360), we noticed that infection of these cells with Mycobacterium tuberculosis causes transcriptional response, comparable with the one caused by listeria in human DC. In fact, granuloma in tuberculosis and listeriosis in vivo are enriched for myeloid DC and macrophages characterized by regulatory phenotype. In summary, regulatory myeloid DC and macrophages may play a dual role during life-threatening granulomatous infections, such as tuberculosis: on one hand, regulatory myeloid cells promote pathogen containment by efficiently killing intracellular bacteria, on the other hand these cells inhibit granuloma-associated T cells and thereby might be involved in the retention of TNF-controlled granuloma integrity protecting the host from granuloma break-down and pathogen dissemination. 					1114	9899	1266	8756	221914	6774	55527	3572	404544	5371	4147	2645	10412	55020	7057	10985	80022	9525	8204	23560	348938	23126	23076	54957	81566	257068	130074	6556	55784	65249	3742	8842	4215	10656	1523	7421	5551	6531	130940	6289	129685	2677	10076	84243	9058	3190	55728	2969	7049	126119	10023	3267	84916	100506658	1832	56953	7536	56129	2185	176	55833	29115	57596	23479	2828	54518	54472	340152	29950	23339	9146	80004	10827	84626	63982	84953	4775	79608	80271	1761	27145	50615	51274	23399	6752	84132	10463	255394	5253	22835	3849	4092	219333	3484	374378	140862	57057	10718	90637	7316	346171	6932	4045	3167	57463	9721	3655	128817	441061	85463	9612	2980	51176	6911	121227	340267	51050	79815	6992	166793	10404	1264	81551	222537	552	23067	55783	79628	694	10687	127002	22885	79675	8312	7469	10318	339345	196463	25929	348807
GSE9946_IMMATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN	M422		18802101	Popov A,Driesen J,Abdullah Z,Wickenhauser C,Beyer M,Debey-Pascher S,Saric T,Kummer S,Takikawa O,Domann E,Chakraborty T,Krönke M,Utermöhlen O,Schultze JL	GSE9946	GSE9946_2755_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in dendritic cells: immature versus mature inhibitory treated by prostaglandin E2 [PubChem=5280360].	Myeloid dendritic cells (DC) and macrophages play an important role in pathogen sensing and antimicrobial defense. Recently we demonstrated that infection of human DC with intracellular bacterium Listeria monocytogenes (L.monocytogenes) leads to the induction of the immunoinhibitory enzyme indoleamine 2,3-dioxygenase (Popov et al., J Clin Invest, 2006), while in the previous studies L.monocytogenes infection was associated with a rather stimulatory DC phenotype. To clarify this discrepancy we performed comparative microarray analysis of immature mo-DC (immDC), mature stimulatory mo-DC (matDC) and mature inhibitory DC either stimulated with prostaglandin E2 (PGE2-DC) or infected with L.monocytogenes (infDC). Studying infection of human myeloid DC with Listeria monocytogenes, we found out, that infected DC are modified by the pathogen to express multiple inhibitory molecules, including indoleamine 2,3-dioxygenase (IDO), cyclooxygenase-2, interleukin 10 and CD25, which acts on DC as IL-2 scavenger. All these inhibitory molecules, expressed on regulatory DC (DCreg), are strictly TNF-dependent and are in concert suppressing T-cell responses. Moreover, only DCreg can efficiently control the number of intracellular listeria, mostly by IDO-mediated mechanisms and by other factors, remaining to be identified. Analyzing publicly acessible data of transcriptional changes in DC and macrophages, infected by various pathogens and parasites (GEO, GSE360), we noticed that infection of these cells with Mycobacterium tuberculosis causes transcriptional response, comparable with the one caused by listeria in human DC. In fact, granuloma in tuberculosis and listeriosis in vivo are enriched for myeloid DC and macrophages characterized by regulatory phenotype. In summary, regulatory myeloid DC and macrophages may play a dual role during life-threatening granulomatous infections, such as tuberculosis: on one hand, regulatory myeloid cells promote pathogen containment by efficiently killing intracellular bacteria, on the other hand these cells inhibit granuloma-associated T cells and thereby might be involved in the retention of TNF-controlled granuloma integrity protecting the host from granuloma break-down and pathogen dissemination. 					23650	10816	149699	5911	55858	79801	54675	7130	54331	1815	23555	55973	10855	493829	10111	23026	57619	64151	84641	135138	222611	10371	3012	1760	256536	9911	79258	11073	51335	374907	83988	2328	388698	388818	9793	4361	337974	7704	51377	84517	6329	11169	338761	54874	10677	91663	85865	166379	386617	2669	220001	7272	9350	51012	51209	26280	51751	8787	1806	608	11082	11321	164045	55815	348980	7106	9372	152559	2762	836	79772	3859	340069	57626	1956	390259	286676	158046	2049	7517	83882	79412	9455	4109	675	151056	23224	5049	3382	2299	114783	8520	90668	2059	3815	79728	139596	92105	2529	55509	4014	159090	3142	641	820	4619	51720	80228	115908	57161	84101	341640	5701	51421	27023	6746	516	2701	4515	1491	79026	51378	25975	79053	4750	4194	10660	13	432	5906	339855	56956	56992	7441	10410	398	5422	79083	51673	2561	643236
GSE9946_MATURE_STIMULATORY_VS_LISTERIA_INF_MATURE_DC_UP	M423		18802101	Popov A,Driesen J,Abdullah Z,Wickenhauser C,Beyer M,Debey-Pascher S,Saric T,Kummer S,Takikawa O,Domann E,Chakraborty T,Krönke M,Utermöhlen O,Schultze JL	GSE9946	GSE9946_2756_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in mature dendritic cells: stimulatory versus inhibitory infected with L. monocytogenes.	Myeloid dendritic cells (DC) and macrophages play an important role in pathogen sensing and antimicrobial defense. Recently we demonstrated that infection of human DC with intracellular bacterium Listeria monocytogenes (L.monocytogenes) leads to the induction of the immunoinhibitory enzyme indoleamine 2,3-dioxygenase (Popov et al., J Clin Invest, 2006), while in the previous studies L.monocytogenes infection was associated with a rather stimulatory DC phenotype. To clarify this discrepancy we performed comparative microarray analysis of immature mo-DC (immDC), mature stimulatory mo-DC (matDC) and mature inhibitory DC either stimulated with prostaglandin E2 (PGE2-DC) or infected with L.monocytogenes (infDC). Studying infection of human myeloid DC with Listeria monocytogenes, we found out, that infected DC are modified by the pathogen to express multiple inhibitory molecules, including indoleamine 2,3-dioxygenase (IDO), cyclooxygenase-2, interleukin 10 and CD25, which acts on DC as IL-2 scavenger. All these inhibitory molecules, expressed on regulatory DC (DCreg), are strictly TNF-dependent and are in concert suppressing T-cell responses. Moreover, only DCreg can efficiently control the number of intracellular listeria, mostly by IDO-mediated mechanisms and by other factors, remaining to be identified. Analyzing publicly acessible data of transcriptional changes in DC and macrophages, infected by various pathogens and parasites (GEO, GSE360), we noticed that infection of these cells with Mycobacterium tuberculosis causes transcriptional response, comparable with the one caused by listeria in human DC. In fact, granuloma in tuberculosis and listeriosis in vivo are enriched for myeloid DC and macrophages characterized by regulatory phenotype. In summary, regulatory myeloid DC and macrophages may play a dual role during life-threatening granulomatous infections, such as tuberculosis: on one hand, regulatory myeloid cells promote pathogen containment by efficiently killing intracellular bacteria, on the other hand these cells inhibit granuloma-associated T cells and thereby might be involved in the retention of TNF-controlled granuloma integrity protecting the host from granuloma break-down and pathogen dissemination. 					57570	29940	8907	80271	6668	135644	9612	23061	23067	129285	91862	4092	1613	85364	121227	5893	1259	84064	116092	4725	1975	10611	3955	4088	152519	10103	2799	83877	4094	51341	130074	1605	11145	64219	10026	51684	150864	1979	29115	84626	338557	26589	6202	64789	79753	80742	7049	84936	2734	203286	388730	143879	51295	90416	172	7469	64598	51101	129563	3556	64222	5253	23225	91782	54896	2886	5004	84919	166793	5721	200132	151254	23094	57446	65110	92345	7224	7088	391	5371	79939	124044	8893	79017	9842	53349	126119	222255	51151	9467	283869	51176	5576	643904	1639	1497	386724	79890	83446	1523	145567	2150	91754	51704	84881	9114	54981	1211	55591	55750	2330	23324	864	64236	23212	84317	4215	23023	54960	127391	8349	222698	1401	3572	51586
GSE9946_MATURE_STIMULATORY_VS_LISTERIA_INF_MATURE_DC_DN	M425		18802101	Popov A,Driesen J,Abdullah Z,Wickenhauser C,Beyer M,Debey-Pascher S,Saric T,Kummer S,Takikawa O,Domann E,Chakraborty T,Krönke M,Utermöhlen O,Schultze JL	GSE9946	GSE9946_2756_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in mature dendritic cells: stimulatory versus inhibitory infected with L. monocytogenes.	Myeloid dendritic cells (DC) and macrophages play an important role in pathogen sensing and antimicrobial defense. Recently we demonstrated that infection of human DC with intracellular bacterium Listeria monocytogenes (L.monocytogenes) leads to the induction of the immunoinhibitory enzyme indoleamine 2,3-dioxygenase (Popov et al., J Clin Invest, 2006), while in the previous studies L.monocytogenes infection was associated with a rather stimulatory DC phenotype. To clarify this discrepancy we performed comparative microarray analysis of immature mo-DC (immDC), mature stimulatory mo-DC (matDC) and mature inhibitory DC either stimulated with prostaglandin E2 (PGE2-DC) or infected with L.monocytogenes (infDC). Studying infection of human myeloid DC with Listeria monocytogenes, we found out, that infected DC are modified by the pathogen to express multiple inhibitory molecules, including indoleamine 2,3-dioxygenase (IDO), cyclooxygenase-2, interleukin 10 and CD25, which acts on DC as IL-2 scavenger. All these inhibitory molecules, expressed on regulatory DC (DCreg), are strictly TNF-dependent and are in concert suppressing T-cell responses. Moreover, only DCreg can efficiently control the number of intracellular listeria, mostly by IDO-mediated mechanisms and by other factors, remaining to be identified. Analyzing publicly acessible data of transcriptional changes in DC and macrophages, infected by various pathogens and parasites (GEO, GSE360), we noticed that infection of these cells with Mycobacterium tuberculosis causes transcriptional response, comparable with the one caused by listeria in human DC. In fact, granuloma in tuberculosis and listeriosis in vivo are enriched for myeloid DC and macrophages characterized by regulatory phenotype. In summary, regulatory myeloid DC and macrophages may play a dual role during life-threatening granulomatous infections, such as tuberculosis: on one hand, regulatory myeloid cells promote pathogen containment by efficiently killing intracellular bacteria, on the other hand these cells inhibit granuloma-associated T cells and thereby might be involved in the retention of TNF-controlled granuloma integrity protecting the host from granuloma break-down and pathogen dissemination. 					8654	122706	836	93664	56344	27179	79844	285525	2264	9372	6330	10021	7163	113091	374887	83482	57453	348487	339291	118788	1133	79258	3776	6583	135138	29995	7852	3162	23544	2529	79623	91181	1956	8995	8406	9719	56660	84779	23584	3213	284040	133	126374	8839	6736	1005	64762	3931	145873	6279	440503	1081	7167	5912	8291	6385	3703	4225	60559	5021	151056	3309	165829	2921	221184	6910	5230	127124	342865	22822	341640	90668	27033	688	139596	4248	116832	8655	5357	27006	404203	1950	390594	23109	146862	830	28968	338328	4619	4641	114818	79414	10052	23436	9	3592	55349	27031	4821	10404	10687	158763	221264	161247	56605	3574	6745	84033	9390	10231	4023	4759	164237	3554	3669	149018	2865	182	56300	4109	643236	2678	23650	57626	5354	79728
GSE9946_MATURE_STIMULATORY_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP	M428		18802101	Popov A,Driesen J,Abdullah Z,Wickenhauser C,Beyer M,Debey-Pascher S,Saric T,Kummer S,Takikawa O,Domann E,Chakraborty T,Krönke M,Utermöhlen O,Schultze JL	GSE9946	GSE9946_2757_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in mature dendritic cells: stimulatory versus inhibitory treated by prostaglandin E2 [PubChem=5280360].	Myeloid dendritic cells (DC) and macrophages play an important role in pathogen sensing and antimicrobial defense. Recently we demonstrated that infection of human DC with intracellular bacterium Listeria monocytogenes (L.monocytogenes) leads to the induction of the immunoinhibitory enzyme indoleamine 2,3-dioxygenase (Popov et al., J Clin Invest, 2006), while in the previous studies L.monocytogenes infection was associated with a rather stimulatory DC phenotype. To clarify this discrepancy we performed comparative microarray analysis of immature mo-DC (immDC), mature stimulatory mo-DC (matDC) and mature inhibitory DC either stimulated with prostaglandin E2 (PGE2-DC) or infected with L.monocytogenes (infDC). Studying infection of human myeloid DC with Listeria monocytogenes, we found out, that infected DC are modified by the pathogen to express multiple inhibitory molecules, including indoleamine 2,3-dioxygenase (IDO), cyclooxygenase-2, interleukin 10 and CD25, which acts on DC as IL-2 scavenger. All these inhibitory molecules, expressed on regulatory DC (DCreg), are strictly TNF-dependent and are in concert suppressing T-cell responses. Moreover, only DCreg can efficiently control the number of intracellular listeria, mostly by IDO-mediated mechanisms and by other factors, remaining to be identified. Analyzing publicly acessible data of transcriptional changes in DC and macrophages, infected by various pathogens and parasites (GEO, GSE360), we noticed that infection of these cells with Mycobacterium tuberculosis causes transcriptional response, comparable with the one caused by listeria in human DC. In fact, granuloma in tuberculosis and listeriosis in vivo are enriched for myeloid DC and macrophages characterized by regulatory phenotype. In summary, regulatory myeloid DC and macrophages may play a dual role during life-threatening granulomatous infections, such as tuberculosis: on one hand, regulatory myeloid cells promote pathogen containment by efficiently killing intracellular bacteria, on the other hand these cells inhibit granuloma-associated T cells and thereby might be involved in the retention of TNF-controlled granuloma integrity protecting the host from granuloma break-down and pathogen dissemination. 					130074	57554	79109	50628	135644	6774	338567	778	5713	221823	84922	338557	55527	114824	158234	83756	6196	80271	1361	79626	6927	23072	5271	4215	5004	9842	4969	1832	115752	914	4189	90226	54896	25994	83733	7433	10344	79663	221504	2870	23532	81488	9562	9739	56970	54957	7866	51382	5740	55020	3955	145942	83876	126119	23180	79657	1538	388730	2702	3579	441168	29068	10023	121227	3704	55884	220972	313	11235	4775	1401	6932	55156	386724	139221	4688	64223	5284	8312	784	348807	79020	79913	22854	9825	6653	2743	2977	23082	80004	646424	65094	91782	27102	83440	9069	3646	8563	9331	2581	124044	10076	3229	169714	51571	4939	388364	124454	10054	140731	134288	81858	8662	203447	149233	22885	115701	388650	285966	284252	260293	140578	344807	1639	23093	23041	23378
GSE9946_MATURE_STIMULATORY_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN	M429		18802101	Popov A,Driesen J,Abdullah Z,Wickenhauser C,Beyer M,Debey-Pascher S,Saric T,Kummer S,Takikawa O,Domann E,Chakraborty T,Krönke M,Utermöhlen O,Schultze JL	GSE9946	GSE9946_2757_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in mature dendritic cells: stimulatory versus inhibitory treated by prostaglandin E2 [PubChem=5280360].	Myeloid dendritic cells (DC) and macrophages play an important role in pathogen sensing and antimicrobial defense. Recently we demonstrated that infection of human DC with intracellular bacterium Listeria monocytogenes (L.monocytogenes) leads to the induction of the immunoinhibitory enzyme indoleamine 2,3-dioxygenase (Popov et al., J Clin Invest, 2006), while in the previous studies L.monocytogenes infection was associated with a rather stimulatory DC phenotype. To clarify this discrepancy we performed comparative microarray analysis of immature mo-DC (immDC), mature stimulatory mo-DC (matDC) and mature inhibitory DC either stimulated with prostaglandin E2 (PGE2-DC) or infected with L.monocytogenes (infDC). Studying infection of human myeloid DC with Listeria monocytogenes, we found out, that infected DC are modified by the pathogen to express multiple inhibitory molecules, including indoleamine 2,3-dioxygenase (IDO), cyclooxygenase-2, interleukin 10 and CD25, which acts on DC as IL-2 scavenger. All these inhibitory molecules, expressed on regulatory DC (DCreg), are strictly TNF-dependent and are in concert suppressing T-cell responses. Moreover, only DCreg can efficiently control the number of intracellular listeria, mostly by IDO-mediated mechanisms and by other factors, remaining to be identified. Analyzing publicly acessible data of transcriptional changes in DC and macrophages, infected by various pathogens and parasites (GEO, GSE360), we noticed that infection of these cells with Mycobacterium tuberculosis causes transcriptional response, comparable with the one caused by listeria in human DC. In fact, granuloma in tuberculosis and listeriosis in vivo are enriched for myeloid DC and macrophages characterized by regulatory phenotype. In summary, regulatory myeloid DC and macrophages may play a dual role during life-threatening granulomatous infections, such as tuberculosis: on one hand, regulatory myeloid cells promote pathogen containment by efficiently killing intracellular bacteria, on the other hand these cells inhibit granuloma-associated T cells and thereby might be involved in the retention of TNF-controlled granuloma integrity protecting the host from granuloma break-down and pathogen dissemination. 					55596	5288	11346	836	2791	3284	3736	64078	90843	54734	4750	2006	123745	4756	115650	221468	136853	6663	22979	1813	5422	7163	1956	388698	55258	220001	29760	3934	197322	11001	64094	2701	81492	79414	287	162282	2843	27185	1903	4487	23555	2195	59341	161253	89777	1394	392255	8839	127534	8468	3578	7441	145873	8754	146862	51720	6385	13	116	1760	219699	338328	4257	7349	168330	56475	391123	54874	654429	25959	644021	158763	64762	55815	338761	6753	353143	1409	84517	64102	2561	9828	7436	115908	1005	7984	255488	10816	5730	284353	5911	3746	255022	143689	182	392617	221662	56123	2213	143941	7062	54544	2022	84867	130612	26013	337974	8291	10052	8817	78999	376267	153	378884	10516	1048	10388	54682	3569	4629	8533	689	23217	91646	114786	9462	23024
GSE9946_LISTERIA_INF_MATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP	M430		18802101	Popov A,Driesen J,Abdullah Z,Wickenhauser C,Beyer M,Debey-Pascher S,Saric T,Kummer S,Takikawa O,Domann E,Chakraborty T,Krönke M,Utermöhlen O,Schultze JL	GSE9946	GSE9946_2758_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in mature inhibitory dendritic cells: L. monocytogenes infection versus prostaglandin E2 [PubChem=5280360].	Myeloid dendritic cells (DC) and macrophages play an important role in pathogen sensing and antimicrobial defense. Recently we demonstrated that infection of human DC with intracellular bacterium Listeria monocytogenes (L.monocytogenes) leads to the induction of the immunoinhibitory enzyme indoleamine 2,3-dioxygenase (Popov et al., J Clin Invest, 2006), while in the previous studies L.monocytogenes infection was associated with a rather stimulatory DC phenotype. To clarify this discrepancy we performed comparative microarray analysis of immature mo-DC (immDC), mature stimulatory mo-DC (matDC) and mature inhibitory DC either stimulated with prostaglandin E2 (PGE2-DC) or infected with L.monocytogenes (infDC). Studying infection of human myeloid DC with Listeria monocytogenes, we found out, that infected DC are modified by the pathogen to express multiple inhibitory molecules, including indoleamine 2,3-dioxygenase (IDO), cyclooxygenase-2, interleukin 10 and CD25, which acts on DC as IL-2 scavenger. All these inhibitory molecules, expressed on regulatory DC (DCreg), are strictly TNF-dependent and are in concert suppressing T-cell responses. Moreover, only DCreg can efficiently control the number of intracellular listeria, mostly by IDO-mediated mechanisms and by other factors, remaining to be identified. Analyzing publicly acessible data of transcriptional changes in DC and macrophages, infected by various pathogens and parasites (GEO, GSE360), we noticed that infection of these cells with Mycobacterium tuberculosis causes transcriptional response, comparable with the one caused by listeria in human DC. In fact, granuloma in tuberculosis and listeriosis in vivo are enriched for myeloid DC and macrophages characterized by regulatory phenotype. In summary, regulatory myeloid DC and macrophages may play a dual role during life-threatening granulomatous infections, such as tuberculosis: on one hand, regulatory myeloid cells promote pathogen containment by efficiently killing intracellular bacteria, on the other hand these cells inhibit granuloma-associated T cells and thereby might be involved in the retention of TNF-controlled granuloma integrity protecting the host from granuloma break-down and pathogen dissemination. 					5087	79109	57554	4088	64420	130074	10103	29979	85403	54877	338567	9610	10536	84317	1215	5068	402682	5371	5683	9862	51684	6196	51540	64407	784	6507	10309	5826	9146	196513	222484	9898	84132	2243	129807	23180	23545	64423	3632	2185	23076	643904	150864	5576	6424	283459	284352	3843	5276	7547	6558	55821	355	4046	9562	7726	51151	84851	6653	22882	4804	752	266743	79039	55142	23671	22906	2149	84936	9467	9739	28996	22877	9980	9612	64598	135644	3069	138307	84631	6844	57546	23177	129685	49856	83538	440590	5929	83990	346171	25942	56890	9114	337878	4763	51267	1538	88	348807	6462	9028	10276	7088	83876	222255	9139	8888	57630	10392	8894	5350	91445	1821	2115	25992	23013	4703	2317	84217	79838	23507	6774	349136	57610
GSE9946_LISTERIA_INF_MATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN	M431		18802101	Popov A,Driesen J,Abdullah Z,Wickenhauser C,Beyer M,Debey-Pascher S,Saric T,Kummer S,Takikawa O,Domann E,Chakraborty T,Krönke M,Utermöhlen O,Schultze JL	GSE9946	GSE9946_2758_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in mature inhibitory dendritic cells: L. monocytogenes infection versus prostaglandin E2 [PubChem=5280360].	Myeloid dendritic cells (DC) and macrophages play an important role in pathogen sensing and antimicrobial defense. Recently we demonstrated that infection of human DC with intracellular bacterium Listeria monocytogenes (L.monocytogenes) leads to the induction of the immunoinhibitory enzyme indoleamine 2,3-dioxygenase (Popov et al., J Clin Invest, 2006), while in the previous studies L.monocytogenes infection was associated with a rather stimulatory DC phenotype. To clarify this discrepancy we performed comparative microarray analysis of immature mo-DC (immDC), mature stimulatory mo-DC (matDC) and mature inhibitory DC either stimulated with prostaglandin E2 (PGE2-DC) or infected with L.monocytogenes (infDC). Studying infection of human myeloid DC with Listeria monocytogenes, we found out, that infected DC are modified by the pathogen to express multiple inhibitory molecules, including indoleamine 2,3-dioxygenase (IDO), cyclooxygenase-2, interleukin 10 and CD25, which acts on DC as IL-2 scavenger. All these inhibitory molecules, expressed on regulatory DC (DCreg), are strictly TNF-dependent and are in concert suppressing T-cell responses. Moreover, only DCreg can efficiently control the number of intracellular listeria, mostly by IDO-mediated mechanisms and by other factors, remaining to be identified. Analyzing publicly acessible data of transcriptional changes in DC and macrophages, infected by various pathogens and parasites (GEO, GSE360), we noticed that infection of these cells with Mycobacterium tuberculosis causes transcriptional response, comparable with the one caused by listeria in human DC. In fact, granuloma in tuberculosis and listeriosis in vivo are enriched for myeloid DC and macrophages characterized by regulatory phenotype. In summary, regulatory myeloid DC and macrophages may play a dual role during life-threatening granulomatous infections, such as tuberculosis: on one hand, regulatory myeloid cells promote pathogen containment by efficiently killing intracellular bacteria, on the other hand these cells inhibit granuloma-associated T cells and thereby might be involved in the retention of TNF-controlled granuloma integrity protecting the host from granuloma break-down and pathogen dissemination. 					29944	10368	221468	55901	1491	149018	4248	51226	374907	51071	388818	59272	23026	81832	51388	100125288	84953	8706	3784	221143	2974	493829	8787	23593	2596	2257	7837	7390	3859	2213	283208	80125	64208	168002	63904	1414	27185	91522	158763	4293	29850	51406	85480	10158	54550	1956	414918	121355	2646	64172	7102	113091	9911	650	1687	63924	2013	55016	165530	79101	55089	9476	5874	130271	1005	4855	2998	6205	6910	8613	143689	150280	118980	22931	142680	2264	56603	7436	120114	7167	1950	54661	346653	440503	730	339967	1361	7411	4733	55863	10232	200879	6518	135892	1636	2488	83659	170589	658	55258	374569	91862	200728	730130	221	398	143471	266727	114757	11005	255743
GSE12484_HEALTHY_VS_PERIDONTITIS_NEUTROPHILS_DN	M432		18832737	Wright HJ,Matthews JB,Chapple IL,Ling-Mountford N,Cooper PR	GSE12484	GSE12484_2752_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in neutrophils isolated from: healthy versus patients with peridontitis.	Peripheral blood neutrophils from periodontitis patients exhibit a hyper-reactive and hyper-active phenotype (collectively termed hyper-responsivity) in terms of production of reactive oxygen species (ROS) however the molecular basis for this observation is yet to be determined. Our objectives were to identify genes differentially expressed in hyper-responsive peripheral blood neutrophils from chronic periodontitis patients relative to periodontally healthy controls and use this data to identify potential contributory pathways to the hyper-responsive neutrophil phenotype.					10985	57596	3054	7409	79657	219333	4830	11144	5408	29922	9962	10463	257068	29950	51311	84317	8570	9886	2702	55020	145942	79658	30849	9861	839	10076	10197	6051	5837	80036	1650	2317	270	5713	729025	5828	4063	23768	5686	7547	4354	5576	286053	9899	9328	5226	865	1655	9712	10737	55266	3229	23177	27022	8893	51655	83450	388698	7135	2653	3778	9392	55294	22876	23167	7469	283358	23059	55622	140731	6522	441168	1621	55531	23479	54497	2330	526	84919	57510	26190	780	5519	100	282679	171389	84631	1975	5427	79134	79607	55884	7204	57446	631	29940	129685	158234	64222	8851	81566	10907	84340	353288	27229	79711	23154	2926	23641	55113	57716	10208	153830	161247	55052	11222	5655	366	9114	64145	4124	3267	126402	2909	55821	84132	84365	25782	145864	10171	5478	10066	51626	11102	123688	55783	339345	353345	60528	5093	8563	5550	63933	7965	10910	54537	114960	60561	221823
GSE12484_HEALTHY_VS_PERIDONTITIS_NEUTROPHILS_UP	M433		18832737	Wright HJ,Matthews JB,Chapple IL,Ling-Mountford N,Cooper PR	GSE12484	GSE12484_2752_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in neutrophils isolated from: healthy versus patients with peridontitis.	Peripheral blood neutrophils from periodontitis patients exhibit a hyper-reactive and hyper-active phenotype (collectively termed hyper-responsivity) in terms of production of reactive oxygen species (ROS) however the molecular basis for this observation is yet to be determined. Our objectives were to identify genes differentially expressed in hyper-responsive peripheral blood neutrophils from chronic periodontitis patients relative to periodontally healthy controls and use this data to identify potential contributory pathways to the hyper-responsive neutrophil phenotype.					4014	5313	3055	79370	9022	89885	10858	151230	493829	3339	4225	51285	54112	123745	64682	26525	392255	94033	54331	10516	136853	29944	1950	9411	340706	56475	2850	135138	6534	6886	83886	10561	343	5021	284040	3918	83657	9911	6474	89777	27299	3931	22925	2705	9290	4056	29984	5893	222894	5222	10407	642273	200728	161514	202018	1140	1427	116	6862	5319	9217	2046	53630	57699	22999	5949	6657	80332	6916	285525	414918	1048	8541	929	114784	2947	3458	126075	387990	2781	120224	51249	2624	8913	55349	786	93034	257019	81615	124402	121256	64102	9177	27031	8497	200879	389400	162387	255426	4194	55068	5774	84749	2134	346	84002	158248	4756	4745	64805	30010	9610	55553	353143	51339	388931	64518	2049	3204	81492	124535	362	51267	5054	8817	7704	84343	55897	9073	8468	153733	23705
GSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_UP	M438		18854153	Cisse B,Caton ML,Lehner M,Maeda T,Scheu S,Locksley R,Holmberg D,Zweier C,Hollander den NS,Kant SG,Holter W,Rauch A,Zhuang Y,Reizis B	GSE12507	GSE12507_2252_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CAL1 cells (plasmacytoid dendritic cells) versus MOLT4 (immature T cells).	Analysis of expression profiles of human pDC cell line (CAL1) compared to an immature T cell line (MOLT4) 					374354	149175	10733	10096	80319	122706	5366	6745	3284	8438	166379	1021	5319	125965	548645	64116	79370	2762	10426	60401	9846	79621	6950	55706	64783	100131755	10194	6731	9641	27085	152137	4193	51096	4763	64172	59272	4173	26509	114	3895	27010	51426	63967	1447	10581	7216	5906	55203	8645	51378	79003	2521	6400	89777	2176	283742	5932	11168	5446	6340	55125	7167	440	80021	55347	2673	5230	1081	2187	5276	116442	139231	8453	586	1363	6240	4174	5471	54206	54443	9793	2597	6925	51520	3669	9156	131583	54762	2813	90550	2650	78988	900	10892	10560	54801	286148	3838	8148	64151	29914	2620	7398	55320	143279	27242	9372	81542	5358	10158	159195	55973	57082	6675	132954	79959	23035	10926	4999	9789	258	92906	5558	9246	54875	3382	10208	64089	1437	134492	23468	6520	93035	23517	1060	462	5355	1635	4361	2670	9197	10404	6451	3936	54682	340120	4194	26272	80224	27229	10276
GSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_DN	M440		18854153	Cisse B,Caton ML,Lehner M,Maeda T,Scheu S,Locksley R,Holmberg D,Zweier C,Hollander den NS,Kant SG,Holter W,Rauch A,Zhuang Y,Reizis B	GSE12507	GSE12507_2252_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CAL1 cells (plasmacytoid dendritic cells) versus MOLT4 (immature T cells).	Analysis of expression profiles of human pDC cell line (CAL1) compared to an immature T cell line (MOLT4) 					8516	11113	140732	9862	53630	3767	8723	55506	4356	64208	653361	56123	5184	84000	694	55027	51143	26960	5826	9132	3655	3284	220032	8495	197322	1215	1380	1307	10642	60481	7044	9911	114788	23673	84779	127534	492	6098	10560	55211	8841	2596	786	6242	641372	1278	2645	79801	200879	9633	55973	149998	4158	340706	10953	900	55207	9783	23544	81542	284353	56287	91181	23413	165530	114818	8654	83890	342931	79611	4054	23508	154150	51379	157570	353143	9712	27299	4360	2840	64083	9464	135892	140766	84952	3574	116	23650	5493	56992	51052	153733	9023	125058	5284	26256	287	124739	2059	200845	7080	338761	90668	84236	55016	253012	10595	10266	152831	644021	64102	55299	386672	3860	167826	27095	686	6862	5030	3776	5874	23760	6474	348378	23107	8876	6000	4535	341405	51249	4327	137735	120224	79621
GSE12839_CTRL_VS_IL12_TREATED_PBMC_DN	M441		19001140	Watford WT,Hissong BD,Durant LR,Yamane H,Muul LM,Kanno Y,Tato CM,Ramos HL,Berger AE,Mielke L,Pesu M,Solomon B,Frucht DM,Paul WE,Sher A,Jankovic D,Tsichlis PN,O'Shea JJ	GSE12839	GSE12839_2401_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in peripheral blood monocytes (PBMC): control versus IL-12 stimulation.	The cytokine interleukin-12 (IL-12) is known to play a central role in adaptive and innate immunity. We employed microarray analysis of IL-12 induced gene expression to provide further insights into its effects on immune response. 					2116	7123	161823	404544	27202	122786	4842	79153	57554	6289	92017	22906	3189	120114	51701	54852	9149	6574	170384	4761	81566	135644	23451	124961	26762	5837	27145	130560	2006	27158	116986	114	8570	84985	83546	10985	1831	1953	115701	144193	1687	124912	6567	54623	23072	6844	10998	51082	9697	177	9962	80863	7137	85569	4804	9028	8074	124056	7373	63891	223117	112609	1655	342035	6774	64506	166348	23536	55531	83538	51479	51684	343702	9152	221914	84779	93661	140731	200407	170370	10827	4485	88	29116	7454	287	83733	152519	29068	55339	3423	284613	54497	1112	23225	441024	326342	6000	51560	7276	1259	3543	152273	79870	6911	2531	169026	494513	8929	6707	221823	29109	3853	22953	23023	84631	23550
GSE12839_CTRL_VS_IL12_TREATED_PBMC_UP	M442		19001140	Watford WT,Hissong BD,Durant LR,Yamane H,Muul LM,Kanno Y,Tato CM,Ramos HL,Berger AE,Mielke L,Pesu M,Solomon B,Frucht DM,Paul WE,Sher A,Jankovic D,Tsichlis PN,O'Shea JJ	GSE12839	GSE12839_2401_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in peripheral blood monocytes (PBMC): control versus IL-12 stimulation.	The cytokine interleukin-12 (IL-12) is known to play a central role in adaptive and innate immunity. We employed microarray analysis of IL-12 induced gene expression to provide further insights into its effects on immune response. 					1650	55812	1894	55012	2597	6642	3998	5288	6871	3090	2670	9209	3761	23612	51727	4282	7164	29922	79809	255252	84515	219699	4779	131583	9846	7074	1363	1212	84928	53354	11044	5828	100125288	116	79801	9246	84324	57222	150280	10200	23052	10926	3012	54331	23555	22837	11336	6125	55347	51335	51154	55859	23197	219844	6612	440	10342	10561	1207	11321	1409	54948	5890	54443	26003	56950	6484	4745	284418	9631	8447	63979	54675	2299	22883	56126	123263	6845	55142	60485	54704	55627	1447	10959	1893	55245	55596	55294	84275	7411	51096	152137	10149	50628	84896	6746	7138	55203	27089	6520	64855	27044	64065	57465	84333	844	8360	5933	90843	11072	8836	8800	2110	5558	157570	64499	63982	123355	6624	84101	9177	84879	125965	8805	5000	55915	2720	388698	25945	11113	28973	197322	8639	60386	558	54206	5686	3915	25975	1374	1397	56475	79053	672	4201	641	10483	3976
GSE12963_UNINF_VS_ENV_AND_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_UP	M447		19050264	Dabrowska A,Kim N,Aldovini A	GSE12963	GSE12963_2629_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in control CD4 [GeneID=920] T cells versus those infected with HIV-1 viruses lacking Env, Vpr and Nef.	The high mutation rate of HIV is linked to the generation of viruses expressing proteins with altered function whose impact on disease progression is unknown. We investigated the effects of HIV-1 viruses lacking Env, Vpr and Nef on CD4+ T cell gene expression using high-density DNA microarray analysis and functional assays. 					57007	8763	51082	8756	56898	2743	11183	285782	5451	4686	387921	57626	388730	55975	1832	11274	3167	122786	84289	51151	6898	3849	221955	84514	6295	8349	346171	54943	152831	84498	959	134288	9139	23386	84674	151112	26205	839	51232	257068	283897	65005	7373	627	9920	11005	51701	23283	3759	5805	64599	3628	57463	9962	51652	5567	284611	1259	23641	55339	57542	54883	54951	28962	27102	27241	57057	2533	23023	83538	93973	53841	9270	6574	7597	2135	152926	5786	64219	65249	10827	10333	375287	6775	8439	3020	25942	129563	170082	1600	55531	112703	23339	9931	4214	55823	83546	2217	223117	4090	140880	6879	282679	79872	57665	571	4045	9130	283927	4811	9236	79658	6621	167826	55617	129285	23635	2850	83890	9841	51167	26762	152519	81576	59349	79618	22800	63933	10765	23613
GSE12963_UNINF_VS_ENV_AND_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_DN	M448		19050264	Dabrowska A,Kim N,Aldovini A	GSE12963	GSE12963_2629_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in control CD4 [GeneID=920] T cells versus those infected with HIV-1 viruses lacking Env, Vpr and Nef.	The high mutation rate of HIV is linked to the generation of viruses expressing proteins with altered function whose impact on disease progression is unknown. We investigated the effects of HIV-1 viruses lacking Env, Vpr and Nef on CD4+ T cell gene expression using high-density DNA microarray analysis and functional assays. 					55901	23246	8438	7057	23612	644444	6385	4282	3821	3249	51429	5902	321	6351	55840	56950	22837	1745	2769	79075	1894	79711	11346	5270	8600	55859	55173	255626	114	23212	54897	80323	80318	5223	23120	10452	30814	1397	79094	2774	79083	8613	387712	3383	10342	730249	131578	27242	7064	747	2921	9343	6002	11138	84617	23	124930	81832	221184	55812	7511	1956	260429	9828	128853	23649	80319	65244	118788	2597	9500	285800	54443	5662	79883	10066	51804	1813	3822	153733	54957	60485	404093	5355	64065	51561	54829	55349	997	140738	2670	378884	1329	6464	22883	56981	55815	83743	5721	119391	54970	221409	84867	27255	493829	150771	388595	63967	4291	346653	3838	78991	23109	2998	7272	85463	126075	79147	55561	3055	5624	390443	8893	682	5068	10149	27089	790	23544	2161	10158	23207
GSE12963_UNINF_VS_ENV_AND_NEF_DEFICIENT_HIV1_INF_CD4_TCELL_UP	M449		19050264	Dabrowska A,Kim N,Aldovini A	GSE12963	GSE12963_2628_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in control CD4 [GeneID=920] T cells versus those infected with HIV-1 viruses lacking Env and Nef.	The high mutation rate of HIV is linked to the generation of viruses expressing proteins with altered function whose impact on disease progression is unknown. We investigated the effects of HIV-1 viruses lacking Env, Vpr and Nef on CD4+ T cell gene expression using high-density DNA microarray analysis and functional assays. 					3757	56257	63891	1114	80228	114824	64761	714	8449	26523	80143	23154	50805	1783	64222	54623	84240	56121	6668	1746	778	146	11181	10564	79813	83546	112703	79618	284613	80331	3665	3849	1831	150864	200132	64219	1181	118424	287015	130074	8312	2952	55339	29942	80271	2900	51335	126003	6305	55113	64599	2785	3853	124402	64784	50846	79781	10425	5409	8912	57542	161145	84851	55568	4088	80863	7597	7454	1128	29985	51450	752	122786	222255	2185	23479	9402	3460	4325	353288	161823	170591	84629	6208	23072	11060	9425	2743	1364	1186	84895	3776	4090	79663	784	134288	55020	57659	10076	64598	140732	129807	23094	6141	1401	139285	6507	55033	51000	7049	2811	84247	1211	268	55971	55742	129685	3995	151112	7726	23067	6299	51204	2810	84985	9331	283514	79754	4025	7054	916	51684	8497	10463	80303	122481	9130
GSE12963_UNINF_VS_ENV_AND_NEF_DEFICIENT_HIV1_INF_CD4_TCELL_DN	M452		19050264	Dabrowska A,Kim N,Aldovini A	GSE12963	GSE12963_2628_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in control CD4 [GeneID=920] T cell versus those infected with HIV-1 viruses lacking Env and Nef.	The high mutation rate of HIV is linked to the generation of viruses expressing proteins with altered function whose impact on disease progression is unknown. We investigated the effects of HIV-1 viruses lacking Env, Vpr and Nef on CD4+ T cell gene expression using high-density DNA microarray analysis and functional assays. 					900	9209	2769	1894	221188	2762	5906	5471	3077	64327	2013	11278	1674	84515	22843	9631	5366	8438	55320	3161	404203	1956	1687	5890	63904	10733	79621	9793	151230	79075	5354	8836	55815	1048	345275	23654	10926	26509	2118	4591	57465	57619	55901	55833	7105	414918	4071	84978	3843	80218	1615	63967	6910	11199	3703	81848	10592	79083	56950	56907	6624	55203	10845	26279	1005	153733	283208	221184	5603	2791	8468	10054	1813	64065	53354	378884	2521	672	5911	6385	580	1728	1434	79959	3839	1329	929	9652	57082	5288	3838	91663	6925	92345	830	89885	65987	120227	3620	129642	149420	8534	60559	79159	4771	63979	4622	57194	2326	7163	990	131583	222553	11113	8817	730130	3488	64783	2596	9580	338761	23127	2491	26960	23279	64499	54443	6344	9125	3131	7398	9	200728	78988	92105
GSE12963_ENV_NEF_VS_ENV_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_UP	M455		19050264	Dabrowska A,Kim N,Aldovini A	GSE12963	GSE12963_2630_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells infected with Env/Nef deficient HIV-1 viruses versus those infected with HIV-1 viruses lacking Env, Nef and Vpr.	The high mutation rate of HIV is linked to the generation of viruses expressing proteins with altered function whose impact on disease progression is unknown. We investigated the effects of HIV-1 viruses lacking Env, Vpr and Nef on CD4+ T cell gene expression using high-density DNA microarray analysis and functional assays. 					686	58525	23211	8477	22906	2533	79618	4189	255043	64222	27158	7351	57542	1497	2267	9612	8888	1112	100130771	10953	284273	54877	571	1259	9962	196996	5371	7536	80143	51701	172	283777	26205	9525	5837	4798	64922	22885	57799	26235	54883	222698	9416	143879	54520	64145	51232	54558	3635	55823	30849	54957	116092	914	6574	6707	3811	9712	7320	4092	338557	84456	79017	5045	130752	91875	10620	2683	6916	140578	5791	25992	152926	79939	57554	23536	85441	22864	391002	55339	51230	4204	10333	27241	1538	170384	375287	284654	346171	5581	6780	79781	284252	9931	56850	23438	59349	23030	2072	64319	4617	8315	11176	51560	80004	5150	407738	6649	8449	79813	79663	84643	23386	10827	3556	9841	23221	23023	22877	780	8491	51479	8570	9980	57488
GSE12963_ENV_NEF_VS_ENV_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_DN	M458		19050264	Dabrowska A,Kim N,Aldovini A	GSE12963	GSE12963_2630_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells infected with Env/Nef deficient HIV-1 viruses versus those infected with HIV-1 viruses lacking Env, Nef and Vpr.	The high mutation rate of HIV is linked to the generation of viruses expressing proteins with altered function whose impact on disease progression is unknown. We investigated the effects of HIV-1 viruses lacking Env, Vpr and Nef on CD4+ T cell gene expression using high-density DNA microarray analysis and functional assays. 					51154	9324	51728	29091	8335	79370	1894	3383	3767	6857	79696	130612	1329	2264	221468	6385	84515	92840	5226	79801	8324	7130	283152	1650	157570	4591	85445	22883	197322	221184	3161	6624	23649	2207	2103	3090	8170	79094	8438	9001	51226	22925	23052	414918	50628	56475	56907	5890	64102	5902	3692	6240	54443	23612	11044	91614	182	154197	10928	55379	79607	4830	2597	9390	6746	10403	255022	4173	23596	3821	7167	170589	151473	6512	8613	257236	151246	4356	1132	27242	1006	4487	23107	80157	56287	64762	55831	93661	3382	284013	55052	990	79101	302	462	84324	1636	4174	4756	493829	64600	5874	153745	23555	126820	56950	5270	2491	51293	5800	3761	9376	54206	1728	4642	9156	326342	7272	63979	641	65110	221188	3148	25975	150771	355	64802	5230	85463	11030	55812	7980	51252	997	79053	388121	23767	27023	474	3832	6002	81928	2769	64407	51388	7253
GSE11367_CTRL_VS_IL17_TREATED_SMOOTH_MUSCLE_CELL_UP	M460		19075290	Rao DA,Eid RE,Qin L,Yi T,Kirkiles-Smith NC,Tellides G,Pober JS	GSE11367	GSE11367_3380_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in vascular smooth muscle cells: control versus treated with IL17A [GeneID=3605].	Investigate the effect of recombinant human IL-17A on vascular smooth muscle cells cultured from human aortas.					171169	389827	5933	57596	199786	55742	4917	23593	23072	6668	27430	246330	6734	7916	144193	79632	6507	9139	23126	339291	29944	115426	4045	256380	4041	6774	79039	91862	287015	128218	10954	84033	23030	27022	89894	3646	219333	119467	164237	151112	80863	4248	63895	79955	51684	133022	8120	23067	25937	7373	7351	121227	5409	10425	55833	10928	100506658	55784	1291	202018	1180	414301	442721	56888	5576	10103	54805	6291	10076	10160	440955	11160	80022	23768	196463	4158	5533	4821	140766	9825	22882	3993	2006	159	29979	441061	64222	83886	80004	3507	8929	8372	9781	84317	124044	3267	55821	8756	6857	54842	286828	2649	118812	55527	8785	3209	3054	284467	58475	51475	348807	442425	134265	6424	7051	124402	147409	2969	83446	64319	49856	9866	6909	284252	196527	9313	6531	92691	784	27039	79781	83844
GSE11367_CTRL_VS_IL17_TREATED_SMOOTH_MUSCLE_CELL_DN	M461		19075290	Rao DA,Eid RE,Qin L,Yi T,Kirkiles-Smith NC,Tellides G,Pober JS	GSE11367	GSE11367_3380_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in vascular smooth muscle cells: control versus treated with IL17A [GeneID=3605].	Investigate the effect of recombinant human IL-17A on vascular smooth muscle cells cultured from human aortas.					1329	1728	120227	55783	2974	5226	341640	221188	3991	23191	55859	79412	6656	64762	1102	7441	55203	166785	221	55347	64419	59353	132141	200845	3223	8993	54852	79068	830	84647	11006	11025	85445	56126	5657	440699	51378	27077	85480	130612	29943	55298	2752	8800	3359	83643	54874	221662	85865	10269	84000	159686	2521	151230	5874	5004	5152	266977	147	10158	340061	386672	387758	353189	9	54549	92105	7453	64922	4481	1491	55341	2769	81928	387712	3669	339967	7518	887	79083	79871	79087	8942	4046	57115	929	6745	79607	90293	6344	10816	3070	2561	312	7052	54331	2681	1495	3696	10902	1081	79745	126820	339416	79623	80380	55016	9779	2023
GSE13887_ACT_CD4_VS_NO_TREATED_CD4_TCELL_DN	M474		19201859	Fernandez DR,Telarico T,Bonilla E,Li Q,Banerjee S,Middleton FA,Phillips PE,Crow MK,Oess S,Muller-Esterl W,Perl A	GSE13887	GSE13887_2807_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells from healthy donors: activated by anti-CD3 and anti-CD28 versus nitric oxide [PubChem=145068] treatment.	CD3-positive T cells were negatively isolated from 10 SLE patients and 9 healthy controls without SLE. All of the SLE samples and control samples were compared with one another to identify baseline differences in expression due to the disease. Next, T cell preparations from 4 of the control subjects were stimulated with either Nitric Oxide (NOC-18) 600 uM for 24hr or stimulated through CD3/CD28 for 24hr to determine which genes were responsive to these signaling mechanisms. Here, we show that activity of the mammalian target of rapamycin (mTOR), which is a sensor of the mitochondrial transmembrane potential, is increased in SLE T cells. Activation of mTOR was inducible by NO, a key trigger of MHP which in turn enhanced the expression of HRES-1/Rab4, a small GTPase that regulates recycling of surface receptors through early endosomes. Expression of HRES-1/Rab4 was increased in SLE T cells and, in accordance with its dominant impact on the endocytic recycling of CD4, it was inversely correlated with diminished CD4 expression. HRES-1/Rab4 over-expression was also inversely correlated with diminished TCRζ protein levels. Combined with follow up studies, these results suggest that activation of mTOR causes the loss of TCRζ in lupus T cells through HRES-1/Rab4-dependent lysosomal degradation.					26509	4242	6751	113091	285368	50865	64761	4147	84623	387266	1419	55334	64784	64208	59353	84247	283948	130013	51208	10637	92610	3479	131377	58157	6507	3202	140686	287015	251	11085	7454	286	131616	51450	126868	5959	23017	1581	25937	27091	170690	27257	54921	5067	169611	201501	3543	80331	2735	10564	10656	7355	886	22921	94235	54849	7049	54546	2642	11309	43847	8538	170591	10777	10949	80031	4887	160897	22808	2975	285220	283869	7094	3868	146852	5564	100130302	55113	84951	83450	4829	64222	26279	92211	27304	8578	343450	390598	260429	11076	55190	2810	11131	118980	5373	778	8404	89866	29985	64806	377007	340156	8727	116729	27063	2946	10017	8692	256646	50506	160364	89886	7862	84691	338599	80303	3297	2627	151531	63891	9390	392862	147746	253559
GSE13887_HEALTHY_VS_LUPUS_RESTING_CD4_TCELL_DN	M475		19201859	Fernandez DR,Telarico T,Bonilla E,Li Q,Banerjee S,Middleton FA,Phillips PE,Crow MK,Oess S,Muller-Esterl W,Perl A	GSE13887	GSE13887_2804_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in resting CD4 [GeneID=920] T cells: healthy versus systemic lupus erythrematosus (SLE).	CD3-positive T cells were negatively isolated from 10 SLE patients and 9 healthy controls without SLE. All of the SLE samples and control samples were compared with one another to identify baseline differences in expression due to the disease. Next, T cell preparations from 4 of the control subjects were stimulated with either Nitric Oxide (NOC-18) 600 uM for 24hr or stimulated through CD3/CD28 for 24hr to determine which genes were responsive to these signaling mechanisms. Here, we show that activity of the mammalian target of rapamycin (mTOR), which is a sensor of the mitochondrial transmembrane potential, is increased in SLE T cells. Activation of mTOR was inducible by NO, a key trigger of MHP which in turn enhanced the expression of HRES-1/Rab4, a small GTPase that regulates recycling of surface receptors through early endosomes. Expression of HRES-1/Rab4 was increased in SLE T cells and, in accordance with its dominant impact on the endocytic recycling of CD4, it was inversely correlated with diminished CD4 expression. HRES-1/Rab4 over-expression was also inversely correlated with diminished TCRζ protein levels. Combined with follow up studies, these results suggest that activation of mTOR causes the loss of TCRζ in lupus T cells through HRES-1/Rab4-dependent lysosomal degradation.					1634	57605	8447	10845	55125	11051	493861	11253	8836	284992	360226	10928	55785	56133	1512	333929	57489	8945	55973	29889	23768	3184	4009	340371	1615	7334	3164	3683	84919	800	114836	9650	85445	10768	26994	9859	53822	113235	153562	5333	2555	23380	5993	26135	1179	25926	285180	158787	175	159686	80018	11311	84969	9747	4958	51361	4750	51517	7398	3839	79870	55277	9	573	6545	5515	147645	22843	9723	3552	79789	4900	23294	51372	2665	256764	6642	900	54866	2875	65977	219844	9033	414918	5358	865	8785	5757	57105	54801	56970	1060	23531	6736	54842	54505	84547	10265	54841	10943	149420	6159	23071	1063	2553	387712	6059	5957	394	11034	7073	9743	84108	51762	27333	84675
GSE13887_RESTING_VS_ACT_CD4_TCELL_UP	M478		19201859	Fernandez DR,Telarico T,Bonilla E,Li Q,Banerjee S,Middleton FA,Phillips PE,Crow MK,Oess S,Muller-Esterl W,Perl A	GSE13887	GSE13887_2805_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells from healthy donors: resting versus activated by anti-CD3 and anti-CD28.	CD3-positive T cells were negatively isolated from 10 SLE patients and 9 healthy controls without SLE. All of the SLE samples and control samples were compared with one another to identify baseline differences in expression due to the disease. Next, T cell preparations from 4 of the control subjects were stimulated with either Nitric Oxide (NOC-18) 600 uM for 24hr or stimulated through CD3/CD28 for 24hr to determine which genes were responsive to these signaling mechanisms. Here, we show that activity of the mammalian target of rapamycin (mTOR), which is a sensor of the mitochondrial transmembrane potential, is increased in SLE T cells. Activation of mTOR was inducible by NO, a key trigger of MHP which in turn enhanced the expression of HRES-1/Rab4, a small GTPase that regulates recycling of surface receptors through early endosomes. Expression of HRES-1/Rab4 was increased in SLE T cells and, in accordance with its dominant impact on the endocytic recycling of CD4, it was inversely correlated with diminished CD4 expression. HRES-1/Rab4 over-expression was also inversely correlated with diminished TCRζ protein levels. Combined with follow up studies, these results suggest that activation of mTOR causes the loss of TCRζ in lupus T cells through HRES-1/Rab4-dependent lysosomal degradation.					286	6355	4199	11190	23030	89778	7976	3812	3698	151254	85414	112609	3213	23491	3552	4318	5314	23211	92822	962	55334	195977	284119	4887	338879	57582	57459	79068	284904	116337	9771	51686	105	121278	386724	431707	358	280660	4921	7916	83481	89777	60488	260429	51804	26999	219736	342371	27304	22808	23251	1773	4773	23671	254228	2975	57198	5957	51604	1411	130399	89886	150921	6649	79442	85293	25885	79613	23127	645694	6406	5720	50865	1068	8315	84247	153657	83860	134864	6707	7358	4802	9350	135228	3620	252969	118491	5148	2709	5289	116092	84953	25854	5445	3938	100130771	120526	284654	142680	399909	1778
GSE13887_RESTING_VS_NO_TREATED_CD4_TCELL_DN	M479		19201859	Fernandez DR,Telarico T,Bonilla E,Li Q,Banerjee S,Middleton FA,Phillips PE,Crow MK,Oess S,Muller-Esterl W,Perl A	GSE13887	GSE13887_2806_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells from healthy donors: resting versus nitric oxide [PubChem=145068].	CD3-positive T cells were negatively isolated from 10 SLE patients and 9 healthy controls without SLE. All of the SLE samples and control samples were compared with one another to identify baseline differences in expression due to the disease. Next, T cell preparations from 4 of the control subjects were stimulated with either Nitric Oxide (NOC-18) 600 uM for 24hr or stimulated through CD3/CD28 for 24hr to determine which genes were responsive to these signaling mechanisms. Here, we show that activity of the mammalian target of rapamycin (mTOR), which is a sensor of the mitochondrial transmembrane potential, is increased in SLE T cells. Activation of mTOR was inducible by NO, a key trigger of MHP which in turn enhanced the expression of HRES-1/Rab4, a small GTPase that regulates recycling of surface receptors through early endosomes. Expression of HRES-1/Rab4 was increased in SLE T cells and, in accordance with its dominant impact on the endocytic recycling of CD4, it was inversely correlated with diminished CD4 expression. HRES-1/Rab4 over-expression was also inversely correlated with diminished TCRζ protein levels. Combined with follow up studies, these results suggest that activation of mTOR causes the loss of TCRζ in lupus T cells through HRES-1/Rab4-dependent lysosomal degradation.					3417	3422	10955	51293	28978	2350	64837	5593	5145	23291	5080	50628	51256	219844	222611	3696	26012	5423	6281	64407	10928	54386	23633	6222	2157	55602	8787	355	79025	139599	2898	440021	55133	59	10438	4067	4626	8671	1524	84102	8814	153527	8351	55277	6159	5874	60494	343099	6457	10455	493860	23596	3145	22931	4321	26996	1509	645432	50487	84324	5504	25934	7168	1063	8504	64743	29896	414918	64225	10923	883	960	2620	11079	6143	54841	4818	573	374618	9747	139562	6247	54221	2717	63908	1393	7462	84869	51372	6048	27445	3456	6170	5270	528	64320	952	4883	2273	56130	1349	2108	2664	2222	10253	114826	9412	23641
GSE13887_ACT_CD4_VS_NO_TREATED_CD4_TCELL_UP	M481		19201859	Fernandez DR,Telarico T,Bonilla E,Li Q,Banerjee S,Middleton FA,Phillips PE,Crow MK,Oess S,Muller-Esterl W,Perl A	GSE13887	GSE13887_2807_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells from healthy donors: activated by anti-CD3 and anti-CD28 versus nitric oxide [PubChem=145068] treatment.	CD3-positive T cells were negatively isolated from 10 SLE patients and 9 healthy controls without SLE. All of the SLE samples and control samples were compared with one another to identify baseline differences in expression due to the disease. Next, T cell preparations from 4 of the control subjects were stimulated with either Nitric Oxide (NOC-18) 600 uM for 24hr or stimulated through CD3/CD28 for 24hr to determine which genes were responsive to these signaling mechanisms. Here, we show that activity of the mammalian target of rapamycin (mTOR), which is a sensor of the mitochondrial transmembrane potential, is increased in SLE T cells. Activation of mTOR was inducible by NO, a key trigger of MHP which in turn enhanced the expression of HRES-1/Rab4, a small GTPase that regulates recycling of surface receptors through early endosomes. Expression of HRES-1/Rab4 was increased in SLE T cells and, in accordance with its dominant impact on the endocytic recycling of CD4, it was inversely correlated with diminished CD4 expression. HRES-1/Rab4 over-expression was also inversely correlated with diminished TCRζ protein levels. Combined with follow up studies, these results suggest that activation of mTOR causes the loss of TCRζ in lupus T cells through HRES-1/Rab4-dependent lysosomal degradation.					60437	360226	5911	84814	124872	221468	2016	55785	130013	3765	163589	57497	155066	713	50865	358	10345	222642	153657	23772	55532	55812	117248	64581	4588	9886	128218	84700	10637	338917	10017	5317	27189	5002	79825	23562	246330	1113	10998	64208	84448	64081	114898	8170	4055	22854	80144	2826	89797	348378	387264	11341	23682	23217	81565	4041	2829	2703	27063	11309	25924	287015	431707	143282	170690	25937	353500	64386	83481	7916	1068	306	251	624	1188	54546	4886	338	440503	285848	57582	219699	139728	60482	92912	51804	9963	4917	26279	58475	83886	84992	83448	283807	83953	146845	122706	1013	254050	147746	442425	727957	5683	131034	6291	22986	124535	7200	89792	728361	27133	55076	23676	6792	84247	7026	696	3213	26999	4248	89886	150921
GSE13887_RESTING_VS_ACT_CD4_TCELL_DN	M484		19201859	Fernandez DR,Telarico T,Bonilla E,Li Q,Banerjee S,Middleton FA,Phillips PE,Crow MK,Oess S,Muller-Esterl W,Perl A	GSE13887	GSE13887_2805_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells from healthy donors: resting versus activated by anti-CD3 and anti-CD28.	CD3-positive T cells were negatively isolated from 10 SLE patients and 9 healthy controls without SLE. All of the SLE samples and control samples were compared with one another to identify baseline differences in expression due to the disease. Next, T cell preparations from 4 of the control subjects were stimulated with either Nitric Oxide (NOC-18) 600 uM for 24hr or stimulated through CD3/CD28 for 24hr to determine which genes were responsive to these signaling mechanisms. Here, we show that activity of the mammalian target of rapamycin (mTOR), which is a sensor of the mitochondrial transmembrane potential, is increased in SLE T cells. Activation of mTOR was inducible by NO, a key trigger of MHP which in turn enhanced the expression of HRES-1/Rab4, a small GTPase that regulates recycling of surface receptors through early endosomes. Expression of HRES-1/Rab4 was increased in SLE T cells and, in accordance with its dominant impact on the endocytic recycling of CD4, it was inversely correlated with diminished CD4 expression. HRES-1/Rab4 over-expression was also inversely correlated with diminished TCRζ protein levels. Combined with follow up studies, these results suggest that activation of mTOR causes the loss of TCRζ in lupus T cells through HRES-1/Rab4-dependent lysosomal degradation.					832	8517	91624	26269	11057	5004	4685	55295	10923	127018	5757	3665	222484	55602	6731	80059	10412	79087	1896	921	6159	11326	23588	374618	5597	7681	5423	84940	6782	2631	3157	11253	3081	51654	64837	10100	22901	10438	10039	7498	25972	835	9742	84078	285313	9	143888	9139	84675	301	54386	11097	2677	7441	8812	5564	79654	23569	1877	670	9173	3422	1879	25978	8287	26499	55283	56127	159686	414918	9411	2690	883	54840	144402	121665	79979	92714	3987	5172	4292	114787	11213	5145	64127	677769	26548	29929	203102	148753	9973	404093	23353	1432	55759	3683	147645	84324	51667	3141	55277	650	3854	57129	2521	84668	8945	151194	4122	11025	3185	2745	8807	25988	196403	10768	140775	10072	131870	3696	5608	81929	3663	2114
GSE13887_RESTING_VS_NO_TREATED_CD4_TCELL_UP	M485		19201859	Fernandez DR,Telarico T,Bonilla E,Li Q,Banerjee S,Middleton FA,Phillips PE,Crow MK,Oess S,Muller-Esterl W,Perl A	GSE13887	GSE13887_2806_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells from healthy donors: resting versus nitric oxide [PubChem=145068].	CD3-positive T cells were negatively isolated from 10 SLE patients and 9 healthy controls without SLE. All of the SLE samples and control samples were compared with one another to identify baseline differences in expression due to the disease. Next, T cell preparations from 4 of the control subjects were stimulated with either Nitric Oxide (NOC-18) 600 uM for 24hr or stimulated through CD3/CD28 for 24hr to determine which genes were responsive to these signaling mechanisms. Here, we show that activity of the mammalian target of rapamycin (mTOR), which is a sensor of the mitochondrial transmembrane potential, is increased in SLE T cells. Activation of mTOR was inducible by NO, a key trigger of MHP which in turn enhanced the expression of HRES-1/Rab4, a small GTPase that regulates recycling of surface receptors through early endosomes. Expression of HRES-1/Rab4 was increased in SLE T cells and, in accordance with its dominant impact on the endocytic recycling of CD4, it was inversely correlated with diminished CD4 expression. HRES-1/Rab4 over-expression was also inversely correlated with diminished TCRζ protein levels. Combined with follow up studies, these results suggest that activation of mTOR causes the loss of TCRζ in lupus T cells through HRES-1/Rab4-dependent lysosomal degradation.					157922	6345	84951	1809	9420	7976	1240	2266	2864	11173	79956	128153	5877	92745	30819	7980	641700	154150	3765	342898	5067	89866	112609	140706	105	134266	56131	6320	60675	11190	57582	187	2642	260293	80108	50506	94122	126433	51156	342945	160728	134391	7200	138046	7399	10097	8578	51311	1620	126969	283948	92235	201501	10693	91404	9350	285800	2298	22854	2258	3714	5314	139596	83594	55350	5297	79442	116173	374569	158219	118980	3866	8778	85474	6557	6568	319	132299	347730	51207	2829	375189	3747	10570	254295	3270	23676	2780	3892	6569	27286	284427	353500	60343	108	387712	337968	2563	80070	57677	4308	9632	93145	5625	30850	64418	3081	127933	346673	2677	3620	57192	29949	123263	7541	5596	5362	60482	645694	83895	1733	3812	6855	64081	10951	255101	3061
GSE13887_HEALTHY_VS_LUPUS_RESTING_CD4_TCELL_UP	M1889		19201859	Fernandez DR,Telarico T,Bonilla E,Li Q,Banerjee S,Middleton FA,Phillips PE,Crow MK,Oess S,Muller-Esterl W,Perl A	GSE13887	GSE13887_2804_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in resting CD4 [GeneID=920] T cells: healthy versus systemic lupus erythrematosus (SLE).	CD3-positive T cells were negatively isolated from 10 SLE patients and 9 healthy controls without SLE. All of the SLE samples and control samples were compared with one another to identify baseline differences in expression due to the disease. Next, T cell preparations from 4 of the control subjects were stimulated with either Nitric Oxide (NOC-18) 600 uM for 24hr or stimulated through CD3/CD28 for 24hr to determine which genes were responsive to these signaling mechanisms. Here, we show that activity of the mammalian target of rapamycin (mTOR), which is a sensor of the mitochondrial transmembrane potential, is increased in SLE T cells. Activation of mTOR was inducible by NO, a key trigger of MHP which in turn enhanced the expression of HRES-1/Rab4, a small GTPase that regulates recycling of surface receptors through early endosomes. Expression of HRES-1/Rab4 was increased in SLE T cells and, in accordance with its dominant impact on the endocytic recycling of CD4, it was inversely correlated with diminished CD4 expression. HRES-1/Rab4 over-expression was also inversely correlated with diminished TCRζ protein levels. Combined with follow up studies, these results suggest that activation of mTOR causes the loss of TCRζ in lupus T cells through HRES-1/Rab4-dependent lysosomal degradation.					3678	11025	351	7498	921	25934	58490	84552	10365	340069	94097	7168	11253	128553	282679	3417	25833	55076	4247	6642	259236	2235	23475	3579	94026	374	116535	10215	26267	10039	51263	3909	11273	285848	79934	10199	116337	120400	23294	200312	55342	157753	1060	2009	2319	140576	137735	3004	10537	344018	78994	23531	222611	6348	10265	6143	10002	4293	4082	51114	342931	51571	2760	6387	11230	353345	51702	54101	3852	832	80313	8528	10687	3854	339231	2157	4128	2107	55810	2027	624	4935	7216	221395	3916	23569	4225	144402	4151	5004	81031	1176	388931	1393	23266	84993	124359	23038	63908	57402	25928	645432	84315	1101	10382	404093	5940	7173	64168	2131	23295	91544
GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_DN	M1891		19201860	Széles L,Keresztes G,Töröcsik D,Balajthy Z,Krenács L,Póliska S,Steinmeyer A,Zuegel U,Pruenster M,Rot A,Nagy L	GSE13762	GSE13762_3470_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in dendritic cells (5 days): control versus 25-hydroxyvitamin D3 [PubChem=1593].	We have carried out global gene expression analysis to clarify the interrelationship between 1,25-dihydroxyvitamin D3 and differentiation-driven gene expression patterns in developing human monocyte-derived dendritic cells. Monocytes were treated with 10 nM 1,25-dihydroxyvitamin D3 or vehicle 14 hours after plating for 12 hours or 5 days. Monocytes, differentiating dendritic cells (+/-1,25-dihydroxyvitamin D3 for 12 hours) and immature dendritic cells (+/-1,25-dihydroxyvitamin D3 for 5 days) were harvested. This design allows one to identify genes regulated by differentiation and/or 1,25-dihydroxyvitamin D3 in human monocyte-derived dendritic cells.					132203	24145	90019	51082	5777	56848	51266	2799	28954	5918	140576	79639	27164	2914	55647	1269	1936	4222	51249	8997	127579	151230	6035	84891	79191	51231	342897	51321	23417	9547	441061	57722	5995	100132476	3775	2626	282616	60385	84885	6786	51335	3678	153	9671	9340	1627	23475	84836	5164	63976	10435	58190	3442	2261	222553	8847	391123	4155	948	2564	388228	2981	29850	3159	55897	80728	613	491	4250	8483	124626	11145	7200	79842	257	23542	26049	10753	85455	6819	116966	401265	65003	353135	125972	2256	8577	11264	5024	54879	26469	84705	378925	85004	64096	80304	5170	55850	3226	9507	192111	2272	26272	114987	50649	1043	3552	54531	100505381	26519	83479	2886	3707	284451	2298	378884	5268	8277	120071	56659	23187	4666	80761	90326	25975	6660	622	1211	6141
GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_UP	M1892		19201860	Széles L,Keresztes G,Töröcsik D,Balajthy Z,Krenács L,Póliska S,Steinmeyer A,Zuegel U,Pruenster M,Rot A,Nagy L	GSE13762	GSE13762_3471_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in dendritic cells (12 days): control versus 25-hydroxyvitamin D3 [PubChem=1593].	We have carried out global gene expression analysis to clarify the interrelationship between 1,25-dihydroxyvitamin D3 and differentiation-driven gene expression patterns in developing human monocyte-derived dendritic cells. Monocytes were treated with 10 nM 1,25-dihydroxyvitamin D3 or vehicle 14 hours after plating for 12 hours or 5 days. Monocytes, differentiating dendritic cells (+/-1,25-dihydroxyvitamin D3 for 12 hours) and immature dendritic cells (+/-1,25-dihydroxyvitamin D3 for 5 days) were harvested. This design allows one to identify genes regulated by differentiation and/or 1,25-dihydroxyvitamin D3 in human monocyte-derived dendritic cells.					55997	10347	8128	401612	54207	6906	79934	653509	9290	92092	25989	148979	3936	4199	55813	29969	9859	2254	57491	27284	374986	80164	9753	10888	10111	8539	23443	11168	80012	91851	8744	4193	4763	57105	730249	51426	284307	1063	65977	9188	90627	160857	5027	8326	132864	79003	338692	4703	144501	8738	675	25917	64005	10527	54935	26960	55835	1062	92906	65979	6575	55871	83604	27010	3880	7879	79925	79915	29091	9079	50801	286148	4605	93035	3309	22824	283847	79053	9211	6010	79954	4745	196403	10802	3062	246176	10939	8876	348378	149345	56123	2787	143570	3669	347404	55335	5075	112937	205860	5332	6928	11006	9585	10495	80146	146852	131450	7073	5478	55125	65062	26225	23673	10528	146050	28	11174	23074	8602	6332	317	1137	1725	7299	143279	54854	3283	4036	84061	192134	54407	2057	5212	2523	219736	637	7802	26585	22926	55831	2935	3065	629	8453	23201	151742	3164
GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_UP	M1894		19201860	Széles L,Keresztes G,Töröcsik D,Balajthy Z,Krenács L,Póliska S,Steinmeyer A,Zuegel U,Pruenster M,Rot A,Nagy L	GSE13762	GSE13762_3470_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in dendritic cells (5 days): control versus 25-hydroxyvitamin D3 [PubChem=1593].	We have carried out global gene expression analysis to clarify the interrelationship between 1,25-dihydroxyvitamin D3 and differentiation-driven gene expression patterns in developing human monocyte-derived dendritic cells. Monocytes were treated with 10 nM 1,25-dihydroxyvitamin D3 or vehicle 14 hours after plating for 12 hours or 5 days. Monocytes, differentiating dendritic cells (+/-1,25-dihydroxyvitamin D3 for 12 hours) and immature dendritic cells (+/-1,25-dihydroxyvitamin D3 for 5 days) were harvested. This design allows one to identify genes regulated by differentiation and/or 1,25-dihydroxyvitamin D3 in human monocyte-derived dendritic cells.					133522	57140	116832	25934	6175	57126	1749	79025	8705	1581	2277	389432	145270	6347	57626	10522	727936	2946	55742	201501	27253	6718	4975	54546	9899	9911	114824	51673	222611	116448	7439	220359	4956	7130	9150	4062	64499	54472	27257	148738	8912	3660	4675	11047	27189	29916	493829	2893	10289	577	2852	64784	4606	579	26206	140732	696	57010	170690	5021	8911	1746	10465	1591	80303	9632	5697	10156	6329	253017	347454	58531	282973	125336	94025	55738	162387	145864	10461	608	92154	23564	51335	2195	64072	10777	731220	90324	5539	1044	3766	6508	25928	3776	421	6668	3642	285368	157773	146	55225	6231	114783	54998	8404	1401	2811	4224	6911	84466	56884	130827	5654	57494	387914	9455	9095	317719	63891	1910	55020	268	63898	10936	9533	4855	55160	4242	10423
GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_DN	M1896		19201860	Széles L,Keresztes G,Töröcsik D,Balajthy Z,Krenács L,Póliska S,Steinmeyer A,Zuegel U,Pruenster M,Rot A,Nagy L	GSE13762	GSE13762_3471_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in dendritic cells (12 days): control versus 25-hydroxyvitamin D3 [PubChem=1593].	We have carried out global gene expression analysis to clarify the interrelationship between 1,25-dihydroxyvitamin D3 and differentiation-driven gene expression patterns in developing human monocyte-derived dendritic cells. Monocytes were treated with 10 nM 1,25-dihydroxyvitamin D3 or vehicle 14 hours after plating for 12 hours or 5 days. Monocytes, differentiating dendritic cells (+/-1,25-dihydroxyvitamin D3 for 12 hours) and immature dendritic cells (+/-1,25-dihydroxyvitamin D3 for 5 days) were harvested. This design allows one to identify genes regulated by differentiation and/or 1,25-dihydroxyvitamin D3 in human monocyte-derived dendritic cells.					1634	3077	7442	286	63971	55811	112937	7153	140609	23560	63967	22920	64327	55973	2561	65123	6691	7424	84978	23232	80212	4925	5764	140462	319	5729	11249	158297	64151	10890	51412	1833	197135	9156	642968	7057	1543	100126572	8036	83933	2921	3270	345275	8496	375189	27343	84879	6375	64853	2251	54905	4147	2028	25926	84280	6545	11085	6280	10135	192666	55344	7957	3620	6323	163	11073	56169	5526	84752	7047	58496	64847	401262	4633	5333	5351	79934	221188	137868	29889	388633	27333	9033	55746	347273	339403	84823	5906	1173	613212	57600	55125	1017	56907	360226	9507	2239	2890	27079	55833	84230	223	2444	55901	59274	6284	147111	84955	56704	9480	1615	55731	23052	2857	112942	10999	4703	374786	26960	128817	118430	6385	10576	7873	81488	56992	255928	22822
GSE14386_UNTREATED_VS_IFNA_TREATED_ACT_PBMC_MS_PATIENT_UP	M2977		19265172	Zhang X,Jin J,Tang Y,Speer D,Sujkowska D,Markovic-Plese S	GSE14386	GSE14386_2514_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in peripheral blood mononclear cells (PBMC) from multiple sclerosis (MS) patient: untreated versus IFNB1 [GeneID=3456].	IFNβ, an effective therapy against relapsing-remitting (RR) multiple sclerosis (MS) is naturally secreted during the innate immune response against viral pathogens. The objective of this study was to characterize the immunomodulatory mechanisms of IFNβ targeting innate immune response and their effects on DC-mediated regulation of T-cell differentiation. We found that IFNβ−1a in-vitro treatment of human monocyte-derived dendritic cells (DCs) induced the expression of TLR7 and the members of its downstream signaling pathway, including myeloid differentiation factor 88 (MyD88), IL-1R-associated kinase (IRAK)4, and TNF receptor-associated factor (TRAF)6, while it inhibited the expression of IL-1R. Using siRNA TLR7 gene silencing, we confirmed that IFNβ-1a-induced changes in MyD88, IRAK4 and IL-1R expression were dependent on TLR7. TLR7 expression was also necessary for the IFNβ-1a-induced inhibition of IL-1β and IL-23, and the induction of IL-27 secretion by DCs. Supernatant (SN) transfer experiments confirmed that IFNβ-1a-induced changes in DCs’ cytokine secretion inhibit Th17 cell differentiation as evidenced by the inhibition of retinoic acid-related orphan nuclear hormone receptor C (RORC) and IL-17A gene expression and IL-17A secretion. Our study has identified a novel therapeutic mechanism of IFNβ−1a, that selectively targets the autoimmune response in MS. 					53637	3172	3764	3625	8786	9064	79786	10123	55262	54596	57537	57338	415116	197135	284004	81558	7399	63027	81605	151176	3001	57412	2217	284266	143279	10677	8913	9839	6338	3716	144717	7226	493869	387264	80243	85455	3082	3355	91181	220359	5816	257629	79632	158724	145447	56917	5340	1389	1524	51466	5155	60343	2928	78991	140738	162417	3426	10512	64175	3910	5010	5986	8972	22904	4862	23181	1482	284612	80045	6693	1950	25830	5077	388121	23620	754	56130	1723	3269	6929	84691	1296	6345	114794	60385	9651	353134	23541	1103	3061	64854	3743	919	54549	30010	125336	254263	79874	3549	3759	54946	8928	83875	65062	6954	118670	7441	97	90525	51673	10863	90673	11082	8082	80142	9136	255349	171019	51207	83895	360200	5455	116	7080	1139	646019	1909	7704	84674	388610	10669	729085	284615	51471	29119	283571	57467	6697	9416
GSE14386_UNTREATED_VS_IFNA_TREATED_ACT_PBMC_MS_PATIENT_DN	M2979		19265172	Zhang X,Jin J,Tang Y,Speer D,Sujkowska D,Markovic-Plese S	GSE14386	GSE14386_2514_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in peripheral blood mononclear cells (PBMC) from multiple sclerosis (MS) patient: untreated versus IFNB1 [GeneID=3456].	IFNβ, an effective therapy against relapsing-remitting (RR) multiple sclerosis (MS) is naturally secreted during the innate immune response against viral pathogens. The objective of this study was to characterize the immunomodulatory mechanisms of IFNβ targeting innate immune response and their effects on DC-mediated regulation of T-cell differentiation. We found that IFNβ−1a in-vitro treatment of human monocyte-derived dendritic cells (DCs) induced the expression of TLR7 and the members of its downstream signaling pathway, including myeloid differentiation factor 88 (MyD88), IL-1R-associated kinase (IRAK)4, and TNF receptor-associated factor (TRAF)6, while it inhibited the expression of IL-1R. Using siRNA TLR7 gene silencing, we confirmed that IFNβ-1a-induced changes in MyD88, IRAK4 and IL-1R expression were dependent on TLR7. TLR7 expression was also necessary for the IFNβ-1a-induced inhibition of IL-1β and IL-23, and the induction of IL-27 secretion by DCs. Supernatant (SN) transfer experiments confirmed that IFNβ-1a-induced changes in DCs’ cytokine secretion inhibit Th17 cell differentiation as evidenced by the inhibition of retinoic acid-related orphan nuclear hormone receptor C (RORC) and IL-17A gene expression and IL-17A secretion. Our study has identified a novel therapeutic mechanism of IFNβ−1a, that selectively targets the autoimmune response in MS. 					54941	10803	3665	11243	51015	91543	4084	132299	7852	80760	3437	932	10875	55186	53829	2357	1462	4602	1374	80824	6375	23208	9901	822	7163	10447	9452	9034	3604	85463	123	7227	23764	9760	5657	23588	8935	3091	7029	6004	4998	57584	64108	960	1493	8754	256126	868	55300	4353	65244	7850	10018	57045	4703	8411	10538	115330	28996	253558	91768	81930	57404	7050	7293	952	387921	23586	26051	3662	3070	9697	151195	6875	6347	9712	684	29969	10437	9156	54466	8676	3572	953	201633	84898	27115	2173	93082	27145	8784	10614	26040	6094	9592	91947	84879	5610	4783	4815	10397	5133	79879	6470	9446	683	122809	64761	672	51643	374	9516	10561	330	79915	55296	57493	9859	55559	51284	2162	22822	6820	3164	79657	5272	10733	11126	3669	3459	7353	29993	147841	4064	10135	2176	9173	3627	92906	10844	2114	92579	9910	7220	55872	5727	84959	6774	8556
GSE12198_LOW_IL2_STIM_NK_CELL_VS_HIGH_IL2_STIM_NK_CELL_UP	M7064		19383914	Fujisaki H,Kakuda H,Shimasaki N,Imai C,Ma J,Lockey T,Eldridge P,Leung WH,Campana D	GSE12198	GSE12198_3191_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in NK cells: low dose versus high dose of IL2 [GeneID=3558].	Transcriptional profiling of NKAES-derived NK cells after 7 days of culture compared to primary human NK cells and NK cells stimulated by low or high dose IL2 after 7 days of culture.					5073	140459	23219	55572	80306	4038	144363	25836	83787	79912	10427	3107	26472	23379	64746	23062	55726	63891	466	79101	9238	3480	2027	29985	257415	10223	79178	25912	25963	60468	3091	7124	1453	122786	51398	81552	6311	10982	200734	83590	4087	10225	79020	10651	51495	2342	80017	92822	94241	23367	6049	2131	57396	51150	4616	661	58487	56477	64092	4050	29883	83737	6737	116541	151050	476	55054	11010	55324	114926	83637	54878	51763	23144	114990	147965	6835	9987	90637	3344	91010	3996	10768	50618	55131	51780	158219	22872	9439	26511	25766	166378	10009	221421	7832	92703	10395	5639	963	4507	6932	5108	9612	5662	5976	4216	8433	10594	80148	94240	9452	79736	81539	6361	10049	51386	53615	51124	8398	3204	3658	497661	84811	54936	3646	7257	54996	5708	57799	1995	10195	64860	23132	1196	11334	7316	55697	3177	11156	81887	9790	662	10221	56970	8601	23080	147929	7701	9663	55738	253832	9230	64231	124245	57820	25972	400451	128869	375341	64102	23517	8784	10589	2052	29901	43	25822	79922	51726	2736	64428	7508	92140	92906	955	6452	115939	10139	11321	6518	348093	63917	55140	29085	51102	55929	988	11011	254263	9879	55326	4772	7158	10125	29789	79760	28969	5695	9641	10807
GSE12198_NK_VS_NK_ACT_EXPANSION_SYSTEM_DERIVED_NK_CELL_DN	M7065		19383914	Fujisaki H,Kakuda H,Shimasaki N,Imai C,Ma J,Lockey T,Eldridge P,Leung WH,Campana D	GSE12198	GSE12198_3188_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in NK cells: primary versus activated and expanded.	Transcriptional profiling of NKAES-derived NK cells after 7 days of culture compared to primary human NK cells and NK cells stimulated by low or high dose IL2 after 7 days of culture.					377677	5663	91526	140691	4171	2110	23332	51649	10955	4049	8508	64132	84954	388272	65993	5832	51186	56998	81926	5734	84124	10945	25961	57153	1933	3939	102	56905	26528	93663	6711	3575	9600	11200	2054	25896	1508	200185	1510	9643	221092	5899	90203	26091	3490	10121	3069	51031	6580	55246	11070	676	6721	5901	123207	8487	6545	10203	149111	51227	5147	27258	2135	54414	26275	3418	10148	10787	94134	55604	27316	3957	29945	79073	85463	80201	396	9169	9328	10540	6619	51552	10175	6513	8682	201161	5780	64327	84288	10952	3017	5236	9541	80173	221037	221443	5965	9619	5191	55161	57161	84337	9040	2628	1879	682	22980	56656	101	125488	22927	3035	51174	51097	26133	56882	151354	7465	10100	10007	63874	55743	5274	8702	10313	3955	28960	4841	1471	1476	79567	51646	6845	65124	10552	5902	65057	29988	27163	55051	9604	1031	54107	3364	285237	10279	254102	79828	388364	3623	8801	4646	755	9706	55213	84869	1267	54896	150275	4678	6119	4154	9370	10367	3570	23531	3093	4835	7039	7798	57513	5715	10606	28955	57104	11164	4521	2224	5532	79172	51634	7516	3903	150962	10643	6446	55166	5277	145482	283120	113000	10611	3831	130617	4524	2519	5358	8892	814	29920
GSE12198_LOW_IL2_STIM_NK_CELL_VS_HIGH_IL2_STIM_NK_CELL_DN	M7066		19383914	Fujisaki H,Kakuda H,Shimasaki N,Imai C,Ma J,Lockey T,Eldridge P,Leung WH,Campana D	GSE12198	GSE12198_3191_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in NK cells: low dose versus high dose of IL2 [GeneID=3558].	Transcriptional profiling of NKAES-derived NK cells after 7 days of culture compared to primary human NK cells and NK cells stimulated by low or high dose IL2 after 7 days of culture.					54832	90957	9194	1793	57017	57642	2327	579	6793	785	1045	7532	6707	56125	5087	4049	55721	8738	3603	8237	9622	5080	8449	10551	3823	3882	4216	3775	409	56674	7412	9407	4987	2258	51365	133746	80306	114990	27072	10686	960	10467	50846	7473	5494	7486	124739	283446	55032	203228	9145	2923	1060	56261	55286	4665	10692	420	3422	22822	6697	1729	5422	389541	1396	817	4643	552	9890	23491	6878	51057	135154	219438	8689	133308	163786	79575	157807	7365	56246	2784	7111	6331	1081	10107	1029	59271	10678	832	4547	126695	122060	11072	1814	1297	4927	729359	2882	54106	862	5284	59345	221476	22823	133482	10608	460	22929	80208	313	80853	57150	6542	3171	51251	6670	3937	5169	4751	23133	2822	91683	23617	4093	23326	2700	2036	55540	6236	151011	9350	6320	18	1747	55620	4725	4852	53344	1794	9868	528	389856	1132	23054	343930	6309	130916	2649	2268	26262	3083	131965	10658	9497	9610	54766	51043	130120	27040	1114	220064	90506	3693	29088	10519	29766	1513	81855	23231	8682	64600	7472	23358	131375	29980	7125	8534	9776	3938	123016	83755	203069	259266	5996	2906	6786	5149	10382	79903	440026	55856	8747	3856	1465	11080	55572	8521	84557	765
GSE12198_CTRL_VS_HIGH_IL2_STIM_NK_CELL_UP	M7067		19383914	Fujisaki H,Kakuda H,Shimasaki N,Imai C,Ma J,Lockey T,Eldridge P,Leung WH,Campana D	GSE12198	GSE12198_3190_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in NK cells: primary versus stimulated by high dose of IL2 [GeneID=3558].	Transcriptional profiling of NKAES-derived NK cells after 7 days of culture compared to primary human NK cells and NK cells stimulated by low or high dose IL2 after 7 days of culture.					466	7179	8703	79801	57576	55776	51657	388701	10087	81565	3036	11149	5125	1789	64108	23468	8312	84717	4673	81577	100131378	80169	126006	2859	255743	55281	8078	4481	5828	8076	64094	273	116135	9489	362	5893	7484	7475	6725	8648	80896	56897	345275	347	1291	1159	90273	9021	10657	57655	955	9967	285521	84707	134359	3718	9071	64506	1384	52	5074	6416	27445	5330	845	23503	8731	252983	10610	2628	65095	2824	255189	8477	7332	128414	51497	2235	390	140461	3508	221421	80824	138429	6843	4591	7268	23673	339	617	171177	84069	9498	54855	3283	10139	118813	11278	1499	1769	3853	57462	2572	474	10098	150372	79190	54972	22850	2159	1639	122616	5818	27429	5243	9448	7753	4009	140838	197407	2969	57055	55243	8456	5152	2314	80157	6095	23177	4142	330	57153	51316	3646	6403	177	5335	55182	83607	80196	8525	284371	23765	63926	3141	5557	51020	602	375346	5046	6351	729230	90933	113278	165721	4946	3714	1369	5452	65983	50509	83637	3885	79901	57626	80168	2209	54093	54557	254428	8572	21	9020	780	29802	6528	147929	55323	80320	129080	6532	3705	1848	80148	1325	8115	7703	22807	140578	167681	7360	81029	10286	5597	2319	9943	7060	79096	121643	55352
GSE12198_CTRL_VS_HIGH_IL2_STIM_NK_CELL_DN	M7070		19383914	Fujisaki H,Kakuda H,Shimasaki N,Imai C,Ma J,Lockey T,Eldridge P,Leung WH,Campana D	GSE12198	GSE12198_3190_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in NK cells: primary versus stimulated by high dose of IL2 [GeneID=3558].	Transcriptional profiling of NKAES-derived NK cells after 7 days of culture compared to primary human NK cells and NK cells stimulated by low or high dose IL2 after 7 days of culture.					3460	4249	656	3183	2152	9040	8608	9124	2566	3490	8803	26262	51264	7186	9181	337970	10199	898	4927	8724	3603	10888	51582	51021	9322	1743	84549	55233	2288	9313	118424	23761	83871	389362	26504	10478	10138	128	57513	5917	84267	6470	2674	9785	84569	64375	2251	5729	5876	599	53340	2123	55081	79180	285	5571	56937	4776	78988	113235	6924	9777	5147	28989	51177	4627	7483	4689	9370	2735	25829	83892	1907	8820	415117	91010	6945	1959	4853	84923	27306	11179	9592	58489	51652	114885	55118	388581	51497	5602	3627	27042	6723	56265	55785	347252	22943	7307	2589	4733	716	27316	2971	8878	58476	2683	6038	125476	4300	9283	27033	22944	51564	199870	84240	4792	5547	7083	1432	10938	8560	55656	29088	113878	445	23353	80256	4049	81786	3182	10261	822	64968	894	23268	80201	55573	10809	84993	80737	4794	7077	5777	54934	4953	29108	2317	7841	81832	6004	112939	25879	1454	57820	27351	1154	253190	22907	54858	25865	64091	6623	55111	57549	25791	9869	10769	8459	8861	84876	64236	5592	64118	84193	2791	6423	51227	6572	79080	29925	9475	1794	10039	3268	285231	116238	5824	47	57602	8498	9397	54558	51063	23495	7709	22933	391	221472	4857	8562
GSE12198_NK_VS_NK_ACT_EXPANSION_SYSTEM_DERIVED_NK_CELL_UP	M7072		19383914	Fujisaki H,Kakuda H,Shimasaki N,Imai C,Ma J,Lockey T,Eldridge P,Leung WH,Campana D	GSE12198	GSE12198_3188_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in NK cells: primary versus activated and expanded.	Transcriptional profiling of NKAES-derived NK cells after 7 days of culture compared to primary human NK cells and NK cells stimulated by low or high dose IL2 after 7 days of culture.					2877	112574	3796	286075	59307	5621	348093	3234	116150	5463	7321	253714	9514	54206	3214	84162	51517	81847	9355	122786	10914	54842	9672	9861	92675	9753	54930	8446	23392	8932	160897	8477	22926	3048	57655	3920	53342	91746	4091	55529	23085	8767	10495	55719	51303	10799	285172	4026	9200	4360	92014	23765	57007	23167	28951	5892	4622	4783	6999	1992	5175	23548	10653	8694	7741	2813	51455	81029	7975	1058	205	4528	57542	51125	55617	115701	65055	54960	22902	2979	51111	3632	79607	55851	55353	91137	51606	9639	10455	27290	84232	10404	3229	195827	11035	9236	2550	665	29085	11051	389434	23112	9231	6921	845	79157	549	2634	168455	4502	254950	85460	132864	65009	51742	2905	583	84912	10110	5893	81688	30849	8935	85463	84245	2319	388552	11264	10606	79830	9054	51701	171425	79993	8899	6304	3028	254428	5168	7782	79071	58497	6303	121268	6185	6696	6346	2936	242	729230	60559	9489	1486	92715	4076	5317	81550	255877	91057	7328	79096	339324	283578	11235	8193	5296	115330	60673	130507	122830	687	84747	5983	51160	55256	54806	5236	55317	79441	84926	129804	5054	30009	10299	1605	7538	55251	55186	55768	1032	367	10912	125488	4217	3142	1326	14	1585	140700	4850
GSE12198_CTRL_VS_LOW_IL2_STIM_NK_CELL_UP	M7073		19383914	Fujisaki H,Kakuda H,Shimasaki N,Imai C,Ma J,Lockey T,Eldridge P,Leung WH,Campana D	GSE12198	GSE12198_3189_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in NK cells: primary versus stimulated by low dose of IL2 [GeneID=3558].	Transcriptional profiling of NKAES-derived NK cells after 7 days of culture compared to primary human NK cells and NK cells stimulated by low or high dose IL2 after 7 days of culture.					9053	4005	8974	256364	51780	8028	51430	10505	7566	6294	27163	123	54206	23400	3418	54978	8526	8994	5498	145567	81029	2342	152185	84552	150372	9271	824	6999	10121	414328	9643	23175	51596	10397	23626	55054	79089	79718	84498	83461	29079	1729	201299	9110	1755	54464	10053	25930	3384	4478	81622	25909	135114	8887	11264	79048	51251	51316	94233	63891	6196	25925	284058	399909	374618	6303	6821	11104	6901	10137	4152	91	181	1006	3001	79830	6850	11169	2330	51734	55529	3096	5995	100131187	23344	10205	3383	6176	51322	388272	392	55765	22924	51393	9991	4482	10425	3791	7732	55283	51274	22990	80312	4916	81532	9922	10124	2256	23070	10847	57459	55374	23505	4597	10717	55166	27347	23613	170575	8459	11145	5269	81894	80315	9159	51135	10420	387	8575	2272	54331	3705	116236	926	2995	79573	5295	4524	11235	6451	4329	8243	83640	3669	58986	285753	7589	88	83742	6777	8943	765	6282	10227	6993	55365	8780	1822	9419	89797	80321	92749	8546	5480	4899	51309	4974	567	26275	55361	54870	80212	26260	3008	79618	54832	170954	760	6941	6892	6018	388701	5096	963	9924	5970	51232	5495	9814	155368	1962	7294	10333	51593	256281	420	1958	356	1730	23609
GSE12198_CTRL_VS_LOW_IL2_STIM_NK_CELL_DN	M7074		19383914	Fujisaki H,Kakuda H,Shimasaki N,Imai C,Ma J,Lockey T,Eldridge P,Leung WH,Campana D	GSE12198	GSE12198_3189_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in NK cells: primary versus stimulated by low dose of IL2 [GeneID=3558].	Transcriptional profiling of NKAES-derived NK cells after 7 days of culture compared to primary human NK cells and NK cells stimulated by low or high dose IL2 after 7 days of culture.					51278	84336	114026	84134	3601	6452	84274	79622	23205	286262	1827	79158	11146	29086	414919	79088	92703	8639	55272	10539	9218	1961	51329	3397	51068	29902	3090	2063	6674	9289	7374	79767	51649	25973	7982	3936	388552	25766	3064	91408	2909	8744	150356	10223	23636	49856	8882	51126	81606	25907	134492	4528	388581	6187	51409	8893	23256	1839	55124	65083	389941	4038	51398	81502	5781	1029	1583	10587	55254	141	92675	64344	27341	6637	2876	3458	3482	7850	2176	6884	2108	11154	10914	51259	1041	6361	81926	740	1317	9538	57002	123016	84299	4001	8548	8314	4665	266722	7681	54919	7307	51633	54940	6770	348	79006	9049	60560	246184	84816	51506	6855	3783	79586	3312	400569	127733	26145	27040	10331	7286	2017	6367	1642	8668	3083	51367	5831	64975	10165	79447	283600	80155	54541	25920	113419	10282	2730	80306	2979	51125	11193	51752	6631	58525	51647	2065	1743	9318	1371	399979	56339	84317	638	4705	124808	27111	66005	1677	56953	5352	200504	51162	84233	10573	57410	8444	79033	10768	55333	57109	55181	10592	1263	3069	6648	29099	5161	291	5719	91647	79091	6729	11041	9690	4772	115939	285237	23275	65123	3034	2739	7008	9325	56681	642	138716	55071	53407	79896
GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_DN	M7075		19414752	Bosco A,McKenna KL,Firth MJ,Sly PD,Holt PG	GSE14908	GSE14908_3607_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells from atopic patients: resting versus stimulated with allergen (house dust mite).	The aim of this study was to employ a systems-level analysis to elucidate gene expression networks operating in the CD4 T-cell responses which underpin human atopic disease. 					23558	79912	23446	394	91612	387338	677	80331	157769	81704	10494	8887	6659	100009676	4616	6670	51251	63917	10205	1027	8225	7791	2512	9605	5663	56997	302	7108	88	29895	81855	11235	6046	596	84720	9636	54870	7805	51780	9053	10121	56063	55217	388272	6584	942	8673	27075	6732	1310	607	80760	5583	323	7204	3514	124512	2330	27327	10890	9588	9611	55765	3482	27086	55667	83640	6668	8569	1031	2258	25988	824	8446	54918	65992	1639	112770	84498	29761	2308	23557	84681	375287	4689	6455	23505	768	196403	29993	5330	23137	10135	55636	83737	4162	3963	5591	65217	56172	9748	1983	54586	9706	5087	79971	51205	8028	55283	8089	10927	80321	55015	594	80824	4343	23225	132789	25983	23204	8784	114908	79618	79590	80013	4487	3001	23293	143686	2669	57459	151613	8324	51763	8813	64795	84343	3603	1453	134553	83732	9489	54946	8545	54206	11162	8932	2355	10194	29903	1398	113828	51380	4209	113278	56656	5564	381	59286	54940	931	10513	57605	5959	124401	254170	1822	8934	28984	6176	337867	2664	10124	1181	253260	222166	90441	2011	91	57020	9948	25972	122830	56946	23070	7566	54978	4329	678	152185	6596	10125	6942	1729	10267	91373	10285	150372	79872	51232
GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_UP	M7077		19414752	Bosco A,McKenna KL,Firth MJ,Sly PD,Holt PG	GSE14908	GSE14908_3607_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells from atopic patients: resting versus stimulated with allergen (house dust mite).	The aim of this study was to employ a systems-level analysis to elucidate gene expression networks operating in the CD4 T-cell responses which underpin human atopic disease. 					10164	1968	79158	80306	84934	22920	10227	54069	137392	9817	9669	2585	53838	53918	92856	55298	11238	5682	84336	716	54065	65993	9218	26164	51422	4925	5931	6839	51706	1642	84930	55272	307	51260	84946	79095	1933	1666	4927	8668	55915	64393	1017	22926	10328	80006	58525	3281	494143	9435	92667	23291	11146	130355	283600	5692	23138	6187	10072	1973	54878	9790	444	5631	11097	134492	223	8568	55623	147912	48	84924	8140	203260	64747	60560	9324	26278	55796	4735	84817	63893	3015	123207	11015	142679	29922	266722	5201	29889	4001	902	400	5423	51022	7541	57466	6749	4192	8744	53615	4076	11194	892	3065	84902	79751	202052	23160	10629	56342	10247	25907	51399	30062	573	6881	49856	56851	57630	8416	26233	84650	55695	92703	4131	7515	79896	26994	51490	1551	203069	389362	3069	57555	6666	23392	84188	387758	10287	80762	113510	57194	3312	51649	8504	51506	81567	55929	813	141	161742	64802	4338	285672	10116	6130	11051	10069	51528	11091	59269	79042	51510	4817	2280	143098	2224	151011	23511	54849	29094	147007	23332	22950	9512	27067	57650	5873	60492	642	80213	57050	2063	54806	54478	124808	9088	7979	8532	51122	3326	6897	6949	8574	2971	79568	7913	1317	51063
GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_NONATOPIC_PATIENT_DN	M7080		19414752	Bosco A,McKenna KL,Firth MJ,Sly PD,Holt PG	GSE14908	GSE14908_3608_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells from non-atopic donors: resting versus stimulated with allergen (house dust mite).	The aim of this study was to employ a systems-level analysis to elucidate gene expression networks operating in the CD4 T-cell responses which underpin human atopic disease. 					56997	10169	10735	8723	51278	10124	7536	51251	3096	25988	2959	8225	256364	83877	85456	84124	381	10955	80167	10505	392	56979	5257	29919	11094	6821	121665	10765	10267	80760	79364	92749	28955	94015	90441	6668	3034	10140	79872	23186	94107	3512	26578	23032	3661	26994	81532	83640	126669	26260	57826	5600	84441	25831	79961	389125	7205	25909	97	1730	7259	6840	79618	8887	57799	2909	150372	3140	4646	2071	55823	727957	51714	51567	81502	155368	221496	79819	51430	124512	5199	9159	84552	9991	10616	6251	2207	1729	8993	4668	6282	3097	1778	6850	22872	23626	55256	151295	387338	25	57585	3726	55726	4616	54923	80351	397	7454	9296	23133	10565	6652	9730	6584	10927	23074	23396	89910	26580	60436	1499	11342	10109	88	112770	79603	5663	56270	10125	5329	10163	51631	55048	1611	55279	8720	154141	2342	5997	57655	114908	25942	23200	7305	56949	54978	2123	64860	55146	27327	3001	5297	1497	201266	10397	6643	55337	29761	6156	10053	1020	6847	6744	23424	64601	55540	9525	3482	23268	55803	54926	5862	23400	8239	5533	25976	5571	5058	9636	337867	4643	9061	2248	54838	10947	8546	100131439	55233	27072	6188	1181	162494	57117	931	57456	757	10049	51340	51752	64130
GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_RESTING_CD4_TCELL_DN	M7083		19414752	Bosco A,McKenna KL,Firth MJ,Sly PD,Holt PG	GSE14908	GSE14908_3609_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in resting CD4 [GeneID=920] T cells: atopy versus healthy.	The aim of this study was to employ a systems-level analysis to elucidate gene expression networks operating in the CD4 T-cell responses which underpin human atopic disease. 					84134	6637	10539	81567	10438	222229	22926	5621	5631	54815	29901	56851	84324	8477	203069	47	51002	7541	64682	51490	64802	65123	622	9218	54998	3833	126328	223	6606	79102	657	285672	4724	51031	3014	7374	3703	222545	8895	123207	7466	81570	4722	25813	85463	6130	55131	6051	11102	53838	653361	246184	2591	51136	8518	55915	55631	26574	4298	3552	5723	5780	84317	25920	9557	9790	58480	1939	2896	54888	10622	10116	114034	51649	221443	1476	10227	149371	2189	10962	5019	3783	161742	6152	5612	892	902	55254	10799	54584	79581	23633	51399	9270	7378	29960	57465	1994	113829	662	2091	11156	3069	7385	4708	26064	1337	306	57630	7791	10785	26259	91749	51293	6836	80155	26608	55421	9904	29889	58525	84946	5770	3312	2965	372	90871	51706	10424	25800	22920	8661	4678	48	123016	55161	813	64359	65263	84288	2947	6742	10329	59269	390243	1583	4351	1031	4047	116225	1008	3612	90639	27042	7384	51343	91647	10808	1723	896	1351	51726	8668	642	84930	8634	80762	51028	5822	6729	23332	3420	22916	7106	1340	79155	7307	5704	2957	2288	56915	9854	741	5336	27297	498	989	5437	2990	51259	5442	11047	210	22845	727910	83463	64116	4735	388753	3093
GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_NONATOPIC_PATIENT_UP	M7086		19414752	Bosco A,McKenna KL,Firth MJ,Sly PD,Holt PG	GSE14908	GSE14908_3608_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells from non-atopic donors: resting versus stimulated with allergen (house dust mite).	The aim of this study was to employ a systems-level analysis to elucidate gene expression networks operating in the CD4 T-cell responses which underpin human atopic disease. 					51278	79364	3646	54870	79912	9139	3487	27071	7812	157769	90441	9605	54918	123096	81704	4487	181	5199	144165	9736	167681	80760	10169	387338	7566	7070	381	3778	3043	8718	10735	51150	3512	4615	1497	4087	54885	3003	54467	7150	25988	57826	92749	23521	10333	84708	8682	51430	9987	9394	606495	25930	26260	56997	140691	6282	10767	6508	56656	22872	8672	208	11145	2564	57828	92595	9909	29895	10418	149076	55636	84329	4616	57704	6840	81029	10114	60490	5515	9588	81622	100131187	57117	92822	3202	25942	55262	256364	3037	10053	65084	5862	222166	9919	124512	9760	4780	607	25831	55122	151295	83590	54623	54676	55540	765	57515	81532	90799	9271	80321	4646	26502	323	80774	8993	84498	5329	88	10927	10765	51251	84720	51752	55014	440567	1453	23339	50488	8440	79048	55726	3658	2626	84552	64743	7503	10979	143686	400258	11183	2123	375033	29766	2323	201266	604	3306	55861	55283	8613	51322	23475	7011	7007	5087	51562	145781	9159	823	60685	10426	9991	56181	2566	23014	7456	6156	219972	55082	3097	1457	9716	10468	348262	6196	11012	83732	26140	8315	4916	23626	64210	201931	140465	6455	55743	1665	253260	4296	6584	2741	10900	10507	59286	8449	9049	80207	79089	2580
GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_HDM_STIM_CD4_TCELL_UP	M7091		19414752	Bosco A,McKenna KL,Firth MJ,Sly PD,Holt PG	GSE14908	GSE14908_3610_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells stimulated with allergen (house dust mite): atopy versus healthy.	The aim of this study was to employ a systems-level analysis to elucidate gene expression networks operating in the CD4 T-cell responses which underpin human atopic disease. 					221443	6637	377677	317662	59269	7385	59307	11180	29781	54065	91689	54878	10539	10438	23354	90121	84134	2628	56851	5216	8514	2937	55298	64802	8216	8477	9435	196463	81889	79158	23332	2189	25973	26574	5331	55012	1528	79095	10020	4711	2063	5906	3623	9530	8841	55929	23205	123	64975	8140	3703	374618	51726	51260	145270	50814	23633	3604	51426	2947	84324	306	6742	3957	65265	9425	4722	10945	55300	54815	8661	23291	79042	23466	57489	57194	1994	55131	3688	5780	56998	92140	3783	126328	388753	138716	8673	29086	4817	161742	120534	55254	5723	8895	54840	57002	9538	989	6729	5093	64146	642	286053	7278	140290	3064	4744	283600	9669	8893	26747	10313	6152	3420	51174	5931	57555	66005	23670	10586	5631	55741	1059	6836	26548	10951	1642	7979	5595	223	115209	79934	27042	10663	23514	57226	7913	57465	29887	10920	55071	55296	1871	4298	54929	84336	81542	4651	10329	4507	2620	93183	8785	23452	3017	6768	3558	6187	51125	144233	55721	55760	27067	6259	29901	11343	64393	57415	81567	51463	9749	10000	4689	79064	6835	1121	123207	1337	55421	6629	27247	5883	2769	10094	5612	8644	2067	4047	10400	57513	1827	11128	6351	84288	2098	5429	3417	54819	81615	219855
GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_RESTING_CD4_TCELL_UP	M7092		19414752	Bosco A,McKenna KL,Firth MJ,Sly PD,Holt PG	GSE14908	GSE14908_3609_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in resting CD4 [GeneID=920] T cells: atopy versus healthy.	The aim of this study was to employ a systems-level analysis to elucidate gene expression networks operating in the CD4 T-cell responses which underpin human atopic disease. 					22980	79893	79679	6596	4794	7014	2319	9236	11315	203562	64115	164656	2674	64332	55793	5879	7408	10947	10063	760	6617	11153	5583	1843	253782	79602	5660	5912	51637	333926	23670	9817	79754	10466	4092	5564	9846	201931	7454	9397	7133	1796	63933	56255	1912	1824	23126	2746	92	90809	283431	127281	29965	83638	116496	7267	123722	57804	60685	81555	942	84433	399	55144	63923	8674	2281	81579	26994	7016	90843	83597	100131187	57709	51100	79890	152217	3420	1400	57109	51125	10970	23376	54879	57446	51696	9447	9553	5518	80019	4084	3508	5753	9541	4267	80223	51164	5147	9725	23423	6814	9577	150275	286097	6489	23161	92689	11316	200185	3340	51272	83715	119392	29035	9618	9311	221178	4700	84330	56650	83737	3675	9554	5305	9445	57326	84269	9870	80781	6772	51504	2581	114826	10256	4899	91978	4204	4013	27236	2885	10138	84270	170954	1742	6675	170825	6097	11011	26762	1519	11201	79094	27086	963	7163	653333	1903	2833	23122	6717	51231	51647	8879	9218	29998	5533	22818	85027	54991	23075	90324	8464	51035	81566	6608	54732	1432	119559	84236	4218	84926	116068	53344	117608	147700	83959	80315	245812	80336	10193	645	23011	28978	2617	7068	3164	55625	23510	65997	280636
GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_HDM_STIM_CD4_TCELL_DN	M7097		19414752	Bosco A,McKenna KL,Firth MJ,Sly PD,Holt PG	GSE14908	GSE14908_3610_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells stimulated with allergen (house dust mite): atopy versus healthy.	The aim of this study was to employ a systems-level analysis to elucidate gene expression networks operating in the CD4 T-cell responses which underpin human atopic disease. 					7416	51535	1503	9283	7293	26589	55206	50814	79723	64848	9982	10755	55177	4704	256076	55627	28971	56648	51194	2237	5176	4248	22874	353	10856	10713	51463	1183	80755	10248	339488	5928	27173	8651	170384	10907	29920	84282	92736	23481	5691	5133	283899	3251	245932	10295	50865	130813	8841	9768	65124	5433	10058	126792	22823	7780	161145	283152	84267	91419	80312	10888	51379	7398	8707	8711	29968	84876	58478	25932	23594	83903	2171	79693	653509	11161	5510	2697	81624	9047	8574	79084	3430	51380	29093	51422	6431	6182	64801	1973	51163	7737	91272	285671	9801	9238	375387	997	23649	27159	5719	695	283078	1174	84076	1521	153768	9388	10159	5333	3712	11319	84078	55798	57608	4502	55705	9057	10534	5216	51117	4706	55081	143888	716	3617	140461	23404	3065	55341	7019	2079	51601	388611	8784	345611	26511	7982	1738	285367	84250	84899	317705	374354	10419	307	5917	51018	8573	51507	4336	494143	55273	5931	7161	7277	5412	4050	3052	8994	80146	201965	84896	27332	51010	597	338442	8065	54496	51013	85479	64146	3978	158	219743	127703	494115	10914	5777	166012	149095	6515	55718	347344	140767	10240	4126	51148	113655	29078	133491	55299	387787	55646	332	64425	10678	352999	5701	79080
GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_DN	M7099		19414807	Daryadel A,Yousefi S,Troi D,Schmid I,Schmidt-Mende J,Mordasini C,Dahinden CA,Ziemiecki A,Simon HU	GSE15139	GSE15139_2742_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in neutrophils treated with CSF2 [GeneID=1437] versus control.	The objective of this study was to compare the transcriptional repertoire of mature human neutrophils before and after GM-CSF treatment by using oligonucleotide microarrays. Leukotriene B4 (LTB4) is an important pro-inflammatory lipid mediator generated by neutrophils upon activation. Granulocyte/macrophage colony-stimulating factor (GM-CSF) stimulation is known to enhance agonist-mediated LTB4 production of neutrophils within minutes, a process called “priming”. Here, we demonstrate that GM-CSF also limits the production of LTB4 by neutrophils via a transcriptional mechanism at later time points. We identified hematopoietic specific Ras homologous (RhoH)/translocation three four (TTF), which was induced following GM-CSF stimulation in neutrophils, as a key regulator in this process. Neutrophils derived from RhoH/TTF-deficient (Rhoh-/-) mice demonstrated increased LTB4 production upon activation compared with normal mouse neutrophils. Moreover, neutrophils from cystic fibrosis patients expressed enhanced levels of RhoH/TTF and generated less LTB4 upon activation compared with normal human neutrophils. Taken together, these data suggest that RhoH/TTF represents an inducible feedback inhibitor in neutrophils that is involved in the limitation of innate immune responses.					85363	4644	51692	2177	81887	10772	11231	8607	84249	9735	26278	7706	55790	26959	22906	9656	55466	57678	114987	80007	121536	7529	5435	55213	57583	4124	10283	55697	54888	54584	1368	10940	5036	66005	56919	899	5832	51752	5496	11072	26093	57157	63877	134218	25963	675	4780	6389	130814	864	22920	11260	79886	379	491	160622	23587	170394	1495	157769	25927	9097	57584	5347	55035	1316	57654	26019	79780	6426	1021	1431	23478	9647	324	81562	494115	7071	51318	80185	353	10587	8030	462	5426	57210	5583	29063	5955	283899	25929	116496	23344	6341	5727	253959	2548	84451	253980	11129	23248	10081	9827	27000	56895	79682	5116	4938	54923	54505	7485	23185	2521	79132	79174	1397	1371	10203	58513	10097	833	9202	23367	81575	23137	79877	115209	57099	5588	103	78990	8797	253430	6541	4790	10949	9659	10146	5788	29916	9238	9124	388564	55159	8672	55208	117246	51633	80823	6418	79791	64840	5831	23049	1122	5927	11022	9113	503542	57496	4899	55599	1656	9697	64801	8726	55858	51363	64422	10007	6403	146198	83637	51726	4893	23609	84798	9249	54867	51552	8790	29890	6776	50810	27071	55055	55656	51343	6731	55959	6304	55133	60592	79019	83884	84498	2321	60528	10499	50937
GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_UP	M7100		19414807	Daryadel A,Yousefi S,Troi D,Schmid I,Schmidt-Mende J,Mordasini C,Dahinden CA,Ziemiecki A,Simon HU	GSE15139	GSE15139_2742_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in neutrophils treated with CSF2 [GeneID=1437] versus control.	The objective of this study was to compare the transcriptional repertoire of mature human neutrophils before and after GM-CSF treatment by using oligonucleotide microarrays. Leukotriene B4 (LTB4) is an important pro-inflammatory lipid mediator generated by neutrophils upon activation. Granulocyte/macrophage colony-stimulating factor (GM-CSF) stimulation is known to enhance agonist-mediated LTB4 production of neutrophils within minutes, a process called “priming”. Here, we demonstrate that GM-CSF also limits the production of LTB4 by neutrophils via a transcriptional mechanism at later time points. We identified hematopoietic specific Ras homologous (RhoH)/translocation three four (TTF), which was induced following GM-CSF stimulation in neutrophils, as a key regulator in this process. Neutrophils derived from RhoH/TTF-deficient (Rhoh-/-) mice demonstrated increased LTB4 production upon activation compared with normal mouse neutrophils. Moreover, neutrophils from cystic fibrosis patients expressed enhanced levels of RhoH/TTF and generated less LTB4 upon activation compared with normal human neutrophils. Taken together, these data suggest that RhoH/TTF represents an inducible feedback inhibitor in neutrophils that is involved in the limitation of innate immune responses.					6232	81631	29982	7988	51701	6102	1843	9337	1595	374395	730130	55793	9837	64432	5763	2644	255919	83606	27345	4267	84517	5133	133308	5827	23710	3988	345	2244	8507	129787	5828	84981	7374	55831	9499	4729	818	80306	84268	3476	128240	6775	1731	9039	221262	51247	2531	284992	4294	27236	8581	114826	5699	26234	51150	26511	22818	55054	5527	200844	9205	204851	10211	51125	79002	914	6307	11020	285362	26260	8818	51547	9046	6581	2947	9550	84984	2358	121457	51074	4716	5501	9910	84769	4811	7681	23335	85025	57477	51322	29899	57396	5805	84733	83988	3290	926	51149	51501	10274	9217	23625	8520	391	10535	26167	501	54958	84315	80237	5620	114883	6590	6483	2237	3656	740	51283	10950	440603	84287	90459	1826	55308	54707	6988	147700	4597	54534	8802	2395	10228	84326	23301	7850	3638	92703	3293	23152	23349	647024	10179	2669	64925	23052	4861	65258	283298	55848	55654	115992	149951	8575	83642	55732	64092	10449	2319	8930	84231	11112	165918	284076	171019	6183	27352	90390	134145	5547	4330	84060	4048	130367	60677	147007	1998	57650	170384	1192	25957	1465	8674	60485	1848	9391	56947	56890	55148	283991	537	10276	9509	51138	84337	56965	51306	55017	1540	8545	2582
GSE15271_CXCR4_POS_VS_NEG_GC_BCELL_DN	M7101		19494283	Caron G,Gallou Le S,Lamy T,Tarte K,Fest T	GSE15271	GSE15271_3464_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in centroblasts versus centrocytes.	Functional discrimination between normal centroblast and centrocyte obtained from human inflamed tonsils after cell sorting. We used microarrays to detail the segregation between these two B cell subsets					23533	2625	9121	1236	4084	4035	80351	3001	64786	129685	51444	196	100131439	142891	256364	57610	51	6352	51266	26524	9473	162427	222487	8535	5916	400961	64131	58986	64784	221937	103910	9437	953	4067	309	2870	7392	64333	5564	9213	11226	51621	219333	11342	7189	10261	6584	283420	6780	55540	11232	10659	330	5293	50649	23368	326342	11345	8826	3665	166	51311	57333	8440	8527	23150	150275	80219	399687	80709	51669	10014	8723	6095	79887	7305	84133	489	23048	51302	57705	2643	4773	54941	2683	8887	375056	149041	79630	8816	50640	9637	2316	56270	8718	1847	84078	57185	64780	9451	8897	8728	79865	90196	9644	5530	5552	5045	7975	4650	1791	1859	57169	9453	9842	23293	56255	10140	93408	359948	114908	54947	678	272	54469	10206	1657	57704	25948	9782	79720	85461	23335	55225	8609	6659	10671	7316	391002	7726	283316	11236	9051	1153	28959	2131	84958	11057	79699	79026	639	57688	23233	57460	7844	4828	51280	54518	3398	51278	10628	706	2678	7049	283518	8289	53637	27299
GSE15271_CXCR4_POS_VS_NEG_GC_BCELL_UP	M7103		19494283	Caron G,Gallou Le S,Lamy T,Tarte K,Fest T	GSE15271	GSE15271_3464_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in centroblasts versus centrocytes.	Functional discrimination between normal centroblast and centrocyte obtained from human inflamed tonsils after cell sorting. We used microarrays to detail the segregation between these two B cell subsets					353	921	2952	26354	1608	9862	283373	5429	165324	4682	7422	55239	8570	9512	6992	5427	5887	10291	160762	2189	80198	2026	57026	164	6635	27090	10921	23052	23468	10295	374291	11160	10797	22824	51082	1802	1978	90407	55326	210	2982	4841	6613	9926	9894	151354	6391	51102	10212	22858	9221	9282	271	100188893	3329	96764	1823	55204	54487	25923	23450	387787	51429	8886	25788	23173	2824	3939	3839	80762	23597	51406	29789	1615	5558	51706	390916	6628	617	3843	55759	4836	54476	3018	124995	9546	131474	8531	8566	348995	117247	1491	3054	10195	286827	6502	9188	80347	26228	1460	165	10190	11130	4609	5612	205	5691	4677	2146	7153	92912	10592	1635	130340	85465	6894	64756	79896	10322	10042	26355	29956	10474	79877	5757	51373	23160	26012	79084	10651	51386	10714	57409	4869	65123	10541	26135	64710	25828	55705	84172	1786	11040	3609	4708	4779	4345	83743	29914	221002	90550	91942	8761	25853	10678	79947	84967	132	1965	55723	5985	116238	29078	835	3420	23647	80179	22934	8939	9363	6941	10935	55775	1479
GSE9960_HEALTHY_VS_GRAM_NEG_SEPSIS_PBMC_UP	M7118		19535937	Payen D,Lukaszewicz AC	GSE9960	GSE9960_3816_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in peripheral blood monocytes (PMBC): healthy versus Gram negative sepsis.	To identify signature genes that help distinguish (1) sepsis from non-infectious causes of systemic inflammatory response syndrome, (2) between Gram-positive and Gram-negative sepsis.					51097	54436	10782	55704	26469	201965	51449	8125	9936	8798	116064	80854	2548	6239	23382	5330	5184	353324	56242	219654	115207	1184	9528	145226	10873	60677	7737	80270	10437	2746	7099	1978	6850	84838	51385	23492	7347	123803	4521	51366	7048	6184	84851	5912	55699	26471	23077	91544	55684	8935	8673	2592	3087	80349	219833	22982	144193	126731	7384	388	55691	51300	80821	57496	2073	535	1201	4601	23042	84934	2778	53373	245972	928	10144	3069	54935	5297	5175	3071	154141	54978	9644	56606	65993	28966	80150	4775	285181	770	55652	10009	338661	9535	55862	10026	5264	9046	1176	64755	7077	7165	51596	29108	9990	79890	222234	138151	397	23731	6929	10951	10678	50862	10463	55796	203547	3241	6643	23344	10363	1312	10960	9980	51573	27242	2034	6397	221	253558	83931	3032	115209	8677	285761	9897	80212	4715	57181	2896	29952	54982	9620	80896	58484	472	2217	80139	114112	51397	55589	10430	55194	25793	64949	84310	3073	170622	55161	9114	28976	166012	57659	8609	57645	26009	1937	4350	90410	58511	63917	23097	9879	10491	4772	55328	51028	94239	645	140738	4853	84898	56255	152518	6817	10559	790	220042	115273	2037	79832	10365	5204	51495	4066	1200	10904	2030	5867	30061
GSE9960_HEALTHY_VS_GRAM_NEG_SEPSIS_PBMC_DN	M7119		19535937	Payen D,Lukaszewicz AC	GSE9960	GSE9960_3816_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in peripheral blood monocytes (PMBC): healthy versus Gram negative sepsis.	To identify signature genes that help distinguish (1) sepsis from non-infectious causes of systemic inflammatory response syndrome, (2) between Gram-positive and Gram-negative sepsis.					7804	3669	247	25816	10010	83737	960	51537	1847	9322	9641	2615	30001	6574	2140	8407	84791	118788	801	5684	10213	25932	50486	205	10139	9683	7360	27351	27319	4174	202052	85403	64651	8837	965	694	29887	5782	57128	2561	5008	2526	2146	3574	6504	10048	602	114769	100	231	1438	51510	4790	54820	79135	80014	9589	5157	123879	1439	54762	64319	7163	10950	26051	5996	374443	4001	10614	2180	2152	4316	55332	3055	4792	57823	51056	3624	51606	54498	53831	125476	200734	51131	9175	23446	114789	50856	3656	7444	7546	47	85458	8310	182	10538	84270	91694	1846	8611	440896	2713	127544	55848	56938	5908	5721	64859	1203	834	26253	22936	57655	54918	377	649	84641	2015	9595	1457	167838	389072	10459	1594	10775	5720	9050	272	8577	10507	64005	55207	637	10099	5033	5683	3660	51703	5886	338339	9693	727701	112399	4241	9435	6897	4836	148022	27314	7039	8495	718	57149	92482	23597	7185	64750	91010	2811	129026	117584	56650	3665	54165	223082	11193	10957	731424	81565	3576	641384	3604	286451	133	65264	23474	5054	3475	8877	5329	203102	2643	8760	196	9352	64928	64135	2117	10410	5265	8835	115004	4289	629	84081	6671	79931	1359	5682	64116
GSE9960_HEALTHY_VS_GRAM_POS_SEPSIS_PBMC_UP	M7120		19535937	Payen D,Lukaszewicz AC	GSE9960	GSE9960_3817_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in peripheral blood monocytes (PMBC):healthy versus Gram positive sepsis.	To identify signature genes that help distinguish (1) sepsis from non-infectious causes of systemic inflammatory response syndrome, (2) between Gram-positive and Gram-negative sepsis.					9342	642980	29937	51082	256979	10467	257106	1071	4712	6171	442216	158521	54928	140823	59286	222234	134553	4809	9718	79414	90507	100292959	8019	84215	55845	23023	1346	25901	2051	522	84992	283454	10928	55851	1136	170394	128338	10465	57691	80148	23394	493753	27106	25853	58493	403	6202	26018	84817	2972	100128731	23244	80301	51479	9846	81853	6257	10681	149628	8450	6194	55651	9580	145773	55975	100288721	2958	3094	388552	10555	400692	683	686	84851	643155	55289	7775	148103	26035	9620	440465	347734	11212	9167	65243	388327	729083	26249	54968	125144	94239	23266	114112	54664	55017	27101	51292	51552	284996	55902	8636	91893	51499	92912	644873	51234	128977	6320	128240	1793	10313	284106	23261	10365	25821	7407	1432	2987	29974	7220	55700	6154	51529	54536	23495	6230	138716	3297	91662	58505	56993	51142	5931	55788	3818	84661	51133	59307	3396	58190	1953	147694	150094	2107	3615	84502	4293	10519	6845	35	342926	8226	4987	79791	10811	84293	6138	493856	22905	23065	11014	10682	2762	6217	81926	55922	84314	23173	27235	10399	6631	285761	55194	1831	11260	55954	55182	5499	23064	9522	145226	9556	51146	55856	123920	10490	51573	57864	6566	254863	81892	155066	5423	285147	6251	51192	93974	1936	3064
GSE9960_HEALTHY_VS_GRAM_POS_SEPSIS_PBMC_DN	M7121		19535937	Payen D,Lukaszewicz AC	GSE9960	GSE9960_3817_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in peripheral blood monocytes (PMBC):healthy versus Gram positive sepsis.	To identify signature genes that help distinguish (1) sepsis from non-infectious causes of systemic inflammatory response syndrome, (2) between Gram-positive and Gram-negative sepsis.					5325	9852	85403	64109	123720	129026	150350	8324	2117	8775	2842	10186	3669	8310	51447	2706	284454	182	247	9232	51703	4047	6932	941	7295	55337	7804	1594	114789	3475	3842	9435	9582	11005	3604	30836	6046	2766	7163	57823	2580	1847	6772	100506988	8339	8454	6352	55120	285628	653464	123688	10673	716	10148	6773	205	10125	4683	3834	90407	57101	219285	10199	83737	347	84419	22902	169355	87178	3620	10410	286009	123811	93082	3315	56940	23049	9636	4014	65264	3431	378938	8828	10507	100170841	3624	255231	7185	149478	84901	84166	6198	50486	3433	4940	84333	2643	54726	10658	694	7128	93653	5332	79166	152926	3575	9129	4628	83637	441108	143689	55055	53833	629	4330	7130	29121	158830	5216	9175	79135	4323	6614	3566	10906	3429	644090	9830	8760	54820	6648	494115	4939	83874	2015	10276	8519	64135	8932	2811	84068	91543	11182	51667	10964	65220	84981	340348	123872	9595	10561	780776	84270	330	8349	7270	374443	26010	257152	165324	9217	4316	5734	4791	688	100	9209	55601	84081	4884	23560	203102	29126	55008	23413	359787	81576	441168	80174	27319	9050	23022	196	7293	11021	55014	8495	1808	3665	57171	3718	8553	23178	4234	55629	3759	4783	54809
GSE9960_HEALTHY_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP	M7123		19535937	Payen D,Lukaszewicz AC	GSE9960	GSE9960_3818_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in peripheral blood monocytes (PMBC): healthy versus mixed infection sepsis.	To identify signature genes that help distinguish (1) sepsis from non-infectious causes of systemic inflammatory response syndrome, (2) between Gram-positive and Gram-negative sepsis.					6000	2900	11055	400550	4585	26689	678	8078	100130232	79729	150094	22989	56241	10879	10188	2822	26100	27035	10991	2980	3933	23024	3883	63923	100289641	8200	145773	729178	203328	339855	64852	6422	253842	54716	2972	1944	5863	57626	100287704	83889	5080	116985	326624	54972	796	3042	1807	100292534	338864	55289	9780	727738	26231	1145	57657	1071	85352	51224	84461	56127	57689	4284	3363	50855	26083	10345	7862	4293	100422737	3164	79006	10715	81855	728437	338	139628	23495	90586	100233209	185	100507508	3358	285943	51716	56956	222229	387597	27296	5396	160762	3110	6376	146512	2668	4862	22983	6521	23286	5629	85395	27289	118812	100287576	727930	55653	7703	150160	84552	91851	268	124930	57697	1262	26211	100131017	100133019	93611	10178	84302	207	55603	2567	4855	642980	5136	26082	284439	26579	284187	10814	56950	54544	10516	6050	1421	144766	26254	8538	6712	22849	4588	286223	729083	140730	134	152	81792	1917	5232	1136	9342	114817	51705	3899	166614	4796	378832	100290481	27033	53345	124842	441094	1760	26206	55118	2779	390999	56894	153090	388662	79846	171558	9478	23109	619455	89870	4185	338661	57125	3885	3645	3208	2125	5104	491	100288640	1774	4907	728441	203062	220980	27319	4486	148014	81858
GSE9960_HEALTHY_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN	M7124		19535937	Payen D,Lukaszewicz AC	GSE9960	GSE9960_3818_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in peripheral blood monocytes (PMBC): healthy versus mixed infection sepsis.	To identify signature genes that help distinguish (1) sepsis from non-infectious causes of systemic inflammatory response syndrome, (2) between Gram-positive and Gram-negative sepsis.					387921	10434	152815	57128	8942	2553	55907	891	51030	196513	390066	27333	9263	54799	360023	130367	4495	51015	23250	5295	285282	84933	10100	8790	65977	146956	80196	26253	10282	7709	147948	7594	53831	3656	219333	27229	5325	441124	9338	51042	22992	2146	8850	5033	57149	4711	85003	166968	150568	546	145482	29966	6355	10463	284307	150274	6715	57475	112849	9631	54165	9451	157680	100288139	23469	10166	8539	100289209	9232	8747	55814	7764	131544	23099	9180	8844	9873	23671	29887	144571	1359	204851	7743	6868	55216	79612	201595	494115	100287932	285830	28982	79088	142940	9966	987	54943	163081	23041	10199	79694	647115	57168	55206	7741	283508	9889	493911	23137	158830	10730	55762	6638	83930	117584	27107	135154	169200	91748	51135	11064	152503	122553	285172	3394	9204	29978	8577	64324	63939	285147	8353	79676	282966	118987	26531	55529	130535	23080	285605	9209	203427	51028	4794	55914	253959	23660	85403	54205	965	9589	121441	122060	79096	55032	196294	5530	11083	51808	163747	9852	80213	8658	889	51360	65983	7270	22936	6415	54454	11182	64854	55276	100306951	23014	9683	283518	1490	6990	9050	55681	79634	84376	285628	55900	79886	84513	137392	144715	10911	22889	26036	160335	56242	80311	142891	9352	51279	93082	644246
GSE9960_HEALTHY_VS_SEPSIS_PBMC_UP	M7125		19535937	Payen D,Lukaszewicz AC	GSE9960	GSE9960_3819_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in peripheral blood monocytes (PMBC): healthy versus sepsis.	To identify signature genes that help distinguish (1) sepsis from non-infectious causes of systemic inflammatory response syndrome, (2) between Gram-positive and Gram-negative sepsis.					2218	79822	533	8111	10329	87	23446	51082	55845	3371	4256	4317	284252	9094	26024	1464	8772	6361	6769	4319	89886	51480	3820	100128731	4499	26297	2152	56659	79658	7035	6734	154467	25821	11334	54165	23474	84817	5315	100130889	3052	9260	5810	51142	10383	6330	84144	92126	4321	10200	55240	6692	157273	3556	221016	8835	54762	51506	80342	8001	9318	54509	57687	51021	166824	3516	1033	132789	3346	2781	10230	1915	8372	10297	23352	80381	260434	11040	80273	5740	1603	63932	4322	23433	150350	478	112399	80311	201243	5437	4049	1879	6845	8318	200734	79817	54555	83597	5627	4717	348995	4907	3972	5881	84525	8995	80060	7329	1503	6520	140809	28996	9452	5792	145553	79066	23037	51155	100129656	338004	64102	128434	51192	91869	644135	100286921	401317	259217	149466	84696	9167	728437	93185	28972	138311	6369	30836	1435	676	253128	55017	8843	221150	4956	79639	5201	80235	4809	143471	85437	5571	8703	55920	54498	5244	116150	598	1134	84885	9817	124401	253012	2802	6675	27043	64078	56675	7153	100129455	151	8740	100507564	23396	29098	26515	4643	149047	65008	6449	10193	4704	7743	149345	2811	3170	84304	51204	79626	9232	57535	149111	55254	4729	8497	5587	10067	10016	100506054	4301
GSE9960_HEALTHY_VS_SEPSIS_PBMC_DN	M7127		19535937	Payen D,Lukaszewicz AC	GSE9960	GSE9960_3819_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in peripheral blood monocytes (PMBC): healthy versus sepsis.	To identify signature genes that help distinguish (1) sepsis from non-infectious causes of systemic inflammatory response syndrome, (2) between Gram-positive and Gram-negative sepsis.					138948	255480	390616	80318	84068	168374	10164	78990	6941	4647	100302650	7454	204851	221662	2799	23075	9436	100506757	59339	284551	552900	161142	4983	9582	196872	686	100288765	5228	441666	729806	400581	64795	2157	6295	54822	3758	5581	26341	646019	2047	4884	1946	389289	54862	3198	146779	3592	100132735	55603	57573	149297	1777	169355	387763	6898	5028	9172	51361	51574	100101467	55722	55671	4354	10842	23325	124626	815	26242	146057	6794	3107	79966	84709	100128281	84176	80173	84765	91452	375287	3619	643641	94134	79089	100289341	83758	8775	653319	440300	283685	10427	2241	115265	8034	80712	442117	56623	55140	3315	8867	200315	3790	283861	11131	255022	115350	55124	85329	6473	254827	9079	90678	26118	9992	9095	285955	91543	117531	386618	219899	125997	55194	133584	3352	163786	653394	374768	672	29801	57088	10678	7538	414899	3952	22928	246704	8434	100505718	1016	100131814	116113	643529	285178	9113	4853	388581	162387	3146	22829	187	3429	134147	132989	26471	100505696	9880	442213	751816	4299	257144	166979	29978	93444	100288798	3428	55213	1544	730202	146279	22803	3964	10658	123264	51444	204801	3138	5595	158158	90441	51102	100289563	100507423	219285	115560	91355	55726	284029	266917	284723	2712	645524	10927	84436	7398
GSE9960_GRAM_NEG_VS_GRAM_POS_SEPSIS_PBMC_UP	M7128		19535937	Payen D,Lukaszewicz AC	GSE9960	GSE9960_3820_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in peripheral blood monocytes (PMBC): Gram negative sepsis versus Gram positive sepsis.	To identify signature genes that help distinguish (1) sepsis from non-infectious causes of systemic inflammatory response syndrome, (2) between Gram-positive and Gram-negative sepsis.					10410	651746	2615	2028	29887	54831	247	219285	148022	57708	151636	51510	4638	5683	115004	10538	3383	694	3055	5885	100	4174	55311	8407	6000	3604	57657	3718	55515	10950	84964	5720	2713	223082	9322	3437	54739	389072	10500	8061	100129656	4836	80179	170954	25816	9683	10221	114769	80219	84270	55223	9111	8837	2146	284632	1026	3883	3068	10067	57179	83440	602	375790	57823	11193	10139	9693	5008	553115	56938	7111	5187	389898	6483	81565	23590	205	137964	5996	202052	9695	51191	2495	3587	55254	84875	10663	5306	27351	159090	352961	5686	5329	26024	5734	801	338339	10015	5033	684	143187	1439	4745	9435	27338	2152	10099	8454	221786	54820	57801	94240	2015	8577	7185	56970	85441	3601	5684	79016	4218	64787	79822	3665	10581	5706	4693	4779	5316	222229	3624	126820	731424	965	9081	91012	2811	84933	27239	203068	27173	79155	79825	57655	149134	10561	284739	10964	2643	8744	84919	127687	3669	10125	415116	118788	4316	3500	163183	93185	2356	2633	57149	64859	3995	6774	3696	340348	9595	90407	11274	374443	84955	440704	29015	7293	57412	283416	10276	196385	11182	1846	4141	339344	7360	6892	10962	64834	90874	6772	10397	5782	3656	2117	9318	5268	2710	4323	8706
GSE9960_GRAM_NEG_VS_GRAM_POS_SEPSIS_PBMC_DN	M7129		19535937	Payen D,Lukaszewicz AC	GSE9960	GSE9960_3820_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in peripheral blood monocytes (PMBC): Gram negative sepsis versus Gram positive sepsis.	To identify signature genes that help distinguish (1) sepsis from non-infectious causes of systemic inflammatory response syndrome, (2) between Gram-positive and Gram-negative sepsis.					51255	933	11282	84851	2073	10678	9046	27079	2720	55704	5738	25906	54893	388	5378	55667	440465	23659	3073	23097	54982	2628	10400	55900	3920	51117	2896	2034	22881	9445	5264	1201	5108	84838	25864	8125	286101	79064	4436	390616	60370	79832	51382	57136	472	5330	23531	58484	51573	7284	51495	2595	7737	5184	9236	84310	56994	3064	51060	201562	140738	79672	84514	54545	5058	79887	144193	56997	320	54941	4601	55644	8455	55201	376940	4718	51300	23412	7915	8491	196463	2217	11264	118881	8635	26469	6599	283897	353324	60412	10919	23112	9936	285181	56606	100132406	23075	6397	4716	51449	85315	10559	50862	57678	7464	90231	10168	84725	94241	285193	10008	57181	27072	29125	79680	80349	3839	57532	57496	162	8445	412	2729	80020	65265	55699	53373	51097	144363	360023	463	285513	64802	7813	10788	23077	51768	5934	5165	535	53829	140	8935	56674	441631	8677	10873	1353	9338	79986	3069	56255	84898	2037	9692	83449	27242	9444	23080	3033	387032	121512	1978	64098	9697	10951	65125	1955	205428	10472	84188	51362	246175	54751	91452	79890	397	8798	5912	5867	79745	55333	100113407	1176	163081	27440	83938	132160	7109	155066	10961	5150	7561	115209	56986	6184	130535	333929	80896	57645
GSE9960_GRAM_NEG_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP	M7130		19535937	Payen D,Lukaszewicz AC	GSE9960	GSE9960_3821_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in peripheral blood monocytes (PMBC): Gram negative sepsis versus mixed infection sepsis.	To identify signature genes that help distinguish (1) sepsis from non-infectious causes of systemic inflammatory response syndrome, (2) between Gram-positive and Gram-negative sepsis.					6861	55629	152485	255762	10663	10345	123720	100288893	84619	219285	1995	55515	6712	26012	4762	90407	6772	57626	9177	255480	10891	3433	93082	400223	4157	9436	10148	11262	6932	4065	10410	4284	22902	3898	94059	9721	284454	2117	285628	285708	6495	23178	388948	100133019	8339	688	8454	255738	3604	3620	9985	1016	2740	84333	100288496	100130232	57823	2900	1588	51231	337878	9852	1946	10964	6773	100421561	339768	64109	340348	161291	266727	10234	51214	5148	7379	26024	5792	10199	8775	4693	146206	3042	55593	30000	100499467	651746	87178	3437	51574	80256	1741	3669	57619	22833	2906	9514	4599	84214	54739	4047	5080	107	5645	694	672	8519	441108	8313	286009	3029	10893	283848	85352	26219	54862	28908	147081	84901	149478	727930	9435	4939	8932	247	10454	729177	3753	623	8822	3933	7130	3431	55337	81622	2786	10383	619207	53345	64121	54825	27299	146512	54625	26097	4628	6331	204219	284632	400550	6352	10409	51667	7295	100289341	11274	3566	4588	57801	1746	57657	3718	1185	5456	60506	205	22839	85441	54516	3434	7185	55721	10581	170825	113878	1889	79148	81796	23286	142684	8349	55237	23560	2831	79009	84166	629	6624	23242	6572	1029	3273	796	169693	653319	10561	1606	199731	140893
GSE9960_GRAM_NEG_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN	M7131		19535937	Payen D,Lukaszewicz AC	GSE9960	GSE9960_3821_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in peripheral blood monocytes (PMBC): Gram negative sepsis versus mixed infection sepsis.	To identify signature genes that help distinguish (1) sepsis from non-infectious causes of systemic inflammatory response syndrome, (2) between Gram-positive and Gram-negative sepsis.					4712	132949	6638	80349	80204	54764	23157	128240	100128731	130535	23385	140823	285605	282974	57678	170394	222236	23112	29880	79441	147948	51479	131544	139231	142940	221504	8038	7554	23023	79137	2108	4899	137392	166929	11334	891	55975	441212	3493	84851	55851	54675	10465	79626	2944	54680	3094	51389	57634	54949	57691	64219	285147	8773	401466	163081	55217	157680	7738	128977	286144	1500	683	81853	10390	387032	56993	10623	2876	51629	10171	113201	155066	8518	55845	55662	10856	147949	284323	51082	79676	147694	5286	203427	23648	10526	58478	58508	79096	84262	8658	145482	29028	1353	10380	29937	7576	51241	23787	84266	493753	8450	51060	23405	1611	360023	80311	79701	347734	51340	9094	388962	2948	28972	65243	7549	26297	403	26127	64395	64216	51187	390616	85476	9530	6222	25888	91893	26035	118672	5003	126231	746	84992	196527	94122	79621	7561	149420	440465	10499	375757	51809	58493	254128	10196	64766	5193	51619	64147	29085	163131	8520	84817	84250	7696	81790	26003	51542	10151	23394	4828	116461	123920	987	284106	9847	9556	6604	199990	23378	135154	7172	51142	1371	27079	9439	100131067	100303755	51133	54778	64776	131616	4717	147947	54664	51021	55746	55276	55201	23287	7019	6655	5816	55070	10732	900	10423	55182
GSE9960_GRAM_POS_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP	M7132		19535937	Payen D,Lukaszewicz AC	GSE9960	GSE9960_3822_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in peripheral blood monocytes (PMBC): Gram positive sepsis versus mixed infection sepsis.	To identify signature genes that help distinguish (1) sepsis from non-infectious causes of systemic inflammatory response syndrome, (2) between Gram-positive and Gram-negative sepsis.					1676	6480	27131	2353	4361	11274	9500	3429	57038	80777	678	7318	8829	90355	10436	64062	388753	2167	22950	23077	410	55783	5591	84522	2872	54996	29966	3437	8402	51474	5184	29	51373	6275	8613	9111	8726	3433	53635	1654	55861	54499	5439	65109	4354	90933	63948	10574	1616	60492	10311	3659	26207	56947	6606	7538	4722	8850	81572	55572	1843	1936	10723	57533	22828	29904	5641	695	6603	3000	4063	6164	6217	23179	22931	9994	29058	157769	4711	51318	9868	6742	9391	2242	51491	27000	4061	4594	5281	64763	84661	1666	64219	55870	3570	7106	6938	9093	7016	9898	1052	3579	4343	4300	23761	10636	9126	28973	129285	51534	1788	558	79145	58533	83699	6311	6194	170622	6697	80789	30836	4014	79829	51567	4860	79810	3669	23528	51780	3490	9130	57228	5052	51116	3155	6210	4915	9159	55233	7046	9935	5311	22928	9314	1441	2354	51575	54820	51690	1848	10140	65123	22948	11168	7852	7001	4086	142	8666	22820	390916	3725	567	6925	11152	388	285362	8491	8861	6612	100	10204	6453	7181	3384	56339	6239	3297	8714	3394	473	80349	467	3276	23111	2671	10875	23016	124997	9410	55435	23741	8904	7409	1488	2110	60592	22795	23548	8502
GSE9960_GRAM_POS_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN	M7133		19535937	Payen D,Lukaszewicz AC	GSE9960	GSE9960_3822_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in peripheral blood monocytes (PMBC): Gram positive sepsis versus mixed infection sepsis.	To identify signature genes that help distinguish (1) sepsis from non-infectious causes of systemic inflammatory response syndrome, (2) between Gram-positive and Gram-negative sepsis.					4363	4664	100507444	4288	387893	2781	6005	6845	2553	3017	9265	338917	4601	2798	8864	3096	212	51012	136	5829	11193	3783	50624	5653	5967	29933	63036	4794	960	4084	6814	5053	10538	85463	23568	9108	84790	9463	23315	2357	130120	10938	51109	3707	1755	9469	5728	79570	6335	3081	10206	5407	440387	55038	6035	55167	639	84694	4689	203228	3398	4311	51738	388533	5968	257397	5068	79720	26224	653808	284371	8671	119392	483	26240	8780	58158	3720	64747	602	3934	57610	116844	80142	54922	10018	55808	267	5923	8110	6836	1208	83896	2053	2925	788	342898	1511	3678	8928	1499	113878	59338	1365	3552	7430	5409	2	55	23212	3097	4331	2904	8986	4791	10890	4043	3977	26020	4973	26525	2736	7690	10406	204	7404	57409	4233	30001	3929	2014	3290	1056	633	64837	3241	91010	6557	7294	1977	2319	990	9053	8437	10318	653361	27239	10383	6198	56270	8411	7153	6820	1112	56916	3149	51268	26253	1586	3978	84270	54981	10458	51514	2070	3240	1594	23580	3015	64114	10011	5739	474	3006	23673	3399	6843	57568	83541	23173	7003	28974	9467	279	135	114790	6366	51341	330	829	1506	79577	51762	7481	25930	29118	10930	9604	5727	23352
GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_2H_UP	M7156		19698979	Wang Z,Zang C,Cui K,Schones DE,Barski A,Peng W,Zhao K	GSE15735	GSE15735_2248_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells: control versus treated with HDAC inhibitors for 2h.	Histone acetyltransferases (HATs) and deacetylases (HDACs) function antagonistically to control histone acetylation. As acetylation is a histone mark for active transcription, HATs have been associated with active and HDACs with inactive genes. We describe here genome-wide mapping of HATs and HDACs binding on chromatin and ﬁnd that both are found at active genes with acetylated histones. Our data provide evidence that HATs and HDACs are both targeted to transcribed regions of active genes by phosphorylated RNA Pol II. Furthermore, the majority of HDACs in the human genome function to reset chromatin by removing acetylation at active genes. Inactive genes that are primed by MLL-mediated histone H3K4 methylation are subject to a dynamic cycle of acetylation and deacetylation by transient HAT/HDAC binding, preventing Pol II from binding to these genes but poising them for future activation. Silent genes without any H3K4 methylation signal show no evidence of being bound by HDACs.					4049	57180	25927	11243	2896	374907	64781	80205	23392	11184	64407	51460	10695	91775	57544	4245	58526	56269	127829	122945	399687	9278	11217	160518	23400	5452	11078	317671	5660	66004	166614	3895	10000	221472	8613	348	84803	10509	30844	330	388228	3606	145781	5600	4070	5580	54536	10367	9497	79701	817	254359	4925	23456	8419	10260	10955	83478	1269	2268	5355	2776	25932	5199	5547	9094	122622	3514	6929	8754	80231	9324	2889	7305	8767	22843	7099	6451	9399	5341	5430	85365	9712	22936	11259	153020	489	29952	347733	3636	128178	51316	26160	9842	5579	3568	64098	301	1960	55114	26958	7942	26262	79832	9734	23138	958	5993	64792	22837	100302692	2650	145226	29802	23258	4643	9252	7407	9444	822	9400	197322	6480	253012	4257	55589	65987	84288	80148	10019	9582	1871	10970	91010	9342	114804	23164	131583	2790	5294	200576	6452	26228	11031	214	84329	10855	22992	5966	6050	11213	23308	11182	4267	22898	284004	55652	57584	3017	726	23424	26090	80230	5982	23075	5777	1846	23087	60386	57565	4942	604	7011	1075	80020	26051	1978	8412	23240	3991	653361	5210	79874	1445	58497	138241	5581	4082	126298	26099	9110	153562	57804	283578	3340	50862	57407	81788	114908	5641
GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_12H_DN	M7157		19698979	Wang Z,Zang C,Cui K,Schones DE,Barski A,Peng W,Zhao K	GSE15735	GSE15735_2249_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells: control versus treated with HDAC inhibitors for 12h.	Histone acetyltransferases (HATs) and deacetylases (HDACs) function antagonistically to control histone acetylation. As acetylation is a histone mark for active transcription, HATs have been associated with active and HDACs with inactive genes. We describe here genome-wide mapping of HATs and HDACs binding on chromatin and ﬁnd that both are found at active genes with acetylated histones. Our data provide evidence that HATs and HDACs are both targeted to transcribed regions of active genes by phosphorylated RNA Pol II. Furthermore, the majority of HDACs in the human genome function to reset chromatin by removing acetylation at active genes. Inactive genes that are primed by MLL-mediated histone H3K4 methylation are subject to a dynamic cycle of acetylation and deacetylation by transient HAT/HDAC binding, preventing Pol II from binding to these genes but poising them for future activation. Silent genes without any H3K4 methylation signal show no evidence of being bound by HDACs.					155368	10801	51809	174	1026	123879	3959	5912	3434	10870	10924	23175	5525	10051	158866	57154	143689	84680	5027	126432	22859	84254	196446	8938	161436	54997	23170	8914	1265	154661	57488	6574	134957	138429	92922	326624	9527	9831	8705	374897	3748	92092	6041	6095	896	6732	9973	5160	93589	51108	221188	203068	23621	51762	7039	26119	28992	92558	3290	79598	6249	5732	28232	6775	11240	84172	55601	57162	57198	392275	7498	51232	55640	4637	3716	159371	79575	221178	23076	51129	2135	9265	270	54923	55667	259236	5954	1606	3689	3707	51015	2936	64215	4907	51466	5721	388796	23151	3796	3570	112936	2342	27345	6915	4154	115330	29103	4891	3664	63892	51752	2258	388886	8631	23646	9136	83986	135295	91523	3572	84973	8320	9920	2051	23205	27240	54093	153745	163126	152185	10015	254013	924	23533	54982	402778	5720	90135	27440	23102	57701	57580	54914	5768	55568	9374	54941	83636	8525	22803	2838	6526	5567	56606	3695	57713	6342	3929	54843	1742	144404	54622	5571	55217	79895	23043	3927	254531	23218	379	23635	5916	392	84174	285195	55691	54842	56253	10803	3955	8807	55194	2023	10449	5272	4155	622	91683	9759	83786	92370	11329	222487	5998	333926	1201	80228	7535	132720	79713
GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_UP	M7159		19698979	Wang Z,Zang C,Cui K,Schones DE,Barski A,Peng W,Zhao K	GSE15735	GSE15735_2250_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells treated with HDAC inhibitors: 2h versus 12h.	Histone acetyltransferases (HATs) and deacetylases (HDACs) function antagonistically to control histone acetylation. As acetylation is a histone mark for active transcription, HATs have been associated with active and HDACs with inactive genes. We describe here genome-wide mapping of HATs and HDACs binding on chromatin and ﬁnd that both are found at active genes with acetylated histones. Our data provide evidence that HATs and HDACs are both targeted to transcribed regions of active genes by phosphorylated RNA Pol II. Furthermore, the majority of HDACs in the human genome function to reset chromatin by removing acetylation at active genes. Inactive genes that are primed by MLL-mediated histone H3K4 methylation are subject to a dynamic cycle of acetylation and deacetylation by transient HAT/HDAC binding, preventing Pol II from binding to these genes but poising them for future activation. Silent genes without any H3K4 methylation signal show no evidence of being bound by HDACs.					51043	822	91775	11187	940	3005	28951	4688	253782	4345	8718	222255	3690	375035	392465	23129	10216	338596	51409	10888	356	975	23285	1001	201799	6856	10437	80760	8572	162394	5027	55652	27111	6414	80146	10797	5106	9639	22876	390243	9497	126	57472	4646	5664	5025	96459	920	445	54997	3664	3897	92906	26524	1152	400746	9411	54843	55013	4217	23168	7293	57134	2051	81618	57336	10451	94	23095	222484	22902	7351	11037	7049	151888	1154	1870	147710	169200	116841	9882	11123	5217	147015	7867	928	9972	23142	1595	51379	3559	825	55758	9531	54855	10268	26205	79085	8829	57713	50943	9139	3684	53905	6309	921	3275	54434	3925	8600	64919	2319	9761	347733	1400	1153	84187	9920	6480	25998	55589	11078	2060	51474	26509	5210	2280	131450	92	25897	8897	50807	92126	399687	9867	57610	286753	9595	29957	84937	3482	5925	1893	22901	54455	2181	10077	5734	157378	9429	10254	50937	6497	333926	7074	5934	1510	7494	6526	50814	64092	9788	23466	259230	5641	3487	283985	51062	57514	55852	10000	56852	10367	5600	7046	55617	1612	919	1493	57045	3091	6251	163882	57409	2323	23464	1880	50852	113263	25822	56905	54476	57479	60485	388969	5873	23382	64109	9452	58485
GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_2H_DN	M7161		19698979	Wang Z,Zang C,Cui K,Schones DE,Barski A,Peng W,Zhao K	GSE15735	GSE15735_2248_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells: control versus treated with HDAC inhibitors for 2h.	Histone acetyltransferases (HATs) and deacetylases (HDACs) function antagonistically to control histone acetylation. As acetylation is a histone mark for active transcription, HATs have been associated with active and HDACs with inactive genes. We describe here genome-wide mapping of HATs and HDACs binding on chromatin and ﬁnd that both are found at active genes with acetylated histones. Our data provide evidence that HATs and HDACs are both targeted to transcribed regions of active genes by phosphorylated RNA Pol II. Furthermore, the majority of HDACs in the human genome function to reset chromatin by removing acetylation at active genes. Inactive genes that are primed by MLL-mediated histone H3K4 methylation are subject to a dynamic cycle of acetylation and deacetylation by transient HAT/HDAC binding, preventing Pol II from binding to these genes but poising them for future activation. Silent genes without any H3K4 methylation signal show no evidence of being bound by HDACs.					132720	2217	4818	3111	974	3748	55508	1521	91522	29103	256394	152007	8320	29127	152579	8530	11040	8728	162966	66000	55691	9922	2022	2054	51523	6404	8938	8555	65981	56253	971	8237	291	51316	340024	51227	126859	153745	3241	139716	2583	8111	3682	11202	7549	84172	420	64218	7791	22803	7164	1351	5138	8434	255231	10712	5551	93587	9928	10803	79834	88	57348	85302	159371	6566	221188	4647	23433	10868	94120	79070	54847	55316	388886	653361	22800	23621	60412	79895	333929	3824	94240	389206	57333	286676	402778	23116	23410	84002	10609	4891	116236	3712	1269	926	2149	7070	1803	10938	54815	22874	925	54414	55603	113201	24149	6775	4234	22856	2678	186	23498	401612	92922	3004	23062	57486	55337	6653	54433	116966	30832	150223	53346	8754	81624	8870	127707	146439	5021	23218	64744	5480	5274	10787	1140	51177	10947	90624	55789	401409	78997	5277	55163	93517	6147	201161	255809	9200	26191	94081	7407	64780	84245	196446	6231	64098	388796	10333	10171	79993	51504	9120	1075	55619	23529	309	56950	57165	9582	57707	50486	9404	55561	5341	5720	55667	55784	10211	9936	10644	63951	84455	51564	6472	11320	54517	54958	7086	2258	3108	8407	26227	84174	2067	4917	25911	26229	11197
GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_DN	M7162		19698979	Wang Z,Zang C,Cui K,Schones DE,Barski A,Peng W,Zhao K	GSE15735	GSE15735_2250_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells treated with HDAC inhibitors: 2h versus 12h.	Histone acetyltransferases (HATs) and deacetylases (HDACs) function antagonistically to control histone acetylation. As acetylation is a histone mark for active transcription, HATs have been associated with active and HDACs with inactive genes. We describe here genome-wide mapping of HATs and HDACs binding on chromatin and ﬁnd that both are found at active genes with acetylated histones. Our data provide evidence that HATs and HDACs are both targeted to transcribed regions of active genes by phosphorylated RNA Pol II. Furthermore, the majority of HDACs in the human genome function to reset chromatin by removing acetylation at active genes. Inactive genes that are primed by MLL-mediated histone H3K4 methylation are subject to a dynamic cycle of acetylation and deacetylation by transient HAT/HDAC binding, preventing Pol II from binding to these genes but poising them for future activation. Silent genes without any H3K4 methylation signal show no evidence of being bound by HDACs.					2054	83445	11133	147807	375790	221092	395	6836	1730	80223	1130	3992	10602	219333	8870	10924	57823	2319	55521	4605	2776	150468	6790	7358	84330	55454	10615	10206	57169	4841	7086	1954	2146	286319	864	23380	80146	115677	9831	672	8574	51343	5932	5606	28954	55959	1808	55839	8740	348654	306	9249	10613	55355	22929	5926	1727	157753	91687	2122	21	6776	79132	54841	10906	6263	23158	27071	8497	3055	51006	27036	171023	94240	11073	51148	865	10008	3897	55686	23603	9134	8702	2529	4173	2665	768	90459	140710	571	3572	5899	5118	23673	163259	28982	11031	201266	3595	10342	128387	10592	3991	54103	9181	51015	253714	643008	4734	55631	7511	8993	85027	79895	154661	57449	7444	80169	7083	195828	3606	3597	5599	153733	921	4176	2673	10403	11202	5933	9712	57613	1633	23625	114548	899	6539	10734	57580	7804	90390	64098	4939	3903	131544	920	2059	126308	55032	30851	7100	285362	1522	3695	3988	124935	10156	57460	168544	7468	2651	283130	8673	4046	3117	55048	56996	5426	896	126282	4086	2177	147015	286128	2828	29887	24137	23201	5062	2934	57519	55768	283446	144404	10451	10507	27333	1827	337867	151903	285195	81562	3633	80765	55262	5155	9020	126432	10113	22920
GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_12H_UP	M7163		19698979	Wang Z,Zang C,Cui K,Schones DE,Barski A,Peng W,Zhao K	GSE15735	GSE15735_2249_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells: control versus treated with HDAC inhibitors for 12h.	Histone acetyltransferases (HATs) and deacetylases (HDACs) function antagonistically to control histone acetylation. As acetylation is a histone mark for active transcription, HATs have been associated with active and HDACs with inactive genes. We describe here genome-wide mapping of HATs and HDACs binding on chromatin and ﬁnd that both are found at active genes with acetylated histones. Our data provide evidence that HATs and HDACs are both targeted to transcribed regions of active genes by phosphorylated RNA Pol II. Furthermore, the majority of HDACs in the human genome function to reset chromatin by removing acetylation at active genes. Inactive genes that are primed by MLL-mediated histone H3K4 methylation are subject to a dynamic cycle of acetylation and deacetylation by transient HAT/HDAC binding, preventing Pol II from binding to these genes but poising them for future activation. Silent genes without any H3K4 methylation signal show no evidence of being bound by HDACs.					10131	11184	9120	138241	144233	54847	64420	4070	8187	622	6415	79717	6168	25904	8785	54707	79697	11153	83959	80305	80700	85007	9618	84299	92715	6173	160518	873	200728	23087	171568	23263	29914	3895	226	56922	26099	2949	6566	10955	26751	246777	10514	64219	84836	401612	168455	23344	7357	3755	122945	55129	513	817	222484	84525	79064	6513	10970	11334	55017	145781	79760	958	5134	81873	90871	30011	23277	51645	83719	4832	51588	11213	5518	7084	55760	6689	23521	9657	100302692	84247	64207	56913	1269	56985	957	81567	84248	60488	1510	150383	54474	113612	9400	60468	55902	57511	57699	256380	51259	83878	57670	23368	284273	91523	25927	79192	64146	3716	83605	10184	2729	7019	255809	23092	10084	501	10519	5463	202018	9897	79039	26268	80185	148789	5122	9117	388536	54663	116534	138716	7380	57678	23195	3384	10633	54996	84288	22843	374969	114112	2193	10809	8601	6648	374907	55140	79731	79865	64172	3275	66008	55028	6231	56904	29803	54433	8645	64689	8761	551	7430	7579	259230	217	83606	83692	9903	51690	6949	1267	7328	471	5936	153562	130617	726	81890	118	124976	23318	51400	2953	90196	83891	27240	285761	57533	80347	10905	54800	489	79922	274	79777	56474	257364	2805	5571
GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_UP	M7168		19965666	Suryani S,Fulcher DA,Santner-Nanan B,Nanan R,Wong M,Shaw PJ,Gibson J,Williams A,Tangye SG	GSE17186	GSE17186_3139_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in transitional B lymphocytes: CR2 [GeneID=1380] low versus CR2 [GeneID=1380] high.	Goals/objectives: to identify various gene expression in B cell subsets derived from human PBMC and cord blood 					54741	348654	259266	54821	28954	6539	10401	89958	3689	6302	5579	4939	9498	2037	10561	115548	57519	1992	7804	6790	5359	3708	975	3636	9414	2146	144501	1130	162394	253782	9585	84343	26958	144404	284207	55081	3135	133619	8497	286319	401541	125058	9212	11183	5600	779	4938	23138	55004	4035	7327	80318	1454	4301	672	5524	388341	11259	54502	126133	375387	9181	79070	7936	151556	6237	7298	54455	10695	8439	375346	55959	2651	195828	5747	207	9249	23075	25780	28970	11031	84515	84617	124359	114548	4121	1312	171023	2628	147015	401145	115209	55032	4734	25	284996	11277	10615	16	6856	54478	5641	3516	5791	9020	3563	71	57863	29028	2529	23559	3627	971	9409	351	27134	4942	10112	23495	23240	7272	9734	7074	2589	22929	80776	57091	538	65987	330	5777	63979	64946	6238	23108	9709	8575	7124	5982	8411	5774	80820	56172	64098	7112	6721	10549	55604	10403	2030	990	9134	4064	51006	9256	701	2237	9813	1119	100506144	389206	22974	80139	92906	9846	10602	90952	27429	3340	1063	10635	80169	221914	11177	317649	5892	55331	84722	2059	80231	80728	157570	23328	9742	8556	196743	1827	55320	349136	56996	4689	80205	219333	80230	57217	79671	85027	9918	10592	9844
GSE17186_MEMORY_VS_NAIVE_BCELL_UP	M7170		19965666	Suryani S,Fulcher DA,Santner-Nanan B,Nanan R,Wong M,Shaw PJ,Gibson J,Williams A,Tangye SG	GSE17186	GSE17186_3134_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in B lymphocytes: memory versus naïve.	Goals/objectives: to identify various gene expression in B cell subsets derived from human PBMC and cord blood 					6723	29103	2021	51601	55667	57488	51246	388796	4891	5880	56652	23344	60468	8514	138429	221178	87769	79598	100009676	9650	10447	10207	6497	10057	23095	23170	8609	11145	256933	6574	388646	4234	401612	873	56948	6404	7277	5096	6173	3664	6415	135295	57621	4869	158866	23030	10436	7549	147710	93109	54663	3384	9894	339324	51019	65983	6911	8313	4907	55622	23271	162239	6775	7518	83605	23635	84552	27345	957	11334	9120	340024	51439	30832	55766	170384	1302	7705	55103	28969	513	253832	10678	79575	5732	57610	55178	5269	4647	57336	23438	728621	2583	4088	57710	84002	51564	23370	83786	10865	145853	8320	78999	64420	27434	6938	6504	51701	55568	286257	153745	9973	6732	22796	6609	87	252839	622	55272	6588	30008	55140	51809	51495	51368	3396	55217	10399	2634	921	10803	2051	390637	7357	84916	541565	23404	3929	63951	1368	1510	118672	8459	333926	10858	27344	90871	10870	4604	162515	1236	144233	6477	55256	130271	3216	55258	51129	64754	705	59307	23358	8884	63910	10905	122416	6789	9138	9117	8785	10198	55824	5525	4065	23205	84331	283209	8445	5230	390243	471	9124	220107	64207	27430	202052	3707	5019	8705	399665	4881	1769	84163	9750	379	119559	4609	59349	5245	55129
GSE17186_MEMORY_VS_NAIVE_BCELL_DN	M7171		19965666	Suryani S,Fulcher DA,Santner-Nanan B,Nanan R,Wong M,Shaw PJ,Gibson J,Williams A,Tangye SG	GSE17186	GSE17186_3134_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in B lymphocytes: memory versus naïve.	Goals/objectives: to identify various gene expression in B cell subsets derived from human PBMC and cord blood 					80270	3111	4055	11133	8438	1104	27333	64766	168544	136	55233	10592	5606	11321	80146	100128927	5933	4702	57182	4605	5912	9831	91522	9905	131544	115825	30851	10376	5926	5055	5924	171023	57142	6692	259173	6790	63939	128239	115677	256949	326624	84937	84282	55454	3340	51382	375387	11200	161436	30818	5763	54960	5608	11001	395	80184	2214	10926	1636	10734	1030	8702	317	2180	29957	286319	100113407	55601	22839	8934	3575	93550	7074	1730	9056	768	51134	51371	286144	5598	55909	85027	205428	54874	1827	8564	150368	10159	10127	8792	54808	3005	7798	22920	6503	84330	4046	114789	9652	133686	80205	8435	64114	54492	10146	29028	23310	953	22929	84938	6342	337867	55839	55884	3958	3988	114294	8402	201725	147841	10113	27036	5879	27071	71	79823	126382	9755	3595	162966	151011	55631	4644	1052	3455	84617	941	9493	9685	83463	23608	9445	23240	7046	3840	6051	9459	83667	90313	8560	10109	1803	9911	81796	7428	527	9700	2828	571	29982	9716	1826	4086	26267	116236	3991	23625	23094	147965	9476	144501	7570	58504	6237	9055	4053	3083	8574	6745	55521	9658	7086	282991	5576	10602	331	55471	154661	3123	2004	25854	5996	339122	22818	467	79895	55737	7444	10312	126393
GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_UP	M7172		19965666	Suryani S,Fulcher DA,Santner-Nanan B,Nanan R,Wong M,Shaw PJ,Gibson J,Williams A,Tangye SG	GSE17186	GSE17186_3141_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in B lymphocytes from cord blood: naïve versus transitional CR2 [GeneID=1380] high.	Goals/objectives: to identify various gene expression in B cell subsets derived from human PBMC and cord blood 					55720	26099	90871	80185	54847	686	28987	23234	6390	9466	284273	226	29950	6415	10084	9687	222484	153830	55621	9120	26354	84326	5019	26268	57180	3431	9870	8340	10471	25973	51187	23149	25764	55127	6513	83719	3033	10125	64925	4282	22823	9342	10248	873	406	57511	3716	51400	65985	171568	5664	64222	8607	118	55795	7099	54700	8892	84464	4925	4141	138241	200185	112770	4690	83878	6929	374907	80347	25896	23138	23087	144233	4354	219402	6150	221830	23368	54534	83606	51564	129607	10905	50650	81617	5687	29100	441054	84138	9400	706	81558	9	8883	5439	116534	11184	113246	285636	10775	7389	284018	90196	10955	7277	6689	166614	5826	153562	5167	27430	166815	274	6990	6168	84335	10043	11213	2288	57659	55785	29079	55037	9169	401612	6938	6414	9781	90231	513	8187	25904	57226	64789	5134	79661	1603	4050	833	54496	84265	1353	55191	4258	22856	8395	8645	54853	55312	79630	23344	6711	25898	257364	10567	114112	3032	3566	8668	55505	3482	219623	9367	5700	63934	84319	95	23041	2794	253832	64420	3384	26061	26227	60386	124454	10927	83692	57129	54800	29802	4758	740	55166	152185	4049	374969	202018	10166	9941	54942	64852	4300	79064	3895	963	817	255809	2145	256380
GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_DN	M7174		19965666	Suryani S,Fulcher DA,Santner-Nanan B,Nanan R,Wong M,Shaw PJ,Gibson J,Williams A,Tangye SG	GSE17186	GSE17186_3139_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in transitional B lymphocytes: CR2 [GeneID=1380] low versus CR2 [GeneID=1380] high.	Goals/objectives: to identify various gene expression in B cell subsets derived from human PBMC and cord blood 					5966	80270	79070	64710	1052	84191	55233	5774	6451	890	54802	4055	3925	3978	6696	10892	136	55915	80820	54892	92335	6400	144501	84188	4176	115727	54554	8402	1840	57821	23603	100113407	7358	1104	80146	280636	100288695	1827	5906	55165	151556	64151	25798	3398	8702	64766	983	57407	27306	5598	7097	53	331	1826	5984	25771	1075	5321	144455	3656	57863	7098	29028	958	9911	55909	3455	23125	330	79956	6624	147841	25801	55619	9658	29929	55717	83930	8853	1730	3516	8710	83667	30851	1119	219931	8869	55110	7040	7408	9034	9331	7942	2876	5055	6692	79682	7086	9212	5791	11073	5998	9918	6941	10592	784	2180	9133	5524	768	54947	283446	6502	388650	7324	1317	115677	3595	51125	286319	219972	55163	90417	10146	5243	23446	79982	140739	5412	4066	345757	71	4191	3991	55114	5256	11243	5888	4942	23361	58488	3553	207	9414	10392	9055	23354	9582	9909	63979	375387	157570	162966	5579	650	2650	55737	55521	79915	283985	7145	124359	57406	5576	153020	51517	8520	1031	81788	81607	55454	2271	10625	6790	23753	571	124935	51371	1209	23479	29942	57613	116236	7772	10477	6484	5155	54529	7532	7297	5255	80824	51225	659	701	2790	140825	130814	374907	338322
GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_CORD_BLOOD_UP	M7175		19965666	Suryani S,Fulcher DA,Santner-Nanan B,Nanan R,Wong M,Shaw PJ,Gibson J,Williams A,Tangye SG	GSE17186	GSE17186_3140_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in B lymphocytes from cord blood: naïve versus transitional CR2 [GeneID=1380].	Goals/objectives: to identify various gene expression in B cell subsets derived from human PBMC and cord blood 					9973	5160	2969	1102	55568	6443	23626	1032	4282	65018	51701	65258	56262	10801	10905	116841	1510	3431	1653	23526	55505	84002	164091	3384	8260	54475	117584	29895	6001	1616	84939	3033	130132	8861	8526	80342	27430	84326	6125	4345	115024	10644	8906	400916	5590	284273	10123	51019	5830	5019	3695	2634	374403	1603	5134	221785	402415	51368	55194	10043	28232	8445	349565	4690	1794	85461	118	11322	51564	6643	92126	54914	9267	26001	57559	51669	1802	3396	166	23180	4437	8667	9535	83786	95	10263	23064	3561	80152	7048	920	23568	284194	114770	8434	144699	64926	9744	10125	23368	5214	51809	118672	200185	23585	3032	841	51185	25897	57560	1154	54558	9	9466	552900	2590	64789	90987	79071	64801	6477	25902	994	10320	55529	81558	116985	57514	84187	51361	10051	4329	399	8604	122786	59307	6181	489	1240	23358	29920	91612	64756	388646	27345	1912	163351	5230	149478	64718	3614	3434	22803	57701	339324	79912	4302	6938	113246	5339	51193	83719	2308	127262	9590	23648	54965	55103	4012	375444	51108	8535	22873	7991	7402	6304	26207	158866	2534	6281	5786	10916	22821	10207	4155	133522	23492	2313	51016	64925	7277	7597	219899	7433	9452	120	4241	11035	6402	92558
GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_CORD_BLOOD_DN	M7177		19965666	Suryani S,Fulcher DA,Santner-Nanan B,Nanan R,Wong M,Shaw PJ,Gibson J,Williams A,Tangye SG	GSE17186	GSE17186_3140_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in B lymphocytes from cord blood: naïve versus transitional CR2 [GeneID=1380].	Goals/objectives: to identify various gene expression in B cell subsets derived from human PBMC and cord blood 					124599	11243	147015	6451	5774	375387	9212	9414	3516	6277	7272	6856	2889	4035	286319	840	84617	195828	7464	9918	140825	1826	71	144501	5791	10392	1636	7046	126133	84678	2214	100113407	4055	5888	3142	3015	3689	990	330	10112	1209	128239	54741	6237	9319	80820	57863	64766	7327	80184	941	1119	151011	56154	3460	338322	122945	10000	5359	6790	401548	2790	91057	57175	51074	162966	7145	7351	11182	79915	991	7112	29924	7298	196743	26958	124359	5802	51552	5579	5763	5358	779	7096	80169	56478	85027	6721	84343	388650	25939	1803	83716	131583	317	8986	57406	5338	91614	23566	4048	399512	51460	5576	5243	9742	1052	83930	4085	5347	8073	133619	9444	30818	2628	3619	114908	2650	25801	9652	9447	11031	6624	7813	6692	3636	54476	284207	10127	286144	4238	2027	9409	2957	285231	6302	10734	83667	11277	1827	23468	143872	80776	3005	130814	701	55959	9252	1871	51125	9043	23240	57407	22853	3684	7532	10250	332	207	150962	53	9459	9700	92521	54554	7107	10367	7185	7936	8869	123016	11133	30844	100506144	23075	63979	56172	84696	7169	9663	9110	84188	115209	10892	3688	5055	1063	96459	151556	79070	8402	890	221472	3295	4283	4046	55165	155185	23446	116984
GSE17186_BLOOD_VS_CORD_BLOOD_NAIVE_BCELL_DN	M7178		19965666	Suryani S,Fulcher DA,Santner-Nanan B,Nanan R,Wong M,Shaw PJ,Gibson J,Williams A,Tangye SG	GSE17186	GSE17186_3143_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in naïve B lymphocytes versus those from cord blood.	Goals/objectives: to identify various gene expression in B cell subsets derived from human PBMC and cord blood 					10801	5019	155368	55568	1032	6938	4302	27430	57710	6001	4891	10051	7277	84285	57621	135295	5160	51439	8535	22993	3716	56006	3033	10924	200916	285636	1603	65983	55217	78999	132720	489	56606	1794	9674	84002	23528	8459	2077	8938	57488	65981	400916	90025	81579	390637	339324	23635	6477	23051	6415	23568	221785	3384	57447	100009676	404550	3032	113246	390243	51368	8445	55621	4282	3434	9265	921	6775	5551	284194	10922	255809	8111	379	30008	541565	53373	122416	5021	392275	51227	55279	5732	117584	55851	10198	2067	10905	158866	4234	25902	6100	152185	57571	23585	10788	706	1370	26472	57701	144699	440957	83786	54865	84319	2584	23609	59307	399	51019	23064	23358	11174	55258	51701	8807	64926	23095	9781	23318	51495	420	114879	29899	3396	285193	115024	161357	27340	55103	10567	3959	55766	7549	23043	23180	401612	11240	55178	84674	2316	6181	2634	23170	29103	3561	57602	7091	100287482	283232	51129	1102	10803	340024	4050	4869	5134	153745	64231	3560	333926	23344	9138	51809	6414	28232	152519	26272	252839	51092	118	374403	6222	6176	79598	9710	2021	6404	586	27345	8525	54517	26608	90135	54663	26001	5230	9590	51564	221178	50486	7430	57162	55622	64925	23621	5583	1663	253832	29901
GSE17186_MEMORY_VS_CD21LOW_TRANSITIONAL_BCELL_UP	M7180		19965666	Suryani S,Fulcher DA,Santner-Nanan B,Nanan R,Wong M,Shaw PJ,Gibson J,Williams A,Tangye SG	GSE17186	GSE17186_3135_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in B lymphocytes: memory versus transitional CR2 [GeneID=1380] low.	Goals/objectives: to identify various gene expression in B cell subsets derived from human PBMC and cord blood 					9748	9911	27122	23241	23677	2776	6790	1973	1954	4055	84897	253782	90459	6642	3705	5698	60528	11073	55631	2517	8702	5305	10491	23022	23201	23625	2037	128239	93550	8509	10159	6584	92610	6776	8682	80851	9150	953	1102	6836	64326	80146	11200	7351	2923	10013	54977	948	143282	5570	26034	7841	399687	55706	90861	7381	5663	2783	51009	54478	54802	306	10615	94240	60678	54808	2245	23094	23299	154807	54443	389610	22920	3563	51292	7417	8728	2055	91289	10211	150468	6612	55969	1500	3101	114548	9094	64098	55785	83990	7840	755	286319	55041	5763	28970	51520	9341	840	84542	11240	3795	955	9522	1808	254887	1803	126393	144501	93974	1611	10397	55255	5272	310	8733	23673	2617	1933	653121	53827	80017	31	1396	10078	23345	3633	3839	283219	154141	79728	285362	3455	942	83930	22875	3416	55737	5153	374354	84641	28977	1104	57449	4436	29	3117	22929	8892	7879	440503	3059	3613	143471	84061	11145	160418	5955	1314	51599	26027	57823	4145	3597	7444	26035	115677	9197	9754	8612	9878	3344	3073	286148	151648	123016	941	203259	64881	11276	10156	83877	84904	6416	79065	5062	9685	768	9700	23741	84838	10376	4173	6277	51134	85465	203068	10015	57142	90780
GSE17186_MEMORY_VS_CD21LOW_TRANSITIONAL_BCELL_DN	M7183		19965666	Suryani S,Fulcher DA,Santner-Nanan B,Nanan R,Wong M,Shaw PJ,Gibson J,Williams A,Tangye SG	GSE17186	GSE17186_3135_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in B lymphocytes: memory versus transitional CR2 [GeneID=1380] low.	Goals/objectives: to identify various gene expression in B cell subsets derived from human PBMC and cord blood 					8837	257364	246777	4758	54847	537	1760	57693	79064	388585	338322	114049	144233	994	2583	79865	1943	677	84749	55028	5394	4070	29954	63932	5395	51773	1353	84909	8428	283383	353322	256380	27250	6603	6414	1138	3338	51497	84525	145781	23318	26017	513	10278	282809	1455	51475	124512	9590	5620	1997	126298	4791	92312	6402	11217	2683	57062	6637	10813	3716	22843	963	51368	23066	90441	5016	83596	23232	9716	57060	84148	138241	25998	57677	10855	51184	4303	6202	4772	64852	92715	51095	686	116984	489	79598	28990	55192	22930	55116	84034	57678	7549	80342	166815	8492	11226	3748	3858	57605	344905	84309	7095	79777	8851	84002	9138	9781	55738	3157	340061	8698	255809	2023	90204	23384	56985	401612	5551	9262	8625	9730	64420	3915	10128	6938	8187	22992	196513	85457	9400	1267	84433	123041	84265	80231	6643	84955	7019	6513	51504	25920	23234	80298	5771	23358	55766	9053	6100	57704	7520	11224	53335	10970	3916	1937	118	4258	23030	406	55131	2793	64207	54956	147495	64333	1983	29999	1445	5579	50484	91801	64897	145553	5571	80185	11172	8915	84248	8645	51429	81887	9342	837	3758	29946	27241	602	65265	4478	4515	23416	22876	5463	60436	51621	51588	79039	122060
GSE17186_BLOOD_VS_CORD_BLOOD_CD21HIGH_TRANSITIONAL_BCELL_UP	M7185		19965666	Suryani S,Fulcher DA,Santner-Nanan B,Nanan R,Wong M,Shaw PJ,Gibson J,Williams A,Tangye SG	GSE17186	GSE17186_3145_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in transitional CR2 [GeneID=1380] high B lymphocytes versus those from cord blood.	Goals/objectives: to identify various gene expression in B cell subsets derived from human PBMC and cord blood 					10204	51065	23092	29957	10477	85463	378708	55706	23673	840	23787	23741	1396	23423	5663	51599	58986	79888	11270	2137	3703	54874	291	9787	25796	64121	25801	6502	57134	128239	23022	6302	7011	51629	83990	1622	6747	11243	162681	64114	830	10019	9261	55353	84282	54802	4145	6416	55819	8464	4074	2783	2207	55737	4055	6790	8766	60678	9374	2593	55704	207	8402	5955	6924	3708	396	3455	637	4942	3094	126321	81614	81611	310	55163	7840	55110	55320	56998	64326	3101	8673	1062	9655	890	80318	79980	9516	286676	79832	11184	8702	2923	55090	1869	60370	26030	55915	6666	5780	1104	83442	5902	51056	952	55233	9101	8509	7280	6627	23399	7097	1827	79817	3613	28996	253714	84314	5550	55120	874	399687	92579	285148	55454	85440	79370	5984	55013	79140	55717	56886	30851	9043	3839	83877	55286	80301	29028	7532	4485	5272	51172	8165	4600	283431	9344	2491	10146	3159	6632	10280	4853	3071	4791	63916	3597	30834	90355	51091	7494	1854	285362	128077	2124	3798	55012	10733	160418	9937	8318	729852	51098	55508	22920	9493	51012	2650	4738	10855	8992	1798	7286	26035	55255	51167	29887	286148	57679	79982	54910	7040	10588	7913	3843	259307	79728	811	64222
GSE17186_BLOOD_VS_CORD_BLOOD_CD21HIGH_TRANSITIONAL_BCELL_DN	M7186		19965666	Suryani S,Fulcher DA,Santner-Nanan B,Nanan R,Wong M,Shaw PJ,Gibson J,Williams A,Tangye SG	GSE17186	GSE17186_3145_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in transitional CR2 [GeneID=1380] high B lymphocytes versus those from cord blood.	Goals/objectives: to identify various gene expression in B cell subsets derived from human PBMC and cord blood 					355	23526	23168	2979	6402	115294	27430	24145	402415	2686	79865	22876	9990	4478	353	2634	55505	10447	286046	23285	219899	64801	57060	154661	1656	57655	3507	174	91	219681	54509	9590	9537	971	339929	80342	10644	122786	9931	54498	6777	5590	140883	23358	22821	57476	1106	54901	6574	84861	22800	64895	11168	2531	117584	256380	283149	340061	963	56917	9486	4049	84153	1032	2731	5175	55074	144233	57713	118672	5912	146857	79780	6804	6281	54440	5916	8446	23568	10318	11174	10947	152006	51184	344905	27250	23457	84309	9730	1794	57552	51368	3693	100506736	3955	3572	127262	54584	92126	93589	5463	79590	1836	4329	4627	9267	79598	2308	2534	84329	51280	84961	1785	4249	56262	873	1802	84159	81794	26164	8567	10888	79603	53938	23626	50484	64072	7535	27345	22859	56985	117247	11226	11123	57062	661	11224	79912	84937	3664	57099	924	9452	2870	51715	6125	55851	221785	8897	5148	3633	133522	90313	26998	10610	3757	23586	116984	7750	59307	392275	3899	23585	118	2678	166815	401546	5571	162494	25819	79712	406	84909	159	54	28992	11202	85441	116115	7728	79713	414328	79961	388886	55716	11284	8625	83606	9973	8408	6497	51409	149018	120	84958	22852	23180	56829	9413	10579
GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_DN	M7187		19965666	Suryani S,Fulcher DA,Santner-Nanan B,Nanan R,Wong M,Shaw PJ,Gibson J,Williams A,Tangye SG	GSE17186	GSE17186_3138_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in B lymphocytes: naïve versus transitional CR2 [GeneID=1380] high.	Goals/objectives: to identify various gene expression in B cell subsets derived from human PBMC and cord blood 					84343	56886	65987	6790	11243	128239	952	9261	84061	342371	6666	28996	55760	55706	122953	79370	7423	64114	3708	755	2593	55120	9197	55704	90522	23559	59084	8509	54821	285195	83692	286319	10955	57175	7327	10800	51599	7272	57217	23333	683	23443	207	25801	147015	284207	55353	126133	79888	5892	26225	6993	84981	3798	154807	9260	54741	9043	2137	2040	6584	1396	6302	8853	8310	26056	29028	23094	134829	55004	203259	6856	84513	54802	9937	5524	51520	56998	51074	91057	80020	55331	9813	832	9855	85364	9459	840	3563	2491	7532	255758	51460	340526	10615	54977	4942	3015	54502	9585	79832	64222	80851	1798	9754	26090	8556	23172	55970	6692	221955	5955	220002	55013	84100	25	11142	92181	64098	6916	2650	93129	3835	5359	4055	3636	79728	5763	2581	9655	5795	151011	3619	10549	85463	1786	5639	90780	701	254887	55320	10397	2519	10130	1827	83696	80318	5608	2776	80169	1063	1871	9605	55286	26958	7798	7840	196	3613	2923	51552	80301	5272	114548	93663	9854	80005	9663	133619	7112	10261	9697	10169	401541	196883	27235	65220	779	941	4925	55236	50515	10100	7011	11276	201562	91694	4734	64419	6992	2124	23787	51053	9252	348235	3141	55615	9341	10629	16
GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_DN	M7190		19965666	Suryani S,Fulcher DA,Santner-Nanan B,Nanan R,Wong M,Shaw PJ,Gibson J,Williams A,Tangye SG	GSE17186	GSE17186_3141_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in B lymphocytes from cord blood: naïve versus transitional CR2 [GeneID=1380] high.	Goals/objectives: to identify various gene expression in B cell subsets derived from human PBMC and cord blood 					53373	219770	55218	6936	27430	55851	9486	340061	54901	85019	379	23358	162239	84265	152006	64744	186	4302	11174	4092	55667	50810	54509	3956	100506736	255104	1267	9537	5916	6566	23526	23621	222487	1656	84172	124512	8313	6100	1794	29943	51439	29103	5912	3929	55630	10922	51237	93589	174	56474	8555	139716	1729	132720	51225	51276	2634	10051	5525	23030	414328	6201	4282	161931	9656	10436	5908	23095	152185	392275	4604	23568	117247	924	2005	51444	1032	2683	10171	154661	398	27	283149	65250	951	116984	23232	55217	51504	8535	153745	4758	22883	28969	6202	143686	84144	388796	55793	10787	10678	55609	51760	66002	339929	23484	5533	3716	270	9781	5452	84804	123722	10609	3921	6281	873	84552	30832	3572	51247	401612	27345	1200	6169	921	11226	90025	22859	51665	10139	79865	144233	4869	6189	125061	6574	84626	55721	117584	55256	3748	57571	54760	55178	4647	8698	10447	118672	2256	10318	84329	23331	541565	63951	6497	54742	54517	283232	54843	83448	7549	8525	57678	57488	10239	23338	339324	9590	605	11202	91433	492311	7277	221078	2649	6504	199699	7535	420	23318	55505	4088	7173	5329	6793	9138	6045	3507	51317	4049	326624	140825	90135	30008	79598	6477	51466	9770	9953
GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_UP	M7192		19965666	Suryani S,Fulcher DA,Santner-Nanan B,Nanan R,Wong M,Shaw PJ,Gibson J,Williams A,Tangye SG	GSE17186	GSE17186_3142_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in transitional B lymphocytes from cord blood: CR2 [GeneID=1380] low versus CR2 [GeneID=1380] high.	Goals/objectives: to identify various gene expression in B cell subsets derived from human PBMC and cord blood 					80772	27293	8509	27333	768	117178	374655	948	8676	9878	93323	5611	58155	22920	26267	401409	48	10890	23625	27122	64326	64764	6692	8792	84904	10370	60528	3123	23094	91828	3959	2783	57198	5879	5926	993	5570	84542	7840	10013	408	840	219931	80279	493753	5911	9394	6642	286319	230	7184	11282	50813	9685	4704	131544	347733	56894	1476	5305	9445	1973	950	51143	9341	200734	2776	26034	4043	9197	55631	64743	123016	81502	11276	10629	115286	31	80223	8683	10015	1500	5155	11240	8773	54103	23556	5861	115817	143888	51809	3597	6891	9831	6540	84516	57580	6836	3005	8574	1102	63916	4924	23326	10682	147015	8942	157769	9322	2135	3685	5603	1808	7297	10066	7106	120103	6386	79630	55048	56834	253782	351	55691	7097	8635	8569	23218	23181	2550	4649	51015	286148	201266	3101	23328	26270	285362	10451	51124	23533	3268	755	50853	51382	11332	256949	10801	55041	55803	10491	6051	90861	10095	23380	259173	5721	54828	83930	4702	25	941	27339	10581	7511	25938	8934	8438	3083	56650	54458	83692	56996	80017	28970	23175	56660	5547	8702	196463	23673	2137	84678	21	254427	53635	2744	2673	147965	26035	22875	3572	8497	80301	55454	2245	550643	285440	8736	1050
GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_DN	M7193		19965666	Suryani S,Fulcher DA,Santner-Nanan B,Nanan R,Wong M,Shaw PJ,Gibson J,Williams A,Tangye SG	GSE17186	GSE17186_3142_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in transitional B lymphocytes from cord blood: CR2 [GeneID=1380] low versus CR2 [GeneID=1380] high.	Goals/objectives: to identify various gene expression in B cell subsets derived from human PBMC and cord blood 					6850	8915	388585	406	57180	1353	1445	4354	5471	5634	5395	10813	79717	9476	197370	50628	5604	9194	51284	686	22890	3431	217	6168	118	126003	145553	3033	23059	6513	6637	160518	6173	26228	9169	10970	10084	7430	4758	6609	1723	83606	23041	23338	84142	23334	80231	6938	1676	817	23171	3087	3716	7343	9870	4690	8883	51130	51564	958	23550	84836	138241	245812	5394	6929	2188	4515	55892	5452	9053	2953	55191	26227	79064	9524	7520	63932	54847	92241	3895	5016	55312	23195	57693	10955	8645	3690	2004	10938	23318	3755	57678	140831	7453	11235	55339	5412	126298	51184	55621	23344	134266	3384	8237	8861	116534	246175	27250	5252	30011	57677	6709	4258	8412	4772	2145	10014	55028	84288	124512	359845	54629	25979	3588	150383	4063	9399	375287	7515	54956	441054	54980	5579	8187	10608	5770	23228	203328	83719	56904	80298	7597	55257	201292	374907	84525	84450	79598	29950	54463	122060	64207	57568	168455	54996	22803	120	3514	92170	7019	64781	171568	85007	692227	84934	9400	25914	6603	8089	726	4049	3738	10188	79603	26269	55127	8763	9781	6100	51588	7084	24145	4070	221443	112616	602	4647	84932	91523	144233	114799	55251	5160	6775	51542	4345	10519	23474	57605
GSE17186_BLOOD_VS_CORD_BLOOD_NAIVE_BCELL_UP	M7194		19965666	Suryani S,Fulcher DA,Santner-Nanan B,Nanan R,Wong M,Shaw PJ,Gibson J,Williams A,Tangye SG	GSE17186	GSE17186_3143_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in naïve B lymphocytes versus those from cord blood.	Goals/objectives: to identify various gene expression in B cell subsets derived from human PBMC and cord blood 					2137	65987	84062	1318	150962	401409	29957	23423	93323	6451	25796	351	7184	64764	27333	768	285148	58505	4285	5524	2286	6546	394	23741	4924	92335	55829	3627	58155	399687	5684	131544	1798	6400	8994	788	3703	51809	64114	11243	55861	8460	55270	79077	2317	51125	840	4717	55165	63916	345757	80820	5552	80301	3094	8766	9734	26012	10396	3597	2582	55915	285440	23380	7532	10960	80864	2671	64838	28996	64326	2650	8509	162966	9296	25816	58986	54436	55233	2673	6692	55163	84282	960	11145	23326	6241	51091	1783	58191	23433	84824	48	63027	23787	3070	207	91404	9603	23545	130814	533	1059	3685	23341	11276	23673	26259	54802	1351	100113407	390	22978	6540	57821	23307	637	201161	2790	4233	65124	286676	347733	958	729852	10611	51477	11184	123016	116496	1468	5898	1869	9743	11282	9197	55114	5603	5720	51629	55691	27128	286319	10581	55764	5931	25801	3417	55803	6184	5955	7840	91828	7324	64761	340526	1439	92579	7040	5688	463	5791	7913	79982	6271	9658	10096	23505	51643	6272	5911	1269	9261	63875	7494	83930	51393	51371	79888	83877	10632	5151	81563	286148	8612	60370	10221	56650	836	9820	754	9749	3988	4853	27293	51599	401397	3553	3101	25852
GSE17186_BLOOD_VS_CORD_BLOOD_CD21LOW_TRANSITIONAL_BCELL_UP	M7195		19965666	Suryani S,Fulcher DA,Santner-Nanan B,Nanan R,Wong M,Shaw PJ,Gibson J,Williams A,Tangye SG	GSE17186	GSE17186_3144_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in transitional CR2 [GeneID=1380] low B lymphocytes versus those from cord blood.	Goals/objectives: to identify various gene expression in B cell subsets derived from human PBMC and cord blood 					3937	3431	146857	3621	2969	64108	92370	9267	6168	400916	4063	3384	4627	57552	51150	118672	23353	55848	10188	166	54	5316	6574	3033	8883	83693	10947	51280	138050	8861	2634	388886	9725	129531	118	50615	83606	3738	50649	9583	25777	10318	51735	93589	84650	54207	23168	9524	3433	24145	340277	92797	1628	152006	23335	79603	26524	5066	2534	55544	55601	10320	10447	9829	5525	831	164091	8445	11235	4012	8897	5252	57537	51696	5770	57099	7535	57162	120	84937	841	23765	3899	6125	197370	4690	3028	9368	23585	56997	79960	54850	6777	64801	92241	6204	55902	51184	22803	6915	56262	81844	147741	26227	79780	11202	5922	23151	9047	29851	4155	7430	4049	3693	54726	7024	392275	23248	162993	85464	9411	22821	133522	8535	54965	84187	84861	85441	11226	79961	7323	326624	2590	4478	3396	10139	140883	219899	359845	10750	3482	64718	57559	23064	2014	9960	56172	80342	27244	55856	665	54681	3930	10123	57621	26119	50619	4302	8434	57153	10294	2870	23475	9486	10051	149478	1616	23457	79590	2051	55103	2583	135	27250	57687	3695	5912	84456	83605	7343	57189	8446	84934	9788	5269	28992	84726	55729	114883	51564	51043	10216	27430	2308	375287	5463	4775	23568	64895	92558
GSE17186_BLOOD_VS_CORD_BLOOD_CD21LOW_TRANSITIONAL_BCELL_DN	M7196		19965666	Suryani S,Fulcher DA,Santner-Nanan B,Nanan R,Wong M,Shaw PJ,Gibson J,Williams A,Tangye SG	GSE17186	GSE17186_3144_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in transitional CR2 [GeneID=1380] low B lymphocytes versus those from cord blood.	Goals/objectives: to identify various gene expression in B cell subsets derived from human PBMC and cord blood 					5603	28996	9252	197322	941	11243	9197	64114	23094	65987	8509	25	2769	9813	57217	51517	8556	5565	286319	2997	143888	2137	6184	196463	9855	5899	203245	9134	8310	8411	64764	7184	351	27242	1798	6546	83692	57544	23172	150962	8853	396	7327	7532	2650	255758	2790	23380	80223	1318	3135	10629	395	5358	6451	8772	81563	131544	151195	8536	116449	7464	3636	130814	10003	1992	50862	29775	51125	207	23326	8829	6400	3070	51552	8930	26270	22862	79038	54821	23052	3988	79077	8497	5791	54436	89781	115286	10890	3685	6540	399687	127829	340152	5151	347734	201161	100113407	7297	3005	9261	63916	91694	92	6721	11234	284207	10581	1783	51809	7840	23164	51074	332	6692	54531	9936	4493	55274	7074	9768	1439	374655	5359	607	127253	8460	83853	64147	394	56660	9043	51780	11142	64645	129880	57493	7127	23433	11282	161835	755	91614	79856	157769	2146	51599	80301	9734	345757	8754	349136	50937	9672	25852	3017	84678	6652	2217	155185	122622	538	55270	91828	219931	133619	23001	123016	55048	26273	4288	65220	56996	23505	1468	94	318	116985	9663	29957	3417	9341	55143	79070	252995	84747	79888	81618	5606	9712	340526	1122	51429	840	154807	302	4064	7169	1871	26031
GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_DN	M7197		19965666	Suryani S,Fulcher DA,Santner-Nanan B,Nanan R,Wong M,Shaw PJ,Gibson J,Williams A,Tangye SG	GSE17186	GSE17186_3137_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in B lymphocytes: naïve versus transitional CR2 [GeneID=1380] low.	Goals/objectives: to identify various gene expression in B cell subsets derived from human PBMC and cord blood 					4063	4302	8535	9535	2892	3956	10051	5551	347344	23038	5525	3560	116966	27244	57621	64108	392275	3384	1628	146857	23095	57162	55218	2533	92370	1729	118672	84319	25902	9486	56474	29103	6566	54997	221294	3921	5916	6574	2323	284058	1509	55609	56948	155368	3033	55972	6609	2634	10550	5269	57153	83693	23344	53373	6202	2004	93589	23635	6045	55622	390243	23358	6100	23585	129080	152006	79960	388796	79144	286257	79575	200916	84265	50619	8938	4943	55544	1794	388886	10447	129531	8313	326624	84135	57537	10139	5395	2021	79918	5880	1880	6173	1663	79780	11202	20	4214	22882	92241	83982	118	2051	54760	10188	154661	135295	139716	55766	26119	6777	56006	8445	7323	27430	3716	2022	392	123722	64744	11235	6793	23331	6671	283209	64207	2014	2683	50615	9053	84174	80055	11226	10628	220107	29116	51564	1267	5912	23338	158866	84456	841	5316	441054	55103	10436	55339	23568	9267	100506736	51542	11059	55667	7535	122060	27340	6938	728621	389384	23177	23205	974	57571	23064	51531	79603	6223	252839	124512	6477	51129	7077	11174	6232	541565	84626	9674	8459	161882	3621	88	159371	51504	340024	83605	10171	9807	9781	9770	55902	5442	55217	7508	414328	57488	7430	57602	379	4775	9258
GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_UP	M7198		19965666	Suryani S,Fulcher DA,Santner-Nanan B,Nanan R,Wong M,Shaw PJ,Gibson J,Williams A,Tangye SG	GSE17186	GSE17186_3138_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in B lymphocytes: naïve versus transitional CR2 [GeneID=1380] high.	Goals/objectives: to identify various gene expression in B cell subsets derived from human PBMC and cord blood 					10039	11284	23536	54093	51129	6398	9049	25840	84572	51105	23639	6171	157695	10568	9236	54902	28232	3800	9653	54995	5270	83742	7782	100507656	64969	256676	55198	25831	333929	163882	5224	22980	94030	9526	9139	8263	64216	10623	145864	11326	253980	653	4218	23404	397	55362	85014	255919	6041	9486	10279	8815	139716	7049	83443	83693	127700	1236	6341	3983	259173	165918	51264	135138	54541	27303	219736	5567	284352	1006	10870	83464	6932	64601	5336	126074	23108	27037	11226	57820	51522	83661	646603	7227	54497	1991	1508	100009676	340024	124641	26054	353288	3787	253512	5507	89766	613227	442721	883	6282	54923	84818	90204	146894	51008	6249	13	136051	27329	88	11082	2820	1585	5657	643904	116255	94031	3487	64771	5145	84811	10302	9051	115209	27095	85027	2322	152519	148113	28959	257106	8809	27345	80352	84792	51257	25932	1992	8572	55167	9535	80217	374467	130576	93058	84236	9244	148581	6490	51256	3693	7798	55568	57030	10589	64410	58511	8543	121551	1015	116442	55636	55365	3958	132014	150383	27068	2323	51172	64180	5631	63905	4340	23157	79817	9555	10263	9638	201254	10320	514	5214	3751	6789	7204	79961	57010	10999	22873	9590	4046	309	388931	285556	3959	5450	2981	7498	255877	145258
GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_UP	M7200		19965666	Suryani S,Fulcher DA,Santner-Nanan B,Nanan R,Wong M,Shaw PJ,Gibson J,Williams A,Tangye SG	GSE17186	GSE17186_3136_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in B lymphocytes: memory versus transitional CR2 [GeneID=1380] high.	Goals/objectives: to identify various gene expression in B cell subsets derived from human PBMC and cord blood 					83659	4848	51429	150483	55274	4255	8443	3195	8993	253827	23528	6772	4814	23657	1154	9963	55780	677	5138	54453	2065	2339	5743	5122	50804	9462	54795	644353	5292	6457	4653	84181	4602	53947	150280	159195	255043	55811	10462	197370	3709	222662	147685	10207	2888	8971	7732	58504	84936	23650	57798	6647	8886	11037	387758	4190	8125	8506	10330	7322	91522	57156	3785	11123	10138	3653	145773	114088	9324	65059	8829	3662	51561	4715	84164	3656	987	4681	113174	23588	2184	54881	51181	5547	10603	3568	154043	7102	7293	339324	375061	5617	2021	9500	27429	22876	989	8784	758	79848	55746	4830	10542	29889	28983	5528	51633	10491	4072	10265	9666	4703	1582	4293	203074	54737	7840	1728	1795	57393	598	25989	7027	2037	5106	2934	338	3383	55750	4993	8776	8403	113278	117289	8291	912	79797	9551	23767	316	27134	124923	3643	9880	22916	5013	5787	146664	5575	80133	9409	11043	80271	7126	10219	11020	5890	56171	29994	57096	64968	4902	253152	9223	114609	80760	202333	219855	1306	200312	23191	5479	132625	2199	23492	9177	55831	3586	84861	5207	81544	4152	140809	5243	84886	4677	391002	9350	147699	6777	307	79944	23321	51659	22832	2553	4613	164633	440836	1140
GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_DN	M7205		19965666	Suryani S,Fulcher DA,Santner-Nanan B,Nanan R,Wong M,Shaw PJ,Gibson J,Williams A,Tangye SG	GSE17186	GSE17186_3136_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in B lymphocytes: memory versus transitional CR2 [GeneID=1380] high.	Goals/objectives: to identify various gene expression in B cell subsets derived from human PBMC and cord blood 					6503	54820	54069	3433	5720	6793	10125	79143	2643	6907	3664	356	3627	6778	5567	27042	920	64132	6650	29126	231	55041	25923	1666	8826	1803	5110	157695	7155	79161	7133	5293	29942	7444	51317	6515	9308	50807	3163	221178	7038	58527	2037	57559	2533	3575	161145	3561	5696	57591	824	27244	224	3783	994	7297	6711	4033	92241	4046	102	51465	5998	30011	26272	10420	23531	1236	64135	4602	25874	23048	196383	5151	114294	51429	50650	23239	10735	56990	5175	91526	653	51363	9452	11145	115350	57472	6890	23438	23200	9265	4967	79169	3898	112616	4155	60481	8546	140609	23394	8600	9061	5062	345611	10235	1043	51451	27327	286827	3241	6932	6693	26091	26036	26228	6375	27086	10051	3096	23678	10225	8906	113	6117	9493	83637	8437	10451	4258	25970	120	116840	1465	6281	55315	2166	8502	51564	5621	3164	4245	23549	7535	10924	10018	25842	2060	5580	7905	8767	972	3454	3588	2583	5721	163351	79026	9516	11126	51340	10245	80344	8204	83593	51606	150864	54602	6775	29927	58190	90268	8525	4154	23648	79832	11112	2274	2995	23559	9641	10743	1108	9742	6772	55670	94240	3930	53343	3267	5727	976	54458	55893	10725	87	10068	1997	134430	29103
GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_UP	M7206		19965666	Suryani S,Fulcher DA,Santner-Nanan B,Nanan R,Wong M,Shaw PJ,Gibson J,Williams A,Tangye SG	GSE17186	GSE17186_3137_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in B lymphocytes: naïve versus transitional CR2 [GeneID=1380] low.	Goals/objectives: to identify various gene expression in B cell subsets derived from human PBMC and cord blood 					23150	3397	59307	84159	80829	22926	5775	81490	10783	4711	7409	7317	5873	3398	51649	154141	1164	8629	940	57045	6050	64080	2672	9435	4783	10912	166378	3566	200185	23413	51566	51542	9818	112399	5715	81537	5501	64849	11266	382	9021	1121	7782	2879	11161	1051	2012	131450	8859	208	55647	5910	51608	88745	340061	79073	51390	8550	10101	3098	170463	1508	128866	9404	56937	56005	131544	197370	80728	55636	8802	10130	2530	6047	639	84230	3516	8799	10171	5770	10067	6097	63973	4988	27338	3487	4121	81579	10642	339929	6403	51026	81671	3559	5469	79577	10899	2356	64951	2937	146857	5627	10007	7296	26999	10538	148223	23399	6746	84909	375	64422	157567	5588	3718	923	9051	3726	51316	93183	127544	6095	115330	23612	5089	10507	133418	5315	6304	9489	55799	202	196	9909	7818	29911	8935	25983	51278	10203	65260	80777	7369	9063	5771	2131	2936	154791	516	85027	1032	29887	54475	50615	7187	56894	11068	56985	22933	4088	55298	944	64897	9403	8477	3002	9144	3565	84522	65095	7873	10211	90313	602	1493	839	161424	4713	3090	549	10248	7076	51529	466	83444	1522	2323	3383	2120	56061	5583	4939	90007	94120	6391	3725	55658	57019	3662	8482
GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_DN	M7280		20173022	Chan G,Nogalski MT,Bentz GL,Smith MS,Parmater A,Yurochko AD	GSE19772	GSE19772_3042_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes pre-treated with Ly294002 [PubChem=3973]: control versus HCMV infection.	Human cytomegalovirus (HCMV) induces pro-inflammatory monocytes following infection and we have evidence that phosphatidylinositol 3-kinase [PI(3)K] is a key mediator in this activation. To begin to address how this signalling pathway is responsible for the functional changes in infected monocytes, we examined the role this pathway played in the transcriptome of infected monocytes. Global transcriptional profiling using cDNA microarrays revealed a significant number of genes were regulated in a PI(3)K-dependent manner, identifying this pathway as a key cellular control point in the conversion of monocytes to an activated pro-inflammatory state following HCMV infection. 					222487	6517	391013	55799	202	1943	1501	5590	9002	25911	6402	81029	51155	10610	64978	3305	4705	6652	4744	3671	25937	1014	1266	10989	10381	5570	191	6608	10922	51340	7455	2934	222171	9960	132720	7846	2593	51611	431707	9246	474381	103910	10861	64601	4774	29078	10589	4239	3587	10206	2247	28969	10577	765	2246	8698	221545	283377	140628	5723	957	83786	115950	1236	23272	1503	3215	2288	51690	10335	10123	91461	762	10539	79089	60343	27241	55005	4726	65244	4878	1871	3762	84519	126669	10509	84504	11199	84458	6646	7066	190	5441	28973	2877	181	8320	328	3570	113829	6641	57228	7356	51686	3290	4233	1428	56886	3872	5204	283578	94	23016	649	1600	7277	5173	51564	2342	11123	54893	2553	148423	3297	23062	6749	2563	1791	5480	58497	3767	359845	9469	148113	7046	2739	55845	432	22955	4998	2678	55651	862	7077	83743	5091	3293	9625	3776	54853	8076	10961	313	1611	56905	27340	23654	5999	57171	6493	115584	29958	10329	2765	10620	914	23417	5912	56903	2618	5449	174	94081	4867	55572	56271	7782	129303	9118	2870	23760	10124	8738	6531	29777	3712	1942	7015	1510	2902	9318	6520	6482	7164	57465	8653	10266	9402	8815	9955
GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_UP	M7282		20173022	Chan G,Nogalski MT,Bentz GL,Smith MS,Parmater A,Yurochko AD	GSE19772	GSE19772_3041_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes: control versus HCMV infection.	Human cytomegalovirus (HCMV) induces pro-inflammatory monocytes following infection and we have evidence that phosphatidylinositol 3-kinase [PI(3)K] is a key mediator in this activation. To begin to address how this signalling pathway is responsible for the functional changes in infected monocytes, we examined the role this pathway played in the transcriptome of infected monocytes. Global transcriptional profiling using cDNA microarrays revealed a significant number of genes were regulated in a PI(3)K-dependent manner, identifying this pathway as a key cellular control point in the conversion of monocytes to an activated pro-inflammatory state following HCMV infection. 					84747	79971	51744	760	4947	6375	64411	834	23169	825	83982	4790	5359	1437	8773	4300	5133	57045	64400	56605	56253	3685	7360	23191	29969	10018	285440	10916	84233	8411	7305	256586	8784	5264	253558	22859	3482	10010	301	1666	80760	23530	6897	9265	22926	11079	11274	9497	10875	11126	8548	3631	51321	3815	9446	597	8848	4599	975	9516	5422	3394	6352	148808	5664	23710	9232	115992	79145	27130	9476	1634	1588	7182	3516	6890	3107	324	8600	5783	57157	4643	3291	3267	9429	64135	7035	10077	55151	1362	3604	196	9467	3073	79602	7498	2207	644096	10135	3663	379	79670	79026	1140	51170	33	439996	10657	10094	8546	345611	158219	2706	928	1374	6004	4204	57462	84263	3308	8728	819	1493	10379	157567	6303	670	677	302	22918	9683	6948	6642	55509	7462	5716	728392	1959	22823	2123	4828	29984	5934	3240	51768	6259	2037	2672	8531	55915	2334	81618	25897	8739	9538	8829	6737	6271	115207	64222	2992	23048	5805	5583	4345	6678	4739	23433	11345	2027	4990	7158	427	604	2184	5820	6048	6288	54602	51205	8293	727	6924	6654	257397	116150	356	9590	3433	9741	8439	2113	3106	5689	7188	64375	22929	9317	9559
GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_UP	M7283		20173022	Chan G,Nogalski MT,Bentz GL,Smith MS,Parmater A,Yurochko AD	GSE19772	GSE19772_3043_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes after HCMV infection: untreated versus pre-treated with Ly294002 [PubChem=3973].	Human cytomegalovirus (HCMV) induces pro-inflammatory monocytes following infection and we have evidence that phosphatidylinositol 3-kinase [PI(3)K] is a key mediator in this activation. To begin to address how this signalling pathway is responsible for the functional changes in infected monocytes, we examined the role this pathway played in the transcriptome of infected monocytes. Global transcriptional profiling using cDNA microarrays revealed a significant number of genes were regulated in a PI(3)K-dependent manner, identifying this pathway as a key cellular control point in the conversion of monocytes to an activated pro-inflammatory state following HCMV infection. 					10989	926	10123	84458	1236	23152	23452	1943	9021	92749	7259	153090	6610	7247	9620	7046	7125	83439	1014	1186	25849	22955	10501	91461	9002	688	57657	973	306	340527	7376	9118	4320	3423	9442	6493	9960	140290	2829	2668	10293	54520	2887	112	649	1791	115584	8665	10661	136227	95	25822	9356	7007	3570	976	6652	80139	2709	359845	6230	4921	116840	6531	5076	100	28969	6514	27240	6895	8190	8288	117	5199	4878	51621	5159	6320	148423	977	25953	80031	146223	2870	4676	5947	719	55317	91010	2077	2159	6256	4616	3671	10570	3798	348262	6423	7173	733	4851	11340	5316	25937	4605	9955	3872	2034	79089	23397	84617	80725	222171	55363	5796	1990	2947	51412	100129128	84792	23654	3912	10914	5441	5453	5590	100271849	1979	8786	7916	2321	51686	1723	8760	4998	56033	3887	922	64326	4485	10266	340419	1050	815	2678	4175	7289	1823	23396	2593	7421	3359	5354	6583	2005	4005	25946	5864	1041	1641	6521	9156	165530	6490	2264	171558	729330	3818	516	58	10620	347252	1741	3728	81029	5173	23208	29123	7849	2199	23764	174	1366	2703	3053	2250	3767	56673	2850	9275	8438	9079	7223	2153	6567	51156	4635	8581	60493	8671
GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_DN	M7286		20173022	Chan G,Nogalski MT,Bentz GL,Smith MS,Parmater A,Yurochko AD	GSE19772	GSE19772_3043_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes after HCMV infection: untreated versus pre-treated with Ly294002 [PubChem=3973].	Human cytomegalovirus (HCMV) induces pro-inflammatory monocytes following infection and we have evidence that phosphatidylinositol 3-kinase [PI(3)K] is a key mediator in this activation. To begin to address how this signalling pathway is responsible for the functional changes in infected monocytes, we examined the role this pathway played in the transcriptome of infected monocytes. Global transcriptional profiling using cDNA microarrays revealed a significant number of genes were regulated in a PI(3)K-dependent manner, identifying this pathway as a key cellular control point in the conversion of monocytes to an activated pro-inflammatory state following HCMV infection. 					760	5359	51744	9265	84747	302	3073	3831	6352	10094	5264	80760	55288	56172	51128	3308	57019	26225	1362	64781	9538	79971	8784	2632	284371	9446	29969	114879	253558	7305	8411	8848	6897	5274	8683	5805	23076	7307	834	84233	51768	79026	1666	3824	356	115207	5664	137695	5532	9516	2123	928	7498	51574	64411	285440	29880	642	23433	256586	5093	400	23234	23710	23193	8674	10018	10875	4033	8531	4643	3815	4790	23191	8293	597	10670	7188	6924	158219	9476	3612	57584	64400	819	56994	4218	51429	4947	29984	11126	54940	7158	79902	8935	10402	5494	79145	7035	9741	4739	2706	3554	55536	9039	55038	6004	54432	2961	29934	5716	5954	10982	3005	5917	5583	2926	54741	84299	23047	5884	51316	9410	1234	9562	56605	4436	8530	84950	3685	10159	4734	10678	11163	8600	23169	7050	10063	3107	84844	23604	23186	58477	5422	1374	23582	26035	1644	4953	51526	3070	33	55303	5723	55529	255231	6510	51280	9709	1495	122622	427	401612	23741	23446	8036	3575	80005	3398	6642	9802	375757	5997	1385	10776	55269	121665	64065	1622	9375	58517	51805	6375	50484	10574	8869	6925	7182	51528	1363	54820	133418	81618	91543	25972	6713	23350	640	153222
GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_DN	M7287		20173022	Chan G,Nogalski MT,Bentz GL,Smith MS,Parmater A,Yurochko AD	GSE19772	GSE19772_3041_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes: control versus HCMV infection.	Human cytomegalovirus (HCMV) induces pro-inflammatory monocytes following infection and we have evidence that phosphatidylinositol 3-kinase [PI(3)K] is a key mediator in this activation. To begin to address how this signalling pathway is responsible for the functional changes in infected monocytes, we examined the role this pathway played in the transcriptome of infected monocytes. Global transcriptional profiling using cDNA microarrays revealed a significant number of genes were regulated in a PI(3)K-dependent manner, identifying this pathway as a key cellular control point in the conversion of monocytes to an activated pro-inflammatory state following HCMV infection. 					10003	27202	2565	1650	64430	844	79140	161882	5933	111	131540	283659	26063	119	23567	340542	239	7629	55260	123096	23557	199920	5358	26267	80332	2559	158035	11253	9033	285966	3993	83955	125113	54777	84940	92086	6748	51310	100131067	100128071	5672	140825	5019	63874	81671	10786	440149	90271	9375	51426	128077	149297	57282	30062	4012	56477	338321	387097	55616	23468	142679	139170	155038	84872	7694	386678	57215	339201	84327	81533	56106	9528	84662	84645	285605	84536	116449	339593	5284	1538	645676	340206	283914	93622	23389	283435	161247	80000	123624	6678	149483	55821	100129196	81697	23253	6207	85004	53981	246704	11282	1842	5538	5935	23176	4915	10026	7763	3155	388533	245806	9698	4113	146198	100288805	51496	8738	57504	646168	8436	10110	63826	84973	10293	55625	1777	144481	100133885	10159	9873	10549	100169750	22832	1536	10550	1891	112399	23635	962	253128	1208	86	79982	400590	5912	84249	5378	55764	10633	2256	80213	84148	2035	150992	259308	100192378	23122	1768	54455	56998	113201	9741	8455	1201	57146	9966	5589	219409	338817	6990	7567	57045	10126	79921	2799	957	3032	56099	8777	64110	9120	6477	1112	6451	152195	140699	1497	1856	400620	54664	23469	25959	7508	5565	8125	118430	283507	653464	79015
GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_UP	M7288		20173022	Chan G,Nogalski MT,Bentz GL,Smith MS,Parmater A,Yurochko AD	GSE19772	GSE19772_3042_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes pre-treated with Ly294002 [PubChem=3973]: control versus HCMV infection.	Human cytomegalovirus (HCMV) induces pro-inflammatory monocytes following infection and we have evidence that phosphatidylinositol 3-kinase [PI(3)K] is a key mediator in this activation. To begin to address how this signalling pathway is responsible for the functional changes in infected monocytes, we examined the role this pathway played in the transcriptome of infected monocytes. Global transcriptional profiling using cDNA microarrays revealed a significant number of genes were regulated in a PI(3)K-dependent manner, identifying this pathway as a key cellular control point in the conversion of monocytes to an activated pro-inflammatory state following HCMV infection. 					27153	57542	6754	55957	64084	55917	5511	64859	10202	8392	64748	284551	151888	27107	79868	1134	57120	330	344558	90268	9673	128346	85377	1144	161753	5515	8226	100131998	488	80131	28955	79442	51272	253962	147687	55969	4824	65083	4026	494558	55802	53637	2801	255919	54107	477	55660	93081	10514	881	80232	64768	8139	57541	401546	399967	644852	54531	9856	84767	6924	64083	9754	158427	7355	84823	4650	2194	84259	79581	55161	57089	51236	114034	27352	5551	219931	55341	85465	285548	401124	2931	391712	6391	163049	100287584	66036	645722	51023	642426	115939	8079	57602	11182	5458	55502	10113	92292	84301	80207	23219	134549	3773	79692	55844	84654	84522	285848	4004	6770	58476	92241	7461	64332	10492	329	100129654	6242	91298	10328	3014	9854	11196	8879	9790	10622	55800	23568	873	60626	27287	84971	3918	865	10221	136263	79160	5293	10969	23592	10376	51022	51308	8294	5277	151903	8331	55661	54619	54480	41	122809	6723	6729	54205	55095	23765	10270	9586	90627	116519	55915	53371	729680	10726	11128	400410	84790	55223	10200	100129112	51733	24148	54471	80219	56945	387755	6525	6730	9129	10799	1010	123876	7874	4651	27	27338	200159	10664	5142	28988	158809	55628	133619	9248	26528	440026	23140
GSE18893_TCONV_VS_TREG_24H_CULTURE_DN	M7289		20181891	Nagar M,Jacob-Hirsch J,Vernitsky H,Berkun Y,Ben-Horin S,Amariglio N,Bank I,Kloog Y,Rechavi G,Goldstein I	GSE18893	GSE18893_1274_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in lymphocytes treated with medium for 24h: T conv versus T reg cells.	Here we show that tumor necrosis factor (TNF) induced in human T-regulatory cells (Treg), as compared to conventional T cells (Tcon), a transcription program highly enriched for typical NF-κB target genes, such as: the cytokines LTA and TNF; the TNF-receptor super family members FAS, 4-1BB and OX-40; various anti-apoptotic genes; and other important immune-response genes. As an initial approach to examine the cellular program induced by TNF in Tregs versus Tcon cells, we employed microarray gene expression analysis at 2 and 24 hrs following TNF treatment.					23635	55283	219623	128178	55728	9590	139716	22876	948	10964	840	3433	23129	29802	6304	64781	60468	92610	1955	2119	10420	317649	22918	55165	1466	5121	50615	7782	4599	8837	1848	604	602	901	259307	100131755	51566	56624	2146	143458	55859	10517	80326	4602	23401	2208	54210	84803	51684	1368	28834	9053	9169	1760	7328	406	1960	10451	23484	57658	51676	8467	9938	1021	130557	912	57565	3592	5138	79132	199786	401251	8914	90843	28951	5641	57674	7227	80823	19	285148	4061	1236	64135	57405	9402	4033	256987	129080	8440	3690	5321	59269	2308	129607	8638	93323	4600	84807	253714	54892	9771	2185	3665	971	439996	8898	84100	6385	10098	1762	8564	2037	699	6772	132720	51296	153020	64895	8553	28514	7096	607	220134	10561	29968	79071	5971	120892	1058	8503	10603	26012	51669	55342	659	9860	9212	26115	3932	114836	2258	1111	9325	253782	85027	23397	65998	6868	57182	3437	10161	29015	6877	5199	605	6003	7153	114804	51177	26576	169200	10396	79801	57507	1269	166614	10926	10800	5087	285282	760	1063	11069	54908	124976	151888	54947	3628	83540	84265	9738	2114	3065	84083	1647	340061	9319	83461	6653	1062	2187	10957	868	115350	10099	9842	79890	4354	5932
GSE18893_TCONV_VS_TREG_24H_CULTURE_UP	M7290		20181891	Nagar M,Jacob-Hirsch J,Vernitsky H,Berkun Y,Ben-Horin S,Amariglio N,Bank I,Kloog Y,Rechavi G,Goldstein I	GSE18893	GSE18893_1274_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in lymphocytes treated with medium for 24h: T conv versus T reg cells.	Here we show that tumor necrosis factor (TNF) induced in human T-regulatory cells (Treg), as compared to conventional T cells (Tcon), a transcription program highly enriched for typical NF-κB target genes, such as: the cytokines LTA and TNF; the TNF-receptor super family members FAS, 4-1BB and OX-40; various anti-apoptotic genes; and other important immune-response genes. As an initial approach to examine the cellular program induced by TNF in Tregs versus Tcon cells, we employed microarray gene expression analysis at 2 and 24 hrs following TNF treatment.					58158	51280	941	5151	6277	9886	6300	9124	6480	4301	445	92105	302	65987	3783	80380	10970	3500	56548	163126	5359	11092	962	83606	84617	1400	79746	27237	89886	27033	5355	135	8417	3516	2799	3899	8407	29087	6275	201266	779	7133	255394	54	51733	5576	5590	1880	256586	3958	57537	90407	1396	5184	1845	8828	301	53827	145226	9046	6281	25849	113146	3695	83742	22821	274	54923	55013	118	168537	7431	622	976	55092	2014	4306	7107	342667	4756	3708	3956	57333	90550	9331	822	7090	9342	5865	7082	84532	51474	147965	79026	6038	253012	122622	7163	54587	21	10924	2217	170463	7038	254295	3512	23158	23108	1397	968	3315	83943	3937	91663	84650	9578	26037	55303	2886	29126	6276	55041	27034	6446	957	10166	8905	4784	23495	388341	309	6259	3977	408	93185	4005	8574	3631	126432	152007	375061	5909	81855	6569	285704	5734	5613	100128927	7023	22933	65220	1954	7275	57458	8303	2618	389119	146760	27120	55958	5990	51201	8514	8577	6541	5329	11137	3688	54332	83937	81846	222962	9265	3141	6453	64410	57045	26578	55501	5050	5296	100129269	23151	4778	308	84897	1891	57476	55312	2876	158067	8682	2683	6660	26472	9516	4811	310	2134	11076
GSE18893_TCONV_VS_TREG_24H_TNF_STIM_DN	M7291		20181891	Nagar M,Jacob-Hirsch J,Vernitsky H,Berkun Y,Ben-Horin S,Amariglio N,Bank I,Kloog Y,Rechavi G,Goldstein I	GSE18893	GSE18893_1280_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in lymphocytes treated with TNF [GeneID=7124] for 24h: T conv versus T reg cells.	Here we show that tumor necrosis factor (TNF) induced in human T-regulatory cells (Treg), as compared to conventional T cells (Tcon), a transcription program highly enriched for typical NF-κB target genes, such as: the cytokines LTA and TNF; the TNF-receptor super family members FAS, 4-1BB and OX-40; various anti-apoptotic genes; and other important immune-response genes. As an initial approach to examine the cellular program induced by TNF in Tregs versus Tcon cells, we employed microarray gene expression analysis at 2 and 24 hrs following TNF treatment.					5810	58486	7781	84650	27244	54148	51284	51306	115209	57693	3073	116143	10267	10984	59269	221143	23049	643641	54841	26355	10077	4354	54344	1978	5883	10579	23269	6230	51635	51596	114928	84309	85406	25874	22852	51650	9474	148789	54458	56171	550643	2308	29090	9788	7247	7155	84867	55233	10590	81572	201965	199699	128240	116842	10542	84548	8471	51293	3858	8836	58500	22954	5202	64087	58505	149951	1838	10196	2987	3480	6227	1937	54532	57569	54918	517	8216	55507	4726	10750	7322	84451	9456	79664	64960	3603	139341	23358	57486	100131755	80145	54469	3026	118487	55968	79447	6251	56947	57157	51804	27332	1432	9308	123207	128977	29068	266743	23275	373509	8611	9829	23446	7903	2581	23406	440567	26517	9737	84299	51124	2523	83742	9522	80344	80320	54460	199990	6300	11321	1181	246184	54065	55657	10051	51547	23710	9984	4552	10747	10575	6188	54491	133308	84705	55793	347344	81551	5596	23495	58531	229	122945	54543	29960	146310	163259	11112	8558	9831	5160	3336	493753	56655	401097	28992	55140	9203	6637	143872	57096	733	84197	4063	231	2876	50964	113	100271873	1933	6205	80133	83860	27030	284443	493829	26017	670	55312	23379	285855	4926	54985	9551	25901	6992	27032	1265	2027	10360	30833
GSE18893_TCONV_VS_TREG_2H_CULTURE_DN	M7293		20181891	Nagar M,Jacob-Hirsch J,Vernitsky H,Berkun Y,Ben-Horin S,Amariglio N,Bank I,Kloog Y,Rechavi G,Goldstein I	GSE18893	GSE18893_1273_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in lymphocytes treated with medium for 2h: T conv versus T reg cells.	Here we show that tumor necrosis factor (TNF) induced in human T-regulatory cells (Treg), as compared to conventional T cells (Tcon), a transcription program highly enriched for typical NF-κB target genes, such as: the cytokines LTA and TNF; the TNF-receptor super family members FAS, 4-1BB and OX-40; various anti-apoptotic genes; and other important immune-response genes. As an initial approach to examine the cellular program induced by TNF in Tregs versus Tcon cells, we employed microarray gene expression analysis at 2 and 24 hrs following TNF treatment.					151636	7318	4217	10116	23102	976	2081	730094	22862	55662	59339	5720	4780	114757	6446	961	7466	5696	65983	958	23457	5110	5721	5331	9021	2822	51542	8572	55500	653361	6643	3002	90861	4641	5699	11082	4735	1192	51100	1026	60592	441478	5501	51161	23270	55365	4938	1435	1073	10491	23673	4124	11244	56895	2767	1499	51429	51465	4026	23142	23230	5025	8445	23224	10472	5272	6780	345611	375287	118427	153769	10274	11145	3107	5770	56262	6814	5355	8482	28996	3659	7431	64750	5756	5286	6237	2841	56241	7097	7514	3418	2634	9341	10410	4140	8545	6400	747	92703	6890	11198	81502	56261	79657	7048	51199	9246	3586	3383	9663	4703	10552	8850	141	3398	2323	259236	3017	3705	64859	91947	3632	57104	4121	10336	6502	51316	23308	81030	3689	8754	64761	9113	51175	10560	123879	10906	195828	1398	2332	91452	26119	10124	79956	55080	7494	29959	254065	79140	950	23586	51552	116984	9908	5910	84287	6683	1486	94120	22834	201475	103910	5829	5887	5861	8459	55329	29	80024	7920	26057	784	8893	1535	3458	53840	1236	30009	10237	10162	55501	864	283991	3108	84938	26225	55636	9934	28959	11320	10135	10938	5993	3669	1075	8702	2191	6904	9196	144501
GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_UP	M7294		20181891	Nagar M,Jacob-Hirsch J,Vernitsky H,Berkun Y,Ben-Horin S,Amariglio N,Bank I,Kloog Y,Rechavi G,Goldstein I	GSE18893	GSE18893_1276_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in T reg cells (2h): medium versus TNF [GeneID=7124].	Here we show that tumor necrosis factor (TNF) induced in human T-regulatory cells (Treg), as compared to conventional T cells (Tcon), a transcription program highly enriched for typical NF-κB target genes, such as: the cytokines LTA and TNF; the TNF-receptor super family members FAS, 4-1BB and OX-40; various anti-apoptotic genes; and other important immune-response genes. As an initial approach to examine the cellular program induced by TNF in Tregs versus Tcon cells, we employed microarray gene expression analysis at 2 and 24 hrs following TNF treatment.					80017	254428	55585	253782	7741	7204	348	149603	345757	136319	4735	5579	9728	51669	2734	9973	84196	54943	55041	55300	6311	9813	26523	8491	115825	22848	56910	84102	9575	143686	84248	5814	340061	4013	3725	6925	9223	6729	36	84858	55182	84803	2790	2872	9294	10612	50626	1112	23048	23097	10857	79849	116379	5955	2153	10409	132720	8409	4026	2869	8675	23111	3977	84301	396	51150	5467	28996	27154	5296	6907	127933	1024	11277	9456	10924	54741	5577	2005	324	2668	6302	23233	285195	120103	163882	1937	5635	57128	11341	26137	112495	25923	400	84173	23133	9962	116113	58485	56987	57140	6474	25996	11343	1515	8972	221178	54629	10994	91369	10105	25962	90411	9061	2081	6652	3688	30851	8609	51366	51194	60685	9275	79770	64393	23338	8932	10951	399979	55194	81926	57692	388	6872	199699	115207	7431	2145	57045	360023	3189	55758	121260	10397	51647	7268	4208	2778	344807	865	55589	144348	26191	26225	54438	54097	2308	84987	57189	222068	9788	139231	139322	168544	129831	51009	659	25953	143384	1605	10000	10614	4205	28955	56681	79685	10806	4904	5879	339324	1107	27	9197	2879	22918	8805	56994	9173	27248	92014	10106	64395	7096	5613	80012	85403	8654	5033	6602	5813
GSE18893_CTRL_VS_TNF_TREATED_TCONV_2H_UP	M7295		20181891	Nagar M,Jacob-Hirsch J,Vernitsky H,Berkun Y,Ben-Horin S,Amariglio N,Bank I,Kloog Y,Rechavi G,Goldstein I	GSE18893	GSE18893_1275_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in T conv cells (2h): medium versus TNF [GeneID=7124].	Here we show that tumor necrosis factor (TNF) induced in human T-regulatory cells (Treg), as compared to conventional T cells (Tcon), a transcription program highly enriched for typical NF-κB target genes, such as: the cytokines LTA and TNF; the TNF-receptor super family members FAS, 4-1BB and OX-40; various anti-apoptotic genes; and other important immune-response genes. As an initial approach to examine the cellular program induced by TNF in Tregs versus Tcon cells, we employed microarray gene expression analysis at 2 and 24 hrs following TNF treatment.					1760	5331	84656	3948	54454	9908	10652	83732	374395	51324	283897	80762	388969	55789	23474	942	64129	3290	529	9798	9123	10904	89849	5868	9559	5537	11104	339456	23515	1891	11078	10605	25934	54529	10096	154791	8869	50619	57826	3106	94	6945	2806	5439	22879	55666	28511	51255	23228	8455	80305	8649	10999	10311	6631	79154	832	79613	64411	79180	55034	152404	9885	7701	55002	10410	28958	5716	136895	10007	2997	51117	1621	51259	55113	6696	399	29855	83442	6993	54882	6728	153745	151516	11156	29117	8482	387338	126432	3148	23224	415117	201973	3702	56098	23268	64794	84418	90390	6416	492	23131	9554	3799	1535	7317	84080	494143	55181	27102	10094	91603	23483	3840	259173	11138	64963	9380	83464	79947	93487	10287	55010	10438	51291	219285	389203	102	5922	7165	7027	1762	392	87	6908	90835	5179	64146	2591	23569	51371	84419	9526	3884	2581	94101	55437	8514	132	83933	51003	3842	10735	23345	23498	11336	7358	118987	5917	80230	51350	10154	7702	93661	55835	51074	8766	1973	149840	54852	80148	139741	23218	286187	29959	64598	122953	23046	286256	141	1687	4542	10588	6483	23639	9926	5696	115584	9802	79228	79886	23294	55909	26958	3927	26277	11213	5698	3673	81617
GSE18893_CTRL_VS_TNF_TREATED_TREG_24H_DN	M7296		20181891	Nagar M,Jacob-Hirsch J,Vernitsky H,Berkun Y,Ben-Horin S,Amariglio N,Bank I,Kloog Y,Rechavi G,Goldstein I	GSE18893	GSE18893_1278_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in T reg cells: 2h versus 24h medium treatment.	Here we show that tumor necrosis factor (TNF) induced in human T-regulatory cells (Treg), as compared to conventional T cells (Tcon), a transcription program highly enriched for typical NF-κB target genes, such as: the cytokines LTA and TNF; the TNF-receptor super family members FAS, 4-1BB and OX-40; various anti-apoptotic genes; and other important immune-response genes. As an initial approach to examine the cellular program induced by TNF in Tregs versus Tcon cells, we employed microarray gene expression analysis at 2 and 24 hrs following TNF treatment.					54494	6018	27109	9659	55835	29951	567	22915	100505741	26031	6901	1608	6039	2081	22893	51660	2778	5225	10462	23094	51203	9910	4515	1101	6988	130535	5580	253714	1796	55106	3295	196441	51741	51062	9870	55761	84926	83605	10150	64784	7137	374378	2940	23002	80232	2982	84105	6307	9759	85365	25875	2888	310	51079	51696	5087	57658	285852	9636	196513	3936	9256	65124	51315	7905	23741	654429	83541	165918	254359	6590	9990	9852	7297	3170	285195	84376	83606	29780	1116	9360	54443	7733	54529	2925	135295	29994	8609	51594	80342	3216	84173	23394	140894	353274	113246	80325	54875	29089	81894	135112	65990	3581	51130	546	2005	60412	9205	83860	283927	374907	126298	8867	22838	100009676	84246	84838	374877	23059	793	84067	6352	3899	5066	5457	93550	57655	558	64777	253190	3949	820	6834	4739	85364	84826	51667	8774	11234	403	8840	1213	4013	51297	161	29035	8340	201299	101	8813	3111	5196	9853	3006	153222	51093	259173	26191	26512	162605	10948	10347	55303	90809	25793	116496	94056	53829	8178	3918	22908	11144	23053	54585	55066	6536	837	342945	57821	8613	113402	29997	7351	84162	8243	79899	84364	118813	6721	51160	58508	6545	123811	100506736	3038	8436	10518	3691	81626	1475
GSE18893_TCONV_VS_TREG_2H_TNF_STIM_UP	M7297		20181891	Nagar M,Jacob-Hirsch J,Vernitsky H,Berkun Y,Ben-Horin S,Amariglio N,Bank I,Kloog Y,Rechavi G,Goldstein I	GSE18893	GSE18893_1279_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in lymphocytes treated with TNF [GeneID=7124] for 2h: T conv versus T reg cells.	Here we show that tumor necrosis factor (TNF) induced in human T-regulatory cells (Treg), as compared to conventional T cells (Tcon), a transcription program highly enriched for typical NF-κB target genes, such as: the cytokines LTA and TNF; the TNF-receptor super family members FAS, 4-1BB and OX-40; various anti-apoptotic genes; and other important immune-response genes. As an initial approach to examine the cellular program induced by TNF in Tregs versus Tcon cells, we employed microarray gene expression analysis at 2 and 24 hrs following TNF treatment.					622	51006	64096	5684	7873	10842	3267	55300	4836	50813	9232	25791	116447	10634	10745	56996	5436	10432	3839	30851	58478	8099	26225	11021	55203	27245	64219	124936	7180	55039	388394	51172	9894	656	55165	130340	6281	3559	159090	166348	257160	10656	646480	254394	9829	79174	401399	2702	30815	5729	79689	6627	6147	84866	84073	440026	2487	79083	113828	283208	3590	7508	93109	5075	6604	27005	26254	64240	121053	10437	79029	10400	81563	3191	55321	23355	57583	57179	5862	285521	2067	657	23654	2843	91775	221472	56910	59274	9961	4616	29094	2837	8972	2979	4009	55164	3359	23468	2547	5737	983	123920	51582	254531	28991	5634	200958	5446	6443	23461	136	128209	2294	55293	81928	5129	7380	24147	140707	9455	10155	8884	5105	83998	645369	8482	23531	93380	399693	153733	165679	340719	57124	7264	6579	57506	51009	9736	23171	5903	2891	57016	5193	29956	79663	3362	283600	64072	6730	2495	25941	22835	54664	119391	1586	124404	3386	100130613	254887	79176	121275	440138	221883	6004	9914	152579	5453	9859	79048	6097	10204	2829	56181	79035	81831	84300	140735	134391	1795	4430	56905	113451	161176	2237	7247	174	441518	947	58485	57140	93185	1379	29765	135398	51807	79001	9588	7448	6566
GSE18893_CTRL_VS_TNF_TREATED_TREG_24H_UP	M7299		20181891	Nagar M,Jacob-Hirsch J,Vernitsky H,Berkun Y,Ben-Horin S,Amariglio N,Bank I,Kloog Y,Rechavi G,Goldstein I	GSE18893	GSE18893_1278_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in T reg cells: 2h versus 24h medium treatment.	Here we show that tumor necrosis factor (TNF) induced in human T-regulatory cells (Treg), as compared to conventional T cells (Tcon), a transcription program highly enriched for typical NF-κB target genes, such as: the cytokines LTA and TNF; the TNF-receptor super family members FAS, 4-1BB and OX-40; various anti-apoptotic genes; and other important immune-response genes. As an initial approach to examine the cellular program induced by TNF in Tregs versus Tcon cells, we employed microarray gene expression analysis at 2 and 24 hrs following TNF treatment.					63892	780	55872	60676	57577	93663	55106	9058	8915	79823	844	83648	85397	150094	162073	84246	2643	55163	84984	197358	11238	27190	255043	7779	112802	83853	6945	5894	81894	83716	7345	80351	6344	5698	3705	5189	10252	9117	151295	144347	285590	642273	111	55357	7334	8447	140462	79572	84073	124056	1717	10645	83881	2069	1476	22934	4967	22850	84162	820	2305	81611	135	1644	81558	1847	6545	8943	93487	11314	80824	3398	345274	5788	55034	388125	90550	2222	8809	127435	29970	3067	27342	140809	89887	140807	5829	55197	51447	55885	29775	8091	6712	5020	93	23255	9183	118980	5993	3422	79258	83690	353143	2052	729830	3630	4193	80774	8689	388284	1066	9619	378	9031	23474	6309	30844	100506736	2057	84243	10767	152579	55552	91368	56938	4973	80173	90861	122809	90060	25807	6747	54883	197135	246329	26000	57634	81609	56934	29888	9927	26136	2997	10525	6183	3082	1284	285601	57643	54505	23344	25912	9180	29923	3273	55679	51657	23506	7132	25934	3106	64761	2678	1014	55262	7287	3340	57826	64855	3183	84443	219285	60675	57473	3199	91523	9926	6789	402381	3434	132158	7978	387103	164656	79071	1293	10205	6908	3656	55347	81565	2995	26985	23070	339344	55785	146760	29057	100113407	55654
GSE18893_TCONV_VS_TREG_2H_CULTURE_UP	M7301		20181891	Nagar M,Jacob-Hirsch J,Vernitsky H,Berkun Y,Ben-Horin S,Amariglio N,Bank I,Kloog Y,Rechavi G,Goldstein I	GSE18893	GSE18893_1273_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in lymphocytes treated with medium for 2h: T conv versus T reg cells.	Here we show that tumor necrosis factor (TNF) induced in human T-regulatory cells (Treg), as compared to conventional T cells (Tcon), a transcription program highly enriched for typical NF-κB target genes, such as: the cytokines LTA and TNF; the TNF-receptor super family members FAS, 4-1BB and OX-40; various anti-apoptotic genes; and other important immune-response genes. As an initial approach to examine the cellular program induced by TNF in Tregs versus Tcon cells, we employed microarray gene expression analysis at 2 and 24 hrs following TNF treatment.					23548	10482	56912	121536	23582	26145	22907	10865	84301	9120	23678	1327	93436	57095	113878	9869	9351	6337	9039	26580	128240	55788	3633	64400	4004	6289	746	51194	27068	10434	494470	514	123355	54014	4302	57680	148932	23051	23036	79156	5611	9846	51105	187	23043	10211	23649	140890	3600	85315	63933	283635	9482	6122	51201	8972	8225	51751	9813	25764	5204	10870	55300	57482	25953	88745	984	84219	80020	89857	64968	3141	2280	1198	56931	10472	56900	54462	2529	1837	839	55705	9801	2475	54958	84329	55839	3214	81847	283298	29070	48	53343	51186	51101	57109	55101	64398	2181	27248	146722	27109	80700	4012	5636	83861	58493	9706	10148	26960	51099	2793	54434	7375	10912	7533	80318	7580	54623	94086	64897	116151	646457	64215	4607	27018	55332	54949	54491	974	9519	116379	23585	153768	3551	124044	22995	115209	51333	221120	2034	79874	84451	7441	57621	196294	6834	64975	5921	5160	1937	85313	3592	124565	55276	9555	2784	51566	79145	1191	6705	36	84266	79036	57020	23048	219931	56987	11221	57478	83544	253782	4594	127544	1528	11228	139341	84932	1175	137209	11019	57037	25941	10658	55603	9719	89910	114793	919	4722	23433	7045	8409	1326	84295	396	11165	10084	65220	6251
GSE18893_CTRL_VS_TNF_TREATED_TCONV_2H_DN	M7302		20181891	Nagar M,Jacob-Hirsch J,Vernitsky H,Berkun Y,Ben-Horin S,Amariglio N,Bank I,Kloog Y,Rechavi G,Goldstein I	GSE18893	GSE18893_1275_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in T conv cells (2h): medium versus TNF [GeneID=7124].	Here we show that tumor necrosis factor (TNF) induced in human T-regulatory cells (Treg), as compared to conventional T cells (Tcon), a transcription program highly enriched for typical NF-κB target genes, such as: the cytokines LTA and TNF; the TNF-receptor super family members FAS, 4-1BB and OX-40; various anti-apoptotic genes; and other important immune-response genes. As an initial approach to examine the cellular program induced by TNF in Tregs versus Tcon cells, we employed microarray gene expression analysis at 2 and 24 hrs following TNF treatment.					255919	56648	60558	4502	55229	6197	220042	4298	55005	8578	196294	8454	5188	2625	83989	84896	84705	28991	441168	55152	4221	56946	47	4683	9324	6867	4976	64798	56948	150472	221143	91612	339324	54470	9391	771	55760	672	51004	9601	79714	57697	27257	92667	79836	51643	51006	5426	115939	1738	2814	5705	115353	28971	3875	1660	6603	83480	8924	55204	9069	6618	29087	10946	54617	56652	9088	81555	5692	3710	10101	60493	29928	4704	22809	152926	79147	1479	5034	3265	63915	10818	151195	9817	9870	11137	5511	55775	92342	83549	84337	79959	27	54620	114791	100131755	5163	255231	6389	129401	6181	64852	57521	55256	23168	7284	10743	283254	9688	91298	160857	10081	285440	55657	7760	6631	14	1798	54665	116238	1459	9694	1973	29078	79693	55112	25864	26100	2339	84135	51124	26973	1725	55049	54069	9338	3161	2187	54708	8800	54414	48	4638	29777	118924	166379	6878	741	23478	56852	8502	1677	6929	22903	29801	51726	401397	92305	28978	2137	26589	8073	79882	7541	55609	5996	1628	23167	684	54820	84317	1819	7874	401548	415116	9941	92856	197259	56605	8449	6198	5688	4676	10447	8634	10656	10072	1284	23091	51807	64395	56902	64928	134145	506	5478	51253	8087	30833	92935
GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_DN	M7303		20181891	Nagar M,Jacob-Hirsch J,Vernitsky H,Berkun Y,Ben-Horin S,Amariglio N,Bank I,Kloog Y,Rechavi G,Goldstein I	GSE18893	GSE18893_1276_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in T reg cells (2h): medium versus TNF [GeneID=7124].	Here we show that tumor necrosis factor (TNF) induced in human T-regulatory cells (Treg), as compared to conventional T cells (Tcon), a transcription program highly enriched for typical NF-κB target genes, such as: the cytokines LTA and TNF; the TNF-receptor super family members FAS, 4-1BB and OX-40; various anti-apoptotic genes; and other important immune-response genes. As an initial approach to examine the cellular program induced by TNF in Tregs versus Tcon cells, we employed microarray gene expression analysis at 2 and 24 hrs following TNF treatment.					8528	1901	51274	79906	57154	4267	10048	54558	916	9900	150160	3037	391	84059	122553	3081	164153	57567	80013	554	26065	55763	696	727897	400569	5322	113828	26267	6484	195827	80235	375	10865	81631	10947	8878	65250	3831	8674	7018	10066	7827	92400	200942	55544	9114	871	390992	85363	408	2571	51547	2249	10652	54494	1960	94086	83737	286257	162387	23197	254950	11082	57787	81562	7428	147798	28511	202333	9745	91543	440026	6051	53947	2000	7223	338692	6094	1435	3916	4641	1781	55031	2529	55002	5023	7320	10228	4355	727957	80208	23201	399726	5128	7979	9827	51439	254122	6357	55024	3559	84876	7776	94059	7784	199	283927	124535	4007	56938	23630	8618	3660	55008	91947	10251	10928	56914	57190	29035	285636	4257	147808	3709	55276	78994	2581	152006	4308	10936	3702	9066	6781	64211	155	183	79815	23462	2128	79083	1992	10135	51043	10023	4640	57214	79846	22933	161829	5045	611	199964	326624	2580	55789	116071	84140	9625	10309	10299	84232	642968	55904	4124	54963	25977	80176	5914	7781	113246	138065	4064	677	6900	497189	162461	26030	3352	54899	10725	64150	51307	1376	64778	51366	55362	88	147011	55022	4627	10965	494551	1186	339906	5498	80019	116985	339983	976	134864
GSE18893_CTRL_VS_TNF_TREATED_TCONV_24H_UP	M7304		20181891	Nagar M,Jacob-Hirsch J,Vernitsky H,Berkun Y,Ben-Horin S,Amariglio N,Bank I,Kloog Y,Rechavi G,Goldstein I	GSE18893	GSE18893_1277_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in T conv cells (24h): medium versus TNF [GeneID=7124].	Here we show that tumor necrosis factor (TNF) induced in human T-regulatory cells (Treg), as compared to conventional T cells (Tcon), a transcription program highly enriched for typical NF-κB target genes, such as: the cytokines LTA and TNF; the TNF-receptor super family members FAS, 4-1BB and OX-40; various anti-apoptotic genes; and other important immune-response genes. As an initial approach to examine the cellular program induced by TNF in Tregs versus Tcon cells, we employed microarray gene expression analysis at 2 and 24 hrs following TNF treatment.					23256	6768	10539	119504	26009	2110	10482	6676	7050	92906	6236	83852	22995	7798	4867	84268	134266	4926	128977	1660	8892	10360	55275	47	50865	126792	124801	4635	8909	1665	10293	3265	55603	401397	1798	51559	10245	144165	441168	11143	51155	6142	283431	9324	10597	79754	5682	10153	996	55632	3954	10072	54822	10393	196074	1014	9650	51750	29080	26146	51074	26523	150368	8539	90060	7072	23530	220929	153527	2814	51186	56271	27067	126626	8021	84219	8464	53981	79090	79003	55112	701	84173	79693	153562	55794	84962	8665	9179	115950	55133	23264	8322	57102	55847	219990	9632	375743	10437	23548	9823	6160	113189	5478	57216	64762	25920	10933	5029	399664	26115	9910	11064	400916	9058	11017	1803	29068	51021	84936	10412	6403	6867	6238	83734	1476	5781	130355	65990	9967	114825	64764	26128	4735	84912	124995	84720	222236	51175	166378	200933	57521	9414	2803	670	29945	10294	3842	84939	9703	130502	8548	79918	23300	79613	27348	84826	6584	7317	11228	4900	57466	81930	128077	4161	79960	54865	57706	81624	318	25864	6780	6856	7770	23405	7541	79668	65998	27335	24149	728780	394	79085	79913	10394	81542	93408	51084	56928	57786	2487	51690	3030	2356	80179	25963	4300	55094	6693	23171
GSE18893_CTRL_VS_TNF_TREATED_TCONV_24H_DN	M7305		20181891	Nagar M,Jacob-Hirsch J,Vernitsky H,Berkun Y,Ben-Horin S,Amariglio N,Bank I,Kloog Y,Rechavi G,Goldstein I	GSE18893	GSE18893_1277_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in T conv cells (24h): medium versus TNF [GeneID=7124].	Here we show that tumor necrosis factor (TNF) induced in human T-regulatory cells (Treg), as compared to conventional T cells (Tcon), a transcription program highly enriched for typical NF-κB target genes, such as: the cytokines LTA and TNF; the TNF-receptor super family members FAS, 4-1BB and OX-40; various anti-apoptotic genes; and other important immune-response genes. As an initial approach to examine the cellular program induced by TNF in Tregs versus Tcon cells, we employed microarray gene expression analysis at 2 and 24 hrs following TNF treatment.					90835	116071	55031	55700	80204	6911	5142	222642	3726	55024	9145	221223	63035	93166	2103	3788	5912	2184	63905	7033	286410	780	9982	23484	5583	3672	2760	79058	7018	29108	9576	10425	80168	57475	100288695	84343	4055	56751	341032	23232	5957	8556	597	54536	55022	140	1183	92689	5537	10947	4124	324	26580	11129	284129	1580	10006	23185	26511	26751	57705	54828	91522	26262	374946	2801	3985	549	284992	27087	112611	51000	7026	59067	54360	55002	10930	5573	79853	221079	1647	160851	755	116236	79627	91012	54776	7053	285676	168090	389813	6199	5071	54507	9697	11248	84457	126432	54896	55054	6337	7871	55770	475	79794	5463	57804	9413	6884	55870	27148	51693	727957	57549	1437	10435	8805	116442	84807	2868	10451	65980	10005	344387	83636	57035	7855	440699	51294	5445	50807	8510	56253	26038	2737	10652	51201	26043	85352	533	7041	127428	6670	57621	79903	7763	29952	1783	90187	9270	9049	10928	3073	120103	1750	8829	5516	55041	116068	23268	84708	285704	58513	84660	65250	4094	51503	2529	692205	1184	253430	55835	165215	148327	389072	6883	83463	5309	84230	9564	23085	8546	284297	81575	79772	254225	84981	25874	3960	21	23130	7320	10140	129685	55124	1263	10390	6102	1121	333
GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN	M7306		20181891	Nagar M,Jacob-Hirsch J,Vernitsky H,Berkun Y,Ben-Horin S,Amariglio N,Bank I,Kloog Y,Rechavi G,Goldstein I	GSE18893	GSE18893_1279_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in lymphocytes treated with TNF [GeneID=7124] for 2h: T conv versus T reg cells.	Here we show that tumor necrosis factor (TNF) induced in human T-regulatory cells (Treg), as compared to conventional T cells (Tcon), a transcription program highly enriched for typical NF-κB target genes, such as: the cytokines LTA and TNF; the TNF-receptor super family members FAS, 4-1BB and OX-40; various anti-apoptotic genes; and other important immune-response genes. As an initial approach to examine the cellular program induced by TNF in Tregs versus Tcon cells, we employed microarray gene expression analysis at 2 and 24 hrs following TNF treatment.					50640	8972	79027	7644	64089	10520	51136	23268	653390	23077	6934	23390	80318	388685	80853	7096	51601	255394	604	338758	490	22878	5621	84458	55196	694	51125	22906	153577	23389	23637	10384	133746	100288673	23092	6322	9802	389072	80325	55914	259282	131583	114548	90693	430	10746	2043	9839	9969	55088	51316	924	27106	10957	155038	7743	472	51422	388677	9798	10129	81847	9765	7673	27125	7057	6653	101	5791	7852	57466	80204	26959	128346	51111	6789	3135	939	5341	10559	29994	55603	2355	571	51274	286101	92	100132406	10482	11119	23253	55727	7289	202020	23081	57600	26053	84449	9857	83479	1475	284129	3105	6940	151556	100129550	6778	1387	57396	9236	2117	10521	11214	8189	29068	84981	81566	196394	26115	100130872	55096	11120	7538	3106	7709	26524	85012	81606	334	51646	23129	649446	11118	203228	57515	57649	121274	5527	8065	114224	201895	58475	57690	84440	222161	286437	55762	51150	114881	7707	153222	5412	254887	284391	79627	9473	1266	5265	83888	57118	54454	22882	54210	57732	440352	11320	255967	1051	54434	23167	113791	51696	931	5782	1362	8764	54799	7763	10472	57614	352954	10602	84460	57728	7769	92285	376497	6046	23492	54790	83440	51131	114785	9435	8500	57458	10475	113	10079	145483
GSE18893_TCONV_VS_TREG_24H_TNF_STIM_UP	M7308		20181891	Nagar M,Jacob-Hirsch J,Vernitsky H,Berkun Y,Ben-Horin S,Amariglio N,Bank I,Kloog Y,Rechavi G,Goldstein I	GSE18893	GSE18893_1280_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in lymphocytes treated with TNF [GeneID=7124] for 24h: T conv versus T reg cells.	Here we show that tumor necrosis factor (TNF) induced in human T-regulatory cells (Treg), as compared to conventional T cells (Tcon), a transcription program highly enriched for typical NF-κB target genes, such as: the cytokines LTA and TNF; the TNF-receptor super family members FAS, 4-1BB and OX-40; various anti-apoptotic genes; and other important immune-response genes. As an initial approach to examine the cellular program induced by TNF in Tregs versus Tcon cells, we employed microarray gene expression analysis at 2 and 24 hrs following TNF treatment.					4702	220042	5591	9232	23741	54460	64785	23170	1017	5424	51053	51182	2194	2956	54969	8697	78988	28972	388962	1537	60490	83596	51493	25941	2806	11051	5558	10962	3145	9735	92259	23421	286827	6240	151648	8668	7112	55848	201254	5902	63922	899	7167	55055	125988	129401	54821	10988	3015	3014	286053	55101	3070	91433	746	4162	220134	144455	51318	1164	57017	5984	54148	7001	7037	147841	1345	5719	5422	55157	10632	29128	51596	55168	2108	539	131118	4715	83990	9837	990	27346	64975	51501	11001	23016	5982	23649	83461	2109	86	1351	55839	10024	3843	2937	119559	689	89958	873	84798	90381	51155	790	126789	10926	80071	4171	10635	83787	5701	993	6390	55559	1854	54058	8502	56954	3608	203068	81620	10131	51805	1737	113130	4436	26271	91057	113540	5111	51428	7353	112479	90459	9134	51142	1869	4695	57407	157570	672	1718	93081	3149	4358	7443	4176	51614	29127	9631	8208	81928	63979	84722	1192	204	89891	283742	51073	57082	8727	518	66005	79682	1163	1652	8266	4709	2542	10535	6941	6182	79866	9258	27068	51011	9184	55789	55835	29893	63901	84313	56992	51248	128061	51187	79102	6839	25804	10376	79135	1396	83879	2671	4521	11113	4605	4173	51002	84259
GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_DN	M7310		20190146	Baram D,Dekel O,Mekori YA,Sagi-Eisenberg R	GSE19888	GSE19888_3592_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in HMC-1 (mast leukemia) cells: untreated versus incubated with the peptide ALL1.	We demonstrate that the G protein Gi3 is the cellular target of the adenosine A3 receptor (A3R). By using a cell permeable peptide comprising the C-terminal end of Gαi3 fused to an importation sequence (ALL1) as a selective inhibitor of Gi3 signaling, we show that by coupling to Gi3, the A3R stimulates multiple signaling pathways in human mast cells, leading to upregulation of cytokines, chemokines and growth factors.Following contact with activated T cell membranes, endogenous adenosine binds to and activates the A3R, resulting in Gi3-mediated signaling. Specifically, the majority of ERK1/2 signaling initiated by contact with activated T cell membranes, is mediated by Gi3, giving rise to ALL1-inhibitable cellular responses. These results unveil the physiological GPCR that couples to Gi3 and establish the important role played by this G-protein in inflammatory conditions that involve adenosine-activated mast cells. We used microarrays to detail the effect of ALL1 on gene expression of HMC-1 cells activated directly by the A3 receptor, or by contact with activated T cell membranes.					50640	23129	2495	8976	4077	1843	571	284129	406893	147929	9969	27018	9765	56940	9135	255394	65986	220213	222161	254048	7324	9819	6934	9473	64718	10443	23389	54916	338758	115352	10000	80853	100287572	9821	8972	7050	10106	22841	3576	114327	26959	4082	64324	51111	84159	694	6653	116985	151657	222255	57118	10957	55914	10472	203414	5412	2509	23411	2149	100129550	10135	153222	55196	1475	2799	50717	133746	9839	202020	57162	26043	490	604	5898	3122	25957	4688	79627	203228	57515	133	8764	11152	6205	23011	80318	79663	10396	84458	649446	5997	10520	50861	1236	26137	1387	29896	7852	219539	29994	7259	9665	100288730	8615	57396	115548	51247	94241	51696	152485	373	7165	60370	114548	5552	53349	100286909	3423	3459	23387	2043	5140	375190	5329	84961	80700	57658	27106	7709	379025	3688	80325	5243	1602	10614	9236	7057	8301	51646	7538	201895	8843	7805	56605	6940	9063	1880	80218	113791	6734	5204	55251	653390	7128	51274	334	3575	5920	9975	9655	6480	57688	23067	55599	54790	6169	124935	100132406	10129	115294	23312	79042	84419	100288673	50486	4253	29068	9857	2309	83719	7750	8942	4763	7764	3043	27332	64397	26994	5473	57223	26115	7716	100270804	10023	57161	259282	25840	85463	9852	23174
GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_UP	M7311		20190146	Baram D,Dekel O,Mekori YA,Sagi-Eisenberg R	GSE19888	GSE19888_3592_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in HMC-1 (mast leukemia) cells: untreated versus incubated with the peptide ALL1.	We demonstrate that the G protein Gi3 is the cellular target of the adenosine A3 receptor (A3R). By using a cell permeable peptide comprising the C-terminal end of Gαi3 fused to an importation sequence (ALL1) as a selective inhibitor of Gi3 signaling, we show that by coupling to Gi3, the A3R stimulates multiple signaling pathways in human mast cells, leading to upregulation of cytokines, chemokines and growth factors.Following contact with activated T cell membranes, endogenous adenosine binds to and activates the A3R, resulting in Gi3-mediated signaling. Specifically, the majority of ERK1/2 signaling initiated by contact with activated T cell membranes, is mediated by Gi3, giving rise to ALL1-inhibitable cellular responses. These results unveil the physiological GPCR that couples to Gi3 and establish the important role played by this G-protein in inflammatory conditions that involve adenosine-activated mast cells. We used microarrays to detail the effect of ALL1 on gene expression of HMC-1 cells activated directly by the A3 receptor, or by contact with activated T cell membranes.					79864	84885	1015	1870	51065	374393	89891	2954	5902	26128	518	79140	84328	1235	3185	54982	9238	57017	284106	23568	84918	60490	2733	3184	144455	4507	90459	6428	25804	79017	10988	51444	4118	2584	4710	51182	9585	126789	1298	55353	64981	81691	29968	84279	84904	1017	2582	116064	147841	29880	54058	4190	6182	10112	4628	23463	9735	3838	7468	8968	91647	899	4702	51253	10456	8894	3704	9156	84967	4605	83443	10056	84547	5347	2176	1967	26284	84154	6626	84969	84561	285753	80185	83982	65062	675	84911	11270	149951	80179	3145	634	25975	51279	79166	151230	51192	7037	4236	81624	4242	3054	5440	27346	8520	25941	25886	65080	127602	54948	63901	9133	1725	4358	9692	1329	22976	88745	9824	28231	4171	440145	54503	84263	154467	34	150468	10632	283638	16	6636	80775	81620	205251	84668	1622	200081	6491	1737	7520	93323	7804	10073	80328	6821	140823	201725	4714	6941	9534	84920	1798	89958	54867	4704	83932	51161	3163	57730	1434	10962	79723	283951	6525	146956	23649	64858	55055	221150	148741	64801	11001	157313	84681	6628	3217	92667	6307	64386	348654	55848	587	3182	90135	118881	11200	28998	993	83658	8636	4277	8110	401251	11091	64375	28978	5393	51805	4522	66005
GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_UP	M7313		20190146	Baram D,Dekel O,Mekori YA,Sagi-Eisenberg R	GSE19888	GSE19888_3605_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in HMC-1 (mast leukemia) cells incubated with the peptide ALL1 followed by treatment with: Cl-IB-MECA [PubChem=3035850] versus T cell membranes.	We demonstrate that the G protein Gi3 is the cellular target of the adenosine A3 receptor (A3R). By using a cell permeable peptide comprising the C-terminal end of Gαi3 fused to an importation sequence (ALL1) as a selective inhibitor of Gi3 signaling, we show that by coupling to Gi3, the A3R stimulates multiple signaling pathways in human mast cells, leading to upregulation of cytokines, chemokines and growth factors.Following contact with activated T cell membranes, endogenous adenosine binds to and activates the A3R, resulting in Gi3-mediated signaling. Specifically, the majority of ERK1/2 signaling initiated by contact with activated T cell membranes, is mediated by Gi3, giving rise to ALL1-inhibitable cellular responses. These results unveil the physiological GPCR that couples to Gi3 and establish the important role played by this G-protein in inflammatory conditions that involve adenosine-activated mast cells. We used microarrays to detail the effect of ALL1 on gene expression of HMC-1 cells activated directly by the A3 receptor, or by contact with activated T cell membranes.					5552	51111	10106	9895	10000	5898	196394	7750	1655	202020	8976	324	26959	10614	2275	100129550	4077	57118	7764	1844	23389	7050	23129	116985	338758	114548	80853	490	2495	23637	6303	5412	9839	4069	694	8837	10957	30011	79663	1843	53349	7852	604	6940	255394	375190	379025	373	114327	406893	8878	9821	571	220213	55914	23411	259282	51247	64718	678	1601	960	10513	10443	55251	54799	55837	7259	1459	64224	472	4688	10472	26043	259230	80218	100287572	2309	57688	4082	55196	50640	27430	57466	334	23094	1475	9473	25957	100302692	22882	9765	9969	56940	5329	5209	729614	7057	9655	27018	22841	7716	23608	3459	254048	8972	2799	59348	821	284129	7320	5997	57728	11152	64744	8204	79627	7538	151657	57609	57396	1975	56995	84146	147929	10135	54790	6653	7128	29994	100288730	5290	148189	7799	64324	51646	313	3576	84159	54916	54665	5140	222255	6156	79188	133746	10384	55525	57515	3836	28984	133	115548	9665	546	8013	113791	80700	647979	10023	582	80318	9456	84872	27345	25897	23011	8942	27106	9788	359948	3575	6934	9516	6638	64089	9541	10746	50807	2043	6498	153577	64397	55361	84961	751816	23492	6659	6157	219539	200298	2509	5473	65986	80306	8301	100288410	26994	6160	55599
GSE19888_ADENOSINE_A3R_ACT_VS_A3R_ACT_WITH_A3R_INH_PRETREATMENT_IN_MAST_CELL_UP	M7316		20190146	Baram D,Dekel O,Mekori YA,Sagi-Eisenberg R	GSE19888	GSE19888_3601_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in HMC-1 (mast leukemia) cells: Cl-IB-MECA [PubChem=3035850] versus incubated with the ALL1 peptide followed by treatment with Cl-IB-MECA [PubChem=3035850].	We demonstrate that the G protein Gi3 is the cellular target of the adenosine A3 receptor (A3R). By using a cell permeable peptide comprising the C-terminal end of Gαi3 fused to an importation sequence (ALL1) as a selective inhibitor of Gi3 signaling, we show that by coupling to Gi3, the A3R stimulates multiple signaling pathways in human mast cells, leading to upregulation of cytokines, chemokines and growth factors.Following contact with activated T cell membranes, endogenous adenosine binds to and activates the A3R, resulting in Gi3-mediated signaling. Specifically, the majority of ERK1/2 signaling initiated by contact with activated T cell membranes, is mediated by Gi3, giving rise to ALL1-inhibitable cellular responses. These results unveil the physiological GPCR that couples to Gi3 and establish the important role played by this G-protein in inflammatory conditions that involve adenosine-activated mast cells. We used microarrays to detail the effect of ALL1 on gene expression of HMC-1 cells activated directly by the A3 receptor, or by contact with activated T cell membranes.					2687	11013	5147	54982	5723	80185	113540	79050	60490	7332	55592	90135	9143	123811	147841	51161	126789	55157	25886	84904	64858	587	51279	79864	26128	140823	286151	50814	54503	80071	2954	5902	84279	388507	10632	3149	201725	4580	8673	219738	22994	1870	80775	1460	5719	4507	84547	8266	79622	326625	1939	25994	2617	83982	995	6955	730101	103910	2224	128061	93517	675	89891	54058	1723	11051	9585	790	92840	729515	93611	56339	285753	10926	51253	30968	79634	9775	23221	6626	10276	27346	3613	813	10112	10988	10635	11116	53347	29925	10042	63943	5347	580	100128594	1616	10962	9735	100128191	197335	80714	91368	9173	55149	116028	1869	1841	4733	3033	51065	57149	84450	440	29899	360	84967	84923	118881	91107	65080	2271	79172	6182	10056	401884	56259	89958	1798	10073	4710	56954	112479	88745	1725	8821	285203	3838	1062	3619	55359	79980	57415	7398	1478	51124	2937	51021	283951	79145	29893	63931	92667	80832	9482	64219	25804	8045	79102	144455	10200	55829	79140	93081	6307	92002	84153	84883	8260	3184	51444	899	51805	84969	1138	28231	51142	374393	2323	100288693	204	518	122769	55353	79968	16	3185	57048	767811	26262	157570	10467	57419	51659	7936	3976	6919	84313	22976	51192	84276
GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_IN_MAST_CELL_DN	M7317		20190146	Baram D,Dekel O,Mekori YA,Sagi-Eisenberg R	GSE19888	GSE19888_3602_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in HMC-1 (mast leukemia) cells: Cl-IB-MECA [PubChem=3035850] versus T cell membranes.	We demonstrate that the G protein Gi3 is the cellular target of the adenosine A3 receptor (A3R). By using a cell permeable peptide comprising the C-terminal end of Gαi3 fused to an importation sequence (ALL1) as a selective inhibitor of Gi3 signaling, we show that by coupling to Gi3, the A3R stimulates multiple signaling pathways in human mast cells, leading to upregulation of cytokines, chemokines and growth factors.Following contact with activated T cell membranes, endogenous adenosine binds to and activates the A3R, resulting in Gi3-mediated signaling. Specifically, the majority of ERK1/2 signaling initiated by contact with activated T cell membranes, is mediated by Gi3, giving rise to ALL1-inhibitable cellular responses. These results unveil the physiological GPCR that couples to Gi3 and establish the important role played by this G-protein in inflammatory conditions that involve adenosine-activated mast cells. We used microarrays to detail the effect of ALL1 on gene expression of HMC-1 cells activated directly by the A3 receptor, or by contact with activated T cell membranes.					868	9986	57459	8539	8085	55013	51107	6583	6641	79134	6351	26651	8125	9520	79940	8968	79711	5327	8408	160	85013	1361	7559	374618	58526	114882	4820	56652	2353	441245	10116	23380	10884	27231	1788	113235	9592	10513	339476	2534	83590	285812	63935	55893	5455	151790	84657	7469	147381	100130155	23451	677811	83447	8661	83892	55735	8358	151194	64651	22828	23386	23431	285740	25778	56101	665	219988	26512	203427	9704	51552	1802	64795	6092	54867	54865	23081	1992	55182	402483	100506783	349114	170506	55128	59274	23038	2801	5933	8161	7175	25909	64965	79850	100131827	54834	9169	4791	9619	80060	5163	205	9294	23279	7750	441631	221935	57602	140735	56981	100506325	79364	147179	27340	55088	5089	7879	266655	401282	29979	10260	2634	57628	2185	22863	114905	100287237	114609	91445	23403	79893	200765	22835	3796	10318	55183	2521	92104	100129482	6003	200373	23036	51569	23376	10992	100130741	9670	100507470	2957	5970	134860	6878	153364	27246	1145	55435	6170	4176	3595	117584	646701	100272217	196500	9820	7422	2553	23125	253639	8407	168850	63924	124936	378938	79691	9146	9138	27013	10911	23569	4089	389125	144245	399716	8089	57051	9976	9609	374946	55717	148479	51564	8650	87769	79269	197021	57473	55697	26057
GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_UP	M7318		20190146	Baram D,Dekel O,Mekori YA,Sagi-Eisenberg R	GSE19888	GSE19888_3603_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in HMC-1 (mast leukemia) cells: Cl-IB-MECA [PubChem=3035850] versus incubated with the peptide ALL1 followed by stimulation with T cell membranes.	We demonstrate that the G protein Gi3 is the cellular target of the adenosine A3 receptor (A3R). By using a cell permeable peptide comprising the C-terminal end of Gαi3 fused to an importation sequence (ALL1) as a selective inhibitor of Gi3 signaling, we show that by coupling to Gi3, the A3R stimulates multiple signaling pathways in human mast cells, leading to upregulation of cytokines, chemokines and growth factors.Following contact with activated T cell membranes, endogenous adenosine binds to and activates the A3R, resulting in Gi3-mediated signaling. Specifically, the majority of ERK1/2 signaling initiated by contact with activated T cell membranes, is mediated by Gi3, giving rise to ALL1-inhibitable cellular responses. These results unveil the physiological GPCR that couples to Gi3 and establish the important role played by this G-protein in inflammatory conditions that involve adenosine-activated mast cells. We used microarrays to detail the effect of ALL1 on gene expression of HMC-1 cells activated directly by the A3 receptor, or by contact with activated T cell membranes.					84950	9447	595	27230	51289	4110	146857	55039	3875	9022	55763	80346	3608	56649	27107	63976	5813	8444	25907	151556	7780	9037	8340	54823	7873	613266	64718	283070	10892	283152	3881	9950	54987	5053	533	497634	171586	201254	55010	3122	3195	5723	5351	51367	147276	5708	54529	100287025	158297	23155	79145	9402	91450	26539	3958	64374	29105	10728	10467	10109	84909	80895	443	100287182	6856	131177	128989	127003	91227	170370	5225	114987	8552	9482	79698	9349	11074	286121	79022	5590	84064	100129271	9630	4055	140809	10538	6747	56923	387263	260434	10903	54209	5367	64431	51596	51763	56975	90417	80135	399693	6788	6687	79807	257177	28971	266722	206358	26251	146712	23308	341405	54821	25984	10950	84264	22802	8764	267002	80008	84727	84255	100128298	3416	3295	56099	3281	5705	146852	93986	1003	146433	80025	14	5825	3142	4651	23333	51155	284475	56676	79169	27303	10314	54947	400748	3303	55005	9726	10980	8620	79906	79652	81502	146279	1796	143630	55721	4637	84923	728558	51327	80279	11034	129025	51188	25871	5331	283578	643834	64805	55024	1849	492311	226	8189	5861	25937	83538	28986	3621	11085	10598	92129	57536	153020	497189	2990	9966	4913	10347	10239	84316	50861	5020	169026	9290	30846	57568	386597
GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN	M7319		20190146	Baram D,Dekel O,Mekori YA,Sagi-Eisenberg R	GSE19888	GSE19888_3603_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in HMC-1 (mast leukemia) cells: Cl-IB-MECA [PubChem=3035850] versus incubated with the peptide ALL1 followed by stimulation with T cell membranes.	We demonstrate that the G protein Gi3 is the cellular target of the adenosine A3 receptor (A3R). By using a cell permeable peptide comprising the C-terminal end of Gαi3 fused to an importation sequence (ALL1) as a selective inhibitor of Gi3 signaling, we show that by coupling to Gi3, the A3R stimulates multiple signaling pathways in human mast cells, leading to upregulation of cytokines, chemokines and growth factors.Following contact with activated T cell membranes, endogenous adenosine binds to and activates the A3R, resulting in Gi3-mediated signaling. Specifically, the majority of ERK1/2 signaling initiated by contact with activated T cell membranes, is mediated by Gi3, giving rise to ALL1-inhibitable cellular responses. These results unveil the physiological GPCR that couples to Gi3 and establish the important role played by this G-protein in inflammatory conditions that involve adenosine-activated mast cells. We used microarrays to detail the effect of ALL1 on gene expression of HMC-1 cells activated directly by the A3 receptor, or by contact with activated T cell membranes.					64359	55558	1294	5784	10928	55657	57680	84909	9651	10363	85377	25777	84962	2842	130074	84726	6621	5792	2886	54361	8711	1676	2195	55082	2263	2114	1942	55561	653145	10725	4643	51593	23492	6901	375444	10188	7074	51433	2065	283131	5618	22993	57610	27106	121665	9481	84290	6843	29888	113828	57127	57153	643549	9610	10181	10867	64866	1565	3687	57142	6158	7384	64065	6811	6382	57799	4092	54845	80725	51195	3852	143458	3709	55620	8323	9757	57496	64745	132014	4297	338440	6709	7159	26015	3675	135228	23370	128853	9725	6002	7021	8446	79977	29068	7089	26505	192670	4097	3149	286467	84254	339488	1159	53905	10625	4318	688	4194	55349	23031	2803	4534	56256	51259	5571	54522	201501	80237	64857	8525	5317	642938	4854	8125	7020	10075	375035	26523	6203	4282	7267	80346	54540	3068	90226	64760	10013	9990	57630	55692	6691	55971	7182	51112	57473	140576	55540	50649	652968	85461	3006	999	5976	57447	11123	152503	1605	114785	23266	10076	780	55107	23413	2261	1952	8626	7335	25953	57492	55374	26986	53335	26135	4216	6988	80262	90576	10653	23608	341640	1537	196441	1397	6840	6603	3898	26033	1832	4209	4363	4240	51449	735	84951	286077	79669	83643	6535	2013	9520
GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP	M7320		20190146	Baram D,Dekel O,Mekori YA,Sagi-Eisenberg R	GSE19888	GSE19888_3604_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in HMC-1 (mast leukemia) cells: incubated with the peptide ALL1 and then treated with Cl-IB-MECA [PubChem=3035850] versus stimulation by T cell membranes.	We demonstrate that the G protein Gi3 is the cellular target of the adenosine A3 receptor (A3R). By using a cell permeable peptide comprising the C-terminal end of Gαi3 fused to an importation sequence (ALL1) as a selective inhibitor of Gi3 signaling, we show that by coupling to Gi3, the A3R stimulates multiple signaling pathways in human mast cells, leading to upregulation of cytokines, chemokines and growth factors.Following contact with activated T cell membranes, endogenous adenosine binds to and activates the A3R, resulting in Gi3-mediated signaling. Specifically, the majority of ERK1/2 signaling initiated by contact with activated T cell membranes, is mediated by Gi3, giving rise to ALL1-inhibitable cellular responses. These results unveil the physiological GPCR that couples to Gi3 and establish the important role played by this G-protein in inflammatory conditions that involve adenosine-activated mast cells. We used microarrays to detail the effect of ALL1 on gene expression of HMC-1 cells activated directly by the A3 receptor, or by contact with activated T cell membranes.					7453	116071	57674	6773	1616	10068	151636	3055	344807	11274	55008	958	3659	2214	10379	2175	9636	6890	5371	3669	55500	219285	4940	54739	81030	5720	146857	345611	64135	129607	3586	8417	5698	4938	29126	5696	971	83666	6772	54708	9582	2643	5699	163351	388646	8638	57097	4600	9246	23586	6737	439996	2634	9111	79132	64761	25939	91543	64853	4283	56833	134111	29887	103	10537	64108	10333	3430	1633	162394	841	3135	3600	6373	8743	3437	54625	4939	3434	4860	6402	414328	115361	2209	4599	9388	9750	5721	144811	23070	221302	3628	3561	3433	94240	118788	10039	197259	3627	9473	3002	441168	168537	4067	199	637	64222	3706	717	5610	7318	313	27147	84617	3101	27163	79792	9334	3133	2717	3903	9695	6892	10577	10561	3394	375287	55072	23562	53829	83852	347475	10964	163786	55201	6812	9870	163590	5908	7127	59345	5788	7098	219972	10865	683	695	9718	340061	10410	9153	4061	22797	5033	317649	57169	200172	55303	6352	6039	57823	2042	85363	79415	7099	161145	54734	64092	10135	10906	10326	4013	3937	10312	8842	6347	53840	53827	55080	4064	3665	7993	1234	4524	5272	10020	433	5613	7076	7706	684	83661	837	834	22914	1808	3431	10320	127544	3110
GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_DN	M7321		20190146	Baram D,Dekel O,Mekori YA,Sagi-Eisenberg R	GSE19888	GSE19888_3604_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in HMC-1 (mast leukemia) cells: incubated with the peptide ALL1 and then treated with Cl-IB-MECA [PubChem=3035850] versus stimulation by T cell membranes.	We demonstrate that the G protein Gi3 is the cellular target of the adenosine A3 receptor (A3R). By using a cell permeable peptide comprising the C-terminal end of Gαi3 fused to an importation sequence (ALL1) as a selective inhibitor of Gi3 signaling, we show that by coupling to Gi3, the A3R stimulates multiple signaling pathways in human mast cells, leading to upregulation of cytokines, chemokines and growth factors.Following contact with activated T cell membranes, endogenous adenosine binds to and activates the A3R, resulting in Gi3-mediated signaling. Specifically, the majority of ERK1/2 signaling initiated by contact with activated T cell membranes, is mediated by Gi3, giving rise to ALL1-inhibitable cellular responses. These results unveil the physiological GPCR that couples to Gi3 and establish the important role played by this G-protein in inflammatory conditions that involve adenosine-activated mast cells. We used microarrays to detail the effect of ALL1 on gene expression of HMC-1 cells activated directly by the A3 receptor, or by contact with activated T cell membranes.					4318	130557	10363	22845	54522	2535	6811	4209	23171	23510	200185	29	24144	26033	55128	92014	3479	51465	27106	339896	7205	54434	6829	11123	7905	81621	389203	54956	10541	5832	10498	57037	84826	23275	94059	27304	84920	92840	9931	57095	26000	90268	162989	9194	4040	7508	64897	64115	6899	643549	4694	25953	375346	57678	51195	23247	9812	3014	3998	57799	81572	790	54540	6280	5892	7071	79643	10608	7580	25871	2072	10043	10585	79675	5037	5207	5986	155435	6342	6279	5867	124222	375444	55793	80781	10013	10827	154043	1643	344595	201266	255252	54512	51313	65009	89866	2235	11275	57680	6988	8906	79102	116835	388815	11333	51684	11047	79770	23240	145788	8612	27250	90324	9451	23587	1666	56931	51205	23167	119504	1039	22822	50515	84749	159371	55339	116225	219743	51309	79002	50854	3149	54850	10455	7107	54345	2119	30011	26058	6624	8161	4855	25873	57182	83442	1877	256076	57496	100128731	5634	7090	9446	4771	26121	8106	115111	6147	9159	2671	9869	8541	26580	22794	9700	222234	83871	7268	84080	6158	10745	84626	222236	286343	339488	6156	1337	6886	25920	818	84269	27433	9487	91283	2886	131616	100093630	10844	1565	79089	51567	55297	5435	149371	54985	399818	121457	23613	57136	29951	28951
GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_UP	M7322		20190146	Baram D,Dekel O,Mekori YA,Sagi-Eisenberg R	GSE19888	GSE19888_3598_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in HMC-1 (mast leukemia) cells incubated the peptide ALL1 versus those followed by treatment with Cl-IB-MECA [PubChem=3035850].	We demonstrate that the G protein Gi3 is the cellular target of the adenosine A3 receptor (A3R). By using a cell permeable peptide comprising the C-terminal end of Gαi3 fused to an importation sequence (ALL1) as a selective inhibitor of Gi3 signaling, we show that by coupling to Gi3, the A3R stimulates multiple signaling pathways in human mast cells, leading to upregulation of cytokines, chemokines and growth factors.Following contact with activated T cell membranes, endogenous adenosine binds to and activates the A3R, resulting in Gi3-mediated signaling. Specifically, the majority of ERK1/2 signaling initiated by contact with activated T cell membranes, is mediated by Gi3, giving rise to ALL1-inhibitable cellular responses. These results unveil the physiological GPCR that couples to Gi3 and establish the important role played by this G-protein in inflammatory conditions that involve adenosine-activated mast cells. We used microarrays to detail the effect of ALL1 on gene expression of HMC-1 cells activated directly by the A3 receptor, or by contact with activated T cell membranes.					7453	54514	6773	116071	4524	55008	3659	6890	115584	10562	1616	57097	2214	8743	103	10068	5696	57674	11274	151636	23586	6772	129607	5371	1447	91543	4939	162394	55061	64761	958	4599	653	4940	345611	3426	2175	344807	388646	163351	219285	64135	3669	54625	9246	2643	81030	255220	64108	3055	9023	4600	8638	10379	7783	3433	3437	6373	9636	439996	54739	29126	7318	4938	2634	7098	139604	83666	54708	5699	79132	85441	55500	146857	3434	56914	6737	717	6039	9313	3628	10875	441168	414328	1633	4283	3431	10577	1005	3002	969	51209	3135	115361	25939	22914	4860	2209	23070	9111	64853	5720	51246	6398	5698	3627	10561	85363	10178	3133	6354	7134	2554	1602	6999	5604	567	29887	5610	140886	57684	3586	117154	58158	79650	161725	25932	3600	378	22802	53840	3890	4818	6357	6847	7378	28968	8792	57169	2357	133491	347	143279	7994	9582	10410	6262	390442	10964	3430	2623	23440	145645	93035	127254	9473	1068	147837	1128	1473	57713	127733	100131244	83852	219990	9870	56833	219972	401409	3620	118788	11249	2257	10110	3920	5272	10392	59345	79799	221302	3758	94120	27199	1285	221833	221468	2358	163786	100125288	84569	55905	3665	780789	4061	169026	4435	6568	3169	29083	64168
GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_DN	M7323		20190146	Baram D,Dekel O,Mekori YA,Sagi-Eisenberg R	GSE19888	GSE19888_3598_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in HMC-1 (mast leukemia) cells incubated the peptide ALL1 versus those followed by treatment with Cl-IB-MECA [PubChem=3035850].	We demonstrate that the G protein Gi3 is the cellular target of the adenosine A3 receptor (A3R). By using a cell permeable peptide comprising the C-terminal end of Gαi3 fused to an importation sequence (ALL1) as a selective inhibitor of Gi3 signaling, we show that by coupling to Gi3, the A3R stimulates multiple signaling pathways in human mast cells, leading to upregulation of cytokines, chemokines and growth factors.Following contact with activated T cell membranes, endogenous adenosine binds to and activates the A3R, resulting in Gi3-mediated signaling. Specifically, the majority of ERK1/2 signaling initiated by contact with activated T cell membranes, is mediated by Gi3, giving rise to ALL1-inhibitable cellular responses. These results unveil the physiological GPCR that couples to Gi3 and establish the important role played by this G-protein in inflammatory conditions that involve adenosine-activated mast cells. We used microarrays to detail the effect of ALL1 on gene expression of HMC-1 cells activated directly by the A3 receptor, or by contact with activated T cell membranes.					3745	64901	10082	64699	1814	84167	3017	79365	10388	115584	80342	85478	128414	56912	221935	84182	84418	79863	9828	9761	270	335	3757	130497	55324	124773	10603	3149	4857	126326	2830	23621	161514	2875	6781	11238	10660	11061	55624	1050	7481	79414	9452	64748	6862	9839	136991	6508	755	266727	55273	9793	1612	57158	2542	89796	58531	9759	387707	28971	25953	84624	4062	3171	226	7136	92304	168433	9812	374907	5816	89	5420	83475	1800	112398	7225	997	127002	5236	4608	11185	79791	11082	1158	5525	342346	51272	2987	786	79660	84331	29999	6586	2819	5156	2335	85474	767	89866	10099	9260	84269	245930	57710	4284	200539	8785	7134	1674	58529	9806	653509	64689	3293	6094	118426	51337	8078	5315	8761	1144	284948	56998	115557	64900	3674	93210	65010	10267	2495	9308	7448	50813	28954	9679	5837	64115	53841	3911	7135	27089	6576	2766	10102	126402	142	54112	2969	201627	3266	1181	9592	10555	3281	10332	11047	10573	23498	55367	8398	57574	9618	2139	7373	27075	8630	50632	2260	779	9136	113026	58497	402	64837	389941	4255	197135	53916	90293	1762	5768	6336	57804	11165	9578	23170	51083	8671	274	70	441151	1910	26133	9173	9590	9746	55811	6015	84814
GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP	M7324		20190146	Baram D,Dekel O,Mekori YA,Sagi-Eisenberg R	GSE19888	GSE19888_3599_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in HMC-1 (mast leukemia) cells: incubated with the peptide ALL1 versus stimulated with T cell membranes.	We demonstrate that the G protein Gi3 is the cellular target of the adenosine A3 receptor (A3R). By using a cell permeable peptide comprising the C-terminal end of Gαi3 fused to an importation sequence (ALL1) as a selective inhibitor of Gi3 signaling, we show that by coupling to Gi3, the A3R stimulates multiple signaling pathways in human mast cells, leading to upregulation of cytokines, chemokines and growth factors.Following contact with activated T cell membranes, endogenous adenosine binds to and activates the A3R, resulting in Gi3-mediated signaling. Specifically, the majority of ERK1/2 signaling initiated by contact with activated T cell membranes, is mediated by Gi3, giving rise to ALL1-inhibitable cellular responses. These results unveil the physiological GPCR that couples to Gi3 and establish the important role played by this G-protein in inflammatory conditions that involve adenosine-activated mast cells. We used microarrays to detail the effect of ALL1 on gene expression of HMC-1 cells activated directly by the A3 receptor, or by contact with activated T cell membranes.					163351	345611	5696	388646	29126	11274	439996	6890	151636	103	91543	6772	6737	4283	3659	115361	10379	129607	57674	54625	2634	4600	85441	54739	64761	64108	57097	3437	64135	7127	3824	9636	6773	4939	5720	9111	3627	7098	85363	3133	6373	55008	5698	375287	146857	83666	8743	81844	55905	5621	11011	54708	51246	375790	54877	4599	1633	94120	100128927	389856	3236	3433	3430	717	116071	971	81030	8091	221302	5613	84166	4938	115004	84002	220002	79670	5721	23586	163590	7706	10561	958	2214	9267	93273	3628	3434	4524	472	10537	6892	26872	83852	51179	23076	10068	343450	64799	11216	3002	150290	582	4068	137735	83591	55500	51111	219285	57096	3458	3717	54514	162394	79969	160335	84216	84132	26122	51490	79161	1616	84163	167227	9870	7547	79754	1447	4619	56829	401145	152926	25939	7318	7485	5990	129531	10181	343099	84333	837	3431	25975	79132	84626	200403	25988	9246	23678	4818	79809	83447	25932	84888	5699	389072	29066	27063	3738	388969	7850	170082	9961	7185	1842	5371	6564	55356	6809	23368	340146	84236	23351	92667	57336	11172	8914	2842	220064	56658	4650	9023	10797	84901	1797	2357	3706	339559	3899	5272	22794	132720	64863	7014	197370	4731	9313	1749	53335	55184
GSE19888_CTRL_VS_A3R_ACTIVATION_MAST_CELL_UP	M7325		20190146	Baram D,Dekel O,Mekori YA,Sagi-Eisenberg R	GSE19888	GSE19888_3593_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in HMC-1 (mast leukemia) cells: untreated versus Cl-IB-MECA [PubChem=3035850].	We demonstrate that the G protein Gi3 is the cellular target of the adenosine A3 receptor (A3R). By using a cell permeable peptide comprising the C-terminal end of Gαi3 fused to an importation sequence (ALL1) as a selective inhibitor of Gi3 signaling, we show that by coupling to Gi3, the A3R stimulates multiple signaling pathways in human mast cells, leading to upregulation of cytokines, chemokines and growth factors.Following contact with activated T cell membranes, endogenous adenosine binds to and activates the A3R, resulting in Gi3-mediated signaling. Specifically, the majority of ERK1/2 signaling initiated by contact with activated T cell membranes, is mediated by Gi3, giving rise to ALL1-inhibitable cellular responses. These results unveil the physiological GPCR that couples to Gi3 and establish the important role played by this G-protein in inflammatory conditions that involve adenosine-activated mast cells. We used microarrays to detail the effect of ALL1 on gene expression of HMC-1 cells activated directly by the A3 receptor, or by contact with activated T cell membranes.					51780	53349	54522	4283	83596	51433	6890	10139	6843	80742	22859	5696	23207	25777	26230	5871	7453	57680	6398	950	57473	5016	10363	7316	84166	8630	26015	6773	57142	84726	135138	3149	567	84676	286467	56914	55558	642938	1106	80765	159	7378	283131	4209	55082	624	81610	200312	29888	1314	55657	1605	283174	10155	92715	4703	827	267	375	79932	54921	64753	643549	90226	4216	148398	27345	192670	5630	23019	64745	1663	434	81669	26034	8525	140612	5298	286128	22889	79172	5690	81603	9656	5250	56833	2239	25788	26958	6904	23220	79019	10521	134187	10181	2875	79810	255743	400506	128486	6187	5347	6840	23167	3853	3321	26003	340527	51504	64061	80854	2072	2619	81858	64784	735	2318	203068	57630	55692	8462	1294	860	9463	811	23450	10984	84660	103910	149603	7273	55540	81839	64359	1080	84909	25953	51593	8786	55789	23613	4638	4899	64760	2307	905	84961	847	9722	9753	10635	132014	9967	7384	4191	58517	54361	23197	64397	1147	57568	22993	3609	151126	10188	252983	8897	9793	377	122773	84135	483	64399	26135	4097	527	1537	23370	84747	8813	4259	55719	91687	6856	1676	6899	146909	9333	11176	91875	92335	23046	10383	51776	3204	57610	55374	79969	3371	2195
GSE19888_CTRL_VS_A3R_ACTIVATION_MAST_CELL_DN	M7326		20190146	Baram D,Dekel O,Mekori YA,Sagi-Eisenberg R	GSE19888	GSE19888_3593_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in HMC-1 (mast leukemia) cells: untreated versus Cl-IB-MECA [PubChem=3035850].	We demonstrate that the G protein Gi3 is the cellular target of the adenosine A3 receptor (A3R). By using a cell permeable peptide comprising the C-terminal end of Gαi3 fused to an importation sequence (ALL1) as a selective inhibitor of Gi3 signaling, we show that by coupling to Gi3, the A3R stimulates multiple signaling pathways in human mast cells, leading to upregulation of cytokines, chemokines and growth factors.Following contact with activated T cell membranes, endogenous adenosine binds to and activates the A3R, resulting in Gi3-mediated signaling. Specifically, the majority of ERK1/2 signaling initiated by contact with activated T cell membranes, is mediated by Gi3, giving rise to ALL1-inhibitable cellular responses. These results unveil the physiological GPCR that couples to Gi3 and establish the important role played by this G-protein in inflammatory conditions that involve adenosine-activated mast cells. We used microarrays to detail the effect of ALL1 on gene expression of HMC-1 cells activated directly by the A3 receptor, or by contact with activated T cell membranes.					4617	388585	255220	79623	5724	2243	8968	9582	83446	338323	256076	10047	66002	4068	221687	30832	131375	150465	3266	9542	7103	94120	6767	56956	5657	56164	1101	400451	29990	147945	59350	29992	65009	2066	55195	284716	651302	440307	93661	8600	154288	373156	4690	10267	55509	940	9806	5161	55273	646450	80303	11014	4857	4093	84249	286256	51065	1259	4692	29999	100131897	23412	7141	200504	80263	126820	6361	134147	84281	5179	145497	11144	4284	81626	53342	653567	140831	83447	84504	92667	185	64816	284680	1808	317705	84624	11238	754	387882	5053	3036	64092	7481	94137	6336	134391	389124	54344	340784	11142	4900	10175	6555	260425	56344	221016	169026	283212	1238	389058	222171	10562	3565	63906	10484	124923	727897	4956	5408	1733	79629	91860	5955	55228	407738	51617	6906	84898	57522	84971	4628	256586	7095	163175	93273	7201	170392	1780	4635	1901	57084	1316	5212	5429	359	54206	9750	50937	113622	10365	198437	9464	337	220004	5624	653319	780776	3628	404220	55958	6753	8644	254863	256380	87769	51573	84919	196740	5731	25945	4853	339665	5146	93973	140687	114984	55150	165545	8992	51364	2589	79228	1392	51298	3479	83690	9173	374470	51490	56929	9639	54386	7291	27250	2703	286343	10480	7504	440556	10512
GSE19888_CTRL_VS_A3R_ACT_TREATED_MAST_CELL_PRETREATED_WITH_A3R_INH_UP	M7329		20190146	Baram D,Dekel O,Mekori YA,Sagi-Eisenberg R	GSE19888	GSE19888_3594_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in HMC-1 (mast leukemia) cells: untreated versus incubated with the peptide ALL1 followed by treatment with Cl-IB-MECA [PubChem=3035850].	We demonstrate that the G protein Gi3 is the cellular target of the adenosine A3 receptor (A3R). By using a cell permeable peptide comprising the C-terminal end of Gαi3 fused to an importation sequence (ALL1) as a selective inhibitor of Gi3 signaling, we show that by coupling to Gi3, the A3R stimulates multiple signaling pathways in human mast cells, leading to upregulation of cytokines, chemokines and growth factors.Following contact with activated T cell membranes, endogenous adenosine binds to and activates the A3R, resulting in Gi3-mediated signaling. Specifically, the majority of ERK1/2 signaling initiated by contact with activated T cell membranes, is mediated by Gi3, giving rise to ALL1-inhibitable cellular responses. These results unveil the physiological GPCR that couples to Gi3 and establish the important role played by this G-protein in inflammatory conditions that involve adenosine-activated mast cells. We used microarrays to detail the effect of ALL1 on gene expression of HMC-1 cells activated directly by the A3 receptor, or by contact with activated T cell membranes.					79794	56265	55256	84693	57582	79882	84987	401190	6753	165545	84692	5179	185	90273	11329	2188	4234	83953	255919	3932	6425	1793	23093	23307	165257	57468	254427	339745	284716	1146	6783	90313	9020	3122	9784	727936	5662	83729	338323	51617	349136	100131755	389124	219438	55150	55111	643	54549	9451	54832	51206	11083	93594	4321	2978	51639	2296	1761	3685	79727	9227	84317	149483	2534	51474	117155	22986	63036	8263	6754	441027	284297	353500	8665	27097	146310	79623	64129	266722	10536	725	2286	9806	23704	8644	651302	197358	84661	147945	54557	308	79724	30832	115557	25903	10491	30008	337977	115992	6915	81037	64388	84437	23284	79643	3884	9741	752	8801	85409	4155	55365	253017	7275	3048	339977	8544	374407	4591	27075	402665	60559	6422	54386	8406	6184	3758	11193	54207	2526	220965	56165	129080	10683	56949	114898	373156	10302	2847	25847	3590	5980	9475	4068	3652	5947	7755	56957	5724	54808	256380	51218	954	57689	92595	84269	57631	79370	55509	4232	9687	79982	2621	558	83439	6235	3363	254778	84299	55282	3217	29990	3837	158521	9028	7041	23753	5345	23546	10047	170392	55240	84171	9542	871	60488	79780	2925	9867	2937	9529	947	58508	441161	131375	133686	284307	54732	5636	80700
GSE19888_ADENOSINE_A3R_ACT_VS_A3R_ACT_WITH_A3R_INH_PRETREATMENT_IN_MAST_CELL_DN	M7332		20190146	Baram D,Dekel O,Mekori YA,Sagi-Eisenberg R	GSE19888	GSE19888_3601_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in HMC-1 (mast leukemia) cells: Cl-IB-MECA [PubChem=3035850] versus incubated with the ALL1 peptide followed by treatment with Cl-IB-MECA [PubChem=3035850].	We demonstrate that the G protein Gi3 is the cellular target of the adenosine A3 receptor (A3R). By using a cell permeable peptide comprising the C-terminal end of Gαi3 fused to an importation sequence (ALL1) as a selective inhibitor of Gi3 signaling, we show that by coupling to Gi3, the A3R stimulates multiple signaling pathways in human mast cells, leading to upregulation of cytokines, chemokines and growth factors.Following contact with activated T cell membranes, endogenous adenosine binds to and activates the A3R, resulting in Gi3-mediated signaling. Specifically, the majority of ERK1/2 signaling initiated by contact with activated T cell membranes, is mediated by Gi3, giving rise to ALL1-inhibitable cellular responses. These results unveil the physiological GPCR that couples to Gi3 and establish the important role played by this G-protein in inflammatory conditions that involve adenosine-activated mast cells. We used microarrays to detail the effect of ALL1 on gene expression of HMC-1 cells activated directly by the A3 receptor, or by contact with activated T cell membranes.					1621	65267	64072	5029	4836	57506	5987	4157	353322	22914	6288	2563	163351	7318	1600	10220	2171	57380	54625	55139	5457	9283	439996	9246	388886	100134934	5718	3601	79132	7098	7264	151126	10009	285521	8819	10312	2624	55008	136853	85441	284194	2530	23511	8030	400916	169693	6373	64222	55208	57210	6892	345611	11274	78995	1137	5985	54853	64145	95	6117	8502	3437	969	3434	8743	80896	6773	10962	56833	25998	9191	115209	3002	51611	79884	3055	23023	22936	8927	3627	4600	9832	2629	26168	4283	1179	1355	7429	2744	54739	57555	10248	51554	23491	8480	3430	126353	377	57478	85007	83854	57634	57448	476	8731	5427	1060	9836	5613	83940	22893	122616	158248	84891	5045	91368	80184	27436	23077	100506736	23272	150677	63925	8789	845	157285	29080	4306	148	3959	7378	6772	54621	374887	1427	257397	57761	23158	91543	1994	389072	6173	55835	51132	90826	22875	1160	23586	22891	29915	29761	259236	64223	129607	7276	3665	158135	123904	7112	51266	9031	1545	79751	3800	54877	83875	4355	54784	11172	81620	57674	498	79847	440275	123745	2214	9636	6541	6648	9751	64718	284403	54468	25823	58157	388364	1155	51447	9718	3990	162387	26519	24148	84515	3669	79923	4345	9905	523	56896
GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_IN_MAST_CELL_UP	M7333		20190146	Baram D,Dekel O,Mekori YA,Sagi-Eisenberg R	GSE19888	GSE19888_3602_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in HMC-1 (mast leukemia) cells: Cl-IB-MECA [PubChem=3035850] versus T cell membranes.	We demonstrate that the G protein Gi3 is the cellular target of the adenosine A3 receptor (A3R). By using a cell permeable peptide comprising the C-terminal end of Gαi3 fused to an importation sequence (ALL1) as a selective inhibitor of Gi3 signaling, we show that by coupling to Gi3, the A3R stimulates multiple signaling pathways in human mast cells, leading to upregulation of cytokines, chemokines and growth factors.Following contact with activated T cell membranes, endogenous adenosine binds to and activates the A3R, resulting in Gi3-mediated signaling. Specifically, the majority of ERK1/2 signaling initiated by contact with activated T cell membranes, is mediated by Gi3, giving rise to ALL1-inhibitable cellular responses. These results unveil the physiological GPCR that couples to Gi3 and establish the important role played by this G-protein in inflammatory conditions that involve adenosine-activated mast cells. We used microarrays to detail the effect of ALL1 on gene expression of HMC-1 cells activated directly by the A3 receptor, or by contact with activated T cell membranes.					283659	10870	23495	83706	7305	57333	567	220323	4647	1396	1520	55332	3071	54949	826	1522	338811	2771	2395	10855	167153	3659	2175	5480	3932	23236	9637	6150	9781	51393	4689	441168	9002	23062	26469	2778	29926	161	1211	257106	92610	64005	3903	80830	3101	3910	284297	79895	55830	5118	399948	715	9897	649446	246243	8706	23621	56265	1075	3455	10537	714	4811	83661	5919	51614	58472	84692	123	1486	9509	66005	2882	80381	2634	199	645	9695	79585	4542	83982	4245	6594	2588	27147	64115	85360	1291	641700	4351	55022	6993	51186	9902	63940	54440	124565	713	80023	7405	327	91937	55911	6915	29887	23179	4063	170384	22803	4046	4013	389203	7040	100	10094	84433	317649	1281	7094	578	12	284111	2042	25992	414328	3108	64231	1510	834	3992	339122	3672	6772	3572	57085	10681	4283	2878	116039	91442	84634	57094	3077	5031	23643	2281	1290	7076	79618	30008	56990	6556	27248	3684	27293	54331	54958	656	9672	3394	710	11092	2059	28966	10723	5698	2824	387700	497189	10418	170954	976	1912	4005	6259	644	3092	9338	3233	8828	388646	8038	6392	1634	150372	3920	2078	721	349667	26272	100506742	57020	6404	283130	397	93035	10289	4060	115273	5406
GSE19888_CTRL_VS_T_CELL_MEMBRANES_ACT_MAST_CELL_DN	M7334		20190146	Baram D,Dekel O,Mekori YA,Sagi-Eisenberg R	GSE19888	GSE19888_3595_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in HMC-1 (mast leukemia) cells: untreated versus stimulated with T cell membranes.	We demonstrate that the G protein Gi3 is the cellular target of the adenosine A3 receptor (A3R). By using a cell permeable peptide comprising the C-terminal end of Gαi3 fused to an importation sequence (ALL1) as a selective inhibitor of Gi3 signaling, we show that by coupling to Gi3, the A3R stimulates multiple signaling pathways in human mast cells, leading to upregulation of cytokines, chemokines and growth factors.Following contact with activated T cell membranes, endogenous adenosine binds to and activates the A3R, resulting in Gi3-mediated signaling. Specifically, the majority of ERK1/2 signaling initiated by contact with activated T cell membranes, is mediated by Gi3, giving rise to ALL1-inhibitable cellular responses. These results unveil the physiological GPCR that couples to Gi3 and establish the important role played by this G-protein in inflammatory conditions that involve adenosine-activated mast cells. We used microarrays to detail the effect of ALL1 on gene expression of HMC-1 cells activated directly by the A3 receptor, or by contact with activated T cell membranes.					79772	1747	50488	56675	84962	9147	84722	3606	5362	2651	85366	4133	1825	8796	55512	644815	2810	57549	7851	22903	79071	1534	10205	5753	57537	4719	9721	9278	10903	23443	79671	153562	26098	127534	64393	114907	57447	84891	4620	150696	2263	9240	87	4863	8440	79977	149466	23593	5825	23541	7347	9455	6713	93099	149708	6692	23143	51167	389337	5583	257068	159195	80004	51321	10221	284486	54602	2709	51095	10842	9150	23624	5639	23481	3400	121551	64781	6942	9258	5493	10765	118672	79183	11034	53836	26064	57127	54629	64236	5875	142686	11012	65056	6382	389208	1041	5814	5028	6142	5532	60560	440275	9022	29950	4014	252995	81566	6815	5317	84283	79919	81545	2886	51447	92196	6532	54872	26084	688	90204	148808	9730	27243	4898	51128	55727	153769	874	3070	56997	5774	5268	3858	3552	9545	6416	148	23682	29899	1828	376940	5037	80349	85369	4902	10928	80153	80198	242	79784	2065	79917	4851	57822	9372	81573	253959	6498	79034	366	6597	85364	85377	26751	11073	1159	57402	8493	56910	3945	7566	25818	643414	154141	55805	390275	23120	3202	10845	4792	10252	286077	4048	9736	79815	149473	89778	135228	374	3655	55796	255189	26499	273	55353	26100	51247	196264	643338
GSE19888_CTRL_VS_TCELL_MEMBRANES_ACT_MAST_CELL_PRETREAT_A3R_INH_UP	M7335		20190146	Baram D,Dekel O,Mekori YA,Sagi-Eisenberg R	GSE19888	GSE19888_3596_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in HMC-1 (mast leukemia) cells: untreated versus incubated with the peptide ALL1 followed by stimulation with T cell membranes.	We demonstrate that the G protein Gi3 is the cellular target of the adenosine A3 receptor (A3R). By using a cell permeable peptide comprising the C-terminal end of Gαi3 fused to an importation sequence (ALL1) as a selective inhibitor of Gi3 signaling, we show that by coupling to Gi3, the A3R stimulates multiple signaling pathways in human mast cells, leading to upregulation of cytokines, chemokines and growth factors.Following contact with activated T cell membranes, endogenous adenosine binds to and activates the A3R, resulting in Gi3-mediated signaling. Specifically, the majority of ERK1/2 signaling initiated by contact with activated T cell membranes, is mediated by Gi3, giving rise to ALL1-inhibitable cellular responses. These results unveil the physiological GPCR that couples to Gi3 and establish the important role played by this G-protein in inflammatory conditions that involve adenosine-activated mast cells. We used microarrays to detail the effect of ALL1 on gene expression of HMC-1 cells activated directly by the A3 receptor, or by contact with activated T cell membranes.					134147	1910	57544	148534	339766	9709	8455	957	85480	669	665	54360	136227	178	6414	5569	4711	10060	10527	608	256987	10632	10979	10231	728568	10767	10463	2812	361	9459	55958	26033	51128	254295	64122	23166	10516	781	3026	10965	10352	2662	57181	8991	11309	142	54469	51765	7385	55198	375316	57684	7345	10681	153579	10223	90293	161436	10245	2887	7436	11185	57110	51561	23336	285220	2191	8178	27283	2202	22836	5535	257068	5566	2028	3074	54959	23433	2693	100131439	4122	140578	10434	7072	7092	10350	80055	84376	1436	2335	7267	2327	8789	54752	9603	124404	509	9185	5066	57469	54681	4256	127495	79001	53844	23567	59277	157855	26273	64110	10402	1975	123283	123811	1345	4716	4774	4291	10246	900	84795	84986	10602	55827	9167	131544	8761	79073	6188	57484	83539	54942	9332	10781	3667	23401	5138	28971	339479	130132	79038	57535	1551	8490	5865	5178	51141	7732	55437	10653	657	84153	1876	5818	28977	6480	51188	1491	64327	64123	5406	1287	2057	54014	27286	79816	139728	283212	7419	116362	444	25800	6448	116841	80232	118429	83690	6285	55089	2070	9590	51259	220	7049	1565	51430	56946	57037	23641	114792	6815	367	254956	660	115399	374291	2739	7328	2857	57659
GSE19888_CTRL_VS_TCELL_MEMBRANES_ACT_MAST_CELL_PRETREAT_A3R_INH_DN	M7336		20190146	Baram D,Dekel O,Mekori YA,Sagi-Eisenberg R	GSE19888	GSE19888_3596_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in HMC-1 (mast leukemia) cells: untreated versus incubated with the peptide ALL1 followed by stimulation with T cell membranes.	We demonstrate that the G protein Gi3 is the cellular target of the adenosine A3 receptor (A3R). By using a cell permeable peptide comprising the C-terminal end of Gαi3 fused to an importation sequence (ALL1) as a selective inhibitor of Gi3 signaling, we show that by coupling to Gi3, the A3R stimulates multiple signaling pathways in human mast cells, leading to upregulation of cytokines, chemokines and growth factors.Following contact with activated T cell membranes, endogenous adenosine binds to and activates the A3R, resulting in Gi3-mediated signaling. Specifically, the majority of ERK1/2 signaling initiated by contact with activated T cell membranes, is mediated by Gi3, giving rise to ALL1-inhibitable cellular responses. These results unveil the physiological GPCR that couples to Gi3 and establish the important role played by this G-protein in inflammatory conditions that involve adenosine-activated mast cells. We used microarrays to detail the effect of ALL1 on gene expression of HMC-1 cells activated directly by the A3 receptor, or by contact with activated T cell membranes.					57497	23533	59345	7412	146857	51540	4068	85363	65265	5996	55116	5610	55075	9870	5806	23779	83982	10577	441168	717	6812	29887	8313	3620	22914	6777	51195	5989	8175	5800	7137	3456	10498	54708	3628	3594	3098	347	2124	89886	10410	602	56833	375287	7832	54714	23367	3569	5613	64853	162394	55054	64135	85441	7706	9703	3133	3434	9111	8237	3659	221302	7127	3656	5777	23424	378	10326	79865	7417	7098	3431	26160	57097	3702	9619	255809	4322	10507	27163	2643	51460	4939	29925	3135	103	9034	399	3665	54514	317649	631	6373	25932	54221	78989	90416	23276	51263	129607	340061	57823	83666	51371	6737	151636	23360	84941	84617	4084	9153	144811	1267	971	118788	64222	144699	958	3683	257106	51479	9023	5879	29126	115290	51316	2185	8914	6004	3561	9334	10379	11274	2175	83852	84419	26010	3067	116071	3627	253980	7097	100	1236	684	259307	55106	4790	344807	3001	55601	388646	151651	2841	146722	9673	55683	219972	22974	4938	9683	1633	7318	54103	10964	53840	6773	163590	27063	5919	91543	9399	55034	54625	51246	2896	84166	3600	10320	2358	6347	607	3433	25939	5272	10068	6443	26092	842	2120	23780	2717	11044	64108	3002	6892	56944	219285	3695	339
GSE19888_ADENOSINE_A3R_INH_VS_ACT_IN_MAST_CELL_UP	M7340		20190146	Baram D,Dekel O,Mekori YA,Sagi-Eisenberg R	GSE19888	GSE19888_3597_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in HMC-1 (mast leukemia) cells incubated with: the peptide ALL1 versus Cl-IB-MECA [PubChem=3035850].	We demonstrate that the G protein Gi3 is the cellular target of the adenosine A3 receptor (A3R). By using a cell permeable peptide comprising the C-terminal end of Gαi3 fused to an importation sequence (ALL1) as a selective inhibitor of Gi3 signaling, we show that by coupling to Gi3, the A3R stimulates multiple signaling pathways in human mast cells, leading to upregulation of cytokines, chemokines and growth factors.Following contact with activated T cell membranes, endogenous adenosine binds to and activates the A3R, resulting in Gi3-mediated signaling. Specifically, the majority of ERK1/2 signaling initiated by contact with activated T cell membranes, is mediated by Gi3, giving rise to ALL1-inhibitable cellular responses. These results unveil the physiological GPCR that couples to Gi3 and establish the important role played by this G-protein in inflammatory conditions that involve adenosine-activated mast cells. We used microarrays to detail the effect of ALL1 on gene expression of HMC-1 cells activated directly by the A3 receptor, or by contact with activated T cell membranes.					161882	5865	1113	51278	23286	10458	6309	26020	5529	3755	5888	79805	51025	342898	3300	6599	79661	11336	57111	387893	23199	497661	11017	29915	79873	124245	27044	84958	6302	1455	51116	57549	3054	51019	90007	50626	9798	7965	64854	5318	23382	55765	80004	83460	10714	54969	25974	142891	10867	1116	90639	79029	3159	4685	5594	84279	85365	51807	51022	6938	23138	285282	84962	7922	1388	9141	3954	79933	9875	64319	22981	203228	57673	80055	10691	4616	56478	7799	4296	2063	9055	391059	85378	84000	389827	382	6908	79036	399909	55049	84448	84141	5097	1647	51599	5831	5467	9342	7257	3726	1760	51188	25820	54439	113452	4696	84552	10314	8266	11116	10769	84316	120071	11135	388552	10189	6860	29028	29920	692227	79568	3215	2288	83874	56931	2125	25879	64779	152519	91137	390999	4905	1159	84100	84131	51012	79594	85480	3183	51538	54926	7917	6921	8409	91612	5898	92703	4259	3265	10670	375061	54460	1939	57291	54954	3557	59285	112939	79669	4676	3622	7037	283337	84557	84128	8533	9592	51372	84733	29982	55012	139231	55355	26037	79651	22928	5763	9521	284361	11154	29934	57060	55573	9555	134359	90850	53836	23240	134429	129138	29984	219541	256302	11260	8525	57486	23581	51187	59343
GSE19888_ADENOSINE_A3R_INH_VS_ACT_IN_MAST_CELL_DN	M7341		20190146	Baram D,Dekel O,Mekori YA,Sagi-Eisenberg R	GSE19888	GSE19888_3597_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in HMC-1 (mast leukemia) cells incubated with: the peptide ALL1 versus Cl-IB-MECA [PubChem=3035850].	We demonstrate that the G protein Gi3 is the cellular target of the adenosine A3 receptor (A3R). By using a cell permeable peptide comprising the C-terminal end of Gαi3 fused to an importation sequence (ALL1) as a selective inhibitor of Gi3 signaling, we show that by coupling to Gi3, the A3R stimulates multiple signaling pathways in human mast cells, leading to upregulation of cytokines, chemokines and growth factors.Following contact with activated T cell membranes, endogenous adenosine binds to and activates the A3R, resulting in Gi3-mediated signaling. Specifically, the majority of ERK1/2 signaling initiated by contact with activated T cell membranes, is mediated by Gi3, giving rise to ALL1-inhibitable cellular responses. These results unveil the physiological GPCR that couples to Gi3 and establish the important role played by this G-protein in inflammatory conditions that involve adenosine-activated mast cells. We used microarrays to detail the effect of ALL1 on gene expression of HMC-1 cells activated directly by the A3 receptor, or by contact with activated T cell membranes.					27147	51209	124961	100506742	55281	64853	2790	5311	6991	64129	92610	80000	22995	3708	93649	9363	54431	10712	284541	221472	3645	4257	54959	83661	255104	7007	283197	637	220004	388381	390667	22915	2934	4013	94233	7454	116085	59067	10003	312	10673	374470	127733	8110	7216	3105	729230	7318	7038	3433	7498	54558	2201	3561	27152	4998	10871	5864	51347	959	57644	25894	91012	3290	684	10327	128553	353497	59345	29956	4638	146722	60526	441168	7450	4774	25959	1102	284194	1571	51316	5173	135112	100499435	80168	50632	8875	1993	125972	1356	10978	23683	160492	8698	10410	167410	283596	84627	6102	80830	7276	8029	5791	3394	5066	2324	2957	1675	57169	25	84912	2214	145957	683	3067	92211	1593	55196	4061	154881	587	285852	139716	11277	163351	57705	3382	27241	8835	56833	3077	8825	4772	2628	7263	340061	151126	388646	1821	79814	9246	127018	1015	3676	4942	29985	64211	3695	84501	63976	51246	117248	55843	55500	26034	55345	57674	9934	26471	646019	5409	5367	3437	254263	54625	56951	1690	3659	6850	64421	51156	1794	6999	717	5699	115361	2799	23424	9173	6039	55041	10875	219972	10933	57628	3512	2824	7920	114787	10022	222171	2634	10220	1238	22852	2159	113791	11130	321	26038
GSE19888_ADENOSINE_A3R_INH_VS_INH_PRETREAT_AND_ACT_WITH_TCELL_MEMBRANES_MAST_CELL_UP	M7342		20190146	Baram D,Dekel O,Mekori YA,Sagi-Eisenberg R	GSE19888	GSE19888_3600_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in HMC-1 (mast leukemia) cells incubated with the peptide ALL1 versus those then stimulated by T cell membranes.	We demonstrate that the G protein Gi3 is the cellular target of the adenosine A3 receptor (A3R). By using a cell permeable peptide comprising the C-terminal end of Gαi3 fused to an importation sequence (ALL1) as a selective inhibitor of Gi3 signaling, we show that by coupling to Gi3, the A3R stimulates multiple signaling pathways in human mast cells, leading to upregulation of cytokines, chemokines and growth factors.Following contact with activated T cell membranes, endogenous adenosine binds to and activates the A3R, resulting in Gi3-mediated signaling. Specifically, the majority of ERK1/2 signaling initiated by contact with activated T cell membranes, is mediated by Gi3, giving rise to ALL1-inhibitable cellular responses. These results unveil the physiological GPCR that couples to Gi3 and establish the important role played by this G-protein in inflammatory conditions that involve adenosine-activated mast cells. We used microarrays to detail the effect of ALL1 on gene expression of HMC-1 cells activated directly by the A3 receptor, or by contact with activated T cell membranes.					187	57674	4524	375444	55450	57602	163351	389362	151636	4628	55971	7726	790955	56203	11274	56922	23042	10404	79701	3122	23171	10630	9882	83875	83982	64108	6039	30835	344595	9931	4939	23167	3600	392636	22919	23395	11238	51635	153768	1690	10955	91543	10396	2004	81621	51029	64102	5218	439996	5892	1666	149345	91012	79677	4283	219749	80310	84624	2313	23530	23204	5538	26137	92370	9451	6617	91894	837	10000	56606	134147	23275	6773	23600	2028	9487	84792	3960	79827	23604	170384	53829	2631	22897	64092	219285	3659	54933	404636	90488	10459	2944	11315	2184	6495	9358	3055	389203	255758	23586	11142	6318	80777	25854	388815	79587	22918	388646	23556	345611	9338	55623	6924	2124	440689	8829	10329	92840	64761	2324	22836	84272	60558	3454	463	84910	81035	58472	834	55355	79770	2978	55110	26471	84327	10981	79627	3394	84516	22845	54462	5157	54625	117289	4897	2581	255252	3234	2799	8340	3992	64222	164091	79633	729440	10345	7108	2131	27005	23066	127829	51768	54629	27349	1571	90293	7138	9636	10742	64231	4938	54431	55322	55704	22862	9590	10979	1998	8483	3340	134145	25998	90268	4705	57590	28966	1555	115361	441054	55033	112849	25900	1774	4126	3421	54681	10964	54434	7010	23483
GSE19888_ADENOSINE_A3R_INH_VS_INH_PRETREAT_AND_ACT_WITH_TCELL_MEMBRANES_MAST_CELL_DN	M7345		20190146	Baram D,Dekel O,Mekori YA,Sagi-Eisenberg R	GSE19888	GSE19888_3600_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in HMC-1 (mast leukemia) cells incubated with the peptide ALL1 versus those then stimulated by T cell membranes.	We demonstrate that the G protein Gi3 is the cellular target of the adenosine A3 receptor (A3R). By using a cell permeable peptide comprising the C-terminal end of Gαi3 fused to an importation sequence (ALL1) as a selective inhibitor of Gi3 signaling, we show that by coupling to Gi3, the A3R stimulates multiple signaling pathways in human mast cells, leading to upregulation of cytokines, chemokines and growth factors.Following contact with activated T cell membranes, endogenous adenosine binds to and activates the A3R, resulting in Gi3-mediated signaling. Specifically, the majority of ERK1/2 signaling initiated by contact with activated T cell membranes, is mediated by Gi3, giving rise to ALL1-inhibitable cellular responses. These results unveil the physiological GPCR that couples to Gi3 and establish the important role played by this G-protein in inflammatory conditions that involve adenosine-activated mast cells. We used microarrays to detail the effect of ALL1 on gene expression of HMC-1 cells activated directly by the A3 receptor, or by contact with activated T cell membranes.					5260	115584	221749	55082	131474	2047	474381	5650	79153	79672	255967	8826	1824	3514	10562	1288	145376	57677	60481	81615	85377	55558	116135	2554	27106	483	27283	2155	7299	6189	89778	5799	7783	390760	84251	127254	221468	10625	481	10047	345079	1477	54544	93035	139735	317705	80728	2590	3592	148398	1847	160857	80775	8875	4642	130560	100507656	80339	51209	6860	137835	6338	51171	1602	1361	8435	90316	128209	55061	7204	84518	200010	23341	92822	30820	25777	85016	5630	3106	8858	134637	389333	6157	6847	6634	26027	120406	57127	3653	11145	10383	123264	116085	27345	5435	51176	22993	728588	79628	55184	6565	81832	54827	6337	827	11170	100130613	1996	619373	640	114805	53841	78991	11249	221833	3426	29851	57495	340205	3788	5066	63976	51179	64699	1676	636	729614	4072	7015	57524	29850	54531	7448	9313	5651	92359	150946	147381	118812	2114	79651	127018	51013	55532	154288	1154	23440	2798	6382	142680	54682	4759	2257	8973	64858	118426	25803	5075	57575	163479	390442	7103	3748	84103	57402	58158	11014	134111	50674	15	153328	2981	23467	84172	27091	7512	3174	7439	84962	928	128025	30845	9881	8287	27299	83931	100129924	29114	6573	222662	340168	50604	120939	646424	7087	10953	6582	3567	54207	2568
GSE19888_NO_PRETREAT_VS_ADENOSINE_A3R_INHIBITOR_PRETREATED_MAST_CELL_TCELL_MEMBRANES_ACT_DN	M7347		20190146	Baram D,Dekel O,Mekori YA,Sagi-Eisenberg R	GSE19888	GSE19888_3606_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in HMC-1 (mast leukemia) cells: stimulated with T cell membranes versus incubated with the peptide ALL1 and then stimulated with T cell membranes.	We demonstrate that the G protein Gi3 is the cellular target of the adenosine A3 receptor (A3R). By using a cell permeable peptide comprising the C-terminal end of Gαi3 fused to an importation sequence (ALL1) as a selective inhibitor of Gi3 signaling, we show that by coupling to Gi3, the A3R stimulates multiple signaling pathways in human mast cells, leading to upregulation of cytokines, chemokines and growth factors.Following contact with activated T cell membranes, endogenous adenosine binds to and activates the A3R, resulting in Gi3-mediated signaling. Specifically, the majority of ERK1/2 signaling initiated by contact with activated T cell membranes, is mediated by Gi3, giving rise to ALL1-inhibitable cellular responses. These results unveil the physiological GPCR that couples to Gi3 and establish the important role played by this G-protein in inflammatory conditions that involve adenosine-activated mast cells. We used microarrays to detail the effect of ALL1 on gene expression of HMC-1 cells activated directly by the A3 receptor, or by contact with activated T cell membranes.					5376	392	119032	1719	257106	2878	3588	23395	10726	22893	1486	55173	401466	51389	79607	3087	84640	51654	3684	399664	5480	50	6608	9639	79567	11068	51263	2896	5898	3135	79145	4354	2995	2281	4060	84693	342897	127687	3600	9334	9636	127281	57210	11244	4695	4338	5217	254863	4076	51177	10884	85415	196500	837	255809	10135	10138	55664	313	203547	8648	100131755	56034	53339	81030	10926	29922	57001	9842	11130	10081	152518	57674	221120	11274	4782	118472	3454	6624	2786	1716	375287	834	64135	8510	387521	25925	54840	439996	54953	79693	55832	55313	84267	56922	55830	5305	79627	55591	60625	493856	3241	64924	79027	55325	57665	56647	55129	84922	5393	10229	2768	84861	4692	971	339324	11117	5303	8829	3340	11234	23476	403313	1003	81890	92105	54899	22998	84317	219927	3843	3437	5464	93663	113277	317	66005	84279	29982	25809	10536	10248	8575	57226	5756	23595	84288	28962	51264	51251	7112	28977	81554	2824	80823	54879	148932	9820	11142	10283	22862	30833	26574	80347	221302	6423	2036	6453	121260	2209	92610	84661	1638	144110	84282	55454	8872	7837	55668	3954	10969	91039	5788	65998	6404	55122	129804	692227	144577	84328	2099	22897	2487	55681	84262	3632	112495	22919	148789	2123
GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_DN	M7350		20190146	Baram D,Dekel O,Mekori YA,Sagi-Eisenberg R	GSE19888	GSE19888_3599_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in HMC-1 (mast leukemia) cells: incubated with the peptide ALL1 versus stimulated with T cell membranes.	We demonstrate that the G protein Gi3 is the cellular target of the adenosine A3 receptor (A3R). By using a cell permeable peptide comprising the C-terminal end of Gαi3 fused to an importation sequence (ALL1) as a selective inhibitor of Gi3 signaling, we show that by coupling to Gi3, the A3R stimulates multiple signaling pathways in human mast cells, leading to upregulation of cytokines, chemokines and growth factors.Following contact with activated T cell membranes, endogenous adenosine binds to and activates the A3R, resulting in Gi3-mediated signaling. Specifically, the majority of ERK1/2 signaling initiated by contact with activated T cell membranes, is mediated by Gi3, giving rise to ALL1-inhibitable cellular responses. These results unveil the physiological GPCR that couples to Gi3 and establish the important role played by this G-protein in inflammatory conditions that involve adenosine-activated mast cells. We used microarrays to detail the effect of ALL1 on gene expression of HMC-1 cells activated directly by the A3 receptor, or by contact with activated T cell membranes.					4948	1557	10786	2567	23229	23039	7408	1621	494551	4318	5451	5066	81832	84620	57541	23386	11194	4779	84962	51700	80339	55139	9956	284541	1996	57153	550631	9877	2261	23624	54797	5317	151871	22953	134637	5409	5358	11113	57402	2690	389941	25861	5075	64866	3157	6208	150356	5928	151354	117532	1894	114908	80816	3187	770	3756	1642	6603	10227	91775	51531	1826	353131	56923	4711	79616	54768	6000	90025	375	345079	55319	57447	6518	4772	1310	645832	389161	283459	171169	150468	22870	207	28969	9573	54539	9413	81794	3191	220047	401647	8351	636	8626	57471	3426	9899	114026	115749	55020	4998	7536	57057	81	9881	1832	774	79363	91608	158219	546	154881	2570	9061	7477	3797	26227	9219	256472	160857	1984	6210	1654	9020	5818	79800	9520	7293	3062	127579	7755	147837	4139	64423	1419	143458	284307	92304	10220	199675	85444	2946	10155	1821	57537	5746	147912	90780	54676	23092	167410	2531	8125	340990	478	4852	137835	9027	11250	55095	6736	11248	729627	92714	341640	3887	2560	56675	79789	6141	6002	8629	283131	6746	23208	79676	20	5729	126626	729756	1676	50488	8399	728656	4534	79901	79187	27092	3487	221443	9844	9524	55558	23650	85377	2195	10005	2636	7258	51433
GSE19888_CTRL_VS_A3R_ACT_TREATED_MAST_CELL_PRETREATED_WITH_A3R_INH_DN	M7351		20190146	Baram D,Dekel O,Mekori YA,Sagi-Eisenberg R	GSE19888	GSE19888_3594_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in HMC-1 (mast leukemia) cells: untreated versus incubated with the peptide ALL1 followed by treatment with Cl-IB-MECA [PubChem=3035850].	We demonstrate that the G protein Gi3 is the cellular target of the adenosine A3 receptor (A3R). By using a cell permeable peptide comprising the C-terminal end of Gαi3 fused to an importation sequence (ALL1) as a selective inhibitor of Gi3 signaling, we show that by coupling to Gi3, the A3R stimulates multiple signaling pathways in human mast cells, leading to upregulation of cytokines, chemokines and growth factors.Following contact with activated T cell membranes, endogenous adenosine binds to and activates the A3R, resulting in Gi3-mediated signaling. Specifically, the majority of ERK1/2 signaling initiated by contact with activated T cell membranes, is mediated by Gi3, giving rise to ALL1-inhibitable cellular responses. These results unveil the physiological GPCR that couples to Gi3 and establish the important role played by this G-protein in inflammatory conditions that involve adenosine-activated mast cells. We used microarrays to detail the effect of ALL1 on gene expression of HMC-1 cells activated directly by the A3 receptor, or by contact with activated T cell membranes.					66008	23396	7283	4841	4604	22879	79791	27122	124842	5959	84878	57194	6369	4595	5564	57026	4704	84871	65980	84705	146712	54752	10174	23729	1741	8549	54443	144165	54918	28962	170463	2597	56925	341032	411	286257	54784	7805	57407	1486	9049	2859	55009	1389	92689	23287	4729	219654	23389	2907	9735	5244	9675	8076	1234	3142	253782	57473	64750	25966	23199	3425	51196	318	4733	51043	60626	84938	9061	203522	4259	4064	117581	4802	253012	392275	126526	4214	2769	6181	489	80097	2588	23265	6237	285704	1506	23463	79713	1264	353116	81794	8260	26259	8685	732	27429	81628	26160	341346	11254	27039	85019	113655	55471	170371	8558	53344	4493	84912	11060	221504	51741	2658	84888	7298	6647	4820	1196	10495	23301	363	84529	57107	29035	26275	80230	124872	1605	23452	3693	8871	412	898	7455	7335	643549	23214	6342	57102	10957	159090	10870	54477	9482	6038	94059	8837	28991	4756	92106	59067	5019	3489	64777	57573	201191	55644	55135	163154	80821	1230	163882	55051	51319	4926	79991	142680	22914	7099	2166	51239	84315	26999	3217	3797	23417	9153	2567	258010	7136	6041	152579	10620	23332	283692	24148	9332	64770	1510	8439	113174	54956	8295	148252	51310	9117	4237	147968	51175
GSE19888_CTRL_VS_T_CELL_MEMBRANES_ACT_MAST_CELL_UP	M7352		20190146	Baram D,Dekel O,Mekori YA,Sagi-Eisenberg R	GSE19888	GSE19888_3595_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in HMC-1 (mast leukemia) cells: untreated versus stimulated with T cell membranes.	We demonstrate that the G protein Gi3 is the cellular target of the adenosine A3 receptor (A3R). By using a cell permeable peptide comprising the C-terminal end of Gαi3 fused to an importation sequence (ALL1) as a selective inhibitor of Gi3 signaling, we show that by coupling to Gi3, the A3R stimulates multiple signaling pathways in human mast cells, leading to upregulation of cytokines, chemokines and growth factors.Following contact with activated T cell membranes, endogenous adenosine binds to and activates the A3R, resulting in Gi3-mediated signaling. Specifically, the majority of ERK1/2 signaling initiated by contact with activated T cell membranes, is mediated by Gi3, giving rise to ALL1-inhibitable cellular responses. These results unveil the physiological GPCR that couples to Gi3 and establish the important role played by this G-protein in inflammatory conditions that involve adenosine-activated mast cells. We used microarrays to detail the effect of ALL1 on gene expression of HMC-1 cells activated directly by the A3 receptor, or by contact with activated T cell membranes.					26273	5987	6676	1967	116092	11179	677	374986	5250	373	2135	135138	5119	10460	4478	2197	84311	84727	10048	64097	6667	1039	148423	5520	10059	5868	9879	976	27316	54890	26276	27332	57679	115286	8479	55847	118424	79902	10165	5908	10124	1635	2744	64421	54901	285521	2030	9202	5884	51371	64975	25929	7398	26225	285636	51574	3916	60560	260425	6642	25921	728661	158	84557	8694	5160	27336	79018	80146	5000	2617	10213	64114	285282	116447	5170	1201	6936	8883	55300	135	573	9475	8454	56154	147929	10006	84665	9348	115004	1912	7270	79876	125170	760	9530	57696	768211	283489	56339	55454	50	57018	204	6194	29966	56829	51629	57474	25801	57095	55862	11078	159195	8266	121053	9191	11258	567	112840	81887	84301	118490	55269	4703	55975	28987	353131	54891	5187	8790	10055	25972	57380	310	6046	51074	57819	1397	26100	3183	2475	56893	197407	130502	493753	9377	1647	64783	91647	2288	3298	6470	8904	158405	26960	23528	137492	134728	125061	6227	124995	1153	4696	388327	7422	5955	9440	3480	23786	3745	51726	131965	8496	23360	64426	6780	6790	10250	8531	79023	64708	5325	26234	161253	11269	51569	7903	3569	401466	79441	64848	271	3035	201931	624	23228	347240	5706	387
GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_DN	M7353		20190146	Baram D,Dekel O,Mekori YA,Sagi-Eisenberg R	GSE19888	GSE19888_3605_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in HMC-1 (mast leukemia) cells incubated with the peptide ALL1 followed by treatment with: Cl-IB-MECA [PubChem=3035850] versus T cell membranes.	We demonstrate that the G protein Gi3 is the cellular target of the adenosine A3 receptor (A3R). By using a cell permeable peptide comprising the C-terminal end of Gαi3 fused to an importation sequence (ALL1) as a selective inhibitor of Gi3 signaling, we show that by coupling to Gi3, the A3R stimulates multiple signaling pathways in human mast cells, leading to upregulation of cytokines, chemokines and growth factors.Following contact with activated T cell membranes, endogenous adenosine binds to and activates the A3R, resulting in Gi3-mediated signaling. Specifically, the majority of ERK1/2 signaling initiated by contact with activated T cell membranes, is mediated by Gi3, giving rise to ALL1-inhibitable cellular responses. These results unveil the physiological GPCR that couples to Gi3 and establish the important role played by this G-protein in inflammatory conditions that involve adenosine-activated mast cells. We used microarrays to detail the effect of ALL1 on gene expression of HMC-1 cells activated directly by the A3 receptor, or by contact with activated T cell membranes.					64776	2306	85315	11153	8021	3956	5583	6197	148423	4650	5790	5926	92400	9134	3418	57620	89849	6524	5564	57552	255043	5649	4899	839	56172	406	100288695	1665	55094	401251	27161	9637	286257	2317	51319	22834	79441	5424	4848	64332	5937	1654	149986	55	51510	2166	375444	10466	7019	202018	84939	5925	4926	64207	23218	83943	55074	9748	84636	55198	57396	22800	285343	6239	197370	114926	22874	219654	220988	5347	1605	152217	55152	5163	55603	23270	85363	4620	329	142679	6590	7163	84282	8546	3608	152185	23609	1198	53917	4647	10499	54954	10463	55364	6431	53339	1353	9590	64788	90693	2197	4218	4893	54540	79172	3622	5782	80315	400916	22897	841	23179	254042	3425	1859	9501	26235	3977	3142	23659	23466	55148	116534	51379	51205	51192	23351	8076	489	10296	54891	23469	84034	3897	1901	10039	11078	80149	9570	221937	84519	1763	9815	150275	2308	57708	54331	64745	8924	6049	29101	23185	79603	3187	4126	60436	55007	341032	11218	81566	26092	54918	55502	7378	25855	58526	10664	3337	537	374897	125061	26140	29766	3398	10981	54934	9706	22871	3990	157567	64319	84447	92935	9991	23199	166614	29123	9908	253832	23530	6133	9367	255520	142	10455	286410	152006	340152	145173	57654
GSE19888_NO_PRETREAT_VS_ADENOSINE_A3R_INHIBITOR_PRETREATED_MAST_CELL_TCELL_MEMBRANES_ACT_UP	M7354		20190146	Baram D,Dekel O,Mekori YA,Sagi-Eisenberg R	GSE19888	GSE19888_3606_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in HMC-1 (mast leukemia) cells: stimulated with T cell membranes versus incubated with the peptide ALL1 and then stimulated with T cell membranes.	We demonstrate that the G protein Gi3 is the cellular target of the adenosine A3 receptor (A3R). By using a cell permeable peptide comprising the C-terminal end of Gαi3 fused to an importation sequence (ALL1) as a selective inhibitor of Gi3 signaling, we show that by coupling to Gi3, the A3R stimulates multiple signaling pathways in human mast cells, leading to upregulation of cytokines, chemokines and growth factors.Following contact with activated T cell membranes, endogenous adenosine binds to and activates the A3R, resulting in Gi3-mediated signaling. Specifically, the majority of ERK1/2 signaling initiated by contact with activated T cell membranes, is mediated by Gi3, giving rise to ALL1-inhibitable cellular responses. These results unveil the physiological GPCR that couples to Gi3 and establish the important role played by this G-protein in inflammatory conditions that involve adenosine-activated mast cells. We used microarrays to detail the effect of ALL1 on gene expression of HMC-1 cells activated directly by the A3 receptor, or by contact with activated T cell membranes.					659	57095	155368	89782	5987	131566	79842	10497	31	3183	25807	84818	83862	4267	8310	1486	23191	2237	23256	8910	10660	79959	80095	10298	79722	81688	57198	55748	5985	147040	6817	153562	148014	54965	203547	84935	79609	23212	3902	10295	123970	27005	653	10749	135	54751	285367	641638	81831	26284	83451	3581	1798	1268	128	28971	3607	2339	9527	51601	8074	115817	8852	7284	55216	8502	1635	4493	6047	25891	84057	8078	55621	8453	1628	54939	10005	63826	9013	54870	624	6483	8193	2135	83700	51264	6391	23512	7517	741	84727	10063	164832	90362	7365	3633	2034	3036	10577	11315	83940	10412	2539	284352	84649	991	57486	64951	6749	7016	51079	23051	2538	161424	200205	4975	8045	396	1201	51260	3911	60493	286053	23317	23220	4548	51253	126119	51366	2158	57291	51202	10436	51096	6523	81621	646174	8726	2850	54585	350	3182	6633	401097	65057	2762	51167	92140	128439	83468	5140	80028	51250	871	5071	222234	57820	207063	221002	58506	26097	684	55617	9477	23165	79858	10526	8029	388125	10650	3559	6566	51125	54790	338811	199964	26060	26259	339344	84665	115106	55308	8467	54543	91419	59344	56648	1912	257415	340419	54487	10098	3099	4350	7494	55238	138428	1431	3300	23385
GSE20198_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_DN	M7361		20304822	Filén S,Ylikoski E,Tripathi S,West A,Björkman M,Nyström J,Ahlfors H,Coffey E,Rao KV,Rasool O,Lahesmaa R	GSE20198	GSE20198_2508_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in the activated CD4 [GeneID=920] T cells (48h): control versus IL-12.	The aim of this study was to identify genes regulated by IL-12, IL-18 and IFN-alpha during early differentiation of human Th1 cells					10735	163087	80319	29940	613	23500	118980	8464	9886	8128	65979	5654	9726	83606	26122	8674	6202	8909	65992	5179	253558	4733	9682	1389	646498	7381	26034	4306	55128	6911	654429	388646	408	5832	64132	10298	7187	57498	7132	9637	515	222658	9236	85019	2548	54477	100128071	111	84078	27163	5889	51006	253012	100131496	6468	79772	84993	124626	23285	8458	5293	171169	23008	55824	27043	29985	55231	27294	5019	140679	1633	1184	283234	11099	726	4598	28971	56006	11073	8493	8575	55106	4782	57605	54762	3705	57489	79109	3690	54507	5934	348235	6545	79364	7283	116840	55729	2015	54619	4800	4756	55780	255520	898	7097	85315	10730	2937	79567	3621	166785	2044	10098	10219	22907	22839	64840	7357	90550	5611	57549	440093	50809	754	72	4292	153768	283927	3897	2306	2800	55333	80318	25943	1822	10314	222643	29988	25913	374868	84167	4005	57513	8924	10495	80263	2826	54970	53829	55356	6596	79892	85365	50515	114794	29957	57704	9380	55031	4208	4548	157680	4221	4145	54795	5609	202	219855	8445	22847	79613	3141	79171	11328	59339	1269	387882	6284	1819	8693	26298	2767	159013	79956	2793	146712	79064	3092	7410	1730	26033	55872	6523	192668	27	57690	6693	55846	2335	375035
GSE20198_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_UP	M7365		20304822	Filén S,Ylikoski E,Tripathi S,West A,Björkman M,Nyström J,Ahlfors H,Coffey E,Rao KV,Rasool O,Lahesmaa R	GSE20198	GSE20198_2508_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in the activated CD4 [GeneID=920] T cells (48h): control versus IL-12.	The aim of this study was to identify genes regulated by IL-12, IL-18 and IFN-alpha during early differentiation of human Th1 cells					1632	659	153562	401397	117246	29093	9656	79142	7873	9659	79086	29986	51430	285704	10845	55758	839	83892	79846	10611	10058	310	7091	29952	9943	27067	7109	54968	6230	8790	23326	25782	9969	10535	51078	55454	374395	10885	5926	1579	63877	375444	2517	23130	23269	55610	85476	50813	222223	10663	219541	79691	57157	5723	196463	1960	976	55825	79581	374986	5910	55746	54973	2243	10592	55677	3516	55166	5879	6676	6095	93487	23246	51138	10152	29911	64978	91687	55152	51726	6934	8672	80007	11161	6921	92597	55709	2358	153222	84146	4033	9742	5216	7508	91875	25929	3557	129852	84376	65993	147929	51463	996	84933	29925	79002	9662	90025	22882	2683	3916	1452	10539	65977	22878	388381	7016	27306	10465	84312	11231	5576	89970	5955	51663	1660	51651	25940	23028	1021	84272	57665	134553	2547	83891	57720	9474	10640	348	10229	8505	9343	4194	8531	54802	23595	5710	81567	55081	8841	57062	154043	345757	8453	2921	79692	23521	51496	3123	9829	195827	114294	56616	10063	84572	9475	10552	55216	9014	6839	27440	79027	11269	65057	55860	25934	79893	137695	2762	7841	51696	55840	79836	27348	10459	149478	2322	3014	9694	51752	22848	80142	285605	133418	84267	23210	8202	29889	5833	54529
GSE20198_UNTREATED_VS_IFNA_TREATED_ACT_CD4_TCELL_UP	M7366		20304822	Filén S,Ylikoski E,Tripathi S,West A,Björkman M,Nyström J,Ahlfors H,Coffey E,Rao KV,Rasool O,Lahesmaa R	GSE20198	GSE20198_2510_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in the activated CD4 [GeneID=920] T cells (48h): control versus interferon alpha.	The aim of this study was to identify genes regulated by IL-12, IL-18 and IFN-alpha during early differentiation of human Th1 cells					50808	124454	768	8904	158135	57026	84498	375387	85019	5335	54954	64342	9851	51366	9320	23285	8651	7187	283991	10865	8128	10633	117177	9922	1302	2213	2145	6272	3849	55028	55972	200734	9139	283659	6772	27143	91746	9637	55683	81693	93107	253959	5580	55691	643866	57636	54662	7069	9768	57654	143384	1572	220064	56895	64755	6464	9951	79903	51684	126308	23137	1384	9963	91663	205	83932	94059	84692	5066	831	64759	55503	4802	26286	2553	55229	54784	10965	80380	55020	27153	824	25822	57678	26298	66005	79863	3017	2872	25989	729515	26024	2907	8905	2591	3232	7297	64750	55051	64093	116983	64132	150275	9580	4921	6340	5269	131583	3290	92305	64428	153020	55183	100093630	9153	79634	5458	56903	142678	5832	29851	9712	64137	3398	7874	219402	389072	257106	994	51192	265	1524	64118	151050	27102	1655	9697	11261	147700	80853	25789	115939	9394	6768	84174	9409	23246	116534	57560	201895	604	5993	3508	5511	5733	140767	2548	5618	26011	57446	54328	85414	171169	5608	148423	955	2348	9611	55364	2162	54929	56124	8314	133522	29966	151556	51592	1287	4744	3936	55311	84913	79171	3601	80221	10966	8729	5518	10043	5308	4723	54896	54495	474381	7791	7732	124872	222865	29906	10683
GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_UP	M7367		20304822	Filén S,Ylikoski E,Tripathi S,West A,Björkman M,Nyström J,Ahlfors H,Coffey E,Rao KV,Rasool O,Lahesmaa R	GSE20198	GSE20198_2512_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in the activated CD4 [GeneID=920] T cells (48h): IL-12 versus interferon alpha.	The aim of this study was to identify genes regulated by IL-12, IL-18 and IFN-alpha during early differentiation of human Th1 cells					11167	56648	153562	2745	3720	83544	23065	7157	84312	8509	7844	55775	23028	6016	4733	63943	80095	4683	136647	10678	253782	10434	147798	5393	80007	83475	23598	2990	90355	440730	55505	55850	51389	6601	81554	23398	85476	55760	64801	91404	55968	64418	51	10528	51776	122786	255758	221937	92345	2932	401466	169714	84955	10938	119504	2358	54785	6141	83862	79596	5007	55146	8841	1452	80145	81932	9557	55593	79086	5244	23548	51529	29066	79902	10755	26191	51752	159371	55848	55066	25804	143187	84146	1398	55081	84188	29085	29093	996	2530	54957	115286	5878	10847	8464	54915	126382	400673	1660	1491	65057	2065	192286	56893	23167	51663	133308	9807	6814	57149	80173	23409	54890	4591	60558	5877	55835	340481	4694	388588	1029	65080	11182	392	56181	55698	3268	339448	7265	53938	8504	9352	493911	3831	56915	83939	65264	6574	51703	8263	10465	79918	9863	29986	84984	56623	6341	79137	55054	51076	26959	147015	92342	9274	7091	9796	26521	254359	4515	29087	57189	51154	9553	4047	6122	55437	54883	641	2742	78987	80142	55111	283742	1974	84128	27173	6775	643549	4735	134359	199692	9837	3187	10014	1611	199857	26260	51074	5439	8662	22809	55150	9480	348793	1025	1355	6721	5947	131601	84696
GSE20198_IL12_IL18_VS_IFNA_TREATED_ACT_CD4_TCELL_DN	M7369		20304822	Filén S,Ylikoski E,Tripathi S,West A,Björkman M,Nyström J,Ahlfors H,Coffey E,Rao KV,Rasool O,Lahesmaa R	GSE20198	GSE20198_2513_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in the activated CD4 [GeneID=920] T cells (48h): IL-12 and IL18 [GeneID=3606] versus interferon alpha.	The aim of this study was to identify genes regulated by IL-12, IL-18 and IFN-alpha during early differentiation of human Th1 cells					6584	6729	894	373	5987	131583	730094	6829	65250	6775	4214	10280	22888	2258	79609	3299	54890	9768	79683	145957	102	10016	387509	51340	81555	7553	55920	6651	10938	1977	29982	10890	22884	9136	9252	115004	158046	4000	2296	26276	8763	57122	388796	4802	3716	51554	54918	5519	11269	56992	55835	65977	55746	22906	63877	26136	9440	10847	100288797	3747	5971	1647	158866	10015	60509	10424	25897	84061	9650	64841	58476	55636	51230	54802	1633	55584	10137	23286	51455	92	51491	200734	3559	7465	342898	80863	6934	58513	6510	137695	56902	768211	23636	4642	27291	59352	375341	100507444	6643	10460	23269	92344	152405	79034	54834	6232	5516	80742	57050	10527	728591	26994	79711	54552	169714	9512	7286	79865	90121	79142	23424	7052	49854	10159	128218	1638	56244	114804	79852	890	4670	55216	55759	23300	25854	4775	6950	5885	27352	56154	24144	55082	7016	8726	54531	55823	51067	5955	81875	6774	22800	54850	9869	3067	947	80820	6614	9673	345757	55916	51696	4205	26228	158135	6839	705	3601	84975	8644	29080	3419	54941	64801	9229	55561	54851	25851	406	2841	57696	29761	29078	51	3376	128486	26191	117581	284406	79884	9782	51000	146923	811	51030	285636	8666	8568	389421	55041
GSE20198_IL12_IL18_VS_IFNA_TREATED_ACT_CD4_TCELL_UP	M7370		20304822	Filén S,Ylikoski E,Tripathi S,West A,Björkman M,Nyström J,Ahlfors H,Coffey E,Rao KV,Rasool O,Lahesmaa R	GSE20198	GSE20198_2513_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in the activated CD4 [GeneID=920] T cells (48h): IL-12 and IL18 [GeneID=3606] versus interferon alpha.	The aim of this study was to identify genes regulated by IL-12, IL-18 and IFN-alpha during early differentiation of human Th1 cells					3956	153642	7070	27109	125150	118980	57095	10465	10363	5438	1595	79364	92797	80095	153527	55146	64895	2745	63891	23214	26260	60560	3633	114836	83594	401397	130162	51380	5580	10930	10267	4086	535	23217	51194	56935	8514	54662	56912	84071	23152	4976	6291	3992	55128	131601	27236	23193	8208	9697	51765	253714	1632	54431	9139	9675	9447	57380	51463	2563	64098	55906	148304	285367	51540	55213	181	10771	85025	6122	9351	121665	5425	59269	55794	6949	5790	4784	143686	339448	57129	5188	1491	55005	84935	675	11331	3797	7345	58506	84674	147040	78994	3420	9920	6688	200933	56915	2762	400629	9815	81894	23582	80173	196463	54477	90933	7376	8909	5589	599	6532	10113	51241	138241	1990	51666	8631	121457	10213	84140	340152	255758	57572	2218	7533	221504	26521	647087	60558	274	768	64118	152006	10745	131118	5912	4255	8609	25902	29985	9807	6202	4913	23087	5106	728489	65110	84326	92610	56478	162073	55593	2313	162	6810	51372	23339	57215	81688	14	581	245812	9770	25972	118924	340562	259307	2990	57446	130612	80146	55657	219972	25961	29894	84888	2931	230	6867	79989	5147	5051	10169	51106	6400	152273	10992	10165	6936	8030	55529	114881	79873	84256	113278	152185	58504	5723	8674
GSE20198_IL12_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_DN	M7372		20304822	Filén S,Ylikoski E,Tripathi S,West A,Björkman M,Nyström J,Ahlfors H,Coffey E,Rao KV,Rasool O,Lahesmaa R	GSE20198	GSE20198_2511_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in the activated CD4 [GeneID=920] T cells (48h): IL-12 versus IL-12 and IL18 [GeneID=3606].	The aim of this study was to identify genes regulated by IL-12, IL-18 and IFN-alpha during early differentiation of human Th1 cells					64839	8451	64132	31	1019	51237	51660	55256	55700	55749	80173	79791	23150	65980	9444	338596	92305	3156	5594	171586	1741	66008	8675	23185	3423	7106	26284	8706	4040	1186	293	11167	8395	26065	8458	4899	5244	285343	197131	5611	55274	10947	2907	84188	7109	1510	22884	51274	255043	975	51455	57584	10311	79364	6016	5140	84159	10006	57493	996	1389	7431	159195	3055	6749	54165	26276	57178	6993	11168	9730	7016	374868	57620	402778	60485	960	2821	23180	114883	79153	8603	11214	9055	4155	6142	5229	51426	10955	6612	79572	51118	65977	8543	55847	80004	2767	6133	1844	9879	54101	3295	11073	9120	8836	3265	1536	55696	55824	7257	26260	267	6122	3842	28984	23635	9842	147015	10207	55589	23358	2730	9467	10425	6051	4893	54477	53829	51523	9531	57572	7268	91369	9647	5877	221092	10723	8445	124056	166785	220988	80262	1912	26262	91694	3914	14	1769	1606	9619	4152	5339	25900	56986	1676	5371	83937	9938	3903	754	83892	93487	26145	1105	9117	25998	6814	23529	9476	919	392	4802	8726	9068	11060	1269	9761	5496	58190	169714	64897	55573	55300	138639	56478	6005	256380	5601	84678	80169	5977	7295	1636	4067	23131	10238	55624	4773
GSE20198_UNTREATED_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_DN	M7373		20304822	Filén S,Ylikoski E,Tripathi S,West A,Björkman M,Nyström J,Ahlfors H,Coffey E,Rao KV,Rasool O,Lahesmaa R	GSE20198	GSE20198_2509_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in the activated CD4 [GeneID=920] T cells (48h): control versus IL-12 and IL18 [GeneID=3606].	The aim of this study was to identify genes regulated by IL-12, IL-18 and IFN-alpha during early differentiation of human Th1 cells					200407	100506049	153527	339390	84981	3849	10228	6721	57505	26960	55829	10905	51701	253782	29851	10331	60493	51101	7334	9694	26589	8467	9590	5878	10248	284443	1353	84248	57592	5519	64806	79634	10370	1506	79886	51366	51451	2672	9130	9341	28977	2619	10574	2029	9424	22868	23478	29095	25943	11080	6884	1635	83743	65057	79441	10063	55663	3746	11010	51248	25983	26123	5524	29926	51614	230	51077	79713	79842	10379	9839	57475	93343	5987	285282	85019	10713	23764	25813	10169	10725	85352	4144	80013	112479	124454	285195	3338	27109	10409	10412	84871	55093	4763	4607	84513	85414	7442	80349	9063	84916	79001	149466	221504	54148	55651	10938	3065	1031	51538	10456	79084	4701	51255	200185	10039	79968	55135	84549	65094	165215	55831	5243	221749	57109	4648	4900	50814	90639	11133	100499467	7376	54958	84058	6523	84293	6452	375616	5066	60481	8030	9894	57143	2669	6737	1316	387338	56521	2258	348995	23643	4724	79609	9477	468	100093630	91010	55898	10908	199857	203547	6431	2794	1655	51290	246269	6004	84727	122616	84691	8819	2353	84696	55071	84259	6541	84720	84135	7978	900	23204	5889	1998	9984	2896	4752	10923	26292	90522	29088	1345	51602	26354	708	29888	153562	1236	23308	90550	79798
GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_DN	M7374		20304822	Filén S,Ylikoski E,Tripathi S,West A,Björkman M,Nyström J,Ahlfors H,Coffey E,Rao KV,Rasool O,Lahesmaa R	GSE20198	GSE20198_2512_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in the activated CD4 [GeneID=920] T cells (48h): IL-12 versus interferon alpha.	The aim of this study was to identify genes regulated by IL-12, IL-18 and IFN-alpha during early differentiation of human Th1 cells					9926	10381	163786	115004	81631	22835	7776	5782	65018	8546	9817	80821	157285	131601	3985	4046	22920	4924	6005	730249	91543	92293	55681	149420	8648	342371	8021	2806	8525	4478	119587	7295	83990	55758	51593	26095	55144	54165	22994	5252	22848	10565	10449	9217	84879	1951	53838	994	10743	11325	5528	55344	983	124045	4124	348	7132	3017	196074	6500	23463	29109	604	3689	160897	220296	6618	1769	9739	144501	55904	131870	117178	23741	29841	7903	10765	65992	286753	26259	200933	546	6907	4744	4665	7334	143686	81616	6840	79090	4317	8289	81502	55183	22908	56970	65220	10769	2137	344807	23087	6596	6194	80146	6857	118490	66036	79960	79733	10194	10312	27072	25851	23157	11011	10057	811	55858	868	4215	7107	27443	37	153733	80764	134492	80790	9842	4733	27349	3988	51028	55092	23043	23469	26273	26260	8626	162427	29957	7580	26511	89891	79153	23710	2931	5256	85294	138050	23424	4634	100128071	26137	79018	57178	55048	113177	157657	3476	158135	29920	5621	29979	56948	8440	4839	9254	85369	221002	5701	246269	2475	30832	2848	1438	29978	51517	9991	81552	411	80774	7994	5986	7074	55760	2222	9600	3732	23529	253012	10493	4217	9852	57606	23394	8427	113	5073	9776	9134
GSE20198_UNTREATED_VS_IFNA_TREATED_ACT_CD4_TCELL_DN	M7376		20304822	Filén S,Ylikoski E,Tripathi S,West A,Björkman M,Nyström J,Ahlfors H,Coffey E,Rao KV,Rasool O,Lahesmaa R	GSE20198	GSE20198_2510_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in the activated CD4 [GeneID=920] T cells (48h): control versus interferon alpha.	The aim of this study was to identify genes regulated by IL-12, IL-18 and IFN-alpha during early differentiation of human Th1 cells					16	813	79714	9836	10987	474344	11161	10124	8074	3099	60509	114799	79863	1465	6717	60526	9631	353	5902	84282	54853	1967	28977	51463	23325	55573	25996	6574	3301	5591	10370	54704	2258	84065	81887	10244	54948	8890	10016	150677	55646	257415	22803	1613	4683	57210	26024	2852	29108	51125	51318	28512	9229	952	55105	22944	2653	5436	493753	8732	401397	1638	25920	4176	28974	54187	3123	57018	9933	23281	22879	55692	159013	64794	581	51554	730094	10813	6509	23560	1725	23603	79003	29982	93589	6047	23029	8669	28985	5435	6472	55009	2138	29081	79852	7097	57045	254263	221079	10947	29090	116447	55093	64783	374395	79876	1595	9553	26205	57560	57007	201595	1352	55798	65003	4942	57180	51000	51154	84267	9801	6988	10628	79760	81890	9677	1263	26519	83732	64747	85363	113174	79663	54905	4738	10063	3304	55920	90025	8563	1119	9397	10611	79048	23243	9824	5625	64859	8504	124995	91298	84289	1998	2547	80233	57050	131583	84872	64225	6619	9659	79948	55770	339487	5698	27445	1647	1615	318	1880	7975	55072	152098	220064	55454	26224	6767	1937	84319	65008	5578	7167	51293	4835	9789	3267	55334	84128	84549	5833	11316	1635	766	5699	22914	100499467	84572	154043	7084	51122
GSE20198_UNTREATED_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_UP	M7379		20304822	Filén S,Ylikoski E,Tripathi S,West A,Björkman M,Nyström J,Ahlfors H,Coffey E,Rao KV,Rasool O,Lahesmaa R	GSE20198	GSE20198_2509_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in the activated CD4 [GeneID=920] T cells (48h): control versus IL-12 and IL18 [GeneID=3606].	The aim of this study was to identify genes regulated by IL-12, IL-18 and IFN-alpha during early differentiation of human Th1 cells					161247	92797	23242	55005	6627	55717	9324	51608	114881	10320	131377	1438	1397	56521	9706	143384	10743	55256	4040	79444	10497	63891	25897	387882	55972	5928	55700	56648	3797	112939	10343	146691	84717	79812	9712	3516	2249	9739	7784	84899	57154	5598	166979	441478	4502	51078	285440	55030	51375	645832	8514	11171	10388	84861	3065	51366	7798	6624	50484	80028	10735	7124	79822	160897	84173	8309	26128	5533	10424	5094	56894	79754	3747	54896	3607	22856	4726	92345	51097	65018	143686	955	4733	5527	4253	7276	3750	346171	7376	80824	57669	6809	6117	219557	85409	339344	7015	26525	84330	4841	51284	9274	8660	118812	1857	51497	54662	8651	4644	79056	152405	1646	27107	80755	64651	4825	1453	5803	26150	2896	333	26065	57085	2185	81894	7465	400629	55201	26020	56896	205	9001	8241	54869	222008	2767	7091	51614	6272	1896	55683	81562	8566	79165	146433	6357	646174	164684	3421	92691	146760	286128	23335	79865	9489	147912	26999	50808	7224	29882	80223	8484	2696	55192	57610	3897	114804	116236	10005	53347	50832	597	80221	125206	4718	284948	4686	9117	4303	85301	5892	5793	79083	10746	844	285966	80335	775	10992	55911	4878	89891	57089	2906	57863	80000	2153	5308	8555
GSE20198_IL12_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_UP	M7380		20304822	Filén S,Ylikoski E,Tripathi S,West A,Björkman M,Nyström J,Ahlfors H,Coffey E,Rao KV,Rasool O,Lahesmaa R	GSE20198	GSE20198_2511_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in the activated CD4 [GeneID=920] T cells (48h): IL-12 versus IL-12 and IL18 [GeneID=3606].	The aim of this study was to identify genes regulated by IL-12, IL-18 and IFN-alpha during early differentiation of human Th1 cells					120379	11179	79731	10267	26521	79714	155368	6197	8208	8784	1798	10939	23514	7978	51340	29982	55300	79009	5832	6883	25828	10199	246175	23589	4690	8509	54996	9447	51478	8664	28978	59345	23399	64225	195827	145482	6749	245812	9338	5510	83480	4190	1844	57149	969	7345	57478	53346	340562	2073	100499467	643	25855	4144	8467	1632	56915	2098	4534	11284	2539	401551	55593	10623	60488	54968	1655	51386	406	6772	80025	28962	55775	4121	51605	4522	51752	9130	230	84889	7072	23036	841	114907	27334	253714	57332	64841	199857	255231	201931	79172	6470	27336	10058	54785	11329	10081	54602	57146	79631	11269	8412	6038	125150	1848	4967	3111	1457	1465	6094	126119	2762	4124	9662	4515	8453	55212	90025	9879	10321	8140	129787	6236	79155	257415	9219	55904	5906	221527	5306	56267	2023	5660	6303	55471	55696	10775	388646	83939	79038	80157	55204	9054	23197	55860	7763	63901	84057	51056	10935	58493	4140	57223	28990	8669	26589	22843	80777	27095	5295	2653	988	134492	84002	84292	80255	65062	10768	25902	1396	2542	85476	1371	729515	90355	51692	8834	92597	119504	10606	1452	143	6227	1665	973	23043	400569	51588	5445	79895	9474	55131	6183	8678	1660	10124	56052	55003	8505
GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_DN	M7382		20335529	Gleissner CA,Shaked I,Little KM,Ley K	GSE20484	GSE20484_2502_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocyte derived macrophages: CSF1 [GeneID=1435] versus PF4 [GeneID=5196].	Human blood monocytes were differentiated over six days with either 100 ng/ml M-CSF or 1 umol/l CXCL4 In atherosclerotic arteries, blood monocytes differentiate to macrophages in the presence of growth factors like macrophage colony-stimulation factor (MCSF) and chemokines like platelet factor 4 (CXCL4). To compare the gene expression signature of CXCL4-induced macrophages with MCSF-induced macrophages or macrophages polarized with IFN-γ/LPS (M1) or IL-4 (M2), we cultured primary human peripheral blood monocytes for six days. mRNA expression was measured by Affymetrix gene chips and differences were analyzed by Local Pooled Error test, Profile of Complex Functionality and Gene Set Enrichment Analysis. 375 genes were differentially expressed between MCSF- and CXCL4-induced macrophages, 206 of them overexpressed in CXCL4 macrophages coding for genes implicated in the inflammatory/immune response, antigen processing/presentation, and lipid metabolism. CXCL4-induced macrophages overexpressed some M1 and M2 genes and the corresponding cytokines at the protein level, however, their transcriptome clustered with neither M1 nor M2 transcriptomes. They almost completely lost the ability to phagocytose zymosan beads. Genes linked to atherosclerosis were not consistently up- or downregulated. Scavenger receptors showed lower and cholesterol efflux transporters higher expression in CXCL4- than MCSF-induced macrophages, resulting in lower LDL content. We conclude that CXCL4 induces a unique macrophage transcriptome distinct from known macrophage types, defining a new macrophage differentiation that we propose to call M4.					29855	11215	23081	23369	55905	220213	54737	8621	10664	9546	285989	51449	23253	10923	9424	3142	151188	57337	153328	441168	7976	4194	53335	100302692	29066	27086	5031	9130	201562	54918	134218	619279	6777	379025	8764	113246	132720	253512	834	8437	8227	80208	2267	6717	2872	5795	23064	79815	114991	3576	90019	3480	8925	745	23259	9759	23012	200894	285281	64421	1235	714	26973	9648	25923	23460	3720	222484	382	10875	4773	64426	100129406	84876	3570	23181	5586	23382	79026	22911	9779	9046	653188	25963	23252	10505	6874	57498	1633	23020	285231	713	10236	1612	64398	79180	11309	80215	5663	51667	165324	4050	4299	3597	55707	6687	6314	124961	23140	911	23424	253782	57118	5143	5305	51315	79735	23635	9044	65258	2650	23332	149233	2359	100289610	148254	23174	7706	254225	10347	5253	51703	9857	55509	9805	55640	310	55596	490	6776	128077	29760	55727	26039	8651	255488	9991	23381	23365	285761	157	113	399491	26034	1472	117584	51111	200081	220972	80148	6668	29915	6039	89853	9341	26036	9703	114785	153733	8530	57486	79622	124923	21	285147	9760	6940	55729	3113	5732	157680	54165	23244	56478	11193	204851	51141	5062	8879	57415	3716	6397	79672	6018	9175	51668	79719	79034	23288	22908
GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_UP	M7384		20335529	Gleissner CA,Shaked I,Little KM,Ley K	GSE20484	GSE20484_2502_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocyte derived macrophages: CSF1 [GeneID=1435] versus PF4 [GeneID=5196].	Human blood monocytes were differentiated over six days with either 100 ng/ml M-CSF or 1 umol/l CXCL4 In atherosclerotic arteries, blood monocytes differentiate to macrophages in the presence of growth factors like macrophage colony-stimulation factor (MCSF) and chemokines like platelet factor 4 (CXCL4). To compare the gene expression signature of CXCL4-induced macrophages with MCSF-induced macrophages or macrophages polarized with IFN-γ/LPS (M1) or IL-4 (M2), we cultured primary human peripheral blood monocytes for six days. mRNA expression was measured by Affymetrix gene chips and differences were analyzed by Local Pooled Error test, Profile of Complex Functionality and Gene Set Enrichment Analysis. 375 genes were differentially expressed between MCSF- and CXCL4-induced macrophages, 206 of them overexpressed in CXCL4 macrophages coding for genes implicated in the inflammatory/immune response, antigen processing/presentation, and lipid metabolism. CXCL4-induced macrophages overexpressed some M1 and M2 genes and the corresponding cytokines at the protein level, however, their transcriptome clustered with neither M1 nor M2 transcriptomes. They almost completely lost the ability to phagocytose zymosan beads. Genes linked to atherosclerosis were not consistently up- or downregulated. Scavenger receptors showed lower and cholesterol efflux transporters higher expression in CXCL4- than MCSF-induced macrophages, resulting in lower LDL content. We conclude that CXCL4 induces a unique macrophage transcriptome distinct from known macrophage types, defining a new macrophage differentiation that we propose to call M4.					282997	6513	79568	257101	117178	10247	64743	9526	16	5998	9167	8801	22796	8270	2157	4707	4719	120103	283651	23647	23208	22868	92106	120526	56652	27349	1104	10195	9245	121642	1992	79833	63974	23710	692205	79590	5917	126074	131474	10036	60436	100507246	256356	126669	57124	5201	6711	962	10186	5594	220323	8607	51222	9213	84247	90871	64792	152992	51363	6331	113000	10102	642924	22949	123016	3726	64127	5639	7367	1911	130951	8802	2618	80185	11162	79036	8079	5348	3732	79631	2309	51088	219855	285830	6354	9500	64078	6515	79789	100507632	5872	51114	79096	56005	7936	25764	10099	23590	4609	55174	28977	100506190	55759	2268	64098	6206	80139	7371	128240	3746	23765	81892	3235	7284	9533	9377	158586	9497	9447	83985	8848	60592	51069	83871	283050	23562	5423	7409	64374	6320	100130135	84179	7866	91624	11118	24147	29015	28996	246243	2050	4715	80008	6152	56851	5467	50808	1124	4286	163882	57089	8668	645460	37	91942	55624	4696	2976	23428	2210	6390	51700	197370	7296	6182	55240	158427	8869	5191	6150	7052	1378	4855	6233	28595	10243	4704	144100	29967	11260	91408	114827	1296	138948	5210	6159	57715	3313	219927	1294	57546	9277	200916	84787	139065	2215	56912	334	133	55179
GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP	M7397		20483728	Peltier DC,Simms A,Farmer JR,Miller DJ	GSE16450	GSE16450_3398_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in the neuron cell line: immature versus mature.	Human neuronal differentiation alters responsiveness to innate immune stimuli and virus infections. We used microarrays to examine the transcriptional responses of the human BE(2)-C neuroblastoma cell line to retinoic acid-induced differentiation and type I IFN stimulation.					23112	7091	113791	7402	8705	65018	727820	282997	7805	5175	7852	3820	1455	9750	4033	26959	26034	90864	10023	8334	23526	55103	9975	283450	100131564	286530	10472	84680	222255	401494	85464	23533	100132999	9806	9923	23067	2934	5295	25777	22861	6314	8925	84961	4155	84166	57326	153222	25900	84532	2043	9583	11119	80063	11214	3003	1120	200298	197358	339988	10397	10913	2841	80833	51274	3983	4214	388685	100129282	3455	123036	25851	440498	285195	901	64174	121551	1656	23389	4763	360	79680	5165	201229	123720	678	1831	388403	8303	153684	57730	22863	10125	22821	246175	53349	54993	10365	100507424	79685	397	57337	51816	5588	89846	2804	23224	219539	84124	283897	79690	4820	10957	100507281	2309	114907	64780	54843	3423	5463	6653	9960	8869	8554	201627	9910	100505696	375593	8875	4118	3655	84726	10750	220972	9267	65258	64224	54103	100289019	378938	27106	22877	11010	57544	57161	51646	406	283927	3575	1043	120	6843	3587	8111	253018	255967	64784	192670	80714	399665	373156	26137	51317	23370	9214	9262	8481	54832	6322	8848	10123	5530	23126	27250	64919	203	64773	256987	23484	643641	256380	166824	23174	472	114224	54441	285955	115992	7844	65981	92482	79629	7162	321	7442	26115	7248	11046	284058
GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_DN	M7401		20483728	Peltier DC,Simms A,Farmer JR,Miller DJ	GSE16450	GSE16450_3398_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in the neuron cell line: immature versus mature.	Human neuronal differentiation alters responsiveness to innate immune stimuli and virus infections. We used microarrays to examine the transcriptional responses of the human BE(2)-C neuroblastoma cell line to retinoic acid-induced differentiation and type I IFN stimulation.					54555	3558	3562	729680	84706	11339	1594	100131262	3586	56052	7124	4049	55135	284018	9768	6674	51659	9456	3604	598	891	7371	2342	127703	100170841	3578	23594	54512	112744	84879	28989	8531	2153	29923	4345	51514	3642	8645	1111	23170	54606	84842	8602	7813	8811	4173	1978	2178	10360	119559	80223	5326	83879	29128	1802	220042	8740	79080	7064	23509	1678	26517	3976	326625	79413	10036	7293	29089	7421	8318	8891	92745	5427	5036	6472	3070	991	6120	10452	317781	2193	51309	6520	27340	10963	55055	55839	55750	56926	1960	81831	8061	9700	9136	84798	10953	2805	23277	25979	10726	54928	8568	9442	79931	10131	10622	5433	5983	140838	6385	5214	92609	3980	3559	100506898	1293	285812	4758	9816	4744	50616	28976	641	56342	84916	90417	3605	6504	5092	9371	11130	54602	6790	7205	59269	84541	10061	29886	8131	80742	55352	1021	23151	25885	124535	92399	9319	64785	5932	797	65083	7272	54984	3394	10189	9424	79723	4234	10514	5603	112812	6631	2966	4839	65993	22984	817	79050	262	3902	5982	2146	10534	3595	2395	51293	55048	23150	23125	6510	10478	6566	60386	51073	27346	95	10400	84002	10469	126789	79682	5425	5270	26227	9097	55071	11163	400410	116238	7804
GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP	M7403		20483728	Peltier DC,Simms A,Farmer JR,Miller DJ	GSE16450	GSE16450_3395_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in immature neuron cell line: control versus interferon alpha (12h).	Human neuronal differentiation alters responsiveness to innate immune stimuli and virus infections. We used microarrays to examine the transcriptional responses of the human BE(2)-C neuroblastoma cell line to retinoic acid-induced differentiation and type I IFN stimulation.					7402	9816	57107	987	9482	157680	84441	63892	9779	55154	51594	23078	2131	55105	1730	9984	51741	171023	285195	55628	80063	4763	55703	641	100132884	2530	201627	27010	254042	7874	10653	26115	10243	54103	65084	8573	2521	57186	22850	7351	55778	9923	27241	23389	23301	85476	23404	55843	10667	222255	11128	26137	153684	6541	2762	27044	5579	27327	64754	7923	4482	83989	51422	152579	1739	100287628	84912	5422	6574	197135	23195	2519	85453	201164	25939	5519	26960	57194	84529	5379	9873	84816	23122	23171	3712	4026	2932	81533	7405	5125	55617	23164	55294	27067	25851	1794	197370	128439	23315	54471	51319	55119	54841	339290	79613	31	10691	57496	5711	84959	158880	9213	729683	5095	80017	1806	11269	64839	8924	132	387723	23043	80746	220988	11278	3189	283687	55706	9577	283450	56474	5521	201266	55604	64764	60526	5073	5019	1153	23613	55187	83860	55056	10954	4668	8732	8945	5514	9021	10693	92675	5588	54914	8935	283927	5116	57150	121551	26272	2776	282997	9120	84319	83695	169981	3655	55846	9682	285282	22877	5191	55086	5192	8540	1662	5924	27	55809	51360	10056	166647	23560	4285	115509	8631	55798	55520	5090	169714	114876	11060	5578	29914	51277	7503	84277	54726	56919	8226	5412
GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_DN	M7406		20483728	Peltier DC,Simms A,Farmer JR,Miller DJ	GSE16450	GSE16450_3395_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in immature neuron cell line: control versus interferon alpha (12h).	Human neuronal differentiation alters responsiveness to innate immune stimuli and virus infections. We used microarrays to examine the transcriptional responses of the human BE(2)-C neuroblastoma cell line to retinoic acid-induced differentiation and type I IFN stimulation.					2232	64782	5033	29923	1643	222029	100129282	8795	3162	9569	27123	5008	581	55135	205	79850	677766	3623	51499	29085	7422	8493	7167	2769	133	84973	83862	26502	467	353322	126789	2597	2026	4193	9123	80086	219287	230	85329	4973	222487	117608	7035	9768	729224	51545	26263	664	6790	7633	3750	8366	58491	51278	64109	5214	284427	443	3960	5111	340357	84236	127495	8111	64065	5494	151658	4313	203260	57484	2274	1796	284475	8045	54455	632	643401	9038	56203	9402	4204	2023	100190938	50855	284801	10229	27111	6385	1647	3992	1466	171019	4601	26499	949	144097	10101	5029	100129488	140710	26261	58528	55338	219539	7016	10114	79156	1838	163255	154661	388886	56834	3036	100506274	4097	26242	90529	7051	134429	94120	84905	10603	4284	112885	92014	11030	120935	5564	9249	7292	1845	151254	126205	28989	284998	57103	5210	285401	2139	83479	91074	22822	6327	85294	645431	8727	10809	64393	8331	55304	55647	164633	8793	29774	1440	79369	30817	140880	51450	970	284023	245938	339316	50846	10079	6904	4758	57192	9047	1369	6513	4066	2821	80714	100287602	9720	23594	57381	653483	2846	8645	126208	10046	4828	55350	441478	23627	8792	1879	3558	23612	51194	100128327	57565	100287056
GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_DN	M7408		20483728	Peltier DC,Simms A,Farmer JR,Miller DJ	GSE16451	GSE16451_3457_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in neuron cell line infected with western equine encephalitis virus: immature versus mature cells.	Human neuronal differentiation alters responsiveness to innate immune stimuli and virus infections. We used microarrays to examine the transcriptional responses of the human BE(2)-C neuroblastoma cell line to infection with western equine encephalitis virus (WEEV).					5966	5154	10329	4026	2764	1021	55177	8723	2140	1958	60386	81533	55110	9904	7867	121642	92399	11339	28976	4792	90701	8733	9213	84908	56916	26995	284106	54726	7064	27044	9319	10098	23078	84942	65008	79080	51659	10452	9700	6504	79711	8187	81890	3562	8479	56993	140838	2178	5873	79081	80745	4998	10653	26519	5198	1719	79187	54512	27033	9984	3902	63931	51629	112495	89978	23640	171568	100132884	339230	378708	55161	54982	5096	4580	481	617	8886	8480	9093	10592	284098	56670	51204	79723	10552	7019	112950	26227	5822	8260	22948	135228	29880	6566	165	10666	8892	93183	84879	55703	79094	9927	9533	8226	2530	116150	23212	9604	78996	10534	5092	80347	55168	79039	54888	729680	116238	7293	3306	4507	7327	119559	79828	29985	55759	22850	9939	5326	29095	27010	51514	55466	84823	7453	5306	200081	10130	5778	79019	4528	5514	1020	127703	81887	64764	131474	6723	6510	475	79109	23509	79912	30009	84798	59269	84313	55646	55254	57415	9703	55847	7124	9816	5433	54606	871	8784	7804	3980	84706	4893	5684	80178	891	5832	64860	81570	10221	9238	6749	55276	55364	25932	3189	10131	10400	64801	85465	2673	9456	1848	51651	81831	728558	55290	4891	1479	8531	23125	3614
GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_DN	M7410		20483728	Peltier DC,Simms A,Farmer JR,Miller DJ	GSE16450	GSE16450_3394_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in immature neuron cell line: control versus interferon alpha (6h).	Human neuronal differentiation alters responsiveness to innate immune stimuli and virus infections. We used microarrays to examine the transcriptional responses of the human BE(2)-C neuroblastoma cell line to retinoic acid-induced differentiation and type I IFN stimulation.					113791	3575	7136	123720	10384	7091	10397	719	79159	283897	83648	10444	162972	100129488	54491	4033	10133	5210	26119	27334	10152	286530	3820	51316	81563	440823	4155	10800	55338	4118	901	3275	4209	8705	9665	23508	127	84726	54785	58473	1831	25777	2509	170394	388685	79690	51646	197358	4926	1440	374403	2145	7805	153222	51439	352954	7476	1028	54820	64780	51440	57326	7035	7508	170575	115294	54762	2232	26959	2495	9265	26053	2124	8698	6843	64760	10957	493	5920	25851	5165	9138	10174	11119	79026	8906	80314	26207	83714	51147	727956	146705	201895	9764	64766	93129	81618	339988	57558	322	5295	7852	9214	84222	84166	27244	10750	100129282	9976	139716	9256	9772	64174	57786	9750	51065	6844	9975	388969	55553	57446	55672	388403	9751	83888	79153	727820	154	286437	94241	84961	339105	4601	59339	5997	57494	23224	64393	51274	994	115817	387751	9910	51512	1499	54	399665	2533	23271	10123	4214	10913	440193	23389	6904	3695	55350	25957	55303	7673	57561	5140	57184	25776	10418	4303	55367	22933	439921	4092	8334	284129	27106	85315	84628	841	301	27128	55333	26157	5144	7582	389289	23129	284454	474344	10230	8795	50650	678	10938	3399	26034	11329	8869	26118	472	100289577	1911
GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_UP	M7411		20483728	Peltier DC,Simms A,Farmer JR,Miller DJ	GSE16450	GSE16450_3397_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in mature neuron cell line: control versus interferon alpha (12h).	Human neuronal differentiation alters responsiveness to innate immune stimuli and virus infections. We used microarrays to examine the transcriptional responses of the human BE(2)-C neuroblastoma cell line to retinoic acid-induced differentiation and type I IFN stimulation.					145258	6344	83595	147700	145645	58497	57030	3490	57149	401262	100506804	23542	80775	27076	1581	5116	5161	440435	26509	57476	9601	10205	4751	57512	55709	26262	2892	4147	143630	3630	4355	128025	55108	8076	5333	57677	392617	645426	6363	143187	286753	22994	27159	55171	79573	7022	5733	11249	284716	3626	1999	132989	288	339829	124460	7376	8996	5797	7802	4629	414157	2303	5596	10603	27241	114801	116154	6662	388135	54518	55733	84059	6656	404217	79575	127833	4485	29986	1952	152098	162239	7258	767	65122	1136	91544	55954	196951	4668	112398	3233	6296	8427	8139	200373	9331	2050	26330	142686	10411	9814	64149	646851	285193	55213	7373	2297	64599	79742	440836	7306	55930	157869	135138	343099	440590	1388	4223	387755	2886	26164	57026	136332	9603	8840	4908	8528	1369	598	8808	51337	140	1545	4330	54757	4825	20	29889	286075	1138	121599	54987	65057	9095	54328	60313	973	54897	150290	7111	2116	8309	11077	3480	6155	2670	23051	6242	2205	57541	9858	337970	26045	479	3636	84152	54626	126917	642968	100128071	163479	3784	64081	364	53836	57152	7089	2712	57007	9343	162515	5157	8787	58530	9575	54557	54870	54344	55643	26150	3543	151531	84570	3489	138639	100506049	112869	3486	6319
GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_DN	M7412		20483728	Peltier DC,Simms A,Farmer JR,Miller DJ	GSE16450	GSE16450_3397_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in mature neuron cell line: control versus interferon alpha (12h).	Human neuronal differentiation alters responsiveness to innate immune stimuli and virus infections. We used microarrays to examine the transcriptional responses of the human BE(2)-C neuroblastoma cell line to retinoic acid-induced differentiation and type I IFN stimulation.					54762	23326	8725	29851	55149	90268	91	6890	975	5564	1787	170384	116092	27097	7520	79869	202018	10314	55571	55850	839	23376	79693	64333	51374	124997	65980	83606	10200	1063	208	55544	6122	318	79572	30837	2957	929	51096	474358	8904	10906	5828	116496	56902	7110	7832	146198	79180	2214	25934	5721	8891	5281	4734	55819	55020	1476	28956	122618	26292	63892	23019	5594	79807	10169	57407	163786	3557	7342	283431	80224	3716	6152	343	51296	54941	10961	64759	26469	7187	51231	10175	7096	2990	57213	8530	6446	26043	1259	28972	84251	3978	56833	254102	348	28959	3839	345079	201931	7319	10231	2972	144110	1783	55596	11064	7464	1432	50856	1996	818	3054	7941	1894	51637	6582	23495	10553	3916	217	11080	23586	79971	55872	22878	8417	2926	55074	26523	1535	285148	2776	4643	83607	771	1460	55794	3689	4363	22914	6670	5422	3835	4257	151903	5538	488	55331	79887	5372	55131	112950	65990	3234	79932	84684	10613	10907	1676	121441	4493	163882	64092	51069	55308	51029	64581	122945	337867	114609	81875	8655	4708	2921	1870	821	4439	4283	9296	55723	84236	3006	51122	10869	51806	84942	6734	55365	114885	4720	9989	55080	58505	51203	57150	2495	26511	9450
GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_UP	M7413		20483728	Peltier DC,Simms A,Farmer JR,Miller DJ	GSE16451	GSE16451_3457_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in neuron cell line infected with western equine encephalitis virus: immature versus mature cells.	Human neuronal differentiation alters responsiveness to innate immune stimuli and virus infections. We used microarrays to examine the transcriptional responses of the human BE(2)-C neuroblastoma cell line to infection with western equine encephalitis virus (WEEV).					25911	79660	2653	2564	55081	4493	2745	92399	23433	123	2054	57179	5747	10981	58528	55748	333926	121441	6580	952	2760	257160	199857	4502	338557	79836	22902	79816	57511	85480	55172	54363	114793	55215	6696	147991	9446	286467	874	5446	57533	54918	4647	4482	57582	54492	152992	9424	56033	7011	221143	134510	10905	27229	3915	57381	8895	4925	51022	80255	5217	79736	168090	54922	948	2017	1666	8408	10787	9926	23111	5184	57333	3669	79140	128061	10549	5827	51031	55589	83943	1528	79752	203547	8100	64116	51203	57405	57570	54887	9482	2230	9761	64747	51074	5269	255252	57038	57404	84230	22929	9094	83547	90060	4907	4952	389124	387680	55062	9053	23087	65062	144165	663	29851	90639	347733	23166	55536	80305	1495	2199	151230	161582	51422	2638	138241	1033	29934	389610	29915	644	26050	2135	2181	140739	135398	5288	5019	133690	307	161176	338440	79850	22916	10544	2171	89796	10635	285753	5008	286077	8496	116841	2762	10237	9325	11243	151648	7280	55970	4751	57633	23178	166815	10150	11097	22981	91683	11180	118429	23025	1774	25847	57180	285141	9867	5422	8434	51426	2720	136259	389856	79713	93010	23216	8743	134429	7414	64708	134829	55617	11112	120379	9653	3613	10293	51752	56983	26130
GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_UP	M7414		20483728	Peltier DC,Simms A,Farmer JR,Miller DJ	GSE16450	GSE16450_3399_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in neuron cell line treated with interferon alpha for 6h: immature versus mature.	Human neuronal differentiation alters responsiveness to innate immune stimuli and virus infections. We used microarrays to examine the transcriptional responses of the human BE(2)-C neuroblastoma cell line to retinoic acid-induced differentiation and type I IFN stimulation.					3801	4837	7092	81693	57732	6343	115207	388931	3480	344018	89887	442213	51523	8648	222487	55784	3627	1992	220213	7776	1014	868	221091	10803	7850	2064	80309	5590	1028	7473	727936	23401	4215	23049	153769	55761	53831	83595	8689	4093	9064	27198	4209	22797	79739	203562	283197	5547	439996	5526	9783	103	3738	283383	9693	2124	200728	606495	3034	3596	79853	10864	29993	4040	149483	51170	64806	90865	151888	3490	50807	84969	23630	4214	23224	2334	137994	7783	3231	3097	402415	79899	80761	10998	6403	5874	2309	8120	64132	8433	2936	133	7366	160760	3958	29909	23276	10207	115123	54435	57205	54764	1101	64837	6786	198437	6857	2690	7712	80237	1942	9751	2813	6653	55861	553	4000	83648	143	83699	51466	8125	146862	29999	2570	955	2822	57690	5210	643549	90226	10234	8085	117154	57621	54799	30812	29943	8564	79026	1803	283987	23135	94137	150677	5125	29994	92483	5916	2444	6288	124540	3902	51177	57719	3226	611	53353	147179	84629	387733	9750	5746	339829	401	92017	3219	8832	25897	91977	55810	165721	6468	100288695	644815	23475	55364	51751	2330	5959	5450	57659	7483	29099	4091	51299	3672	23220	3117	284348	28234	22858	54756	169611	146395	6252	1917	339287	160335	7348
GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_DN	M7415		20483728	Peltier DC,Simms A,Farmer JR,Miller DJ	GSE16450	GSE16450_3399_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in neuron cell line treated with interferon alpha for 6h: immature versus mature.	Human neuronal differentiation alters responsiveness to innate immune stimuli and virus infections. We used microarrays to examine the transcriptional responses of the human BE(2)-C neuroblastoma cell line to retinoic acid-induced differentiation and type I IFN stimulation.					3915	9227	8324	79660	159119	79159	11238	606495	2760	79411	254240	11041	63943	84265	3754	94137	2662	400624	285848	8839	5101	2745	57633	3563	56996	9479	2638	81567	7290	5872	639	113000	619279	9600	8284	51666	399697	55879	8653	130271	7260	90379	25911	84830	337867	64689	6446	90249	1837	196463	3669	64333	249	9002	286046	650	1945	3757	56938	56979	1755	122416	4493	1284	93010	92241	1104	285141	134548	91289	10025	116969	25904	6050	3710	10747	392275	644524	84264	3948	90187	22796	984	56	10178	10616	23277	2794	54566	3566	3092	79583	89766	140545	6585	170825	610	152519	9586	8516	1610	338811	1870	29767	3985	2925	126133	51393	1230	128434	7915	1317	11226	51157	26330	146206	84167	84939	8609	327	1728	643418	220963	6508	51043	131	25793	79877	5664	6261	56905	23246	10293	23498	197187	93107	5329	23026	64098	3507	1302	23541	10095	5791	57504	1138	124626	54929	7301	1440	22823	22865	30968	27439	8372	10636	948	91683	79803	7494	4599	7862	401	7594	29801	221527	2199	54847	4218	8733	6571	6545	55695	253012	7422	81558	7094	28969	9423	3674	91010	23070	7404	132884	6199	5078	79153	5881	387733	54112	341116	255798	3883	59350	203054	256979	4342	10249	3614	57511
GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP	M7417		20483728	Peltier DC,Simms A,Farmer JR,Miller DJ	GSE16450	GSE16450_3394_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in immature neuron cell line: control versus interferon alpha (6h).	Human neuronal differentiation alters responsiveness to innate immune stimuli and virus infections. We used microarrays to examine the transcriptional responses of the human BE(2)-C neuroblastoma cell line to retinoic acid-induced differentiation and type I IFN stimulation.					55884	50943	29909	2135	1021	151888	439996	58486	221294	10225	538	27319	121278	388341	5341	51283	23166	56947	29119	84640	9258	5925	868	79739	4299	8496	604	301	90580	83734	3945	56253	221302	146862	89887	7569	54708	163859	3717	2634	1385	399694	9459	196441	51755	64968	1832	55768	375341	9910	84612	23024	80824	114928	7743	4340	9936	2214	10577	10352	6295	9392	64699	552	9849	26278	57476	29953	25913	7091	1803	115350	1112	389119	114294	8601	157567	8509	64135	51761	84888	2117	29841	1356	7369	7850	255520	55905	401565	57186	81790	187	23233	11320	4851	23516	51363	10039	50616	3029	23527	25897	4853	55589	8029	1824	3040	5519	55186	23231	27283	3899	9037	79074	96459	196527	5967	55364	8676	2060	974	7412	10666	127703	9516	115795	283237	57534	7776	55197	7782	163351	643988	7044	27252	5095	65062	260293	56311	25858	219854	6335	9693	1534	3633	26207	197131	2120	3556	201163	64421	55258	65005	26035	11126	220107	900	157753	85463	9923	4838	4110	6341	26153	6861	57210	8648	2073	324	80063	10138	23033	6504	7267	11001	29068	7105	768239	6092	7098	3376	219539	164781	221710	8233	22843	3077	6239	58513	151647	718	163183	114882	7402	127	53831	10672	348093	9201	55770
GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_DN	M7418		20483728	Peltier DC,Simms A,Farmer JR,Miller DJ	GSE16450	GSE16450_3400_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in neuron cell line treated with interferon alpha for 12h: immature versus mature.	Human neuronal differentiation alters responsiveness to innate immune stimuli and virus infections. We used microarrays to examine the transcriptional responses of the human BE(2)-C neuroblastoma cell line to retinoic acid-induced differentiation and type I IFN stimulation.					3596	23556	375748	51701	56947	6310	23612	84706	57223	23248	5997	5140	83940	22864	151888	1026	6530	49854	79088	51382	2672	54514	56253	57761	25932	1958	1906	4552	3601	116984	5128	23588	23387	10560	87	80219	4795	643836	969	92106	60685	347404	55239	5980	4664	5450	1355	54462	158586	25897	8871	51363	10262	84333	11079	391002	129450	84889	51426	79094	56261	54902	117289	131965	4794	56479	64782	9039	900	57585	6304	4625	84162	54953	790955	54617	5814	819	348093	3458	440	4616	165324	4750	161582	944	8394	1051	51192	3700	5723	356	9527	79895	60436	10245	56154	146433	286319	58513	4846	64172	27340	25973	8553	6232	144811	53371	2804	1119	6388	84792	6541	11137	3699	30011	112495	54870	3376	64429	527	153339	54438	5445	10181	4615	23410	4669	148304	401207	100505876	3558	64135	29089	6303	5870	1978	54842	10597	2009	51136	4628	26273	155185	11116	55814	8467	116238	285971	10600	51106	5932	8837	26973	3717	116254	256643	26263	6617	8729	54957	6330	254122	837	132720	8915	11169	597	27309	221078	22828	10678	55751	2744	5378	440026	6775	9706	54503	5191	10513	6884	5998	93587	10611	55776	55166	6729	1382	55035	79692	6655	80021	65005	51429	100506736	8411	25841	220042	22832
GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP	M7420		20483728	Peltier DC,Simms A,Farmer JR,Miller DJ	GSE16450	GSE16450_3396_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in mature neuron cell line: control versus interferon alpha (6h).	Human neuronal differentiation alters responsiveness to innate immune stimuli and virus infections. We used microarrays to examine the transcriptional responses of the human BE(2)-C neuroblastoma cell line to retinoic acid-induced differentiation and type I IFN stimulation.					8809	7783	58158	92749	441509	6446	57495	28996	23075	6563	4209	7903	8835	84002	51316	64375	3112	2760	7464	257202	25851	5864	9806	3818	4051	641649	79633	83439	84342	8829	9376	284467	26953	128637	9021	317649	10219	64108	1107	10888	729230	83741	58528	79585	55748	57533	26146	23382	10636	3547	84937	1363	1742	114798	3751	22807	196500	7145	79713	5783	1850	89801	8897	2623	57507	80760	401236	1109	170392	29851	9537	11318	10446	2531	9783	342897	29765	23239	84958	10397	3559	55911	7424	84187	23683	5621	6855	1536	5742	84230	8708	55601	10628	11012	123688	1500	221002	1893	151742	4084	56246	6860	132014	6038	79654	29974	10249	51763	9132	2199	4185	2645	10712	9211	245711	80012	4907	3682	9973	5863	23329	29801	3757	53353	22841	161357	387755	375611	942	4151	56934	143471	8828	1748	912	85377	116337	171019	6041	283232	24	2200	151636	7074	388646	5816	83636	480	53373	5295	100128160	5217	55295	81628	80157	51559	8989	2529	57822	3852	163702	5149	6403	81618	4313	152519	8940	7294	83756	646113	55107	7799	285382	11123	23569	344558	57458	947	2266	1628	23504	55643	4258	401647	400451	50507	81832	50863	8850	54434	84935	80210	1361	2550	84866	55540	10394	5954	79971	1493
GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_DN	M7423		20483728	Peltier DC,Simms A,Farmer JR,Miller DJ	GSE16450	GSE16450_3396_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in mature neuron cell line: control versus interferon alpha (6h).	Human neuronal differentiation alters responsiveness to innate immune stimuli and virus infections. We used microarrays to examine the transcriptional responses of the human BE(2)-C neuroblastoma cell line to retinoic acid-induced differentiation and type I IFN stimulation.					4502	689	60313	7329	6484	3184	373863	26502	375318	7353	10807	6294	4627	10983	9423	1465	6606	266655	23480	51574	27436	23658	80228	8405	10097	3738	5175	1975	57617	924	283349	9760	389541	7157	51379	55182	10450	1831	80895	10412	3192	22980	58526	84649	90379	51780	54870	831	378938	3566	57805	2495	219844	55666	84991	54847	23070	6303	527	125988	3140	7174	54815	8289	916	10617	1059	9741	440603	3148	10146	23308	6515	23112	3707	11214	58517	3608	9792	4218	7534	55671	64599	27338	5867	84939	54903	26034	23067	51026	8659	11033	10956	3683	53834	3030	8546	6584	83874	11157	10632	3454	10219	7832	26515	11194	64061	7257	154	1979	10728	27102	10148	6277	222962	131450	399909	5202	23367	135	5914	1153	51366	84335	8073	375775	5216	7265	10443	1233	3688	842	79414	55716	116228	9948	2068	55341	5298	150356	6281	9618	11230	22795	6391	253512	9526	147798	51542	975	3732	51762	11056	6563	963	833	6794	56900	10093	4738	2872	5089	8933	811	2011	3656	2077	9343	51143	8844	1901	3156	3191	84272	10670	50615	55602	1973	10621	56905	1264	10695	5695	202243	445	388730	54469	666	10194	474344	1968	10207	337867	1351	219738	140680	10625	5690	1396	7507
GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_UP	M7424		20483728	Peltier DC,Simms A,Farmer JR,Miller DJ	GSE16451	GSE16451_3455_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in the mature neuron cell line: control versus infected with western equine encephalitis virus.	Human neuronal differentiation alters responsiveness to innate immune stimuli and virus infections. We used microarrays to examine the transcriptional responses of the human BE(2)-C neuroblastoma cell line to infection with western equine encephalitis virus (WEEV).					23008	367	54520	7325	273	27348	3565	51449	132949	50943	93594	8496	9980	55718	57194	345778	10691	1739	59067	93323	55622	1871	55177	118881	65080	245812	145173	4147	6502	2867	5733	5073	3605	1363	51175	54842	23671	2034	898	57826	11321	56853	283596	121551	79944	138050	1308	3796	10463	10714	64218	56919	23062	2191	6295	8317	9057	10785	79156	7247	3690	51533	10113	55	1841	5864	65979	54828	23024	100113407	283152	2937	79671	164781	54997	9901	9583	256126	4752	56942	1628	199990	1259	54757	2697	65018	9725	1453	23099	4043	21	10654	5045	8242	57458	57514	55717	9533	23678	4077	11046	5198	57491	7517	7804	145482	10432	25780	8572	7108	7158	23335	29909	1021	8537	10675	1495	2135	7920	27248	9781	79683	57188	10938	3090	79075	5338	154141	10100	6755	66036	11094	79157	124565	10166	23172	50515	2896	9110	26509	79752	5424	83940	64762	85476	57673	55902	10723	121227	57179	9971	51250	7374	10098	51594	1240	130576	145508	81544	80176	151126	196	148266	8038	140807	3717	124359	11169	9311	25901	6364	401145	375323	3687	57698	718	55195	122769	23002	84064	1832	55331	64073	161742	8914	149840	1001	4292	10849	728621	23588	344387	126526	23309	1789	7126	9016	221711	55094	1112
GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_DN	M7426		20483728	Peltier DC,Simms A,Farmer JR,Miller DJ	GSE16451	GSE16451_3455_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in the mature neuron cell line: control versus infected with western equine encephalitis virus.	Human neuronal differentiation alters responsiveness to innate immune stimuli and virus infections. We used microarrays to examine the transcriptional responses of the human BE(2)-C neuroblastoma cell line to infection with western equine encephalitis virus (WEEV).					57157	23258	51762	3898	253012	822	1235	152002	8784	9173	5050	339855	115825	975	4907	7298	57045	116496	9771	9026	57584	10410	245972	8835	3956	27111	9456	3915	51299	148398	9414	221035	115361	10148	2901	80760	11163	6275	57630	25939	4217	8850	23365	29851	203054	159	56925	6515	64114	5355	84909	9265	23382	4249	5621	375033	57507	6281	302	55114	23597	6868	266743	26996	11037	23239	64092	57560	2768	6827	8411	4641	23075	57179	10099	55796	1739	151742	9497	58528	3480	22807	3656	2822	5583	10581	6504	55013	57545	1466	51164	10538	400916	63874	158405	5128	644353	2027	27033	23205	10678	6856	9371	3383	22806	219738	5900	4947	10888	60485	6277	3718	51542	598	214	79026	11280	1233	729230	550631	8079	10216	825	11033	10219	54103	4345	3559	11034	7571	389856	10188	4643	25999	1362	373863	8600	57231	253558	122786	10051	2982	923	56912	10392	6584	8531	390243	9760	94241	9655	84958	597	64375	9308	3958	5359	401251	1155	157378	7494	1326	56171	91947	58489	3015	200312	55831	9094	9749	9446	5033	8840	9053	3682	254428	8434	54476	55144	22876	953	1050	2052	57099	1154	254887	55312	2623	4094	10013	2672	9435	6097	10916	51201	9423	133308	91694	10912	161742
GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_UP	M7427		20483728	Peltier DC,Simms A,Farmer JR,Miller DJ	GSE16451	GSE16451_3454_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in the immature neuron cell line: control versus infected with western equine encephalitis viruss.	Human neuronal differentiation alters responsiveness to innate immune stimuli and virus infections. We used microarrays to examine the transcriptional responses of the human BE(2)-C neuroblastoma cell line to infection with western equine encephalitis virus (WEEV).					23678	4651	253782	84270	23533	4155	51263	64750	91	56181	1937	23002	6249	160897	6932	51108	23033	11040	113791	87	51449	10198	84440	5096	164091	26578	4833	23607	22873	65003	140545	29940	481	22897	255809	94235	55	64924	28992	10813	150864	2687	1259	5450	55718	10849	79845	81554	6342	29785	10123	1212	5095	3708	7433	54903	9953	81890	6251	93058	8668	130576	5305	2203	54951	6489	25998	55198	2342	51374	83448	10320	5437	9121	54842	3003	51018	83999	10656	57602	201595	10663	152100	3690	1012	57194	79895	4916	6352	1822	34	126	2678	91544	55902	387357	138151	84916	7048	10422	90407	125058	92370	51176	8543	90025	154141	158293	8891	222487	3824	84549	375612	11321	64710	9411	10105	367	283987	10436	9258	203562	79169	91404	782	552889	5822	85014	51678	8303	864	2820	8654	59067	9535	359845	55568	11069	285704	55256	552900	30845	4253	4482	8808	55824	79993	25885	139716	5917	64218	28984	23545	388886	344807	4234	3565	51020	2035	115004	92196	9671	8572	8507	5193	9933	147015	619373	284361	5576	80727	23151	26119	9716	122773	10505	7347	51603	115992	149840	23333	6228	9124	3241	28973	51606	51701	27345	10196	3903	170371	7782	79573	85313	10380	157695	285605	2124	2034	7049
GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_DN	M7428		20483728	Peltier DC,Simms A,Farmer JR,Miller DJ	GSE16451	GSE16451_3454_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in the immature neuron cell line: control versus infected with western equine encephalitis viruss.	Human neuronal differentiation alters responsiveness to innate immune stimuli and virus infections. We used microarrays to examine the transcriptional responses of the human BE(2)-C neuroblastoma cell line to infection with western equine encephalitis virus (WEEV).					4234	25911	57405	3615	4097	348995	155185	23397	23166	64105	64699	5051	64782	51550	7029	64754	7570	5519	55172	112399	50854	4677	6941	1163	10898	64116	3376	2653	391059	54887	9837	1678	55215	55872	29968	51463	151648	54535	8482	29099	2671	80176	115350	6696	387893	166815	1495	1346	79077	161582	30844	29909	51042	3416	5426	64863	10293	6241	51642	306	30009	57038	55106	64393	8731	586	2697	84276	5888	84722	51776	55759	6541	7982	7372	126321	26121	9516	55723	79801	3516	283638	29028	4141	6526	990	1719	8266	64318	22902	55081	23516	10197	51668	9538	3903	92170	1362	51117	692205	9926	92399	51031	256126	5802	214	8444	80746	79836	138199	10783	5422	25896	51022	401541	4493	84419	4837	1111	79816	1026	57570	1583	8496	7867	83540	55798	4521	4641	51805	1021	113179	112464	9019	5281	477	29127	6491	16	63908	113130	5707	22929	10456	55319	84933	22982	123169	51157	54896	10201	5034	3108	83861	79833	22974	7414	90025	64975	79075	257160	140739	3394	115701	90639	26160	56672	284996	26292	64151	768239	55748	79711	440	1595	8438	11022	1978	8644	133308	729533	3064	149478	5019	51752	5359	59353	1939	58486	9683	2171	29934	54892	55388	54433	79980	7782	55770	23433	388341
GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_UP	M7430		20483728	Peltier DC,Simms A,Farmer JR,Miller DJ	GSE16450	GSE16450_3400_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in neuron cell line treated with interferon alpha for 12h: immature versus mature.	Human neuronal differentiation alters responsiveness to innate immune stimuli and virus infections. We used microarrays to examine the transcriptional responses of the human BE(2)-C neuroblastoma cell line to retinoic acid-induced differentiation and type I IFN stimulation.					10219	79958	55349	6733	2760	55601	55194	81553	94240	10636	3738	81833	4215	2570	3034	3074	201799	57571	393	53373	6653	9639	114770	80055	54665	23108	8993	5783	10225	2822	29998	10235	3556	9173	54843	1510	901	270	54739	10347	1195	6275	1880	3696	51000	23239	56990	4145	64333	4051	285382	1893	337867	10870	4828	29116	1616	5564	23586	10803	60682	80709	83693	55790	51232	5924	2982	4542	10392	83699	5608	57205	8832	1840	114836	912	5613	93663	2124	5332	23036	5989	51231	9267	5863	23370	23075	10771	9674	6277	23506	1385	80232	113263	22873	7850	164091	55303	924	23331	375444	81669	375775	27111	81618	6563	926	10924	79132	5243	8204	55870	57560	5027	55904	9706	4121	57569	8829	55861	64857	344807	27075	9744	10602	29765	29948	5252	9600	23248	9026	65065	118	80853	976	3915	25851	1536	79677	50807	6352	6793	84329	9920	9535	158866	9537	2745	9725	203562	51735	10363	272	408	3665	26469	81558	645	1803	8313	9693	302	5641	5791	29994	6447	84206	154743	285195	9486	79792	3018	4329	6997	9771	23345	115294	401251	29035	7402	9750	51742	2051	54587	5274	644353	2184	9988	9806	89848	677	6385	3897	78994	326624	151888	1387	10956	3434	23318
GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_UP	M7478		20501946	Newell KA,Asare A,Kirk AD,Gisler TD,Bourcier K,Suthanthiran M,Burlingham WJ,Marks WH,Sanz I,Lechler RI,Hernandez-Fuentes MP,Turka LA,Seyfert-Margolis VL,LastName M	GSE22229	GSE22229_2395_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in periperal blood monocytes (PBMC) from kidney transplant recipients: tolerant versus immunosuppressive therapy.	In this study, investigators recruited the largest reported cohort of tolerant kidney transplant recipients who maintained their graft after ceasing to take their immunosuppression drug, and compared this cohort to subjects with stable allograft function while on immunosuppression and healthy non transplated, controls. Using gene expression studies, they identified genetic markers that are strong candidates for predicting kidney transplant candidates who may benefit from minimization or withdrawl of immunosuppression. Microarrays were used to detect expressed gene profiles of whole-blood total RNA from subjects in the tolerant, standard immunotherapy and healthy control participants					9466	1769	6482	1762	117145	55287	7248	23432	3976	116224	6990	53335	64077	7205	115273	10628	22871	91748	26207	56895	84878	56130	53358	4853	2273	5272	8841	26037	11145	90362	114112	395	9139	55810	9971	3615	58524	284069	80148	148281	7586	51186	29943	23608	124491	169611	1427	6997	25840	200942	3196	121278	11238	59345	83953	255104	2549	23705	341676	26523	5588	6002	1528	159195	58525	57597	1746	55665	3106	4924	139285	2137	9985	10675	2913	115123	6769	56924	6812	558	10068	3669	5583	79632	222643	27120	387496	1005	84253	387787	285315	8632	3783	121793	121506	135398	125931	148932	84612	57465	2017	85417	744	5371	51112	57088	2978	10158	56623	80005	113	2161	7577	259308	6035	65979	8092	100093630	56288	83759	1312	3959	55790	51232	6515	57185	6415	2952	5009	56477	55108	246	5460	84215	100130933	196403	2309	23645	8340	27075	81577	6363	6608	3620	9034	479	8224	140886	10765	4036	158405	57586	64063	161742	10425	23475	58508	157922	90678	201229	64801	50515	2675	10486	1825	219285	26047	3784	2339	7356	3988	623	57451	23545	9053	889	4093	58191	8528	374407	143241	122704	203238	27347	200734	64599	1958	23131	92815	26751	9397	4675	64744	1181	7003	7430	114880	84504	10580	11126
GSE22229_RENAL_TRANSPLANT_IMMUNOSUPP_THERAPY_VS_HEALTHY_PBMC_DN	M7479		20501946	Newell KA,Asare A,Kirk AD,Gisler TD,Bourcier K,Suthanthiran M,Burlingham WJ,Marks WH,Sanz I,Lechler RI,Hernandez-Fuentes MP,Turka LA,Seyfert-Margolis VL,LastName M	GSE22229	GSE22229_2397_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in periperal blood monocytes (PBMC): kidney transplant recipients receiving immunosuppression therapy versus healthy controls.	In this study, investigators recruited the largest reported cohort of tolerant kidney transplant recipients who maintained their graft after ceasing to take their immunosuppression drug, and compared this cohort to subjects with stable allograft function while on immunosuppression and healthy non transplated, controls. Using gene expression studies, they identified genetic markers that are strong candidates for predicting kidney transplant candidates who may benefit from minimization or withdrawl of immunosuppression. Microarrays were used to detect expressed gene profiles of whole-blood total RNA from subjects in the tolerant, standard immunotherapy and healthy control participants					24146	2212	29099	8842	166929	9050	23236	9060	10350	154664	718	2159	79887	7812	222658	8972	5899	7498	55636	2015	130733	55829	3916	8635	4758	10008	2593	4973	85460	7096	65124	1407	4023	64581	7979	6261	93099	202243	200132	5910	120103	28984	285598	51172	6542	390	8702	56886	143684	940	2286	127544	55852	3084	90141	29986	51506	7074	65987	7358	25824	6856	2224	55151	113444	9695	23474	313	22926	55013	3672	2281	23314	57509	1832	8985	4210	29091	8540	9871	2214	9895	5800	10261	3958	140894	151011	258010	3708	51097	283349	8898	10380	5034	149951	9517	51199	90050	23670	54957	10279	65055	57606	8808	91614	30833	84285	64218	3067	29103	663	166012	167153	129285	8543	6196	23250	11231	10236	3934	84458	211	1951	2683	1991	2289	6238	91300	1508	5214	29128	10159	51061	10603	22856	23601	92181	387914	100130976	23753	65059	79710	4048	117177	55286	78991	932	9709	5889	140609	3690	55508	27163	206358	8604	7584	7804	84962	90701	1734	10613	9948	4128	2817	27034	115677	120892	199	254251	10960	222068	51241	5144	8837	22797	2859	4684	6867	27309	11284	1536	5981	91689	9256	10961	6583	199675	1385	29087	56267	4126	8496	23597	29071	8522	54758	1359	121260	2539	80024
GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_DN	M7480		20501946	Newell KA,Asare A,Kirk AD,Gisler TD,Bourcier K,Suthanthiran M,Burlingham WJ,Marks WH,Sanz I,Lechler RI,Hernandez-Fuentes MP,Turka LA,Seyfert-Margolis VL,LastName M	GSE22229	GSE22229_2396_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in periperal blood monocytes (PBMC): tolerant kidney transplants versus healthy controls.	In this study, investigators recruited the largest reported cohort of tolerant kidney transplant recipients who maintained their graft after ceasing to take their immunosuppression drug, and compared this cohort to subjects with stable allograft function while on immunosuppression and healthy non transplated, controls. Using gene expression studies, they identified genetic markers that are strong candidates for predicting kidney transplant candidates who may benefit from minimization or withdrawl of immunosuppression. Microarrays were used to detect expressed gene profiles of whole-blood total RNA from subjects in the tolerant, standard immunotherapy and healthy control participants					387882	3766	27154	130576	158405	22859	7378	54676	23746	53405	51380	1789	55014	759	79673	84668	51246	64236	114785	91624	57761	2887	28971	7036	10106	284161	84626	10396	152485	26027	5782	8178	59307	57597	23646	6039	1106	25849	1389	8549	10791	6990	115	83759	120071	57659	9710	26523	9815	57655	3429	116449	9961	54462	8324	11145	155060	91748	113675	90233	2139	3750	151556	284119	23254	348	27040	25840	1995	23001	147912	153642	10723	4088	23351	170575	79603	7520	64332	84181	6222	7205	7185	28955	87	2752	23648	23387	388646	11046	2799	127262	9394	132014	159296	10743	4774	8910	7342	64135	197257	7439	150368	6237	80314	8440	90060	79847	8323	729810	53354	26012	23428	23682	7075	11213	1756	4211	285440	2149	122773	222166	83696	4685	153364	51011	3005	2931	4050	257364	2934	57336	975	6601	9429	8435	114770	7001	6812	3674	1454	5371	643641	7706	5058	22915	571	311	5335	79969	56624	64599	4054	153733	116843	5939	3633	23094	84293	3214	3669	4782	57492	81849	63035	2330	51278	23761	4313	51523	10133	9938	439996	4628	6786	63874	55790	64744	550643	754	22936	1911	4345	493	57496	57567	23266	3727	132430	55287	59339	23239	23613	23390	155038	2017	283987	54842	1836	89848
GSE22229_RENAL_TRANSPLANT_IMMUNOSUPP_THERAPY_VS_HEALTHY_PBMC_UP	M7483		20501946	Newell KA,Asare A,Kirk AD,Gisler TD,Bourcier K,Suthanthiran M,Burlingham WJ,Marks WH,Sanz I,Lechler RI,Hernandez-Fuentes MP,Turka LA,Seyfert-Margolis VL,LastName M	GSE22229	GSE22229_2397_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in periperal blood monocytes (PBMC): kidney transplant recipients receiving immunosuppression therapy versus healthy controls.	In this study, investigators recruited the largest reported cohort of tolerant kidney transplant recipients who maintained their graft after ceasing to take their immunosuppression drug, and compared this cohort to subjects with stable allograft function while on immunosuppression and healthy non transplated, controls. Using gene expression studies, they identified genetic markers that are strong candidates for predicting kidney transplant candidates who may benefit from minimization or withdrawl of immunosuppression. Microarrays were used to detect expressed gene profiles of whole-blood total RNA from subjects in the tolerant, standard immunotherapy and healthy control participants					4048	222484	29760	23596	55775	10061	57606	1524	22894	220134	390916	115727	10730	10576	7298	26586	2242	3695	3735	162494	84515	6585	149951	29091	53347	3608	9837	9314	253782	3460	9249	10156	4783	64919	26258	23376	65124	219927	91937	7101	79768	23234	8894	150962	64395	51122	1967	4141	313	11102	387914	79174	84933	637	4143	594	258010	5704	64581	7852	9871	84541	10855	55319	10073	9688	8417	79000	9261	23313	7278	9535	22949	1050	51056	221476	24146	718	51726	81567	5685	54940	23594	112399	26156	83937	100506562	161145	166929	55120	7841	92610	149998	2212	5223	54606	9896	142	5692	26578	9555	4678	10513	663	81704	1607	9447	51678	3929	2171	23360	4210	51429	1113	4973	84329	968	3672	8318	51284	8543	11182	1991	115350	113235	7498	1743	8540	2109	6780	6566	51097	5899	147138	2583	23590	9060	23788	26149	127700	23659	6288	6590	375	3084	3575	56605	81602	5706	5558	51805	167153	23452	6051	6196	1062	84844	65055	80018	91272	6428	51061	9050	80013	10267	1161	81556	85476	10237	10350	1892	84920	168090	1407	10972	9709	4128	51172	51455	6605	6748	5175	5034	3055	3417	55040	2207	9188	79647	55119	8842	2935	84946	8985	7305	55284	90871	26589	9097	55751
GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_DN	M7485		20501946	Newell KA,Asare A,Kirk AD,Gisler TD,Bourcier K,Suthanthiran M,Burlingham WJ,Marks WH,Sanz I,Lechler RI,Hernandez-Fuentes MP,Turka LA,Seyfert-Margolis VL,LastName M	GSE22229	GSE22229_2395_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in periperal blood monocytes (PBMC) from kidney transplant recipients: tolerant versus immunosuppressive therapy.	In this study, investigators recruited the largest reported cohort of tolerant kidney transplant recipients who maintained their graft after ceasing to take their immunosuppression drug, and compared this cohort to subjects with stable allograft function while on immunosuppression and healthy non transplated, controls. Using gene expression studies, they identified genetic markers that are strong candidates for predicting kidney transplant candidates who may benefit from minimization or withdrawl of immunosuppression. Microarrays were used to detect expressed gene profiles of whole-blood total RNA from subjects in the tolerant, standard immunotherapy and healthy control participants					63035	79001	84878	57707	6563	10491	2690	10653	25939	9858	11117	201294	9934	64411	203522	10158	136895	373156	51227	7137	2205	3476	126306	768	54682	9744	25849	5066	2132	91860	23201	196403	23569	10184	20	54970	1666	5911	154214	10561	28992	8991	4882	5218	153579	153364	128866	3108	4126	8801	153020	51380	387787	5592	9317	10809	8436	80318	2355	4782	2330	7132	84883	5867	159296	10133	23492	6990	112574	285315	7185	28966	50810	6453	146857	54498	51754	3133	3674	64284	6886	57722	80896	91624	3690	153642	55365	6272	6708	119710	10379	132299	340485	201266	7791	25875	1521	283130	23345	2887	6837	81607	85358	9722	79871	90362	6545	6809	79816	23608	64114	375033	58472	10765	23048	91107	126917	1762	80148	1376	84284	54739	6821	81849	54785	9813	116449	60370	143888	2256	11031	2273	23022	91807	79746	1282	100506742	9588	57590	145853	50515	1602	10257	1284	55198	8992	7145	29941	2026	10840	89846	391059	126432	2203	2548	8416	11046	9814	388531	1843	151194	8435	55194	121053	114876	26580	255783	1454	9310	80177	4609	5272	168544	1201	3590	123016	5090	4744	4363	64231	9641	284	57674	6236	3973	4692	9573	6497	83938	23259	57465	57555	3945	90407	130576	9985	10347	91748	5947	3623
GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_UP	M7486		20501946	Newell KA,Asare A,Kirk AD,Gisler TD,Bourcier K,Suthanthiran M,Burlingham WJ,Marks WH,Sanz I,Lechler RI,Hernandez-Fuentes MP,Turka LA,Seyfert-Margolis VL,LastName M	GSE22229	GSE22229_2396_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in periperal blood monocytes (PBMC): tolerant kidney transplants versus healthy controls.	In this study, investigators recruited the largest reported cohort of tolerant kidney transplant recipients who maintained their graft after ceasing to take their immunosuppression drug, and compared this cohort to subjects with stable allograft function while on immunosuppression and healthy non transplated, controls. Using gene expression studies, they identified genetic markers that are strong candidates for predicting kidney transplant candidates who may benefit from minimization or withdrawl of immunosuppression. Microarrays were used to detect expressed gene profiles of whole-blood total RNA from subjects in the tolerant, standard immunotherapy and healthy control participants					6038	9156	2475	7410	23062	8543	2113	79930	92241	6123	117177	79925	29899	5253	2483	10615	2841	1803	133121	4860	6790	6598	5393	79183	90488	115650	4124	54629	388228	10229	53347	9775	5294	26053	79833	85476	8303	4063	9516	9130	890	9270	54820	9467	64781	84329	359845	26225	10235	1031	260425	158135	120935	392617	124842	2953	91703	57091	9688	2146	64792	55775	29107	11065	1955	59350	56942	23047	3845	10465	54758	54850	51512	55120	23397	3663	8460	10051	4141	9520	6941	7298	10039	55565	134218	84138	26205	3514	81559	8728	27351	494115	3836	9988	9451	4606	51258	4288	255809	701	57621	57544	9450	10403	1445	51123	274	23143	79576	197370	26586	57405	4061	6396	80757	9595	388753	994	5050	220002	5286	90273	54511	1075	378708	29928	3507	51296	84803	81873	7328	23052	133690	5700	1466	3735	4218	23505	7128	83540	55010	6566	65980	23023	55	58528	6461	1062	54210	11217	339766	10263	9768	11198	974	9232	219	158399	11142	3512	283431	22949	89849	79023	9473	7083	60673	4217	9709	52	8932	221421	54439	406	6385	2162	55270	5889	8326	23313	2675	5550	952	51726	22843	83891	1026	7323	168090	27075	7832	9787	115294	57823	586	10460	59269	90417	91369	55435
GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_UP	M7489		20505160	Juelke K,Killig M,Luetke-Eversloh M,Parente E,Gruen J,Morandi B,Ferlazzo G,Thiel A,Schmitt-Knosalla I,Romagnani C	GSE21774	GSE21774_3813_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in NCAM+ [GeneID=4684] NK cells: SELL bright [GeneID=6402] versus SELL dim [GeneID=6402].	Human Natural Killer (NK) cells comprise two main subsets, CD56bright and CD56dim cells, that differ in function, phenotype and tissue localization. To further dissect the heterogeneity of CD56dim cells, we have performed transcriptome analysis and functional ex vivo characterization of human NK cell subsets according to the expression of markers related to differentiation, migration or competence. Here, we show for the first time that the ability to respond to cytokines or to activating receptors is mutually exclusive in almost all NK cells with the exception of CD56dim CD62L+ cells. Indeed, only these cells combine the ability to produce interferon (IFN)-gamma after cytokines and proliferate in vivo during viral infection with the capacity to kill and produce cytokines upon engagement of activating receptors. Therefore, CD56dim CD62L+ cells represent a unique subset of polyfunctional NK cells. Ex vivo analysis of their function, phenotype, telomere length, frequencies during ageing as well as transfer experiments of NK cell subsets into immunodeficient mice suggest that CD56dim CD62L+ cells represent an intermediate stage of NK cell maturation, which after restimulation can accomplish multiple tasks and further develop into terminally differentiated effectors.					84668	51701	117178	10966	2887	26751	84669	2947	154214	8328	7402	51375	23099	4675	54467	26031	1366	5957	10389	6005	160518	123606	55340	4613	23199	64844	4774	5747	4659	3091	27107	9265	440138	754	116931	23176	203522	79828	3690	8863	27250	26471	358	54941	10479	4352	29957	81573	284307	3068	54749	4300	8460	8780	92344	26960	56897	56271	7049	2995	8395	22915	2650	6708	54877	79625	23043	92745	80315	26207	169200	216	89846	112	9139	59277	3792	3655	54855	222642	92597	5023	161882	3098	284119	2122	51251	4692	759	272	55312	115	2273	139170	9991	7225	7559	79139	5877	114882	10661	151556	677	6453	896	127428	26953	928	64753	5782	54904	10154	2944	10787	221710	1788	5371	134429	23186	80781	366	84898	54521	760	57446	78990	5244	54885	3643	5908	29895	6916	669	10791	64718	54536	10916	326624	23387	22875	23362	57669	28951	10396	4502	7082	5577	7450	6738	147991	905	2690	3433	83891	6007	79884	79595	201595	153222	157506	151742	28962	5318	56907	55363	10370	55907	84302	54503	645	375449	3689	8462	51100	94121	63977	10138	5332	57678	286148	84142	2035	23461	23001	6482	8569	2057	1602	1289	285527	143686	153562	199870	57531	64393	55553	120406	93664	56265	26268
GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP	M7490		20505160	Juelke K,Killig M,Luetke-Eversloh M,Parente E,Gruen J,Morandi B,Ferlazzo G,Thiel A,Schmitt-Knosalla I,Romagnani C	GSE21774	GSE21774_3814_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in NCAM1+ SELL bright [GeneID=4684;6402] versus NCAM1- SELL dim [GeneID=4684;6402].	Human Natural Killer (NK) cells comprise two main subsets, CD56bright and CD56dim cells, that differ in function, phenotype and tissue localization. To further dissect the heterogeneity of CD56dim cells, we have performed transcriptome analysis and functional ex vivo characterization of human NK cell subsets according to the expression of markers related to differentiation, migration or competence. Here, we show for the first time that the ability to respond to cytokines or to activating receptors is mutually exclusive in almost all NK cells with the exception of CD56dim CD62L+ cells. Indeed, only these cells combine the ability to produce interferon (IFN)-gamma after cytokines and proliferate in vivo during viral infection with the capacity to kill and produce cytokines upon engagement of activating receptors. Therefore, CD56dim CD62L+ cells represent a unique subset of polyfunctional NK cells. Ex vivo analysis of their function, phenotype, telomere length, frequencies during ageing as well as transfer experiments of NK cell subsets into immunodeficient mice suggest that CD56dim CD62L+ cells represent an intermediate stage of NK cell maturation, which after restimulation can accomplish multiple tasks and further develop into terminally differentiated effectors.					146378	3394	400757	5223	112574	6402	1043	169792	729230	11185	158787	7852	25960	2833	203197	126282	57103	51517	340061	55971	84159	215	4258	8412	57194	2903	249	55212	5831	10279	57211	84617	84734	83937	26227	7545	196410	7372	718	6653	1638	2162	65059	84283	54210	149069	388595	124935	6468	8829	5455	10603	6404	84948	26033	8706	3507	1852	115827	1436	10261	11230	1956	57089	8851	55911	51284	653361	112399	3786	1903	3934	89790	57568	306	51316	9450	5732	126969	9473	2583	58475	942	3983	969	5212	1050	3055	389337	55600	3801	5657	27296	159989	64115	10673	2280	2841	84667	26996	129049	10156	10439	4689	5031	1791	797	343450	5452	80765	169044	7305	1260	63906	1501	7227	7124	431705	64067	57522	1601	230	2539	221476	4360	7798	302	80024	1511	1003	197370	6709	338557	10457	1266	57509	151126	400745	23621	27143	53346	929	2892	6304	339302	654429	3212	7076	115948	163183	26090	28231	2817	10855	10298	55353	122618	10123	93099	6688	90187	2709	23313	9651	2264	8507	397	187	29062	284346	4783	771	8564	2591	79626	151888	1536	93649	54769	1991	84002	11014	50617	9697	65108	4256	387914	1490	79895	940	6282	118788	55332	3417	6925	84925	9332	55034	80017	55181
GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP	M7491		20505160	Juelke K,Killig M,Luetke-Eversloh M,Parente E,Gruen J,Morandi B,Ferlazzo G,Thiel A,Schmitt-Knosalla I,Romagnani C	GSE21774	GSE21774_3815_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in SELL dim [GeneID=6402] NK cells: NCAM1+ [GeneID=4684] versus NCAM1- [GeneID=4684].	Human Natural Killer (NK) cells comprise two main subsets, CD56bright and CD56dim cells, that differ in function, phenotype and tissue localization. To further dissect the heterogeneity of CD56dim cells, we have performed transcriptome analysis and functional ex vivo characterization of human NK cell subsets according to the expression of markers related to differentiation, migration or competence. Here, we show for the first time that the ability to respond to cytokines or to activating receptors is mutually exclusive in almost all NK cells with the exception of CD56dim CD62L+ cells. Indeed, only these cells combine the ability to produce interferon (IFN)-gamma after cytokines and proliferate in vivo during viral infection with the capacity to kill and produce cytokines upon engagement of activating receptors. Therefore, CD56dim CD62L+ cells represent a unique subset of polyfunctional NK cells. Ex vivo analysis of their function, phenotype, telomere length, frequencies during ageing as well as transfer experiments of NK cell subsets into immunodeficient mice suggest that CD56dim CD62L+ cells represent an intermediate stage of NK cell maturation, which after restimulation can accomplish multiple tasks and further develop into terminally differentiated effectors.					84629	818	6775	3590	1032	340061	6320	5129	92241	153562	7903	143686	4952	10983	2184	253782	7163	643549	84954	686	5151	23254	7409	1794	971	5066	153020	122622	63935	4211	284	23177	953	3111	9476	26060	1466	285267	326624	9452	4938	10865	91012	127281	8916	64407	112399	57216	6714	24147	541565	4353	9938	57507	2135	11167	80025	401494	1454	59269	79993	2113	116496	10561	55194	8826	5058	4818	63976	11237	196394	7738	201232	114770	9737	79178	9619	463	23368	137835	4242	3241	757	2690	8935	60685	79153	6653	168544	3632	2306	256281	152926	5315	1730	9051	10536	5230	10840	3655	90332	91	10174	119559	57406	84617	4026	2245	4313	64651	2004	11151	1788	11172	4189	1511	220963	100128927	9467	90313	28970	54800	100506742	203522	10203	80896	10235	221178	22797	9770	7424	9466	7227	10410	197358	401546	4086	256691	118429	3005	3643	3205	50853	5947	824	79630	7494	8736	307	2120	51661	64761	23014	10161	25959	4054	6513	3074	9252	84254	55536	11214	6197	57716	57097	26022	642938	9620	8125	395	9750	94240	8934	84898	256949	54795	783	57412	1602	375033	59339	7099	241	1734	8100	4688	1203	8809	754	26027	51666	8895	64005	5788	84307	55508	6039	9734	8013	4050
GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_DN	M7492		20505160	Juelke K,Killig M,Luetke-Eversloh M,Parente E,Gruen J,Morandi B,Ferlazzo G,Thiel A,Schmitt-Knosalla I,Romagnani C	GSE21774	GSE21774_3813_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in NCAM+ [GeneID=4684] NK cells: SELL bright [GeneID=6402] versus SELL dim [GeneID=6402].	Human Natural Killer (NK) cells comprise two main subsets, CD56bright and CD56dim cells, that differ in function, phenotype and tissue localization. To further dissect the heterogeneity of CD56dim cells, we have performed transcriptome analysis and functional ex vivo characterization of human NK cell subsets according to the expression of markers related to differentiation, migration or competence. Here, we show for the first time that the ability to respond to cytokines or to activating receptors is mutually exclusive in almost all NK cells with the exception of CD56dim CD62L+ cells. Indeed, only these cells combine the ability to produce interferon (IFN)-gamma after cytokines and proliferate in vivo during viral infection with the capacity to kill and produce cytokines upon engagement of activating receptors. Therefore, CD56dim CD62L+ cells represent a unique subset of polyfunctional NK cells. Ex vivo analysis of their function, phenotype, telomere length, frequencies during ageing as well as transfer experiments of NK cell subsets into immunodeficient mice suggest that CD56dim CD62L+ cells represent an intermediate stage of NK cell maturation, which after restimulation can accomplish multiple tasks and further develop into terminally differentiated effectors.					83746	79572	92840	2054	219743	2057	116541	10940	124454	51002	646486	7389	9238	516	122481	64949	6708	63941	11018	92106	10632	83893	79078	2999	9562	64080	7390	334	374618	134492	8761	4628	132720	220323	23604	10661	79707	646457	54741	26278	79628	126119	222642	22936	2040	63027	51013	1616	10901	79683	2730	3249	3918	2235	10657	80714	482	4052	8862	27429	9185	90480	91801	163732	6517	51016	57147	7109	54749	10988	64393	55707	57602	120406	7511	7809	9044	644186	1603	254528	9401	56675	4522	59349	11343	23333	5820	51062	30813	25897	1376	285641	151295	118980	11336	50632	976	2539	1874	54827	3908	50865	6560	286148	4486	5439	23176	55322	84245	8460	55847	27352	9265	57720	9128	8501	8692	28991	55171	387804	9136	10058	4747	64077	25996	10422	55884	29901	390010	54093	2887	4239	6728	23052	56246	152217	23271	55718	8707	5362	64762	119	54821	26289	92259	220042	200205	645	91442	92745	27000	27443	8869	26519	10389	79791	9200	116987	2671	389125	131118	9093	958	115708	728317	3482	100141515	3732	5455	22934	56271	79066	54855	23170	199	11221	151742	161357	4642	51280	6622	90378	9588	7357	54433	29062	6241	6794	26073	1491	117247	10481	84135	84331	8021	216	57669	388796	3792	80199
GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN	M7495		20505160	Juelke K,Killig M,Luetke-Eversloh M,Parente E,Gruen J,Morandi B,Ferlazzo G,Thiel A,Schmitt-Knosalla I,Romagnani C	GSE21774	GSE21774_3814_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in NCAM1+ SELL bright [GeneID=4684;6402] versus NCAM1- SELL dim [GeneID=4684;6402].	Human Natural Killer (NK) cells comprise two main subsets, CD56bright and CD56dim cells, that differ in function, phenotype and tissue localization. To further dissect the heterogeneity of CD56dim cells, we have performed transcriptome analysis and functional ex vivo characterization of human NK cell subsets according to the expression of markers related to differentiation, migration or competence. Here, we show for the first time that the ability to respond to cytokines or to activating receptors is mutually exclusive in almost all NK cells with the exception of CD56dim CD62L+ cells. Indeed, only these cells combine the ability to produce interferon (IFN)-gamma after cytokines and proliferate in vivo during viral infection with the capacity to kill and produce cytokines upon engagement of activating receptors. Therefore, CD56dim CD62L+ cells represent a unique subset of polyfunctional NK cells. Ex vivo analysis of their function, phenotype, telomere length, frequencies during ageing as well as transfer experiments of NK cell subsets into immunodeficient mice suggest that CD56dim CD62L+ cells represent an intermediate stage of NK cell maturation, which after restimulation can accomplish multiple tasks and further develop into terminally differentiated effectors.					8744	115123	64839	10966	153562	2624	3655	54536	2122	26207	10158	5784	1032	326624	63976	55790	329	7378	64753	121665	285382	9958	55847	4300	4659	23765	7225	55287	8848	676	84668	23387	51666	8863	3131	132430	2549	10180	51379	57446	93664	51380	23175	9710	285440	284371	11200	1911	401494	26268	4692	2273	375033	256691	23461	55553	2309	283337	57669	4774	953	8736	79670	3690	27330	1729	23301	3082	26065	7559	55128	492311	5023	952	64766	54874	6916	54492	11167	7402	222166	51701	79632	26960	760	151742	2035	23362	54762	439996	153222	10561	7049	5742	205428	60680	81619	116835	9924	51616	116843	85016	55704	7248	55340	116931	9415	4675	23043	155435	155038	1876	9139	6453	5208	57678	122773	4352	55384	1456	9071	56254	348093	283450	9205	7029	4613	26523	90952	6708	81577	22982	10142	8613	83943	85444	80760	55374	158219	161882	1366	285331	222642	8869	10773	54629	2643	81553	57198	54469	5996	84302	4301	84552	9656	57088	153768	79712	23001	23509	9827	55014	84898	7982	29761	54904	219285	5128	84941	170575	57532	57336	92104	10396	64921	1829	2944	54954	92745	29978	143686	8567	3664	11141	4122	9411	2664	84307	80014	119392	57531	669	84181	139170	9258	203228	6940	7082	5241	219541
GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN	M7496		20505160	Juelke K,Killig M,Luetke-Eversloh M,Parente E,Gruen J,Morandi B,Ferlazzo G,Thiel A,Schmitt-Knosalla I,Romagnani C	GSE21774	GSE21774_3815_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in SELL dim [GeneID=6402] NK cells: NCAM1+ [GeneID=4684] versus NCAM1- [GeneID=4684].	Human Natural Killer (NK) cells comprise two main subsets, CD56bright and CD56dim cells, that differ in function, phenotype and tissue localization. To further dissect the heterogeneity of CD56dim cells, we have performed transcriptome analysis and functional ex vivo characterization of human NK cell subsets according to the expression of markers related to differentiation, migration or competence. Here, we show for the first time that the ability to respond to cytokines or to activating receptors is mutually exclusive in almost all NK cells with the exception of CD56dim CD62L+ cells. Indeed, only these cells combine the ability to produce interferon (IFN)-gamma after cytokines and proliferate in vivo during viral infection with the capacity to kill and produce cytokines upon engagement of activating receptors. Therefore, CD56dim CD62L+ cells represent a unique subset of polyfunctional NK cells. Ex vivo analysis of their function, phenotype, telomere length, frequencies during ageing as well as transfer experiments of NK cell subsets into immunodeficient mice suggest that CD56dim CD62L+ cells represent an intermediate stage of NK cell maturation, which after restimulation can accomplish multiple tasks and further develop into terminally differentiated effectors.					1040	55821	51061	4758	91689	57576	9709	2212	6402	51734	54815	23423	439921	3579	10875	400757	2591	3290	84617	771	337880	5223	126282	54210	136227	201305	64222	284076	6470	80199	145264	5999	3595	729230	2717	1991	116535	6196	3417	4035	306	83733	57113	9695	1137	10632	4258	3653	56915	140606	6712	2745	3934	54504	1043	154141	8528	8829	84159	629	6282	64581	56005	5354	3061	10849	199675	3240	53905	1310	8751	3552	4130	3801	89790	6641	3394	92689	2583	6755	221476	91445	1438	1852	84277	114789	81839	6730	340562	3945	168620	64975	4317	80852	3786	8537	51442	50509	92369	149998	9450	26003	257068	56246	255101	112574	51237	2813	113746	1601	50832	4126	84501	55357	4973	56341	2023	57568	1230	4616	83871	932	64168	2674	5452	2176	112399	811	211	2242	116844	93099	3265	145508	80263	79895	129530	397	8417	527	84440	653361	159989	6688	400916	56344	10603	2213	4987	407738	254827	15	9238	7305	51042	4921	2134	10235	57699	65124	147699	9294	57509	1951	112483	7477	57348	5230	226	219438	2264	55852	6876	83988	706	9563	3355	5732	6709	2709	388284	6583	80019	929	6445	2892	8985	4689	122402	10261	1412	1511	2706	65260	56	10613	255809	26227	23500	26996
GSE23695_CD57_POS_VS_NEG_NK_CELL_UP	M7784		20733159	Lopez-Vergès S,Milush JM,Pandey S,York VA,Arakawa-Hoyt J,Pircher H,Norris PJ,Nixon DF,Lanier LL	GSE23695	GSE23695_3368_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in NK cells: B3GAT1+ [GeneID=27087] versus B3GAT1- [GeneID=27087].	Thirty to 60% of CD56dimCD16bright NK cells in healthy adults express CD57, which is not expressed on immature CD56bright NK cells or fetal and newborn NK cells. We hypothesized that CD57+ NK cells within the CD56dim mature NK cell subset are highly mature and might be terminally differentiated. We used microarrays to assess the transcriptional differences between CD57+ and CD57neg NK cells within the CD56dim mature NK subset.					51491	64781	6239	8507	3516	729747	221472	129880	133619	55193	55668	55717	391059	327	81554	57707	790955	64118	90427	124801	5515	84936	6183	135154	10479	200081	5209	473	80142	257106	23759	171568	140809	58513	84172	90135	51230	3955	22845	4050	50865	9473	5791	9406	11276	1848	56996	79668	3996	27000	643641	27090	4580	9894	81488	5903	64855	84255	124583	3087	4247	9616	55010	60487	9557	65263	55027	84154	57698	5361	64324	157313	51654	84079	1059	51250	150383	8317	116461	27043	388650	84975	22834	28989	101	6993	57673	157567	9443	23396	5829	151888	9166	22954	10664	203068	84197	8165	338557	221092	219743	338773	51649	284613	23077	493856	54816	1487	153830	83641	6878	8725	26135	9988	285590	84516	92092	728489	55759	60493	9202	6731	6489	55552	54726	10447	80207	28973	8907	51807	5705	8089	2060	29117	975	8672	84617	55315	10597	26091	1743	64976	29966	55140	4288	1102	1435	29078	55163	6693	9532	22827	57655	5739	10534	1050	90353	64859	57514	51193	95681	56623	10427	116224	4152	169714	5198	8427	64092	80829	89849	54433	64423	10102	10322	23151	54882	90480	5822	5073	63901	224	8567	57405	91419	9716	3796	84878	1545	10287	5294	3066	56984	79828	5272	126792	29093	22821	84823	138716
GSE23695_CD57_POS_VS_NEG_NK_CELL_DN	M7786		20733159	Lopez-Vergès S,Milush JM,Pandey S,York VA,Arakawa-Hoyt J,Pircher H,Norris PJ,Nixon DF,Lanier LL	GSE23695	GSE23695_3368_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in NK cells: B3GAT1+ [GeneID=27087] versus B3GAT1- [GeneID=27087].	Thirty to 60% of CD56dimCD16bright NK cells in healthy adults express CD57, which is not expressed on immature CD56bright NK cells or fetal and newborn NK cells. We hypothesized that CD57+ NK cells within the CD56dim mature NK cell subset are highly mature and might be terminally differentiated. We used microarrays to assess the transcriptional differences between CD57+ and CD57neg NK cells within the CD56dim mature NK subset.					54629	3925	1652	3992	79685	1106	158219	65056	1431	11228	84311	81572	143684	29844	23135	10066	10263	6618	83860	113251	56946	6652	54980	140691	10735	55181	1969	6746	2965	6046	5926	57614	285172	414301	50626	3304	10135	23354	4695	79133	94005	10277	51316	57799	151295	23008	5727	219844	23258	56975	4126	133686	84557	6391	114883	26224	133746	1647	9322	84803	47	26001	7414	80853	84318	7862	65981	25807	348793	7316	1263	5327	10368	6827	84706	8887	23764	51077	9120	51318	2683	23099	117247	25932	10924	4214	8884	54472	9153	5499	10978	92	158405	10370	57118	6884	64764	84268	23071	23228	90411	1039	8812	2669	113130	11196	83875	9821	50848	24146	348	5546	79157	5286	84693	80011	51247	51176	51226	254428	5743	54386	10138	97	523	55636	130752	375484	286205	84303	51307	54908	1718	8435	54708	340719	1326	3017	29855	84925	9541	550643	822	51099	1032	64112	427	22877	2962	5095	80019	6651	84930	6497	231	55365	54520	55172	1386	2551	10124	57585	54557	55450	19	5154	51202	124817	1201	57705	3420	5058	11244	10531	56951	10912	11016	83696	7156	269	3280	151556	57690	1031	64116	837	6675	901	55647	51234	5723	27346	84922	1122	338811	10063	54915	100113407	27010	171586
GSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP	M7789		20802500	Kotz KT,Xiao W,Miller-Graziano C,Qian WJ,Russom A,Warner EA,Moldawer LL,De A,Bankey PE,Petritis BO,Camp DG,Rosenbach AE,Goverman J,Fagan SP,Brownstein BH,Irimia D,Xu W,Wilhelmy J,Mindrinos MN,Smith RD,Davis RW,Tompkins RG,Toner M,LastName M	GSE22103	GSE22103_3648_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in neutrophils: untreated versus stimulated by CSF2 and IFNG [GeneID=1437;3458].	Neutrophils play critical roles in modulating the immune response. However, neutrophils have a short circulating half life, are readily stimulated in vitro, and have low levels of cellular mRNA when compared to other blood leukocyte populations. All of these factors have made it difficult to evaluate neutrophils from clinical populations for molecular and functional studies. Here we present a robust methodology for rapidly isolating neutrophils directly from whole blood and develop ‘on- chip’ processing for mRNA and protein isolation for genomics and proteomics. We validate this device with an ex vivo stimulation experiment and demonstrate the ability of the device to discriminate subtle differences in the genomic and proteomic response of peripheral blood neutrophils to direct and indirect stimulation. Lastly, we implement this tool as part of a near patient blood processing system within a multi-center clinical study of the immune response to severe trauma and burn injury and demonstrate that this technique is easy to use by nurses and technical staff yielding excellent quality and sufficient quantity of mRNA for sensitive genomic readout of the host response to injury					7993	23531	2872	5829	221178	84975	6886	127262	125488	83445	388969	56910	53838	9443	64743	63939	64855	114609	6867	57707	55471	79155	283232	25974	375387	83932	975	22978	149076	10559	29925	196527	81501	126626	64854	53918	221927	23195	25853	137492	54919	121268	28955	1973	9069	10181	71	3267	285590	10196	55315	10634	23047	6376	79810	113444	91137	90427	8030	54471	6416	84376	6760	51129	2145	29035	83460	340351	2495	27173	140775	25913	9538	23259	3646	81539	51258	81034	56957	80155	54492	200081	55968	867	1432	1848	2990	158586	84962	10622	55904	11102	23438	8672	4194	11222	58513	29	29979	387787	55749	55379	388650	55188	23603	23637	5395	221656	4602	8507	4204	7257	124997	54861	10008	84864	6575	27304	5774	26065	7295	9424	10608	80789	4926	134430	10989	10717	23082	311	6002	79183	1743	10657	57684	25959	4659	79018	162073	138050	3014	54994	54765	8402	50865	114034	57613	79072	91937	9903	9738	7074	23583	55355	136	10768	8295	29942	56916	389206	3295	388228	92092	5471	54832	9252	493911	8658	63901	79675	3460	64763	6389	55625	55917	79733	3054	25926	3704	8161	51439	112479	152002	595	84678	23466	114793	1439	116150	56674	1207	9684	60493	4773	84541	84920	25962	64789	51633	84878
GSE22103_UNSTIM_VS_LPS_STIM_NEUTROPHIL_DN	M7790		20802500	Kotz KT,Xiao W,Miller-Graziano C,Qian WJ,Russom A,Warner EA,Moldawer LL,De A,Bankey PE,Petritis BO,Camp DG,Rosenbach AE,Goverman J,Fagan SP,Brownstein BH,Irimia D,Xu W,Wilhelmy J,Mindrinos MN,Smith RD,Davis RW,Tompkins RG,Toner M,LastName M	GSE22103	GSE22103_3647_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in neutrophils: untreated versus LPS.	Neutrophils play critical roles in modulating the immune response. However, neutrophils have a short circulating half life, are readily stimulated in vitro, and have low levels of cellular mRNA when compared to other blood leukocyte populations. All of these factors have made it difficult to evaluate neutrophils from clinical populations for molecular and functional studies. Here we present a robust methodology for rapidly isolating neutrophils directly from whole blood and develop ‘on- chip’ processing for mRNA and protein isolation for genomics and proteomics. We validate this device with an ex vivo stimulation experiment and demonstrate the ability of the device to discriminate subtle differences in the genomic and proteomic response of peripheral blood neutrophils to direct and indirect stimulation. Lastly, we implement this tool as part of a near patient blood processing system within a multi-center clinical study of the immune response to severe trauma and burn injury and demonstrate that this technique is easy to use by nurses and technical staff yielding excellent quality and sufficient quantity of mRNA for sensitive genomic readout of the host response to injury					11054	1843	586	440689	54407	2353	1826	4047	3613	2921	54985	11055	79077	25805	2109	84433	57799	57535	47	3338	7140	2645	9232	117155	51646	84954	280636	64748	9900	79145	54958	374291	3303	54187	79019	1198	79812	219557	54543	253190	6921	4783	10654	375484	30844	163154	23025	5260	51285	3280	256281	3315	285800	9715	10397	3164	10412	63982	23764	27106	10018	7305	51042	55145	83881	6651	8351	6150	9553	85014	51025	8626	8320	1475	84930	6468	8313	340719	80003	54850	3304	3552	9390	100134934	4487	51232	3925	80323	5595	1106	83660	388701	9120	22839	6722	643338	3004	85028	7064	177	84722	3553	1476	158405	11011	1491	223	6509	9140	51079	5710	390992	23175	991	231	79720	79958	346	1154	692227	1969	8572	5016	8153	10263	26227	286753	4091	9314	79844	79006	25796	25819	29911	25804	121642	3720	114876	64968	90993	162417	3017	10769	6103	10615	400916	2582	29937	5077	6733	7975	57761	10284	9735	23464	158038	55602	7316	10614	55621	467	6615	57060	79802	51655	7205	79627	5201	6482	54976	64121	51540	393	54462	3489	16	4524	26064	4717	51554	4668	2286	3199	2965	1152	81849	27253	6223	833	3337	203260	55647	51440	7862	6232	10312	29992	2717	51389	58494
GSE22103_LPS_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_DN	M7791		20802500	Kotz KT,Xiao W,Miller-Graziano C,Qian WJ,Russom A,Warner EA,Moldawer LL,De A,Bankey PE,Petritis BO,Camp DG,Rosenbach AE,Goverman J,Fagan SP,Brownstein BH,Irimia D,Xu W,Wilhelmy J,Mindrinos MN,Smith RD,Davis RW,Tompkins RG,Toner M,LastName M	GSE22103	GSE22103_3649_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in neutrophils: LPS versus stimulated by CSF2 and IFNG [GeneID=1437;3458].	Neutrophils play critical roles in modulating the immune response. However, neutrophils have a short circulating half life, are readily stimulated in vitro, and have low levels of cellular mRNA when compared to other blood leukocyte populations. All of these factors have made it difficult to evaluate neutrophils from clinical populations for molecular and functional studies. Here we present a robust methodology for rapidly isolating neutrophils directly from whole blood and develop ‘on- chip’ processing for mRNA and protein isolation for genomics and proteomics. We validate this device with an ex vivo stimulation experiment and demonstrate the ability of the device to discriminate subtle differences in the genomic and proteomic response of peripheral blood neutrophils to direct and indirect stimulation. Lastly, we implement this tool as part of a near patient blood processing system within a multi-center clinical study of the immune response to severe trauma and burn injury and demonstrate that this technique is easy to use by nurses and technical staff yielding excellent quality and sufficient quantity of mRNA for sensitive genomic readout of the host response to injury					11070	114609	60468	84916	9738	9655	80031	8994	7844	5774	4909	55308	5908	3454	27352	285331	3840	283897	81609	4864	65265	196527	27304	490	57606	29979	824	55884	6935	136	8507	2872	55108	84275	162494	22936	126626	3797	302	112950	80829	79893	9578	92126	55654	64789	145864	57648	8818	9989	9639	5606	284371	10150	91137	55628	26115	2909	54832	92935	8408	80775	9950	2067	9516	4552	23111	220929	8496	23082	10087	9816	29942	79572	4674	23092	51164	23190	55609	10725	1859	8915	90427	54542	148789	51561	23384	115350	253143	4194	57147	1476	8621	1495	5193	23710	55741	64318	80263	85465	5971	51231	51542	57198	8030	10321	84678	10127	10181	2731	55623	645	143282	29107	23002	4793	94032	1687	50618	50615	10579	2690	25853	10989	50515	85406	9654	26122	51126	3162	4152	23241	8517	5708	2149	330	27348	79027	3267	51365	54487	80325	55322	54765	23367	84975	8809	10933	55904	392	196528	267	7764	79018	6297	8242	5537	55778	23300	23583	604	382	84803	51272	1677	9748	53838	84878	4493	92181	80351	23587	221749	57608	1112	9414	54867	2803	1030	3824	114793	64863	55321	221927	9475	10938	30851	7776	3579	58191	2280	157378	23438	10106	10081	4758	22906	57659	100128927	56674
GSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_DN	M7792		20802500	Kotz KT,Xiao W,Miller-Graziano C,Qian WJ,Russom A,Warner EA,Moldawer LL,De A,Bankey PE,Petritis BO,Camp DG,Rosenbach AE,Goverman J,Fagan SP,Brownstein BH,Irimia D,Xu W,Wilhelmy J,Mindrinos MN,Smith RD,Davis RW,Tompkins RG,Toner M,LastName M	GSE22103	GSE22103_3648_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in neutrophils: untreated versus stimulated by CSF2 and IFNG [GeneID=1437;3458].	Neutrophils play critical roles in modulating the immune response. However, neutrophils have a short circulating half life, are readily stimulated in vitro, and have low levels of cellular mRNA when compared to other blood leukocyte populations. All of these factors have made it difficult to evaluate neutrophils from clinical populations for molecular and functional studies. Here we present a robust methodology for rapidly isolating neutrophils directly from whole blood and develop ‘on- chip’ processing for mRNA and protein isolation for genomics and proteomics. We validate this device with an ex vivo stimulation experiment and demonstrate the ability of the device to discriminate subtle differences in the genomic and proteomic response of peripheral blood neutrophils to direct and indirect stimulation. Lastly, we implement this tool as part of a near patient blood processing system within a multi-center clinical study of the immune response to severe trauma and burn injury and demonstrate that this technique is easy to use by nurses and technical staff yielding excellent quality and sufficient quantity of mRNA for sensitive genomic readout of the host response to injury					57153	83716	58478	3338	10411	5699	4602	200185	112399	1063	8614	333926	1826	215	7350	55020	7167	54478	222229	2175	9232	4436	79077	126432	79627	5188	26517	10008	147965	10235	8351	3280	25776	84552	3683	3199	134147	7064	11284	6320	138311	113246	51398	1849	51020	89958	10975	11202	8438	26227	8609	84941	59307	4173	157313	63940	2040	374291	2197	28960	2353	84331	122704	11065	8153	441478	4716	7374	9046	7125	11184	79064	339451	7272	256281	221	39	6540	56928	8817	944	55857	27077	6155	374618	7305	164395	586	29920	10919	157570	10312	27089	2582	155185	3108	387640	1062	338773	3184	60314	54958	27289	10791	25873	79587	1028	54496	65981	57088	130560	4350	181	4668	29937	11316	95681	5077	55152	7520	10482	5016	4123	11224	6574	10471	8732	150468	6461	122618	873	63967	79071	25894	79792	23410	9557	29108	51025	10788	8428	2915	4174	146760	9735	4285	4542	1763	675	64077	30844	2242	90993	54187	10856	4487	9133	80755	4091	1352	1960	26094	23201	91624	6651	283234	3315	23070	254170	2978	54930	440574	51282	92170	23616	51069	27166	2119	6168	3613	133522	57405	3507	1174	57799	4744	55847	10005	4212	23210	55024	84445	219557	11031	2821	3633	1033	29903	80228	9590
GSE22103_UNSTIM_VS_LPS_STIM_NEUTROPHIL_UP	M7794		20802500	Kotz KT,Xiao W,Miller-Graziano C,Qian WJ,Russom A,Warner EA,Moldawer LL,De A,Bankey PE,Petritis BO,Camp DG,Rosenbach AE,Goverman J,Fagan SP,Brownstein BH,Irimia D,Xu W,Wilhelmy J,Mindrinos MN,Smith RD,Davis RW,Tompkins RG,Toner M,LastName M	GSE22103	GSE22103_3647_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in neutrophils: untreated versus LPS.	Neutrophils play critical roles in modulating the immune response. However, neutrophils have a short circulating half life, are readily stimulated in vitro, and have low levels of cellular mRNA when compared to other blood leukocyte populations. All of these factors have made it difficult to evaluate neutrophils from clinical populations for molecular and functional studies. Here we present a robust methodology for rapidly isolating neutrophils directly from whole blood and develop ‘on- chip’ processing for mRNA and protein isolation for genomics and proteomics. We validate this device with an ex vivo stimulation experiment and demonstrate the ability of the device to discriminate subtle differences in the genomic and proteomic response of peripheral blood neutrophils to direct and indirect stimulation. Lastly, we implement this tool as part of a near patient blood processing system within a multi-center clinical study of the immune response to severe trauma and burn injury and demonstrate that this technique is easy to use by nurses and technical staff yielding excellent quality and sufficient quantity of mRNA for sensitive genomic readout of the host response to injury					116224	153020	279	10672	6416	83855	64925	26512	2188	55623	145864	57661	5780	112858	3726	3096	84992	55179	1198	51321	23396	84081	10133	23048	7745	129880	124641	56160	51272	5970	91582	958	51012	7846	51667	54726	64782	4782	3454	63875	3662	9716	124801	28973	10933	4899	389	6935	5996	9015	997	3383	7187	644096	59269	677	55802	3796	7127	2067	144699	55668	79048	55272	54206	597	7799	9880	3566	90268	79612	3575	391	78999	10767	84617	26051	246243	90353	355	11057	4780	80271	5155	55170	9948	22888	23190	79020	51676	6498	415116	55110	255374	140775	60528	27249	8089	54458	9827	55814	54014	466	4149	94032	317781	55666	57787	55209	51193	3678	26012	64145	6541	57673	27090	129401	22822	8621	10289	1050	139886	84132	51239	5914	3955	5806	60492	84864	9473	84262	8165	138716	55734	50619	308	7376	1398	49854	79954	84243	9394	602	26984	64855	55609	9655	8175	4321	84909	23533	81501	25977	65265	5876	3783	284371	84919	23560	26286	9258	4814	101	10527	26168	7329	200186	56850	51388	112724	1649	2671	10221	26994	29948	9529	29945	7408	84128	10507	5515	64207	51010	285590	81873	372	29093	51225	55958	7867	84975	9766	115708	4302	55295	26519	84277	55677	8427	22887
GSE22103_LPS_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP	M7795		20802500	Kotz KT,Xiao W,Miller-Graziano C,Qian WJ,Russom A,Warner EA,Moldawer LL,De A,Bankey PE,Petritis BO,Camp DG,Rosenbach AE,Goverman J,Fagan SP,Brownstein BH,Irimia D,Xu W,Wilhelmy J,Mindrinos MN,Smith RD,Davis RW,Tompkins RG,Toner M,LastName M	GSE22103	GSE22103_3649_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in neutrophils: LPS versus stimulated by CSF2 and IFNG [GeneID=1437;3458].	Neutrophils play critical roles in modulating the immune response. However, neutrophils have a short circulating half life, are readily stimulated in vitro, and have low levels of cellular mRNA when compared to other blood leukocyte populations. All of these factors have made it difficult to evaluate neutrophils from clinical populations for molecular and functional studies. Here we present a robust methodology for rapidly isolating neutrophils directly from whole blood and develop ‘on- chip’ processing for mRNA and protein isolation for genomics and proteomics. We validate this device with an ex vivo stimulation experiment and demonstrate the ability of the device to discriminate subtle differences in the genomic and proteomic response of peripheral blood neutrophils to direct and indirect stimulation. Lastly, we implement this tool as part of a near patient blood processing system within a multi-center clinical study of the immune response to severe trauma and burn injury and demonstrate that this technique is easy to use by nurses and technical staff yielding excellent quality and sufficient quantity of mRNA for sensitive genomic readout of the host response to injury					523	7414	84693	138241	11244	5080	5742	29099	83696	9500	10066	93663	57584	9016	25851	7456	201973	197370	28514	84324	55329	5810	4710	116143	26502	3925	6345	1164	80169	54927	79847	5499	8318	285172	140885	115330	113251	80352	23253	1027	23240	81624	55062	51528	23649	255394	93323	116228	55055	254428	9380	23380	115106	9750	65981	5066	26608	9590	25914	7804	4726	4678	10668	80727	143684	3939	23306	286053	5577	2135	91057	9555	30811	5576	492311	84959	2120	10277	286205	253782	283459	114883	54020	124512	283431	8848	6839	25797	10284	7402	91942	51496	9213	11174	8479	79627	51228	60481	9236	3241	54629	4172	22982	1675	55088	215	128308	55614	55785	81926	5723	153830	4628	8293	54539	5058	1429	158866	51460	79176	51318	10659	84273	154661	151556	5926	9896	79001	10005	54982	133686	2519	1386	93380	55270	699	4179	983	2146	2876	7103	132789	8895	5202	6391	64839	27086	8208	8543	24146	28977	411	158219	1540	115123	54776	55732	3667	56987	56922	202333	79042	79979	5095	2491	51109	2342	47	8829	23243	85025	38	6392	92797	151742	29781	57614	57134	84668	55148	1719	83641	254251	10712	94241	64764	84950	1786	92	10238	152185	51360	334	231	5860	23387	220213	64793	9551	10138
GSE22589_HEALTHY_VS_HIV_AND_SIV_INFECTED_DC_DN	M7796		20829794	Manel N,Hogstad B,Wang Y,Levy DE,Unutmaz D,Littman DR	GSE22589	GSE22589_3652_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocyte-derived dendritic cells: control versus HIV and SIV infection.	Dendritic cells (DC) serve a key function in host defense, linking innate detection of microbes to the activation of pathogen-specific adaptive immune responses. Whether there is cell-intrinsic recognition of HIV-1 by host innate pattern-recognition receptors and subsequent coupling to antiviral T cell responses is not yet known. DC are largely resistant to infection with HIV-1, but facilitate infection of co-cultured T-helper cells through a process of trans-enhancement. We show here that, when DC resistance to infection is circumvented, HIV-1 induces DC maturation, an antiviral type I interferon response and activation of T cells. This innate response is dependent on the interaction of newly-synthesized HIV-1 capsid (CA) with cellular cyclophilin A (CypA) and the subsequent activation of the transcription factor IRF3. Because the peptidyl-prolyl isomerase CypA also interacts with CA to promote HIV-1 infectivity, our results suggest that CA conformation has evolved under opposing selective pressures for infectivity versus furtiveness. Thus, a cell intrinsic sensor for HIV-1 exists in DC and mediates an antiviral immune response, but it is not typically engaged due to absence of DC infection. The virulence of HIV-1 may be related to evasion of this response, whose manipulation may be necessary to generate an effective HIV-1 vaccine.					23258	9156	90060	10277	27346	83932	5154	54919	220323	83860	23172	80011	10982	25945	50626	9448	84920	54472	55181	84916	10989	51099	28955	10668	80317	5743	9587	25902	5613	80351	66036	30851	57478	4245	5708	81539	7319	79685	23338	116150	311	4763	178	29099	9653	375444	3627	51726	26046	253558	201163	9016	10531	3632	10560	54797	54785	6885	84803	23008	160418	220213	25962	6867	10150	868	100113407	5870	3054	30836	64968	64430	23067	51776	58524	5814	2909	10319	6124	55270	527	58490	79176	92	9541	345778	26959	874	55145	25963	2005	84311	4254	388701	23099	9500	440138	56935	55726	55051	26958	9442	6566	3837	93380	57684	6683	112574	23530	196527	55835	990	55062	10608	5422	7296	6502	51307	94056	3704	51422	55625	8706	100129269	302	1802	8648	81930	26524	27351	55671	1677	79142	26001	8318	7812	157378	255520	158405	1119	56957	171586	54765	5911	114883	29942	6185	10134	64921	26499	10569	55749	84232	7265	126298	283464	140775	84273	57567	3418	65998	10818	79145	11270	133686	4602	10544	55177	11083	24146	8545	5511	5606	51330	222068	51368	390	55088	90580	204851	4340	54386	387263	22887	5583	201725	6391	83875	79157	79717	57020	5795	6341	27	55729	55785	65997	2521	10363	2591
GSE22589_HEALTHY_VS_SIV_INFECTED_DC_UP	M7798		20829794	Manel N,Hogstad B,Wang Y,Levy DE,Unutmaz D,Littman DR	GSE22589	GSE22589_3651_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocyte-derived dendritic cells: control versus SIV infection.	Dendritic cells (DC) serve a key function in host defense, linking innate detection of microbes to the activation of pathogen-specific adaptive immune responses. Whether there is cell-intrinsic recognition of HIV-1 by host innate pattern-recognition receptors and subsequent coupling to antiviral T cell responses is not yet known. DC are largely resistant to infection with HIV-1, but facilitate infection of co-cultured T-helper cells through a process of trans-enhancement. We show here that, when DC resistance to infection is circumvented, HIV-1 induces DC maturation, an antiviral type I interferon response and activation of T cells. This innate response is dependent on the interaction of newly-synthesized HIV-1 capsid (CA) with cellular cyclophilin A (CypA) and the subsequent activation of the transcription factor IRF3. Because the peptidyl-prolyl isomerase CypA also interacts with CA to promote HIV-1 infectivity, our results suggest that CA conformation has evolved under opposing selective pressures for infectivity versus furtiveness. Thus, a cell intrinsic sensor for HIV-1 exists in DC and mediates an antiviral immune response, but it is not typically engaged due to absence of DC infection. The virulence of HIV-1 may be related to evasion of this response, whose manipulation may be necessary to generate an effective HIV-1 vaccine.					4643	338773	55775	83716	5873	3338	401466	2185	10273	9135	26802	152217	27134	4782	283234	63875	84722	222229	25873	55643	114548	9894	4350	9031	8612	81888	3099	84433	9988	4725	55717	6541	64423	6720	84617	23288	1307	8914	56996	27128	28973	468	5791	153020	8725	3303	409	57325	84138	55152	7376	6208	353116	4055	7799	112495	393	54478	9968	6483	26469	1198	59307	84329	171568	10412	3725	463	7205	124641	8550	79159	3083	79890	6778	338692	1267	90417	54496	64792	6733	28958	65990	116988	8732	4795	3337	833	8013	81849	27106	2874	23526	25819	84988	1954	92235	6494	84269	221472	3659	4261	3386	3566	6137	23307	79866	378938	1454	85450	25953	51025	4145	6540	27005	10538	2547	129138	51231	3315	6182	80279	4493	8464	2242	643641	10664	1855	9051	16	60528	9058	10422	3304	11315	51027	10791	675	26012	467	83475	51042	51287	55004	122953	10312	347252	4716	84787	644096	8672	497189	3553	133	54187	8317	7130	29781	10038	57703	3996	10376	5438	2870	26517	23210	84264	90480	84824	84823	79661	9463	29945	51225	131474	738	4298	9416	5439	6513	10636	5424	1613	5296	3949	692227	83706	10008	402055	331	79627	54958	160622	28988	147015	54434	89958	10919	863	1663
GSE22589_SIV_VS_HIV_AND_SIV_INFECTED_DC_DN	M7799		20829794	Manel N,Hogstad B,Wang Y,Levy DE,Unutmaz D,Littman DR	GSE22589	GSE22589_3654_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocyte-derived dendritic cells infected by: SIV versus HIV and SIV.	Dendritic cells (DC) serve a key function in host defense, linking innate detection of microbes to the activation of pathogen-specific adaptive immune responses. Whether there is cell-intrinsic recognition of HIV-1 by host innate pattern-recognition receptors and subsequent coupling to antiviral T cell responses is not yet known. DC are largely resistant to infection with HIV-1, but facilitate infection of co-cultured T-helper cells through a process of trans-enhancement. We show here that, when DC resistance to infection is circumvented, HIV-1 induces DC maturation, an antiviral type I interferon response and activation of T cells. This innate response is dependent on the interaction of newly-synthesized HIV-1 capsid (CA) with cellular cyclophilin A (CypA) and the subsequent activation of the transcription factor IRF3. Because the peptidyl-prolyl isomerase CypA also interacts with CA to promote HIV-1 infectivity, our results suggest that CA conformation has evolved under opposing selective pressures for infectivity versus furtiveness. Thus, a cell intrinsic sensor for HIV-1 exists in DC and mediates an antiviral immune response, but it is not typically engaged due to absence of DC infection. The virulence of HIV-1 may be related to evasion of this response, whose manipulation may be necessary to generate an effective HIV-1 vaccine.					148266	51114	90060	407738	3887	6181	10002	91662	10245	79613	7064	50861	1440	10687	3728	3786	1108	337972	5783	10101	23562	5780	9701	83463	7392	79365	124935	7295	51124	574414	5725	875	3736	256309	23304	54919	7105	9242	51586	8773	9334	10439	6494	1382	57673	647310	55898	50511	11218	152518	402682	170954	4651	8202	8689	5923	757	197342	11313	22893	84572	7141	284382	219539	2842	3080	79641	7010	56910	23113	178	29940	84245	6727	138639	729852	51277	338645	8456	343472	167838	1718	57152	29785	100289635	1644	6920	55844	91687	389337	219557	152559	10523	3754	51123	9289	112724	25778	206358	57151	201965	162605	676	5569	222826	6001	131669	7169	81543	83450	26003	9841	353238	8632	79589	1534	84078	11254	10801	55729	64412	1421	4139	54788	51384	129531	284040	85458	51059	79871	319	359948	112609	11001	242	54509	79742	135644	144699	79411	25959	283120	3092	64714	6558	155185	54978	10991	54567	10661	220002	158586	55504	147945	57576	11211	84133	2778	54014	10569	80298	55540	2188	155066	51248	729756	27161	150696	26229	1854	4487	79729	29803	7384	869	389125	147808	3043	6334	80742	339479	5885	26960	25972	8916	744	4881	23035	1850	84940	442721	4090	6529	1050	22845	54868	10950	1813	4224
GSE22589_HIV_VS_HIV_AND_SIV_INFECTED_DC_UP	M7800		20829794	Manel N,Hogstad B,Wang Y,Levy DE,Unutmaz D,Littman DR	GSE22589	GSE22589_3653_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocyte-derived dendritic cells infected by: HIV versus HIV and SIV.	Dendritic cells (DC) serve a key function in host defense, linking innate detection of microbes to the activation of pathogen-specific adaptive immune responses. Whether there is cell-intrinsic recognition of HIV-1 by host innate pattern-recognition receptors and subsequent coupling to antiviral T cell responses is not yet known. DC are largely resistant to infection with HIV-1, but facilitate infection of co-cultured T-helper cells through a process of trans-enhancement. We show here that, when DC resistance to infection is circumvented, HIV-1 induces DC maturation, an antiviral type I interferon response and activation of T cells. This innate response is dependent on the interaction of newly-synthesized HIV-1 capsid (CA) with cellular cyclophilin A (CypA) and the subsequent activation of the transcription factor IRF3. Because the peptidyl-prolyl isomerase CypA also interacts with CA to promote HIV-1 infectivity, our results suggest that CA conformation has evolved under opposing selective pressures for infectivity versus furtiveness. Thus, a cell intrinsic sensor for HIV-1 exists in DC and mediates an antiviral immune response, but it is not typically engaged due to absence of DC infection. The virulence of HIV-1 may be related to evasion of this response, whose manipulation may be necessary to generate an effective HIV-1 vaccine.					145407	3267	8087	80025	399947	84946	57484	3985	10769	1647	1029	7702	622	64969	25930	7124	55210	415116	10786	146434	4620	151556	1493	29767	269	142679	84612	55130	64651	6716	8394	51720	54626	8635	55285	11277	6331	6764	1958	11333	3082	9655	51561	8940	1506	59283	1796	54762	51534	663	1263	4660	8731	100506736	7913	79016	157638	5149	22875	10180	65057	9692	51379	4123	56903	55785	344758	2826	6814	53829	84364	5128	58515	7128	54952	9622	6975	7189	639	6448	6564	5055	3569	969	203197	4738	2662	1933	54187	1198	166348	4946	151473	147700	23517	23033	23089	22797	220929	56896	8938	116835	5178	57715	80271	5861	9052	26511	1844	11188	5277	55031	54793	84717	25843	54407	5900	219670	554235	10312	53831	8558	6418	7862	404672	4792	3552	6470	7805	63977	1394	941	374868	3156	5077	5142	3091	2622	64092	254439	1773	54206	970	341032	9372	23210	64801	112849	392309	602	7178	25788	2669	3553	822	645323	5229	4880	115294	3656	26958	140680	4217	340205	222643	11107	83548	10343	89941	4288	8048	7096	64090	90141	10242	5053	9034	2488	54665	8602	90507	132671	439996	23116	9419	4645	5008	27429	402117	344905	10208	100505876	64789	27289	476	23189	22823	1128	3725
GSE22589_HIV_VS_HIV_AND_SIV_INFECTED_DC_DN	M7801		20829794	Manel N,Hogstad B,Wang Y,Levy DE,Unutmaz D,Littman DR	GSE22589	GSE22589_3653_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocyte-derived dendritic cells infected by: HIV versus HIV and SIV.	Dendritic cells (DC) serve a key function in host defense, linking innate detection of microbes to the activation of pathogen-specific adaptive immune responses. Whether there is cell-intrinsic recognition of HIV-1 by host innate pattern-recognition receptors and subsequent coupling to antiviral T cell responses is not yet known. DC are largely resistant to infection with HIV-1, but facilitate infection of co-cultured T-helper cells through a process of trans-enhancement. We show here that, when DC resistance to infection is circumvented, HIV-1 induces DC maturation, an antiviral type I interferon response and activation of T cells. This innate response is dependent on the interaction of newly-synthesized HIV-1 capsid (CA) with cellular cyclophilin A (CypA) and the subsequent activation of the transcription factor IRF3. Because the peptidyl-prolyl isomerase CypA also interacts with CA to promote HIV-1 infectivity, our results suggest that CA conformation has evolved under opposing selective pressures for infectivity versus furtiveness. Thus, a cell intrinsic sensor for HIV-1 exists in DC and mediates an antiviral immune response, but it is not typically engaged due to absence of DC infection. The virulence of HIV-1 may be related to evasion of this response, whose manipulation may be necessary to generate an effective HIV-1 vaccine.					622	51129	55700	51194	79671	79086	441282	9637	1388	84939	29982	148266	9891	6878	84864	9188	79956	6018	23491	1955	1962	5029	56648	92935	10762	5150	84798	53346	5498	9258	83743	7164	2119	27336	29104	4335	84678	149603	7392	10208	7529	11190	1723	23076	7105	100131755	403313	3728	283638	51154	79447	8439	84219	23526	6650	51295	79830	80205	3292	2188	26354	29886	1003	79027	1240	3070	93010	8447	26005	4329	92906	23313	54014	54951	64949	283464	23181	55783	195828	149371	63939	90701	9236	51808	11188	115209	150368	23031	7062	23307	728661	3858	54491	80705	10146	3178	64784	154043	29109	7753	79613	84174	3265	51606	22845	6895	10749	25800	10362	10450	10622	54540	27161	78989	8773	9631	84327	90196	9656	54805	7268	116115	3643	79699	8607	90864	4647	126374	55170	51621	90353	4782	80179	92014	5509	4292	133522	10682	5780	9788	51692	84992	9314	1786	3955	56121	79697	7507	100093630	79846	84549	201255	10025	57678	9569	374986	10287	10985	58525	171023	5734	54931	8884	57336	84079	54859	55770	54978	1951	10102	170954	7772	80014	342667	25998	3146	146542	10474	3655	120103	55719	80021	26574	4189	51124	55421	128061	27252	4552	29947	9057	7562	153090	5447	115	57325	126308	7561	7126	136288
GSE22589_SIV_VS_HIV_AND_SIV_INFECTED_DC_UP	M7802		20829794	Manel N,Hogstad B,Wang Y,Levy DE,Unutmaz D,Littman DR	GSE22589	GSE22589_3654_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocyte-derived dendritic cells infected by: SIV versus HIV and SIV.	Dendritic cells (DC) serve a key function in host defense, linking innate detection of microbes to the activation of pathogen-specific adaptive immune responses. Whether there is cell-intrinsic recognition of HIV-1 by host innate pattern-recognition receptors and subsequent coupling to antiviral T cell responses is not yet known. DC are largely resistant to infection with HIV-1, but facilitate infection of co-cultured T-helper cells through a process of trans-enhancement. We show here that, when DC resistance to infection is circumvented, HIV-1 induces DC maturation, an antiviral type I interferon response and activation of T cells. This innate response is dependent on the interaction of newly-synthesized HIV-1 capsid (CA) with cellular cyclophilin A (CypA) and the subsequent activation of the transcription factor IRF3. Because the peptidyl-prolyl isomerase CypA also interacts with CA to promote HIV-1 infectivity, our results suggest that CA conformation has evolved under opposing selective pressures for infectivity versus furtiveness. Thus, a cell intrinsic sensor for HIV-1 exists in DC and mediates an antiviral immune response, but it is not typically engaged due to absence of DC infection. The virulence of HIV-1 may be related to evasion of this response, whose manipulation may be necessary to generate an effective HIV-1 vaccine.					10563	197259	55693	8819	11193	6614	255919	79865	79650	123970	115004	27255	9023	4142	4086	10938	64222	5525	165215	3598	10123	2696	7096	85027	8087	265	533	221223	7436	132720	132671	23070	10129	168391	55106	55905	29767	8372	10673	23251	5540	3665	345757	1946	257169	402117	4792	5423	269	1415	6773	64108	1302	54662	9211	79864	1029	376940	55663	926	221061	80310	11320	2845	30846	1908	53981	29766	9261	157574	6611	122945	3233	1068	157807	4084	10379	2843	5724	349136	257160	8128	199953	114026	4599	2118	881	4600	53904	284382	8651	23586	310	84925	11197	9034	3977	151556	6772	3483	2983	3351	374969	55130	1776	1432	28984	23371	3692	642597	2159	79751	4629	8424	6707	9604	1006	83852	9218	7881	7706	6331	27232	24137	2810	10049	10982	83666	57669	389941	400745	4615	286077	149111	1284	6448	200728	129607	6641	4074	80000	55603	1536	6926	55258	3766	55676	7441	9107	646962	2134	26287	55002	64651	23436	123722	3824	5698	3437	55	79187	116071	221303	1591	51203	602	57710	50615	84971	143941	970	22875	84441	3659	6352	5077	26253	2897	8638	387882	1521	7128	79132	1303	338707	344018	55107	3433	1939	8557	3937	6814	10391	55757	170690	84639	11274	5149	100129128	10392
GSE22589_HEALTHY_VS_HIV_INFECTED_DC_UP	M7805		20829794	Manel N,Hogstad B,Wang Y,Levy DE,Unutmaz D,Littman DR	GSE22589	GSE22589_3650_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocyte-derived dendritic cells: control versus HIV infection.	Dendritic cells (DC) serve a key function in host defense, linking innate detection of microbes to the activation of pathogen-specific adaptive immune responses. Whether there is cell-intrinsic recognition of HIV-1 by host innate pattern-recognition receptors and subsequent coupling to antiviral T cell responses is not yet known. DC are largely resistant to infection with HIV-1, but facilitate infection of co-cultured T-helper cells through a process of trans-enhancement. We show here that, when DC resistance to infection is circumvented, HIV-1 induces DC maturation, an antiviral type I interferon response and activation of T cells. This innate response is dependent on the interaction of newly-synthesized HIV-1 capsid (CA) with cellular cyclophilin A (CypA) and the subsequent activation of the transcription factor IRF3. Because the peptidyl-prolyl isomerase CypA also interacts with CA to promote HIV-1 infectivity, our results suggest that CA conformation has evolved under opposing selective pressures for infectivity versus furtiveness. Thus, a cell intrinsic sensor for HIV-1 exists in DC and mediates an antiviral immune response, but it is not typically engaged due to absence of DC infection. The virulence of HIV-1 may be related to evasion of this response, whose manipulation may be necessary to generate an effective HIV-1 vaccine.					55793	155066	3188	81533	4782	148266	23212	84939	54206	8514	64798	10528	1503	79918	50515	23560	6633	5564	200734	51552	23760	728464	285676	54704	26520	957	4144	10146	10466	23059	3178	10299	93550	142940	6092	10072	114826	22893	57484	150275	90196	23594	79364	93081	55617	1783	56882	4673	22919	84916	9654	10575	9228	51377	6988	27043	84289	51295	56339	57410	5034	1352	54984	23271	64777	51116	5433	10208	84678	29090	51194	55862	83732	6950	7561	3604	150368	8161	201595	101	79693	79711	643155	26135	10781	9530	55156	4714	57695	8565	3710	54965	55003	150465	27339	219743	10015	6134	6137	84549	9861	1955	9656	51575	258010	9136	57118	84233	83860	25920	80143	1951	7772	25940	9200	6556	4234	26027	23398	7342	54433	57325	25906	51018	9847	7029	23491	222487	10236	7057	27000	55186	171546	8666	5036	23082	9513	23395	56257	55269	79699	81875	60493	8555	55037	84798	222008	5051	10165	23435	79027	9532	55768	115708	80021	10054	53346	9739	27097	622	27292	84083	4507	10196	253512	23556	222658	1477	54503	23277	85313	112869	84992	64428	3643	5579	3038	79086	204851	55759	54893	55027	51218	5884	23300	64118	2119	9589	23031	10844	10587	8243	2519	79441	80851	5437	54496	120103	6938	6566
GSE22589_HEALTHY_VS_HIV_INFECTED_DC_DN	M7807		20829794	Manel N,Hogstad B,Wang Y,Levy DE,Unutmaz D,Littman DR	GSE22589	GSE22589_3650_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocyte-derived dendritic cells: control versus HIV infection.	Dendritic cells (DC) serve a key function in host defense, linking innate detection of microbes to the activation of pathogen-specific adaptive immune responses. Whether there is cell-intrinsic recognition of HIV-1 by host innate pattern-recognition receptors and subsequent coupling to antiviral T cell responses is not yet known. DC are largely resistant to infection with HIV-1, but facilitate infection of co-cultured T-helper cells through a process of trans-enhancement. We show here that, when DC resistance to infection is circumvented, HIV-1 induces DC maturation, an antiviral type I interferon response and activation of T cells. This innate response is dependent on the interaction of newly-synthesized HIV-1 capsid (CA) with cellular cyclophilin A (CypA) and the subsequent activation of the transcription factor IRF3. Because the peptidyl-prolyl isomerase CypA also interacts with CA to promote HIV-1 infectivity, our results suggest that CA conformation has evolved under opposing selective pressures for infectivity versus furtiveness. Thus, a cell intrinsic sensor for HIV-1 exists in DC and mediates an antiviral immune response, but it is not typically engaged due to absence of DC infection. The virulence of HIV-1 may be related to evasion of this response, whose manipulation may be necessary to generate an effective HIV-1 vaccine.					5371	116969	80821	731	79877	130612	8819	840	6890	9766	1521	4267	6398	9232	4343	8074	56833	30846	79751	10156	115004	6892	8447	2669	5432	6285	864	595	5699	92675	55002	441476	255520	152926	4600	91775	29899	26253	5721	60686	80018	3595	6489	163351	64211	25961	9023	643037	9576	284	3699	160857	3222	5939	123970	79739	7124	10948	23200	255743	84059	10769	9261	5724	10906	83852	115361	10577	10000	55008	57687	4170	10379	55315	4357	55905	57616	9330	145508	23052	219	3937	388646	2634	55601	10410	3726	8727	81607	11141	84897	55676	401409	6911	221091	970	6542	10206	26160	1536	10458	116254	53	285521	6773	2700	79650	54436	4064	5525	167227	79899	5352	51307	84893	57590	50964	8651	23228	6812	55711	54840	212	132671	28988	25798	55785	84925	55262	2170	4938	94240	10133	10840	283578	684	54662	9191	60506	55603	87178	221981	4818	5156	51606	7042	131566	6768	51284	6857	132720	3785	140687	55691	7098	55591	126637	55069	2995	23424	7318	171019	187	64222	54625	4061	817	3659	6643	646962	4147	55072	374467	64108	127428	60676	375287	29760	9034	7096	3959	728	80059	9153	6780	4599	84674	120892	6373	83636	55	5698	3363	84532	3665	162394	6550	56478	11221	85441
GSE22589_HEALTHY_VS_HIV_AND_SIV_INFECTED_DC_UP	M7808		20829794	Manel N,Hogstad B,Wang Y,Levy DE,Unutmaz D,Littman DR	GSE22589	GSE22589_3652_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocyte-derived dendritic cells: control versus HIV and SIV infection.	Dendritic cells (DC) serve a key function in host defense, linking innate detection of microbes to the activation of pathogen-specific adaptive immune responses. Whether there is cell-intrinsic recognition of HIV-1 by host innate pattern-recognition receptors and subsequent coupling to antiviral T cell responses is not yet known. DC are largely resistant to infection with HIV-1, but facilitate infection of co-cultured T-helper cells through a process of trans-enhancement. We show here that, when DC resistance to infection is circumvented, HIV-1 induces DC maturation, an antiviral type I interferon response and activation of T cells. This innate response is dependent on the interaction of newly-synthesized HIV-1 capsid (CA) with cellular cyclophilin A (CypA) and the subsequent activation of the transcription factor IRF3. Because the peptidyl-prolyl isomerase CypA also interacts with CA to promote HIV-1 infectivity, our results suggest that CA conformation has evolved under opposing selective pressures for infectivity versus furtiveness. Thus, a cell intrinsic sensor for HIV-1 exists in DC and mediates an antiviral immune response, but it is not typically engaged due to absence of DC infection. The virulence of HIV-1 may be related to evasion of this response, whose manipulation may be necessary to generate an effective HIV-1 vaccine.					5884	7873	8260	53838	129285	91689	55700	152579	65109	51117	54014	64798	9585	8458	114881	4782	55149	51129	6878	6897	3903	64777	150368	1352	6729	2653	23398	29880	1039	348995	11171	2958	2733	1207	2188	91663	10153	81873	55847	890	83451	55222	54487	221955	10201	2058	90871	55352	120103	957	3419	28987	9002	64087	1819	81037	55274	4594	150223	2617	1314	26292	3141	54700	4706	54939	5557	92595	729359	1263	114049	60488	6832	5636	54888	29100	25896	79794	51528	50515	9278	9326	23246	140885	79572	6840	93081	1967	2258	1793	81671	253558	56257	9654	55768	90268	10199	2591	55505	28974	55778	10612	6242	120526	55692	1109	8443	26233	157769	26284	5832	6100	4702	5558	201595	10713	6197	1269	6629	253430	84190	3422	79968	8668	7169	79716	55208	55272	6880	143471	8560	9735	10189	22868	81579	64216	258010	84364	113829	84661	131616	11073	5496	222487	6168	6627	54980	26275	7298	8574	4023	5707	55699	9184	56652	83475	23042	2218	221710	643155	10113	84916	91942	56915	6790	80145	10239	23556	55573	23594	57157	57418	139231	113130	728464	10043	51367	9306	92370	5245	25974	27316	6389	23357	6175	55652	55280	5470	118924	55623	55651	9497	10197	91304	84524	2581	10236	7268	5583	2547
GSE22589_HEALTHY_VS_SIV_INFECTED_DC_DN	M7809		20829794	Manel N,Hogstad B,Wang Y,Levy DE,Unutmaz D,Littman DR	GSE22589	GSE22589_3651_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocyte-derived dendritic cells: control versus SIV infection.	Dendritic cells (DC) serve a key function in host defense, linking innate detection of microbes to the activation of pathogen-specific adaptive immune responses. Whether there is cell-intrinsic recognition of HIV-1 by host innate pattern-recognition receptors and subsequent coupling to antiviral T cell responses is not yet known. DC are largely resistant to infection with HIV-1, but facilitate infection of co-cultured T-helper cells through a process of trans-enhancement. We show here that, when DC resistance to infection is circumvented, HIV-1 induces DC maturation, an antiviral type I interferon response and activation of T cells. This innate response is dependent on the interaction of newly-synthesized HIV-1 capsid (CA) with cellular cyclophilin A (CypA) and the subsequent activation of the transcription factor IRF3. Because the peptidyl-prolyl isomerase CypA also interacts with CA to promote HIV-1 infectivity, our results suggest that CA conformation has evolved under opposing selective pressures for infectivity versus furtiveness. Thus, a cell intrinsic sensor for HIV-1 exists in DC and mediates an antiviral immune response, but it is not typically engaged due to absence of DC infection. The virulence of HIV-1 may be related to evasion of this response, whose manipulation may be necessary to generate an effective HIV-1 vaccine.					10156	5371	9846	221061	57621	57475	7047	3963	6890	64081	8634	5530	9201	80821	7679	284992	7262	2817	56884	92749	2101	8887	4604	163	388646	4221	152926	79877	6041	8520	81792	9450	404037	8819	7827	9590	7404	151742	3595	8288	460	5720	57045	6614	7098	10133	84759	65268	2697	10906	402117	3781	5898	2131	30811	4858	10948	79668	11174	140609	4064	25961	4600	442213	4218	9570	5939	80223	10489	6120	51084	10687	66000	7453	9023	56927	2180	79858	10495	28988	10663	4843	339324	255743	23428	91752	55072	55788	23052	5023	8087	11011	7376	6570	64838	55194	54708	28984	84295	26999	3106	3726	54497	1781	219	9296	154881	23325	132671	64147	64747	4792	729830	7482	23228	595	10379	2995	441161	128338	56833	148022	1284	10577	5897	5699	4861	9153	375567	80237	51454	344191	23333	200403	10369	55757	55273	4061	253461	55008	29969	5721	56624	30846	3766	54905	2641	79724	9562	23503	6886	148156	221154	219285	23265	2041	140459	608	3593	8788	65989	2810	51561	7291	836	8530	8934	167153	56129	3575	56848	1606	81858	399694	64222	5432	57592	84166	2643	22914	4435	3709	51283	9537	5209	5977	3598	442721	6992	8895	4338	6753	100288695	6891	6768	114836	3122	79585	10342	338707
GSE22919_RESTING_VS_IL2_IL12_IL15_STIM_NK_CELL_DN	M7836		20944005	Smith MA,Maurin M,Cho HI,Becknell B,Freud AG,Yu J,Wei S,Djeu J,Celis E,Caligiuri MA,Wright KL	GSE22919	GSE22919_2501_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in NK cells: fresh versus stimulated with IL2 [GeneID=3558], IL-12 and IL15 [GeneID=3600].	We used Affymetrix expression arrays to determine changes in gene expression associated with activation of human NK cells mediated through treatment with cytokines IL-2, IL-12 and IL-18 over a 24 hour period.					80012	57659	9678	8556	55717	166614	192670	375287	8774	55074	6563	55728	57707	54800	3112	5175	51053	23421	51668	605	55501	2242	81928	84299	2313	28978	24149	23265	112611	51192	25898	64333	29929	1385	55108	1891	57699	54499	5255	142679	9382	728294	1027	5788	81704	83937	65999	149840	8491	26469	11240	9725	51510	7099	23155	254295	285331	5985	54939	151903	219972	152185	80709	114926	54344	26001	27072	3248	6595	23268	2033	823	79780	26751	23171	8924	26128	50485	51205	55139	197258	961	5696	23354	4594	6920	3418	79447	85378	1797	92815	6821	9060	55840	10865	90799	80853	9750	3621	8738	145226	84859	64764	56922	4673	2841	23526	23621	57674	585	57228	79810	1540	6990	64792	653361	1033	1069	22832	120227	55755	2821	27250	3712	84941	54436	5257	157680	23313	25927	9094	4720	200558	9787	10801	81558	10955	8419	11064	3437	79823	2665	146198	4215	4734	2783	931	78990	84330	4599	55751	252983	389203	9111	9450	138241	51274	8784	147841	6929	29922	163486	8942	301	10392	84456	54539	84263	2189	665	23270	145173	55687	2971	8581	8883	3738	5538	2271	79828	50862	2124	5982	55343	9267	222658	253558	51317	10263	203328	8897	84316	85363	3660	29072	55857	22834	10659	55198	23423
GSE22919_RESTING_VS_IL2_IL12_IL15_STIM_NK_CELL_UP	M7837		20944005	Smith MA,Maurin M,Cho HI,Becknell B,Freud AG,Yu J,Wei S,Djeu J,Celis E,Caligiuri MA,Wright KL	GSE22919	GSE22919_2501_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in NK cells: fresh versus stimulated with IL2 [GeneID=3558], IL-12 and IL15 [GeneID=3600].	We used Affymetrix expression arrays to determine changes in gene expression associated with activation of human NK cells mediated through treatment with cytokines IL-2, IL-12 and IL-18 over a 24 hour period.					28969	2475	84300	8880	10329	56888	25932	727910	9933	4830	57590	9855	5478	57645	100506562	6351	1213	124801	6728	1678	6576	54471	8539	80380	353	11096	3554	11062	5515	5300	10321	64801	4144	9128	51068	25940	6770	23039	26035	64747	285855	9898	83448	6696	7278	113829	6815	84833	5820	1104	115708	9861	54948	64118	55092	27292	23386	4076	6648	8834	80324	23119	5052	51095	51535	51260	121268	11321	22894	3157	57213	51304	55573	9456	166378	84190	9410	79684	10574	10153	26156	16	55164	1969	7264	6510	79723	1537	51603	1981	4676	51455	51082	7936	56893	9961	3192	23002	3094	5151	8624	11267	9044	7165	9144	8607	126321	8629	6832	116988	3837	5203	55858	1665	55299	6713	10232	440138	22993	8692	55752	9688	7866	57727	55207	79159	5931	8891	9972	9100	5584	51109	9129	6509	83931	26995	4772	54468	51575	8273	50628	55052	84444	5435	80746	8140	9141	55027	81502	10254	55907	29889	54758	1789	10600	9440	10313	51025	10133	118881	57761	7163	1802	59269	2194	8192	80349	10920	5973	23512	84331	7753	55135	6632	155060	6547	8879	51128	90639	25929	140739	1984	64397	9904	6627	286451	79646	378884	317781	6304	79101	26589	80273	1207	8662	54107	55884	64121	2531	79077
GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_DN	M7886		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2266_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes (12h) versus macrophages (12h) treated with rosiglitazone [PubChem=77999].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					286827	26127	23107	192111	2671	4155	256302	92610	83460	94241	196	8050	80705	84722	7071	7705	821	8161	5204	90580	8340	51124	253832	23382	6897	29923	3516	5896	5810	90416	9367	29928	150864	54386	6059	6838	51491	29911	5435	9140	6642	7322	53981	54529	90355	122830	51248	55794	90353	54938	8754	1182	90204	63943	83903	116143	29068	80124	5721	139231	6566	1810	6051	54855	84311	64968	57684	3149	9750	8763	10138	140838	9329	85313	84293	23741	754	23398	22803	79706	80335	51569	2773	440145	113791	65005	217	10694	171546	201725	25934	64960	151011	55661	567	493753	84916	157567	54957	55148	7019	29960	80310	740	57095	6203	79576	90417	7283	4904	3981	9325	55142	127687	55293	54956	23118	79568	1355	2992	27183	9453	7528	81608	3840	10961	6191	88745	9061	65080	23248	9570	28960	373	90411	10825	51605	27153	79631	54928	1827	84878	4089	81572	6146	85465	26519	118487	51014	7458	10194	55905	57215	5962	51499	203238	29902	64795	79968	2983	1431	84060	55677	257415	79647	6175	79042	23534	56255	84108	64222	154661	8879	374354	9818	55975	55813	1798	29115	947	2733	29789	8575	285282	9282	5977	3066	130074	1114	784	120103	26065	637	51278	64395	653121	7353	23082	56902	7541
GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_UP	M7889		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2267_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in macrophages (12h): control versus IFNG, TNF [GeneID=3458;7124] and rosiglitazone [PubChem=77999].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					715	338699	3337	5565	26269	116843	1263	1233	140680	84295	57497	64332	94059	58494	84807	9911	51733	9262	1290	23587	116224	2196	1847	2625	85450	7538	599	1960	5756	3036	25898	9587	266722	1959	60673	5732	8233	51010	9592	79693	1809	134549	4781	127018	1844	10289	51474	1132	51286	7033	10892	401115	596	8842	2123	221079	26953	4665	122525	246777	64852	1958	2709	7216	53345	90441	51741	29126	1440	646450	22807	135112	2567	80059	375790	10633	56165	3164	116285	51527	5864	9047	646174	3726	57018	6351	5564	3790	54902	2672	3456	3131	390205	338879	415117	8416	5394	8988	51802	2015	26229	22918	60493	9588	6734	284217	56605	57822	25948	6295	79161	6935	157310	29909	8840	84691	348932	7399	10953	7763	60401	8629	11259	3213	132612	9341	2765	23270	204474	94033	5101	126432	9662	84281	4654	779	23764	3305	8001	145258	80380	4629	6328	83604	60436	23113	26153	10206	4929	59284	29925	25930	24141	969	27327	6276	8863	148281	4311	366	10962	55004	80128	317705	84890	54149	56479	81871	55064	3707	10950	677	11001	79983	9900	252995	4862	759	22849	65983	153443	1030	23620	3399	284366	146433	221322	356	27290	7133	1638	116519	10732	1848	64901	6123	5187	6992	93377	11010
GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_DN	M7891		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2267_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in macrophages (12h): control versus IFNG, TNF [GeneID=3458;7124] and rosiglitazone [PubChem=77999].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					10628	9021	5896	23077	55315	25780	116236	150771	754	84182	84987	3382	1459	113791	125988	54541	23595	126382	5134	54827	84124	140606	54107	1620	5869	9705	84417	5434	3268	689	84057	25870	100129128	29960	351	118427	6155	7490	2119	25957	79637	26548	3704	374659	401551	2169	57639	119504	57663	2774	81873	2562	54206	658	10410	7832	91942	26151	2877	4763	3781	6527	27042	28952	57393	7429	378925	60437	161	3211	80231	10585	7001	204	90871	23120	80306	84909	56683	79156	2793	84881	53340	79706	6294	10411	3772	51302	54886	9140	10052	79777	28991	2840	84804	2296	4621	51441	55335	8714	23404	168417	81691	23325	4774	170392	580	6336	2202	729515	84262	90417	64799	10916	92483	92335	55286	643414	1802	353497	6217	92815	2857	85369	146198	7480	79782	2730	10536	10785	339416	64951	285855	4488	201232	26164	22927	221016	729967	56660	2035	6176	5163	25813	3398	2034	57410	55901	1984	60561	170063	92749	126410	153364	1032	4485	26524	64976	8013	1584	57648	55713	5702	1278	1385	282974	3397	128240	9727	56956	29937	284723	81553	8544	253635	64577	29923	29928	166348	493	201229	5352	55148	83742	57060	163126	26127	63951	1537	5409	283927	23630	25903	7345	116154	7473	92667	22998	64137	9673
GSE16385_ROSIGLITAZONE_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_UP	M7892		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2274_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in macrophages (12h): IFNG, TNF [GeneID=3458;7124] and rosiglitazone [PubChem=77999] versus IL4 [GeneID=3565].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					729	107	84807	29909	7538	921	9749	84281	1959	5613	85450	3726	1844	10957	2353	4747	84295	1503	155185	7128	1843	389434	3164	9592	1958	9934	3309	64332	969	401409	153443	286144	1847	6351	196383	80243	7088	4988	1874	2669	3337	112574	3707	2107	125170	57475	8549	51234	57818	23764	2354	58476	677	1493	5187	6700	80219	2117	51132	9341	7050	8477	65983	64859	440026	140576	343	5597	91947	142679	9262	655	5732	51119	117156	25948	7471	23645	1263	117608	6992	8851	4247	5010	3301	2281	9595	84708	257106	123	4146	84876	8848	83877	4695	22807	26038	1326	5734	415116	678	51114	245806	2560	4602	2255	80213	4060	1195	138046	399665	90441	1880	79723	3329	91748	474344	29990	79414	9615	135152	26269	28971	56605	285848	8942	51094	10123	10752	23341	8639	6722	3062	133491	1654	23150	9936	10073	23613	160857	11259	11213	56999	89870	3290	940	2206	7037	10221	2672	57332	10962	84919	92400	7503	150472	80019	83894	63971	9697	55109	10011	11231	10488	29083	6906	54959	29126	124976	10017	10766	8853	84154	221079	2904	10197	4842	60493	5552	6827	54902	114805	22993	160622	57633	154197	26045	54901	170689	57480	84890	5565	1609	54511	154	51726	79027	26747	619208	4882
GSE16385_MONOCYTE_VS_MACROPHAGE_UP	M7893		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2261_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes versus macrophages.	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					29851	26232	79650	54491	11010	84530	1801	23530	10205	64901	9338	2760	353238	8761	131578	57456	22873	57128	8871	135112	4092	4340	3646	79842	6656	130271	6500	56265	2005	10300	5611	64776	56935	56261	29926	84706	2873	89782	25939	5691	51727	64146	11226	134265	3955	57590	27430	114926	388581	374355	84251	135114	114790	79613	10268	9447	8031	51102	79068	4815	283927	84707	6001	8140	79642	25844	8036	89891	79089	168417	11277	11182	56652	146378	337	10495	55844	51128	160897	2217	57124	26228	23395	128229	59349	1104	9601	81492	9467	2631	55175	6648	25778	23076	8507	94120	6123	9215	51164	147710	4665	57699	51704	631	137835	9812	1538	54940	6451	57405	9130	23479	57165	2173	9100	93210	2100	84418	30832	90993	57180	56165	8738	91612	51154	54586	2793	5134	9111	6729	56256	3111	6770	84698	157506	9933	85463	963	7137	254263	57537	84330	4982	127262	494551	284131	100188893	63826	553115	91860	898	8814	130560	401251	219738	23568	56900	7075	2272	84135	2334	57446	57099	142679	131034	55133	23169	9538	443	2248	5664	790955	9643	1389	10534	4857	23403	145226	30845	55247	25941	1508	23562	6098	119504	3598	816	1447	60468	7988	4720	219539	51012	170261	3071	54536	387338	55118	9275
GSE16385_ROSIGLITAZONE_VS_UNTREATED_IFNG_TNF_STIM_MACROPHAGE_UP	M7894		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2273_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in macrophages (12h): IFNG, TNF [GeneID=3458;7124] and rosiglitazone [PubChem=77999] versus IFNG and TNF [GeneID=3458;7124].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					3429	8693	10022	84912	1791	1536	57583	5025	26127	9232	285598	163351	10644	6993	23569	4249	129831	308	84891	26050	114609	239	79156	8974	83699	83594	1515	1043	56942	4938	122525	163126	2653	5908	57153	8540	116362	83982	22930	4913	7852	29984	11274	157	283600	167826	1465	4058	91544	284467	64802	1510	126308	10686	3037	56890	4430	90427	27089	3488	121268	11052	5698	219285	23300	58472	151011	254428	541565	29919	28834	64090	3606	55520	57657	973	54455	2701	126917	9240	79605	201294	57761	10437	54504	80380	56992	1996	2984	5265	8428	952	83547	7295	80063	481	131965	6450	886	341640	23250	286319	57091	931	26519	9732	65981	8909	148979	4654	25836	55901	23200	25819	152098	2192	64777	135138	55705	6586	1576	3662	29116	158158	7286	79660	27443	7056	29760	64417	2686	55720	27039	283638	6319	113444	9253	10861	7782	84612	90161	5051	9659	199786	4124	7994	9144	4066	1102	284611	4618	56886	112937	123036	6352	203102	54093	84524	84455	1440	57146	6197	23400	4958	80310	535	1848	221424	79905	80321	11037	375318	84203	4293	51239	84662	1776	27065	5142	6567	25943	1368	9697	387718	55839	57565	5450	116843	54939	137814	27348	567	116442	94005	386617	182	116448	54913	9905	10628
GSE16385_ROSIGLITAZONE_VS_UNTREATED_IFNG_TNF_STIM_MACROPHAGE_DN	M7896		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2273_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in macrophages (12h): IFNG, TNF [GeneID=3458;7124] and rosiglitazone [PubChem=77999] versus IFNG and TNF [GeneID=3458;7124].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					6598	5516	26001	5536	54939	204851	81559	79947	9973	71	25921	8878	58493	2793	283899	7268	55850	217	832	11277	2592	624	1370	374877	388581	11284	6123	1643	9275	7355	622	28511	79661	10270	5970	3902	64745	7542	26953	8480	738	57020	85478	51400	9447	24139	23093	10772	1783	55101	8625	3678	219621	3772	57446	4882	79042	3839	79792	9101	51667	55585	79068	54675	4637	4063	7075	1891	29959	4817	10411	6047	8031	8761	55905	57184	35	9513	3991	2885	79591	8140	22820	1737	4982	2990	9354	64901	1797	10300	5018	79144	1565	54518	5768	5564	2821	10121	375189	84330	28991	84706	54469	7705	4943	92703	79829	3071	9862	1796	115353	84516	93973	57599	7424	81532	6829	4001	10953	131965	26063	55175	23157	84173	10039	113791	347541	10548	79041	56681	79934	6810	26100	201163	10211	26058	84269	150160	26127	9631	91775	53345	8509	1120	80271	11151	327	30	226	2581	10280	84958	55251	56941	2815	5589	11010	54923	114327	8945	84069	55843	25920	10961	55707	375444	54847	23767	338699	1388	6780	391002	2873	9559	23759	116138	56913	547	255394	57617	131601	125965	26232	64320	387338	123920	9844	1907	83596	284613	63897	51255	4891	64841	7189	55064	274	55811	7486	57763
GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_UP	M7898		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2263_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes (12h) versus macrophages (12h) treated with IL4 [GeneID=3565] and rosiglitazone [PubChem=77999].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					4712	29890	8019	2595	6231	527	1347	25874	2653	11103	116135	374354	90390	55432	56942	9910	27159	54880	54107	5687	29103	28957	55184	387758	57336	54797	4714	140739	55704	284184	10949	6789	23384	4711	404672	170712	55651	4717	116984	93664	4281	889	10975	26130	80310	6160	1634	85025	221830	6746	6999	51146	389362	4144	1996	260425	643664	4238	10320	55847	91612	58505	170825	7579	50512	60412	283431	10483	1476	3480	51167	84458	57699	57602	1439	1070	908	518	10137	7109	51503	375056	151613	2171	51406	26269	440574	151011	23212	55734	11067	63908	55004	3131	1875	9411	9497	8662	153572	3037	79799	30846	4695	9669	55083	51014	11051	5908	221687	54149	1964	3646	1854	55076	284467	80975	284371	6651	8886	374973	440145	474	7827	6653	7374	10632	147741	9723	54363	7349	51605	80273	283489	5163	161882	81624	57472	9619	643008	1603	10152	3052	91653	84456	5437	84071	58528	23389	54913	6726	1810	51372	4709	387357	9254	284417	54509	1654	26355	6855	30845	84144	5478	644815	23670	51278	131669	84271	6173	51018	54539	5791	139886	120935	3190	140823	3716	167826	4014	114609	9343	116444	90407	65065	23167	9861	58527	1846	10166	51684	116379	4116	56902	6845	10586	23208	9994	9150	5810	7162
GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_DN	M7900		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2263_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes (12h) versus macrophages (12h) treated with IL4 [GeneID=3565] and rosiglitazone [PubChem=77999].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					5547	79022	23385	26001	84135	92014	4001	5583	64718	1831	2005	11132	2583	2967	7357	57542	54870	5597	387	5546	57128	163	9338	2000	2793	81502	79882	2760	9070	124808	285195	1650	84674	4602	56940	55668	51248	9451	55846	63971	6480	79853	10039	399665	51719	9188	2091	204851	56256	822	5832	10280	445	3146	1236	8814	113791	3594	140901	79794	9770	26063	5530	7386	25921	10093	2782	51176	80765	2885	55671	155185	57819	49854	125170	84333	10489	51234	7050	7189	5780	10494	7812	5216	64925	29909	5939	170954	2107	51726	607	56652	4854	57216	23233	1973	57446	11221	4247	79829	4882	122060	154197	6302	1609	3682	5048	81563	100128731	6760	152992	84255	51094	11202	9373	5887	270	79041	201475	8761	9267	7157	7088	23647	112858	57597	54847	3460	951	11226	928	51727	8621	5998	114823	152485	3915	50515	55611	55116	10197	4077	9447	135112	4088	91875	27443	8683	55343	5058	1874	30	5693	3726	29923	4209	1998	3980	377	10478	10289	84069	56681	56474	51114	79006	55069	2166	3192	10123	80318	54901	57332	11034	55920	8878	7705	9423	27304	135	202	404217	3459	79642	65264	169841	6294	2580	2483	5660	10380	391002	26502	84759	9760	26224	6370	60481	56970	1318
GSE16385_MONOCYTE_VS_MACROPHAGE_DN	M7901		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2261_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes versus macrophages.	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					57583	25836	6993	57703	25780	64802	1510	827	150677	10563	10644	54539	5409	1347	23077	116135	27199	23057	389161	11046	1576	1260	9705	55749	1043	9890	4238	1385	2891	26130	23325	84154	130502	3131	170825	83594	6651	54532	4249	55076	25758	8263	6700	23036	4654	644168	100130988	89796	4144	2765	79608	51666	9847	10022	728588	7518	6154	387758	23670	55777	25819	4594	1993	22930	1501	9666	337970	7113	11067	3781	23074	10542	4045	151516	7471	51265	2017	7220	1459	4709	1282	401145	5276	10150	441061	2309	55052	9665	766	2561	729	7098	4325	254827	26872	9553	8909	419	55333	552889	57369	2812	10077	151354	6936	135152	9016	1654	249	93664	4695	5230	83643	221322	1358	10085	4236	115111	6633	116379	405753	55023	10746	60437	4948	116362	6854	113451	57718	26230	132014	130535	4685	55901	27086	84708	4913	5791	94121	1345	627	140578	374973	254048	5724	388630	23461	9936	98	521	5567	2192	1728	285704	3268	26548	166655	160760	55331	255967	6728	8997	79645	440689	55184	2237	4330	8293	9271	142686	55335	54586	219972	4534	100130742	2045	246175	83607	83543	9865	991	9723	3655	4988	51208	51161	3290	116442	8800	201229	283847	201625	1620	4208	25924	27254	115795	54210	7915	5686
GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_UP	M7902		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2262_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes (12h) versus macrophages (12h) treated with IFNG, TNF [GeneID=3458;7124] and rosiglitazone [PubChem=77999].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					23061	1960	22873	2272	10084	25939	5293	6228	1959	5611	2039	79165	64080	60488	2353	9682	29993	29089	57406	1958	25900	2245	81621	135112	4885	170394	253559	79650	493	9223	2005	84811	9361	6838	5626	3684	51021	90624	27345	26030	83590	64326	6051	6152	79734	3295	3248	1031	5683	29985	51170	51124	80709	10205	7132	4841	6897	3831	283927	84320	2760	56924	51727	84984	84717	9071	81706	9255	222553	51317	1104	8761	79672	79080	23265	84696	55247	79613	56950	144406	26168	55007	996	3059	5236	4000	130589	9567	9277	79033	196294	112398	9643	10474	56951	3297	8507	124583	27430	1327	27248	140459	23169	8131	23105	60685	140609	60370	5681	84674	91252	60468	57461	9953	11010	6941	3815	85028	90268	6439	23595	30009	80305	54859	51778	157570	56920	337879	79637	493869	55072	29997	8567	94059	56998	57704	7059	2161	4884	27115	126119	155060	51141	1801	84335	9100	387837	28971	6612	79890	388581	10654	29097	441376	55173	3787	434	79707	57684	400569	23255	4352	22906	101	147670	63915	56135	136853	64784	80745	221504	84152	100287482	9212	259	440567	10569	5971	55633	114785	5691	9228	54863	11104	2963	81029	23095	4952	54963	123720	8882	8660	3682	8694	11124	375567	25778	23765	3726	221955
GSE16385_MONOCYTE_VS_12H_IL4_TREATED_MACROPHAGE_UP	M7903		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2265_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes (12h) versus macrophages (12h) treated with IL4 [GeneID=3565].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					56942	3429	51093	1465	23127	23191	29919	54816	64417	64802	9486	1368	7042	10022	5101	254428	1291	6993	653240	116362	2653	8974	1081	83982	79642	1510	129831	57583	163351	84166	150290	55686	22903	55332	3181	57494	4249	377677	9789	440093	56890	10208	54906	973	2013	90427	7391	92162	3135	9294	352999	1102	3458	27089	286144	84912	342667	3763	57674	9232	7525	389208	10161	958	10379	1489	54832	154881	11052	4124	127281	64094	126638	11274	84443	123688	344148	200132	348110	54531	6385	4016	221223	90843	9322	126859	3606	84612	1515	57477	6119	51668	914	55082	81839	65981	308	56934	283152	2686	84795	8942	727800	10905	56603	55	100506564	10650	2913	10923	284485	259308	2326	375791	5515	157	6210	118611	97	10320	830	5968	123606	345895	100113384	3106	116986	8740	25819	115727	11166	9468	131583	5585	10653	777	65217	79858	10625	220002	79857	85013	100381270	775	124152	8880	168391	51237	111	7781	23279	132014	2814	3290	1235	201780	706	3887	7365	6659	219409	10437	26664	26007	9615	29970	124491	3747	25945	5537	26147	1654	51249	9144	23421	3263	6620	374308	29907	7253	6013	166336	3146	55902	401474	2915	7334	9639	6804	375449	3062	55596	51316	6670	2049	4759	54850	10129	57524	892
GSE16385_MONOCYTE_VS_12H_IL4_TREATED_MACROPHAGE_DN	M7904		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2265_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes (12h) versus macrophages (12h) treated with IL4 [GeneID=3565].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					832	10211	57661	10922	6625	6811	5989	217	23559	9766	2717	79575	60488	6621	64326	126119	133619	11273	6810	85369	8884	54776	57222	11151	51094	4001	549	7094	29902	8289	23511	80305	55079	24144	10953	2253	29993	51124	4798	2140	7318	90324	3936	3991	23406	7515	25792	54540	23149	5565	10347	81559	90525	126308	23533	550	54785	10084	5878	83606	91289	55254	25920	5516	57050	8526	56965	9217	7322	115950	130617	23199	221545	84656	10411	51283	171017	9797	7284	29109	56926	81628	112398	23061	8237	4795	5833	4302	10362	5863	5894	256949	177	9695	284352	79165	399664	163	60672	4296	57605	1642	79629	54757	55585	10585	55072	3059	1743	9223	9649	29888	6911	8760	25900	25970	9466	4898	55	24142	6051	23162	54963	9112	26024	84057	51225	92610	7016	79661	215	127544	9267	22933	57185	23457	81562	90678	6199	53918	11104	9744	10360	123720	784	10126	84335	2874	1140	9028	55683	51564	7919	3104	11021	23764	79934	91304	5442	8694	80152	3927	729967	100287171	129138	9275	81621	30849	10961	7070	4155	8943	5523	8986	79786	27153	81794	1376	79890	4193	5583	166614	7059	57048	26127	1186	2783	23294	1108	9909	57591	10277	51263	79869	64236	26020	2592	81894	5476	5871
GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_UP	M7905		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2266_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes (12h) versus macrophages (12h) treated with rosiglitazone [PubChem=77999].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					5230	92140	347240	56942	5101	231	7385	54539	3767	4695	91647	147323	6383	10077	282996	7813	127018	58494	2653	79039	29775	2262	8973	3606	2538	25780	55967	3488	3224	140838	10556	150290	6249	3251	84522	3213	100506736	521	3292	399726	7465	140739	115399	57472	126014	328	56267	6168	9349	5191	29796	402117	27258	5162	54906	5864	8204	80273	1440	57477	404672	22873	117531	388753	254158	132014	330	2044	4675	140767	56311	94026	80059	92017	2915	94031	2058	10568	54543	153339	221830	1654	51735	8842	2734	57524	28998	51637	7827	10952	170712	132158	348932	23036	11051	129563	132204	55798	54065	151011	122553	55665	4238	255967	55052	669	1262	344148	115123	64922	134187	57519	79857	4222	221074	56902	23096	1748	10786	253832	9719	4281	54532	4714	509	55333	147923	1295	64216	51700	7042	8725	2567	8270	79616	51406	93979	10290	10284	55127	8633	1580	1362	51065	889	6013	9271	25804	9052	30846	54716	202151	57703	1805	3419	2618	266812	28969	126638	92565	1875	63932	10980	643155	2108	6136	116984	2560	366	10389	57221	6636	284443	2267	2820	26130	665	9326	144811	5495	6506	2687	3646	9933	55839	3426	6678	1793	759	55210	375449	29088	84443	23670	55686	666	2326	26664	6718	9276
GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_UP	M7911		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2268_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in macrophages (12h): control versus rosiglitazone [PubChem=77999] and IL4 [GeneID=3565].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					11007	6821	9342	26224	11190	55633	163	83596	474344	83853	79085	56270	7050	3688	1831	2879	5187	55308	55327	85365	84245	506	149076	64951	6625	9948	54870	285195	9322	1236	59343	3728	2035	8428	29085	51175	2483	91875	10602	326624	2872	5467	7088	11253	115330	23765	9267	222950	3382	51398	64802	85369	10775	55920	441518	10197	5049	246329	10494	381	1984	56160	9181	55596	6777	79786	55696	387	7690	284252	5216	54522	3991	2107	196403	51780	10678	1998	267	5411	10410	2923	26511	130120	3460	9859	22834	26001	587	79144	222166	10285	1609	1145	29109	388701	3678	1072	752	1742	440836	6566	6464	4194	6659	55893	338692	84696	1120	115727	9695	25948	57819	391002	4149	81559	25957	5914	93183	6892	3133	78994	29919	5777	5531	26058	116362	10801	80219	468	79660	773	25875	64426	10961	868	54518	84135	5878	1650	7343	817	55167	55111	79663	4665	4001	23648	55216	79668	79796	4150	7090	55315	80709	9582	84656	10411	4072	55209	23385	112858	84328	92014	10507	5089	4247	26127	144097	4049	10000	10262	399665	51135	9727	308	56998	10277	7922	4763	1026	10360	6478	51177	4849	8761	7597	81553	51466	3726	79006	8743	8766	29933	5036	55114	51629	23250	3459	9760
GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_DN	M7913		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2268_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in macrophages (12h): control versus rosiglitazone [PubChem=77999] and IL4 [GeneID=3565].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					10952	81892	22953	113675	2263	627	84984	9375	55717	167127	4440	2187	23077	56203	9978	58505	10190	49855	284273	7471	122769	26060	55247	2776	9969	23287	51430	51068	79838	10848	54108	80243	8725	84154	1401	3646	115572	55967	5999	79077	6727	2790	56999	22938	10213	7104	7265	51637	4635	6424	26269	9497	2299	81542	285704	1789	92140	8633	26610	402665	55120	84708	221749	9213	154743	56910	8100	54823	10556	6725	5567	55964	9732	51141	2272	83732	4709	6707	285672	339855	25816	8538	51650	10885	1379	256643	4059	91949	83716	3040	10949	56995	27332	9474	85457	117145	5439	56922	79833	5277	84181	2914	221223	65059	90288	55240	402682	128439	150726	4747	644943	84271	196294	114792	219348	143503	5501	4014	85013	10142	729	4831	7554	79778	51076	9848	5686	64582	55713	23732	2627	29097	57826	9166	29880	54345	7100	4842	57546	339665	8854	116369	143684	5683	140609	5860	147323	29767	92342	51250	27115	10129	8195	79923	85352	154807	2255	7419	9325	9915	51728	26	9542	143884	54329	127254	136991	241	107	8905	3213	52	6263	5283	51442	25836	164832	4664	64118	51053	81573	375033	51023	10735	51761	22848	3251	114827	137392	7379	8667	57587	9403	5009	9900	54951	22930	6875	3952	100134938
GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_DN	M7915		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2262_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes (12h) versus macrophages (12h) treated with IFNG, TNF [GeneID=3458;7124] and rosiglitazone [PubChem=77999].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					112399	399665	2005	125170	5530	7726	270	5612	5583	84674	51726	200933	387	10194	30845	51390	5058	3300	4783	56256	64805	404217	689	10237	2782	11213	10643	57418	26136	4854	55153	51018	2107	118426	85460	22936	51248	7091	124808	8493	6827	51466	55144	27330	5352	9276	79882	64108	4281	9749	81488	9551	6760	89797	152485	6302	135112	81563	293	55668	51441	64326	1603	8761	26047	6789	54888	285195	5705	9221	54957	5236	57461	655	22834	152992	6582	8165	51465	4953	55069	6457	5832	9516	2617	55604	10982	143282	2936	7579	5471	6907	83460	23085	202	51278	10609	10268	64222	947	1831	4363	7277	4603	51605	29982	8411	84456	30844	678	23613	5515	5165	65983	27443	4247	92014	57514	4092	79647	2580	6396	399687	57673	6477	1869	9750	26191	10007	57142	284996	10949	80762	8882	54855	221178	5435	6489	8161	4088	567	7088	4713	439	8531	56937	10188	2583	283489	283537	23270	54780	921	51114	116541	401409	8829	5226	2199	56652	10380	9590	79794	6772	2512	9188	100507444	54543	4711	8802	637	2091	65003	53981	256586	9150	7798	135295	123169	1788	29089	122060	10101	93380	8893	64135	10365	6051	55720	151987	9070	5608	4647	10146	9522	23014	6391	51727	7165	26511
GSE16386_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_6H_DN	M7916		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16386	GSE16386_2260_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in macrophages (6h): IL4 [GeneID=3565] versus IL4 [GeneID=3565] and rosiglitazone [PubChem=77999].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 6 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml). Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1uM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					116135	1510	827	991	283847	5409	1282	391195	55850	64802	201562	55335	56849	84154	144100	51666	100288869	283927	7473	55812	10022	22925	1501	55777	2765	23057	259232	23036	54108	23595	4703	1939	3161	4735	492	57583	89796	150677	2017	254428	54586	8635	150372	11046	57628	26229	25937	84692	2562	23077	56922	116362	6154	2709	8263	153129	1260	26077	9341	9665	2891	4311	4249	84722	10008	10841	3456	254827	8840	3892	766	9055	3781	1164	26586	81691	2857	54965	84987	25758	345222	78987	51118	2192	5081	10563	127495	1358	1620	284723	256710	169522	55749	55231	6651	157724	57337	27254	55901	11067	338442	3491	2908	1056	9389	8997	23120	4325	148156	132612	143689	2045	9638	10806	131544	2920	79827	3772	26872	6433	8293	1584	57369	390205	353497	196951	2359	374659	90417	84950	129852	8800	10585	341676	125988	94033	221322	9069	387914	10077	3211	10436	51161	157313	2549	85364	4330	6863	51208	140578	2309	254295	788	23409	6860	79645	23236	9180	10017	56675	130502	1381	6833	122402	83607	4520	100131897	146845	4143	340990	130888	27283	7424	126637	219938	118427	9215	3849	55851	28984	70	4978	80231	3574	643037	7429	246184	730130	23209	57663	4913	23316	10930	9963	983	80341	1490	26153	143425	10910
GSE16385_MONOCYTE_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_UP	M7917		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2264_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes (12h) versus macrophages (12h) treated with IFNG and TNF [GeneID=3458;7124].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					1960	1959	55661	135112	9401	30833	2005	4665	7090	4904	27042	483	84456	1958	8761	152485	64799	54107	5898	28969	22888	1984	5702	23587	351	4281	51234	506	116984	79786	22919	119504	201626	3326	389136	4063	8506	10101	692227	387	54868	3184	2004	51621	4170	6294	3959	51466	51441	134549	51611	1059	29993	6051	29089	655	26136	256380	2353	9415	9777	4061	28998	81570	399665	5693	57519	5707	7580	85369	26119	51726	4247	50628	29890	1591	6566	54463	9960	79144	26524	81545	26191	25778	55088	64285	25780	6659	2166	5685	142	166	9871	3652	23620	127829	57479	22800	4706	1537	3204	114932	83999	254887	9859	55148	6118	5163	140467	3732	23389	23741	391002	93661	669	83759	55245	5467	2963	64761	2593	23670	9276	488	7538	51150	9221	23613	83853	80273	493861	2035	23479	338339	26508	116225	25948	7321	84182	3692	26472	57380	51514	9651	55696	54978	1211	27230	1312	25769	10365	84328	5914	115509	420	63917	6181	686	79947	284217	3688	54780	10643	1072	64852	23404	5768	10801	56160	53340	57136	6636	25873	9277	3726	51124	6396	3988	55969	415117	753	5101	56993	7375	2026	55069	29775	56998	9219	6606	135398	59353	79188	55794	759	26018	1028	326624	6480	27243
GSE16385_MONOCYTE_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_DN	M7920		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2264_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes (12h) versus macrophages (12h) treated with IFNG and TNF [GeneID=3458;7124].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					10343	6448	7782	54969	254295	22832	25928	57583	51637	8549	64802	991	26150	22899	51119	114798	1510	283237	3617	51430	257106	84140	285848	140609	80013	51747	283748	79827	26269	84722	64101	9091	5565	221749	7267	9203	2896	117608	6886	9848	164832	170371	6329	6303	11248	1728	4695	49855	10933	11059	154807	155185	64231	116143	79842	22953	283431	54981	1453	64834	79590	11231	79871	113146	50614	201562	84058	117245	3918	10022	128602	84654	137970	83890	60559	10017	3161	1493	143503	84708	83953	5567	59272	8578	9934	8934	29992	403314	5331	9946	729533	57337	55165	2299	285877	117145	3175	7471	79627	4624	80224	788	64180	503542	116362	1628	2267	8310	5654	81544	374354	26153	1307	54869	115209	219972	8575	135152	11116	377007	9535	51552	25950	1345	254428	51280	5692	92211	4124	26059	7172	63827	79823	3927	11259	57761	1789	4014	55149	388403	8701	116442	285148	138151	6649	8293	54621	7067	547	51375	25819	7857	1791	27111	84066	5077	5194	9473	5923	146330	79070	26586	6870	29945	51601	163404	79345	3679	89870	113115	147798	5684	729	575	65109	199	2357	283298	145581	3251	10437	29923	64760	10577	79742	23382	84934	8013	6729	29895	5122	9055	5132	221545	57698	51728	5502	301	10559
GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN	M7925		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2272_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in macrophages (12h): IFNG, TNF [GeneID=3458;7124] and rosiglitazone [PubChem=77999] versus rosiglitazone [PubChem=77999] and IL4 [GeneID=3565].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					4710	4043	1535	55850	64061	6503	4245	10614	390205	200942	23423	3689	7040	523	83667	100128731	3059	54433	4991	5578	26469	8879	27243	9326	3809	2745	54958	374291	29078	123803	201176	103910	529	9235	25864	7046	115653	7386	28956	6874	81037	9480	57674	121260	10284	8277	347918	388403	770	59352	5528	6647	11152	5877	10959	6302	5870	83442	4601	497661	23268	65983	84833	29015	10067	29085	7314	5351	196403	54849	27430	4521	55665	9443	57406	719	9530	9445	84108	65008	8915	5134	686	6415	3151	9903	22870	2799	152559	339988	6251	5683	388962	6921	4627	113402	79602	285193	51601	7013	23516	55845	8631	3490	10944	4047	10476	51067	5621	56894	165186	29086	10467	10005	80119	5372	79137	483	5274	81689	440574	4259	3695	440193	80314	3916	55450	90637	639	5583	51246	55967	1716	158295	5378	23031	29099	60386	10248	90135	65244	5869	79596	6786	7001	284756	4771	834	7060	1362	84299	4067	28978	5465	83982	114881	55795	824	6827	56674	1349	64420	22911	8233	11236	63906	5805	10775	24144	100233209	4711	10151	664	158038	54859	90441	4694	6432	7049	91120	201266	10652	9679	79888	56731	8850	1486	63925	919	441108	9839	3482	6619	6609	10487	54458	55303	4837	389	3074
GSE16385_UNTREATED_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_UP	M7935		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2269_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in macrophages (12h): control versus IFNG and TNF [GeneID=3458;7124].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					8324	3661	92293	10898	646383	26873	23627	254240	22924	56834	144360	4585	4642	4005	83881	100289255	92283	941	158809	388698	219578	147808	81789	55907	10745	387644	8515	7757	4018	79696	55531	388182	1952	118430	55024	80111	22873	127247	30815	84514	79930	10038	23037	28513	7363	25862	55384	1727	116225	215	64123	51428	10174	7102	23500	7542	4157	3064	645984	857	64748	307	256646	284257	11021	55238	5681	5338	9179	79651	375323	8928	5101	255512	1584	4922	149699	259296	64699	84926	162494	79581	6677	51063	2307	9496	441631	493869	149069	3211	126208	84662	100272228	58483	134285	197258	8131	64599	1780	80323	112817	23769	84892	100133321	4995	1384	81890	4123	11283	170370	6999	116238	8792	51530	7306	2868	10881	63891	124751	177	57670	9855	100133308	724094	114798	51011	2010	239	54675	91544	339593	55600	284451	274	79858	124446	9189	83890	204962	259217	64856	25929	1558	5740	114900	9400	1869	3678	79865	23101	57787	6457	51301	10454	26958	348761	285759	64078	131	83642	375057	60672	92292	81617	646548	22933	644809	29995	80759	4645	5188	885	912	80313	7059	2155	2678	145783	3305	26077	7367	10281	51333	3835	140766	2596	22913	51285	56269	124739	29888	286103	100505495	1802	90133	100287051	439931
GSE16385_UNTREATED_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_DN	M7936		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2269_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in macrophages (12h): control versus IFNG and TNF [GeneID=3458;7124].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					8320	144811	641518	5892	146850	51023	224	10098	57415	151230	56654	7175	79607	54874	84102	811	55630	219927	200916	64897	55149	6251	170487	85285	26589	58489	11212	53822	123263	23557	51382	9781	4773	3151	10072	1474	100287289	26220	51001	10244	1307	79192	116496	6227	57823	10135	23603	10538	643155	3832	9188	55062	161436	8870	100129620	80150	1687	80219	91875	9709	65250	118460	5601	140710	26974	80833	56996	84911	11080	10755	5917	65243	348327	55234	908	9308	4633	55509	29128	151987	81614	10006	146705	91869	51009	1155	54059	4779	9435	80231	220929	283	730631	51660	9694	55577	132720	3595	9639	10678	4155	9456	150381	10892	7307	50840	54952	10436	8767	85012	9739	2529	11153	64769	54849	84153	642280	154	51222	595	1267	55884	6355	9920	57562	9761	6624	586	284521	55110	2791	100289612	675	10146	10492	605	9874	10409	84173	55781	6782	1193	84365	5575	283025	220988	85379	285237	93082	9533	6755	4316	3320	339290	288	23594	10279	11031	3704	4283	4125	10620	2135	4839	653308	5887	26637	90411	8689	2059	65062	10140	55238	118788	55748	55299	27044	725	4691	81873	79075	51014	150350	10469	9126	2589	27347	6335	26521	91937	5500	440574	3458	3627	79712	2921	4501	5747	5889
GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_UP	M7940		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2271_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in macrophages (12h): control versus rosiglitazone [PubChem=77999].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					8507	644809	1346	6875	23418	55600	3284	26045	152573	9182	199699	364	7162	288	10718	79066	2905	7412	56946	84922	5458	9423	100129500	57616	57338	10481	89885	100506229	29934	79696	388381	5023	79748	5554	79191	100288968	57232	160428	3849	339593	1193	55175	3361	342357	23150	10867	51661	8528	57569	5803	286154	5174	64321	183	2849	84503	91653	123876	3948	90011	140456	57709	7539	124739	8289	3887	1548	375612	27124	115352	650662	132625	257313	774	1446	145270	154872	3552	64283	26064	147495	643677	117581	56479	64843	4485	100130054	6336	63948	375057	9420	5331	23416	1444	94234	8294	85015	693207	112755	79822	169270	9654	142910	57670	439944	128414	5470	54363	6943	6613	91947	643395	54795	4974	9805	23676	152225	755	730202	3516	285692	1571	134147	85455	138474	374973	285548	64150	55930	2294	10351	8365	22845	100131691	5521	164022	57643	30062	9859	9187	359	1232	100131117	644538	84085	6505	7638	115584	2151	57698	857	7221	50506	116064	100009676	3250	203074	54922	113452	56146	11279	9108	79739	414	83999	100128590	3274	127343	440867	57464	3880	728606	11219	114793	84848	10763	201243	25876	254228	5166	89932	80099	100506433	80737	731223	501	60675	5540	10858	123264	387694	167838
GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_DN	M7942		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2271_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in macrophages (12h): control versus rosiglitazone [PubChem=77999].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					5306	151011	3757	115708	54852	6901	55016	140578	56996	646548	7071	1731	79036	55065	54462	65062	735	55907	83594	80111	970	58524	643911	79644	84102	7343	1438	9673	4049	80150	91937	7180	5553	10157	11069	57823	283078	9992	3276	7757	8445	2543	203069	4857	3856	4501	92170	439931	1787	400768	28976	401166	58986	4502	93210	4589	10911	55260	26122	55116	100287289	23212	149699	547	5089	283579	84002	284459	9914	9158	22989	9920	6277	1520	7089	6355	80852	79794	51195	5467	2213	114625	2719	23769	4496	51117	25855	115098	112812	337879	359787	4544	144809	79607	440021	375057	10279	140880	4814	90204	201140	170679	115701	5479	57491	27351	79865	10509	9429	56342	54555	84230	6283	59336	29985	131	3620	26341	9639	10417	148223	5296	92285	8825	347733	79174	11283	23277	9922	10043	9435	388610	84926	23234	83549	64856	8870	3303	100303728	138429	3627	57731	5047	120935	63948	7542	55127	6999	283278	25862	9576	645745	114900	339105	283174	55531	10273	1474	5639	705	148811	63906	1392	55343	100290973	941	64344	400236	26259	9400	284339	11185	139599	57089	58489	3046	751071	283432	64897	1114	79669	4493	143241	89958	147184	3068	57573	2010	6367	259249	85445	100527964	11031	10195	10409	148014
GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_ROSIGLITAZONE_TREATED_UP	M7943		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2272_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in macrophages (12h): IFNG, TNF [GeneID=3458;7124] and rosiglitazone [PubChem=77999] versus rosiglitazone [PubChem=77999] and IL4 [GeneID=3565].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					85290	440173	9047	394261	81626	230	6591	3866	9022	3676	374907	120376	10961	689	3853	1112	351	9249	6883	3456	7643	4633	54585	148789	84919	55036	9133	84924	25820	10454	23768	815	549	162655	55197	94240	10019	79834	7421	57476	112574	85001	83887	29121	8912	23211	29802	1464	126433	130271	282890	100289378	2009	84669	23633	246175	3198	650794	203245	22885	439938	6303	64207	1466	286077	9846	85403	441666	3002	10350	5732	5570	83719	950	3298	2905	27345	3707	9859	2210	57232	5172	55194	91663	64092	440905	10109	6502	84085	9779	973	23002	79658	726	26523	1179	28639	6613	9804	51700	10740	100128501	1839	7419	9766	359948	383	963	147837	343641	389376	28673	100128252	80212	9883	80824	64122	11025	153830	3090	338324	728114	10950	282809	3428	10351	149685	1390	282679	51321	57162	474171	9555	113451	83547	128338	8941	89885	9638	100130285	85027	3495	27154	3576	113452	112755	5095	55013	90024	29904	285782	23746	5287	5121	384	28517	26228	7565	5133	84503	80095	51205	284576	56246	83648	7046	50808	25934	10635	5521	54207	9928	150726	126731	57578	90167	26278	9644	286002	9182	84066	121512	2952	283578	3887	100505716	79647	9991	23052	91319	23648	645323	5224	2944	10518
GSE16385_UNTREATED_VS_12H_IL4_TREATED_MACROPHAGE_UP	M7959		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2270_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in macrophages (12h): control versus IL4 [GeneID=3565].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					8938	57060	10861	1179	327657	152559	401115	161176	59067	7905	117584	255189	2028	136332	65979	122953	337876	55742	115825	30815	389856	9069	9404	57168	100128071	100128160	116983	7703	348093	282679	999	430	6812	4741	8549	9001	10233	374291	1945	4795	3606	493	25822	27043	641371	80333	145258	7293	8838	79585	54714	84164	79625	3111	5097	79659	9727	5518	3663	644096	3849	29948	79968	146712	2125	462	127700	7189	255043	131831	51433	387700	644353	10368	6277	81855	8676	23308	7850	64063	286046	8809	120224	54535	9172	83539	23288	11243	23008	54434	22806	7704	54331	3559	2322	29099	84271	150223	9697	8859	64792	6281	57153	26227	3956	27255	10293	219438	127343	2077	93611	51341	2257	1113	1786	55034	572	23566	5621	1240	26289	148741	55766	382	139735	10360	1280	81617	10586	89766	55704	55715	219938	6275	138065	10904	57465	23039	3216	84639	22841	285025	643641	65122	64359	6196	8495	4610	55561	5133	84938	10466	8811	8029	2303	53344	64147	65108	10043	9806	145497	2252	8428	134429	57493	22938	401647	953	8566	1750	2305	4204	8481	2081	83443	3055	8372	23236	55311	51299	79827	23593	8751	54857	5226	9214	27033	162966	284086	63874	9994	4881	613	5578	4698	7378	9665	284352	55540	10381
GSE16385_UNTREATED_VS_12H_IL4_TREATED_MACROPHAGE_DN	M7960		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2270_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in macrophages (12h): control versus IL4 [GeneID=3565].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					2195	2740	1738	2327	7479	3267	81833	55906	161514	5825	55783	23285	3066	2253	145781	23580	1233	29909	94101	23423	116379	254240	8562	10324	79007	23185	2110	641515	64645	6708	388536	728215	3052	79974	7163	64976	862	60526	11235	54839	54704	81887	10216	79871	1203	10762	5058	389208	7879	23536	2841	781	8573	2353	651746	646962	26103	221294	3273	55110	10979	79191	64786	260425	54165	6037	56902	9422	7140	51060	84365	347344	10247	3628	53632	55627	79755	57540	7597	29079	80219	5917	155	23256	81792	51260	11015	2925	84896	3140	54832	9130	26986	7332	100131897	93986	7174	27306	10179	101	93978	166378	665	23471	201562	51473	4884	8483	53637	7702	84128	286676	4654	51124	93380	10082	9295	378925	127540	523	55	8936	3652	64753	55760	962	137362	64699	130271	57147	55975	90411	199857	90332	145482	51001	286827	56900	55553	337882	29074	140689	7224	79609	51808	4927	4594	84068	6386	5754	342933	92737	154215	5449	10775	729614	10237	8439	51167	10694	147923	1962	6129	26235	137814	79031	353134	5723	112942	133418	83592	23412	128153	10350	11136	245930	55179	27085	153222	6414	51375	9403	118672	81555	8726	64110	257019	5861	54491	84950	85358	51616	130827	168667	3646	57402	2034	23421	4552	4783
GSE16385_ROSIGLITAZONE_IL4_VS_ROSIGLITAZONE_ALONE_STIM_MACROPHAGE_UP	M7986		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2278_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in macrophages (12h): rosiglitazone [PubChem=77999] and IL4 [GeneID=3565] versus rosiglitazone [PubChem=77999].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					3026	5583	377007	81796	9422	64759	4804	51429	65987	79755	89857	10595	5787	5046	57818	144486	23768	79057	83468	100131378	113451	954	655	8715	80380	23158	54949	7186	51011	11174	9099	7097	22885	387707	950	50624	129049	389320	143879	55357	2334	3903	4675	64779	23090	6506	115677	2566	4858	1149	84959	27036	10949	5621	1130	799	3280	57552	343450	1595	347741	79933	140459	3728	63982	6941	25975	4648	406	25937	128674	140462	389813	26123	10572	2065	1896	108	392636	6692	11251	158219	64805	50617	94033	1395	54800	9788	153339	1101	79574	219738	10904	57683	440836	129138	84674	4916	1583	9619	1134	51308	7539	92521	1299	9076	9118	64421	4975	163351	3780	94059	1687	353116	9663	3750	2735	85414	6570	898	116369	6498	643008	54855	8553	80230	54933	51280	100009676	653140	56204	25825	349149	79718	2880	51523	8826	64518	2149	11329	119391	1215	114822	6448	6276	84443	64577	128602	6258	4814	127247	494115	154467	7421	9023	5139	94031	116151	83606	23191	23660	56903	7046	56341	3694	10631	29109	9885	7881	57568	116931	11145	163882	84525	5997	3783	28231	8658	81855	81847	54845	2524	115650	114294	342667	256714	1400	9543	27143	9443	1292	1901	15	2137	23052	391365	257144	9033	7182	144110
GSE16385_ROSIGLITAZONE_IL4_VS_ROSIGLITAZONE_ALONE_STIM_MACROPHAGE_DN	M7989		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2278_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in macrophages (12h): rosiglitazone [PubChem=77999] and IL4 [GeneID=3565] versus rosiglitazone [PubChem=77999].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					79714	10635	55144	51629	57713	55005	8800	54431	6676	23478	8851	2644	374986	51218	50808	768	26519	2193	2531	2319	253714	51077	2878	1955	55308	5095	3703	11020	50515	5536	23598	54853	29902	3082	50865	23569	50999	51117	150677	159371	908	54093	55028	23235	55872	4354	4848	51091	9352	84108	64798	92342	7465	51199	169714	26292	10950	26253	221545	55017	4176	9631	65990	79039	64285	51004	2887	221061	150468	90550	10678	8536	83451	25782	100131755	220107	79968	51495	123606	145482	7272	55748	6948	1486	5178	63892	55151	51750	9577	203	4317	23760	10360	51097	92170	6389	29068	4593	79882	9585	116224	10253	55906	1583	2620	7390	5922	708	54543	24146	55793	340277	56931	6612	79768	6583	55276	6608	59349	3329	8260	23600	25842	122786	143098	6509	9349	4356	201931	79819	23594	85403	7398	79664	10531	3608	54487	9184	2280	79977	5775	23421	55070	10797	112724	8395	79657	2581	27109	80742	2948	56181	1478	2815	529	131965	84955	9200	65010	6832	8165	81570	5510	60560	8883	10813	53371	648	133619	2162	90381	6541	57673	25940	990	8208	3320	2153	8697	100271873	51451	95	27284	51069	64118	64756	29089	7385	8455	163786	7381	2035	5191	10283	123283	10901	5723	641	51084	4141
GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_UP	M7990		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2279_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in macrophages (12h): IFNG and TNF [GeneID=3458;7124] versus IL4 [GeneID=3565].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					26030	219333	80204	22878	23396	9658	64651	83737	59345	8648	7913	6717	129852	29108	1627	3720	9424	2647	8932	2694	5777	121260	9805	285852	5898	6890	26136	55791	54918	64333	23216	79896	59344	152185	57337	21	114799	639	170954	57591	83742	537	84255	374868	23265	29110	3936	160851	81786	5579	2358	8994	839	659	56172	28996	9252	5747	10749	26090	153222	1974	9020	3055	9258	54850	29109	64759	51225	80709	1794	10625	4650	140885	4649	80303	942	8495	114793	49855	8826	2793	51363	55603	83930	26762	23187	8402	342933	163	2746	10181	144347	154743	8556	5094	5293	55589	285362	3133	388730	345757	85015	1889	10265	9798	2516	79982	4208	56929	2041	56853	6252	2849	89886	3656	826	597	3071	202	55604	84747	317649	153830	146760	8405	162073	54531	118788	64766	146433	1783	7750	1014	51552	54477	79792	6277	340526	5423	595	22800	80020	7809	7408	65983	55654	1524	5698	5476	27129	11344	51271	221504	8200	7481	55743	114907	2800	80314	63940	7444	22898	51704	55013	10613	63891	23673	133491	51347	4140	337977	23308	1072	10947	84519	136319	10287	84824	6531	6142	5229	3274	646262	8574	56204	115294	84662	6569	1398	283638	10307	79180	51466	10238	9107	9709	7280	3269	55668
GSE16385_ROSIGLITAZONE_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_DN	M7993		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2274_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in macrophages (12h): IFNG, TNF [GeneID=3458;7124] and rosiglitazone [PubChem=77999] versus IL4 [GeneID=3565].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					56624	7419	8509	255919	79893	7385	169166	83607	2184	64645	8968	221061	5594	55780	64798	165324	57477	79896	5928	54622	58505	6729	55922	1955	59349	55790	7494	285368	1730	80097	23253	57161	8491	80823	55829	84817	93099	79849	23588	79603	6539	23335	6651	377047	55758	55561	79712	51199	6326	2581	23515	79738	1739	118924	7137	7018	8826	4481	929	23160	91966	4057	65983	231	25840	6375	55297	4354	27109	6571	23171	348995	759	83852	3273	157574	5436	23185	2339	9604	2869	23328	51	5525	7737	60492	80067	285331	29889	5657	84627	22824	51118	130589	28232	55898	84708	4281	23256	10253	27241	8910	23263	2046	54808	10159	10642	80314	79874	1431	585	6342	64135	51076	154043	10235	1285	3720	374569	1191	50509	55676	55709	7127	4329	79753	55536	196403	25913	10855	356	64840	8578	150677	7130	5001	55198	5739	55825	5501	10933	1787	9535	6905	84128	91404	80005	10724	10294	2697	79159	255426	9693	1200	55332	8649	1429	8216	9737	160622	386618	4520	169693	57419	9946	25901	10893	23248	27309	22928	64764	5599	134553	2773	3000	10938	55608	22934	22949	149345	27242	9849	50515	131965	150737	84293	2069	5023	8395	4054	1992	285636	1875	79048	3550	64420	51266	56606	5884	84529
GSE16386_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_6H_UP	M8000		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16386	GSE16386_2260_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in macrophages (6h): IL4 [GeneID=3565] versus IL4 [GeneID=3565] and rosiglitazone [PubChem=77999].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 6 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml). Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1uM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					4635	51375	55144	88745	16	10465	5438	7334	153527	8514	79036	1967	3418	259266	26100	8550	23478	29789	55749	51265	10175	9153	27153	169355	51144	100131755	54431	79714	119032	1819	375387	23421	79685	84705	57713	8443	64285	81887	116238	91433	8861	1176	92609	54814	129138	8731	60561	5426	622	54487	5524	5955	79622	573	10603	134218	2646	9569	80146	113829	5020	79863	23130	6510	113201	122786	79613	4841	5625	23560	126917	6688	4298	25940	908	2683	3201	7580	3178	56852	23212	57704	28973	23162	30	283927	6633	9851	55300	54663	2948	83932	60488	85378	79934	6897	80755	79091	11068	29109	1936	9524	64968	57380	51102	129685	55252	8193	8453	84182	200205	159371	1312	1455	400629	873	374868	4147	124995	64788	8882	51205	55291	51747	54956	51009	84792	8438	51013	51574	2947	25953	64951	11097	8754	2188	196463	100506562	375757	10295	57325	55696	1173	5780	8027	51605	813	5591	701	83853	11073	1654	375341	55824	10535	29902	55702	54948	56606	84260	57461	3014	9179	3336	1111	9099	1965	1491	51377	115024	8502	5245	286826	1622	5516	4145	1376	54858	22823	55705	163786	252983	79084	55168	2617	51118	389203	142940	23264	1370	29103	29911	53371	2535	55627	5494	80097	8815	10592	5228
GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_DN	M8011		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2279_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in macrophages (12h): IFNG and TNF [GeneID=3458;7124] versus IL4 [GeneID=3565].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					55653	83394	728215	750	81494	9182	7189	100302740	202151	83696	57242	79869	5347	83593	100130934	3706	1366	64782	57158	6601	282991	401550	9900	126147	3824	1813	5232	56341	5136	1438	1997	90655	387338	57127	5617	348378	3861	53405	401114	80736	284804	6975	2300	353497	51278	10024	10686	285282	26102	9514	139065	124535	23396	554235	2800	387638	6317	400169	23567	2149	23484	445347	202865	83667	27296	80144	79720	6752	56164	23148	5429	11052	64756	6694	8618	163131	256764	10816	80867	6710	79139	139285	222235	29950	64168	7266	85395	285973	2232	8650	56474	54807	138065	2297	302	1063	84898	4761	673	4193	25843	190	100329135	8796	83737	7105	3364	283208	10367	63943	100128298	54800	138429	1071	10218	64321	2516	414301	83656	1510	130540	5864	7148	83896	146225	140875	1440	8361	6921	10610	115795	130557	142679	7783	96626	23446	5718	252884	11334	8516	140735	51768	89944	138948	100130051	23553	3006	100288805	3906	148231	100289058	924	79191	112858	10299	342945	57614	114904	2312	342979	3229	25799	9607	4544	6499	51046	100507206	284240	373861	54768	627	102	132612	339789	284086	11116	6336	4738	57003	1490	117248	497661	92211	2692	3665	2187	3090	115111	388336	51182	2649	645188	92482
GSE16385_IFNG_TNF_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP	M8012		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2280_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in macrophages (12h): IFNG and TNF [GeneID=3458;7124] versus rosiglitazone [PubChem=77999].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					57616	4850	64783	53944	2744	128869	27229	471	5283	113251	4291	10778	140901	9123	7361	26135	23418	1032	8586	79034	79830	55811	100131180	7942	23401	7565	314	84865	856	284804	168741	63932	80761	9534	148741	387338	5048	84260	23587	9633	3752	1106	401145	285300	221786	10473	284702	121457	84246	4234	5786	342538	644620	27352	7827	9061	643395	253962	8793	56474	6427	7461	10926	3614	80742	7718	64895	5243	10342	5520	9578	90780	100129407	24149	27173	55145	320	1164	205147	11100	55423	25884	5704	100130741	124801	100287814	2846	162073	80185	131566	100130967	54443	57634	100505835	23743	79792	1763	6403	23252	9230	51260	115861	158135	100287765	8315	1857	254312	85409	2244	9184	147929	56901	2969	54807	79960	143684	63948	90632	84824	25980	23360	4800	80006	10772	79171	4739	29095	7327	9382	283521	644186	196951	51412	80765	3579	9412	1915	100507470	6327	5682	1855	5347	1105	90864	100288870	100288944	123207	29115	57727	122704	100288007	114932	11338	9381	2358	51239	3351	26053	116173	5729	200609	284382	9914	400954	64324	84932	30849	1524	266671	23387	8559	1733	8707	10081	8834	57824	55664	7711	57541	64794	55073	9658	56105	653687	644128	26037	27068	6135	55167	6955	118672	10914	7450	80131	1290	56943	57697
GSE16385_IFNG_TNF_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN	M8016		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2280_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in macrophages (12h): IFNG and TNF [GeneID=3458;7124] versus rosiglitazone [PubChem=77999].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					7761	7299	155382	750	150596	282566	100131662	56146	9801	9583	23148	11202	400618	286223	190	254042	644660	284312	64978	51586	378825	117532	146225	9058	90655	3002	441108	339457	55766	285972	51123	100306951	10454	222698	645784	100287375	29013	100128074	2623	89	51438	5870	245936	3813	51281	2998	348120	153218	284069	5136	164656	23446	8542	400957	121441	5789	9852	990	4885	7356	3960	100505967	63826	170685	340206	84957	887	55615	654429	64168	8322	51806	643382	388336	129607	1438	5813	4008	200172	5382	146177	93377	10867	6910	100287237	85453	8840	6909	728215	81623	51351	26648	7775	6300	7225	202865	84253	4159	100132596	100131532	57151	283375	8645	100128175	8933	23194	225689	84996	63929	9638	2297	28595	163131	4638	84826	7062	9636	494150	9514	134111	340085	5407	56904	145447	2694	7286	55061	55576	4163	26279	5304	79012	116285	79879	400451	246122	219793	55853	10686	3552	6450	28965	2931	200010	100130264	90133	163778	285668	91768	11033	220202	3232	150142	8756	57158	6317	10371	348817	100132999	85291	100507064	23558	1826	55653	401093	6561	80217	283579	28968	5654	6927	100128298	26251	145757	160	445	26493	80144	200162	339976	389199	222235	23552	100293559	5463	400657	400946	8013	6677	159090	2567	124590	1269	9156	56	51371	8638
GSE16385_IL4_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP	M8017		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2281_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in macrophages (12h): IL4 [GeneID=3565] versus rosiglitazone [PubChem=77999].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					23499	729799	9397	54407	10142	135228	157506	92105	80153	57761	7267	1827	200933	387755	9918	5018	196074	7259	51616	54902	9743	51129	706	8935	55041	11259	79673	219771	84233	5250	7011	388815	6599	57148	4666	85476	5591	7407	9761	23097	6188	9774	1854	222658	55699	3298	51465	23150	57448	79918	5530	4714	3609	7700	57107	100506686	9112	100289086	23516	5027	56655	51604	9131	650655	3632	139628	79786	79956	161357	776	2271	8507	541565	6722	6392	148156	84725	23460	221545	2802	5436	619279	646762	221035	80152	54799	80194	7248	51802	6310	25822	3313	2909	165215	9957	6191	1102	84795	5825	4145	23369	6059	23344	57786	4668	22881	2590	79707	170371	100130357	6480	79587	8826	23517	6176	55119	2558	64411	6207	26751	7414	5033	5859	6595	29028	3480	286205	152579	4050	84307	10885	1523	59347	80746	2107	11154	26273	23353	6160	7009	728498	79161	57178	79017	8685	55761	55780	7423	9686	57820	11163	284219	6342	10124	10915	23396	54941	80777	8703	56937	84634	22990	343099	54993	157680	26130	25771	60559	81831	1933	285830	8697	55850	56995	28970	6155	6208	2971	79718	64219	84206	55727	6452	728294	100287765	23193	6272	6181	57496	6132	81875	148137	5611	100131180	79228	644242	23613	401166	7358
GSE16385_IL4_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN	M8018		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2281_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in macrophages (12h): IL4 [GeneID=3565] versus rosiglitazone [PubChem=77999].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					254268	285097	5970	100506274	9275	390063	59348	6975	400084	284370	84684	3448	23762	81796	3021	57620	9519	51010	155382	4814	873	3959	113829	283887	27251	55700	3107	9255	56474	84826	3785	55178	84875	386758	30811	29126	7514	4218	117854	10475	100505851	57823	90121	1318	2960	138241	29074	9325	684	728568	3669	29893	9208	260293	8504	84466	28955	55113	3902	100289090	1406	339230	53822	7295	5684	51646	285905	51231	3996	28983	6728	100132285	138255	4909	10507	29803	283131	9468	11119	9025	1366	4779	8557	100289610	100505835	729991	25841	139420	79962	8334	10308	10612	51406	649446	23479	6118	4760	79697	81930	407738	25854	4598	732448	56965	57007	440894	2300	285957	53826	440952	1192	64135	26263	10884	27341	2580	10627	152926	6009	79100	151888	3675	160728	100506898	529	8807	79802	10677	54813	113130	8878	7516	90649	64005	8840	26953	43	57162	5905	201294	11120	170690	347732	168374	9191	112495	140775	338773	6751	64106	9550	10148	4868	9982	91351	56954	5988	11248	284244	29098	350	304	246329	254187	55346	160622	56341	81030	79568	1620	3184	147727	100506392	84281	22920	65999	54971	55321	646962	6569	55337	27237	57621	158234	6282	135138	5443	83444	90827	65264	1992	4236	2649	54850	64108	8495	5371	222698	401176	251
GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_UP	M8021		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2275_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in macrophages (12h): IFNG, TNF [GeneID=3458;7124] and rosiglitazone [PubChem=77999] versus rosiglitazone [PubChem=77999].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					23529	59348	84826	9275	11118	4218	113829	84971	3959	57823	5970	5618	6548	283970	23072	9255	55120	57530	83538	285905	51023	403312	3107	23370	5049	399959	1407	970	9519	30	84433	142680	8027	57620	55335	6827	2300	400692	55083	100289610	3669	3792	1416	80179	10335	147727	4062	154313	990	100288944	392459	84807	4149	139420	403313	10984	100132388	9826	440117	7320	4193	5684	26245	23360	873	100506229	10627	10534	79140	4799	3137	29803	29126	259307	25841	1318	78989	684	200186	151278	4236	162979	7220	28461	100289341	64759	2048	55700	60673	646324	84811	266977	28955	26528	728196	57612	386758	84932	1109	126382	27291	138241	731223	2633	60682	283131	219988	114800	4868	729059	57687	199713	84875	54707	728568	84246	2019	401913	374907	54809	10446	414328	11047	143187	339229	5610	90379	25854	7514	1063	5093	51592	2643	6118	200081	493856	55669	222698	116228	8548	140775	55113	27033	51455	374454	284080	10507	8237	9034	57649	6758	7295	25963	54952	55178	84985	57117	29763	8818	84838	5905	84237	23384	5493	285957	161514	3949	54922	9820	54862	9517	81620	124751	65264	113	90637	10726	54820	389432	3587	203197	6728	5718	285547	8737	64092	4114	81796	26122	2166	55635	64761	113675	124056	157983	5979	3572
GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_DN	M8025		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2276_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in macrophages (12h): rosiglitazone [PubChem=77999] and IL4 [GeneID=3565] versus IFNG and TNF [GeneID=3458;7124].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					220134	51555	216	10635	6819	55776	597	28831	6263	54535	1822	4916	445347	90485	55334	2202	22847	79627	5346	6235	26083	11341	54766	8643	1009	2004	2649	9495	55259	4129	92973	1634	5523	79033	10298	9437	56938	1511	33	54839	5322	2731	54845	5593	64288	3996	6602	441204	491	32	5652	5676	79754	1806	9630	112479	3263	9071	6005	2173	6403	3060	9108	2020	54674	6319	386627	7010	6173	26052	10022	8940	10149	3937	26659	55089	931	55332	727800	4915	2041	79819	79000	10876	8626	84525	3593	7220	5207	79953	51090	23580	55355	140462	115653	53358	57612	58158	55717	23111	4038	64772	2150	3730	3077	9555	30846	10086	6422	4313	5617	29896	2321	65988	5961	11126	4210	11063	3595	6775	79639	9363	9306	80036	5646	10615	81697	3953	100287602	81848	4681	857	64219	23354	84107	1793	79931	22881	23166	8045	284119	55303	4515	83716	100419017	80352	2776	25932	79154	55760	64174	5337	64849	55898	9353	3231	2099	2916	6691	9971	1142	51400	9722	3678	51268	4753	7166	79696	3779	6320	83734	4804	9421	10077	27306	6315	7366	11055	100288941	56891	10665	1946	2697	2780	4013	683	26033	2983	58494	5066	10913	3553	4976	219	10879	54752	8435	54886	131566	2946
GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_UP	M8026		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2277_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in macrophages (12h): rosiglitazone [PubChem=77999] and IL4 [GeneID=3565] versus IL4 [GeneID=3565].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					241	23231	8115	23547	7045	7048	24141	8661	51182	9709	8621	8202	117247	55847	53339	6650	7305	55544	25972	9934	4610	9022	5788	1439	64231	3002	29855	8564	5205	2207	81887	8869	6574	5997	6277	9618	55512	55623	22992	999	9140	55802	4064	7538	27242	3845	51290	7357	952	79677	6890	55684	8887	23030	80155	3726	1054	5730	5529	6689	51547	8481	3572	3512	1880	57602	3669	729230	57130	22876	10964	55704	5562	64761	8930	5927	51284	23054	2824	2767	55142	10618	833	54502	10472	10098	55660	3631	440423	8872	6925	81603	10723	2621	3126	10528	3563	54521	9711	920	2896	8662	9107	9961	23064	3842	3485	79713	23590	84617	23435	5608	284325	23729	5090	9473	11329	11103	25782	5580	5423	6785	54847	26959	93487	10240	3551	4938	730092	3981	92140	6499	8635	89845	51593	5431	27090	6867	23433	5295	6897	9595	5168	55193	55219	9933	55619	55850	54952	9907	2833	50488	6768	55035	5176	56886	9129	1629	51322	57187	3741	9144	9885	7559	9371	6039	10302	11006	30833	2317	23200	6722	10482	8717	10858	55862	11276	5469	5373	1983	10438	26512	7169	8243	11145	1776	6504	9391	3419	3189	79648	51005	388796	5345	81552	5886	23637	10866	51131	483
GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_DN	M8027		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2277_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in macrophages (12h): rosiglitazone [PubChem=77999] and IL4 [GeneID=3565] versus IL4 [GeneID=3565].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					25999	3512	23258	56998	140462	6320	5872	1511	25809	5635	10417	307	1380	9516	26275	23108	6328	2983	7402	3543	6775	8936	7096	80212	445347	51316	7292	1500	27306	58488	7122	301	7035	55819	2729	1992	7127	6674	8835	64921	1857	23189	7923	10079	23171	5732	19	4689	9306	9823	139322	29887	124583	29994	9844	9783	79158	7358	56252	25932	4976	6691	2067	79033	22800	2976	7050	63934	3489	6402	29970	55686	3987	55364	7263	5146	140801	2218	138050	25847	8323	7757	9348	4311	3460	3992	861	26136	163	55255	10161	4239	9202	439921	79630	6602	2184	10451	55617	64764	710	4502	23201	9365	55501	2720	4069	79830	4121	2567	55435	4940	7803	1102	5236	51477	1978	10165	3202	79154	55114	2353	10799	9846	51309	55190	54681	80742	394	599	1806	5877	29969	64092	2762	3280	79068	55622	474344	10287	9168	7743	4338	79070	57178	6121	23677	6171	31	3099	56521	54815	55893	3938	10954	5213	3480	8531	8464	11142	55790	2628	10007	1571	64131	10257	81602	1876	8491	10758	2776	7071	4734	55930	92579	79921	51474	9781	11314	256987	5646	2157	166647	5175	92703	93129	60312	5358	9331	9761	834	10644	57175	1717	26747	9767	158471	5789	1789	55133
GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP	M8030		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2276_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in macrophages (12h): rosiglitazone [PubChem=77999] and IL4 [GeneID=3565] versus IFNG and TNF [GeneID=3458;7124].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					10140	26959	597	8906	4753	8202	8864	23670	117247	4122	9172	23102	9859	6464	3845	3570	7071	25972	79722	5199	2841	4665	1880	51090	6515	8718	10365	6448	1959	4929	9531	55634	8459	54971	26751	10507	64761	64427	51742	9819	114882	91782	57763	4863	1757	9076	5927	4140	90	9262	22992	1387	26012	22930	55729	959	26235	5243	80208	5529	9765	64174	9907	677	7259	66008	2323	55568	113791	2643	9709	9527	80219	79982	8690	55253	79612	89845	55623	5775	23353	6504	57509	9439	3423	814	3001	55303	5128	55229	92822	60468	9724	8717	466	921	9961	10384	25797	157680	2633	329	171023	3572	9913	9129	8675	29916	23178	3096	6049	4049	10427	7779	10127	6503	54674	5495	23030	905	10803	79441	10178	6047	5747	9363	9666	5209	55544	5350	10479	3560	79837	22882	55578	26207	25843	9630	3357	11120	7915	80232	9794	3716	51561	57602	120	1846	7559	3305	87	3029	64780	27020	9806	6322	10866	55601	23586	55739	10026	23274	26046	10274	1263	79652	9648	8204	55914	55660	11123	55636	55619	230	1901	3669	7840	79961	10913	8631	55251	5788	23507	1293	22876	23053	22877	387751	53343	54556	8740	2534	3398	29121	10443	51719	1236	7074	10964	8445
GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN	M8032		21093321	Szanto A,Balint BL,Nagy ZS,Barta E,Dezso B,Pap A,Szeles L,Poliska S,Oros M,Evans RM,Barak Y,Schwabe J,Nagy L	GSE16385	GSE16385_2275_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in macrophages (12h): IFNG, TNF [GeneID=3458;7124] and rosiglitazone [PubChem=77999] versus rosiglitazone [PubChem=77999].	Human CD14 positive monocytes were purified from healthy volunteers’ blood and cultured in vitro for 4, 12, 24, 72 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml) or classically with interferon-gamma (IFNg 100 ng/ml)+tumor necrosis factor (TNF 50 ng/ml) or left without activation. Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1mM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes.					6352	8906	8621	5525	8869	814	80208	4122	10140	7752	4753	54521	9831	57130	10365	9363	51291	8718	10618	6091	64427	11123	79625	26012	57124	57509	8453	23102	5775	5324	905	10302	5786	4863	9709	64417	26751	55251	4140	987	8658	80853	8204	81533	9129	730092	64761	8930	87	4907	2841	9765	28990	55219	66008	22930	65990	3631	53339	2932	728642	10427	9961	3003	1959	824	9039	230	3662	117247	6772	80219	7294	157680	1054	80232	6722	6281	26959	11216	8887	11275	9841	5286	3560	282997	23135	5205	7074	2004	55253	3485	51547	26512	3707	57826	28584	5934	51561	64219	55544	25983	79982	9439	23178	3726	2145	5140	80781	4665	55744	55568	5128	728855	79726	11232	8675	9140	3621	9527	9466	3845	10240	8776	5529	10396	3820	7259	6571	5617	7696	5495	339229	25782	5788	11138	51290	79652	1293	5469	54556	9778	596	23210	25843	51719	10782	1960	9159	155400	3937	54880	7277	313	9046	10507	51706	9488	1117	10735	63916	4929	55623	6504	999	3004	26053	25788	54851	940	8459	54758	7779	55776	84525	2323	6322	10600	4049	9618	29929	120	26235	9904	3823	3572	81619	51742	9172	55660	9107	4938	5199	84060	241	9857	29071	23586	1387	10472
GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_DN	M8033		21108462	Hervas-Stubbs S,Riezu-Boj JI,Gonzalez I,Mancheño U,Dubrot J,Azpilicueta A,Gabari I,Palazon A,Aranguren A,Ruiz J,Prieto J,Larrea E,Melero I	GSE17301	GSE17301_3430_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD8 T cells activated by anti-CD3 and anti-CD28 versus those stimulated by IFNA5 [GeneID=3442].	IFN alpha mediated gene expression pattern. The effect of IFN alpha on human CD8 T cells responding to antigen (signal 1) and costimulatory signals (signal 2) provided by beads coated with anti-CD3 and anti-CD28 mAbs. This analysis examined the effects of IFN alpha on human CD8 T cells responding to antigen (signal 1) and costimulatory signals (signal 2) provided by beads coated with anti-CD3 and anti-CD28 mAbs. Magnetically sorted untouched CD8+CD45R0- T cells from three different donors were unstimulated or stimulated with IFNa2b or with anti-CD3/CD28 Beads alone or along with IFNa2b or IFNa5 for 48 hours. Individual mRNA samples were analyzed using HG-U133A 2.0 array gene chips. 					9934	79691	55114	84864	6251	5168	7305	999	51338	29760	6925	23645	9711	7169	55819	8754	5423	3512	8417	27075	10954	8741	9709	6689	3002	9348	10577	54475	8115	2896	4125	1021	6195	203197	5997	7402	9922	9022	1508	27090	11006	2354	3480	5176	23547	25829	11274	54976	1439	9839	1604	2207	7045	1075	2824	4332	6747	729230	8553	10211	23654	5580	7096	10166	23189	22862	1880	51316	9516	51754	4062	55278	5730	10417	9473	23171	7263	10788	23258	710	3087	3394	5562	55255	54806	3099	22918	2982	3717	51734	55752	57553	1520	10135	51347	10964	8140	2976	29994	79443	60685	9637	3115	57476	1200	55681	22809	1803	6775	3543	3665	54847	23108	2729	114876	6894	1849	23677	4239	24141	486	8682	64231	54517	3113	10019	11314	51651	22797	1536	23643	2067	217	9910	9261	150094	10287	6039	80183	5860	3122	4864	3109	3108	23596	1512	2683	51339	63934	98	7456	1776	139322	2760	10758	7357	2010	7205	23231	822	115207	3429	4208	10007	4067	51635	9425	11010	2720	1992	6198	837	9991	9781	10384	55246	9873	2876	3587	26228	26275	64425	25940	1717	307	3123	54765	10799	9936	1500	284021	64764	608	4644	3563	241	55228	972	55501	4599
GSE17301_CTRL_VS_48H_IFNA2_STIM_CD8_TCELL_DN	M8034		21108462	Hervas-Stubbs S,Riezu-Boj JI,Gonzalez I,Mancheño U,Dubrot J,Azpilicueta A,Gabari I,Palazon A,Aranguren A,Ruiz J,Prieto J,Larrea E,Melero I	GSE17301	GSE17301_3424_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD8 T cells: control versus stimulated by IFNA2 [GeneID=3440].	IFN alpha mediated gene expression pattern. The effect of IFN alpha on human CD8 T cells responding to antigen (signal 1) and costimulatory signals (signal 2) provided by beads coated with anti-CD3 and anti-CD28 mAbs. This analysis examined the effects of IFN alpha on human CD8 T cells responding to antigen (signal 1) and costimulatory signals (signal 2) provided by beads coated with anti-CD3 and anti-CD28 mAbs. Magnetically sorted untouched CD8+CD45R0- T cells from three different donors were unstimulated or stimulated with IFNa2b or with anti-CD3/CD28 Beads alone or along with IFNa2b or IFNa5 for 48 hours. Individual mRNA samples were analyzed using HG-U133A 2.0 array gene chips. 					28639	57125	26205	925	89941	11251	10602	25777	3212	406	54820	55604	6097	1850	22897	375449	10874	80169	90864	23067	23205	8609	26152	2937	51564	10566	51512	56983	6304	177	911	926	27240	51733	23046	64793	10120	11132	4034	9138	81857	5429	375346	80215	604	54811	2051	9806	64132	387535	2717	8342	5796	1183	79187	4240	6457	91289	55511	5357	116496	79735	1043	55738	55351	8242	3738	23623	7349	50626	4650	9851	55048	51706	2185	54101	322	28951	80346	3140	57794	54535	65258	6504	6334	51763	643314	9139	23576	23192	80004	245812	1038	5863	54463	6494	26012	9737	7106	51084	54799	51004	100288765	91782	83463	79929	65980	10057	23439	56301	64718	10347	64762	7092	6901	57326	8573	3700	28785	360	1889	5364	23081	55544	4843	6281	8341	5252	4880	10124	28755	2167	8630	8359	10178	26277	11037	9235	6373	80007	971	2664	206358	9452	23152	8631	54762	116985	5833	29781	8874	6503	8507	919	51147	115123	78994	10265	51554	100289109	6955	64748	90326	662	645784	3177	3552	116984	84914	10981	55716	51228	2562	11167	3097	11063	955	124044	80201	6567	9183	5582	114	79661	7016	55771	28584	10516	3009	7692	60	8330	10868	5287	55690	5447	147	1031	9814	11278
GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA2_STIM_CD8_TCELL_UP	M8035		21108462	Hervas-Stubbs S,Riezu-Boj JI,Gonzalez I,Mancheño U,Dubrot J,Azpilicueta A,Gabari I,Palazon A,Aranguren A,Ruiz J,Prieto J,Larrea E,Melero I	GSE17301	GSE17301_3429_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD8 T cells activated by anti-CD3 and anti-CD28 versus those stimulated by IFNA2 [GeneID=3440].	IFN alpha mediated gene expression pattern. The effect of IFN alpha on human CD8 T cells responding to antigen (signal 1) and costimulatory signals (signal 2) provided by beads coated with anti-CD3 and anti-CD28 mAbs. This analysis examined the effects of IFN alpha on human CD8 T cells responding to antigen (signal 1) and costimulatory signals (signal 2) provided by beads coated with anti-CD3 and anti-CD28 mAbs. Magnetically sorted untouched CD8+CD45R0- T cells from three different donors were unstimulated or stimulated with IFNa2b or with anti-CD3/CD28 Beads alone or along with IFNa2b or IFNa5 for 48 hours. Individual mRNA samples were analyzed using HG-U133A 2.0 array gene chips. 					51314	6599	23277	22883	5867	646808	79915	1511	3094	9134	10623	23648	4172	27230	7015	2821	50515	22902	9532	7531	5591	29803	5687	11222	79865	1537	11338	5426	7686	115703	23240	9486	4904	2848	7869	6790	5984	2919	81930	29122	29015	8292	80032	79087	8547	11343	55798	55697	10061	3418	55635	1047	2956	80218	57513	4267	689	79050	29960	2628	8427	672	50508	693207	8345	5198	80179	55201	2926	90204	51293	55179	8975	97	6794	3113	5425	2846	23321	64428	8506	7405	56125	2775	3192	6964	23640	1875	7029	3015	1791	9348	54478	487	65095	4602	9779	2146	8332	7270	3148	6272	56673	55924	114044	9540	5827	57405	23218	768	54862	6329	8438	8570	3054	6502	2957	2739	8372	7283	2747	9846	58525	3052	23234	5424	57172	64858	156	22981	7940	79006	23205	10130	6626	8563	3934	80321	5685	2710	9640	57553	285596	26000	3925	51284	9258	23397	1524	23589	5250	2792	8564	10733	10772	56935	5886	55862	7083	57570	27289	651	5917	699	1800	3956	346	10293	9679	83990	587	9052	2539	5997	8079	25840	79057	8368	23199	501	2557	51218	51097	6201	55611	2936	2342	10234	2983	64231	4709	23189	483	55055	27242	2735	5345	7153	5577	80183
GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_UP	M8036		21108462	Hervas-Stubbs S,Riezu-Boj JI,Gonzalez I,Mancheño U,Dubrot J,Azpilicueta A,Gabari I,Palazon A,Aranguren A,Ruiz J,Prieto J,Larrea E,Melero I	GSE17301	GSE17301_3431_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD8 T cells stimulated by IFNA2 [GeneID=3440] versus CD8 T cells stimulated by IFNA5 [GeneID=3442] and activated by anti-CD3 and anti-CD28.	IFN alpha mediated gene expression pattern. The effect of IFN alpha on human CD8 T cells responding to antigen (signal 1) and costimulatory signals (signal 2) provided by beads coated with anti-CD3 and anti-CD28 mAbs. This analysis examined the effects of IFN alpha on human CD8 T cells responding to antigen (signal 1) and costimulatory signals (signal 2) provided by beads coated with anti-CD3 and anti-CD28 mAbs. Magnetically sorted untouched CD8+CD45R0- T cells from three different donors were unstimulated or stimulated with IFNa2b or with anti-CD3/CD28 Beads alone or along with IFNa2b or IFNa5 for 48 hours. Individual mRNA samples were analyzed using HG-U133A 2.0 array gene chips. 					90634	27334	22980	6655	64747	11040	10253	9765	22930	387751	4515	23014	23474	55791	9321	9737	8925	9663	10139	81848	905	5411	10472	221037	100129250	7480	9646	57826	55604	1445	55500	23625	386627	87	59338	25909	55030	9337	10396	55601	3443	6777	10464	29104	3797	51084	56941	25898	54812	100288944	81545	919	473	375449	8760	23063	79188	6907	3572	4216	55841	83716	4077	22884	6239	1389	814	406	3382	8220	64772	1649	91	113791	9530	10803	57125	9172	10040	54820	831	64092	2841	3059	64786	10581	3096	23178	28951	3726	1317	55669	57446	115123	9600	861	3305	8870	55795	4170	60468	23287	9254	1958	28978	65258	55219	9049	10418	254102	2041	2643	3875	4478	8934	6672	80342	9896	83440	10023	51531	9592	8745	84159	9456	29065	51696	53347	55364	57147	11120	274	7762	6001	3660	4049	8509	10643	7089	5921	23585	116496	3661	22861	25777	54149	10782	58472	9806	5504	10780	55032	9076	55072	27250	1236	9901	375790	1327	9235	51144	80204	64112	10279	10235	2217	29063	55831	79770	27235	4814	23215	55770	54811	79837	84726	4929	10318	51070	3566	55810	10550	10260	728642	23053	400451	25950	10096	56674	7095	29	27010	23708	8718	57136	5447	9180	10092	2323	10244
GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_DN	M8037		21108462	Hervas-Stubbs S,Riezu-Boj JI,Gonzalez I,Mancheño U,Dubrot J,Azpilicueta A,Gabari I,Palazon A,Aranguren A,Ruiz J,Prieto J,Larrea E,Melero I	GSE17301	GSE17301_3431_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD8 T cells stimulated by IFNA2 [GeneID=3440] versus CD8 T cells stimulated by IFNA5 [GeneID=3442] and activated by anti-CD3 and anti-CD28.	IFN alpha mediated gene expression pattern. The effect of IFN alpha on human CD8 T cells responding to antigen (signal 1) and costimulatory signals (signal 2) provided by beads coated with anti-CD3 and anti-CD28 mAbs. This analysis examined the effects of IFN alpha on human CD8 T cells responding to antigen (signal 1) and costimulatory signals (signal 2) provided by beads coated with anti-CD3 and anti-CD28 mAbs. Magnetically sorted untouched CD8+CD45R0- T cells from three different donors were unstimulated or stimulated with IFNa2b or with anti-CD3/CD28 Beads alone or along with IFNa2b or IFNa5 for 48 hours. Individual mRNA samples were analyzed using HG-U133A 2.0 array gene chips. 					1827	2957	22921	2346	9532	83990	3364	10493	3224	5424	27230	23277	7153	79622	8125	11113	10971	84296	3122	6502	22836	5687	7029	128872	3617	51406	4160	26353	8079	6648	4208	6627	414771	395	2119	56157	4172	3005	9643	57596	5714	388796	3574	55351	64858	3054	2739	1500	6875	4709	4361	3355	29015	55732	51022	5984	1164	3015	2847	78998	863	6282	8795	116138	5591	1645	4915	10403	4904	5897	1601	693207	7472	56124	1663	55277	710	5879	7272	8630	3838	8744	2747	29969	4267	9477	5425	81556	6396	1184	22902	1977	2081	10950	51741	64785	51073	1237	6611	55697	7465	7748	79915	1163	126208	890	7305	5690	55164	6407	5797	1045	79050	25932	1537	79680	220134	3948	79801	7204	23022	8891	8208	56928	6590	23361	2905	80183	10155	23028	3340	5422	9780	51186	8359	50814	487	4176	54976	165	9928	27242	2023	51053	90204	2746	7936	79901	2590	3219	10598	7035	9679	6781	945	9635	79980	6361	8506	10293	25890	5827	5329	2327	3613	9331	25941	83461	51465	80218	55175	23788	4522	2954	10728	6128	5901	79623	8564	54498	6636	112399	1909	10686	5983	29942	4833	1791	29803	10309	7866	26040	6533	3310	10721	54836	3992	394	513	8479
GSE17301_CTRL_VS_48H_IFNA2_STIM_CD8_TCELL_UP	M8038		21108462	Hervas-Stubbs S,Riezu-Boj JI,Gonzalez I,Mancheño U,Dubrot J,Azpilicueta A,Gabari I,Palazon A,Aranguren A,Ruiz J,Prieto J,Larrea E,Melero I	GSE17301	GSE17301_3424_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD8 T cells: control versus stimulated by IFNA2 [GeneID=3440].	IFN alpha mediated gene expression pattern. The effect of IFN alpha on human CD8 T cells responding to antigen (signal 1) and costimulatory signals (signal 2) provided by beads coated with anti-CD3 and anti-CD28 mAbs. This analysis examined the effects of IFN alpha on human CD8 T cells responding to antigen (signal 1) and costimulatory signals (signal 2) provided by beads coated with anti-CD3 and anti-CD28 mAbs. Magnetically sorted untouched CD8+CD45R0- T cells from three different donors were unstimulated or stimulated with IFNa2b or with anti-CD3/CD28 Beads alone or along with IFNa2b or IFNa5 for 48 hours. Individual mRNA samples were analyzed using HG-U133A 2.0 array gene chips. 					10221	64747	23417	7259	22930	55364	2132	427	5711	6210	8887	2173	5026	64601	23014	10892	8525	11040	28990	6477	23063	3275	4170	10914	10472	2531	65983	26984	5929	23344	4152	7779	64219	330	51283	11285	221037	664	84726	23135	7343	5291	57658	55180	5264	9466	1039	221061	84243	79058	10260	5204	55604	23521	10257	7879	5529	23625	53916	51411	55623	23403	5775	23585	9663	3248	51109	54704	55669	60685	51125	51170	55791	219333	51030	905	23516	113791	51643	26065	54812	25950	10723	23505	90	3683	2043	25898	6285	387751	10643	10274	51009	79786	79134	11078	79837	57147	5199	25800	91543	2841	6907	8850	3572	55125	5339	4758	115123	10393	80213	2321	10782	6778	9363	11221	79188	79712	80169	79596	23613	5530	6691	3726	64772	10464	114882	118987	4494	9765	3621	5920	81853	2005	7572	23369	65990	952	5140	4065	919	23033	7095	6604	56889	440352	23036	3845	4798	7187	28951	10396	23263	22934	79903	9562	9592	57761	9166	7107	89910	11322	6281	50649	22861	64895	9235	80176	80301	8934	7092	5152	5495	80219	7561	7752	79929	8446	79415	5525	1445	60489	25909	79913	56851	10807	83941	963	116984	23379	10558	8509	56829	57060	1182	2887	65258	23608	10048	10451
GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_DN	M8039		21108462	Hervas-Stubbs S,Riezu-Boj JI,Gonzalez I,Mancheño U,Dubrot J,Azpilicueta A,Gabari I,Palazon A,Aranguren A,Ruiz J,Prieto J,Larrea E,Melero I	GSE17301	GSE17301_3426_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD8 T cells: control versus stimulated by IFNA2 [GeneID=3440] and activated by anti-CD3 and anti-CD28.	IFN alpha mediated gene expression pattern. The effect of IFN alpha on human CD8 T cells responding to antigen (signal 1) and costimulatory signals (signal 2) provided by beads coated with anti-CD3 and anti-CD28 mAbs. This analysis examined the effects of IFN alpha on human CD8 T cells responding to antigen (signal 1) and costimulatory signals (signal 2) provided by beads coated with anti-CD3 and anti-CD28 mAbs. Magnetically sorted untouched CD8+CD45R0- T cells from three different donors were unstimulated or stimulated with IFNa2b or with anti-CD3/CD28 Beads alone or along with IFNa2b or IFNa5 for 48 hours. Individual mRNA samples were analyzed using HG-U133A 2.0 array gene chips. 					6097	89941	7916	64793	5357	22897	64428	8242	10566	10602	57553	23205	911	2937	26140	486	23640	925	11251	1612	1871	4744	909	63967	3985	3151	3206	23176	23594	926	5896	5429	4605	11167	2288	3938	51512	80142	3148	80228	55755	6510	10124	56928	971	55721	7263	899	1791	11132	284403	2268	3643	2983	8342	8438	5881	54862	8727	7298	10452	8330	6721	26152	151230	913	3204	26048	373863	64858	51237	79915	9183	129080	3146	10874	23354	3679	7015	79661	8364	11113	8148	23464	9537	5428	79816	11186	83475	11133	79829	8086	65999	10573	165	9256	2672	79680	245812	1789	91289	51203	9271	5754	10024	2030	55190	10293	1038	8630	55351	2356	128872	1948	1380	51776	10922	9415	4130	10981	51564	55723	9942	80174	9232	54039	55313	3009	2149	55796	23152	2717	910	56672	51750	83463	94025	64852	1869	9768	7461	91442	9133	4267	23623	2305	26040	10417	3033	7940	6509	6794	81490	4597	54535	55635	983	100506898	79621	29924	9833	672	7122	23139	80183	645784	29781	9088	487	54477	3761	2810	85459	7083	55592	55355	5524	83461	9156	2842	6457	8359	54478	27242	949	6241	5609	80235	79019	9726	1468	1031	51513	22898	390940	4240	55937	27329	7127	9401
GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA2_STIM_CD8_TCELL_DN	M8040		21108462	Hervas-Stubbs S,Riezu-Boj JI,Gonzalez I,Mancheño U,Dubrot J,Azpilicueta A,Gabari I,Palazon A,Aranguren A,Ruiz J,Prieto J,Larrea E,Melero I	GSE17301	GSE17301_3429_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD8 T cells activated by anti-CD3 and anti-CD28 versus those stimulated by IFNA2 [GeneID=3440].	IFN alpha mediated gene expression pattern. The effect of IFN alpha on human CD8 T cells responding to antigen (signal 1) and costimulatory signals (signal 2) provided by beads coated with anti-CD3 and anti-CD28 mAbs. This analysis examined the effects of IFN alpha on human CD8 T cells responding to antigen (signal 1) and costimulatory signals (signal 2) provided by beads coated with anti-CD3 and anti-CD28 mAbs. Magnetically sorted untouched CD8+CD45R0- T cells from three different donors were unstimulated or stimulated with IFNa2b or with anti-CD3/CD28 Beads alone or along with IFNa2b or IFNa5 for 48 hours. Individual mRNA samples were analyzed using HG-U133A 2.0 array gene chips. 					9737	90	54149	23078	10133	1486	10257	1203	9531	3163	6251	10865	55303	5199	2530	3357	23080	84864	55761	7743	9697	9267	10384	80345	4092	64895	8864	80219	253959	64699	9530	9057	1317	1362	26034	55601	26136	6494	6310	5168	92703	26235	23586	51601	1729	1945	79903	9363	5106	10260	55114	3248	23507	9666	1880	11274	9348	3570	22930	22838	7169	4753	90634	578	1387	4968	7699	9765	54826	26234	23155	55327	7096	203197	5154	7779	79414	3096	51339	57446	7071	9823	2633	26130	58488	10666	1901	4758	11108	10954	9730	9781	55340	29116	654817	7803	6940	10513	4616	8690	26207	64768	3434	2799	5350	4863	54681	2719	4832	126231	55636	987	4338	8879	3454	6249	11320	9840	597	84061	8745	51388	63917	440193	8821	64131	5007	10253	6691	138050	6259	388650	9750	26515	22954	54509	57337	1107	5412	64760	23424	1508	7187	4850	64419	26275	64135	55790	23643	58473	81537	51347	55624	837	9139	2531	1429	1602	23174	9236	56829	1514	23474	6571	91543	25777	60685	80063	11120	10287	9516	2308	55702	5128	2323	3212	79722	78991	56913	10782	5243	83480	9711	55339	55770	7752	55622	25797	23683	57175	4929	55741	10807	91782	25809	54778	55353	10611	256987	11216
GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_UP	M8041		21108462	Hervas-Stubbs S,Riezu-Boj JI,Gonzalez I,Mancheño U,Dubrot J,Azpilicueta A,Gabari I,Palazon A,Aranguren A,Ruiz J,Prieto J,Larrea E,Melero I	GSE17301	GSE17301_3430_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD8 T cells activated by anti-CD3 and anti-CD28 versus those stimulated by IFNA5 [GeneID=3442].	IFN alpha mediated gene expression pattern. The effect of IFN alpha on human CD8 T cells responding to antigen (signal 1) and costimulatory signals (signal 2) provided by beads coated with anti-CD3 and anti-CD28 mAbs. This analysis examined the effects of IFN alpha on human CD8 T cells responding to antigen (signal 1) and costimulatory signals (signal 2) provided by beads coated with anti-CD3 and anti-CD28 mAbs. Magnetically sorted untouched CD8+CD45R0- T cells from three different donors were unstimulated or stimulated with IFNa2b or with anti-CD3/CD28 Beads alone or along with IFNa2b or IFNa5 for 48 hours. Individual mRNA samples were analyzed using HG-U133A 2.0 array gene chips. 					3126	9050	3985	2937	64793	23205	911	51512	5524	6097	63967	80142	9183	913	7916	79832	29044	51400	1791	4605	3643	11133	9578	79661	23594	26040	486	3833	1072	83475	7298	1612	10981	56928	7434	64428	114876	11251	1122	54039	55683	1820	910	2983	57553	8342	920	3033	79680	5896	79915	55351	100506898	10874	3148	23143	3938	51237	5091	51203	55723	80174	3146	1468	3206	284403	55511	2030	9348	54806	22918	10566	23152	55721	89941	7106	2618	57596	8438	64858	55796	23623	2845	84796	863	784	6721	11113	2982	1031	6621	55222	899	8630	1671	9768	51776	2305	2587	3151	54976	8578	8729	6241	6509	10024	8727	10265	83463	10573	5881	165	91289	6676	9942	1021	9133	6652	7757	9401	9839	128872	7083	23640	487	2175	10452	2120	10721	83461	9088	4130	10293	54477	23354	8364	8086	162	22795	3679	57824	1789	4288	6713	94025	171558	4891	81888	50862	8613	373863	29781	993	81575	3998	54535	4267	23176	11004	8522	2769	653238	6457	23129	7015	51104	10922	22974	10376	11092	79019	9415	4900	7940	6510	259266	729238	55355	9319	983	79598	9700	83450	5329	54862	1663	30814	53353	8359	55635	9156	23139	401251	2672	25932	9787	9833	80004	1136	253190
GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_UP	M8042		21108462	Hervas-Stubbs S,Riezu-Boj JI,Gonzalez I,Mancheño U,Dubrot J,Azpilicueta A,Gabari I,Palazon A,Aranguren A,Ruiz J,Prieto J,Larrea E,Melero I	GSE17301	GSE17301_3428_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD8 T cells stimulated by IFNA2 [GeneID=3440] versus those activated by anti-CD3 and anti-CD28.	IFN alpha mediated gene expression pattern. The effect of IFN alpha on human CD8 T cells responding to antigen (signal 1) and costimulatory signals (signal 2) provided by beads coated with anti-CD3 and anti-CD28 mAbs. This analysis examined the effects of IFN alpha on human CD8 T cells responding to antigen (signal 1) and costimulatory signals (signal 2) provided by beads coated with anti-CD3 and anti-CD28 mAbs. Magnetically sorted untouched CD8+CD45R0- T cells from three different donors were unstimulated or stimulated with IFNa2b or with anti-CD3/CD28 Beads alone or along with IFNa2b or IFNa5 for 48 hours. Individual mRNA samples were analyzed using HG-U133A 2.0 array gene chips. 					9831	6722	8453	3163	10260	80219	55333	9057	10133	6091	57125	4753	10807	79903	6251	92703	7743	3212	54149	9697	5274	10257	23080	60685	6691	55246	5869	253959	6195	79786	999	5140	203197	6310	51347	3434	4907	1486	64699	9711	26136	5412	55741	10791	7294	6352	6571	80345	7273	79078	1729	6249	6666	259230	64895	9516	83480	11275	1362	5095	22838	9267	54877	54758	79443	51601	8674	987	2531	23417	3823	1387	79712	5007	9765	23586	138050	9363	130916	4863	837	55665	6604	55761	90	9022	7779	388650	30	64132	55114	11320	6646	26130	2218	54726	9903	10166	116985	5775	7508	64760	9781	55303	4502	23033	7752	25777	78991	58488	22930	9750	57403	23046	578	3003	23078	1604	664	5324	55278	440193	79691	10384	80853	5168	11274	6945	4092	23031	7456	79684	23568	55106	57509	54681	55027	5199	4968	54964	10782	10007	55435	26207	23228	284443	55601	2799	84061	26235	2530	26034	79673	5547	22954	9737	80063	23175	8459	84864	94134	55752	23609	56829	57343	26234	5286	8867	23178	5106	23474	2132	8869	6494	51339	9530	9236	7764	2014	3096	1901	10954	10513	6942	23102	2803	6281	54826	9823	80007	6775	256987	11232	2199	25956	26512	6940	11119	654817	66008
GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_DN	M8044		21108462	Hervas-Stubbs S,Riezu-Boj JI,Gonzalez I,Mancheño U,Dubrot J,Azpilicueta A,Gabari I,Palazon A,Aranguren A,Ruiz J,Prieto J,Larrea E,Melero I	GSE17301	GSE17301_3428_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD8 T cells stimulated by IFNA2 [GeneID=3440] versus those activated by anti-CD3 and anti-CD28.	IFN alpha mediated gene expression pattern. The effect of IFN alpha on human CD8 T cells responding to antigen (signal 1) and costimulatory signals (signal 2) provided by beads coated with anti-CD3 and anti-CD28 mAbs. This analysis examined the effects of IFN alpha on human CD8 T cells responding to antigen (signal 1) and costimulatory signals (signal 2) provided by beads coated with anti-CD3 and anti-CD28 mAbs. Magnetically sorted untouched CD8+CD45R0- T cells from three different donors were unstimulated or stimulated with IFNa2b or with anti-CD3/CD28 Beads alone or along with IFNa2b or IFNa5 for 48 hours. Individual mRNA samples were analyzed using HG-U133A 2.0 array gene chips. 					79864	54210	766	55811	7748	1969	56985	7163	54869	51552	6642	7414	9958	1534	8622	51659	9871	2645	10243	1768	1806	2769	4601	8835	27347	4752	3248	1102	9452	5739	6657	4921	1317	9629	23741	7169	9761	8804	7525	9348	6964	23504	2926	7762	9901	3382	1671	400451	140609	7850	79667	4915	728577	9448	9076	2317	26010	9308	55256	1545	7293	10223	5359	4689	60681	55872	6575	5211	56935	11172	388886	4482	81848	4772	56300	91543	2869	54805	79682	6039	8870	55268	28986	3570	2913	611	6261	93210	9630	59067	27303	8600	28683	7286	25827	26499	1610	330	382	79690	2533	1263	22921	3566	79722	10613	170680	23266	8549	784	55821	10512	2887	9920	10981	8745	3431	2232	10376	4798	6776	23136	3601	120	6282	55565	23189	2770	79135	10276	9700	7275	4318	1396	6129	493	1944	4163	4354	123	4938	4792	55351	3965	8914	81570	55277	9767	8672	5578	29767	104	10560	51195	64866	1880	3797	2491	1476	50852	55030	10873	5071	2597	80896	55793	27165	79890	5270	3280	760	5743	6780	3357	55218	54769	55916	8743	5921	7079	2674	10221	1665	65055	56548	4088	2004	863	25797	808	5334	2272	9450	1133	5797	51098	51191	11197	6342
GSE17301_CTRL_VS_48H_ACD3_ACD28_STIM_CD8_TCELL_UP	M8045		21108462	Hervas-Stubbs S,Riezu-Boj JI,Gonzalez I,Mancheño U,Dubrot J,Azpilicueta A,Gabari I,Palazon A,Aranguren A,Ruiz J,Prieto J,Larrea E,Melero I	GSE17301	GSE17301_3425_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD8 T lymphocytes: control versus activated by anti-CD3 and anti-CD28.	IFN alpha mediated gene expression pattern. The effect of IFN alpha on human CD8 T cells responding to antigen (signal 1) and costimulatory signals (signal 2) provided by beads coated with anti-CD3 and anti-CD28 mAbs. This analysis examined the effects of IFN alpha on human CD8 T cells responding to antigen (signal 1) and costimulatory signals (signal 2) provided by beads coated with anti-CD3 and anti-CD28 mAbs. Magnetically sorted untouched CD8+CD45R0- T cells from three different donors were unstimulated or stimulated with IFNa2b or with anti-CD3/CD28 Beads alone or along with IFNa2b or IFNa5 for 48 hours. Individual mRNA samples were analyzed using HG-U133A 2.0 array gene chips. 					2041	50649	65990	2957	6272	254531	54946	9588	79803	406	10077	30008	7188	9500	9440	54861	10788	80222	91646	3507	54862	80758	6128	5563	79006	311	604	26037	26057	5226	6785	22990	440026	57728	23438	23333	26054	5470	57406	1421	81618	11331	31	55888	23498	9256	6867	6320	2997	4051	64087	23199	5355	55179	29799	6201	1974	10544	23523	4744	132	26578	54681	51393	11180	9862	445347	5551	6141	56245	5036	27235	27344	5116	7184	6666	8291	9022	22881	8260	10455	8459	10417	51478	9425	51303	51025	5832	51181	6737	54923	6331	55957	5252	10962	478	7462	8642	5308	3575	11167	158586	8330	3695	59342	976	60685	8703	6352	26112	84560	55509	95	55374	9723	79956	22920	23263	79929	55131	65998	54583	10734	10567	7067	3823	926	11344	9520	11320	23214	7157	54514	26191	79137	22906	3178	5383	1938	83988	80148	3094	23637	4669	8874	3887	79712	9368	6285	79713	8481	27352	25901	6144	3156	26119	11137	57185	55273	81606	10630	85294	5617	26472	23200	4603	3820	23216	4696	8811	864	9806	5790	79037	3667	3238	79797	2664	93594	79025	203	9641	9706	55084	2199	146542	1302	4121	7280	54476	3705	10307	10620	4609	80022	6567	8563	5125	360	57134
GSE17301_CTRL_VS_48H_ACD3_ACD28_STIM_CD8_TCELL_DN	M8046		21108462	Hervas-Stubbs S,Riezu-Boj JI,Gonzalez I,Mancheño U,Dubrot J,Azpilicueta A,Gabari I,Palazon A,Aranguren A,Ruiz J,Prieto J,Larrea E,Melero I	GSE17301	GSE17301_3425_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD8 T lymphocytes: control versus activated by anti-CD3 and anti-CD28.	IFN alpha mediated gene expression pattern. The effect of IFN alpha on human CD8 T cells responding to antigen (signal 1) and costimulatory signals (signal 2) provided by beads coated with anti-CD3 and anti-CD28 mAbs. This analysis examined the effects of IFN alpha on human CD8 T cells responding to antigen (signal 1) and costimulatory signals (signal 2) provided by beads coated with anti-CD3 and anti-CD28 mAbs. Magnetically sorted untouched CD8+CD45R0- T cells from three different donors were unstimulated or stimulated with IFNa2b or with anti-CD3/CD28 Beads alone or along with IFNa2b or IFNa5 for 48 hours. Individual mRNA samples were analyzed using HG-U133A 2.0 array gene chips. 					51142	6428	91828	28232	23479	2769	80149	10318	9683	7092	85463	26471	5142	64419	4615	1730	4282	27293	7941	587	1468	5887	8676	89886	29100	10938	9705	8792	8744	140739	10651	4792	79827	127544	54103	64332	23560	3304	2745	8521	89846	55647	3778	9659	10611	857	81876	121551	65108	84317	3937	6539	6648	3783	372	9868	5452	5209	2224	23075	89978	6382	6275	65220	1522	2358	4323	196383	5684	961	283927	388962	23533	2567	84100	313	4794	23395	53831	377677	7408	1362	8994	23266	9771	7124	10913	29992	4302	5271	119032	3065	6853	7097	122704	1318	7128	10148	1326	718	85440	255758	4651	7040	53	55324	2720	2921	4790	3383	337876	5777	5734	2841	4689	55022	152189	4597	2357	7037	5138	143471	6688	211	29990	55298	127281	55081	5058	117247	55922	972	730249	134121	50856	5971	5900	205	2533	79858	25946	83937	284110	3684	817	10645	5716	55233	3726	3055	374882	4170	441282	284161	10010	6713	51020	10261	57666	9936	4891	5795	6399	9641	2521	3516	51103	23784	3454	84225	5437	837	6277	11213	10519	1512	3561	10205	397	55365	11238	8685	4321	7126	7127	124930	5506	7881	64132	388389	80781	11040	11346	301	3176	2488	971	4067	83637	6352
GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_DN	M8048		21108462	Hervas-Stubbs S,Riezu-Boj JI,Gonzalez I,Mancheño U,Dubrot J,Azpilicueta A,Gabari I,Palazon A,Aranguren A,Ruiz J,Prieto J,Larrea E,Melero I	GSE17301	GSE17301_3427_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD8 T cells: control versus stimulated by IFNA5 [GeneID=3442] and activated by anti-CD3 and anti-CD28.	IFN alpha mediated gene expression pattern. The effect of IFN alpha on human CD8 T cells responding to antigen (signal 1) and costimulatory signals (signal 2) provided by beads coated with anti-CD3 and anti-CD28 mAbs. This analysis examined the effects of IFN alpha on human CD8 T cells responding to antigen (signal 1) and costimulatory signals (signal 2) provided by beads coated with anti-CD3 and anti-CD28 mAbs. Magnetically sorted untouched CD8+CD45R0- T cells from three different donors were unstimulated or stimulated with IFNa2b or with anti-CD3/CD28 Beads alone or along with IFNa2b or IFNa5 for 48 hours. Individual mRNA samples were analyzed using HG-U133A 2.0 array gene chips. 					79157	54805	5395	57600	6483	4056	58526	55148	4253	51449	57134	160851	59338	51560	3915	51284	1102	10311	222484	10267	23097	51100	1901	79837	55839	10198	901	30061	80325	3575	1195	23130	9306	26271	7136	29942	57645	152330	9918	55336	9493	375035	4751	54069	10018	26130	11169	137835	57617	7405	5140	8450	11168	836	28996	81563	10154	57162	53349	4124	23122	79834	7163	131544	225	26207	7048	140467	283489	10628	83636	80817	3622	3716	80705	7328	27134	3631	256643	79759	2491	22918	79625	128239	79665	3142	2805	6468	5378	6790	9700	2040	116984	57563	64754	5786	27075	6877	23233	3925	2992	23468	10291	10161	401494	56929	768211	30	5106	987	8527	51186	150468	3480	57504	5252	84279	8243	84910	79899	7706	138050	54892	9595	890	9938	26001	2189	5933	9451	122786	6671	117178	4783	23327	5595	54621	9481	64400	55872	56034	79735	53635	57484	9846	170384	55355	51567	10451	203068	84804	65981	23469	79089	3073	51733	90637	23268	224	79738	51426	389610	54934	7298	27123	9924	1642	57561	84986	9935	57107	2146	5888	284207	51311	201161	8675	79415	27013	84163	10376	207	4005	10585	5128	387597	8930	26147	6303	5467	51659	6491	91584	5111	80318	25973	83461	162	1054	23258
GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_UP	M8049		21108462	Hervas-Stubbs S,Riezu-Boj JI,Gonzalez I,Mancheño U,Dubrot J,Azpilicueta A,Gabari I,Palazon A,Aranguren A,Ruiz J,Prieto J,Larrea E,Melero I	GSE17301	GSE17301_3426_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD8 T cells: control versus stimulated by IFNA2 [GeneID=3440] and activated by anti-CD3 and anti-CD28.	IFN alpha mediated gene expression pattern. The effect of IFN alpha on human CD8 T cells responding to antigen (signal 1) and costimulatory signals (signal 2) provided by beads coated with anti-CD3 and anti-CD28 mAbs. This analysis examined the effects of IFN alpha on human CD8 T cells responding to antigen (signal 1) and costimulatory signals (signal 2) provided by beads coated with anti-CD3 and anti-CD28 mAbs. Magnetically sorted untouched CD8+CD45R0- T cells from three different donors were unstimulated or stimulated with IFNa2b or with anti-CD3/CD28 Beads alone or along with IFNa2b or IFNa5 for 48 hours. Individual mRNA samples were analyzed using HG-U133A 2.0 array gene chips. 					51160	283742	11157	140809	83451	1787	55156	10534	8655	5199	57418	65003	9604	4953	125150	3303	10519	83937	1843	441282	8270	25764	6687	29925	9554	100128731	1439	6887	23023	27037	2079	4726	7414	84168	7001	27036	5099	3557	7462	396	55365	1730	54210	8880	2222	10800	10963	51042	10613	23136	6281	2159	91937	83475	28959	10544	148066	9688	476	200734	132	55752	9489	5998	3482	119504	112616	2091	330	90861	3329	79730	50856	9093	318	6396	51234	645	790	80781	151651	60491	7511	83855	2885	11066	219743	6390	51400	84264	23082	79792	51144	55702	22894	64092	155	80777	5433	5306	23277	66005	115024	129285	1743	51522	3726	10892	10212	5705	3516	5780	5091	79072	1353	7045	7307	29887	51495	51389	51726	388389	683	25828	4302	55379	6612	3313	84981	10090	54973	51606	397	22822	7841	4792	5880	7358	8891	199	1964	174	55676	85440	55486	8974	146850	11160	51102	2920	9409	80279	7287	84725	10148	400569	27247	2720	2021	6611	1468	10206	140739	29126	84513	56895	5699	10237	51012	23764	4055	8744	79796	251	7097	1647	1104	56950	29097	5695	1362	56975	51478	8828	4327	54662	203197	858	10376	9328	8662	6572	389072	2869	7407	5701	9641	6426	3597	1522
GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_UP	M8050		21108462	Hervas-Stubbs S,Riezu-Boj JI,Gonzalez I,Mancheño U,Dubrot J,Azpilicueta A,Gabari I,Palazon A,Aranguren A,Ruiz J,Prieto J,Larrea E,Melero I	GSE17301	GSE17301_3427_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD8 T cells: control versus stimulated by IFNA5 [GeneID=3442] and activated by anti-CD3 and anti-CD28.	IFN alpha mediated gene expression pattern. The effect of IFN alpha on human CD8 T cells responding to antigen (signal 1) and costimulatory signals (signal 2) provided by beads coated with anti-CD3 and anti-CD28 mAbs. This analysis examined the effects of IFN alpha on human CD8 T cells responding to antigen (signal 1) and costimulatory signals (signal 2) provided by beads coated with anti-CD3 and anti-CD28 mAbs. Magnetically sorted untouched CD8+CD45R0- T cells from three different donors were unstimulated or stimulated with IFNa2b or with anti-CD3/CD28 Beads alone or along with IFNa2b or IFNa5 for 48 hours. Individual mRNA samples were analyzed using HG-U133A 2.0 array gene chips. 					2124	11094	8289	55165	23253	9612	546	177	26260	79567	83719	83640	84265	157313	142678	3643	57228	8760	5128	395	6388	79670	23495	51735	478	54800	3835	51317	5476	4983	51547	11216	64844	26001	114885	3603	4668	80318	51347	642	5347	79157	65059	54453	4836	4354	3398	10982	613227	6448	223	9023	25948	55122	9122	115548	56261	51759	55654	8897	10007	6129	259282	5150	56929	29978	4125	1033	1054	5365	1234	1195	6811	517	8536	23232	6790	79598	5921	1954	22852	4204	10106	2907	96459	388403	339	8905	1058	60412	473	11004	85015	57035	11142	65057	5813	5116	25938	54677	9185	11214	151556	54529	7073	51003	5305	8405	4205	27244	6916	7095	55905	8085	2534	8930	1031	28511	94241	64147	30837	2872	252839	127262	9133	4240	9910	25927	29942	29855	55761	84083	54536	23118	7150	54478	2081	81704	2595	6834	4601	719	57118	4303	119710	8444	10123	57650	50650	153020	10588	348	7716	375035	2650	83593	345757	6924	23034	84898	23531	285753	51129	22933	25836	83641	83464	115330	7056	26123	8665	6095	10051	8564	7089	51439	2621	9429	81618	1152	23112	29116	80148	463	259230	93550	11179	23328	121512	6232	84678	836	10617	901	4051	51635	26009	10048	55957	195827
GSE23984_CTRL_VS_HYPOCALEMIC_VITAMIND_ANALOG_TCELL_UP	M8051		21131424	Baeke F,Korf H,Overbergh L,Verstuyf A,Thorrez L,Lommel Van L,Waer M,Schuit F,Gysemans C,Mathieu C	GSE23984	GSE23984_3463_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in T cells: control versus TX527 (hypocalemic analog of 25-hydroxyvitamin D3 [PubChem=1593]).	Hypocalcemic vitamin D analogs are appealing molecules to exploit the immunomodulatory actions of active vitamin D in vivo. The functional modulation of dendritic cells is regarded as the key mechanism underlying their ability to regulate T cell responses. In contrast, the direct actions of vitamin D and structural analogs on T lymphocytes remain less well characterized. Microarray analysis was performed to gain insight into the direct immunomodulatory actions of TX527, a hypocalcemic vitamin D analog, on human T lymphocytes. Gene expression analysis revealed that TX527 regulated a wide variety of genes involved in different aspects of T cell function, including cellular growth and proliferation, cell death, cellular development, cellular movement and cell-to-cell signalling and interaction. 					174	5993	826	1362	23307	23673	83451	55093	29097	84311	9051	54922	23514	5175	2194	340061	9670	23353	16	715	22919	25921	10576	389337	23173	81671	8604	8906	6399	23312	11315	390916	149041	29933	4953	7428	2542	78987	152	5099	6540	7108	7277	1075	9282	7187	140290	23533	7227	26225	10890	23266	1434	10603	55915	27036	6392	148223	56910	64963	55421	1959	203068	51248	3482	952	26985	5688	124773	337867	10797	527	64784	28984	11320	1468	55325	529	65985	171425	10544	1337	51012	1760	114908	2027	51478	84883	10162	3597	4726	10011	26515	83667	8986	3178	694	122953	9415	10904	11177	129285	29796	7172	7422	1595	3717	5663	4191	7993	4133	1431	4091	4615	90273	1175	8692	54210	8609	2720	2268	245812	84034	80777	4967	10039	6853	100113407	51699	5049	84864	80896	22865	127281	10654	221	5315	92737	10467	56997	116150	3934	79671	347404	11267	79827	132158	55194	945	58527	516	1652	10472	55970	7965	4481	5739	10010	10630	6576	22856	3422	9694	80142	23468	55326	7298	668	2820	153768	10653	51451	9522	202243	2632	255809	23474	9730	2549	1955	199675	5716	1943	283871	144717	9497	3615	5819	1356	54541	5473	9536	4282	55486	7295	351	708	64849	7511	513
GSE23984_CTRL_VS_HYPOCALEMIC_VITAMIND_ANALOG_TCELL_DN	M8052		21131424	Baeke F,Korf H,Overbergh L,Verstuyf A,Thorrez L,Lommel Van L,Waer M,Schuit F,Gysemans C,Mathieu C	GSE23984	GSE23984_3463_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in T cells: control versus TX527 (hypocalemic analog of 25-hydroxyvitamin D3 [PubChem=1593]).	Hypocalcemic vitamin D analogs are appealing molecules to exploit the immunomodulatory actions of active vitamin D in vivo. The functional modulation of dendritic cells is regarded as the key mechanism underlying their ability to regulate T cell responses. In contrast, the direct actions of vitamin D and structural analogs on T lymphocytes remain less well characterized. Microarray analysis was performed to gain insight into the direct immunomodulatory actions of TX527, a hypocalcemic vitamin D analog, on human T lymphocytes. Gene expression analysis revealed that TX527 regulated a wide variety of genes involved in different aspects of T cell function, including cellular growth and proliferation, cell death, cellular development, cellular movement and cell-to-cell signalling and interaction. 					8862	9665	9185	90355	140738	4643	10982	9194	51347	6443	51006	7163	10628	65084	10457	54780	55667	122786	387032	25798	55283	7903	54453	51499	2885	64780	6386	138050	55851	83641	5305	11216	115350	2581	9404	6652	57703	7456	225	8869	55576	153129	6414	3895	25949	83862	1774	23524	8706	55704	1121	57144	10409	8507	130733	55914	4297	3680	126961	79666	940	23177	3005	5911	595	8826	5129	5256	93663	11240	55578	2135	23190	90427	10267	157638	8927	57552	59269	10087	57403	23234	9814	868	153020	55501	55152	1112	27244	219771	10769	151556	10154	9619	57223	27075	3006	4668	116496	84062	23032	6477	5167	64149	55074	3082	23401	6038	122622	5244	285636	23531	5570	9842	27250	283596	51763	91875	100506144	5253	165257	2595	55005	23333	29886	23052	4013	2138	7805	3655	2650	84627	29058	57456	10771	124599	8091	79971	776	2124	57037	203259	55664	23325	1471	285195	378	8491	5184	55222	6314	11059	51635	7444	64759	204851	283131	5031	1606	2332	84532	2033	388815	3575	221002	22926	2857	395	7464	1845	29904	301	214	7248	26094	81688	9467	4035	126321	81544	8932	334	23239	79836	203328	28992	56261	128338	4677	23180	376497	3660	283349	22880	57504	2117	54904	1152	23077	89846
GSE22282_HYPOXIA_VS_NORMOXIA_MYELOID_DC_DN	M8065		21148811	Bosco MC,Pierobon D,Blengio F,Raggi F,Vanni C,Gattorno M,Eva A,Novelli F,Cappello P,Giovarelli M,Varesio L	GSE22282	GSE22282_3498_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in myeloid dendritic cells: hypoxia versus normoxia.	Dendritic cells (DCs) are professional antigen-presenting cells whose activity is intrinsically linked to the microenvironment. Hypoxia is a condition of low oxygen tension occurring in inflammatory tissues that creates a special microenvironment conditioning cell physiology. We studied the effects of hypoxia on the differentiation of human monocytes into DCs and maturation into mature DCs. Mature DCs were differentiated in vitro from human monocytes under normoxic or hypoxic conditions and the gene expression profile was determined.					10935	53349	6335	11261	26953	51380	57003	10451	2561	54033	204474	4644	267	1128	2313	56953	4829	51284	54941	145173	3662	6855	10171	51014	3487	219539	64849	64115	79759	4753	1761	25973	161176	10489	4327	5538	10636	4040	54808	10610	55219	7163	775	55698	148479	83692	137835	148741	11276	63895	80024	112840	940	79415	283	5744	54996	57094	54462	360226	10276	66037	64101	4947	59340	57473	9706	164127	84076	9869	23426	9342	221303	11184	92196	157769	11216	56061	79800	53635	1265	388569	285172	6777	55198	10154	59307	146542	163486	26289	340146	64430	54934	3622	197342	8351	10396	337977	8693	7328	81563	63876	2590	90527	23729	3481	9318	963	4005	92797	23175	152519	145942	400673	84314	319	64901	140	8701	203069	7384	339230	57511	23097	64405	10563	638	401612	57828	6939	23495	56912	6872	5252	7791	51426	90362	375567	23034	3890	3770	389161	154043	114827	9962	10161	5626	6257	131096	115294	55336	7704	5128	79661	7080	375743	8968	8464	341880	6263	54677	10267	84934	5934	338323	57418	7424	23456	7084	92014	54621	4010	64798	23119	84197	173	56270	22918	84899	9786	192670	55425	3170	3603	4688	23327	152007	55218	3480	79671	54344	5294	5414	3108	2207	10585	1901	9441	10678	63932
GSE22282_HYPOXIA_VS_NORMOXIA_MYELOID_DC_UP	M8068		21148811	Bosco MC,Pierobon D,Blengio F,Raggi F,Vanni C,Gattorno M,Eva A,Novelli F,Cappello P,Giovarelli M,Varesio L	GSE22282	GSE22282_3498_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in myeloid dendritic cells: hypoxia versus normoxia.	Dendritic cells (DCs) are professional antigen-presenting cells whose activity is intrinsically linked to the microenvironment. Hypoxia is a condition of low oxygen tension occurring in inflammatory tissues that creates a special microenvironment conditioning cell physiology. We studied the effects of hypoxia on the differentiation of human monocytes into DCs and maturation into mature DCs. Mature DCs were differentiated in vitro from human monocytes under normoxic or hypoxic conditions and the gene expression profile was determined.					167227	8106	5338	84844	400757	6628	4321	51020	8289	3240	3783	6626	55922	5434	140739	134121	6399	6352	10645	11014	9055	857	5684	730249	53831	64419	9659	158135	27293	5251	4738	1317	9771	11249	4857	6648	26093	54906	2044	55081	84705	127544	9718	3184	253782	9372	2919	26471	788	8676	7187	9683	85417	2358	388585	26253	83658	114793	1188	9184	3383	5142	81876	117247	4794	64425	55647	51699	3360	7289	952	4292	9844	57096	65220	122704	11182	79144	7097	29950	23404	7128	7941	199675	7124	9315	130813	9949	64319	54555	5716	50943	10261	65108	58191	2932	1522	4792	51550	85445	8739	8543	27330	6401	3980	5721	25824	57631	858	4664	55178	25897	222008	121256	4323	84154	115024	56123	54799	159119	5095	29089	80333	51703	718	116135	4651	9023	6288	4302	5245	2921	10525	5327	10318	3737	2224	51706	7369	2946	163590	58478	6452	7919	9961	389827	25880	91445	9921	6182	55224	113201	132720	9936	122622	6277	131474	58527	91703	11181	56895	390594	4615	8682	245932	4191	11316	348303	91860	6382	9034	4689	11044	6772	4597	10938	84517	123096	10423	23601	57178	55319	2222	518	3304	59269	84262	2743	865	3726	10650	80153	5464	85440	4682	284340	4158	5734	23767	3557
GSE25085_FETAL_LIVER_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN	M8069		21164017	Mold JE,Venkatasubrahmanyam S,Burt TD,Michaëlsson J,Rivera JM,Galkina SA,Weinberg K,Stoddart CA,McCune JM	GSE25085	GSE25085_2626_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in thymic implants from fetal liver versus those from adult bone marrow.	Human fetal and adult hematopoietic stem cells (HSC) were obtained from fetal liver, fetal bone marrow (BM), and adult BM. These were injected into human fetal thymic implants in SCID-hu Thy/Liv mice (4-6 separate mice per HSC donor) and allowed to mature into single positive CD4+ (SP4) thymocytes over the course of 7-8 weeks. SP4 thymocytes from injected stem cells were subsequently sort-purified from thymic implants and gene expression was performed.					10401	6503	3149	80817	79172	401541	51053	10198	55631	57446	51497	401494	90799	729230	80776	147841	222229	135228	55093	8667	222068	10606	80119	140901	4190	54069	11329	57650	9824	51512	50855	1937	10575	55247	1628	57122	10479	153201	191	10051	3421	79915	1894	79018	55159	79718	51614	9833	156	3140	6839	11270	1652	513	4051	10383	81563	91687	8803	9468	25979	9134	7008	80346	9960	10733	55915	6491	79366	10421	10352	6122	79682	79665	5116	10641	3835	57560	7465	5528	3014	6834	81930	54492	9631	79979	3178	55071	8318	51134	54821	84844	51659	4173	10635	79840	51451	55165	29028	10628	84902	51029	11073	256126	80152	55293	54960	11339	5426	80705	83939	8351	54033	55632	50809	54414	84284	6185	6924	283643	84787	3613	64116	34	2146	57804	4947	23468	64225	29128	51386	79001	10919	11179	25804	123811	2305	23495	5355	5395	9255	11169	4521	7272	55421	4291	64710	10682	3248	201725	5274	84314	83903	340061	995	84519	51629	245812	54878	55154	286827	145508	8087	27338	6118	23397	10112	79866	9918	6693	5558	55010	55336	159090	81611	5090	10586	5422	57082	7172	84572	7846	23097	11035	168544	64333	283237	84823	10134	7013	1062	55143	1111	7443	8408	9585	1032	2177	93550	64397
GSE25085_FETAL_BM_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN	M8070		21164017	Mold JE,Venkatasubrahmanyam S,Burt TD,Michaëlsson J,Rivera JM,Galkina SA,Weinberg K,Stoddart CA,McCune JM	GSE25085	GSE25085_2627_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in thymic implants from fetal versus those from adult bone marrow.	Human fetal and adult hematopoietic stem cells (HSC) were obtained from fetal liver, fetal bone marrow (BM), and adult BM. These were injected into human fetal thymic implants in SCID-hu Thy/Liv mice (4-6 separate mice per HSC donor) and allowed to mature into single positive CD4+ (SP4) thymocytes over the course of 7-8 weeks. SP4 thymocytes from injected stem cells were subsequently sort-purified from thymic implants and gene expression was performed.					718	3416	10938	60485	23367	3732	7037	140739	138050	5900	4664	5338	55652	3454	55129	6051	6643	85463	92017	2119	55884	4891	56833	80821	5971	2167	23646	84317	53844	51621	1718	9683	283131	834	56975	10855	53831	5362	59269	64327	4321	81875	28232	55365	58475	8289	8915	10507	6288	93978	7097	467	9871	79899	51726	81553	55576	6470	1316	65108	89846	7128	26033	7204	255231	3091	8609	55647	6045	10409	7132	4676	27239	307	5763	4121	10555	115708	151195	51706	7170	63933	9445	160897	51699	1730	8615	54984	3557	7185	25798	595	10370	55829	3383	65220	55577	144811	1441	100271873	117584	6648	4794	10237	6868	158135	89978	2921	2171	83937	23272	157285	2358	4323	25897	388815	23266	10536	79174	55848	55332	57703	3184	9050	867	3680	84859	7873	114548	3516	10525	4651	1522	10644	51582	5998	54874	730249	4322	6653	5025	55034	29035	284161	837	130733	3240	27042	10133	5912	2114	313	1958	330	114793	6713	7941	4302	80018	5209	4628	51296	53981	7763	4814	127281	80230	10318	5734	4792	9086	22902	10130	714	8728	53	5684	79154	4784	83931	158219	6853	56052	3006	10769	5341	933	1186	3479	1846	308	28959	57019	374882	10447	3309	23191	146198	5271	64388
GSE25085_FETAL_LIVER_VS_ADULT_BM_SP4_THYMIC_IMPLANT_UP	M8072		21164017	Mold JE,Venkatasubrahmanyam S,Burt TD,Michaëlsson J,Rivera JM,Galkina SA,Weinberg K,Stoddart CA,McCune JM	GSE25085	GSE25085_2626_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in thymic implants from fetal liver versus those from adult bone marrow.	Human fetal and adult hematopoietic stem cells (HSC) were obtained from fetal liver, fetal bone marrow (BM), and adult BM. These were injected into human fetal thymic implants in SCID-hu Thy/Liv mice (4-6 separate mice per HSC donor) and allowed to mature into single positive CD4+ (SP4) thymocytes over the course of 7-8 weeks. SP4 thymocytes from injected stem cells were subsequently sort-purified from thymic implants and gene expression was performed.					689	283237	10140	54883	5395	10943	55013	5446	64789	80817	51449	92703	7008	283349	5355	51053	10311	9706	9656	84272	353322	339324	10399	26061	23410	54539	10635	135228	2876	9219	147841	3014	159090	9837	7465	26151	255809	58493	79096	10628	283991	389541	3833	51614	84678	10983	995	4682	10383	10916	10606	6129	23230	1968	55251	10613	25840	159	1459	9702	6176	26502	9306	7013	26073	957	822	51765	27250	22834	25988	3181	27241	126393	140606	10902	201725	54458	653121	51205	54800	79866	5051	6193	10762	7112	79009	130814	29105	26147	7056	55325	55300	10733	191	10352	55293	79598	6609	6164	79626	118424	6222	84515	7750	10051	7389	151011	221710	5305	7320	51651	2330	192670	55010	84897	80097	1831	9063	83903	11152	123811	55721	6171	58530	83719	54492	84902	146909	56985	54928	51773	9541	7818	9252	5372	7268	57560	285671	222229	167555	1663	6640	57153	4126	54821	55719	29997	55159	55317	23495	90441	23401	388403	2782	54951	55093	54187	256987	91526	3015	497189	51493	5204	25913	79172	26528	489	79979	7494	54793	59307	83641	79930	10987	4046	55336	1164	56993	6461	80705	3835	90488	55272	7832	2519	3622	80346	6880	6342	64116	125988	6202	54927	27134	84823	51035	23354	23157	202243
GSE25085_FETAL_BM_VS_ADULT_BM_SP4_THYMIC_IMPLANT_UP	M8073		21164017	Mold JE,Venkatasubrahmanyam S,Burt TD,Michaëlsson J,Rivera JM,Galkina SA,Weinberg K,Stoddart CA,McCune JM	GSE25085	GSE25085_2627_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in thymic implants from fetal versus those from adult bone marrow.	Human fetal and adult hematopoietic stem cells (HSC) were obtained from fetal liver, fetal bone marrow (BM), and adult BM. These were injected into human fetal thymic implants in SCID-hu Thy/Liv mice (4-6 separate mice per HSC donor) and allowed to mature into single positive CD4+ (SP4) thymocytes over the course of 7-8 weeks. SP4 thymocytes from injected stem cells were subsequently sort-purified from thymic implants and gene expression was performed.					3669	10169	115708	286319	7965	3006	2734	11054	64327	29058	8867	7048	53840	3454	64853	54874	10322	6373	57181	9093	64108	57621	6653	3437	54708	4615	129607	29950	83638	5362	63917	5074	3106	7185	7763	9086	92140	27115	2648	51313	1318	60485	128866	87178	6385	1734	4780	7187	55110	220064	3433	146857	1730	1649	89978	51251	5971	29967	81622	55299	7422	57458	221302	85463	64761	55177	439996	1028	10528	5464	7203	91543	51144	942	1687	115361	8560	51179	284207	2778	23768	1267	65220	80301	79165	23125	10797	219285	6892	55331	55008	55601	55647	81030	127544	6428	4063	5696	7026	467	4939	10052	64135	338442	3163	8459	9021	23380	144811	3416	5095	23266	6737	26228	55829	22936	109	7919	3516	375387	27090	955	11138	351	10507	2171	9232	124359	301	5720	6351	253782	4097	1292	6182	2745	84888	1186	5218	10536	8728	10855	5496	9830	7170	115004	3575	527	3988	11216	8495	5272	4600	3431	54625	285521	4318	121599	54877	4664	3665	958	3732	10598	85441	8566	4144	4061	57158	8638	25972	22875	3937	55572	4064	28969	8886	9636	10644	84333	9961	10237	3430	1958	57703	4322	441168	23645	116071	7316	23424	55884	54765	55080	23272	51116	55720	3717	51335	5142
GSE25085_FETAL_LIVER_VS_FETAL_BM_SP4_THYMIC_IMPLANT_UP	M8075		21164017	Mold JE,Venkatasubrahmanyam S,Burt TD,Michaëlsson J,Rivera JM,Galkina SA,Weinberg K,Stoddart CA,McCune JM	GSE25085	GSE25085_2625_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in thymic implants from fetal liver versus those from fetal bone marrow.	Human fetal and adult hematopoietic stem cells (HSC) were obtained from fetal liver, fetal bone marrow (BM), and adult BM. These were injected into human fetal thymic implants in SCID-hu Thy/Liv mice (4-6 separate mice per HSC donor) and allowed to mature into single positive CD4+ (SP4) thymocytes over the course of 7-8 weeks. SP4 thymocytes from injected stem cells were subsequently sort-purified from thymic implants and gene expression was performed.					689	983	9476	115209	8567	23307	6139	587	10576	58513	890	23075	9735	8027	857	9459	57109	23533	392275	25974	3382	6498	54331	2923	80336	55843	221154	11164	9958	9705	9032	91978	8874	64236	6837	64864	51428	29090	55143	221078	11224	64789	71	27000	28957	4831	9706	10489	84340	80208	54799	50814	57805	257106	9129	51406	38	11336	1975	9133	51393	5763	60492	1062	4056	3156	5800	6730	129285	3615	2124	3646	7678	55619	93663	6390	10267	6161	63915	3073	3065	11332	11040	90871	7334	2015	2539	8940	55070	5567	55325	8625	28960	6769	84749	54606	94241	9055	26133	5257	4354	3695	10165	1479	389119	56154	128240	6515	8905	90957	56660	1468	2526	5423	93081	30011	84836	203068	3937	6223	150468	84722	25800	283130	23361	3384	5051	51203	3248	51479	27244	7745	9768	10392	6137	9709	91801	81624	11344	6503	9898	6790	539	10587	8906	27335	25977	55957	11065	29122	25814	51386	51474	283	65220	1318	8087	81562	63894	150962	6729	28970	11314	285855	4925	5138	9552	64407	84311	84897	3421	9861	51248	10992	23326	92906	6016	6001	23549	201973	8833	51103	3835	79932	2628	84864	221143	10412	2224	29127	90135	5888	6992	134429	3015	11151	4051	8516	145553	54187
GSE25085_FETAL_LIVER_VS_FETAL_BM_SP4_THYMIC_IMPLANT_DN	M8076		21164017	Mold JE,Venkatasubrahmanyam S,Burt TD,Michaëlsson J,Rivera JM,Galkina SA,Weinberg K,Stoddart CA,McCune JM	GSE25085	GSE25085_2625_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in thymic implants from fetal liver versus those from fetal bone marrow.	Human fetal and adult hematopoietic stem cells (HSC) were obtained from fetal liver, fetal bone marrow (BM), and adult BM. These were injected into human fetal thymic implants in SCID-hu Thy/Liv mice (4-6 separate mice per HSC donor) and allowed to mature into single positive CD4+ (SP4) thymocytes over the course of 7-8 weeks. SP4 thymocytes from injected stem cells were subsequently sort-purified from thymic implants and gene expression was performed.					1102	2358	54625	1901	57561	55069	103910	1892	6041	1902	140738	3006	9702	400916	3575	2214	10491	79161	4321	942	8932	5055	25824	4318	7706	85027	65977	53829	706	8685	166929	254295	79836	84898	205428	26115	5271	64343	165324	6840	2664	90411	283131	169792	8613	6539	140290	8644	23767	1647	5698	23483	351	54014	9516	57136	64207	29126	6550	79827	146754	255231	11035	51296	3920	2620	22822	124872	84617	197187	23312	2697	2495	2805	2879	126961	7941	972	6590	683	57182	1462	468	5321	3726	26747	55144	2357	5552	384	10857	8460	9934	2944	8517	9848	163351	7050	28996	2643	81669	90693	54498	2729	25801	2119	51390	341640	6566	10950	2212	7498	1838	55714	2651	26064	692205	405	6352	5105	201475	79887	1241	2171	9935	1983	715	5732	131583	4258	10410	57491	912	2908	441024	28966	2268	57480	5008	9975	219931	23135	116150	253512	57673	9595	1958	754	54664	9465	84166	79659	64778	56659	2793	3624	4343	2159	4651	1310	4317	7163	51099	79652	6372	55824	55748	1136	9034	29071	4481	3107	9522	2167	4783	5376	2870	5562	5911	84858	23474	26234	23333	383	7018	3572	5033	1959	55500	8763	80853	2838	134285	3240	395	85441	10253	51573	182
GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_UP	M8127		21220698	Smith SM,Moran AP,Duggan SP,Ahmed SE,Mohamed AS,Windle HJ,O'Neill LA,Kelleher DP	GSE25146	GSE25146_3045_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in AGS cells (gastric adenocarcinoma): control versus H. pylori LPS.	This study set out to identify global changes in gene expression in AGS gastric epithelial cells following 8 hours stimulation with 10 μg/ml lipopolysaccharide (LPS) from the gastric pathogen H. pylori. Microarray analysis was used to compare changes in gene expression between cells treated with 10 μg/ml H. pylori LPS and untreated cells at the same time point.					6625	2491	25780	54443	63922	129607	11177	1763	55632	55011	7011	9774	5780	56926	9744	150468	6305	55312	22907	10914	8938	29128	6872	154075	90326	79733	146956	3187	23168	6885	3595	695	8078	284403	29097	29028	81794	2869	11253	5782	9918	9632	64412	6432	27340	6047	9110	84000	10059	2664	54487	360023	51497	9958	151246	9879	23649	1586	10581	57655	260425	79646	29899	953	23397	140735	333926	83692	143684	3621	7070	4193	4292	51393	5498	10113	57109	51809	90799	1783	23193	10625	79443	5286	84108	10154	22873	80335	10771	55578	255520	64783	5352	57404	837	5577	3024	60560	23287	9641	5888	11169	6241	3192	79101	23162	51750	6431	81790	672	1031	10146	9761	29127	5127	80119	55320	9129	257106	64218	51131	10198	8435	115362	11113	85437	29894	9131	5778	54540	4173	9205	7175	6839	27293	91687	79915	157570	9329	5347	79158	6747	56992	23526	57695	151648	9793	6522	22985	84986	10563	1186	10125	30000	54522	27229	9700	55197	64946	4033	23310	114034	25821	5894	23483	8881	51602	10807	200081	10235	26205	10131	657	3070	55706
GSE25147_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_MKN45_CELL_DN	M8128		21220698	Smith SM,Moran AP,Duggan SP,Ahmed SE,Mohamed AS,Windle HJ,O'Neill LA,Kelleher DP	GSE25147	GSE25147_3046_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in MKN45 cells (stomach cancer): control versus H. pylori LPS.	This study set out to identify global changes in gene expression in MKN45 gastric epithelial cells following 8 hours stimulation with 10 μg/ml lipopolysaccharide (LPS) from the gastric pathogen H. pylori. Microarray analysis was used to compare changes in gene expression between cells treated with 10 μg/ml H. pylori LPS and untreated cells at the same time point.					3655	26115	134285	5155	51594	5935	475	64236	2108	79613	1325	79083	128434	1327	9001	288	10009	4900	9501	6745	84320	253558	7422	55603	5998	10391	5924	51562	214	57616	5307	51805	256586	1211	57419	817	5133	79712	8870	83941	25814	1953	57619	2246	387694	440	9978	55973	6152	9218	2785	389362	83786	100125288	8034	7227	51444	814	3679	8073	6764	5493	4255	689	50509	120400	920	359	125050	8739	126567	56954	10447	10500	90050	100131897	94030	6301	5626	8091	81029	83715	2583	59277	126129	8667	145567	4218	64839	84259	54800	84976	4285	64170	22899	11057	8836	23011	9293	9294	146760	63948	4054	2815	390226	9819	9124	6752	374407	4437	51406	92359	80194	2150	22953	367	10398	81607	65991	4861	481	5579	341405	48	3674	51232	644844	6277	6023	65078	10269	9949	9374	2790	23066	8928	9024	196463	677813	85025	7136	832	8829	54558	51014	51330	729627	51176	10634	79192	64342	987	2848	8674	392255	55	55788	10651	23038	57646	6147	3664
GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN	M8129		21220698	Smith SM,Moran AP,Duggan SP,Ahmed SE,Mohamed AS,Windle HJ,O'Neill LA,Kelleher DP	GSE25146	GSE25146_3045_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in AGS cells (gastric adenocarcinoma): control versus H. pylori LPS.	This study set out to identify global changes in gene expression in AGS gastric epithelial cells following 8 hours stimulation with 10 μg/ml lipopolysaccharide (LPS) from the gastric pathogen H. pylori. Microarray analysis was used to compare changes in gene expression between cells treated with 10 μg/ml H. pylori LPS and untreated cells at the same time point.					5996	29889	1848	259282	154075	5330	64921	11006	113402	84961	11064	81669	7072	27125	90637	57504	54900	4602	5971	23032	3416	54496	79958	5612	360023	27436	29066	143686	905	50618	56829	984	27327	9121	5138	8418	969	4013	154661	57396	10521	6510	9584	55128	6314	1654	55119	57018	5316	196441	23102	3895	23404	5921	953	84910	23196	51742	7175	29933	8036	25957	1039	9402	10625	64333	643	2354	100131211	205564	170506	25836	6772	25929	115362	1186	2483	8411	55870	4609	5534	8233	10236	8473	55671	6432	5303	7185	84166	3512	10199	54460	56926	84456	6431	9774	54855	26953	51547	10135	90799	54869	112950	23077	1510	151613	126308	22803	3187	10892	55000	8482	85313	3164	6574	51028	6810	6348	26040	6198	6621	5144	55262	80021	60490	1493	4820	4154	5286	23405	55914	4791	4599	1452	9583	84937	6427	3964	51317	5163	64844	27347	80317	115361	51147	55763	23348	3783	1655	55814	3689	3716	55619	10153	163351	9868	79882	23162	83548	904	54739	8899
GSE25147_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_MKN45_CELL_UP	M8130		21220698	Smith SM,Moran AP,Duggan SP,Ahmed SE,Mohamed AS,Windle HJ,O'Neill LA,Kelleher DP	GSE25147	GSE25147_3046_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in MKN45 cells (stomach cancer): control versus H. pylori LPS.	This study set out to identify global changes in gene expression in MKN45 gastric epithelial cells following 8 hours stimulation with 10 μg/ml lipopolysaccharide (LPS) from the gastric pathogen H. pylori. Microarray analysis was used to compare changes in gene expression between cells treated with 10 μg/ml H. pylori LPS and untreated cells at the same time point.					340784	5683	57099	4900	126433	1327	9124	6147	23648	84668	84298	5613	9218	25907	390916	79699	51382	5961	9501	9094	163486	6165	6392	3672	154807	8836	57570	285527	10575	10910	6301	79042	57216	832	84630	9857	11100	22982	1949	56666	1662	48	66036	60488	288	28960	9066	28959	956	134187	51108	4201	7419	80205	10643	5473	83482	5036	3145	9464	54927	80741	63935	117283	333	6902	114798	1716	252995	120400	25978	90050	54626	6023	659	84661	10190	117579	80135	51082	55784	8829	5719	84327	6337	51176	2752	6085	23011	6327	113220	10529	6629	2256	81027	10434	5133	84950	51642	148281	340706	6668	7105	115948	79192	201965	26278	3921	64976	1944	55734	5052	10921	2079	150274	54800	23568	6100	6631	826	98	223082	23008	9245	7791	1365	90459	619565	5707	11034	2785	201595	23788	56751	256586	6921	3093	51599	1479	208	29087	51024	55617	23415	116987	692087	283571	94234	79031	2132	124857	100128927	115752	55332	374768	55039	90673	10189	3073	7335	196996	26511	317762	10200	55909	55667
GSE22342_CD11C_HIGH_VS_LOW_DECIDUAL_MACROPHAGES_UP	M8131		21257965	Houser BL,Tilburgs T,Hill J,Nicotra ML,Strominger JL	GSE22342	GSE22342_3044_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in decidual macrophages with ITGAX [GeneID=3687] high versus low.	Decidual macrophage populations, CD11cHI and CD11cLO cells were analyzed for expression profiles and unique characteristics. We used microarrays to detail the global program of gene expression and to determine differences between these two unique decidual macrophage populations.					92014	2104	148268	9658	81614	7132	285600	91272	9530	80298	100499483	8787	9665	57050	8225	136263	54033	4783	631	7134	10053	64377	3077	54476	22931	6625	4116	643155	9444	4627	9847	5611	84636	81544	7109	5584	8672	608	59084	1173	29028	51022	84249	79847	1491	2939	84547	27327	8644	29101	8529	390261	56882	5341	56655	5557	54554	92344	57724	245930	7136	1763	23646	965	7388	9699	146779	10244	143662	23601	128025	6302	51005	3579	22864	222171	4247	317	202052	121665	51439	267	832	389791	27198	134860	84172	2760	23078	28988	80205	25791	84669	2137	4302	9126	5732	85016	138050	4734	60560	27065	8944	29127	84189	10655	79029	2316	155061	833	55628	56670	392307	201627	54757	161357	8491	80714	142940	131920	23052	63971	143879	56987	26256	347902	55689	55023	5621	10152	676	1109	152503	4644	286828	80124	729603	55291	55069	148213	79088	90627	84279	26049	166824	79026	6487	11174	401124	80727	10427	759	7310	1432	9527	5690	55062	284525	114971	9611	5700	56262	9267	55802	10320	55508	219445	11165	6160	130872	6786	11283	80832	55285	29095	3683	8875	22981	1797	5207	501	3908	5527	8756	5727	10586	79158	23102	63979	151473	79274	889	57567
GSE22342_CD11C_HIGH_VS_LOW_DECIDUAL_MACROPHAGES_DN	M8132		21257965	Houser BL,Tilburgs T,Hill J,Nicotra ML,Strominger JL	GSE22342	GSE22342_3044_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in decidual macrophages with ITGAX [GeneID=3687] high versus low.	Decidual macrophage populations, CD11cHI and CD11cLO cells were analyzed for expression profiles and unique characteristics. We used microarrays to detail the global program of gene expression and to determine differences between these two unique decidual macrophage populations.					8832	153830	157697	780776	2538	64417	79050	90249	10203	8988	223117	1053	3373	3096	84988	399898	341799	7554	254552	441509	283229	81627	28514	1015	7188	54903	4632	50856	636	2838	5451	10985	150378	5142	55728	51174	26276	10877	162427	342898	192683	29959	64718	4744	619518	3736	27303	509	222643	730167	27295	79018	139793	100506127	9079	3021	3866	26528	140767	80333	152573	2857	79689	6526	57522	256051	4488	284837	219623	336	8804	23195	222545	79751	64216	8335	9246	81442	51050	6785	1767	55214	642938	4319	56848	57180	7296	118881	22915	133	23406	1436	677837	10149	64222	131578	10326	23038	8557	171169	81469	2028	23191	6546	3957	55506	2100	7374	3762	1587	219493	79810	23408	389114	390059	8811	400867	23336	29922	3109	29924	5747	128346	394263	22832	5317	146722	23209	84959	146850	54535	1593	133121	56998	84722	22845	84912	84643	8840	441394	4063	340543	9843	4041	3117	134829	51350	146723	57482	50832	100129476	4583	57519	391059	285172	342538	57617	57060	10863	5789	10813	202018	254827	3595	51218	8574	114884	6723	84870	9187	8521	83879	337960	7761	83606	403273	400850	80816	4688	51725	389337	3399	11185	150383	56849	23368	9666	6431	80059	1287	56033
GSE22611_UNSTIM_VS_6H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_UP	M8147		21335489	Billmann-Born S,Till A,Arlt A,Lipinski S,Sina C,Latiano A,Annese V,Häsler R,Kerick M,Manke T,Seegert D,Hanidu A,Schäfer H,Heel van D,Li J,Schreiber S,Rosenstiel P	GSE22611	GSE22611_3477_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in HEK293 cells over-expressing wildtype NOD2 [GeneID=64127]: untreated versus muramyl dipeptide [PubChem=11620162] for 6h.	NOD2 is an intracellular receptor for the bacterial cell wall component muramyl dipeptide (MDP) and variants of NOD2 are associated with chronic inflammatory diseases of barrier organs e.g. Crohn disease, asthma and atopic eczema. It is known that activation of NOD2 induces a variety of inflammatory and antibacterial factors. The exact transcriptomal signatures that define the cellular programs downstream of NOD2 activation and the influence of the Crohn-associated variant L1007fsinsC are yet to be defined. To describe the MDP-induced activation program, we analyzed the transcriptomal reactions of isogenic HEK293 cells expressing NOD2wt or NOD2L1007fsinsC to stimulation with MDP. Importantly, a clear loss-of-function could be observed in the cells carrying the Crohn-associated variant L1007fsinsC, while the NOD2wt cells showed differential regulation of growth factors, chemokines and several antagonists of NF-κB, e.g. TNFAIP3 (A20) and IER3.					28984	4888	8796	2005	57235	6439	6804	56996	1134	718	4781	22800	4976	23291	652147	221960	4552	2658	22899	1750	6383	4175	283683	51619	9727	83444	2185	50848	7850	9201	4158	2670	23174	1087	6195	27286	3959	220134	6095	9118	488	65997	2931	285	140290	79368	5694	54962	7710	10903	56676	5119	89910	8727	7049	7525	80000	79178	80745	728683	3823	57157	85021	55316	7551	23366	5789	55655	79160	60485	1080	157680	64901	576	5414	22806	3980	9457	23286	6339	8382	341	51090	57338	55567	6002	26472	1327	636	50613	55206	10255	55081	79890	8418	79634	9469	56951	1999	1727	29909	55970	26152	1000	196441	7170	2121	23132	56983	36	6664	54785	221981	80215	347	4340	2828	10912	3779	8471	11167	3927	9545	2590	5016	55613	23404	1513	6928	5478	3667	598	79676	10621	2191	91746	56674	6007	9130	11075	29999	54914	54978	29068	7705	10914	23563	5228	57720	83440	8336	11046	9215	25896	567	64981	10911	4289	9829	26037	5003	10328	889	10050	55765	4285	6742	6469	4047	26586	11004	79034	3231	56980	1399	4058	51704	11253	9638	4141	29880	4685	8209	23467	49860	9156	64111	11182	80221	23086	382	25841	7428	6880	2237	7372	79799	27236	6277	54998
GSE22611_MUTANT_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_6H_DN	M8148		21335489	Billmann-Born S,Till A,Arlt A,Lipinski S,Sina C,Latiano A,Annese V,Häsler R,Kerick M,Manke T,Seegert D,Hanidu A,Schäfer H,Heel van D,Li J,Schreiber S,Rosenstiel P	GSE22611	GSE22611_3480_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in HEK293 cells at 6h after stimulation by muramyl dipeptide [PubChem=11620162]: over-expressing mutant NOD2 [GeneID=64127] versus control.	NOD2 is an intracellular receptor for the bacterial cell wall component muramyl dipeptide (MDP) and variants of NOD2 are associated with chronic inflammatory diseases of barrier organs e.g. Crohn disease, asthma and atopic eczema. It is known that activation of NOD2 induces a variety of inflammatory and antibacterial factors. The exact transcriptomal signatures that define the cellular programs downstream of NOD2 activation and the influence of the Crohn-associated variant L1007fsinsC are yet to be defined. To describe the MDP-induced activation program, we analyzed the transcriptomal reactions of isogenic HEK293 cells expressing NOD2wt or NOD2L1007fsinsC to stimulation with MDP. Importantly, a clear loss-of-function could be observed in the cells carrying the Crohn-associated variant L1007fsinsC, while the NOD2wt cells showed differential regulation of growth factors, chemokines and several antagonists of NF-κB, e.g. TNFAIP3 (A20) and IER3.					23250	10370	6322	283537	50814	114883	22916	10539	79784	3691	2868	8878	51540	1238	1829	51236	6992	54987	51023	54974	23318	23769	2801	55830	1212	11216	23244	2762	5274	55129	26664	116138	23254	10671	64794	54850	9873	100129460	5350	8609	261734	5915	4193	4055	4188	10038	9926	1112	100129500	57663	7552	51669	23550	57805	56270	8440	56300	2780	9725	11248	9245	7352	685	23314	27035	64600	7363	54780	90864	2917	2631	84440	6781	79893	64222	1939	27237	5193	55785	57763	26156	5589	10026	89781	53944	421	23019	23165	10959	23598	3371	8189	10899	23196	2113	80131	5408	59341	5641	55301	2553	22911	5094	92154	4793	54474	5027	3157	55624	30835	22927	27339	26039	6546	92104	8526	728882	5069	81620	2547	9859	6480	2251	3856	6320	1437	27229	9811	79707	10367	10019	56969	26190	11155	6251	9104	2712	7024	4720	6389	26118	56978	6641	11054	767	29842	6581	90233	55084	8837	83660	9547	25959	63982	107	6509	8404	375790	9123	2562	10544	2920	26010	5074	3569	8408	1820	57048	6595	3420	5600	2707	11340	784	51285	7837	54471	50937	10425	84034	2314	642636	3883	80349	1474	55193	5783	3340	799	28954	80279	9219	7343	9147	54852	22906	79630	55762	9112	26088
GSE22611_UNSTIM_VS_2H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_UP	M8151		21335489	Billmann-Born S,Till A,Arlt A,Lipinski S,Sina C,Latiano A,Annese V,Häsler R,Kerick M,Manke T,Seegert D,Hanidu A,Schäfer H,Heel van D,Li J,Schreiber S,Rosenstiel P	GSE22611	GSE22611_3475_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in HEK293 cells over-expressing wildtype NOD2 [GeneID=64127]: untreated versus muramyl dipeptide [PubChem=11620162] for 2h.	NOD2 is an intracellular receptor for the bacterial cell wall component muramyl dipeptide (MDP) and variants of NOD2 are associated with chronic inflammatory diseases of barrier organs e.g. Crohn disease, asthma and atopic eczema. It is known that activation of NOD2 induces a variety of inflammatory and antibacterial factors. The exact transcriptomal signatures that define the cellular programs downstream of NOD2 activation and the influence of the Crohn-associated variant L1007fsinsC are yet to be defined. To describe the MDP-induced activation program, we analyzed the transcriptomal reactions of isogenic HEK293 cells expressing NOD2wt or NOD2L1007fsinsC to stimulation with MDP. Importantly, a clear loss-of-function could be observed in the cells carrying the Crohn-associated variant L1007fsinsC, while the NOD2wt cells showed differential regulation of growth factors, chemokines and several antagonists of NF-κB, e.g. TNFAIP3 (A20) and IER3.					5789	7764	84722	63917	1820	221981	6059	55278	1123	8935	3060	9320	23532	5705	11167	2628	2932	4849	3290	4781	23366	85021	57834	9149	9746	10255	5682	6947	27245	10682	7087	3419	51090	55147	64083	387328	718	8394	10576	10603	5885	6002	27069	54677	57235	64419	11143	10915	8526	11176	7049	25818	9895	11129	4869	22887	163	55830	8456	26586	231	3588	3726	3092	26503	9412	2931	7307	29923	10775	2180	50848	1134	84059	5225	10549	1136	6383	9185	7094	2675	51513	64111	1387	444	64864	60506	56676	54876	4502	10903	10024	7324	23291	3141	79999	8382	1727	728683	26499	5198	55277	3925	79368	3914	3428	5687	3149	5530	50514	343	3439	51236	51118	26354	10990	337	3745	22800	1501	124801	63876	55503	10237	3301	8985	3084	605	80196	26589	10665	1965	9169	29028	7347	353514	5179	8704	2960	83444	6742	2005	6222	57157	2914	10150	6953	100129500	7710	2039	27340	9118	515	57415	1158	1609	6899	56342	4296	285	80000	181	51176	65094	79720	5016	160824	2767	10059	27440	100287204	1070	3218	64787	6541	2658	220134	80704	2624	6812	53838	55655	344	23132	56912	2992	4670	5322	6339	23213	8471	84869	2670	51	101	22899	6629	5534	522	27238
GSE22611_UNSTIM_VS_2H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_DN	M8152		21335489	Billmann-Born S,Till A,Arlt A,Lipinski S,Sina C,Latiano A,Annese V,Häsler R,Kerick M,Manke T,Seegert D,Hanidu A,Schäfer H,Heel van D,Li J,Schreiber S,Rosenstiel P	GSE22611	GSE22611_3475_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in HEK293 cells over-expressing wildtype NOD2 [GeneID=64127]: untreated versus muramyl dipeptide [PubChem=11620162] for 2h.	NOD2 is an intracellular receptor for the bacterial cell wall component muramyl dipeptide (MDP) and variants of NOD2 are associated with chronic inflammatory diseases of barrier organs e.g. Crohn disease, asthma and atopic eczema. It is known that activation of NOD2 induces a variety of inflammatory and antibacterial factors. The exact transcriptomal signatures that define the cellular programs downstream of NOD2 activation and the influence of the Crohn-associated variant L1007fsinsC are yet to be defined. To describe the MDP-induced activation program, we analyzed the transcriptomal reactions of isogenic HEK293 cells expressing NOD2wt or NOD2L1007fsinsC to stimulation with MDP. Importantly, a clear loss-of-function could be observed in the cells carrying the Crohn-associated variant L1007fsinsC, while the NOD2wt cells showed differential regulation of growth factors, chemokines and several antagonists of NF-κB, e.g. TNFAIP3 (A20) and IER3.					3693	2861	56300	54939	595	100131510	5550	58513	9512	81579	440387	54928	54813	650	1437	9351	4913	9048	10513	54532	23542	2560	8687	54707	8893	1580	10884	8310	347902	2645	1278	1939	10733	201626	55630	79733	7450	27240	64848	8209	2116	3612	51385	6144	55635	4312	22850	57000	1434	9362	11021	23598	23626	23318	29	55173	389898	4437	7329	5792	6940	2631	10671	1788	6573	8811	182	55796	55086	1382	23507	2271	1155	64794	79962	55612	10103	8544	4862	6553	79706	55165	5480	9545	7428	10572	6638	10146	80144	8621	25828	10647	4496	8518	30835	55295	23022	574	5923	51617	4017	4188	54453	64395	10326	254896	9128	1299	1118	24137	64091	9474	9616	7572	56918	9037	3642	9987	2823	54093	4922	10320	2564	1180	8270	80975	56547	114818	3569	79230	4661	64579	2683	6424	56980	2239	7036	4597	9440	23035	1628	9609	23466	91445	27087	5152	3708	5635	59272	940	79792	9499	10399	613	8989	11343	6554	5636	55270	57380	5250	50628	840	8273	25940	80174	1781	65986	2288	10846	55544	9112	79153	8575	79861	7678	9694	6431	221443	645745	1015	9635	5025	54516	3624	57446	23558	79804	9618	10193	10907	701	843	54482	26189	10726	56901	6338	28962	2330
GSE22611_MUTANT_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_6H_UP	M8157		21335489	Billmann-Born S,Till A,Arlt A,Lipinski S,Sina C,Latiano A,Annese V,Häsler R,Kerick M,Manke T,Seegert D,Hanidu A,Schäfer H,Heel van D,Li J,Schreiber S,Rosenstiel P	GSE22611	GSE22611_3480_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in HEK293 cells at 6h after stimulation by muramyl dipeptide [PubChem=11620162]: over-expressing mutant NOD2 [GeneID=64127] versus control.	NOD2 is an intracellular receptor for the bacterial cell wall component muramyl dipeptide (MDP) and variants of NOD2 are associated with chronic inflammatory diseases of barrier organs e.g. Crohn disease, asthma and atopic eczema. It is known that activation of NOD2 induces a variety of inflammatory and antibacterial factors. The exact transcriptomal signatures that define the cellular programs downstream of NOD2 activation and the influence of the Crohn-associated variant L1007fsinsC are yet to be defined. To describe the MDP-induced activation program, we analyzed the transcriptomal reactions of isogenic HEK293 cells expressing NOD2wt or NOD2L1007fsinsC to stimulation with MDP. Importantly, a clear loss-of-function could be observed in the cells carrying the Crohn-associated variant L1007fsinsC, while the NOD2wt cells showed differential regulation of growth factors, chemokines and several antagonists of NF-κB, e.g. TNFAIP3 (A20) and IER3.					80221	22806	221960	23366	718	7049	889	6095	8382	36	8938	636	55206	4888	23404	4141	4976	6664	728683	29068	2931	11046	247	23291	9469	3980	5016	6953	3779	8644	29893	23215	56676	7170	25823	6439	55316	1999	347	5884	50848	58530	79368	221981	4306	51092	2670	64981	10903	23286	57338	10912	4685	27097	57720	64840	22979	9457	1727	1521	3852	5228	157680	4753	10761	55970	4058	847	23272	3237	22899	26005	11318	6541	57157	54978	8294	7127	9825	100287590	11079	9249	3823	80168	6906	1014	51280	5184	81616	64210	11119	283212	283683	6542	79654	60401	11075	341	10218	64901	4634	3606	4665	54904	80212	55655	79018	9629	488	55016	8634	57134	5562	55073	4233	10621	10911	55182	11167	481	56833	8736	23627	7535	4703	55254	80243	79370	80093	59338	56912	51704	5064	23030	1152	27299	1087	4624	8419	10050	29909	127833	9860	105	7372	10947	1602	10052	81602	10061	201895	1135	7355	2012	80222	1395	374819	56339	5820	79605	150759	1589	8590	11133	56924	64061	1618	29999	11182	25841	1134	54014	79918	79800	2669	84179	285203	5864	3895	63897	274	56948	6701	5063	51195	344	10725	221830	80215	25999	6293	9353	79890	5993	89927	6742	9204	84759	2272	9453
GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP	M8158		21335489	Billmann-Born S,Till A,Arlt A,Lipinski S,Sina C,Latiano A,Annese V,Häsler R,Kerick M,Manke T,Seegert D,Hanidu A,Schäfer H,Heel van D,Li J,Schreiber S,Rosenstiel P	GSE22611	GSE22611_3476_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in HEK293 cells expressing mutant NOD2 [GeneID=64127]: untreated versus muramyl dipeptide [PubChem=11620162] for 2h.	NOD2 is an intracellular receptor for the bacterial cell wall component muramyl dipeptide (MDP) and variants of NOD2 are associated with chronic inflammatory diseases of barrier organs e.g. Crohn disease, asthma and atopic eczema. It is known that activation of NOD2 induces a variety of inflammatory and antibacterial factors. The exact transcriptomal signatures that define the cellular programs downstream of NOD2 activation and the influence of the Crohn-associated variant L1007fsinsC are yet to be defined. To describe the MDP-induced activation program, we analyzed the transcriptomal reactions of isogenic HEK293 cells expressing NOD2wt or NOD2L1007fsinsC to stimulation with MDP. Importantly, a clear loss-of-function could be observed in the cells carrying the Crohn-associated variant L1007fsinsC, while the NOD2wt cells showed differential regulation of growth factors, chemokines and several antagonists of NF-κB, e.g. TNFAIP3 (A20) and IER3.					51669	8609	54987	27229	56969	57763	81569	9926	5589	54973	9147	4215	9828	1155	64222	255812	79630	9404	3708	11236	56300	51540	56965	11153	10140	182	26225	93	53339	900	22921	7884	56940	10422	79738	80223	9844	79657	54733	8404	54916	4217	6908	11160	3983	3635	9589	79866	9138	6451	9616	113	222658	5600	9635	26574	223	2186	100288939	60481	51098	8187	55013	23294	54434	50840	50616	6862	55644	1808	200315	64784	10567	211	2631	197	5955	2745	7045	57570	8527	2920	10930	1436	9129	5024	3765	131408	79153	6452	10636	25828	54957	8799	3357	8353	8613	11073	6566	10572	54811	2730	2835	8440	1633	9040	10408	784	55662	60528	79661	51506	55191	26190	9649	23270	3475	308	4889	10944	9784	23022	81	285527	9191	5781	10288	5089	80194	25777	23492	5025	7295	63035	10641	2494	5243	7692	23139	10928	10093	10519	5994	833	54850	7755	1147	1642	79589	1421	10613	2553	8817	8303	6845	2928	203069	56981	3638	11343	28972	6919	3082	6389	966	64601	28232	88	8476	8858	1437	27018	629	60385	9840	5337	2999	51501	10461	51228	11041	26637	4838	57823	22833	1477	54715	1326	313	5715	7252	6992	23318	55332	3593	49856	1108	80006	10127	5565
GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_6H_UP	M8159		21335489	Billmann-Born S,Till A,Arlt A,Lipinski S,Sina C,Latiano A,Annese V,Häsler R,Kerick M,Manke T,Seegert D,Hanidu A,Schäfer H,Heel van D,Li J,Schreiber S,Rosenstiel P	GSE22611	GSE22611_3839_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in HEK293 cells at 6h after stimulation by muramyl dipeptide [PubChem=11620162]: over-expressing wildtype NOD2 [GeneID=64127] versus control.	NOD2 is an intracellular receptor for the bacterial cell wall component muramyl dipeptide (MDP) and variants of NOD2 are associated with chronic inflammatory diseases of barrier organs e.g. Crohn disease, asthma and atopic eczema. It is known that activation of NOD2 induces a variety of inflammatory and antibacterial factors. The exact transcriptomal signatures that define the cellular programs downstream of NOD2 activation and the influence of the Crohn-associated variant L1007fsinsC are yet to be defined. To describe the MDP-induced activation program, we analyzed the transcriptomal reactions of isogenic HEK293 cells expressing NOD2wt or NOD2L1007fsinsC to stimulation with MDP. Importantly, a clear loss-of-function could be observed in the cells carrying the Crohn-associated variant L1007fsinsC, while the NOD2wt cells showed differential regulation of growth factors, chemokines and several antagonists of NF-κB, e.g. TNFAIP3 (A20) and IER3.					57209	5606	8844	9118	26586	80153	1136	81626	51065	3702	9037	1780	2931	9590	9746	9692	51776	221981	220134	284119	11119	7127	4133	64901	2071	2005	9240	54677	338	27115	50831	285755	1666	27091	10205	11267	2185	90199	261734	5917	889	231	5521	4739	164	54826	4745	3084	80135	2642	718	6899	10255	25813	63917	1843	6247	3303	3980	2840	6855	23386	2619	54498	5686	26154	7710	5789	652147	6002	5414	728683	3823	8605	10499	2488	23313	29992	83942	3779	1586	50835	10199	488	9985	10493	9727	9315	85021	57338	81617	4234	81552	6046	7049	54433	444	1087	9688	65094	8704	7030	57157	26353	9092	2713	7323	114818	55316	55055	10092	221960	6222	9028	3185	65095	11181	283131	4781	63876	26539	7093	4841	55567	2524	157680	353514	10050	5908	3808	4685	3030	91752	27236	51135	1609	23636	23366	23214	4247	51552	11167	51078	80000	4711	23213	100129410	55206	3626	10765	705	4814	4104	23321	5820	7372	4794	8087	8718	2624	283212	3561	1944	5213	55655	4141	1080	6742	10282	79019	64111	181	56676	51100	8382	283683	57664	80032	26508	4664	238	10903	2670	6383	7347	9201	2658	79368	101	6953	23291	50848	1513	91298	79160	22800	6664	50674	158471	80227
GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_6H_DN	M8160		21335489	Billmann-Born S,Till A,Arlt A,Lipinski S,Sina C,Latiano A,Annese V,Häsler R,Kerick M,Manke T,Seegert D,Hanidu A,Schäfer H,Heel van D,Li J,Schreiber S,Rosenstiel P	GSE22611	GSE22611_3839_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in HEK293 cells at 6h after stimulation by muramyl dipeptide [PubChem=11620162]: over-expressing wildtype NOD2 [GeneID=64127] versus control.	NOD2 is an intracellular receptor for the bacterial cell wall component muramyl dipeptide (MDP) and variants of NOD2 are associated with chronic inflammatory diseases of barrier organs e.g. Crohn disease, asthma and atopic eczema. It is known that activation of NOD2 induces a variety of inflammatory and antibacterial factors. The exact transcriptomal signatures that define the cellular programs downstream of NOD2 activation and the influence of the Crohn-associated variant L1007fsinsC are yet to be defined. To describe the MDP-induced activation program, we analyzed the transcriptomal reactions of isogenic HEK293 cells expressing NOD2wt or NOD2L1007fsinsC to stimulation with MDP. Importantly, a clear loss-of-function could be observed in the cells carrying the Crohn-associated variant L1007fsinsC, while the NOD2wt cells showed differential regulation of growth factors, chemokines and several antagonists of NF-κB, e.g. TNFAIP3 (A20) and IER3.					8447	10148	5875	10408	400451	9811	5272	100288944	3543	8817	54968	50506	5550	51599	27122	347344	55721	11154	4486	27240	23174	9478	85458	8812	23598	85452	22918	56005	51236	116832	92973	55057	55333	10278	81848	6472	23569	1902	64794	1636	29903	57823	9712	7625	23530	8787	3785	9414	55848	2730	51281	2920	54987	51495	1437	55750	23270	10003	5774	7022	5771	54996	9616	9245	55812	9122	182	56300	55332	65084	3763	80094	51594	3248	486	1538	3612	4744	54839	770	8170	5743	90333	54850	30849	26013	3643	8659	23614	6510	8480	57016	5250	29015	4620	9926	55544	79153	80380	64222	952	384	9620	4319	5635	50840	7098	26873	23780	8029	55173	6338	3696	10019	5822	3690	3749	80111	8692	10038	8756	6035	1302	3745	4884	54939	9318	2206	9812	412	5566	5092	4062	1029	4621	23165	8440	25828	55366	9022	4751	2863	2264	79583	201626	90864	685	10321	201191	7348	23038	11343	2334	1133	3535	4913	1470	6992	51228	7473	400	29	56270	5600	1785	6362	6505	92154	23397	2212	8609	1307	2683	81831	60481	100288679	11063	6579	23654	1040	375346	1112	79754	51593	51571	57048	8082	734	79929	148229	5193	5371	7008	79084	6209	100292959	23139	54584	5004
GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_2H_UP	M8161		21335489	Billmann-Born S,Till A,Arlt A,Lipinski S,Sina C,Latiano A,Annese V,Häsler R,Kerick M,Manke T,Seegert D,Hanidu A,Schäfer H,Heel van D,Li J,Schreiber S,Rosenstiel P	GSE22611	GSE22611_3840_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in HEK293 cells at 2h after stimulation by muramyl dipeptide [PubChem=11620162]: over-expressing mutant NOD2 [GeneID=64127] versus control.	NOD2 is an intracellular receptor for the bacterial cell wall component muramyl dipeptide (MDP) and variants of NOD2 are associated with chronic inflammatory diseases of barrier organs e.g. Crohn disease, asthma and atopic eczema. It is known that activation of NOD2 induces a variety of inflammatory and antibacterial factors. The exact transcriptomal signatures that define the cellular programs downstream of NOD2 activation and the influence of the Crohn-associated variant L1007fsinsC are yet to be defined. To describe the MDP-induced activation program, we analyzed the transcriptomal reactions of isogenic HEK293 cells expressing NOD2wt or NOD2L1007fsinsC to stimulation with MDP. Importantly, a clear loss-of-function could be observed in the cells carrying the Crohn-associated variant L1007fsinsC, while the NOD2wt cells showed differential regulation of growth factors, chemokines and several antagonists of NF-κB, e.g. TNFAIP3 (A20) and IER3.					55316	6383	57235	80221	29909	9727	4141	344	55655	10911	285	283683	2670	23291	56674	2931	36	10255	341	728683	25823	80215	1999	54785	3823	22899	1087	4552	23366	55970	221981	10761	6095	9638	8938	1513	51552	4976	576	10050	79368	221960	9201	58530	10914	23362	22806	636	10912	10903	4888	4306	79654	6742	8382	80323	8336	157680	8644	6664	7010	5884	481	11167	29999	26031	80031	54904	283212	220134	64840	2004	23272	80243	26586	55073	3748	3293	4753	6318	3779	11095	56848	8471	9118	1000	730101	57338	1727	114112	11046	387535	23286	10225	63897	81616	6541	8294	4685	9457	4094	221830	25841	2658	10947	26298	57720	23404	27097	23132	3718	3232	79634	54801	8464	8455	8590	921	27147	253959	2064	8287	80212	7093	23627	4634	127833	79178	2145	765	1152	22863	23524	4968	5201	9629	9971	64123	7044	64061	7710	54491	79917	29991	5562	374819	671	11318	2735	9914	1136	6683	6658	635	27129	8884	80060	7741	3912	79799	8419	9099	1134	59338	2005	55016	50939	8505	1361	79883	23263	79018	1370	51309	60485	55622	57211	55876	11211	80093	64219	26257	80304	10634	89927	3797	1184	4703	1521	2052	2012	83448	55206	9825	201895	5166	2001	2272	56676	285203
GSE22611_UNSTIM_VS_6H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP	M8162		21335489	Billmann-Born S,Till A,Arlt A,Lipinski S,Sina C,Latiano A,Annese V,Häsler R,Kerick M,Manke T,Seegert D,Hanidu A,Schäfer H,Heel van D,Li J,Schreiber S,Rosenstiel P	GSE22611	GSE22611_3478_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in HEK293 cells expressing mutant NOD2 [GeneID=64127]: untreated versus muramyl dipeptide [PubChem=11620162] for 6h.	NOD2 is an intracellular receptor for the bacterial cell wall component muramyl dipeptide (MDP) and variants of NOD2 are associated with chronic inflammatory diseases of barrier organs e.g. Crohn disease, asthma and atopic eczema. It is known that activation of NOD2 induces a variety of inflammatory and antibacterial factors. The exact transcriptomal signatures that define the cellular programs downstream of NOD2 activation and the influence of the Crohn-associated variant L1007fsinsC are yet to be defined. To describe the MDP-induced activation program, we analyzed the transcriptomal reactions of isogenic HEK293 cells expressing NOD2wt or NOD2L1007fsinsC to stimulation with MDP. Importantly, a clear loss-of-function could be observed in the cells carrying the Crohn-associated variant L1007fsinsC, while the NOD2wt cells showed differential regulation of growth factors, chemokines and several antagonists of NF-κB, e.g. TNFAIP3 (A20) and IER3.					51669	79153	54987	3612	81831	5550	79958	27018	5509	56969	22911	4720	9404	4188	8613	55602	6885	4215	10899	3199	56270	1762	10659	7450	50616	9926	10038	56893	3420	962	25828	9748	4889	55301	51727	79671	11221	57823	311	64222	23379	63035	10140	60493	1140	26225	92335	5972	8603	51290	4641	79631	56521	9467	11041	8714	27141	4995	23339	26751	63894	7179	9255	51696	3098	57658	10555	8030	896	146712	54916	84695	55113	2960	22828	27250	79960	10498	6908	22853	5270	57402	64129	319	10106	11011	2720	26577	4656	27347	23395	22944	113457	9410	3850	8697	619426	80021	3034	8850	79652	171392	7045	7804	54537	6229	2646	56978	57205	64784	6778	5629	25829	284021	55860	4357	53347	50840	22838	100288939	411	54872	23478	10406	27257	4311	8110	5790	5768	26762	10819	23091	1793	3708	79627	100506898	56300	3635	51257	51299	81565	51506	53407	29	51654	8079	11073	53615	23125	5780	1477	10148	55173	6875	10019	23562	56172	4323	10007	58189	57171	1155	50813	51163	79953	6431	55701	5621	2747	51236	9247	23287	1445	23598	23510	9968	64794	220972	968	55191	8609	6102	100170939	144699	648	100132285	57000	64856	3916	659	8604	5778	2135	7171	79630	11031	55679	4267	192286	23164
GSE22611_UNSTIM_VS_6H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN	M8163		21335489	Billmann-Born S,Till A,Arlt A,Lipinski S,Sina C,Latiano A,Annese V,Häsler R,Kerick M,Manke T,Seegert D,Hanidu A,Schäfer H,Heel van D,Li J,Schreiber S,Rosenstiel P	GSE22611	GSE22611_3478_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in HEK293 cells expressing mutant NOD2 [GeneID=64127]: untreated versus muramyl dipeptide [PubChem=11620162] for 6h.	NOD2 is an intracellular receptor for the bacterial cell wall component muramyl dipeptide (MDP) and variants of NOD2 are associated with chronic inflammatory diseases of barrier organs e.g. Crohn disease, asthma and atopic eczema. It is known that activation of NOD2 induces a variety of inflammatory and antibacterial factors. The exact transcriptomal signatures that define the cellular programs downstream of NOD2 activation and the influence of the Crohn-associated variant L1007fsinsC are yet to be defined. To describe the MDP-induced activation program, we analyzed the transcriptomal reactions of isogenic HEK293 cells expressing NOD2wt or NOD2L1007fsinsC to stimulation with MDP. Importantly, a clear loss-of-function could be observed in the cells carrying the Crohn-associated variant L1007fsinsC, while the NOD2wt cells showed differential regulation of growth factors, chemokines and several antagonists of NF-κB, e.g. TNFAIP3 (A20) and IER3.					6843	1538	976	114	81930	50862	338645	100131613	22849	79605	753	79809	5357	115703	7173	2585	257407	6039	2780	26333	23604	23	10460	254896	4634	5624	5175	65110	1310	51312	5595	650	100294145	5281	9016	79860	57599	1876	7421	105	55237	2020	3797	10900	6051	4208	6497	115207	7827	219595	64397	57228	9860	10300	101	2150	4998	1109	6256	223	6583	54967	6494	81577	1454	84162	22937	327	29986	7727	3305	51635	59348	8993	3579	23165	63926	10919	3229	54815	5947	4798	11152	79656	5462	313	8507	4210	7432	3192	23032	54836	2571	8876	5045	7090	55924	6275	832	9658	271	100129410	23287	146712	152	81603	9107	57326	30817	51318	26502	4815	9936	5172	11041	23102	26330	79822	23220	64410	1015	55844	10695	8557	8794	2852	5305	65258	84861	65018	1831	57380	6655	4493	139081	5833	80060	7096	138151	6663	10210	57051	7299	5864	79906	5594	4332	6853	219699	171586	9263	978	2120	27036	80349	579	3754	2275	8795	2549	9573	79918	5829	10267	2719	10046	55671	23601	79603	91860	64411	5228	10741	80086	79414	3598	64400	1907	7541	7903	79890	4848	1183	112398	57188	2878	4000	22879	8538	6857	284439	712	23431	1420	23176	57804	11151	23268	29075	9811
GSE22611_NOD2_VS_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP	M8164		21335489	Billmann-Born S,Till A,Arlt A,Lipinski S,Sina C,Latiano A,Annese V,Häsler R,Kerick M,Manke T,Seegert D,Hanidu A,Schäfer H,Heel van D,Li J,Schreiber S,Rosenstiel P	GSE22611	GSE22611_3472_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in HEK293 cells expressing: wildtype NOD2 [GeneID=64127] versus mutant NOD2 [GeneID=64127].	NOD2 is an intracellular receptor for the bacterial cell wall component muramyl dipeptide (MDP) and variants of NOD2 are associated with chronic inflammatory diseases of barrier organs e.g. Crohn disease, asthma and atopic eczema. It is known that activation of NOD2 induces a variety of inflammatory and antibacterial factors. The exact transcriptomal signatures that define the cellular programs downstream of NOD2 activation and the influence of the Crohn-associated variant L1007fsinsC are yet to be defined. To describe the MDP-induced activation program, we analyzed the transcriptomal reactions of isogenic HEK293 cells expressing NOD2wt or NOD2L1007fsinsC to stimulation with MDP. Importantly, a clear loss-of-function could be observed in the cells carrying the Crohn-associated variant L1007fsinsC, while the NOD2wt cells showed differential regulation of growth factors, chemokines and several antagonists of NF-κB, e.g. TNFAIP3 (A20) and IER3.					65057	92689	54952	29028	80145	314	64215	9276	7334	51377	5866	53373	4047	8575	28511	10120	64840	3911	10951	8078	26024	6626	5682	80764	22833	64793	23317	23247	4306	56910	514	10432	146057	83638	26574	4048	10775	7266	3708	81558	80317	9610	8723	54796	6128	8839	8722	7533	201895	2195	435	10661	3269	56940	8459	57823	3300	60485	3849	51031	79705	738	54939	84909	56259	2835	92	25996	266655	9326	9071	9421	27229	933	6134	81566	1457	8925	80167	56342	10274	51335	79596	51540	5532	11051	80148	49856	8799	4495	9698	10507	440423	10110	5025	10381	11017	80131	79847	51207	308	7481	8672	10408	79979	2920	7755	124044	79901	79573	3593	8353	383	126070	6988	8187	90121	10270	79683	5382	10948	23384	6184	1437	7301	100507605	9640	55697	966	534	79629	9034	55466	26521	54946	63892	11343	80198	55140	4214	55041	79589	56101	3093	79947	23095	10418	629	11238	1643	90	6362	10959	80310	2730	79171	5562	9618	2161	5596	843	695	10567	4985	11123	51621	51109	11065	641	728855	54681	2928	8492	8801	5337	8864	55355	84901	10155	9957	56912	1592	64789	8613	4593	55711	25775	6558	10991	6170	2520	728882	88	5459	55090	10422	9969	2810	197	56300
GSE22611_NOD2_VS_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN	M8165		21335489	Billmann-Born S,Till A,Arlt A,Lipinski S,Sina C,Latiano A,Annese V,Häsler R,Kerick M,Manke T,Seegert D,Hanidu A,Schäfer H,Heel van D,Li J,Schreiber S,Rosenstiel P	GSE22611	GSE22611_3472_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in HEK293 cells expressing: wildtype NOD2 [GeneID=64127] versus mutant NOD2 [GeneID=64127].	NOD2 is an intracellular receptor for the bacterial cell wall component muramyl dipeptide (MDP) and variants of NOD2 are associated with chronic inflammatory diseases of barrier organs e.g. Crohn disease, asthma and atopic eczema. It is known that activation of NOD2 induces a variety of inflammatory and antibacterial factors. The exact transcriptomal signatures that define the cellular programs downstream of NOD2 activation and the influence of the Crohn-associated variant L1007fsinsC are yet to be defined. To describe the MDP-induced activation program, we analyzed the transcriptomal reactions of isogenic HEK293 cells expressing NOD2wt or NOD2L1007fsinsC to stimulation with MDP. Importantly, a clear loss-of-function could be observed in the cells carrying the Crohn-associated variant L1007fsinsC, while the NOD2wt cells showed differential regulation of growth factors, chemokines and several antagonists of NF-κB, e.g. TNFAIP3 (A20) and IER3.					10777	11086	57082	3718	23305	285	23524	5080	781	284244	79736	57104	8365	79813	3595	23380	171586	2981	1960	6923	9783	60598	4832	8635	54629	23051	57597	54868	60686	100293679	1373	23504	54345	100507605	30845	55888	54490	100093698	2800	56301	51172	8492	100272147	23166	91316	4361	201626	80206	5897	9027	6369	2641	90273	54967	79676	54549	9892	1418	27285	79788	79058	1677	55063	157869	27336	29967	348	10742	79631	2645	79927	79703	28517	55374	2911	26998	7093	3128	55036	22843	25890	6187	2140	9104	36	56897	23591	1735	5562	1031	10576	5742	3010	55178	26275	1178	51013	9716	6357	7010	1014	9555	55079	3572	1278	79934	7216	8913	11255	79689	2058	10808	4634	5585	23119	4544	57326	60488	8355	486	112950	5210	79033	63897	4091	64149	6198	29968	23321	64837	280658	8727	26007	55109	3235	3386	65982	9356	54968	56659	10741	9016	3661	8840	84617	4360	55876	3467	80739	57228	4867	2571	27240	55764	10141	27178	5781	10572	283683	81490	5733	4133	28992	5412	10126	84436	5367	3839	6401	8358	10769	3551	56899	10186	5682	10321	6014	9495	8644	1140	23002	2817	55622	161291	79962	55295	3204	1203	100289109	57045	1015	132	10402	8633	671	55633	51507	10224	3776	8993
GSE22611_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_UP	M8166		21335489	Billmann-Born S,Till A,Arlt A,Lipinski S,Sina C,Latiano A,Annese V,Häsler R,Kerick M,Manke T,Seegert D,Hanidu A,Schäfer H,Heel van D,Li J,Schreiber S,Rosenstiel P	GSE22611	GSE22611_3473_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in HEK293 cells: over-expressing wildtype NOD2 [GeneID=64127] versus control.	NOD2 is an intracellular receptor for the bacterial cell wall component muramyl dipeptide (MDP) and variants of NOD2 are associated with chronic inflammatory diseases of barrier organs e.g. Crohn disease, asthma and atopic eczema. It is known that activation of NOD2 induces a variety of inflammatory and antibacterial factors. The exact transcriptomal signatures that define the cellular programs downstream of NOD2 activation and the influence of the Crohn-associated variant L1007fsinsC are yet to be defined. To describe the MDP-induced activation program, we analyzed the transcriptomal reactions of isogenic HEK293 cells expressing NOD2wt or NOD2L1007fsinsC to stimulation with MDP. Importantly, a clear loss-of-function could be observed in the cells carrying the Crohn-associated variant L1007fsinsC, while the NOD2wt cells showed differential regulation of growth factors, chemokines and several antagonists of NF-κB, e.g. TNFAIP3 (A20) and IER3.					89927	126017	11221	8613	79400	91298	9971	60493	23478	10950	962	51654	23168	100288007	8603	22863	11258	9410	84193	55696	10915	3024	8892	56674	4357	117153	64417	54583	7179	10180	28823	29127	10911	5250	51554	7739	57823	63894	10565	79709	7263	8208	1983	10479	8975	7706	6102	1062	80774	9535	994	6229	80777	26017	3440	9046	7003	51501	8427	4504	54796	8464	51451	23164	5169	79023	171392	442216	3480	81542	55270	1429	2960	3797	10678	3030	347853	10007	27034	3708	22838	2720	54708	3835	323	9879	55039	8022	8402	3612	80243	8560	4778	56954	23339	51809	183	5243	4917	283450	55228	51101	8451	5369	81926	23224	10406	9255	27340	3108	8405	395	54834	2132	4121	9076	23436	55611	71	4267	85458	8930	84079	1445	57336	25801	8767	968	275	55108	9790	90326	28998	51233	25813	9541	51780	152006	51181	7267	1200	8569	490	55159	64976	7067	10055	9824	53615	10913	26031	1798	11024	3146	50813	9177	958	10148	9589	51304	9826	4358	92689	51111	51006	205	79572	5337	64284	53826	57235	3638	4172	652147	4680	29071	4670	221692	56300	822	7442	10430	8933	11284	23155	1984	65980	64710	6375	6428	11022	3838	9968	6535	23764	10695	23395	8877	8216	2527
GSE22611_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_DN	M8169		21335489	Billmann-Born S,Till A,Arlt A,Lipinski S,Sina C,Latiano A,Annese V,Häsler R,Kerick M,Manke T,Seegert D,Hanidu A,Schäfer H,Heel van D,Li J,Schreiber S,Rosenstiel P	GSE22611	GSE22611_3473_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in HEK293 cells: over-expressing wildtype NOD2 [GeneID=64127] versus control.	NOD2 is an intracellular receptor for the bacterial cell wall component muramyl dipeptide (MDP) and variants of NOD2 are associated with chronic inflammatory diseases of barrier organs e.g. Crohn disease, asthma and atopic eczema. It is known that activation of NOD2 induces a variety of inflammatory and antibacterial factors. The exact transcriptomal signatures that define the cellular programs downstream of NOD2 activation and the influence of the Crohn-associated variant L1007fsinsC are yet to be defined. To describe the MDP-induced activation program, we analyzed the transcriptomal reactions of isogenic HEK293 cells expressing NOD2wt or NOD2L1007fsinsC to stimulation with MDP. Importantly, a clear loss-of-function could be observed in the cells carrying the Crohn-associated variant L1007fsinsC, while the NOD2wt cells showed differential regulation of growth factors, chemokines and several antagonists of NF-κB, e.g. TNFAIP3 (A20) and IER3.					4958	10300	2533	30817	54901	1612	9077	8557	9478	11275	85373	51112	2597	84162	6583	5510	3621	9263	4712	80231	10677	55628	60481	7421	29108	23030	23510	85459	23564	50810	5281	6494	50862	53829	93349	4070	84560	9712	5045	8766	7846	5175	8543	240	2150	26108	5423	3930	80223	55680	5351	10460	56255	113	11344	84436	9333	22937	51307	4634	9936	10928	80167	1831	23	2120	6542	660	2838	7086	6314	3475	79739	3606	4588	83743	10620	678	4033	49856	7341	6653	2539	9630	10210	8698	57107	26578	3781	23604	4782	29068	91860	200315	7803	271	56269	146712	80254	10951	81603	54762	27315	3087	5997	4892	8513	51504	56245	51411	5894	11151	3340	55589	23401	5982	4580	26048	23347	9960	2353	2981	23112	3577	11010	4215	10057	10461	3939	8644	442240	4208	375056	90273	313	6256	13	22849	55103	9252	3579	84986	51668	3385	23404	51312	55924	55656	51635	9236	3034	3516	7263	55313	50515	7277	64132	818	6445	8794	79668	54943	79829	978	3549	26502	51720	65258	6392	10745	8795	10404	114883	6655	397	9658	7994	55172	7064	57763	5864	9881	4332	80025	10224	55270	7791	5339	192670	23304	79705	2591	6907	2309	3156	23406	6402	10636	6275	81626
GSE22611_MUTANT_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_UP	M8170		21335489	Billmann-Born S,Till A,Arlt A,Lipinski S,Sina C,Latiano A,Annese V,Häsler R,Kerick M,Manke T,Seegert D,Hanidu A,Schäfer H,Heel van D,Li J,Schreiber S,Rosenstiel P	GSE22611	GSE22611_3474_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in HEK293 cells: expressing mutant NOD2 [GeneID=64127] versus control.	NOD2 is an intracellular receptor for the bacterial cell wall component muramyl dipeptide (MDP) and variants of NOD2 are associated with chronic inflammatory diseases of barrier organs e.g. Crohn disease, asthma and atopic eczema. It is known that activation of NOD2 induces a variety of inflammatory and antibacterial factors. The exact transcriptomal signatures that define the cellular programs downstream of NOD2 activation and the influence of the Crohn-associated variant L1007fsinsC are yet to be defined. To describe the MDP-induced activation program, we analyzed the transcriptomal reactions of isogenic HEK293 cells expressing NOD2wt or NOD2L1007fsinsC to stimulation with MDP. Importantly, a clear loss-of-function could be observed in the cells carrying the Crohn-associated variant L1007fsinsC, while the NOD2wt cells showed differential regulation of growth factors, chemokines and several antagonists of NF-κB, e.g. TNFAIP3 (A20) and IER3.					440738	9828	6835	6650	8839	57109	10507	64137	23513	7252	26539	4117	389	3708	4833	6626	10557	93	7443	4701	6170	8803	56969	80975	7134	6171	80212	4047	8535	3357	51575	2109	10360	1103	84790	27097	10069	23127	151	9933	56259	85446	5243	28234	988	7704	4736	54977	1263	3251	5184	6352	26024	3029	383	1933	8363	64216	56300	2730	2920	100288413	1400	65110	3638	64598	653639	64850	4753	9589	8613	474170	8552	7278	6364	182	6588	10589	1845	5337	11041	5331	64210	1108	4036	10020	55215	54879	2494	5602	3689	22833	5626	57733	9329	2928	5498	1440	3142	8530	10376	2643	3593	54674	2038	25775	9792	80052	9404	80152	26053	388969	3383	79875	1437	54939	285231	79860	51501	2588	6134	55714	57823	7301	3937	1984	4488	2819	6130	5024	933	10408	26658	9451	55332	10725	56940	27067	55041	3553	1326	3624	5745	80099	25932	29015	60626	1431	966	51303	10418	999	6894	5707	2561	9882	9659	4616	90410	5025	222161	6147	8817	11123	55140	6210	1946	185	51200	197	2040	23034	1363	1147	28511	5743	3985	3137	27236	83638	8683	7124	80329	89845	3569	51460	55072	5595	65082	8398	54916	6362	7037	56667	11343	5995	6775	308	5459	2526
GSE22611_MUTANT_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_DN	M8171		21335489	Billmann-Born S,Till A,Arlt A,Lipinski S,Sina C,Latiano A,Annese V,Häsler R,Kerick M,Manke T,Seegert D,Hanidu A,Schäfer H,Heel van D,Li J,Schreiber S,Rosenstiel P	GSE22611	GSE22611_3474_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in HEK293 cells: expressing mutant NOD2 [GeneID=64127] versus control.	NOD2 is an intracellular receptor for the bacterial cell wall component muramyl dipeptide (MDP) and variants of NOD2 are associated with chronic inflammatory diseases of barrier organs e.g. Crohn disease, asthma and atopic eczema. It is known that activation of NOD2 induces a variety of inflammatory and antibacterial factors. The exact transcriptomal signatures that define the cellular programs downstream of NOD2 activation and the influence of the Crohn-associated variant L1007fsinsC are yet to be defined. To describe the MDP-induced activation program, we analyzed the transcriptomal reactions of isogenic HEK293 cells expressing NOD2wt or NOD2L1007fsinsC to stimulation with MDP. Importantly, a clear loss-of-function could be observed in the cells carrying the Crohn-associated variant L1007fsinsC, while the NOD2wt cells showed differential regulation of growth factors, chemokines and several antagonists of NF-κB, e.g. TNFAIP3 (A20) and IER3.					55295	51181	1178	4360	80034	79365	2517	8892	1373	26578	4589	51018	2535	6392	11163	10734	6476	3500	64759	10457	22807	1410	23166	341	7136	8366	30837	100129250	51668	64067	51555	23380	51816	80324	84560	80304	23508	221395	10516	7371	55732	79676	4133	55211	57597	9629	56986	100287697	7220	144404	10467	8434	1653	6657	64180	386627	64123	6570	10106	201254	23051	28972	51133	79631	2159	22843	23646	64743	7507	1607	4832	23362	10321	79805	644450	83714	10402	4023	7318	26298	2538	2797	54875	55812	2771	9711	6187	1396	2515	6343	5979	3718	873	2572	80204	9356	55086	55178	3292	51686	79789	23759	139081	1677	9282	10018	9555	2203	1364	23743	4134	56897	9633	55037	51755	55876	53353	222255	1841	60343	3642	53832	56928	4829	6783	4146	384	57175	60488	3339	80128	6369	60529	6749	6663	254531	4105	55613	2036	6102	80262	1555	2823	8727	5433	26046	63967	83450	3959	11063	2099	1295	1153	23059	25972	81691	85459	228	9706	6499	54785	2775	7534	84124	3594	55857	5024	3817	10558	125058	5412	671	28992	22986	8368	83990	8644	7846	4605	2641	283683	56899	5969	100293679	57403	5682	9746	79774	27136	56521	10186	30850	5166	5470	8633	7782	29075	51152	9475	23493
GSE22611_UNSTIM_VS_6H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_DN	M8173		21335489	Billmann-Born S,Till A,Arlt A,Lipinski S,Sina C,Latiano A,Annese V,Häsler R,Kerick M,Manke T,Seegert D,Hanidu A,Schäfer H,Heel van D,Li J,Schreiber S,Rosenstiel P	GSE22611	GSE22611_3477_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in HEK293 cells over-expressing wildtype NOD2 [GeneID=64127]: untreated versus muramyl dipeptide [PubChem=11620162] for 6h.	NOD2 is an intracellular receptor for the bacterial cell wall component muramyl dipeptide (MDP) and variants of NOD2 are associated with chronic inflammatory diseases of barrier organs e.g. Crohn disease, asthma and atopic eczema. It is known that activation of NOD2 induces a variety of inflammatory and antibacterial factors. The exact transcriptomal signatures that define the cellular programs downstream of NOD2 activation and the influence of the Crohn-associated variant L1007fsinsC are yet to be defined. To describe the MDP-induced activation program, we analyzed the transcriptomal reactions of isogenic HEK293 cells expressing NOD2wt or NOD2L1007fsinsC to stimulation with MDP. Importantly, a clear loss-of-function could be observed in the cells carrying the Crohn-associated variant L1007fsinsC, while the NOD2wt cells showed differential regulation of growth factors, chemokines and several antagonists of NF-κB, e.g. TNFAIP3 (A20) and IER3.					1070	158471	8613	57823	55776	4323	11221	3417	140803	51564	51101	51427	2960	4784	55274	22841	6447	9373	22853	5319	4708	25996	9659	54629	1184	6229	28823	79991	57716	23262	79364	51466	54987	5836	29078	23168	1983	170960	49855	84196	1606	79876	51301	962	10101	51554	822	1161	7389	1102	5446	856	126231	9103	9467	968	3454	5905	55617	140290	10148	55697	90326	64976	1448	5369	23228	687	3708	10388	9654	3420	26031	9946	6362	10950	196743	4312	56300	8019	54780	8767	10840	9910	9541	285282	10007	26040	64132	205	10161	4907	10234	30008	213	3442	4172	4886	9687	1984	6492	1392	8878	9021	65003	79415	2900	6364	3860	55907	9968	23491	29125	22839	54482	2580	55198	490	51320	8568	1230	6005	5016	10949	89910	545	23007	9696	3597	56107	6636	9684	6569	89797	51704	4548	9134	11000	7204	1200	23657	8996	5524	53615	91647	6868	5196	834	5861	25861	5337	3638	9437	7077	81621	5000	10884	29015	958	1476	6714	23764	5027	2145	5566	5004	730101	100287076	23187	2253	1906	27288	29063	26099	9034	9704	79784	79572	51149	23645	6375	55315	59272	23136	441151	26034	6541	283459	3916	960	9322	23142	8877	11148	284649	6515	1892	22873	5394	4891
GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_2H_DN	M8174		21335489	Billmann-Born S,Till A,Arlt A,Lipinski S,Sina C,Latiano A,Annese V,Häsler R,Kerick M,Manke T,Seegert D,Hanidu A,Schäfer H,Heel van D,Li J,Schreiber S,Rosenstiel P	GSE22611	GSE22611_3840_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in HEK293 cells at 2h after stimulation by muramyl dipeptide [PubChem=11620162]: over-expressing mutant NOD2 [GeneID=64127] versus control.	NOD2 is an intracellular receptor for the bacterial cell wall component muramyl dipeptide (MDP) and variants of NOD2 are associated with chronic inflammatory diseases of barrier organs e.g. Crohn disease, asthma and atopic eczema. It is known that activation of NOD2 induces a variety of inflammatory and antibacterial factors. The exact transcriptomal signatures that define the cellular programs downstream of NOD2 activation and the influence of the Crohn-associated variant L1007fsinsC are yet to be defined. To describe the MDP-induced activation program, we analyzed the transcriptomal reactions of isogenic HEK293 cells expressing NOD2wt or NOD2L1007fsinsC to stimulation with MDP. Importantly, a clear loss-of-function could be observed in the cells carrying the Crohn-associated variant L1007fsinsC, while the NOD2wt cells showed differential regulation of growth factors, chemokines and several antagonists of NF-κB, e.g. TNFAIP3 (A20) and IER3.					27328	6098	4139	1829	199731	246176	9843	1740	79953	107	403314	6003	55130	79258	3890	1951	93	11254	4091	56961	146852	116443	2781	1641	7224	56000	5026	196410	5646	1807	51252	79740	29106	8975	3950	389075	131920	162494	143279	116442	29765	15	79789	4585	30818	6725	65009	150483	90161	154865	389125	23141	79412	1237	3207	117	11149	54810	283455	1991	2565	9048	1133	3447	83698	8224	2328	83450	51335	222008	115399	3204	339983	685	254263	6457	2249	3562	4143	151254	56704	2028	5205	143241	142685	646019	2774	83447	644168	11000	29881	3752	84254	23677	10814	222865	64084	79957	9172	1394	63904	146212	10911	255189	140732	9884	3589	118856	8503	9152	7287	386618	65266	343413	340024	28	3738	775	286676	11061	57379	84700
GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN	M8175		21335489	Billmann-Born S,Till A,Arlt A,Lipinski S,Sina C,Latiano A,Annese V,Häsler R,Kerick M,Manke T,Seegert D,Hanidu A,Schäfer H,Heel van D,Li J,Schreiber S,Rosenstiel P	GSE22611	GSE22611_3476_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in HEK293 cells expressing mutant NOD2 [GeneID=64127]: untreated versus muramyl dipeptide [PubChem=11620162] for 2h.	NOD2 is an intracellular receptor for the bacterial cell wall component muramyl dipeptide (MDP) and variants of NOD2 are associated with chronic inflammatory diseases of barrier organs e.g. Crohn disease, asthma and atopic eczema. It is known that activation of NOD2 induces a variety of inflammatory and antibacterial factors. The exact transcriptomal signatures that define the cellular programs downstream of NOD2 activation and the influence of the Crohn-associated variant L1007fsinsC are yet to be defined. To describe the MDP-induced activation program, we analyzed the transcriptomal reactions of isogenic HEK293 cells expressing NOD2wt or NOD2L1007fsinsC to stimulation with MDP. Importantly, a clear loss-of-function could be observed in the cells carrying the Crohn-associated variant L1007fsinsC, while the NOD2wt cells showed differential regulation of growth factors, chemokines and several antagonists of NF-κB, e.g. TNFAIP3 (A20) and IER3.					7091	51084	29015	92140	8728	79932	4947	9129	406	23054	84859	8533	2768	11140	942	5978	56894	128239	9871	55153	10615	25961	1662	84246	55041	10483	822	23523	86	26019	255488	8563	51474	57804	9510	57118	5218	51773	8540	64092	9739	84464	84164	196527	80124	3735	440275	57412	55361	54832	115727	80216	79877	2280	55705	10982	9797	3156	27229	10019	5917	9750	6938	6873	81609	3988	11222	8520	64101	8737	7409	79050	9091	57461	7174	254170	91452	6731	23534	255967	64398	5264	285527	369	5695	4905	5147	56900	54455	163	6480	26003	55759	57680	9644	3091	351	57187	204851	23185	56950	10670	58533	112939	84844	9559	6499	55275	23310	27097	64764	8525	57620	10513	5095	10106	10495	7110	6924	1452	768211	8578	292	9807	387921	83752	191	2739	8603	2551	1453	22985	5579	8729	65123	8454	26958	23137	7803	705	26993	908	3188	7084	64852	5558	4154	5876	79577	1523	7248	27436	4853	10682	1737	2580	3033	65057	8867	5567	6950	11196	80821	9392	54820	81037	5336	79573	55116	83742	2734	79888	10098	9031	5910	79947	131965	10274	10277	84191	55585	26073	8607	11006	84295
GSE22611_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_2H_UP	M8177		21335489	Billmann-Born S,Till A,Arlt A,Lipinski S,Sina C,Latiano A,Annese V,Häsler R,Kerick M,Manke T,Seegert D,Hanidu A,Schäfer H,Heel van D,Li J,Schreiber S,Rosenstiel P	GSE22611	GSE22611_3479_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in HEK293 cells at 2h after stimulation by muramyl dipeptide [PubChem=11620162]: over-expressing wildtype NOD2 [GeneID=64127] versus control.	NOD2 is an intracellular receptor for the bacterial cell wall component muramyl dipeptide (MDP) and variants of NOD2 are associated with chronic inflammatory diseases of barrier organs e.g. Crohn disease, asthma and atopic eczema. It is known that activation of NOD2 induces a variety of inflammatory and antibacterial factors. The exact transcriptomal signatures that define the cellular programs downstream of NOD2 activation and the influence of the Crohn-associated variant L1007fsinsC are yet to be defined. To describe the MDP-induced activation program, we analyzed the transcriptomal reactions of isogenic HEK293 cells expressing NOD2wt or NOD2L1007fsinsC to stimulation with MDP. Importantly, a clear loss-of-function could be observed in the cells carrying the Crohn-associated variant L1007fsinsC, while the NOD2wt cells showed differential regulation of growth factors, chemokines and several antagonists of NF-κB, e.g. TNFAIP3 (A20) and IER3.					143686	4832	80162	51114	54828	1997	933	23586	54677	11132	1857	3065	124842	90007	9604	55312	19	54331	83985	8027	55850	80315	1368	4084	474344	221692	22978	5830	115992	1384	22806	2841	23221	246754	27230	311	4642	25844	3983	4602	22949	29969	79668	10509	6659	5217	83478	55654	6482	330	54951	22933	4067	976	10231	5649	51147	246175	54827	26051	8408	115361	3096	113263	1616	60343	8372	55729	79837	255252	27086	51466	5734	340061	79137	149951	79666	79845	10659	527	56894	375287	102	3683	1471	3636	9535	1611	406	1958	5880	25829	3916	124790	2799	5244	3660	7805	5883	5330	79874	54861	9249	9342	84988	90634	10066	1236	129607	2138	3433	9917	79770	11264	8328	22839	4520	22918	4046	8907	9451	9990	28962	5777	5869	81704	115350	54939	259230	9275	255394	79585	51439	526	5778	6446	8648	1734	4758	3689	10114	8764	6811	3394	54957	533	22837	7009	5255	7903	10765	51246	29952	64420	6948	92014	2775	201163	30851	81631	1959	51274	8310	255061	5829	9846	64781	283537	9260	29959	9230	4208	659	51135	54472
GSE22611_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_2H_DN	M8178		21335489	Billmann-Born S,Till A,Arlt A,Lipinski S,Sina C,Latiano A,Annese V,Häsler R,Kerick M,Manke T,Seegert D,Hanidu A,Schäfer H,Heel van D,Li J,Schreiber S,Rosenstiel P	GSE22611	GSE22611_3479_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in HEK293 cells at 2h after stimulation by muramyl dipeptide [PubChem=11620162]: over-expressing wildtype NOD2 [GeneID=64127] versus control.	NOD2 is an intracellular receptor for the bacterial cell wall component muramyl dipeptide (MDP) and variants of NOD2 are associated with chronic inflammatory diseases of barrier organs e.g. Crohn disease, asthma and atopic eczema. It is known that activation of NOD2 induces a variety of inflammatory and antibacterial factors. The exact transcriptomal signatures that define the cellular programs downstream of NOD2 activation and the influence of the Crohn-associated variant L1007fsinsC are yet to be defined. To describe the MDP-induced activation program, we analyzed the transcriptomal reactions of isogenic HEK293 cells expressing NOD2wt or NOD2L1007fsinsC to stimulation with MDP. Importantly, a clear loss-of-function could be observed in the cells carrying the Crohn-associated variant L1007fsinsC, while the NOD2wt cells showed differential regulation of growth factors, chemokines and several antagonists of NF-κB, e.g. TNFAIP3 (A20) and IER3.					23516	10723	246213	5822	219927	26121	6513	4856	23450	4953	57510	3613	26355	254531	57705	56479	10243	5214	80222	10797	9446	283871	10572	7064	6484	2030	2887	10598	28957	51018	7290	221472	8502	1154	5163	6509	157506	23085	9377	51477	2987	6390	94025	54890	8668	6748	23481	163351	654321	6541	51409	6720	79102	84154	6723	54475	80324	10146	8165	4049	23511	7804	5211	80351	1327	990	79094	5198	26519	8651	51295	2130	79711	29896	81577	10130	6902	3069	57478	54583	170463	3843	9021	10125	3978	23224	1974	114112	51611	1786	55276	3418	54981	57576	7407	51603	27097	3141	6608	27044	5890	1439	9136	9735	55127	142	3326	9489	25929	1869	4171	55243	84062	23037	1763	10690	63893	51234	83943	5426	790	51522	7027	3099	23160	5093	57099	4363	6184	83440	4157	142940	23533	4924	8482	955	5425	3939	340273	1393	10397	54487	26354	10058	586	5536	55644	516	10534	84172	80755	10525	3313	79918	126789	4191	1337	51559	64397	23195	93621	6634	93408	3921	56915	4830	1407	255231	23223	83879	54865	54974	949	5583	54532	54517	91775	4591	222234	221184
GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_DN	M8208		21411757	Vrzalikova K,Vockerodt M,Leonard S,Bell A,Wei W,Schrader A,Wright KL,Kube D,Rowe M,Woodman CB,Murray PG	GSE27670	GSE27670_3494_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in germinal center B lymphocytes: control versus over-expressing PRDM1 [GeneID=639].	In this study, we have investigated the effect of BLIMP1α on gene expression, cell differentiation and pathogenesis in normal human GC B cells using a non-viral vector based system					54566	6648	148808	2230	2770	7067	89797	666	669	11080	79586	65981	51019	157657	1787	2059	55213	5272	23446	10962	84817	144100	4698	23632	6509	7078	8671	85477	11130	5480	64129	6237	8322	672	10402	1290	9420	54148	51474	8848	1962	23580	55690	8456	1488	3069	1673	54477	50848	80021	8999	2701	1114	1363	28514	1545	8660	2649	9823	22955	4345	9242	10040	100506742	55000	6678	6535	659	1154	10758	159	1489	64397	79971	5954	64506	2743	6713	29965	8614	3214	5314	4008	6382	3491	58476	1073	7113	3625	4493	2690	7436	3312	2767	6495	5179	4430	2028	3912	55500	29099	9958	3320	345611	7058	84246	55971	22998	10628	1534	54206	3836	2730	5395	6309	6711	6118	1738	488	154796	10787	4026	80349	7043	329	53344	138050	27333	3675	5165	8871	54949	2669	8460	81796	6263	5268	79745	1374	4646	214	10923	1948	3554	837	9053	64332	201456	2058	84694	57045	9453	10465	2266	2920	5606	6318	26528	4072	54810	221061	3326	54463	439996	4318	55108	4642	23466	3198	657	6376	1902	4065	10736	79071	57035	3108	23286	5178	1503	8626	390916	3990	254013	1829	51421	55364	5087	286077	255743	55573	2697	9289	5756	288	5074	8543	54065	9804	26520
GSE27670_BLIMP1_VS_LMP1_TRANSDUCED_GC_BCELL_UP	M8209		21411757	Vrzalikova K,Vockerodt M,Leonard S,Bell A,Wei W,Schrader A,Wright KL,Kube D,Rowe M,Woodman CB,Murray PG	GSE27670	GSE27670_3496_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in germinal center B lymphocytes over-expressing: PRDM1 [GeneID=639] versus Epstein-Barr virus protein LMP1.	In this study, we have investigated the effect of BLIMP1α on gene expression, cell differentiation and pathogenesis in normal human GC B cells using a non-viral vector based system					552900	51284	2768	10333	93185	2735	84532	2815	481	131601	1512	735	8829	9210	23179	113	5305	9659	3155	22933	9450	6520	2947	3693	7805	2978	219972	10948	346	23406	5816	338339	974	402778	962	353	5409	2242	4115	79581	3950	9869	1788	7249	23530	222487	5660	10538	28960	23625	5453	1302	404550	6911	26576	112802	2054	1959	4146	1215	10743	56271	51177	3756	5866	6468	56903	377	55509	7305	200350	1814	51043	79618	10999	80820	7275	2799	2990	8985	8986	3418	341	129285	3689	57169	9056	9362	8406	8497	344	79102	5447	55352	83903	8906	55741	23166	2322	2925	5582	53	5336	5865	3241	10057	2629	4225	3038	6569	9737	6347	29956	10316	10610	3785	5338	6478	54	6813	5371	5106	79829	7376	54855	1346	9446	1973	6746	2956	4542	10017	4669	64781	23587	29760	57175	64837	7011	4524	83982	4063	100134934	7087	3663	1536	3055	23423	1293	23048	3071	8263	54976	1039	2065	1839	79142	1525	85460	10533	1144	10043	27090	29	84193	5452	558	10156	6256	3988	348235	5167	7942	5306	51246	53343	7106	373156	3142	9099	79887	2109	6453	1650	122618	79415	51291	5329	3249	10525	140885	1436	3059	1906	949	5293	2896	717	2209	1441
GSE27670_BLIMP1_VS_LMP1_TRANSDUCED_GC_BCELL_DN	M8211		21411757	Vrzalikova K,Vockerodt M,Leonard S,Bell A,Wei W,Schrader A,Wright KL,Kube D,Rowe M,Woodman CB,Murray PG	GSE27670	GSE27670_3496_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in germinal center B lymphocytes over-expressing: PRDM1 [GeneID=639] versus Epstein-Barr virus protein LMP1.	In this study, we have investigated the effect of BLIMP1α on gene expression, cell differentiation and pathogenesis in normal human GC B cells using a non-viral vector based system					79071	201895	10240	79810	1787	2319	79575	6489	682	54520	51550	138050	2356	55500	6510	2271	8660	6730	2051	84516	7095	5897	23743	58533	3164	1633	9127	4686	51571	26073	11123	23309	3140	23462	79745	3340	7922	57017	10228	10329	9133	951	23380	3421	51019	3069	94101	11169	64324	60493	124997	4124	9694	4286	5921	57609	1287	8671	5888	6376	9274	118980	29902	8079	55156	10449	9420	8427	5096	1912	4296	55186	51226	4001	23433	64333	3978	10724	94081	23317	29956	9308	23633	1399	92335	255743	54566	6323	51699	4524	57153	4926	79819	5165	23054	83706	6560	51479	6602	2743	4209	79882	51466	829	3090	7046	23457	2309	6737	84817	51497	23369	84881	10006	5867	23530	51025	445	10198	9403	11156	10360	6382	6237	1902	11260	9126	990	57446	3199	51564	2649	8502	162	10954	824	51639	5594	1454	5316	80349	5709	23554	377	3932	7328	153830	10576	79971	64397	55568	5428	11103	5090	10465	345611	6392	552889	1265	1212	55049	6660	5255	54472	1489	84858	646	29968	9213	22955	57678	6643	25941	2055	2079	9908	10426	5580	80335	4065	5089	51474	4354	2551	10923	80781	144100	401115	8635	54780	5394	10436	10867	3632	923	594	8453	25996	64116	28984
GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_UP	M8212		21411757	Vrzalikova K,Vockerodt M,Leonard S,Bell A,Wei W,Schrader A,Wright KL,Kube D,Rowe M,Woodman CB,Murray PG	GSE27670	GSE27670_3494_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in germinal center B lymphocytes: control versus over-expressing PRDM1 [GeneID=639].	In this study, we have investigated the effect of BLIMP1α on gene expression, cell differentiation and pathogenesis in normal human GC B cells using a non-viral vector based system					552900	91461	4241	4486	5630	3858	29952	475	65003	64283	1109	6700	5340	5159	27063	4084	3700	8835	7135	114	1080	7105	113878	5476	7373	3949	22926	837	3375	200931	6346	4543	767	54460	8618	757	922	8809	165530	51510	84418	6523	1380	5407	1394	4948	6445	25803	8174	100129128	80305	3046	9517	10505	5055	646480	1293	6712	5337	4793	4744	6833	1201	6580	1180	25833	4321	26286	5284	8842	118429	6559	94121	81671	306	6446	399665	9446	55079	3055	3169	5187	10219	1973	3950	595	2990	1437	4070	79581	80021	3929	608	203228	3294	242	1508	5744	3592	5575	7252	56172	84798	55089	2019	6447	84246	3642	1066	1999	65009	6776	1583	3604	64093	2662	55352	83787	2952	3860	59345	1039	201456	10804	124925	351	347	3892	10158	797	7293	126208	1264	7021	8869	25777	6013	123920	2147	6279	10769	4035	8803	389075	64747	65055	124872	79188	1512	5589	6506	51079	56985	4852	4058	29760	2166	55312	9709	57142	5721	4828	84560	126	1992	660	2001	1409	6556	7185	3489	229	2203	90019	1308	1030	9791	55119	3938	5806	114785	2208	54855	4951	3890	4062	85462	27285	4645	54539	4118	8404	285	7216	10563	7783	3848	7480	6256	5321
GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_UP	M8216		21411757	Vrzalikova K,Vockerodt M,Leonard S,Bell A,Wei W,Schrader A,Wright KL,Kube D,Rowe M,Woodman CB,Murray PG	GSE27670	GSE27670_3495_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in germinal center B lymphocytes: control versus over-expressing Epstein-Barr virus protein LMP1.	In this study, we have investigated the effect of BLIMP1α on gene expression, cell differentiation and pathogenesis in normal human GC B cells using a non-viral vector based system					1164	4973	6252	9939	4084	54206	3791	3204	837	23344	55615	6261	54437	3671	3990	2820	200350	2027	5407	202	80331	59345	3081	163590	7545	10556	689	57019	597	6432	2054	375757	9878	5720	57169	51599	7124	6275	1144	101	329	83892	6517	6156	64218	784	319	6584	2997	1479	64951	8482	4793	8438	1030	3394	4791	10783	2261	3663	8460	6525	3824	3613	337867	5371	5743	164	672	9212	3312	6404	388585	6696	1852	7979	27000	6415	222658	2014	26286	3109	290	54477	50848	23327	729230	8728	55509	90780	9111	6602	6697	10465	440689	10954	5729	3094	5892	3123	4321	6170	7481	2798	23070	65009	57657	1488	8745	8906	51091	3662	9519	84324	517	3601	5423	50807	2312	5218	84817	51074	25830	79668	8994	2905	259307	55589	4605	257236	55859	1351	8914	29933	10432	10769	10092	983	84824	1026	2729	9076	4610	389084	6134	1385	5763	51031	5558	55661	11344	5087	29943	51647	4982	4733	928	2829	84833	90701	10797	6514	7453	11179	9945	54148	595	10439	3188	5931	757	150572	7293	7832	11274	56605	25953	4600	4092	51177	340348	5687	249	23683	995	9319	7153	2281	10923	10412	9476	56139	6118	9032	3108	5518	23636	2271	350	55723
GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_DN	M8217		21411757	Vrzalikova K,Vockerodt M,Leonard S,Bell A,Wei W,Schrader A,Wright KL,Kube D,Rowe M,Woodman CB,Murray PG	GSE27670	GSE27670_3495_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in germinal center B lymphocytes: control versus over-expressing Epstein-Barr virus protein LMP1.	In this study, we have investigated the effect of BLIMP1α on gene expression, cell differentiation and pathogenesis in normal human GC B cells using a non-viral vector based system					1441	1293	10845	7109	3033	29924	50650	8404	117581	10455	3223	388	84247	2947	3631	6007	10801	10965	2065	10871	2043	3761	23175	1302	4211	2549	3069	3158	6640	51284	9159	6014	55852	64342	9191	57685	2052	30815	109	1515	8727	1401	4162	84258	138050	55186	23371	4040	3586	23474	23400	9892	9978	81622	4878	7172	134147	158586	7067	51611	118980	79618	23646	6837	279	64781	84947	9249	83871	140885	23600	8729	6556	5830	28514	6835	5360	51661	211	27285	338339	54520	201456	23530	114790	3280	873	23179	57465	2309	955	717	9659	5880	79137	29085	2677	80728	1371	5337	1397	9099	5269	10518	1215	11260	6468	5641	718	6015	58529	11153	84284	4609	5127	7037	54899	1179	4131	201163	286	121599	3693	9935	714	3162	98	3429	51084	8722	54934	8829	51429	51310	5159	1291	55818	5452	7570	55176	4524	404550	53	10610	7078	4008	2017	1508	5900	9518	7024	10060	51	3140	10128	28981	9145	7498	89797	922	2067	2167	7376	339929	3241	7106	2015	8613	6916	348	114785	1832	65244	2624	5025	6497	9056	3915	1892	146198	4354	4026	23654	10038	83985	56246	57619	254013	537	25	10333	24142	114879	5866	222487	131601	920	28970	4035	11328
GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP	M8298		21551231	Ghisi M,Corradin A,Basso K,Frasson C,Serafin V,Mukherjee S,Mussolin L,Ruggero K,Bonanno L,Guffanti A,Bellis De G,Gerosa G,Stellin G,D'Agostino DM,Basso G,Bronte V,Indraccolo S,Amadori A,Zanovello P	GSE26156	GSE26156_3497_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in thymocytes: double positive versus CD4 [GeneID=920] single positive.	Gene expression of Double Positive, and Single Positive CD4+ human thymocytes					10123	6167	3590	9802	51669	23224	9267	8476	6210	9043	6202	23201	4335	8398	9929	919	8225	6234	8710	8519	6137	4118	9095	3674	26053	6235	25976	6164	374	7013	4925	6431	113791	6161	5934	9697	11236	57460	8666	6224	2260	6207	53335	7832	9905	9976	9924	5187	10983	54741	23263	2217	7846	837	10693	22883	1649	10614	9987	9605	8227	3964	10049	6169	678	6160	55544	9846	26105	6206	3133	81550	23240	3916	5333	338	9819	6228	7096	1647	5903	6901	6146	115	6159	9550	22990	7182	4616	8379	10561	5142	8525	29851	3300	1153	9584	7593	10628	22821	23541	688	10178	23645	694	6135	11143	9374	845	9958	6309	6386	54861	92	23067	9760	6446	3696	7204	3726	23568	10014	3008	6932	23710	9873	4601	11043	100	28793	23484	7318	2572	3655	23506	5176	7247	1654	23370	275	54629	2137	1521	6156	6134	51035	26999	8675	8507	10402	5568	6218	26020	26054	11119	7169	9214	4496	6653	6001	2051	6233	6809	166	10174	3959	1839	7048	1112	2648	3727	5996	4952	4502	23324	5204	120	22861	1974	7178	9701	663	80003	1236	3188	10956	26751	3707	5080	6158	5467	138046	3575	92482	1831	1390	7320	5588	4050	4832
GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN	M8299		21551231	Ghisi M,Corradin A,Basso K,Frasson C,Serafin V,Mukherjee S,Mussolin L,Ruggero K,Bonanno L,Guffanti A,Bellis De G,Gerosa G,Stellin G,D'Agostino DM,Basso G,Bronte V,Indraccolo S,Amadori A,Zanovello P	GSE26156	GSE26156_3497_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in thymocytes: double positive versus CD4 [GeneID=920] single positive.	Gene expression of Double Positive, and Single Positive CD4+ human thymocytes					79022	7531	8933	4830	2030	3939	7157	1965	622	3703	3418	3902	3068	10606	191	7415	80867	3611	9322	6652	8682	1846	2058	4172	8566	10573	891	8772	10989	6790	5052	10449	10245	3185	308	51603	3326	967	1622	1175	10969	1293	8935	1429	10227	10036	2633	8803	3151	8651	10376	3033	10935	171546	2171	1618	6715	26227	8425	8508	4605	10856	3832	7419	27240	4522	10949	5984	8030	27338	4714	4914	23474	1192	22948	54732	55856	3002	8655	9380	5698	9787	995	5831	3281	27341	10473	4134	587	4818	3937	8624	1062	11196	6624	10654	5693	7374	10213	10897	2760	55651	5634	9131	9793	8443	23208	5519	4893	80777	6637	142	4701	6723	2961	3612	10360	27069	6566	1164	11113	7453	2271	2026	9133	2193	908	3161	8317	3485	205	1063	64976	3182	11332	10452	10527	11065	4049	5106	10229	7295	5873	3843	4744	7283	518	11169	8458	2146	10456	3833	1033	5436	11144	79921	6352	990	701	5422	3014	2023	4692	1973	8740	1503	5096	1111	4145	5983	5690	439	6510	10318	10615	6905	85458	10617	81	5230	5687	6118	5714	1337	5557	7298	898	9645	5962	22974	6150	1632	7074	1130	6472	10797	475	140465	5347	2237
GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_VA24NEG_NKTCELL_DN	M8303		21632718	Constantinides MG,Picard D,Savage AK,Bendelac A	GSE28726	GSE28726_3366_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in naïve T cells: CD4 [GeneID=920] versus Va24- NKT.	Microarray analysis was performed to determine the transcriptional profiles of NKT, CD1d-aGC+ Va24-, and CD4 T cells.					6473	3985	3741	10948	11199	9311	678	845	11309	688	2319	120	100507436	6494	7128	9019	11247	10013	11143	3148	5837	8517	9048	9892	10401	5470	2980	23526	3700	1577	6870	1606	217	7067	3590	28951	4192	7029	55544	2099	23660	51149	2899	9929	5528	5568	3385	115123	60343	9229	26576	1000	6332	994	7852	51741	23201	2208	9993	25801	2260	56	4163	4926	8787	374	8858	4502	1850	3151	7299	3337	8519	7402	113791	51742	8336	54541	3008	5467	8875	4633	25777	5099	1760	7280	9095	9826	157697	8366	29	5368	4986	1839	639	7096	7554	8971	362	25792	9776	6795	5118	54	1241	26999	10663	10758	54587	9936	148	10871	6899	257407	1513	10235	770	27240	9231	2139	53335	951	27165	8346	3284	1062	4629	8605	3678	10174	5023	3689	27185	8342	4496	7380	66002	5264	40	10628	5639	6653	11151	6821	168544	6234	4150	3727	5600	9080	25956	150094	9744	415	26112	1236	3674	55643	5593	4952	4650	4185	728767	10614	166	22981	100	9697	8476	23067	10869	1565	11223	4170	93	23359	22839	4301	57228	92482	274	1237	5349	5871	2217	4582	5959	7498	5333	6515	5292	3661	8379	10133	9168	393	1649	7169	5362	388699
GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_UP	M8305		21632718	Constantinides MG,Picard D,Savage AK,Bendelac A	GSE28726	GSE28726_3367_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in activated T cells: CD4 [GeneID=920] versus Va24- NKT.	Microarray analysis was performed to determine the transcriptional profiles of NKT, CD1d-aGC+ Va24-, and CD4 T cells.					2023	10190	2181	3595	104	3981	26175	2571	27069	55651	220988	7321	51020	1019	5229	3908	8837	1847	940	10548	7752	23518	51499	5707	4744	65125	11234	10975	3002	4234	10282	10473	7748	10180	7867	8767	79080	6713	113419	4860	55644	4141	5378	23244	3554	1622	5552	928	1973	11137	5903	2923	10666	483	3419	10360	84890	27341	292	5694	5134	7327	10528	10920	27292	5515	356	23150	6632	4772	90861	8803	2395	6434	10902	391	3837	6118	55922	9987	27074	4023	1964	9841	7124	8838	3052	9183	6749	10775	4145	10907	8672	8420	10440	7374	2787	26574	9844	4907	5954	8425	23269	3097	2824	27340	3422	9112	3939	27348	10376	4289	11325	3937	9816	10651	4830	81565	5713	4927	22911	6723	22856	4942	6621	2961	79888	5036	5693	8505	23279	7419	5501	10054	8886	27161	23022	7415	5315	4282	10923	8439	6059	54499	10787	22800	9194	10046	3251	8099	9470	10989	10982	8682	55559	3553	5538	3185	10525	5230	7295	2963	9014	10067	51096	79017	7936	29889	23107	11097	8225	23511	5436	1827	5691	10898	2288	1371	7266	3604	10954	2521	4783	6183	9724	23640	2030	26123	81875	6364	7626	830	171546	3183	6310	55621	11336	1070	2632	4836
GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_DN	M8306		21632718	Constantinides MG,Picard D,Savage AK,Bendelac A	GSE28726	GSE28726_3367_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in activated T cells: CD4 [GeneID=920] versus Va24- NKT.	Microarray analysis was performed to determine the transcriptional profiles of NKT, CD1d-aGC+ Va24-, and CD4 T cells.					9802	120	26053	1107	166	8106	9267	8661	7128	10049	26959	23568	2194	25957	64112	10018	9231	23224	23345	3707	10209	3590	6653	23370	23506	4502	3655	5142	9905	6431	23324	7846	9516	6386	2137	824	4154	7852	7832	10628	217	10270	1850	6670	1649	9993	10482	9846	2319	6160	9584	9776	8556	3133	9349	8227	3726	1059	25777	51669	4925	6844	7805	7247	9819	6169	4118	1655	951	6210	6161	51176	1513	57493	113791	6932	25900	1654	6901	552889	9697	4240	9214	7327	26751	2533	7280	1647	7534	10123	7318	374	4832	9881	5786	9741	6232	3021	23263	51465	837	10140	23526	3674	1519	5298	26112	7375	3337	5871	5552	55544	4170	3964	6659	5863	23484	801	2051	10847	994	1153	5903	54861	6155	9589	1200	22890	55251	10178	55233	1901	694	283755	55623	6924	85453	22981	3916	2874	8875	1982	9813	7048	23067	51112	23338	427	53335	2131	5997	3575	23524	5080	5775	1112	1998	5996	9701	7593	9806	28951	1880	1983	54014	126299	9873	81550	10235	10402	11143	10561	7799	10014	84901	65258	26052	157680	2959	57019	10188	5144	9736	8971	5128	489	3983	23378	393	6942	26065	54555	10904	8312	1201	6235	2043	3669	10424	23002
GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_VA24NEG_NKTCELL_UP	M8308		21632718	Constantinides MG,Picard D,Savage AK,Bendelac A	GSE28726	GSE28726_3366_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in naïve T cells: CD4 [GeneID=920] versus Va24- NKT.	Microarray analysis was performed to determine the transcriptional profiles of NKT, CD1d-aGC+ Va24-, and CD4 T cells.					2026	1965	622	10376	1063	1192	16	79022	4144	10797	1019	378708	3326	3028	191	3611	23150	9232	1163	27240	3902	6472	4171	4751	8317	7185	80777	4830	2876	1495	8553	4522	23208	7157	10360	10969	10606	3485	22974	8933	55215	22948	6119	6282	2030	891	3832	7419	11332	6652	9645	1351	5983	5873	5315	6790	7298	5425	8364	51043	5270	2171	2999	8566	1337	226	6723	26227	5052	5106	2787	5557	7004	5687	200081	9133	2584	8624	1717	4817	7153	2193	3155	890	10592	9768	8837	10452	10935	2710	5230	10856	5606	84986	9700	2821	10456	2146	8449	9371	466	5831	1632	81620	7436	8819	81691	4282	2632	1719	2023	3161	4783	7283	7272	283459	3487	4173	84140	6567	7416	6870	2950	9040	5872	4605	27338	8530	1312	7225	6619	10617	3615	3157	7064	4582	6241	23397	8726	10227	8807	3558	51517	552	8099	3939	4289	701	990	7074	7083	9782	4361	3833	9918	6855	587	4860	1164	2585	10635	475	4701	8676	11260	9521	1978	1033	3426	7293	5892	10403	5130	230	10768	3604	11001	9532	23139	586	3329	8458	8914	983	440	894	4818	5427	8443	5698	8318	2717	25828	11344	10954	7167	6319	4172	51360	11004
GSE28726_NAIVE_VS_ACTIVATED_VA24NEG_NKTCELL_DN	M8309		21632718	Constantinides MG,Picard D,Savage AK,Bendelac A	GSE28726	GSE28726_3363_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in Va24- NKT cells: naïve versus activated.	Microarray analysis was performed to determine the transcriptional profiles of NKT, CD1d-aGC+ Va24-, and CD4 T cells.					6899	770	5346	3087	93	8705	4303	8710	5470	60343	8366	946	79095	2319	1606	7852	6870	81578	3674	3284	113791	7262	51742	6473	23264	1717	11031	11113	359	9706	5528	1000	80765	9380	11309	10174	9826	100507436	51149	10628	3846	7299	4887	9993	55544	7727	257407	23263	5467	51517	688	8676	8858	728215	9827	23149	3641	10663	11077	5187	5099	2099	11143	2980	3234	1577	5349	9045	40	4832	4293	27240	6309	26018	6694	994	10408	157697	26105	1521	10871	4829	25792	2648	3337	5476	4952	5600	8532	55251	9214	10481	7318	10391	1734	8875	4360	435	7498	28793	3207	28951	1630	2137	9080	8605	51350	9095	11040	11247	5308	5082	10401	9049	23205	388	8344	51741	1647	3614	6453	5080	7597	55558	22985	7554	140885	57798	2516	4597	2020	23660	94039	653808	8698	4646	415	412	11277	57460	3726	51347	55643	26115	5026	728767	1757	1565	89845	51043	8476	3955	5595	10758	1401	10612	5176	284439	10869	7169	9148	25830	1536	1907	4633	9170	622	388699	7247	168544	5837	1953	23061	4747	10614	5746	221749	10249	7056	4502	5261	3818	23495	11199	362	10165	30	5959	5292	51560	9980	1087	8618	7380	64405	1360	6482	23769	5362	9130
GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_NKTCELL_UP	M8310		21632718	Constantinides MG,Picard D,Savage AK,Bendelac A	GSE28726	GSE28726_3364_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in naïve T cells: CD4 [GeneID=920] versus NK.	Microarray analysis was performed to determine the transcriptional profiles of NKT, CD1d-aGC+ Va24-, and CD4 T cells.					10548	8439	8682	10920	9816	23160	2237	6617	7095	2672	1192	467	4595	3981	490	2553	9724	3097	23212	959	928	356	11234	10606	7321	200081	196	5055	10376	7748	8760	9456	7280	2787	51406	10436	25940	81565	5552	8809	10492	10797	10252	2876	7531	349152	10528	8504	22911	643314	9948	3556	6675	23217	8864	1965	6670	6868	5515	56902	7408	80055	7158	7791	8034	27348	8140	55322	6102	10473	3423	962	3281	3182	6804	813	3612	11127	2551	10302	22800	23683	5606	1847	25945	8425	8728	3937	1503	1977	6185	57050	4790	5270	4800	27341	1476	2181	5822	5450	6351	2633	9043	760	23126	10575	5810	10768	2124	7185	4780	7846	5133	4296	5355	6364	2286	1959	391	1982	4345	54838	23002	915	2744	1960	7372	9765	26039	79161	9221	10989	2146	8882	81855	5693	8655	6001	6624	4682	5223	54732	4145	6637	27243	597	965	5052	10527	2026	7936	9986	8030	8870	1687	9014	10982	7283	3662	9859	6009	57403	5903	29851	54205	9604	6674	23135	7266	8690	9637	8837	2770	10923	55832	908	55884	5914	8905	127703	387263	5713	4289	805	6282	26175	51096	262	7431	23035	22876	3212	2597	5198	2012	3909	81875	523	4772	6311
GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_NKTCELL_DN	M8311		21632718	Constantinides MG,Picard D,Savage AK,Bendelac A	GSE28726	GSE28726_3364_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in naïve T cells: CD4 [GeneID=920] versus NK.	Microarray analysis was performed to determine the transcriptional profiles of NKT, CD1d-aGC+ Va24-, and CD4 T cells.					9400	54474	6899	120	49	10401	7402	5026	11240	8366	25956	8618	11031	3741	678	10663	4147	3700	3590	5368	1647	5568	3397	93	5595	1606	23149	7276	5346	2139	5528	23526	3674	1045	199	9826	7262	3727	3655	3148	9267	8710	10758	274	26999	8519	4301	23263	51149	8858	3337	9776	9993	9788	374	1649	28951	5261	5662	23660	22924	23370	10174	4303	2020	9706	3726	3385	2099	22990	10614	10013	5187	359	54587	54	4633	3087	6387	9846	3284	3151	4926	7096	4240	9060	64405	51742	3630	26145	7299	113791	9311	56998	8535	5600	2986	1117	22992	51517	55643	5211	1513	2994	5467	10869	362	27185	284439	3885	946	435	55544	5806	10628	3959	8698	113177	7542	4170	140885	11065	217	9080	770	10133	57228	5396	3768	8705	6494	11199	2217	10879	221749	81544	25801	10871	11277	994	8556	11151	9028	60343	2213	8787	166	1577	5176	5871	1360	3995	5099	8555	10235	1815	2593	10140	2260	8557	4650	9672	275	5199	5333	63940	7498	28232	2626	3202	4952	154	1512	23067	6284	3689	3955	4115	3083	10410	6515	9918	2185	27240	22981	1953	26112	1001	2100	8312	845	2319	9516	2208	8476	7852	3990	5476	5336	2261
GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_UP	M8312		21632718	Constantinides MG,Picard D,Savage AK,Bendelac A	GSE28726	GSE28726_3365_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in activated T cells: CD4 [GeneID=920] versus NKT.	Microarray analysis was performed to determine the transcriptional profiles of NKT, CD1d-aGC+ Va24-, and CD4 T cells.					2023	9603	26175	2181	6789	7321	2571	8728	1019	5983	1847	11234	10473	220988	6119	5713	5707	7748	6001	3554	7327	8439	10920	11154	104	5538	6732	51020	23518	9816	5694	5984	55832	5134	8668	2521	2923	56005	6434	9043	6949	90861	9112	5954	940	4141	51499	27042	356	25988	2030	3002	80777	10376	4772	10775	8225	7752	6392	79080	1622	5501	9987	523	10282	55922	5436	821	6351	23517	6723	55651	6617	6717	23507	5515	3843	6670	5481	8553	8669	10902	10067	65125	3052	1718	55644	4864	2787	8837	10440	2770	7419	27292	10190	10058	11325	6185	10204	7295	10856	23203	4790	9844	6118	127703	4907	50628	200081	8803	6183	27161	2961	4234	2271	1737	5873	10575	81565	2017	79888	3939	10525	25814	4726	65220	4830	23022	27341	7264	262	22876	8682	4869	6621	53615	26747	3097	6631	9657	8099	6310	23499	84890	79161	10907	2180	9456	1960	23107	5230	27348	10982	79017	23450	3185	81875	7416	5550	26574	23279	27074	4927	8807	7124	3553	6650	10428	8454	3422	7133	5315	80055	4800	8504	1130	9859	25974	2171	9582	1642	7431	3326	8886	9841	3251	2597	7167	22800	7867	4817	10923	54674	10252	4289	10197	3559	9326	6282	404672
GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_DN	M8313		21632718	Constantinides MG,Picard D,Savage AK,Bendelac A	GSE28726	GSE28726_3365_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in activated T cells: CD4 [GeneID=920] versus NKT.	Microarray analysis was performed to determine the transcriptional profiles of NKT, CD1d-aGC+ Va24-, and CD4 T cells.					7178	114034	51669	1107	166	7128	1153	64112	9267	8525	26959	51465	23370	10209	8336	6653	9263	8227	9905	7846	1655	6304	120	5937	4335	9993	3916	3590	10049	6160	11236	6431	5515	6386	7852	801	8517	1487	7013	53335	6159	9776	54861	955	9095	22992	92482	11143	23295	9697	1649	51112	26751	10018	10482	4118	23240	3707	84364	552889	81578	56948	5552	23526	23568	6446	10123	10408	4925	9550	3202	8312	9516	1606	9214	6625	55968	2217	10291	25956	1901	9584	10188	10140	23338	7318	2051	5934	5993	5142	7832	3572	51347	10472	9924	9929	8705	4926	8648	1540	5144	23506	6793	10014	9986	22924	8556	4299	3655	28951	393	150094	51035	57460	9774	10235	6232	26053	9874	84901	951	7169	6168	26112	6748	8559	3716	1647	3726	7320	3983	2874	9589	11043	3133	9987	2495	10402	3188	8971	256987	3337	8661	5996	94039	55544	5997	1201	3021	6235	7247	4601	7249	57493	100	6515	6204	5903	1195	6827	10424	1997	9873	837	8698	4489	23355	7430	57019	7535	26065	10423	7805	1263	10628	1200	3187	5588	22838	10758	2533	10904	126299	11054	283755	6430	9057	5920	55818	6169	55623	1850	4124	23258	25957	26105	5187	694	3189	3635
GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_DN	M8314		21632718	Constantinides MG,Picard D,Savage AK,Bendelac A	GSE28726	GSE28726_3361_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells: naïve versus activated.	Microarray analysis was performed to determine the transcriptional profiles of NKT, CD1d-aGC+ Va24-, and CD4 T cells.					4830	4893	1437	1019	9156	3939	1965	2020	16	1312	8438	9787	8553	6472	9212	2876	1846	10808	10606	8819	1337	8676	55120	6364	80777	8364	890	26227	5052	2950	4744	891	4605	10969	1192	11113	23176	191	7272	3832	7298	1063	22948	23191	79022	10856	4049	5270	10573	1495	1796	9232	6019	5315	8624	5606	2821	10935	9768	4173	4013	5106	4174	3604	1718	4860	378708	2787	552	3151	5326	4282	9837	10452	9179	5230	6352	6723	27165	4171	3485	10635	622	3558	5873	4288	7415	4361	6387	55215	2999	2023	6870	9521	1351	7064	995	6183	990	9133	10768	5425	10654	967	7453	25941	22974	3843	5355	2171	81	10617	9700	8740	5111	226	23179	9833	1607	9706	3958	38	5276	5528	25974	1164	466	8836	672	1503	7124	5691	11144	3028	2146	5686	4023	2271	6790	5698	100287387	991	2026	813	5336	9801	6241	283459	6150	7074	1676	1622	3956	404672	405	9918	4783	25804	11169	2651	4521	6510	23380	1130	2184	3002	7531	8530	23404	9604	8318	7372	9371	27338	3157	4144	55353	3615	2237	5687	7283	9322	5213	4172	27295	10527	1033	10058	6652	11332	8566	6282	10592	9645	11065	3662	11344	1719	5763	10376
GSE28726_NAIVE_VS_ACTIVATED_NKTCELL_UP	M8318		21632718	Constantinides MG,Picard D,Savage AK,Bendelac A	GSE28726	GSE28726_3362_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in NKT cells: naïve versus activated.	Microarray analysis was performed to determine the transcriptional profiles of NKT, CD1d-aGC+ Va24-, and CD4 T cells.					770	8710	688	79095	11113	8366	9993	9048	9170	60343	4829	10628	2319	2260	7852	9936	11143	84140	10445	3337	8676	1647	26707	7727	93	2020	9918	1606	8698	7067	9780	5528	2139	5662	57798	3955	51517	11184	8605	4832	54039	284439	3614	5871	28951	30	64405	1360	6387	5319	7169	5467	25792	284001	3397	11277	26145	362	8396	7318	7345	5292	23769	1577	1106	113791	6288	9697	8344	27240	11240	57228	100	26576	3726	2821	5600	9049	5837	283755	1001	22974	6446	55544	8346	25777	5179	23085	5649	5211	3630	6309	1565	3083	11247	489	5080	8557	3689	4913	138046	7168	3112	8517	2099	23541	7597	157697	23149	23474	5346	1953	1059	622	9826	2986	728767	11031	51208	8532	4192	10408	5073	94039	27295	2342	7029	2648	9862	9380	51149	7162	5595	11027	1087	7247	2980	10013	9045	3300	84148	9214	4325	6677	23062	10401	81544	6332	9168	217	1536	2208	678	23067	5333	22821	23205	5463	5187	3248	6550	23251	8787	150094	64135	4669	51741	23613	1521	8618	2950	148	9706	6855	6473	5365	89	9060	2899	221749	6640	11213	415	9355	9473	23378	6482	22869	56998	4902	10869	55643	1831	115	146542	9400	23543	3202	6659	26048
GSE28726_NAIVE_VS_ACTIVATED_NKTCELL_DN	M8319		21632718	Constantinides MG,Picard D,Savage AK,Bendelac A	GSE28726	GSE28726_3362_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in NKT cells: naïve versus activated.	Microarray analysis was performed to determine the transcriptional profiles of NKT, CD1d-aGC+ Va24-, and CD4 T cells.					79161	6789	1965	23212	6119	6001	7321	4289	597	8809	4800	3556	8690	490	8807	23141	7095	10302	5606	3475	391	8837	8767	71	9208	196	7748	8504	8772	483	10252	523	467	9816	8034	4864	5515	2237	2000	7185	3981	2770	7019	5552	2551	959	10213	9724	23126	3185	7531	10949	10527	79888	6670	8611	2146	1476	375	3281	81565	1847	1901	65125	10602	22948	4345	8655	56902	5223	127703	10063	5903	4790	2180	2669	55215	4664	1977	3182	965	4780	760	7280	7225	3566	5810	8140	25940	4860	9878	5229	27161	7430	7419	6675	10768	3612	10597	152559	29889	2961	1839	5326	961	27292	4296	51406	84890	57050	6351	22800	26191	9948	843	10492	23002	9020	10190	26278	5713	80055	5270	9637	54205	91369	2787	23545	26039	22911	10606	22916	8882	10778	8864	26128	10797	2965	29851	1514	2286	5715	6804	8803	27243	9521	7133	10625	6637	8559	7718	55958	7372	7936	607	10418	8870	23022	8030	200081	1982	2672	9595	10935	5693	1192	7699	9667	3558	2553	10436	23082	26286	10219	5355	22856	1959	10018	6103	60312	57403	10432	5707	25945	26175	1960	23279	7347	3937	11234	10383	975	4154	9047	10947	53	29994	6526	93081	10199
GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_UP	M8320		21632718	Constantinides MG,Picard D,Savage AK,Bendelac A	GSE28726	GSE28726_3361_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells: naïve versus activated.	Microarray analysis was performed to determine the transcriptional profiles of NKT, CD1d-aGC+ Va24-, and CD4 T cells.					3985	3008	1647	9929	11151	5261	678	23345	1519	79095	3590	54741	919	23201	3669	6210	1606	2830	845	9170	166	5996	8618	9881	7280	3727	199	6653	10401	8605	2139	11143	951	6932	6224	23526	8366	3385	9788	10188	3148	274	9918	9993	9324	8698	8556	9168	8971	8519	27240	3337	26999	23541	3955	22992	5528	2185	10755	9231	53335	1236	6494	5080	1649	84140	8875	5176	28951	5467	5333	9744	25956	2217	9311	10758	11309	22974	6446	955	6234	688	5641	3959	7805	8525	2533	3655	10663	6208	4303	22821	63940	25792	23506	120	3087	9516	23067	49	10791	4293	10408	3083	54541	23474	7169	4582	2319	409	1513	54587	6164	7373	3397	3630	57326	3678	150094	23263	9980	8342	393	2020	8555	3575	4170	5959	1734	22981	6901	1774	80342	3964	11031	5871	6404	6217	100507436	51149	5099	3983	6482	994	9263	11236	3418	23333	5292	6793	29	57460	23484	6173	10628	5264	9936	113791	10235	1794	57228	4599	26959	81544	22924	9697	4240	2495	9701	10140	1062	10801	6709	3248	3476	100130418	3300	25801	4952	11277	9806	6843	100	6202	7402	9229	7318	8717	23324	8357	1540	6309	284001	4215	55823	51257	5600	6659	6515	25900
GSE28726_NAIVE_VS_ACTIVATED_VA24NEG_NKTCELL_UP	M8322		21632718	Constantinides MG,Picard D,Savage AK,Bendelac A	GSE28726	GSE28726_3363_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in Va24- NKT cells: naïve versus activated.	Microarray analysis was performed to determine the transcriptional profiles of NKT, CD1d-aGC+ Va24-, and CD4 T cells.					8504	7813	2023	10607	55958	84525	6652	8439	2395	7321	10492	9761	1019	1847	10046	51603	26175	9724	2571	11234	6713	2030	1192	10245	23545	10128	3276	10799	4790	91543	10575	51406	80742	3908	79143	10436	4772	80055	7347	79080	104	587	10073	8803	3185	27341	908	56902	1718	23141	2968	8809	6351	26747	10949	8915	26509	7293	56926	10525	8600	9221	4171	5903	5515	2770	23212	6654	1337	6723	27042	3265	200081	6434	4145	292	5450	6364	4860	5831	2058	51690	63826	6621	11336	6119	11014	8454	5606	3604	645961	5315	6902	9603	51020	6566	6050	10058	8666	55651	10063	8034	25940	29889	7023	2153	10653	5860	57050	11260	10768	9841	8225	26031	10308	79888	8099	10200	6059	5106	967	7264	4726	50628	8420	6118	3326	2625	5713	821	8611	158	16	3704	5873	1503	27338	10195	5984	3937	10252	23518	55621	8449	6637	3097	2633	5245	25797	10204	8624	5687	23269	2237	10452	2744	10952	10645	26039	5693	84890	10954	10302	4141	5052	7336	1495	23150	23640	10920	7453	5198	1973	8655	4282	5707	9933	5435	805	5810	10456	6503	2805	55559	6185	9612	3838	4904	6717	29851	4809	10548	6150	7295	1642	9183	5437	51096	10856	8864
GSE22501_PERIPHERAL_BLOOD_VS_CORD_BLOOD_TREG_DN	M8367		21732086	Torelli GF,Maggio R,Peragine N,Chiaretti S,Propris De MS,Lucarelli B,Screnci M,Mascolo MG,Milano F,Iori AP,Girelli G,Guarini A,Foà R	GSE22501	GSE22501_3835_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in T reg from: peripheral blood versus cord blood.	Since the role of cord blood (CB) regulatory T cells (Tregs) for the suppression of the allogeneic T-cell response is under investigation, we analyzed and compared the functional properties and gene expression profile of Tregs expanded from CB units or from the peripheral blood (PB) of helathy donors. Tregs were purified from 23 CB units and from the PB of 13 donors and expanded for 6 days with anti-CD3, anti-CD28 and IL-2. Immunophenotypic analyses were performed, and suppressor activity of expanded Tregs was measured in mixed lymphocyte reaction (MLR) cultures. The IL-10 production capacity was tested and gene expression profile experiments were performed on 6 Tregs from PB and 4 from CB. CB and PB Tregs had similar immunophenotypic features. Tregs from CB presented a higher expansion capacity and genomic characterization showed in CB-derived Tregs a significant enrichments of genes involved in cell proliferation, chromatin modification and regulation of gene expression in CB-derived Tregs. All samples were positive for the Foxp3 gene and protein after expansion. CB and PB expanded Tregs exerted a comparable and potent suppressive function of MLR and presented a high in vitro IL-10 production capacity. Gene profile analysis also revealed for PB Tregs a significant enrichments of genes involved in the adaptive immune response.					1737	9462	22996	10160	5179	6403	5321	23252	57214	3680	2538	5613	5978	6348	9712	6286	2034	3251	9720	1234	6402	5261	6691	10653	7481	115207	6997	6319	65057	10752	4104	7905	9020	57720	6097	7159	2124	6868	8087	6503	1178	55041	5523	23217	23240	8767	1839	5995	3417	11116	2331	23001	3557	4232	3321	2215	1615	3881	10018	6317	1901	10989	55312	3242	1943	5408	5972	4245	1462	3592	3606	6282	677	4942	654	676	6835	80853	22979	84851	2059	28951	389715	9969	2998	7225	8287	6117	9934	6718	3566	7486	10875	5446	3937	9495	6655	54674	9787	241	378708	552	27257	961	55806	6514	4783	157	196993	340591	192683	1880	57035	5732	6386	9486	9847	6278	2977	1237	8651	5791	4811	3077	89944	23768	23013	23358	79109	5770	29957	4711	2056	23318	10675	4744	1938	3586	4684	5803	719	926	2296	4891	462	2672	7363	8349	1181	10326	1021	9407	8545	7494	9815	70	369	10286	6351	3416	6993	206358	10219	22908	23143	162427	8611	8733	6161	100131510	1244	652963	83604	22809	84243	51099	23015	2018	10201	10013	9754	23390	8807	3587	2109	3910	10657	6582	25847	9133	26659	23512	4040	29899	8774	23276	51592	10379	64116	2123
GSE22501_PERIPHERAL_BLOOD_VS_CORD_BLOOD_TREG_UP	M8370		21732086	Torelli GF,Maggio R,Peragine N,Chiaretti S,Propris De MS,Lucarelli B,Screnci M,Mascolo MG,Milano F,Iori AP,Girelli G,Guarini A,Foà R	GSE22501	GSE22501_3835_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in T reg from: peripheral blood versus cord blood.	Since the role of cord blood (CB) regulatory T cells (Tregs) for the suppression of the allogeneic T-cell response is under investigation, we analyzed and compared the functional properties and gene expression profile of Tregs expanded from CB units or from the peripheral blood (PB) of helathy donors. Tregs were purified from 23 CB units and from the PB of 13 donors and expanded for 6 days with anti-CD3, anti-CD28 and IL-2. Immunophenotypic analyses were performed, and suppressor activity of expanded Tregs was measured in mixed lymphocyte reaction (MLR) cultures. The IL-10 production capacity was tested and gene expression profile experiments were performed on 6 Tregs from PB and 4 from CB. CB and PB Tregs had similar immunophenotypic features. Tregs from CB presented a higher expansion capacity and genomic characterization showed in CB-derived Tregs a significant enrichments of genes involved in cell proliferation, chromatin modification and regulation of gene expression in CB-derived Tregs. All samples were positive for the Foxp3 gene and protein after expansion. CB and PB expanded Tregs exerted a comparable and potent suppressive function of MLR and presented a high in vitro IL-10 production capacity. Gene profile analysis also revealed for PB Tregs a significant enrichments of genes involved in the adaptive immune response.					5420	2886	3567	7050	2444	8744	55697	3064	10599	8431	4598	1909	23109	6253	2815	3752	9404	3597	331	135152	2218	2264	54541	23312	2765	6346	487	5174	1675	11122	3927	2038	5829	11078	51454	10737	27122	3628	389	6036	4922	9024	2561	5663	7035	2568	6833	56137	9734	1365	8578	5784	2687	4063	415	7639	8111	976	9947	7113	124565	540	1656	3158	8786	25801	1490	100288679	728361	10265	89	10803	27324	10229	27302	5046	4990	25843	1307	10493	10321	5340	54788	3617	27287	2921	6545	2920	8724	8789	7162	3570	3543	1459	3710	3851	10753	636	23604	5744	6919	1828	2922	10766	169841	3399	3215	3164	2004	2395	5274	23595	913	10401	1849	6560	23233	402055	3196	1869	1847	4014	56548	580	54498	6400	2823	3460	7133	286	10215	23199	11240	1048	9398	6368	8372	8740	4215	6452	92973	2892	79191	438	7718	23097	4281	6770	3491	5649	100287602	85360	27293	4860	670	2063	215	23649	5360	3588	4151	635	2701	8076	221692	7368	3909	1295	9429	3434	2051	56967	10564	10076	4923	25961	5507	534	22843	22795	590	2776	3240	23168	57799	31	23040	6492	5801	6764	8856	7100	5275	26872	4332	3638	5917	10656	6869	9925
GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_UP	M8371		21768398	Lee JH,Ulrich B,Cho J,Park J,Kim CH	GSE22025	GSE22025_3459_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells: untreated versus TGFB1 [GeneID=7040].	We examined the global gene expression pattern of T cells regulated by progesterone to gain further insights into the regulatory mechanisms of progesterone. We found 325-347 cord blood T cell genes up or down-regulated by P4 in the presence or absence of exogenous TGFb1. Peripheral blood T cells were relatively unresponsive with only 30-70 genes regulated by P4. IL-6 receptor (IL-6R) expression was greatly down-regulated by progesterone in cord blood, but not PB, T cells. Overall, these differences in gene expression are consistent with the differential responses of cord blood and peripheral blood T cells to progesterone. To gain insights into the differences of progesterone and control dendritic cells, we performed a microarray study and found ~180 genes regulated by progesterone in dendritic cells. The gene expression information suggests that progesterone has the potential to alter dendritic cell responses to cytokines, chemokine production, and migration which in combination would control T cell differentiation.					776	10653	23228	7277	23428	5917	311	1839	6334	5868	5825	301	22981	1730	1062	2109	2792	1384	493	9752	85458	10693	1282	8882	2180	164656	2026	80273	2887	7737	3725	7533	79734	9052	5167	51606	375035	22862	3742	6520	4544	9122	11169	127703	5300	6036	27089	6993	26051	8728	4233	6286	4775	7153	3083	5238	2868	93081	1244	2770	6663	1514	9808	55353	6863	25776	5161	22795	7074	5054	9407	9592	3556	9415	5019	8408	9133	58528	8528	126353	1476	2034	23545	10647	286	7450	10281	9047	26148	183	6721	51665	2806	6637	3684	2153	8600	5188	2672	11045	9766	9389	7077	11102	4292	2530	1326	6402	23171	23392	2554	10395	51594	7159	115201	6531	23223	1965	6846	4862	22870	4145	1558	347902	7019	4122	9537	2915	6004	5128	414	8444	1951	2769	961	2331	865	91543	8445	100287602	10912	6480	22899	1880	8324	4794	271	10432	5090	644128	2702	114	9450	7978	10786	6503	3321	7353	7932	1298	11005	23012	90627	5514	10383	10523	4659	4354	5045	23035	4695	23231	3638	7122	1804	2241	5569	467	10212	4087	2131	4048	3759	8651	8140	85865	5443	4604	64116	3587	1285	659	10160	2879	10531	348	22809	6522	10409	10021
GSE22025_UNTREATED_VS_PROGESTERONE_TREATED_CD4_TCELL_UP	M8377		21768398	Lee JH,Ulrich B,Cho J,Park J,Kim CH	GSE22025	GSE22025_3458_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells: untreated versus progesterone [PubChem=5994].	We examined the global gene expression pattern of T cells regulated by progesterone to gain further insights into the regulatory mechanisms of progesterone. We found 325-347 cord blood T cell genes up or down-regulated by P4 in the presence or absence of exogenous TGFb1. Peripheral blood T cells were relatively unresponsive with only 30-70 genes regulated by P4. IL-6 receptor (IL-6R) expression was greatly down-regulated by progesterone in cord blood, but not PB, T cells. Overall, these differences in gene expression are consistent with the differential responses of cord blood and peripheral blood T cells to progesterone. To gain insights into the differences of progesterone and control dendritic cells, we performed a microarray study and found ~180 genes regulated by progesterone in dendritic cells. The gene expression information suggests that progesterone has the potential to alter dendritic cell responses to cytokines, chemokine production, and migration which in combination would control T cell differentiation.					25859	5450	7466	3445	84263	23344	9976	1893	140710	11120	54474	683	4714	5277	5696	6247	2048	6331	6612	230	141	100128124	1174	4589	4013	6755	595	1012	26239	85359	23255	5619	8555	8433	3641	51465	976	433	221692	26034	58473	55937	5271	11001	2959	8934	3699	28	9806	3891	55567	4745	2330	9474	3428	4014	55503	11135	65243	8538	54739	7348	26002	6837	81553	7221	5744	255057	2302	116828	9582	2550	11197	57171	2636	79022	993	3911	796	8504	26045	8237	51257	7984	5335	4063	3315	400410	3717	51752	684	157567	22900	11199	6560	587	10753	3169	22861	5151	5055	5452	23194	287	2735	4685	8909	10745	1471	8832	7043	528	2634	9242	1394	112	3659	9341	5630	58487	27245	7068	1060	347733	51561	9666	5319	7349	939	11040	4294	25849	10406	5602	7111	128	4729	27095	11157	4651	7356	3178	57824	100287076	10987	1130	9749	116228	79921	9332	4734	26056	199870	5557	64135	8927	3695	2191	9659	2939	10590	4038	5889	3669	3899	3109	3305	29969	1565	9232	1534	3633	2185	432	23358	5066	22844	2904	4193	25901	3091	5164	6347	3399	730101	7083	25865	5947	9636	3846	8749	11240	9060	57172	1638	80055	22890	4883	23646	2487
GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN	M8379		21768398	Lee JH,Ulrich B,Cho J,Park J,Kim CH	GSE22025	GSE22025_3461_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells: progesterone [PubChem=5994] versus TGFB1 [GeneID=7040] and progesterone [PubChem=5994].	We examined the global gene expression pattern of T cells regulated by progesterone to gain further insights into the regulatory mechanisms of progesterone. We found 325-347 cord blood T cell genes up or down-regulated by P4 in the presence or absence of exogenous TGFb1. Peripheral blood T cells were relatively unresponsive with only 30-70 genes regulated by P4. IL-6 receptor (IL-6R) expression was greatly down-regulated by progesterone in cord blood, but not PB, T cells. Overall, these differences in gene expression are consistent with the differential responses of cord blood and peripheral blood T cells to progesterone. To gain insights into the differences of progesterone and control dendritic cells, we performed a microarray study and found ~180 genes regulated by progesterone in dendritic cells. The gene expression information suggests that progesterone has the potential to alter dendritic cell responses to cytokines, chemokine production, and migration which in combination would control T cell differentiation.					85865	9674	8309	23608	9122	4064	1573	83988	613	6166	9453	9592	10693	10570	1810	7873	9450	6372	5978	51050	961	10786	5825	154796	2672	25936	4494	91543	359	10395	100287600	126353	10200	301	6286	4794	26033	9687	1017	999	3937	6993	5054	23212	112611	27299	6402	5868	2770	1143	1992	4036	26051	4490	7802	3426	6846	3587	7533	8777	5328	644128	100129973	51375	9020	57019	8605	4107	23550	2109	23171	2710	9134	7448	9886	25805	10249	1824	9768	3083	1476	7353	3998	11321	23769	3320	9331	55503	51606	23365	2887	2638	388714	4145	1756	7932	10669	7694	1389	836	4048	1434	5193	7314	8329	56926	10748	23545	3601	1437	10653	225	58528	3556	4691	23228	11247	22862	3742	4775	5973	9833	7813	2782	57030	11251	3763	6360	7098	23331	2208	10075	1318	2651	7077	5549	7022	10209	1783	8600	7074	865	9099	5100	1356	10135	5903	7159	115207	1965	2131	5732	2769	54474	3222	8611	7905	383	2153	2625	27067	9697	6637	8793	3614	4288	64116	9758	148	22826	55346	18	11064	22878	306	23168	25999	5539	1880	1213	10456	3938	23498	7122	3684	6480	3241	100287602	3612	1013	6430	10158	11009	6507	4087	3490	8445	10971	9244	10063
GSE22025_TGFB1_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP	M8380		21768398	Lee JH,Ulrich B,Cho J,Park J,Kim CH	GSE22025	GSE22025_3462_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells: TGFB1 [GeneID=7040] versus TGFB1 [GeneID=7040] and progesterone [PubChem=5994].	We examined the global gene expression pattern of T cells regulated by progesterone to gain further insights into the regulatory mechanisms of progesterone. We found 325-347 cord blood T cell genes up or down-regulated by P4 in the presence or absence of exogenous TGFb1. Peripheral blood T cells were relatively unresponsive with only 30-70 genes regulated by P4. IL-6 receptor (IL-6R) expression was greatly down-regulated by progesterone in cord blood, but not PB, T cells. Overall, these differences in gene expression are consistent with the differential responses of cord blood and peripheral blood T cells to progesterone. To gain insights into the differences of progesterone and control dendritic cells, we performed a microarray study and found ~180 genes regulated by progesterone in dendritic cells. The gene expression information suggests that progesterone has the potential to alter dendritic cell responses to cytokines, chemokine production, and migration which in combination would control T cell differentiation.					9487	29969	5450	7111	3713	10215	3479	23344	23384	2788	57148	3621	25859	6616	4063	8794	3399	378708	3933	54838	100287051	7805	26959	8544	3423	6596	2266	3911	6019	7360	10181	9242	5213	3589	7162	2627	9183	1160	6837	10554	5140	8425	2634	8843	84986	547	26034	57824	5630	1174	157	5027	8934	51308	6556	10052	1525	26998	3680	5151	1056	81553	9463	5619	4879	55353	5271	1893	3487	8857	7058	81552	1346	23111	8847	1462	5358	7783	27352	1291	7091	27095	3672	3717	2317	5122	27245	2058	57711	25901	5099	55589	2043	10714	23208	728361	3198	2081	1506	51109	80853	8497	2846	2744	8420	6004	80055	786	1910	684	5443	23646	2766	6096	9537	23369	5355	8832	83989	199870	939	9582	7205	4013	6364	9562	6915	219654	2335	2185	5048	5959	3128	5452	976	3669	5784	131566	683	1272	51257	9468	23285	5696	3659	9806	6170	1593	23324	8273	4929	5564	171558	3603	4842	3678	2051	3340	221981	5341	51100	28	6548	605	928	51601	25865	3641	8909	24149	5993	1293	923	10447	11318	4651	27076	58487	2230	10494	2920	71	27232	10188	25939	9232	23024	7040	4654	1447	2898	9249	6584	7516	23012	23178	10217	4070	1950	23286
GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP	M8381		21768398	Lee JH,Ulrich B,Cho J,Park J,Kim CH	GSE22025	GSE22025_3461_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells: progesterone [PubChem=5994] versus TGFB1 [GeneID=7040] and progesterone [PubChem=5994].	We examined the global gene expression pattern of T cells regulated by progesterone to gain further insights into the regulatory mechanisms of progesterone. We found 325-347 cord blood T cell genes up or down-regulated by P4 in the presence or absence of exogenous TGFb1. Peripheral blood T cells were relatively unresponsive with only 30-70 genes regulated by P4. IL-6 receptor (IL-6R) expression was greatly down-regulated by progesterone in cord blood, but not PB, T cells. Overall, these differences in gene expression are consistent with the differential responses of cord blood and peripheral blood T cells to progesterone. To gain insights into the differences of progesterone and control dendritic cells, we performed a microarray study and found ~180 genes regulated by progesterone in dendritic cells. The gene expression information suggests that progesterone has the potential to alter dendritic cell responses to cytokines, chemokine production, and migration which in combination would control T cell differentiation.					4712	3725	1326	5955	467	11097	9122	23036	55830	8776	7050	9736	23531	22925	965	6726	23499	6504	5243	6526	2180	23759	6168	57634	3146	642	9173	10396	7694	8894	8445	22	6596	22981	2669	4929	104	9859	1514	6880	85458	2787	9592	10494	3437	5966	10866	6102	6787	8550	8444	9909	8777	10693	25888	10418	9453	10125	10409	5747	2277	9904	976	5669	22889	11020	9748	90	10943	7419	6217	9927	10521	9520	203197	196	1839	2308	55312	11169	23091	84890	3459	22876	6230	9403	9988	2908	6004	5325	7718	22938	4774	22863	4735	11072	546	25898	9819	6139	10422	7637	7071	8404	5229	3516	23015	3604	8895	9698	6364	2182	11056	5311	11153	10147	1062	27042	58517	6233	23125	7528	5903	23180	2171	8600	923	1362	1942	644128	51561	23710	9562	7074	10042	6036	94239	4615	25972	1039	5521	23389	10950	1371	9839	2526	27339	4862	8683	57211	5154	10237	6282	5136	9766	26136	9308	4794	4299	5355	5868	10670	9443	1453	4092	23012	2589	4319	103910	7702	8726	515	2020	7699	2332	4724	9657	7337	5358	1595	9446	6683	9731	81566	5538	51526	3937	115207	2869	6814	50628	8165	10557	5128	5018	11073	1293	10527	1317
GSE22025_UNTREATED_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP	M8383		21768398	Lee JH,Ulrich B,Cho J,Park J,Kim CH	GSE22025	GSE22025_3460_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells: untreated versus TGFB1 [GeneID=7040] and progesterone [PubChem=5994].	We examined the global gene expression pattern of T cells regulated by progesterone to gain further insights into the regulatory mechanisms of progesterone. We found 325-347 cord blood T cell genes up or down-regulated by P4 in the presence or absence of exogenous TGFb1. Peripheral blood T cells were relatively unresponsive with only 30-70 genes regulated by P4. IL-6 receptor (IL-6R) expression was greatly down-regulated by progesterone in cord blood, but not PB, T cells. Overall, these differences in gene expression are consistent with the differential responses of cord blood and peripheral blood T cells to progesterone. To gain insights into the differences of progesterone and control dendritic cells, we performed a microarray study and found ~180 genes regulated by progesterone in dendritic cells. The gene expression information suggests that progesterone has the potential to alter dendritic cell responses to cytokines, chemokine production, and migration which in combination would control T cell differentiation.					4761	27245	1763	4193	3142	23208	2101	177	2781	2568	5568	23066	64067	4072	23109	23086	9654	143244	11344	364	4303	5480	22874	4990	6331	10437	64405	10223	26240	9846	2815	1028	57468	540	2214	10554	341	6091	22844	4811	7434	1368	3768	8859	5122	1417	6387	3479	4249	1730	55702	4688	84679	4829	7634	4184	6906	1071	8914	57658	9374	4624	22849	2920	5985	2645	84148	2972	23564	319	1613	8744	157	4685	2627	4047	6299	1556	3856	53916	7111	6573	6415	4669	6716	26052	3911	5465	8277	26998	2267	3641	3169	3491	1410	2705	1500	3064	1758	6271	1280	493	2660	10633	6677	56136	10163	3831	8707	9649	2119	64285	5097	2299	202559	2949	63036	11021	9267	6911	116828	4660	4038	1134	64582	11339	1593	7058	1187	7125	100507605	6781	1609	9230	23233	79921	6017	57821	6518	1523	8572	70	390940	10535	842	5563	6543	221692	5784	1018	247	6532	2947	4293	9807	5754	7554	3012	10404	122616	7249	2081	4070	5140	116985	7274	5551	306	3755	6988	7168	343990	11237	339	835	8646	25865	2042	1585	4223	5732	1462	6579	8712	7288	138151	1501	489	6195	27302	4968	1842	10052	2637	10529	2550	23464	51439	24142	9060
GSE22025_UNTREATED_VS_PROGESTERONE_TREATED_CD4_TCELL_DN	M8384		21768398	Lee JH,Ulrich B,Cho J,Park J,Kim CH	GSE22025	GSE22025_3458_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells: untreated versus progesterone [PubChem=5994].	We examined the global gene expression pattern of T cells regulated by progesterone to gain further insights into the regulatory mechanisms of progesterone. We found 325-347 cord blood T cell genes up or down-regulated by P4 in the presence or absence of exogenous TGFb1. Peripheral blood T cells were relatively unresponsive with only 30-70 genes regulated by P4. IL-6 receptor (IL-6R) expression was greatly down-regulated by progesterone in cord blood, but not PB, T cells. Overall, these differences in gene expression are consistent with the differential responses of cord blood and peripheral blood T cells to progesterone. To gain insights into the differences of progesterone and control dendritic cells, we performed a microarray study and found ~180 genes regulated by progesterone in dendritic cells. The gene expression information suggests that progesterone has the potential to alter dendritic cell responses to cytokines, chemokine production, and migration which in combination would control T cell differentiation.					6503	84726	23172	5273	5045	3725	8566	8329	7277	10912	659	91543	3021	1558	22862	6729	9122	6846	1839	7803	8140	8600	9453	2109	5425	10212	8318	9014	3439	23223	5825	140890	5130	10653	2770	1207	6133	4036	1942	10786	1810	6993	3008	301	7533	25842	26051	7813	79868	5903	7074	4728	7857	56926	23035	7159	5167	9150	7077	8728	7203	1143	9407	2769	2806	4775	23545	7314	85458	9556	131	961	9628	9592	3556	6945	25928	26235	8444	9766	3321	346157	9584	57144	1965	1901	23299	2205	5732	2887	1434	4145	1820	1514	10985	3587	55353	9815	6286	374977	23228	64116	1642	10184	11075	5868	9398	1620	2153	6897	1389	1476	2180	7991	10647	116832	10434	8312	6282	10163	2935	7525	6375	3336	10063	597	6228	51606	23215	805	90627	1192	7818	9562	6426	11153	10531	1880	4985	23212	9486	4615	8820	3320	10409	6489	9313	6173	2672	7019	2879	54499	11102	10444	54629	22885	7095	23283	10971	3485	5521	2526	22809	7353	1728	6004	1977	9450	5298	10383	10395	51665	6402	493	8445	22936	79036	58528	10538	925	25945	23174	2776	11321	5355	6160	2915	1979	8651	965	865	10523	4048	8882	5019	6675	4092	6166	6531	3638
GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_DN	M8385		21768398	Lee JH,Ulrich B,Cho J,Park J,Kim CH	GSE22025	GSE22025_3459_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells: untreated versus TGFB1 [GeneID=7040].	We examined the global gene expression pattern of T cells regulated by progesterone to gain further insights into the regulatory mechanisms of progesterone. We found 325-347 cord blood T cell genes up or down-regulated by P4 in the presence or absence of exogenous TGFb1. Peripheral blood T cells were relatively unresponsive with only 30-70 genes regulated by P4. IL-6 receptor (IL-6R) expression was greatly down-regulated by progesterone in cord blood, but not PB, T cells. Overall, these differences in gene expression are consistent with the differential responses of cord blood and peripheral blood T cells to progesterone. To gain insights into the differences of progesterone and control dendritic cells, we performed a microarray study and found ~180 genes regulated by progesterone in dendritic cells. The gene expression information suggests that progesterone has the potential to alter dendritic cell responses to cytokines, chemokine production, and migration which in combination would control T cell differentiation.					3903	5450	8914	1763	3624	2999	10076	100287076	7984	10650	3765	6853	684	4063	6560	140901	10281	9170	63036	2979	4714	3766	3818	2939	6347	10749	976	3680	3889	4669	5929	3239	22874	161	8435	26953	728361	7067	5055	129080	4184	23288	6482	8555	5051	57824	1950	820	4692	23109	9027	23255	1006	32	55567	5547	7978	2634	23245	5371	7111	23344	4301	57214	51308	64067	9806	3036	65243	7692	3811	2843	11001	27289	1910	6781	6533	43	3991	8839	6331	10231	10505	201191	8788	11135	1373	7626	84679	23285	4761	5696	5118	7432	339105	10073	2846	79084	9249	83989	6017	3717	219654	3899	10618	3108	7033	58487	1056	1388	8447	2051	7634	4807	2059	56941	221692	9947	116228	3351	5889	309	610	10798	5092	3695	26093	9679	7730	290	1628	53340	4291	25859	3227	5205	9582	1215	23308	11130	6695	6337	8433	1523	2185	84560	4133	2920	2624	3399	3687	10554	2735	6988	157	146712	4651	10333	22905	3883	8790	6340	6649	116987	4889	4745	971	51257	786	8416	56339	6483	1589	9982	22997	4327	4923	24139	5089	22861	10223	6002	29969	939	332	8544	64405	9654	1577	6015	7273	26998	5731	3846	10379	8727	27352	8459	124044	25865
GSE22025_UNTREATED_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN	M8386		21768398	Lee JH,Ulrich B,Cho J,Park J,Kim CH	GSE22025	GSE22025_3460_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells: untreated versus TGFB1 [GeneID=7040] and progesterone [PubChem=5994].	We examined the global gene expression pattern of T cells regulated by progesterone to gain further insights into the regulatory mechanisms of progesterone. We found 325-347 cord blood T cell genes up or down-regulated by P4 in the presence or absence of exogenous TGFb1. Peripheral blood T cells were relatively unresponsive with only 30-70 genes regulated by P4. IL-6 receptor (IL-6R) expression was greatly down-regulated by progesterone in cord blood, but not PB, T cells. Overall, these differences in gene expression are consistent with the differential responses of cord blood and peripheral blood T cells to progesterone. To gain insights into the differences of progesterone and control dendritic cells, we performed a microarray study and found ~180 genes regulated by progesterone in dendritic cells. The gene expression information suggests that progesterone has the potential to alter dendritic cell responses to cytokines, chemokine production, and migration which in combination would control T cell differentiation.					3885	5949	284	482	5596	5500	57096	6002	196740	4360	25805	4794	92342	2853	5151	3034	130	9936	23170	6582	434	4775	6993	51050	5141	10787	10326	10246	54665	22809	51752	22862	845	390999	26239	2056	730	4094	860	3836	1998	9758	10552	775	2917	6528	6247	1087	7165	4719	22902	3897	100507605	10626	4129	3109	25859	221692	245	946	3659	8329	2653	27072	10162	400410	54474	1965	8499	3083	6837	3846	1271	2838	116228	5071	8555	4241	89	10558	22900	1656	8938	7464	6518	27290	2157	595	4430	6362	23365	22844	5322	3663	26056	2634	5932	2710	8856	684	2525	7033	478	28571	6736	5423	10249	11082	8722	10693	11199	5449	11006	2735	2244	55503	7221	8929	5893	2562	4107	4048	1357	2302	10439	7139	401251	2237	6846	5017	1536	10135	9518	83737	9636	1944	22824	9736	716	7159	10456	58500	8208	10321	5978	2983	10474	4761	5046	5319	7057	23576	84163	2487	10599	1949	993	3221	5268	9436	64746	9270	9833	11157	4729	9369	7336	26953	9734	3796	1770	11120	3742	5732	26154	5347	9453	6691	25943	100128124	5111	5396	2957	51761	3769	9447	6870	5055	28513	23646	100286972	7043	112	4589	2941	56242	57172	2352	301	3990
GSE22025_TGFB1_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN	M8388		21768398	Lee JH,Ulrich B,Cho J,Park J,Kim CH	GSE22025	GSE22025_3462_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells: TGFB1 [GeneID=7040] versus TGFB1 [GeneID=7040] and progesterone [PubChem=5994].	We examined the global gene expression pattern of T cells regulated by progesterone to gain further insights into the regulatory mechanisms of progesterone. We found 325-347 cord blood T cell genes up or down-regulated by P4 in the presence or absence of exogenous TGFb1. Peripheral blood T cells were relatively unresponsive with only 30-70 genes regulated by P4. IL-6 receptor (IL-6R) expression was greatly down-regulated by progesterone in cord blood, but not PB, T cells. Overall, these differences in gene expression are consistent with the differential responses of cord blood and peripheral blood T cells to progesterone. To gain insights into the differences of progesterone and control dendritic cells, we performed a microarray study and found ~180 genes regulated by progesterone in dendritic cells. The gene expression information suggests that progesterone has the potential to alter dendritic cell responses to cytokines, chemokine production, and migration which in combination would control T cell differentiation.					1514	3201	7277	7343	3358	51308	5606	8714	23035	259217	7409	9612	8728	10281	5969	4168	3725	1282	6169	5128	6678	25945	6445	2702	2180	4741	9480	9537	766	23523	23334	2997	9183	1160	3672	10188	25891	71	9463	3014	22873	5443	6291	1291	10523	10637	4680	6675	5355	960	923	8566	3487	2494	2879	3748	1828	7805	3569	9686	3375	22895	6004	8569	89870	10554	114882	1054	6899	733	2627	26191	400961	643	5045	114	3976	2783	8600	2215	6482	10794	1991	26017	2138	2266	467	5310	481	5161	8471	9677	23236	26025	22981	7162	3093	9468	7180	6659	22795	11330	5966	2331	2898	4828	7471	147	7016	5052	4803	23012	5099	8444	3423	3198	10362	9653	810	2806	7058	3373	6239	6596	973	8273	2823	8718	1839	131566	8740	30837	7545	2314	10882	9829	1293	7040	4929	6364	10816	1063	2264	9175	23271	4300	9766	9446	27232	115123	9948	683	55353	10052	6474	22983	6539	1365	9138	3399	11005	4292	676	6566	2669	4887	9562	6504	4978	4321	2026	8941	5495	10111	10432	8661	126353	659	26716	1041	4693	25803	6964	9019	10500	1730	23223	9389	23286	3886	10409	8662	84302	190	26102	57154	22898	995	10265	4586
GSE30153_LUPUS_VS_HEALTHY_DONOR_BCELL_DN	M8424		21886837	Garaud JC,Schickel JN,Blaison G,Knapp AM,Dembele D,Ruer-Laventie J,Korganow AS,Martin T,Soulas-Sprauel P,Pasquali JL	GSE30153	GSE30153_3539_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in B lymphocytes: systemic lupus erythematosous (SLE) versus healthy.	Systemic lupus erythematosous (SLE) is an autoimmune disease with an important clinical and biological heterogeneity. B lymphocytes appear central to the development of SLE which is characterized by the production of a large variety of autoantibodies and hypergammaglobulinemia. In mice, immature B cells from spontaneous lupus prone animals are able to produce autoantibodies when transferred into immunodeficient mice, strongly suggesting the existence of intrinsic B cell defects during lupus. In order to approach these defects in humans, we compared the peripheral B cell transcriptomes of quiescent lupus patients to normal B cell transcriptomes.					8632	6869	6778	7542	9542	6011	23208	3383	1027	493	5476	9462	2897	5995	205	10495	3082	4795	29970	4818	8807	3008	10150	30837	3687	9043	6690	4104	23261	55658	5045	24149	3575	863	6247	56311	916	9645	462	10636	189	1106	10024	3763	1018	11122	6531	3852	10631	6018	5740	4758	155	100293553	5032	8190	133619	6919	6424	6527	26469	6545	2009	10307	4128	3662	6014	3316	651	4208	23150	3617	9945	881	5617	54505	8029	5193	2694	51347	50628	22869	23625	9021	8324	26610	6855	2921	11102	4199	10437	4883	2590	100419017	8605	1145	6237	3696	11230	7453	151011	6507	10423	8644	3119	5277	55643	7486	6337	7568	3995	1144	496	55885	9891	8973	6546	25830	51196	8200	55786	1785	80350	2913	22992	11001	26013	1992	8694	6795	9957	5986	2170	920	33	50804	6015	7433	753	4052	9563	23645	6822	925	3458	5756	157562	577	5081	9831	3375	5979	3128	1131	9640	5973	25956	8443	4100	9013	1301	8629	835	3938	8976	1942	56269	11342	10979	23315	146227	1016	2220	8705	25898	11328	4077	23105	23166	5170	5318	257407	242	3902	6532	1305	2769	4593	818	2214	9719	7379	3002	4836	2999	6598	8739	1740	6829	8326
GSE30153_LUPUS_VS_HEALTHY_DONOR_BCELL_UP	M8425		21886837	Garaud JC,Schickel JN,Blaison G,Knapp AM,Dembele D,Ruer-Laventie J,Korganow AS,Martin T,Soulas-Sprauel P,Pasquali JL	GSE30153	GSE30153_3539_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in B lymphocytes: systemic lupus erythematosous (SLE) versus healthy.	Systemic lupus erythematosous (SLE) is an autoimmune disease with an important clinical and biological heterogeneity. B lymphocytes appear central to the development of SLE which is characterized by the production of a large variety of autoantibodies and hypergammaglobulinemia. In mice, immature B cells from spontaneous lupus prone animals are able to produce autoantibodies when transferred into immunodeficient mice, strongly suggesting the existence of intrinsic B cell defects during lupus. In order to approach these defects in humans, we compared the peripheral B cell transcriptomes of quiescent lupus patients to normal B cell transcriptomes.					23314	1006	6317	4062	93164	1072	23216	6442	23230	6204	22989	253782	4644	8864	2615	55001	1955	57403	116372	9637	11221	9651	8504	4332	25812	8453	100287372	164	1233	66008	337	23358	11152	7982	11196	23255	6415	114088	10607	5782	4049	112611	377	9844	4050	51588	1130	81576	9456	3507	3769	4015	1281	2674	7096	54014	8607	9647	10420	2639	9107	186	4335	27072	6940	11144	729230	5651	196	29890	56253	10009	993	7220	115426	1407	92482	56902	185	8842	4744	10362	5189	7803	6121	23276	223117	90338	1306	2792	1075	740	10267	1901	5921	2230	3627	347902	3904	57711	6929	23169	9671	23253	9969	1117	2830	9842	23516	10946	10457	7259	171546	6445	3320	9027	6907	1431	3958	5597	5601	3308	1147	50852	4753	6251	3705	1628	2124	9812	990	10289	8975	26146	9636	644128	9787	51032	136	9332	63982	23389	6566	25758	2992	27241	54674	1605	10146	23036	9829	135138	6924	6050	8884	6327	11333	904	5719	6846	1446	8939	6483	869	6683	5261	10142	4152	5478	7699	1540	9570	5435	23236	50846	25913	1460	9761	100292813	2770	4016	22903	27324	4830	9585	200734	3164	8416	10943	137886	3604	7291	29894	23028	11014	892	130	7862	1120	2960
GSE23321_EFFECTOR_MEMORY_VS_NAIVE_CD8_TCELL_UP	M8428		21926977	Gattinoni L,Lugli E,Ji Y,Pos Z,Paulos CM,Quigley MF,Almeida JR,Gostick E,Yu Z,Carpenito C,Wang E,Douek DC,Price DA,June CH,Marincola FM,Roederer M,Restifo NP	GSE23321	GSE23321_2650_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD8 T cells: effector memory versus naïve.	An early-differentiated CD8+ memory T cell subset with stem cell-like properties (TSCM) can be identified within the naïve-like T cell population by the expression of CD95/Fas. Based on experiments including exon- and gene-level expression analysis, we provide evidence that this subset of antigen-specific cells represents an early precursor of conventional central (TCM) and effector (TEM) memory CD8+ T cells with enhanced self-renewal capacity and proliferative potential. We identified 900 genes differentially expressed between major T cell subsets defined along with memory T cell commitment. Based on the analysis of these genes, CD95+ naïve T cells (TSCM) cluster closer to the CD8+ T memory compartment than to classical (CD95-) naïve T (TN) cells, and display an intermittent phenotype between classical TN and TCM cells in terms of all major T cell differentiation markers analyzed.					2020	4826	10948	4774	9469	6988	5276	221830	4891	8366	1559	6498	6248	8544	3887	10226	2590	10423	29970	11191	1538	4061	7379	3995	189	3075	4495	201626	54741	10493	23504	23179	4758	9900	317648	8632	5803	10409	1890	5341	2904	9706	10481	23348	9855	10737	2316	388699	3818	2913	3516	6405	10495	146227	7982	9256	257407	8605	1080	6462	2773	2694	5045	23759	3169	4014	57476	1446	7030	9444	10268	8625	9719	27350	384	9604	5321	6542	3676	8976	57242	3449	9462	85458	623	5241	8854	434	7352	347	3798	8091	5286	6335	4586	50488	8742	3386	9834	4316	3664	7433	11131	57447	23294	9083	2650	11037	8807	1572	4803	7421	2191	4703	57711	22993	755	51704	9331	9021	5794	6271	2155	1796	4199	4634	2041	100289494	23254	4162	2919	3860	23072	2833	8651	2494	5081	8871	4752	25843	9899	22869	8324	8082	4301	282808	4000	10254	490	8273	100287387	3910	23381	1186	9526	4099	22841	3782	23361	5463	9437	3696	183	493	23051	54535	6352	9640	4322	3607	1944	10485	84263	9826	9833	3953	8832	8490	6004	8814	11250	10663	3977	84164	151011	2215	3257	4818	2248	11230	7799	9121	22926	23166	1045	1240	7103	1958	1669	3208
GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_UP	M8429		21926977	Gattinoni L,Lugli E,Ji Y,Pos Z,Paulos CM,Quigley MF,Almeida JR,Gostick E,Yu Z,Carpenito C,Wang E,Douek DC,Price DA,June CH,Marincola FM,Roederer M,Restifo NP	GSE23321	GSE23321_2646_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD8 T cells: stem cell memory versus effector memory.	An early-differentiated CD8+ memory T cell subset with stem cell-like properties (TSCM) can be identified within the naïve-like T cell population by the expression of CD95/Fas. Based on experiments including exon- and gene-level expression analysis, we provide evidence that this subset of antigen-specific cells represents an early precursor of conventional central (TCM) and effector (TEM) memory CD8+ T cells with enhanced self-renewal capacity and proliferative potential. We identified 900 genes differentially expressed between major T cell subsets defined along with memory T cell commitment. Based on the analysis of these genes, CD95+ naïve T cells (TSCM) cluster closer to the CD8+ T memory compartment than to classical (CD95-) naïve T (TN) cells, and display an intermittent phenotype between classical TN and TCM cells in terms of all major T cell differentiation markers analyzed.					8336	10043	310	2193	54504	23216	9532	4082	5025	7284	11342	9618	7753	84890	8975	11104	597	1147	2830	5151	10204	10154	157	2690	23013	6871	6616	54674	10682	11007	65123	26002	22924	25855	23230	837	55966	9248	23185	9491	53340	6317	4783	8916	223	23164	6461	1272	205	55970	9844	55001	8811	5465	112611	10190	11116	8842	2059	23522	8504	921	1287	23473	10307	7310	1209	1316	4254	7291	26151	5530	3587	24138	168374	4600	4319	4481	34	3459	1130	10195	10435	4899	6882	5719	55215	84140	57205	3507	7357	23276	26058	6907	5782	958	126299	4103	55567	10285	79441	546	10645	4490	5552	5426	1352	10726	27346	53405	5778	6489	5226	9570	5594	4956	10802	2615	2139	9520	5478	27113	1587	10943	8448	4363	5713	6827	8530	7353	3843	51780	10432	2053	23090	8294	22823	5976	1627	9435	25948	5867	23	5797	7110	650	9294	108	2885	23229	84901	2589	8019	23659	2580	8904	10981	8354	115426	81578	10762	10732	2957	8747	4118	23295	6571	7108	8303	3310	475	994	100292813	56339	940	92104	9851	6622	23169	11336	23476	5326	3034	6415	785	2992	9986	8864	2157	5293	9646	5195	7288	8295	10524	221443	2841	22866	10668	174
GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_DN	M8430		21926977	Gattinoni L,Lugli E,Ji Y,Pos Z,Paulos CM,Quigley MF,Almeida JR,Gostick E,Yu Z,Carpenito C,Wang E,Douek DC,Price DA,June CH,Marincola FM,Roederer M,Restifo NP	GSE23321	GSE23321_2646_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD8 T cells: stem cell memory versus effector memory.	An early-differentiated CD8+ memory T cell subset with stem cell-like properties (TSCM) can be identified within the naïve-like T cell population by the expression of CD95/Fas. Based on experiments including exon- and gene-level expression analysis, we provide evidence that this subset of antigen-specific cells represents an early precursor of conventional central (TCM) and effector (TEM) memory CD8+ T cells with enhanced self-renewal capacity and proliferative potential. We identified 900 genes differentially expressed between major T cell subsets defined along with memory T cell commitment. Based on the analysis of these genes, CD95+ naïve T cells (TSCM) cluster closer to the CD8+ T memory compartment than to classical (CD95-) naïve T (TN) cells, and display an intermittent phenotype between classical TN and TCM cells in terms of all major T cell differentiation markers analyzed.					7884	2067	2975	7314	8887	27336	5595	7378	51585	5714	23175	26994	8916	47	10287	8504	226	4190	27291	8566	4208	23299	3554	6742	9363	27089	1808	23150	10244	6993	51567	9493	9741	9780	5165	3837	5045	10457	4134	7538	3832	2355	10844	6813	1051	8624	8973	1781	4253	5636	2286	382	9319	9683	5598	24139	5879	6386	498	9231	23429	11140	9262	9798	2632	92856	5825	967	26469	1316	5631	6598	25936	2316	6647	1538	2805	23215	51663	11034	9867	5873	23516	9553	11073	10657	3720	5360	3726	9016	940	9275	9550	10291	5908	5901	372	1880	51552	3688	9528	339287	9020	100292236	6282	10020	221154	9774	2769	2108	2770	5934	597	6304	10672	5034	10899	11340	51029	6917	10434	1315	2072	23047	5341	9759	2617	2773	3710	623	8531	1349	7110	3614	23469	23318	10762	4041	8079	10432	9556	2339	6355	754	57476	27338	6241	9604	9218	81691	7421	25972	26610	10653	9039	7027	221443	26509	6902	8651	23646	8971	56929	6541	57035	4921	3566	7128	65110	4627	292	8140	8514	1738	3587	23195	7105	11154	23344	4809	10857	7846	7322	7373	10426	7417	6429	7536	1032	890	23177	1001	51103	6793	3662	10125	23479	8894	760	4299
GSE23321_CENTRAL_MEMORY_VS_NAIVE_CD8_TCELL_DN	M8431		21926977	Gattinoni L,Lugli E,Ji Y,Pos Z,Paulos CM,Quigley MF,Almeida JR,Gostick E,Yu Z,Carpenito C,Wang E,Douek DC,Price DA,June CH,Marincola FM,Roederer M,Restifo NP	GSE23321	GSE23321_2649_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD8 T cells: central memory versus naïve.	An early-differentiated CD8+ memory T cell subset with stem cell-like properties (TSCM) can be identified within the naïve-like T cell population by the expression of CD95/Fas. Based on experiments including exon- and gene-level expression analysis, we provide evidence that this subset of antigen-specific cells represents an early precursor of conventional central (TCM) and effector (TEM) memory CD8+ T cells with enhanced self-renewal capacity and proliferative potential. We identified 900 genes differentially expressed between major T cell subsets defined along with memory T cell commitment. Based on the analysis of these genes, CD95+ naïve T cells (TSCM) cluster closer to the CD8+ T memory compartment than to classical (CD95-) naïve T (TN) cells, and display an intermittent phenotype between classical TN and TCM cells in terms of all major T cell differentiation markers analyzed.					23552	492	5977	646934	1287	10468	112611	8630	4061	22989	3933	5798	2835	58504	775	6792	3273	22920	9463	3268	7753	1775	55503	4014	9605	3691	4015	4839	6884	1562	284	7221	1482	23269	25854	84991	157697	7003	66008	2535	2792	80740	10692	248	9248	9860	9625	2049	5365	5530	11052	29105	5026	7691	6340	2913	5068	92482	5576	9223	5727	2798	6702	22808	6554	10892	3866	23221	7021	10946	11075	2697	3239	7226	9420	1121	7135	6898	9283	100287107	4023	54788	1421	10924	5293	26583	1208	8632	640	3008	8785	1586	135138	1536	27349	5864	1890	441151	25813	27239	6327	80301	3780	8419	337	9671	3699	10750	794	55	10587	8613	79080	2520	3613	66002	26085	28996	24138	4650	317781	1825	11330	6347	6497	2139	5651	3950	8200	2004	4628	56905	5319	2575	22839	57205	55651	3394	54504	8193	23431	5600	11012	55806	2994	9278	54014	5338	6772	5539	9647	9914	4481	2690	182	205564	4689	9745	51090	10	2350	9806	4647	9843	284001	8857	9715	23075	2170	4654	26154	196740	3284	5681	20	51704	6820	55565	717	8618	5818	23127	54363	9365	2621	1991	5332	8904	11278	783	8038	1306	27242	108	63941	283537	57125	55970	534	51343
GSE23321_CENTRAL_VS_EFFECTOR_MEMORY_CD8_TCELL_UP	M8433		21926977	Gattinoni L,Lugli E,Ji Y,Pos Z,Paulos CM,Quigley MF,Almeida JR,Gostick E,Yu Z,Carpenito C,Wang E,Douek DC,Price DA,June CH,Marincola FM,Roederer M,Restifo NP	GSE23321	GSE23321_2648_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD8 T cells: central memory versus effector memory.	An early-differentiated CD8+ memory T cell subset with stem cell-like properties (TSCM) can be identified within the naïve-like T cell population by the expression of CD95/Fas. Based on experiments including exon- and gene-level expression analysis, we provide evidence that this subset of antigen-specific cells represents an early precursor of conventional central (TCM) and effector (TEM) memory CD8+ T cells with enhanced self-renewal capacity and proliferative potential. We identified 900 genes differentially expressed between major T cell subsets defined along with memory T cell commitment. Based on the analysis of these genes, CD95+ naïve T cells (TSCM) cluster closer to the CD8+ T memory compartment than to classical (CD95-) naïve T (TN) cells, and display an intermittent phenotype between classical TN and TCM cells in terms of all major T cell differentiation markers analyzed.					5243	7903	7052	100129128	5626	64968	11334	253558	196	84909	114799	2176	137695	8760	26750	23145	4783	23452	8829	5732	4665	57035	10291	57466	23462	63971	24145	4864	54839	340075	2824	8530	834	6915	10654	54442	196383	100506736	23052	55647	83667	79571	988	84889	7077	7273	4520	6911	55967	4887	9123	63027	79977	79932	3081	51747	56301	347734	127544	10950	125488	2245	3973	199731	131965	901	3214	5763	161291	168537	9169	5781	89876	54407	1371	7756	7270	7133	84304	23365	57533	987	643	753	9144	55013	57679	54345	4094	6714	9320	11222	339122	51474	203197	79020	3799	5696	5922	389792	7185	39	85395	8242	51429	80818	56889	30811	3759	5315	1050	975	10783	4485	84282	3902	85462	55544	7102	56241	4355	9619	782	2896	143686	7205	54855	3337	9695	2768	4641	2317	80301	30846	633	27111	10069	23505	5780	4255	55741	5610	375033	2348	23138	59274	9308	5339	8744	904	65264	6093	3586	23178	79718	558	306	55129	27044	64080	150275	55256	4772	100131439	81618	23191	79070	23293	836	5552	4534	3682	23466	80176	837	7099	4319	10116	6590	602	58191	64417	10193	23022	7200	7056	9985	1747	10106	79441	23210	8767	9667	160760	2296	23531	60436	651746	5049	56137
GSE23321_CENTRAL_VS_EFFECTOR_MEMORY_CD8_TCELL_DN	M8434		21926977	Gattinoni L,Lugli E,Ji Y,Pos Z,Paulos CM,Quigley MF,Almeida JR,Gostick E,Yu Z,Carpenito C,Wang E,Douek DC,Price DA,June CH,Marincola FM,Roederer M,Restifo NP	GSE23321	GSE23321_2648_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD8 T cells: central memory versus effector memory.	An early-differentiated CD8+ memory T cell subset with stem cell-like properties (TSCM) can be identified within the naïve-like T cell population by the expression of CD95/Fas. Based on experiments including exon- and gene-level expression analysis, we provide evidence that this subset of antigen-specific cells represents an early precursor of conventional central (TCM) and effector (TEM) memory CD8+ T cells with enhanced self-renewal capacity and proliferative potential. We identified 900 genes differentially expressed between major T cell subsets defined along with memory T cell commitment. Based on the analysis of these genes, CD95+ naïve T cells (TSCM) cluster closer to the CD8+ T memory compartment than to classical (CD95-) naïve T (TN) cells, and display an intermittent phenotype between classical TN and TCM cells in terms of all major T cell differentiation markers analyzed.					79993	51116	4528	4833	1509	9254	10286	3187	1412	29080	9362	201627	84885	6135	6988	3796	134637	3034	97	4705	152185	388552	56890	54956	6884	10663	3845	25873	79810	9057	118672	79874	10999	7534	27339	90843	11218	149603	79575	128	51108	51257	64925	123811	23327	34	79971	5898	2012	10018	6141	10402	65992	7508	57613	6167	583	10123	113444	6815	1515	29058	64844	23683	6667	59277	7507	55846	8936	126	51300	8693	2192	2054	55283	2149	80298	30845	27292	1876	2904	388753	27131	135154	85025	23339	10486	25963	3664	23678	124995	134429	55824	4257	29117	7433	51668	60492	7091	8086	55007	121665	23582	55818	93587	55558	150737	92399	92558	7277	5495	90864	55362	9590	121512	25764	8263	1662	8491	8881	9064	116461	55760	5245	114770	55600	118429	23530	23132	158234	255189	420	51076	54802	51115	51194	1269	28981	10233	3568	8543	151050	11232	401548	11185	2064	81492	1739	9818	283232	10013	55117	9050	670	284352	4286	134359	961	9984	1718	84524	84364	7086	4205	28958	7347	84293	7353	23301	174	7455	55374	26015	6191	9278	1647	171546	29116	3646	84939	6652	144165	2067	10620	8815	83460	8697	6095	10399	25925	144699	3112	1477	4926	53917	65260	7555	6304	9277	6836
GSE23321_CENTRAL_MEMORY_VS_NAIVE_CD8_TCELL_UP	M8435		21926977	Gattinoni L,Lugli E,Ji Y,Pos Z,Paulos CM,Quigley MF,Almeida JR,Gostick E,Yu Z,Carpenito C,Wang E,Douek DC,Price DA,June CH,Marincola FM,Roederer M,Restifo NP	GSE23321	GSE23321_2649_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD8 T cells: central memory versus naïve.	An early-differentiated CD8+ memory T cell subset with stem cell-like properties (TSCM) can be identified within the naïve-like T cell population by the expression of CD95/Fas. Based on experiments including exon- and gene-level expression analysis, we provide evidence that this subset of antigen-specific cells represents an early precursor of conventional central (TCM) and effector (TEM) memory CD8+ T cells with enhanced self-renewal capacity and proliferative potential. We identified 900 genes differentially expressed between major T cell subsets defined along with memory T cell commitment. Based on the analysis of these genes, CD95+ naïve T cells (TSCM) cluster closer to the CD8+ T memory compartment than to classical (CD95-) naïve T (TN) cells, and display an intermittent phenotype between classical TN and TCM cells in terms of all major T cell differentiation markers analyzed.					80331	51750	1958	55222	2549	60493	53918	137872	55591	29777	953	57600	4778	10815	5279	2588	51253	6515	2921	57703	22822	3674	158067	2768	90423	7305	3934	91748	4057	55630	10235	51669	5831	23463	83862	58526	64332	26355	51266	6696	6280	196527	6793	19	8804	1116	3294	5634	6279	1839	64411	1725	51768	4318	55103	5055	2491	4066	8832	8622	6402	10741	51635	6310	80231	26034	142891	9938	51773	115416	129285	3624	57126	10902	55	222487	5138	4585	5008	820	7077	23423	3249	4482	84265	6919	4257	411	7071	4217	64714	26275	5732	283927	3309	1687	9754	29915	55746	54878	51317	153020	260425	25976	7378	8351	5743	1520	4907	7511	158	10641	4317	3665	57509	2919	55034	8288	6569	10217	4899	55114	11080	8178	9969	3164	2353	4285	55650	1263	55784	2539	100506562	6446	56975	79701	9141	23569	58476	170712	583	84803	11127	51316	79660	963	762	3579	3552	9317	151516	83861	89846	5096	23131	64285	51666	26037	51030	58533	9108	326624	5175	54969	93594	2357	960	3690	9429	6840	7009	28966	8685	94097	7515	2302	7850	1435	25840	8208	23210	225	952	51192	10565	8443	2593	65062	272	885	51167	1164	5162	10051	375790	10972	3382	8613	2124	84058
GSE23321_CD8_STEM_CELL_MEMORY_VS_CENTRAL_MEMORY_CD8_TCELL_UP	M8436		21926977	Gattinoni L,Lugli E,Ji Y,Pos Z,Paulos CM,Quigley MF,Almeida JR,Gostick E,Yu Z,Carpenito C,Wang E,Douek DC,Price DA,June CH,Marincola FM,Roederer M,Restifo NP	GSE23321	GSE23321_2645_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD8 T cells: stem cell memory versus central memory.	An early-differentiated CD8+ memory T cell subset with stem cell-like properties (TSCM) can be identified within the naïve-like T cell population by the expression of CD95/Fas. Based on experiments including exon- and gene-level expression analysis, we provide evidence that this subset of antigen-specific cells represents an early precursor of conventional central (TCM) and effector (TEM) memory CD8+ T cells with enhanced self-renewal capacity and proliferative potential. We identified 900 genes differentially expressed between major T cell subsets defined along with memory T cell commitment. Based on the analysis of these genes, CD95+ naïve T cells (TSCM) cluster closer to the CD8+ T memory compartment than to classical (CD95-) naïve T (TN) cells, and display an intermittent phenotype between classical TN and TCM cells in terms of all major T cell differentiation markers analyzed.					90806	153527	401546	5506	10686	79884	5618	57616	971	81029	23529	146439	8092	3984	55322	171019	7130	284119	58986	6326	146845	79949	79012	144404	2564	130367	163882	3642	130399	64073	6776	84733	64089	399473	153769	84654	9805	23263	90522	8436	91574	3662	4920	390072	9075	9382	221336	10084	155066	1389	10725	6525	349149	25830	57057	89781	23608	3263	60625	4829	55229	9338	3788	7026	5324	9890	55789	51334	10891	5590	27133	10718	53345	84838	10888	23609	2138	54933	9635	775	5883	6011	1141	55509	51804	120939	8884	1879	10654	256979	2557	29904	168433	57677	11187	285513	346689	10867	9424	1795	5869	4616	200035	5241	285051	8128	55089	129138	915	25793	55214	57409	89876	51327	6649	9815	5956	23533	8565	202333	6327	126308	3111	283219	5890	283130	90317	2202	1006	9389	57622	26468	55620	54510	64218	57127	3645	51177	252995	9476	220107	114818	254228	1593	80380	9215	10157	10584	85016	84465	90161	4171	284359	10233	93649	148753	9709	348110	9052	7798	10716	1008	7325	8526	24148	168667	9267	57211	54913	23237	400120	1756	440279	134391	64699	51085	401612	121355	64478	8577	254528	65009	5255	158763	149466	5348	23542	11199	4681	273	140	4298	5654	128209	65123	7481	55061	9414	140578
GSE23321_CD8_STEM_CELL_MEMORY_VS_CENTRAL_MEMORY_CD8_TCELL_DN	M8438		21926977	Gattinoni L,Lugli E,Ji Y,Pos Z,Paulos CM,Quigley MF,Almeida JR,Gostick E,Yu Z,Carpenito C,Wang E,Douek DC,Price DA,June CH,Marincola FM,Roederer M,Restifo NP	GSE23321	GSE23321_2645_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD8 T cells: stem cell memory versus central memory.	An early-differentiated CD8+ memory T cell subset with stem cell-like properties (TSCM) can be identified within the naïve-like T cell population by the expression of CD95/Fas. Based on experiments including exon- and gene-level expression analysis, we provide evidence that this subset of antigen-specific cells represents an early precursor of conventional central (TCM) and effector (TEM) memory CD8+ T cells with enhanced self-renewal capacity and proliferative potential. We identified 900 genes differentially expressed between major T cell subsets defined along with memory T cell commitment. Based on the analysis of these genes, CD95+ naïve T cells (TSCM) cluster closer to the CD8+ T memory compartment than to classical (CD95-) naïve T (TN) cells, and display an intermittent phenotype between classical TN and TCM cells in terms of all major T cell differentiation markers analyzed.					826	11161	84875	29098	25782	23471	56260	1387	54820	100134937	81575	81559	7175	25828	8455	23225	8556	51191	9665	80212	3188	375056	39	51734	8479	57020	738	10682	6903	223082	6733	5528	5298	337867	57118	2936	11232	144699	116092	9550	4033	100131067	54503	54495	1774	29901	4242	84719	11143	8985	84861	10972	84270	79612	64926	55501	51112	10592	64771	221908	84250	7248	493856	23178	3551	90378	3937	93185	100131814	53635	10138	26152	4603	55449	5371	23193	352961	118429	91419	208	87769	200186	55755	8502	23514	9477	27072	51257	1729	1677	84932	6415	3033	57654	55073	10094	10745	26122	10336	79811	26118	260294	84836	284900	3652	23218	11160	355	83442	284702	59342	54851	339803	65018	400657	5775	50808	59307	139886	56950	57120	27291	100505696	23272	4245	199745	9926	10180	23383	841	6653	4863	79041	53827	3841	51071	23005	29068	51060	10916	57583	25865	2971	6687	84142	373863	6464	5898	140688	83988	84727	9946	10919	9813	55856	284323	25875	1445	64005	374659	5933	284040	57724	5093	64172	9976	2976	9500	7171	23231	9881	55683	2733	51105	10732	9525	144363	5883	4343	5955	127281	196513	100129482	400960	171586	79903	84314	5333	10379	83692	80196	144245	1355	955	116236	643977	6837	1121	79699	57473
GSE23321_CD8_STEM_CELL_MEMORY_VS_NAIVE_CD8_TCELL_UP	M8440		21926977	Gattinoni L,Lugli E,Ji Y,Pos Z,Paulos CM,Quigley MF,Almeida JR,Gostick E,Yu Z,Carpenito C,Wang E,Douek DC,Price DA,June CH,Marincola FM,Roederer M,Restifo NP	GSE23321	GSE23321_2647_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD8 T cells: stem cell memory versus naïve.	An early-differentiated CD8+ memory T cell subset with stem cell-like properties (TSCM) can be identified within the naïve-like T cell population by the expression of CD95/Fas. Based on experiments including exon- and gene-level expression analysis, we provide evidence that this subset of antigen-specific cells represents an early precursor of conventional central (TCM) and effector (TEM) memory CD8+ T cells with enhanced self-renewal capacity and proliferative potential. We identified 900 genes differentially expressed between major T cell subsets defined along with memory T cell commitment. Based on the analysis of these genes, CD95+ naïve T cells (TSCM) cluster closer to the CD8+ T memory compartment than to classical (CD95-) naïve T (TN) cells, and display an intermittent phenotype between classical TN and TCM cells in terms of all major T cell differentiation markers analyzed.					10600	55319	10985	90784	908	7064	8813	23642	255231	3178	93953	23413	4495	27043	10477	49854	10808	5591	4291	400236	2905	57695	4904	286023	3267	4800	773	10939	54707	80018	100507564	4783	284454	149401	3954	22934	10237	2135	10228	121457	5708	6911	56246	140838	25915	388	91298	114971	83641	5569	64645	10666	6004	6720	10725	26659	375196	114800	399694	131076	5971	51430	6944	55661	7128	55324	55052	1164	84991	116228	79954	10897	26503	24145	2230	84295	125228	7133	6617	27314	4706	22850	136647	84818	4076	1973	284695	2193	148738	5831	9654	55239	29889	9153	1457	864	6307	221692	92558	65083	3566	60493	9394	151987	8704	27349	116447	201161	55829	30000	10549	3066	30836	64983	81887	2525	6390	23139	51714	285958	7161	214	6775	83443	8676	64225	55920	725	11319	10765	137492	128866	22984	10921	51029	10389	3706	23279	388407	6990	29100	64327	64595	55207	23576	7071	5275	203510	55308	55339	55153	5954	7694	10440	51081	54882	9538	3157	26747	3747	5496	975	51144	7458	60676	2023	149041	64897	11171	85395	10059	51406	7068	7633	55090	51253	157697	25902	9939	27304	54953	284098	2208	392459	23212	10953	133383	26012	6836	219541	3656	9294	51605	51493	4691	55486	80110	404217	10772	10954
GSE23321_CD8_STEM_CELL_MEMORY_VS_NAIVE_CD8_TCELL_DN	M8441		21926977	Gattinoni L,Lugli E,Ji Y,Pos Z,Paulos CM,Quigley MF,Almeida JR,Gostick E,Yu Z,Carpenito C,Wang E,Douek DC,Price DA,June CH,Marincola FM,Roederer M,Restifo NP	GSE23321	GSE23321_2647_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD8 T cells: stem cell memory versus naïve.	An early-differentiated CD8+ memory T cell subset with stem cell-like properties (TSCM) can be identified within the naïve-like T cell population by the expression of CD95/Fas. Based on experiments including exon- and gene-level expression analysis, we provide evidence that this subset of antigen-specific cells represents an early precursor of conventional central (TCM) and effector (TEM) memory CD8+ T cells with enhanced self-renewal capacity and proliferative potential. We identified 900 genes differentially expressed between major T cell subsets defined along with memory T cell commitment. Based on the analysis of these genes, CD95+ naïve T cells (TSCM) cluster closer to the CD8+ T memory compartment than to classical (CD95-) naïve T (TN) cells, and display an intermittent phenotype between classical TN and TCM cells in terms of all major T cell differentiation markers analyzed.					54858	5116	1445	64853	7581	55013	282997	162427	26578	84309	11253	1774	9473	51092	5933	284702	3275	85464	9236	7257	9252	29796	374395	83692	643836	284926	51439	54432	283899	2035	11320	3930	55676	10474	64839	5147	3071	55125	8209	8906	285464	11118	23140	8705	10475	10057	80017	23468	7318	57732	11119	3676	130617	196074	55741	50840	5140	9397	5557	51652	55876	2957	9910	3300	10384	54462	54497	4763	3305	23593	129285	90231	5871	80173	6671	54828	201799	65018	25771	219854	25875	118491	27013	79958	5498	57697	284029	23338	255967	10460	80325	6638	5141	197258	63901	1854	6293	55197	8545	3832	84318	23300	493856	10422	6041	8658	29	221443	2591	10618	64747	51065	55823	119392	80345	25900	29028	8760	56674	54464	402	4149	84266	84984	22879	57654	10487	427	1783	1894	10403	1666	84958	80208	27010	286272	10905	127018	55501	255520	23523	64112	399665	100289019	80312	55758	9860	29901	375757	3148	149603	90806	124446	81857	10636	4938	145389	3903	80194	23112	55252	51135	23130	113510	11100	10681	64135	55634	25938	57551	5880	85315	84869	112574	10273	84964	9528	23503	51292	56890	7764	79956	26020	414328	126308	84250	51112	5257	7454	23178	3661	257160	11041	646870	404636	25864	220972	10928	1859
GSE23321_EFFECTOR_MEMORY_VS_NAIVE_CD8_TCELL_DN	M8442		21926977	Gattinoni L,Lugli E,Ji Y,Pos Z,Paulos CM,Quigley MF,Almeida JR,Gostick E,Yu Z,Carpenito C,Wang E,Douek DC,Price DA,June CH,Marincola FM,Roederer M,Restifo NP	GSE23321	GSE23321_2650_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD8 T cells: effector memory versus naïve.	An early-differentiated CD8+ memory T cell subset with stem cell-like properties (TSCM) can be identified within the naïve-like T cell population by the expression of CD95/Fas. Based on experiments including exon- and gene-level expression analysis, we provide evidence that this subset of antigen-specific cells represents an early precursor of conventional central (TCM) and effector (TEM) memory CD8+ T cells with enhanced self-renewal capacity and proliferative potential. We identified 900 genes differentially expressed between major T cell subsets defined along with memory T cell commitment. Based on the analysis of these genes, CD95+ naïve T cells (TSCM) cluster closer to the CD8+ T memory compartment than to classical (CD95-) naïve T (TN) cells, and display an intermittent phenotype between classical TN and TCM cells in terms of all major T cell differentiation markers analyzed.					51232	3836	51126	23035	56957	11040	63826	23511	6950	54498	1033	148423	192111	55352	10560	55527	10884	1457	54962	4665	152992	200424	54934	51150	7781	84287	7185	122809	6520	114049	54726	262	10885	3592	10969	83440	406991	79794	23760	27340	6386	92558	1435	6674	8662	6400	7372	2107	64940	8761	2353	55379	11266	100506898	10813	54700	4000	3840	219333	51604	3692	9939	84955	23429	3376	65220	55621	81614	1662	159	407975	23011	80745	11177	23529	4927	9880	4800	84524	6675	9261	5272	10469	10328	5971	96764	60673	51561	29949	5433	196383	6880	8676	11103	84541	51388	57464	55854	8458	51075	123606	3091	9308	5440	162073	1326	51762	10007	79568	81892	1362	8844	7037	91734	200081	8140	619505	81565	160760	9816	100506233	55183	29107	5315	22907	55509	83460	7832	81671	4772	51524	51081	84946	65977	81577	169714	10105	83732	80110	53371	4783	25879	673	55081	7813	7975	8420	126792	23212	84306	344	55161	3383	5936	728489	23	7417	54931	5326	10308	57546	391	9181	10531	54865	221079	60488	23261	10128	10153	8061	27033	85465	6434	10102	64794	5520	25929	253982	10425	64318	100133660	1678	28984	5718	55299	57673	51001	3182	84919	23223	9136	692227	23761	29078	155060	54707	3662	282566
GSE27291_0H_VS_6H_STIM_GAMMADELTA_TCELL_UP	M8446		21968650	Pont F,Familiades J,Déjean S,Fruchon S,Cendron D,Poupot M,Poupot R,L'faqihi-Olive F,Prade N,Ycart B,Fournié JJ	GSE27291	GSE27291_3197_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in gamma delta T cells activated by phophoantigen BrHPP and IL2 [GeneID=3558]: 0h versus 6h.	We used microarrays to detail the global programme of gene expression by circulating TCRVgamma9+ gamma delta T cells isolated from healthy individuals,tested either as resting cells or cells activated by phosphoantigen BrHPP and IL-2at an early(+6hrs) and a late (+7days) timepoint. We find that with more “NK cell” genes than alphabeta T cells and more “T cell” genes than NK cells, the circulating TCRVgamma9+ gamma delta T cells cells have a hybrid transcriptome. The gene signature of the activated cells recapitulates their physiological functions: Th1 cytokine, chemokine and cytotoxic activities at first and mitotic activity at later time points. The gene expression pattern of activated normal gamma delta T cells is nevertheless clearly distinctive from that of NK/T and peripheral T cell lymphomas of the gamma delta subtype.					387644	3299	10747	28952	54921	6565	10008	387338	100128554	440915	119467	10598	7728	6430	55695	164781	5211	23081	124801	55082	695	55116	10800	57020	54212	55506	148203	130535	260294	8394	57696	26330	203562	342898	6563	1731	51150	340591	3361	51233	11126	220992	245928	124930	84818	114793	8710	6721	185	64168	22904	54848	155400	55718	285989	285498	2746	3558	100132354	7157	4783	4849	10054	54093	200312	26973	10626	10535	54664	55722	129450	80823	359948	1298	3142	83879	79836	54681	51043	80279	283150	55065	11073	100288656	51217	57817	94121	342892	283737	10277	26168	171017	9203	284912	1237	248	7586	6947	8678	5797	6767	153443	8613	23138	388962	7580	339559	6135	8555	113457	50616	9882	80176	5315	57467	348807	57001	114908	192286	51729	8323	55702	25806	390059	10235	6778	10198	6202	119	57211	90780	203547	2194	10445	56897	2334	10412	5134	8761	6431	80152	2299	4150	4104	80351	5042	2781	55647	8668	55011	2182	84928	10175	63967	6173	2239	57549	374291	3568	400926	5629	442216	283417	55620	284459	55262	6233	10838	93190	342908	51614	6522	53838	394	81543	5464	100289045	6920	57111	23318	2830	196951	57291	4482	123207	51380	55015	64960	5575	3658	25870	100506314	117196	10147	53826	6897	56927	55592	283682
GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_UP	M8452		21968650	Pont F,Familiades J,Déjean S,Fruchon S,Cendron D,Poupot M,Poupot R,L'faqihi-Olive F,Prade N,Ycart B,Fournié JJ	GSE27291	GSE27291_3198_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in gamma delta T cells activated by phophoantigen BrHPP and IL2 [GeneID=3558]: 0h versus 7 days.	We used microarrays to detail the global programme of gene expression by circulating TCRVgamma9+ gamma delta T cells isolated from healthy individuals,tested either as resting cells or cells activated by phosphoantigen BrHPP and IL-2at an early(+6hrs) and a late (+7days) timepoint. We find that with more “NK cell” genes than alphabeta T cells and more “T cell” genes than NK cells, the circulating TCRVgamma9+ gamma delta T cells cells have a hybrid transcriptome. The gene signature of the activated cells recapitulates their physiological functions: Th1 cytokine, chemokine and cytotoxic activities at first and mitotic activity at later time points. The gene expression pattern of activated normal gamma delta T cells is nevertheless clearly distinctive from that of NK/T and peripheral T cell lymphomas of the gamma delta subtype.					100293705	23657	23417	2737	7852	57471	55062	66036	23198	23229	84310	2235	283585	1876	604	55102	10717	6519	915	7874	6964	64754	331	51285	3248	7841	644656	57082	55297	719	126669	140290	9535	80205	79891	27333	10457	136371	64215	23219	64081	60492	64940	3656	5649	6583	1647	90592	64766	646870	2658	10672	54386	116068	214	4249	84981	6687	26339	8365	65059	26130	10237	79649	64764	9043	7704	57186	114825	440200	100288225	400	8451	56995	7132	9730	7442	9120	10950	23099	51277	51053	23764	114799	51099	6256	374860	7456	222161	80896	127670	10903	170082	1234	285512	6793	5639	10125	150244	6539	54856	55236	22863	9325	23131	151657	83443	4899	30834	55683	4253	147429	5603	10260	57579	11079	54472	7993	51024	100506658	699	2802	56955	64065	23232	23011	2803	56940	221336	149018	5996	170712	3006	10499	619190	1649	477	2620	10521	59343	147172	84640	146225	51542	2110	257629	9765	149954	170506	25972	9829	2861	128872	55589	80215	84933	54465	4690	3927	100131993	84280	55208	54859	5332	403314	285761	6248	2355	11141	51588	730631	23291	2681	441394	55526	23041	23140	353355	7707	284576	494150	25809	56987	51278	55857	80255	29062	23468	7223	9885	148189	27112	143384	130026	83661
GSE27291_0H_VS_6H_STIM_GAMMADELTA_TCELL_DN	M8453		21968650	Pont F,Familiades J,Déjean S,Fruchon S,Cendron D,Poupot M,Poupot R,L'faqihi-Olive F,Prade N,Ycart B,Fournié JJ	GSE27291	GSE27291_3197_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in gamma delta T cells activated by phophoantigen BrHPP and IL2 [GeneID=3558]: 0h versus 6h.	We used microarrays to detail the global programme of gene expression by circulating TCRVgamma9+ gamma delta T cells isolated from healthy individuals,tested either as resting cells or cells activated by phosphoantigen BrHPP and IL-2at an early(+6hrs) and a late (+7days) timepoint. We find that with more “NK cell” genes than alphabeta T cells and more “T cell” genes than NK cells, the circulating TCRVgamma9+ gamma delta T cells cells have a hybrid transcriptome. The gene signature of the activated cells recapitulates their physiological functions: Th1 cytokine, chemokine and cytotoxic activities at first and mitotic activity at later time points. The gene expression pattern of activated normal gamma delta T cells is nevertheless clearly distinctive from that of NK/T and peripheral T cell lymphomas of the gamma delta subtype.					9882	26166	27340	8313	388815	283682	7385	5371	9094	27159	55239	390998	8382	4706	79629	480	5578	157855	55052	100507436	58157	6631	283463	283953	100288413	7727	6434	79831	79590	55252	442216	10998	375686	283854	1519	286499	55384	229	440101	55118	6911	8613	9277	283777	9506	10988	6839	9967	10575	57190	57507	285352	11333	51250	5728	54953	388630	130535	100499171	28954	2847	94160	90987	56135	153579	55608	59340	388962	6750	220980	54972	56993	55192	84504	2693	79581	56269	388714	60526	285386	6882	148066	100287572	653275	8618	10969	51150	54962	152100	10856	84293	348825	80336	5596	23630	10762	143458	90525	1953	57187	647589	6820	57594	96764	157285	80349	10587	338324	7553	113622	9831	91461	8675	30968	8555	100129175	2239	57820	29080	5972	10574	55278	3238	3313	619427	221395	56917	84268	10800	5203	150084	203286	9761	22927	401	170949	10269	55661	729799	100505783	79048	4715	8318	10240	191	90161	25938	4947	55157	146325	6635	6520	55163	56142	171482	7812	6738	116224	5437	23158	1537	25966	53942	54805	2015	4711	11046	100134361	57663	5832	285627	91942	1748	115703	84896	114049	91147	2793	11073	54429	493753	5493	9639	283150	387723	10768	112495	51293	79339	100287932	124626	29081	7327	6605	84191	143279	7084	51389	256764	57107
GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_DN	M8457		21968650	Pont F,Familiades J,Déjean S,Fruchon S,Cendron D,Poupot M,Poupot R,L'faqihi-Olive F,Prade N,Ycart B,Fournié JJ	GSE27291	GSE27291_3198_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in gamma delta T cells activated by phophoantigen BrHPP and IL2 [GeneID=3558]: 0h versus 7 days.	We used microarrays to detail the global programme of gene expression by circulating TCRVgamma9+ gamma delta T cells isolated from healthy individuals,tested either as resting cells or cells activated by phosphoantigen BrHPP and IL-2at an early(+6hrs) and a late (+7days) timepoint. We find that with more “NK cell” genes than alphabeta T cells and more “T cell” genes than NK cells, the circulating TCRVgamma9+ gamma delta T cells cells have a hybrid transcriptome. The gene signature of the activated cells recapitulates their physiological functions: Th1 cytokine, chemokine and cytotoxic activities at first and mitotic activity at later time points. The gene expression pattern of activated normal gamma delta T cells is nevertheless clearly distinctive from that of NK/T and peripheral T cell lymphomas of the gamma delta subtype.					6964	100293705	28755	9252	352954	286410	5908	9905	84072	54469	3710	7832	27107	51320	6671	222484	27316	80095	29035	405	54521	55023	439921	100133109	117178	102	8287	7693	114789	140688	6955	55752	55387	100132999	23344	54855	7037	64333	1955	7378	63901	9931	10983	5290	163486	4050	55667	10870	2745	7091	51069	84514	5305	55810	4665	65010	55337	7704	56940	90634	79960	148479	93185	6335	388394	5603	100130344	51099	1032	1606	100128782	8330	81704	152006	1195	10531	389320	1945	9046	116412	23433	10628	8553	355	1912	139716	84140	1026	1362	134957	22889	10048	9794	3932	642361	7750	6583	25852	51177	146434	50618	120227	1847	64769	3955	283897	10507	5128	23531	4149	10225	197259	51330	3034	27240	10868	9990	284309	147138	259197	163081	3303	374403	7155	6497	51460	4763	51466	223082	8175	9493	84678	3727	8974	9619	10009	467	150356	1130	55764	8493	1453	441441	83593	7402	1380	130749	64098	399	171586	90024	57157	79745	79666	55080	84628	54553	1466	114882	645431	214	58508	443	57396	126859	2186	84146	4616	389161	6744	100134368	10748	8731	1033	56997	26049	5778	55448	1387	100506233	2672	1844	29123	7709	23435	4088	165545	6856	51523	23240	85313	3683	284804	9833	80232	694	23347	253512	57343
GSE27291_6H_VS_7D_STIM_GAMMADELTA_TCELL_UP	M8459		21968650	Pont F,Familiades J,Déjean S,Fruchon S,Cendron D,Poupot M,Poupot R,L'faqihi-Olive F,Prade N,Ycart B,Fournié JJ	GSE27291	GSE27291_3199_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in gamma delta T cells activated by phosphoantigen BrHPP and IL2 [GeneID=3558]: 6h versus 7 days.	We used microarrays to detail the global programme of gene expression by circulating TCRVgamma9+ gamma delta T cells isolated from healthy individuals,tested either as resting cells or cells activated by phosphoantigen BrHPP and IL-2at an early(+6hrs) and a late (+7days) timepoint. We find that with more “NK cell” genes than alphabeta T cells and more “T cell” genes than NK cells, the circulating TCRVgamma9+ gamma delta T cells cells have a hybrid transcriptome. The gene signature of the activated cells recapitulates their physiological functions: Th1 cytokine, chemokine and cytotoxic activities at first and mitotic activity at later time points. The gene expression pattern of activated normal gamma delta T cells is nevertheless clearly distinctive from that of NK/T and peripheral T cell lymphomas of the gamma delta subtype.					10015	10980	285282	5211	79711	9038	64105	169966	5768	168374	28977	4620	3956	440915	374383	10179	63906	53838	24139	4185	7108	7458	23530	114908	9703	55657	84520	369	26035	51393	54664	6950	54212	132954	84666	6573	445347	6430	319089	1992	388531	6619	161424	81542	145957	1591	4076	84443	9943	7050	6275	51253	327	5557	130367	4482	130535	9046	55276	55330	11157	51246	788	1855	9204	100288656	93627	3695	9528	1352	84079	283652	8668	9477	4686	23582	54522	132	201294	9801	85014	7323	5982	147660	55709	3386	4340	23247	2014	5968	196527	3575	3823	1652	246126	55324	1738	22821	8625	338864	6390	112936	84940	401474	148413	10017	3312	55223	25843	307	26155	708	55629	9961	100131311	10445	1527	23062	26156	10001	3550	79966	5901	11179	9238	1973	127254	84928	3554	23336	375341	22993	79017	388	54921	4922	23589	9397	2747	10308	10544	201255	1032	6632	137695	8407	10004	9526	6345	5481	9025	51411	54985	100505549	955	148824	55848	10539	10062	23462	374291	27147	4054	10379	7411	64863	257062	4609	10575	55621	136647	1880	347902	125115	8883	55011	100288797	55266	83853	5547	23081	729975	7388	2562	3687	10855	387	302	5696	6635	5531	5499	710	643650	397	155368	7372	79414
GSE27291_6H_VS_7D_STIM_GAMMADELTA_TCELL_DN	M8460		21968650	Pont F,Familiades J,Déjean S,Fruchon S,Cendron D,Poupot M,Poupot R,L'faqihi-Olive F,Prade N,Ycart B,Fournié JJ	GSE27291	GSE27291_3199_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in gamma delta T cells activated by phosphoantigen BrHPP and IL2 [GeneID=3558]: 6h versus 7 days.	We used microarrays to detail the global programme of gene expression by circulating TCRVgamma9+ gamma delta T cells isolated from healthy individuals,tested either as resting cells or cells activated by phosphoantigen BrHPP and IL-2at an early(+6hrs) and a late (+7days) timepoint. We find that with more “NK cell” genes than alphabeta T cells and more “T cell” genes than NK cells, the circulating TCRVgamma9+ gamma delta T cells cells have a hybrid transcriptome. The gene signature of the activated cells recapitulates their physiological functions: Th1 cytokine, chemokine and cytotoxic activities at first and mitotic activity at later time points. The gene expression pattern of activated normal gamma delta T cells is nevertheless clearly distinctive from that of NK/T and peripheral T cell lymphomas of the gamma delta subtype.					222161	6925	57082	27333	100506658	100293705	161823	4690	9905	55297	23746	283130	401324	2213	285512	3479	11119	80205	4159	7852	10618	170689	56270	64926	148870	23140	4915	285761	10499	6941	26762	646870	25973	10221	6687	1760	100288225	5142	8347	64130	5996	64081	1393	399716	51177	1506	10105	9829	283219	1757	104	28970	79874	440101	55683	79772	29940	730631	23657	140290	284382	2208	2678	401145	54542	5540	55030	376497	254013	753	55750	6613	9284	51237	193629	285533	93408	27229	26503	144608	400960	79970	7107	64750	23179	5069	3248	8195	18	2534	80895	55749	23531	2495	84186	339044	1161	441150	641700	645961	5930	65975	23240	1153	57526	1316	8365	55686	55209	1845	100286987	159091	643733	10874	84698	8935	25972	92181	6539	11231	1519	7030	56981	8535	728	10336	149563	143425	10457	653121	23041	57720	644620	286451	100129380	440348	123624	149483	79949	23291	3700	100287411	285852	284992	56955	9927	100507495	23705	103	5226	8897	5731	100128081	91653	440307	146395	1857	554207	59343	53834	400745	1448	51592	79927	403314	5639	286149	400	717	29018	339685	8140	115827	4338	6121	55768	55137	90632	26052	51313	8795	10396	55281	6047	219972	1408	399491	200298	57509	604	80896	51144	84464	51306	92086	23670	157773	3310
GSE26351_UNSTIM_VS_WNT_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN	M8476		22036566	Trompouki E,Bowman TV,Lawton LN,Fan ZP,Wu DC,DiBiase A,Martin CS,Cech JN,Sessa AK,Leblanc JL,Li P,Durand EM,Mosimann C,Heffner GC,Daley GQ,Paulson RF,Young RA,Zon LI	GSE26351	GSE26351_2245_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD34+ [GeneID=947] cells: control versus treated with GSK-3 Inhibitor IX (BIO) [PubChem=5287844].	Analysis of mobilized peripheral blood CD34+ cells from a healthy volunteer under erythroid differentiation conditions with and without stimulation to the BMP or Wnt signaling pathways. For erythroid differentiation, expanded CD34+ cells were placed in Stemspan SFEM medium supplemented with 2% pen/strep, 20ng/ml SCF, 1U/ml Epo, 5ng/ml IL3, 2uM dexamethasone, and 1uM beta-estradiol. Arrays were performed 2 hours after addition of cytokines. For signaling pathway stimulation, cells were exposed to 0.5uM BIO (a GSK3 inhibitor) for Wnt pathway activation, 25ng/ml rhBMP4 for BMP pathway activation, or vehicle control for 2 hours. Three biological replicates were performed per treatment group. We used microarrays to detail the global program of gene expression changes after Wnt or BMP pathway stimulation in human CD34+ hematopoietic progenitors under erythroid differentiation conditions.					2730	51762	8540	84928	113419	201895	54834	10447	5256	8754	51776	28984	2961	57585	254225	6767	9487	3104	122953	128387	25805	10404	7001	2022	10198	10549	8882	26984	54915	494115	10539	9969	4086	2909	501	54838	90522	27246	80318	285704	23076	84065	51520	10106	64374	25977	3632	55194	170384	115294	594	9329	84881	65084	54476	5515	51247	1434	8607	92610	196463	27072	26122	64788	150465	538	4335	79983	54708	7419	51226	26511	158135	9859	7095	8726	10455	23190	64397	5294	642	613	6610	51099	2107	79031	81603	84331	115416	25824	5868	29100	64794	27309	1906	197131	129787	10865	7584	9605	5991	9962	3315	1948	5529	65018	56941	5190	79930	80325	196394	5192	6924	11097	5198	6711	54800	51542	2683	84248	84961	1386	55588	90799	8800	5859	54799	4633	4594	22845	4802	26128	8202	64216	63932	221749	5694	202333	51230	9236	29095	4092	5110	81631	26608	138050	1379	79792	115209	10928	4126	2542	51393	23039	285636	30849	64840	9448	8987	50485	3837	4698	56005	55701	25938	5786	10390	2054	10585	283219	91782	1877	55140	84306	348	80851	9942	155435	169792	3397	10396	1891	6714	56624	55922	51291	55916	59339	93380	375341	8061	1647	79971	25879	57539	6990	91582	7111	128229	29940
GSE26351_WNT_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP	M8477		22036566	Trompouki E,Bowman TV,Lawton LN,Fan ZP,Wu DC,DiBiase A,Martin CS,Cech JN,Sessa AK,Leblanc JL,Li P,Durand EM,Mosimann C,Heffner GC,Daley GQ,Paulson RF,Young RA,Zon LI	GSE26351	GSE26351_2247_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD34+ [GeneID=947] cells treated with GSK-3 Inhibitor IX (BIO) [PubChem=5287844] versus those stimulated by BMP4 [GeneID=652].	Analysis of mobilized peripheral blood CD34+ cells from a healthy volunteer under erythroid differentiation conditions with and without stimulation to the BMP or Wnt signaling pathways. For erythroid differentiation, expanded CD34+ cells were placed in Stemspan SFEM medium supplemented with 2% pen/strep, 20ng/ml SCF, 1U/ml Epo, 5ng/ml IL3, 2uM dexamethasone, and 1uM beta-estradiol. Arrays were performed 2 hours after addition of cytokines. For signaling pathway stimulation, cells were exposed to 0.5uM BIO (a GSK3 inhibitor) for Wnt pathway activation, 25ng/ml rhBMP4 for BMP pathway activation, or vehicle control for 2 hours. Three biological replicates were performed per treatment group. We used microarrays to detail the global program of gene expression changes after Wnt or BMP pathway stimulation in human CD34+ hematopoietic progenitors under erythroid differentiation conditions.					26047	2744	576	100505841	2821	8776	1278	8473	6119	6451	10887	3689	2103	286319	10733	22854	84667	4849	7866	9415	29101	55839	60313	6141	51134	7462	25939	768	2029	2534	2889	286	10063	10690	1297	8270	1396	64897	5906	84332	6606	23677	55055	28991	6632	80821	10809	126695	56992	6695	5324	63948	1180	4837	196410	3718	161436	2189	51267	6736	80254	171546	120939	112939	57096	4130	7358	220988	285613	6422	22803	1063	51083	83543	23480	5978	20	115727	51473	9915	5902	23658	242	54039	597	126282	3984	91862	6252	81563	4700	3882	256329	11078	5714	2925	758	4200	2529	631	11194	644925	1870	386617	8574	55329	221092	386618	83982	57175	23426	784	79987	122553	57805	126432	745	10362	56999	54963	64137	51337	150962	6418	1874	983	140807	1027	79048	55295	6173	116840	4942	5933	10272	10435	374618	4065	89894	7032	8078	79817	1894	26001	5426	65095	81606	9055	401097	10226	6281	5531	23053	150094	5347	79733	5608	692205	57144	79370	55503	6496	7052	84230	64925	51588	3336	80274	167127	25764	58529	57495	7443	3642	387856	220134	284111	284086	6636	2705	1968	9968	9918	7464	55111	2079	26502	32	6530	120	5424	23555	55095	5305	539	148753	64866	641	29796	11259
GSE26351_WNT_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN	M8480		22036566	Trompouki E,Bowman TV,Lawton LN,Fan ZP,Wu DC,DiBiase A,Martin CS,Cech JN,Sessa AK,Leblanc JL,Li P,Durand EM,Mosimann C,Heffner GC,Daley GQ,Paulson RF,Young RA,Zon LI	GSE26351	GSE26351_2247_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD34+ [GeneID=947] cells treated with GSK-3 Inhibitor IX (BIO) [PubChem=5287844] versus those stimulated by BMP4 [GeneID=652].	Analysis of mobilized peripheral blood CD34+ cells from a healthy volunteer under erythroid differentiation conditions with and without stimulation to the BMP or Wnt signaling pathways. For erythroid differentiation, expanded CD34+ cells were placed in Stemspan SFEM medium supplemented with 2% pen/strep, 20ng/ml SCF, 1U/ml Epo, 5ng/ml IL3, 2uM dexamethasone, and 1uM beta-estradiol. Arrays were performed 2 hours after addition of cytokines. For signaling pathway stimulation, cells were exposed to 0.5uM BIO (a GSK3 inhibitor) for Wnt pathway activation, 25ng/ml rhBMP4 for BMP pathway activation, or vehicle control for 2 hours. Three biological replicates were performed per treatment group. We used microarrays to detail the global program of gene expression changes after Wnt or BMP pathway stimulation in human CD34+ hematopoietic progenitors under erythroid differentiation conditions.					421	5756	81603	80318	65117	79719	3104	56946	29090	11214	1379	26608	118987	2021	5452	202333	10078	26984	1500	6990	51499	594	10160	59269	54915	137695	79832	10447	1877	389827	158219	2022	119710	221749	10672	54708	85369	79971	23039	55298	7073	375387	84680	119392	7266	27246	146857	196463	3101	401612	84243	100009676	23492	3707	4057	23506	501	55622	142940	134510	25950	54965	197131	8540	5606	55969	23233	5863	124401	9031	339983	63932	54890	64840	23369	23076	5110	8558	79893	51227	83940	120227	133619	79161	79792	22843	54799	83636	157378	51441	4643	643641	57231	5121	158471	50999	54541	51230	23184	30849	79701	8325	3572	7008	23580	23059	388403	22879	154007	57182	5515	10296	54800	4318	64210	130557	85378	63929	54953	51382	4520	64777	153129	22845	8139	730094	79874	58489	2054	5873	26128	55023	444	1687	51056	7111	6683	54476	29099	140831	51246	55922	64216	2258	8517	51310	84514	10869	55088	23095	51631	9306	64788	92	79876	28971	51068	55250	4216	80267	10634	9942	8863	5108	124512	85021	51133	4217	8530	55017	64417	10982	7138	8233	79637	11021	5581	8660	114034	138050	51250	9331	7110	7798	8851	23421	199857	115294	90441	55929	8726	8567	130535	55140	8694	140775	170384	64121	7580	143471
GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN	M8481		22036566	Trompouki E,Bowman TV,Lawton LN,Fan ZP,Wu DC,DiBiase A,Martin CS,Cech JN,Sessa AK,Leblanc JL,Li P,Durand EM,Mosimann C,Heffner GC,Daley GQ,Paulson RF,Young RA,Zon LI	GSE26351	GSE26351_2246_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD34+ [GeneID=947] cells: control versus stimulated by BMP4 [GeneID=652].	Analysis of mobilized peripheral blood CD34+ cells from a healthy volunteer under erythroid differentiation conditions with and without stimulation to the BMP or Wnt signaling pathways. For erythroid differentiation, expanded CD34+ cells were placed in Stemspan SFEM medium supplemented with 2% pen/strep, 20ng/ml SCF, 1U/ml Epo, 5ng/ml IL3, 2uM dexamethasone, and 1uM beta-estradiol. Arrays were performed 2 hours after addition of cytokines. For signaling pathway stimulation, cells were exposed to 0.5uM BIO (a GSK3 inhibitor) for Wnt pathway activation, 25ng/ml rhBMP4 for BMP pathway activation, or vehicle control for 2 hours. Three biological replicates were performed per treatment group. We used microarrays to detail the global program of gene expression changes after Wnt or BMP pathway stimulation in human CD34+ hematopoietic progenitors under erythroid differentiation conditions.					26047	64283	65258	6208	27338	1874	6442	10205	55658	26001	54963	51555	6559	116173	25939	22854	8853	6203	56244	23053	7866	54662	2642	9868	5499	27018	91875	3064	63891	54550	522	55785	9772	54821	374618	2059	576	163589	653333	57805	126432	954	127254	333926	4130	218	84987	126006	79817	10971	7570	388389	7032	9899	11151	51166	60528	145508	53916	8992	3898	59084	161835	100188893	59344	57674	140735	387856	5175	143	9088	55165	80731	57696	84930	440574	221472	26469	81796	159989	9134	23254	83658	79071	7384	196264	9588	10458	112858	79095	7179	100128927	2321	3141	408186	55080	51337	55227	1388	10677	26053	1611	6154	11273	6305	9150	5577	54949	3070	6829	81502	1159	4637	6776	1137	2783	22895	51384	6451	10712	5478	126695	7185	9374	2232	9468	5064	1590	5291	57577	11173	84263	57144	11245	285613	8405	9509	7287	6175	27089	347862	340990	50832	6188	89894	23144	207063	6129	22803	3549	2706	23682	51267	2773	83852	59285	80853	103	51529	56935	386618	51028	2821	50853	81622	83543	10591	151473	388394	116449	9060	342346	23607	387733	3148	55014	2317	4485	3146	150962	11277	3563	518	1297	284184	10613	25804	4697	6242	28991	377	6427	94104	7074	363	84330	6606	23468	203260	50632
GSE26351_UNSTIM_VS_WNT_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP	M8482		22036566	Trompouki E,Bowman TV,Lawton LN,Fan ZP,Wu DC,DiBiase A,Martin CS,Cech JN,Sessa AK,Leblanc JL,Li P,Durand EM,Mosimann C,Heffner GC,Daley GQ,Paulson RF,Young RA,Zon LI	GSE26351	GSE26351_2245_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD34+ [GeneID=947] cells: control versus treated with GSK-3 Inhibitor IX (BIO) [PubChem=5287844].	Analysis of mobilized peripheral blood CD34+ cells from a healthy volunteer under erythroid differentiation conditions with and without stimulation to the BMP or Wnt signaling pathways. For erythroid differentiation, expanded CD34+ cells were placed in Stemspan SFEM medium supplemented with 2% pen/strep, 20ng/ml SCF, 1U/ml Epo, 5ng/ml IL3, 2uM dexamethasone, and 1uM beta-estradiol. Arrays were performed 2 hours after addition of cytokines. For signaling pathway stimulation, cells were exposed to 0.5uM BIO (a GSK3 inhibitor) for Wnt pathway activation, 25ng/ml rhBMP4 for BMP pathway activation, or vehicle control for 2 hours. Three biological replicates were performed per treatment group. We used microarrays to detail the global program of gene expression changes after Wnt or BMP pathway stimulation in human CD34+ hematopoietic progenitors under erythroid differentiation conditions.					79016	10609	51310	23184	23276	65244	3575	7186	389	57140	29952	11160	1654	57701	79834	55761	64282	55626	55636	80097	54531	224	51333	168544	7071	1802	57659	374868	9519	4784	10472	26996	54863	10066	84962	55917	23433	57060	2909	94120	64400	6925	1649	55337	2339	10320	29966	4122	10209	8565	254359	5634	123016	56920	54855	23116	27090	7629	8897	26471	533	9101	5190	10198	64921	8454	4647	285671	4090	211	54676	9391	79720	1398	1793	2720	83719	65979	8609	50615	4141	57514	79161	197131	9704	2766	353274	6692	84167	79641	54812	7133	56985	6520	130074	10111	6494	753	10724	4798	8325	23585	162427	81566	26608	9941	10160	23076	5663	55975	83706	25974	113402	143903	58476	91694	4092	55262	3920	4493	124583	149647	28955	1741	57580	9851	440093	5514	84749	51449	5351	124401	57458	58525	57727	79969	80139	4839	27153	10043	81622	388646	1723	64207	55094	57559	51666	25798	10585	57617	388588	4802	55207	55024	23171	473	118987	3429	6640	23096	56521	977	9706	255520	79735	5819	81618	57700	6655	813	6988	79719	28970	9429	8411	5442	115350	79932	10014	5501	388403	23031	283489	169792	1500	9013	5955	26149	3487	79042	11163	90313	10597	9679	4043	10625	4193	1655	56674	51063
GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP	M8483		22036566	Trompouki E,Bowman TV,Lawton LN,Fan ZP,Wu DC,DiBiase A,Martin CS,Cech JN,Sessa AK,Leblanc JL,Li P,Durand EM,Mosimann C,Heffner GC,Daley GQ,Paulson RF,Young RA,Zon LI	GSE26351	GSE26351_2246_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD34+ [GeneID=947] cells: control versus stimulated by BMP4 [GeneID=652].	Analysis of mobilized peripheral blood CD34+ cells from a healthy volunteer under erythroid differentiation conditions with and without stimulation to the BMP or Wnt signaling pathways. For erythroid differentiation, expanded CD34+ cells were placed in Stemspan SFEM medium supplemented with 2% pen/strep, 20ng/ml SCF, 1U/ml Epo, 5ng/ml IL3, 2uM dexamethasone, and 1uM beta-estradiol. Arrays were performed 2 hours after addition of cytokines. For signaling pathway stimulation, cells were exposed to 0.5uM BIO (a GSK3 inhibitor) for Wnt pathway activation, 25ng/ml rhBMP4 for BMP pathway activation, or vehicle control for 2 hours. Three biological replicates were performed per treatment group. We used microarrays to detail the global program of gene expression changes after Wnt or BMP pathway stimulation in human CD34+ hematopoietic progenitors under erythroid differentiation conditions.					5424	25996	1407	1069	8428	2821	5682	5437	79817	5422	6037	9260	196446	7272	79956	5525	6175	8310	8514	8653	25804	7398	64422	83658	79630	79158	51651	6993	162989	29101	56993	7385	25939	26512	3111	84440	8815	10803	80212	8407	2665	23480	26191	5695	84316	54881	5464	55704	9933	8438	220134	81606	51042	1633	64975	253782	5692	64951	128506	890	84941	863	22948	126003	4869	11151	6203	2775	11004	52	23658	126282	79184	6189	10480	23410	10008	81502	3065	1736	10124	64780	51134	10100	29093	10987	6208	5360	25833	93190	23022	51493	53335	4668	9744	79716	5524	6304	6884	25841	83742	3606	3306	2044	65258	29097	55646	223	3899	200159	55110	8417	11092	4700	55847	55049	10458	5664	3396	9360	835	5984	9600	1844	4065	65220	31	4253	50489	9553	23770	11116	10801	79622	221154	6367	23705	11329	55651	113278	285641	6147	5688	641638	23568	958	2534	3092	10616	23011	4925	515	10000	55011	8612	6632	4694	92181	84992	26469	10063	1164	51668	1627	1528	55505	1810	2833	9412	10428	64581	6390	112942	79897	8464	29107	118487	522	11164	7297	1351	9076	30834	57333	93974	79366	154141	122704	50650	9533	3093	5538	9672	10397	55766	56833	60528	2869	5058	8914
GSE32164_RESTING_DIFFERENTIATED_VS_ALTERNATIVELY_ACT_M2_MACROPHAGE_DN	M8524		22067385	Pello OM,Pizzol De M,Mirolo M,Soucek L,Zammataro L,Amabile A,Doni A,Nebuloni M,Swigart LB,Evan GI,Mantovani A,Locati M	GSE32164	GSE32164_3500_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in macrophages: resting differentiated versus alternatively activated M2.	In response to microenvironmental signals macrophages undergo different activation, indicated as classic/M1 and alternative/M2 polarization. C-Myc transcription factor could be an essential player in M2 polarization. Functional relevance of c-Myc in M2 macrophage biology is investigated by evaluating the effect of 100-58F4, on the transcriptional profile induced on human macrophages by IL-4.					3117	639	29969	25820	3123	1877	56995	65080	3249	55186	2790	22914	7084	4189	23191	9538	81846	3512	1982	84525	51720	10924	1234	10188	2149	597	933	768211	9588	9275	22908	56990	640	51526	2869	301	10791	8784	10672	8435	9046	2833	3636	3689	64859	23077	7323	930	79026	5552	26994	65109	51495	940	8829	113402	1183	4828	55365	3514	8835	356	138050	9908	2817	81618	51184	729230	10875	2634	3575	406	79887	7514	51324	3458	10285	3732	22928	3688	3383	8694	1152	8807	3565	8809	219972	123	79668	6038	9770	1479	2625	7456	11153	3106	8732	221178	164	3043	5551	118429	5481	3658	2113	10219	10950	5698	9497	10299	54529	51528	6294	2123	4318	64969	677	53917	840	5734	10423	1535	51379	23608	51170	466	5272	51552	55667	23380	1289	1729	10955	2071	55929	26137	7318	64645	4005	1512	10402	9528	149951	51571	60526	841	5167	8553	9950	54855	10134	5664	25912	6499	8411	317781	10567	3587	55071	3107	84309	9445	115207	81552	54453	80196	3398	10097	6468	84919	5997	81559	3188	953	971	55041	3663	5580	80150	7412	2339	9034	754	221477	3309	23446	10906	8408	8452	5971	3588	51255	8543	10270	51136	10077	10482	6184	54491	2139
GSE32164_RESTING_DIFFERENTIATED_VS_ALTERNATIVELY_ACT_M2_MACROPHAGE_UP	M8527		22067385	Pello OM,Pizzol De M,Mirolo M,Soucek L,Zammataro L,Amabile A,Doni A,Nebuloni M,Swigart LB,Evan GI,Mantovani A,Locati M	GSE32164	GSE32164_3500_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in macrophages: resting differentiated versus alternatively activated M2.	In response to microenvironmental signals macrophages undergo different activation, indicated as classic/M1 and alternative/M2 polarization. C-Myc transcription factor could be an essential player in M2 polarization. Functional relevance of c-Myc in M2 macrophage biology is investigated by evaluating the effect of 100-58F4, on the transcriptional profile induced on human macrophages by IL-4.					5590	10787	7019	7846	8323	7223	1278	80725	8290	10189	9124	2532	54443	9021	51264	25849	1111	6932	9452	1718	79733	3399	328	1901	113235	26586	191	51316	441282	991	326	55647	983	9294	3578	4060	5216	7083	3914	926	7088	6001	5355	5743	1282	4521	10403	93974	8569	51617	8433	1163	9644	25842	123099	1317	81620	344191	1004	641638	890	11113	6402	79140	64105	51203	5340	9960	5111	79071	55143	92749	2146	55766	3364	126282	5979	23234	81624	50486	51690	137492	6446	5888	9532	7350	7153	83461	29127	79828	3156	3485	24137	9156	8971	6713	4548	9768	10112	9493	220202	4778	4686	4085	5464	9133	126669	9212	3682	5947	22809	1396	10861	214	3760	3484	203068	925	1236	4609	54626	908	4861	995	332	5329	54962	3925	3838	1029	1058	6231	23397	4846	53635	3201	29895	675	54544	3902	7164	4913	28984	7782	55799	87	1595	55363	51294	2618	1750	4052	6521	291	5557	6382	2161	2521	29128	2014	5723	990	3490	55004	2258	23594	23649	5902	9055	84263	6835	2622	7289	116541	81579	8318	30012	5427	1760	157695	319	610	2171	6241	9448	7515	23326	6659	3204	3651	57451	1956	10536	2709	88	3910	4023	3908	3835	1462
GSE32164_ALTERNATIVELY_ACT_M2_VS_CMYC_INHIBITED_MACROPHAGE_UP	M8528		22067385	Pello OM,Pizzol De M,Mirolo M,Soucek L,Zammataro L,Amabile A,Doni A,Nebuloni M,Swigart LB,Evan GI,Mantovani A,Locati M	GSE32164	GSE32164_3502_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in macrophages: alternatively activated M2 versus MYC [GeneID=4609] inhibited.	In response to microenvironmental signals macrophages undergo different activation, indicated as classic/M1 and alternative/M2 polarization. C-Myc transcription factor could be an essential player in M2 polarization. Functional relevance of c-Myc in M2 macrophage biology is investigated by evaluating the effect of 100-58F4, on the transcriptional profile induced on human macrophages by IL-4.					51720	9878	7850	3123	84525	7084	3117	3945	8807	359845	84364	9538	3514	10048	3512	5551	8435	834	3712	23218	79001	8698	8703	84461	51495	348	94103	28969	221496	10948	356	9046	922	5236	8233	1535	84909	80196	123	1183	7456	2101	57533	81618	3661	22914	1982	1509	4005	3383	3043	3565	10188	81894	64859	3689	3458	210	27240	914	22936	1455	2817	1974	4050	79887	5187	10134	3398	55761	22928	9275	6603	25914	2072	25941	113402	83593	81559	10771	729230	22980	3570	79575	923	23164	1512	4125	80279	11070	8861	337867	28988	27348	202	7407	4318	1840	10219	973	402778	55071	4802	51170	9761	8732	54453	3106	7529	27044	51552	222487	2060	8835	3603	3732	4074	10077	4615	6499	164	55870	6038	8440	54956	3249	11153	8439	10567	55795	2131	23152	115207	301	6236	9784	55288	3709	940	3040	1943	64601	10097	5167	5106	3507	5971	10482	5531	6352	55593	51763	3688	2055	816	2947	23250	149951	7293	27072	57703	5430	5880	1436	56605	1152	83985	57175	8394	920	953	10791	1729	51528	55303	4689	6890	118429	65109	2833	768211	3109	138050	406	3636	79586	11054	6610	5771	219972	971	9908	26015	8943	56990	26993	56257	6850	9261	54855
GSE32164_ALTERNATIVELY_ACT_M2_VS_CMYC_INHIBITED_MACROPHAGE_DN	M8530		22067385	Pello OM,Pizzol De M,Mirolo M,Soucek L,Zammataro L,Amabile A,Doni A,Nebuloni M,Swigart LB,Evan GI,Mantovani A,Locati M	GSE32164	GSE32164_3502_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in macrophages: alternatively activated M2 versus MYC [GeneID=4609] inhibited.	In response to microenvironmental signals macrophages undergo different activation, indicated as classic/M1 and alternative/M2 polarization. C-Myc transcription factor could be an essential player in M2 polarization. Functional relevance of c-Myc in M2 macrophage biology is investigated by evaluating the effect of 100-58F4, on the transcriptional profile induced on human macrophages by IL-4.					3676	9188	1595	6659	5274	10051	163786	7371	2584	55299	4782	1622	4751	6932	1317	5422	5355	9265	2146	5425	5557	5093	1362	117178	84504	328	3422	3014	1164	644890	3149	825	54799	92749	641638	54443	51321	22944	23234	774	7086	8848	84100	6446	6713	29081	3399	23005	8290	5985	3682	6790	22821	7153	6001	7782	5935	9493	9124	1111	1004	214	4001	8531	2764	93974	51744	359	3613	84624	427	51514	79723	51316	760	23710	5433	581	6402	259266	286827	57162	925	7295	4534	54602	1278	9768	302	5427	10460	23397	924	64105	3418	3815	8971	25864	1182	2014	1718	119504	79140	6094	29127	87	3902	10235	1678	10239	928	84272	1901	79071	10229	3276	5216	1146	51655	55723	26578	10962	255231	2618	84844	5020	9532	990	25847	332	29968	2653	8293	5478	1396	2182	10189	1163	145781	6251	3156	3978	51154	8773	51617	11014	7455	113130	3832	26586	9055	1719	2079	2274	5359	399	22809	53822	10901	699	133418	8609	51203	3567	8140	9448	9960	983	6231	9587	291	991	8433	51205	6271	1603	7035	55143	29895	9319	51668	56267	8672	28957	23468	51264	5898	115817	84991	9846	7297	8557	1737	6631	5983	27065	5372	56650	1266
GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_DN	M8531		22067385	Pello OM,Pizzol De M,Mirolo M,Soucek L,Zammataro L,Amabile A,Doni A,Nebuloni M,Swigart LB,Evan GI,Mantovani A,Locati M	GSE32164	GSE32164_3501_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in macrophages: resting differentiated versus MYC [GeneID=4609] inhibited.	In response to microenvironmental signals macrophages undergo different activation, indicated as classic/M1 and alternative/M2 polarization. C-Myc transcription factor could be an essential player in M2 polarization. Functional relevance of c-Myc in M2 macrophage biology is investigated by evaluating the effect of 100-58F4, on the transcriptional profile induced on human macrophages by IL-4.					51495	65080	8477	10762	373156	8446	51274	55959	3932	56674	9047	2149	5214	919	6811	79575	9753	51318	29103	84246	5551	9046	80150	23380	81608	124565	5880	8394	9111	8784	1515	8315	2335	3512	5691	171546	2625	57231	9184	6277	10594	5720	1455	57175	9775	83985	222229	64116	6275	81502	226	10797	1154	6827	3249	4615	10712	8807	22820	3429	23608	55748	4851	5536	355	161882	64135	4646	54855	1509	4695	55365	84897	3732	57713	5998	55845	1234	29085	10682	7284	83593	7185	22928	1454	122786	2071	84525	85021	64333	3627	51108	54187	64215	5531	14	10577	8434	5696	2023	729230	9588	23259	51503	5292	7454	1152	51382	27229	917	939	1493	9232	81618	8502	2534	9452	27250	9258	1436	832	140735	10538	921	3398	27341	54491	54741	1603	639	64859	3688	3001	9197	10225	3992	2817	10228	5567	8809	440574	3824	10211	6786	8829	960	3241	81671	10950	2230	25844	3265	123	55011	573	8986	4686	6932	23270	2583	6143	28959	1840	923	79071	81892	3267	23466	10219	10553	79002	9555	26136	84309	10016	83931	23250	6352	54499	5589	8435	55958	100287932	28969	7067	356	10263	5734	3945	7371	55568	3433	2745	816	23218	6281	3437	27240	2323	3383
GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_UP	M8532		22067385	Pello OM,Pizzol De M,Mirolo M,Soucek L,Zammataro L,Amabile A,Doni A,Nebuloni M,Swigart LB,Evan GI,Mantovani A,Locati M	GSE32164	GSE32164_3501_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in macrophages: resting differentiated versus MYC [GeneID=4609] inhibited.	In response to microenvironmental signals macrophages undergo different activation, indicated as classic/M1 and alternative/M2 polarization. C-Myc transcription factor could be an essential player in M2 polarization. Functional relevance of c-Myc in M2 macrophage biology is investigated by evaluating the effect of 100-58F4, on the transcriptional profile induced on human macrophages by IL-4.					59345	11142	6770	2213	138241	330	51655	4956	4942	1278	25840	9026	5580	7299	604	56605	3112	3578	214	4121	3676	2045	1901	6521	8754	140679	4261	27086	81605	10670	4643	3399	5450	64844	4082	57157	930	9868	9326	933	6610	715	5777	2768	9362	217	7782	11080	5570	4647	84902	80821	2556	9957	201895	951	8411	79683	4067	6850	623	23062	25932	1058	2571	827	4534	7020	285636	23234	8609	7019	6925	3720	64324	6713	51523	84504	4214	2906	7088	729330	5424	9194	1059	6689	695	6688	975	57584	1512	710	55773	760	2037	131	52	7465	54899	3662	27063	23313	3060	5899	154	3623	8994	10148	6165	6402	6865	84617	255231	335	3890	53981	2934	5913	6453	4644	55103	91663	2516	2645	3394	8930	51429	1075	2264	1520	64924	286827	54107	85463	55269	259307	1235	958	5360	863	3292	4935	3223	6261	146223	4515	1879	10999	1032	5025	133619	7163	81620	55205	1647	6856	3109	148534	9079	5546	7462	726	631	2876	4208	1004	56262	7127	8013	2217	4245	3914	1184	328	5020	1266	4673	10882	26100	55793	5371	1384	4070	8460	10235	3663	4350	7414	5438	8826	3920	952	7480	5145	57544	27230	1415	540	842	3507
GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_DN	M8533		22086415	Walker LJ,Kang YH,Smith MO,Tharmalingham H,Ramamurthy N,Fleming VM,Sahgal N,Leslie A,Oo Y,Geremia A,Scriba TJ,Hanekom WA,Lauer GM,Lantz O,Adams DH,Powrie F,Barnes E,Klenerman P	GSE33374	GSE33374_3499_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in KLRB1 high [GeneID=3820] T cells: CD8A [GeneID=925] versus CD8A CD8B [GeneID=925;926].	We used microarrays to compare gene expression between healthy human CD161++CD8aa and CD161++CD8ab T cells.					51495	122786	64135	5696	84246	3992	7412	355	5373	7805	359845	1259	4692	6038	124565	10948	2629	10924	64215	529	10788	8890	10188	23246	79145	23283	81502	1877	939	88	1509	5830	644096	8986	28969	3732	8446	5567	2583	57175	1611	23	8807	57713	5720	2817	790	3720	921	3932	64116	7185	5214	1455	10267	8502	64333	8694	1152	3437	26121	8784	604	6094	5691	414328	3689	5715	51701	5998	79575	1729	2149	3249	53616	22928	1666	4646	8435	8892	81558	6609	10762	2314	5202	9775	550	5551	51108	6786	56674	9046	374395	39	9600	5698	3627	27240	3433	11202	140735	5536	55303	51466	79002	9636	55748	6932	55795	7486	81671	10134	391	7070	7454	64859	6352	26993	5027	6143	5880	81618	6304	8600	80150	29085	10801	81608	5734	916	55667	83985	152007	5702	222487	6890	83593	80011	1515	23218	919	6520	1939	9343	2534	9261	247	10797	1183	3824	25777	10023	22820	221496	85021	8993	5531	10111	940	23380	3133	4828	7409	402778	80306	64426	2139	9592	10803	3001	3455	54453	5588	4792	6183	10219	1603	9047	7384	65997	5187	4686	9361	79668	55845	10077	79716	8533	3105	5829	202	917	51202	79142	6468	10228	9184	1154	57162	9527
GSE33424_CD161_HIGH_VS_INT_CD8_TCELL_UP	M8534		22086415	Walker LJ,Kang YH,Smith MO,Tharmalingham H,Ramamurthy N,Fleming VM,Sahgal N,Leslie A,Oo Y,Geremia A,Scriba TJ,Hanekom WA,Lauer GM,Lantz O,Adams DH,Powrie F,Barnes E,Klenerman P	GSE33424	GSE33424_3490_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD8 T cells: KLRB1 high [GeneID=3820] versus KLRB1 int [GeneID=3820].	We used microarray to compare gene expression between CD161++/CD161+/CD161-CD8+ T cells from human cord blood.					5274	4942	3990	23313	23787	1512	5025	129285	51170	1366	8754	3960	79887	55103	81605	11260	5292	8460	7414	11142	2059	5580	3507	10365	201895	5020	55973	10166	91663	3676	9247	5581	84263	7011	55269	440275	9456	3920	22821	908	3783	219972	5876	57648	2653	85463	9194	4735	128338	23327	9750	2739	3364	84617	9056	25976	29097	8994	54407	140679	10549	1638	10243	6288	930	57157	4245	84902	1075	3587	23062	403	25932	4644	834	9314	4609	4534	6850	4067	5446	1879	1326	115207	7324	25864	6261	7050	3112	4783	6925	6281	9532	3838	2123	2184	6277	640	7107	29105	4121	11031	10213	10636	4673	3654	6865	3087	4072	51316	81846	5371	145781	4861	3655	1105	1605	4214	138241	8082	302	51154	115361	6251	191	4257	6402	4869	84817	4261	51523	9516	1266	4637	79140	7163	6856	3099	2784	285172	51095	5805	10247	53981	122622	4170	9988	116064	10586	122618	22	5450	2060	7337	56262	842	9362	7019	9451	5570	27230	5412	952	8531	5184	64645	6319	4005	4070	3615	5359	1415	114908	3623	58517	5634	27075	1230	5360	54107	390916	5329	5906	10381	255231	6521	51655	4647	2230	2556	57584	51112	933	4811	7465	6713	7846	56605	3055	1317
GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP	M8538		22086415	Walker LJ,Kang YH,Smith MO,Tharmalingham H,Ramamurthy N,Fleming VM,Sahgal N,Leslie A,Oo Y,Geremia A,Scriba TJ,Hanekom WA,Lauer GM,Lantz O,Adams DH,Powrie F,Barnes E,Klenerman P	GSE33374	GSE33374_3499_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in KLRB1 high [GeneID=3820] T cells: CD8A [GeneID=925] versus CD8A CD8B [GeneID=925;926].	We used microarrays to compare gene expression between healthy human CD161++CD8aa and CD161++CD8ab T cells.					2532	55766	926	10989	11113	57657	9620	10123	8175	5286	7376	88	221955	6622	1130	925	7515	84461	4005	3745	55808	79887	27240	3855	80781	7223	8506	2776	1112	11340	5307	54437	285	123099	973	9442	8165	9021	1462	23152	29844	6363	1158	54093	9156	246	8786	6499	7040	28511	2248	29099	3201	23452	8566	319	25946	2687	10900	1236	6610	25865	27089	4212	4921	219348	57111	4878	7786	10514	55795	3651	6402	140767	342574	1613	51043	128308	914	10400	3950	6256	2246	64975	92749	5796	4605	9955	1056	7760	29888	24142	9753	8703	7289	25906	8777	4299	1278	6462	51564	9960	136853	3661	610	10743	7200	84717	920	1294	6602	4684	8342	546	1943	8433	22985	7476	113675	55527	4925	95	81624	57130	602	2103	9402	25930	57475	2767	84458	3757	863	23587	673	6777	26468	9397	11230	9283	23633	6492	8569	79140	51117	3000	2668	475	5590	1291	340527	136	22809	1741	714	359845	1411	3592	4851	4303	4861	23316	26001	943	10893	56961	3566	10938	1723	10861	9784	6714	2676	60386	5731	3239	2947	4052	7259	29785	3606	7125	3980	2526	79570	923	3269	6820	10661	733	8705	652	972	2255	3489	112869	187	1791	8941	9275
GSE33425_CD161_INT_VS_NEG_CD8_TCELL_UP	M8539		22086415	Walker LJ,Kang YH,Smith MO,Tharmalingham H,Ramamurthy N,Fleming VM,Sahgal N,Leslie A,Oo Y,Geremia A,Scriba TJ,Hanekom WA,Lauer GM,Lantz O,Adams DH,Powrie F,Barnes E,Klenerman P	GSE33425	GSE33425_3149_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD8 T cells: KLRB1 int [GeneID=3820] versus KLRB1- [GeneID=3820].	This SuperSeries is composed of the SubSeries listed below.					53917	2790	79026	29969	928	26994	760	9265	3190	427	10890	8935	7323	5552	8411	5412	26225	302	528	8784	6683	51744	57019	51136	5481	9039	286827	2037	55907	3732	10134	80824	7533	23741	6251	6294	84693	51379	64645	5359	356	8560	79709	55234	115207	23468	5093	5698	378	10159	4218	51526	5532	3676	8600	51128	9445	5500	54432	79811	9	166378	84309	11112	677	23193	6389	81671	23186	400	6510	9538	819	84747	26035	1362	8434	10955	6938	80760	9476	3073	214	51316	114879	51691	11163	382	9616	6352	10916	29887	9802	1024	5445	9590	79441	9364	196294	3685	51768	10875	9375	8674	54491	10924	3842	58533	6489	7871	23234	2079	3824	10625	5274	10285	23433	55041	133418	2182	6048	2632	9791	23350	64859	128	80762	11083	5997	26578	59338	6309	5664	10869	64121	102	8899	9317	23683	80005	25912	6281	10175	6093	10018	9525	466	5583	5527	9588	10678	23588	3157	6713	10430	51095	51429	56897	8073	6595	9126	4900	158219	5862	56947	3459	3575	284996	64411	5783	55299	597	8726	2961	79753	5264	9741	408	3107	80351	4735	6134	26065	26191	4189	10901	55754	10063	57162	387263	7188	118429	253943	1495	5230	4601	80349	55327	2060	64065
GSE33424_CD161_HIGH_VS_INT_CD8_TCELL_DN	M8540		22086415	Walker LJ,Kang YH,Smith MO,Tharmalingham H,Ramamurthy N,Fleming VM,Sahgal N,Leslie A,Oo Y,Geremia A,Scriba TJ,Hanekom WA,Lauer GM,Lantz O,Adams DH,Powrie F,Barnes E,Klenerman P	GSE33424	GSE33424_3490_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD8 T cells: KLRB1 high [GeneID=3820] versus KLRB1 int [GeneID=3820].	We used microarray to compare gene expression between CD161++/CD161+/CD161-CD8+ T cells from human cord blood.					64411	10376	8290	5464	873	80725	5783	50486	23635	84833	6827	366	29127	65265	55702	4171	23466	10787	4521	4851	1493	5723	1468	9452	5064	2672	6001	191	27089	79071	54491	9960	8502	9644	6697	112936	51617	991	10505	6275	9124	88	3835	6777	100	1282	9768	4686	94081	93974	926	326	1457	3241	51108	57465	25849	4146	27341	284996	116541	64975	6281	3575	402778	6171	83461	983	23594	28969	28984	9021	201965	23397	9620	9753	9532	917	6277	7153	63931	4605	302	4712	7294	87	64231	3855	10189	7846	8829	6932	26586	51690	9527	53635	221143	3490	3344	10123	2585	136541	91689	894	10577	10574	4695	80279	8728	51264	5743	2146	27240	641638	7515	5478	10514	890	925	80145	4548	6404	2532	9133	1644	3429	3925	10211	54855	57657	5888	203068	9588	9695	28957	4784	26191	1111	51596	4632	5954	3482	7070	291	4646	7535	5340	915	57713	475	10112	113235	940	1718	1163	23452	6750	7917	181	928	995	133418	51128	3484	92906	5902	1259	51762	6231	9156	7295	706	4010	56942	53827	8530	5214	10536	348303	81624	3702	126282	92749	7371	51203	3992	2192	5223	4778	3122	355	2149	5230	8434	54626	157695	4698	8786	3682	10267
GSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_UP	M8541		22086415	Walker LJ,Kang YH,Smith MO,Tharmalingham H,Ramamurthy N,Fleming VM,Sahgal N,Leslie A,Oo Y,Geremia A,Scriba TJ,Hanekom WA,Lauer GM,Lantz O,Adams DH,Powrie F,Barnes E,Klenerman P	GSE33424	GSE33424_3491_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD8 T cells: KLRB1 high [GeneID=3820] versus KLRB1- [GeneID=3820].	We used microarray to compare gene expression between CD161++/CD161+/CD161-CD8+ T cells from human cord blood.					6498	161145	3628	23433	53917	10809	11142	51571	8674	7084	4643	4261	3112	2790	26225	79683	57409	597	958	9798	23191	401612	1579	5580	4170	972	25946	51720	6643	55041	4066	1555	6689	5125	29969	10285	9570	2037	5552	5336	63979	23062	5450	6850	9476	2650	51429	695	3073	84919	285220	4887	6294	6402	4644	2113	10019	23193	9770	930	219972	214	7378	8935	2213	23741	9957	4925	26524	51379	9926	604	933	3632	29760	55278	3308	10767	3043	80004	3658	6925	79709	7323	11153	274	8994	9	84824	1269	1075	4189	9450	25912	55205	971	81533	440275	8930	466	9497	56605	51490	284371	1982	10955	5009	138241	2799	85463	3425	9169	259307	64924	640	6300	57544	28834	55103	2209	4208	931	10270	19	1859	4688	216	55342	5412	2947	3383	760	10463	8013	10294	10391	3055	54529	3895	23446	5660	51095	65109	974	134266	134510	3109	1512	27434	22908	55054	11193	1992	1827	23077	696	1235	55692	10672	3117	9364	3663	115207	136319	7813	837	201595	55186	4067	51552	102	8726	643	5981	79887	3636	952	6856	25820	6595	3588	677	5999	10814	4942	2208	64222	23761	26137	330	4245	164	5570	8411	3123	51147	9590	26035	9308	26576
GSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_DN	M8542		22086415	Walker LJ,Kang YH,Smith MO,Tharmalingham H,Ramamurthy N,Fleming VM,Sahgal N,Leslie A,Oo Y,Geremia A,Scriba TJ,Hanekom WA,Lauer GM,Lantz O,Adams DH,Powrie F,Barnes E,Klenerman P	GSE33424	GSE33424_3491_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD8 T cells: KLRB1 high [GeneID=3820] versus KLRB1- [GeneID=3820].	We used microarray to compare gene expression between CD161++/CD161+/CD161-CD8+ T cells from human cord blood.					3925	2532	88	873	4171	50486	359845	7805	4521	152877	65265	4686	26586	3932	5694	5783	326	116541	983	27240	10189	5902	83461	9960	80725	6446	64231	6001	522	4884	51264	51617	6932	11113	55702	10198	7350	51043	890	9644	9768	940	3575	2258	355	1278	79145	2672	28970	64975	51108	6775	7070	9620	29127	126	112936	4316	991	23354	5888	1259	1959	6942	6094	8290	3423	7294	4692	9532	27089	29968	926	4851	28984	80145	672	10787	9695	23175	51203	22985	28969	3992	92906	374454	2149	57162	8323	3201	54443	2146	10290	1282	100	4712	1175	6749	10267	10123	4778	915	92749	6717	6827	3399	7153	9249	917	9452	4176	10898	9055	916	165	5111	8660	4646	113235	23635	5723	1163	8829	64105	1111	4146	2534	7535	28957	54544	5947	2030	3241	8692	3156	6304	6171	79071	55105	641638	441282	90313	55143	5163	7515	10514	4931	25819	332	4695	57455	51466	5064	93974	759	9133	191	3702	126282	5691	3902	2192	84717	4299	128308	1644	7260	2150	925	8530	3835	51596	10505	10803	547	26136	3914	4548	56942	122786	995	157695	84833	5214	9527	280636	4493	2625	4085	5985	8433	10723	4605	2200	3105	414328	415116	9448	5721	8434
GSE33425_CD161_INT_VS_NEG_CD8_TCELL_DN	M8543		22086415	Walker LJ,Kang YH,Smith MO,Tharmalingham H,Ramamurthy N,Fleming VM,Sahgal N,Leslie A,Oo Y,Geremia A,Scriba TJ,Hanekom WA,Lauer GM,Lantz O,Adams DH,Powrie F,Barnes E,Klenerman P	GSE33425	GSE33425_3149_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD8 T cells: KLRB1 int [GeneID=3820] versus KLRB1- [GeneID=3820].	This SuperSeries is composed of the SubSeries listed below.					408	53917	11153	958	51571	23191	11142	29887	5660	23433	5580	6184	29969	9314	8674	7011	3112	953	6294	55103	9056	3632	4644	10890	65109	91663	7741	3658	51316	972	1075	1105	1213	2037	51720	54529	8994	5125	640	55041	9570	6643	164	51147	7323	6850	157769	930	79887	23062	4942	102	11018	643	136319	25976	5664	5481	10166	4925	4066	27131	51552	9525	9039	57409	56990	9308	22908	3308	25912	4261	84902	219972	5359	2113	4257	1512	55278	26035	1380	23077	23193	8801	931	51284	4170	7107	5151	51095	11193	6925	5805	55692	3587	4189	6194	301	4072	6093	302	23761	10213	8082	23258	9476	29760	60492	8581	3055	2799	55365	26994	54432	84617	9798	2790	5090	27290	900	56995	310	5552	128338	5412	79140	51324	221477	85463	28834	64222	6689	10809	2123	9497	133	974	84824	7084	1326	81846	10961	10494	2059	11031	51170	3636	4008	79026	2060	1396	3831	23446	5450	57544	440275	695	7019	6856	8411	138241	4245	5355	401612	8417	10625	6300	25820	33	952	4067	5329	4005	51136	81533	23070	339	246	5906	3117	9538	7326	196294	22862	5336	6814	11083	3340	55269	6275	25946	55312	933	4811	4124	8522	85365	928	3842	6251
GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_DN	M8545		22086415	Walker LJ,Kang YH,Smith MO,Tharmalingham H,Ramamurthy N,Fleming VM,Sahgal N,Leslie A,Oo Y,Geremia A,Scriba TJ,Hanekom WA,Lauer GM,Lantz O,Adams DH,Powrie F,Barnes E,Klenerman P	GSE33425	GSE33425_3147_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD8 T cells: KLRB1 high [GeneID=3820] versus KLRB1 int [GeneID=3820].	This SuperSeries is composed of the SubSeries listed below.					3422	10901	1493	5480	9429	6484	2146	29127	7086	5214	93974	7498	23397	3613	3398	7371	1509	84991	51079	6404	928	284996	7272	825	2584	3932	4001	3267	6608	27250	55702	55299	706	5230	6001	3604	57162	4704	2672	9265	9753	79441	4751	10049	81618	1176	51321	8784	1164	87	5425	9493	55748	79071	23169	5478	84779	5464	5111	28957	163786	3992	3482	5685	401115	128866	8502	7295	8565	6231	2764	4542	2590	112936	55151	112	7035	57465	7153	55958	5557	9768	10577	10225	10712	5567	3241	4281	6352	5527	23016	64859	57713	3824	1603	644890	3418	6309	9131	1622	23457	9960	5152	23635	79077	4288	23218	84747	133418	84693	51128	917	6840	54491	51744	9588	2969	25847	5433	939	641638	10682	3956	9620	8209	7294	1363	302	6932	581	23710	5691	1737	26275	990	6282	29968	200734	54855	5422	4521	55723	5045	2730	924	2617	5583	3682	51762	26578	22914	5721	51371	8477	64105	3702	117178	641	25966	25844	925	10123	6697	28969	2280	699	5723	9047	51389	894	51617	2678	3149	58505	81671	22859	3937	51669	4010	203068	23480	4851	5859	2530	7182	6281	29925	1154	120534	5985	84950	29081	8530	27347	23111	9141	6117	6171	8435
GSE33425_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP	M8547		22086415	Walker LJ,Kang YH,Smith MO,Tharmalingham H,Ramamurthy N,Fleming VM,Sahgal N,Leslie A,Oo Y,Geremia A,Scriba TJ,Hanekom WA,Lauer GM,Lantz O,Adams DH,Powrie F,Barnes E,Klenerman P	GSE33425	GSE33425_3146_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in KLRB1 high [GeneID=3820] T cells: CD8A [GeneID=925] versus CD8A CD8B [GeneID=925;926].	This SuperSeries is composed of the SubSeries listed below.					57541	4942	6494	1520	6850	25946	57409	8703	348	3073	80230	9139	84364	5451	4067	138241	3895	57157	5306	55870	10077	83759	972	4892	6643	4925	6402	23433	57544	22936	8013	23062	2947	84461	6688	1979	3112	23203	91663	2213	359845	930	5450	974	274	4669	5580	4261	29123	4689	6689	7378	2799	5570	51429	958	6925	5187	4802	57143	7084	9476	1269	4170	56605	57153	3040	6300	6603	9026	1641	440275	6294	3658	695	1859	9450	2934	7163	7543	4066	975	29760	51379	933	9869	5579	3043	23558	4779	8826	837	3108	84824	10105	1196	6453	127385	3628	55589	1263	84909	5106	57533	1266	80021	863	5297	55168	4515	259307	55795	10463	19	5981	117	51720	7702	10437	8732	6367	28834	10989	1235	9497	3097	5412	971	80213	55103	6261	9955	24142	54529	599	4688	2138	5336	10948	3566	3055	1147	11142	81565	9079	81559	973	1974	23607	1512	3111	11153	23761	715	4208	1982	6653	5899	29110	124401	8994	931	3663	54934	55342	3109	2523	10955	3425	64924	26576	3712	9926	10019	55527	1073	25906	844	92359	4245	27131	3507	604	677	51552	2571	4684	25914	9194	7466	2060	127833	115207	3394	201895	7376	2526	8569	3117	27348
GSE33425_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_DN	M8548		22086415	Walker LJ,Kang YH,Smith MO,Tharmalingham H,Ramamurthy N,Fleming VM,Sahgal N,Leslie A,Oo Y,Geremia A,Scriba TJ,Hanekom WA,Lauer GM,Lantz O,Adams DH,Powrie F,Barnes E,Klenerman P	GSE33425	GSE33425_3146_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in KLRB1 high [GeneID=3820] T cells: CD8A [GeneID=925] versus CD8A CD8B [GeneID=925;926].	This SuperSeries is composed of the SubSeries listed below.					3992	3937	81618	825	1747	27347	5425	88	3613	5214	5567	5698	55748	7498	56882	6932	940	5694	5902	3936	6352	2590	3707	1994	7486	7070	8502	6001	55151	2146	641	10023	6446	3932	7805	6836	64975	92749	939	2730	1509	54443	23401	1164	2934	80011	57162	3014	5783	84747	9768	55702	2706	83658	5433	359845	5685	29968	23452	64333	57650	133418	2764	9620	7371	284996	23710	117178	9493	1176	7272	5691	8498	389541	4001	6094	8784	54758	93974	23218	55723	5985	6404	8209	2672	51205	84779	1369	163786	79441	10018	7035	9960	64105	80145	3925	3824	3683	5557	5152	51128	5163	51154	7294	10198	7182	332	1647	4521	6484	5480	7260	117177	3702	2584	7153	22985	3398	10051	3902	84844	25819	5422	9265	1603	5495	112936	990	8600	3604	641638	915	375	57713	28957	4542	1719	203069	8848	10123	8859	1786	3399	51617	4288	4599	4851	644890	983	5790	4176	259266	22914	4171	6208	4900	917	4218	8565	10901	1841	113130	10801	10458	10723	9232	2969	126	51669	22944	9055	22859	7535	8435	400916	200734	3422	11126	51691	1622	5588	3482	8530	23635	25929	10682	3241	23397	6117	2254	286827	51762	8318	51466	596	6749	55845	826	51371
GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_UP	M8550		22086415	Walker LJ,Kang YH,Smith MO,Tharmalingham H,Ramamurthy N,Fleming VM,Sahgal N,Leslie A,Oo Y,Geremia A,Scriba TJ,Hanekom WA,Lauer GM,Lantz O,Adams DH,Powrie F,Barnes E,Klenerman P	GSE33425	GSE33425_3147_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD8 T cells: KLRB1 high [GeneID=3820] versus KLRB1 int [GeneID=3820].	This SuperSeries is composed of the SubSeries listed below.					9275	5451	84617	4942	91663	27131	8754	9730	27044	8013	6850	974	953	55103	9314	80230	1213	4067	5481	7280	930	10166	84909	5151	972	8548	23433	3507	60592	440275	1266	255231	6643	8732	22936	57544	129285	25946	11153	23062	6261	5090	2060	9056	7414	2799	9139	5580	3661	3112	11142	65109	10890	51552	1512	10213	958	79140	51316	408	7163	4689	819	6294	57157	3831	23607	55975	7756	79001	3655	1520	6925	5430	8581	3087	157769	54529	55621	55783	1605	8826	138241	10961	23191	55527	4925	84902	8082	5977	5660	340527	133	3606	10077	643	55870	23558	834	9331	246	4245	29887	6300	390916	3658	11083	79887	8994	51720	57648	136319	8460	57533	29760	11021	4066	7107	51170	9476	115825	7741	931	5805	25976	3055	4170	3108	57409	7326	10563	10955	122618	10437	90273	221477	5570	28834	219972	64397	5412	23152	6402	57143	114908	1105	4189	6288	6103	2790	201895	1147	84824	5450	2551	3636	8417	6689	1522	3609	11342	4208	914	339	599	5446	85463	4735	5184	81565	127833	115361	4008	6688	9525	55324	5581	51119	5641	10494	3663	9258	4811	128338	4005	29105	728294	51255	5925	56605	9247	5579	695	55737	27072	3117	64147	29766	8801	7011
GSE33425_CD161_HIGH_VS_NEG_CD8_TCELL_UP	M8551		22086415	Walker LJ,Kang YH,Smith MO,Tharmalingham H,Ramamurthy N,Fleming VM,Sahgal N,Leslie A,Oo Y,Geremia A,Scriba TJ,Hanekom WA,Lauer GM,Lantz O,Adams DH,Powrie F,Barnes E,Klenerman P	GSE33425	GSE33425_3148_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD8 T cells: KLRB1 high [GeneID=3820] versus KLRB1- [GeneID=3820].	This SuperSeries is composed of the SubSeries listed below.					55054	6790	6304	27242	113402	126282	51380	55795	55361	3437	284194	10762	84640	4929	23316	8880	2934	30010	29128	80728	5777	51804	7290	9646	11169	100	23354	3117	8887	8545	79869	129685	5893	1059	10072	133308	2550	3351	23011	2571	9924	26287	694	79668	5422	3290	6498	7384	1235	201163	2534	57153	3945	6584	9592	3065	8732	338917	7091	9320	4092	3720	1511	5150	1445	10765	5961	1647	25819	6653	2650	4261	8692	83759	56985	126003	629	23216	25914	3394	84717	2116	4256	10994	3109	91107	8509	7782	4792	2820	5087	2819	4141	726	359845	3603	6754	27131	5626	10156	8326	3399	644890	1786	406	5476	92335	30827	1615	84519	1642	63893	4208	7408	4602	8888	117177	7702	55572	6241	971	51702	6402	6196	3087	80270	79676	9452	51479	54899	2011	25942	5187	2997	84947	6804	1369	5424	55108	84271	51574	10198	3663	604	3040	1000	23635	1301	8263	9051	10592	7409	81620	1982	6945	280636	5981	3638	259	1747	6609	4049	64924	4884	6494	596	390992	1058	129080	11156	154	4175	1175	8864	2150	5899	57455	10318	8890	3587	5641	142	23646	1266	23401	6568	23526	10487	733	5495	391	114790	3707	79073	8200	55743	3123	22903	55611	6829
GSE33425_CD161_HIGH_VS_NEG_CD8_TCELL_DN	M8552		22086415	Walker LJ,Kang YH,Smith MO,Tharmalingham H,Ramamurthy N,Fleming VM,Sahgal N,Leslie A,Oo Y,Geremia A,Scriba TJ,Hanekom WA,Lauer GM,Lantz O,Adams DH,Powrie F,Barnes E,Klenerman P	GSE33425	GSE33425_3148_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD8 T cells: KLRB1 high [GeneID=3820] versus KLRB1- [GeneID=3820].	This SuperSeries is composed of the SubSeries listed below.					9445	727800	3654	55623	9516	5292	27250	84902	7411	9522	2653	55975	1737	445	6275	27290	4257	51316	4751	55614	4811	3055	941	219972	54541	4072	1583	10243	8082	4673	573	5165	2745	153339	51128	8835	10437	571	5184	114908	1510	80279	7337	28959	29889	133418	5931	23505	3418	8836	80146	388646	5634	57146	1396	255231	310	4189	115361	6451	133	246	54499	1493	23392	4735	84693	3600	5191	132	6288	55269	29105	4258	8438	25820	7038	81846	81618	81671	55303	9868	5264	5412	388558	79621	302	23250	7011	29058	201595	6038	2530	5516	84694	81559	2166	3739	2059	501	8801	3480	391059	291	6277	3655	10097	94081	136319	10213	7107	7371	6251	3344	9446	85463	5906	390916	3632	3960	55958	514	928	4534	4869	4609	51170	79084	968	6271	56905	25912	116064	122622	2023	2184	639	83699	64114	2335	4591	7001	11332	217	3990	1105	9056	2739	7280	440574	84617	660	29766	3572	53827	84272	64645	25996	7381	29880	4861	51099	10924	9247	10247	1116	1820	29127	3636	400506	11167	7163	26137	7324	196294	6629	130814	6282	3568	11079	26191	4734	10741	3514	10166	6708	5151	10875	23423	863	11260	1186	6281	9258	824	834	4942	11171	54491	8407
GSE33424_CD161_INT_VS_NEG_CD8_TCELL_DN	M8553		22086415	Walker LJ,Kang YH,Smith MO,Tharmalingham H,Ramamurthy N,Fleming VM,Sahgal N,Leslie A,Oo Y,Geremia A,Scriba TJ,Hanekom WA,Lauer GM,Lantz O,Adams DH,Powrie F,Barnes E,Klenerman P	GSE33424	GSE33424_3492_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD8 T cells: KLRB1 int [GeneID=3820] versus KLRB1- [GeneID=3820].	We used microarray to compare gene expression between CD161++/CD161+/CD161-CD8+ T cells from human cord blood.					1911	151556	197335	55907	51506	8848	23164	790955	222166	4320	57565	150465	178	21	5911	115825	51733	4947	84959	29980	55561	245812	30835	1870	83937	84230	1593	643641	994	6652	124817	145226	83606	7846	127262	222643	6133	4734	29094	1643	3275	131544	221749	51011	5217	6860	9583	7029	1058	8943	1512	390	4152	957	121457	26207	4811	59284	81605	11240	2268	339929	8515	308	154043	3977	23436	10397	197358	54539	1368	51422	550631	977	2534	23705	23710	23608	387	9342	84925	8452	81567	29904	11269	400673	83692	10493	79885	860	10477	56886	3695	80727	2330	214	56172	80148	1140	10782	57134	29934	7067	3763	5138	93974	92797	255394	754	6414	81539	353322	26056	64393	125061	55893	93185	9886	10491	8567	256302	284018	1466	9419	1742	30851	27013	301	8428	64780	9920	4925	402415	5981	9167	3632	25950	8492	27067	112479	56940	57221	257144	1339	219654	93380	5734	57692	219681	136319	93663	94121	9183	2868	124976	4752	56882	1781	3014	80143	23509	26033	6504	11031	199990	9644	51184	23008	54769	51439	64837	55520	124997	120	79065	23761	55502	122773	2892	6271	9117	163882	23643	55857	84314	1845	131583	23446	23261	2483	359845	11046	79174	6727	2934	124565	80318	272	170384	651746
GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP	M8554		22086415	Walker LJ,Kang YH,Smith MO,Tharmalingham H,Ramamurthy N,Fleming VM,Sahgal N,Leslie A,Oo Y,Geremia A,Scriba TJ,Hanekom WA,Lauer GM,Lantz O,Adams DH,Powrie F,Barnes E,Klenerman P	GSE33424	GSE33424_3492_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD8 T cells: KLRB1 int [GeneID=3820] versus KLRB1- [GeneID=3820].	We used microarray to compare gene expression between CD161++/CD161+/CD161-CD8+ T cells from human cord blood.					10135	3659	55283	4600	84166	83852	3627	221302	4939	219972	30845	84941	129531	11177	26986	6443	85363	83666	23586	54847	57674	22891	151636	94240	11274	7098	28514	6772	353116	23424	6737	51251	162394	55601	163351	10410	55281	440	10379	163590	644353	54708	5464	3434	51316	23317	894	162239	23367	1616	51284	64135	129607	55008	439996	345611	11044	388646	9730	9636	91543	3594	56902	54625	7812	5610	4938	9001	5570	55604	129881	2634	4599	3665	64761	2995	118980	9324	8638	3309	3433	219285	57018	10561	3055	5371	6773	837	3133	3669	56937	64108	2120	25939	441168	10906	10964	9683	55319	6187	54739	29909	22948	3437	9404	81030	50854	8565	1536	10161	6892	27000	10402	969	27340	942	146857	84365	10199	51056	8743	3430	79754	56954	3628	1269	153020	285521	4258	55703	5933	2123	8477	54108	27115	29126	5226	375790	84128	100506736	83636	1997	961	53344	146722	57162	57407	5209	5717	1803	135112	87178	9450	9839	2618	9111	8460	6041	4940	9868	57097	29104	5243	10419	80237	5274	64222	9068	115004	9933	51601	4522	10066	85457	23195	79132	152926	283991	9034	56950	54877	8604	26747	122481	26354	137886	6767	50485	55636	1435	51602	84310	116931	65008	56987	7050	10204	3959	90025	84548
GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_DN	M8558		22174157	Takata H,Naruto T,Takiguchi M	GSE26890	GSE26890_3493_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in effector CD8 T cells: CXCR1+ [GeneID=3577] versus CXCR1- [GeneID=3577].	Effector CD8+ T cells are believed to be terminally differentiated cells having cytotoxic activity and the ability to produce effector cytokines such as INF-γ and TNF-α. We investigated the difference between CXCR1+ and CXCR1- subsets of human effector CD27-CD28-CD8+ T cells. Both subsets similarly expressed cytolytic molecules and exerted substantial cytolytic activity, whereas only the CXCR1- subset had IL-2 productivity and self-proliferative activity and was more resistant to cell death than the CXCR1+ subset. These differences were explained by the specific up-regulation of CAMK4, SPRY2, and IL-7R in the CXCR1- subset and that of pro-apoptotic DAPK1 in the CXCR1+ subset. The IL-2 producers were more frequently found in the IL-7R+ subset of the CXCR1- effector CD8+ T cells than in the IL-7R- subset. IL-7/IL-7R signaling promoted cell survival only in the CXCR1- subset. The present study has highlighted a novel subset of effector CD8+ T cells producing IL-2 and suggests the importance of this subset in the homeostasis of effector CD8+ T cells.					4049	84947	994	23163	115825	55561	125113	221092	81562	22927	390	11269	126823	23514	10287	23067	219749	1846	4925	1643	5900	537	387	113201	29094	54806	1791	23261	3418	84680	7083	241	23164	3695	541565	272	284106	10509	6515	1911	7494	10671	26228	23234	414918	83937	340061	27013	83959	10482	219623	55726	27241	1120	200634	6709	9924	374659	1184	2316	1339	7408	23258	91010	56548	137362	51366	100505478	28956	200734	481	55657	84656	83752	56616	57473	7187	84902	2948	84264	83986	400673	55752	3903	5199	27332	23061	10487	11161	10462	2949	3611	54921	11270	57568	25975	219771	7205	143	284018	27037	56731	9682	9647	4660	3990	80727	150465	23559	10424	84299	55776	2184	8636	3977	1107	4683	924	637	28231	79446	9249	129285	4320	6843	2990	54929	471	201254	3014	5372	57707	1515	64092	6238	22872	57134	1611	5253	57565	81572	84317	2583	1992	10126	51704	253980	25902	51540	25780	731	9183	1497	100	24145	113115	9133	5414	339230	83648	122622	23406	9742	4302	10013	79885	84844	84260	54991	23710	84450	10007	9895	5335	192286	1760	2804	56925	84102	9342	51011	56479	6993	55219	280636	355	9501	602	5121	8925	55356	6945	968	811	23313	9898	85365	9380	958	54505
GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP	M8559		22174157	Takata H,Naruto T,Takiguchi M	GSE26890	GSE26890_3493_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in effector CD8 T cells: CXCR1+ [GeneID=3577] versus CXCR1- [GeneID=3577].	Effector CD8+ T cells are believed to be terminally differentiated cells having cytotoxic activity and the ability to produce effector cytokines such as INF-γ and TNF-α. We investigated the difference between CXCR1+ and CXCR1- subsets of human effector CD27-CD28-CD8+ T cells. Both subsets similarly expressed cytolytic molecules and exerted substantial cytolytic activity, whereas only the CXCR1- subset had IL-2 productivity and self-proliferative activity and was more resistant to cell death than the CXCR1+ subset. These differences were explained by the specific up-regulation of CAMK4, SPRY2, and IL-7R in the CXCR1- subset and that of pro-apoptotic DAPK1 in the CXCR1+ subset. The IL-2 producers were more frequently found in the IL-7R+ subset of the CXCR1- effector CD8+ T cells than in the IL-7R- subset. IL-7/IL-7R signaling promoted cell survival only in the CXCR1- subset. The present study has highlighted a novel subset of effector CD8+ T cells producing IL-2 and suggests the importance of this subset in the homeostasis of effector CD8+ T cells.					6443	137886	10135	353116	10410	2995	4076	116931	57493	129531	55604	2634	3133	51246	1536	2191	79971	4600	246175	3627	55248	9908	134429	4849	51284	8821	9001	10921	6737	221178	4047	2123	57674	56937	55030	11179	5272	29093	25841	8725	55719	597	203238	55106	3669	51316	8743	441168	57162	55686	23317	26986	23318	60412	2222	2976	84941	51187	53981	57805	1616	25939	7812	64761	83737	4067	91748	25948	10906	158219	80124	10513	94240	129607	1803	375790	84548	942	221302	92140	219972	115004	10728	3665	129881	56650	11274	6341	54625	28514	7913	23367	5464	10161	83852	4938	9761	84166	65008	151636	23586	81030	9868	135112	387804	55008	3422	8638	9636	56954	3638	55601	6772	7098	83666	9877	23141	11177	219285	3659	5298	1997	961	146050	163351	53840	54708	55636	114932	85459	9324	51406	64222	4939	8570	162394	23506	439996	54799	558	9034	10813	6041	9404	5371	57018	10561	3628	256471	27086	57552	64853	285521	54739	3959	79627	57097	51251	146857	83903	79754	26063	10645	5813	23253	7498	116496	6713	51575	9839	91543	64135	54790	64108	9140	23424	29126	10379	55281	10964	51126	4258	388646	4940	87178	4772	55023	85477	10548	29761	5610	3434	1355	23431	3433	57585	55777	55246	9943	30845
GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN	M8664		22447076	Schenk M,Krutzik SR,Sieling PA,Lee DJ,Teles RM,Ochoa MT,Komisopoulou E,Sarno EN,Rea TH,Graeber TG,Kim S,Cheng G,Modlin RL	GSE34156	GSE34156_2942_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes (6h): untreated versus muramyl dipeptide [PubChem=11620162] andM. tuberculosis 19 kDa lipopeptide.	human blood monocytes were isolated, activated and harvested at several timepoints In this study, we identified genes that were differentially expressed in human monocytes activated with eiter NOD2L and/or TLR2/1L.					23451	81030	55233	11253	1788	9934	10279	29760	3627	64761	23586	4939	125476	4086	23133	7088	4940	2908	4599	64859	5636	30844	6773	158471	116496	9567	113277	26037	55072	23097	3720	9633	162394	6890	11200	54101	55601	64123	3665	6772	54665	84687	170506	8841	10875	23424	57228	29766	835	8743	5698	57211	10914	3433	10006	6672	2130	26228	23262	25939	3434	133308	64135	54904	65082	4343	23389	120400	4600	118490	26958	161145	202	23075	116986	25963	3658	64092	219285	9802	9111	3977	23200	4967	57674	5834	4735	11274	390	115362	387751	9693	115350	10561	64108	2635	10299	7096	23081	53840	3705	55500	971	3708	22981	4061	5610	57097	9246	54165	7098	10664	23070	3676	54951	388650	9181	57703	6453	257106	103	115727	84230	4238	329	9646	10320	93273	2744	118788	157638	54874	6935	5332	5663	9681	81537	91543	152518	55656	389610	96764	27035	9644	2833	51191	54739	9927	9830	9371	4905	8720	3437	6737
GSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_UP	M8665		22447076	Schenk M,Krutzik SR,Sieling PA,Lee DJ,Teles RM,Ochoa MT,Komisopoulou E,Sarno EN,Rea TH,Graeber TG,Kim S,Cheng G,Modlin RL	GSE34156	GSE34156_2940_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes (6h): untreated versus muramyl dipeptide [PubChem=11620162].	human blood monocytes were isolated, activated and harvested at several timepoints In this study, we identified genes that were differentially expressed in human monocytes activated with eiter NOD2L and/or TLR2/1L.					23770	6583	80019	306	79144	4240	81565	1892	10138	10801	6888	8517	200312	80777	51312	9730	1607	5318	114804	51081	9124	1849	10695	118672	5436	11107	139886	7390	6256	3297	3663	4067	5480	2940	7040	60558	56893	7289	8808	8178	27440	1050	202018	29982	864	51256	5605	54938	7319	8480	60685	3929	8622	9051	9218	55793	84560	3241	254552	51573	114327	9217	3656	402682	338773	53335	64114	29984	22994	373156	975	10043	341880	56882	5914	475	9517	10529	657	3033	6755	3937	123	137735	84106	9588	91461	10814	64979	10602	2730	207	80273	56953	55647	6543	23399	10848	1499	51341	2030	6642	5166	23135	91582	4321	93643	2936	22934	7128	928	7263	283989	114971	10418	6238	79760	90324	3049	170463	54472	4715	163126	117584	10184	1820	95	259230	201799	5052	142891	55144	3984	57001	26151	3672	5742	683	55824	9755	79888	116447	9374	349565	23479	3162	4705	80142	284001	54956	4580	54825	55191	9550	4701	85369	23295	116841	84062	5986	9372	2495	65080	79842	1893
GSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_DN	M8666		22447076	Schenk M,Krutzik SR,Sieling PA,Lee DJ,Teles RM,Ochoa MT,Komisopoulou E,Sarno EN,Rea TH,Graeber TG,Kim S,Cheng G,Modlin RL	GSE34156	GSE34156_2940_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes (6h): untreated versus muramyl dipeptide [PubChem=11620162].	human blood monocytes were isolated, activated and harvested at several timepoints In this study, we identified genes that were differentially expressed in human monocytes activated with eiter NOD2L and/or TLR2/1L.					23239	115362	1781	10903	25921	1040	51643	9111	23294	51015	1616	116379	11274	51131	64376	6935	163590	10912	57169	6480	4208	7975	4524	6774	23052	219	23382	3991	5218	29843	25890	85441	375287	255809	54741	7783	1267	5621	5800	6252	25961	944	55177	6672	3430	3437	558	28988	170712	53840	64651	6373	89885	969	8792	29899	29110	157638	23141	9672	79958	7088	834	23150	84282	1906	841	219285	79754	8509	4602	57666	4615	2634	83892	390	2635	8914	8439	901	3660	8932	54904	8460	4343	79666	55603	53981	8841	285195	4939	2908	124446	757	401494	51338	8743	113277	4300	4152	57540	25963	83852	51296	5352	51747	6737	6772	9388	9404	2962	79668	9399	80196	23200	6387	3669	54676	2534	7098	5371	115361	57194	9693	55803	51307	3965	8013	23351	3067	1844	80176	30844	57515	84255	3431	2321	10675	10947	6812	50809	9232	6892	8482	55714	414918	10906	54739	835	629	4038	64761	81607	9777	255520	719	26065	23768	257160	57018	202	865	8564	7464	29785	55835	84333	777	129607	4005	54813
GSE34156_UNTREATED_VS_6H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN	M8667		22447076	Schenk M,Krutzik SR,Sieling PA,Lee DJ,Teles RM,Ochoa MT,Komisopoulou E,Sarno EN,Rea TH,Graeber TG,Kim S,Cheng G,Modlin RL	GSE34156	GSE34156_2941_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes (6h): untreated versus M. tuberculosis 19 kDa lipopeptide.	human blood monocytes were isolated, activated and harvested at several timepoints In this study, we identified genes that were differentially expressed in human monocytes activated with eiter NOD2L and/or TLR2/1L.					150771	858	2907	5480	84975	55623	1329	51588	79836	11159	11130	345757	1497	90637	55117	54436	9217	58504	64979	342667	22848	252839	23046	2889	51533	376497	5445	10940	51503	28955	10043	91419	54981	8805	81602	115353	4836	81565	3661	84769	221184	338692	29920	83464	1432	29952	84727	22887	1050	127829	7050	26993	23181	51439	90204	84266	1119	8772	64342	153443	54014	51389	29948	80851	867	55858	23220	91947	55212	7205	57591	5605	64745	11021	10959	3614	8019	23787	8780	84976	79735	5341	874	116064	6583	9551	26270	55033	130576	27161	89846	10199	3611	5565	124935	1509	1020	10240	57602	57473	1384	79888	79589	9702	2776	64170	4478	93058	11337	115024	26524	6272	3482	6015	253512	928	1488	140885	8816	9550	283871	11183	54520	4321	55154	1460	83541	662	80745	117143	4800	6427	51596	126789	116143	84062	2940	8165	64077	23770	10671	3929	51128	80728	25873	8661	142891	140459	246754	1937	2531	140809	8861	10144	79791	80325	23522	5052	50488	8572	51552	30968	143903	23682	4055	929	84890	123	388341	374986	116729	338339	10540
GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP	M8668		22447076	Schenk M,Krutzik SR,Sieling PA,Lee DJ,Teles RM,Ochoa MT,Komisopoulou E,Sarno EN,Rea TH,Graeber TG,Kim S,Cheng G,Modlin RL	GSE34156	GSE34156_2942_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes (6h): untreated versus muramyl dipeptide [PubChem=11620162] andM. tuberculosis 19 kDa lipopeptide.	human blood monocytes were isolated, activated and harvested at several timepoints In this study, we identified genes that were differentially expressed in human monocytes activated with eiter NOD2L and/or TLR2/1L.					25799	126364	200933	84614	9733	57717	57610	139231	56005	339593	9413	6209	55330	81850	5067	64579	54586	51010	4724	51076	3184	9992	7283	5583	10741	64388	6730	308	28513	79607	79983	79723	22871	100133116	9785	2923	83700	2301	388327	4131	285500	414194	219333	257177	136	7348	23387	51726	7075	9015	147948	29013	1789	84694	493869	133308	55322	11179	129852	1603	1447	145282	51128	286828	79820	93661	10542	26175	7579	10154	192669	9076	84643	10888	6049	29928	7051	3373	8065	51650	1908	127428	4544	1362	8447	266919	23117	158586	79097	128209	10768	10203	653140	1910	8383	675	6208	100133075	25792	79992	6613	7381	55857	662	64641	54539	10140	1459	100505518	81491	6721	259217	401022	26135	55231	339622	55661	374739	57085	81031	100130837	401320	11074	55824	2773	94137	652995	54478	89891	9131	100128922	2051	8927	83714	7184	2058	55290	203413	11176	10910	8038	2157	4440	7066	1395	54900	284757	4986	100130344	63895	57591	5510	22944	51204	9135	55363	66008	80005	64002	219990	1009	5763	51200	5255	6416	150082	10279	389376	5327	55646	27286	4289	517	387535	644068	4878	7772	493812	55714	25898	84138	1580	83606	64066	55198	1582	10000	415	170850	729810	54931
GSE34156_UNTREATED_VS_24H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN	M8670		22447076	Schenk M,Krutzik SR,Sieling PA,Lee DJ,Teles RM,Ochoa MT,Komisopoulou E,Sarno EN,Rea TH,Graeber TG,Kim S,Cheng G,Modlin RL	GSE34156	GSE34156_2948_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes (24h): untreated versus muramyl dipeptide [PubChem=11620162] andM. tuberculosis 19 kDa lipopeptide.	human blood monocytes were isolated, activated and harvested at several timepoints In this study, we identified genes that were differentially expressed in human monocytes activated with eiter NOD2L and/or TLR2/1L.					140711	9684	22949	11188	414260	254099	1014	57016	677824	9028	145853	114898	56961	25789	83875	644815	157740	5524	7173	113179	4157	3762	646962	27035	170679	9024	146664	389043	5408	64078	646934	114879	100505879	100288152	440137	8193	339541	5480	401264	54754	100129884	100288679	80274	64799	63920	100288685	55756	55698	79057	11055	8642	285613	55544	64849	84752	286075	421	4832	404281	100290663	285498	10994	838	100130992	81629	7483	220001	286128	6324	56894	57057	79852	23274	8190	132243	441052	153745	688	8574	8704	7125	100130938	22801	4951	135293	100128998	9609	93986	10882	131578	29065	9963	126208	6915	54468	2357	283481	3207	161835	64208	374655	286256	10743	152206	2038	116028	112885	79042	9671	113026	27231	255031	81553	83987	100506013	92070	2621	728061	100129309	55259	3351	51480	286367	51087	400794	51308	4597	8396	1565	5545	7166	750	80235	401312	8290	64926	28952	85302	100129034	5296	114987	23491	338588	57553	89884	26240	9997	1813	9200	440354	100132911	4291	285708	126147	11004	2580	3697	285668	9568	127841	56302	148327	728342	353135	135935	9547	10025	55997	170463	4728	55201	51138	245932	7093	171169	1907	55778	3671	6863	3913	84464	7223	7105	64423	57876	100125288	56120	80724	7857	8748	1002	127845	200728	147646	10523	144193	9099
GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP	M8671		22447076	Schenk M,Krutzik SR,Sieling PA,Lee DJ,Teles RM,Ochoa MT,Komisopoulou E,Sarno EN,Rea TH,Graeber TG,Kim S,Cheng G,Modlin RL	GSE34156	GSE34156_2949_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes (24h): muramyl dipeptide [PubChem=11620162] versus M. tuberculosis 19 kDa lipopeptide.	human blood monocytes were isolated, activated and harvested at several timepoints In this study, we identified genes that were differentially expressed in human monocytes activated with eiter NOD2L and/or TLR2/1L.					53834	3782	286	6097	375248	6564	51303	54439	5867	8363	729887	259197	54718	8178	80070	677766	57489	10979	151871	126731	6498	84060	1737	11334	51460	752	4150	65265	4680	1235	735	2315	9231	283899	55721	3820	80020	340094	54821	8556	5803	54566	84262	6504	139420	147727	11149	339483	55132	5525	6836	59350	645591	4094	115	6049	3710	57282	83872	10146	55646	6046	23542	196264	266671	58499	285429	170949	26821	6440	100507495	10053	169270	136853	652147	11163	100129069	677769	23545	1803	5494	1258	152641	64776	283358	51647	201294	1838	116236	283745	285126	84066	163404	122945	57338	5339	50617	26168	200420	201134	5479	1586	9972	100129129	1981	339988	2191	1535	83853	11238	158326	100287289	222545	285513	619207	266722	2237	8289	57447	57606	130827	9094	3215	64837	6887	762	3725	56647	23138	729224	6476	90199	131583	9806	7223	10219	1454	9755	8085	404266	51762	150147	286272	784	3815	64763	5300	285600	283888	5781	79039	285627	30811	122830	100287499	389320	266675	23038	7481	1003	64849	2673	388011	1975	10608	2898	4050	25829	10436	6541	5589	3984	51012	10162	22800	5937	640	11283	55137	127435	50836	346562	50839	284998	3695	131096	339896	256472	79144	4791	81696	363	23413	286238	970	123624	643837	79960
GSE34156_UNTREATED_VS_6H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP	M8672		22447076	Schenk M,Krutzik SR,Sieling PA,Lee DJ,Teles RM,Ochoa MT,Komisopoulou E,Sarno EN,Rea TH,Graeber TG,Kim S,Cheng G,Modlin RL	GSE34156	GSE34156_2941_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes (6h): untreated versus M. tuberculosis 19 kDa lipopeptide.	human blood monocytes were isolated, activated and harvested at several timepoints In this study, we identified genes that were differentially expressed in human monocytes activated with eiter NOD2L and/or TLR2/1L.					55959	1462	4689	4811	308	140885	221438	427	29992	65264	63905	6925	1518	400793	55092	23544	4354	59345	7444	26509	9181	146862	6714	19	2713	3126	1438	85027	7453	170591	11025	929	100287147	219972	100288079	586	211	3597	22797	4257	9332	3957	10695	5553	526	79091	23136	54502	2710	84270	8828	7422	91404	533	2512	8491	6888	146722	51312	3956	81688	2358	58486	10437	25801	27071	51363	23012	9120	64759	55048	100113407	9103	58191	11162	4688	10011	7045	645984	2212	3418	290	11006	250	5879	8754	1436	79774	29940	219855	3055	5468	9732	10859	5376	5724	7879	54839	2896	3958	3663	10863	57458	3448	528	57609	51313	11031	79689	2702	23654	8825	9625	2752	1536	3112	10577	8804	55505	221	51309	1687	23603	23597	1200	2217	9050	2760	1439	23001	10288	8986	10261	8031	9953	5777	5025	10855	1593	5889	64747	133	55255	5689	6556	285628	942	4005	8843	4710	3759	30817	25932	25946	83871	10184	58480	2919	6102	8942	100312848	444	313	2322	9446	3816	5328	23312	56975	1522	967	57685	3977	8848	2876	1839	100128590	51171	84419	2357	25798	345557	5660	55654	26276	4332	55647	126014	7056	124935	23643	374969	9935	3162	84803	4481	79168	79930	65220	7097
GSE34156_UNTREATED_VS_24H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP	M8674		22447076	Schenk M,Krutzik SR,Sieling PA,Lee DJ,Teles RM,Ochoa MT,Komisopoulou E,Sarno EN,Rea TH,Graeber TG,Kim S,Cheng G,Modlin RL	GSE34156	GSE34156_2948_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes (24h): untreated versus muramyl dipeptide [PubChem=11620162] andM. tuberculosis 19 kDa lipopeptide.	human blood monocytes were isolated, activated and harvested at several timepoints In this study, we identified genes that were differentially expressed in human monocytes activated with eiter NOD2L and/or TLR2/1L.					977	64763	7033	3782	942	5034	153090	57210	959	8178	156	5868	2549	762	5479	9754	283345	29780	2185	3492	6097	10876	5998	80020	1235	56005	2191	3710	3820	8647	400360	57636	131566	654817	5645	6836	3663	29058	23547	57710	8650	5724	57452	286	64321	54510	4318	115	116236	29944	2539	286071	131583	5025	50836	8463	10570	219690	619207	6282	259197	9580	339988	60	266722	50614	56342	3815	10361	6238	80070	26220	26173	503639	23413	9123	9654	23603	126119	149986	6184	5352	57282	158326	80019	2896	501	26524	3955	84926	108	84689	147727	54849	9148	6051	10255	7310	100130691	140885	968	27246	643677	100288225	388585	10437	79166	9948	5973	752	126731	5781	7036	5045	339896	4584	7094	1258	6564	22870	83999	9462	2664	10979	4045	2070	139420	57338	54841	6504	80301	54442	4547	1586	965	2782	100131980	1902	56902	284759	51156	83853	7481	79986	81037	23288	10725	9231	5867	29992	2000	10602	10763	9265	11025	9332	100506540	7066	1509	4014	140902	58499	4855	1678	375	2564	136991	83758	29940	6541	23616	152641	90701	10313	136853	1270	121260	51232	54566	5568	2018	3936	387885	160364	8786	100287499	2769	4586	440149	122651	123591	9510	494470	4241	7025	79856	363	3242	285429	1000
GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN	M8675		22447076	Schenk M,Krutzik SR,Sieling PA,Lee DJ,Teles RM,Ochoa MT,Komisopoulou E,Sarno EN,Rea TH,Graeber TG,Kim S,Cheng G,Modlin RL	GSE34156	GSE34156_2950_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes (24h): muramyl dipeptide [PubChem=11620162] versus muramyl dipeptide [PubChem=11620162] and M. tuberculosis 19 kDa lipopeptide.	human blood monocytes were isolated, activated and harvested at several timepoints In this study, we identified genes that were differentially expressed in human monocytes activated with eiter NOD2L and/or TLR2/1L.					1965	692236	387119	84843	55066	11177	129293	79048	26960	282996	55823	200765	3921	390980	80146	57396	926	51562	56948	29945	285527	51175	22853	4710	79066	26276	84893	51309	4621	57609	8667	27314	7919	113510	100270804	4753	9924	8776	6181	340351	641518	10777	28986	6158	100533182	83595	150291	55364	7181	64753	286410	54680	6160	144363	51275	257397	26249	6964	25977	23398	79161	641977	100128252	55250	25956	550643	9978	3163	645460	765	6170	285989	89890	80204	100129250	29092	7182	81688	6433	10935	23029	166824	4131	56890	150737	4118	10943	55968	57134	137682	55199	55777	23067	9666	3572	11232	79027	9923	6155	55837	6165	283464	1823	9556	1327	5820	3622	51123	1038	10695	55180	4124	8766	282997	54529	112812	26519	85369	221154	80830	120	7273	6419	23531	1350	163227	400027	91408	5125	55746	125144	57125	2218	123720	645261	63901	51241	9712	2533	375748	55329	6687	144132	4363	2956	4836	9487	8690	4522	4232	11258	23521	79774	131076	79086	55739	151888	8760	51001	10075	8302	6235	54482	7311	222166	22877	6284	84190	8875	10399	171425	83998	9847	5578	84908	55505	87	84324	6880	58486	80055	55291	5954	6205	80018	388815	5264	285282	7267	4712	79675	55013	5889	11044	65264	51227	51082	440122	6230	220042
GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP	M8676		22447076	Schenk M,Krutzik SR,Sieling PA,Lee DJ,Teles RM,Ochoa MT,Komisopoulou E,Sarno EN,Rea TH,Graeber TG,Kim S,Cheng G,Modlin RL	GSE34156	GSE34156_2951_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes (24h): M. tuberculosis 19 kDa lipopeptide versus M. tuberculosis 19 kDa lipopeptide and muramyl dipeptide [PubChem=11620162].	human blood monocytes were isolated, activated and harvested at several timepoints In this study, we identified genes that were differentially expressed in human monocytes activated with eiter NOD2L and/or TLR2/1L.					7879	6238	51363	977	25946	10288	4811	2630	2204	6714	30817	1514	10855	26509	2358	1536	5025	54453	4082	654817	22797	4005	290	55048	5868	171019	11025	3957	55959	719	131566	9332	2921	9120	9935	6718	1438	55092	59345	80045	6556	283248	23136	1462	282969	55819	51312	25798	199713	7453	4354	29992	3126	7305	3779	4210	338323	2710	3820	3597	7097	8843	7094	29940	4257	400622	64151	1522	10211	427	23413	84419	80301	3199	140885	30012	83706	219972	10437	4689	4014	146722	89886	2799	1230	94097	643616	27159	586	10261	23625	4688	11270	7422	1439	5328	7045	1509	3958	8828	81621	1593	526	55704	65220	126014	81037	6303	84069	2752	7444	2212	2512	3162	2713	11006	4067	10863	3663	54502	2896	79930	4035	23312	58191	3987	11031	8942	144811	8754	9050	64859	5581	2919	2217	2760	8804	7099	5660	10184	7076	308	5376	5306	3055	84270	440896	57458	942	10011	215	729986	2000	5724	5791	8491	3759	60	23603	9265	25932	5027	10287	23001	22918	6850	10097	5468	1845	115749	10461	64759	1848	65264	1192	4481	6888	929	8031	1436	7462	79168	23654	9103	9732	7171	27306	440101	27071	3965	5879	3459	253970	822	219855	5862	79572	26253	10956
GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN	M8678		22447076	Schenk M,Krutzik SR,Sieling PA,Lee DJ,Teles RM,Ochoa MT,Komisopoulou E,Sarno EN,Rea TH,Graeber TG,Kim S,Cheng G,Modlin RL	GSE34156	GSE34156_2949_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes (24h): muramyl dipeptide [PubChem=11620162] versus M. tuberculosis 19 kDa lipopeptide.	human blood monocytes were isolated, activated and harvested at several timepoints In this study, we identified genes that were differentially expressed in human monocytes activated with eiter NOD2L and/or TLR2/1L.					254158	1965	55781	6137	22992	4300	137682	253782	64753	54977	10899	84268	4621	387119	85457	55709	79066	10162	49856	23029	926	57212	51460	23410	4131	11257	161779	85021	25956	59350	26155	8690	158830	56897	498	10225	4118	90273	28986	57633	254428	285989	283579	91746	57186	735	2308	54821	55777	6235	9804	29078	9512	9374	57690	79918	11334	339483	89890	27122	6964	197320	100131564	81887	7443	8479	55339	84324	10772	121053	54680	375248	6169	51499	125981	84881	56271	696	65083	100287808	219541	2272	11040	55779	26127	6173	113510	57125	22796	729224	9217	5922	765	8161	79161	64776	80762	757	94104	6155	100129250	2073	56647	3326	90390	6880	550643	144363	6135	516	275	6188	92002	55180	3921	81572	5631	9924	5411	11266	11044	7984	84893	7486	401474	26249	83480	84820	57017	10600	388815	9205	10412	83595	84529	55837	54931	51503	100127972	84274	2091	6170	29929	645460	641977	84843	6638	117246	23398	4927	51406	10808	165545	10943	8760	84908	55364	134430	285463	7342	80152	6181	5820	7267	440122	342357	29945	55226	57396	79726	23283	51335	6129	27034	79183	51175	26515	51275	84083	54870	7182	6204	8409	6702	284900	1737	55746	9410	79035	10199	379025	914	130827	150737	2177	28987	10955	399	60686	5202
GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP	M8679		22447076	Schenk M,Krutzik SR,Sieling PA,Lee DJ,Teles RM,Ochoa MT,Komisopoulou E,Sarno EN,Rea TH,Graeber TG,Kim S,Cheng G,Modlin RL	GSE34156	GSE34156_2950_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes (24h): muramyl dipeptide [PubChem=11620162] versus muramyl dipeptide [PubChem=11620162] and M. tuberculosis 19 kDa lipopeptide.	human blood monocytes were isolated, activated and harvested at several timepoints In this study, we identified genes that were differentially expressed in human monocytes activated with eiter NOD2L and/or TLR2/1L.					284067	1009	9785	64579	64388	6209	55330	158586	9413	2923	6613	203413	25799	3949	10768	81491	56269	127602	84614	139135	9733	170850	55328	3452	6667	26010	192669	28513	4901	79850	26135	10232	83692	160428	22871	10000	51204	100287808	8237	5728	64321	10062	2256	193629	3747	51076	143872	23333	285971	10955	9015	1212	6554	54586	133308	9429	100290278	84138	85016	55322	4878	55679	83884	150082	390705	5669	54108	149643	25792	259217	283229	10631	5702	245802	282775	200933	64093	27232	729595	23500	645188	1356	83606	9162	148738	51726	1373	83714	7189	55324	222389	2820	5583	219990	23585	1459	57610	6416	8756	5067	9975	114049	414194	83850	55159	2301	6331	283748	9131	55200	10140	84643	50507	7348	100131993	164656	440072	64838	11176	6730	23566	4440	80319	10739	50640	58500	6208	11179	415	11280	316	100133075	79820	517	23387	100293735	53345	10203	8087	3936	162282	57480	29967	9550	4724	128209	8707	128674	23117	100131816	80777	27030	64218	169841	6049	5314	51258	286828	4638	25769	308	11343	100271722	127428	26583	246122	54763	4990	64860	25823	1613	100128071	5294	55661	2058	160824	285150	10248	285489	114798	64002	100505718	1362	2011	211	4325	22820	26468	11074	113691	54808	57717	123970	55370
GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN	M8680		22447076	Schenk M,Krutzik SR,Sieling PA,Lee DJ,Teles RM,Ochoa MT,Komisopoulou E,Sarno EN,Rea TH,Graeber TG,Kim S,Cheng G,Modlin RL	GSE34156	GSE34156_2945_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes (6h): M. tuberculosis 19 kDa lipopeptide versus M. tuberculosis 19 kDa lipopeptide and muramyl dipeptide [PubChem=11620162].	human blood monocytes were isolated, activated and harvested at several timepoints In this study, we identified genes that were differentially expressed in human monocytes activated with eiter NOD2L and/or TLR2/1L.					145853	100288152	9028	414260	1565	29949	56961	8574	100131613	284656	4037	338588	11188	79831	57326	254099	8704	10554	9684	79852	10463	220001	9024	22824	23095	64078	285613	7093	51127	23310	84203	7483	26499	23274	146664	8642	157740	6262	113675	51138	6915	80346	2261	646962	57553	201514	84552	4502	79875	146723	24141	2564	6387	100506274	10994	3857	5524	79679	286083	339442	4157	6051	26064	23061	2733	7052	1589	64091	63897	8764	11055	1672	57235	57016	79919	89792	283152	23281	338799	27231	1363	80022	6753	199713	85302	63920	9124	59344	64784	6511	147004	5409	8506	28227	23632	147650	100288685	401074	55567	284912	84848	80274	117532	6324	2580	8748	100126784	51513	100129884	170679	54432	2982	84276	116447	389023	8170	4291	6608	147111	642313	100132319	643714	26063	100288640	100288679	7173	3891	55800	57628	8190	140711	5676	51090	389114	84326	84658	400624	501	23532	3543	23207	161725	100131211	9641	7166	79269	440354	2151	4117	124790	2621	135293	11181	8751	3680	441204	257	7125	147	58189	4951	80764	116983	54437	83983	114879	51052	255031	8455	3493	79042	3351	1003	6167	388939	9099	126147	83642	11004	1768	4675	10242	113179	81629	92359	22801	80093	3429	94015	80055	5480	54094	90050	100128998	3350	400579	55201
GSE34156_UNTREATED_VS_24H_NOD2_LIGAND_TREATED_MONOCYTE_UP	M8681		22447076	Schenk M,Krutzik SR,Sieling PA,Lee DJ,Teles RM,Ochoa MT,Komisopoulou E,Sarno EN,Rea TH,Graeber TG,Kim S,Cheng G,Modlin RL	GSE34156	GSE34156_2946_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes (24h): untreated versus muramyl dipeptide [PubChem=11620162].	human blood monocytes were isolated, activated and harvested at several timepoints In this study, we identified genes that were differentially expressed in human monocytes activated with eiter NOD2L and/or TLR2/1L.					6097	170949	375248	286	10608	6182	23524	222663	259197	6964	55721	54718	9510	729887	54094	400550	404266	57489	6564	149233	3167	10146	1235	23171	8822	8706	90488	126731	4760	9231	5591	126370	100287289	54854	3362	11149	727930	3820	51303	4618	6504	388692	55132	8085	4147	54566	284661	199990	54578	51762	9262	8556	23230	54955	7223	57453	9865	389043	2001	752	26821	5167	50839	57447	80020	122945	220965	8363	8178	6498	6541	6476	147727	1737	6049	7475	283899	54439	65265	64321	285513	1005	55137	4094	3815	414777	6440	139420	196264	64776	6836	79144	253128	3710	677769	1838	2237	59350	165545	645591	138162	5525	10219	112724	3744	84146	84060	83444	781	4593	283358	157506	84735	1803	246119	200420	26341	114795	8786	100507299	441666	2191	10979	1981	100292408	3204	23293	197021	116225	9153	149041	131583	283481	284950	23138	339483	285126	79960	55658	8464	83853	1421	5867	64772	146556	285627	158763	619207	3008	29915	25829	84971	9806	27246	2673	146433	84433	5790	131177	10194	51012	287	23542	554206	652147	1209	200933	219409	2849	4585	266722	339988	6953	284485	25804	5432	57495	130888	1717	259266	54586	9235	5479	132014	219541	140832	57605	83450	23038	2765	10162	3725	9096	284111	3950	147409	11334
GSE34156_UNTREATED_VS_24H_NOD2_LIGAND_TREATED_MONOCYTE_DN	M8682		22447076	Schenk M,Krutzik SR,Sieling PA,Lee DJ,Teles RM,Ochoa MT,Komisopoulou E,Sarno EN,Rea TH,Graeber TG,Kim S,Cheng G,Modlin RL	GSE34156	GSE34156_2946_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes (24h): untreated versus muramyl dipeptide [PubChem=11620162].	human blood monocytes were isolated, activated and harvested at several timepoints In this study, we identified genes that were differentially expressed in human monocytes activated with eiter NOD2L and/or TLR2/1L.					9181	23001	4689	3597	8828	1462	8491	140885	308	427	26022	63905	26509	5724	85027	55352	27071	219972	3055	3663	2713	91404	5689	8031	1536	4354	2876	2896	64759	29992	526	23136	79774	7045	26276	55959	290	8804	4257	51312	6888	9103	19	929	22797	1687	55509	57609	54502	11006	59345	11031	201475	7453	5553	5889	55255	1438	2512	55048	2710	57613	65264	11025	9144	10437	51313	163227	25932	7227	2212	55647	29940	150	58191	80045	942	3957	6102	830	7421	5226	79143	586	25798	100113407	56975	2919	23643	6714	9904	5777	23603	151121	8447	3958	3126	23075	79930	8942	705	7879	1593	25801	348825	7422	3956	4688	6925	10855	9332	1436	9120	2760	8825	9050	3759	2907	11337	4825	926	1318	146722	313	1439	9953	58486	5879	81929	51363	146862	65220	10859	10261	211	26175	4811	8754	90874	1200	4005	79091	4710	3005	10863	133	114786	10184	80114	10956	10062	400569	10011	58480	23312	27180	10577	91662	55344	7077	144423	7110	4974	24145	84034	30817	11235	3418	2752	4332	115207	84419	9559	84270	1495	221	25946	5306	64747	5328	6556	6303	100128590	5791	55505	92597	10943	3965	54455	9732	444	55654	3109	10288	221656	8848	2358	5535	10695	55092
GSE34156_UNTREATED_VS_24H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP	M8683		22447076	Schenk M,Krutzik SR,Sieling PA,Lee DJ,Teles RM,Ochoa MT,Komisopoulou E,Sarno EN,Rea TH,Graeber TG,Kim S,Cheng G,Modlin RL	GSE34156	GSE34156_2947_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes (24h): untreated versus M. tuberculosis 19 kDa lipopeptide.	human blood monocytes were isolated, activated and harvested at several timepoints In this study, we identified genes that were differentially expressed in human monocytes activated with eiter NOD2L and/or TLR2/1L.					57210	138652	9754	8463	136991	2896	57453	23430	23547	503639	25787	100128178	8178	186	79674	80020	10361	8786	2081	1235	85414	339442	6238	6564	6836	286	6051	6447	441204	3820	27246	5479	5034	56005	80070	133923	259197	654817	147744	400410	7310	153090	6184	5724	339260	4547	23138	340090	54566	9654	149041	51156	131583	54094	4147	2001	3815	26524	11247	6324	100287114	199990	3984	56970	784	339988	284338	84909	23603	51232	5568	4584	80019	50614	375	5064	27123	1869	84232	752	220382	6199	80868	92359	6337	619207	100240728	57282	151009	64763	10867	29763	51350	23654	10437	149233	3710	100129935	4585	11334	2191	1902	1750	2539	8085	1000	63876	228	56342	400550	2564	9123	4586	5781	26001	6097	2737	116236	5045	7094	23616	4036	85509	23191	9231	200420	84894	122616	83758	4062	28513	3987	6332	22898	824	7512	79856	55095	79143	23140	728361	29780	959	285627	147912	5589	60506	124565	29058	160364	6373	1209	64321	126374	26286	26993	7652	157556	23095	9948	3077	23129	1678	382	5167	6504	2000	121260	152225	3137	2904	1310	10602	23564	23413	59340	1650	100133612	434	285043	5791	5010	9265	220388	100128830	54442	4597	4318	51214	5587	64123	3459	6440	1288	123624	136371	650662
GSE34156_UNTREATED_VS_24H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN	M8685		22447076	Schenk M,Krutzik SR,Sieling PA,Lee DJ,Teles RM,Ochoa MT,Komisopoulou E,Sarno EN,Rea TH,Graeber TG,Kim S,Cheng G,Modlin RL	GSE34156	GSE34156_2947_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes (24h): untreated versus M. tuberculosis 19 kDa lipopeptide.	human blood monocytes were isolated, activated and harvested at several timepoints In this study, we identified genes that were differentially expressed in human monocytes activated with eiter NOD2L and/or TLR2/1L.					390980	55096	29092	51309	129293	692236	10695	79048	200765	286410	926	9666	23521	641518	26960	84843	125144	81688	1350	100533182	84135	285463	10935	54101	7391	6170	4710	89890	115399	645460	80204	23398	56890	8302	85369	4753	4232	4621	1965	5889	57017	55739	51175	3572	6158	29945	23067	26275	55082	57134	4118	7181	3112	26249	51275	55066	9923	57609	79161	282996	387263	10524	1823	100128252	55505	80146	51082	6964	11177	222166	1731	144363	56897	7273	4124	220042	8760	5188	79135	5820	55250	4363	9556	6155	23029	9751	112812	340351	84259	6160	6635	27314	57181	8667	765	641977	57125	79027	10987	10943	144455	100506451	25956	3622	5578	60625	5224	26276	3445	51227	3765	414301	84417	387119	6228	100130557	6293	85302	442075	56948	54529	4131	54433	63901	653319	7919	3921	2956	10399	9861	91355	56912	54827	282997	5427	10166	1196	10362	51097	1038	6433	123720	83998	58486	26519	22914	378832	91646	171425	23549	25801	9924	115426	55837	79066	8520	253782	2053	25977	23531	283464	6419	728448	5125	5264	51585	100129250	51574	79612	55773	64180	55815	3931	6169	2533	4862	6222	26036	131076	55823	10472	23759	57666	10062	23310	285989	84908	55291	100270804	8857	11232	23518	1327	285282	91408	9487	10075	221154
GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN	M8686		22447076	Schenk M,Krutzik SR,Sieling PA,Lee DJ,Teles RM,Ochoa MT,Komisopoulou E,Sarno EN,Rea TH,Graeber TG,Kim S,Cheng G,Modlin RL	GSE34156	GSE34156_2943_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes (6h): muramyl dipeptide [PubChem=11620162] versus M. tuberculosis 19 kDa lipopeptide.	human blood monocytes were isolated, activated and harvested at several timepoints In this study, we identified genes that were differentially expressed in human monocytes activated with eiter NOD2L and/or TLR2/1L.					6303	100507584	25946	215	51312	3786	8828	290	977	100128590	4082	1536	90874	3597	641372	63971	51363	8031	7030	26254	54453	5468	89886	196527	133396	586	1230	55120	59345	2204	140885	4689	1514	5782	51313	26509	79143	9348	100169750	2630	57458	79930	654817	23136	83706	7453	10288	2896	9935	25907	3126	65220	5025	7305	4005	84419	427	60	8804	83550	84270	3055	719	11031	9332	526	7045	3957	1687	30817	55819	4257	219972	3820	29940	29992	8491	5306	2921	7097	4688	8843	124935	1462	79890	80045	2876	11006	25798	7422	2760	822	220441	25932	51806	3910	9050	4481	2358	10437	308	5226	5724	11025	55314	80301	54502	10855	55048	10211	7879	6238	2130	84868	7227	9103	1522	55092	55959	5320	2713	7076	5328	1509	3965	2799	9120	4067	23312	94	8754	54892	4035	6405	3663	10184	7421	22797	3958	1439	84658	2512	56975	645	58191	100506815	23654	10956	79572	144811	255025	643616	23678	1192	3987	3759	2212	9934	22918	2919	339442	10261	6326	79168	5768	8942	2000	27071	84034	929	942	4354	23120	7094	27180	362	55352	64759	55997	9144	2752	339665	83394	23603	2710	151121	2520	126208	27121	19	124912	10863	6484	79901	3576	9625	5027	2180	9265
GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP	M8687		22447076	Schenk M,Krutzik SR,Sieling PA,Lee DJ,Teles RM,Ochoa MT,Komisopoulou E,Sarno EN,Rea TH,Graeber TG,Kim S,Cheng G,Modlin RL	GSE34156	GSE34156_2944_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes (6h): muramyl dipeptide [PubChem=11620162] versus muramyl dipeptide [PubChem=11620162] and M. tuberculosis 19 kDa lipopeptide.	human blood monocytes were isolated, activated and harvested at several timepoints In this study, we identified genes that were differentially expressed in human monocytes activated with eiter NOD2L and/or TLR2/1L.					6964	6137	6170	64432	10162	89890	54931	57212	254158	23029	55781	5959	54977	55777	6716	10990	55837	91746	4300	54956	84676	27122	8161	6135	10899	55339	498	1965	79066	51175	926	6155	414157	2308	285989	5411	55709	26135	84135	165545	81572	25956	22992	137682	1933	644794	79959	49856	57820	56897	29092	285463	121053	85021	65083	6129	4621	253782	79612	100270804	161779	84893	2515	84851	5711	8834	10001	275	9410	254359	6169	84324	100131564	9258	57017	144132	8760	54762	90273	50832	3921	10412	57633	10419	158830	7342	144363	254428	757	55199	6207	100130958	100131298	1998	5820	84549	64776	11044	79918	84529	26036	6143	5432	83480	7311	64149	117246	10955	9861	84268	4118	54101	10600	28987	94104	80135	9617	23398	55644	26127	150737	100129250	80762	55779	84881	2091	54989	401074	60686	57690	6235	57695	5194	22796	26249	54680	57125	27034	9326	4927	6670	26960	387119	6188	7126	85457	645460	55180	65265	23175	10622	23517	100134937	79144	8409	254100	100127972	10717	129293	28974	3326	84083	414301	64921	641977	125144	54870	202018	51499	9512	84294	79183	79960	89894	6222	728377	51406	81887	79161	140730	10199	55156	79027	7267	54521	5922	84820	23588	51399	8123	6942	28986	390980	55602	29945	23091	9374	4131	29929	55342
GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN	M8688		22447076	Schenk M,Krutzik SR,Sieling PA,Lee DJ,Teles RM,Ochoa MT,Komisopoulou E,Sarno EN,Rea TH,Graeber TG,Kim S,Cheng G,Modlin RL	GSE34156	GSE34156_2944_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes (6h): muramyl dipeptide [PubChem=11620162] versus muramyl dipeptide [PubChem=11620162] and M. tuberculosis 19 kDa lipopeptide.	human blood monocytes were isolated, activated and harvested at several timepoints In this study, we identified genes that were differentially expressed in human monocytes activated with eiter NOD2L and/or TLR2/1L.					84365	1665	6854	10320	222642	27148	9435	100134934	10	7434	4072	4477	9903	55156	5055	51260	6559	3033	6652	84516	55553	201456	51096	56975	7053	3720	1340	4340	11224	149775	22839	3083	1459	5020	10178	2976	57541	113419	6236	286077	3954	283130	7040	80139	57657	56950	55041	10243	1046	246184	64395	3963	643664	9782	84947	50813	6754	2572	9587	5833	2034	132720	26525	10681	333	2877	23464	590	1272	149371	1240	6196	1551	5957	5290	1289	51078	5001	9356	2251	9073	6242	3002	94101	9454	116832	1160	200933	4688	56947	3352	653361	5053	11055	56957	23203	344018	55294	4641	429	6015	23743	3882	2561	9247	4744	8490	1836	2733	9945	65055	64284	640	9551	670	84317	1757	23505	8550	1718	2562	6895	326	10437	25940	10171	84321	51255	1829	165530	115557	10509	4800	348	7818	29920	137492	4620	4504	6942	8293	84274	6726	57050	598	3055	64147	5154	5091	317781	3603	7378	1760	128308	79710	65981	55608	3851	26018	3040	4632	6606	4975	1747	10219	279	5707	6793	7319	51114	1962	127385	767	3034	8694	64816	7511	22925	3783	114823	1844	54888	3751	126282	2876	55095	10477	26751	285172	9619	5866	84946	445	25844	57697	2653	763	79140	2637	7857
GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP	M8690		22447076	Schenk M,Krutzik SR,Sieling PA,Lee DJ,Teles RM,Ochoa MT,Komisopoulou E,Sarno EN,Rea TH,Graeber TG,Kim S,Cheng G,Modlin RL	GSE34156	GSE34156_2943_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes (6h): muramyl dipeptide [PubChem=11620162] versus M. tuberculosis 19 kDa lipopeptide.	human blood monocytes were isolated, activated and harvested at several timepoints In this study, we identified genes that were differentially expressed in human monocytes activated with eiter NOD2L and/or TLR2/1L.					5371	9111	10312	55593	64135	7291	7013	23070	284194	6891	103	1616	4615	5116	3106	4600	10906	9636	3627	345611	3437	6772	51479	7706	10379	4860	8651	3107	388646	163590	57169	4599	3959	10628	7975	10912	347	2634	11274	115361	11054	439996	6737	5720	3433	7318	9246	3659	127544	3430	5696	9673	8517	9517	54	10135	10922	3158	64222	25939	8030	6890	28514	55177	9180	5699	1462	9683	4343	54708	84333	1346	26057	11261	7050	53344	8535	961	57035	87178	26468	10410	84897	51667	5610	2242	2155	57713	79670	3669	6892	3569	25932	8743	23291	4061	6468	5721	6812	51246	10577	3752	7498	202	100506742	64326	3581	3667	3725	1778	57162	51542	837	5272	57140	9445	55500	91543	3665	84889	3597	5713	57062	10616	9314	55361	6554	3717	219972	1843	51015	5990	3459	4779	7259	5269	51268	3600	7461	9519	231	5784	5604	5216	580	4296	10758	6097	284	6809	375790	1592	25816	113878	5910	339	25983	7133	1745	51526	81669	7036	8895	5698	84978	7188	2907	2255	8835	65265	384	26005	57761	55622	7293	1831	8819	84263	54551	10068	27302	2691	5454	23635	3663	8509	80176	3589	80824	59345	100506736	1503	22862	11188	7538	5783	2332	10672	8581	5581
GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN	M8691		22447076	Schenk M,Krutzik SR,Sieling PA,Lee DJ,Teles RM,Ochoa MT,Komisopoulou E,Sarno EN,Rea TH,Graeber TG,Kim S,Cheng G,Modlin RL	GSE34156	GSE34156_2951_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes (24h): M. tuberculosis 19 kDa lipopeptide versus M. tuberculosis 19 kDa lipopeptide and muramyl dipeptide [PubChem=11620162].	human blood monocytes were isolated, activated and harvested at several timepoints In this study, we identified genes that were differentially expressed in human monocytes activated with eiter NOD2L and/or TLR2/1L.					5618	10656	89782	55212	63036	1490	25853	23560	80765	6594	59339	79947	10393	92370	5133	55800	80856	5997	100505478	6418	894	159195	337972	51673	2165	29945	8817	401207	3097	604	3123	126206	8660	84333	90874	54928	6046	9684	8612	23065	7813	5192	116238	7101	130340	51014	64123	11075	164395	80173	7088	1729	7555	462	23196	84886	23201	1039	6774	8706	57589	213	83478	3084	54869	373509	64407	389856	55840	57403	3201	7251	57685	151354	2857	2566	63928	1593	3053	493861	287	6655	92369	1207	8870	1459	84100	960	7350	5052	405	51531	8061	887	2863	10910	2717	55635	344191	152559	8932	3727	9462	51077	5198	10049	27237	10904	646262	222255	388533	58472	375341	4616	7562	10447	80724	797	25776	3238	4520	1264	116085	441518	6425	5591	51406	57492	5305	158067	9595	57576	144577	7068	1607	114804	6147	6741	55106	9826	8435	7678	83446	768211	57534	27123	25805	9015	55624	10631	90233	5087	84814	85476	845	3177	8539	94274	54867	166	25758	5528	63929	83990	4985	167410	1755	134510	3755	153396	79823	7534	27288	153657	2650	147183	3991	5886	79095	6399	5547	79003	128506	1512	23551	3569	79778	151050	9616	84695	144097	84225	79836	7097	140460	6860	57146	220965	54521
GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP	M8693		22447076	Schenk M,Krutzik SR,Sieling PA,Lee DJ,Teles RM,Ochoa MT,Komisopoulou E,Sarno EN,Rea TH,Graeber TG,Kim S,Cheng G,Modlin RL	GSE34156	GSE34156_2945_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes (6h): M. tuberculosis 19 kDa lipopeptide versus M. tuberculosis 19 kDa lipopeptide and muramyl dipeptide [PubChem=11620162].	human blood monocytes were isolated, activated and harvested at several timepoints In this study, we identified genes that were differentially expressed in human monocytes activated with eiter NOD2L and/or TLR2/1L.					10320	57478	6614	56890	9879	7179	8549	79831	10220	80114	30832	2967	4969	147700	223117	23657	57452	5973	6625	54872	51147	6813	5064	4653	2792	51015	89796	259307	5034	6540	63035	4077	11092	5241	3656	55303	3283	10788	4218	10266	100129271	54112	57498	79042	5620	4763	147906	401551	9807	51747	253512	3688	5993	80128	116064	84992	8174	284352	1365	1960	375061	112	9076	170712	399814	11165	197187	1832	80342	4781	9856	610	6122	5053	79645	6431	51763	6490	254122	23603	6272	9055	23731	56654	79748	10044	54825	51439	158798	83875	51696	4321	3960	10363	10501	79583	646174	7020	3360	54708	483	353131	8527	9821	6502	58538	23554	56000	2150	94086	79990	717	25821	57472	84961	390243	643414	10443	29924	8745	80781	55039	9555	10893	4048	256536	2555	221184	55620	3664	10350	151888	10403	5515	23099	157769	57655	84230	7704	9124	124842	6175	414918	3206	80301	51705	25814	9583	65065	55210	7052	1266	221692	55190	7593	9764	55088	90693	28970	7862	64072	1066	29015	9805	7706	9559	10068	170392	8555	54763	127707	81844	56660	2039	168620	23200	7408	121599	22921	285590	11231	79776	55808	84894	28951	26133	23533	7503	6528	1630	125931	6932	80727	2912	10156	80821	8309	83636	90019
GSE34515_CD16_NEG_MONOCYTE_VS_DC_UP	M8761		22531920	Frankenberger M,Hofer TP,Marei A,Dayyani F,Schewe S,Strasser C,Aldraihim A,Stanzel F,Lang R,Hoffmann R,Costa da Prazeres O,Buch T,Ziegler-Heitbrock L	GSE34515	GSE34515_3421_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD16- monocytes versus dendritic cells.	In this study gene expression of human blood classical monocytes (CD14++CD16-), CD16 positive monocytes (consisting of non-classical CD14+16++ and intermediate CD14++CD16+ monocytes) and CD1c+ CD19- dendritic cells from healthy subjects were investigated.					91775	3676	6645	4772	6670	3632	5788	221035	901	57606	9683	161742	2358	2810	10728	8764	84959	440193	6237	60672	27107	2131	100128191	11182	146225	253832	162989	719	100131434	9802	79651	126731	80315	8536	29097	171586	6390	5606	4012	27131	7277	5023	10044	4043	286144	84186	57192	25984	9061	8760	2533	9741	404093	22936	3588	59342	2867	9778	718	55275	7940	729991	10924	10461	8869	974	100131096	3015	6102	1848	84162	175	5326	7107	83541	339745	55803	8780	7378	54793	96626	950	53917	6744	135932	3753	27244	84958	80896	7867	151306	114882	5119	54556	6533	4200	1847	89894	85442	79901	10577	94241	29766	2332	4478	6398	57396	51363	1062	8876	151556	5978	54596	7133	54918	54552	5265	93323	571	23075	4005	116362	2015	10335	11138	154141	51552	23031	6683	6556	201627	199	3101	4048	221656	140609	255488	4121	653739	9107	1859	83464	5295	123803	6648	389895	4601	8875	3096	143458	6441	11275	2634	100505622	10042	55840	2517	56949	2124	84282	7096	5175	5756	4666	57153	54997	3688	389	65220	255919	51379	146722	7704	1849	10474	2207	26037	1612	23389	57493	23608	5921	282974	10154	55062	340239	8932	124152	51278	28962	65124	23462	51341	57134	9236	4193	79758	427	55133
GSE34515_CD16_NEG_VS_POS_MONOCYTE_DN	M8762		22531920	Frankenberger M,Hofer TP,Marei A,Dayyani F,Schewe S,Strasser C,Aldraihim A,Stanzel F,Lang R,Hoffmann R,Costa da Prazeres O,Buch T,Ziegler-Heitbrock L	GSE34515	GSE34515_3420_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in monocytes: CD16- versus CD16+.	In this study gene expression of human blood classical monocytes (CD14++CD16-), CD16 positive monocytes (consisting of non-classical CD14+16++ and intermediate CD14++CD16+ monocytes) and CD1c+ CD19- dendritic cells from healthy subjects were investigated.					6122	63897	6626	57143	708	84288	5901	8501	6137	2954	6742	516	100505761	134728	23596	6421	64902	2968	6484	5872	55704	3116	1503	27335	51706	84988	28957	23474	23261	8672	3329	51309	56948	118429	9837	51205	27143	10653	8140	54718	10927	1184	55917	55248	388962	109	952	131450	4056	55004	51276	10399	2882	4580	6141	26995	64960	340348	27115	9521	79713	10952	5445	79864	57128	53826	23157	22868	143888	84058	9533	9557	4643	1615	9933	55204	5434	55176	9768	3695	135886	9618	152579	6689	79064	10488	53916	605	55421	55194	5738	51117	112464	5479	8975	23220	91647	1601	55333	5939	81579	90313	199990	11142	9274	9143	123263	6146	217	57820	9553	8969	667	2010	5519	65983	100288640	54541	60677	5031	860	58505	5578	6181	90594	9053	3490	29903	9338	2769	117143	4000	1381	2171	84679	196	123606	2621	85012	10038	913	11116	4597	3033	11184	57494	51738	51506	7289	80003	6402	1312	22929	6636	117145	7108	1175	4261	286527	25842	333929	6222	6192	23212	55847	1196	60436	80349	5577	116447	51314	347918	6843	3662	221749	5019	23647	84245	10972	144097	3608	944	6193	4728	84306	23547	64225	2162	84230	5641	402	9117	60412	123920	64231	28978	374882	10455	642852	221143
GSE34515_CD16_POS_MONOCYTE_VS_DC_DN	M8763		22531920	Frankenberger M,Hofer TP,Marei A,Dayyani F,Schewe S,Strasser C,Aldraihim A,Stanzel F,Lang R,Hoffmann R,Costa da Prazeres O,Buch T,Ziegler-Heitbrock L	GSE34515	GSE34515_3422_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD16+ monocytes versus dendritic cells.	In this study gene expression of human blood classical monocytes (CD14++CD16-), CD16 positive monocytes (consisting of non-classical CD14+16++ and intermediate CD14++CD16+ monocytes) and CD1c+ CD19- dendritic cells from healthy subjects were investigated.					51284	57185	57600	6051	439996	115950	196500	64411	64132	7852	57561	650	23328	5376	54625	57118	26123	2947	5836	5326	7056	57161	79595	7107	10567	1316	121512	79895	26999	2209	3487	118788	8905	6993	23327	9980	3433	10902	55861	2033	27429	80262	93663	144110	153020	64231	285440	80317	56204	11059	9032	81544	26235	10771	154007	94104	26090	9153	7533	284996	65065	9185	25798	7187	57610	219855	4814	1901	151636	55125	5498	53349	2140	58155	51504	8675	728	53373	1628	241	1536	10725	64236	375444	3575	84270	651746	22918	10409	4354	7048	9034	80255	116987	85441	92610	92815	4170	4240	132864	10396	9331	29116	85459	9050	201895	391059	255394	9936	79673	10447	255488	91614	51092	441168	8464	115548	118429	55198	25906	79772	54934	7097	3394	2145	8536	11180	51734	6433	285800	254251	2241	54676	26469	57484	1326	3627	11127	9252	100506144	8714	3071	22889	4851	192670	58986	84727	94240	348	201163	143684	157638	283537	5447	389072	84166	2185	1195	23049	57705	100287171	272	3683	30061	768211	89857	83641	57659	5294	10788	2517	6237	9657	665	121260	5538	4005	5336	23258	81609	23338	10410	90634	51719	55108	91526	9518	5106	5338	55650	905	994	56648	23048	6834	151903	55601	340152	9815	51094
GSE34515_CD16_NEG_VS_POS_MONOCYTE_UP	M8764		22531920	Frankenberger M,Hofer TP,Marei A,Dayyani F,Schewe S,Strasser C,Aldraihim A,Stanzel F,Lang R,Hoffmann R,Costa da Prazeres O,Buch T,Ziegler-Heitbrock L	GSE34515	GSE34515_3420_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in monocytes: CD16- versus CD16+.	In this study gene expression of human blood classical monocytes (CD14++CD16-), CD16 positive monocytes (consisting of non-classical CD14+16++ and intermediate CD14++CD16+ monocytes) and CD1c+ CD19- dendritic cells from healthy subjects were investigated.					64708	84331	57094	54606	10801	29108	196264	50	2194	400916	3572	100288797	7188	471	10890	539	3995	282969	284119	5214	9046	10125	114987	11132	23277	8503	51559	9314	3949	64834	130367	219	55785	3111	839	2159	53371	25932	4597	29796	58505	11112	163933	5580	94137	958	56975	51726	4121	4351	11000	1351	2745	1043	535	9238	22845	399948	3777	51075	92259	3632	154791	285973	10437	80142	1345	55652	6323	6542	23378	3662	9645	2289	9400	7866	5028	100131439	9666	5742	4783	6750	113451	50814	293	199704	506	643418	1339	6392	643008	8870	3983	55304	7384	5631	1522	51295	10462	6566	1846	6748	5866	2593	51617	27445	8767	7782	95	10221	388815	389792	4222	29126	6510	5699	32	54622	51264	3321	5019	56894	81030	91442	23593	51086	5318	5803	81876	4982	146556	23263	4696	53342	350	51454	23389	10280	55840	26472	64744	7284	259	5322	51596	898	51477	3687	2766	56172	28969	2335	3479	164633	85407	2139	778	3717	4493	55733	7022	151112	51172	51296	11009	203197	6691	613227	23768	54884	79581	2224	388284	113829	522	6474	90050	374955	170463	27163	5798	9873	57447	549	9424	687	10439	51066	25840	6369	9719	51398	960	3108	9136	7278	27089	1854	80139	128506
GSE34515_CD16_POS_MONOCYTE_VS_DC_UP	M8765		22531920	Frankenberger M,Hofer TP,Marei A,Dayyani F,Schewe S,Strasser C,Aldraihim A,Stanzel F,Lang R,Hoffmann R,Costa da Prazeres O,Buch T,Ziegler-Heitbrock L	GSE34515	GSE34515_3422_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD16+ monocytes versus dendritic cells.	In this study gene expression of human blood classical monocytes (CD14++CD16-), CD16 positive monocytes (consisting of non-classical CD14+16++ and intermediate CD14++CD16+ monocytes) and CD1c+ CD19- dendritic cells from healthy subjects were investigated.					4664	57178	5756	2932	6582	5187	7112	162073	3267	10749	112616	100131755	27097	9806	29982	4306	9465	9768	26122	122786	80351	11073	3839	91010	151050	6236	10318	203522	10171	51727	7844	54465	22908	2230	939	9663	10771	83541	55754	2521	8790	1368	64225	10730	11183	7716	2534	10299	2074	166336	168850	3600	4249	3320	153396	311	65980	6780	26993	205428	9156	1140	9213	56925	728661	55794	23283	80258	1739	3091	7840	65109	2686	55852	27	3720	55183	10657	5828	8993	8726	55364	5592	1030	7812	255758	71	10955	892	8851	9403	10148	9249	79959	54453	5217	4644	5359	81565	3423	63874	6373	3683	7158	10943	8030	55854	5500	10097	254394	8938	80776	91694	253461	440193	2317	26511	154743	29994	2188	84248	9262	8723	58527	10521	1316	10450	57708	94	1826	57473	81555	54762	6785	55858	10865	253714	659	921	11137	54808	26986	9994	9987	440275	1879	5445	9360	79876	9019	400746	55003	25816	25843	6434	56681	283489	10610	23264	11180	3309	3169	27033	116068	55788	55959	151613	6457	59269	637	25782	56948	3726	4000	56898	57157	6815	7159	4818	9424	1407	10875	9631	3482	27230	9871	119392	4643	2872	60386	245711	7429	6117	4792	80853	23048	8204	701	9445	79657
GSE34515_CD16_NEG_MONOCYTE_VS_DC_DN	M8766		22531920	Frankenberger M,Hofer TP,Marei A,Dayyani F,Schewe S,Strasser C,Aldraihim A,Stanzel F,Lang R,Hoffmann R,Costa da Prazeres O,Buch T,Ziegler-Heitbrock L	GSE34515	GSE34515_3421_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD16- monocytes versus dendritic cells.	In this study gene expression of human blood classical monocytes (CD14++CD16-), CD16 positive monocytes (consisting of non-classical CD14+16++ and intermediate CD14++CD16+ monocytes) and CD1c+ CD19- dendritic cells from healthy subjects were investigated.					10946	6584	28987	2290	55108	143941	7132	84937	5959	56912	29086	53347	64852	6046	4478	81603	158056	957	55009	760	26145	54888	26034	51056	8685	4023	51230	2212	6533	23603	79866	23526	10113	2697	57035	8574	64834	84284	5912	255520	57325	7433	8841	1269	9191	23064	23327	6618	284106	79691	5271	402	8904	29093	7580	8804	94101	10449	55845	221143	5720	261729	11331	65983	91	201294	2793	9730	83985	4725	143686	285051	79091	9246	4708	2073	6472	7357	57608	8048	118611	57184	79807	79005	5536	2124	1398	9555	8266	2185	80231	1460	1789	7453	23505	26001	51084	10066	3594	51199	79156	8140	55829	56927	976	170463	29085	682	771	57478	79071	2990	7390	10437	147015	65993	344387	2030	51761	80777	5001	5298	2583	84557	3988	84681	84268	25932	51018	79899	100134934	10412	10287	8896	22980	115209	10523	7249	10139	4149	23464	9911	55152	5989	841	56616	51493	8420	84861	93436	353116	22875	57620	113655	23536	25983	51693	133121	3430	28973	3903	65012	2889	991	1032	51225	79364	83933	84315	65005	27013	90522	10399	5635	6812	8666	23157	9647	5204	6143	253782	54870	22818	215	5452	8518	121665	6834	79780	83666	4850	10537	79695	55695	80011	5878	10663	56181	5175	129685
GSE32901_TH1_VS_TH17_ENRICHED_CD4_TCELL_DN	M8920		22715389	Zhang W,Ferguson J,Ng SM,Hui K,Goh G,Lin A,Esplugues E,Flavell RA,Abraham C,Zhao H,Cho JH	GSE32901	GSE32901_3355_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells: Th1 versus Th17 enriched.	In this study, we examined differential gene expression in naïve human CD4+ T cells, as well as in effector Th1, Th17-negative and Th17-enriched CD4- T cell subsets. We observed a marked enrichment for increased gene expression in effector CD4+ T cells compared to naive CD4+ among immune-mediated disease oci genes. Within effector T cells, expression of disease-associated genes was increased in Th17-enriched compared to Th17-negative cells. We used microarray to examine the gene expresssion profile and level of human naïve, Th1 and effector T cell subsets.					23481	388	8890	10445	10193	8717	81567	56955	64087	9936	267	65018	84134	100131439	79064	641371	3065	9733	83475	79607	10681	84314	119504	5649	6137	55211	3843	219855	54996	57409	115399	553115	10686	8738	79944	5004	26112	79663	55109	1044	314	10572	10330	51084	51389	1396	23508	5833	22822	2116	84950	118980	10577	5710	254295	149998	64601	2950	8663	220416	4318	2967	55450	307	83547	84219	79754	401505	6865	4771	195814	54675	1259	132430	133015	79139	55967	4191	389362	51647	9797	55644	283130	51026	619571	734	222658	11331	29085	2681	5994	80279	7922	8992	59067	51278	51478	4552	9313	5686	4728	26952	26580	8565	5715	162282	3732	79998	3276	3626	23409	55229	10598	54843	256364	4063	84231	1119	84897	23404	22928	5211	3157	151556	254251	26469	25816	10807	25880	6564	202052	11252	5834	493901	51460	10440	151194	54534	4942	740	114971	116966	2885	5536	200504	390790	9093	53829	347404
GSE32901_TH1_VS_TH17_NEG_CD4_TCELL_UP	M8922		22715389	Zhang W,Ferguson J,Ng SM,Hui K,Goh G,Lin A,Esplugues E,Flavell RA,Abraham C,Zhao H,Cho JH	GSE32901	GSE32901_3356_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells: Th1 versus Th17 negative.	In this study, we examined differential gene expression in naïve human CD4+ T cells, as well as in effector Th1, Th17-negative and Th17-enriched CD4- T cell subsets. We observed a marked enrichment for increased gene expression in effector CD4+ T cells compared to naive CD4+ among immune-mediated disease oci genes. Within effector T cells, expression of disease-associated genes was increased in Th17-enriched compared to Th17-negative cells. We used microarray to examine the gene expresssion profile and level of human naïve, Th1 and effector T cell subsets.					115548	11001	55254	4862	221895	57172	9924	11213	100126572	952	342125	5800	84916	83468	25902	25939	343641	10279	4012	83939	80005	6307	152559	56605	9200	632	6890	115019	54908	8334	55379	118856	2196	27286	1439	7072	26057	9780	10714	1983	9175	7357	9180	55315	55186	94097	6734	56888	23131	23360	55022	29072	5933	221711	23220	26	81850	55283	85865	50489	2643	26608	9543	51022	1672	115727	55026	51368	116931	80162	6774	90204	59342	79816	729330	124359	83660	55914	6331	26512	8725	55190	407010	9289	9113	89886	22997	55591	3081	5023	7852	6332	6938	2260	4342	10675	1810	10921	5036	152006	22915	27253	64598	5257	26034	113263	55937	1386	9730	56241	7538	5552	23318	5028	131034	63894	60685	10892	27067	8036	51050	835	65987	374659	340024	113251
GSE32901_TH1_VS_TH17_NEG_CD4_TCELL_DN	M8923		22715389	Zhang W,Ferguson J,Ng SM,Hui K,Goh G,Lin A,Esplugues E,Flavell RA,Abraham C,Zhao H,Cho JH	GSE32901	GSE32901_3356_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells: Th1 versus Th17 negative.	In this study, we examined differential gene expression in naïve human CD4+ T cells, as well as in effector Th1, Th17-negative and Th17-enriched CD4- T cell subsets. We observed a marked enrichment for increased gene expression in effector CD4+ T cells compared to naive CD4+ among immune-mediated disease oci genes. Within effector T cells, expression of disease-associated genes was increased in Th17-enriched compared to Th17-negative cells. We used microarray to examine the gene expresssion profile and level of human naïve, Th1 and effector T cell subsets.					192666	4599	7378	51478	991	79962	55143	3362	23468	11034	285126	84734	283554	575	146956	822	5133	29767	8744	8671	1066	11267	1163	29951	10497	57508	6526	6351	9308	55800	84948	3772	22865	402	4358	1203	9214	1760	9450	837	7088	637	80157	4745	8412	55779	387267	1630	54456	4025	930	8111	131583	1959	84233	3300	221391	727897	4678	136	92421	973	5232	152098	26027	25825	10424	594855	10403	219623	79072	3507	258010	22921	54436	388533	52	1267	6590	58480	8438	4033	83844	8581	122622	2944	90861	51174	1821	83878	27306	4916	932	4632	63979	23075	128308	51497	255758	162073	80741	25816	8270	283316	65108	6348	2861	3131	51226	117178	79789	9476	5251	392255	54910	5982	641451	26280
GSE32901_TH1_VS_TH17_ENRICHED_CD4_TCELL_UP	M8925		22715389	Zhang W,Ferguson J,Ng SM,Hui K,Goh G,Lin A,Esplugues E,Flavell RA,Abraham C,Zhao H,Cho JH	GSE32901	GSE32901_3355_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells: Th1 versus Th17 enriched.	In this study, we examined differential gene expression in naïve human CD4+ T cells, as well as in effector Th1, Th17-negative and Th17-enriched CD4- T cell subsets. We observed a marked enrichment for increased gene expression in effector CD4+ T cells compared to naive CD4+ among immune-mediated disease oci genes. Within effector T cells, expression of disease-associated genes was increased in Th17-enriched compared to Th17-negative cells. We used microarray to examine the gene expresssion profile and level of human naïve, Th1 and effector T cell subsets.					117583	257068	135644	8540	51176	255275	51763	55914	64746	5588	10043	3983	5567	1901	9600	51232	115111	1432	83737	84067	3658	58487	55636	10628	60481	54454	5892	55773	161291	5788	10051	841	57165	57551	57804	57531	2972	9969	11329	59343	155066	6619	90693	8178	255967	9595	11001	6885	23327	83719	120	116461	8452	84937	64320	64418	25851	143187	9701	7185	6402	4607	5175	1656	57460	6775	115548	23457	2908	23228	56829	1606	27075	4092	27097	79836	55131	50487	57162	159	80223	147040	145226	56944	347273	3932	55277	474344	201140	10048	55291	55339	286336	10006	8526	10818	9213	1455	58155	5991	60685	7155	4627	9402	57708	3927	57580	130576	85464	54752	64718	3716	64333	23552	57560	65999	8658	84173	3611	2771	831	152185	5292	57337	6653	23395	3560	1655	393	11151	26037	25831	928	51773	84071	64919	22858	23546	6935	10605	201595	26191	25855	9528	3141	9750	9725	1105	246213	57692	26263	55023	9879	6932	257415	346653	92241	8028	342184	23157	84125	2131	54915	483	254050	26034	8887	8821	50618	284427	23370
GSE32901_NAIVE_VS_TH1_CD4_TCELL_DN	M8926		22715389	Zhang W,Ferguson J,Ng SM,Hui K,Goh G,Lin A,Esplugues E,Flavell RA,Abraham C,Zhao H,Cho JH	GSE32901	GSE32901_3352_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells: naïve versus Th1.	In this study, we examined differential gene expression in naïve human CD4+ T cells, as well as in effector Th1, Th17-negative and Th17-enriched CD4- T cell subsets. We observed a marked enrichment for increased gene expression in effector CD4+ T cells compared to naive CD4+ among immune-mediated disease oci genes. Within effector T cells, expression of disease-associated genes was increased in Th17-enriched compared to Th17-negative cells. We used microarray to examine the gene expresssion profile and level of human naïve, Th1 and effector T cell subsets.					10437	8581	8784	3394	90701	115727	4208	4609	9308	4033	5777	1163	8438	972	4064	9214	391365	974	5627	9473	50615	79630	952	64092	57823	1536	81622	930	84816	113251	90678	10296	10769	1105	23481	10152	2952	57508	84964	7124	5341	637	26576	157570	3362	973	115650	3030	122618	5366	5890	5256	1512	1154	51069	146850	23468	64397	1891	4067	6856	54910	29760	2213	7134	2109	9476	5981	29930	27090	3164	147841	6599	51324	2620	128239	1893	10193	65979	23075	5468	4751	3836	60412	2822	348654	4916	9450	11332	6002	2953	3778	991	640	10219	4285	7035	6039	153339	6451	51524	5270	822	11243	51194	84142	54552	9126	8412	10171	116447	6598	64225	9324	941	55103	11169	79954	64332	22850	1959	1841	6351	5079	81605	8482	9585	175	5393	5510	23178	89886	27077	9669	152098	9125	9859	33	728294	4361	6767	1653	1212	9873	84154	7293	220359	6271	81930	59342	144455	57705	64782	1786	253827	152137	23173	60386	152559	57216	10445	55388	10661	931
GSE32901_NAIVE_VS_TH17_ENRICHED_CD4_TCELL_UP	M8927		22715389	Zhang W,Ferguson J,Ng SM,Hui K,Goh G,Lin A,Esplugues E,Flavell RA,Abraham C,Zhao H,Cho JH	GSE32901	GSE32901_3353_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] naïve versus Th17 enriched.	In this study, we examined differential gene expression in naïve human CD4+ T cells, as well as in effector Th1, Th17-negative and Th17-enriched CD4- T cell subsets. We observed a marked enrichment for increased gene expression in effector CD4+ T cells compared to naive CD4+ among immune-mediated disease oci genes. Within effector T cells, expression of disease-associated genes was increased in Th17-enriched compared to Th17-negative cells. We used microarray to examine the gene expresssion profile and level of human naïve, Th1 and effector T cell subsets.					2056	246213	57655	54454	64506	441168	7274	4056	283897	65018	1901	3955	155066	3932	54491	79670	268	339745	27094	57460	4626	1195	56603	282679	286205	9217	9153	25800	6414	57097	25865	256364	1998	55343	89846	1259	55773	9402	6402	2568	3983	57646	54855	10788	338596	26119	9453	137835	8313	4324	6641	26953	30845	29109	80279	64795	2800	10051	120	283130	196513	5175	56961	197358	10284	390226	159371	7098	8715	6016	11168	5588	378938	132160	7433	64919	149628	11329	9595	6732	11185	54996	89801	3695	55757	254170	10317	25851	889	118980	91775	9973	92304	84206	26469	58529	729025	267	23765	5138	1813	2206	84067	286336	8418	8505	57396	80736	51176	9903	51379	55629	92196	4145	129787	28951	22925	2113	80319	124491	3981	81562	146227	157848	9314	10225	685	976	5994	474344	56829	1831	139599	23499	7484	150275	89857	56311	8911	9852	1359	4850	338773	10522	10423	5874	57018	59343	131	100129583	84085
GSE32901_NAIVE_VS_TH17_ENRICHED_CD4_TCELL_DN	M8928		22715389	Zhang W,Ferguson J,Ng SM,Hui K,Goh G,Lin A,Esplugues E,Flavell RA,Abraham C,Zhao H,Cho JH	GSE32901	GSE32901_3353_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] naïve versus Th17 enriched.	In this study, we examined differential gene expression in naïve human CD4+ T cells, as well as in effector Th1, Th17-negative and Th17-enriched CD4- T cell subsets. We observed a marked enrichment for increased gene expression in effector CD4+ T cells compared to naive CD4+ among immune-mediated disease oci genes. Within effector T cells, expression of disease-associated genes was increased in Th17-enriched compared to Th17-negative cells. We used microarray to examine the gene expresssion profile and level of human naïve, Th1 and effector T cell subsets.					123	85451	56061	598	10296	118426	8204	54463	8694	973	1236	55669	3658	163126	56957	11174	969	84295	3059	51646	55256	91869	64092	96764	54915	7494	124359	10769	30001	51132	90678	841	154661	9969	1213	5530	6611	64332	55914	3099	5890	22926	8614	113251	814	8674	10006	23048	5264	54558	51450	11001	9709	2953	152137	7072	10043	6605	378	6925	5832	2139	54941	90550	201931	1026	60412	64419	2935	6856	10059	824	23178	6141	546	160851	201562	8564	10667	10628	79882	389	64418	9473	4649	10199	8609	257068	343099	55144	11332	5996	4012	2182	118788	79979	1983	6503	3843	81488	113263	51150	2010	10274	7803	79630	1105	51678	134430	23673	56180	10605	57804	9910	135644	55159	6504	8784	7871	7280	9169	79370	26133	5468	116983	6047	51573	11124	5583	1879	55277	3021	54438	5036	115548	89796	63894	1656	3326	4354	5868	65986	55852	3416	8581	64225	8540	1176	1612	3066	6731	4361	51773	11231	4189	29015	3065	112	9949	57337	952	144100	64839	55335	59353	23028	29966	5079	84246	55186	122618	93643	3645	4643
GSE32901_TH17_EMRICHED_VS_TH17_NEG_CD4_TCELL_UP	M8929		22715389	Zhang W,Ferguson J,Ng SM,Hui K,Goh G,Lin A,Esplugues E,Flavell RA,Abraham C,Zhao H,Cho JH	GSE32901	GSE32901_3357_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] Th17 T cells: enriched versus negative.	In this study, we examined differential gene expression in naïve human CD4+ T cells, as well as in effector Th1, Th17-negative and Th17-enriched CD4- T cell subsets. We observed a marked enrichment for increased gene expression in effector CD4+ T cells compared to naive CD4+ among immune-mediated disease oci genes. Within effector T cells, expression of disease-associated genes was increased in Th17-enriched compared to Th17-negative cells. We used microarray to examine the gene expresssion profile and level of human naïve, Th1 and effector T cell subsets.					57332	51019	27439	8890	23440	258010	388335	149371	3300	9936	139741	6132	2116	254170	81579	4626	7045	9903	1636	6202	283897	7107	79944	7448	339390	89782	57597	23480	154796	1831	1267	219623	93986	1580	10497	643866	3283	58503	54854	254552	56267	56666	353238	10603	646643	10139	28951	3290	27094	10870	55800	64434	402682	200132	51603	246213	23746	5311	54551	79962	51601	2693	493860	54544	171177	4025	346171	54328	11061	58529	55039	84451	29107	84735	51478	6865	6207	29896	2950	6550	55757	54855	145864	1811	130074	113675	58480	27165	154	26153	7098	8313	115399	80148	2277	9630	2690	91775	6526	27335	474382	9973	22866	56603	10078	8822	79057	22921	9046	55967	7378	56000	399474	131118	2912	80319	1816	641372	114879	9852
GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_DN	M8930		22715389	Zhang W,Ferguson J,Ng SM,Hui K,Goh G,Lin A,Esplugues E,Flavell RA,Abraham C,Zhao H,Cho JH	GSE32901	GSE32901_3354_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] T cells: naïve versus Th17 negative.	In this study, we examined differential gene expression in naïve human CD4+ T cells, as well as in effector Th1, Th17-negative and Th17-enriched CD4- T cell subsets. We observed a marked enrichment for increased gene expression in effector CD4+ T cells compared to naive CD4+ among immune-mediated disease oci genes. Within effector T cells, expression of disease-associated genes was increased in Th17-enriched compared to Th17-negative cells. We used microarray to examine the gene expresssion profile and level of human naïve, Th1 and effector T cell subsets.					153733	3778	116369	165530	129446	51514	8537	18	9172	341359	8842	4953	5764	23495	3371	56899	10481	7866	3222	8532	54443	4488	898	968	169044	389206	79923	5796	1068	9214	2674	6351	653361	80761	114294	6941	41	10437	4605	29760	8639	2981	1362	8482	257236	22974	6427	57639	57705	9118	972	51523	115650	55089	4430	51289	10721	57699	1775	2891	9156	9132	3624	2587	991	974	56652	9308	57631	10590	9787	2515	9040	160364	3604	6547	81543	8351	196374	152330	1831	6723	11095	4632	5050	253012	3441	122618	8689	327657	7462	140032	4288	399694	9319	5340	7130	147372	5355	150468	64106	144455	7289	1290	57338	3479	22983	631	84125	23779	56267	6532	79812	24147	4778	1445	51174	127124	84872	5037	81622	6004
GSE32901_TH17_EMRICHED_VS_TH17_NEG_CD4_TCELL_DN	M8931		22715389	Zhang W,Ferguson J,Ng SM,Hui K,Goh G,Lin A,Esplugues E,Flavell RA,Abraham C,Zhao H,Cho JH	GSE32901	GSE32901_3357_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in CD4 [GeneID=920] Th17 T cells: enriched versus negative.	In this study, we examined differential gene expression in naïve human CD4+ T cells, as well as in effector Th1, Th17-negative and Th17-enriched CD4- T cell subsets. We observed a marked enrichment for increased gene expression in effector CD4+ T cells compared to naive CD4+ among immune-mediated disease oci genes. Within effector T cells, expression of disease-associated genes was increased in Th17-enriched compared to Th17-negative cells. We used microarray to examine the gene expresssion profile and level of human naïve, Th1 and effector T cell subsets.					130502	493856	10048	84163	28969	1891	57097	65983	10113	55065	9595	374407	79720	8694	1106	169792	3091	140609	8496	10628	64332	125170	268	80305	11001	59353	5529	154661	6489	79661	26127	5138	54941	33	123	7185	9475	7538	84067	5520	25814	10043	10379	284129	54812	9653	5892	55929	79188	11127	286336	54820	6503	1962	10769	64108	11057	64718	9429	26122	10006	55667	10449	84532	5608	414918	54904	387751	4790	140461	259173	55902	23181	57182	4218	7128	55750	23351	6603	388403	64135	5150	55611	57185	3759	10898	57118	4303	7486	64223	23626	6641	64801	23347	24145	55166	23566	5476	84961	140469	9049	8161	51447	64333	122060	2969	285362	4092	54583	26191	11129	221178	6596	57531	92	23457	1404	113828	83641	4792	3257	548645	642	8045	10670	23309	959	25841	8774	255394	9236	3337	11188	54850	6560	10611	10013	375775	81858	126119	22907	26233	23510	57446	55666	5588	2551	10723	286205	64756	54471	23765	3059	51592	8631	51363	55745	5289	256987	5140	220074	604	817	6414	220213	57142	9275	10057	158747	116985
GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_UP	M8932		22715389	Zhang W,Ferguson J,Ng SM,Hui K,Goh G,Lin A,Esplugues E,Flavell RA,Abraham C,Zhao H,Cho JH	GSE32901	GSE32901_3354_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells: naïve versus Th17 negative.	In this study, we examined differential gene expression in naïve human CD4+ T cells, as well as in effector Th1, Th17-negative and Th17-enriched CD4- T cell subsets. We observed a marked enrichment for increased gene expression in effector CD4+ T cells compared to naive CD4+ among immune-mediated disease oci genes. Within effector T cells, expression of disease-associated genes was increased in Th17-enriched compared to Th17-negative cells. We used microarray to examine the gene expresssion profile and level of human naïve, Th1 and effector T cell subsets.					1380	5523	51512	51084	10445	7083	29015	8694	6427	9476	81567	1495	150468	930	8482	4208	64005	30844	8784	7293	115350	933	4641	51523	9334	3002	995	57705	9100	8754	5292	9055	51514	79931	83540	11001	23382	3832	7494	219972	10437	84824	116496	1235	123	7052	1163	30834	1975	3604	6277	3326	4953	9324	3065	931	914	2109	7813	55103	64946	23643	157313	51614	84304	2896	9214	2491	1959	6491	1894	25780	6941	9308	1522	4067	953	307	952	7462	84668	55723	1536	56154	9585	6632	22837	28959	7410	1476	10769	29760	5468	890	54443	374407	9961	6689	23191	972	973	9493	63967	9918	327657	8564	9450	3619	1362	833	9319	821	1154	1512	4288	79801	6385	5427	3613	2953	1233	3161	8411	4818	8520	7332	115650	55024	64332	219855	8501	8365	79733	8581	1062	23165	5287	974	55070	6925	122618	3978	5199	22974	1893	841	3662	5627	10643	4609	3708	55320	57082	701	10162	56992	4643	637	128209	899	1650	640	9443	84231	9735	822	6856
GSE32901_NAIVE_VS_TH1_CD4_TCELL_UP	M8933		22715389	Zhang W,Ferguson J,Ng SM,Hui K,Goh G,Lin A,Esplugues E,Flavell RA,Abraham C,Zhao H,Cho JH	GSE32901	GSE32901_3352_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in CD4 [GeneID=920] T cells: naïve versus Th1.	In this study, we examined differential gene expression in naïve human CD4+ T cells, as well as in effector Th1, Th17-negative and Th17-enriched CD4- T cell subsets. We observed a marked enrichment for increased gene expression in effector CD4+ T cells compared to naive CD4+ among immune-mediated disease oci genes. Within effector T cells, expression of disease-associated genes was increased in Th17-enriched compared to Th17-negative cells. We used microarray to examine the gene expresssion profile and level of human naïve, Th1 and effector T cell subsets.					57097	8418	3603	9200	27237	10723	10225	79993	23765	6489	27286	130576	25841	284406	84283	140545	259173	8334	255809	7424	3811	79873	120	54625	56132	5787	58986	149233	203100	85417	3676	54855	9312	123228	256380	146923	5140	343	3930	57172	116984	84766	9651	79645	190	1804	9600	56944	957	57542	8507	286336	6641	149371	51704	387357	7433	9113	11213	346171	54700	387751	7263	1436	79637	64108	84513	3101	144193	150726	2969	64881	10505	11069	118672	50801	10014	3756	23768	9882	1733	4092	5138	154	54796	84153	51287	6480	28232	223082	158326	57545	374569	57446	64718	23301	55591	732	5161	79589	83985	10365	441478	1107	338596	390916	57488	525	348378	11117	349136	51105	57152	632	23626	64794	79188	7852	7057	65983	5744	4899	8631	57524	55602	221302
GSE38697_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP	M9007		22740445	Victora GD,Dominguez-Sola D,Holmes AB,Deroubaix S,Dalla-Favera R,Nussenzweig MC	GSE38697	GSE38697_3172_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in B lymphocytes: light zone versus dark zone.	Microarrays of gene expression in human germinal center light zone and dark zone B cells sorted according to the expression of cell surface molecules CD83 and CXCR4 We used microarray data to identify genes differentially expressed by B cells in the light and dark zones of germinal centers from human tonsil specimens.					92597	9181	221409	9446	123720	9650	10438	132320	23443	634	84959	54529	55751	10063	8013	8905	51496	27301	23333	5316	139341	667	57140	6792	56919	7035	79868	9894	7070	9779	5727	4772	6310	5520	1176	286826	23589	51063	25914	10678	158866	51586	941	84524	4256	56984	60560	80313	54331	64802	84188	64768	51134	8347	2593	130340	1959	175	51621	164592	51706	10807	10666	117155	9348	137735	27347	5257	94104	84311	4863	10393	51635	64793	91137	1781	131450	23164	10617	1982	9753	7257	10890	79576	221421	11275	58515	92259	189	969	705	11311	79895	260425	10495	201176	318	114836	54518	23604	5438	201799	10199	84255	54885	5585	686	54585	9512	64645	51241	64960	80224	54103	23118	54834	56925	2961	3021	9878	5445	4189	10806	549	2932	55860	8915	2838	1875	6431	79695	10001	8737	11344	144715	9910	83986	55758	4952	4784	54439	222229	7096	23176	89874	120935	7903	83732	9447	11019	1379	10240	60487	10922	11102	145447	8439	285025	4026	9919	55171	9306	962	259230	23259	734	57493	7073	116138
GSE38697_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN	M9010		22740445	Victora GD,Dominguez-Sola D,Holmes AB,Deroubaix S,Dalla-Favera R,Nussenzweig MC	GSE38697	GSE38697_3172_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in B lymphocytes: light zone versus dark zone.	Microarrays of gene expression in human germinal center light zone and dark zone B cells sorted according to the expression of cell surface molecules CD83 and CXCR4 We used microarray data to identify genes differentially expressed by B cells in the light and dark zones of germinal centers from human tonsil specimens.					216	1453	171177	203447	863	3699	51334	1284	401067	4248	793	126014	11187	200162	64093	286256	8323	389827	146227	51208	84752	93010	5284	5067	131583	27123	78989	53616	4781	91754	5319	23566	157724	4306	1591	23231	5069	219287	23552	64084	5020	201798	2734	79888	229	3491	4014	284040	376267	3995	79917	2897	238	4982	619562	83694	1750	116988	27231	100132911	222171	84717	1138	84171	3872	57549	26151	65055	79623	7471	8877	130540	10630	386653	83648	57451	387787	91653	11144	138311	8399	84689	1610	148641	245973	286	3207	93099	80034	84332	114898	85462	84159	2813	7802	120379	50507	220963	257194	136332	6783	51471	115701	6927	5017	113675	51384	9467	56955	29953	23127	254187	4852	151531	80319	3219	159371	127255	254240	132141	4486	100505381
GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10POS_BONE_MARROW_UP	M9077		22941246	Kohn LA,Hao QL,Sasidharan R,Parekh C,Ge S,Zhu Y,Mikkola HK,Crooks GM	GSE35685	GSE35685_2633_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in the bone marrow CD34+ [GeneID=947] cells: CD38- [GeneID=952] versus MME+ [GeneID=4311].	Studies of adult human hematopoiesis have until now relied on the expression of CD10 to define lymphoid commitment. We report a novel lymphoid-primed population in human bone marrow that is generated from hematopoietic stem cells (HSC) prior to the onset of CD10 expression and B cell commitment, and is identified by high levels of the homing molecule L-selectin (CD62L). CD10-CD62Lhi progenitors have full lymphoid (B/T/NK) potential, and show reduced myeloid and absent erythroid potential. Genome-wide gene expression analysis demonstrates that the CD10-CD62Lhi population represents an intermediate stage of differentiation between CD34+CD38- HSC and CD34+lin-CD10+ progenitors marked by down-regulation of TAL1 and MPL, upregulation of E2A, CD3E and IL2RG expression, and absent B cell commitment or RAG1/2 expression. Immature CD34+CD1a- thymocytes are also CD62Lhi and L-selectin ligands are expressed at the cortico-medullary junction, suggesting a possible role for L-selectin in human thymic homing. These studies identify the earliest stage of lymphoid priming in human bone marrow.					553115	1775	6539	678	4782	217	10318	129685	3587	11334	6452	1524	55176	388558	5178	388	10007	3162	5539	406	85457	3364	7841	5580	9500	11083	26191	2052	29988	10023	57649	2152	7050	5966	2969	57462	9903	5636	57621	84340	64975	80728	8869	222229	1382	5007	79581	55907	10461	25777	3283	1634	3418	121457	64708	55317	4155	84693	1454	767	83401	221955	9673	10762	27244	83719	3046	3835	390010	343	10928	5581	55818	10957	898	6582	26580	337879	2353	7057	11126	29088	7469	1917	64795	2077	7832	10636	286826	55544	9260	10125	2550	6468	10468	169044	1975	50855	1581	4066	9950	11080	115950	26012	788	5355	10296	10970	8848	376497	64745	4146	79888	3603	54520	4193	81605	5791	2309	54934	51655	842	2872	50814	23175	6320	51184	23192	3592	6535	389203	5571	57648	391	152	11344	7431	10233	201456	8508	6257	1911	4935	1179	5590	4814	1282	51177	4363	79720	56257	5438	1432	51673	55140	6239	6439	50626	3371	6449	2205	100506612	57591	440957	2767	1576	4829	140738	219743	9625	3588	23456	51629	6935	8792	2067	599	23414	283337	2906	6614	57035	7105	54800	26240	348980	5468	163	7301	23218	7786	5576	57089	7007	92745	90637	6422	10871	142	6618
GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10POS_BONE_MARROW_DN	M9079		22941246	Kohn LA,Hao QL,Sasidharan R,Parekh C,Ge S,Zhu Y,Mikkola HK,Crooks GM	GSE35685	GSE35685_2633_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in the bone marrow CD34+ [GeneID=947] cells: CD38- [GeneID=952] versus MME+ [GeneID=4311].	Studies of adult human hematopoiesis have until now relied on the expression of CD10 to define lymphoid commitment. We report a novel lymphoid-primed population in human bone marrow that is generated from hematopoietic stem cells (HSC) prior to the onset of CD10 expression and B cell commitment, and is identified by high levels of the homing molecule L-selectin (CD62L). CD10-CD62Lhi progenitors have full lymphoid (B/T/NK) potential, and show reduced myeloid and absent erythroid potential. Genome-wide gene expression analysis demonstrates that the CD10-CD62Lhi population represents an intermediate stage of differentiation between CD34+CD38- HSC and CD34+lin-CD10+ progenitors marked by down-regulation of TAL1 and MPL, upregulation of E2A, CD3E and IL2RG expression, and absent B cell commitment or RAG1/2 expression. Immature CD34+CD1a- thymocytes are also CD62Lhi and L-selectin ligands are expressed at the cortico-medullary junction, suggesting a possible role for L-selectin in human thymic homing. These studies identify the earliest stage of lymphoid priming in human bone marrow.					602	1326	3597	7538	255231	9766	2549	23190	10723	55589	23765	9516	10912	1230	5019	5770	3267	8896	284194	23528	5292	10397	5359	4792	9086	6351	839	7357	83877	6513	3937	571	3627	6484	942	6357	9023	64222	8703	3717	7763	4215	4299	1052	388646	80824	64332	5866	8754	7189	55636	6890	8013	837	8460	3725	3600	6774	3099	345611	7220	2643	115361	64771	55500	8744	10497	3659	54708	1810	5698	3566	5371	3633	22862	7090	7532	2651	4615	317	284996	2634	8721	4860	80196	2209	10135	87178	23367	25819	196	25879	8870	57169	8027	2213	5395	9517	6354	8651	1647	2978	637	57162	5702	51534	10875	1032	197370	4493	5878	127544	3397	51001	27090	153339	22926	4502	1439	8835	79002	1234	254428	9308	824	5321	3775	26234	7993	28969	2697	7076	84316	25976	90007	81671	1633	2730	64135	2870	50650	23673	29950	53371	55177	6443	23082	9636	1601	834	4067	4716	55106	473	85437	90355	26091	3430	283991	11274	6129	55003	128866	2908	7296	7045	56650	6403	6238	84946	7132	3716	494115	10906	2710	114609	3394	57533	57062	26515	51602	27023	1462	2271	6347	10379	5917	162494	3433	30836	4790	26057	2319	5214	8453	8780	163590	3312	84333	51571
GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_UP	M9080		22941246	Kohn LA,Hao QL,Sasidharan R,Parekh C,Ge S,Zhu Y,Mikkola HK,Crooks GM	GSE35685	GSE35685_2634_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in the bone marrow CD34+ [GeneID=947] cells: MME- SELL+[GeneID=4311;6402] versus MME+ [GeneID=4311].	Studies of adult human hematopoiesis have until now relied on the expression of CD10 to define lymphoid commitment. We report a novel lymphoid-primed population in human bone marrow that is generated from hematopoietic stem cells (HSC) prior to the onset of CD10 expression and B cell commitment, and is identified by high levels of the homing molecule L-selectin (CD62L). CD10-CD62Lhi progenitors have full lymphoid (B/T/NK) potential, and show reduced myeloid and absent erythroid potential. Genome-wide gene expression analysis demonstrates that the CD10-CD62Lhi population represents an intermediate stage of differentiation between CD34+CD38- HSC and CD34+lin-CD10+ progenitors marked by down-regulation of TAL1 and MPL, upregulation of E2A, CD3E and IL2RG expression, and absent B cell commitment or RAG1/2 expression. Immature CD34+CD1a- thymocytes are also CD62Lhi and L-selectin ligands are expressed at the cortico-medullary junction, suggesting a possible role for L-selectin in human thymic homing. These studies identify the earliest stage of lymphoid priming in human bone marrow.					2729	26191	55342	8829	91107	5376	23405	2530	56257	9612	678	8869	824	11034	3054	7589	3479	9446	4023	10318	8848	5412	768211	7086	223	22821	1152	339665	4673	1374	2317	343	5860	56975	6888	55850	202	54908	23218	79720	7533	376497	11180	55037	47	6128	2879	80762	2353	23446	3304	51386	64121	968	10280	8091	101	9563	1454	79026	9761	5571	129285	4782	4733	5576	3992	25873	1774	84270	2653	7871	84196	55907	58526	56172	115992	4193	1396	9493	4864	55667	51719	64219	122622	55920	100134934	64114	5786	54810	54934	8560	3835	7267	4800	9091	51280	54463	6535	10569	3187	11151	11345	1605	91663	10155	4155	23705	28956	55435	9217	200933	842	4436	27242	2921	11080	217	6539	5580	5110	28977	286826	23505	83892	929	171546	57142	3087	987	83787	285527	55317	65990	121457	25798	23014	5147	6222	54982	4292	3034	64795	26035	10636	8801	27327	2746	10111	7389	4702	4739	3033	3421	1432	404093	5106	4814	146542	6196	5579	63875	51477	9500	4091	8878	10928	23473	4154	23077	6279	3619	55856	9258	79031	51393	10017	2926	57157	2768	408	1460	90273	259266	5269	6611	2054	5445	5130	222229	87	159	149076	56474	8819	142	5161	80728	10625	334
GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_DN	M9081		22941246	Kohn LA,Hao QL,Sasidharan R,Parekh C,Ge S,Zhu Y,Mikkola HK,Crooks GM	GSE35685	GSE35685_2634_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in the bone marrow CD34+ [GeneID=947] cells: MME- SELL+[GeneID=4311;6402] versus MME+ [GeneID=4311].	Studies of adult human hematopoiesis have until now relied on the expression of CD10 to define lymphoid commitment. We report a novel lymphoid-primed population in human bone marrow that is generated from hematopoietic stem cells (HSC) prior to the onset of CD10 expression and B cell commitment, and is identified by high levels of the homing molecule L-selectin (CD62L). CD10-CD62Lhi progenitors have full lymphoid (B/T/NK) potential, and show reduced myeloid and absent erythroid potential. Genome-wide gene expression analysis demonstrates that the CD10-CD62Lhi population represents an intermediate stage of differentiation between CD34+CD38- HSC and CD34+lin-CD10+ progenitors marked by down-regulation of TAL1 and MPL, upregulation of E2A, CD3E and IL2RG expression, and absent B cell commitment or RAG1/2 expression. Immature CD34+CD1a- thymocytes are also CD62Lhi and L-selectin ligands are expressed at the cortico-medullary junction, suggesting a possible role for L-selectin in human thymic homing. These studies identify the earliest stage of lymphoid priming in human bone marrow.					1241	10746	10723	1326	5878	2271	6367	7538	7045	3791	5756	9766	3433	602	5770	5371	6774	11011	8870	5866	3718	64859	7076	83877	55589	255231	9023	8754	4860	10497	3659	90007	27075	1266	26515	4615	115361	201965	2171	162	2193	7763	7090	837	3309	10875	5698	6347	3937	284194	10068	6403	1462	51762	53916	3597	5292	3633	345611	1910	535	10135	3964	5167	203228	4084	5699	3566	3707	839	3720	11127	54918	100506736	10397	23673	10333	2634	57153	3267	2213	55636	9516	56673	527	2022	2651	3725	4061	2209	2034	26277	8935	1230	317	9086	2697	10237	1075	87178	2029	9448	388646	963	435	3627	197370	9643	9636	9798	254428	10199	4245	64332	9919	3162	8703	6890	1439	8651	27090	4905	114885	4282	81565	7132	9935	10912	834	706	6453	147183	58533	7920	23647	216	80824	10867	3601	51744	23528	4880	1052	57533	4600	6776	6357	200185	5359	3312	1601	3093	6642	3198	22926	28969	860	6626	25816	2319	51231	81671	136541	2549	7873	10410	6616	7976	27023	9723	3028	100	4811	6354	26056	54890	942	8460	1690	5861	4891	50807	388962	54708	6945	9270	10320	55280	161	5321	3064	6772	10291	3763	51421	5627	83732	11230	5295	6351
GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_UP	M9083		22941246	Kohn LA,Hao QL,Sasidharan R,Parekh C,Ge S,Zhu Y,Mikkola HK,Crooks GM	GSE35685	GSE35685_2632_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in the bone marrow CD34+ [GeneID=947] cells: CD38- [GeneID=952] versus MME- SELL+ [GeneID=4311;6402].	Studies of adult human hematopoiesis have until now relied on the expression of CD10 to define lymphoid commitment. We report a novel lymphoid-primed population in human bone marrow that is generated from hematopoietic stem cells (HSC) prior to the onset of CD10 expression and B cell commitment, and is identified by high levels of the homing molecule L-selectin (CD62L). CD10-CD62Lhi progenitors have full lymphoid (B/T/NK) potential, and show reduced myeloid and absent erythroid potential. Genome-wide gene expression analysis demonstrates that the CD10-CD62Lhi population represents an intermediate stage of differentiation between CD34+CD38- HSC and CD34+lin-CD10+ progenitors marked by down-regulation of TAL1 and MPL, upregulation of E2A, CD3E and IL2RG expression, and absent B cell commitment or RAG1/2 expression. Immature CD34+CD1a- thymocytes are also CD62Lhi and L-selectin ligands are expressed at the cortico-medullary junction, suggesting a possible role for L-selectin in human thymic homing. These studies identify the earliest stage of lymphoid priming in human bone marrow.					26191	10569	483	202	1774	7533	55636	9258	79026	8869	7189	4023	5376	4790	7589	51433	4733	22931	2530	824	4644	89797	5412	2012	54463	1152	171546	7296	4215	1396	92521	90355	129285	3479	2653	22821	55435	57162	23597	84896	80762	11180	6128	1374	79622	92259	987	56947	159	3914	223	57142	8091	1528	6222	9446	55037	55761	55352	26225	8452	961	9094	23528	7251	23360	200933	647087	602	51102	6727	3066	122622	1979	1052	7871	5786	6726	1794	56925	64114	3600	376497	7414	473	9782	2776	80824	8560	8915	127262	4942	6134	98	64219	4288	400	6434	6193	34	54460	4869	6888	1337	26035	11345	338339	91663	929	222658	25873	92140	28977	55119	51719	9563	323	23327	7267	4154	2643	26065	6535	5860	8027	8878	3187	23243	4033	6709	5052	10857	5269	8819	57231	10549	2770	1605	3421	4700	768211	5339	55850	118	404093	64963	5445	219972	128240	6173	23705	1499	3033	10460	27072	7411	4005	55667	1788	9308	8826	84270	10425	1939	64332	928	6001	85437	1810	301	65125	721	23077	1642	1183	5516	115992	2746	2014	100288695	10203	6231	653	334	10975	10209	115	55907	87	51386	60682	23476	514	5583	23473	8723	23505	217	10063	4841
GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_DN	M9084		22941246	Kohn LA,Hao QL,Sasidharan R,Parekh C,Ge S,Zhu Y,Mikkola HK,Crooks GM	GSE35685	GSE35685_2632_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in the bone marrow CD34+ [GeneID=947] cells: CD38- [GeneID=952] versus MME- SELL+ [GeneID=4311;6402].	Studies of adult human hematopoiesis have until now relied on the expression of CD10 to define lymphoid commitment. We report a novel lymphoid-primed population in human bone marrow that is generated from hematopoietic stem cells (HSC) prior to the onset of CD10 expression and B cell commitment, and is identified by high levels of the homing molecule L-selectin (CD62L). CD10-CD62Lhi progenitors have full lymphoid (B/T/NK) potential, and show reduced myeloid and absent erythroid potential. Genome-wide gene expression analysis demonstrates that the CD10-CD62Lhi population represents an intermediate stage of differentiation between CD34+CD38- HSC and CD34+lin-CD10+ progenitors marked by down-regulation of TAL1 and MPL, upregulation of E2A, CD3E and IL2RG expression, and absent B cell commitment or RAG1/2 expression. Immature CD34+CD1a- thymocytes are also CD62Lhi and L-selectin ligands are expressed at the cortico-medullary junction, suggesting a possible role for L-selectin in human thymic homing. These studies identify the earliest stage of lymphoid priming in human bone marrow.					7045	2623	4919	50855	23192	1241	3718	54856	11127	7076	2619	706	2213	10237	153328	2209	3860	53916	3707	680	203228	4343	25840	83877	6239	10746	6642	51762	9625	162	5167	10397	216	6626	26270	64708	9350	1173	55589	3720	3162	3763	152	1266	2907	55201	2171	6774	197370	114885	56848	3064	8435	5791	629	8557	10875	2101	10333	100	55859	54893	4905	1512	56673	9546	816	3708	9196	6453	160	54890	3283	5731	4084	90576	4908	527	57089	4880	7873	64859	10068	3597	8395	3567	1327	55163	55152	10291	1829	2152	229	80331	64975	25816	3977	4762	137814	6777	8792	8600	1780	391	845	2046	10979	3454	1317	3046	4061	400916	1910	1453	6776	4661	9632	4902	4026	5875	740	11107	81605	26056	54867	10410	3746	6051	64866	2004	8019	1579	23274	5721	6769	10845	1785	23647	170463	10989	28512	9277	4829	79176	578	2597	161	2048	3887	7031	6945	80128	23671	143098	54758	10743	3489	389075	7480	3222	50846	933	1180	6455	11251	6530	79810	58533	26020	29927	29993	4245	64499	90102	201965	29895	2271	80737	4146	5819	388	5698	6385	6646	1945	5866	65983	91833	405	9620	50807	435	1075	3859	8569	10874	10775	55324	4582	7917
GSE40184_HEALTHY_VS_HCV_INFECTED_DONOR_PBMC_DN	M9404		23067362	Bolen CR,Robek MD,Brodsky L,Schulz V,Lim JK,Taylor MW,Kleinstein SH	GSE40184	GSE40184_3228_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in peripheral blood monocytes (PBMC): healthy donors versus patients with HCV infection.	This study characterizes the effects of chronic Hepatitis C virus (HCV) infection on gene expression by analyzing blood samples from 10 treatment-naive HCV patients and 6 healthy volunteers. Differential expression analysis of microarray data from peripheral blood mononuclear cells (PBMCs) identified a 136 gene signature, including 66 genes elevated in infected individuals. Most of the up-regulated genes were associated with interferon (IFN) activity (including members of the OAS and MX families, ISG15 and IRF7), suggesting an ongoing immune response. This HCV signature was also found to be consistently enriched in many other viral infection and vaccination datasets. Validation of these genes was carried out using a second cohort composed of 5 HCV patients and 5 healthy volunteers, confirming the up-regulation of the IFN signature. In summary, this is the first study to directly compare blood transcriptional profiles from HCV patients with healthy controls. The results show that chronic HCV infection has a pronounced effect on gene expression in PBMCs of infected individuals, and significantly elevates the expression of a subset of interferon-stimulated genes.					153527	514	10194	639	9871	57592	23299	64421	10483	2817	80146	2907	6717	29959	2149	8079	9744	1650	10865	10133	84337	25844	705	10267	22834	51225	3595	9040	5306	10089	3338	23710	55667	9685	83541	1102	2286	11267	2262	5971	33	54808	55954	4722	440730	4061	10227	116969	9953	57019	64005	55593	283337	221895	6468	199990	81532	3559	90313	7629	2821	5833	51451	6150	5045	57590	4893	54331	9627	92558	3656	3695	92922	64764	64116	7486	516	29103	3268	63935	84572	10533	5552	55777	25970	9780	822	9047	55852	220965	5326	27023	2731	9474	10723	11325	57210	6836	54843	84830	51389	25851	23545	79924	6521	84246	113829	387914	26136	201562	57154	11108	5438	10093	84266	11216	6891	29882	151903	8553	10922	2323	3690	8815	9787	3897	65110	150356	121536	84419	60313	51676	4924	10632	80347	57057	391195	51466	54863	333	151963	54997	6277	23423	5976	25797	115098	23061	6443	113278	11040	65125	11213	91807	83732	64780	8743	1761	284058	83877	2119	91283	64852	6385	5836	920	84067	490	7167	7134	8394	9910	8428	28957	1992	23770	7087	8807	3458	55585	2035	5962	2651	3824	79443	64423	55776	5533	10300	3959	91978	8086	55276	7368	8665	23613	5605	11184	152007	54622
GSE40184_HEALTHY_VS_HCV_INFECTED_DONOR_PBMC_UP	M9405		23067362	Bolen CR,Robek MD,Brodsky L,Schulz V,Lim JK,Taylor MW,Kleinstein SH	GSE40184	GSE40184_3228_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in peripheral blood monocytes (PBMC): healthy donors versus patients with HCV infection.	This study characterizes the effects of chronic Hepatitis C virus (HCV) infection on gene expression by analyzing blood samples from 10 treatment-naive HCV patients and 6 healthy volunteers. Differential expression analysis of microarray data from peripheral blood mononuclear cells (PBMCs) identified a 136 gene signature, including 66 genes elevated in infected individuals. Most of the up-regulated genes were associated with interferon (IFN) activity (including members of the OAS and MX families, ISG15 and IRF7), suggesting an ongoing immune response. This HCV signature was also found to be consistently enriched in many other viral infection and vaccination datasets. Validation of these genes was carried out using a second cohort composed of 5 HCV patients and 5 healthy volunteers, confirming the up-regulation of the IFN signature. In summary, this is the first study to directly compare blood transcriptional profiles from HCV patients with healthy controls. The results show that chronic HCV infection has a pronounced effect on gene expression in PBMCs of infected individuals, and significantly elevates the expression of a subset of interferon-stimulated genes.					118611	165215	9052	3741	643	5551	57512	5599	51523	9650	120892	27	55788	22905	729810	4144	5782	29994	6492	349565	5016	171425	5463	80320	6622	144501	9831	79731	5025	27036	4222	8555	127	9882	63910	50854	201163	55906	2150	2863	348932	11082	80895	90799	2914	284114	57645	1196	4595	285636	7280	51239	8792	3202	1831	79661	84899	1727	7247	4068	3747	80262	1956	3665	5000	1280	6160	4929	644353	196	8643	27330	1962	3352	23195	1562	9013	18	7475	1200	23236	2034	4486	55756	56673	64844	239	83992	2595	114294	25843	645426	50808	374986	3241	240	162681	9736	135935	23588	3840	3845	79624	286128	9203	728	23062	72	219931	3344	3460	7516	827	22983	25819	55190	90135	138046	8320	26872	140883	7130	3587	22821	3198	10916	1803	79641	6426	3567	55106	9277	10814	157378	54700	59342	115827	23462	1647	23047	199221	57545	51259	468	2038	1901	54107	56751	3489	51110	57414	23087	945	257364	51104	89891	51617	3899	54827	89894	151556	29841	4815	5213	494551	123263	6583	9804	145873	199675	29942	54822	153830	6948	129607	256394	122060	3283	904	4839	388650	84331	51495	115350	23232	7107	85460	79573	337959	79822	7571	8100	6840	132	30832	53834	2258	1856	25902	221079
GSE41087_WT_VS_FOXP3_MUT_ANTI_CD3_CD28_STIM_CD4_TCELL_UP	M9527		23169781	McMurchy AN,Gillies J,Gizzi MC,Riba M,Garcia-Manteiga JM,Cittaro D,Lazarevic D,Nunzio Di S,Piras IS,Bulfone A,Roncarolo MG,Stupka E,Bacchetta R,Levings MK	GSE41087	GSE41087_3902_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in activated CD4 [GeneID=920] T cells expressing: wildtype versus mutant form of FOXP3 [GeneID=50943].	Investigation of the role of FOXP3 in CD4+ T effector cells. FOXP3 is transiently upregulated in T effector cells under activation. This temporary expression in Teff cells is insufficient to suppress expression of reported targets of FOXP3 repressor activity. The role of FOXP3 in T effector cells remains unclear. We used microarray analysis to detail the differentially expressed genes between FOXP3 wild type and 2T>C(mut) clones and identified classes of up-regulated or down-regulated genes based upon FOXP3 expression.					4664	467	23013	9143	84942	1438	9260	84271	2791	1474	1729	290	9776	9487	8334	28232	57823	1843	7450	51760	9308	6367	50515	5142	80228	5971	1593	10010	3587	3055	8530	6383	3662	6208	2069	388677	2710	330	54812	9242	3134	4048	8106	56605	23035	10921	3108	51232	3123	5338	80765	9647	7128	26253	9120	6648	23338	79136	4014	7422	8842	50810	23351	5739	2275	29094	5327	4973	59351	55096	23657	1844	27074	27202	921	7178	11182	78994	3115	10563	3726	7038	8837	4792	10772	5199	2897	148022	8942	10521	602	3772	10318	637	2120	4688	7185	23180	7994	6714	729580	2787	6283	23760	10046	3017	55666	10957	9595	2509	1983	729230	29068	65108	3113	3620	64411	1234	2309	11010	571	100286895	7852	6385	9455	25822	51334	7453	23067	10181	7156	3669	55233	3117	55686	2219	123872	3119	3936	366	85236	55294	23308	84859	196	8085	4295	928	3682	7292	6286	960	79894	51311	79188	4794	55640	92	3561	9146	54964	3423	93643	56905	3659	1831	8545	2713	1236	5196	7832	5732	55761	222161	9435	23601	3122	116496	79047	4088	3386	476	1439	8346	10000	6134	4790	157562	5140	2534	7293	3133	1606	7402	9020	1880	9654	4069	10866	9188
GSE41087_WT_VS_FOXP3_MUT_ANTI_CD3_CD28_STIM_CD4_TCELL_DN	M9528		23169781	McMurchy AN,Gillies J,Gizzi MC,Riba M,Garcia-Manteiga JM,Cittaro D,Lazarevic D,Nunzio Di S,Piras IS,Bulfone A,Roncarolo MG,Stupka E,Bacchetta R,Levings MK	GSE41087	GSE41087_3902_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in activated CD4 [GeneID=920] T cells expressing: wildtype versus mutant form of FOXP3 [GeneID=50943].	Investigation of the role of FOXP3 in CD4+ T effector cells. FOXP3 is transiently upregulated in T effector cells under activation. This temporary expression in Teff cells is insufficient to suppress expression of reported targets of FOXP3 repressor activity. The role of FOXP3 in T effector cells remains unclear. We used microarray analysis to detail the differentially expressed genes between FOXP3 wild type and 2T>C(mut) clones and identified classes of up-regulated or down-regulated genes based upon FOXP3 expression.					7083	55129	2037	157567	9551	10160	145389	3099	5832	23475	29844	9652	6636	8318	29899	8672	30	10954	6720	23593	2350	929	9672	23166	154	4522	9581	83464	10327	2805	29099	10493	81035	48	6391	2162	7123	57102	4709	4259	966	7388	55970	4987	55161	3241	54914	55332	8553	54958	7260	23335	1515	51367	55693	6809	51382	2585	91373	10112	80210	1329	327	506	22954	8933	7077	8742	4481	55215	2135	3978	1211	5866	10651	9582	5037	84193	1605	54	51650	54681	7280	55340	64151	3925	29760	79017	23171	10635	4258	79733	93210	11322	90355	4726	79980	5524	1718	5693	5899	6185	55691	53	3588	79731	25941	5973	65018	22977	10490	8724	2760	8801	8226	55759	9670	7106	25788	3064	11161	6622	8178	2210	9577	125058	10247	10615	51236	7027	7272	393	2258	3607	54976	26035	9529	3163	9131	518	31	683	9886	138050	2207	80227	51409	64598	2647	645	2189	4288	2990	79004	5860	9361	6652	3033	55799	1019	7112	6036	27010	54969	1849	509	6404	27089	150759	9232	216	1033	23151	3430	2992	79714	2034	8895	5033	5427	8829	4013	5328	93594	5052	11188	55556	55236	64231	3479	701	51056	11257	79135	29108	10403	9133	8508	4191	26275
GSE43700_UNTREATED_VS_IL10_TREATED_PBMC_UP	M9622		23449998	Teles RM,Graeber TG,Krutzik SR,Montoya D,Schenk M,Lee DJ,Komisopoulou E,Kelly-Scumpia K,Chun R,Iyer SS,Sarno EN,Rea TH,Hewison M,Adams JS,Popper SJ,Relman DA,Stenger S,Bloom BR,Cheng G,Modlin RL	GSE43700	GSE43700_3701_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in peripheral blood monocytes (PBMC): control versus IL10 [GeneID=3586].	The immune mechanisms that control resistance vs. susceptibility to mycobacterial infection in humans were investigated by studying leprosy skin lesions, the site where the battle between the host and the pathogen is joined. Using an integrative genomics approach, we found an inverse correlation between of IFN-beta and IFN-gamma gene expression programs at the site of disease. The Type II IFN, IFN-gamma and its downstream vitamin D-dependent antimicrobial genes were preferentially expressed in the lesions from patients with the self-healing tuberculoid form of the disease and mediated antimicrobial activity against the pathogen, Mycobacterium leprae in vitro. In contrast, the Type I IFN, IFN-beta and its downstream genes, including IL-27 and IL-10, were induced in monocytes by M. leprae in vitro, and were preferentially expressed in the lesions of disseminated and progressive lepromatous form. The IFN-gamma induced macrophage antimicrobial response was inhibited by IFN-beta/IL-10, by a mechanism involving blocking the generation of bioactive 1,25-dihyroxy vitamin D as well as inhibiting induction of antimicrobial peptides cathelicidin and DEFB4. The ability of IFN-B to inhibit the IFN-gamma induced vitamin D pathway including antimicrobial activity was reversed by neutralization of IL-10, suggesting a possible target for therapeutic intervention. Finally, a common IFN-beta and IL-10 gene signature was identified in both the skin lesions of leprosy patients and in the peripheral blood of active tuberculosis patients. Together these data suggest that the ability of IFN-beta to downregulate protective IFN-gamma responses provides one general mechanism by which some bacterial pathogens of humans evade protective host responses and contribute to pathogenesis.					27010	5567	3178	4774	8856	100507444	10907	5158	55714	5805	2297	1999	57649	1164	1969	7027	51449	8497	9456	55000	3054	7248	64682	604	4241	6700	6618	126003	1912	51444	4735	3759	64795	30062	597	10653	1419	6833	3645	24147	10225	4605	64343	8507	8000	6574	901	1733	54454	218	388588	7319	51478	9275	6746	8431	54934	1459	8449	54908	1778	11321	8233	388419	8091	6117	4826	4780	2741	2921	26330	114915	4090	3148	337972	9139	1525	259266	1503	324	10461	10062	23581	25906	50809	3758	9869	5605	11276	1808	8648	22906	1844	4853	6363	388753	3187	8915	63908	9034	2353	84124	2191	3475	54407	8190	7137	7428	84867	51429	92675	9563	1641	9595	23369	54491	25798	5051	1843	6815	4318	128308	388	55661	25842	10492	1544	6309	7133	10576	6975	7025	1427	2957	7482	5348	2618	6690	3399	22822	2358	23392	730249	27239	26009	414919	4343	57169	10370	60682	8822	10570	79720	3052	10079	81671	3931	25885	678	91010	3552	6623	10491	5623	25983	7276	5376	54766	84991	1462	402778	79699	1215	7130	7123	8022	22994	335	1804	63036	212	154	9341	4828	2359	2642	22916	3257	6160	10201	467	3164	1958	55852	3843	5997	9317	54853	4175	7070
GSE43700_UNTREATED_VS_IL10_TREATED_PBMC_DN	M9623		23449998	Teles RM,Graeber TG,Krutzik SR,Montoya D,Schenk M,Lee DJ,Komisopoulou E,Kelly-Scumpia K,Chun R,Iyer SS,Sarno EN,Rea TH,Hewison M,Adams JS,Popper SJ,Relman DA,Stenger S,Bloom BR,Cheng G,Modlin RL	GSE43700	GSE43700_3701_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in peripheral blood monocytes (PBMC): control versus IL10 [GeneID=3586].	The immune mechanisms that control resistance vs. susceptibility to mycobacterial infection in humans were investigated by studying leprosy skin lesions, the site where the battle between the host and the pathogen is joined. Using an integrative genomics approach, we found an inverse correlation between of IFN-beta and IFN-gamma gene expression programs at the site of disease. The Type II IFN, IFN-gamma and its downstream vitamin D-dependent antimicrobial genes were preferentially expressed in the lesions from patients with the self-healing tuberculoid form of the disease and mediated antimicrobial activity against the pathogen, Mycobacterium leprae in vitro. In contrast, the Type I IFN, IFN-beta and its downstream genes, including IL-27 and IL-10, were induced in monocytes by M. leprae in vitro, and were preferentially expressed in the lesions of disseminated and progressive lepromatous form. The IFN-gamma induced macrophage antimicrobial response was inhibited by IFN-beta/IL-10, by a mechanism involving blocking the generation of bioactive 1,25-dihyroxy vitamin D as well as inhibiting induction of antimicrobial peptides cathelicidin and DEFB4. The ability of IFN-B to inhibit the IFN-gamma induced vitamin D pathway including antimicrobial activity was reversed by neutralization of IL-10, suggesting a possible target for therapeutic intervention. Finally, a common IFN-beta and IL-10 gene signature was identified in both the skin lesions of leprosy patients and in the peripheral blood of active tuberculosis patients. Together these data suggest that the ability of IFN-beta to downregulate protective IFN-gamma responses provides one general mechanism by which some bacterial pathogens of humans evade protective host responses and contribute to pathogenesis.					8968	54849	8773	7498	1942	23173	10501	1020	29925	4702	84105	203	948	54884	56681	862	5446	5264	2893	375444	955	8876	8877	9023	1964	4118	1359	388646	1032	7884	115557	9382	9857	1300	54968	5211	10006	10239	5307	55776	1572	3659	64949	4854	7167	7520	2029	55861	631	56261	6335	4729	1030	57804	6351	8703	79050	27095	1147	6016	22917	3437	4296	533	10487	5361	284654	402	3067	5901	79575	9145	80824	341359	25819	5327	2937	3767	6509	5824	156	1677	54206	23062	1528	2077	6097	5734	22931	58526	284695	1289	6777	7258	84798	90007	2213	9326	4704	1326	1933	29919	3627	54676	7003	10023	4493	1499	80318	388585	1827	50486	6014	23258	6204	10019	1647	10714	123876	246184	4615	9232	8785	5881	117178	2145	51805	122961	57089	9581	7763	5053	6403	84284	695	6640	255231	259	1729	3394	4502	57713	432	29934	51006	3932	23179	26017	54541	23764	285598	1841	113235	1810	84259	11313	5116	11130	4987	2034	55847	6513	6118	283116	9329	4726	53342	11315	117143	9021	7841	9442	4283	5132	2243	51412	222642	3882	51184	1854	6284	1292	10912	11258	7322	5359	9421	9048	27000	140739	4783	3569	2171	196	145282	10544	1052	9572	646480	56984
GSE44732_UNSTIM_VS_IL27_STIM_IMATURE_DC_UP	M9699		23527130	Chen Q,Swaminathan S,Yang D,Dai L,Sui H,Yang J,Hornung RL,Wang Y,Huang W da,Hu X,Lempicki RA,Imamichi T	GSE44732	GSE44732_3800_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in immature dendritic cells: untreated versus IL27 [GeneID=246778].	IL-27 treated DCs were shown to be highly potent inhibitors of cis HIV-1, particularly of CCR5 tropic strains. Microarray studies of IL-27 treated DCs showed no up-regulation of Type I (IFN) gene expression. Neutralization of the Type-I IFN receptor had no impact on the HIV inhibition. Lastly, IL-27 mediated inhibition was shown to act post-viral entry and prior to completion of reverse transcription. These results show for the first time that IL-27 is a potent inhibitor of cis HIV-1 infection in DCs by a Type I IFN independent mechanism.					79801	7277	7916	27013	1892	2140	83937	10645	6624	79152	9322	56905	84803	56910	2665	64581	85441	10809	25816	7262	10614	79865	121274	5464	196264	79135	51065	910	5909	3630	8837	3556	8664	83637	1847	9595	9050	283237	57134	10554	29785	79663	9284	29109	51172	57020	3561	121053	57172	2687	29083	7124	65123	5631	506	3615	57761	8578	6261	5763	85379	23255	7170	2017	88745	8241	55735	91010	81873	4729	10459	8482	64748	8111	23518	2274	4833	4610	9455	3109	55967	8346	4218	2788	92856	56731	51684	1389	3142	8345	23180	7014	1000	57591	51477	80127	23017	118881	140685	1026	27	5939	7879	486	84946	27143	55205	835	23171	9910	7804	57705	1729	2319	79016	7293	864	50807	29796	51530	84166	157697	1962	2289	29789	1793	6553	10155	9612	78996	152098	23677	2595	2664	1438	5372	122618	27101	22883	90850	3054	56940	91966	23424	5734	8353	7386	622	89853	126638	909	202018	84056	3956	10875	8321	8906	220963	9413	2877	9143	913	284998	54532	130074	6361	55197	4122	10940	340348	387718	30850	7417	84864	57514	54108	1954	2553	26258	122525	1786	10020	64969	10923	9175	4001	199746	23048	6517	55658	26027	129607	5445	3663	10444	1439	51667	9546	124961	60313
GSE44732_UNSTIM_VS_IL27_STIM_IMATURE_DC_DN	M9700		23527130	Chen Q,Swaminathan S,Yang D,Dai L,Sui H,Yang J,Hornung RL,Wang Y,Huang W da,Hu X,Lempicki RA,Imamichi T	GSE44732	GSE44732_3800_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in immature dendritic cells: untreated versus IL27 [GeneID=246778].	IL-27 treated DCs were shown to be highly potent inhibitors of cis HIV-1, particularly of CCR5 tropic strains. Microarray studies of IL-27 treated DCs showed no up-regulation of Type I (IFN) gene expression. Neutralization of the Type-I IFN receptor had no impact on the HIV inhibition. Lastly, IL-27 mediated inhibition was shown to act post-viral entry and prior to completion of reverse transcription. These results show for the first time that IL-27 is a potent inhibitor of cis HIV-1 infection in DCs by a Type I IFN independent mechanism.					7464	100287628	8021	9404	84106	7436	284837	8875	144983	3241	27177	23062	158219	79639	2217	3955	23508	11314	7466	23220	5447	54187	2022	2874	808	3575	79605	84942	3753	2180	85439	81562	5742	57568	5429	10873	4695	683	5579	79887	6746	23254	9489	3985	3930	10162	3433	3732	2034	4938	8514	6279	55647	4635	2268	199675	146722	645	7164	219854	55776	3417	23231	57406	3916	333929	1378	5269	84976	119385	4758	29998	9601	5305	55357	7040	79651	11133	11329	646450	912	8848	7265	51126	6205	57224	29058	341	80339	3683	10739	123	57720	861	10788	6868	55039	403313	115273	5091	26005	23710	23200	58484	968	2272	90853	1043	6916	2990	334	5195	3437	51531	1535	10519	10635	100128002	51726	57102	6641	11221	3455	91768	5476	3493	7099	283726	3074	55732	3097	85414	1979	55344	29100	1666	718	56647	10623	51097	80820	28958	2248	9903	9836	51102	284266	467	1891	9832	22808	51099	85479	199720	1509	3682	6453	1911	9429	3675	1757	23307	5440	4311	219833	3290	9060	26608	285513	10825	26298	375061	55840	729967	56261	100133109	55654	5581	3550	51171	23258	23612	200634	2069	81501	10062	23423	677778	55640	842	79092	4013	644	91775	53407	51614	6280	79157	51060
GSE44955_MCSF_VS_MCSF_AND_IL27_STIM_MACROPHAGE_DN	M9701		23535375	Swaminathan S,Hu X,Zheng X,Kriga Y,Shetty J,Zhao Y,Stephens R,Tran B,Baseler MW,Yang J,Lempicki RA,Huang D,Lane HC,Imamichi T	GSE44955	GSE44955_3901_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in macrophage differentiated by: CSF1 [GeneID=1435] versus CSF1 [GeneID=1435] and IL27 [GeneID=246778].	In this study, we hypothesized that IL-27 could induce the expression of novel miRNAs in macrophages which may have functional relevance in terms of anti-viral activity. In this study, primary monocytes were differentiated into macrophages using M-CSF (M-Mac) or with a combination of M-CSF and IL-27 (I-Mac) for seven days. Following this, total RNA was extracted from these cells and deep sequencing was performed, in parallel with gene expression microarrays. Using the novel miRNA discovery software, miRDeep, seven novel miRNAs were discovered in the macrophages, four of which were expressed higher in I-Mac (miRNAs 2.1, 8.1, 9.1 and 14.2) whilst three were detected in both M-Mac and I-Mac (miRNAs 9.3, 13.6 and 15.8). The expression of six of the seven novel miRNAs was highly correlated with qRT-PCR using specific primer/probes designed for the novel miRNAs. Gene expression microarray further demonstrated that a number of genes were potentially targeted by these differentially expressed novel miRNAs.					6305	645634	283234	9537	27013	7274	6769	65980	7277	129607	23171	9887	57157	85441	1472	65123	23677	23523	83892	3201	6553	152579	79758	92840	2289	656	83541	7408	7879	152007	4061	1605	27163	4828	29855	196264	824	57705	148254	221749	29109	10300	84230	5339	6747	129807	57134	8379	6464	51172	7414	253832	54811	3556	6276	84687	66005	56910	124093	1473	283237	121274	8241	124961	80127	83608	6778	92	25800	643401	2113	255488	9414	152189	64981	1495	29083	4898	23288	55197	8815	1471	11184	8578	801	6404	55343	55084	126917	3674	136	57591	3561	909	2843	835	6576	9424	27	5598	5631	28964	51684	125336	54108	4881	79865	5646	128346	26034	57180	27243	360	5315	1796	25898	1175	11000	23239	8525	148281	5331	23172	100506229	10809	51537	1729	3635	5626	388581	4246	604	5445	27301	10487	57509	9909	144717	51143	27143	140461	207	135886	7916	9674	90809	3939	9543	286204	10383	5118	8664	23557	51530	148252	2101	9779	29116	9470	2116	1954	85379	9262	3490	10956	9612	4985	2978	79801	8837	25858	79734	112724	30844	23200	10658	26258	23015	79686	118424	8233	56654	5914	201134	3956	79641	2319	2783	100288617	30850	57128	7549	26249	5345	89853	9363	1981	5420	51295	116138
GSE44955_MCSF_VS_MCSF_AND_IL27_STIM_MACROPHAGE_UP	M9704		23535375	Swaminathan S,Hu X,Zheng X,Kriga Y,Shetty J,Zhao Y,Stephens R,Tran B,Baseler MW,Yang J,Lempicki RA,Huang D,Lane HC,Imamichi T	GSE44955	GSE44955_3901_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in macrophage differentiated by: CSF1 [GeneID=1435] versus CSF1 [GeneID=1435] and IL27 [GeneID=246778].	In this study, we hypothesized that IL-27 could induce the expression of novel miRNAs in macrophages which may have functional relevance in terms of anti-viral activity. In this study, primary monocytes were differentiated into macrophages using M-CSF (M-Mac) or with a combination of M-CSF and IL-27 (I-Mac) for seven days. Following this, total RNA was extracted from these cells and deep sequencing was performed, in parallel with gene expression microarrays. Using the novel miRNA discovery software, miRDeep, seven novel miRNAs were discovered in the macrophages, four of which were expressed higher in I-Mac (miRNAs 2.1, 8.1, 9.1 and 14.2) whilst three were detected in both M-Mac and I-Mac (miRNAs 9.3, 13.6 and 15.8). The expression of six of the seven novel miRNAs was highly correlated with qRT-PCR using specific primer/probes designed for the novel miRNAs. Gene expression microarray further demonstrated that a number of genes were potentially targeted by these differentially expressed novel miRNAs.					1832	29933	29058	1536	11314	10576	718	120939	79651	389203	283687	124599	4695	124152	201501	55055	55168	23052	9361	9654	5147	10525	254102	11319	3109	7378	9641	55647	912	1026	26230	4171	4709	23231	90634	92259	5447	2615	57406	23216	29107	2152	6641	10519	22864	10289	23480	8303	10800	2961	116379	10577	6993	144983	5805	971	8204	5721	23531	56895	1857	3116	56975	64419	51726	51279	352954	3097	219833	284367	26504	9275	4973	2180	130589	7371	9326	8140	25845	2268	80005	10906	57568	5155	400410	1378	56983	55556	6352	9588	51363	359845	54806	64776	8495	115209	10635	203197	7133	117854	85439	84225	285181	257236	9550	4715	117145	272	220002	671	100130705	9368	5095	140838	6205	197259	131474	53407	51676	22808	57458	7965	55277	6303	1604	51667	79930	5270	100132735	9836	27436	59274	54438	6509	81558	334	3654	23307	113675	2990	5579	60312	146722	7076	81562	1933	529	22836	139886	27075	7016	4542	4241	115361	4001	4234	10011	8407	2235	57099	56675	6921	7570	3572	3903	3659	3620	390	26608	6347	440400	10330	84106	4830	7127	3553	53826	51524	10240	147463	8767	4121	55357	1593	5322	8237	60489	683	51009	11057	7075	7052	6002	8871	5954	147991	3606	120103	7059	647115
GSE46143_CTRL_VS_LMP2A_TRANSDUCED_CD10_POS_GC_BCELL_UP	M9771		23592216	Vockerodt M,Wei W,Nagy E,Prouzova Z,Schrader A,Kube D,Rowe M,Woodman CB,Murray PG	GSE46143	GSE46143_3799_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in MME+ [GeneID=4311] germinal center B lymphocytes: control versus over-expressing viral (EBV) gene LMP2A.	In this study, we have investigated the effect of LMP2A on gene expression in normal human GC B cells using a non-viral vector based system					129080	786	55799	79586	5133	8664	10501	7225	1385	55558	9446	51128	3200	10135	54808	27090	3059	23354	8260	5361	6093	58155	114897	6919	2956	8292	5394	84258	56681	5437	4855	7866	5816	4793	4144	6657	9577	3358	20	1747	5589	64147	55600	56943	26585	54976	2819	55049	16	83460	79631	4821	23130	55544	51386	4352	51069	6582	7071	441518	115584	2297	100507444	1109	27063	9124	60528	80222	64411	57396	5959	160	1917	64344	51294	6175	4923	5595	4248	148	5651	51310	8643	8660	51156	3064	5892	83463	9423	54626	9100	1440	10716	5521	84844	24144	4143	6351	898	7422	2013	4311	10425	55379	5062	6517	10452	10471	29895	3090	1912	5890	23166	6506	319	1944	23160	5901	3164	10803	5923	3017	6328	8859	2306	10607	55720	51599	6769	285598	1991	2079	7392	133619	55898	56181	126792	9274	390992	2810	11091	8663	26354	83475	9903	11346	1376	51253	29071	25873	55568	1628	7031	9054	23367	126382	5593	60436	9136	91782	4146	29959	8626	80781	5329	6193	100131823	81605	5950	23481	54555	6753	7287	10456	10894	28960	9463	81029	65268	4256	53615	342898	6503	8661	9455	222229	64419	10953	322	501	199746	645832	5464	54884	80326	6689	6574	7262	64324	25987
GSE46143_CTRL_VS_LMP2A_TRANSDUCED_CD10_POS_GC_BCELL_DN	M9773		23592216	Vockerodt M,Wei W,Nagy E,Prouzova Z,Schrader A,Kube D,Rowe M,Woodman CB,Murray PG	GSE46143	GSE46143_3799_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in MME+ [GeneID=4311] germinal center B lymphocytes: control versus over-expressing viral (EBV) gene LMP2A.	In this study, we have investigated the effect of LMP2A on gene expression in normal human GC B cells using a non-viral vector based system					30	3075	51335	570	79026	84833	5428	5362	10426	196294	54468	5782	89796	94103	5277	5147	90196	10401	222068	55870	754	3824	151613	5243	10330	51542	9535	57697	392	81889	29760	29956	1234	11073	5306	51692	3948	56063	57035	2992	133418	87178	5451	1438	399	10404	1848	831	7871	64431	2869	4345	9957	1069	10509	4053	254013	10882	2710	6282	10239	79590	83592	2926	374395	92342	6453	7905	5530	55276	55975	28988	4841	79022	5733	6948	134510	3953	9587	9364	819	10782	54512	901	2620	79971	6726	23243	5439	3046	64708	26057	8924	9978	473	11154	23654	10038	65124	5880	4245	55088	23259	170575	9452	84263	4284	8707	7267	50813	1650	8813	84671	4709	153339	1337	56990	57140	6856	8402	92799	79568	112869	26207	2637	51510	8289	163786	10299	27123	9451	92797	79710	3936	1879	353323	50650	9910	53827	54465	199990	23433	159013	125965	54919	83877	55793	10927	7043	162239	22822	51075	5340	8428	11099	2542	8930	27242	55122	10109	10482	9070	2975	90204	8887	2323	10677	56889	2335	84824	3001	2213	9276	90933	5800	5110	57584	9892	56985	8732	283337	3689	6428	1312	201475	142	22821	10016	6237	10162	2909	51255	2678	9	6277	2631	5707	4061	1850	9375
GSE42724_MEMORY_BCELL_VS_PLASMABLAST_UP	M9786		23613519	Covens K,Verbinnen B,Geukens N,Meyts I,Schuit F,Lommel Van L,Jacquemin M,Bossuyt X	GSE42724	GSE42724_3699_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in B lymphocytes: memory versus plasmablasts.	The recent discovery of the human B1 cells, identified by the expression of CD20, CD27 and CD43 in absence of expression of CD70 and CD69 has been subject of debate. Some studies have raised the possibility that these cells are B cells differentiating towards the plasmablast and plasma cell stage rather than being the human counterpart of murine B1 cells. No further in depth studies have been performed. Therefore, a functional comparison was made between, the proposed B1 cells and plasmablasts. We observed that for several functional characteristics (distribution of isotypes of spontaneously producted antibodies, production of antigen-specific antibodies after vaccination with both T-cell dependent as well as T-cell independent antigen, the proposed B1 cells behaved similar to plasmablasts. In addition, we were able to differentiate the proposed B1 cells in vitro, indicating that they are not from a distinct lineage as the murine B1 cells. Gene expression analysis revealed that these cells cluster between memory B cells and plasmablasts, contradicting them being the genuine human counterpart of murine B1 cells, rather revealing a preplasmablast phenotype.					51143	141	9267	79712	255189	6775	3633	9326	54621	8837	64651	3559	55601	23250	639	4599	378	257160	57713	22870	11217	116238	441027	6576	84925	9425	51081	1389	200894	5966	10409	3178	643	6002	7050	51667	4628	317	8482	115677	9567	26224	6689	79627	2995	23587	11132	29126	7804	8394	129607	5654	4297	57606	10142	219988	56985	84057	9399	84919	10569	5621	27033	7186	7318	79132	11274	4601	34	80219	83606	113277	3569	5272	2071	29097	2553	25932	10602	2828	80176	84333	3895	60685	5335	64802	65986	1201	84872	64092	55850	28511	6477	9498	10623	127544	51542	2643	4641	256987	2108	22906	1880	259307	11168	9980	2035	23070	10099	10401	3604	10666	6773	79228	127687	3600	1198	3601	4939	5371	51652	83959	80824	8906	57104	3557	23214	10725	9639	11172	1236	25820	784	200035	5359	64968	7791	2117	5597	3949	283991	152519	9889	221302	6373	5978	23479	79822	51535	10482	11235	6772	22898	2582	5586	1950	4811	162394	2010	2026	51251	392	54625	51150	3566	9777	57186	7421	55500	23011	8554	553115	8520	64792	9674	92	3303	3267	11237	152926	11072	9367	79902	3383	4790	2869	56521	55620	51003	65056	6404	51478	3665	84206	5187	11108	6891	79155	8407	5133
GSE42724_B1_BCELL_VS_PLASMABLAST_UP	M9787		23613519	Covens K,Verbinnen B,Geukens N,Meyts I,Schuit F,Lommel Van L,Jacquemin M,Bossuyt X	GSE42724	GSE42724_3700_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in B lymphocytes: B1 versus plasmablasts.	The recent discovery of the human B1 cells, identified by the expression of CD20, CD27 and CD43 in absence of expression of CD70 and CD69 has been subject of debate. Some studies have raised the possibility that these cells are B cells differentiating towards the plasmablast and plasma cell stage rather than being the human counterpart of murine B1 cells. No further in depth studies have been performed. Therefore, a functional comparison was made between, the proposed B1 cells and plasmablasts. We observed that for several functional characteristics (distribution of isotypes of spontaneously producted antibodies, production of antigen-specific antibodies after vaccination with both T-cell dependent as well as T-cell independent antigen, the proposed B1 cells behaved similar to plasmablasts. In addition, we were able to differentiate the proposed B1 cells in vitro, indicating that they are not from a distinct lineage as the murine B1 cells. Gene expression analysis revealed that these cells cluster between memory B cells and plasmablasts, contradicting them being the genuine human counterpart of murine B1 cells, rather revealing a preplasmablast phenotype.					221091	2549	254173	5213	3693	51170	54929	79567	2327	3217	57477	10575	79697	10188	254263	340075	9344	79573	29924	10668	222171	4714	140823	9956	5097	26022	9026	5860	409	174	9935	57519	115273	5303	6456	2931	90993	766	51454	10469	55144	10422	167838	114026	9790	59284	26576	9167	654	130560	196527	283871	2620	225	10713	4842	4952	143471	84923	26207	23052	339229	286	89781	60509	54915	160	2057	1622	10500	58472	55924	3921	11189	51574	64420	5051	199	26140	6469	116841	11076	91252	2752	145376	54539	345557	5578	55230	217	9325	51079	64772	3162	51022	51117	201232	55861	55009	124817	54331	83463	23682	84153	56894	51075	80139	55167	138151	80746	1352	79672	2597	79747	86	5609	534	1581	84331	92126	993	54935	116987	144233	10661	10992	79612	79637	23154	29990	332	23170	27304	147841	8128	6646	1267	85302	6013	9533	51693	3783	56659	27348	8241	200014	8863	153562	29781	1510	63875	122945	5454	25936	127703	64432	87769	27043	25822	374882	378938	2937	6902	5889	84277	1910	126731	3760	3488	2260	57180	51596	202151	440400	153	54093	2997	54930	131669	4774	47	10988	56848	4711	9455	11041	54738	29780	29886	8736	100499435	25828	8539	2648	64949	50488	9942	4170	27128	221074
GSE42724_B1_BCELL_VS_PLASMABLAST_DN	M9789		23613519	Covens K,Verbinnen B,Geukens N,Meyts I,Schuit F,Lommel Van L,Jacquemin M,Bossuyt X	GSE42724	GSE42724_3700_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in B lymphocytes: B1 versus plasmablasts.	The recent discovery of the human B1 cells, identified by the expression of CD20, CD27 and CD43 in absence of expression of CD70 and CD69 has been subject of debate. Some studies have raised the possibility that these cells are B cells differentiating towards the plasmablast and plasma cell stage rather than being the human counterpart of murine B1 cells. No further in depth studies have been performed. Therefore, a functional comparison was made between, the proposed B1 cells and plasmablasts. We observed that for several functional characteristics (distribution of isotypes of spontaneously producted antibodies, production of antigen-specific antibodies after vaccination with both T-cell dependent as well as T-cell independent antigen, the proposed B1 cells behaved similar to plasmablasts. In addition, we were able to differentiate the proposed B1 cells in vitro, indicating that they are not from a distinct lineage as the murine B1 cells. Gene expression analysis revealed that these cells cluster between memory B cells and plasmablasts, contradicting them being the genuine human counterpart of murine B1 cells, rather revealing a preplasmablast phenotype.					26273	387680	414919	84284	114882	9394	3459	9694	55217	114791	56946	2029	84947	374986	10287	115677	9249	55793	55005	9253	254122	55760	150372	9836	51005	79022	2313	57088	84759	79602	1794	160897	64839	25840	2110	50813	55212	7106	8805	54345	55204	147183	51079	81550	257106	9338	51499	9946	818	201595	152217	26123	9391	55719	112611	51533	51247	282991	56124	29068	285172	57610	5311	80274	3690	55758	51142	81794	29952	1990	5170	79591	25778	4077	54849	8861	79033	10553	27107	131870	517	25927	5184	283638	55364	9126	79863	5338	7181	26996	11101	5160	90268	79590	28978	25864	79731	11215	55862	205428	81688	219654	5906	678	30814	7678	3636	6048	4946	5001	7515	9139	54949	10009	192286	2517	79805	81618	55334	55148	84135	78987	57185	80347	4209	6794	5989	84498	285025	55007	24148	1901	63940	25851	8661	6468	55850	8575	57459	51208	353	55609	10296	55198	6787	1973	23154	4040	397	57189	79752	10781	4552	84461	91782	90196	152579	5805	9678	23510	55308	3945	84975	6609	9451	84266	4046	4144	5879	4817	27106	2734	54841	91694	9820	197358	28968	54934	11284	7580	284058	157769	57418	8890	9794	53349	25776	129685	146542	283897	81619	146198	79089	54868	5269	399664	9513	528	29978	150274
GSE42724_NAIVE_VS_B1_BCELL_UP	M9790		23613519	Covens K,Verbinnen B,Geukens N,Meyts I,Schuit F,Lommel Van L,Jacquemin M,Bossuyt X	GSE42724	GSE42724_3696_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in B lymphocytes: naïve versus B1.	The recent discovery of the human B1 cells, identified by the expression of CD20, CD27 and CD43 in absence of expression of CD70 and CD69 has been subject of debate. Some studies have raised the possibility that these cells are B cells differentiating towards the plasmablast and plasma cell stage rather than being the human counterpart of murine B1 cells. No further in depth studies have been performed. Therefore, a functional comparison was made between, the proposed B1 cells and plasmablasts. We observed that for several functional characteristics (distribution of isotypes of spontaneously producted antibodies, production of antigen-specific antibodies after vaccination with both T-cell dependent as well as T-cell independent antigen, the proposed B1 cells behaved similar to plasmablasts. In addition, we were able to differentiate the proposed B1 cells in vitro, indicating that they are not from a distinct lineage as the murine B1 cells. Gene expression analysis revealed that these cells cluster between memory B cells and plasmablasts, contradicting them being the genuine human counterpart of murine B1 cells, rather revealing a preplasmablast phenotype.					79668	54915	4794	5520	1186	9136	22884	1437	84807	89777	3099	3633	347273	158358	8545	220	4193	9497	5727	53836	2193	2802	2678	3659	859	4124	4902	285051	55002	84919	51101	55356	7408	3726	6398	51239	4860	683	5371	53981	55835	9766	79754	5966	25891	9604	23179	2744	387804	136263	147968	9108	11177	56006	9917	1263	85450	9261	7484	8828	389125	3434	3098	7444	23516	6662	54470	54964	2907	2697	6925	132720	8509	5780	125950	5464	57109	2908	7994	83699	1606	7128	1109	79720	5601	80018	4140	54766	23367	7453	79577	6764	55332	79712	55650	3656	9830	51379	400629	55813	6773	6935	57549	2332	374868	79612	151987	54880	90576	10219	84443	5699	3839	284382	51308	5352	6891	22882	23428	5452	10554	123720	51076	339488	54467	7124	9334	11078	692205	5926	10370	4675	51100	9887	6774	23566	23587	116835	9570	55626	79666	55500	10390	9693	83666	57666	2596	55023	168391	90293	5142	5685	2209	25961	161176	5331	83852	2553	64651	10068	11231	80196	8048	85027	23092	10206	148581	57647	10786	317	3067	22822	10880	9367	9355	201625	23360	91272	55691	23671	84133	1462	9180	152926	834	51647	7474	54906	58480	26020	84959	54454	50613	3304	57097	23677	90355	3454	80223	5993
GSE42724_MEMORY_BCELL_VS_PLASMABLAST_DN	M9791		23613519	Covens K,Verbinnen B,Geukens N,Meyts I,Schuit F,Lommel Van L,Jacquemin M,Bossuyt X	GSE42724	GSE42724_3699_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in B lymphocytes: memory versus plasmablasts.	The recent discovery of the human B1 cells, identified by the expression of CD20, CD27 and CD43 in absence of expression of CD70 and CD69 has been subject of debate. Some studies have raised the possibility that these cells are B cells differentiating towards the plasmablast and plasma cell stage rather than being the human counterpart of murine B1 cells. No further in depth studies have been performed. Therefore, a functional comparison was made between, the proposed B1 cells and plasmablasts. We observed that for several functional characteristics (distribution of isotypes of spontaneously producted antibodies, production of antigen-specific antibodies after vaccination with both T-cell dependent as well as T-cell independent antigen, the proposed B1 cells behaved similar to plasmablasts. In addition, we were able to differentiate the proposed B1 cells in vitro, indicating that they are not from a distinct lineage as the murine B1 cells. Gene expression analysis revealed that these cells cluster between memory B cells and plasmablasts, contradicting them being the genuine human counterpart of murine B1 cells, rather revealing a preplasmablast phenotype.					7786	5229	26030	4066	4154	9338	56172	113655	55222	6201	51230	57325	80232	10801	6793	5256	23603	140458	8675	2581	54918	8575	256364	535	3956	51529	51160	57210	57544	2734	949	6197	118429	375035	146198	839	5657	6840	115677	90268	10611	53615	5627	6867	9706	4040	25927	22937	29952	375444	6468	6713	124222	57190	219654	81563	56624	27250	6430	29886	9126	6596	5962	8518	148304	1153	8672	51319	3251	6191	5997	55793	3077	84899	55183	11166	4208	622	7029	2109	55374	7086	57088	6048	25804	23193	10267	5573	4841	80055	5634	4005	9375	10745	1312	10606	197131	201254	54842	5338	230	1058	5501	159	27294	221035	208	63971	79695	5019	5255	653240	7257	150864	8568	8555	9584	51313	3268	1213	10482	59307	221710	677768	285440	92521	6721	10903	6916	6494	51031	374907	10095	55327	10370	2739	5027	5160	9882	1798	23175	2790	223	66008	57704	79780	79590	5638	149076	83742	23362	8991	10602	9061	23741	25778	2650	114885	10772	80230	5257	57504	550643	23331	5439	85457	5096	7286	55041	2534	22920	126308	6160	340061	64777	5913	23116	38	6168	8648	7597	4763	1200	79830	23304	8874	2309	64798	9709	9879	1429	3421	2014	23301	10984	83787	10712	5813	85019	84153
GSE42724_NAIVE_VS_MEMORY_BCELL_UP	M9792		23613519	Covens K,Verbinnen B,Geukens N,Meyts I,Schuit F,Lommel Van L,Jacquemin M,Bossuyt X	GSE42724	GSE42724_3695_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in B lymphocytes: naïve versus memory.	The recent discovery of the human B1 cells, identified by the expression of CD20, CD27 and CD43 in absence of expression of CD70 and CD69 has been subject of debate. Some studies have raised the possibility that these cells are B cells differentiating towards the plasmablast and plasma cell stage rather than being the human counterpart of murine B1 cells. No further in depth studies have been performed. Therefore, a functional comparison was made between, the proposed B1 cells and plasmablasts. We observed that for several functional characteristics (distribution of isotypes of spontaneously producted antibodies, production of antigen-specific antibodies after vaccination with both T-cell dependent as well as T-cell independent antigen, the proposed B1 cells behaved similar to plasmablasts. In addition, we were able to differentiate the proposed B1 cells in vitro, indicating that they are not from a distinct lineage as the murine B1 cells. Gene expression analysis revealed that these cells cluster between memory B cells and plasmablasts, contradicting them being the genuine human counterpart of murine B1 cells, rather revealing a preplasmablast phenotype.					51430	4856	60676	220	57620	22980	55054	29959	10603	3656	3301	4629	84451	3695	388646	864	23671	199	11255	64147	285282	23179	594855	130367	7295	8818	84981	239	4690	5354	5743	1140	8685	53344	819	5699	10938	493753	655	79929	8743	129804	137362	80024	84247	116986	10254	377047	22818	55676	64112	338872	29765	8543	114548	90196	84315	2533	2823	92703	160851	55695	55666	23436	2979	5048	221336	3454	2064	91	54106	10446	643664	9527	6532	3159	51248	4794	144363	4599	5977	9917	149775	2553	23385	661	10219	57604	89845	80311	3625	4600	9382	220002	55287	4815	174	56997	56121	493911	414328	143282	1240	5224	339745	136	259307	55257	80333	84553	2745	4045	952	8495	2643	90249	760	54494	201294	55660	131566	4481	27329	5449	57117	148113	55181	4836	56311	57147	10011	22823	26054	80223	56848	124995	256471	3553	57105	7316	79577	29850	330	2937	23645	646962	5900	2820	2634	6772	3906	54	129450	140459	158297	338442	25939	11072	10808	23545	4878	728637	131965	10125	51282	256394	2957	3109	322	11153	2203	729359	8195	9491	58191	11177	10318	83852	51608	2209	80308	64746	7290	203228	79005	2936	7484	1103	2323	84171	11098	3240	2995	8837	139322	7122	64789	1073	126859	151195
GSE42724_NAIVE_VS_MEMORY_BCELL_DN	M9793		23613519	Covens K,Verbinnen B,Geukens N,Meyts I,Schuit F,Lommel Van L,Jacquemin M,Bossuyt X	GSE42724	GSE42724_3695_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in B lymphocytes: naïve versus memory.	The recent discovery of the human B1 cells, identified by the expression of CD20, CD27 and CD43 in absence of expression of CD70 and CD69 has been subject of debate. Some studies have raised the possibility that these cells are B cells differentiating towards the plasmablast and plasma cell stage rather than being the human counterpart of murine B1 cells. No further in depth studies have been performed. Therefore, a functional comparison was made between, the proposed B1 cells and plasmablasts. We observed that for several functional characteristics (distribution of isotypes of spontaneously producted antibodies, production of antigen-specific antibodies after vaccination with both T-cell dependent as well as T-cell independent antigen, the proposed B1 cells behaved similar to plasmablasts. In addition, we were able to differentiate the proposed B1 cells in vitro, indicating that they are not from a distinct lineage as the murine B1 cells. Gene expression analysis revealed that these cells cluster between memory B cells and plasmablasts, contradicting them being the genuine human counterpart of murine B1 cells, rather revealing a preplasmablast phenotype.					4482	4841	80315	83852	10903	1462	23678	65018	115004	116496	6169	90355	9665	54828	100130988	161742	79886	9497	80176	116071	9308	55835	57198	84864	837	7994	337977	4124	10267	1211	10963	5525	2744	2152	1827	10840	3676	146857	57348	23160	219333	9355	7791	63898	132720	7292	3482	23673	388646	9683	5142	51776	23516	4939	969	6373	79080	57018	5926	8672	29066	56929	51703	23122	6774	100131187	7178	713	6164	8030	6208	3487	9817	29887	5229	7112	55332	60485	93487	2644	550643	51283	4299	200159	5305	9555	65265	3783	53831	9798	5932	2746	10228	10427	28996	83741	80231	10127	6414	3233	54915	6205	1355	84899	157310	83666	5986	6721	760	23096	5238	25932	494115	3142	55691	5352	5292	221035	6815	11104	84293	55500	79228	9868	5937	208	10320	2802	6203	80824	51076	5830	54904	2109	8767	9615	84081	3949	23683	29896	64778	23262	7534	8438	139341	161176	3824	8819	207063	201161	6474	23143	155066	152926	9972	6416	6385	301	167227	23092	139886	51747	84188	64332	9108	11320	6398	958	5520	5903	5627	83990	23005	3597	54467	6168	3601	56987	64135	79618	613212	84162	340061	55616	29946	1910	2176	6204	4640	310	2534	3015	414918	29113	81552	135114	56034	54910	29982	56624
GSE42724_MEMORY_VS_B1_BCELL_UP	M9794		23613519	Covens K,Verbinnen B,Geukens N,Meyts I,Schuit F,Lommel Van L,Jacquemin M,Bossuyt X	GSE42724	GSE42724_3698_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in B lymphocytes: memory versus B1.	The recent discovery of the human B1 cells, identified by the expression of CD20, CD27 and CD43 in absence of expression of CD70 and CD69 has been subject of debate. Some studies have raised the possibility that these cells are B cells differentiating towards the plasmablast and plasma cell stage rather than being the human counterpart of murine B1 cells. No further in depth studies have been performed. Therefore, a functional comparison was made between, the proposed B1 cells and plasmablasts. We observed that for several functional characteristics (distribution of isotypes of spontaneously producted antibodies, production of antigen-specific antibodies after vaccination with both T-cell dependent as well as T-cell independent antigen, the proposed B1 cells behaved similar to plasmablasts. In addition, we were able to differentiate the proposed B1 cells in vitro, indicating that they are not from a distinct lineage as the murine B1 cells. Gene expression analysis revealed that these cells cluster between memory B cells and plasmablasts, contradicting them being the genuine human counterpart of murine B1 cells, rather revealing a preplasmablast phenotype.					79058	5147	5564	149478	655	755	9391	373	55081	4815	57465	83606	8497	22818	22893	5001	130733	81555	148266	53339	84947	2048	148304	55287	22980	4968	2533	57396	55364	55198	84135	26959	55	23478	6399	22823	55700	201725	441151	4704	253430	2874	196441	553115	7941	79960	342898	9725	440026	84232	5685	79712	3344	5925	25807	683	126308	57326	22928	55758	10179	9488	29915	145482	8079	54957	22848	1644	55666	7079	26046	10213	51601	54471	84464	7134	6655	6603	337959	79654	55788	4902	3796	84065	10270	28982	6608	2055	8731	4057	84451	594855	64768	63877	7469	30827	2907	80034	81037	168455	10597	6612	9836	9987	401548	81490	56061	9474	9946	79789	9419	57003	9518	54704	663	57659	79830	54751	4045	818	80864	23339	29942	200734	1153	3624	9179	168537	79932	84916	9146	10208	51030	10193	6898	917	29116	113612	79768	84263	51752	57707	55741	2301	5283	399664	147007	9783	84936	80194	342897	140606	149775	5395	84725	56913	5451	8685	84986	64112	79581	54849	1043	23609	60592	54955	65980	130367	6540	84337	1613	6198	58497	56970	81572	54901	55869	23541	1628	3240	440400	143187	5261	6452	387787	55858	54965	51255	375444	7316	4117	23636	23192	9681	8548	57585	51247	5636	5596	79269
GSE42724_NAIVE_VS_B1_BCELL_DN	M9796		23613519	Covens K,Verbinnen B,Geukens N,Meyts I,Schuit F,Lommel Van L,Jacquemin M,Bossuyt X	GSE42724	GSE42724_3696_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in B lymphocytes: naïve versus B1.	The recent discovery of the human B1 cells, identified by the expression of CD20, CD27 and CD43 in absence of expression of CD70 and CD69 has been subject of debate. Some studies have raised the possibility that these cells are B cells differentiating towards the plasmablast and plasma cell stage rather than being the human counterpart of murine B1 cells. No further in depth studies have been performed. Therefore, a functional comparison was made between, the proposed B1 cells and plasmablasts. We observed that for several functional characteristics (distribution of isotypes of spontaneously producted antibodies, production of antigen-specific antibodies after vaccination with both T-cell dependent as well as T-cell independent antigen, the proposed B1 cells behaved similar to plasmablasts. In addition, we were able to differentiate the proposed B1 cells in vitro, indicating that they are not from a distinct lineage as the murine B1 cells. Gene expression analysis revealed that these cells cluster between memory B cells and plasmablasts, contradicting them being the genuine human counterpart of murine B1 cells, rather revealing a preplasmablast phenotype.					2091	64951	54928	9521	3843	92609	3603	10399	51118	2878	6193	2319	1642	100288152	57666	58505	125144	27044	6187	51275	79053	79017	60488	133522	6138	10120	4716	340205	5591	6129	54929	22933	51116	2271	7388	2395	51300	84216	10952	79637	93144	56833	1329	5018	29997	56886	203069	146822	10540	10430	6125	29090	6188	6916	10469	22883	498	2976	155066	81876	3921	51386	23107	6124	55313	23481	57447	8802	6272	6194	285955	254263	54998	22846	100288617	320	6154	56683	6130	3420	64978	10632	4722	728361	154467	23521	282973	1345	339483	285326	4130	79675	51495	6159	55630	4201	51073	64682	140825	6256	391356	22873	23218	23171	6182	1108	328	65990	7168	79064	10492	56975	10128	8761	79077	8677	522	6132	408	7417	23765	64979	23423	84329	1939	54442	123096	115098	84823	9911	6731	51642	4338	89941	2308	6122	57580	65993	515	64210	90871	6218	23404	26001	493812	1933	5213	192286	7327	6418	4900	53635	116447	10440	5864	84221	3276	1795	894	6137	5431	114041	8853	3141	6950	2316	27335	6280	8694	6633	201255	54976	10244	79590	56262	2995	64216	6201	201514	2859	6146	60674	146310	54902	3235	6164	51329	51537	256281	8270	5425	3615	23225	219855	293	55706	9692	1802	51222
GSE42724_NAIVE_BCELL_VS_PLASMABLAST_UP	M9797		23613519	Covens K,Verbinnen B,Geukens N,Meyts I,Schuit F,Lommel Van L,Jacquemin M,Bossuyt X	GSE42724	GSE42724_3697_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in B lymphocytes: naïve versus plasmablasts.	The recent discovery of the human B1 cells, identified by the expression of CD20, CD27 and CD43 in absence of expression of CD70 and CD69 has been subject of debate. Some studies have raised the possibility that these cells are B cells differentiating towards the plasmablast and plasma cell stage rather than being the human counterpart of murine B1 cells. No further in depth studies have been performed. Therefore, a functional comparison was made between, the proposed B1 cells and plasmablasts. We observed that for several functional characteristics (distribution of isotypes of spontaneously producted antibodies, production of antigen-specific antibodies after vaccination with both T-cell dependent as well as T-cell independent antigen, the proposed B1 cells behaved similar to plasmablasts. In addition, we were able to differentiate the proposed B1 cells in vitro, indicating that they are not from a distinct lineage as the murine B1 cells. Gene expression analysis revealed that these cells cluster between memory B cells and plasmablasts, contradicting them being the genuine human counterpart of murine B1 cells, rather revealing a preplasmablast phenotype.					3669	151636	11262	65987	3700	3665	79132	684	2633	8775	100132735	51191	2766	3430	6614	54739	441108	100506742	80830	85441	65979	4189	81030	5157	952	3434	4600	8820	55281	4061	55008	4940	129450	3695	5883	629	23070	11274	10561	3902	5698	81698	64108	3437	338339	23607	83666	9246	55080	3431	1128	80821	51267	26010	4938	10964	84875	11080	85363	100132884	1267	9636	3959	10379	129607	3433	87178	64761	6891	51251	5720	114769	54625	55603	3601	4939	5610	9076	834	134429	219988	6890	55601	8638	91543	8519	558	114907	64976	6772	91624	54988	51271	94240	5371	84166	57169	115362	7098	11277	348110	23586	1649	3134	3429	6737	64135	84941	23380	65220	64651	54809	100131733	710	55337	51246	51427	80219	2040	8737	152926	4174	219285	257019	26270	6252	4599	1890	28511	8204	10346	81894	89848	8542	6773	6583	9961	9111	8334	4615	23034	27351	51667	5359	3627	84930	147645	51056	9447	3364	116071	79733	8743	200315	54823	2643	7286	84419	9587	57613	283482	10906	23214	6373	91351	55243	7982	54033	7318	7706	91937	10678	574414	9381	132112	5920	10950	645744	375056	132321	2526	2048	6741	203197	4218	950	5685	168002	139420	8878	115361	9633	4343	54749	23424	83990	84333	2730	3659
GSE42724_NAIVE_BCELL_VS_PLASMABLAST_DN	M9800		23613519	Covens K,Verbinnen B,Geukens N,Meyts I,Schuit F,Lommel Van L,Jacquemin M,Bossuyt X	GSE42724	GSE42724_3697_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in B lymphocytes: naïve versus plasmablasts.	The recent discovery of the human B1 cells, identified by the expression of CD20, CD27 and CD43 in absence of expression of CD70 and CD69 has been subject of debate. Some studies have raised the possibility that these cells are B cells differentiating towards the plasmablast and plasma cell stage rather than being the human counterpart of murine B1 cells. No further in depth studies have been performed. Therefore, a functional comparison was made between, the proposed B1 cells and plasmablasts. We observed that for several functional characteristics (distribution of isotypes of spontaneously producted antibodies, production of antigen-specific antibodies after vaccination with both T-cell dependent as well as T-cell independent antigen, the proposed B1 cells behaved similar to plasmablasts. In addition, we were able to differentiate the proposed B1 cells in vitro, indicating that they are not from a distinct lineage as the murine B1 cells. Gene expression analysis revealed that these cells cluster between memory B cells and plasmablasts, contradicting them being the genuine human counterpart of murine B1 cells, rather revealing a preplasmablast phenotype.					23142	1102	2162	121274	140	64407	729570	100131993	284391	200424	55536	170394	55667	56172	7099	4900	1019	57645	51276	55819	3269	55843	54704	317649	10077	6867	401494	154881	57182	3579	29125	286144	153328	56994	29988	64285	64174	8905	113	9046	133418	85315	90957	9413	10313	285761	9220	9886	5058	7940	10007	126731	3109	1729	54491	10801	54852	23397	10732	10161	79686	283537	51207	1368	57095	387032	219654	57519	8522	55732	55521	11184	28966	3622	56204	8863	57192	11200	10217	54920	63971	3613	1445	490	144402	64098	60677	27241	472	23151	79663	9637	29883	54978	5567	65258	54892	84230	945	64756	23255	100507392	5820	7168	51665	84892	155066	80124	136	144110	3108	1176	55839	4208	9625	30837	4775	51741	10123	126068	148418	26160	9761	4122	4642	80150	65018	100133321	320	7048	57659	678	64770	6917	112574	4033	57168	114659	4521	57446	10466	79447	84898	91057	152189	3033	121506	25927	3603	824	90550	2857	84327	115330	148254	54518	64418	10170	3087	1786	7879	29956	53346	729967	100130771	6461	149076	148203	9380	6781	128346	51172	57496	5090	909	90120	284161	9477	5140	219855	84247	388327	148266	8742	219771	2517	5321	7325	23066	9236	4688	2217	9934	55577	64805	4155	54935	9459	7850
GSE42724_MEMORY_VS_B1_BCELL_DN	M9801		23613519	Covens K,Verbinnen B,Geukens N,Meyts I,Schuit F,Lommel Van L,Jacquemin M,Bossuyt X	GSE42724	GSE42724_3698_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in B lymphocytes: memory versus B1.	The recent discovery of the human B1 cells, identified by the expression of CD20, CD27 and CD43 in absence of expression of CD70 and CD69 has been subject of debate. Some studies have raised the possibility that these cells are B cells differentiating towards the plasmablast and plasma cell stage rather than being the human counterpart of murine B1 cells. No further in depth studies have been performed. Therefore, a functional comparison was made between, the proposed B1 cells and plasmablasts. We observed that for several functional characteristics (distribution of isotypes of spontaneously producted antibodies, production of antigen-specific antibodies after vaccination with both T-cell dependent as well as T-cell independent antigen, the proposed B1 cells behaved similar to plasmablasts. In addition, we were able to differentiate the proposed B1 cells in vitro, indicating that they are not from a distinct lineage as the murine B1 cells. Gene expression analysis revealed that these cells cluster between memory B cells and plasmablasts, contradicting them being the genuine human counterpart of murine B1 cells, rather revealing a preplasmablast phenotype.					284018	7128	1594	8329	3718	6303	4170	5232	84419	1847	57655	3659	1026	440896	7422	64332	7185	5770	3575	64109	55072	6506	5142	6717	3559	1647	2023	4790	84159	8542	6352	84317	84807	283651	3017	247	6307	740	56951	9322	10125	441108	10957	5338	4345	9021	2643	64651	11182	10938	84000	79993	3949	9019	10409	4001	4616	10102	83666	6648	10614	285958	8784	401152	7186	94015	9695	10018	29933	7293	64859	56938	79155	10139	3620	92370	6324	23180	7852	553115	23657	7130	84875	8837	55336	7127	65999	54509	115361	56925	6385	255231	64005	2633	6890	5552	145864	10133	3601	51478	4316	1438	4174	5327	94240	85236	81553	415116	51513	7126	50615	3992	5819	29126	6687	25841	5696	3156	2495	3669	6624	91694	5639	285957	50848	122258	11201	8717	6309	715	3624	80833	90634	4636	8334	2224	8344	3422	22902	11040	64856	84525	1236	1846	8343	23429	9938	124944	140606	2811	9415	4792	653583	10002	4832	958	3914	27173	7295	3604	8346	54145	84790	5971	8942	23258	133308	23070	10148	8331	1717	160622	53826	1294	5771	26235	8934	9595	716	23644	205	23446	57169	202052	8440	6319	29940	9238	100130744	84557	1506	3898	100132884	8365	43	114897	56961	6775	9840	11026
GSE42088_UNINF_VS_LEISHMANIA_INF_DC_24H_UP	M9895		24808365	Favila MA,Geraci NS,Zeng E,Harker B,Condon D,Cotton RN,Jayakumar A,Tripathi V,McDowell MA	GSE42088	GSE42088_3826_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in dendritic cells: untreated versus 24h after infection of Leishmania major.	Leishmania major infected human dendritic cells (DCs) exhibit a marked induction of IL-12 ultimately promoting a robust Th1-mediated response associated with parasite killing and protective immunity. In this study, we utilized Affymetrix Genechips to globally assess the host cell genes and pathways associated with L. major infection during early infection (2, 4, 8, and 24 hrs) in human myeloid-derived DCs. Bioinformatic analyses of the hybridized microarray chips identified 728 genes, represented by 848 unique probe sets, which, when compared to uninfected samples were observed to be significantly differentially expressed by one-way ANOVA. Altogether, the data provide a genome-wide perspective on the transcriptional influences Leishmania species exert within human DCs during early infection, and provides a platform for further investigations toward functionally characterizing candidate genes of importance to the IL-12 based immune response to infections. In the current study, we further investigate the L. major infected DC transcriptional during early time points after infection via microarray analysis.					9647	23112	10123	3727	22906	1831	50488	5757	64581	59307	5997	23526	9488	5018	1843	79887	3930	9208	27128	6867	54436	3643	3587	7086	8522	3148	2185	5175	9764	1975	942	6448	3646	3635	64847	969	5983	10365	9314	10659	83955	7538	4122	5859	2124	427	271	5165	10614	83452	9473	4179	4126	22	819	59342	54946	2123	79364	55568	5912	3689	3108	6430	6901	9744	23130	8202	831	3146	3676	80223	1441	56731	54545	26112	91137	7099	8635	842	58526	2878	51170	9445	83716	3164	9936	5094	4929	8971	65258	1455	217	79890	6461	3988	23406	5579	1997	4666	114883	728	728498	55905	393	3109	3631	3784	678	677	863	51380	706	8801	8495	3684	9922	25875	55625	9867	51230	9189	57820	3459	3965	10746	23451	9905	9770	51274	10458	23347	4048	8514	8776	23287	51646	7812	56924	23594	10363	738	1052	25828	22898	26191	4208	1958	6494	1119	2313	4580	1462	51307	10147	7297	1182	1794	64921	166	373156	54861	5423	1060	864	1456	9555	5829	63917	23522	5734	51351	25796	22890	10927	64710	9249	55055	5295	29116	4084	54431	5900	23469	23033	951	64222	9138	51182	5884	57570	4739	83440	6683	388	64781	22861	6503	51604	80305
GSE42088_UNINF_VS_LEISHMANIA_INF_DC_24H_DN	M9897		24808365	Favila MA,Geraci NS,Zeng E,Harker B,Condon D,Cotton RN,Jayakumar A,Tripathi V,McDowell MA	GSE42088	GSE42088_3826_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in dendritic cells: untreated versus 24h after infection of Leishmania major.	Leishmania major infected human dendritic cells (DCs) exhibit a marked induction of IL-12 ultimately promoting a robust Th1-mediated response associated with parasite killing and protective immunity. In this study, we utilized Affymetrix Genechips to globally assess the host cell genes and pathways associated with L. major infection during early infection (2, 4, 8, and 24 hrs) in human myeloid-derived DCs. Bioinformatic analyses of the hybridized microarray chips identified 728 genes, represented by 848 unique probe sets, which, when compared to uninfected samples were observed to be significantly differentially expressed by one-way ANOVA. Altogether, the data provide a genome-wide perspective on the transcriptional influences Leishmania species exert within human DCs during early infection, and provides a platform for further investigations toward functionally characterizing candidate genes of importance to the IL-12 based immune response to infections. In the current study, we further investigate the L. major infected DC transcriptional during early time points after infection via microarray analysis.					205	7107	10000	7296	51334	9659	2730	10512	56300	6374	6507	4693	5687	55686	5872	79931	6372	29967	57045	9817	124583	51232	1193	6197	2664	4643	7295	6016	3601	9322	57823	308	57149	7415	4216	1476	10979	27032	6611	1047	55884	6924	57089	55795	2919	54093	91369	54972	23590	8568	5052	10342	966	10211	1440	10133	29949	7866	705	26015	51154	3269	10626	84268	441024	6690	10850	7268	11047	2247	10148	29927	26133	10202	4047	2717	4626	196483	701	63899	55353	51733	219333	5693	114897	9948	26298	79693	8310	4323	5684	9832	7980	100	29095	5270	57626	10539	4234	9242	5192	90204	116496	6253	25932	6624	10531	79230	5218	23028	54512	3624	55755	56061	1738	51399	8828	55022	2182	4891	960	1802	445	8566	29968	718	3561	1381	6300	1594	10254	5327	7408	2887	23480	988	8896	23154	1906	10440	598	3242	4651	214	5646	1728	80185	79155	85377	3569	27351	3620	3593	8837	51700	10538	7158	2618	55332	10606	5238	7205	50810	64759	1514	5688	4319	5962	3604	56902	112399	23560	83460	4828	8632	3142	10953	27020	9570	29959	6373	7474	23361	4800	55521	5533	10548	3980	151011	6369	840	11001	51606	4830	8655	64089	304	51491	57720	29925
GSE42088_2H_VS_24H_LEISHMANIA_INF_DC_UP	M9899		24808365	Favila MA,Geraci NS,Zeng E,Harker B,Condon D,Cotton RN,Jayakumar A,Tripathi V,McDowell MA	GSE42088	GSE42088_3827_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in dendritic cells infected by Leishmania major: 2h versus 24h.	Leishmania major infected human dendritic cells (DCs) exhibit a marked induction of IL-12 ultimately promoting a robust Th1-mediated response associated with parasite killing and protective immunity. In this study, we utilized Affymetrix Genechips to globally assess the host cell genes and pathways associated with L. major infection during early infection (2, 4, 8, and 24 hrs) in human myeloid-derived DCs. Bioinformatic analyses of the hybridized microarray chips identified 728 genes, represented by 848 unique probe sets, which, when compared to uninfected samples were observed to be significantly differentially expressed by one-way ANOVA. Altogether, the data provide a genome-wide perspective on the transcriptional influences Leishmania species exert within human DCs during early infection, and provides a platform for further investigations toward functionally characterizing candidate genes of importance to the IL-12 based immune response to infections. In the current study, we further investigate the L. major infected DC transcriptional during early time points after infection via microarray analysis.					942	5175	2124	3689	59342	3148	427	217	397	79887	5912	5997	51170	59307	373156	9445	8635	5859	10961	6451	1441	240	10659	10123	51660	4048	2123	6039	2203	79890	55819	7077	3459	517	1831	3109	219654	831	3115	2990	2185	9314	9208	3385	7045	120	4615	9936	23406	200315	728	50488	5355	51614	83716	706	7086	2876	23646	2219	79095	64127	929	5829	4046	951	9488	9473	5018	51596	10581	3073	6144	2217	51669	7940	2353	2810	1043	920	3684	10682	6275	6155	5757	6404	80223	6234	9524	9450	26112	51646	83955	54539	9647	683	10491	9764	56255	4354	6342	10982	9236	54946	6171	64174	9770	409	6398	393	8477	1471	192286	4335	8514	2821	2029	5538	6160	4332	10410	8897	293	4929	81544	738	166	9487	4942	677	8665	3162	7805	1520	57820	1265	54440	79789	3646	5094	11261	3930	3784	55013	3965	10399	1939	5423	3727	10460	7538	6235	51763	80024	3164	22861	65258	8309	5165	54436	4061	6867	6207	1509	51185	8971	6203	100272147	5547	6210	4069	79663	79752	55049	51386	2872	64222	58526	10695	23741	5264	6548	29108	6604	6173	27128	10365	51338	4122	51754	230	54997	79587	50854	4601	271	80097	978	80346	51604
GSE42088_UNINF_VS_LEISHMANIA_INF_DC_2H_UP	M9900		24808365	Favila MA,Geraci NS,Zeng E,Harker B,Condon D,Cotton RN,Jayakumar A,Tripathi V,McDowell MA	GSE42088	GSE42088_3823_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in dendritic cells: untreated versus 2h after infection of Leishmania major.	Leishmania major infected human dendritic cells (DCs) exhibit a marked induction of IL-12 ultimately promoting a robust Th1-mediated response associated with parasite killing and protective immunity. In this study, we utilized Affymetrix Genechips to globally assess the host cell genes and pathways associated with L. major infection during early infection (2, 4, 8, and 24 hrs) in human myeloid-derived DCs. Bioinformatic analyses of the hybridized microarray chips identified 728 genes, represented by 848 unique probe sets, which, when compared to uninfected samples were observed to be significantly differentially expressed by one-way ANOVA. Altogether, the data provide a genome-wide perspective on the transcriptional influences Leishmania species exert within human DCs during early infection, and provides a platform for further investigations toward functionally characterizing candidate genes of importance to the IL-12 based immune response to infections. In the current study, we further investigate the L. major infected DC transcriptional during early time points after infection via microarray analysis.					4323	79931	55686	51232	4216	10148	5327	205	6507	3624	8568	3601	55795	10000	5238	5954	9322	5316	23590	7107	6374	661	55750	4234	4496	3569	29927	4493	9021	4047	10606	116496	5361	51334	6372	7295	58516	3329	2664	4501	57823	645745	29949	3326	7980	2673	26298	6624	5872	3593	6924	22836	4502	10538	4830	51150	3696	2618	1662	2919	9659	5533	1594	54517	5962	56300	10963	114897	1577	23362	1476	4891	5687	10979	27032	29925	9832	3620	840	4319	48	8837	29968	9933	7296	718	51561	56061	186	27351	4494	7035	441024	9904	308	10591	4693	54662	9662	9817	960	4145	1047	51399	8451	29967	57579	7415	10090	3312	3559	122704	23511	347902	7293	4312	85377	1440	7268	91752	51154	9966	6690	705	4217	4828	2321	6483	4495	79693	51703	23016	27074	3843	23480	5684	79794	3576	3321	1687	26010	1193	29959	4779	27299	3269	55884	9371	4763	55848	5688	55379	9734	9242	11047	6654	10598	11009	5707	3336	6253	79970	7158	2887	6310	64089	4189	5052	375790	6307	57089	11153	2288	5218	57149	9701	51765	23462	8710	400	11343	10254	5795	5686	80013	10539	9435	55500	10282	51606	100507436	26750	4643	3183	1437	56005	272	5425	55194	9129
GSE42088_UNINF_VS_LEISHMANIA_INF_DC_2H_DN	M9901		24808365	Favila MA,Geraci NS,Zeng E,Harker B,Condon D,Cotton RN,Jayakumar A,Tripathi V,McDowell MA	GSE42088	GSE42088_3823_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in dendritic cells: untreated versus 2h after infection of Leishmania major.	Leishmania major infected human dendritic cells (DCs) exhibit a marked induction of IL-12 ultimately promoting a robust Th1-mediated response associated with parasite killing and protective immunity. In this study, we utilized Affymetrix Genechips to globally assess the host cell genes and pathways associated with L. major infection during early infection (2, 4, 8, and 24 hrs) in human myeloid-derived DCs. Bioinformatic analyses of the hybridized microarray chips identified 728 genes, represented by 848 unique probe sets, which, when compared to uninfected samples were observed to be significantly differentially expressed by one-way ANOVA. Altogether, the data provide a genome-wide perspective on the transcriptional influences Leishmania species exert within human DCs during early infection, and provides a platform for further investigations toward functionally characterizing candidate genes of importance to the IL-12 based immune response to infections. In the current study, we further investigate the L. major infected DC transcriptional during early time points after infection via microarray analysis.					2219	1441	3385	10123	200315	2124	1997	79890	51386	3148	11314	59307	83716	8665	6209	6159	8021	969	6169	689	671	2354	6207	2353	1880	6154	57132	7056	6152	9592	8667	240	5165	4736	4666	4929	6155	9314	83955	7538	6205	8638	3164	54997	7099	9045	79974	6161	6428	6146	1524	1052	51744	56905	6275	6036	1396	6167	6129	2000	5204	6204	10399	1937	29777	10412	2591	6203	5423	6234	114034	10365	60490	7311	6156	6160	6286	3646	2153	334	26136	6147	3490	10078	6173	6130	6201	5914	6604	80022	6135	2197	3695	29997	6398	6202	2091	9409	433	1843	1105	6128	10695	1975	221692	1831	6143	51170	29896	24140	3726	51187	10581	5023	6210	6432	753	8409	10023	63877	6431	8407	51763	7852	9013	1025	6281	6217	6158	51274	7091	6854	9368	2185	7803	120	6137	6157	1649	6229	6144	6132	10903	29116	10982	5621	10410	51646	9398	1938	6222	4974	84124	79364	3384	10491	64127	5295	53827	23223	7086	10911	683	951	6235	23012	10175	25949	51082	3727	27202	6134	6615	25873	4750	5355	55013	6124	22861	93144	301	6653	3858	6439	4033	6165	3034	23564	4048	54861	6139	7090	56998	285830	22856	29890	4210	11224	4208	55056
GSE42088_UNINF_VS_LEISHMANIA_INF_DC_4H_UP	M9903		24808365	Favila MA,Geraci NS,Zeng E,Harker B,Condon D,Cotton RN,Jayakumar A,Tripathi V,McDowell MA	GSE42088	GSE42088_3824_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in dendritic cells: untreated versus 4h after infection of Leishmania major.	Leishmania major infected human dendritic cells (DCs) exhibit a marked induction of IL-12 ultimately promoting a robust Th1-mediated response associated with parasite killing and protective immunity. In this study, we utilized Affymetrix Genechips to globally assess the host cell genes and pathways associated with L. major infection during early infection (2, 4, 8, and 24 hrs) in human myeloid-derived DCs. Bioinformatic analyses of the hybridized microarray chips identified 728 genes, represented by 848 unique probe sets, which, when compared to uninfected samples were observed to be significantly differentially expressed by one-way ANOVA. Altogether, the data provide a genome-wide perspective on the transcriptional influences Leishmania species exert within human DCs during early infection, and provides a platform for further investigations toward functionally characterizing candidate genes of importance to the IL-12 based immune response to infections. In the current study, we further investigate the L. major infected DC transcriptional during early time points after infection via microarray analysis.					375790	7107	23102	4047	1594	6507	6367	7295	55848	29967	51232	2673	6307	55686	64771	1476	2717	4363	5962	2744	3593	7296	9659	1368	4693	57045	7360	10102	4891	64761	203068	6624	116496	10591	27074	59349	56951	8544	10148	55697	6483	7357	7293	58472	9817	64398	79712	48	51400	813	6310	4216	3290	9546	4643	55741	5092	5872	4758	23180	4779	967	2495	50807	7474	8829	5052	5033	675	4744	11282	79970	2820	154881	26298	51606	9321	23396	4023	1116	5693	1593	5361	83637	3315	79365	57798	11343	54981	57720	23590	83937	3601	8615	63874	7941	941	27032	4360	3984	10651	3482	3624	55026	4026	9397	2224	23613	54662	63899	1203	8568	9322	966	3301	1389	3783	9766	29937	55755	1728	6767	9204	10626	2730	55704	23008	23596	84656	64108	51466	2802	4430	25932	9701	5226	55856	30835	8888	151011	9827	23657	53343	23461	221749	6383	10908	113878	58533	81627	10963	29844	975	55884	285203	4286	64759	231	57823	7039	374354	1718	29959	25800	4128	7415	7804	529	11147	51567	9031	9462	114897	171220	9793	5066	7226	1514	7767	29992	3326	10383	411	5707	5819	51347	5826	51103	23384	23179	56339	622	1193	1459	23511	11345	2947	55240	23274	10498
GSE42088_UNINF_VS_LEISHMANIA_INF_DC_4H_DN	M9907		24808365	Favila MA,Geraci NS,Zeng E,Harker B,Condon D,Cotton RN,Jayakumar A,Tripathi V,McDowell MA	GSE42088	GSE42088_3824_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in dendritic cells: untreated versus 4h after infection of Leishmania major.	Leishmania major infected human dendritic cells (DCs) exhibit a marked induction of IL-12 ultimately promoting a robust Th1-mediated response associated with parasite killing and protective immunity. In this study, we utilized Affymetrix Genechips to globally assess the host cell genes and pathways associated with L. major infection during early infection (2, 4, 8, and 24 hrs) in human myeloid-derived DCs. Bioinformatic analyses of the hybridized microarray chips identified 728 genes, represented by 848 unique probe sets, which, when compared to uninfected samples were observed to be significantly differentially expressed by one-way ANOVA. Altogether, the data provide a genome-wide perspective on the transcriptional influences Leishmania species exert within human DCs during early infection, and provides a platform for further investigations toward functionally characterizing candidate genes of importance to the IL-12 based immune response to infections. In the current study, we further investigate the L. major infected DC transcriptional during early time points after infection via microarray analysis.					7852	1843	3385	6144	1441	3727	3119	79890	219654	6205	4846	6160	84124	3137	29997	1198	6135	23710	1831	694	5366	1975	6207	10365	9730	1937	114034	6132	3148	25976	8667	951	8897	6430	51386	969	200315	57132	9595	6217	1997	9846	7311	6169	3384	54861	63976	8698	166	900	689	2197	57018	6129	4929	4601	6167	293	4666	3115	8314	51187	6161	93144	6156	59307	6045	6202	6428	6176	3134	6223	51646	5094	51763	10903	56548	1675	6210	10399	2166	4208	6235	81631	23645	54855	6170	6286	5734	10994	824	6222	2000	6157	57596	6229	5621	5743	7803	50854	7376	6181	7071	6165	6672	5152	54210	8761	114881	8665	54956	64221	1153	6158	146562	5018	9448	3122	6793	8676	10123	2354	22861	6164	7032	3164	1604	4914	1589	3646	3120	2634	220972	83463	6141	54504	10294	7874	120	54545	6155	6134	10235	100129128	972	51185	6744	417	23521	8638	51307	6191	644068	1936	6201	51754	9878	10961	6154	5829	25823	5912	671	5606	6208	5008	27230	6137	6339	29115	2064	79647	3872	2185	10291	6203	3699	79706	5914	1654	7099	10869	81492	6146	51744	79364	54758	55544	4640	59342	10410	9138	3784	5859	6604	362	3475	60490	23787	7832
GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_UP	M9909		24808365	Favila MA,Geraci NS,Zeng E,Harker B,Condon D,Cotton RN,Jayakumar A,Tripathi V,McDowell MA	GSE42088	GSE42088_3825_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in dendritic cells: untreated versus 8h after infection of Leishmania major.	Leishmania major infected human dendritic cells (DCs) exhibit a marked induction of IL-12 ultimately promoting a robust Th1-mediated response associated with parasite killing and protective immunity. In this study, we utilized Affymetrix Genechips to globally assess the host cell genes and pathways associated with L. major infection during early infection (2, 4, 8, and 24 hrs) in human myeloid-derived DCs. Bioinformatic analyses of the hybridized microarray chips identified 728 genes, represented by 848 unique probe sets, which, when compared to uninfected samples were observed to be significantly differentially expressed by one-way ANOVA. Altogether, the data provide a genome-wide perspective on the transcriptional influences Leishmania species exert within human DCs during early infection, and provides a platform for further investigations toward functionally characterizing candidate genes of importance to the IL-12 based immune response to infections. In the current study, we further investigate the L. major infected DC transcriptional during early time points after infection via microarray analysis.					6447	4499	79931	7980	51334	10544	6624	4693	55686	4323	4495	910	6507	55240	645745	4493	23043	30835	100507436	8544	51232	6769	5872	913	1594	7371	79365	4496	29967	56833	55299	6369	4494	4501	4643	4360	56938	27299	55151	4830	4128	51474	5334	5361	4301	10148	10606	6372	6374	375790	4502	8829	23768	475	1824	6346	10630	79135	23078	55848	55755	29104	5693	2618	126231	91752	53	4234	6367	1116	54512	1154	203068	4053	1368	55757	51154	1389	6363	3620	83637	4744	909	10940	64943	10885	718	2203	51186	54517	57228	25903	5168	26585	51760	2213	2288	911	80746	400	145389	50856	2717	10585	4763	8577	7804	23212	4047	7045	2934	4318	80010	8578	151011	10419	57447	7037	5360	8569	84656	55110	79876	23613	3290	79712	79624	48	81831	10563	5471	26005	25895	6361	55277	2530	5266	10243	4907	79080	11188	55435	2335	10062	3624	27032	114897	3320	55353	9562	27036	10549	975	11309	2119	7474	2919	23095	1479	84890	8091	23556	26010	4094	10102	25800	8836	374354	7358	10773	533	2512	6812	79630	1718	7107	6253	8714	63920	27074	3312	10165	10383	5031	63899	11326	2630	4319	9197	1593	27068	5791	84658	10651	5578	1497	5437	24147	55697	64759
GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_DN	M9910		24808365	Favila MA,Geraci NS,Zeng E,Harker B,Condon D,Cotton RN,Jayakumar A,Tripathi V,McDowell MA	GSE42088	GSE42088_3825_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in dendritic cells: untreated versus 8h after infection of Leishmania major.	Leishmania major infected human dendritic cells (DCs) exhibit a marked induction of IL-12 ultimately promoting a robust Th1-mediated response associated with parasite killing and protective immunity. In this study, we utilized Affymetrix Genechips to globally assess the host cell genes and pathways associated with L. major infection during early infection (2, 4, 8, and 24 hrs) in human myeloid-derived DCs. Bioinformatic analyses of the hybridized microarray chips identified 728 genes, represented by 848 unique probe sets, which, when compared to uninfected samples were observed to be significantly differentially expressed by one-way ANOVA. Altogether, the data provide a genome-wide perspective on the transcriptional influences Leishmania species exert within human DCs during early infection, and provides a platform for further investigations toward functionally characterizing candidate genes of importance to the IL-12 based immune response to infections. In the current study, we further investigate the L. major infected DC transcriptional during early time points after infection via microarray analysis.					8708	29803	80011	54808	8395	2122	5601	3452	10036	81491	56918	57399	225	56924	50489	7476	23626	10458	22953	6293	314	55184	3562	83452	5919	79634	55388	79133	95681	4760	3763	90011	6645	54762	9865	1490	5673	56242	55526	131544	92483	9098	79730	81931	404093	27445	5098	79933	9200	346157	54465	57282	55888	10577	9319	9210	8792	411	728142	7592	9697	27239	6120	53353	7594	4137	818	8994	322	4703	26575	79057	1004	1244	10243	89795	7733	57343	9682	64344	79612	6550	100287076	54622	6857	4261	26263	5660	5741	4103	55288	284217	478	10325	4070	5071	1549	56992	22981	9586	5210	50848	51626	2556	51454	10149	1446	23503	51594	3257	55805	10038	51449	91775	55676	1200	55752	27179	84612	83440	4782	9555	5998	100287008	23552	25859	8352	9891	51307	9705	5422	54904	2065	9016	353189	8913	9001	2917	56955	440348	57509	5176	1182	5145	27094	658	55217	90865	154796	22897	240	3851	326	5357	5175	10493	54538	23623	63876	54545	4212	8526	1671	3587	139081	10214	4887	55266	3664	1300	80206	667	1787	9627	9949	55293	91120	4923	22852	55106	56252	2876	3459	2335	55105	5338	79834	1911	57698	57007	5697	29802	6649	374868	83447	9653	140462	8633	26960	25937
GSE42088_2H_VS_24H_LEISHMANIA_INF_DC_DN	M9912		24808365	Favila MA,Geraci NS,Zeng E,Harker B,Condon D,Cotton RN,Jayakumar A,Tripathi V,McDowell MA	GSE42088	GSE42088_3827_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in dendritic cells infected by Leishmania major: 2h versus 24h.	Leishmania major infected human dendritic cells (DCs) exhibit a marked induction of IL-12 ultimately promoting a robust Th1-mediated response associated with parasite killing and protective immunity. In this study, we utilized Affymetrix Genechips to globally assess the host cell genes and pathways associated with L. major infection during early infection (2, 4, 8, and 24 hrs) in human myeloid-derived DCs. Bioinformatic analyses of the hybridized microarray chips identified 728 genes, represented by 848 unique probe sets, which, when compared to uninfected samples were observed to be significantly differentially expressed by one-way ANOVA. Altogether, the data provide a genome-wide perspective on the transcriptional influences Leishmania species exert within human DCs during early infection, and provides a platform for further investigations toward functionally characterizing candidate genes of importance to the IL-12 based immune response to infections. In the current study, we further investigate the L. major infected DC transcriptional during early time points after infection via microarray analysis.					2516	6755	3238	4880	27180	3290	26015	2172	7786	2170	100287204	9351	26024	10380	56899	79844	4832	4998	4693	6455	57626	98	8425	28	256949	25961	2668	4985	80072	57180	90121	3887	2593	1954	1241	9904	27158	7542	5908	54386	4058	26648	3298	63941	1381	284800	1627	100293679	23660	2875	100287590	5192	2300	3783	4861	2444	25876	23614	4357	51480	81858	8557	26227	9217	7553	5540	91369	8310	7036	55111	5127	283871	54345	1113	246243	23143	23218	3467	26073	57664	78997	26873	23547	8674	10656	10316	79943	1264	29780	7727	79078	3980	1154	9883	83714	10850	26097	113612	8330	366	27329	57149	9056	1609	10102	23359	6302	11162	79712	9684	23483	10758	55210	1616	8368	28227	51193	79183	3933	5209	58477	2159	7107	9366	400410	55095	27019	80778	5558	23245	3614	7415	5281	11047	26108	340591	23327	6580	51077	10135	6611	9719	59335	10924	78996	1066	22893	701	56941	7064	80222	610	11332	6278	10171	4796	165	148022	27178	10078	54939	5064	375449	1659	54972	56969	5783	83445	2996	10289	5420	23254	27121	81553	10954	4007	7350	64170	898	51154	9175	5711	59349	1917	5074	430	6832	113457	190	991	84991	26276	5232	23423	1525	54867	5153	5806	3804	79946
GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_UP	M9953		26405566	Haymaker CL,Wu RC,Ritthipichai K,Bernatchez C,Forget MA,Chen JQ,Liu H,Wang E,Marincola F,Hwu P,Radvanyi LG	GSE43260	GSE43260_3423_200_UP			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes up-regulated in tumor-infiltrating CD8 T cells: BTLA+ [GeneID=151888] versus BTLA- [GeneID=151888].	Adoptive T-cell Therapy (ACT) involves using tumor-infiltrating lymphocytes (TIL) isolated from metastatic melanoma and expanding them ex vivo prior to infusion into lympho-depleted patients. This is one of the most promising approaches to treat metastatic melanoma, with the rates of clinical response between 48-50% based on studies done at NCI, M.D. Anderson Cancer Center (Houston, TX), and Sheba Medical Center (Tel Aviv, Israel). In the Phase II ACT Trial at M.D. Anderson Cancer Center , our group has uncovered an association between positive clinical response and the amount of CD8+ tumor-infiltrating lymphocytes expressing B and T Lymphocyte Attenuator (BTLA), a reported inhibitory receptor on T-cells. We used microarrays to detail the differences in the global programme of gene expression between CD8+BTLA+ vs CD8+BTLA- TILs in order to understand the molecular basis of the clinical association.					9535	10626	5252	6184	23223	10553	54732	1857	4864	3695	9114	967	5238	6286	1164	6428	5713	7184	9454	2205	7415	9874	58528	5928	302	10105	2923	9853	4000	2203	6238	7419	115353	90411	9601	4854	3192	11014	9871	2012	1981	706	7328	2647	23760	9817	55651	6811	6675	5306	226	115	23192	11047	2219	11006	51020	3073	1535	4713	7016	64061	2730	10457	5900	3725	6047	6923	4849	5901	6617	3654	5717	10134	127703	206358	832	123	53635	527	2077	79109	10971	8560	2673	5034	3689	5447	9842	241	8439	9658	10184	11153	2896	5714	10589	4069	6793	645	9788	6036	7922	5805	23216	6396	5468	9332	2107	8878	2936	1728	3109	10615	23210	3162	3916	2184	9936	1785	9120	2801	51096	23061	64764	8225	4924	7307	1662	3265	7468	79036	682	8061	79171	22862	9694	50999	8544	3054	4521	3603	5007	10525	10975	11273	94039	7353	5125	1509	22980	2696	2950	3831	11231	826	3309	8623	22919	7850	4481	813	10939	10130	4735	5479	6150	6039	2286	2729	1514	10484	200081	1066	3678	313	2987	10440	2551	6275	22872	56005	5702	4694	10952	10007	23275	25998	8459	440026	2130	154881	10567	4904	9917	64112	955	27095	7035	211
GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_DN	M9954		26405566	Haymaker CL,Wu RC,Ritthipichai K,Bernatchez C,Forget MA,Chen JQ,Liu H,Wang E,Marincola F,Hwu P,Radvanyi LG	GSE43260	GSE43260_3423_200_DN			HUMAN_GENE_SYMBOL	Jernej Godec	Nick Haining lab (DFCI)	Genes down-regulated in tumor-infiltrating CD8 T cells: BTLA+ [GeneID=151888] versus BTLA- [GeneID=151888].	Adoptive T-cell Therapy (ACT) involves using tumor-infiltrating lymphocytes (TIL) isolated from metastatic melanoma and expanding them ex vivo prior to infusion into lympho-depleted patients. This is one of the most promising approaches to treat metastatic melanoma, with the rates of clinical response between 48-50% based on studies done at NCI, M.D. Anderson Cancer Center (Houston, TX), and Sheba Medical Center (Tel Aviv, Israel). In the Phase II ACT Trial at M.D. Anderson Cancer Center , our group has uncovered an association between positive clinical response and the amount of CD8+ tumor-infiltrating lymphocytes expressing B and T Lymphocyte Attenuator (BTLA), a reported inhibitory receptor on T-cells. We used microarrays to detail the differences in the global programme of gene expression between CD8+BTLA+ vs CD8+BTLA- TILs in order to understand the molecular basis of the clinical association.					6210	100507436	5311	5562	5909	22926	9618	5018	7556	399979	2022	4502	8449	1557	2074	137886	7728	3133	2271	498	23028	203068	5423	4067	3716	23180	4905	2321	3211	5194	9791	51433	23125	22930	6202	79882	65108	10907	9973	27348	5771	100	9918	2119	3017	5439	25787	4627	1207	8344	6259	6744	81553	11277	10228	23048	10412	6903	2182	377	214	2631	131544	6741	3593	8342	6934	10423	11056	2939	5218	7128	7321	5162	11157	27235	352961	9690	26035	2098	60496	191	4005	8340	8651	114932	1936	5532	6522	8884	3476	8368	54505	6732	30	7107	23071	8346	5281	6450	10512	3030	5977	11097	223	1040	7741	9849	8507	6528	3615	2132	9371	26986	9812	2739	7813	4729	5710	157567	8417	58495	6827	1938	24145	4126	8341	7355	27074	6175	11031	8349	11331	23401	23335	8030	7130	6187	8031	85236	509	6139	7752	9094	10443	10395	6687	10865	9308	22863	10758	6176	4489	8402	7903	4217	5795	27309	8916	1196	10399	56890	10252	3655	4552	7988	2124	8347	5351	10128	3140	8879	23598	5965	1992	11215	10477	10938	4673	262	9519	23341	6480	3566	116138	5147	9702	8343	1282	1806	51035	10559	6775	54556	114548	7584	6990	113419	127544	1431
